id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
163039948|NCT03638466|588855847|FG000|Overall Study|Early Termination|0|||
163039949|NCT03638466|588855848|FG001|Overall Study|Early Termination|1|||
163039950|NCT02576977|588855849|FG000|Overall Study|Adverse Event|13|||
163039951|NCT02576977|588855850|FG001|Overall Study|Adverse Event|2|||
163039952|NCT02576977|588855849|FG000|Overall Study|Death|73|||
163039953|NCT02576977|588855850|FG001|Overall Study|Death|60|||
163039954|NCT02576977|588855849|FG000|Overall Study|Screen failure|1|||
163039955|NCT02576977|588855850|FG001|Overall Study|Screen failure|0|||
163039956|NCT02576977|588855849|FG000|Overall Study|Study Terminated at Selected Sites|27|||
163039957|NCT02576977|588855850|FG001|Overall Study|Study Terminated at Selected Sites|50|||
163039958|NCT02576977|588855849|FG000|Overall Study|Withdrawal by Subject|11|||
163039959|NCT02576977|588855850|FG001|Overall Study|Withdrawal by Subject|11|||
163039960|NCT02576977|588855849|FG000|Overall Study|Final Disposition Unknown|0|||
163039961|NCT02576977|588855850|FG001|Overall Study|Final Disposition Unknown|1|||
163039962|NCT02576977|588855849|FG000|Overall Study|Lost to Follow-up|1|||
163039963|NCT02576977|588855850|FG001|Overall Study|Lost to Follow-up|0|||
163039964|NCT02576977|588855849|FG000|Overall Study|Progressive Disease|0|||
163039965|NCT02576977|588855850|FG001|Overall Study|Progressive Disease|1|||
163039966|NCT02447328|588855855|FG000|Overall Study|Withdrawal by Subject|1|||
163039967|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
163039968|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
163039969|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
163039970|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
162925581|NCT01607398|588430331|FG000|Overall Study|Adverse Event|0|||
163039971|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
163039972|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039973|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039974|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
163039975|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
163039976|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
163039977|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
163039978|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
163039979|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
163039980|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039981|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039982|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
163039983|NCT02362425|588855856|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
163039984|NCT02362425|588855857|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
163039985|NCT02362425|588855858|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
163039986|NCT02362425|588855859|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
163039987|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039988|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039989|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
163039990|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
163039991|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039992|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039993|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
163039994|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
163039995|NCT02362425|588855856|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039996|NCT02362425|588855857|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039997|NCT02362425|588855858|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
163039998|NCT02362425|588855859|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
163039999|NCT02688764|588855869|FG000|Overall Study|Adverse Event|3|||
163040000|NCT02688764|588855870|FG001|Overall Study|Adverse Event|3|||
163040001|NCT02688764|588855869|FG000|Overall Study|AE/Kidney transplant|1|||
163040002|NCT02688764|588855870|FG001|Overall Study|AE/Kidney transplant|0|||
163040003|NCT02688764|588855869|FG000|Overall Study|AE/Lack of efficacy|1|||
163040004|NCT02688764|588855870|FG001|Overall Study|AE/Lack of efficacy|0|||
163040005|NCT02688764|588855869|FG000|Overall Study|AE/Non-compl.|1|||
163040006|NCT02688764|588855870|FG001|Overall Study|AE/Non-compl.|0|||
163040007|NCT02688764|588855869|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
163040008|NCT02688764|588855870|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
163040009|NCT02688764|588855869|FG000|Overall Study|AE/Other|0|||
163040010|NCT02688764|588855870|FG001|Overall Study|AE/Other|1|||
163040011|NCT02688764|588855869|FG000|Overall Study|AE/Physician decision|1|||
163040012|NCT02688764|588855870|FG001|Overall Study|AE/Physician decision|0|||
163040013|NCT02688764|588855869|FG000|Overall Study|AE/Withd. parent|3|||
163040014|NCT02688764|588855870|FG001|Overall Study|AE/Withd. parent|0|||
163040015|NCT02688764|588855869|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
163040016|NCT02688764|588855870|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
163040017|NCT02688764|588855869|FG000|Overall Study|AE/Withd. subject|1|||
163154859|NCT02079246|589283631|FG000|OLEX|Withdrawal before treatment|1|||
163040018|NCT02688764|588855870|FG001|Overall Study|AE/Withd. subject|0|||
163040019|NCT02688764|588855869|FG000|Overall Study|Kidney transplant|10|||
163040020|NCT02688764|588855870|FG001|Overall Study|Kidney transplant|4|||
163040021|NCT02688764|588855869|FG000|Overall Study|Lack of Efficacy|3|||
163040022|NCT02688764|588855870|FG001|Overall Study|Lack of Efficacy|2|||
163040023|NCT02688764|588855869|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
163040024|NCT02688764|588855870|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
163040025|NCT02688764|588855869|FG000|Overall Study|Non-compliance with study drug|4|||
163040026|NCT02688764|588855870|FG001|Overall Study|Non-compliance with study drug|0|||
163040027|NCT02688764|588855869|FG000|Overall Study|Non-compl./Physician decision|2|||
163040028|NCT02688764|588855870|FG001|Overall Study|Non-compl./Physician decision|0|||
163040029|NCT02688764|588855869|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
163040030|NCT02688764|588855870|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
163040031|NCT02688764|588855869|FG000|Overall Study|Non-compl./Withd. subject|0|||
163040032|NCT02688764|588855870|FG001|Overall Study|Non-compl./Withd. subject|2|||
163040033|NCT02688764|588855869|FG000|Overall Study|Phosphorus level outside safe range|0|||
163040034|NCT02688764|588855870|FG001|Overall Study|Phosphorus level outside safe range|1|||
163040035|NCT02688764|588855869|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
163040036|NCT02688764|588855870|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
163040037|NCT02688764|588855869|FG000|Overall Study|Study drug taste/Withd. parent|1|||
163040038|NCT02688764|588855870|FG001|Overall Study|Study drug taste/Withd. parent|0|||
163040039|NCT02688764|588855869|FG000|Overall Study|Subject moving out|2|||
163040040|NCT02688764|588855870|FG001|Overall Study|Subject moving out|0|||
163040041|NCT02688764|588855869|FG000|Overall Study|Subject taken off dialysis|1|||
163040042|NCT02688764|588855870|FG001|Overall Study|Subject taken off dialysis|0|||
163040043|NCT02688764|588855869|FG000|Overall Study|Withdrawal by parent|3|||
163040044|NCT02688764|588855870|FG001|Overall Study|Withdrawal by parent|0|||
163040045|NCT02579382|588855871|FG000|Main Study Phase|Lost to Follow-up|0|||
163040046|NCT02579382|588855872|FG001|Main Study Phase|Lost to Follow-up|0|||
163040047|NCT02579382|588855873|FG002|Main Study Phase|Lost to Follow-up|2|||
163040048|NCT02579382|588855874|FG003|Main Study Phase|Lost to Follow-up|0|||
163040049|NCT02579382|588855871|FG000|Main Study Phase|Withdrew Consent|0|||
163040050|NCT02579382|588855872|FG001|Main Study Phase|Withdrew Consent|0|||
163040051|NCT02579382|588855873|FG002|Main Study Phase|Withdrew Consent|0|||
163040052|NCT02579382|588855874|FG003|Main Study Phase|Withdrew Consent|2|||
163040053|NCT02579382|588855871|FG000|Main Study Phase|Lack of Efficacy|0|||
163040054|NCT02579382|588855872|FG001|Main Study Phase|Lack of Efficacy|0|||
163040055|NCT02579382|588855873|FG002|Main Study Phase|Lack of Efficacy|0|||
163040056|NCT02579382|588855874|FG003|Main Study Phase|Lack of Efficacy|1|||
163040057|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
163040058|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
163040059|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
163040060|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
163040061|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
163040062|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
163040063|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
163040064|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
163040065|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
163040066|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040067|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040068|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
163040069|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040070|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
163040071|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040072|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
163040073|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
162810872|NCT02647320|588019975|FG000|Overall Study|Adverse Event|0|||
162810873|NCT02647320|588019976|FG001|Overall Study|Adverse Event|1|||
162810874|NCT02647320|588019977|FG002|Overall Study|Adverse Event|3|||
162810875|NCT02647320|588019978|FG003|Overall Study|Adverse Event|2|||
162810876|NCT02647320|588019979|FG004|Overall Study|Adverse Event|1|||
162925582|NCT01607398|588430332|FG001|Overall Study|Adverse Event|2|||
162925583|NCT01607398|588430331|FG000|Overall Study|Severe COPD|2|||
162925584|NCT01607398|588430332|FG001|Overall Study|Severe COPD|0|||
162925585|NCT01211613|588430333|FG000|Overall Study|Lost to Follow-up|2|||
162925586|NCT01211613|588430334|FG001|Overall Study|Lost to Follow-up|2|||
162925587|NCT01211613|588430335|FG002|Overall Study|Lost to Follow-up|2|||
162925588|NCT01211613|588430333|FG000|Overall Study|Withdrawal by Subject|1|||
162925589|NCT01211613|588430334|FG001|Overall Study|Withdrawal by Subject|0|||
162925590|NCT01211613|588430335|FG002|Overall Study|Withdrawal by Subject|0|||
162925591|NCT03853213|588430336|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
162925592|NCT03853213|588430337|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
163040074|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
163040075|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
163040076|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
163040077|NCT02579382|588855871|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040078|NCT02579382|588855872|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
163040079|NCT02579382|588855873|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040080|NCT02579382|588855874|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
163040081|NCT03026283|588855875|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
162925593|NCT03853213|588430336|FG000|Overall Study|Other (e.g., too busy)|0|||
162925594|NCT03853213|588430337|FG001|Overall Study|Other (e.g., too busy)|2|||
162925595|NCT03044431|588430340|FG000|Overall Study|Lost to Follow-up|59|||
162925596|NCT04470622|588430341|FG000|Overall Study|Withdrawal by Subject|0|||
162925597|NCT04470622|588430342|FG001|Overall Study|Withdrawal by Subject|1|||
162925598|NCT04470622|588430341|FG000|Overall Study|Screen Failure|0|||
163040082|NCT03026283|588855876|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
163040083|NCT03026283|588855877|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
163040084|NCT03026283|588855878|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
162925599|NCT04470622|588430342|FG001|Overall Study|Screen Failure|1|||
162925600|NCT04470622|588430341|FG000|Overall Study|Death|0|||
162925601|NCT04470622|588430342|FG001|Overall Study|Death|1|||
162925602|NCT02576054|588430345|FG000|Overall Study|Withdrawal by Subject|1|||
162925603|NCT00791154|588430346|FG000|Overall Study|Noncompliance|0|||
162925604|NCT00791154|588430347|FG001|Overall Study|Noncompliance|1|||
162925605|NCT00791154|588430348|FG002|Overall Study|Noncompliance|0|||
162925606|NCT00791154|588430349|FG003|Overall Study|Noncompliance|0|||
162925607|NCT00791154|588430350|FG004|Overall Study|Noncompliance|1|||
162925608|NCT00791154|588430351|FG005|Overall Study|Noncompliance|1|||
162925609|NCT00791154|588430352|FG006|Overall Study|Noncompliance|1|||
162925610|NCT00791154|588430346|FG000|Overall Study|Adverse Event|0|||
162925611|NCT00791154|588430347|FG001|Overall Study|Adverse Event|0|||
162925612|NCT00791154|588430348|FG002|Overall Study|Adverse Event|0|||
162925613|NCT00791154|588430349|FG003|Overall Study|Adverse Event|0|||
162925614|NCT00791154|588430350|FG004|Overall Study|Adverse Event|2|||
162925615|NCT00791154|588430351|FG005|Overall Study|Adverse Event|0|||
162925616|NCT00791154|588430352|FG006|Overall Study|Adverse Event|1|||
162925617|NCT00791154|588430346|FG000|Overall Study|Full Consent withdrawn|1|||
162925618|NCT00791154|588430347|FG001|Overall Study|Full Consent withdrawn|3|||
162925619|NCT00791154|588430348|FG002|Overall Study|Full Consent withdrawn|0|||
162925620|NCT00791154|588430349|FG003|Overall Study|Full Consent withdrawn|0|||
162925621|NCT00791154|588430350|FG004|Overall Study|Full Consent withdrawn|1|||
162925622|NCT00791154|588430351|FG005|Overall Study|Full Consent withdrawn|3|||
163040085|NCT03026283|588855879|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
163040086|NCT03026283|588855880|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
163040087|NCT03026283|588855881|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
162925623|NCT00791154|588430352|FG006|Overall Study|Full Consent withdrawn|1|||
162925624|NCT00791154|588430346|FG000|Overall Study|Lost to Follow-up|0|||
162925625|NCT00791154|588430347|FG001|Overall Study|Lost to Follow-up|0|||
162925626|NCT00791154|588430348|FG002|Overall Study|Lost to Follow-up|0|||
162925627|NCT00791154|588430349|FG003|Overall Study|Lost to Follow-up|1|||
162925628|NCT00791154|588430350|FG004|Overall Study|Lost to Follow-up|2|||
162925629|NCT00791154|588430351|FG005|Overall Study|Lost to Follow-up|0|||
162925630|NCT00791154|588430352|FG006|Overall Study|Lost to Follow-up|4|||
162925631|NCT00791154|588430346|FG000|Overall Study|Death|5|||
162925632|NCT00791154|588430347|FG001|Overall Study|Death|4|||
162925633|NCT00791154|588430348|FG002|Overall Study|Death|4|||
162925634|NCT00791154|588430349|FG003|Overall Study|Death|7|||
162925635|NCT00791154|588430350|FG004|Overall Study|Death|54|||
162925636|NCT00791154|588430351|FG005|Overall Study|Death|54|||
162925637|NCT00791154|588430352|FG006|Overall Study|Death|52|||
162925638|NCT00791154|588430346|FG000|Overall Study|Other event|0|||
162925639|NCT00791154|588430347|FG001|Overall Study|Other event|0|||
162925640|NCT00791154|588430348|FG002|Overall Study|Other event|2|||
163040088|NCT03026283|588855882|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
163040089|NCT03026283|588855875|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
163040090|NCT03026283|588855876|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
162925641|NCT00791154|588430349|FG003|Overall Study|Other event|0|||
162925642|NCT00791154|588430350|FG004|Overall Study|Other event|2|||
162925643|NCT00791154|588430351|FG005|Overall Study|Other event|4|||
163040091|NCT03026283|588855877|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
163040092|NCT03026283|588855878|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
163040093|NCT03026283|588855879|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
162810877|NCT02647320|588019975|FG000|Overall Study|Protocol Violation|0|||
163040094|NCT03026283|588855880|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
163040095|NCT03026283|588855881|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
162925644|NCT00791154|588430352|FG006|Overall Study|Other event|2|||
162925645|NCT00953927|588430353|FG000|Overall Study|Lost to Follow-up|61|||
162925646|NCT00953927|588430354|FG001|Overall Study|Lost to Follow-up|65|||
163040096|NCT03026283|588855882|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
163040097|NCT03026283|588855875|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040098|NCT03026283|588855876|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
163040099|NCT03026283|588855877|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040100|NCT03026283|588855878|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040101|NCT03026283|588855879|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040102|NCT03026283|588855880|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040103|NCT03026283|588855881|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040104|NCT03026283|588855882|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
163040105|NCT03026283|588855875|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040106|NCT03026283|588855876|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040107|NCT03026283|588855877|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
163040108|NCT03026283|588855878|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040109|NCT03026283|588855879|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040110|NCT03026283|588855880|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040111|NCT03026283|588855881|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040112|NCT03026283|588855882|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
163040113|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040114|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040115|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040116|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
163040117|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
163040118|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040119|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040120|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
163040121|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040122|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040123|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040124|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
163040125|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
163040126|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
163040127|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040128|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
163040129|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040130|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040131|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040132|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
163040133|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040134|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
163040135|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040136|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
163040137|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040138|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040139|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040140|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
163040141|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040142|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040143|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040144|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
163040145|NCT03026283|588855875|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040146|NCT03026283|588855876|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040147|NCT03026283|588855877|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040148|NCT03026283|588855878|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040149|NCT03026283|588855879|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
163040150|NCT03026283|588855880|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
163040151|NCT03026283|588855881|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040152|NCT03026283|588855882|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
163040153|NCT00824655|588855883|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
163040154|NCT00824655|588855884|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
163040155|NCT00824655|588855883|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
163040156|NCT00824655|588855884|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
163040157|NCT02906579|588855891|FG000|Overall Study|Adverse Event|1|||
162696272|NCT00603265|587599456|FG000|Overall Study|Adverse Event|2|||
163040158|NCT02906579|588855891|FG000|Overall Study|Physician Decision|1|||
163040159|NCT01826981|588855892|FG000|Overall Study|Lack of Efficacy|0|||
163040160|NCT01826981|588855893|FG001|Overall Study|Lack of Efficacy|1|||
163040161|NCT01826981|588855894|FG002|Overall Study|Lack of Efficacy|0|||
163040162|NCT01826981|588855895|FG003|Overall Study|Lack of Efficacy|0|||
163040163|NCT01826981|588855896|FG004|Overall Study|Lack of Efficacy|5|||
163040164|NCT01826981|588855897|FG005|Overall Study|Lack of Efficacy|0|||
163040165|NCT01826981|588855898|FG006|Overall Study|Lack of Efficacy|0|||
163040166|NCT01826981|588855899|FG007|Overall Study|Lack of Efficacy|8|||
163040167|NCT01826981|588855900|FG008|Overall Study|Lack of Efficacy|7|||
163040168|NCT01826981|588855901|FG009|Overall Study|Lack of Efficacy|0|||
163040169|NCT01826981|588855902|FG010|Overall Study|Lack of Efficacy|1|||
163040170|NCT01826981|588855903|FG011|Overall Study|Lack of Efficacy|0|||
163040171|NCT01826981|588855904|FG012|Overall Study|Lack of Efficacy|0|||
163040172|NCT01826981|588855905|FG013|Overall Study|Lack of Efficacy|3|||
163040173|NCT01826981|588855906|FG014|Overall Study|Lack of Efficacy|0|||
163040174|NCT01826981|588855892|FG000|Overall Study|Lost to Follow-up|0|||
163040175|NCT01826981|588855893|FG001|Overall Study|Lost to Follow-up|0|||
163040176|NCT01826981|588855894|FG002|Overall Study|Lost to Follow-up|0|||
163040177|NCT01826981|588855895|FG003|Overall Study|Lost to Follow-up|0|||
163040178|NCT01826981|588855896|FG004|Overall Study|Lost to Follow-up|1|||
163040179|NCT01826981|588855897|FG005|Overall Study|Lost to Follow-up|1|||
163040180|NCT01826981|588855898|FG006|Overall Study|Lost to Follow-up|0|||
163040181|NCT01826981|588855899|FG007|Overall Study|Lost to Follow-up|1|||
163040182|NCT01826981|588855900|FG008|Overall Study|Lost to Follow-up|0|||
163040183|NCT01826981|588855901|FG009|Overall Study|Lost to Follow-up|1|||
163040184|NCT01826981|588855902|FG010|Overall Study|Lost to Follow-up|1|||
163040185|NCT01826981|588855903|FG011|Overall Study|Lost to Follow-up|1|||
163040186|NCT01826981|588855904|FG012|Overall Study|Lost to Follow-up|1|||
163040187|NCT01826981|588855905|FG013|Overall Study|Lost to Follow-up|0|||
163040188|NCT01826981|588855906|FG014|Overall Study|Lost to Follow-up|0|||
163040189|NCT01826981|588855892|FG000|Overall Study|Withdrew Consent|0|||
163040190|NCT01826981|588855893|FG001|Overall Study|Withdrew Consent|0|||
163040191|NCT01826981|588855894|FG002|Overall Study|Withdrew Consent|0|||
163040192|NCT01826981|588855895|FG003|Overall Study|Withdrew Consent|0|||
163040193|NCT01826981|588855896|FG004|Overall Study|Withdrew Consent|0|||
163040194|NCT01826981|588855897|FG005|Overall Study|Withdrew Consent|0|||
163040195|NCT01826981|588855898|FG006|Overall Study|Withdrew Consent|1|||
163040196|NCT01826981|588855899|FG007|Overall Study|Withdrew Consent|1|||
163040197|NCT01826981|588855900|FG008|Overall Study|Withdrew Consent|0|||
163040198|NCT01826981|588855901|FG009|Overall Study|Withdrew Consent|0|||
163040199|NCT01826981|588855902|FG010|Overall Study|Withdrew Consent|0|||
163040200|NCT01826981|588855903|FG011|Overall Study|Withdrew Consent|1|||
163040201|NCT01826981|588855904|FG012|Overall Study|Withdrew Consent|0|||
163040202|NCT01826981|588855905|FG013|Overall Study|Withdrew Consent|1|||
163040203|NCT01826981|588855906|FG014|Overall Study|Withdrew Consent|0|||
163040204|NCT01826981|588855892|FG000|Overall Study|Adverse Event|0|||
163040205|NCT01826981|588855893|FG001|Overall Study|Adverse Event|0|||
163040206|NCT01826981|588855894|FG002|Overall Study|Adverse Event|0|||
163040207|NCT01826981|588855895|FG003|Overall Study|Adverse Event|0|||
163040208|NCT01826981|588855896|FG004|Overall Study|Adverse Event|1|||
163040209|NCT01826981|588855897|FG005|Overall Study|Adverse Event|0|||
163040210|NCT01826981|588855898|FG006|Overall Study|Adverse Event|0|||
163040211|NCT01826981|588855899|FG007|Overall Study|Adverse Event|0|||
163040212|NCT01826981|588855900|FG008|Overall Study|Adverse Event|0|||
163040213|NCT01826981|588855901|FG009|Overall Study|Adverse Event|0|||
163040214|NCT01826981|588855902|FG010|Overall Study|Adverse Event|0|||
163040215|NCT01826981|588855903|FG011|Overall Study|Adverse Event|0|||
163040216|NCT01826981|588855904|FG012|Overall Study|Adverse Event|0|||
163040217|NCT01826981|588855905|FG013|Overall Study|Adverse Event|0|||
163040218|NCT01826981|588855906|FG014|Overall Study|Adverse Event|0|||
163040219|NCT01826981|588855892|FG000|Overall Study|Upper G-I Haemorrhage|0|||
163040220|NCT01826981|588855893|FG001|Overall Study|Upper G-I Haemorrhage|0|||
163040221|NCT01826981|588855894|FG002|Overall Study|Upper G-I Haemorrhage|0|||
162810878|NCT02647320|588019976|FG001|Overall Study|Protocol Violation|0|||
162810879|NCT02647320|588019977|FG002|Overall Study|Protocol Violation|3|||
163040222|NCT01826981|588855895|FG003|Overall Study|Upper G-I Haemorrhage|0|||
163040223|NCT01826981|588855896|FG004|Overall Study|Upper G-I Haemorrhage|0|||
163040224|NCT01826981|588855897|FG005|Overall Study|Upper G-I Haemorrhage|0|||
163040225|NCT01826981|588855898|FG006|Overall Study|Upper G-I Haemorrhage|0|||
163040226|NCT01826981|588855899|FG007|Overall Study|Upper G-I Haemorrhage|0|||
163040227|NCT01826981|588855900|FG008|Overall Study|Upper G-I Haemorrhage|0|||
163040228|NCT01826981|588855901|FG009|Overall Study|Upper G-I Haemorrhage|0|||
163040229|NCT01826981|588855902|FG010|Overall Study|Upper G-I Haemorrhage|0|||
163040230|NCT01826981|588855903|FG011|Overall Study|Upper G-I Haemorrhage|0|||
163040231|NCT01826981|588855904|FG012|Overall Study|Upper G-I Haemorrhage|0|||
163040232|NCT01826981|588855905|FG013|Overall Study|Upper G-I Haemorrhage|1|||
163040233|NCT01826981|588855906|FG014|Overall Study|Upper G-I Haemorrhage|0|||
163040234|NCT01826981|588855892|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040235|NCT01826981|588855893|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040236|NCT01826981|588855894|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040237|NCT01826981|588855895|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040238|NCT01826981|588855896|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040239|NCT01826981|588855897|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040240|NCT01826981|588855898|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040241|NCT01826981|588855899|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
163040242|NCT01826981|588855900|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040243|NCT01826981|588855901|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040244|NCT01826981|588855902|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040245|NCT01826981|588855903|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040246|NCT01826981|588855904|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040247|NCT01826981|588855905|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040248|NCT01826981|588855906|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
163040249|NCT00759655|588855907|FG000|Overall Study|Termination of the study by sponsor|1|||
163040250|NCT02753816|588855910|FG000|Overall Study|Protocol Violation|0|||
163040251|NCT02753816|588855911|FG001|Overall Study|Protocol Violation|1|||
163040252|NCT02753816|588855912|FG002|Overall Study|Protocol Violation|0|||
163040253|NCT01704755|588855915|FG000|Overall Study|Adverse Event|4|||
163040254|NCT01704755|588855916|FG001|Overall Study|Adverse Event|1|||
163040255|NCT01704755|588855915|FG000|Overall Study|Lost to Follow-up|3|||
163040256|NCT01704755|588855916|FG001|Overall Study|Lost to Follow-up|4|||
163040257|NCT01704755|588855915|FG000|Overall Study|Withdrew consent|1|||
163040258|NCT01704755|588855916|FG001|Overall Study|Withdrew consent|1|||
163040259|NCT01704755|588855915|FG000|Overall Study|Other (not specified)|3|||
163040260|NCT01704755|588855916|FG001|Overall Study|Other (not specified)|1|||
163040261|NCT01704755|588855915|FG000|Overall Study|Withdrew consent and personal issues|1|||
163040262|NCT01704755|588855916|FG001|Overall Study|Withdrew consent and personal issues|0|||
163040263|NCT02821416|588855923|FG000|Overall Study|Adverse Event|0|||
163040264|NCT02821416|588855924|FG001|Overall Study|Adverse Event|1|||
163040265|NCT02821416|588855923|FG000|Overall Study|Withdrawal by Subject|2|||
163040266|NCT02821416|588855924|FG001|Overall Study|Withdrawal by Subject|0|||
163040267|NCT02821416|588855923|FG000|Overall Study|Lost to Follow-up|1|||
163040268|NCT02821416|588855924|FG001|Overall Study|Lost to Follow-up|0|||
163040269|NCT01763203|588855927|FG000|Overall Study|Death|4|||
163040270|NCT01763203|588855928|FG001|Overall Study|Death|7|||
163040271|NCT01763203|588855927|FG000|Overall Study|Lost to Follow-up|12|||
163040272|NCT01763203|588855928|FG001|Overall Study|Lost to Follow-up|12|||
163040273|NCT01763203|588855927|FG000|Overall Study|Withdrawal by Subject|8|||
163040274|NCT01763203|588855928|FG001|Overall Study|Withdrawal by Subject|12|||
163040275|NCT01763203|588855927|FG000|Overall Study|Moved out of study region|7|||
163040276|NCT01763203|588855928|FG001|Overall Study|Moved out of study region|10|||
163040277|NCT01763203|588855927|FG000|Overall Study|Physician Decision|2|||
163040278|NCT01763203|588855928|FG001|Overall Study|Physician Decision|1|||
163040279|NCT02256917|588855929|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
163040280|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
163040281|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
163040282|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
163040283|NCT02256917|588855929|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
163040284|NCT02933528|588855930|FG000|Overall Study|Lost to Follow-up|2|||
163040285|NCT01639703|588855931|FG000|Overall Study|Withdrawal by Subject|5|||
163040286|NCT01639703|588855931|FG000|Overall Study|Other reason|7|||
162925647|NCT00953927|588430353|FG000|Overall Study|Withdrawal by Subject|36|||
162925648|NCT00953927|588430354|FG001|Overall Study|Withdrawal by Subject|25|||
162925649|NCT00953927|588430353|FG000|Overall Study|Death|7|||
162925650|NCT00953927|588430354|FG001|Overall Study|Death|4|||
162925651|NCT00953927|588430353|FG000|Overall Study|Other study discontinuation|1|||
162925652|NCT00953927|588430354|FG001|Overall Study|Other study discontinuation|1|||
162925653|NCT01396161|588430355|FG000|Overall Study|Withdrawal by Subject|0|||
162925654|NCT01396161|588430356|FG001|Overall Study|Withdrawal by Subject|0|||
162925655|NCT01396161|588430357|FG002|Overall Study|Withdrawal by Subject|0|||
162925656|NCT01396161|588430358|FG003|Overall Study|Withdrawal by Subject|0|||
162925657|NCT01396161|588430359|FG004|Overall Study|Withdrawal by Subject|1|||
162925658|NCT01396161|588430360|FG005|Overall Study|Withdrawal by Subject|0|||
162925659|NCT01396161|588430361|FG006|Overall Study|Withdrawal by Subject|0|||
162925660|NCT01396161|588430355|FG000|Overall Study|Other|0|||
163040287|NCT02982863|588855933|FG000|Overall Study|Not eligible patients|809|||
163040288|NCT02982863|588855934|FG001|Overall Study|Not eligible patients|4261|||
163040289|NCT02982863|588855935|FG002|Overall Study|Not eligible patients|1852|||
163040290|NCT02982863|588855936|FG003|Overall Study|Not eligible patients|1400|||
163040291|NCT02982863|588855937|FG004|Overall Study|Not eligible patients|492|||
163040292|NCT03739710|588855938|FG000|Overall Study|Screen Failed|81|||
163040293|NCT01753115|588855939|FG000|Overall Study|Lost to Follow-up|3|||
162925661|NCT01396161|588430356|FG001|Overall Study|Other|0|||
162925662|NCT01396161|588430357|FG002|Overall Study|Other|0|||
162925663|NCT01396161|588430358|FG003|Overall Study|Other|0|||
162925664|NCT01396161|588430359|FG004|Overall Study|Other|0|||
163040294|NCT01753115|588855940|FG001|Overall Study|Lost to Follow-up|6|||
163040295|NCT01753115|588855941|FG002|Overall Study|Lost to Follow-up|8|||
163040296|NCT01753115|588855939|FG000|Overall Study|Withdrawal by Subject|6|||
163040297|NCT01753115|588855940|FG001|Overall Study|Withdrawal by Subject|5|||
163040298|NCT01753115|588855941|FG002|Overall Study|Withdrawal by Subject|6|||
163040299|NCT01753115|588855939|FG000|Overall Study|Subject non-compliant|3|||
163040300|NCT01753115|588855940|FG001|Overall Study|Subject non-compliant|3|||
163040301|NCT01753115|588855941|FG002|Overall Study|Subject non-compliant|0|||
163040302|NCT01753115|588855939|FG000|Overall Study|Used excluded drug|0|||
163040303|NCT01753115|588855940|FG001|Overall Study|Used excluded drug|1|||
163040304|NCT01753115|588855941|FG002|Overall Study|Used excluded drug|0|||
163040305|NCT04313400|588855947|FG000|Overall Study|Withdrawal by Subject|0|||
163040306|NCT04313400|588855948|FG001|Overall Study|Withdrawal by Subject|0|||
163040307|NCT04313400|588855949|FG002|Overall Study|Withdrawal by Subject|0|||
163040308|NCT04313400|588855950|FG003|Overall Study|Withdrawal by Subject|0|||
163040309|NCT04313400|588855951|FG004|Overall Study|Withdrawal by Subject|0|||
163040310|NCT04313400|588855952|FG005|Overall Study|Withdrawal by Subject|4|||
163040311|NCT04313400|588855953|FG006|Overall Study|Withdrawal by Subject|1|||
163040312|NCT04313400|588855947|FG000|Overall Study|Adverse Event|0|||
163040313|NCT04313400|588855948|FG001|Overall Study|Adverse Event|0|||
163040314|NCT04313400|588855949|FG002|Overall Study|Adverse Event|0|||
163040315|NCT04313400|588855950|FG003|Overall Study|Adverse Event|0|||
163040316|NCT04313400|588855951|FG004|Overall Study|Adverse Event|0|||
163040317|NCT04313400|588855952|FG005|Overall Study|Adverse Event|1|||
162925665|NCT01396161|588430360|FG005|Overall Study|Other|0|||
162925666|NCT01396161|588430361|FG006|Overall Study|Other|1|||
163040318|NCT04313400|588855953|FG006|Overall Study|Adverse Event|0|||
163040319|NCT04313400|588855947|FG000|Overall Study|Lost to Follow-up|0|||
163040320|NCT04313400|588855948|FG001|Overall Study|Lost to Follow-up|0|||
163040321|NCT04313400|588855949|FG002|Overall Study|Lost to Follow-up|0|||
163040322|NCT04313400|588855950|FG003|Overall Study|Lost to Follow-up|0|||
163040323|NCT04313400|588855951|FG004|Overall Study|Lost to Follow-up|0|||
163040324|NCT04313400|588855952|FG005|Overall Study|Lost to Follow-up|1|||
163040325|NCT04313400|588855953|FG006|Overall Study|Lost to Follow-up|0|||
163040326|NCT02091414|588855954|FG000|Overall Study|Withdrawal by Subject|2|||
163040327|NCT02091414|588855954|FG000|Overall Study|Death|2|||
163040328|NCT02521792|588855957|FG000|Overall Study|Study Terminated|6|||
162925667|NCT03976076|588430362|FG000|Overall Study|Withdrawal by Subject|2|||
162925668|NCT02962739|588430363|FG000|Overall Study|Withdrawal by Subject|0|||
162925669|NCT02962739|588430364|FG001|Overall Study|Withdrawal by Subject|1|||
163040329|NCT00902746|588855958|FG000|Overall Study|Protocol Violation|7|||
163040330|NCT00902746|588855958|FG000|Overall Study|Withdrawal by Subject|16|||
163040331|NCT00902746|588855958|FG000|Overall Study|Adverse Event|8|||
163040332|NCT00902746|588855958|FG000|Overall Study|Lost to Follow-up|3|||
163040333|NCT00902746|588855958|FG000|Overall Study|Physician Decision|2|||
163040334|NCT02081001|588855959|FG000|Overall Study|Adverse Event|0|||
163040335|NCT02081001|588855960|FG001|Overall Study|Adverse Event|0|||
163040336|NCT02081001|588855961|FG002|Overall Study|Adverse Event|0|||
163040337|NCT02081001|588855962|FG003|Overall Study|Adverse Event|0|||
163040338|NCT02081001|588855963|FG004|Overall Study|Adverse Event|1|||
163040339|NCT02081001|588855964|FG005|Overall Study|Adverse Event|0|||
163040340|NCT02081001|588855965|FG006|Overall Study|Adverse Event|0|||
163040341|NCT02081001|588855966|FG007|Overall Study|Adverse Event|0|||
163040342|NCT02081001|588855967|FG008|Overall Study|Adverse Event|0|||
163040343|NCT02081001|588855968|FG009|Overall Study|Adverse Event|0|||
163040344|NCT02081001|588855969|FG010|Overall Study|Adverse Event|0|||
163040345|NCT02081001|588855970|FG011|Overall Study|Adverse Event|0|||
163040346|NCT02937636|588855971|FG000|Overall Study|Other (Not specified)|3|||
163040347|NCT02937636|588855972|FG001|Overall Study|Other (Not specified)|2|||
163040348|NCT00359294|588855973|FG000|Overall Study|Progressive disease|1|||
163040349|NCT00359294|588855974|FG001|Overall Study|Progressive disease|1|||
163040350|NCT00359294|588855975|FG002|Overall Study|Progressive disease|2|||
163040351|NCT00359294|588855976|FG003|Overall Study|Progressive disease|3|||
163040352|NCT00359294|588855977|FG004|Overall Study|Progressive disease|2|||
163040353|NCT00359294|588855973|FG000|Overall Study|Withdrawal by Subject|0|||
163040354|NCT00359294|588855974|FG001|Overall Study|Withdrawal by Subject|0|||
162925670|NCT02962739|588430365|FG002|Overall Study|Withdrawal by Subject|0|||
162925671|NCT02962739|588430366|FG003|Overall Study|Withdrawal by Subject|0|||
162925672|NCT02962739|588430367|FG004|Overall Study|Withdrawal by Subject|0|||
163040355|NCT00359294|588855975|FG002|Overall Study|Withdrawal by Subject|0|||
163040356|NCT00359294|588855976|FG003|Overall Study|Withdrawal by Subject|0|||
163040357|NCT00359294|588855977|FG004|Overall Study|Withdrawal by Subject|1|||
163040358|NCT00359294|588855973|FG000|Overall Study|Not treated|0|||
163040359|NCT00359294|588855974|FG001|Overall Study|Not treated|0|||
163040360|NCT00359294|588855975|FG002|Overall Study|Not treated|0|||
163040361|NCT00359294|588855976|FG003|Overall Study|Not treated|1|||
163040362|NCT00359294|588855977|FG004|Overall Study|Not treated|0|||
163040363|NCT00359294|588855973|FG000|Overall Study|Physician Decision|0|||
163040364|NCT00359294|588855974|FG001|Overall Study|Physician Decision|0|||
163040365|NCT00359294|588855975|FG002|Overall Study|Physician Decision|1|||
163040366|NCT00359294|588855976|FG003|Overall Study|Physician Decision|0|||
163040367|NCT00359294|588855977|FG004|Overall Study|Physician Decision|0|||
163040368|NCT04208412|588855978|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
163040369|NCT04208412|588855979|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
163040370|NCT04208412|588855978|FG000|Overall Study|Withdrawal by Subject|1|||
163040371|NCT04208412|588855979|FG001|Overall Study|Withdrawal by Subject|0|||
163040372|NCT04208412|588855978|FG000|Overall Study|Lost to Follow-up|0|||
163040373|NCT04208412|588855979|FG001|Overall Study|Lost to Follow-up|1|||
163040374|NCT03762681|588855980|FG000|Part 1|Withdrawal by Subject|0|||
163040375|NCT03762681|588855981|FG001|Part 1|Withdrawal by Subject|0|||
163040376|NCT03762681|588855982|FG002|Part 1|Withdrawal by Subject|0|||
163040377|NCT03762681|588855983|FG003|Part 1|Withdrawal by Subject|1|||
163040378|NCT03762681|588855984|FG004|Part 1|Withdrawal by Subject|0|||
163040379|NCT03762681|588855985|FG005|Part 1|Withdrawal by Subject|0|||
163040380|NCT03762681|588855986|FG006|Part 1|Withdrawal by Subject|0|||
163040381|NCT03762681|588855987|FG007|Part 1|Withdrawal by Subject|0|||
163040382|NCT03762681|588855980|FG000|Part 2a|Pandemic Travel Restrictions|0|||
163040383|NCT03762681|588855981|FG001|Part 2a|Pandemic Travel Restrictions|0|||
163040384|NCT03762681|588855982|FG002|Part 2a|Pandemic Travel Restrictions|0|||
163040385|NCT03762681|588855983|FG003|Part 2a|Pandemic Travel Restrictions|0|||
163040386|NCT03762681|588855984|FG004|Part 2a|Pandemic Travel Restrictions|0|||
163040387|NCT03762681|588855985|FG005|Part 2a|Pandemic Travel Restrictions|0|||
163040388|NCT03762681|588855986|FG006|Part 2a|Pandemic Travel Restrictions|0|||
163040389|NCT03762681|588855987|FG007|Part 2a|Pandemic Travel Restrictions|1|||
163040390|NCT03148067|588855988|FG000|Overall Study|Lost to Follow-up|3|||
163040391|NCT03148067|588855988|FG000|Overall Study|Death|1|||
163040392|NCT00435188|588855990|FG000|Overall Study|Death|1|||
163040393|NCT00435188|588855991|FG001|Overall Study|Death|6|||
163040394|NCT00435188|588855990|FG000|Overall Study|Withdrawal by Subject|16|||
163040395|NCT00435188|588855991|FG001|Overall Study|Withdrawal by Subject|11|||
163040396|NCT00435188|588855990|FG000|Overall Study|Lost to Follow-up|5|||
163040397|NCT00435188|588855991|FG001|Overall Study|Lost to Follow-up|6|||
163040398|NCT01915771|588855992|FG000|Day 1|Withdrawal by Subject|1|||
163040399|NCT01915771|588855992|FG000|Day 15|Withdrawal by Subject|1|||
163040400|NCT02774005|588855999|FG000|Overall Study|Adverse Event|8|||
163040401|NCT02774005|588855999|FG000|Overall Study|Withdrawal by Subject|23|||
163040402|NCT02774005|588855999|FG000|Overall Study|Lost to Follow-up|7|||
163040403|NCT02774005|588855999|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
163040404|NCT02774005|588855999|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
163040405|NCT02774005|588855999|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
163040406|NCT02774005|588855999|FG000|Overall Study|Death|1|||
163040407|NCT02774005|588855999|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
163040408|NCT02774005|588855999|FG000|Overall Study|Lack of compliance with study medication|4|||
163040409|NCT02774005|588855999|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
163040410|NCT02774005|588855999|FG000|Overall Study|another study|1|||
162810880|NCT02647320|588019978|FG003|Overall Study|Protocol Violation|0|||
162810881|NCT02647320|588019979|FG004|Overall Study|Protocol Violation|0|||
162810882|NCT02647320|588019975|FG000|Overall Study|Withdrawal by Subject|7|||
162810883|NCT02647320|588019976|FG001|Overall Study|Withdrawal by Subject|4|||
162810884|NCT02647320|588019977|FG002|Overall Study|Withdrawal by Subject|2|||
162810885|NCT02647320|588019978|FG003|Overall Study|Withdrawal by Subject|2|||
162810886|NCT02647320|588019979|FG004|Overall Study|Withdrawal by Subject|7|||
162810887|NCT02647320|588019975|FG000|Overall Study|Persistent hyperglycemia|0|||
162810888|NCT02647320|588019976|FG001|Overall Study|Persistent hyperglycemia|1|||
162810889|NCT02647320|588019977|FG002|Overall Study|Persistent hyperglycemia|1|||
162810890|NCT02647320|588019978|FG003|Overall Study|Persistent hyperglycemia|1|||
162810891|NCT02647320|588019979|FG004|Overall Study|Persistent hyperglycemia|1|||
162810892|NCT02647320|588019975|FG000|Overall Study|Study terminated by sponsor|1|||
162810893|NCT02647320|588019976|FG001|Overall Study|Study terminated by sponsor|1|||
162810894|NCT02647320|588019977|FG002|Overall Study|Study terminated by sponsor|1|||
162810895|NCT02647320|588019978|FG003|Overall Study|Study terminated by sponsor|1|||
162810896|NCT02647320|588019979|FG004|Overall Study|Study terminated by sponsor|2|||
162810897|NCT02647320|588019975|FG000|Overall Study|Reason not provided|0|||
162810898|NCT02647320|588019976|FG001|Overall Study|Reason not provided|0|||
162696273|NCT00603265|587599457|FG001|Overall Study|Adverse Event|11|||
162696274|NCT00603265|587599458|FG002|Overall Study|Adverse Event|1|||
162810899|NCT02647320|588019977|FG002|Overall Study|Reason not provided|1|||
162810900|NCT02647320|588019978|FG003|Overall Study|Reason not provided|0|||
163040411|NCT02774005|588855999|FG000|Overall Study|cardiologist imposed travel restriction|1|||
163040412|NCT00723697|588856000|FG000|Overall Study|Physician questionnaires not received|2|||
163040413|NCT00723697|588856000|FG000|Overall Study|Missing Informed Consent Form|10|||
163040414|NCT00723697|588856000|FG000|Overall Study|Other exclusion criteria applied|6|||
163040415|NCT03275389|588856001|FG000|Overall Study|Lost to Follow-up|10|||
163040416|NCT03275389|588856002|FG001|Overall Study|Lost to Follow-up|10|||
162696275|NCT00603265|587599456|FG000|Overall Study|Withdrawal by Subject|1|||
162696276|NCT00603265|587599457|FG001|Overall Study|Withdrawal by Subject|2|||
162696277|NCT00603265|587599458|FG002|Overall Study|Withdrawal by Subject|1|||
162696278|NCT00603265|587599456|FG000|Overall Study|Lack of Efficacy|3|||
162696279|NCT00603265|587599457|FG001|Overall Study|Lack of Efficacy|0|||
162696280|NCT00603265|587599458|FG002|Overall Study|Lack of Efficacy|3|||
162696281|NCT00603265|587599456|FG000|Overall Study|Lost to Follow-up|0|||
162696282|NCT00603265|587599457|FG001|Overall Study|Lost to Follow-up|1|||
162696283|NCT00603265|587599458|FG002|Overall Study|Lost to Follow-up|0|||
162696284|NCT00603265|587599456|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
162696285|NCT00603265|587599457|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
162696286|NCT00603265|587599458|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
162810901|NCT02647320|588019979|FG004|Overall Study|Reason not provided|2|||
162810902|NCT02647320|588019975|FG000|Overall Study|Lost to Follow-up|1|||
162810903|NCT02647320|588019976|FG001|Overall Study|Lost to Follow-up|1|||
162810904|NCT02647320|588019977|FG002|Overall Study|Lost to Follow-up|0|||
162810905|NCT02647320|588019978|FG003|Overall Study|Lost to Follow-up|0|||
162810906|NCT02647320|588019979|FG004|Overall Study|Lost to Follow-up|0|||
162810907|NCT02647320|588019975|FG000|Overall Study|Develop anemia|1|||
162810908|NCT02647320|588019976|FG001|Overall Study|Develop anemia|0|||
162810909|NCT02647320|588019977|FG002|Overall Study|Develop anemia|0|||
162810910|NCT02647320|588019978|FG003|Overall Study|Develop anemia|0|||
162810911|NCT02647320|588019979|FG004|Overall Study|Develop anemia|0|||
162810912|NCT02647320|588019975|FG000|Overall Study|Lack of Efficacy|0|||
162810913|NCT02647320|588019976|FG001|Overall Study|Lack of Efficacy|0|||
162810914|NCT02647320|588019977|FG002|Overall Study|Lack of Efficacy|0|||
162810915|NCT02647320|588019978|FG003|Overall Study|Lack of Efficacy|1|||
162810916|NCT02647320|588019979|FG004|Overall Study|Lack of Efficacy|0|||
162810917|NCT02647320|588019975|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
163040417|NCT03275389|588856003|FG002|Overall Study|Lost to Follow-up|19|||
163040418|NCT03275389|588856004|FG003|Overall Study|Lost to Follow-up|12|||
163040419|NCT03275389|588856005|FG004|Overall Study|Lost to Follow-up|11|||
163040420|NCT03275389|588856006|FG005|Overall Study|Lost to Follow-up|12|||
163040421|NCT03275389|588856007|FG006|Overall Study|Lost to Follow-up|21|||
163040422|NCT03275389|588856008|FG007|Overall Study|Lost to Follow-up|15|||
163040423|NCT03275389|588856009|FG008|Overall Study|Lost to Follow-up|12|||
163040424|NCT03275389|588856010|FG009|Overall Study|Lost to Follow-up|14|||
163040425|NCT03275389|588856001|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040426|NCT03275389|588856002|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040427|NCT03275389|588856003|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040428|NCT03275389|588856004|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040429|NCT03275389|588856005|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040430|NCT03275389|588856006|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
163154860|NCT02079246|589283632|FG001|OLEX|Withdrawal before treatment|0|||
163154861|NCT02079246|589283631|FG000|OLEX|Death|11|||
163040431|NCT03275389|588856007|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163154862|NCT02079246|589283632|FG001|OLEX|Death|0|||
163154863|NCT02079246|589283631|FG000|OLEX|Adverse Event|66|||
163154864|NCT02079246|589283632|FG001|OLEX|Adverse Event|0|||
163154865|NCT02079246|589283631|FG000|OLEX|Withdrawal by Subject|60|||
163154866|NCT02079246|589283632|FG001|OLEX|Withdrawal by Subject|0|||
163154867|NCT02079246|589283631|FG000|OLEX|Lost to Follow-up|6|||
163154868|NCT02079246|589283632|FG001|OLEX|Lost to Follow-up|0|||
163154869|NCT02079246|589283631|FG000|OLEX|Protocol Violation|6|||
163154870|NCT02079246|589283632|FG001|OLEX|Protocol Violation|0|||
163154871|NCT02079246|589283631|FG000|OLEX|Lack of Efficacy|3|||
163154872|NCT02079246|589283632|FG001|OLEX|Lack of Efficacy|0|||
163154873|NCT02079246|589283631|FG000|OLEX|Results of the lead-in studies|58|||
163154874|NCT02079246|589283632|FG001|OLEX|Results of the lead-in studies|0|||
163154875|NCT02079246|589283631|FG000|OLEX|Other: Disallowed medication|8|||
163154876|NCT02079246|589283632|FG001|OLEX|Other: Disallowed medication|0|||
163154877|NCT02079246|589283631|FG000|OLEX|Other: Insufficient compliance|2|||
163154878|NCT02079246|589283632|FG001|OLEX|Other: Insufficient compliance|0|||
163154879|NCT02079246|589283631|FG000|OLEX|Other: Caregiver unavailable|3|||
163154880|NCT02079246|589283632|FG001|OLEX|Other: Caregiver unavailable|0|||
163154881|NCT02079246|589283631|FG000|OLEX|Other: Coordinator decision|1|||
163154882|NCT02079246|589283632|FG001|OLEX|Other: Coordinator decision|0|||
163154883|NCT02079246|589283631|FG000|OLEX|Other: Worsening of condition|1|||
162810918|NCT02647320|588019976|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
163154884|NCT02079246|589283632|FG001|OLEX|Other: Worsening of condition|0|||
163154885|NCT02079246|589283631|FG000|OLEX|Other: Moved to nursing home|1|||
163154886|NCT02079246|589283632|FG001|OLEX|Other: Moved to nursing home|0|||
162810919|NCT02647320|588019977|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
162810920|NCT02647320|588019978|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
163040432|NCT03275389|588856008|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163040433|NCT03275389|588856009|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
163154887|NCT02079246|589283631|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
163154888|NCT02079246|589283632|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
163154889|NCT02079246|589283631|FG000|OLEX-MEM|Adverse Event|0|||
163154890|NCT02079246|589283632|FG001|OLEX-MEM|Adverse Event|6|||
163154891|NCT02079246|589283631|FG000|OLEX-MEM|Withdrawal by Subject|0|||
163154892|NCT02079246|589283632|FG001|OLEX-MEM|Withdrawal by Subject|7|||
163154893|NCT02079246|589283631|FG000|OLEX-MEM|Protocol Violation|0|||
163154894|NCT02079246|589283632|FG001|OLEX-MEM|Protocol Violation|2|||
163154895|NCT02079246|589283631|FG000|OLEX-MEM|Lost to Follow-up|0|||
163154896|NCT02079246|589283632|FG001|OLEX-MEM|Lost to Follow-up|1|||
163154897|NCT02079246|589283631|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
163154898|NCT02079246|589283632|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
162810921|NCT02647320|588019979|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
162810922|NCT00081770|588019980|FG000|Overall Study|Adverse Event|130|||
162810923|NCT00081770|588019981|FG001|Overall Study|Adverse Event|98|||
162810924|NCT00081770|588019982|FG002|Overall Study|Adverse Event|136|||
162810925|NCT00081770|588019980|FG000|Overall Study|Lack of Efficacy|262|||
162810926|NCT00081770|588019981|FG001|Overall Study|Lack of Efficacy|357|||
162810927|NCT00081770|588019982|FG002|Overall Study|Lack of Efficacy|211|||
162810928|NCT00081770|588019980|FG000|Overall Study|Lost to Follow-up|45|||
162810929|NCT00081770|588019981|FG001|Overall Study|Lost to Follow-up|34|||
162810930|NCT00081770|588019982|FG002|Overall Study|Lost to Follow-up|45|||
162810931|NCT00081770|588019980|FG000|Overall Study|Protocol Violation|15|||
162810932|NCT00081770|588019981|FG001|Overall Study|Protocol Violation|10|||
162810933|NCT00081770|588019982|FG002|Overall Study|Protocol Violation|10|||
162810934|NCT00081770|588019980|FG000|Overall Study|Withdrawal by Subject|45|||
162810935|NCT00081770|588019981|FG001|Overall Study|Withdrawal by Subject|40|||
162810936|NCT00081770|588019982|FG002|Overall Study|Withdrawal by Subject|42|||
162810937|NCT00081770|588019980|FG000|Overall Study|Did not meet protocol eligibility|2|||
162810938|NCT00081770|588019981|FG001|Overall Study|Did not meet protocol eligibility|0|||
162810939|NCT00081770|588019982|FG002|Overall Study|Did not meet protocol eligibility|3|||
162810940|NCT00081770|588019980|FG000|Overall Study|Administrative|1|||
162810941|NCT00081770|588019981|FG001|Overall Study|Administrative|0|||
162810942|NCT00081770|588019982|FG002|Overall Study|Administrative|1|||
162810943|NCT00081770|588019980|FG000|Overall Study|Other|2|||
162810944|NCT00081770|588019981|FG001|Overall Study|Other|7|||
162810945|NCT00081770|588019982|FG002|Overall Study|Other|8|||
162810946|NCT01072877|588019983|FG000|Overall Study|Lost to Follow-up|1|||
162810947|NCT01072877|588019984|FG001|Overall Study|Lost to Follow-up|1|||
162810948|NCT01072877|588019985|FG002|Overall Study|Lost to Follow-up|0|||
162810949|NCT01072877|588019986|FG003|Overall Study|Lost to Follow-up|2|||
162810950|NCT01072877|588019987|FG004|Overall Study|Lost to Follow-up|0|||
162810951|NCT00601419|588019988|FG000|Overall Study|Lost to Follow-up|3|||
162810952|NCT00601419|588019988|FG000|Overall Study|Missed Visits|1|||
162810953|NCT01217957|588019999|FG000|Phase 1|Withdrawal by Patient|1|||
162810954|NCT01217957|588020000|FG001|Phase 1|Withdrawal by Patient|0|||
162810955|NCT01217957|588020001|FG002|Phase 1|Withdrawal by Patient|1|||
162810956|NCT01217957|588020002|FG003|Phase 1|Withdrawal by Patient|1|||
162810957|NCT01217957|588020003|FG004|Phase 1|Withdrawal by Patient|0|||
162810958|NCT01217957|588019999|FG000|Phase 2|Withdrawal by Patient|0|||
162810959|NCT01217957|588020000|FG001|Phase 2|Withdrawal by Patient|0|||
162810960|NCT01217957|588020001|FG002|Phase 2|Withdrawal by Patient|0|||
162810961|NCT01217957|588020002|FG003|Phase 2|Withdrawal by Patient|0|||
162810962|NCT01217957|588020003|FG004|Phase 2|Withdrawal by Patient|1|||
162810963|NCT00971932|588020004|FG000|Overall Study|Withdrawal by Subject|1|||
162810964|NCT00971932|588020004|FG000|Overall Study|Investigator's decision|2|||
162810965|NCT00971932|588020004|FG000|Overall Study|Ongoing|4|||
162810966|NCT01640054|588020005|FG000|Overall Study|Study-specific disc criteria|1|||
162810967|NCT01640054|588020005|FG000|Overall Study|Lack of Efficacy|3|||
162810968|NCT01640054|588020005|FG000|Overall Study|Adverse Event|2|||
162810969|NCT01206777|588020007|FG000|Overall Study|Death|1|||
162810970|NCT01206777|588020007|FG000|Overall Study|Adverse Event|1|||
162810971|NCT02382016|588020008|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
162810972|NCT02382016|588020009|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
162810973|NCT02382016|588020008|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
162810974|NCT02382016|588020009|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
162810975|NCT02382016|588020008|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
162810976|NCT02382016|588020009|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
162810977|NCT02382016|588020008|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
162810978|NCT02382016|588020009|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
162810979|NCT02382016|588020008|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
162810980|NCT02382016|588020009|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
162810981|NCT02382016|588020008|FG000|Open-label (OL) Treatment Period|Death|4|||
162810982|NCT02382016|588020009|FG001|Open-label (OL) Treatment Period|Death|0|||
162810983|NCT02382016|588020008|FG000|OL Extension Period|Physician Decision|3|||
162810984|NCT02382016|588020009|FG001|OL Extension Period|Physician Decision|0|||
162810985|NCT02382016|588020008|FG000|OL Extension Period|Death|2|||
162810986|NCT02382016|588020009|FG001|OL Extension Period|Death|0|||
163154899|NCT03591406|589283637|FG000|Overall Study|Adverse Event|5|||
163154900|NCT03591406|589283638|FG001|Overall Study|Adverse Event|3|||
162810987|NCT02382016|588020008|FG000|OL Extension Period|Withdrawal by Subject|1|||
162810988|NCT02382016|588020009|FG001|OL Extension Period|Withdrawal by Subject|0|||
162810989|NCT00730171|588020014|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
162810990|NCT00730171|588020014|FG000|Overall Study|Adverse Event|193|||
162810991|NCT00730171|588020014|FG000|Overall Study|Protocol Violation|48|||
162810992|NCT00730171|588020014|FG000|Overall Study|Withdrawal by Subject|202|||
162810993|NCT00730171|588020014|FG000|Overall Study|Lost to Follow-up|121|||
163154901|NCT03591406|589283637|FG000|Overall Study|Protocol Violation|2|||
163154902|NCT03591406|589283638|FG001|Overall Study|Protocol Violation|1|||
163154903|NCT03591406|589283637|FG000|Overall Study|Withdrawal by Subject|0|||
163154904|NCT03591406|589283638|FG001|Overall Study|Withdrawal by Subject|5|||
162810994|NCT00730171|588020014|FG000|Overall Study|Insufficient Therapeutic Response|141|||
162810995|NCT00730171|588020014|FG000|Overall Study|Other|61|||
162810996|NCT01729156|588020015|FG000|Overall Study|Withdrawal by Subject|1|||
162810997|NCT01729156|588020016|FG001|Overall Study|Withdrawal by Subject|0|||
162810998|NCT01729156|588020017|FG002|Overall Study|Withdrawal by Subject|0|||
162810999|NCT01256658|588020020|FG000|Period 1|Lost to Follow-up|837|||
162811000|NCT01256658|588020021|FG001|Period 1|Lost to Follow-up|661|||
162811001|NCT01256658|588020020|FG000|Period 1|Withdrawal by Subject|35|||
162811002|NCT01256658|588020021|FG001|Period 1|Withdrawal by Subject|43|||
162811003|NCT01256658|588020020|FG000|Period 1|Death|48|||
162811004|NCT01256658|588020021|FG001|Period 1|Death|44|||
162811005|NCT00719563|588020022|FG000|Overall Study|Adverse Event|16|||
162811006|NCT00719563|588020023|FG001|Overall Study|Adverse Event|13|||
162811007|NCT00719563|588020022|FG000|Overall Study|Medical condition changed|3|||
162811008|NCT00719563|588020023|FG001|Overall Study|Medical condition changed|5|||
162811009|NCT00719563|588020022|FG000|Overall Study|Lack of Efficacy|3|||
162811010|NCT00719563|588020023|FG001|Overall Study|Lack of Efficacy|7|||
162811011|NCT00719563|588020022|FG000|Overall Study|Personal reasons|6|||
162811012|NCT00719563|588020023|FG001|Overall Study|Personal reasons|7|||
162811013|NCT00719563|588020022|FG000|Overall Study|Unknown reasons|4|||
162811014|NCT00719563|588020023|FG001|Overall Study|Unknown reasons|6|||
162811015|NCT00719563|588020022|FG000|Overall Study|Noncompliant|1|||
162811016|NCT00719563|588020023|FG001|Overall Study|Noncompliant|1|||
162811017|NCT00719563|588020022|FG000|Overall Study|Lost to Follow-up|5|||
162811018|NCT00719563|588020023|FG001|Overall Study|Lost to Follow-up|3|||
162811019|NCT02120625|588020028|FG000|Overall Study|Physician Decision|2|||
162811020|NCT00975507|588020031|FG000|Overall Study|Adverse Event|1|||
162811021|NCT00975507|588020032|FG001|Overall Study|Adverse Event|0|||
162811022|NCT00975507|588020031|FG000|Overall Study|Lost to Follow-up|7|||
162811023|NCT00975507|588020032|FG001|Overall Study|Lost to Follow-up|1|||
162811024|NCT00975507|588020031|FG000|Overall Study|Protocol Violation|2|||
162811025|NCT00975507|588020032|FG001|Overall Study|Protocol Violation|0|||
162811026|NCT00975507|588020031|FG000|Overall Study|Withdrawal by Subject|10|||
162811027|NCT00975507|588020032|FG001|Overall Study|Withdrawal by Subject|3|||
162811028|NCT03249714|588020033|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
162811029|NCT03249714|588020034|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
162811030|NCT03249714|588020033|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
162811031|NCT03249714|588020034|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
162811032|NCT03249714|588020033|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
162811033|NCT03249714|588020034|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
162811034|NCT03249714|588020033|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
162811035|NCT03249714|588020034|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
162811036|NCT00879762|588020037|FG000|Overall Study|Lost to Follow-up|3|||
162811037|NCT00879762|588020038|FG001|Overall Study|Lost to Follow-up|1|||
162811038|NCT04754477|588020041|FG000|Overall Study|Withdrawal by Subject|1|||
162811039|NCT02699983|588020043|FG000|Overall Study|Withdrawal by Subject|1|||
162811040|NCT02699983|588020044|FG001|Overall Study|Withdrawal by Subject|0|||
162811041|NCT03575143|588020045|FG000|Overall Study|Lost to Follow-up|0|||
162811042|NCT03575143|588020046|FG001|Overall Study|Lost to Follow-up|0|||
162811043|NCT03575143|588020047|FG002|Overall Study|Lost to Follow-up|4|||
162811044|NCT03575143|588020045|FG000|Overall Study|Withdrawal by Subject|0|||
162811045|NCT03575143|588020046|FG001|Overall Study|Withdrawal by Subject|0|||
162811046|NCT03575143|588020047|FG002|Overall Study|Withdrawal by Subject|5|||
162811047|NCT03575143|588020045|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
162811048|NCT03575143|588020046|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
162811049|NCT03575143|588020047|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
162811050|NCT01211197|588020051|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162811051|NCT01211197|588020052|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162811052|NCT01211197|588020053|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
162811053|NCT01211197|588020054|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162811054|NCT01211197|588020055|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163154905|NCT01389596|589283639|FG000|Overall Study|Protocol Violation|3|||
162811055|NCT01211197|588020056|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162811056|NCT01211197|588020051|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
163154906|NCT01389596|589283640|FG001|Overall Study|Protocol Violation|4|||
163154907|NCT01389596|589283641|FG002|Overall Study|Protocol Violation|3|||
163154908|NCT01389596|589283639|FG000|Overall Study|Withdrawal by Subject|1|||
163154909|NCT01389596|589283640|FG001|Overall Study|Withdrawal by Subject|2|||
163154910|NCT01389596|589283641|FG002|Overall Study|Withdrawal by Subject|2|||
163154911|NCT01389596|589283639|FG000|Overall Study|Insufficient Clinical Response|3|||
163154912|NCT01389596|589283640|FG001|Overall Study|Insufficient Clinical Response|4|||
163154913|NCT01389596|589283641|FG002|Overall Study|Insufficient Clinical Response|5|||
163154914|NCT01389596|589283639|FG000|Overall Study|Adverse Event|1|||
163154915|NCT01389596|589283640|FG001|Overall Study|Adverse Event|4|||
163154916|NCT01389596|589283641|FG002|Overall Study|Adverse Event|0|||
163154917|NCT01389596|589283639|FG000|Overall Study|Death|0|||
163154918|NCT01389596|589283640|FG001|Overall Study|Death|1|||
163154919|NCT01389596|589283641|FG002|Overall Study|Death|0|||
163154920|NCT01389596|589283639|FG000|Overall Study|Other Unspecified|2|||
163154921|NCT01389596|589283640|FG001|Overall Study|Other Unspecified|1|||
163154922|NCT01389596|589283641|FG002|Overall Study|Other Unspecified|0|||
163154923|NCT01709084|589283642|FG000|Overall Study|Lost to Follow-up|4|||
163154924|NCT01709084|589283643|FG001|Overall Study|Lost to Follow-up|7|||
163154925|NCT01709084|589283642|FG000|Overall Study|Withdrawal by Subject|2|||
163154926|NCT01709084|589283643|FG001|Overall Study|Withdrawal by Subject|2|||
163154927|NCT01709084|589283642|FG000|Overall Study|Adverse Event|5|||
163154928|NCT01709084|589283643|FG001|Overall Study|Adverse Event|0|||
163154929|NCT01709084|589283642|FG000|Overall Study|Other|5|||
163154930|NCT01709084|589283643|FG001|Overall Study|Other|3|||
163154931|NCT01709084|589283642|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
163154932|NCT01709084|589283643|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
163154933|NCT01709084|589283642|FG000|Overall Study|Not Treated|0|||
163154934|NCT01709084|589283643|FG001|Overall Study|Not Treated|2|||
163154935|NCT00214201|589283644|FG000|Overall Study|Withdrawal by Subject|2|||
163154936|NCT00214201|589283645|FG001|Overall Study|Withdrawal by Subject|0|||
163154937|NCT00214201|589283644|FG000|Overall Study|Death|0|||
163154938|NCT00214201|589283645|FG001|Overall Study|Death|2|||
163154939|NCT00463567|589283649|FG000|Overall Study|Adverse Event|29|||
163154940|NCT00463567|589283650|FG001|Overall Study|Adverse Event|26|||
163154941|NCT00463567|589283651|FG002|Overall Study|Adverse Event|17|||
163154942|NCT00463567|589283652|FG003|Overall Study|Adverse Event|46|||
163154943|NCT00463567|589283653|FG004|Overall Study|Adverse Event|10|||
163154944|NCT00463567|589283654|FG005|Overall Study|Adverse Event|10|||
163154945|NCT00463567|589283655|FG006|Overall Study|Adverse Event|4|||
163154946|NCT00463567|589283649|FG000|Overall Study|Withdrawal by Subject|29|||
163154947|NCT00463567|589283650|FG001|Overall Study|Withdrawal by Subject|22|||
163154948|NCT00463567|589283651|FG002|Overall Study|Withdrawal by Subject|20|||
163154949|NCT00463567|589283652|FG003|Overall Study|Withdrawal by Subject|37|||
163154950|NCT00463567|589283653|FG004|Overall Study|Withdrawal by Subject|6|||
163154951|NCT00463567|589283654|FG005|Overall Study|Withdrawal by Subject|5|||
163154952|NCT00463567|589283655|FG006|Overall Study|Withdrawal by Subject|1|||
163154953|NCT00463567|589283649|FG000|Overall Study|Protocol Deviation|13|||
163154954|NCT00463567|589283650|FG001|Overall Study|Protocol Deviation|9|||
163154955|NCT00463567|589283651|FG002|Overall Study|Protocol Deviation|14|||
163154956|NCT00463567|589283652|FG003|Overall Study|Protocol Deviation|11|||
163154957|NCT00463567|589283653|FG004|Overall Study|Protocol Deviation|1|||
163154958|NCT00463567|589283654|FG005|Overall Study|Protocol Deviation|1|||
163154959|NCT00463567|589283655|FG006|Overall Study|Protocol Deviation|2|||
163154960|NCT00463567|589283649|FG000|Overall Study|Lost to Follow-up|12|||
163154961|NCT00463567|589283650|FG001|Overall Study|Lost to Follow-up|6|||
163154962|NCT00463567|589283651|FG002|Overall Study|Lost to Follow-up|13|||
163040434|NCT03275389|588856010|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
163040435|NCT03275389|588856001|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
163040436|NCT03275389|588856002|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163040437|NCT03275389|588856003|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
163040438|NCT03275389|588856004|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
163040439|NCT03275389|588856005|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040440|NCT03275389|588856006|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040441|NCT03275389|588856007|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040442|NCT03275389|588856008|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
163040443|NCT03275389|588856009|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163154963|NCT00463567|589283652|FG003|Overall Study|Lost to Follow-up|8|||
163154964|NCT00463567|589283653|FG004|Overall Study|Lost to Follow-up|1|||
163154965|NCT00463567|589283654|FG005|Overall Study|Lost to Follow-up|1|||
163154966|NCT00463567|589283655|FG006|Overall Study|Lost to Follow-up|1|||
163154967|NCT00463567|589283649|FG000|Overall Study|Administrative problems|5|||
163154968|NCT00463567|589283650|FG001|Overall Study|Administrative problems|3|||
163154969|NCT00463567|589283651|FG002|Overall Study|Administrative problems|6|||
163154970|NCT00463567|589283652|FG003|Overall Study|Administrative problems|9|||
163154971|NCT00463567|589283653|FG004|Overall Study|Administrative problems|3|||
163154972|NCT00463567|589283654|FG005|Overall Study|Administrative problems|2|||
162811057|NCT01211197|588020052|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
162811058|NCT01211197|588020053|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
162811059|NCT01211197|588020054|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
162811060|NCT01211197|588020055|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
162811061|NCT01211197|588020056|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
162811062|NCT04781387|588020057|FG000|Overall Study|Withdrawal by Subject|1|||
162811063|NCT04781387|588020058|FG001|Overall Study|Withdrawal by Subject|0|||
162811064|NCT04781387|588020059|FG002|Overall Study|Withdrawal by Subject|1|||
162811065|NCT04781387|588020057|FG000|Overall Study|Lost to Follow-up|1|||
162811066|NCT04781387|588020058|FG001|Overall Study|Lost to Follow-up|0|||
162811067|NCT04781387|588020059|FG002|Overall Study|Lost to Follow-up|0|||
162811068|NCT01636960|588020060|FG000|Induction Phase|Adverse Event|2|||
162811069|NCT01636960|588020060|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
162811070|NCT01636960|588020060|FG000|Maintenance Phase|Adverse Event|3|||
162811071|NCT01636960|588020060|FG000|Maintenance Phase|Progressive disease|1|||
162811072|NCT01209780|588020061|FG000|Overall Study|Adverse Event|0|||
162811073|NCT01209780|588020062|FG001|Overall Study|Adverse Event|1|||
162811074|NCT01209780|588020063|FG002|Overall Study|Adverse Event|0|||
162811075|NCT01209780|588020064|FG003|Overall Study|Adverse Event|0|||
162811076|NCT01209780|588020065|FG004|Overall Study|Adverse Event|0|||
162811077|NCT01209780|588020061|FG000|Overall Study|Withdrawal by Subject|9|||
162811078|NCT01209780|588020062|FG001|Overall Study|Withdrawal by Subject|2|||
162811079|NCT01209780|588020063|FG002|Overall Study|Withdrawal by Subject|1|||
162811080|NCT01209780|588020064|FG003|Overall Study|Withdrawal by Subject|1|||
162811081|NCT01209780|588020065|FG004|Overall Study|Withdrawal by Subject|0|||
162811082|NCT01209780|588020061|FG000|Overall Study|Lost to Follow-up|17|||
162811083|NCT01209780|588020062|FG001|Overall Study|Lost to Follow-up|12|||
162811084|NCT01209780|588020063|FG002|Overall Study|Lost to Follow-up|3|||
162811085|NCT01209780|588020064|FG003|Overall Study|Lost to Follow-up|9|||
162811086|NCT01209780|588020065|FG004|Overall Study|Lost to Follow-up|4|||
162811087|NCT01209780|588020061|FG000|Overall Study|Protocol Violation|0|||
162811088|NCT01209780|588020062|FG001|Overall Study|Protocol Violation|1|||
162811089|NCT01209780|588020063|FG002|Overall Study|Protocol Violation|0|||
162811090|NCT01209780|588020064|FG003|Overall Study|Protocol Violation|0|||
162811091|NCT01209780|588020065|FG004|Overall Study|Protocol Violation|0|||
162811092|NCT01209780|588020061|FG000|Overall Study|Inappropriate enrollment|0|||
162811093|NCT01209780|588020062|FG001|Overall Study|Inappropriate enrollment|2|||
162811094|NCT01209780|588020063|FG002|Overall Study|Inappropriate enrollment|0|||
162811095|NCT01209780|588020064|FG003|Overall Study|Inappropriate enrollment|0|||
162811096|NCT01209780|588020065|FG004|Overall Study|Inappropriate enrollment|1|||
162811097|NCT02318797|588020069|FG000|Overall Study|Death|3|||
162811098|NCT02318797|588020070|FG001|Overall Study|Death|6|||
162811099|NCT02318797|588020069|FG000|Overall Study|Lost to Follow-up|85|||
162811100|NCT02318797|588020070|FG001|Overall Study|Lost to Follow-up|96|||
162811101|NCT02709096|588020075|FG000|Overall Study|non-compliance|1|||
162811102|NCT02709096|588020076|FG001|Overall Study|non-compliance|1|||
162811103|NCT00505284|588020077|FG000|Overall Study|Adverse Event|3|||
162811104|NCT00505284|588020078|FG001|Overall Study|Adverse Event|7|||
162811105|NCT00505284|588020079|FG002|Overall Study|Adverse Event|9|||
162811106|NCT00505284|588020080|FG003|Overall Study|Adverse Event|14|||
162811107|NCT00505284|588020081|FG004|Overall Study|Adverse Event|22|||
162811108|NCT00505284|588020077|FG000|Overall Study|Protocol Violation|0|||
162811109|NCT00505284|588020078|FG001|Overall Study|Protocol Violation|1|||
162811110|NCT00505284|588020079|FG002|Overall Study|Protocol Violation|1|||
162811111|NCT00505284|588020080|FG003|Overall Study|Protocol Violation|0|||
162811112|NCT00505284|588020081|FG004|Overall Study|Protocol Violation|0|||
162811113|NCT00505284|588020077|FG000|Overall Study|Withdrawal by Subject|2|||
162811114|NCT00505284|588020078|FG001|Overall Study|Withdrawal by Subject|6|||
162811115|NCT00505284|588020079|FG002|Overall Study|Withdrawal by Subject|1|||
162811116|NCT00505284|588020080|FG003|Overall Study|Withdrawal by Subject|0|||
162811117|NCT00505284|588020081|FG004|Overall Study|Withdrawal by Subject|6|||
162811118|NCT00505284|588020077|FG000|Overall Study|Lack of Efficacy|0|||
162811119|NCT00505284|588020078|FG001|Overall Study|Lack of Efficacy|1|||
162811120|NCT00505284|588020079|FG002|Overall Study|Lack of Efficacy|1|||
162811121|NCT00505284|588020080|FG003|Overall Study|Lack of Efficacy|1|||
162811122|NCT00505284|588020081|FG004|Overall Study|Lack of Efficacy|1|||
162811123|NCT00505284|588020077|FG000|Overall Study|Physician Decision|0|||
162811124|NCT00505284|588020078|FG001|Overall Study|Physician Decision|1|||
162811125|NCT00505284|588020079|FG002|Overall Study|Physician Decision|0|||
162811126|NCT00505284|588020080|FG003|Overall Study|Physician Decision|0|||
162811127|NCT00505284|588020081|FG004|Overall Study|Physician Decision|0|||
162811128|NCT00505284|588020077|FG000|Overall Study|Other|5|||
162811129|NCT00505284|588020078|FG001|Overall Study|Other|0|||
162811130|NCT00505284|588020079|FG002|Overall Study|Other|0|||
162811131|NCT00505284|588020080|FG003|Overall Study|Other|4|||
162811132|NCT00505284|588020081|FG004|Overall Study|Other|4|||
162811133|NCT00940108|588020082|FG000|Overall Study|Adverse Event|2|||
162811134|NCT00940108|588020083|FG001|Overall Study|Adverse Event|4|||
162811135|NCT00940108|588020084|FG002|Overall Study|Adverse Event|0|||
162811136|NCT00940108|588020085|FG003|Overall Study|Adverse Event|2|||
162811137|NCT00940108|588020082|FG000|Overall Study|Withdrew Consent|2|||
162811138|NCT00940108|588020083|FG001|Overall Study|Withdrew Consent|1|||
162811139|NCT00940108|588020084|FG002|Overall Study|Withdrew Consent|0|||
162811140|NCT00940108|588020085|FG003|Overall Study|Withdrew Consent|1|||
162811141|NCT00940108|588020082|FG000|Overall Study|Dose 2 contraindicated|1|||
162811142|NCT00940108|588020083|FG001|Overall Study|Dose 2 contraindicated|1|||
162811143|NCT00940108|588020084|FG002|Overall Study|Dose 2 contraindicated|0|||
162811144|NCT00940108|588020085|FG003|Overall Study|Dose 2 contraindicated|1|||
162811145|NCT00940108|588020082|FG000|Overall Study|Declined further vaccination|0|||
162811146|NCT00940108|588020083|FG001|Overall Study|Declined further vaccination|1|||
162811147|NCT00940108|588020084|FG002|Overall Study|Declined further vaccination|3|||
162811148|NCT00940108|588020085|FG003|Overall Study|Declined further vaccination|0|||
162811149|NCT00940108|588020082|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
162811150|NCT00940108|588020083|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
162811151|NCT00940108|588020084|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
162811152|NCT00940108|588020085|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
162811153|NCT00940108|588020082|FG000|Overall Study|Viral illness after Dose 1|0|||
162811154|NCT00940108|588020083|FG001|Overall Study|Viral illness after Dose 1|1|||
162811155|NCT00940108|588020084|FG002|Overall Study|Viral illness after Dose 1|0|||
162811156|NCT00940108|588020085|FG003|Overall Study|Viral illness after Dose 1|0|||
162811157|NCT00940108|588020082|FG000|Overall Study|Diagnosed with H1N1|0|||
162811158|NCT00940108|588020083|FG001|Overall Study|Diagnosed with H1N1|0|||
162811159|NCT00940108|588020084|FG002|Overall Study|Diagnosed with H1N1|0|||
162811160|NCT00940108|588020085|FG003|Overall Study|Diagnosed with H1N1|1|||
162811161|NCT01740323|588020086|FG000|Overall Study|Adverse Event|1|||
162811162|NCT01740323|588020087|FG001|Overall Study|Adverse Event|0|||
162811163|NCT01740323|588020086|FG000|Overall Study|Randomized but did not take study drug|1|||
162811164|NCT01740323|588020087|FG001|Overall Study|Randomized but did not take study drug|0|||
162811165|NCT06338462|588020088|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
162811166|NCT00928447|588020089|FG000|Overall Study|Withdrawal by Subject|1|||
162811167|NCT00928447|588020089|FG000|Overall Study|Investigator's decision|1|||
162811168|NCT02533570|588020093|FG000|Overall Study|Adverse Event|0|||
162811169|NCT02533570|588020094|FG001|Overall Study|Adverse Event|1|||
162811170|NCT02533570|588020095|FG002|Overall Study|Adverse Event|1|||
162811171|NCT01163916|588020096|FG000|Overall Study|Withdrawal by Subject|2|||
162811172|NCT01163916|588020097|FG001|Overall Study|Withdrawal by Subject|0|||
162811173|NCT01163916|588020098|FG002|Overall Study|Withdrawal by Subject|2|||
162811174|NCT01163916|588020096|FG000|Overall Study|Adverse Event|2|||
162811175|NCT01163916|588020097|FG001|Overall Study|Adverse Event|0|||
162811176|NCT01163916|588020098|FG002|Overall Study|Adverse Event|1|||
162811177|NCT01163916|588020096|FG000|Overall Study|Lack of Efficacy|2|||
162811178|NCT01163916|588020097|FG001|Overall Study|Lack of Efficacy|0|||
162811179|NCT01163916|588020098|FG002|Overall Study|Lack of Efficacy|1|||
162811180|NCT01163916|588020096|FG000|Overall Study|Other|24|||
162811181|NCT01163916|588020097|FG001|Overall Study|Other|4|||
162811182|NCT01163916|588020098|FG002|Overall Study|Other|16|||
162811183|NCT01315353|588020099|FG000|Overall Study|Death|2|||
162811184|NCT01315353|588020100|FG001|Overall Study|Death|1|||
162811185|NCT01315353|588020101|FG002|Overall Study|Death|0|||
162811186|NCT01315353|588020099|FG000|Overall Study|Withdrawal by Subject|2|||
162811187|NCT01315353|588020100|FG001|Overall Study|Withdrawal by Subject|6|||
162811188|NCT01315353|588020101|FG002|Overall Study|Withdrawal by Subject|1|||
162811189|NCT01315353|588020099|FG000|Overall Study|Lost to Follow-up|13|||
162811190|NCT01315353|588020100|FG001|Overall Study|Lost to Follow-up|6|||
162811191|NCT01315353|588020101|FG002|Overall Study|Lost to Follow-up|6|||
162811192|NCT01315353|588020099|FG000|Overall Study|Unwilling to adhere to requirements|5|||
162811193|NCT01315353|588020100|FG001|Overall Study|Unwilling to adhere to requirements|5|||
162811194|NCT01315353|588020101|FG002|Overall Study|Unwilling to adhere to requirements|4|||
162811195|NCT01315353|588020099|FG000|Overall Study|Site closing|7|||
162811196|NCT01315353|588020100|FG001|Overall Study|Site closing|4|||
162811197|NCT01315353|588020101|FG002|Overall Study|Site closing|0|||
162811198|NCT01315353|588020099|FG000|Overall Study|Taken off study by site in error|0|||
162811199|NCT01315353|588020100|FG001|Overall Study|Taken off study by site in error|1|||
162811200|NCT01315353|588020101|FG002|Overall Study|Taken off study by site in error|0|||
162811201|NCT01315353|588020099|FG000|Overall Study|Inadvertent randomization/assignment|0|||
162811202|NCT01315353|588020100|FG001|Overall Study|Inadvertent randomization/assignment|0|||
162811203|NCT01315353|588020101|FG002|Overall Study|Inadvertent randomization/assignment|2|||
162811204|NCT01009580|588020102|FG000|Overall Study|Adverse Event|4|||
162811205|NCT01009580|588020103|FG001|Overall Study|Adverse Event|4|||
163040444|NCT03275389|588856010|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163040445|NCT03275389|588856001|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162811206|NCT01009580|588020102|FG000|Overall Study|Lack of Efficacy|0|||
162811207|NCT01009580|588020103|FG001|Overall Study|Lack of Efficacy|1|||
162811208|NCT01009580|588020102|FG000|Overall Study|Protocol Violation|2|||
162811209|NCT01009580|588020103|FG001|Overall Study|Protocol Violation|3|||
162811210|NCT01009580|588020102|FG000|Overall Study|Withdrawal Criteria|4|||
162811211|NCT01009580|588020103|FG001|Overall Study|Withdrawal Criteria|6|||
162811212|NCT01009580|588020102|FG000|Overall Study|Unclassified|17|||
162811213|NCT01009580|588020103|FG001|Overall Study|Unclassified|21|||
162811214|NCT04469270|588020104|FG000|Overall Study|Adverse Event|2|||
162811215|NCT04469270|588020105|FG001|Overall Study|Adverse Event|0|||
162811216|NCT04469270|588020104|FG000|Overall Study|Lost to Follow-up|4|||
162811217|NCT04469270|588020105|FG001|Overall Study|Lost to Follow-up|3|||
162811218|NCT04469270|588020104|FG000|Overall Study|Withdrawal by Subject|7|||
162811219|NCT04469270|588020105|FG001|Overall Study|Withdrawal by Subject|3|||
162811220|NCT04469270|588020104|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
162811221|NCT04469270|588020105|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
162811222|NCT04469270|588020104|FG000|Overall Study|missing|1|||
162811223|NCT04469270|588020105|FG001|Overall Study|missing|0|||
162811224|NCT00112047|588020108|FG000|Randomized Phase|Lost to Follow-up|26|||
162811225|NCT00112047|588020109|FG001|Randomized Phase|Lost to Follow-up|33|||
162811226|NCT00112047|588020108|FG000|Randomized Phase|Adverse Event|10|||
162811227|NCT00112047|588020109|FG001|Randomized Phase|Adverse Event|10|||
162811228|NCT00112047|588020108|FG000|Randomized Phase|Withrawal of consent|10|||
162811229|NCT00112047|588020109|FG001|Randomized Phase|Withrawal of consent|18|||
162811230|NCT00112047|588020108|FG000|Randomized Phase|Sub-optimal virological response|3|||
162811231|NCT00112047|588020109|FG001|Randomized Phase|Sub-optimal virological response|13|||
162811232|NCT00112047|588020108|FG000|Randomized Phase|Noncompliance|8|||
162811233|NCT00112047|588020109|FG001|Randomized Phase|Noncompliance|4|||
162811234|NCT00112047|588020108|FG000|Randomized Phase|Protocol Violation|2|||
162811235|NCT00112047|588020109|FG001|Randomized Phase|Protocol Violation|0|||
162811236|NCT00112047|588020108|FG000|Randomized Phase|Pregnancy|3|||
162811237|NCT00112047|588020109|FG001|Randomized Phase|Pregnancy|1|||
162811238|NCT00112047|588020108|FG000|Randomized Phase|Death|1|||
162811239|NCT00112047|588020109|FG001|Randomized Phase|Death|3|||
162811240|NCT00112047|588020108|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
162811241|NCT00112047|588020109|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
162811242|NCT00112047|588020108|FG000|Randomized Phase|Inability to swallow pills|0|||
162811243|NCT00112047|588020109|FG001|Randomized Phase|Inability to swallow pills|1|||
162811244|NCT00112047|588020108|FG000|Randomized Phase|Incarceration|3|||
162811245|NCT00112047|588020109|FG001|Randomized Phase|Incarceration|2|||
162811246|NCT00112047|588020108|FG000|Randomized Phase|Moved out of State|0|||
162811247|NCT00112047|588020109|FG001|Randomized Phase|Moved out of State|1|||
162811248|NCT00112047|588020108|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
162811249|NCT00112047|588020109|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
162811250|NCT00112047|588020108|FG000|Randomized Phase|High Hepatitis B DNA|0|||
162811251|NCT00112047|588020109|FG001|Randomized Phase|High Hepatitis B DNA|1|||
162811252|NCT00112047|588020108|FG000|Atripla Phase|Adverse Event|2|||
162811253|NCT00112047|588020109|FG001|Atripla Phase|Adverse Event|1|||
162811254|NCT00112047|588020108|FG000|Atripla Phase|Lost to Follow-up|5|||
162811255|NCT00112047|588020109|FG001|Atripla Phase|Lost to Follow-up|7|||
162811256|NCT00112047|588020108|FG000|Atripla Phase|Pregnancy|0|||
162811257|NCT00112047|588020109|FG001|Atripla Phase|Pregnancy|1|||
162811258|NCT00112047|588020108|FG000|Atripla Phase|Death|0|||
162811259|NCT00112047|588020109|FG001|Atripla Phase|Death|2|||
162811260|NCT00112047|588020108|FG000|Atripla Phase|Withdrew consent|7|||
162811261|NCT00112047|588020109|FG001|Atripla Phase|Withdrew consent|7|||
162811262|NCT00112047|588020108|FG000|Atripla Phase|Sub-optimal virological response|0|||
162811263|NCT00112047|588020109|FG001|Atripla Phase|Sub-optimal virological response|1|||
162811264|NCT00112047|588020108|FG000|Atripla Phase|Non-compliance|1|||
162811265|NCT00112047|588020109|FG001|Atripla Phase|Non-compliance|0|||
162811266|NCT00112047|588020108|FG000|Atripla Phase|Other|3|||
162811267|NCT00112047|588020109|FG001|Atripla Phase|Other|1|||
162811268|NCT01307579|588020110|FG000|Overall Study|Death|3|||
162811269|NCT01307579|588020111|FG001|Overall Study|Death|6|||
162811270|NCT01307579|588020110|FG000|Overall Study|Physician Decision|26|||
162811271|NCT01307579|588020111|FG001|Overall Study|Physician Decision|29|||
162811272|NCT01307579|588020110|FG000|Overall Study|Withdrawal by Subject|7|||
162811273|NCT01307579|588020111|FG001|Overall Study|Withdrawal by Subject|3|||
162811274|NCT01307579|588020110|FG000|Overall Study|Institutional diagnosis of IFD|21|||
162811275|NCT01307579|588020111|FG001|Overall Study|Institutional diagnosis of IFD|36|||
162811276|NCT01307579|588020110|FG000|Overall Study|Begin conditioning for HSCT|42|||
162811277|NCT01307579|588020111|FG001|Overall Study|Begin conditioning for HSCT|44|||
163040446|NCT03275389|588856002|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163040447|NCT03275389|588856003|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163040448|NCT03275389|588856004|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
162811278|NCT01307579|588020110|FG000|Overall Study|Refractory or relapsed AML|38|||
162811279|NCT01307579|588020111|FG001|Overall Study|Refractory or relapsed AML|23|||
162811280|NCT01307579|588020110|FG000|Overall Study|Ineligible|3|||
162811281|NCT01307579|588020111|FG001|Overall Study|Ineligible|4|||
162811282|NCT05677893|588021637|FG000|Overall Study|Withdrawal by Subject|0|||
162811283|NCT05677893|588021638|FG001|Overall Study|Withdrawal by Subject|0|||
162811284|NCT05677893|588021639|FG002|Overall Study|Withdrawal by Subject|0|||
162811285|NCT05677893|588021640|FG003|Overall Study|Withdrawal by Subject|0|||
162811286|NCT05677893|588021641|FG004|Overall Study|Withdrawal by Subject|1|||
162811287|NCT05677893|588021642|FG005|Overall Study|Withdrawal by Subject|1|||
162811288|NCT05677893|588021643|FG006|Overall Study|Withdrawal by Subject|0|||
162811289|NCT05677893|588021637|FG000|Overall Study|Others|1|||
162811290|NCT05677893|588021638|FG001|Overall Study|Others|0|||
162811291|NCT05677893|588021639|FG002|Overall Study|Others|0|||
162811292|NCT05677893|588021640|FG003|Overall Study|Others|0|||
162811293|NCT05677893|588021641|FG004|Overall Study|Others|0|||
162811294|NCT05677893|588021642|FG005|Overall Study|Others|0|||
162811295|NCT05677893|588021643|FG006|Overall Study|Others|0|||
162811296|NCT03217266|588021644|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
162811297|NCT03217266|588021645|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
162811298|NCT03217266|588021646|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
162811299|NCT03217266|588021647|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
162811300|NCT03217266|588021644|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
162811301|NCT03217266|588021645|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
162811302|NCT03217266|588021646|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
162811303|NCT03217266|588021647|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
162811304|NCT03217266|588021644|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
162811305|NCT03217266|588021645|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
162811306|NCT03217266|588021646|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
162811307|NCT03217266|588021647|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
162811308|NCT02101034|588021648|FG000|Overall Study|Enrolled but did not start treatment|0|||
162811309|NCT02101034|588021649|FG001|Overall Study|Enrolled but did not start treatment|0|||
162811310|NCT02101034|588021650|FG002|Overall Study|Enrolled but did not start treatment|1|||
162811311|NCT02101034|588021651|FG003|Overall Study|Enrolled but did not start treatment|0|||
162811312|NCT02101034|588021652|FG004|Overall Study|Enrolled but did not start treatment|0|||
162811313|NCT01101477|588021654|FG000|Overall Study|Protocol Violation|5|||
162811314|NCT01101477|588021655|FG001|Overall Study|Protocol Violation|3|||
162811315|NCT01101477|588021656|FG002|Overall Study|Protocol Violation|1|||
162811316|NCT01222507|588021657|FG000|Overall Study|Physician Decision|1|||
162811317|NCT01222507|588021657|FG000|Overall Study|Withdrawal by Subject|1|||
162811318|NCT01786174|588021662|FG000|Overall Study|Discontinued Study Drug|2|||
162811319|NCT01786174|588021663|FG001|Overall Study|Discontinued Study Drug|0|||
162811320|NCT00995020|588021664|FG000|Overall Study|margin analysis not performed|2|||
162811321|NCT00995020|588021665|FG001|Overall Study|margin analysis not performed|5|||
162811322|NCT00995020|588021664|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
162811323|NCT00995020|588021665|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
162811324|NCT01614197|588021666|FG000|Overall Study|Withdrawal by Subject|0|||
162811325|NCT01614197|588021667|FG001|Overall Study|Withdrawal by Subject|1|||
162811326|NCT01614197|588021668|FG002|Overall Study|Withdrawal by Subject|0|||
162925673|NCT02962739|588430368|FG005|Overall Study|Withdrawal by Subject|0|||
162925674|NCT02962739|588430363|FG000|Overall Study|Protocol Violation|0|||
162925675|NCT02962739|588430364|FG001|Overall Study|Protocol Violation|0|||
162925676|NCT02962739|588430365|FG002|Overall Study|Protocol Violation|1|||
162925677|NCT02962739|588430366|FG003|Overall Study|Protocol Violation|0|||
162925678|NCT02962739|588430367|FG004|Overall Study|Protocol Violation|1|||
162925679|NCT02962739|588430368|FG005|Overall Study|Protocol Violation|0|||
162925680|NCT00414011|588430369|FG000|Overall Study|Physician Decision|3|||
162925681|NCT00414011|588430369|FG000|Overall Study|Withdrawal by Subject|2|||
162925682|NCT00981409|588430374|FG000|Overall Study|Adverse Event|4|||
162925683|NCT00981409|588430375|FG001|Overall Study|Adverse Event|0|||
162925684|NCT00981409|588430374|FG000|Overall Study|Protocol Violation|0|||
162925685|NCT00981409|588430375|FG001|Overall Study|Protocol Violation|1|||
162925686|NCT00981409|588430374|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
162925687|NCT00981409|588430375|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
162925688|NCT00450177|588430376|FG000|Overall Study|Adverse Event|7|||
162925689|NCT00450177|588430377|FG001|Overall Study|Adverse Event|4|||
162925690|NCT00450177|588430376|FG000|Overall Study|Withdrawal by Subject|1|||
163040449|NCT03275389|588856005|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162925691|NCT00450177|588430377|FG001|Overall Study|Withdrawal by Subject|6|||
162925692|NCT00450177|588430376|FG000|Overall Study|Withdrawal by Primary Team|1|||
162925693|NCT00450177|588430377|FG001|Overall Study|Withdrawal by Primary Team|1|||
162925694|NCT03869684|588430382|FG000|Overall Study|Adverse Event|0|||
162925695|NCT03869684|588430383|FG001|Overall Study|Adverse Event|3|||
162925696|NCT03869684|588430384|FG002|Overall Study|Adverse Event|1|||
162925697|NCT03869684|588430382|FG000|Overall Study|Withdrawal by Subject|1|||
163040450|NCT03275389|588856006|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162925698|NCT03869684|588430383|FG001|Overall Study|Withdrawal by Subject|0|||
162925699|NCT03869684|588430384|FG002|Overall Study|Withdrawal by Subject|0|||
162925700|NCT03869684|588430382|FG000|Overall Study|Lost to Follow-up|1|||
162925701|NCT03869684|588430383|FG001|Overall Study|Lost to Follow-up|0|||
162925702|NCT03869684|588430384|FG002|Overall Study|Lost to Follow-up|0|||
162811327|NCT01614197|588021669|FG003|Overall Study|Withdrawal by Subject|0|||
162811328|NCT03442985|588021670|FG000|Overall Study|Sponsor Request|55|||
162811329|NCT03442985|588021671|FG001|Overall Study|Sponsor Request|60|||
162811330|NCT03442985|588021672|FG002|Overall Study|Sponsor Request|54|||
162811331|NCT03442985|588021670|FG000|Overall Study|Lost to Follow-up|5|||
162811332|NCT03442985|588021671|FG001|Overall Study|Lost to Follow-up|2|||
162811333|NCT03442985|588021672|FG002|Overall Study|Lost to Follow-up|7|||
162811334|NCT03442985|588021670|FG000|Overall Study|Withdrawal by Subject|2|||
162811335|NCT03442985|588021671|FG001|Overall Study|Withdrawal by Subject|3|||
162811336|NCT03442985|588021672|FG002|Overall Study|Withdrawal by Subject|4|||
162811337|NCT03442985|588021670|FG000|Overall Study|Adverse Event|0|||
162811338|NCT03442985|588021671|FG001|Overall Study|Adverse Event|1|||
162811339|NCT03442985|588021672|FG002|Overall Study|Adverse Event|0|||
162811340|NCT00876694|588021674|FG000|Overall Study|Adverse Event|10|||
162811341|NCT00876694|588021675|FG001|Overall Study|Adverse Event|7|||
162811342|NCT00876694|588021674|FG000|Overall Study|Subject withdrew consent|6|||
162811343|NCT00876694|588021675|FG001|Overall Study|Subject withdrew consent|4|||
162811344|NCT00876694|588021674|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162811345|NCT00876694|588021675|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162811346|NCT00876694|588021674|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162811347|NCT00876694|588021675|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162811348|NCT00876694|588021674|FG000|Overall Study|Administrative problems|1|||
162811349|NCT00876694|588021675|FG001|Overall Study|Administrative problems|1|||
162811350|NCT00876694|588021674|FG000|Overall Study|Death|1|||
162811351|NCT00876694|588021675|FG001|Overall Study|Death|0|||
162811352|NCT00288509|588021676|FG000|Treatment Cycle 1|Adverse Event|1|||
162811353|NCT00288509|588021676|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
162811354|NCT00288509|588021676|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
162811355|NCT00288509|588021676|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
162811356|NCT00288509|588021676|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
162811357|NCT00288509|588021676|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
162811358|NCT00288509|588021676|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
162811359|NCT00288509|588021676|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
162811360|NCT00288509|588021676|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
162811361|NCT00288509|588021676|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
162811362|NCT00288509|588021676|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
162811363|NCT00288509|588021676|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
162811364|NCT00288509|588021676|FG000|Treatment Cycle 4|Physician Decision|4|||
162811365|NCT00288509|588021676|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
162811366|NCT00084266|588021677|FG000|Overall Study|Death|42|||
162811367|NCT00084266|588021678|FG001|Overall Study|Death|39|||
162811368|NCT00084266|588021677|FG000|Overall Study|Adverse Event|8|||
162811369|NCT00084266|588021678|FG001|Overall Study|Adverse Event|5|||
162811370|NCT00084266|588021677|FG000|Overall Study|Lack of Efficacy|2|||
162811371|NCT00084266|588021678|FG001|Overall Study|Lack of Efficacy|4|||
162811372|NCT00084266|588021677|FG000|Overall Study|Lost to Follow-up|5|||
162811373|NCT00084266|588021678|FG001|Overall Study|Lost to Follow-up|3|||
162811374|NCT00084266|588021677|FG000|Overall Study|Participant not willing to participate|3|||
162811375|NCT00084266|588021678|FG001|Overall Study|Participant not willing to participate|8|||
162811376|NCT00084266|588021677|FG000|Overall Study|Other|360|||
162811377|NCT00084266|588021678|FG001|Overall Study|Other|344|||
162811378|NCT00084266|588021677|FG000|Overall Study|Randomized not treated|21|||
162811379|NCT00084266|588021678|FG001|Overall Study|Randomized not treated|20|||
162811380|NCT01215422|588021679|FG000|Overall Study|Relocation|1|||
163040451|NCT03275389|588856007|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163040452|NCT03275389|588856008|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162811381|NCT01215422|588021680|FG001|Overall Study|Relocation|0|||
162811382|NCT01215422|588021681|FG002|Overall Study|Relocation|0|||
162811383|NCT01215422|588021682|FG003|Overall Study|Relocation|0|||
162811384|NCT01215422|588021679|FG000|Overall Study|Failed intubations|0|||
162811385|NCT01215422|588021680|FG001|Overall Study|Failed intubations|0|||
162811386|NCT01215422|588021681|FG002|Overall Study|Failed intubations|3|||
162811387|NCT01215422|588021682|FG003|Overall Study|Failed intubations|8|||
162811388|NCT01215422|588021679|FG000|Overall Study|Did not complete all intubations|7|||
162811389|NCT01215422|588021680|FG001|Overall Study|Did not complete all intubations|0|||
162811390|NCT01215422|588021681|FG002|Overall Study|Did not complete all intubations|0|||
162811391|NCT01215422|588021682|FG003|Overall Study|Did not complete all intubations|0|||
162811392|NCT01386788|588021689|FG000|Overall Study|Lost to Follow-up|2|||
163040453|NCT03275389|588856009|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162811393|NCT00462865|588021690|FG000|Overall Study|Adverse Event|1|||
162811394|NCT02864381|588021691|FG000|Overall Study|Death|58|||
162811395|NCT02864381|588021692|FG001|Overall Study|Death|61|||
162811396|NCT02864381|588021691|FG000|Overall Study|Withdrew Consent|5|||
162811397|NCT02864381|588021692|FG001|Overall Study|Withdrew Consent|6|||
162811398|NCT02864381|588021691|FG000|Overall Study|Reason Unknown|7|||
162811399|NCT02864381|588021692|FG001|Overall Study|Reason Unknown|3|||
162811400|NCT02864381|588021691|FG000|Overall Study|Lost to Follow-up|1|||
163040454|NCT03275389|588856010|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163040455|NCT03275389|588856001|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040456|NCT03275389|588856002|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040457|NCT03275389|588856003|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163040458|NCT03275389|588856004|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040459|NCT03275389|588856005|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040460|NCT03275389|588856006|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040461|NCT03275389|588856007|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040462|NCT03275389|588856008|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040463|NCT03275389|588856009|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163040464|NCT03275389|588856010|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163040465|NCT03275389|588856001|FG000|Overall Study|Other|0|||
163040466|NCT03275389|588856002|FG001|Overall Study|Other|4|||
163040467|NCT03275389|588856003|FG002|Overall Study|Other|3|||
163040468|NCT03275389|588856004|FG003|Overall Study|Other|2|||
163040469|NCT03275389|588856005|FG004|Overall Study|Other|2|||
163040470|NCT03275389|588856006|FG005|Overall Study|Other|2|||
163040471|NCT03275389|588856007|FG006|Overall Study|Other|0|||
163040472|NCT03275389|588856008|FG007|Overall Study|Other|0|||
163040473|NCT03275389|588856009|FG008|Overall Study|Other|1|||
163040474|NCT03275389|588856010|FG009|Overall Study|Other|0|||
163040475|NCT00978341|588856015|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
163040476|NCT00978341|588856016|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
163040477|NCT03035916|588856017|FG000|Overall Study|Puncture failed|0|||
163040478|NCT03035916|588856018|FG001|Overall Study|Puncture failed|2|||
163040479|NCT03035916|588856019|FG002|Overall Study|Puncture failed|0|||
163040480|NCT03885999|588856020|FG000|Overall Study|Adverse Event|1|||
162811401|NCT02864381|588021692|FG001|Overall Study|Lost to Follow-up|1|||
162811402|NCT02864381|588021691|FG000|Overall Study|Investigator's Discretion|1|||
162811403|NCT02864381|588021692|FG001|Overall Study|Investigator's Discretion|0|||
162811404|NCT02864381|588021691|FG000|Overall Study|Protocol Violation|0|||
162811405|NCT02864381|588021692|FG001|Overall Study|Protocol Violation|1|||
162811406|NCT02986334|588021694|FG000|Overall Study|Withdrawal by Subject|0|||
162811407|NCT02986334|588021695|FG001|Overall Study|Withdrawal by Subject|1|||
162811408|NCT02986334|588021696|FG002|Overall Study|Withdrawal by Subject|2|||
162811409|NCT02986334|588021694|FG000|Overall Study|Lost to Follow-up|1|||
162811410|NCT02986334|588021695|FG001|Overall Study|Lost to Follow-up|2|||
162811411|NCT02986334|588021696|FG002|Overall Study|Lost to Follow-up|1|||
162811412|NCT02986334|588021694|FG000|Overall Study|Adverse Event|0|||
162811413|NCT02986334|588021695|FG001|Overall Study|Adverse Event|2|||
162811414|NCT02986334|588021696|FG002|Overall Study|Adverse Event|1|||
162811415|NCT02986334|588021694|FG000|Overall Study|non compliance in phone ratings|2|||
162811416|NCT02986334|588021695|FG001|Overall Study|non compliance in phone ratings|1|||
162811417|NCT02986334|588021696|FG002|Overall Study|non compliance in phone ratings|2|||
162811418|NCT02986334|588021694|FG000|Overall Study|undisclosed comorbidities|0|||
162811419|NCT02986334|588021695|FG001|Overall Study|undisclosed comorbidities|1|||
162811420|NCT02986334|588021696|FG002|Overall Study|undisclosed comorbidities|1|||
162811421|NCT04142450|588021697|FG000|Overall Study|Screen Failure|1|||
162811422|NCT04142450|588021697|FG000|Overall Study|Lost to Follow-up|1|||
162811423|NCT00120406|588021698|FG000|Overall Study|Death|9|||
162811424|NCT00120406|588021699|FG001|Overall Study|Death|4|||
162811425|NCT00120406|588021698|FG000|Overall Study|Withdrawal by Subject|5|||
162811426|NCT00120406|588021699|FG001|Overall Study|Withdrawal by Subject|7|||
162811427|NCT00120406|588021698|FG000|Overall Study|Lost to Follow-up|5|||
162811428|NCT00120406|588021699|FG001|Overall Study|Lost to Follow-up|2|||
162811429|NCT00120406|588021698|FG000|Overall Study|received non-study stent|0|||
162811430|NCT00120406|588021699|FG001|Overall Study|received non-study stent|2|||
162811431|NCT00120406|588021698|FG000|Overall Study|patient moved but has not withdrawn|0|||
162811432|NCT00120406|588021699|FG001|Overall Study|patient moved but has not withdrawn|1|||
162811433|NCT06336603|588021700|FG000|Overall Study|Withdrawal by Subject|1|||
162811434|NCT06336603|588021700|FG000|Overall Study|Lost to Follow-up|2|||
162811435|NCT01295034|588021706|FG000|Overall Study|Lost to Follow-up|5|||
162811436|NCT01295034|588021707|FG001|Overall Study|Lost to Follow-up|5|||
162811437|NCT00824161|588021709|FG000|Overall Study|Withdrawal by Subject|1|||
162811438|NCT00824161|588021709|FG000|Overall Study|Screen Failure|1|||
162811439|NCT00667355|588021710|FG000|Overall Study|Adverse Event|5|||
163040481|NCT02452554|588856021|FG000|Overall Study|Death|2|||
163040482|NCT02452554|588856022|FG001|Overall Study|Death|1|||
163040483|NCT02452554|588856023|FG002|Overall Study|Death|0|||
163040484|NCT02452554|588856024|FG003|Overall Study|Death|0|||
163040485|NCT02452554|588856025|FG004|Overall Study|Death|0|||
163040486|NCT02452554|588856026|FG005|Overall Study|Death|0|||
163040487|NCT02452554|588856021|FG000|Overall Study|Lack of Efficacy|13|||
162811440|NCT00667355|588021710|FG000|Overall Study|Lost to Follow-up|1|||
163040488|NCT02452554|588856022|FG001|Overall Study|Lack of Efficacy|14|||
163040489|NCT02452554|588856023|FG002|Overall Study|Lack of Efficacy|9|||
163040490|NCT02452554|588856024|FG003|Overall Study|Lack of Efficacy|1|||
162811441|NCT00667355|588021710|FG000|Overall Study|Other reason was not specified|5|||
162811442|NCT01323647|588021715|FG000|Overall Study|Migrated/moved from study area|2|||
162811443|NCT01323647|588021716|FG001|Overall Study|Migrated/moved from study area|0|||
162811444|NCT01323647|588021715|FG000|Overall Study|Withdrawal by Subject|5|||
162811445|NCT01323647|588021716|FG001|Overall Study|Withdrawal by Subject|0|||
162811446|NCT01323647|588021715|FG000|Overall Study|Lost to Follow-up|2|||
162811447|NCT01323647|588021716|FG001|Overall Study|Lost to Follow-up|0|||
162811448|NCT02768870|588021719|FG000|Overall Study|Death|1|||
162811449|NCT02768870|588021719|FG000|Overall Study|Reoperation|6|||
162811450|NCT02768870|588021719|FG000|Overall Study|Lost to Follow-up|1|||
162811451|NCT02768870|588021719|FG000|Overall Study|Exit|4|||
162811452|NCT02963610|588021720|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
162811453|NCT01774110|588021721|FG000|Overall Study|Lost to Follow-up|7|||
162811454|NCT00063154|588021722|FG000|Overall Study|Disease progression|27|||
162811455|NCT00063154|588021722|FG000|Overall Study|Adverse Event|2|||
162811456|NCT00063154|588021722|FG000|Overall Study|Physician Decision|10|||
162811457|NCT00063154|588021722|FG000|Overall Study|Death|3|||
162811458|NCT00063154|588021722|FG000|Overall Study|Reason unspecified|1|||
162811459|NCT00063154|588021722|FG000|Overall Study|Did not receive treatment|8|||
162811460|NCT02203695|588021723|FG000|Overall Study|Patient withdrew consent|1|||
162811461|NCT02203695|588021724|FG001|Overall Study|Patient withdrew consent|1|||
162811462|NCT02203695|588021723|FG000|Overall Study|Started non-study treatment|1|||
162811463|NCT02203695|588021724|FG001|Overall Study|Started non-study treatment|0|||
162811464|NCT01259726|588021725|FG000|Overall Study|Death|1|||
162811465|NCT01259726|588021726|FG001|Overall Study|Death|0|||
162811466|NCT01259726|588021727|FG002|Overall Study|Death|0|||
162811467|NCT01259726|588021728|FG003|Overall Study|Death|0|||
162811468|NCT01259726|588021725|FG000|Overall Study|Physician Decision|2|||
162811469|NCT01259726|588021726|FG001|Overall Study|Physician Decision|0|||
162811470|NCT01259726|588021727|FG002|Overall Study|Physician Decision|1|||
162811471|NCT01259726|588021728|FG003|Overall Study|Physician Decision|1|||
162811472|NCT01259726|588021725|FG000|Overall Study|Withdrawal by Subject|1|||
162811473|NCT01259726|588021726|FG001|Overall Study|Withdrawal by Subject|3|||
162811474|NCT01259726|588021727|FG002|Overall Study|Withdrawal by Subject|2|||
162925703|NCT03869684|588430382|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
162925704|NCT03869684|588430383|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
162811475|NCT01259726|588021728|FG003|Overall Study|Withdrawal by Subject|1|||
162925705|NCT03869684|588430384|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
162925706|NCT04056299|588430385|FG000|Overall Study|Sponsor discontinued study|3|||
162925707|NCT04056299|588430386|FG001|Overall Study|Sponsor discontinued study|3|||
162925708|NCT01227954|588430391|FG000|Overall Study|Protocol Violation|6|||
162925709|NCT01227954|588430391|FG000|Overall Study|No protocol treatment|7|||
162925710|NCT00078312|588430394|FG000|Overall Study|Adverse Event|43|||
162925711|NCT00078312|588430394|FG000|Overall Study|Lack of Efficacy|15|||
162925712|NCT00078312|588430394|FG000|Overall Study|Lost to Follow-up|41|||
162925713|NCT00078312|588430394|FG000|Overall Study|Physician Decision|9|||
162925714|NCT00078312|588430394|FG000|Overall Study|Protocol Violation|3|||
162925715|NCT00078312|588430394|FG000|Overall Study|Withdrawal by Subject|33|||
162925716|NCT00078312|588430394|FG000|Overall Study|Miscellaneous|33|||
162925717|NCT01268683|588430395|FG000|Overall Study|Lost to Follow-up|1|||
162925718|NCT01268683|588430395|FG000|Overall Study|Death|1|||
162925719|NCT04256759|588430396|FG000|Overall Study|Physician Decision|1|||
162925720|NCT04256759|588430396|FG000|Overall Study|Lack of Efficacy|1|||
162811476|NCT01259726|588021725|FG000|Overall Study|Lost to Follow-up|1|||
162811477|NCT01259726|588021726|FG001|Overall Study|Lost to Follow-up|1|||
162811478|NCT01259726|588021727|FG002|Overall Study|Lost to Follow-up|1|||
162925721|NCT03901352|588430401|FG000|Double-blind Phase|Adverse Event|6|||
162925722|NCT03901352|588430402|FG001|Double-blind Phase|Adverse Event|4|||
162811479|NCT01259726|588021728|FG003|Overall Study|Lost to Follow-up|3|||
162811480|NCT00261846|588021729|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
162811481|NCT00261846|588021730|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
162811482|NCT00261846|588021731|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
162811483|NCT00261846|588021732|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162925723|NCT03901352|588430401|FG000|Double-blind Phase|Death|1|||
162925724|NCT03901352|588430402|FG001|Double-blind Phase|Death|0|||
162811484|NCT00261846|588021733|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811485|NCT00261846|588021734|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811486|NCT00261846|588021735|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811487|NCT00261846|588021736|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811488|NCT00261846|588021737|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811489|NCT00261846|588021738|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811490|NCT00261846|588021739|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162811491|NCT00261846|588021740|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162925725|NCT03901352|588430401|FG000|Double-blind Phase|Lack of Efficacy|0|||
162925726|NCT03901352|588430402|FG001|Double-blind Phase|Lack of Efficacy|1|||
162925727|NCT03901352|588430401|FG000|Double-blind Phase|Protocol Violation|0|||
162925728|NCT03901352|588430402|FG001|Double-blind Phase|Protocol Violation|1|||
162811492|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811493|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811494|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811495|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
162811496|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811497|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811498|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811499|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811500|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
162811501|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811502|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811503|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162811504|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811505|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811506|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811507|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
162811508|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
162811509|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
162811510|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
162811511|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
162811512|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811513|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
162811514|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811515|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162811516|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811517|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811518|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811519|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
162811520|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162811521|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811522|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162925729|NCT03901352|588430401|FG000|Double-blind Phase|Withdrawal by Subject|10|||
162925730|NCT03901352|588430402|FG001|Double-blind Phase|Withdrawal by Subject|8|||
162925731|NCT03901352|588430401|FG000|Open-label Extension Phase|Adverse Event|24|||
162925732|NCT03901352|588430402|FG001|Open-label Extension Phase|Adverse Event|0|||
162811523|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811524|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
162811525|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162811526|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162811527|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162811528|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
162811529|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
162811530|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
162811531|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
162811532|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
162811533|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
162811534|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
162811535|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
162925733|NCT03901352|588430401|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
162925734|NCT03901352|588430402|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
162925735|NCT03901352|588430401|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
162925736|NCT03901352|588430402|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
162925737|NCT03901352|588430401|FG000|Open-label Extension Phase|Other|1|||
162925738|NCT03901352|588430402|FG001|Open-label Extension Phase|Other|0|||
162925739|NCT01826201|588430405|FG000|Overall Study|Non compliance with protocol|4|||
162925740|NCT02742818|588430406|FG000|Overall Study|Adverse Event|0|||
162925741|NCT02742818|588430407|FG001|Overall Study|Adverse Event|1|||
162925742|NCT02742818|588430406|FG000|Overall Study|Protocol Violation|0|||
162925743|NCT02742818|588430407|FG001|Overall Study|Protocol Violation|1|||
162925744|NCT04701658|588430408|FG000|Overall Study|Lost to Follow-up|6|||
162925745|NCT00756652|588430409|FG000|Original Phase|Withdrawal by Subject|864|||
162925746|NCT00756652|588430410|FG001|Original Phase|Withdrawal by Subject|23|||
162925747|NCT00756652|588430409|FG000|Original Phase|Lost to Follow-up|601|||
162925748|NCT00756652|588430410|FG001|Original Phase|Lost to Follow-up|0|||
162925749|NCT00756652|588430409|FG000|Original Phase|Other Discontinuation|797|||
162925750|NCT00756652|588430410|FG001|Original Phase|Other Discontinuation|5|||
162925751|NCT00756652|588430409|FG000|Original Phase|Participant Noncompliance|18622|||
162925752|NCT00756652|588430410|FG001|Original Phase|Participant Noncompliance|424|||
162925753|NCT00756652|588430409|FG000|Original Phase|Unknown Discontinuation Reason|2|||
162925754|NCT00756652|588430410|FG001|Original Phase|Unknown Discontinuation Reason|0|||
162925755|NCT00756652|588430409|FG000|Original Phase|Participants without data|3259|||
162811536|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
162811537|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
162811538|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
162811539|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
162811540|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
162811541|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
162811542|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
162811543|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
162811544|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
162811545|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
162811546|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
162811547|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
162811548|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
162811549|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
162811550|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
162811551|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
162811552|NCT00261846|588021729|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
162811553|NCT00261846|588021730|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
162811554|NCT00261846|588021731|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
162811555|NCT00261846|588021732|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
162811556|NCT00261846|588021733|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
162811557|NCT00261846|588021734|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
162811558|NCT00261846|588021735|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
162811559|NCT00261846|588021736|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
162811560|NCT00261846|588021737|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
162811561|NCT00261846|588021738|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
162811562|NCT00261846|588021739|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
162811563|NCT00261846|588021740|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
162811564|NCT01745848|588021745|FG000|Overall Study|Adverse Event|6|||
162811565|NCT00926211|588021751|FG000|Overall Study|Lost to Follow-up|1|||
162811566|NCT03581825|588021752|FG000|Period 1|Lens Discomfort|1|||
162811567|NCT03581825|588021753|FG001|Period 1|Lens Discomfort|0|||
162811568|NCT03581825|588021752|FG000|Period 2|Unsatisfactory Vision to Test|0|||
162811569|NCT03581825|588021753|FG001|Period 2|Unsatisfactory Vision to Test|1|||
162811570|NCT00585195|588021755|FG000|Overall Study|Adverse Event|0|||
162811571|NCT00585195|588021756|FG001|Overall Study|Adverse Event|0|||
162811572|NCT00585195|588021757|FG002|Overall Study|Adverse Event|0|||
162811573|NCT00585195|588021758|FG003|Overall Study|Adverse Event|0|||
162811574|NCT00585195|588021759|FG004|Overall Study|Adverse Event|2|||
162925756|NCT00756652|588430410|FG001|Original Phase|Participants without data|466|||
162925757|NCT00756652|588430409|FG000|Original Phase|Death|168|||
162925758|NCT00756652|588430410|FG001|Original Phase|Death|1|||
162925759|NCT00756652|588430409|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
162925760|NCT00756652|588430410|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
162925761|NCT00756652|588430409|FG000|Re-Op Phase|Withdrawal by Subject|62|||
162925762|NCT00756652|588430410|FG001|Re-Op Phase|Withdrawal by Subject|0|||
162925763|NCT00756652|588430409|FG000|Re-Op Phase|Death|6|||
162925764|NCT00756652|588430410|FG001|Re-Op Phase|Death|0|||
162925765|NCT00756652|588430409|FG000|Re-Op Phase|Lost to Follow-up|340|||
162925766|NCT00756652|588430410|FG001|Re-Op Phase|Lost to Follow-up|0|||
162925767|NCT00756652|588430409|FG000|Re-Op Phase|Site Closed|2454|||
162925768|NCT00756652|588430410|FG001|Re-Op Phase|Site Closed|0|||
162925769|NCT00756652|588430409|FG000|Re-Op Phase|Withdrawn after explant|14|||
162925770|NCT00756652|588430410|FG001|Re-Op Phase|Withdrawn after explant|0|||
162925771|NCT05349188|588430411|FG000|Overall Study|Withdrawal by Subject|1|||
162811575|NCT00585195|588021760|FG005|Overall Study|Adverse Event|1|||
162811576|NCT00585195|588021761|FG006|Overall Study|Adverse Event|0|||
162811577|NCT00585195|588021762|FG007|Overall Study|Adverse Event|1|||
162811578|NCT00585195|588021763|FG008|Overall Study|Adverse Event|0|||
162811579|NCT00585195|588021764|FG009|Overall Study|Adverse Event|0|||
162811580|NCT00585195|588021765|FG010|Overall Study|Adverse Event|3|||
162811581|NCT00585195|588021766|FG011|Overall Study|Adverse Event|0|||
162811582|NCT00585195|588021767|FG012|Overall Study|Adverse Event|8|||
162811583|NCT00585195|588021768|FG013|Overall Study|Adverse Event|6|||
162811584|NCT00585195|588021769|FG014|Overall Study|Adverse Event|4|||
162811585|NCT00585195|588021770|FG015|Overall Study|Adverse Event|1|||
162811586|NCT00585195|588021771|FG016|Overall Study|Adverse Event|14|||
162811587|NCT00585195|588021772|FG017|Overall Study|Adverse Event|9|||
162811588|NCT00585195|588021773|FG018|Overall Study|Adverse Event|2|||
162811589|NCT00585195|588021774|FG019|Overall Study|Adverse Event|3|||
162811590|NCT00585195|588021775|FG020|Overall Study|Adverse Event|1|||
162811591|NCT00585195|588021755|FG000|Overall Study|Progressive Disease|2|||
162811592|NCT00585195|588021756|FG001|Overall Study|Progressive Disease|2|||
162811593|NCT00585195|588021757|FG002|Overall Study|Progressive Disease|5|||
163040491|NCT02452554|588856025|FG004|Overall Study|Lack of Efficacy|5|||
162811594|NCT00585195|588021758|FG003|Overall Study|Progressive Disease|4|||
162811595|NCT00585195|588021759|FG004|Overall Study|Progressive Disease|6|||
162925772|NCT05349188|588430412|FG001|Overall Study|Withdrawal by Subject|0|||
162925773|NCT03889197|588430419|FG000|Overall Study|Withdrawal by Subject|1|||
162811596|NCT00585195|588021760|FG005|Overall Study|Progressive Disease|4|||
162811597|NCT00585195|588021761|FG006|Overall Study|Progressive Disease|6|||
162811598|NCT00585195|588021762|FG007|Overall Study|Progressive Disease|3|||
162811599|NCT00585195|588021763|FG008|Overall Study|Progressive Disease|0|||
162811600|NCT00585195|588021764|FG009|Overall Study|Progressive Disease|5|||
162811601|NCT00585195|588021765|FG010|Overall Study|Progressive Disease|2|||
162811602|NCT00585195|588021766|FG011|Overall Study|Progressive Disease|25|||
162811603|NCT00585195|588021767|FG012|Overall Study|Progressive Disease|29|||
162811604|NCT00585195|588021768|FG013|Overall Study|Progressive Disease|26|||
162811605|NCT00585195|588021769|FG014|Overall Study|Progressive Disease|21|||
162811606|NCT00585195|588021770|FG015|Overall Study|Progressive Disease|12|||
162811607|NCT00585195|588021771|FG016|Overall Study|Progressive Disease|94|||
162811608|NCT00585195|588021772|FG017|Overall Study|Progressive Disease|42|||
162811609|NCT00585195|588021773|FG018|Overall Study|Progressive Disease|4|||
162811610|NCT00585195|588021774|FG019|Overall Study|Progressive Disease|9|||
162811611|NCT00585195|588021775|FG020|Overall Study|Progressive Disease|8|||
162811612|NCT00585195|588021755|FG000|Overall Study|Withdrawal by Subject|1|||
162811613|NCT00585195|588021756|FG001|Overall Study|Withdrawal by Subject|1|||
162925774|NCT03889197|588430420|FG001|Overall Study|Withdrawal by Subject|0|||
162925775|NCT03889197|588430419|FG000|Overall Study|Physician Decision|0|||
162925776|NCT03889197|588430420|FG001|Overall Study|Physician Decision|1|||
162925777|NCT03889197|588430419|FG000|Overall Study|met exclusion criteria|0|||
162925778|NCT03889197|588430420|FG001|Overall Study|met exclusion criteria|1|||
162925779|NCT03889197|588430419|FG000|Overall Study|Protocol Violation|1|||
162925780|NCT03889197|588430420|FG001|Overall Study|Protocol Violation|0|||
162811614|NCT00585195|588021757|FG002|Overall Study|Withdrawal by Subject|2|||
162811615|NCT00585195|588021758|FG003|Overall Study|Withdrawal by Subject|2|||
162811616|NCT00585195|588021759|FG004|Overall Study|Withdrawal by Subject|0|||
162811617|NCT00585195|588021760|FG005|Overall Study|Withdrawal by Subject|0|||
162811618|NCT00585195|588021761|FG006|Overall Study|Withdrawal by Subject|0|||
162811619|NCT00585195|588021762|FG007|Overall Study|Withdrawal by Subject|1|||
162811620|NCT00585195|588021763|FG008|Overall Study|Withdrawal by Subject|0|||
162811621|NCT00585195|588021764|FG009|Overall Study|Withdrawal by Subject|0|||
162811622|NCT00585195|588021765|FG010|Overall Study|Withdrawal by Subject|3|||
162811623|NCT00585195|588021766|FG011|Overall Study|Withdrawal by Subject|8|||
162811624|NCT00585195|588021767|FG012|Overall Study|Withdrawal by Subject|15|||
162811625|NCT00585195|588021768|FG013|Overall Study|Withdrawal by Subject|0|||
162811626|NCT00585195|588021769|FG014|Overall Study|Withdrawal by Subject|3|||
162811627|NCT00585195|588021770|FG015|Overall Study|Withdrawal by Subject|0|||
162811628|NCT00585195|588021771|FG016|Overall Study|Withdrawal by Subject|7|||
162811629|NCT00585195|588021772|FG017|Overall Study|Withdrawal by Subject|1|||
162811630|NCT00585195|588021773|FG018|Overall Study|Withdrawal by Subject|2|||
162811631|NCT00585195|588021774|FG019|Overall Study|Withdrawal by Subject|2|||
162811632|NCT00585195|588021775|FG020|Overall Study|Withdrawal by Subject|0|||
162811633|NCT00585195|588021755|FG000|Overall Study|Other|0|||
162811634|NCT00585195|588021756|FG001|Overall Study|Other|1|||
162925781|NCT03193190|588430426|FG000|Stage 1|Arm Terminated by Sponsor|0|||
162925782|NCT03193190|588430427|FG001|Stage 1|Arm Terminated by Sponsor|0|||
163040492|NCT02452554|588856026|FG005|Overall Study|Lack of Efficacy|8|||
163040493|NCT02452554|588856021|FG000|Overall Study|Physician Decision|0|||
163040494|NCT02452554|588856022|FG001|Overall Study|Physician Decision|1|||
163040495|NCT02452554|588856023|FG002|Overall Study|Physician Decision|0|||
163040496|NCT02452554|588856024|FG003|Overall Study|Physician Decision|0|||
163040497|NCT02452554|588856025|FG004|Overall Study|Physician Decision|0|||
163040498|NCT02452554|588856026|FG005|Overall Study|Physician Decision|0|||
163040499|NCT02452554|588856021|FG000|Overall Study|Withdrawal by Subject|1|||
162925783|NCT03193190|588430428|FG002|Stage 1|Arm Terminated by Sponsor|0|||
162925784|NCT03193190|588430429|FG003|Stage 1|Arm Terminated by Sponsor|1|||
163040500|NCT02452554|588856022|FG001|Overall Study|Withdrawal by Subject|0|||
163040501|NCT02452554|588856023|FG002|Overall Study|Withdrawal by Subject|2|||
163040502|NCT02452554|588856024|FG003|Overall Study|Withdrawal by Subject|0|||
162925785|NCT03193190|588430430|FG004|Stage 1|Arm Terminated by Sponsor|0|||
162925786|NCT03193190|588430431|FG005|Stage 1|Arm Terminated by Sponsor|2|||
162925787|NCT03193190|588430432|FG006|Stage 1|Arm Terminated by Sponsor|0|||
162925788|NCT03193190|588430433|FG007|Stage 1|Arm Terminated by Sponsor|0|||
162925789|NCT03193190|588430434|FG008|Stage 1|Arm Terminated by Sponsor|0|||
162925790|NCT03193190|588430435|FG009|Stage 1|Arm Terminated by Sponsor|0|||
162925791|NCT03193190|588430436|FG010|Stage 1|Arm Terminated by Sponsor|0|||
163040503|NCT02452554|588856025|FG004|Overall Study|Withdrawal by Subject|0|||
163040504|NCT02452554|588856026|FG005|Overall Study|Withdrawal by Subject|1|||
163040505|NCT02452554|588856021|FG000|Overall Study|Ineligible|0|||
162925792|NCT03193190|588430437|FG011|Stage 1|Arm Terminated by Sponsor|0|||
162925793|NCT03193190|588430438|FG012|Stage 1|Arm Terminated by Sponsor|0|||
162925794|NCT03193190|588430439|FG013|Stage 1|Arm Terminated by Sponsor|0|||
162925795|NCT03193190|588430440|FG014|Stage 1|Arm Terminated by Sponsor|0|||
162925796|NCT03193190|588430441|FG015|Stage 1|Arm Terminated by Sponsor|0|||
163040506|NCT02452554|588856022|FG001|Overall Study|Ineligible|1|||
163040507|NCT02452554|588856023|FG002|Overall Study|Ineligible|0|||
162925797|NCT03193190|588430426|FG000|Stage 1|Death|22|||
162925798|NCT03193190|588430427|FG001|Stage 1|Death|8|||
162925799|NCT03193190|588430428|FG002|Stage 1|Death|23|||
163040508|NCT02452554|588856024|FG003|Overall Study|Ineligible|0|||
163040509|NCT02452554|588856025|FG004|Overall Study|Ineligible|0|||
163040510|NCT02452554|588856026|FG005|Overall Study|Ineligible|0|||
163040511|NCT02452554|588856021|FG000|Overall Study|Never Received Treatment|1|||
163040512|NCT02452554|588856022|FG001|Overall Study|Never Received Treatment|0|||
163040513|NCT02452554|588856023|FG002|Overall Study|Never Received Treatment|0|||
163040514|NCT02452554|588856024|FG003|Overall Study|Never Received Treatment|0|||
163040515|NCT02452554|588856025|FG004|Overall Study|Never Received Treatment|0|||
163040516|NCT02452554|588856026|FG005|Overall Study|Never Received Treatment|0|||
163040517|NCT01790516|588856027|FG000|Overall Study|Physician Decision|1|||
163040518|NCT01790516|588856028|FG001|Overall Study|Physician Decision|0|||
163040519|NCT01402986|588856029|FG000|Overall Study|Withdrawal by Subject|7|||
163040520|NCT01402986|588856030|FG001|Overall Study|Withdrawal by Subject|10|||
163040521|NCT01402986|588856031|FG002|Overall Study|Withdrawal by Subject|7|||
163040522|NCT01402986|588856032|FG003|Overall Study|Withdrawal by Subject|13|||
163040523|NCT01402986|588856029|FG000|Overall Study|Death|0|||
163040524|NCT01402986|588856030|FG001|Overall Study|Death|0|||
163040525|NCT01402986|588856031|FG002|Overall Study|Death|0|||
163040526|NCT01402986|588856032|FG003|Overall Study|Death|2|||
163040527|NCT01402986|588856029|FG000|Overall Study|Lost to Follow-up|0|||
163040528|NCT01402986|588856030|FG001|Overall Study|Lost to Follow-up|0|||
163040529|NCT01402986|588856031|FG002|Overall Study|Lost to Follow-up|0|||
163040530|NCT01402986|588856032|FG003|Overall Study|Lost to Follow-up|1|||
163040531|NCT01402986|588856029|FG000|Overall Study|Other|2|||
163040532|NCT01402986|588856030|FG001|Overall Study|Other|5|||
163040533|NCT01402986|588856031|FG002|Overall Study|Other|1|||
163040534|NCT01402986|588856032|FG003|Overall Study|Other|6|||
163040535|NCT01085084|588856033|FG000|Overall Study|Withdrawal by Subject|1|||
163040536|NCT01085084|588856034|FG001|Overall Study|Withdrawal by Subject|0|||
163040537|NCT01085084|588856035|FG002|Overall Study|Withdrawal by Subject|0|||
163040538|NCT01085084|588856033|FG000|Overall Study|Lost to Follow-up|2|||
163040539|NCT01085084|588856034|FG001|Overall Study|Lost to Follow-up|1|||
163040540|NCT01085084|588856035|FG002|Overall Study|Lost to Follow-up|1|||
163040541|NCT01085084|588856033|FG000|Overall Study|Adverse Event|4|||
163040542|NCT01085084|588856034|FG001|Overall Study|Adverse Event|3|||
163040543|NCT01085084|588856035|FG002|Overall Study|Adverse Event|6|||
163040544|NCT01085084|588856033|FG000|Overall Study|Treatment Failure|0|||
163040545|NCT01085084|588856034|FG001|Overall Study|Treatment Failure|1|||
163040546|NCT01085084|588856035|FG002|Overall Study|Treatment Failure|2|||
163040547|NCT02749799|588856036|FG000|Overall Study|Adverse Event|2|||
163040548|NCT02749799|588856036|FG000|Overall Study|Lost to Follow-up|4|||
163040549|NCT02749799|588856036|FG000|Overall Study|Protocol Violation|1|||
163040550|NCT02749799|588856036|FG000|Overall Study|Withdrawal by Subject|1|||
163040551|NCT02070978|588856037|FG000|Overall Study|Adverse Event|6|||
163040552|NCT02070978|588856038|FG001|Overall Study|Adverse Event|2|||
163040553|NCT02070978|588856039|FG002|Overall Study|Adverse Event|0|||
163040554|NCT02070978|588856037|FG000|Overall Study|Lost to Follow-up|1|||
163040555|NCT02070978|588856038|FG001|Overall Study|Lost to Follow-up|3|||
163040556|NCT02070978|588856039|FG002|Overall Study|Lost to Follow-up|4|||
163040557|NCT02070978|588856037|FG000|Overall Study|Withdrawal by Subject|3|||
163154973|NCT00463567|589283655|FG006|Overall Study|Administrative problems|2|||
162925800|NCT03193190|588430429|FG003|Stage 1|Death|14|||
162925801|NCT03193190|588430430|FG004|Stage 1|Death|34|||
162925802|NCT03193190|588430431|FG005|Stage 1|Death|28|||
162925803|NCT03193190|588430432|FG006|Stage 1|Death|19|||
162925804|NCT03193190|588430433|FG007|Stage 1|Death|21|||
162925805|NCT03193190|588430434|FG008|Stage 1|Death|14|||
162925806|NCT03193190|588430435|FG009|Stage 1|Death|10|||
162925807|NCT03193190|588430436|FG010|Stage 1|Death|59|||
162925808|NCT03193190|588430437|FG011|Stage 1|Death|14|||
162925809|NCT03193190|588430438|FG012|Stage 1|Death|14|||
162925810|NCT03193190|588430439|FG013|Stage 1|Death|0|||
162925811|NCT03193190|588430440|FG014|Stage 1|Death|0|||
162925812|NCT03193190|588430441|FG015|Stage 1|Death|0|||
163040558|NCT02070978|588856038|FG001|Overall Study|Withdrawal by Subject|5|||
163040559|NCT02070978|588856039|FG002|Overall Study|Withdrawal by Subject|3|||
163040560|NCT02070978|588856037|FG000|Overall Study|Protocol Violation|1|||
163040561|NCT02070978|588856038|FG001|Overall Study|Protocol Violation|0|||
163040562|NCT02070978|588856039|FG002|Overall Study|Protocol Violation|3|||
163040563|NCT02070978|588856037|FG000|Overall Study|Lack of Efficacy|0|||
163040564|NCT02070978|588856038|FG001|Overall Study|Lack of Efficacy|1|||
163040565|NCT02070978|588856039|FG002|Overall Study|Lack of Efficacy|0|||
163040566|NCT02070978|588856037|FG000|Overall Study|Death|0|||
163040567|NCT02070978|588856038|FG001|Overall Study|Death|0|||
163154974|NCT00463567|589283649|FG000|Overall Study|Lack of Efficacy|4|||
162925813|NCT03193190|588430426|FG000|Stage 1|Lost to Follow-up|2|||
162925814|NCT03193190|588430427|FG001|Stage 1|Lost to Follow-up|1|||
162925815|NCT03193190|588430428|FG002|Stage 1|Lost to Follow-up|1|||
162925816|NCT03193190|588430429|FG003|Stage 1|Lost to Follow-up|0|||
163040568|NCT02070978|588856039|FG002|Overall Study|Death|2|||
163040569|NCT02070978|588856037|FG000|Overall Study|Un-specified|3|||
163040570|NCT02070978|588856038|FG001|Overall Study|Un-specified|2|||
162925817|NCT03193190|588430430|FG004|Stage 1|Lost to Follow-up|0|||
162925818|NCT03193190|588430431|FG005|Stage 1|Lost to Follow-up|0|||
162925819|NCT03193190|588430432|FG006|Stage 1|Lost to Follow-up|1|||
162925820|NCT03193190|588430433|FG007|Stage 1|Lost to Follow-up|0|||
162925821|NCT03193190|588430434|FG008|Stage 1|Lost to Follow-up|0|||
162925822|NCT03193190|588430435|FG009|Stage 1|Lost to Follow-up|0|||
162925823|NCT03193190|588430436|FG010|Stage 1|Lost to Follow-up|0|||
162925824|NCT03193190|588430437|FG011|Stage 1|Lost to Follow-up|0|||
162925825|NCT03193190|588430438|FG012|Stage 1|Lost to Follow-up|0|||
162925826|NCT03193190|588430439|FG013|Stage 1|Lost to Follow-up|0|||
162925827|NCT03193190|588430440|FG014|Stage 1|Lost to Follow-up|0|||
162925828|NCT03193190|588430441|FG015|Stage 1|Lost to Follow-up|0|||
162925829|NCT03193190|588430426|FG000|Stage 1|Reason not Specified|1|||
162925830|NCT03193190|588430427|FG001|Stage 1|Reason not Specified|0|||
162925831|NCT03193190|588430428|FG002|Stage 1|Reason not Specified|0|||
162925832|NCT03193190|588430429|FG003|Stage 1|Reason not Specified|1|||
162925833|NCT03193190|588430430|FG004|Stage 1|Reason not Specified|0|||
162925834|NCT03193190|588430431|FG005|Stage 1|Reason not Specified|1|||
162925835|NCT03193190|588430432|FG006|Stage 1|Reason not Specified|2|||
162925836|NCT03193190|588430433|FG007|Stage 1|Reason not Specified|2|||
162925837|NCT03193190|588430434|FG008|Stage 1|Reason not Specified|0|||
162925838|NCT03193190|588430435|FG009|Stage 1|Reason not Specified|1|||
163040571|NCT02070978|588856039|FG002|Overall Study|Un-specified|2|||
163040572|NCT02070978|588856037|FG000|Overall Study|Terminated by Sponsor|33|||
163040573|NCT02070978|588856038|FG001|Overall Study|Terminated by Sponsor|40|||
163040574|NCT02070978|588856039|FG002|Overall Study|Terminated by Sponsor|39|||
163040575|NCT03749109|588856040|FG000|Overall Study|Adverse Event|2|||
163040576|NCT03749109|588856041|FG001|Overall Study|Adverse Event|0|||
163040577|NCT03951753|588856042|FG000|Overall Study|Adverse Event|1|||
163040578|NCT03951753|588856043|FG001|Overall Study|Adverse Event|0|||
163040579|NCT03951753|588856044|FG002|Overall Study|Adverse Event|3|||
163040580|NCT03951753|588856042|FG000|Overall Study|Withdrawal by Subject|3|||
163040581|NCT03951753|588856043|FG001|Overall Study|Withdrawal by Subject|1|||
163040582|NCT03951753|588856044|FG002|Overall Study|Withdrawal by Subject|0|||
163040583|NCT03951753|588856042|FG000|Overall Study|Lost to Follow-up|0|||
163040584|NCT03951753|588856043|FG001|Overall Study|Lost to Follow-up|0|||
163040585|NCT03951753|588856044|FG002|Overall Study|Lost to Follow-up|1|||
163040586|NCT03178851|588856045|FG000|Overall Study|Death|48|||
163040587|NCT03178851|588856046|FG001|Overall Study|Death|2|||
163040588|NCT03178851|588856047|FG002|Overall Study|Death|25|||
163040589|NCT03178851|588856045|FG000|Overall Study|Withdrawal by Subject|8|||
163154975|NCT00463567|589283650|FG001|Overall Study|Lack of Efficacy|9|||
162925839|NCT03193190|588430436|FG010|Stage 1|Reason not Specified|3|||
162925840|NCT03193190|588430437|FG011|Stage 1|Reason not Specified|0|||
162925841|NCT03193190|588430438|FG012|Stage 1|Reason not Specified|1|||
162925842|NCT03193190|588430439|FG013|Stage 1|Reason not Specified|0|||
162925843|NCT03193190|588430440|FG014|Stage 1|Reason not Specified|0|||
162925844|NCT03193190|588430441|FG015|Stage 1|Reason not Specified|0|||
162925845|NCT03193190|588430426|FG000|Stage 1|Physician Decision|0|||
162925846|NCT03193190|588430427|FG001|Stage 1|Physician Decision|0|||
162925847|NCT03193190|588430428|FG002|Stage 1|Physician Decision|0|||
162925848|NCT03193190|588430429|FG003|Stage 1|Physician Decision|0|||
162925849|NCT03193190|588430430|FG004|Stage 1|Physician Decision|0|||
162925850|NCT03193190|588430431|FG005|Stage 1|Physician Decision|0|||
162925851|NCT03193190|588430432|FG006|Stage 1|Physician Decision|0|||
162925852|NCT03193190|588430433|FG007|Stage 1|Physician Decision|0|||
162925853|NCT03193190|588430434|FG008|Stage 1|Physician Decision|0|||
162925854|NCT03193190|588430435|FG009|Stage 1|Physician Decision|0|||
162925855|NCT03193190|588430436|FG010|Stage 1|Physician Decision|0|||
162925856|NCT03193190|588430437|FG011|Stage 1|Physician Decision|1|||
162925857|NCT03193190|588430438|FG012|Stage 1|Physician Decision|0|||
162925858|NCT03193190|588430439|FG013|Stage 1|Physician Decision|0|||
162925859|NCT03193190|588430440|FG014|Stage 1|Physician Decision|0|||
162925860|NCT03193190|588430441|FG015|Stage 1|Physician Decision|0|||
162925861|NCT03193190|588430426|FG000|Stage 1|Progressive Disease|1|||
162925862|NCT03193190|588430427|FG001|Stage 1|Progressive Disease|0|||
162925863|NCT03193190|588430428|FG002|Stage 1|Progressive Disease|0|||
162925864|NCT03193190|588430429|FG003|Stage 1|Progressive Disease|0|||
162925865|NCT03193190|588430430|FG004|Stage 1|Progressive Disease|0|||
162925866|NCT03193190|588430431|FG005|Stage 1|Progressive Disease|0|||
162925867|NCT03193190|588430432|FG006|Stage 1|Progressive Disease|0|||
162925868|NCT03193190|588430433|FG007|Stage 1|Progressive Disease|0|||
162925869|NCT03193190|588430434|FG008|Stage 1|Progressive Disease|0|||
163040590|NCT03178851|588856046|FG001|Overall Study|Withdrawal by Subject|0|||
162925870|NCT03193190|588430435|FG009|Stage 1|Progressive Disease|0|||
162925871|NCT03193190|588430436|FG010|Stage 1|Progressive Disease|0|||
162925872|NCT03193190|588430437|FG011|Stage 1|Progressive Disease|0|||
163040591|NCT03178851|588856047|FG002|Overall Study|Withdrawal by Subject|0|||
163040592|NCT03178851|588856045|FG000|Overall Study|Lost to Follow-up|5|||
163040593|NCT03178851|588856046|FG001|Overall Study|Lost to Follow-up|2|||
163040594|NCT03178851|588856047|FG002|Overall Study|Lost to Follow-up|0|||
163040595|NCT03178851|588856045|FG000|Overall Study|Adverse Event|0|||
163040596|NCT03178851|588856046|FG001|Overall Study|Adverse Event|0|||
163040597|NCT03178851|588856047|FG002|Overall Study|Adverse Event|1|||
163040598|NCT03178851|588856045|FG000|Overall Study|Study Termination by Sponsor|31|||
162925873|NCT03193190|588430438|FG012|Stage 1|Progressive Disease|0|||
162925874|NCT03193190|588430439|FG013|Stage 1|Progressive Disease|0|||
163040599|NCT03178851|588856046|FG001|Overall Study|Study Termination by Sponsor|7|||
163040600|NCT03178851|588856047|FG002|Overall Study|Study Termination by Sponsor|26|||
163040601|NCT01905592|588856050|FG000|Overall Study|Disease Progression|51|||
163040602|NCT01905592|588856051|FG001|Overall Study|Disease Progression|110|||
163040603|NCT01905592|588856050|FG000|Overall Study|Toxicity|1|||
163040604|NCT01905592|588856051|FG001|Overall Study|Toxicity|16|||
163040605|NCT01905592|588856050|FG000|Overall Study|Physician Decision|0|||
163040606|NCT01905592|588856051|FG001|Overall Study|Physician Decision|2|||
163040607|NCT01905592|588856050|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
163040608|NCT01905592|588856051|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
163040609|NCT01905592|588856050|FG000|Overall Study|Protocol Violation|0|||
163040610|NCT01905592|588856051|FG001|Overall Study|Protocol Violation|1|||
163040611|NCT01905592|588856050|FG000|Overall Study|Sponsor's decision|1|||
163040612|NCT01905592|588856051|FG001|Overall Study|Sponsor's decision|1|||
163040613|NCT01905592|588856050|FG000|Overall Study|Not treated|7|||
163040614|NCT01905592|588856051|FG001|Overall Study|Not treated|3|||
163040615|NCT01905592|588856050|FG000|Overall Study|Withdrawal by Subject|10|||
163040616|NCT01905592|588856051|FG001|Overall Study|Withdrawal by Subject|2|||
163040617|NCT02669043|588856052|FG000|Overall Study|Didn't meet I/E criteria|4|||
163040618|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
163040619|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040620|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040621|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
163040622|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
163040623|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
163040624|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
163040625|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040626|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040627|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040628|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040629|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040630|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040631|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
163040632|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040633|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040634|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040635|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040636|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040637|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040638|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
163040639|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040640|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040641|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040642|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040643|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040644|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040645|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
163040646|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
163040647|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040648|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040649|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040650|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040651|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040652|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040653|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040654|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040655|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040656|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040657|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040658|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
162925875|NCT03193190|588430440|FG014|Stage 1|Progressive Disease|0|||
162925876|NCT03193190|588430441|FG015|Stage 1|Progressive Disease|0|||
162925877|NCT03193190|588430426|FG000|Stage 1|Study Terminated By Sponsor|3|||
163040659|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
163040660|NCT01483599|588856053|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
163040661|NCT01483599|588856054|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
163040662|NCT01483599|588856055|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
163040663|NCT01483599|588856056|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
163154976|NCT00463567|589283651|FG002|Overall Study|Lack of Efficacy|9|||
163154977|NCT00463567|589283652|FG003|Overall Study|Lack of Efficacy|17|||
163154978|NCT00463567|589283653|FG004|Overall Study|Lack of Efficacy|1|||
163154979|NCT00463567|589283654|FG005|Overall Study|Lack of Efficacy|0|||
163040664|NCT01483599|588856057|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
163040665|NCT01483599|588856058|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
163040666|NCT01483599|588856059|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
163040667|NCT01483599|588856060|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
163040668|NCT01483599|588856061|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
163040669|NCT01483599|588856062|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
163040670|NCT01483599|588856063|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
163040671|NCT01483599|588856064|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
163040672|NCT01483599|588856065|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
163040673|NCT01483599|588856066|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
163040674|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
163040675|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
163040676|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
163040677|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
163040678|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
163040679|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
163040680|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
163040681|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
163040682|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
163040683|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
163040684|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
163040685|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
163040686|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
163040687|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
163154980|NCT00463567|589283655|FG006|Overall Study|Lack of Efficacy|1|||
163154981|NCT00463567|589283649|FG000|Overall Study|Abnormal lab value(s)|1|||
163154982|NCT00463567|589283650|FG001|Overall Study|Abnormal lab value(s)|1|||
163154983|NCT00463567|589283651|FG002|Overall Study|Abnormal lab value(s)|2|||
163154984|NCT00463567|589283652|FG003|Overall Study|Abnormal lab value(s)|1|||
163154985|NCT00463567|589283653|FG004|Overall Study|Abnormal lab value(s)|1|||
163154986|NCT00463567|589283654|FG005|Overall Study|Abnormal lab value(s)|0|||
163154987|NCT00463567|589283655|FG006|Overall Study|Abnormal lab value(s)|0|||
163154988|NCT00463567|589283649|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163154989|NCT00463567|589283650|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163154990|NCT00463567|589283651|FG002|Overall Study|Abnormal test procedure result(s)|6|||
163154991|NCT00463567|589283652|FG003|Overall Study|Abnormal test procedure result(s)|2|||
163154992|NCT00463567|589283653|FG004|Overall Study|Abnormal test procedure result(s)|0|||
163154993|NCT00463567|589283654|FG005|Overall Study|Abnormal test procedure result(s)|2|||
163154994|NCT00463567|589283655|FG006|Overall Study|Abnormal test procedure result(s)|0|||
163154995|NCT00463567|589283649|FG000|Overall Study|Death|1|||
163154996|NCT00463567|589283650|FG001|Overall Study|Death|0|||
163154997|NCT00463567|589283651|FG002|Overall Study|Death|2|||
163154998|NCT00463567|589283652|FG003|Overall Study|Death|0|||
163154999|NCT00463567|589283653|FG004|Overall Study|Death|0|||
163155000|NCT00463567|589283654|FG005|Overall Study|Death|0|||
163155001|NCT00463567|589283655|FG006|Overall Study|Death|0|||
163155002|NCT01712399|589283660|FG000|Overall Study|Lost to Follow-up|1|||
163155003|NCT01712399|589283660|FG000|Overall Study|Withdrawal by Subject|39|||
163155004|NCT01712399|589283660|FG000|Overall Study|Death|1|||
163155005|NCT01712399|589283660|FG000|Overall Study|Adverse Event|11|||
163155006|NCT01712399|589283660|FG000|Overall Study|Study closure|345|||
163155007|NCT01705509|589283666|FG000|Inclusion CPET|Screen Failure|5|||
163155008|NCT01705509|589283666|FG000|Inclusion CPET|Withdrawal by Subject|2|||
163155009|NCT01705509|589283666|FG000|CPET w/ Ranexa|Screen Failure|2|||
163155010|NCT00904033|589283667|FG000|Overall Study|Withdrawal by Subject|1|||
163155011|NCT00904033|589283668|FG001|Overall Study|Withdrawal by Subject|1|||
163155012|NCT00904033|589283669|FG002|Overall Study|Withdrawal by Subject|0|||
163155013|NCT00904033|589283670|FG003|Overall Study|Withdrawal by Subject|0|||
163155014|NCT00904033|589283667|FG000|Overall Study|Physician Decision|0|||
163155015|NCT00904033|589283668|FG001|Overall Study|Physician Decision|0|||
163155016|NCT00904033|589283669|FG002|Overall Study|Physician Decision|1|||
163155017|NCT00904033|589283670|FG003|Overall Study|Physician Decision|0|||
163155018|NCT00904033|589283667|FG000|Overall Study|Unable to obtain final blood draw|0|||
163155019|NCT00904033|589283668|FG001|Overall Study|Unable to obtain final blood draw|0|||
163040688|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040689|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040690|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163155020|NCT00904033|589283669|FG002|Overall Study|Unable to obtain final blood draw|0|||
163155021|NCT00904033|589283670|FG003|Overall Study|Unable to obtain final blood draw|2|||
163155022|NCT01357850|589283671|FG000|Overall Study|Lost to Follow-up|1|||
163155023|NCT01357850|589283672|FG001|Overall Study|Lost to Follow-up|0|||
163155024|NCT01357850|589283673|FG002|Overall Study|Lost to Follow-up|0|||
163155025|NCT01357850|589283674|FG003|Overall Study|Lost to Follow-up|0|||
163155026|NCT02736890|589283675|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
163155027|NCT02736890|589283676|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
163155028|NCT02736890|589283675|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
163155029|NCT02736890|589283676|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
163155030|NCT01803607|589283678|FG000|Overall Study|Adverse Event|5|||
163155031|NCT01803607|589283679|FG001|Overall Study|Adverse Event|3|||
163155032|NCT01803607|589283678|FG000|Overall Study|Lack of Efficacy|0|||
163155033|NCT01803607|589283679|FG001|Overall Study|Lack of Efficacy|1|||
163155034|NCT01803607|589283678|FG000|Overall Study|Protocol Violation|3|||
163155035|NCT01803607|589283679|FG001|Overall Study|Protocol Violation|2|||
163155036|NCT01803607|589283678|FG000|Overall Study|Study terminated by sponsor|54|||
163155037|NCT01803607|589283679|FG001|Overall Study|Study terminated by sponsor|56|||
163155038|NCT01803607|589283678|FG000|Overall Study|Withdrawal by Subject|6|||
163155039|NCT01803607|589283679|FG001|Overall Study|Withdrawal by Subject|5|||
163155040|NCT03077412|589283680|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
163155041|NCT03077412|589283681|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
163155042|NCT03077412|589283682|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
163155043|NCT03077412|589283680|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
163155044|NCT03077412|589283681|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
163155045|NCT03077412|589283682|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
163155046|NCT03077412|589283680|FG000|Overall Study|Adverse Event|1|||
163155047|NCT03077412|589283681|FG001|Overall Study|Adverse Event|2|||
163155048|NCT03077412|589283682|FG002|Overall Study|Adverse Event|2|||
163155049|NCT03077412|589283680|FG000|Overall Study|Investigator's Discretion|0|||
163155050|NCT03077412|589283681|FG001|Overall Study|Investigator's Discretion|1|||
163155051|NCT03077412|589283682|FG002|Overall Study|Investigator's Discretion|1|||
163155052|NCT03077412|589283680|FG000|Overall Study|Withdrew Consent|0|||
163155053|NCT03077412|589283681|FG001|Overall Study|Withdrew Consent|2|||
163155054|NCT03077412|589283682|FG002|Overall Study|Withdrew Consent|0|||
163155055|NCT02351856|589283686|FG000|Overall Study|Adverse Event|2|||
163155056|NCT02351856|589283686|FG000|Overall Study|Physician Decision|5|||
163155057|NCT02351856|589283686|FG000|Overall Study|Study terminated by sponsor|1|||
163155058|NCT03038100|589283697|FG000|Overall Study|Death|289|||
163155059|NCT03038100|589283698|FG001|Overall Study|Death|272|||
163155060|NCT03038100|589283697|FG000|Overall Study|Lost to Follow-up|9|||
162925878|NCT03193190|588430427|FG001|Stage 1|Study Terminated By Sponsor|0|||
163155061|NCT03038100|589283698|FG001|Overall Study|Lost to Follow-up|10|||
163155062|NCT03038100|589283697|FG000|Overall Study|Protocol Deviation|1|||
163155063|NCT03038100|589283698|FG001|Overall Study|Protocol Deviation|4|||
163155064|NCT03038100|589283697|FG000|Overall Study|Withdrawal by Subject|45|||
163155065|NCT03038100|589283698|FG001|Overall Study|Withdrawal by Subject|51|||
163155066|NCT03038100|589283697|FG000|Overall Study|Study Terminated By Sponsor|305|||
163155067|NCT03038100|589283698|FG001|Overall Study|Study Terminated By Sponsor|311|||
163155068|NCT03038100|589283697|FG000|Overall Study|Physician Decision|1|||
163155069|NCT03038100|589283698|FG001|Overall Study|Physician Decision|3|||
163155070|NCT01774721|589283702|FG000|Overall Study|Death|133|||
163155071|NCT01774721|589283703|FG001|Overall Study|Death|152|||
163155072|NCT01774721|589283702|FG000|Overall Study|Withdrawal by Subject|20|||
163155073|NCT01774721|589283703|FG001|Overall Study|Withdrawal by Subject|14|||
163155074|NCT01774721|589283702|FG000|Overall Study|Lost to Follow-up|6|||
163155075|NCT01774721|589283703|FG001|Overall Study|Lost to Follow-up|7|||
163155076|NCT01774721|589283702|FG000|Overall Study|Did not meet eligibility criteria|0|||
163155077|NCT01774721|589283703|FG001|Overall Study|Did not meet eligibility criteria|3|||
163155078|NCT01774721|589283702|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
163155079|NCT01774721|589283703|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
163155080|NCT01774721|589283702|FG000|Overall Study|Study terminated by sponsor|5|||
163155081|NCT01774721|589283703|FG001|Overall Study|Study terminated by sponsor|0|||
163155082|NCT01774721|589283702|FG000|Overall Study|Disease progression|5|||
163155083|NCT01774721|589283703|FG001|Overall Study|Disease progression|0|||
163155084|NCT01936870|589283704|FG000|Overall Study|No Visit After Treatment|176|||
163155085|NCT01936870|589283704|FG000|Overall Study|Protocol Violation|12|||
163155086|NCT01936870|589283704|FG000|Overall Study|No Drug Administration|1|||
163155087|NCT00248040|589283705|FG000|Overall Study|transplantectomy|2|||
162925879|NCT03193190|588430428|FG002|Stage 1|Study Terminated By Sponsor|0|||
163155088|NCT00248040|589283706|FG001|Overall Study|transplantectomy|1|||
163155089|NCT00248040|589283707|FG002|Overall Study|transplantectomy|3|||
163155090|NCT00248040|589283705|FG000|Overall Study|transplant cancelled post treat start|1|||
163155091|NCT00248040|589283706|FG001|Overall Study|transplant cancelled post treat start|0|||
163155092|NCT00248040|589283707|FG002|Overall Study|transplant cancelled post treat start|0|||
163155093|NCT00248040|589283705|FG000|Overall Study|Death|0|||
163155094|NCT00248040|589283706|FG001|Overall Study|Death|0|||
163155095|NCT00248040|589283707|FG002|Overall Study|Death|1|||
163155096|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
163155097|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
163155098|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
163155099|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
163155100|NCT00118417|589283710|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
163155101|NCT00118417|589283711|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
163155102|NCT00118417|589283710|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
163155103|NCT00118417|589283711|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
163155104|NCT00118417|589283710|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
163155105|NCT00118417|589283711|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
163155106|NCT02978781|589283712|FG000|Part A|Adverse Event|1|||
163155107|NCT02978781|589283713|FG001|Part A|Adverse Event|1|||
163155108|NCT02978781|589283714|FG002|Part A|Adverse Event|0|||
163155109|NCT02978781|589283715|FG003|Part A|Adverse Event|0|||
163155110|NCT02978781|589283716|FG004|Part A|Adverse Event|0|||
163155111|NCT02978781|589283712|FG000|Part A|Withdrawal by Subject|0|||
163155112|NCT02978781|589283713|FG001|Part A|Withdrawal by Subject|1|||
163155113|NCT02978781|589283714|FG002|Part A|Withdrawal by Subject|0|||
163155114|NCT02978781|589283715|FG003|Part A|Withdrawal by Subject|0|||
163155115|NCT02978781|589283716|FG004|Part A|Withdrawal by Subject|0|||
163155116|NCT02978781|589283712|FG000|Part B|Withdrawal by Subject|0|||
163155117|NCT02978781|589283713|FG001|Part B|Withdrawal by Subject|0|||
163155118|NCT02978781|589283714|FG002|Part B|Withdrawal by Subject|0|||
163155119|NCT02978781|589283715|FG003|Part B|Withdrawal by Subject|1|||
163155120|NCT02978781|589283716|FG004|Part B|Withdrawal by Subject|0|||
163155121|NCT02978781|589283712|FG000|Part C|Adverse Event|0|||
163155122|NCT02978781|589283713|FG001|Part C|Adverse Event|0|||
163155123|NCT02978781|589283714|FG002|Part C|Adverse Event|0|||
163155124|NCT02978781|589283715|FG003|Part C|Adverse Event|0|||
163155125|NCT02978781|589283716|FG004|Part C|Adverse Event|2|||
163155126|NCT02978781|589283712|FG000|Part C|Withdrawal by Subject|0|||
163155127|NCT02978781|589283713|FG001|Part C|Withdrawal by Subject|0|||
163155128|NCT02978781|589283714|FG002|Part C|Withdrawal by Subject|0|||
163155129|NCT02978781|589283715|FG003|Part C|Withdrawal by Subject|0|||
163155130|NCT02978781|589283716|FG004|Part C|Withdrawal by Subject|1|||
163155131|NCT02978781|589283712|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155132|NCT02978781|589283713|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155133|NCT02978781|589283714|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155134|NCT02978781|589283715|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
163155135|NCT02978781|589283716|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
163155136|NCT01383356|589283717|FG000|Period 1|Adverse Event|5|||
163155137|NCT01383356|589283718|FG001|Period 1|Adverse Event|3|||
163155138|NCT01383356|589283717|FG000|Period 1|Non-compliance|3|||
163155139|NCT01383356|589283718|FG001|Period 1|Non-compliance|0|||
163155140|NCT01383356|589283717|FG000|Period 1|Out of Range Mid-study-Test|0|||
163155141|NCT01383356|589283718|FG001|Period 1|Out of Range Mid-study-Test|1|||
163155142|NCT01383356|589283717|FG000|Period 1|Personal|0|||
163155143|NCT01383356|589283718|FG001|Period 1|Personal|2|||
163155144|NCT02054104|589283720|FG000|Overall Study|Did not want to continue due to college classes|1|||
163155145|NCT02054104|589283721|FG001|Overall Study|Did not want to continue due to college classes|0|||
163155146|NCT02054104|589283720|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
163155147|NCT02054104|589283721|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
163155148|NCT02054104|589283720|FG000|Overall Study|No evidence of immunologic response|2|||
163155149|NCT02054104|589283721|FG001|Overall Study|No evidence of immunologic response|2|||
163155150|NCT02054104|589283720|FG000|Overall Study|Disease Progression On Study|4|||
163155151|NCT02054104|589283721|FG001|Overall Study|Disease Progression On Study|5|||
163155152|NCT02054104|589283720|FG000|Overall Study|Diagnosis of lymphoma|0|||
163155153|NCT02054104|589283721|FG001|Overall Study|Diagnosis of lymphoma|1|||
163155154|NCT02054104|589283720|FG000|Overall Study|Inconclusive response|0|||
163155155|NCT02054104|589283721|FG001|Overall Study|Inconclusive response|1|||
163155156|NCT00084136|589283724|FG000|PI Comparison|Death|10|||
163155157|NCT00084136|589283725|FG001|PI Comparison|Death|9|||
163155158|NCT00084136|589283726|FG002|PI Comparison|Death|0|||
163155159|NCT00084136|589283724|FG000|PI Comparison|Lost to Follow-up|11|||
163155160|NCT00084136|589283725|FG001|PI Comparison|Lost to Follow-up|8|||
163155161|NCT00084136|589283726|FG002|PI Comparison|Lost to Follow-up|0|||
163155162|NCT00084136|589283724|FG000|PI Comparison|Withdrawal by Subject|33|||
163155163|NCT00084136|589283725|FG001|PI Comparison|Withdrawal by Subject|30|||
163155164|NCT00084136|589283726|FG002|PI Comparison|Withdrawal by Subject|0|||
163155165|NCT00084136|589283724|FG000|PI Comparison|Clinic site closed|1|||
163155166|NCT00084136|589283725|FG001|PI Comparison|Clinic site closed|0|||
163155167|NCT00084136|589283726|FG002|PI Comparison|Clinic site closed|0|||
163155168|NCT00084136|589283724|FG000|NRTI Comparison|Death|20|||
163155169|NCT00084136|589283725|FG001|NRTI Comparison|Death|0|||
163155170|NCT00084136|589283726|FG002|NRTI Comparison|Death|18|||
163155171|NCT00084136|589283724|FG000|NRTI Comparison|Lost to Follow-up|14|||
163155172|NCT00084136|589283725|FG001|NRTI Comparison|Lost to Follow-up|0|||
163155173|NCT00084136|589283726|FG002|NRTI Comparison|Lost to Follow-up|12|||
163155174|NCT00084136|589283724|FG000|NRTI Comparison|Withdrawal by Subject|54|||
163155175|NCT00084136|589283725|FG001|NRTI Comparison|Withdrawal by Subject|0|||
163155176|NCT00084136|589283726|FG002|NRTI Comparison|Withdrawal by Subject|38|||
163155177|NCT00084136|589283724|FG000|NRTI Comparison|Clinic site closed|12|||
163155178|NCT00084136|589283725|FG001|NRTI Comparison|Clinic site closed|0|||
163155179|NCT00084136|589283726|FG002|NRTI Comparison|Clinic site closed|14|||
163155180|NCT00084136|589283724|FG000|NRTI Comparison|Not reason above|1|||
163155181|NCT00084136|589283725|FG001|NRTI Comparison|Not reason above|0|||
163155182|NCT00084136|589283726|FG002|NRTI Comparison|Not reason above|0|||
163155183|NCT02633306|589283732|FG000|Overall Study|Withdrawal by Subject|3|||
163155184|NCT02131259|589283733|FG000|Overall Study|Progressive disease|751|||
163155185|NCT02131259|589283733|FG000|Overall Study|Adverse Event|341|||
163155186|NCT02131259|589283733|FG000|Overall Study|Lost to Follow-up|7|||
163155187|NCT02131259|589283733|FG000|Overall Study|Relocation|32|||
163155188|NCT02131259|589283733|FG000|Overall Study|Other|63|||
163155189|NCT02131259|589283733|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
163155190|NCT02131259|589283733|FG000|Overall Study|Progressive disease/relocation|1|||
163155191|NCT02131259|589283733|FG000|Overall Study|Progressive disease/other|2|||
163155192|NCT02131259|589283733|FG000|Overall Study|AE/lost to follow-up|1|||
163155193|NCT02131259|589283733|FG000|Overall Study|AE/other|1|||
163155194|NCT02131259|589283733|FG000|Overall Study|Progressive disease/AE/other|1|||
163155195|NCT02131259|589283733|FG000|Overall Study|Missing|3|||
163155196|NCT01472289|589283738|FG000|Overall Study|Death|2|||
163155197|NCT00907335|589283739|FG000|Overall Study|Withdrawal by Subject|2|||
163155198|NCT00907335|589283740|FG001|Overall Study|Withdrawal by Subject|0|||
163155199|NCT00907335|589283739|FG000|Overall Study|Adverse Event|4|||
163155200|NCT00907335|589283740|FG001|Overall Study|Adverse Event|1|||
163155201|NCT00907335|589283739|FG000|Overall Study|Lost to Follow-up|2|||
163155202|NCT00907335|589283740|FG001|Overall Study|Lost to Follow-up|0|||
163155203|NCT03879772|589283741|FG000|Overall Study|Adverse Event|2|||
163155204|NCT03879772|589283742|FG001|Overall Study|Adverse Event|2|||
163155205|NCT03879772|589283743|FG002|Overall Study|Adverse Event|3|||
163155206|NCT03879772|589283744|FG003|Overall Study|Adverse Event|4|||
163155207|NCT03879772|589283745|FG004|Overall Study|Adverse Event|3|||
163155208|NCT03879772|589283741|FG000|Overall Study|Treatment Failure|1|||
163155209|NCT03879772|589283742|FG001|Overall Study|Treatment Failure|0|||
163155210|NCT03879772|589283743|FG002|Overall Study|Treatment Failure|0|||
163155211|NCT03879772|589283744|FG003|Overall Study|Treatment Failure|2|||
163155212|NCT03879772|589283745|FG004|Overall Study|Treatment Failure|1|||
163155213|NCT03879772|589283741|FG000|Overall Study|Lost to Follow-up|0|||
163155214|NCT03879772|589283742|FG001|Overall Study|Lost to Follow-up|0|||
163155215|NCT03879772|589283743|FG002|Overall Study|Lost to Follow-up|0|||
163155216|NCT03879772|589283744|FG003|Overall Study|Lost to Follow-up|0|||
163155217|NCT03879772|589283745|FG004|Overall Study|Lost to Follow-up|1|||
163155218|NCT03879772|589283741|FG000|Overall Study|Withdrawal by Subject|0|||
163155219|NCT03879772|589283742|FG001|Overall Study|Withdrawal by Subject|1|||
163155220|NCT03879772|589283743|FG002|Overall Study|Withdrawal by Subject|3|||
163155221|NCT03879772|589283744|FG003|Overall Study|Withdrawal by Subject|1|||
163155222|NCT03879772|589283745|FG004|Overall Study|Withdrawal by Subject|1|||
163155223|NCT03879772|589283741|FG000|Overall Study|Protocol Violation|0|||
163155224|NCT03879772|589283742|FG001|Overall Study|Protocol Violation|0|||
163155225|NCT03879772|589283743|FG002|Overall Study|Protocol Violation|3|||
163155226|NCT03879772|589283744|FG003|Overall Study|Protocol Violation|1|||
163155227|NCT03879772|589283745|FG004|Overall Study|Protocol Violation|2|||
163155228|NCT03879772|589283741|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
163155229|NCT03879772|589283742|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
163155230|NCT03879772|589283743|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
163155231|NCT03879772|589283744|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
163155232|NCT03879772|589283745|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
163155233|NCT00389610|589283757|FG000|Overall Study|Disease Progression|0|||
163155234|NCT00389610|589283758|FG001|Overall Study|Disease Progression|19|||
163155235|NCT00389610|589283757|FG000|Overall Study|Death|0|||
163155236|NCT00389610|589283758|FG001|Overall Study|Death|1|||
163155237|NCT00389610|589283757|FG000|Overall Study|Physician Decision|0|||
163155238|NCT00389610|589283758|FG001|Overall Study|Physician Decision|1|||
163155239|NCT00389610|589283757|FG000|Overall Study|Withdrawal by Subject|0|||
163155240|NCT00389610|589283758|FG001|Overall Study|Withdrawal by Subject|1|||
163155241|NCT00887809|589283759|FG000|Overall Study|Patient Not Treated|3|||
163155242|NCT00887809|589283760|FG001|Overall Study|Patient Not Treated|0|||
163155243|NCT00887809|589283759|FG000|Overall Study|Death|1|||
163155244|NCT00887809|589283760|FG001|Overall Study|Death|0|||
163155245|NCT03131570|589283761|FG000|Overall Study|Adverse Event|1|||
163155246|NCT03131570|589283762|FG001|Overall Study|Adverse Event|0|||
163155247|NCT04596267|589283763|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
163155248|NCT04596267|589283764|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
163155249|NCT04596267|589283763|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
163155250|NCT04596267|589283764|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
163155251|NCT00071058|589283765|FG000|Overall Study|brain tumor-removed from study|1|||
163155252|NCT04189952|589283771|FG000|Follow-up Period|Death|1|||
163155253|NCT04189952|589283771|FG000|Follow-up Period|Withdrawal by Subject|1|||
163155254|NCT00870740|589283772|FG000|Overall Study|Adverse Event|2|||
163155255|NCT00870740|589283773|FG001|Overall Study|Adverse Event|1|||
163155256|NCT00870740|589283774|FG002|Overall Study|Adverse Event|3|||
163155257|NCT00870740|589283775|FG003|Overall Study|Adverse Event|2|||
163155258|NCT00870740|589283776|FG004|Overall Study|Adverse Event|1|||
163155259|NCT00870740|589283777|FG005|Overall Study|Adverse Event|6|||
163155260|NCT00870740|589283772|FG000|Overall Study|Consent Withdrawn|6|||
163155261|NCT00870740|589283773|FG001|Overall Study|Consent Withdrawn|3|||
163155262|NCT00870740|589283774|FG002|Overall Study|Consent Withdrawn|4|||
163155263|NCT00870740|589283775|FG003|Overall Study|Consent Withdrawn|6|||
163155264|NCT00870740|589283776|FG004|Overall Study|Consent Withdrawn|6|||
163155265|NCT00870740|589283777|FG005|Overall Study|Consent Withdrawn|5|||
163155266|NCT00870740|589283772|FG000|Overall Study|Investigator Decision|2|||
163155267|NCT00870740|589283773|FG001|Overall Study|Investigator Decision|0|||
163155268|NCT00870740|589283774|FG002|Overall Study|Investigator Decision|1|||
163155269|NCT00870740|589283775|FG003|Overall Study|Investigator Decision|0|||
163155270|NCT00870740|589283776|FG004|Overall Study|Investigator Decision|0|||
163155271|NCT00870740|589283777|FG005|Overall Study|Investigator Decision|0|||
163155272|NCT00870740|589283772|FG000|Overall Study|Subject Non-compliance|0|||
163155273|NCT00870740|589283773|FG001|Overall Study|Subject Non-compliance|0|||
163155274|NCT00870740|589283774|FG002|Overall Study|Subject Non-compliance|0|||
163155275|NCT00870740|589283775|FG003|Overall Study|Subject Non-compliance|0|||
163155276|NCT00870740|589283776|FG004|Overall Study|Subject Non-compliance|0|||
163155277|NCT00870740|589283777|FG005|Overall Study|Subject Non-compliance|1|||
163155278|NCT00870740|589283772|FG000|Overall Study|Death|0|||
163155279|NCT00870740|589283773|FG001|Overall Study|Death|0|||
163155280|NCT00870740|589283774|FG002|Overall Study|Death|0|||
163155281|NCT00870740|589283775|FG003|Overall Study|Death|0|||
163155282|NCT00870740|589283776|FG004|Overall Study|Death|1|||
163155283|NCT00870740|589283777|FG005|Overall Study|Death|0|||
163155284|NCT00870740|589283772|FG000|Overall Study|Other|2|||
163155285|NCT00870740|589283773|FG001|Overall Study|Other|5|||
163155286|NCT00870740|589283774|FG002|Overall Study|Other|2|||
163155287|NCT00870740|589283775|FG003|Overall Study|Other|4|||
163155288|NCT00870740|589283776|FG004|Overall Study|Other|3|||
163155289|NCT00870740|589283777|FG005|Overall Study|Other|5|||
163155290|NCT00453206|589283785|FG000|Overall Study|Death|1|||
163155291|NCT04672239|589283790|FG000|Week 2 Survey|Failed survey check items|1|||
163155292|NCT04672239|589283791|FG001|Week 2 Survey|Failed survey check items|2|||
163155293|NCT04672239|589283792|FG002|Week 2 Survey|Failed survey check items|3|||
163155294|NCT04672239|589283790|FG000|Week 2 Survey|Partially completed survey|7|||
163155295|NCT04672239|589283791|FG001|Week 2 Survey|Partially completed survey|1|||
163155296|NCT04672239|589283792|FG002|Week 2 Survey|Partially completed survey|4|||
163155297|NCT04672239|589283790|FG000|Week 2 Survey|Withdrawal by Subject|0|||
163155298|NCT04672239|589283791|FG001|Week 2 Survey|Withdrawal by Subject|1|||
163155299|NCT04672239|589283792|FG002|Week 2 Survey|Withdrawal by Subject|0|||
163155300|NCT04672239|589283790|FG000|Week 2 Survey|Lost to Follow-up|3|||
163155301|NCT04672239|589283791|FG001|Week 2 Survey|Lost to Follow-up|2|||
163155302|NCT04672239|589283792|FG002|Week 2 Survey|Lost to Follow-up|5|||
163155303|NCT04672239|589283790|FG000|Week 6 Survey|Failed survey check items|2|||
163155304|NCT04672239|589283791|FG001|Week 6 Survey|Failed survey check items|2|||
163155305|NCT04672239|589283792|FG002|Week 6 Survey|Failed survey check items|2|||
163155306|NCT04672239|589283790|FG000|Week 6 Survey|Partially completed survey|3|||
163155307|NCT04672239|589283791|FG001|Week 6 Survey|Partially completed survey|3|||
163155308|NCT04672239|589283792|FG002|Week 6 Survey|Partially completed survey|2|||
163155309|NCT04672239|589283790|FG000|Week 6 Survey|Withdrawal by Subject|1|||
163155310|NCT04672239|589283791|FG001|Week 6 Survey|Withdrawal by Subject|1|||
163155311|NCT04672239|589283792|FG002|Week 6 Survey|Withdrawal by Subject|1|||
163155312|NCT04672239|589283790|FG000|Week 6 Survey|Withdrawn by PI|0|||
162811635|NCT00585195|588021757|FG002|Overall Study|Other|1|||
163155313|NCT04672239|589283791|FG001|Week 6 Survey|Withdrawn by PI|1|||
163155314|NCT04672239|589283792|FG002|Week 6 Survey|Withdrawn by PI|0|||
163155315|NCT04672239|589283790|FG000|Week 6 Survey|Lost to Follow-up|12|||
163155316|NCT04672239|589283791|FG001|Week 6 Survey|Lost to Follow-up|2|||
163155317|NCT04672239|589283792|FG002|Week 6 Survey|Lost to Follow-up|5|||
163155318|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
163155319|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
163155320|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
163155321|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
163155322|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
163155323|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
163155324|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
163155325|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
163155326|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
163155327|NCT04672239|589283790|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
163155328|NCT04672239|589283791|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
163155329|NCT04672239|589283792|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
163155330|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
163155331|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
163155332|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
163155333|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
163155334|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
163155335|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
163155336|NCT04672239|589283790|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
163155337|NCT04672239|589283791|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
163040691|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040692|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040693|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040694|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040695|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040696|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040697|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040698|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040699|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
163040700|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040701|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
163040702|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040703|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040704|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040705|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040706|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040707|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040708|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040709|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040710|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040711|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040712|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040713|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040714|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
163040715|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
163040716|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040717|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040718|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163155338|NCT04672239|589283792|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
163155339|NCT03866577|589283795|FG000|Overall Study|Protocol Violation|0|||
163155340|NCT03866577|589283796|FG001|Overall Study|Protocol Violation|0|||
163155341|NCT03866577|589283797|FG002|Overall Study|Protocol Violation|0|||
163155342|NCT03866577|589283798|FG003|Overall Study|Protocol Violation|0|||
163155343|NCT03866577|589283799|FG004|Overall Study|Protocol Violation|0|||
163155344|NCT03866577|589283800|FG005|Overall Study|Protocol Violation|0|||
163155345|NCT03866577|589283801|FG006|Overall Study|Protocol Violation|0|||
163155346|NCT03866577|589283802|FG007|Overall Study|Protocol Violation|0|||
163155347|NCT03866577|589283803|FG008|Overall Study|Protocol Violation|0|||
163155348|NCT03866577|589283804|FG009|Overall Study|Protocol Violation|0|||
163155349|NCT03866577|589283805|FG010|Overall Study|Protocol Violation|0|||
163155350|NCT03866577|589283806|FG011|Overall Study|Protocol Violation|1|||
163155351|NCT03866577|589283807|FG012|Overall Study|Protocol Violation|0|||
163155352|NCT03866577|589283795|FG000|Overall Study|Withdrawal by Subject|0|||
163155353|NCT03866577|589283796|FG001|Overall Study|Withdrawal by Subject|0|||
163155354|NCT03866577|589283797|FG002|Overall Study|Withdrawal by Subject|0|||
163155355|NCT03866577|589283798|FG003|Overall Study|Withdrawal by Subject|0|||
163155356|NCT03866577|589283799|FG004|Overall Study|Withdrawal by Subject|0|||
163155357|NCT03866577|589283800|FG005|Overall Study|Withdrawal by Subject|0|||
163155358|NCT03866577|589283801|FG006|Overall Study|Withdrawal by Subject|0|||
163155359|NCT03866577|589283802|FG007|Overall Study|Withdrawal by Subject|0|||
163155360|NCT03866577|589283803|FG008|Overall Study|Withdrawal by Subject|1|||
163155361|NCT03866577|589283804|FG009|Overall Study|Withdrawal by Subject|1|||
163155362|NCT03866577|589283805|FG010|Overall Study|Withdrawal by Subject|0|||
163155363|NCT03866577|589283806|FG011|Overall Study|Withdrawal by Subject|0|||
163155364|NCT03866577|589283807|FG012|Overall Study|Withdrawal by Subject|0|||
163155365|NCT03866577|589283795|FG000|Overall Study|Not qualified for IVIg infusion|0|||
163155366|NCT03866577|589283796|FG001|Overall Study|Not qualified for IVIg infusion|0|||
163155367|NCT03866577|589283797|FG002|Overall Study|Not qualified for IVIg infusion|0|||
163155368|NCT03866577|589283798|FG003|Overall Study|Not qualified for IVIg infusion|0|||
163155369|NCT03866577|589283799|FG004|Overall Study|Not qualified for IVIg infusion|0|||
163155370|NCT03866577|589283800|FG005|Overall Study|Not qualified for IVIg infusion|0|||
163155371|NCT03866577|589283801|FG006|Overall Study|Not qualified for IVIg infusion|0|||
163155372|NCT03866577|589283802|FG007|Overall Study|Not qualified for IVIg infusion|0|||
163155373|NCT03866577|589283803|FG008|Overall Study|Not qualified for IVIg infusion|0|||
163155374|NCT03866577|589283804|FG009|Overall Study|Not qualified for IVIg infusion|1|||
163155375|NCT03866577|589283805|FG010|Overall Study|Not qualified for IVIg infusion|0|||
163155376|NCT03866577|589283806|FG011|Overall Study|Not qualified for IVIg infusion|0|||
163155377|NCT03866577|589283807|FG012|Overall Study|Not qualified for IVIg infusion|0|||
163155378|NCT04825678|589283808|FG000|Overall Study|Decision by Sponsor|2|||
163155379|NCT04825678|589283809|FG001|Overall Study|Decision by Sponsor|3|||
163155380|NCT04825678|589283808|FG000|Overall Study|Withdrawal of Consent From Study|7|||
163155381|NCT04825678|589283809|FG001|Overall Study|Withdrawal of Consent From Study|9|||
163155382|NCT04825678|589283808|FG000|Overall Study|Lost to Follow-up|3|||
163155383|NCT04825678|589283809|FG001|Overall Study|Lost to Follow-up|4|||
163155384|NCT04825678|589283808|FG000|Overall Study|Never Received Investigational Product|1|||
163155385|NCT04825678|589283809|FG001|Overall Study|Never Received Investigational Product|1|||
163155386|NCT01342211|589283810|FG000|Overall Study|Lost to Follow-up|0|||
163155387|NCT01342211|589283811|FG001|Overall Study|Lost to Follow-up|0|||
163155388|NCT01342211|589283812|FG002|Overall Study|Lost to Follow-up|0|||
163155389|NCT01342211|589283813|FG003|Overall Study|Lost to Follow-up|1|||
163155390|NCT01342211|589283814|FG004|Overall Study|Lost to Follow-up|0|||
163155391|NCT01342211|589283810|FG000|Overall Study|Adverse Event|0|||
163155392|NCT01342211|589283811|FG001|Overall Study|Adverse Event|0|||
163155393|NCT01342211|589283812|FG002|Overall Study|Adverse Event|0|||
163155394|NCT01342211|589283813|FG003|Overall Study|Adverse Event|0|||
163155395|NCT01342211|589283814|FG004|Overall Study|Adverse Event|1|||
163155396|NCT01342211|589283810|FG000|Overall Study|Withdrawal by Subject|0|||
163155397|NCT01342211|589283811|FG001|Overall Study|Withdrawal by Subject|0|||
163155398|NCT01342211|589283812|FG002|Overall Study|Withdrawal by Subject|0|||
163155399|NCT01342211|589283813|FG003|Overall Study|Withdrawal by Subject|1|||
163155400|NCT01342211|589283814|FG004|Overall Study|Withdrawal by Subject|0|||
163155401|NCT01342211|589283810|FG000|Overall Study|Randomized, but not Treated|0|||
163155402|NCT01342211|589283811|FG001|Overall Study|Randomized, but not Treated|2|||
163155403|NCT01342211|589283812|FG002|Overall Study|Randomized, but not Treated|0|||
163155404|NCT01342211|589283813|FG003|Overall Study|Randomized, but not Treated|0|||
163155405|NCT01342211|589283814|FG004|Overall Study|Randomized, but not Treated|1|||
163155406|NCT05430854|589283815|FG000|Overall Study|Trial terminated by Sponsor|39|||
163155407|NCT05430854|589283816|FG001|Overall Study|Trial terminated by Sponsor|50|||
163155408|NCT05430854|589283817|FG002|Overall Study|Trial terminated by Sponsor|46|||
163155409|NCT05430854|589283815|FG000|Overall Study|Withdrawal by Subject|0|||
163155410|NCT05430854|589283816|FG001|Overall Study|Withdrawal by Subject|3|||
163155411|NCT05430854|589283817|FG002|Overall Study|Withdrawal by Subject|0|||
163155412|NCT01824836|589283820|FG000|Overall Study|Adverse Event|48|||
163155413|NCT01824836|589283820|FG000|Overall Study|Withdrawal by Subject|63|||
163155414|NCT01824836|589283820|FG000|Overall Study|Other complicating disease|116|||
162631046|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
162631047|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
162631048|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
162631049|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
162631050|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
162631051|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
162631052|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
162631053|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
162631054|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
162631055|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
162631056|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
162925880|NCT03193190|588430429|FG003|Stage 1|Study Terminated By Sponsor|0|||
162925881|NCT03193190|588430430|FG004|Stage 1|Study Terminated By Sponsor|6|||
162925882|NCT03193190|588430431|FG005|Stage 1|Study Terminated By Sponsor|0|||
162925883|NCT03193190|588430432|FG006|Stage 1|Study Terminated By Sponsor|0|||
162925884|NCT03193190|588430433|FG007|Stage 1|Study Terminated By Sponsor|0|||
162925885|NCT03193190|588430434|FG008|Stage 1|Study Terminated By Sponsor|0|||
162925886|NCT03193190|588430435|FG009|Stage 1|Study Terminated By Sponsor|0|||
162696287|NCT00603265|587599456|FG000|Overall Study|Participant Left Country, No Responses|0|||
162925887|NCT03193190|588430436|FG010|Stage 1|Study Terminated By Sponsor|0|||
162925888|NCT03193190|588430437|FG011|Stage 1|Study Terminated By Sponsor|0|||
163155415|NCT01824836|589283820|FG000|Overall Study|Disease progression|5|||
163155416|NCT01824836|589283820|FG000|Overall Study|Alternative therapy|2|||
163155417|NCT01824836|589283820|FG000|Overall Study|Depression|1|||
163155418|NCT01824836|589283820|FG000|Overall Study|Non-compliance|3|||
163155419|NCT01824836|589283820|FG000|Overall Study|Patient regained ovarian function|3|||
163155420|NCT01824836|589283820|FG000|Overall Study|Lost to Follow-up|8|||
163155421|NCT01824836|589283820|FG000|Overall Study|Physician Decision|2|||
163155422|NCT01824836|589283820|FG000|Overall Study|Research office was closed|3|||
163155423|NCT01824836|589283820|FG000|Overall Study|Relocation|3|||
163155424|NCT01824836|589283820|FG000|Overall Study|Insurance-related issue|1|||
163155425|NCT01824836|589283820|FG000|Overall Study|Transportation issue|1|||
163155426|NCT01824836|589283820|FG000|Overall Study|Patient transferred care|1|||
163155427|NCT01824836|589283820|FG000|Overall Study|Unknown reasons|4|||
163155428|NCT01824836|589283820|FG000|Overall Study|Never started treatment|16|||
163155429|NCT03253393|589283821|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
163155430|NCT03253393|589283822|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
163155431|NCT03253393|589283823|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
162925889|NCT03193190|588430438|FG012|Stage 1|Study Terminated By Sponsor|0|||
162696288|NCT00603265|587599457|FG001|Overall Study|Participant Left Country, No Responses|1|||
162925890|NCT03193190|588430439|FG013|Stage 1|Study Terminated By Sponsor|0|||
162925891|NCT03193190|588430440|FG014|Stage 1|Study Terminated By Sponsor|0|||
162925892|NCT03193190|588430441|FG015|Stage 1|Study Terminated By Sponsor|0|||
162925893|NCT03193190|588430426|FG000|Stage 1|Withdrawal by Subject|6|||
163155432|NCT00554216|589285688|FG000|Overall Study|Lost to Follow-up|92|||
163155433|NCT00554216|589285689|FG001|Overall Study|Lost to Follow-up|31|||
163155434|NCT00554216|589285690|FG002|Overall Study|Lost to Follow-up|63|||
163155435|NCT00554216|589285688|FG000|Overall Study|Adverse Event|16|||
163155436|NCT00554216|589285689|FG001|Overall Study|Adverse Event|16|||
163155437|NCT00554216|589285690|FG002|Overall Study|Adverse Event|36|||
163155438|NCT00554216|589285688|FG000|Overall Study|Withdrawal by Subject|92|||
163155439|NCT00554216|589285689|FG001|Overall Study|Withdrawal by Subject|31|||
163155440|NCT00554216|589285690|FG002|Overall Study|Withdrawal by Subject|43|||
163155441|NCT00554216|589285688|FG000|Overall Study|Non compliance|10|||
163155442|NCT00554216|589285689|FG001|Overall Study|Non compliance|4|||
163155443|NCT00554216|589285690|FG002|Overall Study|Non compliance|5|||
163155444|NCT00554216|589285688|FG000|Overall Study|Pregnancy|2|||
163155445|NCT00554216|589285689|FG001|Overall Study|Pregnancy|1|||
163155446|NCT00554216|589285690|FG002|Overall Study|Pregnancy|14|||
163155447|NCT00554216|589285688|FG000|Overall Study|Restricted med|3|||
163155448|NCT00554216|589285689|FG001|Overall Study|Restricted med|1|||
163155449|NCT00554216|589285690|FG002|Overall Study|Restricted med|1|||
163155450|NCT00554216|589285688|FG000|Overall Study|Other|12|||
163155451|NCT00554216|589285689|FG001|Overall Study|Other|7|||
163155452|NCT00554216|589285690|FG002|Overall Study|Other|10|||
163155453|NCT00554216|589285688|FG000|Overall Study|Lack of Efficacy|15|||
163155454|NCT00554216|589285689|FG001|Overall Study|Lack of Efficacy|3|||
163155455|NCT00554216|589285690|FG002|Overall Study|Lack of Efficacy|0|||
163155456|NCT05291520|589285691|FG000|Overall Study|Lost to Follow-up|0|||
163155457|NCT05291520|589285692|FG001|Overall Study|Lost to Follow-up|0|||
163155458|NCT05291520|589285693|FG002|Overall Study|Lost to Follow-up|1|||
163155459|NCT01347112|589285694|FG000|Overall Study|Withdrawal by Subject|1|||
163155460|NCT01347112|589285695|FG001|Overall Study|Withdrawal by Subject|7|||
163155461|NCT01347112|589285694|FG000|Overall Study|Lost to Follow-up|3|||
163155462|NCT01347112|589285695|FG001|Overall Study|Lost to Follow-up|5|||
163155463|NCT05462756|589285698|FG000|Treatment Period|Adverse Event|3|||
163155464|NCT05462756|589285699|FG001|Treatment Period|Adverse Event|0|||
163155465|NCT05462756|589285698|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
163155466|NCT05462756|589285699|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
163155467|NCT05462756|589285698|FG000|Treatment Period|Death|0|||
163155468|NCT05462756|589285699|FG001|Treatment Period|Death|1|||
163155469|NCT05462756|589285698|FG000|Treatment Period|Lost to Follow-up|2|||
163155470|NCT05462756|589285699|FG001|Treatment Period|Lost to Follow-up|1|||
163155471|NCT05462756|589285698|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
163155472|NCT05462756|589285699|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
163155473|NCT05462756|589285698|FG000|Treatment Period|Physician Decision|2|||
163155474|NCT05462756|589285699|FG001|Treatment Period|Physician Decision|0|||
163155475|NCT05462756|589285698|FG000|Treatment Period|Protocol Violation|0|||
163155476|NCT05462756|589285699|FG001|Treatment Period|Protocol Violation|1|||
163155477|NCT05462756|589285698|FG000|Treatment Period|Withdrawal by Subject|5|||
163155478|NCT05462756|589285699|FG001|Treatment Period|Withdrawal by Subject|12|||
163155479|NCT05462756|589285698|FG000|Follow-Up Period|Adverse Event|1|||
163155480|NCT05462756|589285699|FG001|Follow-Up Period|Adverse Event|0|||
163155481|NCT05462756|589285698|FG000|Follow-Up Period|Death|1|||
163155482|NCT05462756|589285699|FG001|Follow-Up Period|Death|0|||
163155483|NCT05462756|589285698|FG000|Follow-Up Period|Lost to Follow-up|3|||
163155484|NCT05462756|589285699|FG001|Follow-Up Period|Lost to Follow-up|1|||
163155485|NCT05462756|589285698|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163155486|NCT05462756|589285699|FG001|Follow-Up Period|Withdrawal by Subject|4|||
163155487|NCT02144610|589285702|FG000|Overall Study|Physician Decision|1|||
163155488|NCT02144610|589285703|FG001|Overall Study|Physician Decision|0|||
163155489|NCT02144610|589285702|FG000|Overall Study|Withdrawal by Subject|1|||
163155490|NCT02144610|589285703|FG001|Overall Study|Withdrawal by Subject|5|||
163155491|NCT02144610|589285702|FG000|Overall Study|Death|2|||
163155492|NCT02144610|589285703|FG001|Overall Study|Death|2|||
163155493|NCT02144610|589285702|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
163155494|NCT02144610|589285703|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
163155495|NCT02144610|589285702|FG000|Overall Study|Other|0|||
163155496|NCT02144610|589285703|FG001|Overall Study|Other|1|||
163155497|NCT01354899|589285708|FG000|Overall Study|discharge from the hospital|2|||
163155498|NCT01354899|589285708|FG000|Overall Study|Protocol Violation|1|||
163155499|NCT01432730|589285711|FG000|Period 1|Adverse Event|2|||
163155500|NCT01432730|589285712|FG001|Period 1|Adverse Event|0|||
163155501|NCT01432730|589285711|FG000|Period 2|Adverse Event|0|||
163155502|NCT01432730|589285712|FG001|Period 2|Adverse Event|4|||
163155503|NCT00641667|589285715|FG000|Overall Study|Withdrawal by Subject|1|||
163155504|NCT00641667|589285715|FG000|Overall Study|Adverse Event|1|||
162811636|NCT00585195|588021758|FG003|Overall Study|Other|1|||
163155505|NCT00641667|589285715|FG000|Overall Study|Physician Decision|1|||
163155506|NCT00641667|589285715|FG000|Overall Study|Worsening of underlying disease|3|||
163155507|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
163155508|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
163155509|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
163155510|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
163155511|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
163155512|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
163155513|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
163155514|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
163155515|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
163155516|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
163155517|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
163155518|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
163155519|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
163155520|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
163155521|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
163155522|NCT01235741|589285716|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
163155523|NCT01235741|589285717|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
163155524|NCT01235741|589285718|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
163155525|NCT01235741|589285716|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
163155526|NCT01235741|589285717|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
163155527|NCT01235741|589285718|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
163155528|NCT01235741|589285716|FG000|Randomized to Treatment|Adverse Event|0|||
163155529|NCT01235741|589285717|FG001|Randomized to Treatment|Adverse Event|1|||
163155530|NCT01235741|589285718|FG002|Randomized to Treatment|Adverse Event|1|||
163155531|NCT01235741|589285716|FG000|Randomized to Treatment|Sponsor terminated study|0|||
163155532|NCT01235741|589285717|FG001|Randomized to Treatment|Sponsor terminated study|35|||
163155533|NCT01235741|589285718|FG002|Randomized to Treatment|Sponsor terminated study|34|||
163155534|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
163155535|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
163155536|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
163155537|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
163155538|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
163155539|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
163155540|NCT01235741|589285716|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
163155541|NCT01235741|589285717|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
163155542|NCT01235741|589285718|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
163155543|NCT01421719|589285719|FG000|Overall Study|Withdrawal by Subject|4|||
163155544|NCT01124006|589285720|FG000|Overall Study|Withdrawal by Subject|2|||
163155545|NCT01124006|589285721|FG001|Overall Study|Withdrawal by Subject|2|||
163155546|NCT01124006|589285722|FG002|Overall Study|Withdrawal by Subject|0|||
163155547|NCT01124006|589285720|FG000|Overall Study|Lost to Follow-up|1|||
163155548|NCT01124006|589285721|FG001|Overall Study|Lost to Follow-up|0|||
163155549|NCT01124006|589285722|FG002|Overall Study|Lost to Follow-up|1|||
163155550|NCT01124006|589285720|FG000|Overall Study|Other|0|||
163155551|NCT01124006|589285721|FG001|Overall Study|Other|0|||
163155552|NCT01124006|589285722|FG002|Overall Study|Other|1|||
163155553|NCT03847896|589285736|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155554|NCT03847896|589285737|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155555|NCT03847896|589285738|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
163155556|NCT03847896|589285739|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155557|NCT03847896|589285740|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
163155558|NCT03847896|589285736|FG000|Overall Study|Withdrawal by Subject|2|||
163155559|NCT03847896|589285737|FG001|Overall Study|Withdrawal by Subject|10|||
163155560|NCT03847896|589285738|FG002|Overall Study|Withdrawal by Subject|5|||
163155561|NCT03847896|589285739|FG003|Overall Study|Withdrawal by Subject|9|||
163155562|NCT03847896|589285740|FG004|Overall Study|Withdrawal by Subject|8|||
163155563|NCT03847896|589285736|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163155564|NCT03847896|589285737|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163155565|NCT03847896|589285738|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163155566|NCT03847896|589285739|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163155567|NCT03847896|589285740|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163155568|NCT03847896|589285736|FG000|Overall Study|Adverse Event|2|||
163155569|NCT03847896|589285737|FG001|Overall Study|Adverse Event|1|||
163155570|NCT03847896|589285738|FG002|Overall Study|Adverse Event|3|||
163155571|NCT03847896|589285739|FG003|Overall Study|Adverse Event|2|||
162925894|NCT03193190|588430427|FG001|Stage 1|Withdrawal by Subject|0|||
163155572|NCT03847896|589285740|FG004|Overall Study|Adverse Event|4|||
163155573|NCT03847896|589285736|FG000|Overall Study|A severe exacerbation event|0|||
163155574|NCT03847896|589285737|FG001|Overall Study|A severe exacerbation event|0|||
163155575|NCT03847896|589285738|FG002|Overall Study|A severe exacerbation event|0|||
162925895|NCT03193190|588430428|FG002|Stage 1|Withdrawal by Subject|1|||
162925896|NCT03193190|588430429|FG003|Stage 1|Withdrawal by Subject|0|||
163155576|NCT03847896|589285739|FG003|Overall Study|A severe exacerbation event|0|||
163155577|NCT03847896|589285740|FG004|Overall Study|A severe exacerbation event|3|||
163155578|NCT03847896|589285736|FG000|Overall Study|Protocol Violation|0|||
163155579|NCT03847896|589285737|FG001|Overall Study|Protocol Violation|2|||
163155580|NCT03847896|589285738|FG002|Overall Study|Protocol Violation|1|||
163155581|NCT03847896|589285739|FG003|Overall Study|Protocol Violation|0|||
163155582|NCT03847896|589285740|FG004|Overall Study|Protocol Violation|2|||
162925897|NCT03193190|588430430|FG004|Stage 1|Withdrawal by Subject|2|||
162925898|NCT03193190|588430431|FG005|Stage 1|Withdrawal by Subject|0|||
163155583|NCT03847896|589285736|FG000|Overall Study|Lost to Follow-up|0|||
163155584|NCT03847896|589285737|FG001|Overall Study|Lost to Follow-up|0|||
163155585|NCT03847896|589285738|FG002|Overall Study|Lost to Follow-up|0|||
163155586|NCT03847896|589285739|FG003|Overall Study|Lost to Follow-up|1|||
163155587|NCT03847896|589285740|FG004|Overall Study|Lost to Follow-up|0|||
163155588|NCT03847896|589285736|FG000|Overall Study|Condition under investigation worsened|0|||
163155589|NCT03847896|589285737|FG001|Overall Study|Condition under investigation worsened|0|||
163155590|NCT03847896|589285738|FG002|Overall Study|Condition under investigation worsened|0|||
163155591|NCT03847896|589285739|FG003|Overall Study|Condition under investigation worsened|1|||
163155592|NCT03847896|589285740|FG004|Overall Study|Condition under investigation worsened|1|||
163155593|NCT03847896|589285736|FG000|Overall Study|Lack of Efficacy|0|||
163155594|NCT03847896|589285737|FG001|Overall Study|Lack of Efficacy|0|||
163155595|NCT03847896|589285738|FG002|Overall Study|Lack of Efficacy|0|||
163155596|NCT03847896|589285739|FG003|Overall Study|Lack of Efficacy|2|||
163155597|NCT03847896|589285740|FG004|Overall Study|Lack of Efficacy|2|||
163155598|NCT03847896|589285736|FG000|Overall Study|Other reasons|3|||
163155599|NCT03847896|589285737|FG001|Overall Study|Other reasons|3|||
163155600|NCT03847896|589285738|FG002|Overall Study|Other reasons|1|||
163155601|NCT03847896|589285739|FG003|Overall Study|Other reasons|2|||
163155602|NCT03847896|589285740|FG004|Overall Study|Other reasons|1|||
163155603|NCT02395471|589285741|FG000|Overall Study|Lost to Follow-up|2|||
163155604|NCT02395471|589285742|FG001|Overall Study|Lost to Follow-up|0|||
163155605|NCT02395471|589285741|FG000|Overall Study|Withdrawal by Subject|2|||
163155606|NCT02395471|589285742|FG001|Overall Study|Withdrawal by Subject|1|||
163155607|NCT02395471|589285741|FG000|Overall Study|Physician Decision|1|||
163155608|NCT02395471|589285742|FG001|Overall Study|Physician Decision|0|||
163155609|NCT02395471|589285741|FG000|Overall Study|Protocol Violation|0|||
163155610|NCT02395471|589285742|FG001|Overall Study|Protocol Violation|1|||
163155611|NCT02395471|589285741|FG000|Overall Study|Failure to swollow sponge twice|1|||
163155612|NCT02395471|589285742|FG001|Overall Study|Failure to swollow sponge twice|0|||
163155613|NCT02395471|589285741|FG000|Overall Study|Patient did not return for procedure|0|||
163155614|NCT02395471|589285742|FG001|Overall Study|Patient did not return for procedure|1|||
163155615|NCT02395471|589285741|FG000|Overall Study|Subject not eligible|1|||
163155616|NCT02395471|589285742|FG001|Overall Study|Subject not eligible|0|||
163155617|NCT02035267|589285743|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
163155618|NCT02035267|589285744|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
163155619|NCT02035267|589285745|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
163155620|NCT02035267|589285746|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
163155621|NCT02035267|589285743|FG000|Overall Study|Adverse Event|0|||
163155622|NCT02035267|589285744|FG001|Overall Study|Adverse Event|0|||
163155623|NCT02035267|589285745|FG002|Overall Study|Adverse Event|1|||
163155624|NCT02035267|589285746|FG003|Overall Study|Adverse Event|0|||
163155625|NCT02035267|589285743|FG000|Overall Study|Lost to Follow-up|0|||
163155626|NCT02035267|589285744|FG001|Overall Study|Lost to Follow-up|0|||
163155627|NCT02035267|589285745|FG002|Overall Study|Lost to Follow-up|0|||
163155628|NCT02035267|589285746|FG003|Overall Study|Lost to Follow-up|1|||
163155629|NCT02035267|589285743|FG000|Overall Study|Other unspecified|0|||
163155630|NCT02035267|589285744|FG001|Overall Study|Other unspecified|1|||
163155631|NCT02035267|589285745|FG002|Overall Study|Other unspecified|0|||
163155632|NCT02035267|589285746|FG003|Overall Study|Other unspecified|0|||
163155633|NCT03038880|589285752|FG000|Overall Study|Death|1|||
163155634|NCT03038880|589285753|FG001|Overall Study|Death|2|||
163155635|NCT03038880|589285754|FG002|Overall Study|Death|0|||
163155636|NCT03038880|589285752|FG000|Overall Study|Physician Decision|2|||
162925899|NCT03193190|588430432|FG006|Stage 1|Withdrawal by Subject|3|||
162925900|NCT03193190|588430433|FG007|Stage 1|Withdrawal by Subject|2|||
163155637|NCT03038880|589285753|FG001|Overall Study|Physician Decision|1|||
163155638|NCT03038880|589285754|FG002|Overall Study|Physician Decision|0|||
163155639|NCT03926611|589285759|FG000|Overall Study|Adverse Event|0|||
163155640|NCT03926611|589285760|FG001|Overall Study|Adverse Event|0|||
163155641|NCT03926611|589285761|FG002|Overall Study|Adverse Event|0|||
163155642|NCT03926611|589285762|FG003|Overall Study|Adverse Event|3|||
163155643|NCT03926611|589285763|FG004|Overall Study|Adverse Event|1|||
163155644|NCT03926611|589285764|FG005|Overall Study|Adverse Event|3|||
163155645|NCT03926611|589285765|FG006|Overall Study|Adverse Event|0|||
163155646|NCT03926611|589285759|FG000|Overall Study|Lack of Efficacy|1|||
163155647|NCT03926611|589285760|FG001|Overall Study|Lack of Efficacy|2|||
163155648|NCT03926611|589285761|FG002|Overall Study|Lack of Efficacy|0|||
163155649|NCT03926611|589285762|FG003|Overall Study|Lack of Efficacy|0|||
163155650|NCT03926611|589285763|FG004|Overall Study|Lack of Efficacy|1|||
163155651|NCT03926611|589285764|FG005|Overall Study|Lack of Efficacy|0|||
163155652|NCT03926611|589285765|FG006|Overall Study|Lack of Efficacy|1|||
163155653|NCT03926611|589285759|FG000|Overall Study|Physician Decision|0|||
163155654|NCT03926611|589285760|FG001|Overall Study|Physician Decision|0|||
163155655|NCT03926611|589285761|FG002|Overall Study|Physician Decision|0|||
163155656|NCT03926611|589285762|FG003|Overall Study|Physician Decision|0|||
163155657|NCT03926611|589285763|FG004|Overall Study|Physician Decision|0|||
163155658|NCT03926611|589285764|FG005|Overall Study|Physician Decision|1|||
163155659|NCT03926611|589285765|FG006|Overall Study|Physician Decision|0|||
163155660|NCT03926611|589285759|FG000|Overall Study|Protocol Violation|1|||
163155661|NCT03926611|589285760|FG001|Overall Study|Protocol Violation|0|||
163155662|NCT03926611|589285761|FG002|Overall Study|Protocol Violation|0|||
163155663|NCT03926611|589285762|FG003|Overall Study|Protocol Violation|1|||
163155664|NCT03926611|589285763|FG004|Overall Study|Protocol Violation|1|||
163155665|NCT03926611|589285764|FG005|Overall Study|Protocol Violation|1|||
163155666|NCT03926611|589285765|FG006|Overall Study|Protocol Violation|1|||
163155667|NCT03926611|589285759|FG000|Overall Study|Technical problems|0|||
163155668|NCT03926611|589285760|FG001|Overall Study|Technical problems|0|||
163155669|NCT03926611|589285761|FG002|Overall Study|Technical problems|0|||
163155670|NCT03926611|589285762|FG003|Overall Study|Technical problems|0|||
163155671|NCT03926611|589285763|FG004|Overall Study|Technical problems|0|||
163155672|NCT03926611|589285764|FG005|Overall Study|Technical problems|1|||
163155673|NCT03926611|589285765|FG006|Overall Study|Technical problems|0|||
163155674|NCT03926611|589285759|FG000|Overall Study|Withdrawal by Subject|1|||
163155675|NCT03926611|589285760|FG001|Overall Study|Withdrawal by Subject|1|||
163155676|NCT03926611|589285761|FG002|Overall Study|Withdrawal by Subject|1|||
163155677|NCT03926611|589285762|FG003|Overall Study|Withdrawal by Subject|0|||
163155678|NCT03926611|589285763|FG004|Overall Study|Withdrawal by Subject|0|||
163155679|NCT03926611|589285764|FG005|Overall Study|Withdrawal by Subject|1|||
163155680|NCT03926611|589285765|FG006|Overall Study|Withdrawal by Subject|3|||
163155681|NCT03926611|589285759|FG000|Overall Study|Covid-19 pandemic|0|||
163155682|NCT03926611|589285760|FG001|Overall Study|Covid-19 pandemic|0|||
163155683|NCT03926611|589285761|FG002|Overall Study|Covid-19 pandemic|1|||
163155684|NCT03926611|589285762|FG003|Overall Study|Covid-19 pandemic|0|||
163155685|NCT03926611|589285763|FG004|Overall Study|Covid-19 pandemic|1|||
163155686|NCT03926611|589285764|FG005|Overall Study|Covid-19 pandemic|2|||
163155687|NCT03926611|589285765|FG006|Overall Study|Covid-19 pandemic|0|||
163155688|NCT00836693|589285766|FG000|Overall Study|Adverse Event|4|||
163155689|NCT00836693|589285767|FG001|Overall Study|Adverse Event|1|||
163155690|NCT00836693|589285766|FG000|Overall Study|Sponsor Decision|0|||
163155691|NCT00836693|589285767|FG001|Overall Study|Sponsor Decision|1|||
163155692|NCT00836693|589285766|FG000|Overall Study|Physician Decision|2|||
163155693|NCT00836693|589285767|FG001|Overall Study|Physician Decision|0|||
163155694|NCT00836693|589285766|FG000|Overall Study|Withdrawal by Subject|9|||
163155695|NCT00836693|589285767|FG001|Overall Study|Withdrawal by Subject|4|||
163155696|NCT00836693|589285766|FG000|Overall Study|Protocol Violation|1|||
163155697|NCT00836693|589285767|FG001|Overall Study|Protocol Violation|0|||
163155698|NCT00836693|589285766|FG000|Overall Study|Lost to Follow-up|1|||
163155699|NCT00836693|589285767|FG001|Overall Study|Lost to Follow-up|0|||
163155700|NCT02612779|589285768|FG000|Overall Study|Administrative reason by sponsor|4|||
163155701|NCT02612779|589285769|FG001|Overall Study|Administrative reason by sponsor|1|||
163155702|NCT02612779|589285768|FG000|Overall Study|No longer meet study criteria|0|||
163155703|NCT02612779|589285769|FG001|Overall Study|No longer meet study criteria|1|||
163155704|NCT02612779|589285768|FG000|Overall Study|Disease progression|29|||
163155705|NCT02612779|589285769|FG001|Overall Study|Disease progression|2|||
163155706|NCT02612779|589285768|FG000|Overall Study|Study drug toxicity|10|||
163155707|NCT02612779|589285769|FG001|Overall Study|Study drug toxicity|1|||
163155708|NCT02612779|589285768|FG000|Overall Study|Death|1|||
163155709|NCT02612779|589285769|FG001|Overall Study|Death|0|||
163155710|NCT02612779|589285768|FG000|Overall Study|Adverse event unrelated to study drug|5|||
163155711|NCT02612779|589285769|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163155712|NCT02612779|589285768|FG000|Overall Study|Participant withdrew consent|4|||
163155713|NCT02612779|589285769|FG001|Overall Study|Participant withdrew consent|0|||
163155714|NCT02612779|589285768|FG000|Overall Study|Lost to Follow-up|1|||
163155715|NCT02612779|589285769|FG001|Overall Study|Lost to Follow-up|0|||
163155716|NCT02612779|589285768|FG000|Overall Study|Maximum clinical benefit|10|||
163155717|NCT02612779|589285769|FG001|Overall Study|Maximum clinical benefit|1|||
163155718|NCT02612779|589285768|FG000|Overall Study|Other reasons|4|||
163155719|NCT02612779|589285769|FG001|Overall Study|Other reasons|0|||
163155720|NCT01657019|589285772|FG000|Overall Study|Withdrawal by Subject|65|||
163155721|NCT01657019|589285772|FG000|Overall Study|Adverse Event|55|||
163155722|NCT01657019|589285772|FG000|Overall Study|Lost to Follow-up|48|||
163155723|NCT01657019|589285772|FG000|Overall Study|Protocol Violation|6|||
163155724|NCT01657019|589285772|FG000|Overall Study|Lack of Efficacy|3|||
163155725|NCT01657019|589285772|FG000|Overall Study|Other|58|||
163155726|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155727|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163155728|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163155729|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155730|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155731|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
163155732|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
163155733|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155734|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155735|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155736|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155737|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155738|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
163155739|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
163155740|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155741|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155742|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155743|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
163155744|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155745|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155746|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
163155747|NCT00129402|589285789|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155748|NCT00129402|589285790|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155749|NCT00129402|589285791|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
163155750|NCT00129402|589285792|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155751|NCT00129402|589285793|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
163155752|NCT00129402|589285794|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155753|NCT00129402|589285795|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
163155754|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155755|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155756|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
163040719|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040720|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040721|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040722|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040723|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040724|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
163040725|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040726|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
163040727|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040728|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
163040729|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
163040730|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040731|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040732|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040733|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040734|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040735|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040736|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040737|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040738|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
163040739|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040740|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040741|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
163040742|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
163040743|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
163040744|NCT01483599|588856053|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
163040745|NCT01483599|588856054|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
163040746|NCT01483599|588856055|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
163040747|NCT01483599|588856056|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
163040748|NCT01483599|588856057|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
163040749|NCT01483599|588856058|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
163040750|NCT01483599|588856059|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
163040751|NCT01483599|588856060|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
163040752|NCT01483599|588856061|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
163040753|NCT01483599|588856062|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
163155757|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155758|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155759|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155760|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
163155761|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155762|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155763|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
163155764|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155765|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155766|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
163155767|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
163155768|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155769|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155770|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
163155771|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155772|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155773|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155774|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
163155775|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155776|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155777|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
163155778|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155779|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155780|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
163155781|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
163155782|NCT00129402|589285789|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155783|NCT00129402|589285790|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155784|NCT00129402|589285791|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
163155785|NCT00129402|589285792|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155786|NCT00129402|589285793|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155787|NCT00129402|589285794|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
162925901|NCT03193190|588430434|FG008|Stage 1|Withdrawal by Subject|2|||
162925902|NCT03193190|588430435|FG009|Stage 1|Withdrawal by Subject|4|||
162925903|NCT03193190|588430436|FG010|Stage 1|Withdrawal by Subject|9|||
162925904|NCT03193190|588430437|FG011|Stage 1|Withdrawal by Subject|1|||
162925905|NCT03193190|588430438|FG012|Stage 1|Withdrawal by Subject|0|||
162925906|NCT03193190|588430439|FG013|Stage 1|Withdrawal by Subject|0|||
162925907|NCT03193190|588430440|FG014|Stage 1|Withdrawal by Subject|0|||
162925908|NCT03193190|588430441|FG015|Stage 1|Withdrawal by Subject|0|||
162925909|NCT03193190|588430426|FG000|Stage 2|Death|0|||
162925910|NCT03193190|588430427|FG001|Stage 2|Death|0|||
162925911|NCT03193190|588430428|FG002|Stage 2|Death|0|||
162925912|NCT03193190|588430429|FG003|Stage 2|Death|0|||
162925913|NCT03193190|588430430|FG004|Stage 2|Death|0|||
162925914|NCT03193190|588430431|FG005|Stage 2|Death|0|||
162925915|NCT03193190|588430432|FG006|Stage 2|Death|0|||
162925916|NCT03193190|588430433|FG007|Stage 2|Death|0|||
162925917|NCT03193190|588430434|FG008|Stage 2|Death|0|||
162925918|NCT03193190|588430435|FG009|Stage 2|Death|0|||
162925919|NCT03193190|588430436|FG010|Stage 2|Death|0|||
162925920|NCT03193190|588430437|FG011|Stage 2|Death|0|||
162925921|NCT03193190|588430438|FG012|Stage 2|Death|0|||
162925922|NCT03193190|588430439|FG013|Stage 2|Death|14|||
162925923|NCT03193190|588430440|FG014|Stage 2|Death|4|||
162925924|NCT03193190|588430441|FG015|Stage 2|Death|1|||
162925925|NCT03193190|588430426|FG000|Stage 2|Lost to Follow-up|0|||
162925926|NCT03193190|588430427|FG001|Stage 2|Lost to Follow-up|0|||
162925927|NCT03193190|588430428|FG002|Stage 2|Lost to Follow-up|0|||
162925928|NCT03193190|588430429|FG003|Stage 2|Lost to Follow-up|0|||
162925929|NCT03193190|588430430|FG004|Stage 2|Lost to Follow-up|0|||
162925930|NCT03193190|588430431|FG005|Stage 2|Lost to Follow-up|0|||
162925931|NCT03193190|588430432|FG006|Stage 2|Lost to Follow-up|0|||
162925932|NCT03193190|588430433|FG007|Stage 2|Lost to Follow-up|0|||
162925933|NCT03193190|588430434|FG008|Stage 2|Lost to Follow-up|0|||
162925934|NCT03193190|588430435|FG009|Stage 2|Lost to Follow-up|0|||
162925935|NCT03193190|588430436|FG010|Stage 2|Lost to Follow-up|0|||
162925936|NCT03193190|588430437|FG011|Stage 2|Lost to Follow-up|0|||
162925937|NCT03193190|588430438|FG012|Stage 2|Lost to Follow-up|0|||
162925938|NCT03193190|588430439|FG013|Stage 2|Lost to Follow-up|0|||
162925939|NCT03193190|588430440|FG014|Stage 2|Lost to Follow-up|1|||
162925940|NCT03193190|588430441|FG015|Stage 2|Lost to Follow-up|0|||
162925941|NCT03193190|588430426|FG000|Stage 2|Withdrawal by Subject|0|||
162925942|NCT03193190|588430427|FG001|Stage 2|Withdrawal by Subject|0|||
162925943|NCT03193190|588430428|FG002|Stage 2|Withdrawal by Subject|0|||
162925944|NCT03193190|588430429|FG003|Stage 2|Withdrawal by Subject|0|||
162925945|NCT03193190|588430430|FG004|Stage 2|Withdrawal by Subject|0|||
162925946|NCT03193190|588430431|FG005|Stage 2|Withdrawal by Subject|0|||
162925947|NCT03193190|588430432|FG006|Stage 2|Withdrawal by Subject|0|||
162925948|NCT03193190|588430433|FG007|Stage 2|Withdrawal by Subject|0|||
162925949|NCT03193190|588430434|FG008|Stage 2|Withdrawal by Subject|0|||
162925950|NCT03193190|588430435|FG009|Stage 2|Withdrawal by Subject|0|||
162925951|NCT03193190|588430436|FG010|Stage 2|Withdrawal by Subject|0|||
162925952|NCT03193190|588430437|FG011|Stage 2|Withdrawal by Subject|0|||
162925953|NCT03193190|588430438|FG012|Stage 2|Withdrawal by Subject|0|||
162925954|NCT03193190|588430439|FG013|Stage 2|Withdrawal by Subject|1|||
162925955|NCT03193190|588430440|FG014|Stage 2|Withdrawal by Subject|1|||
162925956|NCT03193190|588430441|FG015|Stage 2|Withdrawal by Subject|0|||
162925957|NCT03532295|588430442|FG000|Overall Study|Did not start treatment|0|||
162925958|NCT03532295|588430443|FG001|Overall Study|Did not start treatment|2|||
162925959|NCT05004181|588430447|FG000|Overall Study|Withdrawal of consent|0|||
162925960|NCT05004181|588430448|FG001|Overall Study|Withdrawal of consent|0|||
162925961|NCT05004181|588430449|FG002|Overall Study|Withdrawal of consent|1|||
162925962|NCT05004181|588430450|FG003|Overall Study|Withdrawal of consent|3|||
162925963|NCT05004181|588430451|FG004|Overall Study|Withdrawal of consent|3|||
162925964|NCT05004181|588430452|FG005|Overall Study|Withdrawal of consent|0|||
162925965|NCT05004181|588430453|FG006|Overall Study|Withdrawal of consent|30|||
162925966|NCT05004181|588430454|FG007|Overall Study|Withdrawal of consent|9|||
162925967|NCT05004181|588430455|FG008|Overall Study|Withdrawal of consent|3|||
162925968|NCT05004181|588430456|FG009|Overall Study|Withdrawal of consent|2|||
162925969|NCT05004181|588430457|FG010|Overall Study|Withdrawal of consent|5|||
162925970|NCT05004181|588430458|FG011|Overall Study|Withdrawal of consent|1|||
162925971|NCT05004181|588430447|FG000|Overall Study|Lost to Follow-up|2|||
162925972|NCT05004181|588430448|FG001|Overall Study|Lost to Follow-up|4|||
162925973|NCT05004181|588430449|FG002|Overall Study|Lost to Follow-up|2|||
162925974|NCT05004181|588430450|FG003|Overall Study|Lost to Follow-up|3|||
162925975|NCT05004181|588430451|FG004|Overall Study|Lost to Follow-up|5|||
162925976|NCT05004181|588430452|FG005|Overall Study|Lost to Follow-up|2|||
162925977|NCT05004181|588430453|FG006|Overall Study|Lost to Follow-up|15|||
162925978|NCT05004181|588430454|FG007|Overall Study|Lost to Follow-up|12|||
162925979|NCT05004181|588430455|FG008|Overall Study|Lost to Follow-up|38|||
162925980|NCT05004181|588430456|FG009|Overall Study|Lost to Follow-up|6|||
162925981|NCT05004181|588430457|FG010|Overall Study|Lost to Follow-up|6|||
162925982|NCT05004181|588430458|FG011|Overall Study|Lost to Follow-up|0|||
162925983|NCT05004181|588430447|FG000|Overall Study|Death|0|||
162925984|NCT05004181|588430448|FG001|Overall Study|Death|0|||
162925985|NCT05004181|588430449|FG002|Overall Study|Death|0|||
162925986|NCT05004181|588430450|FG003|Overall Study|Death|0|||
162925987|NCT05004181|588430451|FG004|Overall Study|Death|0|||
162925988|NCT05004181|588430452|FG005|Overall Study|Death|0|||
162925989|NCT05004181|588430453|FG006|Overall Study|Death|1|||
162925990|NCT05004181|588430454|FG007|Overall Study|Death|0|||
162925991|NCT05004181|588430455|FG008|Overall Study|Death|2|||
162925992|NCT05004181|588430456|FG009|Overall Study|Death|0|||
162925993|NCT05004181|588430457|FG010|Overall Study|Death|0|||
162925994|NCT05004181|588430458|FG011|Overall Study|Death|0|||
163155788|NCT00129402|589285795|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
163155789|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155790|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155791|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155792|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155793|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155794|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
163155795|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
163155796|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155797|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155798|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155799|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155800|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162925995|NCT05004181|588430447|FG000|Overall Study|Physician Decision|0|||
162925996|NCT05004181|588430448|FG001|Overall Study|Physician Decision|0|||
162925997|NCT05004181|588430449|FG002|Overall Study|Physician Decision|0|||
162925998|NCT05004181|588430450|FG003|Overall Study|Physician Decision|0|||
162925999|NCT05004181|588430451|FG004|Overall Study|Physician Decision|0|||
162926000|NCT05004181|588430452|FG005|Overall Study|Physician Decision|0|||
162926001|NCT05004181|588430453|FG006|Overall Study|Physician Decision|2|||
162926002|NCT05004181|588430454|FG007|Overall Study|Physician Decision|0|||
162926003|NCT05004181|588430455|FG008|Overall Study|Physician Decision|7|||
162926004|NCT05004181|588430456|FG009|Overall Study|Physician Decision|0|||
162926005|NCT05004181|588430457|FG010|Overall Study|Physician Decision|0|||
162926006|NCT05004181|588430458|FG011|Overall Study|Physician Decision|0|||
162926007|NCT05004181|588430447|FG000|Overall Study|Withdrawal by Subject|2|||
162926008|NCT05004181|588430448|FG001|Overall Study|Withdrawal by Subject|3|||
163155801|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
163155802|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
163155803|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155804|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155805|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155806|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155807|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155808|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
163155809|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
163155810|NCT00129402|589285789|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155811|NCT00129402|589285790|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155812|NCT00129402|589285791|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155813|NCT00129402|589285792|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155814|NCT00129402|589285793|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155815|NCT00129402|589285794|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
163155816|NCT00129402|589285795|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
163155817|NCT00763035|589285796|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
163155818|NCT00763035|589285797|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
163155819|NCT00763035|589285796|FG000|First Intervention|Adverse Event|0|||
163155820|NCT00763035|589285797|FG001|First Intervention|Adverse Event|1|||
163155821|NCT00763035|589285796|FG000|Second Intervention|Adverse Event|1|||
163155822|NCT00763035|589285797|FG001|Second Intervention|Adverse Event|0|||
163155823|NCT00763035|589285796|FG000|Second Intervention|Physician Decision|2|||
163155824|NCT00763035|589285797|FG001|Second Intervention|Physician Decision|0|||
163155825|NCT00702221|589285800|FG000|Overall Study|Adverse Event|4|||
163155826|NCT00702221|589285801|FG001|Overall Study|Adverse Event|3|||
163155827|NCT02900378|589285802|FG000|Randomization (Visit 2)|Adverse Event|14|||
163155828|NCT02900378|589285803|FG001|Randomization (Visit 2)|Adverse Event|11|||
163155829|NCT02900378|589285802|FG000|Randomization (Visit 2)|Death|1|||
163155830|NCT02900378|589285803|FG001|Randomization (Visit 2)|Death|4|||
163155831|NCT02900378|589285802|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
163155832|NCT02900378|589285803|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
163155833|NCT02900378|589285802|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
163155834|NCT02900378|589285803|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
163155835|NCT02900378|589285802|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
163155836|NCT02900378|589285803|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
163155837|NCT02900378|589285802|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
163155838|NCT02900378|589285803|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
163155839|NCT02900378|589285802|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
163155840|NCT02900378|589285803|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
163155841|NCT01134055|589285804|FG000|Overall Study|Adverse Event|5|||
163155842|NCT01134055|589285805|FG001|Overall Study|Adverse Event|2|||
163155843|NCT01134055|589285806|FG002|Overall Study|Adverse Event|2|||
163155844|NCT01134055|589285807|FG003|Overall Study|Adverse Event|2|||
163155845|NCT01134055|589285808|FG004|Overall Study|Adverse Event|5|||
163155846|NCT01134055|589285809|FG005|Overall Study|Adverse Event|7|||
163155847|NCT01134055|589285810|FG006|Overall Study|Adverse Event|2|||
163155848|NCT01134055|589285804|FG000|Overall Study|Lost to Follow-up|0|||
163155849|NCT01134055|589285805|FG001|Overall Study|Lost to Follow-up|1|||
163155850|NCT01134055|589285806|FG002|Overall Study|Lost to Follow-up|0|||
163155851|NCT01134055|589285807|FG003|Overall Study|Lost to Follow-up|1|||
163155852|NCT01134055|589285808|FG004|Overall Study|Lost to Follow-up|0|||
163155853|NCT01134055|589285809|FG005|Overall Study|Lost to Follow-up|0|||
163155854|NCT01134055|589285810|FG006|Overall Study|Lost to Follow-up|0|||
163155855|NCT01134055|589285804|FG000|Overall Study|Withdrawal by Subject|3|||
163155856|NCT01134055|589285805|FG001|Overall Study|Withdrawal by Subject|3|||
163155857|NCT01134055|589285806|FG002|Overall Study|Withdrawal by Subject|1|||
163155858|NCT01134055|589285807|FG003|Overall Study|Withdrawal by Subject|2|||
163155859|NCT01134055|589285808|FG004|Overall Study|Withdrawal by Subject|0|||
163155860|NCT01134055|589285809|FG005|Overall Study|Withdrawal by Subject|0|||
163155861|NCT01134055|589285810|FG006|Overall Study|Withdrawal by Subject|8|||
163155862|NCT01134055|589285804|FG000|Overall Study|Protocol Violation|0|||
163155863|NCT01134055|589285805|FG001|Overall Study|Protocol Violation|0|||
163155864|NCT01134055|589285806|FG002|Overall Study|Protocol Violation|0|||
163155865|NCT01134055|589285807|FG003|Overall Study|Protocol Violation|1|||
163155866|NCT01134055|589285808|FG004|Overall Study|Protocol Violation|1|||
163155867|NCT01134055|589285809|FG005|Overall Study|Protocol Violation|0|||
163155868|NCT01134055|589285810|FG006|Overall Study|Protocol Violation|0|||
163155869|NCT01134055|589285804|FG000|Overall Study|Physician Decision|0|||
163155870|NCT01134055|589285805|FG001|Overall Study|Physician Decision|0|||
163155871|NCT01134055|589285806|FG002|Overall Study|Physician Decision|0|||
163155872|NCT01134055|589285807|FG003|Overall Study|Physician Decision|0|||
162696289|NCT00603265|587599458|FG002|Overall Study|Participant Left Country, No Responses|0|||
163155873|NCT01134055|589285808|FG004|Overall Study|Physician Decision|0|||
163155874|NCT01134055|589285809|FG005|Overall Study|Physician Decision|0|||
163155875|NCT01134055|589285810|FG006|Overall Study|Physician Decision|1|||
163155876|NCT03345784|589285813|FG000|Overall Study|Withdrawal by Subject|2|||
163155877|NCT03345784|589285814|FG001|Overall Study|Withdrawal by Subject|1|||
163155878|NCT00001959|589285822|FG000|Overall Study|newly diagnosed colon cancer|1|||
163155879|NCT00001959|589285822|FG000|Overall Study|disabling sedation|1|||
163040754|NCT01483599|588856063|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
163155880|NCT00001959|589285822|FG000|Overall Study|non-compliance|1|||
163155881|NCT04298697|589285825|FG000|Overall Study|Lost to Follow-up|5|||
163155882|NCT04298697|589285826|FG001|Overall Study|Lost to Follow-up|5|||
163155883|NCT04298697|589285827|FG002|Overall Study|Lost to Follow-up|1|||
163155884|NCT04298697|589285828|FG003|Overall Study|Lost to Follow-up|0|||
163155885|NCT04298697|589285825|FG000|Overall Study|Withdrawal by Subject|0|||
163155886|NCT04298697|589285826|FG001|Overall Study|Withdrawal by Subject|3|||
163155887|NCT04298697|589285827|FG002|Overall Study|Withdrawal by Subject|2|||
163155888|NCT04298697|589285828|FG003|Overall Study|Withdrawal by Subject|3|||
163155889|NCT03995368|589285829|FG000|Overall Study|Lost to Follow-up|1|||
163155890|NCT03995368|589285830|FG001|Overall Study|Lost to Follow-up|4|||
163155891|NCT03995368|589285831|FG002|Overall Study|Lost to Follow-up|1|||
163155892|NCT03995368|589285829|FG000|Overall Study|Did not meet inclusion criteria|1|||
163155893|NCT03995368|589285830|FG001|Overall Study|Did not meet inclusion criteria|6|||
163155894|NCT03995368|589285831|FG002|Overall Study|Did not meet inclusion criteria|3|||
163155895|NCT03995368|589285829|FG000|Overall Study|Withdrawal by Subject|0|||
163155896|NCT03995368|589285830|FG001|Overall Study|Withdrawal by Subject|1|||
163155897|NCT03995368|589285831|FG002|Overall Study|Withdrawal by Subject|1|||
163155898|NCT03592186|589285832|FG000|Overall Study|Withdrawal by Subject|1|||
163155899|NCT03592186|589285833|FG001|Overall Study|Withdrawal by Subject|0|||
163155900|NCT03592186|589285832|FG000|Overall Study|Lost to Follow-up|16|||
163155901|NCT03592186|589285833|FG001|Overall Study|Lost to Follow-up|11|||
163155902|NCT03755934|589285834|FG000|Overall Study|Adverse Event|4|||
163155903|NCT03755934|589285835|FG001|Overall Study|Adverse Event|1|||
163155904|NCT03755934|589285836|FG002|Overall Study|Adverse Event|1|||
163155905|NCT03755934|589285837|FG003|Overall Study|Adverse Event|3|||
163155906|NCT03755934|589285834|FG000|Overall Study|Physician Decision|2|||
163155907|NCT03755934|589285835|FG001|Overall Study|Physician Decision|0|||
163155908|NCT03755934|589285836|FG002|Overall Study|Physician Decision|0|||
163155909|NCT03755934|589285837|FG003|Overall Study|Physician Decision|1|||
163155910|NCT03755934|589285834|FG000|Overall Study|Withdrawal by Subject|5|||
163155911|NCT03755934|589285835|FG001|Overall Study|Withdrawal by Subject|0|||
163155912|NCT03755934|589285836|FG002|Overall Study|Withdrawal by Subject|0|||
163040755|NCT01483599|588856064|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
163040756|NCT01483599|588856065|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
163155913|NCT03755934|589285837|FG003|Overall Study|Withdrawal by Subject|1|||
163155914|NCT03755934|589285834|FG000|Overall Study|Other|3|||
163155915|NCT03755934|589285835|FG001|Overall Study|Other|1|||
163155916|NCT03755934|589285836|FG002|Overall Study|Other|3|||
163155917|NCT03755934|589285837|FG003|Overall Study|Other|1|||
163155918|NCT01498068|589285838|FG000|Overall Study|Withdrawal by Subject|1|||
163155919|NCT01498068|589285839|FG001|Overall Study|Withdrawal by Subject|1|||
163155920|NCT00361296|589285842|FG000|Overall Study|Physician Decision|1|||
163155921|NCT00361296|589285842|FG000|Overall Study|Lack of Efficacy|2|||
163155922|NCT02594124|589285843|FG000|Overall Study|Adverse Event|0|||
163155923|NCT02594124|589285844|FG001|Overall Study|Adverse Event|5|||
163155924|NCT02594124|589285845|FG002|Overall Study|Adverse Event|8|||
163155925|NCT02594124|589285846|FG003|Overall Study|Adverse Event|1|||
163155926|NCT02594124|589285847|FG004|Overall Study|Adverse Event|0|||
163155927|NCT02594124|589285848|FG005|Overall Study|Adverse Event|0|||
163155928|NCT02594124|589285849|FG006|Overall Study|Adverse Event|2|||
163155929|NCT02594124|589285850|FG007|Overall Study|Adverse Event|2|||
163155930|NCT02594124|589285851|FG008|Overall Study|Adverse Event|0|||
163155931|NCT02594124|589285843|FG000|Overall Study|Withdrawal by Subject|2|||
163155932|NCT02594124|589285844|FG001|Overall Study|Withdrawal by Subject|3|||
163155933|NCT02594124|589285845|FG002|Overall Study|Withdrawal by Subject|5|||
163155934|NCT02594124|589285846|FG003|Overall Study|Withdrawal by Subject|1|||
163155935|NCT02594124|589285847|FG004|Overall Study|Withdrawal by Subject|8|||
163155936|NCT02594124|589285848|FG005|Overall Study|Withdrawal by Subject|4|||
163155937|NCT02594124|589285849|FG006|Overall Study|Withdrawal by Subject|13|||
163155938|NCT02594124|589285850|FG007|Overall Study|Withdrawal by Subject|19|||
163155939|NCT02594124|589285851|FG008|Overall Study|Withdrawal by Subject|0|||
163155940|NCT02594124|589285843|FG000|Overall Study|Physician Decision|0|||
163155941|NCT02594124|589285844|FG001|Overall Study|Physician Decision|2|||
163155942|NCT02594124|589285845|FG002|Overall Study|Physician Decision|0|||
163155943|NCT02594124|589285846|FG003|Overall Study|Physician Decision|0|||
163155944|NCT02594124|589285847|FG004|Overall Study|Physician Decision|0|||
163155945|NCT02594124|589285848|FG005|Overall Study|Physician Decision|0|||
163155946|NCT02594124|589285849|FG006|Overall Study|Physician Decision|0|||
163155947|NCT02594124|589285850|FG007|Overall Study|Physician Decision|1|||
163155948|NCT02594124|589285851|FG008|Overall Study|Physician Decision|0|||
163155949|NCT02594124|589285843|FG000|Overall Study|Commercial drug|0|||
163155950|NCT02594124|589285844|FG001|Overall Study|Commercial drug|1|||
163155951|NCT02594124|589285845|FG002|Overall Study|Commercial drug|6|||
163155952|NCT02594124|589285846|FG003|Overall Study|Commercial drug|3|||
163155953|NCT02594124|589285847|FG004|Overall Study|Commercial drug|0|||
163155954|NCT02594124|589285848|FG005|Overall Study|Commercial drug|0|||
163155955|NCT02594124|589285849|FG006|Overall Study|Commercial drug|7|||
163155956|NCT02594124|589285850|FG007|Overall Study|Commercial drug|11|||
163155957|NCT02594124|589285851|FG008|Overall Study|Commercial drug|2|||
163155958|NCT02594124|589285843|FG000|Overall Study|Reason Not Specified|1|||
163155959|NCT02594124|589285844|FG001|Overall Study|Reason Not Specified|3|||
163155960|NCT02594124|589285845|FG002|Overall Study|Reason Not Specified|4|||
163155961|NCT02594124|589285846|FG003|Overall Study|Reason Not Specified|0|||
163155962|NCT02594124|589285847|FG004|Overall Study|Reason Not Specified|0|||
163155963|NCT02594124|589285848|FG005|Overall Study|Reason Not Specified|1|||
163155964|NCT02594124|589285849|FG006|Overall Study|Reason Not Specified|1|||
163155965|NCT02594124|589285850|FG007|Overall Study|Reason Not Specified|6|||
162926009|NCT05004181|588430449|FG002|Overall Study|Withdrawal by Subject|2|||
162926010|NCT05004181|588430450|FG003|Overall Study|Withdrawal by Subject|2|||
162926011|NCT05004181|588430451|FG004|Overall Study|Withdrawal by Subject|4|||
162926012|NCT05004181|588430452|FG005|Overall Study|Withdrawal by Subject|2|||
162926013|NCT05004181|588430453|FG006|Overall Study|Withdrawal by Subject|4|||
162926014|NCT05004181|588430454|FG007|Overall Study|Withdrawal by Subject|22|||
162926015|NCT05004181|588430455|FG008|Overall Study|Withdrawal by Subject|8|||
162926016|NCT05004181|588430456|FG009|Overall Study|Withdrawal by Subject|1|||
162926017|NCT05004181|588430457|FG010|Overall Study|Withdrawal by Subject|3|||
162926018|NCT05004181|588430458|FG011|Overall Study|Withdrawal by Subject|2|||
162926019|NCT05004181|588430447|FG000|Overall Study|Protocol Violation|2|||
162926020|NCT05004181|588430448|FG001|Overall Study|Protocol Violation|3|||
162926021|NCT05004181|588430449|FG002|Overall Study|Protocol Violation|0|||
162926022|NCT05004181|588430450|FG003|Overall Study|Protocol Violation|0|||
162926023|NCT05004181|588430451|FG004|Overall Study|Protocol Violation|1|||
162926024|NCT05004181|588430452|FG005|Overall Study|Protocol Violation|0|||
162926025|NCT05004181|588430453|FG006|Overall Study|Protocol Violation|16|||
162926026|NCT05004181|588430454|FG007|Overall Study|Protocol Violation|18|||
162926027|NCT05004181|588430455|FG008|Overall Study|Protocol Violation|2|||
162926028|NCT05004181|588430456|FG009|Overall Study|Protocol Violation|2|||
162926029|NCT05004181|588430457|FG010|Overall Study|Protocol Violation|2|||
162926030|NCT05004181|588430458|FG011|Overall Study|Protocol Violation|1|||
162926031|NCT05004181|588430447|FG000|Overall Study|Not further specified|1|||
162926032|NCT05004181|588430448|FG001|Overall Study|Not further specified|0|||
162926033|NCT05004181|588430449|FG002|Overall Study|Not further specified|0|||
162926034|NCT05004181|588430450|FG003|Overall Study|Not further specified|0|||
162926035|NCT05004181|588430451|FG004|Overall Study|Not further specified|0|||
162926036|NCT05004181|588430452|FG005|Overall Study|Not further specified|0|||
162926037|NCT05004181|588430453|FG006|Overall Study|Not further specified|1|||
162926038|NCT05004181|588430454|FG007|Overall Study|Not further specified|0|||
162926039|NCT05004181|588430455|FG008|Overall Study|Not further specified|2|||
162926040|NCT05004181|588430456|FG009|Overall Study|Not further specified|1|||
162926041|NCT05004181|588430457|FG010|Overall Study|Not further specified|0|||
162926042|NCT05004181|588430458|FG011|Overall Study|Not further specified|1|||
162926043|NCT03868059|588430460|FG000|Overall Study|Adverse Event|3|||
162926044|NCT03868059|588430460|FG000|Overall Study|Lost to Follow-up|3|||
162926045|NCT03868059|588430460|FG000|Overall Study|Withdrawal by Subject|6|||
163155966|NCT02594124|589285851|FG008|Overall Study|Reason Not Specified|1|||
163155967|NCT05523089|589285852|FG000|Overall Study|Withdrawal by Subject|1|||
162926046|NCT04278872|588430461|FG000|Overall Study|Adverse Event|1|||
162926047|NCT04278872|588430462|FG001|Overall Study|Adverse Event|0|||
162926048|NCT04278872|588430461|FG000|Overall Study|Protocol Violation|0|||
162926049|NCT04278872|588430462|FG001|Overall Study|Protocol Violation|1|||
162926050|NCT04278872|588430461|FG000|Overall Study|Study Termination|2|||
162926051|NCT04278872|588430462|FG001|Overall Study|Study Termination|0|||
162926052|NCT02392377|588430463|FG000|Overall Study|Withdrawal by Subject|0|||
162926053|NCT02392377|588430464|FG001|Overall Study|Withdrawal by Subject|1|||
162926054|NCT01298661|588430465|FG000|Overall Study|Withdrawal by Subject|2|||
162926055|NCT01298661|588430466|FG001|Overall Study|Withdrawal by Subject|0|||
162926056|NCT01298661|588430467|FG002|Overall Study|Withdrawal by Subject|2|||
162978976|NCT01660022|588623539|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
162978977|NCT01660022|588623540|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
163155968|NCT05523089|589285853|FG001|Overall Study|Withdrawal by Subject|0|||
163155969|NCT05523089|589285854|FG002|Overall Study|Withdrawal by Subject|0|||
162978978|NCT01660022|588623541|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
162978979|NCT01660022|588623542|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
162978980|NCT01660022|588623543|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
162978981|NCT01660022|588623538|FG000|First Sequence (7 Days)|Adverse Event|0|||
163155970|NCT05523089|589285852|FG000|Overall Study|Lost to Follow-up|1|||
162926057|NCT02239692|588431731|FG000|Overall Study|Incomplete colonoscopy|1|||
162926058|NCT02239692|588431732|FG001|Overall Study|Incomplete colonoscopy|2|||
162926059|NCT02239692|588431731|FG000|Overall Study|Adverse Event|0|||
162926060|NCT02239692|588431732|FG001|Overall Study|Adverse Event|1|||
162926061|NCT02239692|588431731|FG000|Overall Study|Physician Decision|0|||
162926062|NCT02239692|588431732|FG001|Overall Study|Physician Decision|1|||
162926063|NCT02239692|588431731|FG000|Overall Study|Lost to Follow-up|1|||
162926064|NCT02239692|588431732|FG001|Overall Study|Lost to Follow-up|4|||
162926065|NCT02239692|588431731|FG000|Overall Study|Withdrawal by Subject|3|||
162926066|NCT02239692|588431732|FG001|Overall Study|Withdrawal by Subject|5|||
162926067|NCT02239692|588431731|FG000|Overall Study|Other reason|1|||
162926068|NCT02239692|588431732|FG001|Overall Study|Other reason|0|||
162926069|NCT01901146|588431737|FG000|Neoadjuvant Phase|Death|1|||
162926070|NCT01901146|588431738|FG001|Neoadjuvant Phase|Death|2|||
162926071|NCT01901146|588431739|FG002|Neoadjuvant Phase|Death|0|||
162926072|NCT01901146|588431740|FG003|Neoadjuvant Phase|Death|0|||
162926073|NCT01901146|588431741|FG004|Neoadjuvant Phase|Death|0|||
162926074|NCT01901146|588431737|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
162926075|NCT01901146|588431738|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
162926076|NCT01901146|588431739|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926077|NCT01901146|588431740|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926078|NCT01901146|588431741|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
162926079|NCT01901146|588431737|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
162926080|NCT01901146|588431738|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
162926081|NCT01901146|588431739|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
162926082|NCT01901146|588431740|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
162926083|NCT01901146|588431741|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
162926084|NCT01901146|588431737|FG000|Neoadjuvant Phase|Physician Decision|1|||
162926085|NCT01901146|588431738|FG001|Neoadjuvant Phase|Physician Decision|2|||
162926086|NCT01901146|588431739|FG002|Neoadjuvant Phase|Physician Decision|0|||
162926087|NCT01901146|588431740|FG003|Neoadjuvant Phase|Physician Decision|0|||
162926088|NCT01901146|588431741|FG004|Neoadjuvant Phase|Physician Decision|0|||
162926089|NCT01901146|588431737|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
162926090|NCT01901146|588431738|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
162926091|NCT01901146|588431739|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926092|NCT01901146|588431740|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926093|NCT01901146|588431741|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
162926094|NCT01901146|588431737|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926095|NCT01901146|588431738|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
162926096|NCT01901146|588431739|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926097|NCT01901146|588431740|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926098|NCT01901146|588431741|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
162926099|NCT01901146|588431737|FG000|Adjuvant Phase|Other|0|||
162926100|NCT01901146|588431738|FG001|Adjuvant Phase|Other|0|||
162926101|NCT01901146|588431739|FG002|Adjuvant Phase|Other|1|||
162926102|NCT01901146|588431740|FG003|Adjuvant Phase|Other|0|||
162926103|NCT01901146|588431741|FG004|Adjuvant Phase|Other|0|||
162926104|NCT01901146|588431737|FG000|Adjuvant Phase|Death|0|||
162926105|NCT01901146|588431738|FG001|Adjuvant Phase|Death|0|||
162926106|NCT01901146|588431739|FG002|Adjuvant Phase|Death|0|||
162926107|NCT01901146|588431740|FG003|Adjuvant Phase|Death|0|||
162926108|NCT01901146|588431741|FG004|Adjuvant Phase|Death|3|||
162926109|NCT01901146|588431737|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
162926110|NCT01901146|588431738|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
162926111|NCT01901146|588431739|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
162926112|NCT01901146|588431740|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
162926113|NCT01901146|588431741|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
162926114|NCT01901146|588431737|FG000|Adjuvant Phase|Physician Decision|0|||
162926115|NCT01901146|588431738|FG001|Adjuvant Phase|Physician Decision|0|||
162926116|NCT01901146|588431739|FG002|Adjuvant Phase|Physician Decision|9|||
162926117|NCT01901146|588431740|FG003|Adjuvant Phase|Physician Decision|2|||
162926118|NCT01901146|588431741|FG004|Adjuvant Phase|Physician Decision|4|||
162926119|NCT01901146|588431737|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
162926120|NCT01901146|588431738|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
162926121|NCT01901146|588431739|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
162926122|NCT01901146|588431740|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
162926123|NCT01901146|588431741|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
162926124|NCT00297492|588431742|FG000|Set Quit Date|Lost to Follow-up|7|||
162926125|NCT00297492|588431743|FG001|Set Quit Date|Lost to Follow-up|13|||
162926126|NCT00297492|588431744|FG002|Set Quit Date|Lost to Follow-up|5|||
162926127|NCT00297492|588431742|FG000|6 Month Follow-up|Lost to Follow-up|63|||
162926128|NCT00297492|588431743|FG001|6 Month Follow-up|Lost to Follow-up|49|||
162926129|NCT00297492|588431744|FG002|6 Month Follow-up|Lost to Follow-up|27|||
162926130|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926131|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926132|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
162926133|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
162926134|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
162926135|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
162926136|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
162926137|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
162926138|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
162926139|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
162926140|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
162926141|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
162926142|NCT02675426|588431745|FG000|Period 1: Week 1 to Week 12|Other|2|||
162926143|NCT02675426|588431746|FG001|Period 1: Week 1 to Week 12|Other|1|||
162926144|NCT02675426|588431747|FG002|Period 1: Week 1 to Week 12|Other|0|||
162926145|NCT02675426|588431748|FG003|Period 1: Week 1 to Week 12|Other|2|||
162926146|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
162926147|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
162926148|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
162926149|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
162926150|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
162926151|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
162926152|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
162926153|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
162926154|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
162926155|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
162926156|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
162926157|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
162926158|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
162926159|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
162926160|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
162926161|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
162926162|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
162926163|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
162926164|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
162926165|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
162926166|NCT02675426|588431745|FG000|Period 2: Week 12 to Week 260|Other|8|||
162926167|NCT02675426|588431746|FG001|Period 2: Week 12 to Week 260|Other|12|||
162926168|NCT02675426|588431747|FG002|Period 2: Week 12 to Week 260|Other|23|||
162926169|NCT02675426|588431748|FG003|Period 2: Week 12 to Week 260|Other|15|||
162926170|NCT03724968|588431751|FG000|Overall Study|Insurance issues|0|||
162926171|NCT03724968|588431752|FG001|Overall Study|Insurance issues|1|||
162926172|NCT03724968|588431751|FG000|Overall Study|Study closed|0|||
162926173|NCT03724968|588431752|FG001|Overall Study|Study closed|1|||
162926174|NCT01784419|588431753|FG000|Overall Study|Adverse Event|3|||
162926175|NCT02237118|588431754|FG000|Overall Study|Protocol Violation|0|||
162926176|NCT02237118|588431755|FG001|Overall Study|Protocol Violation|1|||
162926177|NCT02237118|588431754|FG000|Overall Study|consent withdrawn|1|||
162926178|NCT02237118|588431755|FG001|Overall Study|consent withdrawn|0|||
162926179|NCT00080288|588431756|FG000|Overall Study|Adverse Event|7|||
162926180|NCT00080288|588431757|FG001|Overall Study|Adverse Event|4|||
162926181|NCT00080288|588431756|FG000|Overall Study|Lost to Follow-up|3|||
162926182|NCT00080288|588431757|FG001|Overall Study|Lost to Follow-up|5|||
162926183|NCT00080288|588431756|FG000|Overall Study|Physician Decision|6|||
162926184|NCT00080288|588431757|FG001|Overall Study|Physician Decision|2|||
162926185|NCT00080288|588431756|FG000|Overall Study|Withdrawal by Subject|3|||
162926186|NCT00080288|588431757|FG001|Overall Study|Withdrawal by Subject|16|||
162926187|NCT00080288|588431756|FG000|Overall Study|Miscellaneous|11|||
162926188|NCT00080288|588431757|FG001|Overall Study|Miscellaneous|11|||
162926189|NCT00569231|588431758|FG000|Overall Study|Study unrelated surgery|1|||
162926190|NCT00569231|588431758|FG000|Overall Study|Airfare expense|2|||
162926191|NCT00569231|588431758|FG000|Overall Study|Withdrawal by Subject|1|||
162926192|NCT00569231|588431758|FG000|Overall Study|Car accident injury|1|||
162926193|NCT00569231|588431758|FG000|Overall Study|Non-compliance|2|||
162926194|NCT03456726|588431759|FG000|Overall Study|Disease Progression|6|||
162926195|NCT03456726|588431760|FG001|Overall Study|Disease Progression|1|||
162926196|NCT03456726|588431759|FG000|Overall Study|Adverse Event|4|||
162926197|NCT03456726|588431760|FG001|Overall Study|Adverse Event|2|||
162696290|NCT00603265|587599456|FG000|Overall Study|Protocol Violation|1|||
162926198|NCT03456726|588431759|FG000|Overall Study|Withdrawal by Subject|1|||
162926199|NCT03456726|588431760|FG001|Overall Study|Withdrawal by Subject|0|||
162926200|NCT03456726|588431759|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
162926201|NCT03456726|588431760|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
162926202|NCT03978117|588431763|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
162926203|NCT03978117|588431764|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
162926204|NCT03978117|588431763|FG000|Overall Study|Lost to Follow-up|4|||
162926205|NCT03978117|588431764|FG001|Overall Study|Lost to Follow-up|4|||
162926206|NCT02923115|588431765|FG000|Overall Study|Lost to Follow-up|0|||
162926207|NCT02923115|588431766|FG001|Overall Study|Lost to Follow-up|0|||
162926208|NCT02923115|588431767|FG002|Overall Study|Lost to Follow-up|0|||
162926209|NCT02923115|588431768|FG003|Overall Study|Lost to Follow-up|1|||
162926210|NCT02923115|588431769|FG004|Overall Study|Lost to Follow-up|0|||
162926211|NCT02923115|588431770|FG005|Overall Study|Lost to Follow-up|0|||
162926212|NCT02923115|588431765|FG000|Overall Study|Withdrawal by Subject|0|||
162926213|NCT02923115|588431766|FG001|Overall Study|Withdrawal by Subject|1|||
162926214|NCT02923115|588431767|FG002|Overall Study|Withdrawal by Subject|0|||
162926215|NCT02923115|588431768|FG003|Overall Study|Withdrawal by Subject|0|||
162926216|NCT02923115|588431769|FG004|Overall Study|Withdrawal by Subject|0|||
162926217|NCT02923115|588431770|FG005|Overall Study|Withdrawal by Subject|0|||
162926218|NCT02923115|588431765|FG000|Overall Study|Randomized, but not dosed|0|||
162926219|NCT02923115|588431766|FG001|Overall Study|Randomized, but not dosed|0|||
162926220|NCT02923115|588431767|FG002|Overall Study|Randomized, but not dosed|3|||
162926221|NCT02923115|588431768|FG003|Overall Study|Randomized, but not dosed|1|||
162926222|NCT02923115|588431769|FG004|Overall Study|Randomized, but not dosed|5|||
162926223|NCT02923115|588431770|FG005|Overall Study|Randomized, but not dosed|0|||
162926224|NCT01296152|588431771|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
162926225|NCT01875991|588431772|FG000|Overall Study|Withdrawal by Subject|6|||
162926226|NCT01875991|588431773|FG001|Overall Study|Withdrawal by Subject|6|||
162926227|NCT01875991|588431772|FG000|Overall Study|Sponsor Decision|1|||
162926228|NCT01875991|588431773|FG001|Overall Study|Sponsor Decision|0|||
162926229|NCT03981614|588431774|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
162926230|NCT03981614|588431775|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
162926231|NCT03981614|588431776|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
162926232|NCT04732728|588431777|FG000|Overall Study|Death|12|||
162926233|NCT04732728|588431777|FG000|Overall Study|Withdrawn|136|||
162926234|NCT04971226|588431778|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162926235|NCT04971226|588431779|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162926236|NCT04971226|588431780|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
162926237|NCT04971226|588431781|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
162926238|NCT04971226|588431778|FG000|Overall Study|Adverse Event|6|||
162926239|NCT04971226|588431779|FG001|Overall Study|Adverse Event|5|||
162926240|NCT04971226|588431780|FG002|Overall Study|Adverse Event|11|||
162926241|NCT04971226|588431781|FG003|Overall Study|Adverse Event|10|||
162926242|NCT04971226|588431778|FG000|Overall Study|Progressive disease|2|||
162926243|NCT04971226|588431779|FG001|Overall Study|Progressive disease|0|||
162926244|NCT04971226|588431780|FG002|Overall Study|Progressive disease|3|||
162926245|NCT04971226|588431781|FG003|Overall Study|Progressive disease|1|||
162926246|NCT04971226|588431778|FG000|Overall Study|Protocol Deviation|1|||
162926247|NCT04971226|588431779|FG001|Overall Study|Protocol Deviation|0|||
162926248|NCT04971226|588431780|FG002|Overall Study|Protocol Deviation|1|||
162926249|NCT04971226|588431781|FG003|Overall Study|Protocol Deviation|1|||
162926250|NCT04971226|588431778|FG000|Overall Study|Subject Decision|0|||
162926251|NCT04971226|588431779|FG001|Overall Study|Subject Decision|1|||
162926252|NCT04971226|588431780|FG002|Overall Study|Subject Decision|1|||
162926253|NCT04971226|588431781|FG003|Overall Study|Subject Decision|1|||
162926254|NCT04971226|588431778|FG000|Overall Study|Pregnancy|0|||
162926255|NCT04971226|588431779|FG001|Overall Study|Pregnancy|0|||
162926256|NCT04971226|588431780|FG002|Overall Study|Pregnancy|0|||
162926257|NCT04971226|588431781|FG003|Overall Study|Pregnancy|1|||
162926258|NCT04971226|588431778|FG000|Overall Study|Participants not treated|1|||
162926259|NCT04971226|588431779|FG001|Overall Study|Participants not treated|0|||
162926260|NCT04971226|588431780|FG002|Overall Study|Participants not treated|2|||
162926261|NCT04971226|588431781|FG003|Overall Study|Participants not treated|1|||
162926262|NCT06065176|588431786|FG000|Overall Study|Lost to Follow-up|11|||
162926263|NCT06065176|588431787|FG001|Overall Study|Lost to Follow-up|11|||
162926264|NCT06065176|588431788|FG002|Overall Study|Lost to Follow-up|10|||
162926265|NCT06065176|588431786|FG000|Overall Study|Withdrawal by Subject|1|||
162926266|NCT06065176|588431787|FG001|Overall Study|Withdrawal by Subject|1|||
162926267|NCT06065176|588431788|FG002|Overall Study|Withdrawal by Subject|2|||
162926268|NCT06065176|588431786|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
162926269|NCT06065176|588431787|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
162926270|NCT06065176|588431788|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
162926271|NCT04521608|588431789|FG000|Overall Study|Death|8|||
162926272|NCT04521608|588431790|FG001|Overall Study|Death|9|||
162926273|NCT04521608|588431789|FG000|Overall Study|Withdrawal by Subject|25|||
162926274|NCT04521608|588431790|FG001|Overall Study|Withdrawal by Subject|18|||
162926275|NCT04521608|588431789|FG000|Overall Study|Disease Progression|3|||
162926276|NCT04521608|588431790|FG001|Overall Study|Disease Progression|10|||
162926277|NCT04521608|588431789|FG000|Overall Study|Complicating Disease|6|||
162926278|NCT04521608|588431790|FG001|Overall Study|Complicating Disease|3|||
162926279|NCT04521608|588431789|FG000|Overall Study|Lost Contact|25|||
162926280|NCT04521608|588431790|FG001|Overall Study|Lost Contact|27|||
162926281|NCT04521608|588431789|FG000|Overall Study|Ineligible|1|||
162926282|NCT04521608|588431790|FG001|Overall Study|Ineligible|0|||
162926283|NCT04521608|588431789|FG000|Overall Study|Refused Further Study Participation|13|||
162926284|NCT04521608|588431790|FG001|Overall Study|Refused Further Study Participation|7|||
162926285|NCT04083378|588431793|FG000|Overall Study|Death|18|||
162926286|NCT04083378|588431794|FG001|Overall Study|Death|4|||
162926287|NCT04083378|588431793|FG000|Overall Study|Lost to Follow-up|4|||
162926288|NCT04083378|588431794|FG001|Overall Study|Lost to Follow-up|0|||
162926289|NCT05824273|588431795|FG000|Overall Study|Lost to Follow-up|16|||
162926290|NCT05824273|588431796|FG001|Overall Study|Lost to Follow-up|13|||
162926291|NCT04050293|588431797|FG000|Overall Study|Lost to Follow-up|1|||
162926292|NCT04050293|588431798|FG001|Overall Study|Lost to Follow-up|2|||
162926293|NCT04050293|588431797|FG000|Overall Study|Withdrawal by Subject|2|||
162926294|NCT04050293|588431798|FG001|Overall Study|Withdrawal by Subject|0|||
162926295|NCT04644237|588431801|FG000|Overall Study|Death|4|||
162926296|NCT04644237|588431802|FG001|Overall Study|Death|2|||
162926297|NCT04644237|588431801|FG000|Overall Study|Adverse Event|18|||
162926298|NCT04644237|588431802|FG001|Overall Study|Adverse Event|19|||
162926299|NCT04644237|588431801|FG000|Overall Study|Progressive Disease|61|||
162926300|NCT04644237|588431802|FG001|Overall Study|Progressive Disease|23|||
162926301|NCT04644237|588431801|FG000|Overall Study|Clinical Progression|4|||
162926302|NCT04644237|588431802|FG001|Overall Study|Clinical Progression|1|||
162926303|NCT04644237|588431801|FG000|Overall Study|Withdrawal by Subject|4|||
162926304|NCT04644237|588431802|FG001|Overall Study|Withdrawal by Subject|2|||
162926305|NCT04644237|588431801|FG000|Overall Study|Physician Decision|4|||
162926306|NCT04644237|588431802|FG001|Overall Study|Physician Decision|0|||
162926307|NCT04644237|588431801|FG000|Overall Study|Other|6|||
162926308|NCT04644237|588431802|FG001|Overall Study|Other|3|||
162926309|NCT04644237|588431801|FG000|Overall Study|Randomized but not Treated|1|||
162926310|NCT04644237|588431802|FG001|Overall Study|Randomized but not Treated|0|||
162926311|NCT03131817|588431803|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
162926312|NCT02061293|588431805|FG000|Overall Study|Elevated Blood Pressure|1|||
162926313|NCT02061293|588431806|FG001|Overall Study|Elevated Blood Pressure|1|||
162926314|NCT02949219|588431813|FG000|Overall Study|Withdrawal by Subject|1|||
162926315|NCT03494816|588431814|FG000|Overall Study|Protocol Violation|2|||
162926316|NCT03494816|588431814|FG000|Overall Study|Physician Decision|2|||
162926317|NCT03494816|588431814|FG000|Overall Study|Did not start trial treatment|1|||
162926318|NCT03494816|588431814|FG000|Overall Study|Adverse Event|1|||
162926319|NCT00633217|588431828|FG000|Overall Study|Adverse Event|5|||
162926320|NCT00633217|588431829|FG001|Overall Study|Adverse Event|9|||
162926321|NCT00633217|588431828|FG000|Overall Study|Lack of Efficacy|0|||
162926322|NCT00633217|588431829|FG001|Overall Study|Lack of Efficacy|2|||
162926323|NCT00633217|588431828|FG000|Overall Study|Protocol Violation|3|||
162926324|NCT00633217|588431829|FG001|Overall Study|Protocol Violation|7|||
162926325|NCT00633217|588431828|FG000|Overall Study|Lost to Follow-up|2|||
162926326|NCT00633217|588431829|FG001|Overall Study|Lost to Follow-up|2|||
162926327|NCT00633217|588431828|FG000|Overall Study|Investigator Discretion|2|||
162926328|NCT00633217|588431829|FG001|Overall Study|Investigator Discretion|0|||
162926329|NCT00633217|588431828|FG000|Overall Study|Withdrew Consent|3|||
162926330|NCT00633217|588431829|FG001|Overall Study|Withdrew Consent|3|||
162926331|NCT05838755|588431830|FG000|Overall Study|Adverse Event|1|||
162926332|NCT05838755|588431831|FG001|Overall Study|Adverse Event|0|||
162926333|NCT05838755|588431832|FG002|Overall Study|Adverse Event|0|||
162926334|NCT05838755|588431830|FG000|Overall Study|Lack of Efficacy|1|||
162926335|NCT05838755|588431831|FG001|Overall Study|Lack of Efficacy|0|||
162926336|NCT05838755|588431832|FG002|Overall Study|Lack of Efficacy|1|||
162926337|NCT05838755|588431830|FG000|Overall Study|Lost to Follow-up|0|||
162926338|NCT05838755|588431831|FG001|Overall Study|Lost to Follow-up|1|||
162926339|NCT05838755|588431832|FG002|Overall Study|Lost to Follow-up|4|||
162926340|NCT05838755|588431830|FG000|Overall Study|Withdrawal by Subject|0|||
162926341|NCT05838755|588431831|FG001|Overall Study|Withdrawal by Subject|2|||
162926342|NCT05838755|588431832|FG002|Overall Study|Withdrawal by Subject|0|||
162926343|NCT05838755|588431830|FG000|Overall Study|Study terminated by sponsor|26|||
162926344|NCT05838755|588431831|FG001|Overall Study|Study terminated by sponsor|27|||
162926345|NCT05838755|588431832|FG002|Overall Study|Study terminated by sponsor|26|||
162926346|NCT05838755|588431830|FG000|Overall Study|Randomized, not treated|2|||
162926347|NCT05838755|588431831|FG001|Overall Study|Randomized, not treated|0|||
162926348|NCT05838755|588431832|FG002|Overall Study|Randomized, not treated|1|||
162926349|NCT05838755|588431830|FG000|Overall Study|Pregnancy|0|||
162926350|NCT05838755|588431831|FG001|Overall Study|Pregnancy|1|||
162926351|NCT05838755|588431832|FG002|Overall Study|Pregnancy|0|||
162926352|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
162926353|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
162926354|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
162926355|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
162926356|NCT01283282|588431833|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
162926357|NCT01283282|588431834|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
162926358|NCT01682681|588431841|FG000|Overall Study|Lack of Efficacy|62|||
162926359|NCT01682681|588431841|FG000|Overall Study|Withdrawal by Subject|1|||
162926360|NCT01682681|588431841|FG000|Overall Study|Moved to other hospital|10|||
162926361|NCT01682681|588431841|FG000|Overall Study|Lost to Follow-up|174|||
162926362|NCT01682681|588431841|FG000|Overall Study|Adverse Event|46|||
162926363|NCT01682681|588431841|FG000|Overall Study|tapering of topiramate|5|||
162926364|NCT01682681|588431841|FG000|Overall Study|Other|21|||
162926365|NCT01682681|588431841|FG000|Overall Study|Low compliance|13|||
162926366|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
162926367|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
162926368|NCT02044094|588431842|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
162926369|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
162926370|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
162926371|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
162926372|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
162926373|NCT02044094|588431842|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
162926374|NCT03205163|588431845|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
162926375|NCT03205163|588431846|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
162926376|NCT00005879|588431847|FG000|Overall Study|Withdrawal by Subject|8|||
162926377|NCT00005879|588431848|FG001|Overall Study|Withdrawal by Subject|10|||
162926378|NCT01238172|588431849|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
162926379|NCT01238172|588431850|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
162926380|NCT01238172|588431849|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
162926381|NCT01238172|588431850|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
162926382|NCT05022121|588431851|FG000|Overall Study|Lack of Efficacy|1|||
162926383|NCT05022121|588431852|FG001|Overall Study|Lack of Efficacy|0|||
162926384|NCT05022121|588431851|FG000|Overall Study|Lost to Follow-up|0|||
162926385|NCT05022121|588431852|FG001|Overall Study|Lost to Follow-up|2|||
162926386|NCT01020773|588433712|FG000|Overall Study|Withdrawal by Subject|4|||
162926387|NCT01020773|588433713|FG001|Overall Study|Withdrawal by Subject|3|||
162926388|NCT03302299|588433714|FG000|Overall Study|Protocol Violation|1|||
162926389|NCT01458132|588433715|FG000|Overall Study|Other|15|||
162926390|NCT01458132|588433716|FG001|Overall Study|Other|3|||
162926391|NCT01788163|588433722|FG000|Overall Study|Other|53|||
162926392|NCT01788163|588433723|FG001|Overall Study|Other|0|||
162926393|NCT01788163|588433724|FG002|Overall Study|Other|0|||
162926394|NCT01788163|588433725|FG003|Overall Study|Other|0|||
162926395|NCT01788163|588433726|FG004|Overall Study|Other|0|||
162926396|NCT01788163|588433727|FG005|Overall Study|Other|7|||
162926397|NCT01788163|588433728|FG006|Overall Study|Other|1|||
162926398|NCT01788163|588433729|FG007|Overall Study|Other|48|||
162926399|NCT01788163|588433730|FG008|Overall Study|Other|15|||
162926400|NCT01788163|588433722|FG000|Overall Study|Withdrawal by Subject|2|||
162926401|NCT01788163|588433723|FG001|Overall Study|Withdrawal by Subject|0|||
162926402|NCT01788163|588433724|FG002|Overall Study|Withdrawal by Subject|0|||
162926403|NCT01788163|588433725|FG003|Overall Study|Withdrawal by Subject|0|||
162926404|NCT01788163|588433726|FG004|Overall Study|Withdrawal by Subject|0|||
162926405|NCT01788163|588433727|FG005|Overall Study|Withdrawal by Subject|0|||
162926406|NCT01788163|588433728|FG006|Overall Study|Withdrawal by Subject|0|||
162926407|NCT01788163|588433729|FG007|Overall Study|Withdrawal by Subject|0|||
162926408|NCT01788163|588433730|FG008|Overall Study|Withdrawal by Subject|1|||
162926409|NCT02803138|588433733|FG000|Overall Study|Failure to return|38|||
162926410|NCT02803138|588433733|FG000|Overall Study|Insufficient virological response|2|||
162926411|NCT02803138|588433733|FG000|Overall Study|Withdrawn consent|1|||
162926412|NCT02803138|588433733|FG000|Overall Study|Death|1|||
162926413|NCT02803138|588433733|FG000|Overall Study|Other, not specified|28|||
162926414|NCT00424515|588433734|FG000|Overall Study|Progressive Disease|10|||
162926415|NCT00424515|588433735|FG001|Overall Study|Progressive Disease|11|||
162926416|NCT00424515|588433734|FG000|Overall Study|Adverse Event|0|||
162926417|NCT00424515|588433735|FG001|Overall Study|Adverse Event|1|||
162926418|NCT00424515|588433734|FG000|Overall Study|Intercurrent Illness|0|||
162926419|NCT00424515|588433735|FG001|Overall Study|Intercurrent Illness|1|||
162926420|NCT00424515|588433734|FG000|Overall Study|Withdrawal by Subject|1|||
162926421|NCT00424515|588433735|FG001|Overall Study|Withdrawal by Subject|0|||
162926422|NCT04318535|588433736|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
162926423|NCT04318535|588433737|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
162926424|NCT04318535|588433738|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
162926425|NCT00021229|588433742|FG000|Overall Study|Adverse Event|10|||
162926426|NCT00021229|588433743|FG001|Overall Study|Adverse Event|5|||
162926427|NCT00021229|588433744|FG002|Overall Study|Adverse Event|2|||
162926428|NCT00021229|588433742|FG000|Overall Study|Death|0|||
162926429|NCT00021229|588433743|FG001|Overall Study|Death|1|||
162926430|NCT00021229|588433744|FG002|Overall Study|Death|0|||
162926431|NCT00021229|588433742|FG000|Overall Study|Withdrawal by Subject|7|||
162926432|NCT00021229|588433743|FG001|Overall Study|Withdrawal by Subject|7|||
162926433|NCT00021229|588433744|FG002|Overall Study|Withdrawal by Subject|1|||
162926434|NCT00021229|588433742|FG000|Overall Study|Progressive Disease|15|||
162926435|NCT00021229|588433743|FG001|Overall Study|Progressive Disease|19|||
162926436|NCT00021229|588433744|FG002|Overall Study|Progressive Disease|12|||
162926437|NCT00021229|588433742|FG000|Overall Study|Protocol Violation|1|||
162926438|NCT00021229|588433743|FG001|Overall Study|Protocol Violation|1|||
162926439|NCT00021229|588433744|FG002|Overall Study|Protocol Violation|0|||
162926440|NCT00021229|588433742|FG000|Overall Study|Physician Decision|0|||
162926441|NCT00021229|588433743|FG001|Overall Study|Physician Decision|0|||
162926442|NCT00021229|588433744|FG002|Overall Study|Physician Decision|1|||
162926443|NCT00021229|588433742|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
162926444|NCT00021229|588433743|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
162926445|NCT00021229|588433744|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
162926446|NCT02156466|588433745|FG000|Overall Study|Adverse Event|0|||
162926447|NCT02156466|588433746|FG001|Overall Study|Adverse Event|0|||
162926448|NCT02156466|588433747|FG002|Overall Study|Adverse Event|1|||
162926449|NCT02156466|588433748|FG003|Overall Study|Adverse Event|1|||
162926450|NCT02156466|588433749|FG004|Overall Study|Adverse Event|0|||
162926451|NCT02156466|588433745|FG000|Overall Study|Quantiferon Positivity|0|||
162926452|NCT02156466|588433746|FG001|Overall Study|Quantiferon Positivity|0|||
162926453|NCT02156466|588433747|FG002|Overall Study|Quantiferon Positivity|0|||
162926454|NCT02156466|588433748|FG003|Overall Study|Quantiferon Positivity|1|||
162926455|NCT02156466|588433749|FG004|Overall Study|Quantiferon Positivity|0|||
162926456|NCT00306852|588433750|FG000|Overall Study|Death|14|||
162926457|NCT00306852|588433751|FG001|Overall Study|Death|14|||
162926458|NCT00306852|588433750|FG000|Overall Study|Lost to Follow-up|15|||
162926459|NCT00306852|588433751|FG001|Overall Study|Lost to Follow-up|24|||
162926460|NCT00817778|588433752|FG000|Overall Study|Adverse Event|1|||
162926461|NCT00817778|588433753|FG001|Overall Study|Adverse Event|0|||
162926462|NCT00817778|588433752|FG000|Overall Study|Withdrawal by Subject|1|||
162926463|NCT00817778|588433753|FG001|Overall Study|Withdrawal by Subject|1|||
162926464|NCT00817778|588433752|FG000|Overall Study|Protocol Violation|0|||
162926465|NCT00817778|588433753|FG001|Overall Study|Protocol Violation|1|||
162926466|NCT00817778|588433752|FG000|Overall Study|Study-specific discontinuation criteria|0|||
162926467|NCT00817778|588433753|FG001|Overall Study|Study-specific discontinuation criteria|1|||
162926468|NCT00817778|588433752|FG000|Overall Study|Poor venous access|1|||
162926469|NCT00817778|588433753|FG001|Overall Study|Poor venous access|0|||
162926470|NCT00883740|588433754|FG000|First Intervention|Lost to Follow-up|1|||
162926471|NCT00883740|588433755|FG001|First Intervention|Lost to Follow-up|0|||
162926472|NCT00883740|588433754|FG000|First Intervention|No longer willing to participate|2|||
162926473|NCT00883740|588433755|FG001|First Intervention|No longer willing to participate|0|||
162926474|NCT00883740|588433754|FG000|First Intervention|Protocol Violation|3|||
162926475|NCT00883740|588433755|FG001|First Intervention|Protocol Violation|6|||
162926476|NCT00883740|588433754|FG000|First Intervention|Adverse Event|1|||
162926477|NCT00883740|588433755|FG001|First Intervention|Adverse Event|2|||
162926478|NCT00883740|588433754|FG000|Second Intervention|Protocol Violation|1|||
162926479|NCT00883740|588433755|FG001|Second Intervention|Protocol Violation|0|||
162926480|NCT00883740|588433754|FG000|Second Intervention|No longer willing to participate|0|||
162926481|NCT00883740|588433755|FG001|Second Intervention|No longer willing to participate|1|||
162926482|NCT01286207|588433756|FG000|Overall Study|Adverse Event|27|||
162926483|NCT01286207|588433757|FG001|Overall Study|Adverse Event|41|||
162926484|NCT01286207|588433758|FG002|Overall Study|Adverse Event|8|||
162926485|NCT01286207|588433756|FG000|Overall Study|Lost to Follow-up|49|||
162926486|NCT01286207|588433757|FG001|Overall Study|Lost to Follow-up|43|||
162926487|NCT01286207|588433758|FG002|Overall Study|Lost to Follow-up|20|||
162926488|NCT01286207|588433756|FG000|Overall Study|Withdrawal by Subject|93|||
162926489|NCT01286207|588433757|FG001|Overall Study|Withdrawal by Subject|79|||
162926490|NCT01286207|588433758|FG002|Overall Study|Withdrawal by Subject|41|||
162926491|NCT01286207|588433756|FG000|Overall Study|Lack of Response|92|||
162926492|NCT01286207|588433757|FG001|Overall Study|Lack of Response|38|||
162926493|NCT01286207|588433758|FG002|Overall Study|Lack of Response|8|||
162926494|NCT01286207|588433756|FG000|Overall Study|Other|37|||
162926495|NCT01286207|588433757|FG001|Overall Study|Other|47|||
162926496|NCT01286207|588433758|FG002|Overall Study|Other|13|||
162926497|NCT00103259|588433763|FG000|Overall Study|Death|3|||
162926498|NCT00103259|588433764|FG001|Overall Study|Death|2|||
162926499|NCT00103259|588433763|FG000|Overall Study|Withdrawal by Subject|2|||
162926500|NCT00103259|588433764|FG001|Overall Study|Withdrawal by Subject|3|||
162926501|NCT00103259|588433763|FG000|Overall Study|alternative therapy|1|||
162926502|NCT00103259|588433764|FG001|Overall Study|alternative therapy|0|||
162926503|NCT00103259|588433763|FG000|Overall Study|other (reasons were not specified)|2|||
162926504|NCT00103259|588433764|FG001|Overall Study|other (reasons were not specified)|1|||
162926505|NCT00103259|588433763|FG000|Overall Study|ineligible/no protocol therapy|4|||
162926506|NCT00103259|588433764|FG001|Overall Study|ineligible/no protocol therapy|6|||
162926507|NCT03224234|588433765|FG000|Main Study|Lost to Follow-up|5|||
162926508|NCT03224234|588433766|FG001|Main Study|Lost to Follow-up|5|||
162926509|NCT02610842|588433767|FG000|Overall Study|Lost to Follow-up|5|||
162926510|NCT02494583|588433770|FG000|Overall Study|Death|224|||
162926511|NCT02494583|588433771|FG001|Overall Study|Death|214|||
162926512|NCT02494583|588433772|FG002|Overall Study|Death|225|||
162926513|NCT02494583|588433770|FG000|Overall Study|Lost to Follow-up|1|||
162926514|NCT02494583|588433771|FG001|Overall Study|Lost to Follow-up|0|||
162926515|NCT02494583|588433772|FG002|Overall Study|Lost to Follow-up|0|||
162926516|NCT02494583|588433770|FG000|Overall Study|Protocol Violation|1|||
162926517|NCT02494583|588433771|FG001|Overall Study|Protocol Violation|2|||
162926518|NCT02494583|588433772|FG002|Overall Study|Protocol Violation|0|||
162926519|NCT02494583|588433770|FG000|Overall Study|Screen Failure|0|||
162926520|NCT02494583|588433771|FG001|Overall Study|Screen Failure|1|||
162926521|NCT02494583|588433772|FG002|Overall Study|Screen Failure|0|||
162926522|NCT02494583|588433770|FG000|Overall Study|Transferred to Extension Study|15|||
162926523|NCT02494583|588433771|FG001|Overall Study|Transferred to Extension Study|15|||
162926524|NCT02494583|588433772|FG002|Overall Study|Transferred to Extension Study|6|||
162926525|NCT02494583|588433770|FG000|Overall Study|Did Not Continue on Extension Study|8|||
162926526|NCT02494583|588433771|FG001|Overall Study|Did Not Continue on Extension Study|10|||
162926527|NCT02494583|588433772|FG002|Overall Study|Did Not Continue on Extension Study|4|||
162926528|NCT02494583|588433770|FG000|Overall Study|Withdrawal by Subject|7|||
162926529|NCT02494583|588433771|FG001|Overall Study|Withdrawal by Subject|15|||
162926530|NCT02494583|588433772|FG002|Overall Study|Withdrawal by Subject|15|||
162926531|NCT00627458|588433773|FG000|Overall Study|Migrated from study area|1|||
162926532|NCT00627458|588433774|FG001|Overall Study|Migrated from study area|0|||
162926533|NCT00627458|588433775|FG002|Overall Study|Migrated from study area|1|||
162926534|NCT00627458|588433773|FG000|Overall Study|Withdrawal by Subject|2|||
162926535|NCT00627458|588433774|FG001|Overall Study|Withdrawal by Subject|6|||
162926536|NCT00627458|588433775|FG002|Overall Study|Withdrawal by Subject|5|||
162926537|NCT00627458|588433773|FG000|Overall Study|Lost to Follow-up|1|||
162926538|NCT00627458|588433774|FG001|Overall Study|Lost to Follow-up|1|||
162926539|NCT00627458|588433775|FG002|Overall Study|Lost to Follow-up|0|||
162926540|NCT03151707|588433776|FG000|Overall Study|Lost to Follow-up|6|||
162926541|NCT04439149|588433777|FG000|Overall Study|Ineligible|1|||
162926542|NCT04439149|588433777|FG000|Overall Study|Never start protocol therapy|1|||
162926543|NCT04439149|588433777|FG000|Overall Study|Adverse Event|4|||
162926544|NCT04439149|588433777|FG000|Overall Study|Disease Progression|14|||
162926545|NCT04439149|588433777|FG000|Overall Study|Complicating disease|1|||
162926546|NCT04439149|588433777|FG000|Overall Study|Withdrawal by Subject|3|||
162926547|NCT02617446|588433778|FG000|Overall Study|Withdrawal by Subject|0|||
162926548|NCT02617446|588433779|FG001|Overall Study|Withdrawal by Subject|2|||
162926549|NCT02617446|588433780|FG002|Overall Study|Withdrawal by Subject|0|||
162926550|NCT02617446|588433778|FG000|Overall Study|Adverse Event|1|||
162926551|NCT02617446|588433779|FG001|Overall Study|Adverse Event|0|||
162926552|NCT02617446|588433780|FG002|Overall Study|Adverse Event|5|||
162926553|NCT02617446|588433778|FG000|Overall Study|Lost to Follow-up|3|||
162926554|NCT02617446|588433779|FG001|Overall Study|Lost to Follow-up|0|||
162926555|NCT02617446|588433780|FG002|Overall Study|Lost to Follow-up|0|||
162926556|NCT02617446|588433778|FG000|Overall Study|Death|0|||
162926557|NCT02617446|588433779|FG001|Overall Study|Death|0|||
162926558|NCT02617446|588433780|FG002|Overall Study|Death|2|||
162926559|NCT00530088|588433789|FG000|Overall Study|Disease Progression|4|||
162926560|NCT00530088|588433789|FG000|Overall Study|Physician Decision|4|||
162926561|NCT00530088|588433789|FG000|Overall Study|Other Not Specified|2|||
162926562|NCT05264506|588433792|FG000|Overall Study|Adverse Event|59|||
162926563|NCT05264506|588433792|FG000|Overall Study|Lost to Follow-up|204|||
162926564|NCT05264506|588433792|FG000|Overall Study|Protocol Violation|185|||
162926565|NCT05264506|588433792|FG000|Overall Study|Pregnancy|60|||
162926566|NCT05264506|588433792|FG000|Overall Study|Physician Decision|6|||
162926567|NCT05264506|588433792|FG000|Overall Study|Non-compliance with Study Drug|29|||
162926568|NCT05264506|588433792|FG000|Overall Study|Study termination|677|||
162926569|NCT05264506|588433792|FG000|Overall Study|Withdrawal by Subject|208|||
162926570|NCT05264506|588433792|FG000|Overall Study|Discontinued prior treatment|89|||
162926571|NCT00644228|588433793|FG000|Randomization & Eligibility|Ineligible|31|||
162926572|NCT00644228|588433794|FG001|Randomization & Eligibility|Ineligible|21|||
162926573|NCT00644228|588433793|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
162926574|NCT00644228|588433794|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
162926575|NCT00644228|588433793|FG000|Randomization & Eligibility|Invalid Consent|0|||
162926576|NCT00644228|588433794|FG001|Randomization & Eligibility|Invalid Consent|1|||
162926577|NCT00644228|588433793|FG000|Induction Therapy|Adverse Event|22|||
162926578|NCT00644228|588433794|FG001|Induction Therapy|Adverse Event|55|||
162926579|NCT00644228|588433793|FG000|Induction Therapy|Withdrawal by Subject|10|||
162926580|NCT00644228|588433794|FG001|Induction Therapy|Withdrawal by Subject|3|||
162926581|NCT00644228|588433793|FG000|Induction Therapy|Progression/Relapse|24|||
162926582|NCT00644228|588433794|FG001|Induction Therapy|Progression/Relapse|12|||
162926583|NCT00644228|588433793|FG000|Induction Therapy|Death|3|||
162926584|NCT00644228|588433794|FG001|Induction Therapy|Death|7|||
162926585|NCT00644228|588433793|FG000|Induction Therapy|Not Protocol-Specified|24|||
162926586|NCT00644228|588433794|FG001|Induction Therapy|Not Protocol-Specified|28|||
162926587|NCT00644228|588433793|FG000|Maintenance|Adverse Event|27|||
162926588|NCT00644228|588433794|FG001|Maintenance|Adverse Event|31|||
162926589|NCT00644228|588433793|FG000|Maintenance|Withdrawal by Subject|6|||
162926590|NCT00644228|588433794|FG001|Maintenance|Withdrawal by Subject|4|||
162926591|NCT00644228|588433793|FG000|Maintenance|Progression/Relapse|67|||
162926592|NCT00644228|588433794|FG001|Maintenance|Progression/Relapse|42|||
162926593|NCT00644228|588433793|FG000|Maintenance|Death|3|||
162926594|NCT00644228|588433794|FG001|Maintenance|Death|3|||
162926595|NCT00644228|588433793|FG000|Maintenance|Not Protocol-Specified|14|||
162926596|NCT00644228|588433794|FG001|Maintenance|Not Protocol-Specified|15|||
162926597|NCT00644228|588433793|FG000|Maintenance|On Treatment|26|||
162926598|NCT00644228|588433794|FG001|Maintenance|On Treatment|40|||
162926599|NCT06078124|588433795|FG000|Overall Study|Lost to Follow-up|14|||
162926600|NCT06078124|588433796|FG001|Overall Study|Lost to Follow-up|14|||
162926601|NCT03252756|588433805|FG000|Overall Study|Protocol Violation|2|||
162926602|NCT03252756|588433806|FG001|Overall Study|Protocol Violation|4|||
162926603|NCT03252756|588433805|FG000|Overall Study|COVID-19 Pandemic|1|||
162926604|NCT03252756|588433806|FG001|Overall Study|COVID-19 Pandemic|1|||
162926605|NCT03252756|588433805|FG000|Overall Study|Study Drug Expiration|0|||
162926606|NCT03252756|588433806|FG001|Overall Study|Study Drug Expiration|1|||
162926607|NCT04223193|588433807|FG000|Overall Study|Adverse Event|6|||
162926608|NCT04223193|588433808|FG001|Overall Study|Adverse Event|36|||
162926609|NCT04223193|588433807|FG000|Overall Study|Lack of Efficacy|2|||
162926610|NCT04223193|588433808|FG001|Overall Study|Lack of Efficacy|2|||
162926611|NCT04223193|588433807|FG000|Overall Study|Lost to Follow-up|1|||
162926612|NCT04223193|588433808|FG001|Overall Study|Lost to Follow-up|1|||
162926613|NCT04223193|588433807|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
162926614|NCT04223193|588433808|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
162926615|NCT04223193|588433807|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
162926616|NCT04223193|588433808|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
162926617|NCT04223193|588433807|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162926618|NCT04223193|588433808|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162926619|NCT04223193|588433807|FG000|Overall Study|Physician Decision|0|||
162926620|NCT04223193|588433808|FG001|Overall Study|Physician Decision|1|||
162926621|NCT04223193|588433807|FG000|Overall Study|Protocol Violation|1|||
162926622|NCT04223193|588433808|FG001|Overall Study|Protocol Violation|1|||
162926623|NCT04223193|588433807|FG000|Overall Study|Site Terminated by Sponsor|1|||
162926624|NCT04223193|588433808|FG001|Overall Study|Site Terminated by Sponsor|3|||
162926625|NCT04223193|588433807|FG000|Overall Study|Withdrawal by Subject|5|||
162926626|NCT04223193|588433808|FG001|Overall Study|Withdrawal by Subject|6|||
162926627|NCT04223193|588433807|FG000|Overall Study|Other|3|||
162926628|NCT04223193|588433808|FG001|Overall Study|Other|6|||
162926629|NCT03594175|588433809|FG000|Overall Study|Not treated|8|||
162926630|NCT03594175|588433810|FG001|Overall Study|Not treated|1|||
162926631|NCT03594175|588433811|FG002|Overall Study|Not treated|5|||
162926632|NCT03594175|588433809|FG000|Overall Study|Adverse Event|3|||
162926633|NCT03594175|588433810|FG001|Overall Study|Adverse Event|0|||
162926634|NCT03594175|588433811|FG002|Overall Study|Adverse Event|0|||
162926635|NCT03594175|588433809|FG000|Overall Study|Withdrawal by Subject|3|||
162926636|NCT03594175|588433810|FG001|Overall Study|Withdrawal by Subject|0|||
162926637|NCT03594175|588433811|FG002|Overall Study|Withdrawal by Subject|0|||
162926638|NCT03594175|588433809|FG000|Overall Study|Protocol Violation|2|||
162926639|NCT03594175|588433810|FG001|Overall Study|Protocol Violation|2|||
162926640|NCT03594175|588433811|FG002|Overall Study|Protocol Violation|2|||
162926641|NCT03732677|588433812|FG000|Overall Study|Terminated the study|154|||
162926642|NCT03732677|588433813|FG001|Overall Study|Terminated the study|197|||
162926643|NCT03732677|588433812|FG000|Overall Study|Continuing study off treatment|379|||
162926644|NCT03732677|588433813|FG001|Overall Study|Continuing study off treatment|333|||
162926645|NCT04066894|588433815|FG000|Overall Study|Lack of Efficacy|1|||
162926646|NCT04066894|588433815|FG000|Overall Study|Screen Failure|1|||
162926647|NCT01500434|588433816|FG000|Overall Study|Death|1|||
162926648|NCT01500434|588433816|FG000|Overall Study|Withdrawal by Subject|1|||
162926649|NCT01500434|588433816|FG000|Overall Study|Missed 12-month follow-up|5|||
162926650|NCT00096031|588433817|FG000|Overall Study|Adverse Event|3|||
162926651|NCT00096031|588433817|FG000|Overall Study|Lack of Efficacy|42|||
162926652|NCT00096031|588433817|FG000|Overall Study|Death|4|||
162926653|NCT00096031|588433817|FG000|Overall Study|Withdrawal by Subject|1|||
162926654|NCT00096031|588433817|FG000|Overall Study|Ineligible|8|||
162926655|NCT00096031|588433817|FG000|Overall Study|Not protocol specified|5|||
162926656|NCT00483717|588433818|FG000|Overall Study|Protocol Violation|5|||
162926657|NCT00483717|588433819|FG001|Overall Study|Protocol Violation|7|||
162926658|NCT00483717|588433818|FG000|Overall Study|Time of dosing missing|1|||
162926659|NCT00483717|588433819|FG001|Overall Study|Time of dosing missing|1|||
162926660|NCT00483717|588433818|FG000|Overall Study|No treatment for migraine|16|||
162926661|NCT00483717|588433819|FG001|Overall Study|No treatment for migraine|13|||
162926662|NCT00483717|588433818|FG000|Overall Study|Lost to Follow-up|1|||
162926663|NCT00483717|588433819|FG001|Overall Study|Lost to Follow-up|0|||
162926664|NCT00483717|588433818|FG000|Overall Study|Withdrawal by Subject|1|||
162926665|NCT00483717|588433819|FG001|Overall Study|Withdrawal by Subject|0|||
162926666|NCT00083226|588433820|FG000|Overall Study|Lack of Efficacy|19|||
162926667|NCT00083226|588433820|FG000|Overall Study|Adverse Event|9|||
162926668|NCT00083226|588433820|FG000|Overall Study|Death|4|||
162926669|NCT00083226|588433820|FG000|Overall Study|Withdrawal by Subject|4|||
162926670|NCT00083226|588433820|FG000|Overall Study|Other|2|||
162926671|NCT00083226|588433820|FG000|Overall Study|ineligible or not receiving treatment|4|||
162926672|NCT00909857|588433821|FG000|Overall Study|Withdrawal by Subject|6|||
162926673|NCT00909857|588433822|FG001|Overall Study|Withdrawal by Subject|10|||
162926674|NCT00909857|588433821|FG000|Overall Study|Adverse Event|5|||
162926675|NCT00909857|588433822|FG001|Overall Study|Adverse Event|5|||
162926676|NCT00909857|588433821|FG000|Overall Study|Lost to Follow-up|2|||
162926677|NCT00909857|588433822|FG001|Overall Study|Lost to Follow-up|5|||
162926678|NCT00909857|588433821|FG000|Overall Study|Protocol Violation|2|||
162926679|NCT00909857|588433822|FG001|Overall Study|Protocol Violation|1|||
162926680|NCT00909857|588433821|FG000|Overall Study|Pregnancy|1|||
162926681|NCT00909857|588433822|FG001|Overall Study|Pregnancy|0|||
162926682|NCT00909857|588433821|FG000|Overall Study|Other|1|||
162926683|NCT00909857|588433822|FG001|Overall Study|Other|0|||
162926684|NCT00909857|588433821|FG000|Overall Study|Did not receive study medication|19|||
162926685|NCT00909857|588433822|FG001|Overall Study|Did not receive study medication|24|||
162926686|NCT03878108|588433823|FG000|Overall Study|Adverse Event|1|||
162926687|NCT03878108|588433824|FG001|Overall Study|Adverse Event|0|||
162926688|NCT00604175|588433825|FG000|Entry Through Week 28|Death|2|||
162926689|NCT00604175|588433826|FG001|Entry Through Week 28|Death|0|||
162926690|NCT00604175|588433827|FG002|Entry Through Week 28|Death|0|||
162926691|NCT00604175|588433825|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
162926692|NCT00604175|588433826|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
162926693|NCT00604175|588433827|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
162926694|NCT00604175|588433825|FG000|Entry Through Week 28|Lost to Follow-up|4|||
162926695|NCT00604175|588433826|FG001|Entry Through Week 28|Lost to Follow-up|3|||
162926696|NCT00604175|588433827|FG002|Entry Through Week 28|Lost to Follow-up|0|||
162926697|NCT00604175|588433825|FG000|Entry Through Week 28|Ineligible|1|||
162926698|NCT00604175|588433826|FG001|Entry Through Week 28|Ineligible|0|||
162926699|NCT00604175|588433827|FG002|Entry Through Week 28|Ineligible|0|||
162926700|NCT00604175|588433825|FG000|Entry Through Week 28|Did not start intervention|2|||
162926701|NCT00604175|588433826|FG001|Entry Through Week 28|Did not start intervention|0|||
162926702|NCT00604175|588433827|FG002|Entry Through Week 28|Did not start intervention|1|||
162926703|NCT00604175|588433825|FG000|Week 29 Through Week 72|Death|0|||
162926704|NCT00604175|588433826|FG001|Week 29 Through Week 72|Death|0|||
162926705|NCT00604175|588433827|FG002|Week 29 Through Week 72|Death|1|||
162926706|NCT00604175|588433825|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
162926707|NCT00604175|588433826|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
162926708|NCT00604175|588433827|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
162926709|NCT00604175|588433825|FG000|Week 29 Through Week 72|Site closure|0|||
162926710|NCT00604175|588433826|FG001|Week 29 Through Week 72|Site closure|1|||
162926711|NCT00604175|588433827|FG002|Week 29 Through Week 72|Site closure|0|||
162926712|NCT00604175|588433825|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
162926713|NCT00604175|588433826|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
162926714|NCT00604175|588433827|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
162926715|NCT03353415|588433828|FG000|Masked CGM Wear|Lost to Follow-up|2|||
162926716|NCT03353415|588433828|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
162926717|NCT00131937|588433829|FG000|Overall Study|Adverse Event|3|||
162926718|NCT00131937|588433829|FG000|Overall Study|Withdrawal by Subject|2|||
162926719|NCT00131937|588433829|FG000|Overall Study|Physician Decision|1|||
162926720|NCT00131937|588433829|FG000|Overall Study|Disease Progression|7|||
162926721|NCT00131937|588433829|FG000|Overall Study|Alternative therapy|1|||
162926722|NCT04647253|588433836|FG000|Overall Study|Death ≤ 365 Days|16|||
162926723|NCT04647253|588433837|FG001|Overall Study|Death ≤ 365 Days|7|||
162926724|NCT04647253|588433836|FG000|Overall Study|Physician Decision|0|||
162926725|NCT04647253|588433837|FG001|Overall Study|Physician Decision|1|||
162926726|NCT04647253|588433836|FG000|Overall Study|Withdrawal by Subject|7|||
162926727|NCT04647253|588433837|FG001|Overall Study|Withdrawal by Subject|2|||
162926728|NCT04647253|588433836|FG000|Overall Study|Missed 12-Month Visit|9|||
162926729|NCT04647253|588433837|FG001|Overall Study|Missed 12-Month Visit|7|||
162926730|NCT04647253|588433836|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
162926731|NCT04647253|588433837|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
162926732|NCT04502862|588433840|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
162926733|NCT04502862|588433841|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
162926734|NCT04502862|588433840|FG000|Overall Study|Withdrawal by Subject|1|||
162926735|NCT04502862|588433841|FG001|Overall Study|Withdrawal by Subject|0|||
162926736|NCT04502862|588433840|FG000|Overall Study|Adverse Event|1|||
162926737|NCT04502862|588433841|FG001|Overall Study|Adverse Event|1|||
162926738|NCT02038959|588435143|FG000|Overall Study|Withdrawal by Subject|6|||
162926739|NCT02038959|588435144|FG001|Overall Study|Withdrawal by Subject|8|||
162926740|NCT00819091|588435150|FG000|Overall Study|Adverse Event|3|||
162926741|NCT00819091|588435151|FG001|Overall Study|Adverse Event|5|||
162926742|NCT00819091|588435150|FG000|Overall Study|Protocol Violation|0|||
162926743|NCT00819091|588435151|FG001|Overall Study|Protocol Violation|1|||
162926744|NCT00819091|588435150|FG000|Overall Study|Lost to Follow-up|2|||
162926745|NCT00819091|588435151|FG001|Overall Study|Lost to Follow-up|0|||
162926746|NCT00819091|588435150|FG000|Overall Study|Withdrawal by Subject|1|||
162926747|NCT00819091|588435151|FG001|Overall Study|Withdrawal by Subject|2|||
162926748|NCT00819091|588435150|FG000|Overall Study|Other|1|||
162926749|NCT00819091|588435151|FG001|Overall Study|Other|2|||
162926750|NCT00545441|588435152|FG000|Overall Study|Fistula draining at 6 months|2|||
162926751|NCT00545441|588435153|FG001|Overall Study|Fistula draining at 6 months|4|||
162926752|NCT00545441|588435152|FG000|Overall Study|Lost to Follow-up|9|||
162926753|NCT00545441|588435153|FG001|Overall Study|Lost to Follow-up|5|||
162926754|NCT00545441|588435152|FG000|Overall Study|Technical failure|0|||
162926755|NCT00545441|588435153|FG001|Overall Study|Technical failure|1|||
162926756|NCT00545441|588435152|FG000|Overall Study|Withdrawal by Subject|1|||
162926757|NCT00545441|588435153|FG001|Overall Study|Withdrawal by Subject|1|||
162926758|NCT00545441|588435152|FG000|Overall Study|Persistence or recurrence of fistula|5|||
162926759|NCT00545441|588435153|FG001|Overall Study|Persistence or recurrence of fistula|2|||
162926760|NCT00545441|588435152|FG000|Overall Study|Patients were not treated|1|||
162926761|NCT00545441|588435153|FG001|Overall Study|Patients were not treated|3|||
162926762|NCT03911960|588435154|FG000|Overall Study|Lost to Follow-up|5|||
162926763|NCT03911960|588435155|FG001|Overall Study|Lost to Follow-up|3|||
162926764|NCT00265239|588435156|FG000|Overall Study|Adverse Event|2|||
162926765|NCT00265239|588435157|FG001|Overall Study|Adverse Event|1|||
162926766|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Death|4|||
162926767|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Death|2|||
162926768|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Death|8|||
162926769|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Death|0|||
162926770|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Death|0|||
162926771|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926772|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926773|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
162926774|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926775|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
162926776|NCT04071366|588435158|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
162926777|NCT04071366|588435159|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926778|NCT04071366|588435160|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
162926779|NCT04071366|588435161|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926780|NCT04071366|588435162|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
162926781|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Death|0|||
162926782|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Death|0|||
162926783|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Death|0|||
162926784|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Death|2|||
162926785|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Death|2|||
162926786|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926787|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926788|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926789|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
162926790|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
162926791|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926792|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926793|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926794|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
162926795|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
162926796|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926797|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926798|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
162926799|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
162926800|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
162926801|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926802|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926803|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926804|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
162926805|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
162926806|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926807|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926808|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926809|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
162926810|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
162926811|NCT04071366|588435158|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926812|NCT04071366|588435159|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926813|NCT04071366|588435160|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926814|NCT04071366|588435161|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
162926815|NCT04071366|588435162|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
162926816|NCT01858558|588435163|FG000|Overall Study|Death|1|||
162926817|NCT01858558|588435164|FG001|Overall Study|Death|1|||
162926818|NCT01858558|588435163|FG000|Overall Study|Lost to Follow-up|1|||
162926819|NCT01858558|588435164|FG001|Overall Study|Lost to Follow-up|0|||
162926820|NCT01858558|588435163|FG000|Overall Study|Disease progression|3|||
162926821|NCT01858558|588435164|FG001|Overall Study|Disease progression|1|||
162926822|NCT01858558|588435163|FG000|Overall Study|Product contamination|2|||
162926823|NCT01858558|588435164|FG001|Overall Study|Product contamination|0|||
162926824|NCT01858558|588435163|FG000|Overall Study|Failed expansion of cell product|2|||
162926825|NCT01858558|588435164|FG001|Overall Study|Failed expansion of cell product|0|||
162926826|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
162926827|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926828|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926829|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162926830|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
162926831|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926832|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926833|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162926834|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
162926835|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926836|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926837|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
162926838|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
162926839|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926840|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926841|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
162926842|NCT01336608|588435165|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
162926843|NCT01336608|588435166|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926844|NCT01336608|588435167|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926845|NCT01336608|588435168|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162926846|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
162926847|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
162926848|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
162926849|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
162926850|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926851|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
162926852|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926853|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162926854|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
162926855|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
162926856|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
162926857|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
162926858|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162926859|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
162926860|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
162926861|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
162926862|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
162926863|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
162926864|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
162926865|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
162926866|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926867|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
162926868|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926869|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162926870|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
162926871|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
162926872|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
162926873|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
162926874|NCT01336608|588435165|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162926875|NCT01336608|588435166|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
162926876|NCT01336608|588435167|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
162926877|NCT01336608|588435168|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
162926878|NCT00399490|588435173|FG000|Overall Study|Adverse Event|19|||
162926879|NCT00399490|588435173|FG000|Overall Study|Lack of Efficacy|31|||
162926880|NCT00399490|588435173|FG000|Overall Study|Lost to Follow-up|5|||
162926881|NCT00399490|588435173|FG000|Overall Study|Withdrawal by Subject|18|||
162926882|NCT00399490|588435173|FG000|Overall Study|Other|25|||
162926883|NCT02437890|588435174|FG000|Overall Study|Non-compliance to study drug|0|||
162926884|NCT02437890|588435175|FG001|Overall Study|Non-compliance to study drug|1|||
162926885|NCT02437890|588435176|FG002|Overall Study|Non-compliance to study drug|0|||
162926886|NCT02437890|588435177|FG003|Overall Study|Non-compliance to study drug|0|||
162926887|NCT02437890|588435178|FG004|Overall Study|Non-compliance to study drug|1|||
162926888|NCT02437890|588435174|FG000|Overall Study|Sponsor's decision|1|||
162926889|NCT02437890|588435175|FG001|Overall Study|Sponsor's decision|1|||
162926890|NCT02437890|588435176|FG002|Overall Study|Sponsor's decision|4|||
162926891|NCT02437890|588435177|FG003|Overall Study|Sponsor's decision|0|||
162926892|NCT02437890|588435178|FG004|Overall Study|Sponsor's decision|2|||
162926893|NCT02437890|588435174|FG000|Overall Study|Physician Decision|0|||
162926894|NCT02437890|588435175|FG001|Overall Study|Physician Decision|0|||
162926895|NCT02437890|588435176|FG002|Overall Study|Physician Decision|0|||
162926896|NCT02437890|588435177|FG003|Overall Study|Physician Decision|1|||
162926897|NCT02437890|588435178|FG004|Overall Study|Physician Decision|0|||
162926898|NCT02437890|588435174|FG000|Overall Study|Unable to attend visit(s)|1|||
162926899|NCT02437890|588435175|FG001|Overall Study|Unable to attend visit(s)|0|||
162926900|NCT02437890|588435176|FG002|Overall Study|Unable to attend visit(s)|0|||
162926901|NCT02437890|588435177|FG003|Overall Study|Unable to attend visit(s)|0|||
162926902|NCT02437890|588435178|FG004|Overall Study|Unable to attend visit(s)|0|||
162926903|NCT02437890|588435174|FG000|Overall Study|Lack of Efficacy|1|||
162926904|NCT02437890|588435175|FG001|Overall Study|Lack of Efficacy|3|||
162926905|NCT02437890|588435176|FG002|Overall Study|Lack of Efficacy|0|||
162926906|NCT02437890|588435177|FG003|Overall Study|Lack of Efficacy|3|||
162926907|NCT02437890|588435178|FG004|Overall Study|Lack of Efficacy|1|||
162926908|NCT02437890|588435174|FG000|Overall Study|Adverse Event|4|||
162926909|NCT02437890|588435175|FG001|Overall Study|Adverse Event|9|||
162926910|NCT02437890|588435176|FG002|Overall Study|Adverse Event|5|||
162926911|NCT02437890|588435177|FG003|Overall Study|Adverse Event|11|||
162926912|NCT02437890|588435178|FG004|Overall Study|Adverse Event|7|||
162926913|NCT02437890|588435174|FG000|Overall Study|Withdrawal by Subject|1|||
162926914|NCT02437890|588435175|FG001|Overall Study|Withdrawal by Subject|2|||
162926915|NCT02437890|588435176|FG002|Overall Study|Withdrawal by Subject|6|||
162926916|NCT02437890|588435177|FG003|Overall Study|Withdrawal by Subject|5|||
162926917|NCT02437890|588435178|FG004|Overall Study|Withdrawal by Subject|5|||
162926918|NCT02437890|588435174|FG000|Overall Study|Death|0|||
162926919|NCT02437890|588435175|FG001|Overall Study|Death|0|||
162926920|NCT02437890|588435176|FG002|Overall Study|Death|0|||
162926921|NCT02437890|588435177|FG003|Overall Study|Death|2|||
162926922|NCT02437890|588435178|FG004|Overall Study|Death|0|||
162696291|NCT00603265|587599457|FG001|Overall Study|Protocol Violation|0|||
162926923|NCT02328547|588435179|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
162926924|NCT02328547|588435180|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
162926925|NCT02328547|588435179|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162926926|NCT02328547|588435180|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
162926927|NCT00344305|588435181|FG000|Overall Study|Lost to Follow-up|2|||
162926928|NCT00344305|588435182|FG001|Overall Study|Lost to Follow-up|0|||
162926929|NCT00344305|588435181|FG000|Overall Study|Participant was not contacted in window|0|||
162926930|NCT00344305|588435182|FG001|Overall Study|Participant was not contacted in window|1|||
162926931|NCT01422720|588435184|FG000|Overall Study|Adverse Event|16|||
162926932|NCT01422720|588435184|FG000|Overall Study|Lack of Efficacy|1|||
162926933|NCT01422720|588435184|FG000|Overall Study|Withdrawal by Subject|4|||
162926934|NCT01422720|588435184|FG000|Overall Study|Ineligibility|1|||
162926935|NCT01796860|588435188|FG000|Overall Study|Withdrawal by Subject|3|||
162926936|NCT00647426|588435196|FG000|Overall Study|Withdrawal by Subject|2|||
162926937|NCT01537549|588435198|FG000|Overall Study|Lost to Follow-up|1|||
162926938|NCT01537549|588435198|FG000|Overall Study|Withdrawal by Subject|2|||
162926939|NCT00068406|588435201|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
162926940|NCT00068406|588435201|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
162926941|NCT02609178|588435202|FG000|First Crown|Withdrawal by Subject|0|||
162926942|NCT02609178|588435203|FG001|First Crown|Withdrawal by Subject|0|||
162926943|NCT02609178|588435204|FG002|First Crown|Withdrawal by Subject|1|||
162926944|NCT02609178|588435205|FG003|First Crown|Withdrawal by Subject|1|||
162926945|NCT02609178|588435206|FG004|First Crown|Withdrawal by Subject|0|||
162926946|NCT02609178|588435207|FG005|First Crown|Withdrawal by Subject|0|||
162926947|NCT00902265|588435210|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
162926948|NCT00902265|588435210|FG000|Overall Study|Adverse Event|2|||
162926949|NCT00902265|588435210|FG000|Overall Study|Lack of Efficacy|2|||
162926950|NCT00902265|588435210|FG000|Overall Study|Protocol Violation|1|||
162926951|NCT02866695|588435211|FG000|Overall Study|Adverse Event|1|||
162926952|NCT02866695|588435211|FG000|Overall Study|Lost to Follow-up|1|||
162926953|NCT05016765|588435212|FG000|Overall Study|Lost to Follow-up|4|||
162926954|NCT03891875|588435215|FG000|Overall Study|Withdrawal by Subject|20|||
162926955|NCT03891875|588435216|FG001|Overall Study|Withdrawal by Subject|3|||
162926956|NCT03891875|588435215|FG000|Overall Study|Adverse Event|10|||
162926957|NCT03891875|588435216|FG001|Overall Study|Adverse Event|4|||
162926958|NCT03891875|588435215|FG000|Overall Study|Physician Decision|1|||
162926959|NCT03891875|588435216|FG001|Overall Study|Physician Decision|1|||
162926960|NCT03891875|588435215|FG000|Overall Study|Protocol Violation|1|||
162926961|NCT03891875|588435216|FG001|Overall Study|Protocol Violation|0|||
162926962|NCT03891875|588435215|FG000|Overall Study|Lost to Follow-up|1|||
162926963|NCT03891875|588435216|FG001|Overall Study|Lost to Follow-up|0|||
162926964|NCT03891875|588435215|FG000|Overall Study|COVID-19 infection|1|||
162926965|NCT03891875|588435216|FG001|Overall Study|COVID-19 infection|0|||
162926966|NCT00285012|588435235|FG000|Assigned to Study Treatment (Tx)|Other|2|||
162926967|NCT00285012|588435236|FG001|Assigned to Study Treatment (Tx)|Other|3|||
162926968|NCT00285012|588435235|FG000|Received Study Tx|Death|2|||
162926969|NCT00285012|588435236|FG001|Received Study Tx|Death|1|||
162926970|NCT00285012|588435235|FG000|Received Study Tx|Adverse Event|5|||
162926971|NCT00285012|588435236|FG001|Received Study Tx|Adverse Event|11|||
162926972|NCT00285012|588435235|FG000|Received Study Tx|Lack of Efficacy|0|||
162926973|NCT00285012|588435236|FG001|Received Study Tx|Lack of Efficacy|3|||
162926974|NCT00285012|588435235|FG000|Received Study Tx|Lost to Follow-up|29|||
162926975|NCT00285012|588435236|FG001|Received Study Tx|Lost to Follow-up|31|||
162926976|NCT00285012|588435235|FG000|Received Study Tx|Withdrawal by Subject|31|||
162926977|NCT00285012|588435236|FG001|Received Study Tx|Withdrawal by Subject|43|||
162926978|NCT00285012|588435235|FG000|Received Study Tx|Other|5|||
162926979|NCT00285012|588435236|FG001|Received Study Tx|Other|5|||
162926980|NCT05631093|588435239|FG000|Overall Study|Death|0|||
162926981|NCT05631093|588435240|FG001|Overall Study|Death|1|||
162926982|NCT05631093|588435239|FG000|Overall Study|Lost to Follow-up|1|||
162926983|NCT05631093|588435240|FG001|Overall Study|Lost to Follow-up|2|||
162926984|NCT05631093|588435239|FG000|Overall Study|Physician Decision|1|||
162926985|NCT05631093|588435240|FG001|Overall Study|Physician Decision|0|||
162926986|NCT05631093|588435239|FG000|Overall Study|Withdrawal by Subject|4|||
162926987|NCT05631093|588435240|FG001|Overall Study|Withdrawal by Subject|1|||
162926988|NCT05631093|588435239|FG000|Overall Study|Ongoing|353|||
162926989|NCT05631093|588435240|FG001|Overall Study|Ongoing|177|||
162926990|NCT05631093|588435239|FG000|Overall Study|Adverse Event|0|||
162926991|NCT05631093|588435240|FG001|Overall Study|Adverse Event|1|||
162926992|NCT02873195|588435241|FG000|Overall Study|Ineligible|5|||
162926993|NCT02873195|588435242|FG001|Overall Study|Ineligible|0|||
162926994|NCT03107715|588435243|FG000|Overall Study|did not deliver at the home hospital|4|||
162926995|NCT03107715|588435244|FG001|Overall Study|did not deliver at the home hospital|6|||
162926996|NCT03107715|588435243|FG000|Overall Study|infant stillborn|0|||
162926997|NCT03107715|588435244|FG001|Overall Study|infant stillborn|1|||
162926998|NCT04822701|588435247|FG000|Overall Study|Not treated|2|||
162926999|NCT04822701|588435248|FG001|Overall Study|Not treated|0|||
162927000|NCT04822701|588435247|FG000|Overall Study|Lost to Follow-up|1|||
162927001|NCT04822701|588435248|FG001|Overall Study|Lost to Follow-up|0|||
162927002|NCT04822701|588435247|FG000|Overall Study|Withdrawal by Subject|1|||
162927003|NCT04822701|588435248|FG001|Overall Study|Withdrawal by Subject|0|||
162927004|NCT02706353|588435249|FG000|Dose Level 1|Disease Progression|1|||
162927005|NCT02706353|588435250|FG001|Dose Level 1|Disease Progression|0|||
162927006|NCT02706353|588435251|FG002|Dose Level 1|Disease Progression|0|||
162927007|NCT02706353|588435252|FG003|Dose Level 1|Disease Progression|0|||
162927008|NCT02706353|588435253|FG004|Dose Level 1|Disease Progression|0|||
162927009|NCT02706353|588435254|FG005|Dose Level 1|Disease Progression|0|||
162927010|NCT02706353|588435249|FG000|Dose Level 3|Disease Progression|0|||
162927011|NCT02706353|588435250|FG001|Dose Level 3|Disease Progression|0|||
162927012|NCT02706353|588435251|FG002|Dose Level 3|Disease Progression|2|||
162927013|NCT02706353|588435252|FG003|Dose Level 3|Disease Progression|0|||
162927014|NCT02706353|588435253|FG004|Dose Level 3|Disease Progression|0|||
162927015|NCT02706353|588435254|FG005|Dose Level 3|Disease Progression|0|||
162927016|NCT02706353|588435249|FG000|Dose Level 4|Disease Progression|0|||
162927017|NCT02706353|588435250|FG001|Dose Level 4|Disease Progression|0|||
162927018|NCT02706353|588435251|FG002|Dose Level 4|Disease Progression|0|||
162927019|NCT02706353|588435252|FG003|Dose Level 4|Disease Progression|1|||
162927020|NCT02706353|588435253|FG004|Dose Level 4|Disease Progression|0|||
162927021|NCT02706353|588435254|FG005|Dose Level 4|Disease Progression|0|||
162927022|NCT02706353|588435249|FG000|Dose Level 4|Toxicity|0|||
162927023|NCT02706353|588435250|FG001|Dose Level 4|Toxicity|0|||
162927024|NCT02706353|588435251|FG002|Dose Level 4|Toxicity|0|||
162927025|NCT02706353|588435252|FG003|Dose Level 4|Toxicity|1|||
162927026|NCT02706353|588435253|FG004|Dose Level 4|Toxicity|0|||
162927027|NCT02706353|588435254|FG005|Dose Level 4|Toxicity|0|||
162927028|NCT02706353|588435249|FG000|Dose Level 4|Death|0|||
162927029|NCT02706353|588435250|FG001|Dose Level 4|Death|0|||
162927030|NCT02706353|588435251|FG002|Dose Level 4|Death|0|||
162927031|NCT02706353|588435252|FG003|Dose Level 4|Death|1|||
162927032|NCT02706353|588435253|FG004|Dose Level 4|Death|0|||
162927033|NCT02706353|588435254|FG005|Dose Level 4|Death|0|||
162927034|NCT02706353|588435249|FG000|Dose Level 5|Toxicity|0|||
162927035|NCT02706353|588435250|FG001|Dose Level 5|Toxicity|0|||
162927036|NCT02706353|588435251|FG002|Dose Level 5|Toxicity|0|||
162927037|NCT02706353|588435252|FG003|Dose Level 5|Toxicity|0|||
162927038|NCT02706353|588435253|FG004|Dose Level 5|Toxicity|1|||
162927039|NCT02706353|588435254|FG005|Dose Level 5|Toxicity|0|||
162927040|NCT02706353|588435249|FG000|Dose Level 5|Disease Progression|0|||
162927041|NCT02706353|588435250|FG001|Dose Level 5|Disease Progression|0|||
162927042|NCT02706353|588435251|FG002|Dose Level 5|Disease Progression|0|||
162927043|NCT02706353|588435252|FG003|Dose Level 5|Disease Progression|0|||
162927044|NCT02706353|588435253|FG004|Dose Level 5|Disease Progression|3|||
162927045|NCT02706353|588435254|FG005|Dose Level 5|Disease Progression|2|||
162927046|NCT02706353|588435249|FG000|Dose Level 5|Death|0|||
162927047|NCT02706353|588435250|FG001|Dose Level 5|Death|0|||
162927048|NCT02706353|588435251|FG002|Dose Level 5|Death|0|||
162927049|NCT02706353|588435252|FG003|Dose Level 5|Death|0|||
162927050|NCT02706353|588435253|FG004|Dose Level 5|Death|1|||
162927051|NCT02706353|588435254|FG005|Dose Level 5|Death|6|||
162927052|NCT02706353|588435249|FG000|Dose Level 5|Withdrawal by Subject|0|||
162927053|NCT02706353|588435250|FG001|Dose Level 5|Withdrawal by Subject|0|||
162927054|NCT02706353|588435251|FG002|Dose Level 5|Withdrawal by Subject|0|||
162927055|NCT02706353|588435252|FG003|Dose Level 5|Withdrawal by Subject|0|||
162927056|NCT02706353|588435253|FG004|Dose Level 5|Withdrawal by Subject|0|||
162927057|NCT02706353|588435254|FG005|Dose Level 5|Withdrawal by Subject|2|||
162927058|NCT03560466|588435255|FG000|Overall Study|Adverse Event|1|||
162927059|NCT03560466|588435256|FG001|Overall Study|Adverse Event|2|||
162927060|NCT03560466|588435257|FG002|Overall Study|Adverse Event|0|||
162927061|NCT03560466|588435255|FG000|Overall Study|Poor Compliance to Protocol|0|||
162927062|NCT03560466|588435256|FG001|Overall Study|Poor Compliance to Protocol|2|||
162927063|NCT03560466|588435257|FG002|Overall Study|Poor Compliance to Protocol|0|||
162927064|NCT03560466|588435255|FG000|Overall Study|Other|6|||
162927065|NCT03560466|588435256|FG001|Overall Study|Other|8|||
162927066|NCT03560466|588435257|FG002|Overall Study|Other|1|||
162927067|NCT01190098|588437051|FG000|Overall Study|Adverse Event|2|||
162927068|NCT01190098|588437052|FG001|Overall Study|Adverse Event|0|||
162927069|NCT01190098|588437051|FG000|Overall Study|Patient coomorbidity|0|||
162927070|NCT01190098|588437052|FG001|Overall Study|Patient coomorbidity|1|||
162927071|NCT01190098|588437051|FG000|Overall Study|Lack of transportation|1|||
162927072|NCT01190098|588437052|FG001|Overall Study|Lack of transportation|0|||
162927073|NCT01190098|588437051|FG000|Overall Study|Other|0|||
162927074|NCT01190098|588437052|FG001|Overall Study|Other|1|||
162927075|NCT04723173|588437057|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
162927076|NCT02996448|588437058|FG000|Overall Study|Study terminated due to adverse effects|3|||
163040757|NCT01483599|588856066|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
163040758|NCT02109445|588856068|FG000|Overall Study|Symptomatic deterioration|2|||
163040759|NCT02109445|588856068|FG000|Overall Study|Adverse Event|1|||
163040760|NCT00966355|588856073|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
163040761|NCT00966355|588856074|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
163040762|NCT00966355|588856075|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
163040763|NCT00966355|588856073|FG000|Overall Study|newly diagnosed advanced HCC|11|||
163040764|NCT00966355|588856074|FG001|Overall Study|newly diagnosed advanced HCC|12|||
163040765|NCT00966355|588856075|FG002|Overall Study|newly diagnosed advanced HCC|10|||
163040766|NCT00966355|588856073|FG000|Overall Study|Lost to Follow-up|5|||
163040767|NCT00966355|588856074|FG001|Overall Study|Lost to Follow-up|4|||
163040768|NCT00966355|588856075|FG002|Overall Study|Lost to Follow-up|3|||
163058529|NCT00042289|588924263|FG028|Overall Study|Severe debilitation, unable to continue|0|||
163058530|NCT00042289|588924264|FG029|Overall Study|Severe debilitation, unable to continue|0|||
163058531|NCT00042289|588924265|FG030|Overall Study|Severe debilitation, unable to continue|0|||
163058532|NCT00042289|588924266|FG031|Overall Study|Severe debilitation, unable to continue|1|||
162927077|NCT00606801|588437059|FG000|Intervention|Protocol Violation|3|||
162927078|NCT00606801|588437060|FG001|Intervention|Protocol Violation|3|||
162927079|NCT02082262|588437061|FG000|Overall Study|Withdrawal by Subject|3|||
162927080|NCT02082262|588437061|FG000|Overall Study|Adverse Event|48|||
162927081|NCT02748616|588437078|FG000|Overall Study|Lost to Follow-up|1|||
162927082|NCT02748616|588437078|FG000|Overall Study|Withdrawal by Subject|2|||
162927083|NCT02748616|588437078|FG000|Overall Study|Physician Decision|2|||
162927084|NCT02748616|588437078|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
162927085|NCT02018042|588437079|FG000|Overall Study|Withdrawal by Subject|1|||
162927086|NCT03231709|588437080|FG000|Treatment Period 1|Reason not Specified|0|||
162927087|NCT03231709|588437081|FG001|Treatment Period 1|Reason not Specified|1|||
162927088|NCT03231709|588437080|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
163058533|NCT00042289|588924267|FG032|Overall Study|Severe debilitation, unable to continue|1|||
163058534|NCT00042289|588924268|FG033|Overall Study|Severe debilitation, unable to continue|0|||
162927089|NCT03231709|588437081|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
162927090|NCT02419469|588437082|FG000|Overall Study|Withdrawal by Subject|1|||
162927091|NCT01785875|588437083|FG000|Overall Study|Withdrawal by Subject|41|||
162927092|NCT01785875|588437084|FG001|Overall Study|Withdrawal by Subject|34|||
162927093|NCT01785875|588437085|FG002|Overall Study|Withdrawal by Subject|36|||
163058535|NCT00042289|588924269|FG034|Overall Study|Severe debilitation, unable to continue|0|||
163058536|NCT00042289|588924270|FG035|Overall Study|Severe debilitation, unable to continue|0|||
162927094|NCT01785875|588437083|FG000|Overall Study|Lost to Follow-up|19|||
162927095|NCT01785875|588437084|FG001|Overall Study|Lost to Follow-up|22|||
162927096|NCT01785875|588437085|FG002|Overall Study|Lost to Follow-up|6|||
162927097|NCT01785875|588437083|FG000|Overall Study|Death|27|||
162927098|NCT01785875|588437084|FG001|Overall Study|Death|16|||
162927099|NCT01785875|588437085|FG002|Overall Study|Death|7|||
162927100|NCT01785875|588437083|FG000|Overall Study|Sponsor Decision|0|||
162927101|NCT01785875|588437084|FG001|Overall Study|Sponsor Decision|2|||
162927102|NCT01785875|588437085|FG002|Overall Study|Sponsor Decision|0|||
162927103|NCT01785875|588437083|FG000|Overall Study|Protocol Specified Criteria|207|||
162927104|NCT01785875|588437084|FG001|Overall Study|Protocol Specified Criteria|214|||
162927105|NCT01785875|588437085|FG002|Overall Study|Protocol Specified Criteria|55|||
162927106|NCT01785875|588437083|FG000|Overall Study|Missing|0|||
162927107|NCT01785875|588437084|FG001|Overall Study|Missing|1|||
162927108|NCT01785875|588437085|FG002|Overall Study|Missing|3|||
162927109|NCT04840901|588437088|FG000|Overall Study|Lost to Follow-up|3|||
162927110|NCT04840901|588437089|FG001|Overall Study|Lost to Follow-up|1|||
162927111|NCT04840901|588437088|FG000|Overall Study|Moved|1|||
162927112|NCT04840901|588437089|FG001|Overall Study|Moved|0|||
162927113|NCT04840901|588437088|FG000|Overall Study|Unable to comply with study schedule|0|||
162927114|NCT04840901|588437089|FG001|Overall Study|Unable to comply with study schedule|1|||
162927115|NCT04840901|588437088|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
162927116|NCT04840901|588437089|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
162927117|NCT01414062|588437090|FG000|Overall Study|Lost to Follow-up|3|||
162927118|NCT01414062|588437091|FG001|Overall Study|Lost to Follow-up|2|||
162927119|NCT01414062|588437090|FG000|Overall Study|Left Country|1|||
162927120|NCT01414062|588437091|FG001|Overall Study|Left Country|1|||
162927121|NCT01414062|588437090|FG000|Overall Study|Family Disapproval|1|||
162927122|NCT01414062|588437091|FG001|Overall Study|Family Disapproval|0|||
162927123|NCT01414062|588437090|FG000|Overall Study|Withdrawal by Subject|0|||
162927124|NCT01414062|588437091|FG001|Overall Study|Withdrawal by Subject|1|||
162927125|NCT04075292|588437092|FG000|Overall Study|Withdrawal by Subject|1|||
162927126|NCT04075292|588437093|FG001|Overall Study|Withdrawal by Subject|9|||
162927127|NCT04075292|588437092|FG000|Overall Study|Death|2|||
162927128|NCT04075292|588437093|FG001|Overall Study|Death|5|||
162927129|NCT04075292|588437092|FG000|Overall Study|Remained on study at time of DCO|74|||
163040769|NCT00401193|588857900|FG000|Overall Study|Adverse Event|1|||
163040770|NCT00401193|588857901|FG001|Overall Study|Adverse Event|3|||
162927130|NCT04075292|588437093|FG001|Overall Study|Remained on study at time of DCO|64|||
162927131|NCT01988493|588437095|FG000|Overall Study|Randomized but not treated|0|||
162927132|NCT01988493|588437096|FG001|Overall Study|Randomized but not treated|0|||
162927133|NCT01988493|588437097|FG002|Overall Study|Randomized but not treated|0|||
162927134|NCT01988493|588437098|FG003|Overall Study|Randomized but not treated|0|||
162927135|NCT01988493|588437099|FG004|Overall Study|Randomized but not treated|1|||
162927136|NCT00185731|588437104|FG000|Overall Study|Withdrawal by Subject|1|||
162927137|NCT00185731|588437104|FG000|Overall Study|Not Eligible|1|||
162927138|NCT03087773|588437105|FG000|Overall Study|Withdrawal by Subject|8|||
162927139|NCT03087773|588437106|FG001|Overall Study|Withdrawal by Subject|4|||
162927140|NCT03087773|588437105|FG000|Overall Study|Lost to Follow-up|12|||
162927141|NCT03087773|588437106|FG001|Overall Study|Lost to Follow-up|8|||
162927142|NCT05144477|588437109|FG000|Overall Study|Withdrawal by Subject|1|||
162927143|NCT05144477|588437110|FG001|Overall Study|Withdrawal by Subject|1|||
162927144|NCT01787188|588437115|FG000|Overall Study|Adverse Event|2|||
162927145|NCT01787188|588437116|FG001|Overall Study|Adverse Event|4|||
162927146|NCT01787188|588437117|FG002|Overall Study|Adverse Event|6|||
162927147|NCT01787188|588437115|FG000|Overall Study|Lack of Efficacy|7|||
162927148|NCT01787188|588437116|FG001|Overall Study|Lack of Efficacy|3|||
162927149|NCT01787188|588437117|FG002|Overall Study|Lack of Efficacy|5|||
162927150|NCT01787188|588437115|FG000|Overall Study|Non-compliance with Study Drug|0|||
162927151|NCT01787188|588437116|FG001|Overall Study|Non-compliance with Study Drug|1|||
162927152|NCT01787188|588437117|FG002|Overall Study|Non-compliance with Study Drug|0|||
162927153|NCT01787188|588437115|FG000|Overall Study|Withdrawal by Subject|4|||
162927154|NCT01787188|588437116|FG001|Overall Study|Withdrawal by Subject|3|||
162927155|NCT01787188|588437117|FG002|Overall Study|Withdrawal by Subject|2|||
162927156|NCT01787188|588437115|FG000|Overall Study|Protocol Violation|3|||
162927157|NCT01787188|588437116|FG001|Overall Study|Protocol Violation|2|||
162927158|NCT01787188|588437117|FG002|Overall Study|Protocol Violation|3|||
162927159|NCT01787188|588437115|FG000|Overall Study|Lost to Follow-up|1|||
162927160|NCT01787188|588437116|FG001|Overall Study|Lost to Follow-up|2|||
162927161|NCT01787188|588437117|FG002|Overall Study|Lost to Follow-up|2|||
162927162|NCT01787188|588437115|FG000|Overall Study|Other, including patient moved|0|||
162927163|NCT01787188|588437116|FG001|Overall Study|Other, including patient moved|3|||
162927164|NCT01787188|588437117|FG002|Overall Study|Other, including patient moved|0|||
162927165|NCT00854607|588437118|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
162927166|NCT01783483|588437124|FG000|Overall Study|Death|3|||
163040771|NCT00401193|588857902|FG002|Overall Study|Adverse Event|1|||
162927167|NCT01783483|588437125|FG001|Overall Study|Death|3|||
162927168|NCT01783483|588437124|FG000|Overall Study|Lost to Follow-up|14|||
162927169|NCT01783483|588437125|FG001|Overall Study|Lost to Follow-up|10|||
163040772|NCT00401193|588857900|FG000|Overall Study|Protocol Violation|3|||
162927170|NCT01783483|588437124|FG000|Overall Study|Withdrawal by Subject|2|||
163040773|NCT00401193|588857901|FG001|Overall Study|Protocol Violation|1|||
163040774|NCT00401193|588857902|FG002|Overall Study|Protocol Violation|1|||
163040775|NCT00401193|588857900|FG000|Overall Study|Lost to Follow-up|6|||
163040776|NCT00401193|588857901|FG001|Overall Study|Lost to Follow-up|5|||
163040777|NCT00401193|588857902|FG002|Overall Study|Lost to Follow-up|1|||
163040778|NCT00401193|588857900|FG000|Overall Study|Withdrawal by Subject|2|||
163040779|NCT00401193|588857901|FG001|Overall Study|Withdrawal by Subject|0|||
163040780|NCT00401193|588857902|FG002|Overall Study|Withdrawal by Subject|1|||
162927171|NCT01783483|588437125|FG001|Overall Study|Withdrawal by Subject|1|||
162927172|NCT01783483|588437124|FG000|Overall Study|Physician Decision|1|||
162927173|NCT01783483|588437125|FG001|Overall Study|Physician Decision|1|||
162927174|NCT02268045|588437126|FG000|Overall Study|Death|4|||
162927175|NCT02268045|588437127|FG001|Overall Study|Death|4|||
162927176|NCT02268045|588437126|FG000|Overall Study|Disease Progression|2|||
162927177|NCT02268045|588437127|FG001|Overall Study|Disease Progression|1|||
162927178|NCT02268045|588437126|FG000|Overall Study|Adverse Event|7|||
162927179|NCT02268045|588437127|FG001|Overall Study|Adverse Event|7|||
162927180|NCT02268045|588437126|FG000|Overall Study|Withdrawal by Subject|2|||
162927181|NCT02268045|588437127|FG001|Overall Study|Withdrawal by Subject|6|||
162927182|NCT02268045|588437126|FG000|Overall Study|Physician Decision|0|||
162927183|NCT02268045|588437127|FG001|Overall Study|Physician Decision|1|||
162927184|NCT02268045|588437126|FG000|Overall Study|Protocol Violation|1|||
162927185|NCT02268045|588437127|FG001|Overall Study|Protocol Violation|1|||
162927186|NCT01766310|588437128|FG000|Overall Study|Lost to Follow-up|1|||
162927187|NCT01766310|588437129|FG001|Overall Study|Lost to Follow-up|3|||
162927188|NCT00835068|588437130|FG000|Overall Study|Death|1|||
163040781|NCT00401193|588857900|FG000|Overall Study|Other Event|3|||
163040782|NCT00401193|588857901|FG001|Overall Study|Other Event|2|||
163040783|NCT00401193|588857902|FG002|Overall Study|Other Event|2|||
163040784|NCT04378569|588857904|FG000|Overall Study|Adverse Event|0|||
163040785|NCT04378569|588857905|FG001|Overall Study|Adverse Event|0|||
163040786|NCT04378569|588857906|FG002|Overall Study|Adverse Event|2|||
163040787|NCT04378569|588857907|FG003|Overall Study|Adverse Event|0|||
163040788|NCT04378569|588857908|FG004|Overall Study|Adverse Event|3|||
163040789|NCT04378569|588857909|FG005|Overall Study|Adverse Event|3|||
163040790|NCT04378569|588857904|FG000|Overall Study|Lost to Follow-up|0|||
163040791|NCT04378569|588857905|FG001|Overall Study|Lost to Follow-up|3|||
163040792|NCT04378569|588857906|FG002|Overall Study|Lost to Follow-up|1|||
163155971|NCT05523089|589285853|FG001|Overall Study|Lost to Follow-up|0|||
163155972|NCT05523089|589285854|FG002|Overall Study|Lost to Follow-up|0|||
163155973|NCT05530252|589285855|FG000|Overall Study|Lost to Follow-up|1|||
163155974|NCT05530252|589285856|FG001|Overall Study|Lost to Follow-up|1|||
163155975|NCT05530252|589285857|FG002|Overall Study|Lost to Follow-up|1|||
162927189|NCT00835068|588437131|FG001|Overall Study|Death|0|||
163155976|NCT01350999|589285858|FG000|Overall Study|Adverse Event|4|||
163155977|NCT01350999|589285859|FG001|Overall Study|Adverse Event|9|||
163155978|NCT01350999|589285860|FG002|Overall Study|Adverse Event|10|||
163155979|NCT01350999|589285858|FG000|Overall Study|Voluntary withdrawal|3|||
163155980|NCT01350999|589285859|FG001|Overall Study|Voluntary withdrawal|4|||
163155981|NCT01350999|589285860|FG002|Overall Study|Voluntary withdrawal|6|||
163155982|NCT01350999|589285858|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
163155983|NCT01350999|589285859|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
163155984|NCT01350999|589285860|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
162927190|NCT00835068|588437130|FG000|Overall Study|Adverse Event|0|||
162927191|NCT00835068|588437131|FG001|Overall Study|Adverse Event|1|||
162927192|NCT00835068|588437130|FG000|Overall Study|Other|8|||
162927193|NCT00835068|588437131|FG001|Overall Study|Other|0|||
162927194|NCT00835068|588437130|FG000|Overall Study|Withdrawal by Subject|1|||
162927195|NCT00835068|588437131|FG001|Overall Study|Withdrawal by Subject|0|||
162927196|NCT01591499|588437132|FG000|Baseline Visit|Withdrawal by Subject|0|||
162927197|NCT01591499|588437133|FG001|Baseline Visit|Withdrawal by Subject|2|||
162927198|NCT01591499|588437134|FG002|Baseline Visit|Withdrawal by Subject|0|||
162927199|NCT01591499|588437135|FG003|Baseline Visit|Withdrawal by Subject|2|||
163155985|NCT01987453|589287728|FG000|Overall Study|Death|0|||
163155986|NCT01987453|589287729|FG001|Overall Study|Death|0|||
163155987|NCT01987453|589287730|FG002|Overall Study|Death|1|||
163155988|NCT01987453|589287728|FG000|Overall Study|Lack of Efficacy|1|||
162927200|NCT01591499|588437132|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
162927201|NCT01591499|588437133|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
162927202|NCT01591499|588437134|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
162927203|NCT01591499|588437135|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
162927204|NCT01591499|588437132|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
162927205|NCT01591499|588437133|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
163040793|NCT04378569|588857907|FG003|Overall Study|Lost to Follow-up|0|||
163040794|NCT04378569|588857908|FG004|Overall Study|Lost to Follow-up|1|||
163155989|NCT01987453|589287729|FG001|Overall Study|Lack of Efficacy|12|||
163155990|NCT01987453|589287730|FG002|Overall Study|Lack of Efficacy|0|||
163155991|NCT04040933|589287736|FG000|Overall Study|Protocol Violation|1|||
162927206|NCT01591499|588437134|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
162927207|NCT01591499|588437135|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
162927208|NCT02125734|588437136|FG000|Period 2|Adverse Event|0|||
162927209|NCT02125734|588437137|FG001|Period 2|Adverse Event|1|||
162927210|NCT01308762|588437138|FG000|Overall Study|Protocol Violation|0|||
162927211|NCT01308762|588437139|FG001|Overall Study|Protocol Violation|1|||
162927212|NCT01308762|588437140|FG002|Overall Study|Protocol Violation|0|||
162927213|NCT00646282|588437141|FG000|Overall Study|Protocol terminated|4|||
162927214|NCT00646282|588437142|FG001|Overall Study|Protocol terminated|4|||
162927215|NCT01556490|588437143|FG000|Randomized Patients Summary|Protocol Violation|22|||
162927216|NCT01556490|588437144|FG001|Randomized Patients Summary|Protocol Violation|23|||
162927217|NCT01556490|588437143|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
162927218|NCT01556490|588437144|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
162927219|NCT00902278|588437145|FG000|Overall Study|Physician Decision|1|||
162927220|NCT00902278|588437146|FG001|Overall Study|Physician Decision|0|||
162927221|NCT00902278|588437147|FG002|Overall Study|Physician Decision|2|||
162927222|NCT00902278|588437148|FG003|Overall Study|Physician Decision|0|||
162927223|NCT00902278|588437149|FG004|Overall Study|Physician Decision|1|||
162927224|NCT00902278|588437145|FG000|Overall Study|Lost to Follow-up|3|||
162927225|NCT00902278|588437146|FG001|Overall Study|Lost to Follow-up|2|||
162927226|NCT00902278|588437147|FG002|Overall Study|Lost to Follow-up|3|||
162927227|NCT00902278|588437148|FG003|Overall Study|Lost to Follow-up|0|||
162927228|NCT00902278|588437149|FG004|Overall Study|Lost to Follow-up|1|||
162927229|NCT01652872|588437152|FG000|Overall Study|Death|36|||
162927230|NCT01652872|588437153|FG001|Overall Study|Death|39|||
162927231|NCT01652872|588437152|FG000|Overall Study|Lost to Follow-up|28|||
162927232|NCT01652872|588437153|FG001|Overall Study|Lost to Follow-up|23|||
162927233|NCT01652872|588437152|FG000|Overall Study|Decision by sponsor|5|||
162927234|NCT01652872|588437153|FG001|Overall Study|Decision by sponsor|7|||
162927235|NCT01652872|588437152|FG000|Overall Study|Withdrawal by Subject|76|||
162927236|NCT01652872|588437153|FG001|Overall Study|Withdrawal by Subject|84|||
162927237|NCT00758706|588437154|FG000|Overall Study|Adverse Event|4|||
162927238|NCT00758706|588437155|FG001|Overall Study|Adverse Event|4|||
162927239|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
162927240|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
162927241|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
162927242|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
162927243|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
162927244|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
162927245|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
162927246|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927247|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
162927248|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927249|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
162927250|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
162927251|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927252|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927253|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927254|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
162927255|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927256|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
162927257|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
162927258|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
162927259|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
162927260|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
162927261|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
162927262|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
162927263|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
162927264|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
162927265|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
162927266|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
163155992|NCT04040933|589287736|FG000|Overall Study|Withdrawal by Subject|2|||
162631057|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
162927267|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
162927268|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
162927269|NCT03985293|588437159|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
162927270|NCT03985293|588437160|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
162927271|NCT03985293|588437161|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
162927272|NCT03985293|588437162|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
162927273|NCT03985293|588437163|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
162927274|NCT03985293|588437164|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
162927275|NCT03985293|588437159|FG000|FOLLOW-UP|Lost to Follow-up|0|||
162927276|NCT03985293|588437160|FG001|FOLLOW-UP|Lost to Follow-up|0|||
162927277|NCT03985293|588437161|FG002|FOLLOW-UP|Lost to Follow-up|1|||
162927278|NCT03985293|588437162|FG003|FOLLOW-UP|Lost to Follow-up|0|||
162927279|NCT03985293|588437163|FG004|FOLLOW-UP|Lost to Follow-up|0|||
162927280|NCT03985293|588437164|FG005|FOLLOW-UP|Lost to Follow-up|0|||
162927281|NCT02588651|588437165|FG000|Overall Study|Adverse Event|1|||
162927282|NCT02588651|588437165|FG000|Overall Study|Withdrawal by Subject|2|||
162927283|NCT02588651|588437165|FG000|Overall Study|Death|1|||
162927284|NCT02588651|588437165|FG000|Overall Study|Lack of Efficacy|13|||
162927285|NCT02588651|588437165|FG000|Overall Study|Lost to Follow-up|1|||
162927286|NCT02588651|588437165|FG000|Overall Study|Physician Decision|1|||
162927287|NCT02588651|588437165|FG000|Overall Study|Disease progression|2|||
162927288|NCT05899218|588437166|FG000|Overall Study|Lost to Follow-up|2|||
162927289|NCT05899218|588437167|FG001|Overall Study|Lost to Follow-up|2|||
162927290|NCT05899218|588437166|FG000|Overall Study|deemed ineligible out of country|1|||
162927291|NCT05899218|588437167|FG001|Overall Study|deemed ineligible out of country|0|||
162927292|NCT02587325|588437172|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
162927293|NCT02587325|588437173|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927294|NCT02587325|588437174|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927295|NCT02587325|588437175|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
163155993|NCT02066181|589287737|FG000|Overall Study|Withdrawal by Subject|1|||
163155994|NCT02066181|589287738|FG001|Overall Study|Withdrawal by Subject|1|||
163155995|NCT00775190|589287743|FG000|Overall Study|Lost to Follow-up|2|||
163155996|NCT00775190|589287744|FG001|Overall Study|Lost to Follow-up|3|||
163155997|NCT00775190|589287743|FG000|Overall Study|Withdrawal by Subject|1|||
163155998|NCT00775190|589287744|FG001|Overall Study|Withdrawal by Subject|2|||
163155999|NCT00775190|589287743|FG000|Overall Study|Protocol Violation|1|||
163156000|NCT00775190|589287744|FG001|Overall Study|Protocol Violation|0|||
163156001|NCT02141295|589287745|FG000|Overall Study|Adverse Event|1|||
163156002|NCT02141295|589287746|FG001|Overall Study|Adverse Event|18|||
163156003|NCT02141295|589287747|FG002|Overall Study|Adverse Event|11|||
163156004|NCT02141295|589287745|FG000|Overall Study|Physician Decision|2|||
163156005|NCT02141295|589287746|FG001|Overall Study|Physician Decision|19|||
163156006|NCT02141295|589287747|FG002|Overall Study|Physician Decision|14|||
163156007|NCT02141295|589287745|FG000|Overall Study|Study terminated by sponsor|0|||
163156008|NCT02141295|589287746|FG001|Overall Study|Study terminated by sponsor|6|||
163156009|NCT02141295|589287747|FG002|Overall Study|Study terminated by sponsor|6|||
163156010|NCT02141295|589287745|FG000|Overall Study|Non-compliance|0|||
163156011|NCT02141295|589287746|FG001|Overall Study|Non-compliance|1|||
163156012|NCT02141295|589287747|FG002|Overall Study|Non-compliance|0|||
163156013|NCT02141295|589287745|FG000|Overall Study|Progressive disease|3|||
163156014|NCT02141295|589287746|FG001|Overall Study|Progressive disease|32|||
163156015|NCT02141295|589287747|FG002|Overall Study|Progressive disease|50|||
163156016|NCT02141295|589287745|FG000|Overall Study|Reason not specified|0|||
163156017|NCT02141295|589287746|FG001|Overall Study|Reason not specified|9|||
163156018|NCT02141295|589287747|FG002|Overall Study|Reason not specified|10|||
163156019|NCT02141295|589287745|FG000|Overall Study|Withdrawal by Subject|0|||
163156020|NCT02141295|589287746|FG001|Overall Study|Withdrawal by Subject|9|||
163156021|NCT02141295|589287747|FG002|Overall Study|Withdrawal by Subject|4|||
163156022|NCT01710501|589287748|FG000|Overall Study|Lost to Follow-up|2|||
163156023|NCT01710501|589287749|FG001|Overall Study|Lost to Follow-up|0|||
163156024|NCT01710501|589287750|FG002|Overall Study|Lost to Follow-up|0|||
163156025|NCT02536976|589287751|FG000|Overall Study|Physician Decision|0|||
163156026|NCT02536976|589287752|FG001|Overall Study|Physician Decision|1|||
163156027|NCT01671319|589287755|FG000|Overall Study|Withdrawal by Subject|1|||
163156028|NCT01376804|589287756|FG000|Treatment Period|Withdrawal by Subject|1|||
163156029|NCT01376804|589287756|FG000|Treatment Period|Adverse Event|6|||
163156030|NCT01376804|589287756|FG000|Treatment Period|Patient did not receive study drug|1|||
163156031|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
163156032|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
163156033|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
163156034|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
163156035|NCT02904954|589287761|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
163156036|NCT02904954|589287762|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
163156037|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Recurrence|2|||
163156038|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Recurrence|0|||
163156039|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Adverse Event|2|||
163156040|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Adverse Event|6|||
163156041|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Participant wishes|12|||
162927296|NCT02587325|588437176|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
162927297|NCT02587325|588437172|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927298|NCT02587325|588437173|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927299|NCT02587325|588437174|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
162927300|NCT02587325|588437175|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
162927301|NCT02587325|588437176|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
163156042|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Participant wishes|7|||
162927302|NCT02587325|588437172|FG000|32-Week Optional Extension Part|Adverse Event|0|||
163040795|NCT04378569|588857909|FG005|Overall Study|Lost to Follow-up|1|||
163156043|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Physician Decision|2|||
162927303|NCT02587325|588437173|FG001|32-Week Optional Extension Part|Adverse Event|0|||
162927304|NCT02587325|588437174|FG002|32-Week Optional Extension Part|Adverse Event|1|||
162927305|NCT02587325|588437175|FG003|32-Week Optional Extension Part|Adverse Event|0|||
162927306|NCT02587325|588437176|FG004|32-Week Optional Extension Part|Adverse Event|0|||
162927307|NCT02587325|588437172|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927308|NCT02587325|588437173|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927309|NCT02587325|588437174|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
162927310|NCT02587325|588437175|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
162927311|NCT02587325|588437176|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
162927312|NCT00390572|588437177|FG000|Overall Study|Lost to Follow-up|8|||
163156044|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Physician Decision|1|||
163156045|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
163156046|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
163156047|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Death|0|||
163156048|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Death|1|||
163156049|NCT02904954|589287761|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
163156050|NCT02904954|589287762|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
163156051|NCT01281124|589287763|FG000|Overall Study|Death|1|||
163156052|NCT01198795|589287764|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
163040796|NCT04378569|588857904|FG000|Overall Study|Protocol Violation|0|||
163040797|NCT04378569|588857905|FG001|Overall Study|Protocol Violation|0|||
163040798|NCT04378569|588857906|FG002|Overall Study|Protocol Violation|0|||
163040799|NCT04378569|588857907|FG003|Overall Study|Protocol Violation|0|||
163040800|NCT04378569|588857908|FG004|Overall Study|Protocol Violation|0|||
163040801|NCT04378569|588857909|FG005|Overall Study|Protocol Violation|1|||
163040802|NCT04378569|588857904|FG000|Overall Study|Withdrawal by Subject|0|||
163040803|NCT04378569|588857905|FG001|Overall Study|Withdrawal by Subject|6|||
163040804|NCT04378569|588857906|FG002|Overall Study|Withdrawal by Subject|7|||
163040805|NCT04378569|588857907|FG003|Overall Study|Withdrawal by Subject|4|||
163040806|NCT04378569|588857908|FG004|Overall Study|Withdrawal by Subject|5|||
163040807|NCT04378569|588857909|FG005|Overall Study|Withdrawal by Subject|4|||
163040808|NCT04378569|588857904|FG000|Overall Study|Lack of response|0|||
163040809|NCT04378569|588857905|FG001|Overall Study|Lack of response|0|||
163040810|NCT04378569|588857906|FG002|Overall Study|Lack of response|1|||
163040811|NCT04378569|588857907|FG003|Overall Study|Lack of response|0|||
163040812|NCT04378569|588857908|FG004|Overall Study|Lack of response|1|||
163040813|NCT04378569|588857909|FG005|Overall Study|Lack of response|1|||
163040814|NCT01844817|588857910|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
163040815|NCT01844817|588857911|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
163040816|NCT01844817|588857910|FG000|Treatment|Progressive Disease|27|||
163040817|NCT01844817|588857911|FG001|Treatment|Progressive Disease|36|||
163040818|NCT01844817|588857910|FG000|Treatment|Adverse Event|17|||
163040819|NCT01844817|588857911|FG001|Treatment|Adverse Event|9|||
163040820|NCT01844817|588857910|FG000|Treatment|Withdrawal by Subject|10|||
163040821|NCT01844817|588857911|FG001|Treatment|Withdrawal by Subject|6|||
163040822|NCT01844817|588857910|FG000|Treatment|Death|10|||
163040823|NCT01844817|588857911|FG001|Treatment|Death|8|||
163040824|NCT01844817|588857910|FG000|Treatment|Lost to Follow-up|0|||
163040825|NCT01844817|588857911|FG001|Treatment|Lost to Follow-up|1|||
163040826|NCT01844817|588857910|FG000|Treatment|Other|0|||
163040827|NCT01844817|588857911|FG001|Treatment|Other|3|||
163040828|NCT04530838|588857914|FG000|Overall Study|Other|2|||
163156053|NCT01198795|589287764|FG000|Overall Study|Withdrawal by Subject|17|||
163156054|NCT01198795|589287764|FG000|Overall Study|Lost to Follow-up|15|||
163156055|NCT01198795|589287764|FG000|Overall Study|Adverse Event|9|||
163156056|NCT01198795|589287764|FG000|Overall Study|Lack of Efficacy|5|||
163156057|NCT01198795|589287764|FG000|Overall Study|Protocol Violation|2|||
163156058|NCT01198795|589287764|FG000|Overall Study|Other Reason|4|||
163156059|NCT00706238|589287765|FG000|Overall Study|Disease progression|4|||
163156060|NCT00706238|589287765|FG000|Overall Study|Other|1|||
163156061|NCT00753506|589287766|FG000|Overall Study|Withdrawal by Subject|4|||
163156062|NCT00753506|589287767|FG001|Overall Study|Withdrawal by Subject|1|||
163156063|NCT00753506|589287766|FG000|Overall Study|Lost to Follow-up|2|||
163156064|NCT00753506|589287767|FG001|Overall Study|Lost to Follow-up|0|||
163156065|NCT00753506|589287766|FG000|Overall Study|Other reason|1|||
163156066|NCT00753506|589287767|FG001|Overall Study|Other reason|1|||
163156067|NCT03819114|589287768|FG000|Overall Study|Protocol Violation|0|||
163156068|NCT03819114|589287769|FG001|Overall Study|Protocol Violation|1|||
163156069|NCT03819114|589287770|FG002|Overall Study|Protocol Violation|1|||
163156070|NCT03819114|589287771|FG003|Overall Study|Protocol Violation|0|||
163156071|NCT03819114|589287768|FG000|Overall Study|Lost to Follow-up|0|||
163156072|NCT03819114|589287769|FG001|Overall Study|Lost to Follow-up|0|||
163156073|NCT03819114|589287770|FG002|Overall Study|Lost to Follow-up|1|||
163040829|NCT04530838|588857915|FG001|Overall Study|Other|1|||
163040830|NCT04530838|588857916|FG002|Overall Study|Other|0|||
163040831|NCT04530838|588857914|FG000|Overall Study|Physician Decision|0|||
163040832|NCT04530838|588857915|FG001|Overall Study|Physician Decision|0|||
163040833|NCT04530838|588857916|FG002|Overall Study|Physician Decision|1|||
163156074|NCT03819114|589287771|FG003|Overall Study|Lost to Follow-up|0|||
163040834|NCT04530838|588857914|FG000|Overall Study|Death|0|||
163040835|NCT04530838|588857915|FG001|Overall Study|Death|0|||
163040836|NCT04530838|588857916|FG002|Overall Study|Death|1|||
163040837|NCT04530838|588857914|FG000|Overall Study|Adverse Event|0|||
163040838|NCT04530838|588857915|FG001|Overall Study|Adverse Event|1|||
163040839|NCT04530838|588857916|FG002|Overall Study|Adverse Event|0|||
163040840|NCT04530838|588857914|FG000|Overall Study|No longer meets eligibility criteria|1|||
163040841|NCT04530838|588857915|FG001|Overall Study|No longer meets eligibility criteria|0|||
163040842|NCT04530838|588857916|FG002|Overall Study|No longer meets eligibility criteria|2|||
163040843|NCT04530838|588857914|FG000|Overall Study|Withdrawal by parent/guardian|5|||
163040844|NCT04530838|588857915|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163040845|NCT04530838|588857916|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163040846|NCT02155309|588857921|FG000|Overall Study|Protocol Violation|0|||
163040847|NCT02155309|588857922|FG001|Overall Study|Protocol Violation|0|||
163040848|NCT02155309|588857923|FG002|Overall Study|Protocol Violation|1|||
163040849|NCT02501161|588857925|FG000|Overall Study|Adverse Event|2|||
163040850|NCT02501161|588857926|FG001|Overall Study|Adverse Event|6|||
163040851|NCT02501161|588857925|FG000|Overall Study|Lost to Follow-up|7|||
163040852|NCT02501161|588857926|FG001|Overall Study|Lost to Follow-up|4|||
163040853|NCT02501161|588857925|FG000|Overall Study|Withdrawal by Subject|10|||
163040854|NCT02501161|588857926|FG001|Overall Study|Withdrawal by Subject|15|||
163040855|NCT02501161|588857925|FG000|Overall Study|Other|3|||
163040856|NCT02501161|588857926|FG001|Overall Study|Other|0|||
163040857|NCT04336475|588857927|FG000|Overall Study|pain|1|||
163040858|NCT04336475|588857928|FG001|Overall Study|pain|0|||
163040859|NCT04336475|588857927|FG000|Overall Study|upper respiratory infection|1|||
163040860|NCT04336475|588857928|FG001|Overall Study|upper respiratory infection|0|||
163040861|NCT04336475|588857927|FG000|Overall Study|Lost to Follow-up|0|||
163040862|NCT04336475|588857928|FG001|Overall Study|Lost to Follow-up|2|||
163040863|NCT02030119|588857937|FG000|Overall Study|Withdrawal by Subject|3|||
163040864|NCT02030119|588857938|FG001|Overall Study|Withdrawal by Subject|1|||
163040865|NCT02030119|588857939|FG002|Overall Study|Withdrawal by Subject|5|||
163040866|NCT02030119|588857940|FG003|Overall Study|Withdrawal by Subject|3|||
163040867|NCT02030119|588857937|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
163040868|NCT02030119|588857938|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
163040869|NCT02030119|588857939|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
163040870|NCT02030119|588857940|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
163040871|NCT02213380|588857945|FG000|Underwent Randomization|Withdrawal by Subject|2|||
163040872|NCT02213380|588857946|FG001|Underwent Randomization|Withdrawal by Subject|0|||
163040873|NCT02213380|588857945|FG000|Underwent Randomization|Not treated|3|||
163040874|NCT02213380|588857946|FG001|Underwent Randomization|Not treated|3|||
163040875|NCT02213380|588857945|FG000|Per-protocol Analysis|Protocol Violation|32|||
163040876|NCT02213380|588857946|FG001|Per-protocol Analysis|Protocol Violation|36|||
163040877|NCT00905567|588857955|FG000|Washout|Withdrawal by Subject|0|||
163040878|NCT00905567|588857956|FG001|Washout|Withdrawal by Subject|1|||
163040879|NCT01465230|588857957|FG000|Overall Study|Withdrawal by Subject|2|||
163040880|NCT01738919|588857963|FG000|Overall Study|Lost to Follow-up|1|||
163040881|NCT01738919|588857964|FG001|Overall Study|Lost to Follow-up|0|||
163040882|NCT01738919|588857963|FG000|Overall Study|Immigrated|0|||
163040883|NCT01738919|588857964|FG001|Overall Study|Immigrated|1|||
163040884|NCT01738919|588857963|FG000|Overall Study|Withdrawal by Subject|0|||
163040885|NCT01738919|588857964|FG001|Overall Study|Withdrawal by Subject|1|||
163040886|NCT01738919|588857963|FG000|Overall Study|Not treated in accordance to guidelines|0|||
163040887|NCT01738919|588857964|FG001|Overall Study|Not treated in accordance to guidelines|1|||
162927313|NCT00390572|588437178|FG001|Overall Study|Lost to Follow-up|4|||
162927314|NCT00390572|588437177|FG000|Overall Study|health condition|0|||
162927315|NCT00390572|588437178|FG001|Overall Study|health condition|1|||
162927316|NCT02913261|588437185|FG000|Overall Study|Technical problems|0|||
162927317|NCT02913261|588437186|FG001|Overall Study|Technical problems|1|||
162927318|NCT02913261|588437185|FG000|Overall Study|Lack of Efficacy|32|||
162927319|NCT02913261|588437186|FG001|Overall Study|Lack of Efficacy|69|||
162927320|NCT02913261|588437185|FG000|Overall Study|Adverse Event|27|||
162927321|NCT02913261|588437186|FG001|Overall Study|Adverse Event|5|||
162927322|NCT02913261|588437185|FG000|Overall Study|Death|25|||
163040888|NCT01473940|588857965|FG000|Induction Therapy|Death|0|||
162927323|NCT02913261|588437186|FG001|Overall Study|Death|22|||
162927324|NCT02913261|588437185|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
163040889|NCT01473940|588857966|FG001|Induction Therapy|Death|0|||
163040890|NCT01473940|588857967|FG002|Induction Therapy|Death|1|||
163040891|NCT01473940|588857968|FG003|Induction Therapy|Death|1|||
163040892|NCT01473940|588857965|FG000|Induction Therapy|Progressive Disease|0|||
163040893|NCT01473940|588857966|FG001|Induction Therapy|Progressive Disease|1|||
163040894|NCT01473940|588857967|FG002|Induction Therapy|Progressive Disease|1|||
163040895|NCT01473940|588857968|FG003|Induction Therapy|Progressive Disease|0|||
163040896|NCT01473940|588857965|FG000|Maintenance Therapy|Progressive Disease|1|||
163040897|NCT01473940|588857966|FG001|Maintenance Therapy|Progressive Disease|2|||
163040898|NCT01473940|588857967|FG002|Maintenance Therapy|Progressive Disease|1|||
162927325|NCT02913261|588437186|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
162927326|NCT02913261|588437185|FG000|Overall Study|Disease relapse|8|||
162927327|NCT02913261|588437186|FG001|Overall Study|Disease relapse|13|||
162927328|NCT02913261|588437185|FG000|Overall Study|Physician Decision|8|||
163040899|NCT01473940|588857968|FG003|Maintenance Therapy|Progressive Disease|4|||
163040900|NCT00534248|588857969|FG000|Overall Study|Adverse Event|19|||
163040901|NCT00534248|588857970|FG001|Overall Study|Adverse Event|29|||
163040902|NCT00534248|588857969|FG000|Overall Study|Lost to Follow-up|353|||
163040903|NCT00534248|588857970|FG001|Overall Study|Lost to Follow-up|375|||
163040904|NCT00534248|588857969|FG000|Overall Study|Other protocol specified criteria|13|||
163040905|NCT00534248|588857970|FG001|Overall Study|Other protocol specified criteria|3|||
163040906|NCT00534248|588857969|FG000|Overall Study|Physician Decision|10|||
163040907|NCT00534248|588857970|FG001|Overall Study|Physician Decision|7|||
163040908|NCT00534248|588857969|FG000|Overall Study|Protocol Violation|3|||
163040909|NCT00534248|588857970|FG001|Overall Study|Protocol Violation|4|||
163040910|NCT00534248|588857969|FG000|Overall Study|Withdrawal by Subject|263|||
163040911|NCT00534248|588857970|FG001|Overall Study|Withdrawal by Subject|255|||
163040912|NCT02849171|588857971|FG000|Overall Study|Withdrawal by Subject|1|||
163040913|NCT02849171|588857971|FG000|Overall Study|Not treated|1|||
163040914|NCT02532257|588857972|FG000|Overall Study|Adverse Event|2|||
163040915|NCT02532257|588857972|FG000|Overall Study|Physician Decision|4|||
163040916|NCT02532257|588857972|FG000|Overall Study|Withdrawal by Subject|3|||
163040917|NCT02532257|588857972|FG000|Overall Study|Progressive Disease|10|||
163040918|NCT02259400|588857973|FG000|Overall Study|Death|0|||
163040919|NCT02259400|588857974|FG001|Overall Study|Death|2|||
163040920|NCT03498313|588857978|FG000|Experimental Period 1|Adverse Event|1|||
163040921|NCT03498313|588857979|FG001|Experimental Period 1|Adverse Event|0|||
163040922|NCT03498313|588857980|FG002|Experimental Period 1|Adverse Event|0|||
163040923|NCT03498313|588857981|FG003|Experimental Period 1|Adverse Event|1|||
163040924|NCT03498313|588857982|FG004|Experimental Period 1|Adverse Event|0|||
163040925|NCT03498313|588857983|FG005|Experimental Period 1|Adverse Event|0|||
163040926|NCT03498313|588857978|FG000|Experimental Period 1|Withdrawal by Subject|0|||
163040927|NCT03498313|588857979|FG001|Experimental Period 1|Withdrawal by Subject|1|||
163040928|NCT03498313|588857980|FG002|Experimental Period 1|Withdrawal by Subject|0|||
163040929|NCT03498313|588857981|FG003|Experimental Period 1|Withdrawal by Subject|0|||
163040930|NCT03498313|588857982|FG004|Experimental Period 1|Withdrawal by Subject|0|||
163040931|NCT03498313|588857983|FG005|Experimental Period 1|Withdrawal by Subject|0|||
163040932|NCT03498313|588857978|FG000|Washout Period 1|Anovulation|1|||
163040933|NCT03498313|588857979|FG001|Washout Period 1|Anovulation|0|||
163040934|NCT03498313|588857980|FG002|Washout Period 1|Anovulation|0|||
163040935|NCT03498313|588857981|FG003|Washout Period 1|Anovulation|0|||
163040936|NCT03498313|588857982|FG004|Washout Period 1|Anovulation|0|||
163040937|NCT03498313|588857983|FG005|Washout Period 1|Anovulation|0|||
163040938|NCT03498313|588857978|FG000|Washout Period 1|Withdrawal by Subject|0|||
163040939|NCT03498313|588857979|FG001|Washout Period 1|Withdrawal by Subject|3|||
163040940|NCT03498313|588857980|FG002|Washout Period 1|Withdrawal by Subject|0|||
163040941|NCT03498313|588857981|FG003|Washout Period 1|Withdrawal by Subject|1|||
163156075|NCT04226742|589287772|FG000|Overall Study|Lost to Follow-up|16|||
162927329|NCT02913261|588437186|FG001|Overall Study|Physician Decision|9|||
162927330|NCT02913261|588437185|FG000|Overall Study|Subject/guardian decision|4|||
162927331|NCT02913261|588437186|FG001|Overall Study|Subject/guardian decision|6|||
162927332|NCT02913261|588437185|FG000|Overall Study|Graft loss|2|||
162927333|NCT02913261|588437186|FG001|Overall Study|Graft loss|0|||
162927334|NCT02304302|588437211|FG000|Overall Study|Adverse Event|2|||
162927335|NCT02304302|588437212|FG001|Overall Study|Adverse Event|3|||
162927336|NCT02304302|588437211|FG000|Overall Study|Lost to Follow-up|1|||
162927337|NCT02304302|588437212|FG001|Overall Study|Lost to Follow-up|4|||
162927338|NCT02304302|588437211|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
162927339|NCT02304302|588437212|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
162927340|NCT00391118|588437213|FG000|Overall Study|Adverse Event|3|||
162927341|NCT00391118|588437214|FG001|Overall Study|Adverse Event|10|||
162927342|NCT00391118|588437215|FG002|Overall Study|Adverse Event|7|||
162927343|NCT00391118|588437213|FG000|Overall Study|Lost to Follow-up|0|||
162927344|NCT00391118|588437214|FG001|Overall Study|Lost to Follow-up|2|||
162927345|NCT00391118|588437215|FG002|Overall Study|Lost to Follow-up|3|||
162927346|NCT00391118|588437213|FG000|Overall Study|Withdrawal by Subject|0|||
163040942|NCT03498313|588857982|FG004|Washout Period 1|Withdrawal by Subject|0|||
163040943|NCT03498313|588857983|FG005|Washout Period 1|Withdrawal by Subject|1|||
162696292|NCT00603265|587599458|FG002|Overall Study|Protocol Violation|0|||
162927347|NCT00391118|588437214|FG001|Overall Study|Withdrawal by Subject|9|||
163040944|NCT03498313|588857978|FG000|Experimental Period 2|Adverse Event|0|||
163040945|NCT03498313|588857979|FG001|Experimental Period 2|Adverse Event|0|||
163040946|NCT03498313|588857980|FG002|Experimental Period 2|Adverse Event|0|||
163040947|NCT03498313|588857981|FG003|Experimental Period 2|Adverse Event|0|||
163040948|NCT03498313|588857982|FG004|Experimental Period 2|Adverse Event|1|||
163040949|NCT03498313|588857983|FG005|Experimental Period 2|Adverse Event|2|||
163040950|NCT03498313|588857978|FG000|Washout Period 2|Physician Decision|1|||
162927348|NCT00391118|588437215|FG002|Overall Study|Withdrawal by Subject|1|||
162927349|NCT00391118|588437213|FG000|Overall Study|Death|0|||
162927350|NCT00391118|588437214|FG001|Overall Study|Death|1|||
162927351|NCT00391118|588437215|FG002|Overall Study|Death|0|||
162927352|NCT00391118|588437213|FG000|Overall Study|Physician Decision|0|||
162927353|NCT00391118|588437214|FG001|Overall Study|Physician Decision|3|||
162927354|NCT00391118|588437215|FG002|Overall Study|Physician Decision|0|||
162927355|NCT00391118|588437213|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
162927356|NCT00391118|588437214|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
162927357|NCT00391118|588437215|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
162927358|NCT00391118|588437213|FG000|Overall Study|Progressive Disease|7|||
162927359|NCT00391118|588437214|FG001|Overall Study|Progressive Disease|26|||
162927360|NCT00391118|588437215|FG002|Overall Study|Progressive Disease|43|||
162927361|NCT00391118|588437213|FG000|Overall Study|Sponsor Decision|0|||
162927362|NCT00391118|588437214|FG001|Overall Study|Sponsor Decision|1|||
162927363|NCT00391118|588437215|FG002|Overall Study|Sponsor Decision|3|||
163040951|NCT03498313|588857979|FG001|Washout Period 2|Physician Decision|0|||
163040952|NCT03498313|588857980|FG002|Washout Period 2|Physician Decision|0|||
163040953|NCT03498313|588857981|FG003|Washout Period 2|Physician Decision|1|||
163040954|NCT03498313|588857982|FG004|Washout Period 2|Physician Decision|0|||
163040955|NCT03498313|588857983|FG005|Washout Period 2|Physician Decision|1|||
163040956|NCT03498313|588857978|FG000|Washout Period 2|Withdrawal by Subject|3|||
163040957|NCT03498313|588857979|FG001|Washout Period 2|Withdrawal by Subject|2|||
163040958|NCT03498313|588857980|FG002|Washout Period 2|Withdrawal by Subject|0|||
163040959|NCT03498313|588857981|FG003|Washout Period 2|Withdrawal by Subject|0|||
163040960|NCT03498313|588857982|FG004|Washout Period 2|Withdrawal by Subject|2|||
163040961|NCT03498313|588857983|FG005|Washout Period 2|Withdrawal by Subject|0|||
163040962|NCT03498313|588857978|FG000|Washout Period 2|Anovulation|0|||
163040963|NCT03498313|588857979|FG001|Washout Period 2|Anovulation|0|||
163040964|NCT03498313|588857980|FG002|Washout Period 2|Anovulation|0|||
163040965|NCT03498313|588857981|FG003|Washout Period 2|Anovulation|0|||
163040966|NCT03498313|588857982|FG004|Washout Period 2|Anovulation|0|||
163040967|NCT03498313|588857983|FG005|Washout Period 2|Anovulation|1|||
163040968|NCT02372383|588857989|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
163040969|NCT02372383|588857990|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
163040970|NCT02372383|588857991|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
163040971|NCT03084302|588857994|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
163040972|NCT03084302|588857994|FG000|Overall Study|No valid objective monitor data|6|||
163040973|NCT00621257|588857995|FG000|Overall Study|Lost to Follow-up|4|||
163040974|NCT00621257|588857996|FG001|Overall Study|Lost to Follow-up|0|||
163040975|NCT00621257|588857997|FG002|Overall Study|Lost to Follow-up|2|||
163040976|NCT00621257|588857998|FG003|Overall Study|Lost to Follow-up|4|||
163040977|NCT00621257|588857999|FG004|Overall Study|Lost to Follow-up|7|||
163040978|NCT00621257|588857995|FG000|Overall Study|Adverse Event|0|||
163040979|NCT00621257|588857996|FG001|Overall Study|Adverse Event|1|||
163040980|NCT00621257|588857997|FG002|Overall Study|Adverse Event|1|||
163040981|NCT00621257|588857998|FG003|Overall Study|Adverse Event|0|||
163040982|NCT00621257|588857999|FG004|Overall Study|Adverse Event|0|||
163040983|NCT00621257|588857995|FG000|Overall Study|Physician Decision|0|||
163040984|NCT00621257|588857996|FG001|Overall Study|Physician Decision|2|||
163040985|NCT00621257|588857997|FG002|Overall Study|Physician Decision|0|||
163040986|NCT00621257|588857998|FG003|Overall Study|Physician Decision|1|||
163040987|NCT00621257|588857999|FG004|Overall Study|Physician Decision|1|||
163040988|NCT00621257|588857995|FG000|Overall Study|Withdrawal by Subject|0|||
163040989|NCT00621257|588857996|FG001|Overall Study|Withdrawal by Subject|0|||
163040990|NCT00621257|588857997|FG002|Overall Study|Withdrawal by Subject|0|||
163040991|NCT00621257|588857998|FG003|Overall Study|Withdrawal by Subject|1|||
163040992|NCT00621257|588857999|FG004|Overall Study|Withdrawal by Subject|1|||
163040993|NCT01255904|588858000|FG000|Overall Study|Physician Decision|1|||
163040994|NCT01255904|588858001|FG001|Overall Study|Physician Decision|4|||
163040995|NCT02075008|588858011|FG000|Overall Study|Technical problems|1|||
163040996|NCT02075008|588858011|FG000|Overall Study|Pregnancy|1|||
162927364|NCT00391118|588437213|FG000|Overall Study|Protocol Violation|1|||
162927365|NCT00391118|588437214|FG001|Overall Study|Protocol Violation|0|||
163040997|NCT02075008|588858011|FG000|Overall Study|Physician Decision|1|||
163040998|NCT02075008|588858011|FG000|Overall Study|Lost to Follow-up|1|||
163156076|NCT04226742|589287773|FG001|Overall Study|Lost to Follow-up|13|||
162696293|NCT04399551|587599459|FG000|Overall Study|Adverse Event|15|||
162927366|NCT00391118|588437215|FG002|Overall Study|Protocol Violation|0|||
162927367|NCT03078192|588437218|FG000|Overall Study|Withdrawal by Subject|2|||
162927368|NCT03078192|588437219|FG001|Overall Study|Withdrawal by Subject|1|||
163040999|NCT02075008|588858011|FG000|Overall Study|Lack of Efficacy|1|||
163041000|NCT02075008|588858011|FG000|Overall Study|Death|1|||
163041001|NCT02075008|588858011|FG000|Overall Study|Adverse Event|5|||
163041002|NCT02075008|588858011|FG000|Overall Study|Withdrawal by Subject|6|||
163041003|NCT02075008|588858011|FG000|Overall Study|Study terminated by Sponsor|159|||
163041004|NCT02328937|588858018|FG000|Period 1|Lost to Follow-up|0|||
163041005|NCT02328937|588858019|FG001|Period 1|Lost to Follow-up|0|||
162927369|NCT03078192|588437218|FG000|Overall Study|screen failure|0|||
162927370|NCT03078192|588437219|FG001|Overall Study|screen failure|3|||
162927371|NCT01311505|588437220|FG000|First Intervention Period|Protocol Violation|0|||
162927372|NCT01311505|588437221|FG001|First Intervention Period|Protocol Violation|1|||
162927373|NCT00532779|588437225|FG000|Overall Study|Adverse Event|122|||
162927374|NCT00532779|588437226|FG001|Overall Study|Adverse Event|112|||
162927375|NCT00532779|588437227|FG002|Overall Study|Adverse Event|56|||
162927376|NCT00532779|588437225|FG000|Overall Study|Lost to Follow-up|76|||
162927377|NCT00532779|588437226|FG001|Overall Study|Lost to Follow-up|65|||
162927378|NCT00532779|588437227|FG002|Overall Study|Lost to Follow-up|66|||
162927379|NCT00532779|588437225|FG000|Overall Study|Withdrawal by Subject|63|||
162927380|NCT00532779|588437226|FG001|Overall Study|Withdrawal by Subject|60|||
162927381|NCT00532779|588437227|FG002|Overall Study|Withdrawal by Subject|90|||
162927382|NCT00532779|588437225|FG000|Overall Study|Lack of Efficacy|12|||
162927383|NCT00532779|588437226|FG001|Overall Study|Lack of Efficacy|12|||
162927384|NCT00532779|588437227|FG002|Overall Study|Lack of Efficacy|40|||
162927385|NCT00532779|588437225|FG000|Overall Study|Protocol Violation|5|||
162927386|NCT00532779|588437226|FG001|Overall Study|Protocol Violation|9|||
162927387|NCT00532779|588437227|FG002|Overall Study|Protocol Violation|7|||
162927388|NCT00532779|588437225|FG000|Overall Study|Pregnancy|2|||
162927389|NCT00532779|588437226|FG001|Overall Study|Pregnancy|5|||
162927390|NCT00532779|588437227|FG002|Overall Study|Pregnancy|3|||
162927391|NCT00532779|588437225|FG000|Overall Study|Death|0|||
162927392|NCT00532779|588437226|FG001|Overall Study|Death|1|||
162927393|NCT00532779|588437227|FG002|Overall Study|Death|0|||
162927394|NCT00532779|588437225|FG000|Overall Study|Drug noncompliance, moved, other|14|||
162927395|NCT00532779|588437226|FG001|Overall Study|Drug noncompliance, moved, other|23|||
162927396|NCT00532779|588437227|FG002|Overall Study|Drug noncompliance, moved, other|29|||
162927397|NCT00828516|588437234|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
162927398|NCT00689273|588437235|FG000|Overall Study|Adverse Event|3|||
162927399|NCT00689273|588437236|FG001|Overall Study|Adverse Event|1|||
162927400|NCT00689273|588437235|FG000|Overall Study|Lack of Efficacy|3|||
162927401|NCT00689273|588437236|FG001|Overall Study|Lack of Efficacy|0|||
162927402|NCT00689273|588437235|FG000|Overall Study|Lost to Follow-up|0|||
162927403|NCT00689273|588437236|FG001|Overall Study|Lost to Follow-up|2|||
162927404|NCT00689273|588437235|FG000|Overall Study|Other|6|||
162927405|NCT00689273|588437236|FG001|Overall Study|Other|2|||
162927406|NCT00689273|588437235|FG000|Overall Study|Randomized but not Treated|1|||
162927407|NCT00689273|588437236|FG001|Overall Study|Randomized but not Treated|0|||
162927408|NCT03703297|588437240|FG000|Overall Study|Death|115|||
162927409|NCT03703297|588437241|FG001|Overall Study|Death|0|||
162927410|NCT03703297|588437242|FG002|Overall Study|Death|144|||
162927411|NCT03703297|588437240|FG000|Overall Study|Withdrawal by Subject|9|||
162927412|NCT03703297|588437241|FG001|Overall Study|Withdrawal by Subject|0|||
162927413|NCT03703297|588437242|FG002|Overall Study|Withdrawal by Subject|11|||
162927414|NCT03703297|588437240|FG000|Overall Study|Ongoing at the time of DCO|140|||
162927415|NCT03703297|588437241|FG001|Overall Study|Ongoing at the time of DCO|200|||
162927416|NCT03703297|588437242|FG002|Overall Study|Ongoing at the time of DCO|111|||
162927417|NCT02414854|588439112|FG000|Overall Study|Adverse Event|9|||
162927418|NCT02414854|588439113|FG001|Overall Study|Adverse Event|7|||
162927419|NCT02414854|588439114|FG002|Overall Study|Adverse Event|1|||
162927420|NCT02414854|588439115|FG003|Overall Study|Adverse Event|12|||
162927421|NCT02414854|588439112|FG000|Overall Study|Poor compliance to protocol|1|||
162927422|NCT02414854|588439113|FG001|Overall Study|Poor compliance to protocol|1|||
162927423|NCT02414854|588439114|FG002|Overall Study|Poor compliance to protocol|2|||
162927424|NCT02414854|588439115|FG003|Overall Study|Poor compliance to protocol|2|||
162927425|NCT02414854|588439112|FG000|Overall Study|Other than specified above|12|||
162927426|NCT02414854|588439113|FG001|Overall Study|Other than specified above|37|||
162927427|NCT02414854|588439114|FG002|Overall Study|Other than specified above|17|||
162927428|NCT02414854|588439115|FG003|Overall Study|Other than specified above|37|||
162927429|NCT01355523|588439116|FG000|Overall Study|Withdrawal by Subject|1|||
162927430|NCT01355523|588439117|FG001|Overall Study|Withdrawal by Subject|4|||
162927431|NCT01355523|588439116|FG000|Overall Study|Lost to Follow-up|0|||
162927432|NCT01355523|588439117|FG001|Overall Study|Lost to Follow-up|2|||
162927433|NCT01355523|588439116|FG000|Overall Study|Protocol Violation|0|||
162927434|NCT01355523|588439117|FG001|Overall Study|Protocol Violation|2|||
162927435|NCT01355523|588439116|FG000|Overall Study|Adverse Event|0|||
162927436|NCT01355523|588439117|FG001|Overall Study|Adverse Event|2|||
162927437|NCT01726335|588439120|FG000|Overall Study|Lost to Follow-up|2|||
162927438|NCT01726335|588439120|FG000|Overall Study|Withdrawal by Subject|15|||
162927439|NCT01726335|588439120|FG000|Overall Study|Adverse Event|4|||
162927440|NCT01726335|588439120|FG000|Overall Study|Lost to Follow-up|2|||
162927441|NCT01726335|588439120|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
162927442|NCT01586624|588439121|FG000|Overall Study|Adverse Event|3|||
162927443|NCT01586624|588439122|FG001|Overall Study|Adverse Event|0|||
162927444|NCT01586624|588439123|FG002|Overall Study|Adverse Event|2|||
162927445|NCT01586624|588439124|FG003|Overall Study|Adverse Event|1|||
162927446|NCT01586624|588439125|FG004|Overall Study|Adverse Event|3|||
162927447|NCT01586624|588439126|FG005|Overall Study|Adverse Event|3|||
162927448|NCT01586624|588439127|FG006|Overall Study|Adverse Event|2|||
162927449|NCT01586624|588439128|FG007|Overall Study|Adverse Event|3|||
162927450|NCT01586624|588439121|FG000|Overall Study|Physician Decision|0|||
162927451|NCT01586624|588439122|FG001|Overall Study|Physician Decision|1|||
162927452|NCT01586624|588439123|FG002|Overall Study|Physician Decision|1|||
162927453|NCT01586624|588439124|FG003|Overall Study|Physician Decision|0|||
162927454|NCT01586624|588439125|FG004|Overall Study|Physician Decision|2|||
162927455|NCT01586624|588439126|FG005|Overall Study|Physician Decision|0|||
162927456|NCT01586624|588439127|FG006|Overall Study|Physician Decision|1|||
162927457|NCT01586624|588439128|FG007|Overall Study|Physician Decision|1|||
162927458|NCT01586624|588439121|FG000|Overall Study|Withdrawal by Subject|0|||
162927459|NCT01586624|588439122|FG001|Overall Study|Withdrawal by Subject|0|||
162927460|NCT01586624|588439123|FG002|Overall Study|Withdrawal by Subject|0|||
162927461|NCT01586624|588439124|FG003|Overall Study|Withdrawal by Subject|1|||
162927462|NCT01586624|588439125|FG004|Overall Study|Withdrawal by Subject|0|||
162927463|NCT01586624|588439126|FG005|Overall Study|Withdrawal by Subject|0|||
162927464|NCT01586624|588439127|FG006|Overall Study|Withdrawal by Subject|0|||
162927465|NCT01586624|588439128|FG007|Overall Study|Withdrawal by Subject|0|||
162927466|NCT01586624|588439121|FG000|Overall Study|Evidence of disease progression|1|||
162927467|NCT01586624|588439122|FG001|Overall Study|Evidence of disease progression|3|||
162927468|NCT01586624|588439123|FG002|Overall Study|Evidence of disease progression|2|||
162927469|NCT01586624|588439124|FG003|Overall Study|Evidence of disease progression|5|||
162927470|NCT01586624|588439125|FG004|Overall Study|Evidence of disease progression|3|||
162927471|NCT01586624|588439126|FG005|Overall Study|Evidence of disease progression|5|||
162927472|NCT01586624|588439127|FG006|Overall Study|Evidence of disease progression|4|||
162927473|NCT01586624|588439128|FG007|Overall Study|Evidence of disease progression|6|||
162927474|NCT01586624|588439121|FG000|Overall Study|Screen failure (no treatment received)|0|||
162927475|NCT01586624|588439122|FG001|Overall Study|Screen failure (no treatment received)|0|||
162927476|NCT01586624|588439123|FG002|Overall Study|Screen failure (no treatment received)|0|||
162927477|NCT01586624|588439124|FG003|Overall Study|Screen failure (no treatment received)|0|||
162927478|NCT01586624|588439125|FG004|Overall Study|Screen failure (no treatment received)|0|||
162927479|NCT01586624|588439126|FG005|Overall Study|Screen failure (no treatment received)|0|||
162927480|NCT01586624|588439127|FG006|Overall Study|Screen failure (no treatment received)|1|||
162927481|NCT01586624|588439128|FG007|Overall Study|Screen failure (no treatment received)|0|||
162927482|NCT01074307|588439130|FG000|Overall Study|No primary endpoint evaluation|14|||
162927483|NCT01074307|588439131|FG001|Overall Study|No primary endpoint evaluation|6|||
162927484|NCT01074307|588439130|FG000|Overall Study|Exclusion criterion|0|||
162927485|NCT01074307|588439131|FG001|Overall Study|Exclusion criterion|1|||
162927486|NCT01074307|588439130|FG000|Overall Study|Protocol Violation|8|||
162927487|NCT01074307|588439131|FG001|Overall Study|Protocol Violation|5|||
162927488|NCT01408576|588439136|FG000|Overall Study|Lack of Efficacy|17|||
162927489|NCT01408576|588439137|FG001|Overall Study|Lack of Efficacy|30|||
162927490|NCT01408576|588439138|FG002|Overall Study|Lack of Efficacy|48|||
162927491|NCT01408576|588439136|FG000|Overall Study|Protocol Violation|1|||
162927492|NCT01408576|588439137|FG001|Overall Study|Protocol Violation|2|||
162927493|NCT01408576|588439138|FG002|Overall Study|Protocol Violation|2|||
162927494|NCT01408576|588439136|FG000|Overall Study|Lost to Follow-up|10|||
162927495|NCT01408576|588439137|FG001|Overall Study|Lost to Follow-up|9|||
162927496|NCT01408576|588439138|FG002|Overall Study|Lost to Follow-up|17|||
162927497|NCT01408576|588439136|FG000|Overall Study|Withdrawal by Subject|34|||
162927498|NCT01408576|588439137|FG001|Overall Study|Withdrawal by Subject|60|||
162927499|NCT01408576|588439138|FG002|Overall Study|Withdrawal by Subject|66|||
162927500|NCT01408576|588439136|FG000|Overall Study|Sponsor terminated study|89|||
162927501|NCT01408576|588439137|FG001|Overall Study|Sponsor terminated study|333|||
162927502|NCT01408576|588439138|FG002|Overall Study|Sponsor terminated study|330|||
162927503|NCT01408576|588439136|FG000|Overall Study|AE, serious fatal|4|||
162927504|NCT01408576|588439137|FG001|Overall Study|AE, serious fatal|4|||
162927505|NCT01408576|588439138|FG002|Overall Study|AE, serious fatal|1|||
162927506|NCT01408576|588439136|FG000|Overall Study|SAE, non-fatal|11|||
162927507|NCT01408576|588439137|FG001|Overall Study|SAE, non-fatal|23|||
162927508|NCT01408576|588439138|FG002|Overall Study|SAE, non-fatal|14|||
162927509|NCT01408576|588439136|FG000|Overall Study|AE, non-serious non-fatal|12|||
162927510|NCT01408576|588439137|FG001|Overall Study|AE, non-serious non-fatal|19|||
162927511|NCT01408576|588439138|FG002|Overall Study|AE, non-serious non-fatal|11|||
162927512|NCT01408576|588439136|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162927513|NCT01408576|588439137|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162927514|NCT01408576|588439138|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162927515|NCT01408576|588439136|FG000|Overall Study|AE, unknown type|0|||
162927516|NCT01408576|588439137|FG001|Overall Study|AE, unknown type|1|||
162927517|NCT01408576|588439138|FG002|Overall Study|AE, unknown type|0|||
162927518|NCT01408576|588439136|FG000|Overall Study|Other|10|||
162927519|NCT01408576|588439137|FG001|Overall Study|Other|16|||
162927520|NCT01408576|588439138|FG002|Overall Study|Other|18|||
162927521|NCT02703454|588439142|FG000|Overall Study|Not treated|1|||
162927522|NCT02703454|588439143|FG001|Overall Study|Not treated|3|||
162927523|NCT02703454|588439142|FG000|Overall Study|Withdrawal by Subject|4|||
162927524|NCT02703454|588439143|FG001|Overall Study|Withdrawal by Subject|3|||
162927525|NCT02703454|588439142|FG000|Overall Study|Lost to Follow-up|1|||
162927526|NCT02703454|588439143|FG001|Overall Study|Lost to Follow-up|2|||
162927527|NCT02703454|588439142|FG000|Overall Study|Study discontinuation|5|||
162927528|NCT02703454|588439143|FG001|Overall Study|Study discontinuation|8|||
162927529|NCT02284373|588439144|FG000|Overall Study|Withdrawal by Subject|0|||
162927530|NCT02284373|588439145|FG001|Overall Study|Withdrawal by Subject|1|||
162927531|NCT02284373|588439146|FG002|Overall Study|Withdrawal by Subject|0|||
162927532|NCT02284373|588439144|FG000|Overall Study|Other|0|||
162927533|NCT02284373|588439145|FG001|Overall Study|Other|1|||
162927534|NCT02284373|588439146|FG002|Overall Study|Other|0|||
162927535|NCT02284373|588439144|FG000|Overall Study|Lost to Follow-up|0|||
162927536|NCT02284373|588439145|FG001|Overall Study|Lost to Follow-up|1|||
162927537|NCT02284373|588439146|FG002|Overall Study|Lost to Follow-up|0|||
162927538|NCT02016755|588439147|FG000|Overall Study|Major amputation of index limb|2|||
162927539|NCT02016755|588439147|FG000|Overall Study|Adverse Event|2|||
162927540|NCT02016755|588439147|FG000|Overall Study|Physician Decision|1|||
162927541|NCT02016755|588439147|FG000|Overall Study|Death|2|||
162927542|NCT02476851|588439148|FG000|Overall Study|Protocol Violation|1|||
162927543|NCT02476851|588439149|FG001|Overall Study|Protocol Violation|1|||
162927544|NCT02360397|588439157|FG000|Overall Study|Incomplete screening|3|||
162927545|NCT02360397|588439157|FG000|Overall Study|Adverse Event|1|||
162927546|NCT03543046|588439160|FG000|Overall Study|Adverse Event|1|||
162927547|NCT03543046|588439161|FG001|Overall Study|Adverse Event|1|||
162927548|NCT03543046|588439160|FG000|Overall Study|Physician Decision|1|||
162927549|NCT03543046|588439161|FG001|Overall Study|Physician Decision|1|||
162927550|NCT03543046|588439160|FG000|Overall Study|Protocol Violation|1|||
162927551|NCT03543046|588439161|FG001|Overall Study|Protocol Violation|0|||
162927552|NCT03174925|588439162|FG000|Overall Study|Elastographic images not retrievable|2|||
162927553|NCT03174925|588439162|FG000|Overall Study|Elastography image not interpretable|1|||
162927554|NCT04247594|588439163|FG000|Overall Study|Withdrawal by Subject|4|||
162927555|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
162927556|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
162927557|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
162927558|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
162927559|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
162927560|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
162927561|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
162927562|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
162927563|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927564|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927565|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927566|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
162927567|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
162927568|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927569|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927570|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
162927571|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
162927572|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
162927573|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
162927574|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
162927575|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
162927576|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
162927577|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
162927578|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
162927579|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
162927580|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927581|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
162927582|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927583|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
162927584|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927585|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927586|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
162927587|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
162927588|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927589|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
162927590|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
162927591|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
163041006|NCT02328937|588858020|FG002|Period 1|Lost to Follow-up|0|||
163041007|NCT02328937|588858021|FG003|Period 1|Lost to Follow-up|1|||
163041008|NCT02328937|588858022|FG004|Period 1|Lost to Follow-up|0|||
163041009|NCT02328937|588858023|FG005|Period 1|Lost to Follow-up|0|||
163041010|NCT02328937|588858018|FG000|Period 2|Adverse Event|0|||
163041011|NCT02328937|588858019|FG001|Period 2|Adverse Event|0|||
163041012|NCT02328937|588858020|FG002|Period 2|Adverse Event|1|||
163041013|NCT02328937|588858021|FG003|Period 2|Adverse Event|0|||
163041014|NCT02328937|588858022|FG004|Period 2|Adverse Event|0|||
163041015|NCT02328937|588858023|FG005|Period 2|Adverse Event|0|||
163041016|NCT00435461|588858028|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
163041017|NCT00435461|588858029|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
163041018|NCT00435461|588858030|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
163041019|NCT00435461|588858028|FG000|Overall Study|Protocol Violation|6|||
163041020|NCT00435461|588858029|FG001|Overall Study|Protocol Violation|9|||
163041021|NCT00435461|588858030|FG002|Overall Study|Protocol Violation|10|||
163041022|NCT00435461|588858028|FG000|Overall Study|Participant randomized(inadequate score)|1|||
163041023|NCT00435461|588858029|FG001|Overall Study|Participant randomized(inadequate score)|0|||
163041024|NCT00435461|588858030|FG002|Overall Study|Participant randomized(inadequate score)|0|||
163041025|NCT00435461|588858028|FG000|Overall Study|Compliance less than 80 percent|1|||
163041026|NCT00435461|588858029|FG001|Overall Study|Compliance less than 80 percent|0|||
163041027|NCT00435461|588858030|FG002|Overall Study|Compliance less than 80 percent|0|||
163041028|NCT00435461|588858028|FG000|Overall Study|In error, two study medications switched|1|||
163041029|NCT00435461|588858029|FG001|Overall Study|In error, two study medications switched|0|||
163041030|NCT00435461|588858030|FG002|Overall Study|In error, two study medications switched|0|||
163041031|NCT00435461|588858028|FG000|Overall Study|Lack of Efficacy|2|||
163041032|NCT00435461|588858029|FG001|Overall Study|Lack of Efficacy|1|||
163041033|NCT00435461|588858030|FG002|Overall Study|Lack of Efficacy|0|||
163041034|NCT00435461|588858028|FG000|Overall Study|Withdrawal by Subject|1|||
163041035|NCT00435461|588858029|FG001|Overall Study|Withdrawal by Subject|0|||
163041036|NCT00435461|588858030|FG002|Overall Study|Withdrawal by Subject|2|||
163041037|NCT00435461|588858028|FG000|Overall Study|Randomized in error|1|||
163041038|NCT00435461|588858029|FG001|Overall Study|Randomized in error|0|||
163041039|NCT00435461|588858030|FG002|Overall Study|Randomized in error|0|||
163041040|NCT00435461|588858028|FG000|Overall Study|Participant could not tolerate symptoms|0|||
163041041|NCT00435461|588858029|FG001|Overall Study|Participant could not tolerate symptoms|0|||
163041042|NCT00435461|588858030|FG002|Overall Study|Participant could not tolerate symptoms|1|||
163041043|NCT00435461|588858028|FG000|Overall Study|Participant could not swallow capsule|0|||
163041044|NCT00435461|588858029|FG001|Overall Study|Participant could not swallow capsule|0|||
163041045|NCT00435461|588858030|FG002|Overall Study|Participant could not swallow capsule|1|||
163041046|NCT00435461|588858028|FG000|Overall Study|Pregnancy|2|||
163041047|NCT00435461|588858029|FG001|Overall Study|Pregnancy|0|||
163041048|NCT00435461|588858030|FG002|Overall Study|Pregnancy|0|||
163041049|NCT00435461|588858028|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
163041050|NCT00435461|588858029|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
163041051|NCT00435461|588858030|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
163041052|NCT00435461|588858028|FG000|Overall Study|Participant ended study one day early|1|||
163041053|NCT00435461|588858029|FG001|Overall Study|Participant ended study one day early|0|||
163041054|NCT00435461|588858030|FG002|Overall Study|Participant ended study one day early|0|||
163041055|NCT00435461|588858028|FG000|Overall Study|Noncompliance with study requirements|1|||
163041056|NCT00435461|588858029|FG001|Overall Study|Noncompliance with study requirements|1|||
163041057|NCT00435461|588858030|FG002|Overall Study|Noncompliance with study requirements|1|||
163041058|NCT00435461|588858028|FG000|Overall Study|Adverse Event|1|||
163041059|NCT00435461|588858029|FG001|Overall Study|Adverse Event|2|||
163041060|NCT00435461|588858030|FG002|Overall Study|Adverse Event|6|||
163041061|NCT00435461|588858028|FG000|Overall Study|Non-Compliance of diary|2|||
163041062|NCT00435461|588858029|FG001|Overall Study|Non-Compliance of diary|0|||
163041063|NCT00435461|588858030|FG002|Overall Study|Non-Compliance of diary|1|||
163041064|NCT00435461|588858028|FG000|Overall Study|Lost to Follow-up|1|||
163041065|NCT00435461|588858029|FG001|Overall Study|Lost to Follow-up|1|||
163041066|NCT00435461|588858030|FG002|Overall Study|Lost to Follow-up|2|||
163041067|NCT02782377|588858033|FG000|Overall Study|Physician Decision|5|||
163041068|NCT01188668|588858037|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
163041069|NCT01188668|588858037|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
162696294|NCT04399551|587599459|FG000|Overall Study|Withdrawal by Subject|6|||
162696295|NCT04399551|587599459|FG000|Overall Study|Physician Decision|3|||
163041070|NCT01188668|588858037|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
163041071|NCT02588092|588858051|FG000|Overall Study|Death|4|||
163041072|NCT02588092|588858052|FG001|Overall Study|Death|3|||
163041073|NCT02588092|588858053|FG002|Overall Study|Death|3|||
163041074|NCT02588092|588858054|FG003|Overall Study|Death|3|||
163041075|NCT02588092|588858055|FG004|Overall Study|Death|2|||
163041076|NCT02588092|588858056|FG005|Overall Study|Death|2|||
163041077|NCT02588092|588858057|FG006|Overall Study|Death|2|||
163041078|NCT02588092|588858058|FG007|Overall Study|Death|1|||
163041079|NCT02588092|588858059|FG008|Overall Study|Death|5|||
163041080|NCT02588092|588858060|FG009|Overall Study|Death|2|||
163041081|NCT02588092|588858051|FG000|Overall Study|Withdrawal by Subject|0|||
163156077|NCT04226742|589287772|FG000|Overall Study|Withdrawal by Subject|5|||
163156078|NCT04226742|589287773|FG001|Overall Study|Withdrawal by Subject|3|||
163156079|NCT05097963|589287776|FG000|Overall Study|Protocol Violation|13|||
163156080|NCT05097963|589287776|FG000|Overall Study|Withdrawal by Subject|21|||
163156081|NCT02492763|589287777|FG000|Overall Study|Withdrawal by Subject|0|||
163156082|NCT02492763|589287778|FG001|Overall Study|Withdrawal by Subject|2|||
163156083|NCT02492763|589287779|FG002|Overall Study|Withdrawal by Subject|1|||
163156084|NCT02492763|589287780|FG003|Overall Study|Withdrawal by Subject|0|||
163156085|NCT02492763|589287777|FG000|Overall Study|Adverse Event|3|||
163156086|NCT02492763|589287778|FG001|Overall Study|Adverse Event|1|||
163156087|NCT02492763|589287779|FG002|Overall Study|Adverse Event|1|||
163156088|NCT02492763|589287780|FG003|Overall Study|Adverse Event|2|||
163156089|NCT02492763|589287777|FG000|Overall Study|Death|0|||
163156090|NCT02492763|589287778|FG001|Overall Study|Death|0|||
163156091|NCT02492763|589287779|FG002|Overall Study|Death|1|||
163156092|NCT02492763|589287780|FG003|Overall Study|Death|0|||
163156093|NCT02492763|589287777|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
163156094|NCT02492763|589287778|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
163156095|NCT02492763|589287779|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
163156096|NCT02492763|589287780|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
162927592|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927593|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
162927594|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
162927595|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927596|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927597|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
162927598|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
162927599|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927600|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
162927601|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
162927602|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
162927603|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
162927604|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
162927605|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927606|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
162927607|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927608|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927609|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927610|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
162927611|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
162927612|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
162927613|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
162927614|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
162927615|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
162927616|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
162927617|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
162927618|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
162927619|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
162927620|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
162927621|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
162927622|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
162927623|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
162927624|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
163156097|NCT02492763|589287777|FG000|Overall Study|Lost to Follow-up|0|||
163156098|NCT02492763|589287778|FG001|Overall Study|Lost to Follow-up|0|||
163156099|NCT02492763|589287779|FG002|Overall Study|Lost to Follow-up|1|||
163156100|NCT02492763|589287780|FG003|Overall Study|Lost to Follow-up|0|||
163156101|NCT02492763|589287777|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163156102|NCT02492763|589287778|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163156103|NCT02492763|589287779|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163156104|NCT02492763|589287780|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163156105|NCT02492763|589287777|FG000|Overall Study|Screen Failure|0|||
163156106|NCT02492763|589287778|FG001|Overall Study|Screen Failure|0|||
163156107|NCT02492763|589287779|FG002|Overall Study|Screen Failure|0|||
163156108|NCT02492763|589287780|FG003|Overall Study|Screen Failure|1|||
163156109|NCT02492763|589287777|FG000|Overall Study|Study Terminated by Sponsor|13|||
163156110|NCT02492763|589287778|FG001|Overall Study|Study Terminated by Sponsor|10|||
163156111|NCT02492763|589287779|FG002|Overall Study|Study Terminated by Sponsor|6|||
163156112|NCT02492763|589287780|FG003|Overall Study|Study Terminated by Sponsor|10|||
163156113|NCT01193244|589287781|FG000|Overall Study|Withdrawal by Subject|79|||
163156114|NCT01193244|589287782|FG001|Overall Study|Withdrawal by Subject|97|||
163156115|NCT01193244|589287781|FG000|Overall Study|Other|303|||
163156116|NCT01193244|589287782|FG001|Overall Study|Other|278|||
163156117|NCT01193244|589287781|FG000|Overall Study|Lost to Follow-up|6|||
163156118|NCT01193244|589287782|FG001|Overall Study|Lost to Follow-up|15|||
163156119|NCT03848832|589287783|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
163156120|NCT03848832|589287784|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
163156121|NCT03848832|589287785|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
163156122|NCT03848832|589287783|FG000|Overall Study|Withdrawal by Subject|0|||
163156123|NCT03848832|589287784|FG001|Overall Study|Withdrawal by Subject|0|||
163156124|NCT03848832|589287785|FG002|Overall Study|Withdrawal by Subject|1|||
163156125|NCT03848832|589287783|FG000|Overall Study|Withdrawal (Covid-19)|0|||
163156126|NCT03848832|589287784|FG001|Overall Study|Withdrawal (Covid-19)|2|||
163156127|NCT03848832|589287785|FG002|Overall Study|Withdrawal (Covid-19)|0|||
163156128|NCT03848832|589287783|FG000|Overall Study|Physician Decision|2|||
163156129|NCT03848832|589287784|FG001|Overall Study|Physician Decision|1|||
163156130|NCT03848832|589287785|FG002|Overall Study|Physician Decision|3|||
163156131|NCT03848832|589287783|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
163156132|NCT03848832|589287784|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
163156133|NCT03848832|589287785|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
163156134|NCT03848832|589287783|FG000|Overall Study|Adverse Event|1|||
163156135|NCT03848832|589287784|FG001|Overall Study|Adverse Event|0|||
163156136|NCT03848832|589287785|FG002|Overall Study|Adverse Event|0|||
163156137|NCT00865566|589287786|FG000|Overall Study|Death|1|||
163156138|NCT00865566|589287787|FG001|Overall Study|Death|11|||
163156139|NCT00865566|589287786|FG000|Overall Study|Lost to Follow-up|314|||
163156140|NCT00865566|589287787|FG001|Overall Study|Lost to Follow-up|315|||
163156141|NCT00865566|589287786|FG000|Overall Study|Withdrawal by Subject|45|||
163156142|NCT00865566|589287787|FG001|Overall Study|Withdrawal by Subject|65|||
163156143|NCT00865566|589287786|FG000|Overall Study|Physician Decision|0|||
163156144|NCT00865566|589287787|FG001|Overall Study|Physician Decision|1|||
163156145|NCT00865566|589287786|FG000|Overall Study|Participant relocated|78|||
163156146|NCT00865566|589287787|FG001|Overall Study|Participant relocated|107|||
163156147|NCT00865566|589287786|FG000|Overall Study|Participant unable to adhere|27|||
163156148|NCT00865566|589287787|FG001|Overall Study|Participant unable to adhere|42|||
163156149|NCT00865566|589287786|FG000|Overall Study|Other; N=245 due to early study closure|154|||
163156150|NCT00865566|589287787|FG001|Overall Study|Other; N=245 due to early study closure|139|||
163156151|NCT00865566|589287786|FG000|Overall Study|HIV infection|5|||
163156152|NCT00865566|589287787|FG001|Overall Study|HIV infection|7|||
163156153|NCT01039376|589287788|FG000|Overall Study|Lost to Follow-up|5|||
163156154|NCT01039376|589287789|FG001|Overall Study|Lost to Follow-up|12|||
163156155|NCT01039376|589287788|FG000|Overall Study|Physician Decision|15|||
163156156|NCT01039376|589287789|FG001|Overall Study|Physician Decision|10|||
163156157|NCT01039376|589287788|FG000|Overall Study|Withdrawal by Subject|20|||
163156158|NCT01039376|589287789|FG001|Overall Study|Withdrawal by Subject|32|||
163156159|NCT01039376|589287788|FG000|Overall Study|Study terminated by Sponsor|90|||
163156160|NCT01039376|589287789|FG001|Overall Study|Study terminated by Sponsor|72|||
163156161|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
163156162|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
163156163|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Adverse Event|31|||
163156164|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Adverse Event|21|||
163156165|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
163156166|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
163156167|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
163156168|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
163156169|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
163156170|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
163156171|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
163156172|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
163156173|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Administrative problems|3|||
163156174|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Administrative problems|3|||
163156175|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Death|5|||
163156176|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Death|8|||
163156177|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Disease progression|139|||
163156178|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Disease progression|119|||
163156179|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
163156180|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
163156181|NCT00785785|589287790|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
163156182|NCT00785785|589287791|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
163156183|NCT00785785|589287790|FG000|Optional Extension Phase|Adverse Event|4|||
163156184|NCT00785785|589287791|FG001|Optional Extension Phase|Adverse Event|5|||
163156185|NCT00785785|589287790|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
163156186|NCT00785785|589287791|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
163156187|NCT00785785|589287790|FG000|Optional Extension Phase|Lost to Follow-up|1|||
163156188|NCT00785785|589287791|FG001|Optional Extension Phase|Lost to Follow-up|0|||
163156189|NCT00785785|589287790|FG000|Optional Extension Phase|Administrative problems|2|||
163156190|NCT00785785|589287791|FG001|Optional Extension Phase|Administrative problems|0|||
163156191|NCT00785785|589287790|FG000|Optional Extension Phase|Death|1|||
163156192|NCT00785785|589287791|FG001|Optional Extension Phase|Death|5|||
163156193|NCT00785785|589287790|FG000|Optional Extension Phase|Disease progression|22|||
163156194|NCT00785785|589287791|FG001|Optional Extension Phase|Disease progression|70|||
163156195|NCT00785785|589287790|FG000|Optional Extension Phase|Protocol deviation|0|||
163156196|NCT00785785|589287791|FG001|Optional Extension Phase|Protocol deviation|2|||
163156197|NCT00785785|589287790|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
163156198|NCT00785785|589287791|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
163156199|NCT03252925|589287792|FG000|Overall Study|Withdrawal by Subject|1|||
163156200|NCT03252925|589287793|FG001|Overall Study|Withdrawal by Subject|0|||
163156201|NCT03252925|589287792|FG000|Overall Study|Protocol Violation|6|||
163156202|NCT03252925|589287793|FG001|Overall Study|Protocol Violation|0|||
163156203|NCT03252925|589287792|FG000|Overall Study|Adverse Event|1|||
163156204|NCT03252925|589287793|FG001|Overall Study|Adverse Event|0|||
163156205|NCT03252925|589287792|FG000|Overall Study|Lost to Follow-up|6|||
163156206|NCT03252925|589287793|FG001|Overall Study|Lost to Follow-up|6|||
163156207|NCT01244893|589287794|FG000|Baseline|Protocol Violation|0|||
163156208|NCT01244893|589287795|FG001|Baseline|Protocol Violation|1|||
163156209|NCT01244893|589287794|FG000|1-Week Follow Up|Lost to Follow-up|1|||
163156210|NCT01244893|589287795|FG001|1-Week Follow Up|Lost to Follow-up|0|||
163156211|NCT00357552|589287796|FG000|Screening|Did not meet eligibility criteria|84|||
163156212|NCT00357552|589287796|FG000|Weeks 0 to 24|Death|1|||
163156213|NCT00357552|589287796|FG000|Weeks 24 to 104|Death|3|||
163156214|NCT00357552|589287796|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
163156215|NCT00521404|589287799|FG000|Overall Study|Adverse Event|13|||
163156216|NCT00521404|589287799|FG000|Overall Study|Disease Progression|33|||
163156217|NCT00521404|589287799|FG000|Overall Study|Investigator decision|5|||
163156218|NCT00521404|589287799|FG000|Overall Study|Withdrawal of consent|3|||
163156219|NCT00521404|589287799|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
163156220|NCT00521404|589287799|FG000|Overall Study|Other|7|||
163156221|NCT04555616|589287800|FG000|Overall Study|Death|1|||
163156222|NCT04555616|589287801|FG001|Overall Study|Death|0|||
163156223|NCT04555616|589287802|FG002|Overall Study|Death|1|||
163156224|NCT04555616|589287800|FG000|Overall Study|Withdrawal by Subject|2|||
163156225|NCT04555616|589287801|FG001|Overall Study|Withdrawal by Subject|1|||
163156226|NCT04555616|589287802|FG002|Overall Study|Withdrawal by Subject|0|||
163156227|NCT00882557|589287805|FG000|Overall Study|Withdrawal by Subject|1|||
163156228|NCT00882557|589287806|FG001|Overall Study|Withdrawal by Subject|0|||
163156229|NCT00882557|589287805|FG000|Overall Study|Trouble with Vein Access|1|||
163156230|NCT00882557|589287806|FG001|Overall Study|Trouble with Vein Access|0|||
163156231|NCT00882557|589287805|FG000|Overall Study|Randomized Not Treated|0|||
163156232|NCT00882557|589287806|FG001|Overall Study|Randomized Not Treated|1|||
163156233|NCT02282605|589287807|FG000|Overall Study|negative SA result on Day -1|3|||
163156234|NCT02282605|589287808|FG001|Overall Study|negative SA result on Day -1|0|||
163156235|NCT02282605|589287809|FG002|Overall Study|negative SA result on Day -1|0|||
163156236|NCT00711191|589287810|FG000|Overall Study|Adverse Event|1|||
163156237|NCT00711191|589287811|FG001|Overall Study|Adverse Event|1|||
163156238|NCT00711191|589287812|FG002|Overall Study|Adverse Event|2|||
163156239|NCT00711191|589287810|FG000|Overall Study|Objective progression or relapse|2|||
163156240|NCT00711191|589287811|FG001|Overall Study|Objective progression or relapse|3|||
163156241|NCT00711191|589287812|FG002|Overall Study|Objective progression or relapse|7|||
163156242|NCT00711191|589287810|FG000|Overall Study|Withdrawal by Subject|0|||
163156243|NCT00711191|589287811|FG001|Overall Study|Withdrawal by Subject|1|||
163156244|NCT00711191|589287812|FG002|Overall Study|Withdrawal by Subject|3|||
163156245|NCT02404025|589287813|FG000|Overall Study|Adverse Event|1|||
163156246|NCT02404025|589287813|FG000|Overall Study|Lack of Efficacy|3|||
163156247|NCT01744977|589287815|FG000|Overall Study|Withdrawal by Subject|1|||
163156248|NCT01744977|589287816|FG001|Overall Study|Withdrawal by Subject|2|||
163156249|NCT01744977|589287815|FG000|Overall Study|Death|2|||
163156250|NCT01744977|589287816|FG001|Overall Study|Death|3|||
163156251|NCT01744977|589287815|FG000|Overall Study|Lost to Follow-up|2|||
163156252|NCT01744977|589287816|FG001|Overall Study|Lost to Follow-up|0|||
163156253|NCT01744977|589287815|FG000|Overall Study|No longer meets inclusion|6|||
163156254|NCT01744977|589287816|FG001|Overall Study|No longer meets inclusion|0|||
163156255|NCT01750229|589287819|FG000|Randomized Crossover Phase|Adverse Event|1|||
163156256|NCT01750229|589287819|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
163156257|NCT01750229|589287819|FG000|Long-term Follow-up Phase|Adverse Event|2|||
163156258|NCT01750229|589287819|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
163156259|NCT03774576|589287820|FG000|Period 2|Adverse Event|1|||
163156260|NCT01746901|589287821|FG000|Naloxone Challenge Phase|Adverse Event|2|||
163156261|NCT01746901|589287822|FG001|Naloxone Challenge Phase|Adverse Event|0|||
163156262|NCT01746901|589287823|FG002|Naloxone Challenge Phase|Adverse Event|0|||
163156263|NCT01746901|589287824|FG003|Naloxone Challenge Phase|Adverse Event|0|||
163156264|NCT01746901|589287825|FG004|Naloxone Challenge Phase|Adverse Event|0|||
163156265|NCT01746901|589287826|FG005|Naloxone Challenge Phase|Adverse Event|0|||
163156266|NCT01746901|589287827|FG006|Naloxone Challenge Phase|Adverse Event|0|||
163156267|NCT01746901|589287828|FG007|Naloxone Challenge Phase|Adverse Event|0|||
163156268|NCT01746901|589287829|FG008|Naloxone Challenge Phase|Adverse Event|0|||
163156269|NCT01746901|589287821|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
163156270|NCT01746901|589287822|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156271|NCT01746901|589287823|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156272|NCT01746901|589287824|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156273|NCT01746901|589287825|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156274|NCT01746901|589287826|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156275|NCT01746901|589287827|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156276|NCT01746901|589287828|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156277|NCT01746901|589287829|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
163156278|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156279|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
163156280|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156281|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162927625|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
162927626|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
162927627|NCT04440163|588439165|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
162927628|NCT04440163|588439166|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
162927629|NCT04440163|588439167|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
162927630|NCT04440163|588439168|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
162927631|NCT04440163|588439169|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
162927632|NCT04440163|588439170|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
162927633|NCT04440163|588439171|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
162927634|NCT04440163|588439172|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
162927635|NCT04440163|588439165|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
162927636|NCT04440163|588439166|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
162927637|NCT04440163|588439167|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927638|NCT04440163|588439168|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927639|NCT04440163|588439169|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
163156282|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162927640|NCT04440163|588439170|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
162927641|NCT04440163|588439171|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
162927642|NCT04440163|588439172|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
162927643|NCT04440163|588439165|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927644|NCT04440163|588439166|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927645|NCT04440163|588439167|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927646|NCT04440163|588439168|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
162927647|NCT04440163|588439169|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927648|NCT04440163|588439170|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927649|NCT04440163|588439171|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927650|NCT04440163|588439172|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
162927651|NCT00589693|588439176|FG000|Overall Study|randomized in error|12|||
162927652|NCT00589693|588439177|FG001|Overall Study|randomized in error|6|||
162927653|NCT00589693|588439176|FG000|Overall Study|Adverse Event|4|||
162927654|NCT00589693|588439177|FG001|Overall Study|Adverse Event|4|||
162927655|NCT00589693|588439176|FG000|Overall Study|Death|26|||
162927656|NCT00589693|588439177|FG001|Overall Study|Death|16|||
162927657|NCT00589693|588439176|FG000|Overall Study|Lack of Efficacy|0|||
162927658|NCT00589693|588439177|FG001|Overall Study|Lack of Efficacy|1|||
162927659|NCT00589693|588439176|FG000|Overall Study|Lost to Follow-up|1|||
162927660|NCT00589693|588439177|FG001|Overall Study|Lost to Follow-up|0|||
162927661|NCT00589693|588439176|FG000|Overall Study|Physician Decision|0|||
162927662|NCT00589693|588439177|FG001|Overall Study|Physician Decision|1|||
163156283|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156284|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156285|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156286|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
163156287|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162696296|NCT04399551|587599459|FG000|Overall Study|Lost to Follow-up|2|||
162927663|NCT00589693|588439176|FG000|Overall Study|Protocol Violation|1|||
162927664|NCT00589693|588439177|FG001|Overall Study|Protocol Violation|1|||
162927665|NCT01128153|588439178|FG000|Overall Study|Adverse Event|1|||
163156288|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
163156289|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
163156290|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156291|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156292|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156293|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156294|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156295|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
163156296|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156297|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
163156298|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
163156299|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156300|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156301|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156302|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156303|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156304|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
163156305|NCT01746901|589287821|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156306|NCT01746901|589287822|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
163156307|NCT01746901|589287823|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
163156308|NCT01746901|589287824|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156309|NCT01746901|589287825|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162927666|NCT01128153|588439179|FG001|Overall Study|Adverse Event|3|||
162927667|NCT01128153|588439178|FG000|Overall Study|Condition under investigation worsened|8|||
162927668|NCT01128153|588439179|FG001|Overall Study|Condition under investigation worsened|7|||
162927669|NCT01128153|588439178|FG000|Overall Study|Withdrawal by Subject|2|||
162927670|NCT01128153|588439179|FG001|Overall Study|Withdrawal by Subject|3|||
162927671|NCT01128153|588439178|FG000|Overall Study|Incorrect enrolment to study|2|||
162927672|NCT01128153|588439179|FG001|Overall Study|Incorrect enrolment to study|1|||
162927673|NCT01128153|588439178|FG000|Overall Study|Protocol Violation|2|||
162927674|NCT01128153|588439179|FG001|Overall Study|Protocol Violation|0|||
162927675|NCT01128153|588439178|FG000|Overall Study|Developed discontinuation criteria|1|||
162927676|NCT01128153|588439179|FG001|Overall Study|Developed discontinuation criteria|1|||
162927677|NCT01954082|588439180|FG000|Overall Study|Study Suspension|42|||
162927678|NCT01954082|588439181|FG001|Overall Study|Study Suspension|36|||
162927679|NCT01954082|588439180|FG000|Overall Study|Adverse Event|10|||
162927680|NCT01954082|588439181|FG001|Overall Study|Adverse Event|4|||
162927681|NCT01954082|588439180|FG000|Overall Study|Intolerance|0|||
162927682|NCT01954082|588439181|FG001|Overall Study|Intolerance|1|||
162927683|NCT01954082|588439180|FG000|Overall Study|Non-compliance|6|||
162927684|NCT01954082|588439181|FG001|Overall Study|Non-compliance|4|||
162927685|NCT01954082|588439180|FG000|Overall Study|Physician Decision|2|||
162927686|NCT01954082|588439181|FG001|Overall Study|Physician Decision|0|||
162927687|NCT01954082|588439180|FG000|Overall Study|Parent Decision|1|||
162927688|NCT01954082|588439181|FG001|Overall Study|Parent Decision|0|||
162927689|NCT01954082|588439180|FG000|Overall Study|Withdrawal by Subject|0|||
162927690|NCT01954082|588439181|FG001|Overall Study|Withdrawal by Subject|1|||
162927691|NCT01954082|588439180|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
162927692|NCT01954082|588439181|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
162927693|NCT01954082|588439180|FG000|Overall Study|Redirection of Care|0|||
162927694|NCT01954082|588439181|FG001|Overall Study|Redirection of Care|2|||
162927695|NCT01954082|588439180|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
162927696|NCT01954082|588439181|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
162927697|NCT01954082|588439180|FG000|Overall Study|Comfort Care|0|||
162927698|NCT01954082|588439181|FG001|Overall Study|Comfort Care|1|||
162927699|NCT01954082|588439180|FG000|Overall Study|Infant Moved|0|||
162927700|NCT01954082|588439181|FG001|Overall Study|Infant Moved|1|||
162927701|NCT01954082|588439180|FG000|Overall Study|Randomized not Treated|4|||
162927702|NCT01954082|588439181|FG001|Overall Study|Randomized not Treated|2|||
162927703|NCT01682512|588439182|FG000|Overall Study|Adverse Event|6|||
163156310|NCT01746901|589287826|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156311|NCT01746901|589287827|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156312|NCT01746901|589287828|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
163156313|NCT01746901|589287829|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162927704|NCT01682512|588439183|FG001|Overall Study|Adverse Event|5|||
162927705|NCT01682512|588439184|FG002|Overall Study|Adverse Event|2|||
162927706|NCT01682512|588439182|FG000|Overall Study|Withdrawal by Subject|2|||
162927707|NCT01682512|588439183|FG001|Overall Study|Withdrawal by Subject|6|||
162927708|NCT01682512|588439184|FG002|Overall Study|Withdrawal by Subject|3|||
162927709|NCT01682512|588439182|FG000|Overall Study|Physician Decision|0|||
162927710|NCT01682512|588439183|FG001|Overall Study|Physician Decision|2|||
162927711|NCT01682512|588439184|FG002|Overall Study|Physician Decision|0|||
162927712|NCT01682512|588439182|FG000|Overall Study|Study terminated by sponsor|46|||
162927713|NCT01682512|588439183|FG001|Overall Study|Study terminated by sponsor|43|||
162927714|NCT01682512|588439184|FG002|Overall Study|Study terminated by sponsor|0|||
162927715|NCT01682512|588439182|FG000|Overall Study|Lost to Follow-up|3|||
162927716|NCT01682512|588439183|FG001|Overall Study|Lost to Follow-up|0|||
162927717|NCT01682512|588439184|FG002|Overall Study|Lost to Follow-up|2|||
162927718|NCT01682512|588439182|FG000|Overall Study|Protocol Violation|2|||
162927719|NCT01682512|588439183|FG001|Overall Study|Protocol Violation|3|||
162927720|NCT01682512|588439184|FG002|Overall Study|Protocol Violation|2|||
162927721|NCT01682512|588439182|FG000|Overall Study|Primary lack of efficacy|10|||
162927722|NCT01682512|588439183|FG001|Overall Study|Primary lack of efficacy|7|||
162927723|NCT01682512|588439184|FG002|Overall Study|Primary lack of efficacy|7|||
162927724|NCT01682512|588439182|FG000|Overall Study|Secondary lack of efficacy|1|||
162927725|NCT01682512|588439183|FG001|Overall Study|Secondary lack of efficacy|1|||
162927726|NCT01682512|588439184|FG002|Overall Study|Secondary lack of efficacy|0|||
162927727|NCT01682512|588439182|FG000|Overall Study|Other than stated above|2|||
162927728|NCT01682512|588439183|FG001|Overall Study|Other than stated above|4|||
162927729|NCT01682512|588439184|FG002|Overall Study|Other than stated above|2|||
162927730|NCT01377233|588439185|FG000|Open-label|Adverse Event|1|||
162927731|NCT01377233|588439186|FG001|Open-label|Adverse Event|0|||
162927732|NCT01377233|588439187|FG002|Open-label|Adverse Event|0|||
162927733|NCT01377233|588439188|FG003|Open-label|Adverse Event|0|||
162927734|NCT01377233|588439189|FG004|Open-label|Adverse Event|0|||
162927735|NCT01377233|588439185|FG000|Open-label|Withdrawal by Subject|3|||
162927736|NCT01377233|588439186|FG001|Open-label|Withdrawal by Subject|0|||
162927737|NCT01377233|588439187|FG002|Open-label|Withdrawal by Subject|0|||
162927738|NCT01377233|588439188|FG003|Open-label|Withdrawal by Subject|0|||
162927739|NCT01377233|588439189|FG004|Open-label|Withdrawal by Subject|0|||
162927740|NCT01377233|588439185|FG000|Double-blind|Adverse Event|0|||
162927741|NCT01377233|588439186|FG001|Double-blind|Adverse Event|1|||
162927742|NCT01377233|588439187|FG002|Double-blind|Adverse Event|2|||
162927743|NCT01377233|588439188|FG003|Double-blind|Adverse Event|2|||
162927744|NCT01377233|588439189|FG004|Double-blind|Adverse Event|0|||
162927745|NCT01377233|588439185|FG000|Double-blind|Protocol Violation|0|||
162927746|NCT01377233|588439186|FG001|Double-blind|Protocol Violation|0|||
162927747|NCT01377233|588439187|FG002|Double-blind|Protocol Violation|0|||
162927748|NCT01377233|588439188|FG003|Double-blind|Protocol Violation|0|||
162927749|NCT01377233|588439189|FG004|Double-blind|Protocol Violation|1|||
162927750|NCT01377233|588439185|FG000|Double-blind|Withdrawal by Subject|0|||
162927751|NCT01377233|588439186|FG001|Double-blind|Withdrawal by Subject|0|||
162927752|NCT01377233|588439187|FG002|Double-blind|Withdrawal by Subject|0|||
163156314|NCT01746901|589287821|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
163156315|NCT01746901|589287822|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
163156316|NCT01746901|589287823|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
163156317|NCT01746901|589287824|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
163156318|NCT01746901|589287825|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
163156319|NCT01746901|589287826|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
163156320|NCT01746901|589287827|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
163156321|NCT01746901|589287828|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
163156322|NCT01746901|589287829|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
163156323|NCT01746901|589287821|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156324|NCT01746901|589287822|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156325|NCT01746901|589287823|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156326|NCT01746901|589287824|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156327|NCT01746901|589287825|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156328|NCT01746901|589287826|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156329|NCT01746901|589287827|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156330|NCT01746901|589287828|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
163156331|NCT01746901|589287829|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
163156332|NCT01746901|589287821|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156333|NCT01746901|589287822|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156334|NCT01746901|589287823|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156335|NCT01746901|589287824|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156336|NCT01746901|589287825|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156337|NCT01746901|589287826|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
163156338|NCT01746901|589287827|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
163156339|NCT01746901|589287828|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
163156340|NCT01746901|589287829|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
162927753|NCT01377233|588439188|FG003|Double-blind|Withdrawal by Subject|1|||
162927754|NCT01377233|588439189|FG004|Double-blind|Withdrawal by Subject|0|||
162927755|NCT01377233|588439185|FG000|Double-blind|Administrative or other|0|||
162927756|NCT01377233|588439186|FG001|Double-blind|Administrative or other|0|||
163156341|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162927757|NCT01377233|588439187|FG002|Double-blind|Administrative or other|0|||
163156342|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156343|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156344|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
163156345|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156346|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156347|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156348|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156349|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
163156350|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156351|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156352|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156353|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156354|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156355|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
162927758|NCT01377233|588439188|FG003|Double-blind|Administrative or other|1|||
162927759|NCT01377233|588439189|FG004|Double-blind|Administrative or other|1|||
162927760|NCT00417027|588439190|FG000|Overall Study|Protocol Violation|0|||
162927761|NCT00417027|588439191|FG001|Overall Study|Protocol Violation|5|||
162927762|NCT00417027|588439192|FG002|Overall Study|Protocol Violation|5|||
162927763|NCT03137082|588439193|FG000|Overall Study|Withdrawal by Subject|1|||
162927764|NCT03137082|588439194|FG001|Overall Study|Withdrawal by Subject|1|||
162927765|NCT03137082|588439193|FG000|Overall Study|Lost to Follow-up|1|||
162927766|NCT03137082|588439194|FG001|Overall Study|Lost to Follow-up|0|||
162927767|NCT02787785|588439195|FG000|Overall Study|Death|3|||
162927768|NCT02787785|588439196|FG001|Overall Study|Death|4|||
162927769|NCT02787785|588439195|FG000|Overall Study|Lost to Follow-up|1|||
162927770|NCT02787785|588439196|FG001|Overall Study|Lost to Follow-up|1|||
162927771|NCT02787785|588439195|FG000|Overall Study|Withdrawal by Subject|0|||
162927772|NCT02787785|588439196|FG001|Overall Study|Withdrawal by Subject|5|||
162927773|NCT01440595|588439207|FG000|Overall Study|Lost to Follow-up|0|||
162927774|NCT01440595|588439208|FG001|Overall Study|Lost to Follow-up|1|||
162927775|NCT01440595|588439209|FG002|Overall Study|Lost to Follow-up|0|||
162927776|NCT01440595|588439207|FG000|Overall Study|Study terminated by sponsor.|1|||
162927777|NCT01440595|588439208|FG001|Overall Study|Study terminated by sponsor.|2|||
162927778|NCT01440595|588439209|FG002|Overall Study|Study terminated by sponsor.|1|||
162927779|NCT01447628|588439212|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927780|NCT01447628|588439213|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927781|NCT01447628|588439214|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
162927782|NCT01447628|588439215|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
162927783|NCT00965263|588439226|FG000|Overall Study|Physician Decision|2|||
162927784|NCT00965263|588439227|FG001|Overall Study|Physician Decision|0|||
162927785|NCT00965263|588439226|FG000|Overall Study|Family emergency|0|||
162927786|NCT00965263|588439227|FG001|Overall Study|Family emergency|1|||
162927787|NCT00965263|588439226|FG000|Overall Study|Protocol Violation|0|||
162927788|NCT00965263|588439227|FG001|Overall Study|Protocol Violation|2|||
162927789|NCT03959137|588439228|FG000|Overall Study|Protocol Violation|6|||
162927790|NCT03496207|588439229|FG000|Base Study|Adverse Event|0|||
162927791|NCT03496207|588439230|FG001|Base Study|Adverse Event|0|||
162927792|NCT03496207|588439231|FG002|Base Study|Adverse Event|1|||
162927793|NCT03496207|588439232|FG003|Base Study|Adverse Event|1|||
162927794|NCT03496207|588439233|FG004|Base Study|Adverse Event|4|||
162927795|NCT03496207|588439229|FG000|Base Study|Death|0|||
162927796|NCT03496207|588439230|FG001|Base Study|Death|0|||
162927797|NCT03496207|588439231|FG002|Base Study|Death|0|||
162927798|NCT03496207|588439232|FG003|Base Study|Death|0|||
162927799|NCT03496207|588439233|FG004|Base Study|Death|1|||
162927800|NCT03496207|588439229|FG000|Base Study|Withdrawal by Subject|0|||
162927801|NCT03496207|588439230|FG001|Base Study|Withdrawal by Subject|0|||
162927802|NCT03496207|588439231|FG002|Base Study|Withdrawal by Subject|1|||
162927803|NCT03496207|588439232|FG003|Base Study|Withdrawal by Subject|0|||
162927804|NCT03496207|588439233|FG004|Base Study|Withdrawal by Subject|1|||
162927805|NCT03496207|588439229|FG000|Extension Period|Adverse Event|0|||
162927806|NCT03496207|588439230|FG001|Extension Period|Adverse Event|0|||
162927807|NCT03496207|588439231|FG002|Extension Period|Adverse Event|0|||
162927808|NCT03496207|588439232|FG003|Extension Period|Adverse Event|1|||
162927809|NCT03496207|588439233|FG004|Extension Period|Adverse Event|1|||
162927810|NCT03496207|588439229|FG000|Extension Period|Death|1|||
162927811|NCT03496207|588439230|FG001|Extension Period|Death|0|||
162927812|NCT03496207|588439231|FG002|Extension Period|Death|0|||
162927813|NCT03496207|588439232|FG003|Extension Period|Death|1|||
162927814|NCT03496207|588439233|FG004|Extension Period|Death|2|||
162927815|NCT03496207|588439229|FG000|Extension Period|Withdrawal by Subject|1|||
162927816|NCT03496207|588439230|FG001|Extension Period|Withdrawal by Subject|0|||
162927817|NCT03496207|588439231|FG002|Extension Period|Withdrawal by Subject|0|||
162927818|NCT03496207|588439232|FG003|Extension Period|Withdrawal by Subject|1|||
162927819|NCT03496207|588439233|FG004|Extension Period|Withdrawal by Subject|1|||
162927820|NCT03496207|588439229|FG000|Extension Period|Elevated hemoglobin levels|0|||
162927821|NCT03496207|588439230|FG001|Extension Period|Elevated hemoglobin levels|0|||
162927822|NCT03496207|588439231|FG002|Extension Period|Elevated hemoglobin levels|0|||
162927823|NCT03496207|588439232|FG003|Extension Period|Elevated hemoglobin levels|0|||
162927824|NCT03496207|588439233|FG004|Extension Period|Elevated hemoglobin levels|1|||
162927825|NCT02756078|588439234|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
162927826|NCT02756078|588439235|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
162927827|NCT02756078|588439234|FG000|Period 1|Lost to Follow-up|0|||
162927828|NCT02756078|588439235|FG001|Period 1|Lost to Follow-up|2|||
162927829|NCT02756078|588439234|FG000|Period 1|Protocol Violation|0|||
162927830|NCT02756078|588439235|FG001|Period 1|Protocol Violation|1|||
162927831|NCT02756078|588439234|FG000|Period 1|Adverse Event|1|||
162927832|NCT02756078|588439235|FG001|Period 1|Adverse Event|10|||
162927833|NCT02756078|588439234|FG000|Period 1|Withdrawal by Subject|6|||
162927834|NCT02756078|588439235|FG001|Period 1|Withdrawal by Subject|6|||
162927835|NCT02756078|588439234|FG000|Period 1|Lens Discomfort|2|||
162927836|NCT02756078|588439235|FG001|Period 1|Lens Discomfort|2|||
162927837|NCT02756078|588439234|FG000|Period 2|Adverse Event|3|||
162927838|NCT02756078|588439235|FG001|Period 2|Adverse Event|5|||
162927839|NCT02756078|588439234|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
162927840|NCT02756078|588439235|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
162927841|NCT02756078|588439234|FG000|Period 2|Withdrawal by Subject|3|||
162927842|NCT02756078|588439235|FG001|Period 2|Withdrawal by Subject|1|||
162927843|NCT00810615|588439236|FG000|Overall Study|Withdrawal by Subject|1|||
162927844|NCT00810615|588439237|FG001|Overall Study|Withdrawal by Subject|1|||
162927845|NCT02058368|588439241|FG000|Overall Study|Adverse Event|15|||
162927846|NCT02058368|588439242|FG001|Overall Study|Adverse Event|20|||
162927847|NCT02058368|588439241|FG000|Overall Study|Lack of Efficacy|0|||
162927848|NCT02058368|588439242|FG001|Overall Study|Lack of Efficacy|1|||
162927849|NCT02058368|588439241|FG000|Overall Study|Protocol Violation|0|||
162927850|NCT02058368|588439242|FG001|Overall Study|Protocol Violation|4|||
162927851|NCT02058368|588439241|FG000|Overall Study|Lost to Follow-up|2|||
162927852|NCT02058368|588439242|FG001|Overall Study|Lost to Follow-up|0|||
162927853|NCT02058368|588439241|FG000|Overall Study|Physician Decision|2|||
162927854|NCT02058368|588439242|FG001|Overall Study|Physician Decision|3|||
162927855|NCT02058368|588439241|FG000|Overall Study|Withdrawal by Subject|22|||
162927856|NCT02058368|588439242|FG001|Overall Study|Withdrawal by Subject|26|||
162927857|NCT02181842|588439243|FG000|Overall Study|Case Report Forms Uncollected|2|||
163041082|NCT02588092|588858052|FG001|Overall Study|Withdrawal by Subject|0|||
163041083|NCT02588092|588858053|FG002|Overall Study|Withdrawal by Subject|0|||
163041084|NCT02588092|588858054|FG003|Overall Study|Withdrawal by Subject|0|||
163041085|NCT02588092|588858055|FG004|Overall Study|Withdrawal by Subject|0|||
163041086|NCT02588092|588858056|FG005|Overall Study|Withdrawal by Subject|1|||
163041087|NCT02588092|588858057|FG006|Overall Study|Withdrawal by Subject|1|||
163041088|NCT02588092|588858058|FG007|Overall Study|Withdrawal by Subject|2|||
163041089|NCT02588092|588858059|FG008|Overall Study|Withdrawal by Subject|0|||
163041090|NCT02588092|588858060|FG009|Overall Study|Withdrawal by Subject|0|||
163041091|NCT02588092|588858051|FG000|Overall Study|Started Another Treatment|0|||
163041092|NCT02588092|588858052|FG001|Overall Study|Started Another Treatment|0|||
163041093|NCT02588092|588858053|FG002|Overall Study|Started Another Treatment|0|||
163041094|NCT02588092|588858054|FG003|Overall Study|Started Another Treatment|0|||
163041095|NCT02588092|588858055|FG004|Overall Study|Started Another Treatment|1|||
163041096|NCT02588092|588858056|FG005|Overall Study|Started Another Treatment|0|||
163041097|NCT02588092|588858057|FG006|Overall Study|Started Another Treatment|0|||
163041098|NCT02588092|588858058|FG007|Overall Study|Started Another Treatment|1|||
163041099|NCT02588092|588858059|FG008|Overall Study|Started Another Treatment|0|||
163041100|NCT02588092|588858060|FG009|Overall Study|Started Another Treatment|0|||
163041101|NCT02588092|588858051|FG000|Overall Study|Sponsor Decision|0|||
163041102|NCT02588092|588858052|FG001|Overall Study|Sponsor Decision|0|||
163156356|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
163156357|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162927858|NCT02441179|588439244|FG000|Overall Study|Withdrawal by Subject|1|||
162927859|NCT02441179|588439245|FG001|Overall Study|Withdrawal by Subject|1|||
162927860|NCT01488071|588439246|FG000|Overall Study|Adverse Event|15|||
163156358|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
163156359|NCT01746901|589287821|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156360|NCT01746901|589287822|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156361|NCT01746901|589287823|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156362|NCT01746901|589287824|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156363|NCT01746901|589287825|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156364|NCT01746901|589287826|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156365|NCT01746901|589287827|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
163156366|NCT01746901|589287828|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
163156367|NCT01746901|589287829|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
163156368|NCT03594110|589287830|FG000|Interventional Part|Participant concerned about study treatment|23|||
163156369|NCT03594110|589287831|FG001|Interventional Part|Participant concerned about study treatment|28|||
163156370|NCT03594110|589287830|FG000|Interventional Part|Doctor advice|38|||
163156371|NCT03594110|589287831|FG001|Interventional Part|Doctor advice|40|||
163156372|NCT03594110|589287830|FG000|Interventional Part|Participants' wish|89|||
163156373|NCT03594110|589287831|FG001|Interventional Part|Participants' wish|68|||
163156374|NCT03594110|589287830|FG000|Interventional Part|Adverse event-non-fatal events|119|||
163156375|NCT03594110|589287831|FG001|Interventional Part|Adverse event-non-fatal events|116|||
163156376|NCT03594110|589287830|FG000|Interventional Part|Study drug stopped, reason missing|336|||
163156377|NCT03594110|589287831|FG001|Interventional Part|Study drug stopped, reason missing|294|||
163156378|NCT03594110|589287830|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
163156379|NCT03594110|589287831|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
163156380|NCT03594110|589287830|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
163156381|NCT03594110|589287831|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
163156382|NCT03594110|589287830|FG000|Interventional Part|Contraindicated drug started|32|||
163156383|NCT03594110|589287831|FG001|Interventional Part|Contraindicated drug started|18|||
163156384|NCT03594110|589287830|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
163156385|NCT03594110|589287831|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
163156386|NCT03594110|589287830|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
163156387|NCT03594110|589287831|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
163156388|NCT03594110|589287830|FG000|Non-interventional Part|Withdrawal by Subject|3|||
163156389|NCT03594110|589287831|FG001|Non-interventional Part|Withdrawal by Subject|4|||
163156390|NCT03594110|589287830|FG000|Non-interventional Part|Lost to Follow-up|45|||
163156391|NCT03594110|589287831|FG001|Non-interventional Part|Lost to Follow-up|41|||
163156392|NCT03041038|589287832|FG000|Overall Study|Withdrawal by Subject|4|||
163156393|NCT03041038|589287833|FG001|Overall Study|Withdrawal by Subject|0|||
163156394|NCT03041038|589287832|FG000|Overall Study|Lost to Follow-up|1|||
163156395|NCT03041038|589287833|FG001|Overall Study|Lost to Follow-up|1|||
163156396|NCT03041038|589287832|FG000|Overall Study|Protocol Violation|1|||
163156397|NCT03041038|589287833|FG001|Overall Study|Protocol Violation|1|||
163156398|NCT02796170|589287834|FG000|Overall Study|Lost to Follow-up|3|||
163156399|NCT02796170|589287835|FG001|Overall Study|Lost to Follow-up|0|||
163156400|NCT01527370|589287836|FG000|Overall Study|Withdrawal by Subject|4|||
163156401|NCT01527370|589287836|FG000|Overall Study|Physician Decision|1|||
163156402|NCT01527370|589287836|FG000|Overall Study|Death|1|||
163156403|NCT02177032|589287837|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
163156404|NCT02177032|589287838|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
163156405|NCT02177032|589287839|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
163156406|NCT02177032|589287840|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
163156407|NCT02177032|589287837|FG000|Overall Study|Lost to Follow-up|0|||
163156408|NCT02177032|589287838|FG001|Overall Study|Lost to Follow-up|2|||
163156409|NCT02177032|589287839|FG002|Overall Study|Lost to Follow-up|0|||
163156410|NCT02177032|589287840|FG003|Overall Study|Lost to Follow-up|0|||
163156411|NCT02177032|589287837|FG000|Overall Study|OTHER|2|||
163156412|NCT02177032|589287838|FG001|Overall Study|OTHER|0|||
163156413|NCT02177032|589287839|FG002|Overall Study|OTHER|1|||
163156414|NCT02177032|589287840|FG003|Overall Study|OTHER|0|||
163156415|NCT02177032|589287837|FG000|Overall Study|Withdrawal by Subject|1|||
163156416|NCT02177032|589287838|FG001|Overall Study|Withdrawal by Subject|0|||
163156417|NCT02177032|589287839|FG002|Overall Study|Withdrawal by Subject|1|||
163156418|NCT02177032|589287840|FG003|Overall Study|Withdrawal by Subject|0|||
163156419|NCT00930046|589287841|FG000|Overall Study|Wound catheter malfunctioned|1|||
163156420|NCT00930046|589287842|FG001|Overall Study|Wound catheter malfunctioned|2|||
163156421|NCT01598532|589287843|FG000|Overall Study|Lost to Follow-up|3|||
163156422|NCT01598532|589287843|FG000|Overall Study|Did not meet inclusion criteria|8|||
163156423|NCT00912808|589287844|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
163156424|NCT00912808|589287845|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163156425|NCT00912808|589287844|FG000|Washout|Withdrawal by Subject|0|||
163156426|NCT00912808|589287845|FG001|Washout|Withdrawal by Subject|1|||
163156427|NCT00912808|589287844|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163156428|NCT00912808|589287845|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
163156429|NCT00912808|589287844|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
163156430|NCT00912808|589287845|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
163156431|NCT04798196|589287849|FG000|Overall Study|Lost to Follow-up|3|||
163156432|NCT04798196|589287850|FG001|Overall Study|Lost to Follow-up|1|||
163156433|NCT04798196|589287851|FG002|Overall Study|Lost to Follow-up|3|||
163156434|NCT01249261|589287852|FG000|Overall Study|Withdrawal by Subject|1|||
163156435|NCT01249261|589287853|FG001|Overall Study|Withdrawal by Subject|0|||
163156436|NCT01967940|589287860|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156437|NCT01967940|589287861|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156438|NCT01967940|589287862|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
163156439|NCT01967940|589287863|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
163156440|NCT01967940|589287860|FG000|Part 2|Adverse Event|0|||
163156441|NCT01967940|589287861|FG001|Part 2|Adverse Event|0|||
163156442|NCT01967940|589287862|FG002|Part 2|Adverse Event|0|||
163156443|NCT01967940|589287863|FG003|Part 2|Adverse Event|1|||
163156444|NCT01967940|589287860|FG000|Part 2|Unknown Reason|0|||
163156445|NCT01967940|589287861|FG001|Part 2|Unknown Reason|0|||
163156446|NCT01967940|589287862|FG002|Part 2|Unknown Reason|0|||
163156447|NCT01967940|589287863|FG003|Part 2|Unknown Reason|1|||
163156448|NCT01550003|589287864|FG000|Overall Study|Adverse Event|0|||
163156449|NCT01550003|589287865|FG001|Overall Study|Adverse Event|9|||
163156450|NCT01550003|589287866|FG002|Overall Study|Adverse Event|15|||
163156451|NCT01550003|589287864|FG000|Overall Study|Lack of Efficacy|4|||
163156452|NCT01550003|589287865|FG001|Overall Study|Lack of Efficacy|11|||
163156453|NCT01550003|589287866|FG002|Overall Study|Lack of Efficacy|15|||
163156454|NCT01550003|589287864|FG000|Overall Study|Protocol Violation|0|||
163156455|NCT01550003|589287865|FG001|Overall Study|Protocol Violation|3|||
163156456|NCT01550003|589287866|FG002|Overall Study|Protocol Violation|2|||
163156457|NCT01550003|589287864|FG000|Overall Study|Lost to Follow-up|1|||
163156458|NCT01550003|589287865|FG001|Overall Study|Lost to Follow-up|4|||
163156459|NCT01550003|589287866|FG002|Overall Study|Lost to Follow-up|8|||
163156460|NCT01550003|589287864|FG000|Overall Study|Consent withdrawn|2|||
163156461|NCT01550003|589287865|FG001|Overall Study|Consent withdrawn|11|||
163156462|NCT01550003|589287866|FG002|Overall Study|Consent withdrawn|23|||
163156463|NCT01550003|589287864|FG000|Overall Study|Missing|1|||
163156464|NCT01550003|589287865|FG001|Overall Study|Missing|0|||
163156465|NCT01550003|589287866|FG002|Overall Study|Missing|2|||
163156466|NCT01550003|589287864|FG000|Overall Study|Study closure as announced by sponsor|7|||
163156467|NCT01550003|589287865|FG001|Overall Study|Study closure as announced by sponsor|6|||
163156468|NCT01550003|589287866|FG002|Overall Study|Study closure as announced by sponsor|24|||
163156469|NCT01550003|589287864|FG000|Overall Study|Protocol Noncompliance|1|||
163156470|NCT01550003|589287865|FG001|Overall Study|Protocol Noncompliance|0|||
163156471|NCT01550003|589287866|FG002|Overall Study|Protocol Noncompliance|0|||
163156472|NCT01550003|589287864|FG000|Overall Study|Study closure|0|||
163156473|NCT01550003|589287865|FG001|Overall Study|Study closure|1|||
163156474|NCT01550003|589287866|FG002|Overall Study|Study closure|1|||
163156475|NCT01550003|589287864|FG000|Overall Study|Patient reached adulthood|0|||
163156476|NCT01550003|589287865|FG001|Overall Study|Patient reached adulthood|1|||
163156477|NCT01550003|589287866|FG002|Overall Study|Patient reached adulthood|0|||
163156478|NCT01550003|589287864|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
163156479|NCT01550003|589287865|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
163156480|NCT01550003|589287866|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
163156481|NCT01550003|589287864|FG000|Overall Study|Sponsor's order|0|||
163156482|NCT01550003|589287865|FG001|Overall Study|Sponsor's order|3|||
163156483|NCT01550003|589287866|FG002|Overall Study|Sponsor's order|3|||
163156484|NCT01550003|589287864|FG000|Overall Study|Sponsor's decision|1|||
163156485|NCT01550003|589287865|FG001|Overall Study|Sponsor's decision|5|||
163156486|NCT01550003|589287866|FG002|Overall Study|Sponsor's decision|4|||
163156487|NCT01550003|589287864|FG000|Overall Study|Subject mother passed away|0|||
163156488|NCT01550003|589287865|FG001|Overall Study|Subject mother passed away|1|||
163156489|NCT01550003|589287866|FG002|Overall Study|Subject mother passed away|0|||
163156490|NCT01550003|589287864|FG000|Overall Study|Discontinuation|0|||
163156491|NCT01550003|589287865|FG001|Overall Study|Discontinuation|1|||
163156492|NCT01550003|589287866|FG002|Overall Study|Discontinuation|0|||
163156493|NCT01550003|589287864|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
162927861|NCT01488071|588439247|FG001|Overall Study|Adverse Event|23|||
163156494|NCT01550003|589287865|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
163156495|NCT01550003|589287866|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
163156496|NCT01550003|589287864|FG000|Overall Study|Site closure|0|||
163156497|NCT01550003|589287865|FG001|Overall Study|Site closure|2|||
163156498|NCT01550003|589287866|FG002|Overall Study|Site closure|0|||
163156499|NCT01550003|589287864|FG000|Overall Study|Pregnancy|0|||
163156500|NCT01550003|589287865|FG001|Overall Study|Pregnancy|1|||
163156501|NCT01550003|589287866|FG002|Overall Study|Pregnancy|0|||
163156502|NCT01550003|589287864|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
163156503|NCT01550003|589287865|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
163156504|NCT01550003|589287866|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
163041103|NCT02588092|588858053|FG002|Overall Study|Sponsor Decision|0|||
163041104|NCT02588092|588858054|FG003|Overall Study|Sponsor Decision|0|||
163041105|NCT02588092|588858055|FG004|Overall Study|Sponsor Decision|0|||
163041106|NCT02588092|588858056|FG005|Overall Study|Sponsor Decision|0|||
163041107|NCT02588092|588858057|FG006|Overall Study|Sponsor Decision|0|||
163041108|NCT02588092|588858058|FG007|Overall Study|Sponsor Decision|0|||
163041109|NCT02588092|588858059|FG008|Overall Study|Sponsor Decision|1|||
163041110|NCT02588092|588858060|FG009|Overall Study|Sponsor Decision|1|||
163041111|NCT01348100|588858061|FG000|Overall Study|Subject Withdrew Consent|0|||
163041112|NCT01348100|588858062|FG001|Overall Study|Subject Withdrew Consent|0|||
163041113|NCT01348100|588858063|FG002|Overall Study|Subject Withdrew Consent|2|||
163041114|NCT01348100|588858064|FG003|Overall Study|Subject Withdrew Consent|0|||
163041115|NCT01348100|588858065|FG004|Overall Study|Subject Withdrew Consent|1|||
163041116|NCT01348100|588858066|FG005|Overall Study|Subject Withdrew Consent|0|||
163041117|NCT01348100|588858067|FG006|Overall Study|Subject Withdrew Consent|1|||
163041118|NCT01348100|588858061|FG000|Overall Study|Protocol Deviation|0|||
163041119|NCT01348100|588858062|FG001|Overall Study|Protocol Deviation|0|||
163041120|NCT01348100|588858063|FG002|Overall Study|Protocol Deviation|0|||
163041121|NCT01348100|588858064|FG003|Overall Study|Protocol Deviation|1|||
163041122|NCT01348100|588858065|FG004|Overall Study|Protocol Deviation|0|||
163041123|NCT01348100|588858066|FG005|Overall Study|Protocol Deviation|0|||
163041124|NCT01348100|588858067|FG006|Overall Study|Protocol Deviation|0|||
163041125|NCT01348100|588858061|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163156505|NCT01550003|589287864|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
163156506|NCT01550003|589287865|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
163156507|NCT01550003|589287866|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
163156508|NCT01550003|589287864|FG000|Overall Study|Switching to adult rheumatologist|0|||
163156509|NCT01550003|589287865|FG001|Overall Study|Switching to adult rheumatologist|0|||
163156510|NCT01550003|589287866|FG002|Overall Study|Switching to adult rheumatologist|1|||
163156511|NCT01550003|589287864|FG000|Overall Study|Patient transition to adult care|0|||
163156512|NCT01550003|589287865|FG001|Overall Study|Patient transition to adult care|0|||
163156513|NCT01550003|589287866|FG002|Overall Study|Patient transition to adult care|1|||
163156514|NCT01550003|589287864|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
163156515|NCT01550003|589287865|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
163156516|NCT01550003|589287866|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
163156517|NCT01550003|589287864|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
163156518|NCT01550003|589287865|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
163156519|NCT01550003|589287866|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
163156520|NCT01550003|589287864|FG000|Overall Study|Per Sponsor request|1|||
163156521|NCT01550003|589287865|FG001|Overall Study|Per Sponsor request|0|||
163156522|NCT01550003|589287866|FG002|Overall Study|Per Sponsor request|1|||
163156523|NCT01550003|589287864|FG000|Overall Study|Patient not compliance|0|||
163156524|NCT01550003|589287865|FG001|Overall Study|Patient not compliance|0|||
163156525|NCT01550003|589287866|FG002|Overall Study|Patient not compliance|1|||
163156526|NCT01550003|589287864|FG000|Overall Study|Non-compliance|0|||
163156527|NCT01550003|589287865|FG001|Overall Study|Non-compliance|0|||
163156528|NCT01550003|589287866|FG002|Overall Study|Non-compliance|1|||
163156529|NCT01550003|589287864|FG000|Overall Study|Study closed|0|||
163156530|NCT01550003|589287865|FG001|Overall Study|Study closed|1|||
163156531|NCT01550003|589287866|FG002|Overall Study|Study closed|0|||
163156532|NCT01550003|589287864|FG000|Overall Study|Transitioned to adult rheumatology|0|||
163156533|NCT01550003|589287865|FG001|Overall Study|Transitioned to adult rheumatology|0|||
163156534|NCT01550003|589287866|FG002|Overall Study|Transitioned to adult rheumatology|1|||
163156535|NCT05567783|589287867|FG000|Overall Study|Death|2|||
163156536|NCT05567783|589287868|FG001|Overall Study|Death|3|||
163156537|NCT05567783|589287869|FG002|Overall Study|Death|0|||
163156538|NCT05567783|589287867|FG000|Overall Study|Lost to Follow-up|25|||
163156539|NCT05567783|589287868|FG001|Overall Study|Lost to Follow-up|19|||
163041126|NCT01348100|588858062|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041127|NCT01348100|588858063|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041128|NCT01348100|588858064|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041129|NCT01348100|588858065|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041130|NCT01348100|588858066|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163041131|NCT01348100|588858067|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163041132|NCT01348100|588858061|FG000|Overall Study|Lost to Follow-up|0|||
163041133|NCT01348100|588858062|FG001|Overall Study|Lost to Follow-up|0|||
163041134|NCT01348100|588858063|FG002|Overall Study|Lost to Follow-up|0|||
163041135|NCT01348100|588858064|FG003|Overall Study|Lost to Follow-up|0|||
163041136|NCT01348100|588858065|FG004|Overall Study|Lost to Follow-up|0|||
163041137|NCT01348100|588858066|FG005|Overall Study|Lost to Follow-up|0|||
163041138|NCT01348100|588858067|FG006|Overall Study|Lost to Follow-up|1|||
163041139|NCT01348100|588858061|FG000|Overall Study|Administrative Problems|0|||
163041140|NCT01348100|588858062|FG001|Overall Study|Administrative Problems|0|||
163041141|NCT01348100|588858063|FG002|Overall Study|Administrative Problems|0|||
163041142|NCT01348100|588858064|FG003|Overall Study|Administrative Problems|0|||
163156540|NCT05567783|589287869|FG002|Overall Study|Lost to Follow-up|17|||
163156541|NCT05567783|589287867|FG000|Overall Study|Physician Decision|10|||
163156542|NCT05567783|589287868|FG001|Overall Study|Physician Decision|7|||
163156543|NCT05567783|589287869|FG002|Overall Study|Physician Decision|9|||
163156544|NCT05567783|589287867|FG000|Overall Study|Study Terminated by Sponsor|924|||
163156545|NCT05567783|589287868|FG001|Overall Study|Study Terminated by Sponsor|937|||
163156546|NCT05567783|589287869|FG002|Overall Study|Study Terminated by Sponsor|941|||
163156547|NCT05567783|589287867|FG000|Overall Study|Withdrawal by Subject|23|||
163156548|NCT05567783|589287868|FG001|Overall Study|Withdrawal by Subject|27|||
163156549|NCT05567783|589287869|FG002|Overall Study|Withdrawal by Subject|24|||
163156550|NCT05567783|589287867|FG000|Overall Study|Incarcerated|1|||
163156551|NCT05567783|589287868|FG001|Overall Study|Incarcerated|0|||
163156552|NCT05567783|589287869|FG002|Overall Study|Incarcerated|0|||
163156553|NCT05567783|589287867|FG000|Overall Study|Participant randomized in error|4|||
163156554|NCT05567783|589287868|FG001|Overall Study|Participant randomized in error|2|||
163156555|NCT05567783|589287869|FG002|Overall Study|Participant randomized in error|2|||
163156556|NCT03675126|589287872|FG000|Overall Study|Study Terminated by Sponsor|9|||
163156557|NCT03675126|589287872|FG000|Overall Study|Death|2|||
163156558|NCT03675126|589287872|FG000|Overall Study|Withdrawal by Subject|4|||
163156559|NCT00904982|589287874|FG000|Overall Study|Withdrawal by Subject|2|||
163156560|NCT00904982|589287875|FG001|Overall Study|Withdrawal by Subject|0|||
163156561|NCT00904982|589287876|FG002|Overall Study|Withdrawal by Subject|0|||
163156562|NCT00904982|589287877|FG003|Overall Study|Withdrawal by Subject|0|||
163156563|NCT02072668|589287883|FG000|Second Intervention|Lost to Follow-up|1|||
163156564|NCT02072668|589287884|FG001|Second Intervention|Lost to Follow-up|0|||
163156565|NCT01353898|589287885|FG000|Overall Study|Study site terminated|0|||
163156566|NCT01353898|589287886|FG001|Overall Study|Study site terminated|0|||
163156567|NCT01353898|589287887|FG002|Overall Study|Study site terminated|0|||
163156568|NCT01353898|589287888|FG003|Overall Study|Study site terminated|0|||
163156569|NCT01353898|589287889|FG004|Overall Study|Study site terminated|0|||
163156570|NCT01353898|589287890|FG005|Overall Study|Study site terminated|1|||
163156571|NCT01352793|589287892|FG000|Overall Study|Lost to Follow-up|289|||
163156572|NCT01352793|589287893|FG001|Overall Study|Lost to Follow-up|125|||
163156573|NCT01352793|589287892|FG000|Overall Study|Withdrawal by Subject|120|||
163156574|NCT01352793|589287893|FG001|Overall Study|Withdrawal by Subject|55|||
163156575|NCT01352793|589287892|FG000|Overall Study|Protocol Violation|44|||
163156576|NCT01352793|589287893|FG001|Overall Study|Protocol Violation|23|||
163156577|NCT01352793|589287892|FG000|Overall Study|Adverse Event|44|||
163156578|NCT01352793|589287893|FG001|Overall Study|Adverse Event|10|||
163156579|NCT01352793|589287892|FG000|Overall Study|Physician Decision|1|||
163156580|NCT01352793|589287893|FG001|Overall Study|Physician Decision|0|||
163156581|NCT01352793|589287892|FG000|Overall Study|Pregnancy|26|||
163041143|NCT01348100|588858065|FG004|Overall Study|Administrative Problems|0|||
163041144|NCT01348100|588858066|FG005|Overall Study|Administrative Problems|1|||
163041145|NCT01348100|588858067|FG006|Overall Study|Administrative Problems|1|||
163041146|NCT03882957|588858070|FG000|Overall Study|Did not complete all three arms|1|||
163041147|NCT00531947|588858074|FG000|Overall Study|Adverse Event|5|||
162696297|NCT04399551|587599459|FG000|Overall Study|Protocol Deviation|2|||
162811637|NCT00585195|588021759|FG004|Overall Study|Other|0|||
162927862|NCT01488071|588439246|FG000|Overall Study|Lack of Efficacy|11|||
162696298|NCT01912781|587599466|FG000|Overall Study|Withdrawal by Subject|2|||
162696299|NCT01912781|587599467|FG001|Overall Study|Withdrawal by Subject|0|||
162696300|NCT03377790|587599470|FG000|Overall Study|Withdrawal by Subject|1|||
162696301|NCT03377790|587599471|FG001|Overall Study|Withdrawal by Subject|0|||
162696302|NCT03377790|587599470|FG000|Overall Study|Adverse Event|1|||
162696303|NCT03377790|587599471|FG001|Overall Study|Adverse Event|0|||
162696304|NCT03377790|587599470|FG000|Overall Study|Lost to Follow-up|0|||
162696305|NCT03377790|587599471|FG001|Overall Study|Lost to Follow-up|2|||
162696306|NCT03377790|587599470|FG000|Overall Study|Randomized but not treated|1|||
162696307|NCT03377790|587599471|FG001|Overall Study|Randomized but not treated|0|||
162696308|NCT03377790|587599470|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
162696309|NCT03377790|587599471|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
162696310|NCT01533714|587599472|FG000|Overall Study|Adverse Event|0|||
162696311|NCT01533714|587599473|FG001|Overall Study|Adverse Event|1|||
162696312|NCT01533714|587599474|FG002|Overall Study|Adverse Event|2|||
162696313|NCT01533714|587599475|FG003|Overall Study|Adverse Event|2|||
162927863|NCT01488071|588439247|FG001|Overall Study|Lack of Efficacy|17|||
162927864|NCT01488071|588439246|FG000|Overall Study|Non-compliance with study drug|2|||
162927865|NCT01488071|588439247|FG001|Overall Study|Non-compliance with study drug|0|||
162927866|NCT01488071|588439246|FG000|Overall Study|Protocol Violation|5|||
162927867|NCT01488071|588439247|FG001|Overall Study|Protocol Violation|7|||
162927868|NCT01488071|588439246|FG000|Overall Study|Withdrawal of Consent|14|||
162927869|NCT01488071|588439247|FG001|Overall Study|Withdrawal of Consent|12|||
162927870|NCT01488071|588439246|FG000|Overall Study|Lost to Follow-up|1|||
162927871|NCT01488071|588439247|FG001|Overall Study|Lost to Follow-up|0|||
162927872|NCT01488071|588439246|FG000|Overall Study|Administrative or Other Reason(s)|5|||
162927873|NCT01488071|588439247|FG001|Overall Study|Administrative or Other Reason(s)|4|||
162927874|NCT02139306|588439248|FG000|Overall Study|Withdrawal by Subject|4|||
162927875|NCT02139306|588439249|FG001|Overall Study|Withdrawal by Subject|6|||
162927876|NCT02139306|588439248|FG000|Overall Study|Adverse Event|3|||
162927877|NCT02139306|588439249|FG001|Overall Study|Adverse Event|4|||
162927878|NCT02139306|588439248|FG000|Overall Study|Physician Decision|0|||
162927879|NCT02139306|588439249|FG001|Overall Study|Physician Decision|1|||
162927880|NCT02139306|588439248|FG000|Overall Study|Other Unspecified|2|||
162927881|NCT02139306|588439249|FG001|Overall Study|Other Unspecified|3|||
162927882|NCT02139306|588439248|FG000|Overall Study|Protocol Violation|4|||
162927883|NCT02139306|588439249|FG001|Overall Study|Protocol Violation|0|||
162927884|NCT04449354|588439250|FG000|Overall Study|Withdrawal by Subject|1|||
162927885|NCT05789420|588439251|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
163041148|NCT00531947|588858075|FG001|Overall Study|Adverse Event|10|||
163041149|NCT00531947|588858074|FG000|Overall Study|Lost to Follow-up|12|||
163041150|NCT00531947|588858075|FG001|Overall Study|Lost to Follow-up|9|||
163041151|NCT00531947|588858074|FG000|Overall Study|Withdrawal by Subject|14|||
163041152|NCT00531947|588858075|FG001|Overall Study|Withdrawal by Subject|19|||
163041153|NCT00531947|588858074|FG000|Overall Study|Protocol Violation|2|||
163041154|NCT00531947|588858075|FG001|Overall Study|Protocol Violation|1|||
163041155|NCT00531947|588858074|FG000|Overall Study|Non-Compliance|4|||
163041156|NCT00531947|588858075|FG001|Overall Study|Non-Compliance|7|||
163041157|NCT00531947|588858074|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
163041158|NCT00531947|588858075|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
163041159|NCT02383355|588858079|FG000|Overall Study|Adverse Event|2|||
163041160|NCT02383355|588858080|FG001|Overall Study|Adverse Event|0|||
163041161|NCT00334295|588858084|FG000|Overall Study|Patients received fewer than 3 injection|5|||
163041162|NCT00893971|588858085|FG000|Overall Study|Physician Decision|3|||
163041163|NCT04811664|588858086|FG000|Overall Study|Lost to Follow-up|78|||
162927886|NCT05789420|588439251|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
162927887|NCT02278952|588439252|FG000|Overall Study|Insufficient Sample|6|||
162927888|NCT01220128|588439253|FG000|Overall Study|Progressive disease|0|||
162927889|NCT01220128|588439254|FG001|Overall Study|Progressive disease|0|||
162927890|NCT01220128|588439255|FG002|Overall Study|Progressive disease|2|||
162927891|NCT01220128|588439256|FG003|Overall Study|Progressive disease|0|||
162927892|NCT01220128|588439257|FG004|Overall Study|Progressive disease|0|||
162927893|NCT01220128|588439258|FG005|Overall Study|Progressive disease|0|||
162927894|NCT01220128|588439259|FG006|Overall Study|Progressive disease|0|||
162927895|NCT01220128|588439253|FG000|Overall Study|Sponsor study termination|0|||
162927896|NCT01220128|588439254|FG001|Overall Study|Sponsor study termination|1|||
162927897|NCT01220128|588439255|FG002|Overall Study|Sponsor study termination|0|||
162927898|NCT01220128|588439256|FG003|Overall Study|Sponsor study termination|0|||
162927899|NCT01220128|588439257|FG004|Overall Study|Sponsor study termination|0|||
162927900|NCT01220128|588439258|FG005|Overall Study|Sponsor study termination|0|||
162927901|NCT01220128|588439259|FG006|Overall Study|Sponsor study termination|1|||
162927902|NCT01220128|588439253|FG000|Overall Study|Adverse event, serious fatal|2|||
162927903|NCT01220128|588439254|FG001|Overall Study|Adverse event, serious fatal|0|||
162927904|NCT01220128|588439255|FG002|Overall Study|Adverse event, serious fatal|0|||
162927905|NCT01220128|588439256|FG003|Overall Study|Adverse event, serious fatal|0|||
162927906|NCT01220128|588439257|FG004|Overall Study|Adverse event, serious fatal|0|||
162927907|NCT01220128|588439258|FG005|Overall Study|Adverse event, serious fatal|0|||
162927908|NCT01220128|588439259|FG006|Overall Study|Adverse event, serious fatal|1|||
162927909|NCT01220128|588439253|FG000|Overall Study|Adverse event, non-fatal|1|||
162927910|NCT01220128|588439254|FG001|Overall Study|Adverse event, non-fatal|0|||
162927911|NCT01220128|588439255|FG002|Overall Study|Adverse event, non-fatal|0|||
162927912|NCT01220128|588439256|FG003|Overall Study|Adverse event, non-fatal|0|||
162927913|NCT01220128|588439257|FG004|Overall Study|Adverse event, non-fatal|0|||
162927914|NCT01220128|588439258|FG005|Overall Study|Adverse event, non-fatal|0|||
162927915|NCT01220128|588439259|FG006|Overall Study|Adverse event, non-fatal|3|||
162927916|NCT01220128|588439253|FG000|Overall Study|Other|0|||
162927917|NCT01220128|588439254|FG001|Overall Study|Other|0|||
162927918|NCT01220128|588439255|FG002|Overall Study|Other|1|||
162927919|NCT01220128|588439256|FG003|Overall Study|Other|0|||
162927920|NCT01220128|588439257|FG004|Overall Study|Other|0|||
162927921|NCT01220128|588439258|FG005|Overall Study|Other|0|||
162927922|NCT01220128|588439259|FG006|Overall Study|Other|0|||
162927923|NCT01220128|588439253|FG000|Overall Study|Consent withdrawn by subject|1|||
162927924|NCT01220128|588439254|FG001|Overall Study|Consent withdrawn by subject|0|||
162927925|NCT01220128|588439255|FG002|Overall Study|Consent withdrawn by subject|0|||
162927926|NCT01220128|588439256|FG003|Overall Study|Consent withdrawn by subject|0|||
162927927|NCT01220128|588439257|FG004|Overall Study|Consent withdrawn by subject|0|||
162927928|NCT01220128|588439258|FG005|Overall Study|Consent withdrawn by subject|0|||
162927929|NCT01220128|588439259|FG006|Overall Study|Consent withdrawn by subject|0|||
162927930|NCT02787746|588439261|FG000|Overall Study|Adverse Event|42|||
162927931|NCT02787746|588439261|FG000|Overall Study|Withdrawal by Subject|65|||
162927932|NCT02787746|588439261|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
162927933|NCT01142466|588441200|FG000|Overall Study|Adverse Event|2|||
162927934|NCT01142466|588441201|FG001|Overall Study|Adverse Event|1|||
162927935|NCT01142466|588441200|FG000|Overall Study|Withdrawal by Subject|1|||
162927936|NCT01142466|588441201|FG001|Overall Study|Withdrawal by Subject|1|||
162927937|NCT00700310|588441206|FG000|Overall Study|Adverse Event|6|||
162927938|NCT00700310|588441207|FG001|Overall Study|Adverse Event|10|||
162927939|NCT00700310|588441208|FG002|Overall Study|Adverse Event|5|||
162927940|NCT00700310|588441209|FG003|Overall Study|Adverse Event|11|||
162927941|NCT00700310|588441206|FG000|Overall Study|Lost to Follow-up|4|||
162927942|NCT00700310|588441207|FG001|Overall Study|Lost to Follow-up|1|||
162927943|NCT00700310|588441208|FG002|Overall Study|Lost to Follow-up|0|||
162927944|NCT00700310|588441209|FG003|Overall Study|Lost to Follow-up|1|||
162927945|NCT00700310|588441206|FG000|Overall Study|Withdrawal by Subject|8|||
162927946|NCT00700310|588441207|FG001|Overall Study|Withdrawal by Subject|9|||
162927947|NCT00700310|588441208|FG002|Overall Study|Withdrawal by Subject|8|||
162927948|NCT00700310|588441209|FG003|Overall Study|Withdrawal by Subject|8|||
162927949|NCT00700310|588441206|FG000|Overall Study|Lack of Efficacy|0|||
162927950|NCT00700310|588441207|FG001|Overall Study|Lack of Efficacy|3|||
162927951|NCT00700310|588441208|FG002|Overall Study|Lack of Efficacy|0|||
162927952|NCT00700310|588441209|FG003|Overall Study|Lack of Efficacy|1|||
162927953|NCT00700310|588441206|FG000|Overall Study|Administrative/Other|1|||
162927954|NCT00700310|588441207|FG001|Overall Study|Administrative/Other|3|||
162927955|NCT00700310|588441208|FG002|Overall Study|Administrative/Other|1|||
162927956|NCT00700310|588441209|FG003|Overall Study|Administrative/Other|3|||
162927957|NCT00700310|588441206|FG000|Overall Study|Randomized, Not Treated|2|||
162927958|NCT00700310|588441207|FG001|Overall Study|Randomized, Not Treated|0|||
162927959|NCT00700310|588441208|FG002|Overall Study|Randomized, Not Treated|2|||
162927960|NCT00700310|588441209|FG003|Overall Study|Randomized, Not Treated|2|||
162927961|NCT00303316|588441210|FG000|Overall Study|Protocol Violation|1|||
162927962|NCT00303316|588441211|FG001|Overall Study|Protocol Violation|0|||
162927963|NCT00303316|588441210|FG000|Overall Study|Lost to Follow-up|0|||
162927964|NCT00303316|588441211|FG001|Overall Study|Lost to Follow-up|1|||
162927965|NCT00303316|588441210|FG000|Overall Study|Withdrawal by Subject|1|||
162927966|NCT00303316|588441211|FG001|Overall Study|Withdrawal by Subject|2|||
162927967|NCT02162511|588441214|FG000|Overall Study|Lack of Efficacy|0|||
162927968|NCT02162511|588441215|FG001|Overall Study|Lack of Efficacy|0|||
162927969|NCT02162511|588441216|FG002|Overall Study|Lack of Efficacy|2|||
162927970|NCT01160198|588441217|FG000|Overall Study|Withdrawal by Subject|2|||
162927971|NCT01160198|588441218|FG001|Overall Study|Withdrawal by Subject|1|||
162927972|NCT01160198|588441219|FG002|Overall Study|Withdrawal by Subject|0|||
162927973|NCT01160198|588441217|FG000|Overall Study|Adverse Event|0|||
162927974|NCT01160198|588441218|FG001|Overall Study|Adverse Event|1|||
162927975|NCT01160198|588441219|FG002|Overall Study|Adverse Event|0|||
162927976|NCT01160198|588441217|FG000|Overall Study|Lost to Follow-up|0|||
162927977|NCT01160198|588441218|FG001|Overall Study|Lost to Follow-up|1|||
162927978|NCT01160198|588441219|FG002|Overall Study|Lost to Follow-up|0|||
162927979|NCT01160198|588441217|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
162927980|NCT01160198|588441218|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
162927981|NCT01160198|588441219|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
162927982|NCT00802529|588441220|FG000|Overall Study|Lost to Follow-up|0|||
162927983|NCT00802529|588441221|FG001|Overall Study|Lost to Follow-up|1|||
162927984|NCT00552617|588441224|FG000|Overall Study|Not Treated|0|||
162927985|NCT00552617|588441225|FG001|Overall Study|Not Treated|0|||
162927986|NCT00552617|588441226|FG002|Overall Study|Not Treated|1|||
162927987|NCT00552617|588441227|FG003|Overall Study|Not Treated|0|||
162927988|NCT00552617|588441228|FG004|Overall Study|Not Treated|0|||
162927989|NCT00552617|588441229|FG005|Overall Study|Not Treated|0|||
162927990|NCT00552617|588441230|FG006|Overall Study|Not Treated|0|||
162927991|NCT00552617|588441231|FG007|Overall Study|Not Treated|0|||
162927992|NCT00552617|588441232|FG008|Overall Study|Not Treated|0|||
162927993|NCT00552617|588441233|FG009|Overall Study|Not Treated|1|||
162927994|NCT00552617|588441224|FG000|Overall Study|Lost to Follow-up|0|||
162927995|NCT00552617|588441225|FG001|Overall Study|Lost to Follow-up|0|||
162927996|NCT00552617|588441226|FG002|Overall Study|Lost to Follow-up|0|||
162927997|NCT00552617|588441227|FG003|Overall Study|Lost to Follow-up|1|||
162927998|NCT00552617|588441228|FG004|Overall Study|Lost to Follow-up|0|||
162927999|NCT00552617|588441229|FG005|Overall Study|Lost to Follow-up|2|||
162928000|NCT00552617|588441230|FG006|Overall Study|Lost to Follow-up|0|||
162928001|NCT00552617|588441231|FG007|Overall Study|Lost to Follow-up|0|||
162928002|NCT00552617|588441232|FG008|Overall Study|Lost to Follow-up|2|||
162928003|NCT00552617|588441233|FG009|Overall Study|Lost to Follow-up|0|||
162928004|NCT04651218|588441234|FG000|Overall Study|Withdrawal by Subject|0|||
162928005|NCT04651218|588441235|FG001|Overall Study|Withdrawal by Subject|2|||
162928006|NCT01399125|588441238|FG000|Overall Study|Adverse Event|32|||
162928007|NCT01399125|588441239|FG001|Overall Study|Adverse Event|30|||
162928008|NCT01399125|588441238|FG000|Overall Study|Abnormal Lab values|0|||
162928009|NCT01399125|588441239|FG001|Overall Study|Abnormal Lab values|1|||
162928010|NCT01399125|588441238|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162928011|NCT01399125|588441239|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162928012|NCT01399125|588441238|FG000|Overall Study|Withdrawal by Subject|5|||
162928013|NCT01399125|588441239|FG001|Overall Study|Withdrawal by Subject|8|||
162928014|NCT01399125|588441238|FG000|Overall Study|Lost to Follow-up|2|||
162928015|NCT01399125|588441239|FG001|Overall Study|Lost to Follow-up|3|||
162928016|NCT01399125|588441238|FG000|Overall Study|Administrative Problems|7|||
162928017|NCT01399125|588441239|FG001|Overall Study|Administrative Problems|11|||
162928018|NCT01399125|588441238|FG000|Overall Study|Death|0|||
162928019|NCT01399125|588441239|FG001|Overall Study|Death|1|||
162928020|NCT01399125|588441238|FG000|Overall Study|Protocol Deviation|5|||
162928021|NCT01399125|588441239|FG001|Overall Study|Protocol Deviation|2|||
162928022|NCT01902134|588441240|FG000|Overall Study|Adverse Event|3|||
162928023|NCT01902134|588441241|FG001|Overall Study|Adverse Event|1|||
162928024|NCT01902134|588441242|FG002|Overall Study|Adverse Event|2|||
162928025|NCT01902134|588441243|FG003|Overall Study|Adverse Event|1|||
162928026|NCT01902134|588441244|FG004|Overall Study|Adverse Event|1|||
162928027|NCT01902134|588441245|FG005|Overall Study|Adverse Event|3|||
162928028|NCT01902134|588441240|FG000|Overall Study|Lack of Efficacy|0|||
162928029|NCT01902134|588441241|FG001|Overall Study|Lack of Efficacy|0|||
162928030|NCT01902134|588441242|FG002|Overall Study|Lack of Efficacy|2|||
162928031|NCT01902134|588441243|FG003|Overall Study|Lack of Efficacy|0|||
162928032|NCT01902134|588441244|FG004|Overall Study|Lack of Efficacy|0|||
162928033|NCT01902134|588441245|FG005|Overall Study|Lack of Efficacy|1|||
162928034|NCT01902134|588441240|FG000|Overall Study|Physician Decision|0|||
162928035|NCT01902134|588441241|FG001|Overall Study|Physician Decision|1|||
162928036|NCT01902134|588441242|FG002|Overall Study|Physician Decision|0|||
162928037|NCT01902134|588441243|FG003|Overall Study|Physician Decision|0|||
162928038|NCT01902134|588441244|FG004|Overall Study|Physician Decision|0|||
162928039|NCT01902134|588441245|FG005|Overall Study|Physician Decision|0|||
162928040|NCT01902134|588441240|FG000|Overall Study|Protocol Violation|0|||
162928041|NCT01902134|588441241|FG001|Overall Study|Protocol Violation|0|||
162928042|NCT01902134|588441242|FG002|Overall Study|Protocol Violation|0|||
162928043|NCT01902134|588441243|FG003|Overall Study|Protocol Violation|0|||
162928044|NCT01902134|588441244|FG004|Overall Study|Protocol Violation|0|||
162928045|NCT01902134|588441245|FG005|Overall Study|Protocol Violation|1|||
162928046|NCT01902134|588441240|FG000|Overall Study|Withdrawal by Subject|4|||
162928047|NCT01902134|588441241|FG001|Overall Study|Withdrawal by Subject|8|||
163041164|NCT04811664|588858087|FG001|Overall Study|Lost to Follow-up|125|||
162928048|NCT01902134|588441242|FG002|Overall Study|Withdrawal by Subject|9|||
162928049|NCT01902134|588441243|FG003|Overall Study|Withdrawal by Subject|1|||
163041165|NCT04811664|588858088|FG002|Overall Study|Lost to Follow-up|46|||
162928050|NCT01902134|588441244|FG004|Overall Study|Withdrawal by Subject|5|||
162928051|NCT01902134|588441245|FG005|Overall Study|Withdrawal by Subject|4|||
162928052|NCT01902134|588441240|FG000|Overall Study|no compliance|1|||
162928053|NCT01902134|588441241|FG001|Overall Study|no compliance|0|||
162928054|NCT01902134|588441242|FG002|Overall Study|no compliance|0|||
162928055|NCT01902134|588441243|FG003|Overall Study|no compliance|0|||
162928056|NCT01902134|588441244|FG004|Overall Study|no compliance|0|||
162928057|NCT01902134|588441245|FG005|Overall Study|no compliance|0|||
162928058|NCT01902134|588441240|FG000|Overall Study|Other|0|||
162928059|NCT01902134|588441241|FG001|Overall Study|Other|1|||
162928060|NCT01902134|588441242|FG002|Overall Study|Other|2|||
162928061|NCT01902134|588441243|FG003|Overall Study|Other|0|||
162928062|NCT01902134|588441244|FG004|Overall Study|Other|1|||
162928063|NCT01902134|588441245|FG005|Overall Study|Other|0|||
162928064|NCT00305110|588441246|FG000|Overall Study|Missing data|29|||
162928065|NCT00337129|588441247|FG000|Overall Study|Adverse Event|4|||
162928066|NCT00337129|588441247|FG000|Overall Study|Withdrawal by Subject|1|||
162928067|NCT00337129|588441247|FG000|Overall Study|Lack of Efficacy|32|||
162928068|NCT00337129|588441247|FG000|Overall Study|Death|2|||
162928069|NCT00337129|588441247|FG000|Overall Study|not protocol specified|1|||
162928070|NCT01272193|588441253|FG000|Overall Study|Adverse Event|1|||
162928071|NCT01272193|588441254|FG001|Overall Study|Adverse Event|1|||
162928072|NCT01272193|588441253|FG000|Overall Study|Lack of Efficacy|0|||
162928073|NCT01272193|588441254|FG001|Overall Study|Lack of Efficacy|3|||
162928074|NCT01272193|588441253|FG000|Overall Study|Withdrawal Criteria|1|||
162928075|NCT01272193|588441254|FG001|Overall Study|Withdrawal Criteria|1|||
162928076|NCT01272193|588441253|FG000|Overall Study|Unclassified|8|||
162928077|NCT01272193|588441254|FG001|Overall Study|Unclassified|7|||
162928078|NCT03578276|588441261|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
162928079|NCT03578276|588441262|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
162928080|NCT02626182|588441263|FG000|Overall Study|Adverse Event|2|||
162928081|NCT02626182|588441264|FG001|Overall Study|Adverse Event|0|||
162928082|NCT01084603|588441269|FG000|Baseline|Withdrawal by Subject|2|||
162928083|NCT01084603|588441269|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
162928084|NCT01084603|588441269|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
162928085|NCT01084603|588441269|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
162928086|NCT01084603|588441269|FG000|Washout Period 4|Adverse Event|1|||
162928087|NCT02766088|588441272|FG000|Overall Study|Sponsor study termination|498|||
162928088|NCT02766088|588441272|FG000|Overall Study|Migrated/moved from the study area|1|||
162928089|NCT02766088|588441272|FG000|Overall Study|Lost to Follow-up|5|||
162928090|NCT02766088|588441272|FG000|Overall Study|Other|1|||
162928091|NCT02766088|588441272|FG000|Overall Study|Death|1|||
162928092|NCT01508325|588441275|FG000|Overall Study|Withdrawal by Subject|8|||
162928093|NCT01508325|588441276|FG001|Overall Study|Withdrawal by Subject|9|||
162928094|NCT01508325|588441275|FG000|Overall Study|Protocol Violation|0|||
162928095|NCT01508325|588441276|FG001|Overall Study|Protocol Violation|3|||
162928096|NCT01508325|588441275|FG000|Overall Study|Physician Decision|2|||
162928097|NCT01508325|588441276|FG001|Overall Study|Physician Decision|1|||
162928098|NCT01508325|588441275|FG000|Overall Study|Adverse Event|1|||
162928099|NCT01508325|588441276|FG001|Overall Study|Adverse Event|0|||
162928100|NCT01508325|588441275|FG000|Overall Study|Lost to Follow-up|5|||
162928101|NCT01508325|588441276|FG001|Overall Study|Lost to Follow-up|6|||
162928102|NCT01508325|588441275|FG000|Overall Study|Other|2|||
162928103|NCT01508325|588441276|FG001|Overall Study|Other|2|||
162928104|NCT01392170|588441277|FG000|Overall Study|Withdrawal by Subject|1|||
162928105|NCT01392170|588441277|FG000|Overall Study|Ineligible|1|||
162928106|NCT00763269|588441285|FG000|Overall Study|Lost to Follow-up|12|||
162928107|NCT00763269|588441286|FG001|Overall Study|Lost to Follow-up|13|||
162928108|NCT04285983|588441293|FG000|Overall Study|Protocol Violation|6|||
162928109|NCT04936334|588441294|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
162928110|NCT01347879|588441295|FG000|Overall Study|Adverse Event|0|||
162928111|NCT01347879|588441296|FG001|Overall Study|Adverse Event|12|||
162928112|NCT01347879|588441295|FG000|Overall Study|Lost to Follow-up|2|||
162928113|NCT01347879|588441296|FG001|Overall Study|Lost to Follow-up|0|||
162928114|NCT01347879|588441295|FG000|Overall Study|Withdrawal by Subject|3|||
162928115|NCT01347879|588441296|FG001|Overall Study|Withdrawal by Subject|2|||
162928116|NCT01347879|588441295|FG000|Overall Study|Other|2|||
162928117|NCT01347879|588441296|FG001|Overall Study|Other|3|||
162928118|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928119|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
162928120|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928121|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
162928122|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
162928123|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
162928124|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
162928125|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
162928126|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928127|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
162928128|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928129|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
162928130|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
162928131|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
162928132|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
162928133|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
162978982|NCT01660022|588623539|FG001|First Sequence (7 Days)|Adverse Event|0|||
162928134|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
162928135|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
162928136|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
162928137|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
162928138|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928139|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
162928140|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928141|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
162928142|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
162928143|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928144|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928145|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
162928146|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
162928147|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
162928148|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
162928149|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
162928150|NCT03747939|588441297|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928151|NCT03747939|588441298|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
162928152|NCT03747939|588441299|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928153|NCT03747939|588441300|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
162928154|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
162928155|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
162928156|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
162928157|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
162928158|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
162928159|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
162928160|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
162928161|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
162928162|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
162928163|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
162928164|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
162928165|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
162928166|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
162928167|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
162928168|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
162928169|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
162928170|NCT03747939|588441297|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928171|NCT03747939|588441298|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928172|NCT03747939|588441299|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
162928173|NCT03747939|588441300|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
162928174|NCT01850108|588441301|FG000|Overall Study|Lost to Follow-up|4|||
162928175|NCT01850108|588441301|FG000|Overall Study|Not eligible|1|||
162928176|NCT01850108|588441301|FG000|Overall Study|Failed engraftment|2|||
162928177|NCT01850108|588441301|FG000|Overall Study|Physician Decision|1|||
162928178|NCT03273712|588441302|FG000|Overall Study|Death|5|||
162928179|NCT03273712|588441302|FG000|Overall Study|Adverse Event|1|||
162928180|NCT03273712|588441302|FG000|Overall Study|Disease Progression|1|||
162928181|NCT01542736|588441303|FG000|Overall Study|Death|1|||
162928182|NCT03674827|588441304|FG000|Treatment Phase|Adverse Event|0|||
162928183|NCT03674827|588441305|FG001|Treatment Phase|Adverse Event|0|||
162928184|NCT03674827|588441306|FG002|Treatment Phase|Adverse Event|0|||
162928185|NCT03674827|588441307|FG003|Treatment Phase|Adverse Event|0|||
162928186|NCT03674827|588441308|FG004|Treatment Phase|Adverse Event|0|||
162928187|NCT03674827|588441309|FG005|Treatment Phase|Adverse Event|2|||
162928188|NCT03674827|588441304|FG000|Treatment Phase|Death|2|||
162928189|NCT03674827|588441305|FG001|Treatment Phase|Death|0|||
162928190|NCT03674827|588441306|FG002|Treatment Phase|Death|0|||
162928191|NCT03674827|588441307|FG003|Treatment Phase|Death|0|||
162928192|NCT03674827|588441308|FG004|Treatment Phase|Death|1|||
162928193|NCT03674827|588441309|FG005|Treatment Phase|Death|0|||
162928194|NCT03674827|588441304|FG000|Treatment Phase|Progressive Disease|0|||
162928195|NCT03674827|588441305|FG001|Treatment Phase|Progressive Disease|4|||
162928196|NCT03674827|588441306|FG002|Treatment Phase|Progressive Disease|3|||
162928197|NCT03674827|588441307|FG003|Treatment Phase|Progressive Disease|4|||
162928198|NCT03674827|588441308|FG004|Treatment Phase|Progressive Disease|4|||
162928199|NCT03674827|588441309|FG005|Treatment Phase|Progressive Disease|9|||
162928200|NCT03674827|588441304|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
162928201|NCT03674827|588441305|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
162928202|NCT03674827|588441306|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
162928203|NCT03674827|588441307|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
162928204|NCT03674827|588441308|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
162928205|NCT03674827|588441309|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
162928206|NCT03674827|588441304|FG000|Treatment Phase|Withdrawal by Subject|0|||
162928207|NCT03674827|588441305|FG001|Treatment Phase|Withdrawal by Subject|0|||
162928208|NCT03674827|588441306|FG002|Treatment Phase|Withdrawal by Subject|0|||
162928209|NCT03674827|588441307|FG003|Treatment Phase|Withdrawal by Subject|0|||
162928210|NCT03674827|588441308|FG004|Treatment Phase|Withdrawal by Subject|0|||
162928211|NCT03674827|588441309|FG005|Treatment Phase|Withdrawal by Subject|1|||
162928212|NCT03674827|588441304|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
162928213|NCT03674827|588441305|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
162928214|NCT03674827|588441306|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
162928215|NCT03674827|588441307|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
162928216|NCT03674827|588441308|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
163041166|NCT04811664|588858086|FG000|Overall Study|Withdrawal by Subject|39|||
163041167|NCT04811664|588858087|FG001|Overall Study|Withdrawal by Subject|76|||
163041168|NCT04811664|588858088|FG002|Overall Study|Withdrawal by Subject|12|||
162928217|NCT03674827|588441309|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
162928218|NCT03674827|588441304|FG000|Treatment Phase|Other|0|||
162928219|NCT03674827|588441305|FG001|Treatment Phase|Other|1|||
162928220|NCT03674827|588441306|FG002|Treatment Phase|Other|0|||
162928221|NCT03674827|588441307|FG003|Treatment Phase|Other|0|||
162928222|NCT03674827|588441308|FG004|Treatment Phase|Other|0|||
162696314|NCT01533714|587599476|FG004|Overall Study|Adverse Event|2|||
162928223|NCT03674827|588441309|FG005|Treatment Phase|Other|1|||
162928224|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Death|2|||
163041169|NCT04811664|588858086|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
163041170|NCT04811664|588858087|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
162696315|NCT01533714|587599477|FG005|Overall Study|Adverse Event|1|||
162928225|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Death|4|||
162928226|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Death|2|||
162928227|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Death|3|||
162928228|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Death|2|||
162928229|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Death|6|||
162928230|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
162928231|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
162928232|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
162928233|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
162928234|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
162928235|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
162928236|NCT03674827|588441304|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928237|NCT03674827|588441305|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928238|NCT03674827|588441306|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
162928239|NCT03674827|588441307|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
162928240|NCT03674827|588441308|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
162928241|NCT03674827|588441309|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
162928242|NCT01289990|588441310|FG000|Overall Study|Death|0|||
162928243|NCT01289990|588441311|FG001|Overall Study|Death|0|||
162928244|NCT01289990|588441312|FG002|Overall Study|Death|0|||
162928245|NCT01289990|588441313|FG003|Overall Study|Death|1|||
162928246|NCT01289990|588441314|FG004|Overall Study|Death|2|||
162928247|NCT01289990|588441315|FG005|Overall Study|Death|1|||
162928248|NCT01289990|588441316|FG006|Overall Study|Death|0|||
162928249|NCT01289990|588441317|FG007|Overall Study|Death|0|||
162928250|NCT01289990|588441318|FG008|Overall Study|Death|0|||
162928251|NCT01289990|588441319|FG009|Overall Study|Death|0|||
162928252|NCT01289990|588441320|FG010|Overall Study|Death|0|||
162928253|NCT01289990|588441321|FG011|Overall Study|Death|1|||
162928254|NCT01289990|588441322|FG012|Overall Study|Death|0|||
162928255|NCT01289990|588441310|FG000|Overall Study|Lost to Follow-up|3|||
162928256|NCT01289990|588441311|FG001|Overall Study|Lost to Follow-up|2|||
162928257|NCT01289990|588441312|FG002|Overall Study|Lost to Follow-up|5|||
162928258|NCT01289990|588441313|FG003|Overall Study|Lost to Follow-up|5|||
162928259|NCT01289990|588441314|FG004|Overall Study|Lost to Follow-up|3|||
162928260|NCT01289990|588441315|FG005|Overall Study|Lost to Follow-up|4|||
162928261|NCT01289990|588441316|FG006|Overall Study|Lost to Follow-up|2|||
162928262|NCT01289990|588441317|FG007|Overall Study|Lost to Follow-up|2|||
162928263|NCT01289990|588441318|FG008|Overall Study|Lost to Follow-up|1|||
162928264|NCT01289990|588441319|FG009|Overall Study|Lost to Follow-up|4|||
162928265|NCT01289990|588441320|FG010|Overall Study|Lost to Follow-up|2|||
162928266|NCT01289990|588441321|FG011|Overall Study|Lost to Follow-up|1|||
162928267|NCT01289990|588441322|FG012|Overall Study|Lost to Follow-up|2|||
162928268|NCT01289990|588441310|FG000|Overall Study|Withdrawal by Subject|15|||
162928269|NCT01289990|588441311|FG001|Overall Study|Withdrawal by Subject|14|||
162928270|NCT01289990|588441312|FG002|Overall Study|Withdrawal by Subject|12|||
162928271|NCT01289990|588441313|FG003|Overall Study|Withdrawal by Subject|13|||
162928272|NCT01289990|588441314|FG004|Overall Study|Withdrawal by Subject|8|||
162928273|NCT01289990|588441315|FG005|Overall Study|Withdrawal by Subject|7|||
162928274|NCT01289990|588441316|FG006|Overall Study|Withdrawal by Subject|13|||
162928275|NCT01289990|588441317|FG007|Overall Study|Withdrawal by Subject|9|||
162928276|NCT01289990|588441318|FG008|Overall Study|Withdrawal by Subject|12|||
162928277|NCT01289990|588441319|FG009|Overall Study|Withdrawal by Subject|13|||
162928278|NCT01289990|588441320|FG010|Overall Study|Withdrawal by Subject|11|||
162928279|NCT01289990|588441321|FG011|Overall Study|Withdrawal by Subject|13|||
162928280|NCT01289990|588441322|FG012|Overall Study|Withdrawal by Subject|16|||
162928281|NCT01289990|588441310|FG000|Overall Study|discontinued in preceding trial|18|||
162928282|NCT01289990|588441311|FG001|Overall Study|discontinued in preceding trial|20|||
162928283|NCT01289990|588441312|FG002|Overall Study|discontinued in preceding trial|41|||
162928284|NCT01289990|588441313|FG003|Overall Study|discontinued in preceding trial|17|||
162928285|NCT01289990|588441314|FG004|Overall Study|discontinued in preceding trial|11|||
162928286|NCT01289990|588441315|FG005|Overall Study|discontinued in preceding trial|12|||
162928287|NCT01289990|588441316|FG006|Overall Study|discontinued in preceding trial|18|||
162928288|NCT01289990|588441317|FG007|Overall Study|discontinued in preceding trial|8|||
162928289|NCT01289990|588441318|FG008|Overall Study|discontinued in preceding trial|17|||
162928290|NCT01289990|588441319|FG009|Overall Study|discontinued in preceding trial|21|||
162928291|NCT01289990|588441320|FG010|Overall Study|discontinued in preceding trial|17|||
162928292|NCT01289990|588441321|FG011|Overall Study|discontinued in preceding trial|17|||
162928293|NCT01289990|588441322|FG012|Overall Study|discontinued in preceding trial|24|||
162928294|NCT01289990|588441310|FG000|Overall Study|did not continue in extension|41|||
162928295|NCT01289990|588441311|FG001|Overall Study|did not continue in extension|45|||
162928296|NCT01289990|588441312|FG002|Overall Study|did not continue in extension|51|||
162928297|NCT01289990|588441313|FG003|Overall Study|did not continue in extension|51|||
162928298|NCT01289990|588441314|FG004|Overall Study|did not continue in extension|48|||
162928299|NCT01289990|588441315|FG005|Overall Study|did not continue in extension|50|||
162928300|NCT01289990|588441316|FG006|Overall Study|did not continue in extension|54|||
163156582|NCT01352793|589287893|FG001|Overall Study|Pregnancy|8|||
162928301|NCT01289990|588441317|FG007|Overall Study|did not continue in extension|36|||
162928302|NCT01289990|588441318|FG008|Overall Study|did not continue in extension|44|||
162928303|NCT01289990|588441319|FG009|Overall Study|did not continue in extension|48|||
162928304|NCT01289990|588441320|FG010|Overall Study|did not continue in extension|45|||
162928305|NCT01289990|588441321|FG011|Overall Study|did not continue in extension|34|||
162928306|NCT01289990|588441322|FG012|Overall Study|did not continue in extension|56|||
162928307|NCT01289990|588441310|FG000|Overall Study|Not treated|0|||
162928308|NCT01289990|588441311|FG001|Overall Study|Not treated|0|||
162928309|NCT01289990|588441312|FG002|Overall Study|Not treated|0|||
162928310|NCT01289990|588441313|FG003|Overall Study|Not treated|0|||
162928311|NCT01289990|588441314|FG004|Overall Study|Not treated|0|||
162928312|NCT01289990|588441315|FG005|Overall Study|Not treated|0|||
162928313|NCT01289990|588441316|FG006|Overall Study|Not treated|1|||
162928314|NCT01289990|588441317|FG007|Overall Study|Not treated|0|||
162928315|NCT01289990|588441318|FG008|Overall Study|Not treated|1|||
162928316|NCT01289990|588441319|FG009|Overall Study|Not treated|0|||
162928317|NCT01289990|588441320|FG010|Overall Study|Not treated|1|||
162928318|NCT01289990|588441321|FG011|Overall Study|Not treated|2|||
162928319|NCT01289990|588441322|FG012|Overall Study|Not treated|0|||
162928320|NCT00363129|588441325|FG000|Overall Study|Withdrawal by Subject|11|||
162928321|NCT00363129|588441326|FG001|Overall Study|Withdrawal by Subject|18|||
162928322|NCT00363129|588441325|FG000|Overall Study|Adverse Event|8|||
162928323|NCT00363129|588441326|FG001|Overall Study|Adverse Event|3|||
162928324|NCT00363129|588441325|FG000|Overall Study|Alternate Treatment|2|||
162928325|NCT00363129|588441326|FG001|Overall Study|Alternate Treatment|4|||
162928326|NCT00363129|588441325|FG000|Overall Study|Other Medical Problems|2|||
162928327|NCT00363129|588441326|FG001|Overall Study|Other Medical Problems|4|||
162928328|NCT00363129|588441325|FG000|Overall Study|Death|0|||
162928329|NCT00363129|588441326|FG001|Overall Study|Death|1|||
162928330|NCT00363129|588441325|FG000|Overall Study|Other Reasons|6|||
162928331|NCT00363129|588441326|FG001|Overall Study|Other Reasons|3|||
162928332|NCT03454672|588441327|FG000|Overall Study|Adverse Event|1|||
162928333|NCT03454672|588441328|FG001|Overall Study|Adverse Event|1|||
162928334|NCT03454672|588441327|FG000|Overall Study|Lost to Follow-up|1|||
162928335|NCT03454672|588441328|FG001|Overall Study|Lost to Follow-up|3|||
162928336|NCT03454672|588441327|FG000|Overall Study|painful|1|||
162928337|NCT03454672|588441328|FG001|Overall Study|painful|2|||
162928338|NCT03454672|588441327|FG000|Overall Study|Non-compliance|2|||
162928339|NCT03454672|588441328|FG001|Overall Study|Non-compliance|4|||
162928340|NCT03454672|588441327|FG000|Overall Study|personal reasons|3|||
162928341|NCT03454672|588441328|FG001|Overall Study|personal reasons|2|||
162928342|NCT03454672|588441327|FG000|Overall Study|Withdrawal by Subject|1|||
162928343|NCT03454672|588441328|FG001|Overall Study|Withdrawal by Subject|0|||
162928344|NCT05166512|588441329|FG000|Randomized|Lost to Follow-up|2|||
162928345|NCT05166512|588441330|FG001|Randomized|Lost to Follow-up|0|||
162928346|NCT05166512|588441329|FG000|Randomized|Withdrawal by Subject|1|||
162928347|NCT05166512|588441330|FG001|Randomized|Withdrawal by Subject|0|||
162928348|NCT05166512|588441329|FG000|Baseline Data Collection|Lost to Follow-up|0|||
162928349|NCT05166512|588441330|FG001|Baseline Data Collection|Lost to Follow-up|3|||
162928350|NCT05166512|588441329|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
162928351|NCT05166512|588441330|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
162928352|NCT05166512|588441329|FG000|Baseline Data Collection|Protocol Violation|2|||
162928353|NCT05166512|588441330|FG001|Baseline Data Collection|Protocol Violation|0|||
162928354|NCT05166512|588441329|FG000|4 Month Data Collection|Lost to Follow-up|1|||
162928355|NCT05166512|588441330|FG001|4 Month Data Collection|Lost to Follow-up|0|||
162928356|NCT05166512|588441329|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
162928357|NCT05166512|588441330|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
162928358|NCT05166512|588441329|FG000|12 Month Data Collection|Lost to Follow-up|3|||
162928359|NCT05166512|588441330|FG001|12 Month Data Collection|Lost to Follow-up|1|||
162928360|NCT05166512|588441329|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
162928361|NCT05166512|588441330|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
162928362|NCT00420849|588441331|FG000|Overall Study|Lack of Efficacy|154|||
162928363|NCT00420849|588441331|FG000|Overall Study|Adverse Event|107|||
162928364|NCT00420849|588441331|FG000|Overall Study|Withdrawal by Subject|28|||
162928365|NCT00420849|588441331|FG000|Overall Study|Death|18|||
162928366|NCT00420849|588441331|FG000|Overall Study|Other|14|||
162928367|NCT00420849|588441331|FG000|Overall Study|Transplant|8|||
162928368|NCT00420849|588441331|FG000|Overall Study|Protocol Violation|1|||
162928369|NCT00420849|588441331|FG000|Overall Study|Lost to Follow-up|1|||
162928370|NCT00659581|588441332|FG000|Overall Study|Adverse Event|1006|||
162928371|NCT00659581|588441332|FG000|Overall Study|Lack of Efficacy|1183|||
162928372|NCT00659581|588441332|FG000|Overall Study|Other|6393|||
162928373|NCT05473247|588441336|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
162928374|NCT01345058|588441337|FG000|Overall Study|Withdrawal by Subject|1|||
162928375|NCT01345058|588441338|FG001|Overall Study|Withdrawal by Subject|0|||
162928376|NCT01345058|588441337|FG000|Overall Study|Participant Reported Increase in Events|1|||
162928377|NCT01345058|588441338|FG001|Overall Study|Participant Reported Increase in Events|0|||
162928378|NCT01345058|588441337|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
162928379|NCT01345058|588441338|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
162928380|NCT01345058|588441337|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
162928381|NCT01345058|588441338|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
162928382|NCT01345058|588441337|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
162928383|NCT01345058|588441338|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
162928384|NCT01892020|588441340|FG000|Period 1|Adverse Event|1|||
162928385|NCT01892020|588441341|FG001|Period 1|Adverse Event|1|||
162928386|NCT01892020|588441340|FG000|Period 1|Protocol Violation|2|||
162928387|NCT01892020|588441341|FG001|Period 1|Protocol Violation|4|||
162928388|NCT01892020|588441340|FG000|Period 1|Unclassified|0|||
162928389|NCT01892020|588441341|FG001|Period 1|Unclassified|1|||
162928390|NCT01892020|588441340|FG000|Period 2|Protocol Violation|1|||
162928391|NCT01892020|588441341|FG001|Period 2|Protocol Violation|0|||
162928392|NCT00000135|588441342|FG000|Overall Study|Death|27|||
162928393|NCT00000135|588441343|FG001|Overall Study|Death|14|||
162928394|NCT01831596|588441345|FG000|Overall Study|Other|8|||
162928395|NCT02149199|588441351|FG000|Overall Study|Study specific withdrawal criteria|4|||
162928396|NCT02149199|588441352|FG001|Overall Study|Study specific withdrawal criteria|21|||
162928397|NCT02149199|588441353|FG002|Overall Study|Study specific withdrawal criteria|6|||
162928398|NCT02149199|588441351|FG000|Overall Study|Other|20|||
162928399|NCT02149199|588441352|FG001|Overall Study|Other|25|||
162928400|NCT02149199|588441353|FG002|Overall Study|Other|20|||
162928401|NCT02149199|588441351|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
162928402|NCT02149199|588441352|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
162928403|NCT02149199|588441353|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
162928404|NCT02149199|588441351|FG000|Overall Study|Withdrawal by Subject|75|||
162928405|NCT02149199|588441352|FG001|Overall Study|Withdrawal by Subject|93|||
162928406|NCT02149199|588441353|FG002|Overall Study|Withdrawal by Subject|77|||
162928407|NCT02149199|588441351|FG000|Overall Study|Protocol Violation|16|||
162928408|NCT02149199|588441352|FG001|Overall Study|Protocol Violation|13|||
162928409|NCT02149199|588441353|FG002|Overall Study|Protocol Violation|15|||
162928410|NCT02149199|588441351|FG000|Overall Study|Lost to Follow-up|3|||
162928411|NCT02149199|588441352|FG001|Overall Study|Lost to Follow-up|12|||
162928412|NCT02149199|588441353|FG002|Overall Study|Lost to Follow-up|11|||
162928413|NCT02149199|588441351|FG000|Overall Study|Death|0|||
162928414|NCT02149199|588441352|FG001|Overall Study|Death|0|||
162928415|NCT02149199|588441353|FG002|Overall Study|Death|1|||
162928416|NCT02149199|588441351|FG000|Overall Study|Adverse Event|6|||
162928417|NCT02149199|588441352|FG001|Overall Study|Adverse Event|15|||
162928418|NCT02149199|588441353|FG002|Overall Study|Adverse Event|9|||
162928419|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928420|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928421|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928422|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928423|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928424|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928425|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928426|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928427|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928428|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928429|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928430|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928431|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928432|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
162928433|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162928434|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
162928435|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
162928436|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
162928437|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
162928438|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928439|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928440|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928441|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928442|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928443|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928444|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928445|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928446|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928447|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928448|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928449|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928450|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928451|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928452|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928453|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
162928454|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928455|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
162928456|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
162928457|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928458|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928459|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928460|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928461|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928462|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928463|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928464|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928465|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928466|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928467|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928468|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928469|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928470|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928471|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
162928472|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928473|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928474|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
162928475|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
162928476|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928477|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928478|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928479|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928480|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928481|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928482|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928483|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928484|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928485|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928486|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928487|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928488|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928489|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928490|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928491|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928492|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928493|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
162928494|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
162928495|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928496|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928497|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928498|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928499|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928500|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928501|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928502|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928503|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928504|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928505|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928506|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928507|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
162928508|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
162928509|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
162928510|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928511|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
162928512|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
162928513|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
162928514|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928515|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928516|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
162928517|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928518|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928519|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928520|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928521|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928522|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928523|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928524|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928525|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928526|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928527|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928528|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928529|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
162928530|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
162928531|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
162928532|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
162928533|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928534|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928535|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928536|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928537|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
162928538|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928539|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928540|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928541|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928542|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
162928543|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928544|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928545|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928546|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928547|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928548|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928549|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928550|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928551|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
162928552|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928553|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928554|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928555|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928556|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928557|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928558|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928559|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928560|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928561|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928562|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
162928563|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928564|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928565|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
162928566|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
162928567|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
162928568|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
162928569|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
162928570|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
162928571|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928572|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928573|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928574|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928575|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928576|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928577|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928578|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928579|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928580|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928581|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
162928582|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928583|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928584|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928585|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928586|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928587|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928588|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928589|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
162928590|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928591|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928592|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928593|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928594|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928595|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928596|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928597|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928598|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928599|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928600|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928601|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928602|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928603|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928604|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
162928605|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
162928606|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
162928607|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
162928608|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
162928609|NCT01915498|588441356|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
162928610|NCT01915498|588441357|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928611|NCT01915498|588441358|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928612|NCT01915498|588441359|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
162928613|NCT01915498|588441360|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
162928614|NCT01915498|588441361|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
162928615|NCT01915498|588441362|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
162928616|NCT01915498|588441363|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
162928617|NCT01915498|588441364|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
162928618|NCT01915498|588441365|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
162928619|NCT01915498|588441366|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928620|NCT01915498|588441367|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
162928621|NCT01915498|588441368|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
162928622|NCT01915498|588441369|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
162928623|NCT01915498|588441370|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
162928624|NCT01915498|588441371|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
162928625|NCT01915498|588441372|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
162928626|NCT01915498|588441373|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
162928627|NCT01915498|588441374|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
162928628|NCT01915498|588441356|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928629|NCT01915498|588441357|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928630|NCT01915498|588441358|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928631|NCT01915498|588441359|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928632|NCT01915498|588441360|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928633|NCT01915498|588441361|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928634|NCT01915498|588441362|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928635|NCT01915498|588441363|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928636|NCT01915498|588441364|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928637|NCT01915498|588441365|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
163041171|NCT04811664|588858088|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
163041172|NCT04811664|588858086|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
163156583|NCT01352793|589287892|FG000|Overall Study|Other|25|||
162928638|NCT01915498|588441366|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928639|NCT01915498|588441367|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928640|NCT01915498|588441368|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928641|NCT01915498|588441369|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928642|NCT01915498|588441370|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928643|NCT01915498|588441371|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928644|NCT01915498|588441372|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928645|NCT01915498|588441373|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
162928646|NCT01915498|588441374|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
162928647|NCT01915498|588441356|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928648|NCT01915498|588441357|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928649|NCT01915498|588441358|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928650|NCT01915498|588441359|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928651|NCT01915498|588441360|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928652|NCT01915498|588441361|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928653|NCT01915498|588441362|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928654|NCT01915498|588441363|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928655|NCT01915498|588441364|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928656|NCT01915498|588441365|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928657|NCT01915498|588441366|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928658|NCT01915498|588441367|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928659|NCT01915498|588441368|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928660|NCT01915498|588441369|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928661|NCT01915498|588441370|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928662|NCT01915498|588441371|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928663|NCT01915498|588441372|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928664|NCT01915498|588441373|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
162928665|NCT01915498|588441374|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
162928666|NCT01915498|588441356|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928667|NCT01915498|588441357|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928668|NCT01915498|588441358|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928669|NCT01915498|588441359|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928670|NCT01915498|588441360|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928671|NCT01915498|588441361|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928672|NCT01915498|588441362|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928673|NCT01915498|588441363|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928674|NCT01915498|588441364|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928675|NCT01915498|588441365|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928676|NCT01915498|588441366|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928677|NCT01915498|588441367|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928678|NCT01915498|588441368|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928679|NCT01915498|588441369|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928680|NCT01915498|588441370|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928681|NCT01915498|588441371|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928682|NCT01915498|588441372|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928683|NCT01915498|588441373|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
162928684|NCT01915498|588441374|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
162928685|NCT00314262|588441380|FG000|Overall Study|Adverse Event|2|||
162928686|NCT00314262|588441380|FG000|Overall Study|Withdrawal by Subject|2|||
162928687|NCT00314262|588441380|FG000|Overall Study|Physician Decision|1|||
162928688|NCT01185639|588441381|FG000|Overall Study|Progressed and didn't receive therapy|2|||
162928689|NCT02662556|588441382|FG000|Overall Study|Adverse Event|4|||
162928690|NCT02662556|588441382|FG000|Overall Study|Lack of Efficacy|4|||
162928691|NCT00563524|588443704|FG000|Overall Study|Adverse Event|0|||
162928692|NCT00563524|588443705|FG001|Overall Study|Adverse Event|1|||
162928693|NCT00563524|588443706|FG002|Overall Study|Adverse Event|0|||
162928694|NCT00563524|588443707|FG003|Overall Study|Adverse Event|0|||
162928695|NCT00563524|588443708|FG004|Overall Study|Adverse Event|2|||
162928696|NCT00563524|588443709|FG005|Overall Study|Adverse Event|0|||
162928697|NCT00563524|588443704|FG000|Overall Study|Lost to Follow-up|1|||
162928698|NCT00563524|588443705|FG001|Overall Study|Lost to Follow-up|0|||
162928699|NCT00563524|588443706|FG002|Overall Study|Lost to Follow-up|0|||
162928700|NCT00563524|588443707|FG003|Overall Study|Lost to Follow-up|0|||
162928701|NCT00563524|588443708|FG004|Overall Study|Lost to Follow-up|0|||
162928702|NCT00563524|588443709|FG005|Overall Study|Lost to Follow-up|0|||
162928703|NCT00563524|588443704|FG000|Overall Study|Protocol Violation|0|||
162928704|NCT00563524|588443705|FG001|Overall Study|Protocol Violation|1|||
162928705|NCT00563524|588443706|FG002|Overall Study|Protocol Violation|0|||
162928706|NCT00563524|588443707|FG003|Overall Study|Protocol Violation|0|||
162928707|NCT00563524|588443708|FG004|Overall Study|Protocol Violation|0|||
162928708|NCT00563524|588443709|FG005|Overall Study|Protocol Violation|0|||
162928709|NCT00563524|588443704|FG000|Overall Study|Withdrawal by Subject|1|||
162928710|NCT00563524|588443705|FG001|Overall Study|Withdrawal by Subject|1|||
162928711|NCT00563524|588443706|FG002|Overall Study|Withdrawal by Subject|3|||
162928712|NCT00563524|588443707|FG003|Overall Study|Withdrawal by Subject|0|||
162928713|NCT00563524|588443708|FG004|Overall Study|Withdrawal by Subject|0|||
162928714|NCT00563524|588443709|FG005|Overall Study|Withdrawal by Subject|1|||
162928715|NCT01467570|588443711|FG000|Overall Study|Lost to Follow-up|8|||
162928716|NCT01467570|588443712|FG001|Overall Study|Lost to Follow-up|9|||
162928717|NCT01222715|588443717|FG000|Overall Study|Adverse Event|0|||
162928718|NCT01222715|588443718|FG001|Overall Study|Adverse Event|4|||
162928719|NCT01222715|588443717|FG000|Overall Study|Death|0|||
162928720|NCT01222715|588443718|FG001|Overall Study|Death|1|||
162928721|NCT01222715|588443717|FG000|Overall Study|Lack of Efficacy|22|||
162928722|NCT01222715|588443718|FG001|Overall Study|Lack of Efficacy|14|||
162928723|NCT01222715|588443717|FG000|Overall Study|Physician Decision|12|||
162928724|NCT01222715|588443718|FG001|Overall Study|Physician Decision|2|||
162928725|NCT01222715|588443717|FG000|Overall Study|Refusal of further protocol therapy|0|||
162928726|NCT01222715|588443718|FG001|Overall Study|Refusal of further protocol therapy|4|||
162928727|NCT01222715|588443717|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
162928728|NCT01222715|588443718|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
162928729|NCT01222715|588443717|FG000|Overall Study|Ineligible|0|||
162928730|NCT01222715|588443718|FG001|Overall Study|Ineligible|1|||
162928731|NCT01222715|588443717|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
162928732|NCT01222715|588443718|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
162928733|NCT03836729|588443719|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
162928734|NCT00520494|588443727|FG000|Overall Study|Withdrawal by Subject|1|||
162928735|NCT00544557|588443730|FG000|Overall Study|Adverse Event|140|||
162928736|NCT00544557|588443730|FG000|Overall Study|Lack of Efficacy|196|||
162928737|NCT00544557|588443730|FG000|Overall Study|Other|98|||
162928738|NCT00467818|588443731|FG000|Overall Study|Adverse Event|1|||
162928739|NCT00467818|588443732|FG001|Overall Study|Adverse Event|0|||
162928740|NCT00467818|588443731|FG000|Overall Study|Lost to Follow-up|2|||
162928741|NCT00467818|588443732|FG001|Overall Study|Lost to Follow-up|2|||
162928742|NCT01830920|588443734|FG000|Overall Study|Adverse Event|1|||
162928743|NCT01830920|588443735|FG001|Overall Study|Adverse Event|0|||
162928744|NCT01830920|588443736|FG002|Overall Study|Adverse Event|1|||
162928745|NCT01830920|588443737|FG003|Overall Study|Adverse Event|0|||
162928746|NCT01830920|588443738|FG004|Overall Study|Adverse Event|0|||
162928747|NCT01830920|588443734|FG000|Overall Study|Withdrawal by Subject|2|||
162928748|NCT01830920|588443735|FG001|Overall Study|Withdrawal by Subject|2|||
162928749|NCT01830920|588443736|FG002|Overall Study|Withdrawal by Subject|1|||
162928750|NCT01830920|588443737|FG003|Overall Study|Withdrawal by Subject|7|||
162928751|NCT01830920|588443738|FG004|Overall Study|Withdrawal by Subject|1|||
162928752|NCT01830920|588443734|FG000|Overall Study|Death|3|||
162928753|NCT01830920|588443735|FG001|Overall Study|Death|3|||
162928754|NCT01830920|588443736|FG002|Overall Study|Death|5|||
162928755|NCT01830920|588443737|FG003|Overall Study|Death|4|||
162928756|NCT01830920|588443738|FG004|Overall Study|Death|4|||
162928757|NCT01830920|588443734|FG000|Overall Study|Other|15|||
162928758|NCT01830920|588443735|FG001|Overall Study|Other|1|||
162928759|NCT01830920|588443736|FG002|Overall Study|Other|1|||
162928760|NCT01830920|588443737|FG003|Overall Study|Other|5|||
162928761|NCT01830920|588443738|FG004|Overall Study|Other|3|||
162928762|NCT01313728|588443739|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
162928763|NCT02216214|588443740|FG000|Overall Study|Randomized Never Received Study Drug|1|||
162928764|NCT02216214|588443741|FG001|Overall Study|Randomized Never Received Study Drug|0|||
162928765|NCT02216214|588443740|FG000|Overall Study|Adverse Event|10|||
162928766|NCT02216214|588443741|FG001|Overall Study|Adverse Event|8|||
162928767|NCT02216214|588443740|FG000|Overall Study|Lack of Efficacy|2|||
162928768|NCT02216214|588443741|FG001|Overall Study|Lack of Efficacy|2|||
162928769|NCT02216214|588443740|FG000|Overall Study|Lost to Follow-up|3|||
162928770|NCT02216214|588443741|FG001|Overall Study|Lost to Follow-up|2|||
162928771|NCT02216214|588443740|FG000|Overall Study|Protocol Violation|4|||
162928772|NCT02216214|588443741|FG001|Overall Study|Protocol Violation|2|||
162928773|NCT02216214|588443740|FG000|Overall Study|Withdrawal by Subject|22|||
162928774|NCT02216214|588443741|FG001|Overall Study|Withdrawal by Subject|20|||
162928775|NCT02216214|588443740|FG000|Overall Study|Study Terminated By Sponsor|0|||
162928776|NCT02216214|588443741|FG001|Overall Study|Study Terminated By Sponsor|1|||
162928777|NCT02216214|588443740|FG000|Overall Study|Miscellaneous|1|||
162928778|NCT02216214|588443741|FG001|Overall Study|Miscellaneous|1|||
162928779|NCT05354206|588443743|FG000|Overall Study|Withdrawal by Subject|1|||
162928780|NCT05354206|588443744|FG001|Overall Study|Withdrawal by Subject|0|||
162928781|NCT00713830|588443747|FG000|Overall Study|Adverse Event|23|||
162928782|NCT00713830|588443748|FG001|Overall Study|Adverse Event|71|||
162928783|NCT00713830|588443747|FG000|Overall Study|Lack of Efficacy|24|||
162928784|NCT00713830|588443748|FG001|Overall Study|Lack of Efficacy|16|||
162928785|NCT00713830|588443747|FG000|Overall Study|Lost to Follow-up|2|||
162928786|NCT00713830|588443748|FG001|Overall Study|Lost to Follow-up|9|||
162928787|NCT00713830|588443747|FG000|Overall Study|Withdrawal by Subject|13|||
162928788|NCT00713830|588443748|FG001|Overall Study|Withdrawal by Subject|23|||
162928789|NCT00713830|588443747|FG000|Overall Study|Poor Compliance to Protocol|7|||
162928790|NCT00713830|588443748|FG001|Overall Study|Poor Compliance to Protocol|14|||
162928791|NCT00713830|588443747|FG000|Overall Study|Familial and Personal Reasons|9|||
162928792|NCT00713830|588443748|FG001|Overall Study|Familial and Personal Reasons|34|||
162928793|NCT00713830|588443747|FG000|Overall Study|Sponsor Decision|4|||
162928794|NCT00713830|588443748|FG001|Overall Study|Sponsor Decision|10|||
162928795|NCT04057118|588443751|FG000|Overall Study|Adverse Event|1|||
162928796|NCT04057118|588443752|FG001|Overall Study|Adverse Event|0|||
162928797|NCT04057118|588443753|FG002|Overall Study|Adverse Event|1|||
162928798|NCT04057118|588443754|FG003|Overall Study|Adverse Event|1|||
162928799|NCT04057118|588443751|FG000|Overall Study|Physician Decision|0|||
162928800|NCT04057118|588443752|FG001|Overall Study|Physician Decision|0|||
162928801|NCT04057118|588443753|FG002|Overall Study|Physician Decision|1|||
162928802|NCT04057118|588443754|FG003|Overall Study|Physician Decision|1|||
162928803|NCT04057118|588443751|FG000|Overall Study|Withdrawal by Subject|2|||
162928804|NCT04057118|588443752|FG001|Overall Study|Withdrawal by Subject|2|||
163041173|NCT04811664|588858087|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
162928805|NCT04057118|588443753|FG002|Overall Study|Withdrawal by Subject|0|||
162928806|NCT04057118|588443754|FG003|Overall Study|Withdrawal by Subject|2|||
162928807|NCT04057118|588443751|FG000|Overall Study|Not Specific|0|||
162928808|NCT04057118|588443752|FG001|Overall Study|Not Specific|0|||
162928809|NCT04057118|588443753|FG002|Overall Study|Not Specific|1|||
162928810|NCT04057118|588443754|FG003|Overall Study|Not Specific|1|||
162928811|NCT03402126|588443757|FG000|Overall Study|Lost to Follow-up|6|||
162928812|NCT03402126|588443757|FG000|Overall Study|Protocol Violation|10|||
162928813|NCT03402126|588443757|FG000|Overall Study|Sponsor request/Study termination|29|||
162928814|NCT03402126|588443757|FG000|Overall Study|Study product no longer in use|1|||
162928815|NCT03402126|588443757|FG000|Overall Study|Technical problems|1|||
162928816|NCT03402126|588443757|FG000|Overall Study|Withdrawal by Subject|6|||
162928817|NCT03402126|588443757|FG000|Overall Study|Physician Decision|2|||
162928818|NCT03402126|588443757|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
162928819|NCT03402126|588443757|FG000|Overall Study|Death|4|||
162928820|NCT02261974|588443758|FG000|Overall Study|Withdrawal by Subject|3|||
162928821|NCT02261974|588443759|FG001|Overall Study|Withdrawal by Subject|2|||
162928822|NCT02261974|588443758|FG000|Overall Study|Pregnancy|0|||
162928823|NCT02261974|588443759|FG001|Overall Study|Pregnancy|1|||
162928824|NCT02261974|588443758|FG000|Overall Study|Missed treatment cut-off date|6|||
162928825|NCT02261974|588443759|FG001|Overall Study|Missed treatment cut-off date|3|||
162928826|NCT02261974|588443758|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
162928827|NCT02261974|588443759|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
162928828|NCT02261974|588443758|FG000|Overall Study|Lost to Follow-up|2|||
162928829|NCT02261974|588443759|FG001|Overall Study|Lost to Follow-up|0|||
162928830|NCT02261974|588443758|FG000|Overall Study|Adverse Event|1|||
162928831|NCT02261974|588443759|FG001|Overall Study|Adverse Event|0|||
162928832|NCT02030834|588443760|FG000|Overall Study|Death|4|||
162928833|NCT02030834|588443761|FG001|Overall Study|Death|0|||
162928834|NCT02030834|588443762|FG002|Overall Study|Death|0|||
162928835|NCT02030834|588443760|FG000|Overall Study|Manufacturing failure|2|||
162928836|NCT02030834|588443761|FG001|Overall Study|Manufacturing failure|0|||
162928837|NCT02030834|588443762|FG002|Overall Study|Manufacturing failure|1|||
162928838|NCT02030834|588443760|FG000|Overall Study|Disease progression|2|||
162928839|NCT02030834|588443761|FG001|Overall Study|Disease progression|0|||
162928840|NCT02030834|588443762|FG002|Overall Study|Disease progression|2|||
162928841|NCT02030834|588443760|FG000|Overall Study|Lost to Follow-up|1|||
162928842|NCT02030834|588443761|FG001|Overall Study|Lost to Follow-up|0|||
162928843|NCT02030834|588443762|FG002|Overall Study|Lost to Follow-up|0|||
162928844|NCT02030834|588443760|FG000|Overall Study|Withdrawal by Subject|1|||
162928845|NCT02030834|588443761|FG001|Overall Study|Withdrawal by Subject|0|||
162928846|NCT02030834|588443762|FG002|Overall Study|Withdrawal by Subject|0|||
162928847|NCT02030834|588443760|FG000|Overall Study|Lack of funding|1|||
162928848|NCT02030834|588443761|FG001|Overall Study|Lack of funding|0|||
162928849|NCT02030834|588443762|FG002|Overall Study|Lack of funding|0|||
162928850|NCT04440007|588443763|FG000|Overall Study|Adverse Event|0|||
162928851|NCT04440007|588443764|FG001|Overall Study|Adverse Event|1|||
162928852|NCT04440007|588443763|FG000|Overall Study|Lost to Follow-up|1|||
162928853|NCT04440007|588443764|FG001|Overall Study|Lost to Follow-up|3|||
162928854|NCT04440007|588443763|FG000|Overall Study|Death|7|||
162928855|NCT04440007|588443764|FG001|Overall Study|Death|2|||
162928856|NCT04440007|588443763|FG000|Overall Study|Physician Decision|1|||
162928857|NCT04440007|588443764|FG001|Overall Study|Physician Decision|1|||
162928858|NCT04440007|588443763|FG000|Overall Study|Withdrawal by Subject|2|||
162928859|NCT04440007|588443764|FG001|Overall Study|Withdrawal by Subject|1|||
162928860|NCT04440007|588443763|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
162928861|NCT04440007|588443764|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
162928862|NCT04440007|588443763|FG000|Overall Study|Discontinued prior to dosing|0|||
162928863|NCT04440007|588443764|FG001|Overall Study|Discontinued prior to dosing|2|||
162928864|NCT01466673|588443765|FG000|Overall Study|Non-compliance with study treatment|2|||
162928865|NCT01466673|588443766|FG001|Overall Study|Non-compliance with study treatment|0|||
162928866|NCT01466673|588443765|FG000|Overall Study|Lost to Follow-up|3|||
162928867|NCT01466673|588443766|FG001|Overall Study|Lost to Follow-up|5|||
162928868|NCT01466673|588443765|FG000|Overall Study|Adverse Event|2|||
162928869|NCT01466673|588443766|FG001|Overall Study|Adverse Event|1|||
162928870|NCT04529499|588443770|FG000|Overall Study|Withdrawal by Subject|9|||
162928871|NCT04529499|588443771|FG001|Overall Study|Withdrawal by Subject|11|||
162928872|NCT04529499|588443770|FG000|Overall Study|Physician Decision|1|||
162928873|NCT04529499|588443771|FG001|Overall Study|Physician Decision|2|||
162928874|NCT04529499|588443770|FG000|Overall Study|Adverse Event|4|||
162928875|NCT04529499|588443771|FG001|Overall Study|Adverse Event|4|||
162928876|NCT04529499|588443770|FG000|Overall Study|Death|14|||
162928877|NCT04529499|588443771|FG001|Overall Study|Death|11|||
162928878|NCT04529499|588443770|FG000|Overall Study|Lost to Follow-up|1|||
162928879|NCT04529499|588443771|FG001|Overall Study|Lost to Follow-up|1|||
162928880|NCT04529499|588443770|FG000|Overall Study|Others|7|||
162928881|NCT04529499|588443771|FG001|Overall Study|Others|11|||
162928882|NCT00683904|588443772|FG000|Dose Level 1|Disease progression|2|||
162928883|NCT00683904|588443773|FG001|Dose Level 1|Disease progression|0|||
162928884|NCT00683904|588443772|FG000|Dose Level 1|Adverse Event|1|||
162928885|NCT00683904|588443773|FG001|Dose Level 1|Adverse Event|0|||
162928886|NCT00683904|588443772|FG000|Dose Level 2|Adverse Event|0|||
162928887|NCT00683904|588443773|FG001|Dose Level 2|Adverse Event|2|||
162928888|NCT02702271|588443774|FG000|Overall Study|Death|36|||
162928889|NCT02702271|588443775|FG001|Overall Study|Death|7|||
162928890|NCT02702271|588443774|FG000|Overall Study|Lost to Follow-up|12|||
162928891|NCT02702271|588443775|FG001|Overall Study|Lost to Follow-up|0|||
162928892|NCT02702271|588443774|FG000|Overall Study|Withdrawal by Subject|8|||
162928893|NCT02702271|588443775|FG001|Overall Study|Withdrawal by Subject|1|||
162928894|NCT02702271|588443774|FG000|Overall Study|Physician Decision|2|||
162928895|NCT02702271|588443775|FG001|Overall Study|Physician Decision|0|||
162928896|NCT02702271|588443774|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
162928897|NCT02702271|588443775|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
162928898|NCT01494649|588443776|FG000|Overall Study|Lost to Follow-up|0|||
162928899|NCT01494649|588443777|FG001|Overall Study|Lost to Follow-up|1|||
162928900|NCT03091400|588443778|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
162928901|NCT03091400|588443779|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
162928902|NCT00975884|588443780|FG000|Overall Study|Adverse Event|1|||
162928903|NCT00975884|588443781|FG001|Overall Study|Adverse Event|0|||
162928904|NCT00975884|588443780|FG000|Overall Study|Lost to Follow-up|5|||
162928905|NCT00975884|588443781|FG001|Overall Study|Lost to Follow-up|3|||
162928906|NCT00975884|588443780|FG000|Overall Study|Withdrawal by Subject|9|||
162928907|NCT00975884|588443781|FG001|Overall Study|Withdrawal by Subject|9|||
162928908|NCT00975884|588443780|FG000|Overall Study|Other|1|||
162928909|NCT00975884|588443781|FG001|Overall Study|Other|3|||
162928910|NCT03707522|588443782|FG000|Overall Study|Lost to Follow-up|24|||
162928911|NCT03707522|588443783|FG001|Overall Study|Lost to Follow-up|27|||
162928912|NCT03707522|588443784|FG002|Overall Study|Lost to Follow-up|41|||
162928913|NCT03707522|588443785|FG003|Overall Study|Lost to Follow-up|36|||
162928914|NCT00383019|588443786|FG000|Overall Study|Adverse Event|5|||
162928915|NCT00383019|588443787|FG001|Overall Study|Adverse Event|1|||
162928916|NCT00383019|588443786|FG000|Overall Study|Withdrawal by Subject|0|||
162928917|NCT00383019|588443787|FG001|Overall Study|Withdrawal by Subject|1|||
162928918|NCT02508649|588443788|FG000|Overall Study|Withdrawal by Subject|4|||
162928919|NCT02508649|588443789|FG001|Overall Study|Withdrawal by Subject|6|||
162928920|NCT02508649|588443790|FG002|Overall Study|Withdrawal by Subject|5|||
162928921|NCT02508649|588443791|FG003|Overall Study|Withdrawal by Subject|6|||
162928922|NCT02508649|588443788|FG000|Overall Study|Investigator withdrew the subject|1|||
162928923|NCT02508649|588443789|FG001|Overall Study|Investigator withdrew the subject|2|||
162928924|NCT02508649|588443790|FG002|Overall Study|Investigator withdrew the subject|1|||
162928925|NCT02508649|588443791|FG003|Overall Study|Investigator withdrew the subject|0|||
162928926|NCT02508649|588443788|FG000|Overall Study|Post randomization screening failure|12|||
162928927|NCT02508649|588443789|FG001|Overall Study|Post randomization screening failure|4|||
162928928|NCT02508649|588443790|FG002|Overall Study|Post randomization screening failure|9|||
162928929|NCT02508649|588443791|FG003|Overall Study|Post randomization screening failure|3|||
162928930|NCT02508649|588443788|FG000|Overall Study|Lost to Follow-up|1|||
162928931|NCT02508649|588443789|FG001|Overall Study|Lost to Follow-up|1|||
162928932|NCT02508649|588443790|FG002|Overall Study|Lost to Follow-up|0|||
162928933|NCT02508649|588443791|FG003|Overall Study|Lost to Follow-up|1|||
162928934|NCT00446134|588443792|FG000|Overall Study|Adverse Event|7|||
162928935|NCT00446134|588443793|FG001|Overall Study|Adverse Event|17|||
162928936|NCT00446134|588443794|FG002|Overall Study|Adverse Event|13|||
162928937|NCT00446134|588443795|FG003|Overall Study|Adverse Event|18|||
162928938|NCT00446134|588443792|FG000|Overall Study|Lack of Efficacy|19|||
162928939|NCT00446134|588443793|FG001|Overall Study|Lack of Efficacy|19|||
162928940|NCT00446134|588443794|FG002|Overall Study|Lack of Efficacy|24|||
162928941|NCT00446134|588443795|FG003|Overall Study|Lack of Efficacy|19|||
162928942|NCT00446134|588443792|FG000|Overall Study|Protocol Violation|0|||
162928943|NCT00446134|588443793|FG001|Overall Study|Protocol Violation|2|||
162928944|NCT00446134|588443794|FG002|Overall Study|Protocol Violation|1|||
162928945|NCT00446134|588443795|FG003|Overall Study|Protocol Violation|0|||
162928946|NCT00446134|588443792|FG000|Overall Study|Lost to Follow-up|1|||
162928947|NCT00446134|588443793|FG001|Overall Study|Lost to Follow-up|3|||
162928948|NCT00446134|588443794|FG002|Overall Study|Lost to Follow-up|1|||
162928949|NCT00446134|588443795|FG003|Overall Study|Lost to Follow-up|1|||
162928950|NCT00446134|588443792|FG000|Overall Study|Withdrawal by Subject|3|||
162928951|NCT00446134|588443793|FG001|Overall Study|Withdrawal by Subject|3|||
162928952|NCT00446134|588443794|FG002|Overall Study|Withdrawal by Subject|1|||
162928953|NCT00446134|588443795|FG003|Overall Study|Withdrawal by Subject|3|||
162928954|NCT00446134|588443792|FG000|Overall Study|Physician Decision|0|||
162928955|NCT00446134|588443793|FG001|Overall Study|Physician Decision|0|||
162928956|NCT00446134|588443794|FG002|Overall Study|Physician Decision|0|||
162928957|NCT00446134|588443795|FG003|Overall Study|Physician Decision|2|||
162928958|NCT00446134|588443792|FG000|Overall Study|Adverse Event-Diarrhea|1|||
162928959|NCT00446134|588443793|FG001|Overall Study|Adverse Event-Diarrhea|1|||
162928960|NCT00446134|588443794|FG002|Overall Study|Adverse Event-Diarrhea|2|||
162928961|NCT00446134|588443795|FG003|Overall Study|Adverse Event-Diarrhea|0|||
162928962|NCT00446134|588443792|FG000|Overall Study|Reason Not Completed|3|||
162928963|NCT00446134|588443793|FG001|Overall Study|Reason Not Completed|0|||
162928964|NCT00446134|588443794|FG002|Overall Study|Reason Not Completed|1|||
162928965|NCT00446134|588443795|FG003|Overall Study|Reason Not Completed|2|||
162928966|NCT00567996|588443799|FG000|Overall Study|Adverse Event|18|||
162928967|NCT00567996|588443800|FG001|Overall Study|Adverse Event|16|||
162928968|NCT00567996|588443801|FG002|Overall Study|Adverse Event|13|||
162928969|NCT00567996|588443799|FG000|Overall Study|Protocol Deviation|9|||
162928970|NCT00567996|588443800|FG001|Overall Study|Protocol Deviation|11|||
162928971|NCT00567996|588443801|FG002|Overall Study|Protocol Deviation|13|||
162928972|NCT00567996|588443799|FG000|Overall Study|Withdrawal by Subject|8|||
162928973|NCT00567996|588443800|FG001|Overall Study|Withdrawal by Subject|12|||
162928974|NCT00567996|588443801|FG002|Overall Study|Withdrawal by Subject|22|||
162928975|NCT00567996|588443799|FG000|Overall Study|Abnormal Lab value(s)|2|||
162928976|NCT00567996|588443800|FG001|Overall Study|Abnormal Lab value(s)|1|||
162928977|NCT00567996|588443801|FG002|Overall Study|Abnormal Lab value(s)|2|||
162928978|NCT00567996|588443799|FG000|Overall Study|Abnormal test procedure result(s)|2|||
162928979|NCT00567996|588443800|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162928980|NCT00567996|588443801|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162928981|NCT00567996|588443799|FG000|Overall Study|Lost to Follow-up|2|||
162928982|NCT00567996|588443800|FG001|Overall Study|Lost to Follow-up|5|||
162928983|NCT00567996|588443801|FG002|Overall Study|Lost to Follow-up|2|||
162928984|NCT00567996|588443799|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162928985|NCT00567996|588443800|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162928986|NCT00567996|588443801|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
162928987|NCT00567996|588443799|FG000|Overall Study|Administrative problems|1|||
162928988|NCT00567996|588443800|FG001|Overall Study|Administrative problems|1|||
162928989|NCT00567996|588443801|FG002|Overall Study|Administrative problems|0|||
162928990|NCT00567996|588443799|FG000|Overall Study|Death|1|||
162928991|NCT00567996|588443800|FG001|Overall Study|Death|0|||
162928992|NCT00567996|588443801|FG002|Overall Study|Death|2|||
162928993|NCT00567996|588443799|FG000|Overall Study|Patient's inability to use the device|0|||
162928994|NCT00567996|588443800|FG001|Overall Study|Patient's inability to use the device|1|||
162928995|NCT00567996|588443801|FG002|Overall Study|Patient's inability to use the device|0|||
162928996|NCT02956005|588443803|FG000|Overall Study|Not eligible|1|||
162928997|NCT02956005|588443803|FG000|Overall Study|Withdrawal by Subject|3|||
162928998|NCT02956005|588443803|FG000|Overall Study|Physician Decision|12|||
162928999|NCT03125629|588443804|FG000|Overall Study|Withdrawal by Subject|2|||
162929000|NCT03125629|588443804|FG000|Overall Study|Equipment malfunction|1|||
162929001|NCT00743119|588443805|FG000|Overall Study|unreliable|3|||
162929002|NCT00743119|588443805|FG000|Overall Study|Withdrawal by Subject|1|||
162929003|NCT02524665|588443806|FG000|Overall Study|Lost to Follow-up|1|||
162929004|NCT02989610|588443807|FG000|Overall Study|Withdrawal by Subject|20|||
162929005|NCT02989610|588443807|FG000|Overall Study|Departure of PI from Site|8|||
162929006|NCT02989610|588443807|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
162929007|NCT02989610|588443807|FG000|Overall Study|Lost to Follow-up|3|||
162929008|NCT02989610|588443807|FG000|Overall Study|Death|3|||
162929009|NCT02989610|588443807|FG000|Overall Study|System Explant|3|||
162929010|NCT02989610|588443807|FG000|Overall Study|Subject Non-Compliance|2|||
162929011|NCT02989610|588443807|FG000|Overall Study|System Revision|2|||
162929012|NCT02989610|588443807|FG000|Overall Study|PI Left, Study Closing|1|||
162929013|NCT02989610|588443807|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
162929014|NCT02989610|588443807|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
162929015|NCT02602080|588443810|FG000|Overall Study|Protocol Violation|6|||
162929016|NCT02602080|588443811|FG001|Overall Study|Protocol Violation|1|||
162929017|NCT02602080|588443812|FG002|Overall Study|Protocol Violation|3|||
162929018|NCT04508621|588443820|FG000|Overall Study|Adverse Event|39|||
162929019|NCT04508621|588443821|FG001|Overall Study|Adverse Event|16|||
162929020|NCT04508621|588443820|FG000|Overall Study|Lack of Efficacy|2|||
162929021|NCT04508621|588443821|FG001|Overall Study|Lack of Efficacy|8|||
162929022|NCT04508621|588443820|FG000|Overall Study|Physician Decision|0|||
162929023|NCT04508621|588443821|FG001|Overall Study|Physician Decision|1|||
162929024|NCT04508621|588443820|FG000|Overall Study|Withdrawal by Subject|10|||
162929025|NCT04508621|588443821|FG001|Overall Study|Withdrawal by Subject|14|||
162929026|NCT04508621|588443820|FG000|Overall Study|Lost to Follow-up|12|||
162929027|NCT04508621|588443821|FG001|Overall Study|Lost to Follow-up|9|||
162929028|NCT04508621|588443820|FG000|Overall Study|COVID-19 related crisis|3|||
162929029|NCT04508621|588443821|FG001|Overall Study|COVID-19 related crisis|0|||
162929030|NCT04508621|588443820|FG000|Overall Study|Subject non-compliance|1|||
162929031|NCT04508621|588443821|FG001|Overall Study|Subject non-compliance|0|||
162929032|NCT01066039|588443822|FG000|Overall Study|Adverse Event|6|||
162929033|NCT01066039|588443822|FG000|Overall Study|Withdrawal by Subject|17|||
162929034|NCT01066039|588443822|FG000|Overall Study|Protocol Violation|2|||
162929035|NCT01066039|588443822|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
162929036|NCT01066039|588443822|FG000|Overall Study|Investigator's Request|1|||
162929037|NCT01066039|588443822|FG000|Overall Study|Dropout due to Insulin Administration|1|||
162929038|NCT01066039|588443822|FG000|Overall Study|Additional Antihypertensive Required|4|||
163156584|NCT01352793|589287893|FG001|Overall Study|Other|7|||
162929039|NCT01066039|588443822|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
162929040|NCT01066039|588443822|FG000|Overall Study|Failure to Control Blood Pressure|1|||
162929041|NCT01066039|588443822|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
162929042|NCT02574260|588443823|FG000|Overall Study|Disease Progression|1|||
162929043|NCT00752895|588443824|FG000|Overall Study|Withdrawal by Subject|8|||
162929044|NCT00752895|588443825|FG001|Overall Study|Withdrawal by Subject|3|||
162929045|NCT03022799|588443826|FG000|Overall Study|Adverse Event|0|||
162929046|NCT03022799|588443827|FG001|Overall Study|Adverse Event|0|||
162929047|NCT03022799|588443828|FG002|Overall Study|Adverse Event|0|||
162929048|NCT03022799|588443829|FG003|Overall Study|Adverse Event|0|||
162929049|NCT03022799|588443830|FG004|Overall Study|Adverse Event|0|||
162929050|NCT03022799|588443831|FG005|Overall Study|Adverse Event|0|||
162929051|NCT03022799|588443832|FG006|Overall Study|Adverse Event|0|||
162929052|NCT03022799|588443833|FG007|Overall Study|Adverse Event|0|||
162929053|NCT03022799|588443834|FG008|Overall Study|Adverse Event|0|||
162929054|NCT03022799|588443835|FG009|Overall Study|Adverse Event|1|||
162929055|NCT03022799|588443836|FG010|Overall Study|Adverse Event|1|||
162929056|NCT03022799|588443837|FG011|Overall Study|Adverse Event|0|||
162929057|NCT03022799|588443838|FG012|Overall Study|Adverse Event|0|||
162929058|NCT04881448|588443839|FG000|Overall Study|Study cancelled by sponsor|220|||
162929059|NCT04881448|588443839|FG000|Overall Study|Withdrawal by Subject|2|||
162929060|NCT04881448|588443839|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
162929061|NCT01966107|588443841|FG000|Overall Study|excluded from FAS|21|||
162929062|NCT01966107|588443842|FG001|Overall Study|excluded from FAS|20|||
162929063|NCT01966107|588443841|FG000|Overall Study|discontinued treatment|345|||
162929064|NCT01966107|588443842|FG001|Overall Study|discontinued treatment|372|||
162929065|NCT01966107|588443841|FG000|Overall Study|due to study closure|164|||
162929066|NCT01966107|588443842|FG001|Overall Study|due to study closure|186|||
162929067|NCT01966107|588443841|FG000|Overall Study|withdrew from the study|272|||
162929068|NCT01966107|588443842|FG001|Overall Study|withdrew from the study|303|||
162929069|NCT02200614|588443843|FG000|Double Blind Treatment|Adverse Event|86|||
162929070|NCT02200614|588443844|FG001|Double Blind Treatment|Adverse Event|48|||
162929071|NCT02200614|588443843|FG000|Double Blind Treatment|Confirmed metastasis|120|||
163041174|NCT04811664|588858088|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
163041175|NCT04811664|588858086|FG000|Overall Study|Protocol Violation|0|||
163041176|NCT04811664|588858087|FG001|Overall Study|Protocol Violation|5|||
163041177|NCT04811664|588858088|FG002|Overall Study|Protocol Violation|11|||
163041178|NCT04811664|588858086|FG000|Overall Study|Study Terminated by Sponsor|4|||
163041179|NCT04811664|588858087|FG001|Overall Study|Study Terminated by Sponsor|3|||
163041180|NCT04811664|588858088|FG002|Overall Study|Study Terminated by Sponsor|34|||
163041181|NCT04811664|588858086|FG000|Overall Study|Early Study Closure|3|||
163041182|NCT04811664|588858087|FG001|Overall Study|Early Study Closure|7|||
163041183|NCT04811664|588858088|FG002|Overall Study|Early Study Closure|79|||
163041184|NCT04811664|588858086|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
163041185|NCT04811664|588858087|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
163041186|NCT04811664|588858088|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
163041187|NCT02717442|588858089|FG000|Overall Study|Study Terminated by Sponsor|31|||
162929072|NCT02200614|588443844|FG001|Double Blind Treatment|Confirmed metastasis|140|||
162929073|NCT02200614|588443843|FG000|Double Blind Treatment|Judgment of the investigator|59|||
162929074|NCT02200614|588443844|FG001|Double Blind Treatment|Judgment of the investigator|99|||
162929075|NCT02200614|588443843|FG000|Double Blind Treatment|Metastasis by local reading|1|||
162929076|NCT02200614|588443844|FG001|Double Blind Treatment|Metastasis by local reading|3|||
162929077|NCT02200614|588443843|FG000|Double Blind Treatment|Other reason|6|||
162929078|NCT02200614|588443844|FG001|Double Blind Treatment|Other reason|2|||
162929079|NCT02200614|588443843|FG000|Double Blind Treatment|Personal reason|77|||
162929080|NCT02200614|588443844|FG001|Double Blind Treatment|Personal reason|85|||
162929081|NCT02200614|588443843|FG000|Double Blind Treatment|Protocol deviation|14|||
162929082|NCT02200614|588443844|FG001|Double Blind Treatment|Protocol deviation|7|||
162929083|NCT02200614|588443843|FG000|Double Blind Treatment|Not treated|1|||
162929084|NCT02200614|588443844|FG001|Double Blind Treatment|Not treated|0|||
162929085|NCT02200614|588443843|FG000|Open Label|Adverse Event|41|||
162929086|NCT02200614|588443844|FG001|Open Label|Adverse Event|11|||
162929087|NCT02200614|588443843|FG000|Open Label|Confirmed metastasis|1|||
162929088|NCT02200614|588443844|FG001|Open Label|Confirmed metastasis|0|||
162929089|NCT02200614|588443843|FG000|Open Label|Judgment of the investigator|29|||
162929090|NCT02200614|588443844|FG001|Open Label|Judgment of the investigator|2|||
162929091|NCT02200614|588443843|FG000|Open Label|Metastasis by local reading|138|||
162929092|NCT02200614|588443844|FG001|Open Label|Metastasis by local reading|27|||
162929093|NCT02200614|588443843|FG000|Open Label|Other reason|22|||
162929094|NCT02200614|588443844|FG001|Open Label|Other reason|4|||
162929095|NCT02200614|588443843|FG000|Open Label|Personal reason|60|||
162929096|NCT02200614|588443844|FG001|Open Label|Personal reason|8|||
162929097|NCT02200614|588443843|FG000|Open Label|Protocol deviation|3|||
162929098|NCT02200614|588443844|FG001|Open Label|Protocol deviation|2|||
162929099|NCT02200614|588443843|FG000|Open Label|Missing|2|||
162929100|NCT02200614|588443844|FG001|Open Label|Missing|2|||
162929101|NCT01898884|588443845|FG000|Multiple Dose Period|Adverse Event|0|||
162929102|NCT01898884|588443846|FG001|Multiple Dose Period|Adverse Event|0|||
162929103|NCT01898884|588443847|FG002|Multiple Dose Period|Adverse Event|0|||
162929104|NCT01898884|588443848|FG003|Multiple Dose Period|Adverse Event|0|||
162929105|NCT01898884|588443849|FG004|Multiple Dose Period|Adverse Event|0|||
162929106|NCT01898884|588443850|FG005|Multiple Dose Period|Adverse Event|0|||
162929107|NCT01898884|588443851|FG006|Multiple Dose Period|Adverse Event|1|||
162929108|NCT01898884|588443852|FG007|Multiple Dose Period|Adverse Event|0|||
162929109|NCT01898884|588443853|FG008|Multiple Dose Period|Adverse Event|0|||
162929110|NCT01898884|588443845|FG000|Multiple Dose Period|Randomized Not Treated|0|||
162929111|NCT01898884|588443846|FG001|Multiple Dose Period|Randomized Not Treated|0|||
162929112|NCT01898884|588443847|FG002|Multiple Dose Period|Randomized Not Treated|0|||
162929113|NCT01898884|588443848|FG003|Multiple Dose Period|Randomized Not Treated|0|||
162929114|NCT01898884|588443849|FG004|Multiple Dose Period|Randomized Not Treated|0|||
162929115|NCT01898884|588443850|FG005|Multiple Dose Period|Randomized Not Treated|0|||
162929116|NCT01898884|588443851|FG006|Multiple Dose Period|Randomized Not Treated|0|||
162929117|NCT01898884|588443852|FG007|Multiple Dose Period|Randomized Not Treated|0|||
162929118|NCT01898884|588443853|FG008|Multiple Dose Period|Randomized Not Treated|1|||
162929119|NCT00434148|588443854|FG000|Overall Study|Adverse Event|18|||
162929120|NCT00434148|588443855|FG001|Overall Study|Adverse Event|18|||
162929121|NCT00434148|588443854|FG000|Overall Study|Lack of Efficacy|25|||
163041188|NCT02717442|588858090|FG001|Overall Study|Study Terminated by Sponsor|29|||
162696316|NCT01533714|587599472|FG000|Overall Study|Lack of Efficacy|0|||
162929122|NCT00434148|588443855|FG001|Overall Study|Lack of Efficacy|28|||
162929123|NCT00434148|588443854|FG000|Overall Study|Withdrawal by Subject|15|||
162929124|NCT00434148|588443855|FG001|Overall Study|Withdrawal by Subject|15|||
162929125|NCT00434148|588443854|FG000|Overall Study|Protocol Violation|4|||
162929126|NCT00434148|588443855|FG001|Overall Study|Protocol Violation|0|||
162929127|NCT00434148|588443854|FG000|Overall Study|Administrative problems|6|||
162929128|NCT00434148|588443855|FG001|Overall Study|Administrative problems|10|||
162929129|NCT00434148|588443854|FG000|Overall Study|Lost to Follow-up|0|||
162929130|NCT00434148|588443855|FG001|Overall Study|Lost to Follow-up|1|||
162929131|NCT00434148|588443854|FG000|Overall Study|Condition no longer requires study drug|1|||
162929132|NCT00434148|588443855|FG001|Overall Study|Condition no longer requires study drug|0|||
162929133|NCT00434148|588443854|FG000|Overall Study|Abnormal test procedure result|0|||
162929134|NCT00434148|588443855|FG001|Overall Study|Abnormal test procedure result|1|||
162929135|NCT00759759|588443856|FG000|Overall Study|didn't return for period 2|1|||
162929136|NCT00759759|588443857|FG001|Overall Study|didn't return for period 2|0|||
162929137|NCT00759759|588443856|FG000|Overall Study|Didn't receive drug in period 2|1|||
162929138|NCT00759759|588443857|FG001|Overall Study|Didn't receive drug in period 2|0|||
162929139|NCT00759759|588443856|FG000|Overall Study|Withdrawal by Subject|2|||
162929140|NCT00759759|588443857|FG001|Overall Study|Withdrawal by Subject|1|||
162929141|NCT01556165|588443861|FG000|Overall Study|Adverse Event|5|||
162929142|NCT01556165|588443862|FG001|Overall Study|Adverse Event|3|||
162929143|NCT01556165|588443861|FG000|Overall Study|Protocol Violation|0|||
162929144|NCT01556165|588443862|FG001|Overall Study|Protocol Violation|3|||
162929145|NCT01556165|588443861|FG000|Overall Study|Withdrawal of Consent|7|||
162929146|NCT01556165|588443862|FG001|Overall Study|Withdrawal of Consent|1|||
162929147|NCT02531698|588443865|FG000|Overall Study|Adverse Event|2|||
162929148|NCT02531698|588443866|FG001|Overall Study|Adverse Event|1|||
162929149|NCT02531698|588443865|FG000|Overall Study|Withdrawal by Subject|6|||
162929150|NCT02531698|588443866|FG001|Overall Study|Withdrawal by Subject|1|||
162929151|NCT02531698|588443865|FG000|Overall Study|Protocol Violation|2|||
162929152|NCT02531698|588443866|FG001|Overall Study|Protocol Violation|0|||
162929153|NCT02531698|588443865|FG000|Overall Study|Lost to Follow-up|1|||
162929154|NCT02531698|588443866|FG001|Overall Study|Lost to Follow-up|0|||
162929155|NCT01861717|588443867|FG000|Overall Study|Lost to Follow-up|1|||
162929156|NCT01861717|588443867|FG000|Overall Study|Withdrawal by Subject|1|||
162929157|NCT02395536|588443873|FG000|Overall Study|Lost to Follow-up|4|||
162929158|NCT02395536|588443874|FG001|Overall Study|Lost to Follow-up|4|||
162929159|NCT02395536|588443873|FG000|Overall Study|Death|2|||
162929160|NCT02395536|588443874|FG001|Overall Study|Death|0|||
162929161|NCT02395536|588443873|FG000|Overall Study|Physician Decision|4|||
162929162|NCT02395536|588443874|FG001|Overall Study|Physician Decision|6|||
162929163|NCT02395536|588443873|FG000|Overall Study|Withdrawal by Subject|9|||
162929164|NCT02395536|588443874|FG001|Overall Study|Withdrawal by Subject|17|||
162929165|NCT02395536|588443873|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
162929166|NCT02395536|588443874|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
162929167|NCT02395536|588443873|FG000|Overall Study|Insurance issue|0|||
162929168|NCT02395536|588443874|FG001|Overall Study|Insurance issue|1|||
162929169|NCT00701558|588443875|FG000|Overall Study|Death|7|||
162929170|NCT00701558|588443875|FG000|Overall Study|Lost to Follow-up|8|||
162929171|NCT01640964|588443878|FG000|Overall Study|Lost to Follow-up|0|||
162929172|NCT01640964|588443879|FG001|Overall Study|Lost to Follow-up|0|||
162929173|NCT01640964|588443880|FG002|Overall Study|Lost to Follow-up|1|||
162929174|NCT01640964|588443878|FG000|Overall Study|Protocol Deviation|1|||
162929175|NCT01640964|588443879|FG001|Overall Study|Protocol Deviation|1|||
162929176|NCT01640964|588443880|FG002|Overall Study|Protocol Deviation|2|||
162929177|NCT01416142|588445689|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
162929178|NCT01416142|588445690|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
162929179|NCT01416142|588445691|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
162929180|NCT02464059|588445692|FG000|Overall Study|Lost to Follow-up|6|||
162929181|NCT02499406|588445695|FG000|Overall Study|missed 3 treatment sessions|4|||
162929182|NCT03591107|588445699|FG000|Overall Study|Same patient in both arms|1|||
162929183|NCT03591107|588445700|FG001|Overall Study|Same patient in both arms|1|||
162929184|NCT03591107|588445699|FG000|Overall Study|Sought care at other clinics|0|||
162929185|NCT03591107|588445700|FG001|Overall Study|Sought care at other clinics|2|||
162929186|NCT03591107|588445699|FG000|Overall Study|Discharged from clinic|0|||
162929187|NCT03591107|588445700|FG001|Overall Study|Discharged from clinic|1|||
162929188|NCT03591107|588445699|FG000|Overall Study|Withdrawal by Subject|0|||
162929189|NCT03591107|588445700|FG001|Overall Study|Withdrawal by Subject|1|||
162929190|NCT00304954|588445701|FG000|Overall Study|Withdrawal by Subject|0|||
162929191|NCT00304954|588445702|FG001|Overall Study|Withdrawal by Subject|0|||
162929192|NCT00304954|588445703|FG002|Overall Study|Withdrawal by Subject|1|||
162929193|NCT00304954|588445704|FG003|Overall Study|Withdrawal by Subject|0|||
162929194|NCT00304954|588445701|FG000|Overall Study|Adverse Event|1|||
162929195|NCT00304954|588445702|FG001|Overall Study|Adverse Event|0|||
162929196|NCT00304954|588445703|FG002|Overall Study|Adverse Event|0|||
162929197|NCT00304954|588445704|FG003|Overall Study|Adverse Event|0|||
162929198|NCT00350519|588445705|FG000|Overall Study|Death|0|||
162929199|NCT00350519|588445706|FG001|Overall Study|Death|1|||
162929200|NCT00350519|588445705|FG000|Overall Study|Physician Decision|0|||
162929201|NCT00350519|588445706|FG001|Overall Study|Physician Decision|1|||
162929202|NCT00350519|588445705|FG000|Overall Study|Protocol Violation|1|||
162929203|NCT00350519|588445706|FG001|Overall Study|Protocol Violation|2|||
162929204|NCT00350519|588445705|FG000|Overall Study|Withdrawal by Subject|3|||
162929205|NCT00350519|588445706|FG001|Overall Study|Withdrawal by Subject|2|||
162929206|NCT00736099|588445708|FG000|Overall Study|Adverse Event|61|||
162929207|NCT00736099|588445709|FG001|Overall Study|Adverse Event|18|||
162929208|NCT00736099|588445708|FG000|Overall Study|Protocol Violation|10|||
162929209|NCT00736099|588445709|FG001|Overall Study|Protocol Violation|4|||
162929210|NCT00736099|588445708|FG000|Overall Study|Lost to Follow-up|12|||
162929211|NCT00736099|588445709|FG001|Overall Study|Lost to Follow-up|5|||
162929212|NCT00736099|588445708|FG000|Overall Study|Withdrawal by Subject|42|||
162929213|NCT00736099|588445709|FG001|Overall Study|Withdrawal by Subject|13|||
162929214|NCT00736099|588445708|FG000|Overall Study|Lack of Efficacy|15|||
162929215|NCT00736099|588445709|FG001|Overall Study|Lack of Efficacy|8|||
162929216|NCT00736099|588445708|FG000|Overall Study|Other reason|43|||
162929217|NCT00736099|588445709|FG001|Overall Study|Other reason|10|||
162929218|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
162929219|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
162929220|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
162929221|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
162929222|NCT00948025|588445710|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
162929223|NCT00948025|588445711|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
162929224|NCT04006847|588445714|FG000|Overall Study|Product issue|1|||
162929225|NCT03555890|588445722|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929226|NCT03555890|588445723|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929227|NCT03555890|588445724|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162929228|NCT03555890|588445725|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162929229|NCT03372369|588445726|FG000|Qualification Period|Withdrawal by Subject|16|||
162929230|NCT03372369|588445727|FG001|Qualification Period|Withdrawal by Subject|13|||
162929231|NCT03372369|588445726|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
162929232|NCT03372369|588445727|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
162929233|NCT03372369|588445726|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
162929234|NCT03372369|588445727|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
162929235|NCT01383954|588445728|FG000|Overall Study|Lack of Efficacy|2|||
162929236|NCT01383954|588445728|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
162929237|NCT01383954|588445728|FG000|Overall Study|Adverse Event|1|||
162929238|NCT01383954|588445728|FG000|Overall Study|Reason Not Specified|9|||
162929239|NCT01791127|588445729|FG000|Overall Study|Death|356|||
162929240|NCT01791127|588445729|FG000|Overall Study|Patient has withdrawn from study|293|||
162929241|NCT01791127|588445729|FG000|Overall Study|Lost to Follow-up|42|||
162929242|NCT01791127|588445729|FG000|Overall Study|All Siello leads are explanted|31|||
162929243|NCT01791127|588445729|FG000|Overall Study|Completion of 30 day safety registry|1|||
162929244|NCT01791127|588445729|FG000|Overall Study|Study terminated for EP Passion|749|||
162929245|NCT04023994|588445738|FG000|Overall Study|Lost to Follow-up|0|||
162929246|NCT04023994|588445739|FG001|Overall Study|Lost to Follow-up|1|||
162929247|NCT04023994|588445740|FG002|Overall Study|Lost to Follow-up|2|||
162929248|NCT04023994|588445741|FG003|Overall Study|Lost to Follow-up|0|||
162929249|NCT04023994|588445742|FG004|Overall Study|Lost to Follow-up|0|||
162929250|NCT04023994|588445743|FG005|Overall Study|Lost to Follow-up|0|||
162929251|NCT04023994|588445738|FG000|Overall Study|Withdrawal by Subject|0|||
162929252|NCT04023994|588445739|FG001|Overall Study|Withdrawal by Subject|0|||
162929253|NCT04023994|588445740|FG002|Overall Study|Withdrawal by Subject|0|||
162929254|NCT04023994|588445741|FG003|Overall Study|Withdrawal by Subject|1|||
162929255|NCT04023994|588445742|FG004|Overall Study|Withdrawal by Subject|0|||
162929256|NCT04023994|588445743|FG005|Overall Study|Withdrawal by Subject|0|||
162929257|NCT00707174|588445744|FG000|Overall Study|Adverse Event|1|||
162929258|NCT00707174|588445745|FG001|Overall Study|Adverse Event|6|||
162929259|NCT00707174|588445744|FG000|Overall Study|Withdrawal by Subject|4|||
162929260|NCT00707174|588445745|FG001|Overall Study|Withdrawal by Subject|1|||
162929261|NCT01017029|588445746|FG000|Overall Study|Lost to Follow-up|1|||
162929262|NCT01017029|588445747|FG001|Overall Study|Lost to Follow-up|0|||
162929263|NCT01017029|588445746|FG000|Overall Study|Administrative problem|0|||
162929264|NCT01017029|588445747|FG001|Overall Study|Administrative problem|1|||
162929265|NCT01017029|588445746|FG000|Overall Study|Death|3|||
162929266|NCT01017029|588445747|FG001|Overall Study|Death|1|||
162929267|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
162929268|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
162929269|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
162929270|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
162929271|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
162929272|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
162929273|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
163156585|NCT01352793|589287892|FG000|Overall Study|Medication error|2|||
163041189|NCT02717442|588858089|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
163041190|NCT02717442|588858090|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
163041191|NCT02717442|588858089|FG000|Overall Study|Other - Not Specified|2|||
162929274|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
162929275|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
162929276|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
162929277|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
162929278|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
162929279|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
162929280|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929281|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929282|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
162929283|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
162929284|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
162929285|NCT00422058|588445748|FG000|Double-Blind, Week 0-20|Other|11|||
162929286|NCT00422058|588445749|FG001|Double-Blind, Week 0-20|Other|3|||
162929287|NCT00422058|588445750|FG002|Double-Blind, Week 0-20|Other|8|||
162929288|NCT00422058|588445751|FG003|Double-Blind, Week 0-20|Other|8|||
162929289|NCT00422058|588445752|FG004|Double-Blind, Week 0-20|Other|4|||
162929290|NCT00422058|588445753|FG005|Double-Blind, Week 0-20|Other|10|||
162929291|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
162929292|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
162929293|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
162929294|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
162929295|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
162929296|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
162929297|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
162929298|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929299|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
162929300|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929301|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
162929302|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
162929303|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
162929304|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
162929305|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
162929306|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
162929307|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
162929308|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
162929309|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
162929310|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
162929311|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
162929312|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
162929313|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
162929314|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
162929315|NCT00422058|588445748|FG000|Open-Label Extension, Week 20-104|Other|13|||
162929316|NCT00422058|588445749|FG001|Open-Label Extension, Week 20-104|Other|14|||
162929317|NCT00422058|588445750|FG002|Open-Label Extension, Week 20-104|Other|6|||
162929318|NCT00422058|588445751|FG003|Open-Label Extension, Week 20-104|Other|13|||
162929319|NCT00422058|588445752|FG004|Open-Label Extension, Week 20-104|Other|16|||
162929320|NCT00422058|588445753|FG005|Open-Label Extension, Week 20-104|Other|18|||
162929321|NCT00572156|588445754|FG000|Overall Study|Adverse Event|3|||
162929322|NCT00572156|588445755|FG001|Overall Study|Adverse Event|1|||
162929323|NCT00572156|588445756|FG002|Overall Study|Adverse Event|5|||
162929324|NCT00572156|588445757|FG003|Overall Study|Adverse Event|1|||
162929325|NCT00572156|588445754|FG000|Overall Study|Lost to Follow-up|1|||
162929326|NCT00572156|588445755|FG001|Overall Study|Lost to Follow-up|1|||
162929327|NCT00572156|588445756|FG002|Overall Study|Lost to Follow-up|1|||
162929328|NCT00572156|588445757|FG003|Overall Study|Lost to Follow-up|0|||
162929329|NCT00572156|588445754|FG000|Overall Study|Protocol Violation|1|||
162929330|NCT00572156|588445755|FG001|Overall Study|Protocol Violation|2|||
162929331|NCT00572156|588445756|FG002|Overall Study|Protocol Violation|0|||
162929332|NCT00572156|588445757|FG003|Overall Study|Protocol Violation|2|||
162929333|NCT00572156|588445754|FG000|Overall Study|Patient/Parent Decision|1|||
162929334|NCT00572156|588445755|FG001|Overall Study|Patient/Parent Decision|6|||
162929335|NCT00572156|588445756|FG002|Overall Study|Patient/Parent Decision|4|||
162929336|NCT00572156|588445757|FG003|Overall Study|Patient/Parent Decision|3|||
162929337|NCT00572156|588445754|FG000|Overall Study|Sponsor Decision|20|||
162929338|NCT00572156|588445755|FG001|Overall Study|Sponsor Decision|16|||
162929339|NCT00572156|588445756|FG002|Overall Study|Sponsor Decision|17|||
162929340|NCT00572156|588445757|FG003|Overall Study|Sponsor Decision|19|||
162929341|NCT03216954|588445760|FG000|Overall Study|Adverse Event|0|||
162929342|NCT03216954|588445761|FG001|Overall Study|Adverse Event|0|||
162929343|NCT03216954|588445762|FG002|Overall Study|Adverse Event|1|||
162929344|NCT03216954|588445763|FG003|Overall Study|Adverse Event|0|||
162929345|NCT03216954|588445764|FG004|Overall Study|Adverse Event|1|||
162929346|NCT03216954|588445760|FG000|Overall Study|Withdrawal by Subject|2|||
162929347|NCT03216954|588445761|FG001|Overall Study|Withdrawal by Subject|0|||
162929348|NCT03216954|588445762|FG002|Overall Study|Withdrawal by Subject|0|||
162929349|NCT03216954|588445763|FG003|Overall Study|Withdrawal by Subject|0|||
162929350|NCT03216954|588445764|FG004|Overall Study|Withdrawal by Subject|0|||
162929351|NCT03216954|588445760|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929352|NCT03216954|588445761|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
162929353|NCT03216954|588445762|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929354|NCT03216954|588445763|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929355|NCT03216954|588445764|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
162929356|NCT04333199|588445767|FG000|Evaluated Patients|Lost to Follow-up|0|||
162929357|NCT04333199|588445768|FG001|Evaluated Patients|Lost to Follow-up|1|||
162929358|NCT04333199|588445769|FG002|Evaluated Patients|Lost to Follow-up|2|||
162929359|NCT01333475|588445771|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
162929360|NCT01333475|588445772|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
162929361|NCT01333475|588445771|FG000|Overall Study|Toxicity|1|||
162929362|NCT01333475|588445772|FG001|Overall Study|Toxicity|3|||
162929363|NCT02981602|588445773|FG000|Overall Study|Adverse Event|0|||
162929364|NCT02981602|588445774|FG001|Overall Study|Adverse Event|0|||
162929365|NCT02981602|588445775|FG002|Overall Study|Adverse Event|0|||
162929366|NCT02981602|588445776|FG003|Overall Study|Adverse Event|1|||
162929367|NCT02981602|588445777|FG004|Overall Study|Adverse Event|0|||
162929368|NCT00666718|588445778|FG000|Overall Study|Adverse Event|0|||
162929369|NCT00666718|588445779|FG001|Overall Study|Adverse Event|1|||
162929370|NCT00666718|588445778|FG000|Overall Study|Death|1|||
162929371|NCT00666718|588445779|FG001|Overall Study|Death|0|||
162929372|NCT00666718|588445778|FG000|Overall Study|Lost to Follow-up|1|||
162929373|NCT00666718|588445779|FG001|Overall Study|Lost to Follow-up|0|||
162929374|NCT00666718|588445778|FG000|Overall Study|Entry Criteria Not Met|2|||
162929375|NCT00666718|588445779|FG001|Overall Study|Entry Criteria Not Met|0|||
162929376|NCT00666718|588445778|FG000|Overall Study|Protocol Violation|1|||
162929377|NCT00666718|588445779|FG001|Overall Study|Protocol Violation|3|||
162929378|NCT00666718|588445778|FG000|Overall Study|Withdrawal by Subject|7|||
162929379|NCT00666718|588445779|FG001|Overall Study|Withdrawal by Subject|12|||
162929380|NCT00666718|588445778|FG000|Overall Study|Physician Decision|0|||
162929381|NCT00666718|588445779|FG001|Overall Study|Physician Decision|2|||
162929382|NCT02567266|588445789|FG000|Overall Study|Withdrawal by Subject|10|||
162929383|NCT02567266|588445790|FG001|Overall Study|Withdrawal by Subject|7|||
162929384|NCT02567266|588445791|FG002|Overall Study|Withdrawal by Subject|6|||
162929385|NCT02567266|588445789|FG000|Overall Study|Lost to Follow-up|13|||
162929386|NCT02567266|588445790|FG001|Overall Study|Lost to Follow-up|8|||
162929387|NCT02567266|588445791|FG002|Overall Study|Lost to Follow-up|10|||
162929388|NCT02983227|588445792|FG000|Overall Study|Adverse Event|21|||
162929389|NCT02983227|588445793|FG001|Overall Study|Adverse Event|3|||
162929390|NCT02983227|588445792|FG000|Overall Study|Death|3|||
162929391|NCT02983227|588445793|FG001|Overall Study|Death|0|||
162929392|NCT02983227|588445792|FG000|Overall Study|Lack of Efficacy|8|||
162929393|NCT02983227|588445793|FG001|Overall Study|Lack of Efficacy|1|||
162929394|NCT02983227|588445792|FG000|Overall Study|Lost to Follow-up|3|||
162929395|NCT02983227|588445793|FG001|Overall Study|Lost to Follow-up|0|||
162929396|NCT02983227|588445792|FG000|Overall Study|Multiple Reasons|2|||
162929397|NCT02983227|588445793|FG001|Overall Study|Multiple Reasons|1|||
162929398|NCT02983227|588445792|FG000|Overall Study|Physician Decision|3|||
162929399|NCT02983227|588445793|FG001|Overall Study|Physician Decision|1|||
162929400|NCT02983227|588445792|FG000|Overall Study|Withdrawal by Subject|19|||
162929401|NCT02983227|588445793|FG001|Overall Study|Withdrawal by Subject|8|||
162929402|NCT02164539|588445796|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
162929403|NCT02164539|588445797|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
162929404|NCT02164539|588445798|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
162696317|NCT01533714|587599473|FG001|Overall Study|Lack of Efficacy|0|||
162929405|NCT02164539|588445799|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
162929406|NCT02164539|588445800|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
162929407|NCT02164539|588445801|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
162929408|NCT02164539|588445802|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
162929409|NCT02164539|588445796|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
162929410|NCT02164539|588445797|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
162929411|NCT02164539|588445798|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
162929412|NCT02164539|588445799|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
162929413|NCT02164539|588445800|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
162929414|NCT02164539|588445801|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
162929415|NCT02164539|588445802|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
162929416|NCT02164539|588445796|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
162929417|NCT02164539|588445797|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
162929418|NCT02164539|588445798|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
162929419|NCT02164539|588445799|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
162929420|NCT02164539|588445800|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
162929421|NCT02164539|588445801|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
162929422|NCT02164539|588445802|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
162929423|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
162929424|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929425|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929426|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929427|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929428|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929429|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
162929430|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
162929431|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
162929432|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
162929433|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
162929434|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
162929435|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
162929436|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
162929437|NCT02164539|588445796|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
162929438|NCT02164539|588445797|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
162929439|NCT02164539|588445798|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
162929440|NCT02164539|588445799|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
162929441|NCT02164539|588445800|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
162929442|NCT02164539|588445801|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
162929443|NCT02164539|588445802|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
162929444|NCT01255722|588445803|FG000|Overall Study|Adverse Event|0|||
162929445|NCT01255722|588445804|FG001|Overall Study|Adverse Event|1|||
162929446|NCT01255722|588445805|FG002|Overall Study|Adverse Event|1|||
162929447|NCT01255722|588445803|FG000|Overall Study|asymptomatic patient|1|||
162929448|NCT01255722|588445804|FG001|Overall Study|asymptomatic patient|0|||
162929449|NCT01255722|588445805|FG002|Overall Study|asymptomatic patient|0|||
162929450|NCT01255722|588445803|FG000|Overall Study|beta-blocker contraindicated|2|||
162929451|NCT01255722|588445804|FG001|Overall Study|beta-blocker contraindicated|0|||
162929452|NCT01255722|588445805|FG002|Overall Study|beta-blocker contraindicated|0|||
162929453|NCT00527397|588445808|FG000|Overall Study|Adverse Event|3|||
162929454|NCT00527397|588445808|FG000|Overall Study|Lack of Efficacy|1|||
162929455|NCT00527397|588445808|FG000|Overall Study|Protocol Violation|1|||
162929456|NCT00527397|588445808|FG000|Overall Study|Withdrawal by Subject|6|||
162929457|NCT00527397|588445808|FG000|Overall Study|Study terminated by sponsor|13|||
162929458|NCT02065791|588445812|FG000|Overall Study|Closed Site|1|||
162929459|NCT02065791|588445813|FG001|Overall Study|Closed Site|1|||
162929460|NCT02065791|588445812|FG000|Overall Study|Withdrawal by Subject|11|||
162929461|NCT02065791|588445813|FG001|Overall Study|Withdrawal by Subject|5|||
162929462|NCT02065791|588445812|FG000|Overall Study|Lost to Follow-up|13|||
162929463|NCT02065791|588445813|FG001|Overall Study|Lost to Follow-up|9|||
162929464|NCT04529096|588445814|FG000|Overall Study|Adverse Event|6|||
162929465|NCT04529096|588445815|FG001|Overall Study|Adverse Event|1|||
162929466|NCT04529096|588445814|FG000|Overall Study|Lack of Efficacy|1|||
162929467|NCT04529096|588445815|FG001|Overall Study|Lack of Efficacy|0|||
162929468|NCT04529096|588445814|FG000|Overall Study|Lost to Follow-up|1|||
162929469|NCT04529096|588445815|FG001|Overall Study|Lost to Follow-up|1|||
162929470|NCT04529096|588445814|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162929471|NCT04529096|588445815|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162929472|NCT04529096|588445814|FG000|Overall Study|Physician Decision|1|||
162929473|NCT04529096|588445815|FG001|Overall Study|Physician Decision|3|||
162929474|NCT04529096|588445814|FG000|Overall Study|Withdrawal by Subject|5|||
162929475|NCT04529096|588445815|FG001|Overall Study|Withdrawal by Subject|0|||
162929476|NCT03467971|588445816|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162929477|NCT03467971|588445817|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162929478|NCT01619085|588445818|FG000|Overall Study|Adverse Event|231|||
162929479|NCT01619085|588445818|FG000|Overall Study|Protocol Violation|4|||
163041192|NCT02717442|588858090|FG001|Overall Study|Other - Not Specified|0|||
163041193|NCT03251482|588860644|FG000|Overall Study|Withdrawal by Subject|0|||
163041194|NCT03251482|588860645|FG001|Overall Study|Withdrawal by Subject|1|||
163041195|NCT03251482|588860646|FG002|Overall Study|Withdrawal by Subject|0|||
163041196|NCT03251482|588860647|FG003|Overall Study|Withdrawal by Subject|0|||
163041197|NCT03251482|588860648|FG004|Overall Study|Withdrawal by Subject|0|||
163041198|NCT02823470|588860649|FG000|Overall Study|Adverse Event|1|||
163041199|NCT02823470|588860650|FG001|Overall Study|Adverse Event|0|||
163041200|NCT02823470|588860649|FG000|Overall Study|Study terminated by sponsor|8|||
163041201|NCT02823470|588860650|FG001|Overall Study|Study terminated by sponsor|15|||
163041202|NCT01490840|588860651|FG000|Phase 1|Lost to Follow-up|1|||
163041203|NCT01490840|588860652|FG001|Phase 1|Lost to Follow-up|0|||
163041204|NCT01490840|588860651|FG000|Phase 1|Adverse Event|2|||
163041205|NCT01490840|588860652|FG001|Phase 1|Adverse Event|1|||
163041206|NCT01490840|588860651|FG000|Phase 1|Withdrawal by Subject|6|||
163041207|NCT01490840|588860652|FG001|Phase 1|Withdrawal by Subject|5|||
163041208|NCT01490840|588860651|FG000|Phase 1|Visit 6a omitted|1|||
163041209|NCT01490840|588860652|FG001|Phase 1|Visit 6a omitted|0|||
163041210|NCT01490840|588860651|FG000|Phase 2|Withdrawal by Subject|4|||
163041211|NCT01490840|588860652|FG001|Phase 2|Withdrawal by Subject|3|||
163041212|NCT01490840|588860651|FG000|Phase 2|Permanent interruption of fingolimod|0|||
163041213|NCT01490840|588860652|FG001|Phase 2|Permanent interruption of fingolimod|1|||
163041214|NCT01490840|588860651|FG000|Phase 2|Lost to Follow-up|1|||
163041215|NCT01490840|588860652|FG001|Phase 2|Lost to Follow-up|1|||
163041216|NCT01490840|588860651|FG000|Phase 2|Adverse Event|1|||
163041217|NCT01490840|588860652|FG001|Phase 2|Adverse Event|1|||
163041218|NCT00184002|588860653|FG000|Overall Study|Adverse Event|9|||
163041219|NCT00184002|588860653|FG000|Overall Study|Death|3|||
163041220|NCT00184002|588860653|FG000|Overall Study|Physician Decision|1|||
163041221|NCT00184002|588860653|FG000|Overall Study|Withdrawal by Subject|4|||
163041222|NCT00694356|588860654|FG000|Overall Study|Adverse Event|1|||
163041223|NCT00694356|588860655|FG001|Overall Study|Adverse Event|0|||
163041224|NCT00694356|588860656|FG002|Overall Study|Adverse Event|0|||
163041225|NCT00694356|588860654|FG000|Overall Study|Progressive Disease|2|||
163041226|NCT00694356|588860655|FG001|Overall Study|Progressive Disease|6|||
163041227|NCT00694356|588860656|FG002|Overall Study|Progressive Disease|6|||
163041228|NCT02756819|588860657|FG000|Overall Study|Lost for observation|23|||
163041229|NCT02756819|588860657|FG000|Overall Study|Patient's unwillingness|16|||
163041230|NCT02756819|588860657|FG000|Overall Study|Insufficient efficacy|2|||
163041231|NCT02756819|588860657|FG000|Overall Study|Adverse Event|2|||
163041232|NCT02756819|588860657|FG000|Overall Study|Reason not Specified|9|||
162929480|NCT01619085|588445818|FG000|Overall Study|Lost to Follow-up|3|||
162929481|NCT01619085|588445818|FG000|Overall Study|Withdrawal by Subject|45|||
162929482|NCT01619085|588445818|FG000|Overall Study|Other than specified|96|||
162929483|NCT01619085|588445818|FG000|Overall Study|Not treated|1|||
162929484|NCT01619085|588445818|FG000|Overall Study|Death|145|||
162929485|NCT00883129|588445821|FG000|Overall Study|Adverse Event|7|||
162929486|NCT00883129|588445822|FG001|Overall Study|Adverse Event|15|||
162929487|NCT00883129|588445821|FG000|Overall Study|Withdrawal by Subject|8|||
162929488|NCT00883129|588445822|FG001|Overall Study|Withdrawal by Subject|9|||
162929489|NCT00883129|588445821|FG000|Overall Study|Non-compliance|3|||
162929490|NCT00883129|588445822|FG001|Overall Study|Non-compliance|6|||
162929491|NCT00883129|588445821|FG000|Overall Study|Lost to Follow-up|1|||
162929492|NCT00883129|588445822|FG001|Overall Study|Lost to Follow-up|2|||
162929493|NCT00883129|588445821|FG000|Overall Study|Death|1|||
162929494|NCT00883129|588445822|FG001|Overall Study|Death|2|||
162929495|NCT00883129|588445821|FG000|Overall Study|Defined Treatment Failure|0|||
162929496|NCT00883129|588445822|FG001|Overall Study|Defined Treatment Failure|2|||
162929497|NCT03273257|588445823|FG000|Overall Study|Death|0|||
162929498|NCT03273257|588445824|FG001|Overall Study|Death|1|||
162929499|NCT03273257|588445823|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
162929500|NCT03273257|588445824|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
162929501|NCT03273257|588445823|FG000|Overall Study|Study terminated|3|||
162929502|NCT03273257|588445824|FG001|Overall Study|Study terminated|2|||
162929503|NCT00833976|588447366|FG000|Overall Study|Withdrawal by Subject|5|||
162929504|NCT00833976|588447366|FG000|Overall Study|Lost to Follow-up|4|||
162929505|NCT00833976|588447366|FG000|Overall Study|Did not meet eligibility criteria|41|||
162929506|NCT00833976|588447366|FG000|Overall Study|Physician Decision|1|||
162929507|NCT01246973|588447371|FG000|Overall Study|Other|38|||
162929508|NCT01246973|588447372|FG001|Overall Study|Other|25|||
163041233|NCT00741598|588860658|FG000|Overall Study|Lost to Follow-up|3|||
163041234|NCT00741598|588860659|FG001|Overall Study|Lost to Follow-up|4|||
163041235|NCT00741598|588860658|FG000|Overall Study|Lack of Efficacy|1|||
163041236|NCT00741598|588860659|FG001|Overall Study|Lack of Efficacy|2|||
163041237|NCT00741598|588860658|FG000|Overall Study|Physician Decision|1|||
163041238|NCT00741598|588860659|FG001|Overall Study|Physician Decision|1|||
163041239|NCT00741598|588860658|FG000|Overall Study|Pregnancy|1|||
163041240|NCT00741598|588860659|FG001|Overall Study|Pregnancy|0|||
163041241|NCT00741598|588860658|FG000|Overall Study|Withdrawal by Subject|3|||
162929509|NCT01246973|588447371|FG000|Overall Study|Adverse Event|16|||
162929510|NCT01246973|588447372|FG001|Overall Study|Adverse Event|9|||
162929511|NCT01246973|588447371|FG000|Overall Study|Withdrawal by Subject|7|||
162929512|NCT01246973|588447372|FG001|Overall Study|Withdrawal by Subject|13|||
162929513|NCT02598622|588447373|FG000|Overall Study|Withdrawal by Subject|3|||
162929514|NCT02598622|588447374|FG001|Overall Study|Withdrawal by Subject|0|||
162929515|NCT02598622|588447373|FG000|Overall Study|Physician Decision|3|||
162929516|NCT02598622|588447374|FG001|Overall Study|Physician Decision|0|||
162929517|NCT00678379|588447375|FG000|Overall Study|Injection performed after tonsillectomy|2|||
162929518|NCT00678379|588447376|FG001|Overall Study|Injection performed after tonsillectomy|0|||
162929519|NCT00678379|588447377|FG002|Overall Study|Injection performed after tonsillectomy|1|||
162929520|NCT00678379|588447375|FG000|Overall Study|Incomplete Data|4|||
162929521|NCT00678379|588447376|FG001|Overall Study|Incomplete Data|3|||
162929522|NCT00678379|588447377|FG002|Overall Study|Incomplete Data|3|||
162929523|NCT01835470|588447378|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
162929524|NCT01835470|588447378|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
162929525|NCT01011907|588447379|FG000|Overall Study|Withdrawal by Subject|13|||
162929526|NCT01011907|588447380|FG001|Overall Study|Withdrawal by Subject|11|||
162929527|NCT01011907|588447379|FG000|Overall Study|Adverse Event|1|||
162929528|NCT01011907|588447380|FG001|Overall Study|Adverse Event|4|||
162929529|NCT01637961|588447385|FG000|Overall Study|Ineligible: wrong primary|1|||
162929530|NCT01637961|588447385|FG000|Overall Study|Ineligible: inadequate pathology|1|||
162929531|NCT02239601|588447386|FG000|Overall Study|Withdrawal by Subject|3|||
162929532|NCT02239601|588447387|FG001|Overall Study|Withdrawal by Subject|4|||
162929533|NCT02239601|588447386|FG000|Overall Study|Protocol Violation|4|||
162929534|NCT02239601|588447387|FG001|Overall Study|Protocol Violation|2|||
162929535|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
162929536|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
162929537|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
162929538|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
162929539|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
163041242|NCT00741598|588860659|FG001|Overall Study|Withdrawal by Subject|2|||
163041243|NCT02087670|588860662|FG000|Overall Study|Withdrawal by Subject|3|||
163041244|NCT02087670|588860663|FG001|Overall Study|Withdrawal by Subject|2|||
163041245|NCT03117361|588860665|FG000|Overall Study|Progressive disease|5|||
163041246|NCT03117361|588860665|FG000|Overall Study|Death|1|||
163041247|NCT03117361|588860665|FG000|Overall Study|Physician Decision|2|||
163041248|NCT03117361|588860665|FG000|Overall Study|On study treatment at the end of study|1|||
163041249|NCT03117361|588860665|FG000|Overall Study|Treatment-related adverse event|1|||
163041250|NCT00878800|588860666|FG000|Overall Study|Adverse Event|0|||
163041251|NCT00878800|588860667|FG001|Overall Study|Adverse Event|0|||
163041252|NCT00878800|588860668|FG002|Overall Study|Adverse Event|2|||
163041253|NCT00878800|588860669|FG003|Overall Study|Adverse Event|0|||
163041254|NCT00878800|588860670|FG004|Overall Study|Adverse Event|1|||
163041255|NCT00878800|588860666|FG000|Overall Study|Progressive disease|1|||
163041256|NCT00878800|588860667|FG001|Overall Study|Progressive disease|5|||
163041257|NCT00878800|588860668|FG002|Overall Study|Progressive disease|6|||
163041258|NCT00878800|588860669|FG003|Overall Study|Progressive disease|5|||
163041259|NCT00878800|588860670|FG004|Overall Study|Progressive disease|13|||
163041260|NCT00878800|588860666|FG000|Overall Study|Withdrew consent|1|||
163041261|NCT00878800|588860667|FG001|Overall Study|Withdrew consent|1|||
163041262|NCT00878800|588860668|FG002|Overall Study|Withdrew consent|0|||
163041263|NCT00878800|588860669|FG003|Overall Study|Withdrew consent|1|||
163041264|NCT00878800|588860670|FG004|Overall Study|Withdrew consent|1|||
163041265|NCT00878800|588860666|FG000|Overall Study|Death|0|||
163041266|NCT00878800|588860667|FG001|Overall Study|Death|0|||
163041267|NCT00878800|588860668|FG002|Overall Study|Death|1|||
163041268|NCT00878800|588860669|FG003|Overall Study|Death|0|||
163041269|NCT00878800|588860670|FG004|Overall Study|Death|0|||
163041270|NCT00878800|588860666|FG000|Overall Study|Other|1|||
163041271|NCT00878800|588860667|FG001|Overall Study|Other|1|||
163041272|NCT00878800|588860668|FG002|Overall Study|Other|0|||
163041273|NCT00878800|588860669|FG003|Overall Study|Other|0|||
163041274|NCT00878800|588860670|FG004|Overall Study|Other|1|||
163041275|NCT02072941|588860671|FG000|Overall Study|Withdrawal by Subject|29|||
163041276|NCT02072941|588860672|FG001|Overall Study|Withdrawal by Subject|21|||
163041277|NCT02072941|588860671|FG000|Overall Study|Lost to Follow-up|4|||
163041278|NCT02072941|588860672|FG001|Overall Study|Lost to Follow-up|4|||
163041279|NCT02072941|588860671|FG000|Overall Study|Death|3|||
163041280|NCT02072941|588860672|FG001|Overall Study|Death|2|||
163041281|NCT02072941|588860671|FG000|Overall Study|Removed by Study Staff|2|||
163041282|NCT02072941|588860672|FG001|Overall Study|Removed by Study Staff|2|||
163041283|NCT01247350|588860675|FG000|Overall Study|Adverse Event|0|||
163041284|NCT01247350|588860676|FG001|Overall Study|Adverse Event|0|||
163041285|NCT01247350|588860677|FG002|Overall Study|Adverse Event|1|||
163041286|NCT01247350|588860678|FG003|Overall Study|Adverse Event|0|||
163041287|NCT01247350|588860679|FG004|Overall Study|Adverse Event|0|||
163041288|NCT01247350|588860675|FG000|Overall Study|Withdrawal by Subject|0|||
163041289|NCT01247350|588860676|FG001|Overall Study|Withdrawal by Subject|0|||
163041290|NCT01247350|588860677|FG002|Overall Study|Withdrawal by Subject|0|||
163041291|NCT01247350|588860678|FG003|Overall Study|Withdrawal by Subject|1|||
163041292|NCT01247350|588860679|FG004|Overall Study|Withdrawal by Subject|0|||
163041293|NCT01247350|588860675|FG000|Overall Study|Entry criteria not met|0|||
163041294|NCT01247350|588860676|FG001|Overall Study|Entry criteria not met|0|||
163041295|NCT01247350|588860677|FG002|Overall Study|Entry criteria not met|0|||
163041296|NCT01247350|588860678|FG003|Overall Study|Entry criteria not met|0|||
163041297|NCT01247350|588860679|FG004|Overall Study|Entry criteria not met|1|||
163041298|NCT00169104|588860680|FG000|Overall Study|Withdrawal by Subject|2|||
163041299|NCT00169104|588860681|FG001|Overall Study|Withdrawal by Subject|0|||
163041300|NCT00169104|588860680|FG000|Overall Study|Protocol Violation|0|||
163041301|NCT00169104|588860681|FG001|Overall Study|Protocol Violation|1|||
163041302|NCT00169104|588860680|FG000|Overall Study|Physician Decision|0|||
163041303|NCT00169104|588860681|FG001|Overall Study|Physician Decision|1|||
163041304|NCT00715299|588860687|FG000|Overall Study|Withdrawal by Subject|1|||
163041305|NCT00715299|588860687|FG000|Overall Study|Adverse Event|3|||
163041306|NCT00715299|588860687|FG000|Overall Study|failed the pre-screen exercise test|2|||
163041307|NCT02020889|588860688|FG000|Overall Study|Adverse Event|0|||
163041308|NCT02020889|588860689|FG001|Overall Study|Adverse Event|1|||
163041309|NCT02020889|588860688|FG000|Overall Study|Lack of Efficacy|1|||
163041310|NCT02020889|588860689|FG001|Overall Study|Lack of Efficacy|0|||
163041311|NCT02020889|588860688|FG000|Overall Study|Lost to Follow-up|1|||
163041312|NCT02020889|588860689|FG001|Overall Study|Lost to Follow-up|0|||
163041313|NCT02020889|588860688|FG000|Overall Study|Physician Decision|2|||
163041314|NCT02020889|588860689|FG001|Overall Study|Physician Decision|0|||
163041315|NCT02020889|588860688|FG000|Overall Study|Withdrawal by Subject|3|||
163041316|NCT02020889|588860689|FG001|Overall Study|Withdrawal by Subject|2|||
163041317|NCT01540981|588860690|FG000|Overall Study|Withdrawal by Subject|1|||
163041318|NCT01540981|588860691|FG001|Overall Study|Withdrawal by Subject|0|||
163041319|NCT00809094|588860692|FG000|Overall Study|Lost to Follow-up|0|||
163041320|NCT00809094|588860693|FG001|Overall Study|Lost to Follow-up|1|||
163041321|NCT00232557|588860694|FG000|Overall Study|Lost to Follow-up|3|||
163041322|NCT00232557|588860695|FG001|Overall Study|Lost to Follow-up|5|||
163041323|NCT02457195|588860700|FG000|Overall Study|Adverse Event|3|||
163041324|NCT02457195|588860700|FG000|Overall Study|Protocol Violation|2|||
163041325|NCT02457195|588860700|FG000|Overall Study|Withdrawal by Subject|4|||
163041326|NCT05980013|588860702|FG000|Overall Study|Withdrawal by Subject|0|||
163041327|NCT05980013|588860703|FG001|Overall Study|Withdrawal by Subject|1|||
163041328|NCT05980013|588860702|FG000|Overall Study|Device Error|0|||
163041329|NCT05980013|588860703|FG001|Overall Study|Device Error|1|||
163041330|NCT04892446|588860704|FG000|Overall Study|Death|4|||
163041331|NCT04892446|588860705|FG001|Overall Study|Death|4|||
163041332|NCT04892446|588860706|FG002|Overall Study|Death|0|||
163041333|NCT04892446|588860704|FG000|Overall Study|Withdrew consent|3|||
163041334|NCT04892446|588860705|FG001|Overall Study|Withdrew consent|0|||
163041335|NCT04892446|588860706|FG002|Overall Study|Withdrew consent|1|||
163041336|NCT04892446|588860704|FG000|Overall Study|Investigator's discretion|1|||
163041337|NCT04892446|588860705|FG001|Overall Study|Investigator's discretion|1|||
163041338|NCT04892446|588860706|FG002|Overall Study|Investigator's discretion|0|||
163041339|NCT04892446|588860704|FG000|Overall Study|Study terminated by sponsor|0|||
163041340|NCT04892446|588860705|FG001|Overall Study|Study terminated by sponsor|0|||
163041341|NCT04892446|588860706|FG002|Overall Study|Study terminated by sponsor|2|||
163041342|NCT04676724|588860709|FG000|Overall Study|Adverse Event|2|||
163041343|NCT04676724|588860710|FG001|Overall Study|Adverse Event|0|||
163041344|NCT04676724|588860709|FG000|Overall Study|Lost to Follow-up|1|||
163041345|NCT04676724|588860710|FG001|Overall Study|Lost to Follow-up|0|||
163041346|NCT04676724|588860709|FG000|Overall Study|Physician Decision|0|||
163041347|NCT04676724|588860710|FG001|Overall Study|Physician Decision|1|||
163041348|NCT04676724|588860709|FG000|Overall Study|Withdrawal by Subject|3|||
163041349|NCT04676724|588860710|FG001|Overall Study|Withdrawal by Subject|2|||
163041350|NCT00398047|588860711|FG000|Overall Study|all patient progressed before completion|3|||
163041351|NCT00237692|588860712|FG000|Overall Study|Lost to Follow-up|9|||
163041352|NCT00237692|588860713|FG001|Overall Study|Lost to Follow-up|3|||
163041353|NCT00237692|588860714|FG002|Overall Study|Lost to Follow-up|5|||
163041354|NCT00237692|588860715|FG003|Overall Study|Lost to Follow-up|3|||
163041355|NCT00237692|588860712|FG000|Overall Study|Death|1|||
163041356|NCT00237692|588860713|FG001|Overall Study|Death|2|||
163041357|NCT00237692|588860714|FG002|Overall Study|Death|2|||
163041358|NCT00237692|588860715|FG003|Overall Study|Death|3|||
163041359|NCT00237692|588860712|FG000|Overall Study|Excluded - did not meet criteria|4|||
163041360|NCT00237692|588860713|FG001|Overall Study|Excluded - did not meet criteria|3|||
163041361|NCT00237692|588860714|FG002|Overall Study|Excluded - did not meet criteria|5|||
163041362|NCT00237692|588860715|FG003|Overall Study|Excluded - did not meet criteria|9|||
163041363|NCT00237692|588860712|FG000|Overall Study|Withdrawal by Subject|4|||
163041364|NCT00237692|588860713|FG001|Overall Study|Withdrawal by Subject|6|||
163041365|NCT00237692|588860714|FG002|Overall Study|Withdrawal by Subject|10|||
163041366|NCT00237692|588860715|FG003|Overall Study|Withdrawal by Subject|4|||
163041367|NCT00685360|588860716|FG000|Overall Study|Lost to Follow-up|0|||
163041368|NCT00685360|588860717|FG001|Overall Study|Lost to Follow-up|1|||
163041369|NCT00685360|588860718|FG002|Overall Study|Lost to Follow-up|2|||
163041370|NCT00685360|588860716|FG000|Overall Study|Adverse Event|4|||
163041371|NCT00685360|588860717|FG001|Overall Study|Adverse Event|6|||
163041372|NCT00685360|588860718|FG002|Overall Study|Adverse Event|4|||
163041373|NCT00685360|588860716|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
163041374|NCT00685360|588860717|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
163041375|NCT00685360|588860718|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
163041376|NCT00685360|588860716|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
163041377|NCT00685360|588860717|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
163041378|NCT00685360|588860718|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
163041379|NCT00685360|588860716|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
163041380|NCT00685360|588860717|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
163041381|NCT00685360|588860718|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
163041382|NCT00685360|588860716|FG000|Overall Study|Protocol Deviation|0|||
163041383|NCT00685360|588860717|FG001|Overall Study|Protocol Deviation|1|||
163041384|NCT00685360|588860718|FG002|Overall Study|Protocol Deviation|1|||
163041385|NCT01386944|588860725|FG000|Overall Study|Adverse Event|26|||
163041386|NCT01386944|588860725|FG000|Overall Study|Lack of Efficacy|14|||
163041387|NCT01386944|588860725|FG000|Overall Study|Lost to Follow-up|8|||
163041388|NCT01386944|588860725|FG000|Overall Study|Unspecified reason|8|||
163041389|NCT00524680|588860726|FG000|Overall Study|progression|0|||
163041390|NCT00524680|588860727|FG001|Overall Study|progression|0|||
163041391|NCT00524680|588860728|FG002|Overall Study|progression|0|||
163041392|NCT00524680|588860729|FG003|Overall Study|progression|1|||
163041393|NCT00524680|588860726|FG000|Overall Study|Adverse Event|2|||
163041394|NCT00524680|588860727|FG001|Overall Study|Adverse Event|0|||
163041395|NCT00524680|588860728|FG002|Overall Study|Adverse Event|0|||
163041396|NCT00524680|588860729|FG003|Overall Study|Adverse Event|1|||
163041397|NCT00524680|588860726|FG000|Overall Study|Other|0|||
163041398|NCT00524680|588860727|FG001|Overall Study|Other|1|||
163041399|NCT00524680|588860728|FG002|Overall Study|Other|2|||
163041400|NCT00524680|588860729|FG003|Overall Study|Other|3|||
163041401|NCT00524680|588860726|FG000|Overall Study|Withdrawal by Subject|1|||
163041402|NCT00524680|588860727|FG001|Overall Study|Withdrawal by Subject|0|||
163041403|NCT00524680|588860728|FG002|Overall Study|Withdrawal by Subject|1|||
163041404|NCT00524680|588860729|FG003|Overall Study|Withdrawal by Subject|1|||
163041405|NCT01146561|588860732|FG000|Overall Study|Withdrawal by Subject|1|||
163041406|NCT01146561|588860732|FG000|Overall Study|Lost to Follow-up|1|||
163041407|NCT03092791|588860738|FG000|Overall Study|Lost to Follow-up|0|||
163041408|NCT03092791|588860739|FG001|Overall Study|Lost to Follow-up|0|||
163041409|NCT03092791|588860740|FG002|Overall Study|Lost to Follow-up|0|||
163041410|NCT03092791|588860741|FG003|Overall Study|Lost to Follow-up|0|||
163041411|NCT03092791|588860742|FG004|Overall Study|Lost to Follow-up|0|||
163041412|NCT03092791|588860743|FG005|Overall Study|Lost to Follow-up|0|||
163041413|NCT03092791|588860744|FG006|Overall Study|Lost to Follow-up|1|||
163041414|NCT03092791|588860745|FG007|Overall Study|Lost to Follow-up|0|||
163041415|NCT03092791|588860738|FG000|Overall Study|Withdrawal of Consent|0|||
163041416|NCT03092791|588860739|FG001|Overall Study|Withdrawal of Consent|0|||
163041417|NCT03092791|588860740|FG002|Overall Study|Withdrawal of Consent|0|||
163041418|NCT03092791|588860741|FG003|Overall Study|Withdrawal of Consent|0|||
163041419|NCT03092791|588860742|FG004|Overall Study|Withdrawal of Consent|4|||
163041420|NCT03092791|588860743|FG005|Overall Study|Withdrawal of Consent|12|||
163041421|NCT03092791|588860744|FG006|Overall Study|Withdrawal of Consent|6|||
163041422|NCT03092791|588860745|FG007|Overall Study|Withdrawal of Consent|4|||
163041423|NCT03092791|588860738|FG000|Overall Study|Study Termination|0|||
163041424|NCT03092791|588860739|FG001|Overall Study|Study Termination|0|||
163041425|NCT03092791|588860740|FG002|Overall Study|Study Termination|0|||
163041426|NCT03092791|588860741|FG003|Overall Study|Study Termination|0|||
163041427|NCT03092791|588860742|FG004|Overall Study|Study Termination|55|||
163041428|NCT03092791|588860743|FG005|Overall Study|Study Termination|46|||
163041429|NCT03092791|588860744|FG006|Overall Study|Study Termination|53|||
163041430|NCT03092791|588860745|FG007|Overall Study|Study Termination|55|||
163041431|NCT03092791|588860738|FG000|Overall Study|Death|0|||
163041432|NCT03092791|588860739|FG001|Overall Study|Death|0|||
163041433|NCT03092791|588860740|FG002|Overall Study|Death|0|||
163041434|NCT03092791|588860741|FG003|Overall Study|Death|0|||
163041435|NCT03092791|588860742|FG004|Overall Study|Death|0|||
163041436|NCT03092791|588860743|FG005|Overall Study|Death|1|||
163041437|NCT03092791|588860744|FG006|Overall Study|Death|0|||
163041438|NCT03092791|588860745|FG007|Overall Study|Death|1|||
163041439|NCT03092791|588860738|FG000|Overall Study|Reason Not Specified|0|||
163041440|NCT03092791|588860739|FG001|Overall Study|Reason Not Specified|0|||
163041441|NCT03092791|588860740|FG002|Overall Study|Reason Not Specified|0|||
163041442|NCT03092791|588860741|FG003|Overall Study|Reason Not Specified|0|||
163041443|NCT03092791|588860742|FG004|Overall Study|Reason Not Specified|1|||
163041444|NCT03092791|588860743|FG005|Overall Study|Reason Not Specified|1|||
163041445|NCT03092791|588860744|FG006|Overall Study|Reason Not Specified|0|||
163041446|NCT03092791|588860745|FG007|Overall Study|Reason Not Specified|0|||
163041447|NCT02182830|588860749|FG000|Overall Study|Not Treated|1|||
163041448|NCT02182830|588860750|FG001|Overall Study|Not Treated|1|||
163041449|NCT02182830|588860749|FG000|Overall Study|Trial stopped, reason missing|3|||
163041450|NCT02182830|588860750|FG001|Overall Study|Trial stopped, reason missing|3|||
163041451|NCT02182830|588860749|FG000|Overall Study|Consent withdrawn|8|||
163041452|NCT02182830|588860750|FG001|Overall Study|Consent withdrawn|8|||
163041453|NCT02182830|588860749|FG000|Overall Study|Lost to Follow-up|3|||
163041454|NCT02182830|588860750|FG001|Overall Study|Lost to Follow-up|3|||
163041455|NCT04399538|588860751|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
163041456|NCT04399538|588860752|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
163041457|NCT04399538|588860753|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
163041458|NCT04399538|588860754|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
163041459|NCT04399538|588860755|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
163041460|NCT04399538|588860751|FG000|Double-Blind Treatment|Adverse Event|0|||
163041461|NCT04399538|588860752|FG001|Double-Blind Treatment|Adverse Event|0|||
163041462|NCT04399538|588860753|FG002|Double-Blind Treatment|Adverse Event|0|||
163041463|NCT04399538|588860754|FG003|Double-Blind Treatment|Adverse Event|0|||
163041464|NCT04399538|588860755|FG004|Double-Blind Treatment|Adverse Event|1|||
163041465|NCT04399538|588860751|FG000|Follow-Up|Adverse Event|0|||
163041466|NCT04399538|588860752|FG001|Follow-Up|Adverse Event|0|||
163041467|NCT04399538|588860753|FG002|Follow-Up|Adverse Event|0|||
163041468|NCT04399538|588860754|FG003|Follow-Up|Adverse Event|0|||
163041469|NCT04399538|588860755|FG004|Follow-Up|Adverse Event|1|||
163041470|NCT04399538|588860751|FG000|Follow-Up|Withdrawal by Subject|0|||
163041471|NCT04399538|588860752|FG001|Follow-Up|Withdrawal by Subject|0|||
163041472|NCT04399538|588860753|FG002|Follow-Up|Withdrawal by Subject|0|||
163041473|NCT04399538|588860754|FG003|Follow-Up|Withdrawal by Subject|2|||
163041474|NCT04399538|588860755|FG004|Follow-Up|Withdrawal by Subject|0|||
163041475|NCT00586898|588860760|FG000|Overall Study|Adverse Event|1|||
163041476|NCT00586898|588860760|FG000|Overall Study|Patiemt Non-compliance|1|||
163041477|NCT00586898|588860760|FG000|Overall Study|Evaluable for Toxicity Only|5|||
163041478|NCT01588405|588860761|FG000|Overall Study|Adverse Event|1|||
163041479|NCT01588405|588860761|FG000|Overall Study|Clinical Worsening|1|||
163041480|NCT03268005|588860762|FG000|Overall Study|Death|2|||
163041481|NCT03268005|588860763|FG001|Overall Study|Death|1|||
163041482|NCT03268005|588860762|FG000|Overall Study|Lost to Follow-up|2|||
163041483|NCT03268005|588860763|FG001|Overall Study|Lost to Follow-up|2|||
163041484|NCT03268005|588860762|FG000|Overall Study|Withdrawal by Subject|11|||
163041485|NCT03268005|588860763|FG001|Overall Study|Withdrawal by Subject|11|||
163041486|NCT01926197|588860764|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
163041487|NCT01926197|588860765|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
163041488|NCT01926197|588860764|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
163041489|NCT01926197|588860765|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
163041490|NCT00492232|588860766|FG000|Placebo Run-in|Adverse Event|0|||
163041491|NCT00492232|588860767|FG001|Placebo Run-in|Adverse Event|2|||
163041492|NCT00492232|588860766|FG000|Placebo Run-in|Protocol Violation|0|||
163041493|NCT00492232|588860767|FG001|Placebo Run-in|Protocol Violation|3|||
163041494|NCT00492232|588860766|FG000|Placebo Run-in|Lost to Follow-up|0|||
163041495|NCT00492232|588860767|FG001|Placebo Run-in|Lost to Follow-up|3|||
163041496|NCT00492232|588860766|FG000|Placebo Run-in|Withdrawal by Subject|0|||
163041497|NCT00492232|588860767|FG001|Placebo Run-in|Withdrawal by Subject|8|||
163041498|NCT00492232|588860766|FG000|Placebo Run-in|Pregnancy|0|||
163041499|NCT00492232|588860767|FG001|Placebo Run-in|Pregnancy|1|||
163041500|NCT00492232|588860766|FG000|Placebo Run-in|Entrance criteria not met|0|||
163041501|NCT00492232|588860767|FG001|Placebo Run-in|Entrance criteria not met|45|||
163041502|NCT00492232|588860766|FG000|Placebo Run-in|Other|0|||
163041503|NCT00492232|588860767|FG001|Placebo Run-in|Other|6|||
163041504|NCT00492232|588860766|FG000|Placebo Run-in|Missing|0|||
163041505|NCT00492232|588860767|FG001|Placebo Run-in|Missing|2|||
163041506|NCT00492232|588860766|FG000|Double-Blind Treatment|Adverse Event|1|||
163041507|NCT00492232|588860767|FG001|Double-Blind Treatment|Adverse Event|2|||
163041508|NCT00492232|588860766|FG000|Double-Blind Treatment|Protocol Violation|3|||
163041509|NCT00492232|588860767|FG001|Double-Blind Treatment|Protocol Violation|7|||
163041510|NCT00492232|588860766|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
163041511|NCT00492232|588860767|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
163041512|NCT00492232|588860766|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
163041513|NCT00492232|588860767|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
163041514|NCT00492232|588860766|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
163041515|NCT00492232|588860767|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
163041516|NCT00492232|588860766|FG000|Double-Blind Treatment|Other|6|||
163041517|NCT00492232|588860767|FG001|Double-Blind Treatment|Other|5|||
163041518|NCT00492232|588860766|FG000|Double-Blind Treatment|Randomized not treated|1|||
163041519|NCT00492232|588860767|FG001|Double-Blind Treatment|Randomized not treated|0|||
163041520|NCT00492232|588860766|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
163041521|NCT00492232|588860767|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163041522|NCT00980655|588860768|FG000|Overall Study|Adverse Event|13|||
163041523|NCT00980655|588860769|FG001|Overall Study|Adverse Event|31|||
163041524|NCT00980655|588860768|FG000|Overall Study|Death|0|||
163041525|NCT00980655|588860769|FG001|Overall Study|Death|7|||
163041526|NCT00980655|588860768|FG000|Overall Study|Protocol Violation|2|||
163041527|NCT00980655|588860769|FG001|Overall Study|Protocol Violation|7|||
163041528|NCT00980655|588860768|FG000|Overall Study|Withdrawal by Subject|0|||
163041529|NCT00980655|588860769|FG001|Overall Study|Withdrawal by Subject|4|||
163041530|NCT00980655|588860768|FG000|Overall Study|Lost to Follow-up|0|||
163041531|NCT00980655|588860769|FG001|Overall Study|Lost to Follow-up|1|||
163041532|NCT00980655|588860768|FG000|Overall Study|Parent/legal guardian request|1|||
163041533|NCT00980655|588860769|FG001|Overall Study|Parent/legal guardian request|0|||
163041534|NCT00980655|588860768|FG000|Overall Study|Other|0|||
163041535|NCT00980655|588860769|FG001|Overall Study|Other|1|||
163041536|NCT04162795|588860770|FG000|Overall Study|Other|16|||
163041537|NCT04162795|588860770|FG000|Overall Study|Screen failures|10|||
163041538|NCT01416155|588860774|FG000|Overall Study|Adverse Event|8|||
163041539|NCT01416155|588860774|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
163041540|NCT01416155|588860774|FG000|Overall Study|Withdrawal by Subject|33|||
163041541|NCT01416155|588860774|FG000|Overall Study|Investigator decision|8|||
163041542|NCT01416155|588860774|FG000|Overall Study|Other|7|||
163041543|NCT00829829|588860778|FG000|Overall Study|Protocol Violation|0|||
163041544|NCT00829829|588860779|FG001|Overall Study|Protocol Violation|3|||
163041545|NCT00829829|588860780|FG002|Overall Study|Protocol Violation|0|||
163041546|NCT00829829|588860778|FG000|Overall Study|Adverse Event|4|||
163041547|NCT00829829|588860779|FG001|Overall Study|Adverse Event|4|||
163041548|NCT00829829|588860780|FG002|Overall Study|Adverse Event|3|||
163041549|NCT00829829|588860778|FG000|Overall Study|Withdrawal by Subject|8|||
163041550|NCT00829829|588860779|FG001|Overall Study|Withdrawal by Subject|4|||
163041551|NCT00829829|588860780|FG002|Overall Study|Withdrawal by Subject|2|||
163041552|NCT00829829|588860778|FG000|Overall Study|Decision by the Sponsor|1|||
163041553|NCT00829829|588860779|FG001|Overall Study|Decision by the Sponsor|0|||
163041554|NCT00829829|588860780|FG002|Overall Study|Decision by the Sponsor|2|||
163041555|NCT00829829|588860778|FG000|Overall Study|Lost to Follow-up|7|||
163041556|NCT00829829|588860779|FG001|Overall Study|Lost to Follow-up|3|||
163041557|NCT00829829|588860780|FG002|Overall Study|Lost to Follow-up|3|||
163041558|NCT00829829|588860778|FG000|Overall Study|Other than specified above|2|||
163041559|NCT00829829|588860779|FG001|Overall Study|Other than specified above|2|||
163041560|NCT00829829|588860780|FG002|Overall Study|Other than specified above|1|||
163041561|NCT00382109|588860781|FG000|Overall Study|Adverse Event|3|||
163041562|NCT00382109|588860782|FG001|Overall Study|Adverse Event|0|||
163041563|NCT00382109|588860781|FG000|Overall Study|Physician Decision|6|||
163041564|NCT00382109|588860782|FG001|Overall Study|Physician Decision|1|||
163041565|NCT00382109|588860781|FG000|Overall Study|Withdrawal by Subject|1|||
163041566|NCT00382109|588860782|FG001|Overall Study|Withdrawal by Subject|0|||
163041567|NCT00382109|588860781|FG000|Overall Study|ineligible|2|||
163041568|NCT00382109|588860782|FG001|Overall Study|ineligible|0|||
163041569|NCT00382109|588860781|FG000|Overall Study|Other|0|||
163041570|NCT00382109|588860782|FG001|Overall Study|Other|2|||
163041571|NCT00382109|588860781|FG000|Overall Study|consent withdrawal|0|||
163041572|NCT00382109|588860782|FG001|Overall Study|consent withdrawal|1|||
163041573|NCT05052697|588860783|FG000|Substudy A|Lost to Follow-up|0|||
163041574|NCT05052697|588860784|FG001|Substudy A|Lost to Follow-up|0|||
163041575|NCT05052697|588860785|FG002|Substudy A|Lost to Follow-up|0|||
163041576|NCT05052697|588860786|FG003|Substudy A|Lost to Follow-up|0|||
163041577|NCT05052697|588860787|FG004|Substudy A|Lost to Follow-up|0|||
163041578|NCT05052697|588860788|FG005|Substudy A|Lost to Follow-up|1|||
163041579|NCT05052697|588860789|FG006|Substudy A|Lost to Follow-up|0|||
163041580|NCT05052697|588860790|FG007|Substudy A|Lost to Follow-up|0|||
163041581|NCT05052697|588860791|FG008|Substudy A|Lost to Follow-up|0|||
163041582|NCT05052697|588860792|FG009|Substudy A|Lost to Follow-up|0|||
163041583|NCT05052697|588860793|FG010|Substudy A|Lost to Follow-up|0|||
163041584|NCT05052697|588860794|FG011|Substudy A|Lost to Follow-up|0|||
163041585|NCT05052697|588860795|FG012|Substudy A|Lost to Follow-up|0|||
163041586|NCT05052697|588860796|FG013|Substudy A|Lost to Follow-up|0|||
163041587|NCT05052697|588860797|FG014|Substudy A|Lost to Follow-up|0|||
163041588|NCT05052697|588860798|FG015|Substudy A|Lost to Follow-up|2|||
163041589|NCT05052697|588860799|FG016|Substudy A|Lost to Follow-up|0|||
163041590|NCT05052697|588860800|FG017|Substudy A|Lost to Follow-up|0|||
163041591|NCT05052697|588860801|FG018|Substudy A|Lost to Follow-up|0|||
163041592|NCT05052697|588860802|FG019|Substudy A|Lost to Follow-up|0|||
163041593|NCT05052697|588860803|FG020|Substudy A|Lost to Follow-up|0|||
163041594|NCT05052697|588860804|FG021|Substudy A|Lost to Follow-up|0|||
163041595|NCT05052697|588860805|FG022|Substudy A|Lost to Follow-up|0|||
163041596|NCT05052697|588860806|FG023|Substudy A|Lost to Follow-up|0|||
163041597|NCT05052697|588860807|FG024|Substudy A|Lost to Follow-up|0|||
163041598|NCT05052697|588860808|FG025|Substudy A|Lost to Follow-up|0|||
163041599|NCT05052697|588860809|FG026|Substudy A|Lost to Follow-up|0|||
163041600|NCT05052697|588860810|FG027|Substudy A|Lost to Follow-up|0|||
163041601|NCT05052697|588860811|FG028|Substudy A|Lost to Follow-up|0|||
163041602|NCT05052697|588860812|FG029|Substudy A|Lost to Follow-up|0|||
163041603|NCT05052697|588860813|FG030|Substudy A|Lost to Follow-up|0|||
163041604|NCT05052697|588860814|FG031|Substudy A|Lost to Follow-up|0|||
163041605|NCT05052697|588860815|FG032|Substudy A|Lost to Follow-up|0|||
163041606|NCT05052697|588860816|FG033|Substudy A|Lost to Follow-up|0|||
163041607|NCT05052697|588860783|FG000|Substudy A|No longer met eligibility criteria|0|||
163041608|NCT05052697|588860784|FG001|Substudy A|No longer met eligibility criteria|0|||
163041609|NCT05052697|588860785|FG002|Substudy A|No longer met eligibility criteria|0|||
163041610|NCT05052697|588860786|FG003|Substudy A|No longer met eligibility criteria|0|||
163041611|NCT05052697|588860787|FG004|Substudy A|No longer met eligibility criteria|0|||
163041612|NCT05052697|588860788|FG005|Substudy A|No longer met eligibility criteria|0|||
163041613|NCT05052697|588860789|FG006|Substudy A|No longer met eligibility criteria|0|||
163041614|NCT05052697|588860790|FG007|Substudy A|No longer met eligibility criteria|0|||
163041615|NCT05052697|588860791|FG008|Substudy A|No longer met eligibility criteria|0|||
163041616|NCT05052697|588860792|FG009|Substudy A|No longer met eligibility criteria|0|||
163041617|NCT05052697|588860793|FG010|Substudy A|No longer met eligibility criteria|0|||
163041618|NCT05052697|588860794|FG011|Substudy A|No longer met eligibility criteria|0|||
163041619|NCT05052697|588860795|FG012|Substudy A|No longer met eligibility criteria|0|||
163156586|NCT01352793|589287893|FG001|Overall Study|Medication error|2|||
163156587|NCT01352793|589287892|FG000|Overall Study|Death|1|||
163156588|NCT01352793|589287893|FG001|Overall Study|Death|0|||
163156589|NCT01352793|589287892|FG000|Overall Study|Randomized but not vaccinated|8|||
163156590|NCT01352793|589287893|FG001|Overall Study|Randomized but not vaccinated|0|||
163156591|NCT01352793|589287892|FG000|Overall Study|No longer meets eligibility criteria|25|||
163156592|NCT01352793|589287893|FG001|Overall Study|No longer meets eligibility criteria|15|||
163156593|NCT04322526|589287896|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
163156594|NCT04322526|589287897|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163156595|NCT04322526|589287896|FG000|Washout (1 Week)|Lost to Follow-up|1|||
163156596|NCT04322526|589287897|FG001|Washout (1 Week)|Lost to Follow-up|2|||
163156597|NCT03205423|589287898|FG000|Overall Study|Personal|1|||
163156598|NCT03205423|589287899|FG001|Overall Study|Personal|1|||
163156599|NCT03205423|589287898|FG000|Overall Study|Physician Decision|0|||
163156600|NCT03205423|589287899|FG001|Overall Study|Physician Decision|2|||
163156601|NCT02083354|589289695|FG000|Overall Study|Withdrawal by Subject|9|||
163156602|NCT02083354|589289695|FG000|Overall Study|Lost to Follow-up|1|||
163156603|NCT02083354|589289695|FG000|Overall Study|Adverse Event|3|||
163156604|NCT02083354|589289695|FG000|Overall Study|Disease progression|46|||
163156605|NCT02083354|589289695|FG000|Overall Study|Study closed/terminated|5|||
163156606|NCT00628108|589289696|FG000|Overall Study|Adverse Event|0|||
163156607|NCT00628108|589289697|FG001|Overall Study|Adverse Event|3|||
163156608|NCT00628108|589289696|FG000|Overall Study|Withdrawal by Subject|1|||
163156609|NCT00628108|589289697|FG001|Overall Study|Withdrawal by Subject|0|||
163041620|NCT05052697|588860796|FG013|Substudy A|No longer met eligibility criteria|1|||
163041621|NCT05052697|588860797|FG014|Substudy A|No longer met eligibility criteria|0|||
163041622|NCT05052697|588860798|FG015|Substudy A|No longer met eligibility criteria|0|||
163041623|NCT05052697|588860799|FG016|Substudy A|No longer met eligibility criteria|0|||
163041624|NCT05052697|588860800|FG017|Substudy A|No longer met eligibility criteria|0|||
163041625|NCT05052697|588860801|FG018|Substudy A|No longer met eligibility criteria|0|||
163041626|NCT05052697|588860802|FG019|Substudy A|No longer met eligibility criteria|0|||
163041627|NCT05052697|588860803|FG020|Substudy A|No longer met eligibility criteria|0|||
163041628|NCT05052697|588860804|FG021|Substudy A|No longer met eligibility criteria|0|||
163041629|NCT05052697|588860805|FG022|Substudy A|No longer met eligibility criteria|0|||
163041630|NCT05052697|588860806|FG023|Substudy A|No longer met eligibility criteria|0|||
163041631|NCT05052697|588860807|FG024|Substudy A|No longer met eligibility criteria|0|||
163041632|NCT05052697|588860808|FG025|Substudy A|No longer met eligibility criteria|0|||
163041633|NCT05052697|588860809|FG026|Substudy A|No longer met eligibility criteria|0|||
163041634|NCT05052697|588860810|FG027|Substudy A|No longer met eligibility criteria|0|||
163041635|NCT05052697|588860811|FG028|Substudy A|No longer met eligibility criteria|0|||
163041636|NCT05052697|588860812|FG029|Substudy A|No longer met eligibility criteria|0|||
163041637|NCT05052697|588860813|FG030|Substudy A|No longer met eligibility criteria|0|||
163041638|NCT05052697|588860814|FG031|Substudy A|No longer met eligibility criteria|0|||
163041639|NCT05052697|588860815|FG032|Substudy A|No longer met eligibility criteria|0|||
163041640|NCT05052697|588860816|FG033|Substudy A|No longer met eligibility criteria|0|||
163041641|NCT05052697|588860783|FG000|Substudy A|Not vaccinated|0|||
163041642|NCT05052697|588860784|FG001|Substudy A|Not vaccinated|0|||
163041643|NCT05052697|588860785|FG002|Substudy A|Not vaccinated|0|||
163156610|NCT02453321|589289698|FG000|Overall Study|Weakness|1|||
163156611|NCT02453321|589289699|FG001|Overall Study|Weakness|1|||
163041644|NCT05052697|588860786|FG003|Substudy A|Not vaccinated|1|||
163041645|NCT05052697|588860787|FG004|Substudy A|Not vaccinated|0|||
163041646|NCT05052697|588860788|FG005|Substudy A|Not vaccinated|0|||
163041647|NCT05052697|588860789|FG006|Substudy A|Not vaccinated|0|||
163041648|NCT05052697|588860790|FG007|Substudy A|Not vaccinated|0|||
163041649|NCT05052697|588860791|FG008|Substudy A|Not vaccinated|1|||
163041650|NCT05052697|588860792|FG009|Substudy A|Not vaccinated|0|||
163041651|NCT05052697|588860793|FG010|Substudy A|Not vaccinated|0|||
163041652|NCT05052697|588860794|FG011|Substudy A|Not vaccinated|0|||
163041653|NCT05052697|588860795|FG012|Substudy A|Not vaccinated|0|||
163041654|NCT05052697|588860796|FG013|Substudy A|Not vaccinated|0|||
163041655|NCT05052697|588860797|FG014|Substudy A|Not vaccinated|0|||
163041656|NCT05052697|588860798|FG015|Substudy A|Not vaccinated|0|||
163041657|NCT05052697|588860799|FG016|Substudy A|Not vaccinated|0|||
163041658|NCT05052697|588860800|FG017|Substudy A|Not vaccinated|0|||
163041659|NCT05052697|588860801|FG018|Substudy A|Not vaccinated|0|||
163041660|NCT05052697|588860802|FG019|Substudy A|Not vaccinated|0|||
163041661|NCT05052697|588860803|FG020|Substudy A|Not vaccinated|0|||
163041662|NCT05052697|588860804|FG021|Substudy A|Not vaccinated|0|||
163041663|NCT05052697|588860805|FG022|Substudy A|Not vaccinated|0|||
163041664|NCT05052697|588860806|FG023|Substudy A|Not vaccinated|0|||
163041665|NCT05052697|588860807|FG024|Substudy A|Not vaccinated|0|||
163041666|NCT05052697|588860808|FG025|Substudy A|Not vaccinated|0|||
163041667|NCT05052697|588860809|FG026|Substudy A|Not vaccinated|0|||
163041668|NCT05052697|588860810|FG027|Substudy A|Not vaccinated|0|||
163041669|NCT05052697|588860811|FG028|Substudy A|Not vaccinated|0|||
163041670|NCT05052697|588860812|FG029|Substudy A|Not vaccinated|0|||
163041671|NCT05052697|588860813|FG030|Substudy A|Not vaccinated|0|||
163041672|NCT05052697|588860814|FG031|Substudy A|Not vaccinated|0|||
163041673|NCT05052697|588860815|FG032|Substudy A|Not vaccinated|0|||
163041674|NCT05052697|588860816|FG033|Substudy A|Not vaccinated|0|||
163041675|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041676|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041677|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041678|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041679|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041680|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041681|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041682|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041683|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041684|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041685|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041686|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041687|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041688|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041689|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041690|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041691|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041692|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041693|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041694|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041695|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041696|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
163041697|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
163041698|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041699|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041700|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041701|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041702|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041703|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041704|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041705|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041706|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041707|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041708|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
163041709|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041710|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041711|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041712|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041713|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041714|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041715|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041716|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041717|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041718|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041719|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041720|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041721|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041722|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041723|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041724|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041725|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041726|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
163041727|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
162696318|NCT01533714|587599474|FG002|Overall Study|Lack of Efficacy|0|||
163041728|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041729|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041730|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041731|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041732|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041733|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041734|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041735|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041736|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041737|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041738|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041739|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
163156612|NCT02453321|589289700|FG002|Overall Study|Weakness|2|||
163156613|NCT02453321|589289698|FG000|Overall Study|Deep Venous Thrombosis|0|||
163156614|NCT02453321|589289699|FG001|Overall Study|Deep Venous Thrombosis|1|||
163156615|NCT02453321|589289700|FG002|Overall Study|Deep Venous Thrombosis|0|||
163156616|NCT00098813|589289701|FG000|Overall Study|Death|8|||
163156617|NCT00098813|589289701|FG000|Overall Study|Protocol Violation|1|||
163156618|NCT00098813|589289701|FG000|Overall Study|Withdrawal by Subject|7|||
163156619|NCT00098813|589289701|FG000|Overall Study|Progression of Disease|1|||
163156620|NCT00098813|589289701|FG000|Overall Study|Other complicating disease|1|||
163156621|NCT00098813|589289701|FG000|Overall Study|Reversal of RAI resistance|1|||
163156622|NCT02230670|589289702|FG000|Overall Study|Adverse Event|1|||
163156623|NCT02230670|589289703|FG001|Overall Study|Adverse Event|2|||
163156624|NCT02230670|589289702|FG000|Overall Study|Withdrawal by Subject|2|||
163156625|NCT02230670|589289703|FG001|Overall Study|Withdrawal by Subject|2|||
163156626|NCT02230670|589289702|FG000|Overall Study|Physician Decision|0|||
163156627|NCT02230670|589289703|FG001|Overall Study|Physician Decision|1|||
163156628|NCT02230670|589289702|FG000|Overall Study|Protocol Violation|0|||
163156629|NCT02230670|589289703|FG001|Overall Study|Protocol Violation|1|||
163156630|NCT02230670|589289702|FG000|Overall Study|Progression to Child-Pugh C|1|||
163156631|NCT02230670|589289703|FG001|Overall Study|Progression to Child-Pugh C|2|||
163156632|NCT01907854|589289708|FG000|Overall Study|Protocol Violation|1|||
163156633|NCT01907854|589289709|FG001|Overall Study|Protocol Violation|1|||
163156634|NCT01907854|589289708|FG000|Overall Study|Withdrawal by Subject|9|||
163156635|NCT01907854|589289709|FG001|Overall Study|Withdrawal by Subject|7|||
163156636|NCT01907854|589289708|FG000|Overall Study|Lost to Follow-up|2|||
163156637|NCT01907854|589289709|FG001|Overall Study|Lost to Follow-up|2|||
163156638|NCT01907854|589289708|FG000|Overall Study|Unclassified|4|||
163156639|NCT01907854|589289709|FG001|Overall Study|Unclassified|3|||
163156640|NCT02106390|589289710|FG000|Overall Study|Withdrawal by Subject|15|||
163156641|NCT02106390|589289711|FG001|Overall Study|Withdrawal by Subject|16|||
163156642|NCT02106390|589289712|FG002|Overall Study|Withdrawal by Subject|15|||
163156643|NCT02106390|589289710|FG000|Overall Study|Lost to Follow-up|25|||
163156644|NCT02106390|589289711|FG001|Overall Study|Lost to Follow-up|20|||
163156645|NCT02106390|589289712|FG002|Overall Study|Lost to Follow-up|13|||
163156646|NCT02106390|589289710|FG000|Overall Study|Other: Administrative Reason|8|||
163156647|NCT02106390|589289711|FG001|Overall Study|Other: Administrative Reason|5|||
163156648|NCT02106390|589289712|FG002|Overall Study|Other: Administrative Reason|12|||
163156649|NCT02106390|589289710|FG000|Overall Study|Other: Unspecified|1|||
163156650|NCT02106390|589289711|FG001|Overall Study|Other: Unspecified|4|||
163156651|NCT02106390|589289712|FG002|Overall Study|Other: Unspecified|2|||
163156652|NCT02106390|589289710|FG000|Overall Study|Adverse Event|0|||
163156653|NCT02106390|589289711|FG001|Overall Study|Adverse Event|2|||
163156654|NCT02106390|589289712|FG002|Overall Study|Adverse Event|1|||
163156655|NCT02106390|589289710|FG000|Overall Study|Protocol Violation|0|||
163156656|NCT02106390|589289711|FG001|Overall Study|Protocol Violation|1|||
163156657|NCT02106390|589289712|FG002|Overall Study|Protocol Violation|0|||
163156658|NCT02968004|589289713|FG000|Main Study Phase|Adverse Event|1|||
163156659|NCT02968004|589289714|FG001|Main Study Phase|Adverse Event|0|||
163156660|NCT02968004|589289713|FG000|Main Study Phase|Withdrawal by Subject|0|||
163156661|NCT02968004|589289714|FG001|Main Study Phase|Withdrawal by Subject|1|||
163156662|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
163156663|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
163156664|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
163156665|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
163156666|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
163156667|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
163156668|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
163156669|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
163156670|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
163156671|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
163156672|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
163156673|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
163156674|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
163156675|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
163156676|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
163156677|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
163156678|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
163156679|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
163156680|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
163156681|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
163156682|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
163156683|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
163156684|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
163156685|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
163156686|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
163156687|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
163156688|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
163156689|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
163156690|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
163156691|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
163156692|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
163156693|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
163156694|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
163156695|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
163156696|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
163156697|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
163156698|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
163156699|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
163156700|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
163156701|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
163156702|NCT02968004|589289713|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
163156703|NCT02968004|589289714|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
163156704|NCT00803569|589289716|FG000|Overall Study|Progressive Disease|3|||
163156705|NCT00803569|589289716|FG000|Overall Study|Noncompliance|1|||
163156706|NCT02504151|589289717|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
163156707|NCT02504151|589289718|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
163156708|NCT02504151|589289717|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163156709|NCT02504151|589289718|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163156710|NCT02504151|589289717|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163156711|NCT02504151|589289718|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163156712|NCT02504151|589289717|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
163156713|NCT02504151|589289718|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
163156714|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
163156715|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
163156716|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
163156717|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
163156718|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
163156719|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
163156720|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
163156721|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
163156722|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
163156723|NCT00538902|589289719|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156724|NCT00538902|589289720|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156725|NCT00538902|589289721|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
163156726|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
163156727|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
163156728|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
163156729|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
163156730|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
163156731|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
163156732|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
163156733|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
163156734|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
163156735|NCT00538902|589289719|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
163156736|NCT00538902|589289720|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
163156737|NCT00538902|589289721|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
163156738|NCT01454102|589289722|FG000|Overall Study|Continuing in the treatment period|0|||
163156739|NCT01454102|589289723|FG001|Overall Study|Continuing in the treatment period|0|||
163156740|NCT01454102|589289724|FG002|Overall Study|Continuing in the treatment period|0|||
163156741|NCT01454102|589289725|FG003|Overall Study|Continuing in the treatment period|0|||
163156742|NCT01454102|589289726|FG004|Overall Study|Continuing in the treatment period|3|||
163156743|NCT01454102|589289727|FG005|Overall Study|Continuing in the treatment period|3|||
163156744|NCT01454102|589289728|FG006|Overall Study|Continuing in the treatment period|2|||
163156745|NCT01454102|589289729|FG007|Overall Study|Continuing in the treatment period|0|||
163156746|NCT01454102|589289730|FG008|Overall Study|Continuing in the treatment period|1|||
163156747|NCT01454102|589289731|FG009|Overall Study|Continuing in the treatment period|0|||
163156748|NCT01454102|589289732|FG010|Overall Study|Continuing in the treatment period|0|||
163156749|NCT01454102|589289733|FG011|Overall Study|Continuing in the treatment period|4|||
163156750|NCT01454102|589289734|FG012|Overall Study|Continuing in the treatment period|7|||
163156751|NCT01454102|589289735|FG013|Overall Study|Continuing in the treatment period|4|||
162696319|NCT01533714|587599475|FG003|Overall Study|Lack of Efficacy|0|||
163156752|NCT01454102|589289736|FG014|Overall Study|Continuing in the treatment period|3|||
163156753|NCT01454102|589289737|FG015|Overall Study|Continuing in the treatment period|1|||
163156754|NCT01782378|589289740|FG000|First Series|Lost to Follow-up|7|||
163156755|NCT01782378|589289741|FG001|First Series|Lost to Follow-up|8|||
163156756|NCT01782378|589289740|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
163156757|NCT01782378|589289741|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
163156758|NCT01782378|589289740|FG000|Second Series|Lost to Follow-up|8|||
163156759|NCT01782378|589289741|FG001|Second Series|Lost to Follow-up|7|||
163156760|NCT01782378|589289740|FG000|Second Series|Did not choose to complete S2 Optional|18|||
163156761|NCT01782378|589289741|FG001|Second Series|Did not choose to complete S2 Optional|0|||
163156762|NCT00705016|589289742|FG000|Overall Study|Adverse Event|6|||
163156763|NCT00705016|589289743|FG001|Overall Study|Adverse Event|11|||
163156764|NCT00705016|589289744|FG002|Overall Study|Adverse Event|10|||
163156765|NCT00705016|589289742|FG000|Overall Study|Death|5|||
163156766|NCT00705016|589289743|FG001|Overall Study|Death|7|||
163156767|NCT00705016|589289744|FG002|Overall Study|Death|5|||
163156768|NCT00705016|589289742|FG000|Overall Study|Protocol Violation|0|||
163156769|NCT00705016|589289743|FG001|Overall Study|Protocol Violation|1|||
163156770|NCT00705016|589289744|FG002|Overall Study|Protocol Violation|1|||
163156771|NCT00705016|589289742|FG000|Overall Study|Withdrawal by Subject|4|||
163156772|NCT00705016|589289743|FG001|Overall Study|Withdrawal by Subject|3|||
163156773|NCT00705016|589289744|FG002|Overall Study|Withdrawal by Subject|2|||
163156774|NCT00705016|589289742|FG000|Overall Study|Progressive Disease|33|||
163156775|NCT00705016|589289743|FG001|Overall Study|Progressive Disease|29|||
163156776|NCT00705016|589289744|FG002|Overall Study|Progressive Disease|33|||
163156777|NCT00705016|589289742|FG000|Overall Study|Symptomatic Deterioration|3|||
163156778|NCT00705016|589289743|FG001|Overall Study|Symptomatic Deterioration|1|||
163156779|NCT00705016|589289744|FG002|Overall Study|Symptomatic Deterioration|1|||
163156780|NCT00705016|589289742|FG000|Overall Study|Other|9|||
163156781|NCT00705016|589289743|FG001|Overall Study|Other|6|||
163156782|NCT00705016|589289744|FG002|Overall Study|Other|6|||
163156783|NCT00942604|589289747|FG000|Overall Study|Protocol Violation|1|||
163156784|NCT00942604|589289748|FG001|Overall Study|Protocol Violation|1|||
163156785|NCT00942604|589289747|FG000|Overall Study|Adverse Event|0|||
163156786|NCT00942604|589289748|FG001|Overall Study|Adverse Event|1|||
163156787|NCT00942604|589289747|FG000|Overall Study|Withdrawal by Subject|0|||
163156788|NCT00942604|589289748|FG001|Overall Study|Withdrawal by Subject|1|||
163156789|NCT00942604|589289747|FG000|Overall Study|Patient relocation|1|||
163156790|NCT00942604|589289748|FG001|Overall Study|Patient relocation|1|||
163156791|NCT01188343|589289749|FG000|Overall Study|Not vaccinated|0|||
163156792|NCT01188343|589289750|FG001|Overall Study|Not vaccinated|2|||
163156793|NCT01188343|589289751|FG002|Overall Study|Not vaccinated|1|||
163156794|NCT01188343|589289749|FG000|Overall Study|Withdrawal by Subject|1|||
163156795|NCT01188343|589289750|FG001|Overall Study|Withdrawal by Subject|24|||
163156796|NCT01188343|589289751|FG002|Overall Study|Withdrawal by Subject|0|||
163156797|NCT04109547|589289752|FG000|Overall Study|Withdrawal by Subject|3|||
163156798|NCT04109547|589289753|FG001|Overall Study|Withdrawal by Subject|2|||
163156799|NCT04109547|589289754|FG002|Overall Study|Withdrawal by Subject|6|||
163156800|NCT04109547|589289755|FG003|Overall Study|Withdrawal by Subject|6|||
163156801|NCT04109547|589289752|FG000|Overall Study|Lost to Follow-up|0|||
163156802|NCT04109547|589289753|FG001|Overall Study|Lost to Follow-up|0|||
163156803|NCT04109547|589289754|FG002|Overall Study|Lost to Follow-up|0|||
163156804|NCT04109547|589289755|FG003|Overall Study|Lost to Follow-up|1|||
163156805|NCT04109547|589289752|FG000|Overall Study|Physician Decision|1|||
163156806|NCT04109547|589289753|FG001|Overall Study|Physician Decision|2|||
163156807|NCT04109547|589289754|FG002|Overall Study|Physician Decision|0|||
163156808|NCT04109547|589289755|FG003|Overall Study|Physician Decision|0|||
163156809|NCT01663103|589289756|FG000|Overall Study|Withdrawal by Subject|1|||
163156810|NCT01663103|589289757|FG001|Overall Study|Withdrawal by Subject|2|||
163156811|NCT01663103|589289756|FG000|Overall Study|Adverse Event|1|||
163156812|NCT01663103|589289757|FG001|Overall Study|Adverse Event|0|||
163156813|NCT01663103|589289756|FG000|Overall Study|dog bite|1|||
163156814|NCT01663103|589289757|FG001|Overall Study|dog bite|0|||
163156815|NCT01499355|589289762|FG000|Run-In Period|Study Termination|15|||
163156816|NCT01499355|589289763|FG001|Run-In Period|Study Termination|0|||
163156817|NCT01499355|589289764|FG002|Run-In Period|Study Termination|0|||
163156818|NCT01499355|589289765|FG003|Run-In Period|Study Termination|0|||
163156819|NCT01499355|589289762|FG000|Run-In Period|Other|3|||
163156820|NCT01499355|589289763|FG001|Run-In Period|Other|0|||
163156821|NCT01499355|589289764|FG002|Run-In Period|Other|0|||
163156822|NCT01499355|589289765|FG003|Run-In Period|Other|0|||
163156823|NCT01499355|589289762|FG000|Run-In Period|Death|2|||
163156824|NCT01499355|589289763|FG001|Run-In Period|Death|0|||
163156825|NCT01499355|589289764|FG002|Run-In Period|Death|0|||
163156826|NCT01499355|589289765|FG003|Run-In Period|Death|0|||
163156827|NCT01499355|589289762|FG000|Run-In Period|Investigator Decision|2|||
163156828|NCT01499355|589289763|FG001|Run-In Period|Investigator Decision|0|||
163156829|NCT01499355|589289764|FG002|Run-In Period|Investigator Decision|0|||
163041740|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041741|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041742|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
163041743|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041744|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041745|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041746|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041747|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041748|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041749|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041750|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041751|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041752|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041753|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163156830|NCT01499355|589289765|FG003|Run-In Period|Investigator Decision|0|||
163156831|NCT01499355|589289762|FG000|Run-In Period|Consent Withdrawn|1|||
163156832|NCT01499355|589289763|FG001|Run-In Period|Consent Withdrawn|0|||
163156833|NCT01499355|589289764|FG002|Run-In Period|Consent Withdrawn|0|||
163156834|NCT01499355|589289765|FG003|Run-In Period|Consent Withdrawn|0|||
163156835|NCT01499355|589289762|FG000|Run-In Period|Adverse Event|8|||
163156836|NCT01499355|589289763|FG001|Run-In Period|Adverse Event|0|||
163156837|NCT01499355|589289764|FG002|Run-In Period|Adverse Event|0|||
163156838|NCT01499355|589289765|FG003|Run-In Period|Adverse Event|0|||
163156839|NCT01499355|589289762|FG000|Double-Blind Period|Adverse Event|0|||
163156840|NCT01499355|589289763|FG001|Double-Blind Period|Adverse Event|2|||
163156841|NCT01499355|589289764|FG002|Double-Blind Period|Adverse Event|3|||
163156842|NCT01499355|589289765|FG003|Double-Blind Period|Adverse Event|2|||
163156843|NCT01499355|589289762|FG000|Double-Blind Period|Study Termination|0|||
163156844|NCT01499355|589289763|FG001|Double-Blind Period|Study Termination|18|||
163156845|NCT01499355|589289764|FG002|Double-Blind Period|Study Termination|16|||
163156846|NCT01499355|589289765|FG003|Double-Blind Period|Study Termination|14|||
163156847|NCT01499355|589289762|FG000|Double-Blind Period|Other|0|||
163156848|NCT01499355|589289763|FG001|Double-Blind Period|Other|1|||
163156849|NCT01499355|589289764|FG002|Double-Blind Period|Other|2|||
163156850|NCT01499355|589289765|FG003|Double-Blind Period|Other|2|||
163156851|NCT01499355|589289762|FG000|Double-Blind Period|Death|0|||
163156852|NCT01499355|589289763|FG001|Double-Blind Period|Death|1|||
163156853|NCT01499355|589289764|FG002|Double-Blind Period|Death|0|||
163156854|NCT01499355|589289765|FG003|Double-Blind Period|Death|0|||
163156855|NCT01499355|589289762|FG000|Double-Blind Period|Investigator Decision|0|||
163156856|NCT01499355|589289763|FG001|Double-Blind Period|Investigator Decision|0|||
163156857|NCT01499355|589289764|FG002|Double-Blind Period|Investigator Decision|3|||
163156858|NCT01499355|589289765|FG003|Double-Blind Period|Investigator Decision|3|||
163156859|NCT01499355|589289762|FG000|Double-Blind Period|Consent Withdrawn|0|||
163156860|NCT01499355|589289763|FG001|Double-Blind Period|Consent Withdrawn|0|||
163156861|NCT01499355|589289764|FG002|Double-Blind Period|Consent Withdrawn|1|||
163156862|NCT01499355|589289765|FG003|Double-Blind Period|Consent Withdrawn|2|||
163156863|NCT01499355|589289762|FG000|Double-Blind Period|Lost to Follow-up|0|||
163156864|NCT01499355|589289763|FG001|Double-Blind Period|Lost to Follow-up|1|||
163156865|NCT01499355|589289764|FG002|Double-Blind Period|Lost to Follow-up|0|||
163156866|NCT01499355|589289765|FG003|Double-Blind Period|Lost to Follow-up|0|||
163156867|NCT02668653|589289766|FG000|Overall Study|Refractory disease|41|||
163156868|NCT02668653|589289767|FG001|Overall Study|Refractory disease|70|||
163156869|NCT02668653|589289766|FG000|Overall Study|Relapse|44|||
163156870|NCT02668653|589289767|FG001|Overall Study|Relapse|65|||
163156871|NCT02668653|589289766|FG000|Overall Study|Adverse Event|58|||
163156872|NCT02668653|589289767|FG001|Overall Study|Adverse Event|23|||
163156873|NCT02668653|589289766|FG000|Overall Study|Subject decision to stop study drug|25|||
163156874|NCT02668653|589289767|FG001|Overall Study|Subject decision to stop study drug|23|||
163156875|NCT02668653|589289766|FG000|Overall Study|Other reasons not specified|16|||
163156876|NCT02668653|589289767|FG001|Overall Study|Other reasons not specified|11|||
163156877|NCT02668653|589289766|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
163156878|NCT02668653|589289767|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
163156879|NCT02668653|589289766|FG000|Overall Study|Investigator decision|10|||
163156880|NCT02668653|589289767|FG001|Overall Study|Investigator decision|7|||
163041754|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041755|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163156881|NCT02668653|589289766|FG000|Overall Study|Failure to meet continuation criteria|5|||
163156882|NCT02668653|589289767|FG001|Overall Study|Failure to meet continuation criteria|12|||
163156883|NCT02668653|589289766|FG000|Overall Study|Lost to Follow-up|1|||
163156884|NCT02668653|589289767|FG001|Overall Study|Lost to Follow-up|0|||
163156885|NCT02668653|589289766|FG000|Overall Study|Pregnancy|0|||
163156886|NCT02668653|589289767|FG001|Overall Study|Pregnancy|1|||
163156887|NCT02668653|589289766|FG000|Overall Study|Death|0|||
163156888|NCT02668653|589289767|FG001|Overall Study|Death|1|||
163156889|NCT00686712|589289768|FG000|Overall Study|Protocol Violation|8|||
163041756|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041757|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041758|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041759|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041760|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041761|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041762|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
163041763|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041764|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041765|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041766|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041767|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041768|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041769|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041770|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041771|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041772|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041773|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041774|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041775|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041776|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
163041777|NCT05052697|588860783|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041778|NCT05052697|588860784|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041779|NCT05052697|588860785|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041780|NCT05052697|588860786|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041781|NCT05052697|588860787|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041782|NCT05052697|588860788|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041783|NCT05052697|588860789|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041784|NCT05052697|588860790|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041785|NCT05052697|588860791|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041786|NCT05052697|588860792|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041787|NCT05052697|588860793|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041788|NCT05052697|588860794|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041789|NCT05052697|588860795|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041790|NCT05052697|588860796|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041791|NCT05052697|588860797|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041792|NCT05052697|588860798|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041793|NCT05052697|588860799|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041794|NCT05052697|588860800|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041795|NCT05052697|588860801|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041796|NCT05052697|588860802|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041797|NCT05052697|588860803|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041798|NCT05052697|588860804|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041799|NCT05052697|588860805|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041800|NCT05052697|588860806|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041801|NCT05052697|588860807|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041802|NCT05052697|588860808|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041803|NCT05052697|588860809|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041804|NCT05052697|588860810|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
163041805|NCT05052697|588860811|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041806|NCT05052697|588860812|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041807|NCT05052697|588860813|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041808|NCT05052697|588860814|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041809|NCT05052697|588860815|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041810|NCT05052697|588860816|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
163041811|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041812|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041813|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041814|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041815|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041816|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041817|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041818|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041819|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041820|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041821|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041822|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041823|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041824|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163156890|NCT00686712|589289769|FG001|Overall Study|Protocol Violation|8|||
163156891|NCT00686712|589289770|FG002|Overall Study|Protocol Violation|10|||
163156892|NCT00686712|589289768|FG000|Overall Study|Lost to Follow-up|1|||
163156893|NCT00686712|589289769|FG001|Overall Study|Lost to Follow-up|2|||
163156894|NCT00686712|589289770|FG002|Overall Study|Lost to Follow-up|3|||
163156895|NCT00686712|589289768|FG000|Overall Study|Adverse Event|1|||
163156896|NCT00686712|589289769|FG001|Overall Study|Adverse Event|1|||
163156897|NCT00686712|589289770|FG002|Overall Study|Adverse Event|0|||
163156898|NCT04119414|589289771|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
163156899|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
163156900|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
163156901|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
163156902|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
163156903|NCT01929317|589289785|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
163156904|NCT01929317|589289786|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
163156905|NCT01929317|589289785|FG000|Long-term Phase|Adverse Event|5|||
163156906|NCT01929317|589289786|FG001|Long-term Phase|Adverse Event|1|||
163156907|NCT01929317|589289785|FG000|Long-term Phase|Physician Decision|3|||
163156908|NCT01929317|589289786|FG001|Long-term Phase|Physician Decision|0|||
163156909|NCT01929317|589289785|FG000|Long-term Phase|Withdrawal by Subject|4|||
163156910|NCT01929317|589289786|FG001|Long-term Phase|Withdrawal by Subject|0|||
163156911|NCT01929317|589289785|FG000|Long-term Phase|Protocol Violation|1|||
163156912|NCT01929317|589289786|FG001|Long-term Phase|Protocol Violation|0|||
163156913|NCT01929317|589289785|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
163156914|NCT01929317|589289786|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
163156915|NCT01929317|589289785|FG000|Long-term Phase|Study Closed/Terminated|5|||
163156916|NCT01929317|589289786|FG001|Long-term Phase|Study Closed/Terminated|3|||
163156917|NCT00993967|589289790|FG000|Overall Study|Adverse Event|8|||
163156918|NCT00993967|589289790|FG000|Overall Study|Death|1|||
163156919|NCT00993967|589289790|FG000|Overall Study|Lost to Follow-up|14|||
163156920|NCT00993967|589289790|FG000|Overall Study|Withdrawal by Subject|36|||
163156921|NCT00993967|589289790|FG000|Overall Study|Protocol Violation|2|||
163156922|NCT03815929|589289799|FG000|Overall Study|Lost to Follow-up|2|||
163156923|NCT03815929|589289800|FG001|Overall Study|Lost to Follow-up|1|||
163156924|NCT03815929|589289801|FG002|Overall Study|Lost to Follow-up|0|||
163156925|NCT03815929|589289799|FG000|Overall Study|Physician Decision|2|||
163156926|NCT03815929|589289800|FG001|Overall Study|Physician Decision|2|||
163156927|NCT03815929|589289801|FG002|Overall Study|Physician Decision|0|||
163156928|NCT03815929|589289799|FG000|Overall Study|Withdrawal by Subject|0|||
163156929|NCT03815929|589289800|FG001|Overall Study|Withdrawal by Subject|0|||
163156930|NCT03815929|589289801|FG002|Overall Study|Withdrawal by Subject|1|||
163156931|NCT03313037|589289802|FG000|Overall Study|Protocol Violation|4|||
163156932|NCT03313037|589289803|FG001|Overall Study|Protocol Violation|1|||
163156933|NCT03313037|589289802|FG000|Overall Study|Other|1|||
163156934|NCT03313037|589289803|FG001|Overall Study|Other|1|||
163156935|NCT03313037|589289802|FG000|Overall Study|Withdrawal by Subject|4|||
163156936|NCT03313037|589289803|FG001|Overall Study|Withdrawal by Subject|3|||
163156937|NCT03313037|589289802|FG000|Overall Study|No longer meets eligibility criteria|1|||
163156938|NCT03313037|589289803|FG001|Overall Study|No longer meets eligibility criteria|7|||
163156939|NCT03313037|589289802|FG000|Overall Study|Lost to Follow-up|9|||
163156940|NCT03313037|589289803|FG001|Overall Study|Lost to Follow-up|8|||
163156941|NCT03313037|589289802|FG000|Overall Study|Randomized but not treated|1|||
163156942|NCT03313037|589289803|FG001|Overall Study|Randomized but not treated|0|||
163156943|NCT02760498|589289804|FG000|Overall Study|Adverse Event|3|||
163156944|NCT02760498|589289805|FG001|Overall Study|Adverse Event|3|||
163156945|NCT02760498|589289806|FG002|Overall Study|Adverse Event|1|||
163156946|NCT02760498|589289807|FG003|Overall Study|Adverse Event|1|||
163156947|NCT02760498|589289808|FG004|Overall Study|Adverse Event|0|||
163156948|NCT02760498|589289809|FG005|Overall Study|Adverse Event|6|||
163156949|NCT02760498|589289804|FG000|Overall Study|Death|7|||
163156950|NCT02760498|589289805|FG001|Overall Study|Death|5|||
163156951|NCT02760498|589289806|FG002|Overall Study|Death|5|||
163156952|NCT02760498|589289807|FG003|Overall Study|Death|7|||
163156953|NCT02760498|589289808|FG004|Overall Study|Death|0|||
163156954|NCT02760498|589289809|FG005|Overall Study|Death|23|||
163156955|NCT02760498|589289804|FG000|Overall Study|Lost to Follow-up|0|||
163156956|NCT02760498|589289805|FG001|Overall Study|Lost to Follow-up|0|||
163156957|NCT02760498|589289806|FG002|Overall Study|Lost to Follow-up|0|||
163156958|NCT02760498|589289807|FG003|Overall Study|Lost to Follow-up|0|||
163156959|NCT02760498|589289808|FG004|Overall Study|Lost to Follow-up|0|||
163156960|NCT02760498|589289809|FG005|Overall Study|Lost to Follow-up|3|||
163156961|NCT02760498|589289804|FG000|Overall Study|Non-compliance with study drug|0|||
163156962|NCT02760498|589289805|FG001|Overall Study|Non-compliance with study drug|2|||
163156963|NCT02760498|589289806|FG002|Overall Study|Non-compliance with study drug|0|||
163156964|NCT02760498|589289807|FG003|Overall Study|Non-compliance with study drug|0|||
163041825|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041826|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041827|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041828|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041829|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041830|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041831|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041832|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041833|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041834|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041835|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041836|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041837|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041838|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041839|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
163041840|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041841|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041842|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041843|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
163041844|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
163041845|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041846|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041847|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041848|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041849|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041850|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041851|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041852|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041853|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041854|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041855|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041856|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041857|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041858|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041859|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041860|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041861|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041862|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041863|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041864|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041865|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041866|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041867|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041868|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041869|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041870|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041871|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041872|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041873|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
163041874|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
163041875|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
163041876|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
163041877|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
163041878|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
163041879|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041880|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041881|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041882|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041883|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041884|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041885|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156965|NCT02760498|589289808|FG004|Overall Study|Non-compliance with study drug|0|||
163041886|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041887|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156966|NCT02760498|589289809|FG005|Overall Study|Non-compliance with study drug|0|||
163041888|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041889|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041890|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163156967|NCT02760498|589289804|FG000|Overall Study|Participant decision|1|||
163156968|NCT02760498|589289805|FG001|Overall Study|Participant decision|4|||
163156969|NCT02760498|589289806|FG002|Overall Study|Participant decision|2|||
163156970|NCT02760498|589289807|FG003|Overall Study|Participant decision|2|||
163156971|NCT02760498|589289808|FG004|Overall Study|Participant decision|1|||
163156972|NCT02760498|589289809|FG005|Overall Study|Participant decision|6|||
163156973|NCT02760498|589289804|FG000|Overall Study|Sponsor decision|0|||
163156974|NCT02760498|589289805|FG001|Overall Study|Sponsor decision|0|||
163156975|NCT02760498|589289806|FG002|Overall Study|Sponsor decision|0|||
163156976|NCT02760498|589289807|FG003|Overall Study|Sponsor decision|3|||
163156977|NCT02760498|589289808|FG004|Overall Study|Sponsor decision|0|||
163156978|NCT02760498|589289809|FG005|Overall Study|Sponsor decision|0|||
163156979|NCT02760498|589289804|FG000|Overall Study|Physician Decision|3|||
163156980|NCT02760498|589289805|FG001|Overall Study|Physician Decision|4|||
163156981|NCT02760498|589289806|FG002|Overall Study|Physician Decision|1|||
163156982|NCT02760498|589289807|FG003|Overall Study|Physician Decision|4|||
163156983|NCT02760498|589289808|FG004|Overall Study|Physician Decision|0|||
163156984|NCT02760498|589289809|FG005|Overall Study|Physician Decision|2|||
163156985|NCT02760498|589289804|FG000|Overall Study|Disease progression|21|||
163156986|NCT02760498|589289805|FG001|Overall Study|Disease progression|19|||
163156987|NCT02760498|589289806|FG002|Overall Study|Disease progression|20|||
163156988|NCT02760498|589289807|FG003|Overall Study|Disease progression|18|||
163156989|NCT02760498|589289808|FG004|Overall Study|Disease progression|4|||
163156990|NCT02760498|589289809|FG005|Overall Study|Disease progression|55|||
163156991|NCT02760498|589289804|FG000|Overall Study|Withdrawal by Subject|4|||
163156992|NCT02760498|589289805|FG001|Overall Study|Withdrawal by Subject|7|||
163156993|NCT02760498|589289806|FG002|Overall Study|Withdrawal by Subject|5|||
163041891|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041892|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041893|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041894|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041895|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041896|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041897|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041898|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041899|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041900|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041901|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041902|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041903|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041904|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041905|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041906|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041907|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041908|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041909|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041910|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041911|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
163041912|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
163041913|NCT05052697|588860783|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041914|NCT05052697|588860784|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041915|NCT05052697|588860785|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041916|NCT05052697|588860786|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041917|NCT05052697|588860787|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041918|NCT05052697|588860788|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041919|NCT05052697|588860789|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041920|NCT05052697|588860790|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041921|NCT05052697|588860791|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041922|NCT05052697|588860792|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041923|NCT05052697|588860793|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041924|NCT05052697|588860794|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041925|NCT05052697|588860795|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041926|NCT05052697|588860796|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041927|NCT05052697|588860797|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041928|NCT05052697|588860798|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041929|NCT05052697|588860799|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041930|NCT05052697|588860800|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041931|NCT05052697|588860801|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041932|NCT05052697|588860802|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041933|NCT05052697|588860803|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041934|NCT05052697|588860804|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041935|NCT05052697|588860805|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041936|NCT05052697|588860806|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041937|NCT05052697|588860807|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041938|NCT05052697|588860808|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041939|NCT05052697|588860809|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041940|NCT05052697|588860810|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041941|NCT05052697|588860811|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
163041942|NCT05052697|588860812|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
163041943|NCT05052697|588860813|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
163041944|NCT05052697|588860814|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041945|NCT05052697|588860815|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041946|NCT05052697|588860816|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
163041947|NCT03796676|588860817|FG000|Overall Study|Adverse Event|2|||
163041948|NCT03796676|588860818|FG001|Overall Study|Adverse Event|1|||
163041949|NCT03796676|588860819|FG002|Overall Study|Adverse Event|2|||
163041950|NCT03796676|588860817|FG000|Overall Study|Lost to Follow-up|2|||
163041951|NCT03796676|588860818|FG001|Overall Study|Lost to Follow-up|1|||
163041952|NCT03796676|588860819|FG002|Overall Study|Lost to Follow-up|0|||
163041953|NCT03796676|588860817|FG000|Overall Study|Protocol Violation|0|||
163041954|NCT03796676|588860818|FG001|Overall Study|Protocol Violation|0|||
163041955|NCT03796676|588860819|FG002|Overall Study|Protocol Violation|1|||
163041956|NCT03796676|588860817|FG000|Overall Study|Withdrawal by Subject|1|||
163041957|NCT03796676|588860818|FG001|Overall Study|Withdrawal by Subject|1|||
163041958|NCT03796676|588860819|FG002|Overall Study|Withdrawal by Subject|0|||
163041959|NCT03796676|588860817|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
163156994|NCT02760498|589289807|FG003|Overall Study|Withdrawal by Subject|1|||
163156995|NCT02760498|589289808|FG004|Overall Study|Withdrawal by Subject|0|||
163156996|NCT02760498|589289809|FG005|Overall Study|Withdrawal by Subject|6|||
163156997|NCT02760498|589289804|FG000|Overall Study|Other than specified|1|||
163156998|NCT02760498|589289805|FG001|Overall Study|Other than specified|6|||
163156999|NCT02760498|589289806|FG002|Overall Study|Other than specified|0|||
163157000|NCT02760498|589289807|FG003|Overall Study|Other than specified|3|||
163157001|NCT02760498|589289808|FG004|Overall Study|Other than specified|1|||
163157002|NCT02760498|589289809|FG005|Overall Study|Other than specified|0|||
163157003|NCT02760498|589289804|FG000|Overall Study|Not treated|0|||
163157004|NCT02760498|589289805|FG001|Overall Study|Not treated|0|||
163157005|NCT02760498|589289806|FG002|Overall Study|Not treated|0|||
163157006|NCT02760498|589289807|FG003|Overall Study|Not treated|0|||
163157007|NCT02760498|589289808|FG004|Overall Study|Not treated|0|||
163157008|NCT02760498|589289809|FG005|Overall Study|Not treated|2|||
163157009|NCT02205736|589289810|FG000|Overall Study|Lost to Follow-up|106|||
163157010|NCT01198977|589289814|FG000|Overall Study|Lost to Follow-up|1|||
163157011|NCT01198977|589289815|FG001|Overall Study|Lost to Follow-up|0|||
163157012|NCT01899040|589289817|FG000|Overall Study|Randomized in error|0|||
163157013|NCT01899040|589289818|FG001|Overall Study|Randomized in error|1|||
163157014|NCT01899040|589289819|FG002|Overall Study|Randomized in error|1|||
163157015|NCT01899040|589289817|FG000|Overall Study|Adverse Event|3|||
163157016|NCT01899040|589289818|FG001|Overall Study|Adverse Event|1|||
163157017|NCT01899040|589289819|FG002|Overall Study|Adverse Event|2|||
163157018|NCT01899040|589289817|FG000|Overall Study|Unspecified reasons|4|||
163157019|NCT01899040|589289818|FG001|Overall Study|Unspecified reasons|4|||
163157020|NCT01899040|589289819|FG002|Overall Study|Unspecified reasons|0|||
163157021|NCT01899040|589289817|FG000|Overall Study|Compliance issues|1|||
163157022|NCT01899040|589289818|FG001|Overall Study|Compliance issues|2|||
163157023|NCT01899040|589289819|FG002|Overall Study|Compliance issues|0|||
163157024|NCT02638220|589289825|FG000|Overall Study|Lost to Follow-up|6|||
163157025|NCT02638220|589289825|FG000|Overall Study|Withdrawal by Subject|3|||
163157026|NCT02638220|589289825|FG000|Overall Study|Physician Decision|1|||
163157027|NCT02638220|589289825|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
163157028|NCT04323124|589289834|FG000|Overall Study|Adverse Event|0|||
163157029|NCT04323124|589289835|FG001|Overall Study|Adverse Event|0|||
163157030|NCT04323124|589289836|FG002|Overall Study|Adverse Event|0|||
163157031|NCT04323124|589289837|FG003|Overall Study|Adverse Event|0|||
163157032|NCT04323124|589289838|FG004|Overall Study|Adverse Event|0|||
163157033|NCT04323124|589289839|FG005|Overall Study|Adverse Event|1|||
163157034|NCT04323124|589289840|FG006|Overall Study|Adverse Event|0|||
163157035|NCT04323124|589289841|FG007|Overall Study|Adverse Event|1|||
163157036|NCT04323124|589289842|FG008|Overall Study|Adverse Event|1|||
163157037|NCT04323124|589289843|FG009|Overall Study|Adverse Event|0|||
163157038|NCT04323124|589289844|FG010|Overall Study|Adverse Event|0|||
163157039|NCT04323124|589289845|FG011|Overall Study|Adverse Event|0|||
163157040|NCT04323124|589289846|FG012|Overall Study|Adverse Event|0|||
163157041|NCT04323124|589289847|FG013|Overall Study|Adverse Event|0|||
163157042|NCT04323124|589289848|FG014|Overall Study|Adverse Event|0|||
163157043|NCT04323124|589289834|FG000|Overall Study|Other|0|||
163157044|NCT04323124|589289835|FG001|Overall Study|Other|0|||
163157045|NCT04323124|589289836|FG002|Overall Study|Other|0|||
163157046|NCT04323124|589289837|FG003|Overall Study|Other|0|||
163157047|NCT04323124|589289838|FG004|Overall Study|Other|1|||
163157048|NCT04323124|589289839|FG005|Overall Study|Other|0|||
163157049|NCT04323124|589289840|FG006|Overall Study|Other|0|||
163157050|NCT04323124|589289841|FG007|Overall Study|Other|0|||
163157051|NCT04323124|589289842|FG008|Overall Study|Other|1|||
163157052|NCT04323124|589289843|FG009|Overall Study|Other|0|||
163157053|NCT04323124|589289844|FG010|Overall Study|Other|0|||
163157054|NCT04323124|589289845|FG011|Overall Study|Other|0|||
163157055|NCT04323124|589289846|FG012|Overall Study|Other|0|||
163157056|NCT04323124|589289847|FG013|Overall Study|Other|0|||
163157057|NCT04323124|589289848|FG014|Overall Study|Other|0|||
163157058|NCT04323124|589289834|FG000|Overall Study|Coming from a red zone (COVID)|0|||
163157059|NCT04323124|589289835|FG001|Overall Study|Coming from a red zone (COVID)|0|||
163157060|NCT04323124|589289836|FG002|Overall Study|Coming from a red zone (COVID)|0|||
163157061|NCT04323124|589289837|FG003|Overall Study|Coming from a red zone (COVID)|0|||
163157062|NCT04323124|589289838|FG004|Overall Study|Coming from a red zone (COVID)|1|||
162696320|NCT01533714|587599476|FG004|Overall Study|Lack of Efficacy|0|||
163157063|NCT04323124|589289839|FG005|Overall Study|Coming from a red zone (COVID)|1|||
163157064|NCT04323124|589289840|FG006|Overall Study|Coming from a red zone (COVID)|0|||
163157065|NCT04323124|589289841|FG007|Overall Study|Coming from a red zone (COVID)|0|||
163157066|NCT04323124|589289842|FG008|Overall Study|Coming from a red zone (COVID)|0|||
163157067|NCT04323124|589289843|FG009|Overall Study|Coming from a red zone (COVID)|0|||
163157068|NCT04323124|589289844|FG010|Overall Study|Coming from a red zone (COVID)|0|||
163157069|NCT04323124|589289845|FG011|Overall Study|Coming from a red zone (COVID)|0|||
163157070|NCT04323124|589289846|FG012|Overall Study|Coming from a red zone (COVID)|0|||
163157071|NCT04323124|589289847|FG013|Overall Study|Coming from a red zone (COVID)|0|||
163157072|NCT04323124|589289848|FG014|Overall Study|Coming from a red zone (COVID)|0|||
163157073|NCT04323124|589289834|FG000|Overall Study|No longer meets eligibility criteria|0|||
163157074|NCT04323124|589289835|FG001|Overall Study|No longer meets eligibility criteria|0|||
163157075|NCT04323124|589289836|FG002|Overall Study|No longer meets eligibility criteria|0|||
163157076|NCT04323124|589289837|FG003|Overall Study|No longer meets eligibility criteria|0|||
163157077|NCT04323124|589289838|FG004|Overall Study|No longer meets eligibility criteria|0|||
163157078|NCT04323124|589289839|FG005|Overall Study|No longer meets eligibility criteria|0|||
163157079|NCT04323124|589289840|FG006|Overall Study|No longer meets eligibility criteria|0|||
163157080|NCT04323124|589289841|FG007|Overall Study|No longer meets eligibility criteria|1|||
163157081|NCT04323124|589289842|FG008|Overall Study|No longer meets eligibility criteria|0|||
163157082|NCT04323124|589289843|FG009|Overall Study|No longer meets eligibility criteria|0|||
163157083|NCT04323124|589289844|FG010|Overall Study|No longer meets eligibility criteria|0|||
163157084|NCT04323124|589289845|FG011|Overall Study|No longer meets eligibility criteria|0|||
163157085|NCT04323124|589289846|FG012|Overall Study|No longer meets eligibility criteria|0|||
163157086|NCT04323124|589289847|FG013|Overall Study|No longer meets eligibility criteria|1|||
163157087|NCT04323124|589289848|FG014|Overall Study|No longer meets eligibility criteria|1|||
163157088|NCT04323124|589289834|FG000|Overall Study|Study terminated by sponsor|0|||
163157089|NCT04323124|589289835|FG001|Overall Study|Study terminated by sponsor|0|||
163157090|NCT04323124|589289836|FG002|Overall Study|Study terminated by sponsor|0|||
163157091|NCT04323124|589289837|FG003|Overall Study|Study terminated by sponsor|0|||
163157092|NCT04323124|589289838|FG004|Overall Study|Study terminated by sponsor|0|||
163157093|NCT04323124|589289839|FG005|Overall Study|Study terminated by sponsor|0|||
163157094|NCT04323124|589289840|FG006|Overall Study|Study terminated by sponsor|0|||
163157095|NCT04323124|589289841|FG007|Overall Study|Study terminated by sponsor|0|||
163157096|NCT04323124|589289842|FG008|Overall Study|Study terminated by sponsor|0|||
163157097|NCT04323124|589289843|FG009|Overall Study|Study terminated by sponsor|0|||
163157098|NCT04323124|589289844|FG010|Overall Study|Study terminated by sponsor|0|||
163157099|NCT04323124|589289845|FG011|Overall Study|Study terminated by sponsor|2|||
163157100|NCT04323124|589289846|FG012|Overall Study|Study terminated by sponsor|1|||
163157101|NCT04323124|589289847|FG013|Overall Study|Study terminated by sponsor|0|||
163157102|NCT04323124|589289848|FG014|Overall Study|Study terminated by sponsor|0|||
163157103|NCT04586205|589289849|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
163157104|NCT04586205|589289850|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
163157105|NCT01417377|589291640|FG000|Overall Study|Lost to Follow-up|12|||
163157106|NCT01417377|589291640|FG000|Overall Study|Enrolled, but not treated|1|||
163157107|NCT01772316|589291642|FG000|Overall Study|Serious adverse event|1|||
163157108|NCT01772316|589291642|FG000|Overall Study|Inform consent withdrawn|1|||
163157109|NCT01772316|589291642|FG000|Overall Study|Withdrawn by sponsor decision|5|||
163157110|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
163157111|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
163157112|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
163157113|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
163157114|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
163157115|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
163157116|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
163157117|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
163157118|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
163157119|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
163157120|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
163157121|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
163157122|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
163157123|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
163157124|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
163157125|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
163157126|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
163157127|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
163157128|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
163157129|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
163157130|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
163157131|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
163157132|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
163157133|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
163157134|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
163157135|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
163157136|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
163157137|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
163157138|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157139|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157140|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157141|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157142|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157143|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157144|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
163157145|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157146|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157147|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157148|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157149|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157150|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163157151|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
163041960|NCT03796676|588860818|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
163041961|NCT03796676|588860819|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
163041962|NCT01900899|588860822|FG000|Overall Study|Withdrawal by Subject|7|||
163041963|NCT01900899|588860823|FG001|Overall Study|Withdrawal by Subject|1|||
163041964|NCT01900899|588860822|FG000|Overall Study|Migrated from study area|2|||
163041965|NCT01900899|588860823|FG001|Overall Study|Migrated from study area|0|||
163041966|NCT02772809|588860829|FG000|Overall Study|not completed some tasks|6|||
163157152|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Transplant|0|||
163157153|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Transplant|1|||
163157154|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Transplant|0|||
163157155|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Transplant|0|||
163157156|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Transplant|0|||
163157157|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Transplant|1|||
163157158|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Transplant|0|||
163157159|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Transplant|0|||
163157160|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Transplant|0|||
163157161|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Transplant|0|||
163157162|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Transplant|0|||
163157163|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Transplant|0|||
163157164|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Transplant|0|||
162696321|NCT01533714|587599477|FG005|Overall Study|Lack of Efficacy|1|||
163041967|NCT00534105|588860830|FG000|Overall Study|Lost to Follow-up|23|||
163041968|NCT00534105|588860831|FG001|Overall Study|Lost to Follow-up|39|||
163041969|NCT02226120|588860832|FG000|Overall Study|Adverse Event|60|||
163041970|NCT02226120|588860832|FG000|Overall Study|Death|172|||
163041971|NCT02226120|588860832|FG000|Overall Study|Study terminated by sponsor|1|||
163041972|NCT02226120|588860832|FG000|Overall Study|Technical problems|4|||
163041973|NCT02226120|588860832|FG000|Overall Study|Lost to Follow-up|13|||
163041974|NCT02226120|588860832|FG000|Overall Study|Physician Decision|21|||
163041975|NCT02226120|588860832|FG000|Overall Study|Withdrawal by parent/guardian|36|||
163041976|NCT02226120|588860832|FG000|Overall Study|Non-compliance with study drug|10|||
163041977|NCT02226120|588860832|FG000|Overall Study|Protocol deviation|1|||
163041978|NCT02226120|588860832|FG000|Overall Study|missing treatment disposition pages|2|||
163041979|NCT03034135|588860834|FG000|Overall Study|Withdrawal by Subject|2|||
163041980|NCT00467558|588860837|FG000|Overall Study|Lost to Follow-up|2|||
163041981|NCT00467558|588860838|FG001|Overall Study|Lost to Follow-up|0|||
163041982|NCT02636439|588860839|FG000|Overall Study|Adverse Event|2|||
163041983|NCT02636439|588860840|FG001|Overall Study|Adverse Event|2|||
163041984|NCT02636439|588860839|FG000|Overall Study|Lost to Follow-up|1|||
163041985|NCT02636439|588860840|FG001|Overall Study|Lost to Follow-up|0|||
163041986|NCT02636439|588860839|FG000|Overall Study|Non-compliance|1|||
163041987|NCT02636439|588860840|FG001|Overall Study|Non-compliance|1|||
163041988|NCT02636439|588860839|FG000|Overall Study|Personal reasons|2|||
163041989|NCT02636439|588860840|FG001|Overall Study|Personal reasons|0|||
163041990|NCT02494401|588860842|FG000|Overall Study|Lost to Follow-up|22|||
163041991|NCT02494401|588860843|FG001|Overall Study|Lost to Follow-up|25|||
163041992|NCT02494401|588860842|FG000|Overall Study|Withdrawal by Subject|3|||
163041993|NCT02494401|588860843|FG001|Overall Study|Withdrawal by Subject|2|||
163041994|NCT05188729|588860844|FG000|Overall Study|Withdrawal by Subject|0|||
163041995|NCT05188729|588860845|FG001|Overall Study|Withdrawal by Subject|0|||
163041996|NCT05188729|588860846|FG002|Overall Study|Withdrawal by Subject|0|||
163041997|NCT05188729|588860847|FG003|Overall Study|Withdrawal by Subject|0|||
163041998|NCT05188729|588860848|FG004|Overall Study|Withdrawal by Subject|0|||
163041999|NCT05188729|588860849|FG005|Overall Study|Withdrawal by Subject|0|||
163042000|NCT05188729|588860850|FG006|Overall Study|Withdrawal by Subject|0|||
163042001|NCT05188729|588860851|FG007|Overall Study|Withdrawal by Subject|0|||
163042002|NCT05188729|588860852|FG008|Overall Study|Withdrawal by Subject|0|||
163042003|NCT05188729|588860853|FG009|Overall Study|Withdrawal by Subject|1|||
163042004|NCT05188729|588860854|FG010|Overall Study|Withdrawal by Subject|0|||
163042005|NCT05188729|588860855|FG011|Overall Study|Withdrawal by Subject|0|||
163042006|NCT05188729|588860856|FG012|Overall Study|Withdrawal by Subject|0|||
163042007|NCT05188729|588860844|FG000|Overall Study|Lost to Follow-up|0|||
163042008|NCT05188729|588860845|FG001|Overall Study|Lost to Follow-up|0|||
163042009|NCT05188729|588860846|FG002|Overall Study|Lost to Follow-up|0|||
163042010|NCT05188729|588860847|FG003|Overall Study|Lost to Follow-up|0|||
163042011|NCT05188729|588860848|FG004|Overall Study|Lost to Follow-up|0|||
163042012|NCT05188729|588860849|FG005|Overall Study|Lost to Follow-up|0|||
163157165|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Transplant|0|||
163157166|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
163157167|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
163157168|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
163157169|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
163157170|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
163157171|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
163157172|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
163157173|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
163157174|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
163157175|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
163157176|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
163157177|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
163157178|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
163157179|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
163157180|NCT02113982|589291643|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
163157181|NCT02113982|589291644|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
163157182|NCT02113982|589291645|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
163157183|NCT02113982|589291646|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
163157184|NCT02113982|589291647|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
163157185|NCT02113982|589291648|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
163157186|NCT02113982|589291649|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
163157187|NCT02113982|589291650|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
163157188|NCT02113982|589291651|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
163157189|NCT02113982|589291652|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
163157190|NCT02113982|589291653|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
163157191|NCT02113982|589291654|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
163157192|NCT02113982|589291655|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
163157193|NCT02113982|589291656|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
163157194|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
163157195|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
163157196|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
163157197|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
163157198|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
163157199|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
163157200|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
163157201|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
163157202|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
163157203|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
163157204|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
163157205|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
163042013|NCT05188729|588860850|FG006|Overall Study|Lost to Follow-up|0|||
163042014|NCT05188729|588860851|FG007|Overall Study|Lost to Follow-up|0|||
163042015|NCT05188729|588860852|FG008|Overall Study|Lost to Follow-up|0|||
163042016|NCT05188729|588860853|FG009|Overall Study|Lost to Follow-up|0|||
163042017|NCT05188729|588860854|FG010|Overall Study|Lost to Follow-up|1|||
163042018|NCT05188729|588860855|FG011|Overall Study|Lost to Follow-up|1|||
163042019|NCT05188729|588860856|FG012|Overall Study|Lost to Follow-up|0|||
163042020|NCT00520767|588860858|FG000|Overall Study|Death|2|||
163042021|NCT00803712|588862409|FG000|Overall Study|Noncompliance|3|||
163042022|NCT00803712|588862410|FG001|Overall Study|Noncompliance|0|||
163042023|NCT00803712|588862409|FG000|Overall Study|Adverse Event|5|||
163042024|NCT00803712|588862410|FG001|Overall Study|Adverse Event|0|||
163042025|NCT00803712|588862409|FG000|Overall Study|Death|8|||
163042026|NCT00803712|588862410|FG001|Overall Study|Death|7|||
163042027|NCT00803712|588862409|FG000|Overall Study|Lost to Follow-up|3|||
163042028|NCT00803712|588862410|FG001|Overall Study|Lost to Follow-up|1|||
163042029|NCT00803712|588862409|FG000|Overall Study|Withdrawal by Subject|2|||
163042030|NCT00803712|588862410|FG001|Overall Study|Withdrawal by Subject|4|||
163042031|NCT00803712|588862409|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
163042032|NCT00803712|588862410|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
163042033|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (other)|0|||
163157206|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
163157207|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
163042034|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (other)|2|||
163157208|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
163042035|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
163042036|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
163042037|NCT00803712|588862409|FG000|Overall Study|Administrative decision|2|||
163042038|NCT00803712|588862410|FG001|Overall Study|Administrative decision|3|||
163042039|NCT00803712|588862409|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
163042040|NCT00803712|588862410|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
163042041|NCT01310127|588862411|FG000|Overall Study|Protocol Violation|1|||
163042042|NCT01310127|588862412|FG001|Overall Study|Protocol Violation|1|||
163042043|NCT01310127|588862411|FG000|Overall Study|advanced psc cataract outlier|1|||
163042044|NCT01310127|588862412|FG001|Overall Study|advanced psc cataract outlier|0|||
163042045|NCT01025284|588862416|FG000|Overall Study|Investigator Decision|0|||
163042046|NCT01025284|588862417|FG001|Overall Study|Investigator Decision|1|||
163042047|NCT01025284|588862418|FG002|Overall Study|Investigator Decision|0|||
163042048|NCT01025284|588862416|FG000|Overall Study|Withdrawal by Subject|0|||
163042049|NCT01025284|588862417|FG001|Overall Study|Withdrawal by Subject|1|||
163042050|NCT01025284|588862418|FG002|Overall Study|Withdrawal by Subject|0|||
163042051|NCT00547248|588862423|FG000|Overall Study|Protocol Violation|0|||
163042052|NCT00547248|588862424|FG001|Overall Study|Protocol Violation|0|||
163042053|NCT00547248|588862425|FG002|Overall Study|Protocol Violation|1|||
163042054|NCT00547248|588862426|FG003|Overall Study|Protocol Violation|1|||
163042055|NCT00547248|588862423|FG000|Overall Study|Migrated/moved from study area|0|||
163042056|NCT00547248|588862424|FG001|Overall Study|Migrated/moved from study area|0|||
163042057|NCT00547248|588862425|FG002|Overall Study|Migrated/moved from study area|2|||
163042058|NCT00547248|588862426|FG003|Overall Study|Migrated/moved from study area|0|||
163042059|NCT00547248|588862423|FG000|Overall Study|Withdrawal by Subject|0|||
163042060|NCT00547248|588862424|FG001|Overall Study|Withdrawal by Subject|0|||
163042061|NCT00547248|588862425|FG002|Overall Study|Withdrawal by Subject|7|||
163042062|NCT00547248|588862426|FG003|Overall Study|Withdrawal by Subject|1|||
163042063|NCT00305227|588862430|FG000|Overall Study|Lost to Follow-up|7|||
163042064|NCT00305227|588862431|FG001|Overall Study|Lost to Follow-up|6|||
163042065|NCT05133323|588862433|FG000|Overall Study|Lack of Efficacy|0|||
163042066|NCT05133323|588862434|FG001|Overall Study|Lack of Efficacy|0|||
163042067|NCT05133323|588862435|FG002|Overall Study|Lack of Efficacy|1|||
163042068|NCT05133323|588862433|FG000|Overall Study|Withdrawal by Subject|2|||
163042069|NCT05133323|588862434|FG001|Overall Study|Withdrawal by Subject|1|||
163042070|NCT05133323|588862435|FG002|Overall Study|Withdrawal by Subject|0|||
163042071|NCT04152083|588862442|FG000|Overall Study|Lost to Follow-up|2|||
163042072|NCT04152083|588862443|FG001|Overall Study|Lost to Follow-up|1|||
163042073|NCT04152083|588862442|FG000|Overall Study|Adverse Event|1|||
163042074|NCT04152083|588862443|FG001|Overall Study|Adverse Event|0|||
163042075|NCT04152083|588862442|FG000|Overall Study|Randomized but not treated|3|||
163042076|NCT04152083|588862443|FG001|Overall Study|Randomized but not treated|2|||
163042077|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
163042078|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
163042079|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
163042080|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
163042081|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
163042082|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042083|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042084|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
163042085|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
163042086|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
163042087|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
163042088|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
163042089|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042090|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042091|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
163042092|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
163042093|NCT01042392|588862444|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
163042094|NCT01042392|588862445|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042095|NCT01042392|588862446|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042096|NCT01042392|588862447|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
163042097|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
163042098|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
162811638|NCT00585195|588021760|FG005|Overall Study|Other|1|||
162811639|NCT00585195|588021761|FG006|Overall Study|Other|0|||
163042099|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
163042100|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
163042101|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
163042102|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042103|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042104|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
163042105|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042106|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042107|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
163042108|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
163042109|NCT01042392|588862444|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
163042110|NCT01042392|588862445|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042111|NCT01042392|588862446|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042112|NCT01042392|588862447|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
163042113|NCT03318003|588862448|FG000|Overall Study|Withdrawal by Subject|1|||
163042114|NCT03318003|588862449|FG001|Overall Study|Withdrawal by Subject|1|||
163042115|NCT03318003|588862448|FG000|Overall Study|fetal loss|0|||
163042116|NCT03318003|588862449|FG001|Overall Study|fetal loss|1|||
163042117|NCT02768792|588862454|FG000|Overall Study|Adverse Event|1|||
163042118|NCT04819438|588862455|FG000|Overall Study|Withdrawal by Subject|1|||
163042119|NCT04819438|588862456|FG001|Overall Study|Withdrawal by Subject|0|||
163042120|NCT04819438|588862455|FG000|Overall Study|Adverse Event|0|||
163042121|NCT04819438|588862456|FG001|Overall Study|Adverse Event|1|||
163042122|NCT04819438|588862455|FG000|Overall Study|Protocol Violation|0|||
163042123|NCT04819438|588862456|FG001|Overall Study|Protocol Violation|1|||
163042124|NCT04607135|588862458|FG000|Overall Study|Physician Decision|1|||
163042125|NCT04607135|588862458|FG000|Overall Study|Withdrawal by Subject|1|||
163042126|NCT04607135|588862458|FG000|Overall Study|Equipment not working|3|||
163042127|NCT03465709|588862459|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
163042128|NCT03465709|588862459|FG000|Overall Study|Withdrawal by Subject|3|||
163042129|NCT05359952|588862460|FG000|Overall Study|Lost to Follow-up|1|||
163042130|NCT05359952|588862461|FG001|Overall Study|Lost to Follow-up|0|||
163042131|NCT03836209|588862462|FG000|Overall Study|Adverse Event|5|||
163042132|NCT03836209|588862463|FG001|Overall Study|Adverse Event|2|||
163042133|NCT03836209|588862462|FG000|Overall Study|Death|4|||
163042134|NCT03836209|588862463|FG001|Overall Study|Death|1|||
163042135|NCT03836209|588862462|FG000|Overall Study|Lack of Efficacy|7|||
163042136|NCT03836209|588862463|FG001|Overall Study|Lack of Efficacy|10|||
163042137|NCT03836209|588862462|FG000|Overall Study|Physician Decision|7|||
163042138|NCT03836209|588862463|FG001|Overall Study|Physician Decision|11|||
163042139|NCT03836209|588862462|FG000|Overall Study|Protocol Violation|0|||
163042140|NCT03836209|588862463|FG001|Overall Study|Protocol Violation|3|||
163042141|NCT03836209|588862462|FG000|Overall Study|Withdrawal by Subject|2|||
163042142|NCT03836209|588862463|FG001|Overall Study|Withdrawal by Subject|10|||
163042143|NCT03836209|588862462|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
163042144|NCT03836209|588862463|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
163042145|NCT01768559|588862465|FG000|Overall Study|Randomized but not treated|0|||
163042146|NCT01768559|588862466|FG001|Overall Study|Randomized but not treated|0|||
163042147|NCT01768559|588862467|FG002|Overall Study|Randomized but not treated|1|||
163042148|NCT01768559|588862465|FG000|Overall Study|Adverse Event|15|||
163042149|NCT01768559|588862466|FG001|Overall Study|Adverse Event|2|||
163042150|NCT01768559|588862467|FG002|Overall Study|Adverse Event|5|||
163042151|NCT01768559|588862465|FG000|Overall Study|Lack of Efficacy|6|||
163042152|NCT01768559|588862466|FG001|Overall Study|Lack of Efficacy|4|||
163042153|NCT01768559|588862467|FG002|Overall Study|Lack of Efficacy|0|||
163042154|NCT01768559|588862465|FG000|Overall Study|Poor compliance to protocol|0|||
163042155|NCT01768559|588862466|FG001|Overall Study|Poor compliance to protocol|3|||
163042156|NCT01768559|588862467|FG002|Overall Study|Poor compliance to protocol|2|||
163042157|NCT01768559|588862465|FG000|Overall Study|Other than specified|9|||
163042158|NCT01768559|588862466|FG001|Overall Study|Other than specified|8|||
163042159|NCT01768559|588862467|FG002|Overall Study|Other than specified|5|||
163042160|NCT01737879|588862470|FG000|Overall Study|Death|1|||
163042161|NCT01737879|588862470|FG000|Overall Study|Sponsor decision|40|||
163042162|NCT04978337|588862471|FG000|Overall Study|Withdrawal by Subject|0|||
163042163|NCT04978337|588862472|FG001|Overall Study|Withdrawal by Subject|1|||
163042164|NCT01436227|588862478|FG000|Overall Study|Adverse Event|7|||
163042165|NCT01436227|588862478|FG000|Overall Study|Death|1|||
163042166|NCT01436227|588862478|FG000|Overall Study|Lack of Efficacy|1|||
163042167|NCT01436227|588862478|FG000|Overall Study|Lost to Follow-up|3|||
163042168|NCT01436227|588862478|FG000|Overall Study|Physician Decision|1|||
163042169|NCT01436227|588862478|FG000|Overall Study|Withdrawal by Subject|7|||
163042170|NCT01436227|588862478|FG000|Overall Study|Disease progression, relapse|6|||
163042171|NCT04865419|588862481|FG000|Overall Study|Other|1|||
163042172|NCT04865419|588862482|FG001|Overall Study|Other|2|||
163042173|NCT04865419|588862483|FG002|Overall Study|Other|2|||
163042174|NCT04865419|588862484|FG003|Overall Study|Other|1|||
163042175|NCT04865419|588862485|FG004|Overall Study|Other|3|||
163042176|NCT04865419|588862486|FG005|Overall Study|Other|0|||
163042177|NCT04865419|588862487|FG006|Overall Study|Other|0|||
163042178|NCT04865419|588862488|FG007|Overall Study|Other|1|||
163042179|NCT04865419|588862489|FG008|Overall Study|Other|0|||
163042180|NCT04865419|588862490|FG009|Overall Study|Other|0|||
163042181|NCT04865419|588862491|FG010|Overall Study|Other|0|||
163042182|NCT04865419|588862481|FG000|Overall Study|Withdrawal by Subject|0|||
163042183|NCT04865419|588862482|FG001|Overall Study|Withdrawal by Subject|1|||
163042184|NCT04865419|588862483|FG002|Overall Study|Withdrawal by Subject|1|||
163042185|NCT04865419|588862484|FG003|Overall Study|Withdrawal by Subject|0|||
163042186|NCT04865419|588862485|FG004|Overall Study|Withdrawal by Subject|0|||
163042187|NCT04865419|588862486|FG005|Overall Study|Withdrawal by Subject|0|||
163042188|NCT04865419|588862487|FG006|Overall Study|Withdrawal by Subject|0|||
163042189|NCT04865419|588862488|FG007|Overall Study|Withdrawal by Subject|1|||
163042190|NCT04865419|588862489|FG008|Overall Study|Withdrawal by Subject|2|||
163042191|NCT04865419|588862490|FG009|Overall Study|Withdrawal by Subject|1|||
163042192|NCT04865419|588862491|FG010|Overall Study|Withdrawal by Subject|0|||
163042193|NCT04865419|588862481|FG000|Overall Study|Study terminated by Sponsor|0|||
163042194|NCT04865419|588862482|FG001|Overall Study|Study terminated by Sponsor|0|||
163042195|NCT04865419|588862483|FG002|Overall Study|Study terminated by Sponsor|0|||
163042196|NCT04865419|588862484|FG003|Overall Study|Study terminated by Sponsor|2|||
163042197|NCT04865419|588862485|FG004|Overall Study|Study terminated by Sponsor|2|||
163042198|NCT04865419|588862486|FG005|Overall Study|Study terminated by Sponsor|0|||
163042199|NCT04865419|588862487|FG006|Overall Study|Study terminated by Sponsor|0|||
163042200|NCT04865419|588862488|FG007|Overall Study|Study terminated by Sponsor|0|||
163042201|NCT04865419|588862489|FG008|Overall Study|Study terminated by Sponsor|0|||
163042202|NCT04865419|588862490|FG009|Overall Study|Study terminated by Sponsor|0|||
163042203|NCT04865419|588862491|FG010|Overall Study|Study terminated by Sponsor|1|||
163042204|NCT04865419|588862481|FG000|Overall Study|Death|3|||
163042205|NCT04865419|588862482|FG001|Overall Study|Death|1|||
163042206|NCT04865419|588862483|FG002|Overall Study|Death|4|||
163042207|NCT04865419|588862484|FG003|Overall Study|Death|2|||
163042208|NCT04865419|588862485|FG004|Overall Study|Death|5|||
163042209|NCT04865419|588862486|FG005|Overall Study|Death|2|||
163042210|NCT04865419|588862487|FG006|Overall Study|Death|1|||
163042211|NCT04865419|588862488|FG007|Overall Study|Death|1|||
163042212|NCT04865419|588862489|FG008|Overall Study|Death|2|||
163042213|NCT04865419|588862490|FG009|Overall Study|Death|2|||
163042214|NCT04865419|588862491|FG010|Overall Study|Death|1|||
163042215|NCT04865419|588862481|FG000|Overall Study|Lost to Follow-up|0|||
163042216|NCT04865419|588862482|FG001|Overall Study|Lost to Follow-up|0|||
163042217|NCT04865419|588862483|FG002|Overall Study|Lost to Follow-up|0|||
163042218|NCT04865419|588862484|FG003|Overall Study|Lost to Follow-up|0|||
163042219|NCT04865419|588862485|FG004|Overall Study|Lost to Follow-up|0|||
163042220|NCT04865419|588862486|FG005|Overall Study|Lost to Follow-up|0|||
163042221|NCT04865419|588862487|FG006|Overall Study|Lost to Follow-up|0|||
163042222|NCT04865419|588862488|FG007|Overall Study|Lost to Follow-up|0|||
163042223|NCT04865419|588862489|FG008|Overall Study|Lost to Follow-up|0|||
163042224|NCT04865419|588862490|FG009|Overall Study|Lost to Follow-up|1|||
163042225|NCT04865419|588862491|FG010|Overall Study|Lost to Follow-up|0|||
163042226|NCT05446142|588862492|FG000|Period 2|Adverse Event|1|||
163042227|NCT05446142|588862493|FG001|Period 2|Adverse Event|0|||
163042228|NCT05446142|588862494|FG002|Period 2|Adverse Event|0|||
163042229|NCT05446142|588862495|FG003|Period 2|Adverse Event|0|||
163042230|NCT05446142|588862496|FG004|Period 2|Adverse Event|0|||
163042231|NCT05446142|588862497|FG005|Period 2|Adverse Event|0|||
163042232|NCT00547157|588862502|FG000|Overall Study|Other|1|||
163042233|NCT00547157|588862503|FG001|Overall Study|Other|0|||
163042234|NCT00547157|588862502|FG000|Overall Study|Death|38|||
163042235|NCT00547157|588862503|FG001|Overall Study|Death|18|||
163042236|NCT00547157|588862502|FG000|Overall Study|Withdrawal by Subject|3|||
163042237|NCT00547157|588862503|FG001|Overall Study|Withdrawal by Subject|1|||
163042238|NCT00547157|588862502|FG000|Overall Study|Administrative decision|3|||
163042239|NCT00547157|588862503|FG001|Overall Study|Administrative decision|2|||
163042240|NCT00547157|588862502|FG000|Overall Study|Lost to Follow-up|4|||
163042241|NCT00547157|588862503|FG001|Overall Study|Lost to Follow-up|2|||
163042242|NCT03853291|588862504|FG000|Overall Study|Lost to Follow-up|1|||
163042243|NCT03853291|588862505|FG001|Overall Study|Lost to Follow-up|2|||
163042244|NCT03853291|588862506|FG002|Overall Study|Lost to Follow-up|0|||
163042245|NCT03853291|588862507|FG003|Overall Study|Lost to Follow-up|0|||
163042246|NCT03853291|588862508|FG004|Overall Study|Lost to Follow-up|0|||
163042247|NCT03853291|588862509|FG005|Overall Study|Lost to Follow-up|0|||
163042248|NCT03853291|588862504|FG000|Overall Study|Determined to be ineligible|1|||
163157209|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
163157210|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
163157211|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
163157212|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
163157213|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
163157214|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
163157215|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
163157216|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
163157217|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
163157218|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
163157219|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
163157220|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
163157221|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
163157222|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157223|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157224|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157225|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157226|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157227|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157228|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157229|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
163157230|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157231|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
163157232|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
163157233|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157234|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157235|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
163157236|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157237|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157238|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157239|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157240|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157241|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157242|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157243|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
163157244|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157245|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
163157246|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157247|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157248|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157249|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
163157250|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157251|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157252|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157253|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157254|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157255|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157256|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157257|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
163157258|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157259|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157260|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157261|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157262|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157263|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163157264|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Transplant|0|||
163157265|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Transplant|0|||
163157266|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Transplant|0|||
163157267|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Transplant|0|||
163157268|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Transplant|0|||
163157269|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Transplant|0|||
163157270|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Transplant|0|||
163157271|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Transplant|0|||
163157272|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Transplant|0|||
163157273|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Transplant|4|||
163157274|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Transplant|2|||
163157275|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Transplant|0|||
163157276|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Transplant|0|||
163157277|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Transplant|0|||
163157278|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
162811640|NCT00585195|588021762|FG007|Overall Study|Other|0|||
163157279|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
163157280|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
163157281|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
163157282|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
163157283|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
163157284|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
163157285|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
163157286|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
163157287|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
163157288|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
163157289|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
163157290|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
163157291|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
163157292|NCT02113982|589291643|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
163157293|NCT02113982|589291644|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
163157294|NCT02113982|589291645|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
163157295|NCT02113982|589291646|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
163157296|NCT02113982|589291647|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
163157297|NCT02113982|589291648|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
163157298|NCT02113982|589291649|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
163157299|NCT02113982|589291650|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
163157300|NCT02113982|589291651|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
163157301|NCT02113982|589291652|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
163157302|NCT02113982|589291653|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
163157303|NCT02113982|589291654|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
163157304|NCT02113982|589291655|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
163157305|NCT02113982|589291656|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
163157306|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157307|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157308|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157309|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157310|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157311|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157312|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157313|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157314|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157315|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157316|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157317|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
163157318|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157319|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
163157320|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157321|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157322|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157323|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157324|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157325|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157326|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157327|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157328|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157329|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157330|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157331|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
163157332|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157333|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
163157334|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157335|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157336|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157337|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157338|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157339|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157340|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157341|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157342|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157343|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157344|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157345|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
163157346|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157347|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
163157348|NCT02113982|589291643|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
163157349|NCT02113982|589291644|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
163157350|NCT02113982|589291645|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
163157351|NCT02113982|589291646|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
163157352|NCT02113982|589291647|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
163157353|NCT02113982|589291648|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
163157354|NCT02113982|589291649|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
163157355|NCT02113982|589291650|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
163157356|NCT02113982|589291651|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
163157357|NCT02113982|589291652|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
163157358|NCT02113982|589291653|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
163157359|NCT02113982|589291654|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
163157360|NCT02113982|589291655|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
163157361|NCT02113982|589291656|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
163157362|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157363|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157364|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157365|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157366|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157367|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157368|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157369|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157370|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157371|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157372|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157373|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157374|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
163157375|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
163157376|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157377|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157378|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157379|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157380|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157381|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157382|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157383|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157384|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157385|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157386|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157387|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163157388|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
163157389|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
163157390|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157391|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157392|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157393|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157394|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157395|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157396|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157397|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157398|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157399|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157400|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157401|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
163157402|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
163157403|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
163157404|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157405|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157406|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157407|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157408|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157409|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157410|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157411|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157412|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157413|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157414|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157415|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
163157416|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
163157417|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
163157418|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157419|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157420|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157421|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157422|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157423|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157424|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157425|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157426|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157427|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157428|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157429|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157430|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
163157431|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
163157432|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157433|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157434|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157435|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157436|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157437|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157438|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157439|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157440|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157441|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157442|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157443|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157444|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
163157445|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163157446|NCT02113982|589291643|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157447|NCT02113982|589291644|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157448|NCT02113982|589291645|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157449|NCT02113982|589291646|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157450|NCT02113982|589291647|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157451|NCT02113982|589291648|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157452|NCT02113982|589291649|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157453|NCT02113982|589291650|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157454|NCT02113982|589291651|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157455|NCT02113982|589291652|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157456|NCT02113982|589291653|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157457|NCT02113982|589291654|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157458|NCT02113982|589291655|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
163157459|NCT02113982|589291656|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
163157460|NCT02085161|589291657|FG000|Overall Study|Not Treated|1|||
163157461|NCT02085161|589291658|FG001|Overall Study|Not Treated|0|||
163157462|NCT02085161|589291659|FG002|Overall Study|Not Treated|0|||
163157463|NCT02085161|589291660|FG003|Overall Study|Not Treated|0|||
163157464|NCT02085161|589291657|FG000|Overall Study|Adverse Event|8|||
163157465|NCT02085161|589291658|FG001|Overall Study|Adverse Event|5|||
163157466|NCT02085161|589291659|FG002|Overall Study|Adverse Event|4|||
163157467|NCT02085161|589291660|FG003|Overall Study|Adverse Event|5|||
163157468|NCT02085161|589291657|FG000|Overall Study|Protocol Violation|0|||
163157469|NCT02085161|589291658|FG001|Overall Study|Protocol Violation|1|||
163157470|NCT02085161|589291659|FG002|Overall Study|Protocol Violation|0|||
163157471|NCT02085161|589291660|FG003|Overall Study|Protocol Violation|1|||
163157472|NCT02085161|589291657|FG000|Overall Study|Withdrawal by Subject|2|||
163157473|NCT02085161|589291658|FG001|Overall Study|Withdrawal by Subject|4|||
163157474|NCT02085161|589291659|FG002|Overall Study|Withdrawal by Subject|0|||
163157475|NCT02085161|589291660|FG003|Overall Study|Withdrawal by Subject|3|||
163157476|NCT02085161|589291657|FG000|Overall Study|Other Reason|1|||
163157477|NCT02085161|589291658|FG001|Overall Study|Other Reason|0|||
163157478|NCT02085161|589291659|FG002|Overall Study|Other Reason|1|||
163157479|NCT02085161|589291660|FG003|Overall Study|Other Reason|1|||
163157480|NCT00068692|589291671|FG000|Step 1: Registration|Disese progression/relapse|5|||
163157481|NCT00068692|589291672|FG001|Step 1: Registration|Disese progression/relapse|0|||
163157482|NCT00068692|589291673|FG002|Step 1: Registration|Disese progression/relapse|0|||
163157483|NCT00068692|589291674|FG003|Step 1: Registration|Disese progression/relapse|0|||
163157484|NCT00068692|589291675|FG004|Step 1: Registration|Disese progression/relapse|0|||
163157485|NCT00068692|589291676|FG005|Step 1: Registration|Disese progression/relapse|0|||
163157486|NCT00068692|589291677|FG006|Step 1: Registration|Disese progression/relapse|0|||
163157487|NCT00068692|589291678|FG007|Step 1: Registration|Disese progression/relapse|0|||
163157488|NCT00068692|589291671|FG000|Step 1: Registration|Adverse Event|7|||
163157489|NCT00068692|589291672|FG001|Step 1: Registration|Adverse Event|0|||
163157490|NCT00068692|589291673|FG002|Step 1: Registration|Adverse Event|0|||
163157491|NCT00068692|589291674|FG003|Step 1: Registration|Adverse Event|0|||
163157492|NCT00068692|589291675|FG004|Step 1: Registration|Adverse Event|0|||
163157493|NCT00068692|589291676|FG005|Step 1: Registration|Adverse Event|0|||
163157494|NCT00068692|589291677|FG006|Step 1: Registration|Adverse Event|0|||
163157495|NCT00068692|589291678|FG007|Step 1: Registration|Adverse Event|0|||
163157496|NCT00068692|589291671|FG000|Step 1: Registration|Death|1|||
163157497|NCT00068692|589291672|FG001|Step 1: Registration|Death|0|||
163157498|NCT00068692|589291673|FG002|Step 1: Registration|Death|0|||
163157499|NCT00068692|589291674|FG003|Step 1: Registration|Death|0|||
163157500|NCT00068692|589291675|FG004|Step 1: Registration|Death|0|||
163157501|NCT00068692|589291676|FG005|Step 1: Registration|Death|0|||
163157502|NCT00068692|589291677|FG006|Step 1: Registration|Death|0|||
163157503|NCT00068692|589291678|FG007|Step 1: Registration|Death|0|||
163157504|NCT00068692|589291671|FG000|Step 1: Registration|Withdrawal by Subject|11|||
163157505|NCT00068692|589291672|FG001|Step 1: Registration|Withdrawal by Subject|0|||
163157506|NCT00068692|589291673|FG002|Step 1: Registration|Withdrawal by Subject|0|||
163157507|NCT00068692|589291674|FG003|Step 1: Registration|Withdrawal by Subject|0|||
163157508|NCT00068692|589291675|FG004|Step 1: Registration|Withdrawal by Subject|0|||
163157509|NCT00068692|589291676|FG005|Step 1: Registration|Withdrawal by Subject|0|||
163157510|NCT00068692|589291677|FG006|Step 1: Registration|Withdrawal by Subject|0|||
163157511|NCT00068692|589291678|FG007|Step 1: Registration|Withdrawal by Subject|0|||
163157512|NCT00068692|589291671|FG000|Step 1: Registration|Alternative therapy|2|||
163157513|NCT00068692|589291672|FG001|Step 1: Registration|Alternative therapy|0|||
163157514|NCT00068692|589291673|FG002|Step 1: Registration|Alternative therapy|0|||
163157515|NCT00068692|589291674|FG003|Step 1: Registration|Alternative therapy|0|||
163157516|NCT00068692|589291675|FG004|Step 1: Registration|Alternative therapy|0|||
163157517|NCT00068692|589291676|FG005|Step 1: Registration|Alternative therapy|0|||
163157518|NCT00068692|589291677|FG006|Step 1: Registration|Alternative therapy|0|||
163157519|NCT00068692|589291678|FG007|Step 1: Registration|Alternative therapy|0|||
163157520|NCT00068692|589291671|FG000|Step 1: Registration|Complicating disease|2|||
163157521|NCT00068692|589291672|FG001|Step 1: Registration|Complicating disease|0|||
163157522|NCT00068692|589291673|FG002|Step 1: Registration|Complicating disease|0|||
163157523|NCT00068692|589291674|FG003|Step 1: Registration|Complicating disease|0|||
163157524|NCT00068692|589291675|FG004|Step 1: Registration|Complicating disease|0|||
163157525|NCT00068692|589291676|FG005|Step 1: Registration|Complicating disease|0|||
163157526|NCT00068692|589291677|FG006|Step 1: Registration|Complicating disease|0|||
163157527|NCT00068692|589291678|FG007|Step 1: Registration|Complicating disease|0|||
163157528|NCT00068692|589291671|FG000|Step 1: Registration|Protocol Violation|1|||
163157529|NCT00068692|589291672|FG001|Step 1: Registration|Protocol Violation|0|||
163157530|NCT00068692|589291673|FG002|Step 1: Registration|Protocol Violation|0|||
163157531|NCT00068692|589291674|FG003|Step 1: Registration|Protocol Violation|0|||
163157532|NCT00068692|589291675|FG004|Step 1: Registration|Protocol Violation|0|||
163157533|NCT00068692|589291676|FG005|Step 1: Registration|Protocol Violation|0|||
163157534|NCT00068692|589291677|FG006|Step 1: Registration|Protocol Violation|0|||
163157535|NCT00068692|589291678|FG007|Step 1: Registration|Protocol Violation|0|||
163157536|NCT00068692|589291671|FG000|Step 1: Registration|Not eligible|6|||
163157537|NCT00068692|589291672|FG001|Step 1: Registration|Not eligible|0|||
163157538|NCT00068692|589291673|FG002|Step 1: Registration|Not eligible|0|||
163157539|NCT00068692|589291674|FG003|Step 1: Registration|Not eligible|0|||
163157540|NCT00068692|589291675|FG004|Step 1: Registration|Not eligible|0|||
163157541|NCT00068692|589291676|FG005|Step 1: Registration|Not eligible|0|||
163157542|NCT00068692|589291677|FG006|Step 1: Registration|Not eligible|0|||
163157543|NCT00068692|589291678|FG007|Step 1: Registration|Not eligible|0|||
163157544|NCT00068692|589291671|FG000|Step 1: Registration|Other|2|||
163157545|NCT00068692|589291672|FG001|Step 1: Registration|Other|0|||
163157546|NCT00068692|589291673|FG002|Step 1: Registration|Other|0|||
163157547|NCT00068692|589291674|FG003|Step 1: Registration|Other|0|||
163157548|NCT00068692|589291675|FG004|Step 1: Registration|Other|0|||
163157549|NCT00068692|589291676|FG005|Step 1: Registration|Other|0|||
163157550|NCT00068692|589291677|FG006|Step 1: Registration|Other|0|||
163157551|NCT00068692|589291678|FG007|Step 1: Registration|Other|0|||
163157552|NCT00068692|589291671|FG000|Step 1: Registration|Not start protocol therapy|3|||
163157553|NCT00068692|589291672|FG001|Step 1: Registration|Not start protocol therapy|0|||
162811641|NCT00585195|588021763|FG008|Overall Study|Other|2|||
163157554|NCT00068692|589291673|FG002|Step 1: Registration|Not start protocol therapy|0|||
163157555|NCT00068692|589291674|FG003|Step 1: Registration|Not start protocol therapy|0|||
163157556|NCT00068692|589291675|FG004|Step 1: Registration|Not start protocol therapy|0|||
163157557|NCT00068692|589291676|FG005|Step 1: Registration|Not start protocol therapy|0|||
163157558|NCT00068692|589291677|FG006|Step 1: Registration|Not start protocol therapy|0|||
163157559|NCT00068692|589291678|FG007|Step 1: Registration|Not start protocol therapy|0|||
163157560|NCT00068692|589291671|FG000|Step 1: Registration|Registered but not randomized|0|||
163157561|NCT00068692|589291672|FG001|Step 1: Registration|Registered but not randomized|1|||
163042249|NCT03853291|588862505|FG001|Overall Study|Determined to be ineligible|1|||
163042250|NCT03853291|588862506|FG002|Overall Study|Determined to be ineligible|0|||
163042251|NCT03853291|588862507|FG003|Overall Study|Determined to be ineligible|0|||
163042252|NCT03853291|588862508|FG004|Overall Study|Determined to be ineligible|0|||
163042253|NCT03853291|588862509|FG005|Overall Study|Determined to be ineligible|0|||
163042254|NCT03883477|588862510|FG000|Overall Study|Death|1|||
163042255|NCT03883477|588862511|FG001|Overall Study|Death|0|||
163042256|NCT03883477|588862510|FG000|Overall Study|Protocol Violation|0|||
163042257|NCT03883477|588862511|FG001|Overall Study|Protocol Violation|1|||
163042258|NCT04186221|588862512|FG000|Overall Study|Death|1|||
163042259|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
163042260|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
163042261|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
163042262|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
163042263|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
163042264|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
163042265|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
163042266|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
163042267|NCT00972283|588862518|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
163042268|NCT00972283|588862519|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
163042269|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
163042270|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
163042271|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
163042272|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
163042273|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
163042274|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
163042275|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
163042276|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
163042277|NCT00972283|588862518|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
163042278|NCT00972283|588862519|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
163042279|NCT03124537|588862520|FG000|Overall Study|Lost to Follow-up|3|||
163042280|NCT03124537|588862521|FG001|Overall Study|Lost to Follow-up|5|||
163042281|NCT03124537|588862520|FG000|Overall Study|App Crash, Incomplete Data|7|||
163042282|NCT03124537|588862521|FG001|Overall Study|App Crash, Incomplete Data|8|||
163042283|NCT00830518|588862524|FG000|Overall Study|Progressive Disease|18|||
163042284|NCT00830518|588862525|FG001|Overall Study|Progressive Disease|8|||
163042285|NCT00830518|588862524|FG000|Overall Study|Symptomatic Deterioration|4|||
163042286|NCT00830518|588862525|FG001|Overall Study|Symptomatic Deterioration|1|||
163042287|NCT00830518|588862524|FG000|Overall Study|Adverse Event|14|||
163042288|NCT00830518|588862525|FG001|Overall Study|Adverse Event|1|||
163042289|NCT00830518|588862524|FG000|Overall Study|Withdrawal by Patient|2|||
163042290|NCT00830518|588862525|FG001|Overall Study|Withdrawal by Patient|0|||
163042291|NCT00830518|588862524|FG000|Overall Study|Reason not Specified|8|||
163042292|NCT00830518|588862525|FG001|Overall Study|Reason not Specified|1|||
163042293|NCT02348008|588862526|FG000|Overall Study|Adverse Event|2|||
163042294|NCT02348008|588862527|FG001|Overall Study|Adverse Event|3|||
163042295|NCT02348008|588862528|FG002|Overall Study|Adverse Event|3|||
163042296|NCT02348008|588862526|FG000|Overall Study|Disease Progression|1|||
163042297|NCT02348008|588862527|FG001|Overall Study|Disease Progression|5|||
163042298|NCT02348008|588862528|FG002|Overall Study|Disease Progression|16|||
163042299|NCT02348008|588862526|FG000|Overall Study|Withdrawal by Subject|0|||
163042300|NCT02348008|588862527|FG001|Overall Study|Withdrawal by Subject|1|||
163042301|NCT02348008|588862528|FG002|Overall Study|Withdrawal by Subject|0|||
163042302|NCT02348008|588862526|FG000|Overall Study|Symptomatic Deterioration|0|||
163042303|NCT02348008|588862527|FG001|Overall Study|Symptomatic Deterioration|1|||
163042304|NCT02348008|588862528|FG002|Overall Study|Symptomatic Deterioration|0|||
163042305|NCT02029274|588862531|FG000|Overall Study|Adverse Event|1|||
163042306|NCT02029274|588862532|FG001|Overall Study|Adverse Event|0|||
163042307|NCT02029274|588862533|FG002|Overall Study|Adverse Event|2|||
163042308|NCT02029274|588862534|FG003|Overall Study|Adverse Event|2|||
163042309|NCT02756364|588862535|FG000|Overall Study|Site Terminated by Sponsor|24|||
163042310|NCT02756364|588862536|FG001|Overall Study|Site Terminated by Sponsor|30|||
163042311|NCT02756364|588862537|FG002|Overall Study|Site Terminated by Sponsor|21|||
163042312|NCT02756364|588862535|FG000|Overall Study|Death|20|||
163042313|NCT02756364|588862536|FG001|Overall Study|Death|15|||
163042314|NCT02756364|588862537|FG002|Overall Study|Death|18|||
163042315|NCT02756364|588862535|FG000|Overall Study|Withdrawal by Patient|2|||
163042316|NCT02756364|588862536|FG001|Overall Study|Withdrawal by Patient|1|||
163042317|NCT02756364|588862537|FG002|Overall Study|Withdrawal by Patient|8|||
163042318|NCT02756364|588862535|FG000|Overall Study|Lost to Follow-up|0|||
163042319|NCT02756364|588862536|FG001|Overall Study|Lost to Follow-up|1|||
163042320|NCT02756364|588862537|FG002|Overall Study|Lost to Follow-up|1|||
163042321|NCT02223364|588862538|FG000|Overall Study|Protocol Violation|3|||
163042322|NCT02223364|588862539|FG001|Overall Study|Protocol Violation|0|||
163042323|NCT02223364|588862540|FG002|Overall Study|Protocol Violation|3|||
163157562|NCT00068692|589291673|FG002|Step 1: Registration|Registered but not randomized|0|||
163157563|NCT00068692|589291674|FG003|Step 1: Registration|Registered but not randomized|0|||
163157564|NCT00068692|589291675|FG004|Step 1: Registration|Registered but not randomized|0|||
163157565|NCT00068692|589291676|FG005|Step 1: Registration|Registered but not randomized|0|||
163157566|NCT00068692|589291677|FG006|Step 1: Registration|Registered but not randomized|0|||
163157567|NCT00068692|589291678|FG007|Step 1: Registration|Registered but not randomized|0|||
163157568|NCT00068692|589291671|FG000|Step 2: Randomization|Disesae progression/replase|0|||
163157569|NCT00068692|589291672|FG001|Step 2: Randomization|Disesae progression/replase|0|||
163157570|NCT00068692|589291673|FG002|Step 2: Randomization|Disesae progression/replase|1|||
163157571|NCT00068692|589291674|FG003|Step 2: Randomization|Disesae progression/replase|1|||
163157572|NCT00068692|589291675|FG004|Step 2: Randomization|Disesae progression/replase|0|||
163157573|NCT00068692|589291676|FG005|Step 2: Randomization|Disesae progression/replase|0|||
163157574|NCT00068692|589291677|FG006|Step 2: Randomization|Disesae progression/replase|0|||
163157575|NCT00068692|589291678|FG007|Step 2: Randomization|Disesae progression/replase|0|||
163157576|NCT00068692|589291671|FG000|Step 2: Randomization|Adverse Event|0|||
163157577|NCT00068692|589291672|FG001|Step 2: Randomization|Adverse Event|0|||
163157578|NCT00068692|589291673|FG002|Step 2: Randomization|Adverse Event|4|||
163157579|NCT00068692|589291674|FG003|Step 2: Randomization|Adverse Event|2|||
163157580|NCT00068692|589291675|FG004|Step 2: Randomization|Adverse Event|2|||
163157581|NCT00068692|589291676|FG005|Step 2: Randomization|Adverse Event|3|||
163157582|NCT00068692|589291677|FG006|Step 2: Randomization|Adverse Event|4|||
163157583|NCT00068692|589291678|FG007|Step 2: Randomization|Adverse Event|4|||
163157584|NCT00068692|589291671|FG000|Step 2: Randomization|Death|0|||
163157585|NCT00068692|589291672|FG001|Step 2: Randomization|Death|0|||
163157586|NCT00068692|589291673|FG002|Step 2: Randomization|Death|0|||
163157587|NCT00068692|589291674|FG003|Step 2: Randomization|Death|0|||
163157588|NCT00068692|589291675|FG004|Step 2: Randomization|Death|1|||
163157589|NCT00068692|589291676|FG005|Step 2: Randomization|Death|0|||
163157590|NCT00068692|589291677|FG006|Step 2: Randomization|Death|0|||
163157591|NCT00068692|589291678|FG007|Step 2: Randomization|Death|1|||
163157592|NCT00068692|589291671|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
163157593|NCT00068692|589291672|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
163157594|NCT00068692|589291673|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
163157595|NCT00068692|589291674|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
163157596|NCT00068692|589291675|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
163157597|NCT00068692|589291676|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
163157598|NCT00068692|589291677|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
163157599|NCT00068692|589291678|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
163157600|NCT00068692|589291671|FG000|Step 2: Randomization|alternative therapy|0|||
163157601|NCT00068692|589291672|FG001|Step 2: Randomization|alternative therapy|0|||
163157602|NCT00068692|589291673|FG002|Step 2: Randomization|alternative therapy|0|||
163157603|NCT00068692|589291674|FG003|Step 2: Randomization|alternative therapy|1|||
163157604|NCT00068692|589291675|FG004|Step 2: Randomization|alternative therapy|1|||
163157605|NCT00068692|589291676|FG005|Step 2: Randomization|alternative therapy|0|||
163157606|NCT00068692|589291677|FG006|Step 2: Randomization|alternative therapy|0|||
163157607|NCT00068692|589291678|FG007|Step 2: Randomization|alternative therapy|0|||
163157608|NCT00068692|589291671|FG000|Step 2: Randomization|Physician Decision|0|||
163157609|NCT00068692|589291672|FG001|Step 2: Randomization|Physician Decision|0|||
163157610|NCT00068692|589291673|FG002|Step 2: Randomization|Physician Decision|0|||
163157611|NCT00068692|589291674|FG003|Step 2: Randomization|Physician Decision|1|||
163157612|NCT00068692|589291675|FG004|Step 2: Randomization|Physician Decision|1|||
163157613|NCT00068692|589291676|FG005|Step 2: Randomization|Physician Decision|0|||
163157614|NCT00068692|589291677|FG006|Step 2: Randomization|Physician Decision|0|||
163157615|NCT00068692|589291678|FG007|Step 2: Randomization|Physician Decision|0|||
163157616|NCT00068692|589291671|FG000|Step 2: Randomization|Other|0|||
163157617|NCT00068692|589291672|FG001|Step 2: Randomization|Other|0|||
163157618|NCT00068692|589291673|FG002|Step 2: Randomization|Other|0|||
163157619|NCT00068692|589291674|FG003|Step 2: Randomization|Other|1|||
163157620|NCT00068692|589291675|FG004|Step 2: Randomization|Other|0|||
163157621|NCT00068692|589291676|FG005|Step 2: Randomization|Other|1|||
163157622|NCT00068692|589291677|FG006|Step 2: Randomization|Other|0|||
163157623|NCT00068692|589291678|FG007|Step 2: Randomization|Other|0|||
163157624|NCT00068692|589291671|FG000|Step 2: Randomization|never start protocol therapy|0|||
163157625|NCT00068692|589291672|FG001|Step 2: Randomization|never start protocol therapy|0|||
163157626|NCT00068692|589291673|FG002|Step 2: Randomization|never start protocol therapy|1|||
163157627|NCT00068692|589291674|FG003|Step 2: Randomization|never start protocol therapy|0|||
163157628|NCT00068692|589291675|FG004|Step 2: Randomization|never start protocol therapy|1|||
163157629|NCT00068692|589291676|FG005|Step 2: Randomization|never start protocol therapy|0|||
163157630|NCT00068692|589291677|FG006|Step 2: Randomization|never start protocol therapy|0|||
163157631|NCT00068692|589291678|FG007|Step 2: Randomization|never start protocol therapy|0|||
163157632|NCT01600716|589291680|FG000|Overall Study|Other Reasons|3|||
163157633|NCT01600716|589291681|FG001|Overall Study|Other Reasons|1|||
163157634|NCT01600716|589291680|FG000|Overall Study|Personal Reasons|0|||
163157635|NCT01600716|589291681|FG001|Overall Study|Personal Reasons|2|||
163157636|NCT01600716|589291680|FG000|Overall Study|Lost to Follow-up|0|||
163157637|NCT01600716|589291681|FG001|Overall Study|Lost to Follow-up|2|||
163157638|NCT01600716|589291680|FG000|Overall Study|Pregnancy|1|||
163157639|NCT01600716|589291681|FG001|Overall Study|Pregnancy|0|||
163157640|NCT01600716|589291680|FG000|Overall Study|Lack of Efficacy|2|||
163157641|NCT01600716|589291681|FG001|Overall Study|Lack of Efficacy|1|||
163157642|NCT01600716|589291680|FG000|Overall Study|Adverse Event|1|||
163157643|NCT01600716|589291681|FG001|Overall Study|Adverse Event|1|||
163157644|NCT03557034|589291684|FG000|Overall Study|Withdrawal by Subject|1|||
163157645|NCT03557034|589291685|FG001|Overall Study|Withdrawal by Subject|0|||
163157646|NCT00123422|589291686|FG000|Overall Study|Physician Decision|2|||
163157647|NCT00123422|589291687|FG001|Overall Study|Physician Decision|2|||
163157648|NCT00123422|589291688|FG002|Overall Study|Physician Decision|6|||
163157649|NCT00123422|589291686|FG000|Overall Study|Withdrawal by Subject|1|||
163157650|NCT00123422|589291687|FG001|Overall Study|Withdrawal by Subject|2|||
163157651|NCT00123422|589291688|FG002|Overall Study|Withdrawal by Subject|2|||
163157652|NCT00123422|589291686|FG000|Overall Study|Lost to Follow-up|1|||
163157653|NCT00123422|589291687|FG001|Overall Study|Lost to Follow-up|2|||
163157654|NCT00123422|589291688|FG002|Overall Study|Lost to Follow-up|2|||
163157655|NCT01938716|589291693|FG000|Overall Study|Physician Decision|2|||
163157656|NCT01938716|589291693|FG000|Overall Study|Withdrawal by Subject|2|||
163157657|NCT00823615|589291694|FG000|Period 2|Lost to Follow-up|2|||
163157658|NCT00823615|589291695|FG001|Period 2|Lost to Follow-up|0|||
163157659|NCT00823615|589291694|FG000|Period 2|Time/Job Conflict|1|||
163157660|NCT00823615|589291695|FG001|Period 2|Time/Job Conflict|2|||
163157661|NCT02446899|589291696|FG000|Overall Study|Adverse Event|4|||
163157662|NCT02446899|589291697|FG001|Overall Study|Adverse Event|7|||
163157663|NCT02446899|589291696|FG000|Overall Study|Condition Under Investigation Worsened|1|||
163157664|NCT02446899|589291697|FG001|Overall Study|Condition Under Investigation Worsened|4|||
163157665|NCT02446899|589291696|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
163157666|NCT02446899|589291697|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
163157667|NCT02446899|589291696|FG000|Overall Study|Lack of Efficacy|2|||
163157668|NCT02446899|589291697|FG001|Overall Study|Lack of Efficacy|8|||
163157669|NCT02446899|589291696|FG000|Overall Study|Lost to Follow-up|1|||
163157670|NCT02446899|589291697|FG001|Overall Study|Lost to Follow-up|3|||
163157671|NCT02446899|589291696|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
163157672|NCT02446899|589291697|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
163157673|NCT02446899|589291696|FG000|Overall Study|Withdrawal by Subject|11|||
163157674|NCT02446899|589291697|FG001|Overall Study|Withdrawal by Subject|19|||
163157675|NCT02446899|589291696|FG000|Overall Study|Miscellaneous|5|||
163157676|NCT02446899|589291697|FG001|Overall Study|Miscellaneous|4|||
163157677|NCT02446899|589291696|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163157678|NCT02446899|589291697|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163157679|NCT01002339|589291698|FG000|Overall Study|Withdrawal by Subject|0|||
163157680|NCT01002339|589291699|FG001|Overall Study|Withdrawal by Subject|1|||
163157681|NCT01002339|589291700|FG002|Overall Study|Withdrawal by Subject|0|||
163157682|NCT01002339|589291698|FG000|Overall Study|Incorrect treatment assignment|0|||
163157683|NCT01002339|589291699|FG001|Overall Study|Incorrect treatment assignment|0|||
163157684|NCT01002339|589291700|FG002|Overall Study|Incorrect treatment assignment|1|||
163157685|NCT01002339|589291698|FG000|Overall Study|Protocol Violation|0|||
163157686|NCT01002339|589291699|FG001|Overall Study|Protocol Violation|0|||
163157687|NCT01002339|589291700|FG002|Overall Study|Protocol Violation|2|||
163157688|NCT01002339|589291698|FG000|Overall Study|Lung cancer detected before transplant|0|||
163157689|NCT01002339|589291699|FG001|Overall Study|Lung cancer detected before transplant|0|||
163157690|NCT01002339|589291700|FG002|Overall Study|Lung cancer detected before transplant|1|||
163157691|NCT01002339|589291698|FG000|Overall Study|Randomized. Not transplanted|0|||
163157692|NCT01002339|589291699|FG001|Overall Study|Randomized. Not transplanted|0|||
163157693|NCT01002339|589291700|FG002|Overall Study|Randomized. Not transplanted|1|||
163157694|NCT02215252|589291701|FG000|Overall Study|Adverse Event|1|||
163157695|NCT02215252|589291702|FG001|Overall Study|Adverse Event|5|||
163157696|NCT02215252|589291703|FG002|Overall Study|Adverse Event|2|||
163157697|NCT02215252|589291701|FG000|Overall Study|Lost to Follow-up|0|||
163157698|NCT02215252|589291702|FG001|Overall Study|Lost to Follow-up|0|||
163157699|NCT02215252|589291703|FG002|Overall Study|Lost to Follow-up|1|||
163157700|NCT02215252|589291701|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
163157701|NCT02215252|589291702|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
163157702|NCT02215252|589291703|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
163157703|NCT02215252|589291701|FG000|Overall Study|Protocol Violation|0|||
163157704|NCT02215252|589291702|FG001|Overall Study|Protocol Violation|1|||
163157705|NCT02215252|589291703|FG002|Overall Study|Protocol Violation|0|||
163157706|NCT02215252|589291701|FG000|Overall Study|Withdrawal by Subject|1|||
163157707|NCT02215252|589291702|FG001|Overall Study|Withdrawal by Subject|0|||
163157708|NCT02215252|589291703|FG002|Overall Study|Withdrawal by Subject|0|||
163157709|NCT02215252|589291701|FG000|Overall Study|Other|0|||
163157710|NCT02215252|589291702|FG001|Overall Study|Other|1|||
163157711|NCT02215252|589291703|FG002|Overall Study|Other|1|||
163042324|NCT02223364|588862538|FG000|Overall Study|subject expired before surgery|1|||
163042325|NCT02223364|588862539|FG001|Overall Study|subject expired before surgery|0|||
163042326|NCT02223364|588862540|FG002|Overall Study|subject expired before surgery|0|||
163042327|NCT02223364|588862538|FG000|Overall Study|Physician Decision|1|||
163042328|NCT02223364|588862539|FG001|Overall Study|Physician Decision|0|||
163042329|NCT02223364|588862540|FG002|Overall Study|Physician Decision|0|||
163042330|NCT02984267|588862542|FG000|Overall Study|Protocol Violation|1|||
163042331|NCT02984267|588862543|FG001|Overall Study|Protocol Violation|0|||
163042332|NCT02984267|588862542|FG000|Overall Study|Withdrawal by Subject|0|||
163157712|NCT00892099|589291705|FG000|Overall Study|Death|1|||
163042333|NCT02984267|588862543|FG001|Overall Study|Withdrawal by Subject|1|||
163042334|NCT02685072|588862544|FG000|Treatment Period|Lost to Follow-up|12|||
163042335|NCT02685072|588862545|FG001|Treatment Period|Lost to Follow-up|6|||
163042336|NCT02685072|588862544|FG000|Treatment Period|Withdrawal by Subject|1|||
163042337|NCT02685072|588862545|FG001|Treatment Period|Withdrawal by Subject|3|||
163042338|NCT02685072|588862544|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
163042339|NCT02685072|588862545|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
163042340|NCT01994902|588862546|FG000|Test Period 1|Withdrawal by Subject|3|||
163042341|NCT01994902|588862547|FG001|Test Period 1|Withdrawal by Subject|0|||
163042342|NCT01994902|588862546|FG000|Test Period 1|device deficiency with adverse event|0|||
163042343|NCT01994902|588862547|FG001|Test Period 1|device deficiency with adverse event|1|||
163042344|NCT01994902|588862546|FG000|Test Period 1|Adverse Event|2|||
163042345|NCT01994902|588862547|FG001|Test Period 1|Adverse Event|1|||
163042346|NCT01994902|588862546|FG000|Test Period 1|Lack of Efficacy|0|||
163042347|NCT01994902|588862547|FG001|Test Period 1|Lack of Efficacy|1|||
163157713|NCT00892099|589291706|FG001|Overall Study|Death|0|||
163157714|NCT00892099|589291707|FG002|Overall Study|Death|1|||
163157715|NCT00892099|589291705|FG000|Overall Study|Adverse Event|1|||
163157716|NCT00892099|589291706|FG001|Overall Study|Adverse Event|0|||
163157717|NCT00892099|589291707|FG002|Overall Study|Adverse Event|0|||
163157718|NCT00892099|589291705|FG000|Overall Study|replocated|1|||
163157719|NCT00892099|589291706|FG001|Overall Study|replocated|0|||
163157720|NCT00892099|589291707|FG002|Overall Study|replocated|2|||
163157721|NCT00892099|589291705|FG000|Overall Study|Prolonged hospitalization|1|||
163157722|NCT00892099|589291706|FG001|Overall Study|Prolonged hospitalization|0|||
163157723|NCT00892099|589291707|FG002|Overall Study|Prolonged hospitalization|1|||
163157724|NCT00892099|589291705|FG000|Overall Study|no further details|1|||
163157725|NCT00892099|589291706|FG001|Overall Study|no further details|0|||
163042348|NCT01994902|588862546|FG000|Test Period 1|bag too small|1|||
163042349|NCT01994902|588862547|FG001|Test Period 1|bag too small|0|||
163042350|NCT01994902|588862546|FG000|Test Period 2|Withdrawal by Subject|0|||
163157726|NCT00892099|589291707|FG002|Overall Study|no further details|1|||
163157727|NCT00892099|589291705|FG000|Overall Study|kidney function recovered|0|||
163157728|NCT00892099|589291706|FG001|Overall Study|kidney function recovered|1|||
163157729|NCT00892099|589291707|FG002|Overall Study|kidney function recovered|0|||
163157730|NCT00892099|589291705|FG000|Overall Study|investigator decision|0|||
163157731|NCT00892099|589291706|FG001|Overall Study|investigator decision|0|||
163157732|NCT00892099|589291707|FG002|Overall Study|investigator decision|1|||
163157733|NCT00892099|589291705|FG000|Overall Study|Lost to Follow-up|0|||
163157734|NCT00892099|589291706|FG001|Overall Study|Lost to Follow-up|0|||
163157735|NCT00892099|589291707|FG002|Overall Study|Lost to Follow-up|1|||
163157736|NCT00433004|589291708|FG000|Overall Study|Lost to Follow-up|5|||
163157737|NCT00433004|589291709|FG001|Overall Study|Lost to Follow-up|7|||
163157738|NCT03910244|589291710|FG000|Overall Study|Adverse Event|14|||
163157739|NCT03910244|589291711|FG001|Overall Study|Adverse Event|0|||
163157740|NCT03910244|589291710|FG000|Overall Study|Death|1|||
163157741|NCT03910244|589291711|FG001|Overall Study|Death|0|||
163157742|NCT03910244|589291710|FG000|Overall Study|Lost to Follow-up|0|||
163157743|NCT03910244|589291711|FG001|Overall Study|Lost to Follow-up|2|||
163157744|NCT03910244|589291710|FG000|Overall Study|Joint withdrawal decision|1|||
163157745|NCT03910244|589291711|FG001|Overall Study|Joint withdrawal decision|0|||
163157746|NCT03910244|589291710|FG000|Overall Study|Study Terminated by Sponsor|7|||
163042351|NCT01994902|588862547|FG001|Test Period 2|Withdrawal by Subject|2|||
163042352|NCT01994902|588862546|FG000|Test Period 2|Lack of Efficacy|0|||
163042353|NCT01994902|588862547|FG001|Test Period 2|Lack of Efficacy|1|||
163042354|NCT01994902|588862546|FG000|Test Period 2|Other|0|||
163042355|NCT01994902|588862547|FG001|Test Period 2|Other|3|||
163042356|NCT03597139|588862549|FG000|Overall Study|Adverse Event|3|||
163042357|NCT03597139|588862550|FG001|Overall Study|Adverse Event|0|||
163042358|NCT03597139|588862549|FG000|Overall Study|Protocol Non-compliance|1|||
163157747|NCT03910244|589291711|FG001|Overall Study|Study Terminated by Sponsor|4|||
163157748|NCT03910244|589291710|FG000|Overall Study|Physician Decision|1|||
163157749|NCT03910244|589291711|FG001|Overall Study|Physician Decision|0|||
163157750|NCT03910244|589291710|FG000|Overall Study|Protocol Violation|1|||
163157751|NCT03910244|589291711|FG001|Overall Study|Protocol Violation|0|||
163157752|NCT03910244|589291710|FG000|Overall Study|Withdrawal by Subject|7|||
163157753|NCT03910244|589291711|FG001|Overall Study|Withdrawal by Subject|2|||
163157754|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
163157755|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
163157756|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
163157757|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163157758|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163157759|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
163157760|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
163157761|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
163157762|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
163157763|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
163157764|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
163157765|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
163157766|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
163157767|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
163157768|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
163157769|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163157770|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163157771|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163157772|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
163157773|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
163157774|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
163157775|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
163157776|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
163157777|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
163157778|NCT01106690|589291712|FG000|Core Period: Baseline to Week 26|Other|10|||
163157779|NCT01106690|589291713|FG001|Core Period: Baseline to Week 26|Other|2|||
163157780|NCT01106690|589291714|FG002|Core Period: Baseline to Week 26|Other|6|||
163157781|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163157782|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163157783|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
163157784|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163157785|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163157786|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163157787|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163157788|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163157789|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163157790|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163157791|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163157792|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
163157793|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163157794|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163157795|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163157796|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Other|8|||
163157797|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Other|3|||
163157798|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Other|4|||
163157799|NCT01106690|589291712|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
163157800|NCT01106690|589291713|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163157801|NCT01106690|589291714|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163157802|NCT04455815|589291715|FG000|Randomisation Phase|Adverse Event|1|||
163157803|NCT04455815|589291716|FG001|Randomisation Phase|Adverse Event|0|||
163157804|NCT04455815|589291715|FG000|Treatment Phase|Adverse Event|0|||
163157805|NCT04455815|589291716|FG001|Treatment Phase|Adverse Event|1|||
163157806|NCT04455815|589291715|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
163157807|NCT04455815|589291716|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
163157808|NCT04455815|589291715|FG000|Treatment Phase|Withdrawal by Subject|1|||
163157809|NCT04455815|589291716|FG001|Treatment Phase|Withdrawal by Subject|1|||
163157810|NCT03219528|589291721|FG000|Overall Study|Lost to Follow-up|5|||
163157811|NCT03219528|589291722|FG001|Overall Study|Lost to Follow-up|4|||
163157812|NCT03219528|589291721|FG000|Overall Study|Withdrawal by Subject|4|||
163157813|NCT03219528|589291722|FG001|Overall Study|Withdrawal by Subject|4|||
163157814|NCT03809104|589291723|FG000|Overall Study|Withdrawal by Subject|3|||
163157815|NCT00790842|589291724|FG000|Dose Level 1|Adverse Event|1|||
163157816|NCT00790842|589291725|FG001|Dose Level 1|Adverse Event|0|||
163157817|NCT00790842|589291726|FG002|Dose Level 1|Adverse Event|0|||
163157818|NCT00790842|589291727|FG003|Dose Level 1|Adverse Event|2|||
163157819|NCT00790842|589291728|FG004|Dose Level 1|Adverse Event|0|||
163157820|NCT00790842|589291729|FG005|Dose Level 1|Adverse Event|0|||
163157821|NCT00790842|589291730|FG006|Dose Level 1|Adverse Event|0|||
163042359|NCT03597139|588862550|FG001|Overall Study|Protocol Non-compliance|0|||
163042360|NCT01249833|588862551|FG000|Overall Study|Lost to Follow-up|0|||
163042361|NCT01249833|588862552|FG001|Overall Study|Lost to Follow-up|1|||
163042362|NCT02427802|588862553|FG000|Overall Study|Adverse Event|11|||
163042363|NCT02427802|588862554|FG001|Overall Study|Adverse Event|3|||
163042364|NCT02427802|588862555|FG002|Overall Study|Adverse Event|7|||
163042365|NCT02427802|588862553|FG000|Overall Study|Death|0|||
163042366|NCT02427802|588862554|FG001|Overall Study|Death|4|||
163042367|NCT02427802|588862555|FG002|Overall Study|Death|1|||
163042368|NCT02427802|588862553|FG000|Overall Study|Lost to Follow-up|13|||
163042369|NCT02427802|588862554|FG001|Overall Study|Lost to Follow-up|8|||
163042370|NCT02427802|588862555|FG002|Overall Study|Lost to Follow-up|8|||
163042371|NCT02427802|588862553|FG000|Overall Study|Physician Decision|4|||
163042372|NCT02427802|588862554|FG001|Overall Study|Physician Decision|2|||
163042373|NCT02427802|588862555|FG002|Overall Study|Physician Decision|4|||
163042374|NCT02427802|588862553|FG000|Overall Study|Withdrawal by Subject|10|||
163042375|NCT02427802|588862554|FG001|Overall Study|Withdrawal by Subject|5|||
163042376|NCT02427802|588862555|FG002|Overall Study|Withdrawal by Subject|11|||
163042377|NCT02427802|588862553|FG000|Overall Study|Protocol Violation|3|||
163042378|NCT02427802|588862554|FG001|Overall Study|Protocol Violation|1|||
163042379|NCT02427802|588862555|FG002|Overall Study|Protocol Violation|1|||
163042380|NCT02427802|588862553|FG000|Overall Study|protocol specific treatment unrelated|18|||
163042381|NCT02427802|588862554|FG001|Overall Study|protocol specific treatment unrelated|11|||
163042382|NCT02427802|588862555|FG002|Overall Study|protocol specific treatment unrelated|11|||
163042383|NCT01073163|588863844|FG000|Overall Study|Adverse Event|1|||
163042384|NCT01073163|588863844|FG000|Overall Study|Disease Progression|1|||
163042385|NCT01073163|588863844|FG000|Overall Study|Early termination|1|||
163042386|NCT00802672|588863845|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
163042387|NCT00802672|588863846|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
163042388|NCT00802672|588863847|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
163042389|NCT00802672|588863845|FG000|Overall Study|Adverse Event|1|||
163042390|NCT00802672|588863846|FG001|Overall Study|Adverse Event|1|||
163042391|NCT00802672|588863847|FG002|Overall Study|Adverse Event|1|||
163042392|NCT00802672|588863845|FG000|Overall Study|Protocol Violation|2|||
163042393|NCT00802672|588863846|FG001|Overall Study|Protocol Violation|1|||
163042394|NCT00802672|588863847|FG002|Overall Study|Protocol Violation|1|||
163042395|NCT00802672|588863845|FG000|Overall Study|Lost to Follow-up|5|||
163042396|NCT00802672|588863846|FG001|Overall Study|Lost to Follow-up|5|||
163042397|NCT00802672|588863847|FG002|Overall Study|Lost to Follow-up|3|||
163042398|NCT00802672|588863845|FG000|Overall Study|Withdrawal by Subject|1|||
163042399|NCT00802672|588863846|FG001|Overall Study|Withdrawal by Subject|1|||
163042400|NCT00802672|588863847|FG002|Overall Study|Withdrawal by Subject|2|||
163042401|NCT00802672|588863845|FG000|Overall Study|other|3|||
163042402|NCT00802672|588863846|FG001|Overall Study|other|1|||
163042403|NCT00802672|588863847|FG002|Overall Study|other|2|||
163042404|NCT00703677|588863848|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
163042405|NCT03859648|588863853|FG000|Overall Study|Lost to Follow-up|1|||
163042406|NCT03859648|588863853|FG000|Overall Study|Adverse Event|1|||
163042407|NCT01990573|588863858|FG000|Overall Study|Physician Decision|0|||
163042408|NCT01990573|588863859|FG001|Overall Study|Physician Decision|0|||
163042409|NCT01990573|588863860|FG002|Overall Study|Physician Decision|1|||
163042410|NCT03335813|588863874|FG000|Overall Study|Withdrawal by Subject|1|||
163042411|NCT00697593|588863877|FG000|Overall Study|Adverse Event|3|||
163157822|NCT00790842|589291731|FG007|Dose Level 1|Adverse Event|1|||
163042412|NCT00697593|588863877|FG000|Overall Study|Protocol Violation|1|||
163042413|NCT00697593|588863877|FG000|Overall Study|Lack of Efficacy|3|||
163157823|NCT00790842|589291732|FG008|Dose Level 1|Adverse Event|0|||
163157824|NCT00790842|589291733|FG009|Dose Level 1|Adverse Event|0|||
163157825|NCT00790842|589291734|FG010|Dose Level 1|Adverse Event|0|||
163157826|NCT00790842|589291724|FG000|Dose Level 1|Physician Decision|1|||
163157827|NCT00790842|589291725|FG001|Dose Level 1|Physician Decision|0|||
163157828|NCT00790842|589291726|FG002|Dose Level 1|Physician Decision|0|||
163157829|NCT00790842|589291727|FG003|Dose Level 1|Physician Decision|0|||
163157830|NCT00790842|589291728|FG004|Dose Level 1|Physician Decision|0|||
163157831|NCT00790842|589291729|FG005|Dose Level 1|Physician Decision|0|||
163157832|NCT00790842|589291730|FG006|Dose Level 1|Physician Decision|0|||
163157833|NCT00790842|589291731|FG007|Dose Level 1|Physician Decision|1|||
163157834|NCT00790842|589291732|FG008|Dose Level 1|Physician Decision|0|||
163157835|NCT00790842|589291733|FG009|Dose Level 1|Physician Decision|0|||
163157836|NCT00790842|589291734|FG010|Dose Level 1|Physician Decision|0|||
163157837|NCT00790842|589291724|FG000|Dose Level 1|Withdrawal by Subject|1|||
163157838|NCT00790842|589291725|FG001|Dose Level 1|Withdrawal by Subject|0|||
163157839|NCT00790842|589291726|FG002|Dose Level 1|Withdrawal by Subject|0|||
163042414|NCT00697593|588863877|FG000|Overall Study|Suspension of the study by sponsor|12|||
163042415|NCT00411450|588863886|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
163042416|NCT00614874|588863887|FG000|Overall Study|Protocol Violation|1|||
163157840|NCT00790842|589291727|FG003|Dose Level 1|Withdrawal by Subject|0|||
163042417|NCT00614874|588863887|FG000|Overall Study|Withdrawal by Subject|1|||
163042418|NCT03904420|588863888|FG000|Overall Study|Study terminated|2|||
162929540|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
163042419|NCT03904420|588863889|FG001|Overall Study|Study terminated|2|||
163042420|NCT04435808|588863890|FG000|Overall Study|Study stopped by DSMB|0|||
163042421|NCT04435808|588863891|FG001|Overall Study|Study stopped by DSMB|1|||
163042422|NCT00807612|588863892|FG000|Overall Study|Death|8|||
163042423|NCT00807612|588863892|FG000|Overall Study|Study early termination|5|||
163042424|NCT00807612|588863892|FG000|Overall Study|Withdrawal by Subject|1|||
163042425|NCT00705341|588863893|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
163042426|NCT00705341|588863894|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
163042427|NCT00705341|588863895|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
163042428|NCT00705341|588863896|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
163042429|NCT00705341|588863893|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042430|NCT00705341|588863894|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042431|NCT00705341|588863895|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
163042432|NCT00705341|588863896|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
163042433|NCT02959918|588863899|FG000|Overall Study|Adverse Event|1|||
163042434|NCT02959918|588863900|FG001|Overall Study|Adverse Event|1|||
163042435|NCT02959918|588863901|FG002|Overall Study|Adverse Event|2|||
163042436|NCT02959918|588863902|FG003|Overall Study|Adverse Event|0|||
163042437|NCT02959918|588863903|FG004|Overall Study|Adverse Event|0|||
163042438|NCT02959918|588863904|FG005|Overall Study|Adverse Event|2|||
163042439|NCT02959918|588863905|FG006|Overall Study|Adverse Event|2|||
163042440|NCT02959918|588863906|FG007|Overall Study|Adverse Event|1|||
163042441|NCT02959918|588863907|FG008|Overall Study|Adverse Event|2|||
163042442|NCT02959918|588863908|FG009|Overall Study|Adverse Event|1|||
163042443|NCT02959918|588863909|FG010|Overall Study|Adverse Event|1|||
163042444|NCT02959918|588863910|FG011|Overall Study|Adverse Event|3|||
163042445|NCT02959918|588863911|FG012|Overall Study|Adverse Event|2|||
163042446|NCT02959918|588863912|FG013|Overall Study|Adverse Event|4|||
163042447|NCT02959918|588863899|FG000|Overall Study|Lost to Follow-up|0|||
163042448|NCT02959918|588863900|FG001|Overall Study|Lost to Follow-up|0|||
163042449|NCT02959918|588863901|FG002|Overall Study|Lost to Follow-up|0|||
163042450|NCT02959918|588863902|FG003|Overall Study|Lost to Follow-up|0|||
163042451|NCT02959918|588863903|FG004|Overall Study|Lost to Follow-up|0|||
163042452|NCT02959918|588863904|FG005|Overall Study|Lost to Follow-up|0|||
163042453|NCT02959918|588863905|FG006|Overall Study|Lost to Follow-up|0|||
163042454|NCT02959918|588863906|FG007|Overall Study|Lost to Follow-up|0|||
163042455|NCT02959918|588863907|FG008|Overall Study|Lost to Follow-up|0|||
163042456|NCT02959918|588863908|FG009|Overall Study|Lost to Follow-up|1|||
163042457|NCT02959918|588863909|FG010|Overall Study|Lost to Follow-up|0|||
163042458|NCT02959918|588863910|FG011|Overall Study|Lost to Follow-up|0|||
163042459|NCT02959918|588863911|FG012|Overall Study|Lost to Follow-up|1|||
163042460|NCT02959918|588863912|FG013|Overall Study|Lost to Follow-up|0|||
163042461|NCT02959918|588863899|FG000|Overall Study|Withdrawal by Subject|0|||
163042462|NCT02959918|588863900|FG001|Overall Study|Withdrawal by Subject|0|||
163042463|NCT02959918|588863901|FG002|Overall Study|Withdrawal by Subject|1|||
163042464|NCT02959918|588863902|FG003|Overall Study|Withdrawal by Subject|2|||
163042465|NCT02959918|588863903|FG004|Overall Study|Withdrawal by Subject|0|||
163042466|NCT02959918|588863904|FG005|Overall Study|Withdrawal by Subject|0|||
163042467|NCT02959918|588863905|FG006|Overall Study|Withdrawal by Subject|1|||
163042468|NCT02959918|588863906|FG007|Overall Study|Withdrawal by Subject|0|||
163042469|NCT02959918|588863907|FG008|Overall Study|Withdrawal by Subject|1|||
163042470|NCT02959918|588863908|FG009|Overall Study|Withdrawal by Subject|1|||
163042471|NCT02959918|588863909|FG010|Overall Study|Withdrawal by Subject|2|||
163042472|NCT02959918|588863910|FG011|Overall Study|Withdrawal by Subject|3|||
163042473|NCT02959918|588863911|FG012|Overall Study|Withdrawal by Subject|1|||
163042474|NCT02959918|588863912|FG013|Overall Study|Withdrawal by Subject|1|||
163042475|NCT02959918|588863899|FG000|Overall Study|Protocol Violation|0|||
163042476|NCT02959918|588863900|FG001|Overall Study|Protocol Violation|0|||
163042477|NCT02959918|588863901|FG002|Overall Study|Protocol Violation|1|||
163042478|NCT02959918|588863902|FG003|Overall Study|Protocol Violation|0|||
163042479|NCT02959918|588863903|FG004|Overall Study|Protocol Violation|0|||
163042480|NCT02959918|588863904|FG005|Overall Study|Protocol Violation|1|||
163042481|NCT02959918|588863905|FG006|Overall Study|Protocol Violation|0|||
163042482|NCT02959918|588863906|FG007|Overall Study|Protocol Violation|0|||
163042483|NCT02959918|588863907|FG008|Overall Study|Protocol Violation|2|||
163042484|NCT02959918|588863908|FG009|Overall Study|Protocol Violation|1|||
163042485|NCT02959918|588863909|FG010|Overall Study|Protocol Violation|0|||
163042486|NCT02959918|588863910|FG011|Overall Study|Protocol Violation|1|||
163042487|NCT02959918|588863911|FG012|Overall Study|Protocol Violation|1|||
163042488|NCT02959918|588863912|FG013|Overall Study|Protocol Violation|0|||
163042489|NCT02959918|588863899|FG000|Overall Study|Stopping Rule Met|1|||
163042490|NCT02959918|588863900|FG001|Overall Study|Stopping Rule Met|0|||
163042491|NCT02959918|588863901|FG002|Overall Study|Stopping Rule Met|3|||
163042492|NCT02959918|588863902|FG003|Overall Study|Stopping Rule Met|4|||
163042493|NCT02959918|588863903|FG004|Overall Study|Stopping Rule Met|5|||
163042494|NCT02959918|588863904|FG005|Overall Study|Stopping Rule Met|3|||
163042495|NCT02959918|588863905|FG006|Overall Study|Stopping Rule Met|2|||
163042496|NCT02959918|588863906|FG007|Overall Study|Stopping Rule Met|4|||
163042497|NCT02959918|588863907|FG008|Overall Study|Stopping Rule Met|1|||
163042498|NCT02959918|588863908|FG009|Overall Study|Stopping Rule Met|1|||
163042499|NCT02959918|588863909|FG010|Overall Study|Stopping Rule Met|3|||
163157841|NCT00790842|589291728|FG004|Dose Level 1|Withdrawal by Subject|0|||
163042500|NCT02959918|588863910|FG011|Overall Study|Stopping Rule Met|5|||
163157842|NCT00790842|589291729|FG005|Dose Level 1|Withdrawal by Subject|0|||
163157843|NCT00790842|589291730|FG006|Dose Level 1|Withdrawal by Subject|0|||
163157844|NCT00790842|589291731|FG007|Dose Level 1|Withdrawal by Subject|0|||
163157845|NCT00790842|589291732|FG008|Dose Level 1|Withdrawal by Subject|0|||
163157846|NCT00790842|589291733|FG009|Dose Level 1|Withdrawal by Subject|0|||
163157847|NCT00790842|589291734|FG010|Dose Level 1|Withdrawal by Subject|0|||
163157848|NCT00790842|589291724|FG000|Dose Level 2|Death|0|||
163157849|NCT00790842|589291725|FG001|Dose Level 2|Death|1|||
163157850|NCT00790842|589291726|FG002|Dose Level 2|Death|0|||
163157851|NCT00790842|589291727|FG003|Dose Level 2|Death|0|||
163157852|NCT00790842|589291728|FG004|Dose Level 2|Death|1|||
163157853|NCT00790842|589291729|FG005|Dose Level 2|Death|0|||
163157854|NCT00790842|589291730|FG006|Dose Level 2|Death|0|||
163157855|NCT00790842|589291731|FG007|Dose Level 2|Death|0|||
163157856|NCT00790842|589291732|FG008|Dose Level 2|Death|0|||
163157857|NCT00790842|589291733|FG009|Dose Level 2|Death|0|||
163157858|NCT00790842|589291734|FG010|Dose Level 2|Death|0|||
163157859|NCT00790842|589291724|FG000|Dose Level 2|Physician Decision|0|||
163157860|NCT00790842|589291725|FG001|Dose Level 2|Physician Decision|1|||
163157861|NCT00790842|589291726|FG002|Dose Level 2|Physician Decision|0|||
163157862|NCT00790842|589291727|FG003|Dose Level 2|Physician Decision|0|||
163157863|NCT00790842|589291728|FG004|Dose Level 2|Physician Decision|0|||
163157864|NCT00790842|589291729|FG005|Dose Level 2|Physician Decision|0|||
163157865|NCT00790842|589291730|FG006|Dose Level 2|Physician Decision|0|||
163157866|NCT00790842|589291731|FG007|Dose Level 2|Physician Decision|0|||
163157867|NCT00790842|589291732|FG008|Dose Level 2|Physician Decision|0|||
163157868|NCT00790842|589291733|FG009|Dose Level 2|Physician Decision|0|||
163157869|NCT00790842|589291734|FG010|Dose Level 2|Physician Decision|0|||
163042501|NCT02959918|588863911|FG012|Overall Study|Stopping Rule Met|2|||
163042502|NCT02959918|588863912|FG013|Overall Study|Stopping Rule Met|1|||
163042503|NCT02959918|588863899|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
163042504|NCT02959918|588863900|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
163042505|NCT02959918|588863901|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
163157870|NCT00790842|589291724|FG000|Dose Level 2|Withdrawal by Subject|0|||
163157871|NCT00790842|589291725|FG001|Dose Level 2|Withdrawal by Subject|1|||
162811642|NCT00585195|588021764|FG009|Overall Study|Other|1|||
163042506|NCT02959918|588863902|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
163042507|NCT02959918|588863903|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042508|NCT02959918|588863904|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042509|NCT02959918|588863905|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042510|NCT02959918|588863906|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042511|NCT02959918|588863907|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042512|NCT02959918|588863908|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042513|NCT02959918|588863909|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042514|NCT02959918|588863910|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042515|NCT02959918|588863911|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042516|NCT02959918|588863912|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
163042517|NCT02959918|588863899|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042518|NCT02959918|588863900|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042519|NCT02959918|588863901|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042520|NCT02959918|588863902|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042521|NCT02959918|588863903|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042522|NCT02959918|588863904|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163058537|NCT00042289|588924271|FG036|Overall Study|Severe debilitation, unable to continue|0|||
163058538|NCT00042289|588924272|FG037|Overall Study|Severe debilitation, unable to continue|0|||
163058539|NCT00042289|588924273|FG038|Overall Study|Severe debilitation, unable to continue|0|||
163058540|NCT00042289|588924274|FG039|Overall Study|Severe debilitation, unable to continue|0|||
163058541|NCT00042289|588924275|FG040|Overall Study|Severe debilitation, unable to continue|0|||
163058542|NCT00042289|588924276|FG041|Overall Study|Severe debilitation, unable to continue|0|||
163058543|NCT00042289|588924277|FG042|Overall Study|Severe debilitation, unable to continue|0|||
163058544|NCT00042289|588924278|FG043|Overall Study|Severe debilitation, unable to continue|0|||
163058545|NCT00042289|588924279|FG044|Overall Study|Severe debilitation, unable to continue|0|||
163058546|NCT00042289|588924280|FG045|Overall Study|Severe debilitation, unable to continue|0|||
163058547|NCT00042289|588924281|FG046|Overall Study|Severe debilitation, unable to continue|0|||
163058548|NCT00042289|588924235|FG000|Overall Study|Site closed|0|||
163058549|NCT00042289|588924236|FG001|Overall Study|Site closed|0|||
163058550|NCT00042289|588924237|FG002|Overall Study|Site closed|0|||
163157872|NCT00790842|589291726|FG002|Dose Level 2|Withdrawal by Subject|0|||
163157873|NCT00790842|589291727|FG003|Dose Level 2|Withdrawal by Subject|0|||
163157874|NCT00790842|589291728|FG004|Dose Level 2|Withdrawal by Subject|0|||
163157875|NCT00790842|589291729|FG005|Dose Level 2|Withdrawal by Subject|0|||
163157876|NCT00790842|589291730|FG006|Dose Level 2|Withdrawal by Subject|0|||
163157877|NCT00790842|589291731|FG007|Dose Level 2|Withdrawal by Subject|0|||
163157878|NCT00790842|589291732|FG008|Dose Level 2|Withdrawal by Subject|0|||
163157879|NCT00790842|589291733|FG009|Dose Level 2|Withdrawal by Subject|0|||
163157880|NCT00790842|589291734|FG010|Dose Level 2|Withdrawal by Subject|0|||
162929541|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162929542|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162929543|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162929544|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162929545|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
162929546|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162929547|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929548|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929549|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162929550|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929551|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
162929552|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929553|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929554|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
162929555|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
163157881|NCT00790842|589291724|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157882|NCT00790842|589291725|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157883|NCT00790842|589291726|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157884|NCT00790842|589291727|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157885|NCT00790842|589291728|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157886|NCT00790842|589291729|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157887|NCT00790842|589291730|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157888|NCT00790842|589291731|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157889|NCT00790842|589291732|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
163157890|NCT00790842|589291733|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157891|NCT00790842|589291734|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
163157892|NCT00790842|589291724|FG000|Dose Level 3|Adverse Event|0|||
163157893|NCT00790842|589291725|FG001|Dose Level 3|Adverse Event|0|||
163157894|NCT00790842|589291726|FG002|Dose Level 3|Adverse Event|1|||
163157895|NCT00790842|589291727|FG003|Dose Level 3|Adverse Event|0|||
163157896|NCT00790842|589291728|FG004|Dose Level 3|Adverse Event|0|||
162811643|NCT00585195|588021765|FG010|Overall Study|Other|0|||
163042523|NCT02959918|588863905|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042524|NCT02959918|588863906|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
163042525|NCT02959918|588863907|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042526|NCT02959918|588863908|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042527|NCT02959918|588863909|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042528|NCT02959918|588863910|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042529|NCT02959918|588863911|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042530|NCT02959918|588863912|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163042531|NCT02959918|588863899|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042532|NCT02959918|588863900|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042533|NCT02959918|588863901|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042534|NCT02959918|588863902|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042535|NCT02959918|588863903|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042536|NCT02959918|588863904|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042537|NCT02959918|588863905|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042538|NCT02959918|588863906|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042539|NCT02959918|588863907|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
163042540|NCT02959918|588863908|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042541|NCT02959918|588863909|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042542|NCT02959918|588863910|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042543|NCT02959918|588863911|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042544|NCT02959918|588863912|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163042545|NCT02959918|588863899|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042546|NCT02959918|588863900|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042547|NCT02959918|588863901|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042548|NCT02959918|588863902|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042549|NCT02959918|588863903|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042550|NCT02959918|588863904|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042551|NCT02959918|588863905|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042552|NCT02959918|588863906|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042553|NCT02959918|588863907|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042554|NCT02959918|588863908|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
163042555|NCT02959918|588863909|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042556|NCT02959918|588863910|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042557|NCT02959918|588863911|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042558|NCT02959918|588863912|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
163042559|NCT03173456|588863914|FG000|Baseline|Medication dispensing system malfunction'|0|||
163042560|NCT03173456|588863915|FG001|Baseline|Medication dispensing system malfunction'|1|||
163042561|NCT03173456|588863916|FG002|Baseline|Medication dispensing system malfunction'|0|||
163042562|NCT03173456|588863917|FG003|Baseline|Medication dispensing system malfunction'|0|||
163042563|NCT03173456|588863918|FG004|Baseline|Medication dispensing system malfunction'|2|||
163042564|NCT03173456|588863914|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
163042565|NCT03173456|588863915|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
163042566|NCT03173456|588863916|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
163042567|NCT03173456|588863917|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
163042568|NCT03173456|588863918|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
163042569|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
163042570|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
163042571|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
163042572|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
163042573|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
163042574|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
163042575|NCT01733121|588863919|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
163042576|NCT01733121|588863920|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
163042577|NCT03061188|588863921|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
163042578|NCT03061188|588863922|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
163042579|NCT03061188|588863923|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
163042580|NCT03061188|588863924|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
163042581|NCT03061188|588863921|FG000|On Follow-up for 3 Years|Death|0|||
163042582|NCT03061188|588863922|FG001|On Follow-up for 3 Years|Death|3|||
163042583|NCT03061188|588863923|FG002|On Follow-up for 3 Years|Death|5|||
163042584|NCT03061188|588863924|FG003|On Follow-up for 3 Years|Death|4|||
163042585|NCT03061188|588863921|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163042586|NCT03061188|588863922|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163042587|NCT03061188|588863923|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
163042588|NCT03061188|588863924|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
163042589|NCT01151345|588863926|FG000|First Intervention Period|Protocol Violation|0|||
163042590|NCT01151345|588863927|FG001|First Intervention Period|Protocol Violation|1|||
163042591|NCT01658904|588863929|FG000|Overall Study|Principal Investigator discretion|2|||
163042592|NCT01658904|588863930|FG001|Overall Study|Principal Investigator discretion|0|||
163042593|NCT01658904|588863931|FG002|Overall Study|Principal Investigator discretion|0|||
163042594|NCT01087203|588863934|FG000|Overall Study|Lost to Follow-up|2|||
163042595|NCT01087203|588863935|FG001|Overall Study|Lost to Follow-up|0|||
163042596|NCT01087203|588863934|FG000|Overall Study|Withdrawal by Subject|2|||
163042597|NCT01087203|588863935|FG001|Overall Study|Withdrawal by Subject|6|||
163042598|NCT01087203|588863934|FG000|Overall Study|Lack of Efficacy|1|||
163042599|NCT01087203|588863935|FG001|Overall Study|Lack of Efficacy|2|||
163042600|NCT01087203|588863934|FG000|Overall Study|Study terminated by sponsor|27|||
163042601|NCT01087203|588863935|FG001|Overall Study|Study terminated by sponsor|27|||
163042602|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
163042603|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
163042604|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
163042605|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
163042606|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
163042607|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
163042608|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
163042609|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
163042610|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
163042611|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
163042612|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042613|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042614|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042615|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
163042616|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042617|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042618|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
163042619|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
163042620|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042621|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
163042622|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042623|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042624|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
163042625|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042626|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042627|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042628|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042629|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042630|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042631|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
163042632|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042633|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042634|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042635|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042636|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042637|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
163042638|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042639|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
163042640|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042641|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
163042642|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042643|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042644|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042645|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042646|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
163042647|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
163042648|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042649|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042650|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163058551|NCT00042289|588924238|FG003|Overall Study|Site closed|0|||
163042651|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
163042652|NCT04074330|588863939|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042653|NCT04074330|588863940|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042654|NCT04074330|588863941|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042655|NCT04074330|588863942|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042656|NCT04074330|588863943|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042657|NCT04074330|588863944|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
163042658|NCT04074330|588863945|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042659|NCT04074330|588863946|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042660|NCT04074330|588863947|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042661|NCT04074330|588863948|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
163042662|NCT04074330|588863939|FG000|Dose Expansion (up to 42 Months)|Death|0|||
163042663|NCT04074330|588863940|FG001|Dose Expansion (up to 42 Months)|Death|0|||
163042664|NCT04074330|588863941|FG002|Dose Expansion (up to 42 Months)|Death|0|||
163042665|NCT04074330|588863942|FG003|Dose Expansion (up to 42 Months)|Death|0|||
163157897|NCT00790842|589291729|FG005|Dose Level 3|Adverse Event|0|||
163157898|NCT00790842|589291730|FG006|Dose Level 3|Adverse Event|0|||
163157899|NCT00790842|589291731|FG007|Dose Level 3|Adverse Event|0|||
163157900|NCT00790842|589291732|FG008|Dose Level 3|Adverse Event|0|||
163157901|NCT00790842|589291733|FG009|Dose Level 3|Adverse Event|0|||
163157902|NCT00790842|589291734|FG010|Dose Level 3|Adverse Event|0|||
163157903|NCT00790842|589291724|FG000|Dose Level 3|Withdrawal by Subject|0|||
163157904|NCT00790842|589291725|FG001|Dose Level 3|Withdrawal by Subject|0|||
163157905|NCT00790842|589291726|FG002|Dose Level 3|Withdrawal by Subject|3|||
163157906|NCT00790842|589291727|FG003|Dose Level 3|Withdrawal by Subject|0|||
163157907|NCT00790842|589291728|FG004|Dose Level 3|Withdrawal by Subject|0|||
163157908|NCT00790842|589291729|FG005|Dose Level 3|Withdrawal by Subject|0|||
163157909|NCT00790842|589291730|FG006|Dose Level 3|Withdrawal by Subject|0|||
163042666|NCT04074330|588863943|FG004|Dose Expansion (up to 42 Months)|Death|0|||
163042667|NCT04074330|588863944|FG005|Dose Expansion (up to 42 Months)|Death|0|||
163042668|NCT04074330|588863945|FG006|Dose Expansion (up to 42 Months)|Death|0|||
163042669|NCT04074330|588863946|FG007|Dose Expansion (up to 42 Months)|Death|0|||
163042670|NCT04074330|588863947|FG008|Dose Expansion (up to 42 Months)|Death|1|||
163042671|NCT04074330|588863948|FG009|Dose Expansion (up to 42 Months)|Death|0|||
163042672|NCT04074330|588863939|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042673|NCT04074330|588863940|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042674|NCT04074330|588863941|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042675|NCT04074330|588863942|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042676|NCT04074330|588863943|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042677|NCT04074330|588863944|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042678|NCT04074330|588863945|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042679|NCT04074330|588863946|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
163042680|NCT04074330|588863947|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
163042681|NCT04074330|588863948|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
163042682|NCT01429298|588863953|FG000|Overall Study|Protocol Violation|4|||
163042683|NCT01429298|588863954|FG001|Overall Study|Protocol Violation|6|||
163042684|NCT02903420|588863955|FG000|Overall Study|Death|3|||
163042685|NCT00181883|588863958|FG000|Overall Study|Lack of Efficacy|2|||
163042686|NCT00181883|588863958|FG000|Overall Study|Treatment Limiting AEs|3|||
163042687|NCT00181883|588863958|FG000|Overall Study|Withdrawal by Subject|4|||
163042688|NCT00181883|588863958|FG000|Overall Study|Lost to Follow-up|1|||
163042689|NCT05305989|588863959|FG000|Overall Study|Other|3|||
163042690|NCT05305989|588863960|FG001|Overall Study|Other|2|||
163042691|NCT05305989|588863961|FG002|Overall Study|Other|0|||
163042692|NCT05305989|588863959|FG000|Overall Study|Sponsor decision|2|||
163042693|NCT05305989|588863960|FG001|Overall Study|Sponsor decision|1|||
163042694|NCT05305989|588863961|FG002|Overall Study|Sponsor decision|0|||
163042695|NCT05305989|588863959|FG000|Overall Study|Protocol Violation|0|||
163042696|NCT05305989|588863960|FG001|Overall Study|Protocol Violation|1|||
163042697|NCT05305989|588863961|FG002|Overall Study|Protocol Violation|0|||
163042698|NCT05305989|588863959|FG000|Overall Study|Investigator decision|1|||
163042699|NCT05305989|588863960|FG001|Overall Study|Investigator decision|2|||
163042700|NCT05305989|588863961|FG002|Overall Study|Investigator decision|0|||
163042701|NCT05305989|588863959|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
163042702|NCT05305989|588863960|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
163042703|NCT05305989|588863961|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
163042704|NCT05305989|588863959|FG000|Overall Study|Adverse Event|1|||
163042705|NCT05305989|588863960|FG001|Overall Study|Adverse Event|1|||
163042706|NCT05305989|588863961|FG002|Overall Study|Adverse Event|0|||
163042707|NCT05305989|588863959|FG000|Overall Study|Enrolled but never dosed|3|||
163042708|NCT05305989|588863960|FG001|Overall Study|Enrolled but never dosed|2|||
163042709|NCT05305989|588863961|FG002|Overall Study|Enrolled but never dosed|1|||
163042710|NCT03162328|588863962|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
163042711|NCT03162328|588863963|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
163042712|NCT03162328|588863964|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
163042713|NCT03162328|588863962|FG000|Screening Period|Withdrawal by Subject|1|||
163042714|NCT03162328|588863963|FG001|Screening Period|Withdrawal by Subject|0|||
163042715|NCT03162328|588863964|FG002|Screening Period|Withdrawal by Subject|0|||
163042716|NCT03162328|588863962|FG000|Study Period|Withdrawal by Subject|0|||
163042717|NCT03162328|588863963|FG001|Study Period|Withdrawal by Subject|0|||
163042718|NCT03162328|588863964|FG002|Study Period|Withdrawal by Subject|1|||
163042719|NCT00913770|588863965|FG000|Overall Study|Unable to contact|24|||
163042720|NCT00913770|588863966|FG001|Overall Study|Unable to contact|19|||
163042721|NCT00913770|588863967|FG002|Overall Study|Unable to contact|13|||
163042722|NCT00913770|588863965|FG000|Overall Study|Refused|11|||
163042723|NCT00913770|588863966|FG001|Overall Study|Refused|10|||
163042724|NCT00913770|588863967|FG002|Overall Study|Refused|8|||
163042725|NCT01990768|588863968|FG000|Intervention Started|Found to be ineligible|14|||
163042726|NCT01990768|588863969|FG001|Intervention Started|Found to be ineligible|13|||
163042727|NCT01990768|588863970|FG002|Intervention Started|Found to be ineligible|11|||
163042728|NCT01990768|588863968|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
163042729|NCT01990768|588863969|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
163042730|NCT01990768|588863970|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
163042731|NCT01990768|588863968|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
163042732|NCT01990768|588863969|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
163042733|NCT01990768|588863970|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
163042734|NCT01990768|588863968|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
163042735|NCT01990768|588863969|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
163042736|NCT01990768|588863970|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
163042737|NCT01990768|588863968|FG000|Intervention Started|Patient care priority|1|||
163042738|NCT01990768|588863969|FG001|Intervention Started|Patient care priority|2|||
163042739|NCT01990768|588863970|FG002|Intervention Started|Patient care priority|3|||
163042740|NCT01990768|588863968|FG000|Intervention Started|IV lost|2|||
163042741|NCT01990768|588863969|FG001|Intervention Started|IV lost|2|||
163042742|NCT01990768|588863970|FG002|Intervention Started|IV lost|2|||
163042743|NCT01990768|588863968|FG000|Intervention Started|Required CPR|1|||
163042744|NCT01990768|588863969|FG001|Intervention Started|Required CPR|1|||
163042745|NCT01990768|588863970|FG002|Intervention Started|Required CPR|0|||
163042746|NCT01990768|588863968|FG000|Intervention Started|Seizure or hx of seizure|0|||
163042747|NCT01990768|588863969|FG001|Intervention Started|Seizure or hx of seizure|0|||
163042748|NCT01990768|588863970|FG002|Intervention Started|Seizure or hx of seizure|2|||
163042749|NCT01990768|588863968|FG000|Intervention Started|Discovered to be pregnant|0|||
163042750|NCT01990768|588863969|FG001|Intervention Started|Discovered to be pregnant|1|||
163042751|NCT01990768|588863970|FG002|Intervention Started|Discovered to be pregnant|0|||
163042752|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
163042753|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
163042754|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
163042755|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
163058552|NCT00042289|588924239|FG004|Overall Study|Site closed|0|||
163157910|NCT00790842|589291731|FG007|Dose Level 3|Withdrawal by Subject|0|||
163157911|NCT00790842|589291732|FG008|Dose Level 3|Withdrawal by Subject|0|||
163157912|NCT00790842|589291733|FG009|Dose Level 3|Withdrawal by Subject|2|||
163157913|NCT00790842|589291734|FG010|Dose Level 3|Withdrawal by Subject|0|||
163157914|NCT00790842|589291724|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157915|NCT00790842|589291725|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157916|NCT00790842|589291726|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157917|NCT00790842|589291727|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157918|NCT00790842|589291728|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157919|NCT00790842|589291729|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
163157920|NCT00790842|589291730|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157921|NCT00790842|589291731|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157922|NCT00790842|589291732|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157923|NCT00790842|589291733|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157924|NCT00790842|589291734|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
163157925|NCT00790842|589291724|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157926|NCT00790842|589291725|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157927|NCT00790842|589291726|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
163157928|NCT00790842|589291727|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157929|NCT00790842|589291728|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157930|NCT00790842|589291729|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157931|NCT00790842|589291730|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157932|NCT00790842|589291731|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157933|NCT00790842|589291732|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157934|NCT00790842|589291733|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157935|NCT00790842|589291734|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
163157936|NCT00790842|589291724|FG000|Dose Level 4|Adverse Event|0|||
163157937|NCT00790842|589291725|FG001|Dose Level 4|Adverse Event|0|||
163157938|NCT00790842|589291726|FG002|Dose Level 4|Adverse Event|0|||
163157939|NCT00790842|589291727|FG003|Dose Level 4|Adverse Event|0|||
163157940|NCT00790842|589291728|FG004|Dose Level 4|Adverse Event|0|||
163157941|NCT00790842|589291729|FG005|Dose Level 4|Adverse Event|0|||
163157942|NCT00790842|589291730|FG006|Dose Level 4|Adverse Event|1|||
163157943|NCT00790842|589291731|FG007|Dose Level 4|Adverse Event|0|||
163157944|NCT00790842|589291732|FG008|Dose Level 4|Adverse Event|0|||
163157945|NCT00790842|589291733|FG009|Dose Level 4|Adverse Event|0|||
163157946|NCT00790842|589291734|FG010|Dose Level 4|Adverse Event|0|||
163157947|NCT00790842|589291724|FG000|Dose Level 4|Physician Decision|0|||
163157948|NCT00790842|589291725|FG001|Dose Level 4|Physician Decision|0|||
163157949|NCT00790842|589291726|FG002|Dose Level 4|Physician Decision|0|||
163157950|NCT00790842|589291727|FG003|Dose Level 4|Physician Decision|0|||
163157951|NCT00790842|589291728|FG004|Dose Level 4|Physician Decision|0|||
163042756|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
163042757|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
163042758|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
163042759|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
163042760|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
163042761|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
163042762|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
163042763|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
163042764|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Death|3|||
163042765|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Death|1|||
163157952|NCT00790842|589291729|FG005|Dose Level 4|Physician Decision|0|||
163157953|NCT00790842|589291730|FG006|Dose Level 4|Physician Decision|1|||
163157954|NCT00790842|589291731|FG007|Dose Level 4|Physician Decision|0|||
163157955|NCT00790842|589291732|FG008|Dose Level 4|Physician Decision|0|||
163157956|NCT00790842|589291733|FG009|Dose Level 4|Physician Decision|0|||
163157957|NCT00790842|589291734|FG010|Dose Level 4|Physician Decision|1|||
163042766|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Death|1|||
163042767|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Discharged|2|||
163042768|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Discharged|1|||
163042769|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Discharged|0|||
163042770|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
163042771|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
163042772|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
163058553|NCT00042289|588924240|FG005|Overall Study|Site closed|0|||
163042773|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
163042774|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
163042775|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
163042776|NCT01990768|588863968|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
163042777|NCT01990768|588863969|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
163042778|NCT01990768|588863970|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
163042779|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
163042780|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
163042781|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
163042782|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
163042783|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
163157958|NCT00790842|589291724|FG000|Dose Level 4|Withdrawal by Subject|0|||
163157959|NCT00790842|589291725|FG001|Dose Level 4|Withdrawal by Subject|0|||
163157960|NCT00790842|589291726|FG002|Dose Level 4|Withdrawal by Subject|0|||
163157961|NCT00790842|589291727|FG003|Dose Level 4|Withdrawal by Subject|0|||
163157962|NCT00790842|589291728|FG004|Dose Level 4|Withdrawal by Subject|0|||
163157963|NCT00790842|589291729|FG005|Dose Level 4|Withdrawal by Subject|0|||
163157964|NCT00790842|589291730|FG006|Dose Level 4|Withdrawal by Subject|0|||
163157965|NCT00790842|589291731|FG007|Dose Level 4|Withdrawal by Subject|0|||
163157966|NCT00790842|589291732|FG008|Dose Level 4|Withdrawal by Subject|0|||
163157967|NCT00790842|589291733|FG009|Dose Level 4|Withdrawal by Subject|0|||
163157968|NCT00790842|589291734|FG010|Dose Level 4|Withdrawal by Subject|1|||
163157969|NCT00790842|589291724|FG000|Expansion Cohort|Adverse Event|0|||
163157970|NCT00790842|589291725|FG001|Expansion Cohort|Adverse Event|0|||
163157971|NCT00790842|589291726|FG002|Expansion Cohort|Adverse Event|0|||
163157972|NCT00790842|589291727|FG003|Expansion Cohort|Adverse Event|0|||
163157973|NCT00790842|589291728|FG004|Expansion Cohort|Adverse Event|0|||
163157974|NCT00790842|589291729|FG005|Expansion Cohort|Adverse Event|0|||
163157975|NCT00790842|589291730|FG006|Expansion Cohort|Adverse Event|1|||
163157976|NCT00790842|589291731|FG007|Expansion Cohort|Adverse Event|0|||
163157977|NCT00790842|589291732|FG008|Expansion Cohort|Adverse Event|0|||
163157978|NCT00790842|589291733|FG009|Expansion Cohort|Adverse Event|0|||
163157979|NCT00790842|589291734|FG010|Expansion Cohort|Adverse Event|0|||
163157980|NCT00790842|589291724|FG000|Expansion Cohort|Death|0|||
163157981|NCT00790842|589291725|FG001|Expansion Cohort|Death|0|||
163157982|NCT00790842|589291726|FG002|Expansion Cohort|Death|2|||
163157983|NCT00790842|589291727|FG003|Expansion Cohort|Death|0|||
163157984|NCT00790842|589291728|FG004|Expansion Cohort|Death|0|||
163157985|NCT00790842|589291729|FG005|Expansion Cohort|Death|0|||
163157986|NCT00790842|589291730|FG006|Expansion Cohort|Death|0|||
163157987|NCT00790842|589291731|FG007|Expansion Cohort|Death|0|||
163157988|NCT00790842|589291732|FG008|Expansion Cohort|Death|0|||
163157989|NCT00790842|589291733|FG009|Expansion Cohort|Death|0|||
163157990|NCT00790842|589291734|FG010|Expansion Cohort|Death|0|||
163157991|NCT00790842|589291724|FG000|Expansion Cohort|Physician Decision|0|||
163157992|NCT00790842|589291725|FG001|Expansion Cohort|Physician Decision|0|||
163157993|NCT00790842|589291726|FG002|Expansion Cohort|Physician Decision|1|||
163157994|NCT00790842|589291727|FG003|Expansion Cohort|Physician Decision|0|||
163157995|NCT00790842|589291728|FG004|Expansion Cohort|Physician Decision|0|||
163157996|NCT00790842|589291729|FG005|Expansion Cohort|Physician Decision|0|||
163157997|NCT00790842|589291730|FG006|Expansion Cohort|Physician Decision|0|||
163157998|NCT00790842|589291731|FG007|Expansion Cohort|Physician Decision|0|||
163157999|NCT00790842|589291732|FG008|Expansion Cohort|Physician Decision|0|||
163158000|NCT00790842|589291733|FG009|Expansion Cohort|Physician Decision|0|||
163158001|NCT00790842|589291734|FG010|Expansion Cohort|Physician Decision|0|||
163158002|NCT00790842|589291724|FG000|Expansion Cohort|Withdrawal by Subject|0|||
163158003|NCT00790842|589291725|FG001|Expansion Cohort|Withdrawal by Subject|0|||
163158004|NCT00790842|589291726|FG002|Expansion Cohort|Withdrawal by Subject|3|||
163158005|NCT00790842|589291727|FG003|Expansion Cohort|Withdrawal by Subject|0|||
163158006|NCT00790842|589291728|FG004|Expansion Cohort|Withdrawal by Subject|0|||
163158007|NCT00790842|589291729|FG005|Expansion Cohort|Withdrawal by Subject|0|||
163158008|NCT00790842|589291730|FG006|Expansion Cohort|Withdrawal by Subject|0|||
163158009|NCT00790842|589291731|FG007|Expansion Cohort|Withdrawal by Subject|0|||
163158010|NCT00790842|589291732|FG008|Expansion Cohort|Withdrawal by Subject|0|||
163158011|NCT00790842|589291733|FG009|Expansion Cohort|Withdrawal by Subject|0|||
163158012|NCT00790842|589291734|FG010|Expansion Cohort|Withdrawal by Subject|0|||
163158013|NCT00790842|589291724|FG000|Expansion Cohort|Study Closure|0|||
163158014|NCT00790842|589291725|FG001|Expansion Cohort|Study Closure|0|||
163158015|NCT00790842|589291726|FG002|Expansion Cohort|Study Closure|1|||
163158016|NCT00790842|589291727|FG003|Expansion Cohort|Study Closure|0|||
163158017|NCT00790842|589291728|FG004|Expansion Cohort|Study Closure|0|||
163158018|NCT00790842|589291729|FG005|Expansion Cohort|Study Closure|0|||
163158019|NCT00790842|589291730|FG006|Expansion Cohort|Study Closure|0|||
163158020|NCT00790842|589291731|FG007|Expansion Cohort|Study Closure|0|||
163158021|NCT00790842|589291732|FG008|Expansion Cohort|Study Closure|0|||
163158022|NCT00790842|589291733|FG009|Expansion Cohort|Study Closure|0|||
163158023|NCT00790842|589291734|FG010|Expansion Cohort|Study Closure|0|||
163158024|NCT05029362|589291735|FG000|Overall Study|Lost to Follow-up|9|||
163158025|NCT00419952|589291739|FG000|Overall Study|Adverse Event|8|||
163158026|NCT00419952|589291740|FG001|Overall Study|Adverse Event|10|||
163158027|NCT00419952|589291739|FG000|Overall Study|Withdrawal by Subject|44|||
163158028|NCT00419952|589291740|FG001|Overall Study|Withdrawal by Subject|43|||
163158029|NCT00419952|589291739|FG000|Overall Study|Lost to Follow-up|43|||
163158030|NCT00419952|589291740|FG001|Overall Study|Lost to Follow-up|34|||
163158031|NCT00419952|589291739|FG000|Overall Study|Protocol Violation|32|||
163158032|NCT00419952|589291740|FG001|Overall Study|Protocol Violation|24|||
163158033|NCT00419952|589291739|FG000|Overall Study|Pregnancy|4|||
163158034|NCT00419952|589291740|FG001|Overall Study|Pregnancy|2|||
163158035|NCT00419952|589291739|FG000|Overall Study|Physician Decision|1|||
163158036|NCT00419952|589291740|FG001|Overall Study|Physician Decision|3|||
163158037|NCT00419952|589291739|FG000|Overall Study|Incorrectly enrolled|10|||
163158038|NCT00419952|589291740|FG001|Overall Study|Incorrectly enrolled|3|||
163158039|NCT00419952|589291739|FG000|Overall Study|Intake of prohibited medication|2|||
163158040|NCT00419952|589291740|FG001|Overall Study|Intake of prohibited medication|2|||
163158041|NCT00419952|589291739|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
163158042|NCT00419952|589291740|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
163158043|NCT00419952|589291739|FG000|Overall Study|Diary or medication non-compliance|2|||
163158044|NCT00419952|589291740|FG001|Overall Study|Diary or medication non-compliance|4|||
163158045|NCT00419952|589291739|FG000|Overall Study|Abnormal ECG|1|||
163158046|NCT00419952|589291740|FG001|Overall Study|Abnormal ECG|0|||
163158047|NCT03126591|589291745|FG000|Overall Study|Death|6|||
163158048|NCT03126591|589291746|FG001|Overall Study|Death|3|||
163158049|NCT03126591|589291747|FG002|Overall Study|Death|17|||
163158050|NCT03126591|589291745|FG000|Overall Study|Progressive Disease|0|||
163158051|NCT03126591|589291746|FG001|Overall Study|Progressive Disease|1|||
163158052|NCT03126591|589291747|FG002|Overall Study|Progressive Disease|2|||
163158053|NCT03126591|589291745|FG000|Overall Study|Terminated by Sponsor|0|||
163158054|NCT03126591|589291746|FG001|Overall Study|Terminated by Sponsor|1|||
163158055|NCT03126591|589291747|FG002|Overall Study|Terminated by Sponsor|4|||
163158056|NCT03126591|589291745|FG000|Overall Study|Withdrawal by Subject|1|||
163158057|NCT03126591|589291746|FG001|Overall Study|Withdrawal by Subject|1|||
163158058|NCT03126591|589291747|FG002|Overall Study|Withdrawal by Subject|4|||
163158059|NCT03722238|589291750|FG000|Overall Study|Protocol Violation|1|||
163158060|NCT03722238|589291751|FG001|Overall Study|Protocol Violation|0|||
163158061|NCT03722238|589291750|FG000|Overall Study|Physician Decision|1|||
163158062|NCT03722238|589291751|FG001|Overall Study|Physician Decision|0|||
163158063|NCT03722238|589291750|FG000|Overall Study|Death|1|||
163158064|NCT03722238|589291751|FG001|Overall Study|Death|0|||
163158065|NCT03722238|589291750|FG000|Overall Study|Lost to Follow-up|6|||
163158066|NCT03722238|589291751|FG001|Overall Study|Lost to Follow-up|0|||
163158067|NCT03722238|589291750|FG000|Overall Study|Partial missing data|44|||
163158068|NCT03722238|589291751|FG001|Overall Study|Partial missing data|1|||
163158069|NCT03722238|589291750|FG000|Overall Study|Withdrawal by Subject|2|||
163158070|NCT03722238|589291751|FG001|Overall Study|Withdrawal by Subject|0|||
163158071|NCT03722238|589291750|FG000|Overall Study|Other|4|||
163158072|NCT03722238|589291751|FG001|Overall Study|Other|0|||
163158073|NCT03722238|589291750|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
163158074|NCT03722238|589291751|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
163158075|NCT03722238|589291750|FG000|Overall Study|Did not meet risk classification group criteria|90|||
163158076|NCT03722238|589291751|FG001|Overall Study|Did not meet risk classification group criteria|0|||
163158077|NCT03722238|589291750|FG000|Overall Study|Did not sign consent|17|||
163158078|NCT03722238|589291751|FG001|Overall Study|Did not sign consent|0|||
163158079|NCT03722238|589291750|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
163158080|NCT03722238|589291751|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
163158081|NCT03722238|589291750|FG000|Overall Study|Not willing to purchase study medication|142|||
163158082|NCT03722238|589291751|FG001|Overall Study|Not willing to purchase study medication|0|||
163158083|NCT03722238|589291750|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
163158084|NCT03722238|589291751|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
163158085|NCT02085460|589291752|FG000|Overall Study|Adverse Event|2|||
163158086|NCT02085460|589291753|FG001|Overall Study|Adverse Event|2|||
163158087|NCT02085460|589291754|FG002|Overall Study|Adverse Event|1|||
163158088|NCT02085460|589291752|FG000|Overall Study|Physician Decision|1|||
163158089|NCT02085460|589291753|FG001|Overall Study|Physician Decision|1|||
163158090|NCT02085460|589291754|FG002|Overall Study|Physician Decision|2|||
163158091|NCT02085460|589291752|FG000|Overall Study|Withdrawal by Subject|11|||
163158092|NCT02085460|589291753|FG001|Overall Study|Withdrawal by Subject|5|||
163158093|NCT02085460|589291754|FG002|Overall Study|Withdrawal by Subject|7|||
163158094|NCT01285323|589291755|FG000|Overall Study|Adverse Event|9|||
163158095|NCT01285323|589291756|FG001|Overall Study|Adverse Event|8|||
163158096|NCT01285323|589291755|FG000|Overall Study|Lack of Efficacy|4|||
163158097|NCT01285323|589291756|FG001|Overall Study|Lack of Efficacy|2|||
163158098|NCT01285323|589291755|FG000|Overall Study|Withdrawal by Subject|15|||
163158099|NCT01285323|589291756|FG001|Overall Study|Withdrawal by Subject|11|||
163158100|NCT01285323|589291755|FG000|Overall Study|Protocol Violation|1|||
163158101|NCT01285323|589291756|FG001|Overall Study|Protocol Violation|2|||
163158102|NCT01285323|589291755|FG000|Overall Study|Non-compliance with study procedures|2|||
163158103|NCT01285323|589291756|FG001|Overall Study|Non-compliance with study procedures|3|||
163158104|NCT01285323|589291755|FG000|Overall Study|Lost to Follow-up|1|||
163158105|NCT01285323|589291756|FG001|Overall Study|Lost to Follow-up|1|||
163158106|NCT01285323|589291755|FG000|Overall Study|Other|1|||
163158107|NCT01285323|589291756|FG001|Overall Study|Other|3|||
163158108|NCT02606643|589291757|FG000|Overall Study|did not meet inclusion criteria|1|||
163158109|NCT02606643|589291758|FG001|Overall Study|did not meet inclusion criteria|3|||
163158110|NCT02158546|589291765|FG000|Overall Study|Physician Decision|0|||
163158111|NCT02158546|589291766|FG001|Overall Study|Physician Decision|1|||
163158112|NCT02158546|589291767|FG002|Overall Study|Physician Decision|0|||
163158113|NCT02158546|589291768|FG003|Overall Study|Physician Decision|0|||
163158114|NCT02158546|589291765|FG000|Overall Study|Non-compliance|0|||
163158115|NCT02158546|589291766|FG001|Overall Study|Non-compliance|1|||
163158116|NCT02158546|589291767|FG002|Overall Study|Non-compliance|0|||
163158117|NCT02158546|589291768|FG003|Overall Study|Non-compliance|1|||
163158118|NCT02158546|589291765|FG000|Overall Study|Failure to meet eligibility criteria|0|||
163158119|NCT02158546|589291766|FG001|Overall Study|Failure to meet eligibility criteria|1|||
163158120|NCT02158546|589291767|FG002|Overall Study|Failure to meet eligibility criteria|0|||
163158121|NCT02158546|589291768|FG003|Overall Study|Failure to meet eligibility criteria|0|||
163158122|NCT02158546|589291765|FG000|Overall Study|Lack of Efficacy|1|||
163158123|NCT02158546|589291766|FG001|Overall Study|Lack of Efficacy|1|||
163158124|NCT02158546|589291767|FG002|Overall Study|Lack of Efficacy|0|||
163158125|NCT02158546|589291768|FG003|Overall Study|Lack of Efficacy|0|||
163158126|NCT02158546|589291765|FG000|Overall Study|Adverse Event|2|||
163158127|NCT02158546|589291766|FG001|Overall Study|Adverse Event|2|||
163158128|NCT02158546|589291767|FG002|Overall Study|Adverse Event|0|||
163158129|NCT02158546|589291768|FG003|Overall Study|Adverse Event|0|||
163158130|NCT02158546|589291765|FG000|Overall Study|Withdrawal by Subject|6|||
163158131|NCT02158546|589291766|FG001|Overall Study|Withdrawal by Subject|2|||
163158132|NCT02158546|589291767|FG002|Overall Study|Withdrawal by Subject|1|||
163158133|NCT02158546|589291768|FG003|Overall Study|Withdrawal by Subject|0|||
163158134|NCT02158546|589291765|FG000|Overall Study|Lost to Follow-up|5|||
163158135|NCT02158546|589291766|FG001|Overall Study|Lost to Follow-up|4|||
163158136|NCT02158546|589291767|FG002|Overall Study|Lost to Follow-up|0|||
163158137|NCT02158546|589291768|FG003|Overall Study|Lost to Follow-up|1|||
163158138|NCT02158546|589291765|FG000|Overall Study|Site Excluded|5|||
163158139|NCT02158546|589291766|FG001|Overall Study|Site Excluded|5|||
162696322|NCT01533714|587599472|FG000|Overall Study|Withdrawal by Subject|0|||
162696323|NCT01533714|587599473|FG001|Overall Study|Withdrawal by Subject|1|||
162696324|NCT01533714|587599474|FG002|Overall Study|Withdrawal by Subject|0|||
162696325|NCT01533714|587599475|FG003|Overall Study|Withdrawal by Subject|1|||
162696326|NCT01533714|587599476|FG004|Overall Study|Withdrawal by Subject|1|||
162696327|NCT01533714|587599477|FG005|Overall Study|Withdrawal by Subject|0|||
162696328|NCT01533714|587599472|FG000|Overall Study|Exclusion criteria|0|||
162696329|NCT01533714|587599473|FG001|Overall Study|Exclusion criteria|1|||
162696330|NCT01533714|587599474|FG002|Overall Study|Exclusion criteria|0|||
162696331|NCT01533714|587599475|FG003|Overall Study|Exclusion criteria|0|||
162696332|NCT01533714|587599476|FG004|Overall Study|Exclusion criteria|0|||
162696333|NCT01533714|587599477|FG005|Overall Study|Exclusion criteria|0|||
162696334|NCT01533714|587599472|FG000|Overall Study|Positive for purified protein derivative|0|||
162696335|NCT01533714|587599473|FG001|Overall Study|Positive for purified protein derivative|0|||
162696336|NCT01533714|587599474|FG002|Overall Study|Positive for purified protein derivative|1|||
163158140|NCT02158546|589291767|FG002|Overall Study|Site Excluded|3|||
163158141|NCT02158546|589291768|FG003|Overall Study|Site Excluded|4|||
163158142|NCT02351817|589291770|FG000|Period 1|Adverse Event|1|||
163158143|NCT02351817|589291771|FG001|Period 1|Adverse Event|2|||
163158144|NCT02351817|589291770|FG000|Period 1|Lack of Efficacy|0|||
163158145|NCT02351817|589291771|FG001|Period 1|Lack of Efficacy|1|||
163158146|NCT02351817|589291770|FG000|Period 2|Adverse Event|0|||
163158147|NCT02351817|589291771|FG001|Period 2|Adverse Event|2|||
163158148|NCT02351817|589291770|FG000|Period 2|Protocol Violation|1|||
163158149|NCT02351817|589291771|FG001|Period 2|Protocol Violation|0|||
163158150|NCT00891904|589291776|FG000|Overall Study|Death|1|||
163158151|NCT00891904|589291776|FG000|Overall Study|Adverse Event|1|||
163158152|NCT01208207|589291777|FG000|Part I|Adverse Event|19|||
163158153|NCT01208207|589291778|FG001|Part I|Adverse Event|2|||
163158154|NCT01208207|589291779|FG002|Part I|Adverse Event|6|||
163158155|NCT01208207|589291780|FG003|Part I|Adverse Event|0|||
163158156|NCT01208207|589291781|FG004|Part I|Adverse Event|0|||
163158157|NCT01208207|589291782|FG005|Part I|Adverse Event|0|||
163158158|NCT01208207|589291783|FG006|Part I|Adverse Event|0|||
163158159|NCT01208207|589291777|FG000|Part I|Lack of Efficacy|21|||
163158160|NCT01208207|589291778|FG001|Part I|Lack of Efficacy|3|||
163158161|NCT01208207|589291779|FG002|Part I|Lack of Efficacy|2|||
163158162|NCT01208207|589291780|FG003|Part I|Lack of Efficacy|0|||
163158163|NCT01208207|589291781|FG004|Part I|Lack of Efficacy|0|||
163158164|NCT01208207|589291782|FG005|Part I|Lack of Efficacy|0|||
163158165|NCT01208207|589291783|FG006|Part I|Lack of Efficacy|0|||
163158166|NCT01208207|589291777|FG000|Part I|Lost to Follow-up|6|||
163158167|NCT01208207|589291778|FG001|Part I|Lost to Follow-up|1|||
163158168|NCT01208207|589291779|FG002|Part I|Lost to Follow-up|0|||
162696337|NCT01533714|587599475|FG003|Overall Study|Positive for purified protein derivative|0|||
163158169|NCT01208207|589291780|FG003|Part I|Lost to Follow-up|0|||
163158170|NCT01208207|589291781|FG004|Part I|Lost to Follow-up|0|||
163158171|NCT01208207|589291782|FG005|Part I|Lost to Follow-up|0|||
163158172|NCT01208207|589291783|FG006|Part I|Lost to Follow-up|0|||
163158173|NCT01208207|589291777|FG000|Part I|Non-Compliance With Study Drug|1|||
163158174|NCT01208207|589291778|FG001|Part I|Non-Compliance With Study Drug|0|||
163158175|NCT01208207|589291779|FG002|Part I|Non-Compliance With Study Drug|1|||
163158176|NCT01208207|589291780|FG003|Part I|Non-Compliance With Study Drug|0|||
163158177|NCT01208207|589291781|FG004|Part I|Non-Compliance With Study Drug|0|||
163158178|NCT01208207|589291782|FG005|Part I|Non-Compliance With Study Drug|0|||
163158179|NCT01208207|589291783|FG006|Part I|Non-Compliance With Study Drug|0|||
163158180|NCT01208207|589291777|FG000|Part I|Physician Decision|0|||
163158181|NCT01208207|589291778|FG001|Part I|Physician Decision|1|||
163158182|NCT01208207|589291779|FG002|Part I|Physician Decision|0|||
163158183|NCT01208207|589291780|FG003|Part I|Physician Decision|0|||
163158184|NCT01208207|589291781|FG004|Part I|Physician Decision|0|||
163158185|NCT01208207|589291782|FG005|Part I|Physician Decision|0|||
163158186|NCT01208207|589291783|FG006|Part I|Physician Decision|0|||
163158187|NCT01208207|589291777|FG000|Part I|Progressive Disease|1|||
163158188|NCT01208207|589291778|FG001|Part I|Progressive Disease|0|||
163158189|NCT01208207|589291779|FG002|Part I|Progressive Disease|0|||
163158190|NCT01208207|589291780|FG003|Part I|Progressive Disease|0|||
163158191|NCT01208207|589291781|FG004|Part I|Progressive Disease|0|||
163158192|NCT01208207|589291782|FG005|Part I|Progressive Disease|0|||
163158193|NCT01208207|589291783|FG006|Part I|Progressive Disease|0|||
163158194|NCT01208207|589291777|FG000|Part I|Protocol Violation|8|||
163158195|NCT01208207|589291778|FG001|Part I|Protocol Violation|0|||
163158196|NCT01208207|589291779|FG002|Part I|Protocol Violation|2|||
163158197|NCT01208207|589291780|FG003|Part I|Protocol Violation|0|||
163158198|NCT01208207|589291781|FG004|Part I|Protocol Violation|0|||
163158199|NCT01208207|589291782|FG005|Part I|Protocol Violation|0|||
163158200|NCT01208207|589291783|FG006|Part I|Protocol Violation|0|||
163158201|NCT01208207|589291777|FG000|Part I|Withdrawal by Subject|14|||
163158202|NCT01208207|589291778|FG001|Part I|Withdrawal by Subject|4|||
163158203|NCT01208207|589291779|FG002|Part I|Withdrawal by Subject|4|||
163158204|NCT01208207|589291780|FG003|Part I|Withdrawal by Subject|0|||
163158205|NCT01208207|589291781|FG004|Part I|Withdrawal by Subject|0|||
163158206|NCT01208207|589291782|FG005|Part I|Withdrawal by Subject|0|||
163158207|NCT01208207|589291783|FG006|Part I|Withdrawal by Subject|0|||
163158208|NCT01208207|589291777|FG000|Part II|Withdrawal by Subject|0|||
163158209|NCT01208207|589291778|FG001|Part II|Withdrawal by Subject|0|||
163158210|NCT01208207|589291779|FG002|Part II|Withdrawal by Subject|0|||
163158211|NCT01208207|589291780|FG003|Part II|Withdrawal by Subject|10|||
163158212|NCT01208207|589291781|FG004|Part II|Withdrawal by Subject|9|||
163158213|NCT01208207|589291782|FG005|Part II|Withdrawal by Subject|3|||
163158214|NCT01208207|589291783|FG006|Part II|Withdrawal by Subject|5|||
163158215|NCT01208207|589291777|FG000|Part II|Adverse Event|0|||
163158216|NCT01208207|589291778|FG001|Part II|Adverse Event|0|||
163158217|NCT01208207|589291779|FG002|Part II|Adverse Event|0|||
163158218|NCT01208207|589291780|FG003|Part II|Adverse Event|5|||
163158219|NCT01208207|589291781|FG004|Part II|Adverse Event|9|||
163158220|NCT01208207|589291782|FG005|Part II|Adverse Event|4|||
163158221|NCT01208207|589291783|FG006|Part II|Adverse Event|2|||
163158222|NCT01208207|589291777|FG000|Part II|Lack of Efficacy|0|||
163158223|NCT01208207|589291778|FG001|Part II|Lack of Efficacy|0|||
163158224|NCT01208207|589291779|FG002|Part II|Lack of Efficacy|0|||
163158225|NCT01208207|589291780|FG003|Part II|Lack of Efficacy|6|||
163158226|NCT01208207|589291781|FG004|Part II|Lack of Efficacy|4|||
163158227|NCT01208207|589291782|FG005|Part II|Lack of Efficacy|3|||
163158228|NCT01208207|589291783|FG006|Part II|Lack of Efficacy|3|||
163158229|NCT01208207|589291777|FG000|Part II|Lost to Follow-up|0|||
163158230|NCT01208207|589291778|FG001|Part II|Lost to Follow-up|0|||
163158231|NCT01208207|589291779|FG002|Part II|Lost to Follow-up|0|||
163158232|NCT01208207|589291780|FG003|Part II|Lost to Follow-up|4|||
163158233|NCT01208207|589291781|FG004|Part II|Lost to Follow-up|0|||
163158234|NCT01208207|589291782|FG005|Part II|Lost to Follow-up|2|||
163158235|NCT01208207|589291783|FG006|Part II|Lost to Follow-up|1|||
163158236|NCT01208207|589291777|FG000|Part II|Non-Compliance With Study Drug|0|||
163158237|NCT01208207|589291778|FG001|Part II|Non-Compliance With Study Drug|0|||
163158238|NCT01208207|589291779|FG002|Part II|Non-Compliance With Study Drug|0|||
163158239|NCT01208207|589291780|FG003|Part II|Non-Compliance With Study Drug|4|||
163158240|NCT01208207|589291781|FG004|Part II|Non-Compliance With Study Drug|1|||
163158241|NCT01208207|589291782|FG005|Part II|Non-Compliance With Study Drug|1|||
163158242|NCT01208207|589291783|FG006|Part II|Non-Compliance With Study Drug|0|||
163158243|NCT01208207|589291777|FG000|Part II|Physician Decision|0|||
163158244|NCT01208207|589291778|FG001|Part II|Physician Decision|0|||
163158245|NCT01208207|589291779|FG002|Part II|Physician Decision|0|||
163158246|NCT01208207|589291780|FG003|Part II|Physician Decision|1|||
163158247|NCT01208207|589291781|FG004|Part II|Physician Decision|0|||
163158248|NCT01208207|589291782|FG005|Part II|Physician Decision|2|||
163158249|NCT01208207|589291783|FG006|Part II|Physician Decision|0|||
163158250|NCT01208207|589291777|FG000|Part II|Protocol Violation|0|||
163158251|NCT01208207|589291778|FG001|Part II|Protocol Violation|0|||
163158252|NCT01208207|589291779|FG002|Part II|Protocol Violation|0|||
163158253|NCT01208207|589291780|FG003|Part II|Protocol Violation|1|||
163158254|NCT01208207|589291781|FG004|Part II|Protocol Violation|0|||
163158255|NCT01208207|589291782|FG005|Part II|Protocol Violation|0|||
163158256|NCT01208207|589291783|FG006|Part II|Protocol Violation|0|||
163158257|NCT01208207|589291777|FG000|Part II|Technical Problems|0|||
163158258|NCT01208207|589291778|FG001|Part II|Technical Problems|0|||
163158259|NCT01208207|589291779|FG002|Part II|Technical Problems|0|||
163158260|NCT01208207|589291780|FG003|Part II|Technical Problems|1|||
163158261|NCT01208207|589291781|FG004|Part II|Technical Problems|0|||
163158262|NCT01208207|589291782|FG005|Part II|Technical Problems|1|||
163158263|NCT01208207|589291783|FG006|Part II|Technical Problems|0|||
163158264|NCT04041414|589291786|FG000|Overall Study|Lost to Follow-up|1|||
163158265|NCT04041414|589291787|FG001|Overall Study|Lost to Follow-up|2|||
163158266|NCT00665652|589291788|FG000|Overall Study|Adverse Event|4|||
163158267|NCT00665652|589291788|FG000|Overall Study|Death|1|||
163158268|NCT00665652|589291788|FG000|Overall Study|No longer met inclusion criteria.|1|||
163158269|NCT01055197|589291799|FG000|Overall Study|Protocol Violation|7|||
163158270|NCT01055197|589291800|FG001|Overall Study|Protocol Violation|2|||
163158271|NCT01055197|589291799|FG000|Overall Study|Withdrawal by Subject|2|||
163158272|NCT01055197|589291800|FG001|Overall Study|Withdrawal by Subject|0|||
163158273|NCT00734539|589291801|FG000|Main Study|Death|33|||
163158274|NCT00734539|589291802|FG001|Main Study|Death|32|||
163158275|NCT00734539|589291801|FG000|Main Study|Physician Decision|2|||
163158276|NCT00734539|589291802|FG001|Main Study|Physician Decision|0|||
163158277|NCT00734539|589291801|FG000|Main Study|Withdrawal by Subject|1|||
163158278|NCT00734539|589291802|FG001|Main Study|Withdrawal by Subject|3|||
163158279|NCT00734539|589291801|FG000|Main Study|Enrolled in error; ineligible|1|||
163158280|NCT00734539|589291802|FG001|Main Study|Enrolled in error; ineligible|0|||
163158281|NCT00830440|589291803|FG000|Overall Study|Protocol Violation|1|||
163158282|NCT00830440|589291804|FG001|Overall Study|Protocol Violation|0|||
163158283|NCT00830440|589291803|FG000|Overall Study|Withdrawal by Subject|1|||
163158284|NCT00830440|589291804|FG001|Overall Study|Withdrawal by Subject|0|||
163158285|NCT00830440|589291803|FG000|Overall Study|unsuccessful procedure|4|||
163158286|NCT00830440|589291804|FG001|Overall Study|unsuccessful procedure|0|||
163158287|NCT00830440|589291803|FG000|Overall Study|Adverse Event|2|||
163158288|NCT00830440|589291804|FG001|Overall Study|Adverse Event|0|||
163158289|NCT01721044|589291805|FG000|Treatment Period|Adverse Event|7|||
163158290|NCT01721044|589291806|FG001|Treatment Period|Adverse Event|7|||
163158291|NCT01721044|589291807|FG002|Treatment Period|Adverse Event|10|||
163158292|NCT01721044|589291805|FG000|Treatment Period|Death|0|||
163158293|NCT01721044|589291806|FG001|Treatment Period|Death|0|||
163158294|NCT01721044|589291807|FG002|Treatment Period|Death|1|||
163158295|NCT01721044|589291805|FG000|Treatment Period|Lack of Efficacy|16|||
163158296|NCT01721044|589291806|FG001|Treatment Period|Lack of Efficacy|4|||
163158297|NCT01721044|589291807|FG002|Treatment Period|Lack of Efficacy|4|||
163158298|NCT01721044|589291805|FG000|Treatment Period|Lost to Follow-up|0|||
163158299|NCT01721044|589291806|FG001|Treatment Period|Lost to Follow-up|0|||
163158300|NCT01721044|589291807|FG002|Treatment Period|Lost to Follow-up|1|||
163158301|NCT01721044|589291805|FG000|Treatment Period|Physician Decision|1|||
163158302|NCT01721044|589291806|FG001|Treatment Period|Physician Decision|0|||
163158303|NCT01721044|589291807|FG002|Treatment Period|Physician Decision|2|||
163158304|NCT01721044|589291805|FG000|Treatment Period|Protocol Violation|1|||
163158305|NCT01721044|589291806|FG001|Treatment Period|Protocol Violation|0|||
163158306|NCT01721044|589291807|FG002|Treatment Period|Protocol Violation|0|||
163158307|NCT01721044|589291805|FG000|Treatment Period|Withdrawal by Subject|7|||
163158308|NCT01721044|589291806|FG001|Treatment Period|Withdrawal by Subject|6|||
163158309|NCT01721044|589291807|FG002|Treatment Period|Withdrawal by Subject|1|||
163158310|NCT02420821|589291818|FG000|Overall Study|Lost to Follow-up|6|||
163158311|NCT02420821|589291819|FG001|Overall Study|Lost to Follow-up|6|||
163158312|NCT02420821|589291818|FG000|Overall Study|Non-compliance|0|||
163158313|NCT02420821|589291819|FG001|Overall Study|Non-compliance|2|||
163158314|NCT02420821|589291818|FG000|Overall Study|Physician Decision|6|||
163158315|NCT02420821|589291819|FG001|Overall Study|Physician Decision|2|||
163158316|NCT02420821|589291818|FG000|Overall Study|Withdrawal by Subject|32|||
163158317|NCT02420821|589291819|FG001|Overall Study|Withdrawal by Subject|25|||
163158318|NCT02420821|589291818|FG000|Overall Study|Death|270|||
163158319|NCT02420821|589291819|FG001|Overall Study|Death|263|||
163158320|NCT02420821|589291818|FG000|Overall Study|Study Terminated By Sponsor|145|||
163158321|NCT02420821|589291819|FG001|Overall Study|Study Terminated By Sponsor|149|||
163158322|NCT02420821|589291818|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
163158323|NCT02420821|589291819|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
163158324|NCT02420821|589291818|FG000|Overall Study|Adverse Event|0|||
163158325|NCT02420821|589291819|FG001|Overall Study|Adverse Event|1|||
163158326|NCT02420821|589291818|FG000|Overall Study|Protinuria|0|||
163158327|NCT02420821|589291819|FG001|Overall Study|Protinuria|1|||
163158328|NCT02420821|589291818|FG000|Overall Study|Progressive Disease|1|||
163158329|NCT02420821|589291819|FG001|Overall Study|Progressive Disease|1|||
163158330|NCT02420821|589291818|FG000|Overall Study|Disease Progression|0|||
163158331|NCT02420821|589291819|FG001|Overall Study|Disease Progression|1|||
163158332|NCT02420821|589291818|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
163158333|NCT02420821|589291819|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
163158334|NCT01318915|589291821|FG000|Overall Study|Lost to Follow-up|1|||
163158335|NCT03987503|589291822|FG000|Overall Study|Lost to Follow-up|20|||
163158336|NCT03987503|589291822|FG000|Overall Study|Withdrawal by Subject|2|||
163158337|NCT01588522|589291836|FG000|Overall Study|Withdrawal by Subject|1|||
163158338|NCT01588522|589291837|FG001|Overall Study|Withdrawal by Subject|5|||
163158339|NCT01588522|589291838|FG002|Overall Study|Withdrawal by Subject|3|||
163158340|NCT01588522|589291839|FG003|Overall Study|Withdrawal by Subject|1|||
163158341|NCT01588522|589291840|FG004|Overall Study|Withdrawal by Subject|2|||
163158342|NCT01588522|589291841|FG005|Overall Study|Withdrawal by Subject|0|||
163158343|NCT01588522|589291836|FG000|Overall Study|Lack of Efficacy|0|||
163158344|NCT01588522|589291837|FG001|Overall Study|Lack of Efficacy|0|||
163158345|NCT01588522|589291838|FG002|Overall Study|Lack of Efficacy|0|||
163158346|NCT01588522|589291839|FG003|Overall Study|Lack of Efficacy|0|||
163158347|NCT01588522|589291840|FG004|Overall Study|Lack of Efficacy|1|||
163158348|NCT01588522|589291841|FG005|Overall Study|Lack of Efficacy|0|||
163158349|NCT01588522|589291836|FG000|Overall Study|Adverse Event|0|||
163158350|NCT01588522|589291837|FG001|Overall Study|Adverse Event|0|||
163158351|NCT01588522|589291838|FG002|Overall Study|Adverse Event|0|||
163158352|NCT01588522|589291839|FG003|Overall Study|Adverse Event|1|||
163158353|NCT01588522|589291840|FG004|Overall Study|Adverse Event|0|||
163158354|NCT01588522|589291841|FG005|Overall Study|Adverse Event|0|||
163158355|NCT01588522|589291836|FG000|Overall Study|Grade 2 alopecia|1|||
163158356|NCT01588522|589291837|FG001|Overall Study|Grade 2 alopecia|0|||
163158357|NCT01588522|589291838|FG002|Overall Study|Grade 2 alopecia|0|||
163158358|NCT01588522|589291839|FG003|Overall Study|Grade 2 alopecia|0|||
163158359|NCT01588522|589291840|FG004|Overall Study|Grade 2 alopecia|0|||
163158360|NCT01588522|589291841|FG005|Overall Study|Grade 2 alopecia|0|||
163158361|NCT01588522|589291836|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
163158362|NCT01588522|589291837|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
163158363|NCT01588522|589291838|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
163158364|NCT01588522|589291839|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
163158365|NCT01588522|589291840|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
163158366|NCT01588522|589291841|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
163158367|NCT01588522|589291836|FG000|Overall Study|Taken off taxane-based regimen|0|||
163158368|NCT01588522|589291837|FG001|Overall Study|Taken off taxane-based regimen|0|||
163158369|NCT01588522|589291838|FG002|Overall Study|Taken off taxane-based regimen|0|||
163158370|NCT01588522|589291839|FG003|Overall Study|Taken off taxane-based regimen|1|||
163158371|NCT01588522|589291840|FG004|Overall Study|Taken off taxane-based regimen|0|||
163158372|NCT01588522|589291841|FG005|Overall Study|Taken off taxane-based regimen|0|||
163158373|NCT01588522|589291836|FG000|Overall Study|Did not initiate chemotherapy|0|||
163158374|NCT01588522|589291837|FG001|Overall Study|Did not initiate chemotherapy|0|||
163158375|NCT01588522|589291838|FG002|Overall Study|Did not initiate chemotherapy|0|||
163158376|NCT01588522|589291839|FG003|Overall Study|Did not initiate chemotherapy|0|||
163158377|NCT01588522|589291840|FG004|Overall Study|Did not initiate chemotherapy|1|||
163158378|NCT01588522|589291841|FG005|Overall Study|Did not initiate chemotherapy|0|||
163158379|NCT02855125|589291846|FG000|Overall Study|Withdrawal by Subject|2|||
163158380|NCT02855125|589291847|FG001|Overall Study|Withdrawal by Subject|2|||
163158381|NCT02855125|589291846|FG000|Overall Study|Clinical Disease Progression|5|||
163158382|NCT02855125|589291847|FG001|Overall Study|Clinical Disease Progression|4|||
163158383|NCT02855125|589291846|FG000|Overall Study|Radiologic Disease Progression|36|||
163158384|NCT02855125|589291847|FG001|Overall Study|Radiologic Disease Progression|39|||
163158385|NCT02855125|589291846|FG000|Overall Study|Adverse Event|11|||
163158386|NCT02855125|589291847|FG001|Overall Study|Adverse Event|7|||
163158387|NCT02855125|589291846|FG000|Overall Study|Physician Decision|1|||
163158388|NCT02855125|589291847|FG001|Overall Study|Physician Decision|0|||
163158389|NCT02855125|589291846|FG000|Overall Study|On Treatment|9|||
163158390|NCT02855125|589291847|FG001|Overall Study|On Treatment|11|||
163158391|NCT02855125|589291846|FG000|Overall Study|Randomized but not treated|0|||
163158392|NCT02855125|589291847|FG001|Overall Study|Randomized but not treated|1|||
163158393|NCT04467905|589291848|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
163158394|NCT04467905|589291849|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
163158395|NCT04467905|589291850|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
163158396|NCT04467905|589291848|FG000|Overall Study|Conversion to SR|0|||
163158397|NCT04467905|589291849|FG001|Overall Study|Conversion to SR|0|||
163158398|NCT04467905|589291850|FG002|Overall Study|Conversion to SR|3|||
163158399|NCT04467905|589291848|FG000|Overall Study|Technical issue with Holter ECG|0|||
163158400|NCT04467905|589291849|FG001|Overall Study|Technical issue with Holter ECG|0|||
163158401|NCT04467905|589291850|FG002|Overall Study|Technical issue with Holter ECG|3|||
163158402|NCT04467905|589291848|FG000|Overall Study|Hemodynamic instability|0|||
163158403|NCT04467905|589291849|FG001|Overall Study|Hemodynamic instability|0|||
163158404|NCT04467905|589291850|FG002|Overall Study|Hemodynamic instability|1|||
163158405|NCT04467905|589291848|FG000|Overall Study|Site misinterpretation of protocol|0|||
163158406|NCT04467905|589291849|FG001|Overall Study|Site misinterpretation of protocol|0|||
163158407|NCT04467905|589291850|FG002|Overall Study|Site misinterpretation of protocol|1|||
163158408|NCT02514083|589291855|FG000|Overall Study|Adverse Event|1|||
163158409|NCT02017405|589291856|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158410|NCT02017405|589291857|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158411|NCT02017405|589291858|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158412|NCT02017405|589291859|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158413|NCT02017405|589291860|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
163158414|NCT02017405|589291861|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
163158415|NCT02017405|589291856|FG000|Open-label Phase|Adverse Event|1|||
163158416|NCT02017405|589291857|FG001|Open-label Phase|Adverse Event|1|||
163158417|NCT02017405|589291858|FG002|Open-label Phase|Adverse Event|0|||
163158418|NCT02017405|589291859|FG003|Open-label Phase|Adverse Event|0|||
163158419|NCT02017405|589291860|FG004|Open-label Phase|Adverse Event|0|||
163158420|NCT02017405|589291861|FG005|Open-label Phase|Adverse Event|0|||
163158421|NCT02202759|589293146|FG000|Overall Study|Study Terminated by Sponsor|3|||
163158422|NCT02202759|589293147|FG001|Overall Study|Study Terminated by Sponsor|3|||
163158423|NCT02202759|589293148|FG002|Overall Study|Study Terminated by Sponsor|3|||
163158424|NCT02202759|589293146|FG000|Overall Study|Withdrawal by Subject|2|||
163158425|NCT02202759|589293147|FG001|Overall Study|Withdrawal by Subject|1|||
163158426|NCT02202759|589293148|FG002|Overall Study|Withdrawal by Subject|1|||
163158427|NCT02202759|589293146|FG000|Overall Study|Reason not Specified|4|||
163158428|NCT02202759|589293147|FG001|Overall Study|Reason not Specified|11|||
163158429|NCT02202759|589293148|FG002|Overall Study|Reason not Specified|10|||
163158430|NCT01590888|589293149|FG000|Overall Study|Adverse Event|3|||
163158431|NCT01590888|589293150|FG001|Overall Study|Adverse Event|0|||
163158432|NCT01590888|589293151|FG002|Overall Study|Adverse Event|1|||
163158433|NCT01590888|589293149|FG000|Overall Study|Lost to Follow-up|1|||
163158434|NCT01590888|589293150|FG001|Overall Study|Lost to Follow-up|0|||
163158435|NCT01590888|589293151|FG002|Overall Study|Lost to Follow-up|0|||
163158436|NCT04953728|589293152|FG000|Overall Study|Withdrawal by Subject|3|||
163158437|NCT04953728|589293152|FG000|Overall Study|Physician Decision|1|||
163158438|NCT01646125|589293153|FG000|Overall Study|Untreated|2|||
163158439|NCT01646125|589293154|FG001|Overall Study|Untreated|5|||
163158440|NCT01646125|589293153|FG000|Overall Study|Adverse Event|2|||
163158441|NCT01646125|589293154|FG001|Overall Study|Adverse Event|1|||
163158442|NCT01646125|589293153|FG000|Overall Study|Death|1|||
163158443|NCT01646125|589293154|FG001|Overall Study|Death|1|||
163158444|NCT01646125|589293153|FG000|Overall Study|Physician Decision|1|||
163158445|NCT01646125|589293154|FG001|Overall Study|Physician Decision|3|||
163158446|NCT01646125|589293153|FG000|Overall Study|Progressive disease|22|||
163158447|NCT01646125|589293154|FG001|Overall Study|Progressive disease|16|||
163158448|NCT01646125|589293153|FG000|Overall Study|Study terminated by sponsor|2|||
163158449|NCT01646125|589293154|FG001|Overall Study|Study terminated by sponsor|1|||
163158450|NCT01646125|589293153|FG000|Overall Study|Subject/Guardian decision|1|||
163158451|NCT01646125|589293154|FG001|Overall Study|Subject/Guardian decision|1|||
163158452|NCT02105662|589293155|FG000|Overall Study|Lost to Follow-up|5|||
163158453|NCT02105662|589293155|FG000|Overall Study|Withdrawal by Subject|1|||
163158454|NCT03349034|589293160|FG000|Overall Study|catheters dislodged during transport|2|||
163158455|NCT03349034|589293161|FG001|Overall Study|catheters dislodged during transport|0|||
163158456|NCT03349034|589293160|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
163158457|NCT03349034|589293161|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
163158458|NCT03349034|589293160|FG000|Overall Study|soft tissue flap used|1|||
163158459|NCT03349034|589293161|FG001|Overall Study|soft tissue flap used|0|||
163158460|NCT03349034|589293160|FG000|Overall Study|Other|0|||
163158461|NCT03349034|589293161|FG001|Overall Study|Other|1|||
163158462|NCT01759446|589293162|FG000|Overall Study|Protocol Violation|1|||
162811644|NCT00585195|588021766|FG011|Overall Study|Other|19|||
163158463|NCT01759446|589293163|FG001|Overall Study|Protocol Violation|0|||
163158464|NCT01759446|589293164|FG002|Overall Study|Protocol Violation|1|||
163158465|NCT01759446|589293165|FG003|Overall Study|Protocol Violation|0|||
163158466|NCT01759446|589293166|FG004|Overall Study|Protocol Violation|0|||
163158467|NCT01759446|589293162|FG000|Overall Study|Withdrawal by Subject|0|||
163158468|NCT01759446|589293163|FG001|Overall Study|Withdrawal by Subject|1|||
163158469|NCT01759446|589293164|FG002|Overall Study|Withdrawal by Subject|0|||
163158470|NCT01759446|589293165|FG003|Overall Study|Withdrawal by Subject|1|||
163158471|NCT01759446|589293166|FG004|Overall Study|Withdrawal by Subject|0|||
163158472|NCT01760733|589293167|FG000|Waiting List|Death|18|||
163158473|NCT01760733|589293167|FG000|Waiting List|Removed from waiting list|41|||
163158474|NCT01760733|589293167|FG000|Waiting List|Not received a transplant yet|13|||
163158475|NCT01760733|589293167|FG000|Transplanted|Not reached 10 years post transplant|184|||
163158476|NCT01760733|589293167|FG000|Transplanted|Death|26|||
163158477|NCT01760733|589293167|FG000|Transplanted|Graft loss|7|||
163158478|NCT00719472|589293170|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
163158479|NCT00719472|589293170|FG000|Enrolled in Study|Subject decision to withdraw|8|||
163158480|NCT00719472|589293170|FG000|Enrolled in Study|Various Reasons|17|||
163158481|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
163158482|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Death|5|||
163158483|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
163158484|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
163158485|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
163158486|NCT00719472|589293170|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
163158487|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
163158488|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Death|6|||
163158489|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Disease progression|3|||
163158490|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
163158491|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
163158492|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
163158493|NCT00719472|589293170|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
163158494|NCT00815659|589293171|FG000|Overall Study|Adverse Event|9|||
163158495|NCT00815659|589293171|FG000|Overall Study|Withdrawal by Subject|9|||
163158496|NCT00815659|589293171|FG000|Overall Study|Lost to Follow-up|4|||
163158497|NCT00815659|589293171|FG000|Overall Study|Protocol Violation|1|||
163158498|NCT03584789|589293175|FG000|Overall Study|refused EHR permission|19|||
163158499|NCT03584789|589293176|FG001|Overall Study|refused EHR permission|28|||
163158500|NCT03584789|589293177|FG002|Overall Study|refused EHR permission|23|||
163158501|NCT03584789|589293175|FG000|Overall Study|patients tied to a provider who retired|0|||
163158502|NCT03584789|589293176|FG001|Overall Study|patients tied to a provider who retired|0|||
163158503|NCT03584789|589293177|FG002|Overall Study|patients tied to a provider who retired|3|||
163158504|NCT04646044|589293179|FG000|Overall Study|Lost to Follow-up|0|||
163158505|NCT04646044|589293180|FG001|Overall Study|Lost to Follow-up|0|||
163158506|NCT04646044|589293181|FG002|Overall Study|Lost to Follow-up|1|||
163158507|NCT04646044|589293182|FG003|Overall Study|Lost to Follow-up|0|||
163158508|NCT04646044|589293179|FG000|Overall Study|Withdrawal by Subject|0|||
163158509|NCT04646044|589293180|FG001|Overall Study|Withdrawal by Subject|1|||
163158510|NCT04646044|589293181|FG002|Overall Study|Withdrawal by Subject|0|||
163158511|NCT04646044|589293182|FG003|Overall Study|Withdrawal by Subject|0|||
163158512|NCT00602472|589293183|FG000|Overall Study|Adverse Event|5|||
163158513|NCT00602472|589293184|FG001|Overall Study|Adverse Event|23|||
163158514|NCT00602472|589293183|FG000|Overall Study|Protocol Violation|4|||
163158515|NCT00602472|589293184|FG001|Overall Study|Protocol Violation|19|||
163158516|NCT00602472|589293183|FG000|Overall Study|Withdrawal by Subject|8|||
163158517|NCT00602472|589293184|FG001|Overall Study|Withdrawal by Subject|14|||
163158518|NCT00602472|589293183|FG000|Overall Study|Other incl. lack of efficacy|4|||
163158519|NCT00602472|589293184|FG001|Overall Study|Other incl. lack of efficacy|2|||
163158520|NCT01908803|589293185|FG000|Overall Study|Adverse Event|1|||
163158521|NCT01908803|589293186|FG001|Overall Study|Adverse Event|0|||
163158522|NCT01908803|589293185|FG000|Overall Study|Physician Decision|0|||
163158523|NCT01908803|589293186|FG001|Overall Study|Physician Decision|1|||
163158524|NCT01908803|589293185|FG000|Overall Study|Withdrawal by Subject|1|||
163158525|NCT01908803|589293186|FG001|Overall Study|Withdrawal by Subject|0|||
163158526|NCT01908803|589293185|FG000|Overall Study|Randomization Error|1|||
163158527|NCT01908803|589293186|FG001|Overall Study|Randomization Error|0|||
163158528|NCT01908803|589293185|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
163158529|NCT01908803|589293186|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
163158530|NCT00742235|589293187|FG000|Overall Study|Lost to Follow-up|0|||
163158531|NCT00742235|589293188|FG001|Overall Study|Lost to Follow-up|31|||
163158532|NCT04730271|589293190|FG000|Overall Study|Adverse Event|0|||
163158533|NCT04730271|589293191|FG001|Overall Study|Adverse Event|2|||
163158534|NCT04730271|589293190|FG000|Overall Study|Withdrawal by Subject|1|||
163158535|NCT04730271|589293191|FG001|Overall Study|Withdrawal by Subject|1|||
163158536|NCT04730271|589293190|FG000|Overall Study|Protocol Violation|7|||
163158537|NCT04730271|589293191|FG001|Overall Study|Protocol Violation|13|||
163158538|NCT04730271|589293190|FG000|Overall Study|Lost to Follow-up|3|||
163158539|NCT04730271|589293191|FG001|Overall Study|Lost to Follow-up|3|||
163158540|NCT04730271|589293190|FG000|Overall Study|Death|1|||
163158541|NCT04730271|589293191|FG001|Overall Study|Death|0|||
163158542|NCT00998296|589293192|FG000|Overall Study|Progressive disease|0|||
163158543|NCT00998296|589293193|FG001|Overall Study|Progressive disease|1|||
163158544|NCT00998296|589293194|FG002|Overall Study|Progressive disease|0|||
163158545|NCT00998296|589293195|FG003|Overall Study|Progressive disease|0|||
163158546|NCT00998296|589293196|FG004|Overall Study|Progressive disease|0|||
163158547|NCT00998296|589293197|FG005|Overall Study|Progressive disease|0|||
163158548|NCT00998296|589293198|FG006|Overall Study|Progressive disease|1|||
163158549|NCT00998296|589293199|FG007|Overall Study|Progressive disease|0|||
163158550|NCT00998296|589293200|FG008|Overall Study|Progressive disease|0|||
163158551|NCT00998296|589293201|FG009|Overall Study|Progressive disease|14|||
163158552|NCT00998296|589293202|FG010|Overall Study|Progressive disease|5|||
163158553|NCT00998296|589293192|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158554|NCT00998296|589293193|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158555|NCT00998296|589293194|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158556|NCT00998296|589293195|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158557|NCT00998296|589293196|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
163158558|NCT00998296|589293197|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158559|NCT00998296|589293198|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158560|NCT00998296|589293199|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
163158561|NCT00998296|589293200|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
163158562|NCT00998296|589293201|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158563|NCT00998296|589293202|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
163158564|NCT00998296|589293192|FG000|Overall Study|Other adverse event|0|||
163158565|NCT00998296|589293193|FG001|Overall Study|Other adverse event|0|||
162811645|NCT00585195|588021767|FG012|Overall Study|Other|24|||
163158566|NCT00998296|589293194|FG002|Overall Study|Other adverse event|0|||
163158567|NCT00998296|589293195|FG003|Overall Study|Other adverse event|0|||
163158568|NCT00998296|589293196|FG004|Overall Study|Other adverse event|1|||
163158569|NCT00998296|589293197|FG005|Overall Study|Other adverse event|0|||
163158570|NCT00998296|589293198|FG006|Overall Study|Other adverse event|0|||
163158571|NCT00998296|589293199|FG007|Overall Study|Other adverse event|0|||
163158572|NCT00998296|589293200|FG008|Overall Study|Other adverse event|0|||
163158573|NCT00998296|589293201|FG009|Overall Study|Other adverse event|1|||
163158574|NCT00998296|589293202|FG010|Overall Study|Other adverse event|2|||
163158575|NCT00998296|589293192|FG000|Overall Study|Refused to continue taking trial med.|0|||
163158576|NCT00998296|589293193|FG001|Overall Study|Refused to continue taking trial med.|0|||
163158577|NCT00998296|589293194|FG002|Overall Study|Refused to continue taking trial med.|0|||
163158578|NCT00998296|589293195|FG003|Overall Study|Refused to continue taking trial med.|0|||
163158579|NCT00998296|589293196|FG004|Overall Study|Refused to continue taking trial med.|0|||
163158580|NCT00998296|589293197|FG005|Overall Study|Refused to continue taking trial med.|0|||
163158581|NCT00998296|589293198|FG006|Overall Study|Refused to continue taking trial med.|0|||
163158582|NCT00998296|589293199|FG007|Overall Study|Refused to continue taking trial med.|0|||
163158583|NCT00998296|589293200|FG008|Overall Study|Refused to continue taking trial med.|0|||
163158584|NCT00998296|589293201|FG009|Overall Study|Refused to continue taking trial med.|2|||
163158585|NCT00998296|589293202|FG010|Overall Study|Refused to continue taking trial med.|0|||
163158586|NCT00998296|589293192|FG000|Overall Study|Reason other than those specified above|0|||
163158587|NCT00998296|589293193|FG001|Overall Study|Reason other than those specified above|0|||
163158588|NCT00998296|589293194|FG002|Overall Study|Reason other than those specified above|0|||
163158589|NCT00998296|589293195|FG003|Overall Study|Reason other than those specified above|0|||
163158590|NCT00998296|589293196|FG004|Overall Study|Reason other than those specified above|0|||
163158591|NCT00998296|589293197|FG005|Overall Study|Reason other than those specified above|0|||
163158592|NCT00998296|589293198|FG006|Overall Study|Reason other than those specified above|0|||
163158593|NCT00998296|589293199|FG007|Overall Study|Reason other than those specified above|0|||
163158594|NCT00998296|589293200|FG008|Overall Study|Reason other than those specified above|0|||
163158595|NCT00998296|589293201|FG009|Overall Study|Reason other than those specified above|1|||
163158596|NCT00998296|589293202|FG010|Overall Study|Reason other than those specified above|0|||
163158597|NCT02346721|589293203|FG000|Overall Study|Withdrew Consent|3|||
163158598|NCT02346721|589293203|FG000|Overall Study|Lack of Efficacy|1|||
163158599|NCT04396639|589293206|FG000|Overall Study|Withdrawal by Subject|1|||
163158600|NCT04396639|589293206|FG000|Overall Study|Other|1|||
163158601|NCT01544335|589293207|FG000|Overall Study|Lost to Follow-up|27|||
163158602|NCT01544335|589293207|FG000|Overall Study|Death|4|||
163158603|NCT01544335|589293207|FG000|Overall Study|Disease progression|3|||
163158604|NCT01544335|589293207|FG000|Overall Study|Baseline Measurements not Available|19|||
163158605|NCT02488915|589293213|FG000|Overall Study|Death|21|||
163158606|NCT02488915|589293213|FG000|Overall Study|Lost to Follow-up|4|||
163158607|NCT02488915|589293213|FG000|Overall Study|Withdrawal by Subject|1|||
163158608|NCT01532986|589293214|FG000|Overall Study|Death|9|||
163158609|NCT01532986|589293215|FG001|Overall Study|Death|9|||
163158610|NCT01532986|589293214|FG000|Overall Study|Withdrawal by Subject|7|||
163158611|NCT01532986|589293215|FG001|Overall Study|Withdrawal by Subject|10|||
163158612|NCT01532986|589293214|FG000|Overall Study|Physician Decision|7|||
163158613|NCT01532986|589293215|FG001|Overall Study|Physician Decision|5|||
163158614|NCT00885170|589293220|FG000|Overall Study|Adverse Event|12|||
163158615|NCT00885170|589293221|FG001|Overall Study|Adverse Event|4|||
163158616|NCT00885170|589293220|FG000|Overall Study|Excessive bone loss|6|||
163158617|NCT00885170|589293221|FG001|Overall Study|Excessive bone loss|3|||
163158618|NCT00885170|589293220|FG000|Overall Study|Lost to Follow-up|2|||
163158619|NCT00885170|589293221|FG001|Overall Study|Lost to Follow-up|1|||
163158620|NCT00885170|589293220|FG000|Overall Study|Physician Decision|2|||
163158621|NCT00885170|589293221|FG001|Overall Study|Physician Decision|1|||
163158622|NCT00885170|589293220|FG000|Overall Study|Protocol Violation|3|||
163158623|NCT00885170|589293221|FG001|Overall Study|Protocol Violation|1|||
163158624|NCT00885170|589293220|FG000|Overall Study|Withdrawal by Subject|13|||
163158625|NCT00885170|589293221|FG001|Overall Study|Withdrawal by Subject|13|||
163158626|NCT03771664|589293222|FG000|Overall Study|Adverse Event|1|||
163158627|NCT03771664|589293223|FG001|Overall Study|Adverse Event|0|||
163158628|NCT03771664|589293222|FG000|Overall Study|Lost to Follow-up|1|||
163158629|NCT03771664|589293223|FG001|Overall Study|Lost to Follow-up|0|||
163158630|NCT03771664|589293222|FG000|Overall Study|Withdrawal by Participant|1|||
163158631|NCT03771664|589293223|FG001|Overall Study|Withdrawal by Participant|4|||
163158632|NCT03771664|589293222|FG000|Overall Study|Randomized but not Treated|0|||
163158633|NCT03771664|589293223|FG001|Overall Study|Randomized but not Treated|1|||
163158634|NCT02120898|589293224|FG000|Overall Study|Withdrawal by Subject|4|||
163158635|NCT02120898|589293225|FG001|Overall Study|Withdrawal by Subject|2|||
163158636|NCT02120898|589293226|FG002|Overall Study|Withdrawal by Subject|2|||
163158637|NCT02120898|589293224|FG000|Overall Study|Non-compliance with study drug|3|||
163158638|NCT02120898|589293225|FG001|Overall Study|Non-compliance with study drug|0|||
163158639|NCT02120898|589293226|FG002|Overall Study|Non-compliance with study drug|0|||
163158640|NCT02120898|589293224|FG000|Overall Study|Adverse Event|1|||
163158641|NCT02120898|589293225|FG001|Overall Study|Adverse Event|2|||
163158642|NCT02120898|589293226|FG002|Overall Study|Adverse Event|1|||
163158643|NCT02120898|589293224|FG000|Overall Study|Protocol Violation|1|||
163158644|NCT02120898|589293225|FG001|Overall Study|Protocol Violation|2|||
163158645|NCT02120898|589293226|FG002|Overall Study|Protocol Violation|0|||
163158646|NCT02120898|589293224|FG000|Overall Study|Lost to Follow-up|0|||
163158647|NCT02120898|589293225|FG001|Overall Study|Lost to Follow-up|0|||
163158648|NCT02120898|589293226|FG002|Overall Study|Lost to Follow-up|1|||
163158649|NCT00561925|589293227|FG000|14 Day Lead-In Period|Adverse Event|38|||
163158650|NCT00561925|589293228|FG001|14 Day Lead-In Period|Adverse Event|0|||
163158651|NCT00561925|589293229|FG002|14 Day Lead-In Period|Adverse Event|0|||
163158652|NCT00561925|589293230|FG003|14 Day Lead-In Period|Adverse Event|0|||
163158653|NCT00561925|589293231|FG004|14 Day Lead-In Period|Adverse Event|0|||
163158654|NCT00561925|589293227|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
163158655|NCT00561925|589293228|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158656|NCT00561925|589293229|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158657|NCT00561925|589293230|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158658|NCT00561925|589293231|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
163158659|NCT00561925|589293227|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
163158660|NCT00561925|589293228|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
163158661|NCT00561925|589293229|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
163158662|NCT00561925|589293230|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
163158663|NCT00561925|589293231|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
163158664|NCT00561925|589293227|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
163158665|NCT00561925|589293228|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158666|NCT00561925|589293229|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158667|NCT00561925|589293230|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158668|NCT00561925|589293231|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
163158669|NCT00561925|589293227|FG000|14 Day Lead-In Period|Other|5|||
163158670|NCT00561925|589293228|FG001|14 Day Lead-In Period|Other|0|||
163158671|NCT00561925|589293229|FG002|14 Day Lead-In Period|Other|0|||
163158672|NCT00561925|589293230|FG003|14 Day Lead-In Period|Other|0|||
163158673|NCT00561925|589293231|FG004|14 Day Lead-In Period|Other|0|||
163158674|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158675|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
163158676|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
163158677|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158678|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
163158679|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158680|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
163158681|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
163158682|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158683|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
163158684|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158685|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
163158686|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
163158687|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158688|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
163158689|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158690|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
163158691|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
163158692|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158693|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
163158694|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158695|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
163158696|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
163158697|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158698|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
163158699|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158700|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
163158701|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
163158702|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158703|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
163158704|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Death|0|||
163158705|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Death|6|||
163158706|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Death|3|||
163158707|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Death|0|||
163158708|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Death|0|||
163158709|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158710|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
163158711|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158712|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158713|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
163158714|NCT00561925|589293227|FG000|144-week Double-blind, Double-dummy|Other|0|||
163158715|NCT00561925|589293228|FG001|144-week Double-blind, Double-dummy|Other|8|||
163158716|NCT00561925|589293229|FG002|144-week Double-blind, Double-dummy|Other|11|||
163158717|NCT00561925|589293230|FG003|144-week Double-blind, Double-dummy|Other|0|||
163158718|NCT00561925|589293231|FG004|144-week Double-blind, Double-dummy|Other|0|||
163158719|NCT00561925|589293227|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
163158720|NCT00561925|589293228|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
163158721|NCT00561925|589293229|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
163158722|NCT00561925|589293230|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
163158723|NCT00561925|589293231|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
163158724|NCT00684021|589293234|FG000|Overall Study|MRI Contraindicated|1|||
163158725|NCT00684021|589293235|FG001|Overall Study|MRI Contraindicated|1|||
163158726|NCT00684021|589293236|FG002|Overall Study|MRI Contraindicated|1|||
163158727|NCT00684021|589293237|FG003|Overall Study|MRI Contraindicated|0|||
163158728|NCT00684021|589293234|FG000|Overall Study|MRI not performed|0|||
163158729|NCT00684021|589293235|FG001|Overall Study|MRI not performed|1|||
163158730|NCT00684021|589293236|FG002|Overall Study|MRI not performed|1|||
163158731|NCT00684021|589293237|FG003|Overall Study|MRI not performed|2|||
163158732|NCT00684021|589293234|FG000|Overall Study|Death|1|||
163158733|NCT00684021|589293235|FG001|Overall Study|Death|0|||
163158734|NCT00684021|589293236|FG002|Overall Study|Death|0|||
163158735|NCT00684021|589293237|FG003|Overall Study|Death|0|||
163158736|NCT01046396|589293238|FG000|Overall Study|Withdrawal by Subject|5|||
163158737|NCT02161016|589293242|FG000|Overall Study|withdrawn by IRB|1|||
163158738|NCT02556177|589293246|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
163158739|NCT02556177|589293247|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
163158740|NCT03818321|589293250|FG000|Overall Study|Withdrawal by Subject|1|||
163158741|NCT03818321|589293251|FG001|Overall Study|Withdrawal by Subject|2|||
163158742|NCT00275509|589293252|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
163158743|NCT00275509|589293253|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
163158744|NCT00380367|589293255|FG000|Overall Study|Lost to Follow-up|1|||
163158745|NCT00380367|589293255|FG000|Overall Study|Withdrawal by Subject|1|||
163158746|NCT01605799|589293256|FG000|Overall Study|Withdrawal by Subject|2|||
163158747|NCT01605799|589293257|FG001|Overall Study|Withdrawal by Subject|1|||
163158748|NCT01457703|589293261|FG000|Overall Study|Screen Failure|5|||
163158749|NCT01457703|589293262|FG001|Overall Study|Screen Failure|7|||
163158750|NCT01457703|589293261|FG000|Overall Study|Withdrawal by Subject|1|||
163158751|NCT01457703|589293262|FG001|Overall Study|Withdrawal by Subject|4|||
163158752|NCT01658436|589293263|FG000|Overall Study|Adverse Event|6|||
163158753|NCT01658436|589293264|FG001|Overall Study|Adverse Event|5|||
163158754|NCT01658436|589293263|FG000|Overall Study|Physician Decision|1|||
163158755|NCT01658436|589293264|FG001|Overall Study|Physician Decision|0|||
163158756|NCT01658436|589293263|FG000|Overall Study|Progressive disease|12|||
163158757|NCT01658436|589293264|FG001|Overall Study|Progressive disease|4|||
163158758|NCT01658436|589293263|FG000|Overall Study|Study terminated by sponsor|0|||
163158759|NCT01658436|589293264|FG001|Overall Study|Study terminated by sponsor|1|||
163158760|NCT01658436|589293263|FG000|Overall Study|Subject/guardian decision|0|||
163158761|NCT01658436|589293264|FG001|Overall Study|Subject/guardian decision|1|||
163158762|NCT01658436|589293263|FG000|Overall Study|Death|1|||
163158763|NCT01658436|589293264|FG001|Overall Study|Death|0|||
163158764|NCT00926237|589293267|FG000|Overall Study|Withdrawal by Subject|2|||
163158765|NCT00926237|589293268|FG001|Overall Study|Withdrawal by Subject|1|||
163158766|NCT00432172|589293273|FG000|Overall Study|Physician Decision|0|||
163158767|NCT00432172|589293274|FG001|Overall Study|Physician Decision|0|||
163158768|NCT00432172|589293275|FG002|Overall Study|Physician Decision|2|||
163158769|NCT00432172|589293276|FG003|Overall Study|Physician Decision|0|||
163158770|NCT00432172|589293273|FG000|Overall Study|Adverse Event|4|||
163158771|NCT00432172|589293274|FG001|Overall Study|Adverse Event|2|||
163158772|NCT00432172|589293275|FG002|Overall Study|Adverse Event|4|||
163158773|NCT00432172|589293276|FG003|Overall Study|Adverse Event|3|||
163158774|NCT00432172|589293273|FG000|Overall Study|Disease progression|0|||
162811646|NCT00585195|588021768|FG013|Overall Study|Other|7|||
163158775|NCT00432172|589293274|FG001|Overall Study|Disease progression|2|||
163158776|NCT00432172|589293275|FG002|Overall Study|Disease progression|5|||
163158777|NCT00432172|589293276|FG003|Overall Study|Disease progression|1|||
163158778|NCT00432172|589293273|FG000|Overall Study|Withdrawal by Subject|0|||
163158779|NCT00432172|589293274|FG001|Overall Study|Withdrawal by Subject|1|||
163158780|NCT00432172|589293275|FG002|Overall Study|Withdrawal by Subject|0|||
163158781|NCT00432172|589293276|FG003|Overall Study|Withdrawal by Subject|2|||
163158782|NCT00432172|589293273|FG000|Overall Study|No treatment received|2|||
163158783|NCT00432172|589293274|FG001|Overall Study|No treatment received|2|||
163158784|NCT00432172|589293275|FG002|Overall Study|No treatment received|0|||
163158785|NCT00432172|589293276|FG003|Overall Study|No treatment received|1|||
163158786|NCT02331277|589294862|FG000|Overall Study|Withdrawal by Subject|1|||
163158787|NCT02331277|589294863|FG001|Overall Study|Withdrawal by Subject|0|||
163158788|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
163158789|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
163158790|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Patient requirement|20|||
163158791|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Death|5|||
163158792|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Change of therapy|6|||
163158793|NCT01071798|589294865|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
163158794|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
163158795|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
163158796|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
163158797|NCT01071798|589294865|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
163158798|NCT04050202|589294872|FG000|Overall Study|Lost to Follow-up|2|||
163158799|NCT01411891|589294879|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
163158800|NCT01411891|589294880|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
163158801|NCT01075685|589294881|FG000|Overall Study|Protocol Violation|9|||
163158802|NCT01075685|589294882|FG001|Overall Study|Protocol Violation|1|||
163158803|NCT01075685|589294881|FG000|Overall Study|Withdrawal by Subject|20|||
163158804|NCT01075685|589294882|FG001|Overall Study|Withdrawal by Subject|5|||
163158805|NCT01075685|589294881|FG000|Overall Study|Lost to Follow-up|563|||
163158806|NCT01075685|589294882|FG001|Overall Study|Lost to Follow-up|220|||
163158807|NCT03196349|589294885|FG000|Overall Study|Did not receive study drug|0|||
163158808|NCT03196349|589294886|FG001|Overall Study|Did not receive study drug|1|||
163158809|NCT03196349|589294887|FG002|Overall Study|Did not receive study drug|2|||
163158810|NCT03196349|589294885|FG000|Overall Study|No data entered|2|||
163158811|NCT03196349|589294886|FG001|Overall Study|No data entered|4|||
163158812|NCT03196349|589294887|FG002|Overall Study|No data entered|0|||
163158813|NCT03196349|589294885|FG000|Overall Study|Study Terminated early|15|||
163158814|NCT03196349|589294886|FG001|Overall Study|Study Terminated early|9|||
163158815|NCT03196349|589294887|FG002|Overall Study|Study Terminated early|11|||
163158816|NCT03388164|589294892|FG000|Overall Study|Withdrawal by Subject|3|||
163158817|NCT03388164|589294893|FG001|Overall Study|Withdrawal by Subject|1|||
163158818|NCT00499083|589294896|FG000|Overall Study|Not evaluable|3|||
163158819|NCT00477386|589294897|FG000|Overall Study|Adverse Event|4|||
163158820|NCT00477386|589294898|FG001|Overall Study|Adverse Event|8|||
163158821|NCT00477386|589294897|FG000|Overall Study|Disease progression, relapse|3|||
163158822|NCT00477386|589294898|FG001|Overall Study|Disease progression, relapse|4|||
163158823|NCT00477386|589294897|FG000|Overall Study|Disease progression, refractory|1|||
163158824|NCT00477386|589294898|FG001|Overall Study|Disease progression, refractory|3|||
163158825|NCT00477386|589294897|FG000|Overall Study|Other|1|||
163158826|NCT00477386|589294898|FG001|Overall Study|Other|2|||
163158827|NCT00477386|589294897|FG000|Overall Study|Physician Decision|1|||
163158828|NCT00477386|589294898|FG001|Overall Study|Physician Decision|0|||
163158829|NCT00477386|589294897|FG000|Overall Study|Withdrawal by Subject|1|||
163158830|NCT00477386|589294898|FG001|Overall Study|Withdrawal by Subject|0|||
163158831|NCT01254422|589294899|FG000|Overall Study|Protocol Violation|1|||
163158832|NCT01254422|589294900|FG001|Overall Study|Protocol Violation|0|||
163158833|NCT01254422|589294899|FG000|Overall Study|Adverse Event|1|||
163158834|NCT01254422|589294900|FG001|Overall Study|Adverse Event|0|||
163158835|NCT01254422|589294899|FG000|Overall Study|Serious adverse event|0|||
163158836|NCT01254422|589294900|FG001|Overall Study|Serious adverse event|1|||
163158837|NCT01254422|589294899|FG000|Overall Study|Lost to Follow-up|1|||
163158838|NCT01254422|589294900|FG001|Overall Study|Lost to Follow-up|0|||
163158839|NCT00643162|589294901|FG000|Overall Study|Withdrawal by Subject|1|||
163158840|NCT00643162|589294902|FG001|Overall Study|Withdrawal by Subject|1|||
163158841|NCT01812252|589294909|FG000|Overall Study|Persistent Disease|1|||
163158842|NCT01812252|589294910|FG001|Overall Study|Persistent Disease|0|||
163158843|NCT01812252|589294909|FG000|Overall Study|Not transplanted|11|||
163158844|NCT01812252|589294910|FG001|Overall Study|Not transplanted|11|||
163158845|NCT01812252|589294909|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
163158846|NCT01812252|589294910|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
163158847|NCT01812252|589294909|FG000|Overall Study|Withdrawal by Subject|1|||
163158848|NCT01812252|589294910|FG001|Overall Study|Withdrawal by Subject|1|||
163158849|NCT01812252|589294909|FG000|Overall Study|Screen Failure|1|||
163158850|NCT01812252|589294910|FG001|Overall Study|Screen Failure|0|||
163158851|NCT03023397|589294911|FG000|Run-In|Failed screening allergen challenge|1|||
163158852|NCT03023397|589294912|FG001|Run-In|Failed screening allergen challenge|0|||
163158853|NCT03023397|589294913|FG002|Run-In|Failed screening allergen challenge|0|||
163158854|NCT03023397|589294911|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
163158855|NCT03023397|589294912|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
163158856|NCT03023397|589294913|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
163158857|NCT01656408|589294914|FG000|Overall Study|Adverse Event|0|||
163158858|NCT01656408|589294915|FG001|Overall Study|Adverse Event|0|||
163158859|NCT01656408|589294916|FG002|Overall Study|Adverse Event|1|||
163158860|NCT01656408|589294917|FG003|Overall Study|Adverse Event|0|||
163158861|NCT01656408|589294918|FG004|Overall Study|Adverse Event|0|||
163158862|NCT01656408|589294919|FG005|Overall Study|Adverse Event|1|||
163158863|NCT01656408|589294920|FG006|Overall Study|Adverse Event|1|||
163158864|NCT01656408|589294921|FG007|Overall Study|Adverse Event|0|||
163158865|NCT01656408|589294922|FG008|Overall Study|Adverse Event|1|||
163158866|NCT01656408|589294923|FG009|Overall Study|Adverse Event|0|||
163158867|NCT01656408|589294914|FG000|Overall Study|Physician Decision|1|||
163158868|NCT01656408|589294915|FG001|Overall Study|Physician Decision|0|||
163158869|NCT01656408|589294916|FG002|Overall Study|Physician Decision|1|||
163158870|NCT01656408|589294917|FG003|Overall Study|Physician Decision|0|||
163158871|NCT01656408|589294918|FG004|Overall Study|Physician Decision|1|||
163158872|NCT01656408|589294919|FG005|Overall Study|Physician Decision|1|||
163158873|NCT01656408|589294920|FG006|Overall Study|Physician Decision|0|||
163158874|NCT01656408|589294921|FG007|Overall Study|Physician Decision|1|||
163158875|NCT01656408|589294922|FG008|Overall Study|Physician Decision|1|||
163158876|NCT01656408|589294923|FG009|Overall Study|Physician Decision|3|||
163158877|NCT00363480|589294924|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
163158878|NCT00363480|589294924|FG000|Overall Study|Adverse Event|4|||
163158879|NCT00363480|589294924|FG000|Overall Study|Lost to Follow-up|5|||
163158880|NCT00363480|589294924|FG000|Overall Study|Withdrawal by Subject|5|||
163158881|NCT00363480|589294924|FG000|Overall Study|Non-compliance of subject|1|||
163158882|NCT00363480|589294924|FG000|Overall Study|Participant discontinued on its own|1|||
163158883|NCT04634253|589294927|FG000|Overall Study|Adverse Event|1|||
163158884|NCT04634253|589294928|FG001|Overall Study|Adverse Event|1|||
163158885|NCT04634253|589294929|FG002|Overall Study|Adverse Event|0|||
163158886|NCT04634253|589294927|FG000|Overall Study|Physician Decision|0|||
163158887|NCT04634253|589294928|FG001|Overall Study|Physician Decision|1|||
163158888|NCT04634253|589294929|FG002|Overall Study|Physician Decision|0|||
163158889|NCT04634253|589294927|FG000|Overall Study|Withdrawal by Subject|1|||
163158890|NCT04634253|589294928|FG001|Overall Study|Withdrawal by Subject|0|||
163158891|NCT04634253|589294929|FG002|Overall Study|Withdrawal by Subject|3|||
163158892|NCT03133793|589294930|FG000|Overall Study|Withdrawal by Subject|0|||
163158893|NCT03133793|589294931|FG001|Overall Study|Withdrawal by Subject|4|||
163158894|NCT03133793|589294932|FG002|Overall Study|Withdrawal by Subject|2|||
163158895|NCT03133793|589294933|FG003|Overall Study|Withdrawal by Subject|4|||
163158896|NCT03133793|589294930|FG000|Overall Study|Lost to Follow-up|1|||
163158897|NCT03133793|589294931|FG001|Overall Study|Lost to Follow-up|0|||
163158898|NCT03133793|589294932|FG002|Overall Study|Lost to Follow-up|2|||
163158899|NCT03133793|589294933|FG003|Overall Study|Lost to Follow-up|0|||
163158900|NCT03133793|589294930|FG000|Overall Study|Death|0|||
163158901|NCT03133793|589294931|FG001|Overall Study|Death|0|||
163158902|NCT03133793|589294932|FG002|Overall Study|Death|0|||
163158903|NCT03133793|589294933|FG003|Overall Study|Death|1|||
163158904|NCT03486834|589294934|FG000|Overall Study|Withdrawal by Subject|46|||
163158905|NCT03486834|589294935|FG001|Overall Study|Withdrawal by Subject|46|||
163158906|NCT03486834|589294936|FG002|Overall Study|Withdrawal by Subject|52|||
163158907|NCT03486834|589294934|FG000|Overall Study|Adverse Event|8|||
163158908|NCT03486834|589294935|FG001|Overall Study|Adverse Event|7|||
163158909|NCT03486834|589294936|FG002|Overall Study|Adverse Event|0|||
163158910|NCT03486834|589294934|FG000|Overall Study|Lost to Follow-up|41|||
163158911|NCT03486834|589294935|FG001|Overall Study|Lost to Follow-up|24|||
163158912|NCT03486834|589294936|FG002|Overall Study|Lost to Follow-up|39|||
163158913|NCT03486834|589294934|FG000|Overall Study|Non-compliance with Study Drug|2|||
163158914|NCT03486834|589294935|FG001|Overall Study|Non-compliance with Study Drug|2|||
163158915|NCT03486834|589294936|FG002|Overall Study|Non-compliance with Study Drug|0|||
163158916|NCT03486834|589294934|FG000|Overall Study|Physician Decision|5|||
163158917|NCT03486834|589294935|FG001|Overall Study|Physician Decision|2|||
163158918|NCT03486834|589294936|FG002|Overall Study|Physician Decision|3|||
163158919|NCT03486834|589294934|FG000|Overall Study|Pregnancy|10|||
163158920|NCT03486834|589294935|FG001|Overall Study|Pregnancy|12|||
163158921|NCT03486834|589294936|FG002|Overall Study|Pregnancy|12|||
163158922|NCT03486834|589294934|FG000|Overall Study|Protocol Deviation|2|||
163158923|NCT03486834|589294935|FG001|Overall Study|Protocol Deviation|3|||
163158924|NCT03486834|589294936|FG002|Overall Study|Protocol Deviation|3|||
163158925|NCT03486834|589294934|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163158926|NCT03486834|589294935|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163158927|NCT03486834|589294936|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163158928|NCT03486834|589294934|FG000|Overall Study|Randomized but not treated|4|||
163158929|NCT03486834|589294935|FG001|Overall Study|Randomized but not treated|4|||
163158930|NCT03486834|589294936|FG002|Overall Study|Randomized but not treated|1|||
163158931|NCT00888940|589294937|FG000|Overall Study|Adverse Event|12|||
163158932|NCT00888940|589294938|FG001|Overall Study|Adverse Event|3|||
163158933|NCT00888940|589294937|FG000|Overall Study|Lost to Follow-up|5|||
163158934|NCT00888940|589294938|FG001|Overall Study|Lost to Follow-up|5|||
163158935|NCT00888940|589294937|FG000|Overall Study|Randomized Not Treated|11|||
163158936|NCT00888940|589294938|FG001|Overall Study|Randomized Not Treated|13|||
163158937|NCT00515619|589294939|FG000|Overall Study|Adverse Event|34|||
163158938|NCT00515619|589294939|FG000|Overall Study|Lack of Efficacy|92|||
163158939|NCT00515619|589294939|FG000|Overall Study|Withdrawal by Subject|66|||
163158940|NCT00515619|589294939|FG000|Overall Study|Protocol Violation|3|||
163158941|NCT00515619|589294939|FG000|Overall Study|Lost to Follow-up|4|||
163158942|NCT00515619|589294939|FG000|Overall Study|Unsatisfactory compliance|6|||
163158943|NCT00515619|589294939|FG000|Overall Study|Other: Site discontinuing trials|2|||
163158944|NCT00515619|589294939|FG000|Overall Study|Other: Subject cannot attend visits|2|||
163158945|NCT00515619|589294939|FG000|Overall Study|Other: Subject required surgery|1|||
163158946|NCT00515619|589294939|FG000|Overall Study|Other: Subject moved to another country|1|||
163158947|NCT00515619|589294939|FG000|Overall Study|Other: Investigator decision|1|||
163158948|NCT00515619|589294939|FG000|Overall Study|Other: Subject became pregnant|1|||
163158949|NCT00515619|589294939|FG000|Overall Study|Other: Request from sponsor|1|||
163158950|NCT00515619|589294939|FG000|Overall Study|Other: Drug available on license|1|||
163158951|NCT00515619|589294939|FG000|Overall Study|Other: Subject interested in other AED|1|||
163158952|NCT02379091|589294940|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163158953|NCT02379091|589294941|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163158954|NCT02379091|589294942|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163158955|NCT02379091|589294943|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163158956|NCT02379091|589294940|FG000|Overall Study|Principal Investigator Discretion|0|||
163158957|NCT02379091|589294941|FG001|Overall Study|Principal Investigator Discretion|1|||
163158958|NCT02379091|589294942|FG002|Overall Study|Principal Investigator Discretion|0|||
163158959|NCT02379091|589294943|FG003|Overall Study|Principal Investigator Discretion|0|||
163158960|NCT02379091|589294940|FG000|Overall Study|Lost to Follow-up|0|||
163158961|NCT02379091|589294941|FG001|Overall Study|Lost to Follow-up|0|||
163158962|NCT02379091|589294942|FG002|Overall Study|Lost to Follow-up|0|||
163158963|NCT02379091|589294943|FG003|Overall Study|Lost to Follow-up|1|||
162696338|NCT01533714|587599476|FG004|Overall Study|Positive for purified protein derivative|1|||
163158964|NCT02379091|589294940|FG000|Overall Study|Voluntary Withdrawal|2|||
163158965|NCT02379091|589294941|FG001|Overall Study|Voluntary Withdrawal|5|||
163158966|NCT02379091|589294942|FG002|Overall Study|Voluntary Withdrawal|2|||
163158967|NCT02379091|589294943|FG003|Overall Study|Voluntary Withdrawal|4|||
163158968|NCT02379091|589294940|FG000|Overall Study|Study Termination|7|||
163158969|NCT02379091|589294941|FG001|Overall Study|Study Termination|2|||
163158970|NCT02379091|589294942|FG002|Overall Study|Study Termination|5|||
163158971|NCT02379091|589294943|FG003|Overall Study|Study Termination|8|||
163158972|NCT02379091|589294940|FG000|Overall Study|Lack of Efficacy|3|||
163158973|NCT02379091|589294941|FG001|Overall Study|Lack of Efficacy|0|||
163158974|NCT02379091|589294942|FG002|Overall Study|Lack of Efficacy|0|||
163158975|NCT02379091|589294943|FG003|Overall Study|Lack of Efficacy|0|||
163158976|NCT03326713|589294945|FG000|Overall Study|Death|2|||
163158977|NCT03326713|589294946|FG001|Overall Study|Death|1|||
163158978|NCT03326713|589294947|FG002|Overall Study|Death|0|||
163158979|NCT03326713|589294945|FG000|Overall Study|Lost to Follow-up|20|||
163158980|NCT03326713|589294946|FG001|Overall Study|Lost to Follow-up|21|||
163158981|NCT03326713|589294947|FG002|Overall Study|Lost to Follow-up|33|||
163158982|NCT03326713|589294945|FG000|Overall Study|Withdrawal by Subject|1|||
163158983|NCT03326713|589294946|FG001|Overall Study|Withdrawal by Subject|2|||
163158984|NCT03326713|589294947|FG002|Overall Study|Withdrawal by Subject|11|||
163158985|NCT03326713|589294945|FG000|Overall Study|Found Ineligible|11|||
163158986|NCT03326713|589294946|FG001|Overall Study|Found Ineligible|11|||
163158987|NCT03326713|589294947|FG002|Overall Study|Found Ineligible|8|||
163158988|NCT00771758|589294948|FG000|Overall Study|Adverse Event|2|||
163158989|NCT00771758|589294949|FG001|Overall Study|Adverse Event|8|||
163158990|NCT00771758|589294950|FG002|Overall Study|Adverse Event|1|||
163158991|NCT00771758|589294948|FG000|Overall Study|Lack of Efficacy|0|||
163158992|NCT00771758|589294949|FG001|Overall Study|Lack of Efficacy|2|||
163158993|NCT00771758|589294950|FG002|Overall Study|Lack of Efficacy|1|||
163158994|NCT00771758|589294948|FG000|Overall Study|Lost to Follow-up|1|||
163158995|NCT00771758|589294949|FG001|Overall Study|Lost to Follow-up|0|||
163158996|NCT00771758|589294950|FG002|Overall Study|Lost to Follow-up|0|||
163158997|NCT00771758|589294948|FG000|Overall Study|Protocol Violation|1|||
163158998|NCT00771758|589294949|FG001|Overall Study|Protocol Violation|0|||
163158999|NCT00771758|589294950|FG002|Overall Study|Protocol Violation|0|||
163159000|NCT00771758|589294948|FG000|Overall Study|Withdrawal by Subject|1|||
163159001|NCT00771758|589294949|FG001|Overall Study|Withdrawal by Subject|0|||
163159002|NCT00771758|589294950|FG002|Overall Study|Withdrawal by Subject|0|||
163159003|NCT00771758|589294948|FG000|Overall Study|Other|3|||
163159004|NCT00771758|589294949|FG001|Overall Study|Other|2|||
163159005|NCT00771758|589294950|FG002|Overall Study|Other|0|||
163159006|NCT03067077|589294951|FG000|Overall Study|Did not receive surgery|4|||
163159007|NCT03067077|589294952|FG001|Overall Study|Did not receive surgery|5|||
163159008|NCT03067077|589294951|FG000|Overall Study|Lost to Follow-up|3|||
163159009|NCT03067077|589294952|FG001|Overall Study|Lost to Follow-up|2|||
163159010|NCT00935584|589294955|FG000|Overall Study|Withdrawal by Subject|9|||
163159011|NCT00935584|589294956|FG001|Overall Study|Withdrawal by Subject|0|||
163159012|NCT00935584|589294955|FG000|Overall Study|Death|3|||
163159013|NCT00935584|589294956|FG001|Overall Study|Death|0|||
163159014|NCT00935584|589294955|FG000|Overall Study|Lost to Follow-up|8|||
163159015|NCT00935584|589294956|FG001|Overall Study|Lost to Follow-up|0|||
163159016|NCT00935584|589294955|FG000|Overall Study|No show|9|||
163159017|NCT00935584|589294956|FG001|Overall Study|No show|0|||
163159018|NCT00935584|589294955|FG000|Overall Study|Relocated|3|||
163159019|NCT00935584|589294956|FG001|Overall Study|Relocated|0|||
163159020|NCT00935584|589294955|FG000|Overall Study|Patient changed provider|3|||
163159021|NCT00935584|589294956|FG001|Overall Study|Patient changed provider|0|||
163159022|NCT00935584|589294955|FG000|Overall Study|Provider dropped out of study|14|||
163159023|NCT00935584|589294956|FG001|Overall Study|Provider dropped out of study|4|||
163159024|NCT00687193|589294957|FG000|Overall Study|Adverse Event|0|||
163159025|NCT00687193|589294958|FG001|Overall Study|Adverse Event|1|||
163159026|NCT00687193|589294959|FG002|Overall Study|Adverse Event|2|||
163159027|NCT00687193|589294960|FG003|Overall Study|Adverse Event|3|||
163159028|NCT00687193|589294961|FG004|Overall Study|Adverse Event|0|||
163159029|NCT00687193|589294962|FG005|Overall Study|Adverse Event|2|||
163159030|NCT00687193|589294957|FG000|Overall Study|Lack of Efficacy|1|||
163159031|NCT00687193|589294958|FG001|Overall Study|Lack of Efficacy|1|||
163159032|NCT00687193|589294959|FG002|Overall Study|Lack of Efficacy|0|||
163159033|NCT00687193|589294960|FG003|Overall Study|Lack of Efficacy|0|||
163159034|NCT00687193|589294961|FG004|Overall Study|Lack of Efficacy|0|||
163159035|NCT00687193|589294962|FG005|Overall Study|Lack of Efficacy|2|||
163159036|NCT00687193|589294957|FG000|Overall Study|Protocol Violation|1|||
163159037|NCT00687193|589294958|FG001|Overall Study|Protocol Violation|2|||
163159038|NCT00687193|589294959|FG002|Overall Study|Protocol Violation|0|||
163159039|NCT00687193|589294960|FG003|Overall Study|Protocol Violation|1|||
163159040|NCT00687193|589294961|FG004|Overall Study|Protocol Violation|2|||
163159041|NCT00687193|589294962|FG005|Overall Study|Protocol Violation|0|||
163159042|NCT02129699|589294963|FG000|Overall Study|Did not start treatment|3|||
163159043|NCT02129699|589294964|FG001|Overall Study|Did not start treatment|2|||
163159044|NCT01394016|589294965|FG000|Overall Study|Progressive Disease|2|||
163159045|NCT01394016|589294966|FG001|Overall Study|Progressive Disease|0|||
163159046|NCT01394016|589294967|FG002|Overall Study|Progressive Disease|0|||
163159047|NCT01394016|589294968|FG003|Overall Study|Progressive Disease|0|||
163159048|NCT01394016|589294969|FG004|Overall Study|Progressive Disease|0|||
163159049|NCT01394016|589294970|FG005|Overall Study|Progressive Disease|0|||
163159050|NCT01394016|589294971|FG006|Overall Study|Progressive Disease|0|||
163159051|NCT01394016|589294972|FG007|Overall Study|Progressive Disease|0|||
163159052|NCT01394016|589294973|FG008|Overall Study|Progressive Disease|0|||
163159053|NCT01394016|589294974|FG009|Overall Study|Progressive Disease|0|||
163159054|NCT01394016|589294975|FG010|Overall Study|Progressive Disease|0|||
163159055|NCT01394016|589294976|FG011|Overall Study|Progressive Disease|0|||
163159056|NCT01394016|589294977|FG012|Overall Study|Progressive Disease|0|||
163159057|NCT01394016|589294978|FG013|Overall Study|Progressive Disease|0|||
163159058|NCT01394016|589294979|FG014|Overall Study|Progressive Disease|0|||
163159059|NCT01394016|589294980|FG015|Overall Study|Progressive Disease|0|||
163159060|NCT01394016|589294981|FG016|Overall Study|Progressive Disease|0|||
163159061|NCT01394016|589294982|FG017|Overall Study|Progressive Disease|0|||
163159062|NCT01394016|589294983|FG018|Overall Study|Progressive Disease|0|||
163159063|NCT01394016|589294965|FG000|Overall Study|Withdrawal by Subject|0|||
163159064|NCT01394016|589294966|FG001|Overall Study|Withdrawal by Subject|0|||
163159065|NCT01394016|589294967|FG002|Overall Study|Withdrawal by Subject|0|||
163159066|NCT01394016|589294968|FG003|Overall Study|Withdrawal by Subject|0|||
163159067|NCT01394016|589294969|FG004|Overall Study|Withdrawal by Subject|0|||
163159068|NCT01394016|589294970|FG005|Overall Study|Withdrawal by Subject|0|||
163159069|NCT01394016|589294971|FG006|Overall Study|Withdrawal by Subject|0|||
163159070|NCT01394016|589294972|FG007|Overall Study|Withdrawal by Subject|1|||
163159071|NCT01394016|589294973|FG008|Overall Study|Withdrawal by Subject|1|||
163159072|NCT01394016|589294974|FG009|Overall Study|Withdrawal by Subject|1|||
163159073|NCT01394016|589294975|FG010|Overall Study|Withdrawal by Subject|4|||
163159074|NCT01394016|589294976|FG011|Overall Study|Withdrawal by Subject|0|||
163159075|NCT01394016|589294977|FG012|Overall Study|Withdrawal by Subject|0|||
163159076|NCT01394016|589294978|FG013|Overall Study|Withdrawal by Subject|3|||
163159077|NCT01394016|589294979|FG014|Overall Study|Withdrawal by Subject|1|||
163159078|NCT01394016|589294980|FG015|Overall Study|Withdrawal by Subject|3|||
163159079|NCT01394016|589294981|FG016|Overall Study|Withdrawal by Subject|1|||
163159080|NCT01394016|589294982|FG017|Overall Study|Withdrawal by Subject|1|||
163159081|NCT01394016|589294983|FG018|Overall Study|Withdrawal by Subject|2|||
163159082|NCT01394016|589294965|FG000|Overall Study|Adverse Event|0|||
163159083|NCT01394016|589294966|FG001|Overall Study|Adverse Event|0|||
163159084|NCT01394016|589294967|FG002|Overall Study|Adverse Event|0|||
163159085|NCT01394016|589294968|FG003|Overall Study|Adverse Event|0|||
163159086|NCT01394016|589294969|FG004|Overall Study|Adverse Event|0|||
163159087|NCT01394016|589294970|FG005|Overall Study|Adverse Event|0|||
163159088|NCT01394016|589294971|FG006|Overall Study|Adverse Event|0|||
163159089|NCT01394016|589294972|FG007|Overall Study|Adverse Event|0|||
163159090|NCT01394016|589294973|FG008|Overall Study|Adverse Event|0|||
163159091|NCT01394016|589294974|FG009|Overall Study|Adverse Event|1|||
163159092|NCT01394016|589294975|FG010|Overall Study|Adverse Event|0|||
163159093|NCT01394016|589294976|FG011|Overall Study|Adverse Event|0|||
163159094|NCT01394016|589294977|FG012|Overall Study|Adverse Event|0|||
163159095|NCT01394016|589294978|FG013|Overall Study|Adverse Event|0|||
163159096|NCT01394016|589294979|FG014|Overall Study|Adverse Event|0|||
163159097|NCT01394016|589294980|FG015|Overall Study|Adverse Event|0|||
163159098|NCT01394016|589294981|FG016|Overall Study|Adverse Event|1|||
163159099|NCT01394016|589294982|FG017|Overall Study|Adverse Event|1|||
163159100|NCT01394016|589294983|FG018|Overall Study|Adverse Event|0|||
163159101|NCT01394016|589294965|FG000|Overall Study|Sponsor Decision|0|||
163159102|NCT01394016|589294966|FG001|Overall Study|Sponsor Decision|0|||
163159103|NCT01394016|589294967|FG002|Overall Study|Sponsor Decision|0|||
163159104|NCT01394016|589294968|FG003|Overall Study|Sponsor Decision|0|||
163159105|NCT01394016|589294969|FG004|Overall Study|Sponsor Decision|0|||
163159106|NCT01394016|589294970|FG005|Overall Study|Sponsor Decision|0|||
163159107|NCT01394016|589294971|FG006|Overall Study|Sponsor Decision|0|||
163159108|NCT01394016|589294972|FG007|Overall Study|Sponsor Decision|0|||
163159109|NCT01394016|589294973|FG008|Overall Study|Sponsor Decision|0|||
163159110|NCT01394016|589294974|FG009|Overall Study|Sponsor Decision|0|||
163159111|NCT01394016|589294975|FG010|Overall Study|Sponsor Decision|0|||
163159112|NCT01394016|589294976|FG011|Overall Study|Sponsor Decision|0|||
163159113|NCT01394016|589294977|FG012|Overall Study|Sponsor Decision|1|||
163159114|NCT01394016|589294978|FG013|Overall Study|Sponsor Decision|0|||
163159115|NCT01394016|589294979|FG014|Overall Study|Sponsor Decision|0|||
163159116|NCT01394016|589294980|FG015|Overall Study|Sponsor Decision|0|||
163159117|NCT01394016|589294981|FG016|Overall Study|Sponsor Decision|0|||
163159118|NCT01394016|589294982|FG017|Overall Study|Sponsor Decision|0|||
163159119|NCT01394016|589294983|FG018|Overall Study|Sponsor Decision|0|||
163159120|NCT01394016|589294965|FG000|Overall Study|Lost to Follow-up|0|||
163159121|NCT01394016|589294966|FG001|Overall Study|Lost to Follow-up|0|||
163159122|NCT01394016|589294967|FG002|Overall Study|Lost to Follow-up|0|||
163159123|NCT01394016|589294968|FG003|Overall Study|Lost to Follow-up|0|||
163159124|NCT01394016|589294969|FG004|Overall Study|Lost to Follow-up|0|||
163159125|NCT01394016|589294970|FG005|Overall Study|Lost to Follow-up|0|||
163159126|NCT01394016|589294971|FG006|Overall Study|Lost to Follow-up|0|||
163159127|NCT01394016|589294972|FG007|Overall Study|Lost to Follow-up|0|||
163159128|NCT01394016|589294973|FG008|Overall Study|Lost to Follow-up|0|||
163159129|NCT01394016|589294974|FG009|Overall Study|Lost to Follow-up|0|||
163159130|NCT01394016|589294975|FG010|Overall Study|Lost to Follow-up|0|||
163159131|NCT01394016|589294976|FG011|Overall Study|Lost to Follow-up|0|||
163159132|NCT01394016|589294977|FG012|Overall Study|Lost to Follow-up|0|||
163159133|NCT01394016|589294978|FG013|Overall Study|Lost to Follow-up|0|||
163159134|NCT01394016|589294979|FG014|Overall Study|Lost to Follow-up|0|||
163159135|NCT01394016|589294980|FG015|Overall Study|Lost to Follow-up|0|||
163159136|NCT01394016|589294981|FG016|Overall Study|Lost to Follow-up|0|||
163159137|NCT01394016|589294982|FG017|Overall Study|Lost to Follow-up|0|||
163159138|NCT01394016|589294983|FG018|Overall Study|Lost to Follow-up|1|||
163159139|NCT03534804|589294984|FG000|Overall Study|Withdrawal by Subject|1|||
163159140|NCT04161157|589294988|FG000|Overall Study|Lost to Follow-up|4|||
163159141|NCT04161157|589294988|FG000|Overall Study|Death|3|||
163159142|NCT04161157|589294988|FG000|Overall Study|Ineligible|2|||
163159143|NCT04161157|589294988|FG000|Overall Study|Withdrawal by Subject|4|||
163159144|NCT02991768|589294997|FG000|Overall Study|Physician Decision|4|||
163159145|NCT05786651|589295000|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
163159146|NCT02273596|589296407|FG000|24-Week Treatment Period|Adverse Event|3|||
163159147|NCT02273596|589296407|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
163159148|NCT02273596|589296407|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
163159149|NCT02273596|589296407|FG000|24-Week Treatment Period|Physician Decision|1|||
163159150|NCT02273596|589296407|FG000|24-Week Treatment Period|Protocol Deviation|1|||
163159151|NCT02273596|589296407|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
163159152|NCT02273596|589296407|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
163159153|NCT02273596|589296407|FG000|Extension Period|Lost to Follow-up|1|||
163159154|NCT02273596|589296407|FG000|Extension Period|Protocol Deviation|1|||
163159155|NCT02139592|589296409|FG000|Overall Study|Case Report Forms Uncollected|8|||
163159156|NCT02873702|589296414|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
163159157|NCT02873702|589296415|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
163159158|NCT02873702|589296416|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
163159159|NCT02873702|589296417|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
163159160|NCT02873702|589296414|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159161|NCT02873702|589296415|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
163159162|NCT02873702|589296416|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159163|NCT02873702|589296417|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
163159164|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159165|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159166|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
163159167|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
163159168|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
163159169|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
163159170|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
163159171|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
163159172|NCT02873702|589296414|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
163159173|NCT02873702|589296415|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
163159174|NCT02873702|589296416|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
163159175|NCT02873702|589296417|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
163159176|NCT01177397|589296418|FG000|Overall Study|Protocol Violation|0|||
163159177|NCT01177397|589296419|FG001|Overall Study|Protocol Violation|0|||
163159178|NCT01177397|589296420|FG002|Overall Study|Protocol Violation|0|||
163159179|NCT01177397|589296421|FG003|Overall Study|Protocol Violation|0|||
163159180|NCT01177397|589296422|FG004|Overall Study|Protocol Violation|0|||
163159181|NCT01177397|589296423|FG005|Overall Study|Protocol Violation|1|||
163159182|NCT01177397|589296424|FG006|Overall Study|Protocol Violation|0|||
163159183|NCT01177397|589296425|FG007|Overall Study|Protocol Violation|0|||
163159184|NCT01177397|589296426|FG008|Overall Study|Protocol Violation|0|||
163159185|NCT01177397|589296427|FG009|Overall Study|Protocol Violation|0|||
163159186|NCT01177397|589296428|FG010|Overall Study|Protocol Violation|0|||
163159187|NCT01177397|589296429|FG011|Overall Study|Protocol Violation|0|||
163159188|NCT01177397|589296418|FG000|Overall Study|Lost to Follow-up|0|||
163159189|NCT01177397|589296419|FG001|Overall Study|Lost to Follow-up|0|||
163159190|NCT01177397|589296420|FG002|Overall Study|Lost to Follow-up|0|||
163159191|NCT01177397|589296421|FG003|Overall Study|Lost to Follow-up|0|||
163159192|NCT01177397|589296422|FG004|Overall Study|Lost to Follow-up|1|||
163159193|NCT01177397|589296423|FG005|Overall Study|Lost to Follow-up|0|||
163159194|NCT01177397|589296424|FG006|Overall Study|Lost to Follow-up|0|||
163159195|NCT01177397|589296425|FG007|Overall Study|Lost to Follow-up|2|||
163159196|NCT01177397|589296426|FG008|Overall Study|Lost to Follow-up|0|||
163159197|NCT01177397|589296427|FG009|Overall Study|Lost to Follow-up|0|||
163159198|NCT01177397|589296428|FG010|Overall Study|Lost to Follow-up|0|||
163159199|NCT01177397|589296429|FG011|Overall Study|Lost to Follow-up|0|||
163159200|NCT01177397|589296418|FG000|Overall Study|Death|0|||
163159201|NCT01177397|589296419|FG001|Overall Study|Death|0|||
163159202|NCT01177397|589296420|FG002|Overall Study|Death|1|||
163159203|NCT01177397|589296421|FG003|Overall Study|Death|1|||
163159204|NCT01177397|589296422|FG004|Overall Study|Death|0|||
163159205|NCT01177397|589296423|FG005|Overall Study|Death|0|||
163159206|NCT01177397|589296424|FG006|Overall Study|Death|0|||
163159207|NCT01177397|589296425|FG007|Overall Study|Death|5|||
163159208|NCT01177397|589296426|FG008|Overall Study|Death|2|||
163159209|NCT01177397|589296427|FG009|Overall Study|Death|1|||
163159210|NCT01177397|589296428|FG010|Overall Study|Death|0|||
163159211|NCT01177397|589296429|FG011|Overall Study|Death|0|||
163159212|NCT01177397|589296418|FG000|Overall Study|Withdrawal by Subject|0|||
163159213|NCT01177397|589296419|FG001|Overall Study|Withdrawal by Subject|0|||
163159214|NCT01177397|589296420|FG002|Overall Study|Withdrawal by Subject|1|||
163159215|NCT01177397|589296421|FG003|Overall Study|Withdrawal by Subject|1|||
163159216|NCT01177397|589296422|FG004|Overall Study|Withdrawal by Subject|1|||
163159217|NCT01177397|589296423|FG005|Overall Study|Withdrawal by Subject|2|||
163159218|NCT01177397|589296424|FG006|Overall Study|Withdrawal by Subject|0|||
163159219|NCT01177397|589296425|FG007|Overall Study|Withdrawal by Subject|5|||
163159220|NCT01177397|589296426|FG008|Overall Study|Withdrawal by Subject|9|||
163159221|NCT01177397|589296427|FG009|Overall Study|Withdrawal by Subject|1|||
163159222|NCT01177397|589296428|FG010|Overall Study|Withdrawal by Subject|1|||
163159223|NCT01177397|589296429|FG011|Overall Study|Withdrawal by Subject|0|||
163159224|NCT01177397|589296418|FG000|Overall Study|Adverse Event|0|||
163159225|NCT01177397|589296419|FG001|Overall Study|Adverse Event|0|||
163159226|NCT01177397|589296420|FG002|Overall Study|Adverse Event|1|||
163159227|NCT01177397|589296421|FG003|Overall Study|Adverse Event|2|||
163159228|NCT01177397|589296422|FG004|Overall Study|Adverse Event|0|||
163159229|NCT01177397|589296423|FG005|Overall Study|Adverse Event|12|||
163159230|NCT01177397|589296424|FG006|Overall Study|Adverse Event|1|||
163159231|NCT01177397|589296425|FG007|Overall Study|Adverse Event|14|||
163159232|NCT01177397|589296426|FG008|Overall Study|Adverse Event|8|||
163159233|NCT01177397|589296427|FG009|Overall Study|Adverse Event|6|||
163159234|NCT01177397|589296428|FG010|Overall Study|Adverse Event|3|||
163159235|NCT01177397|589296429|FG011|Overall Study|Adverse Event|7|||
163159236|NCT01177397|589296418|FG000|Overall Study|Disease progression|1|||
163159237|NCT01177397|589296419|FG001|Overall Study|Disease progression|2|||
163159238|NCT01177397|589296420|FG002|Overall Study|Disease progression|5|||
163159239|NCT01177397|589296421|FG003|Overall Study|Disease progression|5|||
163159240|NCT01177397|589296422|FG004|Overall Study|Disease progression|4|||
163159241|NCT01177397|589296423|FG005|Overall Study|Disease progression|10|||
163159242|NCT01177397|589296424|FG006|Overall Study|Disease progression|10|||
163159243|NCT01177397|589296425|FG007|Overall Study|Disease progression|21|||
163159244|NCT01177397|589296426|FG008|Overall Study|Disease progression|18|||
163159245|NCT01177397|589296427|FG009|Overall Study|Disease progression|12|||
163159246|NCT01177397|589296428|FG010|Overall Study|Disease progression|10|||
163159247|NCT01177397|589296429|FG011|Overall Study|Disease progression|8|||
163159248|NCT01177397|589296418|FG000|Overall Study|Other reasons|0|||
163159249|NCT01177397|589296419|FG001|Overall Study|Other reasons|0|||
163159250|NCT01177397|589296420|FG002|Overall Study|Other reasons|1|||
163159251|NCT01177397|589296421|FG003|Overall Study|Other reasons|0|||
163159252|NCT01177397|589296422|FG004|Overall Study|Other reasons|1|||
163159253|NCT01177397|589296423|FG005|Overall Study|Other reasons|1|||
163159254|NCT01177397|589296424|FG006|Overall Study|Other reasons|2|||
163159255|NCT01177397|589296425|FG007|Overall Study|Other reasons|6|||
163159256|NCT01177397|589296426|FG008|Overall Study|Other reasons|10|||
163159257|NCT01177397|589296427|FG009|Overall Study|Other reasons|8|||
163159258|NCT01177397|589296428|FG010|Overall Study|Other reasons|0|||
163159259|NCT01177397|589296429|FG011|Overall Study|Other reasons|2|||
163159260|NCT01528969|589296430|FG000|Overall Study|absent from the school at baseline|2|||
163159261|NCT01528969|589296431|FG001|Overall Study|absent from the school at baseline|0|||
163159262|NCT03085797|589296432|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
163159263|NCT03085797|589296433|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
163159264|NCT03085797|589296432|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
163159265|NCT03085797|589296433|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
163159266|NCT03085797|589296432|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
163159267|NCT03085797|589296433|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
163159268|NCT01554241|589296436|FG000|Overall Study|Death|3|||
163159269|NCT01554241|589296437|FG001|Overall Study|Death|1|||
163159270|NCT01554241|589296438|FG002|Overall Study|Death|1|||
163159271|NCT01554241|589296439|FG003|Overall Study|Death|0|||
163159272|NCT01554241|589296436|FG000|Overall Study|protocol specified renal stone|0|||
163159273|NCT01554241|589296437|FG001|Overall Study|protocol specified renal stone|0|||
163159274|NCT01554241|589296438|FG002|Overall Study|protocol specified renal stone|0|||
163159275|NCT01554241|589296439|FG003|Overall Study|protocol specified renal stone|1|||
163159276|NCT01554241|589296436|FG000|Overall Study|protocol specified change in eGFR|0|||
163159277|NCT01554241|589296437|FG001|Overall Study|protocol specified change in eGFR|0|||
163159278|NCT01554241|589296438|FG002|Overall Study|protocol specified change in eGFR|1|||
163159279|NCT01554241|589296439|FG003|Overall Study|protocol specified change in eGFR|0|||
163159280|NCT01554241|589296436|FG000|Overall Study|Withdrawal by Subject|0|||
163159281|NCT01554241|589296437|FG001|Overall Study|Withdrawal by Subject|0|||
163159282|NCT01554241|589296438|FG002|Overall Study|Withdrawal by Subject|2|||
163159283|NCT01554241|589296439|FG003|Overall Study|Withdrawal by Subject|0|||
163159284|NCT05661409|589296440|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
163159285|NCT05661409|589296441|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
163159286|NCT05661409|589296442|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
163159287|NCT05661409|589296443|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
163159288|NCT05661409|589296444|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
163159289|NCT05661409|589296445|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
163159290|NCT05661409|589296440|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
163159291|NCT05661409|589296441|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
162811647|NCT00585195|588021769|FG014|Overall Study|Other|11|||
163159292|NCT05661409|589296442|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
163159293|NCT05661409|589296443|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
163159294|NCT05661409|589296444|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
163159295|NCT05661409|589296445|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
163159296|NCT05661409|589296440|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159297|NCT05661409|589296441|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159298|NCT05661409|589296442|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
163159299|NCT05661409|589296443|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
163159300|NCT05661409|589296444|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
163159301|NCT05661409|589296445|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
163159302|NCT05661409|589296440|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159303|NCT05661409|589296441|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159304|NCT05661409|589296442|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159305|NCT05661409|589296443|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159306|NCT05661409|589296444|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
163159307|NCT05661409|589296445|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
163159308|NCT05661409|589296440|FG000|Overall Study|Miscommu-nication about administration|0|||
163159309|NCT05661409|589296441|FG001|Overall Study|Miscommu-nication about administration|0|||
163159310|NCT05661409|589296442|FG002|Overall Study|Miscommu-nication about administration|0|||
163159311|NCT05661409|589296443|FG003|Overall Study|Miscommu-nication about administration|0|||
163159312|NCT05661409|589296444|FG004|Overall Study|Miscommu-nication about administration|0|||
163159313|NCT05661409|589296445|FG005|Overall Study|Miscommu-nication about administration|1|||
163159314|NCT03198507|589296446|FG000|Overall Study|Withdrawal by Subject|1|||
163159315|NCT03198507|589296447|FG001|Overall Study|Withdrawal by Subject|0|||
163159316|NCT00724698|589296448|FG000|Overall Study|Adverse Event|9|||
163159317|NCT00724698|589296448|FG000|Overall Study|Failure of Therapy|4|||
163159318|NCT00724698|589296448|FG000|Overall Study|Poor Compliance|16|||
163159319|NCT00724698|589296448|FG000|Overall Study|Lost to Follow-up|36|||
163159320|NCT00724698|589296448|FG000|Overall Study|No Info|25|||
163159321|NCT04614974|589296449|FG000|Overall Study|Lost to Follow-up|14|||
163159322|NCT04614974|589296450|FG001|Overall Study|Lost to Follow-up|11|||
163159323|NCT00658359|589296452|FG000|Overall Study|Death|3|||
163159324|NCT00658359|589296453|FG001|Overall Study|Death|1|||
163159325|NCT00658359|589296454|FG002|Overall Study|Death|2|||
163159326|NCT00658359|589296452|FG000|Overall Study|Adverse Event|13|||
163159327|NCT00658359|589296453|FG001|Overall Study|Adverse Event|6|||
163159328|NCT00658359|589296454|FG002|Overall Study|Adverse Event|9|||
163159329|NCT00658359|589296452|FG000|Overall Study|Protocol Violation|1|||
163159330|NCT00658359|589296453|FG001|Overall Study|Protocol Violation|0|||
163159331|NCT00658359|589296454|FG002|Overall Study|Protocol Violation|0|||
163159332|NCT00658359|589296452|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
163159333|NCT00658359|589296453|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
163159334|NCT00658359|589296454|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
163159335|NCT00658359|589296452|FG000|Overall Study|Withdrawal by Subject|7|||
163159336|NCT00658359|589296453|FG001|Overall Study|Withdrawal by Subject|4|||
162696339|NCT01533714|587599477|FG005|Overall Study|Positive for purified protein derivative|0|||
162696340|NCT01533714|587599472|FG000|Overall Study|Withdrawal criteria|0|||
162696341|NCT01533714|587599473|FG001|Overall Study|Withdrawal criteria|0|||
162696342|NCT01533714|587599474|FG002|Overall Study|Withdrawal criteria|1|||
162696343|NCT01533714|587599475|FG003|Overall Study|Withdrawal criteria|0|||
162696344|NCT01533714|587599476|FG004|Overall Study|Withdrawal criteria|3|||
162696345|NCT01533714|587599477|FG005|Overall Study|Withdrawal criteria|1|||
162696346|NCT01533714|587599472|FG000|Overall Study|Ineligibility reason|0|||
163159337|NCT00658359|589296454|FG002|Overall Study|Withdrawal by Subject|2|||
163159338|NCT00658359|589296452|FG000|Overall Study|Lost to Follow-up|2|||
163159339|NCT00658359|589296453|FG001|Overall Study|Lost to Follow-up|2|||
163159340|NCT00658359|589296454|FG002|Overall Study|Lost to Follow-up|4|||
163159341|NCT00658359|589296452|FG000|Overall Study|Lack of Efficacy|0|||
163159342|NCT00658359|589296453|FG001|Overall Study|Lack of Efficacy|1|||
163159343|NCT00658359|589296454|FG002|Overall Study|Lack of Efficacy|0|||
163159344|NCT02560558|589296455|FG000|Overall Study|Adverse Event|1|||
163159345|NCT02560558|589296456|FG001|Overall Study|Adverse Event|0|||
163159346|NCT02560558|589296455|FG000|Overall Study|Death|0|||
163159347|NCT02560558|589296456|FG001|Overall Study|Death|2|||
163159348|NCT02560558|589296455|FG000|Overall Study|Lost to Follow-up|0|||
163159349|NCT02560558|589296456|FG001|Overall Study|Lost to Follow-up|4|||
163159350|NCT02560558|589296455|FG000|Overall Study|Protocol Violation|3|||
163159351|NCT02560558|589296456|FG001|Overall Study|Protocol Violation|0|||
163159352|NCT02560558|589296455|FG000|Overall Study|Withdrawal by Subject|3|||
162696347|NCT01533714|587599473|FG001|Overall Study|Ineligibility reason|0|||
162696348|NCT01533714|587599474|FG002|Overall Study|Ineligibility reason|0|||
163159353|NCT02560558|589296456|FG001|Overall Study|Withdrawal by Subject|0|||
163159354|NCT02819804|589296457|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
163159355|NCT02858362|589296458|FG000|Overall Study|Protocol Violation|0|||
163159356|NCT02858362|589296459|FG001|Overall Study|Protocol Violation|1|||
163159357|NCT02858362|589296460|FG002|Overall Study|Protocol Violation|0|||
163159358|NCT02858362|589296458|FG000|Overall Study|Withdrawal by Subject|1|||
163159359|NCT02858362|589296459|FG001|Overall Study|Withdrawal by Subject|0|||
163159360|NCT02858362|589296460|FG002|Overall Study|Withdrawal by Subject|0|||
163159361|NCT02858362|589296458|FG000|Overall Study|Early Study Termination|0|||
163159362|NCT02858362|589296459|FG001|Overall Study|Early Study Termination|0|||
163159363|NCT02858362|589296460|FG002|Overall Study|Early Study Termination|3|||
163159364|NCT02858362|589296458|FG000|Overall Study|Lost to Follow-up|1|||
163159365|NCT02858362|589296459|FG001|Overall Study|Lost to Follow-up|0|||
163159366|NCT02858362|589296460|FG002|Overall Study|Lost to Follow-up|0|||
163159367|NCT03967444|589296461|FG000|Overall Study|Lost to Follow-up|1|||
163159368|NCT03967444|589296462|FG001|Overall Study|Lost to Follow-up|2|||
163159369|NCT01821118|589296468|FG000|Overall Study|Death|0|||
163159370|NCT01821118|589296469|FG001|Overall Study|Death|1|||
163159371|NCT00686686|589296470|FG000|Overall Study|Non-compliance|1|||
163159372|NCT00686686|589296470|FG000|Overall Study|Adverse Event|2|||
163159373|NCT00686686|589296470|FG000|Overall Study|Lost to Follow-up|3|||
163159374|NCT00131248|589296471|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
163159375|NCT00131248|589296472|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
163159376|NCT05038982|589296475|FG000|Overall Study|Withdrawal by Subject|0|||
163159377|NCT05038982|589296476|FG001|Overall Study|Withdrawal by Subject|2|||
163159378|NCT01519921|589296486|FG000|Overall Study|Adverse Event|10|||
163159379|NCT01519921|589296487|FG001|Overall Study|Adverse Event|9|||
163159380|NCT01519921|589296486|FG000|Overall Study|Lack of Efficacy|4|||
163159381|NCT01519921|589296487|FG001|Overall Study|Lack of Efficacy|3|||
163159382|NCT01519921|589296486|FG000|Overall Study|Withdrawal by Subject|3|||
163159383|NCT01519921|589296487|FG001|Overall Study|Withdrawal by Subject|0|||
163159384|NCT01519921|589296486|FG000|Overall Study|Lost to Follow-up|2|||
163159385|NCT01519921|589296487|FG001|Overall Study|Lost to Follow-up|1|||
163159386|NCT01519921|589296486|FG000|Overall Study|Treatment refusal|2|||
163159387|NCT01519921|589296487|FG001|Overall Study|Treatment refusal|1|||
163159388|NCT01519921|589296486|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
163159389|NCT01519921|589296487|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
163159390|NCT04032093|589296490|FG000|Overall Study|Lost to Follow-up|7|||
163159391|NCT04032093|589296491|FG001|Overall Study|Lost to Follow-up|7|||
163159392|NCT04032093|589296492|FG002|Overall Study|Lost to Follow-up|6|||
163159393|NCT04032093|589296493|FG003|Overall Study|Lost to Follow-up|10|||
163159394|NCT04032093|589296494|FG004|Overall Study|Lost to Follow-up|13|||
163159395|NCT04032093|589296495|FG005|Overall Study|Lost to Follow-up|7|||
163159396|NCT04032093|589296496|FG006|Overall Study|Lost to Follow-up|7|||
163159397|NCT04032093|589296497|FG007|Overall Study|Lost to Follow-up|5|||
163159398|NCT04032093|589296498|FG008|Overall Study|Lost to Follow-up|9|||
163159399|NCT04032093|589296499|FG009|Overall Study|Lost to Follow-up|12|||
163159400|NCT04032093|589296490|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159401|NCT04032093|589296491|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159402|NCT04032093|589296492|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159403|NCT04032093|589296493|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
163159404|NCT04032093|589296494|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159405|NCT04032093|589296495|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159406|NCT04032093|589296496|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159407|NCT04032093|589296497|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163159408|NCT04032093|589296498|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159409|NCT04032093|589296499|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
163159410|NCT04032093|589296490|FG000|Overall Study|Other|1|||
163159411|NCT04032093|589296491|FG001|Overall Study|Other|0|||
163159412|NCT04032093|589296492|FG002|Overall Study|Other|0|||
163159413|NCT04032093|589296493|FG003|Overall Study|Other|1|||
163159414|NCT04032093|589296494|FG004|Overall Study|Other|1|||
163159415|NCT04032093|589296495|FG005|Overall Study|Other|0|||
163159416|NCT04032093|589296496|FG006|Overall Study|Other|0|||
163159417|NCT04032093|589296497|FG007|Overall Study|Other|0|||
163159418|NCT04032093|589296498|FG008|Overall Study|Other|0|||
163159419|NCT04032093|589296499|FG009|Overall Study|Other|1|||
163159420|NCT04032093|589296490|FG000|Overall Study|Withdrawal by Subject|1|||
163159421|NCT04032093|589296491|FG001|Overall Study|Withdrawal by Subject|3|||
163159422|NCT04032093|589296492|FG002|Overall Study|Withdrawal by Subject|2|||
163159423|NCT04032093|589296493|FG003|Overall Study|Withdrawal by Subject|2|||
163159424|NCT04032093|589296494|FG004|Overall Study|Withdrawal by Subject|3|||
163159425|NCT04032093|589296495|FG005|Overall Study|Withdrawal by Subject|0|||
163159426|NCT04032093|589296496|FG006|Overall Study|Withdrawal by Subject|0|||
163159427|NCT04032093|589296497|FG007|Overall Study|Withdrawal by Subject|0|||
163159428|NCT04032093|589296498|FG008|Overall Study|Withdrawal by Subject|0|||
163159429|NCT04032093|589296499|FG009|Overall Study|Withdrawal by Subject|0|||
163159430|NCT04032093|589296490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163159431|NCT04032093|589296491|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163159432|NCT04032093|589296492|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163159433|NCT04032093|589296493|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163159434|NCT04032093|589296494|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163159435|NCT04032093|589296495|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163159436|NCT04032093|589296496|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
163159437|NCT04032093|589296497|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
163159438|NCT04032093|589296498|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
163159439|NCT04032093|589296499|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
163159440|NCT04032093|589296490|FG000|Overall Study|Adverse Event|0|||
163159441|NCT04032093|589296491|FG001|Overall Study|Adverse Event|0|||
163159442|NCT04032093|589296492|FG002|Overall Study|Adverse Event|0|||
163159443|NCT04032093|589296493|FG003|Overall Study|Adverse Event|0|||
163159444|NCT04032093|589296494|FG004|Overall Study|Adverse Event|0|||
163159445|NCT04032093|589296495|FG005|Overall Study|Adverse Event|0|||
163159446|NCT04032093|589296496|FG006|Overall Study|Adverse Event|0|||
163159447|NCT04032093|589296497|FG007|Overall Study|Adverse Event|0|||
163159448|NCT04032093|589296498|FG008|Overall Study|Adverse Event|0|||
163159449|NCT04032093|589296499|FG009|Overall Study|Adverse Event|1|||
163159450|NCT04032093|589296490|FG000|Overall Study|Physician Decision|0|||
163159451|NCT04032093|589296491|FG001|Overall Study|Physician Decision|0|||
163159452|NCT04032093|589296492|FG002|Overall Study|Physician Decision|0|||
163159453|NCT04032093|589296493|FG003|Overall Study|Physician Decision|0|||
163159454|NCT04032093|589296494|FG004|Overall Study|Physician Decision|0|||
163159455|NCT04032093|589296495|FG005|Overall Study|Physician Decision|1|||
163159456|NCT04032093|589296496|FG006|Overall Study|Physician Decision|0|||
163159457|NCT04032093|589296497|FG007|Overall Study|Physician Decision|0|||
163159458|NCT04032093|589296498|FG008|Overall Study|Physician Decision|0|||
163159459|NCT04032093|589296499|FG009|Overall Study|Physician Decision|0|||
163159460|NCT02565108|589296502|FG000|Overall Study|Adverse Event|1|||
163159461|NCT02565108|589296503|FG001|Overall Study|Adverse Event|0|||
163159462|NCT02565108|589296502|FG000|Overall Study|Withdrew Consent|1|||
163159463|NCT02565108|589296503|FG001|Overall Study|Withdrew Consent|0|||
163159464|NCT01310075|589296504|FG000|Overall Study|Lost to Follow-up|1|||
163159465|NCT01310075|589296505|FG001|Overall Study|Lost to Follow-up|0|||
163159466|NCT01310075|589296504|FG000|Overall Study|Physician Decision|10|||
163159467|NCT01310075|589296505|FG001|Overall Study|Physician Decision|7|||
163159468|NCT01310075|589296504|FG000|Overall Study|Protocol Violation|2|||
163159469|NCT01310075|589296505|FG001|Overall Study|Protocol Violation|2|||
163159470|NCT01310075|589296504|FG000|Overall Study|Withdrawal by Subject|1|||
163159471|NCT01310075|589296505|FG001|Overall Study|Withdrawal by Subject|1|||
163159472|NCT02745119|589296510|FG000|Overall Study|Adverse Event|1|||
163159473|NCT02745119|589296511|FG001|Overall Study|Adverse Event|0|||
163159474|NCT02745119|589296512|FG002|Overall Study|Adverse Event|1|||
163159475|NCT02745119|589296513|FG003|Overall Study|Adverse Event|3|||
163159476|NCT02745119|589296510|FG000|Overall Study|Death|3|||
163159477|NCT02745119|589296511|FG001|Overall Study|Death|3|||
163159478|NCT02745119|589296512|FG002|Overall Study|Death|0|||
163159479|NCT02745119|589296513|FG003|Overall Study|Death|4|||
163159480|NCT02745119|589296510|FG000|Overall Study|Lost to Follow-up|0|||
163159481|NCT02745119|589296511|FG001|Overall Study|Lost to Follow-up|0|||
163159482|NCT02745119|589296512|FG002|Overall Study|Lost to Follow-up|0|||
163159483|NCT02745119|589296513|FG003|Overall Study|Lost to Follow-up|1|||
163159484|NCT02745119|589296510|FG000|Overall Study|Protocol Deviation|0|||
163159485|NCT02745119|589296511|FG001|Overall Study|Protocol Deviation|0|||
163159486|NCT02745119|589296512|FG002|Overall Study|Protocol Deviation|0|||
163159487|NCT02745119|589296513|FG003|Overall Study|Protocol Deviation|1|||
163159488|NCT02745119|589296510|FG000|Overall Study|Withdrawal by Subject|7|||
163159489|NCT02745119|589296511|FG001|Overall Study|Withdrawal by Subject|15|||
163159490|NCT02745119|589296512|FG002|Overall Study|Withdrawal by Subject|8|||
163159491|NCT02745119|589296513|FG003|Overall Study|Withdrawal by Subject|14|||
163159492|NCT02745119|589296510|FG000|Overall Study|Study Terminated by Sponsor|134|||
163159493|NCT02745119|589296511|FG001|Overall Study|Study Terminated by Sponsor|252|||
163159494|NCT02745119|589296512|FG002|Overall Study|Study Terminated by Sponsor|135|||
163159495|NCT02745119|589296513|FG003|Overall Study|Study Terminated by Sponsor|251|||
163159496|NCT02745119|589296510|FG000|Overall Study|Physician Decision|0|||
163159497|NCT02745119|589296511|FG001|Overall Study|Physician Decision|2|||
163159498|NCT02745119|589296512|FG002|Overall Study|Physician Decision|2|||
163159499|NCT02745119|589296513|FG003|Overall Study|Physician Decision|2|||
163159500|NCT02745119|589296510|FG000|Overall Study|Reason Not Specified|0|||
163159501|NCT02745119|589296511|FG001|Overall Study|Reason Not Specified|2|||
163159502|NCT02745119|589296512|FG002|Overall Study|Reason Not Specified|0|||
163159503|NCT02745119|589296513|FG003|Overall Study|Reason Not Specified|1|||
163159504|NCT01696188|589296514|FG000|Overall Study|Protocol Violation|1|||
163159505|NCT01696188|589296515|FG001|Overall Study|Protocol Violation|1|||
163159506|NCT00960999|589296516|FG000|Overall Study|Withdrawal by Subject|1|||
163159507|NCT00960999|589296517|FG001|Overall Study|Withdrawal by Subject|0|||
163159508|NCT00960999|589296516|FG000|Overall Study|Protocol Violation|5|||
163159509|NCT00960999|589296517|FG001|Overall Study|Protocol Violation|2|||
163159510|NCT00960999|589296516|FG000|Overall Study|RT dose constraints not met|2|||
163159511|NCT00960999|589296517|FG001|Overall Study|RT dose constraints not met|0|||
163159512|NCT02536963|589296518|FG000|Overall Study|Withdrawal by Subject|18|||
163159513|NCT02425943|589296519|FG000|Overall Study|Adverse Event|3|||
163159514|NCT02425943|589296520|FG001|Overall Study|Adverse Event|1|||
163159515|NCT02425943|589296519|FG000|Overall Study|Lost to Follow-up|59|||
163159516|NCT02425943|589296520|FG001|Overall Study|Lost to Follow-up|37|||
163159517|NCT02425943|589296519|FG000|Overall Study|Protocol Violation|4|||
163159518|NCT02425943|589296520|FG001|Overall Study|Protocol Violation|1|||
163159519|NCT02425943|589296519|FG000|Overall Study|Withdrawal by Subject|64|||
163159520|NCT02425943|589296520|FG001|Overall Study|Withdrawal by Subject|31|||
163159521|NCT02425943|589296519|FG000|Overall Study|Other|6|||
163159522|NCT02425943|589296520|FG001|Overall Study|Other|0|||
163159523|NCT02668393|589296521|FG000|Overall Study|Progressive disease|6|||
163159524|NCT02668393|589296522|FG001|Overall Study|Progressive disease|3|||
163159525|NCT02668393|589296521|FG000|Overall Study|Adverse Event|0|||
163159526|NCT02668393|589296522|FG001|Overall Study|Adverse Event|2|||
163159527|NCT02668393|589296521|FG000|Overall Study|Withdrawal from the trial|0|||
163159528|NCT02668393|589296522|FG001|Overall Study|Withdrawal from the trial|1|||
163159529|NCT02668393|589296521|FG000|Overall Study|Lack of benefit and side effects|1|||
163159530|NCT02668393|589296522|FG001|Overall Study|Lack of benefit and side effects|0|||
163159531|NCT02141204|589296523|FG000|Overall Study|Lost to Follow-up|2|||
163159532|NCT02141204|589296524|FG001|Overall Study|Lost to Follow-up|1|||
163159533|NCT02141204|589296523|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
163159534|NCT02141204|589296524|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
163159535|NCT02141204|589296523|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
163159536|NCT02141204|589296524|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
163159537|NCT02141204|589296523|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
163159538|NCT02141204|589296524|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
163159539|NCT01209325|589296527|FG000|Overall Study|Lost to Follow-up|24|||
163159540|NCT01209325|589296527|FG000|Overall Study|Adverse Event|1|||
163159541|NCT01209325|589296527|FG000|Overall Study|Relocated|3|||
163159542|NCT01209325|589296527|FG000|Overall Study|Refusal after starting therapy|8|||
163159543|NCT01209325|589296527|FG000|Overall Study|Protocol Violation|4|||
163159544|NCT01209325|589296527|FG000|Overall Study|Refusal prior to therapy|1|||
163159545|NCT01209325|589296527|FG000|Overall Study|Incarceration|2|||
163159546|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
163159547|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
163159548|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
163159549|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
163159550|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
163159551|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
163159552|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
163159553|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
163159554|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
163159555|NCT00174187|589296528|FG000|Period 1 (up to 3 Years)|Other|0|||
163159556|NCT00174187|589296529|FG001|Period 1 (up to 3 Years)|Other|1|||
163159557|NCT00174187|589296530|FG002|Period 1 (up to 3 Years)|Other|0|||
163159558|NCT00174187|589296528|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
163159559|NCT00174187|589296529|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
163159560|NCT00174187|589296530|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
163159561|NCT00174187|589296528|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
163159562|NCT00174187|589296529|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
163159563|NCT00174187|589296530|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
163159564|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
163159565|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
163159566|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
163159567|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
163159568|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
163159569|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
163159570|NCT00174187|589296528|FG000|Period 2 (After 3 Years)|Other|0|||
163159571|NCT00174187|589296529|FG001|Period 2 (After 3 Years)|Other|0|||
163159572|NCT00174187|589296530|FG002|Period 2 (After 3 Years)|Other|5|||
163159573|NCT01285557|589296531|FG000|Overall Study|Death|173|||
163159574|NCT01285557|589296532|FG001|Overall Study|Death|90|||
163159575|NCT01285557|589296531|FG000|Overall Study|Lost to Follow-up|6|||
163159576|NCT01285557|589296532|FG001|Overall Study|Lost to Follow-up|2|||
163159577|NCT01285557|589296531|FG000|Overall Study|Withdrew Consent|6|||
163159578|NCT01285557|589296532|FG001|Overall Study|Withdrew Consent|1|||
163159579|NCT01285557|589296531|FG000|Overall Study|Sponsor Study Termination|23|||
163159580|NCT01285557|589296532|FG001|Overall Study|Sponsor Study Termination|13|||
163159581|NCT01285557|589296531|FG000|Overall Study|Randomized but not treated|1|||
163159582|NCT01285557|589296532|FG001|Overall Study|Randomized but not treated|1|||
163159583|NCT01285557|589296531|FG000|Overall Study|Study follow-up ongoing|28|||
163159584|NCT01285557|589296532|FG001|Overall Study|Study follow-up ongoing|14|||
163159585|NCT01285557|589296531|FG000|Overall Study|Sponsor Decision|2|||
163159586|NCT01285557|589296532|FG001|Overall Study|Sponsor Decision|1|||
163159587|NCT03529422|589296541|FG000|Overall Study|Withdrawal by Subject|1|||
163159588|NCT03529422|589296541|FG000|Overall Study|Protocol Violation|1|||
163159589|NCT03529422|589296541|FG000|Overall Study|Disease progression|2|||
163159590|NCT02000115|589296542|FG000|Overall Study|Death|56|||
163159591|NCT02000115|589296543|FG001|Overall Study|Death|45|||
163159592|NCT02000115|589296544|FG002|Overall Study|Death|0|||
163159593|NCT02000115|589296545|FG003|Overall Study|Death|0|||
163159594|NCT02000115|589296542|FG000|Overall Study|Missed Visit|6|||
163159595|NCT02000115|589296543|FG001|Overall Study|Missed Visit|8|||
163159596|NCT02000115|589296544|FG002|Overall Study|Missed Visit|1|||
163159597|NCT02000115|589296545|FG003|Overall Study|Missed Visit|0|||
163159598|NCT02000115|589296542|FG000|Overall Study|Protocol Violation|2|||
163159599|NCT02000115|589296543|FG001|Overall Study|Protocol Violation|1|||
163159600|NCT02000115|589296544|FG002|Overall Study|Protocol Violation|0|||
163159601|NCT02000115|589296545|FG003|Overall Study|Protocol Violation|0|||
163159602|NCT02000115|589296542|FG000|Overall Study|Physician Decision|2|||
163159603|NCT02000115|589296543|FG001|Overall Study|Physician Decision|0|||
163159604|NCT02000115|589296544|FG002|Overall Study|Physician Decision|0|||
163159605|NCT02000115|589296545|FG003|Overall Study|Physician Decision|0|||
163159606|NCT02000115|589296542|FG000|Overall Study|Withdrawal by Subject|11|||
163159607|NCT02000115|589296543|FG001|Overall Study|Withdrawal by Subject|11|||
163159608|NCT02000115|589296544|FG002|Overall Study|Withdrawal by Subject|0|||
163159609|NCT02000115|589296545|FG003|Overall Study|Withdrawal by Subject|0|||
163159610|NCT02000115|589296542|FG000|Overall Study|Lost to Follow-up|0|||
163159611|NCT02000115|589296543|FG001|Overall Study|Lost to Follow-up|1|||
163159612|NCT02000115|589296544|FG002|Overall Study|Lost to Follow-up|0|||
163159613|NCT02000115|589296545|FG003|Overall Study|Lost to Follow-up|0|||
163159614|NCT02000115|589296542|FG000|Overall Study|Non-compliance|2|||
163159615|NCT02000115|589296543|FG001|Overall Study|Non-compliance|1|||
163159616|NCT02000115|589296544|FG002|Overall Study|Non-compliance|0|||
163159617|NCT02000115|589296545|FG003|Overall Study|Non-compliance|0|||
163159618|NCT02000115|589296542|FG000|Overall Study|Withdrawn on day of randomization|0|||
163159619|NCT02000115|589296543|FG001|Overall Study|Withdrawn on day of randomization|1|||
163159620|NCT02000115|589296544|FG002|Overall Study|Withdrawn on day of randomization|0|||
163159621|NCT02000115|589296545|FG003|Overall Study|Withdrawn on day of randomization|0|||
163159622|NCT02000115|589296542|FG000|Overall Study|Still on Study|0|||
163159623|NCT02000115|589296543|FG001|Overall Study|Still on Study|0|||
163159624|NCT02000115|589296544|FG002|Overall Study|Still on Study|0|||
163159625|NCT02000115|589296545|FG003|Overall Study|Still on Study|53|||
163159626|NCT02484391|589296548|FG000|Overall Study|Lack of Efficacy|15|||
163159627|NCT02484391|589296549|FG001|Overall Study|Lack of Efficacy|14|||
163159628|NCT02484391|589296550|FG002|Overall Study|Lack of Efficacy|3|||
163159629|NCT02484391|589296548|FG000|Overall Study|Lost to Follow-up|0|||
163159630|NCT02484391|589296549|FG001|Overall Study|Lost to Follow-up|0|||
163159631|NCT02484391|589296550|FG002|Overall Study|Lost to Follow-up|2|||
163159632|NCT02484391|589296548|FG000|Overall Study|Physician Decision|1|||
163159633|NCT02484391|589296549|FG001|Overall Study|Physician Decision|3|||
163159634|NCT02484391|589296550|FG002|Overall Study|Physician Decision|0|||
163159635|NCT02484391|589296548|FG000|Overall Study|Went to Transplant|5|||
163159636|NCT02484391|589296549|FG001|Overall Study|Went to Transplant|3|||
163159637|NCT02484391|589296550|FG002|Overall Study|Went to Transplant|2|||
163159638|NCT04922216|589296551|FG000|Overall Study|Withdrawal by Subject|0|||
163159639|NCT04922216|589296552|FG001|Overall Study|Withdrawal by Subject|1|||
163159640|NCT04922216|589296553|FG002|Overall Study|Withdrawal by Subject|0|||
163159641|NCT04922216|589296554|FG003|Overall Study|Withdrawal by Subject|0|||
163159642|NCT04922216|589296555|FG004|Overall Study|Withdrawal by Subject|0|||
163159643|NCT04922216|589296556|FG005|Overall Study|Withdrawal by Subject|0|||
163159644|NCT04922216|589296557|FG006|Overall Study|Withdrawal by Subject|0|||
163159645|NCT04922216|589296558|FG007|Overall Study|Withdrawal by Subject|2|||
163159646|NCT04922216|589296559|FG008|Overall Study|Withdrawal by Subject|0|||
163159647|NCT04922216|589296560|FG009|Overall Study|Withdrawal by Subject|0|||
163159648|NCT04922216|589296561|FG010|Overall Study|Withdrawal by Subject|0|||
163159649|NCT04922216|589296562|FG011|Overall Study|Withdrawal by Subject|0|||
163159650|NCT04922216|589296563|FG012|Overall Study|Withdrawal by Subject|1|||
163159651|NCT04922216|589296564|FG013|Overall Study|Withdrawal by Subject|1|||
163159652|NCT04922216|589296565|FG014|Overall Study|Withdrawal by Subject|1|||
163159653|NCT04922216|589296566|FG015|Overall Study|Withdrawal by Subject|0|||
163159654|NCT04922216|589296567|FG016|Overall Study|Withdrawal by Subject|0|||
163159655|NCT04922216|589296568|FG017|Overall Study|Withdrawal by Subject|1|||
163159656|NCT04922216|589296569|FG018|Overall Study|Withdrawal by Subject|1|||
163159657|NCT04922216|589296570|FG019|Overall Study|Withdrawal by Subject|1|||
163159658|NCT04922216|589296571|FG020|Overall Study|Withdrawal by Subject|1|||
163159659|NCT04922216|589296572|FG021|Overall Study|Withdrawal by Subject|0|||
163159660|NCT04922216|589296573|FG022|Overall Study|Withdrawal by Subject|0|||
163159661|NCT04922216|589296574|FG023|Overall Study|Withdrawal by Subject|2|||
163159662|NCT04922216|589296575|FG024|Overall Study|Withdrawal by Subject|0|||
163159663|NCT04922216|589296576|FG025|Overall Study|Withdrawal by Subject|0|||
163159664|NCT04922216|589296577|FG026|Overall Study|Withdrawal by Subject|1|||
163159665|NCT04922216|589296578|FG027|Overall Study|Withdrawal by Subject|0|||
163159666|NCT04922216|589296579|FG028|Overall Study|Withdrawal by Subject|0|||
163159667|NCT04922216|589296580|FG029|Overall Study|Withdrawal by Subject|0|||
163159668|NCT04922216|589296581|FG030|Overall Study|Withdrawal by Subject|1|||
163159669|NCT04922216|589296582|FG031|Overall Study|Withdrawal by Subject|0|||
163159670|NCT04922216|589296551|FG000|Overall Study|Lost to Follow-up|1|||
163159671|NCT04922216|589296552|FG001|Overall Study|Lost to Follow-up|0|||
163159672|NCT04922216|589296553|FG002|Overall Study|Lost to Follow-up|2|||
163159673|NCT04922216|589296554|FG003|Overall Study|Lost to Follow-up|0|||
163159674|NCT04922216|589296555|FG004|Overall Study|Lost to Follow-up|0|||
163159675|NCT04922216|589296556|FG005|Overall Study|Lost to Follow-up|2|||
163159676|NCT04922216|589296557|FG006|Overall Study|Lost to Follow-up|0|||
163159677|NCT04922216|589296558|FG007|Overall Study|Lost to Follow-up|1|||
163159678|NCT04922216|589296559|FG008|Overall Study|Lost to Follow-up|1|||
163159679|NCT04922216|589296560|FG009|Overall Study|Lost to Follow-up|2|||
163159680|NCT04922216|589296561|FG010|Overall Study|Lost to Follow-up|2|||
163159681|NCT04922216|589296562|FG011|Overall Study|Lost to Follow-up|1|||
163159682|NCT04922216|589296563|FG012|Overall Study|Lost to Follow-up|1|||
163159683|NCT04922216|589296564|FG013|Overall Study|Lost to Follow-up|0|||
163159684|NCT04922216|589296565|FG014|Overall Study|Lost to Follow-up|1|||
163159685|NCT04922216|589296566|FG015|Overall Study|Lost to Follow-up|0|||
163159686|NCT04922216|589296567|FG016|Overall Study|Lost to Follow-up|0|||
163159687|NCT04922216|589296568|FG017|Overall Study|Lost to Follow-up|2|||
163159688|NCT04922216|589296569|FG018|Overall Study|Lost to Follow-up|1|||
163159689|NCT04922216|589296570|FG019|Overall Study|Lost to Follow-up|0|||
163159690|NCT04922216|589296571|FG020|Overall Study|Lost to Follow-up|1|||
163159691|NCT04922216|589296572|FG021|Overall Study|Lost to Follow-up|0|||
163159692|NCT04922216|589296573|FG022|Overall Study|Lost to Follow-up|2|||
163159693|NCT04922216|589296574|FG023|Overall Study|Lost to Follow-up|1|||
163159694|NCT04922216|589296575|FG024|Overall Study|Lost to Follow-up|0|||
163159695|NCT04922216|589296576|FG025|Overall Study|Lost to Follow-up|2|||
163159696|NCT04922216|589296577|FG026|Overall Study|Lost to Follow-up|0|||
163159697|NCT04922216|589296578|FG027|Overall Study|Lost to Follow-up|0|||
163159698|NCT04922216|589296579|FG028|Overall Study|Lost to Follow-up|1|||
163159699|NCT04922216|589296580|FG029|Overall Study|Lost to Follow-up|0|||
163159700|NCT04922216|589296581|FG030|Overall Study|Lost to Follow-up|2|||
163159701|NCT04922216|589296582|FG031|Overall Study|Lost to Follow-up|1|||
163159702|NCT03278249|589296583|FG000|Overall Study|Withdrawal by Subject|2|||
163159703|NCT03278249|589296583|FG000|Overall Study|Lost to Follow-up|1|||
163159704|NCT01442103|589297986|FG000|Overall Study|Lost to Follow-up|2|||
163159705|NCT03207763|589297992|FG000|Overall Study|Lost to Follow-up|1|||
163159706|NCT03207763|589297993|FG001|Overall Study|Lost to Follow-up|0|||
163159707|NCT02102204|589297994|FG000|Overall Study|Withdrawal by Subject|137|||
163159708|NCT02102204|589297994|FG000|Overall Study|Death|92|||
163159709|NCT02102204|589297994|FG000|Overall Study|Lost to Follow-up|65|||
163159710|NCT02102204|589297994|FG000|Overall Study|Sponsor Decision|5|||
163159711|NCT02102204|589297994|FG000|Overall Study|Ongoing|5|||
163159712|NCT02605122|589297995|FG000|Overall Study|Withdrawal by Subject|4|||
163159713|NCT02605122|589297996|FG001|Overall Study|Withdrawal by Subject|1|||
163159714|NCT02605122|589297995|FG000|Overall Study|Lost to Follow-up|1|||
163159715|NCT02605122|589297996|FG001|Overall Study|Lost to Follow-up|1|||
163159716|NCT00990704|589297997|FG000|Overall Study|Adverse Event|1|||
163159717|NCT00990704|589297998|FG001|Overall Study|Adverse Event|1|||
163159718|NCT00990704|589297997|FG000|Overall Study|Physician Decision|0|||
163159719|NCT00990704|589297998|FG001|Overall Study|Physician Decision|1|||
163159720|NCT00807001|589298000|FG000|Overall Study|Non-compliance|0|||
163159721|NCT00807001|589298001|FG001|Overall Study|Non-compliance|1|||
163159722|NCT00807001|589298002|FG002|Overall Study|Non-compliance|0|||
163159723|NCT00807001|589298003|FG003|Overall Study|Non-compliance|0|||
163159724|NCT00807001|589298004|FG004|Overall Study|Non-compliance|0|||
163159725|NCT01399372|589298006|FG000|Overall Study|Protocol Violation|3|||
163159726|NCT01399372|589298007|FG001|Overall Study|Protocol Violation|1|||
163159727|NCT03773796|589298008|FG000|Overall Study|Adverse Event|1|||
163159728|NCT03773796|589298008|FG000|Overall Study|Withdrawal by Subject|1|||
163159729|NCT03773796|589298008|FG000|Overall Study|Lack of Efficacy|1|||
163159730|NCT03805659|589298010|FG000|Overall Study|Withdrawal by Subject|0|||
163159731|NCT03805659|589298011|FG001|Overall Study|Withdrawal by Subject|1|||
163159732|NCT01027273|589298013|FG000|Overall Study|Lost to Follow-up|57|||
163159733|NCT01027273|589298014|FG001|Overall Study|Lost to Follow-up|31|||
163159734|NCT01027273|589298013|FG000|Overall Study|Death|2|||
163159735|NCT01027273|589298014|FG001|Overall Study|Death|2|||
163159736|NCT00499616|589298022|FG000|Overall Study|Death|1|||
163159737|NCT00499616|589298023|FG001|Overall Study|Death|5|||
163159738|NCT00499616|589298024|FG002|Overall Study|Death|3|||
163159739|NCT00499616|589298025|FG003|Overall Study|Death|1|||
163159740|NCT00499616|589298022|FG000|Overall Study|Lack of Efficacy|5|||
163159741|NCT00499616|589298023|FG001|Overall Study|Lack of Efficacy|0|||
163159742|NCT00499616|589298024|FG002|Overall Study|Lack of Efficacy|19|||
163159743|NCT00499616|589298025|FG003|Overall Study|Lack of Efficacy|0|||
163159744|NCT00499616|589298022|FG000|Overall Study|Lost to Follow-up|0|||
163159745|NCT00499616|589298023|FG001|Overall Study|Lost to Follow-up|0|||
163159746|NCT00499616|589298024|FG002|Overall Study|Lost to Follow-up|1|||
163159747|NCT00499616|589298025|FG003|Overall Study|Lost to Follow-up|0|||
163159748|NCT00499616|589298022|FG000|Overall Study|Physician Decision|6|||
163159749|NCT00499616|589298023|FG001|Overall Study|Physician Decision|16|||
163159750|NCT00499616|589298024|FG002|Overall Study|Physician Decision|9|||
163159751|NCT00499616|589298025|FG003|Overall Study|Physician Decision|0|||
163159752|NCT00499616|589298022|FG000|Overall Study|Withdrawal by Subject|1|||
163159753|NCT00499616|589298023|FG001|Overall Study|Withdrawal by Subject|0|||
163159754|NCT00499616|589298024|FG002|Overall Study|Withdrawal by Subject|1|||
163159755|NCT00499616|589298025|FG003|Overall Study|Withdrawal by Subject|0|||
163159756|NCT00499616|589298022|FG000|Overall Study|Ineligible|1|||
163159757|NCT00499616|589298023|FG001|Overall Study|Ineligible|2|||
163159758|NCT00499616|589298024|FG002|Overall Study|Ineligible|0|||
163159759|NCT00499616|589298025|FG003|Overall Study|Ineligible|15|||
163159760|NCT00499616|589298022|FG000|Overall Study|Not evaluable|0|||
163159761|NCT00499616|589298023|FG001|Overall Study|Not evaluable|0|||
163159762|NCT00499616|589298024|FG002|Overall Study|Not evaluable|0|||
163159763|NCT00499616|589298025|FG003|Overall Study|Not evaluable|41|||
163159764|NCT00499616|589298022|FG000|Overall Study|Patient/Parent Refusal|1|||
163159765|NCT00499616|589298023|FG001|Overall Study|Patient/Parent Refusal|5|||
163159766|NCT00499616|589298024|FG002|Overall Study|Patient/Parent Refusal|3|||
163159767|NCT00499616|589298025|FG003|Overall Study|Patient/Parent Refusal|0|||
163159768|NCT02803580|589298026|FG000|Overall Study|Death|13|||
163159769|NCT02803580|589298026|FG000|Overall Study|Lost to Follow-up|19|||
163159770|NCT02803580|589298026|FG000|Overall Study|Withdrawal by Subject|3|||
163159771|NCT02803580|589298026|FG000|Overall Study|Inclusion in clinical trial|1|||
163159772|NCT01358721|589298027|FG000|Overall Study|Withdrawal by Subject|0|||
163159773|NCT01358721|589298028|FG001|Overall Study|Withdrawal by Subject|0|||
163159774|NCT01358721|589298029|FG002|Overall Study|Withdrawal by Subject|0|||
163159775|NCT01358721|589298030|FG003|Overall Study|Withdrawal by Subject|1|||
163159776|NCT01358721|589298027|FG000|Overall Study|Death|0|||
163159777|NCT01358721|589298028|FG001|Overall Study|Death|2|||
163159778|NCT01358721|589298029|FG002|Overall Study|Death|0|||
163159779|NCT01358721|589298030|FG003|Overall Study|Death|0|||
163159780|NCT01358721|589298027|FG000|Overall Study|Study Drug Toxicity|1|||
163159781|NCT01358721|589298028|FG001|Overall Study|Study Drug Toxicity|3|||
163159782|NCT01358721|589298029|FG002|Overall Study|Study Drug Toxicity|4|||
163159783|NCT01358721|589298030|FG003|Overall Study|Study Drug Toxicity|5|||
163159784|NCT01358721|589298027|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
163159785|NCT01358721|589298028|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
163159786|NCT01358721|589298029|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
163159787|NCT01358721|589298030|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
163159788|NCT01358721|589298027|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163159789|NCT01358721|589298028|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
163159790|NCT01358721|589298029|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
163159791|NCT01358721|589298030|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
163159792|NCT01358721|589298027|FG000|Overall Study|Adverse Event related to study drug|1|||
163159793|NCT01358721|589298028|FG001|Overall Study|Adverse Event related to study drug|0|||
163159794|NCT01358721|589298029|FG002|Overall Study|Adverse Event related to study drug|0|||
163159795|NCT01358721|589298030|FG003|Overall Study|Adverse Event related to study drug|1|||
163159796|NCT01358721|589298027|FG000|Overall Study|Disease Progression|19|||
163159797|NCT01358721|589298028|FG001|Overall Study|Disease Progression|15|||
163159798|NCT01358721|589298029|FG002|Overall Study|Disease Progression|17|||
163159799|NCT01358721|589298030|FG003|Overall Study|Disease Progression|15|||
163159800|NCT01358721|589298027|FG000|Overall Study|Out of State/Unmet Criteria|0|||
163159801|NCT01358721|589298028|FG001|Overall Study|Out of State/Unmet Criteria|0|||
163159802|NCT01358721|589298029|FG002|Overall Study|Out of State/Unmet Criteria|1|||
163159803|NCT01358721|589298030|FG003|Overall Study|Out of State/Unmet Criteria|0|||
163159804|NCT02636595|589298031|FG000|Overall Study|Lost to Follow-up|1|||
163159805|NCT02636595|589298031|FG000|Overall Study|Other|1|||
163159806|NCT02223858|589298032|FG000|Overall Study|Death|1|||
163159807|NCT02223858|589298033|FG001|Overall Study|Death|1|||
163159808|NCT02223858|589298032|FG000|Overall Study|Lost to Follow-up|6|||
163159809|NCT02223858|589298033|FG001|Overall Study|Lost to Follow-up|11|||
163159810|NCT02223858|589298032|FG000|Overall Study|Withdrawal by Subject|8|||
163159811|NCT02223858|589298033|FG001|Overall Study|Withdrawal by Subject|5|||
163159812|NCT02223858|589298032|FG000|Overall Study|Refused|9|||
163159813|NCT02223858|589298033|FG001|Overall Study|Refused|9|||
163159814|NCT00241839|589298035|FG000|Overall Study|Withdrawal by Subject|18|||
163159815|NCT00241839|589298036|FG001|Overall Study|Withdrawal by Subject|17|||
163159816|NCT00241839|589298035|FG000|Overall Study|Adverse Event|1|||
163159817|NCT00241839|589298036|FG001|Overall Study|Adverse Event|1|||
163159818|NCT00831181|589298039|FG000|Overall Study|Adverse Event|12|||
163159819|NCT04313244|589298040|FG000|Overall Study|Withdrawal of Consent|3|||
163159820|NCT04313244|589298041|FG001|Overall Study|Withdrawal of Consent|3|||
163159821|NCT04313244|589298040|FG000|Overall Study|Met Exclusion Criteria|1|||
163159822|NCT04313244|589298041|FG001|Overall Study|Met Exclusion Criteria|0|||
163159823|NCT04313244|589298040|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
163159824|NCT04313244|589298041|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
163159825|NCT02976038|589298042|FG000|Overall Study|Physician Decision|22|||
163159826|NCT02976038|589298042|FG000|Overall Study|Withdrawal by Subject|3|||
163159827|NCT02976038|589298042|FG000|Overall Study|Lost to Follow-up|2|||
163159828|NCT02976038|589298042|FG000|Overall Study|Adverse Event|1|||
163159829|NCT05021978|589298045|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
163159830|NCT05021978|589298046|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159831|NCT05021978|589298047|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159832|NCT05021978|589298048|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
163159833|NCT05021978|589298045|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159834|NCT05021978|589298046|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
163159835|NCT05021978|589298047|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159836|NCT05021978|589298048|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
163159837|NCT00196313|589298049|FG000|Overall Study|Protocol Violation|2|||
163159838|NCT00196313|589298050|FG001|Overall Study|Protocol Violation|3|||
163159839|NCT00196313|589298049|FG000|Overall Study|Withdrawal by Subject|3|||
163159840|NCT00196313|589298050|FG001|Overall Study|Withdrawal by Subject|1|||
163159841|NCT00196313|589298049|FG000|Overall Study|Adverse Event|3|||
163159842|NCT00196313|589298050|FG001|Overall Study|Adverse Event|1|||
163159843|NCT00196313|589298049|FG000|Overall Study|Subject Pregnant|1|||
163159844|NCT00196313|589298050|FG001|Overall Study|Subject Pregnant|1|||
163159845|NCT00196313|589298049|FG000|Overall Study|Lost to Follow-up|2|||
163159846|NCT00196313|589298050|FG001|Overall Study|Lost to Follow-up|2|||
163159847|NCT00043979|589298051|FG000|Period 1|recipient with progressive disease|7|||
163159848|NCT00043979|589298052|FG001|Period 1|recipient with progressive disease|4|||
163159849|NCT00043979|589298053|FG002|Period 1|recipient with progressive disease|3|||
163159850|NCT03096288|589298055|FG000|Overall Study|Withdrawal by Subject|0|||
163159851|NCT03096288|589298056|FG001|Overall Study|Withdrawal by Subject|1|||
163159852|NCT03096288|589298057|FG002|Overall Study|Withdrawal by Subject|0|||
163159853|NCT03096288|589298058|FG003|Overall Study|Withdrawal by Subject|1|||
163159854|NCT00414596|589298060|FG000|Overall Study|Protocol Violation|2|||
163159855|NCT04639258|589298061|FG000|Overall Study|Screen failure|5|||
163159856|NCT04639258|589298061|FG000|Overall Study|Physician Decision|2|||
163159857|NCT04639258|589298061|FG000|Overall Study|Early study termination|3|||
163159858|NCT04639258|589298061|FG000|Overall Study|Withdrawal by Subject|1|||
163159859|NCT01635153|589298063|FG000|Overall Study|Lost to Follow-up|40|||
163159860|NCT01635153|589298064|FG001|Overall Study|Lost to Follow-up|43|||
163159861|NCT02754440|589298065|FG000|Overall Study|Protocol Violation|3|||
163159862|NCT02754440|589298066|FG001|Overall Study|Protocol Violation|2|||
163159863|NCT02754440|589298067|FG002|Overall Study|Protocol Violation|2|||
163159864|NCT02754440|589298068|FG003|Overall Study|Protocol Violation|6|||
163159865|NCT02754440|589298065|FG000|Overall Study|Adverse Event|3|||
163159866|NCT02754440|589298066|FG001|Overall Study|Adverse Event|1|||
163159867|NCT02754440|589298067|FG002|Overall Study|Adverse Event|0|||
163159868|NCT02754440|589298068|FG003|Overall Study|Adverse Event|9|||
163159869|NCT02754440|589298065|FG000|Overall Study|Withdrawal by Subject|0|||
163159870|NCT02754440|589298066|FG001|Overall Study|Withdrawal by Subject|0|||
163159871|NCT02754440|589298067|FG002|Overall Study|Withdrawal by Subject|0|||
163159872|NCT02754440|589298068|FG003|Overall Study|Withdrawal by Subject|1|||
163159873|NCT02754440|589298065|FG000|Overall Study|Equipment failure|0|||
163159874|NCT02754440|589298066|FG001|Overall Study|Equipment failure|5|||
163159875|NCT02754440|589298067|FG002|Overall Study|Equipment failure|5|||
163159876|NCT02754440|589298068|FG003|Overall Study|Equipment failure|7|||
163159877|NCT02754440|589298065|FG000|Overall Study|Subject issues not resulting in AE|0|||
163159878|NCT02754440|589298066|FG001|Overall Study|Subject issues not resulting in AE|0|||
163159879|NCT02754440|589298067|FG002|Overall Study|Subject issues not resulting in AE|0|||
163159880|NCT02754440|589298068|FG003|Overall Study|Subject issues not resulting in AE|12|||
163159881|NCT01189032|589298073|FG000|Overall Study|Adverse Event|1|||
163159882|NCT01189032|589298074|FG001|Overall Study|Adverse Event|3|||
163159883|NCT01189032|589298075|FG002|Overall Study|Adverse Event|4|||
163159884|NCT01189032|589298073|FG000|Overall Study|Lack of Efficacy|2|||
163159885|NCT01189032|589298074|FG001|Overall Study|Lack of Efficacy|3|||
163159886|NCT01189032|589298075|FG002|Overall Study|Lack of Efficacy|0|||
163159887|NCT01189032|589298073|FG000|Overall Study|Withdrawal by Subject|1|||
163159888|NCT01189032|589298074|FG001|Overall Study|Withdrawal by Subject|0|||
163159889|NCT01189032|589298075|FG002|Overall Study|Withdrawal by Subject|1|||
163159890|NCT01189032|589298073|FG000|Overall Study|Protocol Violation|1|||
163159891|NCT01189032|589298074|FG001|Overall Study|Protocol Violation|1|||
163159892|NCT01189032|589298075|FG002|Overall Study|Protocol Violation|1|||
163159893|NCT01995838|589298080|FG000|Overall Study|Lost to Follow-up|0|||
163159894|NCT01995838|589298081|FG001|Overall Study|Lost to Follow-up|1|||
163159895|NCT01995838|589298082|FG002|Overall Study|Lost to Follow-up|0|||
163159896|NCT01995838|589298083|FG003|Overall Study|Lost to Follow-up|0|||
163159897|NCT01995838|589298084|FG004|Overall Study|Lost to Follow-up|0|||
163159898|NCT01995838|589298085|FG005|Overall Study|Lost to Follow-up|0|||
163159899|NCT01995838|589298086|FG006|Overall Study|Lost to Follow-up|1|||
163159900|NCT01995838|589298080|FG000|Overall Study|Participant choice|2|||
163159901|NCT01995838|589298081|FG001|Overall Study|Participant choice|0|||
163159902|NCT01995838|589298082|FG002|Overall Study|Participant choice|0|||
163159903|NCT01995838|589298083|FG003|Overall Study|Participant choice|0|||
163159904|NCT01995838|589298084|FG004|Overall Study|Participant choice|0|||
163159905|NCT01995838|589298085|FG005|Overall Study|Participant choice|1|||
163159906|NCT01995838|589298086|FG006|Overall Study|Participant choice|1|||
163159907|NCT01995838|589298080|FG000|Overall Study|Adverse Event|0|||
163159908|NCT01995838|589298081|FG001|Overall Study|Adverse Event|0|||
163159909|NCT01995838|589298082|FG002|Overall Study|Adverse Event|0|||
163159910|NCT01995838|589298083|FG003|Overall Study|Adverse Event|0|||
163159911|NCT01995838|589298084|FG004|Overall Study|Adverse Event|0|||
163159912|NCT01995838|589298085|FG005|Overall Study|Adverse Event|0|||
163159913|NCT01995838|589298086|FG006|Overall Study|Adverse Event|1|||
163159914|NCT01995838|589298080|FG000|Overall Study|Withdrawal by Subject|0|||
163159915|NCT01995838|589298081|FG001|Overall Study|Withdrawal by Subject|0|||
163159916|NCT01995838|589298082|FG002|Overall Study|Withdrawal by Subject|0|||
163159917|NCT01995838|589298083|FG003|Overall Study|Withdrawal by Subject|0|||
163159918|NCT01995838|589298084|FG004|Overall Study|Withdrawal by Subject|1|||
163159919|NCT01995838|589298085|FG005|Overall Study|Withdrawal by Subject|0|||
163159920|NCT01995838|589298086|FG006|Overall Study|Withdrawal by Subject|0|||
163159921|NCT01995838|589298080|FG000|Overall Study|Other|3|||
163159922|NCT01995838|589298081|FG001|Overall Study|Other|1|||
163159923|NCT01995838|589298082|FG002|Overall Study|Other|0|||
163159924|NCT01995838|589298083|FG003|Overall Study|Other|2|||
163159925|NCT01995838|589298084|FG004|Overall Study|Other|1|||
163159926|NCT01995838|589298085|FG005|Overall Study|Other|1|||
163159927|NCT01995838|589298086|FG006|Overall Study|Other|2|||
163159928|NCT01967576|589298087|FG000|Overall Study|Withdrawal by Subject|3|||
163159929|NCT01967576|589298087|FG000|Overall Study|Progressed/Removed from treatment|1|||
163159930|NCT01967576|589298087|FG000|Overall Study|Study closing at site|1|||
163159931|NCT01967576|589298087|FG000|Overall Study|Adverse Event|1|||
163159932|NCT01967576|589298087|FG000|Overall Study|Refused further treatment|1|||
163159933|NCT00345358|589298088|FG000|Primary Vaccination Phase|Other|0|||
163159934|NCT00345358|589298089|FG001|Primary Vaccination Phase|Other|1|||
163159935|NCT00345358|589298090|FG002|Primary Vaccination Phase|Other|1|||
163159936|NCT00345358|589298091|FG003|Primary Vaccination Phase|Other|0|||
163159937|NCT00345358|589298088|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
163159938|NCT00345358|589298089|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
163159939|NCT00345358|589298090|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
163159940|NCT00345358|589298091|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
163159941|NCT00345358|589298088|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
163159942|NCT00345358|589298089|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
163159943|NCT00345358|589298090|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
163159944|NCT00345358|589298091|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
163159945|NCT00345358|589298088|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
163159946|NCT00345358|589298089|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
163159947|NCT00345358|589298090|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
163159948|NCT00345358|589298091|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
163159949|NCT00345358|589298088|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
163159950|NCT00345358|589298089|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162811648|NCT00585195|588021770|FG015|Overall Study|Other|3|||
163159951|NCT00345358|589298090|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
163159952|NCT00345358|589298091|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
163159953|NCT00345358|589298088|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
163159954|NCT00345358|589298089|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
163159955|NCT00345358|589298090|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
163159956|NCT00345358|589298091|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
163159957|NCT00346697|589298092|FG000|Overall Study|Lost to Follow-up|0|||
163159958|NCT00346697|589298093|FG001|Overall Study|Lost to Follow-up|1|||
163159959|NCT00318643|589298096|FG000|Overall Study|Adverse Event|0|||
163159960|NCT00318643|589298097|FG001|Overall Study|Adverse Event|0|||
163159961|NCT00318643|589298098|FG002|Overall Study|Adverse Event|0|||
163159962|NCT00318643|589298099|FG003|Overall Study|Adverse Event|0|||
163159963|NCT00318643|589298100|FG004|Overall Study|Adverse Event|1|||
163159964|NCT00318643|589298096|FG000|Overall Study|Participant's Decision|0|||
163159965|NCT00318643|589298097|FG001|Overall Study|Participant's Decision|0|||
163159966|NCT00318643|589298098|FG002|Overall Study|Participant's Decision|0|||
163159967|NCT00318643|589298099|FG003|Overall Study|Participant's Decision|0|||
163159968|NCT00318643|589298100|FG004|Overall Study|Participant's Decision|1|||
163159969|NCT00318643|589298096|FG000|Overall Study|Investigator's Decision|0|||
163159970|NCT00318643|589298097|FG001|Overall Study|Investigator's Decision|0|||
163159971|NCT00318643|589298098|FG002|Overall Study|Investigator's Decision|0|||
163159972|NCT00318643|589298099|FG003|Overall Study|Investigator's Decision|0|||
163159973|NCT00318643|589298100|FG004|Overall Study|Investigator's Decision|1|||
163159974|NCT02691507|589298103|FG000|Overall Study|Missed Visit 3|0|||
163159975|NCT02691507|589298104|FG001|Overall Study|Missed Visit 3|1|||
163159976|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
163159977|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
163159978|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
163159979|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163159980|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163159981|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163159982|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
163159983|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
163159984|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
163159985|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163159986|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163159987|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
163159988|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
163159989|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
163159990|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
163159991|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
163159992|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
163159993|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
163159994|NCT03739203|589298105|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
163159995|NCT03739203|589298106|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
163159996|NCT03739203|589298107|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
163159997|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
163159998|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
163159999|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
163160000|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
163160001|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
163160002|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
163160003|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
163160004|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
163160005|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
163160006|NCT03739203|589298105|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
163160007|NCT03739203|589298106|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
163160008|NCT03739203|589298107|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
163160009|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
163160010|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
163160011|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
163160012|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
163160013|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
163160014|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
163160015|NCT02592798|589298108|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
163160016|NCT02592798|589298109|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
163160017|NCT02592798|589298108|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
163160018|NCT02592798|589298109|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
163160019|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
163160020|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
163160021|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
163160022|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
163160023|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
163160024|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
163160025|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
163160026|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
163160027|NCT02592798|589298108|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
163160028|NCT02592798|589298109|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
163160029|NCT02592798|589298108|FG000|Transition From DB2 to OLE|Other reasons|1|||
163160030|NCT02592798|589298109|FG001|Transition From DB2 to OLE|Other reasons|0|||
163160031|NCT02592798|589298108|FG000|Open Label Period (OLE)|Other reasons|0|||
163160032|NCT02592798|589298109|FG001|Open Label Period (OLE)|Other reasons|2|||
163160033|NCT02592798|589298108|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
163160034|NCT02592798|589298109|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
163160035|NCT02592798|589298108|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
163160036|NCT02592798|589298109|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
163160037|NCT02592798|589298108|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
163160038|NCT02592798|589298109|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
163160039|NCT02592798|589298108|FG000|Open Label Period (OLE)|Adverse Event|0|||
163160040|NCT02592798|589298109|FG001|Open Label Period (OLE)|Adverse Event|1|||
163160041|NCT01216189|589298110|FG000|Overall Study|Lost to Follow-up|21|||
163160042|NCT01216189|589298111|FG001|Overall Study|Lost to Follow-up|3|||
163160043|NCT01216189|589298110|FG000|Overall Study|Death|4|||
163160044|NCT01216189|589298111|FG001|Overall Study|Death|2|||
163160045|NCT01143246|589298112|FG000|Overall Study|Adverse Event|24|||
163160046|NCT01143246|589298113|FG001|Overall Study|Adverse Event|28|||
163160047|NCT01143246|589298112|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
163160048|NCT01143246|589298113|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
163160049|NCT01143246|589298112|FG000|Overall Study|Lost to Follow-up|0|||
163160050|NCT01143246|589298113|FG001|Overall Study|Lost to Follow-up|1|||
163160051|NCT01143246|589298112|FG000|Overall Study|Death|16|||
163160052|NCT01143246|589298113|FG001|Overall Study|Death|15|||
163160053|NCT01143246|589298112|FG000|Overall Study|Reason not Specified|3|||
163160054|NCT01143246|589298113|FG001|Overall Study|Reason not Specified|5|||
163160055|NCT01146795|589298114|FG000|Overall Study|Withdrawal by Subject|4|||
163160056|NCT01146795|589298114|FG000|Overall Study|Adverse Event|6|||
163160057|NCT01146795|589298114|FG000|Overall Study|Still in treatment at study closure|10|||
163160058|NCT05375760|589298115|FG000|Overall Study|Adverse Event|1|||
163160059|NCT05375760|589298116|FG001|Overall Study|Adverse Event|0|||
163160060|NCT05375760|589298115|FG000|Overall Study|Death|0|||
163160061|NCT05375760|589298116|FG001|Overall Study|Death|1|||
163160062|NCT05375760|589298115|FG000|Overall Study|Lost to Follow-up|6|||
163160063|NCT05375760|589298116|FG001|Overall Study|Lost to Follow-up|6|||
163160064|NCT05375760|589298115|FG000|Overall Study|Withdrawal by Subject|17|||
163160065|NCT05375760|589298116|FG001|Overall Study|Withdrawal by Subject|19|||
163160066|NCT05375760|589298115|FG000|Overall Study|Dosing halted by FDA|96|||
163160067|NCT05375760|589298116|FG001|Overall Study|Dosing halted by FDA|100|||
163160068|NCT05375760|589298115|FG000|Overall Study|Not compliant with study visit|2|||
163160069|NCT05375760|589298116|FG001|Overall Study|Not compliant with study visit|0|||
163160070|NCT05375760|589298115|FG000|Overall Study|Physician Decision|1|||
163160071|NCT05375760|589298116|FG001|Overall Study|Physician Decision|0|||
163160072|NCT05375760|589298115|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
163160073|NCT05375760|589298116|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
163160074|NCT05375760|589298115|FG000|Overall Study|Participant moved|1|||
163160075|NCT05375760|589298116|FG001|Overall Study|Participant moved|0|||
163160076|NCT03853109|589298117|FG000|Overall Study|Withdrawal by Subject|0|||
163160077|NCT03853109|589298118|FG001|Overall Study|Withdrawal by Subject|0|||
163160078|NCT03853109|589298119|FG002|Overall Study|Withdrawal by Subject|1|||
163160079|NCT03853109|589298120|FG003|Overall Study|Withdrawal by Subject|2|||
163160080|NCT03853109|589298121|FG004|Overall Study|Withdrawal by Subject|1|||
163160081|NCT03853109|589298122|FG005|Overall Study|Withdrawal by Subject|4|||
163160082|NCT03853109|589298123|FG006|Overall Study|Withdrawal by Subject|5|||
163160083|NCT03853109|589298124|FG007|Overall Study|Withdrawal by Subject|3|||
163160084|NCT03853109|589298117|FG000|Overall Study|Decision by Sponsor|0|||
163160085|NCT03853109|589298118|FG001|Overall Study|Decision by Sponsor|0|||
163160086|NCT03853109|589298119|FG002|Overall Study|Decision by Sponsor|1|||
163160087|NCT03853109|589298120|FG003|Overall Study|Decision by Sponsor|0|||
163160088|NCT03853109|589298121|FG004|Overall Study|Decision by Sponsor|1|||
163160089|NCT03853109|589298122|FG005|Overall Study|Decision by Sponsor|1|||
163160090|NCT03853109|589298123|FG006|Overall Study|Decision by Sponsor|10|||
163160091|NCT03853109|589298124|FG007|Overall Study|Decision by Sponsor|2|||
163160092|NCT03853109|589298117|FG000|Overall Study|Lost to Follow-up|0|||
163160093|NCT03853109|589298118|FG001|Overall Study|Lost to Follow-up|0|||
163160094|NCT03853109|589298119|FG002|Overall Study|Lost to Follow-up|0|||
163160095|NCT03853109|589298120|FG003|Overall Study|Lost to Follow-up|0|||
163160096|NCT03853109|589298121|FG004|Overall Study|Lost to Follow-up|1|||
163160097|NCT03853109|589298122|FG005|Overall Study|Lost to Follow-up|3|||
163160098|NCT03853109|589298123|FG006|Overall Study|Lost to Follow-up|0|||
163160099|NCT03853109|589298124|FG007|Overall Study|Lost to Follow-up|0|||
163160100|NCT03853109|589298117|FG000|Overall Study|Death|2|||
163160101|NCT03853109|589298118|FG001|Overall Study|Death|5|||
163160102|NCT03853109|589298119|FG002|Overall Study|Death|8|||
163160103|NCT03853109|589298120|FG003|Overall Study|Death|10|||
163160104|NCT03853109|589298121|FG004|Overall Study|Death|3|||
163160105|NCT03853109|589298122|FG005|Overall Study|Death|20|||
163160106|NCT03853109|589298123|FG006|Overall Study|Death|10|||
163160107|NCT03853109|589298124|FG007|Overall Study|Death|5|||
163160108|NCT03751657|589300222|FG000|Overall Study|Physician Decision|0|||
163160109|NCT03751657|589300223|FG001|Overall Study|Physician Decision|1|||
163160110|NCT03751657|589300222|FG000|Overall Study|Withdrawal by Subject|1|||
163160111|NCT03751657|589300223|FG001|Overall Study|Withdrawal by Subject|1|||
163160112|NCT03751657|589300222|FG000|Overall Study|Lost to Follow-up|2|||
163160113|NCT03751657|589300223|FG001|Overall Study|Lost to Follow-up|1|||
163160114|NCT03894813|589300230|FG000|Overall Study|Adverse Event|1|||
163160115|NCT03894813|589300231|FG001|Overall Study|Adverse Event|1|||
163160116|NCT03894813|589300230|FG000|Overall Study|Lack of Efficacy|3|||
163160117|NCT03894813|589300231|FG001|Overall Study|Lack of Efficacy|3|||
163160118|NCT03894813|589300230|FG000|Overall Study|Lost to Follow-up|1|||
163160119|NCT03894813|589300231|FG001|Overall Study|Lost to Follow-up|0|||
163160120|NCT03894813|589300230|FG000|Overall Study|Pregnancy|2|||
163160121|NCT03894813|589300231|FG001|Overall Study|Pregnancy|1|||
163160122|NCT03894813|589300230|FG000|Overall Study|Protocol Violation|3|||
163160123|NCT03894813|589300231|FG001|Overall Study|Protocol Violation|7|||
163160124|NCT03894813|589300230|FG000|Overall Study|Withdrawal by Subject|1|||
163160125|NCT03894813|589300231|FG001|Overall Study|Withdrawal by Subject|3|||
163160126|NCT03894813|589300230|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
163160127|NCT03894813|589300231|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
163160128|NCT02269267|589300233|FG000|Overall Study|Death|5|||
163160129|NCT00145158|589300236|FG000|Overall Study|premature withdrawal|2|||
163160130|NCT00145158|589300237|FG001|Overall Study|premature withdrawal|3|||
163160131|NCT02741518|589300238|FG000|Overall Study|Withdrawal by Subject|1|||
163160132|NCT02741518|589300239|FG001|Overall Study|Withdrawal by Subject|1|||
163160133|NCT00476008|589300240|FG000|Overall Study|Adverse Event|4|||
163160134|NCT00476008|589300241|FG001|Overall Study|Adverse Event|4|||
163160135|NCT00476008|589300240|FG000|Overall Study|Placebo concerns|2|||
163160136|NCT00476008|589300241|FG001|Overall Study|Placebo concerns|2|||
163160137|NCT00476008|589300240|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
163160138|NCT00476008|589300241|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
163160139|NCT00476008|589300240|FG000|Overall Study|Withdrawal by Subject|0|||
163160140|NCT00476008|589300241|FG001|Overall Study|Withdrawal by Subject|1|||
163160141|NCT00476008|589300240|FG000|Overall Study|Death|1|||
163160142|NCT00476008|589300241|FG001|Overall Study|Death|0|||
163160143|NCT01788358|589300242|FG000|Overall Study|Other|11|||
163160144|NCT01788358|589300242|FG000|Overall Study|Logistical difficulties|1|||
163160145|NCT01788358|589300242|FG000|Overall Study|Lost to Follow-up|5|||
163160146|NCT01788358|589300242|FG000|Overall Study|Protocol Violation|3|||
163160147|NCT01788358|589300242|FG000|Overall Study|Withdrawal by Subject|26|||
163160148|NCT01788358|589300242|FG000|Overall Study|Lack of Efficacy|1|||
163160149|NCT01788358|589300242|FG000|Overall Study|Adverse Event|51|||
163160150|NCT01227018|589300243|FG000|Overall Study|Disease progression|9|||
163160151|NCT01227018|589300243|FG000|Overall Study|Toxicity|2|||
163160152|NCT01227018|589300243|FG000|Overall Study|Withdrew after beginning treatment|4|||
163160153|NCT02948634|589300246|FG000|Overall Study|Lack of efficacy and study suspended|10|||
163160154|NCT02948634|589300247|FG001|Overall Study|Lack of efficacy and study suspended|2|||
163160155|NCT00753649|589300252|FG000|Overall Study|Migrated/moved from study area|1|||
163160156|NCT00753649|589300253|FG001|Overall Study|Migrated/moved from study area|0|||
163160157|NCT00753649|589300252|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
163160158|NCT00753649|589300253|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
163160159|NCT00753649|589300252|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
163160160|NCT00753649|589300253|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
163160161|NCT00753649|589300252|FG000|Overall Study|Protocol Violation|2|||
163160162|NCT00753649|589300253|FG001|Overall Study|Protocol Violation|0|||
163160163|NCT01039519|589300259|FG000|Treatment|Progressive disease|20|||
163160164|NCT01039519|589300259|FG000|Treatment|Treatment failure|2|||
163160165|NCT01039519|589300259|FG000|Treatment|Adverse Event|3|||
163160166|NCT01039519|589300259|FG000|Treatment|Physician Decision|2|||
163160167|NCT01039519|589300259|FG000|Survival Follow-up|Death|23|||
163160168|NCT01039519|589300259|FG000|Survival Follow-up|Sponsor decision|4|||
163160169|NCT01255436|589300262|FG000|Overall Study|Lost to Follow-up|178|||
163160170|NCT01255436|589300263|FG001|Overall Study|Lost to Follow-up|191|||
163160171|NCT01255436|589300262|FG000|Overall Study|Death, stroke, or MI|4|||
163160172|NCT01255436|589300263|FG001|Overall Study|Death, stroke, or MI|3|||
163160173|NCT04816669|589300264|FG000|Part 1|Adverse Event|1|||
163160174|NCT04816669|589300265|FG001|Part 1|Adverse Event|1|||
163160175|NCT04816669|589300266|FG002|Part 1|Adverse Event|0|||
163160176|NCT04816669|589300267|FG003|Part 1|Adverse Event|0|||
163160177|NCT04816669|589300264|FG000|Part 1|Lost to Follow-up|2|||
163160178|NCT04816669|589300265|FG001|Part 1|Lost to Follow-up|2|||
163160179|NCT04816669|589300266|FG002|Part 1|Lost to Follow-up|0|||
163160180|NCT04816669|589300267|FG003|Part 1|Lost to Follow-up|0|||
163160181|NCT04816669|589300264|FG000|Part 1|Protocol Violation|0|||
163160182|NCT04816669|589300265|FG001|Part 1|Protocol Violation|1|||
163160183|NCT04816669|589300266|FG002|Part 1|Protocol Violation|0|||
163160184|NCT04816669|589300267|FG003|Part 1|Protocol Violation|0|||
163160185|NCT04816669|589300264|FG000|Part 1|Withdrawal by Subject|1|||
163160186|NCT04816669|589300265|FG001|Part 1|Withdrawal by Subject|2|||
163160187|NCT04816669|589300266|FG002|Part 1|Withdrawal by Subject|0|||
163160188|NCT04816669|589300267|FG003|Part 1|Withdrawal by Subject|0|||
163160189|NCT04816669|589300264|FG000|Part 2|Other|0|||
163160190|NCT04816669|589300265|FG001|Part 2|Other|0|||
163160191|NCT04816669|589300266|FG002|Part 2|Other|1|||
163160192|NCT04816669|589300267|FG003|Part 2|Other|0|||
163160193|NCT04816669|589300264|FG000|Part 2|Withdrawal by Subject|0|||
163160194|NCT04816669|589300265|FG001|Part 2|Withdrawal by Subject|0|||
163160195|NCT04816669|589300266|FG002|Part 2|Withdrawal by Subject|0|||
163160196|NCT04816669|589300267|FG003|Part 2|Withdrawal by Subject|1|||
163160197|NCT04816669|589300264|FG000|Part 2|Lost to Follow-up|0|||
163160198|NCT04816669|589300265|FG001|Part 2|Lost to Follow-up|0|||
163160199|NCT04816669|589300266|FG002|Part 2|Lost to Follow-up|1|||
163160200|NCT04816669|589300267|FG003|Part 2|Lost to Follow-up|0|||
163160201|NCT01229267|589300268|FG000|Overall Study|Adverse Event|4|||
163160202|NCT01229267|589300269|FG001|Overall Study|Adverse Event|6|||
163160203|NCT01229267|589300270|FG002|Overall Study|Adverse Event|3|||
163160204|NCT01229267|589300271|FG003|Overall Study|Adverse Event|2|||
163160205|NCT01229267|589300272|FG004|Overall Study|Adverse Event|10|||
163160206|NCT01229267|589300268|FG000|Overall Study|Death|40|||
163160207|NCT01229267|589300269|FG001|Overall Study|Death|37|||
163160208|NCT01229267|589300270|FG002|Overall Study|Death|35|||
163160209|NCT01229267|589300271|FG003|Overall Study|Death|13|||
163160210|NCT01229267|589300272|FG004|Overall Study|Death|103|||
163160211|NCT01229267|589300268|FG000|Overall Study|Withdrawal by Subject|23|||
163160212|NCT01229267|589300269|FG001|Overall Study|Withdrawal by Subject|22|||
163160213|NCT01229267|589300270|FG002|Overall Study|Withdrawal by Subject|32|||
163160214|NCT01229267|589300271|FG003|Overall Study|Withdrawal by Subject|14|||
163160215|NCT01229267|589300272|FG004|Overall Study|Withdrawal by Subject|59|||
163160216|NCT01229267|589300268|FG000|Overall Study|Protocol Violation|0|||
163160217|NCT01229267|589300269|FG001|Overall Study|Protocol Violation|1|||
163160218|NCT01229267|589300270|FG002|Overall Study|Protocol Violation|0|||
163160219|NCT01229267|589300271|FG003|Overall Study|Protocol Violation|0|||
163160220|NCT01229267|589300272|FG004|Overall Study|Protocol Violation|0|||
163160221|NCT01229267|589300268|FG000|Overall Study|Progressive disease|0|||
163160222|NCT01229267|589300269|FG001|Overall Study|Progressive disease|0|||
163160223|NCT01229267|589300270|FG002|Overall Study|Progressive disease|0|||
163160224|NCT01229267|589300271|FG003|Overall Study|Progressive disease|0|||
163160225|NCT01229267|589300272|FG004|Overall Study|Progressive disease|1|||
163160226|NCT01229267|589300268|FG000|Overall Study|Physician Decision|8|||
163160227|NCT01229267|589300269|FG001|Overall Study|Physician Decision|11|||
163160228|NCT01229267|589300270|FG002|Overall Study|Physician Decision|8|||
163160229|NCT01229267|589300271|FG003|Overall Study|Physician Decision|3|||
163160230|NCT01229267|589300272|FG004|Overall Study|Physician Decision|25|||
163160231|NCT01229267|589300268|FG000|Overall Study|Lost to Follow-up|6|||
163160232|NCT01229267|589300269|FG001|Overall Study|Lost to Follow-up|5|||
163160233|NCT01229267|589300270|FG002|Overall Study|Lost to Follow-up|8|||
163160234|NCT01229267|589300271|FG003|Overall Study|Lost to Follow-up|3|||
163160235|NCT01229267|589300272|FG004|Overall Study|Lost to Follow-up|22|||
163160236|NCT00808080|589300276|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
163160237|NCT01837823|589300279|FG000|Overall Study|Lost to Follow-up|6|||
163160238|NCT03052400|589300280|FG000|Overall Study|Lost to Follow-up|1|||
163160239|NCT03052400|589300281|FG001|Overall Study|Lost to Follow-up|0|||
163160240|NCT03052400|589300280|FG000|Overall Study|Withdrawal by Subject|0|||
163160241|NCT03052400|589300281|FG001|Overall Study|Withdrawal by Subject|1|||
163160242|NCT00867815|589300282|FG000|Overall Study|Lost to Follow-up|1|||
163160243|NCT00001213|589300283|FG000|Overall Study|Death|18|||
163160244|NCT05782179|589300284|FG000|Overall Study|Adverse Event|0|||
163160245|NCT05782179|589300285|FG001|Overall Study|Adverse Event|0|||
163160246|NCT05782179|589300286|FG002|Overall Study|Adverse Event|2|||
163160247|NCT05782179|589300287|FG003|Overall Study|Adverse Event|0|||
163160248|NCT05782179|589300288|FG004|Overall Study|Adverse Event|0|||
163160249|NCT05782179|589300289|FG005|Overall Study|Adverse Event|0|||
163160250|NCT06170242|589300290|FG000|Overall Study|Lost to Follow-up|0|||
163160251|NCT06170242|589300291|FG001|Overall Study|Lost to Follow-up|0|||
163160252|NCT06170242|589300292|FG002|Overall Study|Lost to Follow-up|1|||
163160253|NCT06170242|589300293|FG003|Overall Study|Lost to Follow-up|1|||
163160254|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Adverse Event|9|||
163160255|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Adverse Event|3|||
163160256|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Death|7|||
163160257|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Death|7|||
163160258|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
163160259|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
163160260|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Physician Decision|1|||
163160261|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Physician Decision|0|||
163160262|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
163160263|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
163160264|NCT02558296|589300294|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
163160265|NCT02558296|589300295|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
163160266|NCT02558296|589300294|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
163160267|NCT02558296|589300295|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
163160268|NCT02558296|589300294|FG000|Completed the Study|Adverse Event|14|||
163160269|NCT02558296|589300295|FG001|Completed the Study|Adverse Event|5|||
163160270|NCT02558296|589300294|FG000|Completed the Study|Death|39|||
163160271|NCT02558296|589300295|FG001|Completed the Study|Death|25|||
163160272|NCT02558296|589300294|FG000|Completed the Study|Lost to Follow-up|31|||
163160273|NCT02558296|589300295|FG001|Completed the Study|Lost to Follow-up|23|||
163160274|NCT02558296|589300294|FG000|Completed the Study|Physician Decision|6|||
163160275|NCT02558296|589300295|FG001|Completed the Study|Physician Decision|0|||
163160276|NCT02558296|589300294|FG000|Completed the Study|Protocol Violation|2|||
163160277|NCT02558296|589300295|FG001|Completed the Study|Protocol Violation|1|||
163160278|NCT02558296|589300294|FG000|Completed the Study|Withdrawal by Subject|53|||
163160279|NCT02558296|589300295|FG001|Completed the Study|Withdrawal by Subject|31|||
163160280|NCT02558296|589300294|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
163160281|NCT02558296|589300295|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
163160282|NCT02919995|589300298|FG000|Overall Study|Adverse Event|0|||
163160283|NCT02919995|589300299|FG001|Overall Study|Adverse Event|0|||
163160284|NCT02919995|589300300|FG002|Overall Study|Adverse Event|0|||
163160285|NCT02919995|589300301|FG003|Overall Study|Adverse Event|0|||
163160286|NCT02919995|589300302|FG004|Overall Study|Adverse Event|0|||
163160287|NCT02919995|589300303|FG005|Overall Study|Adverse Event|1|||
163160288|NCT01263197|589300315|FG000|First Intervention (Period 1)|Adverse Event|0|||
163160289|NCT01263197|589300316|FG001|First Intervention (Period 1)|Adverse Event|0|||
163160290|NCT01263197|589300317|FG002|First Intervention (Period 1)|Adverse Event|0|||
163160291|NCT01263197|589300318|FG003|First Intervention (Period 1)|Adverse Event|0|||
163160292|NCT01263197|589300319|FG004|First Intervention (Period 1)|Adverse Event|0|||
163160293|NCT01263197|589300320|FG005|First Intervention (Period 1)|Adverse Event|1|||
163160294|NCT01263197|589300315|FG000|Washout Period 1|Protocol Violation|0|||
163160295|NCT01263197|589300316|FG001|Washout Period 1|Protocol Violation|0|||
163160296|NCT01263197|589300317|FG002|Washout Period 1|Protocol Violation|0|||
163160297|NCT01263197|589300318|FG003|Washout Period 1|Protocol Violation|0|||
163160298|NCT01263197|589300319|FG004|Washout Period 1|Protocol Violation|1|||
163160299|NCT01263197|589300320|FG005|Washout Period 1|Protocol Violation|0|||
163160300|NCT01263197|589300315|FG000|Washout Period 2|Physician Decision|0|||
163160301|NCT01263197|589300316|FG001|Washout Period 2|Physician Decision|0|||
163160302|NCT01263197|589300317|FG002|Washout Period 2|Physician Decision|0|||
163160303|NCT01263197|589300318|FG003|Washout Period 2|Physician Decision|0|||
163160304|NCT01263197|589300319|FG004|Washout Period 2|Physician Decision|0|||
163160305|NCT01263197|589300320|FG005|Washout Period 2|Physician Decision|1|||
163160306|NCT01263197|589300315|FG000|Washout Period 2|Protocol Violation|0|||
163160307|NCT01263197|589300316|FG001|Washout Period 2|Protocol Violation|0|||
163160308|NCT01263197|589300317|FG002|Washout Period 2|Protocol Violation|0|||
163160309|NCT01263197|589300318|FG003|Washout Period 2|Protocol Violation|1|||
163160310|NCT01263197|589300319|FG004|Washout Period 2|Protocol Violation|0|||
163160311|NCT01263197|589300320|FG005|Washout Period 2|Protocol Violation|0|||
163160312|NCT01263197|589300315|FG000|Third Intervention (Period 3)|Adverse Event|0|||
163160313|NCT01263197|589300316|FG001|Third Intervention (Period 3)|Adverse Event|1|||
163160314|NCT01263197|589300317|FG002|Third Intervention (Period 3)|Adverse Event|0|||
163160315|NCT01263197|589300318|FG003|Third Intervention (Period 3)|Adverse Event|0|||
163160316|NCT01263197|589300319|FG004|Third Intervention (Period 3)|Adverse Event|0|||
163160317|NCT01263197|589300320|FG005|Third Intervention (Period 3)|Adverse Event|0|||
163160318|NCT02577718|589300321|FG000|Overall Study|Death|6|||
163160319|NCT02577718|589300321|FG000|Overall Study|Withdrawal by Subject|2|||
163160320|NCT02194985|589300323|FG000|Overall Study|Adverse Event|1|||
163160321|NCT02194985|589300323|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
163160322|NCT02194985|589300323|FG000|Overall Study|Physician Decision|4|||
163160323|NCT02194985|589300323|FG000|Overall Study|Lost to Follow-up|1|||
163160324|NCT02194985|589300323|FG000|Overall Study|Withdrawal by Subject|2|||
163160325|NCT01012440|589300326|FG000|Overall Study|Withdrawal by Subject|2|||
163160326|NCT00594815|589300327|FG000|Overall Study|Never Treated|3|||
163160327|NCT00594815|589300327|FG000|Overall Study|Withdrawal by Subject|2|||
163160328|NCT00594815|589300327|FG000|Overall Study|Toxicity|4|||
163160329|NCT02557139|589300328|FG000|Overall Study|Significant liver elevation|1|||
163160330|NCT02557139|589300329|FG001|Overall Study|Significant liver elevation|0|||
163160331|NCT02557139|589300330|FG002|Overall Study|Significant liver elevation|1|||
163160332|NCT02557139|589300328|FG000|Overall Study|Withdrawal by Subject|1|||
163160333|NCT02557139|589300329|FG001|Overall Study|Withdrawal by Subject|0|||
163160334|NCT02557139|589300330|FG002|Overall Study|Withdrawal by Subject|0|||
163160335|NCT02557139|589300328|FG000|Overall Study|Illness of prohibited medication|0|||
163160336|NCT02557139|589300329|FG001|Overall Study|Illness of prohibited medication|0|||
163160337|NCT02557139|589300330|FG002|Overall Study|Illness of prohibited medication|1|||
163160338|NCT02284243|589300331|FG000|Overall Study|Lack of Efficacy|3|||
163160339|NCT02284243|589300332|FG001|Overall Study|Lack of Efficacy|3|||
163160340|NCT02284243|589300331|FG000|Overall Study|Adverse Event|1|||
163160341|NCT02284243|589300332|FG001|Overall Study|Adverse Event|0|||
163160342|NCT01932437|589300334|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160343|NCT01932437|589300335|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160344|NCT01932437|589300336|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160345|NCT01932437|589300337|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160346|NCT01932437|589300338|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
163160347|NCT01932437|589300339|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
163160348|NCT04269889|589300340|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
163160349|NCT00949702|589300345|FG000|Overall Study|Death|40|||
163160350|NCT00949702|589300345|FG000|Overall Study|Disease progression|7|||
163160351|NCT00949702|589300345|FG000|Overall Study|Withdrawal of consent|1|||
163160352|NCT01654302|589300346|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
163160353|NCT01654302|589300347|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
163160354|NCT02699749|589300350|FG000|Overall Study|Other|0|||
163160355|NCT02699749|589300351|FG001|Overall Study|Other|0|||
163160356|NCT02699749|589300352|FG002|Overall Study|Other|2|||
163160357|NCT02699749|589300353|FG003|Overall Study|Other|0|||
163160358|NCT02699749|589300354|FG004|Overall Study|Other|0|||
163160359|NCT02699749|589300355|FG005|Overall Study|Other|1|||
163160360|NCT02699749|589300356|FG006|Overall Study|Other|1|||
163160361|NCT02699749|589300357|FG007|Overall Study|Other|0|||
163160362|NCT02699749|589300358|FG008|Overall Study|Other|0|||
163160363|NCT02699749|589300359|FG009|Overall Study|Other|0|||
163160364|NCT02699749|589300360|FG010|Overall Study|Other|1|||
163160365|NCT02699749|589300361|FG011|Overall Study|Other|0|||
163160366|NCT02699749|589300362|FG012|Overall Study|Other|0|||
163160367|NCT02699749|589300363|FG013|Overall Study|Other|0|||
163160368|NCT02699749|589300350|FG000|Overall Study|Progressive Disease|3|||
163160369|NCT02699749|589300351|FG001|Overall Study|Progressive Disease|3|||
163160370|NCT02699749|589300352|FG002|Overall Study|Progressive Disease|14|||
163160371|NCT02699749|589300353|FG003|Overall Study|Progressive Disease|3|||
163160372|NCT02699749|589300354|FG004|Overall Study|Progressive Disease|3|||
163160373|NCT02699749|589300355|FG005|Overall Study|Progressive Disease|7|||
163160374|NCT02699749|589300356|FG006|Overall Study|Progressive Disease|5|||
163160375|NCT02699749|589300357|FG007|Overall Study|Progressive Disease|5|||
163160376|NCT02699749|589300358|FG008|Overall Study|Progressive Disease|6|||
163160377|NCT02699749|589300359|FG009|Overall Study|Progressive Disease|6|||
163160378|NCT02699749|589300360|FG010|Overall Study|Progressive Disease|5|||
163160379|NCT02699749|589300361|FG011|Overall Study|Progressive Disease|4|||
163160380|NCT02699749|589300362|FG012|Overall Study|Progressive Disease|3|||
163160381|NCT02699749|589300363|FG013|Overall Study|Progressive Disease|5|||
163160382|NCT02699749|589300350|FG000|Overall Study|Death|0|||
163160383|NCT02699749|589300351|FG001|Overall Study|Death|0|||
163160384|NCT02699749|589300352|FG002|Overall Study|Death|0|||
163160385|NCT02699749|589300353|FG003|Overall Study|Death|0|||
163160386|NCT02699749|589300354|FG004|Overall Study|Death|0|||
163160387|NCT02699749|589300355|FG005|Overall Study|Death|0|||
163160388|NCT02699749|589300356|FG006|Overall Study|Death|0|||
163160389|NCT02699749|589300357|FG007|Overall Study|Death|0|||
163160390|NCT02699749|589300358|FG008|Overall Study|Death|0|||
163160391|NCT02699749|589300359|FG009|Overall Study|Death|0|||
163160392|NCT02699749|589300360|FG010|Overall Study|Death|0|||
163160393|NCT02699749|589300361|FG011|Overall Study|Death|0|||
163160394|NCT02699749|589300362|FG012|Overall Study|Death|0|||
163160395|NCT02699749|589300363|FG013|Overall Study|Death|1|||
163160396|NCT02699749|589300350|FG000|Overall Study|Lost to Follow-up|0|||
163160397|NCT02699749|589300351|FG001|Overall Study|Lost to Follow-up|0|||
163160398|NCT02699749|589300352|FG002|Overall Study|Lost to Follow-up|0|||
163160399|NCT02699749|589300353|FG003|Overall Study|Lost to Follow-up|0|||
163160400|NCT02699749|589300354|FG004|Overall Study|Lost to Follow-up|0|||
163160401|NCT02699749|589300355|FG005|Overall Study|Lost to Follow-up|1|||
163160402|NCT02699749|589300356|FG006|Overall Study|Lost to Follow-up|0|||
163160403|NCT02699749|589300357|FG007|Overall Study|Lost to Follow-up|1|||
163160404|NCT02699749|589300358|FG008|Overall Study|Lost to Follow-up|0|||
163160405|NCT02699749|589300359|FG009|Overall Study|Lost to Follow-up|0|||
163160406|NCT02699749|589300360|FG010|Overall Study|Lost to Follow-up|0|||
163160407|NCT02699749|589300361|FG011|Overall Study|Lost to Follow-up|0|||
163160408|NCT02699749|589300362|FG012|Overall Study|Lost to Follow-up|0|||
163160409|NCT02699749|589300363|FG013|Overall Study|Lost to Follow-up|0|||
163160410|NCT02377817|589300365|FG000|Overall Study|Transportation/childcare barriers.|2|||
163160411|NCT02377817|589300366|FG001|Overall Study|Transportation/childcare barriers.|0|||
163160412|NCT02377817|589300365|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
163160413|NCT02377817|589300366|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
163160414|NCT04139018|589300367|FG000|Overall Study|Screen fail|1|||
163160415|NCT04139018|589300368|FG001|Overall Study|Screen fail|0|||
163160416|NCT04139018|589300367|FG000|Overall Study|Withdrawal by Subject|2|||
163160417|NCT04139018|589300368|FG001|Overall Study|Withdrawal by Subject|0|||
163160418|NCT04139018|589300367|FG000|Overall Study|Lost to Follow-up|0|||
163160419|NCT04139018|589300368|FG001|Overall Study|Lost to Follow-up|1|||
163160420|NCT01094119|589300385|FG000|Overall Study|Lack of Efficacy|2|||
163160421|NCT01094119|589300386|FG001|Overall Study|Lack of Efficacy|4|||
163160422|NCT01106248|589300389|FG000|Overall Study|Adverse Event|1|||
163160423|NCT01106248|589300389|FG000|Overall Study|Administrative|2|||
163160424|NCT00357903|589300390|FG000|Overall Study|Adverse Event|87|||
163160425|NCT00357903|589300391|FG001|Overall Study|Adverse Event|4|||
163160426|NCT00357903|589300390|FG000|Overall Study|Death|33|||
163160427|NCT00357903|589300391|FG001|Overall Study|Death|0|||
163160428|NCT00357903|589300390|FG000|Overall Study|Lost to Follow-up|23|||
163160429|NCT00357903|589300391|FG001|Overall Study|Lost to Follow-up|4|||
163160430|NCT00357903|589300390|FG000|Overall Study|Physician Decision|39|||
163160431|NCT00357903|589300391|FG001|Overall Study|Physician Decision|5|||
163160432|NCT00357903|589300390|FG000|Overall Study|Withdrawal by Subject|57|||
163160433|NCT00357903|589300391|FG001|Overall Study|Withdrawal by Subject|7|||
163160434|NCT00357903|589300390|FG000|Overall Study|Completed month 12 only|0|||
163160435|NCT00357903|589300391|FG001|Overall Study|Completed month 12 only|1|||
163160436|NCT00357903|589300390|FG000|Overall Study|Protocol issues|14|||
163160437|NCT00357903|589300391|FG001|Overall Study|Protocol issues|3|||
163160438|NCT00357903|589300390|FG000|Overall Study|Response status|61|||
163160439|NCT00357903|589300391|FG001|Overall Study|Response status|9|||
163160440|NCT00357903|589300390|FG000|Overall Study|Other|49|||
163160441|NCT00357903|589300391|FG001|Overall Study|Other|10|||
163160442|NCT01160822|589300392|FG000|Overall Study|Adverse Event|0|||
163160443|NCT01160822|589300393|FG001|Overall Study|Adverse Event|0|||
163160444|NCT01160822|589300394|FG002|Overall Study|Adverse Event|0|||
163160445|NCT01160822|589300395|FG003|Overall Study|Adverse Event|0|||
163160446|NCT01160822|589300396|FG004|Overall Study|Adverse Event|1|||
163160447|NCT01160822|589300397|FG005|Overall Study|Adverse Event|2|||
163160448|NCT01160822|589300398|FG006|Overall Study|Adverse Event|5|||
163160449|NCT01160822|589300392|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163160450|NCT01160822|589300393|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163160451|NCT01160822|589300394|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163160452|NCT01160822|589300395|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163160453|NCT01160822|589300396|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
163160454|NCT01160822|589300397|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
163160455|NCT01160822|589300398|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
163160456|NCT01160822|589300392|FG000|Overall Study|Withdrawal by Subject|0|||
163160457|NCT01160822|589300393|FG001|Overall Study|Withdrawal by Subject|0|||
163160458|NCT01160822|589300394|FG002|Overall Study|Withdrawal by Subject|0|||
163160459|NCT01160822|589300395|FG003|Overall Study|Withdrawal by Subject|0|||
163160460|NCT01160822|589300396|FG004|Overall Study|Withdrawal by Subject|0|||
163160461|NCT01160822|589300397|FG005|Overall Study|Withdrawal by Subject|0|||
163160462|NCT01160822|589300398|FG006|Overall Study|Withdrawal by Subject|1|||
163160463|NCT01160822|589300392|FG000|Overall Study|Lost to Follow-up|0|||
163160464|NCT01160822|589300393|FG001|Overall Study|Lost to Follow-up|0|||
163160465|NCT01160822|589300394|FG002|Overall Study|Lost to Follow-up|0|||
163160466|NCT01160822|589300395|FG003|Overall Study|Lost to Follow-up|0|||
163160467|NCT01160822|589300396|FG004|Overall Study|Lost to Follow-up|1|||
163160468|NCT01160822|589300397|FG005|Overall Study|Lost to Follow-up|0|||
163160469|NCT01160822|589300398|FG006|Overall Study|Lost to Follow-up|0|||
163160470|NCT01160822|589300392|FG000|Overall Study|Administrative problems|0|||
163160471|NCT01160822|589300393|FG001|Overall Study|Administrative problems|0|||
163160472|NCT01160822|589300394|FG002|Overall Study|Administrative problems|0|||
163160473|NCT01160822|589300395|FG003|Overall Study|Administrative problems|0|||
163160474|NCT01160822|589300396|FG004|Overall Study|Administrative problems|1|||
163160475|NCT01160822|589300397|FG005|Overall Study|Administrative problems|0|||
163160476|NCT01160822|589300398|FG006|Overall Study|Administrative problems|0|||
163160477|NCT01160822|589300392|FG000|Overall Study|Protocol deviation|0|||
163160478|NCT01160822|589300393|FG001|Overall Study|Protocol deviation|0|||
163160479|NCT01160822|589300394|FG002|Overall Study|Protocol deviation|0|||
163160480|NCT01160822|589300395|FG003|Overall Study|Protocol deviation|0|||
163160481|NCT01160822|589300396|FG004|Overall Study|Protocol deviation|2|||
163160482|NCT01160822|589300397|FG005|Overall Study|Protocol deviation|0|||
163160483|NCT01160822|589300398|FG006|Overall Study|Protocol deviation|0|||
163160484|NCT01648751|589300403|FG000|Overall Study|Withdrawal by Subject|2|||
163160485|NCT01648751|589300404|FG001|Overall Study|Withdrawal by Subject|3|||
163160486|NCT03467750|589300406|FG000|Overall Study|Surgery canceled|1|||
163160487|NCT03467750|589300407|FG001|Overall Study|Surgery canceled|0|||
163160488|NCT03467750|589300406|FG000|Overall Study|Protocol Violation|1|||
163160489|NCT03467750|589300407|FG001|Overall Study|Protocol Violation|1|||
163160490|NCT03467750|589300406|FG000|Overall Study|Withdrawal by Subject|0|||
163160491|NCT03467750|589300407|FG001|Overall Study|Withdrawal by Subject|1|||
163160492|NCT05673876|589300408|FG000|Overall Study|Death|3|||
163160493|NCT05673876|589300409|FG001|Overall Study|Death|1|||
163160494|NCT05673876|589300408|FG000|Overall Study|Study Terminated by Sponsor|0|||
163160495|NCT05673876|589300409|FG001|Overall Study|Study Terminated by Sponsor|1|||
163160496|NCT05673876|589300408|FG000|Overall Study|Physician Decision|0|||
163160497|NCT05673876|589300409|FG001|Overall Study|Physician Decision|1|||
163160498|NCT05006573|589300412|FG000|Double-blind Treatment Period|Physician Decision|2|||
163160499|NCT05006573|589300413|FG001|Double-blind Treatment Period|Physician Decision|0|||
163160500|NCT05006573|589300412|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
163160501|NCT05006573|589300413|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
163160502|NCT05006573|589300412|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163160503|NCT05006573|589300413|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163160504|NCT05006573|589300412|FG000|Double-blind Treatment Period|Protocol Violation|2|||
163160505|NCT05006573|589300413|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163160506|NCT05006573|589300412|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
163160507|NCT05006573|589300413|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
163160508|NCT05006573|589300412|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
163160509|NCT05006573|589300413|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
163160510|NCT01967238|589300414|FG000|Overall Study|Adverse Event|1|||
163160511|NCT01967238|589300415|FG001|Overall Study|Adverse Event|1|||
163160512|NCT01967238|589300416|FG002|Overall Study|Adverse Event|0|||
163160513|NCT01967238|589300414|FG000|Overall Study|Lost to Follow-up|1|||
163160514|NCT01967238|589300415|FG001|Overall Study|Lost to Follow-up|0|||
163160515|NCT01967238|589300416|FG002|Overall Study|Lost to Follow-up|1|||
163160516|NCT01967238|589300414|FG000|Overall Study|Withdrawal by Subject|0|||
163160517|NCT01967238|589300415|FG001|Overall Study|Withdrawal by Subject|0|||
163160518|NCT01967238|589300416|FG002|Overall Study|Withdrawal by Subject|1|||
163160519|NCT02864394|589300423|FG000|Overall Study|Death|184|||
163160520|NCT02864394|589300424|FG001|Overall Study|Death|189|||
163160521|NCT02864394|589300423|FG000|Overall Study|Lost to Follow-up|0|||
163160522|NCT02864394|589300424|FG001|Overall Study|Lost to Follow-up|2|||
163160523|NCT02864394|589300423|FG000|Overall Study|Sponsor Decision|26|||
163160524|NCT02864394|589300424|FG001|Overall Study|Sponsor Decision|11|||
163160525|NCT02864394|589300423|FG000|Overall Study|Withdrawal by Subject|3|||
163160526|NCT02864394|589300424|FG001|Overall Study|Withdrawal by Subject|10|||
163160527|NCT02656693|589302221|FG000|Overall Study|Pregnancy|1|||
163160528|NCT02656693|589302222|FG001|Overall Study|Pregnancy|1|||
163160529|NCT02656693|589302223|FG002|Overall Study|Pregnancy|1|||
163160530|NCT02656693|589302221|FG000|Overall Study|Bariatric surgery|0|||
163160531|NCT02656693|589302222|FG001|Overall Study|Bariatric surgery|1|||
163160532|NCT02656693|589302223|FG002|Overall Study|Bariatric surgery|2|||
163160533|NCT02565784|589302224|FG000|First Treatment|Adverse Event|1|||
163160534|NCT02565784|589302224|FG000|First Treatment|Withdrawal by Subject|1|||
163160535|NCT02565784|589302224|FG000|Second Treatment|Withdrawal by Subject|2|||
163160536|NCT02604160|589302225|FG000|Overall Study|Protocol Violation|0|||
163160537|NCT02604160|589302226|FG001|Overall Study|Protocol Violation|1|||
163160538|NCT02604160|589302225|FG000|Overall Study|Physician Decision|0|||
163160539|NCT02604160|589302226|FG001|Overall Study|Physician Decision|1|||
163160540|NCT01596062|589302227|FG000|Overall Study|Adverse Event|1|||
163160541|NCT01596062|589302228|FG001|Overall Study|Adverse Event|0|||
163160542|NCT01596062|589302229|FG002|Overall Study|Adverse Event|2|||
163160543|NCT01596062|589302227|FG000|Overall Study|Lack of Efficacy|0|||
163160544|NCT01596062|589302228|FG001|Overall Study|Lack of Efficacy|0|||
163160545|NCT01596062|589302229|FG002|Overall Study|Lack of Efficacy|1|||
163160546|NCT01069900|589302230|FG000|Overall Study|Technical problems|0|||
163160547|NCT01069900|589302231|FG001|Overall Study|Technical problems|1|||
163160548|NCT01069900|589302230|FG000|Overall Study|Lost to Follow-up|7|||
163160549|NCT01069900|589302231|FG001|Overall Study|Lost to Follow-up|1|||
163160550|NCT01069900|589302230|FG000|Overall Study|Withdrawal by Subject|6|||
163160551|NCT01069900|589302231|FG001|Overall Study|Withdrawal by Subject|1|||
163160552|NCT01069900|589302230|FG000|Overall Study|Protocol Violation|4|||
163160553|NCT01069900|589302231|FG001|Overall Study|Protocol Violation|1|||
163160554|NCT01069900|589302230|FG000|Overall Study|Insufficient Therapeutic effect|1|||
163160555|NCT01069900|589302231|FG001|Overall Study|Insufficient Therapeutic effect|0|||
163160556|NCT03180840|589302232|FG000|Overall Study|Withdrawal by Subject|1|||
163160557|NCT01168219|589302238|FG000|Overall Study|off study before starting treatment|2|||
163160558|NCT01168219|589302238|FG000|Overall Study|withdrew before transplant|1|||
163160559|NCT01168219|589302238|FG000|Overall Study|ineligible due to CML|2|||
163160560|NCT00859456|589302239|FG000|Overall Study|Adverse Event|3|||
163160561|NCT00859456|589302239|FG000|Overall Study|Progressive disease|2|||
163160562|NCT00859456|589302239|FG000|Overall Study|Non-compliance|3|||
163160563|NCT00927953|589302246|FG000|Overall Study|Death|2|||
163160564|NCT00927953|589302247|FG001|Overall Study|Death|1|||
163160565|NCT02863419|589302248|FG000|Overall Study|Lost to Follow-up|0|||
163160566|NCT02863419|589302249|FG001|Overall Study|Lost to Follow-up|1|||
163160567|NCT02863419|589302250|FG002|Overall Study|Lost to Follow-up|4|||
163160568|NCT02863419|589302248|FG000|Overall Study|Withdrawal by Subject|5|||
163160569|NCT02863419|589302249|FG001|Overall Study|Withdrawal by Subject|5|||
163160570|NCT02863419|589302250|FG002|Overall Study|Withdrawal by Subject|3|||
163160571|NCT02863419|589302248|FG000|Overall Study|Died|3|||
163160572|NCT02863419|589302249|FG001|Overall Study|Died|4|||
163160573|NCT02863419|589302250|FG002|Overall Study|Died|1|||
163160574|NCT01491607|589302251|FG000|Overall Study|Lost to Follow-up|7|||
163160575|NCT01491607|589302251|FG000|Overall Study|Withdrawal by Subject|3|||
163160576|NCT00297258|589302252|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
163160577|NCT00297258|589302252|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
163160578|NCT00297258|589302252|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
163160579|NCT00297258|589302252|FG000|Overall Study|Intercurrent Illness|3|||
163160580|NCT00297258|589302252|FG000|Overall Study|Intercurrent Death|2|||
163160581|NCT00297258|589302252|FG000|Overall Study|Deteriorization of General Condition|1|||
163160582|NCT00297258|589302252|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
163160583|NCT00297258|589302252|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
163160584|NCT00297258|589302252|FG000|Overall Study|Switch to Commercial Treatment|1|||
163160585|NCT00297258|589302252|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
163160586|NCT01470326|589302253|FG000|Overall Study|Protocol Violation|32|||
163160587|NCT01470326|589302253|FG000|Overall Study|No Drug Administration Information|2|||
163160588|NCT01470326|589302253|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
163160589|NCT02561832|589302254|FG000|Overall Study|Withdrawal by Subject|1|||
163160590|NCT02561832|589302255|FG001|Overall Study|Withdrawal by Subject|1|||
163160591|NCT02561832|589302254|FG000|Overall Study|Adverse Event|3|||
163160592|NCT02561832|589302255|FG001|Overall Study|Adverse Event|0|||
163160593|NCT02561832|589302254|FG000|Overall Study|Disease progression|3|||
163160594|NCT02561832|589302255|FG001|Overall Study|Disease progression|3|||
163160595|NCT02839200|589302256|FG000|Overall Study|Withdrawal by Subject|2|||
163160596|NCT02839200|589302257|FG001|Overall Study|Withdrawal by Subject|0|||
163160597|NCT02839200|589302258|FG002|Overall Study|Withdrawal by Subject|1|||
163160598|NCT02839200|589302259|FG003|Overall Study|Withdrawal by Subject|0|||
163160599|NCT02839200|589302260|FG004|Overall Study|Withdrawal by Subject|0|||
163160600|NCT02839200|589302261|FG005|Overall Study|Withdrawal by Subject|1|||
163160601|NCT02839200|589302256|FG000|Overall Study|Lost to Follow-up|2|||
163160602|NCT02839200|589302257|FG001|Overall Study|Lost to Follow-up|0|||
163160603|NCT02839200|589302258|FG002|Overall Study|Lost to Follow-up|0|||
163160604|NCT02839200|589302259|FG003|Overall Study|Lost to Follow-up|0|||
163160605|NCT02839200|589302260|FG004|Overall Study|Lost to Follow-up|1|||
163160606|NCT02839200|589302261|FG005|Overall Study|Lost to Follow-up|0|||
163160607|NCT02839200|589302256|FG000|Overall Study|Adverse Event|0|||
163160608|NCT02839200|589302257|FG001|Overall Study|Adverse Event|0|||
163160609|NCT02839200|589302258|FG002|Overall Study|Adverse Event|0|||
163160610|NCT02839200|589302259|FG003|Overall Study|Adverse Event|0|||
163160611|NCT02839200|589302260|FG004|Overall Study|Adverse Event|1|||
163160612|NCT02839200|589302261|FG005|Overall Study|Adverse Event|0|||
163160613|NCT02839200|589302256|FG000|Overall Study|Randomized in error|0|||
163160614|NCT02839200|589302257|FG001|Overall Study|Randomized in error|1|||
163160615|NCT02839200|589302258|FG002|Overall Study|Randomized in error|0|||
163160616|NCT02839200|589302259|FG003|Overall Study|Randomized in error|0|||
163160617|NCT02839200|589302260|FG004|Overall Study|Randomized in error|0|||
163160618|NCT02839200|589302261|FG005|Overall Study|Randomized in error|0|||
163160619|NCT03614156|589302262|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
163160620|NCT03614156|589302263|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160621|NCT03614156|589302264|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160622|NCT03614156|589302265|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
163160623|NCT03614156|589302262|FG000|Open-Label Treatment Period|Adverse Event|7|||
163160624|NCT03614156|589302263|FG001|Open-Label Treatment Period|Adverse Event|0|||
163160625|NCT03614156|589302264|FG002|Open-Label Treatment Period|Adverse Event|0|||
163160626|NCT03614156|589302265|FG003|Open-Label Treatment Period|Adverse Event|0|||
163160627|NCT03614156|589302262|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
163160628|NCT03614156|589302263|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
163160629|NCT03614156|589302264|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163160630|NCT03614156|589302265|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
163160631|NCT03614156|589302262|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
163160632|NCT03614156|589302263|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160633|NCT03614156|589302264|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160634|NCT03614156|589302265|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
163160635|NCT03614156|589302262|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
163160636|NCT03614156|589302263|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
163160637|NCT03614156|589302264|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
163160638|NCT03614156|589302265|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
163160639|NCT03614156|589302262|FG000|Open-Label Treatment Period|Protocol Violation|2|||
163160640|NCT03614156|589302263|FG001|Open-Label Treatment Period|Protocol Violation|0|||
163160641|NCT03614156|589302264|FG002|Open-Label Treatment Period|Protocol Violation|0|||
163160642|NCT03614156|589302265|FG003|Open-Label Treatment Period|Protocol Violation|0|||
163160643|NCT03614156|589302262|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
163160644|NCT03614156|589302263|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160645|NCT03614156|589302264|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160646|NCT03614156|589302265|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
163160647|NCT03614156|589302262|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
163160648|NCT03614156|589302263|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160649|NCT03614156|589302264|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160650|NCT03614156|589302265|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
163160651|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
163160652|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
163160653|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
163160654|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
163160655|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163160656|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
163160657|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163160658|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163160659|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163160660|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163160661|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
163160662|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
163160663|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
163160664|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160665|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160666|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
163160667|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
163160668|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
163160669|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
163160670|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
163160671|NCT03614156|589302262|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160672|NCT03614156|589302263|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
163160673|NCT03614156|589302264|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160674|NCT03614156|589302265|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
163160675|NCT03614156|589302262|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
163160676|NCT03614156|589302263|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
162811649|NCT00585195|588021771|FG016|Overall Study|Other|28|||
163160677|NCT03614156|589302264|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
163160678|NCT03614156|589302265|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
163160679|NCT03614156|589302262|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160680|NCT03614156|589302263|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160681|NCT03614156|589302264|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
163160682|NCT03614156|589302265|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
163160683|NCT03614156|589302262|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
163160684|NCT03614156|589302263|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
163160685|NCT03614156|589302264|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
163160686|NCT03614156|589302265|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
163160687|NCT01286480|589302267|FG000|Overall Study|Withdrawal by Subject|5|||
163160688|NCT01286480|589302268|FG001|Overall Study|Withdrawal by Subject|3|||
163160689|NCT00834093|589302269|FG000|Overall Study|Progressive Disease|3|||
163160690|NCT00834093|589302269|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
163160691|NCT00885534|589302270|FG000|Overall Study|Patient deemed ineligible|1|||
163160692|NCT02453711|589302271|FG000|Overall Study|Withdrawal by Subject|5|||
163160693|NCT02453711|589302272|FG001|Overall Study|Withdrawal by Subject|4|||
163160694|NCT02453711|589302273|FG002|Overall Study|Withdrawal by Subject|6|||
163160695|NCT02453711|589302274|FG003|Overall Study|Withdrawal by Subject|4|||
163160696|NCT02453711|589302275|FG004|Overall Study|Withdrawal by Subject|1|||
163160697|NCT02453711|589302276|FG005|Overall Study|Withdrawal by Subject|1|||
163160698|NCT02453711|589302277|FG006|Overall Study|Withdrawal by Subject|0|||
163160699|NCT02453711|589302278|FG007|Overall Study|Withdrawal by Subject|1|||
163160700|NCT02453711|589302279|FG008|Overall Study|Withdrawal by Subject|7|||
163160701|NCT02453711|589302271|FG000|Overall Study|Lost to Follow-up|5|||
163160702|NCT02453711|589302272|FG001|Overall Study|Lost to Follow-up|3|||
163160703|NCT02453711|589302273|FG002|Overall Study|Lost to Follow-up|2|||
163160704|NCT02453711|589302274|FG003|Overall Study|Lost to Follow-up|3|||
163160705|NCT02453711|589302275|FG004|Overall Study|Lost to Follow-up|1|||
163160706|NCT02453711|589302276|FG005|Overall Study|Lost to Follow-up|5|||
163160707|NCT02453711|589302277|FG006|Overall Study|Lost to Follow-up|2|||
163160708|NCT02453711|589302278|FG007|Overall Study|Lost to Follow-up|6|||
163160709|NCT02453711|589302279|FG008|Overall Study|Lost to Follow-up|6|||
163160710|NCT02453711|589302271|FG000|Overall Study|Death|0|||
163160711|NCT02453711|589302272|FG001|Overall Study|Death|0|||
163160712|NCT02453711|589302273|FG002|Overall Study|Death|0|||
163160713|NCT02453711|589302274|FG003|Overall Study|Death|0|||
163160714|NCT02453711|589302275|FG004|Overall Study|Death|0|||
163160715|NCT02453711|589302276|FG005|Overall Study|Death|0|||
163160716|NCT02453711|589302277|FG006|Overall Study|Death|1|||
163160717|NCT02453711|589302278|FG007|Overall Study|Death|0|||
163160718|NCT02453711|589302279|FG008|Overall Study|Death|0|||
163160719|NCT02453711|589302271|FG000|Overall Study|Unclassified|1|||
163160720|NCT02453711|589302272|FG001|Overall Study|Unclassified|0|||
163160721|NCT02453711|589302273|FG002|Overall Study|Unclassified|1|||
163160722|NCT02453711|589302274|FG003|Overall Study|Unclassified|0|||
163160723|NCT02453711|589302275|FG004|Overall Study|Unclassified|0|||
163160724|NCT02453711|589302276|FG005|Overall Study|Unclassified|0|||
163160725|NCT02453711|589302277|FG006|Overall Study|Unclassified|0|||
163160726|NCT02453711|589302278|FG007|Overall Study|Unclassified|0|||
163160727|NCT02453711|589302279|FG008|Overall Study|Unclassified|0|||
163160728|NCT01587924|589302280|FG000|Overall Study|Adverse Event|0|||
163160729|NCT01587924|589302281|FG001|Overall Study|Adverse Event|2|||
163160730|NCT01587924|589302282|FG002|Overall Study|Adverse Event|0|||
163160731|NCT01587924|589302283|FG003|Overall Study|Adverse Event|0|||
163160732|NCT01587924|589302280|FG000|Overall Study|Protocol Violation|2|||
163160733|NCT01587924|589302281|FG001|Overall Study|Protocol Violation|1|||
163160734|NCT01587924|589302282|FG002|Overall Study|Protocol Violation|2|||
163160735|NCT01587924|589302283|FG003|Overall Study|Protocol Violation|1|||
163160736|NCT01587924|589302280|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
163160737|NCT01587924|589302281|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
163160738|NCT01587924|589302282|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
163160739|NCT01587924|589302283|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
163160740|NCT01587924|589302280|FG000|Overall Study|Withdrawal by Subject|0|||
163160741|NCT01587924|589302281|FG001|Overall Study|Withdrawal by Subject|1|||
163160742|NCT01587924|589302282|FG002|Overall Study|Withdrawal by Subject|1|||
163160743|NCT01587924|589302283|FG003|Overall Study|Withdrawal by Subject|0|||
163160744|NCT01578486|589302284|FG000|Overall Study|Physician Decision|3|||
163160745|NCT01578486|589302284|FG000|Overall Study|Withdrawal by Subject|2|||
163160746|NCT00606593|589302285|FG000|Overall Study|Adverse Event|0|||
163160747|NCT00606593|589302286|FG001|Overall Study|Adverse Event|0|||
163160748|NCT00606593|589302287|FG002|Overall Study|Adverse Event|0|||
163160749|NCT00606593|589302288|FG003|Overall Study|Adverse Event|1|||
163160750|NCT00606593|589302289|FG004|Overall Study|Adverse Event|1|||
163160751|NCT00606593|589302290|FG005|Overall Study|Adverse Event|0|||
163160752|NCT00606593|589302291|FG006|Overall Study|Adverse Event|1|||
163160753|NCT00606593|589302292|FG007|Overall Study|Adverse Event|2|||
163160754|NCT00606593|589302293|FG008|Overall Study|Adverse Event|1|||
163160755|NCT00606593|589302294|FG009|Overall Study|Adverse Event|0|||
163160756|NCT00606593|589302285|FG000|Overall Study|Withdrawal of consent|1|||
163160757|NCT00606593|589302286|FG001|Overall Study|Withdrawal of consent|0|||
163160758|NCT00606593|589302287|FG002|Overall Study|Withdrawal of consent|1|||
163160759|NCT00606593|589302288|FG003|Overall Study|Withdrawal of consent|0|||
163160760|NCT00606593|589302289|FG004|Overall Study|Withdrawal of consent|0|||
163160761|NCT00606593|589302290|FG005|Overall Study|Withdrawal of consent|0|||
163160762|NCT00606593|589302291|FG006|Overall Study|Withdrawal of consent|0|||
163160763|NCT00606593|589302292|FG007|Overall Study|Withdrawal of consent|0|||
163160764|NCT00606593|589302293|FG008|Overall Study|Withdrawal of consent|0|||
163160765|NCT00606593|589302294|FG009|Overall Study|Withdrawal of consent|0|||
163160766|NCT00606593|589302285|FG000|Overall Study|Administrative/Other|0|||
163160767|NCT00606593|589302286|FG001|Overall Study|Administrative/Other|0|||
163160768|NCT00606593|589302287|FG002|Overall Study|Administrative/Other|1|||
163160769|NCT00606593|589302288|FG003|Overall Study|Administrative/Other|0|||
163160770|NCT00606593|589302289|FG004|Overall Study|Administrative/Other|0|||
163160771|NCT00606593|589302290|FG005|Overall Study|Administrative/Other|0|||
163160772|NCT00606593|589302291|FG006|Overall Study|Administrative/Other|0|||
163160773|NCT00606593|589302292|FG007|Overall Study|Administrative/Other|0|||
163160774|NCT00606593|589302293|FG008|Overall Study|Administrative/Other|0|||
163160775|NCT00606593|589302294|FG009|Overall Study|Administrative/Other|0|||
163160776|NCT03181529|589302295|FG000|Overall Study|Withdrawal by Subject|1|||
163160777|NCT03181529|589302296|FG001|Overall Study|Withdrawal by Subject|1|||
163160778|NCT03181529|589302295|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
163160779|NCT03181529|589302296|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
163160780|NCT00607373|589302297|FG000|Treatment Period|Adverse Event|0|||
163160781|NCT00607373|589302298|FG001|Treatment Period|Adverse Event|4|||
163160782|NCT00607373|589302297|FG000|Treatment Period|Physician Decision|0|||
163160783|NCT00607373|589302298|FG001|Treatment Period|Physician Decision|1|||
163160784|NCT00607373|589302297|FG000|Treatment Period|Withdrawal by Subject|0|||
163160785|NCT00607373|589302298|FG001|Treatment Period|Withdrawal by Subject|1|||
163160786|NCT00607373|589302297|FG000|Follow-up Period|Other|0|||
163160787|NCT00607373|589302298|FG001|Follow-up Period|Other|1|||
163160788|NCT00607373|589302297|FG000|Follow-up Period|Protocol Violation|0|||
163160789|NCT00607373|589302298|FG001|Follow-up Period|Protocol Violation|1|||
163160790|NCT00607373|589302297|FG000|Follow-up Period|Withdrawal by Subject|1|||
163160791|NCT00607373|589302298|FG001|Follow-up Period|Withdrawal by Subject|3|||
163160792|NCT01918306|589302299|FG000|Overall Study|progresive disease|4|||
163160793|NCT01918306|589302300|FG001|Overall Study|progresive disease|0|||
163160794|NCT01918306|589302301|FG002|Overall Study|progresive disease|1|||
163160795|NCT01918306|589302302|FG003|Overall Study|progresive disease|1|||
163160796|NCT01918306|589302299|FG000|Overall Study|Withdrawal by Subject|0|||
163160797|NCT01918306|589302300|FG001|Overall Study|Withdrawal by Subject|0|||
163160798|NCT01918306|589302301|FG002|Overall Study|Withdrawal by Subject|0|||
163160799|NCT01918306|589302302|FG003|Overall Study|Withdrawal by Subject|2|||
162811650|NCT00585195|588021772|FG017|Overall Study|Other|12|||
163160800|NCT01918306|589302299|FG000|Overall Study|neutropenia|1|||
163160801|NCT01918306|589302300|FG001|Overall Study|neutropenia|0|||
163160802|NCT01918306|589302301|FG002|Overall Study|neutropenia|0|||
163160803|NCT01918306|589302302|FG003|Overall Study|neutropenia|0|||
163160804|NCT01918306|589302299|FG000|Overall Study|Lack of Efficacy|1|||
163160805|NCT01918306|589302300|FG001|Overall Study|Lack of Efficacy|0|||
163160806|NCT01918306|589302301|FG002|Overall Study|Lack of Efficacy|0|||
163160807|NCT01918306|589302302|FG003|Overall Study|Lack of Efficacy|0|||
163160808|NCT01918306|589302299|FG000|Overall Study|progress disease, crossover|0|||
163160809|NCT01918306|589302300|FG001|Overall Study|progress disease, crossover|0|||
163160810|NCT01918306|589302301|FG002|Overall Study|progress disease, crossover|1|||
163160811|NCT01918306|589302302|FG003|Overall Study|progress disease, crossover|0|||
163160812|NCT00314795|589302310|FG000|Overall Study|Adverse Event|8|||
163160813|NCT00314795|589302310|FG000|Overall Study|Death|4|||
163160814|NCT00314795|589302310|FG000|Overall Study|Reason not Specified|3|||
163160815|NCT00314795|589302310|FG000|Overall Study|Renal Transplant|3|||
163160816|NCT00314795|589302310|FG000|Overall Study|Participants Withdrew Consent|2|||
163160817|NCT02908672|589302320|FG000|Run-in Period|Death|12|||
163160818|NCT02908672|589302321|FG001|Run-in Period|Death|10|||
163160819|NCT02908672|589302322|FG002|Run-in Period|Death|0|||
163160820|NCT02908672|589302323|FG003|Run-in Period|Death|0|||
163160821|NCT02908672|589302320|FG000|Run-in Period|Lost to Follow-up|1|||
163160822|NCT02908672|589302321|FG001|Run-in Period|Lost to Follow-up|1|||
163160823|NCT02908672|589302322|FG002|Run-in Period|Lost to Follow-up|0|||
163160824|NCT02908672|589302323|FG003|Run-in Period|Lost to Follow-up|0|||
163160825|NCT02908672|589302320|FG000|Run-in Period|Reason Not Specified|2|||
163160826|NCT02908672|589302321|FG001|Run-in Period|Reason Not Specified|0|||
163160827|NCT02908672|589302322|FG002|Run-in Period|Reason Not Specified|0|||
163160828|NCT02908672|589302323|FG003|Run-in Period|Reason Not Specified|0|||
163160829|NCT02908672|589302320|FG000|Run-in Period|Protocol Violation|1|||
163160830|NCT02908672|589302321|FG001|Run-in Period|Protocol Violation|1|||
163160831|NCT02908672|589302322|FG002|Run-in Period|Protocol Violation|0|||
163160832|NCT02908672|589302323|FG003|Run-in Period|Protocol Violation|0|||
163160833|NCT02908672|589302320|FG000|Run-in Period|Study Ended by Sponsor|5|||
163160834|NCT02908672|589302321|FG001|Run-in Period|Study Ended by Sponsor|1|||
163160835|NCT02908672|589302322|FG002|Run-in Period|Study Ended by Sponsor|0|||
163160836|NCT02908672|589302323|FG003|Run-in Period|Study Ended by Sponsor|0|||
163160837|NCT02908672|589302320|FG000|Run-in Period|Withdrawal by Subject|3|||
163160838|NCT02908672|589302321|FG001|Run-in Period|Withdrawal by Subject|9|||
163160839|NCT02908672|589302322|FG002|Run-in Period|Withdrawal by Subject|0|||
163160840|NCT02908672|589302323|FG003|Run-in Period|Withdrawal by Subject|0|||
163160841|NCT02908672|589302320|FG000|Triple Combination Period|Death|0|||
163160842|NCT02908672|589302321|FG001|Triple Combination Period|Death|0|||
163160843|NCT02908672|589302322|FG002|Triple Combination Period|Death|150|||
163160844|NCT02908672|589302323|FG003|Triple Combination Period|Death|127|||
163160845|NCT02908672|589302320|FG000|Triple Combination Period|Lost to Follow-up|0|||
163160846|NCT02908672|589302321|FG001|Triple Combination Period|Lost to Follow-up|0|||
163160847|NCT02908672|589302322|FG002|Triple Combination Period|Lost to Follow-up|6|||
163160848|NCT02908672|589302323|FG003|Triple Combination Period|Lost to Follow-up|8|||
163160849|NCT02908672|589302320|FG000|Triple Combination Period|Reason Not Specified|0|||
163160850|NCT02908672|589302321|FG001|Triple Combination Period|Reason Not Specified|0|||
163160851|NCT02908672|589302322|FG002|Triple Combination Period|Reason Not Specified|0|||
163160852|NCT02908672|589302323|FG003|Triple Combination Period|Reason Not Specified|1|||
163160853|NCT02908672|589302320|FG000|Triple Combination Period|Physician Decision|0|||
163160854|NCT02908672|589302321|FG001|Triple Combination Period|Physician Decision|0|||
163160855|NCT02908672|589302322|FG002|Triple Combination Period|Physician Decision|1|||
163160856|NCT02908672|589302323|FG003|Triple Combination Period|Physician Decision|1|||
163160857|NCT02908672|589302320|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
163160858|NCT02908672|589302321|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
163160859|NCT02908672|589302322|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
163160860|NCT02908672|589302323|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
163160861|NCT02908672|589302320|FG000|Triple Combination Period|Withdrawal by Subject|0|||
163160862|NCT02908672|589302321|FG001|Triple Combination Period|Withdrawal by Subject|0|||
163160863|NCT02908672|589302322|FG002|Triple Combination Period|Withdrawal by Subject|13|||
162811651|NCT00585195|588021773|FG018|Overall Study|Other|10|||
163160864|NCT02908672|589302323|FG003|Triple Combination Period|Withdrawal by Subject|16|||
163160865|NCT02876601|589302327|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160866|NCT02876601|589302328|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160867|NCT02876601|589302329|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
163160868|NCT02876601|589302330|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
163160869|NCT00759941|589302331|FG000|Overall Study|Use of medication|1|||
163160870|NCT00759941|589302332|FG001|Overall Study|Use of medication|0|||
163160871|NCT00759941|589302331|FG000|Overall Study|Adverse Event|1|||
163160872|NCT00759941|589302332|FG001|Overall Study|Adverse Event|0|||
163160873|NCT00759941|589302331|FG000|Overall Study|Exited in error by site|1|||
163160874|NCT00759941|589302332|FG001|Overall Study|Exited in error by site|1|||
163160875|NCT00354432|589302333|FG000|Overall Study|Adverse Event|3|||
163160876|NCT00354432|589302334|FG001|Overall Study|Adverse Event|1|||
163160877|NCT00354432|589302335|FG002|Overall Study|Adverse Event|5|||
163160878|NCT00354432|589302336|FG003|Overall Study|Adverse Event|5|||
163160879|NCT00354432|589302333|FG000|Overall Study|Off/Toxicity|3|||
163160880|NCT00354432|589302334|FG001|Overall Study|Off/Toxicity|7|||
163160881|NCT00354432|589302335|FG002|Overall Study|Off/Toxicity|5|||
163160882|NCT00354432|589302336|FG003|Overall Study|Off/Toxicity|5|||
163160883|NCT03863080|589302337|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160884|NCT03863080|589302338|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160885|NCT03863080|589302339|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
163160886|NCT03863080|589302340|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
163160887|NCT03863080|589302337|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160888|NCT03863080|589302338|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160889|NCT03863080|589302339|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
163160890|NCT03863080|589302340|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
163160891|NCT03863080|589302337|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160892|NCT03863080|589302338|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160893|NCT03863080|589302339|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
163160894|NCT03863080|589302340|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
162811652|NCT00585195|588021774|FG019|Overall Study|Other|4|||
163160895|NCT00802945|589302342|FG000|Overall Study|Death|27|||
163160896|NCT00802945|589302343|FG001|Overall Study|Death|23|||
163160897|NCT00802945|589302342|FG000|Overall Study|Terminated by sponsor|8|||
163058554|NCT00042289|588924241|FG006|Overall Study|Site closed|0|||
163160898|NCT00802945|589302343|FG001|Overall Study|Terminated by sponsor|12|||
163160899|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160900|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
163160901|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160902|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
163160903|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160904|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
163160905|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160906|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
163160907|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
163160908|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
163160909|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
163160910|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
163160911|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
163160912|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
163160913|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
163160914|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
163160915|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160916|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
163160917|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160918|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
163160919|NCT05307692|589302344|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
163160920|NCT05307692|589302345|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
163160921|NCT05307692|589302346|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
163160922|NCT05307692|589302347|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
163160923|NCT05307692|589302344|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160924|NCT05307692|589302345|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160925|NCT05307692|589302346|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
163160926|NCT05307692|589302347|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
163160927|NCT05307692|589302344|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160928|NCT05307692|589302345|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160929|NCT05307692|589302346|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163160930|NCT05307692|589302347|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
163160931|NCT03493464|589302350|FG000|Overall Study|Surgery not performed|1|||
163160932|NCT04949490|589302351|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160933|NCT04949490|589302352|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160934|NCT04949490|589302353|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160935|NCT04949490|589302354|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
163160936|NCT04949490|589302355|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160937|NCT04949490|589302356|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
163160938|NCT04949490|589302351|FG000|Group A and Group B|Withdrawal by Subject|0|||
163160939|NCT04949490|589302352|FG001|Group A and Group B|Withdrawal by Subject|0|||
163160940|NCT04949490|589302353|FG002|Group A and Group B|Withdrawal by Subject|1|||
163160941|NCT04949490|589302354|FG003|Group A and Group B|Withdrawal by Subject|0|||
163160942|NCT04949490|589302355|FG004|Group A and Group B|Withdrawal by Subject|0|||
163160943|NCT04949490|589302356|FG005|Group A and Group B|Withdrawal by Subject|0|||
163160944|NCT04949490|589302351|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160945|NCT04949490|589302352|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160946|NCT04949490|589302353|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160947|NCT04949490|589302354|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160948|NCT04949490|589302355|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
163160949|NCT04949490|589302356|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
163160950|NCT04949490|589302351|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160951|NCT04949490|589302352|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160952|NCT04949490|589302353|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160953|NCT04949490|589302354|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160954|NCT04949490|589302355|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
163160955|NCT04949490|589302356|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
163160956|NCT05232682|589302357|FG000|Overall Study|Lost to Follow-up|2|||
163160957|NCT00905164|589302358|FG000|Period 1|Protocol Violation|0|||
163160958|NCT00905164|589302359|FG001|Period 1|Protocol Violation|1|||
163160959|NCT04730804|589302360|FG000|Overall Study|Physician Decision|0|||
163160960|NCT04730804|589302361|FG001|Overall Study|Physician Decision|0|||
163160961|NCT04730804|589302362|FG002|Overall Study|Physician Decision|0|||
163160962|NCT04730804|589302363|FG003|Overall Study|Physician Decision|0|||
163160963|NCT04730804|589302364|FG004|Overall Study|Physician Decision|0|||
163160964|NCT04730804|589302365|FG005|Overall Study|Physician Decision|1|||
163160965|NCT04730804|589302360|FG000|Overall Study|Withdrawal by Subject|0|||
163160966|NCT04730804|589302361|FG001|Overall Study|Withdrawal by Subject|0|||
163160967|NCT04730804|589302362|FG002|Overall Study|Withdrawal by Subject|0|||
163160968|NCT04730804|589302363|FG003|Overall Study|Withdrawal by Subject|0|||
163160969|NCT04730804|589302364|FG004|Overall Study|Withdrawal by Subject|1|||
163160970|NCT04730804|589302365|FG005|Overall Study|Withdrawal by Subject|2|||
163160971|NCT01077050|589304024|FG000|Overall Study|Subjects signed ICF could not be located|1|||
163160972|NCT01077050|589304024|FG000|Overall Study|Screen failure|8|||
163160973|NCT00684060|589304025|FG000|Overall Study|Lost to Follow-up|1|||
163160974|NCT00684060|589304026|FG001|Overall Study|Lost to Follow-up|0|||
163160975|NCT00684060|589304025|FG000|Overall Study|New stenosis identified|1|||
163160976|NCT00684060|589304026|FG001|Overall Study|New stenosis identified|0|||
163160977|NCT00684060|589304025|FG000|Overall Study|Unable to collect MRI|1|||
163160978|NCT00684060|589304026|FG001|Overall Study|Unable to collect MRI|2|||
163160979|NCT00684060|589304025|FG000|Overall Study|Death|0|||
163160980|NCT00684060|589304026|FG001|Overall Study|Death|1|||
163160981|NCT00702715|589304031|FG000|Overall Study|Lost to Follow-up|1|||
163160982|NCT00702715|589304032|FG001|Overall Study|Lost to Follow-up|0|||
163160983|NCT03126344|589304043|FG000|Overall Study|Lost to Follow-up|0|||
163160984|NCT03126344|589304044|FG001|Overall Study|Lost to Follow-up|0|||
163160985|NCT03126344|589304045|FG002|Overall Study|Lost to Follow-up|5|||
163160986|NCT01715857|589304046|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
163160987|NCT02563067|589304047|FG000|Overall Study|Subject/guardian decision|14|||
163160988|NCT02563067|589304048|FG001|Overall Study|Subject/guardian decision|20|||
163160989|NCT02563067|589304049|FG002|Overall Study|Subject/guardian decision|16|||
163160990|NCT02563067|589304047|FG000|Overall Study|Physician Decision|0|||
163160991|NCT02563067|589304048|FG001|Overall Study|Physician Decision|1|||
163160992|NCT02563067|589304049|FG002|Overall Study|Physician Decision|3|||
163160993|NCT02563067|589304047|FG000|Overall Study|Lost to Follow-up|1|||
163160994|NCT02563067|589304048|FG001|Overall Study|Lost to Follow-up|2|||
163160995|NCT02563067|589304049|FG002|Overall Study|Lost to Follow-up|0|||
163160996|NCT02563067|589304047|FG000|Overall Study|Technical problems|0|||
163160997|NCT02563067|589304048|FG001|Overall Study|Technical problems|1|||
163160998|NCT02563067|589304049|FG002|Overall Study|Technical problems|0|||
163160999|NCT02563067|589304047|FG000|Overall Study|Lack of Efficacy|1|||
163161000|NCT02563067|589304048|FG001|Overall Study|Lack of Efficacy|0|||
163161001|NCT02563067|589304049|FG002|Overall Study|Lack of Efficacy|0|||
163161002|NCT02563067|589304047|FG000|Overall Study|Death|0|||
163161003|NCT02563067|589304048|FG001|Overall Study|Death|1|||
163161004|NCT02563067|589304049|FG002|Overall Study|Death|1|||
163161005|NCT02563067|589304047|FG000|Overall Study|Adverse Event|2|||
163161006|NCT02563067|589304048|FG001|Overall Study|Adverse Event|1|||
163161007|NCT02563067|589304049|FG002|Overall Study|Adverse Event|0|||
163161008|NCT02563067|589304047|FG000|Overall Study|Death post Treatment/safety period|1|||
163161009|NCT02563067|589304048|FG001|Overall Study|Death post Treatment/safety period|0|||
163161010|NCT02563067|589304049|FG002|Overall Study|Death post Treatment/safety period|0|||
163161011|NCT03544333|589304050|FG000|Overall Study|Withdrawal by Subject|1|||
163161012|NCT03544333|589304051|FG001|Overall Study|Withdrawal by Subject|0|||
163161013|NCT00475306|589304059|FG000|Overall Study|Protocol Violation|1|||
163161014|NCT00475306|589304060|FG001|Overall Study|Protocol Violation|1|||
163161015|NCT00475306|589304061|FG002|Overall Study|Protocol Violation|0|||
163161016|NCT00475306|589304062|FG003|Overall Study|Protocol Violation|1|||
163161017|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
163161018|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
163161019|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
163161020|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
163161021|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
163161022|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
163161023|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
163161024|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
163161025|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
163161026|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
163161027|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
163161028|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
163161029|NCT02405442|589304064|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161030|NCT02405442|589304065|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
163161031|NCT02405442|589304066|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161032|NCT02405442|589304067|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
163161033|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
163161034|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
163161035|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
162811653|NCT00585195|588021775|FG020|Overall Study|Other|2|||
163161036|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
163161037|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
163161038|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
163161039|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
163161040|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
163161041|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
163161042|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
163161043|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
163161044|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
163161045|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
163161046|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
163161047|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
163161048|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
163161049|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161050|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
163161051|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161052|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
163161053|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161054|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
163161055|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161056|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
163161057|NCT02405442|589304064|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161058|NCT02405442|589304065|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
163161059|NCT02405442|589304066|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161060|NCT02405442|589304067|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
163161061|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161062|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
163161063|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161064|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
163161065|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161066|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
162924203|NCT02426125|588423829|FG000|Overall Study|Death|185|||
163161067|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161068|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
163161069|NCT02405442|589304064|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
163161070|NCT02405442|589304065|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161071|NCT02405442|589304066|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161072|NCT02405442|589304067|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
163161073|NCT00337675|589304070|FG000|Overall Study|Adverse Event|10|||
163161074|NCT00337675|589304071|FG001|Overall Study|Adverse Event|9|||
163161075|NCT00337675|589304072|FG002|Overall Study|Adverse Event|19|||
163161076|NCT00337675|589304070|FG000|Overall Study|Lack of Efficacy|10|||
163161077|NCT00337675|589304071|FG001|Overall Study|Lack of Efficacy|7|||
163161078|NCT00337675|589304072|FG002|Overall Study|Lack of Efficacy|9|||
163161079|NCT00337675|589304070|FG000|Overall Study|Lost to Follow-up|22|||
163161080|NCT00337675|589304071|FG001|Overall Study|Lost to Follow-up|19|||
163161081|NCT00337675|589304072|FG002|Overall Study|Lost to Follow-up|17|||
163161082|NCT00337675|589304070|FG000|Overall Study|Physician Decision|9|||
163161083|NCT00337675|589304071|FG001|Overall Study|Physician Decision|17|||
163161084|NCT00337675|589304072|FG002|Overall Study|Physician Decision|14|||
163161085|NCT00337675|589304070|FG000|Overall Study|Protocol Violation|21|||
163161086|NCT00337675|589304071|FG001|Overall Study|Protocol Violation|24|||
163161087|NCT00337675|589304072|FG002|Overall Study|Protocol Violation|19|||
163161088|NCT00337675|589304070|FG000|Overall Study|Withdrawal by Subject|25|||
163161089|NCT00337675|589304071|FG001|Overall Study|Withdrawal by Subject|25|||
163161090|NCT00337675|589304072|FG002|Overall Study|Withdrawal by Subject|19|||
162924204|NCT02426125|588423830|FG001|Overall Study|Death|200|||
162696349|NCT01533714|587599475|FG003|Overall Study|Ineligibility reason|1|||
162696350|NCT01533714|587599476|FG004|Overall Study|Ineligibility reason|0|||
162696351|NCT01533714|587599477|FG005|Overall Study|Ineligibility reason|0|||
162696352|NCT02564055|587599478|FG000|Overall Study|Adverse Event|1|||
162696353|NCT02564055|587599479|FG001|Overall Study|Adverse Event|0|||
162696354|NCT02564055|587599480|FG002|Overall Study|Adverse Event|4|||
162696355|NCT02564055|587599481|FG003|Overall Study|Adverse Event|1|||
162696356|NCT02564055|587599482|FG004|Overall Study|Adverse Event|4|||
162696357|NCT02564055|587599483|FG005|Overall Study|Adverse Event|1|||
162696358|NCT02564055|587599478|FG000|Overall Study|Protocol Violation|1|||
162696359|NCT02564055|587599479|FG001|Overall Study|Protocol Violation|0|||
162696360|NCT02564055|587599480|FG002|Overall Study|Protocol Violation|0|||
162696361|NCT02564055|587599481|FG003|Overall Study|Protocol Violation|0|||
162696362|NCT02564055|587599482|FG004|Overall Study|Protocol Violation|0|||
162696363|NCT02564055|587599483|FG005|Overall Study|Protocol Violation|0|||
162696364|NCT02564055|587599478|FG000|Overall Study|Reached stopping criteria|0|||
162696365|NCT02564055|587599479|FG001|Overall Study|Reached stopping criteria|0|||
162696366|NCT02564055|587599480|FG002|Overall Study|Reached stopping criteria|0|||
162696367|NCT02564055|587599481|FG003|Overall Study|Reached stopping criteria|0|||
162696368|NCT02564055|587599482|FG004|Overall Study|Reached stopping criteria|0|||
162696369|NCT02564055|587599483|FG005|Overall Study|Reached stopping criteria|1|||
162696370|NCT02564055|587599478|FG000|Overall Study|Lost to Follow-up|0|||
162696371|NCT02564055|587599479|FG001|Overall Study|Lost to Follow-up|1|||
162696372|NCT02564055|587599480|FG002|Overall Study|Lost to Follow-up|4|||
162696373|NCT02564055|587599481|FG003|Overall Study|Lost to Follow-up|2|||
162696374|NCT02564055|587599482|FG004|Overall Study|Lost to Follow-up|1|||
162696375|NCT02564055|587599483|FG005|Overall Study|Lost to Follow-up|0|||
162696376|NCT02564055|587599478|FG000|Overall Study|Physician Decision|0|||
162696377|NCT02564055|587599479|FG001|Overall Study|Physician Decision|0|||
162696378|NCT02564055|587599480|FG002|Overall Study|Physician Decision|1|||
162696379|NCT02564055|587599481|FG003|Overall Study|Physician Decision|0|||
162696380|NCT02564055|587599482|FG004|Overall Study|Physician Decision|0|||
162696381|NCT02564055|587599483|FG005|Overall Study|Physician Decision|0|||
162696382|NCT02564055|587599478|FG000|Overall Study|Withdrawal by Subject|4|||
162696383|NCT02564055|587599479|FG001|Overall Study|Withdrawal by Subject|4|||
162696384|NCT02564055|587599480|FG002|Overall Study|Withdrawal by Subject|3|||
162696385|NCT02564055|587599481|FG003|Overall Study|Withdrawal by Subject|3|||
162696386|NCT02564055|587599482|FG004|Overall Study|Withdrawal by Subject|10|||
162696387|NCT02564055|587599483|FG005|Overall Study|Withdrawal by Subject|10|||
162696388|NCT00919893|587599487|FG000|Overall Study|Protocol Violation|19|||
162696389|NCT00919893|587599488|FG001|Overall Study|Protocol Violation|9|||
162696390|NCT01375959|587599489|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
162696391|NCT01375959|587599490|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
162696392|NCT01375959|587599489|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
162696393|NCT01375959|587599490|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
162696394|NCT01375959|587599489|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162696395|NCT01375959|587599490|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
162696396|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
162696397|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
162696398|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162696399|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
162696400|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
162696401|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
162696402|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
162696403|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
162696404|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
162696405|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
162696406|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
162696407|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
162696408|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
162696409|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
162696410|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
162696411|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
162696412|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
162696413|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
162696414|NCT00365378|587599498|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
162696415|NCT00365378|587599499|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
162696416|NCT00365378|587599500|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
162696417|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
162696418|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
162696419|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
162696420|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
162696421|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
162696422|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
162696423|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
162696424|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
162696425|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
162696426|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
162696427|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
162696428|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
162696429|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
162696430|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
162696431|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
162696432|NCT00365378|587599498|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
162696433|NCT00365378|587599499|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
162696434|NCT00365378|587599500|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
162696435|NCT00365378|587599498|FG000|Extension|Adverse Event|0|||
162696436|NCT00365378|587599499|FG001|Extension|Adverse Event|0|||
162696437|NCT00365378|587599500|FG002|Extension|Adverse Event|1|||
162696438|NCT00365378|587599498|FG000|Extension|Moved|0|||
162696439|NCT00365378|587599499|FG001|Extension|Moved|0|||
162696440|NCT00365378|587599500|FG002|Extension|Moved|8|||
162696441|NCT00365378|587599498|FG000|Extension|Lost to Follow-up|0|||
162696442|NCT00365378|587599499|FG001|Extension|Lost to Follow-up|0|||
162696443|NCT00365378|587599500|FG002|Extension|Lost to Follow-up|57|||
162696444|NCT00365378|587599498|FG000|Extension|Protocol Violation|0|||
162696445|NCT00365378|587599499|FG001|Extension|Protocol Violation|0|||
162696446|NCT00365378|587599500|FG002|Extension|Protocol Violation|2|||
162696447|NCT00365378|587599498|FG000|Extension|Withdrawal by Subject|0|||
162696448|NCT00365378|587599499|FG001|Extension|Withdrawal by Subject|0|||
162696449|NCT00365378|587599500|FG002|Extension|Withdrawal by Subject|98|||
162696450|NCT00365378|587599498|FG000|Extension|Other|0|||
162696451|NCT00365378|587599499|FG001|Extension|Other|0|||
162696452|NCT00365378|587599500|FG002|Extension|Other|31|||
162696453|NCT04741802|587599501|FG000|Overall Study|Death|1|||
162696454|NCT04741802|587599501|FG000|Overall Study|Lost to Follow-up|11|||
162696455|NCT04161807|587599507|FG000|Overall Study|Withdrawal by Subject|2|||
162696456|NCT04161807|587599507|FG000|Overall Study|Performed only 1 treatment|2|||
162696457|NCT00708305|587599518|FG000|Period 1|Protocol Violation|1|||
162696458|NCT00708305|587599519|FG001|Period 1|Protocol Violation|0|||
162696459|NCT00708305|587599520|FG002|Period 1|Protocol Violation|1|||
162696460|NCT00708305|587599521|FG003|Period 1|Protocol Violation|0|||
162696461|NCT00708305|587599518|FG000|Period 1|Other Reason|0|||
162696462|NCT00708305|587599519|FG001|Period 1|Other Reason|0|||
162696463|NCT00708305|587599520|FG002|Period 1|Other Reason|0|||
162696464|NCT00708305|587599521|FG003|Period 1|Other Reason|2|||
162696465|NCT00708305|587599518|FG000|Period 2|Lost to Follow-up|0|||
162696466|NCT00708305|587599519|FG001|Period 2|Lost to Follow-up|1|||
162696467|NCT00708305|587599520|FG002|Period 2|Lost to Follow-up|0|||
162696468|NCT00708305|587599521|FG003|Period 2|Lost to Follow-up|0|||
162696469|NCT00708305|587599518|FG000|Period 2|Protocol Violation|0|||
162696470|NCT00708305|587599519|FG001|Period 2|Protocol Violation|1|||
162696471|NCT00708305|587599520|FG002|Period 2|Protocol Violation|0|||
162696472|NCT00708305|587599521|FG003|Period 2|Protocol Violation|0|||
162696473|NCT00708305|587599518|FG000|Period 2|Other Reason|1|||
162696474|NCT00708305|587599519|FG001|Period 2|Other Reason|0|||
162696475|NCT00708305|587599520|FG002|Period 2|Other Reason|0|||
162696476|NCT00708305|587599521|FG003|Period 2|Other Reason|1|||
162696477|NCT00708305|587599518|FG000|Period 3|Protocol Violation|0|||
162696478|NCT00708305|587599519|FG001|Period 3|Protocol Violation|2|||
162696479|NCT00708305|587599520|FG002|Period 3|Protocol Violation|0|||
162696480|NCT00708305|587599521|FG003|Period 3|Protocol Violation|0|||
162696481|NCT00708305|587599518|FG000|Period 3|Other Reason|1|||
162696482|NCT00708305|587599519|FG001|Period 3|Other Reason|0|||
162696483|NCT00708305|587599520|FG002|Period 3|Other Reason|0|||
162696484|NCT00708305|587599521|FG003|Period 3|Other Reason|0|||
162696485|NCT00192023|587599526|FG000|Period III - Double-Blind|Adverse Event|3|||
162696486|NCT00192023|587599527|FG001|Period III - Double-Blind|Adverse Event|0|||
162696487|NCT00192023|587599526|FG000|Period III - Double-Blind|Physician Decision|2|||
162696488|NCT00192023|587599527|FG001|Period III - Double-Blind|Physician Decision|0|||
162696489|NCT00192023|587599526|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
162696490|NCT00192023|587599527|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
162696491|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
162696492|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
162696493|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
162696494|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
162696495|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
162696496|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
162696497|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
162696498|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
162696499|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
162696500|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
162696501|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
162696502|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
162696503|NCT00192023|587599526|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
162696504|NCT00192023|587599527|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
162696505|NCT02572817|587599552|FG000|Overall Study|Death|6|||
162696506|NCT02572817|587599553|FG001|Overall Study|Death|3|||
162696507|NCT02572817|587599552|FG000|Overall Study|Lost to Follow-up|3|||
162696508|NCT02572817|587599553|FG001|Overall Study|Lost to Follow-up|3|||
162696509|NCT01258660|587599557|FG000|Overall Study|Adverse Event|2|||
162696510|NCT01258660|587599558|FG001|Overall Study|Adverse Event|4|||
162696511|NCT01258660|587599557|FG000|Overall Study|Withdrawal by Subject|3|||
162696512|NCT01258660|587599558|FG001|Overall Study|Withdrawal by Subject|0|||
162696513|NCT01258660|587599557|FG000|Overall Study|due to relocation|2|||
162696514|NCT01258660|587599558|FG001|Overall Study|due to relocation|0|||
162696515|NCT01258660|587599557|FG000|Overall Study|Protocol Violation|0|||
162696516|NCT01258660|587599558|FG001|Overall Study|Protocol Violation|1|||
162696517|NCT01258660|587599557|FG000|Overall Study|Invalid for primary analysis data set|4|||
162696518|NCT01258660|587599558|FG001|Overall Study|Invalid for primary analysis data set|6|||
162696519|NCT04192630|587599559|FG000|Overall Study|Discontinued before surgery|2|||
162696520|NCT04192630|587599560|FG001|Overall Study|Discontinued before surgery|0|||
162696521|NCT04192630|587599559|FG000|Overall Study|Discontinued after surgery|5|||
162696522|NCT04192630|587599560|FG001|Overall Study|Discontinued after surgery|3|||
162696523|NCT01193582|587599561|FG000|Vaccination Series|Withdrawal by Subject|11|||
162696524|NCT01193582|587599562|FG001|Vaccination Series|Withdrawal by Subject|13|||
162696525|NCT01193582|587599563|FG002|Vaccination Series|Withdrawal by Subject|8|||
162696526|NCT01193582|587599564|FG003|Vaccination Series|Withdrawal by Subject|3|||
162811654|NCT00585195|588021755|FG000|Overall Study|Randomized not treated|0|||
162696527|NCT01193582|587599561|FG000|12 Month Follow-up|Death|0|||
162696528|NCT01193582|587599562|FG001|12 Month Follow-up|Death|0|||
162696529|NCT01193582|587599563|FG002|12 Month Follow-up|Death|1|||
162696530|NCT01193582|587599564|FG003|12 Month Follow-up|Death|0|||
162696531|NCT01193582|587599561|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
162696532|NCT01193582|587599562|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
162696533|NCT01193582|587599563|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
162696534|NCT01193582|587599564|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
162696535|NCT01775930|587599570|FG000|Overall Study|Futility stopping boundary met|1|||
162696536|NCT01208415|587599571|FG000|Overall Study|Death|1|||
162696537|NCT01208415|587599571|FG000|Overall Study|Lost to Follow-up|2|||
162696538|NCT01208415|587599571|FG000|Overall Study|Withdrawal by Subject|3|||
162696539|NCT01208415|587599571|FG000|Overall Study|Device not placed|1|||
162696540|NCT01208415|587599571|FG000|Overall Study|Still be eligible for follow-up|33|||
162696541|NCT02340520|587599572|FG000|Overall Study|Lost to Follow-up|1|||
162696542|NCT02340520|587599572|FG000|Overall Study|Patient did not take drug as specified|1|||
162696543|NCT02340520|587599572|FG000|Overall Study|Withdrawal by Subject|1|||
162696544|NCT01586338|587599574|FG000|Overall Study|Adverse Event|3|||
162696545|NCT01586338|587599574|FG000|Overall Study|Lost to Follow-up|1|||
162696546|NCT01586338|587599574|FG000|Overall Study|Withdrawal by participant|3|||
162696547|NCT01586338|587599574|FG000|Overall Study|Other|1|||
162696548|NCT00896454|587599590|FG000|Overall Study|Death|10|||
162696549|NCT00896454|587599590|FG000|Overall Study|Adverse Event|8|||
162696550|NCT00896454|587599590|FG000|Overall Study|Disease Progression|5|||
162696551|NCT00896454|587599590|FG000|Overall Study|Other|4|||
162696552|NCT00896454|587599590|FG000|Overall Study|Requirement for alternative therapy|3|||
162696553|NCT00896454|587599590|FG000|Overall Study|Ongoing in study|2|||
162696554|NCT00896454|587599590|FG000|Overall Study|Withdrawal by Subject|1|||
162696555|NCT00856661|587599593|FG000|Overall Study|Death|15|||
162696556|NCT00856661|587599594|FG001|Overall Study|Death|18|||
162696557|NCT00856661|587599593|FG000|Overall Study|Protocol Violation|2|||
162696558|NCT00856661|587599594|FG001|Overall Study|Protocol Violation|1|||
162696559|NCT00856661|587599593|FG000|Overall Study|Withdrawal by Subject|1|||
162696560|NCT00856661|587599594|FG001|Overall Study|Withdrawal by Subject|2|||
162696561|NCT00856661|587599593|FG000|Overall Study|Lost to Follow-up|1|||
162696562|NCT00856661|587599594|FG001|Overall Study|Lost to Follow-up|3|||
162696563|NCT00856661|587599593|FG000|Overall Study|Physician Judgement|8|||
162696564|NCT00856661|587599594|FG001|Overall Study|Physician Judgement|5|||
162696565|NCT03936777|587599595|FG000|Overall Study|Adverse Event|3|||
162696566|NCT03936777|587599595|FG000|Overall Study|Death|3|||
162696567|NCT03936777|587599595|FG000|Overall Study|Lack of Efficacy|24|||
162696568|NCT03936777|587599595|FG000|Overall Study|Lost to Follow-up|3|||
162696569|NCT03936777|587599595|FG000|Overall Study|Physician Decision|1|||
162696570|NCT03936777|587599595|FG000|Overall Study|Withdrawal by Subject|11|||
162696571|NCT03936777|587599595|FG000|Overall Study|Subjected Weaned of ZX008|1|||
162696572|NCT03936777|587599595|FG000|Overall Study|Missing|6|||
162696573|NCT02301156|587599596|FG000|Overall Study|Adverse Event|13|||
162696574|NCT02301156|587599597|FG001|Overall Study|Adverse Event|14|||
162696575|NCT02301156|587599596|FG000|Overall Study|Death|1|||
162696576|NCT02301156|587599597|FG001|Overall Study|Death|5|||
162696577|NCT02301156|587599596|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
162696578|NCT02301156|587599597|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
162696579|NCT02301156|587599596|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
162696580|NCT02301156|587599597|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
162696581|NCT02301156|587599596|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
162696582|NCT02301156|587599597|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
162696583|NCT02301156|587599596|FG000|Overall Study|Reason not Specified|6|||
162696584|NCT02301156|587599597|FG001|Overall Study|Reason not Specified|3|||
162696585|NCT03734991|587599602|FG000|Overall Study|Adverse Event|4|||
162696586|NCT03734991|587599603|FG001|Overall Study|Adverse Event|0|||
162696587|NCT03734991|587599602|FG000|Overall Study|Lost to Follow-up|4|||
162696588|NCT03734991|587599603|FG001|Overall Study|Lost to Follow-up|0|||
162696589|NCT03734991|587599602|FG000|Overall Study|Physician Decision|0|||
162696590|NCT03734991|587599603|FG001|Overall Study|Physician Decision|1|||
162696591|NCT03734991|587599602|FG000|Overall Study|Pregnancy|1|||
162696592|NCT03734991|587599603|FG001|Overall Study|Pregnancy|0|||
162696593|NCT03734991|587599602|FG000|Overall Study|Withdrawal by Subject|6|||
162696594|NCT03734991|587599603|FG001|Overall Study|Withdrawal by Subject|3|||
162696595|NCT03734991|587599602|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
162696596|NCT03734991|587599603|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
162696597|NCT03734991|587599602|FG000|Overall Study|Other|2|||
162696598|NCT03734991|587599603|FG001|Overall Study|Other|2|||
162696599|NCT02638623|587599604|FG000|Overall Study|Surgery timing|5|||
162696600|NCT02638623|587599605|FG001|Overall Study|Surgery timing|6|||
162696601|NCT02638623|587599604|FG000|Overall Study|Not given intervention|2|||
162696602|NCT02638623|587599605|FG001|Overall Study|Not given intervention|0|||
162696603|NCT03797326|587599611|FG000|Overall Study|Lost to Follow-up|1|||
162696604|NCT03797326|587599612|FG001|Overall Study|Lost to Follow-up|0|||
162696605|NCT03797326|587599613|FG002|Overall Study|Lost to Follow-up|0|||
162696606|NCT03797326|587599614|FG003|Overall Study|Lost to Follow-up|1|||
162696607|NCT03797326|587599615|FG004|Overall Study|Lost to Follow-up|0|||
162696608|NCT03797326|587599616|FG005|Overall Study|Lost to Follow-up|0|||
162696609|NCT03797326|587599617|FG006|Overall Study|Lost to Follow-up|0|||
162696610|NCT03797326|587599618|FG007|Overall Study|Lost to Follow-up|0|||
162696611|NCT03797326|587599611|FG000|Overall Study|Withdrawal by Subject|0|||
162696612|NCT03797326|587599612|FG001|Overall Study|Withdrawal by Subject|0|||
162696613|NCT03797326|587599613|FG002|Overall Study|Withdrawal by Subject|1|||
162696614|NCT03797326|587599614|FG003|Overall Study|Withdrawal by Subject|3|||
162696615|NCT03797326|587599615|FG004|Overall Study|Withdrawal by Subject|0|||
162696616|NCT03797326|587599616|FG005|Overall Study|Withdrawal by Subject|2|||
162696617|NCT03797326|587599617|FG006|Overall Study|Withdrawal by Subject|2|||
162696618|NCT03797326|587599618|FG007|Overall Study|Withdrawal by Subject|3|||
162696619|NCT03797326|587599611|FG000|Overall Study|Sponsor Decision|3|||
162696620|NCT03797326|587599612|FG001|Overall Study|Sponsor Decision|3|||
162696621|NCT03797326|587599613|FG002|Overall Study|Sponsor Decision|3|||
162696622|NCT03797326|587599614|FG003|Overall Study|Sponsor Decision|6|||
162696623|NCT03797326|587599615|FG004|Overall Study|Sponsor Decision|0|||
162696624|NCT03797326|587599616|FG005|Overall Study|Sponsor Decision|3|||
162696625|NCT03797326|587599617|FG006|Overall Study|Sponsor Decision|3|||
162696626|NCT03797326|587599618|FG007|Overall Study|Sponsor Decision|2|||
162696627|NCT03797326|587599611|FG000|Overall Study|Death|27|||
162696628|NCT03797326|587599612|FG001|Overall Study|Death|28|||
162696629|NCT03797326|587599613|FG002|Overall Study|Death|95|||
162696630|NCT03797326|587599614|FG003|Overall Study|Death|95|||
162696631|NCT03797326|587599615|FG004|Overall Study|Death|30|||
162696632|NCT03797326|587599616|FG005|Overall Study|Death|96|||
162696633|NCT03797326|587599617|FG006|Overall Study|Death|97|||
162696634|NCT03797326|587599618|FG007|Overall Study|Death|98|||
162696635|NCT03797326|587599611|FG000|Overall Study|Enrolled in error|0|||
162696636|NCT03797326|587599612|FG001|Overall Study|Enrolled in error|0|||
162696637|NCT03797326|587599613|FG002|Overall Study|Enrolled in error|3|||
162696638|NCT03797326|587599614|FG003|Overall Study|Enrolled in error|2|||
162696639|NCT03797326|587599615|FG004|Overall Study|Enrolled in error|2|||
162696640|NCT03797326|587599616|FG005|Overall Study|Enrolled in error|1|||
162696641|NCT03797326|587599617|FG006|Overall Study|Enrolled in error|1|||
162696642|NCT03797326|587599618|FG007|Overall Study|Enrolled in error|0|||
162696643|NCT03012061|587599619|FG000|Overall Study|Withdrawal by Subject|1|||
162696644|NCT03012061|587599620|FG001|Overall Study|Withdrawal by Subject|5|||
162696645|NCT03012061|587599621|FG002|Overall Study|Withdrawal by Subject|4|||
162696646|NCT03012061|587599619|FG000|Overall Study|Investigator Site Closed|1|||
162696647|NCT03012061|587599620|FG001|Overall Study|Investigator Site Closed|2|||
162696648|NCT03012061|587599621|FG002|Overall Study|Investigator Site Closed|0|||
162696649|NCT03012061|587599619|FG000|Overall Study|Lost to Follow-up|2|||
162696650|NCT03012061|587599620|FG001|Overall Study|Lost to Follow-up|1|||
162696651|NCT03012061|587599621|FG002|Overall Study|Lost to Follow-up|0|||
162696652|NCT03012061|587599619|FG000|Overall Study|Study closed/ Terminated|0|||
162696653|NCT03012061|587599620|FG001|Overall Study|Study closed/ Terminated|0|||
162696654|NCT03012061|587599621|FG002|Overall Study|Study closed/ Terminated|1|||
162696655|NCT03012061|587599619|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
162696656|NCT03012061|587599620|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
162696657|NCT03012061|587599621|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
162696658|NCT03012061|587599619|FG000|Overall Study|Protocol Violation|0|||
162696659|NCT03012061|587599620|FG001|Overall Study|Protocol Violation|0|||
162696660|NCT03012061|587599621|FG002|Overall Study|Protocol Violation|2|||
162696661|NCT03012061|587599619|FG000|Overall Study|Lack of Efficacy|0|||
162696662|NCT03012061|587599620|FG001|Overall Study|Lack of Efficacy|1|||
162696663|NCT03012061|587599621|FG002|Overall Study|Lack of Efficacy|0|||
162696664|NCT03012061|587599619|FG000|Overall Study|Adverse Event|2|||
162696665|NCT03012061|587599620|FG001|Overall Study|Adverse Event|0|||
162696666|NCT03012061|587599621|FG002|Overall Study|Adverse Event|0|||
162696667|NCT04152343|587599622|FG000|Overall Study|Transplanted|5|||
162696668|NCT04152343|587599622|FG000|Overall Study|Death|20|||
162696669|NCT04152343|587599622|FG000|Overall Study|Lost to Follow-up|3|||
162696670|NCT01965938|587599623|FG000|Overall Study|Withdrawal by Subject|1|||
162696671|NCT01965938|587599624|FG001|Overall Study|Withdrawal by Subject|0|||
162696672|NCT01164228|587599625|FG000|Overall Study|Progression|24|||
162696673|NCT01164228|587599626|FG001|Overall Study|Progression|25|||
162696674|NCT01164228|587599625|FG000|Overall Study|Adverse Event|13|||
162696675|NCT01164228|587599626|FG001|Overall Study|Adverse Event|7|||
162696676|NCT01164228|587599625|FG000|Overall Study|Death|1|||
162696677|NCT01164228|587599626|FG001|Overall Study|Death|1|||
162696678|NCT01164228|587599625|FG000|Overall Study|Withdrawal by Subject|2|||
162696679|NCT01164228|587599626|FG001|Overall Study|Withdrawal by Subject|0|||
162696680|NCT01164228|587599625|FG000|Overall Study|Physician Decision|1|||
162696681|NCT01164228|587599626|FG001|Overall Study|Physician Decision|2|||
162696682|NCT01164228|587599625|FG000|Overall Study|Symptomatic deterioration|1|||
162696683|NCT01164228|587599626|FG001|Overall Study|Symptomatic deterioration|0|||
162696684|NCT01164228|587599625|FG000|Overall Study|Never started treatment|1|||
162696685|NCT01164228|587599626|FG001|Overall Study|Never started treatment|3|||
162696686|NCT01164228|587599625|FG000|Overall Study|Ineligible|1|||
162696687|NCT01164228|587599626|FG001|Overall Study|Ineligible|0|||
162696688|NCT03342053|587599627|FG000|Overall Study|Adverse Event|2|||
162696689|NCT03342053|587599628|FG001|Overall Study|Adverse Event|0|||
162696690|NCT03342053|587599627|FG000|Overall Study|Withdrawal by Subject|0|||
162696691|NCT03342053|587599628|FG001|Overall Study|Withdrawal by Subject|1|||
162696692|NCT00309608|587599631|FG000|Overall Study|Adverse Event|1|||
162696693|NCT00309608|587599632|FG001|Overall Study|Adverse Event|5|||
162696694|NCT00309608|587599633|FG002|Overall Study|Adverse Event|3|||
162696695|NCT00309608|587599634|FG003|Overall Study|Adverse Event|2|||
162696696|NCT00309608|587599635|FG004|Overall Study|Adverse Event|3|||
162696697|NCT00309608|587599631|FG000|Overall Study|Protocol Violation|2|||
162696698|NCT00309608|587599632|FG001|Overall Study|Protocol Violation|0|||
162696699|NCT00309608|587599633|FG002|Overall Study|Protocol Violation|0|||
162696700|NCT00309608|587599634|FG003|Overall Study|Protocol Violation|0|||
162696701|NCT00309608|587599635|FG004|Overall Study|Protocol Violation|0|||
162696702|NCT00309608|587599631|FG000|Overall Study|Lost to Follow-up|0|||
162696703|NCT00309608|587599632|FG001|Overall Study|Lost to Follow-up|0|||
162696704|NCT00309608|587599633|FG002|Overall Study|Lost to Follow-up|2|||
162696705|NCT00309608|587599634|FG003|Overall Study|Lost to Follow-up|0|||
162696706|NCT00309608|587599635|FG004|Overall Study|Lost to Follow-up|1|||
162696707|NCT00309608|587599631|FG000|Overall Study|Withdrawal by Subject|1|||
162696708|NCT00309608|587599632|FG001|Overall Study|Withdrawal by Subject|4|||
162696709|NCT00309608|587599633|FG002|Overall Study|Withdrawal by Subject|2|||
162696710|NCT00309608|587599634|FG003|Overall Study|Withdrawal by Subject|0|||
162696711|NCT00309608|587599635|FG004|Overall Study|Withdrawal by Subject|0|||
162696712|NCT00309608|587599631|FG000|Overall Study|Other incl. Lack of efficacy|10|||
162696713|NCT00309608|587599632|FG001|Overall Study|Other incl. Lack of efficacy|4|||
162696714|NCT00309608|587599633|FG002|Overall Study|Other incl. Lack of efficacy|3|||
162696715|NCT00309608|587599634|FG003|Overall Study|Other incl. Lack of efficacy|4|||
162696716|NCT00309608|587599635|FG004|Overall Study|Other incl. Lack of efficacy|0|||
162696717|NCT00127413|587599636|FG000|Overall Study|Lost to Follow-up|6|||
162696718|NCT00127413|587599637|FG001|Overall Study|Lost to Follow-up|4|||
162696719|NCT00127413|587599638|FG002|Overall Study|Lost to Follow-up|8|||
162696720|NCT00127413|587599639|FG003|Overall Study|Lost to Follow-up|2|||
162696721|NCT01340482|587601192|FG000|Overall Study|Adverse Event|2|||
162696722|NCT01340482|587601193|FG001|Overall Study|Adverse Event|0|||
162696723|NCT01340482|587601194|FG002|Overall Study|Adverse Event|0|||
162696724|NCT01282476|587601195|FG000|Overall Study|Death|11|||
162696725|NCT00592319|587601198|FG000|Overall Study|Lost to Follow-up|0|||
162696726|NCT00592319|587601199|FG001|Overall Study|Lost to Follow-up|3|||
162696727|NCT01912222|587601206|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
162696728|NCT01912222|587601207|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
162696729|NCT01912222|587601208|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
162696730|NCT01912222|587601206|FG000|Part B: Treatment Period|Progressive disease|10|||
162696731|NCT01912222|587601207|FG001|Part B: Treatment Period|Progressive disease|12|||
162696732|NCT01912222|587601208|FG002|Part B: Treatment Period|Progressive disease|15|||
162696733|NCT01912222|587601206|FG000|Part B: Treatment Period|Adverse Event|1|||
162696734|NCT01912222|587601207|FG001|Part B: Treatment Period|Adverse Event|2|||
162696735|NCT01912222|587601208|FG002|Part B: Treatment Period|Adverse Event|3|||
162696736|NCT01912222|587601206|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
162696737|NCT01912222|587601207|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
162696738|NCT01912222|587601208|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
162696739|NCT00154063|587601209|FG000|Overall Study|Adverse Event|4|||
162696740|NCT00154063|587601210|FG001|Overall Study|Adverse Event|8|||
162696741|NCT00154063|587601209|FG000|Overall Study|Protocol Violation|1|||
162696742|NCT00154063|587601210|FG001|Overall Study|Protocol Violation|1|||
162696743|NCT00154063|587601209|FG000|Overall Study|Investigator or Sponsor Request|0|||
162696744|NCT00154063|587601210|FG001|Overall Study|Investigator or Sponsor Request|1|||
162696745|NCT00154063|587601209|FG000|Overall Study|Withdrawal by Subject|4|||
162696746|NCT00154063|587601210|FG001|Overall Study|Withdrawal by Subject|9|||
162696747|NCT00154063|587601209|FG000|Overall Study|Other|3|||
162696748|NCT00154063|587601210|FG001|Overall Study|Other|3|||
162696749|NCT01804673|587601211|FG000|Overall Study|Adverse Event|4|||
162696750|NCT01804673|587601211|FG000|Overall Study|Withdrawal by Subject|1|||
162696751|NCT01804673|587601211|FG000|Overall Study|Lack of Efficacy|9|||
162696752|NCT01804673|587601211|FG000|Overall Study|Change to Oral Therapy|37|||
162696753|NCT01804673|587601211|FG000|Overall Study|No Further Therapy Required|84|||
162696754|NCT01804673|587601211|FG000|Overall Study|Use of Prohibited Medication|1|||
162696755|NCT01804673|587601211|FG000|Overall Study|Other|4|||
162696756|NCT01857934|587601219|FG000|Overall Study|Relapse or progression|2|||
162696757|NCT01857934|587601219|FG000|Overall Study|Unacceptable toxicity|3|||
162696758|NCT01857934|587601219|FG000|Overall Study|Unwillingness or inability to comply|2|||
162696759|NCT01857934|587601219|FG000|Overall Study|Physician Decision|3|||
162696760|NCT04012814|587601226|FG000|Overall Study|Lost to Follow-up|4|||
163042784|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
163042785|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
163042786|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
163042787|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
163042788|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
163042789|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
163042790|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
163042791|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
163042792|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
163042793|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
163042794|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
163042795|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
163042796|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
163042797|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
163042798|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
163042799|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
163042800|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
163042801|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
163042802|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
163042803|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
163042804|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
163042805|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
163042806|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
163042807|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
163042808|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
163042809|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042810|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042811|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
163042812|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
163042813|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
163058555|NCT00042289|588924242|FG007|Overall Study|Site closed|0|||
163058556|NCT00042289|588924243|FG008|Overall Study|Site closed|0|||
163058557|NCT00042289|588924244|FG009|Overall Study|Site closed|0|||
163058558|NCT00042289|588924245|FG010|Overall Study|Site closed|0|||
163058559|NCT00042289|588924246|FG011|Overall Study|Site closed|0|||
163058560|NCT00042289|588924247|FG012|Overall Study|Site closed|0|||
163058561|NCT00042289|588924248|FG013|Overall Study|Site closed|0|||
163058562|NCT00042289|588924249|FG014|Overall Study|Site closed|0|||
163058563|NCT00042289|588924250|FG015|Overall Study|Site closed|0|||
163058564|NCT00042289|588924251|FG016|Overall Study|Site closed|0|||
163058565|NCT00042289|588924252|FG017|Overall Study|Site closed|0|||
163058566|NCT00042289|588924253|FG018|Overall Study|Site closed|0|||
163058567|NCT00042289|588924254|FG019|Overall Study|Site closed|0|||
163058568|NCT00042289|588924255|FG020|Overall Study|Site closed|0|||
163058569|NCT00042289|588924256|FG021|Overall Study|Site closed|0|||
163058570|NCT00042289|588924257|FG022|Overall Study|Site closed|0|||
163058571|NCT00042289|588924258|FG023|Overall Study|Site closed|0|||
163058572|NCT00042289|588924259|FG024|Overall Study|Site closed|0|||
163058573|NCT00042289|588924260|FG025|Overall Study|Site closed|0|||
163058574|NCT00042289|588924261|FG026|Overall Study|Site closed|0|||
163058575|NCT00042289|588924262|FG027|Overall Study|Site closed|0|||
163058576|NCT00042289|588924263|FG028|Overall Study|Site closed|0|||
163058577|NCT00042289|588924264|FG029|Overall Study|Site closed|0|||
163058578|NCT00042289|588924265|FG030|Overall Study|Site closed|0|||
163058579|NCT00042289|588924266|FG031|Overall Study|Site closed|3|||
163058580|NCT00042289|588924267|FG032|Overall Study|Site closed|0|||
163058581|NCT00042289|588924268|FG033|Overall Study|Site closed|0|||
163058582|NCT00042289|588924269|FG034|Overall Study|Site closed|0|||
163058583|NCT00042289|588924270|FG035|Overall Study|Site closed|0|||
163058584|NCT00042289|588924271|FG036|Overall Study|Site closed|1|||
163058585|NCT00042289|588924272|FG037|Overall Study|Site closed|0|||
163058586|NCT00042289|588924273|FG038|Overall Study|Site closed|0|||
163058587|NCT00042289|588924274|FG039|Overall Study|Site closed|0|||
163058588|NCT00042289|588924275|FG040|Overall Study|Site closed|0|||
163058589|NCT00042289|588924276|FG041|Overall Study|Site closed|0|||
163058590|NCT00042289|588924277|FG042|Overall Study|Site closed|1|||
163058591|NCT00042289|588924278|FG043|Overall Study|Site closed|0|||
163058592|NCT00042289|588924279|FG044|Overall Study|Site closed|0|||
163058593|NCT00042289|588924280|FG045|Overall Study|Site closed|0|||
163058594|NCT00042289|588924281|FG046|Overall Study|Site closed|0|||
163058595|NCT00042289|588924235|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
163058596|NCT00042289|588924236|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
163161091|NCT00337675|589304070|FG000|Overall Study|Progressive Disease|0|||
163161092|NCT00337675|589304071|FG001|Overall Study|Progressive Disease|2|||
163161093|NCT00337675|589304072|FG002|Overall Study|Progressive Disease|0|||
163161094|NCT00337675|589304070|FG000|Overall Study|Trial Terminated|0|||
163161095|NCT00337675|589304071|FG001|Overall Study|Trial Terminated|0|||
163161096|NCT00337675|589304072|FG002|Overall Study|Trial Terminated|2|||
163161097|NCT02015637|589304073|FG000|Overall Study|Lost to Follow-up|3|||
163161098|NCT02015637|589304074|FG001|Overall Study|Lost to Follow-up|5|||
163161099|NCT02015637|589304073|FG000|Overall Study|Adverse Event|3|||
163161100|NCT02015637|589304074|FG001|Overall Study|Adverse Event|0|||
163161101|NCT02015637|589304073|FG000|Overall Study|Did not take study drug|2|||
163161102|NCT02015637|589304074|FG001|Overall Study|Did not take study drug|0|||
163161103|NCT01317277|589304079|FG000|Overall Study|Lost to Follow-up|3|||
162696761|NCT04012814|587601226|FG000|Overall Study|Withdrawal by Subject|2|||
162696762|NCT04012814|587601226|FG000|Overall Study|Protocol Violation|1|||
162696763|NCT04012814|587601226|FG000|Overall Study|Adverse Event|1|||
162696764|NCT04789577|587601227|FG000|Overall Study|Withdrawal by Subject|1|||
162696765|NCT04789577|587601228|FG001|Overall Study|Withdrawal by Subject|1|||
162696766|NCT04789577|587601229|FG002|Overall Study|Withdrawal by Subject|1|||
162696767|NCT04789577|587601230|FG003|Overall Study|Withdrawal by Subject|3|||
162696768|NCT04789577|587601231|FG004|Overall Study|Withdrawal by Subject|1|||
162696769|NCT04789577|587601232|FG005|Overall Study|Withdrawal by Subject|7|||
162696770|NCT04789577|587601233|FG006|Overall Study|Withdrawal by Subject|1|||
162696771|NCT04789577|587601227|FG000|Overall Study|Lost to Follow-up|7|||
162696772|NCT04789577|587601228|FG001|Overall Study|Lost to Follow-up|12|||
162696773|NCT04789577|587601229|FG002|Overall Study|Lost to Follow-up|7|||
162696774|NCT04789577|587601230|FG003|Overall Study|Lost to Follow-up|10|||
162696775|NCT04789577|587601231|FG004|Overall Study|Lost to Follow-up|8|||
162696776|NCT04789577|587601232|FG005|Overall Study|Lost to Follow-up|6|||
162696777|NCT04789577|587601233|FG006|Overall Study|Lost to Follow-up|10|||
162696778|NCT04789577|587601227|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
162696779|NCT04789577|587601228|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
162696780|NCT04789577|587601229|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
162696781|NCT04789577|587601230|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
162696782|NCT04789577|587601231|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
162696783|NCT04789577|587601232|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
162696784|NCT04789577|587601233|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
162696785|NCT04789577|587601227|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
162696786|NCT04789577|587601228|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
162696787|NCT04789577|587601229|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
162696788|NCT04789577|587601230|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
162696789|NCT04789577|587601231|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
162696790|NCT04789577|587601232|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
162696791|NCT04789577|587601233|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
162696792|NCT02441946|587601234|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
162696793|NCT02441946|587601235|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
162696794|NCT02441946|587601236|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
162696795|NCT02441946|587601234|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
162696796|NCT02441946|587601235|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
162696797|NCT02441946|587601236|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
162696798|NCT02441946|587601234|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162696799|NCT02441946|587601235|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
162696800|NCT02441946|587601236|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162696801|NCT02441946|587601234|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
162696802|NCT02441946|587601235|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
162696803|NCT02441946|587601236|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
162696804|NCT02441946|587601234|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
162696805|NCT02441946|587601235|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
162696806|NCT02441946|587601236|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
162696807|NCT02441946|587601234|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
162696808|NCT02441946|587601235|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
162696809|NCT02441946|587601236|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
162696810|NCT02441946|587601234|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
162696811|NCT02441946|587601235|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
162696812|NCT02441946|587601236|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
162696813|NCT02441946|587601234|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
162696814|NCT02441946|587601235|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
162696815|NCT02441946|587601236|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
162696816|NCT02441946|587601234|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
162696817|NCT02441946|587601235|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
162696818|NCT02441946|587601236|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
162696819|NCT02441946|587601234|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
162696820|NCT02441946|587601235|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
162696821|NCT02441946|587601236|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
162696822|NCT02441946|587601234|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
162696823|NCT02441946|587601235|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162696824|NCT02441946|587601236|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162696825|NCT00579982|587601241|FG000|Overall Study|Adverse Event|4|||
162696826|NCT00579982|587601241|FG000|Overall Study|Protocol Violation|4|||
162696827|NCT00988351|587601243|FG000|Overall Study|Withdrawal by Subject|8|||
162696828|NCT00988351|587601244|FG001|Overall Study|Withdrawal by Subject|0|||
162696829|NCT00988351|587601243|FG000|Overall Study|Lost to Follow-up|6|||
162696830|NCT00988351|587601244|FG001|Overall Study|Lost to Follow-up|9|||
162696831|NCT00988351|587601243|FG000|Overall Study|not using CPAP|5|||
163161104|NCT01317277|589304080|FG001|Overall Study|Lost to Follow-up|1|||
162696832|NCT00988351|587601244|FG001|Overall Study|not using CPAP|3|||
162696833|NCT02038764|587601245|FG000|Overall Study|Adverse Event|0|||
162696834|NCT02038764|587601246|FG001|Overall Study|Adverse Event|0|||
162696835|NCT02038764|587601247|FG002|Overall Study|Adverse Event|1|||
162696836|NCT02038764|587601248|FG003|Overall Study|Adverse Event|0|||
162696837|NCT02038764|587601249|FG004|Overall Study|Adverse Event|0|||
162696838|NCT02038764|587601245|FG000|Overall Study|Lost to Follow-up|0|||
162696839|NCT02038764|587601246|FG001|Overall Study|Lost to Follow-up|1|||
162696840|NCT02038764|587601247|FG002|Overall Study|Lost to Follow-up|0|||
162696841|NCT02038764|587601248|FG003|Overall Study|Lost to Follow-up|0|||
162696842|NCT02038764|587601249|FG004|Overall Study|Lost to Follow-up|0|||
162696843|NCT02038764|587601245|FG000|Overall Study|Withdrawal by Subject|0|||
162696844|NCT02038764|587601246|FG001|Overall Study|Withdrawal by Subject|0|||
162696845|NCT02038764|587601247|FG002|Overall Study|Withdrawal by Subject|0|||
162696846|NCT02038764|587601248|FG003|Overall Study|Withdrawal by Subject|0|||
162696847|NCT02038764|587601249|FG004|Overall Study|Withdrawal by Subject|1|||
162696848|NCT02038764|587601245|FG000|Overall Study|Other|1|||
162696849|NCT02038764|587601246|FG001|Overall Study|Other|0|||
162696850|NCT02038764|587601247|FG002|Overall Study|Other|1|||
162696851|NCT02038764|587601248|FG003|Overall Study|Other|0|||
162696852|NCT02038764|587601249|FG004|Overall Study|Other|0|||
162696853|NCT01464255|587601258|FG000|Overall Study|unresolve corneal staining|0|||
162696854|NCT01464255|587601259|FG001|Overall Study|unresolve corneal staining|1|||
162696855|NCT04175912|587601269|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
162696856|NCT04175912|587601270|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
162696857|NCT04175912|587601269|FG000|Overall Study|Adverse Event|0|||
162696858|NCT04175912|587601270|FG001|Overall Study|Adverse Event|3|||
162696859|NCT04175912|587601269|FG000|Overall Study|Never started treatment|3|||
162696860|NCT04175912|587601270|FG001|Overall Study|Never started treatment|3|||
162696861|NCT04175912|587601269|FG000|Overall Study|Death|0|||
162696862|NCT04175912|587601270|FG001|Overall Study|Death|1|||
162696863|NCT04654468|587601271|FG000|Overall Study|Death|1|||
162696864|NCT04654468|587601271|FG000|Overall Study|Ongoing in the Study|50|||
162696865|NCT01155661|587601272|FG000|Overall Study|Adverse Event|101|||
162696866|NCT01155661|587601272|FG000|Overall Study|Death|1|||
162696867|NCT01155661|587601272|FG000|Overall Study|Lack of Efficacy|32|||
162696868|NCT01155661|587601272|FG000|Overall Study|Lost to Follow-up|22|||
162696869|NCT01155661|587601272|FG000|Overall Study|Physician Decision|3|||
162696870|NCT01155661|587601272|FG000|Overall Study|Protocol Violation|35|||
162696871|NCT01155661|587601272|FG000|Overall Study|Withdrawal by Subject|73|||
162696872|NCT01155661|587601272|FG000|Overall Study|Sponsor Decision|13|||
162696873|NCT05064735|587601273|FG000|Overall Study|Withdrawal by Subject|7|||
162696874|NCT05064735|587601274|FG001|Overall Study|Withdrawal by Subject|8|||
162696875|NCT05064735|587601273|FG000|Overall Study|Lost to Follow-up|7|||
162696876|NCT05064735|587601274|FG001|Overall Study|Lost to Follow-up|2|||
162696877|NCT05064735|587601273|FG000|Overall Study|Physician Decision|2|||
162696878|NCT05064735|587601274|FG001|Overall Study|Physician Decision|1|||
162696879|NCT05064735|587601273|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
162696880|NCT05064735|587601274|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
162696881|NCT05064735|587601273|FG000|Overall Study|Site Closure|7|||
162696882|NCT05064735|587601274|FG001|Overall Study|Site Closure|2|||
162696883|NCT04844970|587601279|FG000|Overall Study|Adverse Event|0|||
162696884|NCT04844970|587601280|FG001|Overall Study|Adverse Event|1|||
162696885|NCT04844970|587601279|FG000|Overall Study|Withdrawal by Subject|2|||
162696886|NCT04844970|587601280|FG001|Overall Study|Withdrawal by Subject|0|||
162696887|NCT00447954|587601281|FG000|Overall Study|Adverse Event|0|||
162696888|NCT00447954|587601282|FG001|Overall Study|Adverse Event|2|||
162696889|NCT00447954|587601283|FG002|Overall Study|Adverse Event|0|||
162696890|NCT00447954|587601281|FG000|Overall Study|Withdrawal by Subject|0|||
162696891|NCT00447954|587601282|FG001|Overall Study|Withdrawal by Subject|1|||
162696892|NCT00447954|587601283|FG002|Overall Study|Withdrawal by Subject|1|||
163161105|NCT01317277|589304079|FG000|Overall Study|Lost MEMS|1|||
163161106|NCT01317277|589304080|FG001|Overall Study|Lost MEMS|1|||
162696893|NCT00447954|587601281|FG000|Overall Study|Lost to Follow-up|0|||
163161107|NCT01317277|589304079|FG000|Overall Study|Unable to comply with intervention|1|||
162696894|NCT00447954|587601282|FG001|Overall Study|Lost to Follow-up|1|||
162696895|NCT00447954|587601283|FG002|Overall Study|Lost to Follow-up|0|||
162696896|NCT00447954|587601281|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
162696897|NCT00447954|587601282|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
162696898|NCT00447954|587601283|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
163161108|NCT01317277|589304080|FG001|Overall Study|Unable to comply with intervention|0|||
163161109|NCT01317277|589304079|FG000|Overall Study|Withdrawal by Subject|1|||
162696899|NCT03757234|587601284|FG000|Overall Study|Adverse Event|0|||
162696900|NCT03757234|587601285|FG001|Overall Study|Adverse Event|0|||
162696901|NCT03757234|587601286|FG002|Overall Study|Adverse Event|0|||
162696902|NCT03757234|587601287|FG003|Overall Study|Adverse Event|0|||
162696903|NCT03757234|587601288|FG004|Overall Study|Adverse Event|1|||
163161110|NCT01317277|589304080|FG001|Overall Study|Withdrawal by Subject|0|||
162696904|NCT03757234|587601284|FG000|Overall Study|Lost to Follow-up|1|||
162696905|NCT03757234|587601285|FG001|Overall Study|Lost to Follow-up|0|||
162696906|NCT03757234|587601286|FG002|Overall Study|Lost to Follow-up|0|||
162696907|NCT03757234|587601287|FG003|Overall Study|Lost to Follow-up|0|||
162696908|NCT03757234|587601288|FG004|Overall Study|Lost to Follow-up|1|||
162696909|NCT03757234|587601284|FG000|Overall Study|Withdrawal by Subject|1|||
162696910|NCT03757234|587601285|FG001|Overall Study|Withdrawal by Subject|1|||
162696911|NCT03757234|587601286|FG002|Overall Study|Withdrawal by Subject|0|||
162696912|NCT03757234|587601287|FG003|Overall Study|Withdrawal by Subject|1|||
162696913|NCT03757234|587601288|FG004|Overall Study|Withdrawal by Subject|2|||
162696914|NCT03757234|587601284|FG000|Overall Study|Other|1|||
162696915|NCT03757234|587601285|FG001|Overall Study|Other|1|||
162696916|NCT03757234|587601286|FG002|Overall Study|Other|0|||
162696917|NCT03757234|587601287|FG003|Overall Study|Other|0|||
162696918|NCT03757234|587601288|FG004|Overall Study|Other|0|||
162696919|NCT04908449|587601294|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
162696920|NCT04908449|587601295|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
162696921|NCT04908449|587601294|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
162696922|NCT04908449|587601295|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
162696923|NCT02401308|587601296|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
162696924|NCT02401308|587601297|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
162696925|NCT02736968|587601298|FG000|Overall Study|Lost to Follow-up|0|||
162696926|NCT02736968|587601299|FG001|Overall Study|Lost to Follow-up|0|||
162696927|NCT02736968|587601300|FG002|Overall Study|Lost to Follow-up|0|||
162696928|NCT02736968|587601301|FG003|Overall Study|Lost to Follow-up|0|||
162696929|NCT02736968|587601302|FG004|Overall Study|Lost to Follow-up|0|||
162696930|NCT02736968|587601303|FG005|Overall Study|Lost to Follow-up|0|||
162696931|NCT02736968|587601304|FG006|Overall Study|Lost to Follow-up|5|||
162696932|NCT02736968|587601305|FG007|Overall Study|Lost to Follow-up|2|||
162696933|NCT02736968|587601298|FG000|Overall Study|COVID-19 Pandemic|0|||
162696934|NCT02736968|587601299|FG001|Overall Study|COVID-19 Pandemic|0|||
162696935|NCT02736968|587601300|FG002|Overall Study|COVID-19 Pandemic|0|||
162696936|NCT02736968|587601301|FG003|Overall Study|COVID-19 Pandemic|0|||
162696937|NCT02736968|587601302|FG004|Overall Study|COVID-19 Pandemic|0|||
162696938|NCT02736968|587601303|FG005|Overall Study|COVID-19 Pandemic|0|||
162696939|NCT02736968|587601304|FG006|Overall Study|COVID-19 Pandemic|2|||
162696940|NCT02736968|587601305|FG007|Overall Study|COVID-19 Pandemic|0|||
162696941|NCT02736968|587601298|FG000|Overall Study|Withdrawal by Subject|0|||
162696942|NCT02736968|587601299|FG001|Overall Study|Withdrawal by Subject|0|||
162696943|NCT02736968|587601300|FG002|Overall Study|Withdrawal by Subject|0|||
162696944|NCT02736968|587601301|FG003|Overall Study|Withdrawal by Subject|0|||
162696945|NCT02736968|587601302|FG004|Overall Study|Withdrawal by Subject|0|||
162696946|NCT02736968|587601303|FG005|Overall Study|Withdrawal by Subject|0|||
162696947|NCT02736968|587601304|FG006|Overall Study|Withdrawal by Subject|1|||
162696948|NCT02736968|587601305|FG007|Overall Study|Withdrawal by Subject|0|||
162696949|NCT02294474|587601306|FG000|Overall Study|Adverse Event|7|||
162696950|NCT02294474|587601307|FG001|Overall Study|Adverse Event|7|||
162696951|NCT02294474|587601306|FG000|Overall Study|Lack of Efficacy|2|||
162696952|NCT02294474|587601307|FG001|Overall Study|Lack of Efficacy|1|||
162696953|NCT02294474|587601306|FG000|Overall Study|Protocol Violation|4|||
162696954|NCT02294474|587601307|FG001|Overall Study|Protocol Violation|2|||
162696955|NCT02294474|587601306|FG000|Overall Study|Other than specified above|12|||
162696956|NCT02294474|587601307|FG001|Overall Study|Other than specified above|12|||
162696957|NCT02961374|587601308|FG000|Overall Study|Adverse Event|4|||
162696958|NCT00171873|587601309|FG000|Overall Study|Withdrawal by Subject|4|||
163161111|NCT01317277|589304079|FG000|Overall Study|Adverse Event|1|||
163161112|NCT01317277|589304080|FG001|Overall Study|Adverse Event|0|||
163161113|NCT02454517|589304087|FG000|Overall Study|Withdrawal by Subject|3|||
163161114|NCT02454517|589304088|FG001|Overall Study|Withdrawal by Subject|0|||
163161115|NCT02454517|589304087|FG000|Overall Study|Lost to Follow-up|4|||
163161116|NCT02454517|589304088|FG001|Overall Study|Lost to Follow-up|7|||
163161117|NCT02454517|589304087|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
163161118|NCT02454517|589304088|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
163161119|NCT00473382|589304089|FG000|Core Study|Adverse Event|3|||
163161120|NCT00473382|589304090|FG001|Core Study|Adverse Event|1|||
163161121|NCT00473382|589304091|FG002|Core Study|Adverse Event|1|||
163161122|NCT00473382|589304089|FG000|Core Study|Death|3|||
163161123|NCT00473382|589304090|FG001|Core Study|Death|5|||
163161124|NCT00473382|589304091|FG002|Core Study|Death|10|||
163161125|NCT00473382|589304089|FG000|Core Study|Lost to Follow-up|3|||
163161126|NCT00473382|589304090|FG001|Core Study|Lost to Follow-up|3|||
163161127|NCT00473382|589304091|FG002|Core Study|Lost to Follow-up|3|||
163161128|NCT00473382|589304089|FG000|Core Study|Physician Decision|1|||
163161129|NCT00473382|589304090|FG001|Core Study|Physician Decision|2|||
163161130|NCT00473382|589304091|FG002|Core Study|Physician Decision|2|||
163161131|NCT00473382|589304089|FG000|Core Study|Subject non-compliance|5|||
163161132|NCT00473382|589304090|FG001|Core Study|Subject non-compliance|2|||
162696959|NCT00171873|587601310|FG001|Overall Study|Withdrawal by Subject|2|||
162696960|NCT00171873|587601309|FG000|Overall Study|Adverse Event|5|||
162696961|NCT00171873|587601310|FG001|Overall Study|Adverse Event|0|||
162696962|NCT00171873|587601309|FG000|Overall Study|Switched to Octreotide|0|||
162696963|NCT00171873|587601310|FG001|Overall Study|Switched to Octreotide|1|||
162696964|NCT02041923|587601311|FG000|Overall Study|Lost to Follow-up|26|||
162696965|NCT02041923|587601312|FG001|Overall Study|Lost to Follow-up|30|||
162696966|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
162696967|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
162696968|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
162696969|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
163161133|NCT00473382|589304091|FG002|Core Study|Subject non-compliance|1|||
162696970|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
162696971|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
162696972|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
162696973|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
162696974|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
162696975|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
162696976|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
162696977|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
162696978|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
162696979|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
162696980|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
162696981|NCT02023879|587601315|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
162696982|NCT02023879|587601316|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
162696983|NCT02023879|587601317|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
162696984|NCT02023879|587601315|FG000|Extension Open Label Treatment|Adverse Event|1|||
162696985|NCT02023879|587601316|FG001|Extension Open Label Treatment|Adverse Event|7|||
162696986|NCT02023879|587601317|FG002|Extension Open Label Treatment|Adverse Event|3|||
162696987|NCT02023879|587601315|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
162696988|NCT02023879|587601316|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
162696989|NCT02023879|587601317|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
162696990|NCT02023879|587601315|FG000|Extension Open Label Treatment|Participant moved|1|||
162696991|NCT02023879|587601316|FG001|Extension Open Label Treatment|Participant moved|2|||
162696992|NCT02023879|587601317|FG002|Extension Open Label Treatment|Participant moved|0|||
162696993|NCT02023879|587601315|FG000|Extension Open Label Treatment|Other than specified above|2|||
162696994|NCT02023879|587601316|FG001|Extension Open Label Treatment|Other than specified above|7|||
162696995|NCT02023879|587601317|FG002|Extension Open Label Treatment|Other than specified above|2|||
162696996|NCT00874432|587601318|FG000|Overall Study|Withdrawal by Subject|1|||
162696997|NCT00874432|587601319|FG001|Overall Study|Withdrawal by Subject|0|||
162696998|NCT00874432|587601320|FG002|Overall Study|Withdrawal by Subject|0|||
162696999|NCT00874432|587601321|FG003|Overall Study|Withdrawal by Subject|0|||
162697000|NCT00874432|587601318|FG000|Overall Study|Physician Decision|1|||
162697001|NCT00874432|587601319|FG001|Overall Study|Physician Decision|0|||
162697002|NCT00874432|587601320|FG002|Overall Study|Physician Decision|0|||
162697003|NCT00874432|587601321|FG003|Overall Study|Physician Decision|0|||
162697004|NCT00874432|587601318|FG000|Overall Study|Other|1|||
162697005|NCT00874432|587601319|FG001|Overall Study|Other|2|||
162697006|NCT00874432|587601320|FG002|Overall Study|Other|8|||
162697007|NCT00874432|587601321|FG003|Overall Study|Other|3|||
162697008|NCT05256381|587601322|FG000|Overall Study|Withdrawal by Subject|4|||
162697009|NCT05256381|587601323|FG001|Overall Study|Withdrawal by Subject|0|||
162697010|NCT05256381|587601324|FG002|Overall Study|Withdrawal by Subject|2|||
162697011|NCT05256381|587601325|FG003|Overall Study|Withdrawal by Subject|2|||
162697012|NCT05256381|587601326|FG004|Overall Study|Withdrawal by Subject|8|||
162697013|NCT05256381|587601327|FG005|Overall Study|Withdrawal by Subject|6|||
162697014|NCT05256381|587601322|FG000|Overall Study|Physician Decision|0|||
163161134|NCT00473382|589304089|FG000|Core Study|Subject needed other treatment|1|||
163161135|NCT00473382|589304090|FG001|Core Study|Subject needed other treatment|3|||
163161136|NCT00473382|589304091|FG002|Core Study|Subject needed other treatment|2|||
163161137|NCT00473382|589304089|FG000|Core Study|Subject's decision|12|||
162697015|NCT05256381|587601323|FG001|Overall Study|Physician Decision|0|||
162697016|NCT05256381|587601324|FG002|Overall Study|Physician Decision|1|||
162697017|NCT05256381|587601325|FG003|Overall Study|Physician Decision|0|||
162697018|NCT05256381|587601326|FG004|Overall Study|Physician Decision|2|||
162697019|NCT05256381|587601327|FG005|Overall Study|Physician Decision|0|||
162697020|NCT05256381|587601322|FG000|Overall Study|Death|17|||
162697021|NCT05256381|587601323|FG001|Overall Study|Death|3|||
163161138|NCT00473382|589304090|FG001|Core Study|Subject's decision|11|||
163161139|NCT00473382|589304091|FG002|Core Study|Subject's decision|10|||
163161140|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
162697022|NCT05256381|587601324|FG002|Overall Study|Death|4|||
162697023|NCT05256381|587601325|FG003|Overall Study|Death|5|||
162697024|NCT05256381|587601326|FG004|Overall Study|Death|24|||
162697025|NCT05256381|587601327|FG005|Overall Study|Death|21|||
162697026|NCT05256381|587601322|FG000|Overall Study|Other, not specified|0|||
162697027|NCT05256381|587601323|FG001|Overall Study|Other, not specified|0|||
162697028|NCT05256381|587601324|FG002|Overall Study|Other, not specified|0|||
162697029|NCT05256381|587601325|FG003|Overall Study|Other, not specified|0|||
162697030|NCT05256381|587601326|FG004|Overall Study|Other, not specified|2|||
162697031|NCT05256381|587601327|FG005|Overall Study|Other, not specified|1|||
162697032|NCT05256381|587601322|FG000|Overall Study|Study terminated by sponsor|18|||
162697033|NCT05256381|587601323|FG001|Overall Study|Study terminated by sponsor|5|||
162697034|NCT05256381|587601324|FG002|Overall Study|Study terminated by sponsor|5|||
162697035|NCT05256381|587601325|FG003|Overall Study|Study terminated by sponsor|5|||
162697036|NCT05256381|587601326|FG004|Overall Study|Study terminated by sponsor|18|||
162697037|NCT05256381|587601327|FG005|Overall Study|Study terminated by sponsor|11|||
162697038|NCT05256381|587601322|FG000|Overall Study|Lost to Follow-up|1|||
162697039|NCT05256381|587601323|FG001|Overall Study|Lost to Follow-up|0|||
162697040|NCT05256381|587601324|FG002|Overall Study|Lost to Follow-up|0|||
162697041|NCT05256381|587601325|FG003|Overall Study|Lost to Follow-up|0|||
162697042|NCT05256381|587601326|FG004|Overall Study|Lost to Follow-up|1|||
162697043|NCT05256381|587601327|FG005|Overall Study|Lost to Follow-up|0|||
162697044|NCT01518946|587601330|FG000|Open-label Phase|Other|4|||
162697045|NCT01518946|587601331|FG001|Open-label Phase|Other|0|||
162697046|NCT01518946|587601332|FG002|Open-label Phase|Other|0|||
162697047|NCT01518946|587601330|FG000|Randomized Phase (First Intervention)|Other|0|||
162697048|NCT01518946|587601331|FG001|Randomized Phase (First Intervention)|Other|1|||
162697049|NCT01518946|587601332|FG002|Randomized Phase (First Intervention)|Other|0|||
162697050|NCT03918239|587603181|FG000|Overall Study|Lost to Follow-up|3|||
162697051|NCT03918239|587603182|FG001|Overall Study|Lost to Follow-up|1|||
162697052|NCT03918239|587603181|FG000|Overall Study|Pregnancy|0|||
162697053|NCT03918239|587603182|FG001|Overall Study|Pregnancy|2|||
162697054|NCT03918239|587603181|FG000|Overall Study|Withdrawal by Subject|3|||
162697055|NCT03918239|587603182|FG001|Overall Study|Withdrawal by Subject|3|||
162697056|NCT03918239|587603181|FG000|Overall Study|positive urine drug screening results|4|||
162697057|NCT03918239|587603182|FG001|Overall Study|positive urine drug screening results|1|||
162697058|NCT01984424|587603187|FG000|Overall Study|Withdrawal by Subject|3|||
162697059|NCT01984424|587603188|FG001|Overall Study|Withdrawal by Subject|5|||
162697060|NCT01984424|587603187|FG000|Overall Study|Sponsor Decision|0|||
162697061|NCT01984424|587603188|FG001|Overall Study|Sponsor Decision|1|||
162697062|NCT01984424|587603187|FG000|Overall Study|Lost to Follow-up|0|||
162697063|NCT01984424|587603188|FG001|Overall Study|Lost to Follow-up|1|||
162697064|NCT01807221|587603191|FG000|Overall Study|Progressive disease|1|||
162697065|NCT01807221|587603192|FG001|Overall Study|Progressive disease|0|||
162697066|NCT01807221|587603193|FG002|Overall Study|Progressive disease|1|||
162697067|NCT01807221|587603194|FG003|Overall Study|Progressive disease|0|||
162697068|NCT01807221|587603195|FG004|Overall Study|Progressive disease|0|||
162697069|NCT01807221|587603196|FG005|Overall Study|Progressive disease|0|||
162697070|NCT01807221|587603191|FG000|Overall Study|Death|7|||
162697071|NCT01807221|587603192|FG001|Overall Study|Death|9|||
162697072|NCT01807221|587603193|FG002|Overall Study|Death|4|||
162697073|NCT01807221|587603194|FG003|Overall Study|Death|2|||
162697074|NCT01807221|587603195|FG004|Overall Study|Death|1|||
162697075|NCT01807221|587603196|FG005|Overall Study|Death|6|||
162697076|NCT01807221|587603191|FG000|Overall Study|Physician Decision|2|||
162697077|NCT01807221|587603192|FG001|Overall Study|Physician Decision|1|||
162697078|NCT01807221|587603193|FG002|Overall Study|Physician Decision|0|||
162697079|NCT01807221|587603194|FG003|Overall Study|Physician Decision|0|||
162697080|NCT01807221|587603195|FG004|Overall Study|Physician Decision|0|||
162697081|NCT01807221|587603196|FG005|Overall Study|Physician Decision|0|||
162697082|NCT01807221|587603191|FG000|Overall Study|Adverse Event|33|||
162697083|NCT01807221|587603192|FG001|Overall Study|Adverse Event|22|||
162697084|NCT01807221|587603193|FG002|Overall Study|Adverse Event|26|||
162697085|NCT01807221|587603194|FG003|Overall Study|Adverse Event|25|||
162697086|NCT01807221|587603195|FG004|Overall Study|Adverse Event|18|||
162697087|NCT01807221|587603196|FG005|Overall Study|Adverse Event|21|||
162697088|NCT01807221|587603191|FG000|Overall Study|Protocol Violation|0|||
162697089|NCT01807221|587603192|FG001|Overall Study|Protocol Violation|2|||
162697090|NCT01807221|587603193|FG002|Overall Study|Protocol Violation|1|||
162697091|NCT01807221|587603194|FG003|Overall Study|Protocol Violation|2|||
162697092|NCT01807221|587603195|FG004|Overall Study|Protocol Violation|0|||
162697093|NCT01807221|587603196|FG005|Overall Study|Protocol Violation|1|||
162697094|NCT01807221|587603191|FG000|Overall Study|Non-compliance|1|||
162697095|NCT01807221|587603192|FG001|Overall Study|Non-compliance|2|||
162697096|NCT01807221|587603193|FG002|Overall Study|Non-compliance|0|||
162697097|NCT01807221|587603194|FG003|Overall Study|Non-compliance|1|||
162697098|NCT01807221|587603195|FG004|Overall Study|Non-compliance|0|||
162697099|NCT01807221|587603196|FG005|Overall Study|Non-compliance|0|||
162697100|NCT01807221|587603191|FG000|Overall Study|Logistical difficulties|0|||
162697101|NCT01807221|587603192|FG001|Overall Study|Logistical difficulties|1|||
162697102|NCT01807221|587603193|FG002|Overall Study|Logistical difficulties|0|||
162697103|NCT01807221|587603194|FG003|Overall Study|Logistical difficulties|0|||
162697104|NCT01807221|587603195|FG004|Overall Study|Logistical difficulties|1|||
162697105|NCT01807221|587603196|FG005|Overall Study|Logistical difficulties|0|||
162697106|NCT01807221|587603191|FG000|Overall Study|Withdrawal by Subject|33|||
162697107|NCT01807221|587603192|FG001|Overall Study|Withdrawal by Subject|15|||
162697108|NCT01807221|587603193|FG002|Overall Study|Withdrawal by Subject|8|||
162697109|NCT01807221|587603194|FG003|Overall Study|Withdrawal by Subject|14|||
162697110|NCT01807221|587603195|FG004|Overall Study|Withdrawal by Subject|16|||
162697111|NCT01807221|587603196|FG005|Overall Study|Withdrawal by Subject|13|||
162697112|NCT01807221|587603191|FG000|Overall Study|Sponsor decision|2|||
162697113|NCT01807221|587603192|FG001|Overall Study|Sponsor decision|0|||
162697114|NCT01807221|587603193|FG002|Overall Study|Sponsor decision|1|||
162697115|NCT01807221|587603194|FG003|Overall Study|Sponsor decision|1|||
162697116|NCT01807221|587603195|FG004|Overall Study|Sponsor decision|0|||
162697117|NCT01807221|587603196|FG005|Overall Study|Sponsor decision|0|||
162697118|NCT01807221|587603191|FG000|Overall Study|Lost to Follow-up|1|||
162697119|NCT01807221|587603192|FG001|Overall Study|Lost to Follow-up|0|||
162697120|NCT01807221|587603193|FG002|Overall Study|Lost to Follow-up|2|||
162697121|NCT01807221|587603194|FG003|Overall Study|Lost to Follow-up|1|||
162697122|NCT01807221|587603195|FG004|Overall Study|Lost to Follow-up|0|||
162697123|NCT01807221|587603196|FG005|Overall Study|Lost to Follow-up|0|||
162697124|NCT01087723|587603198|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
162697125|NCT01087723|587603199|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
162697126|NCT01087723|587603198|FG000|Overall Study|Withdrawal by Subject|10|||
162697127|NCT01087723|587603199|FG001|Overall Study|Withdrawal by Subject|13|||
162697128|NCT01087723|587603198|FG000|Overall Study|Physician Decision|2|||
162697129|NCT01087723|587603199|FG001|Overall Study|Physician Decision|0|||
162697130|NCT01087723|587603198|FG000|Overall Study|Lost to Follow-up|1|||
162697131|NCT01087723|587603199|FG001|Overall Study|Lost to Follow-up|4|||
162697132|NCT01087723|587603198|FG000|Overall Study|Reason Not Specified|1|||
162697133|NCT01087723|587603199|FG001|Overall Study|Reason Not Specified|2|||
162697134|NCT01868035|587603200|FG000|Overall Study|Lost to Follow-up|3|||
162697135|NCT01868035|587603200|FG000|Overall Study|Withdrawal by Subject|1|||
162697136|NCT01868035|587603200|FG000|Overall Study|Progressive Disease|2|||
162697137|NCT01868035|587603200|FG000|Overall Study|Non-compliance|1|||
162697138|NCT01757665|587603206|FG000|Overall Study|Still on Study - Visit Completed|240|||
162697139|NCT01757665|587603207|FG001|Overall Study|Still on Study - Visit Completed|30|||
162697140|NCT01757665|587603206|FG000|Overall Study|Still on Study - Visit Pending|398|||
162697141|NCT01757665|587603207|FG001|Overall Study|Still on Study - Visit Pending|40|||
162697142|NCT01757665|587603206|FG000|Overall Study|Still on Study - Missed Visit|14|||
162697143|NCT01757665|587603207|FG001|Overall Study|Still on Study - Missed Visit|1|||
162697144|NCT01757665|587603206|FG000|Overall Study|Death|25|||
162697145|NCT01757665|587603207|FG001|Overall Study|Death|8|||
162697146|NCT01757665|587603206|FG000|Overall Study|Explant|1|||
162697147|NCT01757665|587603207|FG001|Overall Study|Explant|2|||
162697148|NCT01757665|587603206|FG000|Overall Study|Withdrawal by Subject|10|||
162697149|NCT01757665|587603207|FG001|Overall Study|Withdrawal by Subject|0|||
162697150|NCT01757665|587603206|FG000|Overall Study|Lost to Follow-up|1|||
162697151|NCT01757665|587603207|FG001|Overall Study|Lost to Follow-up|1|||
162697152|NCT01757665|587603206|FG000|Overall Study|Not Implanted with Device|5|||
162697153|NCT01757665|587603207|FG001|Overall Study|Not Implanted with Device|1|||
162697154|NCT03632434|587603212|FG000|Overall Study|Withdrawal by Subject|2|||
162697155|NCT04297241|587603213|FG000|Overall Study|Withdrawal by Subject|1|||
162697156|NCT04297241|587603213|FG000|Overall Study|Adverse Event|1|||
162697157|NCT04297241|587603213|FG000|Overall Study|Physician Decision|3|||
162697158|NCT02836613|587603220|FG000|Overall Study|Accidental drowning|1|||
162697159|NCT02836613|587603221|FG001|Overall Study|Accidental drowning|0|||
162697160|NCT02836613|587603220|FG000|Overall Study|Lost to Follow-up|0|||
162697161|NCT02836613|587603221|FG001|Overall Study|Lost to Follow-up|1|||
162697162|NCT02836613|587603220|FG000|Overall Study|Withdrawal by Subject|0|||
162697163|NCT02836613|587603221|FG001|Overall Study|Withdrawal by Subject|2|||
162697164|NCT01799720|587603222|FG000|Overall Study|Withdrawal by Subject|3|||
162697165|NCT01799720|587603223|FG001|Overall Study|Withdrawal by Subject|0|||
162697166|NCT01799720|587603224|FG002|Overall Study|Withdrawal by Subject|0|||
162697167|NCT01799720|587603222|FG000|Overall Study|Protocol Violation|0|||
162697168|NCT01799720|587603223|FG001|Overall Study|Protocol Violation|1|||
162697169|NCT01799720|587603224|FG002|Overall Study|Protocol Violation|0|||
162697170|NCT01799720|587603222|FG000|Overall Study|Pregnancy|0|||
162697171|NCT01799720|587603223|FG001|Overall Study|Pregnancy|0|||
162697172|NCT01799720|587603224|FG002|Overall Study|Pregnancy|1|||
162697173|NCT04276090|587603225|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
162697174|NCT04276090|587603226|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
162697175|NCT05407311|587603242|FG000|Overall Study|Withdrawal by Subject|5|||
162697176|NCT05407311|587603242|FG000|Overall Study|Protocol Violation|3|||
162697177|NCT05407311|587603242|FG000|Overall Study|Physician Decision|1|||
162697178|NCT05407311|587603242|FG000|Overall Study|Non-compliance|1|||
162697179|NCT01265823|587603243|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
163161141|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
163161142|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
163161143|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Death|1|||
163161144|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Death|3|||
163161145|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Death|3|||
163161146|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
163161147|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
163161148|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
163161149|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
163161150|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
163161151|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
163161152|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
163161153|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
163161154|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
163161155|NCT00473382|589304089|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
163161156|NCT00473382|589304090|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
163161157|NCT00473382|589304091|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
163161158|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
163161159|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
163161160|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
163161161|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Death|1|||
163161162|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Death|7|||
163161163|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Death|4|||
163161164|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
163161165|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
163161166|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
163161167|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
163161168|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
163161169|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
163161170|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
163161171|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
163161172|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
163161173|NCT00473382|589304089|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
163161174|NCT00473382|589304090|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
163161175|NCT00473382|589304091|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
163161176|NCT03565497|589304092|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
163161177|NCT03565497|589304093|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
163161178|NCT03565497|589304094|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
163161179|NCT03565497|589304092|FG000|Overall Study|Lost to Follow-up|1|||
163161180|NCT03565497|589304093|FG001|Overall Study|Lost to Follow-up|1|||
163161181|NCT03565497|589304094|FG002|Overall Study|Lost to Follow-up|2|||
163161182|NCT03565497|589304092|FG000|Overall Study|Withdrawal by Subject|1|||
163161183|NCT03565497|589304093|FG001|Overall Study|Withdrawal by Subject|1|||
163161184|NCT03565497|589304094|FG002|Overall Study|Withdrawal by Subject|1|||
163161185|NCT02999672|589304095|FG000|Overall Study|Death|0|||
163161186|NCT02999672|589304096|FG001|Overall Study|Death|1|||
163161187|NCT02999672|589304095|FG000|Overall Study|Study Terminated by Sponsor|0|||
163161188|NCT02999672|589304096|FG001|Overall Study|Study Terminated by Sponsor|1|||
163161189|NCT02999672|589304095|FG000|Overall Study|Progressive Disease|9|||
163161190|NCT02999672|589304096|FG001|Overall Study|Progressive Disease|5|||
163161191|NCT02999672|589304095|FG000|Overall Study|Adverse Event|4|||
163161192|NCT02999672|589304096|FG001|Overall Study|Adverse Event|0|||
163161193|NCT01166282|589304097|FG000|Open-label Period|Adverse Event|0|||
163161194|NCT01166282|589304098|FG001|Open-label Period|Adverse Event|0|||
163161195|NCT01166282|589304099|FG002|Open-label Period|Adverse Event|6|||
163161196|NCT01166282|589304097|FG000|Open-label Period|Withdrawal by Subject|0|||
163161197|NCT01166282|589304098|FG001|Open-label Period|Withdrawal by Subject|0|||
163161198|NCT01166282|589304099|FG002|Open-label Period|Withdrawal by Subject|4|||
163161199|NCT01166282|589304097|FG000|Open-label Period|Lack of Efficacy|0|||
163161200|NCT01166282|589304098|FG001|Open-label Period|Lack of Efficacy|0|||
163161201|NCT01166282|589304099|FG002|Open-label Period|Lack of Efficacy|2|||
163161202|NCT01166282|589304097|FG000|Open-label Period|Remission|0|||
162697180|NCT01265823|587603243|FG000|Overall Study|Failure to Return|4|||
162697181|NCT01265823|587603243|FG000|Overall Study|Protocol Violation|1|||
162697182|NCT01265823|587603243|FG000|Overall Study|Participant Request|1|||
162697183|NCT01263106|587603244|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
162697184|NCT01263106|587603245|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
162697185|NCT05027074|587603251|FG000|Overall Study|Death|47|||
162697186|NCT05027074|587603252|FG001|Overall Study|Death|42|||
162697187|NCT05027074|587603253|FG002|Overall Study|Death|39|||
162697188|NCT05027074|587603251|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162697189|NCT05027074|587603252|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162697190|NCT05027074|587603253|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162697191|NCT05027074|587603251|FG000|Overall Study|Site Terminated By Sponsor|3|||
162697192|NCT05027074|587603252|FG001|Overall Study|Site Terminated By Sponsor|0|||
162697193|NCT05027074|587603253|FG002|Overall Study|Site Terminated By Sponsor|2|||
162697194|NCT05027074|587603251|FG000|Overall Study|Withdrawal by Subject|13|||
162697195|NCT05027074|587603252|FG001|Overall Study|Withdrawal by Subject|8|||
162697196|NCT05027074|587603253|FG002|Overall Study|Withdrawal by Subject|10|||
162697197|NCT05027074|587603251|FG000|Overall Study|Lost to Follow-up|2|||
162697198|NCT05027074|587603252|FG001|Overall Study|Lost to Follow-up|4|||
162697199|NCT05027074|587603253|FG002|Overall Study|Lost to Follow-up|3|||
162697200|NCT05027074|587603251|FG000|Overall Study|Status Not Recorded|0|||
162697201|NCT05027074|587603252|FG001|Overall Study|Status Not Recorded|0|||
162697202|NCT05027074|587603253|FG002|Overall Study|Status Not Recorded|1|||
162697203|NCT03169881|587603254|FG000|Overall Study|Incomplete Follow-up|10|||
162697204|NCT03169881|587603255|FG001|Overall Study|Incomplete Follow-up|15|||
162697205|NCT03169881|587603254|FG000|Overall Study|Lost to Follow-up|18|||
162697206|NCT03169881|587603255|FG001|Overall Study|Lost to Follow-up|20|||
162697207|NCT03169881|587603254|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
162697208|NCT03169881|587603255|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
162697209|NCT02180438|587603261|FG000|Overall Study|Lost to Follow-up|1|||
162697210|NCT00785707|587603262|FG000|Overall Study|Lost to Follow-up|7|||
162697211|NCT02090634|587603263|FG000|Overall Study|Lost to Follow-up|0|||
162697212|NCT02090634|587603264|FG001|Overall Study|Lost to Follow-up|1|||
162697213|NCT02090634|587603263|FG000|Overall Study|Death|0|||
162697214|NCT02090634|587603264|FG001|Overall Study|Death|1|||
162697215|NCT02090634|587603263|FG000|Overall Study|Protocol Violation|3|||
162697216|NCT02090634|587603264|FG001|Overall Study|Protocol Violation|1|||
162697217|NCT02090634|587603263|FG000|Overall Study|Adverse Event|2|||
162697218|NCT02090634|587603264|FG001|Overall Study|Adverse Event|0|||
162697219|NCT00147225|587603270|FG000|Overall Study|Withdrawal by Subject|1|||
162697220|NCT00147225|587603271|FG001|Overall Study|Withdrawal by Subject|0|||
162697221|NCT00147225|587603272|FG002|Overall Study|Withdrawal by Subject|1|||
162697222|NCT00147225|587603273|FG003|Overall Study|Withdrawal by Subject|0|||
162697223|NCT00147225|587603274|FG004|Overall Study|Withdrawal by Subject|0|||
162697224|NCT00147225|587603275|FG005|Overall Study|Withdrawal by Subject|1|||
162697225|NCT00147225|587603270|FG000|Overall Study|Adverse Event|0|||
162697226|NCT00147225|587603271|FG001|Overall Study|Adverse Event|0|||
162697227|NCT00147225|587603272|FG002|Overall Study|Adverse Event|1|||
162697228|NCT00147225|587603273|FG003|Overall Study|Adverse Event|1|||
162697229|NCT00147225|587603274|FG004|Overall Study|Adverse Event|0|||
162697230|NCT00147225|587603275|FG005|Overall Study|Adverse Event|0|||
162697231|NCT00147225|587603270|FG000|Overall Study|Screen Failure|0|||
162697232|NCT00147225|587603271|FG001|Overall Study|Screen Failure|0|||
162697233|NCT00147225|587603272|FG002|Overall Study|Screen Failure|0|||
162697234|NCT00147225|587603273|FG003|Overall Study|Screen Failure|0|||
162697235|NCT00147225|587603274|FG004|Overall Study|Screen Failure|1|||
162697236|NCT00147225|587603275|FG005|Overall Study|Screen Failure|0|||
162697237|NCT00147225|587603270|FG000|Overall Study|Chemotherapy Changed|0|||
162697238|NCT00147225|587603271|FG001|Overall Study|Chemotherapy Changed|0|||
162697239|NCT00147225|587603272|FG002|Overall Study|Chemotherapy Changed|0|||
162697240|NCT00147225|587603273|FG003|Overall Study|Chemotherapy Changed|0|||
162697241|NCT00147225|587603274|FG004|Overall Study|Chemotherapy Changed|0|||
162697242|NCT00147225|587603275|FG005|Overall Study|Chemotherapy Changed|1|||
162697243|NCT01032044|587603278|FG000|Overall Study|Protocol Violation|14|||
162697244|NCT01032044|587603279|FG001|Overall Study|Protocol Violation|8|||
162697245|NCT01032044|587603278|FG000|Overall Study|Adverse Event|0|||
162697246|NCT01032044|587603279|FG001|Overall Study|Adverse Event|1|||
162697247|NCT01032044|587603278|FG000|Overall Study|Lost to Follow-up|11|||
162697248|NCT01032044|587603279|FG001|Overall Study|Lost to Follow-up|11|||
162697249|NCT01567865|587603286|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
162697250|NCT01567865|587603287|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
162697251|NCT01567865|587603288|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
162697252|NCT01567865|587603289|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
162697253|NCT01567865|587603286|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
162697254|NCT01567865|587603287|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
162697255|NCT01567865|587603288|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
162697256|NCT01567865|587603289|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
162697257|NCT01051063|587603302|FG000|Overall Study|Death|2|||
162697258|NCT01051063|587603303|FG001|Overall Study|Death|2|||
162697259|NCT01051063|587603302|FG000|Overall Study|Withdrawal by Subject|1|||
162697260|NCT01051063|587603303|FG001|Overall Study|Withdrawal by Subject|1|||
162697261|NCT01051063|587603302|FG000|Overall Study|Termination of the study|5|||
162697262|NCT01051063|587603303|FG001|Overall Study|Termination of the study|0|||
162697263|NCT01051063|587603302|FG000|Overall Study|Moved from the study site area|1|||
162697264|NCT01051063|587603303|FG001|Overall Study|Moved from the study site area|0|||
162697265|NCT01051063|587603302|FG000|Overall Study|Other|1|||
162697266|NCT01051063|587603303|FG001|Overall Study|Other|0|||
162697267|NCT01051063|587603302|FG000|Overall Study|Lost to Follow-up|0|||
162697268|NCT01051063|587603303|FG001|Overall Study|Lost to Follow-up|1|||
162697269|NCT05569954|587603304|FG000|Overall Study|Lost to Follow-up|3|||
162697270|NCT05569954|587603305|FG001|Overall Study|Lost to Follow-up|4|||
162697271|NCT05569954|587603304|FG000|Overall Study|Protocol Violation|1|||
162697272|NCT05569954|587603305|FG001|Overall Study|Protocol Violation|2|||
162697273|NCT05569954|587603304|FG000|Overall Study|Withdrawal by Subject|4|||
162697274|NCT05569954|587603305|FG001|Overall Study|Withdrawal by Subject|2|||
162697275|NCT03857841|587603315|FG000|Overall Study|Death|1|||
162697276|NCT03857841|587603316|FG001|Overall Study|Death|0|||
162697277|NCT03857841|587603317|FG002|Overall Study|Death|0|||
162697278|NCT03857841|587603318|FG003|Overall Study|Death|0|||
162697279|NCT03857841|587603315|FG000|Overall Study|Study Terminated by Sponsor|1|||
162697280|NCT03857841|587603316|FG001|Overall Study|Study Terminated by Sponsor|0|||
162697281|NCT03857841|587603317|FG002|Overall Study|Study Terminated by Sponsor|0|||
162697282|NCT03857841|587603318|FG003|Overall Study|Study Terminated by Sponsor|0|||
162697283|NCT00384059|587603319|FG000|Infant Series|Not consented|2|||
162697284|NCT00384059|587603320|FG001|Infant Series|Not consented|6|||
162697285|NCT00384059|587603319|FG000|Infant Series|Withdrawal by Subject|2|||
162697286|NCT00384059|587603320|FG001|Infant Series|Withdrawal by Subject|2|||
162697287|NCT00384059|587603319|FG000|Infant Series|Adverse Event|1|||
162697288|NCT00384059|587603320|FG001|Infant Series|Adverse Event|2|||
162697289|NCT00384059|587603319|FG000|Infant Series|Protocol Violation|1|||
162697290|NCT00384059|587603320|FG001|Infant Series|Protocol Violation|2|||
162697291|NCT00384059|587603319|FG000|Infant Series|Lost to Follow-up|0|||
162697292|NCT00384059|587603320|FG001|Infant Series|Lost to Follow-up|1|||
162697293|NCT00384059|587603319|FG000|After Infant Series|Protocol Violation|2|||
162697294|NCT00384059|587603320|FG001|After Infant Series|Protocol Violation|3|||
162697295|NCT00384059|587603319|FG000|After Infant Series|Withdrawal by Subject|2|||
162697296|NCT00384059|587603320|FG001|After Infant Series|Withdrawal by Subject|2|||
162697297|NCT00384059|587603319|FG000|After Infant Series|Failed to Return|0|||
162697298|NCT00384059|587603320|FG001|After Infant Series|Failed to Return|2|||
162697299|NCT00384059|587603319|FG000|After Infant Series|Adverse Event|0|||
162697300|NCT00384059|587603320|FG001|After Infant Series|Adverse Event|1|||
162697301|NCT00384059|587603319|FG000|After Infant Series|Physician Decision|0|||
162697302|NCT00384059|587603320|FG001|After Infant Series|Physician Decision|1|||
162697303|NCT00384059|587603319|FG000|After Infant Series|Lost to Follow-up|0|||
162697304|NCT00384059|587603320|FG001|After Infant Series|Lost to Follow-up|1|||
162697305|NCT00384059|587603319|FG000|Toddler Dose|Lost to Follow-up|1|||
162697306|NCT00384059|587603320|FG001|Toddler Dose|Lost to Follow-up|1|||
162697307|NCT00384059|587603319|FG000|Toddler Dose|Failed to return|0|||
162697308|NCT00384059|587603320|FG001|Toddler Dose|Failed to return|1|||
162697309|NCT00381641|587603323|FG000|Overall Study|Withdrawal by Subject|0|||
162697310|NCT00381641|587603324|FG001|Overall Study|Withdrawal by Subject|2|||
162713416|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713417|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
162713418|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713419|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713420|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713421|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713422|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713423|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713424|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713425|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162713426|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
162713427|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713428|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713429|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713430|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163161203|NCT01166282|589304098|FG001|Open-label Period|Remission|0|||
162713431|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713432|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713433|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162697311|NCT00802737|587605353|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
162697312|NCT00802737|587605354|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
162697313|NCT00802737|587605355|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
162697314|NCT00802737|587605353|FG000|Overall Study|Death|6|||
162697315|NCT00802737|587605354|FG001|Overall Study|Death|5|||
162697316|NCT00802737|587605355|FG002|Overall Study|Death|1|||
162697317|NCT00802737|587605353|FG000|Overall Study|Adverse Event|1|||
162697318|NCT00802737|587605354|FG001|Overall Study|Adverse Event|0|||
162697319|NCT00802737|587605355|FG002|Overall Study|Adverse Event|0|||
162697320|NCT00802737|587605353|FG000|Overall Study|Received Prohibited Therapy|1|||
162697321|NCT00802737|587605354|FG001|Overall Study|Received Prohibited Therapy|0|||
162697322|NCT00802737|587605355|FG002|Overall Study|Received Prohibited Therapy|0|||
162697323|NCT00802737|587605353|FG000|Overall Study|Ongoing CLL-Treatment|0|||
162697324|NCT00802737|587605354|FG001|Overall Study|Ongoing CLL-Treatment|1|||
162697325|NCT00802737|587605355|FG002|Overall Study|Ongoing CLL-Treatment|0|||
162697326|NCT00802737|587605353|FG000|Overall Study|Participant too Unwell|0|||
162697327|NCT00802737|587605354|FG001|Overall Study|Participant too Unwell|2|||
162697328|NCT00802737|587605355|FG002|Overall Study|Participant too Unwell|0|||
162697329|NCT03864926|587605358|FG000|Overall Study|Death|0|||
162697330|NCT03864926|587605359|FG001|Overall Study|Death|2|||
162697331|NCT00445601|587605360|FG000|Overall Study|Withdrawal by Subject|11|||
162697332|NCT00445601|587605361|FG001|Overall Study|Withdrawal by Subject|11|||
162697333|NCT00445601|587605360|FG000|Overall Study|TURBT Complication|12|||
162697334|NCT00445601|587605361|FG001|Overall Study|TURBT Complication|8|||
162697335|NCT00445601|587605360|FG000|Overall Study|Incorrect Disease Status|6|||
162697336|NCT00445601|587605361|FG001|Overall Study|Incorrect Disease Status|6|||
162697337|NCT00445601|587605360|FG000|Overall Study|Drug Delivery Issue|2|||
162697338|NCT00445601|587605361|FG001|Overall Study|Drug Delivery Issue|2|||
162697339|NCT00445601|587605360|FG000|Overall Study|Adverse Event|2|||
162697340|NCT00445601|587605361|FG001|Overall Study|Adverse Event|0|||
162697341|NCT00445601|587605360|FG000|Overall Study|Death prior to TURBT|0|||
162697342|NCT00445601|587605361|FG001|Overall Study|Death prior to TURBT|1|||
162697343|NCT00619476|587605362|FG000|Overall Study|Adverse Event|12|||
162697344|NCT00619476|587605363|FG001|Overall Study|Adverse Event|6|||
162697345|NCT00619476|587605364|FG002|Overall Study|Adverse Event|12|||
162697346|NCT00619476|587605365|FG003|Overall Study|Adverse Event|16|||
162697347|NCT00619476|587605362|FG000|Overall Study|Lack of Efficacy|6|||
163161204|NCT01166282|589304099|FG002|Open-label Period|Remission|4|||
163161205|NCT01166282|589304097|FG000|Open-label Period|Irregular Compliance|0|||
163161206|NCT01166282|589304098|FG001|Open-label Period|Irregular Compliance|0|||
163161207|NCT01166282|589304099|FG002|Open-label Period|Irregular Compliance|1|||
163161208|NCT02892448|589304108|FG000|Overall Study|Screening failure|2|||
163161209|NCT02892448|589304109|FG001|Overall Study|Screening failure|2|||
163161210|NCT02892448|589304110|FG002|Overall Study|Screening failure|1|||
163161211|NCT01262989|589304111|FG000|Period 1|Lost to Follow-up|1|||
163161212|NCT01262989|589304112|FG001|Period 1|Lost to Follow-up|1|||
163161213|NCT01262989|589304111|FG000|Period 1|Intercurrent disease|0|||
163161214|NCT01262989|589304112|FG001|Period 1|Intercurrent disease|1|||
163161215|NCT01262989|589304111|FG000|Period 1|Positive answer for exclusion criteria|0|||
163161216|NCT01262989|589304112|FG001|Period 1|Positive answer for exclusion criteria|1|||
163161217|NCT01262989|589304111|FG000|Period 2|Intercurrent disease|0|||
163161218|NCT01262989|589304112|FG001|Period 2|Intercurrent disease|1|||
163161219|NCT03599089|589304113|FG000|Overall Study|Lost to Follow-up|1|||
163161220|NCT03599089|589304114|FG001|Overall Study|Lost to Follow-up|0|||
163161221|NCT03599089|589304115|FG002|Overall Study|Lost to Follow-up|0|||
163161222|NCT03599089|589304116|FG003|Overall Study|Lost to Follow-up|0|||
163161223|NCT03599089|589304113|FG000|Overall Study|Withdrawal by Subject|2|||
163161224|NCT03599089|589304114|FG001|Overall Study|Withdrawal by Subject|1|||
163161225|NCT03599089|589304115|FG002|Overall Study|Withdrawal by Subject|0|||
163161226|NCT03599089|589304116|FG003|Overall Study|Withdrawal by Subject|0|||
163161227|NCT03599089|589304113|FG000|Overall Study|Lack of Efficacy|0|||
162697348|NCT00619476|587605363|FG001|Overall Study|Lack of Efficacy|1|||
162697349|NCT00619476|587605364|FG002|Overall Study|Lack of Efficacy|1|||
162697350|NCT00619476|587605365|FG003|Overall Study|Lack of Efficacy|4|||
162697351|NCT00619476|587605362|FG000|Overall Study|Protocol Violation|5|||
162697352|NCT00619476|587605363|FG001|Overall Study|Protocol Violation|4|||
162697353|NCT00619476|587605364|FG002|Overall Study|Protocol Violation|4|||
162697354|NCT00619476|587605365|FG003|Overall Study|Protocol Violation|9|||
163161228|NCT03599089|589304114|FG001|Overall Study|Lack of Efficacy|0|||
163161229|NCT03599089|589304115|FG002|Overall Study|Lack of Efficacy|1|||
163161230|NCT03599089|589304116|FG003|Overall Study|Lack of Efficacy|2|||
163161231|NCT03214666|589304117|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162697355|NCT00619476|587605362|FG000|Overall Study|Lost to Follow-up|1|||
162697356|NCT00619476|587605363|FG001|Overall Study|Lost to Follow-up|2|||
162697357|NCT00619476|587605364|FG002|Overall Study|Lost to Follow-up|0|||
162697358|NCT00619476|587605365|FG003|Overall Study|Lost to Follow-up|1|||
162697359|NCT00619476|587605362|FG000|Overall Study|Investigator Discretion|2|||
162697360|NCT00619476|587605363|FG001|Overall Study|Investigator Discretion|2|||
162697361|NCT00619476|587605364|FG002|Overall Study|Investigator Discretion|2|||
162697362|NCT00619476|587605365|FG003|Overall Study|Investigator Discretion|0|||
162697363|NCT00619476|587605362|FG000|Overall Study|Withdrawal by Subject|5|||
162697364|NCT00619476|587605363|FG001|Overall Study|Withdrawal by Subject|7|||
162697365|NCT00619476|587605364|FG002|Overall Study|Withdrawal by Subject|5|||
162697366|NCT00619476|587605365|FG003|Overall Study|Withdrawal by Subject|4|||
162697367|NCT01091428|587605366|FG000|Phase 1|Progressive Disease|24|||
162697368|NCT01091428|587605367|FG001|Phase 1|Progressive Disease|8|||
162697369|NCT01091428|587605368|FG002|Phase 1|Progressive Disease|0|||
162697370|NCT01091428|587605369|FG003|Phase 1|Progressive Disease|0|||
162697371|NCT01091428|587605366|FG000|Phase 1|Symptomatic Deterioration|3|||
162697372|NCT01091428|587605367|FG001|Phase 1|Symptomatic Deterioration|2|||
162697373|NCT01091428|587605368|FG002|Phase 1|Symptomatic Deterioration|0|||
162697374|NCT01091428|587605369|FG003|Phase 1|Symptomatic Deterioration|0|||
162697375|NCT01091428|587605366|FG000|Phase 1|Adverse Event|2|||
162697376|NCT01091428|587605367|FG001|Phase 1|Adverse Event|0|||
162697377|NCT01091428|587605368|FG002|Phase 1|Adverse Event|0|||
162697378|NCT01091428|587605369|FG003|Phase 1|Adverse Event|0|||
162697379|NCT01091428|587605366|FG000|Phase 1|Withdrawal by Subject|7|||
162697380|NCT01091428|587605367|FG001|Phase 1|Withdrawal by Subject|0|||
162697381|NCT01091428|587605368|FG002|Phase 1|Withdrawal by Subject|0|||
162697382|NCT01091428|587605369|FG003|Phase 1|Withdrawal by Subject|0|||
162697383|NCT01091428|587605366|FG000|Phase 1|Reason not specified|0|||
162697384|NCT01091428|587605367|FG001|Phase 1|Reason not specified|1|||
162697385|NCT01091428|587605368|FG002|Phase 1|Reason not specified|0|||
162697386|NCT01091428|587605369|FG003|Phase 1|Reason not specified|0|||
162697387|NCT01091428|587605366|FG000|Phase 1|Single-Patient IND|2|||
162697388|NCT01091428|587605367|FG001|Phase 1|Single-Patient IND|0|||
162697389|NCT01091428|587605368|FG002|Phase 1|Single-Patient IND|0|||
162697390|NCT01091428|587605369|FG003|Phase 1|Single-Patient IND|0|||
162697391|NCT01091428|587605366|FG000|Phase 2|Progressive Disease|0|||
162697392|NCT01091428|587605367|FG001|Phase 2|Progressive Disease|0|||
162697393|NCT01091428|587605368|FG002|Phase 2|Progressive Disease|44|||
162697394|NCT01091428|587605369|FG003|Phase 2|Progressive Disease|46|||
162697395|NCT01091428|587605366|FG000|Phase 2|Symptomatic Deterioration|0|||
162697396|NCT01091428|587605367|FG001|Phase 2|Symptomatic Deterioration|0|||
162697397|NCT01091428|587605368|FG002|Phase 2|Symptomatic Deterioration|1|||
162697398|NCT01091428|587605369|FG003|Phase 2|Symptomatic Deterioration|6|||
162697399|NCT01091428|587605366|FG000|Phase 2|Adverse Event|0|||
162697400|NCT01091428|587605367|FG001|Phase 2|Adverse Event|0|||
162697401|NCT01091428|587605368|FG002|Phase 2|Adverse Event|12|||
162697402|NCT01091428|587605369|FG003|Phase 2|Adverse Event|5|||
162697403|NCT01091428|587605366|FG000|Phase 2|Withdrawal by Subject|0|||
162697404|NCT01091428|587605367|FG001|Phase 2|Withdrawal by Subject|0|||
162697405|NCT01091428|587605368|FG002|Phase 2|Withdrawal by Subject|9|||
162697406|NCT01091428|587605369|FG003|Phase 2|Withdrawal by Subject|8|||
162697407|NCT01091428|587605366|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
162697408|NCT01091428|587605367|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
162697409|NCT01091428|587605368|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
162697410|NCT01091428|587605369|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
162697411|NCT01091428|587605366|FG000|Phase 2|Reason not specified|0|||
162697412|NCT01091428|587605367|FG001|Phase 2|Reason not specified|0|||
162697413|NCT01091428|587605368|FG002|Phase 2|Reason not specified|4|||
162697414|NCT01091428|587605369|FG003|Phase 2|Reason not specified|3|||
162697415|NCT01091428|587605366|FG000|Phase 2|Physician Decision|0|||
162697416|NCT01091428|587605367|FG001|Phase 2|Physician Decision|0|||
162697417|NCT01091428|587605368|FG002|Phase 2|Physician Decision|2|||
162697418|NCT01091428|587605369|FG003|Phase 2|Physician Decision|0|||
162697419|NCT01625910|587605374|FG000|Overall Study|Lost to Follow-up|3|||
162697420|NCT01625910|587605375|FG001|Overall Study|Lost to Follow-up|4|||
162697421|NCT02959138|587605376|FG000|Overall Study|Enrolled but Never Treated|0|||
162697422|NCT02959138|587605377|FG001|Overall Study|Enrolled but Never Treated|1|||
162697423|NCT02959138|587605378|FG002|Overall Study|Enrolled but Never Treated|0|||
162697424|NCT02391038|587605379|FG000|Overall Study|Progressive disease|3|||
163161232|NCT03214666|589304118|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162697425|NCT02391038|587605380|FG001|Overall Study|Progressive disease|3|||
162697426|NCT02391038|587605381|FG002|Overall Study|Progressive disease|6|||
162697427|NCT04213989|587605382|FG000|Overall Study|Withdrawal by Subject|3|||
162697428|NCT04213989|587605383|FG001|Overall Study|Withdrawal by Subject|2|||
162697429|NCT04213989|587605382|FG000|Overall Study|Physician Decision|1|||
162697430|NCT04213989|587605383|FG001|Overall Study|Physician Decision|0|||
162697431|NCT04213989|587605382|FG000|Overall Study|Lost to Follow-up|0|||
162697432|NCT04213989|587605383|FG001|Overall Study|Lost to Follow-up|4|||
162697433|NCT01327547|587605384|FG000|Overall Study|Adverse Event|4|||
162697434|NCT01327547|587605385|FG001|Overall Study|Adverse Event|1|||
162697435|NCT01327547|587605384|FG000|Overall Study|Death|1|||
162697436|NCT01327547|587605385|FG001|Overall Study|Death|2|||
162697437|NCT01327547|587605384|FG000|Overall Study|Lost to Follow-up|6|||
162697438|NCT01327547|587605385|FG001|Overall Study|Lost to Follow-up|6|||
162697439|NCT01327547|587605384|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
162697440|NCT01327547|587605385|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
162697441|NCT01327547|587605384|FG000|Overall Study|Withdrawal by Subject|3|||
162697442|NCT01327547|587605385|FG001|Overall Study|Withdrawal by Subject|7|||
162697443|NCT01327547|587605384|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
162697444|NCT01327547|587605385|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
162697445|NCT01327547|587605384|FG000|Overall Study|Protocol Violation|1|||
162697446|NCT01327547|587605385|FG001|Overall Study|Protocol Violation|0|||
162697447|NCT01327547|587605384|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
162697448|NCT01327547|587605385|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
162697449|NCT01327547|587605384|FG000|Overall Study|Required prohibited medication|2|||
162697450|NCT01327547|587605385|FG001|Overall Study|Required prohibited medication|0|||
162697451|NCT01327547|587605384|FG000|Overall Study|Non-compliance with study procedures|1|||
162697452|NCT01327547|587605385|FG001|Overall Study|Non-compliance with study procedures|0|||
162697453|NCT01327547|587605384|FG000|Overall Study|By investigator in subject's interest|0|||
162697454|NCT01327547|587605385|FG001|Overall Study|By investigator in subject's interest|1|||
162697455|NCT03884231|587605386|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
162697456|NCT03884231|587605386|FG000|Overall Study|Subject Withdrew Consent|1|||
162697457|NCT03884231|587605386|FG000|Overall Study|MRI Scan Not Performed|1|||
162697458|NCT00900627|587605387|FG000|Overall Study|Condition under investigation worsened|4|||
162697459|NCT00900627|587605388|FG001|Overall Study|Condition under investigation worsened|0|||
162697460|NCT00900627|587605389|FG002|Overall Study|Condition under investigation worsened|5|||
162697461|NCT00900627|587605390|FG003|Overall Study|Condition under investigation worsened|3|||
162697462|NCT00900627|587605391|FG004|Overall Study|Condition under investigation worsened|0|||
162697463|NCT00900627|587605392|FG005|Overall Study|Condition under investigation worsened|0|||
162697464|NCT00900627|587605387|FG000|Overall Study|Withdrawal by Subject|1|||
162697465|NCT00900627|587605388|FG001|Overall Study|Withdrawal by Subject|0|||
162697466|NCT00900627|587605389|FG002|Overall Study|Withdrawal by Subject|1|||
162697467|NCT00900627|587605390|FG003|Overall Study|Withdrawal by Subject|0|||
162697468|NCT00900627|587605391|FG004|Overall Study|Withdrawal by Subject|1|||
162697469|NCT00900627|587605392|FG005|Overall Study|Withdrawal by Subject|2|||
162697470|NCT00900627|587605387|FG000|Overall Study|Adverse Event|1|||
162697471|NCT00900627|587605388|FG001|Overall Study|Adverse Event|2|||
162697472|NCT00900627|587605389|FG002|Overall Study|Adverse Event|0|||
162697473|NCT00900627|587605390|FG003|Overall Study|Adverse Event|3|||
162697474|NCT00900627|587605391|FG004|Overall Study|Adverse Event|0|||
162697475|NCT00900627|587605392|FG005|Overall Study|Adverse Event|0|||
162697476|NCT00900627|587605387|FG000|Overall Study|Death|0|||
162697477|NCT00900627|587605388|FG001|Overall Study|Death|0|||
162697478|NCT00900627|587605389|FG002|Overall Study|Death|0|||
162697479|NCT00900627|587605390|FG003|Overall Study|Death|0|||
162697480|NCT00900627|587605391|FG004|Overall Study|Death|28|||
162697481|NCT00900627|587605392|FG005|Overall Study|Death|24|||
162697482|NCT00373295|587605393|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162697483|NCT00373295|587605394|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
162697484|NCT00373295|587605395|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162697485|NCT00373295|587605396|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162697486|NCT00373295|587605397|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
162697487|NCT00373295|587605398|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162697488|NCT00830947|587605399|FG000|Overall Study|Lost to Follow-up|4|||
162697489|NCT00830947|587605400|FG001|Overall Study|Lost to Follow-up|4|||
162697490|NCT01474512|587605412|FG000|Induction Period|Adverse Event|6|||
162697491|NCT01474512|587605413|FG001|Induction Period|Adverse Event|10|||
162697492|NCT01474512|587605414|FG002|Induction Period|Adverse Event|10|||
162697493|NCT01474512|587605415|FG003|Induction Period|Adverse Event|0|||
162697494|NCT01474512|587605416|FG004|Induction Period|Adverse Event|0|||
162697495|NCT01474512|587605417|FG005|Induction Period|Adverse Event|0|||
162697496|NCT01474512|587605418|FG006|Induction Period|Adverse Event|0|||
162697497|NCT01474512|587605419|FG007|Induction Period|Adverse Event|0|||
162697498|NCT01474512|587605420|FG008|Induction Period|Adverse Event|0|||
162697499|NCT01474512|587605421|FG009|Induction Period|Adverse Event|0|||
162697500|NCT01474512|587605422|FG010|Induction Period|Adverse Event|0|||
162697501|NCT01474512|587605423|FG011|Induction Period|Adverse Event|0|||
162697502|NCT01474512|587605424|FG012|Induction Period|Adverse Event|0|||
162697503|NCT01474512|587605425|FG013|Induction Period|Adverse Event|0|||
162697504|NCT01474512|587605426|FG014|Induction Period|Adverse Event|0|||
162697505|NCT01474512|587605427|FG015|Induction Period|Adverse Event|0|||
162697506|NCT01474512|587605428|FG016|Induction Period|Adverse Event|0|||
162697507|NCT01474512|587605429|FG017|Induction Period|Adverse Event|0|||
162697508|NCT01474512|587605412|FG000|Induction Period|Lack of Efficacy|7|||
162697509|NCT01474512|587605413|FG001|Induction Period|Lack of Efficacy|1|||
162697510|NCT01474512|587605414|FG002|Induction Period|Lack of Efficacy|0|||
162697511|NCT01474512|587605415|FG003|Induction Period|Lack of Efficacy|0|||
162697512|NCT01474512|587605416|FG004|Induction Period|Lack of Efficacy|0|||
162697513|NCT01474512|587605417|FG005|Induction Period|Lack of Efficacy|0|||
162697514|NCT01474512|587605418|FG006|Induction Period|Lack of Efficacy|0|||
162697515|NCT01474512|587605419|FG007|Induction Period|Lack of Efficacy|0|||
162697516|NCT01474512|587605420|FG008|Induction Period|Lack of Efficacy|0|||
162697517|NCT01474512|587605421|FG009|Induction Period|Lack of Efficacy|0|||
162697518|NCT01474512|587605422|FG010|Induction Period|Lack of Efficacy|0|||
162697519|NCT01474512|587605423|FG011|Induction Period|Lack of Efficacy|0|||
162697520|NCT01474512|587605424|FG012|Induction Period|Lack of Efficacy|0|||
162697521|NCT01474512|587605425|FG013|Induction Period|Lack of Efficacy|0|||
162697522|NCT01474512|587605426|FG014|Induction Period|Lack of Efficacy|0|||
162697523|NCT01474512|587605427|FG015|Induction Period|Lack of Efficacy|0|||
162697524|NCT01474512|587605428|FG016|Induction Period|Lack of Efficacy|0|||
162697525|NCT01474512|587605429|FG017|Induction Period|Lack of Efficacy|0|||
162697526|NCT01474512|587605412|FG000|Induction Period|Withdrawal by Subject|6|||
162697527|NCT01474512|587605413|FG001|Induction Period|Withdrawal by Subject|6|||
162697528|NCT01474512|587605414|FG002|Induction Period|Withdrawal by Subject|5|||
162697529|NCT01474512|587605415|FG003|Induction Period|Withdrawal by Subject|0|||
162697530|NCT01474512|587605416|FG004|Induction Period|Withdrawal by Subject|0|||
162697531|NCT01474512|587605417|FG005|Induction Period|Withdrawal by Subject|0|||
162697532|NCT01474512|587605418|FG006|Induction Period|Withdrawal by Subject|0|||
162697533|NCT01474512|587605419|FG007|Induction Period|Withdrawal by Subject|0|||
162697534|NCT01474512|587605420|FG008|Induction Period|Withdrawal by Subject|0|||
162697535|NCT01474512|587605421|FG009|Induction Period|Withdrawal by Subject|0|||
162697536|NCT01474512|587605422|FG010|Induction Period|Withdrawal by Subject|0|||
162697537|NCT01474512|587605423|FG011|Induction Period|Withdrawal by Subject|0|||
162697538|NCT01474512|587605424|FG012|Induction Period|Withdrawal by Subject|0|||
162697539|NCT01474512|587605425|FG013|Induction Period|Withdrawal by Subject|0|||
162697540|NCT01474512|587605426|FG014|Induction Period|Withdrawal by Subject|0|||
162697541|NCT01474512|587605427|FG015|Induction Period|Withdrawal by Subject|0|||
162697542|NCT01474512|587605428|FG016|Induction Period|Withdrawal by Subject|0|||
162697543|NCT01474512|587605429|FG017|Induction Period|Withdrawal by Subject|0|||
162697544|NCT01474512|587605412|FG000|Induction Period|Protocol Violation|3|||
162697545|NCT01474512|587605413|FG001|Induction Period|Protocol Violation|6|||
162697546|NCT01474512|587605414|FG002|Induction Period|Protocol Violation|0|||
162697547|NCT01474512|587605415|FG003|Induction Period|Protocol Violation|0|||
162697548|NCT01474512|587605416|FG004|Induction Period|Protocol Violation|0|||
162697549|NCT01474512|587605417|FG005|Induction Period|Protocol Violation|0|||
162697550|NCT01474512|587605418|FG006|Induction Period|Protocol Violation|0|||
162697551|NCT01474512|587605419|FG007|Induction Period|Protocol Violation|0|||
162697552|NCT01474512|587605420|FG008|Induction Period|Protocol Violation|0|||
162697553|NCT01474512|587605421|FG009|Induction Period|Protocol Violation|0|||
162697554|NCT01474512|587605422|FG010|Induction Period|Protocol Violation|0|||
162697555|NCT01474512|587605423|FG011|Induction Period|Protocol Violation|0|||
162697556|NCT01474512|587605424|FG012|Induction Period|Protocol Violation|0|||
162697557|NCT01474512|587605425|FG013|Induction Period|Protocol Violation|0|||
162697558|NCT01474512|587605426|FG014|Induction Period|Protocol Violation|0|||
162697559|NCT01474512|587605427|FG015|Induction Period|Protocol Violation|0|||
162697560|NCT01474512|587605428|FG016|Induction Period|Protocol Violation|0|||
162697561|NCT01474512|587605429|FG017|Induction Period|Protocol Violation|0|||
162697562|NCT01474512|587605412|FG000|Induction Period|Sponsor Decision|1|||
162697563|NCT01474512|587605413|FG001|Induction Period|Sponsor Decision|1|||
162697564|NCT01474512|587605414|FG002|Induction Period|Sponsor Decision|1|||
162697565|NCT01474512|587605415|FG003|Induction Period|Sponsor Decision|0|||
162697566|NCT01474512|587605416|FG004|Induction Period|Sponsor Decision|0|||
162697567|NCT01474512|587605417|FG005|Induction Period|Sponsor Decision|0|||
162697568|NCT01474512|587605418|FG006|Induction Period|Sponsor Decision|0|||
162697569|NCT01474512|587605419|FG007|Induction Period|Sponsor Decision|0|||
162697570|NCT01474512|587605420|FG008|Induction Period|Sponsor Decision|0|||
162697571|NCT01474512|587605421|FG009|Induction Period|Sponsor Decision|0|||
162697572|NCT01474512|587605422|FG010|Induction Period|Sponsor Decision|0|||
162697573|NCT01474512|587605423|FG011|Induction Period|Sponsor Decision|0|||
162697574|NCT01474512|587605424|FG012|Induction Period|Sponsor Decision|0|||
162697575|NCT01474512|587605425|FG013|Induction Period|Sponsor Decision|0|||
162697576|NCT01474512|587605426|FG014|Induction Period|Sponsor Decision|0|||
162697577|NCT01474512|587605427|FG015|Induction Period|Sponsor Decision|0|||
162697578|NCT01474512|587605428|FG016|Induction Period|Sponsor Decision|0|||
162697579|NCT01474512|587605429|FG017|Induction Period|Sponsor Decision|0|||
162697580|NCT01474512|587605412|FG000|Induction Period|Lost to Follow-up|1|||
162697581|NCT01474512|587605413|FG001|Induction Period|Lost to Follow-up|0|||
162697582|NCT01474512|587605414|FG002|Induction Period|Lost to Follow-up|2|||
162697583|NCT01474512|587605415|FG003|Induction Period|Lost to Follow-up|0|||
162697584|NCT01474512|587605416|FG004|Induction Period|Lost to Follow-up|0|||
162697585|NCT01474512|587605417|FG005|Induction Period|Lost to Follow-up|0|||
162697586|NCT01474512|587605418|FG006|Induction Period|Lost to Follow-up|0|||
162697587|NCT01474512|587605419|FG007|Induction Period|Lost to Follow-up|0|||
162697588|NCT01474512|587605420|FG008|Induction Period|Lost to Follow-up|0|||
162697589|NCT01474512|587605421|FG009|Induction Period|Lost to Follow-up|0|||
162697590|NCT01474512|587605422|FG010|Induction Period|Lost to Follow-up|0|||
162697591|NCT01474512|587605423|FG011|Induction Period|Lost to Follow-up|0|||
162697592|NCT01474512|587605424|FG012|Induction Period|Lost to Follow-up|0|||
162697593|NCT01474512|587605425|FG013|Induction Period|Lost to Follow-up|0|||
162697594|NCT01474512|587605426|FG014|Induction Period|Lost to Follow-up|0|||
162697595|NCT01474512|587605427|FG015|Induction Period|Lost to Follow-up|0|||
162697596|NCT01474512|587605428|FG016|Induction Period|Lost to Follow-up|0|||
162697597|NCT01474512|587605429|FG017|Induction Period|Lost to Follow-up|0|||
162697598|NCT01474512|587605412|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697599|NCT01474512|587605413|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697600|NCT01474512|587605414|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162811655|NCT00585195|588021756|FG001|Overall Study|Randomized not treated|0|||
162811656|NCT00585195|588021757|FG002|Overall Study|Randomized not treated|1|||
162811657|NCT00585195|588021758|FG003|Overall Study|Randomized not treated|0|||
162811658|NCT00585195|588021759|FG004|Overall Study|Randomized not treated|1|||
162811659|NCT00585195|588021760|FG005|Overall Study|Randomized not treated|0|||
162811660|NCT00585195|588021761|FG006|Overall Study|Randomized not treated|1|||
162811661|NCT00585195|588021762|FG007|Overall Study|Randomized not treated|0|||
162811662|NCT00585195|588021763|FG008|Overall Study|Randomized not treated|0|||
162811663|NCT00585195|588021764|FG009|Overall Study|Randomized not treated|0|||
162811664|NCT00585195|588021765|FG010|Overall Study|Randomized not treated|2|||
162811665|NCT00585195|588021766|FG011|Overall Study|Randomized not treated|0|||
162811666|NCT00585195|588021767|FG012|Overall Study|Randomized not treated|0|||
162811667|NCT00585195|588021768|FG013|Overall Study|Randomized not treated|0|||
162811668|NCT00585195|588021769|FG014|Overall Study|Randomized not treated|0|||
162811669|NCT00585195|588021770|FG015|Overall Study|Randomized not treated|1|||
162811670|NCT00585195|588021771|FG016|Overall Study|Randomized not treated|0|||
162811671|NCT00585195|588021772|FG017|Overall Study|Randomized not treated|1|||
162811672|NCT00585195|588021773|FG018|Overall Study|Randomized not treated|3|||
162811673|NCT00585195|588021774|FG019|Overall Study|Randomized not treated|0|||
162811674|NCT00585195|588021775|FG020|Overall Study|Randomized not treated|2|||
162811675|NCT00585195|588021755|FG000|Overall Study|Death|0|||
162811676|NCT00585195|588021756|FG001|Overall Study|Death|0|||
162811677|NCT00585195|588021757|FG002|Overall Study|Death|0|||
162811678|NCT00585195|588021758|FG003|Overall Study|Death|0|||
162811679|NCT00585195|588021759|FG004|Overall Study|Death|0|||
162811680|NCT00585195|588021760|FG005|Overall Study|Death|0|||
162811681|NCT00585195|588021761|FG006|Overall Study|Death|0|||
162811682|NCT00585195|588021762|FG007|Overall Study|Death|0|||
162811683|NCT00585195|588021763|FG008|Overall Study|Death|1|||
162811684|NCT00585195|588021764|FG009|Overall Study|Death|0|||
162811685|NCT00585195|588021765|FG010|Overall Study|Death|1|||
162811686|NCT00585195|588021766|FG011|Overall Study|Death|1|||
162811687|NCT00585195|588021767|FG012|Overall Study|Death|7|||
162811688|NCT00585195|588021768|FG013|Overall Study|Death|2|||
162811689|NCT00585195|588021769|FG014|Overall Study|Death|8|||
162811690|NCT00585195|588021770|FG015|Overall Study|Death|2|||
162811691|NCT00585195|588021771|FG016|Overall Study|Death|11|||
162811692|NCT00585195|588021772|FG017|Overall Study|Death|0|||
162811693|NCT00585195|588021773|FG018|Overall Study|Death|0|||
162811694|NCT00585195|588021774|FG019|Overall Study|Death|0|||
162811695|NCT00585195|588021775|FG020|Overall Study|Death|1|||
162811696|NCT00585195|588021755|FG000|Overall Study|Lost to Follow-up|0|||
162811697|NCT00585195|588021756|FG001|Overall Study|Lost to Follow-up|0|||
162811698|NCT00585195|588021757|FG002|Overall Study|Lost to Follow-up|0|||
162811699|NCT00585195|588021758|FG003|Overall Study|Lost to Follow-up|0|||
162811700|NCT00585195|588021759|FG004|Overall Study|Lost to Follow-up|0|||
162811701|NCT00585195|588021760|FG005|Overall Study|Lost to Follow-up|0|||
162811702|NCT00585195|588021761|FG006|Overall Study|Lost to Follow-up|0|||
162811703|NCT00585195|588021762|FG007|Overall Study|Lost to Follow-up|0|||
162811704|NCT00585195|588021763|FG008|Overall Study|Lost to Follow-up|0|||
162811705|NCT00585195|588021764|FG009|Overall Study|Lost to Follow-up|0|||
162811706|NCT00585195|588021765|FG010|Overall Study|Lost to Follow-up|0|||
162811707|NCT00585195|588021766|FG011|Overall Study|Lost to Follow-up|0|||
162811708|NCT00585195|588021767|FG012|Overall Study|Lost to Follow-up|1|||
162811709|NCT00585195|588021768|FG013|Overall Study|Lost to Follow-up|0|||
162811710|NCT00585195|588021769|FG014|Overall Study|Lost to Follow-up|0|||
162811711|NCT00585195|588021770|FG015|Overall Study|Lost to Follow-up|0|||
162811712|NCT00585195|588021771|FG016|Overall Study|Lost to Follow-up|0|||
162811713|NCT00585195|588021772|FG017|Overall Study|Lost to Follow-up|2|||
162811714|NCT00585195|588021773|FG018|Overall Study|Lost to Follow-up|0|||
162811715|NCT00585195|588021774|FG019|Overall Study|Lost to Follow-up|0|||
162811716|NCT00585195|588021775|FG020|Overall Study|Lost to Follow-up|0|||
162811717|NCT00585195|588021755|FG000|Overall Study|Site Terminated by Sponsor|0|||
162811718|NCT00585195|588021756|FG001|Overall Study|Site Terminated by Sponsor|0|||
162811719|NCT00585195|588021757|FG002|Overall Study|Site Terminated by Sponsor|0|||
162811720|NCT00585195|588021758|FG003|Overall Study|Site Terminated by Sponsor|0|||
162811721|NCT00585195|588021759|FG004|Overall Study|Site Terminated by Sponsor|0|||
162697601|NCT01474512|587605415|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
162697602|NCT01474512|587605416|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
162697603|NCT01474512|587605417|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
162697604|NCT01474512|587605418|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
162697605|NCT01474512|587605419|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697606|NCT01474512|587605420|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697607|NCT01474512|587605421|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697608|NCT01474512|587605422|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697609|NCT01474512|587605423|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697610|NCT01474512|587605424|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697611|NCT01474512|587605425|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697612|NCT01474512|587605426|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697613|NCT01474512|587605427|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697614|NCT01474512|587605428|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697615|NCT01474512|587605429|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162697616|NCT01474512|587605412|FG000|Maintenance Period|Adverse Event|0|||
162697617|NCT01474512|587605413|FG001|Maintenance Period|Adverse Event|0|||
162697618|NCT01474512|587605414|FG002|Maintenance Period|Adverse Event|0|||
162697619|NCT01474512|587605415|FG003|Maintenance Period|Adverse Event|4|||
162697620|NCT01474512|587605416|FG004|Maintenance Period|Adverse Event|2|||
162697621|NCT01474512|587605417|FG005|Maintenance Period|Adverse Event|7|||
162697622|NCT01474512|587605418|FG006|Maintenance Period|Adverse Event|0|||
162697623|NCT01474512|587605419|FG007|Maintenance Period|Adverse Event|19|||
162697624|NCT01474512|587605420|FG008|Maintenance Period|Adverse Event|1|||
162697625|NCT01474512|587605421|FG009|Maintenance Period|Adverse Event|3|||
162697626|NCT01474512|587605422|FG010|Maintenance Period|Adverse Event|0|||
162697627|NCT01474512|587605423|FG011|Maintenance Period|Adverse Event|0|||
162697628|NCT01474512|587605424|FG012|Maintenance Period|Adverse Event|0|||
162697629|NCT01474512|587605425|FG013|Maintenance Period|Adverse Event|0|||
162697630|NCT01474512|587605426|FG014|Maintenance Period|Adverse Event|0|||
162697631|NCT01474512|587605427|FG015|Maintenance Period|Adverse Event|0|||
162697632|NCT01474512|587605428|FG016|Maintenance Period|Adverse Event|0|||
162697633|NCT01474512|587605429|FG017|Maintenance Period|Adverse Event|0|||
162697634|NCT01474512|587605412|FG000|Maintenance Period|Withdrawal by Subject|0|||
162697635|NCT01474512|587605413|FG001|Maintenance Period|Withdrawal by Subject|0|||
162697636|NCT01474512|587605414|FG002|Maintenance Period|Withdrawal by Subject|0|||
162697637|NCT01474512|587605415|FG003|Maintenance Period|Withdrawal by Subject|6|||
162697638|NCT01474512|587605416|FG004|Maintenance Period|Withdrawal by Subject|2|||
162697639|NCT01474512|587605417|FG005|Maintenance Period|Withdrawal by Subject|3|||
162697640|NCT01474512|587605418|FG006|Maintenance Period|Withdrawal by Subject|1|||
162697641|NCT01474512|587605419|FG007|Maintenance Period|Withdrawal by Subject|6|||
162697642|NCT01474512|587605420|FG008|Maintenance Period|Withdrawal by Subject|3|||
162697643|NCT01474512|587605421|FG009|Maintenance Period|Withdrawal by Subject|1|||
162697644|NCT01474512|587605422|FG010|Maintenance Period|Withdrawal by Subject|0|||
162697645|NCT01474512|587605423|FG011|Maintenance Period|Withdrawal by Subject|0|||
162697646|NCT01474512|587605424|FG012|Maintenance Period|Withdrawal by Subject|0|||
162697647|NCT01474512|587605425|FG013|Maintenance Period|Withdrawal by Subject|0|||
162697648|NCT01474512|587605426|FG014|Maintenance Period|Withdrawal by Subject|0|||
162697649|NCT01474512|587605427|FG015|Maintenance Period|Withdrawal by Subject|0|||
162697650|NCT01474512|587605428|FG016|Maintenance Period|Withdrawal by Subject|0|||
162697651|NCT01474512|587605429|FG017|Maintenance Period|Withdrawal by Subject|0|||
162697652|NCT01474512|587605412|FG000|Maintenance Period|Lost to Follow-up|0|||
162697653|NCT01474512|587605413|FG001|Maintenance Period|Lost to Follow-up|0|||
162697654|NCT01474512|587605414|FG002|Maintenance Period|Lost to Follow-up|0|||
162697655|NCT01474512|587605415|FG003|Maintenance Period|Lost to Follow-up|3|||
162697656|NCT01474512|587605416|FG004|Maintenance Period|Lost to Follow-up|3|||
162697657|NCT01474512|587605417|FG005|Maintenance Period|Lost to Follow-up|0|||
162697658|NCT01474512|587605418|FG006|Maintenance Period|Lost to Follow-up|0|||
162697659|NCT01474512|587605419|FG007|Maintenance Period|Lost to Follow-up|2|||
162697660|NCT01474512|587605420|FG008|Maintenance Period|Lost to Follow-up|1|||
162697661|NCT01474512|587605421|FG009|Maintenance Period|Lost to Follow-up|1|||
163161233|NCT03214666|589304119|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162697662|NCT01474512|587605422|FG010|Maintenance Period|Lost to Follow-up|0|||
162697663|NCT01474512|587605423|FG011|Maintenance Period|Lost to Follow-up|0|||
163161234|NCT03214666|589304120|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
163161235|NCT03214666|589304121|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
163161236|NCT03214666|589304122|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162697664|NCT01474512|587605424|FG012|Maintenance Period|Lost to Follow-up|0|||
162697665|NCT01474512|587605425|FG013|Maintenance Period|Lost to Follow-up|0|||
162697666|NCT01474512|587605426|FG014|Maintenance Period|Lost to Follow-up|0|||
162697667|NCT01474512|587605427|FG015|Maintenance Period|Lost to Follow-up|0|||
162697668|NCT01474512|587605428|FG016|Maintenance Period|Lost to Follow-up|0|||
162697669|NCT01474512|587605429|FG017|Maintenance Period|Lost to Follow-up|0|||
162697670|NCT01474512|587605412|FG000|Maintenance Period|Death|0|||
162697671|NCT01474512|587605413|FG001|Maintenance Period|Death|0|||
162697672|NCT01474512|587605414|FG002|Maintenance Period|Death|0|||
162697673|NCT01474512|587605415|FG003|Maintenance Period|Death|0|||
162697674|NCT01474512|587605416|FG004|Maintenance Period|Death|0|||
162697675|NCT01474512|587605417|FG005|Maintenance Period|Death|2|||
162697676|NCT01474512|587605418|FG006|Maintenance Period|Death|0|||
162697677|NCT01474512|587605419|FG007|Maintenance Period|Death|0|||
162697678|NCT01474512|587605420|FG008|Maintenance Period|Death|0|||
162697679|NCT01474512|587605421|FG009|Maintenance Period|Death|0|||
162697680|NCT01474512|587605422|FG010|Maintenance Period|Death|0|||
162697681|NCT01474512|587605423|FG011|Maintenance Period|Death|0|||
162697682|NCT01474512|587605424|FG012|Maintenance Period|Death|0|||
162697683|NCT01474512|587605425|FG013|Maintenance Period|Death|0|||
162697684|NCT01474512|587605426|FG014|Maintenance Period|Death|0|||
162697685|NCT01474512|587605427|FG015|Maintenance Period|Death|0|||
162697686|NCT01474512|587605428|FG016|Maintenance Period|Death|0|||
162697687|NCT01474512|587605429|FG017|Maintenance Period|Death|0|||
162697688|NCT01474512|587605412|FG000|Maintenance Period|Physician Decision|0|||
162697689|NCT01474512|587605413|FG001|Maintenance Period|Physician Decision|0|||
162697690|NCT01474512|587605414|FG002|Maintenance Period|Physician Decision|0|||
162697691|NCT01474512|587605415|FG003|Maintenance Period|Physician Decision|0|||
162697692|NCT01474512|587605416|FG004|Maintenance Period|Physician Decision|0|||
162697693|NCT01474512|587605417|FG005|Maintenance Period|Physician Decision|1|||
162697694|NCT01474512|587605418|FG006|Maintenance Period|Physician Decision|0|||
162811722|NCT00585195|588021760|FG005|Overall Study|Site Terminated by Sponsor|0|||
162811723|NCT00585195|588021761|FG006|Overall Study|Site Terminated by Sponsor|0|||
162811724|NCT00585195|588021762|FG007|Overall Study|Site Terminated by Sponsor|0|||
162811725|NCT00585195|588021763|FG008|Overall Study|Site Terminated by Sponsor|0|||
162811726|NCT00585195|588021764|FG009|Overall Study|Site Terminated by Sponsor|0|||
162811727|NCT00585195|588021765|FG010|Overall Study|Site Terminated by Sponsor|0|||
162811728|NCT00585195|588021766|FG011|Overall Study|Site Terminated by Sponsor|0|||
162811729|NCT00585195|588021767|FG012|Overall Study|Site Terminated by Sponsor|1|||
162697695|NCT01474512|587605419|FG007|Maintenance Period|Physician Decision|2|||
162697696|NCT01474512|587605420|FG008|Maintenance Period|Physician Decision|0|||
162697697|NCT01474512|587605421|FG009|Maintenance Period|Physician Decision|0|||
162697698|NCT01474512|587605422|FG010|Maintenance Period|Physician Decision|0|||
162697699|NCT01474512|587605423|FG011|Maintenance Period|Physician Decision|0|||
162697700|NCT01474512|587605424|FG012|Maintenance Period|Physician Decision|0|||
162697701|NCT01474512|587605425|FG013|Maintenance Period|Physician Decision|0|||
162697702|NCT01474512|587605426|FG014|Maintenance Period|Physician Decision|0|||
162697703|NCT01474512|587605427|FG015|Maintenance Period|Physician Decision|0|||
162697704|NCT01474512|587605428|FG016|Maintenance Period|Physician Decision|0|||
162697705|NCT01474512|587605429|FG017|Maintenance Period|Physician Decision|0|||
162697706|NCT01474512|587605412|FG000|Maintenance Period|Clinical Relapse|0|||
162697707|NCT01474512|587605413|FG001|Maintenance Period|Clinical Relapse|0|||
162697708|NCT01474512|587605414|FG002|Maintenance Period|Clinical Relapse|0|||
162697709|NCT01474512|587605415|FG003|Maintenance Period|Clinical Relapse|1|||
162697710|NCT01474512|587605416|FG004|Maintenance Period|Clinical Relapse|0|||
162697711|NCT01474512|587605417|FG005|Maintenance Period|Clinical Relapse|0|||
162697712|NCT01474512|587605418|FG006|Maintenance Period|Clinical Relapse|0|||
162697713|NCT01474512|587605419|FG007|Maintenance Period|Clinical Relapse|0|||
162697714|NCT01474512|587605420|FG008|Maintenance Period|Clinical Relapse|0|||
162697715|NCT01474512|587605421|FG009|Maintenance Period|Clinical Relapse|0|||
162697716|NCT01474512|587605422|FG010|Maintenance Period|Clinical Relapse|0|||
162697717|NCT01474512|587605423|FG011|Maintenance Period|Clinical Relapse|0|||
162697718|NCT01474512|587605424|FG012|Maintenance Period|Clinical Relapse|0|||
162697719|NCT01474512|587605425|FG013|Maintenance Period|Clinical Relapse|0|||
162697720|NCT01474512|587605426|FG014|Maintenance Period|Clinical Relapse|0|||
162697721|NCT01474512|587605427|FG015|Maintenance Period|Clinical Relapse|0|||
162697722|NCT01474512|587605428|FG016|Maintenance Period|Clinical Relapse|0|||
162697723|NCT01474512|587605429|FG017|Maintenance Period|Clinical Relapse|0|||
162697724|NCT01474512|587605412|FG000|Maintenance Period|Lack of Efficacy|0|||
162697725|NCT01474512|587605413|FG001|Maintenance Period|Lack of Efficacy|0|||
162697726|NCT01474512|587605414|FG002|Maintenance Period|Lack of Efficacy|0|||
162697727|NCT01474512|587605415|FG003|Maintenance Period|Lack of Efficacy|1|||
162697728|NCT01474512|587605416|FG004|Maintenance Period|Lack of Efficacy|0|||
162697729|NCT01474512|587605417|FG005|Maintenance Period|Lack of Efficacy|0|||
162697730|NCT01474512|587605418|FG006|Maintenance Period|Lack of Efficacy|0|||
162697731|NCT01474512|587605419|FG007|Maintenance Period|Lack of Efficacy|11|||
162697732|NCT01474512|587605420|FG008|Maintenance Period|Lack of Efficacy|11|||
162697733|NCT01474512|587605421|FG009|Maintenance Period|Lack of Efficacy|12|||
162697734|NCT01474512|587605422|FG010|Maintenance Period|Lack of Efficacy|0|||
162697735|NCT01474512|587605423|FG011|Maintenance Period|Lack of Efficacy|0|||
162697736|NCT01474512|587605424|FG012|Maintenance Period|Lack of Efficacy|0|||
162697737|NCT01474512|587605425|FG013|Maintenance Period|Lack of Efficacy|0|||
162697738|NCT01474512|587605426|FG014|Maintenance Period|Lack of Efficacy|0|||
162697739|NCT01474512|587605427|FG015|Maintenance Period|Lack of Efficacy|0|||
162697740|NCT01474512|587605428|FG016|Maintenance Period|Lack of Efficacy|0|||
162697741|NCT01474512|587605429|FG017|Maintenance Period|Lack of Efficacy|0|||
162697742|NCT01474512|587605412|FG000|Maintenance Period|Protocol Violation|0|||
162697743|NCT01474512|587605413|FG001|Maintenance Period|Protocol Violation|0|||
162697744|NCT01474512|587605414|FG002|Maintenance Period|Protocol Violation|0|||
162697745|NCT01474512|587605415|FG003|Maintenance Period|Protocol Violation|1|||
162697746|NCT01474512|587605416|FG004|Maintenance Period|Protocol Violation|0|||
162697747|NCT01474512|587605417|FG005|Maintenance Period|Protocol Violation|0|||
162697748|NCT01474512|587605418|FG006|Maintenance Period|Protocol Violation|0|||
162697749|NCT01474512|587605419|FG007|Maintenance Period|Protocol Violation|1|||
162697750|NCT01474512|587605420|FG008|Maintenance Period|Protocol Violation|0|||
162697751|NCT01474512|587605421|FG009|Maintenance Period|Protocol Violation|1|||
162697752|NCT01474512|587605422|FG010|Maintenance Period|Protocol Violation|0|||
162697753|NCT01474512|587605423|FG011|Maintenance Period|Protocol Violation|0|||
162697754|NCT01474512|587605424|FG012|Maintenance Period|Protocol Violation|0|||
162697755|NCT01474512|587605425|FG013|Maintenance Period|Protocol Violation|0|||
162697756|NCT01474512|587605426|FG014|Maintenance Period|Protocol Violation|0|||
162697757|NCT01474512|587605427|FG015|Maintenance Period|Protocol Violation|0|||
162697758|NCT01474512|587605428|FG016|Maintenance Period|Protocol Violation|0|||
162697759|NCT01474512|587605429|FG017|Maintenance Period|Protocol Violation|0|||
162697760|NCT01474512|587605412|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
162697761|NCT01474512|587605413|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
162697762|NCT01474512|587605414|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
162697763|NCT01474512|587605415|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
162697764|NCT01474512|587605416|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
162697765|NCT01474512|587605417|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
162697766|NCT01474512|587605418|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
162697767|NCT01474512|587605419|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
162697768|NCT01474512|587605420|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
162697769|NCT01474512|587605421|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
162697770|NCT01474512|587605422|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
162697771|NCT01474512|587605423|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
162697772|NCT01474512|587605424|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
162697773|NCT01474512|587605425|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
162697774|NCT01474512|587605426|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
162697775|NCT01474512|587605427|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
162697776|NCT01474512|587605428|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
162697777|NCT01474512|587605429|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
162697778|NCT01474512|587605412|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
162697779|NCT01474512|587605413|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
162697780|NCT01474512|587605414|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
162697781|NCT01474512|587605415|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
162697782|NCT01474512|587605416|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
162697783|NCT01474512|587605417|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
162697784|NCT01474512|587605418|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
162697785|NCT01474512|587605419|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
162697786|NCT01474512|587605420|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
162697787|NCT01474512|587605421|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
162697788|NCT01474512|587605422|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
162697789|NCT01474512|587605423|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
162697790|NCT01474512|587605424|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
162697791|NCT01474512|587605425|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
162697792|NCT01474512|587605426|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
162697793|NCT01474512|587605427|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
162697794|NCT01474512|587605428|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
162697795|NCT01474512|587605429|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
162697796|NCT01474512|587605412|FG000|Long-Term Extension Period|Adverse Event|0|||
162697797|NCT01474512|587605413|FG001|Long-Term Extension Period|Adverse Event|0|||
162697798|NCT01474512|587605414|FG002|Long-Term Extension Period|Adverse Event|0|||
162697799|NCT01474512|587605415|FG003|Long-Term Extension Period|Adverse Event|0|||
162697800|NCT01474512|587605416|FG004|Long-Term Extension Period|Adverse Event|0|||
162697801|NCT01474512|587605417|FG005|Long-Term Extension Period|Adverse Event|0|||
162697802|NCT01474512|587605418|FG006|Long-Term Extension Period|Adverse Event|0|||
162697803|NCT01474512|587605419|FG007|Long-Term Extension Period|Adverse Event|0|||
162697804|NCT01474512|587605420|FG008|Long-Term Extension Period|Adverse Event|0|||
162697805|NCT01474512|587605421|FG009|Long-Term Extension Period|Adverse Event|0|||
162697806|NCT01474512|587605422|FG010|Long-Term Extension Period|Adverse Event|0|||
162697807|NCT01474512|587605423|FG011|Long-Term Extension Period|Adverse Event|1|||
162697808|NCT01474512|587605424|FG012|Long-Term Extension Period|Adverse Event|57|||
162697809|NCT01474512|587605425|FG013|Long-Term Extension Period|Adverse Event|58|||
162697810|NCT01474512|587605426|FG014|Long-Term Extension Period|Adverse Event|0|||
162697811|NCT01474512|587605427|FG015|Long-Term Extension Period|Adverse Event|0|||
162697812|NCT01474512|587605428|FG016|Long-Term Extension Period|Adverse Event|0|||
162697813|NCT01474512|587605429|FG017|Long-Term Extension Period|Adverse Event|0|||
162697814|NCT01474512|587605412|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
162697815|NCT01474512|587605413|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
162697816|NCT01474512|587605414|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
162697817|NCT01474512|587605415|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
162697818|NCT01474512|587605416|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
162697819|NCT01474512|587605417|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
162697820|NCT01474512|587605418|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
162697821|NCT01474512|587605419|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
162697822|NCT01474512|587605420|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
162697823|NCT01474512|587605421|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
162697824|NCT01474512|587605422|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
162697825|NCT01474512|587605423|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
162697826|NCT01474512|587605424|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
162811730|NCT00585195|588021768|FG013|Overall Study|Site Terminated by Sponsor|0|||
162811731|NCT00585195|588021769|FG014|Overall Study|Site Terminated by Sponsor|0|||
162811732|NCT00585195|588021770|FG015|Overall Study|Site Terminated by Sponsor|0|||
162811733|NCT00585195|588021771|FG016|Overall Study|Site Terminated by Sponsor|0|||
162811734|NCT00585195|588021772|FG017|Overall Study|Site Terminated by Sponsor|0|||
162811735|NCT00585195|588021773|FG018|Overall Study|Site Terminated by Sponsor|0|||
162811736|NCT00585195|588021774|FG019|Overall Study|Site Terminated by Sponsor|0|||
162811737|NCT00585195|588021775|FG020|Overall Study|Site Terminated by Sponsor|0|||
162811738|NCT00585195|588021755|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
162811739|NCT00585195|588021756|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
162811740|NCT00585195|588021757|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
162811741|NCT00585195|588021758|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
162811742|NCT00585195|588021759|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
162811743|NCT00585195|588021760|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
162811744|NCT00585195|588021761|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
162811745|NCT00585195|588021762|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
162811746|NCT00585195|588021763|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
162697827|NCT01474512|587605425|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
162697828|NCT01474512|587605426|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
162697829|NCT01474512|587605427|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
162697830|NCT01474512|587605428|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
162697831|NCT01474512|587605429|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
162697832|NCT01474512|587605412|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
162697833|NCT01474512|587605413|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
162697834|NCT01474512|587605414|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
162697835|NCT01474512|587605415|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
162697836|NCT01474512|587605416|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
162697837|NCT01474512|587605417|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
162697838|NCT01474512|587605418|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
162697839|NCT01474512|587605419|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
162697840|NCT01474512|587605420|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
162697841|NCT01474512|587605421|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
162697842|NCT01474512|587605422|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
162697843|NCT01474512|587605423|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
162697844|NCT01474512|587605424|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
162697845|NCT01474512|587605425|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
162697846|NCT01474512|587605426|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
162697847|NCT01474512|587605427|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
162697848|NCT01474512|587605428|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
162697849|NCT01474512|587605429|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
162811747|NCT00585195|588021764|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
162811748|NCT00585195|588021765|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
162811749|NCT00585195|588021766|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
162811750|NCT00585195|588021767|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
162811751|NCT00585195|588021768|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
162811752|NCT00585195|588021769|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
162811753|NCT00585195|588021770|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
162811754|NCT00585195|588021771|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
162811755|NCT00585195|588021772|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
162811756|NCT00585195|588021773|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
162811757|NCT00585195|588021774|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
162811758|NCT00585195|588021775|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
162811759|NCT00770341|588021776|FG000|Overall Study|Did not meet eligibility criteria|1|||
162811760|NCT00770341|588021777|FG001|Overall Study|Did not meet eligibility criteria|0|||
162811761|NCT00770341|588021778|FG002|Overall Study|Did not meet eligibility criteria|0|||
162811762|NCT00770341|588021776|FG000|Overall Study|Withdrawal by Subject|0|||
162811763|NCT00770341|588021777|FG001|Overall Study|Withdrawal by Subject|1|||
162811764|NCT00770341|588021778|FG002|Overall Study|Withdrawal by Subject|0|||
162811765|NCT00770341|588021776|FG000|Overall Study|Clinical Adverse Event|3|||
162811766|NCT00770341|588021777|FG001|Overall Study|Clinical Adverse Event|1|||
162811767|NCT00770341|588021778|FG002|Overall Study|Clinical Adverse Event|2|||
162811768|NCT00770341|588021776|FG000|Overall Study|Laboratory adverse event|3|||
162811769|NCT00770341|588021777|FG001|Overall Study|Laboratory adverse event|3|||
162811770|NCT00770341|588021778|FG002|Overall Study|Laboratory adverse event|0|||
162811771|NCT00770341|588021776|FG000|Overall Study|Lack of Efficacy|3|||
162811772|NCT00770341|588021777|FG001|Overall Study|Lack of Efficacy|0|||
162811773|NCT00770341|588021778|FG002|Overall Study|Lack of Efficacy|1|||
162811774|NCT00770341|588021776|FG000|Overall Study|Other|1|||
162811775|NCT00770341|588021777|FG001|Overall Study|Other|0|||
162811776|NCT00770341|588021778|FG002|Overall Study|Other|0|||
162811777|NCT00770341|588021776|FG000|Overall Study|Not treated|1|||
162811778|NCT00770341|588021777|FG001|Overall Study|Not treated|0|||
162811779|NCT00770341|588021778|FG002|Overall Study|Not treated|0|||
162811780|NCT02739360|588021779|FG000|Overall Study|Adverse Event|1|||
162811781|NCT02739360|588021779|FG000|Overall Study|Study terminated by Sponsor|2|||
162811782|NCT00529958|588021781|FG000|2-Year Follow-up|Lost to Follow-up|1|||
162811783|NCT00529958|588021782|FG001|2-Year Follow-up|Lost to Follow-up|2|||
162811784|NCT00529958|588021783|FG002|2-Year Follow-up|Lost to Follow-up|2|||
162811785|NCT00529958|588021781|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
162811786|NCT00529958|588021782|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
162811787|NCT00529958|588021783|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
162811788|NCT00529958|588021781|FG000|5-Year Follow-up|Lost to Follow-up|2|||
162811789|NCT00529958|588021782|FG001|5-Year Follow-up|Lost to Follow-up|3|||
162811790|NCT00529958|588021783|FG002|5-Year Follow-up|Lost to Follow-up|1|||
162811791|NCT00529958|588021781|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
162811792|NCT00529958|588021782|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
162811793|NCT00529958|588021783|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
162811794|NCT02337751|588021784|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
162811795|NCT02337751|588021785|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
162811796|NCT02337751|588021784|FG000|Overall Study|Voluntary Withdrawal|6|||
162811797|NCT02337751|588021785|FG001|Overall Study|Voluntary Withdrawal|8|||
162811798|NCT02337751|588021784|FG000|Overall Study|Lack of Efficacy|2|||
162811799|NCT02337751|588021785|FG001|Overall Study|Lack of Efficacy|5|||
162811800|NCT02337751|588021784|FG000|Overall Study|Investigator's Judgement|1|||
162811801|NCT02337751|588021785|FG001|Overall Study|Investigator's Judgement|0|||
162811802|NCT01340651|588021786|FG000|Overall Study|Adverse Event|3|||
162811803|NCT01340651|588021786|FG000|Overall Study|Consent Withdrawn|2|||
162811804|NCT01340651|588021786|FG000|Overall Study|Commercial Supply per Sponsor|12|||
162811805|NCT05572021|588021787|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
162811806|NCT05572021|588021788|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
162811807|NCT03319849|588021789|FG000|Overall Study|Adverse Event|1|||
162811808|NCT03319849|588021790|FG001|Overall Study|Adverse Event|0|||
162811809|NCT03319849|588021789|FG000|Overall Study|Physician Decision|0|||
162811810|NCT03319849|588021790|FG001|Overall Study|Physician Decision|1|||
162811811|NCT03319849|588021789|FG000|Overall Study|Withdrawal by Subject|0|||
162811812|NCT03319849|588021790|FG001|Overall Study|Withdrawal by Subject|1|||
162811813|NCT03319849|588021789|FG000|Overall Study|COVID-19|0|||
162811814|NCT03319849|588021790|FG001|Overall Study|COVID-19|1|||
162811815|NCT03319849|588021789|FG000|Overall Study|Other|1|||
162811816|NCT03319849|588021790|FG001|Overall Study|Other|2|||
162811817|NCT03319849|588021789|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
162811818|NCT03319849|588021790|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
162811819|NCT03319849|588021789|FG000|Overall Study|Lost to Follow-up|0|||
162811820|NCT03319849|588021790|FG001|Overall Study|Lost to Follow-up|2|||
162811821|NCT04873232|588021798|FG000|Overall Study|Lost to Follow-up|1|||
162811822|NCT04873232|588021799|FG001|Overall Study|Lost to Follow-up|4|||
162811823|NCT04873232|588021798|FG000|Overall Study|Withdrawal by Subject|1|||
162811824|NCT04873232|588021799|FG001|Overall Study|Withdrawal by Subject|0|||
162811825|NCT01390181|588023707|FG000|Overall Study|Lost to Follow-up|1|||
162811826|NCT01390181|588023707|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
162811827|NCT00720941|588023708|FG000|Overall Study|Protocol Violation|1|||
162811828|NCT00720941|588023709|FG001|Overall Study|Protocol Violation|2|||
162811829|NCT00720941|588023708|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
162924205|NCT02426125|588423829|FG000|Overall Study|Randomized, But Never Treated|5|||
162811830|NCT00720941|588023709|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
162811831|NCT00720941|588023708|FG000|Overall Study|Lost to Follow-up|20|||
162811832|NCT00720941|588023709|FG001|Overall Study|Lost to Follow-up|15|||
162811833|NCT00720941|588023708|FG000|Overall Study|Physician Decision|14|||
162811834|NCT00720941|588023709|FG001|Overall Study|Physician Decision|12|||
162811835|NCT00720941|588023708|FG000|Overall Study|Withdrawal by Subject|29|||
162811836|NCT00720941|588023709|FG001|Overall Study|Withdrawal by Subject|36|||
162811837|NCT03511053|588023710|FG000|Overall Study|Withdrawal by Subject|1|||
162811838|NCT03628898|588023712|FG000|Overall Study|Device deficiency|1|||
162811839|NCT00294554|588023715|FG000|Overall Study|Lack of Efficacy|0|||
162811840|NCT00294554|588023716|FG001|Overall Study|Lack of Efficacy|1|||
162811841|NCT00294554|588023715|FG000|Overall Study|Physician Decision|0|||
162811842|NCT00294554|588023716|FG001|Overall Study|Physician Decision|1|||
162811843|NCT02598557|588023717|FG000|Overall Study|Withdrawal by Subject|1|||
162811844|NCT02598557|588023718|FG001|Overall Study|Withdrawal by Subject|0|||
162811845|NCT02598557|588023719|FG002|Overall Study|Withdrawal by Subject|1|||
162811846|NCT02598557|588023717|FG000|Overall Study|Participant did not start treatment|2|||
162811847|NCT02598557|588023718|FG001|Overall Study|Participant did not start treatment|1|||
162811848|NCT02598557|588023719|FG002|Overall Study|Participant did not start treatment|1|||
162811849|NCT02598557|588023717|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
162811850|NCT02598557|588023718|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
162811851|NCT02598557|588023719|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
162811852|NCT02598557|588023717|FG000|Overall Study|Adverse Event|1|||
162811853|NCT02598557|588023718|FG001|Overall Study|Adverse Event|1|||
162811854|NCT02598557|588023719|FG002|Overall Study|Adverse Event|0|||
162811855|NCT01313637|588023720|FG000|Overall Study|Adverse Event|17|||
162811856|NCT01313637|588023721|FG001|Overall Study|Adverse Event|24|||
162811857|NCT01313637|588023722|FG002|Overall Study|Adverse Event|25|||
162811858|NCT01313637|588023723|FG003|Overall Study|Adverse Event|18|||
162811859|NCT01313637|588023720|FG000|Overall Study|Lack of Efficacy|44|||
162811860|NCT01313637|588023721|FG001|Overall Study|Lack of Efficacy|38|||
162811861|NCT01313637|588023722|FG002|Overall Study|Lack of Efficacy|37|||
162811862|NCT01313637|588023723|FG003|Overall Study|Lack of Efficacy|24|||
162811863|NCT01313637|588023720|FG000|Overall Study|Protocol Violation|4|||
162811864|NCT01313637|588023721|FG001|Overall Study|Protocol Violation|3|||
162811865|NCT01313637|588023722|FG002|Overall Study|Protocol Violation|11|||
162811866|NCT01313637|588023723|FG003|Overall Study|Protocol Violation|5|||
162811867|NCT01313637|588023720|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
162811868|NCT01313637|588023721|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
162811869|NCT01313637|588023722|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
162811870|NCT01313637|588023723|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
162811871|NCT01313637|588023720|FG000|Overall Study|Lost to Follow-up|0|||
162811872|NCT01313637|588023721|FG001|Overall Study|Lost to Follow-up|2|||
162811873|NCT01313637|588023722|FG002|Overall Study|Lost to Follow-up|1|||
162811874|NCT01313637|588023723|FG003|Overall Study|Lost to Follow-up|3|||
163161237|NCT03048578|589304123|FG000|Overall Study|Withdrawal by Subject|5|||
163161238|NCT03048578|589304124|FG001|Overall Study|Withdrawal by Subject|6|||
163161239|NCT03048578|589304123|FG000|Overall Study|Lost to Follow-up|22|||
163161240|NCT03048578|589304124|FG001|Overall Study|Lost to Follow-up|10|||
163161241|NCT03048578|589304123|FG000|Overall Study|Adverse Event|1|||
163161242|NCT03048578|589304124|FG001|Overall Study|Adverse Event|2|||
163161243|NCT03048578|589304123|FG000|Overall Study|Terminated|3|||
163161244|NCT03048578|589304124|FG001|Overall Study|Terminated|2|||
163161245|NCT00459186|589304130|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
163161246|NCT00459186|589304130|FG000|PET Imaging and Assessment|Adverse Event|3|||
163161247|NCT02500797|589304131|FG000|Overall Study|Cancel (rapid disease progression)|0|||
163161248|NCT02500797|589304132|FG001|Overall Study|Cancel (rapid disease progression)|0|||
163161249|NCT02500797|589304133|FG002|Overall Study|Cancel (rapid disease progression)|0|||
163161250|NCT02500797|589304134|FG003|Overall Study|Cancel (rapid disease progression)|0|||
163161251|NCT02500797|589304135|FG004|Overall Study|Cancel (rapid disease progression)|1|||
163161252|NCT02500797|589304136|FG005|Overall Study|Cancel (rapid disease progression)|1|||
163161253|NCT02500797|589304137|FG006|Overall Study|Cancel (rapid disease progression)|0|||
163161254|NCT02500797|589304138|FG007|Overall Study|Cancel (rapid disease progression)|0|||
162811875|NCT01313637|588023720|FG000|Overall Study|Withdrawal by Subject|11|||
163161255|NCT02500797|589304131|FG000|Overall Study|Withdrawal by Subject|1|||
163161256|NCT02500797|589304132|FG001|Overall Study|Withdrawal by Subject|0|||
163161257|NCT02500797|589304133|FG002|Overall Study|Withdrawal by Subject|0|||
162811876|NCT01313637|588023721|FG001|Overall Study|Withdrawal by Subject|13|||
162811877|NCT01313637|588023722|FG002|Overall Study|Withdrawal by Subject|18|||
162811878|NCT01313637|588023723|FG003|Overall Study|Withdrawal by Subject|15|||
162811879|NCT00795951|588023726|FG000|Overall Study|Lost to Follow-up|1|||
162811880|NCT00795951|588023726|FG000|Overall Study|Withdrawal by Subject|1|||
162811881|NCT00655863|588023728|FG000|Overall Study|Lost to Follow-up|0|||
162811882|NCT00655863|588023729|FG001|Overall Study|Lost to Follow-up|0|||
162811883|NCT00655863|588023730|FG002|Overall Study|Lost to Follow-up|1|||
162811884|NCT01138007|588023731|FG000|Overall Study|Adverse Event|4|||
162811885|NCT01138007|588023732|FG001|Overall Study|Adverse Event|12|||
162811886|NCT01138007|588023733|FG002|Overall Study|Adverse Event|9|||
162811887|NCT01138007|588023731|FG000|Overall Study|Lack of Efficacy|2|||
162811888|NCT01138007|588023732|FG001|Overall Study|Lack of Efficacy|0|||
162811889|NCT01138007|588023733|FG002|Overall Study|Lack of Efficacy|6|||
162811890|NCT01138007|588023731|FG000|Overall Study|Protocol Violation|2|||
162811891|NCT01138007|588023732|FG001|Overall Study|Protocol Violation|3|||
162811892|NCT01138007|588023733|FG002|Overall Study|Protocol Violation|2|||
162811893|NCT01138007|588023731|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
162811894|NCT01138007|588023732|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
162811895|NCT01138007|588023733|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
162811896|NCT01138007|588023731|FG000|Overall Study|Lost to Follow-up|3|||
162811897|NCT01138007|588023732|FG001|Overall Study|Lost to Follow-up|3|||
162811898|NCT01138007|588023733|FG002|Overall Study|Lost to Follow-up|5|||
162811899|NCT01138007|588023731|FG000|Overall Study|Physician Decision|0|||
162811900|NCT01138007|588023732|FG001|Overall Study|Physician Decision|5|||
162811901|NCT01138007|588023733|FG002|Overall Study|Physician Decision|3|||
162811902|NCT01138007|588023731|FG000|Overall Study|Withdrawal by Subject|5|||
162811903|NCT01138007|588023732|FG001|Overall Study|Withdrawal by Subject|6|||
162811904|NCT01138007|588023733|FG002|Overall Study|Withdrawal by Subject|15|||
162811905|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
162811906|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
162811907|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
162811908|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
162811909|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
162811910|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
162811911|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
162811912|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
162811913|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
162811914|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
162811915|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
162811916|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
162811917|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
162811918|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
162811919|NCT03548987|588023734|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
162811920|NCT03548987|588023735|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
162811921|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
162811922|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
162811923|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
162811924|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
162811925|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
162811926|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
162811927|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
162811928|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
162811929|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
162811930|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
162811931|NCT03548987|588023734|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
162811932|NCT03548987|588023735|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
162811933|NCT04572841|588023736|FG000|Overall Study|Adverse Event|1|||
162811934|NCT04572841|588023737|FG001|Overall Study|Adverse Event|1|||
162811935|NCT04572841|588023736|FG000|Overall Study|Withdrawal by Subject|2|||
162811936|NCT04572841|588023737|FG001|Overall Study|Withdrawal by Subject|1|||
162811937|NCT04661878|588023738|FG000|Overall Study|Lost to Follow-up|6|||
162811938|NCT04661878|588023739|FG001|Overall Study|Lost to Follow-up|5|||
162811939|NCT00712673|588023742|FG000|Overall Study|Adverse Event|3|||
162811940|NCT00712673|588023743|FG001|Overall Study|Adverse Event|3|||
162811941|NCT00712673|588023744|FG002|Overall Study|Adverse Event|21|||
162811942|NCT00712673|588023745|FG003|Overall Study|Adverse Event|26|||
162811943|NCT00712673|588023742|FG000|Overall Study|Lack of Efficacy|2|||
162811944|NCT00712673|588023743|FG001|Overall Study|Lack of Efficacy|8|||
162811945|NCT00712673|588023744|FG002|Overall Study|Lack of Efficacy|8|||
162811946|NCT00712673|588023745|FG003|Overall Study|Lack of Efficacy|6|||
162811947|NCT00712673|588023742|FG000|Overall Study|Poor Compliance to Protocol|3|||
162811948|NCT00712673|588023743|FG001|Overall Study|Poor Compliance to Protocol|3|||
162811949|NCT00712673|588023744|FG002|Overall Study|Poor Compliance to Protocol|4|||
162811950|NCT00712673|588023745|FG003|Overall Study|Poor Compliance to Protocol|16|||
162811951|NCT00712673|588023742|FG000|Overall Study|Lost to Follow-up|1|||
162811952|NCT00712673|588023743|FG001|Overall Study|Lost to Follow-up|0|||
162811953|NCT00712673|588023744|FG002|Overall Study|Lost to Follow-up|2|||
162811954|NCT00712673|588023745|FG003|Overall Study|Lost to Follow-up|0|||
162811955|NCT00712673|588023742|FG000|Overall Study|Withdrawal by Subject|6|||
162811956|NCT00712673|588023743|FG001|Overall Study|Withdrawal by Subject|7|||
163161258|NCT02500797|589304134|FG003|Overall Study|Withdrawal by Subject|0|||
163161259|NCT02500797|589304135|FG004|Overall Study|Withdrawal by Subject|0|||
163161260|NCT02500797|589304136|FG005|Overall Study|Withdrawal by Subject|0|||
163161261|NCT02500797|589304137|FG006|Overall Study|Withdrawal by Subject|0|||
163161262|NCT02500797|589304138|FG007|Overall Study|Withdrawal by Subject|0|||
163161263|NCT00357006|589304145|FG000|Overall Study|Lost to Follow-up|1|||
163161264|NCT00357006|589304146|FG001|Overall Study|Lost to Follow-up|2|||
163161265|NCT00357006|589304147|FG002|Overall Study|Lost to Follow-up|1|||
163161266|NCT00357006|589304145|FG000|Overall Study|Withdrawal by Subject|1|||
163161267|NCT00357006|589304146|FG001|Overall Study|Withdrawal by Subject|3|||
163161268|NCT00357006|589304147|FG002|Overall Study|Withdrawal by Subject|2|||
163161269|NCT03710161|589304148|FG000|Overall Study|Study halted due to COVID pandemic|3|||
163161270|NCT03710161|589304149|FG001|Overall Study|Study halted due to COVID pandemic|2|||
163161271|NCT02023697|589304154|FG000|Treatment Period|Radiological progression|13|||
163161272|NCT02023697|589304155|FG001|Treatment Period|Radiological progression|17|||
163161273|NCT02023697|589304156|FG002|Treatment Period|Radiological progression|26|||
163161274|NCT02023697|589304154|FG000|Treatment Period|Never Treated|5|||
163161275|NCT02023697|589304155|FG001|Treatment Period|Never Treated|6|||
163161276|NCT02023697|589304156|FG002|Treatment Period|Never Treated|10|||
163161277|NCT02023697|589304154|FG000|Treatment Period|Adverse Event|13|||
163161278|NCT02023697|589304155|FG001|Treatment Period|Adverse Event|25|||
163161279|NCT02023697|589304156|FG002|Treatment Period|Adverse Event|23|||
163161280|NCT02023697|589304154|FG000|Treatment Period|Logistical difficulties|1|||
163161281|NCT02023697|589304155|FG001|Treatment Period|Logistical difficulties|1|||
163161282|NCT02023697|589304156|FG002|Treatment Period|Logistical difficulties|1|||
163161283|NCT02023697|589304154|FG000|Treatment Period|Clinical progression|10|||
163161284|NCT02023697|589304155|FG001|Treatment Period|Clinical progression|8|||
163161285|NCT02023697|589304156|FG002|Treatment Period|Clinical progression|28|||
163161286|NCT02023697|589304154|FG000|Treatment Period|Withdrawal by Subject|4|||
163161287|NCT02023697|589304155|FG001|Treatment Period|Withdrawal by Subject|5|||
163161288|NCT02023697|589304156|FG002|Treatment Period|Withdrawal by Subject|13|||
163161289|NCT02023697|589304154|FG000|Treatment Period|Safety outcome reached|0|||
163161290|NCT02023697|589304155|FG001|Treatment Period|Safety outcome reached|1|||
163161291|NCT02023697|589304156|FG002|Treatment Period|Safety outcome reached|0|||
163161292|NCT02023697|589304154|FG000|Treatment Period|Physician Decision|0|||
163161293|NCT02023697|589304155|FG001|Treatment Period|Physician Decision|0|||
163161294|NCT02023697|589304156|FG002|Treatment Period|Physician Decision|1|||
163161295|NCT02023697|589304154|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
163161296|NCT02023697|589304155|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
163161297|NCT02023697|589304156|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
163161298|NCT02023697|589304154|FG000|Active Follow-up Period|Lost to Follow-up|1|||
163161299|NCT02023697|589304155|FG001|Active Follow-up Period|Lost to Follow-up|1|||
163161300|NCT02023697|589304156|FG002|Active Follow-up Period|Lost to Follow-up|1|||
163161301|NCT02023697|589304154|FG000|Active Follow-up Period|Deterioration of general condition|1|||
163161302|NCT02023697|589304155|FG001|Active Follow-up Period|Deterioration of general condition|1|||
163161303|NCT02023697|589304156|FG002|Active Follow-up Period|Deterioration of general condition|1|||
163161304|NCT02023697|589304154|FG000|Active Follow-up Period|Other unspecified|2|||
163161305|NCT02023697|589304155|FG001|Active Follow-up Period|Other unspecified|0|||
163161306|NCT02023697|589304156|FG002|Active Follow-up Period|Other unspecified|1|||
163161307|NCT02023697|589304154|FG000|Active Follow-up Period|Clinical progression|0|||
163161308|NCT02023697|589304155|FG001|Active Follow-up Period|Clinical progression|2|||
163161309|NCT02023697|589304156|FG002|Active Follow-up Period|Clinical progression|1|||
163161310|NCT02023697|589304154|FG000|Active Follow-up Period|Radiological progression|0|||
163161311|NCT02023697|589304155|FG001|Active Follow-up Period|Radiological progression|0|||
163161312|NCT02023697|589304156|FG002|Active Follow-up Period|Radiological progression|1|||
163161313|NCT02023697|589304154|FG000|Active Follow-up Period|Death|83|||
163161314|NCT02023697|589304155|FG001|Active Follow-up Period|Death|82|||
163161315|NCT02023697|589304156|FG002|Active Follow-up Period|Death|87|||
163161316|NCT02023697|589304154|FG000|Long-term Follow-up Period|Death|9|||
163161317|NCT02023697|589304155|FG001|Long-term Follow-up Period|Death|6|||
163161318|NCT02023697|589304156|FG002|Long-term Follow-up Period|Death|4|||
163161319|NCT02023697|589304154|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
163161320|NCT02023697|589304155|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
163161321|NCT02023697|589304156|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
163161322|NCT02023697|589304154|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
163161323|NCT02023697|589304155|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
163161324|NCT02023697|589304156|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
163161325|NCT02023697|589304154|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163161326|NCT02023697|589304155|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
163161327|NCT02023697|589304156|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163161328|NCT02023697|589304154|FG000|Long-term Follow-up Period|Technical problems|0|||
163161329|NCT02023697|589304155|FG001|Long-term Follow-up Period|Technical problems|0|||
163161330|NCT02023697|589304156|FG002|Long-term Follow-up Period|Technical problems|1|||
163161331|NCT02023697|589304154|FG000|Long-term Follow-up Period|Other unspecified|6|||
163161332|NCT02023697|589304155|FG001|Long-term Follow-up Period|Other unspecified|3|||
163161333|NCT02023697|589304156|FG002|Long-term Follow-up Period|Other unspecified|5|||
163161334|NCT00541385|589304157|FG000|Overall Study|Adverse Event|6|||
163161335|NCT00541385|589304158|FG001|Overall Study|Adverse Event|3|||
163161336|NCT00541385|589304157|FG000|Overall Study|Withdrawal by Subject|2|||
163161337|NCT00541385|589304158|FG001|Overall Study|Withdrawal by Subject|2|||
163161338|NCT00541385|589304157|FG000|Overall Study|Lost to Follow-up|6|||
163161339|NCT00541385|589304158|FG001|Overall Study|Lost to Follow-up|1|||
163161340|NCT00541385|589304157|FG000|Overall Study|Parasite reappearance/malaria|67|||
163161341|NCT00541385|589304158|FG001|Overall Study|Parasite reappearance/malaria|32|||
163161342|NCT01469377|589304159|FG000|Overall Study|Protocol Deviation|7|||
163161343|NCT01469377|589304160|FG001|Overall Study|Protocol Deviation|10|||
163161344|NCT01469377|589304161|FG002|Overall Study|Protocol Deviation|10|||
163161345|NCT01469377|589304159|FG000|Overall Study|Lost to Follow-up|3|||
163161346|NCT01469377|589304160|FG001|Overall Study|Lost to Follow-up|2|||
163161347|NCT01469377|589304161|FG002|Overall Study|Lost to Follow-up|5|||
163161348|NCT01469377|589304159|FG000|Overall Study|Withdrawal of Consent|12|||
163161349|NCT01469377|589304160|FG001|Overall Study|Withdrawal of Consent|14|||
163161350|NCT01469377|589304161|FG002|Overall Study|Withdrawal of Consent|15|||
163161351|NCT01469377|589304159|FG000|Overall Study|Adverse Event|8|||
163161352|NCT01469377|589304160|FG001|Overall Study|Adverse Event|18|||
163161353|NCT01469377|589304161|FG002|Overall Study|Adverse Event|36|||
163161354|NCT01469377|589304159|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163161355|NCT01469377|589304160|FG001|Overall Study|Insufficient Therapeutic Response|4|||
163161356|NCT01469377|589304161|FG002|Overall Study|Insufficient Therapeutic Response|0|||
163161357|NCT01469377|589304159|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163161358|NCT01469377|589304160|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163161359|NCT01469377|589304161|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163161360|NCT01733680|589304162|FG000|Overall Study|Withdrawal by Subject|0|||
163161361|NCT01733680|589304163|FG001|Overall Study|Withdrawal by Subject|1|||
163161362|NCT04139798|589304166|FG000|Overall Study|Withdrawal by Subject|6|||
163161363|NCT04139798|589304167|FG001|Overall Study|Withdrawal by Subject|5|||
163161364|NCT04139798|589304166|FG000|Overall Study|Lost to Follow-up|2|||
163161365|NCT04139798|589304167|FG001|Overall Study|Lost to Follow-up|5|||
163161366|NCT04139798|589304166|FG000|Overall Study|Discontinued|4|||
163161367|NCT04139798|589304167|FG001|Overall Study|Discontinued|2|||
163161368|NCT04139798|589304166|FG000|Overall Study|Adverse Event|1|||
163161369|NCT04139798|589304167|FG001|Overall Study|Adverse Event|3|||
163161370|NCT04139798|589304166|FG000|Overall Study|Protocol Violation|1|||
163161371|NCT04139798|589304167|FG001|Overall Study|Protocol Violation|0|||
163161372|NCT01526733|589304168|FG000|Phase 1|Protocol Violation|1|||
163161373|NCT01526733|589304169|FG001|Phase 1|Protocol Violation|0|||
163161374|NCT01526733|589304168|FG000|Phase 1|Withdrawal by Subject|1|||
163161375|NCT01526733|589304169|FG001|Phase 1|Withdrawal by Subject|1|||
163161376|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
163161377|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
163161378|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
163161379|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
163161380|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
163161381|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
163161382|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
163161383|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
163161384|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
163161385|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
163161386|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
163161387|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
163161388|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
163161389|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
163161390|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
163161391|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
163161392|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
163161393|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
163161394|NCT02952820|589304172|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163161395|NCT02952820|589304173|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163161396|NCT02952820|589304174|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
163161397|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
163161398|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
163161399|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
163161400|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
163161401|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
163161402|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
163161403|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
163161404|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
163161405|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
163161406|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
163161407|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
163161408|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
163161409|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
163161410|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
163161411|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
163161412|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
163161413|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
163161414|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
163161415|NCT02952820|589304172|FG000|Active Treatment Period (6 Months)|Not treated|0|||
163161416|NCT02952820|589304173|FG001|Active Treatment Period (6 Months)|Not treated|0|||
163161417|NCT02952820|589304174|FG002|Active Treatment Period (6 Months)|Not treated|1|||
163161418|NCT03857867|589304175|FG000|Overall Study|Physician Decision|1|||
163161419|NCT03070964|589304176|FG000|Overall Study|Progressive disease|8|||
163161420|NCT03070964|589304176|FG000|Overall Study|Treatment-unrelated adverse event|2|||
163161421|NCT03070964|589304176|FG000|Overall Study|Never treated|1|||
163161422|NCT03070964|589304176|FG000|Overall Study|Physician Decision|1|||
163161423|NCT03070964|589304176|FG000|Overall Study|Withdrawal by Subject|1|||
163161424|NCT03070964|589304176|FG000|Overall Study|Adverse Event|1|||
163161425|NCT02506244|589304180|FG000|Overall Study|Did not undergo active monitoring|458|||
163161426|NCT02506244|589304181|FG001|Overall Study|Did not undergo active monitoring|459|||
163161427|NCT02506244|589304182|FG002|Overall Study|Did not undergo active monitoring|0|||
163161428|NCT02170077|589304187|FG000|Overall Study|Withdrawal by Subject|3|||
163161429|NCT02170077|589304188|FG001|Overall Study|Withdrawal by Subject|4|||
163161430|NCT02170077|589304189|FG002|Overall Study|Withdrawal by Subject|2|||
163161431|NCT02170077|589304187|FG000|Overall Study|Adverse Event|4|||
163161432|NCT02170077|589304188|FG001|Overall Study|Adverse Event|4|||
163161433|NCT02170077|589304189|FG002|Overall Study|Adverse Event|4|||
163161434|NCT02170077|589304187|FG000|Overall Study|Lost to Follow-up|0|||
163161435|NCT02170077|589304188|FG001|Overall Study|Lost to Follow-up|1|||
163161436|NCT02170077|589304189|FG002|Overall Study|Lost to Follow-up|0|||
163161437|NCT02170077|589304187|FG000|Overall Study|Exclusion criteria|2|||
163161438|NCT02170077|589304188|FG001|Overall Study|Exclusion criteria|2|||
163161439|NCT02170077|589304189|FG002|Overall Study|Exclusion criteria|5|||
163161440|NCT02170077|589304187|FG000|Overall Study|Exacerbation of seizures|0|||
163161441|NCT02170077|589304188|FG001|Overall Study|Exacerbation of seizures|2|||
163161442|NCT02170077|589304189|FG002|Overall Study|Exacerbation of seizures|1|||
163161443|NCT01780974|589304190|FG000|Overall Study|Death|1|||
163161444|NCT01780974|589304191|FG001|Overall Study|Death|0|||
163161445|NCT01780974|589304190|FG000|Overall Study|Adverse Event|1|||
163161446|NCT01780974|589304191|FG001|Overall Study|Adverse Event|3|||
163161447|NCT02447003|589304194|FG000|Overall Study|Other|0|||
163161448|NCT02447003|589304195|FG001|Overall Study|Other|4|||
163161449|NCT02447003|589304194|FG000|Overall Study|Site discontinued|0|||
163161450|NCT02447003|589304195|FG001|Overall Study|Site discontinued|2|||
163161451|NCT02447003|589304194|FG000|Overall Study|Physician Decision|0|||
163161452|NCT02447003|589304195|FG001|Overall Study|Physician Decision|1|||
163161453|NCT02447003|589304194|FG000|Overall Study|Withdrawal by Subject|4|||
163161454|NCT02447003|589304195|FG001|Overall Study|Withdrawal by Subject|3|||
163161455|NCT02447003|589304194|FG000|Overall Study|Sponsor Decision|6|||
163161456|NCT02447003|589304195|FG001|Overall Study|Sponsor Decision|11|||
163161457|NCT02447003|589304194|FG000|Overall Study|Progressive Disease|1|||
163161458|NCT02447003|589304195|FG001|Overall Study|Progressive Disease|0|||
163161459|NCT02447003|589304194|FG000|Overall Study|Lost to Follow-up|5|||
163161460|NCT02447003|589304195|FG001|Overall Study|Lost to Follow-up|0|||
162811957|NCT00712673|588023744|FG002|Overall Study|Withdrawal by Subject|15|||
163161461|NCT02447003|589304194|FG000|Overall Study|Death|154|||
163161462|NCT02447003|589304195|FG001|Overall Study|Death|63|||
162811958|NCT00712673|588023745|FG003|Overall Study|Withdrawal by Subject|20|||
163161463|NCT00750438|589304196|FG000|Overall Study|Protocol Violation|4|||
163161464|NCT00750438|589304197|FG001|Overall Study|Protocol Violation|1|||
163161465|NCT00750438|589304196|FG000|Overall Study|Physician Decision|2|||
163161466|NCT00750438|589304197|FG001|Overall Study|Physician Decision|2|||
163161467|NCT00750438|589304196|FG000|Overall Study|Withdrawal by Subject|1|||
163161468|NCT00750438|589304197|FG001|Overall Study|Withdrawal by Subject|1|||
163161469|NCT03848728|589304198|FG000|Overall Study|Death|16|||
163161470|NCT03848728|589304199|FG001|Overall Study|Death|13|||
163161471|NCT03848728|589304198|FG000|Overall Study|Outmigrated to non-study community|98|||
163161472|NCT03848728|589304199|FG001|Overall Study|Outmigrated to non-study community|106|||
163161473|NCT03848728|589304198|FG000|Overall Study|Transfered to non-study clinic|32|||
163161474|NCT03848728|589304199|FG001|Overall Study|Transfered to non-study clinic|48|||
163161475|NCT03848728|589304198|FG000|Overall Study|Withdrawal by Subject|1|||
163161476|NCT03848728|589304199|FG001|Overall Study|Withdrawal by Subject|0|||
163161477|NCT01185080|589304200|FG000|Overall Study|Adverse Event|1|||
163161478|NCT01185080|589304201|FG001|Overall Study|Adverse Event|1|||
163161479|NCT01185080|589304202|FG002|Overall Study|Adverse Event|0|||
163161480|NCT01185080|589304200|FG000|Overall Study|Personal reasons|0|||
163161481|NCT01185080|589304201|FG001|Overall Study|Personal reasons|0|||
163161482|NCT01185080|589304202|FG002|Overall Study|Personal reasons|1|||
163161483|NCT06083506|589304203|FG000|Overall Study|Physician Decision|2|||
163161484|NCT06083506|589304203|FG000|Overall Study|Lack of Efficacy|1|||
163161485|NCT04500158|589304204|FG000|Overall Study|Physician Decision|17|||
163161486|NCT04500158|589304205|FG001|Overall Study|Physician Decision|11|||
163161487|NCT03830892|589305772|FG000|Overall Study|Physician Decision|2|||
163161488|NCT03830892|589305773|FG001|Overall Study|Physician Decision|3|||
163161489|NCT03830892|589305772|FG000|Overall Study|Study terminated due to COVID|4|||
163161490|NCT03830892|589305773|FG001|Overall Study|Study terminated due to COVID|0|||
163161491|NCT03830892|589305772|FG000|Overall Study|Protocol Violation|0|||
163161492|NCT03830892|589305773|FG001|Overall Study|Protocol Violation|1|||
163161493|NCT03830892|589305772|FG000|Overall Study|Withdrawal by Subject|0|||
163161494|NCT03830892|589305773|FG001|Overall Study|Withdrawal by Subject|2|||
163161495|NCT01499277|589305774|FG000|Overall Study|Adverse Event|3|||
163161496|NCT01499277|589305775|FG001|Overall Study|Adverse Event|6|||
163161497|NCT01499277|589305774|FG000|Overall Study|Death|3|||
163161498|NCT01499277|589305775|FG001|Overall Study|Death|2|||
163161499|NCT01499277|589305774|FG000|Overall Study|Lost to Follow-up|15|||
163161500|NCT01499277|589305775|FG001|Overall Study|Lost to Follow-up|8|||
163161501|NCT01499277|589305774|FG000|Overall Study|Protocol Violation|2|||
163161502|NCT01499277|589305775|FG001|Overall Study|Protocol Violation|3|||
163161503|NCT01499277|589305774|FG000|Overall Study|Withdrawal by Subject|16|||
163161504|NCT01499277|589305775|FG001|Overall Study|Withdrawal by Subject|6|||
163161505|NCT01499277|589305774|FG000|Overall Study|Lack of therapeutic response and other|8|||
163161506|NCT01499277|589305775|FG001|Overall Study|Lack of therapeutic response and other|7|||
163161507|NCT00975689|589305776|FG000|Overall Study|Adverse Event|0|||
163161508|NCT00975689|589305777|FG001|Overall Study|Adverse Event|3|||
163161509|NCT00975689|589305776|FG000|Overall Study|Withdrawal by Subject|1|||
163161510|NCT00975689|589305777|FG001|Overall Study|Withdrawal by Subject|0|||
163161511|NCT00975689|589305776|FG000|Overall Study|Physician Decision|1|||
163161512|NCT00975689|589305777|FG001|Overall Study|Physician Decision|0|||
163161513|NCT00372593|589305780|FG000|Overall Study|Adverse Event|43|||
163161514|NCT00372593|589305781|FG001|Overall Study|Adverse Event|45|||
163161515|NCT00372593|589305782|FG002|Overall Study|Adverse Event|0|||
163161516|NCT00372593|589305780|FG000|Overall Study|Death|16|||
163161517|NCT00372593|589305781|FG001|Overall Study|Death|20|||
163161518|NCT00372593|589305782|FG002|Overall Study|Death|1|||
163161519|NCT00372593|589305780|FG000|Overall Study|Lack of Efficacy|82|||
163161520|NCT00372593|589305781|FG001|Overall Study|Lack of Efficacy|71|||
163161521|NCT00372593|589305782|FG002|Overall Study|Lack of Efficacy|2|||
162811959|NCT00712673|588023742|FG000|Overall Study|Familial and Personal Reasons|5|||
162811960|NCT00712673|588023743|FG001|Overall Study|Familial and Personal Reasons|0|||
162811961|NCT00712673|588023744|FG002|Overall Study|Familial and Personal Reasons|5|||
162811962|NCT00712673|588023745|FG003|Overall Study|Familial and Personal Reasons|2|||
162811963|NCT00712673|588023742|FG000|Overall Study|Investigator's Decision|1|||
162811964|NCT00712673|588023743|FG001|Overall Study|Investigator's Decision|0|||
162811965|NCT00712673|588023744|FG002|Overall Study|Investigator's Decision|0|||
162811966|NCT00712673|588023745|FG003|Overall Study|Investigator's Decision|0|||
163161522|NCT00372593|589305780|FG000|Overall Study|Lost to Follow-up|1|||
163161523|NCT00372593|589305781|FG001|Overall Study|Lost to Follow-up|0|||
163161524|NCT00372593|589305782|FG002|Overall Study|Lost to Follow-up|0|||
163161525|NCT00372593|589305780|FG000|Overall Study|Physician Decision|42|||
163161526|NCT00372593|589305781|FG001|Overall Study|Physician Decision|41|||
163161527|NCT00372593|589305782|FG002|Overall Study|Physician Decision|0|||
163161528|NCT00372593|589305780|FG000|Overall Study|Ineligible|20|||
163161529|NCT00372593|589305781|FG001|Overall Study|Ineligible|21|||
163161530|NCT00372593|589305782|FG002|Overall Study|Ineligible|1|||
163161531|NCT02974543|589305783|FG000|Overall Study|Withdrawal by Subject|1|||
163161532|NCT02974543|589305784|FG001|Overall Study|Withdrawal by Subject|0|||
162811967|NCT00712673|588023742|FG000|Overall Study|Protocol Violation|0|||
162811968|NCT00712673|588023743|FG001|Overall Study|Protocol Violation|0|||
163161533|NCT03534180|589305785|FG000|Overall Study|Withdrawal by Subject|1|||
163161534|NCT00220636|589305786|FG000|Overall Study|Withdrawal by Subject|4|||
162811969|NCT00712673|588023744|FG002|Overall Study|Protocol Violation|2|||
163161535|NCT00330967|589305787|FG000|Overall Study|Withdrawal by Subject|0|||
163161536|NCT00330967|589305788|FG001|Overall Study|Withdrawal by Subject|5|||
163161537|NCT00330967|589305787|FG000|Overall Study|Physician Decision|0|||
163161538|NCT00330967|589305788|FG001|Overall Study|Physician Decision|9|||
163161539|NCT01237899|589305789|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
163161540|NCT01237899|589305790|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
163161541|NCT01237899|589305791|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
163161542|NCT01237899|589305792|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
163161543|NCT01237899|589305793|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
163161544|NCT01237899|589305794|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
163161545|NCT01237899|589305795|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
163161546|NCT01237899|589305796|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
163161547|NCT01237899|589305797|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
163161548|NCT01237899|589305798|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
163161549|NCT01237899|589305799|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
163161550|NCT00790088|589305800|FG000|Overall Study|Protocol Violation|11|||
163161551|NCT00790088|589305800|FG000|Overall Study|Withdrawal by Subject|17|||
163161552|NCT00790088|589305800|FG000|Overall Study|Lost to Follow-up|7|||
163161553|NCT00790088|589305800|FG000|Overall Study|Physician Decision|4|||
163161554|NCT02910986|589305801|FG000|Overall Study|non-Latina|14|||
163161555|NCT02910986|589305802|FG001|Overall Study|non-Latina|13|||
163161556|NCT02910986|589305803|FG002|Overall Study|non-Latina|12|||
163161557|NCT02910986|589305801|FG000|Overall Study|Failure to return T! survey|72|||
163161558|NCT02910986|589305802|FG001|Overall Study|Failure to return T! survey|84|||
163161559|NCT02910986|589305803|FG002|Overall Study|Failure to return T! survey|72|||
163161560|NCT02910986|589305801|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
163161561|NCT02910986|589305802|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
163161562|NCT02910986|589305803|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
163161563|NCT02910986|589305801|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
163161564|NCT02910986|589305802|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
163161565|NCT02910986|589305803|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
163161566|NCT03682770|589305814|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161567|NCT03682770|589305815|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
163161568|NCT03682770|589305816|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161569|NCT03682770|589305817|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161570|NCT03682770|589305818|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161571|NCT03682770|589305819|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161572|NCT03682770|589305820|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
163161573|NCT03682770|589305814|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
163161574|NCT03682770|589305815|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
163161575|NCT03682770|589305816|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161576|NCT03682770|589305817|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161577|NCT03682770|589305818|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161578|NCT03682770|589305819|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161579|NCT03682770|589305820|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
163161580|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161581|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161582|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
163161583|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
163161584|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161585|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161586|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
163161587|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161588|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161589|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161590|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
163161591|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161592|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161593|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
163161594|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161595|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161596|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
163161597|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
163161598|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161599|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161600|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
163161601|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161602|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161603|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
163161604|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161605|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162811970|NCT00712673|588023745|FG003|Overall Study|Protocol Violation|0|||
162811971|NCT03603028|588023746|FG000|Overall Study|Withdrawal by Subject|1|||
162811972|NCT00640016|588023749|FG000|Overall Study|Withdrawal by Subject|0|||
162811973|NCT00640016|588023750|FG001|Overall Study|Withdrawal by Subject|1|||
162811974|NCT00640016|588023751|FG002|Overall Study|Withdrawal by Subject|0|||
162811975|NCT00640016|588023752|FG003|Overall Study|Withdrawal by Subject|0|||
162811976|NCT00640016|588023749|FG000|Overall Study|Study termination|2|||
162811977|NCT00640016|588023750|FG001|Overall Study|Study termination|1|||
162811978|NCT00640016|588023751|FG002|Overall Study|Study termination|3|||
162811979|NCT00640016|588023752|FG003|Overall Study|Study termination|2|||
162811980|NCT00640016|588023749|FG000|Overall Study|Adverse Event|0|||
162811981|NCT00640016|588023750|FG001|Overall Study|Adverse Event|0|||
162811982|NCT00640016|588023751|FG002|Overall Study|Adverse Event|0|||
162811983|NCT00640016|588023752|FG003|Overall Study|Adverse Event|1|||
162811984|NCT00846391|588023753|FG000|Overall Study|Physician Decision|0|||
162811985|NCT00846391|588023754|FG001|Overall Study|Physician Decision|0|||
162811986|NCT00846391|588023755|FG002|Overall Study|Physician Decision|1|||
162811987|NCT00846391|588023753|FG000|Overall Study|Study Terminated by Sponsor|1|||
162811988|NCT00846391|588023754|FG001|Overall Study|Study Terminated by Sponsor|2|||
162811989|NCT00846391|588023755|FG002|Overall Study|Study Terminated by Sponsor|2|||
162811990|NCT01287065|588023756|FG000|Treatment Period 1|Adverse Event|0|||
162811991|NCT01287065|588023757|FG001|Treatment Period 1|Adverse Event|0|||
162811992|NCT01287065|588023758|FG002|Treatment Period 1|Adverse Event|0|||
162811993|NCT01287065|588023759|FG003|Treatment Period 1|Adverse Event|0|||
162811994|NCT01287065|588023760|FG004|Treatment Period 1|Adverse Event|1|||
162811995|NCT01287065|588023761|FG005|Treatment Period 1|Adverse Event|0|||
162811996|NCT01287065|588023756|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162811997|NCT01287065|588023757|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162811998|NCT01287065|588023758|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162811999|NCT01287065|588023759|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162812000|NCT01287065|588023760|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162812001|NCT01287065|588023761|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162812002|NCT01580969|588023762|FG000|Overall Study|Physician Decision|3|||
162812003|NCT01580969|588023763|FG001|Overall Study|Physician Decision|0|||
162812004|NCT01580969|588023764|FG002|Overall Study|Physician Decision|0|||
162812005|NCT02019927|588023765|FG000|Overall Study|Lost to Follow-up|2|||
162812006|NCT02019927|588023766|FG001|Overall Study|Lost to Follow-up|4|||
162812007|NCT02019927|588023767|FG002|Overall Study|Lost to Follow-up|1|||
162812008|NCT02019927|588023768|FG003|Overall Study|Lost to Follow-up|2|||
162812009|NCT02019927|588023769|FG004|Overall Study|Lost to Follow-up|3|||
162812010|NCT02019927|588023770|FG005|Overall Study|Lost to Follow-up|1|||
162812011|NCT03181451|588023771|FG000|Overall Study|Adverse Event|0|||
162812012|NCT03181451|588023772|FG001|Overall Study|Adverse Event|1|||
162812013|NCT03181451|588023773|FG002|Overall Study|Adverse Event|0|||
162812014|NCT03181451|588023771|FG000|Overall Study|Withdrawal by Subject|0|||
162812015|NCT03181451|588023772|FG001|Overall Study|Withdrawal by Subject|1|||
162812016|NCT03181451|588023773|FG002|Overall Study|Withdrawal by Subject|0|||
162812017|NCT01259284|588023780|FG000|Overall Study|Study Termination|2|||
162812018|NCT01259284|588023781|FG001|Overall Study|Study Termination|0|||
162812019|NCT01259284|588023782|FG002|Overall Study|Study Termination|0|||
162812020|NCT00069238|588023783|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
162812021|NCT00069238|588023784|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
162812022|NCT00069238|588023785|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
162812023|NCT00069238|588023783|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
162812024|NCT00069238|588023784|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
162812025|NCT00069238|588023785|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
162812026|NCT00069238|588023783|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
162812027|NCT00069238|588023784|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
163161606|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161607|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
163161608|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161609|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161610|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
163161611|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162812028|NCT00069238|588023785|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
162812029|NCT01001832|588023786|FG000|Short-term Period|Adverse Event|2|||
162812030|NCT01001832|588023787|FG001|Short-term Period|Adverse Event|3|||
162812031|NCT01001832|588023786|FG000|Long-term Period|Adverse Event|2|||
162812032|NCT01001832|588023787|FG001|Long-term Period|Adverse Event|1|||
162812033|NCT01001832|588023786|FG000|Long-term Period|Withdrawal by Subject|1|||
163161612|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162812034|NCT01001832|588023787|FG001|Long-term Period|Withdrawal by Subject|0|||
162812035|NCT01001832|588023786|FG000|Long-term Period|Lack of Efficacy|0|||
162812036|NCT01001832|588023787|FG001|Long-term Period|Lack of Efficacy|2|||
162812037|NCT01001832|588023786|FG000|Long-term Period|Other|1|||
162812038|NCT01001832|588023787|FG001|Long-term Period|Other|2|||
162812039|NCT01001832|588023786|FG000|Follow-up Period|Withdrawal by Subject|1|||
162812040|NCT01001832|588023787|FG001|Follow-up Period|Withdrawal by Subject|0|||
162812041|NCT01001832|588023786|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
162812042|NCT01001832|588023787|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
162812043|NCT01001832|588023786|FG000|Follow-up Period|Other|2|||
162812044|NCT01001832|588023787|FG001|Follow-up Period|Other|1|||
162812045|NCT01032382|588023791|FG000|Overall Study|Disease dissemination|1|||
162812046|NCT01032382|588023792|FG001|Overall Study|Disease dissemination|1|||
162812047|NCT01032382|588023791|FG000|Overall Study|Treatment failure|3|||
162812048|NCT01032382|588023792|FG001|Overall Study|Treatment failure|1|||
162812049|NCT01032382|588023791|FG000|Overall Study|Index lesion relapse|1|||
162812050|NCT01032382|588023792|FG001|Overall Study|Index lesion relapse|3|||
162812051|NCT01012713|588023793|FG000|Overall Study|Lack of Efficacy|3|||
162812052|NCT01242800|588023794|FG000|Overall Study|Patient refusal|0|||
162812053|NCT01242800|588023795|FG001|Overall Study|Patient refusal|10|||
162812054|NCT01242800|588023794|FG000|Overall Study|Physician Decision|0|||
162812055|NCT01242800|588023795|FG001|Overall Study|Physician Decision|1|||
162812056|NCT01242800|588023794|FG000|Overall Study|Disease progression|0|||
162812057|NCT01242800|588023795|FG001|Overall Study|Disease progression|3|||
162812058|NCT01242800|588023794|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
162812059|NCT01242800|588023795|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
162812060|NCT01242800|588023794|FG000|Overall Study|Reasons not reported|0|||
162812061|NCT01242800|588023795|FG001|Overall Study|Reasons not reported|4|||
162812062|NCT04508023|588023799|FG000|Overall Study|Withdrawal by Subject|1|||
162812063|NCT04508023|588023800|FG001|Overall Study|Withdrawal by Subject|2|||
162812064|NCT00511901|588023808|FG000|Overall Study|Withdrawal by Subject|1|||
162812065|NCT00511901|588023809|FG001|Overall Study|Withdrawal by Subject|3|||
162812066|NCT02447172|588023810|FG000|Overall Study|Adverse Event|11|||
162812067|NCT02447172|588023811|FG001|Overall Study|Adverse Event|8|||
162812068|NCT02447172|588023812|FG002|Overall Study|Adverse Event|7|||
162812069|NCT02447172|588023810|FG000|Overall Study|Death|3|||
162812070|NCT02447172|588023811|FG001|Overall Study|Death|1|||
162812071|NCT02447172|588023812|FG002|Overall Study|Death|0|||
162812072|NCT02447172|588023810|FG000|Overall Study|Protocol Violation|2|||
162812073|NCT02447172|588023811|FG001|Overall Study|Protocol Violation|1|||
162812074|NCT02447172|588023812|FG002|Overall Study|Protocol Violation|2|||
162812075|NCT02447172|588023810|FG000|Overall Study|Lost to Follow-up|7|||
162812076|NCT02447172|588023811|FG001|Overall Study|Lost to Follow-up|4|||
162812077|NCT02447172|588023812|FG002|Overall Study|Lost to Follow-up|4|||
162812078|NCT02447172|588023810|FG000|Overall Study|Withdrawal by Subject|5|||
162812079|NCT02447172|588023811|FG001|Overall Study|Withdrawal by Subject|1|||
162812080|NCT02447172|588023812|FG002|Overall Study|Withdrawal by Subject|3|||
162812081|NCT02447172|588023810|FG000|Overall Study|protocol specific treatment unrelated|3|||
162812082|NCT02447172|588023811|FG001|Overall Study|protocol specific treatment unrelated|0|||
162812083|NCT02447172|588023812|FG002|Overall Study|protocol specific treatment unrelated|2|||
162812084|NCT03562247|588023816|FG000|Overall Study|Lost to Follow-up|3|||
162812085|NCT03562247|588023817|FG001|Overall Study|Lost to Follow-up|1|||
162812086|NCT03562247|588023818|FG002|Overall Study|Lost to Follow-up|1|||
162812087|NCT00983931|588023819|FG000|14 Day Washout Period|Physician Decision|1|||
162812088|NCT01281969|588023820|FG000|Overall Study|not randomized didn't meet criteria|0|||
162812089|NCT01281969|588023821|FG001|Overall Study|not randomized didn't meet criteria|0|||
162812090|NCT01281969|588023822|FG002|Overall Study|not randomized didn't meet criteria|7|||
162812091|NCT01281969|588023820|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
162812092|NCT01281969|588023821|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
162812093|NCT01281969|588023822|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
162812094|NCT01281969|588023820|FG000|Overall Study|not randomized, child consent not given|0|||
162812095|NCT01281969|588023821|FG001|Overall Study|not randomized, child consent not given|0|||
162812096|NCT01281969|588023822|FG002|Overall Study|not randomized, child consent not given|2|||
162812097|NCT02409368|588023827|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
162812098|NCT02409368|588023828|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
162812099|NCT02409368|588023829|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
162812100|NCT02409368|588023830|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
162812101|NCT02409368|588023827|FG000|ECOG Reclassification|Death|1|||
162812102|NCT02409368|588023828|FG001|ECOG Reclassification|Death|5|||
162812103|NCT02409368|588023829|FG002|ECOG Reclassification|Death|0|||
162812104|NCT02409368|588023830|FG003|ECOG Reclassification|Death|0|||
162812105|NCT02409368|588023827|FG000|ECOG Reclassification|Disease Progression|113|||
162812106|NCT02409368|588023828|FG001|ECOG Reclassification|Disease Progression|382|||
162812107|NCT02409368|588023829|FG002|ECOG Reclassification|Disease Progression|70|||
162812108|NCT02409368|588023830|FG003|ECOG Reclassification|Disease Progression|1|||
162812109|NCT02409368|588023827|FG000|ECOG Reclassification|Lost to Follow-up|1|||
162812110|NCT02409368|588023828|FG001|ECOG Reclassification|Lost to Follow-up|5|||
162812111|NCT02409368|588023829|FG002|ECOG Reclassification|Lost to Follow-up|0|||
162812112|NCT02409368|588023830|FG003|ECOG Reclassification|Lost to Follow-up|0|||
162812113|NCT02409368|588023827|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
162812114|NCT02409368|588023828|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
162812115|NCT02409368|588023829|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
162812116|NCT02409368|588023830|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
162812117|NCT02409368|588023827|FG000|ECOG Reclassification|Poor/non-compliance|0|||
162812118|NCT02409368|588023828|FG001|ECOG Reclassification|Poor/non-compliance|3|||
162812119|NCT02409368|588023829|FG002|ECOG Reclassification|Poor/non-compliance|2|||
162812120|NCT02409368|588023830|FG003|ECOG Reclassification|Poor/non-compliance|0|||
162812121|NCT02409368|588023827|FG000|ECOG Reclassification|Study drug toxicity|17|||
162812122|NCT02409368|588023828|FG001|ECOG Reclassification|Study drug toxicity|42|||
162812123|NCT02409368|588023829|FG002|ECOG Reclassification|Study drug toxicity|7|||
162812124|NCT02409368|588023830|FG003|ECOG Reclassification|Study drug toxicity|0|||
162812125|NCT02409368|588023827|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
162812126|NCT02409368|588023828|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
162812127|NCT02409368|588023829|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
162812128|NCT02409368|588023830|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
162812129|NCT02409368|588023827|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
162812130|NCT02409368|588023828|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
162812131|NCT02409368|588023829|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
162812132|NCT02409368|588023830|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
162812133|NCT02409368|588023827|FG000|ECOG Reclassification|Participant withdrew consent|2|||
162812134|NCT02409368|588023828|FG001|ECOG Reclassification|Participant withdrew consent|3|||
162812135|NCT02409368|588023829|FG002|ECOG Reclassification|Participant withdrew consent|4|||
162812136|NCT02409368|588023830|FG003|ECOG Reclassification|Participant withdrew consent|0|||
162812137|NCT02409368|588023827|FG000|ECOG Reclassification|Other Reasons|5|||
162812138|NCT02409368|588023828|FG001|ECOG Reclassification|Other Reasons|26|||
162812139|NCT02409368|588023829|FG002|ECOG Reclassification|Other Reasons|2|||
162812140|NCT02409368|588023830|FG003|ECOG Reclassification|Other Reasons|0|||
162812141|NCT02409368|588023827|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
162812142|NCT02409368|588023828|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
162812143|NCT02409368|588023829|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
162812144|NCT02409368|588023830|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
162812145|NCT01296347|588023831|FG000|Allocation|Withdrawal by Subject|1|||
162812146|NCT01296347|588023832|FG001|Allocation|Withdrawal by Subject|2|||
162812147|NCT01296347|588023831|FG000|Allocation|Lack of Efficacy|1|||
162812148|NCT01296347|588023832|FG001|Allocation|Lack of Efficacy|2|||
162812149|NCT01296347|588023831|FG000|Allocation|not received infusion|1|||
162812150|NCT01296347|588023832|FG001|Allocation|not received infusion|0|||
162812151|NCT01296347|588023831|FG000|6 Week Follow up|Death|0|||
162812152|NCT01296347|588023832|FG001|6 Week Follow up|Death|1|||
162812153|NCT01296347|588023831|FG000|3 Month Follow up|Death|1|||
162812154|NCT01296347|588023832|FG001|3 Month Follow up|Death|0|||
162812155|NCT01296347|588023831|FG000|3 Month Follow up|Lost to Follow-up|0|||
162812156|NCT01296347|588023832|FG001|3 Month Follow up|Lost to Follow-up|1|||
162812157|NCT01296347|588023831|FG000|6 Month Follow up|Death|2|||
162812158|NCT01296347|588023832|FG001|6 Month Follow up|Death|1|||
162812159|NCT01296347|588023831|FG000|6 Month Follow up|Lost to Follow-up|0|||
162812160|NCT01296347|588023832|FG001|6 Month Follow up|Lost to Follow-up|1|||
162812161|NCT01296347|588023831|FG000|12 Month Follow up|Lost to Follow-up|3|||
162812162|NCT01296347|588023832|FG001|12 Month Follow up|Lost to Follow-up|1|||
162812163|NCT01296347|588023831|FG000|12 Month Follow up|Death|1|||
162812164|NCT01296347|588023832|FG001|12 Month Follow up|Death|1|||
162812165|NCT01296347|588023831|FG000|12 Month Follow up|Withdrawal by Subject|0|||
162812166|NCT01296347|588023832|FG001|12 Month Follow up|Withdrawal by Subject|1|||
162812167|NCT02240693|588023833|FG000|Overall Study|Adverse Event|0|||
162812168|NCT02240693|588023834|FG001|Overall Study|Adverse Event|0|||
162812169|NCT02240693|588023835|FG002|Overall Study|Adverse Event|0|||
163161613|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161614|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
163161615|NCT03682770|589305814|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161616|NCT03682770|589305815|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162812170|NCT02240693|588023836|FG003|Overall Study|Adverse Event|0|||
162812171|NCT02240693|588023837|FG004|Overall Study|Adverse Event|1|||
162812172|NCT02240693|588023833|FG000|Overall Study|Withdrawal by Subject|0|||
162812173|NCT02240693|588023834|FG001|Overall Study|Withdrawal by Subject|0|||
162812174|NCT02240693|588023835|FG002|Overall Study|Withdrawal by Subject|2|||
162812175|NCT02240693|588023836|FG003|Overall Study|Withdrawal by Subject|1|||
162812176|NCT02240693|588023837|FG004|Overall Study|Withdrawal by Subject|0|||
162812177|NCT02240693|588023833|FG000|Overall Study|Other than specified|0|||
162812178|NCT02240693|588023834|FG001|Overall Study|Other than specified|0|||
162812179|NCT02240693|588023835|FG002|Overall Study|Other than specified|2|||
162812180|NCT02240693|588023836|FG003|Overall Study|Other than specified|0|||
162812181|NCT02240693|588023837|FG004|Overall Study|Other than specified|0|||
162812182|NCT03343301|588023838|FG000|Overall Study|Withdrawal by Subject|1|||
162812183|NCT03343301|588023839|FG001|Overall Study|Withdrawal by Subject|1|||
162812184|NCT03343301|588023838|FG000|Overall Study|Death|0|||
162812185|NCT03343301|588023839|FG001|Overall Study|Death|2|||
162812186|NCT03343301|588023838|FG000|Overall Study|Other|0|||
162812187|NCT03343301|588023839|FG001|Overall Study|Other|6|||
162812188|NCT03343301|588023838|FG000|Overall Study|Missing|2|||
162812189|NCT03343301|588023839|FG001|Overall Study|Missing|0|||
162812190|NCT02668185|588023842|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
162812191|NCT02668185|588023843|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
162812192|NCT02668185|588023842|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
162812193|NCT02668185|588023843|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
162812194|NCT02668185|588023842|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
162812195|NCT02668185|588023843|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
162812196|NCT02668185|588023842|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
162812197|NCT02668185|588023843|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
162812198|NCT01013597|588023844|FG000|Overall Study|Withdrawal by Subject|1|||
162812199|NCT02678247|588023845|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
162812200|NCT02678247|588023846|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
162812201|NCT02678247|588023845|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
162812202|NCT02678247|588023846|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
162812203|NCT02678247|588023845|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
162812204|NCT02678247|588023846|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
162812205|NCT02678247|588023845|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
162812206|NCT02678247|588023846|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
162812207|NCT02678247|588023845|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
162812208|NCT02678247|588023846|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
162812209|NCT02678247|588023845|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
162812210|NCT02678247|588023846|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
162812211|NCT05330312|588023852|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
162812212|NCT05330312|588023853|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
162812213|NCT05330312|588023854|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
162812214|NCT05330312|588023852|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
162812215|NCT05330312|588023853|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
162812216|NCT05330312|588023854|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
162812217|NCT05330312|588023852|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
162812218|NCT05330312|588023853|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
162812219|NCT05330312|588023854|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
162812220|NCT05330312|588023852|FG000|Pivotal Investigation - Part 2|Death|1|||
162812221|NCT05330312|588023853|FG001|Pivotal Investigation - Part 2|Death|4|||
162812222|NCT05330312|588023854|FG002|Pivotal Investigation - Part 2|Death|0|||
162812223|NCT04002401|588023855|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
162812224|NCT04002401|588023855|FG000|Overall Study|Death|10|||
162812225|NCT04002401|588023855|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
162812226|NCT04002401|588023855|FG000|Overall Study|Enrolled but Never Treated|1|||
162812227|NCT04002401|588023855|FG000|Overall Study|Lost to Follow-up|1|||
162812228|NCT00423930|588023856|FG000|Overall Study|Withdrawal by Subject|2|||
162812229|NCT00081497|588023864|FG000|Overall Study|Adverse Event|2|||
162812230|NCT00081497|588023865|FG001|Overall Study|Adverse Event|0|||
162812231|NCT00081497|588023864|FG000|Overall Study|Death|0|||
162812232|NCT00081497|588023865|FG001|Overall Study|Death|1|||
162812233|NCT00081497|588023864|FG000|Overall Study|Withdrawal by Subject|1|||
162812234|NCT00081497|588023865|FG001|Overall Study|Withdrawal by Subject|0|||
162812235|NCT00081497|588023864|FG000|Overall Study|Non-compliance|0|||
162812236|NCT00081497|588023865|FG001|Overall Study|Non-compliance|1|||
162812237|NCT02390245|588023866|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
162812238|NCT02390245|588023867|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
162812239|NCT02390245|588023868|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
162812240|NCT02390245|588023866|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
162812241|NCT02390245|588023867|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
162812242|NCT02390245|588023868|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
162924206|NCT02426125|588423830|FG001|Overall Study|Randomized, But Never Treated|2|||
162924207|NCT00077766|588423833|FG000|Overall Study|Adverse Event|1|||
162924208|NCT00077766|588423834|FG001|Overall Study|Adverse Event|1|||
162924209|NCT00077766|588423833|FG000|Overall Study|Withdrawal by Subject|4|||
162924210|NCT00077766|588423834|FG001|Overall Study|Withdrawal by Subject|3|||
162924211|NCT00077766|588423833|FG000|Overall Study|Death|12|||
162924212|NCT00077766|588423834|FG001|Overall Study|Death|10|||
162924213|NCT00077766|588423833|FG000|Overall Study|Lost to Follow-up|2|||
162924214|NCT00077766|588423834|FG001|Overall Study|Lost to Follow-up|0|||
162924215|NCT00077766|588423833|FG000|Overall Study|Protocol Violation|1|||
162924216|NCT00077766|588423834|FG001|Overall Study|Protocol Violation|0|||
162924217|NCT00077766|588423833|FG000|Overall Study|Kidney Transplantation|9|||
162924218|NCT00077766|588423834|FG001|Overall Study|Kidney Transplantation|5|||
162924219|NCT00077766|588423833|FG000|Overall Study|Transplantation|5|||
162812243|NCT02425644|588025345|FG000|Overall Study|Lost to Follow-up|2|||
162812244|NCT02425644|588025346|FG001|Overall Study|Lost to Follow-up|3|||
162812245|NCT02425644|588025345|FG000|Overall Study|Withdrawal by Subject|41|||
162812246|NCT02425644|588025346|FG001|Overall Study|Withdrawal by Subject|36|||
162812247|NCT02425644|588025345|FG000|Overall Study|Lack of Efficacy|3|||
162812248|NCT02425644|588025346|FG001|Overall Study|Lack of Efficacy|10|||
162812249|NCT02425644|588025345|FG000|Overall Study|Adverse Event|13|||
162812250|NCT02425644|588025346|FG001|Overall Study|Adverse Event|3|||
162812251|NCT02425644|588025345|FG000|Overall Study|Death|0|||
162812252|NCT02425644|588025346|FG001|Overall Study|Death|2|||
162812253|NCT02425644|588025345|FG000|Overall Study|Other|18|||
162812254|NCT02425644|588025346|FG001|Overall Study|Other|17|||
162812255|NCT02720536|588025347|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
162812256|NCT02720536|588025347|FG000|Overall Study|PR - pregnancy|2|||
162812257|NCT02720536|588025347|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
162812258|NCT02720536|588025347|FG000|Overall Study|PR - death|1|||
162812259|NCT02720536|588025347|FG000|Overall Study|PR - adverse event|1|||
162812260|NCT02720536|588025347|FG000|Overall Study|PR - abnormal lab value(s)|1|||
162812261|NCT02720536|588025347|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
162812262|NCT00985166|588025348|FG000|Overall Study|Lost to Follow-up|3|||
162812263|NCT00985166|588025349|FG001|Overall Study|Lost to Follow-up|2|||
162812264|NCT00985166|588025350|FG002|Overall Study|Lost to Follow-up|2|||
162812265|NCT00985166|588025348|FG000|Overall Study|Withdrawal by Subject|3|||
162812266|NCT00985166|588025349|FG001|Overall Study|Withdrawal by Subject|2|||
162812267|NCT00985166|588025350|FG002|Overall Study|Withdrawal by Subject|0|||
162812268|NCT00985166|588025348|FG000|Overall Study|Test not done|2|||
162812269|NCT00985166|588025349|FG001|Overall Study|Test not done|0|||
162812270|NCT00985166|588025350|FG002|Overall Study|Test not done|4|||
162812271|NCT00985166|588025348|FG000|Overall Study|Other|1|||
162812272|NCT00985166|588025349|FG001|Overall Study|Other|0|||
162812273|NCT00985166|588025350|FG002|Overall Study|Other|1|||
162812274|NCT00300781|588025351|FG000|Overall Study|Disease Progression|55|||
162812275|NCT00300781|588025352|FG001|Overall Study|Disease Progression|52|||
162812276|NCT00300781|588025351|FG000|Overall Study|Adverse Event|5|||
162812277|NCT00300781|588025352|FG001|Overall Study|Adverse Event|6|||
162812278|NCT00300781|588025351|FG000|Overall Study|Withdrawal by Subject|1|||
162812279|NCT00300781|588025352|FG001|Overall Study|Withdrawal by Subject|2|||
162812280|NCT00300781|588025351|FG000|Overall Study|Physician Decision|1|||
162812281|NCT00300781|588025352|FG001|Overall Study|Physician Decision|0|||
162812282|NCT00300781|588025351|FG000|Overall Study|Not Recorded|0|||
162812283|NCT00300781|588025352|FG001|Overall Study|Not Recorded|1|||
162812284|NCT00300781|588025351|FG000|Overall Study|Symptomatic Deterioration|1|||
162812285|NCT00300781|588025352|FG001|Overall Study|Symptomatic Deterioration|0|||
162812286|NCT00300781|588025351|FG000|Overall Study|Lost to Follow-up|0|||
162812287|NCT00300781|588025352|FG001|Overall Study|Lost to Follow-up|1|||
162812288|NCT00567268|588025353|FG000|Overall Study|Protocol Violation|7|||
162812289|NCT00567268|588025353|FG000|Overall Study|Lost to Follow-up|36|||
162812290|NCT00567268|588025353|FG000|Overall Study|No Visit After First Day of Treatment|2|||
162812291|NCT00567268|588025353|FG000|Overall Study|No Drug Administration|4|||
162812292|NCT00567268|588025353|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
162812293|NCT02525861|588025354|FG000|Overall Study|Adverse Event|1|||
162812294|NCT02525861|588025355|FG001|Overall Study|Adverse Event|0|||
162812295|NCT02525861|588025354|FG000|Overall Study|Withdrawal by Subject|0|||
162812296|NCT02525861|588025355|FG001|Overall Study|Withdrawal by Subject|1|||
162812297|NCT02525861|588025354|FG000|Overall Study|Physician Decision|0|||
162812298|NCT02525861|588025355|FG001|Overall Study|Physician Decision|1|||
162812299|NCT01607554|588025359|FG000|Overall Study|Disease progression|2|||
162812300|NCT05580588|588025360|FG000|Overall Study|Lack of Efficacy|12|||
162812301|NCT00756470|588025363|FG000|Overall Study|Withdrawal by Subject|1|||
162812302|NCT00756470|588025363|FG000|Overall Study|Adverse Event|4|||
162812303|NCT01079741|588025369|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162812304|NCT01079741|588025370|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
162812305|NCT01079741|588025371|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163161617|NCT03682770|589305816|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162812306|NCT01079741|588025372|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162812307|NCT01079741|588025373|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162812308|NCT01079741|588025369|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162812309|NCT01079741|588025370|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162812310|NCT01079741|588025371|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162812311|NCT01079741|588025372|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162812312|NCT01079741|588025373|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
162812313|NCT00511472|588025374|FG000|Overall Study|Clinical Adverse Event|1|||
162812314|NCT00511472|588025375|FG001|Overall Study|Clinical Adverse Event|2|||
162812315|NCT00511472|588025374|FG000|Overall Study|Laboratory Adverse Event|0|||
162812316|NCT00511472|588025375|FG001|Overall Study|Laboratory Adverse Event|2|||
162812317|NCT00511472|588025374|FG000|Overall Study|Not reported|2|||
162812318|NCT00511472|588025375|FG001|Overall Study|Not reported|2|||
162812319|NCT00446992|588025376|FG000|Overall Study|Adverse Event|11|||
162812320|NCT00446992|588025376|FG000|Overall Study|Lost to Follow-up|5|||
162812321|NCT00406653|588025377|FG000|Induction Period|Adverse Event|1|||
162812322|NCT00406653|588025378|FG001|Induction Period|Adverse Event|10|||
162812323|NCT00406653|588025379|FG002|Induction Period|Adverse Event|4|||
162812324|NCT00406653|588025380|FG003|Induction Period|Adverse Event|11|||
162812325|NCT00406653|588025381|FG004|Induction Period|Adverse Event|0|||
162812326|NCT00406653|588025382|FG005|Induction Period|Adverse Event|0|||
162812327|NCT00406653|588025383|FG006|Induction Period|Adverse Event|0|||
162812328|NCT00406653|588025377|FG000|Induction Period|Lack of Efficacy|11|||
162812329|NCT00406653|588025378|FG001|Induction Period|Lack of Efficacy|14|||
162812330|NCT00406653|588025379|FG002|Induction Period|Lack of Efficacy|8|||
162812331|NCT00406653|588025380|FG003|Induction Period|Lack of Efficacy|10|||
162812332|NCT00406653|588025381|FG004|Induction Period|Lack of Efficacy|0|||
162812333|NCT00406653|588025382|FG005|Induction Period|Lack of Efficacy|0|||
162812334|NCT00406653|588025383|FG006|Induction Period|Lack of Efficacy|0|||
162812335|NCT00406653|588025377|FG000|Induction Period|Lost to Follow-up|0|||
162812336|NCT00406653|588025378|FG001|Induction Period|Lost to Follow-up|2|||
162812337|NCT00406653|588025379|FG002|Induction Period|Lost to Follow-up|0|||
162812338|NCT00406653|588025380|FG003|Induction Period|Lost to Follow-up|0|||
162812339|NCT00406653|588025381|FG004|Induction Period|Lost to Follow-up|0|||
162812340|NCT00406653|588025382|FG005|Induction Period|Lost to Follow-up|0|||
162812341|NCT00406653|588025383|FG006|Induction Period|Lost to Follow-up|0|||
162812342|NCT00406653|588025377|FG000|Induction Period|Withdrawal of Consent|2|||
162812343|NCT00406653|588025378|FG001|Induction Period|Withdrawal of Consent|5|||
162812344|NCT00406653|588025379|FG002|Induction Period|Withdrawal of Consent|1|||
162812345|NCT00406653|588025380|FG003|Induction Period|Withdrawal of Consent|2|||
162812346|NCT00406653|588025381|FG004|Induction Period|Withdrawal of Consent|0|||
162812347|NCT00406653|588025382|FG005|Induction Period|Withdrawal of Consent|0|||
162812348|NCT00406653|588025383|FG006|Induction Period|Withdrawal of Consent|0|||
162812349|NCT00406653|588025377|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812350|NCT00406653|588025378|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812351|NCT00406653|588025379|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812352|NCT00406653|588025380|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
162812353|NCT00406653|588025381|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812354|NCT00406653|588025382|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812355|NCT00406653|588025383|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
162812356|NCT00406653|588025377|FG000|Induction Period|Pregnancy|1|||
162812357|NCT00406653|588025378|FG001|Induction Period|Pregnancy|0|||
162812358|NCT00406653|588025379|FG002|Induction Period|Pregnancy|0|||
162812359|NCT00406653|588025380|FG003|Induction Period|Pregnancy|0|||
162812360|NCT00406653|588025381|FG004|Induction Period|Pregnancy|0|||
162812361|NCT00406653|588025382|FG005|Induction Period|Pregnancy|0|||
162812362|NCT00406653|588025383|FG006|Induction Period|Pregnancy|0|||
162812363|NCT00406653|588025377|FG000|Induction Period|Declined participation but followup done|0|||
162812364|NCT00406653|588025378|FG001|Induction Period|Declined participation but followup done|2|||
162812365|NCT00406653|588025379|FG002|Induction Period|Declined participation but followup done|1|||
162812366|NCT00406653|588025380|FG003|Induction Period|Declined participation but followup done|1|||
162812367|NCT00406653|588025381|FG004|Induction Period|Declined participation but followup done|0|||
162812368|NCT00406653|588025382|FG005|Induction Period|Declined participation but followup done|0|||
162812369|NCT00406653|588025383|FG006|Induction Period|Declined participation but followup done|0|||
162812370|NCT00406653|588025377|FG000|Induction Period|Given prohibited drug|0|||
162812371|NCT00406653|588025378|FG001|Induction Period|Given prohibited drug|1|||
162812372|NCT00406653|588025379|FG002|Induction Period|Given prohibited drug|2|||
162812373|NCT00406653|588025380|FG003|Induction Period|Given prohibited drug|0|||
162812374|NCT00406653|588025381|FG004|Induction Period|Given prohibited drug|0|||
162812375|NCT00406653|588025382|FG005|Induction Period|Given prohibited drug|0|||
162812376|NCT00406653|588025383|FG006|Induction Period|Given prohibited drug|0|||
162812377|NCT00406653|588025377|FG000|Induction Period|Incarcerated|0|||
162812378|NCT00406653|588025378|FG001|Induction Period|Incarcerated|0|||
162812379|NCT00406653|588025379|FG002|Induction Period|Incarcerated|1|||
162812380|NCT00406653|588025380|FG003|Induction Period|Incarcerated|0|||
162812381|NCT00406653|588025381|FG004|Induction Period|Incarcerated|0|||
162812382|NCT00406653|588025382|FG005|Induction Period|Incarcerated|0|||
162812383|NCT00406653|588025383|FG006|Induction Period|Incarcerated|0|||
162812384|NCT00406653|588025377|FG000|Induction Period|Patient relocated|0|||
162812385|NCT00406653|588025378|FG001|Induction Period|Patient relocated|0|||
162812386|NCT00406653|588025379|FG002|Induction Period|Patient relocated|1|||
162812387|NCT00406653|588025380|FG003|Induction Period|Patient relocated|0|||
162812388|NCT00406653|588025381|FG004|Induction Period|Patient relocated|0|||
162812389|NCT00406653|588025382|FG005|Induction Period|Patient relocated|0|||
162812390|NCT00406653|588025383|FG006|Induction Period|Patient relocated|0|||
162812391|NCT00406653|588025377|FG000|Maintenance Period|Adverse Event|0|||
162812392|NCT00406653|588025378|FG001|Maintenance Period|Adverse Event|0|||
162812393|NCT00406653|588025379|FG002|Maintenance Period|Adverse Event|0|||
162812394|NCT00406653|588025380|FG003|Maintenance Period|Adverse Event|0|||
163161618|NCT03682770|589305817|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
163161619|NCT03682770|589305818|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161620|NCT03682770|589305819|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161621|NCT03682770|589305820|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
163161622|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161623|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161624|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
163161625|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
162812395|NCT00406653|588025381|FG004|Maintenance Period|Adverse Event|1|||
162812396|NCT00406653|588025382|FG005|Maintenance Period|Adverse Event|1|||
162812397|NCT00406653|588025383|FG006|Maintenance Period|Adverse Event|0|||
162812398|NCT00406653|588025377|FG000|Maintenance Period|Lack of Efficacy|0|||
162812399|NCT00406653|588025378|FG001|Maintenance Period|Lack of Efficacy|0|||
162812400|NCT00406653|588025379|FG002|Maintenance Period|Lack of Efficacy|0|||
162812401|NCT00406653|588025380|FG003|Maintenance Period|Lack of Efficacy|0|||
162812402|NCT00406653|588025381|FG004|Maintenance Period|Lack of Efficacy|20|||
162812403|NCT00406653|588025382|FG005|Maintenance Period|Lack of Efficacy|26|||
163161626|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
163161627|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
163161628|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
163161629|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162812404|NCT00406653|588025383|FG006|Maintenance Period|Lack of Efficacy|0|||
162812405|NCT00406653|588025377|FG000|Maintenance Period|Lost to Follow-up|0|||
162812406|NCT00406653|588025378|FG001|Maintenance Period|Lost to Follow-up|0|||
162812407|NCT00406653|588025379|FG002|Maintenance Period|Lost to Follow-up|0|||
162812408|NCT00406653|588025380|FG003|Maintenance Period|Lost to Follow-up|0|||
162812409|NCT00406653|588025381|FG004|Maintenance Period|Lost to Follow-up|2|||
162812410|NCT00406653|588025382|FG005|Maintenance Period|Lost to Follow-up|1|||
162812411|NCT00406653|588025383|FG006|Maintenance Period|Lost to Follow-up|0|||
162812412|NCT00406653|588025377|FG000|Maintenance Period|Withdrawal of Consent|0|||
162812413|NCT00406653|588025378|FG001|Maintenance Period|Withdrawal of Consent|0|||
162812414|NCT00406653|588025379|FG002|Maintenance Period|Withdrawal of Consent|0|||
162812415|NCT00406653|588025380|FG003|Maintenance Period|Withdrawal of Consent|0|||
162812416|NCT00406653|588025381|FG004|Maintenance Period|Withdrawal of Consent|2|||
162812417|NCT00406653|588025382|FG005|Maintenance Period|Withdrawal of Consent|0|||
162812418|NCT00406653|588025383|FG006|Maintenance Period|Withdrawal of Consent|0|||
162812419|NCT00406653|588025377|FG000|Maintenance Period|Pregnancy|0|||
162812420|NCT00406653|588025378|FG001|Maintenance Period|Pregnancy|0|||
162812421|NCT00406653|588025379|FG002|Maintenance Period|Pregnancy|0|||
162812422|NCT00406653|588025380|FG003|Maintenance Period|Pregnancy|0|||
162812423|NCT00406653|588025381|FG004|Maintenance Period|Pregnancy|0|||
162812424|NCT00406653|588025382|FG005|Maintenance Period|Pregnancy|1|||
162812425|NCT00406653|588025383|FG006|Maintenance Period|Pregnancy|0|||
162812426|NCT00406653|588025377|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
162812427|NCT00406653|588025378|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
162812428|NCT00406653|588025379|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
162812429|NCT00406653|588025380|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
162812430|NCT00406653|588025381|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
162812431|NCT00406653|588025382|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
162812432|NCT00406653|588025383|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
162812433|NCT00406653|588025377|FG000|Maintenance Period|Error in disease score evaluation|0|||
163161630|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161631|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161632|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161633|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
162812434|NCT00406653|588025378|FG001|Maintenance Period|Error in disease score evaluation|0|||
162812435|NCT00406653|588025379|FG002|Maintenance Period|Error in disease score evaluation|0|||
162812436|NCT00406653|588025380|FG003|Maintenance Period|Error in disease score evaluation|0|||
162812437|NCT00406653|588025381|FG004|Maintenance Period|Error in disease score evaluation|1|||
162812438|NCT00406653|588025382|FG005|Maintenance Period|Error in disease score evaluation|0|||
162812439|NCT00406653|588025383|FG006|Maintenance Period|Error in disease score evaluation|0|||
162812440|NCT00406653|588025377|FG000|Open-Label Period|Death|0|||
162812441|NCT00406653|588025378|FG001|Open-Label Period|Death|0|||
162812442|NCT00406653|588025379|FG002|Open-Label Period|Death|0|||
162812443|NCT00406653|588025380|FG003|Open-Label Period|Death|0|||
162812444|NCT00406653|588025381|FG004|Open-Label Period|Death|0|||
162812445|NCT00406653|588025382|FG005|Open-Label Period|Death|0|||
162812446|NCT00406653|588025383|FG006|Open-Label Period|Death|1|||
162812447|NCT00406653|588025377|FG000|Open-Label Period|Adverse Event|0|||
162812448|NCT00406653|588025378|FG001|Open-Label Period|Adverse Event|0|||
162812449|NCT00406653|588025379|FG002|Open-Label Period|Adverse Event|0|||
162812450|NCT00406653|588025380|FG003|Open-Label Period|Adverse Event|0|||
162812451|NCT00406653|588025381|FG004|Open-Label Period|Adverse Event|0|||
162812452|NCT00406653|588025382|FG005|Open-Label Period|Adverse Event|0|||
162812453|NCT00406653|588025383|FG006|Open-Label Period|Adverse Event|18|||
162812454|NCT00406653|588025377|FG000|Open-Label Period|Lack of Efficacy|0|||
162812455|NCT00406653|588025378|FG001|Open-Label Period|Lack of Efficacy|0|||
162812456|NCT00406653|588025379|FG002|Open-Label Period|Lack of Efficacy|0|||
162812457|NCT00406653|588025380|FG003|Open-Label Period|Lack of Efficacy|0|||
162812458|NCT00406653|588025381|FG004|Open-Label Period|Lack of Efficacy|0|||
162812459|NCT00406653|588025382|FG005|Open-Label Period|Lack of Efficacy|0|||
162812460|NCT00406653|588025383|FG006|Open-Label Period|Lack of Efficacy|160|||
162812461|NCT00406653|588025377|FG000|Open-Label Period|Lost to Follow-up|0|||
162812462|NCT00406653|588025378|FG001|Open-Label Period|Lost to Follow-up|0|||
162812463|NCT00406653|588025379|FG002|Open-Label Period|Lost to Follow-up|0|||
162812464|NCT00406653|588025380|FG003|Open-Label Period|Lost to Follow-up|0|||
162812465|NCT00406653|588025381|FG004|Open-Label Period|Lost to Follow-up|0|||
162812466|NCT00406653|588025382|FG005|Open-Label Period|Lost to Follow-up|0|||
162812467|NCT00406653|588025383|FG006|Open-Label Period|Lost to Follow-up|6|||
162812468|NCT00406653|588025377|FG000|Open-Label Period|Withdrawal of Consent|0|||
162812469|NCT00406653|588025378|FG001|Open-Label Period|Withdrawal of Consent|0|||
162812470|NCT00406653|588025379|FG002|Open-Label Period|Withdrawal of Consent|0|||
162812471|NCT00406653|588025380|FG003|Open-Label Period|Withdrawal of Consent|0|||
162812472|NCT00406653|588025381|FG004|Open-Label Period|Withdrawal of Consent|0|||
162812473|NCT00406653|588025382|FG005|Open-Label Period|Withdrawal of Consent|0|||
162812474|NCT00406653|588025383|FG006|Open-Label Period|Withdrawal of Consent|11|||
162812475|NCT00406653|588025377|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812476|NCT00406653|588025378|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812477|NCT00406653|588025379|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812478|NCT00406653|588025380|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812479|NCT00406653|588025381|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812480|NCT00406653|588025382|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162812481|NCT00406653|588025383|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
162812482|NCT00406653|588025377|FG000|Open-Label Period|Pregnancy|0|||
162812483|NCT00406653|588025378|FG001|Open-Label Period|Pregnancy|0|||
162812484|NCT00406653|588025379|FG002|Open-Label Period|Pregnancy|0|||
162812485|NCT00406653|588025380|FG003|Open-Label Period|Pregnancy|0|||
162812486|NCT00406653|588025381|FG004|Open-Label Period|Pregnancy|0|||
162812487|NCT00406653|588025382|FG005|Open-Label Period|Pregnancy|0|||
162812488|NCT00406653|588025383|FG006|Open-Label Period|Pregnancy|2|||
162812489|NCT00406653|588025377|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
162812490|NCT00406653|588025378|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
162812491|NCT00406653|588025379|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
162812492|NCT00406653|588025380|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
162812493|NCT00406653|588025381|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
162812494|NCT00406653|588025382|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
162812495|NCT00406653|588025383|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
162812496|NCT00406653|588025377|FG000|Open-Label Period|Declined participation but followup done|0|||
162812497|NCT00406653|588025378|FG001|Open-Label Period|Declined participation but followup done|0|||
162812498|NCT00406653|588025379|FG002|Open-Label Period|Declined participation but followup done|0|||
162812499|NCT00406653|588025380|FG003|Open-Label Period|Declined participation but followup done|0|||
162812500|NCT00406653|588025381|FG004|Open-Label Period|Declined participation but followup done|0|||
162812501|NCT00406653|588025382|FG005|Open-Label Period|Declined participation but followup done|0|||
162812502|NCT00406653|588025383|FG006|Open-Label Period|Declined participation but followup done|8|||
162812503|NCT00406653|588025377|FG000|Open-Label Period|Discontinued by Sponsor|0|||
162812504|NCT00406653|588025378|FG001|Open-Label Period|Discontinued by Sponsor|0|||
162812505|NCT00406653|588025379|FG002|Open-Label Period|Discontinued by Sponsor|0|||
162812506|NCT00406653|588025380|FG003|Open-Label Period|Discontinued by Sponsor|0|||
162812507|NCT00406653|588025381|FG004|Open-Label Period|Discontinued by Sponsor|0|||
163161634|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
163161635|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162812508|NCT00406653|588025382|FG005|Open-Label Period|Discontinued by Sponsor|0|||
162812509|NCT00406653|588025383|FG006|Open-Label Period|Discontinued by Sponsor|1|||
162812510|NCT00406653|588025377|FG000|Open-Label Period|Refused followup|0|||
162812511|NCT00406653|588025378|FG001|Open-Label Period|Refused followup|0|||
162812512|NCT00406653|588025379|FG002|Open-Label Period|Refused followup|0|||
162812513|NCT00406653|588025380|FG003|Open-Label Period|Refused followup|0|||
163161636|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162812514|NCT00406653|588025381|FG004|Open-Label Period|Refused followup|0|||
162812515|NCT00406653|588025382|FG005|Open-Label Period|Refused followup|0|||
162812516|NCT00406653|588025383|FG006|Open-Label Period|Refused followup|1|||
162812517|NCT00731120|588025384|FG000|Overall Study|Adverse Event|7|||
162812518|NCT00731120|588025385|FG001|Overall Study|Adverse Event|6|||
162812519|NCT00731120|588025386|FG002|Overall Study|Adverse Event|8|||
162812520|NCT00731120|588025384|FG000|Overall Study|Lack of Efficacy|4|||
162812521|NCT00731120|588025385|FG001|Overall Study|Lack of Efficacy|5|||
162812522|NCT00731120|588025386|FG002|Overall Study|Lack of Efficacy|4|||
162812523|NCT00731120|588025384|FG000|Overall Study|Noncompliance with Study Drug|3|||
162812524|NCT00731120|588025385|FG001|Overall Study|Noncompliance with Study Drug|3|||
162812525|NCT00731120|588025386|FG002|Overall Study|Noncompliance with Study Drug|1|||
162812526|NCT00731120|588025384|FG000|Overall Study|Protocol Deviations|1|||
162812527|NCT00731120|588025385|FG001|Overall Study|Protocol Deviations|6|||
162812528|NCT00731120|588025386|FG002|Overall Study|Protocol Deviations|1|||
162812529|NCT00731120|588025384|FG000|Overall Study|Withdrawal of Consent|13|||
162812530|NCT00731120|588025385|FG001|Overall Study|Withdrawal of Consent|8|||
162812531|NCT00731120|588025386|FG002|Overall Study|Withdrawal of Consent|4|||
162812532|NCT00731120|588025384|FG000|Overall Study|Lost to Follow-up|10|||
162812533|NCT00731120|588025385|FG001|Overall Study|Lost to Follow-up|15|||
162812534|NCT00731120|588025386|FG002|Overall Study|Lost to Follow-up|17|||
162812535|NCT00731120|588025384|FG000|Overall Study|Other|4|||
162812536|NCT00731120|588025385|FG001|Overall Study|Other|0|||
162812537|NCT00731120|588025386|FG002|Overall Study|Other|1|||
162812538|NCT02434939|588025393|FG000|Overall Study|Lack of Efficacy|34|||
162812539|NCT02434939|588025394|FG001|Overall Study|Lack of Efficacy|48|||
162812540|NCT02434939|588025393|FG000|Overall Study|Withdrawal by Subject|3|||
162812541|NCT02434939|588025394|FG001|Overall Study|Withdrawal by Subject|0|||
162812542|NCT02434939|588025393|FG000|Overall Study|Adverse Event|0|||
162812543|NCT02434939|588025394|FG001|Overall Study|Adverse Event|1|||
162812544|NCT01326533|588025399|FG000|Overall Study|Lost to Follow-up|2|||
162812545|NCT01326533|588025400|FG001|Overall Study|Lost to Follow-up|0|||
162812546|NCT01326533|588025399|FG000|Overall Study|Withdrawal by Subject|1|||
162812547|NCT01326533|588025400|FG001|Overall Study|Withdrawal by Subject|0|||
162812548|NCT01326533|588025399|FG000|Overall Study|Adverse Event|1|||
162812549|NCT01326533|588025400|FG001|Overall Study|Adverse Event|0|||
162812550|NCT04079803|588025401|FG000|Overall Study|Withdrawal by Subject|0|||
162812551|NCT04079803|588025402|FG001|Overall Study|Withdrawal by Subject|0|||
162812552|NCT04079803|588025403|FG002|Overall Study|Withdrawal by Subject|1|||
162812553|NCT03353350|588025404|FG000|30-week Core Treatment Period|Protocol Violation|1|||
162812554|NCT03353350|588025405|FG001|30-week Core Treatment Period|Protocol Violation|1|||
162812555|NCT03353350|588025406|FG002|30-week Core Treatment Period|Protocol Violation|1|||
162812556|NCT03353350|588025407|FG003|30-week Core Treatment Period|Protocol Violation|0|||
162812557|NCT03353350|588025404|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162812558|NCT03353350|588025405|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162812559|NCT03353350|588025406|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162812560|NCT03353350|588025407|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
162812561|NCT03353350|588025404|FG000|30-week Core Treatment Period|Adverse Event|0|||
162812562|NCT03353350|588025405|FG001|30-week Core Treatment Period|Adverse Event|4|||
162812563|NCT03353350|588025406|FG002|30-week Core Treatment Period|Adverse Event|2|||
162812564|NCT03353350|588025407|FG003|30-week Core Treatment Period|Adverse Event|3|||
162812565|NCT03353350|588025404|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
162812566|NCT03353350|588025405|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
162812567|NCT03353350|588025406|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
162812568|NCT03353350|588025407|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
162812569|NCT03353350|588025404|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
162812570|NCT03353350|588025405|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
162812571|NCT03353350|588025406|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
162812572|NCT03353350|588025407|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
162812573|NCT03353350|588025404|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
162812574|NCT03353350|588025405|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
162812575|NCT03353350|588025406|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
162812576|NCT03353350|588025407|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
162812577|NCT03353350|588025404|FG000|26-week Treatment Extension Period|Adverse Event|1|||
162812578|NCT03353350|588025405|FG001|26-week Treatment Extension Period|Adverse Event|0|||
162812579|NCT03353350|588025406|FG002|26-week Treatment Extension Period|Adverse Event|0|||
163161637|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161638|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161639|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162812580|NCT03353350|588025407|FG003|26-week Treatment Extension Period|Adverse Event|1|||
162812581|NCT03353350|588025404|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
162812582|NCT03353350|588025405|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
162812583|NCT03353350|588025406|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
162812584|NCT03353350|588025407|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
162812585|NCT00985153|588025412|FG000|Overall Study|Lost to Follow-up|16|||
162812586|NCT00985153|588025413|FG001|Overall Study|Lost to Follow-up|19|||
162812587|NCT00985153|588025414|FG002|Overall Study|Lost to Follow-up|17|||
162812588|NCT00985153|588025415|FG003|Overall Study|Lost to Follow-up|20|||
162812589|NCT00985153|588025412|FG000|Overall Study|Protocol Violation|3|||
162812590|NCT00985153|588025413|FG001|Overall Study|Protocol Violation|2|||
162812591|NCT00985153|588025414|FG002|Overall Study|Protocol Violation|4|||
162812592|NCT00985153|588025415|FG003|Overall Study|Protocol Violation|3|||
162812593|NCT00985153|588025412|FG000|Overall Study|Withdrawal by Subject|6|||
162812594|NCT00985153|588025413|FG001|Overall Study|Withdrawal by Subject|11|||
162812595|NCT00985153|588025414|FG002|Overall Study|Withdrawal by Subject|11|||
162812596|NCT00985153|588025415|FG003|Overall Study|Withdrawal by Subject|10|||
162812597|NCT00985153|588025412|FG000|Overall Study|Missed One or More Bleeds|7|||
162812598|NCT00985153|588025413|FG001|Overall Study|Missed One or More Bleeds|7|||
162812599|NCT00985153|588025414|FG002|Overall Study|Missed One or More Bleeds|8|||
162812600|NCT00985153|588025415|FG003|Overall Study|Missed One or More Bleeds|10|||
162812601|NCT00985153|588025412|FG000|Overall Study|Incomplete Safety Follow-up|3|||
162812602|NCT00985153|588025413|FG001|Overall Study|Incomplete Safety Follow-up|5|||
162812603|NCT00985153|588025414|FG002|Overall Study|Incomplete Safety Follow-up|4|||
162812604|NCT00985153|588025415|FG003|Overall Study|Incomplete Safety Follow-up|4|||
162812605|NCT01679405|588025416|FG000|Overall Study|Death|2|||
162812606|NCT01679405|588025417|FG001|Overall Study|Death|5|||
162812607|NCT01536015|588025418|FG000|Overall Study|Adverse Event|1|||
162812608|NCT01536015|588025419|FG001|Overall Study|Adverse Event|4|||
162812609|NCT01536015|588025418|FG000|Overall Study|Lost to Follow-up|0|||
162812610|NCT01536015|588025419|FG001|Overall Study|Lost to Follow-up|1|||
162812611|NCT01536015|588025418|FG000|Overall Study|Inclusion Criterion not met|2|||
162812612|NCT01536015|588025419|FG001|Overall Study|Inclusion Criterion not met|0|||
162812613|NCT01536015|588025418|FG000|Overall Study|Study closure|5|||
162812614|NCT01536015|588025419|FG001|Overall Study|Study closure|5|||
162812615|NCT01668667|588025422|FG000|Overall Study|Adverse Event|3|||
162812616|NCT01668667|588025423|FG001|Overall Study|Adverse Event|6|||
162812617|NCT01668667|588025424|FG002|Overall Study|Adverse Event|4|||
162812618|NCT01668667|588025425|FG003|Overall Study|Adverse Event|4|||
162812619|NCT01668667|588025422|FG000|Overall Study|Lack of Efficacy|3|||
162812620|NCT01668667|588025423|FG001|Overall Study|Lack of Efficacy|2|||
162812621|NCT01668667|588025424|FG002|Overall Study|Lack of Efficacy|2|||
162812622|NCT01668667|588025425|FG003|Overall Study|Lack of Efficacy|3|||
162812623|NCT01668667|588025422|FG000|Overall Study|Protocol Violation|6|||
162812624|NCT01668667|588025423|FG001|Overall Study|Protocol Violation|10|||
162812625|NCT01668667|588025424|FG002|Overall Study|Protocol Violation|12|||
162812626|NCT01668667|588025425|FG003|Overall Study|Protocol Violation|5|||
162812627|NCT01668667|588025422|FG000|Overall Study|Lost to Follow-up|9|||
162812628|NCT01668667|588025423|FG001|Overall Study|Lost to Follow-up|4|||
162812629|NCT01668667|588025424|FG002|Overall Study|Lost to Follow-up|7|||
162812630|NCT01668667|588025425|FG003|Overall Study|Lost to Follow-up|6|||
162812631|NCT01668667|588025422|FG000|Overall Study|Physician Decision|3|||
162812632|NCT01668667|588025423|FG001|Overall Study|Physician Decision|0|||
162812633|NCT01668667|588025424|FG002|Overall Study|Physician Decision|1|||
162812634|NCT01668667|588025425|FG003|Overall Study|Physician Decision|0|||
162812635|NCT01668667|588025422|FG000|Overall Study|Withdrawal by Subject|7|||
162812636|NCT01668667|588025423|FG001|Overall Study|Withdrawal by Subject|4|||
162812637|NCT01668667|588025424|FG002|Overall Study|Withdrawal by Subject|5|||
162812638|NCT01668667|588025425|FG003|Overall Study|Withdrawal by Subject|5|||
162812639|NCT02988622|588025426|FG000|Overall Study|Lost to Follow-up|17|||
162812640|NCT01204398|588025427|FG000|Overall Study|Adverse Event|1|||
162812641|NCT03261700|588025428|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
162812642|NCT03261700|588025429|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
162812643|NCT04640077|588025432|FG000|Period 1|Withdrawal by Subject|4|||
162812644|NCT04640077|588025433|FG001|Period 1|Withdrawal by Subject|5|||
162812645|NCT04640077|588025434|FG002|Period 1|Withdrawal by Subject|0|||
162812646|NCT04640077|588025432|FG000|Period 1|Adverse Event|1|||
162812647|NCT04640077|588025433|FG001|Period 1|Adverse Event|1|||
162812648|NCT04640077|588025434|FG002|Period 1|Adverse Event|0|||
162812649|NCT04640077|588025432|FG000|Period 1|Screen Failure|2|||
163161640|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
163161641|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
162812650|NCT04640077|588025433|FG001|Period 1|Screen Failure|0|||
162812651|NCT04640077|588025434|FG002|Period 1|Screen Failure|0|||
162812652|NCT04640077|588025432|FG000|Period 2|Withdrawal by Subject|0|||
162812653|NCT04640077|588025433|FG001|Period 2|Withdrawal by Subject|0|||
162812654|NCT04640077|588025434|FG002|Period 2|Withdrawal by Subject|18|||
162812655|NCT04640077|588025432|FG000|Period 2|Adverse Event|0|||
162812656|NCT04640077|588025433|FG001|Period 2|Adverse Event|0|||
162812657|NCT04640077|588025434|FG002|Period 2|Adverse Event|6|||
162812658|NCT04640077|588025432|FG000|Period 2|Lost to Follow-up|0|||
162812659|NCT04640077|588025433|FG001|Period 2|Lost to Follow-up|0|||
162812660|NCT04640077|588025434|FG002|Period 2|Lost to Follow-up|2|||
162812661|NCT04640077|588025432|FG000|Period 2|Death|0|||
162812662|NCT04640077|588025433|FG001|Period 2|Death|0|||
162812663|NCT04640077|588025434|FG002|Period 2|Death|2|||
162812664|NCT04640077|588025432|FG000|Period 2|Progressive Disease|0|||
162812665|NCT04640077|588025433|FG001|Period 2|Progressive Disease|0|||
163161642|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162812666|NCT04640077|588025434|FG002|Period 2|Progressive Disease|1|||
162812667|NCT04640077|588025432|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
162812668|NCT04640077|588025433|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
162812669|NCT04640077|588025434|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
162812670|NCT02041520|588025436|FG000|Overall Study|Adverse Event|2|||
162812671|NCT02041520|588025437|FG001|Overall Study|Adverse Event|1|||
162812672|NCT02041520|588025436|FG000|Overall Study|Withdrawal by Subject|3|||
162812673|NCT02041520|588025437|FG001|Overall Study|Withdrawal by Subject|4|||
162812674|NCT02041520|588025436|FG000|Overall Study|Protocol Violation|1|||
162812675|NCT02041520|588025437|FG001|Overall Study|Protocol Violation|0|||
162812676|NCT02041520|588025436|FG000|Overall Study|Lost to Follow-up|0|||
162812677|NCT02041520|588025437|FG001|Overall Study|Lost to Follow-up|1|||
162812678|NCT02041520|588025436|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
162812679|NCT02041520|588025437|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
162812680|NCT00413972|588025438|FG000|Overall Study|Adverse Event|2|||
162812681|NCT00413972|588025439|FG001|Overall Study|Adverse Event|1|||
162812682|NCT00413972|588025440|FG002|Overall Study|Adverse Event|0|||
162812683|NCT00413972|588025441|FG003|Overall Study|Adverse Event|0|||
162812684|NCT00413972|588025438|FG000|Overall Study|Lost to Follow-up|1|||
162812685|NCT00413972|588025439|FG001|Overall Study|Lost to Follow-up|2|||
162812686|NCT00413972|588025440|FG002|Overall Study|Lost to Follow-up|1|||
162812687|NCT00413972|588025441|FG003|Overall Study|Lost to Follow-up|0|||
162812688|NCT00413972|588025438|FG000|Overall Study|Withdrawal by Subject|4|||
162812689|NCT00413972|588025439|FG001|Overall Study|Withdrawal by Subject|5|||
162812690|NCT00413972|588025440|FG002|Overall Study|Withdrawal by Subject|7|||
162812691|NCT00413972|588025441|FG003|Overall Study|Withdrawal by Subject|2|||
162812692|NCT00413972|588025438|FG000|Overall Study|Protocol Violation|0|||
162812693|NCT00413972|588025439|FG001|Overall Study|Protocol Violation|0|||
162812694|NCT00413972|588025440|FG002|Overall Study|Protocol Violation|2|||
162812695|NCT00413972|588025441|FG003|Overall Study|Protocol Violation|0|||
162812696|NCT00413972|588025438|FG000|Overall Study|Other|0|||
162812697|NCT00413972|588025439|FG001|Overall Study|Other|0|||
162812698|NCT00413972|588025440|FG002|Overall Study|Other|0|||
162812699|NCT00413972|588025441|FG003|Overall Study|Other|1|||
162812700|NCT00427895|588025444|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812701|NCT00427895|588025445|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812702|NCT00427895|588025446|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812703|NCT00427895|588025447|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
162812704|NCT00427895|588025448|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812705|NCT00427895|588025449|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812706|NCT00427895|588025450|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812707|NCT00427895|588025451|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162812708|NCT00427895|588025444|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812709|NCT00427895|588025445|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812710|NCT00427895|588025446|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812711|NCT00427895|588025447|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812712|NCT00427895|588025448|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812713|NCT00427895|588025449|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812714|NCT00427895|588025450|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162812715|NCT00427895|588025451|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
162812716|NCT00427895|588025444|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812717|NCT00427895|588025445|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812718|NCT00427895|588025446|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812719|NCT00427895|588025447|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812720|NCT00427895|588025448|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812721|NCT00427895|588025449|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812722|NCT00427895|588025450|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
162812723|NCT00427895|588025451|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
163161643|NCT03682770|589305814|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162812724|NCT00427895|588025444|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
162812725|NCT00427895|588025445|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
162812726|NCT00427895|588025446|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
162812727|NCT00427895|588025447|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
162812728|NCT00427895|588025448|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
162812729|NCT00427895|588025449|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
162812730|NCT00427895|588025450|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
162812731|NCT00427895|588025451|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
162812732|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162812733|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
162812734|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
162812735|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
162812736|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162812737|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162812738|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162812739|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162812740|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
162812741|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162812742|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
162812743|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
162812744|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162812745|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162812746|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162812747|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162812748|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
162812749|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
162812750|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812751|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812752|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812753|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812754|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812755|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162812756|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
162812757|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
162812758|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
162812759|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
162812760|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162812761|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162812762|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162812763|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162812764|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812765|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812766|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812767|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
162812768|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812769|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812770|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812771|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162812772|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
162812773|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
162812774|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
162812775|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
162812776|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162812777|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162812778|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162812779|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162812780|NCT00427895|588025444|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812781|NCT00427895|588025445|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812782|NCT00427895|588025446|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
162812783|NCT00427895|588025447|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
162812784|NCT00427895|588025448|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812785|NCT00427895|588025449|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812786|NCT00427895|588025450|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812787|NCT00427895|588025451|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162812788|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162812789|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
162812790|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
162812791|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
162812792|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162812793|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162812794|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162812795|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162812796|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
162812797|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
162812798|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162812799|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
162812800|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162812801|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162812802|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162812803|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162812804|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
162812805|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
162812806|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
162812807|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
162812808|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162812809|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162812810|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162812811|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162812812|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812813|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
162812814|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812815|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812816|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812817|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812818|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812819|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162812820|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Death|1|||
162812821|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Death|0|||
162812822|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Death|0|||
162812823|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Death|0|||
162812824|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Death|0|||
162812825|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Death|0|||
162812826|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Death|0|||
162812827|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Death|0|||
162812828|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812829|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812830|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
162812831|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
162812832|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812833|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812834|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812835|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162812836|NCT00427895|588025444|FG000|Vax 1/Year 1 Follow-up|Other|0|||
162812837|NCT00427895|588025445|FG001|Vax 1/Year 1 Follow-up|Other|0|||
162812838|NCT00427895|588025446|FG002|Vax 1/Year 1 Follow-up|Other|0|||
162812839|NCT00427895|588025447|FG003|Vax 1/Year 1 Follow-up|Other|2|||
162812840|NCT00427895|588025448|FG004|Vax 1/Year 1 Follow-up|Other|0|||
162812841|NCT00427895|588025449|FG005|Vax 1/Year 1 Follow-up|Other|0|||
162812842|NCT00427895|588025450|FG006|Vax 1/Year 1 Follow-up|Other|0|||
162812843|NCT00427895|588025451|FG007|Vax 1/Year 1 Follow-up|Other|0|||
162812844|NCT00427895|588025444|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
162812845|NCT00427895|588025445|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
162812846|NCT00427895|588025446|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
162812847|NCT00427895|588025447|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
162812848|NCT00427895|588025448|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162812849|NCT00427895|588025449|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162812850|NCT00427895|588025450|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162812851|NCT00427895|588025451|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162812852|NCT02796560|588025454|FG000|Overall Study|Adverse Event|2|||
162812853|NCT02796560|588025455|FG001|Overall Study|Adverse Event|0|||
162812854|NCT02796560|588025454|FG000|Overall Study|Withdrawal by Subject|2|||
162812855|NCT02796560|588025455|FG001|Overall Study|Withdrawal by Subject|2|||
162812856|NCT03816332|588025457|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
162812857|NCT03816332|588025457|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
162812858|NCT03534284|588025458|FG000|Overall Study|Death|2|||
162812859|NCT03534284|588025459|FG001|Overall Study|Death|3|||
162812860|NCT03534284|588025460|FG002|Overall Study|Death|3|||
162812861|NCT03534284|588025458|FG000|Overall Study|Withdrawal by Subject|5|||
162812862|NCT03534284|588025459|FG001|Overall Study|Withdrawal by Subject|0|||
162812863|NCT03534284|588025460|FG002|Overall Study|Withdrawal by Subject|0|||
162812864|NCT03316300|588025461|FG000|Overall Study|Withdrawal by Subject|3|||
162812865|NCT03316300|588025462|FG001|Overall Study|Withdrawal by Subject|2|||
162812866|NCT03316300|588025461|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
162812867|NCT03316300|588025462|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
162812868|NCT03316300|588025461|FG000|Overall Study|Adverse Event|1|||
162812869|NCT03316300|588025462|FG001|Overall Study|Adverse Event|0|||
162812870|NCT03316300|588025461|FG000|Overall Study|COVID-19|0|||
162812871|NCT03316300|588025462|FG001|Overall Study|COVID-19|1|||
162812872|NCT03164564|588025464|FG000|Overall Study|Death|3|||
162812873|NCT03164564|588025465|FG001|Overall Study|Death|0|||
162812874|NCT03164564|588025464|FG000|Overall Study|Withdrawal by Subject|20|||
162812875|NCT03164564|588025465|FG001|Overall Study|Withdrawal by Subject|15|||
162812876|NCT03164564|588025464|FG000|Overall Study|Lost to Follow-up|2|||
162812877|NCT03164564|588025465|FG001|Overall Study|Lost to Follow-up|0|||
162812878|NCT03164564|588025464|FG000|Overall Study|Physician Decision|0|||
162812879|NCT03164564|588025465|FG001|Overall Study|Physician Decision|1|||
162812880|NCT03164564|588025464|FG000|Overall Study|Adverse Event|0|||
162812881|NCT03164564|588025465|FG001|Overall Study|Adverse Event|1|||
162812882|NCT03164564|588025464|FG000|Overall Study|Ongoing|1586|||
162812883|NCT03164564|588025465|FG001|Overall Study|Ongoing|1586|||
162812884|NCT01910181|588025470|FG000|Overall Study|Death|37|||
162812885|NCT01910181|588025470|FG000|Overall Study|Lost to Follow-up|3|||
162812886|NCT01910181|588025470|FG000|Overall Study|Study Terminated by Sponsor|6|||
162812887|NCT03567434|588025474|FG000|Overall Study|Lost to Follow-up|1|||
162812888|NCT03567434|588025475|FG001|Overall Study|Lost to Follow-up|3|||
162812889|NCT02881957|588025479|FG000|Overall Study|Comfort care|0|||
162812890|NCT02881957|588025480|FG001|Overall Study|Comfort care|1|||
162812891|NCT02881957|588025479|FG000|Overall Study|Concurrent trial enrollment|0|||
162812892|NCT02881957|588025480|FG001|Overall Study|Concurrent trial enrollment|1|||
162812893|NCT02881957|588025479|FG000|Overall Study|Discharged within 48 hours|0|||
162812894|NCT02881957|588025480|FG001|Overall Study|Discharged within 48 hours|1|||
162812895|NCT02881957|588025479|FG000|Overall Study|Withdrawal by Subject|2|||
162812896|NCT02881957|588025480|FG001|Overall Study|Withdrawal by Subject|1|||
162812897|NCT02881957|588025479|FG000|Overall Study|Protocol Violation|1|||
162812898|NCT02881957|588025480|FG001|Overall Study|Protocol Violation|0|||
162812899|NCT05269355|588025481|FG000|Overall Study|Progressive Disease|104|||
162812900|NCT05269355|588025482|FG001|Overall Study|Progressive Disease|68|||
162812901|NCT05269355|588025481|FG000|Overall Study|Study Terminated by Sponsor|87|||
162812902|NCT05269355|588025482|FG001|Overall Study|Study Terminated by Sponsor|29|||
162812903|NCT05269355|588025481|FG000|Overall Study|Adverse Event|15|||
162812904|NCT05269355|588025482|FG001|Overall Study|Adverse Event|8|||
162812905|NCT05269355|588025481|FG000|Overall Study|Withdrawal by Subject|18|||
162812906|NCT05269355|588025482|FG001|Overall Study|Withdrawal by Subject|5|||
162812907|NCT05269355|588025481|FG000|Overall Study|Physician Decision|6|||
162812908|NCT05269355|588025482|FG001|Overall Study|Physician Decision|4|||
162812909|NCT05269355|588025481|FG000|Overall Study|Death|3|||
162812910|NCT05269355|588025482|FG001|Overall Study|Death|5|||
162812911|NCT05269355|588025481|FG000|Overall Study|Other Than Specified|5|||
162812912|NCT05269355|588025482|FG001|Overall Study|Other Than Specified|1|||
162812913|NCT05269355|588025481|FG000|Overall Study|Randomized But Not Treated|1|||
162812914|NCT05269355|588025482|FG001|Overall Study|Randomized But Not Treated|0|||
162812915|NCT03705832|588025483|FG000|Overall Study|Physician Decision|0|||
162812916|NCT03705832|588025484|FG001|Overall Study|Physician Decision|1|||
162812917|NCT03705832|588025483|FG000|Overall Study|Withdrawal by Subject|1|||
162812918|NCT03705832|588025484|FG001|Overall Study|Withdrawal by Subject|0|||
162812919|NCT01050790|588025485|FG000|Overall Study|Adverse Event|1|||
162812920|NCT01880528|588025486|FG000|Overall Study|Other|1|||
162812921|NCT01880528|588025487|FG001|Overall Study|Other|1|||
162812922|NCT01439360|588025488|FG000|Overall Study|Adverse Event|4|||
162812923|NCT01439360|588025489|FG001|Overall Study|Adverse Event|16|||
162812924|NCT01439360|588025488|FG000|Overall Study|Lost to Follow-up|43|||
162812925|NCT01439360|588025489|FG001|Overall Study|Lost to Follow-up|58|||
162812926|NCT01439360|588025488|FG000|Overall Study|Others|10|||
162812927|NCT01439360|588025489|FG001|Overall Study|Others|5|||
162812928|NCT01439360|588025488|FG000|Overall Study|Protocol Violation|1|||
162812929|NCT01439360|588025489|FG001|Overall Study|Protocol Violation|0|||
162812930|NCT01439360|588025488|FG000|Overall Study|Withdrawal by Subject|140|||
162812931|NCT01439360|588025489|FG001|Overall Study|Withdrawal by Subject|129|||
162812932|NCT01028222|588027950|FG000|Overall Study|Protocol deviation|1|||
162812933|NCT01028222|588027951|FG001|Overall Study|Protocol deviation|0|||
162812934|NCT01028222|588027950|FG000|Overall Study|Disease progression|33|||
162812935|NCT01028222|588027951|FG001|Overall Study|Disease progression|9|||
162812936|NCT01028222|588027950|FG000|Overall Study|Administrative problems|1|||
163161644|NCT03682770|589305815|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161645|NCT03682770|589305816|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161646|NCT03682770|589305817|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161647|NCT03682770|589305818|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
163161648|NCT03682770|589305819|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
162812937|NCT01028222|588027951|FG001|Overall Study|Administrative problems|1|||
162812938|NCT01028222|588027950|FG000|Overall Study|Lost to Follow-up|0|||
162812939|NCT01028222|588027951|FG001|Overall Study|Lost to Follow-up|1|||
162812940|NCT01028222|588027950|FG000|Overall Study|Withdrawal by Subject|1|||
162812941|NCT01028222|588027951|FG001|Overall Study|Withdrawal by Subject|0|||
162812942|NCT01028222|588027950|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
162812943|NCT01028222|588027951|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
162812944|NCT01028222|588027950|FG000|Overall Study|Adverse Event|2|||
162812945|NCT01028222|588027951|FG001|Overall Study|Adverse Event|0|||
162812946|NCT00146328|588027952|FG000|Overall Study|Adverse Event|39|||
162812947|NCT00146328|588027953|FG001|Overall Study|Adverse Event|48|||
162812948|NCT00146328|588027954|FG002|Overall Study|Adverse Event|79|||
162812949|NCT00146328|588027952|FG000|Overall Study|Protocol Violation|11|||
162812950|NCT00146328|588027953|FG001|Overall Study|Protocol Violation|6|||
162812951|NCT00146328|588027954|FG002|Overall Study|Protocol Violation|12|||
162812952|NCT00146328|588027952|FG000|Overall Study|Lost to Follow-up|7|||
162812953|NCT00146328|588027953|FG001|Overall Study|Lost to Follow-up|4|||
162812954|NCT00146328|588027954|FG002|Overall Study|Lost to Follow-up|7|||
162812955|NCT00146328|588027952|FG000|Overall Study|Withdrawal by Subject|16|||
162812956|NCT00146328|588027953|FG001|Overall Study|Withdrawal by Subject|16|||
162812957|NCT00146328|588027954|FG002|Overall Study|Withdrawal by Subject|22|||
162812958|NCT00146328|588027952|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
162812959|NCT00146328|588027953|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
162812960|NCT00146328|588027954|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
162812961|NCT00146328|588027952|FG000|Overall Study|Trial ended/site closed|8|||
162812962|NCT00146328|588027953|FG001|Overall Study|Trial ended/site closed|2|||
162812963|NCT00146328|588027954|FG002|Overall Study|Trial ended/site closed|19|||
162812964|NCT00146328|588027952|FG000|Overall Study|Patient decision to end|0|||
162812965|NCT00146328|588027953|FG001|Overall Study|Patient decision to end|1|||
162812966|NCT00146328|588027954|FG002|Overall Study|Patient decision to end|6|||
162812967|NCT00146328|588027952|FG000|Overall Study|Enroll into other trial|2|||
162812968|NCT00146328|588027953|FG001|Overall Study|Enroll into other trial|4|||
162812969|NCT00146328|588027954|FG002|Overall Study|Enroll into other trial|2|||
162812970|NCT00146328|588027952|FG000|Overall Study|Death|0|||
162812971|NCT00146328|588027953|FG001|Overall Study|Death|1|||
162812972|NCT00146328|588027954|FG002|Overall Study|Death|1|||
162812973|NCT00146328|588027952|FG000|Overall Study|Moved|2|||
162812974|NCT00146328|588027953|FG001|Overall Study|Moved|0|||
162812975|NCT00146328|588027954|FG002|Overall Study|Moved|0|||
162812976|NCT00146328|588027952|FG000|Overall Study|Interaction with other medication|2|||
162812977|NCT00146328|588027953|FG001|Overall Study|Interaction with other medication|0|||
162812978|NCT00146328|588027954|FG002|Overall Study|Interaction with other medication|1|||
163161649|NCT03682770|589305820|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
163161650|NCT00774566|589305821|FG000|Overall Study|Protocol Violation|18|||
163161651|NCT00774566|589305822|FG001|Overall Study|Protocol Violation|15|||
163161652|NCT04896073|589305823|FG000|Overall Study|Screen failure|0|||
163161653|NCT04896073|589305824|FG001|Overall Study|Screen failure|2|||
163161654|NCT04896073|589305823|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163161655|NCT04896073|589305824|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
163161656|NCT02304367|589305825|FG000|Overall Study|Lack of Response to Bruosumab|1|||
163161657|NCT02304367|589305825|FG000|Overall Study|Sponsor Decision|3|||
163161658|NCT02304367|589305825|FG000|Overall Study|Death|2|||
163161659|NCT02304367|589305825|FG000|Overall Study|Physician Decision|1|||
163161660|NCT02304367|589305825|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
163161661|NCT00573144|589305826|FG000|Overall Study|Withdrawal by Subject|2|||
163161662|NCT00573144|589305827|FG001|Overall Study|Withdrawal by Subject|3|||
163161663|NCT02637037|589305830|FG000|Overall Study|Positive drug screen at admission|1|||
163161664|NCT02637037|589305831|FG001|Overall Study|Positive drug screen at admission|0|||
163161665|NCT02637037|589305830|FG000|Overall Study|Withdrawal by Subject|2|||
163161666|NCT02637037|589305831|FG001|Overall Study|Withdrawal by Subject|1|||
163161667|NCT02637037|589305830|FG000|Overall Study|Adverse Event|1|||
163161668|NCT02637037|589305831|FG001|Overall Study|Adverse Event|0|||
163161669|NCT00074490|589305837|FG000|Overall Study|Progressive malignancy|0|||
163161670|NCT00074490|589305838|FG001|Overall Study|Progressive malignancy|7|||
163161671|NCT00074490|589305839|FG002|Overall Study|Progressive malignancy|0|||
163161672|NCT00074490|589305840|FG003|Overall Study|Progressive malignancy|0|||
163161673|NCT00074490|589305841|FG004|Overall Study|Progressive malignancy|3|||
163161674|NCT00074490|589305842|FG005|Overall Study|Progressive malignancy|0|||
163161675|NCT04411667|589305847|FG000|Overall Study|Physician Decision|1|||
163161676|NCT04411667|589305848|FG001|Overall Study|Physician Decision|0|||
163161677|NCT01147874|589305853|FG000|Overall Study|Adverse Event|5|||
163161678|NCT01147874|589305853|FG000|Overall Study|Investigator's Request|1|||
163161679|NCT01147874|589305853|FG000|Overall Study|Lost to Follow-up|25|||
163161680|NCT01147874|589305853|FG000|Overall Study|Other|5|||
163161681|NCT01147874|589305853|FG000|Overall Study|Protocol Violation|5|||
163161682|NCT01147874|589305853|FG000|Overall Study|Sponsor's Decision|2|||
163161683|NCT01147874|589305853|FG000|Overall Study|Withdrawal by Subject|24|||
163161684|NCT02991040|589305854|FG000|Overall Study|Withdrawal by Subject|2|||
163161685|NCT02991040|589305854|FG000|Overall Study|Lost to Follow-up|2|||
163161686|NCT04287517|589305855|FG000|Overall Study|Withdrawal by Subject|1|||
163161687|NCT04287517|589305856|FG001|Overall Study|Withdrawal by Subject|1|||
163161688|NCT01869764|589305863|FG000|Overall Study|Withdrawal by Subject|0|||
162812979|NCT01717989|588027955|FG000|Overall Study|Ineligibility determined|6|||
163161689|NCT01869764|589305864|FG001|Overall Study|Withdrawal by Subject|2|||
163161690|NCT02175030|589305865|FG000|Overall Study|Failed screen after consent|7|||
163161691|NCT02175030|589305866|FG001|Overall Study|Failed screen after consent|6|||
162812980|NCT01717989|588027955|FG000|Overall Study|Protocol deviation|6|||
162812981|NCT01717989|588027955|FG000|Overall Study|Withdrawal by Subject|11|||
163161692|NCT02175030|589305865|FG000|Overall Study|Failed IUD Insertion|20|||
162812982|NCT01717989|588027955|FG000|Overall Study|Physician Decision|2|||
162812983|NCT01717989|588027955|FG000|Overall Study|Lost to Follow-up|11|||
162812984|NCT01717989|588027955|FG000|Overall Study|Death|439|||
162812985|NCT01717989|588027955|FG000|Overall Study|Protocol-specified criteria|551|||
162812986|NCT01717989|588027955|FG000|Overall Study|Other|40|||
162812987|NCT03224325|588027956|FG000|Overall Study|Adverse Event|1|||
162812988|NCT03224325|588027957|FG001|Overall Study|Adverse Event|0|||
162812989|NCT03224325|588027958|FG002|Overall Study|Adverse Event|0|||
162812990|NCT03224325|588027959|FG003|Overall Study|Adverse Event|0|||
162812991|NCT03224325|588027960|FG004|Overall Study|Adverse Event|0|||
162812992|NCT03224325|588027961|FG005|Overall Study|Adverse Event|0|||
162812993|NCT03224325|588027962|FG006|Overall Study|Adverse Event|1|||
162812994|NCT03224325|588027956|FG000|Overall Study|Withdrawal by Subject|0|||
162812995|NCT03224325|588027957|FG001|Overall Study|Withdrawal by Subject|0|||
162812996|NCT03224325|588027958|FG002|Overall Study|Withdrawal by Subject|0|||
162812997|NCT03224325|588027959|FG003|Overall Study|Withdrawal by Subject|1|||
162812998|NCT03224325|588027960|FG004|Overall Study|Withdrawal by Subject|0|||
162812999|NCT03224325|588027961|FG005|Overall Study|Withdrawal by Subject|0|||
162813000|NCT03224325|588027962|FG006|Overall Study|Withdrawal by Subject|0|||
162813001|NCT02072434|588027966|FG000|Overall Study|Protocol Violation|10|||
162813002|NCT02072434|588027967|FG001|Overall Study|Protocol Violation|9|||
162813003|NCT02072434|588027966|FG000|Overall Study|Physician Decision|5|||
162813004|NCT02072434|588027967|FG001|Overall Study|Physician Decision|10|||
162813005|NCT02072434|588027966|FG000|Overall Study|Adverse event, serious fatal|1|||
162813006|NCT02072434|588027967|FG001|Overall Study|Adverse event, serious fatal|6|||
162813007|NCT02072434|588027966|FG000|Overall Study|Adverse Event|7|||
162813008|NCT02072434|588027967|FG001|Overall Study|Adverse Event|6|||
162813009|NCT02072434|588027966|FG000|Overall Study|Withdrawal by Subject|17|||
162813010|NCT02072434|588027967|FG001|Overall Study|Withdrawal by Subject|29|||
162813011|NCT02072434|588027966|FG000|Overall Study|Other|14|||
162813012|NCT02072434|588027967|FG001|Overall Study|Other|29|||
162813013|NCT02072434|588027966|FG000|Overall Study|Lost to Follow-up|0|||
162813014|NCT02072434|588027967|FG001|Overall Study|Lost to Follow-up|1|||
162813015|NCT01117454|588027972|FG000|Overall Study|Pregnancy|0|||
162813016|NCT01117454|588027973|FG001|Overall Study|Pregnancy|1|||
162813017|NCT00888433|588027974|FG000|Overall Study|Withdrawal by Subject|1|||
162813018|NCT00888433|588027975|FG001|Overall Study|Withdrawal by Subject|2|||
162813019|NCT00888433|588027974|FG000|Overall Study|Missed Visit|2|||
162813020|NCT00888433|588027975|FG001|Overall Study|Missed Visit|1|||
162813021|NCT02544217|588027976|FG000|Overall Study|Withdrawal by Subject|1|||
162813022|NCT02544217|588027977|FG001|Overall Study|Withdrawal by Subject|1|||
162813023|NCT02544217|588027978|FG002|Overall Study|Withdrawal by Subject|0|||
162813024|NCT02544217|588027979|FG003|Overall Study|Withdrawal by Subject|0|||
162813025|NCT02544217|588027980|FG004|Overall Study|Withdrawal by Subject|0|||
162813026|NCT02544217|588027981|FG005|Overall Study|Withdrawal by Subject|0|||
162813027|NCT03952806|588027985|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
162813028|NCT03952806|588027986|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
162813029|NCT03952806|588027985|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
162813030|NCT03952806|588027986|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
162813031|NCT03952806|588027985|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
162813032|NCT03952806|588027986|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
162813033|NCT03952806|588027985|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
162813034|NCT03952806|588027986|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
162813035|NCT03952806|588027985|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
162813036|NCT03952806|588027986|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
162813037|NCT03952806|588027985|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
162813038|NCT03952806|588027986|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
162813039|NCT03952806|588027985|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
162813040|NCT03952806|588027986|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
162813041|NCT03952806|588027985|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
162813042|NCT03952806|588027986|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
163161693|NCT02175030|589305866|FG001|Overall Study|Failed IUD Insertion|21|||
163161694|NCT02175030|589305865|FG000|Overall Study|Physician Decision|1|||
163161695|NCT02175030|589305866|FG001|Overall Study|Physician Decision|1|||
163161696|NCT02175030|589305865|FG000|Overall Study|Lost to Follow-up|6|||
163161697|NCT02175030|589305866|FG001|Overall Study|Lost to Follow-up|6|||
162813043|NCT03952806|588027985|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
162813044|NCT03952806|588027986|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
162813045|NCT03952806|588027985|FG000|OLE Phase (48 Weeks)|Other|16|||
163161698|NCT02175030|589305865|FG000|Overall Study|Withdrawal by Subject|1|||
163161699|NCT02175030|589305866|FG001|Overall Study|Withdrawal by Subject|4|||
163161700|NCT00068419|589305871|FG000|Overall Study|Adverse Event|3|||
162813046|NCT03952806|588027986|FG001|OLE Phase (48 Weeks)|Other|13|||
162813047|NCT02027701|588027990|FG000|Overall Study|Adverse Event|3|||
162813048|NCT02027701|588027990|FG000|Overall Study|Lack of Efficacy|8|||
162813049|NCT02027701|588027990|FG000|Overall Study|Physician Decision|2|||
162813050|NCT02027701|588027990|FG000|Overall Study|Withdrawal by Subject|3|||
162813051|NCT02875977|588027991|FG000|Overall Study|Lost to Follow-up|42|||
162813052|NCT02875977|588027992|FG001|Overall Study|Lost to Follow-up|29|||
162813053|NCT00820027|588027993|FG000|Overall Study|Adverse Event|15|||
162813054|NCT00820027|588027994|FG001|Overall Study|Adverse Event|8|||
162813055|NCT00820027|588027995|FG002|Overall Study|Adverse Event|10|||
162813056|NCT00820027|588027996|FG003|Overall Study|Adverse Event|5|||
162813057|NCT00820027|588027993|FG000|Overall Study|Lack of Efficacy|2|||
162813058|NCT00820027|588027994|FG001|Overall Study|Lack of Efficacy|1|||
162813059|NCT00820027|588027995|FG002|Overall Study|Lack of Efficacy|2|||
162813060|NCT00820027|588027996|FG003|Overall Study|Lack of Efficacy|2|||
162813061|NCT00820027|588027993|FG000|Overall Study|Physician Decision|0|||
162813062|NCT00820027|588027994|FG001|Overall Study|Physician Decision|1|||
162813063|NCT00820027|588027995|FG002|Overall Study|Physician Decision|1|||
162813064|NCT00820027|588027996|FG003|Overall Study|Physician Decision|0|||
162813065|NCT00820027|588027993|FG000|Overall Study|Protocol Violation|3|||
162813066|NCT00820027|588027994|FG001|Overall Study|Protocol Violation|0|||
162813067|NCT00820027|588027995|FG002|Overall Study|Protocol Violation|4|||
162813068|NCT00820027|588027996|FG003|Overall Study|Protocol Violation|0|||
162813069|NCT00820027|588027993|FG000|Overall Study|Withdrawal by Subject|6|||
162813070|NCT00820027|588027994|FG001|Overall Study|Withdrawal by Subject|4|||
162813071|NCT00820027|588027995|FG002|Overall Study|Withdrawal by Subject|4|||
162813072|NCT00820027|588027996|FG003|Overall Study|Withdrawal by Subject|6|||
162813073|NCT02604433|588027997|FG000|Overall Study|Withdrawal by Subject|37|||
162813074|NCT02604433|588027998|FG001|Overall Study|Withdrawal by Subject|16|||
162813075|NCT02604433|588027997|FG000|Overall Study|Adverse Event|4|||
162813076|NCT02604433|588027998|FG001|Overall Study|Adverse Event|0|||
162813077|NCT02604433|588027997|FG000|Overall Study|Other reasons|3|||
162813078|NCT02604433|588027998|FG001|Overall Study|Other reasons|5|||
162813079|NCT02604433|588027997|FG000|Overall Study|Death|4|||
162813080|NCT02604433|588027998|FG001|Overall Study|Death|1|||
162813081|NCT02604433|588027997|FG000|Overall Study|Transition to Rollover Protocol|169|||
162813082|NCT02604433|588027998|FG001|Overall Study|Transition to Rollover Protocol|82|||
162813083|NCT02604433|588027997|FG000|Overall Study|Physician Decision|1|||
162813084|NCT02604433|588027998|FG001|Overall Study|Physician Decision|1|||
162813085|NCT02604433|588027997|FG000|Overall Study|Lack of Efficacy|0|||
162813086|NCT02604433|588027998|FG001|Overall Study|Lack of Efficacy|1|||
162813087|NCT03285178|588027999|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
162813088|NCT03285178|588028000|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813089|NCT03285178|588028001|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813090|NCT03285178|588028002|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813091|NCT03285178|588028003|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813092|NCT03285178|588028004|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813093|NCT03285178|588028005|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162813094|NCT03285178|588027999|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
162813095|NCT03285178|588028000|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813096|NCT03285178|588028001|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813097|NCT03285178|588028002|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813098|NCT03285178|588028003|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813099|NCT03285178|588028004|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813100|NCT03285178|588028005|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162813101|NCT03285178|588027999|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
162813102|NCT03285178|588028000|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
162813103|NCT03285178|588028001|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
162813104|NCT03285178|588028002|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
162813105|NCT03285178|588028003|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
162813106|NCT03285178|588028004|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
162813107|NCT03285178|588028005|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
162813108|NCT03285178|588027999|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
162813109|NCT03285178|588028000|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813110|NCT03285178|588028001|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813111|NCT03285178|588028002|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813112|NCT03285178|588028003|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813113|NCT03285178|588028004|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813114|NCT03285178|588028005|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162813115|NCT03285178|588027999|FG000|Single-Blind Run-In Period|Physician Decision|2|||
162813116|NCT03285178|588028000|FG001|Single-Blind Run-In Period|Physician Decision|0|||
162813117|NCT03285178|588028001|FG002|Single-Blind Run-In Period|Physician Decision|0|||
163042814|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
163161701|NCT00068419|589305871|FG000|Overall Study|Lack of Efficacy|24|||
163161702|NCT00068419|589305871|FG000|Overall Study|Lost to Follow-up|1|||
163161703|NCT00068419|589305871|FG000|Overall Study|Physician Decision|7|||
163161704|NCT00068419|589305871|FG000|Overall Study|Withdrawal by Subject|14|||
163161705|NCT00068419|589305871|FG000|Overall Study|Ineligible|11|||
163161706|NCT04717336|589305876|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
163161707|NCT04717336|589305877|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
163161708|NCT04717336|589305876|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
163161709|NCT04717336|589305877|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
163161710|NCT02039843|589305878|FG000|Randomization and Observation Period|Adverse Event|2|||
163161711|NCT02039843|589305879|FG001|Randomization and Observation Period|Adverse Event|0|||
163161712|NCT02039843|589305878|FG000|Randomization and Observation Period|Death|1|||
163161713|NCT02039843|589305879|FG001|Randomization and Observation Period|Death|0|||
163161714|NCT02039843|589305878|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
163161715|NCT02039843|589305879|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
163161716|NCT02039843|589305878|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
163161717|NCT02039843|589305879|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
163161718|NCT02039843|589305878|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
163161719|NCT02039843|589305879|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
163161720|NCT02039843|589305878|FG000|Pairing With a Study Dog|Death|1|||
163161721|NCT02039843|589305879|FG001|Pairing With a Study Dog|Death|0|||
163161722|NCT02039843|589305878|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
163161723|NCT02039843|589305879|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
163161724|NCT02039843|589305878|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
163161725|NCT02039843|589305879|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
162697850|NCT01474512|587605412|FG000|Long-Term Extension Period|Physician Decision|0|||
162697851|NCT01474512|587605413|FG001|Long-Term Extension Period|Physician Decision|0|||
162697852|NCT01474512|587605414|FG002|Long-Term Extension Period|Physician Decision|0|||
162697853|NCT01474512|587605415|FG003|Long-Term Extension Period|Physician Decision|0|||
162697854|NCT01474512|587605416|FG004|Long-Term Extension Period|Physician Decision|0|||
162697855|NCT01474512|587605417|FG005|Long-Term Extension Period|Physician Decision|0|||
162697856|NCT01474512|587605418|FG006|Long-Term Extension Period|Physician Decision|0|||
162697857|NCT01474512|587605419|FG007|Long-Term Extension Period|Physician Decision|0|||
162697858|NCT01474512|587605420|FG008|Long-Term Extension Period|Physician Decision|0|||
162697859|NCT01474512|587605421|FG009|Long-Term Extension Period|Physician Decision|0|||
162697860|NCT01474512|587605422|FG010|Long-Term Extension Period|Physician Decision|0|||
162697861|NCT01474512|587605423|FG011|Long-Term Extension Period|Physician Decision|0|||
162697862|NCT01474512|587605424|FG012|Long-Term Extension Period|Physician Decision|21|||
162697863|NCT01474512|587605425|FG013|Long-Term Extension Period|Physician Decision|21|||
162697864|NCT01474512|587605426|FG014|Long-Term Extension Period|Physician Decision|0|||
162697865|NCT01474512|587605427|FG015|Long-Term Extension Period|Physician Decision|0|||
162697866|NCT01474512|587605428|FG016|Long-Term Extension Period|Physician Decision|0|||
162697867|NCT01474512|587605429|FG017|Long-Term Extension Period|Physician Decision|0|||
162697868|NCT01474512|587605412|FG000|Long-Term Extension Period|Clinical Relapse|0|||
162697869|NCT01474512|587605413|FG001|Long-Term Extension Period|Clinical Relapse|0|||
162697870|NCT01474512|587605414|FG002|Long-Term Extension Period|Clinical Relapse|0|||
162697871|NCT01474512|587605415|FG003|Long-Term Extension Period|Clinical Relapse|0|||
162697872|NCT01474512|587605416|FG004|Long-Term Extension Period|Clinical Relapse|0|||
162697873|NCT01474512|587605417|FG005|Long-Term Extension Period|Clinical Relapse|0|||
162697874|NCT01474512|587605418|FG006|Long-Term Extension Period|Clinical Relapse|0|||
162697875|NCT01474512|587605419|FG007|Long-Term Extension Period|Clinical Relapse|0|||
162697876|NCT01474512|587605420|FG008|Long-Term Extension Period|Clinical Relapse|0|||
162697877|NCT01474512|587605421|FG009|Long-Term Extension Period|Clinical Relapse|0|||
162697878|NCT01474512|587605422|FG010|Long-Term Extension Period|Clinical Relapse|0|||
162697879|NCT01474512|587605423|FG011|Long-Term Extension Period|Clinical Relapse|0|||
162697880|NCT01474512|587605424|FG012|Long-Term Extension Period|Clinical Relapse|9|||
162697881|NCT01474512|587605425|FG013|Long-Term Extension Period|Clinical Relapse|9|||
162697882|NCT01474512|587605426|FG014|Long-Term Extension Period|Clinical Relapse|0|||
162697883|NCT01474512|587605427|FG015|Long-Term Extension Period|Clinical Relapse|0|||
162697884|NCT01474512|587605428|FG016|Long-Term Extension Period|Clinical Relapse|0|||
162697885|NCT01474512|587605429|FG017|Long-Term Extension Period|Clinical Relapse|0|||
162697886|NCT01474512|587605412|FG000|Long-Term Extension Period|Death|0|||
162697887|NCT01474512|587605413|FG001|Long-Term Extension Period|Death|0|||
162697888|NCT01474512|587605414|FG002|Long-Term Extension Period|Death|0|||
162697889|NCT01474512|587605415|FG003|Long-Term Extension Period|Death|0|||
162697890|NCT01474512|587605416|FG004|Long-Term Extension Period|Death|0|||
162813118|NCT03285178|588028002|FG003|Single-Blind Run-In Period|Physician Decision|0|||
163161726|NCT02039843|589305878|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
163161727|NCT02039843|589305879|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
163161728|NCT01958164|589305883|FG000|Overall Study|Adverse Event|0|||
163161729|NCT01958164|589305884|FG001|Overall Study|Adverse Event|2|||
163161730|NCT01958164|589305883|FG000|Overall Study|Lost to Follow-up|2|||
163161731|NCT01958164|589305884|FG001|Overall Study|Lost to Follow-up|3|||
163161732|NCT00740857|589305885|FG000|Overall Study|Withdrawal by Subject|1|||
163161733|NCT00740857|589305886|FG001|Overall Study|Withdrawal by Subject|0|||
163161734|NCT00740857|589305887|FG002|Overall Study|Withdrawal by Subject|0|||
163161735|NCT02963506|589305888|FG000|Double-Blind Period|Adverse Event|0|||
163161736|NCT02963506|589305889|FG001|Double-Blind Period|Adverse Event|0|||
162813119|NCT03285178|588028003|FG004|Single-Blind Run-In Period|Physician Decision|0|||
162813120|NCT03285178|588028004|FG005|Single-Blind Run-In Period|Physician Decision|0|||
162813121|NCT03285178|588028005|FG006|Single-Blind Run-In Period|Physician Decision|0|||
162813122|NCT03285178|588027999|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162813123|NCT03285178|588028000|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
162813124|NCT03285178|588028001|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
162813125|NCT03285178|588028002|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162813126|NCT03285178|588028003|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162813127|NCT03285178|588028004|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162813128|NCT03285178|588028005|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162813129|NCT03285178|588027999|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162813130|NCT03285178|588028000|FG001|Double-Blind Treatment Period|Adverse Event|0|||
162813131|NCT03285178|588028001|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162813132|NCT03285178|588028002|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162813133|NCT03285178|588028003|FG004|Double-Blind Treatment Period|Adverse Event|0|||
162813134|NCT03285178|588028004|FG005|Double-Blind Treatment Period|Adverse Event|0|||
162813135|NCT03285178|588028005|FG006|Double-Blind Treatment Period|Adverse Event|2|||
162813136|NCT03285178|588027999|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162813137|NCT03285178|588028000|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162813138|NCT03285178|588028001|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
162813139|NCT03285178|588028002|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
162813140|NCT03285178|588028003|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
162813141|NCT03285178|588028004|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
162813142|NCT03285178|588028005|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
162813143|NCT03285178|588027999|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162813144|NCT03285178|588028000|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162813145|NCT03285178|588028001|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162813146|NCT03285178|588028002|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162813147|NCT03285178|588028003|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162813148|NCT03285178|588028004|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162813149|NCT03285178|588028005|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162813150|NCT03285178|588027999|FG000|Double-Blind Treatment Period|COVID-19|0|||
162813151|NCT03285178|588028000|FG001|Double-Blind Treatment Period|COVID-19|0|||
162813152|NCT03285178|588028001|FG002|Double-Blind Treatment Period|COVID-19|1|||
162813153|NCT03285178|588028002|FG003|Double-Blind Treatment Period|COVID-19|0|||
162813154|NCT03285178|588028003|FG004|Double-Blind Treatment Period|COVID-19|0|||
162813155|NCT03285178|588028004|FG005|Double-Blind Treatment Period|COVID-19|0|||
162813156|NCT03285178|588028005|FG006|Double-Blind Treatment Period|COVID-19|0|||
162813157|NCT01128894|588028006|FG000|Overall Study|Adverse Event|31|||
162813158|NCT01128894|588028007|FG001|Overall Study|Adverse Event|41|||
162813159|NCT01128894|588028006|FG000|Overall Study|Protocol Violation|2|||
162813160|NCT01128894|588028007|FG001|Overall Study|Protocol Violation|1|||
162813161|NCT01128894|588028006|FG000|Overall Study|Noncompliance|4|||
162813162|NCT01128894|588028007|FG001|Overall Study|Noncompliance|5|||
163161737|NCT02963506|589305890|FG002|Double-Blind Period|Adverse Event|1|||
163161738|NCT02963506|589305891|FG003|Double-Blind Period|Adverse Event|0|||
163161739|NCT02963506|589305892|FG004|Double-Blind Period|Adverse Event|0|||
163161740|NCT02963506|589305893|FG005|Double-Blind Period|Adverse Event|0|||
163161741|NCT02963506|589305894|FG006|Double-Blind Period|Adverse Event|0|||
163161742|NCT02963506|589305895|FG007|Double-Blind Period|Adverse Event|0|||
163161743|NCT02963506|589305896|FG008|Double-Blind Period|Adverse Event|0|||
163161744|NCT02963506|589305897|FG009|Double-Blind Period|Adverse Event|0|||
163161745|NCT02963506|589305898|FG010|Double-Blind Period|Adverse Event|0|||
163161746|NCT02963506|589305899|FG011|Double-Blind Period|Adverse Event|0|||
163161747|NCT02963506|589305900|FG012|Double-Blind Period|Adverse Event|0|||
163161748|NCT02963506|589305888|FG000|Double-Blind Period|Death|0|||
163161749|NCT02963506|589305889|FG001|Double-Blind Period|Death|0|||
163161750|NCT02963506|589305890|FG002|Double-Blind Period|Death|0|||
162813163|NCT01128894|588028006|FG000|Overall Study|Lost to Follow-up|8|||
162813164|NCT01128894|588028007|FG001|Overall Study|Lost to Follow-up|8|||
162813165|NCT01128894|588028006|FG000|Overall Study|Withdrawal by Subject|10|||
163161751|NCT02963506|589305891|FG003|Double-Blind Period|Death|1|||
162813166|NCT01128894|588028007|FG001|Overall Study|Withdrawal by Subject|12|||
162813167|NCT01128894|588028006|FG000|Overall Study|Physician Decision|2|||
163161752|NCT02963506|589305892|FG004|Double-Blind Period|Death|0|||
163161753|NCT02963506|589305893|FG005|Double-Blind Period|Death|0|||
163161754|NCT02963506|589305894|FG006|Double-Blind Period|Death|0|||
163161755|NCT02963506|589305895|FG007|Double-Blind Period|Death|0|||
163161756|NCT02963506|589305896|FG008|Double-Blind Period|Death|0|||
163161757|NCT02963506|589305897|FG009|Double-Blind Period|Death|0|||
163161758|NCT02963506|589305898|FG010|Double-Blind Period|Death|0|||
163161759|NCT02963506|589305899|FG011|Double-Blind Period|Death|0|||
162813168|NCT01128894|588028007|FG001|Overall Study|Physician Decision|1|||
162813169|NCT01128894|588028006|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
162813170|NCT01128894|588028007|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
162813171|NCT01128738|588028008|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
162813172|NCT01128738|588028009|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
162813173|NCT01128738|588028008|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
162813174|NCT01128738|588028009|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
162813175|NCT01128738|588028008|FG000|Second TP|Lost to Follow-up|0|||
162813176|NCT01128738|588028009|FG001|Second TP|Lost to Follow-up|1|||
162813177|NCT01128738|588028008|FG000|Second TP|Withdrawal by Subject|0|||
162813178|NCT01128738|588028009|FG001|Second TP|Withdrawal by Subject|2|||
162813179|NCT00973362|588028010|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
162813180|NCT00973362|588028011|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
162813181|NCT00973362|588028010|FG000|Baseline Evaluation|No colposcopy visit|62|||
162813182|NCT00973362|588028011|FG001|Baseline Evaluation|No colposcopy visit|0|||
162813183|NCT00973362|588028010|FG000|Baseline Evaluation|Inevaluable|686|||
162813184|NCT00973362|588028011|FG001|Baseline Evaluation|Inevaluable|223|||
162813185|NCT00973362|588028010|FG000|3-Year Follow-up|Lost to Follow-up|17|||
162813186|NCT00973362|588028011|FG001|3-Year Follow-up|Lost to Follow-up|0|||
162813187|NCT00887679|588028014|FG000|Overall Study|Withdrawal by Subject|1|||
162813188|NCT00887679|588028014|FG000|Overall Study|Lost to Follow-up|4|||
162813189|NCT00887679|588028014|FG000|Overall Study|Physician Decision|5|||
162813190|NCT02683941|588028015|FG000|Double-blind Phase|Adverse Event|0|||
162813191|NCT02683941|588028016|FG001|Double-blind Phase|Adverse Event|1|||
162813192|NCT02683941|588028015|FG000|Double-blind Phase|Withdrawal by Subject|4|||
162813193|NCT02683941|588028016|FG001|Double-blind Phase|Withdrawal by Subject|2|||
162813194|NCT02683941|588028015|FG000|Double-blind Phase|Lost to Follow-up|1|||
162813195|NCT02683941|588028016|FG001|Double-blind Phase|Lost to Follow-up|0|||
162813196|NCT02683941|588028015|FG000|Double-blind Phase|Disease Progression|5|||
162813197|NCT02683941|588028016|FG001|Double-blind Phase|Disease Progression|2|||
162813198|NCT02683941|588028015|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
162813199|NCT02683941|588028016|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
162813200|NCT02683941|588028015|FG000|Open-label Treatment Phase|Disease Progression|1|||
162813201|NCT02683941|588028016|FG001|Open-label Treatment Phase|Disease Progression|2|||
162813202|NCT02683941|588028015|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
162813203|NCT02683941|588028016|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
162813204|NCT02683941|588028015|FG000|Open-label Treatment Phase|Other|1|||
162813205|NCT02683941|588028016|FG001|Open-label Treatment Phase|Other|0|||
162813206|NCT02683941|588028015|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
162813207|NCT02683941|588028016|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
162813208|NCT02683941|588028015|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
162813209|NCT02683941|588028016|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
162813210|NCT02683941|588028015|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
162813211|NCT02683941|588028016|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
162813212|NCT02683941|588028015|FG000|Open-label Follow-up Phase|Other|8|||
162813213|NCT02683941|588028016|FG001|Open-label Follow-up Phase|Other|1|||
162813214|NCT00325039|588028017|FG000|Overall Study|Lost to Follow-up|18|||
162813215|NCT00325039|588028018|FG001|Overall Study|Lost to Follow-up|14|||
162813216|NCT01009203|588028020|FG000|Overall Study|Withdrawal by Subject|1|||
162813217|NCT01009203|588028020|FG000|Overall Study|Adverse Event|5|||
162813218|NCT01009203|588028020|FG000|Overall Study|Treatment-unrelated death|1|||
162813219|NCT02974088|588028024|FG000|Overall Study|Lost to Follow-up|0|||
162813220|NCT02974088|588028025|FG001|Overall Study|Lost to Follow-up|2|||
162813221|NCT02974088|588028024|FG000|Overall Study|Adverse Event|0|||
162813222|NCT02974088|588028025|FG001|Overall Study|Adverse Event|1|||
162813223|NCT00892723|588028026|FG000|Overall Study|Lost to Follow-up|1|||
162813224|NCT00892723|588028027|FG001|Overall Study|Lost to Follow-up|3|||
162813225|NCT00892723|588028028|FG002|Overall Study|Lost to Follow-up|1|||
162813226|NCT00892723|588028026|FG000|Overall Study|Withdrawal by Subject|1|||
162813227|NCT00892723|588028027|FG001|Overall Study|Withdrawal by Subject|1|||
162813228|NCT00892723|588028028|FG002|Overall Study|Withdrawal by Subject|1|||
162813229|NCT00150969|588028031|FG000|24 Month Main Study|Adverse Event|3|||
162813230|NCT00150969|588028032|FG001|24 Month Main Study|Adverse Event|4|||
162813231|NCT00150969|588028031|FG000|24 Month Main Study|Death|1|||
162813232|NCT00150969|588028032|FG001|24 Month Main Study|Death|1|||
162813233|NCT00150969|588028031|FG000|24 Month Main Study|Lack of Efficacy|1|||
162813234|NCT00150969|588028032|FG001|24 Month Main Study|Lack of Efficacy|8|||
162813235|NCT00150969|588028031|FG000|24 Month Main Study|Lost to Follow-up|3|||
162813236|NCT00150969|588028032|FG001|24 Month Main Study|Lost to Follow-up|2|||
162813237|NCT00150969|588028031|FG000|24 Month Main Study|Protocol Violation|4|||
162813238|NCT00150969|588028032|FG001|24 Month Main Study|Protocol Violation|2|||
162813239|NCT00150969|588028031|FG000|24 Month Main Study|Withdrawal by Subject|7|||
163042815|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
162813240|NCT00150969|588028032|FG001|24 Month Main Study|Withdrawal by Subject|4|||
162813241|NCT00150969|588028031|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
163161760|NCT02963506|589305900|FG012|Double-Blind Period|Death|0|||
163161761|NCT02963506|589305888|FG000|Double-Blind Period|Lost to Follow-up|0|||
163161762|NCT02963506|589305889|FG001|Double-Blind Period|Lost to Follow-up|1|||
163161763|NCT02963506|589305890|FG002|Double-Blind Period|Lost to Follow-up|0|||
163161764|NCT02963506|589305891|FG003|Double-Blind Period|Lost to Follow-up|0|||
163161765|NCT02963506|589305892|FG004|Double-Blind Period|Lost to Follow-up|0|||
163161766|NCT02963506|589305893|FG005|Double-Blind Period|Lost to Follow-up|0|||
163161767|NCT02963506|589305894|FG006|Double-Blind Period|Lost to Follow-up|0|||
163161768|NCT02963506|589305895|FG007|Double-Blind Period|Lost to Follow-up|0|||
163161769|NCT02963506|589305896|FG008|Double-Blind Period|Lost to Follow-up|0|||
163161770|NCT02963506|589305897|FG009|Double-Blind Period|Lost to Follow-up|0|||
163161771|NCT02963506|589305898|FG010|Double-Blind Period|Lost to Follow-up|0|||
162813242|NCT00150969|588028032|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
162813243|NCT00150969|588028031|FG000|24-48 Month Extension|Lack of Efficacy|0|||
162813244|NCT00150969|588028032|FG001|24-48 Month Extension|Lack of Efficacy|1|||
162813245|NCT00150969|588028031|FG000|24-48 Month Extension|Adverse Event|1|||
162813246|NCT00150969|588028032|FG001|24-48 Month Extension|Adverse Event|3|||
162813247|NCT00150969|588028031|FG000|24-48 Month Extension|Other Reason|81|||
162813248|NCT00150969|588028032|FG001|24-48 Month Extension|Other Reason|91|||
162813249|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
162813250|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
163161772|NCT02963506|589305899|FG011|Double-Blind Period|Lost to Follow-up|0|||
163161773|NCT02963506|589305900|FG012|Double-Blind Period|Lost to Follow-up|0|||
162813251|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
163161774|NCT02963506|589305888|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163161775|NCT02963506|589305889|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162813252|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
162813253|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
162813254|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
162813255|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
162813256|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
162813257|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
162813258|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
162813259|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
162813260|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
162813261|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
162813262|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
162813263|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
162813264|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
162813265|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
162813266|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
162813267|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
163161776|NCT02963506|589305890|FG002|Double-Blind Period|Withdrawal by Subject|1|||
163161777|NCT02963506|589305891|FG003|Double-Blind Period|Withdrawal by Subject|1|||
163161778|NCT02963506|589305892|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163161779|NCT02963506|589305893|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162813268|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
162813269|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
162813270|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
162813271|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
162813272|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
162813273|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
163161780|NCT02963506|589305894|FG006|Double-Blind Period|Withdrawal by Subject|0|||
163161781|NCT02963506|589305895|FG007|Double-Blind Period|Withdrawal by Subject|0|||
163161782|NCT02963506|589305896|FG008|Double-Blind Period|Withdrawal by Subject|0|||
163161783|NCT02963506|589305897|FG009|Double-Blind Period|Withdrawal by Subject|0|||
163161784|NCT02963506|589305898|FG010|Double-Blind Period|Withdrawal by Subject|0|||
163161785|NCT02963506|589305899|FG011|Double-Blind Period|Withdrawal by Subject|0|||
163161786|NCT02963506|589305900|FG012|Double-Blind Period|Withdrawal by Subject|0|||
162813274|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
162813275|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
162813276|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
162813277|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
162813278|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
162813279|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Other|10|||
162813280|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Other|7|||
163161787|NCT02963506|589305888|FG000|Double-Blind Period|No compliance|0|||
163161788|NCT02963506|589305889|FG001|Double-Blind Period|No compliance|1|||
163161789|NCT02963506|589305890|FG002|Double-Blind Period|No compliance|0|||
162924220|NCT00077766|588423834|FG001|Overall Study|Transplantation|1|||
163161790|NCT02963506|589305891|FG003|Double-Blind Period|No compliance|0|||
162813281|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Other|8|||
162813282|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Other|8|||
162813283|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Other|0|||
162813284|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
162813285|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
162813286|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
162813287|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
162813288|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
162813289|NCT00615836|588028033|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
162813290|NCT00615836|588028034|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162813291|NCT00615836|588028035|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162813292|NCT00615836|588028036|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162813293|NCT00615836|588028037|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162813294|NCT01630434|588028038|FG000|Overall Study|Donor lungs turned down|1|||
162813295|NCT01630434|588028039|FG001|Overall Study|Donor lungs turned down|0|||
162813296|NCT01630434|588028038|FG000|Overall Study|Protocol Violation|9|||
162813297|NCT01630434|588028039|FG001|Overall Study|Protocol Violation|4|||
162813298|NCT01630434|588028038|FG000|Overall Study|Death|20|||
162813299|NCT01630434|588028039|FG001|Overall Study|Death|26|||
162813300|NCT00687973|588028040|FG000|Overall Study|Adverse Event|18|||
162813301|NCT00687973|588028041|FG001|Overall Study|Adverse Event|28|||
162813302|NCT00687973|588028040|FG000|Overall Study|Lack of Efficacy|2|||
162813303|NCT00687973|588028041|FG001|Overall Study|Lack of Efficacy|3|||
162813304|NCT00687973|588028040|FG000|Overall Study|Protocol Violation|1|||
162813305|NCT00687973|588028041|FG001|Overall Study|Protocol Violation|2|||
162813306|NCT00687973|588028040|FG000|Overall Study|Administrative Reasons|0|||
162813307|NCT00687973|588028041|FG001|Overall Study|Administrative Reasons|2|||
162813308|NCT00687973|588028040|FG000|Overall Study|Withdrawal by Subject|3|||
162813309|NCT00687973|588028041|FG001|Overall Study|Withdrawal by Subject|3|||
162813310|NCT02075541|588028043|FG000|Overall Study|Serious Adverse Event|1|||
162813311|NCT02075541|588028044|FG001|Overall Study|Serious Adverse Event|4|||
162813312|NCT02075541|588028043|FG000|Overall Study|Protocol Violation|1|||
162813313|NCT02075541|588028044|FG001|Overall Study|Protocol Violation|0|||
162813314|NCT02075541|588028043|FG000|Overall Study|Withdrawal by Subject|1|||
162813315|NCT02075541|588028044|FG001|Overall Study|Withdrawal by Subject|3|||
162813316|NCT02075541|588028043|FG000|Overall Study|Sponsor study termination|0|||
162813317|NCT02075541|588028044|FG001|Overall Study|Sponsor study termination|1|||
162813318|NCT02075541|588028043|FG000|Overall Study|Other- unable to perform study procedure|1|||
162813319|NCT02075541|588028044|FG001|Overall Study|Other- unable to perform study procedure|0|||
162813320|NCT02349360|588028045|FG000|Overall Study|Withdrawal by Subject|0|||
162813321|NCT02349360|588028046|FG001|Overall Study|Withdrawal by Subject|1|||
162813322|NCT01054846|588028047|FG000|Overall Study|Lost to Follow-up|76|||
162813323|NCT01054846|588028048|FG001|Overall Study|Lost to Follow-up|17|||
162813324|NCT00394953|588028049|FG000|First Treatment Period|Adverse Event|1|||
162813325|NCT00394953|588028050|FG001|First Treatment Period|Adverse Event|2|||
162813326|NCT00394953|588028049|FG000|First Treatment Period|Death|6|||
162813327|NCT00394953|588028050|FG001|First Treatment Period|Death|7|||
162813328|NCT00394953|588028049|FG000|First Treatment Period|Lack of Efficacy|1|||
162813329|NCT00394953|588028050|FG001|First Treatment Period|Lack of Efficacy|1|||
162813330|NCT00394953|588028049|FG000|First Treatment Period|Withdrawal by Subject|6|||
162813331|NCT00394953|588028050|FG001|First Treatment Period|Withdrawal by Subject|3|||
162813332|NCT00394953|588028049|FG000|First Treatment Period|Lost to Follow-up|0|||
162813333|NCT00394953|588028050|FG001|First Treatment Period|Lost to Follow-up|1|||
162813334|NCT00394953|588028049|FG000|First Treatment Period|Renal transplant|11|||
162813335|NCT00394953|588028050|FG001|First Treatment Period|Renal transplant|7|||
162813336|NCT00394953|588028049|FG000|First Treatment Period|Not defined|4|||
162813337|NCT00394953|588028050|FG001|First Treatment Period|Not defined|1|||
162813338|NCT00394953|588028049|FG000|Second Treatment Period|Adverse Event|2|||
162813339|NCT00394953|588028050|FG001|Second Treatment Period|Adverse Event|5|||
162813340|NCT00394953|588028049|FG000|Second Treatment Period|Death|8|||
162813341|NCT00394953|588028050|FG001|Second Treatment Period|Death|4|||
162813342|NCT00394953|588028049|FG000|Second Treatment Period|Lack of Efficacy|9|||
162813343|NCT00394953|588028050|FG001|Second Treatment Period|Lack of Efficacy|47|||
162813344|NCT00394953|588028049|FG000|Second Treatment Period|Withdrawal by Subject|3|||
162813345|NCT00394953|588028050|FG001|Second Treatment Period|Withdrawal by Subject|3|||
162813346|NCT00394953|588028049|FG000|Second Treatment Period|Lost to Follow-up|0|||
162813347|NCT00394953|588028050|FG001|Second Treatment Period|Lost to Follow-up|1|||
162813348|NCT00394953|588028049|FG000|Second Treatment Period|Renal transplant|4|||
162813349|NCT00394953|588028050|FG001|Second Treatment Period|Renal transplant|6|||
162813350|NCT00394953|588028049|FG000|Second Treatment Period|Not defined|3|||
162813351|NCT00394953|588028050|FG001|Second Treatment Period|Not defined|8|||
162813352|NCT02446886|588028056|FG000|Overall Study|Adverse Event|1|||
162813353|NCT02446886|588028057|FG001|Overall Study|Adverse Event|3|||
162813354|NCT02446886|588028056|FG000|Overall Study|Withdrawal by Subject|1|||
162813355|NCT02446886|588028057|FG001|Overall Study|Withdrawal by Subject|1|||
162813356|NCT03021954|588028065|FG000|Overall Study|Lost to Follow-up|10|||
162813357|NCT03021954|588028066|FG001|Overall Study|Lost to Follow-up|43|||
162813358|NCT03021954|588028065|FG000|Overall Study|Subjects had avulsion trauma|4|||
162813359|NCT03021954|588028066|FG001|Overall Study|Subjects had avulsion trauma|1|||
162813360|NCT02196714|588028069|FG000|Overall Study|Protocol Violation|0|||
162813361|NCT02196714|588028070|FG001|Overall Study|Protocol Violation|0|||
162813362|NCT02196714|588028071|FG002|Overall Study|Protocol Violation|1|||
162813363|NCT02196714|588028072|FG003|Overall Study|Protocol Violation|0|||
162813364|NCT00807235|588028076|FG000|Overall Study|Adverse Event|1|||
162813365|NCT00807235|588028077|FG001|Overall Study|Adverse Event|0|||
162813366|NCT04677179|588028080|FG000|Induction Treatment Period|Adverse Event|1|||
162813367|NCT04677179|588028081|FG001|Induction Treatment Period|Adverse Event|0|||
162813368|NCT04677179|588028082|FG002|Induction Treatment Period|Adverse Event|0|||
162813369|NCT04677179|588028083|FG003|Induction Treatment Period|Adverse Event|0|||
162813370|NCT04677179|588028084|FG004|Induction Treatment Period|Adverse Event|0|||
162813371|NCT04677179|588028085|FG005|Induction Treatment Period|Adverse Event|0|||
162813372|NCT04677179|588028086|FG006|Induction Treatment Period|Adverse Event|0|||
162813373|NCT04677179|588028087|FG007|Induction Treatment Period|Adverse Event|0|||
162813374|NCT04677179|588028088|FG008|Induction Treatment Period|Adverse Event|0|||
162813375|NCT04677179|588028089|FG009|Induction Treatment Period|Adverse Event|0|||
162813376|NCT04677179|588028080|FG000|Induction Treatment Period|Physician Decision|1|||
162813377|NCT04677179|588028081|FG001|Induction Treatment Period|Physician Decision|0|||
162813378|NCT04677179|588028082|FG002|Induction Treatment Period|Physician Decision|1|||
162813379|NCT04677179|588028083|FG003|Induction Treatment Period|Physician Decision|0|||
162813380|NCT04677179|588028084|FG004|Induction Treatment Period|Physician Decision|0|||
162813381|NCT04677179|588028085|FG005|Induction Treatment Period|Physician Decision|0|||
162813382|NCT04677179|588028086|FG006|Induction Treatment Period|Physician Decision|0|||
162813383|NCT04677179|588028087|FG007|Induction Treatment Period|Physician Decision|0|||
162813384|NCT04677179|588028088|FG008|Induction Treatment Period|Physician Decision|0|||
162813385|NCT04677179|588028089|FG009|Induction Treatment Period|Physician Decision|0|||
162813386|NCT04677179|588028080|FG000|Induction Treatment Period|Protocol Violation|0|||
162813387|NCT04677179|588028081|FG001|Induction Treatment Period|Protocol Violation|1|||
162813388|NCT04677179|588028082|FG002|Induction Treatment Period|Protocol Violation|0|||
162813389|NCT04677179|588028083|FG003|Induction Treatment Period|Protocol Violation|0|||
162813390|NCT04677179|588028084|FG004|Induction Treatment Period|Protocol Violation|0|||
162813391|NCT04677179|588028085|FG005|Induction Treatment Period|Protocol Violation|0|||
162813392|NCT04677179|588028086|FG006|Induction Treatment Period|Protocol Violation|0|||
162813393|NCT04677179|588028087|FG007|Induction Treatment Period|Protocol Violation|0|||
162813394|NCT04677179|588028088|FG008|Induction Treatment Period|Protocol Violation|0|||
162813395|NCT04677179|588028089|FG009|Induction Treatment Period|Protocol Violation|0|||
162813396|NCT04677179|588028080|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
162813397|NCT04677179|588028081|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
162813398|NCT04677179|588028082|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
162813399|NCT04677179|588028083|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
162813400|NCT04677179|588028084|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
162813401|NCT04677179|588028085|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
162813402|NCT04677179|588028086|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
162813403|NCT04677179|588028087|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
162813404|NCT04677179|588028088|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
162813405|NCT04677179|588028089|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
162813406|NCT04677179|588028080|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
162813407|NCT04677179|588028081|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
162813408|NCT04677179|588028082|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
162813409|NCT04677179|588028083|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
162813410|NCT04677179|588028084|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
162813411|NCT04677179|588028085|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
162813412|NCT04677179|588028086|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
162813413|NCT04677179|588028087|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
162813414|NCT04677179|588028088|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
162813415|NCT04677179|588028089|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
162813416|NCT04677179|588028080|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
162813417|NCT04677179|588028081|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
162813418|NCT04677179|588028082|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
162813419|NCT04677179|588028083|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
162813420|NCT04677179|588028084|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
162813421|NCT04677179|588028085|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
162813422|NCT04677179|588028086|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
162813423|NCT04677179|588028087|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
162813424|NCT04677179|588028088|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
162813425|NCT04677179|588028089|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
162813426|NCT04677179|588028080|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813427|NCT04677179|588028081|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813428|NCT04677179|588028082|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813429|NCT04677179|588028083|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
162813430|NCT04677179|588028084|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813431|NCT04677179|588028085|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813432|NCT04677179|588028086|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813433|NCT04677179|588028087|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813434|NCT04677179|588028088|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813435|NCT04677179|588028089|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
162813436|NCT04677179|588028080|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813437|NCT04677179|588028081|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813438|NCT04677179|588028082|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813439|NCT04677179|588028083|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
162813440|NCT04677179|588028084|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
162813441|NCT04677179|588028085|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
162813442|NCT04677179|588028086|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813443|NCT04677179|588028087|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813444|NCT04677179|588028088|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813445|NCT04677179|588028089|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
162813446|NCT04677179|588028080|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162813447|NCT04677179|588028081|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162813448|NCT04677179|588028082|FG002|Extension Treatment Period|Lack of Efficacy|0|||
162813449|NCT04677179|588028083|FG003|Extension Treatment Period|Lack of Efficacy|0|||
162813450|NCT04677179|588028084|FG004|Extension Treatment Period|Lack of Efficacy|0|||
162813451|NCT04677179|588028085|FG005|Extension Treatment Period|Lack of Efficacy|0|||
162813452|NCT04677179|588028086|FG006|Extension Treatment Period|Lack of Efficacy|6|||
162813453|NCT04677179|588028087|FG007|Extension Treatment Period|Lack of Efficacy|0|||
162813454|NCT04677179|588028088|FG008|Extension Treatment Period|Lack of Efficacy|0|||
162813455|NCT04677179|588028089|FG009|Extension Treatment Period|Lack of Efficacy|0|||
162813456|NCT04677179|588028080|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162813457|NCT04677179|588028081|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162813458|NCT04677179|588028082|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
162813459|NCT04677179|588028083|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
162813460|NCT04677179|588028084|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
162813461|NCT04677179|588028085|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
162813462|NCT04677179|588028086|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
162813463|NCT04677179|588028087|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
162813464|NCT04677179|588028088|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
162813465|NCT04677179|588028089|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
162813466|NCT04677179|588028080|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
162813467|NCT04677179|588028081|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
162813468|NCT04677179|588028082|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
162813469|NCT04677179|588028083|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
162813470|NCT04677179|588028084|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
162813471|NCT04677179|588028085|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
162813472|NCT04677179|588028086|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
162813473|NCT04677179|588028087|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
162813474|NCT04677179|588028088|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
162813475|NCT04677179|588028089|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
162813476|NCT04677179|588028080|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
162813477|NCT04677179|588028081|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
162813478|NCT04677179|588028082|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
162813479|NCT04677179|588028083|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
162813480|NCT04677179|588028084|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
162813481|NCT04677179|588028085|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
162813482|NCT04677179|588028086|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
162813483|NCT04677179|588028087|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
162813484|NCT04677179|588028088|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
162813485|NCT04677179|588028089|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
162813486|NCT04677179|588028080|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813487|NCT04677179|588028081|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813488|NCT04677179|588028082|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813489|NCT04677179|588028083|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163161791|NCT02963506|589305892|FG004|Double-Blind Period|No compliance|0|||
162813490|NCT04677179|588028084|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813491|NCT04677179|588028085|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813492|NCT04677179|588028086|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163161792|NCT02963506|589305893|FG005|Double-Blind Period|No compliance|0|||
162813493|NCT04677179|588028087|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
162813494|NCT04677179|588028088|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
162813495|NCT04677179|588028089|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162813496|NCT04677179|588028080|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813497|NCT04677179|588028081|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813498|NCT04677179|588028082|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813499|NCT04677179|588028083|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813500|NCT04677179|588028084|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813501|NCT04677179|588028085|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813502|NCT04677179|588028086|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813503|NCT04677179|588028087|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
162813504|NCT04677179|588028088|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813505|NCT04677179|588028089|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162813506|NCT04677179|588028080|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813507|NCT04677179|588028081|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813508|NCT04677179|588028082|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813509|NCT04677179|588028083|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813510|NCT04677179|588028084|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813511|NCT04677179|588028085|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813512|NCT04677179|588028086|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813513|NCT04677179|588028087|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
162813514|NCT04677179|588028088|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
162813515|NCT04677179|588028089|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162813516|NCT04677179|588028080|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813517|NCT04677179|588028081|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813518|NCT04677179|588028082|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813519|NCT04677179|588028083|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813520|NCT04677179|588028084|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813521|NCT04677179|588028085|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813522|NCT04677179|588028086|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162813523|NCT04677179|588028087|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
162813524|NCT04677179|588028088|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
162813525|NCT04677179|588028089|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
162813526|NCT01723254|588028090|FG000|Overall Study|Conflict with work schedule|0|||
162813527|NCT01723254|588028091|FG001|Overall Study|Conflict with work schedule|0|||
162813528|NCT01723254|588028092|FG002|Overall Study|Conflict with work schedule|0|||
162813529|NCT01723254|588028093|FG003|Overall Study|Conflict with work schedule|0|||
162813530|NCT01723254|588028094|FG004|Overall Study|Conflict with work schedule|0|||
162813531|NCT01723254|588028095|FG005|Overall Study|Conflict with work schedule|0|||
162813532|NCT01723254|588028096|FG006|Overall Study|Conflict with work schedule|0|||
162813533|NCT01723254|588028097|FG007|Overall Study|Conflict with work schedule|1|||
162813534|NCT01723254|588028090|FG000|Overall Study|Personal issues|0|||
162813535|NCT01723254|588028091|FG001|Overall Study|Personal issues|0|||
162813536|NCT01723254|588028092|FG002|Overall Study|Personal issues|0|||
162813537|NCT01723254|588028093|FG003|Overall Study|Personal issues|0|||
162813538|NCT01723254|588028094|FG004|Overall Study|Personal issues|0|||
162813539|NCT01723254|588028095|FG005|Overall Study|Personal issues|1|||
162813540|NCT01723254|588028096|FG006|Overall Study|Personal issues|0|||
162813541|NCT01723254|588028097|FG007|Overall Study|Personal issues|0|||
162813542|NCT01723254|588028090|FG000|Overall Study|No longer have time to participate|0|||
162813543|NCT01723254|588028091|FG001|Overall Study|No longer have time to participate|0|||
162813544|NCT01723254|588028092|FG002|Overall Study|No longer have time to participate|0|||
162813545|NCT01723254|588028093|FG003|Overall Study|No longer have time to participate|1|||
162813546|NCT01723254|588028094|FG004|Overall Study|No longer have time to participate|0|||
162813547|NCT01723254|588028095|FG005|Overall Study|No longer have time to participate|0|||
162813548|NCT01723254|588028096|FG006|Overall Study|No longer have time to participate|0|||
162813549|NCT01723254|588028097|FG007|Overall Study|No longer have time to participate|0|||
162813550|NCT01723254|588028090|FG000|Overall Study|Move/Left to another country/city|0|||
162813551|NCT01723254|588028091|FG001|Overall Study|Move/Left to another country/city|0|||
162813552|NCT01723254|588028092|FG002|Overall Study|Move/Left to another country/city|2|||
162813553|NCT01723254|588028093|FG003|Overall Study|Move/Left to another country/city|1|||
162813554|NCT01723254|588028094|FG004|Overall Study|Move/Left to another country/city|1|||
162813555|NCT01723254|588028095|FG005|Overall Study|Move/Left to another country/city|0|||
162813556|NCT01723254|588028096|FG006|Overall Study|Move/Left to another country/city|0|||
162813557|NCT01723254|588028097|FG007|Overall Study|Move/Left to another country/city|0|||
162813558|NCT01723254|588028090|FG000|Overall Study|Protocol Violation|0|||
162813559|NCT01723254|588028091|FG001|Overall Study|Protocol Violation|1|||
162813560|NCT01723254|588028092|FG002|Overall Study|Protocol Violation|0|||
162813561|NCT01723254|588028093|FG003|Overall Study|Protocol Violation|0|||
162813562|NCT01723254|588028094|FG004|Overall Study|Protocol Violation|0|||
163161793|NCT02963506|589305894|FG006|Double-Blind Period|No compliance|0|||
163161794|NCT02963506|589305895|FG007|Double-Blind Period|No compliance|0|||
163161795|NCT02963506|589305896|FG008|Double-Blind Period|No compliance|0|||
163161796|NCT02963506|589305897|FG009|Double-Blind Period|No compliance|0|||
163161797|NCT02963506|589305898|FG010|Double-Blind Period|No compliance|0|||
163161798|NCT02963506|589305899|FG011|Double-Blind Period|No compliance|0|||
163161799|NCT02963506|589305900|FG012|Double-Blind Period|No compliance|0|||
163161800|NCT02963506|589305888|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161801|NCT02963506|589305889|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
163161802|NCT02963506|589305890|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161803|NCT02963506|589305891|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161804|NCT02963506|589305892|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161805|NCT02963506|589305893|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161806|NCT02963506|589305894|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161807|NCT02963506|589305895|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161808|NCT02963506|589305896|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161809|NCT02963506|589305897|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161810|NCT02963506|589305898|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161811|NCT02963506|589305899|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161812|NCT02963506|589305900|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
163161813|NCT02963506|589305888|FG000|Dose-Blind Period|Adverse Event|0|||
163161814|NCT02963506|589305889|FG001|Dose-Blind Period|Adverse Event|0|||
163161815|NCT02963506|589305890|FG002|Dose-Blind Period|Adverse Event|0|||
163161816|NCT02963506|589305891|FG003|Dose-Blind Period|Adverse Event|0|||
163161817|NCT02963506|589305892|FG004|Dose-Blind Period|Adverse Event|0|||
163161818|NCT02963506|589305893|FG005|Dose-Blind Period|Adverse Event|1|||
163161819|NCT02963506|589305894|FG006|Dose-Blind Period|Adverse Event|3|||
163161820|NCT02963506|589305895|FG007|Dose-Blind Period|Adverse Event|2|||
163161821|NCT02963506|589305896|FG008|Dose-Blind Period|Adverse Event|2|||
163161822|NCT02963506|589305897|FG009|Dose-Blind Period|Adverse Event|2|||
163161823|NCT02963506|589305898|FG010|Dose-Blind Period|Adverse Event|1|||
162697891|NCT01474512|587605417|FG005|Long-Term Extension Period|Death|0|||
162697892|NCT01474512|587605418|FG006|Long-Term Extension Period|Death|0|||
162697893|NCT01474512|587605419|FG007|Long-Term Extension Period|Death|0|||
162697894|NCT01474512|587605420|FG008|Long-Term Extension Period|Death|0|||
162697895|NCT01474512|587605421|FG009|Long-Term Extension Period|Death|0|||
162697896|NCT01474512|587605422|FG010|Long-Term Extension Period|Death|0|||
162697897|NCT01474512|587605423|FG011|Long-Term Extension Period|Death|0|||
162697898|NCT01474512|587605424|FG012|Long-Term Extension Period|Death|9|||
162697899|NCT01474512|587605425|FG013|Long-Term Extension Period|Death|9|||
162697900|NCT01474512|587605426|FG014|Long-Term Extension Period|Death|0|||
162697901|NCT01474512|587605427|FG015|Long-Term Extension Period|Death|0|||
162697902|NCT01474512|587605428|FG016|Long-Term Extension Period|Death|0|||
162697903|NCT01474512|587605429|FG017|Long-Term Extension Period|Death|0|||
162697904|NCT01474512|587605412|FG000|Long-Term Extension Period|Sponsor Decision|0|||
162697905|NCT01474512|587605413|FG001|Long-Term Extension Period|Sponsor Decision|0|||
162697906|NCT01474512|587605414|FG002|Long-Term Extension Period|Sponsor Decision|0|||
162697907|NCT01474512|587605415|FG003|Long-Term Extension Period|Sponsor Decision|0|||
162697908|NCT01474512|587605416|FG004|Long-Term Extension Period|Sponsor Decision|0|||
162697909|NCT01474512|587605417|FG005|Long-Term Extension Period|Sponsor Decision|0|||
162697910|NCT01474512|587605418|FG006|Long-Term Extension Period|Sponsor Decision|0|||
162697911|NCT01474512|587605419|FG007|Long-Term Extension Period|Sponsor Decision|0|||
162697912|NCT01474512|587605420|FG008|Long-Term Extension Period|Sponsor Decision|0|||
162697913|NCT01474512|587605421|FG009|Long-Term Extension Period|Sponsor Decision|0|||
162697914|NCT01474512|587605422|FG010|Long-Term Extension Period|Sponsor Decision|0|||
162697915|NCT01474512|587605423|FG011|Long-Term Extension Period|Sponsor Decision|0|||
162697916|NCT01474512|587605424|FG012|Long-Term Extension Period|Sponsor Decision|6|||
162697917|NCT01474512|587605425|FG013|Long-Term Extension Period|Sponsor Decision|6|||
162697918|NCT01474512|587605426|FG014|Long-Term Extension Period|Sponsor Decision|0|||
162697919|NCT01474512|587605427|FG015|Long-Term Extension Period|Sponsor Decision|0|||
162697920|NCT01474512|587605428|FG016|Long-Term Extension Period|Sponsor Decision|0|||
162697921|NCT01474512|587605429|FG017|Long-Term Extension Period|Sponsor Decision|0|||
162697922|NCT01474512|587605412|FG000|Long-Term Extension Period|Protocol Violation|0|||
162697923|NCT01474512|587605413|FG001|Long-Term Extension Period|Protocol Violation|0|||
162697924|NCT01474512|587605414|FG002|Long-Term Extension Period|Protocol Violation|0|||
162697925|NCT01474512|587605415|FG003|Long-Term Extension Period|Protocol Violation|0|||
162697926|NCT01474512|587605416|FG004|Long-Term Extension Period|Protocol Violation|0|||
162697927|NCT01474512|587605417|FG005|Long-Term Extension Period|Protocol Violation|0|||
162697928|NCT01474512|587605418|FG006|Long-Term Extension Period|Protocol Violation|0|||
162697929|NCT01474512|587605419|FG007|Long-Term Extension Period|Protocol Violation|0|||
163161824|NCT02963506|589305899|FG011|Dose-Blind Period|Adverse Event|1|||
163161825|NCT02963506|589305900|FG012|Dose-Blind Period|Adverse Event|6|||
163161826|NCT02963506|589305888|FG000|Dose-Blind Period|Lack of Efficacy|0|||
162813563|NCT01723254|588028095|FG005|Overall Study|Protocol Violation|0|||
162813564|NCT01723254|588028096|FG006|Overall Study|Protocol Violation|0|||
162813565|NCT01723254|588028097|FG007|Overall Study|Protocol Violation|0|||
162813566|NCT01723254|588028090|FG000|Overall Study|Withdrawal by Subject|1|||
162813567|NCT01723254|588028091|FG001|Overall Study|Withdrawal by Subject|2|||
162813568|NCT01723254|588028092|FG002|Overall Study|Withdrawal by Subject|1|||
162813569|NCT01723254|588028093|FG003|Overall Study|Withdrawal by Subject|0|||
162813570|NCT01723254|588028094|FG004|Overall Study|Withdrawal by Subject|1|||
162813571|NCT01723254|588028095|FG005|Overall Study|Withdrawal by Subject|1|||
162813572|NCT01723254|588028096|FG006|Overall Study|Withdrawal by Subject|1|||
162813573|NCT01723254|588028097|FG007|Overall Study|Withdrawal by Subject|2|||
162813574|NCT01257425|588028098|FG000|Overall Study|Lack of Efficacy|3|||
162813575|NCT01257425|588028099|FG001|Overall Study|Lack of Efficacy|3|||
162813576|NCT01257425|588028098|FG000|Overall Study|Adverse Event|1|||
162813577|NCT01257425|588028099|FG001|Overall Study|Adverse Event|1|||
162813578|NCT01257425|588028098|FG000|Overall Study|Protocol Violation|1|||
162813579|NCT01257425|588028099|FG001|Overall Study|Protocol Violation|1|||
162813580|NCT01257425|588028098|FG000|Overall Study|Withdrawal by Subject|0|||
162813581|NCT01257425|588028099|FG001|Overall Study|Withdrawal by Subject|1|||
162813582|NCT01257425|588028098|FG000|Overall Study|Death|1|||
162813583|NCT01257425|588028099|FG001|Overall Study|Death|0|||
162813584|NCT02656823|588028103|FG000|Overall Study|Adverse Event|3|||
162813585|NCT02656823|588028103|FG000|Overall Study|Lost to Follow-up|2|||
162813586|NCT02903368|588028105|FG000|Part 1|Adverse Event|3|||
162813587|NCT02903368|588028106|FG001|Part 1|Adverse Event|0|||
162813588|NCT02903368|588028107|FG002|Part 1|Adverse Event|0|||
162813589|NCT02903368|588028108|FG003|Part 1|Adverse Event|0|||
162813590|NCT02903368|588028105|FG000|Part 1|Withdrawal by Subject|1|||
162813591|NCT02903368|588028106|FG001|Part 1|Withdrawal by Subject|0|||
162813592|NCT02903368|588028107|FG002|Part 1|Withdrawal by Subject|0|||
162813593|NCT02903368|588028108|FG003|Part 1|Withdrawal by Subject|0|||
162813594|NCT02903368|588028105|FG000|Part 2|Adverse Event|0|||
162813595|NCT02903368|588028106|FG001|Part 2|Adverse Event|0|||
162813596|NCT02903368|588028107|FG002|Part 2|Adverse Event|5|||
162813597|NCT02903368|588028108|FG003|Part 2|Adverse Event|0|||
162813598|NCT02903368|588028105|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162813599|NCT02903368|588028106|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162813600|NCT02903368|588028107|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
162813601|NCT02903368|588028108|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162813602|NCT02903368|588028105|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162813603|NCT02903368|588028106|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162813604|NCT02903368|588028107|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
162813605|NCT02903368|588028108|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162813606|NCT02903368|588028105|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
162813607|NCT02903368|588028106|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
162813608|NCT02903368|588028107|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
162813609|NCT02903368|588028108|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
162813610|NCT03769181|588029524|FG000|Overall Study|Adverse Event|1|||
162813611|NCT03769181|588029525|FG001|Overall Study|Adverse Event|0|||
162813612|NCT03769181|588029526|FG002|Overall Study|Adverse Event|2|||
162813613|NCT03769181|588029527|FG003|Overall Study|Adverse Event|4|||
162813614|NCT03769181|588029524|FG000|Overall Study|Withdrawal by Subject|1|||
162813615|NCT03769181|588029525|FG001|Overall Study|Withdrawal by Subject|0|||
162813616|NCT03769181|588029526|FG002|Overall Study|Withdrawal by Subject|2|||
162813617|NCT03769181|588029527|FG003|Overall Study|Withdrawal by Subject|1|||
162813618|NCT03769181|588029524|FG000|Overall Study|Progressive disease|9|||
162813619|NCT03769181|588029525|FG001|Overall Study|Progressive disease|7|||
162813620|NCT03769181|588029526|FG002|Overall Study|Progressive disease|13|||
162813621|NCT03769181|588029527|FG003|Overall Study|Progressive disease|6|||
162813622|NCT03769181|588029524|FG000|Overall Study|Other - Unspecified|2|||
163161827|NCT02963506|589305889|FG001|Dose-Blind Period|Lack of Efficacy|0|||
163161828|NCT02963506|589305890|FG002|Dose-Blind Period|Lack of Efficacy|0|||
163161829|NCT02963506|589305891|FG003|Dose-Blind Period|Lack of Efficacy|0|||
163161830|NCT02963506|589305892|FG004|Dose-Blind Period|Lack of Efficacy|0|||
162813623|NCT03769181|588029525|FG001|Overall Study|Other - Unspecified|1|||
162813624|NCT03769181|588029526|FG002|Overall Study|Other - Unspecified|0|||
163161831|NCT02963506|589305893|FG005|Dose-Blind Period|Lack of Efficacy|0|||
162813625|NCT03769181|588029527|FG003|Overall Study|Other - Unspecified|0|||
162813626|NCT00826111|588029534|FG000|Overall Study|Lost to Follow-up|0|||
163161832|NCT02963506|589305894|FG006|Dose-Blind Period|Lack of Efficacy|0|||
162813627|NCT00826111|588029535|FG001|Overall Study|Lost to Follow-up|1|||
162813628|NCT00826111|588029534|FG000|Overall Study|Protocol Violation|1|||
162813629|NCT00826111|588029535|FG001|Overall Study|Protocol Violation|0|||
162813630|NCT00826111|588029534|FG000|Overall Study|Withdrawal by Subject|5|||
163161833|NCT02963506|589305895|FG007|Dose-Blind Period|Lack of Efficacy|1|||
162813631|NCT00826111|588029535|FG001|Overall Study|Withdrawal by Subject|0|||
162813632|NCT00826111|588029534|FG000|Overall Study|Physician Decision|1|||
162813633|NCT00826111|588029535|FG001|Overall Study|Physician Decision|1|||
162813634|NCT01195545|588029536|FG000|Overall Study|Protocol Violation|4|||
163161834|NCT02963506|589305896|FG008|Dose-Blind Period|Lack of Efficacy|0|||
163161835|NCT02963506|589305897|FG009|Dose-Blind Period|Lack of Efficacy|1|||
163161836|NCT02963506|589305898|FG010|Dose-Blind Period|Lack of Efficacy|0|||
163161837|NCT02963506|589305899|FG011|Dose-Blind Period|Lack of Efficacy|0|||
163161838|NCT02963506|589305900|FG012|Dose-Blind Period|Lack of Efficacy|0|||
163161839|NCT02963506|589305888|FG000|Dose-Blind Period|Lost to Follow-up|0|||
163161840|NCT02963506|589305889|FG001|Dose-Blind Period|Lost to Follow-up|0|||
163161841|NCT02963506|589305890|FG002|Dose-Blind Period|Lost to Follow-up|0|||
163161842|NCT02963506|589305891|FG003|Dose-Blind Period|Lost to Follow-up|0|||
163161843|NCT02963506|589305892|FG004|Dose-Blind Period|Lost to Follow-up|0|||
163161844|NCT02963506|589305893|FG005|Dose-Blind Period|Lost to Follow-up|1|||
163161845|NCT02963506|589305894|FG006|Dose-Blind Period|Lost to Follow-up|0|||
162813635|NCT01929980|588029537|FG000|Overall Study|Physician Decision|1|||
162813636|NCT02276872|588029538|FG000|Overall Study|Adverse Event|1|||
162813637|NCT02276872|588029539|FG001|Overall Study|Adverse Event|0|||
162813638|NCT02276872|588029540|FG002|Overall Study|Adverse Event|0|||
162813639|NCT04175808|588029541|FG000|Part A|Miscellaneous|2|||
162813640|NCT04175808|588029542|FG001|Part A|Miscellaneous|0|||
162813641|NCT04175808|588029543|FG002|Part A|Miscellaneous|0|||
162813642|NCT04175808|588029544|FG003|Part A|Miscellaneous|0|||
162813643|NCT04175808|588029545|FG004|Part A|Miscellaneous|0|||
162813644|NCT04175808|588029546|FG005|Part A|Miscellaneous|0|||
162813645|NCT04175808|588029547|FG006|Part A|Miscellaneous|0|||
162813646|NCT00402363|588029549|FG000|Overall Study|Adverse Event|9|||
162813647|NCT00402363|588029550|FG001|Overall Study|Adverse Event|14|||
162813648|NCT00402363|588029551|FG002|Overall Study|Adverse Event|2|||
162813649|NCT00402363|588029552|FG003|Overall Study|Adverse Event|2|||
162813650|NCT00402363|588029549|FG000|Overall Study|Withdrew Consent|10|||
162813651|NCT00402363|588029550|FG001|Overall Study|Withdrew Consent|5|||
162813652|NCT00402363|588029551|FG002|Overall Study|Withdrew Consent|2|||
162813653|NCT00402363|588029552|FG003|Overall Study|Withdrew Consent|1|||
162813654|NCT00402363|588029549|FG000|Overall Study|Protocol Violation|3|||
162813655|NCT00402363|588029550|FG001|Overall Study|Protocol Violation|5|||
162813656|NCT00402363|588029551|FG002|Overall Study|Protocol Violation|0|||
162813657|NCT00402363|588029552|FG003|Overall Study|Protocol Violation|3|||
162813658|NCT00402363|588029549|FG000|Overall Study|Lost to Follow-up|5|||
162813659|NCT00402363|588029550|FG001|Overall Study|Lost to Follow-up|4|||
162813660|NCT00402363|588029551|FG002|Overall Study|Lost to Follow-up|0|||
162813661|NCT00402363|588029552|FG003|Overall Study|Lost to Follow-up|2|||
162813662|NCT00402363|588029549|FG000|Overall Study|"Captured as Other"|6|||
162813663|NCT00402363|588029550|FG001|Overall Study|"Captured as Other"|2|||
162813664|NCT00402363|588029551|FG002|Overall Study|"Captured as Other"|2|||
162813665|NCT00402363|588029552|FG003|Overall Study|"Captured as Other"|2|||
162813666|NCT00568321|588029561|FG000|Overall Study|Adverse Event|1|||
162813667|NCT00568321|588029562|FG001|Overall Study|Adverse Event|0|||
162813668|NCT00568321|588029563|FG002|Overall Study|Adverse Event|0|||
162813669|NCT00568321|588029561|FG000|Overall Study|Lack of Efficacy|8|||
162813670|NCT00568321|588029562|FG001|Overall Study|Lack of Efficacy|5|||
162813671|NCT00568321|588029563|FG002|Overall Study|Lack of Efficacy|6|||
162813672|NCT00568321|588029561|FG000|Overall Study|Lost to Follow-up|0|||
162813673|NCT00568321|588029562|FG001|Overall Study|Lost to Follow-up|0|||
163161846|NCT02963506|589305895|FG007|Dose-Blind Period|Lost to Follow-up|0|||
163161847|NCT02963506|589305896|FG008|Dose-Blind Period|Lost to Follow-up|1|||
163161848|NCT02963506|589305897|FG009|Dose-Blind Period|Lost to Follow-up|0|||
163161849|NCT02963506|589305898|FG010|Dose-Blind Period|Lost to Follow-up|0|||
163161850|NCT02963506|589305899|FG011|Dose-Blind Period|Lost to Follow-up|1|||
163161851|NCT02963506|589305900|FG012|Dose-Blind Period|Lost to Follow-up|0|||
162813674|NCT00568321|588029563|FG002|Overall Study|Lost to Follow-up|1|||
162813675|NCT00568321|588029561|FG000|Overall Study|Withdrawal by Subject|2|||
162813676|NCT00568321|588029562|FG001|Overall Study|Withdrawal by Subject|0|||
162813677|NCT00568321|588029563|FG002|Overall Study|Withdrawal by Subject|0|||
162813678|NCT00568321|588029561|FG000|Overall Study|Protocol Violation|0|||
162813679|NCT00568321|588029562|FG001|Overall Study|Protocol Violation|0|||
162813680|NCT00568321|588029563|FG002|Overall Study|Protocol Violation|1|||
162813681|NCT00568321|588029561|FG000|Overall Study|Randomized, not treated|2|||
162813682|NCT00568321|588029562|FG001|Overall Study|Randomized, not treated|0|||
162813683|NCT00568321|588029563|FG002|Overall Study|Randomized, not treated|1|||
162813684|NCT00937833|588029564|FG000|Overall Study|Protocol Violation|1|||
162813685|NCT00937833|588029565|FG001|Overall Study|Protocol Violation|2|||
162813686|NCT00937833|588029564|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
162813687|NCT00937833|588029565|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
162813688|NCT00937833|588029564|FG000|Overall Study|Lost to Follow-up|10|||
162813689|NCT00937833|588029565|FG001|Overall Study|Lost to Follow-up|8|||
162813690|NCT00937833|588029564|FG000|Overall Study|Withdrawal by Subject|4|||
163161852|NCT02963506|589305888|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
163161853|NCT02963506|589305889|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
163161854|NCT02963506|589305890|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
163161855|NCT02963506|589305891|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
163161856|NCT02963506|589305892|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
163161857|NCT02963506|589305893|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
163161858|NCT02963506|589305894|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
163161859|NCT02963506|589305895|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
163161860|NCT02963506|589305896|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
163161861|NCT02963506|589305897|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
163161862|NCT02963506|589305898|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
163161863|NCT02963506|589305899|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
163161864|NCT02963506|589305900|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
163161865|NCT02963506|589305888|FG000|Dose-Blind Period|Sponsor decision|0|||
163161866|NCT02963506|589305889|FG001|Dose-Blind Period|Sponsor decision|0|||
163161867|NCT02963506|589305890|FG002|Dose-Blind Period|Sponsor decision|0|||
163161868|NCT02963506|589305891|FG003|Dose-Blind Period|Sponsor decision|0|||
163161869|NCT02963506|589305892|FG004|Dose-Blind Period|Sponsor decision|0|||
163161870|NCT02963506|589305893|FG005|Dose-Blind Period|Sponsor decision|1|||
163161871|NCT02963506|589305894|FG006|Dose-Blind Period|Sponsor decision|0|||
163161872|NCT02963506|589305895|FG007|Dose-Blind Period|Sponsor decision|0|||
163161873|NCT02963506|589305896|FG008|Dose-Blind Period|Sponsor decision|0|||
163161874|NCT02963506|589305897|FG009|Dose-Blind Period|Sponsor decision|0|||
163161875|NCT02963506|589305898|FG010|Dose-Blind Period|Sponsor decision|0|||
163161876|NCT02963506|589305899|FG011|Dose-Blind Period|Sponsor decision|0|||
163161877|NCT02963506|589305900|FG012|Dose-Blind Period|Sponsor decision|0|||
163161878|NCT02963506|589305888|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161879|NCT02963506|589305889|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161880|NCT02963506|589305890|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161881|NCT02963506|589305891|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161882|NCT02963506|589305892|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161883|NCT02963506|589305893|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161884|NCT02963506|589305894|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161885|NCT02963506|589305895|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161886|NCT02963506|589305896|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162697930|NCT01474512|587605420|FG008|Long-Term Extension Period|Protocol Violation|0|||
162697931|NCT01474512|587605421|FG009|Long-Term Extension Period|Protocol Violation|0|||
162697932|NCT01474512|587605422|FG010|Long-Term Extension Period|Protocol Violation|0|||
162697933|NCT01474512|587605423|FG011|Long-Term Extension Period|Protocol Violation|0|||
162697934|NCT01474512|587605424|FG012|Long-Term Extension Period|Protocol Violation|5|||
162697935|NCT01474512|587605425|FG013|Long-Term Extension Period|Protocol Violation|5|||
162697936|NCT01474512|587605426|FG014|Long-Term Extension Period|Protocol Violation|0|||
162697937|NCT01474512|587605427|FG015|Long-Term Extension Period|Protocol Violation|0|||
162697938|NCT01474512|587605428|FG016|Long-Term Extension Period|Protocol Violation|0|||
162697939|NCT01474512|587605429|FG017|Long-Term Extension Period|Protocol Violation|0|||
162697940|NCT01474512|587605412|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697941|NCT01474512|587605413|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697942|NCT01474512|587605414|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697943|NCT01474512|587605415|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697944|NCT01474512|587605416|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697945|NCT01474512|587605417|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697946|NCT01474512|587605418|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697947|NCT01474512|587605419|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697948|NCT01474512|587605420|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697949|NCT01474512|587605421|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697950|NCT01474512|587605422|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697951|NCT01474512|587605423|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697952|NCT01474512|587605424|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
162697953|NCT01474512|587605425|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
162697954|NCT01474512|587605426|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697955|NCT01474512|587605427|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697956|NCT01474512|587605428|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697957|NCT01474512|587605429|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162697958|NCT01474512|587605412|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697959|NCT01474512|587605413|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697960|NCT01474512|587605414|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697961|NCT01474512|587605415|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697962|NCT01474512|587605416|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697963|NCT01474512|587605417|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697964|NCT01474512|587605418|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697965|NCT01474512|587605419|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163161887|NCT02963506|589305897|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161888|NCT02963506|589305898|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161889|NCT02963506|589305899|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
163161890|NCT02963506|589305900|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
163161891|NCT01724346|589305901|FG000|Overall Study|Death|42|||
163161892|NCT01724346|589305902|FG001|Overall Study|Death|42|||
163161893|NCT01724346|589305901|FG000|Overall Study|Lost to Follow-up|5|||
163161894|NCT01724346|589305902|FG001|Overall Study|Lost to Follow-up|1|||
163161895|NCT01724346|589305901|FG000|Overall Study|Withdrawal by Subject|27|||
163161896|NCT01724346|589305902|FG001|Overall Study|Withdrawal by Subject|19|||
163161897|NCT01724346|589305901|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
163161898|NCT01724346|589305902|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
163161899|NCT00536744|589305905|FG000|Overall Study|Adverse Event|13|||
163161900|NCT00536744|589305906|FG001|Overall Study|Adverse Event|10|||
163161901|NCT00536744|589305905|FG000|Overall Study|Death|2|||
163161902|NCT00536744|589305906|FG001|Overall Study|Death|1|||
163161903|NCT00536744|589305905|FG000|Overall Study|Physician Decision|3|||
163161904|NCT00536744|589305906|FG001|Overall Study|Physician Decision|1|||
163161905|NCT00536744|589305905|FG000|Overall Study|Lost to Follow-up|3|||
163161906|NCT00536744|589305906|FG001|Overall Study|Lost to Follow-up|5|||
163161907|NCT00536744|589305905|FG000|Overall Study|Withdrawal by Subject|7|||
163161908|NCT00536744|589305906|FG001|Overall Study|Withdrawal by Subject|8|||
163161909|NCT00536744|589305905|FG000|Overall Study|PI tried alternative treatment|1|||
163161910|NCT00536744|589305906|FG001|Overall Study|PI tried alternative treatment|3|||
163161911|NCT00787644|589305907|FG000|Overall Study|Lost to Follow-up|1|||
163161912|NCT00787644|589305908|FG001|Overall Study|Lost to Follow-up|1|||
163161913|NCT00787644|589305907|FG000|Overall Study|Withdrawal by Subject|1|||
163161914|NCT00787644|589305908|FG001|Overall Study|Withdrawal by Subject|1|||
163161915|NCT01642589|589305912|FG000|Overall Study|Withdrawal by Subject|1|||
162813691|NCT00937833|588029565|FG001|Overall Study|Withdrawal by Subject|6|||
162813692|NCT03278106|588029568|FG000|Overall Study|No protocol treatment|1|||
162813693|NCT02175004|588029569|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
162813694|NCT02175004|588029570|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
162813695|NCT02175004|588029569|FG000|Overall Study|Investigator Judgment|1|||
162813696|NCT02175004|588029570|FG001|Overall Study|Investigator Judgment|4|||
162813697|NCT02175004|588029569|FG000|Overall Study|Voluntary Withdrawal|6|||
162813698|NCT02175004|588029570|FG001|Overall Study|Voluntary Withdrawal|19|||
162813699|NCT02175004|588029569|FG000|Overall Study|Liver Transplant|1|||
162813700|NCT02175004|588029570|FG001|Overall Study|Liver Transplant|0|||
162813701|NCT02175004|588029569|FG000|Overall Study|Disease Progression|1|||
162813702|NCT02175004|588029570|FG001|Overall Study|Disease Progression|0|||
162813703|NCT02175004|588029569|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
162813704|NCT02175004|588029570|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
162813705|NCT00162032|588029572|FG000|Overall Study|Lost to Follow-up|4|||
162813706|NCT00162032|588029573|FG001|Overall Study|Lost to Follow-up|2|||
162813707|NCT00162032|588029572|FG000|Overall Study|Reason not specified|1|||
162813708|NCT00162032|588029573|FG001|Overall Study|Reason not specified|0|||
162813709|NCT01137955|588029574|FG000|Overall Study|Withdrawal by Subject|5|||
162813710|NCT01137955|588029575|FG001|Overall Study|Withdrawal by Subject|4|||
162813711|NCT04263909|588029576|FG000|Overall Study|Physician Decision|1|||
162813712|NCT04263909|588029577|FG001|Overall Study|Physician Decision|0|||
162813713|NCT04263909|588029578|FG002|Overall Study|Physician Decision|0|||
162813714|NCT04263909|588029576|FG000|Overall Study|Adverse Event|3|||
162813715|NCT04263909|588029577|FG001|Overall Study|Adverse Event|0|||
162813716|NCT04263909|588029578|FG002|Overall Study|Adverse Event|0|||
162813717|NCT04263909|588029576|FG000|Overall Study|Protocol Violation|5|||
162813718|NCT04263909|588029577|FG001|Overall Study|Protocol Violation|0|||
162813719|NCT04263909|588029578|FG002|Overall Study|Protocol Violation|0|||
162813720|NCT00068588|588029579|FG000|Overall Study|Adverse Event|0|||
162813721|NCT00068588|588029580|FG001|Overall Study|Adverse Event|0|||
163161916|NCT01642589|589305913|FG001|Overall Study|Withdrawal by Subject|1|||
163161917|NCT01108185|589305914|FG000|Overall Study|Non-compliance|15|||
163161918|NCT01108185|589305914|FG000|Overall Study|Lost to Follow-up|12|||
162813722|NCT00068588|588029581|FG002|Overall Study|Adverse Event|2|||
162813723|NCT00068588|588029579|FG000|Overall Study|Withdrawal by Subject|0|||
162813724|NCT00068588|588029580|FG001|Overall Study|Withdrawal by Subject|0|||
162813725|NCT00068588|588029581|FG002|Overall Study|Withdrawal by Subject|1|||
162813726|NCT00068588|588029579|FG000|Overall Study|Poor KPS|0|||
163161919|NCT02581410|589305919|FG000|Vaccination Phase|Adverse Event|2|||
163161920|NCT02581410|589305920|FG001|Vaccination Phase|Adverse Event|1|||
163161921|NCT02581410|589305919|FG000|Vaccination Phase|Withdrawal by Subject|0|||
163161922|NCT02581410|589305920|FG001|Vaccination Phase|Withdrawal by Subject|1|||
162813727|NCT00068588|588029580|FG001|Overall Study|Poor KPS|0|||
163161923|NCT02581410|589305919|FG000|Vaccination Phase|Migrated/moved from study area|0|||
162813728|NCT00068588|588029581|FG002|Overall Study|Poor KPS|1|||
162813729|NCT03840486|588029582|FG000|Overall Study|Withdrawal by Subject|0|||
162813730|NCT03840486|588029583|FG001|Overall Study|Withdrawal by Subject|1|||
162813731|NCT03840486|588029584|FG002|Overall Study|Withdrawal by Subject|0|||
162813732|NCT03840486|588029585|FG003|Overall Study|Withdrawal by Subject|0|||
162813733|NCT03840486|588029586|FG004|Overall Study|Withdrawal by Subject|0|||
162813734|NCT03840486|588029587|FG005|Overall Study|Withdrawal by Subject|0|||
162813735|NCT03840486|588029588|FG006|Overall Study|Withdrawal by Subject|0|||
162813736|NCT03840486|588029589|FG007|Overall Study|Withdrawal by Subject|0|||
162813737|NCT03840486|588029590|FG008|Overall Study|Withdrawal by Subject|0|||
162813738|NCT03840486|588029591|FG009|Overall Study|Withdrawal by Subject|0|||
162813739|NCT03840486|588029592|FG010|Overall Study|Withdrawal by Subject|0|||
162813740|NCT03840486|588029593|FG011|Overall Study|Withdrawal by Subject|0|||
162813741|NCT05116046|588029594|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162813742|NCT05116046|588029595|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162813743|NCT05116046|588029596|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162813744|NCT05116046|588029594|FG000|Overall Study|Study terminated by sponsor|14|||
162813745|NCT05116046|588029595|FG001|Overall Study|Study terminated by sponsor|16|||
162813746|NCT05116046|588029596|FG002|Overall Study|Study terminated by sponsor|1|||
162813747|NCT00146757|588029598|FG000|Overall Study|Death|1|||
162813748|NCT00146757|588029599|FG001|Overall Study|Death|0|||
162813749|NCT00146757|588029598|FG000|Overall Study|Adverse Event|1|||
162813750|NCT00146757|588029599|FG001|Overall Study|Adverse Event|0|||
162813751|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
162813752|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
162813753|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Death|0|||
162813754|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Death|2|||
162813755|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162813756|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
162813757|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
162813758|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
162813759|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
162813760|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
162813761|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
162813762|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
162813763|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
162813764|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
162813765|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
162813766|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
162813767|NCT00343252|588029611|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
162813768|NCT00343252|588029612|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
162813769|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
162813770|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
162813771|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Death|3|||
162813772|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Death|3|||
162813773|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162813774|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162813775|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
162813776|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
162813777|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
162813778|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
162813779|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
162813780|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
162813781|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
162813782|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
162813783|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
162813784|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
162813785|NCT00343252|588029611|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
162813786|NCT00343252|588029612|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
162813787|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
162813788|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
162813789|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Death|4|||
162813790|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Death|5|||
162813791|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
162813792|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162813793|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
162813794|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
162813795|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
162813796|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
162813797|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
162813798|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
162813799|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
162813800|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
162813801|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
162813802|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
162813803|NCT00343252|588029611|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
162813804|NCT00343252|588029612|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
162813805|NCT01026454|588029613|FG000|Second Intervention|Pregnancy|1|||
162813806|NCT01026454|588029614|FG001|Second Intervention|Pregnancy|1|||
162813807|NCT01592864|588029617|FG000|Overall Study|Withdrawal by Subject|0|||
162813808|NCT01592864|588029618|FG001|Overall Study|Withdrawal by Subject|1|||
162813809|NCT01971203|588029625|FG000|Overall Study|Protocol Violation|3|||
162813810|NCT01971203|588029626|FG001|Overall Study|Protocol Violation|2|||
162813811|NCT01971203|588029625|FG000|Overall Study|Withdrawal by Subject|5|||
162813812|NCT01971203|588029626|FG001|Overall Study|Withdrawal by Subject|6|||
162813813|NCT01971203|588029625|FG000|Overall Study|Adverse Event|1|||
162813814|NCT01971203|588029626|FG001|Overall Study|Adverse Event|0|||
162813815|NCT03037619|588029627|FG000|Overall Study|Lost to Follow-up|0|||
162813816|NCT03037619|588029628|FG001|Overall Study|Lost to Follow-up|1|||
162813817|NCT00307125|588029633|FG000|Screening Phase|Adverse Event|1|||
162813818|NCT00307125|588029634|FG001|Screening Phase|Adverse Event|0|||
162813819|NCT00307125|588029635|FG002|Screening Phase|Adverse Event|0|||
162813820|NCT00307125|588029633|FG000|Screening Phase|Protocol Violation|27|||
162813821|NCT00307125|588029634|FG001|Screening Phase|Protocol Violation|0|||
162813822|NCT00307125|588029635|FG002|Screening Phase|Protocol Violation|0|||
162813823|NCT00307125|588029633|FG000|Screening Phase|Lost to Follow-up|87|||
162813824|NCT00307125|588029634|FG001|Screening Phase|Lost to Follow-up|0|||
162813825|NCT00307125|588029635|FG002|Screening Phase|Lost to Follow-up|0|||
162813826|NCT00307125|588029633|FG000|Screening Phase|Death|10|||
162813827|NCT00307125|588029634|FG001|Screening Phase|Death|0|||
162813828|NCT00307125|588029635|FG002|Screening Phase|Death|0|||
162813829|NCT00307125|588029633|FG000|Screening Phase|Withdrawal by Subject|77|||
162813830|NCT00307125|588029634|FG001|Screening Phase|Withdrawal by Subject|0|||
162813831|NCT00307125|588029635|FG002|Screening Phase|Withdrawal by Subject|0|||
162813832|NCT00307125|588029633|FG000|Screening Phase|Physician Decision|26|||
162813833|NCT00307125|588029634|FG001|Screening Phase|Physician Decision|0|||
162813834|NCT00307125|588029635|FG002|Screening Phase|Physician Decision|0|||
162813835|NCT00307125|588029633|FG000|Screening Phase|Sponsor Decision|4|||
162813836|NCT00307125|588029634|FG001|Screening Phase|Sponsor Decision|0|||
162813837|NCT00307125|588029635|FG002|Screening Phase|Sponsor Decision|0|||
162813838|NCT00307125|588029633|FG000|Screening Phase|Study Terminated|17|||
162813839|NCT00307125|588029634|FG001|Screening Phase|Study Terminated|0|||
162813840|NCT00307125|588029635|FG002|Screening Phase|Study Terminated|0|||
162813841|NCT00307125|588029633|FG000|Screening Phase|Graft Loss|3|||
162813842|NCT00307125|588029634|FG001|Screening Phase|Graft Loss|0|||
162813843|NCT00307125|588029635|FG002|Screening Phase|Graft Loss|0|||
162813844|NCT00307125|588029633|FG000|Screening Phase|Graft Failure|8|||
162813845|NCT00307125|588029634|FG001|Screening Phase|Graft Failure|0|||
162813846|NCT00307125|588029635|FG002|Screening Phase|Graft Failure|0|||
162813847|NCT00307125|588029633|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
162813848|NCT00307125|588029634|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
162813849|NCT00307125|588029635|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
162813850|NCT00307125|588029633|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
162813851|NCT00307125|588029634|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
162813852|NCT00307125|588029635|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
162813853|NCT00307125|588029633|FG000|Screening Phase|Moved or transferred facilities|34|||
162813854|NCT00307125|588029634|FG001|Screening Phase|Moved or transferred facilities|0|||
162813855|NCT00307125|588029635|FG002|Screening Phase|Moved or transferred facilities|0|||
162813856|NCT00307125|588029633|FG000|Screening Phase|Received Pancreas Transplant|8|||
162813857|NCT00307125|588029634|FG001|Screening Phase|Received Pancreas Transplant|0|||
162813858|NCT00307125|588029635|FG002|Screening Phase|Received Pancreas Transplant|0|||
162813859|NCT00307125|588029633|FG000|Screening Phase|Ineligible for pilot|4|||
162813860|NCT00307125|588029634|FG001|Screening Phase|Ineligible for pilot|0|||
162813861|NCT00307125|588029635|FG002|Screening Phase|Ineligible for pilot|0|||
162813862|NCT00307125|588029633|FG000|Screening Phase|Try to get pregnant|1|||
162813863|NCT00307125|588029634|FG001|Screening Phase|Try to get pregnant|0|||
162813864|NCT00307125|588029635|FG002|Screening Phase|Try to get pregnant|0|||
162813865|NCT00307125|588029633|FG000|Screening Phase|Developed acute leukemia|1|||
162813866|NCT00307125|588029634|FG001|Screening Phase|Developed acute leukemia|0|||
162813867|NCT00307125|588029635|FG002|Screening Phase|Developed acute leukemia|0|||
162813868|NCT00307125|588029633|FG000|Screening Phase|Metastatic colon cancer|1|||
162813869|NCT00307125|588029634|FG001|Screening Phase|Metastatic colon cancer|0|||
162813870|NCT00307125|588029635|FG002|Screening Phase|Metastatic colon cancer|0|||
162813871|NCT00307125|588029633|FG000|Screening Phase|Malignancy|1|||
162813872|NCT00307125|588029634|FG001|Screening Phase|Malignancy|0|||
162813873|NCT00307125|588029635|FG002|Screening Phase|Malignancy|0|||
162813874|NCT00307125|588029633|FG000|Screening Phase|PAK|1|||
162813875|NCT00307125|588029634|FG001|Screening Phase|PAK|0|||
162813876|NCT00307125|588029635|FG002|Screening Phase|PAK|0|||
162813877|NCT00307125|588029633|FG000|Screening Phase|Ineligible|1|||
162813878|NCT00307125|588029634|FG001|Screening Phase|Ineligible|0|||
162813879|NCT00307125|588029635|FG002|Screening Phase|Ineligible|0|||
162813880|NCT00307125|588029633|FG000|Screening Phase|Screen Error|1|||
162813881|NCT00307125|588029634|FG001|Screening Phase|Screen Error|0|||
162813882|NCT00307125|588029635|FG002|Screening Phase|Screen Error|0|||
162813883|NCT00307125|588029633|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
162813884|NCT00307125|588029634|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
162813885|NCT00307125|588029635|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
162813886|NCT00307125|588029633|FG000|Screening Phase|AMR and treated with rituximab|1|||
162813887|NCT00307125|588029634|FG001|Screening Phase|AMR and treated with rituximab|0|||
162813888|NCT00307125|588029635|FG002|Screening Phase|AMR and treated with rituximab|0|||
162813889|NCT00307125|588029633|FG000|Screening Phase|Coronary artery bypass|1|||
163161924|NCT02581410|589305920|FG001|Vaccination Phase|Migrated/moved from study area|1|||
163161925|NCT02581410|589305919|FG000|End of Study Phase|Adverse Event|4|||
163161926|NCT02581410|589305920|FG001|End of Study Phase|Adverse Event|3|||
163161927|NCT02581410|589305919|FG000|End of Study Phase|Withdrawal by Subject|1|||
163161928|NCT02581410|589305920|FG001|End of Study Phase|Withdrawal by Subject|2|||
163161929|NCT02581410|589305919|FG000|End of Study Phase|Migrated/moved from study area|0|||
163161930|NCT02581410|589305920|FG001|End of Study Phase|Migrated/moved from study area|3|||
163161931|NCT02581410|589305919|FG000|End of Study Phase|Lost to Follow-up|0|||
163161932|NCT02581410|589305920|FG001|End of Study Phase|Lost to Follow-up|2|||
163161933|NCT02581410|589305919|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
163161934|NCT02581410|589305920|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
163161935|NCT00670748|589305924|FG000|Overall Study|Death during treatment|1|||
163161936|NCT00670748|589305925|FG001|Overall Study|Death during treatment|1|||
163161937|NCT00670748|589305926|FG002|Overall Study|Death during treatment|1|||
163161938|NCT00670748|589305927|FG003|Overall Study|Death during treatment|0|||
163161939|NCT00670748|589305924|FG000|Overall Study|Not off study|2|||
163161940|NCT00670748|589305925|FG001|Overall Study|Not off study|1|||
163161941|NCT00670748|589305926|FG002|Overall Study|Not off study|1|||
163161942|NCT00670748|589305927|FG003|Overall Study|Not off study|1|||
163161943|NCT02736578|589305930|FG000|Overall Study|Adverse Event|1|||
163161944|NCT02736578|589305931|FG001|Overall Study|Adverse Event|0|||
163161945|NCT05615922|589305934|FG000|Overall Study|Lost to Follow-up|1|||
163161946|NCT04774094|589305940|FG000|Overall Study|Other|2|||
163161947|NCT04774094|589305940|FG000|Overall Study|Withdrawal by Subject|9|||
163161948|NCT04774094|589305940|FG000|Overall Study|Lost to Follow-up|7|||
163161949|NCT04774094|589305940|FG000|Overall Study|Lack of Efficacy|5|||
163161950|NCT04774094|589305940|FG000|Overall Study|Death|17|||
163161951|NCT04774094|589305940|FG000|Overall Study|Adverse Event|4|||
163161952|NCT02374450|589305941|FG000|Overall Study|Protocol Violation|0|||
163161953|NCT02374450|589305942|FG001|Overall Study|Protocol Violation|1|||
163161954|NCT02374450|589305943|FG002|Overall Study|Protocol Violation|0|||
163161955|NCT02374450|589305941|FG000|Overall Study|Withdrawal by Subject|91|||
163161956|NCT02374450|589305942|FG001|Overall Study|Withdrawal by Subject|110|||
163161957|NCT02374450|589305943|FG002|Overall Study|Withdrawal by Subject|4|||
163161958|NCT02374450|589305941|FG000|Overall Study|Lost to Follow-up|168|||
163161959|NCT02374450|589305942|FG001|Overall Study|Lost to Follow-up|194|||
163161960|NCT02374450|589305943|FG002|Overall Study|Lost to Follow-up|138|||
163161961|NCT02374450|589305941|FG000|Overall Study|Death|173|||
163161962|NCT02374450|589305942|FG001|Overall Study|Death|185|||
163161963|NCT02374450|589305943|FG002|Overall Study|Death|81|||
163161964|NCT02374450|589305941|FG000|Overall Study|Migrated from the study area|538|||
163161965|NCT02374450|589305942|FG001|Overall Study|Migrated from the study area|648|||
163161966|NCT02374450|589305943|FG002|Overall Study|Migrated from the study area|181|||
163161967|NCT02374450|589305941|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
163161968|NCT02374450|589305942|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
163161969|NCT02374450|589305943|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
163161970|NCT02374450|589305941|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
163161971|NCT02374450|589305942|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
163161972|NCT02374450|589305943|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
163161973|NCT02374450|589305941|FG000|Overall Study|Other|0|||
163161974|NCT02374450|589305942|FG001|Overall Study|Other|21|||
163161975|NCT02374450|589305943|FG002|Overall Study|Other|79|||
163161976|NCT01006291|589307420|FG000|Overall Study|Adverse Event|2|||
163161977|NCT01006291|589307421|FG001|Overall Study|Adverse Event|1|||
163161978|NCT01006291|589307422|FG002|Overall Study|Adverse Event|2|||
163161979|NCT01006291|589307420|FG000|Overall Study|Lack of Efficacy|2|||
163161980|NCT01006291|589307421|FG001|Overall Study|Lack of Efficacy|2|||
163161981|NCT01006291|589307422|FG002|Overall Study|Lack of Efficacy|1|||
163161982|NCT01006291|589307420|FG000|Overall Study|Protocol Violation|3|||
163161983|NCT01006291|589307421|FG001|Overall Study|Protocol Violation|3|||
163161984|NCT01006291|589307422|FG002|Overall Study|Protocol Violation|3|||
163161985|NCT01006291|589307420|FG000|Overall Study|Withdrawal criteria|5|||
163161986|NCT01006291|589307421|FG001|Overall Study|Withdrawal criteria|4|||
163161987|NCT01006291|589307422|FG002|Overall Study|Withdrawal criteria|4|||
163161988|NCT01006291|589307420|FG000|Overall Study|Other|14|||
163161989|NCT01006291|589307421|FG001|Overall Study|Other|14|||
163161990|NCT01006291|589307422|FG002|Overall Study|Other|17|||
163161991|NCT01677377|589307423|FG000|Overall Study|Protocol Violation|1|||
163161992|NCT01677377|589307424|FG001|Overall Study|Protocol Violation|0|||
163161993|NCT01677377|589307425|FG002|Overall Study|Protocol Violation|0|||
163161994|NCT01677377|589307423|FG000|Overall Study|Lost to Follow-up|0|||
163161995|NCT01677377|589307424|FG001|Overall Study|Lost to Follow-up|1|||
163161996|NCT01677377|589307425|FG002|Overall Study|Lost to Follow-up|1|||
163161997|NCT01677377|589307423|FG000|Overall Study|Withdrawal by Subject|0|||
163161998|NCT01677377|589307424|FG001|Overall Study|Withdrawal by Subject|0|||
163161999|NCT01677377|589307425|FG002|Overall Study|Withdrawal by Subject|3|||
163162000|NCT01677377|589307423|FG000|Overall Study|Lack of Efficacy|0|||
163162001|NCT01677377|589307424|FG001|Overall Study|Lack of Efficacy|0|||
163162002|NCT01677377|589307425|FG002|Overall Study|Lack of Efficacy|1|||
163162003|NCT01677377|589307423|FG000|Overall Study|Pregnancy|0|||
163162004|NCT01677377|589307424|FG001|Overall Study|Pregnancy|0|||
163162005|NCT01677377|589307425|FG002|Overall Study|Pregnancy|1|||
163162006|NCT02260180|589307426|FG000|Overall Study|Adverse Event|2|||
163162007|NCT02260180|589307427|FG001|Overall Study|Adverse Event|0|||
163162008|NCT02260180|589307428|FG002|Overall Study|Adverse Event|1|||
163162009|NCT00943072|589307431|FG000|Overall Study|Adverse Event|0|||
163162010|NCT00943072|589307432|FG001|Overall Study|Adverse Event|3|||
163162011|NCT00943072|589307431|FG000|Overall Study|Death|0|||
163162012|NCT00943072|589307432|FG001|Overall Study|Death|2|||
163162013|NCT00943072|589307431|FG000|Overall Study|Withdrawal by Subject|3|||
163162014|NCT00943072|589307432|FG001|Overall Study|Withdrawal by Subject|1|||
163162015|NCT00943072|589307431|FG000|Overall Study|Protocol Violation|0|||
163162016|NCT00943072|589307432|FG001|Overall Study|Protocol Violation|1|||
163162017|NCT00943072|589307431|FG000|Overall Study|Lost to Follow-up|1|||
163162018|NCT00943072|589307432|FG001|Overall Study|Lost to Follow-up|2|||
163162019|NCT00943072|589307431|FG000|Overall Study|Lack of Efficacy|0|||
163162020|NCT00943072|589307432|FG001|Overall Study|Lack of Efficacy|4|||
163162021|NCT00943072|589307431|FG000|Overall Study|Other|1|||
163162022|NCT00943072|589307432|FG001|Overall Study|Other|1|||
163162023|NCT01193257|589307433|FG000|Overall Study|Death|202|||
163162024|NCT01193257|589307434|FG001|Overall Study|Death|391|||
163162025|NCT01193257|589307433|FG000|Overall Study|Study termination by sponsor|0|||
163162026|NCT01193257|589307434|FG001|Overall Study|Study termination by sponsor|3|||
163162027|NCT01193257|589307433|FG000|Overall Study|Withdrawal by Subject|26|||
163162028|NCT01193257|589307434|FG001|Overall Study|Withdrawal by Subject|86|||
163162029|NCT01193257|589307433|FG000|Overall Study|Lost to Follow-up|2|||
163162030|NCT01193257|589307434|FG001|Overall Study|Lost to Follow-up|3|||
163162031|NCT01193257|589307433|FG000|Overall Study|Unblinded due to futility|135|||
163162032|NCT01193257|589307434|FG001|Overall Study|Unblinded due to futility|251|||
163162033|NCT01330108|589307443|FG000|Overall Study|Withdrawal by Subject|4|||
163162034|NCT00423917|589307446|FG000|Overall Study|Cancel|2|||
163162035|NCT00423917|589307446|FG000|Overall Study|Ineligible|1|||
163162036|NCT00555061|589307447|FG000|Overall Study|Adverse Event|3|||
163162037|NCT00555061|589307447|FG000|Overall Study|Protocol Violation|1|||
163162038|NCT00555061|589307447|FG000|Overall Study|Lost to Follow-up|2|||
163162039|NCT00555061|589307447|FG000|Overall Study|Withdrawal by Subject|2|||
163162040|NCT00555061|589307447|FG000|Overall Study|Participant enrolled, but never treated|1|||
163162041|NCT01175083|589307448|FG000|Primary Epoch|Withdrawal by Subject|0|||
163162042|NCT01175083|589307449|FG001|Primary Epoch|Withdrawal by Subject|0|||
163162043|NCT01175083|589307450|FG002|Primary Epoch|Withdrawal by Subject|0|||
163162044|NCT01175083|589307451|FG003|Primary Epoch|Withdrawal by Subject|0|||
163162045|NCT01175083|589307452|FG004|Primary Epoch|Withdrawal by Subject|0|||
163162046|NCT01175083|589307453|FG005|Primary Epoch|Withdrawal by Subject|2|||
163162047|NCT01175083|589307448|FG000|Primary Epoch|Lost to Follow-up|0|||
163162048|NCT01175083|589307449|FG001|Primary Epoch|Lost to Follow-up|0|||
163162049|NCT01175083|589307450|FG002|Primary Epoch|Lost to Follow-up|0|||
163162050|NCT01175083|589307451|FG003|Primary Epoch|Lost to Follow-up|0|||
163162051|NCT01175083|589307452|FG004|Primary Epoch|Lost to Follow-up|0|||
163162052|NCT01175083|589307453|FG005|Primary Epoch|Lost to Follow-up|1|||
163162053|NCT01175083|589307448|FG000|Booster Epoch|Death|0|||
162813890|NCT00307125|588029634|FG001|Screening Phase|Coronary artery bypass|0|||
162813891|NCT00307125|588029635|FG002|Screening Phase|Coronary artery bypass|0|||
162813892|NCT00307125|588029633|FG000|Pilot Phase|Lost to Follow-up|0|||
162813893|NCT00307125|588029634|FG001|Pilot Phase|Lost to Follow-up|1|||
163162054|NCT01175083|589307449|FG001|Booster Epoch|Death|0|||
163162055|NCT01175083|589307450|FG002|Booster Epoch|Death|1|||
163162056|NCT01175083|589307451|FG003|Booster Epoch|Death|0|||
162813894|NCT00307125|588029635|FG002|Pilot Phase|Lost to Follow-up|0|||
162813895|NCT00307125|588029633|FG000|Pilot Phase|Withdrawal by Subject|0|||
162813896|NCT00307125|588029634|FG001|Pilot Phase|Withdrawal by Subject|1|||
162813897|NCT00307125|588029635|FG002|Pilot Phase|Withdrawal by Subject|1|||
162813898|NCT02571049|588029636|FG000|Screening|Did not meet entry criteria|2|||
162813899|NCT02571049|588029637|FG001|Screening|Did not meet entry criteria|2|||
162813900|NCT02571049|588029636|FG000|Randomization|No migraine attack|0|||
163162057|NCT01175083|589307452|FG004|Booster Epoch|Death|0|||
163162058|NCT01175083|589307453|FG005|Booster Epoch|Death|0|||
163162059|NCT01175083|589307448|FG000|Booster Epoch|Withdrawal by Subject|0|||
163162060|NCT01175083|589307449|FG001|Booster Epoch|Withdrawal by Subject|0|||
163162061|NCT01175083|589307450|FG002|Booster Epoch|Withdrawal by Subject|0|||
162813901|NCT02571049|588029637|FG001|Randomization|No migraine attack|1|||
163162062|NCT01175083|589307451|FG003|Booster Epoch|Withdrawal by Subject|1|||
163162063|NCT01175083|589307452|FG004|Booster Epoch|Withdrawal by Subject|0|||
163162064|NCT01175083|589307453|FG005|Booster Epoch|Withdrawal by Subject|0|||
163162065|NCT02881567|589307454|FG000|Overall Study|Adverse Event|1|||
163162066|NCT02881567|589307454|FG000|Overall Study|Lost to Follow-up|3|||
162813902|NCT02571049|588029636|FG000|Randomization|Adverse Event|0|||
162813903|NCT02571049|588029637|FG001|Randomization|Adverse Event|1|||
162813904|NCT01055262|588029640|FG000|Overall Study|Adverse Event|5|||
162813905|NCT01055262|588029640|FG000|Overall Study|Protocol Violation|3|||
162813906|NCT01055262|588029640|FG000|Overall Study|Uncooperativeness|1|||
162813907|NCT00561951|588029642|FG000|Overall Study|Adverse Event|11|||
162813908|NCT00561951|588029643|FG001|Overall Study|Adverse Event|14|||
162813909|NCT00561951|588029644|FG002|Overall Study|Adverse Event|14|||
162813910|NCT00561951|588029642|FG000|Overall Study|Lack of Efficacy|5|||
162813911|NCT00561951|588029643|FG001|Overall Study|Lack of Efficacy|3|||
162813912|NCT00561951|588029644|FG002|Overall Study|Lack of Efficacy|2|||
162813913|NCT00561951|588029642|FG000|Overall Study|Lost to Follow-up|1|||
162813914|NCT00561951|588029643|FG001|Overall Study|Lost to Follow-up|1|||
162813915|NCT00561951|588029644|FG002|Overall Study|Lost to Follow-up|0|||
162813916|NCT00561951|588029642|FG000|Overall Study|Withdrawal by Subject|10|||
162813917|NCT00561951|588029643|FG001|Overall Study|Withdrawal by Subject|9|||
162813918|NCT00561951|588029644|FG002|Overall Study|Withdrawal by Subject|10|||
162813919|NCT00561951|588029642|FG000|Overall Study|Protocol Violation|4|||
162813920|NCT00561951|588029643|FG001|Overall Study|Protocol Violation|3|||
162813921|NCT00561951|588029644|FG002|Overall Study|Protocol Violation|4|||
162813922|NCT00561951|588029642|FG000|Overall Study|Physician Decision|1|||
162813923|NCT00561951|588029643|FG001|Overall Study|Physician Decision|0|||
162813924|NCT00561951|588029644|FG002|Overall Study|Physician Decision|0|||
162813925|NCT00561951|588029642|FG000|Overall Study|Pregnancy|0|||
162813926|NCT00561951|588029643|FG001|Overall Study|Pregnancy|1|||
162813927|NCT00561951|588029644|FG002|Overall Study|Pregnancy|0|||
162813928|NCT00561951|588029642|FG000|Overall Study|Meet Withdrawal Criterion|0|||
162813929|NCT00561951|588029643|FG001|Overall Study|Meet Withdrawal Criterion|1|||
162813930|NCT00561951|588029644|FG002|Overall Study|Meet Withdrawal Criterion|1|||
162813931|NCT00561951|588029642|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
162813932|NCT00561951|588029643|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
162813933|NCT00561951|588029644|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
162813934|NCT01201265|588029645|FG000|Overall Study|Death|14|||
163162067|NCT02881567|589307454|FG000|Overall Study|Consent withdrawn|1|||
163162068|NCT02881567|589307454|FG000|Overall Study|Investigator decision|1|||
162697966|NCT01474512|587605420|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697967|NCT01474512|587605421|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697968|NCT01474512|587605422|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697969|NCT01474512|587605423|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
162697970|NCT01474512|587605424|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697971|NCT01474512|587605425|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697972|NCT01474512|587605426|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697973|NCT01474512|587605427|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697974|NCT01474512|587605428|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697975|NCT01474512|587605429|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162697976|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
162697977|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
162697978|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
162697979|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
162697980|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
162697981|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
162697982|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
162697983|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
162697984|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
162697985|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
162697986|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
162697987|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
162697988|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
162697989|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
162697990|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
162697991|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
162697992|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
162697993|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
162697994|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162697995|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162697996|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162813935|NCT01201265|588029645|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162813936|NCT01201265|588029645|FG000|Overall Study|Lost to Follow-up|10|||
162813937|NCT01201265|588029645|FG000|Overall Study|Withdrawal by Subject|7|||
162813938|NCT01201265|588029645|FG000|Overall Study|Disease Progression|4|||
162813939|NCT01898923|588029646|FG000|Overall Study|Lack of Efficacy|5|||
162813940|NCT01898923|588029647|FG001|Overall Study|Lack of Efficacy|6|||
162813941|NCT01898923|588029646|FG000|Overall Study|Adverse Event|3|||
163162069|NCT02881567|589307454|FG000|Overall Study|Study terminated by sponsor|9|||
163162070|NCT02881567|589307454|FG000|Overall Study|Reason not Specified|3|||
163162071|NCT00373113|589307456|FG000|Overall Study|Death|1|||
163162072|NCT00373113|589307457|FG001|Overall Study|Death|7|||
163162073|NCT00373113|589307456|FG000|Overall Study|Adverse Event|38|||
163162074|NCT00373113|589307457|FG001|Overall Study|Adverse Event|24|||
163162075|NCT00373113|589307456|FG000|Overall Study|Study terminated by sponsor|9|||
163162076|NCT00373113|589307457|FG001|Overall Study|Study terminated by sponsor|1|||
163162077|NCT00373113|589307456|FG000|Overall Study|Global deterioration of health status|10|||
163162078|NCT00373113|589307457|FG001|Overall Study|Global deterioration of health status|7|||
163162079|NCT00373113|589307456|FG000|Overall Study|Lost to Follow-up|1|||
163162080|NCT00373113|589307457|FG001|Overall Study|Lost to Follow-up|3|||
163162081|NCT00373113|589307456|FG000|Overall Study|Objective progression or relapse|150|||
163162082|NCT00373113|589307457|FG001|Overall Study|Objective progression or relapse|169|||
163162083|NCT00373113|589307456|FG000|Overall Study|Other|14|||
163162084|NCT00373113|589307457|FG001|Overall Study|Other|17|||
163162085|NCT00373113|589307456|FG000|Overall Study|Protocol Violation|5|||
163162086|NCT00373113|589307457|FG001|Overall Study|Protocol Violation|1|||
163162087|NCT00373113|589307456|FG000|Overall Study|Withdrawal by Subject|10|||
163162088|NCT00373113|589307457|FG001|Overall Study|Withdrawal by Subject|15|||
163162089|NCT03275350|589307458|FG000|Overall Study|Lost to Follow-up|4|||
163162090|NCT03275350|589307459|FG001|Overall Study|Lost to Follow-up|6|||
163162091|NCT03275350|589307458|FG000|Overall Study|Death|2|||
163162092|NCT03275350|589307459|FG001|Overall Study|Death|1|||
163162093|NCT03275350|589307458|FG000|Overall Study|Physician Decision|1|||
163162094|NCT03275350|589307459|FG001|Overall Study|Physician Decision|0|||
163162095|NCT03275350|589307458|FG000|Overall Study|Incarcerated|1|||
163162096|NCT03275350|589307459|FG001|Overall Study|Incarcerated|1|||
163162097|NCT00905645|589307462|FG000|Overall Study|Death (not device related)|10|||
163162098|NCT00905645|589307463|FG001|Overall Study|Death (not device related)|4|||
163162099|NCT00905645|589307464|FG002|Overall Study|Death (not device related)|15|||
163162100|NCT00905645|589307465|FG003|Overall Study|Death (not device related)|8|||
163162101|NCT00905645|589307462|FG000|Overall Study|Explantation of study device(s)|78|||
163162102|NCT00905645|589307463|FG001|Overall Study|Explantation of study device(s)|47|||
163162103|NCT00905645|589307464|FG002|Overall Study|Explantation of study device(s)|28|||
163162104|NCT00905645|589307465|FG003|Overall Study|Explantation of study device(s)|21|||
163162105|NCT00905645|589307462|FG000|Overall Study|Subject Request|41|||
163162106|NCT00905645|589307463|FG001|Overall Study|Subject Request|17|||
163162107|NCT00905645|589307464|FG002|Overall Study|Subject Request|13|||
163162108|NCT00905645|589307465|FG003|Overall Study|Subject Request|11|||
163162109|NCT00905645|589307462|FG000|Overall Study|Lost to Follow-up|299|||
163162110|NCT00905645|589307463|FG001|Overall Study|Lost to Follow-up|103|||
163162111|NCT00905645|589307464|FG002|Overall Study|Lost to Follow-up|51|||
163162112|NCT00905645|589307465|FG003|Overall Study|Lost to Follow-up|12|||
163162113|NCT01386970|589307466|FG000|Overall Study|Withdrawal by Subject|0|||
163162114|NCT01386970|589307467|FG001|Overall Study|Withdrawal by Subject|1|||
163162115|NCT01386970|589307466|FG000|Overall Study|Adverse Event|4|||
163162116|NCT01386970|589307467|FG001|Overall Study|Adverse Event|1|||
163162117|NCT04439136|589307468|FG000|Overall Study|Ineligible|1|||
163162118|NCT04439136|589307468|FG000|Overall Study|Never Started Treatment|2|||
163162119|NCT04439136|589307468|FG000|Overall Study|Adverse Event|4|||
163162120|NCT04439136|589307468|FG000|Overall Study|Death|3|||
163162121|NCT04439136|589307468|FG000|Overall Study|Disease Progression|27|||
163162122|NCT04439136|589307468|FG000|Overall Study|Alternative Therapy|1|||
163162123|NCT04439136|589307468|FG000|Overall Study|Increased Tumor Burden|1|||
163162124|NCT04439136|589307468|FG000|Overall Study|Symptomatic Detrioration|1|||
163162125|NCT00578292|589307469|FG000|Overall Study|Death|1|||
163162126|NCT00578292|589307469|FG000|Overall Study|Graft failure|2|||
163162127|NCT04849559|589307470|FG000|Overall Study|Withdrawal by Subject|2|||
163162128|NCT04849559|589307471|FG001|Overall Study|Withdrawal by Subject|1|||
163162129|NCT03901469|589307472|FG000|Overall Study|Radiographic Progression|4|||
163162130|NCT03901469|589307473|FG001|Overall Study|Radiographic Progression|6|||
163162131|NCT03901469|589307474|FG002|Overall Study|Radiographic Progression|3|||
163162132|NCT03901469|589307475|FG003|Overall Study|Radiographic Progression|30|||
163162133|NCT03901469|589307476|FG004|Overall Study|Radiographic Progression|7|||
163162134|NCT03901469|589307477|FG005|Overall Study|Radiographic Progression|2|||
163162135|NCT03901469|589307478|FG006|Overall Study|Radiographic Progression|11|||
163162136|NCT03901469|589307472|FG000|Overall Study|Clinical Progression|0|||
163162137|NCT03901469|589307473|FG001|Overall Study|Clinical Progression|2|||
163162138|NCT03901469|589307474|FG002|Overall Study|Clinical Progression|0|||
163162139|NCT03901469|589307475|FG003|Overall Study|Clinical Progression|7|||
163162140|NCT03901469|589307476|FG004|Overall Study|Clinical Progression|6|||
163162141|NCT03901469|589307477|FG005|Overall Study|Clinical Progression|0|||
163162142|NCT03901469|589307478|FG006|Overall Study|Clinical Progression|2|||
163162143|NCT03901469|589307472|FG000|Overall Study|Adverse Event|1|||
163162144|NCT03901469|589307473|FG001|Overall Study|Adverse Event|0|||
163162145|NCT03901469|589307474|FG002|Overall Study|Adverse Event|0|||
163162146|NCT03901469|589307475|FG003|Overall Study|Adverse Event|0|||
163162147|NCT03901469|589307476|FG004|Overall Study|Adverse Event|0|||
163162148|NCT03901469|589307477|FG005|Overall Study|Adverse Event|0|||
163162149|NCT03901469|589307478|FG006|Overall Study|Adverse Event|9|||
163162150|NCT03901469|589307472|FG000|Overall Study|Physician Decision|0|||
163162151|NCT03901469|589307473|FG001|Overall Study|Physician Decision|0|||
163162152|NCT03901469|589307474|FG002|Overall Study|Physician Decision|0|||
163162153|NCT03901469|589307475|FG003|Overall Study|Physician Decision|1|||
163162154|NCT03901469|589307476|FG004|Overall Study|Physician Decision|0|||
163162155|NCT03901469|589307477|FG005|Overall Study|Physician Decision|0|||
163162156|NCT03901469|589307478|FG006|Overall Study|Physician Decision|0|||
163162157|NCT03901469|589307472|FG000|Overall Study|Withdrawal by Subject|0|||
163162158|NCT03901469|589307473|FG001|Overall Study|Withdrawal by Subject|0|||
163162159|NCT03901469|589307474|FG002|Overall Study|Withdrawal by Subject|0|||
163162160|NCT03901469|589307475|FG003|Overall Study|Withdrawal by Subject|0|||
163162161|NCT03901469|589307476|FG004|Overall Study|Withdrawal by Subject|2|||
163162162|NCT03901469|589307477|FG005|Overall Study|Withdrawal by Subject|0|||
163162163|NCT03901469|589307478|FG006|Overall Study|Withdrawal by Subject|8|||
163162164|NCT03901469|589307472|FG000|Overall Study|Death|0|||
163162165|NCT03901469|589307473|FG001|Overall Study|Death|0|||
163162166|NCT03901469|589307474|FG002|Overall Study|Death|0|||
163162167|NCT03901469|589307475|FG003|Overall Study|Death|3|||
163162168|NCT03901469|589307476|FG004|Overall Study|Death|5|||
163162169|NCT03901469|589307477|FG005|Overall Study|Death|0|||
163162170|NCT03901469|589307478|FG006|Overall Study|Death|1|||
163162171|NCT03901469|589307472|FG000|Overall Study|Termination of study by sponsor|0|||
163162172|NCT03901469|589307473|FG001|Overall Study|Termination of study by sponsor|0|||
163162173|NCT03901469|589307474|FG002|Overall Study|Termination of study by sponsor|0|||
163162174|NCT03901469|589307475|FG003|Overall Study|Termination of study by sponsor|0|||
163162175|NCT03901469|589307476|FG004|Overall Study|Termination of study by sponsor|1|||
163162176|NCT03901469|589307477|FG005|Overall Study|Termination of study by sponsor|1|||
163162177|NCT03901469|589307478|FG006|Overall Study|Termination of study by sponsor|0|||
163162178|NCT03901469|589307472|FG000|Overall Study|Not Reported|1|||
163162179|NCT03901469|589307473|FG001|Overall Study|Not Reported|0|||
163162180|NCT03901469|589307474|FG002|Overall Study|Not Reported|0|||
163162181|NCT03901469|589307475|FG003|Overall Study|Not Reported|1|||
163162182|NCT03901469|589307476|FG004|Overall Study|Not Reported|0|||
163162183|NCT03901469|589307477|FG005|Overall Study|Not Reported|0|||
163162184|NCT03901469|589307478|FG006|Overall Study|Not Reported|1|||
163162185|NCT01662102|589307479|FG000|Overall Study|Sponsor's decision|1|||
163162186|NCT01662102|589307480|FG001|Overall Study|Sponsor's decision|0|||
163162187|NCT02586207|589307481|FG000|Overall Study|Physician Decision|1|||
163162188|NCT02586207|589307481|FG000|Overall Study|Withdrawal by Subject|1|||
163162189|NCT02362282|589307482|FG000|Overall Study|Withdrawal by Subject|1|||
163162190|NCT02362282|589307483|FG001|Overall Study|Withdrawal by Subject|0|||
163162191|NCT02004093|589307484|FG000|Overall Study|Death|2|||
163162192|NCT02004093|589307485|FG001|Overall Study|Death|1|||
163162193|NCT02004093|589307484|FG000|Overall Study|Lack of Efficacy|66|||
163162194|NCT02004093|589307485|FG001|Overall Study|Lack of Efficacy|62|||
163162195|NCT02004093|589307484|FG000|Overall Study|Protocol Violation|0|||
163162196|NCT02004093|589307485|FG001|Overall Study|Protocol Violation|1|||
163162197|NCT02004093|589307484|FG000|Overall Study|Lost to Follow-up|0|||
163162198|NCT02004093|589307485|FG001|Overall Study|Lost to Follow-up|1|||
163162199|NCT02004093|589307484|FG000|Overall Study|Withdrawal by Subject|3|||
163162200|NCT02004093|589307485|FG001|Overall Study|Withdrawal by Subject|7|||
163162201|NCT02004093|589307484|FG000|Overall Study|Other|3|||
163162202|NCT02004093|589307485|FG001|Overall Study|Other|1|||
163162203|NCT04085289|589307486|FG000|Overall Study|Withdrawal by Subject|0|||
163162204|NCT04085289|589307487|FG001|Overall Study|Withdrawal by Subject|0|||
163162205|NCT04085289|589307488|FG002|Overall Study|Withdrawal by Subject|1|||
163162206|NCT00439517|589307489|FG000|Overall Study|Subject on treatment|1|||
163162207|NCT00439517|589307490|FG001|Overall Study|Subject on treatment|0|||
162697997|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163162208|NCT00439517|589307489|FG000|Overall Study|Subject in survival follow-up|1|||
163162209|NCT00439517|589307490|FG001|Overall Study|Subject in survival follow-up|0|||
163162210|NCT03527732|589307493|FG000|Overall Study|Lost to Follow-up|21|||
163162211|NCT03527732|589307494|FG001|Overall Study|Lost to Follow-up|23|||
163162212|NCT03527732|589307495|FG002|Overall Study|Lost to Follow-up|80|||
163162213|NCT03527732|589307496|FG003|Overall Study|Lost to Follow-up|62|||
163162214|NCT03527732|589307497|FG004|Overall Study|Lost to Follow-up|12|||
163162215|NCT03527732|589307498|FG005|Overall Study|Lost to Follow-up|20|||
163162216|NCT00470275|589307499|FG000|Overall Study|Death|1|||
163162217|NCT00470275|589307499|FG000|Overall Study|Lack of Efficacy|7|||
163162218|NCT00470275|589307499|FG000|Overall Study|Withdrawal by Subject|2|||
163162219|NCT02207088|589307500|FG000|Overall Study|Adverse Event|2|||
163162220|NCT03306173|589307502|FG000|Overall Study|Lost to Follow-up|16|||
162697998|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163162221|NCT03306173|589307503|FG001|Overall Study|Lost to Follow-up|23|||
163162222|NCT03306173|589307502|FG000|Overall Study|Withdrawal by Subject|4|||
163162223|NCT03306173|589307503|FG001|Overall Study|Withdrawal by Subject|3|||
163162224|NCT03306173|589307502|FG000|Overall Study|Discontinued|4|||
163162225|NCT03306173|589307503|FG001|Overall Study|Discontinued|4|||
163162226|NCT01077076|589307504|FG000|First Intervention|Withdrawal by Subject|1|||
163162227|NCT01077076|589307505|FG001|First Intervention|Withdrawal by Subject|0|||
163162228|NCT01077076|589307506|FG002|First Intervention|Withdrawal by Subject|0|||
163162229|NCT01077076|589307507|FG003|First Intervention|Withdrawal by Subject|0|||
163162230|NCT01077076|589307508|FG004|First Intervention|Withdrawal by Subject|0|||
163162231|NCT01077076|589307509|FG005|First Intervention|Withdrawal by Subject|0|||
163162232|NCT01077076|589307504|FG000|Third Intervention|Death in the participant's family|0|||
163162233|NCT01077076|589307505|FG001|Third Intervention|Death in the participant's family|0|||
163162234|NCT01077076|589307506|FG002|Third Intervention|Death in the participant's family|0|||
163162235|NCT01077076|589307507|FG003|Third Intervention|Death in the participant's family|0|||
163162236|NCT01077076|589307508|FG004|Third Intervention|Death in the participant's family|0|||
163162237|NCT01077076|589307509|FG005|Third Intervention|Death in the participant's family|1|||
163162238|NCT00060840|589307512|FG000|Overall Study|Change in surgical plan|2|||
163162239|NCT00060840|589307513|FG001|Overall Study|Change in surgical plan|6|||
163162240|NCT00060840|589307512|FG000|Overall Study|Death|0|||
163162241|NCT00060840|589307513|FG001|Overall Study|Death|1|||
163162242|NCT00060840|589307512|FG000|Overall Study|Withdrawal by Subject|0|||
163162243|NCT00060840|589307513|FG001|Overall Study|Withdrawal by Subject|1|||
163162244|NCT00060840|589307512|FG000|Overall Study|Subinvestigator unavailable|0|||
163162245|NCT00060840|589307513|FG001|Overall Study|Subinvestigator unavailable|1|||
163162246|NCT00060840|589307512|FG000|Overall Study|Physician Decision|1|||
163162247|NCT00060840|589307513|FG001|Overall Study|Physician Decision|0|||
163162248|NCT00060840|589307512|FG000|Overall Study|Other|1|||
163162249|NCT00060840|589307513|FG001|Overall Study|Other|0|||
163162250|NCT01388335|589307514|FG000|Period 1|Progressive Disease|1|||
163162251|NCT01388335|589307514|FG000|Period 2|Progressive Disease|2|||
163162252|NCT01388335|589307514|FG000|Period 2|Sponsor Decision|1|||
163162253|NCT01388335|589307514|FG000|Safety Extension|Progressive Disease|7|||
163162254|NCT01415882|589307515|FG000|Overall Study|Ineligible|1|||
163162255|NCT01415882|589307516|FG001|Overall Study|Ineligible|0|||
163162256|NCT01415882|589307517|FG002|Overall Study|Ineligible|0|||
163162257|NCT01415882|589307518|FG003|Overall Study|Ineligible|3|||
163162258|NCT01415882|589307519|FG004|Overall Study|Ineligible|0|||
163162259|NCT01415882|589307515|FG000|Overall Study|Withdrawal by Subject|0|||
163162260|NCT01415882|589307516|FG001|Overall Study|Withdrawal by Subject|1|||
163162261|NCT01415882|589307517|FG002|Overall Study|Withdrawal by Subject|0|||
163162262|NCT01415882|589307518|FG003|Overall Study|Withdrawal by Subject|1|||
163162263|NCT01415882|589307519|FG004|Overall Study|Withdrawal by Subject|0|||
163162264|NCT00976560|589307520|FG000|Overall Study|Adverse Event|5|||
163162265|NCT00976560|589307521|FG001|Overall Study|Adverse Event|5|||
163162266|NCT00976560|589307520|FG000|Overall Study|Lack of Efficacy|3|||
163162267|NCT00976560|589307521|FG001|Overall Study|Lack of Efficacy|5|||
163162268|NCT00976560|589307520|FG000|Overall Study|Protocol Violation|1|||
163162269|NCT00976560|589307521|FG001|Overall Study|Protocol Violation|0|||
163162270|NCT00976560|589307520|FG000|Overall Study|Lost to Follow-up|1|||
163162271|NCT00976560|589307521|FG001|Overall Study|Lost to Follow-up|0|||
163162272|NCT00976560|589307520|FG000|Overall Study|Physician Decision|2|||
163162273|NCT00976560|589307521|FG001|Overall Study|Physician Decision|0|||
163162274|NCT00976560|589307520|FG000|Overall Study|Withdrawal by Subject|2|||
163162275|NCT00976560|589307521|FG001|Overall Study|Withdrawal by Subject|3|||
163162276|NCT00125164|589307524|FG000|Overall Study|Adverse Event|0|||
163162277|NCT00125164|589307525|FG001|Overall Study|Adverse Event|0|||
163162278|NCT00125164|589307526|FG002|Overall Study|Adverse Event|2|||
163162279|NCT00125164|589307527|FG003|Overall Study|Adverse Event|4|||
163162280|NCT00125164|589307524|FG000|Overall Study|Lost to Follow-up|0|||
163162281|NCT00125164|589307525|FG001|Overall Study|Lost to Follow-up|0|||
163162282|NCT00125164|589307526|FG002|Overall Study|Lost to Follow-up|1|||
163162283|NCT00125164|589307527|FG003|Overall Study|Lost to Follow-up|1|||
163162284|NCT00125164|589307524|FG000|Overall Study|Withdrawal by Subject|2|||
163162285|NCT00125164|589307525|FG001|Overall Study|Withdrawal by Subject|0|||
163162286|NCT00125164|589307526|FG002|Overall Study|Withdrawal by Subject|1|||
162813942|NCT01898923|588029647|FG001|Overall Study|Adverse Event|1|||
163162287|NCT00125164|589307527|FG003|Overall Study|Withdrawal by Subject|1|||
163162288|NCT01339052|589307528|FG000|Overall Study|Disease progression|13|||
162813943|NCT01898923|588029646|FG000|Overall Study|Lost to Follow-up|0|||
163162289|NCT01339052|589307529|FG001|Overall Study|Disease progression|46|||
163162290|NCT01339052|589307528|FG000|Overall Study|Adverse Event|1|||
163162291|NCT01339052|589307529|FG001|Overall Study|Adverse Event|1|||
163162292|NCT01339052|589307528|FG000|Overall Study|Withdrawal by Subject|0|||
163162293|NCT01339052|589307529|FG001|Overall Study|Withdrawal by Subject|3|||
163162294|NCT01339052|589307528|FG000|Overall Study|Physician Decision|1|||
163162295|NCT01339052|589307529|FG001|Overall Study|Physician Decision|0|||
163162296|NCT03339219|589307533|FG000|Overall Study|Death|12|||
163042816|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
163162297|NCT03339219|589307533|FG000|Overall Study|Site Terminated by Sponsor|22|||
163162298|NCT03339219|589307533|FG000|Overall Study|Withdrawal by Subject|1|||
163162299|NCT01301027|589307537|FG000|Overall Study|Physician Decision|2|||
163162300|NCT01301027|589307538|FG001|Overall Study|Physician Decision|0|||
163162301|NCT01301027|589307537|FG000|Overall Study|Withdrawal by Subject|2|||
163162302|NCT01301027|589307538|FG001|Overall Study|Withdrawal by Subject|3|||
163162303|NCT01301027|589307537|FG000|Overall Study|Adverse Event|0|||
163162304|NCT01301027|589307538|FG001|Overall Study|Adverse Event|2|||
163162305|NCT01301027|589307537|FG000|Overall Study|Fracture|1|||
163162306|NCT01301027|589307538|FG001|Overall Study|Fracture|3|||
163162307|NCT01301027|589307537|FG000|Overall Study|Transplant|0|||
163162308|NCT01301027|589307538|FG001|Overall Study|Transplant|2|||
163162309|NCT01301027|589307537|FG000|Overall Study|Volume Overload|3|||
163162310|NCT01301027|589307538|FG001|Overall Study|Volume Overload|0|||
163162311|NCT03155841|589307540|FG000|Overall Study|Protocol Violation|3|||
163162312|NCT03155841|589307541|FG001|Overall Study|Protocol Violation|4|||
163162313|NCT04308291|589307542|FG000|Run-In Phase|Withdrawal by Subject|4|||
163162314|NCT04308291|589307542|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
163162315|NCT04308291|589307542|FG000|Study Phase 6-M|Physician Decision|2|||
163162316|NCT04308291|589307542|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
163162317|NCT04308291|589307542|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
163162318|NCT04308291|589307542|FG000|Study Phase 12-M|Physician Decision|2|||
163162319|NCT04308291|589307542|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
163162320|NCT00714870|589307545|FG000|Overall Study|Lost to Follow-up|22|||
163162321|NCT00714870|589307546|FG001|Overall Study|Lost to Follow-up|5|||
163162322|NCT00714870|589307545|FG000|Overall Study|patient unable to come b/c back pain|1|||
163162323|NCT00714870|589307546|FG001|Overall Study|patient unable to come b/c back pain|0|||
163162324|NCT00714870|589307545|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
163162325|NCT00714870|589307546|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
163162326|NCT03399552|589307547|FG000|Overall Study|No evidence of disease|1|||
163162327|NCT03399552|589307547|FG000|Overall Study|Unevaluable|1|||
163162328|NCT02357368|589307548|FG000|Overall Study|Lost to Follow-up|0|||
163162329|NCT02357368|589307549|FG001|Overall Study|Lost to Follow-up|0|||
163162330|NCT02357368|589307550|FG002|Overall Study|Lost to Follow-up|0|||
163162331|NCT02357368|589307551|FG003|Overall Study|Lost to Follow-up|1|||
163162332|NCT02357368|589307548|FG000|Overall Study|Pregnancy|3|||
163162333|NCT02357368|589307549|FG001|Overall Study|Pregnancy|2|||
163162334|NCT02357368|589307550|FG002|Overall Study|Pregnancy|0|||
163162335|NCT02357368|589307551|FG003|Overall Study|Pregnancy|0|||
163162336|NCT02357368|589307548|FG000|Overall Study|Withdrawal by Subject|3|||
163162337|NCT02357368|589307549|FG001|Overall Study|Withdrawal by Subject|1|||
163162338|NCT02357368|589307550|FG002|Overall Study|Withdrawal by Subject|1|||
163162339|NCT02357368|589307551|FG003|Overall Study|Withdrawal by Subject|2|||
163162340|NCT01931566|589307552|FG000|Overall Study|Randomized But Not Treated|6|||
163162341|NCT01931566|589307553|FG001|Overall Study|Randomized But Not Treated|9|||
163162342|NCT01931566|589307554|FG002|Overall Study|Randomized But Not Treated|14|||
163162343|NCT01931566|589307552|FG000|Overall Study|Adverse Event|37|||
163162344|NCT01931566|589307553|FG001|Overall Study|Adverse Event|167|||
163162345|NCT01931566|589307554|FG002|Overall Study|Adverse Event|132|||
163162346|NCT01931566|589307552|FG000|Overall Study|Major Protocol Deviation|5|||
163162347|NCT01931566|589307553|FG001|Overall Study|Major Protocol Deviation|14|||
163162348|NCT01931566|589307554|FG002|Overall Study|Major Protocol Deviation|21|||
163162349|NCT01931566|589307552|FG000|Overall Study|Lost to Follow-up|3|||
163162350|NCT01931566|589307553|FG001|Overall Study|Lost to Follow-up|26|||
163162351|NCT01931566|589307554|FG002|Overall Study|Lost to Follow-up|23|||
163162352|NCT01931566|589307552|FG000|Overall Study|Voluntary Withdrawal|78|||
163162353|NCT01931566|589307553|FG001|Overall Study|Voluntary Withdrawal|245|||
163162354|NCT01931566|589307554|FG002|Overall Study|Voluntary Withdrawal|225|||
163162355|NCT01931566|589307552|FG000|Overall Study|Study Termination|289|||
163162356|NCT01931566|589307553|FG001|Overall Study|Study Termination|968|||
163162357|NCT01931566|589307554|FG002|Overall Study|Study Termination|1037|||
163162358|NCT01931566|589307552|FG000|Overall Study|Reason Not Specified|11|||
163162359|NCT01931566|589307553|FG001|Overall Study|Reason Not Specified|47|||
163162360|NCT01931566|589307554|FG002|Overall Study|Reason Not Specified|53|||
163162361|NCT01931566|589307552|FG000|Overall Study|Missing|0|||
163162362|NCT01931566|589307553|FG001|Overall Study|Missing|0|||
163162363|NCT01931566|589307554|FG002|Overall Study|Missing|1|||
163162364|NCT04625101|589307556|FG000|Overall Study|Withdrawal by Subject|0|||
163162365|NCT04625101|589307557|FG001|Overall Study|Withdrawal by Subject|1|||
163162366|NCT04625101|589307556|FG000|Overall Study|Protocol Deviation|1|||
163162367|NCT04625101|589307557|FG001|Overall Study|Protocol Deviation|0|||
163162368|NCT00467753|589307559|FG000|Overall Study|Lost to Follow-up|1|||
163162369|NCT00467753|589307560|FG001|Overall Study|Lost to Follow-up|2|||
163162370|NCT00467753|589307559|FG000|Overall Study|Adverse Event|2|||
163162371|NCT00467753|589307560|FG001|Overall Study|Adverse Event|0|||
163162372|NCT02533453|589307561|FG000|Overall Study|Adverse Event|6|||
163162373|NCT02533453|589307561|FG000|Overall Study|Protocol Violation|1|||
163162374|NCT02533453|589307561|FG000|Overall Study|Withdrawal by Subject|2|||
163162375|NCT01273519|589307562|FG000|Overall Study|Adverse Event|3|||
163162376|NCT01273519|589307563|FG001|Overall Study|Adverse Event|0|||
163162377|NCT01273519|589307564|FG002|Overall Study|Adverse Event|0|||
163162378|NCT01273519|589307562|FG000|Overall Study|Lost to Follow-up|2|||
163162379|NCT01273519|589307563|FG001|Overall Study|Lost to Follow-up|1|||
163162380|NCT01273519|589307564|FG002|Overall Study|Lost to Follow-up|3|||
163162381|NCT01273519|589307562|FG000|Overall Study|Lack of Efficacy|8|||
163162382|NCT01273519|589307563|FG001|Overall Study|Lack of Efficacy|3|||
163162383|NCT01273519|589307564|FG002|Overall Study|Lack of Efficacy|4|||
163162384|NCT01273519|589307562|FG000|Overall Study|Other|6|||
163162385|NCT01273519|589307563|FG001|Overall Study|Other|1|||
163162386|NCT01273519|589307564|FG002|Overall Study|Other|1|||
163162387|NCT03695367|589307565|FG000|Overall Study|Missed the Day 28 visit.|1|||
163162388|NCT03695367|589307566|FG001|Overall Study|Missed the Day 28 visit.|0|||
163162389|NCT03695367|589307565|FG000|Overall Study|Lost to Follow-up|0|||
163162390|NCT03695367|589307566|FG001|Overall Study|Lost to Follow-up|1|||
163162391|NCT03695367|589307565|FG000|Overall Study|Withdrawal by Subject|0|||
163162392|NCT03695367|589307566|FG001|Overall Study|Withdrawal by Subject|1|||
163162393|NCT03695367|589307565|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
163162394|NCT03695367|589307566|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
163162395|NCT00396253|589307569|FG000|Overall Study|Protocol Violation|1|||
163162396|NCT00396253|589307569|FG000|Overall Study|Withdrawal by Subject|7|||
163162397|NCT00396253|589307569|FG000|Overall Study|Death|3|||
163162398|NCT00396253|589307569|FG000|Overall Study|Physician Decision|1|||
163162399|NCT00396253|589307569|FG000|Overall Study|Change in eligibility status|1|||
163162400|NCT00092443|589307570|FG000|Overall Study|Adverse Event|9|||
163162401|NCT00092443|589307571|FG001|Overall Study|Adverse Event|13|||
163162402|NCT00092443|589307570|FG000|Overall Study|Lost to Follow-up|7|||
163162403|NCT00092443|589307571|FG001|Overall Study|Lost to Follow-up|3|||
163162404|NCT00092443|589307570|FG000|Overall Study|Protocol Violation|11|||
163162405|NCT00092443|589307571|FG001|Overall Study|Protocol Violation|9|||
163162406|NCT00092443|589307570|FG000|Overall Study|Withdrawal by Subject|9|||
163162407|NCT00092443|589307571|FG001|Overall Study|Withdrawal by Subject|11|||
163162408|NCT00092443|589307570|FG000|Overall Study|Moved|5|||
163162409|NCT00092443|589307571|FG001|Overall Study|Moved|5|||
163162410|NCT00092443|589307570|FG000|Overall Study|Other|17|||
163162411|NCT00092443|589307571|FG001|Overall Study|Other|13|||
163162412|NCT01865552|589309630|FG000|Period 1|Adverse Event|1|||
163162413|NCT01865552|589309631|FG001|Period 1|Adverse Event|0|||
163162414|NCT01865552|589309632|FG002|Period 1|Adverse Event|0|||
163162415|NCT01865552|589309633|FG003|Period 1|Adverse Event|1|||
163162416|NCT01865552|589309634|FG004|Period 1|Adverse Event|1|||
163162417|NCT01865552|589309635|FG005|Period 1|Adverse Event|1|||
163162418|NCT01865552|589309630|FG000|Period 1|Pathological lab|0|||
163162419|NCT01865552|589309631|FG001|Period 1|Pathological lab|0|||
163162420|NCT01865552|589309632|FG002|Period 1|Pathological lab|0|||
163162421|NCT01865552|589309633|FG003|Period 1|Pathological lab|0|||
163162422|NCT01865552|589309634|FG004|Period 1|Pathological lab|1|||
163162423|NCT01865552|589309635|FG005|Period 1|Pathological lab|0|||
163162424|NCT01865552|589309630|FG000|Period 1|Other|0|||
163162425|NCT01865552|589309631|FG001|Period 1|Other|0|||
163162426|NCT01865552|589309632|FG002|Period 1|Other|0|||
163162427|NCT01865552|589309633|FG003|Period 1|Other|0|||
163162428|NCT01865552|589309634|FG004|Period 1|Other|1|||
163162429|NCT01865552|589309635|FG005|Period 1|Other|0|||
163162430|NCT03079102|589309638|FG000|Overall Study|Physician Decision|0|||
163162431|NCT03079102|589309639|FG001|Overall Study|Physician Decision|1|||
163162432|NCT02923921|589309640|FG000|Overall Study|Sponsor Decision|39|||
163162433|NCT02923921|589309641|FG001|Overall Study|Sponsor Decision|38|||
163162434|NCT02923921|589309640|FG000|Overall Study|Lost to Follow-up|1|||
163162435|NCT02923921|589309641|FG001|Overall Study|Lost to Follow-up|0|||
163162436|NCT02923921|589309640|FG000|Overall Study|Withdrawal by Subject|6|||
163162437|NCT02923921|589309641|FG001|Overall Study|Withdrawal by Subject|13|||
163162438|NCT02923921|589309640|FG000|Overall Study|Unknown, Not Collected|7|||
163162439|NCT02923921|589309641|FG001|Overall Study|Unknown, Not Collected|6|||
163162440|NCT03083873|589309642|FG000|Overall Study|Death|6|||
163162441|NCT03083873|589309643|FG001|Overall Study|Death|15|||
163162442|NCT03083873|589309644|FG002|Overall Study|Death|13|||
163162443|NCT03083873|589309645|FG003|Overall Study|Death|9|||
163162444|NCT03083873|589309646|FG004|Overall Study|Death|0|||
163162445|NCT03083873|589309642|FG000|Overall Study|Sponsor Terminated Study|0|||
163162446|NCT03083873|589309643|FG001|Overall Study|Sponsor Terminated Study|1|||
163162447|NCT03083873|589309644|FG002|Overall Study|Sponsor Terminated Study|2|||
163162448|NCT03083873|589309645|FG003|Overall Study|Sponsor Terminated Study|3|||
163162449|NCT03083873|589309646|FG004|Overall Study|Sponsor Terminated Study|0|||
163162450|NCT03083873|589309642|FG000|Overall Study|Lost to Follow-up|0|||
163162451|NCT03083873|589309643|FG001|Overall Study|Lost to Follow-up|1|||
163162452|NCT03083873|589309644|FG002|Overall Study|Lost to Follow-up|1|||
163162453|NCT03083873|589309645|FG003|Overall Study|Lost to Follow-up|0|||
163162454|NCT03083873|589309646|FG004|Overall Study|Lost to Follow-up|0|||
163162455|NCT03083873|589309642|FG000|Overall Study|Withdrawal by Subject|2|||
163162456|NCT03083873|589309643|FG001|Overall Study|Withdrawal by Subject|0|||
163162457|NCT03083873|589309644|FG002|Overall Study|Withdrawal by Subject|0|||
163162458|NCT03083873|589309645|FG003|Overall Study|Withdrawal by Subject|0|||
163162459|NCT03083873|589309646|FG004|Overall Study|Withdrawal by Subject|0|||
163162460|NCT03083873|589309642|FG000|Overall Study|Did Not Receive TIL|2|||
163162461|NCT03083873|589309643|FG001|Overall Study|Did Not Receive TIL|5|||
163162462|NCT03083873|589309644|FG002|Overall Study|Did Not Receive TIL|3|||
163162463|NCT03083873|589309645|FG003|Overall Study|Did Not Receive TIL|1|||
163162464|NCT03083873|589309646|FG004|Overall Study|Did Not Receive TIL|0|||
163162465|NCT00854113|589309647|FG000|Overall Study|Adverse Event|0|||
163162466|NCT00854113|589309648|FG001|Overall Study|Adverse Event|0|||
163162467|NCT00854113|589309649|FG002|Overall Study|Adverse Event|0|||
163162468|NCT00854113|589309650|FG003|Overall Study|Adverse Event|0|||
163162469|NCT00854113|589309651|FG004|Overall Study|Adverse Event|0|||
163162470|NCT00854113|589309652|FG005|Overall Study|Adverse Event|0|||
163162471|NCT00854113|589309653|FG006|Overall Study|Adverse Event|0|||
163162472|NCT00854113|589309654|FG007|Overall Study|Adverse Event|2|||
163162473|NCT00854113|589309655|FG008|Overall Study|Adverse Event|0|||
163162474|NCT00854113|589309656|FG009|Overall Study|Adverse Event|0|||
163162475|NCT00854113|589309657|FG010|Overall Study|Adverse Event|0|||
163162476|NCT00854113|589309647|FG000|Overall Study|Withdrawal by Subject|0|||
163162477|NCT00854113|589309648|FG001|Overall Study|Withdrawal by Subject|0|||
163162478|NCT00854113|589309649|FG002|Overall Study|Withdrawal by Subject|0|||
163162479|NCT00854113|589309650|FG003|Overall Study|Withdrawal by Subject|0|||
163162480|NCT00854113|589309651|FG004|Overall Study|Withdrawal by Subject|0|||
163162481|NCT00854113|589309652|FG005|Overall Study|Withdrawal by Subject|0|||
163162482|NCT00854113|589309653|FG006|Overall Study|Withdrawal by Subject|0|||
163162483|NCT00854113|589309654|FG007|Overall Study|Withdrawal by Subject|1|||
163162484|NCT00854113|589309655|FG008|Overall Study|Withdrawal by Subject|1|||
163162485|NCT00854113|589309656|FG009|Overall Study|Withdrawal by Subject|0|||
163162486|NCT00854113|589309657|FG010|Overall Study|Withdrawal by Subject|0|||
163162487|NCT00539864|589309658|FG000|Overall Study|Lost to Follow-up|0|||
163162488|NCT00539864|589309659|FG001|Overall Study|Lost to Follow-up|1|||
163162489|NCT00539864|589309658|FG000|Overall Study|Withdrawal by Subject|1|||
163162490|NCT00539864|589309659|FG001|Overall Study|Withdrawal by Subject|1|||
163162491|NCT01250145|589309660|FG000|Overall Study|Adverse Event|2|||
163162492|NCT01250145|589309661|FG001|Overall Study|Adverse Event|1|||
163162493|NCT01250145|589309660|FG000|Overall Study|Withdrawal by Subject|0|||
163162494|NCT01250145|589309661|FG001|Overall Study|Withdrawal by Subject|4|||
163162495|NCT04661579|589309666|FG000|Overall Study|Lost to Follow-up|19|||
163162496|NCT04661579|589309667|FG001|Overall Study|Lost to Follow-up|10|||
163162497|NCT04661579|589309668|FG002|Overall Study|Lost to Follow-up|2|||
163162498|NCT04661579|589309669|FG003|Overall Study|Lost to Follow-up|7|||
163162499|NCT04661579|589309670|FG004|Overall Study|Lost to Follow-up|11|||
163162500|NCT04661579|589309666|FG000|Overall Study|Physician Decision|2|||
163162501|NCT04661579|589309667|FG001|Overall Study|Physician Decision|0|||
163162502|NCT04661579|589309668|FG002|Overall Study|Physician Decision|0|||
163162503|NCT04661579|589309669|FG003|Overall Study|Physician Decision|1|||
163162504|NCT04661579|589309670|FG004|Overall Study|Physician Decision|0|||
163162505|NCT04661579|589309666|FG000|Overall Study|Withdrawal by Subject|1|||
163162506|NCT04661579|589309667|FG001|Overall Study|Withdrawal by Subject|4|||
163162507|NCT04661579|589309668|FG002|Overall Study|Withdrawal by Subject|0|||
163162508|NCT04661579|589309669|FG003|Overall Study|Withdrawal by Subject|2|||
163162509|NCT04661579|589309670|FG004|Overall Study|Withdrawal by Subject|0|||
163162510|NCT04661579|589309666|FG000|Overall Study|Death|1|||
163162511|NCT04661579|589309667|FG001|Overall Study|Death|0|||
163162512|NCT04661579|589309668|FG002|Overall Study|Death|0|||
163162513|NCT04661579|589309669|FG003|Overall Study|Death|0|||
163162514|NCT04661579|589309670|FG004|Overall Study|Death|0|||
163162515|NCT04661579|589309666|FG000|Overall Study|Other|1|||
163162516|NCT04661579|589309667|FG001|Overall Study|Other|2|||
163162517|NCT04661579|589309668|FG002|Overall Study|Other|1|||
163162518|NCT04661579|589309669|FG003|Overall Study|Other|1|||
163162519|NCT04661579|589309670|FG004|Overall Study|Other|1|||
163162520|NCT04661579|589309666|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
163162521|NCT04661579|589309667|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
162813944|NCT01898923|588029647|FG001|Overall Study|Lost to Follow-up|1|||
163162522|NCT04661579|589309668|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
163162523|NCT04661579|589309669|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
163162524|NCT04661579|589309670|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
163162525|NCT03656562|589309671|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
163162526|NCT03656562|589309672|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
163162527|NCT03656562|589309673|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
163162528|NCT03656562|589309674|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
163162529|NCT03656562|589309671|FG000|Overall Study|Physician Decision|1|||
163162530|NCT03656562|589309672|FG001|Overall Study|Physician Decision|2|||
163162531|NCT03656562|589309673|FG002|Overall Study|Physician Decision|0|||
163162532|NCT03656562|589309674|FG003|Overall Study|Physician Decision|0|||
163162533|NCT03656562|589309671|FG000|Overall Study|Subject Decision|3|||
163162534|NCT03656562|589309672|FG001|Overall Study|Subject Decision|5|||
163162535|NCT03656562|589309673|FG002|Overall Study|Subject Decision|0|||
163162536|NCT03656562|589309674|FG003|Overall Study|Subject Decision|2|||
163162537|NCT04335136|589309675|FG000|Overall Study|Death|8|||
163162538|NCT04335136|589309676|FG001|Overall Study|Death|4|||
163162539|NCT04335136|589309675|FG000|Overall Study|Lost to Follow-up|2|||
163162540|NCT04335136|589309676|FG001|Overall Study|Lost to Follow-up|0|||
163162541|NCT04335136|589309675|FG000|Overall Study|Protocol Violation|1|||
163162542|NCT04335136|589309676|FG001|Overall Study|Protocol Violation|0|||
163162543|NCT04335136|589309675|FG000|Overall Study|Withdrawal by Subject|1|||
163162544|NCT04335136|589309676|FG001|Overall Study|Withdrawal by Subject|1|||
163162545|NCT04335136|589309675|FG000|Overall Study|Health-threatening condition|0|||
163162546|NCT04335136|589309676|FG001|Overall Study|Health-threatening condition|1|||
163162547|NCT04335136|589309675|FG000|Overall Study|Adverse Event|0|||
163162548|NCT04335136|589309676|FG001|Overall Study|Adverse Event|1|||
163162549|NCT04335136|589309675|FG000|Overall Study|Erroneously randomized|2|||
163162550|NCT04335136|589309676|FG001|Overall Study|Erroneously randomized|0|||
163162551|NCT01396447|589309677|FG000|Overall Study|Did Not Receive Treatment|3|||
163162552|NCT01396447|589309678|FG001|Overall Study|Did Not Receive Treatment|2|||
163162553|NCT01396447|589309679|FG002|Overall Study|Did Not Receive Treatment|1|||
163162554|NCT01396447|589309680|FG003|Overall Study|Did Not Receive Treatment|0|||
163162555|NCT01396447|589309677|FG000|Overall Study|Adverse Event|15|||
163162556|NCT01396447|589309678|FG001|Overall Study|Adverse Event|12|||
163162557|NCT01396447|589309679|FG002|Overall Study|Adverse Event|12|||
163162558|NCT01396447|589309680|FG003|Overall Study|Adverse Event|17|||
163162559|NCT01396447|589309677|FG000|Overall Study|Insufficient Therapeutic Response|5|||
163162560|NCT01396447|589309678|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163162561|NCT01396447|589309679|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163162562|NCT01396447|589309680|FG003|Overall Study|Insufficient Therapeutic Response|4|||
163162563|NCT01396447|589309677|FG000|Overall Study|Protocol Violation|5|||
163162564|NCT01396447|589309678|FG001|Overall Study|Protocol Violation|2|||
163162565|NCT01396447|589309679|FG002|Overall Study|Protocol Violation|3|||
163162566|NCT01396447|589309680|FG003|Overall Study|Protocol Violation|7|||
163162567|NCT01396447|589309677|FG000|Overall Study|Withdrawal of Consent|11|||
163162568|NCT01396447|589309678|FG001|Overall Study|Withdrawal of Consent|9|||
163162569|NCT01396447|589309679|FG002|Overall Study|Withdrawal of Consent|4|||
163162570|NCT01396447|589309680|FG003|Overall Study|Withdrawal of Consent|15|||
163162571|NCT01396447|589309677|FG000|Overall Study|Lost to Follow-up|4|||
163162572|NCT01396447|589309678|FG001|Overall Study|Lost to Follow-up|8|||
163162573|NCT01396447|589309679|FG002|Overall Study|Lost to Follow-up|7|||
163162574|NCT01396447|589309680|FG003|Overall Study|Lost to Follow-up|9|||
163162575|NCT01396447|589309677|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163162576|NCT01396447|589309678|FG001|Overall Study|Other Miscellaneous Reasons|2|||
163162577|NCT01396447|589309679|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163162578|NCT01396447|589309680|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163162579|NCT01402102|589309681|FG000|Overall Study|Protocol Violation|1|||
163162580|NCT01402102|589309682|FG001|Overall Study|Protocol Violation|0|||
163162581|NCT01402102|589309681|FG000|Overall Study|Insufficiency of compliance|1|||
163162582|NCT01402102|589309682|FG001|Overall Study|Insufficiency of compliance|1|||
162697999|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698000|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698001|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698002|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698003|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698004|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698005|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698006|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698007|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162698008|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
162698009|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
162698010|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
162698011|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
162698012|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698013|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698014|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698015|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698016|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698017|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698018|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163162583|NCT01402102|589309681|FG000|Overall Study|Withdrawal by Subject|0|||
163162584|NCT01402102|589309682|FG001|Overall Study|Withdrawal by Subject|2|||
163162585|NCT04269265|589309683|FG000|Overall Study|Physician Decision|1|||
163162586|NCT04269265|589309683|FG000|Overall Study|Withdrawal by Subject|1|||
163162587|NCT04269265|589309683|FG000|Overall Study|Overenrolled (sample size reached)|4|||
163162588|NCT04693234|589309684|FG000|Overall Study|Death|79|||
163162589|NCT04693234|589309685|FG001|Overall Study|Death|19|||
163162590|NCT04693234|589309684|FG000|Overall Study|Sponsor Ended Study|47|||
163162591|NCT04693234|589309685|FG001|Overall Study|Sponsor Ended Study|18|||
163162592|NCT04693234|589309684|FG000|Overall Study|Withdrawal by Subject|10|||
163162593|NCT04693234|589309685|FG001|Overall Study|Withdrawal by Subject|2|||
163162594|NCT04693234|589309684|FG000|Overall Study|Lost to Follow-up|2|||
163162595|NCT04693234|589309685|FG001|Overall Study|Lost to Follow-up|1|||
163162596|NCT04838626|589309688|FG000|Overall Study|Adverse Event|2|||
163162597|NCT04838626|589309688|FG000|Overall Study|Physician Decision|6|||
163162598|NCT04838626|589309688|FG000|Overall Study|Protocol Violation|3|||
163162599|NCT04838626|589309688|FG000|Overall Study|Withdrawal by Subject|9|||
163162600|NCT04838626|589309688|FG000|Overall Study|Technical Problems|2|||
163162601|NCT02578706|589309689|FG000|Overall Study|Withdrawal by Subject|1|||
163162602|NCT02578706|589309690|FG001|Overall Study|Withdrawal by Subject|0|||
163162603|NCT02578706|589309691|FG002|Overall Study|Withdrawal by Subject|0|||
163162604|NCT02578706|589309689|FG000|Overall Study|Lost to Follow-up|0|||
163162605|NCT02578706|589309690|FG001|Overall Study|Lost to Follow-up|4|||
163162606|NCT02578706|589309691|FG002|Overall Study|Lost to Follow-up|0|||
163162607|NCT02578706|589309689|FG000|Overall Study|Physician Decision|0|||
163162608|NCT02578706|589309690|FG001|Overall Study|Physician Decision|1|||
163162609|NCT02578706|589309691|FG002|Overall Study|Physician Decision|0|||
163162610|NCT00670306|589309700|FG000|Overall Study|Adverse Event|8|||
163162611|NCT00670306|589309700|FG000|Overall Study|Lack of Efficacy|10|||
163162612|NCT00670306|589309700|FG000|Overall Study|Withdrawal by Subject|9|||
163162613|NCT00670306|589309700|FG000|Overall Study|Physician Decision|1|||
163162614|NCT00670306|589309700|FG000|Overall Study|Lost to Follow-up|8|||
163162615|NCT00670306|589309700|FG000|Overall Study|incl/excl criterias did not meet|19|||
163162616|NCT04939415|589309703|FG000|Overall Study|Withdrawal by Subject|1|||
163162617|NCT04939415|589309704|FG001|Overall Study|Withdrawal by Subject|3|||
163162618|NCT04939415|589309703|FG000|Overall Study|Lost to Follow-up|0|||
163162619|NCT04939415|589309704|FG001|Overall Study|Lost to Follow-up|2|||
163162620|NCT00067002|589309708|FG000|Overall Study|Early Death|1|||
163162621|NCT00067002|589309709|FG001|Overall Study|Early Death|2|||
163162622|NCT00067002|589309708|FG000|Overall Study|Delayed|1|||
163162623|NCT00067002|589309709|FG001|Overall Study|Delayed|1|||
163162624|NCT00067002|589309708|FG000|Overall Study|Graft Failure|5|||
163162625|NCT00067002|589309709|FG001|Overall Study|Graft Failure|6|||
163162626|NCT03350672|589309710|FG000|Overall Study|Withdrawal by Subject|7|||
163162627|NCT03350672|589309711|FG001|Overall Study|Withdrawal by Subject|0|||
163162628|NCT03350672|589309712|FG002|Overall Study|Withdrawal by Subject|0|||
163162629|NCT00478023|589309713|FG000|Overall Study|Adverse Event|11|||
163162630|NCT00478023|589309714|FG001|Overall Study|Adverse Event|7|||
163162631|NCT00478023|589309715|FG002|Overall Study|Adverse Event|8|||
163162632|NCT00478023|589309716|FG003|Overall Study|Adverse Event|14|||
163162633|NCT00478023|589309717|FG004|Overall Study|Adverse Event|6|||
163162634|NCT00478023|589309713|FG000|Overall Study|Death|1|||
163162635|NCT00478023|589309714|FG001|Overall Study|Death|0|||
163162636|NCT00478023|589309715|FG002|Overall Study|Death|0|||
163162637|NCT00478023|589309716|FG003|Overall Study|Death|0|||
163162638|NCT00478023|589309717|FG004|Overall Study|Death|0|||
163162639|NCT00478023|589309713|FG000|Overall Study|Lack of Efficacy|11|||
163162640|NCT00478023|589309714|FG001|Overall Study|Lack of Efficacy|10|||
163162641|NCT00478023|589309715|FG002|Overall Study|Lack of Efficacy|4|||
163162642|NCT00478023|589309716|FG003|Overall Study|Lack of Efficacy|5|||
163162643|NCT00478023|589309717|FG004|Overall Study|Lack of Efficacy|41|||
163162644|NCT00478023|589309713|FG000|Overall Study|Lost to Follow-up|3|||
163162645|NCT00478023|589309714|FG001|Overall Study|Lost to Follow-up|1|||
163162646|NCT00478023|589309715|FG002|Overall Study|Lost to Follow-up|1|||
163162647|NCT00478023|589309716|FG003|Overall Study|Lost to Follow-up|1|||
163162648|NCT00478023|589309717|FG004|Overall Study|Lost to Follow-up|0|||
163162649|NCT00478023|589309713|FG000|Overall Study|Withdrawal by Subject|2|||
163162650|NCT00478023|589309714|FG001|Overall Study|Withdrawal by Subject|3|||
163162651|NCT00478023|589309715|FG002|Overall Study|Withdrawal by Subject|2|||
163162652|NCT00478023|589309716|FG003|Overall Study|Withdrawal by Subject|4|||
163162653|NCT00478023|589309717|FG004|Overall Study|Withdrawal by Subject|5|||
163162654|NCT00478023|589309713|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
163162655|NCT00478023|589309714|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
163162656|NCT00478023|589309715|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
163162657|NCT00478023|589309716|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
163162658|NCT00478023|589309717|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
163162659|NCT03895840|589309719|FG000|Overall Study|Withdrawal by Subject|21|||
163162660|NCT01599637|589309722|FG000|Overall Study|administrative problems|0|||
163162661|NCT01599637|589309723|FG001|Overall Study|administrative problems|2|||
163162662|NCT01599637|589309724|FG002|Overall Study|administrative problems|0|||
163162663|NCT01599637|589309722|FG000|Overall Study|Adverse Event|1|||
163162664|NCT01599637|589309723|FG001|Overall Study|Adverse Event|0|||
163162665|NCT01599637|589309724|FG002|Overall Study|Adverse Event|0|||
163162666|NCT00611026|589309725|FG000|Randomized to Double-blind Treatment|Not treated|2|||
163162667|NCT00611026|589309726|FG001|Randomized to Double-blind Treatment|Not treated|1|||
163162668|NCT00611026|589309727|FG002|Randomized to Double-blind Treatment|Not treated|3|||
163162669|NCT00611026|589309725|FG000|Double-blind Treatment Period|Death|1|||
163162670|NCT00611026|589309726|FG001|Double-blind Treatment Period|Death|0|||
163162671|NCT00611026|589309727|FG002|Double-blind Treatment Period|Death|0|||
163162672|NCT00611026|589309725|FG000|Double-blind Treatment Period|Adverse Event|9|||
163162673|NCT00611026|589309726|FG001|Double-blind Treatment Period|Adverse Event|28|||
163162674|NCT00611026|589309727|FG002|Double-blind Treatment Period|Adverse Event|46|||
163162675|NCT00611026|589309725|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
163162676|NCT00611026|589309726|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
163162677|NCT00611026|589309727|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
163162678|NCT00611026|589309725|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
163162679|NCT00611026|589309726|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
163162680|NCT00611026|589309727|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
163162681|NCT00611026|589309725|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163162682|NCT00611026|589309726|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
163162683|NCT00611026|589309727|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
163162684|NCT00611026|589309725|FG000|Double-blind Treatment Period|Other|13|||
163162685|NCT00611026|589309726|FG001|Double-blind Treatment Period|Other|20|||
163162686|NCT00611026|589309727|FG002|Double-blind Treatment Period|Other|18|||
163162687|NCT00760617|589309728|FG000|Overall Study|Adverse Event|5|||
163162688|NCT00760617|589309729|FG001|Overall Study|Adverse Event|2|||
163162689|NCT00760617|589309730|FG002|Overall Study|Adverse Event|0|||
163162690|NCT00760617|589309728|FG000|Overall Study|Lost to Follow-up|0|||
163162691|NCT00760617|589309729|FG001|Overall Study|Lost to Follow-up|0|||
163162692|NCT00760617|589309730|FG002|Overall Study|Lost to Follow-up|5|||
163162693|NCT01192191|589309731|FG000|Overall Study|Adverse Event|7|||
163162694|NCT01192191|589309732|FG001|Overall Study|Adverse Event|12|||
163162695|NCT01192191|589309731|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
163162696|NCT01192191|589309732|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
163162697|NCT01192191|589309731|FG000|Overall Study|Lost to Follow-up|0|||
163162698|NCT01192191|589309732|FG001|Overall Study|Lost to Follow-up|1|||
163162699|NCT01192191|589309731|FG000|Overall Study|Withdrawal by Subject|1|||
163162700|NCT01192191|589309732|FG001|Overall Study|Withdrawal by Subject|6|||
163162701|NCT01047553|589309733|FG000|Overall Study|Adverse Event|10|||
163162702|NCT01047553|589309734|FG001|Overall Study|Adverse Event|5|||
163162703|NCT01047553|589309733|FG000|Overall Study|Withdrawal by Subject|4|||
163162704|NCT01047553|589309734|FG001|Overall Study|Withdrawal by Subject|2|||
163162705|NCT01047553|589309733|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
163162706|NCT01047553|589309734|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
163162707|NCT01047553|589309733|FG000|Overall Study|Lost to Follow-up|1|||
163162708|NCT01047553|589309734|FG001|Overall Study|Lost to Follow-up|0|||
163162709|NCT01047553|589309733|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
163162710|NCT01047553|589309734|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
162813945|NCT01898923|588029646|FG000|Overall Study|Withdrawal by Subject|4|||
162813946|NCT01898923|588029647|FG001|Overall Study|Withdrawal by Subject|7|||
162813947|NCT01898923|588029646|FG000|Overall Study|Physician Decision|3|||
162813948|NCT01898923|588029647|FG001|Overall Study|Physician Decision|4|||
162813949|NCT01898923|588029646|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
162813950|NCT01898923|588029647|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
162813951|NCT00723021|588029648|FG000|Intervention Period 4|Adverse Event|0|||
162813952|NCT00723021|588029649|FG001|Intervention Period 4|Adverse Event|0|||
162813953|NCT00723021|588029650|FG002|Intervention Period 4|Adverse Event|0|||
162813954|NCT00723021|588029651|FG003|Intervention Period 4|Adverse Event|0|||
162813955|NCT00723021|588029652|FG004|Intervention Period 4|Adverse Event|1|||
162813956|NCT02254278|588029656|FG000|Overall Study|Protocol Violation|1|||
162813957|NCT02254278|588029657|FG001|Overall Study|Protocol Violation|1|||
162813958|NCT05437510|588029660|FG000|Overall Study|Adverse Event|2|||
162813959|NCT05437510|588029661|FG001|Overall Study|Adverse Event|1|||
162813960|NCT05437510|588029660|FG000|Overall Study|Protocol Deviation|1|||
162813961|NCT05437510|588029661|FG001|Overall Study|Protocol Deviation|6|||
162813962|NCT05437510|588029660|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
162813963|NCT05437510|588029661|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
162813964|NCT05437510|588029660|FG000|Overall Study|Lost to Follow-up|265|||
162813965|NCT05437510|588029661|FG001|Overall Study|Lost to Follow-up|358|||
162813966|NCT00147823|588029662|FG000|Overall Study|Lost to Follow-up|6|||
163162711|NCT01047553|589309733|FG000|Overall Study|PI's decision|0|||
163162712|NCT01047553|589309734|FG001|Overall Study|PI's decision|1|||
163162713|NCT02817464|589309736|FG000|Overall Study|Lost to Follow-up|1|||
163162714|NCT02817464|589309737|FG001|Overall Study|Lost to Follow-up|0|||
163162715|NCT02817464|589309736|FG000|Overall Study|Discontinued early due to personal decision|1|||
163162716|NCT02817464|589309737|FG001|Overall Study|Discontinued early due to personal decision|1|||
163162717|NCT04292899|589309739|FG000|Overall Study|Death|21|||
163162718|NCT04292899|589309740|FG001|Overall Study|Death|28|||
163162719|NCT04292899|589309741|FG002|Overall Study|Death|188|||
163162720|NCT04292899|589309742|FG003|Overall Study|Death|371|||
163162721|NCT04292899|589309739|FG000|Overall Study|Lost to Follow-up|8|||
163162722|NCT04292899|589309740|FG001|Overall Study|Lost to Follow-up|4|||
163162723|NCT04292899|589309741|FG002|Overall Study|Lost to Follow-up|22|||
163162724|NCT04292899|589309742|FG003|Overall Study|Lost to Follow-up|235|||
163162725|NCT04292899|589309739|FG000|Overall Study|Withdrew consent|1|||
163162726|NCT04292899|589309740|FG001|Overall Study|Withdrew consent|0|||
163162727|NCT04292899|589309741|FG002|Overall Study|Withdrew consent|11|||
163162728|NCT04292899|589309742|FG003|Overall Study|Withdrew consent|32|||
163162729|NCT04292899|589309739|FG000|Overall Study|Adverse Event|2|||
163162730|NCT04292899|589309740|FG001|Overall Study|Adverse Event|1|||
163162731|NCT04292899|589309741|FG002|Overall Study|Adverse Event|2|||
163162732|NCT04292899|589309742|FG003|Overall Study|Adverse Event|2|||
163162733|NCT04292899|589309739|FG000|Overall Study|Investigator's Discretion|0|||
163162734|NCT04292899|589309740|FG001|Overall Study|Investigator's Discretion|0|||
163162735|NCT04292899|589309741|FG002|Overall Study|Investigator's Discretion|0|||
163162736|NCT04292899|589309742|FG003|Overall Study|Investigator's Discretion|3|||
163162737|NCT04292899|589309739|FG000|Overall Study|Non-compliance With Study Drug|0|||
163162738|NCT04292899|589309740|FG001|Overall Study|Non-compliance With Study Drug|0|||
163162739|NCT04292899|589309741|FG002|Overall Study|Non-compliance With Study Drug|0|||
163162740|NCT04292899|589309742|FG003|Overall Study|Non-compliance With Study Drug|1|||
163162741|NCT04292899|589309739|FG000|Overall Study|Protocol Violation|0|||
163162742|NCT04292899|589309740|FG001|Overall Study|Protocol Violation|0|||
163162743|NCT04292899|589309741|FG002|Overall Study|Protocol Violation|0|||
163162744|NCT04292899|589309742|FG003|Overall Study|Protocol Violation|1|||
163162745|NCT00948441|589309743|FG000|Overall Study|no longer meet inclusion criteria|1|||
163162746|NCT00948441|589309744|FG001|Overall Study|no longer meet inclusion criteria|4|||
163162747|NCT01026324|589309745|FG000|Follow up/Survival|Withdrawal by Subject|1|||
163162748|NCT01026324|589309746|FG001|Follow up/Survival|Withdrawal by Subject|0|||
163162749|NCT01026324|589309747|FG002|Follow up/Survival|Withdrawal by Subject|0|||
163162750|NCT05340478|589309754|FG000|Overall Study|Scheduling Issues|10|||
163162751|NCT05340478|589309755|FG001|Overall Study|Scheduling Issues|4|||
163162752|NCT05340478|589309754|FG000|Overall Study|Neither member of dyad started treatment|2|||
163162753|NCT05340478|589309755|FG001|Overall Study|Neither member of dyad started treatment|2|||
163162754|NCT05340478|589309754|FG000|Overall Study|Withdrawn from study|2|||
163162755|NCT05340478|589309755|FG001|Overall Study|Withdrawn from study|2|||
163162756|NCT05340478|589309754|FG000|Overall Study|Lost to Follow-up|1|||
163162757|NCT05340478|589309755|FG001|Overall Study|Lost to Follow-up|4|||
163162758|NCT01032889|589309758|FG000|Overall Study|Adverse Event|2|||
163162759|NCT01032889|589309759|FG001|Overall Study|Adverse Event|2|||
163162760|NCT01032889|589309760|FG002|Overall Study|Adverse Event|0|||
163162761|NCT01032889|589309758|FG000|Overall Study|Withdrawal of Consent|1|||
163162762|NCT01032889|589309759|FG001|Overall Study|Withdrawal of Consent|2|||
163162763|NCT01032889|589309760|FG002|Overall Study|Withdrawal of Consent|1|||
163162764|NCT01032889|589309758|FG000|Overall Study|Patient Request|0|||
163162765|NCT01032889|589309759|FG001|Overall Study|Patient Request|1|||
163162766|NCT01032889|589309760|FG002|Overall Study|Patient Request|0|||
163162767|NCT01032889|589309758|FG000|Overall Study|Lost to Follow-up|1|||
163162768|NCT01032889|589309759|FG001|Overall Study|Lost to Follow-up|1|||
163162769|NCT01032889|589309760|FG002|Overall Study|Lost to Follow-up|0|||
163162770|NCT01032889|589309758|FG000|Overall Study|Lack of Submental Fat|2|||
163162771|NCT01032889|589309759|FG001|Overall Study|Lack of Submental Fat|8|||
163162772|NCT01032889|589309760|FG002|Overall Study|Lack of Submental Fat|1|||
163162773|NCT01032889|589309758|FG000|Overall Study|Miscellaneous Reasons|2|||
163162774|NCT01032889|589309759|FG001|Overall Study|Miscellaneous Reasons|1|||
163162775|NCT01032889|589309760|FG002|Overall Study|Miscellaneous Reasons|1|||
163162776|NCT01500720|589309761|FG000|Overall Study|Randomized But Not Treated|1|||
163162777|NCT01500720|589309762|FG001|Overall Study|Randomized But Not Treated|1|||
163162778|NCT01500720|589309761|FG000|Overall Study|Other|4|||
163162779|NCT01500720|589309762|FG001|Overall Study|Other|8|||
163162780|NCT02624986|589309763|FG000|Overall Study|Death|0|||
163162781|NCT02624986|589309764|FG001|Overall Study|Death|1|||
163162782|NCT02624986|589309765|FG002|Overall Study|Death|2|||
162813967|NCT00147823|588029663|FG001|Overall Study|Lost to Follow-up|12|||
163162783|NCT02624986|589309766|FG003|Overall Study|Death|2|||
163162784|NCT02624986|589309767|FG004|Overall Study|Death|2|||
163162785|NCT02624986|589309768|FG005|Overall Study|Death|0|||
163162786|NCT02624986|589309769|FG006|Overall Study|Death|0|||
163162787|NCT02624986|589309770|FG007|Overall Study|Death|1|||
163162788|NCT02624986|589309763|FG000|Overall Study|Study Terminated by Sponsor|1|||
163162789|NCT02624986|589309764|FG001|Overall Study|Study Terminated by Sponsor|1|||
163162790|NCT02624986|589309765|FG002|Overall Study|Study Terminated by Sponsor|0|||
163162791|NCT02624986|589309766|FG003|Overall Study|Study Terminated by Sponsor|1|||
163162792|NCT02624986|589309767|FG004|Overall Study|Study Terminated by Sponsor|2|||
163162793|NCT02624986|589309768|FG005|Overall Study|Study Terminated by Sponsor|2|||
163162794|NCT02624986|589309769|FG006|Overall Study|Study Terminated by Sponsor|4|||
163162795|NCT02624986|589309770|FG007|Overall Study|Study Terminated by Sponsor|3|||
163162796|NCT02624986|589309763|FG000|Overall Study|Progressive Disease|0|||
163162797|NCT02624986|589309764|FG001|Overall Study|Progressive Disease|1|||
163162798|NCT02624986|589309765|FG002|Overall Study|Progressive Disease|0|||
163162799|NCT02624986|589309766|FG003|Overall Study|Progressive Disease|0|||
163162800|NCT02624986|589309767|FG004|Overall Study|Progressive Disease|0|||
163162801|NCT02624986|589309768|FG005|Overall Study|Progressive Disease|0|||
163162802|NCT02624986|589309769|FG006|Overall Study|Progressive Disease|0|||
163162803|NCT02624986|589309770|FG007|Overall Study|Progressive Disease|0|||
163162804|NCT02624986|589309763|FG000|Overall Study|Protocol Violation|1|||
163162805|NCT02624986|589309764|FG001|Overall Study|Protocol Violation|0|||
163162806|NCT02624986|589309765|FG002|Overall Study|Protocol Violation|0|||
163162807|NCT02624986|589309766|FG003|Overall Study|Protocol Violation|0|||
163162808|NCT02624986|589309767|FG004|Overall Study|Protocol Violation|0|||
163162809|NCT02624986|589309768|FG005|Overall Study|Protocol Violation|0|||
163162810|NCT02624986|589309769|FG006|Overall Study|Protocol Violation|0|||
163162811|NCT02624986|589309770|FG007|Overall Study|Protocol Violation|0|||
163162812|NCT02624986|589309763|FG000|Overall Study|Withdrawal by Subject|0|||
163162813|NCT02624986|589309764|FG001|Overall Study|Withdrawal by Subject|0|||
163162814|NCT02624986|589309765|FG002|Overall Study|Withdrawal by Subject|0|||
163162815|NCT02624986|589309766|FG003|Overall Study|Withdrawal by Subject|0|||
163162816|NCT02624986|589309767|FG004|Overall Study|Withdrawal by Subject|0|||
163162817|NCT02624986|589309768|FG005|Overall Study|Withdrawal by Subject|0|||
163162818|NCT02624986|589309769|FG006|Overall Study|Withdrawal by Subject|0|||
163162819|NCT02624986|589309770|FG007|Overall Study|Withdrawal by Subject|1|||
163162820|NCT03532451|589309772|FG000|Overall Study|Withdrawal by Subject|0|||
163162821|NCT03532451|589309773|FG001|Overall Study|Withdrawal by Subject|1|||
163162822|NCT03532451|589309772|FG000|Overall Study|Did not undergo surgery|1|||
163162823|NCT03532451|589309773|FG001|Overall Study|Did not undergo surgery|1|||
163162824|NCT02116205|589309774|FG000|Overall Study|Withdrawal by Subject|2|||
163162825|NCT02116205|589309775|FG001|Overall Study|Withdrawal by Subject|4|||
163162826|NCT02116205|589309776|FG002|Overall Study|Withdrawal by Subject|1|||
163162827|NCT02116205|589309777|FG003|Overall Study|Withdrawal by Subject|3|||
163162828|NCT02116205|589309774|FG000|Overall Study|Lost to Follow-up|0|||
163162829|NCT02116205|589309775|FG001|Overall Study|Lost to Follow-up|2|||
163162830|NCT02116205|589309776|FG002|Overall Study|Lost to Follow-up|1|||
163162831|NCT02116205|589309777|FG003|Overall Study|Lost to Follow-up|2|||
163162832|NCT02116205|589309774|FG000|Overall Study|Physician Decision|0|||
163162833|NCT02116205|589309775|FG001|Overall Study|Physician Decision|1|||
163162834|NCT02116205|589309776|FG002|Overall Study|Physician Decision|1|||
163162835|NCT02116205|589309777|FG003|Overall Study|Physician Decision|1|||
163162836|NCT02116205|589309774|FG000|Overall Study|Exclusion criteria|0|||
163162837|NCT02116205|589309775|FG001|Overall Study|Exclusion criteria|0|||
163162838|NCT02116205|589309776|FG002|Overall Study|Exclusion criteria|1|||
163162839|NCT02116205|589309777|FG003|Overall Study|Exclusion criteria|0|||
163162840|NCT00525161|589309780|FG000|Overall Study|Adverse Event|1|||
163162841|NCT01076361|589309781|FG000|Overall Study|22 leads were excluded from analysis|21|||
163162842|NCT00630838|589309791|FG000|Overall Study|Death|0|||
163162843|NCT00630838|589309792|FG001|Overall Study|Death|1|||
163162844|NCT00630838|589309791|FG000|Overall Study|Lost to Follow-up|0|||
163162845|NCT00630838|589309792|FG001|Overall Study|Lost to Follow-up|1|||
163162846|NCT00928408|589309793|FG000|Overall Study|Other|2|||
163162847|NCT00928408|589309793|FG000|Overall Study|Withdrawal by Subject|4|||
163162848|NCT00928408|589309793|FG000|Overall Study|Death|5|||
163162849|NCT00928408|589309793|FG000|Overall Study|Lost to Follow-up|12|||
163162850|NCT00256997|589309798|FG000|Overall Study|Protocol Violation|1|||
163162851|NCT00256997|589309799|FG001|Overall Study|Protocol Violation|4|||
163162852|NCT00256997|589309798|FG000|Overall Study|Lack of Efficacy|1|||
163162853|NCT00256997|589309799|FG001|Overall Study|Lack of Efficacy|4|||
163162854|NCT00256997|589309798|FG000|Overall Study|Death|2|||
163162855|NCT00256997|589309799|FG001|Overall Study|Death|0|||
163162856|NCT00256997|589309798|FG000|Overall Study|Adverse Event|4|||
163162857|NCT00256997|589309799|FG001|Overall Study|Adverse Event|0|||
163162858|NCT00256997|589309798|FG000|Overall Study|Lost to Follow-up|3|||
163162859|NCT00256997|589309799|FG001|Overall Study|Lost to Follow-up|5|||
163162860|NCT00256997|589309798|FG000|Overall Study|Withdrawal by Subject|13|||
163162861|NCT00256997|589309799|FG001|Overall Study|Withdrawal by Subject|3|||
163162862|NCT00256997|589309798|FG000|Overall Study|Started but not treated|2|||
163162863|NCT00256997|589309799|FG001|Overall Study|Started but not treated|0|||
163162864|NCT00256997|589309798|FG000|Overall Study|Other|5|||
163162865|NCT00256997|589309799|FG001|Overall Study|Other|8|||
163162866|NCT00256997|589309798|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
163162867|NCT00256997|589309799|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
163162868|NCT00256997|589309798|FG000|Overall Study|Participant Non-compliant|3|||
163162869|NCT00256997|589309799|FG001|Overall Study|Participant Non-compliant|6|||
163162870|NCT00256997|589309798|FG000|Overall Study|Investigator Withdrew Participant|2|||
163162871|NCT00256997|589309799|FG001|Overall Study|Investigator Withdrew Participant|1|||
163162872|NCT04672655|589309804|FG000|Overall Study|Lost to Follow-up|12|||
163162873|NCT04672655|589309805|FG001|Overall Study|Lost to Follow-up|17|||
163162874|NCT04672655|589309804|FG000|Overall Study|Withdrawal by Subject|1|||
163162875|NCT04672655|589309805|FG001|Overall Study|Withdrawal by Subject|0|||
162813968|NCT00147823|588029662|FG000|Overall Study|Physician Decision|1|||
162813969|NCT00147823|588029663|FG001|Overall Study|Physician Decision|0|||
162813970|NCT00147823|588029662|FG000|Overall Study|Withdrawal by Subject|0|||
162813971|NCT00147823|588029663|FG001|Overall Study|Withdrawal by Subject|1|||
162813972|NCT00147823|588029662|FG000|Overall Study|Did not receive vitoss due to infection|6|||
162813973|NCT00147823|588029663|FG001|Overall Study|Did not receive vitoss due to infection|2|||
162813974|NCT05199571|588032141|FG000|Treatment period|Participant decision|3|||
162813975|NCT05199571|588032141|FG000|Treatment period|Physician Decision|1|||
162813976|NCT05199571|588032141|FG000|Post-treatment follow up period|Participant decision|3|||
162813977|NCT02892344|588032142|FG000|Overall Study|Protocol deviation|3|||
162813978|NCT02892344|588032143|FG001|Overall Study|Protocol deviation|4|||
162813979|NCT02892344|588032142|FG000|Overall Study|Adverse Event|1|||
162813980|NCT02892344|588032143|FG001|Overall Study|Adverse Event|8|||
162813981|NCT02892344|588032142|FG000|Overall Study|Lost to Follow-up|0|||
162813982|NCT02892344|588032143|FG001|Overall Study|Lost to Follow-up|1|||
162813983|NCT02892344|588032142|FG000|Overall Study|Non-compliance with study treatment|0|||
162813984|NCT02892344|588032143|FG001|Overall Study|Non-compliance with study treatment|1|||
162813985|NCT02892344|588032142|FG000|Overall Study|Physician Decision|0|||
162813986|NCT02892344|588032143|FG001|Overall Study|Physician Decision|2|||
162813987|NCT02892344|588032142|FG000|Overall Study|Subject/guardian decision|0|||
162813988|NCT02892344|588032143|FG001|Overall Study|Subject/guardian decision|4|||
162813989|NCT02892344|588032142|FG000|Overall Study|Technical problems|0|||
162813990|NCT02892344|588032143|FG001|Overall Study|Technical problems|1|||
162813991|NCT03938454|588032144|FG000|Overall Study|Protocol Violation|1|||
162813992|NCT03938454|588032144|FG000|Overall Study|Withdrawal by Subject|2|||
162813993|NCT03938454|588032144|FG000|Overall Study|Lost to Follow-up|3|||
162813994|NCT04441905|588032145|FG000|Overall Study|Lost to Follow-up|1|||
162813995|NCT04441905|588032146|FG001|Overall Study|Lost to Follow-up|0|||
162813996|NCT04441905|588032147|FG002|Overall Study|Lost to Follow-up|0|||
162813997|NCT04441905|588032148|FG003|Overall Study|Lost to Follow-up|0|||
162813998|NCT04441905|588032149|FG004|Overall Study|Lost to Follow-up|0|||
162813999|NCT04441905|588032150|FG005|Overall Study|Lost to Follow-up|0|||
162814000|NCT04441905|588032145|FG000|Overall Study|Enrolled but treatment not administered|0|||
162814001|NCT04441905|588032146|FG001|Overall Study|Enrolled but treatment not administered|1|||
162814002|NCT04441905|588032147|FG002|Overall Study|Enrolled but treatment not administered|0|||
162814003|NCT04441905|588032148|FG003|Overall Study|Enrolled but treatment not administered|0|||
162814004|NCT04441905|588032149|FG004|Overall Study|Enrolled but treatment not administered|0|||
162814005|NCT04441905|588032150|FG005|Overall Study|Enrolled but treatment not administered|0|||
162814006|NCT04441905|588032145|FG000|Overall Study|Became ineligible after enrollment|0|||
162814007|NCT04441905|588032146|FG001|Overall Study|Became ineligible after enrollment|0|||
162814008|NCT04441905|588032147|FG002|Overall Study|Became ineligible after enrollment|0|||
162814009|NCT04441905|588032148|FG003|Overall Study|Became ineligible after enrollment|0|||
162814010|NCT04441905|588032149|FG004|Overall Study|Became ineligible after enrollment|1|||
162814011|NCT04441905|588032150|FG005|Overall Study|Became ineligible after enrollment|0|||
162814012|NCT03922802|588032151|FG000|Overall Study|Withdrawal by Subject|4|||
162814013|NCT04486716|588032152|FG000|Core Phase|Subject decision|6|||
162814014|NCT04486716|588032152|FG000|Core Phase|Adverse Event|5|||
162814015|NCT04486716|588032152|FG000|Core Phase|Lost to Follow-up|1|||
162814016|NCT04486716|588032152|FG000|Core Phase|Physician Decision|1|||
162814017|NCT04486716|588032152|FG000|Core Phase|Enrolled subjects not treated|9|||
162814018|NCT05888103|588032153|FG000|Overall Study|Participant decision|3|||
162814019|NCT05888103|588032154|FG001|Overall Study|Participant decision|3|||
162814020|NCT04987307|588032155|FG000|Overall Study|Protocol-specified criteria|2|||
162814021|NCT04987307|588032156|FG001|Overall Study|Protocol-specified criteria|0|||
162814022|NCT04987307|588032157|FG002|Overall Study|Protocol-specified criteria|0|||
162814023|NCT04987307|588032158|FG003|Overall Study|Protocol-specified criteria|3|||
162814024|NCT04987307|588032155|FG000|Overall Study|Withdrawal by Subject|34|||
162814025|NCT04987307|588032156|FG001|Overall Study|Withdrawal by Subject|30|||
162814026|NCT04987307|588032157|FG002|Overall Study|Withdrawal by Subject|29|||
162814027|NCT04987307|588032158|FG003|Overall Study|Withdrawal by Subject|35|||
162814028|NCT04987307|588032155|FG000|Overall Study|Decision by sponsor|10|||
162814029|NCT04987307|588032156|FG001|Overall Study|Decision by sponsor|13|||
162814030|NCT04987307|588032157|FG002|Overall Study|Decision by sponsor|11|||
162814031|NCT04987307|588032158|FG003|Overall Study|Decision by sponsor|9|||
162814032|NCT04987307|588032155|FG000|Overall Study|Lost to Follow-up|1|||
162814033|NCT04987307|588032156|FG001|Overall Study|Lost to Follow-up|0|||
162814034|NCT04987307|588032157|FG002|Overall Study|Lost to Follow-up|0|||
162814035|NCT04987307|588032158|FG003|Overall Study|Lost to Follow-up|0|||
162814036|NCT03650400|588032159|FG000|Overall Study|Study terminated by sponsor|0|||
162814037|NCT03650400|588032160|FG001|Overall Study|Study terminated by sponsor|5|||
162814038|NCT00792805|588032162|FG000|Overall Study|Adverse Event|12|||
162814039|NCT00792805|588032163|FG001|Overall Study|Adverse Event|10|||
162814040|NCT00792805|588032164|FG002|Overall Study|Adverse Event|10|||
162814041|NCT00792805|588032162|FG000|Overall Study|Subject withdrew consent|5|||
162814042|NCT00792805|588032163|FG001|Overall Study|Subject withdrew consent|6|||
162814043|NCT00792805|588032164|FG002|Overall Study|Subject withdrew consent|5|||
163162876|NCT04672655|589309804|FG000|Overall Study|Withdrawal by Study|1|||
163162877|NCT04672655|589309805|FG001|Overall Study|Withdrawal by Study|0|||
163162878|NCT01326104|589309806|FG000|Overall Study|progressed prior to vaccine|0|||
163162879|NCT01326104|589309807|FG001|Overall Study|progressed prior to vaccine|2|||
163162880|NCT01326104|589309806|FG000|Overall Study|unable to make vaccine|0|||
163162881|NCT01326104|589309807|FG001|Overall Study|unable to make vaccine|2|||
163162882|NCT01287741|589309808|FG000|Overall Study|Withdrawal by Subject|35|||
163162883|NCT01287741|589309809|FG001|Overall Study|Withdrawal by Subject|38|||
163162884|NCT01287741|589309808|FG000|Overall Study|Protocol Violation|2|||
163162885|NCT01287741|589309809|FG001|Overall Study|Protocol Violation|0|||
163162886|NCT01287741|589309808|FG000|Overall Study|Physician Decision|15|||
163162887|NCT01287741|589309809|FG001|Overall Study|Physician Decision|23|||
163162888|NCT01287741|589309808|FG000|Overall Study|Non-compliance|8|||
163162889|NCT01287741|589309809|FG001|Overall Study|Non-compliance|6|||
163162890|NCT01287741|589309808|FG000|Overall Study|Lost to Follow-up|10|||
163162891|NCT01287741|589309809|FG001|Overall Study|Lost to Follow-up|8|||
163162892|NCT01287741|589309808|FG000|Overall Study|Death|32|||
163162893|NCT01287741|589309809|FG001|Overall Study|Death|44|||
163162894|NCT01287741|589309808|FG000|Overall Study|Adverse Event|4|||
163162895|NCT01287741|589309809|FG001|Overall Study|Adverse Event|6|||
163162896|NCT01287741|589309808|FG000|Overall Study|Study terminated by Sponsor|307|||
163162897|NCT01287741|589309809|FG001|Overall Study|Study terminated by Sponsor|315|||
163162898|NCT01287741|589309808|FG000|Overall Study|Progressive disease|190|||
163162899|NCT01287741|589309809|FG001|Overall Study|Progressive disease|166|||
163162900|NCT01287741|589309808|FG000|Overall Study|Reason not specified|23|||
163162901|NCT01287741|589309809|FG001|Overall Study|Reason not specified|9|||
163162902|NCT03843541|589309810|FG000|Overall Study|Adverse Event|4|||
163162903|NCT03843541|589309811|FG001|Overall Study|Adverse Event|2|||
163162904|NCT03843541|589309812|FG002|Overall Study|Adverse Event|3|||
163162905|NCT03843541|589309810|FG000|Overall Study|Death|1|||
163162906|NCT03843541|589309811|FG001|Overall Study|Death|0|||
163162907|NCT03843541|589309812|FG002|Overall Study|Death|0|||
163162908|NCT03843541|589309810|FG000|Overall Study|Lack of adherence to study medication|0|||
163162909|NCT03843541|589309811|FG001|Overall Study|Lack of adherence to study medication|0|||
163162910|NCT03843541|589309812|FG002|Overall Study|Lack of adherence to study medication|1|||
163162911|NCT03843541|589309810|FG000|Overall Study|Physician Decision|1|||
163162912|NCT03843541|589309811|FG001|Overall Study|Physician Decision|2|||
163162913|NCT03843541|589309812|FG002|Overall Study|Physician Decision|2|||
163162914|NCT03843541|589309810|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
163162915|NCT03843541|589309811|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
163162916|NCT03843541|589309812|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
163162917|NCT03843541|589309810|FG000|Overall Study|Withdrawal by Subject|6|||
163162918|NCT03843541|589309811|FG001|Overall Study|Withdrawal by Subject|9|||
163162919|NCT03843541|589309812|FG002|Overall Study|Withdrawal by Subject|7|||
163162920|NCT03843541|589309810|FG000|Overall Study|Administration of rescue mucolytic|0|||
163162921|NCT03843541|589309811|FG001|Overall Study|Administration of rescue mucolytic|0|||
163162922|NCT03843541|589309812|FG002|Overall Study|Administration of rescue mucolytic|1|||
163162923|NCT03843541|589309810|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
163162924|NCT03843541|589309811|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
163162925|NCT03843541|589309812|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
163162926|NCT02930018|589309814|FG000|Overall Study|Lost to Follow-up|1|||
163162927|NCT02930018|589309815|FG001|Overall Study|Lost to Follow-up|1|||
163162928|NCT02930018|589309814|FG000|Overall Study|Withdrawal by Subject|5|||
163162929|NCT02930018|589309815|FG001|Overall Study|Withdrawal by Subject|2|||
163162930|NCT02807402|589309816|FG000|Overall Study|Failure to Return|1|||
163162931|NCT02807402|589309816|FG000|Overall Study|Death|3|||
163162932|NCT02807402|589309816|FG000|Overall Study|Other|2|||
163162933|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
163162934|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
163162935|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
163162936|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
163162937|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
163162938|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
163162939|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
163162940|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
163162941|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
163162942|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
163162943|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
163162944|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
163162945|NCT00479687|589311245|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
163162946|NCT00479687|589311246|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
163162947|NCT00479687|589311247|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
163162948|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
163162949|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
163162950|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
163162951|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
163162952|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
163162953|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
163162954|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
163162955|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
163162956|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
163162957|NCT00479687|589311245|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
163162958|NCT00479687|589311246|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
163162959|NCT00479687|589311247|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
163162960|NCT00796419|589311251|FG000|Overall Study|Death|0|||
163162961|NCT00796419|589311252|FG001|Overall Study|Death|1|||
163162962|NCT02840799|589311255|FG000|Phase 1|Physician Decision|1|||
163162963|NCT02840799|589311256|FG001|Phase 1|Physician Decision|3|||
163162964|NCT02840799|589311255|FG000|Phase 1|Withdrawal by Subject|4|||
163162965|NCT02840799|589311256|FG001|Phase 1|Withdrawal by Subject|0|||
163162966|NCT02840799|589311255|FG000|Phase 2 (Crossover)|Adverse Event|0|||
163162967|NCT02840799|589311256|FG001|Phase 2 (Crossover)|Adverse Event|1|||
163162968|NCT02840799|589311255|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
163162969|NCT02840799|589311256|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
163162970|NCT02687191|589311263|FG000|Overall Study|Death|0|||
163162971|NCT02687191|589311264|FG001|Overall Study|Death|1|||
163162972|NCT02687191|589311265|FG002|Overall Study|Death|1|||
163162973|NCT02687191|589311266|FG003|Overall Study|Death|0|||
163162974|NCT02687191|589311267|FG004|Overall Study|Death|1|||
163162975|NCT02687191|589311268|FG005|Overall Study|Death|1|||
163162976|NCT02687191|589311263|FG000|Overall Study|Withdrawal by Subject|0|||
163162977|NCT02687191|589311264|FG001|Overall Study|Withdrawal by Subject|0|||
163162978|NCT02687191|589311265|FG002|Overall Study|Withdrawal by Subject|0|||
163162979|NCT02687191|589311266|FG003|Overall Study|Withdrawal by Subject|1|||
163162980|NCT02687191|589311267|FG004|Overall Study|Withdrawal by Subject|0|||
163162981|NCT02687191|589311268|FG005|Overall Study|Withdrawal by Subject|0|||
163162982|NCT01349049|589311269|FG000|Overall Study|Disease progression|3|||
163162983|NCT01349049|589311270|FG001|Overall Study|Disease progression|5|||
163162984|NCT01349049|589311271|FG002|Overall Study|Disease progression|3|||
163162985|NCT01349049|589311272|FG003|Overall Study|Disease progression|2|||
163162986|NCT01349049|589311273|FG004|Overall Study|Disease progression|2|||
163162987|NCT01349049|589311274|FG005|Overall Study|Disease progression|2|||
163162988|NCT01349049|589311275|FG006|Overall Study|Disease progression|3|||
163162989|NCT01349049|589311276|FG007|Overall Study|Disease progression|2|||
163162990|NCT01349049|589311277|FG008|Overall Study|Disease progression|33|||
163162991|NCT01349049|589311269|FG000|Overall Study|Adverse Event|0|||
163162992|NCT01349049|589311270|FG001|Overall Study|Adverse Event|1|||
163162993|NCT01349049|589311271|FG002|Overall Study|Adverse Event|0|||
163162994|NCT01349049|589311272|FG003|Overall Study|Adverse Event|0|||
163162995|NCT01349049|589311273|FG004|Overall Study|Adverse Event|0|||
163162996|NCT01349049|589311274|FG005|Overall Study|Adverse Event|3|||
163162997|NCT01349049|589311275|FG006|Overall Study|Adverse Event|1|||
163162998|NCT01349049|589311276|FG007|Overall Study|Adverse Event|0|||
163162999|NCT01349049|589311277|FG008|Overall Study|Adverse Event|4|||
163163000|NCT01349049|589311269|FG000|Overall Study|Physician Decision|0|||
163163001|NCT01349049|589311270|FG001|Overall Study|Physician Decision|1|||
163163002|NCT01349049|589311271|FG002|Overall Study|Physician Decision|0|||
163163003|NCT01349049|589311272|FG003|Overall Study|Physician Decision|0|||
163163004|NCT01349049|589311273|FG004|Overall Study|Physician Decision|0|||
163163005|NCT01349049|589311274|FG005|Overall Study|Physician Decision|0|||
163163006|NCT01349049|589311275|FG006|Overall Study|Physician Decision|0|||
163163007|NCT01349049|589311276|FG007|Overall Study|Physician Decision|0|||
163163008|NCT01349049|589311277|FG008|Overall Study|Physician Decision|2|||
163163009|NCT01349049|589311269|FG000|Overall Study|Protocol Violation|0|||
163163010|NCT01349049|589311270|FG001|Overall Study|Protocol Violation|0|||
163163011|NCT01349049|589311271|FG002|Overall Study|Protocol Violation|0|||
163163012|NCT01349049|589311272|FG003|Overall Study|Protocol Violation|0|||
163163013|NCT01349049|589311273|FG004|Overall Study|Protocol Violation|0|||
163163014|NCT01349049|589311274|FG005|Overall Study|Protocol Violation|0|||
163163015|NCT01349049|589311275|FG006|Overall Study|Protocol Violation|0|||
163163016|NCT01349049|589311276|FG007|Overall Study|Protocol Violation|0|||
163163017|NCT01349049|589311277|FG008|Overall Study|Protocol Violation|1|||
163163018|NCT01349049|589311269|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
163163019|NCT01349049|589311270|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
163163020|NCT01349049|589311271|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
163163021|NCT01349049|589311272|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
163163022|NCT01349049|589311273|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
163163023|NCT01349049|589311274|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
163163024|NCT01349049|589311275|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
163163025|NCT01349049|589311276|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
163163026|NCT01349049|589311277|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
163163027|NCT01349049|589311269|FG000|Overall Study|Other|0|||
163163028|NCT01349049|589311270|FG001|Overall Study|Other|0|||
163163029|NCT01349049|589311271|FG002|Overall Study|Other|0|||
163163030|NCT01349049|589311272|FG003|Overall Study|Other|0|||
163163031|NCT01349049|589311273|FG004|Overall Study|Other|0|||
163163032|NCT01349049|589311274|FG005|Overall Study|Other|1|||
163163033|NCT01349049|589311275|FG006|Overall Study|Other|0|||
163163034|NCT01349049|589311276|FG007|Overall Study|Other|0|||
163163035|NCT01349049|589311277|FG008|Overall Study|Other|4|||
163163036|NCT01349049|589311269|FG000|Overall Study|Death|0|||
163163037|NCT01349049|589311270|FG001|Overall Study|Death|0|||
163163038|NCT01349049|589311271|FG002|Overall Study|Death|0|||
163163039|NCT01349049|589311272|FG003|Overall Study|Death|0|||
163163040|NCT01349049|589311273|FG004|Overall Study|Death|0|||
163163041|NCT01349049|589311274|FG005|Overall Study|Death|0|||
163163042|NCT01349049|589311275|FG006|Overall Study|Death|0|||
163163043|NCT01349049|589311276|FG007|Overall Study|Death|1|||
163163044|NCT01349049|589311277|FG008|Overall Study|Death|5|||
163163045|NCT01349049|589311269|FG000|Overall Study|Non-compliance|0|||
163163046|NCT01349049|589311270|FG001|Overall Study|Non-compliance|0|||
163163047|NCT01349049|589311271|FG002|Overall Study|Non-compliance|0|||
163163048|NCT01349049|589311272|FG003|Overall Study|Non-compliance|1|||
163163049|NCT01349049|589311273|FG004|Overall Study|Non-compliance|0|||
163163050|NCT01349049|589311274|FG005|Overall Study|Non-compliance|0|||
163163051|NCT01349049|589311275|FG006|Overall Study|Non-compliance|0|||
163163052|NCT01349049|589311276|FG007|Overall Study|Non-compliance|0|||
163163053|NCT01349049|589311277|FG008|Overall Study|Non-compliance|0|||
163163054|NCT01349049|589311269|FG000|Overall Study|Withdrawal by Subject|0|||
163163055|NCT01349049|589311270|FG001|Overall Study|Withdrawal by Subject|0|||
163163056|NCT01349049|589311271|FG002|Overall Study|Withdrawal by Subject|0|||
163163057|NCT01349049|589311272|FG003|Overall Study|Withdrawal by Subject|0|||
163163058|NCT01349049|589311273|FG004|Overall Study|Withdrawal by Subject|0|||
163163059|NCT01349049|589311274|FG005|Overall Study|Withdrawal by Subject|0|||
163163060|NCT01349049|589311275|FG006|Overall Study|Withdrawal by Subject|0|||
163163061|NCT01349049|589311276|FG007|Overall Study|Withdrawal by Subject|0|||
163163062|NCT01349049|589311277|FG008|Overall Study|Withdrawal by Subject|6|||
163163063|NCT03887702|589311278|FG000|Overall Study|Study terminated|0|||
163163064|NCT03887702|589311279|FG001|Overall Study|Study terminated|0|||
163163065|NCT03887702|589311280|FG002|Overall Study|Study terminated|2|||
163163066|NCT03887702|589311281|FG003|Overall Study|Study terminated|2|||
163163067|NCT01643772|589311282|FG000|Overall Study|Protocol Violation|0|||
163163068|NCT01643772|589311283|FG001|Overall Study|Protocol Violation|0|||
163163069|NCT01643772|589311284|FG002|Overall Study|Protocol Violation|0|||
163163070|NCT01643772|589311285|FG003|Overall Study|Protocol Violation|1|||
163163071|NCT01643772|589311282|FG000|Overall Study|Adverse Event|0|||
163163072|NCT01643772|589311283|FG001|Overall Study|Adverse Event|0|||
163163073|NCT01643772|589311284|FG002|Overall Study|Adverse Event|0|||
163163074|NCT01643772|589311285|FG003|Overall Study|Adverse Event|1|||
163163075|NCT03860818|589311286|FG000|Overall Study|Death|144|||
162814044|NCT00792805|588032162|FG000|Overall Study|Administrative problems|2|||
162814045|NCT00792805|588032163|FG001|Overall Study|Administrative problems|0|||
162814046|NCT00792805|588032164|FG002|Overall Study|Administrative problems|4|||
162814047|NCT00792805|588032162|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162814048|NCT00792805|588032163|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162814049|NCT00792805|588032164|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162814050|NCT00792805|588032162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162814051|NCT00792805|588032163|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162814052|NCT00792805|588032164|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163163076|NCT03860818|589311287|FG001|Overall Study|Death|195|||
163163077|NCT03860818|589311286|FG000|Overall Study|Graft Loss|32|||
163163078|NCT03860818|589311287|FG001|Overall Study|Graft Loss|45|||
163163079|NCT00505778|589311288|FG000|Overall Study|Adverse Event|2|||
163163080|NCT00505778|589311289|FG001|Overall Study|Adverse Event|7|||
163163081|NCT00505778|589311288|FG000|Overall Study|Physician Decision|8|||
163163082|NCT00505778|589311289|FG001|Overall Study|Physician Decision|14|||
163163083|NCT00505778|589311288|FG000|Overall Study|Lost to Follow-up|17|||
163163084|NCT00505778|589311289|FG001|Overall Study|Lost to Follow-up|23|||
163163085|NCT00505778|589311288|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
163163086|NCT00505778|589311289|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
162814053|NCT00792805|588032162|FG000|Overall Study|Lost to Follow-up|1|||
163163087|NCT00505778|589311288|FG000|Overall Study|Protocol Violation|7|||
163163088|NCT00505778|589311289|FG001|Overall Study|Protocol Violation|9|||
163163089|NCT00505778|589311288|FG000|Overall Study|Withdrawal by Subject|29|||
163163090|NCT00505778|589311289|FG001|Overall Study|Withdrawal by Subject|14|||
163163091|NCT00505778|589311288|FG000|Overall Study|Relapse|65|||
163163092|NCT00505778|589311289|FG001|Overall Study|Relapse|65|||
163163093|NCT00505778|589311288|FG000|Overall Study|Took No Study Drug|2|||
163163094|NCT00505778|589311289|FG001|Overall Study|Took No Study Drug|2|||
163163095|NCT03436082|589311290|FG000|Overall Study|Did not undergo procedure|1|||
163163096|NCT03436082|589311291|FG001|Overall Study|Did not undergo procedure|0|||
163163097|NCT01864603|589311294|FG000|Stage 2|DSMB design modification|86056|||
163163098|NCT01864603|589311295|FG001|Stage 2|DSMB design modification|92558|||
163163099|NCT02423902|589311296|FG000|Overall Study|Disease progression|1|||
163163100|NCT02423902|589311297|FG001|Overall Study|Disease progression|4|||
163163101|NCT02136069|589311298|FG000|Overall Study|UC flare-up|1|||
163163102|NCT02136069|589311299|FG001|Overall Study|UC flare-up|0|||
163163103|NCT02136069|589311298|FG000|Overall Study|Adverse Event|6|||
163163104|NCT02136069|589311299|FG001|Overall Study|Adverse Event|8|||
163163105|NCT02136069|589311298|FG000|Overall Study|Death|0|||
163163106|NCT02136069|589311299|FG001|Overall Study|Death|1|||
163163107|NCT02136069|589311298|FG000|Overall Study|Lack of Efficacy|10|||
163163108|NCT02136069|589311299|FG001|Overall Study|Lack of Efficacy|4|||
163163109|NCT02136069|589311298|FG000|Overall Study|Lost to Follow-up|1|||
163163110|NCT02136069|589311299|FG001|Overall Study|Lost to Follow-up|0|||
163163111|NCT02136069|589311298|FG000|Overall Study|Non-Compliance|1|||
163163112|NCT02136069|589311299|FG001|Overall Study|Non-Compliance|0|||
163163113|NCT02136069|589311298|FG000|Overall Study|Physician Decision|5|||
163163114|NCT02136069|589311299|FG001|Overall Study|Physician Decision|4|||
163163115|NCT02136069|589311298|FG000|Overall Study|Withdrawal by Subject|10|||
163163116|NCT02136069|589311299|FG001|Overall Study|Withdrawal by Subject|11|||
163163117|NCT00811018|589311301|FG000|Overall Study|Additional Chronic Treatment|31|||
163163118|NCT00811018|589311301|FG000|Overall Study|Adverse Event|79|||
163163119|NCT00811018|589311301|FG000|Overall Study|Death|147|||
163163120|NCT00811018|589311301|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
163163121|NCT00811018|589311301|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
163163122|NCT00811018|589311301|FG000|Overall Study|Investigator Decision|57|||
163163123|NCT00811018|589311301|FG000|Overall Study|Lost to Follow-up|19|||
163163124|NCT00811018|589311301|FG000|Overall Study|Pregnancy|6|||
163163125|NCT00811018|589311301|FG000|Overall Study|Sponsor Decision|450|||
163163126|NCT00811018|589311301|FG000|Overall Study|Withdrawal by Subject|70|||
163163127|NCT00811018|589311301|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
163163128|NCT00811018|589311301|FG000|Overall Study|Other|26|||
163163129|NCT00392769|589311302|FG000|Overall Study|Clinical Deterioration|9|||
163163130|NCT00392769|589311302|FG000|Overall Study|Adverse Event|1|||
163163131|NCT04154189|589311303|FG000|Overall Study|Withdrawal by Subject|4|||
163163132|NCT04154189|589311304|FG001|Overall Study|Withdrawal by Subject|6|||
163163133|NCT04154189|589311303|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
163163134|NCT04154189|589311304|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
163163135|NCT04154189|589311303|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
163163136|NCT04154189|589311304|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
163163137|NCT04154189|589311303|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
163163138|NCT04154189|589311304|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
163163139|NCT04154189|589311303|FG000|Overall Study|Death|25|||
163163140|NCT04154189|589311304|FG001|Overall Study|Death|25|||
163163141|NCT00845897|589311307|FG000|Overall Study|Lost to Follow-up|1|||
163163142|NCT00845897|589311308|FG001|Overall Study|Lost to Follow-up|1|||
163163143|NCT00845897|589311309|FG002|Overall Study|Lost to Follow-up|0|||
163163144|NCT00845897|589311307|FG000|Overall Study|Withdrawal by Subject|0|||
163163145|NCT00845897|589311308|FG001|Overall Study|Withdrawal by Subject|3|||
163163146|NCT00845897|589311309|FG002|Overall Study|Withdrawal by Subject|2|||
163163147|NCT00845897|589311307|FG000|Overall Study|Ulcer did not heal|1|||
163163148|NCT00845897|589311308|FG001|Overall Study|Ulcer did not heal|0|||
163163149|NCT00845897|589311309|FG002|Overall Study|Ulcer did not heal|1|||
163163150|NCT00845897|589311307|FG000|Overall Study|Too ill to participate|0|||
163163151|NCT00845897|589311308|FG001|Overall Study|Too ill to participate|1|||
163163152|NCT00845897|589311309|FG002|Overall Study|Too ill to participate|0|||
163163153|NCT02722499|589311311|FG000|Overall Study|Lost to Follow-up|2|||
163163154|NCT02722499|589311312|FG001|Overall Study|Lost to Follow-up|0|||
163163155|NCT02722499|589311313|FG002|Overall Study|Lost to Follow-up|1|||
163163156|NCT04999852|589311314|FG000|Overall Study|Withdrawal by Subject|11|||
163163157|NCT04999852|589311315|FG001|Overall Study|Withdrawal by Subject|1|||
163163158|NCT04999852|589311314|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
163163159|NCT04999852|589311315|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
163163160|NCT05626322|589311316|FG000|Overall Study|Death|2|||
163163161|NCT05626322|589311317|FG001|Overall Study|Death|0|||
163163162|NCT05626322|589311318|FG002|Overall Study|Death|0|||
163163163|NCT05626322|589311316|FG000|Overall Study|Physician Decision|1|||
163163164|NCT05626322|589311317|FG001|Overall Study|Physician Decision|0|||
163163165|NCT05626322|589311318|FG002|Overall Study|Physician Decision|0|||
163163166|NCT05626322|589311316|FG000|Overall Study|Progressive Disease|0|||
163163167|NCT05626322|589311317|FG001|Overall Study|Progressive Disease|1|||
163163168|NCT05626322|589311318|FG002|Overall Study|Progressive Disease|1|||
163163169|NCT05626322|589311316|FG000|Overall Study|Study terminated by sponsor|0|||
163163170|NCT05626322|589311317|FG001|Overall Study|Study terminated by sponsor|1|||
163163171|NCT05626322|589311318|FG002|Overall Study|Study terminated by sponsor|0|||
163163172|NCT04758637|589311319|FG000|Overall Study|Lost to Follow-up|0|||
163163173|NCT04758637|589311320|FG001|Overall Study|Lost to Follow-up|1|||
163163174|NCT04758637|589311321|FG002|Overall Study|Lost to Follow-up|0|||
163163175|NCT04758637|589311322|FG003|Overall Study|Lost to Follow-up|0|||
163163176|NCT03610269|589311323|FG000|Overall Study|Physician Decision|10|||
163163177|NCT03610269|589311323|FG000|Overall Study|Protocol Violation|1|||
163163178|NCT03610269|589311323|FG000|Overall Study|Unable to draw blood|1|||
163163179|NCT03610269|589311323|FG000|Overall Study|Screen fail|4|||
163163180|NCT01354314|589311324|FG000|Overall Study|Lost to Follow-up|1|||
163163181|NCT01354314|589311325|FG001|Overall Study|Lost to Follow-up|0|||
163163182|NCT01354314|589311326|FG002|Overall Study|Lost to Follow-up|1|||
163163183|NCT01354314|589311327|FG003|Overall Study|Lost to Follow-up|1|||
163163184|NCT01354314|589311324|FG000|Overall Study|Withdrawal by Subject|0|||
163163185|NCT01354314|589311325|FG001|Overall Study|Withdrawal by Subject|0|||
163163186|NCT01354314|589311326|FG002|Overall Study|Withdrawal by Subject|1|||
163163187|NCT01354314|589311327|FG003|Overall Study|Withdrawal by Subject|0|||
163163188|NCT01354314|589311324|FG000|Overall Study|Adverse Event|0|||
163163189|NCT01354314|589311325|FG001|Overall Study|Adverse Event|0|||
163163190|NCT01354314|589311326|FG002|Overall Study|Adverse Event|0|||
163163191|NCT01354314|589311327|FG003|Overall Study|Adverse Event|1|||
163163192|NCT01354314|589311324|FG000|Overall Study|Protocol Violation|1|||
163163193|NCT01354314|589311325|FG001|Overall Study|Protocol Violation|1|||
163163194|NCT01354314|589311326|FG002|Overall Study|Protocol Violation|0|||
163163195|NCT01354314|589311327|FG003|Overall Study|Protocol Violation|0|||
163163196|NCT01354314|589311324|FG000|Overall Study|Less than 90% Adherence|4|||
163163197|NCT01354314|589311325|FG001|Overall Study|Less than 90% Adherence|2|||
163163198|NCT01354314|589311326|FG002|Overall Study|Less than 90% Adherence|6|||
163163199|NCT01354314|589311327|FG003|Overall Study|Less than 90% Adherence|4|||
163163200|NCT00369265|589311328|FG000|Overall Study|Study terminated|4|||
163163201|NCT00369265|589311329|FG001|Overall Study|Study terminated|7|||
163163202|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
163163203|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
163163204|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
163163205|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
163163206|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163207|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163208|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163209|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163210|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163211|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163212|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
163163213|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163214|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163215|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163216|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
163163217|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
163163218|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
163163219|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
163163220|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163221|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163222|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163223|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
163163224|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163225|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
163163226|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163227|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163228|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163229|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163163230|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
163163231|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
162814054|NCT00792805|588032163|FG001|Overall Study|Lost to Follow-up|1|||
162814055|NCT00792805|588032164|FG002|Overall Study|Lost to Follow-up|6|||
162814056|NCT00792805|588032162|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163163232|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
163163233|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
162814057|NCT00792805|588032163|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163163234|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
163163235|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
163163236|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
163163237|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
163163238|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163239|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163240|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163241|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163242|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163243|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163244|NCT05019521|589311330|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163245|NCT05019521|589311331|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163246|NCT05019521|589311332|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163247|NCT05019521|589311333|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
163163248|NCT05019521|589311334|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163249|NCT05019521|589311335|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163250|NCT05019521|589311336|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163251|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
163163252|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
163163253|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
163163254|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163255|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163256|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
163163257|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
163163258|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163259|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
163163260|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163261|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163262|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163263|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
163163264|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163163265|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
163163266|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163267|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163268|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
163163269|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
163163270|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
163163271|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
163163272|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163273|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
163163274|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
163163275|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163276|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163277|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163278|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
163163279|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163280|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163281|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163282|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163283|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
163163284|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163285|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
163163286|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163287|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163288|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163289|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163290|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163291|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
163163292|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
163163293|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163294|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
163163295|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
163163296|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163297|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163298|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
163163299|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
163163300|NCT05019521|589311330|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
163163301|NCT05019521|589311331|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
163163302|NCT05019521|589311332|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
163163303|NCT05019521|589311333|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
163163304|NCT05019521|589311334|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
163163305|NCT05019521|589311335|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
163163306|NCT05019521|589311336|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
163163307|NCT02721966|589311337|FG000|Overall Study|Protocol Violation|1|||
163163308|NCT02721966|589311338|FG001|Overall Study|Protocol Violation|0|||
163163309|NCT02721966|589311339|FG002|Overall Study|Protocol Violation|0|||
163163310|NCT02721966|589311340|FG003|Overall Study|Protocol Violation|0|||
163163311|NCT02721966|589311341|FG004|Overall Study|Protocol Violation|0|||
163163312|NCT02721966|589311337|FG000|Overall Study|Withdrawal by Subject|9|||
163163313|NCT02721966|589311338|FG001|Overall Study|Withdrawal by Subject|2|||
162814058|NCT00792805|588032164|FG002|Overall Study|Abnormal laboratory value(s)|1|||
162814059|NCT00792805|588032162|FG000|Overall Study|Protocol deviation|0|||
162814060|NCT00792805|588032163|FG001|Overall Study|Protocol deviation|1|||
163163314|NCT02721966|589311339|FG002|Overall Study|Withdrawal by Subject|3|||
163163315|NCT02721966|589311340|FG003|Overall Study|Withdrawal by Subject|7|||
163163316|NCT02721966|589311341|FG004|Overall Study|Withdrawal by Subject|0|||
163163317|NCT02721966|589311337|FG000|Overall Study|Adverse Event|4|||
163163318|NCT02721966|589311338|FG001|Overall Study|Adverse Event|4|||
163163319|NCT02721966|589311339|FG002|Overall Study|Adverse Event|3|||
163163320|NCT02721966|589311340|FG003|Overall Study|Adverse Event|0|||
163163321|NCT02721966|589311341|FG004|Overall Study|Adverse Event|0|||
163163322|NCT02721966|589311337|FG000|Overall Study|Death|1|||
163163323|NCT02721966|589311338|FG001|Overall Study|Death|0|||
163163324|NCT02721966|589311339|FG002|Overall Study|Death|0|||
163163325|NCT02721966|589311340|FG003|Overall Study|Death|0|||
163163326|NCT02721966|589311341|FG004|Overall Study|Death|0|||
163163327|NCT02721966|589311337|FG000|Overall Study|Lack of Efficacy|7|||
163163328|NCT02721966|589311338|FG001|Overall Study|Lack of Efficacy|4|||
163163329|NCT02721966|589311339|FG002|Overall Study|Lack of Efficacy|0|||
163163330|NCT02721966|589311340|FG003|Overall Study|Lack of Efficacy|0|||
163163331|NCT02721966|589311341|FG004|Overall Study|Lack of Efficacy|0|||
163163332|NCT02721966|589311337|FG000|Overall Study|Lost to Follow-up|0|||
163163333|NCT02721966|589311338|FG001|Overall Study|Lost to Follow-up|0|||
163163334|NCT02721966|589311339|FG002|Overall Study|Lost to Follow-up|3|||
163163335|NCT02721966|589311340|FG003|Overall Study|Lost to Follow-up|0|||
163163336|NCT02721966|589311341|FG004|Overall Study|Lost to Follow-up|0|||
163163337|NCT02721966|589311337|FG000|Overall Study|Physician Decision|1|||
163163338|NCT02721966|589311338|FG001|Overall Study|Physician Decision|1|||
163163339|NCT02721966|589311339|FG002|Overall Study|Physician Decision|0|||
163163340|NCT02721966|589311340|FG003|Overall Study|Physician Decision|0|||
163163341|NCT02721966|589311341|FG004|Overall Study|Physician Decision|0|||
163163342|NCT02721966|589311337|FG000|Overall Study|Pregnancy|1|||
163163343|NCT02721966|589311338|FG001|Overall Study|Pregnancy|0|||
163163344|NCT02721966|589311339|FG002|Overall Study|Pregnancy|0|||
163163345|NCT02721966|589311340|FG003|Overall Study|Pregnancy|0|||
163163346|NCT02721966|589311341|FG004|Overall Study|Pregnancy|0|||
162814061|NCT00792805|588032164|FG002|Overall Study|Protocol deviation|1|||
162814062|NCT05541861|588032165|FG000|Overall Study|Withdrawal by Subject|0|||
162814063|NCT05541861|588032166|FG001|Overall Study|Withdrawal by Subject|0|||
162814064|NCT05541861|588032167|FG002|Overall Study|Withdrawal by Subject|0|||
162814065|NCT05541861|588032168|FG003|Overall Study|Withdrawal by Subject|0|||
162814066|NCT05541861|588032169|FG004|Overall Study|Withdrawal by Subject|0|||
162814067|NCT05541861|588032170|FG005|Overall Study|Withdrawal by Subject|0|||
162814068|NCT05541861|588032171|FG006|Overall Study|Withdrawal by Subject|2|||
162814069|NCT05541861|588032172|FG007|Overall Study|Withdrawal by Subject|0|||
162814070|NCT05541861|588032173|FG008|Overall Study|Withdrawal by Subject|0|||
163163347|NCT02721966|589311337|FG000|Overall Study|Did not continue to period 2|5|||
163163348|NCT02721966|589311338|FG001|Overall Study|Did not continue to period 2|12|||
163163349|NCT02721966|589311339|FG002|Overall Study|Did not continue to period 2|0|||
163163350|NCT02721966|589311340|FG003|Overall Study|Did not continue to period 2|0|||
163163351|NCT02721966|589311341|FG004|Overall Study|Did not continue to period 2|5|||
162814071|NCT05541861|588032165|FG000|Overall Study|Randomized but not dosed|0|||
163163352|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
163163353|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
163163354|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
163163355|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
163163356|NCT00828204|589311342|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
163163357|NCT00828204|589311343|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
163163358|NCT00828204|589311342|FG000|Main Study: After Study Restart|Adverse Event|0|||
163163359|NCT00828204|589311343|FG001|Main Study: After Study Restart|Adverse Event|2|||
163163360|NCT00828204|589311342|FG000|Main Study: After Study Restart|Noncompliance|0|||
163163361|NCT00828204|589311343|FG001|Main Study: After Study Restart|Noncompliance|1|||
163163362|NCT00828204|589311342|FG000|Extension Study|Lost to Follow-up|0|||
163163363|NCT00828204|589311343|FG001|Extension Study|Lost to Follow-up|1|||
163163364|NCT00828204|589311342|FG000|Extension Study|Physician Decision|0|||
163163365|NCT00828204|589311343|FG001|Extension Study|Physician Decision|2|||
163163366|NCT02840461|589311344|FG000|Overall Study|Adverse Event|1|||
163163367|NCT02840461|589311345|FG001|Overall Study|Adverse Event|5|||
163163368|NCT02840461|589311346|FG002|Overall Study|Adverse Event|3|||
163163369|NCT02840461|589311344|FG000|Overall Study|Lost to Follow-up|10|||
163163370|NCT02840461|589311345|FG001|Overall Study|Lost to Follow-up|7|||
163163371|NCT02840461|589311346|FG002|Overall Study|Lost to Follow-up|6|||
163163372|NCT02840461|589311344|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
163163373|NCT02840461|589311345|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
163163374|NCT02840461|589311346|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
163163375|NCT02840461|589311344|FG000|Overall Study|Protocol Violation|2|||
163163376|NCT02840461|589311345|FG001|Overall Study|Protocol Violation|3|||
163163377|NCT02840461|589311346|FG002|Overall Study|Protocol Violation|1|||
163163378|NCT02840461|589311344|FG000|Overall Study|Withdrawal by Subject|10|||
163163379|NCT02840461|589311345|FG001|Overall Study|Withdrawal by Subject|6|||
163163380|NCT02840461|589311346|FG002|Overall Study|Withdrawal by Subject|2|||
163163381|NCT02840461|589311344|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
163163382|NCT02840461|589311345|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
163163383|NCT02840461|589311346|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
163163384|NCT04163016|589311349|FG000|Enrollment|Adverse Event|1|||
163163385|NCT04163016|589311350|FG001|Enrollment|Adverse Event|0|||
163163386|NCT04163016|589311351|FG002|Enrollment|Adverse Event|0|||
163163387|NCT04163016|589311352|FG003|Enrollment|Adverse Event|0|||
163163388|NCT04163016|589311349|FG000|Treatment|Adverse Event|0|||
163163389|NCT04163016|589311350|FG001|Treatment|Adverse Event|1|||
162814072|NCT05541861|588032166|FG001|Overall Study|Randomized but not dosed|1|||
162814073|NCT05541861|588032167|FG002|Overall Study|Randomized but not dosed|1|||
162814074|NCT05541861|588032168|FG003|Overall Study|Randomized but not dosed|0|||
162814075|NCT05541861|588032169|FG004|Overall Study|Randomized but not dosed|0|||
162814076|NCT05541861|588032170|FG005|Overall Study|Randomized but not dosed|0|||
162814077|NCT05541861|588032171|FG006|Overall Study|Randomized but not dosed|1|||
162814078|NCT05541861|588032172|FG007|Overall Study|Randomized but not dosed|0|||
163163390|NCT04163016|589311351|FG002|Treatment|Adverse Event|0|||
163163391|NCT04163016|589311352|FG003|Treatment|Adverse Event|0|||
163163392|NCT04163016|589311349|FG000|Treatment|Withdrawal by Subject|0|||
162814079|NCT05541861|588032173|FG008|Overall Study|Randomized but not dosed|1|||
162814080|NCT04452877|588032180|FG000|Overall Study|Adverse Event|5|||
162814081|NCT04452877|588032180|FG000|Overall Study|Lost to Follow-up|1|||
162814082|NCT04452877|588032180|FG000|Overall Study|Physician Decision|4|||
162814083|NCT04452877|588032180|FG000|Overall Study|Progressive Disease|18|||
162814084|NCT04452877|588032180|FG000|Overall Study|Withdrawal by Subject|3|||
162814085|NCT05678959|588032181|FG000|Overall Study|Study Terminated by Sponsor|76|||
162814086|NCT05678959|588032182|FG001|Overall Study|Study Terminated by Sponsor|76|||
162814087|NCT05678959|588032181|FG000|Overall Study|Physician Decision|2|||
162814088|NCT05678959|588032182|FG001|Overall Study|Physician Decision|3|||
162814089|NCT05678959|588032181|FG000|Overall Study|Adverse Event|1|||
162814090|NCT05678959|588032182|FG001|Overall Study|Adverse Event|1|||
162814091|NCT05678959|588032181|FG000|Overall Study|Guardian Decision|1|||
162814092|NCT05678959|588032182|FG001|Overall Study|Guardian Decision|0|||
162814093|NCT05678959|588032181|FG000|Overall Study|Protocol Deviation|0|||
162814094|NCT05678959|588032182|FG001|Overall Study|Protocol Deviation|1|||
162814095|NCT05678959|588032181|FG000|Overall Study|Subject Decision|1|||
162814096|NCT05678959|588032182|FG001|Overall Study|Subject Decision|0|||
163163393|NCT04163016|589311350|FG001|Treatment|Withdrawal by Subject|2|||
163163394|NCT04163016|589311351|FG002|Treatment|Withdrawal by Subject|0|||
163163395|NCT04163016|589311352|FG003|Treatment|Withdrawal by Subject|0|||
163163396|NCT04163016|589311349|FG000|Treatment|Indeterminate TB-test|0|||
163163397|NCT04163016|589311350|FG001|Treatment|Indeterminate TB-test|0|||
163163398|NCT04163016|589311351|FG002|Treatment|Indeterminate TB-test|0|||
163163399|NCT04163016|589311352|FG003|Treatment|Indeterminate TB-test|1|||
163163400|NCT04163016|589311349|FG000|Treatment|Participant did not want to continue in study|0|||
163163401|NCT04163016|589311350|FG001|Treatment|Participant did not want to continue in study|0|||
163163402|NCT04163016|589311351|FG002|Treatment|Participant did not want to continue in study|0|||
163163403|NCT04163016|589311352|FG003|Treatment|Participant did not want to continue in study|1|||
163163404|NCT01104311|589311355|FG000|Overall Study|Withdrawal by Subject|6|||
163163405|NCT01104311|589311356|FG001|Overall Study|Withdrawal by Subject|6|||
163163406|NCT01104311|589311355|FG000|Overall Study|Protocol Violation|0|||
163163407|NCT01104311|589311356|FG001|Overall Study|Protocol Violation|1|||
163163408|NCT01104311|589311355|FG000|Overall Study|Physician Decision|2|||
163163409|NCT01104311|589311356|FG001|Overall Study|Physician Decision|2|||
163163410|NCT01104311|589311355|FG000|Overall Study|low compliance|1|||
163163411|NCT01104311|589311356|FG001|Overall Study|low compliance|1|||
163163412|NCT01104311|589311355|FG000|Overall Study|Adverse Event|1|||
163163413|NCT01104311|589311356|FG001|Overall Study|Adverse Event|2|||
163163414|NCT04434937|589311358|FG000|Overall Study|Death|4|||
163163415|NCT04434937|589311358|FG000|Overall Study|Withdrawal by Subject|1|||
163163416|NCT04434937|589311358|FG000|Overall Study|Transitioned to Rollover Study|19|||
163163417|NCT04434937|589311358|FG000|Overall Study|Progressive Disease|18|||
163163418|NCT04193189|589311363|FG000|Overall Study|Lost to Follow-up|9|||
163163419|NCT04193189|589311364|FG001|Overall Study|Lost to Follow-up|7|||
163163420|NCT04193189|589311365|FG002|Overall Study|Lost to Follow-up|9|||
163163421|NCT04193189|589311366|FG003|Overall Study|Lost to Follow-up|0|||
163163422|NCT04193189|589311363|FG000|Overall Study|Withdrawal by Subject|1|||
163163423|NCT04193189|589311364|FG001|Overall Study|Withdrawal by Subject|2|||
163163424|NCT04193189|589311365|FG002|Overall Study|Withdrawal by Subject|2|||
163163425|NCT04193189|589311366|FG003|Overall Study|Withdrawal by Subject|0|||
163163426|NCT04193189|589311363|FG000|Overall Study|Death|1|||
163163427|NCT04193189|589311364|FG001|Overall Study|Death|1|||
163163428|NCT04193189|589311365|FG002|Overall Study|Death|0|||
163163429|NCT04193189|589311366|FG003|Overall Study|Death|0|||
163163430|NCT04193189|589311363|FG000|Overall Study|Protocol Violation|0|||
163163431|NCT04193189|589311364|FG001|Overall Study|Protocol Violation|0|||
163163432|NCT04193189|589311365|FG002|Overall Study|Protocol Violation|0|||
163163433|NCT04193189|589311366|FG003|Overall Study|Protocol Violation|1|||
163163434|NCT04549545|589312673|FG000|Initial Period|Withdrawal by Subject|4|||
163163435|NCT04549545|589312674|FG001|Initial Period|Withdrawal by Subject|0|||
163163436|NCT04549545|589312673|FG000|Initial Period|Additional ENT Procedure|3|||
163163437|NCT04549545|589312674|FG001|Initial Period|Additional ENT Procedure|0|||
163163438|NCT04549545|589312673|FG000|Initial Period|Lost to Follow-up|3|||
163163439|NCT04549545|589312674|FG001|Initial Period|Lost to Follow-up|1|||
163163440|NCT04549545|589312673|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
163163441|NCT04549545|589312674|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
163163442|NCT04549545|589312673|FG000|Crossover Period|Additional ENT Procedure|0|||
163163443|NCT04549545|589312674|FG001|Crossover Period|Additional ENT Procedure|6|||
163163444|NCT04549545|589312673|FG000|Crossover Period|Lost to Follow-up|0|||
163163445|NCT04549545|589312674|FG001|Crossover Period|Lost to Follow-up|1|||
163163446|NCT04549545|589312673|FG000|Crossover Period|Withdrawal by Subject|0|||
163163447|NCT04549545|589312674|FG001|Crossover Period|Withdrawal by Subject|4|||
163163448|NCT00295880|589312678|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
163163449|NCT00295880|589312678|FG000|Overall Study|Unit randomization did not occur|1|||
163163450|NCT01474239|589312679|FG000|Overall Study|Disease Progression|37|||
163163451|NCT01474239|589312680|FG001|Overall Study|Disease Progression|25|||
163163452|NCT01474239|589312679|FG000|Overall Study|Adverse Event|12|||
163163453|NCT01474239|589312680|FG001|Overall Study|Adverse Event|3|||
163163454|NCT01474239|589312679|FG000|Overall Study|Withdrawal by Subject|1|||
163163455|NCT01474239|589312680|FG001|Overall Study|Withdrawal by Subject|2|||
163163456|NCT01474239|589312679|FG000|Overall Study|Death|1|||
163163457|NCT01474239|589312680|FG001|Overall Study|Death|1|||
163163458|NCT01474239|589312679|FG000|Overall Study|Clinical Disease Progression|7|||
163163459|NCT01474239|589312680|FG001|Overall Study|Clinical Disease Progression|1|||
163163460|NCT01474239|589312679|FG000|Overall Study|Withdrawal for Economic Reason|1|||
163163461|NCT01474239|589312680|FG001|Overall Study|Withdrawal for Economic Reason|0|||
163163462|NCT01243242|589312681|FG000|Overall Study|Adverse Event|1|||
163163463|NCT01243242|589312682|FG001|Overall Study|Adverse Event|1|||
163163464|NCT01243242|589312681|FG000|Overall Study|Withdrawal by Subject|1|||
163163465|NCT01243242|589312682|FG001|Overall Study|Withdrawal by Subject|1|||
163163466|NCT01243242|589312681|FG000|Overall Study|Physician Decision|0|||
163163467|NCT01243242|589312682|FG001|Overall Study|Physician Decision|1|||
163163468|NCT01243242|589312681|FG000|Overall Study|sponsor decision|0|||
163163469|NCT01243242|589312682|FG001|Overall Study|sponsor decision|1|||
163163470|NCT01243242|589312681|FG000|Overall Study|non compliance|1|||
163163471|NCT01243242|589312682|FG001|Overall Study|non compliance|0|||
163163472|NCT03983317|589312683|FG000|Overall Study|Physician Decision|5|||
163163473|NCT01256294|589312689|FG000|Overall Study|Adverse Event|1|||
163163474|NCT01256294|589312690|FG001|Overall Study|Adverse Event|0|||
163163475|NCT01256294|589312689|FG000|Overall Study|Withdrawal by Subject|1|||
163163476|NCT01256294|589312690|FG001|Overall Study|Withdrawal by Subject|1|||
163163477|NCT01256294|589312689|FG000|Overall Study|Protocol deviation|2|||
163163478|NCT01256294|589312690|FG001|Overall Study|Protocol deviation|1|||
163163479|NCT04681352|589312691|FG000|Overall Study|Lost to Follow-up|2|||
163163480|NCT04681352|589312691|FG000|Overall Study|Withdrawal by Subject|22|||
163163481|NCT01675544|589312694|FG000|Overall Study|Withdrawal by Subject|2|||
163163482|NCT00792571|589312695|FG000|Overall Study|Death|1|||
163163483|NCT00792571|589312695|FG000|Overall Study|Adverse Event|4|||
163163484|NCT00792571|589312695|FG000|Overall Study|Withdrawal by Subject|1|||
163163485|NCT00792571|589312695|FG000|Overall Study|Other|4|||
163163486|NCT02600819|589312696|FG000|GEN Phase|Adverse Event|2|||
163163487|NCT02600819|589312697|FG001|GEN Phase|Adverse Event|0|||
163163488|NCT02600819|589312696|FG000|GEN Phase|Death|2|||
163163489|NCT02600819|589312697|FG001|GEN Phase|Death|0|||
163163490|NCT02600819|589312696|FG000|GEN Phase|Investigator's Discretion|4|||
163163491|NCT02600819|589312697|FG001|GEN Phase|Investigator's Discretion|0|||
163163492|NCT02600819|589312696|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
163163493|NCT02600819|589312697|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
163163494|NCT02600819|589312696|FG000|GEN Phase|Withdrew Consent|5|||
163163495|NCT02600819|589312697|FG001|GEN Phase|Withdrew Consent|0|||
163163496|NCT02600819|589312696|FG000|GEN Phase|Lost to Follow-up|2|||
163163497|NCT02600819|589312697|FG001|GEN Phase|Lost to Follow-up|0|||
163163498|NCT01621802|589312699|FG000|Overall Study|Protocol Violation|0|||
163163499|NCT01621802|589312700|FG001|Overall Study|Protocol Violation|0|||
163163500|NCT01621802|589312701|FG002|Overall Study|Protocol Violation|0|||
163163501|NCT01621802|589312702|FG003|Overall Study|Protocol Violation|0|||
163163502|NCT01621802|589312703|FG004|Overall Study|Protocol Violation|0|||
163163503|NCT01621802|589312704|FG005|Overall Study|Protocol Violation|1|||
163163504|NCT01621802|589312699|FG000|Overall Study|Withdrawal by Subject|8|||
163163505|NCT01621802|589312700|FG001|Overall Study|Withdrawal by Subject|4|||
163163506|NCT01621802|589312701|FG002|Overall Study|Withdrawal by Subject|4|||
163163507|NCT01621802|589312702|FG003|Overall Study|Withdrawal by Subject|2|||
163163508|NCT01621802|589312703|FG004|Overall Study|Withdrawal by Subject|2|||
163163509|NCT01621802|589312704|FG005|Overall Study|Withdrawal by Subject|0|||
163163510|NCT01621802|589312699|FG000|Overall Study|Migrated/moved from study area|0|||
163163511|NCT01621802|589312700|FG001|Overall Study|Migrated/moved from study area|0|||
163163512|NCT01621802|589312701|FG002|Overall Study|Migrated/moved from study area|2|||
163163513|NCT01621802|589312702|FG003|Overall Study|Migrated/moved from study area|0|||
163163514|NCT01621802|589312703|FG004|Overall Study|Migrated/moved from study area|1|||
163163515|NCT01621802|589312704|FG005|Overall Study|Migrated/moved from study area|0|||
163163516|NCT01621802|589312699|FG000|Overall Study|Others|3|||
163163517|NCT01621802|589312700|FG001|Overall Study|Others|3|||
163163518|NCT01621802|589312701|FG002|Overall Study|Others|3|||
163163519|NCT01621802|589312702|FG003|Overall Study|Others|2|||
163163520|NCT01621802|589312703|FG004|Overall Study|Others|1|||
163163521|NCT01621802|589312704|FG005|Overall Study|Others|0|||
163163522|NCT01621802|589312699|FG000|Overall Study|Lost to Follow-up|36|||
163163523|NCT01621802|589312700|FG001|Overall Study|Lost to Follow-up|16|||
163163524|NCT01621802|589312701|FG002|Overall Study|Lost to Follow-up|24|||
163163525|NCT01621802|589312702|FG003|Overall Study|Lost to Follow-up|7|||
163163526|NCT01621802|589312703|FG004|Overall Study|Lost to Follow-up|31|||
163163527|NCT01621802|589312704|FG005|Overall Study|Lost to Follow-up|11|||
163163528|NCT03790696|589312706|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
163163529|NCT03790696|589312707|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
163163530|NCT01149148|589312708|FG000|Overall Study|Lost to Follow-up|1|||
163163531|NCT01149148|589312709|FG001|Overall Study|Lost to Follow-up|2|||
163163532|NCT01149148|589312708|FG000|Overall Study|Death|1|||
163163533|NCT01149148|589312709|FG001|Overall Study|Death|0|||
163163534|NCT04896086|589312710|FG000|Overall Study|Lost to Follow-up|0|||
163163535|NCT04896086|589312711|FG001|Overall Study|Lost to Follow-up|2|||
163163536|NCT04896086|589312712|FG002|Overall Study|Lost to Follow-up|1|||
163163537|NCT04896086|589312713|FG003|Overall Study|Lost to Follow-up|0|||
163163538|NCT04896086|589312714|FG004|Overall Study|Lost to Follow-up|0|||
163163539|NCT04896086|589312710|FG000|Overall Study|Physician Decision|0|||
163163540|NCT04896086|589312711|FG001|Overall Study|Physician Decision|1|||
163163541|NCT04896086|589312712|FG002|Overall Study|Physician Decision|0|||
163163542|NCT04896086|589312713|FG003|Overall Study|Physician Decision|0|||
163163543|NCT04896086|589312714|FG004|Overall Study|Physician Decision|0|||
163163544|NCT04896086|589312710|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
162814097|NCT05678959|588032181|FG000|Overall Study|Technical Problem|0|||
163163545|NCT04896086|589312711|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163546|NCT04896086|589312712|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163547|NCT04896086|589312713|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
163163548|NCT04896086|589312714|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
163163549|NCT04896086|589312710|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163550|NCT04896086|589312711|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163551|NCT04896086|589312712|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163552|NCT04896086|589312713|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
163163553|NCT04896086|589312714|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
163163554|NCT02249832|589312715|FG000|Overall Study|Withdrawal by Subject|3|||
163163555|NCT02249832|589312715|FG000|Overall Study|Lost to Follow-up|10|||
163163556|NCT00485134|589312721|FG000|Overall Study|Lost to Follow-up|1|||
163163557|NCT00485134|589312722|FG001|Overall Study|Lost to Follow-up|0|||
163163558|NCT00485134|589312723|FG002|Overall Study|Lost to Follow-up|0|||
163163559|NCT00485134|589312724|FG003|Overall Study|Lost to Follow-up|0|||
163163560|NCT00485134|589312725|FG004|Overall Study|Lost to Follow-up|0|||
163163561|NCT00485134|589312726|FG005|Overall Study|Lost to Follow-up|0|||
163163562|NCT00485134|589312727|FG006|Overall Study|Lost to Follow-up|0|||
163163563|NCT00485134|589312728|FG007|Overall Study|Lost to Follow-up|0|||
163163564|NCT00485134|589312721|FG000|Overall Study|Withdrawal by Subject|0|||
163163565|NCT00485134|589312722|FG001|Overall Study|Withdrawal by Subject|1|||
163163566|NCT00485134|589312723|FG002|Overall Study|Withdrawal by Subject|0|||
163163567|NCT00485134|589312724|FG003|Overall Study|Withdrawal by Subject|0|||
163163568|NCT00485134|589312725|FG004|Overall Study|Withdrawal by Subject|0|||
163163569|NCT00485134|589312726|FG005|Overall Study|Withdrawal by Subject|0|||
163163570|NCT00485134|589312727|FG006|Overall Study|Withdrawal by Subject|0|||
163163571|NCT00485134|589312728|FG007|Overall Study|Withdrawal by Subject|0|||
163163572|NCT00485134|589312721|FG000|Overall Study|Change in health status|0|||
163163573|NCT00485134|589312722|FG001|Overall Study|Change in health status|1|||
163163574|NCT00485134|589312723|FG002|Overall Study|Change in health status|2|||
163163575|NCT00485134|589312724|FG003|Overall Study|Change in health status|1|||
163163576|NCT00485134|589312725|FG004|Overall Study|Change in health status|0|||
163163577|NCT00485134|589312726|FG005|Overall Study|Change in health status|1|||
163163578|NCT00485134|589312727|FG006|Overall Study|Change in health status|0|||
163163579|NCT00485134|589312728|FG007|Overall Study|Change in health status|0|||
163163580|NCT00485134|589312721|FG000|Overall Study|Withdrew for adverse event|0|||
163163581|NCT00485134|589312722|FG001|Overall Study|Withdrew for adverse event|0|||
163163582|NCT00485134|589312723|FG002|Overall Study|Withdrew for adverse event|1|||
163163583|NCT00485134|589312724|FG003|Overall Study|Withdrew for adverse event|0|||
163163584|NCT00485134|589312725|FG004|Overall Study|Withdrew for adverse event|0|||
163163585|NCT00485134|589312726|FG005|Overall Study|Withdrew for adverse event|0|||
163163586|NCT00485134|589312727|FG006|Overall Study|Withdrew for adverse event|0|||
163163587|NCT00485134|589312728|FG007|Overall Study|Withdrew for adverse event|0|||
163163588|NCT00485134|589312721|FG000|Overall Study|Positive drug test|0|||
163163589|NCT00485134|589312722|FG001|Overall Study|Positive drug test|0|||
163163590|NCT00485134|589312723|FG002|Overall Study|Positive drug test|0|||
163163591|NCT00485134|589312724|FG003|Overall Study|Positive drug test|0|||
163163592|NCT00485134|589312725|FG004|Overall Study|Positive drug test|2|||
163163593|NCT00485134|589312726|FG005|Overall Study|Positive drug test|1|||
163163594|NCT00485134|589312727|FG006|Overall Study|Positive drug test|0|||
163163595|NCT00485134|589312728|FG007|Overall Study|Positive drug test|0|||
163163596|NCT00485134|589312721|FG000|Overall Study|Non-compliance|0|||
163163597|NCT00485134|589312722|FG001|Overall Study|Non-compliance|0|||
163163598|NCT00485134|589312723|FG002|Overall Study|Non-compliance|0|||
163163599|NCT00485134|589312724|FG003|Overall Study|Non-compliance|0|||
163163600|NCT00485134|589312725|FG004|Overall Study|Non-compliance|1|||
163163601|NCT00485134|589312726|FG005|Overall Study|Non-compliance|2|||
163163602|NCT00485134|589312727|FG006|Overall Study|Non-compliance|2|||
163163603|NCT00485134|589312728|FG007|Overall Study|Non-compliance|0|||
163163604|NCT00485134|589312721|FG000|Overall Study|Unable to comply with study schedule|0|||
163163605|NCT00485134|589312722|FG001|Overall Study|Unable to comply with study schedule|0|||
163163606|NCT00485134|589312723|FG002|Overall Study|Unable to comply with study schedule|0|||
163163607|NCT00485134|589312724|FG003|Overall Study|Unable to comply with study schedule|0|||
163163608|NCT00485134|589312725|FG004|Overall Study|Unable to comply with study schedule|0|||
163163609|NCT00485134|589312726|FG005|Overall Study|Unable to comply with study schedule|0|||
163163610|NCT00485134|589312727|FG006|Overall Study|Unable to comply with study schedule|0|||
163163611|NCT00485134|589312728|FG007|Overall Study|Unable to comply with study schedule|1|||
163163612|NCT00485134|589312721|FG000|Overall Study|Pregnancy|0|||
163163613|NCT00485134|589312722|FG001|Overall Study|Pregnancy|0|||
163163614|NCT00485134|589312723|FG002|Overall Study|Pregnancy|0|||
163163615|NCT00485134|589312724|FG003|Overall Study|Pregnancy|0|||
163163616|NCT00485134|589312725|FG004|Overall Study|Pregnancy|0|||
163163617|NCT00485134|589312726|FG005|Overall Study|Pregnancy|0|||
163163618|NCT00485134|589312727|FG006|Overall Study|Pregnancy|1|||
163163619|NCT00485134|589312728|FG007|Overall Study|Pregnancy|0|||
163163620|NCT00970684|589312729|FG000|Overall Study|Lack of Efficacy|5|||
163163621|NCT00970684|589312729|FG000|Overall Study|Adverse Event|4|||
163163622|NCT00970684|589312729|FG000|Overall Study|Withdrawal by Subject|1|||
163163623|NCT00481091|589312730|FG000|Overall Study|Withdrawal by Subject|0|||
163163624|NCT00481091|589312731|FG001|Overall Study|Withdrawal by Subject|1|||
163163625|NCT00481091|589312732|FG002|Overall Study|Withdrawal by Subject|1|||
163163626|NCT00481091|589312733|FG003|Overall Study|Withdrawal by Subject|0|||
163163627|NCT00481091|589312734|FG004|Overall Study|Withdrawal by Subject|0|||
163163628|NCT00481091|589312735|FG005|Overall Study|Withdrawal by Subject|0|||
163163629|NCT00481091|589312736|FG006|Overall Study|Withdrawal by Subject|0|||
163163630|NCT00481091|589312737|FG007|Overall Study|Withdrawal by Subject|0|||
163163631|NCT00481091|589312738|FG008|Overall Study|Withdrawal by Subject|1|||
163163632|NCT00481091|589312739|FG009|Overall Study|Withdrawal by Subject|6|||
163163633|NCT00481091|589312730|FG000|Overall Study|Other, Not Specified|0|||
163163634|NCT00481091|589312731|FG001|Overall Study|Other, Not Specified|1|||
163163635|NCT00481091|589312732|FG002|Overall Study|Other, Not Specified|1|||
163163636|NCT00481091|589312733|FG003|Overall Study|Other, Not Specified|0|||
163163637|NCT00481091|589312734|FG004|Overall Study|Other, Not Specified|0|||
163163638|NCT00481091|589312735|FG005|Overall Study|Other, Not Specified|1|||
163163639|NCT00481091|589312736|FG006|Overall Study|Other, Not Specified|0|||
163163640|NCT00481091|589312737|FG007|Overall Study|Other, Not Specified|0|||
163163641|NCT00481091|589312738|FG008|Overall Study|Other, Not Specified|0|||
163163642|NCT00481091|589312739|FG009|Overall Study|Other, Not Specified|4|||
163163643|NCT00481091|589312730|FG000|Overall Study|Adverse Event|1|||
163163644|NCT00481091|589312731|FG001|Overall Study|Adverse Event|2|||
163163645|NCT00481091|589312732|FG002|Overall Study|Adverse Event|0|||
163163646|NCT00481091|589312733|FG003|Overall Study|Adverse Event|1|||
163163647|NCT00481091|589312734|FG004|Overall Study|Adverse Event|1|||
163163648|NCT00481091|589312735|FG005|Overall Study|Adverse Event|1|||
163163649|NCT00481091|589312736|FG006|Overall Study|Adverse Event|2|||
163163650|NCT00481091|589312737|FG007|Overall Study|Adverse Event|1|||
163163651|NCT00481091|589312738|FG008|Overall Study|Adverse Event|1|||
163163652|NCT00481091|589312739|FG009|Overall Study|Adverse Event|6|||
163163653|NCT00481091|589312730|FG000|Overall Study|Progressive disease clinical|0|||
163163654|NCT00481091|589312731|FG001|Overall Study|Progressive disease clinical|0|||
163163655|NCT00481091|589312732|FG002|Overall Study|Progressive disease clinical|0|||
163163656|NCT00481091|589312733|FG003|Overall Study|Progressive disease clinical|0|||
163163657|NCT00481091|589312734|FG004|Overall Study|Progressive disease clinical|0|||
163163658|NCT00481091|589312735|FG005|Overall Study|Progressive disease clinical|0|||
163163659|NCT00481091|589312736|FG006|Overall Study|Progressive disease clinical|0|||
163163660|NCT00481091|589312737|FG007|Overall Study|Progressive disease clinical|0|||
163163661|NCT00481091|589312738|FG008|Overall Study|Progressive disease clinical|1|||
163163662|NCT00481091|589312739|FG009|Overall Study|Progressive disease clinical|7|||
163163663|NCT00481091|589312730|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163664|NCT00481091|589312731|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163665|NCT00481091|589312732|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163666|NCT00481091|589312733|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163667|NCT00481091|589312734|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163668|NCT00481091|589312735|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
163163669|NCT00481091|589312736|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163670|NCT00481091|589312737|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163671|NCT00481091|589312738|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163672|NCT00481091|589312739|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
163163673|NCT00481091|589312730|FG000|Overall Study|Progressive disease other|1|||
163163674|NCT00481091|589312731|FG001|Overall Study|Progressive disease other|1|||
163163675|NCT00481091|589312732|FG002|Overall Study|Progressive disease other|0|||
163163676|NCT00481091|589312733|FG003|Overall Study|Progressive disease other|1|||
163163677|NCT00481091|589312734|FG004|Overall Study|Progressive disease other|1|||
163163678|NCT00481091|589312735|FG005|Overall Study|Progressive disease other|1|||
163163679|NCT00481091|589312736|FG006|Overall Study|Progressive disease other|0|||
163163680|NCT00481091|589312737|FG007|Overall Study|Progressive disease other|2|||
163163681|NCT00481091|589312738|FG008|Overall Study|Progressive disease other|0|||
163163682|NCT00481091|589312739|FG009|Overall Study|Progressive disease other|0|||
163163683|NCT00481091|589312730|FG000|Overall Study|No reason given|0|||
163163684|NCT00481091|589312731|FG001|Overall Study|No reason given|0|||
163163685|NCT00481091|589312732|FG002|Overall Study|No reason given|1|||
163163686|NCT00481091|589312733|FG003|Overall Study|No reason given|1|||
163163687|NCT00481091|589312734|FG004|Overall Study|No reason given|1|||
163163688|NCT00481091|589312735|FG005|Overall Study|No reason given|0|||
163163689|NCT00481091|589312736|FG006|Overall Study|No reason given|1|||
163163690|NCT00481091|589312737|FG007|Overall Study|No reason given|1|||
163163691|NCT00481091|589312738|FG008|Overall Study|No reason given|1|||
163163692|NCT00481091|589312739|FG009|Overall Study|No reason given|4|||
163163693|NCT04294680|589312740|FG000|Overall Study|Withdrawal by Subject|2|||
163163694|NCT04294680|589312741|FG001|Overall Study|Withdrawal by Subject|1|||
163163695|NCT04294680|589312740|FG000|Overall Study|Follow-up visits completed outside of window|1|||
163163696|NCT04294680|589312741|FG001|Overall Study|Follow-up visits completed outside of window|0|||
163163697|NCT02078960|589312744|FG000|Treatment Period|Other|0|||
163163698|NCT02078960|589312745|FG001|Treatment Period|Other|0|||
163163699|NCT02078960|589312746|FG002|Treatment Period|Other|1|||
163163700|NCT02078960|589312744|FG000|Treatment Period|Lack of Efficacy|0|||
163163701|NCT02078960|589312745|FG001|Treatment Period|Lack of Efficacy|1|||
163163702|NCT02078960|589312746|FG002|Treatment Period|Lack of Efficacy|0|||
163163703|NCT02078960|589312744|FG000|Treatment Period|Disease progression - accelerated phase|0|||
163163704|NCT02078960|589312745|FG001|Treatment Period|Disease progression - accelerated phase|1|||
163163705|NCT02078960|589312746|FG002|Treatment Period|Disease progression - accelerated phase|0|||
163163706|NCT02078960|589312744|FG000|Treatment Period|Disease progression - blast phase|1|||
163163707|NCT02078960|589312745|FG001|Treatment Period|Disease progression - blast phase|0|||
163163708|NCT02078960|589312746|FG002|Treatment Period|Disease progression - blast phase|0|||
163163709|NCT02078960|589312744|FG000|Treatment Period|Withdrawal by Subject|0|||
163163710|NCT02078960|589312745|FG001|Treatment Period|Withdrawal by Subject|1|||
163163711|NCT02078960|589312746|FG002|Treatment Period|Withdrawal by Subject|1|||
163163712|NCT02078960|589312744|FG000|Treatment Period|Adverse Event|1|||
163163713|NCT02078960|589312745|FG001|Treatment Period|Adverse Event|0|||
163163714|NCT02078960|589312746|FG002|Treatment Period|Adverse Event|0|||
163163715|NCT02078960|589312744|FG000|Treatment Period|Death|0|||
163163716|NCT02078960|589312745|FG001|Treatment Period|Death|0|||
163163717|NCT02078960|589312746|FG002|Treatment Period|Death|1|||
163163718|NCT02078960|589312744|FG000|Follow-up Period|Death|2|||
163163719|NCT02078960|589312745|FG001|Follow-up Period|Death|0|||
163163720|NCT02078960|589312746|FG002|Follow-up Period|Death|0|||
163163721|NCT02078960|589312744|FG000|Follow-up Period|Lost to Follow-up|0|||
163163722|NCT02078960|589312745|FG001|Follow-up Period|Lost to Follow-up|1|||
163163723|NCT02078960|589312746|FG002|Follow-up Period|Lost to Follow-up|0|||
163163724|NCT04605991|589312748|FG000|Overall Study|Adverse Event|5|||
163163725|NCT04605991|589312748|FG000|Overall Study|Lack of Efficacy|1|||
163163726|NCT04605991|589312748|FG000|Overall Study|Lost to Follow-up|8|||
163163727|NCT04605991|589312748|FG000|Overall Study|Physician Decision|4|||
163163728|NCT04605991|589312748|FG000|Overall Study|Withdrawal by Subject|14|||
163163729|NCT04605991|589312748|FG000|Overall Study|Non-compliance with study|1|||
163163730|NCT04881942|589312751|FG000|Overall Study|Adverse Event|0|||
163163731|NCT04881942|589312752|FG001|Overall Study|Adverse Event|0|||
163163732|NCT04881942|589312753|FG002|Overall Study|Adverse Event|0|||
163163733|NCT04881942|589312754|FG003|Overall Study|Adverse Event|0|||
163163734|NCT04881942|589312755|FG004|Overall Study|Adverse Event|1|||
163163735|NCT04881942|589312751|FG000|Overall Study|Alternates|0|||
163163736|NCT04881942|589312752|FG001|Overall Study|Alternates|0|||
163163737|NCT04881942|589312753|FG002|Overall Study|Alternates|0|||
163163738|NCT04881942|589312754|FG003|Overall Study|Alternates|0|||
163163739|NCT04881942|589312755|FG004|Overall Study|Alternates|2|||
163163740|NCT00859638|589312756|FG000|Overall Study|Lost to Follow-up|6|||
163163741|NCT00859638|589312757|FG001|Overall Study|Lost to Follow-up|1|||
163163742|NCT00859638|589312756|FG000|Overall Study|Withdrawal by Subject|3|||
163163743|NCT00859638|589312757|FG001|Overall Study|Withdrawal by Subject|2|||
163163744|NCT00859638|589312756|FG000|Overall Study|Ill health|1|||
163163745|NCT00859638|589312757|FG001|Overall Study|Ill health|1|||
163163746|NCT00771953|589312761|FG000|Overall Study|Adverse Event|5|||
163163747|NCT00771953|589312762|FG001|Overall Study|Adverse Event|3|||
163163748|NCT00771953|589312761|FG000|Overall Study|Death|2|||
163163749|NCT00771953|589312762|FG001|Overall Study|Death|2|||
163163750|NCT00771953|589312761|FG000|Overall Study|Progression before active Tx|1|||
163163751|NCT00771953|589312762|FG001|Overall Study|Progression before active Tx|2|||
163163752|NCT00771953|589312761|FG000|Overall Study|Sponsor decision|1|||
163163753|NCT00771953|589312762|FG001|Overall Study|Sponsor decision|0|||
163163754|NCT00771953|589312761|FG000|Overall Study|Other complicating disease|1|||
163163755|NCT00771953|589312762|FG001|Overall Study|Other complicating disease|0|||
163163756|NCT00771953|589312761|FG000|Overall Study|Withdrawal by Subject|0|||
163163757|NCT00771953|589312762|FG001|Overall Study|Withdrawal by Subject|3|||
163163758|NCT00947193|589312765|FG000|Overall Study|Lost to Follow-up|1|||
163163759|NCT00947193|589312766|FG001|Overall Study|Lost to Follow-up|0|||
163163760|NCT00947193|589312765|FG000|Overall Study|Withdrawal by Subject|1|||
163163761|NCT00947193|589312766|FG001|Overall Study|Withdrawal by Subject|0|||
163163762|NCT00947193|589312765|FG000|Overall Study|Factor VIII >1%|1|||
163163763|NCT00947193|589312766|FG001|Overall Study|Factor VIII >1%|0|||
163163764|NCT04364984|589312767|FG000|Overall Study|Death|2|||
163163765|NCT04364984|589312768|FG001|Overall Study|Death|2|||
163163766|NCT04364984|589312769|FG002|Overall Study|Death|0|||
163163767|NCT01349959|589312770|FG000|Overall Study|Adverse Event|7|||
163163768|NCT02675634|589312771|FG000|Test Period 1|Adverse Event|0|||
163163769|NCT02675634|589312772|FG001|Test Period 1|Adverse Event|1|||
163163770|NCT02675634|589312773|FG002|Test Period 1|Adverse Event|0|||
163163771|NCT02675634|589312774|FG003|Test Period 1|Adverse Event|1|||
163163772|NCT02675634|589312775|FG004|Test Period 1|Adverse Event|0|||
163163773|NCT02675634|589312776|FG005|Test Period 1|Adverse Event|0|||
163163774|NCT02675634|589312771|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
163163775|NCT02675634|589312772|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
163163776|NCT02675634|589312773|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
163163777|NCT02675634|589312774|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
163163778|NCT02675634|589312775|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
163163779|NCT02675634|589312776|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
163163780|NCT02675634|589312771|FG000|Test Period 2|Lack of Efficacy|1|||
163163781|NCT02675634|589312772|FG001|Test Period 2|Lack of Efficacy|0|||
163163782|NCT02675634|589312773|FG002|Test Period 2|Lack of Efficacy|0|||
163163783|NCT02675634|589312774|FG003|Test Period 2|Lack of Efficacy|0|||
163163784|NCT02675634|589312775|FG004|Test Period 2|Lack of Efficacy|0|||
163163785|NCT02675634|589312776|FG005|Test Period 2|Lack of Efficacy|0|||
163163786|NCT02675634|589312771|FG000|Test Period 2|Adverse Event|0|||
163163787|NCT02675634|589312772|FG001|Test Period 2|Adverse Event|0|||
163163788|NCT02675634|589312773|FG002|Test Period 2|Adverse Event|0|||
163163789|NCT02675634|589312774|FG003|Test Period 2|Adverse Event|0|||
163163790|NCT02675634|589312775|FG004|Test Period 2|Adverse Event|0|||
163163791|NCT02675634|589312776|FG005|Test Period 2|Adverse Event|1|||
163163792|NCT01652534|589312777|FG000|Overall Study|Lack of Efficacy|1|||
163163793|NCT01652534|589312778|FG001|Overall Study|Lack of Efficacy|0|||
163163794|NCT02722304|589312779|FG000|Overall Study|Study Terminated by Sponsor|1|||
163163795|NCT02722304|589312780|FG001|Overall Study|Study Terminated by Sponsor|0|||
163163796|NCT02722304|589312781|FG002|Overall Study|Study Terminated by Sponsor|2|||
163163797|NCT02722304|589312782|FG003|Overall Study|Study Terminated by Sponsor|1|||
163163798|NCT02722304|589312783|FG004|Overall Study|Study Terminated by Sponsor|1|||
163163799|NCT02722304|589312779|FG000|Overall Study|Other|0|||
163163800|NCT02722304|589312780|FG001|Overall Study|Other|0|||
163163801|NCT02722304|589312781|FG002|Overall Study|Other|0|||
163163802|NCT02722304|589312782|FG003|Overall Study|Other|1|||
163163803|NCT02722304|589312783|FG004|Overall Study|Other|1|||
163163804|NCT01727024|589312786|FG000|Period 1|Lost to Follow-up|1|||
163163805|NCT01727024|589312787|FG001|Period 1|Lost to Follow-up|1|||
163163806|NCT01727024|589312786|FG000|Period 1|Withdrawal by Subject|2|||
163163807|NCT01727024|589312787|FG001|Period 1|Withdrawal by Subject|3|||
163163808|NCT02920242|589312788|FG000|Overall Study|Withdrawal by Subject|1|||
163163809|NCT02920242|589312789|FG001|Overall Study|Withdrawal by Subject|0|||
163163810|NCT02920242|589312790|FG002|Overall Study|Withdrawal by Subject|1|||
163163811|NCT02920242|589312788|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
163163812|NCT02920242|589312789|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
163163813|NCT02920242|589312790|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
163163814|NCT04995419|589312796|FG000|Overall Study|Withdrawal by Subject|3|||
163163815|NCT04995419|589312796|FG000|Overall Study|Progressive Disease|19|||
163163816|NCT04995419|589312796|FG000|Overall Study|Adverse Event|2|||
163163817|NCT04995419|589312796|FG000|Overall Study|Ongoing|16|||
163163818|NCT02948088|589312797|FG000|Overall Study|Lost to Follow-up|8|||
163163819|NCT02948088|589312797|FG000|Overall Study|Death|1|||
163163820|NCT02948088|589312797|FG000|Overall Study|Withdrawal by Subject|4|||
163163821|NCT02948088|589312797|FG000|Overall Study|Other|2|||
163163822|NCT00634101|589312798|FG000|Overall Study|Study Terminated|3|||
163163823|NCT00634101|589312799|FG001|Overall Study|Study Terminated|3|||
163163824|NCT00634101|589312798|FG000|Overall Study|Lost to Follow-up|2|||
163163825|NCT00634101|589312799|FG001|Overall Study|Lost to Follow-up|0|||
163163826|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
163163827|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
163163828|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
163163829|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
163163830|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
163163831|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
163163832|NCT00139477|589312800|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
163163833|NCT00139477|589312801|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
163163834|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
163163835|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
163163836|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
163163837|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
163163838|NCT00139477|589312800|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
163163839|NCT00139477|589312801|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
163163840|NCT03776812|589312802|FG000|Overall Study|Death|53|||
163163841|NCT03776812|589312803|FG001|Overall Study|Death|49|||
163163842|NCT03776812|589312804|FG002|Overall Study|Death|56|||
163163843|NCT03776812|589312802|FG000|Overall Study|Withdrawal by Subject|1|||
163163844|NCT03776812|589312803|FG001|Overall Study|Withdrawal by Subject|7|||
163163845|NCT03776812|589312804|FG002|Overall Study|Withdrawal by Subject|2|||
163163846|NCT03776812|589312802|FG000|Overall Study|Lost to Follow-up|1|||
163163847|NCT03776812|589312803|FG001|Overall Study|Lost to Follow-up|1|||
163163848|NCT03776812|589312804|FG002|Overall Study|Lost to Follow-up|0|||
163163849|NCT03776812|589312802|FG000|Overall Study|Did not enter long-term follow-up|3|||
163163850|NCT03776812|589312803|FG001|Overall Study|Did not enter long-term follow-up|3|||
163163851|NCT03776812|589312804|FG002|Overall Study|Did not enter long-term follow-up|2|||
163163852|NCT00552188|589314180|FG000|Overall Study|Adverse Event|0|||
163163853|NCT00552188|589314181|FG001|Overall Study|Adverse Event|2|||
163163854|NCT00552188|589314180|FG000|Overall Study|Lost to Follow-up|2|||
163163855|NCT00552188|589314181|FG001|Overall Study|Lost to Follow-up|1|||
163163856|NCT00552188|589314180|FG000|Overall Study|Withdrawal of consent|0|||
163163857|NCT00552188|589314181|FG001|Overall Study|Withdrawal of consent|1|||
163163858|NCT00552188|589314180|FG000|Overall Study|Subject returned to home country|0|||
163163859|NCT00552188|589314181|FG001|Overall Study|Subject returned to home country|1|||
163163860|NCT01368562|589314182|FG000|Overall Study|Adverse Event|1|||
163163861|NCT01368562|589314182|FG000|Overall Study|Disease progression|1|||
163163862|NCT01368562|589314182|FG000|Overall Study|Lost to Follow-up|1|||
163163863|NCT01368562|589314182|FG000|Overall Study|Death|6|||
163163864|NCT01368562|589314182|FG000|Overall Study|Unresponsive to treatment|5|||
163163865|NCT01368562|589314182|FG000|Overall Study|Other|3|||
163163866|NCT01368562|589314182|FG000|Overall Study|Other than specified|2|||
163163867|NCT00243269|589314187|FG000|Overall Study|Protocol Violation|2|||
163163868|NCT00243269|589314188|FG001|Overall Study|Protocol Violation|1|||
163163869|NCT00243269|589314189|FG002|Overall Study|Protocol Violation|0|||
163163870|NCT00243269|589314190|FG003|Overall Study|Protocol Violation|1|||
163163871|NCT00243269|589314187|FG000|Overall Study|Lost to Follow-up|1|||
163163872|NCT00243269|589314188|FG001|Overall Study|Lost to Follow-up|0|||
163163873|NCT00243269|589314189|FG002|Overall Study|Lost to Follow-up|1|||
163163874|NCT00243269|589314190|FG003|Overall Study|Lost to Follow-up|3|||
163163875|NCT01296672|589314195|FG000|Overall Study|Lost to Follow-up|73|||
163163876|NCT01296672|589314196|FG001|Overall Study|Lost to Follow-up|18|||
163163877|NCT01311024|589314197|FG000|Overall Study|Protocol Violation|35|||
163163878|NCT01311024|589314198|FG001|Overall Study|Protocol Violation|22|||
163163879|NCT00856518|589314199|FG000|Overall Study|Lost to Follow-up|4|||
163163880|NCT00856518|589314200|FG001|Overall Study|Lost to Follow-up|2|||
163163881|NCT02867384|589314201|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
163163882|NCT02867384|589314202|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
163163883|NCT02867384|589314203|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
163163884|NCT02867384|589314201|FG000|Overall Study|Progression/ Relapse|15|||
163163885|NCT02867384|589314202|FG001|Overall Study|Progression/ Relapse|19|||
163163886|NCT02867384|589314203|FG002|Overall Study|Progression/ Relapse|0|||
163163887|NCT02867384|589314201|FG000|Overall Study|Adverse Event|13|||
163163888|NCT02867384|589314202|FG001|Overall Study|Adverse Event|1|||
163163889|NCT02867384|589314203|FG002|Overall Study|Adverse Event|0|||
163163890|NCT02867384|589314201|FG000|Overall Study|Withdrawal by Subject|6|||
163163891|NCT02867384|589314202|FG001|Overall Study|Withdrawal by Subject|5|||
163163892|NCT02867384|589314203|FG002|Overall Study|Withdrawal by Subject|0|||
163163893|NCT02867384|589314201|FG000|Overall Study|Physician Decision|1|||
163163894|NCT02867384|589314202|FG001|Overall Study|Physician Decision|2|||
163163895|NCT02867384|589314203|FG002|Overall Study|Physician Decision|0|||
163163896|NCT02867384|589314201|FG000|Overall Study|Patient compliance|1|||
163163897|NCT02867384|589314202|FG001|Overall Study|Patient compliance|0|||
163163898|NCT02867384|589314203|FG002|Overall Study|Patient compliance|0|||
163163899|NCT02867384|589314201|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
163163900|NCT02867384|589314202|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
163163901|NCT02867384|589314203|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
163163902|NCT02867384|589314201|FG000|Overall Study|Never start treatment|3|||
163163903|NCT02867384|589314202|FG001|Overall Study|Never start treatment|0|||
163163904|NCT02867384|589314203|FG002|Overall Study|Never start treatment|0|||
163163905|NCT01941186|589314204|FG000|Follow-up|Lost to Follow-up|1|||
163163906|NCT01941186|589314205|FG001|Follow-up|Lost to Follow-up|0|||
163163907|NCT02105961|589314206|FG000|Overall Study|Adverse Event|18|||
163163908|NCT02105961|589314207|FG001|Overall Study|Adverse Event|7|||
163163909|NCT02105961|589314208|FG002|Overall Study|Adverse Event|13|||
163163910|NCT02105961|589314206|FG000|Overall Study|Lack of Efficacy|3|||
163163911|NCT02105961|589314207|FG001|Overall Study|Lack of Efficacy|0|||
163163912|NCT02105961|589314208|FG002|Overall Study|Lack of Efficacy|3|||
163163913|NCT02105961|589314206|FG000|Overall Study|Lost to Follow-up|2|||
163163914|NCT02105961|589314207|FG001|Overall Study|Lost to Follow-up|0|||
163163915|NCT02105961|589314208|FG002|Overall Study|Lost to Follow-up|1|||
163163916|NCT02105961|589314206|FG000|Overall Study|Physician Decision|3|||
163163917|NCT02105961|589314207|FG001|Overall Study|Physician Decision|3|||
163163918|NCT02105961|589314208|FG002|Overall Study|Physician Decision|2|||
163163919|NCT02105961|589314206|FG000|Overall Study|Withdrawal by Subject|15|||
163163920|NCT02105961|589314207|FG001|Overall Study|Withdrawal by Subject|7|||
163163921|NCT02105961|589314208|FG002|Overall Study|Withdrawal by Subject|11|||
163163922|NCT00934362|589314212|FG000|Overall Study|Adverse Event|1|||
163163923|NCT00934362|589314213|FG001|Overall Study|Adverse Event|0|||
163163924|NCT01092117|589314216|FG000|Index Procedure to 1 Month|Death|1|||
163163925|NCT01092117|589314216|FG000|1 Month|Death|1|||
163163926|NCT01092117|589314216|FG000|1 Month|Withdrawal by Subject|1|||
163163927|NCT01092117|589314216|FG000|1 Month|Lost to Follow-up|1|||
163163928|NCT01092117|589314216|FG000|6 Months|Death|2|||
163163929|NCT01092117|589314216|FG000|6 Months|Withdrawal by Subject|3|||
163163930|NCT01092117|589314216|FG000|12 Month|Death|11|||
163163931|NCT01092117|589314216|FG000|12 Month|Withdrawal by Subject|2|||
163163932|NCT01092117|589314216|FG000|12 Month|Lost to Follow-up|1|||
163163933|NCT01092117|589314216|FG000|Year 2|Death|5|||
163163934|NCT01092117|589314216|FG000|Year 2|Withdrawal by Subject|4|||
163163935|NCT01092117|589314216|FG000|Year 2|Lost to Follow-up|1|||
163163936|NCT01092117|589314216|FG000|Year 3|Death|7|||
163163937|NCT01092117|589314216|FG000|Year 3|Withdrawal by Subject|9|||
163163938|NCT01092117|589314216|FG000|Year 3|Lost to Follow-up|3|||
163163939|NCT01092117|589314216|FG000|Year 4|Death|8|||
163163940|NCT01092117|589314216|FG000|Year 4|Withdrawal by Subject|4|||
163163941|NCT01092117|589314216|FG000|Year 4|Lost to Follow-up|4|||
163163942|NCT04380519|589314217|FG000|Overall Study|Withdrawal by Subject|4|||
163163943|NCT04380519|589314218|FG001|Overall Study|Withdrawal by Subject|0|||
163163944|NCT04380519|589314219|FG002|Overall Study|Withdrawal by Subject|1|||
163163945|NCT04380519|589314217|FG000|Overall Study|Death|14|||
163163946|NCT04380519|589314218|FG001|Overall Study|Death|9|||
163163947|NCT04380519|589314219|FG002|Overall Study|Death|6|||
163163948|NCT04380519|589314217|FG000|Overall Study|Adverse Event|0|||
163163949|NCT04380519|589314218|FG001|Overall Study|Adverse Event|1|||
163163950|NCT04380519|589314219|FG002|Overall Study|Adverse Event|0|||
163163951|NCT04380519|589314217|FG000|Overall Study|relatives' decision|0|||
163163952|NCT04380519|589314218|FG001|Overall Study|relatives' decision|1|||
163163953|NCT04380519|589314219|FG002|Overall Study|relatives' decision|0|||
163163954|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
163163955|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
163163956|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
163163957|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
163163958|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
163163959|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
163163960|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
163163961|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
163163962|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
163163963|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
163163964|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
163163965|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
163163966|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
163163967|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
163163968|NCT04173494|589314220|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
163163969|NCT04173494|589314221|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
163163970|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
163163971|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
163163972|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
163163973|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
163163974|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
163163975|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
163163976|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
163163977|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
163163978|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
163163979|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
163163980|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
163163981|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
163163982|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
163163983|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
163163984|NCT04173494|589314220|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
163163985|NCT04173494|589314221|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
163163986|NCT01623050|589314222|FG000|Overall Study|Lost to Follow-up|9|||
163163987|NCT00526071|589314225|FG000|Overall Study|Adverse Event|1|||
163163988|NCT00526071|589314225|FG000|Overall Study|Withdrawal by Subject|1|||
162698019|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698020|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698021|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162698022|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163163989|NCT00526071|589314225|FG000|Overall Study|Lack of Response to Study Drug|4|||
163163990|NCT01191762|589314226|FG000|Overall Study|Adverse Event|1|||
163163991|NCT01191762|589314227|FG001|Overall Study|Adverse Event|0|||
163163992|NCT00393861|589314230|FG000|Overall Study|Adverse Event|2|||
163163993|NCT00393861|589314230|FG000|Overall Study|Disease Progression|24|||
163163994|NCT05300763|589314231|FG000|Overall Study|Adverse Event|0|||
163163995|NCT05300763|589314232|FG001|Overall Study|Adverse Event|1|||
163163996|NCT05300763|589314231|FG000|Overall Study|Major Protocol Deviation|1|||
163163997|NCT05300763|589314232|FG001|Overall Study|Major Protocol Deviation|0|||
163163998|NCT05300763|589314231|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
163163999|NCT05300763|589314232|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163164000|NCT01485172|589314233|FG000|Overall Study|Adverse Event|2|||
163164001|NCT01485172|589314234|FG001|Overall Study|Adverse Event|1|||
163164002|NCT01485172|589314235|FG002|Overall Study|Adverse Event|2|||
163164003|NCT01485172|589314236|FG003|Overall Study|Adverse Event|2|||
163164004|NCT01485172|589314237|FG004|Overall Study|Adverse Event|1|||
163164005|NCT01485172|589314238|FG005|Overall Study|Adverse Event|2|||
163164006|NCT01485172|589314233|FG000|Overall Study|Lack of Efficacy|2|||
163164007|NCT01485172|589314234|FG001|Overall Study|Lack of Efficacy|0|||
163164008|NCT01485172|589314235|FG002|Overall Study|Lack of Efficacy|0|||
163164009|NCT01485172|589314236|FG003|Overall Study|Lack of Efficacy|0|||
163164010|NCT01485172|589314237|FG004|Overall Study|Lack of Efficacy|0|||
163164011|NCT01485172|589314238|FG005|Overall Study|Lack of Efficacy|0|||
163164012|NCT01485172|589314233|FG000|Overall Study|Protocol Violation|0|||
163164013|NCT01485172|589314234|FG001|Overall Study|Protocol Violation|0|||
163164014|NCT01485172|589314235|FG002|Overall Study|Protocol Violation|4|||
163164015|NCT01485172|589314236|FG003|Overall Study|Protocol Violation|5|||
163164016|NCT01485172|589314237|FG004|Overall Study|Protocol Violation|1|||
163164017|NCT01485172|589314238|FG005|Overall Study|Protocol Violation|0|||
163164018|NCT01485172|589314233|FG000|Overall Study|Protocol defined stopping criteria|1|||
163164019|NCT01485172|589314234|FG001|Overall Study|Protocol defined stopping criteria|0|||
163164020|NCT01485172|589314235|FG002|Overall Study|Protocol defined stopping criteria|0|||
163164021|NCT01485172|589314236|FG003|Overall Study|Protocol defined stopping criteria|0|||
163164022|NCT01485172|589314237|FG004|Overall Study|Protocol defined stopping criteria|1|||
163164023|NCT01485172|589314238|FG005|Overall Study|Protocol defined stopping criteria|0|||
163164024|NCT01485172|589314233|FG000|Overall Study|Lost to Follow-up|0|||
163164025|NCT01485172|589314234|FG001|Overall Study|Lost to Follow-up|0|||
163164026|NCT01485172|589314235|FG002|Overall Study|Lost to Follow-up|1|||
163164027|NCT01485172|589314236|FG003|Overall Study|Lost to Follow-up|0|||
163164028|NCT01485172|589314237|FG004|Overall Study|Lost to Follow-up|0|||
163164029|NCT01485172|589314238|FG005|Overall Study|Lost to Follow-up|1|||
163164030|NCT01485172|589314233|FG000|Overall Study|Physician Decision|0|||
163164031|NCT01485172|589314234|FG001|Overall Study|Physician Decision|0|||
163164032|NCT01485172|589314235|FG002|Overall Study|Physician Decision|0|||
163164033|NCT01485172|589314236|FG003|Overall Study|Physician Decision|0|||
163164034|NCT01485172|589314237|FG004|Overall Study|Physician Decision|1|||
163164035|NCT01485172|589314238|FG005|Overall Study|Physician Decision|0|||
163164036|NCT01485172|589314233|FG000|Overall Study|Withdrawal by Subject|2|||
163164037|NCT01485172|589314234|FG001|Overall Study|Withdrawal by Subject|0|||
163164038|NCT01485172|589314235|FG002|Overall Study|Withdrawal by Subject|0|||
163164039|NCT01485172|589314236|FG003|Overall Study|Withdrawal by Subject|1|||
163164040|NCT01485172|589314237|FG004|Overall Study|Withdrawal by Subject|1|||
163164041|NCT01485172|589314238|FG005|Overall Study|Withdrawal by Subject|1|||
163164042|NCT01587014|589314239|FG000|Overall Study|Death|2|||
163164043|NCT01409811|589314240|FG000|Overall Study|Insurance denial|1|||
163164044|NCT00441064|589314241|FG000|Overall Study|Adverse Event|1|||
163164045|NCT00441064|589314242|FG001|Overall Study|Adverse Event|0|||
163164046|NCT00441064|589314241|FG000|Overall Study|Abnormal laboratory values|0|||
163164047|NCT00441064|589314242|FG001|Overall Study|Abnormal laboratory values|2|||
163164048|NCT00441064|589314241|FG000|Overall Study|Abnormal test procedure results|0|||
163164049|NCT00441064|589314242|FG001|Overall Study|Abnormal test procedure results|1|||
163164050|NCT00441064|589314241|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163164051|NCT00441064|589314242|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163164052|NCT00441064|589314241|FG000|Overall Study|Protocol Deviation|3|||
163164053|NCT00441064|589314242|FG001|Overall Study|Protocol Deviation|2|||
163164054|NCT00441064|589314241|FG000|Overall Study|Patient withdrew consent|5|||
163164055|NCT00441064|589314242|FG001|Overall Study|Patient withdrew consent|2|||
163164056|NCT03051178|589314243|FG000|Overall Study|Withdrawal by Subject|5|||
163164057|NCT00953056|589314244|FG000|Overall Study|Withdrew Consent|0|||
163164058|NCT00953056|589314245|FG001|Overall Study|Withdrew Consent|0|||
163164059|NCT00953056|589314246|FG002|Overall Study|Withdrew Consent|0|||
163164060|NCT00953056|589314247|FG003|Overall Study|Withdrew Consent|0|||
163164061|NCT00953056|589314248|FG004|Overall Study|Withdrew Consent|2|||
163164062|NCT00953056|589314249|FG005|Overall Study|Withdrew Consent|3|||
163164063|NCT00953056|589314244|FG000|Overall Study|Serious Adverse Event|0|||
163164064|NCT00953056|589314245|FG001|Overall Study|Serious Adverse Event|0|||
163164065|NCT00953056|589314246|FG002|Overall Study|Serious Adverse Event|0|||
163164066|NCT00953056|589314247|FG003|Overall Study|Serious Adverse Event|0|||
163164067|NCT00953056|589314248|FG004|Overall Study|Serious Adverse Event|0|||
163164068|NCT00953056|589314249|FG005|Overall Study|Serious Adverse Event|1|||
163164069|NCT00048074|589314253|FG000|Overall Study|Adverse Event|46|||
163164070|NCT00048074|589314254|FG001|Overall Study|Adverse Event|41|||
163164071|NCT00048074|589314255|FG002|Overall Study|Adverse Event|53|||
163164072|NCT00048074|589314253|FG000|Overall Study|Death|3|||
163164073|NCT00048074|589314254|FG001|Overall Study|Death|3|||
163164074|NCT00048074|589314255|FG002|Overall Study|Death|2|||
163164075|NCT00048074|589314253|FG000|Overall Study|Lost to Follow-up|2|||
163164076|NCT00048074|589314254|FG001|Overall Study|Lost to Follow-up|6|||
163164077|NCT00048074|589314255|FG002|Overall Study|Lost to Follow-up|6|||
163164078|NCT00048074|589314253|FG000|Overall Study|Withdrawal by Subject|28|||
163164079|NCT00048074|589314254|FG001|Overall Study|Withdrawal by Subject|30|||
163164080|NCT00048074|589314255|FG002|Overall Study|Withdrawal by Subject|35|||
163164081|NCT00048074|589314253|FG000|Overall Study|Protocol Violation|1|||
163164082|NCT00048074|589314254|FG001|Overall Study|Protocol Violation|3|||
163164083|NCT00048074|589314255|FG002|Overall Study|Protocol Violation|0|||
163164084|NCT00048074|589314253|FG000|Overall Study|Study participation was terminated|0|||
163164085|NCT00048074|589314254|FG001|Overall Study|Study participation was terminated|1|||
163164086|NCT00048074|589314255|FG002|Overall Study|Study participation was terminated|0|||
163164087|NCT00048074|589314253|FG000|Overall Study|Husband ill|0|||
163164088|NCT00048074|589314254|FG001|Overall Study|Husband ill|1|||
163164089|NCT00048074|589314255|FG002|Overall Study|Husband ill|0|||
163164090|NCT00048074|589314253|FG000|Overall Study|Poor compliance|0|||
163164091|NCT00048074|589314254|FG001|Overall Study|Poor compliance|1|||
163164092|NCT00048074|589314255|FG002|Overall Study|Poor compliance|0|||
163164093|NCT00048074|589314253|FG000|Overall Study|Out of station|0|||
163164094|NCT00048074|589314254|FG001|Overall Study|Out of station|1|||
163164095|NCT00048074|589314255|FG002|Overall Study|Out of station|1|||
163164096|NCT00048074|589314253|FG000|Overall Study|Social reasons|1|||
163164097|NCT00048074|589314254|FG001|Overall Study|Social reasons|0|||
163164098|NCT00048074|589314255|FG002|Overall Study|Social reasons|0|||
163164099|NCT04476797|589314256|FG000|Overall Study|Withdrawal by Subject|1|||
163164100|NCT04476797|589314257|FG001|Overall Study|Withdrawal by Subject|0|||
163164101|NCT04476797|589314258|FG002|Overall Study|Withdrawal by Subject|0|||
163164102|NCT04476797|589314256|FG000|Overall Study|Death|0|||
163164103|NCT04476797|589314257|FG001|Overall Study|Death|1|||
163164104|NCT04476797|589314258|FG002|Overall Study|Death|2|||
163164105|NCT04476797|589314256|FG000|Overall Study|Sponsor Terminated Study|0|||
163164106|NCT04476797|589314257|FG001|Overall Study|Sponsor Terminated Study|18|||
163164107|NCT04476797|589314258|FG002|Overall Study|Sponsor Terminated Study|17|||
163164108|NCT02395081|589314259|FG000|Overall Study|Withdrawal by Subject|1|||
163164109|NCT02395081|589314260|FG001|Overall Study|Withdrawal by Subject|1|||
163164110|NCT02395081|589314261|FG002|Overall Study|Withdrawal by Subject|0|||
163164111|NCT02395081|589314259|FG000|Overall Study|Moved where blood couldn't be collected|4|||
163164112|NCT02395081|589314260|FG001|Overall Study|Moved where blood couldn't be collected|1|||
163164113|NCT02395081|589314261|FG002|Overall Study|Moved where blood couldn't be collected|3|||
163164114|NCT02395081|589314259|FG000|Overall Study|Fetal Loss|2|||
163164115|NCT02395081|589314260|FG001|Overall Study|Fetal Loss|3|||
163164116|NCT02395081|589314261|FG002|Overall Study|Fetal Loss|1|||
163164117|NCT01583296|589314262|FG000|Overall Study|Withdrawal by Subject|11|||
163164118|NCT01583296|589314263|FG001|Overall Study|Withdrawal by Subject|10|||
163164119|NCT01063283|589314264|FG000|Cycle 1|Adverse Event|2|||
163164120|NCT01063283|589314265|FG001|Cycle 1|Adverse Event|0|||
163164121|NCT01063283|589314266|FG002|Cycle 1|Adverse Event|0|||
163164122|NCT01063283|589314264|FG000|Cycle 1|Technical failure in data collection|1|||
163164123|NCT01063283|589314265|FG001|Cycle 1|Technical failure in data collection|0|||
163164124|NCT01063283|589314266|FG002|Cycle 1|Technical failure in data collection|0|||
163164125|NCT02504216|589314269|FG000|Overall Study|Lost to Follow-up|3|||
163164126|NCT02504216|589314270|FG001|Overall Study|Lost to Follow-up|3|||
163164127|NCT02504216|589314269|FG000|Overall Study|Withdrawal by Subject|8|||
163164128|NCT02504216|589314270|FG001|Overall Study|Withdrawal by Subject|12|||
163164129|NCT00223080|589314271|FG000|Overall Study|Withdrawal by Subject|253|||
163164130|NCT00223080|589314272|FG001|Overall Study|Withdrawal by Subject|232|||
163164131|NCT00223080|589314271|FG000|Overall Study|Required contraindicated med|0|||
163164132|NCT00223080|589314272|FG001|Overall Study|Required contraindicated med|1|||
163164133|NCT00223080|589314271|FG000|Overall Study|Non-compliant|7|||
163164134|NCT00223080|589314272|FG001|Overall Study|Non-compliant|7|||
163164135|NCT00223080|589314271|FG000|Overall Study|Moved from study area|37|||
162814098|NCT05678959|588032182|FG001|Overall Study|Technical Problem|1|||
162814099|NCT02065336|588032183|FG000|Extension Phase|Study Terminated by Sponsor|0|||
162814100|NCT02065336|588032184|FG001|Extension Phase|Study Terminated by Sponsor|0|||
162814101|NCT02065336|588032185|FG002|Extension Phase|Study Terminated by Sponsor|0|||
162814102|NCT02065336|588032186|FG003|Extension Phase|Study Terminated by Sponsor|0|||
162814103|NCT02065336|588032187|FG004|Extension Phase|Study Terminated by Sponsor|0|||
163164136|NCT00223080|589314272|FG001|Overall Study|Moved from study area|47|||
163164137|NCT00223080|589314271|FG000|Overall Study|Lost to Follow-up|259|||
163164138|NCT00223080|589314272|FG001|Overall Study|Lost to Follow-up|284|||
163164139|NCT00223080|589314271|FG000|Overall Study|Death|85|||
162814104|NCT02065336|588032188|FG005|Extension Phase|Study Terminated by Sponsor|0|||
162814105|NCT02065336|588032189|FG006|Extension Phase|Study Terminated by Sponsor|0|||
163164140|NCT00223080|589314272|FG001|Overall Study|Death|74|||
163164141|NCT00223080|589314271|FG000|Overall Study|Other|14|||
163164142|NCT00223080|589314272|FG001|Overall Study|Other|11|||
163164143|NCT00223080|589314271|FG000|Overall Study|Reason not provided|141|||
163164144|NCT00223080|589314272|FG001|Overall Study|Reason not provided|140|||
163164145|NCT00223080|589314271|FG000|Overall Study|Adverse Event|0|||
163164146|NCT00223080|589314272|FG001|Overall Study|Adverse Event|1|||
163164147|NCT02598583|589314273|FG000|Extension Period|Withdrawal by Subject|1|||
163164148|NCT02598583|589314274|FG001|Extension Period|Withdrawal by Subject|0|||
163164149|NCT03237286|589314275|FG000|Overall Study|Withdrawal by Subject|1|||
163164150|NCT03237286|589314276|FG001|Overall Study|Withdrawal by Subject|0|||
163164151|NCT03237286|589314277|FG002|Overall Study|Withdrawal by Subject|2|||
163164152|NCT03237286|589314275|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
163164153|NCT03237286|589314276|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
163164154|NCT03237286|589314277|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
163164155|NCT02792829|589314285|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164156|NCT02792829|589314286|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
163164157|NCT02792829|589314287|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164158|NCT02792829|589314288|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164159|NCT02792829|589314289|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164160|NCT02792829|589314290|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164161|NCT02792829|589314291|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164162|NCT02792829|589314292|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
163164163|NCT02792829|589314285|FG000|Treatment Period 2|Adverse Event|0|||
163164164|NCT02792829|589314286|FG001|Treatment Period 2|Adverse Event|0|||
163164165|NCT02792829|589314287|FG002|Treatment Period 2|Adverse Event|0|||
163164166|NCT02792829|589314288|FG003|Treatment Period 2|Adverse Event|0|||
163164167|NCT02792829|589314289|FG004|Treatment Period 2|Adverse Event|1|||
163164168|NCT02792829|589314290|FG005|Treatment Period 2|Adverse Event|0|||
163164169|NCT02792829|589314291|FG006|Treatment Period 2|Adverse Event|1|||
163164170|NCT02792829|589314292|FG007|Treatment Period 2|Adverse Event|1|||
163164171|NCT02792829|589314285|FG000|Treatment Period 2|Use of proscribed medications|0|||
163164172|NCT02792829|589314286|FG001|Treatment Period 2|Use of proscribed medications|0|||
163164173|NCT02792829|589314287|FG002|Treatment Period 2|Use of proscribed medications|0|||
163164174|NCT02792829|589314288|FG003|Treatment Period 2|Use of proscribed medications|0|||
163164175|NCT02792829|589314289|FG004|Treatment Period 2|Use of proscribed medications|0|||
163164176|NCT02792829|589314290|FG005|Treatment Period 2|Use of proscribed medications|0|||
163164177|NCT02792829|589314291|FG006|Treatment Period 2|Use of proscribed medications|0|||
163164178|NCT02792829|589314292|FG007|Treatment Period 2|Use of proscribed medications|1|||
163164179|NCT01262820|589314293|FG000|Overall Study|Adverse Event|5|||
163164180|NCT01262820|589314293|FG000|Overall Study|Lack of Efficacy|9|||
163164181|NCT01262820|589314293|FG000|Overall Study|Drug held for 21+ days|1|||
163164182|NCT00104520|589314295|FG000|Overall Study|Unrelated adverse event|34|||
163164183|NCT00104520|589314296|FG001|Overall Study|Unrelated adverse event|47|||
163164184|NCT00104520|589314295|FG000|Overall Study|Study drug intolerance|0|||
163164185|NCT00104520|589314296|FG001|Overall Study|Study drug intolerance|1|||
163164186|NCT00104520|589314295|FG000|Overall Study|Related adverse event|13|||
163164187|NCT00104520|589314296|FG001|Overall Study|Related adverse event|15|||
163164188|NCT00104520|589314295|FG000|Overall Study|Lost to Follow-up|1|||
163164189|NCT00104520|589314296|FG001|Overall Study|Lost to Follow-up|0|||
163164190|NCT00104520|589314295|FG000|Overall Study|Noncompliance|0|||
163164191|NCT00104520|589314296|FG001|Overall Study|Noncompliance|2|||
163164192|NCT00104520|589314295|FG000|Overall Study|Personal/administrative|1|||
163164193|NCT00104520|589314296|FG001|Overall Study|Personal/administrative|1|||
163164194|NCT00104520|589314295|FG000|Overall Study|Other|1|||
163164195|NCT00104520|589314296|FG001|Overall Study|Other|5|||
163164196|NCT02442804|589314298|FG000|Overall Study|Withdrawal by Subject|0|||
163164197|NCT02442804|589314299|FG001|Overall Study|Withdrawal by Subject|1|||
163164198|NCT02442804|589314298|FG000|Overall Study|Adverse Event|1|||
163164199|NCT02442804|589314299|FG001|Overall Study|Adverse Event|0|||
163164200|NCT02527421|589314306|FG000|Overall Study|Withdrawal by Subject|1|||
163164201|NCT02527421|589314307|FG001|Overall Study|Withdrawal by Subject|0|||
163164202|NCT04200352|589314308|FG000|Overall Study|Death|1|||
163164203|NCT04200352|589314308|FG000|Overall Study|Adverse Event|6|||
163164204|NCT04200352|589314308|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163164205|NCT04200352|589314308|FG000|Overall Study|Lack of Efficacy|1|||
163164206|NCT04200352|589314308|FG000|Overall Study|Other than specified|6|||
163164207|NCT02541604|589314309|FG000|Overall Study|Death|6|||
163164208|NCT02541604|589314310|FG001|Overall Study|Death|5|||
163164209|NCT02541604|589314311|FG002|Overall Study|Death|7|||
163164210|NCT02541604|589314312|FG003|Overall Study|Death|2|||
163164211|NCT02541604|589314313|FG004|Overall Study|Death|9|||
162698023|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163042817|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
163164212|NCT02541604|589314314|FG005|Overall Study|Death|8|||
163164213|NCT02541604|589314315|FG006|Overall Study|Death|9|||
163164214|NCT02541604|589314316|FG007|Overall Study|Death|9|||
163164215|NCT02541604|589314317|FG008|Overall Study|Death|3|||
163164216|NCT02541604|589314318|FG009|Overall Study|Death|4|||
163164217|NCT02541604|589314319|FG010|Overall Study|Death|2|||
163164218|NCT02541604|589314320|FG011|Overall Study|Death|3|||
163164219|NCT02541604|589314309|FG000|Overall Study|Lost to Follow-up|2|||
163164220|NCT02541604|589314310|FG001|Overall Study|Lost to Follow-up|0|||
163164221|NCT02541604|589314311|FG002|Overall Study|Lost to Follow-up|1|||
163164222|NCT02541604|589314312|FG003|Overall Study|Lost to Follow-up|0|||
163164223|NCT02541604|589314313|FG004|Overall Study|Lost to Follow-up|0|||
163164224|NCT02541604|589314314|FG005|Overall Study|Lost to Follow-up|1|||
163164225|NCT02541604|589314315|FG006|Overall Study|Lost to Follow-up|1|||
163164226|NCT02541604|589314316|FG007|Overall Study|Lost to Follow-up|0|||
163164227|NCT02541604|589314317|FG008|Overall Study|Lost to Follow-up|0|||
163164228|NCT02541604|589314318|FG009|Overall Study|Lost to Follow-up|0|||
163164229|NCT02541604|589314319|FG010|Overall Study|Lost to Follow-up|0|||
163164230|NCT02541604|589314320|FG011|Overall Study|Lost to Follow-up|0|||
163164231|NCT02541604|589314309|FG000|Overall Study|Withdrawal by Subject|2|||
163164232|NCT02541604|589314310|FG001|Overall Study|Withdrawal by Subject|0|||
163164233|NCT02541604|589314311|FG002|Overall Study|Withdrawal by Subject|1|||
163164234|NCT02541604|589314312|FG003|Overall Study|Withdrawal by Subject|0|||
163164235|NCT02541604|589314313|FG004|Overall Study|Withdrawal by Subject|1|||
163164236|NCT02541604|589314314|FG005|Overall Study|Withdrawal by Subject|1|||
163164237|NCT02541604|589314315|FG006|Overall Study|Withdrawal by Subject|0|||
163164238|NCT02541604|589314316|FG007|Overall Study|Withdrawal by Subject|0|||
163164239|NCT02541604|589314317|FG008|Overall Study|Withdrawal by Subject|1|||
163164240|NCT02541604|589314318|FG009|Overall Study|Withdrawal by Subject|0|||
163164241|NCT02541604|589314319|FG010|Overall Study|Withdrawal by Subject|0|||
163164242|NCT02541604|589314320|FG011|Overall Study|Withdrawal by Subject|0|||
163164243|NCT02541604|589314309|FG000|Overall Study|Study Terminated by Sponsor|1|||
163164244|NCT02541604|589314310|FG001|Overall Study|Study Terminated by Sponsor|4|||
163164245|NCT02541604|589314311|FG002|Overall Study|Study Terminated by Sponsor|2|||
163164246|NCT02541604|589314312|FG003|Overall Study|Study Terminated by Sponsor|1|||
163164247|NCT02541604|589314313|FG004|Overall Study|Study Terminated by Sponsor|0|||
163164248|NCT02541604|589314314|FG005|Overall Study|Study Terminated by Sponsor|0|||
163164249|NCT02541604|589314315|FG006|Overall Study|Study Terminated by Sponsor|0|||
163164250|NCT02541604|589314316|FG007|Overall Study|Study Terminated by Sponsor|0|||
163164251|NCT02541604|589314317|FG008|Overall Study|Study Terminated by Sponsor|0|||
163164252|NCT02541604|589314318|FG009|Overall Study|Study Terminated by Sponsor|0|||
163164253|NCT02541604|589314319|FG010|Overall Study|Study Terminated by Sponsor|0|||
163164254|NCT02541604|589314320|FG011|Overall Study|Study Terminated by Sponsor|0|||
163164255|NCT02541604|589314309|FG000|Overall Study|Medical condition may jeopardize safety|0|||
163164256|NCT02541604|589314310|FG001|Overall Study|Medical condition may jeopardize safety|0|||
163164257|NCT02541604|589314311|FG002|Overall Study|Medical condition may jeopardize safety|0|||
163164258|NCT02541604|589314312|FG003|Overall Study|Medical condition may jeopardize safety|0|||
163164259|NCT02541604|589314313|FG004|Overall Study|Medical condition may jeopardize safety|0|||
163164260|NCT02541604|589314314|FG005|Overall Study|Medical condition may jeopardize safety|0|||
163164261|NCT02541604|589314315|FG006|Overall Study|Medical condition may jeopardize safety|0|||
163164262|NCT02541604|589314316|FG007|Overall Study|Medical condition may jeopardize safety|1|||
163164263|NCT02541604|589314317|FG008|Overall Study|Medical condition may jeopardize safety|0|||
163164264|NCT02541604|589314318|FG009|Overall Study|Medical condition may jeopardize safety|0|||
163164265|NCT02541604|589314319|FG010|Overall Study|Medical condition may jeopardize safety|0|||
163164266|NCT02541604|589314320|FG011|Overall Study|Medical condition may jeopardize safety|0|||
163164267|NCT00993148|589314321|FG000|Overall Study|Lost to Follow-up|2|||
163164268|NCT00993148|589314321|FG000|Overall Study|never initiated treatment|1|||
163164269|NCT00806819|589314322|FG000|Overall Study|progressive disease (modified RECIST )|217|||
163164270|NCT00806819|589314323|FG001|Overall Study|progressive disease (modified RECIST )|216|||
163164271|NCT00806819|589314322|FG000|Overall Study|Worsening or AE of underlying disease|18|||
163164272|NCT00806819|589314323|FG001|Overall Study|Worsening or AE of underlying disease|25|||
163164273|NCT00806819|589314322|FG000|Overall Study|Other AE|38|||
163164274|NCT00806819|589314323|FG001|Overall Study|Other AE|40|||
163164275|NCT00806819|589314322|FG000|Overall Study|Protocol Violation|9|||
163164276|NCT00806819|589314323|FG001|Overall Study|Protocol Violation|4|||
163164277|NCT00806819|589314322|FG000|Overall Study|Lost to Follow-up|1|||
163164278|NCT00806819|589314323|FG001|Overall Study|Lost to Follow-up|0|||
163164279|NCT00806819|589314322|FG000|Overall Study|Withdrawal by Subject|32|||
163164280|NCT00806819|589314323|FG001|Overall Study|Withdrawal by Subject|29|||
163164281|NCT00806819|589314322|FG000|Overall Study|Not treated|6|||
163164282|NCT00806819|589314323|FG001|Overall Study|Not treated|3|||
163164283|NCT00806819|589314322|FG000|Overall Study|Reasons other than stated above|25|||
163164284|NCT00806819|589314323|FG001|Overall Study|Reasons other than stated above|41|||
163164285|NCT01737502|589314327|FG000|Phase I|Disease progression|2|||
163164286|NCT01737502|589314328|FG001|Phase I|Disease progression|3|||
163164287|NCT01737502|589314327|FG000|Phase I|Complicating disease|1|||
163164288|NCT01737502|589314328|FG001|Phase I|Complicating disease|0|||
163164289|NCT01737502|589314327|FG000|Phase II|Adverse Event|0|||
163164290|NCT01737502|589314328|FG001|Phase II|Adverse Event|3|||
163164291|NCT01737502|589314327|FG000|Phase II|Disease progression|0|||
163164292|NCT01737502|589314328|FG001|Phase II|Disease progression|18|||
163164293|NCT01737502|589314327|FG000|Phase II|Death|0|||
163164294|NCT01737502|589314328|FG001|Phase II|Death|1|||
163164295|NCT01737502|589314327|FG000|Phase II|Transition to hospice care|0|||
163164296|NCT01737502|589314328|FG001|Phase II|Transition to hospice care|1|||
163164297|NCT00912197|589314334|FG000|Overall Study|Withdrawal by Subject|3|||
163164298|NCT00912197|589314335|FG001|Overall Study|Withdrawal by Subject|3|||
163164299|NCT03304249|589314338|FG000|Overall Study|Lost to Follow-up|8|||
163164300|NCT03304249|589314339|FG001|Overall Study|Lost to Follow-up|10|||
163164301|NCT03304249|589314338|FG000|Overall Study|Withdrawal by Subject|12|||
163164302|NCT03304249|589314339|FG001|Overall Study|Withdrawal by Subject|2|||
163164303|NCT03304249|589314338|FG000|Overall Study|Moved Out of District|4|||
163164304|NCT03304249|589314339|FG001|Overall Study|Moved Out of District|2|||
163164305|NCT01395524|589315971|FG000|Overall Study|Non-compliance with study schedule|1|||
163164306|NCT01395524|589315972|FG001|Overall Study|Non-compliance with study schedule|0|||
163164307|NCT01395524|589315973|FG002|Overall Study|Non-compliance with study schedule|1|||
163164308|NCT01395524|589315971|FG000|Overall Study|Lost to Follow-up|3|||
163164309|NCT01395524|589315972|FG001|Overall Study|Lost to Follow-up|1|||
163164310|NCT01395524|589315973|FG002|Overall Study|Lost to Follow-up|1|||
163164311|NCT01395524|589315971|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
163164312|NCT01395524|589315972|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
163164313|NCT01395524|589315973|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
163164314|NCT01395524|589315971|FG000|Overall Study|Severe noncompliance with protocol|1|||
163164315|NCT01395524|589315972|FG001|Overall Study|Severe noncompliance with protocol|0|||
163164316|NCT01395524|589315973|FG002|Overall Study|Severe noncompliance with protocol|0|||
163164317|NCT01395524|589315971|FG000|Overall Study|Adverse Event|4|||
163164318|NCT01395524|589315972|FG001|Overall Study|Adverse Event|4|||
163164319|NCT01395524|589315973|FG002|Overall Study|Adverse Event|3|||
163164320|NCT01395524|589315971|FG000|Overall Study|Death|1|||
163164321|NCT01395524|589315972|FG001|Overall Study|Death|0|||
163164322|NCT01395524|589315973|FG002|Overall Study|Death|0|||
163164323|NCT01395524|589315971|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163164324|NCT01395524|589315972|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163164325|NCT01395524|589315973|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163164326|NCT01395524|589315971|FG000|Overall Study|Withdrawal by Subject|4|||
163164327|NCT01395524|589315972|FG001|Overall Study|Withdrawal by Subject|8|||
163164328|NCT01395524|589315973|FG002|Overall Study|Withdrawal by Subject|8|||
163164329|NCT01395524|589315971|FG000|Overall Study|Did not receive treatment|1|||
163164330|NCT01395524|589315972|FG001|Overall Study|Did not receive treatment|1|||
163164331|NCT01395524|589315973|FG002|Overall Study|Did not receive treatment|3|||
163164332|NCT01395524|589315971|FG000|Overall Study|Subject had spinal surgery|0|||
163164333|NCT01395524|589315972|FG001|Overall Study|Subject had spinal surgery|0|||
163164334|NCT01395524|589315973|FG002|Overall Study|Subject had spinal surgery|1|||
163164335|NCT02175199|589315984|FG000|Overall Study|Withdrawal by Subject|1|||
163164336|NCT02175199|589315985|FG001|Overall Study|Withdrawal by Subject|5|||
163164337|NCT02175199|589315984|FG000|Overall Study|Randomized in Error|1|||
163164338|NCT02175199|589315985|FG001|Overall Study|Randomized in Error|0|||
163164339|NCT02175199|589315984|FG000|Overall Study|Sponsor Decision|1|||
163164340|NCT02175199|589315985|FG001|Overall Study|Sponsor Decision|0|||
163164341|NCT00122980|589315986|FG000|Overall Study|Death|0|||
163164342|NCT00122980|589315987|FG001|Overall Study|Death|1|||
163164343|NCT00122980|589315986|FG000|Overall Study|Physician Decision|2|||
163164344|NCT00122980|589315987|FG001|Overall Study|Physician Decision|0|||
163164345|NCT00122980|589315986|FG000|Overall Study|Protocol Violation|5|||
163164346|NCT00122980|589315987|FG001|Overall Study|Protocol Violation|1|||
163164347|NCT00122980|589315986|FG000|Overall Study|Withdrawal by Subject|2|||
163164348|NCT00122980|589315987|FG001|Overall Study|Withdrawal by Subject|3|||
163164349|NCT00122980|589315986|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
163164350|NCT00122980|589315987|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
163164351|NCT00122980|589315986|FG000|Overall Study|Study termination|27|||
163164352|NCT00122980|589315987|FG001|Overall Study|Study termination|35|||
163164353|NCT01124864|589315990|FG000|Overall Study|Follow up phase competed as per protocol|18|||
163164354|NCT01124864|589315991|FG001|Overall Study|Follow up phase competed as per protocol|22|||
163164355|NCT01124864|589315992|FG002|Overall Study|Follow up phase competed as per protocol|24|||
163164356|NCT01124864|589315993|FG003|Overall Study|Follow up phase competed as per protocol|18|||
163164357|NCT01124864|589315994|FG004|Overall Study|Follow up phase competed as per protocol|26|||
163164358|NCT01124864|589315995|FG005|Overall Study|Follow up phase competed as per protocol|2|||
163042818|NCT01990768|588863968|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
163164359|NCT01124864|589315990|FG000|Overall Study|Death|6|||
163164360|NCT01124864|589315991|FG001|Overall Study|Death|9|||
163164361|NCT01124864|589315992|FG002|Overall Study|Death|6|||
163164362|NCT01124864|589315993|FG003|Overall Study|Death|2|||
163164363|NCT01124864|589315994|FG004|Overall Study|Death|1|||
163164364|NCT01124864|589315995|FG005|Overall Study|Death|0|||
163164365|NCT01124864|589315990|FG000|Overall Study|Withdrawal by Subject|2|||
163164366|NCT01124864|589315991|FG001|Overall Study|Withdrawal by Subject|3|||
163164367|NCT01124864|589315992|FG002|Overall Study|Withdrawal by Subject|4|||
163164368|NCT01124864|589315993|FG003|Overall Study|Withdrawal by Subject|0|||
163164369|NCT01124864|589315994|FG004|Overall Study|Withdrawal by Subject|2|||
163164370|NCT01124864|589315995|FG005|Overall Study|Withdrawal by Subject|1|||
163164371|NCT01124864|589315990|FG000|Overall Study|Lost to Follow-up|1|||
163164372|NCT01124864|589315991|FG001|Overall Study|Lost to Follow-up|1|||
163164373|NCT01124864|589315992|FG002|Overall Study|Lost to Follow-up|0|||
163164374|NCT01124864|589315993|FG003|Overall Study|Lost to Follow-up|1|||
163164375|NCT01124864|589315994|FG004|Overall Study|Lost to Follow-up|0|||
163164376|NCT01124864|589315995|FG005|Overall Study|Lost to Follow-up|0|||
163164377|NCT01124864|589315990|FG000|Overall Study|Protocol Violation|1|||
163164378|NCT01124864|589315991|FG001|Overall Study|Protocol Violation|0|||
163164379|NCT01124864|589315992|FG002|Overall Study|Protocol Violation|0|||
163164380|NCT01124864|589315993|FG003|Overall Study|Protocol Violation|0|||
163164381|NCT01124864|589315994|FG004|Overall Study|Protocol Violation|1|||
163164382|NCT01124864|589315995|FG005|Overall Study|Protocol Violation|0|||
163164383|NCT00798759|589315998|FG000|Overall Study|Adverse Event|3|||
163164384|NCT00798759|589315999|FG001|Overall Study|Adverse Event|3|||
163164385|NCT00798759|589315998|FG000|Overall Study|Lost to Follow-up|1|||
163164386|NCT00798759|589315999|FG001|Overall Study|Lost to Follow-up|1|||
163164387|NCT00798759|589315998|FG000|Overall Study|Protocol Violation|4|||
163164388|NCT00798759|589315999|FG001|Overall Study|Protocol Violation|8|||
163164389|NCT00798759|589315998|FG000|Overall Study|Other|0|||
163164390|NCT00798759|589315999|FG001|Overall Study|Other|1|||
163164391|NCT00724711|589316000|FG000|Overall Study|Adverse Event|7|||
163164392|NCT00724711|589316001|FG001|Overall Study|Adverse Event|3|||
163164393|NCT00724711|589316000|FG000|Overall Study|Pregnancy|0|||
163164394|NCT00724711|589316001|FG001|Overall Study|Pregnancy|1|||
163164395|NCT00724711|589316000|FG000|Overall Study|Lack of Efficacy|0|||
163164396|NCT00724711|589316001|FG001|Overall Study|Lack of Efficacy|1|||
163164397|NCT00724711|589316000|FG000|Overall Study|Physician Decision|0|||
163164398|NCT00724711|589316001|FG001|Overall Study|Physician Decision|3|||
163164399|NCT00724711|589316000|FG000|Overall Study|Withdrawal by Subject|5|||
163164400|NCT00724711|589316001|FG001|Overall Study|Withdrawal by Subject|4|||
163164401|NCT00724711|589316000|FG000|Overall Study|Lost to Follow-up|4|||
163164402|NCT00724711|589316001|FG001|Overall Study|Lost to Follow-up|5|||
163164403|NCT00724711|589316000|FG000|Overall Study|Protocol Violation|1|||
163164404|NCT00724711|589316001|FG001|Overall Study|Protocol Violation|0|||
163164405|NCT03387111|589316002|FG000|Overall Study|Progressive Disease|3|||
163164406|NCT03387111|589316002|FG000|Overall Study|Other|1|||
163164407|NCT00727441|589316006|FG000|Overall Study|Disease Progression|11|||
163164408|NCT00727441|589316007|FG001|Overall Study|Disease Progression|14|||
163164409|NCT00727441|589316008|FG002|Overall Study|Disease Progression|17|||
163164410|NCT00727441|589316006|FG000|Overall Study|Eligibility|7|||
163164411|NCT00727441|589316007|FG001|Overall Study|Eligibility|5|||
163164412|NCT00727441|589316008|FG002|Overall Study|Eligibility|7|||
163164413|NCT00727441|589316006|FG000|Overall Study|Death|0|||
163164414|NCT00727441|589316007|FG001|Overall Study|Death|1|||
163164415|NCT00727441|589316008|FG002|Overall Study|Death|1|||
163164416|NCT00727441|589316006|FG000|Overall Study|Physician Decision|0|||
163164417|NCT00727441|589316007|FG001|Overall Study|Physician Decision|1|||
163164418|NCT00727441|589316008|FG002|Overall Study|Physician Decision|0|||
163164419|NCT00727441|589316006|FG000|Overall Study|Withdrawal by Subject|0|||
163164420|NCT00727441|589316007|FG001|Overall Study|Withdrawal by Subject|1|||
163164421|NCT00727441|589316008|FG002|Overall Study|Withdrawal by Subject|0|||
163164422|NCT01239992|589316009|FG000|Overall Study|Withdrawal by Subject|2|||
163164423|NCT00535288|589316010|FG000|Overall Study|Adverse Event|20|||
163164424|NCT00535288|589316011|FG001|Overall Study|Adverse Event|19|||
163164425|NCT00535288|589316012|FG002|Overall Study|Adverse Event|25|||
162814106|NCT02065336|588032190|FG007|Extension Phase|Study Terminated by Sponsor|0|||
162814107|NCT02065336|588032191|FG008|Extension Phase|Study Terminated by Sponsor|2|||
163164426|NCT00535288|589316013|FG003|Overall Study|Adverse Event|20|||
163164427|NCT00535288|589316014|FG004|Overall Study|Adverse Event|30|||
163164428|NCT00535288|589316010|FG000|Overall Study|Lost to Follow-up|0|||
163164429|NCT00535288|589316011|FG001|Overall Study|Lost to Follow-up|3|||
163164430|NCT00535288|589316012|FG002|Overall Study|Lost to Follow-up|0|||
163164431|NCT00535288|589316013|FG003|Overall Study|Lost to Follow-up|0|||
163164432|NCT00535288|589316014|FG004|Overall Study|Lost to Follow-up|0|||
163164433|NCT00535288|589316010|FG000|Overall Study|Lack of Efficacy|26|||
163164434|NCT00535288|589316011|FG001|Overall Study|Lack of Efficacy|3|||
163164435|NCT00535288|589316012|FG002|Overall Study|Lack of Efficacy|4|||
163164436|NCT00535288|589316013|FG003|Overall Study|Lack of Efficacy|4|||
163164437|NCT00535288|589316014|FG004|Overall Study|Lack of Efficacy|7|||
163164438|NCT00535288|589316010|FG000|Overall Study|Unwilling to cooperate|6|||
163164439|NCT00535288|589316011|FG001|Overall Study|Unwilling to cooperate|6|||
163164440|NCT00535288|589316012|FG002|Overall Study|Unwilling to cooperate|3|||
163164441|NCT00535288|589316013|FG003|Overall Study|Unwilling to cooperate|3|||
163164442|NCT00535288|589316014|FG004|Overall Study|Unwilling to cooperate|4|||
163164443|NCT00535288|589316010|FG000|Overall Study|Other|2|||
163164444|NCT00535288|589316011|FG001|Overall Study|Other|1|||
163164445|NCT00535288|589316012|FG002|Overall Study|Other|1|||
163164446|NCT00535288|589316013|FG003|Overall Study|Other|2|||
163164447|NCT00535288|589316014|FG004|Overall Study|Other|1|||
163164448|NCT02810444|589316015|FG000|Overall Study|Screen Failures|14|||
163164449|NCT02810444|589316015|FG000|Overall Study|Withdrawal by Subject|4|||
163164450|NCT02810444|589316015|FG000|Overall Study|Adverse Event|3|||
163164451|NCT04643158|589316016|FG000|Overall Study|Study terminated by sponsor|0|||
163164452|NCT04643158|589316017|FG001|Overall Study|Study terminated by sponsor|0|||
163164453|NCT04643158|589316018|FG002|Overall Study|Study terminated by sponsor|1|||
163164454|NCT04643158|589316019|FG003|Overall Study|Study terminated by sponsor|0|||
163164455|NCT04643158|589316020|FG004|Overall Study|Study terminated by sponsor|0|||
163164456|NCT04643158|589316021|FG005|Overall Study|Study terminated by sponsor|1|||
163164457|NCT04643158|589316022|FG006|Overall Study|Study terminated by sponsor|0|||
163164458|NCT04643158|589316016|FG000|Overall Study|Global/country situation|0|||
163164459|NCT04643158|589316017|FG001|Overall Study|Global/country situation|0|||
163164460|NCT04643158|589316018|FG002|Overall Study|Global/country situation|1|||
163164461|NCT04643158|589316019|FG003|Overall Study|Global/country situation|0|||
163164462|NCT04643158|589316020|FG004|Overall Study|Global/country situation|0|||
163164463|NCT04643158|589316021|FG005|Overall Study|Global/country situation|0|||
163164464|NCT04643158|589316022|FG006|Overall Study|Global/country situation|0|||
163164465|NCT04643158|589316016|FG000|Overall Study|Withdrawal by Subject|0|||
163164466|NCT04643158|589316017|FG001|Overall Study|Withdrawal by Subject|0|||
163164467|NCT04643158|589316018|FG002|Overall Study|Withdrawal by Subject|0|||
163164468|NCT04643158|589316019|FG003|Overall Study|Withdrawal by Subject|0|||
162814108|NCT02065336|588032192|FG009|Extension Phase|Study Terminated by Sponsor|8|||
162814109|NCT03226392|588032193|FG000|Overall Study|Protocol Deviation|1|||
162814110|NCT03226392|588032194|FG001|Overall Study|Protocol Deviation|0|||
162814111|NCT03226392|588032193|FG000|Overall Study|Physician Decision|1|||
162814112|NCT03226392|588032194|FG001|Overall Study|Physician Decision|0|||
163164469|NCT04643158|589316020|FG004|Overall Study|Withdrawal by Subject|0|||
163164470|NCT04643158|589316021|FG005|Overall Study|Withdrawal by Subject|1|||
163164471|NCT04643158|589316022|FG006|Overall Study|Withdrawal by Subject|0|||
163164472|NCT04329806|589316023|FG000|Overall Study|Physician Decision|3|||
163164473|NCT04329806|589316024|FG001|Overall Study|Physician Decision|4|||
163164474|NCT00622440|589316037|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
163164475|NCT00622440|589316038|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
163164476|NCT00622440|589316037|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
163164477|NCT00622440|589316038|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
163164478|NCT00622440|589316037|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
163164479|NCT00622440|589316038|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
163164480|NCT00622440|589316037|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
163164481|NCT00622440|589316038|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
163164482|NCT02147561|589316044|FG000|Overall Study|Lost to Follow-up|3|||
163164483|NCT02147561|589316044|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
163164484|NCT03023813|589316047|FG000|Overall Study|Lost to Follow-up|1|||
163164485|NCT03023813|589316048|FG001|Overall Study|Lost to Follow-up|2|||
163164486|NCT03023813|589316049|FG002|Overall Study|Lost to Follow-up|0|||
163164487|NCT03710083|589316050|FG000|Overall Study|Withdrawal by Subject|2|||
163164488|NCT03710083|589316050|FG000|Overall Study|Unsuccessful Procedure|1|||
163164489|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
163164490|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
163164491|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
163164492|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
163164493|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
163164494|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
163164495|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
163164496|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
163164497|NCT02283762|589316054|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
162698024|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163164498|NCT02283762|589316055|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
163164499|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
163164500|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
163164501|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
163164502|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
163164503|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
163164504|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
163164505|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
163164506|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
163164507|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
162814113|NCT03226392|588032193|FG000|Overall Study|Lost to Follow-up|1|||
163164508|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
163164509|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
163164510|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
163164511|NCT02283762|589316054|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
163164512|NCT02283762|589316055|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
163164513|NCT00202878|589316056|FG000|Overall Study|Death|964|||
163164514|NCT00202878|589316057|FG001|Overall Study|Death|968|||
163164515|NCT00202878|589316056|FG000|Overall Study|Only Vital Status Known|357|||
163164516|NCT00202878|589316057|FG001|Overall Study|Only Vital Status Known|356|||
163164517|NCT00202878|589316056|FG000|Overall Study|Lost to Follow-up|44|||
163164518|NCT00202878|589316057|FG001|Overall Study|Lost to Follow-up|49|||
163164519|NCT00202878|589316056|FG000|Overall Study|Site Closure|39|||
163164520|NCT00202878|589316057|FG001|Overall Study|Site Closure|36|||
163164521|NCT00202878|589316056|FG000|Overall Study|Withdrawal by Subject|795|||
163164522|NCT00202878|589316057|FG001|Overall Study|Withdrawal by Subject|808|||
163164523|NCT00975780|589316066|FG000|Follow Up|Death|88|||
163164524|NCT00975780|589316067|FG001|Follow Up|Death|122|||
163164525|NCT00975780|589316066|FG000|Follow Up|Facility Withdrawal|7|||
163164526|NCT00975780|589316067|FG001|Follow Up|Facility Withdrawal|23|||
163164527|NCT00975780|589316066|FG000|Follow Up|Discharged from Facility|7|||
163164528|NCT00975780|589316067|FG001|Follow Up|Discharged from Facility|12|||
163164529|NCT02813577|589316068|FG000|Overall Study|Study terminated|4|||
163164530|NCT01976741|589316069|FG000|Overall Study|Withdrawal by Subject|1|||
163164531|NCT01976741|589316070|FG001|Overall Study|Withdrawal by Subject|0|||
163164532|NCT01976741|589316071|FG002|Overall Study|Withdrawal by Subject|1|||
163164533|NCT01976741|589316072|FG003|Overall Study|Withdrawal by Subject|1|||
163164534|NCT01976741|589316073|FG004|Overall Study|Withdrawal by Subject|0|||
163164535|NCT01976741|589316074|FG005|Overall Study|Withdrawal by Subject|0|||
163164536|NCT01976741|589316075|FG006|Overall Study|Withdrawal by Subject|1|||
163164537|NCT01976741|589316076|FG007|Overall Study|Withdrawal by Subject|4|||
163164538|NCT01976741|589316077|FG008|Overall Study|Withdrawal by Subject|0|||
163164539|NCT01976741|589316078|FG009|Overall Study|Withdrawal by Subject|0|||
163164540|NCT01976741|589316069|FG000|Overall Study|Adverse Event|0|||
163164541|NCT01976741|589316070|FG001|Overall Study|Adverse Event|0|||
163164542|NCT01976741|589316071|FG002|Overall Study|Adverse Event|2|||
163164543|NCT01976741|589316072|FG003|Overall Study|Adverse Event|0|||
163164544|NCT01976741|589316073|FG004|Overall Study|Adverse Event|0|||
163164545|NCT01976741|589316074|FG005|Overall Study|Adverse Event|0|||
163164546|NCT01976741|589316075|FG006|Overall Study|Adverse Event|3|||
163164547|NCT01976741|589316076|FG007|Overall Study|Adverse Event|8|||
163164548|NCT01976741|589316077|FG008|Overall Study|Adverse Event|1|||
163164549|NCT01976741|589316078|FG009|Overall Study|Adverse Event|4|||
163164550|NCT00889720|589316079|FG000|Overall Study|Withdrawal by Subject|4|||
163164551|NCT00889720|589316079|FG000|Overall Study|Other|4|||
163164552|NCT03865381|589316089|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
163164553|NCT03865381|589316089|FG000|Overall Study|Withdrawal by Subject|2|||
163164554|NCT02873377|589316093|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
163164555|NCT02873377|589316094|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
163164556|NCT02873377|589316093|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
163164557|NCT02873377|589316094|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
163164558|NCT00452361|589316095|FG000|Overall Study|Adverse Event|8|||
163164559|NCT00452361|589316096|FG001|Overall Study|Adverse Event|0|||
163164560|NCT00452361|589316095|FG000|Overall Study|Withdrawal by Subject|0|||
163164561|NCT00452361|589316096|FG001|Overall Study|Withdrawal by Subject|1|||
163164562|NCT00452361|589316095|FG000|Overall Study|Premature termination|13|||
163164563|NCT00452361|589316096|FG001|Overall Study|Premature termination|9|||
163164564|NCT04421027|589316097|FG000|Treatment Period|Adverse Event|5|||
163164565|NCT04421027|589316098|FG001|Treatment Period|Adverse Event|3|||
163164566|NCT04421027|589316099|FG002|Treatment Period|Adverse Event|0|||
163164567|NCT04421027|589316100|FG003|Treatment Period|Adverse Event|0|||
163164568|NCT04421027|589316097|FG000|Treatment Period|Death|98|||
162698025|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163164569|NCT04421027|589316098|FG001|Treatment Period|Death|61|||
163164570|NCT04421027|589316099|FG002|Treatment Period|Death|0|||
163164571|NCT04421027|589316100|FG003|Treatment Period|Death|0|||
163164572|NCT04421027|589316097|FG000|Treatment Period|Lost to Follow-up|22|||
163164573|NCT04421027|589316098|FG001|Treatment Period|Lost to Follow-up|20|||
163164574|NCT04421027|589316099|FG002|Treatment Period|Lost to Follow-up|0|||
163164575|NCT04421027|589316100|FG003|Treatment Period|Lost to Follow-up|0|||
163164576|NCT04421027|589316097|FG000|Treatment Period|Other-Unknown|15|||
163164577|NCT04421027|589316098|FG001|Treatment Period|Other-Unknown|9|||
162698026|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
162698027|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
162698028|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
162698029|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
162698030|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162814114|NCT03226392|588032194|FG001|Overall Study|Lost to Follow-up|0|||
163164578|NCT04421027|589316099|FG002|Treatment Period|Other-Unknown|0|||
163164579|NCT04421027|589316100|FG003|Treatment Period|Other-Unknown|0|||
163164580|NCT04421027|589316097|FG000|Treatment Period|Physician Decision|1|||
163164581|NCT04421027|589316098|FG001|Treatment Period|Physician Decision|1|||
163164582|NCT04421027|589316099|FG002|Treatment Period|Physician Decision|0|||
163164583|NCT04421027|589316100|FG003|Treatment Period|Physician Decision|0|||
163164584|NCT04421027|589316097|FG000|Treatment Period|Withdrawal by Subject|7|||
163164585|NCT04421027|589316098|FG001|Treatment Period|Withdrawal by Subject|12|||
163164586|NCT04421027|589316099|FG002|Treatment Period|Withdrawal by Subject|0|||
163164587|NCT04421027|589316100|FG003|Treatment Period|Withdrawal by Subject|0|||
163164588|NCT04421027|589316097|FG000|Treatment Period|Randomized Not Dosed|9|||
163164589|NCT04421027|589316098|FG001|Treatment Period|Randomized Not Dosed|14|||
163164590|NCT04421027|589316099|FG002|Treatment Period|Randomized Not Dosed|0|||
163164591|NCT04421027|589316100|FG003|Treatment Period|Randomized Not Dosed|0|||
163164592|NCT04421027|589316097|FG000|Follow-Up Period|Adverse Event|0|||
163164593|NCT04421027|589316098|FG001|Follow-Up Period|Adverse Event|0|||
163164594|NCT04421027|589316099|FG002|Follow-Up Period|Adverse Event|0|||
163164595|NCT04421027|589316100|FG003|Follow-Up Period|Adverse Event|3|||
163164596|NCT04421027|589316097|FG000|Follow-Up Period|Death|0|||
163164597|NCT04421027|589316098|FG001|Follow-Up Period|Death|0|||
163164598|NCT04421027|589316099|FG002|Follow-Up Period|Death|16|||
163164599|NCT04421027|589316100|FG003|Follow-Up Period|Death|17|||
163164600|NCT04421027|589316097|FG000|Follow-Up Period|Lost to Follow-up|0|||
163164601|NCT04421027|589316098|FG001|Follow-Up Period|Lost to Follow-up|0|||
163164602|NCT04421027|589316099|FG002|Follow-Up Period|Lost to Follow-up|7|||
163164603|NCT04421027|589316100|FG003|Follow-Up Period|Lost to Follow-up|7|||
163164604|NCT04421027|589316097|FG000|Follow-Up Period|Protocol Deviation|0|||
163164605|NCT04421027|589316098|FG001|Follow-Up Period|Protocol Deviation|0|||
163164606|NCT04421027|589316099|FG002|Follow-Up Period|Protocol Deviation|1|||
163164607|NCT04421027|589316100|FG003|Follow-Up Period|Protocol Deviation|0|||
163164608|NCT04421027|589316097|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164609|NCT04421027|589316098|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164610|NCT04421027|589316099|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
163164611|NCT04421027|589316100|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163164612|NCT04421027|589316097|FG000|Follow-Up Period|Left message, participant did not call back|0|||
163164613|NCT04421027|589316098|FG001|Follow-Up Period|Left message, participant did not call back|0|||
163164614|NCT04421027|589316099|FG002|Follow-Up Period|Left message, participant did not call back|0|||
163164615|NCT04421027|589316100|FG003|Follow-Up Period|Left message, participant did not call back|1|||
163164616|NCT04421027|589316097|FG000|Follow-Up Period|Participant died|0|||
163164617|NCT04421027|589316098|FG001|Follow-Up Period|Participant died|0|||
163164618|NCT04421027|589316099|FG002|Follow-Up Period|Participant died|0|||
163164619|NCT04421027|589316100|FG003|Follow-Up Period|Participant died|1|||
163164620|NCT04421027|589316097|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164621|NCT04421027|589316098|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164622|NCT04421027|589316099|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163164623|NCT04421027|589316100|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
163164624|NCT00560352|589316105|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163164625|NCT00560352|589316106|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163164626|NCT00560352|589316107|FG002|Overall Study|Adverse event unrelated to study drug|1|||
163164627|NCT00560352|589316105|FG000|Overall Study|Study drug toxicity|3|||
163164628|NCT00560352|589316106|FG001|Overall Study|Study drug toxicity|0|||
163164629|NCT00560352|589316107|FG002|Overall Study|Study drug toxicity|1|||
163164630|NCT00560352|589316105|FG000|Overall Study|Disease progression|0|||
163164631|NCT00560352|589316106|FG001|Overall Study|Disease progression|1|||
163164632|NCT00560352|589316107|FG002|Overall Study|Disease progression|1|||
163164633|NCT00560352|589316105|FG000|Overall Study|Withdrawal by Subject|1|||
163164634|NCT00560352|589316106|FG001|Overall Study|Withdrawal by Subject|1|||
163164635|NCT00560352|589316107|FG002|Overall Study|Withdrawal by Subject|1|||
163164636|NCT00560352|589316105|FG000|Overall Study|Maximum clinical benefit|1|||
163164637|NCT00560352|589316106|FG001|Overall Study|Maximum clinical benefit|0|||
163164638|NCT00560352|589316107|FG002|Overall Study|Maximum clinical benefit|0|||
163164639|NCT03892967|589316111|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
163164640|NCT03892967|589316112|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
163164641|NCT03892967|589316113|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
163164642|NCT03892967|589316114|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
163164643|NCT03892967|589316115|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
163164644|NCT03892967|589316111|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
163164645|NCT03892967|589316112|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
163164646|NCT03892967|589316113|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
163164647|NCT03892967|589316114|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
163164648|NCT03892967|589316115|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
163164649|NCT03892967|589316111|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
163164650|NCT03892967|589316112|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
163164651|NCT03892967|589316113|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
163164652|NCT03892967|589316114|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
163164653|NCT03892967|589316115|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
163164654|NCT03892967|589316111|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
163164655|NCT03892967|589316112|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
163164656|NCT03892967|589316113|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
163164657|NCT03892967|589316114|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
163164658|NCT03892967|589316115|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
163164659|NCT03892967|589316111|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
163164660|NCT03892967|589316112|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
163164661|NCT03892967|589316113|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
163164662|NCT03892967|589316114|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
163164663|NCT03892967|589316115|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
163164664|NCT03892967|589316111|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
163164665|NCT03892967|589316112|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
163164666|NCT03892967|589316113|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
163164667|NCT03892967|589316114|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
163164668|NCT03892967|589316115|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
163164669|NCT05767749|589316119|FG000|Overall Study|Withdrawal by Subject|0|||
163164670|NCT05767749|589316120|FG001|Overall Study|Withdrawal by Subject|0|||
163164671|NCT05767749|589316121|FG002|Overall Study|Withdrawal by Subject|2|||
163164672|NCT05767749|589316122|FG003|Overall Study|Withdrawal by Subject|2|||
163164673|NCT05767749|589316123|FG004|Overall Study|Withdrawal by Subject|2|||
163164674|NCT05767749|589316124|FG005|Overall Study|Withdrawal by Subject|2|||
163164675|NCT03568461|589316125|FG000|Overall Study|Death|7|||
163164676|NCT03568461|589316125|FG000|Overall Study|Physician Decision|5|||
163164677|NCT03568461|589316125|FG000|Overall Study|Subject decision|5|||
163164678|NCT03568461|589316125|FG000|Overall Study|Lost to Follow-up|1|||
163164679|NCT03387085|589316129|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
163164680|NCT02848729|589318208|FG000|Overall Study|Withdrawal by Subject|1|||
163164681|NCT02848729|589318209|FG001|Overall Study|Withdrawal by Subject|0|||
163164682|NCT02848729|589318208|FG000|Overall Study|Emesis|15|||
163164683|NCT02848729|589318209|FG001|Overall Study|Emesis|11|||
163164684|NCT03390101|589318210|FG000|Weeks 0-12|Withdrawal by Subject|0|||
163164685|NCT03390101|589318211|FG001|Weeks 0-12|Withdrawal by Subject|1|||
163164686|NCT03390101|589318212|FG002|Weeks 0-12|Withdrawal by Subject|1|||
163164687|NCT03390101|589318210|FG000|Weeks 0-12|Lost to Follow-up|0|||
163164688|NCT03390101|589318211|FG001|Weeks 0-12|Lost to Follow-up|1|||
163164689|NCT03390101|589318212|FG002|Weeks 0-12|Lost to Follow-up|0|||
163164690|NCT03390101|589318210|FG000|Weeks 12-54|Withdrawal by Subject|0|||
163164691|NCT03390101|589318211|FG001|Weeks 12-54|Withdrawal by Subject|3|||
163164692|NCT03390101|589318212|FG002|Weeks 12-54|Withdrawal by Subject|1|||
163164693|NCT03390101|589318210|FG000|Weeks 12-54|Pregnancy|1|||
163164694|NCT03390101|589318211|FG001|Weeks 12-54|Pregnancy|0|||
163164695|NCT03390101|589318212|FG002|Weeks 12-54|Pregnancy|0|||
163164696|NCT03390101|589318210|FG000|Weeks 12-54|Adverse Event|2|||
163164697|NCT03390101|589318211|FG001|Weeks 12-54|Adverse Event|1|||
163164698|NCT03390101|589318212|FG002|Weeks 12-54|Adverse Event|1|||
163164699|NCT04838977|589318213|FG000|Overall Study|Lost to Follow-up|2|||
163164700|NCT04838977|589318214|FG001|Overall Study|Lost to Follow-up|3|||
163164701|NCT04838977|589318213|FG000|Overall Study|Withdrawal by Subject|1|||
163164702|NCT04838977|589318214|FG001|Overall Study|Withdrawal by Subject|1|||
163164703|NCT00950859|589318218|FG000|Overall Study|Adverse Event|3|||
163164704|NCT00950859|589318219|FG001|Overall Study|Adverse Event|3|||
163164705|NCT00950859|589318218|FG000|Overall Study|Insufficient Viral Load Response|12|||
163164706|NCT00950859|589318219|FG001|Overall Study|Insufficient Viral Load Response|3|||
163164707|NCT00950859|589318218|FG000|Overall Study|Protocol Violation|1|||
163164708|NCT00950859|589318219|FG001|Overall Study|Protocol Violation|1|||
163164709|NCT00950859|589318218|FG000|Overall Study|Lost to Follow-up|0|||
163164710|NCT00950859|589318219|FG001|Overall Study|Lost to Follow-up|3|||
163164711|NCT03583385|589318220|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163164712|NCT03583385|589318221|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163164713|NCT03583385|589318220|FG000|Treatment Period 2|Adverse Event|1|||
163164714|NCT03583385|589318221|FG001|Treatment Period 2|Adverse Event|0|||
163164715|NCT00545272|589318223|FG000|Overall Study|Protocol deviation|0|||
163164716|NCT00545272|589318224|FG001|Overall Study|Protocol deviation|1|||
163164717|NCT00545272|589318225|FG002|Overall Study|Protocol deviation|0|||
163164718|NCT00545272|589318226|FG003|Overall Study|Protocol deviation|1|||
163164719|NCT00545272|589318227|FG004|Overall Study|Protocol deviation|0|||
163164720|NCT00545272|589318228|FG005|Overall Study|Protocol deviation|1|||
163164721|NCT00545272|589318223|FG000|Overall Study|Adverse Event|0|||
163164722|NCT00545272|589318224|FG001|Overall Study|Adverse Event|0|||
163164723|NCT00545272|589318225|FG002|Overall Study|Adverse Event|1|||
163164724|NCT00545272|589318226|FG003|Overall Study|Adverse Event|0|||
163164725|NCT00545272|589318227|FG004|Overall Study|Adverse Event|0|||
163164726|NCT00545272|589318228|FG005|Overall Study|Adverse Event|1|||
163164727|NCT00545272|589318223|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163164728|NCT00545272|589318224|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163164729|NCT00545272|589318225|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163164730|NCT00545272|589318226|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163164731|NCT00545272|589318227|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163164732|NCT00545272|589318228|FG005|Overall Study|Abnormal laboratory value(s)|1|||
163164733|NCT00545272|589318223|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163164734|NCT00545272|589318224|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163164735|NCT00545272|589318225|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163164736|NCT00545272|589318226|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163164737|NCT00545272|589318227|FG004|Overall Study|Abnormal test procedure result(s)|1|||
163164738|NCT00545272|589318228|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163164739|NCT00545272|589318223|FG000|Overall Study|Lost to Follow-up|0|||
163164740|NCT00545272|589318224|FG001|Overall Study|Lost to Follow-up|0|||
163164741|NCT00545272|589318225|FG002|Overall Study|Lost to Follow-up|0|||
163164742|NCT00545272|589318226|FG003|Overall Study|Lost to Follow-up|0|||
163164743|NCT00545272|589318227|FG004|Overall Study|Lost to Follow-up|1|||
163164744|NCT00545272|589318228|FG005|Overall Study|Lost to Follow-up|0|||
163164745|NCT02934503|589318229|FG000|Overall Study|progression of disease|3|||
163164746|NCT02934503|589318229|FG000|Overall Study|Withdrawal by Subject|1|||
163164747|NCT00724867|589318230|FG000|Overall Study|Adverse Event|25|||
163164748|NCT00724867|589318230|FG000|Overall Study|Lack of Efficacy|14|||
163164749|NCT00724867|589318230|FG000|Overall Study|Lost to Follow-up|12|||
163164750|NCT00724867|589318230|FG000|Overall Study|Non-compliance with study drug|6|||
163164751|NCT00724867|589318230|FG000|Overall Study|Physician Decision|17|||
163164752|NCT00724867|589318230|FG000|Overall Study|Protocol Violation|1|||
163164753|NCT00724867|589318230|FG000|Overall Study|Withdrawal by Subject|31|||
163164754|NCT00724867|589318230|FG000|Overall Study|Sponsor decision to end study|14|||
163164755|NCT00724867|589318230|FG000|Overall Study|Subject incarcerated|1|||
163164756|NCT00724867|589318230|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
163164757|NCT00724867|589318230|FG000|Overall Study|Subject moved out of state|1|||
163164758|NCT00724867|589318230|FG000|Overall Study|Elected to exit due to site closure|2|||
163164759|NCT00436345|589318231|FG000|Overall Study|ICU resident beyond follow-up period|3|||
163164760|NCT00436345|589318232|FG001|Overall Study|ICU resident beyond follow-up period|0|||
162698031|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698032|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698033|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698034|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698035|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698036|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698037|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698038|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698039|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698040|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698041|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698042|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698043|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698044|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698045|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162698046|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
162698047|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
163164761|NCT04027608|589318233|FG000|Overall Study|Withdrawal by Subject|13|||
163164762|NCT04027608|589318234|FG001|Overall Study|Withdrawal by Subject|2|||
163164763|NCT04027608|589318233|FG000|Overall Study|Protocol Violation|2|||
163164764|NCT04027608|589318234|FG001|Overall Study|Protocol Violation|1|||
163164765|NCT04027608|589318233|FG000|Overall Study|Physician Decision|1|||
163164766|NCT04027608|589318234|FG001|Overall Study|Physician Decision|0|||
163164767|NCT04027608|589318233|FG000|Overall Study|Lost to Follow-up|20|||
163164768|NCT04027608|589318234|FG001|Overall Study|Lost to Follow-up|4|||
163164769|NCT04248491|589318238|FG000|Overall Study|Lost to Follow-up|1|||
163164770|NCT04248491|589318239|FG001|Overall Study|Lost to Follow-up|0|||
163164771|NCT02474069|589318249|FG000|Selection Phase (SP)|Adverse Event|8|||
163164772|NCT02474069|589318250|FG001|Selection Phase (SP)|Adverse Event|0|||
163164773|NCT02474069|589318251|FG002|Selection Phase (SP)|Adverse Event|0|||
163164774|NCT02474069|589318249|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
163164775|NCT02474069|589318250|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
163164776|NCT02474069|589318251|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
163164777|NCT02474069|589318249|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
163164778|NCT02474069|589318250|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
163164779|NCT02474069|589318251|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
163164780|NCT02474069|589318249|FG000|Selection Phase (SP)|Physician Decision|1|||
163164781|NCT02474069|589318250|FG001|Selection Phase (SP)|Physician Decision|0|||
163164782|NCT02474069|589318251|FG002|Selection Phase (SP)|Physician Decision|0|||
163164783|NCT02474069|589318249|FG000|Selection Phase (SP)|Protocol Violation|1|||
163164784|NCT02474069|589318250|FG001|Selection Phase (SP)|Protocol Violation|0|||
163164785|NCT02474069|589318251|FG002|Selection Phase (SP)|Protocol Violation|0|||
163164786|NCT02474069|589318249|FG000|Selection Phase (SP)|No longer requires treatment|1|||
163164787|NCT02474069|589318250|FG001|Selection Phase (SP)|No longer requires treatment|0|||
163164788|NCT02474069|589318251|FG002|Selection Phase (SP)|No longer requires treatment|0|||
163164789|NCT02474069|589318249|FG000|Selection Phase (SP)|Technical Problem|1|||
163164790|NCT02474069|589318250|FG001|Selection Phase (SP)|Technical Problem|0|||
163164791|NCT02474069|589318251|FG002|Selection Phase (SP)|Technical Problem|0|||
163164792|NCT02474069|589318249|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
163164793|NCT02474069|589318250|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
163164794|NCT02474069|589318251|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
163164795|NCT02474069|589318249|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
163164796|NCT02474069|589318250|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
163164797|NCT02474069|589318251|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
163164798|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
163164799|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
163164800|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
163164801|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
163164802|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
163164803|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
163164804|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
163164805|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
163164806|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
163164807|NCT02474069|589318249|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
163164808|NCT02474069|589318250|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
163164809|NCT02474069|589318251|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
163164810|NCT02123472|589318252|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
163164811|NCT02123472|589318253|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
163164812|NCT00918736|589318254|FG000|Overall Study|Withdrawal by Subject|4|||
163164813|NCT01474018|589318255|FG000|Overall Study|Lost to Follow-up|0|||
163164814|NCT01474018|589318256|FG001|Overall Study|Lost to Follow-up|1|||
163164815|NCT01474018|589318255|FG000|Overall Study|Withdrawal by Subject|0|||
163164816|NCT01474018|589318256|FG001|Overall Study|Withdrawal by Subject|2|||
163164817|NCT03801031|589318257|FG000|Overall Study|Lost to Follow-up|1|||
163164818|NCT03801031|589318258|FG001|Overall Study|Lost to Follow-up|0|||
163164819|NCT03801031|589318257|FG000|Overall Study|Unable to comply|1|||
163164820|NCT03801031|589318258|FG001|Overall Study|Unable to comply|0|||
163164821|NCT03801031|589318257|FG000|Overall Study|Withdrawal by Subject|0|||
163164822|NCT03801031|589318258|FG001|Overall Study|Withdrawal by Subject|1|||
163164823|NCT01942733|589318259|FG000|Overall Study|Lost to Follow-up|1|||
163164824|NCT01942733|589318259|FG000|Overall Study|Non-compliance with IMP|1|||
163164825|NCT01942733|589318259|FG000|Overall Study|Administrative|1|||
163164826|NCT00838513|589318260|FG000|Screening Period|Screen Failure|3|||
163164827|NCT00838513|589318260|FG000|Extension Treatment Period|Death|1|||
163164828|NCT00838513|589318260|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
163164829|NCT00126490|589318261|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
162698048|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
163164830|NCT02925416|589318263|FG000|Overall Study|Adverse Event|2|||
163164831|NCT02925416|589318264|FG001|Overall Study|Adverse Event|0|||
163164832|NCT01598506|589318265|FG000|Overall Study|Withdrawal by Subject|2|||
163164833|NCT03962504|589318266|FG000|Overall Study|Other|11|||
162698049|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
162814115|NCT03226392|588032193|FG000|Overall Study|Adverse Event|1|||
163164834|NCT03962504|589318267|FG001|Overall Study|Other|32|||
163164835|NCT00035932|589318268|FG000|Overall Study|Adverse Event|10|||
163164836|NCT00035932|589318269|FG001|Overall Study|Adverse Event|9|||
163164837|NCT00035932|589318270|FG002|Overall Study|Adverse Event|9|||
163164838|NCT00035932|589318268|FG000|Overall Study|Death|0|||
163164839|NCT00035932|589318269|FG001|Overall Study|Death|0|||
163164840|NCT00035932|589318270|FG002|Overall Study|Death|1|||
163164841|NCT00035932|589318268|FG000|Overall Study|Disease Progression / Relapse|1|||
163164842|NCT00035932|589318269|FG001|Overall Study|Disease Progression / Relapse|1|||
163164843|NCT00035932|589318270|FG002|Overall Study|Disease Progression / Relapse|0|||
163164844|NCT00035932|589318268|FG000|Overall Study|Lost to Follow-up|4|||
163164845|NCT00035932|589318269|FG001|Overall Study|Lost to Follow-up|4|||
163164846|NCT00035932|589318270|FG002|Overall Study|Lost to Follow-up|3|||
163164847|NCT00035932|589318268|FG000|Overall Study|Noncompliance|6|||
163164848|NCT00035932|589318269|FG001|Overall Study|Noncompliance|7|||
163164849|NCT00035932|589318270|FG002|Overall Study|Noncompliance|6|||
163164850|NCT00035932|589318268|FG000|Overall Study|Protocol Violation While on Study|0|||
163164851|NCT00035932|589318269|FG001|Overall Study|Protocol Violation While on Study|1|||
163164852|NCT00035932|589318270|FG002|Overall Study|Protocol Violation While on Study|2|||
163164853|NCT00035932|589318268|FG000|Overall Study|Withdrawal by Subject|1|||
163164854|NCT00035932|589318269|FG001|Overall Study|Withdrawal by Subject|5|||
163164855|NCT00035932|589318270|FG002|Overall Study|Withdrawal by Subject|0|||
163164856|NCT00035932|589318268|FG000|Overall Study|Study Termination by Sponsor|1|||
163164857|NCT00035932|589318269|FG001|Overall Study|Study Termination by Sponsor|0|||
163164858|NCT00035932|589318270|FG002|Overall Study|Study Termination by Sponsor|0|||
163164859|NCT00035932|589318268|FG000|Overall Study|Lack of Efficacy|33|||
163164860|NCT00035932|589318269|FG001|Overall Study|Lack of Efficacy|33|||
163164861|NCT00035932|589318270|FG002|Overall Study|Lack of Efficacy|28|||
163164862|NCT04080167|589318273|FG000|Overall Study|Lost to Follow-up-Patients|7|||
163164863|NCT04080167|589318274|FG001|Overall Study|Lost to Follow-up-Patients|14|||
163164864|NCT04080167|589318275|FG002|Overall Study|Lost to Follow-up-Patients|0|||
163164865|NCT04080167|589318273|FG000|Overall Study|Lost to Follow-up-Providers|2|||
163164866|NCT04080167|589318274|FG001|Overall Study|Lost to Follow-up-Providers|2|||
163164867|NCT04080167|589318275|FG002|Overall Study|Lost to Follow-up-Providers|0|||
163164868|NCT04080167|589318273|FG000|Overall Study|Withdrawal by Subject|1|||
163164869|NCT04080167|589318274|FG001|Overall Study|Withdrawal by Subject|2|||
163164870|NCT04080167|589318275|FG002|Overall Study|Withdrawal by Subject|0|||
163164871|NCT04080167|589318273|FG000|Overall Study|Withdrawal by Provider|0|||
163164872|NCT04080167|589318274|FG001|Overall Study|Withdrawal by Provider|0|||
163164873|NCT04080167|589318275|FG002|Overall Study|Withdrawal by Provider|4|||
163164874|NCT04080167|589318273|FG000|Overall Study|Death-Patient|2|||
163164875|NCT04080167|589318274|FG001|Overall Study|Death-Patient|1|||
163164876|NCT04080167|589318275|FG002|Overall Study|Death-Patient|0|||
163164877|NCT04080167|589318273|FG000|Overall Study|Hydroxyurea New Starts|0|||
163164878|NCT04080167|589318274|FG001|Overall Study|Hydroxyurea New Starts|0|||
163164879|NCT04080167|589318275|FG002|Overall Study|Hydroxyurea New Starts|1|||
163164880|NCT04080167|589318273|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
163164881|NCT04080167|589318274|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
163164882|NCT04080167|589318275|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
163164883|NCT02100696|589318276|FG000|Induction Phase|Adverse Event|0|||
163164884|NCT02100696|589318277|FG001|Induction Phase|Adverse Event|0|||
163164885|NCT02100696|589318278|FG002|Induction Phase|Adverse Event|1|||
163164886|NCT02100696|589318279|FG003|Induction Phase|Adverse Event|0|||
163164887|NCT02100696|589318280|FG004|Induction Phase|Adverse Event|0|||
163164888|NCT02100696|589318281|FG005|Induction Phase|Adverse Event|0|||
163164889|NCT02100696|589318276|FG000|Induction Phase|Lost to Follow-up|1|||
163164890|NCT02100696|589318277|FG001|Induction Phase|Lost to Follow-up|0|||
163164891|NCT02100696|589318278|FG002|Induction Phase|Lost to Follow-up|1|||
162814116|NCT03226392|588032194|FG001|Overall Study|Adverse Event|0|||
162814117|NCT03226392|588032193|FG000|Overall Study|Technical Problems|0|||
162814118|NCT03226392|588032194|FG001|Overall Study|Technical Problems|2|||
162814119|NCT03226392|588032193|FG000|Overall Study|Subject/Guardian Decision|7|||
162814120|NCT03226392|588032194|FG001|Overall Study|Subject/Guardian Decision|6|||
162814121|NCT03056755|588032195|FG000|Core Phase|Progressive disease|89|||
162814122|NCT03056755|588032196|FG001|Core Phase|Progressive disease|88|||
162814123|NCT03056755|588032197|FG002|Core Phase|Progressive disease|90|||
162814124|NCT03056755|588032195|FG000|Core Phase|Adverse Event|20|||
162814125|NCT03056755|588032196|FG001|Core Phase|Adverse Event|14|||
163164892|NCT02100696|589318279|FG003|Induction Phase|Lost to Follow-up|0|||
163164893|NCT02100696|589318280|FG004|Induction Phase|Lost to Follow-up|0|||
163164894|NCT02100696|589318281|FG005|Induction Phase|Lost to Follow-up|0|||
163164895|NCT02100696|589318276|FG000|Induction Phase|Protocol Violation|0|||
163164896|NCT02100696|589318277|FG001|Induction Phase|Protocol Violation|1|||
163164897|NCT02100696|589318278|FG002|Induction Phase|Protocol Violation|1|||
163164898|NCT02100696|589318279|FG003|Induction Phase|Protocol Violation|0|||
162814126|NCT03056755|588032197|FG002|Core Phase|Adverse Event|13|||
162814127|NCT03056755|588032195|FG000|Core Phase|Physician Decision|7|||
163164899|NCT02100696|589318280|FG004|Induction Phase|Protocol Violation|0|||
163164900|NCT02100696|589318281|FG005|Induction Phase|Protocol Violation|0|||
163164901|NCT02100696|589318276|FG000|Induction Phase|Withdrawal by Subject|8|||
163164902|NCT02100696|589318277|FG001|Induction Phase|Withdrawal by Subject|2|||
163164903|NCT02100696|589318278|FG002|Induction Phase|Withdrawal by Subject|13|||
163164904|NCT02100696|589318279|FG003|Induction Phase|Withdrawal by Subject|0|||
163164905|NCT02100696|589318280|FG004|Induction Phase|Withdrawal by Subject|0|||
163164906|NCT02100696|589318281|FG005|Induction Phase|Withdrawal by Subject|0|||
163164907|NCT02100696|589318276|FG000|Induction Phase|Physician Decision|1|||
163164908|NCT02100696|589318277|FG001|Induction Phase|Physician Decision|0|||
163164909|NCT02100696|589318278|FG002|Induction Phase|Physician Decision|2|||
163164910|NCT02100696|589318279|FG003|Induction Phase|Physician Decision|0|||
163164911|NCT02100696|589318280|FG004|Induction Phase|Physician Decision|0|||
163164912|NCT02100696|589318281|FG005|Induction Phase|Physician Decision|0|||
163164913|NCT02100696|589318276|FG000|Induction Phase|Multiple Reasons|5|||
163164914|NCT02100696|589318277|FG001|Induction Phase|Multiple Reasons|2|||
163164915|NCT02100696|589318278|FG002|Induction Phase|Multiple Reasons|8|||
163164916|NCT02100696|589318279|FG003|Induction Phase|Multiple Reasons|0|||
163164917|NCT02100696|589318280|FG004|Induction Phase|Multiple Reasons|0|||
163164918|NCT02100696|589318281|FG005|Induction Phase|Multiple Reasons|0|||
163164919|NCT02100696|589318276|FG000|Maintenance Phase|Adverse Event|0|||
163164920|NCT02100696|589318277|FG001|Maintenance Phase|Adverse Event|0|||
163164921|NCT02100696|589318278|FG002|Maintenance Phase|Adverse Event|0|||
163164922|NCT02100696|589318279|FG003|Maintenance Phase|Adverse Event|0|||
163164923|NCT02100696|589318280|FG004|Maintenance Phase|Adverse Event|0|||
163164924|NCT02100696|589318281|FG005|Maintenance Phase|Adverse Event|2|||
163164925|NCT02100696|589318276|FG000|Maintenance Phase|Lost to Follow-up|0|||
163164926|NCT02100696|589318277|FG001|Maintenance Phase|Lost to Follow-up|0|||
163164927|NCT02100696|589318278|FG002|Maintenance Phase|Lost to Follow-up|0|||
163164928|NCT02100696|589318279|FG003|Maintenance Phase|Lost to Follow-up|0|||
163164929|NCT02100696|589318280|FG004|Maintenance Phase|Lost to Follow-up|1|||
163164930|NCT02100696|589318281|FG005|Maintenance Phase|Lost to Follow-up|0|||
163164931|NCT02100696|589318276|FG000|Maintenance Phase|Protocol Violation|0|||
163164932|NCT02100696|589318277|FG001|Maintenance Phase|Protocol Violation|0|||
163164933|NCT02100696|589318278|FG002|Maintenance Phase|Protocol Violation|0|||
163164934|NCT02100696|589318279|FG003|Maintenance Phase|Protocol Violation|0|||
163164935|NCT02100696|589318280|FG004|Maintenance Phase|Protocol Violation|1|||
163164936|NCT02100696|589318281|FG005|Maintenance Phase|Protocol Violation|0|||
163164937|NCT02100696|589318276|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163164938|NCT02100696|589318277|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163164939|NCT02100696|589318278|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163164940|NCT02100696|589318279|FG003|Maintenance Phase|Withdrawal by Subject|1|||
163164941|NCT02100696|589318280|FG004|Maintenance Phase|Withdrawal by Subject|4|||
163164942|NCT02100696|589318281|FG005|Maintenance Phase|Withdrawal by Subject|2|||
163164943|NCT02100696|589318276|FG000|Maintenance Phase|Physician Decision|0|||
163164944|NCT02100696|589318277|FG001|Maintenance Phase|Physician Decision|0|||
163164945|NCT02100696|589318278|FG002|Maintenance Phase|Physician Decision|0|||
163164946|NCT02100696|589318279|FG003|Maintenance Phase|Physician Decision|0|||
163164947|NCT02100696|589318280|FG004|Maintenance Phase|Physician Decision|1|||
163164948|NCT02100696|589318281|FG005|Maintenance Phase|Physician Decision|0|||
163164949|NCT02100696|589318276|FG000|Maintenance Phase|Multiple Reasons|0|||
163164950|NCT02100696|589318277|FG001|Maintenance Phase|Multiple Reasons|0|||
163164951|NCT02100696|589318278|FG002|Maintenance Phase|Multiple Reasons|0|||
163164952|NCT02100696|589318279|FG003|Maintenance Phase|Multiple Reasons|0|||
163164953|NCT02100696|589318280|FG004|Maintenance Phase|Multiple Reasons|2|||
163164954|NCT02100696|589318281|FG005|Maintenance Phase|Multiple Reasons|1|||
163164955|NCT03566485|589318285|FG000|Overall Study|Disease progression|5|||
163164956|NCT03566485|589318286|FG001|Overall Study|Disease progression|4|||
163164957|NCT03566485|589318285|FG000|Overall Study|Clinical progression|0|||
163164958|NCT03566485|589318286|FG001|Overall Study|Clinical progression|1|||
163164959|NCT03566485|589318285|FG000|Overall Study|Toxicity|0|||
163164960|NCT03566485|589318286|FG001|Overall Study|Toxicity|2|||
163164961|NCT01010867|589318297|FG000|Overall Study|< 50% adherence to probiotic|1|||
163164962|NCT01668589|589318298|FG000|Overall Study|Lost to Follow-up|29|||
163164963|NCT01668589|589318299|FG001|Overall Study|Lost to Follow-up|37|||
163164964|NCT01668589|589318300|FG002|Overall Study|Lost to Follow-up|15|||
163164965|NCT01668589|589318301|FG003|Overall Study|Lost to Follow-up|5|||
163164966|NCT01668589|589318298|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
163164967|NCT01668589|589318299|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
163164968|NCT01668589|589318300|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
163164969|NCT01668589|589318301|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
163164970|NCT01668589|589318298|FG000|Overall Study|Death|12|||
163164971|NCT01668589|589318299|FG001|Overall Study|Death|3|||
163164972|NCT01668589|589318300|FG002|Overall Study|Death|2|||
163164973|NCT01668589|589318301|FG003|Overall Study|Death|11|||
163164974|NCT01668589|589318298|FG000|Overall Study|Other|44|||
163164975|NCT01668589|589318299|FG001|Overall Study|Other|10|||
163164976|NCT01668589|589318300|FG002|Overall Study|Other|7|||
163164977|NCT01668589|589318301|FG003|Overall Study|Other|15|||
163164978|NCT02954172|589318302|FG000|Overall Study|Protocol Violation|3|||
163164979|NCT02954172|589318303|FG001|Overall Study|Protocol Violation|0|||
163164980|NCT02954172|589318302|FG000|Overall Study|allergic reaction|2|||
163164981|NCT02954172|589318303|FG001|Overall Study|allergic reaction|1|||
163164982|NCT02954172|589318302|FG000|Overall Study|non-measurable lesions at baseline|1|||
163164983|NCT02954172|589318303|FG001|Overall Study|non-measurable lesions at baseline|2|||
163164984|NCT00233064|589318304|FG000|Overall Study|Lost to Follow-up|7|||
163164985|NCT00233064|589318305|FG001|Overall Study|Lost to Follow-up|7|||
163164986|NCT00233064|589318304|FG000|Overall Study|Withdrawal by Subject|5|||
163164987|NCT00233064|589318305|FG001|Overall Study|Withdrawal by Subject|3|||
163164988|NCT00233064|589318304|FG000|Overall Study|Death|0|||
163164989|NCT00233064|589318305|FG001|Overall Study|Death|1|||
163164990|NCT00233064|589318304|FG000|Overall Study|Relocation|0|||
163164991|NCT00233064|589318305|FG001|Overall Study|Relocation|1|||
163164992|NCT00233064|589318304|FG000|Overall Study|Protocol Violation|1|||
163164993|NCT00233064|589318305|FG001|Overall Study|Protocol Violation|0|||
163164994|NCT00233064|589318304|FG000|Overall Study|Moved to Dom. Republic|1|||
163164995|NCT00233064|589318305|FG001|Overall Study|Moved to Dom. Republic|0|||
163164996|NCT02302339|589318306|FG000|Overall Study|Lost to Follow-up|1|||
163164997|NCT02302339|589318307|FG001|Overall Study|Lost to Follow-up|0|||
163164998|NCT02302339|589318308|FG002|Overall Study|Lost to Follow-up|0|||
163164999|NCT02302339|589318309|FG003|Overall Study|Lost to Follow-up|0|||
163165000|NCT02302339|589318306|FG000|Overall Study|Withdrawal by Subject|0|||
163165001|NCT02302339|589318307|FG001|Overall Study|Withdrawal by Subject|2|||
163165002|NCT02302339|589318308|FG002|Overall Study|Withdrawal by Subject|1|||
163165003|NCT02302339|589318309|FG003|Overall Study|Withdrawal by Subject|0|||
163165004|NCT01827956|589318312|FG000|Overall Study|Protocol Violation|3|||
163165005|NCT04393454|589318313|FG000|Overall Study|Death|1|||
163165006|NCT04393454|589318313|FG000|Overall Study|Lost to Follow-up|1|||
163165007|NCT02752165|589318314|FG000|Overall Study|Withdrawal by Subject|6|||
163165008|NCT02752165|589318315|FG001|Overall Study|Withdrawal by Subject|6|||
163165009|NCT02752165|589318314|FG000|Overall Study|Protocol Violation|6|||
163165010|NCT02752165|589318315|FG001|Overall Study|Protocol Violation|5|||
163165011|NCT02752165|589318314|FG000|Overall Study|Lost to Follow-up|33|||
163165012|NCT02752165|589318315|FG001|Overall Study|Lost to Follow-up|38|||
163165013|NCT01120964|589318316|FG000|Overall Study|Did not receive full treatment|1|||
163165014|NCT01120964|589318317|FG001|Overall Study|Did not receive full treatment|0|||
163165015|NCT01704599|589318321|FG000|Overall Study|Adverse Event|1|||
163165016|NCT05064358|589318322|FG000|Overall Study|Death|23|||
163165017|NCT05064358|589318323|FG001|Overall Study|Death|23|||
163165018|NCT05064358|589318324|FG002|Overall Study|Death|25|||
163165019|NCT05064358|589318325|FG003|Overall Study|Death|21|||
163165020|NCT05064358|589318326|FG004|Overall Study|Death|5|||
163165021|NCT05064358|589318322|FG000|Overall Study|Lost to Follow-up|1|||
163165022|NCT05064358|589318323|FG001|Overall Study|Lost to Follow-up|2|||
163165023|NCT05064358|589318324|FG002|Overall Study|Lost to Follow-up|0|||
163165024|NCT05064358|589318325|FG003|Overall Study|Lost to Follow-up|2|||
163165025|NCT05064358|589318326|FG004|Overall Study|Lost to Follow-up|0|||
163165026|NCT05064358|589318322|FG000|Overall Study|Physician Decision|1|||
163165027|NCT05064358|589318323|FG001|Overall Study|Physician Decision|1|||
163165028|NCT05064358|589318324|FG002|Overall Study|Physician Decision|2|||
163165029|NCT05064358|589318325|FG003|Overall Study|Physician Decision|0|||
163165030|NCT05064358|589318326|FG004|Overall Study|Physician Decision|0|||
163165031|NCT05064358|589318322|FG000|Overall Study|Withdrawal by Subject|4|||
163165032|NCT05064358|589318323|FG001|Overall Study|Withdrawal by Subject|5|||
163165033|NCT05064358|589318324|FG002|Overall Study|Withdrawal by Subject|3|||
163165034|NCT05064358|589318325|FG003|Overall Study|Withdrawal by Subject|6|||
163165035|NCT05064358|589318326|FG004|Overall Study|Withdrawal by Subject|3|||
163165036|NCT05064358|589318322|FG000|Overall Study|Ongoing at the time of analysis|1|||
163165037|NCT05064358|589318323|FG001|Overall Study|Ongoing at the time of analysis|2|||
163165038|NCT05064358|589318324|FG002|Overall Study|Ongoing at the time of analysis|2|||
163165039|NCT05064358|589318325|FG003|Overall Study|Ongoing at the time of analysis|2|||
163165040|NCT05064358|589318326|FG004|Overall Study|Ongoing at the time of analysis|2|||
163165041|NCT00494676|589318329|FG000|Allocation|Withdrawal by Subject|2|||
163165042|NCT00494676|589318330|FG001|Allocation|Withdrawal by Subject|4|||
163165043|NCT00494676|589318329|FG000|First Intervention|Withdrawal by Subject|1|||
163165044|NCT00494676|589318330|FG001|First Intervention|Withdrawal by Subject|3|||
163165045|NCT00494676|589318329|FG000|Second Intervention|Withdrawal by Subject|1|||
163165046|NCT00494676|589318330|FG001|Second Intervention|Withdrawal by Subject|1|||
163165047|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165048|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
163165049|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165050|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165051|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165052|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165053|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165054|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165055|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165056|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
163165057|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
163165058|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163165059|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
163165060|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163165061|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165062|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165063|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165064|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165065|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165066|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165067|NCT04976192|589318331|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
163165068|NCT04976192|589318332|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165069|NCT04976192|589318333|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
163165070|NCT04976192|589318334|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165071|NCT04976192|589318335|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165072|NCT04976192|589318336|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165073|NCT04976192|589318337|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165074|NCT04976192|589318338|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165075|NCT04976192|589318339|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165076|NCT04976192|589318340|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
163165077|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165078|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165079|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165080|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163165081|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
163165082|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163165083|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163165084|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
163165085|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
163165086|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163165087|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165088|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165089|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165090|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165091|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
163165092|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165093|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165094|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165095|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165096|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163165097|NCT04976192|589318331|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165098|NCT04976192|589318332|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165099|NCT04976192|589318333|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165100|NCT04976192|589318334|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165101|NCT04976192|589318335|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165102|NCT04976192|589318336|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163165103|NCT04976192|589318337|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165104|NCT04976192|589318338|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165105|NCT04976192|589318339|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165106|NCT04976192|589318340|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163165107|NCT02621151|589318341|FG000|Overall Study|Not eligible for trial|6|||
163165108|NCT04073225|589318342|FG000|Overall Study|Lost to Follow-up|4|||
163165109|NCT04073225|589318343|FG001|Overall Study|Lost to Follow-up|3|||
163165110|NCT04238819|589318350|FG000|Overall Study|Ongoing Treatment|0|||
163165111|NCT04238819|589318351|FG001|Overall Study|Ongoing Treatment|0|||
163165112|NCT04238819|589318352|FG002|Overall Study|Ongoing Treatment|0|||
163165113|NCT04238819|589318353|FG003|Overall Study|Ongoing Treatment|0|||
163165114|NCT04238819|589318354|FG004|Overall Study|Ongoing Treatment|1|||
163165115|NCT04238819|589318355|FG005|Overall Study|Ongoing Treatment|4|||
163165116|NCT04238819|589318356|FG006|Overall Study|Ongoing Treatment|0|||
163165117|NCT04238819|589318350|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
162814128|NCT03056755|588032196|FG001|Core Phase|Physician Decision|13|||
163165118|NCT04238819|589318351|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
163165119|NCT04238819|589318352|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
162814129|NCT03056755|588032197|FG002|Core Phase|Physician Decision|5|||
162814130|NCT03056755|588032195|FG000|Core Phase|Subject/guardian decision|5|||
162814131|NCT03056755|588032196|FG001|Core Phase|Subject/guardian decision|8|||
162814132|NCT03056755|588032197|FG002|Core Phase|Subject/guardian decision|4|||
162814133|NCT03056755|588032195|FG000|Core Phase|Death|3|||
162814134|NCT03056755|588032196|FG001|Core Phase|Death|2|||
162814135|NCT03056755|588032197|FG002|Core Phase|Death|4|||
162814136|NCT03056755|588032195|FG000|Core Phase|Protocol deviation|1|||
162814137|NCT03056755|588032196|FG001|Core Phase|Protocol deviation|1|||
162814138|NCT03056755|588032197|FG002|Core Phase|Protocol deviation|0|||
163165120|NCT04238819|589318353|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
162814139|NCT03056755|588032195|FG000|Core Phase|Technical problems|1|||
162814140|NCT03056755|588032196|FG001|Core Phase|Technical problems|0|||
162814141|NCT03056755|588032197|FG002|Core Phase|Technical problems|0|||
162814142|NCT03056755|588032195|FG000|Extension Phase|Physician Decision|1|||
162814143|NCT03056755|588032196|FG001|Extension Phase|Physician Decision|0|||
162814144|NCT03056755|588032197|FG002|Extension Phase|Physician Decision|3|||
162814145|NCT03056755|588032195|FG000|Extension Phase|Adverse Event|0|||
162814146|NCT03056755|588032196|FG001|Extension Phase|Adverse Event|0|||
162814147|NCT03056755|588032197|FG002|Extension Phase|Adverse Event|1|||
162814148|NCT03056755|588032195|FG000|Extension Phase|Subject/guardian decision|0|||
162814149|NCT03056755|588032196|FG001|Extension Phase|Subject/guardian decision|0|||
162814150|NCT03056755|588032197|FG002|Extension Phase|Subject/guardian decision|1|||
162814151|NCT04667949|588032205|FG000|Overall Study|Adverse Event|0|||
162814152|NCT04667949|588032206|FG001|Overall Study|Adverse Event|2|||
162814153|NCT04667949|588032205|FG000|Overall Study|Lost to Follow-up|0|||
162814154|NCT04667949|588032206|FG001|Overall Study|Lost to Follow-up|1|||
162814155|NCT04667949|588032205|FG000|Overall Study|Physician Decision|0|||
162814156|NCT04667949|588032206|FG001|Overall Study|Physician Decision|2|||
162814157|NCT04667949|588032205|FG000|Overall Study|Subject decision|1|||
162814158|NCT04667949|588032206|FG001|Overall Study|Subject decision|7|||
162814159|NCT04504630|588032207|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
162814160|NCT04504630|588032208|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
162814161|NCT04504630|588032207|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
162814162|NCT04504630|588032208|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
162814163|NCT04266301|588032209|FG000|Overall Study|Progressive Disease|111|||
162814164|NCT04266301|588032210|FG001|Overall Study|Progressive Disease|92|||
162814165|NCT04266301|588032209|FG000|Overall Study|Adverse Event|41|||
162814166|NCT04266301|588032210|FG001|Overall Study|Adverse Event|43|||
162814167|NCT04266301|588032209|FG000|Overall Study|Death|26|||
162814168|NCT04266301|588032210|FG001|Overall Study|Death|35|||
162814169|NCT04266301|588032209|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
162814170|NCT04266301|588032210|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
162814171|NCT04266301|588032209|FG000|Overall Study|Study Terminated by Sponsor|22|||
162814172|NCT04266301|588032210|FG001|Overall Study|Study Terminated by Sponsor|27|||
162814173|NCT04266301|588032209|FG000|Overall Study|Participant Decision|22|||
162814174|NCT04266301|588032210|FG001|Overall Study|Participant Decision|28|||
162814175|NCT04266301|588032209|FG000|Overall Study|Physician Decision|14|||
162814176|NCT04266301|588032210|FG001|Overall Study|Physician Decision|9|||
162814177|NCT04266301|588032209|FG000|Overall Study|New Therapy for Study Indication|2|||
162814178|NCT04266301|588032210|FG001|Overall Study|New Therapy for Study Indication|4|||
163165121|NCT04238819|589318354|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
163165122|NCT04238819|589318355|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
163165123|NCT04238819|589318356|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
163165124|NCT02529553|589318357|FG000|Overall Study|Progressive Disease|1|||
163165125|NCT02529553|589318358|FG001|Overall Study|Progressive Disease|0|||
163165126|NCT02529553|589318359|FG002|Overall Study|Progressive Disease|1|||
163165127|NCT02529553|589318360|FG003|Overall Study|Progressive Disease|3|||
163165128|NCT02529553|589318361|FG004|Overall Study|Progressive Disease|2|||
163165129|NCT02529553|589318362|FG005|Overall Study|Progressive Disease|3|||
163165130|NCT02529553|589318363|FG006|Overall Study|Progressive Disease|3|||
163165131|NCT02529553|589318364|FG007|Overall Study|Progressive Disease|5|||
162814179|NCT04266301|588032209|FG000|Overall Study|Protocol Deviation|2|||
162814180|NCT04266301|588032210|FG001|Overall Study|Protocol Deviation|4|||
162814181|NCT04266301|588032209|FG000|Overall Study|Guardian Decision|1|||
162814182|NCT04266301|588032210|FG001|Overall Study|Guardian Decision|0|||
162814183|NCT04266301|588032209|FG000|Overall Study|Lost to Follow-up|1|||
163165132|NCT02529553|589318365|FG008|Overall Study|Progressive Disease|3|||
163165133|NCT02529553|589318357|FG000|Overall Study|Physician Decision|0|||
162814184|NCT04266301|588032210|FG001|Overall Study|Lost to Follow-up|0|||
162814185|NCT04266301|588032209|FG000|Overall Study|Participants Not Treated|1|||
162814186|NCT04266301|588032210|FG001|Overall Study|Participants Not Treated|1|||
162814187|NCT03215758|588032211|FG000|Overall Study|Technical Problems|1|||
162814188|NCT03215758|588032212|FG001|Overall Study|Technical Problems|0|||
162814189|NCT03215758|588032211|FG000|Overall Study|Protocol deviation|0|||
162814190|NCT03215758|588032212|FG001|Overall Study|Protocol deviation|1|||
162814191|NCT03215758|588032211|FG000|Overall Study|Physician Decision|0|||
162814192|NCT03215758|588032212|FG001|Overall Study|Physician Decision|1|||
163165134|NCT02529553|589318358|FG001|Overall Study|Physician Decision|1|||
163165135|NCT02529553|589318359|FG002|Overall Study|Physician Decision|0|||
163165136|NCT02529553|589318360|FG003|Overall Study|Physician Decision|0|||
163165137|NCT02529553|589318361|FG004|Overall Study|Physician Decision|1|||
163165138|NCT02529553|589318362|FG005|Overall Study|Physician Decision|0|||
163165139|NCT02529553|589318363|FG006|Overall Study|Physician Decision|0|||
163165140|NCT02529553|589318364|FG007|Overall Study|Physician Decision|0|||
163165141|NCT02529553|589318365|FG008|Overall Study|Physician Decision|0|||
163165142|NCT02529553|589318357|FG000|Overall Study|Withdrawal by Subject|0|||
163165143|NCT02529553|589318358|FG001|Overall Study|Withdrawal by Subject|0|||
163165144|NCT02529553|589318359|FG002|Overall Study|Withdrawal by Subject|0|||
163165145|NCT02529553|589318360|FG003|Overall Study|Withdrawal by Subject|0|||
163165146|NCT02529553|589318361|FG004|Overall Study|Withdrawal by Subject|0|||
163165147|NCT02529553|589318362|FG005|Overall Study|Withdrawal by Subject|1|||
163165148|NCT02529553|589318363|FG006|Overall Study|Withdrawal by Subject|0|||
163165149|NCT02529553|589318364|FG007|Overall Study|Withdrawal by Subject|1|||
163165150|NCT02529553|589318365|FG008|Overall Study|Withdrawal by Subject|0|||
163165151|NCT00114517|589318366|FG000|Overall Study|Adverse Event|6|||
163165152|NCT00114517|589318367|FG001|Overall Study|Adverse Event|1|||
163165153|NCT00114517|589318368|FG002|Overall Study|Adverse Event|6|||
163165154|NCT00114517|589318369|FG003|Overall Study|Adverse Event|3|||
163165155|NCT00114517|589318366|FG000|Overall Study|Lost to Follow-up|2|||
163165156|NCT00114517|589318367|FG001|Overall Study|Lost to Follow-up|2|||
163165157|NCT00114517|589318368|FG002|Overall Study|Lost to Follow-up|2|||
163165158|NCT00114517|589318369|FG003|Overall Study|Lost to Follow-up|1|||
163165159|NCT00114517|589318366|FG000|Overall Study|Too busy|3|||
163165160|NCT00114517|589318367|FG001|Overall Study|Too busy|1|||
163165161|NCT00114517|589318368|FG002|Overall Study|Too busy|1|||
163165162|NCT00114517|589318369|FG003|Overall Study|Too busy|2|||
163165163|NCT00114517|589318366|FG000|Overall Study|Moved from area|0|||
163165164|NCT00114517|589318367|FG001|Overall Study|Moved from area|3|||
163165165|NCT00114517|589318368|FG002|Overall Study|Moved from area|2|||
163165166|NCT00114517|589318369|FG003|Overall Study|Moved from area|1|||
163165167|NCT00114517|589318366|FG000|Overall Study|Did not want estradiol|1|||
163165168|NCT00114517|589318367|FG001|Overall Study|Did not want estradiol|1|||
163165169|NCT00114517|589318368|FG002|Overall Study|Did not want estradiol|0|||
163165170|NCT00114517|589318369|FG003|Overall Study|Did not want estradiol|0|||
163165171|NCT00114517|589318366|FG000|Overall Study|Armed-services duty|0|||
163165172|NCT00114517|589318367|FG001|Overall Study|Armed-services duty|1|||
163165173|NCT00114517|589318368|FG002|Overall Study|Armed-services duty|0|||
163165174|NCT00114517|589318369|FG003|Overall Study|Armed-services duty|1|||
163165175|NCT00114517|589318366|FG000|Overall Study|Competing family issue|0|||
163165176|NCT00114517|589318367|FG001|Overall Study|Competing family issue|1|||
163165177|NCT00114517|589318368|FG002|Overall Study|Competing family issue|0|||
163165178|NCT00114517|589318369|FG003|Overall Study|Competing family issue|1|||
163165179|NCT00114517|589318366|FG000|Overall Study|Physician Decision|0|||
163165180|NCT00114517|589318367|FG001|Overall Study|Physician Decision|1|||
163165181|NCT00114517|589318368|FG002|Overall Study|Physician Decision|0|||
163165182|NCT00114517|589318369|FG003|Overall Study|Physician Decision|0|||
163165183|NCT00114517|589318366|FG000|Overall Study|Lost interest|0|||
163165184|NCT00114517|589318367|FG001|Overall Study|Lost interest|0|||
163165185|NCT00114517|589318368|FG002|Overall Study|Lost interest|1|||
163165186|NCT00114517|589318369|FG003|Overall Study|Lost interest|0|||
163165187|NCT00114517|589318366|FG000|Overall Study|Weight increase|0|||
163165188|NCT00114517|589318367|FG001|Overall Study|Weight increase|0|||
163165189|NCT00114517|589318368|FG002|Overall Study|Weight increase|1|||
163165190|NCT00114517|589318369|FG003|Overall Study|Weight increase|0|||
163165191|NCT00114517|589318366|FG000|Overall Study|Concern about blood clots|0|||
163165192|NCT00114517|589318367|FG001|Overall Study|Concern about blood clots|0|||
163165193|NCT00114517|589318368|FG002|Overall Study|Concern about blood clots|1|||
163165194|NCT00114517|589318369|FG003|Overall Study|Concern about blood clots|0|||
163165195|NCT00114517|589318366|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165196|NCT00114517|589318367|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165197|NCT00114517|589318368|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
163165198|NCT00114517|589318369|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
163165199|NCT00924027|589318374|FG000|Overall Study|Lost to Further Follow-Up|4|||
163165200|NCT00924027|589318375|FG001|Overall Study|Lost to Further Follow-Up|0|||
163165201|NCT00924027|589318376|FG002|Overall Study|Lost to Further Follow-Up|0|||
163165202|NCT00924027|589318377|FG003|Overall Study|Lost to Further Follow-Up|0|||
163165203|NCT00924027|589318374|FG000|Overall Study|Physician Decision|1|||
163165204|NCT00924027|589318375|FG001|Overall Study|Physician Decision|0|||
163165205|NCT00924027|589318376|FG002|Overall Study|Physician Decision|0|||
163165206|NCT00924027|589318377|FG003|Overall Study|Physician Decision|1|||
163165207|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
163165208|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
163165209|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
163165210|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
163165211|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
163165212|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
163165213|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
163165214|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
163165215|NCT00924027|589318374|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
163165216|NCT00924027|589318375|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
163165217|NCT00924027|589318376|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
163165218|NCT00924027|589318377|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
162814193|NCT03215758|588032211|FG000|Overall Study|Death|0|||
162814194|NCT03215758|588032212|FG001|Overall Study|Death|1|||
162814195|NCT03215758|588032211|FG000|Overall Study|Adverse Event|1|||
162814196|NCT03215758|588032212|FG001|Overall Study|Adverse Event|2|||
162814197|NCT03215758|588032211|FG000|Overall Study|Subject/Guardian Decision|3|||
162814198|NCT03215758|588032212|FG001|Overall Study|Subject/Guardian Decision|3|||
162814199|NCT02977988|588032216|FG000|Overall Study|Lost to Follow-up|13|||
162814200|NCT02977988|588032217|FG001|Overall Study|Lost to Follow-up|7|||
162814201|NCT05341115|588032218|FG000|Overall Study|Adverse Event|1|||
162814202|NCT05341115|588032218|FG000|Overall Study|Lost to Follow-up|1|||
162814203|NCT05630001|588032224|FG000|Overall Study|Adverse Event|1|||
162814204|NCT05386680|588032225|FG000|Overall Study|Guardian decision|2|||
162814205|NCT03946670|588032226|FG000|Overall Study|Progressive Disease|34|||
162814206|NCT03946670|588032227|FG001|Overall Study|Progressive Disease|27|||
162814207|NCT03946670|588032226|FG000|Overall Study|Adverse Event|7|||
162814208|NCT03946670|588032227|FG001|Overall Study|Adverse Event|10|||
162814209|NCT03946670|588032226|FG000|Overall Study|Physician Decision|6|||
162814210|NCT03946670|588032227|FG001|Overall Study|Physician Decision|5|||
162814211|NCT03946670|588032226|FG000|Overall Study|Death|5|||
162814212|NCT03946670|588032227|FG001|Overall Study|Death|8|||
162814213|NCT03946670|588032226|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
162814214|NCT03946670|588032227|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
162814215|NCT03946670|588032226|FG000|Overall Study|Subject Decision|4|||
162814216|NCT03946670|588032227|FG001|Overall Study|Subject Decision|5|||
162814217|NCT03946670|588032226|FG000|Overall Study|Study Terminated By Sponsor|2|||
162814218|NCT03946670|588032227|FG001|Overall Study|Study Terminated By Sponsor|0|||
162814219|NCT03946670|588032226|FG000|Overall Study|New Therapy For Study Indication|1|||
162814220|NCT03946670|588032227|FG001|Overall Study|New Therapy For Study Indication|0|||
162814221|NCT03946670|588032226|FG000|Overall Study|Not Treated|1|||
162814222|NCT03946670|588032227|FG001|Overall Study|Not Treated|1|||
162814223|NCT04652726|588032228|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
162814224|NCT04652726|588032229|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
162814225|NCT04652726|588032230|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
162814226|NCT04652726|588032228|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
162814227|NCT04652726|588032229|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
162814228|NCT04652726|588032230|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
162814229|NCT03780725|588032231|FG000|Overall Study|Progression of disease|3|||
162814230|NCT03780725|588032232|FG001|Overall Study|Progression of disease|4|||
162814231|NCT03780725|588032231|FG000|Overall Study|Adverse Event|0|||
162814232|NCT03780725|588032232|FG001|Overall Study|Adverse Event|1|||
162814233|NCT02738008|588032233|FG000|Overall Study|Study Terminated by Sponsor|1|||
162814234|NCT02738008|588032234|FG001|Overall Study|Study Terminated by Sponsor|5|||
162814235|NCT02738008|588032235|FG002|Overall Study|Study Terminated by Sponsor|3|||
163165219|NCT04236141|589319855|FG000|Overall Study|Death|18|||
163165220|NCT04236141|589319856|FG001|Overall Study|Death|10|||
163165221|NCT04236141|589319855|FG000|Overall Study|Withdrawal by Participant|1|||
163165222|NCT04236141|589319856|FG001|Overall Study|Withdrawal by Participant|0|||
163165223|NCT04236141|589319855|FG000|Overall Study|Reason not Specified|1|||
163165224|NCT04236141|589319856|FG001|Overall Study|Reason not Specified|0|||
162814236|NCT02738008|588032233|FG000|Overall Study|Adverse Event|0|||
162814237|NCT02738008|588032234|FG001|Overall Study|Adverse Event|1|||
162814238|NCT02738008|588032235|FG002|Overall Study|Adverse Event|2|||
162814239|NCT03437278|588032236|FG000|Overall Study|Adverse Event|0|||
162814240|NCT03437278|588032237|FG001|Overall Study|Adverse Event|0|||
162814241|NCT03437278|588032238|FG002|Overall Study|Adverse Event|1|||
162814242|NCT03437278|588032236|FG000|Overall Study|Progressive disease|1|||
162814243|NCT03437278|588032237|FG001|Overall Study|Progressive disease|0|||
162814244|NCT03437278|588032238|FG002|Overall Study|Progressive disease|0|||
162814245|NCT03437278|588032236|FG000|Overall Study|Physician Decision|1|||
162814246|NCT03437278|588032237|FG001|Overall Study|Physician Decision|0|||
162814247|NCT03437278|588032238|FG002|Overall Study|Physician Decision|1|||
162814248|NCT05192382|588032239|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
162814249|NCT05192382|588032240|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
163165225|NCT04236141|589319855|FG000|Overall Study|Study terminated by Sponsor|8|||
163165226|NCT04236141|589319856|FG001|Overall Study|Study terminated by Sponsor|4|||
163165227|NCT01657461|589319857|FG000|Overall Study|Death|9|||
162814250|NCT05192382|588032241|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
162814251|NCT05192382|588032239|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
163165228|NCT01657461|589319858|FG001|Overall Study|Death|12|||
163165229|NCT01657461|589319857|FG000|Overall Study|Lost to Follow-up|0|||
163165230|NCT01657461|589319858|FG001|Overall Study|Lost to Follow-up|3|||
163165231|NCT01657461|589319857|FG000|Overall Study|Physician Decision|0|||
163165232|NCT01657461|589319858|FG001|Overall Study|Physician Decision|2|||
163165233|NCT01657461|589319857|FG000|Overall Study|Withdrawal by Subject|1|||
163165234|NCT01657461|589319858|FG001|Overall Study|Withdrawal by Subject|3|||
163165235|NCT01761162|589319863|FG000|Overall Study|Withdrawal by Subject|3|||
163165236|NCT02160899|589319868|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165237|NCT02160899|589319869|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163165238|NCT02160899|589319870|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165239|NCT02160899|589319871|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
163165240|NCT02160899|589319872|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
163165241|NCT02160899|589319873|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
163165242|NCT04129151|589319874|FG000|Overall Study|Adverse Event|1|||
163165243|NCT04129151|589319874|FG000|Overall Study|Disease Progression|7|||
163165244|NCT04129151|589319874|FG000|Overall Study|Study closure|1|||
163165245|NCT04473235|589319875|FG000|Overall Study|Lost to Follow-up|6|||
163165246|NCT04473235|589319876|FG001|Overall Study|Lost to Follow-up|5|||
163165247|NCT04473235|589319875|FG000|Overall Study|Declined continuation|2|||
163165248|NCT04473235|589319876|FG001|Overall Study|Declined continuation|0|||
163165249|NCT04473235|589319875|FG000|Overall Study|Physician Decision|1|||
163165250|NCT04473235|589319876|FG001|Overall Study|Physician Decision|1|||
163165251|NCT04473235|589319875|FG000|Overall Study|Protocol Violation|10|||
163165252|NCT04473235|589319876|FG001|Overall Study|Protocol Violation|6|||
163165253|NCT01945710|589319879|FG000|Overall Study|Progressive Disease|5|||
163165254|NCT01945710|589319880|FG001|Overall Study|Progressive Disease|4|||
163165255|NCT01945710|589319881|FG002|Overall Study|Progressive Disease|3|||
163165256|NCT01945710|589319882|FG003|Overall Study|Progressive Disease|2|||
163165257|NCT01945710|589319883|FG004|Overall Study|Progressive Disease|7|||
163165258|NCT01945710|589319884|FG005|Overall Study|Progressive Disease|3|||
163165259|NCT01945710|589319885|FG006|Overall Study|Progressive Disease|19|||
163165260|NCT01945710|589319879|FG000|Overall Study|Adverse Event|0|||
163165261|NCT01945710|589319880|FG001|Overall Study|Adverse Event|1|||
163165262|NCT01945710|589319881|FG002|Overall Study|Adverse Event|0|||
163165263|NCT01945710|589319882|FG003|Overall Study|Adverse Event|0|||
163165264|NCT01945710|589319883|FG004|Overall Study|Adverse Event|0|||
163165265|NCT01945710|589319884|FG005|Overall Study|Adverse Event|0|||
163165266|NCT01945710|589319885|FG006|Overall Study|Adverse Event|0|||
163165267|NCT01945710|589319879|FG000|Overall Study|Other|2|||
163165268|NCT01945710|589319880|FG001|Overall Study|Other|0|||
163165269|NCT01945710|589319881|FG002|Overall Study|Other|3|||
163165270|NCT01945710|589319882|FG003|Overall Study|Other|1|||
163165271|NCT01945710|589319883|FG004|Overall Study|Other|1|||
163165272|NCT01945710|589319884|FG005|Overall Study|Other|0|||
163165273|NCT01945710|589319885|FG006|Overall Study|Other|4|||
163165274|NCT01945710|589319879|FG000|Overall Study|Withdrawal by Subject|0|||
163165275|NCT01945710|589319880|FG001|Overall Study|Withdrawal by Subject|1|||
163165276|NCT01945710|589319881|FG002|Overall Study|Withdrawal by Subject|1|||
163165277|NCT01945710|589319882|FG003|Overall Study|Withdrawal by Subject|0|||
163165278|NCT01945710|589319883|FG004|Overall Study|Withdrawal by Subject|1|||
163165279|NCT01945710|589319884|FG005|Overall Study|Withdrawal by Subject|0|||
163165280|NCT01945710|589319885|FG006|Overall Study|Withdrawal by Subject|0|||
163165281|NCT02730195|589319886|FG000|Overall Study|Withdrawal by Subject|1|||
163165282|NCT00745849|589319887|FG000|First Intervention|Withdrawal by Subject|0|||
163165283|NCT00745849|589319888|FG001|First Intervention|Withdrawal by Subject|1|||
163165284|NCT00745849|589319887|FG000|First Intervention|Lost to Follow-up|1|||
163165285|NCT00745849|589319888|FG001|First Intervention|Lost to Follow-up|1|||
163165286|NCT00745849|589319887|FG000|Second Intervention|Lost to Follow-up|2|||
163165287|NCT00745849|589319888|FG001|Second Intervention|Lost to Follow-up|1|||
163165288|NCT01139008|589319889|FG000|Overall Study|Withdrawal by Subject|5|||
163165289|NCT01139008|589319889|FG000|Overall Study|Non-compliant, lost product|1|||
162814252|NCT05192382|588032240|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
162814253|NCT05192382|588032241|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
163165290|NCT01754727|589319892|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
163165291|NCT02785770|589319893|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165292|NCT02785770|589319894|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
163165293|NCT02785770|589319895|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165294|NCT02785770|589319896|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
163165295|NCT02785770|589319893|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
163165296|NCT02785770|589319894|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
163165297|NCT02785770|589319895|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
163165298|NCT02785770|589319896|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
163165299|NCT02785770|589319893|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165300|NCT02785770|589319894|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165301|NCT02785770|589319895|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
163165302|NCT02785770|589319896|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
163165303|NCT00813943|589319900|FG000|Overall Study|Ongoing at cut-off date|5|||
163165304|NCT00813943|589319901|FG001|Overall Study|Ongoing at cut-off date|5|||
163165305|NCT00813943|589319902|FG002|Overall Study|Ongoing at cut-off date|3|||
163165306|NCT05367492|589319903|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
163165307|NCT05367492|589319904|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
163165308|NCT05367492|589319905|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
163165309|NCT05367492|589319903|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
163165310|NCT05367492|589319904|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
163165311|NCT05367492|589319905|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
163165312|NCT05367492|589319903|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
163165313|NCT05367492|589319904|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
163165314|NCT05367492|589319905|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
163165315|NCT05367492|589319903|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
163165316|NCT05367492|589319904|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
163165317|NCT05367492|589319905|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
163165318|NCT00265148|589319906|FG000|Overall Study|Adverse Event|2|||
163165319|NCT00265148|589319907|FG001|Overall Study|Adverse Event|2|||
163165320|NCT00265148|589319906|FG000|Overall Study|Lack of Efficacy|0|||
163165321|NCT00265148|589319907|FG001|Overall Study|Lack of Efficacy|2|||
163165322|NCT00265148|589319906|FG000|Overall Study|Protocol Violation|3|||
163165323|NCT00265148|589319907|FG001|Overall Study|Protocol Violation|2|||
163165324|NCT00265148|589319906|FG000|Overall Study|Lost to Follow-up|0|||
163165325|NCT00265148|589319907|FG001|Overall Study|Lost to Follow-up|1|||
163165326|NCT00265148|589319906|FG000|Overall Study|Withdrawal by Subject|2|||
163165327|NCT00265148|589319907|FG001|Overall Study|Withdrawal by Subject|1|||
163165328|NCT00265148|589319906|FG000|Overall Study|Physician Decision|1|||
163165329|NCT00265148|589319907|FG001|Overall Study|Physician Decision|0|||
163165330|NCT00265148|589319906|FG000|Overall Study|Increasing frailty|0|||
163165331|NCT00265148|589319907|FG001|Overall Study|Increasing frailty|1|||
163165332|NCT00265148|589319906|FG000|Overall Study|Subject chose to change of the dose|1|||
163165333|NCT00265148|589319907|FG001|Overall Study|Subject chose to change of the dose|0|||
163165334|NCT01463007|589319908|FG000|Overall Study|Physician Decision|1|||
163165335|NCT03539549|589319913|FG000|Overall Study|Adverse Event|12|||
163165336|NCT03539549|589319913|FG000|Overall Study|Lost to Follow-up|1|||
163165337|NCT03539549|589319913|FG000|Overall Study|Death|2|||
163165338|NCT03539549|589319913|FG000|Overall Study|Progressive Disease|1|||
163165339|NCT03539549|589319913|FG000|Overall Study|Reason not Specified|1|||
163165340|NCT01652469|589319917|FG000|Overall Study|Withdrawal by Subject|1|||
163165341|NCT01652469|589319918|FG001|Overall Study|Withdrawal by Subject|4|||
163165342|NCT01652469|589319917|FG000|Overall Study|Lost to Follow-up|0|||
163165343|NCT01652469|589319918|FG001|Overall Study|Lost to Follow-up|2|||
163165344|NCT01049009|589319919|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163165345|NCT01049009|589319920|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163165346|NCT01049009|589319919|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163165347|NCT01049009|589319920|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163165348|NCT01049009|589319919|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
163165349|NCT01049009|589319920|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
163165350|NCT01049009|589319919|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
163165351|NCT01049009|589319920|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
163165352|NCT03760731|589319921|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
163165353|NCT03760731|589319922|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
163165354|NCT03760731|589319921|FG000|Treatment|Attended less than 70% of sessions|10|||
163165355|NCT03760731|589319922|FG001|Treatment|Attended less than 70% of sessions|15|||
163165356|NCT01092546|589319923|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
163165357|NCT01970358|589319924|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
163165358|NCT01970358|589319924|FG000|Overall Study|Ineligible at time of second consent|4|||
163165359|NCT02644109|589319925|FG000|Overall Study|Adverse Event|0|||
163165360|NCT02644109|589319926|FG001|Overall Study|Adverse Event|4|||
163165361|NCT04075734|589319927|FG000|Overall Study|Lost to Follow-up|1|||
163165362|NCT04075734|589319928|FG001|Overall Study|Lost to Follow-up|1|||
163165363|NCT04075734|589319929|FG002|Overall Study|Lost to Follow-up|0|||
163165364|NCT04075734|589319927|FG000|Overall Study|Withdrawal by Subject|3|||
163165365|NCT04075734|589319928|FG001|Overall Study|Withdrawal by Subject|0|||
163165366|NCT04075734|589319929|FG002|Overall Study|Withdrawal by Subject|0|||
163165367|NCT02433080|589319931|FG000|Overall Study|Lost to Follow-up|1|||
163165368|NCT02433080|589319932|FG001|Overall Study|Lost to Follow-up|2|||
163165369|NCT02433080|589319931|FG000|Overall Study|Withdrawal by Subject|0|||
163165370|NCT02433080|589319932|FG001|Overall Study|Withdrawal by Subject|2|||
163165371|NCT03462511|589319933|FG000|Overall Study|Withdrawal by Subject|2|||
163165372|NCT03462511|589319934|FG001|Overall Study|Withdrawal by Subject|3|||
163165373|NCT02625909|589319935|FG000|Overall Study|Death|2|||
163165374|NCT02625909|589319936|FG001|Overall Study|Death|0|||
163165375|NCT02625909|589319935|FG000|Overall Study|Lost to Follow-up|3|||
163165376|NCT02625909|589319936|FG001|Overall Study|Lost to Follow-up|5|||
163165377|NCT02625909|589319935|FG000|Overall Study|Lack of Efficacy|9|||
163165378|NCT02625909|589319936|FG001|Overall Study|Lack of Efficacy|2|||
163165379|NCT02625909|589319935|FG000|Overall Study|Reinfection|3|||
163165380|NCT02625909|589319936|FG001|Overall Study|Reinfection|2|||
163165381|NCT02367833|589319937|FG000|Overall Study|Withdrawal by Subject|1|||
163165382|NCT02367833|589319938|FG001|Overall Study|Withdrawal by Subject|1|||
163165383|NCT02367833|589319939|FG002|Overall Study|Withdrawal by Subject|0|||
163165384|NCT02167139|589319944|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
163165385|NCT02167139|589319945|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
163165386|NCT02167139|589319946|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
163165387|NCT02167139|589319947|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
163165388|NCT02167139|589319944|FG000|Randomised, Double-blind|Adverse Event|2|||
163165389|NCT02167139|589319945|FG001|Randomised, Double-blind|Adverse Event|9|||
163165390|NCT02167139|589319946|FG002|Randomised, Double-blind|Adverse Event|0|||
163165391|NCT02167139|589319947|FG003|Randomised, Double-blind|Adverse Event|0|||
163165392|NCT02167139|589319944|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
163165393|NCT02167139|589319945|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
163165394|NCT02167139|589319946|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
163165395|NCT02167139|589319947|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
163165396|NCT02167139|589319944|FG000|Randomised, Double-blind|Other|3|||
163165397|NCT02167139|589319945|FG001|Randomised, Double-blind|Other|0|||
163165398|NCT02167139|589319946|FG002|Randomised, Double-blind|Other|0|||
163165399|NCT02167139|589319947|FG003|Randomised, Double-blind|Other|0|||
163165400|NCT02167139|589319944|FG000|Transition-extension|Adverse Event|2|||
163165401|NCT02167139|589319945|FG001|Transition-extension|Adverse Event|0|||
163165402|NCT02167139|589319946|FG002|Transition-extension|Adverse Event|2|||
163165403|NCT02167139|589319947|FG003|Transition-extension|Adverse Event|3|||
163165404|NCT02167139|589319944|FG000|Transition-extension|Withdrawal by Subject|2|||
163165405|NCT02167139|589319945|FG001|Transition-extension|Withdrawal by Subject|0|||
163165406|NCT02167139|589319946|FG002|Transition-extension|Withdrawal by Subject|4|||
163165407|NCT02167139|589319947|FG003|Transition-extension|Withdrawal by Subject|1|||
163165408|NCT02167139|589319944|FG000|Transition-extension|Lack of Efficacy|0|||
163165409|NCT02167139|589319945|FG001|Transition-extension|Lack of Efficacy|0|||
163165410|NCT02167139|589319946|FG002|Transition-extension|Lack of Efficacy|1|||
163165411|NCT02167139|589319947|FG003|Transition-extension|Lack of Efficacy|1|||
163165412|NCT02167139|589319944|FG000|Transition-extension|Other|1|||
163165413|NCT02167139|589319945|FG001|Transition-extension|Other|0|||
163165414|NCT02167139|589319946|FG002|Transition-extension|Other|1|||
163165415|NCT02167139|589319947|FG003|Transition-extension|Other|0|||
163165416|NCT02167139|589319944|FG000|Transition-extension|Lost to Follow-up|1|||
163165417|NCT02167139|589319945|FG001|Transition-extension|Lost to Follow-up|0|||
163165418|NCT02167139|589319946|FG002|Transition-extension|Lost to Follow-up|0|||
163165419|NCT02167139|589319947|FG003|Transition-extension|Lost to Follow-up|0|||
163165420|NCT02067676|589319948|FG000|Overall Study|Withdrawal by Subject|1|||
163165421|NCT02067676|589319949|FG001|Overall Study|Withdrawal by Subject|0|||
163165422|NCT02067676|589319950|FG002|Overall Study|Withdrawal by Subject|0|||
163165423|NCT02067676|589319951|FG003|Overall Study|Withdrawal by Subject|0|||
163165424|NCT02067676|589319952|FG004|Overall Study|Withdrawal by Subject|0|||
163165425|NCT02067676|589319953|FG005|Overall Study|Withdrawal by Subject|0|||
163165426|NCT00996333|589319954|FG000|Overall Study|Screen failure|1|||
163165427|NCT00996333|589319954|FG000|Overall Study|Withdrawal by Subject|1|||
163165428|NCT00996333|589319954|FG000|Overall Study|Death|4|||
163165429|NCT00996333|589319954|FG000|Overall Study|Adverse Event|1|||
163165430|NCT00996333|589319954|FG000|Overall Study|Physician Decision|1|||
163165431|NCT00996333|589319954|FG000|Overall Study|Other|5|||
163165432|NCT00476229|589319955|FG000|Overall Study|Progressive shortness of breath|1|||
163165433|NCT01387542|589319961|FG000|Overall Study|Adverse Event|3|||
163165434|NCT01387542|589319961|FG000|Overall Study|Withdrawal by Subject|1|||
163165435|NCT01387542|589319961|FG000|Overall Study|Changed diagnosis|1|||
163165436|NCT01387542|589319961|FG000|Overall Study|Insufficient response|1|||
163165437|NCT01387542|589319961|FG000|Overall Study|Non-compliant|1|||
163165438|NCT01387542|589319961|FG000|Overall Study|Lost to Follow-up|1|||
163165439|NCT05422638|589319964|FG000|Overall Study|Withdrawal by Subject|8|||
163165440|NCT05422638|589319965|FG001|Overall Study|Withdrawal by Subject|2|||
163165441|NCT04695977|589319967|FG000|Overall Study|Sponsor Decision|9|||
163165442|NCT04695977|589319968|FG001|Overall Study|Sponsor Decision|4|||
163165443|NCT04695977|589319967|FG000|Overall Study|Death|2|||
163165444|NCT04695977|589319968|FG001|Overall Study|Death|5|||
163165445|NCT01868542|589321541|FG000|Overall Study|Protocol Violation|0|||
163165446|NCT01868542|589321542|FG001|Overall Study|Protocol Violation|1|||
163165447|NCT01868542|589321541|FG000|Overall Study|Unclassified|0|||
163165448|NCT01868542|589321542|FG001|Overall Study|Unclassified|1|||
163165449|NCT00130247|589321543|FG000|Overall Study|Pregnancy|1|||
163165450|NCT00130247|589321544|FG001|Overall Study|Pregnancy|0|||
163165451|NCT00130247|589321543|FG000|Overall Study|Post-randomization exclusion|1|||
163165452|NCT00130247|589321544|FG001|Overall Study|Post-randomization exclusion|2|||
163165453|NCT00130247|589321543|FG000|Overall Study|Not compliant with DOT|0|||
162814254|NCT05192382|588032239|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
162814255|NCT05192382|588032240|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
162814256|NCT05192382|588032241|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
162814257|NCT05192382|588032239|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
162814258|NCT05192382|588032240|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
162814259|NCT05192382|588032241|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
162814260|NCT04328727|588032244|FG000|Overall Study|Guardian Decision|1|||
162814261|NCT04328727|588032244|FG000|Overall Study|Participant decision|4|||
162814262|NCT04328727|588032244|FG000|Overall Study|Death|3|||
162814263|NCT02604199|588032245|FG000|Overall Study|Pregnancy|0|||
162814264|NCT02604199|588032246|FG001|Overall Study|Pregnancy|0|||
162814265|NCT02604199|588032247|FG002|Overall Study|Pregnancy|0|||
162814266|NCT02604199|588032248|FG003|Overall Study|Pregnancy|1|||
162814267|NCT02604199|588032245|FG000|Overall Study|Study terminated by sponsor|0|||
162814268|NCT02604199|588032246|FG001|Overall Study|Study terminated by sponsor|2|||
162814269|NCT02604199|588032247|FG002|Overall Study|Study terminated by sponsor|0|||
162814270|NCT02604199|588032248|FG003|Overall Study|Study terminated by sponsor|2|||
162814271|NCT02604199|588032245|FG000|Overall Study|Withdrawal by Subject|0|||
162814272|NCT02604199|588032246|FG001|Overall Study|Withdrawal by Subject|1|||
162814273|NCT02604199|588032247|FG002|Overall Study|Withdrawal by Subject|0|||
162814274|NCT02604199|588032248|FG003|Overall Study|Withdrawal by Subject|0|||
162814275|NCT02604212|588032249|FG000|Overall Study|Study Terminated by Sponsor|2|||
162814276|NCT02604212|588032250|FG001|Overall Study|Study Terminated by Sponsor|1|||
163165454|NCT00130247|589321544|FG001|Overall Study|Not compliant with DOT|2|||
163165455|NCT03844945|589321545|FG000|Overall Study|Adverse Event|1|||
163165456|NCT03844945|589321546|FG001|Overall Study|Adverse Event|1|||
162814277|NCT02604212|588032251|FG002|Overall Study|Study Terminated by Sponsor|3|||
162814278|NCT02604212|588032252|FG003|Overall Study|Study Terminated by Sponsor|3|||
162814279|NCT02604212|588032249|FG000|Overall Study|Withdrawal by Subject|0|||
162814280|NCT02604212|588032250|FG001|Overall Study|Withdrawal by Subject|0|||
162814281|NCT02604212|588032251|FG002|Overall Study|Withdrawal by Subject|1|||
162814282|NCT02604212|588032252|FG003|Overall Study|Withdrawal by Subject|0|||
162814283|NCT04702776|588032256|FG000|Overall Study|Adverse Event|1|||
162814284|NCT04702776|588032257|FG001|Overall Study|Adverse Event|2|||
162814285|NCT04702776|588032258|FG002|Overall Study|Adverse Event|1|||
162814286|NCT04702776|588032256|FG000|Overall Study|Lost to Follow-up|2|||
162814287|NCT04702776|588032257|FG001|Overall Study|Lost to Follow-up|1|||
162814288|NCT04702776|588032258|FG002|Overall Study|Lost to Follow-up|4|||
162814289|NCT04702776|588032256|FG000|Overall Study|Protocol Violation|2|||
162814290|NCT04702776|588032257|FG001|Overall Study|Protocol Violation|2|||
162814291|NCT04702776|588032258|FG002|Overall Study|Protocol Violation|3|||
162814292|NCT02076178|588032261|FG000|Oral Phase|Adverse Event|0|||
162814293|NCT02076178|588032262|FG001|Oral Phase|Adverse Event|7|||
162814294|NCT02076178|588032261|FG000|Oral Phase|Withdrawal by Subject|0|||
162814295|NCT02076178|588032262|FG001|Oral Phase|Withdrawal by Subject|4|||
162814296|NCT02076178|588032261|FG000|Oral Phase|Physician Decision|0|||
162814297|NCT02076178|588032262|FG001|Oral Phase|Physician Decision|1|||
162814298|NCT02076178|588032261|FG000|Injection Phase|Protocol defined stopping criteria|1|||
162814299|NCT02076178|588032262|FG001|Injection Phase|Protocol defined stopping criteria|0|||
162814300|NCT02076178|588032261|FG000|Injection Phase|Withdrawal by Subject|0|||
162814301|NCT02076178|588032262|FG001|Injection Phase|Withdrawal by Subject|3|||
162814302|NCT02076178|588032261|FG000|Injection Phase|Physician Decision|0|||
162814303|NCT02076178|588032262|FG001|Injection Phase|Physician Decision|3|||
162814304|NCT02076178|588032261|FG000|Injection Phase|Lost to Follow-up|0|||
162814305|NCT02076178|588032262|FG001|Injection Phase|Lost to Follow-up|1|||
162814306|NCT02893930|588032263|FG000|Overall Study|Adverse Event|3|||
162814307|NCT02893930|588032263|FG000|Overall Study|Death|1|||
162814308|NCT02893930|588032263|FG000|Overall Study|Disease progression|5|||
162814309|NCT02893930|588032263|FG000|Overall Study|Withdrawal by Subject|2|||
162814310|NCT02893930|588032263|FG000|Overall Study|Physician Decision|1|||
162814311|NCT02893930|588032263|FG000|Overall Study|Ineligible|1|||
163165457|NCT03844945|589321547|FG002|Overall Study|Adverse Event|4|||
162814312|NCT03370471|588032266|FG000|Overall Study|Withdrawal by Subject|6|||
162814313|NCT03370471|588032267|FG001|Overall Study|Withdrawal by Subject|1|||
162814314|NCT03370471|588032266|FG000|Overall Study|Unable to access veins for blood draw|0|||
162814315|NCT03370471|588032267|FG001|Overall Study|Unable to access veins for blood draw|1|||
162814316|NCT03370471|588032266|FG000|Overall Study|Screen fail|1|||
162814317|NCT03370471|588032267|FG001|Overall Study|Screen fail|0|||
162814318|NCT01765179|588032269|FG000|Overall Study|Adverse Event|3|||
162814319|NCT01765179|588032269|FG000|Overall Study|Lost to Follow-up|5|||
163165458|NCT03844945|589321548|FG003|Overall Study|Adverse Event|0|||
162814320|NCT01765179|588032269|FG000|Overall Study|Non-compliance with study drug|2|||
162814321|NCT01765179|588032269|FG000|Overall Study|Protocol Violation|1|||
162814322|NCT01765179|588032269|FG000|Overall Study|Withdrawal by Subject|8|||
162814323|NCT01765179|588032269|FG000|Overall Study|Hematocrit >54%|3|||
162814324|NCT01765179|588032269|FG000|Overall Study|prohibited med|1|||
163165459|NCT03844945|589321545|FG000|Overall Study|Withdrawal by Subject|0|||
163165460|NCT03844945|589321546|FG001|Overall Study|Withdrawal by Subject|0|||
163165461|NCT03844945|589321547|FG002|Overall Study|Withdrawal by Subject|1|||
163165462|NCT03844945|589321548|FG003|Overall Study|Withdrawal by Subject|0|||
163165463|NCT03844945|589321545|FG000|Overall Study|Lack of Efficacy|0|||
163165464|NCT03844945|589321546|FG001|Overall Study|Lack of Efficacy|0|||
163165465|NCT03844945|589321547|FG002|Overall Study|Lack of Efficacy|0|||
163165466|NCT03844945|589321548|FG003|Overall Study|Lack of Efficacy|1|||
163165467|NCT04518995|589321549|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
163165468|NCT04518995|589321550|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
163165469|NCT04518995|589321551|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
163165470|NCT04518995|589321549|FG000|Overall Study|Lack of Efficacy|2|||
163165471|NCT04518995|589321550|FG001|Overall Study|Lack of Efficacy|1|||
163165472|NCT04518995|589321551|FG002|Overall Study|Lack of Efficacy|0|||
163165473|NCT04518995|589321549|FG000|Overall Study|Non-compliance With Study Drug|0|||
163165474|NCT04518995|589321550|FG001|Overall Study|Non-compliance With Study Drug|3|||
163165475|NCT04518995|589321551|FG002|Overall Study|Non-compliance With Study Drug|2|||
163165476|NCT04518995|589321549|FG000|Overall Study|Pregnancy|0|||
163165477|NCT04518995|589321550|FG001|Overall Study|Pregnancy|0|||
163165478|NCT04518995|589321551|FG002|Overall Study|Pregnancy|1|||
163165479|NCT04518995|589321549|FG000|Overall Study|Protocol Violation|2|||
163165480|NCT04518995|589321550|FG001|Overall Study|Protocol Violation|0|||
163165481|NCT04518995|589321551|FG002|Overall Study|Protocol Violation|1|||
163165482|NCT04518995|589321549|FG000|Overall Study|Reason not Specified|4|||
163165483|NCT04518995|589321550|FG001|Overall Study|Reason not Specified|11|||
162814325|NCT01765179|588032269|FG000|Overall Study|Out of country unable to finish study|1|||
162814326|NCT01765179|588032269|FG000|Overall Study|lack of venous access|1|||
162814327|NCT01765179|588032269|FG000|Overall Study|work conflict|1|||
162814328|NCT01765179|588032269|FG000|Overall Study|Ca elevated 10.6|1|||
162814329|NCT05358717|588032270|FG000|Overall Study|Adverse Event|0|||
162814330|NCT05358717|588032271|FG001|Overall Study|Adverse Event|1|||
162814331|NCT05358717|588032272|FG002|Overall Study|Adverse Event|1|||
162814332|NCT05358717|588032270|FG000|Overall Study|Death|1|||
162814333|NCT05358717|588032271|FG001|Overall Study|Death|1|||
162814334|NCT05358717|588032272|FG002|Overall Study|Death|0|||
162814335|NCT05358717|588032270|FG000|Overall Study|Withdrawal by Subject|1|||
162814336|NCT05358717|588032271|FG001|Overall Study|Withdrawal by Subject|1|||
162814337|NCT05358717|588032272|FG002|Overall Study|Withdrawal by Subject|2|||
162814338|NCT05358717|588032270|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
162814339|NCT05358717|588032271|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
162814340|NCT05358717|588032272|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
162814341|NCT02640157|588032273|FG000|Overall Study|Adverse Event|2|||
162814342|NCT02640157|588032274|FG001|Overall Study|Adverse Event|2|||
162814343|NCT02640157|588032275|FG002|Overall Study|Adverse Event|1|||
162814344|NCT02640157|588032273|FG000|Overall Study|Withdrew consent|2|||
162814345|NCT02640157|588032274|FG001|Overall Study|Withdrew consent|0|||
162814346|NCT02640157|588032275|FG002|Overall Study|Withdrew consent|2|||
162814347|NCT02640157|588032273|FG000|Overall Study|Lost to Follow-up|9|||
162814348|NCT02640157|588032274|FG001|Overall Study|Lost to Follow-up|2|||
162814349|NCT02640157|588032275|FG002|Overall Study|Lost to Follow-up|7|||
162814350|NCT02640157|588032273|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
162814351|NCT02640157|588032274|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
162814352|NCT02640157|588032275|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
162814353|NCT01596621|588032276|FG000|Overall Study|Death|4|||
162814354|NCT01596621|588032276|FG000|Overall Study|Withdrawal by Subject|9|||
162814355|NCT01596621|588032276|FG000|Overall Study|Disease Progression|49|||
162814356|NCT01596621|588032276|FG000|Overall Study|Lost to Follow-up|3|||
162814357|NCT01596621|588032276|FG000|Overall Study|Other than specified|13|||
162814358|NCT00710021|588032277|FG000|Overall Study|Lost to Follow-up|1|||
162814359|NCT00710021|588032278|FG001|Overall Study|Lost to Follow-up|0|||
162814360|NCT00710021|588032279|FG002|Overall Study|Lost to Follow-up|0|||
162814361|NCT00710021|588032277|FG000|Overall Study|Subject's Decision|0|||
163165484|NCT04518995|589321551|FG002|Overall Study|Reason not Specified|2|||
163165485|NCT04518995|589321549|FG000|Overall Study|Lost to Follow-up|1|||
162814362|NCT00710021|588032278|FG001|Overall Study|Subject's Decision|1|||
162814363|NCT00710021|588032279|FG002|Overall Study|Subject's Decision|0|||
162814364|NCT00710021|588032277|FG000|Overall Study|Subject misrandomized|0|||
162814365|NCT00710021|588032278|FG001|Overall Study|Subject misrandomized|1|||
162814366|NCT00710021|588032279|FG002|Overall Study|Subject misrandomized|1|||
162814367|NCT00710021|588032277|FG000|Overall Study|Physician Decision|0|||
162814368|NCT00710021|588032278|FG001|Overall Study|Physician Decision|1|||
162814369|NCT00710021|588032279|FG002|Overall Study|Physician Decision|0|||
162814370|NCT00421707|588032280|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
162814371|NCT00421707|588032281|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
162814372|NCT00421707|588032280|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
163165486|NCT04518995|589321550|FG001|Overall Study|Lost to Follow-up|10|||
163165487|NCT04518995|589321551|FG002|Overall Study|Lost to Follow-up|6|||
162814373|NCT00421707|588032281|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
162814374|NCT00421707|588032280|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
162814375|NCT00421707|588032281|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
162814376|NCT00421707|588032280|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
162814377|NCT00421707|588032281|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
162814378|NCT00421707|588032280|FG000|Period 2: Washout|Adverse Event|1|||
162814379|NCT00421707|588032281|FG001|Period 2: Washout|Adverse Event|1|||
162814380|NCT00421707|588032280|FG000|Period 2: Washout|Withdrawal by Subject|0|||
162814381|NCT00421707|588032281|FG001|Period 2: Washout|Withdrawal by Subject|1|||
162814382|NCT00421707|588032280|FG000|Period 2: Washout|Lost to Follow-up|0|||
162814383|NCT00421707|588032281|FG001|Period 2: Washout|Lost to Follow-up|1|||
162814384|NCT00421707|588032280|FG000|Period 2: Washout|Other: Pregnancy|0|||
162814385|NCT00421707|588032281|FG001|Period 2: Washout|Other: Pregnancy|1|||
162814386|NCT00421707|588032280|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
162814387|NCT00421707|588032281|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
162814388|NCT00421707|588032280|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
162814389|NCT00421707|588032281|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
162814390|NCT00421707|588032280|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
162814391|NCT00421707|588032281|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
162814392|NCT04837040|588032287|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
162814393|NCT04837040|588032288|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
162814394|NCT00602667|588032289|FG000|Overall Study|Still on Therapy|0|||
162814395|NCT00602667|588032290|FG001|Overall Study|Still on Therapy|2|||
162814396|NCT00602667|588032291|FG002|Overall Study|Still on Therapy|2|||
162814397|NCT00602667|588032289|FG000|Overall Study|Death|0|||
162814398|NCT00602667|588032290|FG001|Overall Study|Death|1|||
162814399|NCT00602667|588032291|FG002|Overall Study|Death|1|||
162814400|NCT00602667|588032289|FG000|Overall Study|Family request|3|||
162814401|NCT00602667|588032290|FG001|Overall Study|Family request|25|||
162814402|NCT00602667|588032291|FG002|Overall Study|Family request|6|||
162814403|NCT00602667|588032289|FG000|Overall Study|Excessive toxicity|1|||
162814404|NCT00602667|588032290|FG001|Overall Study|Excessive toxicity|1|||
162814405|NCT00602667|588032291|FG002|Overall Study|Excessive toxicity|0|||
162814406|NCT00602667|588032289|FG000|Overall Study|Second malignancy|0|||
162814407|NCT00602667|588032290|FG001|Overall Study|Second malignancy|1|||
162814408|NCT00602667|588032291|FG002|Overall Study|Second malignancy|0|||
162814409|NCT00602667|588032289|FG000|Overall Study|Physician Decision|2|||
162814410|NCT00602667|588032290|FG001|Overall Study|Physician Decision|3|||
163165488|NCT02052414|589321552|FG000|Overall Study|Adverse Event|12|||
163165489|NCT02052414|589321552|FG000|Overall Study|Lack of Efficacy|2|||
163165490|NCT02052414|589321552|FG000|Overall Study|Withdrawal by Subject|3|||
163165491|NCT01088048|589321558|FG000|Overall Study|Adverse Event|7|||
163165492|NCT01088048|589321559|FG001|Overall Study|Adverse Event|9|||
163165493|NCT01088048|589321560|FG002|Overall Study|Adverse Event|7|||
163165494|NCT01088048|589321561|FG003|Overall Study|Adverse Event|5|||
163165495|NCT01088048|589321562|FG004|Overall Study|Adverse Event|6|||
163165496|NCT01088048|589321563|FG005|Overall Study|Adverse Event|3|||
163165497|NCT01088048|589321564|FG006|Overall Study|Adverse Event|3|||
163165498|NCT01088048|589321565|FG007|Overall Study|Adverse Event|0|||
163165499|NCT01088048|589321566|FG008|Overall Study|Adverse Event|2|||
163165500|NCT01088048|589321567|FG009|Overall Study|Adverse Event|2|||
163165501|NCT01088048|589321558|FG000|Overall Study|Withdrew Consent|1|||
163165502|NCT01088048|589321559|FG001|Overall Study|Withdrew Consent|1|||
163165503|NCT01088048|589321560|FG002|Overall Study|Withdrew Consent|1|||
163165504|NCT01088048|589321561|FG003|Overall Study|Withdrew Consent|1|||
163165505|NCT01088048|589321562|FG004|Overall Study|Withdrew Consent|2|||
163165506|NCT01088048|589321563|FG005|Overall Study|Withdrew Consent|1|||
163165507|NCT01088048|589321564|FG006|Overall Study|Withdrew Consent|0|||
163165508|NCT01088048|589321565|FG007|Overall Study|Withdrew Consent|2|||
163165509|NCT01088048|589321566|FG008|Overall Study|Withdrew Consent|2|||
162814411|NCT00602667|588032291|FG002|Overall Study|Physician Decision|8|||
162814412|NCT00602667|588032289|FG000|Overall Study|Progressive disease|13|||
162814413|NCT00602667|588032290|FG001|Overall Study|Progressive disease|48|||
163165510|NCT01088048|589321567|FG009|Overall Study|Withdrew Consent|1|||
163165511|NCT01088048|589321558|FG000|Overall Study|Concomitant Medication Prohibited|1|||
163165512|NCT01088048|589321559|FG001|Overall Study|Concomitant Medication Prohibited|0|||
163165513|NCT01088048|589321560|FG002|Overall Study|Concomitant Medication Prohibited|0|||
163165514|NCT01088048|589321561|FG003|Overall Study|Concomitant Medication Prohibited|0|||
163165515|NCT01088048|589321562|FG004|Overall Study|Concomitant Medication Prohibited|0|||
163165516|NCT01088048|589321563|FG005|Overall Study|Concomitant Medication Prohibited|0|||
162814414|NCT00602667|588032291|FG002|Overall Study|Progressive disease|45|||
162814415|NCT00602667|588032289|FG000|Overall Study|Progressive disease prior to therapy|0|||
162814416|NCT00602667|588032290|FG001|Overall Study|Progressive disease prior to therapy|0|||
162814417|NCT00602667|588032291|FG002|Overall Study|Progressive disease prior to therapy|1|||
162814418|NCT02975700|588032293|FG000|Overall Study|Adverse Event|1|||
162814419|NCT02975700|588032293|FG000|Overall Study|Progressive disease|3|||
163165517|NCT01088048|589321564|FG006|Overall Study|Concomitant Medication Prohibited|0|||
162814420|NCT02975700|588032293|FG000|Overall Study|Failed screening criteria|2|||
162814421|NCT04765059|588032294|FG000|Overall Study|Failure to meet randomization criteria|1|||
162814422|NCT04765059|588032295|FG001|Overall Study|Failure to meet randomization criteria|0|||
162814423|NCT04765059|588032294|FG000|Overall Study|Withdrawal by Subject|1|||
162814424|NCT04765059|588032295|FG001|Overall Study|Withdrawal by Subject|4|||
162814425|NCT04765059|588032294|FG000|Overall Study|Lost to Follow-up|1|||
162814426|NCT04765059|588032295|FG001|Overall Study|Lost to Follow-up|1|||
162814427|NCT04765059|588032294|FG000|Overall Study|Death|25|||
162814428|NCT04765059|588032295|FG001|Overall Study|Death|28|||
162814429|NCT04765059|588032294|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
162814430|NCT04765059|588032295|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
162814431|NCT04300309|588032296|FG000|Overall Study|Lost to Follow-up|1|||
162814432|NCT04300309|588032297|FG001|Overall Study|Lost to Follow-up|0|||
162814433|NCT02441686|588032298|FG000|Induction|Adverse Event|4|||
162814434|NCT02441686|588032298|FG000|Induction|Complicating disease|1|||
162814435|NCT02441686|588032298|FG000|Induction|Physician Decision|1|||
162814436|NCT02441686|588032298|FG000|Induction|Withdrawal by Subject|1|||
162814437|NCT02441686|588032298|FG000|Induction|Did not receive treatment|1|||
162814438|NCT02441686|588032298|FG000|Maintenance|Remaining on Treatment|23|||
162814439|NCT02441686|588032298|FG000|Maintenance|Physician Decision|1|||
162814440|NCT02441686|588032298|FG000|Maintenance|Adverse Event|3|||
162814441|NCT02441686|588032298|FG000|Maintenance|Progressive Disease|10|||
162814442|NCT02441686|588032298|FG000|Maintenance|Withdrawal by Subject|1|||
162814443|NCT04647526|588032299|FG000|Overall Study|Death|13|||
162814444|NCT04647526|588032300|FG001|Overall Study|Death|76|||
162814445|NCT04647526|588032301|FG002|Overall Study|Death|32|||
162814446|NCT04647526|588032302|FG003|Overall Study|Death|0|||
162814447|NCT04647526|588032299|FG000|Overall Study|Lost to Follow-up|1|||
162814448|NCT04647526|588032300|FG001|Overall Study|Lost to Follow-up|0|||
162814449|NCT04647526|588032301|FG002|Overall Study|Lost to Follow-up|1|||
162814450|NCT04647526|588032302|FG003|Overall Study|Lost to Follow-up|0|||
162814451|NCT04647526|588032299|FG000|Overall Study|Withdrawal by Subject|4|||
162814452|NCT04647526|588032300|FG001|Overall Study|Withdrawal by Subject|15|||
162814453|NCT04647526|588032301|FG002|Overall Study|Withdrawal by Subject|8|||
162814454|NCT04647526|588032302|FG003|Overall Study|Withdrawal by Subject|1|||
162814455|NCT04647526|588032299|FG000|Overall Study|Incorrect enrollment|0|||
162814456|NCT04647526|588032300|FG001|Overall Study|Incorrect enrollment|1|||
162814457|NCT04647526|588032301|FG002|Overall Study|Incorrect enrollment|1|||
162814458|NCT04647526|588032302|FG003|Overall Study|Incorrect enrollment|0|||
162814459|NCT04647526|588032299|FG000|Overall Study|Physician Decision|0|||
162814460|NCT04647526|588032300|FG001|Overall Study|Physician Decision|1|||
162814461|NCT04647526|588032301|FG002|Overall Study|Physician Decision|1|||
162814462|NCT04647526|588032302|FG003|Overall Study|Physician Decision|0|||
162814463|NCT04647526|588032299|FG000|Overall Study|Ongoing|9|||
162814464|NCT04647526|588032300|FG001|Overall Study|Ongoing|183|||
162814465|NCT04647526|588032301|FG002|Overall Study|Ongoing|93|||
162814466|NCT04647526|588032302|FG003|Overall Study|Ongoing|15|||
162814467|NCT04150029|588032303|FG000|Overall Study|Disease Relapse|0|||
162814468|NCT04150029|588032304|FG001|Overall Study|Disease Relapse|18|||
162814469|NCT04150029|588032303|FG000|Overall Study|Progressive Disease|2|||
162814470|NCT04150029|588032304|FG001|Overall Study|Progressive Disease|16|||
162814471|NCT04150029|588032303|FG000|Overall Study|Adverse Event|1|||
162814472|NCT04150029|588032304|FG001|Overall Study|Adverse Event|11|||
162814473|NCT04150029|588032303|FG000|Overall Study|Physician Decision|0|||
162814474|NCT04150029|588032304|FG001|Overall Study|Physician Decision|10|||
162814475|NCT04150029|588032303|FG000|Overall Study|Study Terminated by Sponsor|1|||
162814476|NCT04150029|588032304|FG001|Overall Study|Study Terminated by Sponsor|10|||
162814477|NCT04150029|588032303|FG000|Overall Study|Death|0|||
162814478|NCT04150029|588032304|FG001|Overall Study|Death|8|||
162814479|NCT04150029|588032303|FG000|Overall Study|Participant Decision|0|||
162814480|NCT04150029|588032304|FG001|Overall Study|Participant Decision|7|||
162814481|NCT04150029|588032303|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
162814482|NCT04150029|588032304|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
162814483|NCT05497284|588032305|FG000|Overall Study|Adverse Event|1|||
162814484|NCT05497284|588032306|FG001|Overall Study|Adverse Event|0|||
162814485|NCT05497284|588032305|FG000|Overall Study|Physician Decision|0|||
162814486|NCT05497284|588032306|FG001|Overall Study|Physician Decision|1|||
162814487|NCT05497284|588032305|FG000|Overall Study|Study terminated by sponsor|7|||
162814488|NCT05497284|588032306|FG001|Overall Study|Study terminated by sponsor|4|||
162814489|NCT05497284|588032305|FG000|Overall Study|Subject Decision|0|||
162814490|NCT05497284|588032306|FG001|Overall Study|Subject Decision|1|||
162814491|NCT03816891|588032307|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162814492|NCT03816891|588032308|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162814493|NCT03816891|588032309|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162814494|NCT03816891|588032310|FG003|Double-Blind Period|Withdrawal by Subject|2|||
162814495|NCT03816891|588032311|FG004|Double-Blind Period|Withdrawal by Subject|0|||
162814496|NCT03816891|588032312|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162814497|NCT03816891|588032307|FG000|Double-Blind Period|Adverse Event|0|||
162814498|NCT03816891|588032308|FG001|Double-Blind Period|Adverse Event|0|||
162814499|NCT03816891|588032309|FG002|Double-Blind Period|Adverse Event|2|||
162814500|NCT03816891|588032310|FG003|Double-Blind Period|Adverse Event|0|||
162814501|NCT03816891|588032311|FG004|Double-Blind Period|Adverse Event|0|||
162814502|NCT03816891|588032312|FG005|Double-Blind Period|Adverse Event|0|||
162814503|NCT03816891|588032307|FG000|Double-Blind Period|Lost to Follow-up|2|||
162814504|NCT03816891|588032308|FG001|Double-Blind Period|Lost to Follow-up|0|||
162814505|NCT03816891|588032309|FG002|Double-Blind Period|Lost to Follow-up|0|||
162814506|NCT03816891|588032310|FG003|Double-Blind Period|Lost to Follow-up|0|||
162814507|NCT03816891|588032311|FG004|Double-Blind Period|Lost to Follow-up|0|||
162814508|NCT03816891|588032312|FG005|Double-Blind Period|Lost to Follow-up|1|||
162814509|NCT03816891|588032307|FG000|Double-Blind Period|Physician Decision|0|||
162814510|NCT03816891|588032308|FG001|Double-Blind Period|Physician Decision|0|||
162814511|NCT03816891|588032309|FG002|Double-Blind Period|Physician Decision|0|||
162814512|NCT03816891|588032310|FG003|Double-Blind Period|Physician Decision|1|||
162814513|NCT03816891|588032311|FG004|Double-Blind Period|Physician Decision|0|||
162814514|NCT03816891|588032312|FG005|Double-Blind Period|Physician Decision|0|||
162814515|NCT03816891|588032307|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162814516|NCT03816891|588032308|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162814517|NCT03816891|588032309|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162814518|NCT03816891|588032310|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162814519|NCT03816891|588032311|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162814520|NCT03816891|588032312|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
162814521|NCT03816891|588032307|FG000|Double-Blind Period|Other|1|||
162814522|NCT03816891|588032308|FG001|Double-Blind Period|Other|0|||
162814523|NCT03816891|588032309|FG002|Double-Blind Period|Other|0|||
162814524|NCT03816891|588032310|FG003|Double-Blind Period|Other|0|||
162814525|NCT03816891|588032311|FG004|Double-Blind Period|Other|0|||
162814526|NCT03816891|588032312|FG005|Double-Blind Period|Other|0|||
162814527|NCT03816891|588032307|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162814528|NCT03816891|588032308|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162814529|NCT03816891|588032309|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
162814530|NCT03816891|588032310|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
162814531|NCT03816891|588032311|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
162814532|NCT03816891|588032312|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162814533|NCT03816891|588032307|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
162814534|NCT03816891|588032308|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
162814535|NCT03816891|588032309|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163165518|NCT01088048|589321565|FG007|Overall Study|Concomitant Medication Prohibited|0|||
163165519|NCT01088048|589321566|FG008|Overall Study|Concomitant Medication Prohibited|0|||
163165520|NCT01088048|589321567|FG009|Overall Study|Concomitant Medication Prohibited|0|||
162814536|NCT03816891|588032310|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
162814537|NCT03816891|588032311|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
162814538|NCT03816891|588032312|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
162814539|NCT03816891|588032307|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162814540|NCT03816891|588032308|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162814541|NCT03816891|588032309|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
162814542|NCT03816891|588032310|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162814543|NCT03816891|588032311|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
162814544|NCT03816891|588032312|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162814545|NCT03816891|588032307|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162814546|NCT03816891|588032308|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162814547|NCT03816891|588032309|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162814548|NCT03816891|588032310|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162814549|NCT03816891|588032311|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
162814550|NCT03816891|588032312|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
162814551|NCT03816891|588032307|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
162814552|NCT03816891|588032308|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
162814553|NCT03816891|588032309|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
162814554|NCT03816891|588032310|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
162814555|NCT03816891|588032311|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
163165521|NCT01088048|589321558|FG000|Overall Study|Investigator Request|2|||
163165522|NCT01088048|589321559|FG001|Overall Study|Investigator Request|2|||
162814556|NCT03816891|588032312|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
162814557|NCT02577029|588032313|FG000|Overall Study|Adverse Event|1|||
162814558|NCT02577029|588032314|FG001|Overall Study|Adverse Event|0|||
162814559|NCT02577029|588032315|FG002|Overall Study|Adverse Event|2|||
162814560|NCT02577029|588032316|FG003|Overall Study|Adverse Event|0|||
162814561|NCT02577029|588032317|FG004|Overall Study|Adverse Event|1|||
162814562|NCT02577029|588032318|FG005|Overall Study|Adverse Event|0|||
162814563|NCT02577029|588032319|FG006|Overall Study|Adverse Event|0|||
162814564|NCT02577029|588032320|FG007|Overall Study|Adverse Event|0|||
162814565|NCT02577029|588032313|FG000|Overall Study|Withdrawal by Subject|0|||
163165523|NCT01088048|589321560|FG002|Overall Study|Investigator Request|0|||
162814566|NCT02577029|588032314|FG001|Overall Study|Withdrawal by Subject|0|||
162814567|NCT02577029|588032315|FG002|Overall Study|Withdrawal by Subject|0|||
162814568|NCT02577029|588032316|FG003|Overall Study|Withdrawal by Subject|0|||
162814569|NCT02577029|588032317|FG004|Overall Study|Withdrawal by Subject|0|||
162814570|NCT02577029|588032318|FG005|Overall Study|Withdrawal by Subject|1|||
162814571|NCT02577029|588032319|FG006|Overall Study|Withdrawal by Subject|0|||
162814572|NCT02577029|588032320|FG007|Overall Study|Withdrawal by Subject|0|||
162814573|NCT02577029|588032313|FG000|Overall Study|Sponsor Termination of the Study|9|||
162814574|NCT02577029|588032314|FG001|Overall Study|Sponsor Termination of the Study|2|||
162814575|NCT02577029|588032315|FG002|Overall Study|Sponsor Termination of the Study|5|||
162814576|NCT02577029|588032316|FG003|Overall Study|Sponsor Termination of the Study|12|||
162814577|NCT02577029|588032317|FG004|Overall Study|Sponsor Termination of the Study|10|||
162814578|NCT02577029|588032318|FG005|Overall Study|Sponsor Termination of the Study|12|||
162814579|NCT02577029|588032319|FG006|Overall Study|Sponsor Termination of the Study|12|||
162814580|NCT02577029|588032320|FG007|Overall Study|Sponsor Termination of the Study|12|||
162814581|NCT02961218|588032828|FG000|Overall Study|Lost to Follow-up|0|||
162814582|NCT02961218|588032829|FG001|Overall Study|Lost to Follow-up|2|||
162814583|NCT02961218|588032828|FG000|Overall Study|Physician Decision|0|||
162814584|NCT02961218|588032829|FG001|Overall Study|Physician Decision|2|||
162814585|NCT02961218|588032828|FG000|Overall Study|Subject/Guardian Decision|3|||
162814586|NCT02961218|588032829|FG001|Overall Study|Subject/Guardian Decision|1|||
162814587|NCT04379518|588032832|FG000|Overall Study|Physician Decision|2|||
162814588|NCT04379518|588032833|FG001|Overall Study|Physician Decision|0|||
162814589|NCT04379518|588032834|FG002|Overall Study|Physician Decision|0|||
162814590|NCT04379518|588032835|FG003|Overall Study|Physician Decision|0|||
162814591|NCT04379518|588032836|FG004|Overall Study|Physician Decision|0|||
162814592|NCT04379518|588032832|FG000|Overall Study|Withdrawal by Subject|1|||
162814593|NCT04379518|588032833|FG001|Overall Study|Withdrawal by Subject|0|||
162814594|NCT04379518|588032834|FG002|Overall Study|Withdrawal by Subject|0|||
162814595|NCT04379518|588032835|FG003|Overall Study|Withdrawal by Subject|0|||
162814596|NCT04379518|588032836|FG004|Overall Study|Withdrawal by Subject|0|||
162814597|NCT05666505|588032837|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
162814598|NCT05135000|588032838|FG000|Overall Study|Adverse Event|2|||
162814599|NCT05135000|588032839|FG001|Overall Study|Adverse Event|0|||
162814600|NCT05135000|588032838|FG000|Overall Study|Lost to Follow-up|1|||
162814601|NCT05135000|588032839|FG001|Overall Study|Lost to Follow-up|0|||
162814602|NCT05135000|588032838|FG000|Overall Study|Study Terminated by Sponsor|6|||
162814603|NCT05135000|588032839|FG001|Overall Study|Study Terminated by Sponsor|3|||
162814604|NCT04751656|588034199|FG000|Overall Study|Lost to Follow-up|1|||
162814605|NCT01485354|588034205|FG000|Overall Study|Withdrawal by Subject|5|||
162814606|NCT03566810|588034206|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
162814607|NCT03566810|588034207|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
162814608|NCT03566810|588034208|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
162814609|NCT03566810|588034209|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
162814610|NCT01444651|588034212|FG000|Overall Study|Adverse Event|3|||
162814611|NCT01444651|588034213|FG001|Overall Study|Adverse Event|2|||
163165524|NCT01088048|589321561|FG003|Overall Study|Investigator Request|0|||
163165525|NCT01088048|589321562|FG004|Overall Study|Investigator Request|3|||
163165526|NCT01088048|589321563|FG005|Overall Study|Investigator Request|1|||
163165527|NCT01088048|589321564|FG006|Overall Study|Investigator Request|1|||
163165528|NCT01088048|589321565|FG007|Overall Study|Investigator Request|0|||
163165529|NCT01088048|589321566|FG008|Overall Study|Investigator Request|0|||
163165530|NCT01088048|589321567|FG009|Overall Study|Investigator Request|0|||
163165531|NCT01088048|589321558|FG000|Overall Study|Patient Non-compliance|0|||
163165532|NCT01088048|589321559|FG001|Overall Study|Patient Non-compliance|1|||
163165533|NCT01088048|589321560|FG002|Overall Study|Patient Non-compliance|0|||
163165534|NCT01088048|589321561|FG003|Overall Study|Patient Non-compliance|0|||
163165535|NCT01088048|589321562|FG004|Overall Study|Patient Non-compliance|0|||
162814612|NCT01444651|588034212|FG000|Overall Study|Lost to Follow-up|5|||
162814613|NCT01444651|588034213|FG001|Overall Study|Lost to Follow-up|5|||
162814614|NCT01444651|588034212|FG000|Overall Study|Non-fasting|2|||
162814615|NCT01444651|588034213|FG001|Overall Study|Non-fasting|1|||
162814616|NCT01444651|588034212|FG000|Overall Study|Missing data|1|||
162814617|NCT01444651|588034213|FG001|Overall Study|Missing data|1|||
162814618|NCT03338192|588034214|FG000|Year One to Year Two|High Blood Pressure|7|||
163165536|NCT01088048|589321563|FG005|Overall Study|Patient Non-compliance|0|||
163165537|NCT01088048|589321564|FG006|Overall Study|Patient Non-compliance|0|||
162814619|NCT03338192|588034215|FG001|Year One to Year Two|High Blood Pressure|1|||
162814620|NCT03338192|588034214|FG000|Year One to Year Two|HIV +|1|||
162814621|NCT03338192|588034215|FG001|Year One to Year Two|HIV +|0|||
162814622|NCT03338192|588034214|FG000|Year Two to Year Four|High Blood Pressure|1|||
162814623|NCT03338192|588034215|FG001|Year Two to Year Four|High Blood Pressure|0|||
163165538|NCT01088048|589321565|FG007|Overall Study|Patient Non-compliance|0|||
163165539|NCT01088048|589321566|FG008|Overall Study|Patient Non-compliance|0|||
163165540|NCT01088048|589321567|FG009|Overall Study|Patient Non-compliance|0|||
163165541|NCT01088048|589321558|FG000|Overall Study|Disease Progression|7|||
163165542|NCT01088048|589321559|FG001|Overall Study|Disease Progression|4|||
163165543|NCT01088048|589321560|FG002|Overall Study|Disease Progression|3|||
163165544|NCT01088048|589321561|FG003|Overall Study|Disease Progression|5|||
163165545|NCT01088048|589321562|FG004|Overall Study|Disease Progression|3|||
163165546|NCT01088048|589321563|FG005|Overall Study|Disease Progression|3|||
163165547|NCT01088048|589321564|FG006|Overall Study|Disease Progression|2|||
163165548|NCT01088048|589321565|FG007|Overall Study|Disease Progression|1|||
163165549|NCT01088048|589321566|FG008|Overall Study|Disease Progression|0|||
163165550|NCT01088048|589321567|FG009|Overall Study|Disease Progression|0|||
163165551|NCT01088048|589321558|FG000|Overall Study|Death|1|||
163165552|NCT01088048|589321559|FG001|Overall Study|Death|5|||
163165553|NCT01088048|589321560|FG002|Overall Study|Death|3|||
163165554|NCT01088048|589321561|FG003|Overall Study|Death|3|||
163165555|NCT01088048|589321562|FG004|Overall Study|Death|1|||
163165556|NCT01088048|589321563|FG005|Overall Study|Death|3|||
163165557|NCT01088048|589321564|FG006|Overall Study|Death|0|||
163165558|NCT01088048|589321565|FG007|Overall Study|Death|0|||
163165559|NCT01088048|589321566|FG008|Overall Study|Death|3|||
163165560|NCT01088048|589321567|FG009|Overall Study|Death|1|||
163165561|NCT01088048|589321558|FG000|Overall Study|Other|3|||
163165562|NCT01088048|589321559|FG001|Overall Study|Other|5|||
163165563|NCT01088048|589321560|FG002|Overall Study|Other|0|||
163165564|NCT01088048|589321561|FG003|Overall Study|Other|0|||
163165565|NCT01088048|589321562|FG004|Overall Study|Other|2|||
163165566|NCT01088048|589321563|FG005|Overall Study|Other|0|||
163165567|NCT01088048|589321564|FG006|Overall Study|Other|0|||
163165568|NCT01088048|589321565|FG007|Overall Study|Other|2|||
163165569|NCT01088048|589321566|FG008|Overall Study|Other|0|||
163165570|NCT01088048|589321567|FG009|Overall Study|Other|0|||
163165571|NCT01343693|589321573|FG000|Overall Study|Lost to Follow-up|9|||
163165572|NCT01235598|589321574|FG000|Overall Study|Adverse Event|0|||
163165573|NCT01235598|589321575|FG001|Overall Study|Adverse Event|3|||
163165574|NCT01235598|589321574|FG000|Overall Study|Lack of Efficacy|0|||
163165575|NCT01235598|589321575|FG001|Overall Study|Lack of Efficacy|1|||
163165576|NCT01235598|589321574|FG000|Overall Study|Withdrawal by Subject|1|||
163165577|NCT01235598|589321575|FG001|Overall Study|Withdrawal by Subject|0|||
163165578|NCT00395343|589321576|FG000|Overall Study|Adverse Event|13|||
163165579|NCT00395343|589321577|FG001|Overall Study|Adverse Event|5|||
163165580|NCT00395343|589321576|FG000|Overall Study|Lack of Efficacy|0|||
163165581|NCT00395343|589321577|FG001|Overall Study|Lack of Efficacy|1|||
163165582|NCT00395343|589321576|FG000|Overall Study|Lost to Follow-up|4|||
163165583|NCT00395343|589321577|FG001|Overall Study|Lost to Follow-up|4|||
163165584|NCT00395343|589321576|FG000|Overall Study|Physician Decision|2|||
163165585|NCT00395343|589321577|FG001|Overall Study|Physician Decision|4|||
163165586|NCT00395343|589321576|FG000|Overall Study|Protocol Violation|6|||
163165587|NCT00395343|589321577|FG001|Overall Study|Protocol Violation|8|||
163165588|NCT00395343|589321576|FG000|Overall Study|Withdrawal by Subject|11|||
163165589|NCT00395343|589321577|FG001|Overall Study|Withdrawal by Subject|12|||
163165590|NCT00395343|589321576|FG000|Overall Study|Other|5|||
163165591|NCT00395343|589321577|FG001|Overall Study|Other|2|||
163165592|NCT01667419|589321578|FG000|Overall Study|Reason Not Specified|1|||
163165593|NCT01667419|589321579|FG001|Overall Study|Reason Not Specified|0|||
163165594|NCT01667419|589321580|FG002|Overall Study|Reason Not Specified|0|||
163165595|NCT01667419|589321581|FG003|Overall Study|Reason Not Specified|0|||
163165596|NCT01667419|589321578|FG000|Overall Study|Withdrawal by Subject|16|||
163165597|NCT01667419|589321579|FG001|Overall Study|Withdrawal by Subject|8|||
163165598|NCT01667419|589321580|FG002|Overall Study|Withdrawal by Subject|9|||
163165599|NCT01667419|589321581|FG003|Overall Study|Withdrawal by Subject|8|||
163165600|NCT01667419|589321578|FG000|Overall Study|Non-compliance|0|||
163165601|NCT01667419|589321579|FG001|Overall Study|Non-compliance|0|||
163165602|NCT01667419|589321580|FG002|Overall Study|Non-compliance|0|||
163165603|NCT01667419|589321581|FG003|Overall Study|Non-compliance|1|||
163165604|NCT01667419|589321578|FG000|Overall Study|Protocol Violation|1|||
163165605|NCT01667419|589321579|FG001|Overall Study|Protocol Violation|0|||
163165606|NCT01667419|589321580|FG002|Overall Study|Protocol Violation|0|||
163165607|NCT01667419|589321581|FG003|Overall Study|Protocol Violation|0|||
163165608|NCT01667419|589321578|FG000|Overall Study|Lost to Follow-up|7|||
163165609|NCT01667419|589321579|FG001|Overall Study|Lost to Follow-up|6|||
163165610|NCT01667419|589321580|FG002|Overall Study|Lost to Follow-up|2|||
163165611|NCT01667419|589321581|FG003|Overall Study|Lost to Follow-up|4|||
163165612|NCT01667419|589321578|FG000|Overall Study|Death|18|||
163165613|NCT01667419|589321579|FG001|Overall Study|Death|33|||
163165614|NCT01667419|589321580|FG002|Overall Study|Death|25|||
163165615|NCT01667419|589321581|FG003|Overall Study|Death|26|||
163165616|NCT03869216|589321583|FG000|Overall Study|prostate removed during the study|1|||
163165617|NCT03869216|589321584|FG001|Overall Study|prostate removed during the study|1|||
163165618|NCT03869216|589321583|FG000|Overall Study|Withdrawal by Subject|0|||
163165619|NCT03869216|589321584|FG001|Overall Study|Withdrawal by Subject|1|||
163165620|NCT03869216|589321583|FG000|Overall Study|Lost to Follow-up|3|||
163165621|NCT03869216|589321584|FG001|Overall Study|Lost to Follow-up|12|||
163165622|NCT03869216|589321583|FG000|Overall Study|Changed clinical site or moved out of city|5|||
163165623|NCT03869216|589321584|FG001|Overall Study|Changed clinical site or moved out of city|9|||
163165624|NCT03869216|589321583|FG000|Overall Study|No primary care appointment scheduled|10|||
163165625|NCT03869216|589321584|FG001|Overall Study|No primary care appointment scheduled|4|||
163165626|NCT03869216|589321583|FG000|Overall Study|Death|1|||
163165627|NCT03869216|589321584|FG001|Overall Study|Death|1|||
163165628|NCT03646123|589321585|FG000|Overall Study|Withdrawal by Subject|2|||
163165629|NCT03646123|589321586|FG001|Overall Study|Withdrawal by Subject|2|||
163165630|NCT03646123|589321587|FG002|Overall Study|Withdrawal by Subject|3|||
163165631|NCT03646123|589321585|FG000|Overall Study|Study termination by sponsor|0|||
163165632|NCT03646123|589321586|FG001|Overall Study|Study termination by sponsor|45|||
163165633|NCT03646123|589321587|FG002|Overall Study|Study termination by sponsor|139|||
163165634|NCT03646123|589321585|FG000|Overall Study|Lost to Follow-up|4|||
163165635|NCT03646123|589321586|FG001|Overall Study|Lost to Follow-up|10|||
163165636|NCT03646123|589321587|FG002|Overall Study|Lost to Follow-up|10|||
163165637|NCT03646123|589321585|FG000|Overall Study|Death|2|||
163165638|NCT03646123|589321586|FG001|Overall Study|Death|1|||
163165639|NCT03646123|589321587|FG002|Overall Study|Death|1|||
163165640|NCT03646123|589321585|FG000|Overall Study|Other|2|||
163165641|NCT03646123|589321586|FG001|Overall Study|Other|0|||
163165642|NCT03646123|589321587|FG002|Overall Study|Other|2|||
163165643|NCT03860259|589321594|FG000|Overall Study|Lost to Follow-up|5|||
163165644|NCT03860259|589321595|FG001|Overall Study|Lost to Follow-up|5|||
163165645|NCT03860259|589321594|FG000|Overall Study|Protocol Violation|1|||
163165646|NCT03860259|589321595|FG001|Overall Study|Protocol Violation|0|||
163165647|NCT02280408|589321596|FG000|Overall Study|Lost to Follow-up|0|||
163165648|NCT02280408|589321597|FG001|Overall Study|Lost to Follow-up|2|||
163165649|NCT02280408|589321598|FG002|Overall Study|Lost to Follow-up|0|||
163165650|NCT02280408|589321599|FG003|Overall Study|Lost to Follow-up|0|||
163165651|NCT01068600|589321600|FG000|Overall Study|Withdrawal by Subject|5|||
163165652|NCT01068600|589321601|FG001|Overall Study|Withdrawal by Subject|6|||
163165653|NCT01068600|589321600|FG000|Overall Study|Adverse Event|3|||
163165654|NCT01068600|589321601|FG001|Overall Study|Adverse Event|3|||
163165655|NCT01068600|589321600|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163165656|NCT01068600|589321601|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163165657|NCT01068600|589321600|FG000|Overall Study|Lost to Follow-up|1|||
163165658|NCT01068600|589321601|FG001|Overall Study|Lost to Follow-up|2|||
163165659|NCT01068600|589321600|FG000|Overall Study|Protocol deviation|1|||
163165660|NCT01068600|589321601|FG001|Overall Study|Protocol deviation|1|||
163165661|NCT01068600|589321600|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163165662|NCT01068600|589321601|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163165663|NCT01068600|589321600|FG000|Overall Study|Administrative problems|0|||
163165664|NCT01068600|589321601|FG001|Overall Study|Administrative problems|1|||
163165665|NCT01519869|589321604|FG000|Overall Study|Lost to Follow-up|1|||
163165666|NCT01015638|589321613|FG000|Overall Study|Withdrawal by Subject|1|||
163165667|NCT01015638|589321614|FG001|Overall Study|Withdrawal by Subject|0|||
163165668|NCT02164461|589321615|FG000|Overall Study|Adverse Event|0|||
163165669|NCT02164461|589321616|FG001|Overall Study|Adverse Event|0|||
163165670|NCT02164461|589321617|FG002|Overall Study|Adverse Event|1|||
163165671|NCT02164461|589321615|FG000|Overall Study|Disease Progression|1|||
163165672|NCT02164461|589321616|FG001|Overall Study|Disease Progression|3|||
163165673|NCT02164461|589321617|FG002|Overall Study|Disease Progression|4|||
163165674|NCT02164461|589321615|FG000|Overall Study|Withdrawal by Subject|0|||
163165675|NCT02164461|589321616|FG001|Overall Study|Withdrawal by Subject|3|||
163165676|NCT02164461|589321617|FG002|Overall Study|Withdrawal by Subject|0|||
163165677|NCT00324961|589321619|FG000|Overall Study|Adverse Event|5|||
163165678|NCT00324961|589321619|FG000|Overall Study|Consent Withdrawn|11|||
163165679|NCT00324961|589321619|FG000|Overall Study|Lost to Follow-up|22|||
163165680|NCT00324961|589321619|FG000|Overall Study|Protocol Violation|3|||
163165681|NCT00324961|589321619|FG000|Overall Study|Other|2|||
162698050|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
163165682|NCT00344487|589321620|FG000|Overall Study|immunologic failure|1|||
163165683|NCT04927364|589321623|FG000|Overall Study|Withdrawal by Subject|3|||
163165684|NCT04927364|589321623|FG000|Overall Study|Unable to complete preassessment MRI|1|||
163165685|NCT05188053|589321627|FG000|Overall Study|Lost to Follow-up|23|||
163165686|NCT05188053|589321628|FG001|Overall Study|Lost to Follow-up|30|||
163165687|NCT05188053|589321627|FG000|Overall Study|Protocol Violation|16|||
163165688|NCT05188053|589321628|FG001|Overall Study|Protocol Violation|16|||
163165689|NCT05188053|589321627|FG000|Overall Study|Physician Decision|3|||
163165690|NCT05188053|589321628|FG001|Overall Study|Physician Decision|0|||
163165691|NCT05188053|589321627|FG000|Overall Study|Withdrawal by Subject|0|||
163165692|NCT05188053|589321628|FG001|Overall Study|Withdrawal by Subject|1|||
163165693|NCT01761240|589321632|FG000|Overall Study|Progressive disease:radiology assessment|3|||
163165694|NCT01761240|589321633|FG001|Overall Study|Progressive disease:radiology assessment|3|||
163165695|NCT01761240|589321634|FG002|Overall Study|Progressive disease:radiology assessment|0|||
163165696|NCT01761240|589321635|FG003|Overall Study|Progressive disease:radiology assessment|0|||
163165697|NCT01761240|589321636|FG004|Overall Study|Progressive disease:radiology assessment|0|||
163165698|NCT01761240|589321632|FG000|Overall Study|Progressive disease:clinical assessment|0|||
163165699|NCT01761240|589321633|FG001|Overall Study|Progressive disease:clinical assessment|0|||
163165700|NCT01761240|589321634|FG002|Overall Study|Progressive disease:clinical assessment|3|||
163165701|NCT01761240|589321635|FG003|Overall Study|Progressive disease:clinical assessment|1|||
163165702|NCT01761240|589321636|FG004|Overall Study|Progressive disease:clinical assessment|0|||
163165703|NCT01761240|589321632|FG000|Overall Study|Withdrawal by Subject|0|||
163165704|NCT01761240|589321633|FG001|Overall Study|Withdrawal by Subject|0|||
163165705|NCT01761240|589321634|FG002|Overall Study|Withdrawal by Subject|0|||
163165706|NCT01761240|589321635|FG003|Overall Study|Withdrawal by Subject|3|||
163165707|NCT01761240|589321636|FG004|Overall Study|Withdrawal by Subject|1|||
163165708|NCT01761240|589321632|FG000|Overall Study|Adverse Event|0|||
163165709|NCT01761240|589321633|FG001|Overall Study|Adverse Event|0|||
163165710|NCT01761240|589321634|FG002|Overall Study|Adverse Event|0|||
163165711|NCT01761240|589321635|FG003|Overall Study|Adverse Event|1|||
163165712|NCT01761240|589321636|FG004|Overall Study|Adverse Event|6|||
163165713|NCT01761240|589321632|FG000|Overall Study|Death|0|||
163165714|NCT01761240|589321633|FG001|Overall Study|Death|1|||
163165715|NCT01761240|589321634|FG002|Overall Study|Death|1|||
163165716|NCT01761240|589321635|FG003|Overall Study|Death|2|||
163165717|NCT01761240|589321636|FG004|Overall Study|Death|1|||
163165718|NCT01761240|589321632|FG000|Overall Study|Non-compliance|0|||
163165719|NCT01761240|589321633|FG001|Overall Study|Non-compliance|0|||
163165720|NCT01761240|589321634|FG002|Overall Study|Non-compliance|1|||
163165721|NCT01761240|589321635|FG003|Overall Study|Non-compliance|0|||
163165722|NCT01761240|589321636|FG004|Overall Study|Non-compliance|0|||
163165723|NCT02355184|589321644|FG000|Overall Study|Lost to Follow-up|2|||
163165724|NCT02355184|589321644|FG000|Overall Study|Study Terminated|10|||
163165725|NCT06173063|589321645|FG000|Overall Study|Withdrawal by Subject|2|||
163165726|NCT03254459|589322719|FG000|Overall Study|Adverse Event|7|||
163165727|NCT03254459|589322720|FG001|Overall Study|Adverse Event|20|||
163165728|NCT03254459|589322719|FG000|Overall Study|Withdrawal by Subject Consent|3|||
163165729|NCT03254459|589322720|FG001|Overall Study|Withdrawal by Subject Consent|1|||
163165730|NCT03254459|589322719|FG000|Overall Study|Lost to Follow-up|0|||
163165731|NCT03254459|589322720|FG001|Overall Study|Lost to Follow-up|1|||
163165732|NCT03254459|589322719|FG000|Overall Study|Miscellaneous|0|||
163165733|NCT03254459|589322720|FG001|Overall Study|Miscellaneous|1|||
163165734|NCT01904773|589322721|FG000|Screen|Screen failure|3|||
163165735|NCT01904773|589322722|FG001|Screen|Screen failure|0|||
163165736|NCT01904773|589322723|FG002|Screen|Screen failure|0|||
163165737|NCT01904773|589322724|FG003|Screen|Screen failure|0|||
163165738|NCT01904773|589322725|FG004|Screen|Screen failure|0|||
163165739|NCT01904773|589322726|FG005|Screen|Screen failure|0|||
163165740|NCT01904773|589322727|FG006|Screen|Screen failure|0|||
163165741|NCT01904773|589322728|FG007|Screen|Screen failure|0|||
163165742|NCT01904773|589322729|FG008|Screen|Screen failure|0|||
163165743|NCT01904773|589322721|FG000|Screen|Withdrawal by Subject|1|||
163165744|NCT01904773|589322722|FG001|Screen|Withdrawal by Subject|0|||
163165745|NCT01904773|589322723|FG002|Screen|Withdrawal by Subject|0|||
163165746|NCT01904773|589322724|FG003|Screen|Withdrawal by Subject|0|||
163165747|NCT01904773|589322725|FG004|Screen|Withdrawal by Subject|0|||
163165748|NCT01904773|589322726|FG005|Screen|Withdrawal by Subject|0|||
162814624|NCT03338192|588034214|FG000|Year Two to Year Four|HIV +|2|||
162814625|NCT03338192|588034215|FG001|Year Two to Year Four|HIV +|0|||
162814626|NCT03338192|588034214|FG000|Year Four to Year Six|High Blood Pressure|2|||
163165749|NCT01904773|589322727|FG006|Screen|Withdrawal by Subject|0|||
163165750|NCT01904773|589322728|FG007|Screen|Withdrawal by Subject|0|||
163165751|NCT01904773|589322729|FG008|Screen|Withdrawal by Subject|0|||
163165752|NCT01904773|589322721|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
163165753|NCT01904773|589322722|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165754|NCT01904773|589322723|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165755|NCT01904773|589322724|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165756|NCT01904773|589322725|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165757|NCT01904773|589322726|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165758|NCT01904773|589322727|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165759|NCT01904773|589322728|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165760|NCT01904773|589322729|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
163165761|NCT01904773|589322721|FG000|First Intervention|Adverse Event|0|||
163165762|NCT01904773|589322722|FG001|First Intervention|Adverse Event|0|||
163165763|NCT01904773|589322723|FG002|First Intervention|Adverse Event|0|||
163165764|NCT01904773|589322724|FG003|First Intervention|Adverse Event|0|||
163165765|NCT01904773|589322725|FG004|First Intervention|Adverse Event|0|||
163165766|NCT01904773|589322726|FG005|First Intervention|Adverse Event|0|||
163165767|NCT01904773|589322727|FG006|First Intervention|Adverse Event|1|||
163165768|NCT01904773|589322728|FG007|First Intervention|Adverse Event|0|||
163165769|NCT01904773|589322729|FG008|First Intervention|Adverse Event|0|||
163165770|NCT01904773|589322721|FG000|Placebo Washout First Intervention|Condition worsened|0|||
163165771|NCT01904773|589322722|FG001|Placebo Washout First Intervention|Condition worsened|1|||
163165772|NCT01904773|589322723|FG002|Placebo Washout First Intervention|Condition worsened|0|||
163042819|NCT01990768|588863969|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
163165773|NCT01904773|589322724|FG003|Placebo Washout First Intervention|Condition worsened|0|||
163165774|NCT01904773|589322725|FG004|Placebo Washout First Intervention|Condition worsened|0|||
163165775|NCT01904773|589322726|FG005|Placebo Washout First Intervention|Condition worsened|0|||
163165776|NCT01904773|589322727|FG006|Placebo Washout First Intervention|Condition worsened|0|||
163165777|NCT01904773|589322728|FG007|Placebo Washout First Intervention|Condition worsened|0|||
163165778|NCT01904773|589322729|FG008|Placebo Washout First Intervention|Condition worsened|0|||
163165779|NCT01904773|589322721|FG000|Fifth Intervention|Adverse Event|0|||
163165780|NCT01904773|589322722|FG001|Fifth Intervention|Adverse Event|0|||
163165781|NCT01904773|589322723|FG002|Fifth Intervention|Adverse Event|0|||
163165782|NCT01904773|589322724|FG003|Fifth Intervention|Adverse Event|0|||
163165783|NCT01904773|589322725|FG004|Fifth Intervention|Adverse Event|0|||
163165784|NCT01904773|589322726|FG005|Fifth Intervention|Adverse Event|0|||
163165785|NCT01904773|589322727|FG006|Fifth Intervention|Adverse Event|0|||
163165786|NCT01904773|589322728|FG007|Fifth Intervention|Adverse Event|1|||
163165787|NCT01904773|589322729|FG008|Fifth Intervention|Adverse Event|0|||
163165788|NCT01904773|589322721|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165789|NCT01904773|589322722|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
163165790|NCT01904773|589322723|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165791|NCT01904773|589322724|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165792|NCT01904773|589322725|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165793|NCT01904773|589322726|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165794|NCT01904773|589322727|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165795|NCT01904773|589322728|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165796|NCT01904773|589322729|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
163165797|NCT00220779|589322730|FG000|Overall Study|Adverse Event|1|||
163165798|NCT00220779|589322731|FG001|Overall Study|Adverse Event|0|||
163165799|NCT00220779|589322732|FG002|Overall Study|Adverse Event|0|||
163165800|NCT00220779|589322730|FG000|Overall Study|Withdrawal by Subject|1|||
163165801|NCT00220779|589322731|FG001|Overall Study|Withdrawal by Subject|4|||
163165802|NCT00220779|589322732|FG002|Overall Study|Withdrawal by Subject|1|||
163165803|NCT00220779|589322730|FG000|Overall Study|Non-compliance|1|||
163165804|NCT00220779|589322731|FG001|Overall Study|Non-compliance|0|||
163165805|NCT00220779|589322732|FG002|Overall Study|Non-compliance|0|||
163165806|NCT00220779|589322730|FG000|Overall Study|Too time consuming|1|||
163165807|NCT00220779|589322731|FG001|Overall Study|Too time consuming|0|||
163165808|NCT00220779|589322732|FG002|Overall Study|Too time consuming|0|||
163165809|NCT00220779|589322730|FG000|Overall Study|Pregnancy|0|||
163165810|NCT00220779|589322731|FG001|Overall Study|Pregnancy|0|||
163165811|NCT00220779|589322732|FG002|Overall Study|Pregnancy|2|||
163165812|NCT00220779|589322730|FG000|Overall Study|Lack of Efficacy|3|||
163165813|NCT00220779|589322731|FG001|Overall Study|Lack of Efficacy|0|||
163165814|NCT00220779|589322732|FG002|Overall Study|Lack of Efficacy|1|||
163165815|NCT01511055|589322735|FG000|Overall Study|Withdrawal by Subject|6|||
163165816|NCT04590248|589322740|FG000|Overall Study|Lost to Follow-up|1|||
163165817|NCT04590248|589322740|FG000|Overall Study|Withdrawal by Subject|16|||
163165818|NCT04590248|589322740|FG000|Overall Study|Other|2|||
163165819|NCT02891070|589322743|FG000|Overall Study|Adverse Event|1|||
163165820|NCT02891070|589322744|FG001|Overall Study|Adverse Event|0|||
163165821|NCT02891070|589322743|FG000|Overall Study|Physician Decision|0|||
163165822|NCT02891070|589322744|FG001|Overall Study|Physician Decision|1|||
163165823|NCT02891070|589322743|FG000|Overall Study|Lost to Follow-up|4|||
163165824|NCT02891070|589322744|FG001|Overall Study|Lost to Follow-up|4|||
163165825|NCT02891070|589322743|FG000|Overall Study|Other|1|||
163165826|NCT02891070|589322744|FG001|Overall Study|Other|0|||
163165827|NCT02891070|589322743|FG000|Overall Study|Protocol Violation|0|||
163165828|NCT02891070|589322744|FG001|Overall Study|Protocol Violation|1|||
163165829|NCT02891070|589322743|FG000|Overall Study|Withdrawal by Subject|1|||
163165830|NCT02891070|589322744|FG001|Overall Study|Withdrawal by Subject|2|||
162698051|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
162698052|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
163165831|NCT02891070|589322743|FG000|Overall Study|Death|3|||
163165832|NCT02891070|589322744|FG001|Overall Study|Death|0|||
162698053|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
162698054|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
162698055|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
162698056|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
163165833|NCT02704143|589322745|FG000|Overall Study|disease progression|10|||
163165834|NCT02551991|589322750|FG000|Overall Study|Death|5|||
162698057|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
163165835|NCT02551991|589322751|FG001|Overall Study|Death|7|||
163165836|NCT02551991|589322752|FG002|Overall Study|Death|8|||
163165837|NCT02551991|589322753|FG003|Overall Study|Death|7|||
163165838|NCT02551991|589322754|FG004|Overall Study|Death|17|||
163165839|NCT02551991|589322750|FG000|Overall Study|Withdrawal by Subject|1|||
163165840|NCT02551991|589322751|FG001|Overall Study|Withdrawal by Subject|0|||
163165841|NCT02551991|589322752|FG002|Overall Study|Withdrawal by Subject|0|||
163165842|NCT02551991|589322753|FG003|Overall Study|Withdrawal by Subject|0|||
163165843|NCT02551991|589322754|FG004|Overall Study|Withdrawal by Subject|2|||
163165844|NCT02551991|589322750|FG000|Overall Study|Lost to Follow-up|0|||
163165845|NCT02551991|589322751|FG001|Overall Study|Lost to Follow-up|0|||
163165846|NCT02551991|589322752|FG002|Overall Study|Lost to Follow-up|1|||
163165847|NCT02551991|589322753|FG003|Overall Study|Lost to Follow-up|0|||
163165848|NCT02551991|589322754|FG004|Overall Study|Lost to Follow-up|0|||
163165849|NCT02551991|589322750|FG000|Overall Study|Sponsor Decision|1|||
163165850|NCT02551991|589322751|FG001|Overall Study|Sponsor Decision|0|||
163165851|NCT02551991|589322752|FG002|Overall Study|Sponsor Decision|1|||
163165852|NCT02551991|589322753|FG003|Overall Study|Sponsor Decision|0|||
163165853|NCT02551991|589322754|FG004|Overall Study|Sponsor Decision|5|||
163165854|NCT02551991|589322750|FG000|Overall Study|Other|0|||
163165855|NCT02551991|589322751|FG001|Overall Study|Other|0|||
163165856|NCT02551991|589322752|FG002|Overall Study|Other|0|||
163165857|NCT02551991|589322753|FG003|Overall Study|Other|0|||
163165858|NCT02551991|589322754|FG004|Overall Study|Other|1|||
163165859|NCT00942994|589322758|FG000|Overall Study|Adverse Event|7|||
163165860|NCT00942994|589322759|FG001|Overall Study|Adverse Event|4|||
163165861|NCT00942994|589322758|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163165862|NCT00942994|589322759|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163165863|NCT00942994|589322758|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163165864|NCT00942994|589322759|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163165865|NCT00942994|589322758|FG000|Overall Study|Patient withdrew consent|5|||
163165866|NCT00942994|589322759|FG001|Overall Study|Patient withdrew consent|8|||
163165867|NCT00942994|589322758|FG000|Overall Study|Lost to Follow-up|1|||
162814627|NCT03338192|588034215|FG001|Year Four to Year Six|High Blood Pressure|1|||
162814628|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
162814629|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
162814630|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
162814631|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
162814632|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
162814633|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
162814634|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
162814635|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
162814636|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
162814637|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
163165868|NCT00942994|589322759|FG001|Overall Study|Lost to Follow-up|4|||
163165869|NCT00942994|589322758|FG000|Overall Study|Protocol deviation|1|||
163165870|NCT00942994|589322759|FG001|Overall Study|Protocol deviation|2|||
163165871|NCT00387790|589322760|FG000|Overall Study|Adverse Event|5|||
163165872|NCT00387790|589322760|FG000|Overall Study|Lack of Efficacy|2|||
163165873|NCT00387790|589322760|FG000|Overall Study|Physician Decision|2|||
163165874|NCT00387790|589322760|FG000|Overall Study|Withdrawal by Subject|3|||
163165875|NCT00387790|589322760|FG000|Overall Study|Ineligible for study|2|||
163165876|NCT04491604|589322761|FG000|Overall Study|Withdrawal by Subject|3|||
163165877|NCT01536067|589322765|FG000|Overall Study|Disease Progression|1|||
163165878|NCT00606905|589322766|FG000|Overall Study|No Pregnancy|9|||
163165879|NCT00606905|589322767|FG001|Overall Study|No Pregnancy|6|||
163165880|NCT00606905|589322766|FG000|Overall Study|Non-Index Pregnancy|1|||
163165881|NCT00606905|589322767|FG001|Overall Study|Non-Index Pregnancy|4|||
163165882|NCT00606905|589322766|FG000|Overall Study|Withdrew|5|||
163165883|NCT00606905|589322767|FG001|Overall Study|Withdrew|5|||
163165884|NCT04657666|589322768|FG000|Period 1|Withdrawal of participant consent|2|||
163165885|NCT04657666|589322769|FG001|Period 1|Withdrawal of participant consent|1|||
163165886|NCT04657666|589322768|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
163165887|NCT04657666|589322769|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
163165888|NCT04657666|589322768|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
163165889|NCT04657666|589322769|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
162814638|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
162814639|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
162814640|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Death|3|||
163165890|NCT04657666|589322768|FG000|Period 2|Other|2|||
163165891|NCT04657666|589322769|FG001|Period 2|Other|0|||
163165892|NCT04657666|589322768|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
163165893|NCT04657666|589322769|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
163165894|NCT02386189|589322771|FG000|Overall Study|Lost to Follow-up|2|||
163165895|NCT02386189|589322772|FG001|Overall Study|Lost to Follow-up|3|||
163165896|NCT02386189|589322771|FG000|Overall Study|Withdrawal by Subject|1|||
163165897|NCT02386189|589322772|FG001|Overall Study|Withdrawal by Subject|0|||
163165898|NCT02386189|589322771|FG000|Overall Study|Death|1|||
163165899|NCT02386189|589322772|FG001|Overall Study|Death|0|||
163165900|NCT03120351|589322773|FG000|Overall Study|Physician Decision|1|||
163165901|NCT03120351|589322774|FG001|Overall Study|Physician Decision|1|||
163165902|NCT04931888|589322776|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
163165903|NCT04931888|589322777|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
163165904|NCT04931888|589322778|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
163165905|NCT04931888|589322779|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
163165906|NCT01022398|589322780|FG000|Overall Study|Study terminated|2|||
163165907|NCT01022398|589322781|FG001|Overall Study|Study terminated|2|||
163165908|NCT02969408|589322783|FG000|Overall Study|Adverse Event|2|||
163165909|NCT02969408|589322783|FG000|Overall Study|Withdrawal by Subject|8|||
163165910|NCT02969408|589322783|FG000|Overall Study|Lost to Follow-up|4|||
163165911|NCT02969408|589322783|FG000|Overall Study|Protocol Violation|1|||
163165912|NCT02969408|589322783|FG000|Overall Study|Other than specified|1|||
163165913|NCT02350478|589322784|FG000|Overall Study|Lost to Follow-up|5|||
163165914|NCT02350478|589322785|FG001|Overall Study|Lost to Follow-up|1|||
163165915|NCT03330002|589322786|FG000|Overall Study|Lost to Follow-up|15|||
163165916|NCT03330002|589322786|FG000|Overall Study|Death|7|||
163165917|NCT00486291|589322789|FG000|Overall Study|Adverse Event|3|||
163165918|NCT00486291|589322790|FG001|Overall Study|Adverse Event|4|||
163165919|NCT00486291|589322789|FG000|Overall Study|Lost to Follow-up|3|||
163165920|NCT00486291|589322790|FG001|Overall Study|Lost to Follow-up|7|||
163165921|NCT00486291|589322789|FG000|Overall Study|protocol non-compliance|10|||
163165922|NCT00486291|589322790|FG001|Overall Study|protocol non-compliance|15|||
163165923|NCT00486291|589322789|FG000|Overall Study|requirement for restricted medication|0|||
163165924|NCT00486291|589322790|FG001|Overall Study|requirement for restricted medication|3|||
163165925|NCT02745145|589322791|FG000|Overall Study|Adverse Event|1|||
163165926|NCT02745145|589322792|FG001|Overall Study|Adverse Event|0|||
163165927|NCT02745145|589322793|FG002|Overall Study|Adverse Event|0|||
163165928|NCT02745145|589322791|FG000|Overall Study|Death|0|||
163165929|NCT02745145|589322792|FG001|Overall Study|Death|1|||
163165930|NCT02745145|589322793|FG002|Overall Study|Death|0|||
163165931|NCT02745145|589322791|FG000|Overall Study|Progressive disease|0|||
163165932|NCT02745145|589322792|FG001|Overall Study|Progressive disease|0|||
163165933|NCT02745145|589322793|FG002|Overall Study|Progressive disease|1|||
163165934|NCT02745145|589322791|FG000|Overall Study|Withdrew consent|1|||
163165935|NCT02745145|589322792|FG001|Overall Study|Withdrew consent|1|||
163165936|NCT02745145|589322793|FG002|Overall Study|Withdrew consent|1|||
163165937|NCT02745145|589322791|FG000|Overall Study|Study Termination|8|||
163165938|NCT02745145|589322792|FG001|Overall Study|Study Termination|3|||
163165939|NCT02745145|589322793|FG002|Overall Study|Study Termination|7|||
163165940|NCT04413617|589322799|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165941|NCT04413617|589322800|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165942|NCT04413617|589322801|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165943|NCT04413617|589322802|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
163165944|NCT04413617|589322803|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
163165945|NCT04413617|589322799|FG000|Overall Study|Protocol Violation|0|||
163165946|NCT04413617|589322800|FG001|Overall Study|Protocol Violation|1|||
163165947|NCT04413617|589322801|FG002|Overall Study|Protocol Violation|0|||
163165948|NCT04413617|589322802|FG003|Overall Study|Protocol Violation|0|||
163165949|NCT04413617|589322803|FG004|Overall Study|Protocol Violation|1|||
163165950|NCT04413617|589322799|FG000|Overall Study|Lack of Efficacy|2|||
163165951|NCT04413617|589322800|FG001|Overall Study|Lack of Efficacy|0|||
163165952|NCT04413617|589322801|FG002|Overall Study|Lack of Efficacy|2|||
163165953|NCT04413617|589322802|FG003|Overall Study|Lack of Efficacy|1|||
163165954|NCT04413617|589322803|FG004|Overall Study|Lack of Efficacy|0|||
163165955|NCT04413617|589322799|FG000|Overall Study|Withdrawal by Subject|3|||
163165956|NCT04413617|589322800|FG001|Overall Study|Withdrawal by Subject|4|||
163165957|NCT04413617|589322801|FG002|Overall Study|Withdrawal by Subject|2|||
163165958|NCT04413617|589322802|FG003|Overall Study|Withdrawal by Subject|5|||
163165959|NCT04413617|589322803|FG004|Overall Study|Withdrawal by Subject|3|||
163165960|NCT04413617|589322799|FG000|Overall Study|Death|1|||
163165961|NCT04413617|589322800|FG001|Overall Study|Death|0|||
163165962|NCT04413617|589322801|FG002|Overall Study|Death|0|||
163165963|NCT04413617|589322802|FG003|Overall Study|Death|0|||
163165964|NCT04413617|589322803|FG004|Overall Study|Death|0|||
163165965|NCT04413617|589322799|FG000|Overall Study|Adverse Event|1|||
163165966|NCT04413617|589322800|FG001|Overall Study|Adverse Event|0|||
163165967|NCT04413617|589322801|FG002|Overall Study|Adverse Event|0|||
163165968|NCT04413617|589322802|FG003|Overall Study|Adverse Event|1|||
163165969|NCT04413617|589322803|FG004|Overall Study|Adverse Event|1|||
163165970|NCT04413617|589322799|FG000|Overall Study|COVID-19|0|||
163165971|NCT04413617|589322800|FG001|Overall Study|COVID-19|1|||
163165972|NCT04413617|589322801|FG002|Overall Study|COVID-19|0|||
163165973|NCT04413617|589322802|FG003|Overall Study|COVID-19|0|||
163165974|NCT04413617|589322803|FG004|Overall Study|COVID-19|0|||
163165975|NCT00775593|589322804|FG000|Overall Study|Unmet eligibility criteria|6|||
163165976|NCT00775593|589322804|FG000|Overall Study|Death|1|||
163165977|NCT00984620|589322807|FG000|Overall Study|Adverse Event|5|||
163165978|NCT00984620|589322808|FG001|Overall Study|Adverse Event|5|||
163165979|NCT00984620|589322807|FG000|Overall Study|Lost to Follow-up|1|||
163165980|NCT00984620|589322808|FG001|Overall Study|Lost to Follow-up|1|||
163165981|NCT00984620|589322807|FG000|Overall Study|Withdrawal by Subject|0|||
163165982|NCT00984620|589322808|FG001|Overall Study|Withdrawal by Subject|2|||
163165983|NCT00984620|589322807|FG000|Overall Study|reason other than listed above|0|||
163165984|NCT00984620|589322808|FG001|Overall Study|reason other than listed above|4|||
163165985|NCT01703754|589322809|FG000|Overall Study|Clinically significant disease progression|2|||
163165986|NCT01703754|589322810|FG001|Overall Study|Clinically significant disease progression|2|||
163165987|NCT01703754|589322811|FG002|Overall Study|Clinically significant disease progression|1|||
163165988|NCT01703754|589322809|FG000|Overall Study|Adverse Event|1|||
163165989|NCT01703754|589322810|FG001|Overall Study|Adverse Event|1|||
163165990|NCT01703754|589322811|FG002|Overall Study|Adverse Event|0|||
163165991|NCT01703754|589322809|FG000|Overall Study|Withdrawal by Subject|2|||
163165992|NCT01703754|589322810|FG001|Overall Study|Withdrawal by Subject|0|||
163165993|NCT01703754|589322811|FG002|Overall Study|Withdrawal by Subject|0|||
163165994|NCT00947882|589322812|FG000|Overall Study|Adverse Event|0|||
163165995|NCT00947882|589322813|FG001|Overall Study|Adverse Event|1|||
163165996|NCT00947882|589322814|FG002|Overall Study|Adverse Event|4|||
163165997|NCT00947882|589322815|FG003|Overall Study|Adverse Event|4|||
163165998|NCT00947882|589322812|FG000|Overall Study|Withdrawal by Subject|2|||
163165999|NCT00947882|589322813|FG001|Overall Study|Withdrawal by Subject|0|||
163166000|NCT00947882|589322814|FG002|Overall Study|Withdrawal by Subject|8|||
163166001|NCT00947882|589322815|FG003|Overall Study|Withdrawal by Subject|2|||
163166002|NCT00947882|589322812|FG000|Overall Study|Protocol Violation|0|||
163166003|NCT00947882|589322813|FG001|Overall Study|Protocol Violation|0|||
163166004|NCT00947882|589322814|FG002|Overall Study|Protocol Violation|1|||
163166005|NCT00947882|589322815|FG003|Overall Study|Protocol Violation|0|||
163166006|NCT00947882|589322812|FG000|Overall Study|Lost to Follow-up|0|||
163166007|NCT00947882|589322813|FG001|Overall Study|Lost to Follow-up|2|||
163166008|NCT00947882|589322814|FG002|Overall Study|Lost to Follow-up|1|||
163166009|NCT00947882|589322815|FG003|Overall Study|Lost to Follow-up|0|||
163166010|NCT00947882|589322812|FG000|Overall Study|Other/Unknown|10|||
163166011|NCT00947882|589322813|FG001|Overall Study|Other/Unknown|13|||
163166012|NCT00947882|589322814|FG002|Overall Study|Other/Unknown|3|||
163166013|NCT00947882|589322815|FG003|Overall Study|Other/Unknown|6|||
163166014|NCT00947882|589322812|FG000|Overall Study|Trial Terminated by Sponsor|62|||
163166015|NCT00947882|589322813|FG001|Overall Study|Trial Terminated by Sponsor|61|||
163166016|NCT00947882|589322814|FG002|Overall Study|Trial Terminated by Sponsor|62|||
163166017|NCT00947882|589322815|FG003|Overall Study|Trial Terminated by Sponsor|70|||
163166018|NCT02379637|589322816|FG000|Overall Study|Protocol Violation|0|||
163166019|NCT02379637|589322817|FG001|Overall Study|Protocol Violation|1|||
163166020|NCT02379637|589322816|FG000|Overall Study|Adverse Event|1|||
163166021|NCT02379637|589322817|FG001|Overall Study|Adverse Event|0|||
163166022|NCT02379637|589322816|FG000|Overall Study|Withdrawal by Subject|1|||
163166023|NCT02379637|589322817|FG001|Overall Study|Withdrawal by Subject|0|||
163166024|NCT02447302|589322818|FG000|Overall Study|Physician Decision|1|||
163166025|NCT02447302|589322819|FG001|Overall Study|Physician Decision|0|||
163166026|NCT02447302|589322820|FG002|Overall Study|Physician Decision|0|||
163166027|NCT02447302|589322818|FG000|Overall Study|Adverse Event|4|||
163166028|NCT02447302|589322819|FG001|Overall Study|Adverse Event|3|||
163166029|NCT02447302|589322820|FG002|Overall Study|Adverse Event|0|||
162814641|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Death|1|||
162814642|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
162814643|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
163166030|NCT02447302|589322818|FG000|Overall Study|Withdrawal by Subject|0|||
163166031|NCT02447302|589322819|FG001|Overall Study|Withdrawal by Subject|1|||
163166032|NCT02447302|589322820|FG002|Overall Study|Withdrawal by Subject|5|||
162814644|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Adverse Event|7|||
162814645|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Adverse Event|8|||
162814646|NCT03236246|588034220|FG000|24-Week Dose Titration Period|Captured as Other|1|||
162814647|NCT03236246|588034221|FG001|24-Week Dose Titration Period|Captured as Other|2|||
162814648|NCT03236246|588034220|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
162814649|NCT03236246|588034221|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
162814650|NCT03236246|588034220|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
162814651|NCT03236246|588034221|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
162814652|NCT03236246|588034220|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
162814653|NCT03236246|588034221|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
162814654|NCT03236246|588034220|FG000|24-Week Dose Maintenance Period|Death|0|||
162814655|NCT03236246|588034221|FG001|24-Week Dose Maintenance Period|Death|1|||
162814656|NCT03236246|588034220|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
162814657|NCT03236246|588034221|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
162814658|NCT02952001|588034222|FG000|Overall Study|Adverse Event|3|||
162814659|NCT02952001|588034223|FG001|Overall Study|Adverse Event|0|||
162814660|NCT02952001|588034222|FG000|Overall Study|Prohibited therapy|10|||
162814661|NCT02952001|588034223|FG001|Overall Study|Prohibited therapy|3|||
162814662|NCT02952001|588034222|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
162814663|NCT02952001|588034223|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
162814664|NCT01681628|588034226|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
162814665|NCT01681628|588034227|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
162814666|NCT01681628|588034226|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
162814667|NCT01681628|588034227|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
162814668|NCT01681628|588034226|FG000|19 Months Follow-up|Death|1|||
162814669|NCT01681628|588034227|FG001|19 Months Follow-up|Death|0|||
162814670|NCT01681628|588034226|FG000|19 Months Follow-up|Lost to Follow-up|61|||
162814671|NCT01681628|588034227|FG001|19 Months Follow-up|Lost to Follow-up|43|||
162814672|NCT01794520|588034228|FG000|Overall Study|Adverse events- related to progression|0|||
162814673|NCT01794520|588034229|FG001|Overall Study|Adverse events- related to progression|0|||
162814674|NCT01794520|588034230|FG002|Overall Study|Adverse events- related to progression|1|||
162814675|NCT01794520|588034231|FG003|Overall Study|Adverse events- related to progression|2|||
162814676|NCT01794520|588034232|FG004|Overall Study|Adverse events- related to progression|0|||
162814677|NCT01794520|588034233|FG005|Overall Study|Adverse events- related to progression|1|||
162814678|NCT01794520|588034234|FG006|Overall Study|Adverse events- related to progression|0|||
162814679|NCT01794520|588034228|FG000|Overall Study|Adverse event- not related to progression|1|||
162814680|NCT01794520|588034229|FG001|Overall Study|Adverse event- not related to progression|1|||
162814681|NCT01794520|588034230|FG002|Overall Study|Adverse event- not related to progression|0|||
162814682|NCT01794520|588034231|FG003|Overall Study|Adverse event- not related to progression|0|||
162814683|NCT01794520|588034232|FG004|Overall Study|Adverse event- not related to progression|2|||
162814684|NCT01794520|588034233|FG005|Overall Study|Adverse event- not related to progression|0|||
162814685|NCT01794520|588034234|FG006|Overall Study|Adverse event- not related to progression|0|||
162814686|NCT01794520|588034228|FG000|Overall Study|Progressive disease|5|||
162814687|NCT01794520|588034229|FG001|Overall Study|Progressive disease|6|||
162814688|NCT01794520|588034230|FG002|Overall Study|Progressive disease|2|||
162814689|NCT01794520|588034231|FG003|Overall Study|Progressive disease|5|||
162814690|NCT01794520|588034232|FG004|Overall Study|Progressive disease|27|||
162814691|NCT01794520|588034233|FG005|Overall Study|Progressive disease|18|||
162814692|NCT01794520|588034234|FG006|Overall Study|Progressive disease|0|||
162814693|NCT01794520|588034228|FG000|Overall Study|Withdrew consent|0|||
162814694|NCT01794520|588034229|FG001|Overall Study|Withdrew consent|0|||
162814695|NCT01794520|588034230|FG002|Overall Study|Withdrew consent|1|||
162814696|NCT01794520|588034231|FG003|Overall Study|Withdrew consent|1|||
162814697|NCT01794520|588034232|FG004|Overall Study|Withdrew consent|0|||
162814698|NCT01794520|588034233|FG005|Overall Study|Withdrew consent|0|||
162814699|NCT01794520|588034234|FG006|Overall Study|Withdrew consent|0|||
162814700|NCT01794520|588034228|FG000|Overall Study|Lost to Follow-up|0|||
162814701|NCT01794520|588034229|FG001|Overall Study|Lost to Follow-up|0|||
162814702|NCT01794520|588034230|FG002|Overall Study|Lost to Follow-up|0|||
162814703|NCT01794520|588034231|FG003|Overall Study|Lost to Follow-up|0|||
162814704|NCT01794520|588034232|FG004|Overall Study|Lost to Follow-up|1|||
162814705|NCT01794520|588034233|FG005|Overall Study|Lost to Follow-up|0|||
162814706|NCT01794520|588034234|FG006|Overall Study|Lost to Follow-up|0|||
162814707|NCT01794520|588034228|FG000|Overall Study|Toxicity|0|||
162814708|NCT01794520|588034229|FG001|Overall Study|Toxicity|2|||
162814709|NCT01794520|588034230|FG002|Overall Study|Toxicity|0|||
162814710|NCT01794520|588034231|FG003|Overall Study|Toxicity|0|||
162814711|NCT01794520|588034232|FG004|Overall Study|Toxicity|0|||
162814712|NCT01794520|588034233|FG005|Overall Study|Toxicity|0|||
162814713|NCT01794520|588034234|FG006|Overall Study|Toxicity|0|||
162814714|NCT01794520|588034228|FG000|Overall Study|Study terminated by sponsor|0|||
162814715|NCT01794520|588034229|FG001|Overall Study|Study terminated by sponsor|0|||
162814716|NCT01794520|588034230|FG002|Overall Study|Study terminated by sponsor|1|||
162814717|NCT01794520|588034231|FG003|Overall Study|Study terminated by sponsor|0|||
162814718|NCT01794520|588034232|FG004|Overall Study|Study terminated by sponsor|1|||
162814719|NCT01794520|588034233|FG005|Overall Study|Study terminated by sponsor|0|||
162814720|NCT01794520|588034234|FG006|Overall Study|Study terminated by sponsor|7|||
162814721|NCT01794520|588034228|FG000|Overall Study|Death|0|||
162814722|NCT01794520|588034229|FG001|Overall Study|Death|0|||
162814723|NCT01794520|588034230|FG002|Overall Study|Death|0|||
162814724|NCT01794520|588034231|FG003|Overall Study|Death|0|||
162814725|NCT01794520|588034232|FG004|Overall Study|Death|1|||
162814726|NCT01794520|588034233|FG005|Overall Study|Death|0|||
162814727|NCT01794520|588034234|FG006|Overall Study|Death|22|||
162814728|NCT01794520|588034228|FG000|Overall Study|Other, not specified|0|||
162814729|NCT01794520|588034229|FG001|Overall Study|Other, not specified|0|||
162814730|NCT01794520|588034230|FG002|Overall Study|Other, not specified|1|||
163166033|NCT02447302|589322818|FG000|Overall Study|Sponsor Decision|0|||
163166034|NCT02447302|589322819|FG001|Overall Study|Sponsor Decision|0|||
163166035|NCT02447302|589322820|FG002|Overall Study|Sponsor Decision|1|||
163166036|NCT01561313|589322828|FG000|Overall Study|Withdrawal by Subject|1|||
163166037|NCT01561313|589322829|FG001|Overall Study|Withdrawal by Subject|0|||
163166038|NCT01561313|589322828|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
163166039|NCT01561313|589322829|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
163166040|NCT01742286|589322832|FG000|Escalation Phase|Administrative problems|1|||
163166041|NCT01742286|589322833|FG001|Escalation Phase|Administrative problems|1|||
163166042|NCT01742286|589322834|FG002|Escalation Phase|Administrative problems|0|||
163166043|NCT01742286|589322835|FG003|Escalation Phase|Administrative problems|0|||
163166044|NCT01742286|589322836|FG004|Escalation Phase|Administrative problems|0|||
163166045|NCT01742286|589322837|FG005|Escalation Phase|Administrative problems|0|||
163166046|NCT01742286|589322838|FG006|Escalation Phase|Administrative problems|2|||
163166047|NCT01742286|589322832|FG000|Escalation Phase|Adverse Event|0|||
163166048|NCT01742286|589322833|FG001|Escalation Phase|Adverse Event|1|||
163166049|NCT01742286|589322834|FG002|Escalation Phase|Adverse Event|2|||
163166050|NCT01742286|589322835|FG003|Escalation Phase|Adverse Event|0|||
163166051|NCT01742286|589322836|FG004|Escalation Phase|Adverse Event|0|||
163166052|NCT01742286|589322837|FG005|Escalation Phase|Adverse Event|1|||
163166053|NCT01742286|589322838|FG006|Escalation Phase|Adverse Event|0|||
163166054|NCT01742286|589322832|FG000|Escalation Phase|Disease progression|3|||
163166055|NCT01742286|589322833|FG001|Escalation Phase|Disease progression|7|||
163166056|NCT01742286|589322834|FG002|Escalation Phase|Disease progression|4|||
163166057|NCT01742286|589322835|FG003|Escalation Phase|Disease progression|1|||
163166058|NCT01742286|589322836|FG004|Escalation Phase|Disease progression|4|||
163166059|NCT01742286|589322837|FG005|Escalation Phase|Disease progression|3|||
163166060|NCT01742286|589322838|FG006|Escalation Phase|Disease progression|2|||
163166061|NCT01742286|589322832|FG000|Escalation Phase|Death|0|||
163166062|NCT01742286|589322833|FG001|Escalation Phase|Death|0|||
163166063|NCT01742286|589322834|FG002|Escalation Phase|Death|0|||
163166064|NCT01742286|589322835|FG003|Escalation Phase|Death|0|||
163166065|NCT01742286|589322836|FG004|Escalation Phase|Death|0|||
163166066|NCT01742286|589322837|FG005|Escalation Phase|Death|1|||
163166067|NCT01742286|589322838|FG006|Escalation Phase|Death|0|||
163166068|NCT01742286|589322832|FG000|Escalation Phase|Physician Decision|0|||
163166069|NCT01742286|589322833|FG001|Escalation Phase|Physician Decision|3|||
163166070|NCT01742286|589322834|FG002|Escalation Phase|Physician Decision|0|||
163166071|NCT01742286|589322835|FG003|Escalation Phase|Physician Decision|1|||
163166072|NCT01742286|589322836|FG004|Escalation Phase|Physician Decision|0|||
163166073|NCT01742286|589322837|FG005|Escalation Phase|Physician Decision|0|||
163166074|NCT01742286|589322838|FG006|Escalation Phase|Physician Decision|2|||
163166075|NCT01742286|589322832|FG000|Escalation Phase|Subject/guardian decision|1|||
163166076|NCT01742286|589322833|FG001|Escalation Phase|Subject/guardian decision|0|||
163166077|NCT01742286|589322834|FG002|Escalation Phase|Subject/guardian decision|0|||
163166078|NCT01742286|589322835|FG003|Escalation Phase|Subject/guardian decision|0|||
163166079|NCT01742286|589322836|FG004|Escalation Phase|Subject/guardian decision|0|||
163166080|NCT01742286|589322837|FG005|Escalation Phase|Subject/guardian decision|0|||
163166081|NCT01742286|589322838|FG006|Escalation Phase|Subject/guardian decision|0|||
163166082|NCT01742286|589322832|FG000|Expansion Phase|Administrative problems|0|||
163166083|NCT01742286|589322833|FG001|Expansion Phase|Administrative problems|0|||
163166084|NCT01742286|589322834|FG002|Expansion Phase|Administrative problems|0|||
162814731|NCT01794520|588034231|FG003|Overall Study|Other, not specified|1|||
162814732|NCT01794520|588034232|FG004|Overall Study|Other, not specified|4|||
163166085|NCT01742286|589322835|FG003|Expansion Phase|Administrative problems|0|||
163166086|NCT01742286|589322836|FG004|Expansion Phase|Administrative problems|0|||
163166087|NCT01742286|589322837|FG005|Expansion Phase|Administrative problems|0|||
163166088|NCT01742286|589322838|FG006|Expansion Phase|Administrative problems|5|||
162814733|NCT01794520|588034233|FG005|Overall Study|Other, not specified|1|||
163166089|NCT01742286|589322832|FG000|Expansion Phase|Physician Decision|0|||
163166090|NCT01742286|589322833|FG001|Expansion Phase|Physician Decision|0|||
163166091|NCT01742286|589322834|FG002|Expansion Phase|Physician Decision|4|||
162814734|NCT01794520|588034234|FG006|Overall Study|Other, not specified|2|||
162814735|NCT04796896|588034235|FG000|Overall Study|Adverse Event|1|||
162698058|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
162698059|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
162698060|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
162698061|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
162698062|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
162698063|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
162698064|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
162698065|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
162698066|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698067|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698068|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698069|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698070|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698071|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698072|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698073|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698074|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698075|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698076|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698077|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698078|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698079|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698080|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698081|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
162698082|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
162698083|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
162698084|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
162698085|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
162698086|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
162698087|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
162698088|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
162698089|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
162698090|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
162698091|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
162698092|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
162698093|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
162698094|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
162698095|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
162698096|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
162698097|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
162698098|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
162698099|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
162698100|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
162698101|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
162698102|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698103|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698104|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698105|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698106|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698107|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698108|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698109|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698110|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698111|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698112|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698113|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698114|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698115|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698116|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
162698117|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698118|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
162698119|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
162698120|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698121|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698122|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698123|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698124|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698125|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698126|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698127|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698128|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163166092|NCT01742286|589322835|FG003|Expansion Phase|Physician Decision|0|||
162814736|NCT04796896|588034236|FG001|Overall Study|Adverse Event|0|||
162814737|NCT04796896|588034237|FG002|Overall Study|Adverse Event|0|||
162814738|NCT04796896|588034238|FG003|Overall Study|Adverse Event|0|||
162814739|NCT04796896|588034239|FG004|Overall Study|Adverse Event|0|||
162814740|NCT04796896|588034240|FG005|Overall Study|Adverse Event|1|||
162814741|NCT04796896|588034241|FG006|Overall Study|Adverse Event|1|||
162814742|NCT04796896|588034242|FG007|Overall Study|Adverse Event|0|||
162814743|NCT04796896|588034243|FG008|Overall Study|Adverse Event|1|||
162814744|NCT04796896|588034244|FG009|Overall Study|Adverse Event|1|||
162814745|NCT04796896|588034245|FG010|Overall Study|Adverse Event|1|||
162814746|NCT04796896|588034246|FG011|Overall Study|Adverse Event|0|||
162814747|NCT04796896|588034235|FG000|Overall Study|Lost to Follow-up|24|||
162814748|NCT04796896|588034236|FG001|Overall Study|Lost to Follow-up|15|||
162814749|NCT04796896|588034237|FG002|Overall Study|Lost to Follow-up|6|||
162814750|NCT04796896|588034238|FG003|Overall Study|Lost to Follow-up|4|||
162814751|NCT04796896|588034239|FG004|Overall Study|Lost to Follow-up|21|||
162814752|NCT04796896|588034240|FG005|Overall Study|Lost to Follow-up|55|||
162814753|NCT04796896|588034241|FG006|Overall Study|Lost to Follow-up|237|||
162814754|NCT04796896|588034242|FG007|Overall Study|Lost to Follow-up|52|||
162814755|NCT04796896|588034243|FG008|Overall Study|Lost to Follow-up|221|||
162814756|NCT04796896|588034244|FG009|Overall Study|Lost to Follow-up|43|||
162814757|NCT04796896|588034245|FG010|Overall Study|Lost to Follow-up|142|||
162814758|NCT04796896|588034246|FG011|Overall Study|Lost to Follow-up|18|||
162814759|NCT04796896|588034235|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
162814760|NCT04796896|588034236|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
162698129|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698130|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698131|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698132|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698133|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698134|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
162698135|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698136|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162698137|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
162698138|NCT01474512|587605412|FG000|Post-Treatment Follow-Up|Death|0|||
162698139|NCT01474512|587605413|FG001|Post-Treatment Follow-Up|Death|0|||
162698140|NCT01474512|587605414|FG002|Post-Treatment Follow-Up|Death|0|||
162698141|NCT01474512|587605415|FG003|Post-Treatment Follow-Up|Death|0|||
162698142|NCT01474512|587605416|FG004|Post-Treatment Follow-Up|Death|0|||
162698143|NCT01474512|587605417|FG005|Post-Treatment Follow-Up|Death|0|||
162698144|NCT01474512|587605418|FG006|Post-Treatment Follow-Up|Death|0|||
162698145|NCT01474512|587605419|FG007|Post-Treatment Follow-Up|Death|0|||
162698146|NCT01474512|587605420|FG008|Post-Treatment Follow-Up|Death|0|||
162698147|NCT01474512|587605421|FG009|Post-Treatment Follow-Up|Death|0|||
162698148|NCT01474512|587605422|FG010|Post-Treatment Follow-Up|Death|0|||
162698149|NCT01474512|587605423|FG011|Post-Treatment Follow-Up|Death|0|||
162698150|NCT01474512|587605424|FG012|Post-Treatment Follow-Up|Death|0|||
162698151|NCT01474512|587605425|FG013|Post-Treatment Follow-Up|Death|0|||
162698152|NCT01474512|587605426|FG014|Post-Treatment Follow-Up|Death|0|||
162698153|NCT01474512|587605427|FG015|Post-Treatment Follow-Up|Death|0|||
162698154|NCT01474512|587605428|FG016|Post-Treatment Follow-Up|Death|1|||
162698155|NCT01474512|587605429|FG017|Post-Treatment Follow-Up|Death|0|||
162698156|NCT01118962|587605434|FG000|Overall Study|Adverse Event|2|||
162698157|NCT01118962|587605434|FG000|Overall Study|Lack of Efficacy|1|||
162698158|NCT01118962|587605434|FG000|Overall Study|Protocol Violation|1|||
162698159|NCT01118962|587605434|FG000|Overall Study|Withdrawal by Subject|4|||
162698160|NCT01118962|587605434|FG000|Overall Study|Pregnancy|1|||
162698161|NCT01118962|587605434|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
162698162|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
162698163|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
162698164|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
162698165|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
162698166|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
162698167|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
162698168|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
162698169|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
162698170|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162698171|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162814761|NCT04796896|588034237|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
162814762|NCT04796896|588034238|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
162814763|NCT04796896|588034239|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
162814764|NCT04796896|588034240|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
162698172|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162698173|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162814765|NCT04796896|588034241|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
162814766|NCT04796896|588034242|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
162814767|NCT04796896|588034243|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
162814768|NCT04796896|588034244|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
162814769|NCT04796896|588034245|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
162814770|NCT04796896|588034246|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
162814771|NCT04796896|588034235|FG000|Overall Study|Physician Decision|1|||
162814772|NCT04796896|588034236|FG001|Overall Study|Physician Decision|0|||
162814773|NCT04796896|588034237|FG002|Overall Study|Physician Decision|0|||
162814774|NCT04796896|588034238|FG003|Overall Study|Physician Decision|0|||
162814775|NCT04796896|588034239|FG004|Overall Study|Physician Decision|0|||
162814776|NCT04796896|588034240|FG005|Overall Study|Physician Decision|3|||
162814777|NCT04796896|588034241|FG006|Overall Study|Physician Decision|18|||
162814778|NCT04796896|588034242|FG007|Overall Study|Physician Decision|1|||
162814779|NCT04796896|588034243|FG008|Overall Study|Physician Decision|7|||
162814780|NCT04796896|588034244|FG009|Overall Study|Physician Decision|0|||
162814781|NCT04796896|588034245|FG010|Overall Study|Physician Decision|5|||
162814782|NCT04796896|588034246|FG011|Overall Study|Physician Decision|0|||
162814783|NCT04796896|588034235|FG000|Overall Study|Withdrawal by Subject|36|||
162814784|NCT04796896|588034236|FG001|Overall Study|Withdrawal by Subject|31|||
162814785|NCT04796896|588034237|FG002|Overall Study|Withdrawal by Subject|11|||
162814786|NCT04796896|588034238|FG003|Overall Study|Withdrawal by Subject|8|||
162814787|NCT04796896|588034239|FG004|Overall Study|Withdrawal by Subject|16|||
162814788|NCT04796896|588034240|FG005|Overall Study|Withdrawal by Subject|162|||
162814789|NCT04796896|588034241|FG006|Overall Study|Withdrawal by Subject|299|||
162814790|NCT04796896|588034242|FG007|Overall Study|Withdrawal by Subject|149|||
162814791|NCT04796896|588034243|FG008|Overall Study|Withdrawal by Subject|303|||
162814792|NCT04796896|588034244|FG009|Overall Study|Withdrawal by Subject|94|||
162814793|NCT04796896|588034245|FG010|Overall Study|Withdrawal by Subject|192|||
162814794|NCT04796896|588034246|FG011|Overall Study|Withdrawal by Subject|16|||
162814795|NCT04796896|588034235|FG000|Overall Study|Other Than Specified|6|||
162814796|NCT04796896|588034236|FG001|Overall Study|Other Than Specified|5|||
162814797|NCT04796896|588034237|FG002|Overall Study|Other Than Specified|3|||
162814798|NCT04796896|588034238|FG003|Overall Study|Other Than Specified|2|||
162814799|NCT04796896|588034239|FG004|Overall Study|Other Than Specified|6|||
162814800|NCT04796896|588034240|FG005|Overall Study|Other Than Specified|31|||
162814801|NCT04796896|588034241|FG006|Overall Study|Other Than Specified|86|||
162814802|NCT04796896|588034242|FG007|Overall Study|Other Than Specified|66|||
162814803|NCT04796896|588034243|FG008|Overall Study|Other Than Specified|388|||
162814804|NCT04796896|588034244|FG009|Overall Study|Other Than Specified|48|||
162814805|NCT04796896|588034245|FG010|Overall Study|Other Than Specified|258|||
162814806|NCT04796896|588034246|FG011|Overall Study|Other Than Specified|4|||
162814807|NCT04796896|588034235|FG000|Overall Study|Protocol Deviation|0|||
162814808|NCT04796896|588034236|FG001|Overall Study|Protocol Deviation|0|||
162814809|NCT04796896|588034237|FG002|Overall Study|Protocol Deviation|0|||
162814810|NCT04796896|588034238|FG003|Overall Study|Protocol Deviation|1|||
162814811|NCT04796896|588034239|FG004|Overall Study|Protocol Deviation|1|||
162814812|NCT04796896|588034240|FG005|Overall Study|Protocol Deviation|2|||
162814813|NCT04796896|588034241|FG006|Overall Study|Protocol Deviation|2|||
162814814|NCT04796896|588034242|FG007|Overall Study|Protocol Deviation|2|||
162814815|NCT04796896|588034243|FG008|Overall Study|Protocol Deviation|2|||
162814816|NCT04796896|588034244|FG009|Overall Study|Protocol Deviation|1|||
162814817|NCT04796896|588034245|FG010|Overall Study|Protocol Deviation|0|||
162814818|NCT04796896|588034246|FG011|Overall Study|Protocol Deviation|0|||
162814819|NCT04796896|588034235|FG000|Overall Study|Missing|0|||
162814820|NCT04796896|588034236|FG001|Overall Study|Missing|0|||
162814821|NCT04796896|588034237|FG002|Overall Study|Missing|0|||
162814822|NCT04796896|588034238|FG003|Overall Study|Missing|0|||
162814823|NCT04796896|588034239|FG004|Overall Study|Missing|0|||
162814824|NCT04796896|588034240|FG005|Overall Study|Missing|0|||
162814825|NCT04796896|588034241|FG006|Overall Study|Missing|2|||
162814826|NCT04796896|588034242|FG007|Overall Study|Missing|1|||
162814827|NCT04796896|588034243|FG008|Overall Study|Missing|2|||
162814828|NCT04796896|588034244|FG009|Overall Study|Missing|1|||
162814829|NCT04796896|588034245|FG010|Overall Study|Missing|1|||
162814830|NCT04796896|588034246|FG011|Overall Study|Missing|0|||
162814831|NCT04796896|588034235|FG000|Overall Study|Death|0|||
162814832|NCT04796896|588034236|FG001|Overall Study|Death|0|||
162814833|NCT04796896|588034237|FG002|Overall Study|Death|0|||
162814834|NCT04796896|588034238|FG003|Overall Study|Death|0|||
162814835|NCT04796896|588034239|FG004|Overall Study|Death|0|||
162814836|NCT04796896|588034240|FG005|Overall Study|Death|0|||
162814837|NCT04796896|588034241|FG006|Overall Study|Death|0|||
162814838|NCT04796896|588034242|FG007|Overall Study|Death|0|||
162814839|NCT04796896|588034243|FG008|Overall Study|Death|1|||
162814840|NCT04796896|588034244|FG009|Overall Study|Death|0|||
162814841|NCT04796896|588034245|FG010|Overall Study|Death|0|||
162814842|NCT04796896|588034246|FG011|Overall Study|Death|0|||
162814843|NCT02021292|588034247|FG000|Overall Study|Physician Decision|0|||
162814844|NCT02021292|588034248|FG001|Overall Study|Physician Decision|1|||
162814845|NCT02021292|588034247|FG000|Overall Study|Lost to Follow-up|0|||
162814846|NCT02021292|588034248|FG001|Overall Study|Lost to Follow-up|1|||
162814847|NCT02021292|588034247|FG000|Overall Study|Death|0|||
162814848|NCT02021292|588034248|FG001|Overall Study|Death|1|||
162814849|NCT04356183|588034249|FG000|Overall Study|Lost to Follow-up|1|||
162814850|NCT04356183|588034250|FG001|Overall Study|Lost to Follow-up|0|||
162814851|NCT04356183|588034249|FG000|Overall Study|Withdrawal by Subject|1|||
162814852|NCT04356183|588034250|FG001|Overall Study|Withdrawal by Subject|1|||
162814853|NCT01637623|588034251|FG000|Overall Study|Lost to Follow-up|0|||
162814854|NCT01637623|588034252|FG001|Overall Study|Lost to Follow-up|0|||
162814855|NCT01637623|588034253|FG002|Overall Study|Lost to Follow-up|2|||
162814856|NCT01637623|588034251|FG000|Overall Study|Physician Decision|1|||
162814857|NCT01637623|588034252|FG001|Overall Study|Physician Decision|0|||
162814858|NCT01637623|588034253|FG002|Overall Study|Physician Decision|1|||
162814859|NCT02824263|588034256|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
162814860|NCT02824263|588034257|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
162814861|NCT02824263|588034256|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
162814862|NCT02824263|588034257|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
162814863|NCT01676909|588034258|FG000|Overall Study|Withdrawal by Subject|3|||
162814864|NCT01676909|588034259|FG001|Overall Study|Withdrawal by Subject|5|||
162814865|NCT01676909|588034258|FG000|Overall Study|Lost to Follow-up|15|||
162814866|NCT01676909|588034259|FG001|Overall Study|Lost to Follow-up|9|||
162814867|NCT04615247|588034260|FG000|Overall Study|Adverse Event|0|||
162814868|NCT04615247|588034261|FG001|Overall Study|Adverse Event|2|||
162814869|NCT04615247|588034260|FG000|Overall Study|Withdrawal by Subject|1|||
162814870|NCT04615247|588034261|FG001|Overall Study|Withdrawal by Subject|1|||
162814871|NCT00823901|588034264|FG000|Overall Study|Adverse Event|1|||
163166093|NCT01742286|589322836|FG004|Expansion Phase|Physician Decision|0|||
163166094|NCT01742286|589322837|FG005|Expansion Phase|Physician Decision|0|||
163166095|NCT01742286|589322838|FG006|Expansion Phase|Physician Decision|9|||
163166096|NCT01742286|589322832|FG000|Expansion Phase|Adverse Event|0|||
162814872|NCT00823901|588034265|FG001|Overall Study|Adverse Event|1|||
162814873|NCT00823901|588034264|FG000|Overall Study|Lack of Efficacy|1|||
162814874|NCT00823901|588034265|FG001|Overall Study|Lack of Efficacy|0|||
162814875|NCT00823901|588034264|FG000|Overall Study|Lost to Follow-up|2|||
162814876|NCT00823901|588034265|FG001|Overall Study|Lost to Follow-up|1|||
162814877|NCT01369511|588034266|FG000|Overall Study|Adverse Event|1|||
162814878|NCT01369511|588034267|FG001|Overall Study|Adverse Event|1|||
162814879|NCT01369511|588034268|FG002|Overall Study|Adverse Event|5|||
162814880|NCT01369511|588034269|FG003|Overall Study|Adverse Event|0|||
162814881|NCT01369511|588034266|FG000|Overall Study|Entry criteria not met|2|||
162814882|NCT01369511|588034267|FG001|Overall Study|Entry criteria not met|0|||
162814883|NCT01369511|588034268|FG002|Overall Study|Entry criteria not met|0|||
162814884|NCT01369511|588034269|FG003|Overall Study|Entry criteria not met|1|||
162814885|NCT01369511|588034266|FG000|Overall Study|Lost to Follow-up|0|||
162814886|NCT01369511|588034267|FG001|Overall Study|Lost to Follow-up|1|||
162814887|NCT01369511|588034268|FG002|Overall Study|Lost to Follow-up|1|||
162814888|NCT01369511|588034269|FG003|Overall Study|Lost to Follow-up|2|||
162814889|NCT01369511|588034266|FG000|Overall Study|Protocol Violation|0|||
162814890|NCT01369511|588034267|FG001|Overall Study|Protocol Violation|1|||
162814891|NCT01369511|588034268|FG002|Overall Study|Protocol Violation|0|||
162814892|NCT01369511|588034269|FG003|Overall Study|Protocol Violation|2|||
162814893|NCT01369511|588034266|FG000|Overall Study|Physician Decision|3|||
162814894|NCT01369511|588034267|FG001|Overall Study|Physician Decision|4|||
162814895|NCT01369511|588034268|FG002|Overall Study|Physician Decision|0|||
162814896|NCT01369511|588034269|FG003|Overall Study|Physician Decision|0|||
162814897|NCT01369511|588034266|FG000|Overall Study|Sponsor decision|2|||
162814898|NCT01369511|588034267|FG001|Overall Study|Sponsor decision|0|||
162814899|NCT01369511|588034268|FG002|Overall Study|Sponsor decision|1|||
162814900|NCT01369511|588034269|FG003|Overall Study|Sponsor decision|0|||
162814901|NCT01369511|588034266|FG000|Overall Study|Withdrawal by Subject|5|||
162814902|NCT01369511|588034267|FG001|Overall Study|Withdrawal by Subject|6|||
162814903|NCT01369511|588034268|FG002|Overall Study|Withdrawal by Subject|4|||
162814904|NCT01369511|588034269|FG003|Overall Study|Withdrawal by Subject|6|||
162814905|NCT01376349|588034270|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
162814906|NCT01376349|588034271|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
162814907|NCT01376349|588034272|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
162814908|NCT01376349|588034270|FG000|Raondomized Treatment|Adverse Event|13|||
162814909|NCT01376349|588034271|FG001|Raondomized Treatment|Adverse Event|17|||
163166097|NCT01742286|589322833|FG001|Expansion Phase|Adverse Event|0|||
162814910|NCT01376349|588034272|FG002|Raondomized Treatment|Adverse Event|14|||
162814911|NCT01376349|588034270|FG000|Raondomized Treatment|Unkown|1|||
162814912|NCT01376349|588034271|FG001|Raondomized Treatment|Unkown|2|||
162814913|NCT01376349|588034272|FG002|Raondomized Treatment|Unkown|1|||
162814914|NCT01376349|588034270|FG000|Raondomized Treatment|Alternative Treatment|0|||
162814915|NCT01376349|588034271|FG001|Raondomized Treatment|Alternative Treatment|0|||
162814916|NCT01376349|588034272|FG002|Raondomized Treatment|Alternative Treatment|1|||
162814917|NCT00718640|588034273|FG000|Overall Study|Adverse Event|4|||
162814918|NCT00718640|588034273|FG000|Overall Study|Death|1|||
162814919|NCT00718640|588034273|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
162814920|NCT05193500|588034274|FG000|Overall Study|Withdrawal by Subject|7|||
162814921|NCT05193500|588034275|FG001|Overall Study|Withdrawal by Subject|4|||
162814922|NCT05193500|588034276|FG002|Overall Study|Withdrawal by Subject|3|||
162814923|NCT05193500|588034277|FG003|Overall Study|Withdrawal by Subject|5|||
162814924|NCT05458479|588034278|FG000|Overall Study|Lost to Follow-up|1|||
162814925|NCT01978262|588034279|FG000|Overall Study|Withdrawal by Subject|9|||
162814926|NCT01978262|588034279|FG000|Overall Study|Lost to Follow-up|2|||
162814927|NCT02202551|588034280|FG000|Overall Study|Adverse Event|8|||
162814928|NCT02202551|588034281|FG001|Overall Study|Adverse Event|19|||
162814929|NCT02202551|588034282|FG002|Overall Study|Adverse Event|5|||
162814930|NCT02202551|588034283|FG003|Overall Study|Adverse Event|9|||
162814931|NCT02202551|588034280|FG000|Overall Study|Death|3|||
162814932|NCT02202551|588034281|FG001|Overall Study|Death|2|||
162814933|NCT02202551|588034282|FG002|Overall Study|Death|1|||
162814934|NCT02202551|588034283|FG003|Overall Study|Death|1|||
162814935|NCT02202551|588034280|FG000|Overall Study|Lost to Follow-up|0|||
162814936|NCT02202551|588034281|FG001|Overall Study|Lost to Follow-up|1|||
162814937|NCT02202551|588034282|FG002|Overall Study|Lost to Follow-up|0|||
162814938|NCT02202551|588034283|FG003|Overall Study|Lost to Follow-up|1|||
162814939|NCT02202551|588034280|FG000|Overall Study|Needed to take excluded medication|0|||
162814940|NCT02202551|588034281|FG001|Overall Study|Needed to take excluded medication|2|||
162814941|NCT02202551|588034282|FG002|Overall Study|Needed to take excluded medication|0|||
162814942|NCT02202551|588034283|FG003|Overall Study|Needed to take excluded medication|1|||
162814943|NCT02202551|588034280|FG000|Overall Study|Subject moved away|0|||
162814944|NCT02202551|588034281|FG001|Overall Study|Subject moved away|1|||
162814945|NCT02202551|588034282|FG002|Overall Study|Subject moved away|0|||
162814946|NCT02202551|588034283|FG003|Overall Study|Subject moved away|0|||
162814947|NCT02202551|588034280|FG000|Overall Study|DBS surgery|3|||
162814948|NCT02202551|588034281|FG001|Overall Study|DBS surgery|0|||
162814949|NCT02202551|588034282|FG002|Overall Study|DBS surgery|0|||
162814950|NCT02202551|588034283|FG003|Overall Study|DBS surgery|0|||
162814951|NCT02202551|588034280|FG000|Overall Study|Dyskinesia upon taper|1|||
162814952|NCT02202551|588034281|FG001|Overall Study|Dyskinesia upon taper|0|||
162814953|NCT02202551|588034282|FG002|Overall Study|Dyskinesia upon taper|0|||
162814954|NCT02202551|588034283|FG003|Overall Study|Dyskinesia upon taper|0|||
162814955|NCT02202551|588034280|FG000|Overall Study|Lack of Efficacy|0|||
162814956|NCT02202551|588034281|FG001|Overall Study|Lack of Efficacy|1|||
162814957|NCT02202551|588034282|FG002|Overall Study|Lack of Efficacy|0|||
162814958|NCT02202551|588034283|FG003|Overall Study|Lack of Efficacy|0|||
162814959|NCT02202551|588034280|FG000|Overall Study|Physician Decision|1|||
162814960|NCT02202551|588034281|FG001|Overall Study|Physician Decision|0|||
162814961|NCT02202551|588034282|FG002|Overall Study|Physician Decision|0|||
162814962|NCT02202551|588034283|FG003|Overall Study|Physician Decision|0|||
162814963|NCT02202551|588034280|FG000|Overall Study|Site closure|3|||
162814964|NCT02202551|588034281|FG001|Overall Study|Site closure|0|||
162814965|NCT02202551|588034282|FG002|Overall Study|Site closure|0|||
162814966|NCT02202551|588034283|FG003|Overall Study|Site closure|1|||
162814967|NCT02202551|588034280|FG000|Overall Study|Unable to complete visits per protocol|1|||
162814968|NCT02202551|588034281|FG001|Overall Study|Unable to complete visits per protocol|0|||
162814969|NCT02202551|588034282|FG002|Overall Study|Unable to complete visits per protocol|0|||
162814970|NCT02202551|588034283|FG003|Overall Study|Unable to complete visits per protocol|0|||
162814971|NCT02202551|588034280|FG000|Overall Study|Worsening Dyskinesia|0|||
162814972|NCT02202551|588034281|FG001|Overall Study|Worsening Dyskinesia|0|||
162814973|NCT02202551|588034282|FG002|Overall Study|Worsening Dyskinesia|0|||
162814974|NCT02202551|588034283|FG003|Overall Study|Worsening Dyskinesia|1|||
162814975|NCT02202551|588034280|FG000|Overall Study|Protocol Violation|0|||
162814976|NCT02202551|588034281|FG001|Overall Study|Protocol Violation|1|||
162814977|NCT02202551|588034282|FG002|Overall Study|Protocol Violation|0|||
162814978|NCT02202551|588034283|FG003|Overall Study|Protocol Violation|0|||
162814979|NCT02202551|588034280|FG000|Overall Study|Sponsor's decision|2|||
162814980|NCT02202551|588034281|FG001|Overall Study|Sponsor's decision|0|||
162814981|NCT02202551|588034282|FG002|Overall Study|Sponsor's decision|0|||
162814982|NCT02202551|588034283|FG003|Overall Study|Sponsor's decision|0|||
162814983|NCT02202551|588034280|FG000|Overall Study|Subject unwilling to proceed|1|||
162814984|NCT02202551|588034281|FG001|Overall Study|Subject unwilling to proceed|5|||
162814985|NCT02202551|588034282|FG002|Overall Study|Subject unwilling to proceed|3|||
162814986|NCT02202551|588034283|FG003|Overall Study|Subject unwilling to proceed|5|||
162814987|NCT02202551|588034280|FG000|Overall Study|Subject consent withdrawn|0|||
162814988|NCT02202551|588034281|FG001|Overall Study|Subject consent withdrawn|3|||
162814989|NCT02202551|588034282|FG002|Overall Study|Subject consent withdrawn|1|||
162814990|NCT02202551|588034283|FG003|Overall Study|Subject consent withdrawn|2|||
162814991|NCT02202551|588034280|FG000|Overall Study|eGFR<50mL/min/m2|2|||
162814992|NCT02202551|588034281|FG001|Overall Study|eGFR<50mL/min/m2|2|||
162814993|NCT02202551|588034282|FG002|Overall Study|eGFR<50mL/min/m2|0|||
162814994|NCT02202551|588034283|FG003|Overall Study|eGFR<50mL/min/m2|1|||
162814995|NCT02121834|588034284|FG000|Overall Study|Protocol Violation|0|||
162814996|NCT02121834|588034285|FG001|Overall Study|Protocol Violation|1|||
162814997|NCT02121834|588034286|FG002|Overall Study|Protocol Violation|0|||
162814998|NCT02121834|588034287|FG003|Overall Study|Protocol Violation|0|||
162814999|NCT02121834|588034288|FG004|Overall Study|Protocol Violation|0|||
162815000|NCT02121834|588034289|FG005|Overall Study|Protocol Violation|0|||
162815001|NCT02121834|588034290|FG006|Overall Study|Protocol Violation|0|||
162815002|NCT02121834|588034284|FG000|Overall Study|Withdrawal by Subject|0|||
162815003|NCT02121834|588034285|FG001|Overall Study|Withdrawal by Subject|1|||
162815004|NCT02121834|588034286|FG002|Overall Study|Withdrawal by Subject|1|||
162815005|NCT02121834|588034287|FG003|Overall Study|Withdrawal by Subject|0|||
162815006|NCT02121834|588034288|FG004|Overall Study|Withdrawal by Subject|0|||
162815007|NCT02121834|588034289|FG005|Overall Study|Withdrawal by Subject|0|||
162815008|NCT02121834|588034290|FG006|Overall Study|Withdrawal by Subject|0|||
162815009|NCT02121834|588034284|FG000|Overall Study|Lost to Follow-up|0|||
162815010|NCT02121834|588034285|FG001|Overall Study|Lost to Follow-up|0|||
162815011|NCT02121834|588034286|FG002|Overall Study|Lost to Follow-up|1|||
162815012|NCT02121834|588034287|FG003|Overall Study|Lost to Follow-up|0|||
162815013|NCT02121834|588034288|FG004|Overall Study|Lost to Follow-up|0|||
162815014|NCT02121834|588034289|FG005|Overall Study|Lost to Follow-up|0|||
162815015|NCT02121834|588034290|FG006|Overall Study|Lost to Follow-up|0|||
162815016|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
162815017|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
162815018|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
162815019|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
162815020|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
162815021|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
162815022|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
162815023|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
162815024|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
162815025|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
162815026|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
162815027|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
162815028|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
162815029|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
162815030|NCT01294683|588034293|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
162815031|NCT01294683|588034294|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
162815032|NCT01294683|588034293|FG000|Post Crossover (Period III)|Adverse Event|6|||
162815033|NCT01294683|588034294|FG001|Post Crossover (Period III)|Adverse Event|6|||
162815034|NCT01294683|588034293|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
162815035|NCT01294683|588034294|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
162815036|NCT01294683|588034293|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
162815037|NCT01294683|588034294|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
162815038|NCT01294683|588034293|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
162815039|NCT01294683|588034294|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
162815040|NCT01794923|588034295|FG000|Overall Study|Adverse Event|0|||
162815041|NCT01794923|588034296|FG001|Overall Study|Adverse Event|0|||
162815042|NCT01794923|588034297|FG002|Overall Study|Adverse Event|1|||
162815043|NCT01881750|588034298|FG000|Overall Study|Changes in concomitant therapies|2|||
162815044|NCT01881750|588034299|FG001|Overall Study|Changes in concomitant therapies|3|||
162815045|NCT01881750|588034298|FG000|Overall Study|Lost to Follow-up|0|||
162815046|NCT01881750|588034299|FG001|Overall Study|Lost to Follow-up|1|||
162815047|NCT00051363|588034300|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
162815048|NCT00051363|588034301|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
162815049|NCT00051363|588034300|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
162815050|NCT00051363|588034301|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
162815051|NCT00051363|588034300|FG000|Overall Study|Death|2|||
162815052|NCT00051363|588034301|FG001|Overall Study|Death|2|||
162815053|NCT00051363|588034300|FG000|Overall Study|Excluded Pre-Randomization|2|||
162815054|NCT00051363|588034301|FG001|Overall Study|Excluded Pre-Randomization|5|||
162815055|NCT00026208|588034306|FG000|Overall Study|Complications of auto accident|1|||
162815056|NCT00026208|588034307|FG001|Overall Study|Complications of auto accident|0|||
162815057|NCT03282240|588034308|FG000|Overall Study|Adverse Event|2|||
162815058|NCT03282240|588034309|FG001|Overall Study|Adverse Event|2|||
162815059|NCT03282240|588034310|FG002|Overall Study|Adverse Event|0|||
162815060|NCT03282240|588034308|FG000|Overall Study|Lost to Follow-up|3|||
162815061|NCT03282240|588034309|FG001|Overall Study|Lost to Follow-up|0|||
162815062|NCT03282240|588034310|FG002|Overall Study|Lost to Follow-up|0|||
162815063|NCT03282240|588034308|FG000|Overall Study|Protocol Deviation|4|||
162815064|NCT03282240|588034309|FG001|Overall Study|Protocol Deviation|1|||
162815065|NCT03282240|588034310|FG002|Overall Study|Protocol Deviation|2|||
162815066|NCT03282240|588034308|FG000|Overall Study|Withdrawal by Subject|1|||
162815067|NCT03282240|588034309|FG001|Overall Study|Withdrawal by Subject|0|||
162815068|NCT03282240|588034310|FG002|Overall Study|Withdrawal by Subject|1|||
162815069|NCT01675479|588034311|FG000|Overall Study|Lost to Follow-up|11|||
162815070|NCT02910739|588034312|FG000|Overall Study|Adverse Event|1|||
162815071|NCT02910739|588034313|FG001|Overall Study|Adverse Event|0|||
162815072|NCT02910739|588034314|FG002|Overall Study|Adverse Event|0|||
162815073|NCT02910739|588034315|FG003|Overall Study|Adverse Event|0|||
162815074|NCT01572922|588034318|FG000|Overall Study|Adverse Event|1|||
162815075|NCT01572922|588034318|FG000|Overall Study|Protocol Violation|1|||
162815076|NCT01572922|588034318|FG000|Overall Study|Death|1|||
162815077|NCT05089656|588034320|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
162815078|NCT05089656|588034321|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
162815079|NCT05089656|588034320|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
162815080|NCT05089656|588034321|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
162815081|NCT05089656|588034320|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
162815082|NCT05089656|588034321|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
162815083|NCT05089656|588034320|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
162815084|NCT05089656|588034321|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
162815085|NCT02535416|588034322|FG000|Overall Study|Family bereavement overseas|1|||
162815086|NCT02535416|588034323|FG001|Overall Study|Family bereavement overseas|0|||
162815087|NCT02535416|588034324|FG002|Overall Study|Family bereavement overseas|0|||
162815088|NCT02535416|588034325|FG003|Overall Study|Family bereavement overseas|0|||
162815089|NCT02535416|588034326|FG004|Overall Study|Family bereavement overseas|0|||
162815090|NCT02535416|588034327|FG005|Overall Study|Family bereavement overseas|0|||
162815091|NCT02535416|588034328|FG006|Overall Study|Family bereavement overseas|0|||
162815092|NCT02535416|588034329|FG007|Overall Study|Family bereavement overseas|0|||
162815093|NCT02535416|588034330|FG008|Overall Study|Family bereavement overseas|0|||
162815094|NCT01103245|588036412|FG000|Overall Study|Withdrawal by Subject|1|||
162815095|NCT01103245|588036413|FG001|Overall Study|Withdrawal by Subject|0|||
162815096|NCT01103245|588036414|FG002|Overall Study|Withdrawal by Subject|3|||
162815097|NCT01103245|588036415|FG003|Overall Study|Withdrawal by Subject|0|||
162815098|NCT01103245|588036412|FG000|Overall Study|Inadequate IV access|1|||
162815099|NCT01103245|588036413|FG001|Overall Study|Inadequate IV access|0|||
162815100|NCT01103245|588036414|FG002|Overall Study|Inadequate IV access|0|||
162815101|NCT01103245|588036415|FG003|Overall Study|Inadequate IV access|0|||
162815102|NCT01103245|588036412|FG000|Overall Study|Adverse Event|0|||
162815103|NCT01103245|588036413|FG001|Overall Study|Adverse Event|2|||
162815104|NCT01103245|588036414|FG002|Overall Study|Adverse Event|1|||
162815105|NCT01103245|588036415|FG003|Overall Study|Adverse Event|0|||
162815106|NCT01103245|588036412|FG000|Overall Study|Physician Decision|1|||
162815107|NCT01103245|588036413|FG001|Overall Study|Physician Decision|0|||
162815108|NCT01103245|588036414|FG002|Overall Study|Physician Decision|0|||
162815109|NCT01103245|588036415|FG003|Overall Study|Physician Decision|0|||
162815110|NCT03078907|588036420|FG000|Overall Study|Adverse Event|2|||
162815111|NCT03078907|588036421|FG001|Overall Study|Adverse Event|0|||
162815112|NCT03078907|588036420|FG000|Overall Study|Other|1|||
162815113|NCT03078907|588036421|FG001|Overall Study|Other|0|||
162815114|NCT03078907|588036420|FG000|Overall Study|Protocol Violation|0|||
162815115|NCT03078907|588036421|FG001|Overall Study|Protocol Violation|1|||
162815116|NCT01955122|588036422|FG000|Overall Study|Physician Decision|5|||
162815117|NCT01955122|588036423|FG001|Overall Study|Physician Decision|5|||
162815118|NCT01672788|588036424|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
162815119|NCT01672788|588036425|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
162815120|NCT01672788|588036426|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
162815121|NCT01672788|588036427|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
162815122|NCT01128361|588036437|FG000|Overall Study|Lost to Follow-up|0|||
162815123|NCT01128361|588036438|FG001|Overall Study|Lost to Follow-up|1|||
162815124|NCT01128361|588036437|FG000|Overall Study|Withdrawal by Subject|5|||
162815125|NCT01128361|588036438|FG001|Overall Study|Withdrawal by Subject|2|||
162815126|NCT02464228|588036439|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
162815127|NCT02464228|588036440|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
162815128|NCT02464228|588036441|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
162815129|NCT02464228|588036442|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
162815130|NCT02464228|588036439|FG000|Overall Study|Physician Decision|2|||
162815131|NCT02464228|588036440|FG001|Overall Study|Physician Decision|0|||
162815132|NCT02464228|588036441|FG002|Overall Study|Physician Decision|1|||
162815133|NCT02464228|588036442|FG003|Overall Study|Physician Decision|0|||
162815134|NCT02464228|588036439|FG000|Overall Study|Miscellaneous|1|||
162815135|NCT02464228|588036440|FG001|Overall Study|Miscellaneous|0|||
162815136|NCT02464228|588036441|FG002|Overall Study|Miscellaneous|1|||
162815137|NCT02464228|588036442|FG003|Overall Study|Miscellaneous|0|||
162815138|NCT02464228|588036439|FG000|Overall Study|Adverse Event|9|||
162815139|NCT02464228|588036440|FG001|Overall Study|Adverse Event|0|||
162815140|NCT02464228|588036441|FG002|Overall Study|Adverse Event|3|||
162815141|NCT02464228|588036442|FG003|Overall Study|Adverse Event|0|||
162815142|NCT02464228|588036439|FG000|Overall Study|Withdrawal by Subject|1|||
162815143|NCT02464228|588036440|FG001|Overall Study|Withdrawal by Subject|1|||
162815144|NCT02464228|588036441|FG002|Overall Study|Withdrawal by Subject|1|||
162815145|NCT02464228|588036442|FG003|Overall Study|Withdrawal by Subject|0|||
162815146|NCT02464228|588036439|FG000|Overall Study|Disease Progression|22|||
162815147|NCT02464228|588036440|FG001|Overall Study|Disease Progression|12|||
162815148|NCT02464228|588036441|FG002|Overall Study|Disease Progression|5|||
162815149|NCT02464228|588036442|FG003|Overall Study|Disease Progression|2|||
162815150|NCT05972733|588036453|FG000|Overall Study|Lost to Follow-up|2|||
162815151|NCT05972733|588036453|FG000|Overall Study|Withdrawal by Subject|1|||
162815152|NCT01177787|588036454|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
162815153|NCT01177787|588036454|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
162815154|NCT01177787|588036454|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
162815155|NCT00818389|588036457|FG000|Overall Study|Death|1|||
162815156|NCT00818389|588036458|FG001|Overall Study|Death|3|||
162815157|NCT00818389|588036457|FG000|Overall Study|ALS Disease Progression|1|||
162815158|NCT00818389|588036458|FG001|Overall Study|ALS Disease Progression|0|||
162815159|NCT00818389|588036457|FG000|Overall Study|Withdrawal by Subject|2|||
162815160|NCT00818389|588036458|FG001|Overall Study|Withdrawal by Subject|2|||
162815161|NCT00818389|588036457|FG000|Overall Study|Adverse Event|0|||
162815162|NCT00818389|588036458|FG001|Overall Study|Adverse Event|1|||
162815163|NCT03871829|588036461|FG000|Overall Study|Lost to Follow-up|0|||
162815164|NCT03871829|588036462|FG001|Overall Study|Lost to Follow-up|1|||
162815165|NCT03871829|588036461|FG000|Overall Study|Withdrawal by Subject|1|||
162815166|NCT03871829|588036462|FG001|Overall Study|Withdrawal by Subject|1|||
162815167|NCT03871829|588036461|FG000|Overall Study|Death|12|||
162815168|NCT03871829|588036462|FG001|Overall Study|Death|8|||
162815169|NCT03871829|588036461|FG000|Overall Study|Study terminated by sponsor|31|||
162815170|NCT03871829|588036462|FG001|Overall Study|Study terminated by sponsor|34|||
162815171|NCT02993523|588036463|FG000|Overall Study|Withdrew Consent|0|||
162815172|NCT02993523|588036464|FG001|Overall Study|Withdrew Consent|0|||
162815173|NCT02993523|588036465|FG002|Overall Study|Withdrew Consent|2|||
162815174|NCT02993523|588036466|FG003|Overall Study|Withdrew Consent|9|||
162815175|NCT02993523|588036467|FG004|Overall Study|Withdrew Consent|0|||
162815176|NCT02993523|588036463|FG000|Overall Study|Lost to Follow-up|0|||
162815177|NCT02993523|588036464|FG001|Overall Study|Lost to Follow-up|0|||
162815178|NCT02993523|588036465|FG002|Overall Study|Lost to Follow-up|3|||
162815179|NCT02993523|588036466|FG003|Overall Study|Lost to Follow-up|6|||
162815180|NCT02993523|588036467|FG004|Overall Study|Lost to Follow-up|0|||
162815181|NCT02993523|588036463|FG000|Overall Study|Death|1|||
162815182|NCT02993523|588036464|FG001|Overall Study|Death|1|||
162815183|NCT02993523|588036465|FG002|Overall Study|Death|138|||
162815184|NCT02993523|588036466|FG003|Overall Study|Death|222|||
162815185|NCT02993523|588036467|FG004|Overall Study|Death|6|||
162815186|NCT02993523|588036463|FG000|Overall Study|Reason not Specified|0|||
162815187|NCT02993523|588036464|FG001|Overall Study|Reason not Specified|0|||
162815188|NCT02993523|588036465|FG002|Overall Study|Reason not Specified|1|||
162815189|NCT02993523|588036466|FG003|Overall Study|Reason not Specified|1|||
162815190|NCT02993523|588036467|FG004|Overall Study|Reason not Specified|0|||
162815191|NCT03694418|588036468|FG000|Overall Study|Lost to Follow-up|115|||
162815192|NCT03694418|588036469|FG001|Overall Study|Lost to Follow-up|23|||
162815193|NCT03694418|588036470|FG002|Overall Study|Lost to Follow-up|12|||
162815194|NCT03694418|588036471|FG003|Overall Study|Lost to Follow-up|12|||
162815195|NCT03694418|588036472|FG004|Overall Study|Lost to Follow-up|13|||
162815196|NCT04288778|588036475|FG000|Overall Study|Withdrawal by Subject|2|||
162815197|NCT04288778|588036475|FG000|Overall Study|Adverse Event|5|||
162815198|NCT04288778|588036475|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162815199|NCT04288778|588036475|FG000|Overall Study|Other|1|||
162815200|NCT04288778|588036475|FG000|Overall Study|Started but not treated|2|||
162815201|NCT04442737|588036476|FG000|Overall Study|Lost to Follow-up|1|||
162815202|NCT04442737|588036477|FG001|Overall Study|Lost to Follow-up|3|||
162815203|NCT04442737|588036476|FG000|Overall Study|Withdrawal by Subject|3|||
162815204|NCT04442737|588036477|FG001|Overall Study|Withdrawal by Subject|2|||
162815205|NCT04442737|588036476|FG000|Overall Study|Adverse Event|3|||
162815206|NCT04442737|588036477|FG001|Overall Study|Adverse Event|2|||
162815207|NCT04442737|588036476|FG000|Overall Study|Death|0|||
162815208|NCT04442737|588036477|FG001|Overall Study|Death|1|||
162815209|NCT04442737|588036476|FG000|Overall Study|Protocol Violation|0|||
162815210|NCT04442737|588036477|FG001|Overall Study|Protocol Violation|2|||
162815211|NCT04442737|588036476|FG000|Overall Study|Other|1|||
162815212|NCT04442737|588036477|FG001|Overall Study|Other|1|||
162815213|NCT01139021|588036478|FG000|Overall Study|Adverse Event|0|||
162815214|NCT01139021|588036479|FG001|Overall Study|Adverse Event|0|||
162815215|NCT01139021|588036480|FG002|Overall Study|Adverse Event|0|||
162815216|NCT01139021|588036481|FG003|Overall Study|Adverse Event|0|||
162815217|NCT01139021|588036482|FG004|Overall Study|Adverse Event|1|||
162815218|NCT01139021|588036483|FG005|Overall Study|Adverse Event|0|||
162815219|NCT01139021|588036478|FG000|Overall Study|Lost to Follow-up|0|||
162815220|NCT01139021|588036479|FG001|Overall Study|Lost to Follow-up|0|||
162815221|NCT01139021|588036480|FG002|Overall Study|Lost to Follow-up|0|||
162815222|NCT01139021|588036481|FG003|Overall Study|Lost to Follow-up|0|||
162815223|NCT01139021|588036482|FG004|Overall Study|Lost to Follow-up|2|||
162815224|NCT01139021|588036483|FG005|Overall Study|Lost to Follow-up|0|||
162815225|NCT01139021|588036478|FG000|Overall Study|Protocol Violation|1|||
162815226|NCT01139021|588036479|FG001|Overall Study|Protocol Violation|0|||
162698174|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
162698175|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
162698176|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162698177|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162698178|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162698179|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162698180|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162698181|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
162698182|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162698183|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162698184|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162698185|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162698186|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
162698187|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
162698188|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
162698189|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
162698190|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
162698191|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
162698192|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
162698193|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
162698194|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162815227|NCT01139021|588036480|FG002|Overall Study|Protocol Violation|0|||
162815228|NCT01139021|588036481|FG003|Overall Study|Protocol Violation|0|||
162815229|NCT01139021|588036482|FG004|Overall Study|Protocol Violation|2|||
162815230|NCT01139021|588036483|FG005|Overall Study|Protocol Violation|0|||
162815231|NCT01139021|588036478|FG000|Overall Study|Withdrawal by Subject|0|||
162815232|NCT01139021|588036479|FG001|Overall Study|Withdrawal by Subject|0|||
162815233|NCT01139021|588036480|FG002|Overall Study|Withdrawal by Subject|0|||
162815234|NCT01139021|588036481|FG003|Overall Study|Withdrawal by Subject|1|||
162815235|NCT01139021|588036482|FG004|Overall Study|Withdrawal by Subject|4|||
162815236|NCT01139021|588036483|FG005|Overall Study|Withdrawal by Subject|0|||
162815237|NCT00784693|588036488|FG000|Overall Study|Lost to Follow-up|0|||
162815238|NCT00784693|588036489|FG001|Overall Study|Lost to Follow-up|1|||
162815239|NCT00784693|588036488|FG000|Overall Study|Lack of Efficacy|1|||
162815240|NCT00784693|588036489|FG001|Overall Study|Lack of Efficacy|1|||
162815241|NCT00784693|588036488|FG000|Overall Study|Withdrawal by Subject|0|||
162815242|NCT00784693|588036489|FG001|Overall Study|Withdrawal by Subject|4|||
162815243|NCT00784693|588036488|FG000|Overall Study|Randomized but not Treated|1|||
162815244|NCT00784693|588036489|FG001|Overall Study|Randomized but not Treated|0|||
162815245|NCT00784693|588036488|FG000|Overall Study|Other|1|||
162815246|NCT00784693|588036489|FG001|Overall Study|Other|0|||
162815247|NCT02982187|588036490|FG000|Overall Study|Withdrawal by Subject|0|||
162815248|NCT02982187|588036491|FG001|Overall Study|Withdrawal by Subject|0|||
162815249|NCT02982187|588036492|FG002|Overall Study|Withdrawal by Subject|0|||
162815250|NCT02982187|588036493|FG003|Overall Study|Withdrawal by Subject|0|||
162815251|NCT02982187|588036494|FG004|Overall Study|Withdrawal by Subject|0|||
162815252|NCT02982187|588036495|FG005|Overall Study|Withdrawal by Subject|0|||
162815253|NCT02982187|588036496|FG006|Overall Study|Withdrawal by Subject|1|||
162815254|NCT02982187|588036497|FG007|Overall Study|Withdrawal by Subject|0|||
162815255|NCT02349451|588036501|FG000|Overall Study|Withdrawal by Subject|0|||
162815256|NCT02349451|588036502|FG001|Overall Study|Withdrawal by Subject|1|||
162815257|NCT02349451|588036503|FG002|Overall Study|Withdrawal by Subject|2|||
162815258|NCT02349451|588036504|FG003|Overall Study|Withdrawal by Subject|1|||
162815259|NCT02168842|588036505|FG000|Overall Study|Withdrawal by Subject|5|||
162815260|NCT02168842|588036506|FG001|Overall Study|Withdrawal by Subject|3|||
162815261|NCT02168842|588036505|FG000|Overall Study|Lost to Follow-up|0|||
162815262|NCT02168842|588036506|FG001|Overall Study|Lost to Follow-up|2|||
162815263|NCT02168842|588036505|FG000|Overall Study|Death|2|||
162815264|NCT02168842|588036506|FG001|Overall Study|Death|1|||
162815265|NCT02168842|588036505|FG000|Overall Study|Physician Decision|1|||
162815266|NCT02168842|588036506|FG001|Overall Study|Physician Decision|2|||
162815267|NCT02147353|588036507|FG000|Overall Study|Lost to Follow-up|2|||
162815268|NCT02147353|588036508|FG001|Overall Study|Lost to Follow-up|0|||
162815269|NCT02147353|588036507|FG000|Overall Study|unable to make visits|4|||
162815270|NCT02147353|588036508|FG001|Overall Study|unable to make visits|0|||
162815271|NCT02147353|588036507|FG000|Overall Study|medication noncompliance|3|||
162815272|NCT02147353|588036508|FG001|Overall Study|medication noncompliance|0|||
162815273|NCT02578862|588036516|FG000|Overall Study|Withdrawal by Subject|0|||
162815274|NCT02578862|588036517|FG001|Overall Study|Withdrawal by Subject|1|||
162815275|NCT02578862|588036516|FG000|Overall Study|Unplanned unilateral procedure|0|||
162815276|NCT02578862|588036517|FG001|Overall Study|Unplanned unilateral procedure|1|||
162815277|NCT01230788|588036526|FG000|Overall Study|Prescribed exclusion drug|1|||
162815278|NCT01142596|588036527|FG000|Overall Study|Withdrawal by Subject|9|||
162815279|NCT01142596|588036528|FG001|Overall Study|Withdrawal by Subject|35|||
162815280|NCT01142596|588036527|FG000|Overall Study|Adverse Event|8|||
162815281|NCT01142596|588036528|FG001|Overall Study|Adverse Event|35|||
162815282|NCT01142596|588036527|FG000|Overall Study|Lack of Efficacy|5|||
162815283|NCT01142596|588036528|FG001|Overall Study|Lack of Efficacy|9|||
162815284|NCT01142596|588036527|FG000|Overall Study|Lost to Follow-up|2|||
162815285|NCT01142596|588036528|FG001|Overall Study|Lost to Follow-up|3|||
162815286|NCT01142596|588036527|FG000|Overall Study|Other reason (not specified)|5|||
162815287|NCT01142596|588036528|FG001|Overall Study|Other reason (not specified)|4|||
162815288|NCT01423253|588036529|FG000|Overall Study|Adverse Event|2|||
162815289|NCT01423253|588036529|FG000|Overall Study|Lack of Efficacy|2|||
162815290|NCT01423253|588036529|FG000|Overall Study|Lost to Follow-up|1|||
162815291|NCT01423253|588036529|FG000|Overall Study|Protocol Violation|2|||
162815292|NCT01423253|588036529|FG000|Overall Study|Withdrawal by Subject|2|||
162815293|NCT01290601|588036532|FG000|Overall Study|Adverse Event|0|||
162815294|NCT01290601|588036533|FG001|Overall Study|Adverse Event|2|||
162815295|NCT01290601|588036534|FG002|Overall Study|Adverse Event|0|||
162815296|NCT01290601|588036535|FG003|Overall Study|Adverse Event|0|||
162815297|NCT01290601|588036532|FG000|Overall Study|Lack of Efficacy|2|||
163166098|NCT01742286|589322834|FG002|Expansion Phase|Adverse Event|0|||
162815298|NCT01290601|588036533|FG001|Overall Study|Lack of Efficacy|1|||
162815299|NCT01290601|588036534|FG002|Overall Study|Lack of Efficacy|0|||
162815300|NCT01290601|588036535|FG003|Overall Study|Lack of Efficacy|0|||
162815301|NCT01290601|588036532|FG000|Overall Study|Lost to Follow-up|7|||
162815302|NCT01290601|588036533|FG001|Overall Study|Lost to Follow-up|2|||
163166099|NCT01742286|589322835|FG003|Expansion Phase|Adverse Event|0|||
162815303|NCT01290601|588036534|FG002|Overall Study|Lost to Follow-up|0|||
162815304|NCT01290601|588036535|FG003|Overall Study|Lost to Follow-up|0|||
162815305|NCT01290601|588036532|FG000|Overall Study|Other|1|||
162815306|NCT01290601|588036533|FG001|Overall Study|Other|0|||
162815307|NCT01290601|588036534|FG002|Overall Study|Other|0|||
162815308|NCT01290601|588036535|FG003|Overall Study|Other|0|||
162815309|NCT01290601|588036532|FG000|Overall Study|Protocol Violation|1|||
162815310|NCT01290601|588036533|FG001|Overall Study|Protocol Violation|0|||
162815311|NCT01290601|588036534|FG002|Overall Study|Protocol Violation|0|||
162815312|NCT01290601|588036535|FG003|Overall Study|Protocol Violation|0|||
162815313|NCT00775450|588036536|FG000|Overall Study|Serious Adverse Event|2|||
162815314|NCT00775450|588036537|FG001|Overall Study|Serious Adverse Event|0|||
162815315|NCT00775450|588036538|FG002|Overall Study|Serious Adverse Event|0|||
162815316|NCT00775450|588036539|FG003|Overall Study|Serious Adverse Event|0|||
162815317|NCT00775450|588036540|FG004|Overall Study|Serious Adverse Event|0|||
162815318|NCT00775450|588036536|FG000|Overall Study|Protocol Violation|0|||
162815319|NCT00775450|588036537|FG001|Overall Study|Protocol Violation|0|||
162815320|NCT00775450|588036538|FG002|Overall Study|Protocol Violation|0|||
162815321|NCT00775450|588036539|FG003|Overall Study|Protocol Violation|0|||
162815322|NCT00775450|588036540|FG004|Overall Study|Protocol Violation|1|||
162815323|NCT00775450|588036536|FG000|Overall Study|Withdrawal by Subject|1|||
162815324|NCT00775450|588036537|FG001|Overall Study|Withdrawal by Subject|0|||
162815325|NCT00775450|588036538|FG002|Overall Study|Withdrawal by Subject|0|||
162815326|NCT00775450|588036539|FG003|Overall Study|Withdrawal by Subject|0|||
162815327|NCT00775450|588036540|FG004|Overall Study|Withdrawal by Subject|1|||
162815328|NCT01749540|588036548|FG000|Overall Study|Protocol Violation|0|||
162815329|NCT01749540|588036549|FG001|Overall Study|Protocol Violation|0|||
162815330|NCT01749540|588036550|FG002|Overall Study|Protocol Violation|0|||
162815331|NCT01749540|588036551|FG003|Overall Study|Protocol Violation|0|||
162815332|NCT01749540|588036552|FG004|Overall Study|Protocol Violation|0|||
162815333|NCT01749540|588036553|FG005|Overall Study|Protocol Violation|1|||
162815334|NCT01749540|588036554|FG006|Overall Study|Protocol Violation|1|||
162815335|NCT01749540|588036548|FG000|Overall Study|Withdrawal by Subject|0|||
162815336|NCT01749540|588036549|FG001|Overall Study|Withdrawal by Subject|0|||
162815337|NCT01749540|588036550|FG002|Overall Study|Withdrawal by Subject|0|||
162815338|NCT01749540|588036551|FG003|Overall Study|Withdrawal by Subject|1|||
162815339|NCT01749540|588036552|FG004|Overall Study|Withdrawal by Subject|0|||
162815340|NCT01749540|588036553|FG005|Overall Study|Withdrawal by Subject|0|||
162815341|NCT01749540|588036554|FG006|Overall Study|Withdrawal by Subject|0|||
162815342|NCT01749540|588036548|FG000|Overall Study|Initiated into extension study A536-06|0|||
162815343|NCT01749540|588036549|FG001|Overall Study|Initiated into extension study A536-06|0|||
162815344|NCT01749540|588036550|FG002|Overall Study|Initiated into extension study A536-06|0|||
162815345|NCT01749540|588036551|FG003|Overall Study|Initiated into extension study A536-06|0|||
162815346|NCT01749540|588036552|FG004|Overall Study|Initiated into extension study A536-06|0|||
162815347|NCT01749540|588036553|FG005|Overall Study|Initiated into extension study A536-06|2|||
162815348|NCT01749540|588036554|FG006|Overall Study|Initiated into extension study A536-06|24|||
162815349|NCT00752622|588036566|FG000|Induction Phase|Adverse Event|3|||
162815350|NCT00752622|588036566|FG000|Induction Phase|Other|3|||
162815351|NCT00752622|588036566|FG000|Induction Phase|Non-responder|14|||
162815352|NCT00752622|588036566|FG000|Induction Phase|Withdrawal by Subject|1|||
162815353|NCT00752622|588036566|FG000|Induction Phase|Premature study termination|14|||
162815354|NCT00752622|588036566|FG000|Observational Phase|Premature Study Termination|36|||
162815355|NCT00752622|588036566|FG000|Observational Phase|Non-responder|2|||
162815356|NCT00752622|588036566|FG000|Observational Phase|Withdrawal by Subject|2|||
162815357|NCT00752622|588036566|FG000|Observational Phase|Adverse Event|1|||
162815358|NCT00752622|588036566|FG000|Observational Phase|Other|2|||
162815359|NCT00752622|588036566|FG000|Interventional Phase|Non-responder|2|||
162815360|NCT00752622|588036566|FG000|Interventional Phase|Physician Decision|1|||
162815361|NCT00752622|588036566|FG000|Interventional Phase|Premature Study Termination|5|||
162815362|NCT00576836|588036567|FG000|Overall Study|Death|0|||
162815363|NCT00576836|588036568|FG001|Overall Study|Death|1|||
162815364|NCT00576836|588036567|FG000|Overall Study|Physician Decision|0|||
162815365|NCT00576836|588036568|FG001|Overall Study|Physician Decision|1|||
162815366|NCT00392327|588036571|FG000|Overall Study|Death|1|||
162815367|NCT00392327|588036572|FG001|Overall Study|Death|0|||
163166100|NCT01742286|589322836|FG004|Expansion Phase|Adverse Event|0|||
162815368|NCT00392327|588036573|FG002|Overall Study|Death|1|||
162815369|NCT00392327|588036574|FG003|Overall Study|Death|0|||
162815370|NCT00392327|588036575|FG004|Overall Study|Death|0|||
162815371|NCT00392327|588036576|FG005|Overall Study|Death|0|||
162815372|NCT00392327|588036577|FG006|Overall Study|Death|0|||
162815373|NCT00392327|588036578|FG007|Overall Study|Death|0|||
162815374|NCT00392327|588036571|FG000|Overall Study|Lack of Efficacy|8|||
162815375|NCT00392327|588036572|FG001|Overall Study|Lack of Efficacy|8|||
162815376|NCT00392327|588036573|FG002|Overall Study|Lack of Efficacy|9|||
162815377|NCT00392327|588036574|FG003|Overall Study|Lack of Efficacy|6|||
162815378|NCT00392327|588036575|FG004|Overall Study|Lack of Efficacy|3|||
162815379|NCT00392327|588036576|FG005|Overall Study|Lack of Efficacy|3|||
162815380|NCT00392327|588036577|FG006|Overall Study|Lack of Efficacy|3|||
162815381|NCT00392327|588036578|FG007|Overall Study|Lack of Efficacy|3|||
162815382|NCT00392327|588036571|FG000|Overall Study|Physician Decision|3|||
162815383|NCT00392327|588036572|FG001|Overall Study|Physician Decision|5|||
162815384|NCT00392327|588036573|FG002|Overall Study|Physician Decision|2|||
162815385|NCT00392327|588036574|FG003|Overall Study|Physician Decision|2|||
162815386|NCT00392327|588036575|FG004|Overall Study|Physician Decision|0|||
162815387|NCT00392327|588036576|FG005|Overall Study|Physician Decision|1|||
162815388|NCT00392327|588036577|FG006|Overall Study|Physician Decision|5|||
162815389|NCT00392327|588036578|FG007|Overall Study|Physician Decision|3|||
162815390|NCT00392327|588036571|FG000|Overall Study|Protocol Violation|0|||
162815391|NCT00392327|588036572|FG001|Overall Study|Protocol Violation|0|||
162815392|NCT00392327|588036573|FG002|Overall Study|Protocol Violation|1|||
162815393|NCT00392327|588036574|FG003|Overall Study|Protocol Violation|0|||
162815394|NCT00392327|588036575|FG004|Overall Study|Protocol Violation|0|||
162815395|NCT00392327|588036576|FG005|Overall Study|Protocol Violation|0|||
162815396|NCT00392327|588036577|FG006|Overall Study|Protocol Violation|0|||
162815397|NCT00392327|588036578|FG007|Overall Study|Protocol Violation|0|||
162815398|NCT00392327|588036571|FG000|Overall Study|Withdrawal by Subject|3|||
162815399|NCT00392327|588036572|FG001|Overall Study|Withdrawal by Subject|2|||
162815400|NCT00392327|588036573|FG002|Overall Study|Withdrawal by Subject|4|||
162815401|NCT00392327|588036574|FG003|Overall Study|Withdrawal by Subject|6|||
162815402|NCT00392327|588036575|FG004|Overall Study|Withdrawal by Subject|0|||
162815403|NCT00392327|588036576|FG005|Overall Study|Withdrawal by Subject|1|||
162815404|NCT00392327|588036577|FG006|Overall Study|Withdrawal by Subject|1|||
162815405|NCT00392327|588036578|FG007|Overall Study|Withdrawal by Subject|5|||
162815406|NCT00392327|588036571|FG000|Overall Study|Ineligible|0|||
162815407|NCT00392327|588036572|FG001|Overall Study|Ineligible|4|||
162815408|NCT00392327|588036573|FG002|Overall Study|Ineligible|3|||
162815409|NCT00392327|588036574|FG003|Overall Study|Ineligible|2|||
162815410|NCT00392327|588036575|FG004|Overall Study|Ineligible|0|||
162815411|NCT00392327|588036576|FG005|Overall Study|Ineligible|0|||
162815412|NCT00392327|588036577|FG006|Overall Study|Ineligible|0|||
162815413|NCT00392327|588036578|FG007|Overall Study|Ineligible|0|||
162815414|NCT00894686|588036579|FG000|Overall Study|Withdrawal by Subject|50|||
162815415|NCT00894686|588036579|FG000|Overall Study|Physician Decision|1|||
162815416|NCT00894686|588036579|FG000|Overall Study|Other|5|||
162815417|NCT03267940|588036580|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
162815418|NCT03267940|588036581|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
162815419|NCT03267940|588036582|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
162815420|NCT03267940|588036583|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
162815421|NCT03267940|588036584|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
162815422|NCT03267940|588036585|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
162815423|NCT03267940|588036580|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
162815424|NCT03267940|588036581|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
162815425|NCT03267940|588036582|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
162815426|NCT03267940|588036583|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
162815427|NCT03267940|588036584|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
162815428|NCT03267940|588036585|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
162815429|NCT03267940|588036580|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
162815430|NCT03267940|588036581|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
162815431|NCT03267940|588036582|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
162815432|NCT03267940|588036583|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
162815433|NCT03267940|588036584|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
162815434|NCT03267940|588036585|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
162815435|NCT03267940|588036580|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
162815436|NCT03267940|588036581|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
162815437|NCT03267940|588036582|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
162815438|NCT03267940|588036583|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
162815439|NCT03267940|588036584|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
162815440|NCT03267940|588036585|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
162815441|NCT03267940|588036580|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
162815442|NCT03267940|588036581|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
162815443|NCT03267940|588036582|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
162815444|NCT03267940|588036583|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
162815445|NCT03267940|588036584|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
162815446|NCT03267940|588036585|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
162815447|NCT03267940|588036580|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
162815448|NCT03267940|588036581|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
162815449|NCT03267940|588036582|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
163166101|NCT01742286|589322837|FG005|Expansion Phase|Adverse Event|0|||
163166102|NCT01742286|589322838|FG006|Expansion Phase|Adverse Event|6|||
162815450|NCT03267940|588036583|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
162815451|NCT03267940|588036584|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
162815452|NCT03267940|588036585|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
162815453|NCT03267940|588036580|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
162815454|NCT03267940|588036581|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
162815455|NCT03267940|588036582|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
162815456|NCT03267940|588036583|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
162815457|NCT03267940|588036584|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
162815458|NCT03267940|588036585|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
162815459|NCT03267940|588036580|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
162815460|NCT03267940|588036581|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
162815461|NCT03267940|588036582|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
162815462|NCT03267940|588036583|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
162815463|NCT03267940|588036584|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
162815464|NCT03267940|588036585|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
162815465|NCT03267940|588036580|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
162815466|NCT03267940|588036581|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
162815467|NCT03267940|588036582|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
162815468|NCT03267940|588036583|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
162815469|NCT03267940|588036584|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
162815470|NCT03267940|588036585|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
162815471|NCT00178126|588036592|FG000|Overall Study|Lost to Follow-up|21|||
162815472|NCT00178126|588036593|FG001|Overall Study|Lost to Follow-up|21|||
162815473|NCT00178126|588036592|FG000|Overall Study|did not receive intervention|4|||
162815474|NCT00178126|588036593|FG001|Overall Study|did not receive intervention|6|||
162815475|NCT01074216|588036594|FG000|Overall Study|Physician Decision|1|||
162815476|NCT01074216|588036594|FG000|Overall Study|Not Treated|12|||
162815477|NCT01323634|588036595|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
162815478|NCT01323634|588036596|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
162815479|NCT01323634|588036597|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
162815480|NCT01323634|588036595|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
162815481|NCT01323634|588036596|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
162815482|NCT01323634|588036597|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
162815483|NCT01323634|588036595|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
162815484|NCT01323634|588036596|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162815485|NCT01323634|588036597|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162815486|NCT01323634|588036595|FG000|2-week Run-in Period|Physician Decision|5|||
162815487|NCT01323634|588036596|FG001|2-week Run-in Period|Physician Decision|0|||
162815488|NCT01323634|588036597|FG002|2-week Run-in Period|Physician Decision|0|||
162815489|NCT01323634|588036595|FG000|2-week Run-in Period|Protocol Violation|1|||
162815490|NCT01323634|588036596|FG001|2-week Run-in Period|Protocol Violation|0|||
162815491|NCT01323634|588036597|FG002|2-week Run-in Period|Protocol Violation|0|||
162815492|NCT01323634|588036595|FG000|2-week Run-in Period|Adverse Event|1|||
162815493|NCT01323634|588036596|FG001|2-week Run-in Period|Adverse Event|0|||
162815494|NCT01323634|588036597|FG002|2-week Run-in Period|Adverse Event|0|||
162815495|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162815496|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
162815497|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
162815498|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162815499|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162815500|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
162815501|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162815502|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
162815503|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
162815504|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162815505|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162815506|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162815507|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
162815508|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
162815509|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
162815510|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162815511|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
162815512|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
162815513|NCT01323634|588036595|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
162815514|NCT01323634|588036596|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
162815515|NCT01323634|588036597|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
162815516|NCT05056987|588036598|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
162815517|NCT05056987|588036599|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
162815518|NCT05056987|588036598|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
162815519|NCT05056987|588036599|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
162815520|NCT01182194|588036600|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
162815521|NCT01182194|588036601|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
162815522|NCT01948908|588036602|FG000|Overall Study|Protocol Violation|1|||
162815523|NCT01948908|588036603|FG001|Overall Study|Protocol Violation|0|||
162815524|NCT01948908|588036604|FG002|Overall Study|Protocol Violation|2|||
162815525|NCT01585987|588036605|FG000|Randomized|Withdrawal by Subject|0|||
162815526|NCT01585987|588036606|FG001|Randomized|Withdrawal by Subject|4|||
162815527|NCT01585987|588036605|FG000|Randomized|No longer met criteria|0|||
162815528|NCT01585987|588036606|FG001|Randomized|No longer met criteria|2|||
162815529|NCT01585987|588036605|FG000|Treated|Disease Progression|39|||
162815530|NCT01585987|588036606|FG001|Treated|Disease Progression|36|||
162815531|NCT01585987|588036605|FG000|Treated|Study Drug Toxicity|9|||
162815532|NCT01585987|588036606|FG001|Treated|Study Drug Toxicity|5|||
162815533|NCT01585987|588036605|FG000|Treated|Adverse Event|3|||
162815534|NCT01585987|588036606|FG001|Treated|Adverse Event|0|||
162815535|NCT01585987|588036605|FG000|Treated|Withdrawal by Subject|1|||
162815536|NCT01585987|588036606|FG001|Treated|Withdrawal by Subject|2|||
162815537|NCT01585987|588036605|FG000|Treated|Death|1|||
162815538|NCT01585987|588036606|FG001|Treated|Death|0|||
162815539|NCT01585987|588036605|FG000|Treated|Lost to Follow-up|0|||
162815540|NCT01585987|588036606|FG001|Treated|Lost to Follow-up|1|||
162815541|NCT01585987|588036605|FG000|Treated|Maximum Clinical Benefit|0|||
162815542|NCT01585987|588036606|FG001|Treated|Maximum Clinical Benefit|1|||
162815543|NCT01585987|588036605|FG000|Treated|Non-Specified|1|||
162815544|NCT01585987|588036606|FG001|Treated|Non-Specified|2|||
162815545|NCT01585987|588036605|FG000|Treated|Subject Request|0|||
162815546|NCT01585987|588036606|FG001|Treated|Subject Request|1|||
162815547|NCT01585987|588036605|FG000|Treated|Poor/Non-Compliance|0|||
162815548|NCT01585987|588036606|FG001|Treated|Poor/Non-Compliance|1|||
162815549|NCT03291587|588036607|FG000|Overall Study|Lost to Follow-up|62|||
162815550|NCT03291587|588036608|FG001|Overall Study|Lost to Follow-up|43|||
162815551|NCT03291587|588036607|FG000|Overall Study|Refused to Answer|5|||
162815552|NCT03291587|588036608|FG001|Overall Study|Refused to Answer|2|||
162815553|NCT03291587|588036607|FG000|Overall Study|Death|2|||
162815554|NCT03291587|588036608|FG001|Overall Study|Death|4|||
162815555|NCT03291587|588036607|FG000|Overall Study|Not interested in participating|8|||
162815556|NCT03291587|588036608|FG001|Overall Study|Not interested in participating|6|||
162815557|NCT03291587|588036607|FG000|Overall Study|Too busy to participate|4|||
162815558|NCT03291587|588036608|FG001|Overall Study|Too busy to participate|2|||
162815559|NCT00796120|588036609|FG000|Overall Study|Death|3|||
162815560|NCT00796120|588036610|FG001|Overall Study|Death|0|||
162815561|NCT00796120|588036609|FG000|Overall Study|Adverse Event|11|||
162815562|NCT00796120|588036610|FG001|Overall Study|Adverse Event|6|||
162815563|NCT00796120|588036609|FG000|Overall Study|Progressive disease|22|||
162815564|NCT00796120|588036610|FG001|Overall Study|Progressive disease|13|||
162815565|NCT00796120|588036609|FG000|Overall Study|Participant refusal|3|||
162815566|NCT00796120|588036610|FG001|Overall Study|Participant refusal|4|||
162815567|NCT00796120|588036609|FG000|Overall Study|Other|6|||
162815568|NCT00796120|588036610|FG001|Overall Study|Other|17|||
162815569|NCT00796120|588036609|FG000|Overall Study|Physician Decision|16|||
162815570|NCT00796120|588036610|FG001|Overall Study|Physician Decision|17|||
163042820|NCT01990768|588863970|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
162815571|NCT00796120|588036609|FG000|Overall Study|Randomized but not treated|0|||
162815572|NCT00796120|588036610|FG001|Overall Study|Randomized but not treated|3|||
162815573|NCT01411839|588036615|FG000|Overall Study|Lost to Follow-up|4|||
162815574|NCT01411839|588036616|FG001|Overall Study|Lost to Follow-up|3|||
162815575|NCT04641299|588038323|FG000|Overall Study|Adverse Event|0|||
162815576|NCT04641299|588038324|FG001|Overall Study|Adverse Event|0|||
162815577|NCT04641299|588038325|FG002|Overall Study|Adverse Event|2|||
162815578|NCT04641299|588038326|FG003|Overall Study|Adverse Event|0|||
162815579|NCT04641299|588038323|FG000|Overall Study|Lost to Follow-up|0|||
162815580|NCT04641299|588038324|FG001|Overall Study|Lost to Follow-up|1|||
162815581|NCT04641299|588038325|FG002|Overall Study|Lost to Follow-up|0|||
162815582|NCT04641299|588038326|FG003|Overall Study|Lost to Follow-up|0|||
162815583|NCT04641299|588038323|FG000|Overall Study|Withdrawal by Subject|1|||
162815584|NCT04641299|588038324|FG001|Overall Study|Withdrawal by Subject|0|||
162815585|NCT04641299|588038325|FG002|Overall Study|Withdrawal by Subject|0|||
162815586|NCT04641299|588038326|FG003|Overall Study|Withdrawal by Subject|0|||
162815587|NCT04641299|588038323|FG000|Overall Study|Reason not given|1|||
162815588|NCT04641299|588038324|FG001|Overall Study|Reason not given|0|||
162815589|NCT04641299|588038325|FG002|Overall Study|Reason not given|0|||
162815590|NCT04641299|588038326|FG003|Overall Study|Reason not given|0|||
162815591|NCT01890148|588038329|FG000|Overall Study|Adverse Event|1|||
162815592|NCT05736211|588038341|FG000|Overall Study|Lost to Follow-up|6|||
162815593|NCT05736211|588038342|FG001|Overall Study|Lost to Follow-up|0|||
162815594|NCT04658186|588038344|FG000|Overall Study|Adverse Event|4|||
162815595|NCT04658186|588038345|FG001|Overall Study|Adverse Event|18|||
162815596|NCT04658186|588038346|FG002|Overall Study|Adverse Event|15|||
162815597|NCT04658186|588038344|FG000|Overall Study|Lack of Efficacy|1|||
162815598|NCT04658186|588038345|FG001|Overall Study|Lack of Efficacy|1|||
162815599|NCT04658186|588038346|FG002|Overall Study|Lack of Efficacy|0|||
162815600|NCT04658186|588038344|FG000|Overall Study|Protocol Violation|0|||
162815601|NCT04658186|588038345|FG001|Overall Study|Protocol Violation|0|||
162815602|NCT04658186|588038346|FG002|Overall Study|Protocol Violation|1|||
162815603|NCT04658186|588038344|FG000|Overall Study|Lost to Follow-up|0|||
162815604|NCT04658186|588038345|FG001|Overall Study|Lost to Follow-up|0|||
162815605|NCT04658186|588038346|FG002|Overall Study|Lost to Follow-up|2|||
162815606|NCT04658186|588038344|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
162815607|NCT04658186|588038345|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
162815608|NCT04658186|588038346|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
162815609|NCT04658186|588038344|FG000|Overall Study|Participant is Moving in Another Province|0|||
162815610|NCT04658186|588038345|FG001|Overall Study|Participant is Moving in Another Province|1|||
162815611|NCT04658186|588038346|FG002|Overall Study|Participant is Moving in Another Province|0|||
162815612|NCT04658186|588038344|FG000|Overall Study|Non-Compliance|0|||
162815613|NCT04658186|588038345|FG001|Overall Study|Non-Compliance|1|||
162815614|NCT04658186|588038346|FG002|Overall Study|Non-Compliance|1|||
162815615|NCT04658186|588038344|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
162815616|NCT04658186|588038345|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
162815617|NCT04658186|588038346|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
162815618|NCT04658186|588038344|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
162815619|NCT04658186|588038345|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
162815620|NCT04658186|588038346|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
162815621|NCT04658186|588038344|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
162815622|NCT04658186|588038345|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
162815623|NCT04658186|588038346|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
162815624|NCT04658186|588038344|FG000|Overall Study|PI Decision due to Participant Safety|0|||
162815625|NCT04658186|588038345|FG001|Overall Study|PI Decision due to Participant Safety|0|||
162815626|NCT04658186|588038346|FG002|Overall Study|PI Decision due to Participant Safety|1|||
162815627|NCT04658186|588038344|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
162815628|NCT04658186|588038345|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
162815629|NCT04658186|588038346|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
162815630|NCT04098068|588038347|FG000|Overall Study|Disease Progression|7|||
162815631|NCT04098068|588038347|FG000|Overall Study|Withdrawal by Subject|2|||
162815632|NCT04098068|588038347|FG000|Overall Study|New Cancer Diagnosis|1|||
162815633|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
162815634|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
162815635|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Death|0|||
162815636|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Death|1|||
162815637|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
162815638|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
162815639|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
162815640|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
162815641|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
162815642|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
162815643|NCT00323297|588038362|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
162815644|NCT00323297|588038363|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
162815645|NCT00323297|588038362|FG000|Part B (Open-label)|Death|0|||
162815646|NCT00323297|588038363|FG001|Part B (Open-label)|Death|1|||
162815647|NCT00323297|588038362|FG000|Part B (Open-label)|Reason unspecified|0|||
162815648|NCT00323297|588038363|FG001|Part B (Open-label)|Reason unspecified|1|||
162815649|NCT00323297|588038362|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
162815650|NCT00323297|588038363|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
162815651|NCT00323297|588038362|FG000|Part B (Open-label)|Lack of Efficacy|3|||
162815652|NCT00323297|588038363|FG001|Part B (Open-label)|Lack of Efficacy|1|||
162815653|NCT00323297|588038362|FG000|Part B (Open-label)|Adverse Event|5|||
162815654|NCT00323297|588038363|FG001|Part B (Open-label)|Adverse Event|5|||
162815655|NCT00323297|588038362|FG000|Part B (Open-label)|Protocol Violation|0|||
162815656|NCT00323297|588038363|FG001|Part B (Open-label)|Protocol Violation|1|||
162815657|NCT01176773|588038364|FG000|Overall Study|Screen Failure|2|||
162815658|NCT01176773|588038364|FG000|Overall Study|Withdrew consent|1|||
162815659|NCT01498289|588038369|FG000|Overall Study|Adverse Event|16|||
162815660|NCT01498289|588038370|FG001|Overall Study|Adverse Event|18|||
162815661|NCT01498289|588038369|FG000|Overall Study|Death|6|||
162815662|NCT01498289|588038370|FG001|Overall Study|Death|8|||
162815663|NCT01498289|588038369|FG000|Overall Study|Withdrawal unrelated to AE|16|||
162815664|NCT01498289|588038370|FG001|Overall Study|Withdrawal unrelated to AE|16|||
162815665|NCT01498289|588038369|FG000|Overall Study|Progression/relapse|53|||
162815666|NCT01498289|588038370|FG001|Overall Study|Progression/relapse|59|||
162815667|NCT01498289|588038369|FG000|Overall Study|Not protocol specified|7|||
162815668|NCT01498289|588038370|FG001|Overall Study|Not protocol specified|2|||
162815669|NCT01498289|588038369|FG000|Overall Study|Reason under review|0|||
162815670|NCT01498289|588038370|FG001|Overall Study|Reason under review|1|||
162815671|NCT01575028|588038371|FG000|Overall Study|Physician Decision|0|||
162815672|NCT01575028|588038372|FG001|Overall Study|Physician Decision|1|||
162815673|NCT01759407|588038375|FG000|Overall Study|Protocol Violation|0|||
162815674|NCT01759407|588038376|FG001|Overall Study|Protocol Violation|2|||
162815675|NCT02520284|588038377|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
162815676|NCT02520284|588038378|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
162815677|NCT02520284|588038379|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
162815678|NCT02520284|588038377|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
162815679|NCT02520284|588038378|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
162815680|NCT02520284|588038379|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
162815681|NCT02520284|588038377|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
162815682|NCT02520284|588038378|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
162815683|NCT02520284|588038379|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
162815684|NCT02520284|588038377|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
162815685|NCT02520284|588038378|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
162815686|NCT02520284|588038379|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
162815687|NCT02520284|588038377|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
162815688|NCT02520284|588038378|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
162815689|NCT02520284|588038379|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
162815690|NCT02520284|588038377|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
162815691|NCT02520284|588038378|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
162815692|NCT02520284|588038379|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
162815693|NCT02520284|588038377|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
162815694|NCT02520284|588038378|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
162815695|NCT02520284|588038379|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
162815696|NCT02520284|588038377|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
162815697|NCT02520284|588038378|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
162815698|NCT02520284|588038379|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
162815699|NCT02520284|588038377|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
162815700|NCT02520284|588038378|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
162815701|NCT02520284|588038379|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
162815702|NCT02520284|588038377|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
162815703|NCT02520284|588038378|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
162815704|NCT02520284|588038379|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
162815705|NCT02520284|588038377|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
162815706|NCT02520284|588038378|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
162815707|NCT02520284|588038379|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
162815708|NCT03737474|588038380|FG000|Overall Study|Adverse Event|18|||
162815709|NCT03737474|588038381|FG001|Overall Study|Adverse Event|48|||
162815710|NCT03737474|588038380|FG000|Overall Study|Lack of Efficacy|1|||
162815711|NCT03737474|588038381|FG001|Overall Study|Lack of Efficacy|3|||
162815712|NCT03737474|588038380|FG000|Overall Study|Protocol Violation|0|||
162815713|NCT03737474|588038381|FG001|Overall Study|Protocol Violation|8|||
162815714|NCT03737474|588038380|FG000|Overall Study|Withdrawal by Subject|5|||
162815715|NCT03737474|588038381|FG001|Overall Study|Withdrawal by Subject|20|||
162815716|NCT03737474|588038380|FG000|Overall Study|Non-compliance With Study Drug|0|||
162815717|NCT03737474|588038381|FG001|Overall Study|Non-compliance With Study Drug|1|||
162815718|NCT03737474|588038380|FG000|Overall Study|Physician Decision|1|||
162815719|NCT03737474|588038381|FG001|Overall Study|Physician Decision|4|||
162815720|NCT02513745|588038384|FG000|Overall Study|Criteria at time of surgery not met.|3|||
163166103|NCT01742286|589322832|FG000|Expansion Phase|Disease progression|0|||
163166104|NCT01742286|589322833|FG001|Expansion Phase|Disease progression|0|||
163166105|NCT01742286|589322834|FG002|Expansion Phase|Disease progression|3|||
162815721|NCT02513745|588038385|FG001|Overall Study|Criteria at time of surgery not met.|3|||
162815722|NCT04526197|588038386|FG000|Period 1|Adverse Event|0|||
162815723|NCT04526197|588038387|FG001|Period 1|Adverse Event|1|||
162815724|NCT04526197|588038386|FG000|Period 1|Withdrawal by Subject|1|||
162815725|NCT04526197|588038387|FG001|Period 1|Withdrawal by Subject|0|||
162815726|NCT04526197|588038386|FG000|Period 2|Adverse Event|0|||
162815727|NCT04526197|588038387|FG001|Period 2|Adverse Event|1|||
162815728|NCT04526197|588038386|FG000|Period 2|Withdrawal by Subject|0|||
162815729|NCT04526197|588038387|FG001|Period 2|Withdrawal by Subject|1|||
162815730|NCT01209143|588038388|FG000|Overall Study|Adverse Event|2|||
162815731|NCT01209143|588038389|FG001|Overall Study|Adverse Event|1|||
162815732|NCT01209143|588038388|FG000|Overall Study|Death|0|||
162815733|NCT01209143|588038389|FG001|Overall Study|Death|1|||
162815734|NCT01209143|588038388|FG000|Overall Study|Physician Decision|3|||
162815735|NCT01209143|588038389|FG001|Overall Study|Physician Decision|1|||
162815736|NCT01209143|588038388|FG000|Overall Study|Lost to Follow-up|1|||
162815737|NCT01209143|588038389|FG001|Overall Study|Lost to Follow-up|0|||
162815738|NCT01209143|588038388|FG000|Overall Study|Withdrawal by Subject|2|||
162815739|NCT01209143|588038389|FG001|Overall Study|Withdrawal by Subject|1|||
162815740|NCT01209143|588038388|FG000|Overall Study|Disease progression|11|||
162815741|NCT01209143|588038389|FG001|Overall Study|Disease progression|16|||
162815742|NCT00381303|588038390|FG000|Overall Study|Lost to Follow-up|25|||
162815743|NCT00381303|588038391|FG001|Overall Study|Lost to Follow-up|9|||
162815744|NCT00381303|588038390|FG000|Overall Study|AE/HIV-related event|22|||
162815745|NCT00381303|588038391|FG001|Overall Study|AE/HIV-related event|6|||
162815746|NCT00381303|588038390|FG000|Overall Study|Non-Adherence|13|||
162815747|NCT00381303|588038391|FG001|Overall Study|Non-Adherence|6|||
162815748|NCT00381303|588038390|FG000|Overall Study|Withdrawal by Subject|13|||
162815749|NCT00381303|588038391|FG001|Overall Study|Withdrawal by Subject|6|||
162815750|NCT00381303|588038390|FG000|Overall Study|Virologic failure|6|||
162815751|NCT00381303|588038391|FG001|Overall Study|Virologic failure|4|||
162815752|NCT00381303|588038390|FG000|Overall Study|Ineligible to continue the trial|2|||
162815753|NCT00381303|588038391|FG001|Overall Study|Ineligible to continue the trial|1|||
162815754|NCT00381303|588038390|FG000|Overall Study|Pregnancy|2|||
162815755|NCT00381303|588038391|FG001|Overall Study|Pregnancy|0|||
162815756|NCT00381303|588038390|FG000|Overall Study|Physician Decision|1|||
162815757|NCT00381303|588038391|FG001|Overall Study|Physician Decision|0|||
162815758|NCT00381303|588038390|FG000|Overall Study|Physician's decision to close the site|3|||
162815759|NCT00381303|588038391|FG001|Overall Study|Physician's decision to close the site|1|||
162815760|NCT00381303|588038390|FG000|Overall Study|Subject moved out of state|2|||
162815761|NCT00381303|588038391|FG001|Overall Study|Subject moved out of state|0|||
162815762|NCT00381303|588038390|FG000|Overall Study|Subject taking too many different meds|1|||
162815763|NCT00381303|588038391|FG001|Overall Study|Subject taking too many different meds|0|||
162815764|NCT00381303|588038390|FG000|Overall Study|No virologic response by week 12|1|||
162815765|NCT00381303|588038391|FG001|Overall Study|No virologic response by week 12|0|||
162815766|NCT00381303|588038390|FG000|Overall Study|Subject was too busy for appointments|1|||
162815767|NCT00381303|588038391|FG001|Overall Study|Subject was too busy for appointments|0|||
162815768|NCT00381303|588038390|FG000|Overall Study|Subject did not continue visits|1|||
162815769|NCT00381303|588038391|FG001|Overall Study|Subject did not continue visits|0|||
162815770|NCT00381303|588038390|FG000|Overall Study|Subject primary physician's decision|1|||
162815771|NCT00381303|588038391|FG001|Overall Study|Subject primary physician's decision|0|||
162815772|NCT01136811|588038392|FG000|Overall Study|Physician Decision|11|||
162815773|NCT01211522|588038394|FG000|Overall Study|Withdrawal by Subject|3|||
162815774|NCT01211522|588038395|FG001|Overall Study|Withdrawal by Subject|7|||
162815775|NCT01211522|588038396|FG002|Overall Study|Withdrawal by Subject|5|||
162815776|NCT01116882|588038402|FG000|30-day|Lost to Follow-up|50|||
162815777|NCT01116882|588038403|FG001|30-day|Lost to Follow-up|21|||
162815778|NCT01116882|588038402|FG000|30-day|Withdrawal by Subject|2|||
162815779|NCT01116882|588038403|FG001|30-day|Withdrawal by Subject|4|||
162815780|NCT01116882|588038402|FG000|30-day|Other Reasons|16|||
162815781|NCT01116882|588038403|FG001|30-day|Other Reasons|6|||
162815782|NCT01116882|588038402|FG000|12-month|Lost to Follow-up|111|||
162815783|NCT01116882|588038403|FG001|12-month|Lost to Follow-up|42|||
162815784|NCT01116882|588038402|FG000|12-month|Other Reasons|151|||
162815785|NCT01116882|588038403|FG001|12-month|Other Reasons|49|||
162815786|NCT01116882|588038402|FG000|12-month|Withdrawal by Subject|5|||
162815787|NCT01116882|588038403|FG001|12-month|Withdrawal by Subject|8|||
162815788|NCT00547365|588038404|FG000|Overall Study|Physician Decision|1|||
162815789|NCT00547365|588038404|FG000|Overall Study|Lost to Follow-up|1|||
162815790|NCT00547365|588038404|FG000|Overall Study|Protocol Violation|2|||
162815791|NCT00547365|588038404|FG000|Overall Study|death (not related to study)|4|||
162815792|NCT01139658|588038405|FG000|Overall Study|Adverse Event|10|||
162815793|NCT01139658|588038406|FG001|Overall Study|Adverse Event|27|||
162815794|NCT01139658|588038405|FG000|Overall Study|Lack of Efficacy|15|||
162815795|NCT01139658|588038406|FG001|Overall Study|Lack of Efficacy|7|||
162815796|NCT01139658|588038405|FG000|Overall Study|Withdrawal by Subject|2|||
162815797|NCT01139658|588038406|FG001|Overall Study|Withdrawal by Subject|4|||
162815798|NCT01139658|588038405|FG000|Overall Study|No documentation of treatment|1|||
162815799|NCT01139658|588038406|FG001|Overall Study|No documentation of treatment|0|||
162815800|NCT01139658|588038405|FG000|Overall Study|Other|28|||
162815801|NCT01139658|588038406|FG001|Overall Study|Other|75|||
162815802|NCT01777269|588038409|FG000|Overall Study|Adverse Event|24|||
162815803|NCT01777269|588038410|FG001|Overall Study|Adverse Event|33|||
162815804|NCT01777269|588038409|FG000|Overall Study|Lack of Efficacy|8|||
162815805|NCT01777269|588038410|FG001|Overall Study|Lack of Efficacy|10|||
162815806|NCT01777269|588038409|FG000|Overall Study|Protocol Violation|4|||
162815807|NCT01777269|588038410|FG001|Overall Study|Protocol Violation|4|||
162815808|NCT01777269|588038409|FG000|Overall Study|Participants reached stopping criteria|1|||
162815809|NCT01777269|588038410|FG001|Overall Study|Participants reached stopping criteria|1|||
162815810|NCT01777269|588038409|FG000|Overall Study|Lost to Follow-up|4|||
162815811|NCT01777269|588038410|FG001|Overall Study|Lost to Follow-up|0|||
162815812|NCT01777269|588038409|FG000|Overall Study|Physician Decision|5|||
162815813|NCT01777269|588038410|FG001|Overall Study|Physician Decision|2|||
162815814|NCT01777269|588038409|FG000|Overall Study|Withdrawal by Subject|9|||
162815815|NCT01777269|588038410|FG001|Overall Study|Withdrawal by Subject|9|||
162815816|NCT00504881|588038411|FG000|Overall Study|Lack of Efficacy|1|||
162815817|NCT00504881|588038412|FG001|Overall Study|Lack of Efficacy|5|||
162815818|NCT00504881|588038411|FG000|Overall Study|Lost to Follow-up|0|||
162815819|NCT00504881|588038412|FG001|Overall Study|Lost to Follow-up|2|||
162815820|NCT00504881|588038411|FG000|Overall Study|Withdrawal by Subject|1|||
162815821|NCT00504881|588038412|FG001|Overall Study|Withdrawal by Subject|4|||
162815822|NCT00504881|588038411|FG000|Overall Study|Non-Compliance|1|||
162815823|NCT00504881|588038412|FG001|Overall Study|Non-Compliance|0|||
162815824|NCT00504881|588038411|FG000|Overall Study|No Birth Control|0|||
162815825|NCT00504881|588038412|FG001|Overall Study|No Birth Control|1|||
162815826|NCT00504881|588038411|FG000|Overall Study|Safety Visit not performed|0|||
162815827|NCT00504881|588038412|FG001|Overall Study|Safety Visit not performed|1|||
162815828|NCT00504881|588038411|FG000|Overall Study|AE, serious fatal|0|||
162815829|NCT00504881|588038412|FG001|Overall Study|AE, serious fatal|1|||
162815830|NCT00504881|588038411|FG000|Overall Study|SAE, non-fatal|2|||
162815831|NCT00504881|588038412|FG001|Overall Study|SAE, non-fatal|6|||
162815832|NCT00504881|588038411|FG000|Overall Study|AE, non-serious non-fatal|4|||
162815833|NCT00504881|588038412|FG001|Overall Study|AE, non-serious non-fatal|14|||
162815834|NCT00504881|588038411|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162815835|NCT00504881|588038412|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
162815836|NCT00504881|588038411|FG000|Overall Study|AE of unknown type|1|||
162815837|NCT00504881|588038412|FG001|Overall Study|AE of unknown type|0|||
162815838|NCT00753272|588038420|FG000|Overall Study|Adverse Event|878|||
162815839|NCT00753272|588038421|FG001|Overall Study|Adverse Event|869|||
162815840|NCT00753272|588038420|FG000|Overall Study|Protocol Violation|28|||
162815841|NCT00753272|588038421|FG001|Overall Study|Protocol Violation|46|||
162815842|NCT00753272|588038420|FG000|Overall Study|Withdrawal by Subject|2481|||
162815843|NCT00753272|588038421|FG001|Overall Study|Withdrawal by Subject|2407|||
162815844|NCT00753272|588038420|FG000|Overall Study|Lost to Follow-up|491|||
162815845|NCT00753272|588038421|FG001|Overall Study|Lost to Follow-up|497|||
162815846|NCT00753272|588038420|FG000|Overall Study|Other|1104|||
162815847|NCT00753272|588038421|FG001|Overall Study|Other|1088|||
162815848|NCT00803270|588038422|FG000|Overall Study|Lost to Follow-up|1|||
162815849|NCT00803270|588038423|FG001|Overall Study|Lost to Follow-up|2|||
162815850|NCT01966471|588038424|FG000|Overall Study|Death|44|||
162815851|NCT01966471|588038425|FG001|Overall Study|Death|56|||
162815852|NCT01966471|588038424|FG000|Overall Study|Lost to Follow-up|46|||
162815853|NCT01966471|588038425|FG001|Overall Study|Lost to Follow-up|39|||
162815854|NCT01966471|588038424|FG000|Overall Study|Various reasons|4|||
162815855|NCT01966471|588038425|FG001|Overall Study|Various reasons|4|||
162815856|NCT01966471|588038424|FG000|Overall Study|Physician Decision|7|||
162815857|NCT01966471|588038425|FG001|Overall Study|Physician Decision|5|||
162815858|NCT01966471|588038424|FG000|Overall Study|Study Terminated By Sponsor|758|||
162815859|NCT01966471|588038425|FG001|Overall Study|Study Terminated By Sponsor|773|||
162815860|NCT01966471|588038424|FG000|Overall Study|Withdrawal by Subject|59|||
162815861|NCT01966471|588038425|FG001|Overall Study|Withdrawal by Subject|51|||
162815862|NCT02092220|588038429|FG000|Period 1|Unrelated Illness|0|||
162815863|NCT02092220|588038430|FG001|Period 1|Unrelated Illness|2|||
162815864|NCT02092220|588038429|FG000|Period 2|Severe Hypoglycaemia|1|||
162815865|NCT02092220|588038430|FG001|Period 2|Severe Hypoglycaemia|0|||
162815866|NCT02092220|588038429|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
162815867|NCT02092220|588038430|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
162815868|NCT00960531|588038431|FG000|Overall Study|Lack of Efficacy|1|||
162815869|NCT00960531|588038432|FG001|Overall Study|Lack of Efficacy|0|||
162815870|NCT00960531|588038433|FG002|Overall Study|Lack of Efficacy|0|||
162815871|NCT00960531|588038434|FG003|Overall Study|Lack of Efficacy|0|||
162815872|NCT00960531|588038435|FG004|Overall Study|Lack of Efficacy|0|||
162815873|NCT00960531|588038436|FG005|Overall Study|Lack of Efficacy|0|||
162815874|NCT00960531|588038437|FG006|Overall Study|Lack of Efficacy|0|||
162815875|NCT00960531|588038438|FG007|Overall Study|Lack of Efficacy|0|||
162815876|NCT00960531|588038439|FG008|Overall Study|Lack of Efficacy|0|||
162815877|NCT00960531|588038440|FG009|Overall Study|Lack of Efficacy|0|||
162815878|NCT00960531|588038431|FG000|Overall Study|Withdrawal by Subject|1|||
162815879|NCT00960531|588038432|FG001|Overall Study|Withdrawal by Subject|0|||
162815880|NCT00960531|588038433|FG002|Overall Study|Withdrawal by Subject|5|||
162815881|NCT00960531|588038434|FG003|Overall Study|Withdrawal by Subject|2|||
162815882|NCT00960531|588038435|FG004|Overall Study|Withdrawal by Subject|0|||
162815883|NCT00960531|588038436|FG005|Overall Study|Withdrawal by Subject|0|||
162815884|NCT00960531|588038437|FG006|Overall Study|Withdrawal by Subject|2|||
162815885|NCT00960531|588038438|FG007|Overall Study|Withdrawal by Subject|0|||
162815886|NCT00960531|588038439|FG008|Overall Study|Withdrawal by Subject|1|||
162815887|NCT00960531|588038440|FG009|Overall Study|Withdrawal by Subject|0|||
162815888|NCT00960531|588038431|FG000|Overall Study|Caregiver Request|2|||
162815889|NCT00960531|588038432|FG001|Overall Study|Caregiver Request|0|||
162815890|NCT00960531|588038433|FG002|Overall Study|Caregiver Request|6|||
162815891|NCT00960531|588038434|FG003|Overall Study|Caregiver Request|5|||
162815892|NCT00960531|588038435|FG004|Overall Study|Caregiver Request|0|||
162815893|NCT00960531|588038436|FG005|Overall Study|Caregiver Request|2|||
162815894|NCT00960531|588038437|FG006|Overall Study|Caregiver Request|3|||
162815895|NCT00960531|588038438|FG007|Overall Study|Caregiver Request|1|||
162815896|NCT00960531|588038439|FG008|Overall Study|Caregiver Request|3|||
162815897|NCT00960531|588038440|FG009|Overall Study|Caregiver Request|0|||
162815898|NCT00960531|588038431|FG000|Overall Study|Investigator Request|0|||
162815899|NCT00960531|588038432|FG001|Overall Study|Investigator Request|0|||
162815900|NCT00960531|588038433|FG002|Overall Study|Investigator Request|1|||
162815901|NCT00960531|588038434|FG003|Overall Study|Investigator Request|0|||
162815902|NCT00960531|588038435|FG004|Overall Study|Investigator Request|0|||
162815903|NCT00960531|588038436|FG005|Overall Study|Investigator Request|0|||
162815904|NCT00960531|588038437|FG006|Overall Study|Investigator Request|0|||
162815905|NCT00960531|588038438|FG007|Overall Study|Investigator Request|0|||
162815906|NCT00960531|588038439|FG008|Overall Study|Investigator Request|0|||
162815907|NCT00960531|588038440|FG009|Overall Study|Investigator Request|0|||
162815908|NCT00960531|588038431|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
162815909|NCT00960531|588038432|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162815910|NCT00960531|588038433|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
162815911|NCT00960531|588038434|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
162815912|NCT00960531|588038435|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
162815913|NCT00960531|588038436|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
162815914|NCT00960531|588038437|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
162815915|NCT00960531|588038438|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
162815916|NCT00960531|588038439|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
162815917|NCT00960531|588038440|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
162815918|NCT00960531|588038431|FG000|Overall Study|Lost to Follow-up|0|||
162815919|NCT00960531|588038432|FG001|Overall Study|Lost to Follow-up|0|||
162815920|NCT00960531|588038433|FG002|Overall Study|Lost to Follow-up|1|||
162815921|NCT00960531|588038434|FG003|Overall Study|Lost to Follow-up|0|||
162815922|NCT00960531|588038435|FG004|Overall Study|Lost to Follow-up|0|||
162815923|NCT00960531|588038436|FG005|Overall Study|Lost to Follow-up|0|||
162815924|NCT00960531|588038437|FG006|Overall Study|Lost to Follow-up|1|||
162815925|NCT00960531|588038438|FG007|Overall Study|Lost to Follow-up|0|||
162815926|NCT00960531|588038439|FG008|Overall Study|Lost to Follow-up|0|||
162815927|NCT00960531|588038440|FG009|Overall Study|Lost to Follow-up|0|||
162815928|NCT00960531|588038431|FG000|Overall Study|Failed to Return|2|||
162815929|NCT00960531|588038432|FG001|Overall Study|Failed to Return|0|||
162815930|NCT00960531|588038433|FG002|Overall Study|Failed to Return|0|||
162815931|NCT00960531|588038434|FG003|Overall Study|Failed to Return|0|||
162815932|NCT00960531|588038435|FG004|Overall Study|Failed to Return|0|||
162815933|NCT00960531|588038436|FG005|Overall Study|Failed to Return|0|||
162815934|NCT00960531|588038437|FG006|Overall Study|Failed to Return|0|||
162815935|NCT00960531|588038438|FG007|Overall Study|Failed to Return|2|||
162815936|NCT00960531|588038439|FG008|Overall Study|Failed to Return|0|||
162815937|NCT00960531|588038440|FG009|Overall Study|Failed to Return|0|||
162815938|NCT00960531|588038431|FG000|Overall Study|Adverse Event (AE)|2|||
162815939|NCT00960531|588038432|FG001|Overall Study|Adverse Event (AE)|0|||
162815940|NCT00960531|588038433|FG002|Overall Study|Adverse Event (AE)|0|||
162815941|NCT00960531|588038434|FG003|Overall Study|Adverse Event (AE)|0|||
162815942|NCT00960531|588038435|FG004|Overall Study|Adverse Event (AE)|0|||
162815943|NCT00960531|588038436|FG005|Overall Study|Adverse Event (AE)|1|||
162815944|NCT00960531|588038437|FG006|Overall Study|Adverse Event (AE)|2|||
162815945|NCT00960531|588038438|FG007|Overall Study|Adverse Event (AE)|0|||
162815946|NCT00960531|588038439|FG008|Overall Study|Adverse Event (AE)|2|||
162815947|NCT00960531|588038440|FG009|Overall Study|Adverse Event (AE)|0|||
162815948|NCT00960531|588038431|FG000|Overall Study|Reason not Specified|2|||
162815949|NCT00960531|588038432|FG001|Overall Study|Reason not Specified|1|||
162815950|NCT00960531|588038433|FG002|Overall Study|Reason not Specified|13|||
162815951|NCT00960531|588038434|FG003|Overall Study|Reason not Specified|1|||
162815952|NCT00960531|588038435|FG004|Overall Study|Reason not Specified|2|||
162815953|NCT00960531|588038436|FG005|Overall Study|Reason not Specified|0|||
162815954|NCT00960531|588038437|FG006|Overall Study|Reason not Specified|16|||
162815955|NCT00960531|588038438|FG007|Overall Study|Reason not Specified|0|||
162815956|NCT00960531|588038439|FG008|Overall Study|Reason not Specified|8|||
162815957|NCT00960531|588038440|FG009|Overall Study|Reason not Specified|1|||
162815958|NCT00593957|588038441|FG000|Overall Study|Physician Decision|0|||
162815959|NCT00593957|588038442|FG001|Overall Study|Physician Decision|1|||
162815960|NCT00593957|588038443|FG002|Overall Study|Physician Decision|2|||
162815961|NCT02411578|588038446|FG000|Crossover Trial Phase|Pregnancy|0|||
162815962|NCT02411578|588038447|FG001|Crossover Trial Phase|Pregnancy|1|||
162815963|NCT00494481|588038448|FG000|Overall Study|Condition under investigation worsened|11|||
162815964|NCT00494481|588038449|FG001|Overall Study|Condition under investigation worsened|13|||
162815965|NCT00494481|588038448|FG000|Overall Study|Adverse Event|15|||
162815966|NCT00494481|588038449|FG001|Overall Study|Adverse Event|11|||
162815967|NCT00494481|588038448|FG000|Overall Study|Other|1|||
162815968|NCT00494481|588038449|FG001|Overall Study|Other|0|||
162815969|NCT00494481|588038448|FG000|Overall Study|Never received IP|2|||
162815970|NCT00494481|588038449|FG001|Overall Study|Never received IP|0|||
162815971|NCT01030198|588038450|FG000|Overall Study|Could not measure efficacy accurately|0|||
162815972|NCT01030198|588038451|FG001|Overall Study|Could not measure efficacy accurately|7|||
162815973|NCT00332189|588038452|FG000|Overall Study|Adverse Event|3|||
162815974|NCT00332189|588038452|FG000|Overall Study|Uncooperative/Noncompliant|3|||
162815975|NCT00332189|588038452|FG000|Overall Study|Withdrawal by Subject|9|||
162815976|NCT00332189|588038452|FG000|Overall Study|Lack of Efficacy|4|||
162815977|NCT00332189|588038452|FG000|Overall Study|Moved out of country|2|||
162815978|NCT02370043|588038453|FG000|Overall Study|Withdrawal by Subject|0|||
162815979|NCT02370043|588038454|FG001|Overall Study|Withdrawal by Subject|0|||
162815980|NCT02370043|588038455|FG002|Overall Study|Withdrawal by Subject|0|||
162815981|NCT02370043|588038456|FG003|Overall Study|Withdrawal by Subject|0|||
162815982|NCT02370043|588038457|FG004|Overall Study|Withdrawal by Subject|1|||
162815983|NCT02370043|588038458|FG005|Overall Study|Withdrawal by Subject|1|||
162815984|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
162815985|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
162815986|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
162815987|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
162815988|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
162815989|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
162815990|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
162815991|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
162815992|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
162815993|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
162815994|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
162815995|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
162815996|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
162815997|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
162815998|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
162815999|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
162816000|NCT01231516|588038459|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
162816001|NCT01231516|588038460|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
162816002|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
162816003|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
162816004|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
162816005|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
162816006|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
162816007|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
162816008|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
162816009|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
162816010|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
162816011|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
162816012|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
162816013|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
162816014|NCT01231516|588038459|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
162816015|NCT01231516|588038460|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
162816016|NCT05266586|588038463|FG000|Overall Study|Adverse Event|2|||
162816017|NCT05266586|588038464|FG001|Overall Study|Adverse Event|2|||
162816018|NCT05266586|588038465|FG002|Overall Study|Adverse Event|1|||
162816019|NCT05266586|588038463|FG000|Overall Study|Withdrawal by Subject|1|||
162816020|NCT05266586|588038464|FG001|Overall Study|Withdrawal by Subject|0|||
162816021|NCT05266586|588038465|FG002|Overall Study|Withdrawal by Subject|1|||
162816022|NCT05266586|588038463|FG000|Overall Study|Non-compliance with study drug|0|||
162816023|NCT05266586|588038464|FG001|Overall Study|Non-compliance with study drug|1|||
162816024|NCT05266586|588038465|FG002|Overall Study|Non-compliance with study drug|0|||
162816025|NCT05266586|588038463|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
163166106|NCT01742286|589322835|FG003|Expansion Phase|Disease progression|0|||
163166107|NCT01742286|589322836|FG004|Expansion Phase|Disease progression|0|||
162816026|NCT05266586|588038464|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
162816027|NCT05266586|588038465|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
162816028|NCT02225353|588038466|FG000|Overall Study|Lost to Follow-up|0|||
162816029|NCT02225353|588038467|FG001|Overall Study|Lost to Follow-up|1|||
162816030|NCT02225353|588038468|FG002|Overall Study|Lost to Follow-up|3|||
162816031|NCT02225353|588038466|FG000|Overall Study|Protocol Violation|4|||
162816032|NCT02225353|588038467|FG001|Overall Study|Protocol Violation|5|||
162816033|NCT02225353|588038468|FG002|Overall Study|Protocol Violation|12|||
162816034|NCT03707925|588038469|FG000|Overall Study|Inevaluable|1|||
162816035|NCT01193920|588038470|FG000|Overall Study|Withdrawal by Subject|1|||
162816036|NCT01193920|588038471|FG001|Overall Study|Withdrawal by Subject|0|||
162816037|NCT01193920|588038472|FG002|Overall Study|Withdrawal by Subject|5|||
162816038|NCT01193920|588038473|FG003|Overall Study|Withdrawal by Subject|1|||
162816039|NCT01193920|588038474|FG004|Overall Study|Withdrawal by Subject|3|||
162816040|NCT01193920|588038475|FG005|Overall Study|Withdrawal by Subject|1|||
162816041|NCT01193920|588038476|FG006|Overall Study|Withdrawal by Subject|3|||
162816042|NCT01193920|588038477|FG007|Overall Study|Withdrawal by Subject|0|||
162816043|NCT01193920|588038478|FG008|Overall Study|Withdrawal by Subject|1|||
162816044|NCT01193920|588038479|FG009|Overall Study|Withdrawal by Subject|0|||
162816045|NCT01193920|588038470|FG000|Overall Study|Lost to Follow-up|1|||
162816046|NCT01193920|588038471|FG001|Overall Study|Lost to Follow-up|0|||
162816047|NCT01193920|588038472|FG002|Overall Study|Lost to Follow-up|1|||
162816048|NCT01193920|588038473|FG003|Overall Study|Lost to Follow-up|1|||
162816049|NCT01193920|588038474|FG004|Overall Study|Lost to Follow-up|3|||
162816050|NCT01193920|588038475|FG005|Overall Study|Lost to Follow-up|3|||
162816051|NCT01193920|588038476|FG006|Overall Study|Lost to Follow-up|1|||
162816052|NCT01193920|588038477|FG007|Overall Study|Lost to Follow-up|0|||
162816053|NCT01193920|588038478|FG008|Overall Study|Lost to Follow-up|2|||
162816054|NCT01193920|588038479|FG009|Overall Study|Lost to Follow-up|3|||
162816055|NCT01193920|588038470|FG000|Overall Study|Protocol Violation|1|||
162816056|NCT01193920|588038471|FG001|Overall Study|Protocol Violation|0|||
162816057|NCT01193920|588038472|FG002|Overall Study|Protocol Violation|0|||
162816058|NCT01193920|588038473|FG003|Overall Study|Protocol Violation|0|||
162816059|NCT01193920|588038474|FG004|Overall Study|Protocol Violation|0|||
162816060|NCT01193920|588038475|FG005|Overall Study|Protocol Violation|0|||
162816061|NCT01193920|588038476|FG006|Overall Study|Protocol Violation|0|||
162816062|NCT01193920|588038477|FG007|Overall Study|Protocol Violation|0|||
162816063|NCT01193920|588038478|FG008|Overall Study|Protocol Violation|0|||
162816064|NCT01193920|588038479|FG009|Overall Study|Protocol Violation|0|||
162816065|NCT01193920|588038470|FG000|Overall Study|Death|0|||
162816066|NCT01193920|588038471|FG001|Overall Study|Death|0|||
162816067|NCT01193920|588038472|FG002|Overall Study|Death|0|||
162816068|NCT01193920|588038473|FG003|Overall Study|Death|1|||
162816069|NCT01193920|588038474|FG004|Overall Study|Death|0|||
162816070|NCT01193920|588038475|FG005|Overall Study|Death|0|||
162816071|NCT01193920|588038476|FG006|Overall Study|Death|2|||
162816072|NCT01193920|588038477|FG007|Overall Study|Death|3|||
162816073|NCT01193920|588038478|FG008|Overall Study|Death|2|||
162816074|NCT01193920|588038479|FG009|Overall Study|Death|4|||
162816075|NCT01193920|588038470|FG000|Overall Study|Unable to classify|0|||
162816076|NCT01193920|588038471|FG001|Overall Study|Unable to classify|0|||
162816077|NCT01193920|588038472|FG002|Overall Study|Unable to classify|0|||
162816078|NCT01193920|588038473|FG003|Overall Study|Unable to classify|1|||
162816079|NCT01193920|588038474|FG004|Overall Study|Unable to classify|0|||
162816080|NCT01193920|588038475|FG005|Overall Study|Unable to classify|0|||
162816081|NCT01193920|588038476|FG006|Overall Study|Unable to classify|0|||
162816082|NCT01193920|588038477|FG007|Overall Study|Unable to classify|1|||
162816083|NCT01193920|588038478|FG008|Overall Study|Unable to classify|0|||
162816084|NCT01193920|588038479|FG009|Overall Study|Unable to classify|0|||
162816085|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
162816086|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
162816087|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
162816088|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
162816089|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
162816090|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
162816091|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
162816092|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
162816093|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
162816094|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
162816095|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
162816096|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
162816097|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
162816098|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
162816099|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
162816100|NCT01323621|588038480|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
162816101|NCT01323621|588038481|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
162816102|NCT01323621|588038482|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
162816103|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
162816104|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
162816105|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
162816106|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
162816107|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
162816108|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
162816109|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
162816110|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
162816111|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
162816112|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162816113|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
162816114|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162816115|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
162816116|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
162816117|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
162816118|NCT01323621|588038480|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162816119|NCT01323621|588038481|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
162816120|NCT01323621|588038482|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
162816121|NCT00954421|588038483|FG000|Screening|screen failures|3|||
162816122|NCT00954421|588038483|FG000|6 Months of DBS|Withdrawal by Subject|1|||
162816123|NCT00954421|588038483|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
162816124|NCT00883051|588038484|FG000|Overall Study|Lost to Follow-up|0|||
162816125|NCT00883051|588038485|FG001|Overall Study|Lost to Follow-up|0|||
162816126|NCT00883051|588038486|FG002|Overall Study|Lost to Follow-up|0|||
162816127|NCT00883051|588038487|FG003|Overall Study|Lost to Follow-up|0|||
162816128|NCT00883051|588038488|FG004|Overall Study|Lost to Follow-up|1|||
162816129|NCT00883051|588038484|FG000|Overall Study|Did not use study medication|24|||
162816130|NCT00883051|588038485|FG001|Overall Study|Did not use study medication|22|||
162816131|NCT00883051|588038486|FG002|Overall Study|Did not use study medication|29|||
162816132|NCT00883051|588038487|FG003|Overall Study|Did not use study medication|29|||
162816133|NCT00883051|588038488|FG004|Overall Study|Did not use study medication|17|||
162816134|NCT00458341|588038489|FG000|Cycle 1|Adverse Event|1|||
162816135|NCT00458341|588038490|FG001|Cycle 1|Adverse Event|0|||
162816136|NCT06515483|588038491|FG000|Overall Study|Subject withdraw due to family issues|1|||
162816137|NCT06515483|588038492|FG001|Overall Study|Subject withdraw due to family issues|0|||
162816138|NCT05104476|588040033|FG000|Overall Study|Randomized But Not Treated|1|||
162816139|NCT05104476|588040034|FG001|Overall Study|Randomized But Not Treated|2|||
162816140|NCT05104476|588040033|FG000|Overall Study|Adverse Event|2|||
162816141|NCT05104476|588040034|FG001|Overall Study|Adverse Event|2|||
162816142|NCT05104476|588040033|FG000|Overall Study|Withdrawal by Subject|3|||
162816143|NCT05104476|588040034|FG001|Overall Study|Withdrawal by Subject|3|||
162816144|NCT05104476|588040033|FG000|Overall Study|Other Than Specified|0|||
162816145|NCT05104476|588040034|FG001|Overall Study|Other Than Specified|3|||
162816146|NCT00992511|588040037|FG000|Overall Study|Migrated/moved from study area|1|||
162816147|NCT00992511|588040038|FG001|Overall Study|Migrated/moved from study area|0|||
162816148|NCT00992511|588040039|FG002|Overall Study|Migrated/moved from study area|1|||
162816149|NCT00992511|588040040|FG003|Overall Study|Migrated/moved from study area|2|||
162816150|NCT00992511|588040037|FG000|Overall Study|Lost to Follow-up|1|||
162816151|NCT00992511|588040038|FG001|Overall Study|Lost to Follow-up|0|||
162816152|NCT00992511|588040039|FG002|Overall Study|Lost to Follow-up|0|||
162816153|NCT00992511|588040040|FG003|Overall Study|Lost to Follow-up|2|||
162816154|NCT00992511|588040037|FG000|Overall Study|Withdrawal by Subject|0|||
162816155|NCT00992511|588040038|FG001|Overall Study|Withdrawal by Subject|0|||
162816156|NCT00992511|588040039|FG002|Overall Study|Withdrawal by Subject|1|||
162816157|NCT00992511|588040040|FG003|Overall Study|Withdrawal by Subject|1|||
162816158|NCT01180998|588040041|FG000|Overall Study|Poor Vision|0|||
162816159|NCT01180998|588040042|FG001|Overall Study|Poor Vision|2|||
162816160|NCT01180998|588040043|FG002|Overall Study|Poor Vision|2|||
162816161|NCT01180998|588040041|FG000|Overall Study|Lost to Follow-up|0|||
162816162|NCT01180998|588040042|FG001|Overall Study|Lost to Follow-up|0|||
162816163|NCT01180998|588040043|FG002|Overall Study|Lost to Follow-up|1|||
162816164|NCT01180998|588040041|FG000|Overall Study|Protocol Violation|1|||
162816165|NCT01180998|588040042|FG001|Overall Study|Protocol Violation|2|||
162816166|NCT01180998|588040043|FG002|Overall Study|Protocol Violation|0|||
162816167|NCT01180998|588040041|FG000|Overall Study|Withdrawal by Subject|0|||
162816168|NCT01180998|588040042|FG001|Overall Study|Withdrawal by Subject|0|||
162816169|NCT01180998|588040043|FG002|Overall Study|Withdrawal by Subject|1|||
162816170|NCT01180998|588040041|FG000|Overall Study|Poor comfort|3|||
162816171|NCT01180998|588040042|FG001|Overall Study|Poor comfort|0|||
162816172|NCT01180998|588040043|FG002|Overall Study|Poor comfort|4|||
162816173|NCT01180998|588040041|FG000|Overall Study|Poor lens handling|0|||
162816174|NCT01180998|588040042|FG001|Overall Study|Poor lens handling|0|||
162816175|NCT01180998|588040043|FG002|Overall Study|Poor lens handling|2|||
162816176|NCT01176968|588040044|FG000|Overall Study|Adverse Event|10|||
162816177|NCT01176968|588040045|FG001|Overall Study|Adverse Event|11|||
162816178|NCT01176968|588040044|FG000|Overall Study|Death|2|||
162816179|NCT01176968|588040045|FG001|Overall Study|Death|3|||
162816180|NCT01176968|588040044|FG000|Overall Study|Lack of Efficacy|0|||
162816181|NCT01176968|588040045|FG001|Overall Study|Lack of Efficacy|1|||
162816182|NCT01176968|588040044|FG000|Overall Study|Lost to Follow-up|16|||
162816183|NCT01176968|588040045|FG001|Overall Study|Lost to Follow-up|14|||
162816184|NCT01176968|588040044|FG000|Overall Study|Withdrawal by Subject|48|||
162816185|NCT01176968|588040045|FG001|Overall Study|Withdrawal by Subject|48|||
162816186|NCT01176968|588040044|FG000|Overall Study|Protocol Violation|2|||
162816187|NCT01176968|588040045|FG001|Overall Study|Protocol Violation|1|||
162816188|NCT01176968|588040044|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162816189|NCT01176968|588040045|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
162816190|NCT01176968|588040044|FG000|Overall Study|Study terminated by sponsor|0|||
162816191|NCT01176968|588040045|FG001|Overall Study|Study terminated by sponsor|1|||
162816192|NCT01176968|588040044|FG000|Overall Study|Reason not defined|5|||
162816193|NCT01176968|588040045|FG001|Overall Study|Reason not defined|3|||
162816194|NCT00744523|588040046|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
162816195|NCT00744523|588040047|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
162816196|NCT05057247|588040048|FG000|Overall Study|Death|4|||
162816197|NCT05057247|588040048|FG000|Overall Study|Physician Decision|3|||
162816198|NCT05057247|588040048|FG000|Overall Study|Progressive Disease|7|||
162816199|NCT05057247|588040048|FG000|Overall Study|Withdrawal by Subject|3|||
162816200|NCT05057247|588040048|FG000|Overall Study|Adverse Event|6|||
162816201|NCT05057247|588040048|FG000|Overall Study|Subject Non-Compliance|1|||
162816202|NCT05057247|588040048|FG000|Overall Study|On treatment|2|||
162816203|NCT03588728|588040052|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
162816204|NCT03588728|588040053|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
162816205|NCT03588728|588040054|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
162816206|NCT03588728|588040055|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
162816207|NCT03588728|588040052|FG000|Overall Study|Lab shut down due to COVID-19|0|||
162816208|NCT03588728|588040053|FG001|Overall Study|Lab shut down due to COVID-19|0|||
162816209|NCT03588728|588040054|FG002|Overall Study|Lab shut down due to COVID-19|0|||
162816210|NCT03588728|588040055|FG003|Overall Study|Lab shut down due to COVID-19|1|||
162816211|NCT03588728|588040052|FG000|Overall Study|multiple technical issues|1|||
162816212|NCT03588728|588040053|FG001|Overall Study|multiple technical issues|0|||
162816213|NCT03588728|588040054|FG002|Overall Study|multiple technical issues|0|||
162816214|NCT03588728|588040055|FG003|Overall Study|multiple technical issues|0|||
162816215|NCT03588728|588040052|FG000|Overall Study|Hospitalized for COVID|1|||
162816216|NCT03588728|588040053|FG001|Overall Study|Hospitalized for COVID|0|||
162816217|NCT03588728|588040054|FG002|Overall Study|Hospitalized for COVID|0|||
162816218|NCT03588728|588040055|FG003|Overall Study|Hospitalized for COVID|0|||
162816219|NCT03588728|588040052|FG000|Overall Study|Schedule change unable to attend sessions|1|||
162816220|NCT03588728|588040053|FG001|Overall Study|Schedule change unable to attend sessions|0|||
162816221|NCT03588728|588040054|FG002|Overall Study|Schedule change unable to attend sessions|0|||
162816222|NCT03588728|588040055|FG003|Overall Study|Schedule change unable to attend sessions|0|||
162816223|NCT01388790|588040056|FG000|Overall Study|Ongoing at data cut-off date|8|||
162816224|NCT00528866|588040057|FG000|Overall Study|Protocol Violation|6|||
162816225|NCT00993915|588040058|FG000|Overall Study|Insufficient clinical response|3|||
162816226|NCT00993915|588040058|FG000|Overall Study|Withdrawal by Subject|2|||
162816227|NCT00993915|588040058|FG000|Overall Study|Other|1|||
162816228|NCT00993915|588040058|FG000|Overall Study|Ongoing|3|||
162816229|NCT01386658|588040059|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
162816230|NCT01386658|588040060|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
162816231|NCT01386658|588040059|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
162816232|NCT01386658|588040060|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
162816233|NCT02465463|588040061|FG000|Overall Study|Lost to Follow-up|2|||
162816234|NCT02465463|588040062|FG001|Overall Study|Lost to Follow-up|1|||
162816235|NCT02465463|588040061|FG000|Overall Study|Death|1|||
162816236|NCT02465463|588040062|FG001|Overall Study|Death|0|||
162816237|NCT02465463|588040061|FG000|Overall Study|Protocol Violation|1|||
162816238|NCT02465463|588040062|FG001|Overall Study|Protocol Violation|0|||
162816239|NCT01067326|588040067|FG000|Overall Study|Adverse Event|0|||
162816240|NCT01067326|588040068|FG001|Overall Study|Adverse Event|2|||
162816241|NCT01067326|588040067|FG000|Overall Study|Withdrawal by Subject|1|||
162816242|NCT01067326|588040068|FG001|Overall Study|Withdrawal by Subject|0|||
162816243|NCT01067326|588040067|FG000|Overall Study|Early Study Termination|1|||
162816244|NCT01067326|588040068|FG001|Overall Study|Early Study Termination|1|||
162816245|NCT00132496|588040078|FG000|Overall Study|Withdrawal by Subject|1|||
162816246|NCT00132496|588040079|FG001|Overall Study|Withdrawal by Subject|2|||
162816247|NCT00132496|588040078|FG000|Overall Study|Physician Decision|1|||
162816248|NCT00132496|588040079|FG001|Overall Study|Physician Decision|0|||
162816249|NCT00986440|588040082|FG000|Overall Study|Progressive disease|27|||
162816250|NCT00986440|588040083|FG001|Overall Study|Progressive disease|37|||
162816251|NCT00986440|588040082|FG000|Overall Study|Serious adverse event or adverse event|9|||
162816252|NCT00986440|588040083|FG001|Overall Study|Serious adverse event or adverse event|2|||
162816253|NCT00986440|588040082|FG000|Overall Study|Withdrawal by Subject|1|||
162816254|NCT00986440|588040083|FG001|Overall Study|Withdrawal by Subject|2|||
162816255|NCT00986440|588040082|FG000|Overall Study|Screen failure (not dosed)|4|||
162816256|NCT00986440|588040083|FG001|Overall Study|Screen failure (not dosed)|2|||
162816257|NCT00388154|588040084|FG000|Overall Study|Withdrawal by Subject|1|||
162816258|NCT03431857|588040093|FG000|Overall Study|Death|6|||
162816259|NCT03431857|588040093|FG000|Overall Study|Lost to Follow-up|41|||
162816260|NCT03431857|588040093|FG000|Overall Study|Adverse Event|6|||
162816261|NCT03431857|588040093|FG000|Overall Study|Withdrawal by Subject|1|||
162816262|NCT01117857|588040097|FG000|Overall Study|Lost to Follow-up|4|||
162816263|NCT01117857|588040097|FG000|Overall Study|Withdrawal by Subject|4|||
162816264|NCT01117857|588040097|FG000|Overall Study|Physician Decision|1|||
162816265|NCT02876835|588040098|FG000|Treatment Period (51.1 Month)|Other|1|||
162816266|NCT02876835|588040099|FG001|Treatment Period (51.1 Month)|Other|0|||
162816267|NCT02876835|588040098|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
162816268|NCT02876835|588040099|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
162816269|NCT02876835|588040098|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
162816270|NCT02876835|588040099|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
162816271|NCT02876835|588040098|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
162816272|NCT02876835|588040099|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
162816273|NCT01119001|588040100|FG000|Overall Study|Withdrawal by Subject|2|||
162816274|NCT05245097|588040103|FG000|Overall Study|Adverse Event|13|||
162816275|NCT05245097|588040104|FG001|Overall Study|Adverse Event|2|||
162816276|NCT05245097|588040103|FG000|Overall Study|Protocol Violation|8|||
162816277|NCT05245097|588040104|FG001|Overall Study|Protocol Violation|6|||
162816278|NCT05245097|588040103|FG000|Overall Study|Withdrawal by Subject|18|||
162816279|NCT05245097|588040104|FG001|Overall Study|Withdrawal by Subject|0|||
162816280|NCT05245097|588040103|FG000|Overall Study|Death|6|||
162816281|NCT05245097|588040104|FG001|Overall Study|Death|7|||
162816282|NCT05245097|588040103|FG000|Overall Study|Physician Decision|6|||
162816283|NCT05245097|588040104|FG001|Overall Study|Physician Decision|0|||
162816284|NCT05245097|588040103|FG000|Overall Study|Relocation|4|||
162816285|NCT05245097|588040104|FG001|Overall Study|Relocation|3|||
162816286|NCT04683731|588040107|FG000|Overall Study|Withdrawal by Subject|1|||
162816287|NCT04683731|588040108|FG001|Overall Study|Withdrawal by Subject|0|||
162816288|NCT04683731|588040109|FG002|Overall Study|Withdrawal by Subject|3|||
162816289|NCT04683731|588040110|FG003|Overall Study|Withdrawal by Subject|2|||
162816290|NCT04683731|588040107|FG000|Overall Study|Determined patient was not eligible|3|||
162816291|NCT04683731|588040108|FG001|Overall Study|Determined patient was not eligible|3|||
162816292|NCT04683731|588040109|FG002|Overall Study|Determined patient was not eligible|12|||
162816293|NCT04683731|588040110|FG003|Overall Study|Determined patient was not eligible|3|||
162816294|NCT03604523|588040113|FG000|Overall Study|Physician Decision|1|||
162816295|NCT03604523|588040114|FG001|Overall Study|Physician Decision|0|||
162816296|NCT05461794|588040115|FG000|Overall Study|Withdrawal by Subject|1|||
162816297|NCT05461794|588040116|FG001|Overall Study|Withdrawal by Subject|1|||
162816298|NCT05461794|588040117|FG002|Overall Study|Withdrawal by Subject|3|||
162816299|NCT05461794|588040115|FG000|Overall Study|Study Terminated By Sponsor|18|||
162816300|NCT05461794|588040116|FG001|Overall Study|Study Terminated By Sponsor|13|||
162816301|NCT05461794|588040117|FG002|Overall Study|Study Terminated By Sponsor|16|||
162816302|NCT05461794|588040115|FG000|Overall Study|Death|20|||
162816303|NCT05461794|588040116|FG001|Overall Study|Death|5|||
162816304|NCT05461794|588040117|FG002|Overall Study|Death|19|||
162816305|NCT02730598|588040120|FG000|Overall Study|Withdrawal by Subject|3|||
162816306|NCT02730598|588040121|FG001|Overall Study|Withdrawal by Subject|3|||
162816307|NCT02730598|588040120|FG000|Overall Study|Protocol Violation|0|||
162816308|NCT02730598|588040121|FG001|Overall Study|Protocol Violation|1|||
162816309|NCT02730598|588040120|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
162816310|NCT02730598|588040121|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
162816311|NCT00810394|588040122|FG000|Overall Study|Withdrawal by Subject|3|||
162816312|NCT00467285|588040125|FG000|Overall Study|Lost to Follow-up|4|||
162816313|NCT00467285|588040126|FG001|Overall Study|Lost to Follow-up|4|||
162816314|NCT03891524|588040127|FG000|Overall Study|Death|0|||
162816315|NCT03891524|588040128|FG001|Overall Study|Death|0|||
162816316|NCT03891524|588040129|FG002|Overall Study|Death|0|||
162816317|NCT03891524|588040130|FG003|Overall Study|Death|0|||
162816318|NCT03891524|588040131|FG004|Overall Study|Death|0|||
162816319|NCT03891524|588040132|FG005|Overall Study|Death|0|||
162816320|NCT03891524|588040133|FG006|Overall Study|Death|0|||
162816321|NCT03891524|588040134|FG007|Overall Study|Death|1|||
162816322|NCT03891524|588040127|FG000|Overall Study|Withdrawal by Subject|0|||
162816323|NCT03891524|588040128|FG001|Overall Study|Withdrawal by Subject|1|||
162816324|NCT03891524|588040129|FG002|Overall Study|Withdrawal by Subject|2|||
162816325|NCT03891524|588040130|FG003|Overall Study|Withdrawal by Subject|1|||
162816326|NCT03891524|588040131|FG004|Overall Study|Withdrawal by Subject|2|||
162816327|NCT03891524|588040132|FG005|Overall Study|Withdrawal by Subject|2|||
162816328|NCT03891524|588040133|FG006|Overall Study|Withdrawal by Subject|2|||
162816329|NCT03891524|588040134|FG007|Overall Study|Withdrawal by Subject|1|||
162816330|NCT01210118|588040135|FG000|Overall Study|Lost to Follow-up|1|||
162816331|NCT01210118|588040136|FG001|Overall Study|Lost to Follow-up|1|||
162816332|NCT01210118|588040135|FG000|Overall Study|Protocol Violation|1|||
162816333|NCT01210118|588040136|FG001|Overall Study|Protocol Violation|1|||
162816334|NCT01210118|588040135|FG000|Overall Study|Spontaneous abortion|1|||
162816335|NCT01210118|588040136|FG001|Overall Study|Spontaneous abortion|3|||
162816336|NCT01079130|588040137|FG000|Overall Study|Adverse Event|1|||
162816337|NCT01079130|588040138|FG001|Overall Study|Adverse Event|1|||
162816338|NCT01079130|588040139|FG002|Overall Study|Adverse Event|0|||
162816339|NCT01079130|588040140|FG003|Overall Study|Adverse Event|1|||
162816340|NCT01079130|588040141|FG004|Overall Study|Adverse Event|5|||
162816341|NCT01079130|588040142|FG005|Overall Study|Adverse Event|1|||
162816342|NCT01079130|588040137|FG000|Overall Study|Administrative problems|1|||
162816343|NCT01079130|588040138|FG001|Overall Study|Administrative problems|3|||
162816344|NCT01079130|588040139|FG002|Overall Study|Administrative problems|0|||
162816345|NCT01079130|588040140|FG003|Overall Study|Administrative problems|0|||
162816346|NCT01079130|588040141|FG004|Overall Study|Administrative problems|0|||
162816347|NCT01079130|588040142|FG005|Overall Study|Administrative problems|1|||
162816348|NCT01079130|588040137|FG000|Overall Study|Withdrawal by Subject|0|||
162816349|NCT01079130|588040138|FG001|Overall Study|Withdrawal by Subject|1|||
162816350|NCT01079130|588040139|FG002|Overall Study|Withdrawal by Subject|0|||
162816351|NCT01079130|588040140|FG003|Overall Study|Withdrawal by Subject|0|||
162816352|NCT01079130|588040141|FG004|Overall Study|Withdrawal by Subject|1|||
162816353|NCT01079130|588040142|FG005|Overall Study|Withdrawal by Subject|3|||
162816354|NCT01079130|588040137|FG000|Overall Study|Protocol deviation|0|||
162816355|NCT01079130|588040138|FG001|Overall Study|Protocol deviation|2|||
162816356|NCT01079130|588040139|FG002|Overall Study|Protocol deviation|1|||
162816357|NCT01079130|588040140|FG003|Overall Study|Protocol deviation|2|||
162816358|NCT01079130|588040141|FG004|Overall Study|Protocol deviation|0|||
162816359|NCT01079130|588040142|FG005|Overall Study|Protocol deviation|0|||
162816360|NCT01079130|588040137|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162816361|NCT01079130|588040138|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162816362|NCT01079130|588040139|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162816363|NCT01079130|588040140|FG003|Overall Study|Abnormal test procedure result(s)|0|||
162816364|NCT01079130|588040141|FG004|Overall Study|Abnormal test procedure result(s)|1|||
162816365|NCT01079130|588040142|FG005|Overall Study|Abnormal test procedure result(s)|0|||
162816366|NCT01079130|588040137|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162816367|NCT01079130|588040138|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162816368|NCT01079130|588040139|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162816369|NCT01079130|588040140|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162816370|NCT01079130|588040141|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
163166108|NCT01742286|589322837|FG005|Expansion Phase|Disease progression|0|||
163166109|NCT01742286|589322838|FG006|Expansion Phase|Disease progression|15|||
163166110|NCT01742286|589322832|FG000|Expansion Phase|Withdrawal by Subject|0|||
163166111|NCT01742286|589322833|FG001|Expansion Phase|Withdrawal by Subject|0|||
163166112|NCT01742286|589322834|FG002|Expansion Phase|Withdrawal by Subject|0|||
163166113|NCT01742286|589322835|FG003|Expansion Phase|Withdrawal by Subject|0|||
163166114|NCT01742286|589322836|FG004|Expansion Phase|Withdrawal by Subject|0|||
163166115|NCT01742286|589322837|FG005|Expansion Phase|Withdrawal by Subject|0|||
163166116|NCT01742286|589322838|FG006|Expansion Phase|Withdrawal by Subject|1|||
163166117|NCT01233232|589322839|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
163166118|NCT01233232|589322840|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
163166119|NCT01233232|589322841|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
163166120|NCT04198714|589322842|FG000|Overall Study|Physician Decision|0|||
162816371|NCT01079130|588040142|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
162816372|NCT01079130|588040137|FG000|Overall Study|Lost to Follow-up|0|||
162816373|NCT01079130|588040138|FG001|Overall Study|Lost to Follow-up|0|||
162816374|NCT01079130|588040139|FG002|Overall Study|Lost to Follow-up|0|||
162816375|NCT01079130|588040140|FG003|Overall Study|Lost to Follow-up|0|||
162816376|NCT01079130|588040141|FG004|Overall Study|Lost to Follow-up|1|||
162816377|NCT01079130|588040142|FG005|Overall Study|Lost to Follow-up|0|||
162816378|NCT00475033|588040149|FG000|Infant Series|Failed to return|3|||
163166121|NCT04198714|589322843|FG001|Overall Study|Physician Decision|1|||
163166122|NCT01925131|589325589|FG000|Overall Study|Death|0|||
163166123|NCT01925131|589325590|FG001|Overall Study|Death|0|||
162816379|NCT00475033|588040150|FG001|Infant Series|Failed to return|4|||
162816380|NCT00475033|588040149|FG000|Infant Series|Parent or legal guardian request|1|||
163166124|NCT01925131|589325591|FG002|Overall Study|Death|1|||
162816381|NCT00475033|588040150|FG001|Infant Series|Parent or legal guardian request|5|||
162816382|NCT00475033|588040149|FG000|Infant Series|Protocol Violation|1|||
162816383|NCT00475033|588040150|FG001|Infant Series|Protocol Violation|2|||
162816384|NCT00475033|588040149|FG000|Infant Series|Lost to Follow-up|2|||
162816385|NCT00475033|588040150|FG001|Infant Series|Lost to Follow-up|0|||
162816386|NCT00475033|588040149|FG000|Infant Series|Adverse Event|0|||
162816387|NCT00475033|588040150|FG001|Infant Series|Adverse Event|2|||
162816388|NCT00475033|588040149|FG000|After the Infant Series|Adverse Event|0|||
162816389|NCT00475033|588040150|FG001|After the Infant Series|Adverse Event|4|||
162816390|NCT00475033|588040149|FG000|After the Infant Series|Parent or legal guardian request|2|||
162816391|NCT00475033|588040150|FG001|After the Infant Series|Parent or legal guardian request|2|||
162816392|NCT00475033|588040149|FG000|After the Infant Series|Failed to return|2|||
162816393|NCT00475033|588040150|FG001|After the Infant Series|Failed to return|1|||
162816394|NCT00475033|588040149|FG000|After the Infant Series|Protocol Violation|1|||
162816395|NCT00475033|588040150|FG001|After the Infant Series|Protocol Violation|0|||
162816396|NCT00475033|588040149|FG000|After the Infant Series|Lost to Follow-up|1|||
162816397|NCT00475033|588040150|FG001|After the Infant Series|Lost to Follow-up|0|||
162816398|NCT00475033|588040149|FG000|After the Infant Series|Other|0|||
162816399|NCT00475033|588040150|FG001|After the Infant Series|Other|1|||
162816400|NCT00475033|588040149|FG000|Toddler Dose|Parent or legal guardian request|2|||
162816401|NCT00475033|588040150|FG001|Toddler Dose|Parent or legal guardian request|0|||
162816402|NCT00475033|588040149|FG000|Toddler Dose|Failed to return|1|||
162816403|NCT00475033|588040150|FG001|Toddler Dose|Failed to return|0|||
162816404|NCT00475033|588040149|FG000|Toddler Dose|Lost to Follow-up|1|||
162816405|NCT00475033|588040150|FG001|Toddler Dose|Lost to Follow-up|0|||
162816406|NCT01696942|588040153|FG000|Overall Study|Withdrawal by Subject|1|||
162816407|NCT01696942|588040154|FG001|Overall Study|Withdrawal by Subject|0|||
162816408|NCT01696942|588040153|FG000|Overall Study|Protocol Violation|1|||
162816409|NCT01696942|588040154|FG001|Overall Study|Protocol Violation|2|||
162816410|NCT01696942|588040153|FG000|Overall Study|screen failure|0|||
162816411|NCT01696942|588040154|FG001|Overall Study|screen failure|1|||
162816412|NCT01335009|588040155|FG000|Overall Study|Too ill to travel to study sites|1|||
162816413|NCT01335009|588040156|FG001|Overall Study|Too ill to travel to study sites|0|||
162816414|NCT01335009|588040155|FG000|Overall Study|Death|28|||
162816415|NCT01335009|588040156|FG001|Overall Study|Death|32|||
162816416|NCT01335009|588040155|FG000|Overall Study|Withdrawal by Subject|1|||
162816417|NCT01335009|588040156|FG001|Overall Study|Withdrawal by Subject|1|||
162816418|NCT01335009|588040155|FG000|Overall Study|Lost to Follow-up|1|||
162816419|NCT01335009|588040156|FG001|Overall Study|Lost to Follow-up|0|||
162816420|NCT04824521|588040157|FG000|Overall Study|Lost to Follow-up|1|||
162816421|NCT01598311|588040158|FG000|Overall Study|Physician Decision|4|||
162816422|NCT01598311|588040159|FG001|Overall Study|Physician Decision|5|||
162816423|NCT01598311|588040158|FG000|Overall Study|Adverse Event|9|||
162816424|NCT01598311|588040159|FG001|Overall Study|Adverse Event|13|||
162816425|NCT01598311|588040158|FG000|Overall Study|Lost to Follow-up|7|||
162816426|NCT01598311|588040159|FG001|Overall Study|Lost to Follow-up|12|||
162816427|NCT01598311|588040158|FG000|Overall Study|Withdrawal by Subject|9|||
162816428|NCT01598311|588040159|FG001|Overall Study|Withdrawal by Subject|13|||
162816429|NCT01598311|588040158|FG000|Overall Study|No reason provided.|0|||
162816430|NCT01598311|588040159|FG001|Overall Study|No reason provided.|5|||
162816431|NCT01598311|588040158|FG000|Overall Study|Randomized but never treated|8|||
162816432|NCT01598311|588040159|FG001|Overall Study|Randomized but never treated|5|||
162816433|NCT01598311|588040158|FG000|Overall Study|Treated but no confirmed CDAD|9|||
162816434|NCT01598311|588040159|FG001|Overall Study|Treated but no confirmed CDAD|8|||
162816435|NCT01598311|588040158|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
162816436|NCT01598311|588040159|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
162816437|NCT03144804|588040160|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
162816438|NCT00959647|588040161|FG000|Overall Study|Adverse Event|2|||
162816439|NCT00959647|588040161|FG000|Overall Study|Progressive disease|6|||
162816440|NCT00959647|588040161|FG000|Overall Study|Study terminated by sponsor|4|||
162816441|NCT00959647|588040161|FG000|Overall Study|Withdrawal by Subject|7|||
162816442|NCT04223856|588040162|FG000|Overall Study|Progressive disease|153|||
162816443|NCT04223856|588040163|FG001|Overall Study|Progressive disease|73|||
162816444|NCT04223856|588040162|FG000|Overall Study|Adverse Event|97|||
162816445|NCT04223856|588040163|FG001|Overall Study|Adverse Event|62|||
162816446|NCT04223856|588040162|FG000|Overall Study|Physician Decision|9|||
162816447|NCT04223856|588040163|FG001|Overall Study|Physician Decision|28|||
162816448|NCT04223856|588040162|FG000|Overall Study|Withdrawal by Subject|22|||
162816449|NCT04223856|588040163|FG001|Overall Study|Withdrawal by Subject|24|||
162816450|NCT04223856|588040162|FG000|Overall Study|Other|7|||
162816451|NCT04223856|588040163|FG001|Overall Study|Other|2|||
162816452|NCT04223856|588040162|FG000|Overall Study|Randomized but not treated|2|||
162816453|NCT04223856|588040163|FG001|Overall Study|Randomized but not treated|11|||
162816454|NCT04223856|588040162|FG000|Overall Study|On-treatment|144|||
162816455|NCT04223856|588040163|FG001|Overall Study|On-treatment|0|||
162816456|NCT00523718|588042304|FG000|Overall Study|Withdrawal by Subject|1|||
162816457|NCT00523718|588042305|FG001|Overall Study|Withdrawal by Subject|0|||
162816458|NCT00523718|588042304|FG000|Overall Study|Protocol Violation|2|||
162816459|NCT00523718|588042305|FG001|Overall Study|Protocol Violation|0|||
162816460|NCT01306890|588042306|FG000|Overall Study|Adverse Event|2|||
162816461|NCT01306890|588042306|FG000|Overall Study|Death|1223|||
162816462|NCT01306890|588042306|FG000|Overall Study|Lost to Follow-up|58|||
162816463|NCT01306890|588042306|FG000|Overall Study|Withdrawal by Subject|88|||
162816464|NCT01306890|588042306|FG000|Overall Study|Unspecified reasons|104|||
162816465|NCT01306890|588042306|FG000|Overall Study|Study Termination|3|||
162816466|NCT01306890|588042306|FG000|Overall Study|No discontinuation documentation|41|||
162816467|NCT02217436|588042307|FG000|Overall Study|Protocol Violation|1|||
162816468|NCT02217436|588042308|FG001|Overall Study|Protocol Violation|1|||
162816469|NCT02217436|588042307|FG000|Overall Study|Incomplete data|0|||
162816470|NCT02217436|588042308|FG001|Overall Study|Incomplete data|1|||
162816471|NCT00234494|588042313|FG000|Overall Study|Protocol Violation|2|||
162816472|NCT02634346|588042317|FG000|Overall Study|Withdrawal by Subject|8|||
162816473|NCT02634346|588042318|FG001|Overall Study|Withdrawal by Subject|9|||
162816474|NCT02634346|588042319|FG002|Overall Study|Withdrawal by Subject|8|||
162816475|NCT02634346|588042317|FG000|Overall Study|Adverse Event|2|||
162816476|NCT02634346|588042318|FG001|Overall Study|Adverse Event|2|||
162816477|NCT02634346|588042319|FG002|Overall Study|Adverse Event|7|||
162816478|NCT02634346|588042317|FG000|Overall Study|Lack of Efficacy|1|||
162816479|NCT02634346|588042318|FG001|Overall Study|Lack of Efficacy|2|||
162816480|NCT02634346|588042319|FG002|Overall Study|Lack of Efficacy|8|||
162816481|NCT02634346|588042317|FG000|Overall Study|Lost to Follow-up|1|||
162816482|NCT02634346|588042318|FG001|Overall Study|Lost to Follow-up|0|||
162816483|NCT02634346|588042319|FG002|Overall Study|Lost to Follow-up|0|||
162816484|NCT02634346|588042317|FG000|Overall Study|Protocol Violation|0|||
162816485|NCT02634346|588042318|FG001|Overall Study|Protocol Violation|1|||
162816486|NCT02634346|588042319|FG002|Overall Study|Protocol Violation|0|||
162816487|NCT02170389|588042320|FG000|Overall Study|Study terminated prior to start of treat|1|||
162816488|NCT04485104|588042326|FG000|Overall Study|Physician Decision|2|||
162816489|NCT04485104|588042327|FG001|Overall Study|Physician Decision|0|||
162816490|NCT04485104|588042326|FG000|Overall Study|Decision by sponsor|0|||
162816491|NCT04485104|588042327|FG001|Overall Study|Decision by sponsor|1|||
162816492|NCT00908232|588042328|FG000|Cycle 1 to 4|Death|5|||
162816493|NCT00908232|588042329|FG001|Cycle 1 to 4|Death|0|||
162816494|NCT00908232|588042330|FG002|Cycle 1 to 4|Death|0|||
162816495|NCT00908232|588042331|FG003|Cycle 1 to 4|Death|0|||
162816496|NCT00908232|588042328|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
162816497|NCT00908232|588042329|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
162816498|NCT00908232|588042330|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
162816499|NCT00908232|588042331|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
162816500|NCT00908232|588042328|FG000|Cycle 1 to 4|Progressive Disease|6|||
162816501|NCT00908232|588042329|FG001|Cycle 1 to 4|Progressive Disease|0|||
162816502|NCT00908232|588042330|FG002|Cycle 1 to 4|Progressive Disease|0|||
162816503|NCT00908232|588042331|FG003|Cycle 1 to 4|Progressive Disease|0|||
162816504|NCT00908232|588042328|FG000|Cycle 1 to 4|Adverse Event|12|||
162816505|NCT00908232|588042329|FG001|Cycle 1 to 4|Adverse Event|0|||
162816506|NCT00908232|588042330|FG002|Cycle 1 to 4|Adverse Event|0|||
162816507|NCT00908232|588042331|FG003|Cycle 1 to 4|Adverse Event|0|||
162816508|NCT00908232|588042328|FG000|Cycle 1 to 4|Other|1|||
162816509|NCT00908232|588042329|FG001|Cycle 1 to 4|Other|0|||
162816510|NCT00908232|588042330|FG002|Cycle 1 to 4|Other|0|||
162816511|NCT00908232|588042331|FG003|Cycle 1 to 4|Other|0|||
162816512|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
162816513|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
162816514|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
162816515|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
162816516|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
162816517|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
162816518|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
162816519|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
162816520|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
162816521|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
162816522|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
162816523|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
162816524|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
162816525|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
162816526|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
162816527|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
162816528|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
162816529|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
162816530|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
162816531|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
162816532|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
162816533|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
162816534|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
162816535|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
162816536|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
162816537|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
162816538|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
162816539|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
162816540|NCT00908232|588042328|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
162816541|NCT00908232|588042329|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
162816542|NCT00908232|588042330|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
162816543|NCT00908232|588042331|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
162816544|NCT03153137|588042332|FG000|Overall Study|Lost to Follow-up|1|||
162816545|NCT03153137|588042333|FG001|Overall Study|Lost to Follow-up|0|||
162816546|NCT03153137|588042332|FG000|Overall Study|Withdrawal by Subject|2|||
162816547|NCT03153137|588042333|FG001|Overall Study|Withdrawal by Subject|1|||
162816548|NCT03153137|588042332|FG000|Overall Study|Physician Decision|0|||
162816549|NCT03153137|588042333|FG001|Overall Study|Physician Decision|3|||
162816550|NCT00195507|588042337|FG000|Overall Study|Adverse Event|24|||
162816551|NCT00195507|588042338|FG001|Overall Study|Adverse Event|13|||
162816552|NCT00195507|588042337|FG000|Overall Study|Death|0|||
162816553|NCT00195507|588042338|FG001|Overall Study|Death|1|||
162816554|NCT00195507|588042337|FG000|Overall Study|Failed to Return|4|||
162816555|NCT00195507|588042338|FG001|Overall Study|Failed to Return|3|||
162816556|NCT00195507|588042337|FG000|Overall Study|Physician Decision|1|||
162816557|NCT00195507|588042338|FG001|Overall Study|Physician Decision|2|||
162816558|NCT00195507|588042337|FG000|Overall Study|Lost to Follow-up|3|||
162816559|NCT00195507|588042338|FG001|Overall Study|Lost to Follow-up|2|||
162816560|NCT00195507|588042337|FG000|Overall Study|Protocol Violation|5|||
162816561|NCT00195507|588042338|FG001|Overall Study|Protocol Violation|4|||
162816562|NCT00195507|588042337|FG000|Overall Study|Lack of Efficacy|40|||
162816563|NCT00195507|588042338|FG001|Overall Study|Lack of Efficacy|67|||
162816564|NCT00195507|588042337|FG000|Overall Study|Withdrawal by Subject|16|||
162816565|NCT00195507|588042338|FG001|Overall Study|Withdrawal by Subject|23|||
162816566|NCT00195507|588042337|FG000|Overall Study|Protocol Deviation|6|||
162816567|NCT00195507|588042338|FG001|Overall Study|Protocol Deviation|3|||
162816568|NCT00769860|588042344|FG000|Overall Study|Withdrawal by Subject|2|||
162816569|NCT00769860|588042345|FG001|Overall Study|Withdrawal by Subject|0|||
162816570|NCT01106404|588042347|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
162816571|NCT01106404|588042348|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
162816572|NCT01106404|588042347|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
162816573|NCT01106404|588042348|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
162816574|NCT01106404|588042347|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
162816575|NCT01106404|588042348|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
162816576|NCT01106404|588042347|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
162816577|NCT01106404|588042348|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
162816578|NCT01774084|588042349|FG000|Overall Study|Personal reasons|1|||
162816579|NCT01774084|588042350|FG001|Overall Study|Personal reasons|0|||
162816580|NCT03026127|588042354|FG000|CRISP R61|Adverse Event|5|||
162816581|NCT03026127|588042355|FG001|CRISP R61|Adverse Event|0|||
162816582|NCT03026127|588042356|FG002|CRISP R61|Adverse Event|0|||
162816583|NCT03026127|588042354|FG000|CRISP R61|Lost to Follow-up|2|||
162816584|NCT03026127|588042355|FG001|CRISP R61|Lost to Follow-up|0|||
162816585|NCT03026127|588042356|FG002|CRISP R61|Lost to Follow-up|0|||
162816586|NCT03026127|588042354|FG000|CRISP R61|Dropped before therapy|5|||
162816587|NCT03026127|588042355|FG001|CRISP R61|Dropped before therapy|0|||
162816588|NCT03026127|588042356|FG002|CRISP R61|Dropped before therapy|0|||
162816589|NCT03026127|588042354|FG000|CRISP R33|Lost to Follow-up|0|||
162816590|NCT03026127|588042355|FG001|CRISP R33|Lost to Follow-up|5|||
162816591|NCT03026127|588042356|FG002|CRISP R33|Lost to Follow-up|4|||
162816592|NCT03026127|588042354|FG000|CRISP R33|Adverse Event|0|||
162816593|NCT03026127|588042355|FG001|CRISP R33|Adverse Event|9|||
162816594|NCT03026127|588042356|FG002|CRISP R33|Adverse Event|5|||
162816595|NCT03026127|588042354|FG000|CRISP R33|Withdrawal by Subject|0|||
162816596|NCT03026127|588042355|FG001|CRISP R33|Withdrawal by Subject|9|||
162816597|NCT03026127|588042356|FG002|CRISP R33|Withdrawal by Subject|1|||
162816598|NCT03026127|588042354|FG000|CRISP R33|Lack of Efficacy|0|||
162816599|NCT03026127|588042355|FG001|CRISP R33|Lack of Efficacy|3|||
162816600|NCT03026127|588042356|FG002|CRISP R33|Lack of Efficacy|2|||
162816601|NCT03026127|588042354|FG000|CRISP R33|Physician Decision|0|||
162816602|NCT03026127|588042355|FG001|CRISP R33|Physician Decision|3|||
162816603|NCT03026127|588042356|FG002|CRISP R33|Physician Decision|1|||
162816604|NCT03026127|588042354|FG000|CRISP R33|Transportation|0|||
162816605|NCT03026127|588042355|FG001|CRISP R33|Transportation|2|||
162816606|NCT03026127|588042356|FG002|CRISP R33|Transportation|1|||
162816607|NCT01182766|588042357|FG000|Overall Study|Lost to Follow-up|32|||
162816608|NCT01182766|588042358|FG001|Overall Study|Lost to Follow-up|36|||
162816609|NCT01182766|588042359|FG002|Overall Study|Lost to Follow-up|29|||
162816610|NCT01182766|588042357|FG000|Overall Study|Withdrawal by Subject|14|||
163166125|NCT01925131|589325592|FG003|Overall Study|Death|0|||
162816611|NCT01182766|588042358|FG001|Overall Study|Withdrawal by Subject|3|||
162816612|NCT01182766|588042359|FG002|Overall Study|Withdrawal by Subject|6|||
162816613|NCT01182766|588042357|FG000|Overall Study|Physician Decision|1|||
162816614|NCT01182766|588042358|FG001|Overall Study|Physician Decision|0|||
162816615|NCT01182766|588042359|FG002|Overall Study|Physician Decision|0|||
162816616|NCT01182766|588042357|FG000|Overall Study|Non-compliance|1|||
162816617|NCT01182766|588042358|FG001|Overall Study|Non-compliance|1|||
162816618|NCT01182766|588042359|FG002|Overall Study|Non-compliance|1|||
162816619|NCT03027557|588042360|FG000|Overall Study|Adverse Event|1|||
162816620|NCT03027557|588042361|FG001|Overall Study|Adverse Event|0|||
162816621|NCT03027557|588042362|FG002|Overall Study|Adverse Event|0|||
162816622|NCT02430051|588042365|FG000|Overall Study|Withdrawal by Subject|6|||
162816623|NCT02430051|588042366|FG001|Overall Study|Withdrawal by Subject|3|||
162816624|NCT02430051|588042365|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
162816625|NCT02430051|588042366|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
162816626|NCT02430051|588042365|FG000|Overall Study|Protocol Violation|1|||
162816627|NCT02430051|588042366|FG001|Overall Study|Protocol Violation|0|||
162816628|NCT02030405|588042370|FG000|Overall Study|Withdrawal by Subject|1|||
162816629|NCT02030405|588042370|FG000|Overall Study|Lost to Follow-up|1|||
162816630|NCT00564018|588042371|FG000|Overall Study|Withdrawal by Subject|2|||
162816631|NCT00564018|588042372|FG001|Overall Study|Withdrawal by Subject|3|||
162816632|NCT00564018|588042373|FG002|Overall Study|Withdrawal by Subject|1|||
162816633|NCT01145755|588042376|FG000|Overall Study|Adverse Event|2|||
162816634|NCT01145755|588042377|FG001|Overall Study|Adverse Event|4|||
162816635|NCT01145755|588042378|FG002|Overall Study|Adverse Event|2|||
162816636|NCT01145755|588042376|FG000|Overall Study|Withdrawal by Subject|2|||
162816637|NCT01145755|588042377|FG001|Overall Study|Withdrawal by Subject|2|||
162816638|NCT01145755|588042378|FG002|Overall Study|Withdrawal by Subject|2|||
162816639|NCT01145755|588042376|FG000|Overall Study|Lost to Follow-up|2|||
162816640|NCT01145755|588042377|FG001|Overall Study|Lost to Follow-up|3|||
162816641|NCT01145755|588042378|FG002|Overall Study|Lost to Follow-up|1|||
162816642|NCT01145755|588042376|FG000|Overall Study|Protocol Violation|0|||
162816643|NCT01145755|588042377|FG001|Overall Study|Protocol Violation|3|||
162816644|NCT01145755|588042378|FG002|Overall Study|Protocol Violation|1|||
162816645|NCT01145755|588042376|FG000|Overall Study|Study Closure|14|||
162816646|NCT01145755|588042377|FG001|Overall Study|Study Closure|14|||
162816647|NCT01145755|588042378|FG002|Overall Study|Study Closure|17|||
162816648|NCT01145755|588042376|FG000|Overall Study|Lack of Efficacy|0|||
162816649|NCT01145755|588042377|FG001|Overall Study|Lack of Efficacy|1|||
162816650|NCT01145755|588042378|FG002|Overall Study|Lack of Efficacy|0|||
162816651|NCT01145755|588042376|FG000|Overall Study|Patient could not swollow medication|0|||
162816652|NCT01145755|588042377|FG001|Overall Study|Patient could not swollow medication|0|||
162816653|NCT01145755|588042378|FG002|Overall Study|Patient could not swollow medication|1|||
162816654|NCT01145755|588042376|FG000|Overall Study|Withdrawal by Subject|0|||
162816655|NCT01145755|588042377|FG001|Overall Study|Withdrawal by Subject|0|||
162816656|NCT01145755|588042378|FG002|Overall Study|Withdrawal by Subject|1|||
162816657|NCT01145755|588042376|FG000|Overall Study|Positive urine ethanol|0|||
162816658|NCT01145755|588042377|FG001|Overall Study|Positive urine ethanol|1|||
162816659|NCT01145755|588042378|FG002|Overall Study|Positive urine ethanol|0|||
162816660|NCT01009554|588042381|FG000|Overall Study|Adverse Event|1|||
162816661|NCT01009554|588042382|FG001|Overall Study|Adverse Event|1|||
162816662|NCT01009554|588042381|FG000|Overall Study|Withdrawal by Subject|1|||
162816663|NCT01009554|588042382|FG001|Overall Study|Withdrawal by Subject|3|||
162816664|NCT01009554|588042381|FG000|Overall Study|Noncompliant with Study Product|0|||
162816665|NCT01009554|588042382|FG001|Overall Study|Noncompliant with Study Product|3|||
162816666|NCT01605253|588042383|FG000|Overall Study|Physician Decision|3|||
162816667|NCT01605253|588042384|FG001|Overall Study|Physician Decision|2|||
162816668|NCT01605253|588042383|FG000|Overall Study|Lost to Follow-up|3|||
162816669|NCT01605253|588042384|FG001|Overall Study|Lost to Follow-up|1|||
162816670|NCT02973048|588042385|FG000|Overall Study|Epidural catheter insertion failure|1|||
162816671|NCT02973048|588042386|FG001|Overall Study|Epidural catheter insertion failure|0|||
162816672|NCT02973048|588042385|FG000|Overall Study|Withdrawal by Subject|0|||
162816673|NCT02973048|588042386|FG001|Overall Study|Withdrawal by Subject|3|||
162816674|NCT04427501|588042387|FG000|Overall Study|Death|0|||
162816675|NCT04427501|588042388|FG001|Overall Study|Death|0|||
162816676|NCT04427501|588042389|FG002|Overall Study|Death|0|||
162816677|NCT04427501|588042390|FG003|Overall Study|Death|0|||
162816678|NCT04427501|588042391|FG004|Overall Study|Death|0|||
162816679|NCT04427501|588042392|FG005|Overall Study|Death|15|||
162816680|NCT04427501|588042393|FG006|Overall Study|Death|0|||
162816681|NCT04427501|588042394|FG007|Overall Study|Death|0|||
162816682|NCT04427501|588042395|FG008|Overall Study|Death|0|||
162816683|NCT04427501|588042396|FG009|Overall Study|Death|0|||
162816684|NCT04427501|588042397|FG010|Overall Study|Death|0|||
162816685|NCT04427501|588042398|FG011|Overall Study|Death|0|||
162816686|NCT04427501|588042387|FG000|Overall Study|Lost to Follow-up|5|||
162816687|NCT04427501|588042388|FG001|Overall Study|Lost to Follow-up|1|||
162816688|NCT04427501|588042389|FG002|Overall Study|Lost to Follow-up|2|||
162816689|NCT04427501|588042390|FG003|Overall Study|Lost to Follow-up|0|||
162816690|NCT04427501|588042391|FG004|Overall Study|Lost to Follow-up|2|||
162816691|NCT04427501|588042392|FG005|Overall Study|Lost to Follow-up|11|||
162816692|NCT04427501|588042393|FG006|Overall Study|Lost to Follow-up|10|||
162816693|NCT04427501|588042394|FG007|Overall Study|Lost to Follow-up|10|||
162816694|NCT04427501|588042395|FG008|Overall Study|Lost to Follow-up|2|||
162816695|NCT04427501|588042396|FG009|Overall Study|Lost to Follow-up|5|||
163166126|NCT01925131|589325593|FG004|Overall Study|Death|0|||
163166127|NCT01925131|589325594|FG005|Overall Study|Death|0|||
163166128|NCT01925131|589325589|FG000|Overall Study|Progression/Relapse|1|||
163166129|NCT01925131|589325590|FG001|Overall Study|Progression/Relapse|1|||
163166130|NCT01925131|589325591|FG002|Overall Study|Progression/Relapse|4|||
163166131|NCT01925131|589325592|FG003|Overall Study|Progression/Relapse|0|||
163166132|NCT01925131|589325593|FG004|Overall Study|Progression/Relapse|0|||
163166133|NCT01925131|589325594|FG005|Overall Study|Progression/Relapse|1|||
163166134|NCT01925131|589325589|FG000|Overall Study|Patient Refusal|1|||
163166135|NCT01925131|589325590|FG001|Overall Study|Patient Refusal|0|||
163166136|NCT01925131|589325591|FG002|Overall Study|Patient Refusal|0|||
163166137|NCT01925131|589325592|FG003|Overall Study|Patient Refusal|0|||
163166138|NCT01925131|589325593|FG004|Overall Study|Patient Refusal|0|||
163166139|NCT01925131|589325594|FG005|Overall Study|Patient Refusal|0|||
163166140|NCT01925131|589325589|FG000|Overall Study|Adverse Event|0|||
163166141|NCT01925131|589325590|FG001|Overall Study|Adverse Event|0|||
163166142|NCT01925131|589325591|FG002|Overall Study|Adverse Event|2|||
163166143|NCT01925131|589325592|FG003|Overall Study|Adverse Event|0|||
163166144|NCT01925131|589325593|FG004|Overall Study|Adverse Event|1|||
163166145|NCT01925131|589325594|FG005|Overall Study|Adverse Event|3|||
163166146|NCT01925131|589325589|FG000|Overall Study|Other - Not Protocol Specified|3|||
163166147|NCT01925131|589325590|FG001|Overall Study|Other - Not Protocol Specified|1|||
163166148|NCT01925131|589325591|FG002|Overall Study|Other - Not Protocol Specified|2|||
163166149|NCT01925131|589325592|FG003|Overall Study|Other - Not Protocol Specified|5|||
163166150|NCT01925131|589325593|FG004|Overall Study|Other - Not Protocol Specified|10|||
163166151|NCT01925131|589325594|FG005|Overall Study|Other - Not Protocol Specified|6|||
163166152|NCT05091567|589325595|FG000|Enrollment Phase|Death|37|||
163166153|NCT05091567|589325596|FG001|Enrollment Phase|Death|0|||
163166154|NCT05091567|589325597|FG002|Enrollment Phase|Death|0|||
163166155|NCT05091567|589325595|FG000|Enrollment Phase|Adverse Event|21|||
163166156|NCT05091567|589325596|FG001|Enrollment Phase|Adverse Event|0|||
163166157|NCT05091567|589325597|FG002|Enrollment Phase|Adverse Event|0|||
163166158|NCT05091567|589325595|FG000|Enrollment Phase|Progressive Disease|10|||
163166159|NCT05091567|589325596|FG001|Enrollment Phase|Progressive Disease|0|||
163166160|NCT05091567|589325597|FG002|Enrollment Phase|Progressive Disease|0|||
163166161|NCT05091567|589325595|FG000|Enrollment Phase|Withdrawal by Subject|8|||
163166162|NCT05091567|589325596|FG001|Enrollment Phase|Withdrawal by Subject|0|||
163166163|NCT05091567|589325597|FG002|Enrollment Phase|Withdrawal by Subject|0|||
163166164|NCT05091567|589325595|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
163166165|NCT05091567|589325596|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
163166166|NCT05091567|589325597|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
163166167|NCT05091567|589325595|FG000|Enrollment Phase|Physician Decision|3|||
163166168|NCT05091567|589325596|FG001|Enrollment Phase|Physician Decision|0|||
163166169|NCT05091567|589325597|FG002|Enrollment Phase|Physician Decision|0|||
163166170|NCT05091567|589325595|FG000|Enrollment Phase|Protocol Violation|2|||
163166171|NCT05091567|589325596|FG001|Enrollment Phase|Protocol Violation|0|||
163166172|NCT05091567|589325597|FG002|Enrollment Phase|Protocol Violation|0|||
163166173|NCT05091567|589325595|FG000|Enrollment Phase|Reason not Specified|1|||
163166174|NCT05091567|589325596|FG001|Enrollment Phase|Reason not Specified|0|||
163166175|NCT05091567|589325597|FG002|Enrollment Phase|Reason not Specified|0|||
163166176|NCT05091567|589325595|FG000|Randomized Phase|Death|0|||
163166177|NCT05091567|589325596|FG001|Randomized Phase|Death|135|||
163166178|NCT05091567|589325597|FG002|Randomized Phase|Death|112|||
163166179|NCT05091567|589325595|FG000|Randomized Phase|Progressive Disease|0|||
163166180|NCT05091567|589325596|FG001|Randomized Phase|Progressive Disease|2|||
162816696|NCT04427501|588042397|FG010|Overall Study|Lost to Follow-up|2|||
162816697|NCT04427501|588042398|FG011|Overall Study|Lost to Follow-up|0|||
162816698|NCT04427501|588042387|FG000|Overall Study|Physician Decision|0|||
162816699|NCT04427501|588042388|FG001|Overall Study|Physician Decision|3|||
162816700|NCT04427501|588042389|FG002|Overall Study|Physician Decision|0|||
163166181|NCT05091567|589325597|FG002|Randomized Phase|Progressive Disease|0|||
163166182|NCT05091567|589325595|FG000|Randomized Phase|Withdrawal by Subject|0|||
163166183|NCT05091567|589325596|FG001|Randomized Phase|Withdrawal by Subject|1|||
163166184|NCT05091567|589325597|FG002|Randomized Phase|Withdrawal by Subject|3|||
163166185|NCT05091567|589325595|FG000|Randomized Phase|Lost to Follow-up|0|||
163166186|NCT05091567|589325596|FG001|Randomized Phase|Lost to Follow-up|1|||
163166187|NCT05091567|589325597|FG002|Randomized Phase|Lost to Follow-up|1|||
163166188|NCT05091567|589325595|FG000|Randomized Phase|Ongoing in Study|0|||
162816701|NCT04427501|588042390|FG003|Overall Study|Physician Decision|0|||
162816702|NCT04427501|588042391|FG004|Overall Study|Physician Decision|0|||
162816703|NCT04427501|588042392|FG005|Overall Study|Physician Decision|0|||
162816704|NCT04427501|588042393|FG006|Overall Study|Physician Decision|2|||
162816705|NCT04427501|588042394|FG007|Overall Study|Physician Decision|0|||
162816706|NCT04427501|588042395|FG008|Overall Study|Physician Decision|0|||
162816707|NCT04427501|588042396|FG009|Overall Study|Physician Decision|0|||
162816708|NCT04427501|588042397|FG010|Overall Study|Physician Decision|0|||
162816709|NCT04427501|588042398|FG011|Overall Study|Physician Decision|0|||
162816710|NCT04427501|588042387|FG000|Overall Study|Withdrawal by Subject|9|||
162816711|NCT04427501|588042388|FG001|Overall Study|Withdrawal by Subject|2|||
162816712|NCT04427501|588042389|FG002|Overall Study|Withdrawal by Subject|2|||
162816713|NCT04427501|588042390|FG003|Overall Study|Withdrawal by Subject|3|||
162816714|NCT04427501|588042391|FG004|Overall Study|Withdrawal by Subject|7|||
162816715|NCT04427501|588042392|FG005|Overall Study|Withdrawal by Subject|25|||
162816716|NCT04427501|588042393|FG006|Overall Study|Withdrawal by Subject|15|||
162816717|NCT04427501|588042394|FG007|Overall Study|Withdrawal by Subject|7|||
162816718|NCT04427501|588042395|FG008|Overall Study|Withdrawal by Subject|4|||
162816719|NCT04427501|588042396|FG009|Overall Study|Withdrawal by Subject|1|||
162816720|NCT04427501|588042397|FG010|Overall Study|Withdrawal by Subject|4|||
162816721|NCT04427501|588042398|FG011|Overall Study|Withdrawal by Subject|0|||
162816722|NCT04427501|588042387|FG000|Overall Study|Other - as reported by the investigator|1|||
162816723|NCT04427501|588042388|FG001|Overall Study|Other - as reported by the investigator|0|||
162816724|NCT04427501|588042389|FG002|Overall Study|Other - as reported by the investigator|0|||
162816725|NCT04427501|588042390|FG003|Overall Study|Other - as reported by the investigator|0|||
162816726|NCT04427501|588042391|FG004|Overall Study|Other - as reported by the investigator|0|||
162816727|NCT04427501|588042392|FG005|Overall Study|Other - as reported by the investigator|6|||
162816728|NCT04427501|588042393|FG006|Overall Study|Other - as reported by the investigator|6|||
162816729|NCT04427501|588042394|FG007|Overall Study|Other - as reported by the investigator|0|||
162816730|NCT04427501|588042395|FG008|Overall Study|Other - as reported by the investigator|0|||
162816731|NCT04427501|588042396|FG009|Overall Study|Other - as reported by the investigator|0|||
162816732|NCT04427501|588042397|FG010|Overall Study|Other - as reported by the investigator|0|||
162816733|NCT04427501|588042398|FG011|Overall Study|Other - as reported by the investigator|0|||
162816734|NCT04427501|588042387|FG000|Overall Study|Other|0|||
162816735|NCT04427501|588042388|FG001|Overall Study|Other|0|||
162816736|NCT04427501|588042389|FG002|Overall Study|Other|0|||
162816737|NCT04427501|588042390|FG003|Overall Study|Other|0|||
162816738|NCT04427501|588042391|FG004|Overall Study|Other|0|||
162816739|NCT04427501|588042392|FG005|Overall Study|Other|0|||
162816740|NCT04427501|588042393|FG006|Overall Study|Other|0|||
162816741|NCT04427501|588042394|FG007|Overall Study|Other|0|||
162816742|NCT04427501|588042395|FG008|Overall Study|Other|0|||
162816743|NCT04427501|588042396|FG009|Overall Study|Other|0|||
162816744|NCT04427501|588042397|FG010|Overall Study|Other|0|||
162816745|NCT04427501|588042398|FG011|Overall Study|Other|1|||
162816746|NCT03170154|588042399|FG000|Overall Study|Lost to Follow-up|4|||
162816747|NCT03170154|588042399|FG000|Overall Study|Death|2|||
162816748|NCT03170154|588042399|FG000|Overall Study|Withdrawal by Subject|2|||
162816749|NCT01906346|588042400|FG000|Overall Study|AEs|1|||
162816750|NCT04936841|588042403|FG000|Overall Study|Death|1|||
162816751|NCT02279862|588042404|FG000|Overall Study|Study drug toxicity|3|||
162816752|NCT02279862|588042405|FG001|Overall Study|Study drug toxicity|6|||
162816753|NCT02279862|588042404|FG000|Overall Study|No longer meets criteria|0|||
162816754|NCT02279862|588042405|FG001|Overall Study|No longer meets criteria|1|||
162816755|NCT02279862|588042404|FG000|Overall Study|Administrative reason by sponsor|0|||
162816756|NCT02279862|588042405|FG001|Overall Study|Administrative reason by sponsor|1|||
162816757|NCT02279862|588042404|FG000|Overall Study|Disease progression|5|||
162816758|NCT02279862|588042405|FG001|Overall Study|Disease progression|2|||
162816759|NCT02279862|588042404|FG000|Overall Study|Study closed by sponsor|16|||
162816760|NCT02279862|588042405|FG001|Overall Study|Study closed by sponsor|13|||
162816761|NCT02279862|588042404|FG000|Overall Study|Other|1|||
162816762|NCT02279862|588042405|FG001|Overall Study|Other|2|||
162816763|NCT02279862|588042404|FG000|Overall Study|Withdrawal by Subject|1|||
162816764|NCT02279862|588042405|FG001|Overall Study|Withdrawal by Subject|0|||
162816765|NCT04226833|588042407|FG000|Overall Study|Death|0|||
162816766|NCT04226833|588042408|FG001|Overall Study|Death|0|||
162816767|NCT04226833|588042409|FG002|Overall Study|Death|1|||
162816768|NCT04226833|588042410|FG003|Overall Study|Death|0|||
162816769|NCT00403754|588042413|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
162816770|NCT00403754|588042414|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
162816771|NCT00403754|588042415|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
162816772|NCT00403754|588042416|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
162816773|NCT00403754|588042413|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
162816774|NCT00403754|588042414|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
162816775|NCT00403754|588042415|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
162816776|NCT00403754|588042416|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
162816777|NCT04343248|588042417|FG000|Overall Study|Withdrawal by Subject|5|||
162816778|NCT04343248|588042418|FG001|Overall Study|Withdrawal by Subject|6|||
162816779|NCT04343248|588042417|FG000|Overall Study|Death|1|||
162816780|NCT04343248|588042418|FG001|Overall Study|Death|2|||
162816781|NCT04343248|588042417|FG000|Overall Study|Lost to Follow-up|9|||
162816782|NCT04343248|588042418|FG001|Overall Study|Lost to Follow-up|6|||
162816783|NCT04343248|588042417|FG000|Overall Study|Physician Decision|0|||
162816784|NCT04343248|588042418|FG001|Overall Study|Physician Decision|1|||
162816785|NCT04343248|588042417|FG000|Overall Study|Adverse Event|1|||
162816786|NCT04343248|588042418|FG001|Overall Study|Adverse Event|0|||
162816787|NCT03951220|588042423|FG000|Overall Study|Withdrawal by Subject|9|||
162816788|NCT03951220|588042424|FG001|Overall Study|Withdrawal by Subject|2|||
162816789|NCT03951220|588042425|FG002|Overall Study|Withdrawal by Subject|0|||
162816790|NCT02958267|588042433|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
162816791|NCT02958267|588042434|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
162816792|NCT02958267|588042433|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
162816793|NCT02958267|588042434|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
162816794|NCT02958267|588042433|FG000|Follow-up Visits|Additional treatment pursued|2|||
162816795|NCT02958267|588042434|FG001|Follow-up Visits|Additional treatment pursued|1|||
162816796|NCT04484831|588042435|FG000|Overall Study|Withdrawal by Subject|1|||
162816797|NCT04484831|588042436|FG001|Overall Study|Withdrawal by Subject|0|||
162816798|NCT00174265|588042437|FG000|Overall Study|Adverse Event|7|||
162816799|NCT00174265|588042438|FG001|Overall Study|Adverse Event|4|||
162816800|NCT00174265|588042437|FG000|Overall Study|Lack of Efficacy|2|||
162816801|NCT00174265|588042438|FG001|Overall Study|Lack of Efficacy|2|||
162816802|NCT00174265|588042437|FG000|Overall Study|Withdrawal by Subject|3|||
162816803|NCT00174265|588042438|FG001|Overall Study|Withdrawal by Subject|5|||
162816804|NCT00174265|588042437|FG000|Overall Study|Lost to Follow-up|1|||
162816805|NCT00174265|588042438|FG001|Overall Study|Lost to Follow-up|0|||
162816806|NCT00174265|588042437|FG000|Overall Study|Other (Not specified)|16|||
162816807|NCT00174265|588042438|FG001|Overall Study|Other (Not specified)|10|||
162816808|NCT03231943|588042439|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816809|NCT03231943|588042440|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
162816810|NCT03231943|588042441|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
162816811|NCT03231943|588042442|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816812|NCT03231943|588042443|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816813|NCT03231943|588042444|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816814|NCT03231943|588042445|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816815|NCT03231943|588042446|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816816|NCT03231943|588042447|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816817|NCT03231943|588042448|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816818|NCT03231943|588042449|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816819|NCT03231943|588042450|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816820|NCT03231943|588042451|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
162816821|NCT03231943|588042439|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816822|NCT03231943|588042440|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
162816823|NCT03231943|588042441|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816824|NCT03231943|588042442|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816825|NCT03231943|588042443|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816826|NCT03231943|588042444|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816827|NCT03231943|588042445|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816828|NCT03231943|588042446|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816829|NCT03231943|588042447|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816830|NCT03231943|588042448|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816831|NCT03231943|588042449|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816832|NCT03231943|588042450|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816833|NCT03231943|588042451|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
162816834|NCT03231943|588042439|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
162816835|NCT03231943|588042440|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816836|NCT03231943|588042441|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816837|NCT03231943|588042442|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816838|NCT03231943|588042443|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816839|NCT03231943|588042444|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816840|NCT03231943|588042445|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816841|NCT03231943|588042446|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816842|NCT03231943|588042447|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816843|NCT03231943|588042448|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816844|NCT03231943|588042449|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816845|NCT03231943|588042450|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163166189|NCT05091567|589325596|FG001|Randomized Phase|Ongoing in Study|102|||
162816846|NCT03231943|588042451|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
162816847|NCT03231943|588042439|FG000|Part 2|Adverse Event|0|||
162816848|NCT03231943|588042440|FG001|Part 2|Adverse Event|0|||
162816849|NCT03231943|588042441|FG002|Part 2|Adverse Event|0|||
162816850|NCT03231943|588042442|FG003|Part 2|Adverse Event|0|||
162816851|NCT03231943|588042443|FG004|Part 2|Adverse Event|0|||
162816852|NCT03231943|588042444|FG005|Part 2|Adverse Event|0|||
162816853|NCT03231943|588042445|FG006|Part 2|Adverse Event|0|||
162816854|NCT03231943|588042446|FG007|Part 2|Adverse Event|0|||
162816855|NCT03231943|588042447|FG008|Part 2|Adverse Event|0|||
162816856|NCT03231943|588042448|FG009|Part 2|Adverse Event|0|||
162816857|NCT03231943|588042449|FG010|Part 2|Adverse Event|1|||
162816858|NCT03231943|588042450|FG011|Part 2|Adverse Event|0|||
162816859|NCT03231943|588042451|FG012|Part 2|Adverse Event|0|||
162816860|NCT03231943|588042439|FG000|Part 2|Withdrawal by Subject|0|||
162816861|NCT03231943|588042440|FG001|Part 2|Withdrawal by Subject|0|||
162816862|NCT03231943|588042441|FG002|Part 2|Withdrawal by Subject|0|||
162816863|NCT03231943|588042442|FG003|Part 2|Withdrawal by Subject|0|||
162816864|NCT03231943|588042443|FG004|Part 2|Withdrawal by Subject|0|||
162816865|NCT03231943|588042444|FG005|Part 2|Withdrawal by Subject|0|||
162816866|NCT03231943|588042445|FG006|Part 2|Withdrawal by Subject|0|||
162816867|NCT03231943|588042446|FG007|Part 2|Withdrawal by Subject|0|||
162816868|NCT03231943|588042447|FG008|Part 2|Withdrawal by Subject|0|||
162816869|NCT03231943|588042448|FG009|Part 2|Withdrawal by Subject|0|||
162816870|NCT03231943|588042449|FG010|Part 2|Withdrawal by Subject|0|||
162816871|NCT03231943|588042450|FG011|Part 2|Withdrawal by Subject|1|||
162816872|NCT03231943|588042451|FG012|Part 2|Withdrawal by Subject|0|||
162816873|NCT00047320|588042452|FG000|Overall Study|Lack of Efficacy|8|||
162816874|NCT00047320|588042452|FG000|Overall Study|Lost to Follow-up|1|||
162816875|NCT00047320|588042452|FG000|Overall Study|Physician Decision|8|||
162816876|NCT00047320|588042452|FG000|Overall Study|Withdrawal by Subject|9|||
162816877|NCT00047320|588042452|FG000|Overall Study|Ineligible|2|||
162816878|NCT03471871|588042453|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
162816879|NCT03471871|588042454|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
162816880|NCT03471871|588042455|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
162816881|NCT03471871|588042456|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
162816882|NCT03471871|588042457|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
162816883|NCT03471871|588042453|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
162816884|NCT03471871|588042454|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
162816885|NCT03471871|588042455|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
162816886|NCT03471871|588042456|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
162816887|NCT03471871|588042457|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
162816888|NCT03471871|588042453|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
162816889|NCT03471871|588042454|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
162816890|NCT03471871|588042455|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
162816891|NCT03471871|588042456|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
162816892|NCT03471871|588042457|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
162816893|NCT03471871|588042453|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
162816894|NCT03471871|588042454|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
162816895|NCT03471871|588042455|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
162816896|NCT03471871|588042456|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
162816897|NCT03471871|588042457|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
162816898|NCT03471871|588042453|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
162816899|NCT03471871|588042454|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
162816900|NCT03471871|588042455|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
162816901|NCT03471871|588042456|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
162816902|NCT03471871|588042457|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
162816903|NCT03040622|588042458|FG000|Overall Study|unable to implant device|3|||
162816904|NCT02818920|588042459|FG000|Overall Study|Unresectable|4|||
162816905|NCT02818920|588042459|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
162816906|NCT02818920|588042459|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
162816907|NCT02818920|588042459|FG000|Overall Study|Adverse Event|3|||
162816908|NCT02818920|588042459|FG000|Overall Study|Developed Other Disease|1|||
162816909|NCT02818920|588042459|FG000|Overall Study|Refused Further Treatment|1|||
162816910|NCT00445068|588042460|FG000|Overall Study|Disease progression|26|||
162816911|NCT00445068|588042460|FG000|Overall Study|Adverse Event|5|||
162816912|NCT00445068|588042460|FG000|Overall Study|Abnormal laboratory value|2|||
162816913|NCT00445068|588042460|FG000|Overall Study|Withdrawal by Subject|2|||
162816914|NCT00445068|588042460|FG000|Overall Study|Death|1|||
162816915|NCT02673619|588042461|FG000|Overall Study|Lost to Follow-up|1|||
162816916|NCT02673619|588042462|FG001|Overall Study|Lost to Follow-up|0|||
162816917|NCT02673619|588042463|FG002|Overall Study|Lost to Follow-up|0|||
163166190|NCT05091567|589325597|FG002|Randomized Phase|Ongoing in Study|126|||
162816918|NCT02673619|588042464|FG003|Overall Study|Lost to Follow-up|0|||
162816919|NCT02673619|588042461|FG000|Overall Study|Withdrawal by Subject|1|||
162816920|NCT02673619|588042462|FG001|Overall Study|Withdrawal by Subject|1|||
162816921|NCT02673619|588042463|FG002|Overall Study|Withdrawal by Subject|1|||
162816922|NCT02673619|588042464|FG003|Overall Study|Withdrawal by Subject|0|||
162816923|NCT02673619|588042461|FG000|Overall Study|Adverse Event|0|||
162816924|NCT02673619|588042462|FG001|Overall Study|Adverse Event|0|||
162816925|NCT02673619|588042463|FG002|Overall Study|Adverse Event|1|||
162816926|NCT02673619|588042464|FG003|Overall Study|Adverse Event|0|||
162816927|NCT02673619|588042461|FG000|Overall Study|Lack of Efficacy|0|||
162816928|NCT02673619|588042462|FG001|Overall Study|Lack of Efficacy|0|||
162816929|NCT02673619|588042463|FG002|Overall Study|Lack of Efficacy|1|||
162816930|NCT02673619|588042464|FG003|Overall Study|Lack of Efficacy|0|||
162816931|NCT03444324|588042465|FG000|Overall Study|Withdrawal by Subject|0|||
162816932|NCT03444324|588042466|FG001|Overall Study|Withdrawal by Subject|1|||
162816933|NCT03444324|588042465|FG000|Overall Study|Lost to Follow-up|4|||
162816934|NCT03444324|588042466|FG001|Overall Study|Lost to Follow-up|2|||
162816935|NCT03444324|588042465|FG000|Overall Study|Protocol Violation|0|||
162816936|NCT03444324|588042466|FG001|Overall Study|Protocol Violation|1|||
162816937|NCT03444324|588042465|FG000|Overall Study|Lack of Trial Compliance|1|||
162816938|NCT03444324|588042466|FG001|Overall Study|Lack of Trial Compliance|1|||
162816939|NCT03444324|588042465|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
162816940|NCT03444324|588042466|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
162816941|NCT00658684|588042468|FG000|Overall Study|Adverse Event|10|||
162816942|NCT00658684|588042469|FG001|Overall Study|Adverse Event|8|||
162816943|NCT00658684|588042470|FG002|Overall Study|Adverse Event|2|||
162816944|NCT00658684|588042471|FG003|Overall Study|Adverse Event|0|||
162816945|NCT00658684|588042468|FG000|Overall Study|Withdrawal by Subject|6|||
162816946|NCT00658684|588042469|FG001|Overall Study|Withdrawal by Subject|4|||
162816947|NCT00658684|588042470|FG002|Overall Study|Withdrawal by Subject|1|||
162816948|NCT00658684|588042471|FG003|Overall Study|Withdrawal by Subject|1|||
162816949|NCT00658684|588042468|FG000|Overall Study|Lack of Efficacy|1|||
162816950|NCT00658684|588042469|FG001|Overall Study|Lack of Efficacy|1|||
162816951|NCT00658684|588042470|FG002|Overall Study|Lack of Efficacy|0|||
162816952|NCT00658684|588042471|FG003|Overall Study|Lack of Efficacy|0|||
162816953|NCT00658684|588042468|FG000|Overall Study|Protocol Violation|1|||
162816954|NCT00658684|588042469|FG001|Overall Study|Protocol Violation|1|||
162816955|NCT00658684|588042470|FG002|Overall Study|Protocol Violation|0|||
162816956|NCT00658684|588042471|FG003|Overall Study|Protocol Violation|0|||
162816957|NCT00658684|588042468|FG000|Overall Study|Pregnancy|1|||
162816958|NCT00658684|588042469|FG001|Overall Study|Pregnancy|1|||
162816959|NCT00658684|588042470|FG002|Overall Study|Pregnancy|0|||
162816960|NCT00658684|588042471|FG003|Overall Study|Pregnancy|0|||
162816961|NCT00688103|588042472|FG000|Overall Study|Adverse Event|4|||
162816962|NCT00688103|588042473|FG001|Overall Study|Adverse Event|1|||
162816963|NCT00688103|588042472|FG000|Overall Study|Lack of Efficacy|11|||
162816964|NCT00688103|588042473|FG001|Overall Study|Lack of Efficacy|1|||
162816965|NCT00688103|588042472|FG000|Overall Study|Withdrawal by Subject|4|||
162816966|NCT00688103|588042473|FG001|Overall Study|Withdrawal by Subject|2|||
162816967|NCT00688103|588042472|FG000|Overall Study|complex reasons|11|||
162816968|NCT00688103|588042473|FG001|Overall Study|complex reasons|9|||
162816969|NCT05959629|588042477|FG000|Overall Study|partially necrotic/technical issues|2|||
162816970|NCT05959629|588042478|FG001|Overall Study|partially necrotic/technical issues|2|||
162816971|NCT02076113|588044010|FG000|Overall Study|Lost to Follow-up|4|||
162816972|NCT02076113|588044011|FG001|Overall Study|Lost to Follow-up|1|||
162816973|NCT02076113|588044010|FG000|Overall Study|Withdrawal by Subject|2|||
162816974|NCT02076113|588044011|FG001|Overall Study|Withdrawal by Subject|3|||
162816975|NCT02076113|588044010|FG000|Overall Study|Death|1|||
162816976|NCT02076113|588044011|FG001|Overall Study|Death|3|||
162816977|NCT03942406|588044014|FG000|Overall Study|Lost to Follow-up|4|||
162816978|NCT03942406|588044015|FG001|Overall Study|Lost to Follow-up|5|||
162816979|NCT03942406|588044016|FG002|Overall Study|Lost to Follow-up|3|||
162816980|NCT03942406|588044017|FG003|Overall Study|Lost to Follow-up|7|||
162816981|NCT03942406|588044018|FG004|Overall Study|Lost to Follow-up|1|||
162816982|NCT03942406|588044019|FG005|Overall Study|Lost to Follow-up|0|||
162816983|NCT03942406|588044020|FG006|Overall Study|Lost to Follow-up|0|||
162816984|NCT03942406|588044014|FG000|Overall Study|Withdrawal by Subject|3|||
162816985|NCT03942406|588044015|FG001|Overall Study|Withdrawal by Subject|1|||
162816986|NCT03942406|588044016|FG002|Overall Study|Withdrawal by Subject|1|||
162816987|NCT03942406|588044017|FG003|Overall Study|Withdrawal by Subject|3|||
162816988|NCT03942406|588044018|FG004|Overall Study|Withdrawal by Subject|0|||
162816989|NCT03942406|588044019|FG005|Overall Study|Withdrawal by Subject|0|||
162816990|NCT03942406|588044020|FG006|Overall Study|Withdrawal by Subject|0|||
162816991|NCT03942406|588044014|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
162816992|NCT03942406|588044015|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
162816993|NCT03942406|588044016|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
162816994|NCT03942406|588044017|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
162816995|NCT03942406|588044018|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
162698195|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162698196|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162698197|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162698198|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
162698199|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
162698200|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162698201|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162698202|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162698203|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162698204|NCT01089556|587605435|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
162698205|NCT01089556|587605436|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
162698206|NCT01089556|587605437|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162698207|NCT01089556|587605438|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162698208|NCT01089556|587605439|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162698209|NCT01089556|587605440|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162698210|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
162698211|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
162698212|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
162698213|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
162698214|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
162698215|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
162698216|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
162698217|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
162698218|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162698219|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162698220|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162698221|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162698222|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162698223|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162698224|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162698225|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
162698226|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
162698227|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162698228|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162698229|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162698230|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
162698231|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162698232|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162698233|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162698234|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162698235|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162698236|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162698237|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162698238|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162698239|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162698240|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
162698241|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
162698242|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
162698243|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
162698244|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
162698245|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
162698246|NCT01089556|587605435|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162698247|NCT01089556|587605436|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162698248|NCT01089556|587605437|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
162698249|NCT01089556|587605438|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162698250|NCT01089556|587605439|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
162698251|NCT01089556|587605440|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
162698252|NCT00594906|587605441|FG000|Overall Study|Physician Decision|1|||
162698253|NCT00594906|587605442|FG001|Overall Study|Physician Decision|0|||
162698254|NCT00594906|587605441|FG000|Overall Study|Physician Decision|0|||
162698255|NCT00594906|587605442|FG001|Overall Study|Physician Decision|1|||
162698256|NCT00594906|587605441|FG000|Overall Study|Death|0|||
162698257|NCT00594906|587605442|FG001|Overall Study|Death|1|||
162698258|NCT01027364|587605448|FG000|Overall Study|Adverse Event|1|||
162698259|NCT01027364|587605449|FG001|Overall Study|Adverse Event|0|||
162698260|NCT01027364|587605450|FG002|Overall Study|Adverse Event|1|||
162698261|NCT01027364|587605451|FG003|Overall Study|Adverse Event|0|||
162698262|NCT01027364|587605448|FG000|Overall Study|Lost to Follow-up|1|||
162698263|NCT01027364|587605449|FG001|Overall Study|Lost to Follow-up|0|||
162698264|NCT01027364|587605450|FG002|Overall Study|Lost to Follow-up|0|||
162816996|NCT03942406|588044019|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
162816997|NCT03942406|588044020|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
162816998|NCT02616614|588044021|FG000|Overall Study|Withdrawal by Subject|10|||
162816999|NCT02616614|588044022|FG001|Overall Study|Withdrawal by Subject|5|||
162817000|NCT02616614|588044023|FG002|Overall Study|Withdrawal by Subject|6|||
162817001|NCT02616614|588044021|FG000|Overall Study|Physician Decision|2|||
162817002|NCT02616614|588044022|FG001|Overall Study|Physician Decision|1|||
162817003|NCT02616614|588044023|FG002|Overall Study|Physician Decision|0|||
162817004|NCT02616614|588044021|FG000|Overall Study|Adverse Event|1|||
162817005|NCT02616614|588044022|FG001|Overall Study|Adverse Event|4|||
162817006|NCT02616614|588044023|FG002|Overall Study|Adverse Event|1|||
162817007|NCT02616614|588044021|FG000|Overall Study|Protocol Violation|0|||
162817008|NCT02616614|588044022|FG001|Overall Study|Protocol Violation|3|||
162817009|NCT02616614|588044023|FG002|Overall Study|Protocol Violation|1|||
162817010|NCT02616614|588044021|FG000|Overall Study|Prohibited Medication|12|||
162817011|NCT02616614|588044022|FG001|Overall Study|Prohibited Medication|9|||
162817012|NCT02616614|588044023|FG002|Overall Study|Prohibited Medication|5|||
162817013|NCT02616614|588044021|FG000|Overall Study|More than 3 applications missed|6|||
162817014|NCT02616614|588044022|FG001|Overall Study|More than 3 applications missed|8|||
162817015|NCT02616614|588044023|FG002|Overall Study|More than 3 applications missed|1|||
162817016|NCT02616614|588044021|FG000|Overall Study|Lost to Follow-up|31|||
162817017|NCT02616614|588044022|FG001|Overall Study|Lost to Follow-up|28|||
162817018|NCT02616614|588044023|FG002|Overall Study|Lost to Follow-up|13|||
162817019|NCT02616614|588044021|FG000|Overall Study|Pregnancy|2|||
162817020|NCT02616614|588044022|FG001|Overall Study|Pregnancy|0|||
162817021|NCT02616614|588044023|FG002|Overall Study|Pregnancy|1|||
162817022|NCT02616614|588044021|FG000|Overall Study|Other|1|||
162817023|NCT02616614|588044022|FG001|Overall Study|Other|2|||
162817024|NCT02616614|588044023|FG002|Overall Study|Other|1|||
162817025|NCT02748018|588044024|FG000|Study Period|Adverse Event|1|||
162817026|NCT02748018|588044025|FG001|Study Period|Adverse Event|3|||
162817027|NCT02748018|588044026|FG002|Study Period|Adverse Event|4|||
162817028|NCT02748018|588044027|FG003|Study Period|Adverse Event|0|||
162817029|NCT02748018|588044028|FG004|Study Period|Adverse Event|3|||
162817030|NCT02748018|588044029|FG005|Study Period|Adverse Event|3|||
162817031|NCT02748018|588044024|FG000|Study Period|Withdrawal by Subject|7|||
162817032|NCT02748018|588044025|FG001|Study Period|Withdrawal by Subject|4|||
162817033|NCT02748018|588044026|FG002|Study Period|Withdrawal by Subject|4|||
162817034|NCT02748018|588044027|FG003|Study Period|Withdrawal by Subject|11|||
162817035|NCT02748018|588044028|FG004|Study Period|Withdrawal by Subject|12|||
162817036|NCT02748018|588044029|FG005|Study Period|Withdrawal by Subject|10|||
162817037|NCT02748018|588044024|FG000|Study Period|Pregnancy|0|||
162817038|NCT02748018|588044025|FG001|Study Period|Pregnancy|1|||
162817039|NCT02748018|588044026|FG002|Study Period|Pregnancy|0|||
162817040|NCT02748018|588044027|FG003|Study Period|Pregnancy|0|||
162817041|NCT02748018|588044028|FG004|Study Period|Pregnancy|1|||
162817042|NCT02748018|588044029|FG005|Study Period|Pregnancy|0|||
162817043|NCT02748018|588044024|FG000|Study Period|Physician Decision|2|||
162817044|NCT02748018|588044025|FG001|Study Period|Physician Decision|2|||
162817045|NCT02748018|588044026|FG002|Study Period|Physician Decision|1|||
162817046|NCT02748018|588044027|FG003|Study Period|Physician Decision|0|||
162817047|NCT02748018|588044028|FG004|Study Period|Physician Decision|2|||
162817048|NCT02748018|588044029|FG005|Study Period|Physician Decision|0|||
162817049|NCT02748018|588044024|FG000|Study Period|Lost to Follow-up|0|||
162817050|NCT02748018|588044025|FG001|Study Period|Lost to Follow-up|0|||
162817051|NCT02748018|588044026|FG002|Study Period|Lost to Follow-up|0|||
162817052|NCT02748018|588044027|FG003|Study Period|Lost to Follow-up|2|||
162817053|NCT02748018|588044028|FG004|Study Period|Lost to Follow-up|0|||
162817054|NCT02748018|588044029|FG005|Study Period|Lost to Follow-up|1|||
162817055|NCT02748018|588044024|FG000|Continuation Period|Adverse Event|2|||
162817056|NCT02748018|588044025|FG001|Continuation Period|Adverse Event|0|||
162817057|NCT02748018|588044026|FG002|Continuation Period|Adverse Event|1|||
162817058|NCT02748018|588044027|FG003|Continuation Period|Adverse Event|1|||
162817059|NCT02748018|588044028|FG004|Continuation Period|Adverse Event|1|||
162817060|NCT02748018|588044029|FG005|Continuation Period|Adverse Event|4|||
162817061|NCT02748018|588044024|FG000|Continuation Period|Withdrawal by Subject|3|||
162817062|NCT02748018|588044025|FG001|Continuation Period|Withdrawal by Subject|5|||
162817063|NCT02748018|588044026|FG002|Continuation Period|Withdrawal by Subject|3|||
162817064|NCT02748018|588044027|FG003|Continuation Period|Withdrawal by Subject|9|||
162817065|NCT02748018|588044028|FG004|Continuation Period|Withdrawal by Subject|11|||
162817066|NCT02748018|588044029|FG005|Continuation Period|Withdrawal by Subject|1|||
162817067|NCT02748018|588044024|FG000|Continuation Period|Lost to Follow-up|0|||
162817068|NCT02748018|588044025|FG001|Continuation Period|Lost to Follow-up|2|||
162817069|NCT02748018|588044026|FG002|Continuation Period|Lost to Follow-up|1|||
162817070|NCT02748018|588044027|FG003|Continuation Period|Lost to Follow-up|0|||
162817071|NCT02748018|588044028|FG004|Continuation Period|Lost to Follow-up|1|||
162817072|NCT02748018|588044029|FG005|Continuation Period|Lost to Follow-up|0|||
162817073|NCT02748018|588044024|FG000|Continuation Period|Pregnancy|1|||
162817074|NCT02748018|588044025|FG001|Continuation Period|Pregnancy|2|||
162817075|NCT02748018|588044026|FG002|Continuation Period|Pregnancy|0|||
162817076|NCT02748018|588044027|FG003|Continuation Period|Pregnancy|0|||
162817077|NCT02748018|588044028|FG004|Continuation Period|Pregnancy|0|||
162817078|NCT02748018|588044029|FG005|Continuation Period|Pregnancy|0|||
162817079|NCT02748018|588044024|FG000|Continuation Period|Physician Decision|0|||
162817080|NCT02748018|588044025|FG001|Continuation Period|Physician Decision|1|||
162817081|NCT02748018|588044026|FG002|Continuation Period|Physician Decision|2|||
162817082|NCT02748018|588044027|FG003|Continuation Period|Physician Decision|0|||
162817083|NCT02748018|588044028|FG004|Continuation Period|Physician Decision|2|||
162817084|NCT02748018|588044029|FG005|Continuation Period|Physician Decision|1|||
162817085|NCT02748018|588044024|FG000|Continuation Period|Protocol Violation|0|||
162817086|NCT02748018|588044025|FG001|Continuation Period|Protocol Violation|1|||
162817087|NCT02748018|588044026|FG002|Continuation Period|Protocol Violation|0|||
162817088|NCT02748018|588044027|FG003|Continuation Period|Protocol Violation|0|||
162817089|NCT02748018|588044028|FG004|Continuation Period|Protocol Violation|0|||
162817090|NCT02748018|588044029|FG005|Continuation Period|Protocol Violation|0|||
162817091|NCT06069778|588044030|FG000|Overall Study|Withdrawal by Subject|1|||
162817092|NCT03801902|588044031|FG000|Overall Study|Did not receive protocol treatment.|1|||
162817093|NCT03801902|588044032|FG001|Overall Study|Did not receive protocol treatment.|0|||
162817094|NCT03801902|588044033|FG002|Overall Study|Did not receive protocol treatment.|0|||
162817095|NCT03801902|588044034|FG003|Overall Study|Did not receive protocol treatment.|0|||
162817096|NCT04704336|588044040|FG000|Overall Study|Death|2|||
162817097|NCT04704336|588044041|FG001|Overall Study|Death|2|||
162817098|NCT04704336|588044040|FG000|Overall Study|Lost to Follow-up|33|||
162817099|NCT04704336|588044041|FG001|Overall Study|Lost to Follow-up|40|||
162817100|NCT02260882|588044042|FG000|Overall Study|Protocol Violation|0|||
162817101|NCT02260882|588044043|FG001|Overall Study|Protocol Violation|1|||
162817102|NCT02119325|588044044|FG000|Washout Period 1|Adverse Event|0|||
162817103|NCT02119325|588044045|FG001|Washout Period 1|Adverse Event|1|||
162817104|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
162817105|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
162817106|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
162817107|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
162817108|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
162817109|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
162817110|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
162817111|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
162817112|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Death|1|||
162817113|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Death|1|||
162817114|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
162817115|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
162817116|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
162817117|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
162817118|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
162817119|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
162817120|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
162817121|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
162817122|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
162817123|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
162817124|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
162817125|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
162817126|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
162817127|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
162817128|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
162817129|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
162817130|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
162817131|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
162817132|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
162817133|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
162817134|NCT00559585|588044048|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
162817135|NCT00559585|588044049|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
162817136|NCT00559585|588044048|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
162817137|NCT00559585|588044049|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
162698265|NCT01027364|587605451|FG003|Overall Study|Lost to Follow-up|0|||
162817138|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
162817139|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
162817140|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
162817141|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
162817142|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
162817143|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
162817144|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
162817145|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
162817146|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
162817147|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
162817148|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
162817149|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
162817150|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
162817151|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
162817152|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
162817153|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
162817154|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
162817155|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
162817156|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
162817157|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
162817158|NCT00559585|588044048|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
162817159|NCT00559585|588044049|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
162817160|NCT04209621|588044050|FG000|Overall Study|Death|1|||
162817161|NCT04209621|588044050|FG000|Overall Study|Study Terminated Early|2|||
162817162|NCT02249767|588044051|FG000|Overall Study|Did not use medication|8|||
162817163|NCT02249767|588044052|FG001|Overall Study|Did not use medication|9|||
162817164|NCT02249767|588044053|FG002|Overall Study|Did not use medication|8|||
162817165|NCT01372410|588044054|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
162817166|NCT01372410|588044055|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
162817167|NCT01372410|588044056|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
162817168|NCT01372410|588044057|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
162817169|NCT01372410|588044058|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
162817170|NCT01372410|588044059|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
162817171|NCT01372410|588044060|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
162817172|NCT01372410|588044061|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
162817173|NCT01372410|588044054|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817174|NCT01372410|588044055|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
162817175|NCT01372410|588044056|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817176|NCT01372410|588044057|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817177|NCT01372410|588044058|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817178|NCT01372410|588044059|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817179|NCT01372410|588044060|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
162817180|NCT01372410|588044061|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
162817181|NCT01372410|588044054|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817182|NCT01372410|588044055|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817183|NCT01372410|588044056|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817184|NCT01372410|588044057|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817185|NCT01372410|588044058|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
162817186|NCT01372410|588044059|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817187|NCT01372410|588044060|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817188|NCT01372410|588044061|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162817189|NCT01372410|588044054|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817190|NCT01372410|588044055|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817191|NCT01372410|588044056|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817192|NCT01372410|588044057|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817193|NCT01372410|588044058|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817194|NCT01372410|588044059|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817195|NCT01372410|588044060|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
162817196|NCT01372410|588044061|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162817197|NCT01372410|588044054|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
162817198|NCT01372410|588044055|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
162817199|NCT01372410|588044056|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
162817200|NCT01372410|588044057|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
162817201|NCT01372410|588044058|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163166191|NCT01217307|589325598|FG000|Overall Study|Withdrawal by Subject|0|||
163166192|NCT01217307|589325599|FG001|Overall Study|Withdrawal by Subject|1|||
162817202|NCT01372410|588044059|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
162817203|NCT01372410|588044060|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
162817204|NCT01372410|588044061|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
162817205|NCT01372410|588044054|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817206|NCT01372410|588044055|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817207|NCT01372410|588044056|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817208|NCT01372410|588044057|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817209|NCT01372410|588044058|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
162817210|NCT01372410|588044059|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817211|NCT01372410|588044060|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817212|NCT01372410|588044061|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
162817213|NCT01372410|588044054|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162817214|NCT01372410|588044055|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162817215|NCT01372410|588044056|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162817216|NCT01372410|588044057|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162817217|NCT01372410|588044058|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
162817218|NCT01372410|588044059|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
162817219|NCT01372410|588044060|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
162817220|NCT01372410|588044061|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
162817221|NCT01372410|588044054|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817222|NCT01372410|588044055|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817223|NCT01372410|588044056|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817224|NCT01372410|588044057|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817225|NCT01372410|588044058|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817226|NCT01372410|588044059|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817227|NCT01372410|588044060|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
162817228|NCT01372410|588044061|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
162817229|NCT01372410|588044054|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817230|NCT01372410|588044055|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817231|NCT01372410|588044056|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
162817232|NCT01372410|588044057|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817233|NCT01372410|588044058|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817234|NCT01372410|588044059|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817235|NCT01372410|588044060|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817236|NCT01372410|588044061|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
162817237|NCT01372410|588044054|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817238|NCT01372410|588044055|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817239|NCT01372410|588044056|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817240|NCT01372410|588044057|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817241|NCT01372410|588044058|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817242|NCT01372410|588044059|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
162817243|NCT01372410|588044060|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817244|NCT01372410|588044061|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
162817245|NCT04585646|588044062|FG000|First Intervention|Physician Decision|1|||
162817246|NCT04585646|588044063|FG001|First Intervention|Physician Decision|0|||
162817247|NCT04585646|588044062|FG000|First Intervention|Lost to Follow-up|0|||
162817248|NCT04585646|588044063|FG001|First Intervention|Lost to Follow-up|3|||
162817249|NCT04585646|588044062|FG000|First Intervention|Withdrawal by Subject|0|||
162817250|NCT04585646|588044063|FG001|First Intervention|Withdrawal by Subject|1|||
162817251|NCT04614662|588044066|FG000|Overall Study|Withdrawal by Subject|0|||
162817252|NCT04614662|588044067|FG001|Overall Study|Withdrawal by Subject|1|||
162817253|NCT05085665|588044074|FG000|Overall Study|Physician Decision|2|||
162817254|NCT03294109|588044077|FG000|Overall Study|Withdrawal by Subject|6|||
162817255|NCT03294109|588044078|FG001|Overall Study|Withdrawal by Subject|5|||
162817256|NCT01717768|588044079|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817257|NCT01717768|588044080|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
162817258|NCT01717768|588044081|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817259|NCT01717768|588044082|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817260|NCT01717768|588044083|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817261|NCT01717768|588044084|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817262|NCT01717768|588044085|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817263|NCT01717768|588044086|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817264|NCT01717768|588044087|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817265|NCT01717768|588044088|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817266|NCT01717768|588044089|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817267|NCT01717768|588044090|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
162817268|NCT01717768|588044079|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817269|NCT01717768|588044080|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817270|NCT01717768|588044081|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817271|NCT01717768|588044082|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817272|NCT01717768|588044083|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817273|NCT01717768|588044084|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817274|NCT01717768|588044085|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817275|NCT01717768|588044086|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817276|NCT01717768|588044087|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817277|NCT01717768|588044088|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817278|NCT01717768|588044089|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
162817279|NCT01717768|588044090|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
162817280|NCT01717768|588044079|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817281|NCT01717768|588044080|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817282|NCT01717768|588044081|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817283|NCT01717768|588044082|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817284|NCT01717768|588044083|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817285|NCT01717768|588044084|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817286|NCT01717768|588044085|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817287|NCT01717768|588044086|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
162817288|NCT01717768|588044087|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817289|NCT01717768|588044088|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817290|NCT01717768|588044089|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817291|NCT01717768|588044090|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
162817292|NCT01717768|588044079|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817293|NCT01717768|588044080|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817294|NCT01717768|588044081|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817295|NCT01717768|588044082|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817296|NCT01717768|588044083|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817297|NCT01717768|588044084|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817298|NCT01717768|588044085|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817299|NCT01717768|588044086|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817300|NCT01717768|588044087|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817301|NCT01717768|588044088|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
162817302|NCT01717768|588044089|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817303|NCT01717768|588044090|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
162817304|NCT00448435|588044091|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
162817305|NCT00448435|588044092|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
162817306|NCT02804178|588044097|FG000|Overall Study|Adverse Event|1|||
162817307|NCT00412971|588044098|FG000|Overall Study|Lost to Follow-up|17|||
162817308|NCT00412971|588044099|FG001|Overall Study|Lost to Follow-up|9|||
162817309|NCT00412971|588044098|FG000|Overall Study|Protocol Violation|13|||
162817310|NCT00412971|588044099|FG001|Overall Study|Protocol Violation|1|||
162817311|NCT01387230|588044100|FG000|Overall Study|Adverse Event|0|||
162817312|NCT01387230|588044101|FG001|Overall Study|Adverse Event|1|||
162817313|NCT01387230|588044102|FG002|Overall Study|Adverse Event|3|||
162817314|NCT01387230|588044100|FG000|Overall Study|Lack of Efficacy|8|||
162817315|NCT01387230|588044101|FG001|Overall Study|Lack of Efficacy|5|||
162817316|NCT01387230|588044102|FG002|Overall Study|Lack of Efficacy|4|||
162817317|NCT01387230|588044100|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
162817318|NCT01387230|588044101|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
162817319|NCT01387230|588044102|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
162817320|NCT01387230|588044100|FG000|Overall Study|Lost to Follow-up|0|||
162817321|NCT01387230|588044101|FG001|Overall Study|Lost to Follow-up|0|||
162817322|NCT01387230|588044102|FG002|Overall Study|Lost to Follow-up|1|||
162817323|NCT01387230|588044100|FG000|Overall Study|Withdrawal by Subject|4|||
162817324|NCT01387230|588044101|FG001|Overall Study|Withdrawal by Subject|1|||
162817325|NCT01387230|588044102|FG002|Overall Study|Withdrawal by Subject|0|||
163166193|NCT00843284|589325602|FG000|Overall Study|Adverse Event|39|||
163166194|NCT00843284|589325602|FG000|Overall Study|Lack of Efficacy|5|||
163166195|NCT00843284|589325602|FG000|Overall Study|Lost to Follow-up|11|||
163166196|NCT00843284|589325602|FG000|Overall Study|Other|10|||
163166197|NCT00843284|589325602|FG000|Overall Study|Withdrawal by Subject|4|||
163166198|NCT00843284|589325602|FG000|Overall Study|Death|3|||
163166199|NCT01696929|589325603|FG000|Overall Study|Physician Decision|1|||
163166200|NCT03320824|589325605|FG000|Overall Study|Withdrawal by Subject|8|||
163166201|NCT03320824|589325606|FG001|Overall Study|Withdrawal by Subject|1|||
163166202|NCT03320824|589325605|FG000|Overall Study|Lost to Follow-up|10|||
163166203|NCT03320824|589325606|FG001|Overall Study|Lost to Follow-up|1|||
163166204|NCT03320824|589325605|FG000|Overall Study|moved out of state|0|||
163166205|NCT03320824|589325606|FG001|Overall Study|moved out of state|1|||
163166206|NCT03320824|589325605|FG000|Overall Study|could not complete final visit|0|||
163166207|NCT03320824|589325606|FG001|Overall Study|could not complete final visit|1|||
163166208|NCT00109590|589325607|FG000|Overall Study|Lost to Follow-up|1|||
163166209|NCT00109590|589325608|FG001|Overall Study|Lost to Follow-up|0|||
163166210|NCT00109590|589325609|FG002|Overall Study|Lost to Follow-up|1|||
163166211|NCT00109590|589325607|FG000|Overall Study|Never Started Treatment|1|||
163166212|NCT00109590|589325608|FG001|Overall Study|Never Started Treatment|2|||
162817326|NCT00372385|588044103|FG000|Overall Study|Adverse Event|6|||
162817327|NCT00372385|588044104|FG001|Overall Study|Adverse Event|11|||
162817328|NCT00372385|588044105|FG002|Overall Study|Adverse Event|9|||
163166213|NCT00109590|589325609|FG002|Overall Study|Never Started Treatment|3|||
162817329|NCT00372385|588044106|FG003|Overall Study|Adverse Event|7|||
162817330|NCT00372385|588044103|FG000|Overall Study|Noncompliance|0|||
162817331|NCT00372385|588044104|FG001|Overall Study|Noncompliance|1|||
162817332|NCT00372385|588044105|FG002|Overall Study|Noncompliance|1|||
162817333|NCT00372385|588044106|FG003|Overall Study|Noncompliance|1|||
162817334|NCT00372385|588044103|FG000|Overall Study|Physician Decision|1|||
162817335|NCT00372385|588044104|FG001|Overall Study|Physician Decision|0|||
162817336|NCT00372385|588044105|FG002|Overall Study|Physician Decision|0|||
162817337|NCT00372385|588044106|FG003|Overall Study|Physician Decision|0|||
162817338|NCT00372385|588044103|FG000|Overall Study|Lost to Follow-up|2|||
162817339|NCT00372385|588044104|FG001|Overall Study|Lost to Follow-up|0|||
162817340|NCT00372385|588044105|FG002|Overall Study|Lost to Follow-up|0|||
162817341|NCT00372385|588044106|FG003|Overall Study|Lost to Follow-up|0|||
162817342|NCT00372385|588044103|FG000|Overall Study|Withdrawal by Subject|2|||
162817343|NCT00372385|588044104|FG001|Overall Study|Withdrawal by Subject|1|||
162817344|NCT00372385|588044105|FG002|Overall Study|Withdrawal by Subject|0|||
162817345|NCT00372385|588044106|FG003|Overall Study|Withdrawal by Subject|0|||
162817346|NCT00372385|588044103|FG000|Overall Study|Refusal of Treatment|3|||
162817347|NCT00372385|588044104|FG001|Overall Study|Refusal of Treatment|6|||
162817348|NCT00372385|588044105|FG002|Overall Study|Refusal of Treatment|0|||
162817349|NCT00372385|588044106|FG003|Overall Study|Refusal of Treatment|0|||
162817350|NCT00372385|588044103|FG000|Overall Study|No Response|1|||
162817351|NCT00372385|588044104|FG001|Overall Study|No Response|1|||
162817352|NCT00372385|588044105|FG002|Overall Study|No Response|0|||
162817353|NCT00372385|588044106|FG003|Overall Study|No Response|0|||
162817354|NCT00372385|588044103|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
162817355|NCT00372385|588044104|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162817356|NCT00372385|588044105|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162817357|NCT00372385|588044106|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
162817358|NCT00372385|588044103|FG000|Overall Study|Virologic Stopping Rule|17|||
162817359|NCT00372385|588044104|FG001|Overall Study|Virologic Stopping Rule|0|||
162817360|NCT00372385|588044105|FG002|Overall Study|Virologic Stopping Rule|0|||
162817361|NCT00372385|588044106|FG003|Overall Study|Virologic Stopping Rule|0|||
162817362|NCT02554903|588044109|FG000|Overall Study|Death|1|||
162817363|NCT02554903|588044110|FG001|Overall Study|Death|1|||
162817364|NCT02554903|588044109|FG000|Overall Study|Physician Decision|2|||
162817365|NCT02554903|588044110|FG001|Overall Study|Physician Decision|2|||
162817366|NCT02554903|588044109|FG000|Overall Study|Heart Transplant|1|||
162817367|NCT02554903|588044110|FG001|Overall Study|Heart Transplant|2|||
162817368|NCT01163721|588044117|FG000|Overall Study|Adverse Event|5|||
162817369|NCT01163721|588044118|FG001|Overall Study|Adverse Event|6|||
162817370|NCT01163721|588044117|FG000|Overall Study|Withdrawal by Subject|3|||
162817371|NCT01163721|588044118|FG001|Overall Study|Withdrawal by Subject|4|||
162817372|NCT01163721|588044117|FG000|Overall Study|Lost to Follow-up|0|||
162817373|NCT01163721|588044118|FG001|Overall Study|Lost to Follow-up|1|||
162817374|NCT01163721|588044117|FG000|Overall Study|Physician Decision|0|||
162817375|NCT01163721|588044118|FG001|Overall Study|Physician Decision|1|||
162817376|NCT00364156|588044122|FG000|Overall Study|Withdrawal by Subject|73|||
162817377|NCT00364156|588044123|FG001|Overall Study|Withdrawal by Subject|80|||
162817378|NCT00364156|588044122|FG000|Overall Study|Protocol Violation|6|||
162817379|NCT00364156|588044123|FG001|Overall Study|Protocol Violation|1|||
162817380|NCT01050205|588044124|FG000|Overall Study|Lost to Follow-up|7|||
162817381|NCT01050205|588044125|FG001|Overall Study|Lost to Follow-up|1|||
162817382|NCT01050205|588044124|FG000|Overall Study|Withdrawal by Subject|1|||
162817383|NCT01050205|588044125|FG001|Overall Study|Withdrawal by Subject|1|||
162817384|NCT01050205|588044124|FG000|Overall Study|Relocated from area|1|||
162817385|NCT01050205|588044125|FG001|Overall Study|Relocated from area|2|||
162817386|NCT01050205|588044124|FG000|Overall Study|Discontinued Intervention|2|||
162817387|NCT01050205|588044125|FG001|Overall Study|Discontinued Intervention|0|||
162817388|NCT01472380|588044126|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
162817389|NCT01472380|588044126|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
162817390|NCT02708095|588044127|FG000|Overall Study|Adverse Event|4|||
162817391|NCT02708095|588044128|FG001|Overall Study|Adverse Event|10|||
162817392|NCT02708095|588044129|FG002|Overall Study|Adverse Event|11|||
162817393|NCT02708095|588044127|FG000|Overall Study|Lack of Efficacy|9|||
162817394|NCT02708095|588044128|FG001|Overall Study|Lack of Efficacy|3|||
162817395|NCT02708095|588044129|FG002|Overall Study|Lack of Efficacy|0|||
162817396|NCT02708095|588044127|FG000|Overall Study|Lost to Follow-up|2|||
162817397|NCT02708095|588044128|FG001|Overall Study|Lost to Follow-up|0|||
162817398|NCT02708095|588044129|FG002|Overall Study|Lost to Follow-up|0|||
162817399|NCT02708095|588044127|FG000|Overall Study|Physician Decision|2|||
162817400|NCT02708095|588044128|FG001|Overall Study|Physician Decision|3|||
162817401|NCT02708095|588044129|FG002|Overall Study|Physician Decision|2|||
162817402|NCT02708095|588044127|FG000|Overall Study|Protocol Violation|0|||
162817403|NCT02708095|588044128|FG001|Overall Study|Protocol Violation|0|||
162817404|NCT02708095|588044129|FG002|Overall Study|Protocol Violation|1|||
162817405|NCT02708095|588044127|FG000|Overall Study|Withdrawal by Subject|5|||
162817406|NCT02708095|588044128|FG001|Overall Study|Withdrawal by Subject|3|||
162817407|NCT02708095|588044129|FG002|Overall Study|Withdrawal by Subject|4|||
162817408|NCT03254485|588044142|FG000|Overall Study|Adverse Event|3|||
162817409|NCT03254485|588044143|FG001|Overall Study|Adverse Event|0|||
162817410|NCT03254485|588044144|FG002|Overall Study|Adverse Event|0|||
162817411|NCT03254485|588044145|FG003|Overall Study|Adverse Event|6|||
162817412|NCT03254485|588044142|FG000|Overall Study|Protocol Violation|6|||
162817413|NCT03254485|588044143|FG001|Overall Study|Protocol Violation|0|||
162817414|NCT03254485|588044144|FG002|Overall Study|Protocol Violation|0|||
162817415|NCT03254485|588044145|FG003|Overall Study|Protocol Violation|2|||
162817416|NCT03254485|588044142|FG000|Overall Study|Withdrawal by Subject|1|||
162817417|NCT03254485|588044143|FG001|Overall Study|Withdrawal by Subject|0|||
162817418|NCT03254485|588044144|FG002|Overall Study|Withdrawal by Subject|0|||
162817419|NCT03254485|588044145|FG003|Overall Study|Withdrawal by Subject|4|||
162817420|NCT03254485|588044142|FG000|Overall Study|Death|0|||
162817421|NCT03254485|588044143|FG001|Overall Study|Death|0|||
162817422|NCT03254485|588044144|FG002|Overall Study|Death|0|||
162817423|NCT03254485|588044145|FG003|Overall Study|Death|1|||
162817424|NCT03254485|588044142|FG000|Overall Study|Lost to Follow-up|1|||
162817425|NCT03254485|588044143|FG001|Overall Study|Lost to Follow-up|0|||
162817426|NCT03254485|588044144|FG002|Overall Study|Lost to Follow-up|0|||
162817427|NCT03254485|588044145|FG003|Overall Study|Lost to Follow-up|0|||
162817428|NCT03254485|588044142|FG000|Overall Study|Other|1|||
162817429|NCT03254485|588044143|FG001|Overall Study|Other|0|||
162817430|NCT03254485|588044144|FG002|Overall Study|Other|0|||
162817431|NCT03254485|588044145|FG003|Overall Study|Other|2|||
162817432|NCT03153111|588044146|FG000|Overall Study|Death|2|||
162817433|NCT03153111|588044147|FG001|Overall Study|Death|5|||
162817434|NCT03153111|588044146|FG000|Overall Study|Lost to Follow-up|1|||
162817435|NCT03153111|588044147|FG001|Overall Study|Lost to Follow-up|0|||
162817436|NCT03153111|588044146|FG000|Overall Study|Physician Decision|5|||
162817437|NCT03153111|588044147|FG001|Overall Study|Physician Decision|1|||
162817438|NCT03153111|588044146|FG000|Overall Study|Withdrawal by Subject|3|||
162817439|NCT03153111|588044147|FG001|Overall Study|Withdrawal by Subject|3|||
162817440|NCT02684357|588044148|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
162817441|NCT02684357|588044149|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
162817442|NCT02684357|588044150|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
162817443|NCT02684357|588044151|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
162817444|NCT02684357|588044152|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
162817445|NCT02684357|588044153|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
162817446|NCT02684357|588044148|FG000|Part A|Lost to Follow-up|0|||
162817447|NCT02684357|588044149|FG001|Part A|Lost to Follow-up|2|||
162817448|NCT02684357|588044150|FG002|Part A|Lost to Follow-up|2|||
162817449|NCT02684357|588044151|FG003|Part A|Lost to Follow-up|0|||
162817450|NCT02684357|588044152|FG004|Part A|Lost to Follow-up|0|||
162817451|NCT02684357|588044153|FG005|Part A|Lost to Follow-up|0|||
162817452|NCT02684357|588044148|FG000|Part A|Withdrawal by Subject|3|||
162817453|NCT02684357|588044149|FG001|Part A|Withdrawal by Subject|0|||
162817454|NCT02684357|588044150|FG002|Part A|Withdrawal by Subject|0|||
162817455|NCT02684357|588044151|FG003|Part A|Withdrawal by Subject|0|||
162817456|NCT02684357|588044152|FG004|Part A|Withdrawal by Subject|0|||
162817457|NCT02684357|588044153|FG005|Part A|Withdrawal by Subject|0|||
162817458|NCT02684357|588044148|FG000|Part A|Other|0|||
162817459|NCT02684357|588044149|FG001|Part A|Other|1|||
162817460|NCT02684357|588044150|FG002|Part A|Other|0|||
162817461|NCT02684357|588044151|FG003|Part A|Other|0|||
162817462|NCT02684357|588044152|FG004|Part A|Other|0|||
162817463|NCT02684357|588044153|FG005|Part A|Other|0|||
162817464|NCT02684357|588044148|FG000|Part B|Adverse Event (Other)|0|||
162817465|NCT02684357|588044149|FG001|Part B|Adverse Event (Other)|0|||
162817466|NCT02684357|588044150|FG002|Part B|Adverse Event (Other)|0|||
162817467|NCT02684357|588044151|FG003|Part B|Adverse Event (Other)|1|||
162817468|NCT02684357|588044152|FG004|Part B|Adverse Event (Other)|1|||
162817469|NCT02684357|588044153|FG005|Part B|Adverse Event (Other)|1|||
162817470|NCT02684357|588044148|FG000|Part B|Lost to Follow-up|0|||
162817471|NCT02684357|588044149|FG001|Part B|Lost to Follow-up|0|||
162817472|NCT02684357|588044150|FG002|Part B|Lost to Follow-up|0|||
162817473|NCT02684357|588044151|FG003|Part B|Lost to Follow-up|1|||
162817474|NCT02684357|588044152|FG004|Part B|Lost to Follow-up|1|||
162817475|NCT02684357|588044153|FG005|Part B|Lost to Follow-up|7|||
162817476|NCT02684357|588044148|FG000|Part B|Withdrawal by Subject|0|||
162817477|NCT02684357|588044149|FG001|Part B|Withdrawal by Subject|0|||
162817478|NCT02684357|588044150|FG002|Part B|Withdrawal by Subject|0|||
162817479|NCT02684357|588044151|FG003|Part B|Withdrawal by Subject|0|||
162817480|NCT02684357|588044152|FG004|Part B|Withdrawal by Subject|2|||
162817481|NCT02684357|588044153|FG005|Part B|Withdrawal by Subject|4|||
162817482|NCT02684357|588044148|FG000|Part B|Other|0|||
162817483|NCT02684357|588044149|FG001|Part B|Other|0|||
163166214|NCT00588861|589325610|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
162817484|NCT02684357|588044150|FG002|Part B|Other|0|||
162817485|NCT02684357|588044151|FG003|Part B|Other|1|||
162817486|NCT02684357|588044152|FG004|Part B|Other|0|||
162817487|NCT02684357|588044153|FG005|Part B|Other|1|||
162817488|NCT01853982|588044154|FG000|Overall Study|Withdrawal by Subject|1|||
162817489|NCT01853982|588044155|FG001|Overall Study|Withdrawal by Subject|0|||
162817490|NCT01853982|588044154|FG000|Overall Study|Death|1|||
162817491|NCT01853982|588044155|FG001|Overall Study|Death|0|||
162817492|NCT01853982|588044154|FG000|Overall Study|Lost to Follow-up|0|||
162817493|NCT01853982|588044155|FG001|Overall Study|Lost to Follow-up|1|||
162817494|NCT00390910|588044156|FG000|Overall Study|Adverse Event|1|||
162817495|NCT00390910|588044157|FG001|Overall Study|Adverse Event|0|||
162817496|NCT00390910|588044158|FG002|Overall Study|Adverse Event|0|||
162817497|NCT00390910|588044156|FG000|Overall Study|Lost to Follow-up|0|||
162817498|NCT00390910|588044157|FG001|Overall Study|Lost to Follow-up|1|||
162817499|NCT00390910|588044158|FG002|Overall Study|Lost to Follow-up|5|||
162817500|NCT00390910|588044156|FG000|Overall Study|Withdrawal by Subject|1|||
162817501|NCT00390910|588044157|FG001|Overall Study|Withdrawal by Subject|3|||
162817502|NCT00390910|588044158|FG002|Overall Study|Withdrawal by Subject|2|||
162817503|NCT00390910|588044156|FG000|Overall Study|Migrated/moved from study area|0|||
162817504|NCT00390910|588044157|FG001|Overall Study|Migrated/moved from study area|0|||
162817505|NCT00390910|588044158|FG002|Overall Study|Migrated/moved from study area|3|||
162817506|NCT05066724|588044160|FG000|Overall Study|Adverse Event|1|||
162817507|NCT05066724|588044160|FG000|Overall Study|Non-Compliance With Study Drug|5|||
162817508|NCT05066724|588044160|FG000|Overall Study|Withdrawal by Subject|6|||
162817509|NCT05066724|588044160|FG000|Overall Study|Physician Decision|2|||
162817510|NCT01422850|588044161|FG000|Overall Study|Physician Decision|3|||
162817511|NCT02244996|588044163|FG000|Overall Study|Lack of Efficacy|2|||
162817512|NCT02244996|588044164|FG001|Overall Study|Lack of Efficacy|6|||
162817513|NCT06071754|588044166|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
162817514|NCT03226275|588044167|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
162817515|NCT03226275|588044168|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
162817516|NCT03226275|588044169|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
162817517|NCT03226275|588044170|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
162817518|NCT03226275|588044167|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
162817519|NCT03226275|588044168|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
162817520|NCT03226275|588044169|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
162817521|NCT03226275|588044170|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
162817522|NCT01436071|588045579|FG000|Overall Study|Adverse Event|1|||
162817523|NCT01436071|588045580|FG001|Overall Study|Adverse Event|0|||
162817524|NCT01436071|588045579|FG000|Overall Study|Lack of Efficacy|16|||
162817525|NCT01436071|588045580|FG001|Overall Study|Lack of Efficacy|7|||
162817526|NCT01436071|588045579|FG000|Overall Study|Protocol Violation|0|||
162817527|NCT01436071|588045580|FG001|Overall Study|Protocol Violation|1|||
162817528|NCT01436071|588045579|FG000|Overall Study|Lost to Follow-up|3|||
162817529|NCT01436071|588045580|FG001|Overall Study|Lost to Follow-up|1|||
162817530|NCT01436071|588045579|FG000|Overall Study|Physician Decision|1|||
162817531|NCT01436071|588045580|FG001|Overall Study|Physician Decision|0|||
162817532|NCT01436071|588045579|FG000|Overall Study|Withdrawal by Subject|2|||
162817533|NCT01436071|588045580|FG001|Overall Study|Withdrawal by Subject|2|||
162817534|NCT01436071|588045579|FG000|Overall Study|Did Not Receive Trial Medication|3|||
162817535|NCT01436071|588045580|FG001|Overall Study|Did Not Receive Trial Medication|3|||
162817536|NCT00352885|588045583|FG000|Overall Study|Withdrawal by Subject|0|||
162817537|NCT00352885|588045584|FG001|Overall Study|Withdrawal by Subject|3|||
162817538|NCT00352885|588045583|FG000|Overall Study|Development of major depression|0|||
162817539|NCT00352885|588045584|FG001|Overall Study|Development of major depression|1|||
162817540|NCT00352885|588045583|FG000|Overall Study|Progression of metastatic melanoma|5|||
162817541|NCT00352885|588045584|FG001|Overall Study|Progression of metastatic melanoma|3|||
162817542|NCT00352885|588045583|FG000|Overall Study|Side effects of IL-2 administration|1|||
162817543|NCT00352885|588045584|FG001|Overall Study|Side effects of IL-2 administration|0|||
162817544|NCT01920594|588045585|FG000|Overall Study|Adverse Event|4|||
162817545|NCT01920594|588045586|FG001|Overall Study|Adverse Event|2|||
162817546|NCT01920594|588045585|FG000|Overall Study|Lost to Follow-up|1|||
162817547|NCT01920594|588045586|FG001|Overall Study|Lost to Follow-up|0|||
162817548|NCT01920594|588045585|FG000|Overall Study|Recovery|2|||
162817549|NCT01920594|588045586|FG001|Overall Study|Recovery|0|||
162817550|NCT01920594|588045585|FG000|Overall Study|Investigator discretion|0|||
162817551|NCT01920594|588045586|FG001|Overall Study|Investigator discretion|1|||
162817552|NCT01096342|588045587|FG000|Overall Study|Protocol Violation|1|||
162817553|NCT04906616|588045588|FG000|Overall Study|Divorce|3|||
162817554|NCT04906616|588045589|FG001|Overall Study|Divorce|2|||
163166215|NCT00588861|589325611|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
162817555|NCT01521897|588045590|FG000|Overall Study|Protocol Violation|18|||
162817556|NCT01521897|588045590|FG000|Overall Study|Lost to Follow-up|5|||
162817557|NCT00385203|588045591|FG000|Overall Study|Adverse Event|5|||
162817558|NCT00385203|588045592|FG001|Overall Study|Adverse Event|4|||
162817559|NCT00385203|588045591|FG000|Overall Study|Death|1|||
162817560|NCT00385203|588045592|FG001|Overall Study|Death|0|||
162817561|NCT00385203|588045591|FG000|Overall Study|Condition under investigation worsened|18|||
162817562|NCT00385203|588045592|FG001|Overall Study|Condition under investigation worsened|3|||
162817563|NCT00385203|588045591|FG000|Overall Study|Incorrect enrollment|2|||
162817564|NCT00385203|588045592|FG001|Overall Study|Incorrect enrollment|0|||
162817565|NCT02194062|588045593|FG000|Overall Study|Lost to Follow-up|2|||
162817566|NCT02194062|588045594|FG001|Overall Study|Lost to Follow-up|2|||
162817567|NCT02194062|588045595|FG002|Overall Study|Lost to Follow-up|5|||
162817568|NCT03422172|588045596|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
162817569|NCT03422172|588045596|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
162817570|NCT03422172|588045596|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
162817571|NCT04147234|588045597|FG000|Overall Study|Clinical deterioration|0|||
162817572|NCT04147234|588045598|FG001|Overall Study|Clinical deterioration|0|||
162817573|NCT04147234|588045599|FG002|Overall Study|Clinical deterioration|1|||
162817574|NCT04147234|588045600|FG003|Overall Study|Clinical deterioration|0|||
162817575|NCT04147234|588045601|FG004|Overall Study|Clinical deterioration|0|||
162817576|NCT04147234|588045602|FG005|Overall Study|Clinical deterioration|0|||
162817577|NCT04147234|588045603|FG006|Overall Study|Clinical deterioration|0|||
162817578|NCT04147234|588045597|FG000|Overall Study|Withdrawal by Subject|0|||
162817579|NCT04147234|588045598|FG001|Overall Study|Withdrawal by Subject|1|||
162817580|NCT04147234|588045599|FG002|Overall Study|Withdrawal by Subject|1|||
162817581|NCT04147234|588045600|FG003|Overall Study|Withdrawal by Subject|0|||
162817582|NCT04147234|588045601|FG004|Overall Study|Withdrawal by Subject|0|||
162817583|NCT04147234|588045602|FG005|Overall Study|Withdrawal by Subject|0|||
162817584|NCT04147234|588045603|FG006|Overall Study|Withdrawal by Subject|0|||
162817585|NCT04147234|588045597|FG000|Overall Study|Clinical disease progression|1|||
162817586|NCT04147234|588045598|FG001|Overall Study|Clinical disease progression|3|||
162817587|NCT04147234|588045599|FG002|Overall Study|Clinical disease progression|1|||
162817588|NCT04147234|588045600|FG003|Overall Study|Clinical disease progression|1|||
162817589|NCT04147234|588045601|FG004|Overall Study|Clinical disease progression|0|||
162817590|NCT04147234|588045602|FG005|Overall Study|Clinical disease progression|1|||
162817591|NCT04147234|588045603|FG006|Overall Study|Clinical disease progression|0|||
162817592|NCT04147234|588045597|FG000|Overall Study|Objective disease progression|6|||
162817593|NCT04147234|588045598|FG001|Overall Study|Objective disease progression|4|||
162817594|NCT04147234|588045599|FG002|Overall Study|Objective disease progression|3|||
162817595|NCT04147234|588045600|FG003|Overall Study|Objective disease progression|3|||
162817596|NCT04147234|588045601|FG004|Overall Study|Objective disease progression|5|||
162817597|NCT04147234|588045602|FG005|Overall Study|Objective disease progression|2|||
162817598|NCT04147234|588045603|FG006|Overall Study|Objective disease progression|3|||
162817599|NCT04147234|588045597|FG000|Overall Study|Adverse Event|0|||
162817600|NCT04147234|588045598|FG001|Overall Study|Adverse Event|0|||
162817601|NCT04147234|588045599|FG002|Overall Study|Adverse Event|0|||
162817602|NCT04147234|588045600|FG003|Overall Study|Adverse Event|0|||
162817603|NCT04147234|588045601|FG004|Overall Study|Adverse Event|1|||
162817604|NCT04147234|588045602|FG005|Overall Study|Adverse Event|0|||
162817605|NCT04147234|588045603|FG006|Overall Study|Adverse Event|0|||
162817606|NCT00293722|588045612|FG000|Overall Study|Other|427|||
162817607|NCT04498169|588045617|FG000|Study Completion|Adverse Event|1|||
162817608|NCT04498169|588045618|FG001|Study Completion|Adverse Event|1|||
162817609|NCT01754857|588045619|FG000|Overall Study|Adverse Event|7|||
162817610|NCT01754857|588045619|FG000|Overall Study|Disease progression|3|||
162817611|NCT01754857|588045619|FG000|Overall Study|Physician Decision|2|||
162817612|NCT01754857|588045619|FG000|Overall Study|Withdrawal by Subject|3|||
162817613|NCT01754857|588045619|FG000|Overall Study|other complicating disease|1|||
162817614|NCT01754857|588045619|FG000|Overall Study|ineligible to continue onto maintenance|1|||
162817615|NCT01754857|588045619|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
162817616|NCT01754857|588045619|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
162817617|NCT04964960|588045620|FG000|Overall Study|Withdrawal by Subject|1|||
162817618|NCT04964960|588045620|FG000|Overall Study|Did not complete cycles|1|||
162817619|NCT02960854|588045623|FG000|Overall Study|Not Disclosed|2|||
162817620|NCT02960854|588045624|FG001|Overall Study|Not Disclosed|2|||
162817621|NCT02960854|588045623|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
162817622|NCT02960854|588045624|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
162817623|NCT02960854|588045623|FG000|Overall Study|Subject Withdrew Consent|0|||
162817624|NCT02960854|588045624|FG001|Overall Study|Subject Withdrew Consent|1|||
163166216|NCT00588861|589325610|FG000|6 Months|Patients did not return for follow-up|98|||
162817625|NCT02960854|588045623|FG000|Overall Study|Death|4|||
162817626|NCT02960854|588045624|FG001|Overall Study|Death|6|||
163166217|NCT00588861|589325611|FG001|6 Months|Patients did not return for follow-up|73|||
162817627|NCT00221195|588045625|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
162817628|NCT00221195|588045626|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
162817629|NCT00221195|588045625|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
162817630|NCT00221195|588045626|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
162817631|NCT00221195|588045625|FG000|Washout Period (Months 7-9)|Death|0|||
162817632|NCT00221195|588045626|FG001|Washout Period (Months 7-9)|Death|1|||
162817633|NCT00221195|588045625|FG000|Therapy 2 (Months 10-15)|Death|1|||
162817634|NCT00221195|588045626|FG001|Therapy 2 (Months 10-15)|Death|0|||
163166218|NCT00588861|589325610|FG000|1 Year|Patients did not return for follow-up|89|||
162817635|NCT00221195|588045625|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
162817636|NCT00221195|588045626|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
162817637|NCT01383161|588045628|FG000|Overall Study|Adverse Event|5|||
162817638|NCT01383161|588045629|FG001|Overall Study|Adverse Event|1|||
162817639|NCT01383161|588045628|FG000|Overall Study|Withdrawal by Subject|0|||
162817640|NCT01383161|588045629|FG001|Overall Study|Withdrawal by Subject|2|||
162817641|NCT01383161|588045628|FG000|Overall Study|Lack of Efficacy|0|||
162817642|NCT01383161|588045629|FG001|Overall Study|Lack of Efficacy|1|||
162817643|NCT00833911|588045630|FG000|Titration|Adverse Event|18|||
162817644|NCT00833911|588045630|FG000|Titration|Withdrawal by Subject|3|||
162817645|NCT00833911|588045630|FG000|Maintenance Phase I|Adverse Event|73|||
162817646|NCT00833911|588045630|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
162817647|NCT00833911|588045630|FG000|Maintenance Phase I|Physician Decision|10|||
162817648|NCT00833911|588045630|FG000|Maintenance Phase I|Lack of Efficacy|4|||
162817649|NCT00833911|588045630|FG000|Maintenance Phase II|Adverse Event|6|||
162817650|NCT00833911|588045630|FG000|Maintenance Phase II|Physician Decision|2|||
162817651|NCT00833911|588045630|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
162817652|NCT00833911|588045630|FG000|Maintenance Phase II|Lack of Efficacy|1|||
162817653|NCT01423812|588045637|FG000|Overall Study|Lost to Follow-up|2|||
162817654|NCT01423812|588045638|FG001|Overall Study|Lost to Follow-up|2|||
162817655|NCT01423812|588045637|FG000|Overall Study|Withdrawal by Subject|1|||
162817656|NCT01423812|588045638|FG001|Overall Study|Withdrawal by Subject|2|||
162817657|NCT04464265|588045639|FG000|Overall Study|Physician Decision|2|||
162817658|NCT01862640|588045645|FG000|Overall Study|Adverse Event|4|||
162817659|NCT01862640|588045646|FG001|Overall Study|Adverse Event|10|||
162817660|NCT01862640|588045647|FG002|Overall Study|Adverse Event|6|||
162817661|NCT01862640|588045648|FG003|Overall Study|Adverse Event|8|||
162817662|NCT01862640|588045645|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
162817663|NCT01862640|588045646|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
162817664|NCT01862640|588045647|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
162817665|NCT01862640|588045648|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
162817666|NCT01862640|588045645|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
162817667|NCT01862640|588045646|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
162817668|NCT01862640|588045647|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
162817669|NCT01862640|588045648|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
162817670|NCT01862640|588045645|FG000|Overall Study|Withdrawal by Subject|2|||
162817671|NCT01862640|588045646|FG001|Overall Study|Withdrawal by Subject|4|||
162817672|NCT01862640|588045647|FG002|Overall Study|Withdrawal by Subject|8|||
162817673|NCT01862640|588045648|FG003|Overall Study|Withdrawal by Subject|5|||
162817674|NCT01862640|588045645|FG000|Overall Study|Protocol Deviation|0|||
162817675|NCT01862640|588045646|FG001|Overall Study|Protocol Deviation|0|||
162817676|NCT01862640|588045647|FG002|Overall Study|Protocol Deviation|1|||
162817677|NCT01862640|588045648|FG003|Overall Study|Protocol Deviation|0|||
162817678|NCT02178553|588045651|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
162817679|NCT02178553|588045652|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
162817680|NCT02178553|588045651|FG000|Overall Study|Physician Decision|0|||
162817681|NCT02178553|588045652|FG001|Overall Study|Physician Decision|4|||
162817682|NCT02178553|588045651|FG000|Overall Study|Technical problem with injection|1|||
162817683|NCT02178553|588045652|FG001|Overall Study|Technical problem with injection|3|||
162817684|NCT01699789|588045653|FG000|Overall Study|Withdrawal by Subject|18|||
162817685|NCT01699789|588045654|FG001|Overall Study|Withdrawal by Subject|23|||
162817686|NCT01699789|588045653|FG000|Overall Study|Death|1|||
162817687|NCT01699789|588045654|FG001|Overall Study|Death|2|||
162817688|NCT01699789|588045653|FG000|Overall Study|Lost to Follow-up|83|||
162817689|NCT01699789|588045654|FG001|Overall Study|Lost to Follow-up|101|||
163166219|NCT00588861|589325611|FG001|1 Year|Patients did not return for follow-up|82|||
163166220|NCT00588861|589325610|FG000|2 Years|Patients did not return for follow-up|92|||
163166221|NCT00588861|589325611|FG001|2 Years|Patients did not return for follow-up|87|||
163166222|NCT00588861|589325610|FG000|4 Years|Patients did not return for follow-up|91|||
163166223|NCT00588861|589325611|FG001|4 Years|Patients did not return for follow-up|103|||
163166224|NCT00588861|589325610|FG000|6 Years|Patients did not return for follow-up|104|||
163166225|NCT00588861|589325611|FG001|6 Years|Patients did not return for follow-up|109|||
163166226|NCT00588861|589325610|FG000|8 Years|Patients did not return for follow-up|105|||
163166227|NCT00588861|589325611|FG001|8 Years|Patients did not return for follow-up|114|||
162817690|NCT00639223|588045655|FG000|Overall Study|Lost to Follow-up|0|||
162817691|NCT00639223|588045656|FG001|Overall Study|Lost to Follow-up|2|||
162817692|NCT02511678|588045659|FG000|Overall Study|Withdrawal by Subject|2|||
163166228|NCT00588861|589325610|FG000|10 Years|Incomplete due to study termination|107|||
163166229|NCT00588861|589325611|FG001|10 Years|Incomplete due to study termination|114|||
162817693|NCT02511678|588045659|FG000|Overall Study|Lost to Follow-up|4|||
163166230|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
162817694|NCT02511678|588045659|FG000|Overall Study|Death|19|||
162817695|NCT02511678|588045659|FG000|Overall Study|Adverse Event|1|||
162817696|NCT02511678|588045659|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
163166231|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
163166232|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
163166233|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
163166234|NCT00490529|589325616|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
163166235|NCT00490529|589325616|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
163166236|NCT01129583|589325617|FG000|Overall Study|Death|1|||
163166237|NCT01129583|589325618|FG001|Overall Study|Death|0|||
163166238|NCT01129583|589325617|FG000|Overall Study|Lost to Follow-up|1|||
163166239|NCT01129583|589325618|FG001|Overall Study|Lost to Follow-up|1|||
163166240|NCT01129583|589325617|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
163166241|NCT01129583|589325618|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
163166242|NCT02617485|589325631|FG000|Treatment and Observation Period|Adverse Event|9|||
163166243|NCT02617485|589325632|FG001|Treatment and Observation Period|Adverse Event|1|||
163166244|NCT02617485|589325631|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
163166245|NCT02617485|589325632|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
163166246|NCT02617485|589325631|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
163166247|NCT02617485|589325632|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
163166248|NCT02617485|589325631|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
163166249|NCT02617485|589325632|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
163166250|NCT02617485|589325631|FG000|Treatment and Observation Period|Physician Decision|0|||
163166251|NCT02617485|589325632|FG001|Treatment and Observation Period|Physician Decision|1|||
163166252|NCT02617485|589325631|FG000|Follow-up Period|Adverse Event|1|||
163166253|NCT02617485|589325632|FG001|Follow-up Period|Adverse Event|0|||
163166254|NCT02617485|589325631|FG000|Follow-up Period|Withdrawal by Subject|1|||
163166255|NCT02617485|589325632|FG001|Follow-up Period|Withdrawal by Subject|0|||
163166256|NCT02617485|589325631|FG000|Follow-up Period|Disease progression|2|||
163166257|NCT02617485|589325632|FG001|Follow-up Period|Disease progression|1|||
163166258|NCT02617485|589325631|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
163166259|NCT02617485|589325632|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
163166260|NCT02617485|589325631|FG000|Follow-up Period|Patient needed radiotherapy|9|||
163166261|NCT02617485|589325632|FG001|Follow-up Period|Patient needed radiotherapy|5|||
163166262|NCT02617485|589325631|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
163166263|NCT02617485|589325632|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
163166264|NCT00791076|589325633|FG000|Overall Study|Study was terminated,PI left institution|8|||
163166265|NCT00669409|589325635|FG000|Part 2|Withdrawal by Subject|0|||
162817697|NCT02511678|588045659|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
162817698|NCT02511678|588045659|FG000|Overall Study|Required Radiofrequency Ablation|1|||
162817699|NCT02511678|588045659|FG000|Overall Study|Biopsy was Negative|1|||
163166266|NCT00669409|589325636|FG001|Part 2|Withdrawal by Subject|0|||
163166267|NCT00669409|589325637|FG002|Part 2|Withdrawal by Subject|0|||
163166268|NCT00669409|589325638|FG003|Part 2|Withdrawal by Subject|0|||
163166269|NCT00669409|589325639|FG004|Part 2|Withdrawal by Subject|0|||
163166270|NCT00669409|589325640|FG005|Part 2|Withdrawal by Subject|0|||
163166271|NCT00669409|589325641|FG006|Part 2|Withdrawal by Subject|0|||
163166272|NCT00669409|589325642|FG007|Part 2|Withdrawal by Subject|0|||
163166273|NCT00669409|589325643|FG008|Part 2|Withdrawal by Subject|0|||
163166274|NCT00669409|589325644|FG009|Part 2|Withdrawal by Subject|1|||
163166275|NCT00669409|589325645|FG010|Part 2|Withdrawal by Subject|0|||
163166276|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166277|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166278|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
163166279|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
163166280|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
163166281|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
163166282|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
163166283|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
163166284|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
163166285|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166286|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166287|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166288|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166289|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
162817700|NCT02511678|588045659|FG000|Overall Study|Protocol Violation|1|||
162817701|NCT02511678|588045659|FG000|Overall Study|Received Radiation Treatment|1|||
162817702|NCT01295281|588045662|FG000|First Intervention (7 Days)|Death|0|||
163166290|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166291|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166292|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
163166293|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
163166294|NCT00095940|589325648|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
162817703|NCT01295281|588045663|FG001|First Intervention (7 Days)|Death|1|||
162817704|NCT00292461|588045664|FG000|Overall Study|Adverse Event|4|||
162817705|NCT00292461|588045665|FG001|Overall Study|Adverse Event|2|||
162817706|NCT00292461|588045664|FG000|Overall Study|Lack of Efficacy|1|||
162817707|NCT00292461|588045665|FG001|Overall Study|Lack of Efficacy|0|||
162817708|NCT00292461|588045664|FG000|Overall Study|Withdrawal by Subject|0|||
162817709|NCT00292461|588045665|FG001|Overall Study|Withdrawal by Subject|1|||
162817710|NCT00292461|588045664|FG000|Overall Study|Protocol Violation|4|||
162817711|NCT00292461|588045665|FG001|Overall Study|Protocol Violation|3|||
162817712|NCT00292461|588045664|FG000|Overall Study|Lost to Follow-up|1|||
162817713|NCT00292461|588045665|FG001|Overall Study|Lost to Follow-up|0|||
162817714|NCT00633061|588045670|FG000|Overall Study|Study closed|86|||
162817715|NCT00633061|588045671|FG001|Overall Study|Study closed|0|||
162817716|NCT02000427|588045672|FG000|Overall Study|Death|22|||
162817717|NCT05125679|588045675|FG000|Overall Study|Study Terminated by Sponsor|2|||
162817718|NCT05125679|588045676|FG001|Overall Study|Study Terminated by Sponsor|5|||
162817719|NCT06268288|588045681|FG000|Overall Study|Withdrawal by Subject|1|||
162817720|NCT06268288|588045682|FG001|Overall Study|Withdrawal by Subject|2|||
162817721|NCT03049735|588045683|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
162817722|NCT03049735|588045684|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
162817723|NCT03049735|588045685|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
162817724|NCT03049735|588045683|FG000|Overall Study|Other|5|||
162817725|NCT03049735|588045684|FG001|Overall Study|Other|3|||
162817726|NCT03049735|588045685|FG002|Overall Study|Other|1|||
162817727|NCT03049735|588045683|FG000|Overall Study|Lack of Efficacy|4|||
162817728|NCT03049735|588045684|FG001|Overall Study|Lack of Efficacy|0|||
162817729|NCT03049735|588045685|FG002|Overall Study|Lack of Efficacy|3|||
162817730|NCT03049735|588045683|FG000|Overall Study|Protocol deviation|1|||
162817731|NCT03049735|588045684|FG001|Overall Study|Protocol deviation|0|||
162817732|NCT03049735|588045685|FG002|Overall Study|Protocol deviation|0|||
163166295|NCT00095940|589325649|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166296|NCT00095940|589325650|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
162817733|NCT03049735|588045683|FG000|Overall Study|Pregnancy|0|||
162817734|NCT03049735|588045684|FG001|Overall Study|Pregnancy|0|||
162817735|NCT03049735|588045685|FG002|Overall Study|Pregnancy|1|||
162817736|NCT03049735|588045683|FG000|Overall Study|Adverse Event|7|||
162817737|NCT03049735|588045684|FG001|Overall Study|Adverse Event|18|||
162817738|NCT03049735|588045685|FG002|Overall Study|Adverse Event|5|||
162817739|NCT03049735|588045683|FG000|Overall Study|Withdrawal by Subject|10|||
162817740|NCT03049735|588045684|FG001|Overall Study|Withdrawal by Subject|3|||
162817741|NCT03049735|588045685|FG002|Overall Study|Withdrawal by Subject|7|||
162817742|NCT03049735|588045683|FG000|Overall Study|Lost to Follow-up|1|||
162817743|NCT03049735|588045684|FG001|Overall Study|Lost to Follow-up|5|||
162817744|NCT03049735|588045685|FG002|Overall Study|Lost to Follow-up|5|||
162817745|NCT02146326|588045686|FG000|Overall Study|Lost to Follow-up|3|||
162817746|NCT02146326|588045687|FG001|Overall Study|Lost to Follow-up|3|||
162817747|NCT02146326|588045688|FG002|Overall Study|Lost to Follow-up|11|||
162817748|NCT02146326|588045689|FG003|Overall Study|Lost to Follow-up|19|||
162817749|NCT02146326|588045686|FG000|Overall Study|Withdrawal by Subject|2|||
163166297|NCT00095940|589325651|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166298|NCT00095940|589325652|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166299|NCT00095940|589325653|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166300|NCT00095940|589325654|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
162817750|NCT02146326|588045687|FG001|Overall Study|Withdrawal by Subject|1|||
162817751|NCT02146326|588045688|FG002|Overall Study|Withdrawal by Subject|15|||
162817752|NCT02146326|588045689|FG003|Overall Study|Withdrawal by Subject|11|||
162817753|NCT02146326|588045686|FG000|Overall Study|Separated from mental health center|23|||
163166301|NCT00095940|589325655|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
163166302|NCT00095940|589325656|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
163166303|NCT01874340|589325659|FG000|Overall Study|Study terminated by Sponsor|6|||
162817754|NCT02146326|588045687|FG001|Overall Study|Separated from mental health center|33|||
162817755|NCT02146326|588045688|FG002|Overall Study|Separated from mental health center|0|||
162817756|NCT02146326|588045689|FG003|Overall Study|Separated from mental health center|0|||
162817757|NCT02146326|588045686|FG000|Overall Study|Incarcerated|0|||
162817758|NCT02146326|588045687|FG001|Overall Study|Incarcerated|0|||
162817759|NCT02146326|588045688|FG002|Overall Study|Incarcerated|3|||
162817760|NCT02146326|588045689|FG003|Overall Study|Incarcerated|8|||
162817761|NCT02146326|588045686|FG000|Overall Study|Death|0|||
162817762|NCT02146326|588045687|FG001|Overall Study|Death|0|||
163166304|NCT01874340|589325660|FG001|Overall Study|Study terminated by Sponsor|8|||
162817763|NCT02146326|588045688|FG002|Overall Study|Death|4|||
163166305|NCT01874340|589325661|FG002|Overall Study|Study terminated by Sponsor|8|||
163166306|NCT01874340|589325662|FG003|Overall Study|Study terminated by Sponsor|4|||
163166307|NCT01874340|589325659|FG000|Overall Study|Withdrawal by Subject|0|||
163166308|NCT01874340|589325660|FG001|Overall Study|Withdrawal by Subject|0|||
163166309|NCT01874340|589325661|FG002|Overall Study|Withdrawal by Subject|0|||
163166310|NCT01874340|589325662|FG003|Overall Study|Withdrawal by Subject|1|||
163166311|NCT01716052|589325663|FG000|Overall Study|Withdrawal of funding|1|||
163166312|NCT01716052|589325664|FG001|Overall Study|Withdrawal of funding|1|||
163166313|NCT02864862|589325670|FG000|Overall Study|Lost to Follow-up|1|||
163166314|NCT02864862|589325671|FG001|Overall Study|Lost to Follow-up|0|||
163166315|NCT02864862|589325672|FG002|Overall Study|Lost to Follow-up|1|||
163166316|NCT02864862|589325670|FG000|Overall Study|Protocol Violation|0|||
163166317|NCT02864862|589325671|FG001|Overall Study|Protocol Violation|0|||
163166318|NCT02864862|589325672|FG002|Overall Study|Protocol Violation|1|||
163166319|NCT01523275|589325676|FG000|Overall Study|Lost to Follow-up|1|||
163166320|NCT01523275|589325677|FG001|Overall Study|Lost to Follow-up|2|||
163166321|NCT01523275|589325676|FG000|Overall Study|Withdrawal by Subject|1|||
163166322|NCT01523275|589325677|FG001|Overall Study|Withdrawal by Subject|0|||
163166323|NCT03263702|589325678|FG000|Overall Study|Lost to Follow-up|2|||
163166324|NCT03263702|589325679|FG001|Overall Study|Lost to Follow-up|2|||
163166325|NCT03263702|589325678|FG000|Overall Study|Withdrawal by Subject|1|||
163166326|NCT03263702|589325679|FG001|Overall Study|Withdrawal by Subject|2|||
163166327|NCT03598114|589325680|FG000|Overall Study|Staff turnover/left the program|3|||
163166328|NCT03598114|589325681|FG001|Overall Study|Staff turnover/left the program|39|||
163166329|NCT02527200|589325682|FG000|Overall Study|Withdrawal by Subject|3|||
163166330|NCT02527200|589325683|FG001|Overall Study|Withdrawal by Subject|2|||
163166331|NCT02527200|589325684|FG002|Overall Study|Withdrawal by Subject|1|||
163166332|NCT02527200|589325685|FG003|Overall Study|Withdrawal by Subject|0|||
163166333|NCT02527200|589325682|FG000|Overall Study|Unclassified|0|||
163166334|NCT02527200|589325683|FG001|Overall Study|Unclassified|1|||
163166335|NCT02527200|589325684|FG002|Overall Study|Unclassified|0|||
162817764|NCT02146326|588045689|FG003|Overall Study|Death|4|||
162817765|NCT02146326|588045686|FG000|Overall Study|Unable to complete interview|0|||
162817766|NCT02146326|588045687|FG001|Overall Study|Unable to complete interview|0|||
162817767|NCT02146326|588045688|FG002|Overall Study|Unable to complete interview|10|||
162817768|NCT02146326|588045689|FG003|Overall Study|Unable to complete interview|6|||
162817769|NCT00777946|588045692|FG000|Overall Study|Adverse Event|11|||
162817770|NCT00777946|588045693|FG001|Overall Study|Adverse Event|1|||
162817771|NCT00777946|588045694|FG002|Overall Study|Adverse Event|3|||
162817772|NCT00777946|588045692|FG000|Overall Study|Lack of Efficacy|0|||
162817773|NCT00777946|588045693|FG001|Overall Study|Lack of Efficacy|0|||
162817774|NCT00777946|588045694|FG002|Overall Study|Lack of Efficacy|9|||
162817775|NCT00777946|588045692|FG000|Overall Study|Condition no longer required study drug|1|||
162817776|NCT00777946|588045693|FG001|Overall Study|Condition no longer required study drug|0|||
162817777|NCT00777946|588045694|FG002|Overall Study|Condition no longer required study drug|0|||
162817778|NCT00777946|588045692|FG000|Overall Study|Patient withdrew consent|3|||
162817779|NCT00777946|588045693|FG001|Overall Study|Patient withdrew consent|2|||
162817780|NCT00777946|588045694|FG002|Overall Study|Patient withdrew consent|3|||
162817781|NCT00777946|588045692|FG000|Overall Study|Lost to Follow-up|3|||
162817782|NCT00777946|588045693|FG001|Overall Study|Lost to Follow-up|1|||
162817783|NCT00777946|588045694|FG002|Overall Study|Lost to Follow-up|0|||
162817784|NCT00777946|588045692|FG000|Overall Study|Protocol deviation|2|||
162817785|NCT00777946|588045693|FG001|Overall Study|Protocol deviation|1|||
162817786|NCT00777946|588045694|FG002|Overall Study|Protocol deviation|1|||
162817787|NCT00777946|588045692|FG000|Overall Study|Randomized in error|1|||
162817788|NCT00777946|588045693|FG001|Overall Study|Randomized in error|1|||
162817789|NCT00777946|588045694|FG002|Overall Study|Randomized in error|0|||
163166336|NCT02527200|589325685|FG003|Overall Study|Unclassified|0|||
163166337|NCT02527200|589325682|FG000|Overall Study|Lost to Follow-up|0|||
163166338|NCT02527200|589325683|FG001|Overall Study|Lost to Follow-up|0|||
163166339|NCT02527200|589325684|FG002|Overall Study|Lost to Follow-up|1|||
162817790|NCT04821869|588045706|FG000|Overall Study|Adverse Event|4|||
162817791|NCT04821869|588045706|FG000|Overall Study|Withdrawal by Subject|2|||
162817792|NCT04821869|588045706|FG000|Overall Study|Did not meet FEV1 criteria|1|||
162817793|NCT01313117|588045710|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
163166340|NCT02527200|589325685|FG003|Overall Study|Lost to Follow-up|0|||
163166341|NCT00966875|589325686|FG000|Part A|Adverse Event|2|||
163166342|NCT00966875|589325687|FG001|Part A|Adverse Event|1|||
163166343|NCT00966875|589325688|FG002|Part A|Adverse Event|0|||
163166344|NCT00966875|589325689|FG003|Part A|Adverse Event|1|||
163166345|NCT00966875|589325690|FG004|Part A|Adverse Event|0|||
162817794|NCT01313117|588045710|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
162817795|NCT03602261|588045711|FG000|Overall Study|Adverse Event|5|||
163166346|NCT00966875|589325691|FG005|Part A|Adverse Event|1|||
162817796|NCT03602261|588045712|FG001|Overall Study|Adverse Event|1|||
162817797|NCT03602261|588045711|FG000|Overall Study|Physician Decision|1|||
162817798|NCT03602261|588045712|FG001|Overall Study|Physician Decision|0|||
163166347|NCT00966875|589325692|FG006|Part A|Adverse Event|0|||
163166348|NCT00966875|589325693|FG007|Part A|Adverse Event|3|||
163166349|NCT00966875|589325694|FG008|Part A|Adverse Event|3|||
163166350|NCT00966875|589325686|FG000|Part A|Entry Criteria|0|||
163166351|NCT00966875|589325687|FG001|Part A|Entry Criteria|0|||
163166352|NCT00966875|589325688|FG002|Part A|Entry Criteria|0|||
163166353|NCT00966875|589325689|FG003|Part A|Entry Criteria|0|||
163166354|NCT00966875|589325690|FG004|Part A|Entry Criteria|0|||
163166355|NCT00966875|589325691|FG005|Part A|Entry Criteria|2|||
163166356|NCT00966875|589325692|FG006|Part A|Entry Criteria|0|||
163166357|NCT00966875|589325693|FG007|Part A|Entry Criteria|0|||
163166358|NCT00966875|589325694|FG008|Part A|Entry Criteria|0|||
163166359|NCT00966875|589325686|FG000|Part A|Lack of Efficacy|0|||
163166360|NCT00966875|589325687|FG001|Part A|Lack of Efficacy|1|||
163166361|NCT00966875|589325688|FG002|Part A|Lack of Efficacy|0|||
163166362|NCT00966875|589325689|FG003|Part A|Lack of Efficacy|0|||
163166363|NCT00966875|589325690|FG004|Part A|Lack of Efficacy|0|||
163166364|NCT00966875|589325691|FG005|Part A|Lack of Efficacy|0|||
163166365|NCT00966875|589325692|FG006|Part A|Lack of Efficacy|4|||
163166366|NCT00966875|589325693|FG007|Part A|Lack of Efficacy|0|||
162817799|NCT03602261|588045711|FG000|Overall Study|Withdrawal by Subject|1|||
162817800|NCT03602261|588045712|FG001|Overall Study|Withdrawal by Subject|1|||
162817801|NCT03602261|588045711|FG000|Overall Study|Lack of Efficacy|0|||
162817802|NCT03602261|588045712|FG001|Overall Study|Lack of Efficacy|1|||
162817803|NCT03602261|588045711|FG000|Overall Study|Subject moving out of state|1|||
162817804|NCT03602261|588045712|FG001|Overall Study|Subject moving out of state|0|||
162817805|NCT03442114|588045713|FG000|Overall Study|Lost to Follow-up|13|||
162817806|NCT03442114|588045714|FG001|Overall Study|Lost to Follow-up|13|||
162817807|NCT03442114|588045713|FG000|Overall Study|Physician Decision|2|||
162817808|NCT03442114|588045714|FG001|Overall Study|Physician Decision|2|||
162817809|NCT03442114|588045713|FG000|Overall Study|Protocol Violation|0|||
162817810|NCT03442114|588045714|FG001|Overall Study|Protocol Violation|2|||
162817811|NCT03442114|588045713|FG000|Overall Study|Withdrawal by Subject|1|||
162817812|NCT03442114|588045714|FG001|Overall Study|Withdrawal by Subject|3|||
162817813|NCT03442114|588045713|FG000|Overall Study|Guardianship Change|0|||
162817814|NCT03442114|588045714|FG001|Overall Study|Guardianship Change|1|||
162817815|NCT03808688|588047535|FG000|Overall Study|Adverse Event|13|||
162817816|NCT03808688|588047536|FG001|Overall Study|Adverse Event|17|||
162817817|NCT03808688|588047535|FG000|Overall Study|Lack of Efficacy|2|||
162817818|NCT03808688|588047536|FG001|Overall Study|Lack of Efficacy|0|||
162817819|NCT03808688|588047535|FG000|Overall Study|Lost to Follow-up|0|||
162817820|NCT03808688|588047536|FG001|Overall Study|Lost to Follow-up|2|||
162817821|NCT03808688|588047535|FG000|Overall Study|Withdrawal by Subject|1|||
162817822|NCT03808688|588047536|FG001|Overall Study|Withdrawal by Subject|0|||
162817823|NCT03808688|588047535|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
162817824|NCT03808688|588047536|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
162817825|NCT03808688|588047535|FG000|Overall Study|IOP Too High|1|||
162817826|NCT03808688|588047536|FG001|Overall Study|IOP Too High|1|||
162817827|NCT03808688|588047535|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
162817828|NCT03808688|588047536|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
162817829|NCT03808688|588047535|FG000|Overall Study|Visit Out of Window|0|||
162817830|NCT03808688|588047536|FG001|Overall Study|Visit Out of Window|1|||
162817831|NCT03808688|588047535|FG000|Overall Study|Medication Non-Compliance|0|||
162817832|NCT03808688|588047536|FG001|Overall Study|Medication Non-Compliance|1|||
162817833|NCT03335163|588047540|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
162817834|NCT03335163|588047540|FG000|Overall Study|Withdrawal by Subject|18|||
162817835|NCT01215175|588047542|FG000|Overall Study|Lost to Follow-up|0|||
162817836|NCT01215175|588047543|FG001|Overall Study|Lost to Follow-up|1|||
162817837|NCT01215175|588047544|FG002|Overall Study|Lost to Follow-up|0|||
162817838|NCT01215175|588047545|FG003|Overall Study|Lost to Follow-up|1|||
162817839|NCT01215175|588047546|FG004|Overall Study|Lost to Follow-up|0|||
162817840|NCT01016964|588047547|FG000|Overall Study|Lost to Follow-up|3|||
162817841|NCT01016964|588047548|FG001|Overall Study|Lost to Follow-up|3|||
162817842|NCT03872453|588047549|FG000|Overall Study|Adverse Event|1|||
163166367|NCT00966875|589325694|FG008|Part A|Lack of Efficacy|0|||
163166368|NCT00966875|589325686|FG000|Part A|Lost to Follow-up|2|||
163166369|NCT00966875|589325687|FG001|Part A|Lost to Follow-up|0|||
163166370|NCT00966875|589325688|FG002|Part A|Lost to Follow-up|0|||
163166371|NCT00966875|589325689|FG003|Part A|Lost to Follow-up|0|||
163166372|NCT00966875|589325690|FG004|Part A|Lost to Follow-up|0|||
163166373|NCT00966875|589325691|FG005|Part A|Lost to Follow-up|1|||
163166374|NCT00966875|589325692|FG006|Part A|Lost to Follow-up|0|||
163166375|NCT00966875|589325693|FG007|Part A|Lost to Follow-up|0|||
162817843|NCT03872453|588047550|FG001|Overall Study|Adverse Event|1|||
162817844|NCT03872453|588047551|FG002|Overall Study|Adverse Event|0|||
162817845|NCT03872453|588047552|FG003|Overall Study|Adverse Event|0|||
162817846|NCT03872453|588047549|FG000|Overall Study|Lost to Follow-up|8|||
162817847|NCT03872453|588047550|FG001|Overall Study|Lost to Follow-up|7|||
162817848|NCT03872453|588047551|FG002|Overall Study|Lost to Follow-up|4|||
162817849|NCT03872453|588047552|FG003|Overall Study|Lost to Follow-up|4|||
163166376|NCT00966875|589325694|FG008|Part A|Lost to Follow-up|0|||
163166377|NCT00966875|589325686|FG000|Part A|Parent/Caregiver Decision|0|||
163166378|NCT00966875|589325687|FG001|Part A|Parent/Caregiver Decision|0|||
163166379|NCT00966875|589325688|FG002|Part A|Parent/Caregiver Decision|0|||
163166380|NCT00966875|589325689|FG003|Part A|Parent/Caregiver Decision|1|||
163166381|NCT00966875|589325690|FG004|Part A|Parent/Caregiver Decision|0|||
163166382|NCT00966875|589325691|FG005|Part A|Parent/Caregiver Decision|0|||
163166383|NCT00966875|589325692|FG006|Part A|Parent/Caregiver Decision|0|||
163166384|NCT00966875|589325693|FG007|Part A|Parent/Caregiver Decision|0|||
163166385|NCT00966875|589325694|FG008|Part A|Parent/Caregiver Decision|0|||
163166386|NCT00966875|589325686|FG000|Part A|Physician Decision|0|||
163166387|NCT00966875|589325687|FG001|Part A|Physician Decision|0|||
163166388|NCT00966875|589325688|FG002|Part A|Physician Decision|0|||
163166389|NCT00966875|589325689|FG003|Part A|Physician Decision|0|||
163166390|NCT00966875|589325690|FG004|Part A|Physician Decision|1|||
163166391|NCT00966875|589325691|FG005|Part A|Physician Decision|0|||
163166392|NCT00966875|589325692|FG006|Part A|Physician Decision|1|||
163166393|NCT00966875|589325693|FG007|Part A|Physician Decision|0|||
163166394|NCT00966875|589325694|FG008|Part A|Physician Decision|2|||
163166395|NCT00966875|589325686|FG000|Part A|Sponsor Decision|0|||
163166396|NCT00966875|589325687|FG001|Part A|Sponsor Decision|0|||
163166397|NCT00966875|589325688|FG002|Part A|Sponsor Decision|1|||
163166398|NCT00966875|589325689|FG003|Part A|Sponsor Decision|0|||
163166399|NCT00966875|589325690|FG004|Part A|Sponsor Decision|1|||
163166400|NCT00966875|589325691|FG005|Part A|Sponsor Decision|0|||
163166401|NCT00966875|589325692|FG006|Part A|Sponsor Decision|0|||
163166402|NCT00966875|589325693|FG007|Part A|Sponsor Decision|2|||
163166403|NCT00966875|589325694|FG008|Part A|Sponsor Decision|1|||
163166404|NCT00966875|589325686|FG000|Part A|Withdrawal by Subject|2|||
163166405|NCT00966875|589325687|FG001|Part A|Withdrawal by Subject|2|||
163166406|NCT00966875|589325688|FG002|Part A|Withdrawal by Subject|1|||
163166407|NCT00966875|589325689|FG003|Part A|Withdrawal by Subject|1|||
163166408|NCT00966875|589325690|FG004|Part A|Withdrawal by Subject|3|||
163166409|NCT00966875|589325691|FG005|Part A|Withdrawal by Subject|0|||
163166410|NCT00966875|589325692|FG006|Part A|Withdrawal by Subject|5|||
163166411|NCT00966875|589325693|FG007|Part A|Withdrawal by Subject|1|||
163166412|NCT00966875|589325694|FG008|Part A|Withdrawal by Subject|1|||
163166413|NCT00966875|589325686|FG000|Part A|Protocol Violation|0|||
163166414|NCT00966875|589325687|FG001|Part A|Protocol Violation|0|||
163166415|NCT00966875|589325688|FG002|Part A|Protocol Violation|0|||
163166416|NCT00966875|589325689|FG003|Part A|Protocol Violation|0|||
163166417|NCT00966875|589325690|FG004|Part A|Protocol Violation|0|||
163166418|NCT00966875|589325691|FG005|Part A|Protocol Violation|0|||
163166419|NCT00966875|589325692|FG006|Part A|Protocol Violation|2|||
163166420|NCT00966875|589325693|FG007|Part A|Protocol Violation|1|||
163166421|NCT00966875|589325694|FG008|Part A|Protocol Violation|1|||
163166422|NCT00966875|589325686|FG000|Part B|Adverse Event|0|||
163166423|NCT00966875|589325687|FG001|Part B|Adverse Event|1|||
163166424|NCT00966875|589325688|FG002|Part B|Adverse Event|1|||
163166425|NCT00966875|589325689|FG003|Part B|Adverse Event|0|||
163166426|NCT00966875|589325690|FG004|Part B|Adverse Event|1|||
163166427|NCT00966875|589325691|FG005|Part B|Adverse Event|0|||
163166428|NCT00966875|589325692|FG006|Part B|Adverse Event|5|||
163166429|NCT00966875|589325693|FG007|Part B|Adverse Event|2|||
163166430|NCT00966875|589325694|FG008|Part B|Adverse Event|2|||
163166431|NCT00966875|589325686|FG000|Part B|Death|0|||
163166432|NCT00966875|589325687|FG001|Part B|Death|0|||
163166433|NCT00966875|589325688|FG002|Part B|Death|1|||
163166434|NCT00966875|589325689|FG003|Part B|Death|0|||
163166435|NCT00966875|589325690|FG004|Part B|Death|0|||
163166436|NCT00966875|589325691|FG005|Part B|Death|0|||
163166437|NCT00966875|589325692|FG006|Part B|Death|0|||
163166438|NCT00966875|589325693|FG007|Part B|Death|1|||
163166439|NCT00966875|589325694|FG008|Part B|Death|0|||
163166440|NCT00966875|589325686|FG000|Part B|Lack of Efficacy|2|||
163166441|NCT00966875|589325687|FG001|Part B|Lack of Efficacy|1|||
163166442|NCT00966875|589325688|FG002|Part B|Lack of Efficacy|1|||
163166443|NCT00966875|589325689|FG003|Part B|Lack of Efficacy|1|||
163166444|NCT00966875|589325690|FG004|Part B|Lack of Efficacy|2|||
163166445|NCT00966875|589325691|FG005|Part B|Lack of Efficacy|3|||
163166446|NCT00966875|589325692|FG006|Part B|Lack of Efficacy|12|||
163166447|NCT00966875|589325693|FG007|Part B|Lack of Efficacy|9|||
163166448|NCT00966875|589325694|FG008|Part B|Lack of Efficacy|6|||
163166449|NCT00966875|589325686|FG000|Part B|Lost to Follow-up|0|||
163166450|NCT00966875|589325687|FG001|Part B|Lost to Follow-up|0|||
163166451|NCT00966875|589325688|FG002|Part B|Lost to Follow-up|0|||
163166452|NCT00966875|589325689|FG003|Part B|Lost to Follow-up|1|||
163166453|NCT00966875|589325690|FG004|Part B|Lost to Follow-up|0|||
163166454|NCT00966875|589325691|FG005|Part B|Lost to Follow-up|0|||
163166455|NCT00966875|589325692|FG006|Part B|Lost to Follow-up|0|||
163166456|NCT00966875|589325693|FG007|Part B|Lost to Follow-up|0|||
163166457|NCT00966875|589325694|FG008|Part B|Lost to Follow-up|1|||
163166458|NCT00966875|589325686|FG000|Part B|Physician Decision|0|||
163166459|NCT00966875|589325687|FG001|Part B|Physician Decision|0|||
163166460|NCT00966875|589325688|FG002|Part B|Physician Decision|1|||
163166461|NCT00966875|589325689|FG003|Part B|Physician Decision|0|||
163166462|NCT00966875|589325690|FG004|Part B|Physician Decision|2|||
163166463|NCT00966875|589325691|FG005|Part B|Physician Decision|1|||
163166464|NCT00966875|589325692|FG006|Part B|Physician Decision|0|||
163166465|NCT00966875|589325693|FG007|Part B|Physician Decision|0|||
163166466|NCT00966875|589325694|FG008|Part B|Physician Decision|2|||
163166467|NCT00966875|589325686|FG000|Part B|Sponsor Decision|1|||
163166468|NCT00966875|589325687|FG001|Part B|Sponsor Decision|0|||
163166469|NCT00966875|589325688|FG002|Part B|Sponsor Decision|0|||
163166470|NCT00966875|589325689|FG003|Part B|Sponsor Decision|0|||
163166471|NCT00966875|589325690|FG004|Part B|Sponsor Decision|0|||
163166472|NCT00966875|589325691|FG005|Part B|Sponsor Decision|1|||
163166473|NCT00966875|589325692|FG006|Part B|Sponsor Decision|0|||
163166474|NCT00966875|589325693|FG007|Part B|Sponsor Decision|2|||
163166475|NCT00966875|589325694|FG008|Part B|Sponsor Decision|1|||
163166476|NCT00966875|589325686|FG000|Part B|Withdrawal by Subject|2|||
163166477|NCT00966875|589325687|FG001|Part B|Withdrawal by Subject|1|||
163166478|NCT00966875|589325688|FG002|Part B|Withdrawal by Subject|2|||
163166479|NCT00966875|589325689|FG003|Part B|Withdrawal by Subject|1|||
163166480|NCT00966875|589325690|FG004|Part B|Withdrawal by Subject|2|||
163166481|NCT00966875|589325691|FG005|Part B|Withdrawal by Subject|1|||
163166482|NCT00966875|589325692|FG006|Part B|Withdrawal by Subject|4|||
163166483|NCT00966875|589325693|FG007|Part B|Withdrawal by Subject|5|||
163166484|NCT00966875|589325694|FG008|Part B|Withdrawal by Subject|5|||
163166485|NCT00966875|589325686|FG000|Part B|Entry Criteria|0|||
163166486|NCT00966875|589325687|FG001|Part B|Entry Criteria|0|||
163166487|NCT00966875|589325688|FG002|Part B|Entry Criteria|0|||
163166488|NCT00966875|589325689|FG003|Part B|Entry Criteria|0|||
163166489|NCT00966875|589325690|FG004|Part B|Entry Criteria|0|||
163166490|NCT00966875|589325691|FG005|Part B|Entry Criteria|0|||
163166491|NCT00966875|589325692|FG006|Part B|Entry Criteria|1|||
163166492|NCT00966875|589325693|FG007|Part B|Entry Criteria|0|||
163166493|NCT00966875|589325694|FG008|Part B|Entry Criteria|1|||
163166494|NCT00689117|589325695|FG000|Overall Study|Adverse Event|6|||
163166495|NCT00689117|589325696|FG001|Overall Study|Adverse Event|0|||
163166496|NCT00689117|589325697|FG002|Overall Study|Adverse Event|5|||
163166497|NCT00689117|589325698|FG003|Overall Study|Adverse Event|0|||
163166498|NCT00689117|589325695|FG000|Overall Study|Lost to Follow-up|26|||
163166499|NCT00689117|589325696|FG001|Overall Study|Lost to Follow-up|19|||
163166500|NCT00689117|589325697|FG002|Overall Study|Lost to Follow-up|17|||
163166501|NCT00689117|589325698|FG003|Overall Study|Lost to Follow-up|11|||
163166502|NCT00689117|589325695|FG000|Overall Study|Lack of Efficacy|1|||
163166503|NCT00689117|589325696|FG001|Overall Study|Lack of Efficacy|2|||
163166504|NCT00689117|589325697|FG002|Overall Study|Lack of Efficacy|2|||
163166505|NCT00689117|589325698|FG003|Overall Study|Lack of Efficacy|2|||
163166506|NCT00689117|589325695|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
163166507|NCT00689117|589325696|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
163166508|NCT00689117|589325697|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
163166509|NCT00689117|589325698|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
163166510|NCT00689117|589325695|FG000|Overall Study|Withdrawal by Subject|19|||
163166511|NCT00689117|589325696|FG001|Overall Study|Withdrawal by Subject|18|||
163166512|NCT00689117|589325697|FG002|Overall Study|Withdrawal by Subject|26|||
163166513|NCT00689117|589325698|FG003|Overall Study|Withdrawal by Subject|13|||
163166514|NCT00689117|589325695|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
163166515|NCT00689117|589325696|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
163166516|NCT00689117|589325697|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
163166517|NCT00689117|589325698|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
163166518|NCT00689117|589325695|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
163166519|NCT00689117|589325696|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163166520|NCT00689117|589325697|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163166521|NCT00689117|589325698|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163166522|NCT00689117|589325695|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
163166523|NCT00689117|589325696|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
163166524|NCT00689117|589325697|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
163166525|NCT00689117|589325698|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
163166526|NCT00689117|589325695|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
163166527|NCT00689117|589325696|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
163166528|NCT00689117|589325697|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
163166529|NCT00689117|589325698|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
163166530|NCT00689117|589325695|FG000|Overall Study|Use of Prohibitive Medication|2|||
163166531|NCT00689117|589325696|FG001|Overall Study|Use of Prohibitive Medication|1|||
163166532|NCT00689117|589325697|FG002|Overall Study|Use of Prohibitive Medication|3|||
163166533|NCT00689117|589325698|FG003|Overall Study|Use of Prohibitive Medication|0|||
163166534|NCT00689117|589325695|FG000|Overall Study|Pregnancy|0|||
163166535|NCT00689117|589325696|FG001|Overall Study|Pregnancy|2|||
163166536|NCT00689117|589325697|FG002|Overall Study|Pregnancy|0|||
163166537|NCT00689117|589325698|FG003|Overall Study|Pregnancy|2|||
163166538|NCT00689117|589325695|FG000|Overall Study|Incarceration|2|||
163166539|NCT00689117|589325696|FG001|Overall Study|Incarceration|0|||
163166540|NCT00689117|589325697|FG002|Overall Study|Incarceration|0|||
163166541|NCT00689117|589325698|FG003|Overall Study|Incarceration|0|||
163166542|NCT00689117|589325695|FG000|Overall Study|Fear of Birth Defects|0|||
163166543|NCT00689117|589325696|FG001|Overall Study|Fear of Birth Defects|0|||
163166544|NCT00689117|589325697|FG002|Overall Study|Fear of Birth Defects|1|||
163166545|NCT00689117|589325698|FG003|Overall Study|Fear of Birth Defects|0|||
163166546|NCT00689117|589325695|FG000|Overall Study|Transportation|1|||
163166547|NCT00689117|589325696|FG001|Overall Study|Transportation|0|||
163166548|NCT00689117|589325697|FG002|Overall Study|Transportation|0|||
163166549|NCT00689117|589325698|FG003|Overall Study|Transportation|0|||
163166550|NCT00689117|589325695|FG000|Overall Study|Patient Withdrew from Study|0|||
163166551|NCT00689117|589325696|FG001|Overall Study|Patient Withdrew from Study|0|||
163166552|NCT00689117|589325697|FG002|Overall Study|Patient Withdrew from Study|0|||
163166553|NCT00689117|589325698|FG003|Overall Study|Patient Withdrew from Study|1|||
163166554|NCT00689117|589325695|FG000|Overall Study|Personal Reason|0|||
163166555|NCT00689117|589325696|FG001|Overall Study|Personal Reason|1|||
163166556|NCT00689117|589325697|FG002|Overall Study|Personal Reason|0|||
163166557|NCT00689117|589325698|FG003|Overall Study|Personal Reason|0|||
163166558|NCT00689117|589325695|FG000|Overall Study|Dispensing Error|0|||
163166559|NCT00689117|589325696|FG001|Overall Study|Dispensing Error|1|||
163166560|NCT00689117|589325697|FG002|Overall Study|Dispensing Error|0|||
163166561|NCT00689117|589325698|FG003|Overall Study|Dispensing Error|0|||
163166562|NCT00444678|589325701|FG000|Overall Study|Toxicity|11|||
163166563|NCT00444678|589325701|FG000|Overall Study|Disease Progression|12|||
163166564|NCT00444678|589325701|FG000|Overall Study|Death|3|||
163166565|NCT00444678|589325701|FG000|Overall Study|Physician Decision|3|||
163166566|NCT00444678|589325701|FG000|Overall Study|Withdrawal by Subject|2|||
163166567|NCT02597478|589325703|FG000|Overall Study|Withdrawal by Subject|2|||
163166568|NCT02597478|589325704|FG001|Overall Study|Withdrawal by Subject|0|||
163166569|NCT02597478|589325703|FG000|Overall Study|Change of opioid dose|1|||
163166570|NCT02597478|589325704|FG001|Overall Study|Change of opioid dose|0|||
163166571|NCT02597478|589325703|FG000|Overall Study|Insufficient exertional dyspnea|0|||
163166572|NCT02597478|589325704|FG001|Overall Study|Insufficient exertional dyspnea|1|||
162817850|NCT03872453|588047549|FG000|Overall Study|Never Treated Migraine|19|||
162817851|NCT03872453|588047550|FG001|Overall Study|Never Treated Migraine|17|||
162817852|NCT03872453|588047551|FG002|Overall Study|Never Treated Migraine|13|||
162817853|NCT03872453|588047552|FG003|Overall Study|Never Treated Migraine|12|||
162817854|NCT03872453|588047549|FG000|Overall Study|Pregnancy|1|||
162817855|NCT03872453|588047550|FG001|Overall Study|Pregnancy|0|||
162817856|NCT03872453|588047551|FG002|Overall Study|Pregnancy|0|||
163166573|NCT01305577|589325707|FG000|Overall Study|Adverse Event|2|||
163166574|NCT01305577|589325708|FG001|Overall Study|Adverse Event|2|||
163166575|NCT01305577|589325709|FG002|Overall Study|Adverse Event|1|||
163166576|NCT01305577|589325707|FG000|Overall Study|Withdrawal by Subject|7|||
163166577|NCT01305577|589325708|FG001|Overall Study|Withdrawal by Subject|5|||
163166578|NCT01305577|589325709|FG002|Overall Study|Withdrawal by Subject|6|||
163166579|NCT01305577|589325707|FG000|Overall Study|Lost to Follow-up|4|||
163166580|NCT01305577|589325708|FG001|Overall Study|Lost to Follow-up|3|||
163166581|NCT01305577|589325709|FG002|Overall Study|Lost to Follow-up|2|||
163166582|NCT01305577|589325707|FG000|Overall Study|Protocol Deviation|0|||
163166583|NCT01305577|589325708|FG001|Overall Study|Protocol Deviation|1|||
163166584|NCT01305577|589325709|FG002|Overall Study|Protocol Deviation|1|||
163166585|NCT00796978|589325710|FG000|Overall Study|Cardiac adverse event|5|||
163166586|NCT00796978|589325710|FG000|Overall Study|Adverse Event|4|||
163166587|NCT00796978|589325710|FG000|Overall Study|Withdrawal by Subject|3|||
163166588|NCT01256190|589325711|FG000|Overall Study|Lost to Follow-up|2|||
163166589|NCT01256190|589325712|FG001|Overall Study|Lost to Follow-up|0|||
162817857|NCT03872453|588047552|FG003|Overall Study|Pregnancy|0|||
163166590|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
163166591|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
163166592|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
163166593|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
163166594|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
163166595|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166596|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166597|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
163166598|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
163166599|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
163166600|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
162817858|NCT03872453|588047549|FG000|Overall Study|Protocol Deviation|2|||
163166601|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
163166602|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163166603|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
163166604|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163166605|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
163166606|NCT02834793|589325713|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
162817859|NCT03872453|588047550|FG001|Overall Study|Protocol Deviation|0|||
162817860|NCT03872453|588047551|FG002|Overall Study|Protocol Deviation|0|||
162817861|NCT03872453|588047552|FG003|Overall Study|Protocol Deviation|2|||
162817862|NCT03872453|588047549|FG000|Overall Study|Withdrawal by Subject|0|||
162817863|NCT03872453|588047550|FG001|Overall Study|Withdrawal by Subject|1|||
162817864|NCT03872453|588047551|FG002|Overall Study|Withdrawal by Subject|2|||
162817865|NCT03872453|588047552|FG003|Overall Study|Withdrawal by Subject|0|||
162817866|NCT03872453|588047549|FG000|Overall Study|Other Than Specified|1|||
162817867|NCT03872453|588047550|FG001|Overall Study|Other Than Specified|0|||
162817868|NCT03872453|588047551|FG002|Overall Study|Other Than Specified|0|||
162817869|NCT03872453|588047552|FG003|Overall Study|Other Than Specified|0|||
162817870|NCT01678209|588047553|FG000|Overall Study|could not scan twice|1|||
162817871|NCT01678209|588047554|FG001|Overall Study|could not scan twice|1|||
162817872|NCT01678209|588047555|FG002|Overall Study|could not scan twice|1|||
162817873|NCT01678209|588047553|FG000|Overall Study|scheduling conflicts|0|||
162817874|NCT01678209|588047554|FG001|Overall Study|scheduling conflicts|0|||
162817875|NCT01678209|588047555|FG002|Overall Study|scheduling conflicts|1|||
162817876|NCT01678209|588047553|FG000|Overall Study|screen fail|16|||
162817877|NCT01678209|588047554|FG001|Overall Study|screen fail|17|||
162817878|NCT01678209|588047555|FG002|Overall Study|screen fail|16|||
162817879|NCT03756350|588047560|FG000|Overall Study|Lost to Follow-up|1|||
162817880|NCT00702845|588047564|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
162817881|NCT00702845|588047565|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
162817882|NCT00702845|588047564|FG000|Overall Study|Too high ovarian response|5|||
162817883|NCT00702845|588047565|FG001|Overall Study|Too high ovarian response|1|||
162817884|NCT00702845|588047564|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
162817885|NCT00702845|588047565|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
162817886|NCT00702845|588047564|FG000|Overall Study|Insufficient ovarian response|1|||
162817887|NCT00702845|588047565|FG001|Overall Study|Insufficient ovarian response|0|||
162817888|NCT00702845|588047564|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
162817889|NCT00702845|588047565|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
162817890|NCT00702845|588047564|FG000|Overall Study|No or abnormal fertilization|4|||
162817891|NCT00702845|588047565|FG001|Overall Study|No or abnormal fertilization|2|||
162817892|NCT00702845|588047564|FG000|Overall Study|Patient's decision|2|||
162817893|NCT00702845|588047565|FG001|Overall Study|Patient's decision|1|||
162817894|NCT00702845|588047564|FG000|Overall Study|Not randomized|0|||
162817895|NCT00702845|588047565|FG001|Overall Study|Not randomized|1|||
162817896|NCT00440700|588047566|FG000|Overall Study|Withdrawal by Subject|8|||
162817897|NCT00440700|588047567|FG001|Overall Study|Withdrawal by Subject|8|||
162817898|NCT00440700|588047568|FG002|Overall Study|Withdrawal by Subject|4|||
162817899|NCT00928564|588047569|FG000|Overall Study|Lost to Follow-up|6|||
162817900|NCT00928564|588047570|FG001|Overall Study|Lost to Follow-up|0|||
162817901|NCT03434353|588047577|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
162817902|NCT03434353|588047578|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
162817903|NCT03434353|588047579|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
162817904|NCT03434353|588047580|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
162817905|NCT03434353|588047581|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
162817906|NCT03434353|588047577|FG000|Overall Study|Withdrew consent|1|||
162817907|NCT03434353|588047578|FG001|Overall Study|Withdrew consent|0|||
162817908|NCT03434353|588047579|FG002|Overall Study|Withdrew consent|3|||
162817909|NCT03434353|588047580|FG003|Overall Study|Withdrew consent|0|||
162817910|NCT03434353|588047581|FG004|Overall Study|Withdrew consent|0|||
162817911|NCT03434353|588047577|FG000|Overall Study|Adverse Event|1|||
162817912|NCT03434353|588047578|FG001|Overall Study|Adverse Event|0|||
162817913|NCT03434353|588047579|FG002|Overall Study|Adverse Event|0|||
162817914|NCT03434353|588047580|FG003|Overall Study|Adverse Event|0|||
162817915|NCT03434353|588047581|FG004|Overall Study|Adverse Event|1|||
163166607|NCT02834793|589325714|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
163166608|NCT02834793|589325715|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
163166609|NCT02834793|589325716|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
162817916|NCT03434353|588047577|FG000|Overall Study|Lost to Follow-up|2|||
162817917|NCT03434353|588047578|FG001|Overall Study|Lost to Follow-up|0|||
162817918|NCT03434353|588047579|FG002|Overall Study|Lost to Follow-up|0|||
162817919|NCT03434353|588047580|FG003|Overall Study|Lost to Follow-up|0|||
162817920|NCT03434353|588047581|FG004|Overall Study|Lost to Follow-up|0|||
162817921|NCT00929656|588047582|FG000|Overall Study|Lost to Follow-up|0|||
162817922|NCT00929656|588047583|FG001|Overall Study|Lost to Follow-up|1|||
162817923|NCT03739762|588047584|FG000|Overall Study|Lost to Follow-up|1|||
162817924|NCT03739762|588047585|FG001|Overall Study|Lost to Follow-up|1|||
163166610|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166611|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166612|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
162817925|NCT03739762|588047584|FG000|Overall Study|Withdrawal by Subject|2|||
162817926|NCT03739762|588047585|FG001|Overall Study|Withdrawal by Subject|6|||
162817927|NCT00607880|588047586|FG000|Overall Study|Unable to place port due to occlusion|1|||
163166613|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
163166614|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166615|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166616|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
163166617|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
163166618|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166619|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166620|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
163166621|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
163166622|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166623|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166624|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
163166625|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
163166626|NCT02834793|589325713|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
163166627|NCT02834793|589325714|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
163166628|NCT02834793|589325715|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
163166629|NCT02834793|589325716|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
163166630|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166631|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166632|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
163166633|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
163166634|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166635|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166636|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
163166637|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
163166638|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166639|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166640|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
163166641|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
163166642|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
163166643|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
163166644|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
163166645|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
163166646|NCT02834793|589325713|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166647|NCT02834793|589325714|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166648|NCT02834793|589325715|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
163166649|NCT02834793|589325716|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
163166650|NCT02364336|589325717|FG000|Overall Study|Adverse Event|0|||
163166651|NCT02364336|589325718|FG001|Overall Study|Adverse Event|1|||
163166652|NCT01731938|589325719|FG000|Preliminary Part I|Withdrawal by Subject|2|||
163166653|NCT01731938|589325720|FG001|Preliminary Part I|Withdrawal by Subject|2|||
163166654|NCT01731938|589325719|FG000|Preliminary Part I|Physician Decision|1|||
163166655|NCT01731938|589325720|FG001|Preliminary Part I|Physician Decision|0|||
163166656|NCT01731938|589325719|FG000|Preliminary Part I|Lost to Follow-up|0|||
163166657|NCT01731938|589325720|FG001|Preliminary Part I|Lost to Follow-up|3|||
163166658|NCT01731938|589325719|FG000|Preliminary Part I|Missed Week 6 visit|0|||
163166659|NCT01731938|589325720|FG001|Preliminary Part I|Missed Week 6 visit|3|||
163166660|NCT01731938|589325719|FG000|Primary Part II|Withdrawal by Subject|5|||
163166661|NCT01731938|589325720|FG001|Primary Part II|Withdrawal by Subject|4|||
163166662|NCT01731938|589325719|FG000|Primary Part II|Lost to Follow-up|4|||
163166663|NCT01731938|589325720|FG001|Primary Part II|Lost to Follow-up|5|||
163166664|NCT01731938|589325719|FG000|Primary Part II|Death|2|||
163166665|NCT01731938|589325720|FG001|Primary Part II|Death|1|||
163166666|NCT01731938|589325719|FG000|Primary Part II|Missed Week 6 visit|2|||
163166667|NCT01731938|589325720|FG001|Primary Part II|Missed Week 6 visit|3|||
163166668|NCT03319745|589325721|FG000|Overall Study|Death|1|||
163166669|NCT03319745|589325721|FG000|Overall Study|Toxicity Precluding Surgery|1|||
163166670|NCT00870103|589325722|FG000|Overall Study|Physician Decision|2|||
163166671|NCT00870103|589325722|FG000|Overall Study|Lost to Follow-up|2|||
163166672|NCT01317550|589325723|FG000|Overall Study|Withdrawal by Subject|1|||
163166673|NCT01317550|589325724|FG001|Overall Study|Withdrawal by Subject|0|||
163166674|NCT01317550|589325725|FG002|Overall Study|Withdrawal by Subject|0|||
163166675|NCT01317550|589325726|FG003|Overall Study|Withdrawal by Subject|0|||
163166676|NCT01317550|589325723|FG000|Overall Study|Lack of compliance study med|1|||
163166677|NCT01317550|589325724|FG001|Overall Study|Lack of compliance study med|0|||
163166678|NCT01317550|589325725|FG002|Overall Study|Lack of compliance study med|0|||
163166679|NCT01317550|589325726|FG003|Overall Study|Lack of compliance study med|0|||
163166680|NCT03179202|589325727|FG000|Overall Study|Screen Failure|67|||
163166681|NCT03179202|589325727|FG000|Overall Study|Subject Lost to Follow Up|12|||
163166682|NCT03179202|589325727|FG000|Overall Study|Withdrawal by Subject|7|||
163166683|NCT03179202|589325727|FG000|Overall Study|Adverse Event|3|||
163166684|NCT03179202|589325727|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
163166685|NCT03179202|589325727|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
163166686|NCT03255629|589325728|FG000|Overall Study|Adverse Event|1|||
163166687|NCT03255629|589325729|FG001|Overall Study|Adverse Event|0|||
163166688|NCT03255629|589325728|FG000|Overall Study|did not experience hypoglycemia|2|||
163166689|NCT03255629|589325729|FG001|Overall Study|did not experience hypoglycemia|1|||
163166690|NCT04540198|589325730|FG000|Overall Study|Lost to Follow-up|25|||
163166691|NCT04540198|589325731|FG001|Overall Study|Lost to Follow-up|23|||
163166692|NCT04540198|589325730|FG000|Overall Study|Withdrawal by Subject|15|||
163166693|NCT04540198|589325731|FG001|Overall Study|Withdrawal by Subject|9|||
163166694|NCT04540198|589325730|FG000|Overall Study|Discontinued|1|||
163166695|NCT04540198|589325731|FG001|Overall Study|Discontinued|0|||
163166696|NCT02779556|589325732|FG000|Baseline|Partial baseline interview completed|1|||
163166697|NCT02779556|589325733|FG001|Baseline|Partial baseline interview completed|0|||
163166698|NCT02779556|589325732|FG000|3 Months|Lost to Follow-up|40|||
163166699|NCT02779556|589325733|FG001|3 Months|Lost to Follow-up|29|||
163166700|NCT02779556|589325732|FG000|3 Months|Missed 3 month clinic visit|27|||
163166701|NCT02779556|589325733|FG001|3 Months|Missed 3 month clinic visit|19|||
163166702|NCT02779556|589325732|FG000|6 Month|Lost to Follow-up|33|||
163166703|NCT02779556|589325733|FG001|6 Month|Lost to Follow-up|39|||
163166704|NCT02779556|589325732|FG000|6 Month HbA1c|No value collected during window|69|||
163166705|NCT02779556|589325733|FG001|6 Month HbA1c|No value collected during window|50|||
163166706|NCT02779556|589325732|FG000|12 Month HbA1c|No value collected during window|138|||
163166707|NCT02779556|589325733|FG001|12 Month HbA1c|No value collected during window|102|||
163166708|NCT03110770|589325735|FG000|Overall Study|Death|1|||
163166709|NCT03110770|589325736|FG001|Overall Study|Death|0|||
163166710|NCT03110770|589325737|FG002|Overall Study|Death|0|||
163166711|NCT03110770|589325738|FG003|Overall Study|Death|1|||
163166712|NCT03110770|589325739|FG004|Overall Study|Death|0|||
163166713|NCT03110770|589325735|FG000|Overall Study|Enrolled but did not receive product|0|||
163166714|NCT03110770|589325736|FG001|Overall Study|Enrolled but did not receive product|0|||
163166715|NCT03110770|589325737|FG002|Overall Study|Enrolled but did not receive product|0|||
163166716|NCT03110770|589325738|FG003|Overall Study|Enrolled but did not receive product|8|||
163166717|NCT03110770|589325739|FG004|Overall Study|Enrolled but did not receive product|7|||
163166718|NCT03110770|589325735|FG000|Overall Study|Lost to Follow-up|0|||
163166719|NCT03110770|589325736|FG001|Overall Study|Lost to Follow-up|0|||
163166720|NCT03110770|589325737|FG002|Overall Study|Lost to Follow-up|0|||
163166721|NCT03110770|589325738|FG003|Overall Study|Lost to Follow-up|53|||
163166722|NCT03110770|589325739|FG004|Overall Study|Lost to Follow-up|45|||
163166723|NCT03110770|589325735|FG000|Overall Study|Investigator Decision|0|||
163166724|NCT03110770|589325736|FG001|Overall Study|Investigator Decision|0|||
163166725|NCT03110770|589325737|FG002|Overall Study|Investigator Decision|0|||
163166726|NCT03110770|589325738|FG003|Overall Study|Investigator Decision|5|||
163166727|NCT03110770|589325739|FG004|Overall Study|Investigator Decision|3|||
163166728|NCT03110770|589325735|FG000|Overall Study|Withdrawal by Subject|0|||
163166729|NCT03110770|589325736|FG001|Overall Study|Withdrawal by Subject|0|||
163166730|NCT03110770|589325737|FG002|Overall Study|Withdrawal by Subject|0|||
163166731|NCT03110770|589325738|FG003|Overall Study|Withdrawal by Subject|24|||
163166732|NCT03110770|589325739|FG004|Overall Study|Withdrawal by Subject|24|||
163166733|NCT03110770|589325735|FG000|Overall Study|Moved from area|5|||
163166734|NCT03110770|589325736|FG001|Overall Study|Moved from area|0|||
163166735|NCT03110770|589325737|FG002|Overall Study|Moved from area|2|||
163166736|NCT03110770|589325738|FG003|Overall Study|Moved from area|42|||
163166737|NCT03110770|589325739|FG004|Overall Study|Moved from area|43|||
163166738|NCT03110770|589325735|FG000|Overall Study|Illness/Injury unrelated to product|0|||
163166739|NCT03110770|589325736|FG001|Overall Study|Illness/Injury unrelated to product|0|||
163166740|NCT03110770|589325737|FG002|Overall Study|Illness/Injury unrelated to product|0|||
163166741|NCT03110770|589325738|FG003|Overall Study|Illness/Injury unrelated to product|0|||
163166742|NCT03110770|589325739|FG004|Overall Study|Illness/Injury unrelated to product|1|||
163166743|NCT01086358|589325742|FG000|First Intervention|Lost to Follow-up|9|||
163166744|NCT01086358|589325743|FG001|First Intervention|Lost to Follow-up|4|||
163166745|NCT01086358|589325742|FG000|First Intervention|Withdrawal by Subject|0|||
162817928|NCT00607880|588047587|FG001|Overall Study|Unable to place port due to occlusion|0|||
163166746|NCT01086358|589325743|FG001|First Intervention|Withdrawal by Subject|1|||
163166747|NCT01086358|589325742|FG000|Second Intervention|Lost to Follow-up|4|||
163166748|NCT01086358|589325743|FG001|Second Intervention|Lost to Follow-up|4|||
163166749|NCT02888119|589325746|FG000|Overall Study|Lost to Follow-up|5|||
163166750|NCT02888119|589325747|FG001|Overall Study|Lost to Follow-up|4|||
163166751|NCT02888119|589325748|FG002|Overall Study|Lost to Follow-up|0|||
163166752|NCT05246514|589325752|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
163166753|NCT05246514|589325752|FG000|Overall Study|Withdrawal by Subject|1|||
163166754|NCT05246514|589325752|FG000|Overall Study|Death|13|||
163166755|NCT01802073|589325753|FG000|Overall Study|Lost to Follow-up|0|||
163166756|NCT01802073|589325754|FG001|Overall Study|Lost to Follow-up|1|||
163166757|NCT01802073|589325753|FG000|Overall Study|Non-compliant|4|||
162817929|NCT04606771|588047589|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
163166758|NCT01802073|589325754|FG001|Overall Study|Non-compliant|2|||
163166759|NCT01802073|589325753|FG000|Overall Study|Withdrawal by Subject|1|||
163166760|NCT01802073|589325754|FG001|Overall Study|Withdrawal by Subject|1|||
163166761|NCT01802073|589325753|FG000|Overall Study|Physician Decision|0|||
163166762|NCT01802073|589325754|FG001|Overall Study|Physician Decision|7|||
163166763|NCT01297491|589325763|FG000|Overall Study|Adverse Event|11|||
163166764|NCT01297491|589325764|FG001|Overall Study|Adverse Event|6|||
163166765|NCT01297491|589325763|FG000|Overall Study|Physician Decision|3|||
163166766|NCT01297491|589325764|FG001|Overall Study|Physician Decision|2|||
162817930|NCT04606771|588047590|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
162817931|NCT04606771|588047589|FG000|Overall Study|Death|5|||
162817932|NCT04606771|588047590|FG001|Overall Study|Death|6|||
162817933|NCT04606771|588047589|FG000|Overall Study|Wrong randomisation|0|||
162817934|NCT04606771|588047590|FG001|Overall Study|Wrong randomisation|1|||
162817935|NCT01008696|588047592|FG000|Overall Study|Participant's evasion of hospital visit|5|||
162817936|NCT01008696|588047593|FG001|Overall Study|Participant's evasion of hospital visit|4|||
162817937|NCT01008696|588047592|FG000|Overall Study|Withdrawal by Subject|2|||
162817938|NCT01008696|588047593|FG001|Overall Study|Withdrawal by Subject|4|||
162817939|NCT01008696|588047592|FG000|Overall Study|Physician Decision|5|||
162817940|NCT01008696|588047593|FG001|Overall Study|Physician Decision|1|||
162817941|NCT01008696|588047592|FG000|Overall Study|Adverse Event|1|||
162817942|NCT01008696|588047593|FG001|Overall Study|Adverse Event|0|||
162817943|NCT01008696|588047592|FG000|Overall Study|Participants' non-cooperation|2|||
162817944|NCT01008696|588047593|FG001|Overall Study|Participants' non-cooperation|3|||
162817945|NCT01008696|588047592|FG000|Overall Study|Other|2|||
162817946|NCT01008696|588047593|FG001|Overall Study|Other|3|||
162817947|NCT01008696|588047592|FG000|Overall Study|Other|0|||
162817948|NCT01008696|588047593|FG001|Overall Study|Other|2|||
162817949|NCT01207596|588047594|FG000|Overall Study|Physician Decision|4|||
162817950|NCT01207596|588047594|FG000|Overall Study|Lack of Efficacy|1|||
163166767|NCT01297491|589325763|FG000|Overall Study|Progressive disease|11|||
163166768|NCT01297491|589325764|FG001|Overall Study|Progressive disease|20|||
163166769|NCT01297491|589325763|FG000|Overall Study|Patient/Guardian decision|3|||
163166770|NCT01297491|589325764|FG001|Overall Study|Patient/Guardian decision|4|||
163166771|NCT01297491|589325763|FG000|Overall Study|Death|2|||
163166772|NCT01297491|589325764|FG001|Overall Study|Death|1|||
163166773|NCT01327482|589325770|FG000|Overall Study|Adverse Event|1|||
163166774|NCT00312195|589325771|FG000|Overall Study|Adverse Event|4|||
163166775|NCT00312195|589325772|FG001|Overall Study|Adverse Event|6|||
163166776|NCT00312195|589325771|FG000|Overall Study|Lost to Follow-up|1|||
163166777|NCT00312195|589325772|FG001|Overall Study|Lost to Follow-up|0|||
163166778|NCT00312195|589325771|FG000|Overall Study|Protocol Violation|1|||
163166779|NCT00312195|589325772|FG001|Overall Study|Protocol Violation|0|||
162817951|NCT01207596|588047594|FG000|Overall Study|Adverse Event|3|||
162817952|NCT01207596|588047594|FG000|Overall Study|Withdrawal by Subject|1|||
162817953|NCT03083847|588047595|FG000|Main|Physician Decision|0|||
162817954|NCT03083847|588047596|FG001|Main|Physician Decision|0|||
162817955|NCT03083847|588047597|FG002|Main|Physician Decision|0|||
162817956|NCT03083847|588047598|FG003|Main|Physician Decision|0|||
162817957|NCT03083847|588047599|FG004|Main|Physician Decision|0|||
162817958|NCT03083847|588047600|FG005|Main|Physician Decision|1|||
162817959|NCT03083847|588047601|FG006|Main|Physician Decision|0|||
162817960|NCT03083847|588047602|FG007|Main|Physician Decision|0|||
162817961|NCT03083847|588047603|FG008|Main|Physician Decision|0|||
162817962|NCT03083847|588047604|FG009|Main|Physician Decision|0|||
162817963|NCT03083847|588047595|FG000|Main|Pregnancy|0|||
162817964|NCT03083847|588047596|FG001|Main|Pregnancy|0|||
162817965|NCT03083847|588047597|FG002|Main|Pregnancy|0|||
163166780|NCT01018810|589325773|FG000|Overall Study|Withdrawal by Subject|0|||
163166781|NCT01018810|589325774|FG001|Overall Study|Withdrawal by Subject|1|||
163166782|NCT01018810|589325775|FG002|Overall Study|Withdrawal by Subject|0|||
163166783|NCT01018810|589325776|FG003|Overall Study|Withdrawal by Subject|0|||
163166784|NCT01018810|589325777|FG004|Overall Study|Withdrawal by Subject|0|||
163166785|NCT01018810|589325773|FG000|Overall Study|Sponsor Decision|2|||
163166786|NCT01018810|589325774|FG001|Overall Study|Sponsor Decision|0|||
163166787|NCT01018810|589325775|FG002|Overall Study|Sponsor Decision|1|||
162817966|NCT03083847|588047598|FG003|Main|Pregnancy|0|||
162817967|NCT03083847|588047599|FG004|Main|Pregnancy|0|||
162817968|NCT03083847|588047600|FG005|Main|Pregnancy|0|||
162817969|NCT03083847|588047601|FG006|Main|Pregnancy|0|||
162817970|NCT03083847|588047602|FG007|Main|Pregnancy|1|||
162817971|NCT03083847|588047603|FG008|Main|Pregnancy|0|||
162817972|NCT03083847|588047604|FG009|Main|Pregnancy|0|||
162817973|NCT03083847|588047595|FG000|Main|Adverse Event|0|||
162817974|NCT03083847|588047596|FG001|Main|Adverse Event|0|||
162817975|NCT03083847|588047597|FG002|Main|Adverse Event|0|||
163166788|NCT01018810|589325776|FG003|Overall Study|Sponsor Decision|1|||
163166789|NCT01018810|589325777|FG004|Overall Study|Sponsor Decision|1|||
163166790|NCT04145219|589325778|FG000|Overall Study|Adverse Event|18|||
163166791|NCT04145219|589325779|FG001|Overall Study|Adverse Event|6|||
163166792|NCT04145219|589325778|FG000|Overall Study|Lost to Follow-up|2|||
163166793|NCT04145219|589325779|FG001|Overall Study|Lost to Follow-up|3|||
163166794|NCT04145219|589325778|FG000|Overall Study|Physician Decision|0|||
163166795|NCT04145219|589325779|FG001|Overall Study|Physician Decision|2|||
163166796|NCT04145219|589325778|FG000|Overall Study|Withdrawal by Subject|12|||
163166797|NCT04145219|589325779|FG001|Overall Study|Withdrawal by Subject|8|||
163166798|NCT04145219|589325778|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
163166799|NCT04145219|589325779|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
163166800|NCT01031836|589327570|FG000|Stage I|Adverse Event|1|||
163166801|NCT01031836|589327571|FG001|Stage I|Adverse Event|1|||
163166802|NCT01031836|589327572|FG002|Stage I|Adverse Event|0|||
163166803|NCT01031836|589327573|FG003|Stage I|Adverse Event|0|||
163166804|NCT01031836|589327574|FG004|Stage I|Adverse Event|0|||
163166805|NCT01031836|589327575|FG005|Stage I|Adverse Event|0|||
163166806|NCT01031836|589327570|FG000|Stage I|Other|0|||
163166807|NCT01031836|589327571|FG001|Stage I|Other|1|||
163166808|NCT01031836|589327572|FG002|Stage I|Other|0|||
163166809|NCT01031836|589327573|FG003|Stage I|Other|0|||
163166810|NCT01031836|589327574|FG004|Stage I|Other|0|||
163166811|NCT01031836|589327575|FG005|Stage I|Other|1|||
163166812|NCT01031836|589327570|FG000|Stage II|Adverse Event|0|||
163166813|NCT01031836|589327571|FG001|Stage II|Adverse Event|0|||
163166814|NCT01031836|589327572|FG002|Stage II|Adverse Event|2|||
163166815|NCT01031836|589327573|FG003|Stage II|Adverse Event|2|||
163166816|NCT01031836|589327574|FG004|Stage II|Adverse Event|1|||
163166817|NCT01031836|589327575|FG005|Stage II|Adverse Event|1|||
163166818|NCT01031836|589327570|FG000|Stage II|Other|2|||
163166819|NCT01031836|589327571|FG001|Stage II|Other|0|||
163166820|NCT01031836|589327572|FG002|Stage II|Other|0|||
163166821|NCT01031836|589327573|FG003|Stage II|Other|1|||
163166822|NCT01031836|589327574|FG004|Stage II|Other|1|||
163166823|NCT01031836|589327575|FG005|Stage II|Other|0|||
163166824|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
163166825|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
163166826|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Physician Decision|1|||
163166827|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Physician Decision|1|||
163166828|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
163166829|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
163166830|NCT01888432|589327580|FG000|12-month Analysis (FAS)|Death|4|||
163166831|NCT01888432|589327581|FG001|12-month Analysis (FAS)|Death|3|||
163166832|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Graft loss|0|||
163166833|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Graft loss|1|||
163166834|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
163166835|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
163166836|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Physician Decision|2|||
163166837|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Physician Decision|4|||
163166838|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
163166839|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
163166840|NCT01888432|589327580|FG000|24-month Analysis (FAS)|Death|8|||
163166841|NCT01888432|589327581|FG001|24-month Analysis (FAS)|Death|4|||
163166842|NCT01888432|589327580|FG000|36-month Analysis (Extension)|Death|1|||
163166843|NCT01888432|589327581|FG001|36-month Analysis (Extension)|Death|0|||
163166844|NCT01794338|589327587|FG000|Overall Study|Death|2|||
163166845|NCT01794338|589327588|FG001|Overall Study|Death|0|||
163166846|NCT01794338|589327587|FG000|Overall Study|Lost to Follow-up|6|||
163166847|NCT01794338|589327588|FG001|Overall Study|Lost to Follow-up|9|||
163166848|NCT01754402|589327589|FG000|Overall Study|Death|0|||
163166849|NCT01754402|589327590|FG001|Overall Study|Death|0|||
163166850|NCT01754402|589327591|FG002|Overall Study|Death|1|||
163166851|NCT01754402|589327589|FG000|Overall Study|Adverse Event|2|||
163166852|NCT01754402|589327590|FG001|Overall Study|Adverse Event|2|||
163166853|NCT01754402|589327591|FG002|Overall Study|Adverse Event|1|||
162817976|NCT03083847|588047598|FG003|Main|Adverse Event|0|||
162817977|NCT03083847|588047599|FG004|Main|Adverse Event|0|||
163166854|NCT01754402|589327589|FG000|Overall Study|Withdrawal by Subject|0|||
163166855|NCT01754402|589327590|FG001|Overall Study|Withdrawal by Subject|0|||
163166856|NCT01754402|589327591|FG002|Overall Study|Withdrawal by Subject|1|||
162817978|NCT03083847|588047600|FG005|Main|Adverse Event|0|||
163166857|NCT01754402|589327589|FG000|Overall Study|Lack of Efficacy|0|||
163166858|NCT01754402|589327590|FG001|Overall Study|Lack of Efficacy|0|||
163166859|NCT01754402|589327591|FG002|Overall Study|Lack of Efficacy|1|||
163166860|NCT01282463|589327592|FG000|Overall Study|Lost to Follow-up|1|||
163166861|NCT01282463|589327593|FG001|Overall Study|Lost to Follow-up|0|||
163166862|NCT01282463|589327594|FG002|Overall Study|Lost to Follow-up|0|||
163166863|NCT01282463|589327592|FG000|Overall Study|Withdrawal by Subject|6|||
163166864|NCT01282463|589327593|FG001|Overall Study|Withdrawal by Subject|2|||
163166865|NCT01282463|589327594|FG002|Overall Study|Withdrawal by Subject|3|||
162698266|NCT01027364|587605448|FG000|Overall Study|Protocol Violation|1|||
162817979|NCT03083847|588047601|FG006|Main|Adverse Event|0|||
163166866|NCT01282463|589327592|FG000|Overall Study|"Never Treated Death"|0|||
163166867|NCT01282463|589327593|FG001|Overall Study|"Never Treated Death"|1|||
163166868|NCT01282463|589327594|FG002|Overall Study|"Never Treated Death"|0|||
163166869|NCT01282463|589327592|FG000|Overall Study|"Never Treated PD"|0|||
163166870|NCT01282463|589327593|FG001|Overall Study|"Never Treated PD"|1|||
163166871|NCT01282463|589327594|FG002|Overall Study|"Never Treated PD"|0|||
163166872|NCT01282463|589327592|FG000|Overall Study|Protocol Violation|0|||
163166873|NCT01282463|589327593|FG001|Overall Study|Protocol Violation|0|||
163166874|NCT01282463|589327594|FG002|Overall Study|Protocol Violation|1|||
163166875|NCT01282463|589327592|FG000|Overall Study|Physician Decision|1|||
163166876|NCT01282463|589327593|FG001|Overall Study|Physician Decision|0|||
163166877|NCT01282463|589327594|FG002|Overall Study|Physician Decision|0|||
163166878|NCT02051933|589327595|FG000|Overall Study|Physician Decision|0|||
163166879|NCT02051933|589327596|FG001|Overall Study|Physician Decision|1|||
163166880|NCT01954927|589327597|FG000|Overall Study|Withdrawal by Subject|3|||
163166881|NCT01954927|589327598|FG001|Overall Study|Withdrawal by Subject|1|||
163166882|NCT02156271|589327599|FG000|Overall Study|Physician Decision|4|||
163166883|NCT02156271|589327600|FG001|Overall Study|Physician Decision|3|||
163166884|NCT00955305|589327601|FG000|Overall Study|Disease progression|39|||
163166885|NCT00955305|589327602|FG001|Overall Study|Disease progression|41|||
163166886|NCT00955305|589327601|FG000|Overall Study|Adverse Event|22|||
163166887|NCT00955305|589327602|FG001|Overall Study|Adverse Event|22|||
163166888|NCT00955305|589327601|FG000|Overall Study|Death|2|||
163166889|NCT00955305|589327602|FG001|Overall Study|Death|1|||
163166890|NCT00955305|589327601|FG000|Overall Study|Withdrawal by Subject|5|||
163166891|NCT00955305|589327602|FG001|Overall Study|Withdrawal by Subject|4|||
163166892|NCT00955305|589327601|FG000|Overall Study|Alternative therapy|4|||
163166893|NCT00955305|589327602|FG001|Overall Study|Alternative therapy|0|||
163166894|NCT00955305|589327601|FG000|Overall Study|Other complicating disease|2|||
163166895|NCT00955305|589327602|FG001|Overall Study|Other complicating disease|4|||
163166896|NCT00955305|589327601|FG000|Overall Study|Physician Decision|1|||
163166897|NCT00955305|589327602|FG001|Overall Study|Physician Decision|0|||
163166898|NCT00955305|589327601|FG000|Overall Study|Continued presence of residual disease|0|||
163166899|NCT00955305|589327602|FG001|Overall Study|Continued presence of residual disease|1|||
163166900|NCT00955305|589327601|FG000|Overall Study|Functional decline|2|||
163166901|NCT00955305|589327602|FG001|Overall Study|Functional decline|0|||
163166902|NCT00955305|589327601|FG000|Overall Study|Maximum response achieved|0|||
163166903|NCT00955305|589327602|FG001|Overall Study|Maximum response achieved|1|||
163166904|NCT00955305|589327601|FG000|Overall Study|Lost to Follow-up|0|||
163166905|NCT00955305|589327602|FG001|Overall Study|Lost to Follow-up|1|||
163166906|NCT00955305|589327601|FG000|Overall Study|No off-treatment reason submitted|1|||
163166907|NCT00955305|589327602|FG001|Overall Study|No off-treatment reason submitted|0|||
163166908|NCT00955305|589327601|FG000|Overall Study|Never started protocol treatment|5|||
163166909|NCT00955305|589327602|FG001|Overall Study|Never started protocol treatment|5|||
163166910|NCT00955305|589327601|FG000|Overall Study|Ineligible|5|||
163166911|NCT00955305|589327602|FG001|Overall Study|Ineligible|7|||
163166912|NCT01221285|589327603|FG000|Overall Study|Withdrawal by Subject|1|||
163166913|NCT02123251|589327604|FG000|Overall Study|Death|1|||
163166914|NCT02123251|589327605|FG001|Overall Study|Death|1|||
163166915|NCT02123251|589327604|FG000|Overall Study|Withdrawal by Subject|0|||
163166916|NCT02123251|589327605|FG001|Overall Study|Withdrawal by Subject|3|||
163166917|NCT02123251|589327604|FG000|Overall Study|Lost Medicaid eligibility|29|||
163166918|NCT02123251|589327605|FG001|Overall Study|Lost Medicaid eligibility|22|||
163166919|NCT02123251|589327604|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
162817980|NCT03083847|588047602|FG007|Main|Adverse Event|2|||
162817981|NCT03083847|588047603|FG008|Main|Adverse Event|0|||
162817982|NCT03083847|588047604|FG009|Main|Adverse Event|0|||
162817983|NCT03083847|588047595|FG000|Main|Withdrawal by Subject|0|||
162817984|NCT03083847|588047596|FG001|Main|Withdrawal by Subject|0|||
162817985|NCT03083847|588047597|FG002|Main|Withdrawal by Subject|0|||
162817986|NCT03083847|588047598|FG003|Main|Withdrawal by Subject|0|||
162817987|NCT03083847|588047599|FG004|Main|Withdrawal by Subject|0|||
163166920|NCT02123251|589327605|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
163166921|NCT00375609|589327612|FG000|Overall Study|Did not receive treatment|1|||
163166922|NCT00375609|589327613|FG001|Overall Study|Did not receive treatment|0|||
163166923|NCT00375609|589327614|FG002|Overall Study|Did not receive treatment|0|||
163166924|NCT00375609|589327612|FG000|Overall Study|Adverse Event|0|||
163166925|NCT00375609|589327613|FG001|Overall Study|Adverse Event|3|||
163166926|NCT00375609|589327614|FG002|Overall Study|Adverse Event|0|||
163166927|NCT00375609|589327612|FG000|Overall Study|Lost to Follow-up|1|||
163166928|NCT00375609|589327613|FG001|Overall Study|Lost to Follow-up|0|||
163166929|NCT00375609|589327614|FG002|Overall Study|Lost to Follow-up|0|||
163166930|NCT00375609|589327612|FG000|Overall Study|Physician Decision|0|||
163166931|NCT00375609|589327613|FG001|Overall Study|Physician Decision|0|||
163166932|NCT00375609|589327614|FG002|Overall Study|Physician Decision|1|||
162817988|NCT03083847|588047600|FG005|Main|Withdrawal by Subject|0|||
163166933|NCT00375609|589327612|FG000|Overall Study|Withdrawal by Subject|1|||
163166934|NCT00375609|589327613|FG001|Overall Study|Withdrawal by Subject|4|||
163166935|NCT00375609|589327614|FG002|Overall Study|Withdrawal by Subject|0|||
163166936|NCT00375609|589327612|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
163166937|NCT00375609|589327613|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
163166938|NCT00375609|589327614|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
163166939|NCT02338882|589327615|FG000|Overall Study|Death|1|||
163166940|NCT02338882|589327616|FG001|Overall Study|Death|0|||
163166941|NCT02338882|589327615|FG000|Overall Study|Lost to Follow-up|6|||
163166942|NCT02338882|589327616|FG001|Overall Study|Lost to Follow-up|3|||
163166943|NCT02184455|589327617|FG000|Overall Study|Lost to Follow-up|1|||
163166944|NCT00617669|589327624|FG000|Overall Study|Withdrawal by Subject|71|||
163166945|NCT00617669|589327625|FG001|Overall Study|Withdrawal by Subject|77|||
163166946|NCT00617669|589327624|FG000|Overall Study|Lost to Follow-up|3|||
163166947|NCT00617669|589327625|FG001|Overall Study|Lost to Follow-up|2|||
163166948|NCT00617669|589327624|FG000|Overall Study|Adverse Event|87|||
163166949|NCT00617669|589327625|FG001|Overall Study|Adverse Event|76|||
163166950|NCT00617669|589327624|FG000|Overall Study|Protocol Violation|2|||
163166951|NCT00617669|589327625|FG001|Overall Study|Protocol Violation|3|||
163166952|NCT00617669|589327624|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
163166953|NCT00617669|589327625|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
163166954|NCT00617669|589327624|FG000|Overall Study|Patients randomized but not treated|2|||
163166955|NCT00617669|589327625|FG001|Overall Study|Patients randomized but not treated|3|||
163166956|NCT00926029|589327626|FG000|Overall Study|Lost to Follow-up|2|||
163166957|NCT00926029|589327627|FG001|Overall Study|Lost to Follow-up|1|||
163166958|NCT00926029|589327628|FG002|Overall Study|Lost to Follow-up|1|||
163166959|NCT03206788|589327629|FG000|Overall Study|Withdrawal by Subject|0|||
163166960|NCT03206788|589327630|FG001|Overall Study|Withdrawal by Subject|1|||
163166961|NCT03206788|589327629|FG000|Overall Study|Adverse Event|0|||
163166962|NCT03206788|589327630|FG001|Overall Study|Adverse Event|1|||
163166963|NCT03206788|589327629|FG000|Overall Study|Physician Decision|0|||
163166964|NCT03206788|589327630|FG001|Overall Study|Physician Decision|1|||
163166965|NCT02082340|589327631|FG000|Overall Study|Lost to Follow-up|1|||
163166966|NCT02082340|589327632|FG001|Overall Study|Lost to Follow-up|1|||
163166967|NCT00833417|589327633|FG000|Overall Study|Adverse Event|5|||
163166968|NCT00833417|589327634|FG001|Overall Study|Adverse Event|16|||
163166969|NCT00833417|589327633|FG000|Overall Study|Death|1|||
163166970|NCT00833417|589327634|FG001|Overall Study|Death|3|||
163166971|NCT00833417|589327633|FG000|Overall Study|Lost to Follow-up|1|||
163166972|NCT00833417|589327634|FG001|Overall Study|Lost to Follow-up|2|||
163166973|NCT00833417|589327633|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
163166974|NCT00833417|589327634|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
163166975|NCT00833417|589327633|FG000|Overall Study|Patient Decision to Withdraw|4|||
163166976|NCT00833417|589327634|FG001|Overall Study|Patient Decision to Withdraw|23|||
163166977|NCT00833417|589327633|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
163166978|NCT00833417|589327634|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
163166979|NCT00833417|589327633|FG000|Overall Study|Disease Progression|18|||
163166980|NCT00833417|589327634|FG001|Overall Study|Disease Progression|17|||
163166981|NCT00833417|589327633|FG000|Overall Study|Reason Not Specified|0|||
163166982|NCT00833417|589327634|FG001|Overall Study|Reason Not Specified|1|||
163166983|NCT01625260|589327635|FG000|Overall Study|Adverse Event|3|||
163166984|NCT01625260|589327636|FG001|Overall Study|Adverse Event|0|||
163166985|NCT01625260|589327635|FG000|Overall Study|Study Terminated by Investigator|2|||
163166986|NCT01625260|589327636|FG001|Overall Study|Study Terminated by Investigator|0|||
163166987|NCT01625260|589327635|FG000|Overall Study|Disease Progression|2|||
163166988|NCT01625260|589327636|FG001|Overall Study|Disease Progression|0|||
163166989|NCT01625260|589327635|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
163166990|NCT01625260|589327636|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
163166991|NCT05573386|589327637|FG000|Overall Study|Withdrawal by Subject|3|||
163166992|NCT05573386|589327638|FG001|Overall Study|Withdrawal by Subject|2|||
163166993|NCT03899805|589327639|FG000|Overall Study|Physician Decision|3|||
163166994|NCT03899805|589327640|FG001|Overall Study|Physician Decision|0|||
163166995|NCT03899805|589327641|FG002|Overall Study|Physician Decision|2|||
163166996|NCT03899805|589327639|FG000|Overall Study|Withdrawal by Subject|1|||
163166997|NCT03899805|589327640|FG001|Overall Study|Withdrawal by Subject|0|||
163166998|NCT03899805|589327641|FG002|Overall Study|Withdrawal by Subject|2|||
163166999|NCT03899805|589327639|FG000|Overall Study|Progressive Disease|10|||
163167000|NCT03899805|589327640|FG001|Overall Study|Progressive Disease|18|||
163167001|NCT03899805|589327641|FG002|Overall Study|Progressive Disease|12|||
163167002|NCT03899805|589327639|FG000|Overall Study|Adverse Event|3|||
163167003|NCT03899805|589327640|FG001|Overall Study|Adverse Event|1|||
163167004|NCT03899805|589327641|FG002|Overall Study|Adverse Event|0|||
163167005|NCT03899805|589327639|FG000|Overall Study|Death|2|||
163167006|NCT03899805|589327640|FG001|Overall Study|Death|0|||
163167007|NCT03899805|589327641|FG002|Overall Study|Death|0|||
163167008|NCT03899805|589327639|FG000|Overall Study|Came off for surgery|0|||
163167009|NCT03899805|589327640|FG001|Overall Study|Came off for surgery|0|||
163167010|NCT03899805|589327641|FG002|Overall Study|Came off for surgery|1|||
163167011|NCT04195893|589327642|FG000|Second Intervention|Withdrawal by Subject|1|||
163167012|NCT04195893|589327643|FG001|Second Intervention|Withdrawal by Subject|0|||
163167013|NCT01137604|589327649|FG000|Overall Study|Adverse Event|3|||
163167014|NCT01137604|589327650|FG001|Overall Study|Adverse Event|6|||
163167015|NCT01137604|589327651|FG002|Overall Study|Adverse Event|9|||
163167016|NCT01137604|589327652|FG003|Overall Study|Adverse Event|9|||
163167017|NCT01137604|589327649|FG000|Overall Study|Participant Choice|0|||
163167018|NCT01137604|589327650|FG001|Overall Study|Participant Choice|2|||
163167019|NCT01137604|589327651|FG002|Overall Study|Participant Choice|2|||
163167020|NCT01137604|589327652|FG003|Overall Study|Participant Choice|0|||
163167021|NCT01137604|589327649|FG000|Overall Study|Withdrawal of consent|0|||
163167022|NCT01137604|589327650|FG001|Overall Study|Withdrawal of consent|0|||
163167023|NCT01137604|589327651|FG002|Overall Study|Withdrawal of consent|0|||
163167024|NCT01137604|589327652|FG003|Overall Study|Withdrawal of consent|2|||
163167025|NCT01137604|589327649|FG000|Overall Study|Clinical progression/deterioration|1|||
163167026|NCT01137604|589327650|FG001|Overall Study|Clinical progression/deterioration|2|||
163167027|NCT01137604|589327651|FG002|Overall Study|Clinical progression/deterioration|2|||
163167028|NCT01137604|589327652|FG003|Overall Study|Clinical progression/deterioration|0|||
163167029|NCT01776307|589327653|FG000|Overall Study|Not dosed|0|||
163167030|NCT01776307|589327654|FG001|Overall Study|Not dosed|0|||
163167031|NCT01776307|589327655|FG002|Overall Study|Not dosed|1|||
163167032|NCT00567255|589327656|FG000|Overall Study|Adverse Event|241|||
163167033|NCT00567255|589327657|FG001|Overall Study|Adverse Event|68|||
163167034|NCT00567255|589327656|FG000|Overall Study|Lost to Follow-up|77|||
163167035|NCT00567255|589327657|FG001|Overall Study|Lost to Follow-up|48|||
163167036|NCT00567255|589327656|FG000|Overall Study|Withdrawal by Subject|75|||
163167037|NCT00567255|589327657|FG001|Overall Study|Withdrawal by Subject|56|||
163167038|NCT00567255|589327656|FG000|Overall Study|Lack of Efficacy|19|||
163167039|NCT00567255|589327657|FG001|Overall Study|Lack of Efficacy|33|||
163167040|NCT00567255|589327656|FG000|Overall Study|Protocol Violation|20|||
163167041|NCT00567255|589327657|FG001|Overall Study|Protocol Violation|8|||
163167042|NCT00567255|589327656|FG000|Overall Study|Pregnancy|6|||
163167043|NCT00567255|589327657|FG001|Overall Study|Pregnancy|0|||
163167044|NCT00567255|589327656|FG000|Overall Study|Drug noncompliance,moved,other|25|||
163167045|NCT00567255|589327657|FG001|Overall Study|Drug noncompliance,moved,other|15|||
163167046|NCT03672097|589327660|FG000|Period 1|Withdrawal by Subject|2|||
163167047|NCT03672097|589327660|FG000|Period 1|Adverse Event|1|||
163167048|NCT03672097|589327660|FG000|Period 1|Did not receive treatment|1|||
163167049|NCT03672097|589327660|FG000|Period 2|Withdrawal by Subject|3|||
163167050|NCT03672097|589327660|FG000|Period 2|Other|1|||
163167051|NCT01459497|589327661|FG000|Overall Study|Inability to meet trial constraints.|1|||
163167052|NCT01459497|589327662|FG001|Overall Study|Inability to meet trial constraints.|0|||
163167053|NCT01459497|589327661|FG000|Overall Study|Physician Decision|1|||
163167054|NCT01459497|589327662|FG001|Overall Study|Physician Decision|1|||
163167055|NCT01459497|589327661|FG000|Overall Study|Hospitalization.|0|||
163167056|NCT01459497|589327662|FG001|Overall Study|Hospitalization.|3|||
163167057|NCT01459497|589327661|FG000|Overall Study|Disease progression.|0|||
163167058|NCT01459497|589327662|FG001|Overall Study|Disease progression.|1|||
163167059|NCT00080899|589327663|FG000|Overall Study|Adverse Event|1|||
163167060|NCT02872935|589327664|FG000|Overall Study|Other|0|||
163167061|NCT02872935|589327665|FG001|Overall Study|Other|1|||
163167062|NCT03530124|589327666|FG000|Overall Study|Withdrawal by Subject|0|||
163167063|NCT03530124|589327667|FG001|Overall Study|Withdrawal by Subject|1|||
163167064|NCT03530124|589327666|FG000|Overall Study|Protocol Violation|1|||
163167065|NCT03530124|589327667|FG001|Overall Study|Protocol Violation|0|||
163167066|NCT03530124|589327666|FG000|Overall Study|Discharged prior to study completion|1|||
163167067|NCT03530124|589327667|FG001|Overall Study|Discharged prior to study completion|0|||
163167068|NCT05343624|589327668|FG000|Overall Study|Chart review not completed|1|||
163167069|NCT00862082|589327669|FG000|Overall Study|Sponsor decision to terminate the study|5|||
163167070|NCT00862082|589327670|FG001|Overall Study|Sponsor decision to terminate the study|0|||
163167071|NCT00862082|589327669|FG000|Overall Study|Withdrawal by Subject|0|||
163167072|NCT00862082|589327670|FG001|Overall Study|Withdrawal by Subject|1|||
163167073|NCT02791763|589327674|FG000|Overall Study|Protocol Violation|0|||
162817989|NCT03083847|588047601|FG006|Main|Withdrawal by Subject|1|||
162817990|NCT03083847|588047602|FG007|Main|Withdrawal by Subject|1|||
163167074|NCT02791763|589327675|FG001|Overall Study|Protocol Violation|0|||
163167075|NCT02791763|589327676|FG002|Overall Study|Protocol Violation|1|||
163167076|NCT02791763|589327674|FG000|Overall Study|Withdrawal by Subject|5|||
163167077|NCT02791763|589327675|FG001|Overall Study|Withdrawal by Subject|1|||
163167078|NCT02791763|589327676|FG002|Overall Study|Withdrawal by Subject|0|||
163167079|NCT02791763|589327674|FG000|Overall Study|Physician Decision|0|||
163167080|NCT02791763|589327675|FG001|Overall Study|Physician Decision|1|||
163167081|NCT02791763|589327676|FG002|Overall Study|Physician Decision|0|||
163167082|NCT02791763|589327674|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
163167083|NCT02791763|589327675|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
163167084|NCT02791763|589327676|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
163167085|NCT02791763|589327674|FG000|Overall Study|Cancer event|1|||
163167086|NCT02791763|589327675|FG001|Overall Study|Cancer event|3|||
163167087|NCT02791763|589327676|FG002|Overall Study|Cancer event|0|||
163167088|NCT02791763|589327674|FG000|Overall Study|Participant had renal transplant|3|||
163167089|NCT02791763|589327675|FG001|Overall Study|Participant had renal transplant|0|||
163167090|NCT02791763|589327676|FG002|Overall Study|Participant had renal transplant|0|||
163167091|NCT02791763|589327674|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
163167092|NCT02791763|589327675|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
163167093|NCT02791763|589327676|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
163167094|NCT02791763|589327674|FG000|Overall Study|Adverse Event|12|||
163167095|NCT02791763|589327675|FG001|Overall Study|Adverse Event|13|||
163167096|NCT02791763|589327676|FG002|Overall Study|Adverse Event|7|||
163167097|NCT05334212|589327677|FG000|Overall Study|Study terminated prematurely|7|||
163167098|NCT00910299|589327678|FG000|Overall Study|Withdrawal by Subject|16|||
163167099|NCT00910299|589327679|FG001|Overall Study|Withdrawal by Subject|13|||
163167100|NCT00910299|589327678|FG000|Overall Study|Sponsor Decision|58|||
163167101|NCT00910299|589327679|FG001|Overall Study|Sponsor Decision|60|||
163167102|NCT00910299|589327678|FG000|Overall Study|Didn't receive any study drug|2|||
163167103|NCT00910299|589327679|FG001|Overall Study|Didn't receive any study drug|1|||
163167104|NCT01456897|589327680|FG000|Overall Study|Adverse Event|19|||
163167105|NCT01456897|589327681|FG001|Overall Study|Adverse Event|22|||
163167106|NCT01456897|589327680|FG000|Overall Study|Protocol Violation|3|||
163167107|NCT01456897|589327681|FG001|Overall Study|Protocol Violation|4|||
163167108|NCT01456897|589327680|FG000|Overall Study|Physician Decision|5|||
163167109|NCT01456897|589327681|FG001|Overall Study|Physician Decision|3|||
163167110|NCT01456897|589327680|FG000|Overall Study|Withdrawal by Subject|44|||
163167111|NCT01456897|589327681|FG001|Overall Study|Withdrawal by Subject|17|||
163167112|NCT01456897|589327680|FG000|Overall Study|Lack of Efficacy|4|||
163167113|NCT01456897|589327681|FG001|Overall Study|Lack of Efficacy|11|||
163167114|NCT04535453|589327682|FG000|Overall Study|Death|0|||
163167115|NCT04535453|589327683|FG001|Overall Study|Death|1|||
163167116|NCT04535453|589327684|FG002|Overall Study|Death|0|||
163167117|NCT04535453|589327685|FG003|Overall Study|Death|0|||
163167118|NCT04535453|589327686|FG004|Overall Study|Death|0|||
163167119|NCT04535453|589327687|FG005|Overall Study|Death|0|||
163167120|NCT04535453|589327688|FG006|Overall Study|Death|0|||
163167121|NCT04535453|589327689|FG007|Overall Study|Death|0|||
163167122|NCT04535453|589327690|FG008|Overall Study|Death|0|||
163167123|NCT04535453|589327691|FG009|Overall Study|Death|0|||
163167124|NCT04535453|589327692|FG010|Overall Study|Death|0|||
163167125|NCT04535453|589327693|FG011|Overall Study|Death|0|||
163167126|NCT04535453|589327682|FG000|Overall Study|Lost to Follow-up|1|||
163167127|NCT04535453|589327683|FG001|Overall Study|Lost to Follow-up|1|||
163167128|NCT04535453|589327684|FG002|Overall Study|Lost to Follow-up|1|||
163167129|NCT04535453|589327685|FG003|Overall Study|Lost to Follow-up|0|||
163167130|NCT04535453|589327686|FG004|Overall Study|Lost to Follow-up|3|||
163167131|NCT04535453|589327687|FG005|Overall Study|Lost to Follow-up|1|||
163167132|NCT04535453|589327688|FG006|Overall Study|Lost to Follow-up|0|||
163167133|NCT04535453|589327689|FG007|Overall Study|Lost to Follow-up|0|||
163167134|NCT04535453|589327690|FG008|Overall Study|Lost to Follow-up|1|||
163167135|NCT04535453|589327691|FG009|Overall Study|Lost to Follow-up|1|||
163167136|NCT04535453|589327692|FG010|Overall Study|Lost to Follow-up|0|||
163167137|NCT04535453|589327693|FG011|Overall Study|Lost to Follow-up|0|||
163167138|NCT04535453|589327682|FG000|Overall Study|Physician Decision|0|||
163167139|NCT04535453|589327683|FG001|Overall Study|Physician Decision|0|||
163167140|NCT04535453|589327684|FG002|Overall Study|Physician Decision|0|||
163167141|NCT04535453|589327685|FG003|Overall Study|Physician Decision|1|||
163167142|NCT04535453|589327686|FG004|Overall Study|Physician Decision|0|||
163167143|NCT04535453|589327687|FG005|Overall Study|Physician Decision|0|||
163167144|NCT04535453|589327688|FG006|Overall Study|Physician Decision|0|||
163167145|NCT04535453|589327689|FG007|Overall Study|Physician Decision|0|||
163167146|NCT04535453|589327690|FG008|Overall Study|Physician Decision|0|||
163167147|NCT04535453|589327691|FG009|Overall Study|Physician Decision|0|||
163167148|NCT04535453|589327692|FG010|Overall Study|Physician Decision|0|||
163167149|NCT04535453|589327693|FG011|Overall Study|Physician Decision|0|||
163167150|NCT04535453|589327682|FG000|Overall Study|Withdrawal by Subject|3|||
163167151|NCT04535453|589327683|FG001|Overall Study|Withdrawal by Subject|6|||
163167152|NCT04535453|589327684|FG002|Overall Study|Withdrawal by Subject|3|||
163167153|NCT04535453|589327685|FG003|Overall Study|Withdrawal by Subject|3|||
162817991|NCT03083847|588047603|FG008|Main|Withdrawal by Subject|0|||
163167154|NCT04535453|589327686|FG004|Overall Study|Withdrawal by Subject|2|||
163167155|NCT04535453|589327687|FG005|Overall Study|Withdrawal by Subject|1|||
163167156|NCT04535453|589327688|FG006|Overall Study|Withdrawal by Subject|1|||
163167157|NCT04535453|589327689|FG007|Overall Study|Withdrawal by Subject|1|||
163167158|NCT04535453|589327690|FG008|Overall Study|Withdrawal by Subject|1|||
163167159|NCT04535453|589327691|FG009|Overall Study|Withdrawal by Subject|1|||
163167160|NCT04535453|589327692|FG010|Overall Study|Withdrawal by Subject|0|||
163167161|NCT04535453|589327693|FG011|Overall Study|Withdrawal by Subject|1|||
163167162|NCT04535453|589327682|FG000|Overall Study|Other|0|||
163167163|NCT04535453|589327683|FG001|Overall Study|Other|0|||
163167164|NCT04535453|589327684|FG002|Overall Study|Other|1|||
163167165|NCT04535453|589327685|FG003|Overall Study|Other|0|||
163167166|NCT04535453|589327686|FG004|Overall Study|Other|1|||
163167167|NCT04535453|589327687|FG005|Overall Study|Other|0|||
163167168|NCT04535453|589327688|FG006|Overall Study|Other|1|||
163167169|NCT04535453|589327689|FG007|Overall Study|Other|1|||
163167170|NCT04535453|589327690|FG008|Overall Study|Other|1|||
163167171|NCT04535453|589327691|FG009|Overall Study|Other|0|||
163167172|NCT04535453|589327692|FG010|Overall Study|Other|0|||
163167173|NCT04535453|589327693|FG011|Overall Study|Other|0|||
163167174|NCT02878798|589327694|FG000|Overall Study|Withdrawal by Subject|5|||
163167175|NCT02878798|589327695|FG001|Overall Study|Withdrawal by Subject|4|||
163167176|NCT02878798|589327694|FG000|Overall Study|Lost to Follow-up|2|||
163167177|NCT02878798|589327695|FG001|Overall Study|Lost to Follow-up|2|||
163167178|NCT02878798|589327694|FG000|Overall Study|Protocol Violation|0|||
163167179|NCT02878798|589327695|FG001|Overall Study|Protocol Violation|1|||
163167180|NCT02762370|589327696|FG000|Overall Study|Protocol Violation|1|||
163167181|NCT02762370|589327697|FG001|Overall Study|Protocol Violation|0|||
163167182|NCT01708902|589327701|FG000|Overall Study|Adverse Event|3|||
163167183|NCT01708902|589327702|FG001|Overall Study|Adverse Event|4|||
163167184|NCT01708902|589327703|FG002|Overall Study|Adverse Event|9|||
163167185|NCT01708902|589327704|FG003|Overall Study|Adverse Event|2|||
163167186|NCT01708902|589327705|FG004|Overall Study|Adverse Event|7|||
163167187|NCT01708902|589327706|FG005|Overall Study|Adverse Event|3|||
163167188|NCT01708902|589327707|FG006|Overall Study|Adverse Event|5|||
163167189|NCT01708902|589327701|FG000|Overall Study|Lack of Efficacy|3|||
163167190|NCT01708902|589327702|FG001|Overall Study|Lack of Efficacy|1|||
163167191|NCT01708902|589327703|FG002|Overall Study|Lack of Efficacy|0|||
163167192|NCT01708902|589327704|FG003|Overall Study|Lack of Efficacy|0|||
163167193|NCT01708902|589327705|FG004|Overall Study|Lack of Efficacy|0|||
163167194|NCT01708902|589327706|FG005|Overall Study|Lack of Efficacy|1|||
163167195|NCT01708902|589327707|FG006|Overall Study|Lack of Efficacy|0|||
163167196|NCT01708902|589327701|FG000|Overall Study|Non compliance with protocol|0|||
163167197|NCT01708902|589327702|FG001|Overall Study|Non compliance with protocol|2|||
163167198|NCT01708902|589327703|FG002|Overall Study|Non compliance with protocol|1|||
163167199|NCT01708902|589327704|FG003|Overall Study|Non compliance with protocol|3|||
163167200|NCT01708902|589327705|FG004|Overall Study|Non compliance with protocol|0|||
163167201|NCT01708902|589327706|FG005|Overall Study|Non compliance with protocol|0|||
163167202|NCT01708902|589327707|FG006|Overall Study|Non compliance with protocol|0|||
163167203|NCT01708902|589327701|FG000|Overall Study|Lost to Follow-up|2|||
163167204|NCT01708902|589327702|FG001|Overall Study|Lost to Follow-up|1|||
163167205|NCT01708902|589327703|FG002|Overall Study|Lost to Follow-up|2|||
163167206|NCT01708902|589327704|FG003|Overall Study|Lost to Follow-up|2|||
163167207|NCT01708902|589327705|FG004|Overall Study|Lost to Follow-up|0|||
163167208|NCT01708902|589327706|FG005|Overall Study|Lost to Follow-up|0|||
163167209|NCT01708902|589327707|FG006|Overall Study|Lost to Follow-up|1|||
163167210|NCT01708902|589327701|FG000|Overall Study|Refused to continue trial medication|8|||
163167211|NCT01708902|589327702|FG001|Overall Study|Refused to continue trial medication|0|||
163167212|NCT01708902|589327703|FG002|Overall Study|Refused to continue trial medication|4|||
163167213|NCT01708902|589327704|FG003|Overall Study|Refused to continue trial medication|2|||
163167214|NCT01708902|589327705|FG004|Overall Study|Refused to continue trial medication|8|||
163167215|NCT01708902|589327706|FG005|Overall Study|Refused to continue trial medication|1|||
163167216|NCT01708902|589327707|FG006|Overall Study|Refused to continue trial medication|1|||
163167217|NCT01708902|589327701|FG000|Overall Study|Other Reason|1|||
163167218|NCT01708902|589327702|FG001|Overall Study|Other Reason|0|||
163167219|NCT01708902|589327703|FG002|Overall Study|Other Reason|1|||
163167220|NCT01708902|589327704|FG003|Overall Study|Other Reason|1|||
163167221|NCT01708902|589327705|FG004|Overall Study|Other Reason|1|||
163167222|NCT01708902|589327706|FG005|Overall Study|Other Reason|2|||
163167223|NCT01708902|589327707|FG006|Overall Study|Other Reason|0|||
163167224|NCT00530816|589327711|FG000|Overall Study|Progressive Disease|16|||
163167225|NCT00530816|589327712|FG001|Overall Study|Progressive Disease|24|||
163167226|NCT00530816|589327713|FG002|Overall Study|Progressive Disease|24|||
163167227|NCT00530816|589327711|FG000|Overall Study|Adverse Event|6|||
163167228|NCT00530816|589327712|FG001|Overall Study|Adverse Event|13|||
163167229|NCT00530816|589327713|FG002|Overall Study|Adverse Event|7|||
163167230|NCT00530816|589327711|FG000|Overall Study|Other|3|||
163167231|NCT00530816|589327712|FG001|Overall Study|Other|3|||
163167232|NCT00530816|589327713|FG002|Overall Study|Other|4|||
163167233|NCT00530816|589327711|FG000|Overall Study|Withdrawal by Subject|1|||
163167234|NCT00530816|589327712|FG001|Overall Study|Withdrawal by Subject|2|||
163167235|NCT00530816|589327713|FG002|Overall Study|Withdrawal by Subject|6|||
163167236|NCT02445794|589327714|FG000|Overall Study|Adverse Event|0|||
163167237|NCT02445794|589327715|FG001|Overall Study|Adverse Event|0|||
163167238|NCT02445794|589327716|FG002|Overall Study|Adverse Event|2|||
163167239|NCT02445794|589327717|FG003|Overall Study|Adverse Event|0|||
163167240|NCT01388985|589327718|FG000|Overall Study|Death|0|||
163167241|NCT01388985|589327719|FG001|Overall Study|Death|1|||
163167242|NCT01388985|589327718|FG000|Overall Study|Lost to Follow-up|30|||
163167243|NCT01388985|589327719|FG001|Overall Study|Lost to Follow-up|30|||
163167244|NCT01388985|589327718|FG000|Overall Study|Withdrawal by Subject|13|||
163167245|NCT01388985|589327719|FG001|Overall Study|Withdrawal by Subject|4|||
163167246|NCT01388985|589327718|FG000|Overall Study|Subject unavailable|1|||
163167247|NCT01388985|589327719|FG001|Overall Study|Subject unavailable|1|||
163167248|NCT01388985|589327718|FG000|Overall Study|Other (no reason)|0|||
163167249|NCT01388985|589327719|FG001|Overall Study|Other (no reason)|1|||
163167250|NCT01388985|589327718|FG000|Overall Study|Error of nurse|5|||
163167251|NCT01388985|589327719|FG001|Overall Study|Error of nurse|1|||
163167252|NCT01057589|589327720|FG000|Overall Study|Disease Progression|35|||
163167253|NCT01057589|589327720|FG000|Overall Study|Adverse Event|10|||
163167254|NCT01057589|589327720|FG000|Overall Study|Physician Decision|8|||
163167255|NCT01057589|589327720|FG000|Overall Study|Withdrawal by Subject|3|||
163167256|NCT01057589|589327720|FG000|Overall Study|Sponsor Decision|1|||
163167257|NCT01057589|589327720|FG000|Overall Study|Death|8|||
163167258|NCT01057589|589327720|FG000|Overall Study|Lost to Follow-up|1|||
163167259|NCT01519167|589327723|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
163167260|NCT01519167|589327724|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
163167261|NCT01519167|589327723|FG000|Overall Study|Adverse Event|0|||
163167262|NCT01519167|589327724|FG001|Overall Study|Adverse Event|1|||
163167263|NCT01519167|589327723|FG000|Overall Study|Lack of Efficacy|0|||
163167264|NCT01519167|589327724|FG001|Overall Study|Lack of Efficacy|1|||
163167265|NCT01519167|589327723|FG000|Overall Study|Medical condition changes&deep sedation|0|||
163167266|NCT01519167|589327724|FG001|Overall Study|Medical condition changes&deep sedation|2|||
163167267|NCT01519167|589327723|FG000|Overall Study|Physician Decision|0|||
163167268|NCT01519167|589327724|FG001|Overall Study|Physician Decision|1|||
163167269|NCT00870584|589327730|FG000|Overall Study|Adverse Event|3|||
163167270|NCT00870584|589327731|FG001|Overall Study|Adverse Event|3|||
163167271|NCT00870584|589327730|FG000|Overall Study|Withdrawal by Subject|6|||
163167272|NCT00870584|589327731|FG001|Overall Study|Withdrawal by Subject|7|||
163167273|NCT00870584|589327730|FG000|Overall Study|Lost to Follow-up|5|||
163167274|NCT00870584|589327731|FG001|Overall Study|Lost to Follow-up|1|||
163167275|NCT00870584|589327730|FG000|Overall Study|Protocol Deviation|2|||
163167276|NCT00870584|589327731|FG001|Overall Study|Protocol Deviation|2|||
163167277|NCT02560025|589327732|FG000|Overall Study|Ineligible after consent/ registration|3|||
163167278|NCT01497366|589327733|FG000|Overall Study|Virologic failure|2|||
163167279|NCT01497366|589327734|FG001|Overall Study|Virologic failure|50|||
163167280|NCT01497366|589327733|FG000|Overall Study|Lost to Follow-up|11|||
163167281|NCT01497366|589327734|FG001|Overall Study|Lost to Follow-up|10|||
163167282|NCT01497366|589327733|FG000|Overall Study|Withdrawal by Subject|6|||
163167283|NCT01497366|589327734|FG001|Overall Study|Withdrawal by Subject|6|||
163167284|NCT01497366|589327733|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
163167285|NCT01497366|589327734|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
163167286|NCT01497366|589327733|FG000|Overall Study|Other|5|||
163167287|NCT01497366|589327734|FG001|Overall Study|Other|0|||
163167288|NCT01497366|589327733|FG000|Overall Study|Death|1|||
163167289|NCT01497366|589327734|FG001|Overall Study|Death|1|||
163167290|NCT01497366|589327733|FG000|Overall Study|Randomized but not treated|7|||
163167291|NCT01497366|589327734|FG001|Overall Study|Randomized but not treated|21|||
163167292|NCT02745080|589327744|FG000|Overall Study|Adverse Event|13|||
163167293|NCT02745080|589327745|FG001|Overall Study|Adverse Event|21|||
163167294|NCT02745080|589327744|FG000|Overall Study|Lack of Efficacy|11|||
163167295|NCT02745080|589327745|FG001|Overall Study|Lack of Efficacy|23|||
163167296|NCT02745080|589327744|FG000|Overall Study|Lost to Follow-up|3|||
163167297|NCT02745080|589327745|FG001|Overall Study|Lost to Follow-up|3|||
163167298|NCT02745080|589327744|FG000|Overall Study|Physician Decision|3|||
163167299|NCT02745080|589327745|FG001|Overall Study|Physician Decision|0|||
163167300|NCT02745080|589327744|FG000|Overall Study|Protocol Violation|3|||
163167301|NCT02745080|589327745|FG001|Overall Study|Protocol Violation|1|||
163167302|NCT02745080|589327744|FG000|Overall Study|Withdrawal by Subject|22|||
163167303|NCT02745080|589327745|FG001|Overall Study|Withdrawal by Subject|41|||
163167304|NCT00472030|589327749|FG000|Overall Study|Physician Decision|1|||
162817992|NCT03083847|588047604|FG009|Main|Withdrawal by Subject|0|||
163167305|NCT00472030|589327750|FG001|Overall Study|Physician Decision|0|||
163167306|NCT00829504|589327751|FG000|First Intervention|Adverse Event|1|||
163167307|NCT00829504|589327752|FG001|First Intervention|Adverse Event|0|||
163167308|NCT00829504|589327751|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163167309|NCT00829504|589327752|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163167310|NCT00829504|589327751|FG000|Second Intervention|Physician Decision|1|||
163167311|NCT00829504|589327752|FG001|Second Intervention|Physician Decision|0|||
163167312|NCT02248675|589328962|FG000|Overall Study|Lost to Follow-up|3|||
163167313|NCT02248675|589328963|FG001|Overall Study|Lost to Follow-up|1|||
163167314|NCT03745820|589328966|FG000|Overall Study|Adverse Event|0|||
163167315|NCT03745820|589328967|FG001|Overall Study|Adverse Event|3|||
163167316|NCT03745820|589328968|FG002|Overall Study|Adverse Event|2|||
163167317|NCT03745820|589328966|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163167318|NCT03745820|589328967|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163167319|NCT03745820|589328968|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163167320|NCT03745820|589328966|FG000|Overall Study|Withdrawal by Subject|4|||
163167321|NCT03745820|589328967|FG001|Overall Study|Withdrawal by Subject|4|||
163167322|NCT03745820|589328968|FG002|Overall Study|Withdrawal by Subject|4|||
163167323|NCT03745820|589328966|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
163167324|NCT03745820|589328967|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
163167325|NCT03745820|589328968|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
163167326|NCT03745820|589328966|FG000|Overall Study|Lost to Follow-up|2|||
163167327|NCT03745820|589328967|FG001|Overall Study|Lost to Follow-up|0|||
163167328|NCT03745820|589328968|FG002|Overall Study|Lost to Follow-up|3|||
163167329|NCT03745820|589328966|FG000|Overall Study|Reason not Specified|2|||
163167330|NCT03745820|589328967|FG001|Overall Study|Reason not Specified|4|||
163167331|NCT03745820|589328968|FG002|Overall Study|Reason not Specified|1|||
163167332|NCT04250077|589328977|FG000|Overall Study|Withdrawal by Subject|0|||
163167333|NCT04250077|589328978|FG001|Overall Study|Withdrawal by Subject|1|||
163167334|NCT04250077|589328979|FG002|Overall Study|Withdrawal by Subject|0|||
163167335|NCT04250077|589328977|FG000|Overall Study|Lost to Follow-up|2|||
163167336|NCT04250077|589328978|FG001|Overall Study|Lost to Follow-up|3|||
163167337|NCT04250077|589328979|FG002|Overall Study|Lost to Follow-up|0|||
163167338|NCT02471612|589328980|FG000|Overall Study|Lost to Follow-up|2|||
163167339|NCT01598129|589328981|FG000|Overall Study|Disease progression|6|||
163167340|NCT01598129|589328981|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
163167341|NCT01598129|589328981|FG000|Overall Study|Withdrawal by Subject|1|||
163167342|NCT00591318|589328982|FG000|Overall Study|Lack of Efficacy|2|||
163167343|NCT00591318|589328983|FG001|Overall Study|Lack of Efficacy|0|||
163167344|NCT00591318|589328982|FG000|Overall Study|Adverse Event|2|||
163167345|NCT00591318|589328983|FG001|Overall Study|Adverse Event|0|||
163167346|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
163167347|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
163167348|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
163167349|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
163167350|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
163167351|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
163167352|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
163167353|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
163167354|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
163167355|NCT00647270|589328984|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
163167356|NCT00647270|589328985|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
163167357|NCT00647270|589328986|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
163167358|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
163167359|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
163167360|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
163167361|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
163167362|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
163167363|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
163167364|NCT00647270|589328984|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
163167365|NCT00647270|589328985|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
163167366|NCT00647270|589328986|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
163167367|NCT03615040|589328987|FG000|Overall Study|Withdrawal by Subject|2|||
163167368|NCT03615040|589328988|FG001|Overall Study|Withdrawal by Subject|1|||
163167369|NCT03615040|589328987|FG000|Overall Study|Physician Decision|2|||
163167370|NCT03615040|589328988|FG001|Overall Study|Physician Decision|2|||
163167371|NCT03615040|589328987|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
163167372|NCT03615040|589328988|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
163167373|NCT03615040|589328987|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
163167374|NCT03615040|589328988|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
163167375|NCT03615040|589328987|FG000|Overall Study|Death|0|||
163167376|NCT03615040|589328988|FG001|Overall Study|Death|2|||
163167377|NCT01024309|589328991|FG000|Overall Study|Physician Decision|4|||
163167378|NCT01024309|589328992|FG001|Overall Study|Physician Decision|0|||
163167379|NCT01024309|589328991|FG000|Overall Study|Withdrawal by Subject|4|||
163167380|NCT01024309|589328992|FG001|Overall Study|Withdrawal by Subject|4|||
163167381|NCT01743001|589328993|FG000|Overall Study|Physician Decision|1|||
163167382|NCT01743001|589328994|FG001|Overall Study|Physician Decision|0|||
163167383|NCT01743001|589328993|FG000|Overall Study|Pregnancy|1|||
163167384|NCT01743001|589328994|FG001|Overall Study|Pregnancy|0|||
163167385|NCT01743001|589328993|FG000|Overall Study|Death|1|||
163167386|NCT01743001|589328994|FG001|Overall Study|Death|0|||
163167387|NCT02657408|589328997|FG000|Overall Study|Adverse Event|3|||
163167388|NCT02657408|589328998|FG001|Overall Study|Adverse Event|7|||
163167389|NCT01403948|589328999|FG000|Overall Study|Progressive disease|0|||
163167390|NCT01403948|589329000|FG001|Overall Study|Progressive disease|2|||
163167391|NCT01403948|589329001|FG002|Overall Study|Progressive disease|2|||
163167392|NCT01403948|589329002|FG003|Overall Study|Progressive disease|4|||
163167393|NCT01403948|589329003|FG004|Overall Study|Progressive disease|2|||
163167394|NCT01403948|589329004|FG005|Overall Study|Progressive disease|6|||
163167395|NCT01403948|589329005|FG006|Overall Study|Progressive disease|2|||
163167396|NCT01403948|589329006|FG007|Overall Study|Progressive disease|4|||
163167397|NCT01403948|589329007|FG008|Overall Study|Progressive disease|5|||
163167398|NCT01403948|589329008|FG009|Overall Study|Progressive disease|5|||
163167399|NCT01403948|589328999|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167400|NCT01403948|589329000|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167401|NCT01403948|589329001|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167402|NCT01403948|589329002|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167403|NCT01403948|589329003|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
163167404|NCT01403948|589329004|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167405|NCT01403948|589329005|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
163167406|NCT01403948|589329006|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167407|NCT01403948|589329007|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
163167408|NCT01403948|589329008|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
163167409|NCT01403948|589328999|FG000|Overall Study|Lost to Follow-up|0|||
163167410|NCT01403948|589329000|FG001|Overall Study|Lost to Follow-up|0|||
163167411|NCT01403948|589329001|FG002|Overall Study|Lost to Follow-up|0|||
163167412|NCT01403948|589329002|FG003|Overall Study|Lost to Follow-up|0|||
163167413|NCT01403948|589329003|FG004|Overall Study|Lost to Follow-up|0|||
163167414|NCT01403948|589329004|FG005|Overall Study|Lost to Follow-up|0|||
163167415|NCT01403948|589329005|FG006|Overall Study|Lost to Follow-up|0|||
163167416|NCT01403948|589329006|FG007|Overall Study|Lost to Follow-up|0|||
163167417|NCT01403948|589329007|FG008|Overall Study|Lost to Follow-up|0|||
163167418|NCT01403948|589329008|FG009|Overall Study|Lost to Follow-up|1|||
163167419|NCT01403948|589328999|FG000|Overall Study|Refused cont. medication|0|||
163167420|NCT01403948|589329000|FG001|Overall Study|Refused cont. medication|0|||
163167421|NCT01403948|589329001|FG002|Overall Study|Refused cont. medication|0|||
163167422|NCT01403948|589329002|FG003|Overall Study|Refused cont. medication|0|||
163167423|NCT01403948|589329003|FG004|Overall Study|Refused cont. medication|1|||
163167424|NCT01403948|589329004|FG005|Overall Study|Refused cont. medication|0|||
163167425|NCT01403948|589329005|FG006|Overall Study|Refused cont. medication|0|||
163167426|NCT01403948|589329006|FG007|Overall Study|Refused cont. medication|0|||
163167427|NCT01403948|589329007|FG008|Overall Study|Refused cont. medication|0|||
163167428|NCT01403948|589329008|FG009|Overall Study|Refused cont. medication|1|||
163167429|NCT01403948|589328999|FG000|Overall Study|other than above|1|||
163167430|NCT01403948|589329000|FG001|Overall Study|other than above|2|||
163167431|NCT01403948|589329001|FG002|Overall Study|other than above|1|||
163167432|NCT01403948|589329002|FG003|Overall Study|other than above|0|||
163167433|NCT01403948|589329003|FG004|Overall Study|other than above|1|||
163167434|NCT01403948|589329004|FG005|Overall Study|other than above|1|||
163167435|NCT01403948|589329005|FG006|Overall Study|other than above|2|||
163167436|NCT01403948|589329006|FG007|Overall Study|other than above|0|||
163167437|NCT01403948|589329007|FG008|Overall Study|other than above|0|||
163167438|NCT01403948|589329008|FG009|Overall Study|other than above|0|||
163167439|NCT01090323|589329009|FG000|Overall Study|Adverse Event|12|||
163167440|NCT01090323|589329010|FG001|Overall Study|Adverse Event|2|||
163167441|NCT01090323|589329009|FG000|Overall Study|Abnormal Lab Values|3|||
163167442|NCT01090323|589329010|FG001|Overall Study|Abnormal Lab Values|1|||
163167443|NCT01090323|589329009|FG000|Overall Study|Abnormal Test Procedure Results|2|||
163167444|NCT01090323|589329010|FG001|Overall Study|Abnormal Test Procedure Results|0|||
163167445|NCT01090323|589329009|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163167446|NCT01090323|589329010|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162817993|NCT00216203|588047605|FG000|Overall Study|Withdrawal by Subject|2|||
162817994|NCT02596620|588047608|FG000|Overall Study|Lost to Follow-up|1|||
162817995|NCT02596620|588047609|FG001|Overall Study|Lost to Follow-up|1|||
162817996|NCT03155373|588047619|FG000|Overall Study|No longer required surgery|1|||
162817997|NCT03155373|588047619|FG000|Overall Study|Protocol Violation|1|||
162817998|NCT03155373|588047619|FG000|Overall Study|Death|2|||
162817999|NCT03155373|588047619|FG000|Overall Study|Withdrawal by Subject|3|||
162818000|NCT01054144|588047620|FG000|Overall Study|Death|2|||
162818001|NCT02856893|588047621|FG000|Overall Study|Lack of Efficacy|27|||
162818002|NCT02856893|588047622|FG001|Overall Study|Lack of Efficacy|15|||
162818003|NCT02856893|588047623|FG002|Overall Study|Lack of Efficacy|19|||
162818004|NCT02856893|588047621|FG000|Overall Study|Death|1|||
163167447|NCT01090323|589329009|FG000|Overall Study|Condition no longer requires drug|5|||
163167448|NCT01090323|589329010|FG001|Overall Study|Condition no longer requires drug|4|||
163167449|NCT01090323|589329009|FG000|Overall Study|Protocol Violation|2|||
163167450|NCT01090323|589329010|FG001|Overall Study|Protocol Violation|1|||
163167451|NCT01090323|589329009|FG000|Overall Study|Withdrew consent|33|||
163167452|NCT01090323|589329010|FG001|Overall Study|Withdrew consent|11|||
163167453|NCT01090323|589329009|FG000|Overall Study|Lost to Follow-up|11|||
163167454|NCT01090323|589329010|FG001|Overall Study|Lost to Follow-up|6|||
163167455|NCT01090323|589329009|FG000|Overall Study|Administrative problems|6|||
163167456|NCT01090323|589329010|FG001|Overall Study|Administrative problems|4|||
162818005|NCT02856893|588047622|FG001|Overall Study|Death|0|||
163167457|NCT01090323|589329009|FG000|Overall Study|Death|1|||
162818006|NCT02856893|588047623|FG002|Overall Study|Death|0|||
162818007|NCT02856893|588047621|FG000|Overall Study|Adverse Event|2|||
162818008|NCT02856893|588047622|FG001|Overall Study|Adverse Event|0|||
162818009|NCT02856893|588047623|FG002|Overall Study|Adverse Event|0|||
162818010|NCT02856893|588047621|FG000|Overall Study|Physician Decision|0|||
162818011|NCT02856893|588047622|FG001|Overall Study|Physician Decision|2|||
162818012|NCT02856893|588047623|FG002|Overall Study|Physician Decision|3|||
162818013|NCT02856893|588047621|FG000|Overall Study|Withdrawal by Subject|1|||
162818014|NCT02856893|588047622|FG001|Overall Study|Withdrawal by Subject|1|||
162818015|NCT02856893|588047623|FG002|Overall Study|Withdrawal by Subject|0|||
162818016|NCT02856893|588047621|FG000|Overall Study|Other reasons|2|||
162818017|NCT02856893|588047622|FG001|Overall Study|Other reasons|1|||
162818018|NCT02856893|588047623|FG002|Overall Study|Other reasons|2|||
162818019|NCT02310672|588047624|FG000|Overall Study|Death|1|||
162818020|NCT02310672|588047624|FG000|Overall Study|Lost to Follow-up|1|||
162818021|NCT02310672|588047624|FG000|Overall Study|Withdrawal by Subject|1|||
162818022|NCT02310672|588047624|FG000|Overall Study|Sponsor's decision|12|||
162818023|NCT01214187|588047628|FG000|Overall Study|Adverse Event|6|||
162818024|NCT01214187|588047629|FG001|Overall Study|Adverse Event|2|||
162818025|NCT01214187|588047628|FG000|Overall Study|Death|1|||
162818026|NCT01214187|588047629|FG001|Overall Study|Death|1|||
162818027|NCT01214187|588047628|FG000|Overall Study|Withdrawal by Subject|0|||
162818028|NCT01214187|588047629|FG001|Overall Study|Withdrawal by Subject|3|||
162818029|NCT02308007|588047638|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
162818030|NCT02308007|588047639|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
162818031|NCT02308007|588047640|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
162818032|NCT02308007|588047638|FG000|Overall Study|Positive for STD at Baseline|7|||
162818033|NCT02308007|588047639|FG001|Overall Study|Positive for STD at Baseline|11|||
162818034|NCT02308007|588047640|FG002|Overall Study|Positive for STD at Baseline|7|||
162818035|NCT02308007|588047638|FG000|Overall Study|Lost to Follow-up|3|||
162818036|NCT02308007|588047639|FG001|Overall Study|Lost to Follow-up|0|||
162818037|NCT02308007|588047640|FG002|Overall Study|Lost to Follow-up|1|||
162818038|NCT03118674|588047641|FG000|Overall Study|Lost to Follow-up|2|||
162818039|NCT03118674|588047641|FG000|Overall Study|Screen Faliure|8|||
162818040|NCT03118674|588047641|FG000|Overall Study|Withdrawal by Subject|5|||
162818041|NCT01233869|588047642|FG000|Initial Treatment Period (24 Months)|Death|1|||
162818042|NCT01233869|588047643|FG001|Initial Treatment Period (24 Months)|Death|0|||
162818043|NCT01233869|588047644|FG002|Initial Treatment Period (24 Months)|Death|0|||
162818044|NCT01233869|588047645|FG003|Initial Treatment Period (24 Months)|Death|0|||
162818045|NCT01233869|588047642|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
162818046|NCT01233869|588047643|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
162818047|NCT01233869|588047644|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
162818048|NCT01233869|588047645|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
162818049|NCT01233869|588047642|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
162818050|NCT01233869|588047643|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
162818051|NCT01233869|588047644|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
162818052|NCT01233869|588047645|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
162818053|NCT01233869|588047642|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
162818054|NCT01233869|588047643|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
162818055|NCT01233869|588047644|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163167458|NCT01090323|589329010|FG001|Overall Study|Death|2|||
163167459|NCT01090323|589329009|FG000|Overall Study|Stopped end of core|7|||
163167460|NCT01090323|589329010|FG001|Overall Study|Stopped end of core|0|||
163167461|NCT01090323|589329009|FG000|Overall Study|Stopped end of extension 1#|3|||
163167462|NCT01090323|589329010|FG001|Overall Study|Stopped end of extension 1#|1|||
163167463|NCT05498701|589329011|FG000|Period 3|Adverse Event|1|||
163167464|NCT05498701|589329012|FG001|Period 3|Adverse Event|0|||
163167465|NCT01864005|589329013|FG000|Overall Study|Protocol Violation|0|||
163167466|NCT01864005|589329014|FG001|Overall Study|Protocol Violation|1|||
163167467|NCT01864005|589329013|FG000|Overall Study|Withdrawal by Subject|0|||
163167468|NCT01864005|589329014|FG001|Overall Study|Withdrawal by Subject|1|||
163167469|NCT01864005|589329013|FG000|Overall Study|Incorrect enrolment|1|||
163167470|NCT01864005|589329014|FG001|Overall Study|Incorrect enrolment|0|||
162818056|NCT01233869|588047645|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
162818057|NCT01233869|588047642|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
162818058|NCT01233869|588047643|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
162818059|NCT01233869|588047644|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
163167471|NCT01864005|589329013|FG000|Overall Study|Disease need|1|||
163167472|NCT01864005|589329014|FG001|Overall Study|Disease need|1|||
163167473|NCT01864005|589329013|FG000|Overall Study|Need GP IIb/IIIa|1|||
163167474|NCT01864005|589329014|FG001|Overall Study|Need GP IIb/IIIa|3|||
162818060|NCT01233869|588047645|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
163167475|NCT02424578|589329015|FG000|Overall Study|Withdrawal by Subject|0|||
163167476|NCT02424578|589329016|FG001|Overall Study|Withdrawal by Subject|1|||
163167477|NCT02184572|589329017|FG000|Overall Study|Lost to Follow-up|29|||
163167478|NCT02184572|589329018|FG001|Overall Study|Lost to Follow-up|21|||
163167479|NCT02184572|589329017|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
163167480|NCT02184572|589329018|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
163167481|NCT02184572|589329017|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
163167482|NCT02184572|589329018|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
163167483|NCT02184572|589329017|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
163167484|NCT02184572|589329018|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
163167485|NCT02184572|589329017|FG000|Overall Study|Traveling Outside The Country|1|||
163167486|NCT02184572|589329018|FG001|Overall Study|Traveling Outside The Country|0|||
163167487|NCT02184572|589329017|FG000|Overall Study|Withdrawal by Subject|14|||
163167488|NCT02184572|589329018|FG001|Overall Study|Withdrawal by Subject|9|||
163167489|NCT00763698|589329021|FG000|Overall Study|Unsuccessful Implant|5|||
163167490|NCT00763698|589329021|FG000|Overall Study|Death|4|||
163167491|NCT00763698|589329021|FG000|Overall Study|Withdrawal by Subject|1|||
163167492|NCT03679754|589329026|FG000|Overall Study|Investigator request|1|||
163167493|NCT00964171|589329027|FG000|Overall Study|Death|5|||
163167494|NCT03179319|589329031|FG000|Overall Study|Lost to Follow-up|6|||
163167495|NCT03179319|589329032|FG001|Overall Study|Lost to Follow-up|0|||
163167496|NCT01120717|589329033|FG000|Overall Study|Withdrawal by Subject|11|||
163167497|NCT01120717|589329034|FG001|Overall Study|Withdrawal by Subject|6|||
163167498|NCT01120717|589329033|FG000|Overall Study|Adverse Event|10|||
163167499|NCT01120717|589329034|FG001|Overall Study|Adverse Event|6|||
163167500|NCT01120717|589329033|FG000|Overall Study|Protocol Deviation|2|||
163167501|NCT01120717|589329034|FG001|Overall Study|Protocol Deviation|5|||
163167502|NCT01120717|589329033|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163167503|NCT01120717|589329034|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163167504|NCT01120717|589329033|FG000|Overall Study|Lost to Follow-up|2|||
163167505|NCT01120717|589329034|FG001|Overall Study|Lost to Follow-up|3|||
163167506|NCT01120717|589329033|FG000|Overall Study|Death|3|||
163167507|NCT01120717|589329034|FG001|Overall Study|Death|1|||
163167508|NCT01120717|589329033|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163167509|NCT01120717|589329034|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163167510|NCT02640508|589329039|FG000|Overall Study|Death|19|||
163167511|NCT02640508|589329039|FG000|Overall Study|Withdrawal by Subject|8|||
163167512|NCT02640508|589329039|FG000|Overall Study|Physician Decision|1|||
163167513|NCT02640508|589329039|FG000|Overall Study|Lost to Follow-up|1|||
163167514|NCT04534686|589329041|FG000|Baseline Measurement|Lost to Follow-up|4|||
163167515|NCT04534686|589329042|FG001|Baseline Measurement|Lost to Follow-up|6|||
163167516|NCT04534686|589329041|FG000|Baseline Measurement|Withdrawal by Subject|3|||
163167517|NCT04534686|589329042|FG001|Baseline Measurement|Withdrawal by Subject|1|||
163167518|NCT04534686|589329041|FG000|Intervention|Withdrawal by Subject|2|||
163167519|NCT04534686|589329042|FG001|Intervention|Withdrawal by Subject|2|||
163167520|NCT03179605|589329043|FG000|Overall Study|Withdrawal by Subject|1|||
163167521|NCT00635999|589329044|FG000|Overall Study|Withdrawal by Subject|4|||
163167522|NCT00635999|589329045|FG001|Overall Study|Withdrawal by Subject|2|||
163167523|NCT00635999|589329046|FG002|Overall Study|Withdrawal by Subject|1|||
163167524|NCT00711477|589329047|FG000|Overall Study|Adverse Event|3|||
163167525|NCT00711477|589329048|FG001|Overall Study|Adverse Event|1|||
163167526|NCT00711477|589329047|FG000|Overall Study|Lost to Follow-up|0|||
163167527|NCT00711477|589329048|FG001|Overall Study|Lost to Follow-up|1|||
163167528|NCT00711477|589329047|FG000|Overall Study|Noncompliance|0|||
163167529|NCT00711477|589329048|FG001|Overall Study|Noncompliance|1|||
163167530|NCT01396070|589329050|FG000|Overall Study|Withdrawal by Subject|2|||
163167531|NCT01396070|589329050|FG000|Overall Study|Death|2|||
163167532|NCT01396070|589329050|FG000|Overall Study|Adverse Event|8|||
163167533|NCT01396070|589329050|FG000|Overall Study|Physician Decision|3|||
163167534|NCT01396070|589329050|FG000|Overall Study|Lack of Efficacy|4|||
163167535|NCT02636361|589329051|FG000|Period 4|Physician Decision|0|||
163167536|NCT02636361|589329052|FG001|Period 4|Physician Decision|0|||
163167537|NCT02636361|589329053|FG002|Period 4|Physician Decision|0|||
163167538|NCT02636361|589329054|FG003|Period 4|Physician Decision|1|||
163167539|NCT02636361|589329055|FG004|Period 4|Physician Decision|0|||
163167540|NCT02695420|589329056|FG000|Overall Study|Death|0|||
163167541|NCT02695420|589329057|FG001|Overall Study|Death|1|||
163167542|NCT02695420|589329058|FG002|Overall Study|Death|0|||
163167543|NCT02695420|589329059|FG003|Overall Study|Death|0|||
163167544|NCT00916929|589329063|FG000|Overall Study|Lost to Follow-up|1|||
163167545|NCT00916929|589329064|FG001|Overall Study|Lost to Follow-up|3|||
163167546|NCT00916929|589329063|FG000|Overall Study|Death|5|||
163167547|NCT00916929|589329064|FG001|Overall Study|Death|10|||
163167548|NCT00916929|589329063|FG000|Overall Study|Withdrawal by Subject|1|||
163167549|NCT00916929|589329064|FG001|Overall Study|Withdrawal by Subject|5|||
163167550|NCT00916929|589329063|FG000|Overall Study|Left ventricular epicardial lead|1|||
163167551|NCT00916929|589329064|FG001|Overall Study|Left ventricular epicardial lead|2|||
163167552|NCT00916929|589329063|FG000|Overall Study|Transferred to hospice care|1|||
163167553|NCT00916929|589329064|FG001|Overall Study|Transferred to hospice care|1|||
163167554|NCT00916929|589329063|FG000|Overall Study|System explant|1|||
163167555|NCT00916929|589329064|FG001|Overall Study|System explant|0|||
163167556|NCT00916929|589329063|FG000|Overall Study|Moved to another state|0|||
163167557|NCT00916929|589329064|FG001|Overall Study|Moved to another state|1|||
163167558|NCT00916929|589329063|FG000|Overall Study|Device unable to process impedance data|0|||
163167559|NCT00916929|589329064|FG001|Overall Study|Device unable to process impedance data|7|||
163167560|NCT02929407|589329065|FG000|Overall Study|Adverse Event|1|||
163167561|NCT03037580|589329067|FG000|Overall Study|Withdrawal by Subject|3|||
163167562|NCT03037580|589329068|FG001|Overall Study|Withdrawal by Subject|0|||
163167563|NCT03037580|589329067|FG000|Overall Study|Adverse Event|1|||
163167564|NCT03037580|589329068|FG001|Overall Study|Adverse Event|0|||
163167565|NCT03037580|589329067|FG000|Overall Study|Study Terminated by Sponsor|12|||
163167566|NCT03037580|589329068|FG001|Overall Study|Study Terminated by Sponsor|15|||
163167567|NCT03037580|589329067|FG000|Overall Study|Death|0|||
163167568|NCT03037580|589329068|FG001|Overall Study|Death|1|||
163167569|NCT02036853|589329069|FG000|Overall Study|Adverse Event|0|||
163167570|NCT02036853|589329070|FG001|Overall Study|Adverse Event|2|||
163167571|NCT02036853|589329069|FG000|Overall Study|Lack of Efficacy|0|||
163167572|NCT02036853|589329070|FG001|Overall Study|Lack of Efficacy|2|||
163167573|NCT02036853|589329069|FG000|Overall Study|Physician Decision|0|||
163167574|NCT02036853|589329070|FG001|Overall Study|Physician Decision|1|||
163167575|NCT02036853|589329069|FG000|Overall Study|Withdrawal by Subject|0|||
163167576|NCT02036853|589329070|FG001|Overall Study|Withdrawal by Subject|1|||
163167577|NCT00228553|589329071|FG000|Overall Study|Adverse Event|112|||
163167578|NCT00228553|589329071|FG000|Overall Study|Lack of Efficacy|34|||
163167579|NCT00228553|589329071|FG000|Overall Study|Lost to Follow-up|67|||
163167580|NCT00228553|589329071|FG000|Overall Study|Physician Decision|48|||
163167581|NCT00228553|589329071|FG000|Overall Study|Protocol Violation|6|||
163167582|NCT00228553|589329071|FG000|Overall Study|Withdrawal by Subject|115|||
163167583|NCT00228553|589329071|FG000|Overall Study|Pregnancy|2|||
163167584|NCT00228553|589329071|FG000|Overall Study|Miscellaneous|46|||
163167585|NCT04530136|589329072|FG000|Overall Study|Lost to Follow-up|2|||
163167586|NCT04530136|589329073|FG001|Overall Study|Lost to Follow-up|3|||
163167587|NCT04530136|589329072|FG000|Overall Study|Withdrawal by Subject|1|||
163167588|NCT04530136|589329073|FG001|Overall Study|Withdrawal by Subject|0|||
163167589|NCT04530136|589329072|FG000|Overall Study|Death|0|||
163167590|NCT04530136|589329073|FG001|Overall Study|Death|1|||
163167591|NCT01309282|589329074|FG000|Overall Study|Lost to Follow-up|1|||
163167592|NCT01136785|589329079|FG000|Overall Study|Protocol Violation|2|||
163167593|NCT01136785|589329080|FG001|Overall Study|Protocol Violation|1|||
163167594|NCT02873429|589329081|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
163167595|NCT02873429|589329082|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
163167596|NCT02873429|589329081|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
163167597|NCT02873429|589329082|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
163167598|NCT02873429|589329081|FG000|16 Weeks|Lost to Follow-up|3|||
163167599|NCT02873429|589329082|FG001|16 Weeks|Lost to Follow-up|0|||
163167600|NCT00612807|589329083|FG000|Overall Study|Withdrawal by Subject|2|||
163167601|NCT00612807|589329084|FG001|Overall Study|Withdrawal by Subject|0|||
163167602|NCT01516034|589329085|FG000|Overall Study|Physician Decision|1|||
163167603|NCT01516034|589329085|FG000|Overall Study|Lack of Efficacy|7|||
163167604|NCT01033448|589329086|FG000|Overall Study|Withdrawal by Subject|4|||
163167605|NCT01033448|589329086|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
163167606|NCT01033448|589329086|FG000|Overall Study|Lost to Follow-up|3|||
163167607|NCT01033448|589329086|FG000|Overall Study|Withdrew due to other reasons|3|||
163167608|NCT01033448|589329086|FG000|Overall Study|Unknown disposition|1|||
163167609|NCT05564052|589329087|FG000|Overall Study|Withdrawal by Subject|0|||
163167610|NCT05564052|589329088|FG001|Overall Study|Withdrawal by Subject|0|||
163167611|NCT05564052|589329089|FG002|Overall Study|Withdrawal by Subject|0|||
163167612|NCT05564052|589329090|FG003|Overall Study|Withdrawal by Subject|1|||
163167613|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
163167614|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
163167615|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
163167616|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
163167617|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
163167618|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167619|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167620|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
163167621|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
163167622|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167623|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167624|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
163167625|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
163167626|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167627|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167628|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
163167629|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
163167630|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167631|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167632|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
163167633|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
163167634|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167635|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167636|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
163167637|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
163167638|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167639|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167640|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
163167641|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
163167642|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167643|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167644|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
163167645|NCT03818035|589329093|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
163167646|NCT03818035|589329094|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
163167647|NCT03818035|589329095|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
163167648|NCT03818035|589329096|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
163167649|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167650|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167651|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
163167652|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
163167653|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
163167654|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
163167655|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
163167656|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
163167657|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167658|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167659|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
163167660|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
163167661|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
163167662|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
163167663|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
163167664|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
163167665|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
163167666|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
163167667|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
163167668|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
163167669|NCT03818035|589329093|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
163167670|NCT03818035|589329094|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
163167671|NCT03818035|589329095|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
163167672|NCT03818035|589329096|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
163167673|NCT03338959|589330610|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
163167674|NCT03338959|589330610|FG000|Overall Study|Physician Decision|1|||
163167675|NCT00409331|589330612|FG000|Overall Study|Physician Decision|1|||
163167676|NCT00281658|589330613|FG000|Randomized Phase|Adverse Event|0|||
163167677|NCT00281658|589330614|FG001|Randomized Phase|Adverse Event|2|||
163167678|NCT00281658|589330615|FG002|Randomized Phase|Adverse Event|0|||
163167679|NCT00281658|589330616|FG003|Randomized Phase|Adverse Event|0|||
163167680|NCT00281658|589330613|FG000|Randomized Phase|Lost to Follow-up|34|||
163167681|NCT00281658|589330614|FG001|Randomized Phase|Lost to Follow-up|27|||
163167682|NCT00281658|589330615|FG002|Randomized Phase|Lost to Follow-up|0|||
162818061|NCT01233869|588047642|FG000|Extended Treatment Period (46 Months)|Other|3|||
162818062|NCT01233869|588047643|FG001|Extended Treatment Period (46 Months)|Other|0|||
162818063|NCT01233869|588047644|FG002|Extended Treatment Period (46 Months)|Other|0|||
162818064|NCT01233869|588047645|FG003|Extended Treatment Period (46 Months)|Other|3|||
162818065|NCT01233869|588047642|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
162818066|NCT01233869|588047643|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
162818067|NCT01233869|588047644|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
162818068|NCT01233869|588047645|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
162818069|NCT01324323|588047646|FG000|Overall Study|Withdrawal by Subject|1|||
162818070|NCT00537485|588047647|FG000|Overall Study|Adverse Event|10|||
162818071|NCT00537485|588047648|FG001|Overall Study|Adverse Event|5|||
162818072|NCT00537485|588047647|FG000|Overall Study|Withdrawal by Subject|3|||
162818073|NCT00537485|588047648|FG001|Overall Study|Withdrawal by Subject|2|||
163167683|NCT00281658|589330616|FG003|Randomized Phase|Lost to Follow-up|0|||
162818074|NCT00537485|588047647|FG000|Overall Study|Withdrawal by Subject|1|||
162818075|NCT00537485|588047648|FG001|Overall Study|Withdrawal by Subject|3|||
162818076|NCT00537485|588047647|FG000|Overall Study|Physician Decision|1|||
162818077|NCT00537485|588047648|FG001|Overall Study|Physician Decision|0|||
163167684|NCT00281658|589330613|FG000|Randomized Phase|Withdrawal by Subject|8|||
163167685|NCT00281658|589330614|FG001|Randomized Phase|Withdrawal by Subject|7|||
163167686|NCT00281658|589330615|FG002|Randomized Phase|Withdrawal by Subject|0|||
163167687|NCT00281658|589330616|FG003|Randomized Phase|Withdrawal by Subject|0|||
163167688|NCT00281658|589330613|FG000|Randomized Phase|Study closed/terminated|1|||
163167689|NCT00281658|589330614|FG001|Randomized Phase|Study closed/terminated|1|||
163167690|NCT00281658|589330615|FG002|Randomized Phase|Study closed/terminated|0|||
163167691|NCT00281658|589330616|FG003|Randomized Phase|Study closed/terminated|0|||
163167692|NCT00281658|589330613|FG000|Randomized Phase|Disease progression|36|||
163167693|NCT00281658|589330614|FG001|Randomized Phase|Disease progression|27|||
163167694|NCT00281658|589330615|FG002|Randomized Phase|Disease progression|0|||
163167695|NCT00281658|589330616|FG003|Randomized Phase|Disease progression|0|||
163167696|NCT00281658|589330613|FG000|Randomized Phase|Physician Decision|1|||
163167697|NCT00281658|589330614|FG001|Randomized Phase|Physician Decision|1|||
163167698|NCT00281658|589330615|FG002|Randomized Phase|Physician Decision|0|||
163167699|NCT00281658|589330616|FG003|Randomized Phase|Physician Decision|0|||
163167700|NCT00281658|589330613|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
163167701|NCT00281658|589330614|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
163167702|NCT00281658|589330615|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
163167703|NCT00281658|589330616|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
163167704|NCT00281658|589330613|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
163167705|NCT00281658|589330614|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
163167706|NCT00281658|589330615|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
163167707|NCT00281658|589330616|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
163167708|NCT00281658|589330613|FG000|Randomized Phase|Treatment ongoing|1|||
163167709|NCT00281658|589330614|FG001|Randomized Phase|Treatment ongoing|0|||
163167710|NCT00281658|589330615|FG002|Randomized Phase|Treatment ongoing|0|||
163167711|NCT00281658|589330616|FG003|Randomized Phase|Treatment ongoing|0|||
163167712|NCT00281658|589330613|FG000|Open Label Phase|Adverse Event|0|||
163167713|NCT00281658|589330614|FG001|Open Label Phase|Adverse Event|0|||
163167714|NCT00281658|589330615|FG002|Open Label Phase|Adverse Event|1|||
163167715|NCT00281658|589330616|FG003|Open Label Phase|Adverse Event|0|||
163167716|NCT00281658|589330613|FG000|Open Label Phase|Lost to Follow-up|0|||
163167717|NCT00281658|589330614|FG001|Open Label Phase|Lost to Follow-up|0|||
163167718|NCT00281658|589330615|FG002|Open Label Phase|Lost to Follow-up|16|||
163167719|NCT00281658|589330616|FG003|Open Label Phase|Lost to Follow-up|2|||
163167720|NCT00281658|589330613|FG000|Open Label Phase|Withdrawal by Subject|0|||
163167721|NCT00281658|589330614|FG001|Open Label Phase|Withdrawal by Subject|0|||
163167722|NCT00281658|589330615|FG002|Open Label Phase|Withdrawal by Subject|3|||
163167723|NCT00281658|589330616|FG003|Open Label Phase|Withdrawal by Subject|2|||
163167724|NCT00281658|589330613|FG000|Open Label Phase|Disease progression|0|||
163167725|NCT00281658|589330614|FG001|Open Label Phase|Disease progression|0|||
163167726|NCT00281658|589330615|FG002|Open Label Phase|Disease progression|18|||
163167727|NCT00281658|589330616|FG003|Open Label Phase|Disease progression|0|||
163167728|NCT00281658|589330613|FG000|Open Label Phase|Physician Decision|0|||
163167729|NCT00281658|589330614|FG001|Open Label Phase|Physician Decision|0|||
163167730|NCT00281658|589330615|FG002|Open Label Phase|Physician Decision|1|||
163167731|NCT00281658|589330616|FG003|Open Label Phase|Physician Decision|0|||
163167732|NCT00281658|589330613|FG000|Open Label Phase|Relocation of patient|0|||
163167733|NCT00281658|589330614|FG001|Open Label Phase|Relocation of patient|0|||
163167734|NCT00281658|589330615|FG002|Open Label Phase|Relocation of patient|1|||
163167735|NCT00281658|589330616|FG003|Open Label Phase|Relocation of patient|0|||
163167736|NCT00281658|589330613|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
163167737|NCT00281658|589330614|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
163167738|NCT00281658|589330615|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
163167739|NCT00281658|589330616|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
163167740|NCT02151773|589330617|FG000|Overall Study|Protocol Deviation|64|||
163167741|NCT03680742|589330618|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
163167742|NCT02894502|589330621|FG000|Baseline|Withdrawal by Subject|24|||
163167743|NCT02894502|589330622|FG001|Baseline|Withdrawal by Subject|31|||
163167744|NCT02894502|589330623|FG002|Baseline|Withdrawal by Subject|36|||
163167745|NCT02894502|589330621|FG000|Baseline|Death|3|||
163167746|NCT02894502|589330622|FG001|Baseline|Death|1|||
163167747|NCT02894502|589330623|FG002|Baseline|Death|9|||
163167748|NCT02894502|589330621|FG000|First Follow up|Withdrawal by Subject|32|||
162818078|NCT01601847|588047657|FG000|Overall Study|Death|1|||
162818079|NCT01601847|588047658|FG001|Overall Study|Death|0|||
163167749|NCT02894502|589330622|FG001|First Follow up|Withdrawal by Subject|29|||
163167750|NCT02894502|589330623|FG002|First Follow up|Withdrawal by Subject|37|||
163167751|NCT02894502|589330621|FG000|First Follow up|Death|2|||
163167752|NCT02894502|589330622|FG001|First Follow up|Death|2|||
162818080|NCT01601847|588047657|FG000|Overall Study|Withdrawal by Subject|11|||
162818081|NCT01601847|588047658|FG001|Overall Study|Withdrawal by Subject|7|||
163167753|NCT02894502|589330623|FG002|First Follow up|Death|3|||
162818082|NCT01601847|588047657|FG000|Overall Study|Lost to Follow-up|1|||
163167754|NCT02894502|589330621|FG000|Second Follow up|Withdrawal by Subject|13|||
163167755|NCT02894502|589330622|FG001|Second Follow up|Withdrawal by Subject|15|||
163167756|NCT02894502|589330623|FG002|Second Follow up|Withdrawal by Subject|13|||
163167757|NCT02894502|589330621|FG000|Second Follow up|Death|2|||
163167758|NCT02894502|589330622|FG001|Second Follow up|Death|3|||
163167759|NCT02894502|589330623|FG002|Second Follow up|Death|1|||
163167760|NCT02894502|589330621|FG000|Third Follow up|Withdrawal by Subject|5|||
163167761|NCT02894502|589330622|FG001|Third Follow up|Withdrawal by Subject|6|||
163167762|NCT02894502|589330623|FG002|Third Follow up|Withdrawal by Subject|3|||
163167763|NCT02894502|589330621|FG000|Third Follow up|Death|1|||
163167764|NCT02894502|589330622|FG001|Third Follow up|Death|1|||
163167765|NCT02894502|589330623|FG002|Third Follow up|Death|0|||
163167766|NCT01410357|589330624|FG000|Overall Study|Death|2|||
163167767|NCT01410357|589330625|FG001|Overall Study|Death|1|||
163167768|NCT01410357|589330624|FG000|Overall Study|Withdrawal by Subject|1|||
163167769|NCT01410357|589330625|FG001|Overall Study|Withdrawal by Subject|2|||
163167770|NCT01410357|589330624|FG000|Overall Study|Lost to Follow-up|23|||
163167771|NCT01410357|589330625|FG001|Overall Study|Lost to Follow-up|21|||
163167772|NCT01206322|589330629|FG000|Overall Study|Adverse Event|0|||
163167773|NCT01206322|589330630|FG001|Overall Study|Adverse Event|0|||
163167774|NCT01206322|589330631|FG002|Overall Study|Adverse Event|0|||
163167775|NCT01206322|589330632|FG003|Overall Study|Adverse Event|1|||
163167776|NCT00003590|589330636|FG000|Overall Study|Ineligible Patient|1|||
163167777|NCT00003590|589330636|FG000|Overall Study|Adverse Event|7|||
163167778|NCT00003590|589330636|FG000|Overall Study|Withdrawal by Subject|1|||
163167779|NCT00003590|589330636|FG000|Overall Study|Lack of Efficacy|11|||
163167780|NCT00003590|589330636|FG000|Overall Study|Death|1|||
163167781|NCT00003590|589330636|FG000|Overall Study|Physician Decision|1|||
163167782|NCT01589653|589330637|FG000|Overall Study|Protocol Violation|3|||
163167783|NCT01589653|589330638|FG001|Overall Study|Protocol Violation|1|||
163167784|NCT01589653|589330637|FG000|Overall Study|Withdrawal criteria|4|||
163167785|NCT01589653|589330638|FG001|Overall Study|Withdrawal criteria|7|||
163167786|NCT01589653|589330637|FG000|Overall Study|Unclassified|0|||
163167787|NCT01589653|589330638|FG001|Overall Study|Unclassified|3|||
163167788|NCT03700684|589330641|FG000|Overall Study|COVID-19|0|||
163167789|NCT03700684|589330642|FG001|Overall Study|COVID-19|0|||
163167790|NCT03700684|589330643|FG002|Overall Study|COVID-19|2|||
163167791|NCT01767142|589330645|FG000|Overall Study|Lost to Follow-up|3|||
163167792|NCT03317405|589330646|FG000|Overall Study|Withdrawal by Subject|1|||
163167793|NCT03317405|589330647|FG001|Overall Study|Withdrawal by Subject|0|||
163167794|NCT03317405|589330648|FG002|Overall Study|Withdrawal by Subject|0|||
163167795|NCT03317405|589330646|FG000|Overall Study|Physician Decision|0|||
163167796|NCT03317405|589330647|FG001|Overall Study|Physician Decision|0|||
163167797|NCT03317405|589330648|FG002|Overall Study|Physician Decision|1|||
163167798|NCT03317405|589330646|FG000|Overall Study|Surgery Rescheduled|0|||
163167799|NCT03317405|589330647|FG001|Overall Study|Surgery Rescheduled|1|||
163167800|NCT03317405|589330648|FG002|Overall Study|Surgery Rescheduled|0|||
163167801|NCT00635219|589330649|FG000|Overall Study|Adverse Event|12|||
163167802|NCT00635219|589330650|FG001|Overall Study|Adverse Event|10|||
163167803|NCT00635219|589330651|FG002|Overall Study|Adverse Event|18|||
163167804|NCT00635219|589330652|FG003|Overall Study|Adverse Event|15|||
163167805|NCT00635219|589330653|FG004|Overall Study|Adverse Event|19|||
163167806|NCT00635219|589330649|FG000|Overall Study|Lack of Efficacy|5|||
163167807|NCT00635219|589330650|FG001|Overall Study|Lack of Efficacy|6|||
163167808|NCT00635219|589330651|FG002|Overall Study|Lack of Efficacy|3|||
163167809|NCT00635219|589330652|FG003|Overall Study|Lack of Efficacy|4|||
163167810|NCT00635219|589330653|FG004|Overall Study|Lack of Efficacy|6|||
163167811|NCT00635219|589330649|FG000|Overall Study|Non-compliance With Study Product|0|||
163167812|NCT00635219|589330650|FG001|Overall Study|Non-compliance With Study Product|0|||
163167813|NCT00635219|589330651|FG002|Overall Study|Non-compliance With Study Product|0|||
163167814|NCT00635219|589330652|FG003|Overall Study|Non-compliance With Study Product|2|||
163167815|NCT00635219|589330653|FG004|Overall Study|Non-compliance With Study Product|1|||
163167816|NCT00635219|589330649|FG000|Overall Study|Protocol Violation|0|||
163167817|NCT00635219|589330650|FG001|Overall Study|Protocol Violation|2|||
163167818|NCT00635219|589330651|FG002|Overall Study|Protocol Violation|3|||
163167819|NCT00635219|589330652|FG003|Overall Study|Protocol Violation|2|||
163167820|NCT00635219|589330653|FG004|Overall Study|Protocol Violation|4|||
163167821|NCT00635219|589330649|FG000|Overall Study|Withdrawal of Consent|8|||
163167822|NCT00635219|589330650|FG001|Overall Study|Withdrawal of Consent|6|||
163167823|NCT00635219|589330651|FG002|Overall Study|Withdrawal of Consent|8|||
163167824|NCT00635219|589330652|FG003|Overall Study|Withdrawal of Consent|11|||
163167825|NCT00635219|589330653|FG004|Overall Study|Withdrawal of Consent|8|||
163167826|NCT00635219|589330649|FG000|Overall Study|Lost to Follow-up|0|||
163167827|NCT00635219|589330650|FG001|Overall Study|Lost to Follow-up|0|||
163167828|NCT00635219|589330651|FG002|Overall Study|Lost to Follow-up|2|||
163167829|NCT00635219|589330652|FG003|Overall Study|Lost to Follow-up|0|||
163167830|NCT00635219|589330653|FG004|Overall Study|Lost to Follow-up|3|||
163167831|NCT00635219|589330649|FG000|Overall Study|Administrative or Other Reasons|0|||
163167832|NCT00635219|589330650|FG001|Overall Study|Administrative or Other Reasons|1|||
163167833|NCT00635219|589330651|FG002|Overall Study|Administrative or Other Reasons|1|||
163167834|NCT00635219|589330652|FG003|Overall Study|Administrative or Other Reasons|0|||
163167835|NCT00635219|589330653|FG004|Overall Study|Administrative or Other Reasons|1|||
163167836|NCT04093024|589330656|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
163167837|NCT04093024|589330657|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
163167838|NCT04093024|589330656|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
163167839|NCT04093024|589330657|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
163167840|NCT04093024|589330656|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
163167841|NCT04093024|589330657|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
163167842|NCT04093024|589330656|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
163167843|NCT04093024|589330657|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
162818083|NCT01601847|588047658|FG001|Overall Study|Lost to Follow-up|3|||
162818084|NCT00631189|588047659|FG000|Initial Phase|Protocol Violation|347|||
162818085|NCT00631189|588047660|FG001|Initial Phase|Protocol Violation|0|||
162818086|NCT00631189|588047661|FG002|Initial Phase|Protocol Violation|0|||
162818087|NCT00631189|588047662|FG003|Initial Phase|Protocol Violation|0|||
162818088|NCT00631189|588047659|FG000|Initial Phase|Withdrawal by Subject|4|||
162818089|NCT00631189|588047660|FG001|Initial Phase|Withdrawal by Subject|0|||
162818090|NCT00631189|588047661|FG002|Initial Phase|Withdrawal by Subject|0|||
162818091|NCT00631189|588047662|FG003|Initial Phase|Withdrawal by Subject|0|||
162818092|NCT00631189|588047659|FG000|Treatment Phase|Withdrawal by Subject|0|||
162818093|NCT00631189|588047660|FG001|Treatment Phase|Withdrawal by Subject|2|||
162818094|NCT00631189|588047661|FG002|Treatment Phase|Withdrawal by Subject|1|||
162818095|NCT00631189|588047662|FG003|Treatment Phase|Withdrawal by Subject|1|||
162818096|NCT00631189|588047659|FG000|Treatment Phase|Protocol Violation|0|||
162818097|NCT00631189|588047660|FG001|Treatment Phase|Protocol Violation|1|||
162818098|NCT00631189|588047661|FG002|Treatment Phase|Protocol Violation|6|||
162818099|NCT00631189|588047662|FG003|Treatment Phase|Protocol Violation|2|||
162818100|NCT00631189|588047659|FG000|Treatment Phase|Adverse Event|0|||
162818101|NCT00631189|588047660|FG001|Treatment Phase|Adverse Event|3|||
162818102|NCT00631189|588047661|FG002|Treatment Phase|Adverse Event|2|||
162818103|NCT00631189|588047662|FG003|Treatment Phase|Adverse Event|4|||
162818104|NCT00631189|588047659|FG000|Treatment Phase|Lost to Follow-up|0|||
162818105|NCT00631189|588047660|FG001|Treatment Phase|Lost to Follow-up|1|||
162818106|NCT00631189|588047661|FG002|Treatment Phase|Lost to Follow-up|0|||
162818107|NCT00631189|588047662|FG003|Treatment Phase|Lost to Follow-up|0|||
162818108|NCT00631189|588047659|FG000|Treatment Phase|Pregnancy|0|||
162818109|NCT00631189|588047660|FG001|Treatment Phase|Pregnancy|0|||
162818110|NCT00631189|588047661|FG002|Treatment Phase|Pregnancy|1|||
162818111|NCT00631189|588047662|FG003|Treatment Phase|Pregnancy|0|||
162818112|NCT00631189|588047659|FG000|Treatment Phase|patient did not take pravastatin|0|||
162818113|NCT00631189|588047660|FG001|Treatment Phase|patient did not take pravastatin|0|||
162818114|NCT00631189|588047661|FG002|Treatment Phase|patient did not take pravastatin|1|||
162818115|NCT00631189|588047662|FG003|Treatment Phase|patient did not take pravastatin|0|||
162818116|NCT00954174|588047665|FG000|Overall Study|Adverse Event|28|||
162818117|NCT00954174|588047666|FG001|Overall Study|Adverse Event|23|||
162818118|NCT00954174|588047667|FG002|Overall Study|Adverse Event|4|||
162818119|NCT00954174|588047668|FG003|Overall Study|Adverse Event|9|||
162818120|NCT00954174|588047665|FG000|Overall Study|Death|4|||
162818121|NCT00954174|588047666|FG001|Overall Study|Death|2|||
162818122|NCT00954174|588047667|FG002|Overall Study|Death|0|||
162818123|NCT00954174|588047668|FG003|Overall Study|Death|0|||
162818124|NCT00954174|588047665|FG000|Overall Study|Lack of Efficacy|32|||
162818125|NCT00954174|588047666|FG001|Overall Study|Lack of Efficacy|22|||
162818126|NCT00954174|588047667|FG002|Overall Study|Lack of Efficacy|8|||
162818127|NCT00954174|588047668|FG003|Overall Study|Lack of Efficacy|6|||
162818128|NCT00954174|588047665|FG000|Overall Study|Withdrawal by Subject|14|||
162818129|NCT00954174|588047666|FG001|Overall Study|Withdrawal by Subject|10|||
162818130|NCT00954174|588047667|FG002|Overall Study|Withdrawal by Subject|4|||
162818131|NCT00954174|588047668|FG003|Overall Study|Withdrawal by Subject|3|||
162818132|NCT00954174|588047665|FG000|Overall Study|Medical Reason|4|||
162818133|NCT00954174|588047666|FG001|Overall Study|Medical Reason|2|||
162818134|NCT00954174|588047667|FG002|Overall Study|Medical Reason|1|||
162818135|NCT00954174|588047668|FG003|Overall Study|Medical Reason|0|||
162818136|NCT00954174|588047665|FG000|Overall Study|Ineligible|40|||
162818137|NCT00954174|588047666|FG001|Overall Study|Ineligible|47|||
162818138|NCT00954174|588047667|FG002|Overall Study|Ineligible|7|||
162818139|NCT00954174|588047668|FG003|Overall Study|Ineligible|4|||
162818140|NCT00954174|588047665|FG000|Overall Study|Never Treated|4|||
162818141|NCT00954174|588047666|FG001|Overall Study|Never Treated|17|||
162818142|NCT00954174|588047667|FG002|Overall Study|Never Treated|0|||
162818143|NCT00954174|588047668|FG003|Overall Study|Never Treated|3|||
163167844|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
163167845|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
163167846|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
163167847|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
163167848|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
163167849|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
163167850|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
163167851|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
163167852|NCT00435045|589330664|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
163167853|NCT00435045|589330665|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
163167854|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
163167855|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
163167856|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
163167857|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
163167858|NCT00435045|589330664|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
163167859|NCT00435045|589330665|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
163167860|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
163167861|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
163167862|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
163167863|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
163167864|NCT00435045|589330664|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
163167865|NCT00435045|589330665|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
163167866|NCT03052426|589330666|FG000|Overall Study|Withdrawal by Subject|0|||
163167867|NCT03052426|589330667|FG001|Overall Study|Withdrawal by Subject|1|||
163167868|NCT03052426|589330668|FG002|Overall Study|Withdrawal by Subject|0|||
163167869|NCT03052426|589330666|FG000|Overall Study|Lost to Follow-up|2|||
163167870|NCT03052426|589330667|FG001|Overall Study|Lost to Follow-up|0|||
163167871|NCT03052426|589330668|FG002|Overall Study|Lost to Follow-up|1|||
163167872|NCT01290796|589330675|FG000|Overall Study|Lost to Follow-up|21|||
163167873|NCT01290796|589330675|FG000|Overall Study|Withdrawal by Subject|4|||
163167874|NCT01290796|589330675|FG000|Overall Study|Physician Decision|2|||
163167875|NCT01290796|589330675|FG000|Overall Study|Secondary Surgical Intervention|2|||
163167876|NCT01290796|589330675|FG000|Overall Study|Withdrawal by Sponsor|1|||
163167877|NCT00865280|589330676|FG000|Overall Study|Withdrawal by Subject|4|||
163167878|NCT00865280|589330677|FG001|Overall Study|Withdrawal by Subject|1|||
163167879|NCT00865280|589330676|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
163167880|NCT00865280|589330677|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
163167881|NCT00865280|589330676|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
163167882|NCT00865280|589330677|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
163167883|NCT00865280|589330676|FG000|Overall Study|Exclusion Condition|1|||
163167884|NCT00865280|589330677|FG001|Overall Study|Exclusion Condition|0|||
163167885|NCT00865280|589330676|FG000|Overall Study|Adverse Event|0|||
163167886|NCT00865280|589330677|FG001|Overall Study|Adverse Event|1|||
163167887|NCT00329797|589330678|FG000|Overall Study|Protocol Violation|1|||
163167888|NCT00329797|589330679|FG001|Overall Study|Protocol Violation|0|||
163167889|NCT00329797|589330678|FG000|Overall Study|Withdrawal by Subject|6|||
163167890|NCT00329797|589330679|FG001|Overall Study|Withdrawal by Subject|6|||
163167891|NCT03091348|589330687|FG000|Overall Study|Lost to Follow-up|2|||
163167892|NCT03091348|589330688|FG001|Overall Study|Lost to Follow-up|1|||
163167893|NCT02087423|589330690|FG000|Overall Study|Withdrawal by Subject|20|||
163167894|NCT02087423|589330691|FG001|Overall Study|Withdrawal by Subject|20|||
163167895|NCT02087423|589330692|FG002|Overall Study|Withdrawal by Subject|3|||
163167896|NCT02087423|589330690|FG000|Overall Study|Death|68|||
163167897|NCT02087423|589330691|FG001|Overall Study|Death|207|||
163167898|NCT02087423|589330692|FG002|Overall Study|Death|40|||
163167899|NCT02087423|589330690|FG000|Overall Study|Lost to Follow-up|0|||
163167900|NCT02087423|589330691|FG001|Overall Study|Lost to Follow-up|2|||
163167901|NCT02087423|589330692|FG002|Overall Study|Lost to Follow-up|0|||
163167902|NCT02087423|589330690|FG000|Overall Study|Terminated from study at final DCO|23|||
163167903|NCT02087423|589330691|FG001|Overall Study|Terminated from study at final DCO|36|||
163167904|NCT02087423|589330692|FG002|Overall Study|Terminated from study at final DCO|25|||
163167905|NCT00499590|589330694|FG000|Overall Study|Study Terminated|112|||
163167906|NCT00499590|589330695|FG001|Overall Study|Study Terminated|112|||
163167907|NCT00499590|589330696|FG002|Overall Study|Study Terminated|112|||
163167908|NCT00499590|589330694|FG000|Overall Study|Not treated|1|||
163167909|NCT00499590|589330695|FG001|Overall Study|Not treated|0|||
163167910|NCT00499590|589330696|FG002|Overall Study|Not treated|1|||
163167911|NCT02633020|589330700|FG000|Overall Study|Adverse Event|1|||
163167912|NCT02633020|589330701|FG001|Overall Study|Adverse Event|0|||
163167913|NCT00934440|589330702|FG000|Overall Study|Lost to Follow-up|1|||
163167914|NCT05661851|589330703|FG000|Overall Study|Protocol Violation|1|||
163167915|NCT05661851|589330704|FG001|Overall Study|Protocol Violation|1|||
163167916|NCT05661851|589330703|FG000|Overall Study|Covid-19 Related|3|||
163167917|NCT05661851|589330704|FG001|Overall Study|Covid-19 Related|4|||
163167918|NCT05661851|589330703|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
163167919|NCT05661851|589330704|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
163167920|NCT05661851|589330703|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
163167921|NCT05661851|589330704|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
163167922|NCT02152956|589330705|FG000|Overall Study|Adverse Event|0|||
163167923|NCT02152956|589330706|FG001|Overall Study|Adverse Event|0|||
163167924|NCT02152956|589330707|FG002|Overall Study|Adverse Event|0|||
163167925|NCT02152956|589330708|FG003|Overall Study|Adverse Event|0|||
163167926|NCT02152956|589330709|FG004|Overall Study|Adverse Event|0|||
163167927|NCT02152956|589330710|FG005|Overall Study|Adverse Event|0|||
163167928|NCT02152956|589330711|FG006|Overall Study|Adverse Event|0|||
163167929|NCT02152956|589330712|FG007|Overall Study|Adverse Event|0|||
163167930|NCT02152956|589330713|FG008|Overall Study|Adverse Event|0|||
163167931|NCT02152956|589330714|FG009|Overall Study|Adverse Event|0|||
163167932|NCT02152956|589330715|FG010|Overall Study|Adverse Event|0|||
163167933|NCT02152956|589330716|FG011|Overall Study|Adverse Event|4|||
163167934|NCT02152956|589330717|FG012|Overall Study|Adverse Event|0|||
163167935|NCT02152956|589330705|FG000|Overall Study|Death|0|||
163167936|NCT02152956|589330706|FG001|Overall Study|Death|3|||
163167937|NCT02152956|589330707|FG002|Overall Study|Death|3|||
163167938|NCT02152956|589330708|FG003|Overall Study|Death|4|||
163167939|NCT02152956|589330709|FG004|Overall Study|Death|1|||
163167940|NCT02152956|589330710|FG005|Overall Study|Death|2|||
163167941|NCT02152956|589330711|FG006|Overall Study|Death|6|||
163167942|NCT02152956|589330712|FG007|Overall Study|Death|6|||
163167943|NCT02152956|589330713|FG008|Overall Study|Death|4|||
163167944|NCT02152956|589330714|FG009|Overall Study|Death|5|||
163167945|NCT02152956|589330715|FG010|Overall Study|Death|3|||
163167946|NCT02152956|589330716|FG011|Overall Study|Death|143|||
163167947|NCT02152956|589330717|FG012|Overall Study|Death|12|||
163167948|NCT02152956|589330705|FG000|Overall Study|Lost to Follow-up|0|||
163167949|NCT02152956|589330706|FG001|Overall Study|Lost to Follow-up|1|||
163167950|NCT02152956|589330707|FG002|Overall Study|Lost to Follow-up|0|||
163167951|NCT02152956|589330708|FG003|Overall Study|Lost to Follow-up|0|||
163167952|NCT02152956|589330709|FG004|Overall Study|Lost to Follow-up|0|||
163167953|NCT02152956|589330710|FG005|Overall Study|Lost to Follow-up|0|||
163167954|NCT02152956|589330711|FG006|Overall Study|Lost to Follow-up|0|||
163167955|NCT02152956|589330712|FG007|Overall Study|Lost to Follow-up|0|||
163167956|NCT02152956|589330713|FG008|Overall Study|Lost to Follow-up|0|||
163167957|NCT02152956|589330714|FG009|Overall Study|Lost to Follow-up|0|||
163167958|NCT02152956|589330715|FG010|Overall Study|Lost to Follow-up|0|||
163167959|NCT02152956|589330716|FG011|Overall Study|Lost to Follow-up|3|||
163167960|NCT02152956|589330717|FG012|Overall Study|Lost to Follow-up|0|||
163167961|NCT02152956|589330705|FG000|Overall Study|Withdrawal by Subject|1|||
163167962|NCT02152956|589330706|FG001|Overall Study|Withdrawal by Subject|0|||
163167963|NCT02152956|589330707|FG002|Overall Study|Withdrawal by Subject|1|||
163167964|NCT02152956|589330708|FG003|Overall Study|Withdrawal by Subject|0|||
163167965|NCT02152956|589330709|FG004|Overall Study|Withdrawal by Subject|2|||
163167966|NCT02152956|589330710|FG005|Overall Study|Withdrawal by Subject|2|||
163167967|NCT02152956|589330711|FG006|Overall Study|Withdrawal by Subject|0|||
163167968|NCT02152956|589330712|FG007|Overall Study|Withdrawal by Subject|0|||
163167969|NCT02152956|589330713|FG008|Overall Study|Withdrawal by Subject|1|||
163167970|NCT02152956|589330714|FG009|Overall Study|Withdrawal by Subject|0|||
163167971|NCT02152956|589330715|FG010|Overall Study|Withdrawal by Subject|0|||
163167972|NCT02152956|589330716|FG011|Overall Study|Withdrawal by Subject|4|||
163167973|NCT02152956|589330717|FG012|Overall Study|Withdrawal by Subject|0|||
163167974|NCT02152956|589330705|FG000|Overall Study|Physician Decision|0|||
163167975|NCT02152956|589330706|FG001|Overall Study|Physician Decision|0|||
163167976|NCT02152956|589330707|FG002|Overall Study|Physician Decision|0|||
163167977|NCT02152956|589330708|FG003|Overall Study|Physician Decision|0|||
163167978|NCT02152956|589330709|FG004|Overall Study|Physician Decision|0|||
163167979|NCT02152956|589330710|FG005|Overall Study|Physician Decision|0|||
163167980|NCT02152956|589330711|FG006|Overall Study|Physician Decision|0|||
163167981|NCT02152956|589330712|FG007|Overall Study|Physician Decision|0|||
163167982|NCT02152956|589330713|FG008|Overall Study|Physician Decision|0|||
163167983|NCT02152956|589330714|FG009|Overall Study|Physician Decision|0|||
163167984|NCT02152956|589330715|FG010|Overall Study|Physician Decision|0|||
163167985|NCT02152956|589330716|FG011|Overall Study|Physician Decision|1|||
163167986|NCT02152956|589330717|FG012|Overall Study|Physician Decision|0|||
163167987|NCT02152956|589330705|FG000|Overall Study|Study terminated by sponsor|0|||
163167988|NCT02152956|589330706|FG001|Overall Study|Study terminated by sponsor|0|||
163167989|NCT02152956|589330707|FG002|Overall Study|Study terminated by sponsor|0|||
163167990|NCT02152956|589330708|FG003|Overall Study|Study terminated by sponsor|0|||
163167991|NCT02152956|589330709|FG004|Overall Study|Study terminated by sponsor|0|||
163167992|NCT02152956|589330710|FG005|Overall Study|Study terminated by sponsor|0|||
163167993|NCT02152956|589330711|FG006|Overall Study|Study terminated by sponsor|0|||
163167994|NCT02152956|589330712|FG007|Overall Study|Study terminated by sponsor|0|||
163167995|NCT02152956|589330713|FG008|Overall Study|Study terminated by sponsor|0|||
163167996|NCT02152956|589330714|FG009|Overall Study|Study terminated by sponsor|0|||
163167997|NCT02152956|589330715|FG010|Overall Study|Study terminated by sponsor|0|||
163167998|NCT02152956|589330716|FG011|Overall Study|Study terminated by sponsor|29|||
163167999|NCT02152956|589330717|FG012|Overall Study|Study terminated by sponsor|0|||
163168000|NCT02152956|589330705|FG000|Overall Study|progressive disease|0|||
163168001|NCT02152956|589330706|FG001|Overall Study|progressive disease|0|||
163168002|NCT02152956|589330707|FG002|Overall Study|progressive disease|0|||
163168003|NCT02152956|589330708|FG003|Overall Study|progressive disease|0|||
163168004|NCT02152956|589330709|FG004|Overall Study|progressive disease|0|||
163168005|NCT02152956|589330710|FG005|Overall Study|progressive disease|0|||
163168006|NCT02152956|589330711|FG006|Overall Study|progressive disease|0|||
163168007|NCT02152956|589330712|FG007|Overall Study|progressive disease|0|||
163168008|NCT02152956|589330713|FG008|Overall Study|progressive disease|1|||
163168009|NCT02152956|589330714|FG009|Overall Study|progressive disease|0|||
163168010|NCT02152956|589330715|FG010|Overall Study|progressive disease|0|||
163168011|NCT02152956|589330716|FG011|Overall Study|progressive disease|1|||
163168012|NCT02152956|589330717|FG012|Overall Study|progressive disease|0|||
163168013|NCT01014910|589330718|FG000|Overall Study|Withdrawal by Subject|0|||
163168014|NCT01014910|589330719|FG001|Overall Study|Withdrawal by Subject|2|||
163168015|NCT03753789|589330720|FG000|Overall Study|Withdrawal by Subject|2|||
163168016|NCT00744042|589330724|FG000|Overall Study|Withdrawal by Subject|1|||
163168017|NCT00853567|589330725|FG000|Overall Study|Study prematurely terminated|71|||
163168018|NCT00782834|589330729|FG000|Treatment Phase|fibrous tumor not GIST|1|||
163168019|NCT02055118|589330730|FG000|Overall Study|Withdrawal by Subject|0|||
163168020|NCT02055118|589330731|FG001|Overall Study|Withdrawal by Subject|2|||
163168021|NCT02055118|589330732|FG002|Overall Study|Withdrawal by Subject|0|||
163168022|NCT02281383|589330734|FG000|Overall Study|Progressive Disease|1|||
163168023|NCT02281383|589330734|FG000|Overall Study|Withdrawal by Subject|6|||
163168024|NCT02281383|589330734|FG000|Overall Study|Protocol Violation|2|||
163168025|NCT02281383|589330734|FG000|Overall Study|Death|1|||
163168026|NCT02281383|589330734|FG000|Overall Study|Adverse Event|2|||
163168027|NCT02252939|589330735|FG000|Overall Study|Lost to Follow-up|3|||
163168028|NCT04270370|589330736|FG000|Overall Study|Lost to Follow-up|1|||
163168029|NCT04270370|589330737|FG001|Overall Study|Lost to Follow-up|0|||
163168030|NCT04270370|589330738|FG002|Overall Study|Lost to Follow-up|0|||
163168031|NCT04270370|589330739|FG003|Overall Study|Lost to Follow-up|0|||
163168032|NCT04270370|589330740|FG004|Overall Study|Lost to Follow-up|0|||
163168033|NCT04270370|589330741|FG005|Overall Study|Lost to Follow-up|0|||
163168034|NCT04270370|589330742|FG006|Overall Study|Lost to Follow-up|0|||
163168035|NCT04270370|589330743|FG007|Overall Study|Lost to Follow-up|0|||
163168036|NCT04270370|589330744|FG008|Overall Study|Lost to Follow-up|1|||
163168037|NCT04270370|589330745|FG009|Overall Study|Lost to Follow-up|0|||
163168038|NCT04270370|589330746|FG010|Overall Study|Lost to Follow-up|0|||
163168039|NCT04270370|589330747|FG011|Overall Study|Lost to Follow-up|0|||
163168040|NCT01324141|589330748|FG000|Overall Study|Declined to participate before treatment started|1|||
163168041|NCT01324141|589330748|FG000|Overall Study|Disease progression on study|1|||
163168042|NCT00599339|589330751|FG000|Overall Study|Adverse Event|79|||
163168043|NCT00599339|589330751|FG000|Overall Study|Withdrawal by Subject|137|||
163168044|NCT00599339|589330751|FG000|Overall Study|Other Reason|179|||
163168045|NCT00599339|589330751|FG000|Overall Study|Lost to Follow-up|221|||
163168046|NCT00599339|589330751|FG000|Overall Study|No valid data consent|36|||
163168047|NCT00599339|589330751|FG000|Overall Study|Study Termination Status Unknown|12|||
163168048|NCT04189224|589330752|FG000|Period 2|Adverse Event|0|||
163168049|NCT04189224|589330753|FG001|Period 2|Adverse Event|1|||
163168050|NCT00336856|589332263|FG000|Overall Study|Withdrawal by Subject|3|||
163168051|NCT00336856|589332263|FG000|Overall Study|Found ineligible at time of analysis|1|||
163168052|NCT00843778|589332276|FG000|Overall Study|Adverse Event|15|||
163168053|NCT00843778|589332276|FG000|Overall Study|Lack of Efficacy|14|||
163168054|NCT00843778|589332276|FG000|Overall Study|Loss of efficacy|2|||
163168055|NCT00843778|589332276|FG000|Overall Study|Withdrawal by Subject|4|||
163168056|NCT00830869|589332279|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
163168057|NCT00830869|589332280|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
163168058|NCT00830869|589332281|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
163168059|NCT00830869|589332282|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
163168060|NCT00830869|589332283|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
163168061|NCT00830869|589332284|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
163168062|NCT00830869|589332285|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
163168063|NCT00830869|589332286|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
163168064|NCT00830869|589332287|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
163168065|NCT00830869|589332288|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
163168066|NCT00830869|589332289|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
163168067|NCT00830869|589332290|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
163168068|NCT00830869|589332279|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
163168069|NCT00830869|589332280|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
163168070|NCT00830869|589332281|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
163168071|NCT00830869|589332282|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
163168072|NCT00830869|589332283|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
163168073|NCT00830869|589332284|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
163168074|NCT00830869|589332285|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
163168075|NCT00830869|589332286|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
163168076|NCT00830869|589332287|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
163168077|NCT00830869|589332288|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
163168078|NCT00830869|589332289|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
163168079|NCT00830869|589332290|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
163168080|NCT00830869|589332279|FG000|Period 1: Part 1|Adverse Event|0|||
163168081|NCT00830869|589332280|FG001|Period 1: Part 1|Adverse Event|0|||
163168082|NCT00830869|589332281|FG002|Period 1: Part 1|Adverse Event|0|||
163168083|NCT00830869|589332282|FG003|Period 1: Part 1|Adverse Event|0|||
163168084|NCT00830869|589332283|FG004|Period 1: Part 1|Adverse Event|0|||
163168085|NCT00830869|589332284|FG005|Period 1: Part 1|Adverse Event|1|||
163168086|NCT00830869|589332285|FG006|Period 1: Part 1|Adverse Event|1|||
163168087|NCT00830869|589332286|FG007|Period 1: Part 1|Adverse Event|0|||
163168088|NCT00830869|589332287|FG008|Period 1: Part 1|Adverse Event|0|||
163168089|NCT00830869|589332288|FG009|Period 1: Part 1|Adverse Event|0|||
163168090|NCT00830869|589332289|FG010|Period 1: Part 1|Adverse Event|0|||
163168091|NCT00830869|589332290|FG011|Period 1: Part 1|Adverse Event|0|||
163168092|NCT00830869|589332279|FG000|Period 1: Part 1|Progressive disease|1|||
163168093|NCT00830869|589332280|FG001|Period 1: Part 1|Progressive disease|0|||
163168094|NCT00830869|589332281|FG002|Period 1: Part 1|Progressive disease|1|||
163168095|NCT00830869|589332282|FG003|Period 1: Part 1|Progressive disease|6|||
163168096|NCT00830869|589332283|FG004|Period 1: Part 1|Progressive disease|4|||
163168097|NCT00830869|589332284|FG005|Period 1: Part 1|Progressive disease|4|||
163168098|NCT00830869|589332285|FG006|Period 1: Part 1|Progressive disease|1|||
163168099|NCT00830869|589332286|FG007|Period 1: Part 1|Progressive disease|0|||
163168100|NCT00830869|589332287|FG008|Period 1: Part 1|Progressive disease|0|||
163168101|NCT00830869|589332288|FG009|Period 1: Part 1|Progressive disease|0|||
163168102|NCT00830869|589332289|FG010|Period 1: Part 1|Progressive disease|0|||
163168103|NCT00830869|589332290|FG011|Period 1: Part 1|Progressive disease|0|||
163168104|NCT00830869|589332279|FG000|Period 2: Part 2|Protocol Violation|0|||
163168105|NCT00830869|589332280|FG001|Period 2: Part 2|Protocol Violation|0|||
163168106|NCT00830869|589332281|FG002|Period 2: Part 2|Protocol Violation|0|||
163168107|NCT00830869|589332282|FG003|Period 2: Part 2|Protocol Violation|0|||
163168108|NCT00830869|589332283|FG004|Period 2: Part 2|Protocol Violation|0|||
163168109|NCT00830869|589332284|FG005|Period 2: Part 2|Protocol Violation|0|||
163168110|NCT00830869|589332285|FG006|Period 2: Part 2|Protocol Violation|0|||
163168111|NCT00830869|589332286|FG007|Period 2: Part 2|Protocol Violation|1|||
163168112|NCT00830869|589332287|FG008|Period 2: Part 2|Protocol Violation|0|||
163168113|NCT00830869|589332288|FG009|Period 2: Part 2|Protocol Violation|1|||
163168114|NCT00830869|589332289|FG010|Period 2: Part 2|Protocol Violation|0|||
163168115|NCT00830869|589332290|FG011|Period 2: Part 2|Protocol Violation|0|||
163168116|NCT00830869|589332279|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
163168117|NCT00830869|589332280|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
163168118|NCT00830869|589332281|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
163168119|NCT00830869|589332282|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
163168120|NCT00830869|589332283|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
163168121|NCT00830869|589332284|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
163168122|NCT00830869|589332285|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
163168123|NCT00830869|589332286|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
163168124|NCT00830869|589332287|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
163168125|NCT00830869|589332288|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
163168126|NCT00830869|589332289|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
163168127|NCT00830869|589332290|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
163168128|NCT00830869|589332279|FG000|Period 2: Part 2|Adverse Event|0|||
163168129|NCT00830869|589332280|FG001|Period 2: Part 2|Adverse Event|0|||
163168130|NCT00830869|589332281|FG002|Period 2: Part 2|Adverse Event|0|||
163168131|NCT00830869|589332282|FG003|Period 2: Part 2|Adverse Event|0|||
163168132|NCT00830869|589332283|FG004|Period 2: Part 2|Adverse Event|0|||
163168133|NCT00830869|589332284|FG005|Period 2: Part 2|Adverse Event|0|||
163168134|NCT00830869|589332285|FG006|Period 2: Part 2|Adverse Event|0|||
163168135|NCT00830869|589332286|FG007|Period 2: Part 2|Adverse Event|4|||
163168136|NCT00830869|589332287|FG008|Period 2: Part 2|Adverse Event|3|||
163168137|NCT00830869|589332288|FG009|Period 2: Part 2|Adverse Event|2|||
163168138|NCT00830869|589332289|FG010|Period 2: Part 2|Adverse Event|2|||
163168139|NCT00830869|589332290|FG011|Period 2: Part 2|Adverse Event|0|||
163168140|NCT00830869|589332279|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
163168141|NCT00830869|589332280|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
163168142|NCT00830869|589332281|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
163168143|NCT00830869|589332282|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
163168144|NCT00830869|589332283|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
163168145|NCT00830869|589332284|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
163168146|NCT00830869|589332285|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
163168147|NCT00830869|589332286|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
163168148|NCT00830869|589332287|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
163168149|NCT00830869|589332288|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
163168150|NCT00830869|589332289|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
163168151|NCT00830869|589332290|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
163168152|NCT00830869|589332279|FG000|Period 2: Part 2|Progressive disease|0|||
163168153|NCT00830869|589332280|FG001|Period 2: Part 2|Progressive disease|0|||
163168154|NCT00830869|589332281|FG002|Period 2: Part 2|Progressive disease|0|||
163168155|NCT00830869|589332282|FG003|Period 2: Part 2|Progressive disease|0|||
163168156|NCT00830869|589332283|FG004|Period 2: Part 2|Progressive disease|0|||
163168157|NCT00830869|589332284|FG005|Period 2: Part 2|Progressive disease|0|||
163168158|NCT00830869|589332285|FG006|Period 2: Part 2|Progressive disease|0|||
163168159|NCT00830869|589332286|FG007|Period 2: Part 2|Progressive disease|14|||
163168160|NCT00830869|589332287|FG008|Period 2: Part 2|Progressive disease|11|||
163168161|NCT00830869|589332288|FG009|Period 2: Part 2|Progressive disease|12|||
163168162|NCT00830869|589332289|FG010|Period 2: Part 2|Progressive disease|8|||
163168163|NCT00830869|589332290|FG011|Period 2: Part 2|Progressive disease|15|||
163168164|NCT00830869|589332279|FG000|Period 2: Part 2|Other|0|||
163168165|NCT00830869|589332280|FG001|Period 2: Part 2|Other|0|||
163168166|NCT00830869|589332281|FG002|Period 2: Part 2|Other|0|||
163168167|NCT00830869|589332282|FG003|Period 2: Part 2|Other|0|||
163168168|NCT00830869|589332283|FG004|Period 2: Part 2|Other|0|||
163168169|NCT00830869|589332284|FG005|Period 2: Part 2|Other|0|||
163168170|NCT00830869|589332285|FG006|Period 2: Part 2|Other|0|||
163168171|NCT00830869|589332286|FG007|Period 2: Part 2|Other|0|||
163168172|NCT00830869|589332287|FG008|Period 2: Part 2|Other|0|||
163168173|NCT00830869|589332288|FG009|Period 2: Part 2|Other|1|||
163168174|NCT00830869|589332289|FG010|Period 2: Part 2|Other|0|||
163168175|NCT00830869|589332290|FG011|Period 2: Part 2|Other|0|||
163168176|NCT00507728|589332291|FG000|Randomization to Month 3|Lost to Follow-up|15|||
163168177|NCT00507728|589332292|FG001|Randomization to Month 3|Lost to Follow-up|14|||
163168178|NCT00507728|589332293|FG002|Randomization to Month 3|Lost to Follow-up|20|||
163168179|NCT00507728|589332291|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
163168180|NCT00507728|589332292|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
163168181|NCT00507728|589332293|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
163168182|NCT00730028|589332295|FG000|Overall Study|Adverse Event|23|||
163168183|NCT00730028|589332296|FG001|Overall Study|Adverse Event|26|||
163168184|NCT00730028|589332297|FG002|Overall Study|Adverse Event|16|||
163168185|NCT00730028|589332298|FG003|Overall Study|Adverse Event|20|||
163168186|NCT00730028|589332299|FG004|Overall Study|Adverse Event|43|||
163168187|NCT00730028|589332295|FG000|Overall Study|Lost to Follow-up|13|||
163168188|NCT00730028|589332296|FG001|Overall Study|Lost to Follow-up|26|||
163168189|NCT00730028|589332297|FG002|Overall Study|Lost to Follow-up|22|||
163168190|NCT00730028|589332298|FG003|Overall Study|Lost to Follow-up|26|||
163168191|NCT00730028|589332299|FG004|Overall Study|Lost to Follow-up|25|||
163168192|NCT00730028|589332295|FG000|Overall Study|Protocol Violation|6|||
163168193|NCT00730028|589332296|FG001|Overall Study|Protocol Violation|1|||
163168194|NCT00730028|589332297|FG002|Overall Study|Protocol Violation|1|||
163168195|NCT00730028|589332298|FG003|Overall Study|Protocol Violation|2|||
163168196|NCT00730028|589332299|FG004|Overall Study|Protocol Violation|0|||
163168197|NCT00730028|589332295|FG000|Overall Study|Withdrawal by Subject|9|||
163168198|NCT00730028|589332296|FG001|Overall Study|Withdrawal by Subject|5|||
163168199|NCT00730028|589332297|FG002|Overall Study|Withdrawal by Subject|4|||
163168200|NCT00730028|589332298|FG003|Overall Study|Withdrawal by Subject|5|||
163168201|NCT00730028|589332299|FG004|Overall Study|Withdrawal by Subject|9|||
163168202|NCT00730028|589332295|FG000|Overall Study|Physician Decision|3|||
163168203|NCT00730028|589332296|FG001|Overall Study|Physician Decision|3|||
163168204|NCT00730028|589332297|FG002|Overall Study|Physician Decision|2|||
163168205|NCT00730028|589332298|FG003|Overall Study|Physician Decision|3|||
163168206|NCT00730028|589332299|FG004|Overall Study|Physician Decision|2|||
163168207|NCT00730028|589332295|FG000|Overall Study|Treatment Failure|5|||
163168208|NCT00730028|589332296|FG001|Overall Study|Treatment Failure|5|||
163168209|NCT00730028|589332297|FG002|Overall Study|Treatment Failure|0|||
163168210|NCT00730028|589332298|FG003|Overall Study|Treatment Failure|0|||
163168211|NCT00730028|589332299|FG004|Overall Study|Treatment Failure|1|||
163168212|NCT00730028|589332295|FG000|Overall Study|Randomization Error|1|||
163168213|NCT00730028|589332296|FG001|Overall Study|Randomization Error|0|||
163168214|NCT00730028|589332297|FG002|Overall Study|Randomization Error|0|||
163168215|NCT00730028|589332298|FG003|Overall Study|Randomization Error|0|||
163168216|NCT00730028|589332299|FG004|Overall Study|Randomization Error|2|||
163168217|NCT00615901|589332300|FG000|Overall Study|Withdrawal by Subject|2|||
163168218|NCT00615901|589332300|FG000|Overall Study|Adverse Event|7|||
163168219|NCT01250496|589332301|FG000|Overall Study|Study terminated|124|||
163168220|NCT01250496|589332302|FG001|Overall Study|Study terminated|124|||
163168221|NCT01425463|589332310|FG000|Overall Study|Adverse Event|5|||
163168222|NCT01425463|589332311|FG001|Overall Study|Adverse Event|7|||
162818144|NCT02234323|588047669|FG000|All Enrolled|Not Treated: Completed study in database|2|||
163168223|NCT01425463|589332310|FG000|Overall Study|Lack of Efficacy|1|||
163168224|NCT01425463|589332311|FG001|Overall Study|Lack of Efficacy|1|||
163168225|NCT01425463|589332310|FG000|Overall Study|Protocol Violation|2|||
163168226|NCT01425463|589332311|FG001|Overall Study|Protocol Violation|2|||
163168227|NCT01425463|589332310|FG000|Overall Study|Lost to Follow-up|5|||
163168228|NCT01425463|589332311|FG001|Overall Study|Lost to Follow-up|2|||
163168229|NCT01425463|589332310|FG000|Overall Study|Withdrawal by Subject|7|||
163168230|NCT01425463|589332311|FG001|Overall Study|Withdrawal by Subject|5|||
163168231|NCT01425463|589332310|FG000|Overall Study|Unknown Reason|4|||
163168232|NCT01425463|589332311|FG001|Overall Study|Unknown Reason|7|||
163168233|NCT01332799|589332312|FG000|Overall Study|Insufficient funding|10|||
163168234|NCT01332799|589332313|FG001|Overall Study|Insufficient funding|10|||
163168235|NCT03467152|589332314|FG000|Overall Study|Adverse Event|4|||
163168236|NCT03467152|589332315|FG001|Overall Study|Adverse Event|5|||
163168237|NCT03467152|589332316|FG002|Overall Study|Adverse Event|0|||
163168238|NCT03467152|589332314|FG000|Overall Study|Subject Choice|1|||
163168239|NCT03467152|589332315|FG001|Overall Study|Subject Choice|3|||
163168240|NCT03467152|589332316|FG002|Overall Study|Subject Choice|0|||
163168241|NCT03467152|589332314|FG000|Overall Study|Lost to Follow-up|1|||
163168242|NCT03467152|589332315|FG001|Overall Study|Lost to Follow-up|0|||
163168243|NCT03467152|589332316|FG002|Overall Study|Lost to Follow-up|0|||
163168244|NCT03467152|589332314|FG000|Overall Study|Withdrawal by Subject|4|||
163168245|NCT03467152|589332315|FG001|Overall Study|Withdrawal by Subject|2|||
163168246|NCT03467152|589332316|FG002|Overall Study|Withdrawal by Subject|0|||
163168247|NCT03467152|589332314|FG000|Overall Study|Others|3|||
163168248|NCT03467152|589332315|FG001|Overall Study|Others|0|||
163168249|NCT03467152|589332316|FG002|Overall Study|Others|0|||
163168250|NCT03467152|589332314|FG000|Overall Study|Not treated|3|||
163168251|NCT03467152|589332315|FG001|Overall Study|Not treated|1|||
163168252|NCT03467152|589332316|FG002|Overall Study|Not treated|6|||
163168253|NCT00945906|589332317|FG000|Overall Study|Withdrawal by Subject|1|||
163168254|NCT00945906|589332317|FG000|Overall Study|Did not want to return for last visit|2|||
163168255|NCT00945906|589332317|FG000|Overall Study|Unable to return for last visit|2|||
163168256|NCT00945906|589332317|FG000|Overall Study|Moved to another country|2|||
163168257|NCT01236547|589332319|FG000|Overall Study|Protocol Violation|0|||
163168258|NCT01236547|589332320|FG001|Overall Study|Protocol Violation|1|||
163168259|NCT01236547|589332321|FG002|Overall Study|Protocol Violation|1|||
163168260|NCT01236547|589332322|FG003|Overall Study|Protocol Violation|6|||
163168261|NCT01236547|589332323|FG004|Overall Study|Protocol Violation|12|||
163168262|NCT01120782|589332324|FG000|Overall Study|Test article shipping error|11|||
163168263|NCT04140227|589332325|FG000|Overall Study|Withdrawal by Subject|26|||
163168264|NCT04140227|589332325|FG000|Overall Study|Lost to Follow-up|8|||
163168265|NCT04140227|589332325|FG000|Overall Study|Adverse Event|8|||
163168266|NCT04140227|589332325|FG000|Overall Study|Death|1|||
163168267|NCT04140227|589332325|FG000|Overall Study|Other|3|||
163168268|NCT04140227|589332325|FG000|Overall Study|Protocol Violation|2|||
163168269|NCT00538785|589332326|FG000|Overall Study|Death|9|||
163168270|NCT00538785|589332327|FG001|Overall Study|Death|10|||
163168271|NCT00538785|589332326|FG000|Overall Study|Withdrawal of consent|9|||
163168272|NCT00538785|589332327|FG001|Overall Study|Withdrawal of consent|7|||
163168273|NCT00538785|589332326|FG000|Overall Study|Lost to Follow-up|1|||
163168274|NCT00538785|589332327|FG001|Overall Study|Lost to Follow-up|0|||
163168275|NCT04022733|589332328|FG000|Overall Study|conversion to open surgery|3|||
163168276|NCT04022733|589332329|FG001|Overall Study|conversion to open surgery|2|||
163168277|NCT04022733|589332328|FG000|Overall Study|bradycardia|0|||
163168278|NCT04022733|589332329|FG001|Overall Study|bradycardia|1|||
163168279|NCT01541397|589332330|FG000|Overall Study|Study ended prior to data collection|4|||
163168280|NCT01541397|589332331|FG001|Overall Study|Study ended prior to data collection|2|||
163168281|NCT00233454|589332332|FG000|Overall Study|Death|6|||
163168282|NCT04224688|589332333|FG000|Overall Study|Withdrawal by Subject|1|||
163168283|NCT04224688|589332334|FG001|Overall Study|Withdrawal by Subject|3|||
163168284|NCT04224688|589332333|FG000|Overall Study|Lack of Efficacy|1|||
163168285|NCT04224688|589332334|FG001|Overall Study|Lack of Efficacy|1|||
163168286|NCT04224688|589332333|FG000|Overall Study|Adverse event, not fatal|0|||
163168287|NCT04224688|589332334|FG001|Overall Study|Adverse event, not fatal|2|||
163168288|NCT04224688|589332333|FG000|Overall Study|COVID-19|0|||
163168289|NCT04224688|589332334|FG001|Overall Study|COVID-19|1|||
163168290|NCT03083990|589332335|FG000|Overall Study|Adverse Event|1|||
163168291|NCT03083990|589332336|FG001|Overall Study|Adverse Event|0|||
163168292|NCT01853839|589332337|FG000|Overall Study|Violated inclusion criteria|2|||
163168293|NCT01853839|589332337|FG000|Overall Study|Not meet ITT population definition|58|||
163168294|NCT01853839|589332337|FG000|Overall Study|End of treatment visit too early|33|||
163168295|NCT01853839|589332337|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
163168296|NCT01640314|589332338|FG000|Overall Study|Protocol Violation|0|||
163168297|NCT01640314|589332339|FG001|Overall Study|Protocol Violation|1|||
163168298|NCT02709538|589332341|FG000|Overall Study|Adverse Event|13|||
163168299|NCT02709538|589332342|FG001|Overall Study|Adverse Event|2|||
163168300|NCT02709538|589332343|FG002|Overall Study|Adverse Event|3|||
163168301|NCT02709538|589332341|FG000|Overall Study|Lack of Efficacy|1|||
163168302|NCT02709538|589332342|FG001|Overall Study|Lack of Efficacy|0|||
163168303|NCT02709538|589332343|FG002|Overall Study|Lack of Efficacy|0|||
163168304|NCT02709538|589332341|FG000|Overall Study|Lost to Follow-up|24|||
163168305|NCT02709538|589332342|FG001|Overall Study|Lost to Follow-up|8|||
163168306|NCT02709538|589332343|FG002|Overall Study|Lost to Follow-up|4|||
163168307|NCT02709538|589332341|FG000|Overall Study|Physician Decision|1|||
163168308|NCT02709538|589332342|FG001|Overall Study|Physician Decision|0|||
163168309|NCT02709538|589332343|FG002|Overall Study|Physician Decision|0|||
163168310|NCT02709538|589332341|FG000|Overall Study|Withdrawal by Subject|40|||
163168311|NCT02709538|589332342|FG001|Overall Study|Withdrawal by Subject|7|||
163168312|NCT02709538|589332343|FG002|Overall Study|Withdrawal by Subject|4|||
163168313|NCT02709538|589332341|FG000|Overall Study|Non-compliance with study procedures|5|||
163168314|NCT02709538|589332342|FG001|Overall Study|Non-compliance with study procedures|0|||
163168315|NCT02709538|589332343|FG002|Overall Study|Non-compliance with study procedures|0|||
163168316|NCT02709538|589332341|FG000|Overall Study|Non-compliance with study drug|2|||
163168317|NCT02709538|589332342|FG001|Overall Study|Non-compliance with study drug|0|||
163168318|NCT02709538|589332343|FG002|Overall Study|Non-compliance with study drug|0|||
163168319|NCT02709538|589332341|FG000|Overall Study|Protocol deviation|10|||
163168320|NCT02709538|589332342|FG001|Overall Study|Protocol deviation|4|||
163168321|NCT02709538|589332343|FG002|Overall Study|Protocol deviation|4|||
163168322|NCT02709538|589332341|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
163168323|NCT02709538|589332342|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
163168324|NCT02709538|589332343|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
163168325|NCT02709538|589332341|FG000|Overall Study|Other|16|||
163168326|NCT02709538|589332342|FG001|Overall Study|Other|7|||
163168327|NCT02709538|589332343|FG002|Overall Study|Other|5|||
163168328|NCT00835211|589332345|FG000|First Intervention|Withdrawal by Subject|0|||
163168329|NCT00835211|589332346|FG001|First Intervention|Withdrawal by Subject|1|||
163168330|NCT00835211|589332345|FG000|Washout: 7 Days|Adverse Event|2|||
163168331|NCT00835211|589332346|FG001|Washout: 7 Days|Adverse Event|1|||
163168332|NCT00835211|589332345|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163168333|NCT00835211|589332346|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163168334|NCT02343549|589332347|FG000|Overall Study|Death|11|||
163168335|NCT02343549|589332347|FG000|Overall Study|Withdrawal by Subject|2|||
163168336|NCT03087617|589332348|FG000|Overall Study|Lost to Follow-up|32|||
163168337|NCT03087617|589332349|FG001|Overall Study|Lost to Follow-up|30|||
163168338|NCT03087617|589332350|FG002|Overall Study|Lost to Follow-up|30|||
163168339|NCT03087617|589332351|FG003|Overall Study|Lost to Follow-up|39|||
163168340|NCT02160041|589332353|FG000|Overall Study|Adverse Event|11|||
163168341|NCT02160041|589332353|FG000|Overall Study|Death|2|||
163168342|NCT02160041|589332353|FG000|Overall Study|disease progression|57|||
163168343|NCT02160041|589332353|FG000|Overall Study|Protocol Violation|1|||
163168344|NCT02160041|589332353|FG000|Overall Study|non-compliance with study|1|||
163168345|NCT02160041|589332353|FG000|Overall Study|Physician Decision|3|||
163168346|NCT02160041|589332353|FG000|Overall Study|Withdrawal by Subject|8|||
163168347|NCT02160041|589332353|FG000|Overall Study|study terminated by by sponsor|1|||
163168348|NCT04450381|589332354|FG000|Overall Study|Protocol Violation|4|||
163168349|NCT04450381|589332354|FG000|Overall Study|Wrong device setting|2|||
163168350|NCT00006409|589332357|FG000|Baseline|Protocol Violation|48|||
163168351|NCT00006409|589332358|FG001|Baseline|Protocol Violation|70|||
163168352|NCT00006409|589332359|FG002|Baseline|Protocol Violation|0|||
163168353|NCT00006409|589332360|FG003|Baseline|Protocol Violation|0|||
163168354|NCT00006409|589332361|FG004|Baseline|Protocol Violation|0|||
163168355|NCT00006409|589332362|FG005|Baseline|Protocol Violation|0|||
163168356|NCT00006409|589332357|FG000|Post-2 Year Intervention|Protocol Violation|0|||
163168357|NCT00006409|589332358|FG001|Post-2 Year Intervention|Protocol Violation|0|||
163168358|NCT00006409|589332359|FG002|Post-2 Year Intervention|Protocol Violation|251|||
163168359|NCT00006409|589332360|FG003|Post-2 Year Intervention|Protocol Violation|168|||
163168360|NCT00006409|589332361|FG004|Post-2 Year Intervention|Protocol Violation|0|||
163168361|NCT00006409|589332362|FG005|Post-2 Year Intervention|Protocol Violation|0|||
163168362|NCT00006409|589332357|FG000|Post-3 Year Intervention|Protocol Violation|0|||
163168363|NCT00006409|589332358|FG001|Post-3 Year Intervention|Protocol Violation|0|||
163168364|NCT00006409|589332359|FG002|Post-3 Year Intervention|Protocol Violation|0|||
163168365|NCT00006409|589332360|FG003|Post-3 Year Intervention|Protocol Violation|0|||
163168366|NCT00006409|589332361|FG004|Post-3 Year Intervention|Protocol Violation|62|||
163168367|NCT00006409|589332362|FG005|Post-3 Year Intervention|Protocol Violation|62|||
163168368|NCT04343235|589332365|FG000|Overall Study|Lost to Follow-up|3|||
163168369|NCT04343235|589332366|FG001|Overall Study|Lost to Follow-up|2|||
163168370|NCT00787267|589332367|FG000|Overall Study|Screen failure/Ineligible|10|||
163168371|NCT00787267|589332367|FG000|Overall Study|No Reason Provided|1|||
163168372|NCT00787267|589332367|FG000|Overall Study|Withdrawal by Subject|1|||
163168373|NCT01763996|589332368|FG000|Treatment Period 2|Adverse Event|0|||
163168374|NCT01763996|589332369|FG001|Treatment Period 2|Adverse Event|1|||
163168375|NCT00776919|589332370|FG000|Overall Study|Withdrawal by Subject|16|||
163168376|NCT00776919|589332371|FG001|Overall Study|Withdrawal by Subject|14|||
163168377|NCT00776919|589332372|FG002|Overall Study|Withdrawal by Subject|15|||
163168378|NCT00776919|589332373|FG003|Overall Study|Withdrawal by Subject|26|||
163168379|NCT00776919|589332370|FG000|Overall Study|Lost to Follow-up|8|||
163168380|NCT00776919|589332371|FG001|Overall Study|Lost to Follow-up|12|||
163168381|NCT00776919|589332372|FG002|Overall Study|Lost to Follow-up|11|||
163168382|NCT00776919|589332373|FG003|Overall Study|Lost to Follow-up|8|||
163168383|NCT00776919|589332370|FG000|Overall Study|Adverse Event|1|||
163168384|NCT00776919|589332371|FG001|Overall Study|Adverse Event|0|||
163168385|NCT00776919|589332372|FG002|Overall Study|Adverse Event|2|||
163168386|NCT00776919|589332373|FG003|Overall Study|Adverse Event|2|||
163168387|NCT00776919|589332370|FG000|Overall Study|Protocol Violation|1|||
163168388|NCT00776919|589332371|FG001|Overall Study|Protocol Violation|2|||
163168389|NCT00776919|589332372|FG002|Overall Study|Protocol Violation|0|||
163168390|NCT00776919|589332373|FG003|Overall Study|Protocol Violation|1|||
163168391|NCT00776919|589332370|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
163168392|NCT00776919|589332371|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
163168393|NCT00776919|589332372|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
163168394|NCT00776919|589332373|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
163168395|NCT01396057|589332382|FG000|Overall Study|Adverse Event|2|||
163168396|NCT01396057|589332383|FG001|Overall Study|Adverse Event|6|||
163168397|NCT01396057|589332382|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163168398|NCT01396057|589332383|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163168399|NCT01396057|589332382|FG000|Overall Study|Protocol deviation|4|||
163168400|NCT01396057|589332383|FG001|Overall Study|Protocol deviation|4|||
163168401|NCT01396057|589332382|FG000|Overall Study|Consent withdrawn|3|||
163168402|NCT01396057|589332383|FG001|Overall Study|Consent withdrawn|2|||
163168403|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
163168404|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168405|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168406|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
163168407|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Death|3|||
163168408|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Death|0|||
163168409|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Death|0|||
163168410|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Death|0|||
163168411|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
163168412|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168413|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168414|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163168415|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
163168416|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168417|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168418|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
163168419|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
163168420|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168421|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168422|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
163168423|NCT00884741|589332386|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
163168424|NCT00884741|589332387|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168425|NCT00884741|589332388|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168426|NCT00884741|589332389|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
163168427|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168428|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
163168429|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168430|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
163168431|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
163168432|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
163168433|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
163168434|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
163168435|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168436|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
163168437|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168438|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163168439|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168440|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
163168441|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168442|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163168443|NCT00884741|589332386|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168444|NCT00884741|589332387|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
163168445|NCT00884741|589332388|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168446|NCT00884741|589332389|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
163168447|NCT00884741|589332386|FG000|Randomization|Protocol Violation|0|||
163168448|NCT00884741|589332387|FG001|Randomization|Protocol Violation|0|||
163168449|NCT00884741|589332388|FG002|Randomization|Protocol Violation|8|||
163168450|NCT00884741|589332389|FG003|Randomization|Protocol Violation|8|||
163168451|NCT01324401|589332390|FG000|Overall Study|Withdrawn before any treatment|0|||
163168452|NCT01324401|589332391|FG001|Overall Study|Withdrawn before any treatment|3|||
163168453|NCT01324401|589332390|FG000|Overall Study|Adverse Event|1|||
163168454|NCT01324401|589332391|FG001|Overall Study|Adverse Event|3|||
163168455|NCT02969655|589332392|FG000|Overall Study|Withdrawal by Subject|3|||
163168456|NCT02969655|589332393|FG001|Overall Study|Withdrawal by Subject|2|||
163168457|NCT02969655|589332392|FG000|Overall Study|Physician Decision|4|||
163168458|NCT02969655|589332393|FG001|Overall Study|Physician Decision|3|||
163168459|NCT02969655|589332392|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
163168460|NCT02969655|589332393|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
163168461|NCT02969655|589332392|FG000|Overall Study|Adverse Event|10|||
163168462|NCT02969655|589332393|FG001|Overall Study|Adverse Event|8|||
163168463|NCT01578850|589332395|FG000|Period 1|Insufficient Clinical Response|1|||
163168464|NCT01578850|589332396|FG001|Period 1|Insufficient Clinical Response|0|||
163168465|NCT01578850|589332397|FG002|Period 1|Insufficient Clinical Response|0|||
163168466|NCT01578850|589332395|FG000|Period 1|Adverse Event|11|||
163168467|NCT01578850|589332396|FG001|Period 1|Adverse Event|0|||
163168468|NCT01578850|589332397|FG002|Period 1|Adverse Event|0|||
163168469|NCT01578850|589332395|FG000|Period 1|Death|1|||
163168470|NCT01578850|589332396|FG001|Period 1|Death|0|||
163168471|NCT01578850|589332397|FG002|Period 1|Death|0|||
163168472|NCT01578850|589332395|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
163168473|NCT01578850|589332396|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
163168474|NCT01578850|589332397|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
163168475|NCT01578850|589332395|FG000|Period 1|Withdrawal by Subject|9|||
163168476|NCT01578850|589332396|FG001|Period 1|Withdrawal by Subject|0|||
163168477|NCT01578850|589332397|FG002|Period 1|Withdrawal by Subject|0|||
163168478|NCT01578850|589332395|FG000|Period 1|Study Terminated by Sponsor|3|||
163168479|NCT01578850|589332396|FG001|Period 1|Study Terminated by Sponsor|0|||
163168480|NCT01578850|589332397|FG002|Period 1|Study Terminated by Sponsor|0|||
163168481|NCT01578850|589332395|FG000|Period 2|Insufficient Clinical Response|0|||
163168482|NCT01578850|589332396|FG001|Period 2|Insufficient Clinical Response|1|||
163168483|NCT01578850|589332397|FG002|Period 2|Insufficient Clinical Response|0|||
163168484|NCT01578850|589332395|FG000|Period 2|Adverse Event|0|||
163168485|NCT01578850|589332396|FG001|Period 2|Adverse Event|3|||
163168486|NCT01578850|589332397|FG002|Period 2|Adverse Event|6|||
163168487|NCT01578850|589332395|FG000|Period 2|Lost to Follow-up|0|||
163168488|NCT01578850|589332396|FG001|Period 2|Lost to Follow-up|1|||
163168489|NCT01578850|589332397|FG002|Period 2|Lost to Follow-up|2|||
163168490|NCT01578850|589332395|FG000|Period 2|Withdrawal by Subject|0|||
163168491|NCT01578850|589332396|FG001|Period 2|Withdrawal by Subject|2|||
163168492|NCT01578850|589332397|FG002|Period 2|Withdrawal by Subject|2|||
163168493|NCT01578850|589332395|FG000|Period 2|Study Terminated by Sponsor|0|||
163168494|NCT01578850|589332396|FG001|Period 2|Study Terminated by Sponsor|5|||
163168495|NCT01578850|589332397|FG002|Period 2|Study Terminated by Sponsor|4|||
163168496|NCT01578850|589332395|FG000|Period 2|Unspecified Reasons|0|||
163168497|NCT01578850|589332396|FG001|Period 2|Unspecified Reasons|1|||
163168498|NCT01578850|589332397|FG002|Period 2|Unspecified Reasons|0|||
163168499|NCT02703337|589332401|FG000|Period One (Part A)|Withdrawal by Subject|0|||
163168500|NCT02703337|589332402|FG001|Period One (Part A)|Withdrawal by Subject|0|||
163168501|NCT02703337|589332403|FG002|Period One (Part A)|Withdrawal by Subject|0|||
163168502|NCT02703337|589332404|FG003|Period One (Part A)|Withdrawal by Subject|0|||
163168503|NCT02703337|589332405|FG004|Period One (Part A)|Withdrawal by Subject|1|||
163168504|NCT02703337|589332406|FG005|Period One (Part A)|Withdrawal by Subject|0|||
163168505|NCT02703337|589332407|FG006|Period One (Part A)|Withdrawal by Subject|0|||
163168506|NCT02703337|589332408|FG007|Period One (Part A)|Withdrawal by Subject|0|||
163168507|NCT01001325|589332414|FG000|Overall Study|Lost to Follow-up|16|||
163168508|NCT01001325|589332415|FG001|Overall Study|Lost to Follow-up|10|||
163168509|NCT01001325|589332414|FG000|Overall Study|Protocol Violation|2|||
163168510|NCT01001325|589332415|FG001|Overall Study|Protocol Violation|0|||
163168511|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
163168512|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168513|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168514|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168515|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
163168516|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
163168517|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
163168518|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
163168519|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
163168520|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
163168521|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
163168522|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168523|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168524|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168525|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163168526|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
163168527|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
163168528|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168529|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168530|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
163168531|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
163168532|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168533|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168534|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168535|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
163168536|NCT01584440|589332418|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168537|NCT01584440|589332419|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
163168538|NCT01584440|589332420|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168539|NCT01584440|589332421|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168540|NCT01584440|589332422|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
163168541|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168542|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168543|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
163168544|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
163168545|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
163168546|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
163168547|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
163168548|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
163168549|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
163168550|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
163168551|NCT01584440|589332418|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168552|NCT01584440|589332419|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168553|NCT01584440|589332420|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
163168554|NCT01584440|589332421|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168555|NCT01584440|589332422|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
163168556|NCT04237116|589332423|FG000|Overall Study|Adverse Event|0|||
163168557|NCT04237116|589332424|FG001|Overall Study|Adverse Event|1|||
163168558|NCT04237116|589332423|FG000|Overall Study|Study terminated by Sponsor|4|||
163168559|NCT04237116|589332424|FG001|Overall Study|Study terminated by Sponsor|1|||
163168560|NCT03212144|589332425|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
163168561|NCT03212144|589332426|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
163168562|NCT03212144|589332425|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
163168563|NCT03212144|589332426|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
162818145|NCT02234323|588047669|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
163168564|NCT00899431|589332427|FG000|Overall Study|Physician Decision|1|||
163168565|NCT00899431|589332428|FG001|Overall Study|Physician Decision|0|||
163168566|NCT00899431|589332429|FG002|Overall Study|Physician Decision|0|||
163168567|NCT00661427|589332432|FG000|Overall Study|Adverse Event|5|||
163168568|NCT00661427|589332433|FG001|Overall Study|Adverse Event|5|||
163168569|NCT00661427|589332432|FG000|Overall Study|Patient not treated|0|||
163168570|NCT00661427|589332433|FG001|Overall Study|Patient not treated|2|||
163168571|NCT01821560|589332434|FG000|Overall Study|Lost to Follow-up|5|||
163168572|NCT01821560|589332435|FG001|Overall Study|Lost to Follow-up|5|||
163168573|NCT01821560|589332434|FG000|Overall Study|Withdrawal by Subject|1|||
163168574|NCT01821560|589332435|FG001|Overall Study|Withdrawal by Subject|1|||
163168575|NCT01821560|589332434|FG000|Overall Study|Protocol Violation|0|||
163168576|NCT01821560|589332435|FG001|Overall Study|Protocol Violation|1|||
163168577|NCT01338298|589332436|FG000|Overall Study|Withdrawal by Subject|1|||
163168578|NCT01338298|589332437|FG001|Overall Study|Withdrawal by Subject|1|||
163168579|NCT01338298|589332436|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
163168580|NCT01338298|589332437|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
163168581|NCT01338298|589332436|FG000|Overall Study|Administrative error|0|||
163168582|NCT01338298|589332437|FG001|Overall Study|Administrative error|1|||
163168583|NCT01338298|589332436|FG000|Overall Study|Positive symptom worsening|1|||
163168584|NCT01338298|589332437|FG001|Overall Study|Positive symptom worsening|0|||
163168585|NCT01338298|589332436|FG000|Overall Study|Depressive symptoms and nausea|1|||
163168586|NCT01338298|589332437|FG001|Overall Study|Depressive symptoms and nausea|0|||
163168587|NCT01338298|589332436|FG000|Overall Study|Non-adherence|1|||
163168588|NCT01338298|589332437|FG001|Overall Study|Non-adherence|0|||
163168589|NCT00531427|589332438|FG000|Overall Study|Withdrawal by Subject|7|||
163168590|NCT00531427|589332439|FG001|Overall Study|Withdrawal by Subject|13|||
163168591|NCT00531427|589332438|FG000|Overall Study|Adverse Event|44|||
163168592|NCT00531427|589332439|FG001|Overall Study|Adverse Event|30|||
163168593|NCT00531427|589332438|FG000|Overall Study|Lost to Follow-up|4|||
163168594|NCT00531427|589332439|FG001|Overall Study|Lost to Follow-up|3|||
163168595|NCT00531427|589332438|FG000|Overall Study|Lack of Efficacy|14|||
163168596|NCT00531427|589332439|FG001|Overall Study|Lack of Efficacy|39|||
163168597|NCT00531427|589332438|FG000|Overall Study|Administrative|4|||
163168598|NCT00531427|589332439|FG001|Overall Study|Administrative|9|||
163168599|NCT05477108|589332440|FG000|Overall Study|Participants randomized, not treated|1|||
163168600|NCT05477108|589332441|FG001|Overall Study|Participants randomized, not treated|1|||
163168601|NCT05477108|589332442|FG002|Overall Study|Participants randomized, not treated|1|||
163168602|NCT05477108|589332440|FG000|Overall Study|Physician Decision|0|||
163168603|NCT05477108|589332441|FG001|Overall Study|Physician Decision|0|||
163168604|NCT05477108|589332442|FG002|Overall Study|Physician Decision|1|||
163168605|NCT05477108|589332440|FG000|Overall Study|withdrawn from study|0|||
163168606|NCT05477108|589332441|FG001|Overall Study|withdrawn from study|0|||
163168607|NCT05477108|589332442|FG002|Overall Study|withdrawn from study|1|||
163168608|NCT01253577|589332443|FG000|Overall Study|Lost to Follow-up|3|||
163168609|NCT05688670|589332444|FG000|Overall Study|Change in surgery plan|1|||
163168610|NCT05688670|589332445|FG001|Overall Study|Change in surgery plan|4|||
163168611|NCT05688670|589332444|FG000|Overall Study|Inability to extubate|1|||
163168612|NCT05688670|589332445|FG001|Overall Study|Inability to extubate|2|||
163168613|NCT05688670|589332444|FG000|Overall Study|Day of surgery cancellation|0|||
163168614|NCT05688670|589332445|FG001|Overall Study|Day of surgery cancellation|1|||
163168615|NCT05688670|589332444|FG000|Overall Study|Reintubated on PCICU arrival|0|||
163168616|NCT05688670|589332445|FG001|Overall Study|Reintubated on PCICU arrival|1|||
163168617|NCT00488683|589332446|FG000|Overall Study|Withdrawal by Subject|1|||
163168618|NCT00488683|589332447|FG001|Overall Study|Withdrawal by Subject|2|||
163168619|NCT00488683|589332448|FG002|Overall Study|Withdrawal by Subject|2|||
163168620|NCT00488683|589332446|FG000|Overall Study|Lost to Follow-up|5|||
163168621|NCT00488683|589332447|FG001|Overall Study|Lost to Follow-up|3|||
163168622|NCT00488683|589332448|FG002|Overall Study|Lost to Follow-up|0|||
163168623|NCT00488683|589332446|FG000|Overall Study|Protocol Violation|5|||
163168624|NCT00488683|589332447|FG001|Overall Study|Protocol Violation|1|||
163168625|NCT00488683|589332448|FG002|Overall Study|Protocol Violation|0|||
163168626|NCT00488683|589332446|FG000|Overall Study|Unable to Classify|1|||
163168627|NCT00488683|589332447|FG001|Overall Study|Unable to Classify|0|||
163168628|NCT00488683|589332448|FG002|Overall Study|Unable to Classify|0|||
163168629|NCT00361634|589334467|FG000|Overall Study|Lost to Follow-up|1|||
163168630|NCT00361634|589334467|FG000|Overall Study|Withdrawal by Subject|1|||
163168631|NCT05315908|589334468|FG000|Overall Study|Lost to Follow-up|4477|||
163168632|NCT05315908|589334469|FG001|Overall Study|Lost to Follow-up|4606|||
163168633|NCT00505076|589334478|FG000|Overall Study|Adverse Event|1|||
163168634|NCT00505076|589334479|FG001|Overall Study|Adverse Event|0|||
163168635|NCT00505076|589334480|FG002|Overall Study|Adverse Event|1|||
163168636|NCT00505076|589334478|FG000|Overall Study|Protocol Violation|2|||
163168637|NCT00505076|589334479|FG001|Overall Study|Protocol Violation|1|||
163168638|NCT00505076|589334480|FG002|Overall Study|Protocol Violation|2|||
163168639|NCT00505076|589334478|FG000|Overall Study|Withdrawal by Subject|0|||
163168640|NCT00505076|589334479|FG001|Overall Study|Withdrawal by Subject|1|||
163168641|NCT00505076|589334480|FG002|Overall Study|Withdrawal by Subject|2|||
163168642|NCT01128621|589334481|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
163168643|NCT01128621|589334482|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
163168644|NCT04074161|589334485|FG000|Overall Study|Withdrawal by Subject|2|||
163168645|NCT04074161|589334486|FG001|Overall Study|Withdrawal by Subject|4|||
163168646|NCT04074161|589334487|FG002|Overall Study|Withdrawal by Subject|1|||
163168647|NCT04074161|589334485|FG000|Overall Study|Lost to Follow-up|4|||
163168648|NCT04074161|589334486|FG001|Overall Study|Lost to Follow-up|5|||
163168649|NCT04074161|589334487|FG002|Overall Study|Lost to Follow-up|3|||
163168650|NCT03595228|589334490|FG000|Overall Study|Death|2|||
163168651|NCT03595228|589334490|FG000|Overall Study|Lack of Efficacy|13|||
163168652|NCT03595228|589334490|FG000|Overall Study|Withdrawal by Subject|3|||
163168653|NCT03595228|589334490|FG000|Overall Study|Withdrawal by Sponsor|1|||
163168654|NCT01639729|589334491|FG000|Overall Study|Withdrawal by Subject|1|||
163168655|NCT01639729|589334492|FG001|Overall Study|Withdrawal by Subject|0|||
163168656|NCT01639729|589334493|FG002|Overall Study|Withdrawal by Subject|1|||
163168657|NCT01639729|589334494|FG003|Overall Study|Withdrawal by Subject|1|||
163168658|NCT01639729|589334495|FG004|Overall Study|Withdrawal by Subject|0|||
163168659|NCT01639729|589334496|FG005|Overall Study|Withdrawal by Subject|0|||
163168660|NCT03232333|589334497|FG000|Overall Study|Infection or Osteomyelitis|9|||
163168661|NCT03232333|589334497|FG000|Overall Study|Lost to Follow-up|4|||
163168662|NCT03232333|589334497|FG000|Overall Study|Withdrawal by Subject|2|||
163168663|NCT01155011|589334498|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
163168664|NCT01155011|589334499|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
163168665|NCT01155011|589334498|FG000|Baseline to 6 Months|investigator decision, moved|4|||
163168666|NCT01155011|589334499|FG001|Baseline to 6 Months|investigator decision, moved|5|||
163168667|NCT01155011|589334498|FG000|Baseline to 6 Months|Death|0|||
163168668|NCT01155011|589334499|FG001|Baseline to 6 Months|Death|1|||
163168669|NCT01155011|589334498|FG000|6 to 12 Months|Withdrawal by Subject|8|||
163168670|NCT01155011|589334499|FG001|6 to 12 Months|Withdrawal by Subject|5|||
163168671|NCT01155011|589334498|FG000|6 to 12 Months|Death|1|||
163168672|NCT01155011|589334499|FG001|6 to 12 Months|Death|5|||
163168673|NCT01087736|589334500|FG000|Overall Study|Lost to Follow-up|1|||
163168674|NCT01087736|589334501|FG001|Overall Study|Lost to Follow-up|0|||
163168675|NCT01087736|589334500|FG000|Overall Study|Death|0|||
163168676|NCT01087736|589334501|FG001|Overall Study|Death|1|||
163168677|NCT01087736|589334500|FG000|Overall Study|Withdrawal by Subject|0|||
163168678|NCT01087736|589334501|FG001|Overall Study|Withdrawal by Subject|1|||
163168679|NCT01253811|589334502|FG000|Overall Study|Withdrawal criteria|1|||
163168680|NCT00759564|589334503|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168681|NCT00759564|589334504|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168682|NCT00759564|589334505|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168683|NCT00759564|589334506|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
163168684|NCT00759564|589334507|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
163168685|NCT01565343|589334510|FG000|Overall Study|Administrative decision/technical issues|1|||
163168686|NCT01565343|589334511|FG001|Overall Study|Administrative decision/technical issues|0|||
163168687|NCT01565343|589334512|FG002|Overall Study|Administrative decision/technical issues|0|||
163168688|NCT02059291|589334517|FG000|Epoch 2|Lack of Efficacy|0|||
163168689|NCT02059291|589334518|FG001|Epoch 2|Lack of Efficacy|0|||
163168690|NCT02059291|589334519|FG002|Epoch 2|Lack of Efficacy|0|||
163168691|NCT02059291|589334520|FG003|Epoch 2|Lack of Efficacy|1|||
163168692|NCT02059291|589334521|FG004|Epoch 2|Lack of Efficacy|0|||
163168693|NCT02059291|589334522|FG005|Epoch 2|Lack of Efficacy|1|||
163168694|NCT02059291|589334523|FG006|Epoch 2|Lack of Efficacy|0|||
163168695|NCT02059291|589334524|FG007|Epoch 2|Lack of Efficacy|0|||
163168696|NCT02059291|589334525|FG008|Epoch 2|Lack of Efficacy|0|||
163168697|NCT02059291|589334526|FG009|Epoch 2|Lack of Efficacy|0|||
163168698|NCT02059291|589334527|FG010|Epoch 2|Lack of Efficacy|0|||
163168699|NCT02059291|589334528|FG011|Epoch 2|Lack of Efficacy|0|||
163168700|NCT02059291|589334529|FG012|Epoch 2|Lack of Efficacy|0|||
163168701|NCT02059291|589334530|FG013|Epoch 2|Lack of Efficacy|0|||
163168702|NCT02059291|589334531|FG014|Epoch 2|Lack of Efficacy|0|||
163168703|NCT02059291|589334532|FG015|Epoch 2|Lack of Efficacy|0|||
163168704|NCT02059291|589334533|FG016|Epoch 2|Lack of Efficacy|0|||
163168705|NCT02059291|589334534|FG017|Epoch 2|Lack of Efficacy|0|||
163168706|NCT02059291|589334535|FG018|Epoch 2|Lack of Efficacy|0|||
163168707|NCT02059291|589334536|FG019|Epoch 2|Lack of Efficacy|0|||
163168708|NCT02059291|589334537|FG020|Epoch 2|Lack of Efficacy|0|||
163168709|NCT02059291|589334538|FG021|Epoch 2|Lack of Efficacy|0|||
163168710|NCT02059291|589334539|FG022|Epoch 2|Lack of Efficacy|0|||
163168711|NCT02059291|589334540|FG023|Epoch 2|Lack of Efficacy|0|||
163168712|NCT02059291|589334541|FG024|Epoch 2|Lack of Efficacy|0|||
163168713|NCT02059291|589334517|FG000|Epoch 2|Adverse Event|0|||
163168714|NCT02059291|589334518|FG001|Epoch 2|Adverse Event|0|||
163168715|NCT02059291|589334519|FG002|Epoch 2|Adverse Event|1|||
163168716|NCT02059291|589334520|FG003|Epoch 2|Adverse Event|1|||
163168717|NCT02059291|589334521|FG004|Epoch 2|Adverse Event|0|||
163168718|NCT02059291|589334522|FG005|Epoch 2|Adverse Event|0|||
163168719|NCT02059291|589334523|FG006|Epoch 2|Adverse Event|0|||
163168720|NCT02059291|589334524|FG007|Epoch 2|Adverse Event|1|||
163168721|NCT02059291|589334525|FG008|Epoch 2|Adverse Event|1|||
163168722|NCT02059291|589334526|FG009|Epoch 2|Adverse Event|0|||
163168723|NCT02059291|589334527|FG010|Epoch 2|Adverse Event|0|||
163168724|NCT02059291|589334528|FG011|Epoch 2|Adverse Event|0|||
163168725|NCT02059291|589334529|FG012|Epoch 2|Adverse Event|0|||
163168726|NCT02059291|589334530|FG013|Epoch 2|Adverse Event|0|||
163168727|NCT02059291|589334531|FG014|Epoch 2|Adverse Event|0|||
163168728|NCT02059291|589334532|FG015|Epoch 2|Adverse Event|0|||
163168729|NCT02059291|589334533|FG016|Epoch 2|Adverse Event|0|||
163168730|NCT02059291|589334534|FG017|Epoch 2|Adverse Event|0|||
163168731|NCT02059291|589334535|FG018|Epoch 2|Adverse Event|0|||
163168732|NCT02059291|589334536|FG019|Epoch 2|Adverse Event|0|||
163168733|NCT02059291|589334537|FG020|Epoch 2|Adverse Event|0|||
163168734|NCT02059291|589334538|FG021|Epoch 2|Adverse Event|0|||
163168735|NCT02059291|589334539|FG022|Epoch 2|Adverse Event|0|||
163168736|NCT02059291|589334540|FG023|Epoch 2|Adverse Event|0|||
163168737|NCT02059291|589334541|FG024|Epoch 2|Adverse Event|0|||
163168738|NCT02059291|589334517|FG000|Epoch 2|Withdrawal by Subject|0|||
163168739|NCT02059291|589334518|FG001|Epoch 2|Withdrawal by Subject|1|||
163168740|NCT02059291|589334519|FG002|Epoch 2|Withdrawal by Subject|0|||
163168741|NCT02059291|589334520|FG003|Epoch 2|Withdrawal by Subject|0|||
163168742|NCT02059291|589334521|FG004|Epoch 2|Withdrawal by Subject|0|||
163168743|NCT02059291|589334522|FG005|Epoch 2|Withdrawal by Subject|1|||
163168744|NCT02059291|589334523|FG006|Epoch 2|Withdrawal by Subject|0|||
163168745|NCT02059291|589334524|FG007|Epoch 2|Withdrawal by Subject|0|||
163168746|NCT02059291|589334525|FG008|Epoch 2|Withdrawal by Subject|1|||
163168747|NCT02059291|589334526|FG009|Epoch 2|Withdrawal by Subject|0|||
163168748|NCT02059291|589334527|FG010|Epoch 2|Withdrawal by Subject|0|||
163168749|NCT02059291|589334528|FG011|Epoch 2|Withdrawal by Subject|0|||
163168750|NCT02059291|589334529|FG012|Epoch 2|Withdrawal by Subject|0|||
163168751|NCT02059291|589334530|FG013|Epoch 2|Withdrawal by Subject|0|||
163168752|NCT02059291|589334531|FG014|Epoch 2|Withdrawal by Subject|0|||
163168753|NCT02059291|589334532|FG015|Epoch 2|Withdrawal by Subject|0|||
163168754|NCT02059291|589334533|FG016|Epoch 2|Withdrawal by Subject|0|||
163168755|NCT02059291|589334534|FG017|Epoch 2|Withdrawal by Subject|0|||
163168756|NCT02059291|589334535|FG018|Epoch 2|Withdrawal by Subject|0|||
163168757|NCT02059291|589334536|FG019|Epoch 2|Withdrawal by Subject|0|||
163168758|NCT02059291|589334537|FG020|Epoch 2|Withdrawal by Subject|0|||
163168759|NCT02059291|589334538|FG021|Epoch 2|Withdrawal by Subject|0|||
163168760|NCT02059291|589334539|FG022|Epoch 2|Withdrawal by Subject|0|||
163168761|NCT02059291|589334540|FG023|Epoch 2|Withdrawal by Subject|0|||
163168762|NCT02059291|589334541|FG024|Epoch 2|Withdrawal by Subject|0|||
163168763|NCT02059291|589334517|FG000|Epoch 3|Physician Decision|0|||
163168764|NCT02059291|589334518|FG001|Epoch 3|Physician Decision|0|||
163168765|NCT02059291|589334519|FG002|Epoch 3|Physician Decision|0|||
163168766|NCT02059291|589334520|FG003|Epoch 3|Physician Decision|0|||
163168767|NCT02059291|589334521|FG004|Epoch 3|Physician Decision|0|||
163168768|NCT02059291|589334522|FG005|Epoch 3|Physician Decision|0|||
163168769|NCT02059291|589334523|FG006|Epoch 3|Physician Decision|0|||
163168770|NCT02059291|589334524|FG007|Epoch 3|Physician Decision|0|||
163168771|NCT02059291|589334525|FG008|Epoch 3|Physician Decision|0|||
163168772|NCT02059291|589334526|FG009|Epoch 3|Physician Decision|0|||
163168773|NCT02059291|589334527|FG010|Epoch 3|Physician Decision|0|||
163168774|NCT02059291|589334528|FG011|Epoch 3|Physician Decision|0|||
163168775|NCT02059291|589334529|FG012|Epoch 3|Physician Decision|0|||
163168776|NCT02059291|589334530|FG013|Epoch 3|Physician Decision|1|||
163168777|NCT02059291|589334531|FG014|Epoch 3|Physician Decision|0|||
163168778|NCT02059291|589334532|FG015|Epoch 3|Physician Decision|1|||
163168779|NCT02059291|589334533|FG016|Epoch 3|Physician Decision|0|||
163168780|NCT02059291|589334534|FG017|Epoch 3|Physician Decision|0|||
163168781|NCT02059291|589334535|FG018|Epoch 3|Physician Decision|0|||
163168782|NCT02059291|589334536|FG019|Epoch 3|Physician Decision|0|||
163168783|NCT02059291|589334537|FG020|Epoch 3|Physician Decision|0|||
163168784|NCT02059291|589334538|FG021|Epoch 3|Physician Decision|0|||
163168785|NCT02059291|589334539|FG022|Epoch 3|Physician Decision|0|||
163168786|NCT02059291|589334540|FG023|Epoch 3|Physician Decision|0|||
163168787|NCT02059291|589334541|FG024|Epoch 3|Physician Decision|0|||
163168788|NCT02059291|589334517|FG000|Epoch 3|Adverse Event|0|||
163168789|NCT02059291|589334518|FG001|Epoch 3|Adverse Event|0|||
163168790|NCT02059291|589334519|FG002|Epoch 3|Adverse Event|0|||
163168791|NCT02059291|589334520|FG003|Epoch 3|Adverse Event|0|||
163168792|NCT02059291|589334521|FG004|Epoch 3|Adverse Event|0|||
163168793|NCT02059291|589334522|FG005|Epoch 3|Adverse Event|0|||
163168794|NCT02059291|589334523|FG006|Epoch 3|Adverse Event|0|||
163168795|NCT02059291|589334524|FG007|Epoch 3|Adverse Event|0|||
163168796|NCT02059291|589334525|FG008|Epoch 3|Adverse Event|0|||
163168797|NCT02059291|589334526|FG009|Epoch 3|Adverse Event|0|||
163168798|NCT02059291|589334527|FG010|Epoch 3|Adverse Event|0|||
163168799|NCT02059291|589334528|FG011|Epoch 3|Adverse Event|0|||
163168800|NCT02059291|589334529|FG012|Epoch 3|Adverse Event|0|||
163168801|NCT02059291|589334530|FG013|Epoch 3|Adverse Event|0|||
163168802|NCT02059291|589334531|FG014|Epoch 3|Adverse Event|0|||
163168803|NCT02059291|589334532|FG015|Epoch 3|Adverse Event|1|||
163168804|NCT02059291|589334533|FG016|Epoch 3|Adverse Event|0|||
163168805|NCT02059291|589334534|FG017|Epoch 3|Adverse Event|0|||
163168806|NCT02059291|589334535|FG018|Epoch 3|Adverse Event|0|||
163168807|NCT02059291|589334536|FG019|Epoch 3|Adverse Event|0|||
163168808|NCT02059291|589334537|FG020|Epoch 3|Adverse Event|0|||
163168809|NCT02059291|589334538|FG021|Epoch 3|Adverse Event|0|||
163168810|NCT02059291|589334539|FG022|Epoch 3|Adverse Event|0|||
163168811|NCT02059291|589334540|FG023|Epoch 3|Adverse Event|0|||
163168812|NCT02059291|589334541|FG024|Epoch 3|Adverse Event|0|||
163168813|NCT02059291|589334517|FG000|Epoch 3|Lack of Efficacy|0|||
163168814|NCT02059291|589334518|FG001|Epoch 3|Lack of Efficacy|0|||
162818146|NCT02234323|588047669|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
162818147|NCT02234323|588047669|FG000|All Treated|Death|1|||
162818148|NCT02234323|588047669|FG000|All Treated|Physician Decision|5|||
162818149|NCT02234323|588047669|FG000|All Treated|Lack of Efficacy|3|||
162818150|NCT02234323|588047669|FG000|All Treated|Exceeded lab value limit|2|||
162818151|NCT02234323|588047669|FG000|All Treated|Other|7|||
162818152|NCT02644941|588047670|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
162818153|NCT02644941|588047671|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
162818154|NCT00867113|588047672|FG000|Treatment Period|Adverse Event|15|||
162818155|NCT00867113|588047672|FG000|Treatment Period|Death|2|||
162818156|NCT00867113|588047672|FG000|Treatment Period|Withdrawal by Subject|19|||
162818157|NCT00867113|588047672|FG000|Treatment Period|Lost to Follow-up|3|||
162818158|NCT00867113|588047672|FG000|Treatment Period|Administrative problems|1|||
162818159|NCT00867113|588047672|FG000|Treatment Period|Disease progression/relapse|1|||
162818160|NCT00867113|588047672|FG000|Treatment Period|Protocol Violation|4|||
162818161|NCT00867113|588047672|FG000|Post Treatment After Survival Follow-up|Death|1|||
162818162|NCT00867113|588047672|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
162818163|NCT00867113|588047672|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
162818164|NCT00867113|588047672|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
162818165|NCT01145495|588047673|FG000|Overall Study|Adverse Event|6|||
162818166|NCT01145495|588047673|FG000|Overall Study|Withdrawal by Subject|6|||
162818167|NCT01145495|588047673|FG000|Overall Study|Disease progression after respone|2|||
162818168|NCT01886313|588047676|FG000|Overall Study|Adverse Event|1|||
162818169|NCT01886313|588047677|FG001|Overall Study|Adverse Event|1|||
162818170|NCT01603082|588047678|FG000|Overall Study|Adverse Event|0|||
162818171|NCT01603082|588047679|FG001|Overall Study|Adverse Event|1|||
162818172|NCT01603082|588047678|FG000|Overall Study|Withdrawal by Subject|1|||
162818173|NCT01603082|588047679|FG001|Overall Study|Withdrawal by Subject|0|||
162818174|NCT01603082|588047678|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
162818175|NCT01603082|588047679|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
162818176|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
162818177|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
162818178|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
162818179|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
162818180|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
162818181|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
162818182|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
162818183|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
162818184|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
162818185|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
162818186|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
162818187|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
162818188|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
162818189|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
162818190|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
162818191|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
162818192|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
162818193|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
162818194|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
162818195|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
162818196|NCT01641809|588047683|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
162818197|NCT01641809|588047684|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
162818198|NCT01641809|588047685|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
162818199|NCT01641809|588047686|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
162818200|NCT01641809|588047683|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
162818201|NCT01641809|588047684|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
162818202|NCT01641809|588047685|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
162818203|NCT01641809|588047686|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
162818204|NCT01641809|588047683|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
162818205|NCT01641809|588047684|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
162818206|NCT01641809|588047685|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163168815|NCT02059291|589334519|FG002|Epoch 3|Lack of Efficacy|0|||
163168816|NCT02059291|589334520|FG003|Epoch 3|Lack of Efficacy|0|||
163168817|NCT02059291|589334521|FG004|Epoch 3|Lack of Efficacy|0|||
162818207|NCT01641809|588047686|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
162818208|NCT01641809|588047683|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
162818209|NCT01641809|588047684|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
162818210|NCT01641809|588047685|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
163168818|NCT02059291|589334522|FG005|Epoch 3|Lack of Efficacy|0|||
163168819|NCT02059291|589334523|FG006|Epoch 3|Lack of Efficacy|0|||
163168820|NCT02059291|589334524|FG007|Epoch 3|Lack of Efficacy|0|||
163168821|NCT02059291|589334525|FG008|Epoch 3|Lack of Efficacy|0|||
162818211|NCT01641809|588047686|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
163168822|NCT02059291|589334526|FG009|Epoch 3|Lack of Efficacy|0|||
163168823|NCT02059291|589334527|FG010|Epoch 3|Lack of Efficacy|0|||
163168824|NCT02059291|589334528|FG011|Epoch 3|Lack of Efficacy|0|||
163168825|NCT02059291|589334529|FG012|Epoch 3|Lack of Efficacy|0|||
162818212|NCT01641809|588047683|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
162818213|NCT01641809|588047684|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
162818214|NCT01641809|588047685|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
162818215|NCT01641809|588047686|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
163168826|NCT02059291|589334530|FG013|Epoch 3|Lack of Efficacy|0|||
163168827|NCT02059291|589334531|FG014|Epoch 3|Lack of Efficacy|0|||
162818216|NCT01641809|588047683|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
162818217|NCT01641809|588047684|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
162818218|NCT01641809|588047685|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
162818219|NCT01641809|588047686|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
162818220|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
162818221|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
162818222|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
162818223|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
162818224|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
162818225|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
162818226|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
162818227|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
162818228|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
162818229|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
162818230|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
162818231|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
162818232|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
162818233|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
162818234|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
162818235|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
162818236|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
162818237|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
162818238|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
162818239|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
162818240|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
162818241|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
162818242|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
162818243|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
162818244|NCT01641809|588047683|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
162818245|NCT01641809|588047684|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
162818246|NCT01641809|588047685|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
162818247|NCT01641809|588047686|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
162818248|NCT04195581|588047687|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
162818249|NCT04195581|588047687|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
162818250|NCT04195581|588047687|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
162818251|NCT04195581|588047687|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
162818252|NCT04195581|588047687|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
162818253|NCT04195581|588047687|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
162818254|NCT00821431|588047688|FG000|Overall Study|Adverse Event|6|||
162818255|NCT00821431|588047689|FG001|Overall Study|Adverse Event|3|||
162818256|NCT00821431|588047688|FG000|Overall Study|Withdrawal by Subject|5|||
162818257|NCT00821431|588047689|FG001|Overall Study|Withdrawal by Subject|0|||
162818258|NCT00821431|588047688|FG000|Overall Study|Lost to Follow-up|1|||
162818259|NCT00821431|588047689|FG001|Overall Study|Lost to Follow-up|0|||
162818260|NCT00821431|588047688|FG000|Overall Study|Protocol Violation|3|||
163168828|NCT02059291|589334532|FG015|Epoch 3|Lack of Efficacy|3|||
163168829|NCT02059291|589334533|FG016|Epoch 3|Lack of Efficacy|0|||
163168830|NCT02059291|589334534|FG017|Epoch 3|Lack of Efficacy|0|||
163168831|NCT02059291|589334535|FG018|Epoch 3|Lack of Efficacy|0|||
163168832|NCT02059291|589334536|FG019|Epoch 3|Lack of Efficacy|0|||
163168833|NCT02059291|589334537|FG020|Epoch 3|Lack of Efficacy|0|||
163168834|NCT02059291|589334538|FG021|Epoch 3|Lack of Efficacy|0|||
162818261|NCT00821431|588047689|FG001|Overall Study|Protocol Violation|1|||
163168835|NCT02059291|589334539|FG022|Epoch 3|Lack of Efficacy|0|||
163168836|NCT02059291|589334540|FG023|Epoch 3|Lack of Efficacy|0|||
163168837|NCT02059291|589334541|FG024|Epoch 3|Lack of Efficacy|0|||
163168838|NCT02059291|589334517|FG000|Epoch 3|Withdrawal by Subject|0|||
162698267|NCT01027364|587605449|FG001|Overall Study|Protocol Violation|0|||
163168839|NCT02059291|589334518|FG001|Epoch 3|Withdrawal by Subject|0|||
163168840|NCT02059291|589334519|FG002|Epoch 3|Withdrawal by Subject|0|||
163168841|NCT02059291|589334520|FG003|Epoch 3|Withdrawal by Subject|0|||
163168842|NCT02059291|589334521|FG004|Epoch 3|Withdrawal by Subject|0|||
163168843|NCT02059291|589334522|FG005|Epoch 3|Withdrawal by Subject|0|||
163168844|NCT02059291|589334523|FG006|Epoch 3|Withdrawal by Subject|0|||
163168845|NCT02059291|589334524|FG007|Epoch 3|Withdrawal by Subject|0|||
163168846|NCT02059291|589334525|FG008|Epoch 3|Withdrawal by Subject|0|||
163168847|NCT02059291|589334526|FG009|Epoch 3|Withdrawal by Subject|0|||
163168848|NCT02059291|589334527|FG010|Epoch 3|Withdrawal by Subject|0|||
163168849|NCT02059291|589334528|FG011|Epoch 3|Withdrawal by Subject|0|||
163168850|NCT02059291|589334529|FG012|Epoch 3|Withdrawal by Subject|0|||
163168851|NCT02059291|589334530|FG013|Epoch 3|Withdrawal by Subject|0|||
163168852|NCT02059291|589334531|FG014|Epoch 3|Withdrawal by Subject|0|||
163168853|NCT02059291|589334532|FG015|Epoch 3|Withdrawal by Subject|1|||
163168854|NCT02059291|589334533|FG016|Epoch 3|Withdrawal by Subject|0|||
163168855|NCT02059291|589334534|FG017|Epoch 3|Withdrawal by Subject|0|||
163168856|NCT02059291|589334535|FG018|Epoch 3|Withdrawal by Subject|0|||
163168857|NCT02059291|589334536|FG019|Epoch 3|Withdrawal by Subject|0|||
163168858|NCT02059291|589334537|FG020|Epoch 3|Withdrawal by Subject|0|||
163168859|NCT02059291|589334538|FG021|Epoch 3|Withdrawal by Subject|0|||
163168860|NCT02059291|589334539|FG022|Epoch 3|Withdrawal by Subject|0|||
163168861|NCT02059291|589334540|FG023|Epoch 3|Withdrawal by Subject|0|||
163168862|NCT02059291|589334541|FG024|Epoch 3|Withdrawal by Subject|0|||
163168863|NCT02059291|589334517|FG000|Epoch 4|Adverse Event|0|||
163168864|NCT02059291|589334518|FG001|Epoch 4|Adverse Event|0|||
163168865|NCT02059291|589334519|FG002|Epoch 4|Adverse Event|0|||
163168866|NCT02059291|589334520|FG003|Epoch 4|Adverse Event|0|||
163168867|NCT02059291|589334521|FG004|Epoch 4|Adverse Event|0|||
163168868|NCT02059291|589334522|FG005|Epoch 4|Adverse Event|0|||
163168869|NCT02059291|589334523|FG006|Epoch 4|Adverse Event|0|||
163168870|NCT02059291|589334524|FG007|Epoch 4|Adverse Event|0|||
163168871|NCT02059291|589334525|FG008|Epoch 4|Adverse Event|0|||
163168872|NCT02059291|589334526|FG009|Epoch 4|Adverse Event|0|||
163168873|NCT02059291|589334527|FG010|Epoch 4|Adverse Event|0|||
163168874|NCT02059291|589334528|FG011|Epoch 4|Adverse Event|0|||
163168875|NCT02059291|589334529|FG012|Epoch 4|Adverse Event|0|||
163168876|NCT02059291|589334530|FG013|Epoch 4|Adverse Event|0|||
163168877|NCT02059291|589334531|FG014|Epoch 4|Adverse Event|0|||
163168878|NCT02059291|589334532|FG015|Epoch 4|Adverse Event|0|||
163168879|NCT02059291|589334533|FG016|Epoch 4|Adverse Event|1|||
163168880|NCT02059291|589334534|FG017|Epoch 4|Adverse Event|0|||
163168881|NCT02059291|589334535|FG018|Epoch 4|Adverse Event|0|||
163168882|NCT02059291|589334536|FG019|Epoch 4|Adverse Event|0|||
163168883|NCT02059291|589334537|FG020|Epoch 4|Adverse Event|0|||
163168884|NCT02059291|589334538|FG021|Epoch 4|Adverse Event|0|||
163168885|NCT02059291|589334539|FG022|Epoch 4|Adverse Event|1|||
163168886|NCT02059291|589334540|FG023|Epoch 4|Adverse Event|0|||
163168887|NCT02059291|589334541|FG024|Epoch 4|Adverse Event|0|||
163168888|NCT02059291|589334517|FG000|Epoch 4|Pregnancy|0|||
163168889|NCT02059291|589334518|FG001|Epoch 4|Pregnancy|0|||
162818262|NCT00821431|588047688|FG000|Overall Study|Physician Decision|0|||
162818263|NCT00821431|588047689|FG001|Overall Study|Physician Decision|1|||
163168890|NCT02059291|589334519|FG002|Epoch 4|Pregnancy|0|||
163168891|NCT02059291|589334520|FG003|Epoch 4|Pregnancy|0|||
163168892|NCT02059291|589334521|FG004|Epoch 4|Pregnancy|0|||
163168893|NCT02059291|589334522|FG005|Epoch 4|Pregnancy|0|||
163168894|NCT02059291|589334523|FG006|Epoch 4|Pregnancy|0|||
163168895|NCT02059291|589334524|FG007|Epoch 4|Pregnancy|0|||
162818264|NCT04890054|588048918|FG000|Overall Study|Lost to Follow-up|202|||
162818265|NCT04890054|588048919|FG001|Overall Study|Lost to Follow-up|219|||
162818266|NCT04313153|588048920|FG000|Overall Study|Adverse Event (includes Death)|14|||
162818267|NCT04313153|588048921|FG001|Overall Study|Adverse Event (includes Death)|19|||
162818268|NCT04313153|588048922|FG002|Overall Study|Adverse Event (includes Death)|10|||
162818269|NCT04313153|588048920|FG000|Overall Study|Physician Decision|4|||
163168896|NCT02059291|589334525|FG008|Epoch 4|Pregnancy|0|||
163168897|NCT02059291|589334526|FG009|Epoch 4|Pregnancy|0|||
163168898|NCT02059291|589334527|FG010|Epoch 4|Pregnancy|0|||
163168899|NCT02059291|589334528|FG011|Epoch 4|Pregnancy|0|||
163168900|NCT02059291|589334529|FG012|Epoch 4|Pregnancy|0|||
163168901|NCT02059291|589334530|FG013|Epoch 4|Pregnancy|0|||
163168902|NCT02059291|589334531|FG014|Epoch 4|Pregnancy|0|||
163168903|NCT02059291|589334532|FG015|Epoch 4|Pregnancy|0|||
163168904|NCT02059291|589334533|FG016|Epoch 4|Pregnancy|1|||
163168905|NCT02059291|589334534|FG017|Epoch 4|Pregnancy|0|||
163168906|NCT02059291|589334535|FG018|Epoch 4|Pregnancy|0|||
163168907|NCT02059291|589334536|FG019|Epoch 4|Pregnancy|0|||
163168908|NCT02059291|589334537|FG020|Epoch 4|Pregnancy|0|||
163168909|NCT02059291|589334538|FG021|Epoch 4|Pregnancy|0|||
163168910|NCT02059291|589334539|FG022|Epoch 4|Pregnancy|0|||
163168911|NCT02059291|589334540|FG023|Epoch 4|Pregnancy|0|||
163168912|NCT02059291|589334541|FG024|Epoch 4|Pregnancy|0|||
163168913|NCT02059291|589334517|FG000|Epoch 4|Withdrawal by Subject|0|||
162818270|NCT04313153|588048921|FG001|Overall Study|Physician Decision|2|||
162818271|NCT04313153|588048922|FG002|Overall Study|Physician Decision|1|||
162818272|NCT04313153|588048920|FG000|Overall Study|Withdrawal by Subject|7|||
162818273|NCT04313153|588048921|FG001|Overall Study|Withdrawal by Subject|6|||
162818274|NCT04313153|588048922|FG002|Overall Study|Withdrawal by Subject|2|||
162818275|NCT04313153|588048920|FG000|Overall Study|Lack of Efficacy|3|||
162818276|NCT04313153|588048921|FG001|Overall Study|Lack of Efficacy|3|||
162818277|NCT04313153|588048922|FG002|Overall Study|Lack of Efficacy|0|||
162818278|NCT04313153|588048920|FG000|Overall Study|Lost to Follow-up|1|||
162818279|NCT04313153|588048921|FG001|Overall Study|Lost to Follow-up|0|||
162818280|NCT04313153|588048922|FG002|Overall Study|Lost to Follow-up|2|||
162818281|NCT04313153|588048920|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
162818282|NCT04313153|588048921|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
162818283|NCT04313153|588048922|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
162818284|NCT04313153|588048920|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
162818285|NCT04313153|588048921|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
162818286|NCT04313153|588048922|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
162818287|NCT04313153|588048920|FG000|Overall Study|Change in Dialysis Modality|0|||
162818288|NCT04313153|588048921|FG001|Overall Study|Change in Dialysis Modality|1|||
162818289|NCT04313153|588048922|FG002|Overall Study|Change in Dialysis Modality|2|||
162818290|NCT04313153|588048920|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
162818291|NCT04313153|588048921|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
162818292|NCT04313153|588048922|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
162818293|NCT04313153|588048920|FG000|Overall Study|Other|5|||
162818294|NCT04313153|588048921|FG001|Overall Study|Other|3|||
162818295|NCT04313153|588048922|FG002|Overall Study|Other|2|||
162818296|NCT05586269|588048923|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
162818297|NCT05586269|588048924|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
162818298|NCT05586269|588048925|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
162818299|NCT05586269|588048926|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
162818300|NCT05586269|588048923|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
162818301|NCT05586269|588048924|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
162818302|NCT05586269|588048925|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
162818303|NCT05586269|588048926|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
162818304|NCT01990534|588048930|FG000|Overall Study|Death|22|||
162818305|NCT01990534|588048930|FG000|Overall Study|Progressive disease|3|||
162818306|NCT01990534|588048930|FG000|Overall Study|Protocol Violation|1|||
162818307|NCT01990534|588048930|FG000|Overall Study|Withdrawal of Informed Consent|2|||
163168914|NCT02059291|589334518|FG001|Epoch 4|Withdrawal by Subject|0|||
163168915|NCT02059291|589334519|FG002|Epoch 4|Withdrawal by Subject|0|||
163168916|NCT02059291|589334520|FG003|Epoch 4|Withdrawal by Subject|0|||
163168917|NCT02059291|589334521|FG004|Epoch 4|Withdrawal by Subject|0|||
163168918|NCT02059291|589334522|FG005|Epoch 4|Withdrawal by Subject|0|||
163168919|NCT02059291|589334523|FG006|Epoch 4|Withdrawal by Subject|0|||
163168920|NCT02059291|589334524|FG007|Epoch 4|Withdrawal by Subject|0|||
163168921|NCT02059291|589334525|FG008|Epoch 4|Withdrawal by Subject|0|||
163168922|NCT02059291|589334526|FG009|Epoch 4|Withdrawal by Subject|0|||
163168923|NCT02059291|589334527|FG010|Epoch 4|Withdrawal by Subject|0|||
163168924|NCT02059291|589334528|FG011|Epoch 4|Withdrawal by Subject|0|||
163168925|NCT02059291|589334529|FG012|Epoch 4|Withdrawal by Subject|0|||
163168926|NCT02059291|589334530|FG013|Epoch 4|Withdrawal by Subject|0|||
163168927|NCT02059291|589334531|FG014|Epoch 4|Withdrawal by Subject|0|||
163168928|NCT02059291|589334532|FG015|Epoch 4|Withdrawal by Subject|0|||
163168929|NCT02059291|589334533|FG016|Epoch 4|Withdrawal by Subject|0|||
163168930|NCT02059291|589334534|FG017|Epoch 4|Withdrawal by Subject|0|||
163168931|NCT02059291|589334535|FG018|Epoch 4|Withdrawal by Subject|0|||
163168932|NCT02059291|589334536|FG019|Epoch 4|Withdrawal by Subject|0|||
163168933|NCT02059291|589334537|FG020|Epoch 4|Withdrawal by Subject|1|||
163168934|NCT02059291|589334538|FG021|Epoch 4|Withdrawal by Subject|0|||
162818308|NCT01990534|588048930|FG000|Overall Study|Symptomatic Deterioration|1|||
162818309|NCT01990534|588048930|FG000|Overall Study|Withdrawal by Subject|3|||
162818310|NCT01990534|588048930|FG000|Overall Study|Reason not Specified|2|||
162818311|NCT01990534|588048930|FG000|Overall Study|Lost to Follow-up|1|||
162818312|NCT01831544|588048931|FG000|Overall Study|Death|1|||
162818313|NCT01831544|588048931|FG000|Overall Study|Still on original MVAD device|2|||
162818314|NCT01131351|588048934|FG000|Overall Study|Adverse Event|0|||
162818315|NCT01131351|588048935|FG001|Overall Study|Adverse Event|2|||
162818316|NCT01131351|588048934|FG000|Overall Study|Protocol Deviation|0|||
162818317|NCT01131351|588048935|FG001|Overall Study|Protocol Deviation|1|||
162818318|NCT01284062|588048941|FG000|Overall Study|Adverse Event|4|||
163168935|NCT02059291|589334539|FG022|Epoch 4|Withdrawal by Subject|0|||
163168936|NCT02059291|589334540|FG023|Epoch 4|Withdrawal by Subject|0|||
163168937|NCT02059291|589334541|FG024|Epoch 4|Withdrawal by Subject|0|||
163168938|NCT02059291|589334517|FG000|Epoch 4|Lack of Efficacy|0|||
163168939|NCT02059291|589334518|FG001|Epoch 4|Lack of Efficacy|0|||
163168940|NCT02059291|589334519|FG002|Epoch 4|Lack of Efficacy|0|||
163168941|NCT02059291|589334520|FG003|Epoch 4|Lack of Efficacy|0|||
163168942|NCT02059291|589334521|FG004|Epoch 4|Lack of Efficacy|0|||
163168943|NCT02059291|589334522|FG005|Epoch 4|Lack of Efficacy|0|||
163168944|NCT02059291|589334523|FG006|Epoch 4|Lack of Efficacy|0|||
163168945|NCT02059291|589334524|FG007|Epoch 4|Lack of Efficacy|0|||
163168946|NCT02059291|589334525|FG008|Epoch 4|Lack of Efficacy|0|||
163168947|NCT02059291|589334526|FG009|Epoch 4|Lack of Efficacy|0|||
163168948|NCT02059291|589334527|FG010|Epoch 4|Lack of Efficacy|0|||
163168949|NCT02059291|589334528|FG011|Epoch 4|Lack of Efficacy|0|||
163168950|NCT02059291|589334529|FG012|Epoch 4|Lack of Efficacy|0|||
163168951|NCT02059291|589334530|FG013|Epoch 4|Lack of Efficacy|0|||
163168952|NCT02059291|589334531|FG014|Epoch 4|Lack of Efficacy|0|||
163168953|NCT02059291|589334532|FG015|Epoch 4|Lack of Efficacy|0|||
163168954|NCT02059291|589334533|FG016|Epoch 4|Lack of Efficacy|0|||
163168955|NCT02059291|589334534|FG017|Epoch 4|Lack of Efficacy|0|||
163168956|NCT02059291|589334535|FG018|Epoch 4|Lack of Efficacy|0|||
163168957|NCT02059291|589334536|FG019|Epoch 4|Lack of Efficacy|0|||
163168958|NCT02059291|589334537|FG020|Epoch 4|Lack of Efficacy|0|||
163168959|NCT02059291|589334538|FG021|Epoch 4|Lack of Efficacy|0|||
163168960|NCT02059291|589334539|FG022|Epoch 4|Lack of Efficacy|0|||
163168961|NCT02059291|589334540|FG023|Epoch 4|Lack of Efficacy|1|||
163168962|NCT02059291|589334541|FG024|Epoch 4|Lack of Efficacy|0|||
163168963|NCT04975438|589334545|FG000|Overall Study|Lost to Follow-up|1|||
163168964|NCT04975438|589334546|FG001|Overall Study|Lost to Follow-up|0|||
163168965|NCT04975438|589334547|FG002|Overall Study|Lost to Follow-up|1|||
163168966|NCT04975438|589334548|FG003|Overall Study|Lost to Follow-up|0|||
163168967|NCT04975438|589334545|FG000|Overall Study|Withdrawal by Subject|1|||
163168968|NCT04975438|589334546|FG001|Overall Study|Withdrawal by Subject|0|||
163168969|NCT04975438|589334547|FG002|Overall Study|Withdrawal by Subject|0|||
163168970|NCT04975438|589334548|FG003|Overall Study|Withdrawal by Subject|0|||
163168971|NCT01276054|589334552|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
163168972|NCT01276054|589334553|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
163168973|NCT05405257|589334557|FG000|Overall Study|Withdrawal by Subject|1|||
163168974|NCT01788215|589334560|FG000|Overall Study|Withdrawal by Subject|0|||
163168975|NCT01788215|589334561|FG001|Overall Study|Withdrawal by Subject|1|||
163168976|NCT01788215|589334560|FG000|Overall Study|Lost to Follow-up|2|||
163168977|NCT01788215|589334561|FG001|Overall Study|Lost to Follow-up|0|||
163168978|NCT03116152|589334562|FG000|Overall Study|Disease Progression|49|||
163168979|NCT03116152|589334563|FG001|Overall Study|Disease Progression|47|||
163168980|NCT03116152|589334562|FG000|Overall Study|Death|5|||
163168981|NCT03116152|589334563|FG001|Overall Study|Death|2|||
163168982|NCT03116152|589334562|FG000|Overall Study|Adverse Event|21|||
163168983|NCT03116152|589334563|FG001|Overall Study|Adverse Event|7|||
163168984|NCT03116152|589334562|FG000|Overall Study|Protocol Violation|2|||
163168985|NCT03116152|589334563|FG001|Overall Study|Protocol Violation|2|||
163168986|NCT03116152|589334562|FG000|Overall Study|Withdrawal by Subject|0|||
163168987|NCT03116152|589334563|FG001|Overall Study|Withdrawal by Subject|1|||
163168988|NCT03116152|589334562|FG000|Overall Study|Physician Decision|3|||
163168989|NCT03116152|589334563|FG001|Overall Study|Physician Decision|2|||
163168990|NCT03116152|589334562|FG000|Overall Study|other|11|||
163168991|NCT03116152|589334563|FG001|Overall Study|other|34|||
163168992|NCT03500224|589334568|FG000|Overall Study|Withdrawal by Subject|2|||
163168993|NCT00335764|589334569|FG000|Overall Study|wrong histology|1|||
163168994|NCT00335764|589334570|FG001|Overall Study|wrong histology|0|||
163168995|NCT00335764|589334571|FG002|Overall Study|wrong histology|0|||
163168996|NCT00335764|589334572|FG003|Overall Study|wrong histology|0|||
163168997|NCT00335764|589334573|FG004|Overall Study|wrong histology|1|||
163168998|NCT00929643|589334574|FG000|Overall Study|Protocol Violation|2|||
163168999|NCT00145977|589334575|FG000|Overall Study|Lack of Efficacy|0|||
163169000|NCT00145977|589334576|FG001|Overall Study|Lack of Efficacy|4|||
163169001|NCT00145977|589334575|FG000|Overall Study|Lost to Follow-up|1|||
162818319|NCT01284062|588048942|FG001|Overall Study|Adverse Event|5|||
163169002|NCT00145977|589334576|FG001|Overall Study|Lost to Follow-up|0|||
163169003|NCT00145977|589334575|FG000|Overall Study|Withdrawal by Subject|1|||
163169004|NCT00145977|589334576|FG001|Overall Study|Withdrawal by Subject|0|||
163169005|NCT02717832|589334587|FG000|Overall Study|Inability to place IV|3|||
163169006|NCT01215097|589334588|FG000|Overall Study|Adverse Event|1|||
163169007|NCT01215097|589334589|FG001|Overall Study|Adverse Event|3|||
163169008|NCT01215097|589334588|FG000|Overall Study|Protocol Violation|0|||
163169009|NCT01215097|589334589|FG001|Overall Study|Protocol Violation|2|||
163169010|NCT01215097|589334588|FG000|Overall Study|Lost to Follow-up|2|||
163169011|NCT01215097|589334589|FG001|Overall Study|Lost to Follow-up|0|||
163169012|NCT01215097|589334588|FG000|Overall Study|Withdrawal by Subject|6|||
163169013|NCT01215097|589334589|FG001|Overall Study|Withdrawal by Subject|3|||
163169014|NCT01215097|589334588|FG000|Overall Study|Lack of Efficacy|0|||
163169015|NCT01215097|589334589|FG001|Overall Study|Lack of Efficacy|3|||
163169016|NCT01215097|589334588|FG000|Overall Study|patient's refusal to come|2|||
163169017|NCT01215097|589334589|FG001|Overall Study|patient's refusal to come|2|||
163169018|NCT01215097|589334588|FG000|Overall Study|patient's private reason|1|||
163169019|NCT01215097|589334589|FG001|Overall Study|patient's private reason|1|||
163169020|NCT01818752|589334590|FG000|Overall Study|Adverse Event|64|||
163169021|NCT01818752|589334591|FG001|Overall Study|Adverse Event|74|||
163169022|NCT01818752|589334590|FG000|Overall Study|Death|14|||
163169023|NCT01818752|589334591|FG001|Overall Study|Death|18|||
163169024|NCT01818752|589334590|FG000|Overall Study|Non-compliance|16|||
163169025|NCT01818752|589334591|FG001|Overall Study|Non-compliance|20|||
163169026|NCT01818752|589334590|FG000|Overall Study|Withdrawal by Subject|15|||
163169027|NCT01818752|589334591|FG001|Overall Study|Withdrawal by Subject|14|||
163169028|NCT01818752|589334590|FG000|Overall Study|Physician Decision|9|||
163169029|NCT01818752|589334591|FG001|Overall Study|Physician Decision|8|||
163169030|NCT01818752|589334590|FG000|Overall Study|Disease Progression|54|||
163169031|NCT01818752|589334591|FG001|Overall Study|Disease Progression|48|||
163169032|NCT01818752|589334590|FG000|Overall Study|Other|7|||
163169033|NCT01818752|589334591|FG001|Overall Study|Other|8|||
163169034|NCT01818752|589334590|FG000|Overall Study|Continuing Treatment|1|||
163169035|NCT01818752|589334591|FG001|Overall Study|Continuing Treatment|4|||
163169036|NCT01818752|589334590|FG000|Overall Study|Randomized but not Dosed|7|||
163169037|NCT01818752|589334591|FG001|Overall Study|Randomized but not Dosed|4|||
163169038|NCT04629066|589334592|FG000|Overall Study|Lost to Follow-up|3|||
163169039|NCT04629066|589334593|FG001|Overall Study|Lost to Follow-up|2|||
163169040|NCT00282308|589334598|FG000|Treatment Period|Lost to Follow-up|1|||
163169041|NCT00282308|589334599|FG001|Treatment Period|Lost to Follow-up|0|||
163169042|NCT00282308|589334600|FG002|Treatment Period|Lost to Follow-up|0|||
163169043|NCT00282308|589334598|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
163169044|NCT00282308|589334599|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
163169045|NCT00282308|589334600|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169046|NCT00282308|589334598|FG000|Treatment Period|Adverse Event|0|||
163169047|NCT00282308|589334599|FG001|Treatment Period|Adverse Event|2|||
163169048|NCT00282308|589334600|FG002|Treatment Period|Adverse Event|0|||
163169049|NCT00282308|589334598|FG000|Treatment Period|Not Treated with Study Drug|1|||
163169050|NCT00282308|589334599|FG001|Treatment Period|Not Treated with Study Drug|0|||
163169051|NCT00282308|589334600|FG002|Treatment Period|Not Treated with Study Drug|0|||
163169052|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
163169053|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
163169054|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
163169055|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
163169056|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
163169057|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
163169058|NCT00282308|589334598|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169059|NCT00282308|589334599|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
163169060|NCT00282308|589334600|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
163169061|NCT00282308|589334598|FG000|Safety Follow-up Period|Adverse Event|0|||
163169062|NCT00282308|589334599|FG001|Safety Follow-up Period|Adverse Event|0|||
163169063|NCT00282308|589334600|FG002|Safety Follow-up Period|Adverse Event|1|||
163169064|NCT00282308|589334598|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
163169065|NCT00282308|589334599|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
163169066|NCT00282308|589334600|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
163169067|NCT00282308|589334598|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
163169068|NCT00282308|589334599|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
163169069|NCT00282308|589334600|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
163169070|NCT00282308|589334598|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163169071|NCT00282308|589334599|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163169072|NCT00282308|589334600|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
163169073|NCT02872285|589334602|FG000|Overall Study|Withdrawal by Subject|2|||
163169074|NCT02872285|589334603|FG001|Overall Study|Withdrawal by Subject|0|||
163169075|NCT02872285|589334602|FG000|Overall Study|Lost to Follow-up|2|||
163169076|NCT02872285|589334603|FG001|Overall Study|Lost to Follow-up|2|||
163169077|NCT02872285|589334602|FG000|Overall Study|Discontinued due to back surgery|1|||
163169078|NCT02872285|589334603|FG001|Overall Study|Discontinued due to back surgery|0|||
163169079|NCT02970942|589334604|FG000|Overall Study|Death|0|||
163169080|NCT02970942|589334605|FG001|Overall Study|Death|1|||
163169081|NCT02970942|589334606|FG002|Overall Study|Death|0|||
163169082|NCT02970942|589334607|FG003|Overall Study|Death|0|||
163169083|NCT02970942|589334604|FG000|Overall Study|Lost to Follow-up|1|||
163169084|NCT02970942|589334605|FG001|Overall Study|Lost to Follow-up|0|||
163169085|NCT02970942|589334606|FG002|Overall Study|Lost to Follow-up|2|||
163169086|NCT02970942|589334607|FG003|Overall Study|Lost to Follow-up|1|||
163169087|NCT02970942|589334604|FG000|Overall Study|Withdrawal by Subject|3|||
163169088|NCT02970942|589334605|FG001|Overall Study|Withdrawal by Subject|5|||
163169089|NCT02970942|589334606|FG002|Overall Study|Withdrawal by Subject|3|||
163169090|NCT02970942|589334607|FG003|Overall Study|Withdrawal by Subject|2|||
163169091|NCT01065454|589334610|FG000|Treatment|Adverse Event|7|||
163169092|NCT01065454|589334611|FG001|Treatment|Adverse Event|4|||
163169093|NCT01065454|589334612|FG002|Treatment|Adverse Event|3|||
163169094|NCT01065454|589334613|FG003|Treatment|Adverse Event|6|||
163169095|NCT01065454|589334610|FG000|Treatment|Death|1|||
163169096|NCT01065454|589334611|FG001|Treatment|Death|0|||
163169097|NCT01065454|589334612|FG002|Treatment|Death|0|||
163169098|NCT01065454|589334613|FG003|Treatment|Death|0|||
163169099|NCT01065454|589334610|FG000|Treatment|Non-compliance|1|||
163169100|NCT01065454|589334611|FG001|Treatment|Non-compliance|0|||
163169101|NCT01065454|589334612|FG002|Treatment|Non-compliance|0|||
163169102|NCT01065454|589334613|FG003|Treatment|Non-compliance|1|||
163169103|NCT01065454|589334610|FG000|Treatment|Protocol Decision|0|||
163169104|NCT01065454|589334611|FG001|Treatment|Protocol Decision|0|||
163169105|NCT01065454|589334612|FG002|Treatment|Protocol Decision|3|||
163169106|NCT01065454|589334613|FG003|Treatment|Protocol Decision|2|||
163169107|NCT01065454|589334610|FG000|Treatment|Protocol Violation|1|||
163169108|NCT01065454|589334611|FG001|Treatment|Protocol Violation|0|||
163169109|NCT01065454|589334612|FG002|Treatment|Protocol Violation|1|||
163169110|NCT01065454|589334613|FG003|Treatment|Protocol Violation|0|||
163169111|NCT01065454|589334610|FG000|Treatment|Withdrawal by Subject|3|||
163169112|NCT01065454|589334611|FG001|Treatment|Withdrawal by Subject|1|||
163169113|NCT01065454|589334612|FG002|Treatment|Withdrawal by Subject|2|||
163169114|NCT01065454|589334613|FG003|Treatment|Withdrawal by Subject|3|||
163169115|NCT01065454|589334610|FG000|Follow up|Adverse Event|1|||
163169116|NCT01065454|589334611|FG001|Follow up|Adverse Event|0|||
163169117|NCT01065454|589334612|FG002|Follow up|Adverse Event|0|||
163169118|NCT01065454|589334613|FG003|Follow up|Adverse Event|1|||
163169119|NCT01065454|589334610|FG000|Follow up|Death|0|||
163169120|NCT01065454|589334611|FG001|Follow up|Death|1|||
163169121|NCT01065454|589334612|FG002|Follow up|Death|1|||
163169122|NCT01065454|589334613|FG003|Follow up|Death|0|||
163169123|NCT01065454|589334610|FG000|Follow up|Lost to Follow-up|0|||
163169124|NCT01065454|589334611|FG001|Follow up|Lost to Follow-up|0|||
163169125|NCT01065454|589334612|FG002|Follow up|Lost to Follow-up|0|||
163169126|NCT01065454|589334613|FG003|Follow up|Lost to Follow-up|1|||
163169127|NCT01065454|589334610|FG000|Follow up|Progressive disease|0|||
163169128|NCT01065454|589334611|FG001|Follow up|Progressive disease|0|||
163169129|NCT01065454|589334612|FG002|Follow up|Progressive disease|0|||
163169130|NCT01065454|589334613|FG003|Follow up|Progressive disease|1|||
163169131|NCT01065454|589334610|FG000|Follow up|Withdrawal by Subject|1|||
163169132|NCT01065454|589334611|FG001|Follow up|Withdrawal by Subject|1|||
163169133|NCT01065454|589334612|FG002|Follow up|Withdrawal by Subject|1|||
163169134|NCT01065454|589334613|FG003|Follow up|Withdrawal by Subject|0|||
163169135|NCT01065454|589334610|FG000|Follow up|study ongoing|37|||
163169136|NCT01065454|589334611|FG001|Follow up|study ongoing|22|||
163169137|NCT01065454|589334612|FG002|Follow up|study ongoing|15|||
163169138|NCT01065454|589334613|FG003|Follow up|study ongoing|41|||
163169139|NCT03374202|589334614|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
163169140|NCT03374202|589334615|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
163169141|NCT03374202|589334616|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
163169142|NCT03374202|589334614|FG000|Five Year Long Term Follow Up|Death|0|||
163169143|NCT03374202|589334615|FG001|Five Year Long Term Follow Up|Death|1|||
163169144|NCT03374202|589334616|FG002|Five Year Long Term Follow Up|Death|0|||
163169145|NCT01325337|589336411|FG000|Overall Study|Adverse Event|0|||
163169146|NCT01325337|589336412|FG001|Overall Study|Adverse Event|2|||
163169147|NCT01325337|589336413|FG002|Overall Study|Adverse Event|2|||
163169148|NCT01325337|589336414|FG003|Overall Study|Adverse Event|1|||
163169149|NCT01325337|589336415|FG004|Overall Study|Adverse Event|2|||
163169150|NCT01325337|589336411|FG000|Overall Study|Lost to Follow-up|2|||
163169151|NCT01325337|589336412|FG001|Overall Study|Lost to Follow-up|2|||
163169152|NCT01325337|589336413|FG002|Overall Study|Lost to Follow-up|2|||
163169153|NCT01325337|589336414|FG003|Overall Study|Lost to Follow-up|1|||
163169154|NCT01325337|589336415|FG004|Overall Study|Lost to Follow-up|2|||
163169155|NCT01325337|589336411|FG000|Overall Study|Personal Reasons|2|||
163169156|NCT01325337|589336412|FG001|Overall Study|Personal Reasons|5|||
163169157|NCT01325337|589336413|FG002|Overall Study|Personal Reasons|4|||
163169158|NCT01325337|589336414|FG003|Overall Study|Personal Reasons|8|||
163169159|NCT01325337|589336415|FG004|Overall Study|Personal Reasons|3|||
163169160|NCT01325337|589336411|FG000|Overall Study|Withdrawal by Subject|1|||
163169161|NCT01325337|589336412|FG001|Overall Study|Withdrawal by Subject|0|||
163169162|NCT01325337|589336413|FG002|Overall Study|Withdrawal by Subject|1|||
163169163|NCT01325337|589336414|FG003|Overall Study|Withdrawal by Subject|0|||
163169164|NCT01325337|589336415|FG004|Overall Study|Withdrawal by Subject|1|||
163169165|NCT01604278|589336416|FG000|Overall Study|Lack of Efficacy|0|||
163169166|NCT01604278|589336417|FG001|Overall Study|Lack of Efficacy|1|||
163169167|NCT01604278|589336416|FG000|Overall Study|Lost to Follow-up|1|||
163169168|NCT01604278|589336417|FG001|Overall Study|Lost to Follow-up|0|||
163169169|NCT01604278|589336416|FG000|Overall Study|Administrative problems|2|||
163169170|NCT01604278|589336417|FG001|Overall Study|Administrative problems|1|||
163169171|NCT01604278|589336416|FG000|Overall Study|Withdrawal by Subject|3|||
163169172|NCT01604278|589336417|FG001|Overall Study|Withdrawal by Subject|3|||
163169173|NCT01604278|589336416|FG000|Overall Study|Adverse Event|3|||
163169174|NCT01604278|589336417|FG001|Overall Study|Adverse Event|5|||
163169175|NCT01604278|589336416|FG000|Overall Study|Protocol Deviation|5|||
163169176|NCT01604278|589336417|FG001|Overall Study|Protocol Deviation|3|||
163169177|NCT02500056|589336439|FG000|Overall Study|Lost to Follow-up|3|||
163169178|NCT02500056|589336440|FG001|Overall Study|Lost to Follow-up|7|||
163169179|NCT02500056|589336439|FG000|Overall Study|Recurrence|1|||
163169180|NCT02500056|589336440|FG001|Overall Study|Recurrence|0|||
162818320|NCT01284062|588048943|FG002|Overall Study|Adverse Event|0|||
163169181|NCT02500056|589336439|FG000|Overall Study|Death|3|||
163169182|NCT02500056|589336440|FG001|Overall Study|Death|1|||
163169183|NCT04973436|589336449|FG000|Overall Study|Lost to Follow-up|3|||
163169184|NCT04973436|589336449|FG000|Overall Study|Withdrawal by Subject|1|||
163169185|NCT04973436|589336449|FG000|Overall Study|Death|2|||
163169186|NCT00275340|589336450|FG000|Overall Study|Lost to Follow-up|2|||
163169187|NCT00275340|589336451|FG001|Overall Study|Lost to Follow-up|4|||
163169188|NCT00862641|589336454|FG000|Overall Study|Randomized, but drug not received|1|||
163169189|NCT00862641|589336455|FG001|Overall Study|Randomized, but drug not received|4|||
163169190|NCT00862641|589336456|FG002|Overall Study|Randomized, but drug not received|1|||
163169191|NCT00862641|589336457|FG003|Overall Study|Randomized, but drug not received|4|||
163169192|NCT02365480|589336458|FG000|Overall Study|Withdrawal by Subject|2|||
163169193|NCT02365480|589336459|FG001|Overall Study|Withdrawal by Subject|0|||
163169194|NCT01419197|589336464|FG000|Overall Study|Death|247|||
163169195|NCT01419197|589336465|FG001|Overall Study|Death|122|||
163169196|NCT01419197|589336464|FG000|Overall Study|Physician Decision|4|||
163169197|NCT01419197|589336465|FG001|Overall Study|Physician Decision|4|||
163169198|NCT01419197|589336464|FG000|Overall Study|Non-compliance|3|||
163169199|NCT01419197|589336465|FG001|Overall Study|Non-compliance|1|||
163169200|NCT01419197|589336464|FG000|Overall Study|Withdrawal by Subject|33|||
163169201|NCT01419197|589336465|FG001|Overall Study|Withdrawal by Subject|32|||
163169202|NCT01419197|589336464|FG000|Overall Study|Study Completed by Sponsor|103|||
163169203|NCT01419197|589336465|FG001|Overall Study|Study Completed by Sponsor|34|||
163169204|NCT01419197|589336464|FG000|Overall Study|Reason Not Specified|0|||
163169205|NCT01419197|589336465|FG001|Overall Study|Reason Not Specified|1|||
163169206|NCT01419197|589336464|FG000|Overall Study|Lost to Follow-up|14|||
163169207|NCT01419197|589336465|FG001|Overall Study|Lost to Follow-up|4|||
163169208|NCT01781299|589336466|FG000|Overall Study|Withdrawal by Subject|0|||
163169209|NCT01781299|589336467|FG001|Overall Study|Withdrawal by Subject|1|||
163169210|NCT00146848|589336471|FG000|Pre-randomization|Death|19|||
163169211|NCT00146848|589336472|FG001|Pre-randomization|Death|0|||
163169212|NCT00146848|589336473|FG002|Pre-randomization|Death|0|||
163169213|NCT00146848|589336471|FG000|Pre-randomization|Lost to Follow-up|70|||
163169214|NCT00146848|589336472|FG001|Pre-randomization|Lost to Follow-up|0|||
163169215|NCT00146848|589336473|FG002|Pre-randomization|Lost to Follow-up|0|||
163169216|NCT00146848|589336471|FG000|Pre-randomization|Physician Decision|8|||
163169217|NCT00146848|589336472|FG001|Pre-randomization|Physician Decision|0|||
163169218|NCT00146848|589336473|FG002|Pre-randomization|Physician Decision|0|||
163169219|NCT00146848|589336471|FG000|Pre-randomization|Protocol Violation|172|||
163169220|NCT00146848|589336472|FG001|Pre-randomization|Protocol Violation|0|||
163169221|NCT00146848|589336473|FG002|Pre-randomization|Protocol Violation|0|||
163169222|NCT00146848|589336471|FG000|Pre-randomization|Withdrawal by Subject|40|||
163169223|NCT00146848|589336472|FG001|Pre-randomization|Withdrawal by Subject|0|||
163169224|NCT00146848|589336473|FG002|Pre-randomization|Withdrawal by Subject|0|||
163169225|NCT00146848|589336471|FG000|Post-randomization|Lost to Follow-up|12|||
163169226|NCT00146848|589336472|FG001|Post-randomization|Lost to Follow-up|15|||
163169227|NCT00146848|589336473|FG002|Post-randomization|Lost to Follow-up|12|||
163169228|NCT00146848|589336471|FG000|Post-randomization|Withdrawn|26|||
163169229|NCT00146848|589336472|FG001|Post-randomization|Withdrawn|32|||
163169230|NCT00146848|589336473|FG002|Post-randomization|Withdrawn|27|||
163169231|NCT01798849|589336474|FG000|Overall Study|Physician Decision|0|||
163169232|NCT01798849|589336475|FG001|Overall Study|Physician Decision|0|||
163169233|NCT01798849|589336476|FG002|Overall Study|Physician Decision|1|||
163169234|NCT02395172|589336477|FG000|Overall Study|Participants randomized but not treated|3|||
163169235|NCT02395172|589336478|FG001|Overall Study|Participants randomized but not treated|31|||
163169236|NCT02032238|589336479|FG000|Overall Study|Lost to Follow-up|2|||
163169237|NCT02032238|589336480|FG001|Overall Study|Lost to Follow-up|0|||
163169238|NCT00653939|589336481|FG000|Overall Study|Adverse Event|1|||
163169239|NCT00653939|589336482|FG001|Overall Study|Adverse Event|3|||
163169240|NCT00653939|589336481|FG000|Overall Study|Withdrawal by Subject|3|||
163169241|NCT00653939|589336482|FG001|Overall Study|Withdrawal by Subject|3|||
163169242|NCT00653939|589336481|FG000|Overall Study|Physician Decision|4|||
163169243|NCT00653939|589336482|FG001|Overall Study|Physician Decision|0|||
163169244|NCT00653939|589336481|FG000|Overall Study|Disease Progression|2|||
163169245|NCT00653939|589336482|FG001|Overall Study|Disease Progression|3|||
163169246|NCT00653939|589336481|FG000|Overall Study|Other|2|||
163169247|NCT00653939|589336482|FG001|Overall Study|Other|6|||
163169248|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
163169249|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
163169250|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
163169251|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
163169252|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
163169253|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
163169254|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
163169255|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
163169256|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
163169257|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
163169258|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
163169259|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
163169260|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
163169261|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
163169262|NCT00612105|589336483|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
163169263|NCT00612105|589336484|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
163169264|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
163169265|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
163169266|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
163169267|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
163169268|NCT00612105|589336483|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
163169269|NCT00612105|589336484|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
163169270|NCT00612105|589336483|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
163169271|NCT00612105|589336484|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
163169272|NCT00717236|589336485|FG000|Double-Blind Period|Adverse Event|33|||
163169273|NCT00717236|589336486|FG001|Double-Blind Period|Adverse Event|6|||
163169274|NCT00717236|589336485|FG000|Double-Blind Period|Lack of Efficacy|6|||
163169275|NCT00717236|589336486|FG001|Double-Blind Period|Lack of Efficacy|6|||
163169276|NCT00717236|589336485|FG000|Double-Blind Period|Lost to Follow-up|3|||
163169277|NCT00717236|589336486|FG001|Double-Blind Period|Lost to Follow-up|5|||
163169278|NCT00717236|589336485|FG000|Double-Blind Period|Withdrawal by Subject|10|||
163169279|NCT00717236|589336486|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163169280|NCT00717236|589336485|FG000|Double-Blind Period|Loss of efficacy|3|||
163169281|NCT00717236|589336486|FG001|Double-Blind Period|Loss of efficacy|0|||
163169282|NCT00717236|589336485|FG000|Double-Blind Period|Other: Death|1|||
163169283|NCT00717236|589336486|FG001|Double-Blind Period|Other: Death|0|||
163169284|NCT00717236|589336485|FG000|Double-Blind Period|Other: Pregnancy|1|||
163169285|NCT00717236|589336486|FG001|Double-Blind Period|Other: Pregnancy|0|||
163169286|NCT00717236|589336485|FG000|Double-Blind Period|Other: Protocol Violation|2|||
163169287|NCT00717236|589336486|FG001|Double-Blind Period|Other: Protocol Violation|0|||
163169288|NCT00717236|589336485|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
163169289|NCT00717236|589336486|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
163169290|NCT00717236|589336485|FG000|Double-Blind Period|Other: Site withdrew|2|||
163169291|NCT00717236|589336486|FG001|Double-Blind Period|Other: Site withdrew|0|||
163169292|NCT00717236|589336485|FG000|Double-Blind Period|Other: Screening failure|1|||
163169293|NCT00717236|589336486|FG001|Double-Blind Period|Other: Screening failure|0|||
163169294|NCT00717236|589336485|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
163169295|NCT00717236|589336486|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
163169296|NCT00717236|589336485|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
163169297|NCT00717236|589336486|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
163169298|NCT00717236|589336485|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
163169299|NCT00717236|589336486|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
163169300|NCT00717236|589336485|FG000|Double-Blind Period|Other: History of cancer|1|||
163169301|NCT00717236|589336486|FG001|Double-Blind Period|Other: History of cancer|0|||
163169302|NCT00717236|589336485|FG000|Double-Blind Period|Other: Sponsor request|1|||
163169303|NCT00717236|589336486|FG001|Double-Blind Period|Other: Sponsor request|0|||
163169304|NCT00717236|589336485|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
163169305|NCT00717236|589336486|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
162698268|NCT01027364|587605450|FG002|Overall Study|Protocol Violation|0|||
162698269|NCT01027364|587605451|FG003|Overall Study|Protocol Violation|1|||
163169306|NCT00717236|589336485|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
163169307|NCT00717236|589336486|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
163169308|NCT00717236|589336485|FG000|Double-Blind Period|Other: Subject moved|1|||
162698270|NCT01027364|587605448|FG000|Overall Study|Withdrawal by Subject|1|||
163169309|NCT00717236|589336486|FG001|Double-Blind Period|Other: Subject moved|1|||
163169310|NCT00717236|589336485|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
163169311|NCT00717236|589336486|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
163169312|NCT00717236|589336485|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
163169313|NCT00717236|589336486|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
163169314|NCT00717236|589336485|FG000|Double-Blind Period|Other: Transportation problems|0|||
163169315|NCT00717236|589336486|FG001|Double-Blind Period|Other: Transportation problems|1|||
163169316|NCT00717236|589336485|FG000|Double-Blind Period|Other: Investigator Decision|0|||
163169317|NCT00717236|589336486|FG001|Double-Blind Period|Other: Investigator Decision|1|||
163169318|NCT00717236|589336485|FG000|Open-Label Period|Adverse Event|29|||
163169319|NCT00717236|589336486|FG001|Open-Label Period|Adverse Event|4|||
163169320|NCT00717236|589336485|FG000|Open-Label Period|Lack of Efficacy|30|||
163169321|NCT00717236|589336486|FG001|Open-Label Period|Lack of Efficacy|8|||
163169322|NCT00717236|589336485|FG000|Open-Label Period|Lost to Follow-up|28|||
163169323|NCT00717236|589336486|FG001|Open-Label Period|Lost to Follow-up|4|||
163169324|NCT00717236|589336485|FG000|Open-Label Period|Withdrawal by Subject|20|||
163169325|NCT00717236|589336486|FG001|Open-Label Period|Withdrawal by Subject|2|||
163169326|NCT00717236|589336485|FG000|Open-Label Period|Loss of Efficacy|6|||
163169327|NCT00717236|589336486|FG001|Open-Label Period|Loss of Efficacy|1|||
163169328|NCT00717236|589336485|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
163169329|NCT00717236|589336486|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
163169330|NCT00717236|589336485|FG000|Open-Label Period|Other: Lack of Compliance|1|||
163169331|NCT00717236|589336486|FG001|Open-Label Period|Other: Lack of Compliance|1|||
163169332|NCT00717236|589336485|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
163169333|NCT00717236|589336486|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
163169334|NCT00717236|589336485|FG000|Open-Label Period|Other: Moved|1|||
163169335|NCT00717236|589336486|FG001|Open-Label Period|Other: Moved|0|||
163169336|NCT00717236|589336485|FG000|Open-Label Period|Other: Investigator Decision|1|||
163169337|NCT00717236|589336486|FG001|Open-Label Period|Other: Investigator Decision|0|||
163169338|NCT00717236|589336485|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
163169339|NCT00717236|589336486|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
163169340|NCT00717236|589336485|FG000|Open-Label Period|Other: Sponsor Request|3|||
163169341|NCT00717236|589336486|FG001|Open-Label Period|Other: Sponsor Request|0|||
163169342|NCT00717236|589336485|FG000|Open-Label Period|Other: Cataract Surgery|1|||
163169343|NCT00717236|589336486|FG001|Open-Label Period|Other: Cataract Surgery|0|||
163169344|NCT00717236|589336485|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
163169345|NCT00717236|589336486|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
163169346|NCT00717236|589336485|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
163169347|NCT00717236|589336486|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
163169348|NCT00717236|589336485|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
163169349|NCT00717236|589336486|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
163169350|NCT00475982|589336487|FG000|Overall Study|surgery rescheduled|7|||
163169351|NCT00475982|589336488|FG001|Overall Study|surgery rescheduled|3|||
163169352|NCT01105767|589336489|FG000|Overall Study|Lost to Follow-up|1160|||
163169353|NCT01105767|589336490|FG001|Overall Study|Lost to Follow-up|1614|||
163169354|NCT01105767|589336491|FG002|Overall Study|Lost to Follow-up|1184|||
163169355|NCT00743106|589336492|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
163169356|NCT00743106|589336493|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
163169357|NCT02410343|589336498|FG000|Core Period (24 Weeks)|Adverse Event|1|||
163169358|NCT02410343|589336499|FG001|Core Period (24 Weeks)|Adverse Event|0|||
163169359|NCT02410343|589336498|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
163169360|NCT02410343|589336499|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
163169361|NCT02410343|589336498|FG000|Extension Period (12 Months)|Adverse Event|1|||
163169362|NCT02410343|589336499|FG001|Extension Period (12 Months)|Adverse Event|0|||
163169363|NCT02410343|589336498|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
163169364|NCT02410343|589336499|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
163169365|NCT00029146|589336500|FG000|Overall Study|Lost to Follow-up|2|||
163169366|NCT00029146|589336501|FG001|Overall Study|Lost to Follow-up|1|||
163169367|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
163169368|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
163169369|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
163169370|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
163169371|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
163169372|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
163169373|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
163169374|NCT00946985|589336504|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
163169375|NCT00946985|589336504|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
162818321|NCT01284062|588048944|FG003|Overall Study|Adverse Event|5|||
163169376|NCT00271505|589336505|FG000|Overall Study|Screen Failure|3|||
163169377|NCT00271505|589336505|FG000|Overall Study|Adverse Event|1|||
163169378|NCT00271505|589336505|FG000|Overall Study|Death|1|||
163169379|NCT04556383|589336506|FG000|PCP|Lack of Efficacy|28|||
163169380|NCT04556383|589336507|FG001|PCP|Lack of Efficacy|23|||
163169381|NCT04556383|589336508|FG002|PCP|Lack of Efficacy|23|||
163169382|NCT04556383|589336509|FG003|PCP|Lack of Efficacy|0|||
163169383|NCT04556383|589336506|FG000|PCP|Study terminated by sponsor|15|||
163169384|NCT04556383|589336507|FG001|PCP|Study terminated by sponsor|13|||
163169385|NCT04556383|589336508|FG002|PCP|Study terminated by sponsor|16|||
163169386|NCT04556383|589336509|FG003|PCP|Study terminated by sponsor|0|||
163169387|NCT04556383|589336506|FG000|PCP|Withdrawal by Subject|8|||
163169388|NCT04556383|589336507|FG001|PCP|Withdrawal by Subject|6|||
163169389|NCT04556383|589336508|FG002|PCP|Withdrawal by Subject|6|||
163169390|NCT04556383|589336509|FG003|PCP|Withdrawal by Subject|0|||
163169391|NCT04556383|589336506|FG000|PCP|Adverse Event|1|||
163169392|NCT04556383|589336507|FG001|PCP|Adverse Event|7|||
163169393|NCT04556383|589336508|FG002|PCP|Adverse Event|7|||
163169394|NCT04556383|589336509|FG003|PCP|Adverse Event|0|||
163169395|NCT04556383|589336506|FG000|PCP|Other, Not Specified|1|||
163169396|NCT04556383|589336507|FG001|PCP|Other, Not Specified|2|||
163169397|NCT04556383|589336508|FG002|PCP|Other, Not Specified|1|||
163169398|NCT04556383|589336509|FG003|PCP|Other, Not Specified|0|||
163169399|NCT04556383|589336506|FG000|PCP|Protocol Violation|1|||
163169400|NCT04556383|589336507|FG001|PCP|Protocol Violation|0|||
163169401|NCT04556383|589336508|FG002|PCP|Protocol Violation|1|||
163169402|NCT04556383|589336509|FG003|PCP|Protocol Violation|0|||
163169403|NCT04556383|589336506|FG000|PCP|Lost to Follow-up|1|||
163169404|NCT04556383|589336507|FG001|PCP|Lost to Follow-up|0|||
163169405|NCT04556383|589336508|FG002|PCP|Lost to Follow-up|0|||
163169406|NCT04556383|589336509|FG003|PCP|Lost to Follow-up|0|||
163169407|NCT04556383|589336506|FG000|PCP|Physician Decision|0|||
163169408|NCT04556383|589336507|FG001|PCP|Physician Decision|1|||
163169409|NCT04556383|589336508|FG002|PCP|Physician Decision|0|||
163169410|NCT04556383|589336509|FG003|PCP|Physician Decision|0|||
163169411|NCT04556383|589336506|FG000|PCP|Site terminated by sponsor|0|||
163169412|NCT04556383|589336507|FG001|PCP|Site terminated by sponsor|1|||
163169413|NCT04556383|589336508|FG002|PCP|Site terminated by sponsor|0|||
163169414|NCT04556383|589336509|FG003|PCP|Site terminated by sponsor|0|||
163169415|NCT04556383|589336506|FG000|OLE|Study terminated by sponsor|0|||
163169416|NCT04556383|589336507|FG001|OLE|Study terminated by sponsor|0|||
163169417|NCT04556383|589336508|FG002|OLE|Study terminated by sponsor|0|||
163169418|NCT04556383|589336509|FG003|OLE|Study terminated by sponsor|68|||
163169419|NCT04556383|589336506|FG000|OLE|Withdrawal by Subject|0|||
163169420|NCT04556383|589336507|FG001|OLE|Withdrawal by Subject|0|||
163169421|NCT04556383|589336508|FG002|OLE|Withdrawal by Subject|0|||
163169422|NCT04556383|589336509|FG003|OLE|Withdrawal by Subject|10|||
163169423|NCT04556383|589336506|FG000|OLE|Lack of Efficacy|0|||
163169424|NCT04556383|589336507|FG001|OLE|Lack of Efficacy|0|||
163169425|NCT04556383|589336508|FG002|OLE|Lack of Efficacy|0|||
163169426|NCT04556383|589336509|FG003|OLE|Lack of Efficacy|7|||
163169427|NCT04556383|589336506|FG000|OLE|Adverse Event|0|||
163169428|NCT04556383|589336507|FG001|OLE|Adverse Event|0|||
163169429|NCT04556383|589336508|FG002|OLE|Adverse Event|0|||
163169430|NCT04556383|589336509|FG003|OLE|Adverse Event|2|||
163169431|NCT04556383|589336506|FG000|OLE|Other, Not Specified|0|||
163169432|NCT04556383|589336507|FG001|OLE|Other, Not Specified|0|||
163169433|NCT04556383|589336508|FG002|OLE|Other, Not Specified|0|||
163169434|NCT04556383|589336509|FG003|OLE|Other, Not Specified|2|||
163169435|NCT04556383|589336506|FG000|OLE|Death|0|||
163169436|NCT04556383|589336507|FG001|OLE|Death|0|||
163169437|NCT04556383|589336508|FG002|OLE|Death|0|||
163169438|NCT04556383|589336509|FG003|OLE|Death|1|||
163169439|NCT04556383|589336506|FG000|OLE|Lost to Follow-up|0|||
162698271|NCT01027364|587605449|FG001|Overall Study|Withdrawal by Subject|2|||
162818322|NCT01284062|588048941|FG000|Overall Study|Lack of Efficacy|3|||
163169440|NCT04556383|589336507|FG001|OLE|Lost to Follow-up|0|||
163169441|NCT04556383|589336508|FG002|OLE|Lost to Follow-up|0|||
163169442|NCT04556383|589336509|FG003|OLE|Lost to Follow-up|1|||
163169443|NCT02720042|589336515|FG000|Overall Study|Death|3|||
163169444|NCT02720042|589336515|FG000|Overall Study|Lost to Follow-up|4|||
163169445|NCT02720042|589336515|FG000|Overall Study|Withdrawal by Subject|1|||
163169446|NCT02720042|589336515|FG000|Overall Study|Physician Decision|3|||
163169447|NCT02720042|589336515|FG000|Overall Study|Phasix Mesh explanted|1|||
163169448|NCT02720042|589336515|FG000|Overall Study|unable due to non-study-related illness|3|||
163169449|NCT03704636|589336516|FG000|Overall Study|Inadequate Venous Flow|3|||
163169450|NCT00539188|589336517|FG000|Overall Study|Withdrawal by Subject|1|||
163169451|NCT00539188|589336518|FG001|Overall Study|Withdrawal by Subject|0|||
163169452|NCT00539188|589336517|FG000|Overall Study|Lost to Follow-up|2|||
163169453|NCT00539188|589336518|FG001|Overall Study|Lost to Follow-up|1|||
163169454|NCT04784442|589336519|FG000|Overall Study|Adverse Event|1|||
163169455|NCT04784442|589336520|FG001|Overall Study|Adverse Event|0|||
163169456|NCT04784442|589336521|FG002|Overall Study|Adverse Event|2|||
163169457|NCT04784442|589336522|FG003|Overall Study|Adverse Event|1|||
163169458|NCT04784442|589336519|FG000|Overall Study|Protocol Violation|1|||
163169459|NCT04784442|589336520|FG001|Overall Study|Protocol Violation|0|||
163169460|NCT04784442|589336521|FG002|Overall Study|Protocol Violation|0|||
163169461|NCT04784442|589336522|FG003|Overall Study|Protocol Violation|0|||
163169462|NCT04784442|589336519|FG000|Overall Study|Non-compliance with study drug|1|||
163169463|NCT04784442|589336520|FG001|Overall Study|Non-compliance with study drug|0|||
163169464|NCT04784442|589336521|FG002|Overall Study|Non-compliance with study drug|0|||
163169465|NCT04784442|589336522|FG003|Overall Study|Non-compliance with study drug|0|||
163169466|NCT00509145|589336523|FG000|Overall Study|Death|0|||
163169467|NCT00509145|589336524|FG001|Overall Study|Death|2|||
163169468|NCT00509145|589336523|FG000|Overall Study|Adverse Event|42|||
163169469|NCT00509145|589336524|FG001|Overall Study|Adverse Event|28|||
163169470|NCT00509145|589336523|FG000|Overall Study|Withdrawal by Subject|32|||
163169471|NCT00509145|589336524|FG001|Overall Study|Withdrawal by Subject|38|||
163169472|NCT00509145|589336523|FG000|Overall Study|Physician Decision|11|||
163169473|NCT00509145|589336524|FG001|Overall Study|Physician Decision|14|||
163169474|NCT00509145|589336523|FG000|Overall Study|Protocol Violation|1|||
163169475|NCT00509145|589336524|FG001|Overall Study|Protocol Violation|6|||
163169476|NCT00509145|589336523|FG000|Overall Study|Pregnancy|3|||
163169477|NCT00509145|589336524|FG001|Overall Study|Pregnancy|8|||
163169478|NCT00509145|589336523|FG000|Overall Study|Lost to Follow-up|6|||
163169479|NCT00509145|589336524|FG001|Overall Study|Lost to Follow-up|5|||
163169480|NCT00509145|589336523|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
163169481|NCT00509145|589336524|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
163169482|NCT00509145|589336523|FG000|Overall Study|Other|6|||
163169483|NCT00509145|589336524|FG001|Overall Study|Other|6|||
163169484|NCT01994889|589336527|FG000|Overall Study|Adverse Event|5|||
163169485|NCT01994889|589336528|FG001|Overall Study|Adverse Event|12|||
163169486|NCT01994889|589336529|FG002|Overall Study|Adverse Event|11|||
163169487|NCT01994889|589336527|FG000|Overall Study|Cardiac Device Implantation|0|||
163169488|NCT01994889|589336528|FG001|Overall Study|Cardiac Device Implantation|2|||
163169489|NCT01994889|589336529|FG002|Overall Study|Cardiac Device Implantation|0|||
163169490|NCT01994889|589336527|FG000|Overall Study|Organ Transplantation|1|||
163169491|NCT01994889|589336528|FG001|Overall Study|Organ Transplantation|5|||
163169492|NCT01994889|589336529|FG002|Overall Study|Organ Transplantation|5|||
163169493|NCT01994889|589336527|FG000|Overall Study|No longer willing to participate|8|||
163169494|NCT01994889|589336528|FG001|Overall Study|No longer willing to participate|17|||
163169495|NCT01994889|589336529|FG002|Overall Study|No longer willing to participate|37|||
163169496|NCT01994889|589336527|FG000|Overall Study|Lost to Follow-up|0|||
163169497|NCT01994889|589336528|FG001|Overall Study|Lost to Follow-up|1|||
163169498|NCT01994889|589336529|FG002|Overall Study|Lost to Follow-up|0|||
163169499|NCT01994889|589336527|FG000|Overall Study|Protocol Violation|0|||
163169500|NCT01994889|589336528|FG001|Overall Study|Protocol Violation|1|||
163169501|NCT01994889|589336529|FG002|Overall Study|Protocol Violation|1|||
163169502|NCT01994889|589336527|FG000|Overall Study|Death|14|||
163169503|NCT01994889|589336528|FG001|Overall Study|Death|25|||
163169504|NCT01994889|589336529|FG002|Overall Study|Death|38|||
163169505|NCT01711216|589336533|FG000|Overall Study|Adverse Event|4|||
163169506|NCT01711216|589336533|FG000|Overall Study|Pregnancy|56|||
163169507|NCT01711216|589336533|FG000|Overall Study|Withdrawal by Subject|6|||
163169508|NCT01711216|589336533|FG000|Overall Study|Lost to Follow-up|46|||
163169509|NCT01711216|589336533|FG000|Overall Study|variety of other minor reasons|83|||
163169510|NCT01711216|589336533|FG000|Overall Study|no reason specified|22|||
163169511|NCT02259088|589336534|FG000|Overall Study|Adverse Event|6|||
163169512|NCT02259088|589336535|FG001|Overall Study|Adverse Event|4|||
163169513|NCT02259088|589336534|FG000|Overall Study|Lost to Follow-up|2|||
163169514|NCT02259088|589336535|FG001|Overall Study|Lost to Follow-up|0|||
163169515|NCT02259088|589336534|FG000|Overall Study|Death|2|||
163169516|NCT02259088|589336535|FG001|Overall Study|Death|0|||
163169517|NCT02259088|589336534|FG000|Overall Study|Physician Decision|5|||
163169518|NCT02259088|589336535|FG001|Overall Study|Physician Decision|2|||
163169519|NCT02259088|589336534|FG000|Overall Study|Protocol deviation|5|||
163169520|NCT02259088|589336535|FG001|Overall Study|Protocol deviation|0|||
163169521|NCT02259088|589336534|FG000|Overall Study|Subject/guardian decision|8|||
163169522|NCT02259088|589336535|FG001|Overall Study|Subject/guardian decision|8|||
163169523|NCT03060551|589336537|FG000|Overall Study|Withdrawal by Subject|1|||
163169524|NCT03060551|589336537|FG000|Overall Study|Adverse Event|1|||
163169525|NCT01214395|589336545|FG000|Overall Study|All patients had infection|5|||
163169526|NCT03698591|589336549|FG000|Overall Study|Withdrawal by Subject|2|||
163169527|NCT03698591|589336550|FG001|Overall Study|Withdrawal by Subject|2|||
163169528|NCT03698591|589336549|FG000|Overall Study|Failed drug screen|1|||
163169529|NCT03698591|589336550|FG001|Overall Study|Failed drug screen|1|||
163169530|NCT03698591|589336549|FG000|Overall Study|Failed health screen|0|||
163169531|NCT03698591|589336550|FG001|Overall Study|Failed health screen|1|||
163169532|NCT03698591|589336549|FG000|Overall Study|Ineligible for financial compensation|1|||
163169533|NCT03698591|589336550|FG001|Overall Study|Ineligible for financial compensation|0|||
163169534|NCT03698591|589336549|FG000|Overall Study|Equipment Error|1|||
163169535|NCT03698591|589336550|FG001|Overall Study|Equipment Error|0|||
163169536|NCT03698591|589336549|FG000|Overall Study|Could not establish TMS dosage|0|||
163169537|NCT03698591|589336550|FG001|Overall Study|Could not establish TMS dosage|1|||
163169538|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
163169539|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
163169540|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
163169541|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
163169542|NCT02660983|589336559|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
163169543|NCT02660983|589336560|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
163169544|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
163169545|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
163169546|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
163169547|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
163169548|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
163169549|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
163169550|NCT02660983|589336559|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
163169551|NCT02660983|589336560|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
163169552|NCT00721968|589336569|FG000|Overall Study|Lost to Follow-up|2|||
163169553|NCT00721968|589336570|FG001|Overall Study|Lost to Follow-up|0|||
163169554|NCT01064947|589336571|FG000|Overall Study|negative culture|41|||
163169555|NCT06457204|589336574|FG000|Washout|Adverse Event|0|||
163169556|NCT06457204|589336575|FG001|Washout|Adverse Event|2|||
163169557|NCT01457352|589336576|FG000|Period 1|Adverse Event|2|||
163169558|NCT01457352|589336577|FG001|Period 1|Adverse Event|0|||
163169559|NCT01457352|589336576|FG000|Period 1|Withdrawal by Subject|2|||
163169560|NCT01457352|589336577|FG001|Period 1|Withdrawal by Subject|0|||
163169561|NCT01457352|589336576|FG000|Period 1|Physician Decision|2|||
163169562|NCT01457352|589336577|FG001|Period 1|Physician Decision|0|||
163169563|NCT01457352|589336576|FG000|Period 1|MS related disease progression|1|||
163169564|NCT01457352|589336577|FG001|Period 1|MS related disease progression|0|||
163169565|NCT01457352|589336576|FG000|Period 1|Withdrawn|1|||
163169566|NCT01457352|589336577|FG001|Period 1|Withdrawn|0|||
163169567|NCT01457352|589336576|FG000|Period 1|withdrew per sponsor|1|||
163169568|NCT01457352|589336577|FG001|Period 1|withdrew per sponsor|0|||
163169569|NCT01457352|589336576|FG000|Period 1|Protocol Violation|4|||
163169570|NCT01457352|589336577|FG001|Period 1|Protocol Violation|0|||
163169571|NCT01457352|589336576|FG000|Period 1|Did not meet eligibility criteria|3|||
163169572|NCT01457352|589336577|FG001|Period 1|Did not meet eligibility criteria|0|||
163169573|NCT01457352|589336576|FG000|Period 2|Withdrawal by Subject|23|||
163169574|NCT01457352|589336577|FG001|Period 2|Withdrawal by Subject|0|||
163169575|NCT01457352|589336576|FG000|Period 2|Adverse Event|22|||
163169576|NCT01457352|589336577|FG001|Period 2|Adverse Event|0|||
163169577|NCT01457352|589336576|FG000|Period 2|no analysis|10|||
163169578|NCT01457352|589336577|FG001|Period 2|no analysis|0|||
163169579|NCT01457352|589336576|FG000|Period 2|Lack of Efficacy|8|||
163169580|NCT01457352|589336577|FG001|Period 2|Lack of Efficacy|0|||
163169581|NCT01457352|589336576|FG000|Period 2|Protocol Violation|4|||
163169582|NCT01457352|589336577|FG001|Period 2|Protocol Violation|0|||
163169583|NCT01457352|589336576|FG000|Period 2|Sponsor's withdrawal|7|||
163169584|NCT01457352|589336577|FG001|Period 2|Sponsor's withdrawal|0|||
163169585|NCT01457352|589336576|FG000|Period 2|Lost to Follow-up|1|||
163169586|NCT01457352|589336577|FG001|Period 2|Lost to Follow-up|0|||
163169587|NCT01457352|589336576|FG000|Period 2|dose change|1|||
163169588|NCT01457352|589336577|FG001|Period 2|dose change|0|||
163169589|NCT01457352|589336576|FG000|Period 2|Physician Decision|1|||
163169590|NCT01457352|589336577|FG001|Period 2|Physician Decision|0|||
163169591|NCT01457352|589336576|FG000|Period 2|Did not meet eligibility criteria|3|||
163169592|NCT01457352|589336577|FG001|Period 2|Did not meet eligibility criteria|0|||
163169593|NCT01457352|589336576|FG000|Period 3|Adverse Event|1|||
163169594|NCT01457352|589336577|FG001|Period 3|Adverse Event|1|||
163169595|NCT01457352|589336576|FG000|Period 3|Withdrawal by Subject|0|||
163169596|NCT01457352|589336577|FG001|Period 3|Withdrawal by Subject|2|||
163169597|NCT01457352|589336576|FG000|Period 3|incorrect treatment|0|||
163169598|NCT01457352|589336577|FG001|Period 3|incorrect treatment|1|||
163169599|NCT01457352|589336576|FG000|Period 3|Sponsor's withdrawal|0|||
163169600|NCT01457352|589336577|FG001|Period 3|Sponsor's withdrawal|1|||
163169601|NCT03865316|589338440|FG000|Overall Study|Procedure Cancelled|4|||
163169602|NCT03865316|589338440|FG000|Overall Study|Equipment failure|4|||
163169603|NCT01948193|589338441|FG000|Overall Study|Serious event|2|||
163169604|NCT01948193|589338441|FG000|Overall Study|Lost to Follow-up|7|||
163169605|NCT00668733|589338449|FG000|Overall Study|Lost to Follow-up|2|||
163169606|NCT00668733|589338450|FG001|Overall Study|Lost to Follow-up|3|||
163169607|NCT00668733|589338449|FG000|Overall Study|Withdrawal by Subject|0|||
163169608|NCT00668733|589338450|FG001|Overall Study|Withdrawal by Subject|4|||
163169609|NCT01122264|589338456|FG000|Overall Study|Adverse Event|6|||
163169610|NCT01122264|589338457|FG001|Overall Study|Adverse Event|5|||
163169611|NCT01122264|589338458|FG002|Overall Study|Adverse Event|7|||
163169612|NCT01122264|589338456|FG000|Overall Study|Death|1|||
163169613|NCT01122264|589338457|FG001|Overall Study|Death|0|||
163169614|NCT01122264|589338458|FG002|Overall Study|Death|0|||
163169615|NCT01122264|589338456|FG000|Overall Study|Lost to Follow-up|5|||
163169616|NCT01122264|589338457|FG001|Overall Study|Lost to Follow-up|9|||
163169617|NCT01122264|589338458|FG002|Overall Study|Lost to Follow-up|13|||
163169618|NCT01122264|589338456|FG000|Overall Study|Entry Criteria Not Met|1|||
163169619|NCT01122264|589338457|FG001|Overall Study|Entry Criteria Not Met|0|||
163169620|NCT01122264|589338458|FG002|Overall Study|Entry Criteria Not Met|0|||
163169621|NCT01122264|589338456|FG000|Overall Study|Protocol Violation|7|||
163169622|NCT01122264|589338457|FG001|Overall Study|Protocol Violation|7|||
163169623|NCT01122264|589338458|FG002|Overall Study|Protocol Violation|9|||
163169624|NCT01122264|589338456|FG000|Overall Study|Withdrawal by Subject|6|||
163169625|NCT01122264|589338457|FG001|Overall Study|Withdrawal by Subject|6|||
163169626|NCT01122264|589338458|FG002|Overall Study|Withdrawal by Subject|16|||
163169627|NCT01122264|589338456|FG000|Overall Study|Physician Decision|3|||
163169628|NCT01122264|589338457|FG001|Overall Study|Physician Decision|1|||
163169629|NCT01122264|589338458|FG002|Overall Study|Physician Decision|1|||
163169630|NCT01122264|589338456|FG000|Overall Study|Lack of Efficacy|3|||
163169631|NCT01122264|589338457|FG001|Overall Study|Lack of Efficacy|1|||
163169632|NCT01122264|589338458|FG002|Overall Study|Lack of Efficacy|1|||
163169633|NCT00097981|589338459|FG000|Overall Study|Adverse Event|31|||
163169634|NCT00097981|589338460|FG001|Overall Study|Adverse Event|44|||
163169635|NCT00097981|589338459|FG000|Overall Study|Withdrawal by Subject|10|||
163169636|NCT00097981|589338460|FG001|Overall Study|Withdrawal by Subject|8|||
163169637|NCT00097981|589338459|FG000|Overall Study|Protocol Violation|1|||
163169638|NCT00097981|589338460|FG001|Overall Study|Protocol Violation|1|||
163169639|NCT00097981|589338459|FG000|Overall Study|Death|2|||
163169640|NCT00097981|589338460|FG001|Overall Study|Death|4|||
163169641|NCT00097981|589338459|FG000|Overall Study|Physician Decision|7|||
163169642|NCT00097981|589338460|FG001|Overall Study|Physician Decision|1|||
163169643|NCT00097981|589338459|FG000|Overall Study|Disease Progression|8|||
163169644|NCT00097981|589338460|FG001|Overall Study|Disease Progression|2|||
163169645|NCT00097981|589338459|FG000|Overall Study|Transplant planned|28|||
163169646|NCT00097981|589338460|FG001|Overall Study|Transplant planned|27|||
163169647|NCT00097981|589338459|FG000|Overall Study|Other|19|||
163169648|NCT00097981|589338460|FG001|Overall Study|Other|13|||
163169649|NCT01836276|589338462|FG000|Overall Study|Lost to Follow-up|28|||
163169650|NCT01836276|589338463|FG001|Overall Study|Lost to Follow-up|51|||
163169651|NCT02208063|589338472|FG000|Overall Study|Death|3|||
163169652|NCT02208063|589338473|FG001|Overall Study|Death|5|||
163169653|NCT02208063|589338472|FG000|Overall Study|Not Specified in report|3|||
163169654|NCT02208063|589338473|FG001|Overall Study|Not Specified in report|4|||
163169655|NCT02208063|589338472|FG000|Overall Study|Withdrawal by Subject|5|||
163169656|NCT02208063|589338473|FG001|Overall Study|Withdrawal by Subject|2|||
163169657|NCT02208063|589338472|FG000|Overall Study|Lost to Follow-up|1|||
163169658|NCT02208063|589338473|FG001|Overall Study|Lost to Follow-up|0|||
163169659|NCT00388583|589338474|FG000|Overall Study|Protocol Violation|1|||
163169660|NCT00388583|589338475|FG001|Overall Study|Protocol Violation|0|||
163169661|NCT00388583|589338474|FG000|Overall Study|Withdrawal by Subject|3|||
163169662|NCT00388583|589338475|FG001|Overall Study|Withdrawal by Subject|3|||
163169663|NCT00388583|589338474|FG000|Overall Study|Serious Adverse Event|2|||
163169664|NCT00388583|589338475|FG001|Overall Study|Serious Adverse Event|0|||
163169665|NCT00388583|589338474|FG000|Overall Study|Did not receive vaccine|0|||
163169666|NCT00388583|589338475|FG001|Overall Study|Did not receive vaccine|1|||
163169667|NCT00913458|589338476|FG000|Phase 1|Non-Responder|54|||
163169668|NCT00913458|589338477|FG001|Phase 1|Non-Responder|0|||
163169669|NCT00913458|589338478|FG002|Phase 1|Non-Responder|0|||
163169670|NCT00913458|589338479|FG003|Phase 1|Non-Responder|0|||
163169671|NCT00913458|589338480|FG004|Phase 1|Non-Responder|0|||
163169672|NCT00913458|589338481|FG005|Phase 1|Non-Responder|0|||
163169673|NCT00913458|589338482|FG006|Phase 1|Non-Responder|0|||
163169674|NCT00913458|589338476|FG000|Phase 1|Subject Request|17|||
163169675|NCT00913458|589338477|FG001|Phase 1|Subject Request|0|||
163169676|NCT00913458|589338478|FG002|Phase 1|Subject Request|0|||
163169677|NCT00913458|589338479|FG003|Phase 1|Subject Request|0|||
163169678|NCT00913458|589338480|FG004|Phase 1|Subject Request|0|||
163169679|NCT00913458|589338481|FG005|Phase 1|Subject Request|0|||
163169680|NCT00913458|589338482|FG006|Phase 1|Subject Request|0|||
163169681|NCT00913458|589338476|FG000|Phase 1|Adverse Event|20|||
163169682|NCT00913458|589338477|FG001|Phase 1|Adverse Event|0|||
163169683|NCT00913458|589338478|FG002|Phase 1|Adverse Event|0|||
163169684|NCT00913458|589338479|FG003|Phase 1|Adverse Event|0|||
163169685|NCT00913458|589338480|FG004|Phase 1|Adverse Event|0|||
163169686|NCT00913458|589338481|FG005|Phase 1|Adverse Event|0|||
163169687|NCT00913458|589338482|FG006|Phase 1|Adverse Event|0|||
163169688|NCT00913458|589338476|FG000|Phase 1|Lost to Follow-up|2|||
162698272|NCT01027364|587605450|FG002|Overall Study|Withdrawal by Subject|0|||
163169689|NCT00913458|589338477|FG001|Phase 1|Lost to Follow-up|0|||
163169690|NCT00913458|589338478|FG002|Phase 1|Lost to Follow-up|0|||
163169691|NCT00913458|589338479|FG003|Phase 1|Lost to Follow-up|0|||
163169692|NCT00913458|589338480|FG004|Phase 1|Lost to Follow-up|0|||
163169693|NCT00913458|589338481|FG005|Phase 1|Lost to Follow-up|0|||
163169694|NCT00913458|589338482|FG006|Phase 1|Lost to Follow-up|0|||
163169695|NCT00913458|589338476|FG000|Phase 1|Protocol Violation|10|||
163169696|NCT00913458|589338477|FG001|Phase 1|Protocol Violation|0|||
163169697|NCT00913458|589338478|FG002|Phase 1|Protocol Violation|0|||
163169698|NCT00913458|589338479|FG003|Phase 1|Protocol Violation|0|||
163169699|NCT00913458|589338480|FG004|Phase 1|Protocol Violation|0|||
163169700|NCT00913458|589338481|FG005|Phase 1|Protocol Violation|0|||
163169701|NCT00913458|589338482|FG006|Phase 1|Protocol Violation|0|||
163169702|NCT00913458|589338476|FG000|Phase 1|Sponsor|2|||
163169703|NCT00913458|589338477|FG001|Phase 1|Sponsor|0|||
163169704|NCT00913458|589338478|FG002|Phase 1|Sponsor|0|||
163169705|NCT00913458|589338479|FG003|Phase 1|Sponsor|0|||
163169706|NCT00913458|589338480|FG004|Phase 1|Sponsor|0|||
163169707|NCT00913458|589338481|FG005|Phase 1|Sponsor|0|||
163169708|NCT00913458|589338482|FG006|Phase 1|Sponsor|0|||
163169709|NCT00913458|589338476|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
163169710|NCT00913458|589338477|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
163169711|NCT00913458|589338478|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
163169712|NCT00913458|589338479|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
163169713|NCT00913458|589338480|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
163169714|NCT00913458|589338481|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
163169715|NCT00913458|589338482|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
163169716|NCT00913458|589338476|FG000|Phase 2|Non-Responder|0|||
163169717|NCT00913458|589338477|FG001|Phase 2|Non-Responder|5|||
163169718|NCT00913458|589338478|FG002|Phase 2|Non-Responder|7|||
163169719|NCT00913458|589338479|FG003|Phase 2|Non-Responder|12|||
163169720|NCT00913458|589338480|FG004|Phase 2|Non-Responder|0|||
163169721|NCT00913458|589338481|FG005|Phase 2|Non-Responder|0|||
163169722|NCT00913458|589338482|FG006|Phase 2|Non-Responder|0|||
163169723|NCT00913458|589338476|FG000|Phase 2|Subject Request|0|||
163169724|NCT00913458|589338477|FG001|Phase 2|Subject Request|0|||
163169725|NCT00913458|589338478|FG002|Phase 2|Subject Request|1|||
163169726|NCT00913458|589338479|FG003|Phase 2|Subject Request|2|||
163169727|NCT00913458|589338480|FG004|Phase 2|Subject Request|0|||
163169728|NCT00913458|589338481|FG005|Phase 2|Subject Request|0|||
163169729|NCT00913458|589338482|FG006|Phase 2|Subject Request|0|||
163169730|NCT00913458|589338476|FG000|Phase 2|Adverse Event|0|||
163169731|NCT00913458|589338477|FG001|Phase 2|Adverse Event|3|||
163169732|NCT00913458|589338478|FG002|Phase 2|Adverse Event|0|||
163169733|NCT00913458|589338479|FG003|Phase 2|Adverse Event|1|||
163169734|NCT00913458|589338480|FG004|Phase 2|Adverse Event|0|||
163169735|NCT00913458|589338481|FG005|Phase 2|Adverse Event|0|||
163169736|NCT00913458|589338482|FG006|Phase 2|Adverse Event|0|||
163169737|NCT00913458|589338476|FG000|Phase 2|Lost to Follow-up|0|||
163169738|NCT00913458|589338477|FG001|Phase 2|Lost to Follow-up|0|||
163169739|NCT00913458|589338478|FG002|Phase 2|Lost to Follow-up|0|||
163169740|NCT00913458|589338479|FG003|Phase 2|Lost to Follow-up|1|||
163169741|NCT00913458|589338480|FG004|Phase 2|Lost to Follow-up|0|||
163169742|NCT00913458|589338481|FG005|Phase 2|Lost to Follow-up|0|||
163169743|NCT00913458|589338482|FG006|Phase 2|Lost to Follow-up|0|||
163169744|NCT00913458|589338476|FG000|Phase 2|Protocol Violation|0|||
163169745|NCT00913458|589338477|FG001|Phase 2|Protocol Violation|2|||
163169746|NCT00913458|589338478|FG002|Phase 2|Protocol Violation|0|||
163169747|NCT00913458|589338479|FG003|Phase 2|Protocol Violation|0|||
163169748|NCT00913458|589338480|FG004|Phase 2|Protocol Violation|0|||
163169749|NCT00913458|589338481|FG005|Phase 2|Protocol Violation|0|||
163169750|NCT00913458|589338482|FG006|Phase 2|Protocol Violation|0|||
163169751|NCT00913458|589338476|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
163169752|NCT00913458|589338477|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
163169753|NCT00913458|589338478|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
163169754|NCT00913458|589338479|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
163169755|NCT00913458|589338480|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
163169756|NCT00913458|589338481|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
163169757|NCT00913458|589338482|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
163169758|NCT00913458|589338476|FG000|Phase 3|Adverse Event|0|||
163169759|NCT00913458|589338477|FG001|Phase 3|Adverse Event|0|||
163169760|NCT00913458|589338478|FG002|Phase 3|Adverse Event|0|||
163169761|NCT00913458|589338479|FG003|Phase 3|Adverse Event|0|||
163169762|NCT00913458|589338480|FG004|Phase 3|Adverse Event|5|||
163169763|NCT00913458|589338481|FG005|Phase 3|Adverse Event|4|||
163169764|NCT00913458|589338482|FG006|Phase 3|Adverse Event|1|||
163169765|NCT00913458|589338476|FG000|Phase 3|Lost to Follow-up|0|||
163169766|NCT00913458|589338477|FG001|Phase 3|Lost to Follow-up|0|||
163169767|NCT00913458|589338478|FG002|Phase 3|Lost to Follow-up|0|||
163169768|NCT00913458|589338479|FG003|Phase 3|Lost to Follow-up|0|||
163169769|NCT00913458|589338480|FG004|Phase 3|Lost to Follow-up|2|||
163169770|NCT00913458|589338481|FG005|Phase 3|Lost to Follow-up|0|||
163169771|NCT00913458|589338482|FG006|Phase 3|Lost to Follow-up|0|||
163169772|NCT00913458|589338476|FG000|Phase 3|Non-Responder|0|||
163169773|NCT00913458|589338477|FG001|Phase 3|Non-Responder|0|||
163169774|NCT00913458|589338478|FG002|Phase 3|Non-Responder|0|||
163169775|NCT00913458|589338479|FG003|Phase 3|Non-Responder|0|||
163169776|NCT00913458|589338480|FG004|Phase 3|Non-Responder|0|||
163169777|NCT00913458|589338481|FG005|Phase 3|Non-Responder|1|||
163169778|NCT00913458|589338482|FG006|Phase 3|Non-Responder|3|||
163169779|NCT00913458|589338476|FG000|Phase 3|Withdrawal by Subject|0|||
163169780|NCT00913458|589338477|FG001|Phase 3|Withdrawal by Subject|0|||
163169781|NCT00913458|589338478|FG002|Phase 3|Withdrawal by Subject|0|||
163169782|NCT00913458|589338479|FG003|Phase 3|Withdrawal by Subject|0|||
163169783|NCT00913458|589338480|FG004|Phase 3|Withdrawal by Subject|1|||
163169784|NCT00913458|589338481|FG005|Phase 3|Withdrawal by Subject|2|||
163169785|NCT00913458|589338482|FG006|Phase 3|Withdrawal by Subject|0|||
163169786|NCT00913458|589338476|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
163169787|NCT00913458|589338477|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
163169788|NCT00913458|589338478|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
163169789|NCT00913458|589338479|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
163169790|NCT00913458|589338480|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
163169791|NCT00913458|589338481|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
163169792|NCT00913458|589338482|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
163169793|NCT02366091|589338483|FG000|Overall Study|Withdrawal by Subject|3|||
163169794|NCT02366091|589338484|FG001|Overall Study|Withdrawal by Subject|7|||
163169795|NCT02366091|589338485|FG002|Overall Study|Withdrawal by Subject|3|||
163169796|NCT02366091|589338486|FG003|Overall Study|Withdrawal by Subject|1|||
163169797|NCT05194579|589338487|FG000|Overall Study|Lost to Follow-up|2|||
163169798|NCT05194579|589338488|FG001|Overall Study|Lost to Follow-up|3|||
163169799|NCT05194579|589338487|FG000|Overall Study|Withdrawal by Subject|3|||
163169800|NCT05194579|589338488|FG001|Overall Study|Withdrawal by Subject|4|||
163169801|NCT05194579|589338487|FG000|Overall Study|Refused further study procedures|0|||
163169802|NCT05194579|589338488|FG001|Overall Study|Refused further study procedures|1|||
163169803|NCT05194579|589338487|FG000|Overall Study|Protocol deviation|1|||
163169804|NCT05194579|589338488|FG001|Overall Study|Protocol deviation|0|||
163169805|NCT02338232|589338489|FG000|Overall Study|Screen Failure|3|||
163169806|NCT02338232|589338489|FG000|Overall Study|Withdrawal by Subject|6|||
163169807|NCT02338232|589338489|FG000|Overall Study|Adverse Event|2|||
163169808|NCT03890666|589338490|FG000|Overall Study|Withdrawal by Subject|0|||
163169809|NCT03890666|589338491|FG001|Overall Study|Withdrawal by Subject|1|||
163169810|NCT03890666|589338490|FG000|Overall Study|Protocol deviation|1|||
163169811|NCT03890666|589338491|FG001|Overall Study|Protocol deviation|4|||
163169812|NCT03890666|589338490|FG000|Overall Study|Lost to Follow-up|2|||
163169813|NCT03890666|589338491|FG001|Overall Study|Lost to Follow-up|5|||
163169814|NCT03890666|589338490|FG000|Overall Study|Other than specified|1|||
163169815|NCT03890666|589338491|FG001|Overall Study|Other than specified|8|||
163169816|NCT01105065|589338492|FG000|Overall Study|Adverse Event|5|||
163169817|NCT01105065|589338492|FG000|Overall Study|Technical Problems|1|||
163169818|NCT02122783|589338496|FG000|Overall Study|Adverse Event|0|||
163169819|NCT02122783|589338497|FG001|Overall Study|Adverse Event|1|||
163169820|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
163169821|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
163169822|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
163169823|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
163169824|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
163169825|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
163169826|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
163169827|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
163169828|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
163169829|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
163169830|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
163169831|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
163169832|NCT00322621|589338498|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
163169833|NCT00322621|589338499|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
163169834|NCT00322621|589338500|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
163169835|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
163169836|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
163169837|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
163169838|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
163169839|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
163169840|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
163169841|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
163169842|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
163169843|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
163169844|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
163169845|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
163169846|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
163169847|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
163169848|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
163169849|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
163169850|NCT00322621|589338498|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
163169851|NCT00322621|589338499|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
163169852|NCT00322621|589338500|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
163169853|NCT02213133|589338505|FG000|Overall Study|Participant discontinued study therapy|2|||
163169854|NCT02213133|589338506|FG001|Overall Study|Participant discontinued study therapy|0|||
163169855|NCT02213133|589338507|FG002|Overall Study|Participant discontinued study therapy|0|||
163169856|NCT02213133|589338505|FG000|Overall Study|Participant withdrew informed consent|2|||
163169857|NCT02213133|589338506|FG001|Overall Study|Participant withdrew informed consent|1|||
163169858|NCT02213133|589338507|FG002|Overall Study|Participant withdrew informed consent|2|||
163169859|NCT02213133|589338505|FG000|Overall Study|Disease progression|11|||
163169860|NCT02213133|589338506|FG001|Overall Study|Disease progression|2|||
163169861|NCT02213133|589338507|FG002|Overall Study|Disease progression|0|||
163169862|NCT02213133|589338505|FG000|Overall Study|Adverse Event (AE)|1|||
163169863|NCT02213133|589338506|FG001|Overall Study|Adverse Event (AE)|0|||
163169864|NCT02213133|589338507|FG002|Overall Study|Adverse Event (AE)|0|||
163169865|NCT02213133|589338505|FG000|Overall Study|Death|16|||
163169866|NCT02213133|589338506|FG001|Overall Study|Death|2|||
163169867|NCT02213133|589338507|FG002|Overall Study|Death|1|||
163169868|NCT02213133|589338505|FG000|Overall Study|Other|5|||
163169869|NCT02213133|589338506|FG001|Overall Study|Other|0|||
163169870|NCT02213133|589338507|FG002|Overall Study|Other|0|||
163169871|NCT00638183|589338508|FG000|Overall Study|Adverse Event|23|||
163169872|NCT00638183|589338508|FG000|Overall Study|Lack of Efficacy|14|||
163169873|NCT00638183|589338508|FG000|Overall Study|Physician Decision|9|||
163169874|NCT00638183|589338508|FG000|Overall Study|Lost to Follow-up|46|||
163169875|NCT00638183|589338508|FG000|Overall Study|Other reason not defined above|27|||
163169876|NCT03180619|589338509|FG000|Overall Study|Withdrew Consent|5|||
163169877|NCT03180619|589338510|FG001|Overall Study|Withdrew Consent|0|||
163169878|NCT03180619|589338511|FG002|Overall Study|Withdrew Consent|2|||
163169879|NCT03180619|589338509|FG000|Overall Study|Death|2|||
163169880|NCT03180619|589338510|FG001|Overall Study|Death|1|||
163169881|NCT03180619|589338511|FG002|Overall Study|Death|2|||
163169882|NCT03180619|589338509|FG000|Overall Study|Adverse Event|2|||
163169883|NCT03180619|589338510|FG001|Overall Study|Adverse Event|0|||
163169884|NCT03180619|589338511|FG002|Overall Study|Adverse Event|1|||
163169885|NCT03180619|589338509|FG000|Overall Study|Investigator's discretion|2|||
163169886|NCT03180619|589338510|FG001|Overall Study|Investigator's discretion|0|||
163169887|NCT03180619|589338511|FG002|Overall Study|Investigator's discretion|1|||
163169888|NCT02743611|589338512|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
163169889|NCT02743611|589338513|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
163169890|NCT02743611|589338514|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
163169891|NCT02743611|589338515|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
163169892|NCT00729469|589338516|FG000|Overall Study|Adverse Event|14|||
163169893|NCT00729469|589338517|FG001|Overall Study|Adverse Event|25|||
163169894|NCT00729469|589338516|FG000|Overall Study|Lost to Follow-up|9|||
163169895|NCT00729469|589338517|FG001|Overall Study|Lost to Follow-up|9|||
163169896|NCT00729469|589338516|FG000|Overall Study|Protocol Violation|2|||
163169897|NCT00729469|589338517|FG001|Overall Study|Protocol Violation|1|||
163169898|NCT00729469|589338516|FG000|Overall Study|Withdrawal by Subject|19|||
163169899|NCT00729469|589338517|FG001|Overall Study|Withdrawal by Subject|8|||
163169900|NCT00729469|589338516|FG000|Overall Study|Other-Not mentioned|9|||
163169901|NCT00729469|589338517|FG001|Overall Study|Other-Not mentioned|4|||
163169902|NCT01989208|589338518|FG000|200 mg (7 Days)|Protocol Violation|0|||
163169903|NCT01989208|589338519|FG001|200 mg (7 Days)|Protocol Violation|1|||
163169904|NCT00566696|589338520|FG000|Overall Study|Met Exclusion Criteria|2|||
163169905|NCT00566696|589338520|FG000|Overall Study|Muromonab not available|1|||
163169906|NCT00566696|589338520|FG000|Overall Study|Health Status Change|1|||
163169907|NCT00566696|589338520|FG000|Overall Study|Physician Decision|1|||
163169908|NCT00566696|589338520|FG000|Overall Study|Non-Patient Donors|37|||
163169909|NCT00706342|589338521|FG000|Overall Study|Adverse Event|3|||
163169910|NCT00706342|589338521|FG000|Overall Study|Not responding to treatment|2|||
163169911|NCT00706342|589338521|FG000|Overall Study|Withdrawn due to failure to respond|1|||
163169912|NCT00706342|589338521|FG000|Overall Study|Death|1|||
163169913|NCT00706342|589338521|FG000|Overall Study|Withdrew from the study on his own.|1|||
163169914|NCT00706342|589338521|FG000|Overall Study|Investigator discretion|2|||
163169915|NCT00706342|589338521|FG000|Overall Study|Non-responder Week 12|1|||
163169916|NCT00706342|589338521|FG000|Overall Study|Ongoing|6|||
163169917|NCT00706342|589338521|FG000|Overall Study|WIthdrawal of consent|1|||
163169918|NCT00119678|589338522|FG000|Double-blind Treatment Period|Death|1|||
163169919|NCT00119678|589338523|FG001|Double-blind Treatment Period|Death|0|||
163169920|NCT00119678|589338522|FG000|Double-blind Treatment Period|Adverse Event|7|||
163169921|NCT00119678|589338523|FG001|Double-blind Treatment Period|Adverse Event|1|||
163169922|NCT00119678|589338522|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
163169923|NCT00119678|589338523|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
163169924|NCT00119678|589338522|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163169925|NCT00119678|589338523|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
163169926|NCT00119678|589338522|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
163169927|NCT00119678|589338523|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
163169928|NCT00119678|589338522|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
163169929|NCT00119678|589338523|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
163169930|NCT00119678|589338522|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
163169931|NCT00119678|589338523|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
163169932|NCT00119678|589338522|FG000|Double-blind Treatment Period|Pregnancy|0|||
163169933|NCT00119678|589338523|FG001|Double-blind Treatment Period|Pregnancy|2|||
163169934|NCT00119678|589338522|FG000|Double-blind Treatment Period|Not treated|1|||
163169935|NCT00119678|589338523|FG001|Double-blind Treatment Period|Not treated|2|||
163169936|NCT00119678|589338522|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
163169937|NCT00119678|589338523|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
163169938|NCT00119678|589338522|FG000|Open-label Treatment Period|Death|1|||
163169939|NCT00119678|589338523|FG001|Open-label Treatment Period|Death|0|||
163169940|NCT00119678|589338522|FG000|Open-label Treatment Period|Adverse Event|3|||
163169941|NCT00119678|589338523|FG001|Open-label Treatment Period|Adverse Event|0|||
163169942|NCT00119678|589338522|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
163169943|NCT00119678|589338523|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
163169944|NCT00119678|589338522|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
163169945|NCT00119678|589338523|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163169946|NCT00119678|589338522|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
163169947|NCT00119678|589338523|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
163169948|NCT00119678|589338522|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
163169949|NCT00119678|589338523|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
163169950|NCT00119678|589338522|FG000|Open-label Treatment Period|Pregnancy|1|||
163169951|NCT00119678|589338523|FG001|Open-label Treatment Period|Pregnancy|0|||
163169952|NCT00119678|589338522|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
163169953|NCT00119678|589338523|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
163169954|NCT03567343|589338524|FG000|Overall Study|Lost to Follow-up|2|||
163169955|NCT03567343|589338525|FG001|Overall Study|Lost to Follow-up|1|||
163169956|NCT03567343|589338524|FG000|Overall Study|No longer eligible|2|||
163169957|NCT03567343|589338525|FG001|Overall Study|No longer eligible|1|||
163169958|NCT03567343|589338524|FG000|Overall Study|Adverse Event|1|||
163169959|NCT03567343|589338525|FG001|Overall Study|Adverse Event|0|||
163169960|NCT03567343|589338524|FG000|Overall Study|Protocol Violation|1|||
163169961|NCT03567343|589338525|FG001|Overall Study|Protocol Violation|1|||
163169962|NCT00852371|589338527|FG000|Overall Study|Lost to Follow-up|2|||
163169963|NCT00852371|589338528|FG001|Overall Study|Lost to Follow-up|3|||
163169964|NCT00852371|589338529|FG002|Overall Study|Lost to Follow-up|4|||
163169965|NCT00852371|589338530|FG003|Overall Study|Lost to Follow-up|2|||
163169966|NCT02744040|589338531|FG000|Overall Study|Withdrawal by Subject|3|||
163169967|NCT02744040|589338532|FG001|Overall Study|Withdrawal by Subject|2|||
163169968|NCT02744040|589338533|FG002|Overall Study|Withdrawal by Subject|2|||
163169969|NCT02744040|589338531|FG000|Overall Study|Physician Decision|0|||
163169970|NCT02744040|589338532|FG001|Overall Study|Physician Decision|8|||
163169971|NCT02744040|589338533|FG002|Overall Study|Physician Decision|13|||
163169972|NCT02744040|589338531|FG000|Overall Study|Lost to Follow-up|3|||
163169973|NCT02744040|589338532|FG001|Overall Study|Lost to Follow-up|1|||
163169974|NCT02744040|589338533|FG002|Overall Study|Lost to Follow-up|7|||
163169975|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169976|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169977|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169978|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
163169979|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
163169980|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169981|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169982|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169983|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169984|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
163169985|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169986|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169987|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169988|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169989|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
163169990|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169991|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169992|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169993|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169994|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
163169995|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
163169996|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169997|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169998|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163169999|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
163170000|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170001|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170002|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170003|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170004|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
163170005|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170006|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170007|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
163170008|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170009|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
163170010|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170011|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170012|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170013|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170014|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
163170015|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170016|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170017|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170018|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170019|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
162818323|NCT01284062|588048942|FG001|Overall Study|Lack of Efficacy|2|||
162818324|NCT01284062|588048943|FG002|Overall Study|Lack of Efficacy|2|||
163170020|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170021|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170022|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170023|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170024|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163170025|NCT01185353|589338534|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
163170026|NCT01185353|589338535|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170027|NCT01185353|589338536|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170028|NCT01185353|589338537|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170029|NCT01185353|589338538|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
163170030|NCT01185353|589338539|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170031|NCT01185353|589338540|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170032|NCT01185353|589338541|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170033|NCT01185353|589338542|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162818325|NCT01284062|588048944|FG003|Overall Study|Lack of Efficacy|1|||
162818326|NCT01284062|588048941|FG000|Overall Study|Medication error without adverse event|0|||
162818327|NCT01284062|588048942|FG001|Overall Study|Medication error without adverse event|0|||
162818328|NCT01284062|588048943|FG002|Overall Study|Medication error without adverse event|1|||
163170034|NCT01185353|589338543|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
163170035|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170036|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170037|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
163170038|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170039|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170040|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
163170041|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170042|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170043|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170044|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
163170045|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170046|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
163170047|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170048|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
163170049|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170050|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170051|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170052|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170053|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170054|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
163170055|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170056|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170057|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170058|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
163170059|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170060|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170061|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
163170062|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170063|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170064|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
163170065|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170066|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170067|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
163170068|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
163170069|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170070|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
163170071|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
163170072|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170073|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170074|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
163170075|NCT01185353|589338534|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170076|NCT01185353|589338535|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170077|NCT01185353|589338536|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170078|NCT01185353|589338537|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170079|NCT01185353|589338538|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170080|NCT01185353|589338539|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170081|NCT01185353|589338540|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
163170082|NCT01185353|589338541|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170083|NCT01185353|589338542|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170084|NCT01185353|589338543|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
163170085|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170086|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170087|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170088|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170089|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170090|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170091|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
163170092|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
163170093|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
163170094|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
163170095|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170096|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170097|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170098|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170099|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170100|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170101|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
163170102|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
163170103|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
163170104|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
163170105|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170106|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170107|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170108|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170109|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170110|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170111|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
163170112|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
163170113|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
163170114|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
163170115|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170116|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170117|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170118|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170119|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170120|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170121|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170122|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170123|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
163170124|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
163170125|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Death|0|||
163170126|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Death|0|||
163170127|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Death|0|||
163170128|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Death|0|||
163170129|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Death|0|||
163170130|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Death|0|||
163170131|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Death|0|||
163170132|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Death|0|||
163170133|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Death|0|||
163170134|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Death|1|||
163170135|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170136|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170137|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170138|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170139|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170140|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170141|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170142|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170143|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163170144|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
163170145|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170146|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170147|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170148|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170149|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170150|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170151|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170152|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170153|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163170154|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
163170155|NCT01185353|589338534|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170156|NCT01185353|589338535|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170157|NCT01185353|589338536|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170158|NCT01185353|589338537|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170159|NCT01185353|589338538|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170160|NCT01185353|589338539|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170161|NCT01185353|589338540|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170162|NCT01185353|589338541|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170163|NCT01185353|589338542|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
163170164|NCT01185353|589338543|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
163170165|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170166|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170167|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170168|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170169|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170170|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170171|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
163170172|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
162818329|NCT01284062|588048944|FG003|Overall Study|Medication error without adverse event|0|||
162818330|NCT01284062|588048941|FG000|Overall Study|Protocol Violation|1|||
162818331|NCT01284062|588048942|FG001|Overall Study|Protocol Violation|0|||
162818332|NCT01284062|588048943|FG002|Overall Study|Protocol Violation|0|||
162818333|NCT01284062|588048944|FG003|Overall Study|Protocol Violation|2|||
162818334|NCT01284062|588048941|FG000|Overall Study|Withdrawal by Subject|3|||
162818335|NCT01284062|588048942|FG001|Overall Study|Withdrawal by Subject|1|||
162818336|NCT01284062|588048943|FG002|Overall Study|Withdrawal by Subject|2|||
162818337|NCT01284062|588048944|FG003|Overall Study|Withdrawal by Subject|5|||
162818338|NCT01284062|588048941|FG000|Overall Study|Other|0|||
162818339|NCT01284062|588048942|FG001|Overall Study|Other|0|||
162818340|NCT01284062|588048943|FG002|Overall Study|Other|0|||
162818341|NCT01284062|588048944|FG003|Overall Study|Other|1|||
162818342|NCT01284062|588048941|FG000|Overall Study|Site Closed|0|||
162818343|NCT01284062|588048942|FG001|Overall Study|Site Closed|0|||
162818344|NCT01284062|588048943|FG002|Overall Study|Site Closed|1|||
162818345|NCT01284062|588048944|FG003|Overall Study|Site Closed|0|||
162818346|NCT03189862|588048945|FG000|Overall Study|Withdrawal by Subject|1|||
162818347|NCT03189862|588048946|FG001|Overall Study|Withdrawal by Subject|0|||
162818348|NCT03189862|588048945|FG000|Overall Study|Lost to Follow-up|54|||
162818349|NCT03189862|588048946|FG001|Overall Study|Lost to Follow-up|62|||
162818350|NCT00931944|588048948|FG000|Overall Study|Adverse Event|4|||
162818351|NCT00931944|588048948|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
162818352|NCT00931944|588048948|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
162818353|NCT00931944|588048948|FG000|Overall Study|Death|28|||
162818354|NCT00931944|588048948|FG000|Overall Study|Other|2|||
162818355|NCT00634010|588048957|FG000|Overall Study|Adverse Event|2|||
162818356|NCT00634010|588048958|FG001|Overall Study|Adverse Event|5|||
162818357|NCT00634010|588048957|FG000|Overall Study|Withdrawal by Subject|5|||
162818358|NCT00634010|588048958|FG001|Overall Study|Withdrawal by Subject|6|||
162818359|NCT00634010|588048957|FG000|Overall Study|Physician Decision|1|||
162818360|NCT00634010|588048958|FG001|Overall Study|Physician Decision|1|||
162818361|NCT00634010|588048957|FG000|Overall Study|Disease Progression|1|||
162818362|NCT00634010|588048958|FG001|Overall Study|Disease Progression|1|||
162818363|NCT00634010|588048957|FG000|Overall Study|Non-Compliant|1|||
162818364|NCT00634010|588048958|FG001|Overall Study|Non-Compliant|1|||
162818365|NCT00882310|588048959|FG000|Overall Study|Screen Failure|10|||
162818366|NCT00882310|588048959|FG000|Overall Study|Never received treatment|1|||
162818367|NCT00882310|588048959|FG000|Overall Study|Death|6|||
162818368|NCT00882310|588048959|FG000|Overall Study|Progression of disease|4|||
162818369|NCT00882310|588048959|FG000|Overall Study|Adverse Event|1|||
162818370|NCT04233164|588048964|FG000|Overall Study|Unable to obtain specimen|0|||
162818371|NCT04233164|588048965|FG001|Overall Study|Unable to obtain specimen|1|||
162818372|NCT04201821|588048968|FG000|Overall Study|Withdrawal by Subject|2|||
162818373|NCT00651157|588048969|FG000|Overall Study|Death|1|||
162818374|NCT00651157|588048969|FG000|Overall Study|Protocol Violation|1|||
162818375|NCT01891721|588048971|FG000|Overall Study|Lost to Follow-up|10|||
162818376|NCT01891721|588048972|FG001|Overall Study|Lost to Follow-up|5|||
162818377|NCT01891721|588048973|FG002|Overall Study|Lost to Follow-up|1|||
162818378|NCT03829319|588048974|FG000|Overall Study|Sponsor's Decision|4|||
162818379|NCT03829319|588048975|FG001|Overall Study|Sponsor's Decision|90|||
162818380|NCT03829319|588048976|FG002|Overall Study|Sponsor's Decision|102|||
162818381|NCT03829319|588048974|FG000|Overall Study|Withdrawal by Subject|1|||
162818382|NCT03829319|588048975|FG001|Overall Study|Withdrawal by Subject|5|||
162818383|NCT03829319|588048976|FG002|Overall Study|Withdrawal by Subject|4|||
162818384|NCT03829319|588048974|FG000|Overall Study|Physician Decision|0|||
162818385|NCT03829319|588048975|FG001|Overall Study|Physician Decision|3|||
162818386|NCT03829319|588048976|FG002|Overall Study|Physician Decision|0|||
162818387|NCT03829319|588048974|FG000|Overall Study|Lost to Follow-up|0|||
162818388|NCT03829319|588048975|FG001|Overall Study|Lost to Follow-up|0|||
162818389|NCT03829319|588048976|FG002|Overall Study|Lost to Follow-up|1|||
162818390|NCT03829319|588048974|FG000|Overall Study|Death|8|||
163170173|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
163170174|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162698273|NCT01027364|587605451|FG003|Overall Study|Withdrawal by Subject|0|||
162818391|NCT03829319|588048975|FG001|Overall Study|Death|277|||
162818392|NCT03829319|588048976|FG002|Overall Study|Death|266|||
162818393|NCT04484259|588048977|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
162818394|NCT04484259|588048978|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
162818395|NCT04484259|588048979|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
162818396|NCT04484259|588048980|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
162818397|NCT04484259|588048981|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
162818398|NCT04484259|588048977|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
162818399|NCT04484259|588048978|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
162818400|NCT04484259|588048979|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
162818401|NCT04484259|588048980|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
162818402|NCT04484259|588048981|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163170175|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170176|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170177|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170178|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170179|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170180|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170181|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
163170182|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
163170183|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
163170184|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
163170185|NCT01185353|589338534|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170186|NCT01185353|589338535|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170187|NCT01185353|589338536|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170188|NCT01185353|589338537|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170189|NCT01185353|589338538|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170190|NCT01185353|589338539|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170191|NCT01185353|589338540|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170192|NCT01185353|589338541|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
163170193|NCT01185353|589338542|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
163170194|NCT01185353|589338543|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
163170195|NCT00334113|589338546|FG000|Overall Study|Lost to Follow-up|2|||
163170196|NCT00334113|589338547|FG001|Overall Study|Lost to Follow-up|2|||
163170197|NCT00334113|589338546|FG000|Overall Study|Withdrawal by Subject|0|||
163170198|NCT00334113|589338547|FG001|Overall Study|Withdrawal by Subject|1|||
163170199|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
162818403|NCT04484259|588048977|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
162818404|NCT04484259|588048978|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
162818405|NCT04484259|588048979|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
162818406|NCT04484259|588048980|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
162818407|NCT04484259|588048981|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
162818408|NCT04484259|588048977|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163170200|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
163170201|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
163170202|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
163170203|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Other|2|||
163170204|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
162818409|NCT04484259|588048978|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
162818410|NCT04484259|588048979|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
162818411|NCT04484259|588048980|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
162818412|NCT04484259|588048981|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
162818413|NCT04484259|588048977|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
162818414|NCT04484259|588048978|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
162818415|NCT04484259|588048979|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
162818416|NCT04484259|588048980|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
162818417|NCT04484259|588048981|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
162818418|NCT04484259|588048977|FG000|Randomized Treatment|Withdrawal by Subject|1|||
162818419|NCT04484259|588048978|FG001|Randomized Treatment|Withdrawal by Subject|0|||
162818420|NCT04484259|588048979|FG002|Randomized Treatment|Withdrawal by Subject|0|||
162818421|NCT04484259|588048980|FG003|Randomized Treatment|Withdrawal by Subject|0|||
162818422|NCT04484259|588048981|FG004|Randomized Treatment|Withdrawal by Subject|0|||
162818423|NCT04498832|588048982|FG000|Overall Study|Adverse Event|1|||
162818424|NCT04498832|588048983|FG001|Overall Study|Adverse Event|3|||
163170205|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
163170206|NCT02509026|589338550|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
163170207|NCT02509026|589338550|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
163170208|NCT02509026|589338550|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
163170209|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
163170210|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
163170211|NCT02509026|589338550|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
163170212|NCT01165216|589338551|FG000|Overall Study|Adverse Event|6|||
163170213|NCT01165216|589338552|FG001|Overall Study|Adverse Event|3|||
163170214|NCT01165216|589338551|FG000|Overall Study|Withdrawal by Subject|1|||
163170215|NCT01165216|589338552|FG001|Overall Study|Withdrawal by Subject|1|||
163170216|NCT01165216|589338551|FG000|Overall Study|Disease progression|1|||
163170217|NCT01165216|589338552|FG001|Overall Study|Disease progression|3|||
163170218|NCT00243841|589338556|FG000|Overall Study|Physician Decision|0|||
163170219|NCT00243841|589338557|FG001|Overall Study|Physician Decision|0|||
163170220|NCT00243841|589338558|FG002|Overall Study|Physician Decision|1|||
163170221|NCT00243841|589338559|FG003|Overall Study|Physician Decision|0|||
163170222|NCT00243841|589338560|FG004|Overall Study|Physician Decision|0|||
162818425|NCT04498832|588048982|FG000|Overall Study|Withdrawal by Subject|0|||
162818426|NCT04498832|588048983|FG001|Overall Study|Withdrawal by Subject|1|||
162818427|NCT01313650|588048985|FG000|Overall Study|Adverse Event|9|||
162818428|NCT01313650|588048986|FG001|Overall Study|Adverse Event|34|||
162818429|NCT01313650|588048987|FG002|Overall Study|Adverse Event|24|||
162818430|NCT01313650|588048988|FG003|Overall Study|Adverse Event|23|||
162818431|NCT01313650|588048985|FG000|Overall Study|Lack of Efficacy|37|||
162818432|NCT01313650|588048986|FG001|Overall Study|Lack of Efficacy|20|||
162818433|NCT01313650|588048987|FG002|Overall Study|Lack of Efficacy|32|||
162818434|NCT01313650|588048988|FG003|Overall Study|Lack of Efficacy|20|||
162818435|NCT01313650|588048985|FG000|Overall Study|Lost to Follow-up|1|||
162818436|NCT01313650|588048986|FG001|Overall Study|Lost to Follow-up|0|||
162818437|NCT01313650|588048987|FG002|Overall Study|Lost to Follow-up|3|||
162818438|NCT01313650|588048988|FG003|Overall Study|Lost to Follow-up|2|||
162818439|NCT01313650|588048985|FG000|Overall Study|Withdrawal by Subject|16|||
162818440|NCT01313650|588048986|FG001|Overall Study|Withdrawal by Subject|20|||
162818441|NCT01313650|588048987|FG002|Overall Study|Withdrawal by Subject|15|||
162818442|NCT01313650|588048988|FG003|Overall Study|Withdrawal by Subject|15|||
162818443|NCT01313650|588048985|FG000|Overall Study|Protocol Violation|4|||
162818444|NCT01313650|588048986|FG001|Overall Study|Protocol Violation|7|||
162818445|NCT01313650|588048987|FG002|Overall Study|Protocol Violation|5|||
162818446|NCT01313650|588048988|FG003|Overall Study|Protocol Violation|6|||
162818447|NCT01313650|588048985|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
162818448|NCT01313650|588048986|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
162818449|NCT01313650|588048987|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
162818450|NCT01313650|588048988|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
162818451|NCT04029480|588048989|FG000|Overall Study|Physician Decision|0|||
162818452|NCT04029480|588048990|FG001|Overall Study|Physician Decision|0|||
162818453|NCT04029480|588048991|FG002|Overall Study|Physician Decision|2|||
162818454|NCT04029480|588048992|FG003|Overall Study|Physician Decision|1|||
162818455|NCT04029480|588048989|FG000|Overall Study|Withdrawal by Subject|2|||
162818456|NCT04029480|588048990|FG001|Overall Study|Withdrawal by Subject|0|||
162818457|NCT04029480|588048991|FG002|Overall Study|Withdrawal by Subject|1|||
162818458|NCT04029480|588048992|FG003|Overall Study|Withdrawal by Subject|1|||
162818459|NCT02593786|588048993|FG000|Overall Study|Disease progression|12|||
162818460|NCT02593786|588048994|FG001|Overall Study|Disease progression|16|||
162818461|NCT02593786|588048995|FG002|Overall Study|Disease progression|10|||
162818462|NCT02593786|588048996|FG003|Overall Study|Disease progression|7|||
162818463|NCT02593786|588048993|FG000|Overall Study|Study drug toxicity|1|||
162818464|NCT02593786|588048994|FG001|Overall Study|Study drug toxicity|0|||
162818465|NCT02593786|588048995|FG002|Overall Study|Study drug toxicity|0|||
162818466|NCT02593786|588048996|FG003|Overall Study|Study drug toxicity|0|||
162818467|NCT02593786|588048993|FG000|Overall Study|Adverse event unrelated to study drug|1|||
162818468|NCT02593786|588048994|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162818469|NCT02593786|588048995|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162818470|NCT02593786|588048996|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162818471|NCT02593786|588048993|FG000|Overall Study|Participant request to discontinue study therapy|0|||
162818472|NCT02593786|588048994|FG001|Overall Study|Participant request to discontinue study therapy|2|||
162818473|NCT02593786|588048995|FG002|Overall Study|Participant request to discontinue study therapy|0|||
162818474|NCT02593786|588048996|FG003|Overall Study|Participant request to discontinue study therapy|0|||
162818475|NCT02593786|588048993|FG000|Overall Study|Other reasons|1|||
162818476|NCT02593786|588048994|FG001|Overall Study|Other reasons|1|||
162818477|NCT02593786|588048995|FG002|Overall Study|Other reasons|0|||
162818478|NCT02593786|588048996|FG003|Overall Study|Other reasons|5|||
162818479|NCT01839487|588048997|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
162818480|NCT01839487|588048998|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
162818481|NCT01839487|588048999|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
162818482|NCT01839487|588049000|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
162818483|NCT01839487|588049001|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
162818484|NCT01839487|588049002|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
162818485|NCT01839487|588048997|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
162818486|NCT01839487|588048998|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
162818487|NCT01839487|588048999|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
162818488|NCT01839487|588049000|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
162818489|NCT01839487|588049001|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
162818490|NCT01839487|588049002|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
162818491|NCT01839487|588048997|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
162818492|NCT01839487|588048998|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
162818493|NCT01839487|588048999|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
162818494|NCT01839487|588049000|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
162818495|NCT01839487|588049001|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
162818496|NCT01839487|588049002|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
162818497|NCT01839487|588048997|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
162818498|NCT01839487|588048998|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
162818499|NCT01839487|588048999|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
162818500|NCT01839487|588049000|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
162818501|NCT01839487|588049001|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
162818502|NCT01839487|588049002|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
162818503|NCT01839487|588048997|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
162818504|NCT01839487|588048998|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
162818505|NCT01839487|588048999|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
162818506|NCT01839487|588049000|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
162818507|NCT01839487|588049001|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
162818508|NCT01839487|588049002|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
162818509|NCT01839487|588048997|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
162818510|NCT01839487|588048998|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
162818511|NCT01839487|588048999|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
162818512|NCT01839487|588049000|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
162818513|NCT01839487|588049001|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
162818514|NCT01839487|588049002|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
163170223|NCT00243841|589338561|FG005|Overall Study|Physician Decision|2|||
163170224|NCT00363545|589338562|FG000|Overall Study|Serious Adverse Event|0|||
162818515|NCT01839487|588048997|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
162818516|NCT01839487|588048998|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
162818517|NCT01839487|588048999|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
162818518|NCT01839487|588049000|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
162818519|NCT01839487|588049001|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
162818520|NCT01839487|588049002|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
162818521|NCT01839487|588048997|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
162818522|NCT01839487|588048998|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
162818523|NCT01839487|588048999|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
162818524|NCT01839487|588049000|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
162818525|NCT01839487|588049001|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
162818526|NCT01839487|588049002|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
162818527|NCT01839487|588048997|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
162818528|NCT01839487|588048998|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
162818529|NCT01839487|588048999|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
162818530|NCT01839487|588049000|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
162818531|NCT01839487|588049001|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
162818532|NCT01839487|588049002|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
162818533|NCT01658826|588049006|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
162818534|NCT01658826|588049007|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
162818535|NCT01658826|588049006|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
162818536|NCT01658826|588049007|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
162818537|NCT01658826|588049006|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
162818538|NCT01658826|588049007|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
162818539|NCT01658826|588049006|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
162818540|NCT01658826|588049007|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
162818541|NCT01658826|588049006|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
163170225|NCT00363545|589338563|FG001|Overall Study|Serious Adverse Event|1|||
162818542|NCT01658826|588049007|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
162818543|NCT01658826|588049006|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
162818544|NCT01658826|588049007|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
162818545|NCT01658826|588049006|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
162818546|NCT01658826|588049007|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
162818547|NCT01658826|588049006|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
162818548|NCT01658826|588049007|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
162818549|NCT01658826|588049006|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
162818550|NCT01658826|588049007|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
162818551|NCT01019980|588049011|FG000|Overall Study|Drug not available.|2|||
162818552|NCT01019980|588049012|FG001|Overall Study|Drug not available.|0|||
163170226|NCT00363545|589338562|FG000|Overall Study|Withdrawal by Subject|12|||
163170227|NCT00363545|589338563|FG001|Overall Study|Withdrawal by Subject|15|||
163170228|NCT00363545|589338562|FG000|Overall Study|Migrated/moved from study area|3|||
163170229|NCT00363545|589338563|FG001|Overall Study|Migrated/moved from study area|6|||
163170230|NCT00363545|589338562|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
162818553|NCT02038920|588049022|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
162818554|NCT02038920|588049023|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
162818555|NCT02038920|588049024|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
162818556|NCT02038920|588049025|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
162818557|NCT02038920|588049026|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
162818558|NCT02038920|588049027|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
162818559|NCT02038920|588049022|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
162818560|NCT02038920|588049023|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
162818561|NCT02038920|588049024|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
162818562|NCT02038920|588049025|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
162818563|NCT02038920|588049026|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
162818564|NCT02038920|588049027|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
162818565|NCT02038920|588049022|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
162818566|NCT02038920|588049023|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
162818567|NCT02038920|588049024|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
162818568|NCT02038920|588049025|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
162818569|NCT02038920|588049026|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
162818570|NCT02038920|588049027|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
162818571|NCT02038920|588049022|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
162818572|NCT02038920|588049023|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
162818573|NCT02038920|588049024|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
162818574|NCT02038920|588049025|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
162818575|NCT02038920|588049026|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
162818576|NCT02038920|588049027|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
162818577|NCT02038920|588049022|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
162818578|NCT02038920|588049023|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
162818579|NCT02038920|588049024|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
162818580|NCT02038920|588049025|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
162818581|NCT02038920|588049026|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
162818582|NCT02038920|588049027|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
162818583|NCT02038920|588049022|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
162818584|NCT02038920|588049023|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
162818585|NCT02038920|588049024|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
162818586|NCT02038920|588049025|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
162818587|NCT02038920|588049026|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
162818588|NCT02038920|588049027|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
162818589|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163170231|NCT00363545|589338563|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
163170232|NCT00363545|589338562|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
163170233|NCT00363545|589338563|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
163170234|NCT00363545|589338562|FG000|Overall Study|Others|1|||
163170235|NCT00363545|589338563|FG001|Overall Study|Others|0|||
163170236|NCT04303195|589338564|FG000|Overall Study|Adverse Event|1|||
163170237|NCT04303195|589338565|FG001|Overall Study|Adverse Event|3|||
163170238|NCT04303195|589338566|FG002|Overall Study|Adverse Event|7|||
162818590|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
162818591|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
162818592|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
162818593|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
162818594|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
162818595|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
162818596|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
162818597|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
162818598|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
162818599|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
162818600|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
162818601|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162818602|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162818603|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162818604|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162818605|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162818606|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
162818607|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163170239|NCT04303195|589338567|FG003|Overall Study|Adverse Event|0|||
163170240|NCT04303195|589338564|FG000|Overall Study|Lost to Follow-up|1|||
163170241|NCT04303195|589338565|FG001|Overall Study|Lost to Follow-up|0|||
162818608|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
162818609|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
162818610|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163170242|NCT04303195|589338566|FG002|Overall Study|Lost to Follow-up|1|||
163170243|NCT04303195|589338567|FG003|Overall Study|Lost to Follow-up|4|||
163170244|NCT04303195|589338564|FG000|Overall Study|Withdrawal by Subject|3|||
163170245|NCT04303195|589338565|FG001|Overall Study|Withdrawal by Subject|1|||
163170246|NCT04303195|589338566|FG002|Overall Study|Withdrawal by Subject|1|||
163170247|NCT04303195|589338567|FG003|Overall Study|Withdrawal by Subject|1|||
162818611|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
162818612|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
162818613|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
162818614|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
162818615|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
162818616|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
162818617|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
162818618|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
162818619|NCT02038920|588049022|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162818620|NCT02038920|588049023|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162818621|NCT02038920|588049024|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162818622|NCT02038920|588049025|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162818623|NCT02038920|588049026|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
162818624|NCT02038920|588049027|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
162818625|NCT00866697|588049028|FG000|Overall Study|Study closed/terminated|156|||
162818626|NCT00866697|588049029|FG001|Overall Study|Study closed/terminated|138|||
162818627|NCT00866697|588049028|FG000|Overall Study|Lost to Follow-up|22|||
162818628|NCT00866697|588049029|FG001|Overall Study|Lost to Follow-up|28|||
162818629|NCT00866697|588049028|FG000|Overall Study|Physician Decision|3|||
162818630|NCT00866697|588049029|FG001|Overall Study|Physician Decision|5|||
162818631|NCT00866697|588049028|FG000|Overall Study|Withdrawal by Subject|33|||
162818632|NCT00866697|588049029|FG001|Overall Study|Withdrawal by Subject|57|||
162818633|NCT02906787|588049032|FG000|Overall Study|Withdrawal by Subject|12|||
162818634|NCT02906787|588049033|FG001|Overall Study|Withdrawal by Subject|10|||
162818635|NCT02906787|588049032|FG000|Overall Study|Missed|24|||
162818636|NCT02906787|588049033|FG001|Overall Study|Missed|22|||
162818637|NCT03901053|588049038|FG000|Overall Study|Lost to Follow-up|6|||
162818638|NCT03901053|588049039|FG001|Overall Study|Lost to Follow-up|2|||
162818639|NCT03901053|588049038|FG000|Overall Study|Withdrawal by Subject|4|||
162818640|NCT03901053|588049039|FG001|Overall Study|Withdrawal by Subject|3|||
162818641|NCT03901053|588049038|FG000|Overall Study|Unsatisfactory Device|1|||
163170248|NCT04303195|589338564|FG000|Overall Study|No study drug administered or protocol deviation|0|||
163170249|NCT04303195|589338565|FG001|Overall Study|No study drug administered or protocol deviation|2|||
163170250|NCT04303195|589338566|FG002|Overall Study|No study drug administered or protocol deviation|0|||
163170251|NCT04303195|589338567|FG003|Overall Study|No study drug administered or protocol deviation|2|||
163170252|NCT01601652|589338571|FG000|Overall Study|Death|1|||
163170253|NCT01808092|589338572|FG000|Overall Study|Death|39|||
163170254|NCT01808092|589338573|FG001|Overall Study|Death|29|||
163170255|NCT01808092|589338572|FG000|Overall Study|Lost to Follow-up|3|||
163170256|NCT01808092|589338573|FG001|Overall Study|Lost to Follow-up|7|||
163170257|NCT01808092|589338572|FG000|Overall Study|Withdrawal by Subject|9|||
163170258|NCT01808092|589338573|FG001|Overall Study|Withdrawal by Subject|4|||
162818642|NCT03901053|588049039|FG001|Overall Study|Unsatisfactory Device|2|||
162818643|NCT03901053|588049038|FG000|Overall Study|No longer meets study criteria|1|||
162818644|NCT03901053|588049039|FG001|Overall Study|No longer meets study criteria|3|||
162818645|NCT03901053|588049038|FG000|Overall Study|Subject's Medical Status|0|||
162818646|NCT03901053|588049039|FG001|Overall Study|Subject's Medical Status|1|||
162818647|NCT03901053|588049038|FG000|Overall Study|Screening Failure|1|||
162818648|NCT03901053|588049039|FG001|Overall Study|Screening Failure|0|||
162818649|NCT02408861|588049040|FG000|Overall Study|Death|0|||
162818650|NCT02408861|588049041|FG001|Overall Study|Death|3|||
162818651|NCT02408861|588049042|FG002|Overall Study|Death|1|||
162818652|NCT02408861|588049043|FG003|Overall Study|Death|2|||
162818653|NCT02408861|588049044|FG004|Overall Study|Death|4|||
162818654|NCT02408861|588049045|FG005|Overall Study|Death|1|||
162818655|NCT02408861|588049046|FG006|Overall Study|Death|0|||
162818656|NCT02408861|588049040|FG000|Overall Study|Lost to Follow-up|0|||
163170259|NCT01808092|589338572|FG000|Overall Study|Other Eligibility criteria|3|||
163170260|NCT01808092|589338573|FG001|Overall Study|Other Eligibility criteria|5|||
163170261|NCT01097005|589338579|FG000|Overall Study|Case Report Form not collected|18|||
163170262|NCT01097005|589338579|FG000|Overall Study|Subjects cannot visit the hospital|1|||
163170263|NCT01097005|589338579|FG000|Overall Study|Poor medication compliance|1|||
163170264|NCT01097005|589338579|FG000|Overall Study|No examination data available|244|||
162818657|NCT02408861|588049041|FG001|Overall Study|Lost to Follow-up|0|||
162818658|NCT02408861|588049042|FG002|Overall Study|Lost to Follow-up|1|||
163170265|NCT01097005|589338579|FG000|Overall Study|Deviation from exclusion criteria|37|||
163170266|NCT01097005|589338579|FG000|Overall Study|Adverse Event|14|||
163170267|NCT01097005|589338579|FG000|Overall Study|Discontinuance by complication|50|||
163170268|NCT03425253|589338585|FG000|Overall Study|Adverse Event|2|||
163170269|NCT03425253|589338585|FG000|Overall Study|Lost to Follow-up|3|||
163170270|NCT03425253|589338585|FG000|Overall Study|Withdrew Consent|6|||
163170271|NCT03425253|589338585|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
163170272|NCT04614324|589338588|FG000|Overall Study|Lost to Follow-up|3|||
163170273|NCT04614324|589338588|FG000|Overall Study|Physician Decision|1|||
163170274|NCT04614324|589338588|FG000|Overall Study|Withdrawal by Subject|2|||
163170275|NCT04614324|589338588|FG000|Overall Study|Remaining in Follow up|123|||
163170276|NCT04174365|589338591|FG000|Overall Study|Lost to Follow-up|1|||
163170277|NCT04174365|589338592|FG001|Overall Study|Lost to Follow-up|2|||
163170278|NCT04174365|589338591|FG000|Overall Study|Adverse Event|2|||
163170279|NCT04174365|589338592|FG001|Overall Study|Adverse Event|1|||
163170280|NCT04174365|589338591|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
163170281|NCT04174365|589338592|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
163170282|NCT04174365|589338591|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
163170283|NCT04174365|589338592|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
163170284|NCT04174365|589338591|FG000|Overall Study|Protocol Deviation|1|||
163170285|NCT04174365|589338592|FG001|Overall Study|Protocol Deviation|0|||
162818659|NCT02408861|588049043|FG003|Overall Study|Lost to Follow-up|1|||
162818660|NCT02408861|588049044|FG004|Overall Study|Lost to Follow-up|4|||
162818661|NCT02408861|588049045|FG005|Overall Study|Lost to Follow-up|2|||
162818662|NCT02408861|588049046|FG006|Overall Study|Lost to Follow-up|1|||
162818663|NCT02408861|588049040|FG000|Overall Study|Disease Progression|0|||
162818664|NCT02408861|588049041|FG001|Overall Study|Disease Progression|0|||
162818665|NCT02408861|588049042|FG002|Overall Study|Disease Progression|1|||
162818666|NCT02408861|588049043|FG003|Overall Study|Disease Progression|0|||
162818667|NCT02408861|588049044|FG004|Overall Study|Disease Progression|3|||
162818668|NCT02408861|588049045|FG005|Overall Study|Disease Progression|1|||
162818669|NCT02408861|588049046|FG006|Overall Study|Disease Progression|1|||
162818670|NCT02408861|588049040|FG000|Overall Study|Adverse Event|1|||
162818671|NCT02408861|588049041|FG001|Overall Study|Adverse Event|0|||
162818672|NCT02408861|588049042|FG002|Overall Study|Adverse Event|1|||
162818673|NCT02408861|588049043|FG003|Overall Study|Adverse Event|0|||
162818674|NCT02408861|588049044|FG004|Overall Study|Adverse Event|2|||
162818675|NCT02408861|588049045|FG005|Overall Study|Adverse Event|0|||
162818676|NCT02408861|588049046|FG006|Overall Study|Adverse Event|0|||
162818677|NCT02408861|588049040|FG000|Overall Study|Physician Decision|1|||
162818678|NCT02408861|588049041|FG001|Overall Study|Physician Decision|1|||
162818679|NCT02408861|588049042|FG002|Overall Study|Physician Decision|1|||
162818680|NCT02408861|588049043|FG003|Overall Study|Physician Decision|0|||
162818681|NCT02408861|588049044|FG004|Overall Study|Physician Decision|0|||
162818682|NCT02408861|588049045|FG005|Overall Study|Physician Decision|1|||
162818683|NCT02408861|588049046|FG006|Overall Study|Physician Decision|0|||
162818684|NCT02408861|588049040|FG000|Overall Study|Protocol Violation|1|||
162818685|NCT02408861|588049041|FG001|Overall Study|Protocol Violation|0|||
162818686|NCT02408861|588049042|FG002|Overall Study|Protocol Violation|0|||
162818687|NCT02408861|588049043|FG003|Overall Study|Protocol Violation|0|||
162818688|NCT02408861|588049044|FG004|Overall Study|Protocol Violation|0|||
162818689|NCT02408861|588049045|FG005|Overall Study|Protocol Violation|0|||
162818690|NCT02408861|588049046|FG006|Overall Study|Protocol Violation|0|||
162818691|NCT02408861|588049040|FG000|Overall Study|Withdrawal by Subject|0|||
162818692|NCT02408861|588049041|FG001|Overall Study|Withdrawal by Subject|0|||
162818693|NCT02408861|588049042|FG002|Overall Study|Withdrawal by Subject|0|||
162818694|NCT02408861|588049043|FG003|Overall Study|Withdrawal by Subject|0|||
162818695|NCT02408861|588049044|FG004|Overall Study|Withdrawal by Subject|1|||
163170286|NCT04174365|589338591|FG000|Overall Study|Lack of Efficacy|0|||
163170287|NCT04174365|589338592|FG001|Overall Study|Lack of Efficacy|2|||
162818696|NCT02408861|588049045|FG005|Overall Study|Withdrawal by Subject|1|||
162818697|NCT02408861|588049046|FG006|Overall Study|Withdrawal by Subject|0|||
162818698|NCT02408861|588049040|FG000|Overall Study|Other Treatment|0|||
162818699|NCT02408861|588049041|FG001|Overall Study|Other Treatment|0|||
162818700|NCT02408861|588049042|FG002|Overall Study|Other Treatment|0|||
162818701|NCT02408861|588049043|FG003|Overall Study|Other Treatment|0|||
162818702|NCT02408861|588049044|FG004|Overall Study|Other Treatment|0|||
162818703|NCT02408861|588049045|FG005|Overall Study|Other Treatment|1|||
162818704|NCT02408861|588049046|FG006|Overall Study|Other Treatment|1|||
162818705|NCT04752475|588050586|FG000|Overall Study|Withdrawal by Subject|1|||
162818706|NCT04752475|588050587|FG001|Overall Study|Withdrawal by Subject|1|||
162818707|NCT01310803|588050593|FG000|Overall Study|Subject terminated by Sponsor|1|||
162818708|NCT01310803|588050594|FG001|Overall Study|Subject terminated by Sponsor|0|||
162818709|NCT02113579|588050597|FG000|Overall Study|Adverse Event|1|||
162818710|NCT02113579|588050598|FG001|Overall Study|Adverse Event|0|||
162818711|NCT02113579|588050597|FG000|Overall Study|Withdrawal by Subject|3|||
162818712|NCT02113579|588050598|FG001|Overall Study|Withdrawal by Subject|2|||
162818713|NCT02113579|588050597|FG000|Overall Study|Lost to Follow-up|6|||
162818714|NCT02113579|588050598|FG001|Overall Study|Lost to Follow-up|2|||
162818715|NCT03047551|588050599|FG000|Overall Study|Did not receive TAS|1|||
162818716|NCT03047551|588050600|FG001|Overall Study|Did not receive TAS|0|||
162818717|NCT03047551|588050599|FG000|Overall Study|Physician Decision|1|||
162818718|NCT03047551|588050600|FG001|Overall Study|Physician Decision|0|||
162818719|NCT03047551|588050599|FG000|Overall Study|Withdrawal by Subject|0|||
162818720|NCT03047551|588050600|FG001|Overall Study|Withdrawal by Subject|1|||
162818721|NCT03047551|588050599|FG000|Overall Study|Probe malfunction|0|||
162818722|NCT03047551|588050600|FG001|Overall Study|Probe malfunction|1|||
162818723|NCT03047551|588050599|FG000|Overall Study|Ineligible|0|||
162818724|NCT03047551|588050600|FG001|Overall Study|Ineligible|1|||
162818725|NCT00726622|588050601|FG000|Overall Study|Withdrawal by Subject|16|||
162818726|NCT00726622|588050602|FG001|Overall Study|Withdrawal by Subject|2|||
162818727|NCT00726622|588050601|FG000|Overall Study|Physician Decision|0|||
162818728|NCT00726622|588050602|FG001|Overall Study|Physician Decision|1|||
162818729|NCT00726622|588050601|FG000|Overall Study|Metastasis|2|||
162818730|NCT00726622|588050602|FG001|Overall Study|Metastasis|0|||
162818731|NCT02462928|588050604|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162818732|NCT02462928|588050605|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162818733|NCT02462928|588050606|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
162818734|NCT02462928|588050604|FG000|Overall Study|Adverse Event|47|||
162818735|NCT02462928|588050605|FG001|Overall Study|Adverse Event|51|||
162818736|NCT02462928|588050606|FG002|Overall Study|Adverse Event|25|||
162818737|NCT02462928|588050604|FG000|Overall Study|Lack of Efficacy|3|||
162818738|NCT02462928|588050605|FG001|Overall Study|Lack of Efficacy|8|||
162818739|NCT02462928|588050606|FG002|Overall Study|Lack of Efficacy|3|||
162818740|NCT02462928|588050604|FG000|Overall Study|Lost to Follow-up|4|||
162818741|NCT02462928|588050605|FG001|Overall Study|Lost to Follow-up|4|||
162818742|NCT02462928|588050606|FG002|Overall Study|Lost to Follow-up|1|||
162818743|NCT02462928|588050604|FG000|Overall Study|Withdrawal by Patient|31|||
162818744|NCT02462928|588050605|FG001|Overall Study|Withdrawal by Patient|21|||
162818745|NCT02462928|588050606|FG002|Overall Study|Withdrawal by Patient|21|||
162818746|NCT02462928|588050604|FG000|Overall Study|Protocol Violation|0|||
162818747|NCT02462928|588050605|FG001|Overall Study|Protocol Violation|1|||
162818748|NCT02462928|588050606|FG002|Overall Study|Protocol Violation|0|||
162818749|NCT02462928|588050604|FG000|Overall Study|Reason not Specified|4|||
162818750|NCT02462928|588050605|FG001|Overall Study|Reason not Specified|6|||
162818751|NCT02462928|588050606|FG002|Overall Study|Reason not Specified|5|||
162818752|NCT00395863|588050607|FG000|Overall Study|Patients did not complete both exams|2|||
162818753|NCT00395863|588050608|FG001|Overall Study|Patients did not complete both exams|3|||
162818754|NCT01940354|588050609|FG000|Overall Study|Withdrawal by Subject|4|||
162818755|NCT01940354|588050610|FG001|Overall Study|Withdrawal by Subject|2|||
162818756|NCT02020863|588050611|FG000|Overall Study|Discovery of Metastatic disease|4|||
162818757|NCT02020863|588050611|FG000|Overall Study|Team chose not to place an a line|1|||
162818758|NCT03873493|588050612|FG000|Overall Study|Withdrawal by Subject|1|||
162818759|NCT03873493|588050612|FG000|Overall Study|Death|9|||
162818760|NCT03873493|588050612|FG000|Overall Study|Lost to Follow-up|1|||
162818761|NCT03873493|588050612|FG000|Overall Study|Study Terminated by Sponsor|1|||
162818762|NCT03873493|588050612|FG000|Overall Study|Other|2|||
162818763|NCT00909792|588050619|FG000|Period 1|Did not meet inclusion criteria|0|||
162818764|NCT00909792|588050620|FG001|Period 1|Did not meet inclusion criteria|1|||
162818765|NCT00909792|588050619|FG000|Period 2|Biomicroscopy|1|||
162818766|NCT00909792|588050620|FG001|Period 2|Biomicroscopy|0|||
162818767|NCT00909792|588050619|FG000|Period 2|Lost to Follow-up|0|||
162818768|NCT00909792|588050620|FG001|Period 2|Lost to Follow-up|1|||
162818769|NCT01448213|588050621|FG000|Overall Study|Lost to Follow-up|12|||
162818770|NCT01448213|588050622|FG001|Overall Study|Lost to Follow-up|10|||
162818771|NCT01448213|588050621|FG000|Overall Study|Adverse Event|4|||
162818772|NCT01448213|588050622|FG001|Overall Study|Adverse Event|10|||
162818773|NCT01448213|588050621|FG000|Overall Study|Protocol Violation|1|||
162818774|NCT01448213|588050622|FG001|Overall Study|Protocol Violation|2|||
162818775|NCT03503513|588050627|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
162818776|NCT03503513|588050627|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
162818777|NCT03503513|588050627|FG000|Overall Study|Physician Decision|3|||
162818778|NCT03503513|588050627|FG000|Overall Study|Withdrawal by Subject|2|||
162818779|NCT03503513|588050627|FG000|Overall Study|Lost to Follow-up|1|||
162818780|NCT01170039|588050628|FG000|Overall Study|Withdrawal by Subject|5|||
162818781|NCT01170039|588050629|FG001|Overall Study|Withdrawal by Subject|3|||
162818782|NCT01170039|588050628|FG000|Overall Study|Lack of funding, drug not available|3|||
162818783|NCT01170039|588050629|FG001|Overall Study|Lack of funding, drug not available|3|||
162818784|NCT03308942|588050630|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
162818785|NCT03308942|588050631|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
162818786|NCT03308942|588050632|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
162818787|NCT03308942|588050633|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
162818788|NCT03308942|588050634|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
162818789|NCT03308942|588050630|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
162818790|NCT03308942|588050631|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
162818791|NCT03308942|588050632|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
162818792|NCT03308942|588050633|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
162818793|NCT03308942|588050634|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
162818794|NCT03308942|588050630|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
162818795|NCT03308942|588050631|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
162818796|NCT03308942|588050632|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
162818797|NCT03308942|588050633|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
162818798|NCT03308942|588050634|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
162818799|NCT03308942|588050630|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
162818800|NCT03308942|588050631|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
162818801|NCT03308942|588050632|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
162818802|NCT03308942|588050633|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
162818803|NCT03308942|588050634|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
162818804|NCT03308942|588050630|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
162818805|NCT03308942|588050631|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
162818806|NCT03308942|588050632|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
162818807|NCT03308942|588050633|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
162818808|NCT03308942|588050634|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
162818809|NCT03308942|588050630|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
162818810|NCT03308942|588050631|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
162818811|NCT03308942|588050632|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
162818812|NCT03308942|588050633|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
162818813|NCT03308942|588050634|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
162818814|NCT03308942|588050630|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
162818815|NCT03308942|588050631|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
162818816|NCT03308942|588050632|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
162818817|NCT03308942|588050633|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
162818818|NCT03308942|588050634|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
162818819|NCT01205438|588050635|FG000|Overall Study|Adverse Event|19|||
162818820|NCT01205438|588050636|FG001|Overall Study|Adverse Event|17|||
162818821|NCT01205438|588050637|FG002|Overall Study|Adverse Event|24|||
162818822|NCT01205438|588050635|FG000|Overall Study|Death|1|||
162818823|NCT01205438|588050636|FG001|Overall Study|Death|1|||
162818824|NCT01205438|588050637|FG002|Overall Study|Death|3|||
162818825|NCT01205438|588050635|FG000|Overall Study|Entry Criteria Not Met|16|||
162818826|NCT01205438|588050636|FG001|Overall Study|Entry Criteria Not Met|15|||
162818827|NCT01205438|588050637|FG002|Overall Study|Entry Criteria Not Met|13|||
162818828|NCT01205438|588050635|FG000|Overall Study|Lack of Efficacy|14|||
162818829|NCT01205438|588050636|FG001|Overall Study|Lack of Efficacy|11|||
162818830|NCT01205438|588050637|FG002|Overall Study|Lack of Efficacy|14|||
162818831|NCT01205438|588050635|FG000|Overall Study|Lost to Follow-up|6|||
162818832|NCT01205438|588050636|FG001|Overall Study|Lost to Follow-up|7|||
162818833|NCT01205438|588050637|FG002|Overall Study|Lost to Follow-up|8|||
162818834|NCT01205438|588050635|FG000|Overall Study|Withdrawal by Subject|19|||
162818835|NCT01205438|588050636|FG001|Overall Study|Withdrawal by Subject|25|||
162818836|NCT01205438|588050637|FG002|Overall Study|Withdrawal by Subject|19|||
162818837|NCT01205438|588050635|FG000|Overall Study|Physician Decision|0|||
162818838|NCT01205438|588050636|FG001|Overall Study|Physician Decision|3|||
162818839|NCT01205438|588050637|FG002|Overall Study|Physician Decision|2|||
162818840|NCT01205438|588050635|FG000|Overall Study|Protocol Violation|2|||
162818841|NCT01205438|588050636|FG001|Overall Study|Protocol Violation|7|||
162818842|NCT01205438|588050637|FG002|Overall Study|Protocol Violation|4|||
162818843|NCT01205438|588050635|FG000|Overall Study|Sponsor Decision|0|||
162818844|NCT01205438|588050636|FG001|Overall Study|Sponsor Decision|1|||
162818845|NCT01205438|588050637|FG002|Overall Study|Sponsor Decision|1|||
162818846|NCT00733304|588050641|FG000|Overall Study|Adverse Event|3|||
162818847|NCT00733304|588050642|FG001|Overall Study|Adverse Event|0|||
162818848|NCT00733304|588050643|FG002|Overall Study|Adverse Event|0|||
162818849|NCT00733304|588050641|FG000|Overall Study|Lack of Efficacy|0|||
162818850|NCT00733304|588050642|FG001|Overall Study|Lack of Efficacy|0|||
162818851|NCT00733304|588050643|FG002|Overall Study|Lack of Efficacy|2|||
162818852|NCT00733304|588050641|FG000|Overall Study|Lost to Follow-up|0|||
162818853|NCT00733304|588050642|FG001|Overall Study|Lost to Follow-up|1|||
162818854|NCT00733304|588050643|FG002|Overall Study|Lost to Follow-up|0|||
162818855|NCT00733304|588050641|FG000|Overall Study|Physician Decision|3|||
162818856|NCT00733304|588050642|FG001|Overall Study|Physician Decision|1|||
162818857|NCT00733304|588050643|FG002|Overall Study|Physician Decision|3|||
162818858|NCT00733304|588050641|FG000|Overall Study|Withdrawal by Subject|1|||
162818859|NCT00733304|588050642|FG001|Overall Study|Withdrawal by Subject|1|||
162818860|NCT00733304|588050643|FG002|Overall Study|Withdrawal by Subject|0|||
162818861|NCT00528567|588050644|FG000|Overall Study|Death|4|||
162818862|NCT00528567|588050645|FG001|Overall Study|Death|5|||
162818863|NCT00528567|588050644|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
162818864|NCT00528567|588050645|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
162818865|NCT00528567|588050644|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
162818866|NCT00528567|588050645|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
162818867|NCT00528567|588050644|FG000|Overall Study|Violation Criteria at Entry|3|||
162818868|NCT00528567|588050645|FG001|Overall Study|Violation Criteria at Entry|17|||
162818869|NCT00528567|588050644|FG000|Overall Study|Withdrew Consent|59|||
162818870|NCT00528567|588050645|FG001|Overall Study|Withdrew Consent|55|||
162818871|NCT00528567|588050644|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
162818872|NCT00528567|588050645|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
162818873|NCT00528567|588050644|FG000|Overall Study|Failure to Return|1|||
162818874|NCT00528567|588050645|FG001|Overall Study|Failure to Return|4|||
162818875|NCT00528567|588050644|FG000|Overall Study|Other Protocol Violation|5|||
162818876|NCT00528567|588050645|FG001|Overall Study|Other Protocol Violation|21|||
162818877|NCT00528567|588050644|FG000|Overall Study|Administrative/Other|22|||
162818878|NCT00528567|588050645|FG001|Overall Study|Administrative/Other|75|||
162818879|NCT01122576|588050648|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
162818880|NCT01122576|588050649|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
162818881|NCT01122576|588050650|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
162818882|NCT01122576|588050648|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
163170288|NCT04174365|589338591|FG000|Overall Study|Disease Relapse|1|||
163170289|NCT04174365|589338592|FG001|Overall Study|Disease Relapse|0|||
162818883|NCT01122576|588050649|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
162818884|NCT01122576|588050650|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
162818885|NCT01122576|588050648|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
162818886|NCT01122576|588050649|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
162818887|NCT01122576|588050650|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
162818888|NCT05696236|588050651|FG000|Overall Study|Lost to Follow-up|1|||
162818889|NCT05696236|588050652|FG001|Overall Study|Lost to Follow-up|0|||
162818890|NCT05696236|588050651|FG000|Overall Study|Later determined to not be eligible for participation|0|||
162818891|NCT05696236|588050652|FG001|Overall Study|Later determined to not be eligible for participation|1|||
162818892|NCT05696236|588050651|FG000|Overall Study|Withdrawal by Subject|2|||
162818893|NCT05696236|588050652|FG001|Overall Study|Withdrawal by Subject|2|||
162818894|NCT01829360|588050655|FG000|Overall Study|Protocol Violation|0|||
162818895|NCT01829360|588050656|FG001|Overall Study|Protocol Violation|0|||
162818896|NCT01829360|588050657|FG002|Overall Study|Protocol Violation|1|||
162818897|NCT01829360|588050658|FG003|Overall Study|Protocol Violation|0|||
162818898|NCT01026142|588050659|FG000|Overall Study|Death|136|||
162818899|NCT01026142|588050660|FG001|Overall Study|Death|134|||
162818900|NCT01026142|588050659|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
162818901|NCT01026142|588050660|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
162818902|NCT02545322|588050661|FG000|Overall Study|Withdrawal by Subject|3|||
162818903|NCT00041067|588050662|FG000|Overall Study|Adverse Event|20|||
162818904|NCT00041067|588050662|FG000|Overall Study|Progression|19|||
162818905|NCT00041067|588050662|FG000|Overall Study|Patient refusal|12|||
162818906|NCT00041067|588050662|FG000|Overall Study|Other reasons|23|||
162818907|NCT00041067|588050662|FG000|Overall Study|Ineligible|2|||
162818908|NCT00778622|588050663|FG000|Overall Study|Adverse Event|5|||
162818909|NCT00778622|588050664|FG001|Overall Study|Adverse Event|4|||
162818910|NCT00778622|588050665|FG002|Overall Study|Adverse Event|7|||
162818911|NCT00778622|588050663|FG000|Overall Study|Withdrawal by Subject|4|||
162818912|NCT00778622|588050664|FG001|Overall Study|Withdrawal by Subject|5|||
162818913|NCT00778622|588050665|FG002|Overall Study|Withdrawal by Subject|5|||
162818914|NCT00778622|588050663|FG000|Overall Study|Lost to Follow-up|3|||
162818915|NCT00778622|588050664|FG001|Overall Study|Lost to Follow-up|3|||
162818916|NCT00778622|588050665|FG002|Overall Study|Lost to Follow-up|2|||
162818917|NCT00778622|588050663|FG000|Overall Study|Protocol Violation|0|||
162818918|NCT00778622|588050664|FG001|Overall Study|Protocol Violation|3|||
162818919|NCT00778622|588050665|FG002|Overall Study|Protocol Violation|0|||
162818920|NCT00778622|588050663|FG000|Overall Study|Lack of Efficacy|2|||
163170290|NCT04174365|589338591|FG000|Overall Study|Reason Not Specified|0|||
163170291|NCT04174365|589338592|FG001|Overall Study|Reason Not Specified|1|||
163170292|NCT03472547|589338593|FG000|Overall Study|Withdrawal by Subject|30|||
163170293|NCT05141448|589338594|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170294|NCT05141448|589338595|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
163170295|NCT05141448|589338596|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170296|NCT05141448|589338597|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170297|NCT05141448|589338598|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170298|NCT05141448|589338599|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163170299|NCT05141448|589338594|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170300|NCT05141448|589338595|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170301|NCT05141448|589338596|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170302|NCT05141448|589338597|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170303|NCT05141448|589338598|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
163170304|NCT05141448|589338599|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163170305|NCT05141448|589338594|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170306|NCT05141448|589338595|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163170307|NCT05141448|589338596|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170308|NCT05141448|589338597|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170309|NCT05141448|589338598|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170310|NCT05141448|589338599|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163170311|NCT05141448|589338594|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170312|NCT05141448|589338595|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170313|NCT05141448|589338596|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162818921|NCT00778622|588050664|FG001|Overall Study|Lack of Efficacy|0|||
162818922|NCT00778622|588050665|FG002|Overall Study|Lack of Efficacy|0|||
162818923|NCT00778622|588050663|FG000|Overall Study|immigration|1|||
162818924|NCT00778622|588050664|FG001|Overall Study|immigration|0|||
162818925|NCT00778622|588050665|FG002|Overall Study|immigration|0|||
162818926|NCT00778622|588050663|FG000|Overall Study|Other|1|||
162818927|NCT00778622|588050664|FG001|Overall Study|Other|0|||
162818928|NCT00778622|588050665|FG002|Overall Study|Other|1|||
162818929|NCT01251120|588050667|FG000|Overall Study|Lack of Efficacy|0|||
162818930|NCT01251120|588050668|FG001|Overall Study|Lack of Efficacy|1|||
162818931|NCT01968070|588050669|FG000|Period 1|Withdrawal by Subject|0|||
162818932|NCT01968070|588050670|FG001|Period 1|Withdrawal by Subject|1|||
162818933|NCT01968070|588050671|FG002|Period 1|Withdrawal by Subject|0|||
162818934|NCT01968070|588050672|FG003|Period 1|Withdrawal by Subject|0|||
162818935|NCT01968070|588050673|FG004|Period 1|Withdrawal by Subject|0|||
162818936|NCT01968070|588050674|FG005|Period 1|Withdrawal by Subject|0|||
162818937|NCT01968070|588050675|FG006|Period 1|Withdrawal by Subject|1|||
162818938|NCT01968070|588050676|FG007|Period 1|Withdrawal by Subject|0|||
162818939|NCT01968070|588050677|FG008|Period 1|Withdrawal by Subject|0|||
162818940|NCT01968070|588050678|FG009|Period 1|Withdrawal by Subject|0|||
162818941|NCT01968070|588050679|FG010|Period 1|Withdrawal by Subject|0|||
162818942|NCT01968070|588050680|FG011|Period 1|Withdrawal by Subject|0|||
162818943|NCT01968070|588050681|FG012|Period 1|Withdrawal by Subject|0|||
162818944|NCT01968070|588050682|FG013|Period 1|Withdrawal by Subject|0|||
162818945|NCT01968070|588050683|FG014|Period 1|Withdrawal by Subject|0|||
162818946|NCT01968070|588050684|FG015|Period 1|Withdrawal by Subject|1|||
162818947|NCT01968070|588050685|FG016|Period 1|Withdrawal by Subject|0|||
162818948|NCT01968070|588050686|FG017|Period 1|Withdrawal by Subject|0|||
162818949|NCT01968070|588050669|FG000|Period 1|Protocol Violation|0|||
162818950|NCT01968070|588050670|FG001|Period 1|Protocol Violation|0|||
163170314|NCT05141448|589338597|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170315|NCT05141448|589338598|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163170316|NCT05141448|589338599|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
163170317|NCT05141448|589338594|FG000|Period 2|COVID-19 Related|0|||
163170318|NCT05141448|589338595|FG001|Period 2|COVID-19 Related|0|||
163170319|NCT05141448|589338596|FG002|Period 2|COVID-19 Related|0|||
163170320|NCT05141448|589338597|FG003|Period 2|COVID-19 Related|1|||
163170321|NCT05141448|589338598|FG004|Period 2|COVID-19 Related|0|||
162818951|NCT01968070|588050671|FG002|Period 1|Protocol Violation|0|||
162818952|NCT01968070|588050672|FG003|Period 1|Protocol Violation|1|||
162818953|NCT01968070|588050673|FG004|Period 1|Protocol Violation|1|||
162818954|NCT01968070|588050674|FG005|Period 1|Protocol Violation|0|||
162818955|NCT01968070|588050675|FG006|Period 1|Protocol Violation|0|||
162818956|NCT01968070|588050676|FG007|Period 1|Protocol Violation|0|||
162818957|NCT01968070|588050677|FG008|Period 1|Protocol Violation|0|||
162818958|NCT01968070|588050678|FG009|Period 1|Protocol Violation|0|||
162818959|NCT01968070|588050679|FG010|Period 1|Protocol Violation|0|||
162818960|NCT01968070|588050680|FG011|Period 1|Protocol Violation|0|||
162818961|NCT01968070|588050681|FG012|Period 1|Protocol Violation|0|||
162818962|NCT01968070|588050682|FG013|Period 1|Protocol Violation|0|||
162818963|NCT01968070|588050683|FG014|Period 1|Protocol Violation|0|||
162818964|NCT01968070|588050684|FG015|Period 1|Protocol Violation|0|||
162818965|NCT01968070|588050685|FG016|Period 1|Protocol Violation|0|||
162818966|NCT01968070|588050686|FG017|Period 1|Protocol Violation|0|||
162818967|NCT01968070|588050669|FG000|Period 1|Lost to Follow-up|0|||
162818968|NCT01968070|588050670|FG001|Period 1|Lost to Follow-up|0|||
162818969|NCT01968070|588050671|FG002|Period 1|Lost to Follow-up|0|||
162818970|NCT01968070|588050672|FG003|Period 1|Lost to Follow-up|1|||
162818971|NCT01968070|588050673|FG004|Period 1|Lost to Follow-up|0|||
162818972|NCT01968070|588050674|FG005|Period 1|Lost to Follow-up|0|||
162818973|NCT01968070|588050675|FG006|Period 1|Lost to Follow-up|0|||
162818974|NCT01968070|588050676|FG007|Period 1|Lost to Follow-up|0|||
162818975|NCT01968070|588050677|FG008|Period 1|Lost to Follow-up|0|||
162818976|NCT01968070|588050678|FG009|Period 1|Lost to Follow-up|0|||
162818977|NCT01968070|588050679|FG010|Period 1|Lost to Follow-up|0|||
162818978|NCT01968070|588050680|FG011|Period 1|Lost to Follow-up|0|||
162818979|NCT01968070|588050681|FG012|Period 1|Lost to Follow-up|0|||
162818980|NCT01968070|588050682|FG013|Period 1|Lost to Follow-up|0|||
162818981|NCT01968070|588050683|FG014|Period 1|Lost to Follow-up|0|||
162818982|NCT01968070|588050684|FG015|Period 1|Lost to Follow-up|0|||
162818983|NCT01968070|588050685|FG016|Period 1|Lost to Follow-up|0|||
162818984|NCT01968070|588050686|FG017|Period 1|Lost to Follow-up|0|||
162818985|NCT01968070|588050669|FG000|Period 1|Adverse Event|0|||
162818986|NCT01968070|588050670|FG001|Period 1|Adverse Event|0|||
162818987|NCT01968070|588050671|FG002|Period 1|Adverse Event|0|||
162818988|NCT01968070|588050672|FG003|Period 1|Adverse Event|0|||
162818989|NCT01968070|588050673|FG004|Period 1|Adverse Event|0|||
162818990|NCT01968070|588050674|FG005|Period 1|Adverse Event|0|||
162818991|NCT01968070|588050675|FG006|Period 1|Adverse Event|1|||
162818992|NCT01968070|588050676|FG007|Period 1|Adverse Event|0|||
162818993|NCT01968070|588050677|FG008|Period 1|Adverse Event|0|||
162818994|NCT01968070|588050678|FG009|Period 1|Adverse Event|0|||
162818995|NCT01968070|588050679|FG010|Period 1|Adverse Event|0|||
162818996|NCT01968070|588050680|FG011|Period 1|Adverse Event|0|||
163170322|NCT05141448|589338599|FG005|Period 2|COVID-19 Related|1|||
163170323|NCT05141448|589338594|FG000|3|Covid-19 related|2|||
163170324|NCT05141448|589338595|FG001|3|Covid-19 related|0|||
162818997|NCT01968070|588050681|FG012|Period 1|Adverse Event|0|||
162818998|NCT01968070|588050682|FG013|Period 1|Adverse Event|0|||
162818999|NCT01968070|588050683|FG014|Period 1|Adverse Event|0|||
162819000|NCT01968070|588050684|FG015|Period 1|Adverse Event|0|||
162819001|NCT01968070|588050685|FG016|Period 1|Adverse Event|0|||
162819002|NCT01968070|588050686|FG017|Period 1|Adverse Event|0|||
162819003|NCT01968070|588050669|FG000|Period 1|Physician Decision|0|||
162819004|NCT01968070|588050670|FG001|Period 1|Physician Decision|0|||
162819005|NCT01968070|588050671|FG002|Period 1|Physician Decision|0|||
162819006|NCT01968070|588050672|FG003|Period 1|Physician Decision|0|||
162819007|NCT01968070|588050673|FG004|Period 1|Physician Decision|0|||
162819008|NCT01968070|588050674|FG005|Period 1|Physician Decision|0|||
162819009|NCT01968070|588050675|FG006|Period 1|Physician Decision|0|||
162819010|NCT01968070|588050676|FG007|Period 1|Physician Decision|0|||
162819011|NCT01968070|588050677|FG008|Period 1|Physician Decision|0|||
162819012|NCT01968070|588050678|FG009|Period 1|Physician Decision|0|||
162819013|NCT01968070|588050679|FG010|Period 1|Physician Decision|0|||
162819014|NCT01968070|588050680|FG011|Period 1|Physician Decision|1|||
162819015|NCT01968070|588050681|FG012|Period 1|Physician Decision|0|||
162819016|NCT01968070|588050682|FG013|Period 1|Physician Decision|0|||
162819017|NCT01968070|588050683|FG014|Period 1|Physician Decision|0|||
162819018|NCT01968070|588050684|FG015|Period 1|Physician Decision|0|||
162819019|NCT01968070|588050685|FG016|Period 1|Physician Decision|0|||
162819020|NCT01968070|588050686|FG017|Period 1|Physician Decision|0|||
162819021|NCT01968070|588050669|FG000|Period 2|Withdrawal by Subject|0|||
162819022|NCT01968070|588050670|FG001|Period 2|Withdrawal by Subject|0|||
162819023|NCT01968070|588050671|FG002|Period 2|Withdrawal by Subject|0|||
162819024|NCT01968070|588050672|FG003|Period 2|Withdrawal by Subject|0|||
162819025|NCT01968070|588050673|FG004|Period 2|Withdrawal by Subject|1|||
162819026|NCT01968070|588050674|FG005|Period 2|Withdrawal by Subject|0|||
162819027|NCT01968070|588050675|FG006|Period 2|Withdrawal by Subject|0|||
162819028|NCT01968070|588050676|FG007|Period 2|Withdrawal by Subject|0|||
162819029|NCT01968070|588050677|FG008|Period 2|Withdrawal by Subject|0|||
162819030|NCT01968070|588050678|FG009|Period 2|Withdrawal by Subject|0|||
162819031|NCT01968070|588050679|FG010|Period 2|Withdrawal by Subject|0|||
162819032|NCT01968070|588050680|FG011|Period 2|Withdrawal by Subject|0|||
162819033|NCT01968070|588050681|FG012|Period 2|Withdrawal by Subject|0|||
162819034|NCT01968070|588050682|FG013|Period 2|Withdrawal by Subject|0|||
162819035|NCT01968070|588050683|FG014|Period 2|Withdrawal by Subject|0|||
162819036|NCT01968070|588050684|FG015|Period 2|Withdrawal by Subject|0|||
162819037|NCT01968070|588050685|FG016|Period 2|Withdrawal by Subject|0|||
162819038|NCT01968070|588050686|FG017|Period 2|Withdrawal by Subject|0|||
162819039|NCT01822522|588050689|FG000|Overall Study|Adverse Event|1|||
162819040|NCT01822522|588050690|FG001|Overall Study|Adverse Event|1|||
162819041|NCT01822522|588050691|FG002|Overall Study|Adverse Event|1|||
162819042|NCT01822522|588050692|FG003|Overall Study|Adverse Event|0|||
162819043|NCT01822522|588050693|FG004|Overall Study|Adverse Event|0|||
162819044|NCT01822522|588050694|FG005|Overall Study|Adverse Event|1|||
162819045|NCT01822522|588050689|FG000|Overall Study|Death|3|||
162819046|NCT01822522|588050690|FG001|Overall Study|Death|0|||
162819047|NCT01822522|588050691|FG002|Overall Study|Death|2|||
162819048|NCT01822522|588050692|FG003|Overall Study|Death|0|||
162819049|NCT01822522|588050693|FG004|Overall Study|Death|0|||
162819050|NCT01822522|588050694|FG005|Overall Study|Death|0|||
162819051|NCT01822522|588050689|FG000|Overall Study|Lost to Follow-up|0|||
162819052|NCT01822522|588050690|FG001|Overall Study|Lost to Follow-up|0|||
162819053|NCT01822522|588050691|FG002|Overall Study|Lost to Follow-up|1|||
162819054|NCT01822522|588050692|FG003|Overall Study|Lost to Follow-up|1|||
162819055|NCT01822522|588050693|FG004|Overall Study|Lost to Follow-up|0|||
162819056|NCT01822522|588050694|FG005|Overall Study|Lost to Follow-up|1|||
162819057|NCT01822522|588050689|FG000|Overall Study|Withdrawal by Subject|0|||
162819058|NCT01822522|588050690|FG001|Overall Study|Withdrawal by Subject|0|||
162819059|NCT01822522|588050691|FG002|Overall Study|Withdrawal by Subject|0|||
162819060|NCT01822522|588050692|FG003|Overall Study|Withdrawal by Subject|1|||
162819061|NCT01822522|588050693|FG004|Overall Study|Withdrawal by Subject|0|||
162819062|NCT01822522|588050694|FG005|Overall Study|Withdrawal by Subject|0|||
162819063|NCT01822522|588050689|FG000|Overall Study|Lack of Efficacy|0|||
162819064|NCT01822522|588050690|FG001|Overall Study|Lack of Efficacy|0|||
162819065|NCT01822522|588050691|FG002|Overall Study|Lack of Efficacy|0|||
162819066|NCT01822522|588050692|FG003|Overall Study|Lack of Efficacy|0|||
162819067|NCT01822522|588050693|FG004|Overall Study|Lack of Efficacy|0|||
162819068|NCT01822522|588050694|FG005|Overall Study|Lack of Efficacy|2|||
162819069|NCT00890929|588050695|FG000|Overall Study|Death before treatment|2|||
162819070|NCT00890929|588050695|FG000|Overall Study|Withdrawal by Subject|3|||
162819071|NCT00890929|588050695|FG000|Overall Study|Physician Decision|1|||
162819072|NCT00108069|588050696|FG000|Overall Study|Never rec'd study drug|0|||
162819073|NCT00108069|588050697|FG001|Overall Study|Never rec'd study drug|1|||
162819074|NCT00108069|588050696|FG000|Overall Study|Adverse Event|1|||
162819075|NCT00108069|588050697|FG001|Overall Study|Adverse Event|1|||
162819076|NCT00108069|588050696|FG000|Overall Study|Withdrawal by Subject|1|||
162819077|NCT00108069|588050697|FG001|Overall Study|Withdrawal by Subject|0|||
162819078|NCT00108069|588050696|FG000|Overall Study|Death|1|||
162819079|NCT00108069|588050697|FG001|Overall Study|Death|0|||
162819080|NCT00108069|588050696|FG000|Overall Study|Progessive disease|27|||
162819081|NCT00108069|588050697|FG001|Overall Study|Progessive disease|11|||
162819082|NCT04029116|588050698|FG000|Overall Study|Adverse Event|0|||
162819083|NCT04029116|588050699|FG001|Overall Study|Adverse Event|2|||
162819084|NCT04029116|588050698|FG000|Overall Study|Lost to Follow-up|3|||
162819085|NCT04029116|588050699|FG001|Overall Study|Lost to Follow-up|5|||
162819086|NCT04029116|588050698|FG000|Overall Study|Physician Decision|2|||
162819087|NCT04029116|588050699|FG001|Overall Study|Physician Decision|0|||
162819088|NCT04029116|588050698|FG000|Overall Study|Pregnancy|1|||
162819089|NCT04029116|588050699|FG001|Overall Study|Pregnancy|2|||
162819090|NCT04029116|588050698|FG000|Overall Study|Withdrawal by Subject|4|||
162819091|NCT04029116|588050699|FG001|Overall Study|Withdrawal by Subject|6|||
162819092|NCT04029116|588050698|FG000|Overall Study|Other|2|||
162819093|NCT04029116|588050699|FG001|Overall Study|Other|1|||
162819094|NCT02469896|588050700|FG000|Overall Study|Withdrawal by Subject|2|||
162819095|NCT02469896|588050701|FG001|Overall Study|Withdrawal by Subject|0|||
162819096|NCT02510560|588050702|FG000|Overall Study|Discontinued from Treatment|27|||
162819097|NCT02510560|588050703|FG001|Overall Study|Discontinued from Treatment|18|||
162819098|NCT02510560|588050704|FG002|Overall Study|Discontinued from Treatment|19|||
162819099|NCT02510560|588050702|FG000|Overall Study|Other|4|||
162819100|NCT02510560|588050703|FG001|Overall Study|Other|4|||
162819101|NCT02510560|588050704|FG002|Overall Study|Other|3|||
162819102|NCT02401412|588050705|FG000|Overall Study|Lost to Follow-up|1|||
162819103|NCT02401412|588050706|FG001|Overall Study|Lost to Follow-up|0|||
162819104|NCT02401412|588050705|FG000|Overall Study|Discontinued Intervention|15|||
162819105|NCT02401412|588050706|FG001|Overall Study|Discontinued Intervention|21|||
162819106|NCT02401412|588050705|FG000|Overall Study|Withdrawal by Subject|4|||
162819107|NCT02401412|588050706|FG001|Overall Study|Withdrawal by Subject|4|||
162819108|NCT02401412|588050705|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
162819109|NCT02401412|588050706|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
162819110|NCT02401412|588050705|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
162819111|NCT02401412|588050706|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
162819112|NCT03684642|588050713|FG000|Overall Study|Adverse Event|6|||
162819113|NCT03684642|588050714|FG001|Overall Study|Adverse Event|15|||
162819114|NCT03684642|588050715|FG002|Overall Study|Adverse Event|11|||
162819115|NCT03684642|588050713|FG000|Overall Study|Withdrawal by Subject|35|||
162819116|NCT03684642|588050714|FG001|Overall Study|Withdrawal by Subject|53|||
162819117|NCT03684642|588050715|FG002|Overall Study|Withdrawal by Subject|23|||
162819118|NCT03684642|588050713|FG000|Overall Study|Lack of Efficacy|0|||
162819119|NCT03684642|588050714|FG001|Overall Study|Lack of Efficacy|0|||
162819120|NCT03684642|588050715|FG002|Overall Study|Lack of Efficacy|1|||
162819121|NCT03684642|588050713|FG000|Overall Study|Poor compliance to protocol|0|||
162819122|NCT03684642|588050714|FG001|Overall Study|Poor compliance to protocol|4|||
162819123|NCT03684642|588050715|FG002|Overall Study|Poor compliance to protocol|1|||
162819124|NCT03684642|588050713|FG000|Overall Study|Other than specified|62|||
162819125|NCT03684642|588050714|FG001|Overall Study|Other than specified|60|||
162819126|NCT03684642|588050715|FG002|Overall Study|Other than specified|67|||
162819127|NCT03684642|588050713|FG000|Overall Study|Randomized and not treated|0|||
162819128|NCT03684642|588050714|FG001|Overall Study|Randomized and not treated|0|||
162819129|NCT03684642|588050715|FG002|Overall Study|Randomized and not treated|1|||
162819130|NCT03684642|588050713|FG000|Overall Study|Missing completion status but alive at last contact|0|||
162819131|NCT03684642|588050714|FG001|Overall Study|Missing completion status but alive at last contact|1|||
162819132|NCT03684642|588050715|FG002|Overall Study|Missing completion status but alive at last contact|2|||
162819133|NCT01843218|588050718|FG000|Overall Study|Withdrawal by Subject|5|||
162819134|NCT01431534|588050719|FG000|Treatment Phase|Adverse Event|0|||
162819135|NCT01431534|588050720|FG001|Treatment Phase|Adverse Event|0|||
162819136|NCT01431534|588050721|FG002|Treatment Phase|Adverse Event|1|||
162819137|NCT01431534|588050719|FG000|Treatment Phase|Progressive Disease|4|||
163170325|NCT05141448|589338596|FG002|3|Covid-19 related|0|||
163170326|NCT05141448|589338597|FG003|3|Covid-19 related|0|||
163170327|NCT05141448|589338598|FG004|3|Covid-19 related|0|||
163170328|NCT05141448|589338599|FG005|3|Covid-19 related|1|||
163170329|NCT05141448|589338594|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
163170330|NCT05141448|589338595|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
163170331|NCT05141448|589338596|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
162819138|NCT01431534|588050720|FG001|Treatment Phase|Progressive Disease|3|||
162819139|NCT01431534|588050721|FG002|Treatment Phase|Progressive Disease|10|||
162819140|NCT01395316|588050725|FG000|Overall Study|Lost to Follow-up|2|||
162819141|NCT01395316|588050725|FG000|Overall Study|poor MRI quality|1|||
162819142|NCT00688181|588050726|FG000|Overall Study|Lost to Follow-up|17|||
162819143|NCT00688181|588050726|FG000|Overall Study|Unknown Reason|4|||
162819144|NCT00688181|588050726|FG000|Overall Study|Non-clinical Reason|2|||
162819145|NCT02846532|588050727|FG000|Overall Study|Lost to Follow-up|0|||
162819146|NCT02846532|588050728|FG001|Overall Study|Lost to Follow-up|1|||
162819147|NCT02846532|588050729|FG002|Overall Study|Lost to Follow-up|1|||
162819148|NCT02846532|588050727|FG000|Overall Study|Withdrawal by Subject|1|||
162819149|NCT02846532|588050728|FG001|Overall Study|Withdrawal by Subject|2|||
162819150|NCT02846532|588050729|FG002|Overall Study|Withdrawal by Subject|0|||
162819151|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
162819152|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
162819153|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
162819154|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
162819155|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
162819156|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
162819157|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
162819158|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
162819159|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
162819160|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
162819161|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
162819162|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
162819163|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
162819164|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
162819165|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
162819166|NCT04908189|588050731|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
162819167|NCT04908189|588050732|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
162819168|NCT04908189|588050733|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
162819169|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
162819170|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
162819171|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
162819172|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
162819173|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
162819174|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
162819175|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
162819176|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
162819177|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
162819178|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
162819179|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
162819180|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
162819181|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
162819182|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
162819183|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
162819184|NCT04908189|588050731|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163170332|NCT05141448|589338597|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
163170333|NCT05141448|589338598|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
162819185|NCT04908189|588050732|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
162819186|NCT04908189|588050733|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
162819187|NCT00607022|588050734|FG000|Overall Study|Withdrawal by Subject|1|||
162819188|NCT00607022|588050735|FG001|Overall Study|Withdrawal by Subject|0|||
162819189|NCT00607022|588050736|FG002|Overall Study|Withdrawal by Subject|0|||
162819190|NCT04786119|588050737|FG000|Overall Study|Withdrawal by Subject|4|||
162819191|NCT04786119|588050738|FG001|Overall Study|Withdrawal by Subject|5|||
162819192|NCT04786119|588050737|FG000|Overall Study|Lost to Follow-up|5|||
162819193|NCT04786119|588050738|FG001|Overall Study|Lost to Follow-up|5|||
162819194|NCT04786119|588050737|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
162819195|NCT04786119|588050738|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
162819196|NCT01130051|588050743|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
162819197|NCT01130051|588050744|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
162819198|NCT01130051|588050743|FG000|Washout Period of 14 Days|Protocol Violation|1|||
162819199|NCT01130051|588050744|FG001|Washout Period of 14 Days|Protocol Violation|1|||
162819200|NCT00835120|588050748|FG000|Overall Study|Lack of Efficacy|1|||
162819201|NCT00835120|588050748|FG000|Overall Study|Lost to Follow-up|3|||
162819202|NCT00835120|588050748|FG000|Overall Study|Adverse Event|2|||
162819203|NCT00835120|588050748|FG000|Overall Study|Withdrawal by Subject|2|||
162819204|NCT03610165|588050749|FG000|Overall Study|Device didn't work|0|||
162819205|NCT03610165|588050750|FG001|Overall Study|Device didn't work|1|||
162819206|NCT02383589|588050752|FG000|Treatment Period|Adverse Event|1|||
162819207|NCT02383589|588050753|FG001|Treatment Period|Adverse Event|3|||
162819208|NCT02383589|588050752|FG000|Treatment Period|Lost to Follow-up|0|||
162819209|NCT02383589|588050753|FG001|Treatment Period|Lost to Follow-up|1|||
162819210|NCT02383589|588050752|FG000|Treatment Period|Withdrawal by Subject|0|||
162819211|NCT02383589|588050753|FG001|Treatment Period|Withdrawal by Subject|5|||
162819212|NCT02383589|588050752|FG000|Treatment Period|Non-compliance with study drug|0|||
162819213|NCT02383589|588050753|FG001|Treatment Period|Non-compliance with study drug|1|||
162819214|NCT02383589|588050752|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
162819215|NCT02383589|588050753|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
162819216|NCT02383589|588050752|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
162819217|NCT02383589|588050753|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
162819218|NCT02383589|588050752|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
162819219|NCT02383589|588050753|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
162819220|NCT00447382|588050754|FG000|Overall Study|Adverse Event|1|||
162819221|NCT00447382|588050755|FG001|Overall Study|Adverse Event|1|||
162819222|NCT00447382|588050754|FG000|Overall Study|Lack of Efficacy|1|||
162819223|NCT00447382|588050755|FG001|Overall Study|Lack of Efficacy|0|||
162819224|NCT00447382|588050754|FG000|Overall Study|Protocol Violation|2|||
163170334|NCT05141448|589338599|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
163170335|NCT04627285|589338600|FG000|Overall Study|Adverse Event|0|||
163170336|NCT04627285|589338601|FG001|Overall Study|Adverse Event|2|||
162819225|NCT00447382|588050755|FG001|Overall Study|Protocol Violation|0|||
162819226|NCT00447382|588050754|FG000|Overall Study|Unclassified|2|||
162819227|NCT00447382|588050755|FG001|Overall Study|Unclassified|5|||
162819228|NCT00594516|588052733|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
162819229|NCT00594516|588052734|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
162819230|NCT00594516|588052735|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
163170337|NCT04627285|589338600|FG000|Overall Study|Lost to Follow-up|1|||
163170338|NCT04627285|589338601|FG001|Overall Study|Lost to Follow-up|0|||
163170339|NCT04627285|589338600|FG000|Overall Study|Withdrawal by Subject|1|||
163170340|NCT04627285|589338601|FG001|Overall Study|Withdrawal by Subject|1|||
163170341|NCT04627285|589338600|FG000|Overall Study|Sponsor decision|5|||
162819231|NCT00594516|588052733|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
162819232|NCT00594516|588052734|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
162819233|NCT00594516|588052735|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
162819234|NCT00594516|588052733|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
162819235|NCT00594516|588052734|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
162819236|NCT00594516|588052735|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
162819237|NCT00594516|588052733|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
162819238|NCT00594516|588052734|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
162819239|NCT00594516|588052735|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
162819240|NCT00594516|588052733|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
162819241|NCT00594516|588052734|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
162819242|NCT00594516|588052735|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
162819243|NCT00594516|588052733|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
162819244|NCT00594516|588052734|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
162819245|NCT00594516|588052735|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
162819246|NCT00594516|588052733|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
162819247|NCT00594516|588052734|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
162819248|NCT00594516|588052735|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
162819249|NCT00594516|588052733|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
162819250|NCT00594516|588052734|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
162819251|NCT00594516|588052735|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
162819252|NCT00594516|588052733|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
162819253|NCT00594516|588052734|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
162819254|NCT00594516|588052735|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
162819255|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
162819256|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
162819257|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
162819258|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
162819259|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
162819260|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
162819261|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
162819262|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
162819263|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
162819264|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
162819265|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
162819266|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
162819267|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
162819268|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
162819269|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
162819270|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
162819271|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
162819272|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
162819273|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Early termination|0|||
162819274|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Early termination|0|||
162819275|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Early termination|34|||
162819276|NCT01493557|588052736|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
162819277|NCT01493557|588052737|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
162819278|NCT01493557|588052738|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
162819279|NCT01493557|588052736|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
162819280|NCT01493557|588052737|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
162819281|NCT01493557|588052738|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
162819282|NCT01493557|588052736|FG000|Randomized to Management Strategies|Other adverse event|8|||
162819283|NCT01493557|588052737|FG001|Randomized to Management Strategies|Other adverse event|5|||
162819284|NCT01493557|588052738|FG002|Randomized to Management Strategies|Other adverse event|0|||
162819285|NCT01493557|588052736|FG000|Randomized to Management Strategies|Protocol Violation|3|||
162819286|NCT01493557|588052737|FG001|Randomized to Management Strategies|Protocol Violation|0|||
162819287|NCT01493557|588052738|FG002|Randomized to Management Strategies|Protocol Violation|0|||
162819288|NCT01493557|588052736|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
162819289|NCT01493557|588052737|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
162819290|NCT01493557|588052738|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
162819291|NCT01493557|588052736|FG000|Randomized to Management Strategies|Other than stated above|1|||
162819292|NCT01493557|588052737|FG001|Randomized to Management Strategies|Other than stated above|3|||
162819293|NCT01493557|588052738|FG002|Randomized to Management Strategies|Other than stated above|0|||
162819294|NCT01493557|588052736|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
162819295|NCT01493557|588052737|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
162819296|NCT01493557|588052738|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
162819297|NCT01493557|588052736|FG000|Adding the Second Strategy|Other adverse event|1|||
162819298|NCT01493557|588052737|FG001|Adding the Second Strategy|Other adverse event|2|||
162819299|NCT01493557|588052738|FG002|Adding the Second Strategy|Other adverse event|0|||
162819300|NCT01493557|588052736|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
162819301|NCT01493557|588052737|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
162819302|NCT01493557|588052738|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
162819303|NCT02973425|588052739|FG000|Overall Study|Lost to Follow-up|49|||
162819304|NCT02973425|588052740|FG001|Overall Study|Lost to Follow-up|53|||
162819305|NCT03823404|588052741|FG000|Overall Study|Lost to Follow-up|1|||
162819306|NCT03823404|588052742|FG001|Overall Study|Lost to Follow-up|2|||
162819307|NCT03823404|588052743|FG002|Overall Study|Lost to Follow-up|3|||
162819308|NCT03823404|588052741|FG000|Overall Study|Protocol Violation|2|||
162819309|NCT03823404|588052742|FG001|Overall Study|Protocol Violation|0|||
162819310|NCT03823404|588052743|FG002|Overall Study|Protocol Violation|2|||
162819311|NCT03823404|588052741|FG000|Overall Study|Adverse Event|35|||
162819312|NCT03823404|588052742|FG001|Overall Study|Adverse Event|38|||
162819313|NCT03823404|588052743|FG002|Overall Study|Adverse Event|8|||
162819314|NCT03823404|588052741|FG000|Overall Study|Withdrawal by Subject|38|||
162819315|NCT03823404|588052742|FG001|Overall Study|Withdrawal by Subject|40|||
162819316|NCT03823404|588052743|FG002|Overall Study|Withdrawal by Subject|35|||
162819317|NCT03823404|588052741|FG000|Overall Study|Death|4|||
162819318|NCT03823404|588052742|FG001|Overall Study|Death|0|||
162819319|NCT03823404|588052743|FG002|Overall Study|Death|0|||
162819320|NCT03823404|588052741|FG000|Overall Study|Other: Various reasons provided|5|||
162819321|NCT03823404|588052742|FG001|Overall Study|Other: Various reasons provided|5|||
162819322|NCT03823404|588052743|FG002|Overall Study|Other: Various reasons provided|6|||
162819323|NCT01524133|588052746|FG000|Treatment Phase|Withdrawal by Subject|13|||
162819324|NCT01524133|588052747|FG001|Treatment Phase|Withdrawal by Subject|28|||
162819325|NCT01524133|588052748|FG002|Treatment Phase|Withdrawal by Subject|31|||
162819326|NCT01524133|588052746|FG000|Treatment Phase|Physician Decision|6|||
162819327|NCT01524133|588052747|FG001|Treatment Phase|Physician Decision|3|||
162819328|NCT01524133|588052748|FG002|Treatment Phase|Physician Decision|3|||
162819329|NCT01524133|588052746|FG000|Treatment Phase|Lost to Follow-up|0|||
162819330|NCT01524133|588052747|FG001|Treatment Phase|Lost to Follow-up|1|||
162819331|NCT01524133|588052748|FG002|Treatment Phase|Lost to Follow-up|2|||
162819332|NCT01524133|588052746|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
162819333|NCT01524133|588052747|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
162819334|NCT01524133|588052748|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
162819335|NCT01524133|588052746|FG000|Overall Study 52 Weeks|Physician Decision|1|||
162819336|NCT01524133|588052747|FG001|Overall Study 52 Weeks|Physician Decision|0|||
162819337|NCT01524133|588052748|FG002|Overall Study 52 Weeks|Physician Decision|2|||
162819338|NCT01524133|588052746|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
162819339|NCT01524133|588052747|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
162819340|NCT01524133|588052748|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
162819341|NCT01087957|588052749|FG000|Overall Study|Death|2|||
162819342|NCT01087957|588052750|FG001|Overall Study|Death|2|||
163170342|NCT04627285|589338601|FG001|Overall Study|Sponsor decision|0|||
163170343|NCT04627285|589338600|FG000|Overall Study|Participant left country; aunt informed the site|0|||
163170344|NCT04627285|589338601|FG001|Overall Study|Participant left country; aunt informed the site|1|||
163170345|NCT03658876|589340917|FG000|Overall Study|Protocol Violation|3|||
163170346|NCT03658876|589340918|FG001|Overall Study|Protocol Violation|2|||
163170347|NCT03658876|589340917|FG000|Overall Study|Withdrawal by Subject|2|||
163170348|NCT03658876|589340918|FG001|Overall Study|Withdrawal by Subject|0|||
162819343|NCT01087957|588052749|FG000|Overall Study|Lost to Follow-up|3|||
162819344|NCT01087957|588052750|FG001|Overall Study|Lost to Follow-up|4|||
162819345|NCT01087957|588052749|FG000|Overall Study|Protocol Violation|13|||
162819346|NCT01087957|588052750|FG001|Overall Study|Protocol Violation|25|||
162819347|NCT01087957|588052749|FG000|Overall Study|Withdrawal by Subject|18|||
162819348|NCT01087957|588052750|FG001|Overall Study|Withdrawal by Subject|15|||
162819349|NCT01087957|588052749|FG000|Overall Study|Physician Decision|5|||
162819350|NCT01087957|588052750|FG001|Overall Study|Physician Decision|9|||
162819351|NCT00059839|588052752|FG000|Overall Study|Death|1|||
162819352|NCT00059839|588052753|FG001|Overall Study|Death|1|||
162819353|NCT00059839|588052752|FG000|Overall Study|Lack of Efficacy|6|||
162819354|NCT00059839|588052753|FG001|Overall Study|Lack of Efficacy|5|||
162819355|NCT00059839|588052752|FG000|Overall Study|Lost to Follow-up|2|||
162819356|NCT00059839|588052753|FG001|Overall Study|Lost to Follow-up|0|||
162819357|NCT00059839|588052752|FG000|Overall Study|Physician Decision|1|||
162819358|NCT00059839|588052753|FG001|Overall Study|Physician Decision|2|||
162819359|NCT00059839|588052752|FG000|Overall Study|Withdrawal by Subject|1|||
162819360|NCT00059839|588052753|FG001|Overall Study|Withdrawal by Subject|6|||
162819361|NCT00059839|588052752|FG000|Overall Study|Ineligible|1|||
162819362|NCT00059839|588052753|FG001|Overall Study|Ineligible|3|||
162819363|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
162819364|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
162819365|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
162819366|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
162819367|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
162819368|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
162819369|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
162819370|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
162819371|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
162819372|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
162819373|NCT03829241|588052757|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
162819374|NCT03829241|588052758|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
162819375|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
162819376|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
162819377|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
162819378|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
162819379|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
162819380|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
162819381|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
162819382|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
162819383|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
162819384|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
162819385|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
162819386|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
162819387|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
162819388|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
162819389|NCT03829241|588052757|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
162819390|NCT03829241|588052758|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
162819391|NCT00698451|588052759|FG000|Overall Study|Adverse Event|22|||
162819392|NCT00698451|588052759|FG000|Overall Study|Physician Decision|2|||
162819393|NCT00698451|588052759|FG000|Overall Study|Protocol Violation|6|||
162819394|NCT00698451|588052759|FG000|Overall Study|Withdrawal by Subject|6|||
162819395|NCT00698451|588052759|FG000|Overall Study|Disease progression|3|||
162819396|NCT02224599|588052762|FG000|Overall Study|Physician Decision|1|||
162819397|NCT02224599|588052762|FG000|Overall Study|Progression of Disease|1|||
162819398|NCT05352048|588052769|FG000|Overall Study|Lost to Follow-up|1|||
162819399|NCT05352048|588052769|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
162819400|NCT03085758|588052770|FG000|Overall Study|Death|26|||
162819401|NCT03085758|588052771|FG001|Overall Study|Death|24|||
162819402|NCT03085758|588052772|FG002|Overall Study|Death|53|||
162819403|NCT03085758|588052770|FG000|Overall Study|Lost to Follow-up|1|||
162819404|NCT03085758|588052771|FG001|Overall Study|Lost to Follow-up|1|||
162819405|NCT03085758|588052772|FG002|Overall Study|Lost to Follow-up|1|||
162819406|NCT03085758|588052770|FG000|Overall Study|Withdrawal by Subject|2|||
162819407|NCT03085758|588052771|FG001|Overall Study|Withdrawal by Subject|2|||
162819408|NCT03085758|588052772|FG002|Overall Study|Withdrawal by Subject|1|||
162819409|NCT03085758|588052770|FG000|Overall Study|Refusal to recall it up to day 90|0|||
162819410|NCT03085758|588052771|FG001|Overall Study|Refusal to recall it up to day 90|0|||
162819411|NCT03085758|588052772|FG002|Overall Study|Refusal to recall it up to day 90|1|||
162819412|NCT03085758|588052770|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
162819413|NCT03085758|588052771|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
162819414|NCT03085758|588052772|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
162819415|NCT03974334|588052776|FG000|Overall Study|Lost to Follow-up|1|||
162819416|NCT01109173|588052777|FG000|Overall Study|Adverse Event|15|||
162819417|NCT01109173|588052778|FG001|Overall Study|Adverse Event|17|||
162819418|NCT01109173|588052779|FG002|Overall Study|Adverse Event|9|||
162819419|NCT01109173|588052780|FG003|Overall Study|Adverse Event|6|||
162819420|NCT01109173|588052777|FG000|Overall Study|Lost to Follow-up|0|||
162819421|NCT01109173|588052778|FG001|Overall Study|Lost to Follow-up|1|||
162819422|NCT01109173|588052779|FG002|Overall Study|Lost to Follow-up|0|||
162819423|NCT01109173|588052780|FG003|Overall Study|Lost to Follow-up|0|||
162819424|NCT01109173|588052777|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
162819425|NCT01109173|588052778|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
162819426|NCT01109173|588052779|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
162819427|NCT01109173|588052780|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
162819428|NCT01109173|588052777|FG000|Overall Study|Noncompliance|0|||
162819429|NCT01109173|588052778|FG001|Overall Study|Noncompliance|1|||
162819430|NCT01109173|588052779|FG002|Overall Study|Noncompliance|0|||
162819431|NCT01109173|588052780|FG003|Overall Study|Noncompliance|0|||
162819432|NCT01109173|588052777|FG000|Overall Study|Treatment Failure|25|||
162819433|NCT01109173|588052778|FG001|Overall Study|Treatment Failure|32|||
162819434|NCT01109173|588052779|FG002|Overall Study|Treatment Failure|69|||
162819435|NCT01109173|588052780|FG003|Overall Study|Treatment Failure|64|||
162819436|NCT01109173|588052777|FG000|Overall Study|Protocol Violation|4|||
162819437|NCT01109173|588052778|FG001|Overall Study|Protocol Violation|5|||
162819438|NCT01109173|588052779|FG002|Overall Study|Protocol Violation|1|||
162819439|NCT01109173|588052780|FG003|Overall Study|Protocol Violation|2|||
162819440|NCT01109173|588052777|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
162819441|NCT01109173|588052778|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
162819442|NCT01109173|588052779|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
162819443|NCT01109173|588052780|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
162819444|NCT01109173|588052777|FG000|Overall Study|Not Specifiied|5|||
162819445|NCT01109173|588052778|FG001|Overall Study|Not Specifiied|4|||
162819446|NCT01109173|588052779|FG002|Overall Study|Not Specifiied|9|||
162819447|NCT01109173|588052780|FG003|Overall Study|Not Specifiied|14|||
162819448|NCT00006392|588052787|FG000|Overall Study|Ineligible|11|||
162819449|NCT00006392|588052788|FG001|Overall Study|Ineligible|3|||
162819450|NCT00006392|588052789|FG002|Overall Study|Ineligible|5|||
162819451|NCT00006392|588052790|FG003|Overall Study|Ineligible|5|||
162819452|NCT00006392|588052787|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
162819453|NCT00006392|588052788|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
162819454|NCT00006392|588052789|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
162819455|NCT00006392|588052790|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
162819456|NCT01186796|588052792|FG000|Overall Study|Adverse Event|3|||
162819457|NCT01186796|588052793|FG001|Overall Study|Adverse Event|0|||
162819458|NCT01186796|588052792|FG000|Overall Study|Withdrawal by Subject|1|||
162819459|NCT01186796|588052793|FG001|Overall Study|Withdrawal by Subject|1|||
162819460|NCT01186796|588052792|FG000|Overall Study|Protocol Violation|0|||
162819461|NCT01186796|588052793|FG001|Overall Study|Protocol Violation|1|||
162819462|NCT02459769|588052794|FG000|Overall Study|Withdrawal by Subject|7|||
162819463|NCT02459769|588052795|FG001|Overall Study|Withdrawal by Subject|4|||
162819464|NCT02459769|588052796|FG002|Overall Study|Withdrawal by Subject|8|||
162819465|NCT02459769|588052797|FG003|Overall Study|Withdrawal by Subject|5|||
162819466|NCT02459769|588052794|FG000|Overall Study|Lost to Follow-up|1|||
162819467|NCT02459769|588052795|FG001|Overall Study|Lost to Follow-up|0|||
162819468|NCT02459769|588052796|FG002|Overall Study|Lost to Follow-up|1|||
162819469|NCT02459769|588052797|FG003|Overall Study|Lost to Follow-up|0|||
162819470|NCT03838198|588052798|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
162819471|NCT03838198|588052799|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
162819472|NCT03838198|588052800|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
162819473|NCT03838198|588052801|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
162819474|NCT03838198|588052798|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
162819475|NCT03838198|588052799|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
162819476|NCT03838198|588052800|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
162819477|NCT03838198|588052801|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
162819478|NCT00578786|588052806|FG000|Overall Study|Adverse Event|27|||
162819479|NCT00578786|588052807|FG001|Overall Study|Adverse Event|37|||
162819480|NCT00578786|588052808|FG002|Overall Study|Adverse Event|17|||
162819481|NCT00578786|588052806|FG000|Overall Study|Lack of Efficacy|2|||
162819482|NCT00578786|588052807|FG001|Overall Study|Lack of Efficacy|5|||
162819483|NCT00578786|588052808|FG002|Overall Study|Lack of Efficacy|2|||
162819484|NCT00578786|588052806|FG000|Overall Study|Early Escape from Prior Study|2|||
162819485|NCT00578786|588052807|FG001|Overall Study|Early Escape from Prior Study|1|||
162819486|NCT00578786|588052808|FG002|Overall Study|Early Escape from Prior Study|2|||
162819487|NCT00578786|588052806|FG000|Overall Study|Withdrawal by Subject|7|||
162819488|NCT00578786|588052807|FG001|Overall Study|Withdrawal by Subject|8|||
162819489|NCT00578786|588052808|FG002|Overall Study|Withdrawal by Subject|5|||
162819490|NCT00578786|588052806|FG000|Overall Study|Protocol Violation|0|||
162819491|NCT00578786|588052807|FG001|Overall Study|Protocol Violation|3|||
162819492|NCT00578786|588052808|FG002|Overall Study|Protocol Violation|1|||
162819493|NCT00578786|588052806|FG000|Overall Study|Physician Decision|1|||
162819494|NCT00578786|588052807|FG001|Overall Study|Physician Decision|0|||
162819495|NCT00578786|588052808|FG002|Overall Study|Physician Decision|1|||
162819496|NCT00578786|588052806|FG000|Overall Study|Sponsor Decision|0|||
162819497|NCT00578786|588052807|FG001|Overall Study|Sponsor Decision|0|||
162819498|NCT00578786|588052808|FG002|Overall Study|Sponsor Decision|1|||
162819499|NCT00578786|588052806|FG000|Overall Study|Lost to Follow-up|0|||
162819500|NCT00578786|588052807|FG001|Overall Study|Lost to Follow-up|4|||
162819501|NCT00578786|588052808|FG002|Overall Study|Lost to Follow-up|0|||
162819502|NCT00578786|588052806|FG000|Overall Study|Pregnancy|0|||
162819503|NCT00578786|588052807|FG001|Overall Study|Pregnancy|1|||
162819504|NCT00578786|588052808|FG002|Overall Study|Pregnancy|0|||
162819505|NCT00578786|588052806|FG000|Overall Study|Not Otherwise Specified|0|||
162819506|NCT00578786|588052807|FG001|Overall Study|Not Otherwise Specified|4|||
162819507|NCT00578786|588052808|FG002|Overall Study|Not Otherwise Specified|1|||
162819508|NCT00578786|588052806|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
162819509|NCT00578786|588052807|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
162819510|NCT00578786|588052808|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
162819511|NCT00312221|588052809|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
162819512|NCT00312221|588052810|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
162819513|NCT00312221|588052811|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
162819514|NCT00312221|588052812|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
162819515|NCT00312221|588052809|FG000|Open-label Run-in Period|Adverse Event|74|||
162819516|NCT00312221|588052810|FG001|Open-label Run-in Period|Adverse Event|0|||
162819517|NCT00312221|588052811|FG002|Open-label Run-in Period|Adverse Event|0|||
162819518|NCT00312221|588052812|FG003|Open-label Run-in Period|Adverse Event|0|||
162819519|NCT00312221|588052809|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
162819520|NCT00312221|588052810|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
162819521|NCT00312221|588052811|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
162819522|NCT00312221|588052812|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
162819523|NCT00312221|588052809|FG000|Open-label Run-in Period|Administrative|42|||
162819524|NCT00312221|588052810|FG001|Open-label Run-in Period|Administrative|0|||
162819525|NCT00312221|588052811|FG002|Open-label Run-in Period|Administrative|0|||
162819526|NCT00312221|588052812|FG003|Open-label Run-in Period|Administrative|0|||
162819527|NCT00312221|588052809|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
162819528|NCT00312221|588052810|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
162819529|NCT00312221|588052811|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
162819530|NCT00312221|588052812|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
162819531|NCT00312221|588052809|FG000|Open-label Run-in Period|Did not qualify|5|||
162819532|NCT00312221|588052810|FG001|Open-label Run-in Period|Did not qualify|0|||
162819533|NCT00312221|588052811|FG002|Open-label Run-in Period|Did not qualify|0|||
162819534|NCT00312221|588052812|FG003|Open-label Run-in Period|Did not qualify|0|||
162819535|NCT00312221|588052809|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162819536|NCT00312221|588052810|FG001|Double-blind Phase|Withdrawal by Subject|6|||
162819537|NCT00312221|588052811|FG002|Double-blind Phase|Withdrawal by Subject|8|||
162819538|NCT00312221|588052812|FG003|Double-blind Phase|Withdrawal by Subject|7|||
162819539|NCT00312221|588052809|FG000|Double-blind Phase|Adverse Event|0|||
162819540|NCT00312221|588052810|FG001|Double-blind Phase|Adverse Event|10|||
162819541|NCT00312221|588052811|FG002|Double-blind Phase|Adverse Event|19|||
162819542|NCT00312221|588052812|FG003|Double-blind Phase|Adverse Event|18|||
162819543|NCT00312221|588052809|FG000|Double-blind Phase|Lost to Follow-up|0|||
162819544|NCT00312221|588052810|FG001|Double-blind Phase|Lost to Follow-up|0|||
162819545|NCT00312221|588052811|FG002|Double-blind Phase|Lost to Follow-up|2|||
162819546|NCT00312221|588052812|FG003|Double-blind Phase|Lost to Follow-up|2|||
162819547|NCT00312221|588052809|FG000|Double-blind Phase|Administrative|0|||
162819548|NCT00312221|588052810|FG001|Double-blind Phase|Administrative|26|||
162819549|NCT00312221|588052811|FG002|Double-blind Phase|Administrative|37|||
162819550|NCT00312221|588052812|FG003|Double-blind Phase|Administrative|33|||
162819551|NCT00312221|588052809|FG000|Double-blind Phase|Lack of Efficacy|0|||
162819552|NCT00312221|588052810|FG001|Double-blind Phase|Lack of Efficacy|17|||
162819553|NCT00312221|588052811|FG002|Double-blind Phase|Lack of Efficacy|6|||
162819554|NCT00312221|588052812|FG003|Double-blind Phase|Lack of Efficacy|10|||
162819555|NCT01019317|588052813|FG000|Overall Study|Not Eligible|4|||
162819556|NCT01807923|588052815|FG000|Overall Study|Adverse Event|2|||
162819557|NCT01807923|588052816|FG001|Overall Study|Adverse Event|1|||
162819558|NCT01807923|588052817|FG002|Overall Study|Adverse Event|2|||
162819559|NCT01807923|588052815|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
162819560|NCT01807923|588052816|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
162819561|NCT01807923|588052817|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
162819562|NCT01807923|588052815|FG000|Overall Study|Physician Decision|0|||
162819563|NCT01807923|588052816|FG001|Overall Study|Physician Decision|0|||
162819564|NCT01807923|588052817|FG002|Overall Study|Physician Decision|1|||
162819565|NCT01807923|588052815|FG000|Overall Study|Not Eligible (Genotype)|0|||
162819566|NCT01807923|588052816|FG001|Overall Study|Not Eligible (Genotype)|0|||
162819567|NCT01807923|588052817|FG002|Overall Study|Not Eligible (Genotype)|1|||
162819568|NCT01807923|588052815|FG000|Overall Study|Randomized But Not Treated|3|||
162819569|NCT01807923|588052816|FG001|Overall Study|Randomized But Not Treated|2|||
162819570|NCT01807923|588052817|FG002|Overall Study|Randomized But Not Treated|5|||
162819571|NCT01237340|588052823|FG000|Overall Study|Adverse Event|3|||
162819572|NCT01237340|588052823|FG000|Overall Study|Withdrawal by Subject|1|||
162819573|NCT01237340|588052823|FG000|Overall Study|Early termination of the trial|36|||
162819574|NCT03836807|588052824|FG000|Overall Study|Physician Decision|1|||
162819575|NCT03836807|588052825|FG001|Overall Study|Physician Decision|0|||
162819576|NCT00685685|588052826|FG000|Washout Period of 7 Days|Adverse Event|2|||
162819577|NCT00685685|588052827|FG001|Washout Period of 7 Days|Adverse Event|0|||
162819578|NCT00685685|588052826|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162819579|NCT00685685|588052827|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162819580|NCT01272947|588052828|FG000|Overall Study|Abnormal Laboratory Value|2|||
162819581|NCT01272947|588052829|FG001|Overall Study|Abnormal Laboratory Value|2|||
162819582|NCT02019420|588052832|FG000|Overall Study|Did not receive study drug|2|||
162819583|NCT02019420|588052833|FG001|Overall Study|Did not receive study drug|2|||
162819584|NCT02019420|588052832|FG000|Overall Study|Withdrawal by Subject|1|||
162819585|NCT02019420|588052833|FG001|Overall Study|Withdrawal by Subject|3|||
162819586|NCT02019420|588052832|FG000|Overall Study|At request of sponsor or investigator|0|||
162819587|NCT02019420|588052833|FG001|Overall Study|At request of sponsor or investigator|1|||
162819588|NCT02019420|588052832|FG000|Overall Study|Death|104|||
162819589|NCT02019420|588052833|FG001|Overall Study|Death|99|||
162819590|NCT02019420|588052832|FG000|Overall Study|Transferred to other care facility|1|||
162819591|NCT02019420|588052833|FG001|Overall Study|Transferred to other care facility|1|||
162819592|NCT02014740|588052834|FG000|Overall Study|Lost to Follow-up|4|||
162819593|NCT02014740|588052835|FG001|Overall Study|Lost to Follow-up|4|||
162819594|NCT02014740|588052834|FG000|Overall Study|Withdrawal by Subject|2|||
162819595|NCT02014740|588052835|FG001|Overall Study|Withdrawal by Subject|1|||
162819596|NCT02742766|588052836|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163170349|NCT03658876|589340917|FG000|Overall Study|Death|0|||
163170350|NCT03658876|589340918|FG001|Overall Study|Death|1|||
163170351|NCT03658876|589340917|FG000|Overall Study|Intercurrent illness|6|||
163170352|NCT03658876|589340918|FG001|Overall Study|Intercurrent illness|4|||
163170353|NCT03658876|589340917|FG000|Overall Study|Transplantation/other operation|1|||
163170354|NCT03658876|589340918|FG001|Overall Study|Transplantation/other operation|5|||
163170355|NCT01330017|589340919|FG000|Overall Study|Adverse Event|0|||
163170356|NCT01330017|589340920|FG001|Overall Study|Adverse Event|1|||
163170357|NCT01330017|589340921|FG002|Overall Study|Adverse Event|1|||
163170358|NCT01330017|589340922|FG003|Overall Study|Adverse Event|4|||
163170359|NCT01330017|589340923|FG004|Overall Study|Adverse Event|0|||
163170360|NCT01330017|589340919|FG000|Overall Study|Withdrawal by Subject|0|||
163170361|NCT01330017|589340920|FG001|Overall Study|Withdrawal by Subject|0|||
163170362|NCT01330017|589340921|FG002|Overall Study|Withdrawal by Subject|1|||
163170363|NCT01330017|589340922|FG003|Overall Study|Withdrawal by Subject|0|||
163170364|NCT01330017|589340923|FG004|Overall Study|Withdrawal by Subject|1|||
163170365|NCT01330017|589340919|FG000|Overall Study|Lost to Follow-up|0|||
163170366|NCT01330017|589340920|FG001|Overall Study|Lost to Follow-up|0|||
163170367|NCT01330017|589340921|FG002|Overall Study|Lost to Follow-up|1|||
163170368|NCT01330017|589340922|FG003|Overall Study|Lost to Follow-up|0|||
163170369|NCT01330017|589340923|FG004|Overall Study|Lost to Follow-up|0|||
163170370|NCT01330017|589340919|FG000|Overall Study|Protocol Violation|0|||
163170371|NCT01330017|589340920|FG001|Overall Study|Protocol Violation|0|||
163170372|NCT01330017|589340921|FG002|Overall Study|Protocol Violation|0|||
162819597|NCT02742766|588052837|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819598|NCT02742766|588052838|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819599|NCT02742766|588052839|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163170373|NCT01330017|589340922|FG003|Overall Study|Protocol Violation|1|||
162819600|NCT02742766|588052840|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819601|NCT02742766|588052841|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819602|NCT02742766|588052842|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819603|NCT02742766|588052843|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819604|NCT02742766|588052844|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819605|NCT02742766|588052845|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819606|NCT02742766|588052846|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819607|NCT02742766|588052847|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819608|NCT02742766|588052848|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819609|NCT02742766|588052849|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
162819610|NCT02742766|588052850|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819611|NCT02742766|588052851|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819612|NCT02742766|588052852|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819613|NCT02742766|588052853|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819614|NCT02742766|588052854|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
162819615|NCT02742766|588052836|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819616|NCT02742766|588052837|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819617|NCT02742766|588052838|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819618|NCT02742766|588052839|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819619|NCT02742766|588052840|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819620|NCT02742766|588052841|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819621|NCT02742766|588052842|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819622|NCT02742766|588052843|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819623|NCT02742766|588052844|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819624|NCT02742766|588052845|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819625|NCT02742766|588052846|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819626|NCT02742766|588052847|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819627|NCT02742766|588052848|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
162819628|NCT02742766|588052849|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
162819629|NCT02742766|588052850|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819630|NCT02742766|588052851|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
162819631|NCT02742766|588052852|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819632|NCT02742766|588052853|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819633|NCT02742766|588052854|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
162819634|NCT03739437|588052855|FG000|Overall Study|Lost to Follow-up|2|||
162819635|NCT03739437|588052856|FG001|Overall Study|Lost to Follow-up|5|||
162819636|NCT01130974|588052858|FG000|Overall Study|Protocol Violation|10|||
162819637|NCT01130974|588052859|FG001|Overall Study|Protocol Violation|10|||
162819638|NCT01130974|588052858|FG000|Overall Study|Withdrawal by Subject|0|||
162819639|NCT01130974|588052859|FG001|Overall Study|Withdrawal by Subject|1|||
162819640|NCT01130974|588052858|FG000|Overall Study|Ineligibility criteria|5|||
162819641|NCT01130974|588052859|FG001|Overall Study|Ineligibility criteria|2|||
162819642|NCT03359590|588052861|FG000|First Intervention|Withdrawal by Subject|1|||
162819643|NCT03359590|588052862|FG001|First Intervention|Withdrawal by Subject|1|||
162819644|NCT03359590|588052861|FG000|First Intervention|Protocol Violation|0|||
162819645|NCT03359590|588052862|FG001|First Intervention|Protocol Violation|1|||
162819646|NCT02540538|588052863|FG000|Overall Study|Pregnancy|0|||
162819647|NCT02540538|588052864|FG001|Overall Study|Pregnancy|1|||
162819648|NCT02540538|588052865|FG002|Overall Study|Pregnancy|0|||
162819649|NCT04598477|588052867|FG000|Overall Study|Adverse Event|2|||
162819650|NCT04598477|588052868|FG001|Overall Study|Adverse Event|0|||
162819651|NCT04598477|588052867|FG000|Overall Study|Death|0|||
162819652|NCT04598477|588052868|FG001|Overall Study|Death|1|||
162819653|NCT04598477|588052867|FG000|Overall Study|Lost to Follow-up|1|||
163170374|NCT01330017|589340923|FG004|Overall Study|Protocol Violation|0|||
163170375|NCT01330017|589340919|FG000|Overall Study|Unknown Reason|5|||
162819654|NCT04598477|588052868|FG001|Overall Study|Lost to Follow-up|0|||
162819655|NCT04598477|588052867|FG000|Overall Study|Physician Decision|7|||
162819656|NCT04598477|588052868|FG001|Overall Study|Physician Decision|2|||
162819657|NCT04598477|588052867|FG000|Overall Study|Pregnancy|0|||
162819658|NCT04598477|588052868|FG001|Overall Study|Pregnancy|1|||
162819659|NCT04598477|588052867|FG000|Overall Study|Requires Prohibited Medication|0|||
162819660|NCT04598477|588052868|FG001|Overall Study|Requires Prohibited Medication|1|||
162819661|NCT04598477|588052867|FG000|Overall Study|Study Terminated by Sponsor|18|||
162819662|NCT04598477|588052868|FG001|Overall Study|Study Terminated by Sponsor|12|||
162819663|NCT04598477|588052867|FG000|Overall Study|Withdrawal by Subject|16|||
162819664|NCT04598477|588052868|FG001|Overall Study|Withdrawal by Subject|12|||
162819665|NCT04598477|588052867|FG000|Overall Study|Other|15|||
162819666|NCT04598477|588052868|FG001|Overall Study|Other|8|||
162819667|NCT05579990|588052878|FG000|Overall Study|Lost to Follow-up|3|||
162819668|NCT05118204|588052879|FG000|Overall Study|Lost to Follow-up|3|||
163170376|NCT01330017|589340920|FG001|Overall Study|Unknown Reason|3|||
162819669|NCT05118204|588052880|FG001|Overall Study|Lost to Follow-up|2|||
162819670|NCT05118204|588052879|FG000|Overall Study|Withdrawal by Subject|0|||
162819671|NCT05118204|588052880|FG001|Overall Study|Withdrawal by Subject|2|||
162819672|NCT05393037|588052882|FG000|Part A|Death|1|||
162819673|NCT05393037|588052883|FG001|Part A|Death|0|||
162819674|NCT05393037|588052882|FG000|Part A|Lost to Follow-up|1|||
162819675|NCT05393037|588052883|FG001|Part A|Lost to Follow-up|1|||
162819676|NCT05393037|588052882|FG000|Part A|Withdrawal by Subject|2|||
162819677|NCT05393037|588052883|FG001|Part A|Withdrawal by Subject|4|||
162819678|NCT05393037|588052882|FG000|Part B|Lost to Follow-up|1|||
162819679|NCT05393037|588052883|FG001|Part B|Lost to Follow-up|0|||
162819680|NCT04409353|588052884|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
162819681|NCT04409353|588052885|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
162819682|NCT04409353|588052886|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
162819683|NCT04409353|588052884|FG000|Overall Study|Lost to Follow-up|6|||
162819684|NCT04409353|588052885|FG001|Overall Study|Lost to Follow-up|8|||
162819685|NCT04409353|588052886|FG002|Overall Study|Lost to Follow-up|7|||
162819686|NCT04409353|588052884|FG000|Overall Study|Major surgery during participation window|4|||
162819687|NCT04409353|588052885|FG001|Overall Study|Major surgery during participation window|3|||
162819688|NCT04409353|588052886|FG002|Overall Study|Major surgery during participation window|3|||
162819689|NCT04409353|588052884|FG000|Overall Study|Life event occurred during participation window|3|||
162819690|NCT04409353|588052885|FG001|Overall Study|Life event occurred during participation window|2|||
162819691|NCT04409353|588052886|FG002|Overall Study|Life event occurred during participation window|4|||
162819692|NCT04409353|588052884|FG000|Overall Study|Lack of Efficacy|4|||
162819693|NCT04409353|588052885|FG001|Overall Study|Lack of Efficacy|1|||
162819694|NCT04409353|588052886|FG002|Overall Study|Lack of Efficacy|3|||
162819695|NCT04409353|588052884|FG000|Overall Study|Adverse Event|2|||
162819696|NCT04409353|588052885|FG001|Overall Study|Adverse Event|1|||
162819697|NCT04409353|588052886|FG002|Overall Study|Adverse Event|1|||
162819698|NCT04409353|588052884|FG000|Overall Study|Disease burden - unable to participate|0|||
162819699|NCT04409353|588052885|FG001|Overall Study|Disease burden - unable to participate|1|||
162819700|NCT04409353|588052886|FG002|Overall Study|Disease burden - unable to participate|1|||
162819701|NCT04409353|588052884|FG000|Overall Study|Intervention too complicated|1|||
162819702|NCT04409353|588052885|FG001|Overall Study|Intervention too complicated|0|||
162819703|NCT04409353|588052886|FG002|Overall Study|Intervention too complicated|1|||
162819704|NCT01012739|588052887|FG000|Treatment Period 1|Adverse Event|0|||
162819705|NCT01012739|588052888|FG001|Treatment Period 1|Adverse Event|0|||
162819706|NCT01012739|588052889|FG002|Treatment Period 1|Adverse Event|0|||
162819707|NCT01012739|588052890|FG003|Treatment Period 1|Adverse Event|1|||
162819708|NCT01012739|588052887|FG000|Treatment Period 2|Abnormal test procedure results|0|||
162819709|NCT01012739|588052888|FG001|Treatment Period 2|Abnormal test procedure results|0|||
162819710|NCT01012739|588052889|FG002|Treatment Period 2|Abnormal test procedure results|0|||
162819711|NCT01012739|588052890|FG003|Treatment Period 2|Abnormal test procedure results|1|||
162819712|NCT04540133|588052891|FG000|Overall Study|Lost to Follow-up|1|||
162819713|NCT04540133|588052892|FG001|Overall Study|Lost to Follow-up|0|||
162819714|NCT04014361|588052893|FG000|Period 2|Physician Decision|0|||
162819715|NCT04014361|588052894|FG001|Period 2|Physician Decision|0|||
162819716|NCT04014361|588052895|FG002|Period 2|Physician Decision|0|||
162819717|NCT04014361|588052896|FG003|Period 2|Physician Decision|1|||
162819718|NCT04014361|588052897|FG004|Period 2|Physician Decision|0|||
162819719|NCT04014361|588052898|FG005|Period 2|Physician Decision|0|||
162819720|NCT04014361|588052899|FG006|Period 2|Physician Decision|0|||
162819721|NCT04014361|588052900|FG007|Period 2|Physician Decision|0|||
162819722|NCT06308666|588052901|FG000|Overall Study|Withdrawal by Subject|1|||
162819723|NCT06308666|588052901|FG000|Overall Study|Protocol Violation|2|||
162819724|NCT04252287|588052903|FG000|Overall Study|Death|5|||
162819725|NCT04252287|588052904|FG001|Overall Study|Death|3|||
162819726|NCT04252287|588052903|FG000|Overall Study|Lost to Follow-up|4|||
162819727|NCT04252287|588052904|FG001|Overall Study|Lost to Follow-up|6|||
162819728|NCT04252287|588052903|FG000|Overall Study|Withdrawal by Subject|19|||
162819729|NCT04252287|588052904|FG001|Overall Study|Withdrawal by Subject|16|||
162819730|NCT04252287|588052903|FG000|Overall Study|Protocol Violation|3|||
162819731|NCT04252287|588052904|FG001|Overall Study|Protocol Violation|4|||
162819732|NCT00671554|588052912|FG000|Overall Study|Disease progression|3|||
162819733|NCT04600336|588052922|FG000|Initial Treatment|Withdrawal by Subject|1|||
162819734|NCT04600336|588052923|FG001|Initial Treatment|Withdrawal by Subject|2|||
162819735|NCT04600336|588052924|FG002|Initial Treatment|Withdrawal by Subject|0|||
162819736|NCT04600336|588052925|FG003|Initial Treatment|Withdrawal by Subject|0|||
162819737|NCT04600336|588052922|FG000|Initial Treatment|Adverse Event|0|||
162819738|NCT04600336|588052923|FG001|Initial Treatment|Adverse Event|2|||
162819739|NCT04600336|588052924|FG002|Initial Treatment|Adverse Event|0|||
162819740|NCT04600336|588052925|FG003|Initial Treatment|Adverse Event|0|||
162819741|NCT04600336|588052922|FG000|Initial Treatment|Other complicating disease|0|||
162819742|NCT04600336|588052923|FG001|Initial Treatment|Other complicating disease|0|||
162819743|NCT04600336|588052924|FG002|Initial Treatment|Other complicating disease|1|||
162819744|NCT04600336|588052925|FG003|Initial Treatment|Other complicating disease|0|||
162819745|NCT04600336|588052922|FG000|Crossover Treatment|Withdrawal by Subject|0|||
162819746|NCT04600336|588052923|FG001|Crossover Treatment|Withdrawal by Subject|0|||
162819747|NCT04600336|588052924|FG002|Crossover Treatment|Withdrawal by Subject|2|||
162819748|NCT04600336|588052925|FG003|Crossover Treatment|Withdrawal by Subject|1|||
162819749|NCT04600336|588052922|FG000|Crossover Treatment|Adverse Event|0|||
162819750|NCT04600336|588052923|FG001|Crossover Treatment|Adverse Event|0|||
162819751|NCT04600336|588052924|FG002|Crossover Treatment|Adverse Event|1|||
162819752|NCT04600336|588052925|FG003|Crossover Treatment|Adverse Event|1|||
162819753|NCT00977574|588052926|FG000|Overall Study|Never Treated|4|||
162819754|NCT00977574|588052927|FG001|Overall Study|Never Treated|2|||
162819755|NCT00977574|588052928|FG002|Overall Study|Never Treated|4|||
162819756|NCT04223791|588052929|FG000|Overall Study|Lost to Follow-up|0|||
162819757|NCT04223791|588052930|FG001|Overall Study|Lost to Follow-up|4|||
162819758|NCT04223791|588052929|FG000|Overall Study|Physician Decision|5|||
162819759|NCT04223791|588052930|FG001|Overall Study|Physician Decision|1|||
162819760|NCT04223791|588052929|FG000|Overall Study|Protocol Violation|1|||
162819761|NCT04223791|588052930|FG001|Overall Study|Protocol Violation|1|||
162819762|NCT04223791|588052929|FG000|Overall Study|Withdrawal by Subject|10|||
162819763|NCT04223791|588052930|FG001|Overall Study|Withdrawal by Subject|12|||
162819764|NCT04223791|588052929|FG000|Overall Study|Pregnancy|1|||
162819765|NCT04223791|588052930|FG001|Overall Study|Pregnancy|1|||
162819766|NCT04223791|588052929|FG000|Overall Study|Ongoing in Study|305|||
162819767|NCT04223791|588052930|FG001|Overall Study|Ongoing in Study|302|||
162819768|NCT00332839|588054090|FG000|Core (Months 0 - 12)|Administrative problems|1|||
162819769|NCT00332839|588054091|FG001|Core (Months 0 - 12)|Administrative problems|1|||
162819770|NCT00332839|588054090|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
162819771|NCT00332839|588054091|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
162819772|NCT00332839|588054090|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
162819773|NCT00332839|588054091|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
162819774|NCT00332839|588054090|FG000|Core (Months 0 - 12)|Adverse Event|5|||
162819775|NCT00332839|588054091|FG001|Core (Months 0 - 12)|Adverse Event|15|||
162819776|NCT00332839|588054090|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
162819777|NCT00332839|588054091|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
162819778|NCT00332839|588054090|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
162819779|NCT00332839|588054091|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
162819780|NCT00332839|588054090|FG000|Follow-up (Months 12 - 60)|Death|1|||
162819781|NCT00332839|588054091|FG001|Follow-up (Months 12 - 60)|Death|1|||
162819782|NCT02366728|588054092|FG000|Overall Study|Death|0|||
162819783|NCT02366728|588054093|FG001|Overall Study|Death|0|||
162819784|NCT02366728|588054094|FG002|Overall Study|Death|1|||
162819785|NCT02366728|588054092|FG000|Overall Study|Adverse Event|1|||
162819786|NCT02366728|588054093|FG001|Overall Study|Adverse Event|0|||
162819787|NCT02366728|588054094|FG002|Overall Study|Adverse Event|0|||
162819788|NCT02366728|588054092|FG000|Overall Study|Screen Failure|2|||
162819789|NCT02366728|588054093|FG001|Overall Study|Screen Failure|1|||
162819790|NCT02366728|588054094|FG002|Overall Study|Screen Failure|0|||
162819791|NCT02366728|588054092|FG000|Overall Study|Only yielded 2 vaccines|1|||
162819792|NCT02366728|588054093|FG001|Overall Study|Only yielded 2 vaccines|0|||
162819793|NCT02366728|588054094|FG002|Overall Study|Only yielded 2 vaccines|0|||
162819794|NCT01399190|588054095|FG000|Overall Study|Not Eligible for Final Analysis|5|||
162819795|NCT01399190|588054095|FG000|Overall Study|Adverse Event|8|||
162819796|NCT01399190|588054095|FG000|Overall Study|Participant's Request|5|||
162819797|NCT01399190|588054095|FG000|Overall Study|Physician Decision|2|||
162819798|NCT03842163|588054096|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
162819799|NCT03842163|588054096|FG000|Overall Study|Scintigraphy was not performed|44|||
162819800|NCT01187550|588054098|FG000|Overall Study|Protocol Violation|3|||
162819801|NCT01187550|588054099|FG001|Overall Study|Protocol Violation|1|||
162819802|NCT01187550|588054098|FG000|Overall Study|Other|3|||
162819803|NCT01187550|588054099|FG001|Overall Study|Other|0|||
162819804|NCT01187550|588054098|FG000|Overall Study|Randomized but not treated|8|||
162819805|NCT01187550|588054099|FG001|Overall Study|Randomized but not treated|0|||
162819806|NCT00129623|588054100|FG000|Overall Study|Adverse Event|3|||
162819807|NCT00129623|588054101|FG001|Overall Study|Adverse Event|7|||
162819808|NCT00129623|588054100|FG000|Overall Study|Refused Treatment|5|||
162819809|NCT00129623|588054101|FG001|Overall Study|Refused Treatment|3|||
162819810|NCT00129623|588054100|FG000|Overall Study|Failure to Return|1|||
162819811|NCT00129623|588054101|FG001|Overall Study|Failure to Return|1|||
162819812|NCT00129623|588054100|FG000|Overall Study|Relocated job out of state|1|||
162819813|NCT00129623|588054101|FG001|Overall Study|Relocated job out of state|0|||
162819814|NCT00129623|588054100|FG000|Overall Study|Uncertainty to return|0|||
162819815|NCT00129623|588054101|FG001|Overall Study|Uncertainty to return|1|||
162819816|NCT00596934|588054102|FG000|Overall Study|Protocol Violation|1|||
162819817|NCT00596934|588054102|FG000|Overall Study|Withdrawal by Subject|1|||
162819818|NCT02315898|588054103|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
162819819|NCT02315898|588054104|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
162924221|NCT00077766|588423833|FG000|Overall Study|Investigators Discretion|1|||
163170377|NCT01330017|589340921|FG002|Overall Study|Unknown Reason|5|||
163170378|NCT01330017|589340922|FG003|Overall Study|Unknown Reason|7|||
163170379|NCT01330017|589340923|FG004|Overall Study|Unknown Reason|2|||
163170380|NCT03137069|589340926|FG000|Overall Study|Withdrawal by Subject|1|||
163170381|NCT03137069|589340927|FG001|Overall Study|Withdrawal by Subject|2|||
163170382|NCT03137069|589340928|FG002|Overall Study|Withdrawal by Subject|2|||
163170383|NCT03137069|589340929|FG003|Overall Study|Withdrawal by Subject|2|||
163170384|NCT03137069|589340930|FG004|Overall Study|Withdrawal by Subject|0|||
163170385|NCT03137069|589340931|FG005|Overall Study|Withdrawal by Subject|0|||
162819820|NCT02315898|588054105|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
162819821|NCT02315898|588054106|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
162819822|NCT01330914|588054107|FG000|Overall Study|Withdrawal by Subject|4|||
162819823|NCT01330914|588054107|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
162819824|NCT02445755|588054108|FG000|Overall Study|Withdrawal by Subject|2|||
162819825|NCT02445755|588054108|FG000|Overall Study|Protocol Violation|6|||
162819826|NCT02445755|588054108|FG000|Overall Study|Screen Failure|5|||
162819827|NCT03239483|588054109|FG000|Overall Study|Lost to Follow-up|1|||
162819828|NCT03239483|588054110|FG001|Overall Study|Lost to Follow-up|0|||
162819829|NCT03239483|588054109|FG000|Overall Study|Withdrawal by Subject|1|||
162819830|NCT03239483|588054110|FG001|Overall Study|Withdrawal by Subject|0|||
162819831|NCT03678103|588054120|FG000|Overall Study|Withdrawn prior to completion|4|||
162819832|NCT01674712|588054124|FG000|Overall Study|Adverse Event|5|||
162819833|NCT01674712|588054125|FG001|Overall Study|Adverse Event|6|||
162819834|NCT01674712|588054126|FG002|Overall Study|Adverse Event|3|||
162819835|NCT01674712|588054127|FG003|Overall Study|Adverse Event|4|||
162819836|NCT01674712|588054128|FG004|Overall Study|Adverse Event|6|||
162819837|NCT01674712|588054124|FG000|Overall Study|Lost to Follow-up|1|||
162819838|NCT01674712|588054125|FG001|Overall Study|Lost to Follow-up|0|||
162819839|NCT01674712|588054126|FG002|Overall Study|Lost to Follow-up|0|||
162819840|NCT01674712|588054127|FG003|Overall Study|Lost to Follow-up|0|||
162819841|NCT01674712|588054128|FG004|Overall Study|Lost to Follow-up|0|||
162819842|NCT01674712|588054124|FG000|Overall Study|Protocol Violation|2|||
162819843|NCT01674712|588054125|FG001|Overall Study|Protocol Violation|0|||
162819844|NCT01674712|588054126|FG002|Overall Study|Protocol Violation|0|||
162819845|NCT01674712|588054127|FG003|Overall Study|Protocol Violation|0|||
162819846|NCT01674712|588054128|FG004|Overall Study|Protocol Violation|0|||
162819847|NCT01674712|588054124|FG000|Overall Study|Withdrawal by Subject|2|||
162819848|NCT01674712|588054125|FG001|Overall Study|Withdrawal by Subject|2|||
162819849|NCT01674712|588054126|FG002|Overall Study|Withdrawal by Subject|5|||
162819850|NCT01674712|588054127|FG003|Overall Study|Withdrawal by Subject|4|||
162819851|NCT01674712|588054128|FG004|Overall Study|Withdrawal by Subject|3|||
162819852|NCT01674712|588054124|FG000|Overall Study|Administrative|0|||
162819853|NCT01674712|588054125|FG001|Overall Study|Administrative|1|||
162819854|NCT01674712|588054126|FG002|Overall Study|Administrative|0|||
162819855|NCT01674712|588054127|FG003|Overall Study|Administrative|0|||
162819856|NCT01674712|588054128|FG004|Overall Study|Administrative|1|||
162819857|NCT01674712|588054124|FG000|Overall Study|Lack of Efficacy|0|||
162819858|NCT01674712|588054125|FG001|Overall Study|Lack of Efficacy|0|||
162819859|NCT01674712|588054126|FG002|Overall Study|Lack of Efficacy|1|||
162819860|NCT01674712|588054127|FG003|Overall Study|Lack of Efficacy|0|||
162819861|NCT01674712|588054128|FG004|Overall Study|Lack of Efficacy|1|||
162819862|NCT00056862|588054129|FG000|Overall Study|Protocol Violation|1|||
162819863|NCT00056862|588054130|FG001|Overall Study|Protocol Violation|0|||
162819864|NCT00381563|588054132|FG000|Overall Study|Withdrawal by Subject|5|||
162819865|NCT00381563|588054133|FG001|Overall Study|Withdrawal by Subject|5|||
162819866|NCT00381563|588054132|FG000|Overall Study|Lost to Follow-up|2|||
162819867|NCT00381563|588054133|FG001|Overall Study|Lost to Follow-up|0|||
162819868|NCT00381563|588054132|FG000|Overall Study|Protocol Violation|0|||
162819869|NCT00381563|588054133|FG001|Overall Study|Protocol Violation|1|||
162819870|NCT00024167|588054134|FG000|Overall Study|Death|53|||
162819871|NCT00024167|588054135|FG001|Overall Study|Death|47|||
162819872|NCT01132612|588054136|FG000|Overall Study|Death|0|||
162819873|NCT01132612|588054137|FG001|Overall Study|Death|0|||
162819874|NCT01132612|588054138|FG002|Overall Study|Death|1|||
162819875|NCT01132612|588054136|FG000|Overall Study|Protocol deviation|0|||
162819876|NCT01132612|588054137|FG001|Overall Study|Protocol deviation|0|||
162819877|NCT01132612|588054138|FG002|Overall Study|Protocol deviation|3|||
162819878|NCT01132612|588054136|FG000|Overall Study|Lost to Follow-up|2|||
162819879|NCT01132612|588054137|FG001|Overall Study|Lost to Follow-up|2|||
162819880|NCT01132612|588054138|FG002|Overall Study|Lost to Follow-up|7|||
162819881|NCT01132612|588054136|FG000|Overall Study|Adverse Event|5|||
162819882|NCT01132612|588054137|FG001|Overall Study|Adverse Event|2|||
162819883|NCT01132612|588054138|FG002|Overall Study|Adverse Event|15|||
162819884|NCT01132612|588054136|FG000|Overall Study|Withdrawal by Subject|5|||
162819885|NCT01132612|588054137|FG001|Overall Study|Withdrawal by Subject|8|||
162819886|NCT01132612|588054138|FG002|Overall Study|Withdrawal by Subject|19|||
162819887|NCT01132612|588054136|FG000|Overall Study|Administrative problems|5|||
162819888|NCT01132612|588054137|FG001|Overall Study|Administrative problems|1|||
162819889|NCT01132612|588054138|FG002|Overall Study|Administrative problems|52|||
162819890|NCT01132612|588054136|FG000|Overall Study|Lack of Efficacy|23|||
162819891|NCT01132612|588054137|FG001|Overall Study|Lack of Efficacy|22|||
162819892|NCT01132612|588054138|FG002|Overall Study|Lack of Efficacy|73|||
162819893|NCT02252536|588054143|FG000|Overall Study|Lost to Follow-up|5|||
162819894|NCT02252536|588054144|FG001|Overall Study|Lost to Follow-up|3|||
162819895|NCT01438151|588054145|FG000|Overall Study|study terminated|8|||
162819896|NCT02378220|588054148|FG000|Overall Study|Death|6|||
162819897|NCT02378220|588054149|FG001|Overall Study|Death|1|||
162819898|NCT02060721|588054151|FG000|Overall Study|Lost to Follow-up|1|||
162819899|NCT02060721|588054151|FG000|Overall Study|Physician Decision|2|||
162819900|NCT02060721|588054151|FG000|Overall Study|Death|14|||
162819901|NCT02060721|588054151|FG000|Overall Study|Withdrawal by Subject|2|||
162819902|NCT02060721|588054151|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
162819903|NCT05105789|588054152|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
162819904|NCT00728481|588054153|FG000|Overall Study|Withdrawal by Subject|0|||
162819905|NCT00728481|588054154|FG001|Overall Study|Withdrawal by Subject|1|||
162819906|NCT00728481|588054153|FG000|Overall Study|Adverse Event|0|||
162819907|NCT00728481|588054154|FG001|Overall Study|Adverse Event|1|||
162819908|NCT00728481|588054153|FG000|Overall Study|Study medication non-compliance|0|||
162819909|NCT00728481|588054154|FG001|Overall Study|Study medication non-compliance|2|||
162819910|NCT00728481|588054153|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
162819911|NCT00728481|588054154|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
162819912|NCT03690141|588054155|FG000|Overall Study|Adverse Event|5|||
162819913|NCT03690141|588054155|FG000|Overall Study|Withdrawal by Subject|3|||
162819914|NCT03690141|588054155|FG000|Overall Study|Physician Decision|4|||
162819915|NCT03690141|588054155|FG000|Overall Study|Disease progression|4|||
162819916|NCT01505010|588054156|FG000|Overall Study|Protocol Violation|0|||
162819917|NCT01505010|588054157|FG001|Overall Study|Protocol Violation|1|||
162819918|NCT01505010|588054156|FG000|Overall Study|Lost to Follow-up|0|||
162819919|NCT01505010|588054157|FG001|Overall Study|Lost to Follow-up|1|||
162929556|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
162819920|NCT04744285|588054158|FG000|Overall Study|Withdrawal by Subject|1|||
162819921|NCT04744285|588054159|FG001|Overall Study|Withdrawal by Subject|1|||
162819922|NCT04744285|588054160|FG002|Overall Study|Withdrawal by Subject|2|||
162819923|NCT04744285|588054161|FG003|Overall Study|Withdrawal by Subject|1|||
162819924|NCT02558231|588054168|FG000|Overall Study|Death|4|||
162819925|NCT02558231|588054169|FG001|Overall Study|Death|12|||
162819926|NCT02558231|588054168|FG000|Overall Study|Lost to Follow-up|7|||
162819927|NCT02558231|588054169|FG001|Overall Study|Lost to Follow-up|4|||
162819928|NCT02558231|588054168|FG000|Overall Study|Withdrawal by Subject|7|||
162819929|NCT02558231|588054169|FG001|Overall Study|Withdrawal by Subject|4|||
162819930|NCT02558231|588054168|FG000|Overall Study|Physician Decision|7|||
162819931|NCT02558231|588054169|FG001|Overall Study|Physician Decision|5|||
162819932|NCT02558231|588054168|FG000|Overall Study|Sponsor Decision|0|||
162819933|NCT02558231|588054169|FG001|Overall Study|Sponsor Decision|1|||
162819934|NCT00995007|588054170|FG000|Overall Study|Withdrew consent|1|||
162819935|NCT00995007|588054171|FG001|Overall Study|Withdrew consent|0|||
162819936|NCT00995007|588054170|FG000|Overall Study|Refused further treatment|8|||
162819937|NCT00995007|588054171|FG001|Overall Study|Refused further treatment|2|||
162819938|NCT00995007|588054170|FG000|Overall Study|Toxicity|8|||
162819939|NCT00995007|588054171|FG001|Overall Study|Toxicity|0|||
162819940|NCT03933397|588054172|FG000|Overall Study|No emergency department visit|65|||
162819941|NCT03933397|588054173|FG001|Overall Study|No emergency department visit|71|||
162819942|NCT03933397|588054172|FG000|Overall Study|Missed emergency department visit|25|||
162819943|NCT03933397|588054173|FG001|Overall Study|Missed emergency department visit|30|||
162819944|NCT03933397|588054172|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
162819945|NCT03933397|588054173|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
162819946|NCT03933397|588054172|FG000|Overall Study|Withdrawal by Subject|1|||
162819947|NCT03933397|588054173|FG001|Overall Study|Withdrawal by Subject|0|||
162819948|NCT03933397|588054172|FG000|Overall Study|Physician Decision|1|||
162819949|NCT03933397|588054173|FG001|Overall Study|Physician Decision|1|||
162819950|NCT03933397|588054172|FG000|Overall Study|missing pain score|1|||
162819951|NCT03933397|588054173|FG001|Overall Study|missing pain score|1|||
162819952|NCT03933397|588054172|FG000|Overall Study|Confirmed COVID-19|1|||
162819953|NCT03933397|588054173|FG001|Overall Study|Confirmed COVID-19|2|||
162819954|NCT02066051|588054176|FG000|Overall Study|Subject developed active GVHD|1|||
162819955|NCT01610687|588054177|FG000|Overall Study|Lack of Efficacy|26|||
162819956|NCT01610687|588054177|FG000|Overall Study|Adverse Event|18|||
162819957|NCT01610687|588054177|FG000|Overall Study|Moved out of area|6|||
162819958|NCT01610687|588054177|FG000|Overall Study|Withdrawal by Subject|7|||
162819959|NCT01610687|588054177|FG000|Overall Study|Lost to Follow-up|4|||
162819960|NCT01610687|588054177|FG000|Overall Study|Symptom control without study medication|2|||
162819961|NCT01610687|588054177|FG000|Overall Study|Unable to make journey|1|||
162819962|NCT01610687|588054177|FG000|Overall Study|Death|1|||
162819963|NCT01610687|588054177|FG000|Overall Study|Cannabis affecting job|1|||
162819964|NCT01610687|588054177|FG000|Overall Study|Felt more alter without study medication|1|||
162819965|NCT01294150|588054180|FG000|Overall Study|Physician Decision|2|||
162819966|NCT01294150|588054181|FG001|Overall Study|Physician Decision|2|||
162819967|NCT03675776|588054182|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
162819968|NCT03675776|588054183|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
162819969|NCT03675776|588054184|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
162819970|NCT03675776|588054182|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
162819971|NCT03675776|588054183|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
162819972|NCT03675776|588054184|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
162819973|NCT01093625|588054185|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
162819974|NCT01093625|588054186|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
162819975|NCT01093625|588054185|FG000|2-Week Visit|Withdrawal by Subject|1|||
162819976|NCT01093625|588054186|FG001|2-Week Visit|Withdrawal by Subject|0|||
162819977|NCT01093625|588054185|FG000|1-Month Visit|Lost to Follow-up|2|||
162819978|NCT01093625|588054186|FG001|1-Month Visit|Lost to Follow-up|0|||
162819979|NCT01093625|588054185|FG000|3-Month Visit|Lost to Follow-up|2|||
162819980|NCT01093625|588054186|FG001|3-Month Visit|Lost to Follow-up|0|||
162819981|NCT01093625|588054185|FG000|6-Month Visit|Withdrawal by Subject|6|||
162819982|NCT01093625|588054186|FG001|6-Month Visit|Withdrawal by Subject|7|||
162819983|NCT01093625|588054185|FG000|6-Month Visit|Lost to Follow-up|2|||
162819984|NCT01093625|588054186|FG001|6-Month Visit|Lost to Follow-up|2|||
162819985|NCT01093625|588054185|FG000|1-Year Visit|Lost to Follow-up|5|||
162819986|NCT01093625|588054186|FG001|1-Year Visit|Lost to Follow-up|3|||
162819987|NCT00698932|588054187|FG000|Overall Study|Adverse Event|0|||
162819988|NCT00698932|588054188|FG001|Overall Study|Adverse Event|2|||
162819989|NCT00698932|588054187|FG000|Overall Study|Incorrect enrollment|0|||
162819990|NCT00698932|588054188|FG001|Overall Study|Incorrect enrollment|2|||
162819991|NCT00698932|588054187|FG000|Overall Study|Study specific discontinuation criteria|3|||
162819992|NCT00698932|588054188|FG001|Overall Study|Study specific discontinuation criteria|4|||
162819993|NCT00698932|588054187|FG000|Overall Study|Withdrawal by Subject|11|||
162819994|NCT00698932|588054188|FG001|Overall Study|Withdrawal by Subject|23|||
162819995|NCT00698932|588054187|FG000|Overall Study|Lost to Follow-up|6|||
162819996|NCT00698932|588054188|FG001|Overall Study|Lost to Follow-up|1|||
162819997|NCT00698932|588054187|FG000|Overall Study|Severe non-compliance to protocol|1|||
162819998|NCT00698932|588054188|FG001|Overall Study|Severe non-compliance to protocol|2|||
162819999|NCT00698932|588054187|FG000|Overall Study|Safety reasons|0|||
162820000|NCT00698932|588054188|FG001|Overall Study|Safety reasons|2|||
162820001|NCT00698932|588054187|FG000|Overall Study|Death|1|||
162929557|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
162820002|NCT00698932|588054188|FG001|Overall Study|Death|0|||
162820003|NCT01621542|588054189|FG000|Overall Study|Adverse Event|0|||
162820004|NCT01621542|588054190|FG001|Overall Study|Adverse Event|0|||
162820005|NCT01621542|588054191|FG002|Overall Study|Adverse Event|1|||
162820006|NCT01621542|588054192|FG003|Overall Study|Adverse Event|3|||
162820007|NCT01621542|588054193|FG004|Overall Study|Adverse Event|0|||
162820008|NCT01621542|588054194|FG005|Overall Study|Adverse Event|0|||
162820009|NCT01621542|588054189|FG000|Overall Study|Death|0|||
162820010|NCT01621542|588054190|FG001|Overall Study|Death|1|||
162820011|NCT01621542|588054191|FG002|Overall Study|Death|0|||
162820012|NCT01621542|588054192|FG003|Overall Study|Death|0|||
162820013|NCT01621542|588054193|FG004|Overall Study|Death|0|||
162820014|NCT01621542|588054194|FG005|Overall Study|Death|0|||
162820015|NCT01621542|588054189|FG000|Overall Study|Physician Decision|1|||
162820016|NCT01621542|588054190|FG001|Overall Study|Physician Decision|0|||
162820017|NCT01621542|588054191|FG002|Overall Study|Physician Decision|1|||
162820018|NCT01621542|588054192|FG003|Overall Study|Physician Decision|13|||
162820019|NCT01621542|588054193|FG004|Overall Study|Physician Decision|3|||
162820020|NCT01621542|588054194|FG005|Overall Study|Physician Decision|1|||
162820021|NCT01621542|588054189|FG000|Overall Study|Withdrawal by Subject|2|||
162820022|NCT01621542|588054190|FG001|Overall Study|Withdrawal by Subject|0|||
162820023|NCT01621542|588054191|FG002|Overall Study|Withdrawal by Subject|1|||
162820024|NCT01621542|588054192|FG003|Overall Study|Withdrawal by Subject|3|||
162820025|NCT01621542|588054193|FG004|Overall Study|Withdrawal by Subject|3|||
162820026|NCT01621542|588054194|FG005|Overall Study|Withdrawal by Subject|3|||
162820027|NCT01621542|588054189|FG000|Overall Study|progression/treatment failure|2|||
162820028|NCT01621542|588054190|FG001|Overall Study|progression/treatment failure|4|||
162820029|NCT01621542|588054191|FG002|Overall Study|progression/treatment failure|3|||
162820030|NCT01621542|588054192|FG003|Overall Study|progression/treatment failure|7|||
162820031|NCT01621542|588054193|FG004|Overall Study|progression/treatment failure|3|||
162820032|NCT01621542|588054194|FG005|Overall Study|progression/treatment failure|5|||
162820033|NCT01621542|588054189|FG000|Overall Study|Protocol Violation|0|||
162820034|NCT01621542|588054190|FG001|Overall Study|Protocol Violation|0|||
162820035|NCT01621542|588054191|FG002|Overall Study|Protocol Violation|0|||
162820036|NCT01621542|588054192|FG003|Overall Study|Protocol Violation|1|||
162820037|NCT01621542|588054193|FG004|Overall Study|Protocol Violation|0|||
162820038|NCT01621542|588054194|FG005|Overall Study|Protocol Violation|0|||
162820039|NCT01621542|588054189|FG000|Overall Study|study stopped by sponsor|0|||
162820040|NCT01621542|588054190|FG001|Overall Study|study stopped by sponsor|0|||
162820041|NCT01621542|588054191|FG002|Overall Study|study stopped by sponsor|0|||
162820042|NCT01621542|588054192|FG003|Overall Study|study stopped by sponsor|1|||
162820043|NCT01621542|588054193|FG004|Overall Study|study stopped by sponsor|0|||
162820044|NCT01621542|588054194|FG005|Overall Study|study stopped by sponsor|0|||
162820045|NCT06132425|588054195|FG000|Overall Study|Withdrawal by Subject|3|||
162820046|NCT06132425|588054196|FG001|Overall Study|Withdrawal by Subject|0|||
162820047|NCT06132425|588054195|FG000|Overall Study|Did not follow study instructions|0|||
162820048|NCT06132425|588054196|FG001|Overall Study|Did not follow study instructions|2|||
162820049|NCT06132425|588054195|FG000|Overall Study|Lost to Follow-up|3|||
162820050|NCT06132425|588054196|FG001|Overall Study|Lost to Follow-up|5|||
162820051|NCT00708175|588054197|FG000|Overall Study|Adverse Event|4|||
162820052|NCT00708175|588054198|FG001|Overall Study|Adverse Event|5|||
162820053|NCT00708175|588054197|FG000|Overall Study|Protocol Violation|2|||
162820054|NCT00708175|588054198|FG001|Overall Study|Protocol Violation|3|||
162820055|NCT00708175|588054197|FG000|Overall Study|Lost to Follow-up|5|||
162820056|NCT00708175|588054198|FG001|Overall Study|Lost to Follow-up|3|||
162820057|NCT00708175|588054197|FG000|Overall Study|Withdrawal by Subject|5|||
162820058|NCT00708175|588054198|FG001|Overall Study|Withdrawal by Subject|7|||
162820059|NCT00708175|588054197|FG000|Overall Study|BMD loss >7%|2|||
162820060|NCT00708175|588054198|FG001|Overall Study|BMD loss >7%|3|||
162820061|NCT04435782|588054200|FG000|Overall Study|Study terminated by sponsor|4|||
162820062|NCT03672461|588054201|FG000|Overall Study|COVID Related|4|||
162820063|NCT03672461|588054202|FG001|Overall Study|COVID Related|2|||
162820064|NCT03672461|588054201|FG000|Overall Study|Adverse Event|2|||
162820065|NCT03672461|588054202|FG001|Overall Study|Adverse Event|0|||
162820066|NCT03672461|588054201|FG000|Overall Study|Serious Adverse Event|0|||
162820067|NCT03672461|588054202|FG001|Overall Study|Serious Adverse Event|1|||
162820068|NCT03672461|588054201|FG000|Overall Study|Too Busy|3|||
162820069|NCT03672461|588054202|FG001|Overall Study|Too Busy|1|||
162820070|NCT03672461|588054201|FG000|Overall Study|Lost to Follow-up|1|||
162820071|NCT03672461|588054202|FG001|Overall Study|Lost to Follow-up|2|||
162820072|NCT03672461|588054201|FG000|Overall Study|Family|2|||
162820073|NCT03672461|588054202|FG001|Overall Study|Family|2|||
162820074|NCT03672461|588054201|FG000|Overall Study|No remote technology access|0|||
162820075|NCT03672461|588054202|FG001|Overall Study|No remote technology access|1|||
162820076|NCT03672461|588054201|FG000|Overall Study|Withdrawal by Subject|1|||
162820077|NCT03672461|588054202|FG001|Overall Study|Withdrawal by Subject|0|||
162820078|NCT03672461|588054201|FG000|Overall Study|Cannot tolerate intervention|1|||
162820079|NCT03672461|588054202|FG001|Overall Study|Cannot tolerate intervention|0|||
162820080|NCT03672461|588054201|FG000|Overall Study|Incomplete outcome data|6|||
162820081|NCT03672461|588054202|FG001|Overall Study|Incomplete outcome data|1|||
162820082|NCT04667247|588054203|FG000|Overall Study|Withdrawal by Subject|0|||
162820083|NCT04667247|588054204|FG001|Overall Study|Withdrawal by Subject|1|||
162820084|NCT01876251|588056363|FG000|Overall Study|Clinical progression|1|||
162820085|NCT01876251|588056364|FG001|Overall Study|Clinical progression|0|||
162820086|NCT01876251|588056365|FG002|Overall Study|Clinical progression|0|||
162820087|NCT01876251|588056363|FG000|Overall Study|Death|2|||
162820088|NCT01876251|588056364|FG001|Overall Study|Death|0|||
162820089|NCT01876251|588056365|FG002|Overall Study|Death|1|||
162820090|NCT01876251|588056363|FG000|Overall Study|Participant started new treatment|1|||
162820091|NCT01876251|588056364|FG001|Overall Study|Participant started new treatment|0|||
162820092|NCT01876251|588056365|FG002|Overall Study|Participant started new treatment|1|||
162820093|NCT01876251|588056363|FG000|Overall Study|Participant refused further follow-up|0|||
162820094|NCT01876251|588056364|FG001|Overall Study|Participant refused further follow-up|0|||
162820095|NCT01876251|588056365|FG002|Overall Study|Participant refused further follow-up|1|||
162820096|NCT01876251|588056363|FG000|Overall Study|Study terminated|1|||
162820097|NCT01876251|588056364|FG001|Overall Study|Study terminated|0|||
162820098|NCT01876251|588056365|FG002|Overall Study|Study terminated|0|||
162820099|NCT01876251|588056363|FG000|Overall Study|Objective progression or relapse|10|||
162820100|NCT01876251|588056364|FG001|Overall Study|Objective progression or relapse|3|||
162820101|NCT01876251|588056365|FG002|Overall Study|Objective progression or relapse|8|||
162820102|NCT02012296|588056374|FG000|Overall Study|Lack of Efficacy|0|||
162820103|NCT02012296|588056375|FG001|Overall Study|Lack of Efficacy|0|||
162820104|NCT02012296|588056376|FG002|Overall Study|Lack of Efficacy|15|||
162820105|NCT02012296|588056374|FG000|Overall Study|Adverse Event|0|||
162820106|NCT02012296|588056375|FG001|Overall Study|Adverse Event|0|||
162820107|NCT02012296|588056376|FG002|Overall Study|Adverse Event|2|||
162820108|NCT02012296|588056374|FG000|Overall Study|Early study closure|0|||
162820109|NCT02012296|588056375|FG001|Overall Study|Early study closure|0|||
162820110|NCT02012296|588056376|FG002|Overall Study|Early study closure|5|||
162820111|NCT02012296|588056374|FG000|Overall Study|Protocol Violation|0|||
162820112|NCT02012296|588056375|FG001|Overall Study|Protocol Violation|1|||
162820113|NCT02012296|588056376|FG002|Overall Study|Protocol Violation|0|||
162820114|NCT03876171|588056377|FG000|Overall Study|Withdrawal by Subject|3|||
162820115|NCT03876171|588056378|FG001|Overall Study|Withdrawal by Subject|3|||
162820116|NCT03876171|588056377|FG000|Overall Study|Re-arrest|0|||
162820117|NCT03876171|588056378|FG001|Overall Study|Re-arrest|4|||
162820118|NCT00727649|588056381|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
162820119|NCT00727649|588056382|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
162820120|NCT00727649|588056381|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
162820121|NCT00727649|588056382|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
162820122|NCT00727649|588056381|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
162820123|NCT00727649|588056382|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
162820124|NCT00727649|588056381|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
162820125|NCT00727649|588056382|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
162820126|NCT00727649|588056381|FG000|Second Intervention (4-weeks)|Death|1|||
162820127|NCT00727649|588056382|FG001|Second Intervention (4-weeks)|Death|0|||
162820128|NCT00727649|588056381|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
162820129|NCT00727649|588056382|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
162820130|NCT00727649|588056381|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
162820131|NCT00727649|588056382|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
162820132|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
162820133|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
162820134|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
162820135|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
162820136|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
162820137|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
162820138|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
162820139|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
162820140|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
162820141|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
162820142|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
162820143|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
162820144|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
162820145|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
162820146|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
162820147|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
162820148|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
162820149|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
162820150|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
162820151|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
162820152|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
162820153|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
162820154|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
162820155|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
162820156|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
162820157|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
162820158|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
162820159|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
162820160|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
162820161|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
162820162|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
162820163|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
162820164|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
162820165|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
162820166|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
162924222|NCT00077766|588423834|FG001|Overall Study|Investigators Discretion|0|||
162698274|NCT01394250|587605452|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
162698275|NCT01394250|587605453|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
163170386|NCT03137069|589340926|FG000|Overall Study|Adverse Event|0|||
163170387|NCT03137069|589340927|FG001|Overall Study|Adverse Event|3|||
163170388|NCT03137069|589340928|FG002|Overall Study|Adverse Event|1|||
163170389|NCT03137069|589340929|FG003|Overall Study|Adverse Event|1|||
163170390|NCT03137069|589340930|FG004|Overall Study|Adverse Event|0|||
163170391|NCT03137069|589340931|FG005|Overall Study|Adverse Event|1|||
163170392|NCT03137069|589340926|FG000|Overall Study|Protocol Violation|0|||
163170393|NCT03137069|589340927|FG001|Overall Study|Protocol Violation|1|||
163170394|NCT03137069|589340928|FG002|Overall Study|Protocol Violation|0|||
163170395|NCT03137069|589340929|FG003|Overall Study|Protocol Violation|1|||
163170396|NCT03137069|589340930|FG004|Overall Study|Protocol Violation|1|||
163170397|NCT03137069|589340931|FG005|Overall Study|Protocol Violation|1|||
163170398|NCT03137069|589340926|FG000|Overall Study|Physician Decision|0|||
163170399|NCT03137069|589340927|FG001|Overall Study|Physician Decision|0|||
163170400|NCT03137069|589340928|FG002|Overall Study|Physician Decision|0|||
163170401|NCT03137069|589340929|FG003|Overall Study|Physician Decision|1|||
163170402|NCT03137069|589340930|FG004|Overall Study|Physician Decision|0|||
163170403|NCT03137069|589340931|FG005|Overall Study|Physician Decision|0|||
163170404|NCT03137069|589340926|FG000|Overall Study|Study Terminated by Sponsor|0|||
163170405|NCT03137069|589340927|FG001|Overall Study|Study Terminated by Sponsor|0|||
163170406|NCT03137069|589340928|FG002|Overall Study|Study Terminated by Sponsor|0|||
163170407|NCT03137069|589340929|FG003|Overall Study|Study Terminated by Sponsor|0|||
163170408|NCT03137069|589340930|FG004|Overall Study|Study Terminated by Sponsor|1|||
163170409|NCT03137069|589340931|FG005|Overall Study|Study Terminated by Sponsor|0|||
163170410|NCT03137069|589340926|FG000|Overall Study|Data Entry Error|0|||
163170411|NCT03137069|589340927|FG001|Overall Study|Data Entry Error|0|||
163170412|NCT03137069|589340928|FG002|Overall Study|Data Entry Error|0|||
163170413|NCT03137069|589340929|FG003|Overall Study|Data Entry Error|1|||
163170414|NCT03137069|589340930|FG004|Overall Study|Data Entry Error|0|||
163170415|NCT03137069|589340931|FG005|Overall Study|Data Entry Error|0|||
163170416|NCT01106092|589340933|FG000|Overall Study|Withdrawal by Subject|0|||
163170417|NCT01106092|589340934|FG001|Overall Study|Withdrawal by Subject|0|||
163170418|NCT01106092|589340935|FG002|Overall Study|Withdrawal by Subject|0|||
163170419|NCT01106092|589340936|FG003|Overall Study|Withdrawal by Subject|1|||
163170420|NCT02434471|589340937|FG000|Overall Study|Physician Decision|9|||
163170421|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
163170422|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
163170423|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
163170424|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
163170425|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170426|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170427|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
163170428|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
163170429|NCT00369629|589340942|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
163170430|NCT00369629|589340943|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170431|NCT00369629|589340944|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170432|NCT00369629|589340945|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
163170433|NCT00369629|589340942|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
163170434|NCT00369629|589340943|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
163170435|NCT00369629|589340944|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
163170436|NCT00369629|589340945|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
163170437|NCT00369629|589340942|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
163170438|NCT00369629|589340943|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
163170439|NCT00369629|589340944|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
163170440|NCT00369629|589340945|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
163170441|NCT00369629|589340942|FG000|Completed 4 More Cycles|Progressive disease|2|||
163170442|NCT00369629|589340943|FG001|Completed 4 More Cycles|Progressive disease|1|||
163170443|NCT00369629|589340944|FG002|Completed 4 More Cycles|Progressive disease|2|||
163170444|NCT00369629|589340945|FG003|Completed 4 More Cycles|Progressive disease|0|||
163170445|NCT00369629|589340942|FG000|Follow up for 1 Year|Death|2|||
163170446|NCT00369629|589340943|FG001|Follow up for 1 Year|Death|1|||
163170447|NCT00369629|589340944|FG002|Follow up for 1 Year|Death|1|||
163170448|NCT00369629|589340945|FG003|Follow up for 1 Year|Death|0|||
163170449|NCT00369629|589340942|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
163170450|NCT00369629|589340943|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
163170451|NCT00369629|589340944|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
163170452|NCT00369629|589340945|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
163170453|NCT00369629|589340942|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
162820167|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
162820168|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
162820169|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
162820170|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
162698276|NCT01394250|587605452|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
162698277|NCT01394250|587605453|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
162698278|NCT02222896|587605454|FG000|Abdomen|Did not qualify|34|||
162698279|NCT02222896|587605455|FG001|Abdomen|Did not qualify|10|||
162698280|NCT02222896|587605456|FG002|Abdomen|Did not qualify|32|||
162698281|NCT02222896|587605454|FG000|Groin|Did not qualify|43|||
162698282|NCT02222896|587605455|FG001|Groin|Did not qualify|9|||
162698283|NCT02222896|587605456|FG002|Groin|Did not qualify|40|||
162698284|NCT01865617|587605458|FG000|Overall Study|Death|27|||
162698285|NCT01865617|587605459|FG001|Overall Study|Death|3|||
162698286|NCT01865617|587605460|FG002|Overall Study|Death|1|||
162698287|NCT01865617|587605461|FG003|Overall Study|Death|1|||
162698288|NCT01865617|587605462|FG004|Overall Study|Death|5|||
162698289|NCT01865617|587605463|FG005|Overall Study|Death|1|||
162698290|NCT01865617|587605464|FG006|Overall Study|Death|11|||
162698291|NCT01865617|587605465|FG007|Overall Study|Death|1|||
162698292|NCT01865617|587605466|FG008|Overall Study|Death|11|||
162698293|NCT01865617|587605467|FG009|Overall Study|Death|3|||
162698294|NCT01865617|587605468|FG010|Overall Study|Death|32|||
162698295|NCT01865617|587605469|FG011|Overall Study|Death|6|||
162698296|NCT01865617|587605470|FG012|Overall Study|Death|13|||
162698297|NCT01865617|587605458|FG000|Overall Study|Lost to Follow-up|2|||
162698298|NCT01865617|587605459|FG001|Overall Study|Lost to Follow-up|0|||
162698299|NCT01865617|587605460|FG002|Overall Study|Lost to Follow-up|0|||
162698300|NCT01865617|587605461|FG003|Overall Study|Lost to Follow-up|0|||
162698301|NCT01865617|587605462|FG004|Overall Study|Lost to Follow-up|0|||
162698302|NCT01865617|587605463|FG005|Overall Study|Lost to Follow-up|0|||
162698303|NCT01865617|587605464|FG006|Overall Study|Lost to Follow-up|0|||
162698304|NCT01865617|587605465|FG007|Overall Study|Lost to Follow-up|0|||
162698305|NCT01865617|587605466|FG008|Overall Study|Lost to Follow-up|0|||
162698306|NCT01865617|587605467|FG009|Overall Study|Lost to Follow-up|0|||
162698307|NCT01865617|587605468|FG010|Overall Study|Lost to Follow-up|0|||
162698308|NCT01865617|587605469|FG011|Overall Study|Lost to Follow-up|0|||
162698309|NCT01865617|587605470|FG012|Overall Study|Lost to Follow-up|0|||
162698310|NCT01865617|587605458|FG000|Overall Study|Withdrawal by Subject|1|||
162698311|NCT01865617|587605459|FG001|Overall Study|Withdrawal by Subject|0|||
162698312|NCT01865617|587605460|FG002|Overall Study|Withdrawal by Subject|0|||
162698313|NCT01865617|587605461|FG003|Overall Study|Withdrawal by Subject|0|||
162698314|NCT01865617|587605462|FG004|Overall Study|Withdrawal by Subject|0|||
162698315|NCT01865617|587605463|FG005|Overall Study|Withdrawal by Subject|0|||
162698316|NCT01865617|587605464|FG006|Overall Study|Withdrawal by Subject|0|||
162698317|NCT01865617|587605465|FG007|Overall Study|Withdrawal by Subject|0|||
162698318|NCT01865617|587605466|FG008|Overall Study|Withdrawal by Subject|0|||
162698319|NCT01865617|587605467|FG009|Overall Study|Withdrawal by Subject|0|||
162698320|NCT01865617|587605468|FG010|Overall Study|Withdrawal by Subject|0|||
162698321|NCT01865617|587605469|FG011|Overall Study|Withdrawal by Subject|0|||
162698322|NCT01865617|587605470|FG012|Overall Study|Withdrawal by Subject|0|||
162698323|NCT01865617|587605458|FG000|Overall Study|Patient proceeded to new therapy|0|||
162698324|NCT01865617|587605459|FG001|Overall Study|Patient proceeded to new therapy|0|||
162698325|NCT01865617|587605460|FG002|Overall Study|Patient proceeded to new therapy|0|||
162698326|NCT01865617|587605461|FG003|Overall Study|Patient proceeded to new therapy|0|||
162698327|NCT01865617|587605462|FG004|Overall Study|Patient proceeded to new therapy|2|||
162698328|NCT01865617|587605463|FG005|Overall Study|Patient proceeded to new therapy|0|||
162698329|NCT01865617|587605464|FG006|Overall Study|Patient proceeded to new therapy|0|||
162698330|NCT01865617|587605465|FG007|Overall Study|Patient proceeded to new therapy|0|||
162698331|NCT01865617|587605466|FG008|Overall Study|Patient proceeded to new therapy|0|||
162698332|NCT01865617|587605467|FG009|Overall Study|Patient proceeded to new therapy|0|||
162698333|NCT01865617|587605468|FG010|Overall Study|Patient proceeded to new therapy|0|||
162698334|NCT01865617|587605469|FG011|Overall Study|Patient proceeded to new therapy|0|||
162698335|NCT01865617|587605470|FG012|Overall Study|Patient proceeded to new therapy|0|||
162698336|NCT01865617|587605458|FG000|Overall Study|Other|0|||
162698337|NCT01865617|587605459|FG001|Overall Study|Other|0|||
162698338|NCT01865617|587605460|FG002|Overall Study|Other|0|||
162698339|NCT01865617|587605461|FG003|Overall Study|Other|0|||
162698340|NCT01865617|587605462|FG004|Overall Study|Other|0|||
162698341|NCT01865617|587605463|FG005|Overall Study|Other|0|||
162698342|NCT01865617|587605464|FG006|Overall Study|Other|1|||
162698343|NCT01865617|587605465|FG007|Overall Study|Other|0|||
162698344|NCT01865617|587605466|FG008|Overall Study|Other|0|||
162698345|NCT01865617|587605467|FG009|Overall Study|Other|0|||
162698346|NCT01865617|587605468|FG010|Overall Study|Other|0|||
162820171|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
162820172|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
162698347|NCT01865617|587605469|FG011|Overall Study|Other|0|||
162820173|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
162820174|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
162820175|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
162820176|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
162820177|NCT03627767|588056386|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
162820178|NCT03627767|588056387|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
162820179|NCT03627767|588056388|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
162820180|NCT03627767|588056389|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
162820181|NCT03627767|588056390|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
162820182|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
162820183|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
162820184|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
162820185|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
162820186|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
162820187|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162820188|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162820189|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
162820190|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
162820191|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162820192|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
162820193|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
162820194|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
162820195|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
162820196|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
162820197|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162820198|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
162820199|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
162820200|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
162820201|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162820202|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
162820203|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
162820204|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
162820205|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
162820206|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
162820207|NCT03627767|588056386|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
162820208|NCT03627767|588056387|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
162820209|NCT03627767|588056388|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
162820210|NCT03627767|588056389|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
162820211|NCT03627767|588056390|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
162820212|NCT03627767|588056386|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
162820213|NCT03627767|588056387|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
162820214|NCT03627767|588056388|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
162820215|NCT03627767|588056389|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
162820216|NCT03627767|588056390|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
162820217|NCT03627767|588056386|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
162820218|NCT03627767|588056387|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
162820219|NCT03627767|588056388|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
162820220|NCT03627767|588056389|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
162820221|NCT03627767|588056390|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
162820222|NCT03627767|588056386|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
162820223|NCT03627767|588056387|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
162820224|NCT03627767|588056388|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
162820225|NCT03627767|588056389|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
162820226|NCT03627767|588056390|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
162820227|NCT03627767|588056386|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
162820228|NCT03627767|588056387|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
162820229|NCT03627767|588056388|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
162820230|NCT03627767|588056389|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
162820231|NCT03627767|588056390|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
162820232|NCT00283049|588056391|FG000|Overall Study|Adverse Event|6|||
162820233|NCT00283049|588056392|FG001|Overall Study|Adverse Event|1|||
162820234|NCT00283049|588056393|FG002|Overall Study|Adverse Event|4|||
162820235|NCT00283049|588056391|FG000|Overall Study|Protocol Violation|3|||
162820236|NCT00283049|588056392|FG001|Overall Study|Protocol Violation|0|||
162820237|NCT00283049|588056393|FG002|Overall Study|Protocol Violation|3|||
162820238|NCT00283049|588056391|FG000|Overall Study|Death|1|||
162820239|NCT00283049|588056392|FG001|Overall Study|Death|1|||
162820240|NCT00283049|588056393|FG002|Overall Study|Death|1|||
163170454|NCT00369629|589340943|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
163170455|NCT00369629|589340944|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
163170456|NCT00369629|589340945|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
163170457|NCT04839562|589340946|FG000|Overall Study|Withdrawal by Subject|0|||
163170458|NCT04839562|589340947|FG001|Overall Study|Withdrawal by Subject|1|||
163170459|NCT04839562|589340946|FG000|Overall Study|Physician Decision|0|||
162820241|NCT00283049|588056391|FG000|Overall Study|Lack of Efficacy|0|||
162820242|NCT00283049|588056392|FG001|Overall Study|Lack of Efficacy|1|||
162820243|NCT00283049|588056393|FG002|Overall Study|Lack of Efficacy|1|||
162820244|NCT00283049|588056391|FG000|Overall Study|Lost to Follow-up|4|||
162820245|NCT00283049|588056392|FG001|Overall Study|Lost to Follow-up|2|||
162820246|NCT00283049|588056393|FG002|Overall Study|Lost to Follow-up|5|||
162820247|NCT00283049|588056391|FG000|Overall Study|Withdrawal by Subject|26|||
162820248|NCT00283049|588056392|FG001|Overall Study|Withdrawal by Subject|24|||
162820249|NCT00283049|588056393|FG002|Overall Study|Withdrawal by Subject|19|||
162820250|NCT00283049|588056391|FG000|Overall Study|Discontinuation of Study|18|||
162820251|NCT00283049|588056392|FG001|Overall Study|Discontinuation of Study|16|||
162820252|NCT00283049|588056393|FG002|Overall Study|Discontinuation of Study|20|||
162820253|NCT00283049|588056391|FG000|Overall Study|No longer requires study treatment|0|||
162820254|NCT00283049|588056392|FG001|Overall Study|No longer requires study treatment|0|||
162820255|NCT00283049|588056393|FG002|Overall Study|No longer requires study treatment|1|||
162820256|NCT02953639|588056394|FG000|Overall Study|Adverse Event|2|||
162820257|NCT02953639|588056395|FG001|Overall Study|Adverse Event|0|||
162820258|NCT02953639|588056396|FG002|Overall Study|Adverse Event|1|||
162820259|NCT02953639|588056394|FG000|Overall Study|Lost to Follow-up|8|||
162820260|NCT02953639|588056395|FG001|Overall Study|Lost to Follow-up|4|||
162820261|NCT02953639|588056396|FG002|Overall Study|Lost to Follow-up|3|||
162820262|NCT02953639|588056394|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162820263|NCT02953639|588056395|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162820264|NCT02953639|588056396|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162820265|NCT02953639|588056394|FG000|Overall Study|Multiple Reasons|1|||
162820266|NCT02953639|588056395|FG001|Overall Study|Multiple Reasons|0|||
162820267|NCT02953639|588056396|FG002|Overall Study|Multiple Reasons|1|||
162820268|NCT02953639|588056394|FG000|Overall Study|Physician Decision|1|||
162820269|NCT02953639|588056395|FG001|Overall Study|Physician Decision|0|||
162820270|NCT02953639|588056396|FG002|Overall Study|Physician Decision|0|||
162820271|NCT02953639|588056394|FG000|Overall Study|Withdrawal by Subject|7|||
162820272|NCT02953639|588056395|FG001|Overall Study|Withdrawal by Subject|8|||
162820273|NCT02953639|588056396|FG002|Overall Study|Withdrawal by Subject|10|||
162820274|NCT02953639|588056394|FG000|Overall Study|Completed or Discontinued information is missing|1|||
162820275|NCT02953639|588056395|FG001|Overall Study|Completed or Discontinued information is missing|0|||
162820276|NCT02953639|588056396|FG002|Overall Study|Completed or Discontinued information is missing|0|||
162820277|NCT01667081|588056397|FG000|Overall Study|Death|43|||
162820278|NCT01667081|588056398|FG001|Overall Study|Death|3|||
162820279|NCT01667081|588056397|FG000|Overall Study|Lost to Follow-up|99|||
162820280|NCT01667081|588056398|FG001|Overall Study|Lost to Follow-up|48|||
162820281|NCT01667081|588056397|FG000|Overall Study|Physician Decision|16|||
162820282|NCT01667081|588056398|FG001|Overall Study|Physician Decision|2|||
162820283|NCT01667081|588056397|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
162820284|NCT01667081|588056398|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
162820285|NCT01667081|588056397|FG000|Overall Study|Withdrawal by Subject|90|||
162820286|NCT01667081|588056398|FG001|Overall Study|Withdrawal by Subject|35|||
162820287|NCT03034460|588056399|FG000|Overall Study|Adverse Event|0|||
162820288|NCT03034460|588056400|FG001|Overall Study|Adverse Event|1|||
162820289|NCT03034460|588056399|FG000|Overall Study|Withdrawal by Subject|2|||
162820290|NCT03034460|588056400|FG001|Overall Study|Withdrawal by Subject|2|||
162820291|NCT03034460|588056399|FG000|Overall Study|Personal Reasons|1|||
162820292|NCT03034460|588056400|FG001|Overall Study|Personal Reasons|0|||
162820293|NCT02294682|588056401|FG000|Overall Study|Could not swallow pills|1|||
162820294|NCT02294682|588056402|FG001|Overall Study|Could not swallow pills|0|||
162820295|NCT01516970|588056403|FG000|Overall Study|Lost to Follow-up|7|||
162820296|NCT01516970|588056404|FG001|Overall Study|Lost to Follow-up|8|||
162820297|NCT01516970|588056403|FG000|Overall Study|Adverse Event|1|||
162820298|NCT01516970|588056404|FG001|Overall Study|Adverse Event|5|||
162820299|NCT01516970|588056403|FG000|Overall Study|Withdrawal by Subject|1|||
162820300|NCT01516970|588056404|FG001|Overall Study|Withdrawal by Subject|1|||
162820301|NCT01516970|588056403|FG000|Overall Study|Other|9|||
162820302|NCT01516970|588056404|FG001|Overall Study|Other|7|||
162820303|NCT00434421|588056405|FG000|Overall Study|Withdrawal by Subject|1|||
162820304|NCT00434421|588056405|FG000|Overall Study|Non-compliance with study treatment|1|||
162820305|NCT01296035|588056408|FG000|Overall Study|Withdrawal by Subject|1|||
162820306|NCT00117507|588056419|FG000|Overall Study|Adverse Event|4|||
162820307|NCT00117507|588056419|FG000|Overall Study|Abnormal laboratory values|3|||
162820308|NCT00117507|588056419|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162820309|NCT00117507|588056419|FG000|Overall Study|Patient withdrew consent|4|||
162820310|NCT00117507|588056419|FG000|Overall Study|Death|3|||
162820311|NCT00866723|588056420|FG000|Overall Study|Withdrawal by Subject|1|||
162820312|NCT00866723|588056420|FG000|Overall Study|Disease Progression|4|||
162820313|NCT01003990|588056426|FG000|Overall Study|Adverse Event|8|||
162820314|NCT01003990|588056427|FG001|Overall Study|Adverse Event|5|||
162820315|NCT01003990|588056428|FG002|Overall Study|Adverse Event|11|||
162820316|NCT01003990|588056426|FG000|Overall Study|Death|0|||
162820317|NCT01003990|588056427|FG001|Overall Study|Death|8|||
162820318|NCT01003990|588056428|FG002|Overall Study|Death|1|||
162820319|NCT01003990|588056426|FG000|Overall Study|Lack of Efficacy|10|||
162820320|NCT01003990|588056427|FG001|Overall Study|Lack of Efficacy|2|||
162820321|NCT01003990|588056428|FG002|Overall Study|Lack of Efficacy|3|||
162820322|NCT01003990|588056426|FG000|Overall Study|Lost to Follow-up|30|||
162820323|NCT01003990|588056427|FG001|Overall Study|Lost to Follow-up|12|||
162820324|NCT01003990|588056428|FG002|Overall Study|Lost to Follow-up|7|||
162820325|NCT01003990|588056426|FG000|Overall Study|Reasons Not Identified|14|||
162820326|NCT01003990|588056427|FG001|Overall Study|Reasons Not Identified|13|||
162820327|NCT01003990|588056428|FG002|Overall Study|Reasons Not Identified|8|||
162820328|NCT01003990|588056426|FG000|Overall Study|Poor/Non-compliance|4|||
162820329|NCT01003990|588056427|FG001|Overall Study|Poor/Non-compliance|3|||
162820330|NCT01003990|588056428|FG002|Overall Study|Poor/Non-compliance|2|||
162820331|NCT01003990|588056426|FG000|Overall Study|Pregnancy|10|||
162820332|NCT01003990|588056427|FG001|Overall Study|Pregnancy|2|||
163170460|NCT04839562|589340947|FG001|Overall Study|Physician Decision|1|||
163170461|NCT00877773|589340948|FG000|Overall Study|Disease Progression|44|||
163170462|NCT02907892|589340951|FG000|Overall Study|Lost to Follow-up|27|||
163170463|NCT02907892|589340952|FG001|Overall Study|Lost to Follow-up|40|||
163170464|NCT01347580|589340953|FG000|Overall Study|Withdrawal by Subject|13|||
163170465|NCT01347580|589340954|FG001|Overall Study|Withdrawal by Subject|23|||
163170466|NCT01347580|589340953|FG000|Overall Study|Death|30|||
163170467|NCT01347580|589340954|FG001|Overall Study|Death|19|||
163170468|NCT01347580|589340953|FG000|Overall Study|Protocol Violation|10|||
163170469|NCT01347580|589340954|FG001|Overall Study|Protocol Violation|7|||
163170470|NCT01347580|589340953|FG000|Overall Study|Lost to Follow-up|3|||
163170471|NCT01347580|589340954|FG001|Overall Study|Lost to Follow-up|1|||
163170472|NCT01347580|589340953|FG000|Overall Study|Had other reason|9|||
163170473|NCT01347580|589340954|FG001|Overall Study|Had other reason|6|||
163170474|NCT01964755|589340955|FG000|Overall Study|Death|2|||
163170475|NCT00412373|589340956|FG000|Overall Study|Adverse Event|8|||
163170476|NCT00412373|589340957|FG001|Overall Study|Adverse Event|13|||
163170477|NCT00412373|589340956|FG000|Overall Study|Lack of Efficacy|16|||
163170478|NCT00412373|589340957|FG001|Overall Study|Lack of Efficacy|22|||
163170479|NCT00412373|589340956|FG000|Overall Study|Lost to Follow-up|7|||
163170480|NCT00412373|589340957|FG001|Overall Study|Lost to Follow-up|13|||
163170481|NCT00412373|589340956|FG000|Overall Study|Withdrawal by Subject|8|||
163170482|NCT00412373|589340957|FG001|Overall Study|Withdrawal by Subject|27|||
163170483|NCT00412373|589340956|FG000|Overall Study|Other|2|||
163170484|NCT00412373|589340957|FG001|Overall Study|Other|2|||
163170485|NCT00422513|589340958|FG000|Overall Study|Lack of Efficacy|4|||
163170486|NCT00422513|589340959|FG001|Overall Study|Lack of Efficacy|5|||
163170487|NCT00422513|589340958|FG000|Overall Study|Protocol Violation|23|||
163170488|NCT00422513|589340959|FG001|Overall Study|Protocol Violation|7|||
163170489|NCT00422513|589340958|FG000|Overall Study|Refused Treatment|4|||
163170490|NCT00422513|589340959|FG001|Overall Study|Refused Treatment|2|||
163170491|NCT00422513|589340958|FG000|Overall Study|Withdrawal by Subject|2|||
163170492|NCT00422513|589340959|FG001|Overall Study|Withdrawal by Subject|1|||
163170493|NCT00422513|589340958|FG000|Overall Study|early termination of the study|67|||
163170494|NCT00422513|589340959|FG001|Overall Study|early termination of the study|80|||
163170495|NCT00422513|589340958|FG000|Overall Study|Adverse Event|4|||
163170496|NCT00422513|589340959|FG001|Overall Study|Adverse Event|4|||
163170497|NCT00422513|589340958|FG000|Overall Study|Death|3|||
163170498|NCT00422513|589340959|FG001|Overall Study|Death|7|||
163170499|NCT03135119|589340960|FG000|Overall Study|Lost to Follow-up|2|||
163170500|NCT03135119|589340961|FG001|Overall Study|Lost to Follow-up|0|||
163170501|NCT03135119|589340960|FG000|Overall Study|Physician Decision|1|||
163170502|NCT03135119|589340961|FG001|Overall Study|Physician Decision|1|||
163170503|NCT03135119|589340960|FG000|Overall Study|COVID-19 Shutdown|2|||
163170504|NCT03135119|589340961|FG001|Overall Study|COVID-19 Shutdown|2|||
162820333|NCT01003990|588056428|FG002|Overall Study|Pregnancy|4|||
162820334|NCT01003990|588056426|FG000|Overall Study|No Longer Met Study Criteria|4|||
163170505|NCT01478048|589340962|FG000|Overall Study|Disease Progression|52|||
163170506|NCT01478048|589340963|FG001|Overall Study|Disease Progression|35|||
163170507|NCT01478048|589340962|FG000|Overall Study|study drug toxicity|11|||
163170508|NCT01478048|589340963|FG001|Overall Study|study drug toxicity|14|||
162820335|NCT01003990|588056427|FG001|Overall Study|No Longer Met Study Criteria|1|||
162820336|NCT01003990|588056428|FG002|Overall Study|No Longer Met Study Criteria|0|||
162820337|NCT01003990|588056426|FG000|Overall Study|Subject Withdrew Consent|12|||
163170509|NCT01478048|589340962|FG000|Overall Study|Adverse Event|2|||
163170510|NCT01478048|589340963|FG001|Overall Study|Adverse Event|11|||
163170511|NCT01478048|589340962|FG000|Overall Study|subject request to discontinue treatment|3|||
163170512|NCT01478048|589340963|FG001|Overall Study|subject request to discontinue treatment|5|||
163170513|NCT01478048|589340962|FG000|Overall Study|Withdrawal by Subject|2|||
163170514|NCT01478048|589340963|FG001|Overall Study|Withdrawal by Subject|5|||
163170515|NCT01478048|589340962|FG000|Overall Study|non-specified|6|||
163170516|NCT01478048|589340963|FG001|Overall Study|non-specified|4|||
163170517|NCT01478048|589340962|FG000|Overall Study|poor/non-compliance|0|||
163170518|NCT01478048|589340963|FG001|Overall Study|poor/non-compliance|1|||
163170519|NCT01478048|589340962|FG000|Overall Study|no longer meets study criteria|1|||
163170520|NCT01478048|589340963|FG001|Overall Study|no longer meets study criteria|0|||
163170521|NCT01369329|589340965|FG000|Overall Study|Withdrawal by Subject|8|||
163170522|NCT01369329|589340966|FG001|Overall Study|Withdrawal by Subject|6|||
163170523|NCT01369329|589340967|FG002|Overall Study|Withdrawal by Subject|10|||
163170524|NCT01369329|589340965|FG000|Overall Study|Lost to Follow-up|2|||
163170525|NCT01369329|589340966|FG001|Overall Study|Lost to Follow-up|2|||
163170526|NCT01369329|589340967|FG002|Overall Study|Lost to Follow-up|2|||
163170527|NCT01369329|589340965|FG000|Overall Study|Other|2|||
163170528|NCT01369329|589340966|FG001|Overall Study|Other|3|||
163170529|NCT01369329|589340967|FG002|Overall Study|Other|2|||
163170530|NCT03032380|589340968|FG000|Overall Study|Adverse Event|0|||
163170531|NCT03032380|589340969|FG001|Overall Study|Adverse Event|1|||
163170532|NCT03032380|589340968|FG000|Overall Study|Lack of Efficacy|1|||
163170533|NCT03032380|589340969|FG001|Overall Study|Lack of Efficacy|0|||
163170534|NCT03032380|589340968|FG000|Overall Study|Withdrawal by Subject|2|||
163170535|NCT03032380|589340969|FG001|Overall Study|Withdrawal by Subject|3|||
163170536|NCT03032380|589340968|FG000|Overall Study|Recovery|0|||
163170537|NCT03032380|589340969|FG001|Overall Study|Recovery|1|||
163170538|NCT03032380|589340968|FG000|Overall Study|Death|39|||
163170539|NCT03032380|589340969|FG001|Overall Study|Death|34|||
163170540|NCT03032380|589340968|FG000|Overall Study|Other - Miscellaneous|0|||
163170541|NCT03032380|589340969|FG001|Overall Study|Other - Miscellaneous|1|||
163170542|NCT02937584|589340970|FG000|Period 1|Adverse Event|1|||
163170543|NCT02937584|589340971|FG001|Period 1|Adverse Event|2|||
163170544|NCT02937584|589340970|FG000|Washout|Adverse Event|0|||
163170545|NCT02937584|589340971|FG001|Washout|Adverse Event|1|||
163170546|NCT01883453|589340972|FG000|Overall Study|No episode of common cold|25|||
163170547|NCT01883453|589340973|FG001|Overall Study|No episode of common cold|23|||
163170548|NCT02238080|589340974|FG000|Overall Study|Death|13|||
163170549|NCT02238080|589340974|FG000|Overall Study|Treatment interrupted|6|||
163170550|NCT02238080|589340974|FG000|Overall Study|Withdrawal by Subject|2|||
163170551|NCT02238080|589340974|FG000|Overall Study|Other|4|||
163170552|NCT00796445|589340975|FG000|Overall Study|Protocol Violation|5|||
163170553|NCT00796445|589340976|FG001|Overall Study|Protocol Violation|3|||
163170554|NCT00796445|589340975|FG000|Overall Study|Adverse event, serious fatal|10|||
163170555|NCT00796445|589340976|FG001|Overall Study|Adverse event, serious fatal|5|||
163170556|NCT00796445|589340975|FG000|Overall Study|Adverse event, non-fatal|4|||
163170557|NCT00796445|589340976|FG001|Overall Study|Adverse event, non-fatal|0|||
163170558|NCT00796445|589340975|FG000|Overall Study|Disease progression/recurrence|537|||
163170559|NCT00796445|589340976|FG001|Overall Study|Disease progression/recurrence|268|||
163170560|NCT00796445|589340975|FG000|Overall Study|Other|10|||
163170561|NCT00796445|589340976|FG001|Overall Study|Other|7|||
163170562|NCT00796445|589340975|FG000|Overall Study|Withdrawal by Subject|18|||
163170563|NCT00796445|589340976|FG001|Overall Study|Withdrawal by Subject|9|||
163170564|NCT00796445|589340975|FG000|Overall Study|Invalid Informed Consent Form|1|||
163170565|NCT00796445|589340976|FG001|Overall Study|Invalid Informed Consent Form|0|||
163170566|NCT01038869|589340977|FG000|Overall Study|Withdrawal by Subject|1|||
163170567|NCT01038869|589340977|FG000|Overall Study|Lost to Follow-up|6|||
163170568|NCT04136444|589340978|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
163170569|NCT04136444|589340979|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
163170570|NCT02238067|589340980|FG000|Overall Study|Not completed survey at Month 6|45|||
163170571|NCT02350764|589340982|FG000|Overall Study|Adverse Event|4|||
163170572|NCT02350764|589340982|FG000|Overall Study|Death|3|||
163170573|NCT02350764|589340982|FG000|Overall Study|Physician Decision|2|||
163170574|NCT02350764|589340982|FG000|Overall Study|Withdrawal by Subject|2|||
163170575|NCT01433289|589340983|FG000|Overall Study|Pregnancy|0|||
163170576|NCT01433289|589340984|FG001|Overall Study|Pregnancy|1|||
163170577|NCT01433289|589340985|FG002|Overall Study|Pregnancy|0|||
163170578|NCT01433289|589340986|FG003|Overall Study|Pregnancy|0|||
163170579|NCT00783198|589340991|FG000|Overall Study|Adverse Event|15|||
163170580|NCT00783198|589340992|FG001|Overall Study|Adverse Event|19|||
163170581|NCT00783198|589340993|FG002|Overall Study|Adverse Event|3|||
163170582|NCT00783198|589340991|FG000|Overall Study|Lost to Follow-up|11|||
163170583|NCT00783198|589340992|FG001|Overall Study|Lost to Follow-up|1|||
163170584|NCT00783198|589340993|FG002|Overall Study|Lost to Follow-up|7|||
163170585|NCT00783198|589340991|FG000|Overall Study|Withdrawal by Subject|22|||
163170586|NCT00783198|589340992|FG001|Overall Study|Withdrawal by Subject|14|||
163170587|NCT00783198|589340993|FG002|Overall Study|Withdrawal by Subject|20|||
163170588|NCT00783198|589340991|FG000|Overall Study|Noncompliance with protocol|7|||
163170589|NCT00783198|589340992|FG001|Overall Study|Noncompliance with protocol|7|||
163170590|NCT00783198|589340993|FG002|Overall Study|Noncompliance with protocol|10|||
163170591|NCT00783198|589340991|FG000|Overall Study|Did not meet protocol eligibility|0|||
163170592|NCT00783198|589340992|FG001|Overall Study|Did not meet protocol eligibility|1|||
163170593|NCT00783198|589340993|FG002|Overall Study|Did not meet protocol eligibility|0|||
163170594|NCT00783198|589340991|FG000|Overall Study|Administrative|2|||
163170595|NCT00783198|589340992|FG001|Overall Study|Administrative|1|||
163170596|NCT00783198|589340993|FG002|Overall Study|Administrative|2|||
163170597|NCT01546623|589340994|FG000|Overall Study|Adverse Event|2|||
163170598|NCT01546623|589340995|FG001|Overall Study|Adverse Event|3|||
163170599|NCT01546623|589340994|FG000|Overall Study|Major Protocol Deviation|1|||
163170600|NCT01546623|589340995|FG001|Overall Study|Major Protocol Deviation|1|||
163170601|NCT01546623|589340994|FG000|Overall Study|High Prostate specific antigen|2|||
163170602|NCT01546623|589340995|FG001|Overall Study|High Prostate specific antigen|1|||
163170603|NCT01546623|589340994|FG000|Overall Study|Did Not Receive Study Drug|1|||
163170604|NCT01546623|589340995|FG001|Overall Study|Did Not Receive Study Drug|1|||
163170605|NCT01134705|589340996|FG000|Overall Study|Adverse Event|1|||
163170606|NCT01134705|589340997|FG001|Overall Study|Adverse Event|7|||
163170607|NCT01134705|589340996|FG000|Overall Study|Withdrawal by Subject|6|||
163170608|NCT01134705|589340997|FG001|Overall Study|Withdrawal by Subject|6|||
163170609|NCT01134705|589340996|FG000|Overall Study|Pregnancy|1|||
163170610|NCT01134705|589340997|FG001|Overall Study|Pregnancy|0|||
163170611|NCT01134705|589340996|FG000|Overall Study|Lost to Follow-up|5|||
163170612|NCT01134705|589340997|FG001|Overall Study|Lost to Follow-up|2|||
163170613|NCT01134705|589340996|FG000|Overall Study|Protocol Violation|1|||
163170614|NCT01134705|589340997|FG001|Overall Study|Protocol Violation|1|||
163170615|NCT01134705|589340996|FG000|Overall Study|Other|1|||
163170616|NCT01134705|589340997|FG001|Overall Study|Other|6|||
163170617|NCT00246740|589340998|FG000|Initial Enrollment|Death|1|||
163170618|NCT00246740|589340999|FG001|Initial Enrollment|Death|0|||
163170619|NCT00246740|589340998|FG000|Initial Enrollment|Additional surgery scheduled|0|||
163170620|NCT00246740|589340999|FG001|Initial Enrollment|Additional surgery scheduled|2|||
163170621|NCT00246740|589340998|FG000|Initial Enrollment|Surgery schedule change|4|||
163170622|NCT00246740|589340999|FG001|Initial Enrollment|Surgery schedule change|4|||
163170623|NCT00246740|589340998|FG000|Initial Enrollment|Other|1|||
163170624|NCT00246740|589340999|FG001|Initial Enrollment|Other|2|||
163170625|NCT00101452|589341000|FG000|Overall Study|Adverse Event|2|||
163170626|NCT00101452|589341001|FG001|Overall Study|Adverse Event|0|||
163170627|NCT00101452|589341002|FG002|Overall Study|Adverse Event|1|||
163170628|NCT00101452|589341000|FG000|Overall Study|Lost to Follow-up|13|||
163170629|NCT00101452|589341001|FG001|Overall Study|Lost to Follow-up|8|||
163170630|NCT00101452|589341002|FG002|Overall Study|Lost to Follow-up|14|||
163170631|NCT00101452|589341000|FG000|Overall Study|Withdrawal by Subject|10|||
163170632|NCT00101452|589341001|FG001|Overall Study|Withdrawal by Subject|14|||
163170633|NCT00101452|589341002|FG002|Overall Study|Withdrawal by Subject|9|||
163170634|NCT00101452|589341000|FG000|Overall Study|Baseline Fail|2|||
163170635|NCT00101452|589341001|FG001|Overall Study|Baseline Fail|1|||
163170636|NCT00101452|589341002|FG002|Overall Study|Baseline Fail|2|||
163170637|NCT00101452|589341000|FG000|Overall Study|Physician Decision|0|||
163170638|NCT00101452|589341001|FG001|Overall Study|Physician Decision|3|||
163170639|NCT00101452|589341002|FG002|Overall Study|Physician Decision|2|||
163170640|NCT00101452|589341000|FG000|Overall Study|Protocol Violation|2|||
163170641|NCT00101452|589341001|FG001|Overall Study|Protocol Violation|1|||
163170642|NCT00101452|589341002|FG002|Overall Study|Protocol Violation|3|||
162820338|NCT01003990|588056427|FG001|Overall Study|Subject Withdrew Consent|5|||
163170643|NCT00101452|589341000|FG000|Overall Study|Other|15|||
163170644|NCT00101452|589341001|FG001|Overall Study|Other|16|||
163170645|NCT00101452|589341002|FG002|Overall Study|Other|12|||
162820339|NCT01003990|588056428|FG002|Overall Study|Subject Withdrew Consent|7|||
162820340|NCT01271803|588056429|FG000|Overall Study|Progressive disease|0|||
162820341|NCT01271803|588056430|FG001|Overall Study|Progressive disease|0|||
162820342|NCT01271803|588056431|FG002|Overall Study|Progressive disease|2|||
162820343|NCT01271803|588056429|FG000|Overall Study|Death|53|||
162820344|NCT01271803|588056430|FG001|Overall Study|Death|34|||
162820345|NCT01271803|588056431|FG002|Overall Study|Death|0|||
162820346|NCT01271803|588056429|FG000|Overall Study|Withdrawal by Subject|1|||
162820347|NCT01271803|588056430|FG001|Overall Study|Withdrawal by Subject|5|||
162820348|NCT01271803|588056431|FG002|Overall Study|Withdrawal by Subject|0|||
162820349|NCT01271803|588056429|FG000|Overall Study|Lost to Follow-up|1|||
162820350|NCT01271803|588056430|FG001|Overall Study|Lost to Follow-up|0|||
162820351|NCT01271803|588056431|FG002|Overall Study|Lost to Follow-up|0|||
162820352|NCT05211739|588056432|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
162820353|NCT05211739|588056433|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
162820354|NCT05211739|588056432|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
162820355|NCT05211739|588056433|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
162820356|NCT05211739|588056432|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
162820357|NCT05211739|588056433|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
162820358|NCT05211739|588056432|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
162820359|NCT05211739|588056433|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
162820360|NCT04178967|588056434|FG000|Induction Period|Adverse Event|4|||
162820361|NCT04178967|588056435|FG001|Induction Period|Adverse Event|6|||
162820362|NCT04178967|588056436|FG002|Induction Period|Adverse Event|0|||
162820363|NCT04178967|588056437|FG003|Induction Period|Adverse Event|0|||
162820364|NCT04178967|588056438|FG004|Induction Period|Adverse Event|0|||
162820365|NCT04178967|588056439|FG005|Induction Period|Adverse Event|0|||
162820366|NCT04178967|588056440|FG006|Induction Period|Adverse Event|0|||
162820367|NCT04178967|588056441|FG007|Induction Period|Adverse Event|0|||
162820368|NCT04178967|588056442|FG008|Induction Period|Adverse Event|0|||
162820369|NCT04178967|588056443|FG009|Induction Period|Adverse Event|0|||
162820370|NCT04178967|588056444|FG010|Induction Period|Adverse Event|0|||
162820371|NCT04178967|588056434|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
162820372|NCT04178967|588056435|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
162820373|NCT04178967|588056436|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
162820374|NCT04178967|588056437|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
162820375|NCT04178967|588056438|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
162820376|NCT04178967|588056439|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
162820377|NCT04178967|588056440|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
162820378|NCT04178967|588056441|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
162820379|NCT04178967|588056442|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
162820380|NCT04178967|588056443|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
162820381|NCT04178967|588056444|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
162820382|NCT04178967|588056434|FG000|Induction Period|Lack of Efficacy|4|||
162820383|NCT04178967|588056435|FG001|Induction Period|Lack of Efficacy|1|||
163170646|NCT01510769|589341003|FG000|Overall Study|Adverse Event|7|||
163170647|NCT01510769|589341004|FG001|Overall Study|Adverse Event|6|||
163170648|NCT01510769|589341005|FG002|Overall Study|Adverse Event|4|||
162820384|NCT04178967|588056436|FG002|Induction Period|Lack of Efficacy|0|||
163170649|NCT01510769|589341003|FG000|Overall Study|Gout Flare|0|||
163170650|NCT01510769|589341004|FG001|Overall Study|Gout Flare|3|||
163170651|NCT01510769|589341005|FG002|Overall Study|Gout Flare|1|||
163170652|NCT01510769|589341003|FG000|Overall Study|Protocol Violation|11|||
163170653|NCT01510769|589341004|FG001|Overall Study|Protocol Violation|10|||
163170654|NCT01510769|589341005|FG002|Overall Study|Protocol Violation|9|||
163170655|NCT01510769|589341003|FG000|Overall Study|Lost to Follow-up|5|||
163170656|NCT01510769|589341004|FG001|Overall Study|Lost to Follow-up|1|||
163170657|NCT01510769|589341005|FG002|Overall Study|Lost to Follow-up|5|||
163170658|NCT01510769|589341003|FG000|Overall Study|Withdrawal by Subject|3|||
163170659|NCT01510769|589341004|FG001|Overall Study|Withdrawal by Subject|4|||
163170660|NCT01510769|589341005|FG002|Overall Study|Withdrawal by Subject|3|||
163170661|NCT01510769|589341003|FG000|Overall Study|Death|1|||
163170662|NCT01510769|589341004|FG001|Overall Study|Death|1|||
163170663|NCT01510769|589341005|FG002|Overall Study|Death|0|||
163170664|NCT02674204|589341006|FG000|Overall Study|Adverse Event|1|||
163170665|NCT02674204|589341007|FG001|Overall Study|Adverse Event|0|||
163170666|NCT02466659|589341010|FG000|Overall Study|Lost to Follow-up|5|||
163170667|NCT02466659|589341011|FG001|Overall Study|Lost to Follow-up|2|||
163170668|NCT01536392|589341012|FG000|Overall Study|Adverse Event|2|||
163170669|NCT01536392|589341013|FG001|Overall Study|Adverse Event|2|||
163170670|NCT01536392|589341012|FG000|Overall Study|Physician Decision|2|||
163170671|NCT01536392|589341013|FG001|Overall Study|Physician Decision|3|||
163170672|NCT01536392|589341012|FG000|Overall Study|Withdrawal by Subject|3|||
163170673|NCT01536392|589341013|FG001|Overall Study|Withdrawal by Subject|6|||
163170674|NCT01536392|589341012|FG000|Overall Study|Non Compliance|3|||
163170675|NCT01536392|589341013|FG001|Overall Study|Non Compliance|4|||
163170676|NCT01536392|589341012|FG000|Overall Study|Completed therapy early|3|||
163170677|NCT01536392|589341013|FG001|Overall Study|Completed therapy early|0|||
163170678|NCT02874144|589341014|FG000|Overall Study|Lost to Follow-up|3|||
163170679|NCT02874144|589341015|FG001|Overall Study|Lost to Follow-up|5|||
163170680|NCT00486811|589341018|FG000|Overall Study|Adverse Event|28|||
163170681|NCT00486811|589341019|FG001|Overall Study|Adverse Event|60|||
163170682|NCT00486811|589341020|FG002|Overall Study|Adverse Event|135|||
163170683|NCT00486811|589341018|FG000|Overall Study|Lack of Efficacy|34|||
163170684|NCT00486811|589341019|FG001|Overall Study|Lack of Efficacy|14|||
163170685|NCT00486811|589341020|FG002|Overall Study|Lack of Efficacy|7|||
163170686|NCT00486811|589341018|FG000|Overall Study|Lost to Follow-up|4|||
163170687|NCT00486811|589341019|FG001|Overall Study|Lost to Follow-up|6|||
163170688|NCT00486811|589341020|FG002|Overall Study|Lost to Follow-up|4|||
163170689|NCT00486811|589341018|FG000|Overall Study|Withdrawal by Subject|33|||
163170690|NCT00486811|589341019|FG001|Overall Study|Withdrawal by Subject|44|||
163170691|NCT00486811|589341020|FG002|Overall Study|Withdrawal by Subject|58|||
163170692|NCT00486811|589341018|FG000|Overall Study|Study drug non-compliant|5|||
163170693|NCT00486811|589341019|FG001|Overall Study|Study drug non-compliant|6|||
163170694|NCT00486811|589341020|FG002|Overall Study|Study drug non-compliant|3|||
163170695|NCT00486811|589341018|FG000|Overall Study|All other|18|||
163170696|NCT00486811|589341019|FG001|Overall Study|All other|11|||
163170697|NCT00486811|589341020|FG002|Overall Study|All other|7|||
163170698|NCT04525885|589341024|FG000|Overall Study|Screen Failure|1|||
163170699|NCT04525885|589341025|FG001|Overall Study|Screen Failure|0|||
163170700|NCT04525885|589341026|FG002|Overall Study|Screen Failure|0|||
163170701|NCT04525885|589341024|FG000|Overall Study|Withdrawal by Subject|14|||
163170702|NCT04525885|589341025|FG001|Overall Study|Withdrawal by Subject|6|||
163170703|NCT04525885|589341026|FG002|Overall Study|Withdrawal by Subject|20|||
163170704|NCT04525885|589341024|FG000|Overall Study|Physician Decision|1|||
163170705|NCT04525885|589341025|FG001|Overall Study|Physician Decision|0|||
163170706|NCT04525885|589341026|FG002|Overall Study|Physician Decision|1|||
163170707|NCT02756806|589341027|FG000|Overall Study|Study terminated early|5|||
163170708|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
163170709|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
163170710|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
163170711|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163170712|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
163170713|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
163170714|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163170715|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163170716|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
163170717|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163170718|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
163170719|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163170720|NCT03158285|589341028|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
163170721|NCT03158285|589341029|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
163170722|NCT03158285|589341030|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
163170723|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
163170724|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
163170725|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
163170726|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
163170727|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
163170728|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
163170729|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
163170730|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
163170731|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
163170732|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
163170733|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
163170734|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
163170735|NCT03158285|589341028|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
163170736|NCT03158285|589341029|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
163170737|NCT03158285|589341030|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
163170738|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
163170739|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
163170740|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
163170741|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
163170742|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
163170743|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
163170744|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
163170745|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
163170746|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
163170747|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
163170748|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
163170749|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
163170750|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Death|1|||
163170751|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Death|0|||
163170752|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Death|0|||
163170753|NCT03158285|589341028|FG000|Active Treatment Period: Week 52-100|Other|4|||
163170754|NCT03158285|589341029|FG001|Active Treatment Period: Week 52-100|Other|1|||
163170755|NCT03158285|589341030|FG002|Active Treatment Period: Week 52-100|Other|0|||
163170756|NCT02228980|589341033|FG000|Overall Study|Adverse Event|14|||
163170757|NCT02228980|589341034|FG001|Overall Study|Adverse Event|0|||
163170758|NCT02228980|589341035|FG002|Overall Study|Adverse Event|0|||
163170759|NCT02228980|589341036|FG003|Overall Study|Adverse Event|0|||
163170760|NCT02228980|589341033|FG000|Overall Study|Protocol Violation|7|||
163170761|NCT02228980|589341034|FG001|Overall Study|Protocol Violation|0|||
163170762|NCT02228980|589341035|FG002|Overall Study|Protocol Violation|0|||
163170763|NCT02228980|589341036|FG003|Overall Study|Protocol Violation|0|||
163170764|NCT02228980|589341033|FG000|Overall Study|Withdrawal by Subject|3|||
163170765|NCT02228980|589341034|FG001|Overall Study|Withdrawal by Subject|3|||
163170766|NCT02228980|589341035|FG002|Overall Study|Withdrawal by Subject|2|||
163170767|NCT02228980|589341036|FG003|Overall Study|Withdrawal by Subject|3|||
163170768|NCT00750152|589341037|FG000|Overall Study|Adverse Event|2|||
163170769|NCT00750152|589341038|FG001|Overall Study|Adverse Event|1|||
163170770|NCT00750152|589341037|FG000|Overall Study|Lost to Follow-up|8|||
163170771|NCT00750152|589341038|FG001|Overall Study|Lost to Follow-up|13|||
163170772|NCT00750152|589341037|FG000|Overall Study|Withdrawal by Subject|3|||
163170773|NCT00750152|589341038|FG001|Overall Study|Withdrawal by Subject|3|||
163170774|NCT00750152|589341037|FG000|Overall Study|Physician Decision|1|||
163170775|NCT00750152|589341038|FG001|Overall Study|Physician Decision|1|||
163170776|NCT00750152|589341037|FG000|Overall Study|Non-compliance|0|||
163170777|NCT00750152|589341038|FG001|Overall Study|Non-compliance|1|||
163170778|NCT00750152|589341037|FG000|Overall Study|Termination by sponsor|1|||
163170779|NCT00750152|589341038|FG001|Overall Study|Termination by sponsor|0|||
163170780|NCT00750152|589341037|FG000|Overall Study|Other|7|||
163170781|NCT00750152|589341038|FG001|Overall Study|Other|8|||
163170782|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
163170783|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170784|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170785|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
163170786|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
163170787|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
163170788|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
163170789|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
163170790|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
163170791|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
163170792|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
163170793|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
163170794|NCT01642615|589341039|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
163170795|NCT01642615|589341040|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
163170796|NCT01642615|589341041|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
163170797|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
163170798|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
163170799|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
163170800|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
163170801|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
163170802|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
163170803|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170804|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
163170805|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163170806|NCT01642615|589341039|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
163170807|NCT01642615|589341040|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
163170808|NCT01642615|589341041|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
163170809|NCT00978757|589341046|FG000|Overall Study|Physician Decision|1|||
163170810|NCT00978757|589341047|FG001|Overall Study|Physician Decision|3|||
163170811|NCT00402740|589341048|FG000|Overall Study|Withdrawal by Subject|18|||
163170812|NCT00402740|589341048|FG000|Overall Study|Death|50|||
163170813|NCT00402740|589341048|FG000|Overall Study|Lost to Follow-up|6|||
163170814|NCT00402740|589341048|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
163170815|NCT00402740|589341048|FG000|Overall Study|Subject disposition unknown.|1|||
163170816|NCT01028300|589341049|FG000|Overall Study|Study Terminated|4|||
163170817|NCT00715910|589341052|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
163170818|NCT00715910|589341053|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
163170819|NCT00715910|589341054|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
163170820|NCT00715910|589341055|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
163170821|NCT00715910|589341056|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
163170822|NCT00715910|589341057|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
163170823|NCT00715910|589341052|FG000|Booster and ESFU Phase|Other|0|||
163170824|NCT00715910|589341053|FG001|Booster and ESFU Phase|Other|0|||
162820385|NCT04178967|588056437|FG003|Induction Period|Lack of Efficacy|0|||
162820386|NCT04178967|588056438|FG004|Induction Period|Lack of Efficacy|0|||
162820387|NCT04178967|588056439|FG005|Induction Period|Lack of Efficacy|0|||
162820388|NCT04178967|588056440|FG006|Induction Period|Lack of Efficacy|0|||
162820389|NCT04178967|588056441|FG007|Induction Period|Lack of Efficacy|0|||
162820390|NCT04178967|588056442|FG008|Induction Period|Lack of Efficacy|0|||
162820391|NCT04178967|588056443|FG009|Induction Period|Lack of Efficacy|0|||
162820392|NCT04178967|588056444|FG010|Induction Period|Lack of Efficacy|0|||
162820393|NCT04178967|588056434|FG000|Induction Period|Protocol Violation|0|||
162820394|NCT04178967|588056435|FG001|Induction Period|Protocol Violation|6|||
162820395|NCT04178967|588056436|FG002|Induction Period|Protocol Violation|0|||
162820396|NCT04178967|588056437|FG003|Induction Period|Protocol Violation|0|||
162820397|NCT04178967|588056438|FG004|Induction Period|Protocol Violation|0|||
162820398|NCT04178967|588056439|FG005|Induction Period|Protocol Violation|0|||
162820399|NCT04178967|588056440|FG006|Induction Period|Protocol Violation|0|||
162820400|NCT04178967|588056441|FG007|Induction Period|Protocol Violation|0|||
162820401|NCT04178967|588056442|FG008|Induction Period|Protocol Violation|0|||
163170825|NCT00715910|589341054|FG002|Booster and ESFU Phase|Other|0|||
163170826|NCT00715910|589341055|FG003|Booster and ESFU Phase|Other|5|||
163170827|NCT00715910|589341056|FG004|Booster and ESFU Phase|Other|1|||
163170828|NCT00715910|589341057|FG005|Booster and ESFU Phase|Other|0|||
163170829|NCT00946153|589341058|FG000|Phase 2|Adverse Event|0|||
163170830|NCT00946153|589341059|FG001|Phase 2|Adverse Event|0|||
163170831|NCT00946153|589341060|FG002|Phase 2|Adverse Event|0|||
163170832|NCT00946153|589341061|FG003|Phase 2|Adverse Event|0|||
163170833|NCT00946153|589341062|FG004|Phase 2|Adverse Event|6|||
163170834|NCT00946153|589341058|FG000|Phase 2|Need more reduction of dose|0|||
163170835|NCT00946153|589341059|FG001|Phase 2|Need more reduction of dose|0|||
163170836|NCT00946153|589341060|FG002|Phase 2|Need more reduction of dose|0|||
163170837|NCT00946153|589341061|FG003|Phase 2|Need more reduction of dose|0|||
163170838|NCT00946153|589341062|FG004|Phase 2|Need more reduction of dose|2|||
163170839|NCT00946153|589341058|FG000|Phase 2|Physician Decision|0|||
163170840|NCT00946153|589341059|FG001|Phase 2|Physician Decision|0|||
163170841|NCT00946153|589341060|FG002|Phase 2|Physician Decision|0|||
163170842|NCT00946153|589341061|FG003|Phase 2|Physician Decision|0|||
163170843|NCT00946153|589341062|FG004|Phase 2|Physician Decision|1|||
163170844|NCT00946153|589341058|FG000|Phase 2|14 days washout for recovery due to AE|0|||
163170845|NCT00946153|589341059|FG001|Phase 2|14 days washout for recovery due to AE|0|||
163170846|NCT00946153|589341060|FG002|Phase 2|14 days washout for recovery due to AE|0|||
163170847|NCT00946153|589341061|FG003|Phase 2|14 days washout for recovery due to AE|0|||
163170848|NCT00946153|589341062|FG004|Phase 2|14 days washout for recovery due to AE|4|||
163170849|NCT01030666|589341063|FG000|Overall Study|Lost to Follow-up|3|||
163170850|NCT01030666|589341064|FG001|Overall Study|Lost to Follow-up|2|||
163170851|NCT01144299|589341065|FG000|Overall Study|Lost to Follow-up|1|||
163170852|NCT01144299|589341066|FG001|Overall Study|Lost to Follow-up|0|||
163170853|NCT01144299|589341065|FG000|Overall Study|Withdrawal by Subject|1|||
163170854|NCT01144299|589341066|FG001|Overall Study|Withdrawal by Subject|0|||
163170855|NCT04002908|589341075|FG000|Overall Study|Death|41|||
163170856|NCT04002908|589341076|FG001|Overall Study|Death|0|||
163170857|NCT04002908|589341077|FG002|Overall Study|Death|0|||
163170858|NCT04002908|589341078|FG003|Overall Study|Death|0|||
162820402|NCT04178967|588056443|FG009|Induction Period|Protocol Violation|0|||
163170859|NCT04002908|589341075|FG000|Overall Study|Withdrawal by Subject|112|||
163170860|NCT04002908|589341076|FG001|Overall Study|Withdrawal by Subject|0|||
163170861|NCT04002908|589341077|FG002|Overall Study|Withdrawal by Subject|0|||
163170862|NCT04002908|589341078|FG003|Overall Study|Withdrawal by Subject|0|||
163170863|NCT04002908|589341075|FG000|Overall Study|Lost to Follow-up|72|||
163170864|NCT04002908|589341076|FG001|Overall Study|Lost to Follow-up|0|||
163170865|NCT04002908|589341077|FG002|Overall Study|Lost to Follow-up|0|||
163170866|NCT04002908|589341078|FG003|Overall Study|Lost to Follow-up|0|||
163170867|NCT04002908|589341075|FG000|Overall Study|Infant died, so mother withdrawn|34|||
163170868|NCT04002908|589341076|FG001|Overall Study|Infant died, so mother withdrawn|0|||
163170869|NCT04002908|589341077|FG002|Overall Study|Infant died, so mother withdrawn|0|||
163170870|NCT04002908|589341078|FG003|Overall Study|Infant died, so mother withdrawn|0|||
163170871|NCT04359901|589341083|FG000|Overall Study|Withdrawal by Subject|0|||
163170872|NCT04359901|589341084|FG001|Overall Study|Withdrawal by Subject|1|||
163170873|NCT04359901|589341083|FG000|Overall Study|Death|6|||
162820403|NCT04178967|588056444|FG010|Induction Period|Protocol Violation|0|||
163170874|NCT04359901|589341084|FG001|Overall Study|Death|2|||
163170875|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170876|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
163170877|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170878|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
163170879|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170880|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
163170881|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
163170882|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
163170883|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
163170884|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
163170885|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170886|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
163170887|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170888|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170889|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170890|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170891|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162820404|NCT04178967|588056434|FG000|Induction Period|Withdrawal by Subject|6|||
162820405|NCT04178967|588056435|FG001|Induction Period|Withdrawal by Subject|4|||
162820406|NCT04178967|588056436|FG002|Induction Period|Withdrawal by Subject|0|||
162820407|NCT04178967|588056437|FG003|Induction Period|Withdrawal by Subject|0|||
162820408|NCT04178967|588056438|FG004|Induction Period|Withdrawal by Subject|0|||
162820409|NCT04178967|588056439|FG005|Induction Period|Withdrawal by Subject|0|||
162820410|NCT04178967|588056440|FG006|Induction Period|Withdrawal by Subject|0|||
162820411|NCT04178967|588056441|FG007|Induction Period|Withdrawal by Subject|0|||
162820412|NCT04178967|588056442|FG008|Induction Period|Withdrawal by Subject|0|||
162820413|NCT04178967|588056443|FG009|Induction Period|Withdrawal by Subject|0|||
162820414|NCT04178967|588056444|FG010|Induction Period|Withdrawal by Subject|0|||
162820415|NCT04178967|588056434|FG000|Induction Period|Lost to Follow-up|2|||
162820416|NCT04178967|588056435|FG001|Induction Period|Lost to Follow-up|0|||
162820417|NCT04178967|588056436|FG002|Induction Period|Lost to Follow-up|0|||
162820418|NCT04178967|588056437|FG003|Induction Period|Lost to Follow-up|0|||
162820419|NCT04178967|588056438|FG004|Induction Period|Lost to Follow-up|0|||
162820420|NCT04178967|588056439|FG005|Induction Period|Lost to Follow-up|0|||
162820421|NCT04178967|588056440|FG006|Induction Period|Lost to Follow-up|0|||
162820422|NCT04178967|588056441|FG007|Induction Period|Lost to Follow-up|0|||
162820423|NCT04178967|588056442|FG008|Induction Period|Lost to Follow-up|0|||
162820424|NCT04178967|588056443|FG009|Induction Period|Lost to Follow-up|0|||
162820425|NCT04178967|588056444|FG010|Induction Period|Lost to Follow-up|0|||
162820426|NCT04178967|588056434|FG000|Induction Period|Participant Missed Study Visits|0|||
162820427|NCT04178967|588056435|FG001|Induction Period|Participant Missed Study Visits|1|||
162820428|NCT04178967|588056436|FG002|Induction Period|Participant Missed Study Visits|0|||
162820429|NCT04178967|588056437|FG003|Induction Period|Participant Missed Study Visits|0|||
162820430|NCT04178967|588056438|FG004|Induction Period|Participant Missed Study Visits|0|||
163170892|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
163170893|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170894|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
163170895|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170896|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170897|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170898|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
163170899|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
163170900|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
163170901|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
163170902|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Other|0|||
163170903|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Other|0|||
163170904|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Other|1|||
163170905|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Other|1|||
163170906|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Other|0|||
163170907|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Other|0|||
163170908|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Other|0|||
163170909|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Other|1|||
163170910|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Other|0|||
163170911|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|Death|0|||
162820431|NCT04178967|588056439|FG005|Induction Period|Participant Missed Study Visits|0|||
162820432|NCT04178967|588056440|FG006|Induction Period|Participant Missed Study Visits|0|||
162820433|NCT04178967|588056441|FG007|Induction Period|Participant Missed Study Visits|0|||
162820434|NCT04178967|588056442|FG008|Induction Period|Participant Missed Study Visits|0|||
162820435|NCT04178967|588056443|FG009|Induction Period|Participant Missed Study Visits|0|||
162820436|NCT04178967|588056444|FG010|Induction Period|Participant Missed Study Visits|0|||
162820437|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820438|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820439|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820440|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820441|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820442|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
162820443|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
162820444|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
163170912|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|Death|0|||
163170913|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|Death|0|||
163170914|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|Death|0|||
163170915|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|Death|0|||
163170916|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|Death|1|||
163170917|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|Death|0|||
163170918|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|Death|0|||
163170919|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|Death|0|||
163170920|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170921|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170922|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170923|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170924|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170925|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
163170926|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
163170927|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170928|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
163170929|NCT00557856|589341085|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
163170930|NCT00557856|589341086|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170931|NCT00557856|589341087|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170932|NCT00557856|589341088|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170933|NCT00557856|589341089|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170934|NCT00557856|589341090|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170935|NCT00557856|589341091|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170936|NCT00557856|589341092|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170937|NCT00557856|589341093|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
163170938|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170939|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170940|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170941|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170942|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170943|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170944|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170945|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
163170946|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
163170947|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170948|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170949|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170950|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170951|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170952|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170953|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170954|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163170955|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
163170956|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
163170957|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
163170958|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
163170959|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
163170960|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
163170961|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
163170962|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
163170963|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
163170964|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
163170965|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Other|0|||
163170966|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Other|0|||
163170967|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Other|0|||
163170968|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Other|0|||
163170969|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Other|0|||
163170970|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Other|0|||
163170971|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Other|0|||
163170972|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Other|0|||
163170973|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Other|1|||
163170974|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|Death|0|||
163170975|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|Death|0|||
163170976|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|Death|0|||
163170977|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|Death|0|||
163170978|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|Death|0|||
163170979|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|Death|0|||
163170980|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|Death|0|||
163170981|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|Death|0|||
163170982|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|Death|2|||
163170983|NCT00557856|589341085|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170984|NCT00557856|589341086|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170985|NCT00557856|589341087|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170986|NCT00557856|589341088|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170987|NCT00557856|589341089|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170988|NCT00557856|589341090|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170989|NCT00557856|589341091|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170990|NCT00557856|589341092|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
163170991|NCT00557856|589341093|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
163170992|NCT05601544|589341094|FG000|Phase 2 Period 1|Adverse Event|0|||
163170993|NCT05601544|589341095|FG001|Phase 2 Period 1|Adverse Event|1|||
163170994|NCT05601544|589341096|FG002|Phase 2 Period 1|Adverse Event|0|||
163170995|NCT05601544|589341097|FG003|Phase 2 Period 1|Adverse Event|0|||
163170996|NCT05601544|589341098|FG004|Phase 2 Period 1|Adverse Event|0|||
163170997|NCT05601544|589341099|FG005|Phase 2 Period 1|Adverse Event|0|||
163170998|NCT02537015|589341106|FG000|Overall Study|Adverse Event|3|||
163170999|NCT02537015|589341106|FG000|Overall Study|Withdrawal by Subject|2|||
163171000|NCT02537015|589341106|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163171001|NCT02626624|589341114|FG000|Overall Study|Adverse Event|1|||
163171002|NCT02626624|589341114|FG000|Overall Study|Lost to Follow-up|3|||
163171003|NCT02626624|589341114|FG000|Overall Study|Protocol Violation|4|||
163171004|NCT02626624|589341114|FG000|Overall Study|Death|2|||
163171005|NCT02043899|589342271|FG000|Overall Study|Adverse Event|3|||
163171006|NCT02043899|589342271|FG000|Overall Study|Physician Decision|1|||
163171007|NCT02043899|589342271|FG000|Overall Study|Withdrawal by Subject|2|||
163171008|NCT02043899|589342271|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
163171009|NCT02043899|589342271|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
163171010|NCT02043899|589342271|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
163171011|NCT02043899|589342271|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
163171012|NCT02043899|589342271|FG000|Overall Study|Treatment delayed|1|||
163171013|NCT01659554|589342275|FG000|Overall Study|Study Termination|4|||
163171014|NCT03699475|589342276|FG000|Overall Study|Death|1|||
163171015|NCT00701662|589342279|FG000|Overall Study|Lack of Efficacy|1|||
162820445|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820446|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820447|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
162820448|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820449|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820450|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820451|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820452|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820453|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
162820454|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820455|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820456|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820457|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820458|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162820459|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820460|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820461|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820462|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
163171016|NCT02267317|589342282|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
163171017|NCT02267317|589342283|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171018|NCT02267317|589342284|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171019|NCT02267317|589342285|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171020|NCT02267317|589342286|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
163171021|NCT02267317|589342287|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162929558|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163171022|NCT02267317|589342282|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
163171023|NCT02267317|589342283|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171024|NCT02267317|589342284|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171025|NCT02267317|589342285|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171026|NCT02267317|589342286|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171027|NCT02267317|589342287|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
163171028|NCT03595618|589342288|FG000|Overall Study|Adverse Event|16|||
163171029|NCT03595618|589342289|FG001|Overall Study|Adverse Event|17|||
163171030|NCT03595618|589342290|FG002|Overall Study|Adverse Event|20|||
163171031|NCT03595618|589342291|FG003|Overall Study|Adverse Event|8|||
163171032|NCT03595618|589342288|FG000|Overall Study|Withdrawal by Subject|12|||
163171033|NCT03595618|589342289|FG001|Overall Study|Withdrawal by Subject|14|||
163171034|NCT03595618|589342290|FG002|Overall Study|Withdrawal by Subject|14|||
163171035|NCT03595618|589342291|FG003|Overall Study|Withdrawal by Subject|10|||
163171036|NCT03595618|589342288|FG000|Overall Study|Lost to Follow-up|6|||
163171037|NCT03595618|589342289|FG001|Overall Study|Lost to Follow-up|4|||
163171038|NCT03595618|589342290|FG002|Overall Study|Lost to Follow-up|5|||
163171039|NCT03595618|589342291|FG003|Overall Study|Lost to Follow-up|6|||
163171040|NCT03595618|589342288|FG000|Overall Study|Protocol Violation|2|||
163171041|NCT03595618|589342289|FG001|Overall Study|Protocol Violation|0|||
163171042|NCT03595618|589342290|FG002|Overall Study|Protocol Violation|6|||
163171043|NCT03595618|589342291|FG003|Overall Study|Protocol Violation|2|||
163171044|NCT03595618|589342288|FG000|Overall Study|Physician Decision|0|||
163171045|NCT03595618|589342289|FG001|Overall Study|Physician Decision|0|||
163171046|NCT03595618|589342290|FG002|Overall Study|Physician Decision|1|||
163171047|NCT03595618|589342291|FG003|Overall Study|Physician Decision|2|||
163171048|NCT03595618|589342288|FG000|Overall Study|Miscellaneous|7|||
163171049|NCT03595618|589342289|FG001|Overall Study|Miscellaneous|5|||
163171050|NCT03595618|589342290|FG002|Overall Study|Miscellaneous|10|||
163171051|NCT03595618|589342291|FG003|Overall Study|Miscellaneous|6|||
163171052|NCT02279407|589342292|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
162698348|NCT01865617|587605470|FG012|Overall Study|Other|0|||
162698349|NCT02500979|587605471|FG000|Period 1|Hyperglycemia|1|||
162698350|NCT02500979|587605472|FG001|Period 1|Hyperglycemia|0|||
163171053|NCT02279407|589342293|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
163171054|NCT02279407|589342294|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
163171055|NCT02279407|589342295|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
163171056|NCT02279407|589342292|FG000|Overall Study|Withdrawal by Subject|1|||
163171057|NCT02279407|589342293|FG001|Overall Study|Withdrawal by Subject|0|||
163171058|NCT02279407|589342294|FG002|Overall Study|Withdrawal by Subject|1|||
163171059|NCT02279407|589342295|FG003|Overall Study|Withdrawal by Subject|1|||
163171060|NCT02279407|589342292|FG000|Overall Study|Adverse Event|1|||
163171061|NCT02279407|589342293|FG001|Overall Study|Adverse Event|1|||
163171062|NCT02279407|589342294|FG002|Overall Study|Adverse Event|2|||
163171063|NCT02279407|589342295|FG003|Overall Study|Adverse Event|0|||
163171064|NCT00422084|589342296|FG000|Overall Study|Adverse Event|21|||
163171065|NCT00422084|589342297|FG001|Overall Study|Adverse Event|7|||
163171066|NCT00422084|589342296|FG000|Overall Study|Withdrawal by Subject|12|||
163171067|NCT00422084|589342297|FG001|Overall Study|Withdrawal by Subject|9|||
163171068|NCT00422084|589342296|FG000|Overall Study|Lost to Follow-up|14|||
163171069|NCT00422084|589342297|FG001|Overall Study|Lost to Follow-up|9|||
163171070|NCT00422084|589342296|FG000|Overall Study|Protocol Violation|4|||
163171071|NCT00422084|589342297|FG001|Overall Study|Protocol Violation|1|||
163171072|NCT00422084|589342296|FG000|Overall Study|Lack of Efficacy|40|||
163171073|NCT00422084|589342297|FG001|Overall Study|Lack of Efficacy|42|||
163171074|NCT00422084|589342296|FG000|Overall Study|P. vivax infection|3|||
163171075|NCT00422084|589342297|FG001|Overall Study|P. vivax infection|6|||
163171076|NCT00422084|589342296|FG000|Overall Study|Cyesis|1|||
163171077|NCT00422084|589342297|FG001|Overall Study|Cyesis|0|||
163171078|NCT00422084|589342296|FG000|Overall Study|Withdrawn from study accidentally|1|||
163171079|NCT00422084|589342297|FG001|Overall Study|Withdrawn from study accidentally|0|||
163171080|NCT00422084|589342296|FG000|Overall Study|Non-compliance|1|||
163171081|NCT00422084|589342297|FG001|Overall Study|Non-compliance|0|||
163171082|NCT00422084|589342296|FG000|Overall Study|Re-location|0|||
163171083|NCT00422084|589342297|FG001|Overall Study|Re-location|1|||
163171084|NCT00422084|589342296|FG000|Overall Study|Not defined|1|||
163171085|NCT00422084|589342297|FG001|Overall Study|Not defined|1|||
163171086|NCT03996369|589342304|FG000|Overall Study|Protocol deviation|1|||
163171087|NCT03996369|589342305|FG001|Overall Study|Protocol deviation|1|||
163171088|NCT03996369|589342304|FG000|Overall Study|Physician Decision|4|||
163171089|NCT03996369|589342305|FG001|Overall Study|Physician Decision|2|||
163171090|NCT03996369|589342304|FG000|Overall Study|Participant decision|0|||
163171091|NCT03996369|589342305|FG001|Overall Study|Participant decision|1|||
163171092|NCT03996369|589342304|FG000|Overall Study|Lack of Efficacy|4|||
163171093|NCT03996369|589342305|FG001|Overall Study|Lack of Efficacy|0|||
163171094|NCT03996369|589342304|FG000|Overall Study|Adverse Event|9|||
163171095|NCT03996369|589342305|FG001|Overall Study|Adverse Event|0|||
163171096|NCT03996369|589342304|FG000|Overall Study|Withdrawal by Subject|6|||
163171097|NCT03996369|589342305|FG001|Overall Study|Withdrawal by Subject|8|||
163171098|NCT03996369|589342304|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
163171099|NCT03996369|589342305|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
163171100|NCT03996369|589342304|FG000|Overall Study|Lost to Follow-up|0|||
163171101|NCT03996369|589342305|FG001|Overall Study|Lost to Follow-up|1|||
163171102|NCT01579812|589342306|FG000|Overall Study|Ineligible after treatment start|40|||
163171103|NCT01579812|589342306|FG000|Overall Study|Patient choice|3|||
163171104|NCT01579812|589342306|FG000|Overall Study|Noncompliance|3|||
163171105|NCT01579812|589342306|FG000|Overall Study|Withdrawal by Subject|6|||
163171106|NCT00653432|589342307|FG000|Overall Study|Adverse Event|4|||
163171107|NCT00653432|589342308|FG001|Overall Study|Adverse Event|1|||
163171108|NCT00653432|589342307|FG000|Overall Study|Withdrawal by Subject|4|||
163171109|NCT00653432|589342308|FG001|Overall Study|Withdrawal by Subject|5|||
163171110|NCT00653432|589342307|FG000|Overall Study|Lost to Follow-up|7|||
163171111|NCT00653432|589342308|FG001|Overall Study|Lost to Follow-up|6|||
163171112|NCT00653432|589342307|FG000|Overall Study|Use/Need of Con Therapy|2|||
163171113|NCT00653432|589342308|FG001|Overall Study|Use/Need of Con Therapy|1|||
163171114|NCT00653432|589342307|FG000|Overall Study|Other - Reason Not Provided|5|||
163171115|NCT00653432|589342308|FG001|Overall Study|Other - Reason Not Provided|3|||
163171116|NCT01782469|589342309|FG000|Overall Study|Lost to Follow-up|1|||
163171117|NCT00357760|589342310|FG000|Overall Study|Disease progression|44|||
163171118|NCT00357760|589342311|FG001|Overall Study|Disease progression|17|||
163171119|NCT00357760|589342310|FG000|Overall Study|Adverse Event|10|||
163171120|NCT00357760|589342311|FG001|Overall Study|Adverse Event|7|||
163171121|NCT00357760|589342310|FG000|Overall Study|Death|0|||
163171122|NCT00357760|589342311|FG001|Overall Study|Death|3|||
163171123|NCT00357760|589342310|FG000|Overall Study|Alternative therapy|1|||
163171124|NCT00357760|589342311|FG001|Overall Study|Alternative therapy|0|||
163171125|NCT00357760|589342310|FG000|Overall Study|Withdrawal by Subject|0|||
163171126|NCT00357760|589342311|FG001|Overall Study|Withdrawal by Subject|2|||
163171127|NCT00357760|589342310|FG000|Overall Study|Never started treatment|2|||
163171128|NCT00357760|589342311|FG001|Overall Study|Never started treatment|1|||
163171129|NCT00357760|589342310|FG000|Overall Study|Ineligible|0|||
163171130|NCT00357760|589342311|FG001|Overall Study|Ineligible|2|||
163171131|NCT00357760|589342310|FG000|Overall Study|Physician Decision|2|||
163171132|NCT00357760|589342311|FG001|Overall Study|Physician Decision|1|||
163171133|NCT00357760|589342310|FG000|Overall Study|Protocol Violation|0|||
163171134|NCT00357760|589342311|FG001|Overall Study|Protocol Violation|1|||
163171135|NCT00357760|589342310|FG000|Overall Study|To receive hospice care|0|||
163171136|NCT00357760|589342311|FG001|Overall Study|To receive hospice care|1|||
163171137|NCT02353143|589342312|FG000|Overall Study|Withdrawal by Subject|1|||
163171138|NCT02353143|589342313|FG001|Overall Study|Withdrawal by Subject|0|||
163171139|NCT02353143|589342314|FG002|Overall Study|Withdrawal by Subject|0|||
163171140|NCT02353143|589342315|FG003|Overall Study|Withdrawal by Subject|0|||
163171141|NCT02353143|589342316|FG004|Overall Study|Withdrawal by Subject|1|||
163171142|NCT02353143|589342317|FG005|Overall Study|Withdrawal by Subject|0|||
163171143|NCT02353143|589342318|FG006|Overall Study|Withdrawal by Subject|0|||
163171144|NCT02353143|589342319|FG007|Overall Study|Withdrawal by Subject|1|||
163171145|NCT02353143|589342320|FG008|Overall Study|Withdrawal by Subject|1|||
163171146|NCT02353143|589342312|FG000|Overall Study|Lack of Efficacy|2|||
163171147|NCT02353143|589342313|FG001|Overall Study|Lack of Efficacy|1|||
163171148|NCT02353143|589342314|FG002|Overall Study|Lack of Efficacy|2|||
163171149|NCT02353143|589342315|FG003|Overall Study|Lack of Efficacy|4|||
163171150|NCT02353143|589342316|FG004|Overall Study|Lack of Efficacy|13|||
163171151|NCT02353143|589342317|FG005|Overall Study|Lack of Efficacy|2|||
163171152|NCT02353143|589342318|FG006|Overall Study|Lack of Efficacy|2|||
163171153|NCT02353143|589342319|FG007|Overall Study|Lack of Efficacy|2|||
163171154|NCT02353143|589342320|FG008|Overall Study|Lack of Efficacy|1|||
163171155|NCT02353143|589342312|FG000|Overall Study|reason not specified|1|||
163171156|NCT02353143|589342313|FG001|Overall Study|reason not specified|2|||
163171157|NCT02353143|589342314|FG002|Overall Study|reason not specified|0|||
163171158|NCT02353143|589342315|FG003|Overall Study|reason not specified|0|||
163171159|NCT02353143|589342316|FG004|Overall Study|reason not specified|6|||
163171160|NCT02353143|589342317|FG005|Overall Study|reason not specified|1|||
163171161|NCT02353143|589342318|FG006|Overall Study|reason not specified|0|||
163171162|NCT02353143|589342319|FG007|Overall Study|reason not specified|3|||
163171163|NCT02353143|589342320|FG008|Overall Study|reason not specified|1|||
163171164|NCT02353143|589342312|FG000|Overall Study|Physician Decision|0|||
163171165|NCT02353143|589342313|FG001|Overall Study|Physician Decision|4|||
163171166|NCT02353143|589342314|FG002|Overall Study|Physician Decision|2|||
163171167|NCT02353143|589342315|FG003|Overall Study|Physician Decision|3|||
163171168|NCT02353143|589342316|FG004|Overall Study|Physician Decision|4|||
163171169|NCT02353143|589342317|FG005|Overall Study|Physician Decision|0|||
162820463|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820464|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820465|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163171170|NCT02353143|589342318|FG006|Overall Study|Physician Decision|1|||
163171171|NCT02353143|589342319|FG007|Overall Study|Physician Decision|2|||
163171172|NCT02353143|589342320|FG008|Overall Study|Physician Decision|0|||
163171173|NCT02353143|589342312|FG000|Overall Study|Adverse Event|0|||
163171174|NCT02353143|589342313|FG001|Overall Study|Adverse Event|0|||
163171175|NCT02353143|589342314|FG002|Overall Study|Adverse Event|1|||
163171176|NCT02353143|589342315|FG003|Overall Study|Adverse Event|0|||
163171177|NCT02353143|589342316|FG004|Overall Study|Adverse Event|1|||
163171178|NCT02353143|589342317|FG005|Overall Study|Adverse Event|1|||
163171179|NCT02353143|589342318|FG006|Overall Study|Adverse Event|0|||
163171180|NCT02353143|589342319|FG007|Overall Study|Adverse Event|0|||
163171181|NCT02353143|589342320|FG008|Overall Study|Adverse Event|0|||
163171182|NCT02353143|589342312|FG000|Overall Study|patient receiving other treatment for AML|0|||
163171183|NCT02353143|589342313|FG001|Overall Study|patient receiving other treatment for AML|0|||
163171184|NCT02353143|589342314|FG002|Overall Study|patient receiving other treatment for AML|1|||
163171185|NCT02353143|589342315|FG003|Overall Study|patient receiving other treatment for AML|0|||
163171186|NCT02353143|589342316|FG004|Overall Study|patient receiving other treatment for AML|0|||
163171187|NCT02353143|589342317|FG005|Overall Study|patient receiving other treatment for AML|0|||
163171188|NCT02353143|589342318|FG006|Overall Study|patient receiving other treatment for AML|0|||
163171189|NCT02353143|589342319|FG007|Overall Study|patient receiving other treatment for AML|0|||
163171190|NCT02353143|589342320|FG008|Overall Study|patient receiving other treatment for AML|0|||
163171191|NCT02353143|589342312|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
163171192|NCT02353143|589342313|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
163171193|NCT02353143|589342314|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
163171194|NCT02353143|589342315|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
163171195|NCT02353143|589342316|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
163171196|NCT02353143|589342317|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
163171197|NCT02353143|589342318|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
163171198|NCT02353143|589342319|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
162820466|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820467|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820468|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820469|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162820470|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820471|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820472|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820473|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820474|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820475|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820476|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
162820477|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820478|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820479|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820480|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
162820481|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820482|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820483|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820484|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820485|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
162820486|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
162820487|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820488|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
163171199|NCT02353143|589342320|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
163171200|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171201|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
163171202|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
163171203|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
163171204|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171205|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
163171206|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171207|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
163171208|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
163171209|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171210|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171211|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163171212|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171213|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171214|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
163171215|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171216|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
163171217|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
163171218|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
163171219|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171220|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171221|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171222|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171223|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
163171224|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
163171225|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
163171226|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
163171227|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
163171228|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
163171229|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
163171230|NCT00600119|589342321|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
163171231|NCT00600119|589342322|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
163171232|NCT00600119|589342323|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171233|NCT00600119|589342324|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171234|NCT00600119|589342325|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171235|NCT00600119|589342326|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
163171236|NCT00600119|589342321|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
163171237|NCT00600119|589342322|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171238|NCT00600119|589342323|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171239|NCT00600119|589342324|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
163171240|NCT00600119|589342325|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163171241|NCT00600119|589342326|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
163171242|NCT00600119|589342321|FG000|Double-blind Treatment Period|Other|0|||
163171243|NCT00600119|589342322|FG001|Double-blind Treatment Period|Other|0|||
163171244|NCT00600119|589342323|FG002|Double-blind Treatment Period|Other|0|||
163171245|NCT00600119|589342324|FG003|Double-blind Treatment Period|Other|0|||
163171246|NCT00600119|589342325|FG004|Double-blind Treatment Period|Other|2|||
163171247|NCT00600119|589342326|FG005|Double-blind Treatment Period|Other|1|||
163171248|NCT00600119|589342321|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171249|NCT00600119|589342322|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
163171250|NCT00600119|589342323|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171251|NCT00600119|589342324|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171252|NCT00600119|589342325|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
163171253|NCT00600119|589342326|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
163171254|NCT00600119|589342321|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171255|NCT00600119|589342322|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
163171256|NCT00600119|589342323|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171257|NCT00600119|589342324|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171258|NCT00600119|589342325|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171259|NCT00600119|589342326|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163171260|NCT00600119|589342321|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
163171261|NCT00600119|589342322|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
163171262|NCT00600119|589342323|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
163171263|NCT00600119|589342324|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
163171264|NCT00600119|589342325|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
163171265|NCT00600119|589342326|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
163171266|NCT00600119|589342321|FG000|Double-blind Treatment Period|Physician Decision|2|||
163171267|NCT00600119|589342322|FG001|Double-blind Treatment Period|Physician Decision|0|||
163171268|NCT00600119|589342323|FG002|Double-blind Treatment Period|Physician Decision|0|||
163171269|NCT00600119|589342324|FG003|Double-blind Treatment Period|Physician Decision|0|||
162820489|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820490|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820491|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162820492|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162820493|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162820494|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
162820495|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
162820496|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
162820497|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
162820498|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
162820499|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
162820500|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162820501|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162820502|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
162820503|NCT04178967|588056434|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820504|NCT04178967|588056435|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820505|NCT04178967|588056436|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820506|NCT04178967|588056437|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
162820507|NCT04178967|588056438|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820508|NCT04178967|588056439|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
162820509|NCT04178967|588056440|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
162820510|NCT04178967|588056441|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
162820511|NCT04178967|588056442|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163171270|NCT00600119|589342325|FG004|Double-blind Treatment Period|Physician Decision|0|||
163171271|NCT00600119|589342326|FG005|Double-blind Treatment Period|Physician Decision|0|||
163171272|NCT00600119|589342321|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162820512|NCT04178967|588056443|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820513|NCT04178967|588056444|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162820514|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820515|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820516|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820517|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820518|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820519|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820520|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820521|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820522|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
162820523|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
162820524|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
162820525|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820526|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820527|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820528|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162929559|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
163171273|NCT00600119|589342322|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163171274|NCT00600119|589342323|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163171275|NCT00600119|589342324|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163171276|NCT00600119|589342325|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
163171277|NCT00600119|589342326|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
163171278|NCT00600119|589342321|FG000|Double-blind Treatment Period|Adverse Event|1|||
163171279|NCT00600119|589342322|FG001|Double-blind Treatment Period|Adverse Event|1|||
163171280|NCT00600119|589342323|FG002|Double-blind Treatment Period|Adverse Event|0|||
163171281|NCT00600119|589342324|FG003|Double-blind Treatment Period|Adverse Event|1|||
163171282|NCT00600119|589342325|FG004|Double-blind Treatment Period|Adverse Event|2|||
163171283|NCT00600119|589342326|FG005|Double-blind Treatment Period|Adverse Event|10|||
163171284|NCT00600119|589342321|FG000|Follow-up Period|Adverse Event|0|||
163171285|NCT00600119|589342322|FG001|Follow-up Period|Adverse Event|0|||
163171286|NCT00600119|589342323|FG002|Follow-up Period|Adverse Event|0|||
163171287|NCT00600119|589342324|FG003|Follow-up Period|Adverse Event|0|||
163171288|NCT00600119|589342325|FG004|Follow-up Period|Adverse Event|0|||
163171289|NCT00600119|589342326|FG005|Follow-up Period|Adverse Event|1|||
163171290|NCT00600119|589342321|FG000|Follow-up Period|Other|1|||
163171291|NCT00600119|589342322|FG001|Follow-up Period|Other|0|||
163171292|NCT00600119|589342323|FG002|Follow-up Period|Other|0|||
163171293|NCT00600119|589342324|FG003|Follow-up Period|Other|0|||
163171294|NCT00600119|589342325|FG004|Follow-up Period|Other|0|||
163171295|NCT00600119|589342326|FG005|Follow-up Period|Other|0|||
163171296|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
163171297|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
163171298|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
163171299|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
163171300|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
163171301|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
163171302|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
163171303|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
163171304|NCT04740905|589342327|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
163171305|NCT04740905|589342328|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
163171306|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
163171307|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
163171308|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
163171309|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
163171310|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
163171311|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
163171312|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
163171313|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
163171314|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
163171315|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
163171316|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
163171317|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
163171318|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
163171319|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
163171320|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
163171321|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
163171322|NCT04740905|589342327|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
163171323|NCT04740905|589342328|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
163171324|NCT00561977|589342329|FG000|Overall Study|Withdrawal by Subject|0|||
163171325|NCT00561977|589342330|FG001|Overall Study|Withdrawal by Subject|2|||
163171326|NCT00561977|589342331|FG002|Overall Study|Withdrawal by Subject|1|||
163171327|NCT00561977|589342329|FG000|Overall Study|Pregnancy|0|||
163171328|NCT00561977|589342330|FG001|Overall Study|Pregnancy|1|||
163171329|NCT00561977|589342331|FG002|Overall Study|Pregnancy|1|||
163171330|NCT03077087|589342332|FG000|Overall Study|Physician Decision|2|||
163171331|NCT01989468|589342333|FG000|Overall Study|Adverse Event|10|||
163171332|NCT01989468|589342334|FG001|Overall Study|Adverse Event|15|||
163171333|NCT01989468|589342335|FG002|Overall Study|Adverse Event|4|||
163171334|NCT01989468|589342336|FG003|Overall Study|Adverse Event|5|||
163171335|NCT01989468|589342337|FG004|Overall Study|Adverse Event|4|||
163171336|NCT01989468|589342333|FG000|Overall Study|Lack of Efficacy|11|||
163171337|NCT01989468|589342334|FG001|Overall Study|Lack of Efficacy|11|||
163171338|NCT01989468|589342335|FG002|Overall Study|Lack of Efficacy|7|||
163171339|NCT01989468|589342336|FG003|Overall Study|Lack of Efficacy|4|||
163171340|NCT01989468|589342337|FG004|Overall Study|Lack of Efficacy|2|||
163171341|NCT01989468|589342333|FG000|Overall Study|Lost to Follow-up|5|||
163171342|NCT01989468|589342334|FG001|Overall Study|Lost to Follow-up|2|||
163171343|NCT01989468|589342335|FG002|Overall Study|Lost to Follow-up|0|||
163171344|NCT01989468|589342336|FG003|Overall Study|Lost to Follow-up|1|||
163171345|NCT01989468|589342337|FG004|Overall Study|Lost to Follow-up|1|||
163171346|NCT01989468|589342333|FG000|Overall Study|Physician Decision|4|||
163171347|NCT01989468|589342334|FG001|Overall Study|Physician Decision|1|||
163171348|NCT01989468|589342335|FG002|Overall Study|Physician Decision|0|||
163171349|NCT01989468|589342336|FG003|Overall Study|Physician Decision|1|||
163171350|NCT01989468|589342337|FG004|Overall Study|Physician Decision|0|||
163171351|NCT01989468|589342333|FG000|Overall Study|Pregnancy|0|||
163171352|NCT01989468|589342334|FG001|Overall Study|Pregnancy|1|||
163171353|NCT01989468|589342335|FG002|Overall Study|Pregnancy|0|||
163171354|NCT01989468|589342336|FG003|Overall Study|Pregnancy|0|||
163171355|NCT01989468|589342337|FG004|Overall Study|Pregnancy|0|||
163171356|NCT01989468|589342333|FG000|Overall Study|Technical Problems|3|||
163171357|NCT01989468|589342334|FG001|Overall Study|Technical Problems|1|||
163171358|NCT01989468|589342335|FG002|Overall Study|Technical Problems|3|||
163171359|NCT01989468|589342336|FG003|Overall Study|Technical Problems|1|||
163171360|NCT01989468|589342337|FG004|Overall Study|Technical Problems|0|||
163171361|NCT01989468|589342333|FG000|Overall Study|Subject Guardian Decision|11|||
163171362|NCT01989468|589342334|FG001|Overall Study|Subject Guardian Decision|6|||
163171363|NCT01989468|589342335|FG002|Overall Study|Subject Guardian Decision|4|||
163171364|NCT01989468|589342336|FG003|Overall Study|Subject Guardian Decision|4|||
163171365|NCT01989468|589342337|FG004|Overall Study|Subject Guardian Decision|1|||
163171366|NCT01989468|589342333|FG000|Overall Study|Death|3|||
163171367|NCT01989468|589342334|FG001|Overall Study|Death|0|||
163171368|NCT01989468|589342335|FG002|Overall Study|Death|1|||
163171369|NCT01989468|589342336|FG003|Overall Study|Death|0|||
163171370|NCT01989468|589342337|FG004|Overall Study|Death|0|||
163171371|NCT01224782|589342338|FG000|Overall Study|Lost to Follow-up|177|||
163171372|NCT01224782|589342338|FG000|Overall Study|Withdrawal by Subject|16|||
163171373|NCT01224782|589342338|FG000|Overall Study|Death|14|||
163171374|NCT01224782|589342338|FG000|Overall Study|Improvement|13|||
163171375|NCT01224782|589342338|FG000|Overall Study|Adverse Event|12|||
163171376|NCT01224782|589342338|FG000|Overall Study|Adverse Reaction|11|||
163171377|NCT01224782|589342338|FG000|Overall Study|Noncompliance|10|||
163171378|NCT01224782|589342338|FG000|Overall Study|Other|4|||
163171379|NCT01224782|589342338|FG000|Overall Study|Start of Dialysis|3|||
163171380|NCT01224782|589342338|FG000|Overall Study|Change of Treatment|1|||
163171381|NCT01224782|589342338|FG000|Overall Study|Financial Reasons|1|||
163171382|NCT01224782|589342338|FG000|Overall Study|Deterioration|1|||
163171383|NCT01224782|589342338|FG000|Overall Study|Transplantation|1|||
163171384|NCT01960907|589342339|FG000|Overall Study|Death|4|||
163171385|NCT01960907|589342340|FG001|Overall Study|Death|3|||
163171386|NCT01960907|589342339|FG000|Overall Study|Withdrawal by Subject|32|||
163171387|NCT01960907|589342340|FG001|Overall Study|Withdrawal by Subject|42|||
163171388|NCT01950013|589342343|FG000|Overall Study|Withdrawal by Subject|0|||
163171389|NCT01950013|589342344|FG001|Overall Study|Withdrawal by Subject|2|||
163171390|NCT01950013|589342345|FG002|Overall Study|Withdrawal by Subject|0|||
163171391|NCT01765218|589342350|FG000|Overall Study|Protocol Violation|1|||
163171392|NCT01765218|589342351|FG001|Overall Study|Protocol Violation|2|||
163171393|NCT01590758|589342354|FG000|Overall Study|Withdrawal by Subject|0|||
163171394|NCT01590758|589342355|FG001|Overall Study|Withdrawal by Subject|3|||
163171395|NCT01590758|589342354|FG000|Overall Study|Physician Decision|1|||
163171396|NCT01590758|589342355|FG001|Overall Study|Physician Decision|2|||
163171397|NCT01590758|589342354|FG000|Overall Study|Lost to Follow-up|4|||
163171398|NCT01590758|589342355|FG001|Overall Study|Lost to Follow-up|2|||
163171399|NCT02929498|589342356|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
163171400|NCT02929498|589342357|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
163171401|NCT02929498|589342358|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
163171402|NCT02929498|589342356|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
163171403|NCT02929498|589342357|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
163171404|NCT02929498|589342358|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
163171405|NCT01011309|589342363|FG000|Overall Study|Adverse Event|2|||
163171406|NCT01011309|589342364|FG001|Overall Study|Adverse Event|1|||
163171407|NCT01011309|589342365|FG002|Overall Study|Adverse Event|2|||
163171408|NCT01011309|589342363|FG000|Overall Study|Lack of Efficacy|0|||
163171409|NCT01011309|589342364|FG001|Overall Study|Lack of Efficacy|1|||
163171410|NCT01011309|589342365|FG002|Overall Study|Lack of Efficacy|0|||
163171411|NCT01011309|589342363|FG000|Overall Study|Protocol Violation|0|||
163171412|NCT01011309|589342364|FG001|Overall Study|Protocol Violation|1|||
163171413|NCT01011309|589342365|FG002|Overall Study|Protocol Violation|3|||
163171414|NCT00530504|589342368|FG000|Overall Study|Death|54|||
163171415|NCT00530504|589342368|FG000|Overall Study|Lost to Follow-up|26|||
163171416|NCT00530504|589342368|FG000|Overall Study|Withdrawal by Subject|39|||
163171417|NCT00530504|589342368|FG000|Overall Study|Exited study due to other reasons|33|||
163171418|NCT00006289|589342369|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
163171419|NCT00006289|589342370|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
163171420|NCT00006289|589342369|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
163171421|NCT00006289|589342370|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
163171422|NCT03255083|589342376|FG000|Overall Study|Clinical progression|1|||
163171423|NCT03255083|589342377|FG001|Overall Study|Clinical progression|0|||
163171424|NCT03255083|589342378|FG002|Overall Study|Clinical progression|0|||
163171425|NCT03255083|589342379|FG003|Overall Study|Clinical progression|0|||
163171426|NCT03255083|589342376|FG000|Overall Study|Adverse Event|0|||
163171427|NCT03255083|589342377|FG001|Overall Study|Adverse Event|1|||
163171428|NCT03255083|589342378|FG002|Overall Study|Adverse Event|0|||
163171429|NCT03255083|589342379|FG003|Overall Study|Adverse Event|0|||
163171430|NCT03255083|589342376|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
163171431|NCT03255083|589342377|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
163171432|NCT03255083|589342378|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
163171433|NCT03255083|589342379|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
163171434|NCT03255083|589342376|FG000|Overall Study|Withdrawal by Subject|1|||
163171435|NCT03255083|589342377|FG001|Overall Study|Withdrawal by Subject|1|||
163171436|NCT03255083|589342378|FG002|Overall Study|Withdrawal by Subject|1|||
163171437|NCT03255083|589342379|FG003|Overall Study|Withdrawal by Subject|0|||
162820529|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820530|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820531|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820532|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162820533|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
163171438|NCT05009979|589342380|FG000|Overall Study|Withdrawal by Subject|1|||
163171439|NCT00576420|589343836|FG000|Overall Study|Death|0|||
163171440|NCT00576420|589343837|FG001|Overall Study|Death|0|||
163171441|NCT00576420|589343838|FG002|Overall Study|Death|1|||
163171442|NCT02616146|589343839|FG000|Overall Study|Adverse Event|64|||
163171443|NCT02616146|589343840|FG001|Overall Study|Adverse Event|24|||
163171444|NCT02616146|589343839|FG000|Overall Study|Lost to Follow-up|23|||
162820534|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
162820535|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
162820536|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820537|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820538|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163171445|NCT02616146|589343840|FG001|Overall Study|Lost to Follow-up|13|||
163171446|NCT02616146|589343839|FG000|Overall Study|Non-compliance with study protocol|2|||
163171447|NCT02616146|589343840|FG001|Overall Study|Non-compliance with study protocol|0|||
163171448|NCT02616146|589343839|FG000|Overall Study|Non-compliance with study drug|4|||
163171449|NCT02616146|589343840|FG001|Overall Study|Non-compliance with study drug|2|||
163171450|NCT02616146|589343839|FG000|Overall Study|Pregnancy|2|||
163171451|NCT02616146|589343840|FG001|Overall Study|Pregnancy|2|||
163171452|NCT02616146|589343839|FG000|Overall Study|Pregnancy wish|3|||
163171453|NCT02616146|589343840|FG001|Overall Study|Pregnancy wish|0|||
163171454|NCT02616146|589343839|FG000|Overall Study|Protocol Violation|6|||
163171455|NCT02616146|589343840|FG001|Overall Study|Protocol Violation|3|||
163171456|NCT02616146|589343839|FG000|Overall Study|Study terminated by sponsor|1372|||
163171457|NCT02616146|589343840|FG001|Overall Study|Study terminated by sponsor|432|||
163171458|NCT02616146|589343839|FG000|Overall Study|Participant moved|4|||
163171459|NCT02616146|589343840|FG001|Overall Study|Participant moved|3|||
163171460|NCT02616146|589343839|FG000|Overall Study|Withdrawal by Subject|30|||
163171461|NCT02616146|589343840|FG001|Overall Study|Withdrawal by Subject|24|||
163171462|NCT02616146|589343839|FG000|Overall Study|Physician Decision|2|||
163171463|NCT02616146|589343840|FG001|Overall Study|Physician Decision|1|||
163171464|NCT01221272|589343841|FG000|Period 1|Adverse Event|2|||
163171465|NCT01221272|589343842|FG001|Period 1|Adverse Event|0|||
163171466|NCT01221272|589343841|FG000|Period 1|Consent Withdrawal|0|||
163171467|NCT01221272|589343842|FG001|Period 1|Consent Withdrawal|1|||
163171468|NCT01221272|589343841|FG000|Period 1|Significant Dosing Noncompliance|0|||
163171469|NCT01221272|589343842|FG001|Period 1|Significant Dosing Noncompliance|1|||
163171470|NCT01221272|589343841|FG000|Period 2|Adverse Event|0|||
163171471|NCT01221272|589343842|FG001|Period 2|Adverse Event|2|||
163171472|NCT01340872|589343843|FG000|Double-blind Phase|Adverse Event|6|||
163171473|NCT01340872|589343844|FG001|Double-blind Phase|Adverse Event|4|||
163171474|NCT01340872|589343845|FG002|Double-blind Phase|Adverse Event|0|||
163171475|NCT01340872|589343846|FG003|Double-blind Phase|Adverse Event|0|||
163171476|NCT01340872|589343843|FG000|Double-blind Phase|Withdrawal by Subject|3|||
163171477|NCT01340872|589343844|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163171478|NCT01340872|589343845|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163171479|NCT01340872|589343846|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163171480|NCT01340872|589343843|FG000|Double-blind Phase|Lost to Follow-up|0|||
163171481|NCT01340872|589343844|FG001|Double-blind Phase|Lost to Follow-up|1|||
163171482|NCT01340872|589343845|FG002|Double-blind Phase|Lost to Follow-up|0|||
163171483|NCT01340872|589343846|FG003|Double-blind Phase|Lost to Follow-up|0|||
163171484|NCT01340872|589343843|FG000|Double-blind Phase|Protocol Violation|0|||
163171485|NCT01340872|589343844|FG001|Double-blind Phase|Protocol Violation|1|||
163171486|NCT01340872|589343845|FG002|Double-blind Phase|Protocol Violation|0|||
163171487|NCT01340872|589343846|FG003|Double-blind Phase|Protocol Violation|0|||
163171488|NCT01340872|589343843|FG000|Open-label Phase|Physician Decision|0|||
163171489|NCT01340872|589343844|FG001|Open-label Phase|Physician Decision|0|||
163171490|NCT01340872|589343845|FG002|Open-label Phase|Physician Decision|2|||
163171491|NCT01340872|589343846|FG003|Open-label Phase|Physician Decision|1|||
163171492|NCT01340872|589343843|FG000|Open-label Phase|Pregnancy|0|||
163171493|NCT01340872|589343844|FG001|Open-label Phase|Pregnancy|0|||
163171494|NCT01340872|589343845|FG002|Open-label Phase|Pregnancy|1|||
163171495|NCT01340872|589343846|FG003|Open-label Phase|Pregnancy|0|||
163171496|NCT01340872|589343843|FG000|Open-label Phase|Adverse Event|0|||
163171497|NCT01340872|589343844|FG001|Open-label Phase|Adverse Event|0|||
163171498|NCT01340872|589343845|FG002|Open-label Phase|Adverse Event|8|||
163171499|NCT01340872|589343846|FG003|Open-label Phase|Adverse Event|4|||
163171500|NCT01340872|589343843|FG000|Open-label Phase|Withdrawal by Subject|0|||
163171501|NCT01340872|589343844|FG001|Open-label Phase|Withdrawal by Subject|0|||
163171502|NCT01340872|589343845|FG002|Open-label Phase|Withdrawal by Subject|1|||
163171503|NCT01340872|589343846|FG003|Open-label Phase|Withdrawal by Subject|6|||
163171504|NCT01340872|589343843|FG000|Open-label Phase|Worsening of IBD|0|||
163171505|NCT01340872|589343844|FG001|Open-label Phase|Worsening of IBD|0|||
163171506|NCT01340872|589343845|FG002|Open-label Phase|Worsening of IBD|1|||
163171507|NCT01340872|589343846|FG003|Open-label Phase|Worsening of IBD|0|||
163171508|NCT03039621|589343851|FG000|Overall Study|Violation of inclusion criteria|3|||
163171509|NCT03039621|589343852|FG001|Overall Study|Violation of inclusion criteria|2|||
163171510|NCT03039621|589343851|FG000|Overall Study|Non-compliance with protocol requirement|4|||
163171511|NCT03039621|589343852|FG001|Overall Study|Non-compliance with protocol requirement|5|||
163171512|NCT03039621|589343851|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
163171513|NCT03039621|589343852|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
163171514|NCT03039621|589343851|FG000|Overall Study|Violation of non-inclusion criteria|1|||
163171515|NCT03039621|589343852|FG001|Overall Study|Violation of non-inclusion criteria|2|||
163171516|NCT02522624|589343853|FG000|Overall Study|Technical failure|1|||
163171517|NCT02522624|589343854|FG001|Overall Study|Technical failure|0|||
163171518|NCT03254108|589343855|FG000|Overall Study|Adverse Event|0|||
163171519|NCT03254108|589343856|FG001|Overall Study|Adverse Event|2|||
163171520|NCT03254108|589343857|FG002|Overall Study|Adverse Event|0|||
163171521|NCT03254108|589343858|FG003|Overall Study|Adverse Event|1|||
163171522|NCT03254108|589343859|FG004|Overall Study|Adverse Event|1|||
163171523|NCT03254108|589343855|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171524|NCT03254108|589343856|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171525|NCT03254108|589343857|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171526|NCT03254108|589343858|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163171527|NCT03254108|589343859|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
163171528|NCT01771809|589343860|FG000|Overall Study|Adverse Event|4|||
163171529|NCT01771809|589343861|FG001|Overall Study|Adverse Event|12|||
163171530|NCT01771809|589343860|FG000|Overall Study|Protocol Violation|0|||
163171531|NCT01771809|589343861|FG001|Overall Study|Protocol Violation|1|||
163171532|NCT01771809|589343860|FG000|Overall Study|Withdrawal by Subject|34|||
163171533|NCT01771809|589343861|FG001|Overall Study|Withdrawal by Subject|42|||
163171534|NCT01771809|589343860|FG000|Overall Study|Lost to Follow-up|1|||
163171535|NCT01771809|589343861|FG001|Overall Study|Lost to Follow-up|3|||
163171536|NCT01771809|589343860|FG000|Overall Study|Other (Insufficient clinical response)|22|||
163171537|NCT01771809|589343861|FG001|Overall Study|Other (Insufficient clinical response)|20|||
163171538|NCT01771809|589343860|FG000|Overall Study|Death|1|||
163171539|NCT01771809|589343861|FG001|Overall Study|Death|0|||
163171540|NCT01771809|589343860|FG000|Overall Study|Other (other)|9|||
163171541|NCT01771809|589343861|FG001|Overall Study|Other (other)|5|||
163171542|NCT00362180|589343862|FG000|Treated Period|Withdrawal by Subject|1|||
163171543|NCT00362180|589343863|FG001|Treated Period|Withdrawal by Subject|0|||
163171544|NCT00362180|589343864|FG002|Treated Period|Withdrawal by Subject|0|||
163171545|NCT00362180|589343865|FG003|Treated Period|Withdrawal by Subject|0|||
163171546|NCT00362180|589343866|FG004|Treated Period|Withdrawal by Subject|0|||
163171547|NCT00362180|589343867|FG005|Treated Period|Withdrawal by Subject|0|||
163171548|NCT00362180|589343868|FG006|Treated Period|Withdrawal by Subject|0|||
163171549|NCT00362180|589343869|FG007|Treated Period|Withdrawal by Subject|0|||
163171550|NCT00362180|589343870|FG008|Treated Period|Withdrawal by Subject|0|||
163171551|NCT00362180|589343862|FG000|Treated Period|Adverse Event|0|||
163171552|NCT00362180|589343863|FG001|Treated Period|Adverse Event|0|||
163171553|NCT00362180|589343864|FG002|Treated Period|Adverse Event|0|||
163171554|NCT00362180|589343865|FG003|Treated Period|Adverse Event|0|||
163171555|NCT00362180|589343866|FG004|Treated Period|Adverse Event|0|||
163171556|NCT00362180|589343867|FG005|Treated Period|Adverse Event|1|||
163171557|NCT00362180|589343868|FG006|Treated Period|Adverse Event|0|||
163171558|NCT00362180|589343869|FG007|Treated Period|Adverse Event|1|||
163171559|NCT00362180|589343870|FG008|Treated Period|Adverse Event|0|||
163171560|NCT02600871|589343873|FG000|Overall Study|Lost to Follow-up|13|||
163171561|NCT02600871|589343874|FG001|Overall Study|Lost to Follow-up|10|||
163171562|NCT01246466|589343878|FG000|Overall Study|Death|1|||
163171563|NCT01246466|589343878|FG000|Overall Study|Withdrawal by Subject|1|||
163171564|NCT01142089|589343884|FG000|Overall Study|Physician Decision|1|||
163171565|NCT01142089|589343885|FG001|Overall Study|Physician Decision|0|||
163171566|NCT01142089|589343884|FG000|Overall Study|Withdrawal by Subject|1|||
163171567|NCT01142089|589343885|FG001|Overall Study|Withdrawal by Subject|2|||
163171568|NCT01142089|589343884|FG000|Overall Study|Use of prohibited medications|0|||
163171569|NCT01142089|589343885|FG001|Overall Study|Use of prohibited medications|1|||
163171570|NCT01142089|589343884|FG000|Overall Study|Noncompliance with study procedures|2|||
163171571|NCT01142089|589343885|FG001|Overall Study|Noncompliance with study procedures|1|||
163171572|NCT01142089|589343884|FG000|Overall Study|Patient required rescue medication|8|||
163171573|NCT01142089|589343885|FG001|Overall Study|Patient required rescue medication|17|||
163171574|NCT01974765|589343888|FG000|Overall Study|Withdrawal by Subject|1|||
163171575|NCT01974765|589343888|FG000|Overall Study|Death|1|||
163171576|NCT01974765|589343888|FG000|Overall Study|Adverse Event|2|||
163171577|NCT00348933|589343889|FG000|Overall Study|Withdrawal by Subject|10|||
163171578|NCT00348933|589343889|FG000|Overall Study|Lost to Follow-up|6|||
163171579|NCT00348933|589343889|FG000|Overall Study|Protocol Violation|2|||
163171580|NCT00348933|589343889|FG000|Overall Study|Adverse Event|7|||
163171581|NCT01489111|589343890|FG000|Overall Study|Withdrawal criterion|1|||
163171582|NCT00003472|589343895|FG000|Overall Study|Not evaluable|3|||
163171583|NCT00874939|589343896|FG000|Overall Study|Study terminated|4|||
163171584|NCT02870933|589343897|FG000|Overall Study|Death|2|||
163171585|NCT02870933|589343898|FG001|Overall Study|Death|1|||
163171586|NCT02870933|589343897|FG000|Overall Study|Withdrawal by Subject|0|||
163171587|NCT02870933|589343898|FG001|Overall Study|Withdrawal by Subject|1|||
163171588|NCT02168387|589343899|FG000|Overall Study|Planned exubation|6|||
163171589|NCT02168387|589343900|FG001|Overall Study|Planned exubation|3|||
163171590|NCT02168387|589343899|FG000|Overall Study|Death|1|||
163171591|NCT02168387|589343900|FG001|Overall Study|Death|0|||
163171592|NCT01350544|589343902|FG000|Overall Study|Administrative Withdrawal|0|||
163171593|NCT01350544|589343903|FG001|Overall Study|Administrative Withdrawal|1|||
163171594|NCT01350544|589343902|FG000|Overall Study|Death|1|||
163171595|NCT01350544|589343903|FG001|Overall Study|Death|2|||
163171596|NCT01350544|589343902|FG000|Overall Study|Moved out of LA County|2|||
163171597|NCT01350544|589343903|FG001|Overall Study|Moved out of LA County|2|||
163171598|NCT01350544|589343902|FG000|Overall Study|Medical Issues|1|||
163171599|NCT01350544|589343903|FG001|Overall Study|Medical Issues|1|||
163171600|NCT01350544|589343902|FG000|Overall Study|Withdrawal by Subject|0|||
163171601|NCT01350544|589343903|FG001|Overall Study|Withdrawal by Subject|1|||
162820539|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163171602|NCT01350544|589343902|FG000|Overall Study|Incarceration|1|||
163171603|NCT01350544|589343903|FG001|Overall Study|Incarceration|0|||
163171604|NCT01350544|589343902|FG000|Overall Study|Lost to Follow-up|18|||
163171605|NCT01350544|589343903|FG001|Overall Study|Lost to Follow-up|15|||
163171606|NCT01444092|589343904|FG000|Overall Study|Adverse Event|8|||
163171607|NCT01444092|589343904|FG000|Overall Study|Protocol Violation|1|||
163171608|NCT01444092|589343904|FG000|Overall Study|Withdrawal by Subject|1|||
163171609|NCT01444092|589343904|FG000|Overall Study|Other Eligibility criteria|7|||
163171610|NCT00603590|589343905|FG000|Overall Study|Did not attend study clinic|39|||
163171611|NCT00603590|589343906|FG001|Overall Study|Did not attend study clinic|30|||
163171612|NCT00603590|589343905|FG000|Overall Study|Refused blood test|5|||
163171613|NCT00603590|589343906|FG001|Overall Study|Refused blood test|1|||
163171614|NCT00603590|589343905|FG000|Overall Study|Patient discontinued study drug|22|||
163171615|NCT00603590|589343906|FG001|Overall Study|Patient discontinued study drug|15|||
163171616|NCT00603590|589343905|FG000|Overall Study|Adverse Event|2|||
163171617|NCT00603590|589343906|FG001|Overall Study|Adverse Event|0|||
163171618|NCT00603590|589343905|FG000|Overall Study|Lost to Follow-up|8|||
163171619|NCT00603590|589343906|FG001|Overall Study|Lost to Follow-up|4|||
163171620|NCT00603590|589343905|FG000|Overall Study|Cardiovascular event|0|||
163171621|NCT00603590|589343906|FG001|Overall Study|Cardiovascular event|1|||
163171622|NCT00910624|589343910|FG000|Treatment Phase|Adverse Event|2|||
162820540|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820541|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820542|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163171623|NCT00910624|589343911|FG001|Treatment Phase|Adverse Event|6|||
163171624|NCT00910624|589343912|FG002|Treatment Phase|Adverse Event|6|||
163171625|NCT00910624|589343913|FG003|Treatment Phase|Adverse Event|0|||
163171626|NCT00910624|589343910|FG000|Treatment Phase|Treatment Failure|23|||
163171627|NCT00910624|589343911|FG001|Treatment Phase|Treatment Failure|10|||
163171628|NCT00910624|589343912|FG002|Treatment Phase|Treatment Failure|0|||
163171629|NCT00910624|589343913|FG003|Treatment Phase|Treatment Failure|0|||
163171630|NCT00910624|589343910|FG000|Treatment Phase|Lost to Follow-up|0|||
163171631|NCT00910624|589343911|FG001|Treatment Phase|Lost to Follow-up|0|||
162820543|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820544|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820545|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
162820546|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162820547|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820548|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820549|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163171632|NCT00910624|589343912|FG002|Treatment Phase|Lost to Follow-up|1|||
163171633|NCT00910624|589343913|FG003|Treatment Phase|Lost to Follow-up|0|||
163171634|NCT00910624|589343910|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
163171635|NCT00910624|589343911|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
162820550|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163171636|NCT00910624|589343912|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
163171637|NCT00910624|589343913|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
163171638|NCT00910624|589343910|FG000|Treatment Phase|Withdrawal by Subject|2|||
162820551|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820552|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820553|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820554|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162820555|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
163171639|NCT00910624|589343911|FG001|Treatment Phase|Withdrawal by Subject|1|||
163171640|NCT00910624|589343912|FG002|Treatment Phase|Withdrawal by Subject|0|||
163171641|NCT00910624|589343913|FG003|Treatment Phase|Withdrawal by Subject|0|||
163171642|NCT00910624|589343910|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
163171643|NCT00910624|589343911|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
163171644|NCT00910624|589343912|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
163171645|NCT00910624|589343913|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
163171646|NCT00910624|589343910|FG000|Follow-Up Phase|Adverse Event|0|||
163171647|NCT00910624|589343911|FG001|Follow-Up Phase|Adverse Event|0|||
163171648|NCT00910624|589343912|FG002|Follow-Up Phase|Adverse Event|1|||
163171649|NCT00910624|589343913|FG003|Follow-Up Phase|Adverse Event|0|||
163171650|NCT00910624|589343910|FG000|Follow-Up Phase|Lost to Follow-up|3|||
163171651|NCT00910624|589343911|FG001|Follow-Up Phase|Lost to Follow-up|1|||
163171652|NCT00910624|589343912|FG002|Follow-Up Phase|Lost to Follow-up|2|||
163171653|NCT00910624|589343913|FG003|Follow-Up Phase|Lost to Follow-up|0|||
163171654|NCT00910624|589343910|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
163171655|NCT00910624|589343911|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
163171656|NCT00910624|589343912|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
163171657|NCT00910624|589343913|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
163171658|NCT00910624|589343910|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163171659|NCT00910624|589343911|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163171660|NCT00910624|589343912|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
163171661|NCT00910624|589343913|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
163171662|NCT00910624|589343910|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
163171663|NCT00910624|589343911|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171664|NCT00910624|589343912|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171665|NCT00910624|589343913|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
163171666|NCT00910624|589343910|FG000|Follow-Up Phase|Administrative|0|||
163171667|NCT00910624|589343911|FG001|Follow-Up Phase|Administrative|1|||
163171668|NCT00910624|589343912|FG002|Follow-Up Phase|Administrative|1|||
163171669|NCT00910624|589343913|FG003|Follow-Up Phase|Administrative|0|||
163171670|NCT03005873|589343914|FG000|Overall Study|Prohibited medication use post radnomization|1|||
163171671|NCT03005873|589343915|FG001|Overall Study|Prohibited medication use post radnomization|1|||
163171672|NCT03005873|589343916|FG002|Overall Study|Prohibited medication use post radnomization|1|||
163171673|NCT03005873|589343914|FG000|Overall Study|Withdrew consent|0|||
163171674|NCT03005873|589343915|FG001|Overall Study|Withdrew consent|1|||
163171675|NCT03005873|589343916|FG002|Overall Study|Withdrew consent|2|||
163171676|NCT03005873|589343914|FG000|Overall Study|Lost to Follow-up|0|||
163171677|NCT03005873|589343915|FG001|Overall Study|Lost to Follow-up|1|||
163171678|NCT03005873|589343916|FG002|Overall Study|Lost to Follow-up|0|||
163171679|NCT03005873|589343914|FG000|Overall Study|Ineligible post randomization|0|||
163171680|NCT03005873|589343915|FG001|Overall Study|Ineligible post randomization|0|||
163171681|NCT03005873|589343916|FG002|Overall Study|Ineligible post randomization|1|||
163171682|NCT04585009|589343917|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
163171683|NCT04585009|589343918|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171684|NCT04585009|589343919|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171685|NCT04585009|589343920|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171686|NCT04585009|589343921|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171687|NCT04585009|589343922|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171688|NCT04585009|589343923|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171689|NCT04585009|589343924|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171690|NCT04585009|589343925|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171691|NCT04585009|589343926|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171692|NCT04585009|589343927|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171693|NCT04585009|589343928|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
163171694|NCT04585009|589343917|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
163171695|NCT04585009|589343918|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171696|NCT04585009|589343919|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171697|NCT04585009|589343920|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171698|NCT04585009|589343921|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171699|NCT04585009|589343922|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171700|NCT04585009|589343923|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171701|NCT04585009|589343924|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171702|NCT04585009|589343925|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171703|NCT04585009|589343926|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171704|NCT04585009|589343927|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171705|NCT04585009|589343928|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
163171706|NCT04585009|589343917|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162698351|NCT02500979|587605471|FG000|Period 1|Severe non-compliance to protocol|0|||
162820556|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
162820557|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
162820558|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820559|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820560|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820561|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820562|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820563|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820564|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820565|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820566|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820567|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
162820568|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
162820569|NCT04178967|588056434|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820570|NCT04178967|588056435|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820571|NCT04178967|588056436|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820572|NCT04178967|588056437|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820573|NCT04178967|588056438|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820574|NCT04178967|588056439|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820575|NCT04178967|588056440|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820576|NCT04178967|588056441|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820577|NCT04178967|588056442|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820578|NCT04178967|588056443|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
162820579|NCT04178967|588056444|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
162820580|NCT01975428|588056448|FG000|Overall Study|Lost to Follow-up|17|||
162820581|NCT01975428|588056449|FG001|Overall Study|Lost to Follow-up|4|||
162820582|NCT01975428|588056448|FG000|Overall Study|Withdrawal by Subject|3|||
162820583|NCT01975428|588056449|FG001|Overall Study|Withdrawal by Subject|10|||
162820584|NCT02187809|588056450|FG000|Overall Study|The study was terminated|3|||
162820585|NCT00628251|588056451|FG000|Randomised Part|Withdrawal by Subject|0|||
162820586|NCT00628251|588056452|FG001|Randomised Part|Withdrawal by Subject|0|||
162820587|NCT00628251|588056453|FG002|Randomised Part|Withdrawal by Subject|1|||
162820588|NCT00628251|588056451|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
162820589|NCT00628251|588056452|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
162820590|NCT00628251|588056453|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
162820591|NCT00628251|588056451|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
162820592|NCT00628251|588056452|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
162820593|NCT00628251|588056453|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
162820594|NCT00628251|588056451|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
162820595|NCT00628251|588056452|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
162820596|NCT00628251|588056453|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
162820597|NCT00628251|588056451|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
162820598|NCT00628251|588056452|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
162820599|NCT00628251|588056453|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
162820600|NCT00628251|588056451|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
162820601|NCT00628251|588056452|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
162820602|NCT00628251|588056453|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
162820603|NCT01245387|588056455|FG000|Overall Study|Lost to Follow-up|106|||
162820604|NCT01245387|588056455|FG000|Overall Study|Lack of Efficacy|195|||
162820605|NCT01245387|588056455|FG000|Overall Study|Adverse Event|9|||
162820606|NCT01245387|588056455|FG000|Overall Study|Death|3|||
162820607|NCT01245387|588056455|FG000|Overall Study|Other|131|||
162820608|NCT01245387|588056455|FG000|Overall Study|Missing discontinuation status|369|||
162820609|NCT00601705|588056456|FG000|Overall Study|Withdrawal by Subject|1|||
162820610|NCT04513665|588056457|FG000|Overall Study|Adverse Event|2|||
162820611|NCT04513665|588056458|FG001|Overall Study|Adverse Event|0|||
162820612|NCT04513665|588056457|FG000|Overall Study|Lack of Efficacy|14|||
162820613|NCT04513665|588056458|FG001|Overall Study|Lack of Efficacy|0|||
162820614|NCT02608879|588056462|FG000|Overall Study|Lost to Follow-up|1|||
162820615|NCT02608879|588056463|FG001|Overall Study|Lost to Follow-up|0|||
162820616|NCT02608879|588056464|FG002|Overall Study|Lost to Follow-up|0|||
162820617|NCT02608879|588056462|FG000|Overall Study|Did not meet continuation criteria|0|||
162820618|NCT02608879|588056463|FG001|Overall Study|Did not meet continuation criteria|0|||
162820619|NCT02608879|588056464|FG002|Overall Study|Did not meet continuation criteria|3|||
162820620|NCT04246801|588056465|FG000|Overall Study|Adverse Event|1|||
162820621|NCT04246801|588056466|FG001|Overall Study|Adverse Event|1|||
162820622|NCT04246801|588056465|FG000|Overall Study|Protocol Violation|1|||
162820623|NCT04246801|588056466|FG001|Overall Study|Protocol Violation|1|||
162820624|NCT04246801|588056465|FG000|Overall Study|Lack of Efficacy|0|||
162820625|NCT04246801|588056466|FG001|Overall Study|Lack of Efficacy|2|||
162820626|NCT04246801|588056465|FG000|Overall Study|Lost to Follow-up|1|||
162820627|NCT04246801|588056466|FG001|Overall Study|Lost to Follow-up|1|||
162820628|NCT04246801|588056465|FG000|Overall Study|Withdrawal by Subject|2|||
162820629|NCT04246801|588056466|FG001|Overall Study|Withdrawal by Subject|1|||
162820630|NCT01368042|588056470|FG000|Overall Study|Death|14|||
162820631|NCT01368042|588056470|FG000|Overall Study|Protocol Violation|11|||
162820632|NCT01368042|588056470|FG000|Overall Study|Lost to Follow-up|4|||
162820633|NCT01368042|588056470|FG000|Overall Study|Transplanted|1|||
162820634|NCT02632721|588056472|FG000|Overall Study|Adverse Event|0|||
162820635|NCT02632721|588056473|FG001|Overall Study|Adverse Event|0|||
162820636|NCT02632721|588056474|FG002|Overall Study|Adverse Event|2|||
162820637|NCT02632721|588056475|FG003|Overall Study|Adverse Event|5|||
162820638|NCT02632721|588056476|FG004|Overall Study|Adverse Event|3|||
162820639|NCT02632721|588056472|FG000|Overall Study|Dose limiting toxicity|0|||
162820640|NCT02632721|588056473|FG001|Overall Study|Dose limiting toxicity|0|||
162820641|NCT02632721|588056474|FG002|Overall Study|Dose limiting toxicity|0|||
162820642|NCT02632721|588056475|FG003|Overall Study|Dose limiting toxicity|1|||
162820643|NCT02632721|588056476|FG004|Overall Study|Dose limiting toxicity|0|||
162820644|NCT02632721|588056472|FG000|Overall Study|Progressive disease|3|||
162820645|NCT02632721|588056473|FG001|Overall Study|Progressive disease|0|||
162820646|NCT02632721|588056474|FG002|Overall Study|Progressive disease|4|||
162820647|NCT02632721|588056475|FG003|Overall Study|Progressive disease|6|||
162820648|NCT02632721|588056476|FG004|Overall Study|Progressive disease|5|||
162820649|NCT02632721|588056472|FG000|Overall Study|Refused to continue taking trial medication|0|||
162820650|NCT02632721|588056473|FG001|Overall Study|Refused to continue taking trial medication|1|||
162820651|NCT02632721|588056474|FG002|Overall Study|Refused to continue taking trial medication|1|||
162820652|NCT02632721|588056475|FG003|Overall Study|Refused to continue taking trial medication|1|||
162820653|NCT02632721|588056476|FG004|Overall Study|Refused to continue taking trial medication|2|||
162820654|NCT02632721|588056472|FG000|Overall Study|Inadequate clinical condition|0|||
162820655|NCT02632721|588056473|FG001|Overall Study|Inadequate clinical condition|0|||
162820656|NCT02632721|588056474|FG002|Overall Study|Inadequate clinical condition|0|||
162820657|NCT02632721|588056475|FG003|Overall Study|Inadequate clinical condition|0|||
162820658|NCT02632721|588056476|FG004|Overall Study|Inadequate clinical condition|1|||
162820659|NCT02632721|588056472|FG000|Overall Study|No meet eligibility|0|||
162820660|NCT02632721|588056473|FG001|Overall Study|No meet eligibility|0|||
162820661|NCT02632721|588056474|FG002|Overall Study|No meet eligibility|0|||
162820662|NCT02632721|588056475|FG003|Overall Study|No meet eligibility|0|||
162820663|NCT02632721|588056476|FG004|Overall Study|No meet eligibility|1|||
162820664|NCT02632721|588056472|FG000|Overall Study|Allergic reaction|0|||
162820665|NCT02632721|588056473|FG001|Overall Study|Allergic reaction|0|||
162820666|NCT02632721|588056474|FG002|Overall Study|Allergic reaction|0|||
162820667|NCT02632721|588056475|FG003|Overall Study|Allergic reaction|1|||
162820668|NCT02632721|588056476|FG004|Overall Study|Allergic reaction|0|||
162820669|NCT02632721|588056472|FG000|Overall Study|Receiving Decitabine locally|0|||
162820670|NCT02632721|588056473|FG001|Overall Study|Receiving Decitabine locally|0|||
162820671|NCT02632721|588056474|FG002|Overall Study|Receiving Decitabine locally|1|||
162820672|NCT02632721|588056475|FG003|Overall Study|Receiving Decitabine locally|0|||
162820673|NCT02632721|588056476|FG004|Overall Study|Receiving Decitabine locally|0|||
162820674|NCT02632721|588056472|FG000|Overall Study|No benefit from study treatment|1|||
162820675|NCT02632721|588056473|FG001|Overall Study|No benefit from study treatment|1|||
162820676|NCT02632721|588056474|FG002|Overall Study|No benefit from study treatment|0|||
162820677|NCT02632721|588056475|FG003|Overall Study|No benefit from study treatment|0|||
162820678|NCT02632721|588056476|FG004|Overall Study|No benefit from study treatment|1|||
162820679|NCT02632721|588056472|FG000|Overall Study|Patient wish for other treatment|0|||
162820680|NCT02632721|588056473|FG001|Overall Study|Patient wish for other treatment|1|||
162820681|NCT02632721|588056474|FG002|Overall Study|Patient wish for other treatment|0|||
162820682|NCT02632721|588056475|FG003|Overall Study|Patient wish for other treatment|0|||
162820683|NCT02632721|588056476|FG004|Overall Study|Patient wish for other treatment|0|||
162820684|NCT02632721|588056472|FG000|Overall Study|Relapsed Pneumonia|0|||
162820685|NCT02632721|588056473|FG001|Overall Study|Relapsed Pneumonia|0|||
162820686|NCT02632721|588056474|FG002|Overall Study|Relapsed Pneumonia|0|||
162820687|NCT02632721|588056475|FG003|Overall Study|Relapsed Pneumonia|0|||
162820688|NCT02632721|588056476|FG004|Overall Study|Relapsed Pneumonia|1|||
162820689|NCT02632721|588056472|FG000|Overall Study|Therapy refractory AML|0|||
162820690|NCT02632721|588056473|FG001|Overall Study|Therapy refractory AML|0|||
162820691|NCT02632721|588056474|FG002|Overall Study|Therapy refractory AML|0|||
162820692|NCT02632721|588056475|FG003|Overall Study|Therapy refractory AML|0|||
162820693|NCT02632721|588056476|FG004|Overall Study|Therapy refractory AML|1|||
162820694|NCT02632721|588056472|FG000|Overall Study|Increase of white blood cell count|0|||
162820695|NCT02632721|588056473|FG001|Overall Study|Increase of white blood cell count|0|||
162820696|NCT02632721|588056474|FG002|Overall Study|Increase of white blood cell count|0|||
162820697|NCT02632721|588056475|FG003|Overall Study|Increase of white blood cell count|0|||
162820698|NCT02632721|588056476|FG004|Overall Study|Increase of white blood cell count|1|||
162820699|NCT02632721|588056472|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162820700|NCT02632721|588056473|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162820701|NCT02632721|588056474|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
162820702|NCT02632721|588056475|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162820703|NCT02632721|588056476|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
162820704|NCT00544648|588056480|FG000|Overall Study|Withdrawal by Subject|1|||
162820705|NCT00544648|588056481|FG001|Overall Study|Withdrawal by Subject|0|||
162820706|NCT00544648|588056480|FG000|Overall Study|Adverse Event|1|||
162820707|NCT00544648|588056481|FG001|Overall Study|Adverse Event|1|||
162820708|NCT00544648|588056480|FG000|Overall Study|progression of disease|1|||
162820709|NCT00544648|588056481|FG001|Overall Study|progression of disease|0|||
162820710|NCT02663271|588056482|FG000|Overall Study|Withdrawal by Subject|5|||
162820711|NCT02663271|588056482|FG000|Overall Study|Lack of Efficacy|1|||
162820712|NCT01572675|588056483|FG000|Overall Study|End of prescribed treatment|140|||
162820713|NCT01572675|588056484|FG001|Overall Study|End of prescribed treatment|118|||
162820714|NCT01572675|588056483|FG000|Overall Study|Recovery|16|||
162820715|NCT01572675|588056484|FG001|Overall Study|Recovery|23|||
162820716|NCT01572675|588056483|FG000|Overall Study|Lack of Efficacy|31|||
162820717|NCT01572675|588056484|FG001|Overall Study|Lack of Efficacy|31|||
162820718|NCT01572675|588056483|FG000|Overall Study|Intolerance|6|||
162820719|NCT01572675|588056484|FG001|Overall Study|Intolerance|5|||
162820720|NCT01572675|588056483|FG000|Overall Study|Improved symptoms|8|||
162820721|NCT01572675|588056484|FG001|Overall Study|Improved symptoms|2|||
162820722|NCT01572675|588056483|FG000|Overall Study|Surgical intervention|3|||
162820723|NCT01572675|588056484|FG001|Overall Study|Surgical intervention|6|||
162820724|NCT01572675|588056483|FG000|Overall Study|Withdrawal by Subject|5|||
162820725|NCT01572675|588056484|FG001|Overall Study|Withdrawal by Subject|1|||
162820726|NCT01572675|588056483|FG000|Overall Study|Physician Decision|2|||
162820727|NCT01572675|588056484|FG001|Overall Study|Physician Decision|2|||
162820728|NCT01572675|588056483|FG000|Overall Study|Death unrelated to coxibs|1|||
162820729|NCT01572675|588056484|FG001|Overall Study|Death unrelated to coxibs|1|||
162820730|NCT01572675|588056483|FG000|Overall Study|Other disease detected|1|||
162820731|NCT01572675|588056484|FG001|Overall Study|Other disease detected|1|||
162820732|NCT01572675|588056483|FG000|Overall Study|Unknown reason|1|||
162820733|NCT01572675|588056484|FG001|Overall Study|Unknown reason|1|||
162820734|NCT01572675|588056483|FG000|Overall Study|Rheumatologist new evaluation|0|||
162820735|NCT01572675|588056484|FG001|Overall Study|Rheumatologist new evaluation|1|||
162820736|NCT01572675|588056483|FG000|Overall Study|Missing data|1|||
162820737|NCT01572675|588056484|FG001|Overall Study|Missing data|4|||
162820738|NCT01572675|588056483|FG000|Overall Study|Lost to Follow-up|22|||
162820739|NCT01572675|588056484|FG001|Overall Study|Lost to Follow-up|27|||
162820740|NCT01351623|588056488|FG000|Overall Study|Protocol Violation|2|||
162820741|NCT01351623|588056488|FG000|Overall Study|Adverse Event|4|||
162820742|NCT01351623|588056488|FG000|Overall Study|Withdrawal by Subject|1|||
162820743|NCT01351623|588056488|FG000|Overall Study|Death|2|||
162820744|NCT02966223|588056489|FG000|Overall Study|Physician Decision|3|||
162820745|NCT02966223|588056489|FG000|Overall Study|Withdrawal by Subject|11|||
162820746|NCT02966223|588056489|FG000|Overall Study|Lost to Follow-up|1|||
162820747|NCT01326728|588056490|FG000|Overall Study|Death|13|||
162820748|NCT01326728|588056491|FG001|Overall Study|Death|0|||
162820749|NCT01326728|588056490|FG000|Overall Study|Early closure of study|34|||
162820750|NCT01326728|588056491|FG001|Overall Study|Early closure of study|9|||
162820751|NCT04399122|588056494|FG000|Overall Study|Lost to Follow-up|2|||
162820752|NCT04399122|588056495|FG001|Overall Study|Lost to Follow-up|0|||
162820753|NCT04399122|588056494|FG000|Overall Study|Withdrawal by Subject|1|||
162820754|NCT04399122|588056495|FG001|Overall Study|Withdrawal by Subject|0|||
162820755|NCT02536755|588056497|FG000|Overall Study|Adverse Event|4|||
162820756|NCT04448756|588056501|FG000|Overall Study|Adverse Event|0|||
162820757|NCT04448756|588056502|FG001|Overall Study|Adverse Event|1|||
162820758|NCT04448756|588056503|FG002|Overall Study|Adverse Event|0|||
162820759|NCT04448756|588056501|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
162820760|NCT04448756|588056502|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
162820761|NCT04448756|588056503|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
162820762|NCT04448756|588056501|FG000|Overall Study|Withdrawal by Subject|0|||
162820763|NCT04448756|588056502|FG001|Overall Study|Withdrawal by Subject|3|||
162820764|NCT04448756|588056503|FG002|Overall Study|Withdrawal by Subject|1|||
162820765|NCT04448756|588056501|FG000|Overall Study|Death|2|||
162820766|NCT04448756|588056502|FG001|Overall Study|Death|1|||
162820767|NCT04448756|588056503|FG002|Overall Study|Death|0|||
162820768|NCT02733185|588056504|FG000|Overall Study|Withdrawal by Subject|12|||
162820769|NCT02733185|588056505|FG001|Overall Study|Withdrawal by Subject|10|||
162820770|NCT02733185|588056506|FG002|Overall Study|Withdrawal by Subject|17|||
162820771|NCT02733185|588056507|FG003|Overall Study|Withdrawal by Subject|21|||
162820772|NCT02733185|588056504|FG000|Overall Study|Death|46|||
162820773|NCT02733185|588056505|FG001|Overall Study|Death|34|||
162820774|NCT02733185|588056506|FG002|Overall Study|Death|35|||
162820775|NCT02733185|588056507|FG003|Overall Study|Death|43|||
162820776|NCT02733185|588056504|FG000|Overall Study|Lost to Follow-up|17|||
162820777|NCT02733185|588056505|FG001|Overall Study|Lost to Follow-up|18|||
162820778|NCT02733185|588056506|FG002|Overall Study|Lost to Follow-up|16|||
162820779|NCT02733185|588056507|FG003|Overall Study|Lost to Follow-up|11|||
162820780|NCT02499770|588056511|FG000|Overall Study|Death|17|||
162820781|NCT02499770|588056512|FG001|Overall Study|Death|56|||
162820782|NCT02499770|588056511|FG000|Overall Study|Study completion|1|||
162820783|NCT02499770|588056512|FG001|Overall Study|Study completion|10|||
162820784|NCT02499770|588056511|FG000|Overall Study|Withdrawal by Subject|0|||
162820785|NCT02499770|588056512|FG001|Overall Study|Withdrawal by Subject|7|||
162820786|NCT02499770|588056511|FG000|Overall Study|Lost to Follow-up|0|||
162820787|NCT02499770|588056512|FG001|Overall Study|Lost to Follow-up|2|||
162820788|NCT02499770|588056511|FG000|Overall Study|Subject declined further treatment|1|||
162820789|NCT02499770|588056512|FG001|Overall Study|Subject declined further treatment|0|||
162820790|NCT02499770|588056511|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
162820791|NCT02499770|588056512|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
162820792|NCT02499770|588056511|FG000|Overall Study|Randomized but not enrolled|0|||
162820793|NCT02499770|588056512|FG001|Overall Study|Randomized but not enrolled|1|||
162820794|NCT02129205|588056513|FG000|Overall Study|Withdrawal by Subject|0|||
162820795|NCT02129205|588056514|FG001|Overall Study|Withdrawal by Subject|0|||
162820796|NCT02129205|588056515|FG002|Overall Study|Withdrawal by Subject|0|||
162820797|NCT02129205|588056516|FG003|Overall Study|Withdrawal by Subject|0|||
162820798|NCT02129205|588056517|FG004|Overall Study|Withdrawal by Subject|1|||
162820799|NCT02129205|588056518|FG005|Overall Study|Withdrawal by Subject|1|||
162820800|NCT02129205|588056519|FG006|Overall Study|Withdrawal by Subject|1|||
162820801|NCT02129205|588056520|FG007|Overall Study|Withdrawal by Subject|0|||
162820802|NCT02129205|588056521|FG008|Overall Study|Withdrawal by Subject|1|||
162820803|NCT02129205|588056522|FG009|Overall Study|Withdrawal by Subject|0|||
162820804|NCT02129205|588056513|FG000|Overall Study|Other|1|||
162820805|NCT02129205|588056514|FG001|Overall Study|Other|0|||
162820806|NCT02129205|588056515|FG002|Overall Study|Other|0|||
162820807|NCT02129205|588056516|FG003|Overall Study|Other|0|||
162820808|NCT02129205|588056517|FG004|Overall Study|Other|2|||
162820809|NCT02129205|588056518|FG005|Overall Study|Other|3|||
162820810|NCT02129205|588056519|FG006|Overall Study|Other|3|||
162820811|NCT02129205|588056520|FG007|Overall Study|Other|2|||
162820812|NCT02129205|588056521|FG008|Overall Study|Other|1|||
162820813|NCT02129205|588056522|FG009|Overall Study|Other|0|||
162820814|NCT04275297|588056523|FG000|Overall Study|Lost to Follow-up|1|||
162820815|NCT04275297|588056524|FG001|Overall Study|Lost to Follow-up|1|||
162820816|NCT01093326|588056525|FG000|Overall Study|Death|0|||
162820817|NCT01093326|588056526|FG001|Overall Study|Death|1|||
162820818|NCT01093326|588056527|FG002|Overall Study|Death|0|||
162820819|NCT01093326|588056525|FG000|Overall Study|Lack of Efficacy|7|||
162820820|NCT01093326|588056526|FG001|Overall Study|Lack of Efficacy|6|||
162820821|NCT01093326|588056527|FG002|Overall Study|Lack of Efficacy|3|||
162820822|NCT01093326|588056525|FG000|Overall Study|Lost to Follow-up|2|||
162820823|NCT01093326|588056526|FG001|Overall Study|Lost to Follow-up|5|||
162820824|NCT01093326|588056527|FG002|Overall Study|Lost to Follow-up|4|||
162820825|NCT01093326|588056525|FG000|Overall Study|Physician Decision|3|||
162820826|NCT01093326|588056526|FG001|Overall Study|Physician Decision|1|||
162820827|NCT01093326|588056527|FG002|Overall Study|Physician Decision|3|||
162820828|NCT01093326|588056525|FG000|Overall Study|Withdrawal by Subject|30|||
162820829|NCT01093326|588056526|FG001|Overall Study|Withdrawal by Subject|27|||
162820830|NCT01093326|588056527|FG002|Overall Study|Withdrawal by Subject|26|||
162820831|NCT01093326|588056525|FG000|Overall Study|Adverse Event|2|||
162820832|NCT01093326|588056526|FG001|Overall Study|Adverse Event|1|||
162820833|NCT01093326|588056527|FG002|Overall Study|Adverse Event|4|||
162820834|NCT01093326|588056525|FG000|Overall Study|Other|0|||
162820835|NCT01093326|588056526|FG001|Overall Study|Other|0|||
162820836|NCT01093326|588056527|FG002|Overall Study|Other|1|||
162820837|NCT04225806|588056528|FG000|Overall Study|Trial termination|15|||
162820838|NCT07052682|588056531|FG000|Overall Study|Withdrawal by Subject|4|||
162820839|NCT05460273|588056532|FG000|Overall Study|Death|43|||
162820840|NCT05460273|588056533|FG001|Overall Study|Death|9|||
162820841|NCT05460273|588056532|FG000|Overall Study|Lost to Follow-up|7|||
162820842|NCT05460273|588056533|FG001|Overall Study|Lost to Follow-up|0|||
162820843|NCT05460273|588056532|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
162820844|NCT05460273|588056533|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
162820845|NCT04124614|588056534|FG000|Placebo Run-in Period|Not Randomized|34|||
162820846|NCT04124614|588056535|FG001|Placebo Run-in Period|Not Randomized|0|||
162820847|NCT04124614|588056536|FG002|Placebo Run-in Period|Not Randomized|0|||
162820848|NCT04124614|588056534|FG000|Double Blind Treatment Period|Adverse Event|0|||
162820849|NCT04124614|588056535|FG001|Double Blind Treatment Period|Adverse Event|7|||
162820850|NCT04124614|588056536|FG002|Double Blind Treatment Period|Adverse Event|22|||
162820851|NCT04124614|588056534|FG000|Double Blind Treatment Period|Death|0|||
162820852|NCT04124614|588056535|FG001|Double Blind Treatment Period|Death|0|||
162820853|NCT04124614|588056536|FG002|Double Blind Treatment Period|Death|1|||
162820854|NCT04124614|588056534|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162820855|NCT04124614|588056535|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
162820856|NCT04124614|588056536|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
162820857|NCT04124614|588056534|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
162820858|NCT04124614|588056535|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
162820859|NCT04124614|588056536|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
162820860|NCT04124614|588056534|FG000|Double Blind Treatment Period|Physician Decision|0|||
162820861|NCT04124614|588056535|FG001|Double Blind Treatment Period|Physician Decision|0|||
162820862|NCT04124614|588056536|FG002|Double Blind Treatment Period|Physician Decision|3|||
162820863|NCT04124614|588056534|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
162820864|NCT04124614|588056535|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
162820865|NCT04124614|588056536|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
162820866|NCT04124614|588056534|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
162820867|NCT04124614|588056535|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
162820868|NCT04124614|588056536|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
162820869|NCT04124614|588056534|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
162820870|NCT04124614|588056535|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
162820871|NCT04124614|588056536|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
162820872|NCT05749952|588056537|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
162820873|NCT01650285|588058078|FG000|Overall Study|Adverse Event|1|||
162820874|NCT00907257|588058081|FG000|Overall Study|Adverse Event|0|||
162820875|NCT00907257|588058082|FG001|Overall Study|Adverse Event|4|||
162820876|NCT00907257|588058081|FG000|Overall Study|Protocol Violation|1|||
162820877|NCT00907257|588058082|FG001|Overall Study|Protocol Violation|2|||
162820878|NCT00907257|588058081|FG000|Overall Study|Lost to Follow-up|3|||
162820879|NCT00907257|588058082|FG001|Overall Study|Lost to Follow-up|3|||
162820880|NCT00907257|588058081|FG000|Overall Study|Withdrawal by Subject|1|||
162820881|NCT00907257|588058082|FG001|Overall Study|Withdrawal by Subject|2|||
162820882|NCT00907257|588058081|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
162820883|NCT00907257|588058082|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
162820884|NCT00907257|588058081|FG000|Overall Study|Moved|1|||
162820885|NCT00907257|588058082|FG001|Overall Study|Moved|0|||
162820886|NCT00907257|588058081|FG000|Overall Study|Personal Reasons|6|||
162820887|NCT00907257|588058082|FG001|Overall Study|Personal Reasons|1|||
162820888|NCT04163900|588058083|FG000|Overall Study|Radiological disease progression|112|||
162820889|NCT04163900|588058084|FG001|Overall Study|Radiological disease progression|127|||
162820890|NCT04163900|588058083|FG000|Overall Study|Study closure|98|||
162820891|NCT04163900|588058084|FG001|Overall Study|Study closure|133|||
162820892|NCT04163900|588058083|FG000|Overall Study|Adverse Event|78|||
162820893|NCT04163900|588058084|FG001|Overall Study|Adverse Event|32|||
162820894|NCT04163900|588058083|FG000|Overall Study|Withdrawal by Subject|37|||
162820895|NCT04163900|588058084|FG001|Overall Study|Withdrawal by Subject|34|||
162820896|NCT04163900|588058083|FG000|Overall Study|Death|29|||
162820897|NCT04163900|588058084|FG001|Overall Study|Death|16|||
162820898|NCT04163900|588058083|FG000|Overall Study|Physician Decision|17|||
162820899|NCT04163900|588058084|FG001|Overall Study|Physician Decision|25|||
162820900|NCT04163900|588058083|FG000|Overall Study|Clinical disease progression|14|||
162820901|NCT04163900|588058084|FG001|Overall Study|Clinical disease progression|13|||
162820902|NCT04163900|588058083|FG000|Overall Study|Protocol Violation|3|||
162820903|NCT04163900|588058084|FG001|Overall Study|Protocol Violation|4|||
162820904|NCT04163900|588058083|FG000|Overall Study|Lost to Follow-up|0|||
162820905|NCT04163900|588058084|FG001|Overall Study|Lost to Follow-up|1|||
162820906|NCT01873417|588058086|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
162820907|NCT01873417|588058086|FG000|Overall Study|Adverse Event|24|||
162820908|NCT01873417|588058086|FG000|Overall Study|Lost to Follow-up|2|||
162820909|NCT01873417|588058086|FG000|Overall Study|Withdrawal by Subject|2|||
162820910|NCT01873417|588058086|FG000|Overall Study|Physician Decision|3|||
162820911|NCT00785044|588058087|FG000|Overall Study|Dosed at non-participating sites|152|||
162820912|NCT00785044|588058087|FG000|Overall Study|Death|77|||
162820913|NCT00785044|588058087|FG000|Overall Study|Lost to Follow-up|266|||
162820914|NCT00785044|588058087|FG000|Overall Study|Withdrawal by Subject|1|||
162820915|NCT01830855|588058088|FG000|Overall Study|Other|7|||
162820916|NCT01830855|588058089|FG001|Overall Study|Other|1|||
162820917|NCT01830855|588058090|FG002|Overall Study|Other|4|||
162820918|NCT01830855|588058091|FG003|Overall Study|Other|4|||
162820919|NCT01830855|588058088|FG000|Overall Study|Medication error without associated AE|1|||
162820920|NCT01830855|588058089|FG001|Overall Study|Medication error without associated AE|0|||
162820921|NCT01830855|588058090|FG002|Overall Study|Medication error without associated AE|0|||
162820922|NCT01830855|588058091|FG003|Overall Study|Medication error without associated AE|1|||
162820923|NCT01830855|588058088|FG000|Overall Study|Pregnancy|3|||
162820924|NCT01830855|588058089|FG001|Overall Study|Pregnancy|1|||
162820925|NCT01830855|588058090|FG002|Overall Study|Pregnancy|2|||
162820926|NCT01830855|588058091|FG003|Overall Study|Pregnancy|1|||
162820927|NCT01830855|588058088|FG000|Overall Study|No longer meets eligibility criteria|11|||
162820928|NCT01830855|588058089|FG001|Overall Study|No longer meets eligibility criteria|2|||
162820929|NCT01830855|588058090|FG002|Overall Study|No longer meets eligibility criteria|3|||
162820930|NCT01830855|588058091|FG003|Overall Study|No longer meets eligibility criteria|5|||
162820931|NCT01830855|588058088|FG000|Overall Study|Adverse Event|11|||
162820932|NCT01830855|588058089|FG001|Overall Study|Adverse Event|5|||
162820933|NCT01830855|588058090|FG002|Overall Study|Adverse Event|6|||
162820934|NCT01830855|588058091|FG003|Overall Study|Adverse Event|3|||
162820935|NCT01830855|588058088|FG000|Overall Study|Protocol deviation|10|||
162820936|NCT01830855|588058089|FG001|Overall Study|Protocol deviation|5|||
162820937|NCT01830855|588058090|FG002|Overall Study|Protocol deviation|6|||
162820938|NCT01830855|588058091|FG003|Overall Study|Protocol deviation|6|||
162820939|NCT01830855|588058088|FG000|Overall Study|Withdrawal by Subject|33|||
162820940|NCT01830855|588058089|FG001|Overall Study|Withdrawal by Subject|14|||
162820941|NCT01830855|588058090|FG002|Overall Study|Withdrawal by Subject|10|||
162820942|NCT01830855|588058091|FG003|Overall Study|Withdrawal by Subject|12|||
162820943|NCT01830855|588058088|FG000|Overall Study|No longer willing to participate|32|||
162820944|NCT01830855|588058089|FG001|Overall Study|No longer willing to participate|13|||
162820945|NCT01830855|588058090|FG002|Overall Study|No longer willing to participate|12|||
162820946|NCT01830855|588058091|FG003|Overall Study|No longer willing to participate|17|||
162820947|NCT01830855|588058088|FG000|Overall Study|Lost to Follow-up|47|||
162820948|NCT01830855|588058089|FG001|Overall Study|Lost to Follow-up|20|||
162820949|NCT01830855|588058090|FG002|Overall Study|Lost to Follow-up|23|||
162820950|NCT01830855|588058091|FG003|Overall Study|Lost to Follow-up|33|||
162820951|NCT00295633|588058095|FG000|Overall Study|Lack of Efficacy|19|||
162820952|NCT00295633|588058096|FG001|Overall Study|Lack of Efficacy|7|||
162820953|NCT00295633|588058097|FG002|Overall Study|Lack of Efficacy|16|||
162820954|NCT00295633|588058095|FG000|Overall Study|Withdrawal of consent by subject|16|||
162820955|NCT00295633|588058096|FG001|Overall Study|Withdrawal of consent by subject|16|||
162820956|NCT00295633|588058097|FG002|Overall Study|Withdrawal of consent by subject|26|||
162820957|NCT00295633|588058095|FG000|Overall Study|Adverse Event|9|||
162820958|NCT00295633|588058096|FG001|Overall Study|Adverse Event|17|||
162820959|NCT00295633|588058097|FG002|Overall Study|Adverse Event|9|||
162820960|NCT00295633|588058095|FG000|Overall Study|Lost to Follow-up|6|||
162820961|NCT00295633|588058096|FG001|Overall Study|Lost to Follow-up|11|||
162820962|NCT00295633|588058097|FG002|Overall Study|Lost to Follow-up|7|||
162820963|NCT00295633|588058095|FG000|Overall Study|Physician Decision|9|||
162820964|NCT00295633|588058096|FG001|Overall Study|Physician Decision|10|||
162820965|NCT00295633|588058097|FG002|Overall Study|Physician Decision|8|||
162820966|NCT00295633|588058095|FG000|Overall Study|Poor/Noncompliance|2|||
163171707|NCT04585009|589343918|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171708|NCT04585009|589343919|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171709|NCT04585009|589343920|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171710|NCT04585009|589343921|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171711|NCT04585009|589343922|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171712|NCT04585009|589343923|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171713|NCT04585009|589343924|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
163171714|NCT04585009|589343925|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171715|NCT04585009|589343926|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162820967|NCT00295633|588058096|FG001|Overall Study|Poor/Noncompliance|2|||
162820968|NCT00295633|588058097|FG002|Overall Study|Poor/Noncompliance|6|||
162820969|NCT00295633|588058095|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
162820970|NCT00295633|588058096|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
162820971|NCT00295633|588058097|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
162820972|NCT00295633|588058095|FG000|Overall Study|Death|1|||
162820973|NCT00295633|588058096|FG001|Overall Study|Death|1|||
162820974|NCT00295633|588058097|FG002|Overall Study|Death|0|||
162820975|NCT00295633|588058095|FG000|Overall Study|Administrative reason by sponsor|0|||
162820976|NCT00295633|588058096|FG001|Overall Study|Administrative reason by sponsor|0|||
162820977|NCT00295633|588058097|FG002|Overall Study|Administrative reason by sponsor|1|||
162820978|NCT01950247|588058098|FG000|Overall Study|Withdrawal by Subject|28|||
162820979|NCT01950247|588058099|FG001|Overall Study|Withdrawal by Subject|13|||
162820980|NCT01950247|588058098|FG000|Overall Study|Lost to Follow-up|18|||
162820981|NCT01950247|588058099|FG001|Overall Study|Lost to Follow-up|16|||
162820982|NCT01950247|588058098|FG000|Overall Study|Physician Decision|3|||
162820983|NCT01950247|588058099|FG001|Overall Study|Physician Decision|4|||
162820984|NCT01950247|588058098|FG000|Overall Study|Adverse Event|3|||
162820985|NCT01950247|588058099|FG001|Overall Study|Adverse Event|2|||
162820986|NCT01950247|588058098|FG000|Overall Study|Death|1|||
162820987|NCT01950247|588058099|FG001|Overall Study|Death|1|||
162820988|NCT01950247|588058098|FG000|Overall Study|Not Defined|4|||
162820989|NCT01950247|588058099|FG001|Overall Study|Not Defined|10|||
163171716|NCT04585009|589343927|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
163171717|NCT04585009|589343928|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162820990|NCT01798992|588058102|FG000|Overall Study|Administrative withdrawal|0|||
162820991|NCT01798992|588058103|FG001|Overall Study|Administrative withdrawal|1|||
162820992|NCT01798992|588058104|FG002|Overall Study|Administrative withdrawal|0|||
162820993|NCT01798992|588058105|FG003|Overall Study|Administrative withdrawal|1|||
162820994|NCT01798992|588058102|FG000|Overall Study|Lost to Follow-up|0|||
162820995|NCT01798992|588058103|FG001|Overall Study|Lost to Follow-up|1|||
162820996|NCT01798992|588058104|FG002|Overall Study|Lost to Follow-up|1|||
162820997|NCT01798992|588058105|FG003|Overall Study|Lost to Follow-up|0|||
162820998|NCT01798992|588058102|FG000|Overall Study|Insufficient biopsy tissue|0|||
162820999|NCT01798992|588058103|FG001|Overall Study|Insufficient biopsy tissue|0|||
162821000|NCT01798992|588058104|FG002|Overall Study|Insufficient biopsy tissue|1|||
162821001|NCT01798992|588058105|FG003|Overall Study|Insufficient biopsy tissue|0|||
162821002|NCT01069120|588058106|FG000|Overall Study|Study prematurely terminated|27|||
162821003|NCT00763971|588058107|FG000|Overall Study|Adverse Event|5|||
162821004|NCT00763971|588058108|FG001|Overall Study|Adverse Event|2|||
162821005|NCT00763971|588058109|FG002|Overall Study|Adverse Event|4|||
162821006|NCT00763971|588058107|FG000|Overall Study|Protocol Violation|3|||
162821007|NCT00763971|588058108|FG001|Overall Study|Protocol Violation|3|||
162821008|NCT00763971|588058109|FG002|Overall Study|Protocol Violation|2|||
162821009|NCT00763971|588058107|FG000|Overall Study|Withdrawal by Subject|4|||
162821010|NCT00763971|588058108|FG001|Overall Study|Withdrawal by Subject|5|||
162821011|NCT00763971|588058109|FG002|Overall Study|Withdrawal by Subject|5|||
162821012|NCT00763971|588058107|FG000|Overall Study|Lost to Follow-up|0|||
162821013|NCT00763971|588058108|FG001|Overall Study|Lost to Follow-up|1|||
162821014|NCT00763971|588058109|FG002|Overall Study|Lost to Follow-up|0|||
162821015|NCT00763971|588058107|FG000|Overall Study|Lack of Efficacy|11|||
162821016|NCT00763971|588058108|FG001|Overall Study|Lack of Efficacy|22|||
162821017|NCT00763971|588058109|FG002|Overall Study|Lack of Efficacy|54|||
162821018|NCT00763971|588058107|FG000|Overall Study|Unable to swallow capsule|2|||
162821019|NCT00763971|588058108|FG001|Overall Study|Unable to swallow capsule|1|||
162821020|NCT00763971|588058109|FG002|Overall Study|Unable to swallow capsule|1|||
162821021|NCT00763971|588058107|FG000|Overall Study|Personal reason|3|||
162821022|NCT00763971|588058108|FG001|Overall Study|Personal reason|0|||
162821023|NCT00763971|588058109|FG002|Overall Study|Personal reason|0|||
162821024|NCT00763971|588058107|FG000|Overall Study|Exclusion criteria met|1|||
162821025|NCT00763971|588058108|FG001|Overall Study|Exclusion criteria met|0|||
162821026|NCT00763971|588058109|FG002|Overall Study|Exclusion criteria met|0|||
162821027|NCT00763971|588058107|FG000|Overall Study|Sponsor decision|1|||
162821028|NCT00763971|588058108|FG001|Overall Study|Sponsor decision|0|||
162821029|NCT00763971|588058109|FG002|Overall Study|Sponsor decision|0|||
162821030|NCT00763971|588058107|FG000|Overall Study|Due to holiday season|2|||
162821031|NCT00763971|588058108|FG001|Overall Study|Due to holiday season|0|||
162821032|NCT00763971|588058109|FG002|Overall Study|Due to holiday season|1|||
162821033|NCT00763971|588058107|FG000|Overall Study|Randomization error|0|||
162821034|NCT00763971|588058108|FG001|Overall Study|Randomization error|0|||
162821035|NCT00763971|588058109|FG002|Overall Study|Randomization error|1|||
162821036|NCT00763971|588058107|FG000|Overall Study|Medical monitor decision|0|||
162821037|NCT00763971|588058108|FG001|Overall Study|Medical monitor decision|0|||
162821038|NCT00763971|588058109|FG002|Overall Study|Medical monitor decision|1|||
162821039|NCT00763971|588058107|FG000|Overall Study|Moved to another country|0|||
162821040|NCT00763971|588058108|FG001|Overall Study|Moved to another country|1|||
162821041|NCT00763971|588058109|FG002|Overall Study|Moved to another country|0|||
162821042|NCT00763971|588058107|FG000|Overall Study|Subject wanted dose reduction|0|||
162821043|NCT00763971|588058108|FG001|Overall Study|Subject wanted dose reduction|1|||
162821044|NCT00763971|588058109|FG002|Overall Study|Subject wanted dose reduction|0|||
162821045|NCT00763971|588058107|FG000|Overall Study|Lack of availability|0|||
162821046|NCT00763971|588058108|FG001|Overall Study|Lack of availability|1|||
162821047|NCT00763971|588058109|FG002|Overall Study|Lack of availability|0|||
162821048|NCT00763971|588058107|FG000|Overall Study|Performed final visit on phone|0|||
162821049|NCT00763971|588058108|FG001|Overall Study|Performed final visit on phone|1|||
162821050|NCT00763971|588058109|FG002|Overall Study|Performed final visit on phone|0|||
162821051|NCT00763971|588058107|FG000|Overall Study|Participation in 489-326 required|1|||
162821052|NCT00763971|588058108|FG001|Overall Study|Participation in 489-326 required|0|||
162821053|NCT00763971|588058109|FG002|Overall Study|Participation in 489-326 required|0|||
162821054|NCT02713542|588058114|FG000|Overall Study|Use of prohibited medication|14|||
162821055|NCT02713542|588058115|FG001|Overall Study|Use of prohibited medication|5|||
162821056|NCT02713542|588058114|FG000|Overall Study|Withdrawal by Subject|4|||
162821057|NCT02713542|588058115|FG001|Overall Study|Withdrawal by Subject|1|||
162821058|NCT03631667|588058116|FG000|Overall Study|Withdrawal by Subject|3|||
162821059|NCT00884325|588058128|FG000|Overall Study|Lost to Follow-up|1|||
162821060|NCT00884325|588058129|FG001|Overall Study|Lost to Follow-up|2|||
162821061|NCT00884325|588058128|FG000|Overall Study|Lack of Efficacy|0|||
162821062|NCT00884325|588058129|FG001|Overall Study|Lack of Efficacy|1|||
162821063|NCT00884325|588058128|FG000|Overall Study|Withdrawal by Subject|1|||
162821064|NCT00884325|588058129|FG001|Overall Study|Withdrawal by Subject|1|||
162821065|NCT00884325|588058128|FG000|Overall Study|Not provided|1|||
162821066|NCT00884325|588058129|FG001|Overall Study|Not provided|0|||
162821067|NCT01641237|588058130|FG000|Period II|Withdrawal by Subject|1|||
162821068|NCT01641237|588058131|FG001|Period II|Withdrawal by Subject|0|||
162821069|NCT01641237|588058132|FG002|Period II|Withdrawal by Subject|0|||
162821070|NCT01641237|588058133|FG003|Period II|Withdrawal by Subject|0|||
162821071|NCT01641237|588058130|FG000|Period III|Lost to Follow-up|1|||
162821072|NCT01641237|588058131|FG001|Period III|Lost to Follow-up|0|||
162821073|NCT01641237|588058132|FG002|Period III|Lost to Follow-up|0|||
162821074|NCT01641237|588058133|FG003|Period III|Lost to Follow-up|0|||
162821075|NCT01301456|588058134|FG000|Stage 1|Withdrawal by Subject|0|||
162821076|NCT01301456|588058135|FG001|Stage 1|Withdrawal by Subject|0|||
162821077|NCT01301456|588058136|FG002|Stage 1|Withdrawal by Subject|1|||
162821078|NCT01301456|588058137|FG003|Stage 1|Withdrawal by Subject|0|||
162821079|NCT01301456|588058138|FG004|Stage 1|Withdrawal by Subject|1|||
162821080|NCT01301456|588058139|FG005|Stage 1|Withdrawal by Subject|0|||
162821081|NCT01301456|588058140|FG006|Stage 1|Withdrawal by Subject|0|||
162821082|NCT01301456|588058141|FG007|Stage 1|Withdrawal by Subject|0|||
162821083|NCT01301456|588058142|FG008|Stage 1|Withdrawal by Subject|0|||
162821084|NCT01301456|588058143|FG009|Stage 1|Withdrawal by Subject|0|||
162821085|NCT01301456|588058144|FG010|Stage 1|Withdrawal by Subject|0|||
162821086|NCT01301456|588058145|FG011|Stage 1|Withdrawal by Subject|0|||
162821087|NCT01301456|588058134|FG000|Stage 1|Randomized but not treated|0|||
162821088|NCT01301456|588058135|FG001|Stage 1|Randomized but not treated|0|||
162821089|NCT01301456|588058136|FG002|Stage 1|Randomized but not treated|0|||
162821090|NCT01301456|588058137|FG003|Stage 1|Randomized but not treated|0|||
162821091|NCT01301456|588058138|FG004|Stage 1|Randomized but not treated|0|||
162821092|NCT01301456|588058139|FG005|Stage 1|Randomized but not treated|0|||
162821093|NCT01301456|588058140|FG006|Stage 1|Randomized but not treated|1|||
162821094|NCT01301456|588058141|FG007|Stage 1|Randomized but not treated|0|||
162821095|NCT01301456|588058142|FG008|Stage 1|Randomized but not treated|0|||
162821096|NCT01301456|588058143|FG009|Stage 1|Randomized but not treated|0|||
162821097|NCT01301456|588058144|FG010|Stage 1|Randomized but not treated|0|||
162821098|NCT01301456|588058145|FG011|Stage 1|Randomized but not treated|0|||
162821099|NCT01301456|588058134|FG000|Stage 2|Adverse Event|0|||
162821100|NCT01301456|588058135|FG001|Stage 2|Adverse Event|0|||
162821101|NCT01301456|588058136|FG002|Stage 2|Adverse Event|0|||
162821102|NCT01301456|588058137|FG003|Stage 2|Adverse Event|0|||
162821103|NCT01301456|588058138|FG004|Stage 2|Adverse Event|0|||
162821104|NCT01301456|588058139|FG005|Stage 2|Adverse Event|0|||
162821105|NCT01301456|588058140|FG006|Stage 2|Adverse Event|0|||
162821106|NCT01301456|588058141|FG007|Stage 2|Adverse Event|0|||
162821107|NCT01301456|588058142|FG008|Stage 2|Adverse Event|0|||
162821108|NCT01301456|588058143|FG009|Stage 2|Adverse Event|0|||
162821109|NCT01301456|588058144|FG010|Stage 2|Adverse Event|1|||
162821110|NCT01301456|588058145|FG011|Stage 2|Adverse Event|0|||
162821111|NCT01446016|588058146|FG000|Overall Study|Lost to Follow-up|3|||
162821112|NCT01446016|588058146|FG000|Overall Study|Withdrawal by Subject|1|||
163171718|NCT04585009|589343917|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171719|NCT04585009|589343918|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171720|NCT04585009|589343919|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171721|NCT04585009|589343920|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171722|NCT04585009|589343921|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
163171723|NCT04585009|589343922|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171724|NCT04585009|589343923|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171725|NCT04585009|589343924|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171726|NCT04585009|589343925|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171727|NCT04585009|589343926|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171728|NCT04585009|589343927|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171729|NCT04585009|589343928|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163171730|NCT04585009|589343917|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171731|NCT04585009|589343918|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171732|NCT04585009|589343919|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171733|NCT04585009|589343920|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171734|NCT04585009|589343921|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171735|NCT04585009|589343922|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171736|NCT04585009|589343923|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171737|NCT04585009|589343924|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171738|NCT04585009|589343925|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171739|NCT04585009|589343926|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
163171740|NCT04585009|589343927|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171741|NCT04585009|589343928|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
163171742|NCT04585009|589343917|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171743|NCT04585009|589343918|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171744|NCT04585009|589343919|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171745|NCT04585009|589343920|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171746|NCT04585009|589343921|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171747|NCT04585009|589343922|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171748|NCT04585009|589343923|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171749|NCT04585009|589343924|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171750|NCT04585009|589343925|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171751|NCT04585009|589343926|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171752|NCT04585009|589343927|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163171753|NCT04585009|589343928|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
163171754|NCT04618770|589343937|FG000|Overall Study|Censored from Analysis|12|||
163171755|NCT04618770|589343937|FG000|Overall Study|Early Termination|25|||
163171756|NCT00640224|589343940|FG000|Overall Study|Lost to Follow-up|5|||
163171757|NCT00640224|589343941|FG001|Overall Study|Lost to Follow-up|2|||
163171758|NCT00640224|589343942|FG002|Overall Study|Lost to Follow-up|0|||
163171759|NCT00640224|589343943|FG003|Overall Study|Lost to Follow-up|0|||
163171760|NCT00640224|589343940|FG000|Overall Study|Withdrawal by Subject|1|||
163171761|NCT00640224|589343941|FG001|Overall Study|Withdrawal by Subject|0|||
163171762|NCT00640224|589343942|FG002|Overall Study|Withdrawal by Subject|0|||
163171763|NCT00640224|589343943|FG003|Overall Study|Withdrawal by Subject|0|||
163171764|NCT00640224|589343940|FG000|Overall Study|Headaches|0|||
163171765|NCT00640224|589343941|FG001|Overall Study|Headaches|1|||
163171766|NCT00640224|589343942|FG002|Overall Study|Headaches|0|||
163171767|NCT00640224|589343943|FG003|Overall Study|Headaches|0|||
163171768|NCT01252667|589343944|FG000|Overall Study|Transplant aborted post-conditioning|0|||
163171769|NCT01252667|589343945|FG001|Overall Study|Transplant aborted post-conditioning|0|||
163171770|NCT01252667|589343946|FG002|Overall Study|Transplant aborted post-conditioning|0|||
163171771|NCT01252667|589343947|FG003|Overall Study|Transplant aborted post-conditioning|0|||
163171772|NCT01252667|589343948|FG004|Overall Study|Transplant aborted post-conditioning|0|||
163171773|NCT01252667|589343949|FG005|Overall Study|Transplant aborted post-conditioning|1|||
163171774|NCT04644315|589343950|FG000|Overall Study|Subject withdrawal of consent|1|||
163171775|NCT00294762|589343951|FG000|Overall Study|Did not receive study treatment|3|||
163171776|NCT00294762|589343952|FG001|Overall Study|Did not receive study treatment|3|||
163171777|NCT01738646|589343953|FG000|Overall Study|Still Receiving Treatment|2|||
163171778|NCT04493892|589343960|FG000|Overall Study|Withdrawal by Subject|15|||
163171779|NCT02577887|589343961|FG000|Overall Study|Death|93|||
163171780|NCT02577887|589343961|FG000|Overall Study|Protocol Violation|125|||
162821113|NCT01446016|588058146|FG000|Overall Study|Toxicity|3|||
162821114|NCT00404066|588058153|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
162821115|NCT00404066|588058153|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
162821116|NCT01949155|588058154|FG000|Overall Study|Lost to Follow-up|1|||
162821117|NCT01949155|588058155|FG001|Overall Study|Lost to Follow-up|0|||
162821118|NCT01949155|588058154|FG000|Overall Study|Protocol Violation|1|||
162821119|NCT01949155|588058155|FG001|Overall Study|Protocol Violation|0|||
162821120|NCT05395104|588058156|FG000|Overall Study|Met Liver Stopping Criteria|1|||
162821121|NCT05395104|588058156|FG000|Overall Study|Withdrawal by Subject|1|||
162821122|NCT02448225|588058157|FG000|Overall Study|Withdrawal by Subject|1|||
162821123|NCT02448225|588058157|FG000|Overall Study|Did not get FSPG scan|18|||
162821124|NCT02448225|588058157|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
162821125|NCT01287364|588058162|FG000|Overall Study|Adverse Event|0|||
162821126|NCT01287364|588058163|FG001|Overall Study|Adverse Event|3|||
162821127|NCT01287364|588058162|FG000|Overall Study|Protocol Violation|5|||
162821128|NCT01287364|588058163|FG001|Overall Study|Protocol Violation|5|||
162821129|NCT01287364|588058162|FG000|Overall Study|Other Reason|4|||
162821130|NCT01287364|588058163|FG001|Overall Study|Other Reason|2|||
162821131|NCT04422990|588058165|FG000|Overall Study|Withdrawal by Subject|0|||
162821132|NCT04422990|588058166|FG001|Overall Study|Withdrawal by Subject|1|||
162821133|NCT04422990|588058165|FG000|Overall Study|Travel|3|||
162821134|NCT04422990|588058166|FG001|Overall Study|Travel|0|||
162821135|NCT05372653|588058170|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
162821136|NCT05372653|588058171|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
162821137|NCT05372653|588058170|FG000|Overall Study|Adverse Event|0|||
162821138|NCT05372653|588058171|FG001|Overall Study|Adverse Event|1|||
162821139|NCT00711529|588058172|FG000|Overall Study|Protocol Violation|2|||
162821140|NCT00711529|588058173|FG001|Overall Study|Protocol Violation|0|||
162821141|NCT00711529|588058172|FG000|Overall Study|Withdrawal by Subject|2|||
162821142|NCT00711529|588058173|FG001|Overall Study|Withdrawal by Subject|6|||
162821143|NCT03740997|588058174|FG000|Overall Study|Withdrawal by Subject|1|||
162821144|NCT03740997|588058175|FG001|Overall Study|Withdrawal by Subject|0|||
162821145|NCT03740997|588058174|FG000|Overall Study|Participant was unable to complete study procedures|1|||
162821146|NCT03740997|588058175|FG001|Overall Study|Participant was unable to complete study procedures|0|||
162821147|NCT01849497|588058177|FG000|Overall Study|Withdrawal by Subject|1|||
162821148|NCT01849497|588058178|FG001|Overall Study|Withdrawal by Subject|2|||
162821149|NCT01849497|588058177|FG000|Overall Study|Sponsor Decision|0|||
162821150|NCT01849497|588058178|FG001|Overall Study|Sponsor Decision|1|||
162821151|NCT01849497|588058177|FG000|Overall Study|Lost to Follow-up|0|||
162821152|NCT01849497|588058178|FG001|Overall Study|Lost to Follow-up|1|||
162821153|NCT02146599|588058179|FG000|Overall Study|Failed to meet inclusion criteria|5|||
162821154|NCT02101021|588058180|FG000|Overall Study|Death|4|||
162821155|NCT02101021|588058181|FG001|Overall Study|Death|3|||
162821156|NCT02101021|588058182|FG002|Overall Study|Death|6|||
162821157|NCT02101021|588058183|FG003|Overall Study|Death|0|||
162821158|NCT02101021|588058184|FG004|Overall Study|Death|3|||
162821159|NCT02101021|588058180|FG000|Overall Study|Withdrew Consent from study|1|||
162821160|NCT02101021|588058181|FG001|Overall Study|Withdrew Consent from study|1|||
162821161|NCT02101021|588058182|FG002|Overall Study|Withdrew Consent from study|0|||
162821162|NCT02101021|588058183|FG003|Overall Study|Withdrew Consent from study|2|||
162821163|NCT02101021|588058184|FG004|Overall Study|Withdrew Consent from study|0|||
162821164|NCT02101021|588058180|FG000|Overall Study|Lost to Follow-up|1|||
162821165|NCT02101021|588058181|FG001|Overall Study|Lost to Follow-up|0|||
162821166|NCT02101021|588058182|FG002|Overall Study|Lost to Follow-up|0|||
162821167|NCT02101021|588058183|FG003|Overall Study|Lost to Follow-up|0|||
162821168|NCT02101021|588058184|FG004|Overall Study|Lost to Follow-up|0|||
162821169|NCT02101021|588058180|FG000|Overall Study|Study Terminated by Sponsor|1|||
163171781|NCT02577887|589343961|FG000|Overall Study|Withdrawal by Subject|80|||
163171782|NCT00864916|589343966|FG000|Overall Study|Lost to Follow-up|4|||
163171783|NCT00864916|589343967|FG001|Overall Study|Lost to Follow-up|4|||
163171784|NCT00864916|589343966|FG000|Overall Study|Protocol Violation|1|||
163171785|NCT00864916|589343967|FG001|Overall Study|Protocol Violation|0|||
163171786|NCT00864916|589343966|FG000|Overall Study|Withdrawal by Subject|1|||
163171787|NCT00864916|589343967|FG001|Overall Study|Withdrawal by Subject|0|||
163171788|NCT03774823|589343971|FG000|Overall Study|Withdrawal by Subject|1|||
163171789|NCT03774823|589343972|FG001|Overall Study|Withdrawal by Subject|1|||
163171790|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
162821170|NCT02101021|588058181|FG001|Overall Study|Study Terminated by Sponsor|0|||
162821171|NCT02101021|588058182|FG002|Overall Study|Study Terminated by Sponsor|1|||
162821172|NCT02101021|588058183|FG003|Overall Study|Study Terminated by Sponsor|1|||
162821173|NCT02101021|588058184|FG004|Overall Study|Study Terminated by Sponsor|1|||
162821174|NCT00999713|588058187|FG000|Overall Study|Physician Decision|2|||
162821175|NCT00999713|588058188|FG001|Overall Study|Physician Decision|0|||
162821176|NCT03346057|588058189|FG000|Overall Study|Death|1|||
162821177|NCT03346057|588058190|FG001|Overall Study|Death|2|||
162821178|NCT03346057|588058191|FG002|Overall Study|Death|0|||
163171791|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
163171792|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Adverse Event|7|||
162821179|NCT03346057|588058192|FG003|Overall Study|Death|0|||
162821180|NCT03346057|588058189|FG000|Overall Study|Lost to Follow-up|0|||
162821181|NCT03346057|588058190|FG001|Overall Study|Lost to Follow-up|2|||
162821182|NCT03346057|588058191|FG002|Overall Study|Lost to Follow-up|1|||
162821183|NCT03346057|588058192|FG003|Overall Study|Lost to Follow-up|0|||
162821184|NCT03346057|588058189|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
162821185|NCT03346057|588058190|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
162821186|NCT03346057|588058191|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
162821187|NCT03346057|588058192|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
162821188|NCT03346057|588058189|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
162821189|NCT03346057|588058190|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
162821190|NCT03346057|588058191|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
162821191|NCT03346057|588058192|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
162821192|NCT03346057|588058189|FG000|Overall Study|Physician Decision|3|||
162821193|NCT03346057|588058190|FG001|Overall Study|Physician Decision|2|||
162821194|NCT03346057|588058191|FG002|Overall Study|Physician Decision|0|||
162821195|NCT03346057|588058192|FG003|Overall Study|Physician Decision|2|||
162821196|NCT03346057|588058189|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
162821197|NCT03346057|588058190|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
162821198|NCT03346057|588058191|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
162821199|NCT03346057|588058192|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
162821200|NCT03346057|588058189|FG000|Overall Study|Withdrawal by Subject|1|||
162821201|NCT03346057|588058190|FG001|Overall Study|Withdrawal by Subject|0|||
162821202|NCT03346057|588058191|FG002|Overall Study|Withdrawal by Subject|0|||
162821203|NCT03346057|588058192|FG003|Overall Study|Withdrawal by Subject|0|||
162821204|NCT02322229|588058197|FG000|Overall Study|Physician Decision|2|||
162821205|NCT03065023|588058198|FG000|Overall Study|Progressive Disease|0|||
163171793|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Adverse Event|6|||
163171794|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
163171795|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
163171796|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Physician Decision|4|||
163171797|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Physician Decision|4|||
163171798|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
163171799|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
163171800|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
163171801|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
163171802|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
163171803|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
163171804|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Non-compliance|1|||
163171805|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Non-compliance|0|||
163171806|NCT00470834|589343973|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
163171807|NCT00470834|589343974|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
163171808|NCT00470834|589343973|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
163171809|NCT00470834|589343974|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
163171810|NCT00470834|589343973|FG000|Extension Period (24 Months)|Adverse Event|3|||
163171811|NCT00470834|589343974|FG001|Extension Period (24 Months)|Adverse Event|4|||
163171812|NCT00470834|589343973|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
163171813|NCT00470834|589343974|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
163171814|NCT00470834|589343973|FG000|Extension Period (24 Months)|Physician Decision|4|||
163171815|NCT00470834|589343974|FG001|Extension Period (24 Months)|Physician Decision|3|||
163171816|NCT00470834|589343973|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
163171817|NCT00470834|589343974|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
163171818|NCT00470834|589343973|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
163171819|NCT00470834|589343974|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
163171820|NCT00470834|589343973|FG000|Extension Period (24 Months)|Non-compliance|0|||
163171821|NCT00470834|589343974|FG001|Extension Period (24 Months)|Non-compliance|1|||
163171822|NCT00470834|589343973|FG000|Extension Period (24 Months)|Disease Progression|0|||
163171823|NCT00470834|589343974|FG001|Extension Period (24 Months)|Disease Progression|1|||
163171824|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171825|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171826|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171827|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
163171828|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162821206|NCT03065023|588058199|FG001|Overall Study|Progressive Disease|1|||
162821207|NCT03065023|588058200|FG002|Overall Study|Progressive Disease|0|||
163171829|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
163171830|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162821208|NCT03065023|588058201|FG003|Overall Study|Progressive Disease|0|||
163171831|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171832|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171833|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
162821209|NCT03065023|588058202|FG004|Overall Study|Progressive Disease|0|||
162821210|NCT03065023|588058198|FG000|Overall Study|Death|2|||
162821211|NCT03065023|588058199|FG001|Overall Study|Death|0|||
162821212|NCT03065023|588058200|FG002|Overall Study|Death|1|||
162821213|NCT03065023|588058201|FG003|Overall Study|Death|1|||
162821214|NCT03065023|588058202|FG004|Overall Study|Death|0|||
162821215|NCT03065023|588058198|FG000|Overall Study|Lost to Follow-up|0|||
162821216|NCT03065023|588058199|FG001|Overall Study|Lost to Follow-up|1|||
162821217|NCT03065023|588058200|FG002|Overall Study|Lost to Follow-up|0|||
162821218|NCT03065023|588058201|FG003|Overall Study|Lost to Follow-up|0|||
162821219|NCT03065023|588058202|FG004|Overall Study|Lost to Follow-up|0|||
162821220|NCT03065023|588058198|FG000|Overall Study|Participant Decision|0|||
162821221|NCT03065023|588058199|FG001|Overall Study|Participant Decision|0|||
162821222|NCT03065023|588058200|FG002|Overall Study|Participant Decision|0|||
162821223|NCT03065023|588058201|FG003|Overall Study|Participant Decision|1|||
162821224|NCT03065023|588058202|FG004|Overall Study|Participant Decision|0|||
162821225|NCT03065023|588058198|FG000|Overall Study|Withdrawal by Subject|0|||
162821226|NCT03065023|588058199|FG001|Overall Study|Withdrawal by Subject|0|||
162821227|NCT03065023|588058200|FG002|Overall Study|Withdrawal by Subject|0|||
162821228|NCT03065023|588058201|FG003|Overall Study|Withdrawal by Subject|1|||
162821229|NCT03065023|588058202|FG004|Overall Study|Withdrawal by Subject|0|||
162821230|NCT01102803|588058203|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
162821231|NCT01102803|588058204|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
162821232|NCT01102803|588058203|FG000|Post to Follow-Up|Lost to Follow-up|1|||
162821233|NCT01102803|588058204|FG001|Post to Follow-Up|Lost to Follow-up|3|||
162821234|NCT00705432|588058205|FG000|Treatment Period|Adverse Event|45|||
162821235|NCT00705432|588058206|FG001|Treatment Period|Adverse Event|37|||
162821236|NCT00705432|588058207|FG002|Treatment Period|Adverse Event|51|||
162821237|NCT00705432|588058208|FG003|Treatment Period|Adverse Event|12|||
162821238|NCT00705432|588058209|FG004|Treatment Period|Adverse Event|8|||
162821239|NCT00705432|588058210|FG005|Treatment Period|Adverse Event|9|||
162821240|NCT00705432|588058205|FG000|Treatment Period|Treatment failure|92|||
162821241|NCT00705432|588058206|FG001|Treatment Period|Treatment failure|42|||
162821242|NCT00705432|588058207|FG002|Treatment Period|Treatment failure|33|||
162821243|NCT00705432|588058208|FG003|Treatment Period|Treatment failure|25|||
162821244|NCT00705432|588058209|FG004|Treatment Period|Treatment failure|13|||
162821245|NCT00705432|588058210|FG005|Treatment Period|Treatment failure|14|||
162821246|NCT00705432|588058205|FG000|Treatment Period|Non medical reason|26|||
162821247|NCT00705432|588058206|FG001|Treatment Period|Non medical reason|32|||
162821248|NCT00705432|588058207|FG002|Treatment Period|Non medical reason|37|||
162821249|NCT00705432|588058208|FG003|Treatment Period|Non medical reason|4|||
162821250|NCT00705432|588058209|FG004|Treatment Period|Non medical reason|7|||
162821251|NCT00705432|588058210|FG005|Treatment Period|Non medical reason|7|||
162821252|NCT00705432|588058205|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
162821253|NCT00705432|588058206|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
162821254|NCT00705432|588058207|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
162821255|NCT00705432|588058208|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
162821256|NCT00705432|588058209|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
162821257|NCT00705432|588058210|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
162821258|NCT00705432|588058205|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
162821259|NCT00705432|588058206|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
162821260|NCT00705432|588058207|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
162821261|NCT00705432|588058208|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
162821262|NCT00705432|588058209|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
162821263|NCT00705432|588058210|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
162821264|NCT00521053|588058211|FG000|Observation Phase|Disease Progression|55|||
162821265|NCT00521053|588058211|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
162821266|NCT00521053|588058211|FG000|Observation Phase|Death|2|||
162821267|NCT00521053|588058211|FG000|Observation Phase|Adverse Event|1|||
162821268|NCT00521053|588058211|FG000|Observation Phase|Other non-study melanoma treatment|1|||
162821269|NCT00521053|588058211|FG000|Observation Phase|Physician Decision|1|||
162821270|NCT01557348|588058212|FG000|Overall Study|Adverse Event|6|||
162821271|NCT01557348|588058213|FG001|Overall Study|Adverse Event|16|||
162821272|NCT01557348|588058212|FG000|Overall Study|Infusion reaction event|5|||
162821273|NCT01557348|588058213|FG001|Overall Study|Infusion reaction event|5|||
162821274|NCT01557348|588058212|FG000|Overall Study|Death|7|||
162821275|NCT01557348|588058213|FG001|Overall Study|Death|4|||
162821276|NCT01557348|588058212|FG000|Overall Study|Insufficient Therapeutic Response|13|||
162821277|NCT01557348|588058213|FG001|Overall Study|Insufficient Therapeutic Response|28|||
162821278|NCT01557348|588058212|FG000|Overall Study|Withdrawal by Subject|5|||
162821279|NCT01557348|588058213|FG001|Overall Study|Withdrawal by Subject|4|||
162821280|NCT01557348|588058212|FG000|Overall Study|Lost to Follow-up|26|||
162821281|NCT01557348|588058213|FG001|Overall Study|Lost to Follow-up|22|||
162821282|NCT01557348|588058212|FG000|Overall Study|Administrative|18|||
162821283|NCT01557348|588058213|FG001|Overall Study|Administrative|11|||
162821284|NCT01667107|588058214|FG000|Overall Study|Adverse Event|4|||
162821285|NCT01667107|588058215|FG001|Overall Study|Adverse Event|3|||
162821286|NCT01667107|588058214|FG000|Overall Study|Tolerability issues|0|||
162821287|NCT01667107|588058215|FG001|Overall Study|Tolerability issues|2|||
162821288|NCT01667107|588058214|FG000|Overall Study|Protocol Violation|0|||
162821289|NCT01667107|588058215|FG001|Overall Study|Protocol Violation|1|||
162821290|NCT01667107|588058214|FG000|Overall Study|Lack of Efficacy|0|||
162821291|NCT01667107|588058215|FG001|Overall Study|Lack of Efficacy|1|||
162821292|NCT03427125|588058216|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
162821293|NCT03427125|588058217|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
162821294|NCT03427125|588058218|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
162821295|NCT02281357|588058219|FG000|Overall Study|Adverse Event|2|||
162821296|NCT02281357|588058220|FG001|Overall Study|Adverse Event|1|||
162821297|NCT02281357|588058219|FG000|Overall Study|Lost to Follow-up|1|||
162821298|NCT02281357|588058220|FG001|Overall Study|Lost to Follow-up|0|||
163171834|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171835|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171836|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171837|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
163171838|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
163171839|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171840|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171841|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171842|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171843|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171844|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
163171845|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
163171846|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
163171847|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
163171848|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
163171849|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
163171850|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
163171851|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
163171852|NCT00065429|589343977|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171853|NCT00065429|589343978|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171854|NCT00065429|589343979|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171855|NCT00065429|589343980|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
163171856|NCT00065429|589343981|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
163171857|NCT00065429|589343982|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
163171858|NCT00065429|589343983|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
163171859|NCT00065429|589343977|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171860|NCT00065429|589343978|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171861|NCT00065429|589343979|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171862|NCT00065429|589343980|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171863|NCT00065429|589343981|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
163171864|NCT00065429|589343982|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171865|NCT00065429|589343983|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
163171866|NCT00065429|589343977|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171867|NCT00065429|589343978|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171868|NCT00065429|589343979|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171869|NCT00065429|589343980|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171870|NCT00065429|589343981|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
163171871|NCT00065429|589343982|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171872|NCT00065429|589343983|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
163171873|NCT00977080|589343984|FG000|Overall Study|Adverse Event|2|||
163171874|NCT00977080|589343985|FG001|Overall Study|Adverse Event|7|||
163171875|NCT00977080|589343986|FG002|Overall Study|Adverse Event|7|||
163171876|NCT00977080|589343987|FG003|Overall Study|Adverse Event|7|||
163171877|NCT00977080|589343984|FG000|Overall Study|Withdrawal by Subject|1|||
163171878|NCT00977080|589343985|FG001|Overall Study|Withdrawal by Subject|5|||
163171879|NCT00977080|589343986|FG002|Overall Study|Withdrawal by Subject|1|||
162821299|NCT02281357|588058219|FG000|Overall Study|Withdrawal by Subject|4|||
162821300|NCT02281357|588058220|FG001|Overall Study|Withdrawal by Subject|3|||
162821301|NCT01162239|588058221|FG000|Treatment Phase|Withdrawal by Subject|1|||
163171880|NCT00977080|589343987|FG003|Overall Study|Withdrawal by Subject|5|||
163171881|NCT00977080|589343984|FG000|Overall Study|Protocol Violation|7|||
163171882|NCT00977080|589343985|FG001|Overall Study|Protocol Violation|3|||
163171883|NCT00977080|589343986|FG002|Overall Study|Protocol Violation|4|||
163171884|NCT00977080|589343987|FG003|Overall Study|Protocol Violation|3|||
163171885|NCT00977080|589343984|FG000|Overall Study|Noncompliance|0|||
163171886|NCT00977080|589343985|FG001|Overall Study|Noncompliance|2|||
163171887|NCT00977080|589343986|FG002|Overall Study|Noncompliance|1|||
163171888|NCT00977080|589343987|FG003|Overall Study|Noncompliance|0|||
162821302|NCT01162239|588058222|FG001|Treatment Phase|Withdrawal by Subject|3|||
162821303|NCT01162239|588058223|FG002|Treatment Phase|Withdrawal by Subject|2|||
162821304|NCT01162239|588058224|FG003|Treatment Phase|Withdrawal by Subject|3|||
162821305|NCT01162239|588058221|FG000|Treatment Phase|Death|0|||
162821306|NCT01162239|588058222|FG001|Treatment Phase|Death|0|||
162821307|NCT01162239|588058223|FG002|Treatment Phase|Death|0|||
162821308|NCT01162239|588058224|FG003|Treatment Phase|Death|1|||
162821309|NCT01162239|588058221|FG000|Treatment Phase|Lost to Follow-up|5|||
162821310|NCT01162239|588058222|FG001|Treatment Phase|Lost to Follow-up|4|||
162821311|NCT01162239|588058223|FG002|Treatment Phase|Lost to Follow-up|2|||
162821312|NCT01162239|588058224|FG003|Treatment Phase|Lost to Follow-up|1|||
162821313|NCT01162239|588058221|FG000|Extended Follow-up|Lost to Follow-up|8|||
163171889|NCT00977080|589343984|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171890|NCT00977080|589343985|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171891|NCT00977080|589343986|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
163171892|NCT00977080|589343987|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
163171893|NCT00977080|589343984|FG000|Overall Study|Required kidney transplantation|1|||
163171894|NCT00977080|589343985|FG001|Overall Study|Required kidney transplantation|3|||
163171895|NCT00977080|589343986|FG002|Overall Study|Required kidney transplantation|3|||
163171896|NCT00977080|589343987|FG003|Overall Study|Required kidney transplantation|1|||
163171897|NCT00977080|589343984|FG000|Overall Study|Travel for family reasons|1|||
163171898|NCT00977080|589343985|FG001|Overall Study|Travel for family reasons|0|||
163171899|NCT00977080|589343986|FG002|Overall Study|Travel for family reasons|0|||
163171900|NCT00977080|589343987|FG003|Overall Study|Travel for family reasons|0|||
163171901|NCT00636363|589343991|FG000|Overall Study|Conjunctivitis|0|||
163171902|NCT00636363|589343992|FG001|Overall Study|Conjunctivitis|0|||
163171903|NCT00636363|589343993|FG002|Overall Study|Conjunctivitis|1|||
163171904|NCT00636363|589343991|FG000|Overall Study|Adverse Event|0|||
163171905|NCT00636363|589343992|FG001|Overall Study|Adverse Event|0|||
163171906|NCT00636363|589343993|FG002|Overall Study|Adverse Event|1|||
163171907|NCT00636363|589343991|FG000|Overall Study|Positive slit lamp finding|0|||
163171908|NCT00636363|589343992|FG001|Overall Study|Positive slit lamp finding|2|||
163171909|NCT00636363|589343993|FG002|Overall Study|Positive slit lamp finding|1|||
163171910|NCT00636363|589343991|FG000|Overall Study|Study related symptoms/complaints|8|||
163171911|NCT00636363|589343992|FG001|Overall Study|Study related symptoms/complaints|7|||
163171912|NCT00636363|589343993|FG002|Overall Study|Study related symptoms/complaints|4|||
163171913|NCT00636363|589343991|FG000|Overall Study|Met ineligibility criteria|0|||
163171914|NCT00636363|589343992|FG001|Overall Study|Met ineligibility criteria|0|||
163171915|NCT00636363|589343993|FG002|Overall Study|Met ineligibility criteria|3|||
163171916|NCT00636363|589343991|FG000|Overall Study|Missed > 1 visit|0|||
163171917|NCT00636363|589343992|FG001|Overall Study|Missed > 1 visit|1|||
163171918|NCT00636363|589343993|FG002|Overall Study|Missed > 1 visit|3|||
163171919|NCT00636363|589343991|FG000|Overall Study|Lack of motivation|1|||
163171920|NCT00636363|589343992|FG001|Overall Study|Lack of motivation|0|||
163171921|NCT00636363|589343993|FG002|Overall Study|Lack of motivation|1|||
163171922|NCT00636363|589343991|FG000|Overall Study|Protocol Violation|0|||
163171923|NCT00636363|589343992|FG001|Overall Study|Protocol Violation|3|||
163171924|NCT00636363|589343993|FG002|Overall Study|Protocol Violation|0|||
163171925|NCT00636363|589343991|FG000|Overall Study|Lost to Follow-up|3|||
163171926|NCT00636363|589343992|FG001|Overall Study|Lost to Follow-up|4|||
163171927|NCT00636363|589343993|FG002|Overall Study|Lost to Follow-up|2|||
163171928|NCT00636363|589343991|FG000|Overall Study|Withdrawal by Subject|1|||
163171929|NCT00636363|589343992|FG001|Overall Study|Withdrawal by Subject|3|||
163171930|NCT00636363|589343993|FG002|Overall Study|Withdrawal by Subject|2|||
163171931|NCT00313781|589343994|FG000|Before Crossover|Death|22|||
163171932|NCT00313781|589343995|FG001|Before Crossover|Death|8|||
162821314|NCT01162239|588058222|FG001|Extended Follow-up|Lost to Follow-up|13|||
162821315|NCT01162239|588058223|FG002|Extended Follow-up|Lost to Follow-up|8|||
162821316|NCT01162239|588058224|FG003|Extended Follow-up|Lost to Follow-up|6|||
163171933|NCT00313781|589343996|FG002|Before Crossover|Death|0|||
163171934|NCT00313781|589343994|FG000|Before Crossover|Lost to Follow-up|0|||
163171935|NCT00313781|589343995|FG001|Before Crossover|Lost to Follow-up|3|||
163171936|NCT00313781|589343996|FG002|Before Crossover|Lost to Follow-up|0|||
163171937|NCT00313781|589343994|FG000|Before Crossover|Withdrawal by Subject|3|||
163171938|NCT00313781|589343995|FG001|Before Crossover|Withdrawal by Subject|1|||
163171939|NCT00313781|589343996|FG002|Before Crossover|Withdrawal by Subject|0|||
163171940|NCT00313781|589343994|FG000|Before Crossover|Other|45|||
163171941|NCT00313781|589343995|FG001|Before Crossover|Other|30|||
163171942|NCT00313781|589343996|FG002|Before Crossover|Other|0|||
163171943|NCT00313781|589343994|FG000|Before Crossover|Crossover|0|||
162821317|NCT05390580|588058225|FG000|Overall Study|Physician Decision|3|||
163171944|NCT00313781|589343995|FG001|Before Crossover|Crossover|37|||
163171945|NCT00313781|589343996|FG002|Before Crossover|Crossover|0|||
163171946|NCT00313781|589343994|FG000|Before Crossover|Randomized, not treated|5|||
163171947|NCT00313781|589343995|FG001|Before Crossover|Randomized, not treated|0|||
162821318|NCT05390580|588058226|FG001|Overall Study|Physician Decision|2|||
163171948|NCT00313781|589343996|FG002|Before Crossover|Randomized, not treated|0|||
163171949|NCT00313781|589343994|FG000|After Crossover|Death|0|||
163171950|NCT00313781|589343995|FG001|After Crossover|Death|0|||
163171951|NCT00313781|589343996|FG002|After Crossover|Death|6|||
163171952|NCT00313781|589343994|FG000|After Crossover|Withdrawal by Subject|0|||
163171953|NCT00313781|589343995|FG001|After Crossover|Withdrawal by Subject|0|||
163171954|NCT00313781|589343996|FG002|After Crossover|Withdrawal by Subject|3|||
163171955|NCT00313781|589343994|FG000|After Crossover|Other|0|||
163171956|NCT00313781|589343995|FG001|After Crossover|Other|0|||
163171957|NCT00313781|589343996|FG002|After Crossover|Other|18|||
163171958|NCT03148691|589343997|FG000|Overall Study|Protocol Violation|1|||
162698352|NCT02500979|587605472|FG001|Period 1|Severe non-compliance to protocol|1|||
162821319|NCT02877927|588058229|FG000|Overall Study|Adverse Event|1|||
162821320|NCT02877927|588058230|FG001|Overall Study|Adverse Event|0|||
162821321|NCT02877927|588058229|FG000|Overall Study|Lost to Follow-up|37|||
162821322|NCT02877927|588058230|FG001|Overall Study|Lost to Follow-up|38|||
162821323|NCT02877927|588058229|FG000|Overall Study|Withdrawal by Subject|11|||
162821324|NCT02877927|588058230|FG001|Overall Study|Withdrawal by Subject|12|||
162821325|NCT02877927|588058229|FG000|Overall Study|Physician Decision|0|||
162821326|NCT02877927|588058230|FG001|Overall Study|Physician Decision|1|||
162821327|NCT02877927|588058229|FG000|Overall Study|Missed EOT/PTE Visit|5|||
162821328|NCT02877927|588058230|FG001|Overall Study|Missed EOT/PTE Visit|6|||
162821329|NCT04376060|588058232|FG000|Overall Study|Physician Decision|1|||
162821330|NCT01791803|588058233|FG000|Overall Study|Withdrawal by Subject|0|||
162821331|NCT01791803|588058234|FG001|Overall Study|Withdrawal by Subject|0|||
162821332|NCT01791803|588058235|FG002|Overall Study|Withdrawal by Subject|0|||
162821333|NCT01791803|588058236|FG003|Overall Study|Withdrawal by Subject|2|||
162821334|NCT01791803|588058233|FG000|Overall Study|Physician Decision|0|||
162821335|NCT01791803|588058234|FG001|Overall Study|Physician Decision|2|||
162821336|NCT01791803|588058235|FG002|Overall Study|Physician Decision|0|||
162821337|NCT01791803|588058236|FG003|Overall Study|Physician Decision|1|||
162821338|NCT01791803|588058233|FG000|Overall Study|Death|0|||
162821339|NCT01791803|588058234|FG001|Overall Study|Death|0|||
162821340|NCT01791803|588058235|FG002|Overall Study|Death|2|||
162821341|NCT01791803|588058236|FG003|Overall Study|Death|2|||
162821342|NCT04572854|588058237|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
162821343|NCT04572854|588058238|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
162821344|NCT04572854|588058239|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
162821345|NCT04572854|588058240|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
162821346|NCT04572854|588058237|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
162821347|NCT04572854|588058238|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
162821348|NCT04572854|588058239|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
162821349|NCT04572854|588058240|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
162821350|NCT02246582|588059805|FG000|Overall Study|Withdrawal by Subject|3|||
162821351|NCT02246582|588059806|FG001|Overall Study|Withdrawal by Subject|4|||
162821352|NCT02060383|588059808|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
162821353|NCT02060383|588059809|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
162821354|NCT02060383|588059810|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
162821355|NCT02060383|588059811|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
162821356|NCT02060383|588059812|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
162821357|NCT02060383|588059808|FG000|Core Phase|Adverse Event|2|||
162821358|NCT02060383|588059809|FG001|Core Phase|Adverse Event|0|||
162821359|NCT02060383|588059810|FG002|Core Phase|Adverse Event|0|||
162821360|NCT02060383|588059811|FG003|Core Phase|Adverse Event|2|||
162821361|NCT02060383|588059812|FG004|Core Phase|Adverse Event|6|||
162821362|NCT02060383|588059808|FG000|Core Phase|Administrative problems|0|||
162821363|NCT02060383|588059809|FG001|Core Phase|Administrative problems|1|||
162821364|NCT02060383|588059810|FG002|Core Phase|Administrative problems|0|||
162821365|NCT02060383|588059811|FG003|Core Phase|Administrative problems|0|||
162821366|NCT02060383|588059812|FG004|Core Phase|Administrative problems|0|||
162821367|NCT02060383|588059808|FG000|Core Phase|Protocol Violation|0|||
162821368|NCT02060383|588059809|FG001|Core Phase|Protocol Violation|0|||
162821369|NCT02060383|588059810|FG002|Core Phase|Protocol Violation|0|||
162821370|NCT02060383|588059811|FG003|Core Phase|Protocol Violation|1|||
162821371|NCT02060383|588059812|FG004|Core Phase|Protocol Violation|0|||
162821372|NCT02060383|588059808|FG000|Core Phase|Withdrawal by Subject|0|||
162821373|NCT02060383|588059809|FG001|Core Phase|Withdrawal by Subject|0|||
162821374|NCT02060383|588059810|FG002|Core Phase|Withdrawal by Subject|0|||
163171959|NCT03148691|589343998|FG001|Overall Study|Protocol Violation|2|||
163171960|NCT03148691|589343999|FG002|Overall Study|Protocol Violation|7|||
162698353|NCT02500979|587605471|FG000|Period 1|Adverse Event|1|||
162821375|NCT02060383|588059811|FG003|Core Phase|Withdrawal by Subject|4|||
162821376|NCT02060383|588059812|FG004|Core Phase|Withdrawal by Subject|2|||
162821377|NCT02060383|588059808|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
163171961|NCT03148691|589343997|FG000|Overall Study|Lost to Follow-up|0|||
163171962|NCT03148691|589343998|FG001|Overall Study|Lost to Follow-up|0|||
163171963|NCT03148691|589343999|FG002|Overall Study|Lost to Follow-up|1|||
162821378|NCT02060383|588059809|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
162821379|NCT02060383|588059810|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
162821380|NCT02060383|588059811|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
162821381|NCT02060383|588059812|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
162821382|NCT02060383|588059808|FG000|Extension Phase|Adverse Event|1|||
162821383|NCT02060383|588059809|FG001|Extension Phase|Adverse Event|1|||
162821384|NCT02060383|588059810|FG002|Extension Phase|Adverse Event|2|||
162821385|NCT02060383|588059811|FG003|Extension Phase|Adverse Event|0|||
162821386|NCT02060383|588059812|FG004|Extension Phase|Adverse Event|1|||
162821387|NCT02060383|588059808|FG000|Extension Phase|Withdrawal by Subject|0|||
162821388|NCT02060383|588059809|FG001|Extension Phase|Withdrawal by Subject|1|||
162821389|NCT02060383|588059810|FG002|Extension Phase|Withdrawal by Subject|0|||
162821390|NCT02060383|588059811|FG003|Extension Phase|Withdrawal by Subject|0|||
162821391|NCT02060383|588059812|FG004|Extension Phase|Withdrawal by Subject|2|||
162821392|NCT02060383|588059808|FG000|Extension Phase|Administrative problems|1|||
162821393|NCT02060383|588059809|FG001|Extension Phase|Administrative problems|0|||
162821394|NCT02060383|588059810|FG002|Extension Phase|Administrative problems|0|||
162821395|NCT02060383|588059811|FG003|Extension Phase|Administrative problems|0|||
162821396|NCT02060383|588059812|FG004|Extension Phase|Administrative problems|0|||
162821397|NCT02060383|588059808|FG000|Extension Phase|Death|0|||
162821398|NCT02060383|588059809|FG001|Extension Phase|Death|0|||
162821399|NCT02060383|588059810|FG002|Extension Phase|Death|1|||
162821400|NCT02060383|588059811|FG003|Extension Phase|Death|0|||
162821401|NCT02060383|588059812|FG004|Extension Phase|Death|1|||
162821402|NCT02060383|588059808|FG000|Extension Phase|Protocol Violation|0|||
162821403|NCT02060383|588059809|FG001|Extension Phase|Protocol Violation|0|||
162821404|NCT02060383|588059810|FG002|Extension Phase|Protocol Violation|0|||
162821405|NCT02060383|588059811|FG003|Extension Phase|Protocol Violation|0|||
162821406|NCT02060383|588059812|FG004|Extension Phase|Protocol Violation|1|||
162821407|NCT03426787|588059813|FG000|Overall Study|Withdrawal by Subject|6|||
162821408|NCT03426787|588059813|FG000|Overall Study|Lost to Follow-up|7|||
162821409|NCT03426787|588059813|FG000|Overall Study|Unrelated to intervention death|1|||
162821410|NCT00257166|588059819|FG000|Overall Study|Adverse Event|18|||
162821411|NCT00257166|588059820|FG001|Overall Study|Adverse Event|13|||
162821412|NCT00257166|588059819|FG000|Overall Study|Laboratory abnormality|1|||
162821413|NCT00257166|588059820|FG001|Overall Study|Laboratory abnormality|0|||
162821414|NCT00257166|588059819|FG000|Overall Study|Lost to Follow-up|8|||
162821415|NCT00257166|588059820|FG001|Overall Study|Lost to Follow-up|1|||
162821416|NCT00257166|588059819|FG000|Overall Study|Withdrawal by Subject|9|||
162821417|NCT00257166|588059820|FG001|Overall Study|Withdrawal by Subject|2|||
162821418|NCT00257166|588059819|FG000|Overall Study|Other|16|||
162821419|NCT00257166|588059820|FG001|Overall Study|Other|21|||
162821420|NCT00257166|588059819|FG000|Overall Study|Randomized, but not treated|1|||
162821421|NCT00257166|588059820|FG001|Overall Study|Randomized, but not treated|0|||
162821422|NCT02592551|588059821|FG000|Overall Study|Not evaluable|1|||
162821423|NCT02592551|588059822|FG001|Overall Study|Not evaluable|3|||
162821424|NCT02592551|588059823|FG002|Overall Study|Not evaluable|0|||
162821425|NCT00761306|588059824|FG000|Overall Study|Adverse Event|5|||
162821426|NCT00761306|588059824|FG000|Overall Study|Lack of Efficacy|4|||
162821427|NCT00761306|588059824|FG000|Overall Study|Protocol Violation|2|||
162821428|NCT00761306|588059824|FG000|Overall Study|Withdrawal of Consent|3|||
162821429|NCT00761306|588059824|FG000|Overall Study|Lost to Follow-up|1|||
162821430|NCT00761306|588059824|FG000|Overall Study|Administrative or Other Reasons|5|||
162821431|NCT05162027|588059825|FG000|Overall Study|Adverse Event|1|||
162821432|NCT05162027|588059826|FG001|Overall Study|Adverse Event|0|||
162821433|NCT00525044|588059827|FG000|Overall Study|Lost to Follow-up|0|||
162821434|NCT00525044|588059828|FG001|Overall Study|Lost to Follow-up|1|||
162821435|NCT02460497|588059834|FG000|Overall Study|Participant Requested Withdrawal|4|||
162821436|NCT02460497|588059834|FG000|Overall Study|Non-Compliance|1|||
162821437|NCT02460497|588059834|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
162821438|NCT02460497|588059834|FG000|Overall Study|Lost to Follow-up|2|||
162821439|NCT02460497|588059834|FG000|Overall Study|Investigator Decision|1|||
162821440|NCT00908583|588059835|FG000|Phase 1|Withdrawal by Subject|1|||
162821441|NCT00908583|588059835|FG000|Phase 1|Adverse Event|4|||
162821442|NCT00908583|588059835|FG000|Phase 2|Physician Decision|1|||
162821443|NCT00908583|588059835|FG000|Phase 2|Adverse Event|1|||
162821444|NCT00908583|588059835|FG000|Phase 3|Adverse Event|2|||
162821445|NCT00908583|588059835|FG000|Phase 4|Adverse Event|1|||
162821446|NCT00908583|588059835|FG000|Phase 4|Physician Decision|1|||
162821447|NCT00908583|588059835|FG000|Phase 5|Adverse Event|3|||
162821448|NCT00993954|588059836|FG000|Overall Study|Protocol Violation|21|||
162821449|NCT00993954|588059837|FG001|Overall Study|Protocol Violation|2|||
162821450|NCT00860951|588059840|FG000|Overall Study|Withdrawal by Subject|2|||
162821451|NCT00860951|588059840|FG000|Overall Study|Lost to Follow-up|5|||
162821452|NCT02982239|588059843|FG000|Overall Study|Lost to Follow-up|3|||
162821453|NCT02982239|588059844|FG001|Overall Study|Lost to Follow-up|2|||
162821454|NCT01628107|588059845|FG000|Overall Study|Withdrawal by Subject|17|||
162821455|NCT01628107|588059845|FG000|Overall Study|Lost to Follow-up|4|||
162821456|NCT01628107|588059845|FG000|Overall Study|Adverse Event|33|||
162821457|NCT01628107|588059845|FG000|Overall Study|Physician Decision|2|||
162821458|NCT01628107|588059845|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
162821459|NCT01628107|588059845|FG000|Overall Study|Non-compliant with Study Procedures|10|||
162821460|NCT01628107|588059845|FG000|Overall Study|Not Treated|8|||
162821461|NCT01628107|588059845|FG000|Overall Study|Sponsor Decision|11|||
162821462|NCT01628107|588059845|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
162821463|NCT01628107|588059845|FG000|Overall Study|Relocated|8|||
162821464|NCT01628107|588059845|FG000|Overall Study|Kidney Transplant|9|||
162821465|NCT01628107|588059845|FG000|Overall Study|Use of Standard of Care|9|||
162821466|NCT01086410|588059846|FG000|Overall Study|Adverse Event|1|||
162821467|NCT01086410|588059847|FG001|Overall Study|Adverse Event|0|||
162821468|NCT01086410|588059848|FG002|Overall Study|Adverse Event|0|||
162821469|NCT01086410|588059849|FG003|Overall Study|Adverse Event|2|||
162821470|NCT01086410|588059846|FG000|Overall Study|Lack of Efficacy|1|||
162821471|NCT01086410|588059847|FG001|Overall Study|Lack of Efficacy|1|||
162821472|NCT01086410|588059848|FG002|Overall Study|Lack of Efficacy|0|||
162821473|NCT01086410|588059849|FG003|Overall Study|Lack of Efficacy|0|||
162821474|NCT01086410|588059846|FG000|Overall Study|Protocol Violation|1|||
162821475|NCT01086410|588059847|FG001|Overall Study|Protocol Violation|1|||
162821476|NCT01086410|588059848|FG002|Overall Study|Protocol Violation|0|||
162821477|NCT01086410|588059849|FG003|Overall Study|Protocol Violation|0|||
162821478|NCT01086410|588059846|FG000|Overall Study|Lost to Follow-up|0|||
162821479|NCT01086410|588059847|FG001|Overall Study|Lost to Follow-up|0|||
162821480|NCT01086410|588059848|FG002|Overall Study|Lost to Follow-up|1|||
162821481|NCT01086410|588059849|FG003|Overall Study|Lost to Follow-up|0|||
162821482|NCT02230254|588059850|FG000|Overall Study|Lost to Follow-up|3|||
162821483|NCT00621751|588059851|FG000|Overall Study|Adverse Event|0|||
162821484|NCT00621751|588059852|FG001|Overall Study|Adverse Event|1|||
162821485|NCT03583450|588059861|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
162821486|NCT03583450|588059862|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
162821487|NCT01186939|588059863|FG000|Overall Study|Death|7|||
162821488|NCT01186939|588059863|FG000|Overall Study|Withdrawal by Subject|2|||
162821489|NCT01186939|588059863|FG000|Overall Study|No longer receiving clinical benefit|17|||
162821490|NCT01186939|588059863|FG000|Overall Study|Program closed|5|||
162821491|NCT01186939|588059863|FG000|Overall Study|Sponsor decision|4|||
162821492|NCT01186939|588059863|FG000|Overall Study|Started additional treatment|1|||
162821493|NCT01186939|588059863|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
162821494|NCT01186939|588059863|FG000|Overall Study|Myocardial infarction|1|||
162821495|NCT01186939|588059863|FG000|Overall Study|Bone marrow transplant|1|||
162821496|NCT01186939|588059863|FG000|Overall Study|Transformation to AML|1|||
162821497|NCT05097716|588059864|FG000|Period 1|Adverse Event|1|||
162821498|NCT05097716|588059864|FG000|Period 1|Close contact with highly-transmissible infection|1|||
162821499|NCT00791258|588059867|FG000|Overall Study|Adverse Event|87|||
162821500|NCT00791258|588059867|FG000|Overall Study|Lost to Follow-up|18|||
162821501|NCT00791258|588059867|FG000|Overall Study|Protocol Violation|109|||
162821502|NCT00791258|588059867|FG000|Overall Study|Withdrawal by Subject|40|||
162821503|NCT00791258|588059867|FG000|Overall Study|Did not take medication for >3 days|1|||
162821504|NCT00791258|588059867|FG000|Overall Study|subject left area|2|||
162821505|NCT00791258|588059867|FG000|Overall Study|non-compliance|3|||
162821506|NCT00791258|588059867|FG000|Overall Study|Subject incarcerated|1|||
162821507|NCT00791258|588059867|FG000|Overall Study|Subject required restricted medication|1|||
162821508|NCT00791258|588059867|FG000|Overall Study|Lack of Efficacy|1|||
163171964|NCT03148691|589343997|FG000|Overall Study|Other|1|||
163171965|NCT03148691|589343998|FG001|Overall Study|Other|0|||
163171966|NCT03148691|589343999|FG002|Overall Study|Other|0|||
163171967|NCT03148691|589343997|FG000|Overall Study|Withdrawal by Subject|1|||
163171968|NCT03148691|589343998|FG001|Overall Study|Withdrawal by Subject|0|||
163171969|NCT03148691|589343999|FG002|Overall Study|Withdrawal by Subject|0|||
163171970|NCT00096356|589344000|FG000|Overall Study|Adverse Event|11|||
163171971|NCT00096356|589344001|FG001|Overall Study|Adverse Event|9|||
163171972|NCT00096356|589344000|FG000|Overall Study|Physician Decision|5|||
163171973|NCT00096356|589344001|FG001|Overall Study|Physician Decision|3|||
163171974|NCT00096356|589344000|FG000|Overall Study|Withdrawal by Subject|17|||
163171975|NCT00096356|589344001|FG001|Overall Study|Withdrawal by Subject|23|||
163171976|NCT00096356|589344000|FG000|Overall Study|Lack of Efficacy|1|||
163171977|NCT00096356|589344001|FG001|Overall Study|Lack of Efficacy|0|||
163171978|NCT00096356|589344000|FG000|Overall Study|multiple reasons|10|||
163171979|NCT00096356|589344001|FG001|Overall Study|multiple reasons|18|||
163171980|NCT01181986|589344002|FG000|Phase 1|Lost to Follow-up|0|||
162821509|NCT00436618|588059868|FG000|Overall Study|Withdrawal by Subject|5|||
162821510|NCT00436618|588059869|FG001|Overall Study|Withdrawal by Subject|8|||
162821511|NCT00436618|588059870|FG002|Overall Study|Withdrawal by Subject|11|||
162821512|NCT00436618|588059868|FG000|Overall Study|Adverse Event|8|||
162821513|NCT00436618|588059869|FG001|Overall Study|Adverse Event|8|||
162821514|NCT00436618|588059870|FG002|Overall Study|Adverse Event|9|||
162821515|NCT00436618|588059868|FG000|Overall Study|Alternate Treatment|3|||
162821516|NCT00436618|588059869|FG001|Overall Study|Alternate Treatment|4|||
163171981|NCT01181986|589344003|FG001|Phase 1|Lost to Follow-up|1|||
162821517|NCT00436618|588059870|FG002|Overall Study|Alternate Treatment|12|||
162821518|NCT00436618|588059868|FG000|Overall Study|Other Medical Problems|3|||
162821519|NCT00436618|588059869|FG001|Overall Study|Other Medical Problems|1|||
162821520|NCT00436618|588059870|FG002|Overall Study|Other Medical Problems|7|||
162821521|NCT00436618|588059868|FG000|Overall Study|Death|4|||
162821522|NCT00436618|588059869|FG001|Overall Study|Death|2|||
162821523|NCT00436618|588059870|FG002|Overall Study|Death|3|||
162821524|NCT00436618|588059868|FG000|Overall Study|New Primary or Other Reasons|6|||
162821525|NCT00436618|588059869|FG001|Overall Study|New Primary or Other Reasons|2|||
162821526|NCT00436618|588059870|FG002|Overall Study|New Primary or Other Reasons|12|||
162821527|NCT00436618|588059868|FG000|Overall Study|Still on treatment|1|||
162821528|NCT00436618|588059869|FG001|Overall Study|Still on treatment|2|||
162821529|NCT00436618|588059870|FG002|Overall Study|Still on treatment|7|||
162821530|NCT00698204|588059871|FG000|Overall Study|Withdrawal by Subject|1|||
162821531|NCT00698204|588059872|FG001|Overall Study|Withdrawal by Subject|0|||
162821532|NCT00314249|588059873|FG000|Overall Study|Adverse Event|73|||
162821533|NCT00314249|588059874|FG001|Overall Study|Adverse Event|94|||
162821534|NCT00314249|588059873|FG000|Overall Study|Lack of Efficacy|33|||
162821535|NCT00314249|588059874|FG001|Overall Study|Lack of Efficacy|24|||
162821536|NCT00314249|588059873|FG000|Overall Study|Withdrawal by Subject|21|||
162821537|NCT00314249|588059874|FG001|Overall Study|Withdrawal by Subject|28|||
162821538|NCT00314249|588059873|FG000|Overall Study|Lost to Follow-up|15|||
162821539|NCT00314249|588059874|FG001|Overall Study|Lost to Follow-up|9|||
162821540|NCT00314249|588059873|FG000|Overall Study|Physician Decision|1|||
162821541|NCT00314249|588059874|FG001|Overall Study|Physician Decision|1|||
162821542|NCT00314249|588059873|FG000|Overall Study|Withdrawn for other reasons|4|||
162821543|NCT00314249|588059874|FG001|Overall Study|Withdrawn for other reasons|1|||
162821544|NCT00314249|588059873|FG000|Overall Study|Non-Compliant|5|||
162821545|NCT00314249|588059874|FG001|Overall Study|Non-Compliant|6|||
162821546|NCT00058552|588059875|FG000|Overall Study|Died prior to receiving treatment|4|||
162821547|NCT00058552|588059876|FG001|Overall Study|Died prior to receiving treatment|2|||
162821548|NCT00058552|588059875|FG000|Overall Study|Disease progression|52|||
162821549|NCT00058552|588059876|FG001|Overall Study|Disease progression|44|||
162821550|NCT00058552|588059875|FG000|Overall Study|Adverse Event|4|||
162821551|NCT00058552|588059876|FG001|Overall Study|Adverse Event|2|||
162821552|NCT00058552|588059875|FG000|Overall Study|Withdrawal by Subject|3|||
162821553|NCT00058552|588059876|FG001|Overall Study|Withdrawal by Subject|5|||
162821554|NCT00058552|588059875|FG000|Overall Study|Physician Decision|2|||
163171982|NCT01181986|589344004|FG002|Phase 1|Lost to Follow-up|1|||
163171983|NCT01181986|589344002|FG000|Phase 1|Adverse Event|0|||
163171984|NCT01181986|589344003|FG001|Phase 1|Adverse Event|0|||
163171985|NCT01181986|589344004|FG002|Phase 1|Adverse Event|1|||
163171986|NCT01181986|589344002|FG000|Phase 1|Protocol Violation|1|||
163171987|NCT01181986|589344003|FG001|Phase 1|Protocol Violation|0|||
163171988|NCT01181986|589344004|FG002|Phase 1|Protocol Violation|0|||
163171989|NCT01181986|589344002|FG000|Phase 2|Adverse Event|0|||
163171990|NCT01181986|589344003|FG001|Phase 2|Adverse Event|3|||
163171991|NCT01181986|589344004|FG002|Phase 2|Adverse Event|0|||
163171992|NCT01181986|589344002|FG000|Phase 2|Medical condition|0|||
163171993|NCT01181986|589344003|FG001|Phase 2|Medical condition|1|||
163171994|NCT01181986|589344004|FG002|Phase 2|Medical condition|0|||
163171995|NCT05092360|589344005|FG000|Overall Study|Withdrawal by Subject|21|||
163171996|NCT05092360|589344006|FG001|Overall Study|Withdrawal by Subject|4|||
163171997|NCT05092360|589344007|FG002|Overall Study|Withdrawal by Subject|9|||
163171998|NCT05092360|589344008|FG003|Overall Study|Withdrawal by Subject|26|||
163171999|NCT05092360|589344005|FG000|Overall Study|Death|97|||
163172000|NCT05092360|589344006|FG001|Overall Study|Death|14|||
163172001|NCT05092360|589344007|FG002|Overall Study|Death|31|||
163172002|NCT05092360|589344008|FG003|Overall Study|Death|101|||
163172003|NCT05092360|589344005|FG000|Overall Study|Lost to Follow-up|1|||
163172004|NCT05092360|589344006|FG001|Overall Study|Lost to Follow-up|2|||
163172005|NCT05092360|589344007|FG002|Overall Study|Lost to Follow-up|2|||
163172006|NCT05092360|589344008|FG003|Overall Study|Lost to Follow-up|2|||
163172007|NCT05092360|589344005|FG000|Overall Study|Study terminated by sponsor|65|||
162821555|NCT00058552|588059876|FG001|Overall Study|Physician Decision|5|||
162821556|NCT00058552|588059875|FG000|Overall Study|Clinical disease progression|0|||
162821557|NCT00058552|588059876|FG001|Overall Study|Clinical disease progression|4|||
162821558|NCT02066311|588059877|FG000|Overall Study|Adverse Event|4|||
162821559|NCT02066311|588059877|FG000|Overall Study|Withdrawal by Subject|1|||
162821560|NCT01372150|588059880|FG000|Overall Study|Lack of Efficacy|3|||
162821561|NCT01372150|588059881|FG001|Overall Study|Lack of Efficacy|0|||
162821562|NCT01372150|588059882|FG002|Overall Study|Lack of Efficacy|1|||
162821563|NCT01372150|588059880|FG000|Overall Study|Lost to Follow-up|4|||
162821564|NCT01372150|588059881|FG001|Overall Study|Lost to Follow-up|5|||
162821565|NCT01372150|588059882|FG002|Overall Study|Lost to Follow-up|6|||
162821566|NCT01372150|588059880|FG000|Overall Study|Protocol Violation|1|||
162821567|NCT01372150|588059881|FG001|Overall Study|Protocol Violation|0|||
162821568|NCT01372150|588059882|FG002|Overall Study|Protocol Violation|3|||
162821569|NCT01372150|588059880|FG000|Overall Study|Withdrawal by Subject|2|||
162821570|NCT01372150|588059881|FG001|Overall Study|Withdrawal by Subject|7|||
162821571|NCT01372150|588059882|FG002|Overall Study|Withdrawal by Subject|2|||
162821572|NCT01372150|588059880|FG000|Overall Study|Other|1|||
162821573|NCT01372150|588059881|FG001|Overall Study|Other|0|||
162821574|NCT01372150|588059882|FG002|Overall Study|Other|2|||
162821575|NCT01372150|588059880|FG000|Overall Study|Adverse Event|2|||
162821576|NCT01372150|588059881|FG001|Overall Study|Adverse Event|1|||
162821577|NCT01372150|588059882|FG002|Overall Study|Adverse Event|2|||
162821578|NCT01372150|588059880|FG000|Overall Study|Randomized but not treated|0|||
162821579|NCT01372150|588059881|FG001|Overall Study|Randomized but not treated|1|||
162821580|NCT01372150|588059882|FG002|Overall Study|Randomized but not treated|0|||
162821581|NCT02316340|588059883|FG000|First Progression|Clinical progression|2|||
162821582|NCT02316340|588059884|FG001|First Progression|Clinical progression|1|||
162821583|NCT02316340|588059883|FG000|First Progression|Withdrawal by Subject|1|||
162821584|NCT02316340|588059884|FG001|First Progression|Withdrawal by Subject|0|||
162821585|NCT03781323|588059885|FG000|Overall Study|Withdrawal by Subject|1|||
162821586|NCT00770770|588059888|FG000|Overall Study|Lost to Follow-up|1|||
162821587|NCT00770770|588059889|FG001|Overall Study|Lost to Follow-up|0|||
162821588|NCT00770770|588059888|FG000|Overall Study|Withdrawal by Subject|1|||
162821589|NCT00770770|588059889|FG001|Overall Study|Withdrawal by Subject|0|||
162821590|NCT00770770|588059888|FG000|Overall Study|Death|0|||
162821591|NCT00770770|588059889|FG001|Overall Study|Death|1|||
163172008|NCT05092360|589344006|FG001|Overall Study|Study terminated by sponsor|7|||
163172009|NCT05092360|589344007|FG002|Overall Study|Study terminated by sponsor|13|||
163172010|NCT05092360|589344008|FG003|Overall Study|Study terminated by sponsor|61|||
163172011|NCT01675167|589344009|FG000|Open-label Titration Phase|Adverse Event|81|||
163172012|NCT01675167|589344010|FG001|Open-label Titration Phase|Adverse Event|0|||
162821592|NCT00770770|588059888|FG000|Overall Study|Study Terminated|8|||
162821593|NCT00770770|588059889|FG001|Overall Study|Study Terminated|0|||
162821594|NCT02486653|588059890|FG000|Overall Study|Withdrawal by Subject|1|||
162821595|NCT02486653|588059891|FG001|Overall Study|Withdrawal by Subject|3|||
163172013|NCT01675167|589344011|FG002|Open-label Titration Phase|Adverse Event|0|||
163172014|NCT01675167|589344009|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
163172015|NCT01675167|589344010|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
163172016|NCT01675167|589344011|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
163172017|NCT01675167|589344009|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
163172018|NCT01675167|589344010|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
163172019|NCT01675167|589344011|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
163172020|NCT01675167|589344009|FG000|Open-label Titration Phase|Protocol Violation|43|||
163172021|NCT01675167|589344010|FG001|Open-label Titration Phase|Protocol Violation|0|||
163172022|NCT01675167|589344011|FG002|Open-label Titration Phase|Protocol Violation|0|||
163172023|NCT01675167|589344009|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
163172024|NCT01675167|589344010|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
163172025|NCT01675167|589344011|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
163172026|NCT01675167|589344009|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
163172027|NCT01675167|589344010|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
163172028|NCT01675167|589344011|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
163172029|NCT01675167|589344009|FG000|Open-label Titration Phase|Other|55|||
163172030|NCT01675167|589344010|FG001|Open-label Titration Phase|Other|0|||
163172031|NCT01675167|589344011|FG002|Open-label Titration Phase|Other|0|||
163172032|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
163172033|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
163172034|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
163172035|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163172036|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163172037|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
163172038|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163172039|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Adverse Event|5|||
163172040|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Adverse Event|13|||
163172041|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
163172042|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
163172043|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
163172044|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163172045|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
163172046|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
163172047|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
163172048|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
163172049|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
163172050|NCT01675167|589344009|FG000|Double-blind Treatment Phase|Other|0|||
163172051|NCT01675167|589344010|FG001|Double-blind Treatment Phase|Other|7|||
163172052|NCT01675167|589344011|FG002|Double-blind Treatment Phase|Other|5|||
163172053|NCT04531462|589345161|FG000|Overall Study|Withdrawal by Subject|3|||
163172054|NCT04531462|589345162|FG001|Overall Study|Withdrawal by Subject|1|||
163172055|NCT04531462|589345161|FG000|Overall Study|Adverse Event|3|||
163172056|NCT04531462|589345162|FG001|Overall Study|Adverse Event|3|||
162821596|NCT02486653|588059890|FG000|Overall Study|Protocol Violation|1|||
162821597|NCT02486653|588059891|FG001|Overall Study|Protocol Violation|0|||
162821598|NCT02486653|588059890|FG000|Overall Study|surgery cancelled|4|||
162821599|NCT02486653|588059891|FG001|Overall Study|surgery cancelled|1|||
162821600|NCT00800436|588059892|FG000|Overall Study|Withdrawal by Subject|0|||
162821601|NCT00800436|588059893|FG001|Overall Study|Withdrawal by Subject|0|||
162821602|NCT00800436|588059894|FG002|Overall Study|Withdrawal by Subject|1|||
162821603|NCT00800436|588059895|FG003|Overall Study|Withdrawal by Subject|1|||
162821604|NCT00800436|588059896|FG004|Overall Study|Withdrawal by Subject|0|||
162821605|NCT00800436|588059897|FG005|Overall Study|Withdrawal by Subject|0|||
162821606|NCT00800436|588059898|FG006|Overall Study|Withdrawal by Subject|0|||
162821607|NCT01230554|588059901|FG000|Overall Study|Lost to Follow-up|2|||
162821608|NCT01230554|588059901|FG000|Overall Study|Inability to maintain visit schedule|1|||
162821609|NCT01006265|588059902|FG000|Overall Study|Lost to Follow-up|1|||
162821610|NCT01006265|588059903|FG001|Overall Study|Lost to Follow-up|0|||
162821611|NCT01006265|588059904|FG002|Overall Study|Lost to Follow-up|1|||
162821612|NCT01006265|588059905|FG003|Overall Study|Lost to Follow-up|0|||
162821613|NCT01006265|588059902|FG000|Overall Study|Withdrawal by Subject|4|||
162821614|NCT01006265|588059903|FG001|Overall Study|Withdrawal by Subject|7|||
162821615|NCT01006265|588059904|FG002|Overall Study|Withdrawal by Subject|5|||
162821616|NCT01006265|588059905|FG003|Overall Study|Withdrawal by Subject|5|||
162821617|NCT01006265|588059902|FG000|Overall Study|Administrative reason|1|||
162821618|NCT01006265|588059903|FG001|Overall Study|Administrative reason|2|||
163172057|NCT05338671|589345163|FG000|Overall Study|Lost to Follow-up|2|||
163172058|NCT05338671|589345164|FG001|Overall Study|Lost to Follow-up|2|||
163172059|NCT05338671|589345163|FG000|Overall Study|Root canal completed in a single visit|1|||
163172060|NCT05338671|589345164|FG001|Overall Study|Root canal completed in a single visit|0|||
163172061|NCT03859973|589345165|FG000|Overall Study|Other reason than listed|3|||
163172062|NCT03859973|589345166|FG001|Overall Study|Other reason than listed|2|||
162821619|NCT01006265|588059904|FG002|Overall Study|Administrative reason|3|||
162821620|NCT01006265|588059905|FG003|Overall Study|Administrative reason|0|||
162821621|NCT01177384|588059906|FG000|Overall Study|Adverse Event|6|||
162821622|NCT01177384|588059907|FG001|Overall Study|Adverse Event|4|||
162821623|NCT01177384|588059906|FG000|Overall Study|Lack of Efficacy|0|||
162821624|NCT01177384|588059907|FG001|Overall Study|Lack of Efficacy|1|||
162821625|NCT01177384|588059906|FG000|Overall Study|Lost to Follow-up|3|||
162821626|NCT01177384|588059907|FG001|Overall Study|Lost to Follow-up|4|||
162821627|NCT01177384|588059906|FG000|Overall Study|Physician Decision|0|||
162821628|NCT01177384|588059907|FG001|Overall Study|Physician Decision|3|||
162821629|NCT01177384|588059906|FG000|Overall Study|Protocol Violation|0|||
163172063|NCT03859973|589345165|FG000|Overall Study|COVID-19 related, not due to AE|3|||
163172064|NCT03859973|589345166|FG001|Overall Study|COVID-19 related, not due to AE|4|||
163172065|NCT03859973|589345165|FG000|Overall Study|Withdrawal by Subject|8|||
163172066|NCT03859973|589345166|FG001|Overall Study|Withdrawal by Subject|9|||
163172067|NCT03859973|589345165|FG000|Overall Study|Lost to Follow-up|2|||
163172068|NCT03859973|589345166|FG001|Overall Study|Lost to Follow-up|3|||
163172069|NCT03859973|589345165|FG000|Overall Study|Protocol Violation|1|||
163172070|NCT03859973|589345166|FG001|Overall Study|Protocol Violation|3|||
163172071|NCT03859973|589345165|FG000|Overall Study|Adverse Event|3|||
163172072|NCT03859973|589345166|FG001|Overall Study|Adverse Event|5|||
163172073|NCT03085914|589345167|FG000|Overall Study|Death|6|||
163172074|NCT03085914|589345168|FG001|Overall Study|Death|6|||
163172075|NCT03085914|589345169|FG002|Overall Study|Death|4|||
163172076|NCT03085914|589345170|FG003|Overall Study|Death|1|||
163172077|NCT03085914|589345171|FG004|Overall Study|Death|5|||
163172078|NCT03085914|589345172|FG005|Overall Study|Death|2|||
163172079|NCT03085914|589345173|FG006|Overall Study|Death|2|||
163172080|NCT03085914|589345167|FG000|Overall Study|Withdrawal by Subject|1|||
163172081|NCT03085914|589345168|FG001|Overall Study|Withdrawal by Subject|1|||
163172082|NCT03085914|589345169|FG002|Overall Study|Withdrawal by Subject|2|||
163172083|NCT03085914|589345170|FG003|Overall Study|Withdrawal by Subject|2|||
163172084|NCT03085914|589345171|FG004|Overall Study|Withdrawal by Subject|2|||
163172085|NCT03085914|589345172|FG005|Overall Study|Withdrawal by Subject|0|||
163172086|NCT03085914|589345173|FG006|Overall Study|Withdrawal by Subject|1|||
163172087|NCT03085914|589345167|FG000|Overall Study|Lost to Follow-up|0|||
163172088|NCT03085914|589345168|FG001|Overall Study|Lost to Follow-up|0|||
163172089|NCT03085914|589345169|FG002|Overall Study|Lost to Follow-up|1|||
163172090|NCT03085914|589345170|FG003|Overall Study|Lost to Follow-up|0|||
163172091|NCT03085914|589345171|FG004|Overall Study|Lost to Follow-up|0|||
163172092|NCT03085914|589345172|FG005|Overall Study|Lost to Follow-up|1|||
163172093|NCT03085914|589345173|FG006|Overall Study|Lost to Follow-up|1|||
163172094|NCT03085914|589345167|FG000|Overall Study|Reason was not specified,|2|||
163172095|NCT03085914|589345168|FG001|Overall Study|Reason was not specified,|2|||
163172096|NCT03085914|589345169|FG002|Overall Study|Reason was not specified,|2|||
163172097|NCT03085914|589345170|FG003|Overall Study|Reason was not specified,|3|||
163172098|NCT03085914|589345171|FG004|Overall Study|Reason was not specified,|3|||
163172099|NCT03085914|589345172|FG005|Overall Study|Reason was not specified,|3|||
163172100|NCT03085914|589345173|FG006|Overall Study|Reason was not specified,|6|||
163172101|NCT03085914|589345167|FG000|Overall Study|Progressive Disease|0|||
163172102|NCT03085914|589345168|FG001|Overall Study|Progressive Disease|0|||
163172103|NCT03085914|589345169|FG002|Overall Study|Progressive Disease|2|||
163172104|NCT03085914|589345170|FG003|Overall Study|Progressive Disease|2|||
163172105|NCT03085914|589345171|FG004|Overall Study|Progressive Disease|1|||
163172106|NCT03085914|589345172|FG005|Overall Study|Progressive Disease|1|||
163172107|NCT03085914|589345173|FG006|Overall Study|Progressive Disease|1|||
163172108|NCT03085914|589345167|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163172109|NCT03085914|589345168|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163172110|NCT03085914|589345169|FG002|Overall Study|Study Terminated by the Sponsor|0|||
163172111|NCT03085914|589345170|FG003|Overall Study|Study Terminated by the Sponsor|1|||
163172112|NCT03085914|589345171|FG004|Overall Study|Study Terminated by the Sponsor|2|||
163172113|NCT03085914|589345172|FG005|Overall Study|Study Terminated by the Sponsor|1|||
163172114|NCT03085914|589345173|FG006|Overall Study|Study Terminated by the Sponsor|0|||
163172115|NCT03874429|589345177|FG000|Overall Study|Adverse Event|2|||
163172116|NCT03874429|589345178|FG001|Overall Study|Adverse Event|2|||
163172117|NCT03874429|589345177|FG000|Overall Study|Lack of Efficacy|0|||
163172118|NCT03874429|589345178|FG001|Overall Study|Lack of Efficacy|1|||
163172119|NCT03874429|589345177|FG000|Overall Study|Covid-19 pandemic|4|||
163172120|NCT03874429|589345178|FG001|Overall Study|Covid-19 pandemic|2|||
163172121|NCT00331552|589345179|FG000|Period 3: Phase II|Neurological Symptoms|1|||
163172122|NCT00331552|589345180|FG001|Period 3: Phase II|Neurological Symptoms|0|||
163172123|NCT00331552|589345179|FG000|Period 3: Phase II|Severe Nausea|1|||
163172124|NCT00331552|589345180|FG001|Period 3: Phase II|Severe Nausea|0|||
163172125|NCT03642132|589345181|FG000|Chemotherapy Period|Adverse Event|1|||
163172126|NCT03642132|589345182|FG001|Chemotherapy Period|Adverse Event|1|||
163172127|NCT03642132|589345183|FG002|Chemotherapy Period|Adverse Event|0|||
163172128|NCT03642132|589345181|FG000|Chemotherapy Period|Physician's decision|4|||
163172129|NCT03642132|589345182|FG001|Chemotherapy Period|Physician's decision|1|||
162821630|NCT01177384|588059907|FG001|Overall Study|Protocol Violation|2|||
162821631|NCT01177384|588059906|FG000|Overall Study|Withdrawal by Subject|5|||
163172130|NCT03642132|589345183|FG002|Chemotherapy Period|Physician's decision|0|||
163172131|NCT03642132|589345181|FG000|Chemotherapy Period|Progressive disease|0|||
162698354|NCT02500979|587605472|FG001|Period 1|Adverse Event|0|||
162698355|NCT02500979|587605471|FG000|Period 1|Subject decision|2|||
162698356|NCT02500979|587605472|FG001|Period 1|Subject decision|0|||
162698357|NCT02500979|587605471|FG000|Period 2|Change in risk|1|||
163172132|NCT03642132|589345182|FG001|Chemotherapy Period|Progressive disease|0|||
163172133|NCT03642132|589345183|FG002|Chemotherapy Period|Progressive disease|1|||
162698358|NCT02500979|587605472|FG001|Period 2|Change in risk|0|||
162698359|NCT03772314|587605475|FG000|Overall Study|Adverse Event|7|||
162698360|NCT03772314|587605476|FG001|Overall Study|Adverse Event|2|||
162698361|NCT01613027|587605477|FG000|Overall Study|Lost to Follow-up|5|||
162698362|NCT01613027|587605477|FG000|Overall Study|Switched Physician|1|||
162698363|NCT01613027|587605477|FG000|Overall Study|Lack of Efficacy|1|||
162698364|NCT01613027|587605477|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
162698365|NCT04267614|587605480|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
162698366|NCT04267614|587605480|FG000|Overall Study|Lost to Follow-up|115|||
162698367|NCT00119262|587605484|FG000|Overall Study|Lack of Efficacy|0|||
162698368|NCT00119262|587605485|FG001|Overall Study|Lack of Efficacy|3|||
162698369|NCT00119262|587605484|FG000|Overall Study|Withdrawal by Subject|12|||
162698370|NCT00119262|587605485|FG001|Overall Study|Withdrawal by Subject|11|||
162698371|NCT00119262|587605484|FG000|Overall Study|Adverse Event|33|||
162698372|NCT00119262|587605485|FG001|Overall Study|Adverse Event|35|||
162698373|NCT00119262|587605484|FG000|Overall Study|other disease|0|||
162698374|NCT00119262|587605485|FG001|Overall Study|other disease|2|||
162698375|NCT00119262|587605484|FG000|Overall Study|ineligble|1|||
162698376|NCT00119262|587605485|FG001|Overall Study|ineligble|2|||
162698377|NCT00119262|587605484|FG000|Overall Study|others|0|||
162698378|NCT00119262|587605485|FG001|Overall Study|others|5|||
162698379|NCT03853317|587605486|FG000|Overall Study|Progressive Disease|5|||
162698380|NCT03853317|587605486|FG000|Overall Study|Adverse Event|1|||
162698381|NCT03853317|587605486|FG000|Overall Study|Death|1|||
162698382|NCT03853317|587605486|FG000|Overall Study|other event|2|||
162698383|NCT02141659|587605489|FG000|Overall Study|Major Protocol Deviation|0|||
162698384|NCT02141659|587605490|FG001|Overall Study|Major Protocol Deviation|1|||
162698385|NCT02141659|587605491|FG002|Overall Study|Major Protocol Deviation|0|||
162698386|NCT02141659|587605492|FG003|Overall Study|Major Protocol Deviation|0|||
162698387|NCT02141659|587605493|FG004|Overall Study|Major Protocol Deviation|0|||
162698388|NCT02141659|587605494|FG005|Overall Study|Major Protocol Deviation|0|||
162698389|NCT02141659|587605489|FG000|Overall Study|Lack of Efficacy|0|||
162698390|NCT02141659|587605490|FG001|Overall Study|Lack of Efficacy|0|||
162698391|NCT02141659|587605491|FG002|Overall Study|Lack of Efficacy|0|||
162698392|NCT02141659|587605492|FG003|Overall Study|Lack of Efficacy|0|||
162698393|NCT02141659|587605493|FG004|Overall Study|Lack of Efficacy|0|||
162698394|NCT02141659|587605494|FG005|Overall Study|Lack of Efficacy|1|||
162698395|NCT02141659|587605489|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
162698396|NCT02141659|587605490|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
162698397|NCT02141659|587605491|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
162698398|NCT02141659|587605492|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
162698399|NCT02141659|587605493|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
162698400|NCT02141659|587605494|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
162698401|NCT01927731|587605495|FG000|Overall Study|Graft Failure|1|||
162698402|NCT01927731|587605496|FG001|Overall Study|Graft Failure|2|||
162698403|NCT01927731|587605495|FG000|Overall Study|Physician Decision|2|||
162698404|NCT01927731|587605496|FG001|Overall Study|Physician Decision|3|||
162698405|NCT01927731|587605495|FG000|Overall Study|Withdrawal by Subject|0|||
162698406|NCT01927731|587605496|FG001|Overall Study|Withdrawal by Subject|2|||
163172134|NCT03642132|589345181|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
163172135|NCT03642132|589345182|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
163172136|NCT03642132|589345183|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
163172137|NCT03642132|589345181|FG000|Chemotherapy Period|Other|1|||
163172138|NCT03642132|589345182|FG001|Chemotherapy Period|Other|0|||
163172139|NCT03642132|589345183|FG002|Chemotherapy Period|Other|2|||
163172140|NCT03642132|589345181|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
163172141|NCT03642132|589345182|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
163172142|NCT03642132|589345183|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
163172143|NCT03642132|589345181|FG000|Maintenance Period|Adverse Event|1|||
162698407|NCT01927731|587605495|FG000|Overall Study|Death|0|||
162698408|NCT01927731|587605496|FG001|Overall Study|Death|3|||
162698409|NCT00305864|587605499|FG000|Overall Study|Ineligible / No protocol treatment|0|||
162698410|NCT00305864|587605500|FG001|Overall Study|Ineligible / No protocol treatment|1|||
162698411|NCT00305864|587605501|FG002|Overall Study|Ineligible / No protocol treatment|1|||
162698412|NCT00305864|587605502|FG003|Overall Study|Ineligible / No protocol treatment|13|||
162698413|NCT03881059|587605503|FG000|Treatment Period - Part A|Adverse Event|1|||
162698414|NCT03881059|587605504|FG001|Treatment Period - Part A|Adverse Event|3|||
162698415|NCT03881059|587605505|FG002|Treatment Period - Part A|Adverse Event|4|||
162698416|NCT03881059|587605503|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
163172144|NCT03642132|589345182|FG001|Maintenance Period|Adverse Event|2|||
163172145|NCT03642132|589345183|FG002|Maintenance Period|Adverse Event|0|||
163172146|NCT03642132|589345181|FG000|Maintenance Period|Non-compliance with study drug|0|||
163172147|NCT03642132|589345182|FG001|Maintenance Period|Non-compliance with study drug|0|||
163172148|NCT03642132|589345183|FG002|Maintenance Period|Non-compliance with study drug|1|||
163172149|NCT03642132|589345181|FG000|Maintenance Period|Physician's decision|2|||
163172150|NCT03642132|589345182|FG001|Maintenance Period|Physician's decision|2|||
163172151|NCT03642132|589345183|FG002|Maintenance Period|Physician's decision|2|||
163172152|NCT03642132|589345181|FG000|Maintenance Period|Progressive disease|9|||
163172153|NCT03642132|589345182|FG001|Maintenance Period|Progressive disease|3|||
163172154|NCT03642132|589345183|FG002|Maintenance Period|Progressive disease|6|||
163172155|NCT03642132|589345181|FG000|Maintenance Period|Other|0|||
163172156|NCT03642132|589345182|FG001|Maintenance Period|Other|0|||
163172157|NCT03642132|589345183|FG002|Maintenance Period|Other|3|||
163172158|NCT03642132|589345181|FG000|Maintenance Period|Withdrawal by Subject|1|||
163172159|NCT03642132|589345182|FG001|Maintenance Period|Withdrawal by Subject|1|||
163172160|NCT03642132|589345183|FG002|Maintenance Period|Withdrawal by Subject|2|||
163172161|NCT03642132|589345181|FG000|Follow-up Period|Other|0|||
163172162|NCT03642132|589345182|FG001|Follow-up Period|Other|0|||
163172163|NCT03642132|589345183|FG002|Follow-up Period|Other|1|||
163172164|NCT03642132|589345181|FG000|Follow-up Period|Withdrawal by Subject|1|||
163172165|NCT03642132|589345182|FG001|Follow-up Period|Withdrawal by Subject|2|||
163172166|NCT03642132|589345183|FG002|Follow-up Period|Withdrawal by Subject|0|||
163172167|NCT03642132|589345181|FG000|Follow-up Period|Study terminated by sponsor|1|||
163172168|NCT03642132|589345182|FG001|Follow-up Period|Study terminated by sponsor|0|||
163172169|NCT03642132|589345183|FG002|Follow-up Period|Study terminated by sponsor|1|||
163172170|NCT03642132|589345181|FG000|Follow-up Period|Lack of Efficacy|1|||
163172171|NCT03642132|589345182|FG001|Follow-up Period|Lack of Efficacy|0|||
163172172|NCT03642132|589345183|FG002|Follow-up Period|Lack of Efficacy|0|||
163172173|NCT03642132|589345181|FG000|Follow-up Period|Death|1|||
163172174|NCT03642132|589345182|FG001|Follow-up Period|Death|0|||
163172175|NCT03642132|589345183|FG002|Follow-up Period|Death|2|||
163172176|NCT03642132|589345181|FG000|Follow-up Period|Adverse Event|1|||
163172177|NCT03642132|589345182|FG001|Follow-up Period|Adverse Event|0|||
163172178|NCT03642132|589345183|FG002|Follow-up Period|Adverse Event|0|||
163172179|NCT03560518|589345184|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
163172180|NCT03560518|589345185|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
163172181|NCT03560518|589345186|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
163172182|NCT03560518|589345184|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
162821632|NCT01177384|588059907|FG001|Overall Study|Withdrawal by Subject|12|||
162821633|NCT00955279|588059908|FG000|Overall Study|Other|0|||
162821634|NCT00955279|588059909|FG001|Overall Study|Other|0|||
162821635|NCT00955279|588059910|FG002|Overall Study|Other|3|||
162821636|NCT00955279|588059908|FG000|Overall Study|Death|1|||
162821637|NCT00955279|588059909|FG001|Overall Study|Death|1|||
162821638|NCT00955279|588059910|FG002|Overall Study|Death|1|||
162821639|NCT00955279|588059908|FG000|Overall Study|Lost to Follow-up|0|||
162821640|NCT00955279|588059909|FG001|Overall Study|Lost to Follow-up|3|||
162821641|NCT00955279|588059910|FG002|Overall Study|Lost to Follow-up|1|||
162821642|NCT00955279|588059908|FG000|Overall Study|Withdrawal by Subject|2|||
162821643|NCT00955279|588059909|FG001|Overall Study|Withdrawal by Subject|0|||
162821644|NCT00955279|588059910|FG002|Overall Study|Withdrawal by Subject|3|||
162821645|NCT02921269|588059911|FG000|Overall Study|Did not complete DLT period|1|||
162821646|NCT00387764|588059922|FG000|Overall Study|Adverse Event|12|||
162821647|NCT00387764|588059922|FG000|Overall Study|Withdrawal by Subject|8|||
162821648|NCT00387764|588059922|FG000|Overall Study|Sponsor Terminated Study|1|||
162821649|NCT00387764|588059922|FG000|Overall Study|Physician Decision|1|||
162821650|NCT00387764|588059922|FG000|Overall Study|Other|2|||
162821651|NCT00387764|588059922|FG000|Overall Study|Death|7|||
162821652|NCT01184053|588059923|FG000|Overall Study|progression while on treatment|3|||
162821653|NCT01174238|588059926|FG000|Overall Study|Lost to Follow-up|2|||
163172183|NCT03560518|589345185|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
163172184|NCT03560518|589345186|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
163172185|NCT03560518|589345184|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163172186|NCT03560518|589345185|FG001|Double Blind Treatment Period|Protocol Violation|2|||
163172187|NCT03560518|589345186|FG002|Double Blind Treatment Period|Protocol Violation|0|||
163172188|NCT03560518|589345184|FG000|Double Blind Treatment Period|Pregnancy|0|||
163172189|NCT03560518|589345185|FG001|Double Blind Treatment Period|Pregnancy|2|||
163172190|NCT03560518|589345186|FG002|Double Blind Treatment Period|Pregnancy|0|||
162821654|NCT05975840|588059929|FG000|Overall Study|Other|1|||
162821655|NCT05975840|588059930|FG001|Overall Study|Other|0|||
162821656|NCT05975840|588059931|FG002|Overall Study|Other|0|||
162821657|NCT05975840|588059932|FG003|Overall Study|Other|0|||
162821658|NCT05975840|588059933|FG004|Overall Study|Other|1|||
162821659|NCT05975840|588059934|FG005|Overall Study|Other|0|||
162821660|NCT05975840|588059935|FG006|Overall Study|Other|0|||
162821661|NCT05975840|588059936|FG007|Overall Study|Other|0|||
162821662|NCT05975840|588059929|FG000|Overall Study|Lost to Follow-up|3|||
162821663|NCT05975840|588059930|FG001|Overall Study|Lost to Follow-up|6|||
162821664|NCT05975840|588059931|FG002|Overall Study|Lost to Follow-up|3|||
162821665|NCT05975840|588059932|FG003|Overall Study|Lost to Follow-up|1|||
162821666|NCT05975840|588059933|FG004|Overall Study|Lost to Follow-up|4|||
162821667|NCT05975840|588059934|FG005|Overall Study|Lost to Follow-up|1|||
162821668|NCT05975840|588059935|FG006|Overall Study|Lost to Follow-up|2|||
163172191|NCT03560518|589345184|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
163172192|NCT03560518|589345185|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
163172193|NCT03560518|589345186|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
163172194|NCT03560518|589345184|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
163172195|NCT03560518|589345185|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
163172196|NCT03560518|589345186|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
163172197|NCT03560518|589345184|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
163172198|NCT03560518|589345185|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
163172199|NCT03560518|589345186|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
163172200|NCT03560518|589345184|FG000|Double Blind Treatment Period|Adverse Event|0|||
163172201|NCT03560518|589345185|FG001|Double Blind Treatment Period|Adverse Event|3|||
163172202|NCT03560518|589345186|FG002|Double Blind Treatment Period|Adverse Event|1|||
163172203|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
163172204|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Adverse Event|9|||
163172205|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Death|4|||
163172206|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
163172207|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
163172208|NCT00159822|589345187|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
163172209|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Death|1|||
163172210|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
163172211|NCT00159822|589345187|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
163172212|NCT00958438|589345189|FG000|Overall Study|Protocol Violation|3|||
163172213|NCT00958438|589345190|FG001|Overall Study|Protocol Violation|2|||
163172214|NCT00958438|589345191|FG002|Overall Study|Protocol Violation|2|||
163172215|NCT00958438|589345189|FG000|Overall Study|Withdrawal by Subject|4|||
163172216|NCT00958438|589345190|FG001|Overall Study|Withdrawal by Subject|2|||
163172217|NCT00958438|589345191|FG002|Overall Study|Withdrawal by Subject|1|||
163172218|NCT00958438|589345189|FG000|Overall Study|Adverse Event|0|||
163172219|NCT00958438|589345190|FG001|Overall Study|Adverse Event|3|||
163172220|NCT00958438|589345191|FG002|Overall Study|Adverse Event|0|||
163172221|NCT00958438|589345189|FG000|Overall Study|Physician Decision|1|||
163172222|NCT00958438|589345190|FG001|Overall Study|Physician Decision|0|||
163172223|NCT00958438|589345191|FG002|Overall Study|Physician Decision|1|||
163172224|NCT00958438|589345189|FG000|Overall Study|Other than specified above|2|||
163172225|NCT00958438|589345190|FG001|Overall Study|Other than specified above|3|||
163172226|NCT00958438|589345191|FG002|Overall Study|Other than specified above|2|||
163172227|NCT02946931|589345196|FG000|Overall Study|Did not require collection of CRFs|588|||
163172228|NCT02946931|589345196|FG000|Overall Study|Other than listed|37|||
163172229|NCT02946931|589345196|FG000|Overall Study|Discharge from hospital|118|||
163172230|NCT02946931|589345196|FG000|Overall Study|Adverse Event|81|||
163172231|NCT02946931|589345196|FG000|Overall Study|CRFs not valid|1|||
163172232|NCT02946931|589345196|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
163172233|NCT00869778|589345200|FG000|Overall Study|Adverse Event|2|||
163172234|NCT00869778|589345201|FG001|Overall Study|Adverse Event|0|||
163172235|NCT00869778|589345202|FG002|Overall Study|Adverse Event|0|||
163172236|NCT00869778|589345200|FG000|Overall Study|Withdrawal by Subject|3|||
163172237|NCT00869778|589345201|FG001|Overall Study|Withdrawal by Subject|4|||
163172238|NCT00869778|589345202|FG002|Overall Study|Withdrawal by Subject|5|||
163172239|NCT00869778|589345200|FG000|Overall Study|Pregnancy|1|||
163172240|NCT00869778|589345201|FG001|Overall Study|Pregnancy|0|||
163172241|NCT00869778|589345202|FG002|Overall Study|Pregnancy|0|||
162821669|NCT05975840|588059936|FG007|Overall Study|Lost to Follow-up|4|||
162821670|NCT05975840|588059929|FG000|Overall Study|Migrated/moved from the study area|1|||
162821671|NCT05975840|588059930|FG001|Overall Study|Migrated/moved from the study area|0|||
163172242|NCT00869778|589345200|FG000|Overall Study|Protocol Violation|5|||
163172243|NCT00869778|589345201|FG001|Overall Study|Protocol Violation|3|||
163172244|NCT00869778|589345202|FG002|Overall Study|Protocol Violation|5|||
163172245|NCT00869778|589345200|FG000|Overall Study|Unblinding|1|||
163172246|NCT00869778|589345201|FG001|Overall Study|Unblinding|0|||
163172247|NCT00869778|589345202|FG002|Overall Study|Unblinding|0|||
163172248|NCT03531632|589345207|FG000|Overall Study|Adverse Event|0|||
163172249|NCT03531632|589345208|FG001|Overall Study|Adverse Event|0|||
163172250|NCT03531632|589345209|FG002|Overall Study|Adverse Event|1|||
163172251|NCT03531632|589345207|FG000|Overall Study|Death|4|||
163172252|NCT03531632|589345208|FG001|Overall Study|Death|0|||
163172253|NCT03531632|589345209|FG002|Overall Study|Death|14|||
163172254|NCT03531632|589345207|FG000|Overall Study|Study Terminated|1|||
163172255|NCT03531632|589345208|FG001|Overall Study|Study Terminated|3|||
162821672|NCT05975840|588059931|FG002|Overall Study|Migrated/moved from the study area|0|||
162821673|NCT05975840|588059932|FG003|Overall Study|Migrated/moved from the study area|0|||
162821674|NCT05975840|588059933|FG004|Overall Study|Migrated/moved from the study area|0|||
162821675|NCT05975840|588059934|FG005|Overall Study|Migrated/moved from the study area|0|||
162821676|NCT05975840|588059935|FG006|Overall Study|Migrated/moved from the study area|0|||
162821677|NCT05975840|588059936|FG007|Overall Study|Migrated/moved from the study area|0|||
162821678|NCT05975840|588059929|FG000|Overall Study|Withdrawal by Subject|0|||
162821679|NCT05975840|588059930|FG001|Overall Study|Withdrawal by Subject|5|||
162821680|NCT05975840|588059931|FG002|Overall Study|Withdrawal by Subject|2|||
162821681|NCT05975840|588059932|FG003|Overall Study|Withdrawal by Subject|2|||
162821682|NCT05975840|588059933|FG004|Overall Study|Withdrawal by Subject|0|||
162821683|NCT05975840|588059934|FG005|Overall Study|Withdrawal by Subject|2|||
162821684|NCT05975840|588059935|FG006|Overall Study|Withdrawal by Subject|2|||
162821685|NCT05975840|588059936|FG007|Overall Study|Withdrawal by Subject|1|||
162821686|NCT05975840|588059929|FG000|Overall Study|Protocol Violation|0|||
162821687|NCT05975840|588059930|FG001|Overall Study|Protocol Violation|1|||
162821688|NCT05975840|588059931|FG002|Overall Study|Protocol Violation|0|||
162821689|NCT05975840|588059932|FG003|Overall Study|Protocol Violation|0|||
162821690|NCT05975840|588059933|FG004|Overall Study|Protocol Violation|0|||
162821691|NCT05975840|588059934|FG005|Overall Study|Protocol Violation|0|||
162821692|NCT05975840|588059935|FG006|Overall Study|Protocol Violation|0|||
162821693|NCT05975840|588059936|FG007|Overall Study|Protocol Violation|0|||
162821694|NCT05975840|588059929|FG000|Overall Study|Adverse Event|0|||
162821695|NCT05975840|588059930|FG001|Overall Study|Adverse Event|0|||
162821696|NCT05975840|588059931|FG002|Overall Study|Adverse Event|0|||
162821697|NCT05975840|588059932|FG003|Overall Study|Adverse Event|1|||
162821698|NCT05975840|588059933|FG004|Overall Study|Adverse Event|0|||
162821699|NCT05975840|588059934|FG005|Overall Study|Adverse Event|0|||
162821700|NCT05975840|588059935|FG006|Overall Study|Adverse Event|0|||
162821701|NCT05975840|588059936|FG007|Overall Study|Adverse Event|0|||
162821702|NCT05975840|588059929|FG000|Overall Study|Death|0|||
162821703|NCT05975840|588059930|FG001|Overall Study|Death|1|||
162821704|NCT05975840|588059931|FG002|Overall Study|Death|0|||
162821705|NCT05975840|588059932|FG003|Overall Study|Death|0|||
162821706|NCT05975840|588059933|FG004|Overall Study|Death|0|||
162821707|NCT05975840|588059934|FG005|Overall Study|Death|0|||
162821708|NCT05975840|588059935|FG006|Overall Study|Death|0|||
162821709|NCT05975840|588059936|FG007|Overall Study|Death|1|||
162821710|NCT00232141|588059939|FG000|Overall Study|Adverse Event|9|||
162821711|NCT00232141|588059940|FG001|Overall Study|Adverse Event|4|||
162698417|NCT03881059|587605504|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
162821712|NCT00232141|588059939|FG000|Overall Study|Lack of Efficacy|0|||
162821713|NCT00232141|588059940|FG001|Overall Study|Lack of Efficacy|3|||
162821714|NCT00232141|588059939|FG000|Overall Study|Lost to Follow-up|9|||
162821715|NCT00232141|588059940|FG001|Overall Study|Lost to Follow-up|6|||
162821716|NCT00232141|588059939|FG000|Overall Study|Other|8|||
162821717|NCT00232141|588059940|FG001|Overall Study|Other|10|||
162821718|NCT00232141|588059939|FG000|Overall Study|Withdrawal by Subject|5|||
162821719|NCT00232141|588059940|FG001|Overall Study|Withdrawal by Subject|3|||
162821720|NCT00972777|588059943|FG000|Overall Study|Adverse Event|3|||
162821721|NCT00972777|588059944|FG001|Overall Study|Adverse Event|2|||
162821722|NCT00972777|588059943|FG000|Overall Study|Lost to Follow-up|0|||
162821723|NCT00972777|588059944|FG001|Overall Study|Lost to Follow-up|4|||
162821724|NCT00972777|588059943|FG000|Overall Study|Withdrawal by Subject|4|||
162821725|NCT00972777|588059944|FG001|Overall Study|Withdrawal by Subject|5|||
162821726|NCT00972777|588059943|FG000|Overall Study|Physician Decision|4|||
162821727|NCT00972777|588059944|FG001|Overall Study|Physician Decision|0|||
162821728|NCT00972777|588059943|FG000|Overall Study|Protocol Violation|0|||
162821729|NCT00972777|588059944|FG001|Overall Study|Protocol Violation|2|||
162821730|NCT00972777|588059943|FG000|Overall Study|Screening Failure|2|||
162821731|NCT00972777|588059944|FG001|Overall Study|Screening Failure|1|||
162821732|NCT00972777|588059943|FG000|Overall Study|Missed visit|1|||
162821733|NCT00972777|588059944|FG001|Overall Study|Missed visit|0|||
162821734|NCT06950879|588059945|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
162821735|NCT02229539|588061476|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
162821736|NCT02229539|588061477|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
162821737|NCT02229539|588061478|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
162821738|NCT02229539|588061476|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
162821739|NCT02229539|588061477|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
162821740|NCT02229539|588061478|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
162821741|NCT02229539|588061476|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
162821742|NCT02229539|588061477|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
162821743|NCT02229539|588061478|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
162821744|NCT02229539|588061476|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
162821745|NCT02229539|588061477|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
162821746|NCT02229539|588061478|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
162821747|NCT02229539|588061476|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
162821748|NCT02229539|588061477|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
162821749|NCT02229539|588061478|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
162821750|NCT02229539|588061476|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
162821751|NCT02229539|588061477|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
162821752|NCT02229539|588061478|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
162821753|NCT03441334|588061479|FG000|Overall Study|Withdrawal by Subject|1|||
162821754|NCT03441334|588061480|FG001|Overall Study|Withdrawal by Subject|0|||
162821755|NCT00088907|588061481|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
162821756|NCT00088907|588061482|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
162821757|NCT00088907|588061481|FG000|Randomized Study (Step 1)|Adverse Event|14|||
162821758|NCT00088907|588061482|FG001|Randomized Study (Step 1)|Adverse Event|19|||
162821759|NCT00088907|588061481|FG000|Randomized Study (Step 1)|Death|11|||
162821760|NCT00088907|588061482|FG001|Randomized Study (Step 1)|Death|12|||
162821761|NCT00088907|588061481|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
162821762|NCT00088907|588061482|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
162821763|NCT00088907|588061481|FG000|Randomized Study (Step 1)|complicating disease|3|||
162821764|NCT00088907|588061482|FG001|Randomized Study (Step 1)|complicating disease|1|||
162821765|NCT00088907|588061481|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
162821766|NCT00088907|588061482|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
162821767|NCT00088907|588061481|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
162821768|NCT00088907|588061482|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
162821769|NCT00088907|588061481|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
162821770|NCT00088907|588061482|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
162821771|NCT00088907|588061481|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
162821772|NCT00088907|588061482|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
162821773|NCT00088907|588061481|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
162821774|NCT00088907|588061482|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
162821775|NCT00088907|588061481|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
162821776|NCT00088907|588061482|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
162821777|NCT00682448|588061487|FG000|Overall Study|Adverse Event|1|||
162821778|NCT00682448|588061488|FG001|Overall Study|Adverse Event|2|||
162821779|NCT00682448|588061487|FG000|Overall Study|Lack of Efficacy|1|||
162821780|NCT00682448|588061488|FG001|Overall Study|Lack of Efficacy|0|||
162821781|NCT00682448|588061487|FG000|Overall Study|Lost to Follow-up|1|||
162821782|NCT00682448|588061488|FG001|Overall Study|Lost to Follow-up|3|||
163172256|NCT03531632|589345209|FG002|Overall Study|Study Terminated|11|||
163172257|NCT03051620|589345210|FG000|Overall Study|Lost to Follow-up|6|||
163172258|NCT03051620|589345210|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
163172259|NCT00393510|589345211|FG000|Overall Study|Physician Decision|3|||
163172260|NCT00393510|589345212|FG001|Overall Study|Physician Decision|9|||
163172261|NCT01534182|589345213|FG000|Overall Study|Administrative problems|1|||
163172262|NCT01534182|589345214|FG001|Overall Study|Administrative problems|0|||
163172263|NCT01534182|589345213|FG000|Overall Study|Withdrawal by Subject|4|||
163172264|NCT01534182|589345214|FG001|Overall Study|Withdrawal by Subject|7|||
163172265|NCT01534182|589345213|FG000|Overall Study|Adverse Event|7|||
163172266|NCT01534182|589345214|FG001|Overall Study|Adverse Event|3|||
163172267|NCT02412488|589345215|FG000|Overall Study|Lost to Follow-up|10|||
163172268|NCT02412488|589345215|FG000|Overall Study|Withdrawal by Subject|5|||
163172269|NCT02412488|589345215|FG000|Overall Study|Physician Decision|1|||
163172270|NCT02412488|589345215|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
163172271|NCT02412488|589345215|FG000|Overall Study|Reveal LINQ explant|1|||
163172272|NCT00674154|589345216|FG000|Overall Study|Withdrawal by Subject|3|||
163172273|NCT00674154|589345217|FG001|Overall Study|Withdrawal by Subject|1|||
163172274|NCT00674154|589345216|FG000|Overall Study|Did not want parathyroidectomy|0|||
163172275|NCT00674154|589345217|FG001|Overall Study|Did not want parathyroidectomy|2|||
163172276|NCT00816023|589345218|FG000|Overall Study|Lost to Follow-up|1|||
163172277|NCT00816023|589345219|FG001|Overall Study|Lost to Follow-up|1|||
163172278|NCT00816023|589345220|FG002|Overall Study|Lost to Follow-up|0|||
163172279|NCT00816023|589345221|FG003|Overall Study|Lost to Follow-up|0|||
163172280|NCT00816023|589345218|FG000|Overall Study|Withdrawal by Subject|1|||
163172281|NCT00816023|589345219|FG001|Overall Study|Withdrawal by Subject|0|||
163172282|NCT00816023|589345220|FG002|Overall Study|Withdrawal by Subject|0|||
163172283|NCT00816023|589345221|FG003|Overall Study|Withdrawal by Subject|0|||
163172284|NCT00816023|589345218|FG000|Overall Study|Physician Decision|0|||
163172285|NCT00816023|589345219|FG001|Overall Study|Physician Decision|0|||
163172286|NCT00816023|589345220|FG002|Overall Study|Physician Decision|1|||
163172287|NCT00816023|589345221|FG003|Overall Study|Physician Decision|0|||
163172288|NCT00816023|589345218|FG000|Overall Study|assessments complete prior to window|1|||
163172289|NCT00816023|589345219|FG001|Overall Study|assessments complete prior to window|1|||
163172290|NCT00816023|589345220|FG002|Overall Study|assessments complete prior to window|2|||
163172291|NCT00816023|589345221|FG003|Overall Study|assessments complete prior to window|1|||
163172292|NCT00816023|589345218|FG000|Overall Study|Randomized Not Treated|6|||
163172293|NCT00816023|589345219|FG001|Overall Study|Randomized Not Treated|4|||
163172294|NCT00816023|589345220|FG002|Overall Study|Randomized Not Treated|6|||
163172295|NCT00816023|589345221|FG003|Overall Study|Randomized Not Treated|11|||
163172296|NCT01616693|589345226|FG000|Evaluated for Safety|Physician Decision|1|||
163172297|NCT01616693|589345227|FG001|Evaluated for Safety|Physician Decision|0|||
163172298|NCT01616693|589345228|FG002|Evaluated for Safety|Physician Decision|1|||
163172299|NCT01616693|589345229|FG003|Evaluated for Safety|Physician Decision|0|||
163172300|NCT01616693|589345226|FG000|Received Both Vaccines|Adverse Event|2|||
163172301|NCT01616693|589345227|FG001|Received Both Vaccines|Adverse Event|0|||
163172302|NCT01616693|589345228|FG002|Received Both Vaccines|Adverse Event|0|||
163172303|NCT01616693|589345229|FG003|Received Both Vaccines|Adverse Event|0|||
163172304|NCT01616693|589345226|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
163172305|NCT01616693|589345227|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
163172306|NCT01616693|589345228|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
163172307|NCT01616693|589345229|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
163172308|NCT01616693|589345226|FG000|Received Both Vaccines|Lost to Follow-up|4|||
163172309|NCT01616693|589345227|FG001|Received Both Vaccines|Lost to Follow-up|3|||
162821783|NCT00682448|588061487|FG000|Overall Study|Pregnancy|0|||
162821784|NCT00682448|588061488|FG001|Overall Study|Pregnancy|1|||
162821785|NCT00682448|588061487|FG000|Overall Study|Withdrawal by Subject|2|||
162821786|NCT00682448|588061488|FG001|Overall Study|Withdrawal by Subject|0|||
162821787|NCT00268437|588061491|FG000|Overall Study|Ineligible|1|||
162821788|NCT01022996|588061492|FG000|Overall Study|Adverse Event|14|||
162821789|NCT01022996|588061492|FG000|Overall Study|Withdrawal by Subject|3|||
162821790|NCT01022996|588061492|FG000|Overall Study|Lost to Follow-up|1|||
162821791|NCT01022996|588061492|FG000|Overall Study|Administrative problems|6|||
162821792|NCT01022996|588061492|FG000|Overall Study|Disease Progression|32|||
163172310|NCT01616693|589345228|FG002|Received Both Vaccines|Lost to Follow-up|4|||
163172311|NCT01616693|589345229|FG003|Received Both Vaccines|Lost to Follow-up|4|||
163172312|NCT01616693|589345226|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
163172313|NCT01616693|589345227|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
163172314|NCT01616693|589345228|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
163172315|NCT01616693|589345229|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
163172316|NCT00441116|589345230|FG000|Overall Study|Adverse Event|1|||
163172317|NCT00441116|589345231|FG001|Overall Study|Adverse Event|1|||
163172318|NCT00441116|589345230|FG000|Overall Study|Withdrawal by Subject|1|||
163172319|NCT00441116|589345231|FG001|Overall Study|Withdrawal by Subject|0|||
162821793|NCT01022996|588061492|FG000|Overall Study|Protocol Violation|1|||
162821794|NCT02767323|588061493|FG000|Overall Study|Withdrawal by Subject|17|||
162821795|NCT02767323|588061494|FG001|Overall Study|Withdrawal by Subject|5|||
162821796|NCT02767323|588061495|FG002|Overall Study|Withdrawal by Subject|13|||
162821797|NCT02767323|588061496|FG003|Overall Study|Withdrawal by Subject|0|||
162821798|NCT02767323|588061493|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
162821799|NCT02767323|588061494|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
162821800|NCT02767323|588061495|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
162821801|NCT02767323|588061496|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
162821802|NCT00930722|588061497|FG000|Overall Study|Lost to Follow-up|16|||
162821803|NCT00930722|588061497|FG000|Overall Study|No longer willing to participate|9|||
162821804|NCT00930722|588061497|FG000|Overall Study|Study terminated by sponsor|2|||
162821805|NCT02023242|588061498|FG000|Overall Study|Lost to Follow-up|3|||
162821806|NCT02023242|588061499|FG001|Overall Study|Lost to Follow-up|1|||
162821807|NCT02023242|588061498|FG000|Overall Study|Death|0|||
162821808|NCT02023242|588061499|FG001|Overall Study|Death|1|||
162821809|NCT00710879|588061503|FG000|Overall Study|Lost to Follow-up|2|||
162821810|NCT00710879|588061504|FG001|Overall Study|Lost to Follow-up|1|||
162821811|NCT00710879|588061503|FG000|Overall Study|Protocol Violation|0|||
162821812|NCT00710879|588061504|FG001|Overall Study|Protocol Violation|3|||
162821813|NCT01809132|588061505|FG000|Overall Study|Withdrawal by Subject|0|||
162821814|NCT01809132|588061506|FG001|Overall Study|Withdrawal by Subject|0|||
162821815|NCT01809132|588061507|FG002|Overall Study|Withdrawal by Subject|1|||
162821816|NCT04854434|588061508|FG000|Overall Study|Death|1|||
162821817|NCT04854434|588061509|FG001|Overall Study|Death|3|||
162821818|NCT04854434|588061510|FG002|Overall Study|Death|4|||
162821819|NCT04854434|588061508|FG000|Overall Study|Study Terminated by Sponsor|2|||
162821820|NCT04854434|588061509|FG001|Overall Study|Study Terminated by Sponsor|0|||
162821821|NCT04854434|588061510|FG002|Overall Study|Study Terminated by Sponsor|0|||
162821822|NCT04854434|588061508|FG000|Overall Study|Other|1|||
162821823|NCT04854434|588061509|FG001|Overall Study|Other|1|||
162821824|NCT04854434|588061510|FG002|Overall Study|Other|0|||
162821825|NCT03349775|588061511|FG000|Overall Study|Side Effects|1|||
162821826|NCT03349775|588061512|FG001|Overall Study|Side Effects|2|||
162821827|NCT03349775|588061511|FG000|Overall Study|Withdrawal by Subject|1|||
162821828|NCT03349775|588061512|FG001|Overall Study|Withdrawal by Subject|1|||
162810585|NCT00887250|588018276|FG001|Overall Study|Withdrawal by Subject|1|||
162810586|NCT00887250|588018277|FG002|Overall Study|Withdrawal by Subject|2|||
162810587|NCT00887250|588018275|FG000|Overall Study|Patient uncooperative|0|||
162810588|NCT00887250|588018276|FG001|Overall Study|Patient uncooperative|0|||
162810589|NCT00887250|588018277|FG002|Overall Study|Patient uncooperative|1|||
162810590|NCT05754333|588018278|FG000|Overall Study|Miscellaneous|3|||
162810591|NCT05754333|588018279|FG001|Overall Study|Miscellaneous|0|||
162810592|NCT05754333|588018280|FG002|Overall Study|Miscellaneous|0|||
162810593|NCT05754333|588018281|FG003|Overall Study|Miscellaneous|0|||
162810594|NCT05754333|588018278|FG000|Overall Study|Lost to Follow-up|2|||
162810595|NCT05754333|588018279|FG001|Overall Study|Lost to Follow-up|1|||
162810596|NCT05754333|588018280|FG002|Overall Study|Lost to Follow-up|0|||
162810597|NCT05754333|588018281|FG003|Overall Study|Lost to Follow-up|1|||
162810598|NCT00440999|588018287|FG000|Overall Study|Adverse Event|0|||
162810599|NCT00440999|588018288|FG001|Overall Study|Adverse Event|2|||
162810600|NCT00440999|588018287|FG000|Overall Study|Lack of Efficacy|6|||
162810601|NCT00440999|588018288|FG001|Overall Study|Lack of Efficacy|7|||
162810602|NCT00440999|588018287|FG000|Overall Study|Lost to Follow-up|19|||
162810603|NCT00440999|588018288|FG001|Overall Study|Lost to Follow-up|12|||
162810604|NCT00440999|588018287|FG000|Overall Study|Protocol Violation|1|||
162810605|NCT00440999|588018288|FG001|Overall Study|Protocol Violation|0|||
162810606|NCT00440999|588018287|FG000|Overall Study|Withdrawal by Subject|2|||
162810607|NCT00440999|588018288|FG001|Overall Study|Withdrawal by Subject|5|||
162810608|NCT00440999|588018287|FG000|Overall Study|Subjets missed the visit|1|||
162810609|NCT00440999|588018288|FG001|Overall Study|Subjets missed the visit|0|||
162810610|NCT00440999|588018287|FG000|Overall Study|Mixed infection at entry|1|||
162810611|NCT00440999|588018288|FG001|Overall Study|Mixed infection at entry|0|||
162810612|NCT00440999|588018287|FG000|Overall Study|P. falciparum malaria|5|||
162810613|NCT00440999|588018288|FG001|Overall Study|P. falciparum malaria|14|||
162810614|NCT00440999|588018287|FG000|Overall Study|Subj left hosp without inform staff|0|||
162810615|NCT00440999|588018288|FG001|Overall Study|Subj left hosp without inform staff|1|||
162821829|NCT03349775|588061511|FG000|Overall Study|No primary outcome measurements|0|||
162821830|NCT03349775|588061512|FG001|Overall Study|No primary outcome measurements|1|||
162821831|NCT04479436|588061513|FG000|Overall Study|Progressive disease|26|||
162821832|NCT04479436|588061514|FG001|Overall Study|Progressive disease|1|||
162821833|NCT04479436|588061513|FG000|Overall Study|Adverse Event|6|||
162821834|NCT04479436|588061514|FG001|Overall Study|Adverse Event|0|||
162821835|NCT04479436|588061513|FG000|Overall Study|Withdrawal by Subject|5|||
162821836|NCT04479436|588061514|FG001|Overall Study|Withdrawal by Subject|0|||
162821837|NCT04479436|588061513|FG000|Overall Study|Clinical progression|1|||
162821838|NCT04479436|588061514|FG001|Overall Study|Clinical progression|0|||
162821839|NCT04479436|588061513|FG000|Overall Study|Physician Decision|1|||
162821840|NCT04479436|588061514|FG001|Overall Study|Physician Decision|0|||
162821841|NCT03383289|588061520|FG000|Overall Study|Death|83|||
162821842|NCT03383289|588061521|FG001|Overall Study|Death|78|||
162821843|NCT03383289|588061520|FG000|Overall Study|discharge from facility|84|||
162821844|NCT03383289|588061521|FG001|Overall Study|discharge from facility|84|||
162821845|NCT03383289|588061520|FG000|Overall Study|Withdrawal by Subject|4|||
162821846|NCT03383289|588061521|FG001|Overall Study|Withdrawal by Subject|1|||
162821847|NCT04439071|588061522|FG000|Overall Study|Lost to Follow-up|0|||
162821848|NCT04439071|588061523|FG001|Overall Study|Lost to Follow-up|3|||
162821849|NCT04439071|588061522|FG000|Overall Study|Withdrawal by Subject|3|||
162821850|NCT04439071|588061523|FG001|Overall Study|Withdrawal by Subject|8|||
162821851|NCT04439071|588061522|FG000|Overall Study|Death|6|||
162821852|NCT04439071|588061523|FG001|Overall Study|Death|4|||
162821853|NCT04439071|588061522|FG000|Overall Study|Other than specified|3|||
162821854|NCT04439071|588061523|FG001|Overall Study|Other than specified|3|||
162821855|NCT04439071|588061522|FG000|Overall Study|Randomized but not treated|2|||
162821856|NCT04439071|588061523|FG001|Overall Study|Randomized but not treated|0|||
162821857|NCT00832117|588061524|FG000|Overall Study|Death|1|||
162821858|NCT00832117|588061524|FG000|Overall Study|Disease Progression|11|||
162821859|NCT00892177|588061525|FG000|Phase II|Ineligible|0|||
162821860|NCT00892177|588061526|FG001|Phase II|Ineligible|0|||
162821861|NCT00892177|588061527|FG002|Phase II|Ineligible|0|||
162821862|NCT00892177|588061528|FG003|Phase II|Ineligible|0|||
162821863|NCT00892177|588061529|FG004|Phase II|Ineligible|1|||
162821864|NCT00892177|588061530|FG005|Phase II|Ineligible|1|||
162821865|NCT00892177|588061525|FG000|Phase II|Withdrawal by Subject|0|||
162821866|NCT00892177|588061526|FG001|Phase II|Withdrawal by Subject|0|||
162821867|NCT00892177|588061527|FG002|Phase II|Withdrawal by Subject|0|||
162821868|NCT00892177|588061528|FG003|Phase II|Withdrawal by Subject|0|||
162821869|NCT00892177|588061529|FG004|Phase II|Withdrawal by Subject|4|||
162821870|NCT00892177|588061530|FG005|Phase II|Withdrawal by Subject|1|||
162821871|NCT01011439|588061531|FG000|Overall Study|Death|37|||
162821872|NCT01011439|588061531|FG000|Overall Study|Lost to Follow-up|4|||
162821873|NCT01011439|588061531|FG000|Overall Study|Withdrawal by Subject|1|||
162821874|NCT01011439|588061531|FG000|Overall Study|Sponsor's decision|15|||
162821875|NCT01835015|588061532|FG000|Overall Study|Adverse Event|0|||
162821876|NCT01835015|588061533|FG001|Overall Study|Adverse Event|0|||
162821877|NCT01835015|588061534|FG002|Overall Study|Adverse Event|1|||
162821878|NCT01835015|588061535|FG003|Overall Study|Adverse Event|0|||
162821879|NCT01835015|588061536|FG004|Overall Study|Adverse Event|0|||
162821880|NCT00975715|588061540|FG000|Titration Period|Adverse Event|6|||
162821881|NCT00975715|588061541|FG001|Titration Period|Adverse Event|0|||
162821882|NCT00975715|588061540|FG000|Titration Period|Protocol Violation|1|||
162821883|NCT00975715|588061541|FG001|Titration Period|Protocol Violation|0|||
162821884|NCT00975715|588061540|FG000|Maintenance Period|Adverse Event|2|||
162821885|NCT00975715|588061541|FG001|Maintenance Period|Adverse Event|1|||
162821886|NCT01241552|588061545|FG000|Overall Study|Lack of Efficacy|1|||
162821887|NCT01241552|588061546|FG001|Overall Study|Lack of Efficacy|0|||
162821888|NCT01241552|588061547|FG002|Overall Study|Lack of Efficacy|0|||
162821889|NCT01241552|588061548|FG003|Overall Study|Lack of Efficacy|0|||
162821890|NCT01241552|588061545|FG000|Overall Study|Death|26|||
162821891|NCT01241552|588061546|FG001|Overall Study|Death|30|||
162821892|NCT01241552|588061547|FG002|Overall Study|Death|20|||
162821893|NCT01241552|588061548|FG003|Overall Study|Death|25|||
162821894|NCT01241552|588061545|FG000|Overall Study|Adverse Event|1|||
162821895|NCT01241552|588061546|FG001|Overall Study|Adverse Event|1|||
162821896|NCT01241552|588061547|FG002|Overall Study|Adverse Event|0|||
162821897|NCT01241552|588061548|FG003|Overall Study|Adverse Event|0|||
162821898|NCT01241552|588061545|FG000|Overall Study|Technical Problems|2|||
163172320|NCT00441116|589345230|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
163172321|NCT00441116|589345231|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
163172322|NCT02925338|589345232|FG000|Overall Study|Death|0|||
163172323|NCT02925338|589345233|FG001|Overall Study|Death|2|||
163172324|NCT02925338|589345234|FG002|Overall Study|Death|1|||
163172325|NCT02925338|589345235|FG003|Overall Study|Death|0|||
163172326|NCT02925338|589345236|FG004|Overall Study|Death|0|||
163172327|NCT02925338|589345232|FG000|Overall Study|Lost to Follow-up|30|||
163172328|NCT02925338|589345233|FG001|Overall Study|Lost to Follow-up|10|||
163172329|NCT02925338|589345234|FG002|Overall Study|Lost to Follow-up|1|||
163172330|NCT02925338|589345235|FG003|Overall Study|Lost to Follow-up|16|||
163172331|NCT02925338|589345236|FG004|Overall Study|Lost to Follow-up|3|||
163172332|NCT02925338|589345232|FG000|Overall Study|Withdrawal by Subject|3|||
163172333|NCT02925338|589345233|FG001|Overall Study|Withdrawal by Subject|0|||
163172334|NCT02925338|589345234|FG002|Overall Study|Withdrawal by Subject|3|||
163172335|NCT02925338|589345235|FG003|Overall Study|Withdrawal by Subject|2|||
163172336|NCT02925338|589345236|FG004|Overall Study|Withdrawal by Subject|2|||
163172337|NCT02925338|589345232|FG000|Overall Study|Missing|38|||
163172338|NCT02925338|589345233|FG001|Overall Study|Missing|27|||
163172339|NCT02925338|589345234|FG002|Overall Study|Missing|0|||
163172340|NCT02925338|589345235|FG003|Overall Study|Missing|3|||
163172341|NCT02925338|589345236|FG004|Overall Study|Missing|2|||
162821899|NCT01241552|588061546|FG001|Overall Study|Technical Problems|0|||
162821900|NCT01241552|588061547|FG002|Overall Study|Technical Problems|2|||
162821901|NCT01241552|588061548|FG003|Overall Study|Technical Problems|2|||
162821902|NCT01241552|588061545|FG000|Overall Study|Progressive Disease|0|||
162821903|NCT01241552|588061546|FG001|Overall Study|Progressive Disease|0|||
162821904|NCT01241552|588061547|FG002|Overall Study|Progressive Disease|1|||
162821905|NCT01241552|588061548|FG003|Overall Study|Progressive Disease|2|||
162821906|NCT01241552|588061545|FG000|Overall Study|Protocol Violation|0|||
162821907|NCT01241552|588061546|FG001|Overall Study|Protocol Violation|2|||
162821908|NCT01241552|588061547|FG002|Overall Study|Protocol Violation|6|||
162821909|NCT01241552|588061548|FG003|Overall Study|Protocol Violation|1|||
162821910|NCT01241552|588061545|FG000|Overall Study|Withdrawal by Subject|7|||
162821911|NCT01241552|588061546|FG001|Overall Study|Withdrawal by Subject|15|||
162821912|NCT01241552|588061547|FG002|Overall Study|Withdrawal by Subject|14|||
162821913|NCT01241552|588061548|FG003|Overall Study|Withdrawal by Subject|15|||
162821914|NCT01241552|588061545|FG000|Overall Study|Physician Decision|2|||
162821915|NCT01241552|588061546|FG001|Overall Study|Physician Decision|4|||
162821916|NCT01241552|588061547|FG002|Overall Study|Physician Decision|2|||
162821917|NCT01241552|588061548|FG003|Overall Study|Physician Decision|3|||
162821918|NCT01241552|588061545|FG000|Overall Study|Lost to Follow-up|2|||
162821919|NCT01241552|588061546|FG001|Overall Study|Lost to Follow-up|11|||
162821920|NCT01241552|588061547|FG002|Overall Study|Lost to Follow-up|15|||
162821921|NCT01241552|588061548|FG003|Overall Study|Lost to Follow-up|16|||
162821922|NCT04004429|588061549|FG000|Overall Study|Protocol Violation|1|||
162821923|NCT04004429|588061550|FG001|Overall Study|Protocol Violation|0|||
162821924|NCT04004429|588061551|FG002|Overall Study|Protocol Violation|0|||
162821925|NCT04004429|588061549|FG000|Overall Study|Physician Decision|0|||
162821926|NCT04004429|588061550|FG001|Overall Study|Physician Decision|1|||
162821927|NCT04004429|588061551|FG002|Overall Study|Physician Decision|1|||
162821928|NCT04004429|588061549|FG000|Overall Study|Withdrawal by Subject|1|||
162821929|NCT04004429|588061550|FG001|Overall Study|Withdrawal by Subject|1|||
162821930|NCT04004429|588061551|FG002|Overall Study|Withdrawal by Subject|1|||
162821931|NCT02606461|588061552|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
162821932|NCT02606461|588061553|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
162821933|NCT02606461|588061554|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
162821934|NCT02606461|588061555|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
162821935|NCT02606461|588061556|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
162821936|NCT02606461|588061557|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
162821937|NCT00239226|588061558|FG000|Overall Study|permAF during stabilization period|0|||
162821938|NCT00239226|588061559|FG001|Overall Study|permAF during stabilization period|0|||
162821939|NCT00239226|588061560|FG002|Overall Study|permAF during stabilization period|0|||
162821940|NCT00239226|588061561|FG003|Overall Study|permAF during stabilization period|3|||
162821941|NCT00239226|588061558|FG000|Overall Study|Lost to Follow-up|1|||
162821942|NCT00239226|588061559|FG001|Overall Study|Lost to Follow-up|0|||
162821943|NCT00239226|588061560|FG002|Overall Study|Lost to Follow-up|1|||
162821944|NCT00239226|588061561|FG003|Overall Study|Lost to Follow-up|0|||
162821945|NCT04060563|588061565|FG000|Overall Study|Lost to Follow-up|1|||
162821946|NCT04060563|588061566|FG001|Overall Study|Lost to Follow-up|1|||
162821947|NCT04060563|588061565|FG000|Overall Study|Physician Decision|0|||
163172342|NCT02925338|589345232|FG000|Overall Study|Participant's Decision|11|||
163172343|NCT02925338|589345233|FG001|Overall Study|Participant's Decision|7|||
162821948|NCT04060563|588061566|FG001|Overall Study|Physician Decision|1|||
163172344|NCT02925338|589345234|FG002|Overall Study|Participant's Decision|3|||
163172345|NCT02925338|589345235|FG003|Overall Study|Participant's Decision|8|||
162821949|NCT00851682|588061567|FG000|Overall Study|screen failure|5|||
162821950|NCT00851682|588061568|FG001|Overall Study|screen failure|0|||
162821951|NCT01379573|588061572|FG000|Overall Study|Lost to Follow-up|1|||
162821952|NCT01379573|588061572|FG000|Overall Study|Screen Failure|10|||
162821953|NCT01829425|588061583|FG000|Overall Study|Withdrawal by Subject|4|||
162821954|NCT01829425|588061584|FG001|Overall Study|Withdrawal by Subject|3|||
162821955|NCT01829425|588061583|FG000|Overall Study|Lost to Follow-up|2|||
162821956|NCT01829425|588061584|FG001|Overall Study|Lost to Follow-up|1|||
162821957|NCT03681951|588061585|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
162821958|NCT03681951|588061586|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821959|NCT03681951|588061587|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821960|NCT03681951|588061588|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821961|NCT03681951|588061589|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821962|NCT03681951|588061590|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821963|NCT03681951|588061591|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821964|NCT03681951|588061592|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
162821965|NCT03681951|588061585|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
162821966|NCT03681951|588061586|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821967|NCT03681951|588061587|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821968|NCT03681951|588061588|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821969|NCT03681951|588061589|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821970|NCT03681951|588061590|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821971|NCT03681951|588061591|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821972|NCT03681951|588061592|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
162821973|NCT03681951|588061585|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
162821974|NCT03681951|588061586|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821975|NCT03681951|588061587|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821976|NCT03681951|588061588|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821977|NCT03681951|588061589|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821978|NCT03681951|588061590|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821979|NCT03681951|588061591|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821980|NCT03681951|588061592|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
162821981|NCT01020448|588061593|FG000|Pre-assignment|Adverse Event|6|||
162821982|NCT01020448|588061593|FG000|Pre-assignment|Withdrawal by Subject|5|||
162821983|NCT01020448|588061593|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
162821984|NCT01020448|588061593|FG000|Treatment|Adverse Event|11|||
162821985|NCT01020448|588061593|FG000|Treatment|Consent Withdrawn|3|||
162821986|NCT01020448|588061593|FG000|Treatment|Disease Progression|2|||
162821987|NCT01020448|588061593|FG000|Treatment|Lack of Efficacy|8|||
162821988|NCT01020448|588061593|FG000|Treatment|Lost to Follow-up|2|||
162821989|NCT01390272|588061604|FG000|Overall Study|Death|3|||
162821990|NCT01390272|588061605|FG001|Overall Study|Death|2|||
162821991|NCT01390272|588061604|FG000|Overall Study|Withdrawal by Subject|9|||
162821992|NCT01390272|588061605|FG001|Overall Study|Withdrawal by Subject|5|||
163172346|NCT02925338|589345236|FG004|Overall Study|Participant's Decision|1|||
163172347|NCT02925338|589345232|FG000|Overall Study|Treatment Discontinuation|144|||
163172348|NCT02925338|589345233|FG001|Overall Study|Treatment Discontinuation|65|||
163172349|NCT02925338|589345234|FG002|Overall Study|Treatment Discontinuation|56|||
163172350|NCT02925338|589345235|FG003|Overall Study|Treatment Discontinuation|131|||
163172351|NCT02925338|589345236|FG004|Overall Study|Treatment Discontinuation|22|||
163172352|NCT01008423|589345241|FG000|Overall Study|Adverse Event|13|||
163172353|NCT01008423|589345242|FG001|Overall Study|Adverse Event|6|||
163172354|NCT01008423|589345241|FG000|Overall Study|Withdrawal by Subject|4|||
163172355|NCT01008423|589345242|FG001|Overall Study|Withdrawal by Subject|7|||
163172356|NCT01008423|589345241|FG000|Overall Study|Lost to Follow-up|0|||
163172357|NCT01008423|589345242|FG001|Overall Study|Lost to Follow-up|2|||
163172358|NCT01008423|589345241|FG000|Overall Study|Low Cortisol|0|||
163172359|NCT01008423|589345242|FG001|Overall Study|Low Cortisol|1|||
163172360|NCT01008423|589345241|FG000|Overall Study|Lack of Efficacy|0|||
163172361|NCT01008423|589345242|FG001|Overall Study|Lack of Efficacy|5|||
163172362|NCT01008423|589345241|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
163172363|NCT01008423|589345242|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
162821993|NCT01390272|588061604|FG000|Overall Study|Patient moved, no longer eligible|5|||
162821994|NCT01390272|588061605|FG001|Overall Study|Patient moved, no longer eligible|8|||
162821995|NCT00590044|588061606|FG000|Overall Study|Withdrawal by Subject|2|||
163172364|NCT01008423|589345241|FG000|Overall Study|Personal Conflict|1|||
163172365|NCT01008423|589345242|FG001|Overall Study|Personal Conflict|0|||
162929560|NCT04682639|588447388|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
163172366|NCT01008423|589345241|FG000|Overall Study|Other|0|||
163172367|NCT01008423|589345242|FG001|Overall Study|Other|1|||
163172368|NCT02034409|589345244|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
163172369|NCT02034409|589345245|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
162821996|NCT00590044|588061607|FG001|Overall Study|Withdrawal by Subject|2|||
162821997|NCT00590044|588061606|FG000|Overall Study|wrong insulin arm assigned|1|||
162821998|NCT00590044|588061607|FG001|Overall Study|wrong insulin arm assigned|0|||
162821999|NCT00590044|588061606|FG000|Overall Study|Protocol Violation|1|||
163172370|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
163172371|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
163172372|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
163172373|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
163172374|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
163172375|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
163172376|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
163172377|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
163172378|NCT02034409|589345244|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
163172379|NCT02034409|589345245|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
163172380|NCT02342418|589345246|FG000|Overall Study|Adverse Event|0|||
163172381|NCT02342418|589345247|FG001|Overall Study|Adverse Event|1|||
163172382|NCT01699867|589345248|FG000|Overall Study|Screening Failure|3|||
163172383|NCT04255394|589345249|FG000|Overall Study|Death|35|||
163172384|NCT04255394|589345250|FG001|Overall Study|Death|25|||
162822000|NCT00590044|588061607|FG001|Overall Study|Protocol Violation|0|||
162822001|NCT01514136|588061608|FG000|Test Period 1; Test A|Protocol Violation|1|||
162822002|NCT01514136|588061609|FG001|Test Period 1; Test A|Protocol Violation|0|||
162822003|NCT01514136|588061610|FG002|Test Period 1; Test A|Protocol Violation|0|||
162822004|NCT01514136|588061611|FG003|Test Period 1; Test A|Protocol Violation|0|||
162822005|NCT01514136|588061612|FG004|Test Period 1; Test A|Protocol Violation|0|||
162822006|NCT01514136|588061613|FG005|Test Period 1; Test A|Protocol Violation|0|||
162822007|NCT01514136|588061614|FG006|Test Period 1; Test A|Protocol Violation|0|||
162822008|NCT01514136|588061615|FG007|Test Period 1; Test A|Protocol Violation|0|||
162822009|NCT01514136|588061608|FG000|Test Period 1; Test A|Break from study holiday|2|||
162822010|NCT01514136|588061609|FG001|Test Period 1; Test A|Break from study holiday|0|||
162822011|NCT01514136|588061610|FG002|Test Period 1; Test A|Break from study holiday|0|||
162822012|NCT01514136|588061611|FG003|Test Period 1; Test A|Break from study holiday|0|||
162822013|NCT01514136|588061612|FG004|Test Period 1; Test A|Break from study holiday|0|||
162822014|NCT01514136|588061613|FG005|Test Period 1; Test A|Break from study holiday|0|||
162822015|NCT01514136|588061614|FG006|Test Period 1; Test A|Break from study holiday|0|||
162822016|NCT01514136|588061615|FG007|Test Period 1; Test A|Break from study holiday|0|||
162822017|NCT01514136|588061608|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
162822018|NCT01514136|588061609|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
162822019|NCT01514136|588061610|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
162822020|NCT01514136|588061611|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
162822021|NCT01514136|588061612|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
162822022|NCT01514136|588061613|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
162822023|NCT01514136|588061614|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
162822024|NCT01514136|588061615|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
162822025|NCT01514136|588061608|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822026|NCT01514136|588061609|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822027|NCT01514136|588061610|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822028|NCT01514136|588061611|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
162822029|NCT01514136|588061612|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822030|NCT01514136|588061613|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822031|NCT01514136|588061614|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822032|NCT01514136|588061615|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
162822033|NCT01514136|588061608|FG000|Test Period 2; Test A*|Adverse Event|0|||
162822034|NCT01514136|588061609|FG001|Test Period 2; Test A*|Adverse Event|0|||
162822035|NCT01514136|588061610|FG002|Test Period 2; Test A*|Adverse Event|0|||
162822036|NCT01514136|588061611|FG003|Test Period 2; Test A*|Adverse Event|0|||
162822037|NCT01514136|588061612|FG004|Test Period 2; Test A*|Adverse Event|1|||
162822038|NCT01514136|588061613|FG005|Test Period 2; Test A*|Adverse Event|0|||
162822039|NCT01514136|588061614|FG006|Test Period 2; Test A*|Adverse Event|0|||
162822040|NCT01514136|588061615|FG007|Test Period 2; Test A*|Adverse Event|0|||
162822041|NCT01514136|588061608|FG000|Test Period 2; Test A*|Holiday|0|||
162822042|NCT01514136|588061609|FG001|Test Period 2; Test A*|Holiday|0|||
162822043|NCT01514136|588061610|FG002|Test Period 2; Test A*|Holiday|0|||
162822044|NCT01514136|588061611|FG003|Test Period 2; Test A*|Holiday|0|||
162822045|NCT01514136|588061612|FG004|Test Period 2; Test A*|Holiday|1|||
162822046|NCT01514136|588061613|FG005|Test Period 2; Test A*|Holiday|0|||
162822047|NCT01514136|588061614|FG006|Test Period 2; Test A*|Holiday|0|||
162822048|NCT01514136|588061615|FG007|Test Period 2; Test A*|Holiday|0|||
163172385|NCT04255394|589345249|FG000|Overall Study|Device removed|2|||
162822049|NCT01514136|588061608|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822050|NCT01514136|588061609|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
163172386|NCT04255394|589345250|FG001|Overall Study|Device removed|10|||
163172387|NCT04255394|589345249|FG000|Overall Study|Withdrawal by Subject|9|||
162822051|NCT01514136|588061610|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822052|NCT01514136|588061611|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822053|NCT01514136|588061612|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822054|NCT01514136|588061613|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
162822055|NCT01514136|588061614|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822056|NCT01514136|588061615|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
162822057|NCT01514136|588061608|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822058|NCT01514136|588061609|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822059|NCT01514136|588061610|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822060|NCT01514136|588061611|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822061|NCT01514136|588061612|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822062|NCT01514136|588061613|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822063|NCT01514136|588061614|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
162822064|NCT01514136|588061615|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
162822065|NCT01514136|588061608|FG000|Test Period 2; Test C*|holiday|0|||
162822066|NCT01514136|588061609|FG001|Test Period 2; Test C*|holiday|0|||
162822067|NCT01514136|588061610|FG002|Test Period 2; Test C*|holiday|0|||
162822068|NCT01514136|588061611|FG003|Test Period 2; Test C*|holiday|0|||
162822069|NCT01514136|588061612|FG004|Test Period 2; Test C*|holiday|0|||
162822070|NCT01514136|588061613|FG005|Test Period 2; Test C*|holiday|0|||
162822071|NCT01514136|588061614|FG006|Test Period 2; Test C*|holiday|1|||
163172388|NCT04255394|589345250|FG001|Overall Study|Withdrawal by Subject|8|||
163172389|NCT04255394|589345249|FG000|Overall Study|Screen Failure/Not treated|12|||
162822072|NCT01514136|588061615|FG007|Test Period 2; Test C*|holiday|0|||
162822073|NCT01514136|588061608|FG000|Test Period 2; Test C*|Protocol Violation|0|||
162822074|NCT01514136|588061609|FG001|Test Period 2; Test C*|Protocol Violation|0|||
162822075|NCT01514136|588061610|FG002|Test Period 2; Test C*|Protocol Violation|0|||
163172390|NCT04255394|589345250|FG001|Overall Study|Screen Failure/Not treated|8|||
163172391|NCT04255394|589345249|FG000|Overall Study|Lost to Follow-up|123|||
163172392|NCT04255394|589345250|FG001|Overall Study|Lost to Follow-up|265|||
163172393|NCT04255394|589345249|FG000|Overall Study|Adverse Event|1|||
163172394|NCT04255394|589345250|FG001|Overall Study|Adverse Event|3|||
163172395|NCT00831493|589345255|FG000|Overall Study|Intractable nausea and vomiting|1|||
163172396|NCT00835731|589345258|FG000|Overall Study|Withdrawal by Subject|1|||
163172397|NCT00835731|589345259|FG001|Overall Study|Withdrawal by Subject|0|||
163172398|NCT00835731|589345258|FG000|Overall Study|Physician Decision|1|||
163172399|NCT00835731|589345259|FG001|Overall Study|Physician Decision|1|||
163172400|NCT00348881|589345260|FG000|Overall Study|Lost to Follow-up|12|||
163172401|NCT00348881|589345261|FG001|Overall Study|Lost to Follow-up|6|||
163172402|NCT00348881|589345260|FG000|Overall Study|Withdrawal by Subject|3|||
163172403|NCT00348881|589345261|FG001|Overall Study|Withdrawal by Subject|4|||
163172404|NCT00348881|589345260|FG000|Overall Study|Adverse Event|2|||
163172405|NCT00348881|589345261|FG001|Overall Study|Adverse Event|0|||
163172406|NCT00348881|589345260|FG000|Overall Study|Serious Adverse Event|0|||
163172407|NCT00348881|589345261|FG001|Overall Study|Serious Adverse Event|2|||
163172408|NCT01525225|589345271|FG000|Enrollment|No longer met study criteria|1|||
163172409|NCT01525225|589345271|FG000|Enrollment|Other|1|||
163172410|NCT01182844|589345272|FG000|Overall Study|Withdrawal by Subject|0|||
163172411|NCT01182844|589345273|FG001|Overall Study|Withdrawal by Subject|2|||
163172412|NCT01379508|589345274|FG000|Treatment to Week 104|Adverse Event|2|||
163172413|NCT01379508|589345275|FG001|Treatment to Week 104|Adverse Event|0|||
163172414|NCT01379508|589345276|FG002|Treatment to Week 104|Adverse Event|5|||
163172415|NCT01379508|589345277|FG003|Treatment to Week 104|Adverse Event|0|||
163172416|NCT01379508|589345274|FG000|Treatment to Week 104|Abnormal lab value|1|||
163172417|NCT01379508|589345275|FG001|Treatment to Week 104|Abnormal lab value|0|||
163172418|NCT01379508|589345276|FG002|Treatment to Week 104|Abnormal lab value|0|||
163172419|NCT01379508|589345277|FG003|Treatment to Week 104|Abnormal lab value|0|||
163172420|NCT01379508|589345274|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
163172421|NCT01379508|589345275|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172422|NCT01379508|589345276|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172423|NCT01379508|589345277|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
163172424|NCT01379508|589345274|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
163172425|NCT01379508|589345275|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
162698418|NCT03881059|587605505|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
162822076|NCT01514136|588061611|FG003|Test Period 2; Test C*|Protocol Violation|0|||
162822077|NCT01514136|588061612|FG004|Test Period 2; Test C*|Protocol Violation|0|||
162822078|NCT01514136|588061613|FG005|Test Period 2; Test C*|Protocol Violation|0|||
162822079|NCT01514136|588061614|FG006|Test Period 2; Test C*|Protocol Violation|1|||
163172426|NCT01379508|589345276|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
163172427|NCT01379508|589345277|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
163172428|NCT01379508|589345274|FG000|Treatment to Week 104|Lost to Follow-up|5|||
163172429|NCT01379508|589345275|FG001|Treatment to Week 104|Lost to Follow-up|0|||
163172430|NCT01379508|589345276|FG002|Treatment to Week 104|Lost to Follow-up|3|||
163172431|NCT01379508|589345277|FG003|Treatment to Week 104|Lost to Follow-up|0|||
162822080|NCT01514136|588061615|FG007|Test Period 2; Test C*|Protocol Violation|0|||
162822081|NCT02729740|588061616|FG000|Overall Study|Early Termination|130|||
162822082|NCT02729740|588061616|FG000|Overall Study|Other|1|||
162822083|NCT00757003|588061620|FG000|Overall Study|Death|33|||
162822084|NCT00757003|588061620|FG000|Overall Study|Lost to Follow-up|9|||
162822085|NCT00757003|588061620|FG000|Overall Study|Withdrawal by Subject|4|||
162822086|NCT00757003|588061620|FG000|Overall Study|Surgically explanted|2|||
162822087|NCT00757003|588061620|FG000|Overall Study|Not implanted|1|||
162822088|NCT03044249|588061623|FG000|Overall Study|Adverse Event|4|||
162822089|NCT03044249|588061624|FG001|Overall Study|Adverse Event|9|||
162822090|NCT03044249|588061623|FG000|Overall Study|Lost to Follow-up|1|||
162822091|NCT03044249|588061624|FG001|Overall Study|Lost to Follow-up|0|||
162822092|NCT03044249|588061623|FG000|Overall Study|Non-compliance with Study Drug|1|||
162822093|NCT03044249|588061624|FG001|Overall Study|Non-compliance with Study Drug|0|||
162822094|NCT03044249|588061623|FG000|Overall Study|Study Terminated by Sponsor|2|||
162822095|NCT03044249|588061624|FG001|Overall Study|Study Terminated by Sponsor|0|||
162822096|NCT03044249|588061623|FG000|Overall Study|Withdrawal by Subject|2|||
162822097|NCT03044249|588061624|FG001|Overall Study|Withdrawal by Subject|5|||
162822098|NCT02301936|588061626|FG000|Overall Study|Lost to Follow-up|1|||
162822099|NCT02301936|588061627|FG001|Overall Study|Lost to Follow-up|0|||
162822100|NCT00601250|588061632|FG000|Overall Study|Adverse Event|3|||
162822101|NCT00601250|588061633|FG001|Overall Study|Adverse Event|9|||
162822102|NCT00601250|588061632|FG000|Overall Study|Protocol Violation|3|||
162822103|NCT00601250|588061633|FG001|Overall Study|Protocol Violation|2|||
162822104|NCT00601250|588061632|FG000|Overall Study|Lost to Follow-up|2|||
162822105|NCT00601250|588061633|FG001|Overall Study|Lost to Follow-up|6|||
162822106|NCT00601250|588061632|FG000|Overall Study|Withdrawal by Subject|4|||
162822107|NCT00601250|588061633|FG001|Overall Study|Withdrawal by Subject|13|||
162822108|NCT00601250|588061632|FG000|Overall Study|Other incl. lack of efficacy|2|||
162822109|NCT00601250|588061633|FG001|Overall Study|Other incl. lack of efficacy|9|||
162822110|NCT01810016|588061634|FG000|Overall Study|Progressive disease|1|||
162822111|NCT01810016|588061635|FG001|Overall Study|Progressive disease|1|||
162822112|NCT01810016|588061636|FG002|Overall Study|Progressive disease|0|||
162822113|NCT01810016|588061634|FG000|Overall Study|Death|0|||
162822114|NCT01810016|588061635|FG001|Overall Study|Death|0|||
162822115|NCT01810016|588061636|FG002|Overall Study|Death|1|||
162822116|NCT04263896|588061638|FG000|Overall Study|Withdrawal by Subject|2|||
162822117|NCT04263896|588061639|FG001|Overall Study|Withdrawal by Subject|4|||
162822118|NCT04263896|588061638|FG000|Overall Study|converted to open procedure|0|||
162822119|NCT04263896|588061639|FG001|Overall Study|converted to open procedure|1|||
162822120|NCT04263896|588061638|FG000|Overall Study|Lost to Follow-up|9|||
162822121|NCT04263896|588061639|FG001|Overall Study|Lost to Follow-up|11|||
163172432|NCT01379508|589345274|FG000|Treatment to Week 104|Administrative problems|3|||
163172433|NCT01379508|589345275|FG001|Treatment to Week 104|Administrative problems|1|||
163172434|NCT01379508|589345276|FG002|Treatment to Week 104|Administrative problems|0|||
163172435|NCT01379508|589345277|FG003|Treatment to Week 104|Administrative problems|0|||
163172436|NCT01379508|589345274|FG000|Treatment to Week 104|Protocol Violation|1|||
163172437|NCT01379508|589345275|FG001|Treatment to Week 104|Protocol Violation|1|||
163172438|NCT01379508|589345276|FG002|Treatment to Week 104|Protocol Violation|1|||
163172439|NCT01379508|589345277|FG003|Treatment to Week 104|Protocol Violation|0|||
163172440|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
163172441|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
163172442|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
163172443|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
163172444|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
163172445|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
163172446|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
163172447|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
163172448|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
163172449|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
163172450|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
162822122|NCT04263896|588061638|FG000|Overall Study|surveys lost in mail|5|||
162822123|NCT04263896|588061639|FG001|Overall Study|surveys lost in mail|3|||
162822124|NCT04263896|588061638|FG000|Overall Study|excluded from analysis|1|||
162822125|NCT04263896|588061639|FG001|Overall Study|excluded from analysis|0|||
162822126|NCT04050670|588063083|FG000|Period 3|Physician Decision|0|||
162822127|NCT04050670|588063084|FG001|Period 3|Physician Decision|1|||
162822128|NCT04050670|588063085|FG002|Period 3|Physician Decision|0|||
162822129|NCT02553265|588063086|FG000|Enrollment|Death|0|||
162822130|NCT02553265|588063087|FG001|Enrollment|Death|0|||
162822131|NCT02553265|588063088|FG002|Enrollment|Death|1|||
162822132|NCT02553265|588063086|FG000|First Intervention (28 Days)|Adverse Event|1|||
162822133|NCT02553265|588063087|FG001|First Intervention (28 Days)|Adverse Event|0|||
163172451|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
163172452|NCT01379508|589345274|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
162822134|NCT02553265|588063088|FG002|First Intervention (28 Days)|Adverse Event|0|||
162822135|NCT02553265|588063086|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
162822136|NCT02553265|588063087|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
162822137|NCT02553265|588063088|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
162822138|NCT02553265|588063086|FG000|Second Intervention (28 Days)|Adverse Event|1|||
162822139|NCT02553265|588063087|FG001|Second Intervention (28 Days)|Adverse Event|0|||
162822140|NCT02553265|588063088|FG002|Second Intervention (28 Days)|Adverse Event|0|||
162822141|NCT02553265|588063086|FG000|Third Intervention (28 Days)|Adverse Event|1|||
162822142|NCT02553265|588063087|FG001|Third Intervention (28 Days)|Adverse Event|0|||
162822143|NCT02553265|588063088|FG002|Third Intervention (28 Days)|Adverse Event|0|||
162822144|NCT02553265|588063086|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
162822145|NCT02553265|588063087|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
162822146|NCT02553265|588063088|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
162822147|NCT00659529|588063090|FG000|Overall Study|Withdrawal by Subject|4|||
162822148|NCT00659529|588063090|FG000|Overall Study|Protocol Violation|3|||
162822149|NCT00659529|588063090|FG000|Overall Study|Screen failure|9|||
162822150|NCT00880555|588063093|FG000|Overall Study|Physician Decision|0|||
162822151|NCT00880555|588063094|FG001|Overall Study|Physician Decision|8|||
162822152|NCT00880555|588063095|FG002|Overall Study|Physician Decision|0|||
162822153|NCT00880555|588063096|FG003|Overall Study|Physician Decision|2|||
162822154|NCT00880555|588063097|FG004|Overall Study|Physician Decision|1|||
162822155|NCT00880555|588063098|FG005|Overall Study|Physician Decision|0|||
162822156|NCT00880555|588063093|FG000|Overall Study|Withdrawal by Subject|1|||
162822157|NCT00880555|588063094|FG001|Overall Study|Withdrawal by Subject|1|||
162822158|NCT00880555|588063095|FG002|Overall Study|Withdrawal by Subject|0|||
162822159|NCT00880555|588063096|FG003|Overall Study|Withdrawal by Subject|0|||
162822160|NCT00880555|588063097|FG004|Overall Study|Withdrawal by Subject|0|||
162822161|NCT00880555|588063098|FG005|Overall Study|Withdrawal by Subject|0|||
162822162|NCT00880555|588063093|FG000|Overall Study|Lack of resources (hired rater)|9|||
162822163|NCT00880555|588063094|FG001|Overall Study|Lack of resources (hired rater)|7|||
162822164|NCT00880555|588063095|FG002|Overall Study|Lack of resources (hired rater)|5|||
162822165|NCT00880555|588063096|FG003|Overall Study|Lack of resources (hired rater)|0|||
162822166|NCT00880555|588063097|FG004|Overall Study|Lack of resources (hired rater)|0|||
162822167|NCT00880555|588063098|FG005|Overall Study|Lack of resources (hired rater)|0|||
162822168|NCT00880555|588063093|FG000|Overall Study|Death|0|||
162822169|NCT00880555|588063094|FG001|Overall Study|Death|0|||
162822170|NCT00880555|588063095|FG002|Overall Study|Death|0|||
162822171|NCT00880555|588063096|FG003|Overall Study|Death|0|||
162822172|NCT00880555|588063097|FG004|Overall Study|Death|0|||
162822173|NCT00880555|588063098|FG005|Overall Study|Death|1|||
162822174|NCT00880555|588063093|FG000|Overall Study|Lost to Follow-up|0|||
162822175|NCT00880555|588063094|FG001|Overall Study|Lost to Follow-up|1|||
162822176|NCT00880555|588063095|FG002|Overall Study|Lost to Follow-up|0|||
162822177|NCT00880555|588063096|FG003|Overall Study|Lost to Follow-up|0|||
162822178|NCT00880555|588063097|FG004|Overall Study|Lost to Follow-up|0|||
162822179|NCT00880555|588063098|FG005|Overall Study|Lost to Follow-up|0|||
162822180|NCT04196803|588063100|FG000|Overall Study|Withdrawal by Subject|1|||
163172453|NCT01379508|589345275|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
163172454|NCT01379508|589345276|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
163172455|NCT01379508|589345277|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
163172456|NCT03952039|589345280|FG000|Overall Study|Adverse Event|22|||
163172457|NCT03952039|589345281|FG001|Overall Study|Adverse Event|8|||
163172458|NCT03952039|589345280|FG000|Overall Study|Withdrawal by Participant|17|||
163172459|NCT03952039|589345281|FG001|Overall Study|Withdrawal by Participant|12|||
163172460|NCT03952039|589345280|FG000|Overall Study|Death|13|||
163172461|NCT03952039|589345281|FG001|Overall Study|Death|6|||
163172462|NCT03952039|589345280|FG000|Overall Study|Lack of Efficacy|12|||
163172463|NCT03952039|589345281|FG001|Overall Study|Lack of Efficacy|2|||
163172464|NCT03952039|589345280|FG000|Overall Study|Physician Decision|9|||
163172465|NCT03952039|589345281|FG001|Overall Study|Physician Decision|3|||
163172466|NCT03952039|589345280|FG000|Overall Study|Progressive Disease|6|||
163172467|NCT03952039|589345281|FG001|Overall Study|Progressive Disease|4|||
162698419|NCT03881059|587605503|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
162822181|NCT04196803|588063101|FG001|Overall Study|Withdrawal by Subject|3|||
162822182|NCT04196803|588063100|FG000|Overall Study|Adverse Event|4|||
162822183|NCT04196803|588063101|FG001|Overall Study|Adverse Event|2|||
162822184|NCT04196803|588063100|FG000|Overall Study|Lost to Follow-up|0|||
162822185|NCT04196803|588063101|FG001|Overall Study|Lost to Follow-up|1|||
162822186|NCT01168973|588063102|FG000|Overall Study|Progressive Disease|341|||
162822187|NCT01168973|588063103|FG001|Overall Study|Progressive Disease|429|||
162822188|NCT01168973|588063102|FG000|Overall Study|Adverse Event|94|||
162822189|NCT01168973|588063103|FG001|Overall Study|Adverse Event|55|||
162822190|NCT01168973|588063102|FG000|Overall Study|Withdrawal by Subject|90|||
163172468|NCT03952039|589345280|FG000|Overall Study|Other Reasons|12|||
163172469|NCT03952039|589345281|FG001|Overall Study|Other Reasons|4|||
163172470|NCT02055365|589347194|FG000|Overall Study|Prematurely Withdrawn|1|||
163172471|NCT02656680|589347196|FG000|Overall Study|Lost to Follow-up|0|||
162822191|NCT01168973|588063103|FG001|Overall Study|Withdrawal by Subject|53|||
162822192|NCT01168973|588063102|FG000|Overall Study|Death|42|||
162822193|NCT01168973|588063103|FG001|Overall Study|Death|45|||
162822194|NCT01168973|588063102|FG000|Overall Study|Physician Decision|37|||
162822195|NCT01168973|588063103|FG001|Overall Study|Physician Decision|19|||
162822196|NCT01168973|588063102|FG000|Overall Study|Sponsor Decision|2|||
162822197|NCT01168973|588063103|FG001|Overall Study|Sponsor Decision|1|||
162822198|NCT01168973|588063102|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
162822199|NCT01168973|588063103|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
162822200|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Adverse Event|2|||
162822201|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Adverse Event|2|||
162822202|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Adverse Event|4|||
162822203|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Adverse Event|0|||
162822204|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Adverse Event|0|||
162822205|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Progressive disease|0|||
162822206|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Progressive disease|0|||
162822207|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Progressive disease|1|||
162822208|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Progressive disease|0|||
162822209|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Progressive disease|0|||
162822210|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
162822211|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
162822212|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
162822213|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
162822214|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
162822215|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
162822216|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163172472|NCT02656680|589347197|FG001|Overall Study|Lost to Follow-up|1|||
163172473|NCT02656680|589347198|FG002|Overall Study|Lost to Follow-up|7|||
163172474|NCT01258998|589347199|FG000|Overall Study|Ineligible|1|||
163172475|NCT01143389|589347200|FG000|Overall Study|Lost to Follow-up|26|||
163172476|NCT01143389|589347201|FG001|Overall Study|Lost to Follow-up|25|||
163172477|NCT04966910|589347202|FG000|Baseline|Participant did not complete measure|0|||
163172478|NCT04966910|589347203|FG001|Baseline|Participant did not complete measure|0|||
163172479|NCT04966910|589347204|FG002|Baseline|Participant did not complete measure|1|||
163172480|NCT04966910|589347205|FG003|Baseline|Participant did not complete measure|0|||
163172481|NCT04966910|589347202|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
163172482|NCT04966910|589347203|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
163172483|NCT04966910|589347204|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
163172484|NCT04966910|589347205|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
163172485|NCT04966910|589347202|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
163172486|NCT04966910|589347203|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
163172487|NCT04966910|589347204|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
163172488|NCT04966910|589347205|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
163172489|NCT04966910|589347202|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
163172490|NCT04966910|589347203|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
163172491|NCT04966910|589347204|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
163172492|NCT04966910|589347205|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
163172493|NCT01757691|589347214|FG000|Overall Study|Administrative problems|2|||
163172494|NCT01757691|589347215|FG001|Overall Study|Administrative problems|0|||
163172495|NCT02054481|589347217|FG000|Overall Study|Adverse Event|1|||
163172496|NCT02054481|589347218|FG001|Overall Study|Adverse Event|1|||
162822217|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
162822218|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
162822219|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
162822220|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
162822221|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
162822222|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
162822223|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
162822224|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
162822225|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
162822226|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
162822227|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
162822228|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
162822229|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
162822230|NCT03523728|588063104|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
162822231|NCT03523728|588063105|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
162822232|NCT03523728|588063106|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
162822233|NCT03523728|588063107|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
162822234|NCT03523728|588063108|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
162822235|NCT03523728|588063104|FG000|Stage 2 (24 Months)|Adverse Event|0|||
162822236|NCT03523728|588063105|FG001|Stage 2 (24 Months)|Adverse Event|0|||
162822237|NCT03523728|588063106|FG002|Stage 2 (24 Months)|Adverse Event|0|||
162822238|NCT03523728|588063107|FG003|Stage 2 (24 Months)|Adverse Event|1|||
162822239|NCT03523728|588063108|FG004|Stage 2 (24 Months)|Adverse Event|2|||
162822240|NCT03523728|588063104|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
162822241|NCT03523728|588063105|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
162822242|NCT03523728|588063106|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
162822243|NCT03523728|588063107|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
162822244|NCT03523728|588063108|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
162822245|NCT03523728|588063104|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
162822246|NCT03523728|588063105|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
162822247|NCT03523728|588063106|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
162822248|NCT03523728|588063107|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
162822249|NCT03523728|588063108|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
162822250|NCT03523728|588063104|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
162822251|NCT03523728|588063105|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
162822252|NCT03523728|588063106|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
162822253|NCT03523728|588063107|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
162822254|NCT03523728|588063108|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
162822255|NCT03523728|588063104|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
162822256|NCT03523728|588063105|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
162822257|NCT03523728|588063106|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
162822258|NCT03523728|588063107|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
162822259|NCT03523728|588063108|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
162822260|NCT01274715|588063109|FG000|Overall Study|Lost to Follow-up|1|||
162822261|NCT01274715|588063109|FG000|Overall Study|After consent, met exclusion criteria.|1|||
162822262|NCT01274715|588063109|FG000|Overall Study|After consent, met exclusion criteria.|1|||
162822263|NCT01274715|588063109|FG000|Overall Study|After consent, met exclusion criteria.|1|||
162698420|NCT03881059|587605504|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
162810616|NCT03401229|588018289|FG000|Overall Study|Lost to Follow-up|2|||
162810617|NCT03401229|588018290|FG001|Overall Study|Lost to Follow-up|1|||
162810618|NCT03401229|588018289|FG000|Overall Study|Other|1|||
162810619|NCT03401229|588018290|FG001|Overall Study|Other|3|||
162810620|NCT03401229|588018289|FG000|Overall Study|Adverse Event|8|||
162810621|NCT03401229|588018290|FG001|Overall Study|Adverse Event|6|||
162810622|NCT03401229|588018289|FG000|Overall Study|Withdrawal by Subject|29|||
162810623|NCT03401229|588018290|FG001|Overall Study|Withdrawal by Subject|26|||
162810624|NCT03401229|588018289|FG000|Overall Study|COVID-19|0|||
162810625|NCT03401229|588018290|FG001|Overall Study|COVID-19|1|||
162810626|NCT05333224|588018291|FG000|Overall Study - Infants|Lost to Follow-up|1|||
162810627|NCT05333224|588018292|FG001|Overall Study - Infants|Lost to Follow-up|1|||
162810628|NCT01776424|588018296|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
162810629|NCT01776424|588018297|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
162810630|NCT01776424|588018298|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
162810631|NCT01776424|588018296|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
162810632|NCT01776424|588018297|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
162810633|NCT01776424|588018298|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
162810634|NCT01776424|588018296|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
162810635|NCT01776424|588018297|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
162810636|NCT01776424|588018298|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
162810637|NCT01776424|588018296|FG000|LTOLE Part (Open Label)|Refused|5|||
162810638|NCT01776424|588018297|FG001|LTOLE Part (Open Label)|Refused|2|||
162810639|NCT01776424|588018298|FG002|LTOLE Part (Open Label)|Refused|11|||
162810640|NCT01776424|588018296|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
162810641|NCT01776424|588018297|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
162810642|NCT01776424|588018298|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
162810643|NCT00819390|588018300|FG000|Overall Study|Lost to Follow-up|1|||
162810644|NCT00819390|588018301|FG001|Overall Study|Lost to Follow-up|1|||
162810645|NCT00819390|588018302|FG002|Overall Study|Lost to Follow-up|0|||
162810646|NCT00819390|588018303|FG003|Overall Study|Lost to Follow-up|0|||
162810647|NCT00819390|588018300|FG000|Overall Study|Withdrawal by Subject|2|||
162810648|NCT00819390|588018301|FG001|Overall Study|Withdrawal by Subject|0|||
162810649|NCT00819390|588018302|FG002|Overall Study|Withdrawal by Subject|0|||
162810650|NCT00819390|588018303|FG003|Overall Study|Withdrawal by Subject|0|||
162810651|NCT00819390|588018300|FG000|Overall Study|Adverse Event|0|||
162810652|NCT00819390|588018301|FG001|Overall Study|Adverse Event|0|||
162810653|NCT00819390|588018302|FG002|Overall Study|Adverse Event|1|||
162810654|NCT00819390|588018303|FG003|Overall Study|Adverse Event|0|||
162810655|NCT02294227|588018304|FG000|Overall Study|Death|0|||
162810656|NCT02294227|588018305|FG001|Overall Study|Death|0|||
162810657|NCT02294227|588018306|FG002|Overall Study|Death|1|||
162810658|NCT02294227|588018304|FG000|Overall Study|Subject/Guardian Decision|6|||
162810659|NCT02294227|588018305|FG001|Overall Study|Subject/Guardian Decision|3|||
162810660|NCT02294227|588018306|FG002|Overall Study|Subject/Guardian Decision|7|||
162810661|NCT02294227|588018304|FG000|Overall Study|Physician Decision|1|||
162810662|NCT02294227|588018305|FG001|Overall Study|Physician Decision|2|||
162810663|NCT02294227|588018306|FG002|Overall Study|Physician Decision|1|||
162810664|NCT02294227|588018304|FG000|Overall Study|Lost to Follow-up|1|||
162810665|NCT02294227|588018305|FG001|Overall Study|Lost to Follow-up|0|||
162810666|NCT02294227|588018306|FG002|Overall Study|Lost to Follow-up|0|||
162810667|NCT02294227|588018304|FG000|Overall Study|Lack of Efficacy|11|||
162810668|NCT02294227|588018305|FG001|Overall Study|Lack of Efficacy|12|||
162810669|NCT02294227|588018306|FG002|Overall Study|Lack of Efficacy|8|||
162810670|NCT02294227|588018304|FG000|Overall Study|Adverse Event|6|||
162810671|NCT02294227|588018305|FG001|Overall Study|Adverse Event|8|||
162810672|NCT02294227|588018306|FG002|Overall Study|Adverse Event|2|||
163172497|NCT02054481|589347219|FG002|Overall Study|Adverse Event|0|||
163172498|NCT02054481|589347220|FG003|Overall Study|Adverse Event|1|||
163172499|NCT02054481|589347217|FG000|Overall Study|Lost to Follow-up|1|||
163172500|NCT02054481|589347218|FG001|Overall Study|Lost to Follow-up|0|||
163172501|NCT02054481|589347219|FG002|Overall Study|Lost to Follow-up|0|||
163172502|NCT02054481|589347220|FG003|Overall Study|Lost to Follow-up|0|||
163172503|NCT02054481|589347217|FG000|Overall Study|Other reason|2|||
163172504|NCT02054481|589347218|FG001|Overall Study|Other reason|1|||
163172505|NCT02054481|589347219|FG002|Overall Study|Other reason|2|||
163172506|NCT02054481|589347220|FG003|Overall Study|Other reason|0|||
163172507|NCT01713933|589347221|FG000|Overall Study|Lost to Follow-up|2|||
163172508|NCT01713933|589347221|FG000|Overall Study|Withdrawal by Subject|3|||
163172509|NCT01713933|589347221|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
163172510|NCT00528970|589347222|FG000|Overall Study|Adverse Event|6|||
163172511|NCT00528970|589347223|FG001|Overall Study|Adverse Event|8|||
163172512|NCT00528970|589347224|FG002|Overall Study|Adverse Event|5|||
163172513|NCT00528970|589347222|FG000|Overall Study|Lost to Follow-up|0|||
163172514|NCT00528970|589347223|FG001|Overall Study|Lost to Follow-up|0|||
163172515|NCT00528970|589347224|FG002|Overall Study|Lost to Follow-up|1|||
163172516|NCT00528970|589347222|FG000|Overall Study|Other than specified|2|||
163172517|NCT00528970|589347223|FG001|Overall Study|Other than specified|3|||
163172518|NCT00528970|589347224|FG002|Overall Study|Other than specified|3|||
163172519|NCT00528970|589347222|FG000|Overall Study|Protocol Violation|2|||
163172520|NCT00528970|589347223|FG001|Overall Study|Protocol Violation|1|||
163172521|NCT00528970|589347224|FG002|Overall Study|Protocol Violation|4|||
163172522|NCT00528970|589347222|FG000|Overall Study|Lack of Efficacy|0|||
163172523|NCT00528970|589347223|FG001|Overall Study|Lack of Efficacy|0|||
163172524|NCT00528970|589347224|FG002|Overall Study|Lack of Efficacy|1|||
163172525|NCT00528970|589347222|FG000|Overall Study|Withdrawal by Subject|4|||
163172526|NCT00528970|589347223|FG001|Overall Study|Withdrawal by Subject|3|||
163172527|NCT00528970|589347224|FG002|Overall Study|Withdrawal by Subject|5|||
163172528|NCT00528970|589347222|FG000|Overall Study|Randomized but not treated|0|||
163172529|NCT00528970|589347223|FG001|Overall Study|Randomized but not treated|0|||
163172530|NCT00528970|589347224|FG002|Overall Study|Randomized but not treated|1|||
163172531|NCT02882152|589347225|FG000|Overall Study|Lost to Follow-up|1|||
163172532|NCT02882152|589347226|FG001|Overall Study|Lost to Follow-up|0|||
163172533|NCT01673347|589347229|FG000|Overall Study|failure of allograft|7|||
163172534|NCT01430754|589347230|FG000|Run-In Phase|Circadian Period Ineligible|24|||
163172535|NCT01430754|589347231|FG001|Run-In Phase|Circadian Period Ineligible|0|||
163172536|NCT01430754|589347230|FG000|Run-In Phase|Protocol Violation|6|||
163172537|NCT01430754|589347231|FG001|Run-In Phase|Protocol Violation|0|||
163172538|NCT01430754|589347230|FG000|Run-In Phase|Adverse Event|2|||
163172539|NCT01430754|589347231|FG001|Run-In Phase|Adverse Event|0|||
163172540|NCT01430754|589347230|FG000|Run-In Phase|Other|2|||
163172541|NCT01430754|589347231|FG001|Run-In Phase|Other|0|||
163172542|NCT01430754|589347230|FG000|Run-In Phase|Withdrawal by Subject|2|||
163172543|NCT01430754|589347231|FG001|Run-In Phase|Withdrawal by Subject|0|||
163172544|NCT01430754|589347230|FG000|Run-In Phase|Lost to Follow-up|1|||
163172545|NCT01430754|589347231|FG001|Run-In Phase|Lost to Follow-up|0|||
163172546|NCT00895011|589347232|FG000|Overall Study|Withdrawal by Subject|14|||
163172547|NCT00895011|589347233|FG001|Overall Study|Withdrawal by Subject|7|||
163172548|NCT00895011|589347234|FG002|Overall Study|Withdrawal by Subject|2|||
163172549|NCT00895011|589347232|FG000|Overall Study|Lost to Follow-up|5|||
163172550|NCT00895011|589347233|FG001|Overall Study|Lost to Follow-up|4|||
163172551|NCT00895011|589347234|FG002|Overall Study|Lost to Follow-up|1|||
163172552|NCT00895011|589347232|FG000|Overall Study|Protocol Violation|3|||
163172553|NCT00895011|589347233|FG001|Overall Study|Protocol Violation|1|||
163172554|NCT00895011|589347234|FG002|Overall Study|Protocol Violation|3|||
163172555|NCT00895011|589347232|FG000|Overall Study|Adverse Event|1|||
163172556|NCT00895011|589347233|FG001|Overall Study|Adverse Event|2|||
163172557|NCT00895011|589347234|FG002|Overall Study|Adverse Event|2|||
163172558|NCT00895011|589347232|FG000|Overall Study|schedule conflict|1|||
163172559|NCT00895011|589347233|FG001|Overall Study|schedule conflict|0|||
163172560|NCT00895011|589347234|FG002|Overall Study|schedule conflict|0|||
163172561|NCT02661178|589347242|FG000|Part 1|Protocol Violation|1|||
163172562|NCT02661178|589347243|FG001|Part 1|Protocol Violation|0|||
163172563|NCT02661178|589347244|FG002|Part 1|Protocol Violation|0|||
163172564|NCT02661178|589347245|FG003|Part 1|Protocol Violation|0|||
163172565|NCT02661178|589347246|FG004|Part 1|Protocol Violation|0|||
163172566|NCT02661178|589347247|FG005|Part 1|Protocol Violation|0|||
163172567|NCT02661178|589347248|FG006|Part 1|Protocol Violation|0|||
163172568|NCT02661178|589347249|FG007|Part 1|Protocol Violation|0|||
163172569|NCT02661178|589347250|FG008|Part 1|Protocol Violation|0|||
163172570|NCT02661178|589347251|FG009|Part 1|Protocol Violation|0|||
163172571|NCT02661178|589347252|FG010|Part 1|Protocol Violation|0|||
163172572|NCT02661178|589347253|FG011|Part 1|Protocol Violation|0|||
163172573|NCT02661178|589347254|FG012|Part 1|Protocol Violation|0|||
163172574|NCT02661178|589347255|FG013|Part 1|Protocol Violation|0|||
163172575|NCT02661178|589347256|FG014|Part 1|Protocol Violation|0|||
163172576|NCT02278471|589347257|FG000|Overall Study|Lost to Follow-up|6|||
163172577|NCT02278471|589347258|FG001|Overall Study|Lost to Follow-up|15|||
163172578|NCT02278471|589347257|FG000|Overall Study|Death|2|||
163172579|NCT02278471|589347258|FG001|Overall Study|Death|2|||
163172580|NCT02278471|589347257|FG000|Overall Study|Withdrawal by Subject|0|||
163172581|NCT02278471|589347258|FG001|Overall Study|Withdrawal by Subject|3|||
163172582|NCT04391049|589347259|FG000|Overall Study|Protocol Violation|1|||
163172583|NCT02855541|589347260|FG000|Overall Study|Change in health status|2|||
163172584|NCT02855541|589347260|FG000|Overall Study|Withdrawal by Subject|2|||
163172585|NCT01242813|589347261|FG000|Overall Study|Lost to Follow-up|2|||
163172586|NCT01561898|589347262|FG000|Overall Study|Withdrawal by Subject|0|||
163172587|NCT01561898|589347263|FG001|Overall Study|Withdrawal by Subject|8|||
163172588|NCT01561898|589347264|FG002|Overall Study|Withdrawal by Subject|12|||
163172589|NCT01561898|589347265|FG003|Overall Study|Withdrawal by Subject|5|||
163172590|NCT01561898|589347262|FG000|Overall Study|Lack of Efficacy|0|||
163172591|NCT01561898|589347263|FG001|Overall Study|Lack of Efficacy|8|||
163172592|NCT01561898|589347264|FG002|Overall Study|Lack of Efficacy|10|||
163172593|NCT01561898|589347265|FG003|Overall Study|Lack of Efficacy|5|||
163172594|NCT01561898|589347262|FG000|Overall Study|Worsening of complications|0|||
163172595|NCT01561898|589347263|FG001|Overall Study|Worsening of complications|1|||
163172596|NCT01561898|589347264|FG002|Overall Study|Worsening of complications|0|||
163172597|NCT01561898|589347265|FG003|Overall Study|Worsening of complications|0|||
163172598|NCT01561898|589347262|FG000|Overall Study|Lost to Follow-up|0|||
163172599|NCT01561898|589347263|FG001|Overall Study|Lost to Follow-up|0|||
163172600|NCT01561898|589347264|FG002|Overall Study|Lost to Follow-up|1|||
163172601|NCT01561898|589347265|FG003|Overall Study|Lost to Follow-up|0|||
163172602|NCT01561898|589347262|FG000|Overall Study|Adverse Event|1|||
163172603|NCT01561898|589347263|FG001|Overall Study|Adverse Event|19|||
163172604|NCT01561898|589347264|FG002|Overall Study|Adverse Event|14|||
163172605|NCT01561898|589347265|FG003|Overall Study|Adverse Event|9|||
163172606|NCT01561898|589347262|FG000|Overall Study|Physician Decision|1|||
163172607|NCT01561898|589347263|FG001|Overall Study|Physician Decision|5|||
163172608|NCT01561898|589347264|FG002|Overall Study|Physician Decision|7|||
163172609|NCT01561898|589347265|FG003|Overall Study|Physician Decision|1|||
163172610|NCT01445548|589347266|FG000|Overall Study|Adverse Event|1|||
163172611|NCT00275821|589347268|FG000|Overall Study|Adverse Event|4|||
163172612|NCT00275821|589347269|FG001|Overall Study|Adverse Event|12|||
163172613|NCT00275821|589347270|FG002|Overall Study|Adverse Event|5|||
163172614|NCT00275821|589347268|FG000|Overall Study|Administrative problems|3|||
163172615|NCT00275821|589347269|FG001|Overall Study|Administrative problems|4|||
163172616|NCT00275821|589347270|FG002|Overall Study|Administrative problems|4|||
163172617|NCT00275821|589347268|FG000|Overall Study|Withdrawal by Subject|0|||
163172618|NCT00275821|589347269|FG001|Overall Study|Withdrawal by Subject|2|||
163172619|NCT00275821|589347270|FG002|Overall Study|Withdrawal by Subject|1|||
163172620|NCT00275821|589347268|FG000|Overall Study|Lost to Follow-up|0|||
163172621|NCT00275821|589347269|FG001|Overall Study|Lost to Follow-up|1|||
163172622|NCT00275821|589347270|FG002|Overall Study|Lost to Follow-up|1|||
163172623|NCT00275821|589347268|FG000|Overall Study|Death|0|||
163172624|NCT00275821|589347269|FG001|Overall Study|Death|2|||
163172625|NCT00275821|589347270|FG002|Overall Study|Death|1|||
163172626|NCT00275821|589347268|FG000|Overall Study|Lack of Efficacy|2|||
163172627|NCT00275821|589347269|FG001|Overall Study|Lack of Efficacy|1|||
163172628|NCT00275821|589347270|FG002|Overall Study|Lack of Efficacy|0|||
163172629|NCT00275821|589347268|FG000|Overall Study|Protocol Violation|5|||
163172630|NCT00275821|589347269|FG001|Overall Study|Protocol Violation|1|||
163172631|NCT00275821|589347270|FG002|Overall Study|Protocol Violation|0|||
163172632|NCT01215916|589347271|FG000|Overall Study|Progressive Disease|0|||
163172633|NCT01215916|589347272|FG001|Overall Study|Progressive Disease|2|||
163172634|NCT01215916|589347273|FG002|Overall Study|Progressive Disease|1|||
163172635|NCT01215916|589347274|FG003|Overall Study|Progressive Disease|2|||
163172636|NCT01215916|589347275|FG004|Overall Study|Progressive Disease|5|||
163172637|NCT01215916|589347276|FG005|Overall Study|Progressive Disease|4|||
163172638|NCT01215916|589347277|FG006|Overall Study|Progressive Disease|5|||
162822264|NCT00467779|588063118|FG000|Stage 1|Adverse Event|1|||
162822265|NCT00467779|588063119|FG001|Stage 1|Adverse Event|0|||
162822266|NCT00467779|588063120|FG002|Stage 1|Adverse Event|0|||
162822267|NCT00467779|588063121|FG003|Stage 1|Adverse Event|0|||
162822268|NCT00467779|588063122|FG004|Stage 1|Adverse Event|0|||
162822269|NCT00467779|588063123|FG005|Stage 1|Adverse Event|1|||
162822270|NCT00467779|588063124|FG006|Stage 1|Adverse Event|2|||
162822271|NCT00467779|588063125|FG007|Stage 1|Adverse Event|1|||
162822272|NCT00467779|588063126|FG008|Stage 1|Adverse Event|0|||
162822273|NCT00467779|588063127|FG009|Stage 1|Adverse Event|0|||
162822274|NCT00467779|588063128|FG010|Stage 1|Adverse Event|0|||
162822275|NCT00467779|588063129|FG011|Stage 1|Adverse Event|0|||
162822276|NCT00467779|588063130|FG012|Stage 1|Adverse Event|0|||
162822277|NCT00467779|588063131|FG013|Stage 1|Adverse Event|0|||
162822278|NCT00467779|588063132|FG014|Stage 1|Adverse Event|0|||
162822279|NCT00467779|588063118|FG000|Stage 1|Disease Progression|2|||
162822280|NCT00467779|588063119|FG001|Stage 1|Disease Progression|2|||
162822281|NCT00467779|588063120|FG002|Stage 1|Disease Progression|2|||
162822282|NCT00467779|588063121|FG003|Stage 1|Disease Progression|3|||
162822283|NCT00467779|588063122|FG004|Stage 1|Disease Progression|2|||
162822284|NCT00467779|588063123|FG005|Stage 1|Disease Progression|2|||
162822285|NCT00467779|588063124|FG006|Stage 1|Disease Progression|4|||
162822286|NCT00467779|588063125|FG007|Stage 1|Disease Progression|5|||
162822287|NCT00467779|588063126|FG008|Stage 1|Disease Progression|0|||
162822288|NCT00467779|588063127|FG009|Stage 1|Disease Progression|0|||
162822289|NCT00467779|588063128|FG010|Stage 1|Disease Progression|0|||
162822290|NCT00467779|588063129|FG011|Stage 1|Disease Progression|0|||
162822291|NCT00467779|588063130|FG012|Stage 1|Disease Progression|0|||
162822292|NCT00467779|588063131|FG013|Stage 1|Disease Progression|0|||
162822293|NCT00467779|588063132|FG014|Stage 1|Disease Progression|0|||
162822294|NCT00467779|588063118|FG000|Stage 1|Unspecified Reason|1|||
162822295|NCT00467779|588063119|FG001|Stage 1|Unspecified Reason|0|||
162822296|NCT00467779|588063120|FG002|Stage 1|Unspecified Reason|1|||
162822297|NCT00467779|588063121|FG003|Stage 1|Unspecified Reason|0|||
162822298|NCT00467779|588063122|FG004|Stage 1|Unspecified Reason|1|||
162822299|NCT00467779|588063123|FG005|Stage 1|Unspecified Reason|2|||
162822300|NCT00467779|588063124|FG006|Stage 1|Unspecified Reason|0|||
162822301|NCT00467779|588063125|FG007|Stage 1|Unspecified Reason|0|||
162822302|NCT00467779|588063126|FG008|Stage 1|Unspecified Reason|0|||
162822303|NCT00467779|588063127|FG009|Stage 1|Unspecified Reason|0|||
162822304|NCT00467779|588063128|FG010|Stage 1|Unspecified Reason|0|||
162822305|NCT00467779|588063129|FG011|Stage 1|Unspecified Reason|0|||
162822306|NCT00467779|588063130|FG012|Stage 1|Unspecified Reason|0|||
162822307|NCT00467779|588063131|FG013|Stage 1|Unspecified Reason|0|||
163172639|NCT01215916|589347278|FG007|Overall Study|Progressive Disease|3|||
163172640|NCT01215916|589347279|FG008|Overall Study|Progressive Disease|1|||
163172641|NCT01215916|589347271|FG000|Overall Study|Adverse Event|1|||
163172642|NCT01215916|589347272|FG001|Overall Study|Adverse Event|1|||
162822308|NCT00467779|588063132|FG014|Stage 1|Unspecified Reason|0|||
162822309|NCT00467779|588063118|FG000|Stage 1|Physician Decision|0|||
162822310|NCT00467779|588063119|FG001|Stage 1|Physician Decision|1|||
162822311|NCT00467779|588063120|FG002|Stage 1|Physician Decision|0|||
163172643|NCT01215916|589347273|FG002|Overall Study|Adverse Event|0|||
163172644|NCT01215916|589347274|FG003|Overall Study|Adverse Event|1|||
162822312|NCT00467779|588063121|FG003|Stage 1|Physician Decision|0|||
162822313|NCT00467779|588063122|FG004|Stage 1|Physician Decision|0|||
162822314|NCT00467779|588063123|FG005|Stage 1|Physician Decision|0|||
162822315|NCT00467779|588063124|FG006|Stage 1|Physician Decision|0|||
162822316|NCT00467779|588063125|FG007|Stage 1|Physician Decision|0|||
162822317|NCT00467779|588063126|FG008|Stage 1|Physician Decision|0|||
162822318|NCT00467779|588063127|FG009|Stage 1|Physician Decision|0|||
162822319|NCT00467779|588063128|FG010|Stage 1|Physician Decision|0|||
162822320|NCT00467779|588063129|FG011|Stage 1|Physician Decision|0|||
162822321|NCT00467779|588063130|FG012|Stage 1|Physician Decision|0|||
162822322|NCT00467779|588063131|FG013|Stage 1|Physician Decision|0|||
162822323|NCT00467779|588063132|FG014|Stage 1|Physician Decision|0|||
162822324|NCT00467779|588063118|FG000|Stage 1|Withdrawal by Subject|0|||
162822325|NCT00467779|588063119|FG001|Stage 1|Withdrawal by Subject|0|||
162822326|NCT00467779|588063120|FG002|Stage 1|Withdrawal by Subject|0|||
162822327|NCT00467779|588063121|FG003|Stage 1|Withdrawal by Subject|0|||
162822328|NCT00467779|588063122|FG004|Stage 1|Withdrawal by Subject|0|||
162822329|NCT00467779|588063123|FG005|Stage 1|Withdrawal by Subject|0|||
162822330|NCT00467779|588063124|FG006|Stage 1|Withdrawal by Subject|1|||
162822331|NCT00467779|588063125|FG007|Stage 1|Withdrawal by Subject|1|||
162822332|NCT00467779|588063126|FG008|Stage 1|Withdrawal by Subject|0|||
162822333|NCT00467779|588063127|FG009|Stage 1|Withdrawal by Subject|0|||
162822334|NCT00467779|588063128|FG010|Stage 1|Withdrawal by Subject|0|||
162822335|NCT00467779|588063129|FG011|Stage 1|Withdrawal by Subject|0|||
162822336|NCT00467779|588063130|FG012|Stage 1|Withdrawal by Subject|0|||
162822337|NCT00467779|588063131|FG013|Stage 1|Withdrawal by Subject|0|||
162822338|NCT00467779|588063132|FG014|Stage 1|Withdrawal by Subject|0|||
162822339|NCT00467779|588063118|FG000|Stage 1A|Adverse Event|0|||
162822340|NCT00467779|588063119|FG001|Stage 1A|Adverse Event|0|||
162822341|NCT00467779|588063120|FG002|Stage 1A|Adverse Event|0|||
162822342|NCT00467779|588063121|FG003|Stage 1A|Adverse Event|0|||
162822343|NCT00467779|588063122|FG004|Stage 1A|Adverse Event|0|||
162822344|NCT00467779|588063123|FG005|Stage 1A|Adverse Event|0|||
162822345|NCT00467779|588063124|FG006|Stage 1A|Adverse Event|0|||
162822346|NCT00467779|588063125|FG007|Stage 1A|Adverse Event|0|||
162822347|NCT00467779|588063126|FG008|Stage 1A|Adverse Event|0|||
162822348|NCT00467779|588063127|FG009|Stage 1A|Adverse Event|0|||
162822349|NCT00467779|588063128|FG010|Stage 1A|Adverse Event|0|||
162822350|NCT00467779|588063129|FG011|Stage 1A|Adverse Event|0|||
162822351|NCT00467779|588063130|FG012|Stage 1A|Adverse Event|1|||
162822352|NCT00467779|588063131|FG013|Stage 1A|Adverse Event|0|||
162822353|NCT00467779|588063132|FG014|Stage 1A|Adverse Event|0|||
162822354|NCT00467779|588063118|FG000|Stage 1A|Death|0|||
162822355|NCT00467779|588063119|FG001|Stage 1A|Death|0|||
162822356|NCT00467779|588063120|FG002|Stage 1A|Death|0|||
162822357|NCT00467779|588063121|FG003|Stage 1A|Death|0|||
162822358|NCT00467779|588063122|FG004|Stage 1A|Death|0|||
162822359|NCT00467779|588063123|FG005|Stage 1A|Death|0|||
162822360|NCT00467779|588063124|FG006|Stage 1A|Death|0|||
162822361|NCT00467779|588063125|FG007|Stage 1A|Death|0|||
162822362|NCT00467779|588063126|FG008|Stage 1A|Death|0|||
162822363|NCT00467779|588063127|FG009|Stage 1A|Death|0|||
162822364|NCT00467779|588063128|FG010|Stage 1A|Death|0|||
162822365|NCT00467779|588063129|FG011|Stage 1A|Death|1|||
162822366|NCT00467779|588063130|FG012|Stage 1A|Death|1|||
162822367|NCT00467779|588063131|FG013|Stage 1A|Death|0|||
162822368|NCT00467779|588063132|FG014|Stage 1A|Death|0|||
162822369|NCT00467779|588063118|FG000|Stage 1A|Disease Progression|0|||
162822370|NCT00467779|588063119|FG001|Stage 1A|Disease Progression|0|||
162822371|NCT00467779|588063120|FG002|Stage 1A|Disease Progression|0|||
162822372|NCT00467779|588063121|FG003|Stage 1A|Disease Progression|0|||
162822373|NCT00467779|588063122|FG004|Stage 1A|Disease Progression|0|||
162822374|NCT00467779|588063123|FG005|Stage 1A|Disease Progression|0|||
162822375|NCT00467779|588063124|FG006|Stage 1A|Disease Progression|0|||
163172645|NCT01215916|589347275|FG004|Overall Study|Adverse Event|0|||
163172646|NCT01215916|589347276|FG005|Overall Study|Adverse Event|0|||
163172647|NCT01215916|589347277|FG006|Overall Study|Adverse Event|3|||
163172648|NCT01215916|589347278|FG007|Overall Study|Adverse Event|0|||
163172649|NCT01215916|589347279|FG008|Overall Study|Adverse Event|0|||
163172650|NCT01215916|589347271|FG000|Overall Study|Withdrawal by Subject|0|||
163172651|NCT01215916|589347272|FG001|Overall Study|Withdrawal by Subject|1|||
163172652|NCT01215916|589347273|FG002|Overall Study|Withdrawal by Subject|1|||
163172653|NCT01215916|589347274|FG003|Overall Study|Withdrawal by Subject|2|||
163172654|NCT01215916|589347275|FG004|Overall Study|Withdrawal by Subject|0|||
162822376|NCT00467779|588063125|FG007|Stage 1A|Disease Progression|0|||
162822377|NCT00467779|588063126|FG008|Stage 1A|Disease Progression|0|||
162822378|NCT00467779|588063127|FG009|Stage 1A|Disease Progression|2|||
162822379|NCT00467779|588063128|FG010|Stage 1A|Disease Progression|2|||
162822380|NCT00467779|588063129|FG011|Stage 1A|Disease Progression|5|||
162822381|NCT00467779|588063130|FG012|Stage 1A|Disease Progression|2|||
162822382|NCT00467779|588063131|FG013|Stage 1A|Disease Progression|0|||
162822383|NCT00467779|588063132|FG014|Stage 1A|Disease Progression|0|||
162822384|NCT00467779|588063118|FG000|Stage 1A|Physician Decision|0|||
162822385|NCT00467779|588063119|FG001|Stage 1A|Physician Decision|0|||
162822386|NCT00467779|588063120|FG002|Stage 1A|Physician Decision|0|||
162822387|NCT00467779|588063121|FG003|Stage 1A|Physician Decision|0|||
162822388|NCT00467779|588063122|FG004|Stage 1A|Physician Decision|0|||
162822389|NCT00467779|588063123|FG005|Stage 1A|Physician Decision|0|||
162822390|NCT00467779|588063124|FG006|Stage 1A|Physician Decision|0|||
162822391|NCT00467779|588063125|FG007|Stage 1A|Physician Decision|0|||
162822392|NCT00467779|588063126|FG008|Stage 1A|Physician Decision|0|||
162822393|NCT00467779|588063127|FG009|Stage 1A|Physician Decision|1|||
162822394|NCT00467779|588063128|FG010|Stage 1A|Physician Decision|0|||
162822395|NCT00467779|588063129|FG011|Stage 1A|Physician Decision|0|||
162822396|NCT00467779|588063130|FG012|Stage 1A|Physician Decision|0|||
162822397|NCT00467779|588063131|FG013|Stage 1A|Physician Decision|0|||
163172655|NCT01215916|589347276|FG005|Overall Study|Withdrawal by Subject|0|||
163172656|NCT01215916|589347277|FG006|Overall Study|Withdrawal by Subject|1|||
163172657|NCT01215916|589347278|FG007|Overall Study|Withdrawal by Subject|0|||
162822398|NCT00467779|588063132|FG014|Stage 1A|Physician Decision|0|||
162822399|NCT00467779|588063118|FG000|Stage 1A|Withdrawal by Subject|0|||
162822400|NCT00467779|588063119|FG001|Stage 1A|Withdrawal by Subject|0|||
162822401|NCT00467779|588063120|FG002|Stage 1A|Withdrawal by Subject|0|||
162822402|NCT00467779|588063121|FG003|Stage 1A|Withdrawal by Subject|0|||
162822403|NCT00467779|588063122|FG004|Stage 1A|Withdrawal by Subject|0|||
162822404|NCT00467779|588063123|FG005|Stage 1A|Withdrawal by Subject|0|||
162822405|NCT00467779|588063124|FG006|Stage 1A|Withdrawal by Subject|0|||
162822406|NCT00467779|588063125|FG007|Stage 1A|Withdrawal by Subject|0|||
162822407|NCT00467779|588063126|FG008|Stage 1A|Withdrawal by Subject|0|||
162822408|NCT00467779|588063127|FG009|Stage 1A|Withdrawal by Subject|0|||
162822409|NCT00467779|588063128|FG010|Stage 1A|Withdrawal by Subject|1|||
162698421|NCT03881059|587605505|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
162822410|NCT00467779|588063129|FG011|Stage 1A|Withdrawal by Subject|1|||
162822411|NCT00467779|588063130|FG012|Stage 1A|Withdrawal by Subject|1|||
162822412|NCT00467779|588063131|FG013|Stage 1A|Withdrawal by Subject|0|||
162822413|NCT00467779|588063132|FG014|Stage 1A|Withdrawal by Subject|0|||
162822414|NCT00467779|588063118|FG000|Stage 1A|Unspecified Reason|0|||
162822415|NCT00467779|588063119|FG001|Stage 1A|Unspecified Reason|0|||
162822416|NCT00467779|588063120|FG002|Stage 1A|Unspecified Reason|0|||
162822417|NCT00467779|588063121|FG003|Stage 1A|Unspecified Reason|0|||
162822418|NCT00467779|588063122|FG004|Stage 1A|Unspecified Reason|0|||
162822419|NCT00467779|588063123|FG005|Stage 1A|Unspecified Reason|0|||
162822420|NCT00467779|588063124|FG006|Stage 1A|Unspecified Reason|0|||
162822421|NCT00467779|588063125|FG007|Stage 1A|Unspecified Reason|0|||
162822422|NCT00467779|588063126|FG008|Stage 1A|Unspecified Reason|0|||
162822423|NCT00467779|588063127|FG009|Stage 1A|Unspecified Reason|0|||
162822424|NCT00467779|588063128|FG010|Stage 1A|Unspecified Reason|0|||
162822425|NCT00467779|588063129|FG011|Stage 1A|Unspecified Reason|1|||
162822426|NCT00467779|588063130|FG012|Stage 1A|Unspecified Reason|1|||
162822427|NCT00467779|588063131|FG013|Stage 1A|Unspecified Reason|0|||
162822428|NCT00467779|588063132|FG014|Stage 1A|Unspecified Reason|0|||
162822429|NCT00467779|588063118|FG000|Stage 2|Adverse Event|0|||
162822430|NCT00467779|588063119|FG001|Stage 2|Adverse Event|0|||
162822431|NCT00467779|588063120|FG002|Stage 2|Adverse Event|0|||
162822432|NCT00467779|588063121|FG003|Stage 2|Adverse Event|0|||
162822433|NCT00467779|588063122|FG004|Stage 2|Adverse Event|0|||
162822434|NCT00467779|588063123|FG005|Stage 2|Adverse Event|0|||
162822435|NCT00467779|588063124|FG006|Stage 2|Adverse Event|0|||
162822436|NCT00467779|588063125|FG007|Stage 2|Adverse Event|0|||
162822437|NCT00467779|588063126|FG008|Stage 2|Adverse Event|1|||
162822438|NCT00467779|588063127|FG009|Stage 2|Adverse Event|0|||
162822439|NCT00467779|588063128|FG010|Stage 2|Adverse Event|0|||
162822440|NCT00467779|588063129|FG011|Stage 2|Adverse Event|0|||
162822441|NCT00467779|588063130|FG012|Stage 2|Adverse Event|0|||
162822442|NCT00467779|588063131|FG013|Stage 2|Adverse Event|0|||
162822443|NCT00467779|588063132|FG014|Stage 2|Adverse Event|0|||
162822444|NCT00467779|588063118|FG000|Stage 2|Death|0|||
162822445|NCT00467779|588063119|FG001|Stage 2|Death|0|||
162822446|NCT00467779|588063120|FG002|Stage 2|Death|0|||
162822447|NCT00467779|588063121|FG003|Stage 2|Death|0|||
162822448|NCT00467779|588063122|FG004|Stage 2|Death|0|||
162822449|NCT00467779|588063123|FG005|Stage 2|Death|0|||
162822450|NCT00467779|588063124|FG006|Stage 2|Death|0|||
162822451|NCT00467779|588063125|FG007|Stage 2|Death|0|||
163172658|NCT01215916|589347279|FG008|Overall Study|Withdrawal by Subject|0|||
163172659|NCT01215916|589347271|FG000|Overall Study|Death|0|||
163172660|NCT01215916|589347272|FG001|Overall Study|Death|1|||
163172661|NCT01215916|589347273|FG002|Overall Study|Death|0|||
163172662|NCT01215916|589347274|FG003|Overall Study|Death|0|||
163172663|NCT01215916|589347275|FG004|Overall Study|Death|1|||
163172664|NCT01215916|589347276|FG005|Overall Study|Death|0|||
163172665|NCT01215916|589347277|FG006|Overall Study|Death|0|||
163172666|NCT01215916|589347278|FG007|Overall Study|Death|0|||
163172667|NCT01215916|589347279|FG008|Overall Study|Death|1|||
163172668|NCT01215916|589347271|FG000|Overall Study|Physician Decision|0|||
163172669|NCT01215916|589347272|FG001|Overall Study|Physician Decision|0|||
163172670|NCT01215916|589347273|FG002|Overall Study|Physician Decision|1|||
163172671|NCT01215916|589347274|FG003|Overall Study|Physician Decision|1|||
163172672|NCT01215916|589347275|FG004|Overall Study|Physician Decision|0|||
163172673|NCT01215916|589347276|FG005|Overall Study|Physician Decision|0|||
163172674|NCT01215916|589347277|FG006|Overall Study|Physician Decision|0|||
163172675|NCT01215916|589347278|FG007|Overall Study|Physician Decision|0|||
163172676|NCT01215916|589347279|FG008|Overall Study|Physician Decision|0|||
163172677|NCT02788279|589347280|FG000|Overall Study|Death|62|||
163172678|NCT02788279|589347281|FG001|Overall Study|Death|136|||
163172679|NCT02788279|589347282|FG002|Overall Study|Death|72|||
163172680|NCT02788279|589347280|FG000|Overall Study|Withdrawal by Subject|10|||
163172681|NCT02788279|589347281|FG001|Overall Study|Withdrawal by Subject|15|||
163172682|NCT02788279|589347282|FG002|Overall Study|Withdrawal by Subject|5|||
163172683|NCT02788279|589347280|FG000|Overall Study|Lost to Follow-up|0|||
163172684|NCT02788279|589347281|FG001|Overall Study|Lost to Follow-up|3|||
163172685|NCT02788279|589347282|FG002|Overall Study|Lost to Follow-up|2|||
163172686|NCT02788279|589347280|FG000|Overall Study|Sponsor decision|18|||
163172687|NCT02788279|589347281|FG001|Overall Study|Sponsor decision|29|||
163172688|NCT02788279|589347282|FG002|Overall Study|Sponsor decision|11|||
163172689|NCT00329849|589347284|FG000|Overall Study|Withdrawal by Subject|6|||
163172690|NCT00329849|589347285|FG001|Overall Study|Withdrawal by Subject|4|||
162822452|NCT00467779|588063126|FG008|Stage 2|Death|1|||
162822453|NCT00467779|588063127|FG009|Stage 2|Death|0|||
162822454|NCT00467779|588063128|FG010|Stage 2|Death|0|||
162822455|NCT00467779|588063129|FG011|Stage 2|Death|0|||
162822456|NCT00467779|588063130|FG012|Stage 2|Death|0|||
162822457|NCT00467779|588063131|FG013|Stage 2|Death|0|||
162822458|NCT00467779|588063132|FG014|Stage 2|Death|0|||
162822459|NCT00467779|588063118|FG000|Stage 2|Disease Progression|0|||
162822460|NCT00467779|588063119|FG001|Stage 2|Disease Progression|0|||
162822461|NCT00467779|588063120|FG002|Stage 2|Disease Progression|0|||
163172691|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
163172692|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172693|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172694|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162822462|NCT00467779|588063121|FG003|Stage 2|Disease Progression|0|||
162822463|NCT00467779|588063122|FG004|Stage 2|Disease Progression|0|||
162822464|NCT00467779|588063123|FG005|Stage 2|Disease Progression|0|||
162822465|NCT00467779|588063124|FG006|Stage 2|Disease Progression|0|||
162822466|NCT00467779|588063125|FG007|Stage 2|Disease Progression|0|||
162822467|NCT00467779|588063126|FG008|Stage 2|Disease Progression|16|||
162822468|NCT00467779|588063127|FG009|Stage 2|Disease Progression|0|||
162822469|NCT00467779|588063128|FG010|Stage 2|Disease Progression|0|||
162822470|NCT00467779|588063129|FG011|Stage 2|Disease Progression|0|||
162822471|NCT00467779|588063130|FG012|Stage 2|Disease Progression|0|||
162822472|NCT00467779|588063131|FG013|Stage 2|Disease Progression|0|||
162822473|NCT00467779|588063132|FG014|Stage 2|Disease Progression|0|||
162822474|NCT00467779|588063118|FG000|Stage 2|Unspecified Reason|0|||
162822475|NCT00467779|588063119|FG001|Stage 2|Unspecified Reason|0|||
162822476|NCT00467779|588063120|FG002|Stage 2|Unspecified Reason|0|||
162822477|NCT00467779|588063121|FG003|Stage 2|Unspecified Reason|0|||
162822478|NCT00467779|588063122|FG004|Stage 2|Unspecified Reason|0|||
162822479|NCT00467779|588063123|FG005|Stage 2|Unspecified Reason|0|||
162822480|NCT00467779|588063124|FG006|Stage 2|Unspecified Reason|0|||
162822481|NCT00467779|588063125|FG007|Stage 2|Unspecified Reason|0|||
162822482|NCT00467779|588063126|FG008|Stage 2|Unspecified Reason|3|||
162822483|NCT00467779|588063127|FG009|Stage 2|Unspecified Reason|0|||
162822484|NCT00467779|588063128|FG010|Stage 2|Unspecified Reason|0|||
162822485|NCT00467779|588063129|FG011|Stage 2|Unspecified Reason|0|||
162822486|NCT00467779|588063130|FG012|Stage 2|Unspecified Reason|0|||
162822487|NCT00467779|588063131|FG013|Stage 2|Unspecified Reason|0|||
162822488|NCT00467779|588063132|FG014|Stage 2|Unspecified Reason|0|||
162822489|NCT00467779|588063118|FG000|Stage 2A|Adverse Event|0|||
162822490|NCT00467779|588063119|FG001|Stage 2A|Adverse Event|0|||
162822491|NCT00467779|588063120|FG002|Stage 2A|Adverse Event|0|||
162822492|NCT00467779|588063121|FG003|Stage 2A|Adverse Event|0|||
162822493|NCT00467779|588063122|FG004|Stage 2A|Adverse Event|0|||
162822494|NCT00467779|588063123|FG005|Stage 2A|Adverse Event|0|||
162822495|NCT00467779|588063124|FG006|Stage 2A|Adverse Event|0|||
162822496|NCT00467779|588063125|FG007|Stage 2A|Adverse Event|0|||
162822497|NCT00467779|588063126|FG008|Stage 2A|Adverse Event|0|||
162822498|NCT00467779|588063127|FG009|Stage 2A|Adverse Event|0|||
162822499|NCT00467779|588063128|FG010|Stage 2A|Adverse Event|0|||
162822500|NCT00467779|588063129|FG011|Stage 2A|Adverse Event|0|||
162822501|NCT00467779|588063130|FG012|Stage 2A|Adverse Event|0|||
162822502|NCT00467779|588063131|FG013|Stage 2A|Adverse Event|2|||
162822503|NCT00467779|588063132|FG014|Stage 2A|Adverse Event|0|||
162822504|NCT00467779|588063118|FG000|Stage 2A|Death|0|||
162822505|NCT00467779|588063119|FG001|Stage 2A|Death|0|||
162822506|NCT00467779|588063120|FG002|Stage 2A|Death|0|||
162822507|NCT00467779|588063121|FG003|Stage 2A|Death|0|||
162822508|NCT00467779|588063122|FG004|Stage 2A|Death|0|||
162822509|NCT00467779|588063123|FG005|Stage 2A|Death|0|||
162822510|NCT00467779|588063124|FG006|Stage 2A|Death|0|||
162822511|NCT00467779|588063125|FG007|Stage 2A|Death|0|||
162822512|NCT00467779|588063126|FG008|Stage 2A|Death|0|||
162822513|NCT00467779|588063127|FG009|Stage 2A|Death|0|||
162822514|NCT00467779|588063128|FG010|Stage 2A|Death|0|||
162822515|NCT00467779|588063129|FG011|Stage 2A|Death|0|||
162822516|NCT00467779|588063130|FG012|Stage 2A|Death|0|||
162822517|NCT00467779|588063131|FG013|Stage 2A|Death|1|||
162822518|NCT00467779|588063132|FG014|Stage 2A|Death|0|||
162822519|NCT00467779|588063118|FG000|Stage 2A|Disease Progression|0|||
162822520|NCT00467779|588063119|FG001|Stage 2A|Disease Progression|0|||
162822521|NCT00467779|588063120|FG002|Stage 2A|Disease Progression|0|||
162822522|NCT00467779|588063121|FG003|Stage 2A|Disease Progression|0|||
162822523|NCT00467779|588063122|FG004|Stage 2A|Disease Progression|0|||
162822524|NCT00467779|588063123|FG005|Stage 2A|Disease Progression|0|||
163172695|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172696|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163172697|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
163172698|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172699|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172700|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162822525|NCT00467779|588063124|FG006|Stage 2A|Disease Progression|0|||
162822526|NCT00467779|588063125|FG007|Stage 2A|Disease Progression|0|||
163172701|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172702|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
163172703|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162822527|NCT00467779|588063126|FG008|Stage 2A|Disease Progression|0|||
162822528|NCT00467779|588063127|FG009|Stage 2A|Disease Progression|0|||
162822529|NCT00467779|588063128|FG010|Stage 2A|Disease Progression|0|||
162822530|NCT00467779|588063129|FG011|Stage 2A|Disease Progression|0|||
162822531|NCT00467779|588063130|FG012|Stage 2A|Disease Progression|0|||
162822532|NCT00467779|588063131|FG013|Stage 2A|Disease Progression|10|||
162822533|NCT00467779|588063132|FG014|Stage 2A|Disease Progression|0|||
162822534|NCT00467779|588063118|FG000|Stage 2A|Unspecified Reason|0|||
163172704|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172705|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172706|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172707|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172708|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163172709|NCT01133990|589347290|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
163172710|NCT01133990|589347291|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172711|NCT01133990|589347292|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172712|NCT01133990|589347293|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172713|NCT01133990|589347294|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172714|NCT01133990|589347295|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
163172715|NCT05277337|589347296|FG000|Overall Study|Lost to Follow-up|2|||
162822535|NCT00467779|588063119|FG001|Stage 2A|Unspecified Reason|0|||
162822536|NCT00467779|588063120|FG002|Stage 2A|Unspecified Reason|0|||
162822537|NCT00467779|588063121|FG003|Stage 2A|Unspecified Reason|0|||
162822538|NCT00467779|588063122|FG004|Stage 2A|Unspecified Reason|0|||
162822539|NCT00467779|588063123|FG005|Stage 2A|Unspecified Reason|0|||
162822540|NCT00467779|588063124|FG006|Stage 2A|Unspecified Reason|0|||
162822541|NCT00467779|588063125|FG007|Stage 2A|Unspecified Reason|0|||
162822542|NCT00467779|588063126|FG008|Stage 2A|Unspecified Reason|0|||
162822543|NCT00467779|588063127|FG009|Stage 2A|Unspecified Reason|0|||
162822544|NCT00467779|588063128|FG010|Stage 2A|Unspecified Reason|0|||
162822545|NCT00467779|588063129|FG011|Stage 2A|Unspecified Reason|0|||
162822546|NCT00467779|588063130|FG012|Stage 2A|Unspecified Reason|0|||
162822547|NCT00467779|588063131|FG013|Stage 2A|Unspecified Reason|7|||
162822548|NCT00467779|588063132|FG014|Stage 2A|Unspecified Reason|0|||
162822549|NCT00467779|588063118|FG000|Stage 2A|Withdrawal by Subject|0|||
162822550|NCT00467779|588063119|FG001|Stage 2A|Withdrawal by Subject|0|||
162822551|NCT00467779|588063120|FG002|Stage 2A|Withdrawal by Subject|0|||
162822552|NCT00467779|588063121|FG003|Stage 2A|Withdrawal by Subject|0|||
162822553|NCT00467779|588063122|FG004|Stage 2A|Withdrawal by Subject|0|||
162822554|NCT00467779|588063123|FG005|Stage 2A|Withdrawal by Subject|0|||
162822555|NCT00467779|588063124|FG006|Stage 2A|Withdrawal by Subject|0|||
162822556|NCT00467779|588063125|FG007|Stage 2A|Withdrawal by Subject|0|||
162822557|NCT00467779|588063126|FG008|Stage 2A|Withdrawal by Subject|0|||
162822558|NCT00467779|588063127|FG009|Stage 2A|Withdrawal by Subject|0|||
162822559|NCT00467779|588063128|FG010|Stage 2A|Withdrawal by Subject|0|||
162822560|NCT00467779|588063129|FG011|Stage 2A|Withdrawal by Subject|0|||
162822561|NCT00467779|588063130|FG012|Stage 2A|Withdrawal by Subject|0|||
162822562|NCT00467779|588063131|FG013|Stage 2A|Withdrawal by Subject|1|||
162822563|NCT00467779|588063132|FG014|Stage 2A|Withdrawal by Subject|0|||
162822564|NCT00467779|588063118|FG000|Stage 3|Adverse Event|0|||
162822565|NCT00467779|588063119|FG001|Stage 3|Adverse Event|0|||
162822566|NCT00467779|588063120|FG002|Stage 3|Adverse Event|0|||
162822567|NCT00467779|588063121|FG003|Stage 3|Adverse Event|0|||
162822568|NCT00467779|588063122|FG004|Stage 3|Adverse Event|0|||
162822569|NCT00467779|588063123|FG005|Stage 3|Adverse Event|0|||
162822570|NCT00467779|588063124|FG006|Stage 3|Adverse Event|0|||
162822571|NCT00467779|588063125|FG007|Stage 3|Adverse Event|0|||
162822572|NCT00467779|588063126|FG008|Stage 3|Adverse Event|0|||
162822573|NCT00467779|588063127|FG009|Stage 3|Adverse Event|0|||
162822574|NCT00467779|588063128|FG010|Stage 3|Adverse Event|0|||
162822575|NCT00467779|588063129|FG011|Stage 3|Adverse Event|0|||
162822576|NCT00467779|588063130|FG012|Stage 3|Adverse Event|0|||
162822577|NCT00467779|588063131|FG013|Stage 3|Adverse Event|0|||
162822578|NCT00467779|588063132|FG014|Stage 3|Adverse Event|2|||
162822579|NCT00467779|588063118|FG000|Stage 3|Death|0|||
162822580|NCT00467779|588063119|FG001|Stage 3|Death|0|||
162822581|NCT00467779|588063120|FG002|Stage 3|Death|0|||
162822582|NCT00467779|588063121|FG003|Stage 3|Death|0|||
162822583|NCT00467779|588063122|FG004|Stage 3|Death|0|||
162822584|NCT00467779|588063123|FG005|Stage 3|Death|0|||
162822585|NCT00467779|588063124|FG006|Stage 3|Death|0|||
162822586|NCT00467779|588063125|FG007|Stage 3|Death|0|||
162822587|NCT00467779|588063126|FG008|Stage 3|Death|0|||
162822588|NCT00467779|588063127|FG009|Stage 3|Death|0|||
162822589|NCT00467779|588063128|FG010|Stage 3|Death|0|||
162822590|NCT00467779|588063129|FG011|Stage 3|Death|0|||
162822591|NCT00467779|588063130|FG012|Stage 3|Death|0|||
162822592|NCT00467779|588063131|FG013|Stage 3|Death|0|||
162822593|NCT00467779|588063132|FG014|Stage 3|Death|1|||
162822594|NCT00467779|588063118|FG000|Stage 3|Disease Progression|0|||
162822595|NCT00467779|588063119|FG001|Stage 3|Disease Progression|0|||
162822596|NCT00467779|588063120|FG002|Stage 3|Disease Progression|0|||
162822597|NCT00467779|588063121|FG003|Stage 3|Disease Progression|0|||
162822598|NCT00467779|588063122|FG004|Stage 3|Disease Progression|0|||
162822599|NCT00467779|588063123|FG005|Stage 3|Disease Progression|0|||
162822600|NCT00467779|588063124|FG006|Stage 3|Disease Progression|0|||
162822601|NCT00467779|588063125|FG007|Stage 3|Disease Progression|0|||
162822602|NCT00467779|588063126|FG008|Stage 3|Disease Progression|0|||
162822603|NCT00467779|588063127|FG009|Stage 3|Disease Progression|0|||
162822604|NCT00467779|588063128|FG010|Stage 3|Disease Progression|0|||
162822605|NCT00467779|588063129|FG011|Stage 3|Disease Progression|0|||
162822606|NCT00467779|588063130|FG012|Stage 3|Disease Progression|0|||
162822607|NCT00467779|588063131|FG013|Stage 3|Disease Progression|0|||
162822608|NCT00467779|588063132|FG014|Stage 3|Disease Progression|9|||
162822609|NCT00467779|588063118|FG000|Stage 3|Unspecified Reason|0|||
162822610|NCT00467779|588063119|FG001|Stage 3|Unspecified Reason|0|||
162822611|NCT00467779|588063120|FG002|Stage 3|Unspecified Reason|0|||
162822612|NCT00467779|588063121|FG003|Stage 3|Unspecified Reason|0|||
162822613|NCT00467779|588063122|FG004|Stage 3|Unspecified Reason|0|||
162822614|NCT00467779|588063123|FG005|Stage 3|Unspecified Reason|0|||
162822615|NCT00467779|588063124|FG006|Stage 3|Unspecified Reason|0|||
162822616|NCT00467779|588063125|FG007|Stage 3|Unspecified Reason|0|||
162822617|NCT00467779|588063126|FG008|Stage 3|Unspecified Reason|0|||
162822618|NCT00467779|588063127|FG009|Stage 3|Unspecified Reason|0|||
163172716|NCT05277337|589347297|FG001|Overall Study|Lost to Follow-up|0|||
162822619|NCT00467779|588063128|FG010|Stage 3|Unspecified Reason|0|||
162822620|NCT00467779|588063129|FG011|Stage 3|Unspecified Reason|0|||
162822621|NCT00467779|588063130|FG012|Stage 3|Unspecified Reason|0|||
162822622|NCT00467779|588063131|FG013|Stage 3|Unspecified Reason|0|||
162822623|NCT00467779|588063132|FG014|Stage 3|Unspecified Reason|5|||
162822624|NCT01509079|588063133|FG000|Overall Study|Lack of Efficacy|0|||
162822625|NCT01509079|588063134|FG001|Overall Study|Lack of Efficacy|2|||
162822626|NCT01509079|588063133|FG000|Overall Study|started an excluded medication|0|||
162822627|NCT01509079|588063134|FG001|Overall Study|started an excluded medication|1|||
162822628|NCT01195090|588063135|FG000|Overall Study|Adverse Event|1|||
162822629|NCT01195090|588063136|FG001|Overall Study|Adverse Event|2|||
162822630|NCT01195090|588063135|FG000|Overall Study|Lost to Follow-up|2|||
162822631|NCT01195090|588063136|FG001|Overall Study|Lost to Follow-up|2|||
162822632|NCT01195090|588063135|FG000|Overall Study|Protocol Violation|3|||
162822633|NCT01195090|588063136|FG001|Overall Study|Protocol Violation|4|||
162822634|NCT05111041|588063137|FG000|Overall Study|Lost to Follow-up|6|||
162822635|NCT05111041|588063138|FG001|Overall Study|Lost to Follow-up|7|||
162822636|NCT05111041|588063137|FG000|Overall Study|Withdrawal by Subject|1|||
162822637|NCT05111041|588063138|FG001|Overall Study|Withdrawal by Subject|0|||
162822638|NCT04912245|588063139|FG000|Overall Study|Withdrawal by Subject|21|||
163172717|NCT05277337|589347296|FG000|Overall Study|Withdrawal by Subject|1|||
163172718|NCT05277337|589347297|FG001|Overall Study|Withdrawal by Subject|0|||
163172719|NCT01185301|589347298|FG000|Overall Study|Adverse Event|3|||
163172720|NCT01185301|589347299|FG001|Overall Study|Adverse Event|0|||
163172721|NCT01185301|589347300|FG002|Overall Study|Adverse Event|2|||
163172722|NCT01185301|589347301|FG003|Overall Study|Adverse Event|3|||
163172723|NCT01185301|589347298|FG000|Overall Study|Withdrawal by Subject|7|||
163172724|NCT01185301|589347299|FG001|Overall Study|Withdrawal by Subject|5|||
163172725|NCT01185301|589347300|FG002|Overall Study|Withdrawal by Subject|2|||
163172726|NCT01185301|589347301|FG003|Overall Study|Withdrawal by Subject|3|||
163172727|NCT01185301|589347298|FG000|Overall Study|Lost to Follow-up|2|||
163172728|NCT01185301|589347299|FG001|Overall Study|Lost to Follow-up|0|||
163172729|NCT01185301|589347300|FG002|Overall Study|Lost to Follow-up|0|||
163172730|NCT01185301|589347301|FG003|Overall Study|Lost to Follow-up|1|||
163172731|NCT01185301|589347298|FG000|Overall Study|Other Reason|3|||
163172732|NCT01185301|589347299|FG001|Overall Study|Other Reason|2|||
163172733|NCT01185301|589347300|FG002|Overall Study|Other Reason|2|||
163172734|NCT01185301|589347301|FG003|Overall Study|Other Reason|2|||
163172735|NCT02683746|589347302|FG000|Overall Study|Adverse Event|3|||
163172736|NCT02683746|589347303|FG001|Overall Study|Adverse Event|2|||
163172737|NCT02683746|589347302|FG000|Overall Study|Lost to Follow-up|5|||
163172738|NCT02683746|589347303|FG001|Overall Study|Lost to Follow-up|6|||
163172739|NCT02683746|589347302|FG000|Overall Study|Withdrawal by Subject|6|||
163172740|NCT02683746|589347303|FG001|Overall Study|Withdrawal by Subject|5|||
163172741|NCT02683746|589347302|FG000|Overall Study|Physician Decision|2|||
163172742|NCT02683746|589347303|FG001|Overall Study|Physician Decision|1|||
163172743|NCT04987944|589347308|FG000|Overall Study|Adverse Event|0|||
163172744|NCT04987944|589347309|FG001|Overall Study|Adverse Event|1|||
163172745|NCT04987944|589347308|FG000|Overall Study|Withdrawal by Subject|0|||
163172746|NCT04987944|589347309|FG001|Overall Study|Withdrawal by Subject|1|||
163172747|NCT00409175|589347315|FG000|Overall Study|Adverse Event|4|||
163172748|NCT00409175|589347316|FG001|Overall Study|Adverse Event|3|||
163172749|NCT00409175|589347315|FG000|Overall Study|Withdrawal by Subject|1|||
163172750|NCT00409175|589347316|FG001|Overall Study|Withdrawal by Subject|2|||
163172751|NCT00409175|589347315|FG000|Overall Study|Negative genotype|0|||
163172752|NCT00409175|589347316|FG001|Overall Study|Negative genotype|1|||
163172753|NCT00409175|589347315|FG000|Overall Study|Liver transplantation|13|||
163172754|NCT00409175|589347316|FG001|Overall Study|Liver transplantation|13|||
163172755|NCT03339297|589347317|FG000|Overall Study|Relapse of Hematologic Disease|1|||
163172756|NCT03339297|589347318|FG001|Overall Study|Relapse of Hematologic Disease|0|||
163172757|NCT03339297|589347317|FG000|Overall Study|Death|10|||
163172758|NCT03339297|589347318|FG001|Overall Study|Death|7|||
163172759|NCT03339297|589347317|FG000|Overall Study|Hepatic Candidosis|1|||
163172760|NCT03339297|589347318|FG001|Overall Study|Hepatic Candidosis|0|||
163172761|NCT03339297|589347317|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
163172762|NCT03339297|589347318|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
163172763|NCT03339297|589347317|FG000|Overall Study|Consent Withdrawn by Participant|3|||
163172764|NCT03339297|589347318|FG001|Overall Study|Consent Withdrawn by Participant|3|||
163172765|NCT03339297|589347317|FG000|Overall Study|Disease Relapse|2|||
163172766|NCT03339297|589347318|FG001|Overall Study|Disease Relapse|0|||
163172767|NCT03339297|589347317|FG000|Overall Study|Physician Decision|1|||
163172768|NCT03339297|589347318|FG001|Overall Study|Physician Decision|1|||
163172769|NCT03339297|589347317|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
163172770|NCT03339297|589347318|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
163172771|NCT03339297|589347317|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
163172772|NCT03339297|589347318|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
163172773|NCT03339297|589347317|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
162822639|NCT04912245|588063140|FG001|Overall Study|Withdrawal by Subject|4|||
162822640|NCT04912245|588063139|FG000|Overall Study|Lost to Follow-up|5|||
162822641|NCT04912245|588063140|FG001|Overall Study|Lost to Follow-up|11|||
162822642|NCT01205230|588063141|FG000|Overall Study|Adverse Event|4|||
162822643|NCT01205230|588063142|FG001|Overall Study|Adverse Event|0|||
162822644|NCT01205230|588063141|FG000|Overall Study|Physician Decision|1|||
162822645|NCT01205230|588063142|FG001|Overall Study|Physician Decision|0|||
162822646|NCT03945591|588063143|FG000|Overall Study|Participant not transplanted|1|||
162822647|NCT03945591|588063143|FG000|Overall Study|Change in treatment plan|3|||
162822648|NCT03945591|588063143|FG000|Overall Study|Adverse Event|1|||
162822649|NCT00041080|588063144|FG000|Overall Study|Adverse Event|21|||
162822650|NCT00041080|588063145|FG001|Overall Study|Adverse Event|1|||
162822651|NCT00041080|588063144|FG000|Overall Study|Withdrawal by Subject|6|||
162822652|NCT00041080|588063145|FG001|Overall Study|Withdrawal by Subject|6|||
162822653|NCT00041080|588063144|FG000|Overall Study|Concommitant Illness/Other|1|||
162822654|NCT00041080|588063145|FG001|Overall Study|Concommitant Illness/Other|2|||
162822655|NCT00041080|588063144|FG000|Overall Study|Did not start therapy|1|||
162822656|NCT00041080|588063145|FG001|Overall Study|Did not start therapy|1|||
162822657|NCT00041080|588063144|FG000|Overall Study|Ineligible|1|||
162822658|NCT00041080|588063145|FG001|Overall Study|Ineligible|0|||
162822659|NCT02428855|588063146|FG000|Overall Study|Withdrawal by Subject|2|||
162822660|NCT00210184|588063147|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
162822661|NCT00823823|588063148|FG000|Overall Study|Lost to Follow-up|3|||
162822662|NCT00823823|588063149|FG001|Overall Study|Lost to Follow-up|1|||
162822663|NCT00823823|588063148|FG000|Overall Study|Protocol Violation|5|||
162822664|NCT00823823|588063149|FG001|Overall Study|Protocol Violation|5|||
162822665|NCT01118325|588063150|FG000|Overall Study|Adverse Event|1|||
162822666|NCT01118325|588063151|FG001|Overall Study|Adverse Event|0|||
162822667|NCT01118325|588063152|FG002|Overall Study|Adverse Event|1|||
162822668|NCT03334409|588063153|FG000|Overall Study|Did not meet inclusion criteria|1|||
162822669|NCT03334409|588063154|FG001|Overall Study|Did not meet inclusion criteria|0|||
162822670|NCT00233363|588063164|FG000|Overall Study|Adverse Event|1|||
162822671|NCT00233363|588063165|FG001|Overall Study|Adverse Event|2|||
162822672|NCT00233363|588063164|FG000|Overall Study|Lack of Efficacy|0|||
162822673|NCT00233363|588063165|FG001|Overall Study|Lack of Efficacy|2|||
162822674|NCT00233363|588063164|FG000|Overall Study|Withdrawal by Subject|1|||
162822675|NCT00233363|588063165|FG001|Overall Study|Withdrawal by Subject|1|||
162822676|NCT00233363|588063164|FG000|Overall Study|Aggravation of complication|1|||
162822677|NCT00233363|588063165|FG001|Overall Study|Aggravation of complication|0|||
162822678|NCT05215262|588063166|FG000|Overall Study|Lost to Follow-up|12|||
162822679|NCT05215262|588063167|FG001|Overall Study|Lost to Follow-up|0|||
162822680|NCT04880447|588063169|FG000|Overall Study|No vaccination information|1|||
162822681|NCT04880447|588063169|FG000|Overall Study|No adverse event information (missing information)|1|||
162822682|NCT04880447|588063169|FG000|Overall Study|Disease not covered in this study|35|||
162822683|NCT00718549|588063175|FG000|Induction Phase|Disease Progression|1|||
162822684|NCT00718549|588063176|FG001|Induction Phase|Disease Progression|0|||
162822685|NCT00718549|588063177|FG002|Induction Phase|Disease Progression|0|||
162822686|NCT00718549|588063175|FG000|Induction Phase|Eligibility Criteria Violation|2|||
162822687|NCT00718549|588063176|FG001|Induction Phase|Eligibility Criteria Violation|0|||
162822688|NCT00718549|588063177|FG002|Induction Phase|Eligibility Criteria Violation|0|||
162822689|NCT00718549|588063175|FG000|Induction Phase|Early Termination - No Additional Info|59|||
162822690|NCT00718549|588063176|FG001|Induction Phase|Early Termination - No Additional Info|0|||
162822691|NCT00718549|588063177|FG002|Induction Phase|Early Termination - No Additional Info|0|||
162822692|NCT00718549|588063175|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
162822693|NCT00718549|588063176|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
163172774|NCT03339297|589347318|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
163172775|NCT03339297|589347317|FG000|Overall Study|Adverse Event, Non-fatal|1|||
163172776|NCT03339297|589347318|FG001|Overall Study|Adverse Event, Non-fatal|0|||
162822694|NCT00718549|588063177|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
162822695|NCT00718549|588063175|FG000|Maintenance/ Observation Phase|Death|0|||
162822696|NCT00718549|588063176|FG001|Maintenance/ Observation Phase|Death|1|||
162822697|NCT00718549|588063177|FG002|Maintenance/ Observation Phase|Death|2|||
162822698|NCT00718549|588063175|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
162822699|NCT00718549|588063176|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
162822700|NCT00718549|588063177|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
162822701|NCT00718549|588063175|FG000|Maintenance/ Observation Phase|Progression|0|||
162822702|NCT00718549|588063176|FG001|Maintenance/ Observation Phase|Progression|5|||
162822703|NCT00718549|588063177|FG002|Maintenance/ Observation Phase|Progression|14|||
162822704|NCT00718549|588063175|FG000|Maintenance/ Observation Phase|Relapse|0|||
162822705|NCT00718549|588063176|FG001|Maintenance/ Observation Phase|Relapse|3|||
162822706|NCT00718549|588063177|FG002|Maintenance/ Observation Phase|Relapse|2|||
162822707|NCT01303965|588063180|FG000|Overall Study|Adverse Event|1|||
163172777|NCT03339297|589347317|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
163172778|NCT03339297|589347318|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
163172779|NCT03339297|589347317|FG000|Overall Study|Patient Was Not Eligible|1|||
163172780|NCT03339297|589347318|FG001|Overall Study|Patient Was Not Eligible|0|||
163172781|NCT03726996|589347321|FG000|Overall Study|Parent's decision|2|||
162822708|NCT01303965|588063181|FG001|Overall Study|Adverse Event|1|||
162822709|NCT01303965|588063180|FG000|Overall Study|Death|0|||
162822710|NCT01303965|588063181|FG001|Overall Study|Death|3|||
162822711|NCT01303965|588063180|FG000|Overall Study|Withdrawal by Subject|1|||
162822712|NCT01303965|588063181|FG001|Overall Study|Withdrawal by Subject|0|||
162822713|NCT01303965|588063180|FG000|Overall Study|Disease Progression|1|||
163172782|NCT03726996|589347321|FG000|Overall Study|Study early termination|2|||
163172783|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163172784|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163172785|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163172786|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163172787|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
163172788|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
163172789|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163172790|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172791|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172792|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163172793|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163172794|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
163172795|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172796|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172797|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172798|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163172799|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163172800|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163172801|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172802|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
163172803|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172804|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172805|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
163172806|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
163172807|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
163172808|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172809|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172810|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163172811|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163172812|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163172813|NCT01328444|589347324|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163172814|NCT01328444|589347325|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
163172815|NCT01328444|589347326|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163172816|NCT01328444|589347327|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
163172817|NCT01328444|589347328|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163172818|NCT01328444|589347329|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163172819|NCT01328444|589347324|FG000|Washout Period (14 Days)|Adverse Event|1|||
163172820|NCT01328444|589347325|FG001|Washout Period (14 Days)|Adverse Event|1|||
163172821|NCT01328444|589347326|FG002|Washout Period (14 Days)|Adverse Event|0|||
163172822|NCT01328444|589347327|FG003|Washout Period (14 Days)|Adverse Event|1|||
163172823|NCT01328444|589347328|FG004|Washout Period (14 Days)|Adverse Event|1|||
163172824|NCT01328444|589347329|FG005|Washout Period (14 Days)|Adverse Event|2|||
162929561|NCT04682639|588447389|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
162929562|NCT04682639|588447390|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
162929563|NCT04682639|588447391|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162929564|NCT04682639|588447392|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162929565|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
162929566|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
162929567|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
162929568|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
162929569|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
162929570|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Other|1|||
162929571|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Other|2|||
162929572|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Other|0|||
162929573|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Other|0|||
162929574|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Other|1|||
162929575|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
162929576|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
162929577|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
162929578|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
162929579|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
162822714|NCT01303965|588063181|FG001|Overall Study|Disease Progression|6|||
162822715|NCT02871778|588063186|FG000|Part A: Treatment Period 1|Adverse Event|1|||
162822716|NCT02871778|588063187|FG001|Part A: Treatment Period 1|Adverse Event|1|||
162822717|NCT02871778|588063188|FG002|Part A: Treatment Period 1|Adverse Event|1|||
162822718|NCT02871778|588063189|FG003|Part A: Treatment Period 1|Adverse Event|0|||
162822719|NCT02871778|588063190|FG004|Part A: Treatment Period 1|Adverse Event|0|||
162822720|NCT02871778|588063191|FG005|Part A: Treatment Period 1|Adverse Event|0|||
162822721|NCT02871778|588063192|FG006|Part A: Treatment Period 1|Adverse Event|0|||
162822722|NCT02871778|588063193|FG007|Part A: Treatment Period 1|Adverse Event|0|||
162822723|NCT02871778|588063186|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
162822724|NCT02871778|588063187|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
162822725|NCT02871778|588063188|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162822726|NCT02871778|588063189|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
162822727|NCT02871778|588063190|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162822728|NCT02871778|588063191|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162822729|NCT02871778|588063192|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162822730|NCT02871778|588063193|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162822731|NCT02871778|588063186|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822732|NCT02871778|588063187|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822733|NCT02871778|588063188|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
162822734|NCT02871778|588063189|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822735|NCT02871778|588063190|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822736|NCT02871778|588063191|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822737|NCT02871778|588063192|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822738|NCT02871778|588063193|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162822739|NCT02871778|588063186|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822740|NCT02871778|588063187|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822741|NCT02871778|588063188|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
162822742|NCT02871778|588063189|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822743|NCT02871778|588063190|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822744|NCT02871778|588063191|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822745|NCT02871778|588063192|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822746|NCT02871778|588063193|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
162822747|NCT02871778|588063186|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822748|NCT02871778|588063187|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
162822749|NCT02871778|588063188|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822750|NCT02871778|588063189|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822751|NCT02871778|588063190|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822752|NCT02871778|588063191|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822753|NCT02871778|588063192|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822754|NCT02871778|588063193|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
162822755|NCT02871778|588063186|FG000|Part A: Treatment Period 2|Adverse Event|2|||
162822756|NCT02871778|588063187|FG001|Part A: Treatment Period 2|Adverse Event|2|||
162822757|NCT02871778|588063188|FG002|Part A: Treatment Period 2|Adverse Event|0|||
162822758|NCT02871778|588063189|FG003|Part A: Treatment Period 2|Adverse Event|0|||
162822759|NCT02871778|588063190|FG004|Part A: Treatment Period 2|Adverse Event|0|||
162822760|NCT02871778|588063191|FG005|Part A: Treatment Period 2|Adverse Event|0|||
162822761|NCT02871778|588063192|FG006|Part A: Treatment Period 2|Adverse Event|0|||
162822762|NCT02871778|588063193|FG007|Part A: Treatment Period 2|Adverse Event|0|||
162822763|NCT02871778|588063186|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822764|NCT02871778|588063187|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
162929580|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
162929581|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
162929582|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929583|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929584|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162929585|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162929586|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
162929587|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929588|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929589|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162929590|NCT04682639|588447388|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
162929591|NCT04682639|588447389|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
162929592|NCT04682639|588447390|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
162929593|NCT04682639|588447391|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
162929594|NCT04682639|588447392|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
162929595|NCT04388527|588447393|FG000|Overall Study|Death|14|||
162929596|NCT04388527|588447393|FG000|Overall Study|Withdrawal by Subject|2|||
162929597|NCT04388527|588447393|FG000|Overall Study|Lost to Follow-up|1|||
162929598|NCT00331773|588447394|FG000|Overall Study|Withdrawal by Subject|6|||
162929599|NCT00331773|588447395|FG001|Overall Study|Withdrawal by Subject|4|||
162929600|NCT00331773|588447394|FG000|Overall Study|Protocol Violation|10|||
162929601|NCT00331773|588447395|FG001|Overall Study|Protocol Violation|3|||
162929602|NCT02773446|588447396|FG000|First Admission|Withdrawal by Subject|0|||
162929603|NCT02773446|588447397|FG001|First Admission|Withdrawal by Subject|0|||
163172825|NCT01328444|589347324|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
163172826|NCT01328444|589347325|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
163172827|NCT01328444|589347326|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
163172828|NCT01328444|589347327|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
163172829|NCT01328444|589347328|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
163172830|NCT01328444|589347329|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
163172831|NCT01328444|589347324|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172832|NCT01328444|589347325|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172833|NCT01328444|589347326|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172834|NCT01328444|589347327|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172835|NCT01328444|589347328|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
163172836|NCT01328444|589347329|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
163172837|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
163172838|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163172839|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172840|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172841|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163172842|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163172843|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
163172844|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163172845|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163172846|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162929604|NCT02773446|588447398|FG002|First Admission|Withdrawal by Subject|0|||
162929605|NCT02773446|588447399|FG003|First Admission|Withdrawal by Subject|1|||
162698422|NCT03881059|587605503|FG000|Treatment Period - Part A|Other reasons|2|||
163172847|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
163172848|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
163172849|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
163172850|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172851|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172852|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172853|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
163172854|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
163172855|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172856|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172857|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172858|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
163172859|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
163172860|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
163172861|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163172862|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163172863|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172864|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172865|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163172866|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
163172867|NCT01328444|589347324|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172868|NCT01328444|589347325|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172869|NCT01328444|589347326|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172870|NCT01328444|589347327|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163172871|NCT01328444|589347328|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163172872|NCT01328444|589347329|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163172873|NCT03241368|589347334|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
163172874|NCT03241368|589347334|FG000|Overall Study|Lost to Follow-up|1|||
163172875|NCT03241368|589347334|FG000|Overall Study|Physician Decision|6|||
163172876|NCT03241368|589347334|FG000|Overall Study|Withdrawal by Subject|6|||
163172877|NCT03241368|589347334|FG000|Overall Study|Protocol Violation|1|||
163172878|NCT01119937|589347335|FG000|Overall Study|Adverse Event|11|||
163172879|NCT01119937|589347336|FG001|Overall Study|Adverse Event|5|||
163172880|NCT01119937|589347335|FG000|Overall Study|Protocol deviation|3|||
163172881|NCT01119937|589347336|FG001|Overall Study|Protocol deviation|1|||
163172882|NCT01119937|589347335|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163172883|NCT01119937|589347336|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163172884|NCT01119937|589347335|FG000|Overall Study|Withdrawal by Subject|2|||
163172885|NCT01119937|589347336|FG001|Overall Study|Withdrawal by Subject|1|||
163172886|NCT03316911|589347337|FG000|Overall Study|Lost to Follow-up|33|||
163172887|NCT03316911|589347338|FG001|Overall Study|Lost to Follow-up|29|||
163172888|NCT01270802|589347339|FG000|Overall Study|Withdrawal by Subject|1|||
163172889|NCT01270802|589347340|FG001|Overall Study|Withdrawal by Subject|0|||
163172890|NCT01270802|589347339|FG000|Overall Study|Adverse Event|1|||
163172891|NCT01270802|589347340|FG001|Overall Study|Adverse Event|0|||
163172892|NCT01270802|589347339|FG000|Overall Study|Lost to Follow-up|0|||
163172893|NCT01270802|589347340|FG001|Overall Study|Lost to Follow-up|1|||
163172894|NCT01566214|589347341|FG000|Overall Study|Lost to Follow-up|3|||
163172895|NCT01566214|589347342|FG001|Overall Study|Lost to Follow-up|0|||
163172896|NCT04620798|589347343|FG000|Overall Study|Lost to Follow-up|126|||
163172897|NCT04620798|589347344|FG001|Overall Study|Lost to Follow-up|138|||
163172898|NCT03222492|589347352|FG000|Overall Study|Withdrawal by Subject|0|||
163172899|NCT03222492|589347353|FG001|Overall Study|Withdrawal by Subject|0|||
163172900|NCT03222492|589347354|FG002|Overall Study|Withdrawal by Subject|1|||
163172901|NCT03222492|589347355|FG003|Overall Study|Withdrawal by Subject|0|||
163172902|NCT03222492|589347352|FG000|Overall Study|COVID-19 related|0|||
163172903|NCT03222492|589347353|FG001|Overall Study|COVID-19 related|0|||
163172904|NCT03222492|589347354|FG002|Overall Study|COVID-19 related|1|||
163172905|NCT03222492|589347355|FG003|Overall Study|COVID-19 related|0|||
163172906|NCT02486627|589347358|FG000|Overall Study|Death|1|||
163172907|NCT02486627|589347359|FG001|Overall Study|Death|0|||
163172908|NCT02486627|589347358|FG000|Overall Study|Other Unspecified|0|||
163172909|NCT02486627|589347359|FG001|Overall Study|Other Unspecified|2|||
163172910|NCT02486627|589347358|FG000|Overall Study|Consent Withdrawn by Participant|4|||
163172911|NCT02486627|589347359|FG001|Overall Study|Consent Withdrawn by Participant|3|||
163172912|NCT02486627|589347358|FG000|Overall Study|Significant Participant Noncompliance|1|||
163172913|NCT02486627|589347359|FG001|Overall Study|Significant Participant Noncompliance|1|||
163172914|NCT02486627|589347358|FG000|Overall Study|Lost to Follow-up|1|||
163172915|NCT02486627|589347359|FG001|Overall Study|Lost to Follow-up|3|||
163172916|NCT02112045|589347363|FG000|Overall Study|Withdrawal by Subject|1|||
162929606|NCT02773446|588447400|FG004|First Admission|Withdrawal by Subject|0|||
162929607|NCT02773446|588447401|FG005|First Admission|Withdrawal by Subject|0|||
162929608|NCT02773446|588447396|FG000|First Admission|Lost to Follow-up|1|||
162929609|NCT02773446|588447397|FG001|First Admission|Lost to Follow-up|0|||
162929610|NCT02773446|588447398|FG002|First Admission|Lost to Follow-up|0|||
162929611|NCT02773446|588447399|FG003|First Admission|Lost to Follow-up|0|||
162929612|NCT02773446|588447400|FG004|First Admission|Lost to Follow-up|0|||
162929613|NCT02773446|588447401|FG005|First Admission|Lost to Follow-up|0|||
162929614|NCT02513459|588447402|FG000|Overall Study|Adverse Event|7|||
162929615|NCT02513459|588447402|FG000|Overall Study|Withdrew consent|5|||
162929616|NCT02513459|588447402|FG000|Overall Study|Loss of efficacy|2|||
162929617|NCT02513459|588447402|FG000|Overall Study|Pregnancy|2|||
162929618|NCT02513459|588447402|FG000|Overall Study|Subject decision|2|||
162929619|NCT02513459|588447402|FG000|Overall Study|Lack of response|1|||
162929620|NCT02513459|588447402|FG000|Overall Study|Reproductive plans|1|||
162929621|NCT02513459|588447402|FG000|Overall Study|Surgery planned-- not done|1|||
162929622|NCT00923195|588447403|FG000|Overall Study|Death|0|||
162929623|NCT00923195|588447404|FG001|Overall Study|Death|1|||
162929624|NCT00525031|588447405|FG000|Overall Study|Disease Progression|1|||
162929625|NCT00525031|588447406|FG001|Overall Study|Disease Progression|1|||
162929626|NCT01613131|588447407|FG000|Overall Study|Withdrawal by Subject|3|||
162929627|NCT01613131|588447408|FG001|Overall Study|Withdrawal by Subject|5|||
162929628|NCT02454972|588447411|FG000|Overall Study|Progressive disease|17|||
162929629|NCT02454972|588447412|FG001|Overall Study|Progressive disease|16|||
162929630|NCT02454972|588447413|FG002|Overall Study|Progressive disease|59|||
162929631|NCT02454972|588447414|FG003|Overall Study|Progressive disease|23|||
162929632|NCT02454972|588447415|FG004|Overall Study|Progressive disease|16|||
162929633|NCT02454972|588447416|FG005|Overall Study|Progressive disease|12|||
162929634|NCT02454972|588447417|FG006|Overall Study|Progressive disease|19|||
162929635|NCT02454972|588447418|FG007|Overall Study|Progressive disease|27|||
162929636|NCT02454972|588447419|FG008|Overall Study|Progressive disease|0|||
162929637|NCT02454972|588447411|FG000|Overall Study|Death|0|||
162929638|NCT02454972|588447412|FG001|Overall Study|Death|0|||
162929639|NCT02454972|588447413|FG002|Overall Study|Death|5|||
162929640|NCT02454972|588447414|FG003|Overall Study|Death|1|||
162929641|NCT02454972|588447415|FG004|Overall Study|Death|0|||
162929642|NCT02454972|588447416|FG005|Overall Study|Death|0|||
162929643|NCT02454972|588447417|FG006|Overall Study|Death|0|||
162929644|NCT02454972|588447418|FG007|Overall Study|Death|0|||
162929645|NCT02454972|588447419|FG008|Overall Study|Death|95|||
162929646|NCT02454972|588447411|FG000|Overall Study|Physician Decision|0|||
162929647|NCT02454972|588447412|FG001|Overall Study|Physician Decision|1|||
162929648|NCT02454972|588447413|FG002|Overall Study|Physician Decision|2|||
162929649|NCT02454972|588447414|FG003|Overall Study|Physician Decision|1|||
162929650|NCT02454972|588447415|FG004|Overall Study|Physician Decision|2|||
162929651|NCT02454972|588447416|FG005|Overall Study|Physician Decision|0|||
162929652|NCT02454972|588447417|FG006|Overall Study|Physician Decision|0|||
162929653|NCT02454972|588447418|FG007|Overall Study|Physician Decision|1|||
162929654|NCT02454972|588447419|FG008|Overall Study|Physician Decision|0|||
162929655|NCT02454972|588447411|FG000|Overall Study|Non treatment-related adverse event|2|||
162929656|NCT02454972|588447412|FG001|Overall Study|Non treatment-related adverse event|0|||
162929657|NCT02454972|588447413|FG002|Overall Study|Non treatment-related adverse event|1|||
162929658|NCT02454972|588447414|FG003|Overall Study|Non treatment-related adverse event|0|||
163172917|NCT02112045|589347364|FG001|Overall Study|Withdrawal by Subject|0|||
163172918|NCT00627445|589347365|FG000|Overall Study|Adverse Event|3|||
163172919|NCT00627445|589347366|FG001|Overall Study|Adverse Event|3|||
163172920|NCT00627445|589347365|FG000|Overall Study|Lack of Efficacy|0|||
163172921|NCT00627445|589347366|FG001|Overall Study|Lack of Efficacy|1|||
163172922|NCT00627445|589347365|FG000|Overall Study|Other|6|||
163172923|NCT00627445|589347366|FG001|Overall Study|Other|8|||
163172924|NCT03554486|589347367|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
163172925|NCT03554486|589347368|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
163172926|NCT03554486|589347369|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
163172927|NCT03554486|589347367|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
163172928|NCT03554486|589347368|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
163172929|NCT03554486|589347369|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
163172930|NCT03554486|589347367|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163172931|NCT03554486|589347368|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
163172932|NCT03554486|589347369|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
163172933|NCT02431260|589347374|FG000|Overall Study|Subject Decision|0|||
163172934|NCT02431260|589347375|FG001|Overall Study|Subject Decision|1|||
163172935|NCT02431260|589347376|FG002|Overall Study|Subject Decision|1|||
163172936|NCT02431260|589347377|FG003|Overall Study|Subject Decision|0|||
163172937|NCT02431260|589347378|FG004|Overall Study|Subject Decision|0|||
163172938|NCT02431260|589347379|FG005|Overall Study|Subject Decision|0|||
163172939|NCT02431260|589347380|FG006|Overall Study|Subject Decision|0|||
163172940|NCT02431260|589347381|FG007|Overall Study|Subject Decision|0|||
163172941|NCT02431260|589347382|FG008|Overall Study|Subject Decision|1|||
163172942|NCT02431260|589347383|FG009|Overall Study|Subject Decision|1|||
163172943|NCT02431260|589347384|FG010|Overall Study|Subject Decision|0|||
163172944|NCT02431260|589347385|FG011|Overall Study|Subject Decision|1|||
163172945|NCT02431260|589347386|FG012|Overall Study|Subject Decision|0|||
163172946|NCT02431260|589347387|FG013|Overall Study|Subject Decision|0|||
163172947|NCT02431260|589347374|FG000|Overall Study|Death|4|||
163172948|NCT02431260|589347375|FG001|Overall Study|Death|4|||
163172949|NCT02431260|589347376|FG002|Overall Study|Death|3|||
163172950|NCT02431260|589347377|FG003|Overall Study|Death|4|||
163172951|NCT02431260|589347378|FG004|Overall Study|Death|2|||
163172952|NCT02431260|589347379|FG005|Overall Study|Death|2|||
163172953|NCT02431260|589347380|FG006|Overall Study|Death|3|||
163172954|NCT02431260|589347381|FG007|Overall Study|Death|1|||
163172955|NCT02431260|589347382|FG008|Overall Study|Death|6|||
163172956|NCT02431260|589347383|FG009|Overall Study|Death|6|||
163172957|NCT02431260|589347384|FG010|Overall Study|Death|3|||
163172958|NCT02431260|589347385|FG011|Overall Study|Death|2|||
163172959|NCT02431260|589347386|FG012|Overall Study|Death|5|||
163172960|NCT02431260|589347387|FG013|Overall Study|Death|1|||
163172961|NCT02431260|589347374|FG000|Overall Study|Lost to Follow-up|0|||
163172962|NCT02431260|589347375|FG001|Overall Study|Lost to Follow-up|0|||
163172963|NCT02431260|589347376|FG002|Overall Study|Lost to Follow-up|0|||
163172964|NCT02431260|589347377|FG003|Overall Study|Lost to Follow-up|0|||
163172965|NCT02431260|589347378|FG004|Overall Study|Lost to Follow-up|0|||
163172966|NCT02431260|589347379|FG005|Overall Study|Lost to Follow-up|1|||
163172967|NCT02431260|589347380|FG006|Overall Study|Lost to Follow-up|0|||
163172968|NCT02431260|589347381|FG007|Overall Study|Lost to Follow-up|0|||
163172969|NCT02431260|589347382|FG008|Overall Study|Lost to Follow-up|0|||
163172970|NCT02431260|589347383|FG009|Overall Study|Lost to Follow-up|0|||
163172971|NCT02431260|589347384|FG010|Overall Study|Lost to Follow-up|0|||
163172972|NCT02431260|589347385|FG011|Overall Study|Lost to Follow-up|0|||
163172973|NCT02431260|589347386|FG012|Overall Study|Lost to Follow-up|0|||
163172974|NCT02431260|589347387|FG013|Overall Study|Lost to Follow-up|0|||
163172975|NCT02431260|589347374|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163172976|NCT02431260|589347375|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163172977|NCT02431260|589347376|FG002|Overall Study|Study Terminated by the Sponsor|2|||
163172978|NCT02431260|589347377|FG003|Overall Study|Study Terminated by the Sponsor|1|||
163172979|NCT02431260|589347378|FG004|Overall Study|Study Terminated by the Sponsor|1|||
163172980|NCT02431260|589347379|FG005|Overall Study|Study Terminated by the Sponsor|0|||
163172981|NCT02431260|589347380|FG006|Overall Study|Study Terminated by the Sponsor|1|||
163172982|NCT02431260|589347381|FG007|Overall Study|Study Terminated by the Sponsor|2|||
163172983|NCT02431260|589347382|FG008|Overall Study|Study Terminated by the Sponsor|1|||
163172984|NCT02431260|589347383|FG009|Overall Study|Study Terminated by the Sponsor|1|||
163172985|NCT02431260|589347384|FG010|Overall Study|Study Terminated by the Sponsor|1|||
163172986|NCT02431260|589347385|FG011|Overall Study|Study Terminated by the Sponsor|0|||
163172987|NCT02431260|589347386|FG012|Overall Study|Study Terminated by the Sponsor|4|||
163172988|NCT02431260|589347387|FG013|Overall Study|Study Terminated by the Sponsor|0|||
163172989|NCT02431260|589347374|FG000|Overall Study|Physician Decision|0|||
163172990|NCT02431260|589347375|FG001|Overall Study|Physician Decision|0|||
162929659|NCT02454972|588447415|FG004|Overall Study|Non treatment-related adverse event|0|||
162929660|NCT02454972|588447416|FG005|Overall Study|Non treatment-related adverse event|1|||
162929661|NCT02454972|588447417|FG006|Overall Study|Non treatment-related adverse event|0|||
162929662|NCT02454972|588447418|FG007|Overall Study|Non treatment-related adverse event|1|||
162929663|NCT02454972|588447419|FG008|Overall Study|Non treatment-related adverse event|0|||
162929664|NCT02454972|588447411|FG000|Overall Study|Treatment-related adverse events|0|||
162929665|NCT02454972|588447412|FG001|Overall Study|Treatment-related adverse events|1|||
162929666|NCT02454972|588447413|FG002|Overall Study|Treatment-related adverse events|1|||
162929667|NCT02454972|588447414|FG003|Overall Study|Treatment-related adverse events|0|||
162929668|NCT02454972|588447415|FG004|Overall Study|Treatment-related adverse events|2|||
162929669|NCT02454972|588447416|FG005|Overall Study|Treatment-related adverse events|0|||
162929670|NCT02454972|588447417|FG006|Overall Study|Treatment-related adverse events|0|||
162929671|NCT02454972|588447418|FG007|Overall Study|Treatment-related adverse events|2|||
162929672|NCT02454972|588447419|FG008|Overall Study|Treatment-related adverse events|0|||
162929673|NCT02454972|588447411|FG000|Overall Study|Patient moves to compassionate use|0|||
162929674|NCT02454972|588447412|FG001|Overall Study|Patient moves to compassionate use|0|||
162929675|NCT02454972|588447413|FG002|Overall Study|Patient moves to compassionate use|0|||
162929676|NCT02454972|588447414|FG003|Overall Study|Patient moves to compassionate use|0|||
162929677|NCT02454972|588447415|FG004|Overall Study|Patient moves to compassionate use|0|||
162929678|NCT02454972|588447416|FG005|Overall Study|Patient moves to compassionate use|0|||
162929679|NCT02454972|588447417|FG006|Overall Study|Patient moves to compassionate use|2|||
162929680|NCT02454972|588447418|FG007|Overall Study|Patient moves to compassionate use|0|||
162929681|NCT02454972|588447419|FG008|Overall Study|Patient moves to compassionate use|0|||
162929682|NCT02454972|588447411|FG000|Overall Study|Withdrawal by Subject|0|||
162929683|NCT02454972|588447412|FG001|Overall Study|Withdrawal by Subject|1|||
162929684|NCT02454972|588447413|FG002|Overall Study|Withdrawal by Subject|5|||
162929685|NCT02454972|588447414|FG003|Overall Study|Withdrawal by Subject|2|||
162929686|NCT02454972|588447415|FG004|Overall Study|Withdrawal by Subject|3|||
162929687|NCT02454972|588447416|FG005|Overall Study|Withdrawal by Subject|2|||
162929688|NCT02454972|588447417|FG006|Overall Study|Withdrawal by Subject|0|||
162929689|NCT02454972|588447418|FG007|Overall Study|Withdrawal by Subject|1|||
162929690|NCT02454972|588447419|FG008|Overall Study|Withdrawal by Subject|2|||
162929691|NCT02454972|588447411|FG000|Overall Study|Multiple delay/holds on treatment|0|||
162929692|NCT02454972|588447412|FG001|Overall Study|Multiple delay/holds on treatment|0|||
162929693|NCT02454972|588447413|FG002|Overall Study|Multiple delay/holds on treatment|0|||
162929694|NCT02454972|588447414|FG003|Overall Study|Multiple delay/holds on treatment|1|||
162929695|NCT02454972|588447415|FG004|Overall Study|Multiple delay/holds on treatment|0|||
162929696|NCT02454972|588447416|FG005|Overall Study|Multiple delay/holds on treatment|0|||
162929697|NCT02454972|588447417|FG006|Overall Study|Multiple delay/holds on treatment|0|||
162929698|NCT02454972|588447418|FG007|Overall Study|Multiple delay/holds on treatment|0|||
162929699|NCT02454972|588447419|FG008|Overall Study|Multiple delay/holds on treatment|0|||
162929700|NCT02454972|588447411|FG000|Overall Study|Never treated|0|||
162929701|NCT02454972|588447412|FG001|Overall Study|Never treated|0|||
162929702|NCT02454972|588447413|FG002|Overall Study|Never treated|3|||
162929703|NCT02454972|588447414|FG003|Overall Study|Never treated|1|||
162929704|NCT02454972|588447415|FG004|Overall Study|Never treated|1|||
162929705|NCT02454972|588447416|FG005|Overall Study|Never treated|0|||
162929706|NCT02454972|588447417|FG006|Overall Study|Never treated|0|||
162929707|NCT02454972|588447418|FG007|Overall Study|Never treated|0|||
162929708|NCT02454972|588447419|FG008|Overall Study|Never treated|5|||
162929709|NCT02454972|588447411|FG000|Overall Study|Lost to Follow-up|0|||
162929710|NCT02454972|588447412|FG001|Overall Study|Lost to Follow-up|0|||
162929711|NCT02454972|588447413|FG002|Overall Study|Lost to Follow-up|0|||
162929712|NCT02454972|588447414|FG003|Overall Study|Lost to Follow-up|0|||
162929713|NCT02454972|588447415|FG004|Overall Study|Lost to Follow-up|0|||
162929714|NCT02454972|588447416|FG005|Overall Study|Lost to Follow-up|0|||
162929715|NCT02454972|588447417|FG006|Overall Study|Lost to Follow-up|0|||
162929716|NCT02454972|588447418|FG007|Overall Study|Lost to Follow-up|0|||
162929717|NCT02454972|588447419|FG008|Overall Study|Lost to Follow-up|2|||
162929718|NCT02454972|588447411|FG000|Overall Study|Study termination|0|||
162929719|NCT02454972|588447412|FG001|Overall Study|Study termination|0|||
162929720|NCT02454972|588447413|FG002|Overall Study|Study termination|0|||
162929721|NCT02454972|588447414|FG003|Overall Study|Study termination|0|||
162929722|NCT02454972|588447415|FG004|Overall Study|Study termination|0|||
162929723|NCT02454972|588447416|FG005|Overall Study|Study termination|0|||
162929724|NCT02454972|588447417|FG006|Overall Study|Study termination|0|||
162929725|NCT02454972|588447418|FG007|Overall Study|Study termination|0|||
162929726|NCT02454972|588447419|FG008|Overall Study|Study termination|6|||
162929727|NCT00787566|588447420|FG000|Overall Study|AE related to chemotherapy|0|||
162929728|NCT00787566|588447421|FG001|Overall Study|AE related to chemotherapy|1|||
162929729|NCT00787566|588447422|FG002|Overall Study|AE related to chemotherapy|0|||
162698423|NCT03881059|587605504|FG001|Treatment Period - Part A|Other reasons|1|||
162698424|NCT03881059|587605505|FG002|Treatment Period - Part A|Other reasons|0|||
162929730|NCT02140164|588447423|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
162929731|NCT01814761|588447428|FG000|Overall Study|Other Reasons|1|||
163172991|NCT02431260|589347376|FG002|Overall Study|Physician Decision|0|||
163172992|NCT02431260|589347377|FG003|Overall Study|Physician Decision|0|||
163172993|NCT02431260|589347378|FG004|Overall Study|Physician Decision|0|||
163172994|NCT02431260|589347379|FG005|Overall Study|Physician Decision|1|||
163172995|NCT02431260|589347380|FG006|Overall Study|Physician Decision|0|||
163172996|NCT02431260|589347381|FG007|Overall Study|Physician Decision|0|||
163172997|NCT02431260|589347382|FG008|Overall Study|Physician Decision|0|||
163172998|NCT02431260|589347383|FG009|Overall Study|Physician Decision|0|||
163172999|NCT02431260|589347384|FG010|Overall Study|Physician Decision|0|||
163173000|NCT02431260|589347385|FG011|Overall Study|Physician Decision|0|||
163173001|NCT02431260|589347386|FG012|Overall Study|Physician Decision|0|||
163173002|NCT02431260|589347387|FG013|Overall Study|Physician Decision|0|||
163173003|NCT02431260|589347374|FG000|Overall Study|Other Unspecified|0|||
163173004|NCT02431260|589347375|FG001|Overall Study|Other Unspecified|0|||
163173005|NCT02431260|589347376|FG002|Overall Study|Other Unspecified|0|||
163173006|NCT02431260|589347377|FG003|Overall Study|Other Unspecified|0|||
163173007|NCT02431260|589347378|FG004|Overall Study|Other Unspecified|0|||
163173008|NCT02431260|589347379|FG005|Overall Study|Other Unspecified|0|||
163173009|NCT02431260|589347380|FG006|Overall Study|Other Unspecified|0|||
163173010|NCT02431260|589347381|FG007|Overall Study|Other Unspecified|0|||
163173011|NCT02431260|589347382|FG008|Overall Study|Other Unspecified|0|||
163173012|NCT02431260|589347383|FG009|Overall Study|Other Unspecified|0|||
163173013|NCT02431260|589347384|FG010|Overall Study|Other Unspecified|0|||
163173014|NCT02431260|589347385|FG011|Overall Study|Other Unspecified|1|||
163173015|NCT02431260|589347386|FG012|Overall Study|Other Unspecified|1|||
163173016|NCT02431260|589347387|FG013|Overall Study|Other Unspecified|0|||
163173017|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
163173018|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
163173019|NCT00321646|589347388|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
163173020|NCT02270944|589347389|FG000|Overall Study|Lost to Follow-up|9|||
163173021|NCT02270944|589347390|FG001|Overall Study|Lost to Follow-up|4|||
163173022|NCT02270944|589347389|FG000|Overall Study|Withdrawal by Subject|2|||
163173023|NCT02270944|589347390|FG001|Overall Study|Withdrawal by Subject|1|||
163173024|NCT01375075|589347395|FG000|Overall Study|Adverse Event|0|||
163173025|NCT01375075|589347396|FG001|Overall Study|Adverse Event|0|||
163173026|NCT01375075|589347397|FG002|Overall Study|Adverse Event|3|||
163173027|NCT01375075|589347398|FG003|Overall Study|Adverse Event|1|||
163173028|NCT01375075|589347399|FG004|Overall Study|Adverse Event|0|||
163173029|NCT01375075|589347400|FG005|Overall Study|Adverse Event|1|||
163173030|NCT01375075|589347395|FG000|Overall Study|Entry Criterion Not Met|1|||
163173031|NCT01375075|589347396|FG001|Overall Study|Entry Criterion Not Met|0|||
163173032|NCT01375075|589347397|FG002|Overall Study|Entry Criterion Not Met|0|||
163173033|NCT01375075|589347398|FG003|Overall Study|Entry Criterion Not Met|0|||
163173034|NCT01375075|589347399|FG004|Overall Study|Entry Criterion Not Met|0|||
163173035|NCT01375075|589347400|FG005|Overall Study|Entry Criterion Not Met|1|||
163173036|NCT01375075|589347395|FG000|Overall Study|Withdrawal by Subject|0|||
163173037|NCT01375075|589347396|FG001|Overall Study|Withdrawal by Subject|1|||
162822765|NCT02871778|588063188|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822766|NCT02871778|588063189|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
162822767|NCT02871778|588063190|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822768|NCT02871778|588063191|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822769|NCT02871778|588063192|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822770|NCT02871778|588063193|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
162822771|NCT02871778|588063186|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
162822772|NCT02871778|588063187|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822773|NCT02871778|588063188|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
162822774|NCT02871778|588063189|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822775|NCT02871778|588063190|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822776|NCT02871778|588063191|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822777|NCT02871778|588063192|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822778|NCT02871778|588063193|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162822779|NCT02871778|588063186|FG000|Part B: Treatment Period 3|Adverse Event|0|||
162822780|NCT02871778|588063187|FG001|Part B: Treatment Period 3|Adverse Event|0|||
162822781|NCT02871778|588063188|FG002|Part B: Treatment Period 3|Adverse Event|0|||
163173038|NCT01375075|589347397|FG002|Overall Study|Withdrawal by Subject|0|||
163173039|NCT01375075|589347398|FG003|Overall Study|Withdrawal by Subject|0|||
163173040|NCT01375075|589347399|FG004|Overall Study|Withdrawal by Subject|0|||
163173041|NCT01375075|589347400|FG005|Overall Study|Withdrawal by Subject|1|||
163173042|NCT00129311|589347408|FG000|Overall Study|Withdrawal by Subject|12|||
163173043|NCT00129311|589347409|FG001|Overall Study|Withdrawal by Subject|19|||
163173044|NCT03603509|589349773|FG000|Overall Study|Lost to Follow-up|3|||
163173045|NCT03603509|589349774|FG001|Overall Study|Lost to Follow-up|4|||
163173046|NCT00002931|589349777|FG000|Overall Study|rapidly progressing disease during|2|||
163173047|NCT00504582|589349778|FG000|Overall Study|Lost to Follow-up|1|||
163173048|NCT00504582|589349779|FG001|Overall Study|Lost to Follow-up|0|||
163173049|NCT00504582|589349780|FG002|Overall Study|Lost to Follow-up|0|||
162929732|NCT01814761|588447429|FG001|Overall Study|Other Reasons|10|||
162929733|NCT01814761|588447428|FG000|Overall Study|Ocular Adverse Event|6|||
162929734|NCT01814761|588447429|FG001|Overall Study|Ocular Adverse Event|15|||
162929735|NCT01814761|588447428|FG000|Overall Study|Lost to Follow-up|1|||
162929736|NCT01814761|588447429|FG001|Overall Study|Lost to Follow-up|5|||
162929737|NCT00775983|588447430|FG000|Overall Study|Protocol Violation|1|||
162929738|NCT00775983|588447431|FG001|Overall Study|Protocol Violation|2|||
162929739|NCT01020305|588447434|FG000|Overall Study|Adverse Event|2|||
162929740|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
162929741|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Off-label use|9|||
162929742|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
162929743|NCT01070966|588447437|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
162929744|NCT01070966|588447437|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
162929745|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
162929746|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
162929747|NCT01070966|588447437|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
162929748|NCT01725113|588447438|FG000|Overall Study|Kidney Transplant|1|||
162929749|NCT01725113|588447439|FG001|Overall Study|Kidney Transplant|1|||
162929750|NCT01725113|588447438|FG000|Overall Study|Withdrawal by Subject|0|||
162929751|NCT01725113|588447439|FG001|Overall Study|Withdrawal by Subject|1|||
162929752|NCT02753400|588447441|FG000|Overall Study|Adverse Event|3|||
162929753|NCT02753400|588447442|FG001|Overall Study|Adverse Event|0|||
162929754|NCT02753400|588447441|FG000|Overall Study|Withdrawal by Subject|2|||
162929755|NCT02753400|588447442|FG001|Overall Study|Withdrawal by Subject|1|||
162929756|NCT03989115|588447443|FG000|Overall Study|Withdrawal by Subject|2|||
162929757|NCT03989115|588447444|FG001|Overall Study|Withdrawal by Subject|1|||
162929758|NCT03989115|588447445|FG002|Overall Study|Withdrawal by Subject|3|||
162929759|NCT03989115|588447446|FG003|Overall Study|Withdrawal by Subject|0|||
162929760|NCT03989115|588447447|FG004|Overall Study|Withdrawal by Subject|17|||
162929761|NCT03989115|588447448|FG005|Overall Study|Withdrawal by Subject|1|||
162929762|NCT03989115|588447449|FG006|Overall Study|Withdrawal by Subject|0|||
162929763|NCT03989115|588447450|FG007|Overall Study|Withdrawal by Subject|0|||
162929764|NCT03989115|588447443|FG000|Overall Study|Sponsor decision to terminate the study|1|||
162929765|NCT03989115|588447444|FG001|Overall Study|Sponsor decision to terminate the study|1|||
162929766|NCT03989115|588447445|FG002|Overall Study|Sponsor decision to terminate the study|0|||
162929767|NCT03989115|588447446|FG003|Overall Study|Sponsor decision to terminate the study|1|||
162929768|NCT03989115|588447447|FG004|Overall Study|Sponsor decision to terminate the study|11|||
162929769|NCT03989115|588447448|FG005|Overall Study|Sponsor decision to terminate the study|0|||
162929770|NCT03989115|588447449|FG006|Overall Study|Sponsor decision to terminate the study|2|||
162698425|NCT03881059|587605503|FG000|Treatment Period - Part B|Adverse Event|0|||
162698426|NCT03881059|587605504|FG001|Treatment Period - Part B|Adverse Event|0|||
163173050|NCT02716896|589349781|FG000|Overall Study|Physician Decision|0|||
163173051|NCT02716896|589349782|FG001|Overall Study|Physician Decision|1|||
163173052|NCT01727700|589349783|FG000|Overall Study|Adverse Event|0|||
163173053|NCT01727700|589349784|FG001|Overall Study|Adverse Event|7|||
163173054|NCT01727700|589349785|FG002|Overall Study|Adverse Event|1|||
163173055|NCT01727700|589349783|FG000|Overall Study|Particpant withdrew consent|0|||
163173056|NCT01727700|589349784|FG001|Overall Study|Particpant withdrew consent|3|||
163173057|NCT01727700|589349785|FG002|Overall Study|Particpant withdrew consent|1|||
163173058|NCT01727700|589349783|FG000|Overall Study|Protocol Violation|2|||
163173059|NCT01727700|589349784|FG001|Overall Study|Protocol Violation|0|||
163173060|NCT01727700|589349785|FG002|Overall Study|Protocol Violation|0|||
163173061|NCT01909791|589349803|FG000|Overall Study|Death|9|||
163173062|NCT01909791|589349804|FG001|Overall Study|Death|8|||
163173063|NCT01909791|589349805|FG002|Overall Study|Death|4|||
163173064|NCT01909791|589349803|FG000|Overall Study|Withdrawal by Subject|5|||
163173065|NCT01909791|589349804|FG001|Overall Study|Withdrawal by Subject|9|||
163173066|NCT01909791|589349805|FG002|Overall Study|Withdrawal by Subject|13|||
163173067|NCT01909791|589349803|FG000|Overall Study|Lost to Follow-up|5|||
163173068|NCT01909791|589349804|FG001|Overall Study|Lost to Follow-up|11|||
163173069|NCT01909791|589349805|FG002|Overall Study|Lost to Follow-up|10|||
163173070|NCT01909791|589349803|FG000|Overall Study|Missed Visit|2|||
163173071|NCT01909791|589349804|FG001|Overall Study|Missed Visit|0|||
163173072|NCT01909791|589349805|FG002|Overall Study|Missed Visit|1|||
163173073|NCT01104376|589349810|FG000|Overall Study|Withdrawal by Subject|15|||
163173074|NCT01104376|589349810|FG000|Overall Study|Consented but excluded after labs|13|||
163173075|NCT00797966|589349811|FG000|Phase A|Lost to Follow-up|0|||
163173076|NCT00797966|589349812|FG001|Phase A|Lost to Follow-up|0|||
163173077|NCT00797966|589349813|FG002|Phase A|Lost to Follow-up|0|||
163173078|NCT00797966|589349814|FG003|Phase A|Lost to Follow-up|0|||
163173079|NCT00797966|589349815|FG004|Phase A|Lost to Follow-up|33|||
163173080|NCT00797966|589349816|FG005|Phase A|Lost to Follow-up|0|||
163173081|NCT00797966|589349811|FG000|Phase A|Adverse Event|0|||
163173082|NCT00797966|589349812|FG001|Phase A|Adverse Event|0|||
163173083|NCT00797966|589349813|FG002|Phase A|Adverse Event|0|||
163173084|NCT00797966|589349814|FG003|Phase A|Adverse Event|0|||
163173085|NCT00797966|589349815|FG004|Phase A|Adverse Event|46|||
163173086|NCT00797966|589349816|FG005|Phase A|Adverse Event|0|||
163173087|NCT00797966|589349811|FG000|Phase A|Met withdrawal criteria|0|||
162822782|NCT02871778|588063189|FG003|Part B: Treatment Period 3|Adverse Event|0|||
162822783|NCT02871778|588063190|FG004|Part B: Treatment Period 3|Adverse Event|1|||
162822784|NCT02871778|588063191|FG005|Part B: Treatment Period 3|Adverse Event|1|||
162822785|NCT02871778|588063192|FG006|Part B: Treatment Period 3|Adverse Event|1|||
162822786|NCT02871778|588063193|FG007|Part B: Treatment Period 3|Adverse Event|0|||
162822787|NCT02653300|588063194|FG000|Overall Study|Withdrawal by Subject|2|||
162822788|NCT00911625|588063198|FG000|Overall Study|Lost to Follow-up|7|||
162822789|NCT00911625|588063199|FG001|Overall Study|Lost to Follow-up|0|||
162822790|NCT00888381|588063204|FG000|Overall Study|Lost to Follow-up|0|||
162822791|NCT00888381|588063205|FG001|Overall Study|Lost to Follow-up|1|||
162822792|NCT00307333|588063206|FG000|Overall Study|Lost to Follow-up|11|||
162822793|NCT00307333|588063207|FG001|Overall Study|Lost to Follow-up|3|||
162822794|NCT04166383|588063208|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
162822795|NCT04166383|588063208|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
162822796|NCT04166383|588063208|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
162822797|NCT03044886|588063209|FG000|Overall Study|Lost to Follow-up|15|||
162822798|NCT03044886|588063210|FG001|Overall Study|Lost to Follow-up|10|||
162822799|NCT03044886|588063211|FG002|Overall Study|Lost to Follow-up|12|||
162822800|NCT03785678|588063214|FG000|Overall Study|Death|44|||
162822801|NCT03785678|588063215|FG001|Overall Study|Death|42|||
162822802|NCT03785678|588063214|FG000|Overall Study|Lost to Follow-up|4|||
162822803|NCT03785678|588063215|FG001|Overall Study|Lost to Follow-up|2|||
162822804|NCT03785678|588063214|FG000|Overall Study|Physician Decision|0|||
162822805|NCT03785678|588063215|FG001|Overall Study|Physician Decision|2|||
162822806|NCT03785678|588063214|FG000|Overall Study|Withdrawal by Subject|5|||
162822807|NCT03785678|588063215|FG001|Overall Study|Withdrawal by Subject|3|||
162822808|NCT01159912|588063216|FG000|Overall Study|Adverse Event|2|||
162822809|NCT01159912|588063217|FG001|Overall Study|Adverse Event|2|||
162822810|NCT01159912|588063218|FG002|Overall Study|Adverse Event|3|||
162822811|NCT01159912|588063216|FG000|Overall Study|Lack of Efficacy|23|||
162822812|NCT01159912|588063217|FG001|Overall Study|Lack of Efficacy|15|||
162822813|NCT01159912|588063218|FG002|Overall Study|Lack of Efficacy|14|||
162822814|NCT01159912|588063216|FG000|Overall Study|Protocol Violation|1|||
162822815|NCT01159912|588063217|FG001|Overall Study|Protocol Violation|2|||
162822816|NCT01159912|588063218|FG002|Overall Study|Protocol Violation|3|||
162822817|NCT01159912|588063216|FG000|Overall Study|Lost to Follow-up|4|||
162822818|NCT01159912|588063217|FG001|Overall Study|Lost to Follow-up|0|||
162822819|NCT01159912|588063218|FG002|Overall Study|Lost to Follow-up|0|||
162822820|NCT01159912|588063216|FG000|Overall Study|Physician Decision|0|||
162822821|NCT01159912|588063217|FG001|Overall Study|Physician Decision|0|||
162822822|NCT01159912|588063218|FG002|Overall Study|Physician Decision|3|||
162822823|NCT01159912|588063216|FG000|Overall Study|Withdrawal by Subject|10|||
162822824|NCT01159912|588063217|FG001|Overall Study|Withdrawal by Subject|3|||
162822825|NCT01159912|588063218|FG002|Overall Study|Withdrawal by Subject|3|||
162822826|NCT00375219|588063219|FG000|Overall Study|Failure to achieve a response|16|||
162822827|NCT00375219|588063220|FG001|Overall Study|Failure to achieve a response|2|||
162822828|NCT00375219|588063221|FG002|Overall Study|Failure to achieve a response|0|||
162822829|NCT00375219|588063219|FG000|Overall Study|Adverse Event|8|||
162822830|NCT00375219|588063220|FG001|Overall Study|Adverse Event|2|||
162822831|NCT00375219|588063221|FG002|Overall Study|Adverse Event|1|||
162822832|NCT00375219|588063219|FG000|Overall Study|Protocol Violation|1|||
162822833|NCT00375219|588063220|FG001|Overall Study|Protocol Violation|0|||
162822834|NCT00375219|588063221|FG002|Overall Study|Protocol Violation|1|||
162822835|NCT00375219|588063219|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
162822836|NCT00375219|588063220|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
162822837|NCT00375219|588063221|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
162822838|NCT00375219|588063219|FG000|Overall Study|Lost to Follow-up|1|||
162822839|NCT00375219|588063220|FG001|Overall Study|Lost to Follow-up|1|||
162822840|NCT00375219|588063221|FG002|Overall Study|Lost to Follow-up|0|||
162822841|NCT00375219|588063219|FG000|Overall Study|Disease progression|18|||
162822842|NCT00375219|588063220|FG001|Overall Study|Disease progression|9|||
162822843|NCT00375219|588063221|FG002|Overall Study|Disease progression|12|||
162822844|NCT00375219|588063219|FG000|Overall Study|Death|4|||
162822845|NCT00375219|588063220|FG001|Overall Study|Death|3|||
162822846|NCT00375219|588063221|FG002|Overall Study|Death|7|||
162822847|NCT00375219|588063219|FG000|Overall Study|Hematologic resistance|1|||
162822848|NCT00375219|588063220|FG001|Overall Study|Hematologic resistance|0|||
162822849|NCT00375219|588063221|FG002|Overall Study|Hematologic resistance|0|||
162822850|NCT00375219|588063219|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
162822851|NCT00375219|588063220|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
162822852|NCT00375219|588063221|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
162822853|NCT00375219|588063219|FG000|Overall Study|Allograft|2|||
162822854|NCT00375219|588063220|FG001|Overall Study|Allograft|0|||
162822855|NCT00375219|588063221|FG002|Overall Study|Allograft|0|||
162822856|NCT00375219|588063219|FG000|Overall Study|Cord blood transplantation|1|||
162822857|NCT00375219|588063220|FG001|Overall Study|Cord blood transplantation|0|||
162822858|NCT00375219|588063221|FG002|Overall Study|Cord blood transplantation|0|||
162822859|NCT00375219|588063219|FG000|Overall Study|Withdrawal by Subject|1|||
162822860|NCT00375219|588063220|FG001|Overall Study|Withdrawal by Subject|0|||
162822861|NCT00375219|588063221|FG002|Overall Study|Withdrawal by Subject|0|||
162822862|NCT02684279|588063224|FG000|Overall Study|Adverse Event|87|||
162822863|NCT02684279|588063224|FG000|Overall Study|Lack of Efficacy|4|||
162822864|NCT02684279|588063224|FG000|Overall Study|Lost to Follow-up|61|||
162822865|NCT02684279|588063224|FG000|Overall Study|Protocol Violation|6|||
162822866|NCT02684279|588063224|FG000|Overall Study|Pregnancy|8|||
162822867|NCT02684279|588063224|FG000|Overall Study|Withdrawal by Subject|92|||
162822868|NCT02684279|588063224|FG000|Overall Study|non-compliance with study drug|9|||
162822869|NCT02684279|588063224|FG000|Overall Study|non compliance with study visits|2|||
162822870|NCT02684279|588063224|FG000|Overall Study|subject to have surgery|1|||
162822871|NCT02684279|588063224|FG000|Overall Study|family emergency|1|||
162822872|NCT02684279|588063224|FG000|Overall Study|Site closures|7|||
162822873|NCT02684279|588063224|FG000|Overall Study|Physician Decision|1|||
162822874|NCT00228566|588063225|FG000|Overall Study|Adverse Event|31|||
162822875|NCT00228566|588063225|FG000|Overall Study|Lack of Efficacy|14|||
162822876|NCT00228566|588063225|FG000|Overall Study|Lost to Follow-up|16|||
162822877|NCT00228566|588063225|FG000|Overall Study|Physician Decision|5|||
162822878|NCT00228566|588063225|FG000|Overall Study|Withdrawal by Subject|4|||
162822879|NCT00228566|588063225|FG000|Overall Study|Miscellaneous|1|||
162822880|NCT01479829|588063226|FG000|Overall Study|Withdrawal by Subject|8|||
162822881|NCT01479829|588063227|FG001|Overall Study|Withdrawal by Subject|10|||
162822882|NCT01444456|588063232|FG000|Overall Study|Withdrawal by Subject|21|||
162822883|NCT01444456|588063232|FG000|Overall Study|Physician Decision|9|||
162822884|NCT01444456|588063232|FG000|Overall Study|Lost to Follow-up|37|||
162822885|NCT01444456|588063232|FG000|Overall Study|Death|73|||
162822886|NCT01444456|588063232|FG000|Overall Study|Ineligibility determined|23|||
162822887|NCT01444456|588063232|FG000|Overall Study|Other|18|||
162822888|NCT01444456|588063232|FG000|Overall Study|Not treated|104|||
162822889|NCT02142738|588064774|FG000|Overall Study|Adverse Event|13|||
162822890|NCT02142738|588064775|FG001|Overall Study|Adverse Event|9|||
162822891|NCT02142738|588064774|FG000|Overall Study|Death|92|||
162822892|NCT02142738|588064775|FG001|Overall Study|Death|112|||
162822893|NCT02142738|588064774|FG000|Overall Study|Lost to Follow-up|0|||
162822894|NCT02142738|588064775|FG001|Overall Study|Lost to Follow-up|3|||
162822895|NCT02142738|588064774|FG000|Overall Study|Withdrawal by Subject|6|||
162822896|NCT02142738|588064775|FG001|Overall Study|Withdrawal by Subject|7|||
162822897|NCT02142738|588064774|FG000|Overall Study|Follow up ended by sponsor|43|||
162822898|NCT02142738|588064775|FG001|Overall Study|Follow up ended by sponsor|20|||
162822899|NCT03713034|588064776|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
162822900|NCT03713034|588064777|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
162822901|NCT02615470|588064778|FG000|Overall Study|Lost to Follow-up|21|||
162822902|NCT02615470|588064779|FG001|Overall Study|Lost to Follow-up|32|||
162822903|NCT02982590|588064783|FG000|Overall Study|Lost to Follow-up|0|||
162822904|NCT02982590|588064784|FG001|Overall Study|Lost to Follow-up|1|||
162822905|NCT02982590|588064783|FG000|Overall Study|Death|4|||
162822906|NCT02982590|588064784|FG001|Overall Study|Death|0|||
162822907|NCT00419120|588064785|FG000|Long Term Follow up Period|study ongoing|10|||
162822908|NCT00388505|588064787|FG000|Overall Study|Adverse Event or Death|43|||
162822909|NCT00388505|588064788|FG001|Overall Study|Adverse Event or Death|17|||
162822910|NCT00388505|588064787|FG000|Overall Study|Withdrawal by Subject|24|||
162822911|NCT00388505|588064788|FG001|Overall Study|Withdrawal by Subject|9|||
162822912|NCT00388505|588064787|FG000|Overall Study|Lost to Follow-up|5|||
162822913|NCT00388505|588064788|FG001|Overall Study|Lost to Follow-up|3|||
162822914|NCT00388505|588064787|FG000|Overall Study|Inappropriate Enrollment|0|||
162822915|NCT00388505|588064788|FG001|Overall Study|Inappropriate Enrollment|1|||
162822916|NCT00388505|588064787|FG000|Overall Study|Administrative Reason|1|||
162822917|NCT00388505|588064788|FG001|Overall Study|Administrative Reason|0|||
162822918|NCT00388505|588064787|FG000|Overall Study|Protocol Violation|6|||
162822919|NCT00388505|588064788|FG001|Overall Study|Protocol Violation|5|||
162822920|NCT00388505|588064787|FG000|Overall Study|Unable to classify|4|||
162822921|NCT00388505|588064788|FG001|Overall Study|Unable to classify|3|||
162822922|NCT02667275|588064789|FG000|Overall Study|Protocol Violation|11|||
162822923|NCT02667275|588064790|FG001|Overall Study|Protocol Violation|7|||
162822924|NCT02667275|588064789|FG000|Overall Study|Lost to Follow-up|0|||
162822925|NCT02667275|588064790|FG001|Overall Study|Lost to Follow-up|2|||
162822926|NCT02667275|588064789|FG000|Overall Study|Withdrawal by Subject|0|||
162822927|NCT02667275|588064790|FG001|Overall Study|Withdrawal by Subject|5|||
162822928|NCT02667275|588064789|FG000|Overall Study|Discontinued early without completing|0|||
162822929|NCT02667275|588064790|FG001|Overall Study|Discontinued early without completing|1|||
162822930|NCT01756040|588064791|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
162822931|NCT01756040|588064791|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
162822932|NCT01756040|588064791|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
162822933|NCT01179672|588064802|FG000|Overall Study|Adverse Event|17|||
162822934|NCT01179672|588064803|FG001|Overall Study|Adverse Event|8|||
162822935|NCT01179672|588064802|FG000|Overall Study|Withdrawal by Subject|10|||
162822936|NCT01179672|588064803|FG001|Overall Study|Withdrawal by Subject|12|||
162822937|NCT01179672|588064802|FG000|Overall Study|Entry Criteria Not Met|0|||
162822938|NCT01179672|588064803|FG001|Overall Study|Entry Criteria Not Met|2|||
162822939|NCT01179672|588064802|FG000|Overall Study|Lost to Follow-up|0|||
162822940|NCT01179672|588064803|FG001|Overall Study|Lost to Follow-up|1|||
162822941|NCT01179672|588064802|FG000|Overall Study|Protocol Violation|2|||
162822942|NCT01179672|588064803|FG001|Overall Study|Protocol Violation|2|||
162822943|NCT01179672|588064802|FG000|Overall Study|Physician Decision|1|||
162822944|NCT01179672|588064803|FG001|Overall Study|Physician Decision|1|||
162822945|NCT01994382|588064804|FG000|Overall Study|Informed consent withdrawn|0|||
162822946|NCT01994382|588064805|FG001|Overall Study|Informed consent withdrawn|0|||
162822947|NCT01994382|588064806|FG002|Overall Study|Informed consent withdrawn|0|||
162822948|NCT01994382|588064807|FG003|Overall Study|Informed consent withdrawn|0|||
162822949|NCT01994382|588064808|FG004|Overall Study|Informed consent withdrawn|0|||
162822950|NCT01994382|588064809|FG005|Overall Study|Informed consent withdrawn|0|||
162822951|NCT01994382|588064810|FG006|Overall Study|Informed consent withdrawn|1|||
162822952|NCT01994382|588064811|FG007|Overall Study|Informed consent withdrawn|0|||
162822953|NCT01994382|588064812|FG008|Overall Study|Informed consent withdrawn|0|||
162822954|NCT01994382|588064813|FG009|Overall Study|Informed consent withdrawn|0|||
162822955|NCT01994382|588064814|FG010|Overall Study|Informed consent withdrawn|0|||
162822956|NCT01994382|588064815|FG011|Overall Study|Informed consent withdrawn|0|||
162822957|NCT01994382|588064816|FG012|Overall Study|Informed consent withdrawn|0|||
162822958|NCT01994382|588064817|FG013|Overall Study|Informed consent withdrawn|0|||
162822959|NCT01994382|588064818|FG014|Overall Study|Informed consent withdrawn|0|||
162822960|NCT01994382|588064819|FG015|Overall Study|Informed consent withdrawn|0|||
162822961|NCT01994382|588064820|FG016|Overall Study|Informed consent withdrawn|0|||
162822962|NCT01994382|588064804|FG000|Overall Study|Progressive disease|3|||
162822963|NCT01994382|588064805|FG001|Overall Study|Progressive disease|4|||
162822964|NCT01994382|588064806|FG002|Overall Study|Progressive disease|4|||
162822965|NCT01994382|588064807|FG003|Overall Study|Progressive disease|3|||
162822966|NCT01994382|588064808|FG004|Overall Study|Progressive disease|2|||
162822967|NCT01994382|588064809|FG005|Overall Study|Progressive disease|3|||
162822968|NCT01994382|588064810|FG006|Overall Study|Progressive disease|3|||
162822969|NCT01994382|588064811|FG007|Overall Study|Progressive disease|6|||
162822970|NCT01994382|588064812|FG008|Overall Study|Progressive disease|2|||
162822971|NCT01994382|588064813|FG009|Overall Study|Progressive disease|2|||
162822972|NCT01994382|588064814|FG010|Overall Study|Progressive disease|13|||
162822973|NCT01994382|588064815|FG011|Overall Study|Progressive disease|8|||
162822974|NCT01994382|588064816|FG012|Overall Study|Progressive disease|7|||
162822975|NCT01994382|588064817|FG013|Overall Study|Progressive disease|3|||
162822976|NCT01994382|588064818|FG014|Overall Study|Progressive disease|6|||
162822977|NCT01994382|588064819|FG015|Overall Study|Progressive disease|44|||
162822978|NCT01994382|588064820|FG016|Overall Study|Progressive disease|28|||
162822979|NCT01994382|588064804|FG000|Overall Study|Physician Decision|0|||
162822980|NCT01994382|588064805|FG001|Overall Study|Physician Decision|1|||
162822981|NCT01994382|588064806|FG002|Overall Study|Physician Decision|0|||
162822982|NCT01994382|588064807|FG003|Overall Study|Physician Decision|0|||
162822983|NCT01994382|588064808|FG004|Overall Study|Physician Decision|0|||
162822984|NCT01994382|588064809|FG005|Overall Study|Physician Decision|0|||
162822985|NCT01994382|588064810|FG006|Overall Study|Physician Decision|0|||
162822986|NCT01994382|588064811|FG007|Overall Study|Physician Decision|0|||
162822987|NCT01994382|588064812|FG008|Overall Study|Physician Decision|0|||
162822988|NCT01994382|588064813|FG009|Overall Study|Physician Decision|0|||
162822989|NCT01994382|588064814|FG010|Overall Study|Physician Decision|3|||
162822990|NCT01994382|588064815|FG011|Overall Study|Physician Decision|1|||
162822991|NCT01994382|588064816|FG012|Overall Study|Physician Decision|1|||
162822992|NCT01994382|588064817|FG013|Overall Study|Physician Decision|0|||
162822993|NCT01994382|588064818|FG014|Overall Study|Physician Decision|1|||
162822994|NCT01994382|588064819|FG015|Overall Study|Physician Decision|4|||
162822995|NCT01994382|588064820|FG016|Overall Study|Physician Decision|2|||
162822996|NCT01994382|588064804|FG000|Overall Study|Death|0|||
162822997|NCT01994382|588064805|FG001|Overall Study|Death|0|||
162822998|NCT01994382|588064806|FG002|Overall Study|Death|0|||
162822999|NCT01994382|588064807|FG003|Overall Study|Death|0|||
162823000|NCT01994382|588064808|FG004|Overall Study|Death|1|||
162823001|NCT01994382|588064809|FG005|Overall Study|Death|0|||
162823002|NCT01994382|588064810|FG006|Overall Study|Death|0|||
162823003|NCT01994382|588064811|FG007|Overall Study|Death|0|||
162823004|NCT01994382|588064812|FG008|Overall Study|Death|1|||
162823005|NCT01994382|588064813|FG009|Overall Study|Death|1|||
162823006|NCT01994382|588064814|FG010|Overall Study|Death|0|||
162823007|NCT01994382|588064815|FG011|Overall Study|Death|0|||
162823008|NCT01994382|588064816|FG012|Overall Study|Death|0|||
162823009|NCT01994382|588064817|FG013|Overall Study|Death|0|||
162929771|NCT03989115|588447450|FG007|Overall Study|Sponsor decision to terminate the study|1|||
162929772|NCT03989115|588447443|FG000|Overall Study|Lost to Follow-up|2|||
162929773|NCT03989115|588447444|FG001|Overall Study|Lost to Follow-up|0|||
162929774|NCT03989115|588447445|FG002|Overall Study|Lost to Follow-up|0|||
162929775|NCT03989115|588447446|FG003|Overall Study|Lost to Follow-up|0|||
162929776|NCT03989115|588447447|FG004|Overall Study|Lost to Follow-up|1|||
162929777|NCT03989115|588447448|FG005|Overall Study|Lost to Follow-up|0|||
162929778|NCT03989115|588447449|FG006|Overall Study|Lost to Follow-up|0|||
162929779|NCT03989115|588447450|FG007|Overall Study|Lost to Follow-up|0|||
162929780|NCT03989115|588447443|FG000|Overall Study|Death|2|||
162929781|NCT03989115|588447444|FG001|Overall Study|Death|2|||
162929782|NCT03989115|588447445|FG002|Overall Study|Death|9|||
162929783|NCT03989115|588447446|FG003|Overall Study|Death|6|||
162929784|NCT03989115|588447447|FG004|Overall Study|Death|31|||
162929785|NCT03989115|588447448|FG005|Overall Study|Death|6|||
162929786|NCT03989115|588447449|FG006|Overall Study|Death|2|||
162929787|NCT03989115|588447450|FG007|Overall Study|Death|3|||
162929788|NCT03989115|588447443|FG000|Overall Study|Other|1|||
162929789|NCT03989115|588447444|FG001|Overall Study|Other|2|||
162929790|NCT03989115|588447445|FG002|Overall Study|Other|0|||
162929791|NCT03989115|588447446|FG003|Overall Study|Other|0|||
162929792|NCT03989115|588447447|FG004|Overall Study|Other|5|||
162929793|NCT03989115|588447448|FG005|Overall Study|Other|0|||
162929794|NCT03989115|588447449|FG006|Overall Study|Other|0|||
162929795|NCT03989115|588447450|FG007|Overall Study|Other|0|||
162929796|NCT01415921|588447451|FG000|Overall Study|Adverse Event|0|||
162929797|NCT01415921|588447452|FG001|Overall Study|Adverse Event|1|||
162929798|NCT01415921|588447451|FG000|Overall Study|Physician Decision|1|||
162929799|NCT01415921|588447452|FG001|Overall Study|Physician Decision|1|||
162929800|NCT01415921|588447451|FG000|Overall Study|Withdrawal by Subject|0|||
162929801|NCT01415921|588447452|FG001|Overall Study|Withdrawal by Subject|1|||
162929802|NCT01415921|588447451|FG000|Overall Study|Other|2|||
162929803|NCT01415921|588447452|FG001|Overall Study|Other|0|||
162929804|NCT02143947|588447453|FG000|Overall Study|Lost to Follow-up|4|||
162929805|NCT02143947|588447454|FG001|Overall Study|Lost to Follow-up|2|||
162929806|NCT00697112|588447459|FG000|Overall Study|Adverse Event|8|||
162929807|NCT00697112|588447459|FG000|Overall Study|Lost to Follow-up|1|||
162929808|NCT00697112|588447459|FG000|Overall Study|Did not meet inclusion criteria|1|||
162929809|NCT04736576|588447462|FG000|Overall Study|Progressive disease|3|||
162929810|NCT04736576|588447463|FG001|Overall Study|Progressive disease|1|||
162929811|NCT04736576|588447462|FG000|Overall Study|Death|1|||
162929812|NCT04736576|588447463|FG001|Overall Study|Death|0|||
162929813|NCT00720304|588447464|FG000|Overall Study|Withdrawal by Subject|14|||
162929814|NCT00720304|588447465|FG001|Overall Study|Withdrawal by Subject|1|||
162929815|NCT00720304|588447464|FG000|Overall Study|Death|1|||
162929816|NCT00720304|588447465|FG001|Overall Study|Death|0|||
162929817|NCT00720304|588447464|FG000|Overall Study|Physician Decision|5|||
162929818|NCT00720304|588447465|FG001|Overall Study|Physician Decision|2|||
162929819|NCT00720304|588447464|FG000|Overall Study|Adverse Event|3|||
162929820|NCT00720304|588447465|FG001|Overall Study|Adverse Event|1|||
162929821|NCT00720304|588447464|FG000|Overall Study|Disease progression|6|||
162929822|NCT00720304|588447465|FG001|Overall Study|Disease progression|1|||
162929823|NCT04330482|588447468|FG000|Overall Study|Lost to Follow-up|2|||
162929824|NCT04330482|588447469|FG001|Overall Study|Lost to Follow-up|1|||
162929825|NCT04330482|588447468|FG000|Overall Study|Withdrawal by Subject|0|||
162929826|NCT04330482|588447469|FG001|Overall Study|Withdrawal by Subject|3|||
162929827|NCT05180630|588447470|FG000|First Intervention|Physician Decision|0|||
162929828|NCT05180630|588447471|FG001|First Intervention|Physician Decision|0|||
162929829|NCT05180630|588447472|FG002|First Intervention|Physician Decision|3|||
162929830|NCT00709735|588447475|FG000|Overall Study|Lost to Follow-up|1|||
162929831|NCT00709735|588447476|FG001|Overall Study|Lost to Follow-up|1|||
162929832|NCT00709735|588447475|FG000|Overall Study|Relapse into Opioid Abuse|0|||
162929833|NCT00709735|588447476|FG001|Overall Study|Relapse into Opioid Abuse|1|||
162929834|NCT00709735|588447475|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
162929835|NCT00709735|588447476|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
162929836|NCT02725671|588447478|FG000|Overall Study|Lost to Follow-up|1|||
162929837|NCT00963599|588447479|FG000|Overall Study|Adverse Event|2|||
162929838|NCT00963599|588447480|FG001|Overall Study|Adverse Event|0|||
162929839|NCT00963599|588447481|FG002|Overall Study|Adverse Event|1|||
162929840|NCT00963599|588447482|FG003|Overall Study|Adverse Event|2|||
162929841|NCT00963599|588447479|FG000|Overall Study|Lack of Efficacy|0|||
162929842|NCT00963599|588447480|FG001|Overall Study|Lack of Efficacy|2|||
162929843|NCT00963599|588447481|FG002|Overall Study|Lack of Efficacy|1|||
162929844|NCT00963599|588447482|FG003|Overall Study|Lack of Efficacy|4|||
162823010|NCT01994382|588064818|FG014|Overall Study|Death|0|||
162823011|NCT01994382|588064819|FG015|Overall Study|Death|1|||
162823012|NCT01994382|588064820|FG016|Overall Study|Death|0|||
162823013|NCT01994382|588064804|FG000|Overall Study|Adverse Event|0|||
162823014|NCT01994382|588064805|FG001|Overall Study|Adverse Event|1|||
162823015|NCT01994382|588064806|FG002|Overall Study|Adverse Event|2|||
162823016|NCT01994382|588064807|FG003|Overall Study|Adverse Event|0|||
162823017|NCT01994382|588064808|FG004|Overall Study|Adverse Event|0|||
162823018|NCT01994382|588064809|FG005|Overall Study|Adverse Event|0|||
162823019|NCT01994382|588064810|FG006|Overall Study|Adverse Event|0|||
162823020|NCT01994382|588064811|FG007|Overall Study|Adverse Event|0|||
162823021|NCT01994382|588064812|FG008|Overall Study|Adverse Event|0|||
162823022|NCT01994382|588064813|FG009|Overall Study|Adverse Event|0|||
162823023|NCT01994382|588064814|FG010|Overall Study|Adverse Event|15|||
162823024|NCT01994382|588064815|FG011|Overall Study|Adverse Event|2|||
162823025|NCT01994382|588064816|FG012|Overall Study|Adverse Event|7|||
162823026|NCT01994382|588064817|FG013|Overall Study|Adverse Event|3|||
162823027|NCT01994382|588064818|FG014|Overall Study|Adverse Event|17|||
162823028|NCT01994382|588064819|FG015|Overall Study|Adverse Event|6|||
162823029|NCT01994382|588064820|FG016|Overall Study|Adverse Event|3|||
162823030|NCT01994382|588064804|FG000|Overall Study|Other than specified|0|||
162823031|NCT01994382|588064805|FG001|Overall Study|Other than specified|0|||
162823032|NCT01994382|588064806|FG002|Overall Study|Other than specified|0|||
162823033|NCT01994382|588064807|FG003|Overall Study|Other than specified|0|||
162823034|NCT01994382|588064808|FG004|Overall Study|Other than specified|0|||
162823035|NCT01994382|588064809|FG005|Overall Study|Other than specified|0|||
162823036|NCT01994382|588064810|FG006|Overall Study|Other than specified|0|||
162823037|NCT01994382|588064811|FG007|Overall Study|Other than specified|0|||
162823038|NCT01994382|588064812|FG008|Overall Study|Other than specified|0|||
162823039|NCT01994382|588064813|FG009|Overall Study|Other than specified|0|||
162823040|NCT01994382|588064814|FG010|Overall Study|Other than specified|2|||
162823041|NCT01994382|588064815|FG011|Overall Study|Other than specified|0|||
162823042|NCT01994382|588064816|FG012|Overall Study|Other than specified|2|||
162823043|NCT01994382|588064817|FG013|Overall Study|Other than specified|0|||
162823044|NCT01994382|588064818|FG014|Overall Study|Other than specified|0|||
162823045|NCT01994382|588064819|FG015|Overall Study|Other than specified|4|||
162823046|NCT01994382|588064820|FG016|Overall Study|Other than specified|4|||
162823047|NCT01994382|588064804|FG000|Overall Study|Withdrawal by Subject|0|||
162823048|NCT01994382|588064805|FG001|Overall Study|Withdrawal by Subject|0|||
162823049|NCT01994382|588064806|FG002|Overall Study|Withdrawal by Subject|0|||
162823050|NCT01994382|588064807|FG003|Overall Study|Withdrawal by Subject|0|||
162823051|NCT01994382|588064808|FG004|Overall Study|Withdrawal by Subject|0|||
162823052|NCT01994382|588064809|FG005|Overall Study|Withdrawal by Subject|0|||
162823053|NCT01994382|588064810|FG006|Overall Study|Withdrawal by Subject|0|||
162823054|NCT01994382|588064811|FG007|Overall Study|Withdrawal by Subject|0|||
162823055|NCT01994382|588064812|FG008|Overall Study|Withdrawal by Subject|0|||
162823056|NCT01994382|588064813|FG009|Overall Study|Withdrawal by Subject|0|||
162823057|NCT01994382|588064814|FG010|Overall Study|Withdrawal by Subject|6|||
162823058|NCT01994382|588064815|FG011|Overall Study|Withdrawal by Subject|0|||
162823059|NCT01994382|588064816|FG012|Overall Study|Withdrawal by Subject|2|||
162823060|NCT01994382|588064817|FG013|Overall Study|Withdrawal by Subject|0|||
162929845|NCT00963599|588447479|FG000|Overall Study|Lost to Follow-up|0|||
162929846|NCT00963599|588447480|FG001|Overall Study|Lost to Follow-up|1|||
162929847|NCT00963599|588447481|FG002|Overall Study|Lost to Follow-up|1|||
162823061|NCT01994382|588064818|FG014|Overall Study|Withdrawal by Subject|4|||
162823062|NCT01994382|588064819|FG015|Overall Study|Withdrawal by Subject|3|||
162823063|NCT01994382|588064820|FG016|Overall Study|Withdrawal by Subject|0|||
162823064|NCT01994382|588064804|FG000|Overall Study|Lost to Follow-up|0|||
162823065|NCT01994382|588064805|FG001|Overall Study|Lost to Follow-up|0|||
162929848|NCT00963599|588447482|FG003|Overall Study|Lost to Follow-up|1|||
162823066|NCT01994382|588064806|FG002|Overall Study|Lost to Follow-up|0|||
162929849|NCT00963599|588447479|FG000|Overall Study|Protocol Violation|2|||
162929850|NCT00963599|588447480|FG001|Overall Study|Protocol Violation|2|||
162929851|NCT00963599|588447481|FG002|Overall Study|Protocol Violation|3|||
162929852|NCT00963599|588447482|FG003|Overall Study|Protocol Violation|4|||
162929853|NCT00963599|588447479|FG000|Overall Study|Withdrawal by Subject|2|||
162929854|NCT00963599|588447480|FG001|Overall Study|Withdrawal by Subject|1|||
162929855|NCT00963599|588447481|FG002|Overall Study|Withdrawal by Subject|3|||
162929856|NCT00963599|588447482|FG003|Overall Study|Withdrawal by Subject|3|||
162929857|NCT00190684|588447487|FG000|Overall Study|Adverse Event|86|||
162929858|NCT00190684|588447487|FG000|Overall Study|Satisfactory response|80|||
162929859|NCT00190684|588447487|FG000|Overall Study|Lack of efficacy|204|||
162929860|NCT00190684|588447487|FG000|Overall Study|Lost to Follow-up|232|||
162929861|NCT00190684|588447487|FG000|Overall Study|Patient moved|60|||
162929862|NCT00190684|588447487|FG000|Overall Study|Patient Decision|432|||
162929863|NCT00190684|588447487|FG000|Overall Study|Clinical relapse|67|||
162929864|NCT00190684|588447487|FG000|Overall Study|Sponsor's decision|17|||
162929865|NCT00190684|588447487|FG000|Overall Study|Physician Decision|84|||
162929866|NCT00190684|588447487|FG000|Overall Study|Protocol Violation|123|||
162929867|NCT00190684|588447487|FG000|Overall Study|Study Period III Completed|103|||
162929868|NCT00190684|588447487|FG000|Overall Study|Study Period V Completed|1|||
163173088|NCT00797966|589349812|FG001|Phase A|Met withdrawal criteria|0|||
163173089|NCT00797966|589349813|FG002|Phase A|Met withdrawal criteria|0|||
163173090|NCT00797966|589349814|FG003|Phase A|Met withdrawal criteria|0|||
163173091|NCT00797966|589349815|FG004|Phase A|Met withdrawal criteria|4|||
163173092|NCT00797966|589349816|FG005|Phase A|Met withdrawal criteria|0|||
163173093|NCT00797966|589349811|FG000|Phase A|Physician Decision|0|||
163173094|NCT00797966|589349812|FG001|Phase A|Physician Decision|0|||
162823067|NCT01994382|588064807|FG003|Overall Study|Lost to Follow-up|0|||
162823068|NCT01994382|588064808|FG004|Overall Study|Lost to Follow-up|0|||
162823069|NCT01994382|588064809|FG005|Overall Study|Lost to Follow-up|0|||
162823070|NCT01994382|588064810|FG006|Overall Study|Lost to Follow-up|0|||
162823071|NCT01994382|588064811|FG007|Overall Study|Lost to Follow-up|0|||
162823072|NCT01994382|588064812|FG008|Overall Study|Lost to Follow-up|0|||
162823073|NCT01994382|588064813|FG009|Overall Study|Lost to Follow-up|0|||
162823074|NCT01994382|588064814|FG010|Overall Study|Lost to Follow-up|1|||
162823075|NCT01994382|588064815|FG011|Overall Study|Lost to Follow-up|0|||
162823076|NCT01994382|588064816|FG012|Overall Study|Lost to Follow-up|0|||
162823077|NCT01994382|588064817|FG013|Overall Study|Lost to Follow-up|0|||
162823078|NCT01994382|588064818|FG014|Overall Study|Lost to Follow-up|0|||
162823079|NCT01994382|588064819|FG015|Overall Study|Lost to Follow-up|0|||
162823080|NCT01994382|588064820|FG016|Overall Study|Lost to Follow-up|0|||
162823081|NCT01994382|588064804|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823082|NCT01994382|588064805|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823083|NCT01994382|588064806|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823084|NCT01994382|588064807|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823085|NCT01994382|588064808|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823086|NCT01994382|588064809|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823087|NCT01994382|588064810|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823088|NCT01994382|588064811|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823089|NCT01994382|588064812|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823090|NCT01994382|588064813|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823091|NCT01994382|588064814|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
162823092|NCT01994382|588064815|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823093|NCT01994382|588064816|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
162823094|NCT01994382|588064817|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823095|NCT01994382|588064818|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
162823096|NCT01994382|588064819|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
162823097|NCT01994382|588064820|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
162823098|NCT01994382|588064804|FG000|Overall Study|Protocol violation/noncompliance|0|||
162823099|NCT01994382|588064805|FG001|Overall Study|Protocol violation/noncompliance|0|||
162823100|NCT01994382|588064806|FG002|Overall Study|Protocol violation/noncompliance|0|||
162823101|NCT01994382|588064807|FG003|Overall Study|Protocol violation/noncompliance|0|||
162823102|NCT01994382|588064808|FG004|Overall Study|Protocol violation/noncompliance|0|||
162823103|NCT01994382|588064809|FG005|Overall Study|Protocol violation/noncompliance|0|||
162823104|NCT01994382|588064810|FG006|Overall Study|Protocol violation/noncompliance|0|||
162823105|NCT01994382|588064811|FG007|Overall Study|Protocol violation/noncompliance|0|||
162823106|NCT01994382|588064812|FG008|Overall Study|Protocol violation/noncompliance|0|||
162929869|NCT02354976|588447491|FG000|Overall Study|Other - reason not specified|1|||
162929870|NCT02354976|588447492|FG001|Overall Study|Other - reason not specified|0|||
162929871|NCT02354976|588447493|FG002|Overall Study|Other - reason not specified|1|||
163173095|NCT00797966|589349813|FG002|Phase A|Physician Decision|0|||
163173096|NCT00797966|589349814|FG003|Phase A|Physician Decision|0|||
162929872|NCT02354976|588447491|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
162929873|NCT02354976|588447492|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
162929874|NCT02354976|588447493|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
162929875|NCT02354976|588447491|FG000|Overall Study|Adverse Event|1|||
162929876|NCT02354976|588447492|FG001|Overall Study|Adverse Event|0|||
162929877|NCT02354976|588447493|FG002|Overall Study|Adverse Event|2|||
162929878|NCT01706770|588447494|FG000|Overall Study|Lost to Follow-up|1|||
162929879|NCT01706770|588447495|FG001|Overall Study|Lost to Follow-up|0|||
162929880|NCT01706770|588447494|FG000|Overall Study|Physician Decision|1|||
162929881|NCT01706770|588447495|FG001|Overall Study|Physician Decision|0|||
162929882|NCT00068445|588447496|FG000|Randomization|Cancel|1|||
162929883|NCT00068445|588447497|FG001|Randomization|Cancel|3|||
162929884|NCT00068445|588447496|FG000|Randomization|Ineligible|1|||
162929885|NCT00068445|588447497|FG001|Randomization|Ineligible|1|||
162929886|NCT00068445|588447496|FG000|Treatment|Refused Further Treatment|13|||
162929887|NCT00068445|588447497|FG001|Treatment|Refused Further Treatment|10|||
162929888|NCT00068445|588447496|FG000|Treatment|Adverse Event|7|||
162929889|NCT00068445|588447497|FG001|Treatment|Adverse Event|1|||
162929890|NCT00068445|588447496|FG000|Treatment|Other (Specifics not available)|9|||
162929891|NCT00068445|588447497|FG001|Treatment|Other (Specifics not available)|5|||
162929892|NCT01155284|588447498|FG000|Overall Study|Withdrawal by Subject|4|||
162929893|NCT01155284|588447499|FG001|Overall Study|Withdrawal by Subject|3|||
162929894|NCT01155284|588447498|FG000|Overall Study|Lost to Follow-up|1|||
162929895|NCT01155284|588447499|FG001|Overall Study|Lost to Follow-up|2|||
162929896|NCT01155284|588447498|FG000|Overall Study|Physician Decision|1|||
162929897|NCT01155284|588447499|FG001|Overall Study|Physician Decision|0|||
162929898|NCT01155284|588447498|FG000|Overall Study|Adverse Event|1|||
162929899|NCT01155284|588447499|FG001|Overall Study|Adverse Event|0|||
162929900|NCT01896700|588447500|FG000|Overall Study|Adverse Event|4|||
162929901|NCT01896700|588447501|FG001|Overall Study|Adverse Event|5|||
162929902|NCT01896700|588447500|FG000|Overall Study|Withdrawal by Subject|0|||
162929903|NCT01896700|588447501|FG001|Overall Study|Withdrawal by Subject|1|||
162929904|NCT00123487|588447502|FG000|Randomized|Death prior to starting treatment|0|||
162929905|NCT00123487|588447503|FG001|Randomized|Death prior to starting treatment|1|||
162929906|NCT00123487|588447502|FG000|Randomized|SAE prior to starting treatment|1|||
162929907|NCT00123487|588447503|FG001|Randomized|SAE prior to starting treatment|0|||
162929908|NCT00123487|588447502|FG000|Treated With Study Drug|Adverse Event|23|||
162929909|NCT00123487|588447503|FG001|Treated With Study Drug|Adverse Event|22|||
162929910|NCT00123487|588447502|FG000|Treated With Study Drug|Disease Progression|141|||
162929911|NCT00123487|588447503|FG001|Treated With Study Drug|Disease Progression|122|||
162929912|NCT00123487|588447502|FG000|Treated With Study Drug|Physician Decision|8|||
162929913|NCT00123487|588447503|FG001|Treated With Study Drug|Physician Decision|9|||
162929914|NCT00123487|588447502|FG000|Treated With Study Drug|Other|59|||
162929915|NCT00123487|588447503|FG001|Treated With Study Drug|Other|58|||
162929916|NCT00123487|588447502|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
162929917|NCT00123487|588447503|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
162929918|NCT00123487|588447502|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
162929919|NCT00123487|588447503|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
162929920|NCT00123487|588447502|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
162929921|NCT00123487|588447503|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
162929922|NCT01656967|588447510|FG000|Overall Study|faulty monitor|1|||
162929923|NCT01656967|588447511|FG001|Overall Study|faulty monitor|0|||
162929924|NCT01656967|588447510|FG000|Overall Study|unsuccessful ETT insertion|3|||
162929925|NCT01656967|588447511|FG001|Overall Study|unsuccessful ETT insertion|2|||
162929926|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929927|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
162929928|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929929|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
162929930|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929931|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
162929932|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929933|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
162929934|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
162929935|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
162929936|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
162929937|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
162929938|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
162929939|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
162929940|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
162929941|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
162929942|NCT05788237|588447517|FG000|SSA (Approximately 2 Months)|Death|0|||
162929943|NCT05788237|588447518|FG001|SSA (Approximately 2 Months)|Death|1|||
162929944|NCT05788237|588447519|FG002|SSA (Approximately 2 Months)|Death|0|||
162823107|NCT01994382|588064813|FG009|Overall Study|Protocol violation/noncompliance|0|||
162823108|NCT01994382|588064814|FG010|Overall Study|Protocol violation/noncompliance|0|||
162823109|NCT01994382|588064815|FG011|Overall Study|Protocol violation/noncompliance|1|||
162823110|NCT01994382|588064816|FG012|Overall Study|Protocol violation/noncompliance|0|||
162823111|NCT01994382|588064817|FG013|Overall Study|Protocol violation/noncompliance|0|||
162823112|NCT01994382|588064818|FG014|Overall Study|Protocol violation/noncompliance|0|||
162823113|NCT01994382|588064819|FG015|Overall Study|Protocol violation/noncompliance|0|||
162823114|NCT01994382|588064820|FG016|Overall Study|Protocol violation/noncompliance|2|||
162823115|NCT01994382|588064804|FG000|Overall Study|Rolled over to Phase 2a|0|||
162823116|NCT01994382|588064805|FG001|Overall Study|Rolled over to Phase 2a|0|||
162823117|NCT01994382|588064806|FG002|Overall Study|Rolled over to Phase 2a|1|||
162823118|NCT01994382|588064807|FG003|Overall Study|Rolled over to Phase 2a|0|||
162823119|NCT01994382|588064808|FG004|Overall Study|Rolled over to Phase 2a|0|||
162823120|NCT01994382|588064809|FG005|Overall Study|Rolled over to Phase 2a|0|||
162823121|NCT01994382|588064810|FG006|Overall Study|Rolled over to Phase 2a|0|||
162823122|NCT01994382|588064811|FG007|Overall Study|Rolled over to Phase 2a|0|||
162823123|NCT01994382|588064812|FG008|Overall Study|Rolled over to Phase 2a|0|||
162823124|NCT01994382|588064813|FG009|Overall Study|Rolled over to Phase 2a|2|||
162823125|NCT01994382|588064814|FG010|Overall Study|Rolled over to Phase 2a|0|||
162823126|NCT01994382|588064815|FG011|Overall Study|Rolled over to Phase 2a|0|||
162823127|NCT01994382|588064816|FG012|Overall Study|Rolled over to Phase 2a|0|||
162823128|NCT01994382|588064817|FG013|Overall Study|Rolled over to Phase 2a|0|||
162823129|NCT01994382|588064818|FG014|Overall Study|Rolled over to Phase 2a|0|||
162823130|NCT01994382|588064819|FG015|Overall Study|Rolled over to Phase 2a|0|||
162823131|NCT01994382|588064820|FG016|Overall Study|Rolled over to Phase 2a|0|||
162823132|NCT04667377|588064821|FG000|Dose Escalation Period|Other not specified below|3|||
162823133|NCT04667377|588064822|FG001|Dose Escalation Period|Other not specified below|3|||
162823134|NCT04667377|588064823|FG002|Dose Escalation Period|Other not specified below|2|||
162823135|NCT04667377|588064824|FG003|Dose Escalation Period|Other not specified below|1|||
162823136|NCT04667377|588064825|FG004|Dose Escalation Period|Other not specified below|3|||
162823137|NCT04667377|588064821|FG000|Dose Escalation Period|Protocol Violation|2|||
162823138|NCT04667377|588064822|FG001|Dose Escalation Period|Protocol Violation|2|||
162823139|NCT04667377|588064823|FG002|Dose Escalation Period|Protocol Violation|0|||
162823140|NCT04667377|588064824|FG003|Dose Escalation Period|Protocol Violation|2|||
162823141|NCT04667377|588064825|FG004|Dose Escalation Period|Protocol Violation|1|||
162823142|NCT04667377|588064821|FG000|Dose Escalation Period|Burden of study procedures|2|||
162823143|NCT04667377|588064822|FG001|Dose Escalation Period|Burden of study procedures|1|||
162823144|NCT04667377|588064823|FG002|Dose Escalation Period|Burden of study procedures|1|||
162823145|NCT04667377|588064824|FG003|Dose Escalation Period|Burden of study procedures|1|||
162823146|NCT04667377|588064825|FG004|Dose Escalation Period|Burden of study procedures|5|||
162823147|NCT04667377|588064821|FG000|Dose Escalation Period|Change of residence|0|||
162823148|NCT04667377|588064822|FG001|Dose Escalation Period|Change of residence|0|||
162823149|NCT04667377|588064823|FG002|Dose Escalation Period|Change of residence|1|||
162823150|NCT04667377|588064824|FG003|Dose Escalation Period|Change of residence|0|||
162823151|NCT04667377|588064825|FG004|Dose Escalation Period|Change of residence|0|||
162823152|NCT04667377|588064821|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
162823153|NCT04667377|588064822|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
162823154|NCT04667377|588064823|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
162823155|NCT04667377|588064824|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
162823156|NCT04667377|588064825|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
162823157|NCT04667377|588064821|FG000|Dose Escalation Period|Adverse Event|9|||
162823158|NCT04667377|588064822|FG001|Dose Escalation Period|Adverse Event|10|||
162823159|NCT04667377|588064823|FG002|Dose Escalation Period|Adverse Event|12|||
162823160|NCT04667377|588064824|FG003|Dose Escalation Period|Adverse Event|17|||
162823161|NCT04667377|588064825|FG004|Dose Escalation Period|Adverse Event|3|||
162823162|NCT04667377|588064821|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
162823163|NCT04667377|588064822|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
162823164|NCT04667377|588064823|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
162823165|NCT04667377|588064824|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
162823166|NCT04667377|588064825|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
162823167|NCT04667377|588064821|FG000|Dose Escalation Period|Not treated|1|||
162823168|NCT04667377|588064822|FG001|Dose Escalation Period|Not treated|0|||
162823169|NCT04667377|588064823|FG002|Dose Escalation Period|Not treated|0|||
162823170|NCT04667377|588064824|FG003|Dose Escalation Period|Not treated|0|||
162823171|NCT04667377|588064825|FG004|Dose Escalation Period|Not treated|0|||
162823172|NCT04667377|588064821|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
162823173|NCT04667377|588064822|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
162823174|NCT04667377|588064823|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
163173097|NCT00797966|589349815|FG004|Phase A|Physician Decision|13|||
163173098|NCT00797966|589349816|FG005|Phase A|Physician Decision|0|||
163173099|NCT00797966|589349811|FG000|Phase A|Withdrawal by Subject|0|||
163173100|NCT00797966|589349812|FG001|Phase A|Withdrawal by Subject|0|||
162929945|NCT05788237|588447520|FG003|SSA (Approximately 2 Months)|Death|0|||
162929946|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929947|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929948|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
162929949|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
162929950|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929951|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929952|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
162929953|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
162929954|NCT05788237|588447517|FG000|SSB (Approximately 1 Month)|Other|0|||
162929955|NCT05788237|588447518|FG001|SSB (Approximately 1 Month)|Other|0|||
162929956|NCT05788237|588447519|FG002|SSB (Approximately 1 Month)|Other|0|||
162929957|NCT05788237|588447520|FG003|SSB (Approximately 1 Month)|Other|1|||
162929958|NCT00681824|588448779|FG000|Overall Study|withdrawn by investigator|0|||
162929959|NCT00681824|588448780|FG001|Overall Study|withdrawn by investigator|0|||
162929960|NCT00681824|588448781|FG002|Overall Study|withdrawn by investigator|1|||
162929961|NCT00681824|588448779|FG000|Overall Study|scheduling conflict|1|||
162929962|NCT00681824|588448780|FG001|Overall Study|scheduling conflict|0|||
162929963|NCT00681824|588448781|FG002|Overall Study|scheduling conflict|0|||
162929964|NCT00681824|588448779|FG000|Overall Study|Death|0|||
162929965|NCT00681824|588448780|FG001|Overall Study|Death|1|||
162929966|NCT00681824|588448781|FG002|Overall Study|Death|0|||
162929967|NCT03724916|588448782|FG000|Overall Study|Withdrawal by Subject|0|||
162929968|NCT03724916|588448783|FG001|Overall Study|Withdrawal by Subject|1|||
162929969|NCT03724916|588448784|FG002|Overall Study|Withdrawal by Subject|1|||
162929970|NCT03724916|588448785|FG003|Overall Study|Withdrawal by Subject|2|||
162929971|NCT03724916|588448782|FG000|Overall Study|Randomized but not Treated|1|||
162929972|NCT03724916|588448783|FG001|Overall Study|Randomized but not Treated|0|||
162929973|NCT03724916|588448784|FG002|Overall Study|Randomized but not Treated|0|||
162929974|NCT03724916|588448785|FG003|Overall Study|Randomized but not Treated|0|||
162929975|NCT04575038|588448786|FG000|Overall Study|Withdrawal by Subject|1|||
162929976|NCT04575038|588448787|FG001|Overall Study|Withdrawal by Subject|1|||
162929977|NCT04335110|588448794|FG000|Overall Study|Withdrawal by Subject|1|||
162929978|NCT04335110|588448795|FG001|Overall Study|Withdrawal by Subject|1|||
162929979|NCT04335110|588448794|FG000|Overall Study|Death|0|||
162929980|NCT04335110|588448795|FG001|Overall Study|Death|1|||
162929981|NCT03101293|588448798|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
162929982|NCT03101293|588448799|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
162929983|NCT03333382|588448808|FG000|Overall Study|Lost to Follow-up|1|||
162929984|NCT03333382|588448809|FG001|Overall Study|Lost to Follow-up|0|||
162929985|NCT03471182|588448810|FG000|Overall Study|Withdrawal by Subject|1|||
162929986|NCT03471182|588448811|FG001|Overall Study|Withdrawal by Subject|1|||
162929987|NCT03471182|588448812|FG002|Overall Study|Withdrawal by Subject|0|||
162929988|NCT03471182|588448810|FG000|Overall Study|Technical failure|2|||
162929989|NCT03471182|588448811|FG001|Overall Study|Technical failure|0|||
163173101|NCT00797966|589349813|FG002|Phase A|Withdrawal by Subject|0|||
163173102|NCT00797966|589349814|FG003|Phase A|Withdrawal by Subject|0|||
163173103|NCT00797966|589349815|FG004|Phase A|Withdrawal by Subject|33|||
162823175|NCT04667377|588064824|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
162823176|NCT04667377|588064825|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
162823177|NCT04667377|588064821|FG000|Dose Escalation Period|Lost to Follow-up|0|||
162823178|NCT04667377|588064822|FG001|Dose Escalation Period|Lost to Follow-up|1|||
162823179|NCT04667377|588064823|FG002|Dose Escalation Period|Lost to Follow-up|0|||
162823180|NCT04667377|588064824|FG003|Dose Escalation Period|Lost to Follow-up|0|||
162823181|NCT04667377|588064825|FG004|Dose Escalation Period|Lost to Follow-up|0|||
162823182|NCT04667377|588064821|FG000|Maintenance Period|Perceived lack of efficacy|0|||
162823183|NCT04667377|588064822|FG001|Maintenance Period|Perceived lack of efficacy|2|||
162823184|NCT04667377|588064823|FG002|Maintenance Period|Perceived lack of efficacy|1|||
162823185|NCT04667377|588064824|FG003|Maintenance Period|Perceived lack of efficacy|0|||
162823186|NCT04667377|588064825|FG004|Maintenance Period|Perceived lack of efficacy|1|||
162823187|NCT04667377|588064821|FG000|Maintenance Period|Adverse Event|2|||
162823188|NCT04667377|588064822|FG001|Maintenance Period|Adverse Event|8|||
162823189|NCT04667377|588064823|FG002|Maintenance Period|Adverse Event|5|||
162823190|NCT04667377|588064824|FG003|Maintenance Period|Adverse Event|4|||
162823191|NCT04667377|588064825|FG004|Maintenance Period|Adverse Event|1|||
162823192|NCT04667377|588064821|FG000|Maintenance Period|Adverse event: COVID infection|0|||
162823193|NCT04667377|588064822|FG001|Maintenance Period|Adverse event: COVID infection|1|||
162929990|NCT03471182|588448812|FG002|Overall Study|Technical failure|0|||
162929991|NCT03451331|588448816|FG000|Overall Study|Withdrawal by Subject|1|||
162929992|NCT03451331|588448817|FG001|Overall Study|Withdrawal by Subject|0|||
162929993|NCT03451331|588448816|FG000|Overall Study|Unable to start treatment.|1|||
162929994|NCT03451331|588448817|FG001|Overall Study|Unable to start treatment.|1|||
162929995|NCT00289731|588448818|FG000|Overall Study|Adverse Event|1|||
162929996|NCT00289731|588448819|FG001|Overall Study|Adverse Event|2|||
163173104|NCT00797966|589349816|FG005|Phase A|Withdrawal by Subject|0|||
162929997|NCT00289731|588448820|FG002|Overall Study|Adverse Event|2|||
162929998|NCT00289731|588448818|FG000|Overall Study|Other|1|||
162929999|NCT00289731|588448819|FG001|Overall Study|Other|0|||
162930000|NCT00289731|588448820|FG002|Overall Study|Other|0|||
162930001|NCT00660790|588448829|FG000|Baseline to 3 Months|Death|1|||
162930002|NCT00660790|588448829|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
162930003|NCT00660790|588448829|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
162930004|NCT00686374|588448835|FG000|Overall Study|Lack of Efficacy|10|||
162930005|NCT00686374|588448835|FG000|Overall Study|Adverse Event|8|||
162930006|NCT00686374|588448835|FG000|Overall Study|Withdrew consent|5|||
162930007|NCT00686374|588448835|FG000|Overall Study|Lost to Follow-up|1|||
162930008|NCT00686374|588448835|FG000|Overall Study|Missing reason|33|||
162930009|NCT00686374|588448835|FG000|Overall Study|Other, not specified|4|||
162930010|NCT00618774|588448836|FG000|Overall Study|Adverse Event|5|||
162930011|NCT00618774|588448837|FG001|Overall Study|Adverse Event|3|||
162930012|NCT00618774|588448836|FG000|Overall Study|Withdrawal by Subject|1|||
162930013|NCT00618774|588448837|FG001|Overall Study|Withdrawal by Subject|0|||
162930014|NCT02424565|588448839|FG000|Period 1 (D0)|Protocol Violation|0|||
162930015|NCT02424565|588448840|FG001|Period 1 (D0)|Protocol Violation|1|||
162930016|NCT01808209|588448841|FG000|Overall Study|Lost to Follow-up|0|||
162823194|NCT04667377|588064823|FG002|Maintenance Period|Adverse event: COVID infection|0|||
162823195|NCT04667377|588064824|FG003|Maintenance Period|Adverse event: COVID infection|0|||
162823196|NCT04667377|588064825|FG004|Maintenance Period|Adverse event: COVID infection|0|||
162823197|NCT04667377|588064821|FG000|Maintenance Period|COVID-related|0|||
162823198|NCT04667377|588064822|FG001|Maintenance Period|COVID-related|0|||
162823199|NCT04667377|588064823|FG002|Maintenance Period|COVID-related|1|||
162823200|NCT04667377|588064824|FG003|Maintenance Period|COVID-related|1|||
162823201|NCT04667377|588064825|FG004|Maintenance Period|COVID-related|0|||
162823202|NCT04667377|588064821|FG000|Maintenance Period|Protocol Violation|1|||
162823203|NCT04667377|588064822|FG001|Maintenance Period|Protocol Violation|0|||
162823204|NCT04667377|588064823|FG002|Maintenance Period|Protocol Violation|0|||
162823205|NCT04667377|588064824|FG003|Maintenance Period|Protocol Violation|0|||
162823206|NCT04667377|588064825|FG004|Maintenance Period|Protocol Violation|1|||
162823207|NCT04667377|588064821|FG000|Maintenance Period|Burden of study procedures|1|||
162823208|NCT04667377|588064822|FG001|Maintenance Period|Burden of study procedures|2|||
162823209|NCT04667377|588064823|FG002|Maintenance Period|Burden of study procedures|0|||
162823210|NCT04667377|588064824|FG003|Maintenance Period|Burden of study procedures|1|||
162823211|NCT04667377|588064825|FG004|Maintenance Period|Burden of study procedures|0|||
162823212|NCT04667377|588064821|FG000|Maintenance Period|Change of residence|0|||
162823213|NCT04667377|588064822|FG001|Maintenance Period|Change of residence|1|||
162823214|NCT04667377|588064823|FG002|Maintenance Period|Change of residence|0|||
162823215|NCT04667377|588064824|FG003|Maintenance Period|Change of residence|0|||
162823216|NCT04667377|588064825|FG004|Maintenance Period|Change of residence|1|||
162823217|NCT04667377|588064821|FG000|Maintenance Period|Missing|1|||
162823218|NCT04667377|588064822|FG001|Maintenance Period|Missing|0|||
162823219|NCT04667377|588064823|FG002|Maintenance Period|Missing|0|||
162823220|NCT04667377|588064824|FG003|Maintenance Period|Missing|0|||
162823221|NCT04667377|588064825|FG004|Maintenance Period|Missing|0|||
162823222|NCT04667377|588064821|FG000|Maintenance Period|Other than listed above|2|||
162823223|NCT04667377|588064822|FG001|Maintenance Period|Other than listed above|0|||
162823224|NCT04667377|588064823|FG002|Maintenance Period|Other than listed above|3|||
162823225|NCT04667377|588064824|FG003|Maintenance Period|Other than listed above|2|||
162823226|NCT04667377|588064825|FG004|Maintenance Period|Other than listed above|6|||
162823227|NCT04667377|588064821|FG000|Maintenance Period|Withdrawal by Subject|0|||
162823228|NCT04667377|588064822|FG001|Maintenance Period|Withdrawal by Subject|1|||
162823229|NCT04667377|588064823|FG002|Maintenance Period|Withdrawal by Subject|0|||
162823230|NCT04667377|588064824|FG003|Maintenance Period|Withdrawal by Subject|0|||
162823231|NCT04667377|588064825|FG004|Maintenance Period|Withdrawal by Subject|0|||
162823232|NCT04667377|588064821|FG000|Maintenance Period|Lost to Follow-up|1|||
162823233|NCT04667377|588064822|FG001|Maintenance Period|Lost to Follow-up|0|||
162823234|NCT04667377|588064823|FG002|Maintenance Period|Lost to Follow-up|1|||
162823235|NCT04667377|588064824|FG003|Maintenance Period|Lost to Follow-up|0|||
162823236|NCT04667377|588064825|FG004|Maintenance Period|Lost to Follow-up|1|||
162823237|NCT00359021|588064826|FG000|Overall Study|Adverse Event|26|||
162823238|NCT00359021|588064827|FG001|Overall Study|Adverse Event|8|||
162823239|NCT00359021|588064826|FG000|Overall Study|Subject Non-Compliant|1|||
162823240|NCT00359021|588064827|FG001|Overall Study|Subject Non-Compliant|2|||
162823241|NCT00359021|588064826|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
162930017|NCT01808209|588448842|FG001|Overall Study|Lost to Follow-up|1|||
162930018|NCT04228302|588448849|FG000|Overall Study|Adverse Event|0|||
162930019|NCT04228302|588448850|FG001|Overall Study|Adverse Event|0|||
162930020|NCT04228302|588448851|FG002|Overall Study|Adverse Event|0|||
162930021|NCT04228302|588448852|FG003|Overall Study|Adverse Event|0|||
162930022|NCT04228302|588448853|FG004|Overall Study|Adverse Event|1|||
162930023|NCT04228302|588448854|FG005|Overall Study|Adverse Event|0|||
162930024|NCT00685919|588448855|FG000|Overall Study|Withdrawal by Subject|0|||
162930025|NCT00685919|588448856|FG001|Overall Study|Withdrawal by Subject|0|||
162930026|NCT00685919|588448857|FG002|Overall Study|Withdrawal by Subject|1|||
162930027|NCT00685919|588448858|FG003|Overall Study|Withdrawal by Subject|0|||
162930028|NCT00685919|588448855|FG000|Overall Study|Physician Decision|1|||
162930029|NCT00685919|588448856|FG001|Overall Study|Physician Decision|0|||
162930030|NCT00685919|588448857|FG002|Overall Study|Physician Decision|0|||
162930031|NCT00685919|588448858|FG003|Overall Study|Physician Decision|0|||
162930032|NCT00423488|588448859|FG000|Overall Study|No evidence of study drug intake|2|||
162930033|NCT00423488|588448860|FG001|Overall Study|No evidence of study drug intake|1|||
162930034|NCT00423488|588448859|FG000|Overall Study|No post baseline data|3|||
162930035|NCT00423488|588448860|FG001|Overall Study|No post baseline data|0|||
162930036|NCT03118765|588448861|FG000|Overall Study|Withdrawal by Subject|0|||
162930037|NCT03118765|588448862|FG001|Overall Study|Withdrawal by Subject|0|||
162930038|NCT03118765|588448863|FG002|Overall Study|Withdrawal by Subject|1|||
162930039|NCT03118765|588448864|FG003|Overall Study|Withdrawal by Subject|0|||
162930040|NCT03118765|588448865|FG004|Overall Study|Withdrawal by Subject|0|||
162930041|NCT03118765|588448861|FG000|Overall Study|Adverse Event|1|||
162930042|NCT03118765|588448862|FG001|Overall Study|Adverse Event|1|||
162930043|NCT03118765|588448863|FG002|Overall Study|Adverse Event|1|||
162930044|NCT03118765|588448864|FG003|Overall Study|Adverse Event|1|||
162930045|NCT03118765|588448865|FG004|Overall Study|Adverse Event|1|||
162930046|NCT03118765|588448861|FG000|Overall Study|Non compliance with Study Procedures|0|||
162930047|NCT03118765|588448862|FG001|Overall Study|Non compliance with Study Procedures|0|||
162930048|NCT03118765|588448863|FG002|Overall Study|Non compliance with Study Procedures|0|||
162930049|NCT03118765|588448864|FG003|Overall Study|Non compliance with Study Procedures|1|||
162930050|NCT03118765|588448865|FG004|Overall Study|Non compliance with Study Procedures|0|||
162930051|NCT03118765|588448861|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
163173105|NCT00797966|589349811|FG000|Phase A|Protocol deviation|0|||
163173106|NCT00797966|589349812|FG001|Phase A|Protocol deviation|0|||
163173107|NCT00797966|589349813|FG002|Phase A|Protocol deviation|0|||
163173108|NCT00797966|589349814|FG003|Phase A|Protocol deviation|0|||
163173109|NCT00797966|589349815|FG004|Phase A|Protocol deviation|56|||
163173110|NCT00797966|589349816|FG005|Phase A|Protocol deviation|0|||
163173111|NCT00797966|589349811|FG000|Phase B|Lost to Follow-up|0|||
163173112|NCT00797966|589349812|FG001|Phase B|Lost to Follow-up|1|||
163173113|NCT00797966|589349813|FG002|Phase B|Lost to Follow-up|3|||
163173114|NCT00797966|589349814|FG003|Phase B|Lost to Follow-up|0|||
162823242|NCT00359021|588064827|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
162823243|NCT00359021|588064826|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
162823244|NCT00359021|588064827|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
162823245|NCT00359021|588064826|FG000|Overall Study|Withdrawal by Subject|2|||
162823246|NCT00359021|588064827|FG001|Overall Study|Withdrawal by Subject|9|||
162823247|NCT00359021|588064826|FG000|Overall Study|Lost to Follow-up|1|||
162823248|NCT00359021|588064827|FG001|Overall Study|Lost to Follow-up|0|||
162823249|NCT00359021|588064826|FG000|Overall Study|Other|4|||
162823250|NCT00359021|588064827|FG001|Overall Study|Other|1|||
162823251|NCT00359021|588064826|FG000|Overall Study|Pregnancy|1|||
162823252|NCT00359021|588064827|FG001|Overall Study|Pregnancy|0|||
162823253|NCT03861936|588064828|FG000|Overall Study|Withdrawal by Subject|4|||
162823254|NCT03861936|588064829|FG001|Overall Study|Withdrawal by Subject|1|||
163173115|NCT00797966|589349815|FG004|Phase B|Lost to Follow-up|0|||
163173116|NCT00797966|589349816|FG005|Phase B|Lost to Follow-up|0|||
163173117|NCT00797966|589349811|FG000|Phase B|Adverse Event|2|||
163173118|NCT00797966|589349812|FG001|Phase B|Adverse Event|1|||
163173119|NCT00797966|589349813|FG002|Phase B|Adverse Event|3|||
163173120|NCT00797966|589349814|FG003|Phase B|Adverse Event|1|||
163173121|NCT00797966|589349815|FG004|Phase B|Adverse Event|0|||
163173122|NCT00797966|589349816|FG005|Phase B|Adverse Event|0|||
163173123|NCT00797966|589349811|FG000|Phase B|Met Withdrawal Criteria|3|||
163173124|NCT00797966|589349812|FG001|Phase B|Met Withdrawal Criteria|3|||
163173125|NCT00797966|589349813|FG002|Phase B|Met Withdrawal Criteria|6|||
162823255|NCT03861936|588064830|FG002|Overall Study|Withdrawal by Subject|3|||
162823256|NCT03861936|588064828|FG000|Overall Study|Lost to Follow-up|5|||
162823257|NCT03861936|588064829|FG001|Overall Study|Lost to Follow-up|3|||
162823258|NCT03861936|588064830|FG002|Overall Study|Lost to Follow-up|3|||
162823259|NCT03861936|588064828|FG000|Overall Study|Physician Decision|0|||
162823260|NCT03861936|588064829|FG001|Overall Study|Physician Decision|1|||
162930052|NCT03118765|588448862|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
162930053|NCT03118765|588448863|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
162930054|NCT03118765|588448864|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
162930055|NCT03118765|588448865|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
163173126|NCT00797966|589349814|FG003|Phase B|Met Withdrawal Criteria|1|||
163173127|NCT00797966|589349815|FG004|Phase B|Met Withdrawal Criteria|0|||
163173128|NCT00797966|589349816|FG005|Phase B|Met Withdrawal Criteria|0|||
162823261|NCT03861936|588064830|FG002|Overall Study|Physician Decision|0|||
163173129|NCT00797966|589349811|FG000|Phase B|Physician Decision|1|||
163173130|NCT00797966|589349812|FG001|Phase B|Physician Decision|0|||
163173131|NCT00797966|589349813|FG002|Phase B|Physician Decision|3|||
163173132|NCT00797966|589349814|FG003|Phase B|Physician Decision|1|||
162823262|NCT03861936|588064828|FG000|Overall Study|Protocol Deviation|0|||
162823263|NCT03861936|588064829|FG001|Overall Study|Protocol Deviation|0|||
162823264|NCT03861936|588064830|FG002|Overall Study|Protocol Deviation|1|||
162823265|NCT03861936|588064828|FG000|Overall Study|Reason not Specified|5|||
162823266|NCT03861936|588064829|FG001|Overall Study|Reason not Specified|5|||
162823267|NCT03861936|588064830|FG002|Overall Study|Reason not Specified|3|||
162823268|NCT03198520|588064835|FG000|Overall Study|Physician Decision|2|||
162823269|NCT03198520|588064835|FG000|Overall Study|Protocol Violation|2|||
162823270|NCT03198520|588064835|FG000|Overall Study|Withdrawal by Subject|1|||
162823271|NCT03198520|588064835|FG000|Overall Study|Study Ended|1|||
162823272|NCT01670539|588064836|FG000|Overall Study|Death|3|||
162823273|NCT01670539|588064837|FG001|Overall Study|Death|5|||
162823274|NCT01670539|588064836|FG000|Overall Study|Withdrawal by Subject|3|||
162823275|NCT01670539|588064837|FG001|Overall Study|Withdrawal by Subject|0|||
162823276|NCT04353596|588064838|FG000|Overall Study|Protocol Violation|4|||
162823277|NCT04353596|588064839|FG001|Overall Study|Protocol Violation|4|||
162823278|NCT04353596|588064838|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
162823279|NCT04353596|588064839|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
162823280|NCT01236573|588064840|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823281|NCT01236573|588064841|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163173133|NCT00797966|589349815|FG004|Phase B|Physician Decision|0|||
163173134|NCT00797966|589349816|FG005|Phase B|Physician Decision|0|||
163173135|NCT00797966|589349811|FG000|Phase B|Withdrawal by Subject|1|||
163173136|NCT00797966|589349812|FG001|Phase B|Withdrawal by Subject|4|||
163173137|NCT00797966|589349813|FG002|Phase B|Withdrawal by Subject|3|||
163173138|NCT00797966|589349814|FG003|Phase B|Withdrawal by Subject|3|||
163173139|NCT00797966|589349815|FG004|Phase B|Withdrawal by Subject|0|||
163173140|NCT00797966|589349816|FG005|Phase B|Withdrawal by Subject|0|||
163173141|NCT00797966|589349811|FG000|Phase B|Protocol Deviation|4|||
163173142|NCT00797966|589349812|FG001|Phase B|Protocol Deviation|8|||
163173143|NCT00797966|589349813|FG002|Phase B|Protocol Deviation|2|||
163173144|NCT00797966|589349814|FG003|Phase B|Protocol Deviation|6|||
163173145|NCT00797966|589349815|FG004|Phase B|Protocol Deviation|0|||
163173146|NCT00797966|589349816|FG005|Phase B|Protocol Deviation|0|||
163173147|NCT00797966|589349811|FG000|Phase B|Lack of Efficacy|0|||
163173148|NCT00797966|589349812|FG001|Phase B|Lack of Efficacy|1|||
163173149|NCT00797966|589349813|FG002|Phase B|Lack of Efficacy|1|||
163173150|NCT00797966|589349814|FG003|Phase B|Lack of Efficacy|4|||
163173151|NCT00797966|589349815|FG004|Phase B|Lack of Efficacy|0|||
163173152|NCT00797966|589349816|FG005|Phase B|Lack of Efficacy|0|||
163173153|NCT00797966|589349811|FG000|Phase A+|Lost to Follow-up|0|||
163173154|NCT00797966|589349812|FG001|Phase A+|Lost to Follow-up|0|||
163173155|NCT00797966|589349813|FG002|Phase A+|Lost to Follow-up|0|||
163173156|NCT00797966|589349814|FG003|Phase A+|Lost to Follow-up|0|||
163173157|NCT00797966|589349815|FG004|Phase A+|Lost to Follow-up|0|||
163173158|NCT00797966|589349816|FG005|Phase A+|Lost to Follow-up|9|||
163173159|NCT00797966|589349811|FG000|Phase A+|Met withdrawal criteria|0|||
163173160|NCT00797966|589349812|FG001|Phase A+|Met withdrawal criteria|0|||
163173161|NCT00797966|589349813|FG002|Phase A+|Met withdrawal criteria|0|||
163173162|NCT00797966|589349814|FG003|Phase A+|Met withdrawal criteria|0|||
163173163|NCT00797966|589349815|FG004|Phase A+|Met withdrawal criteria|0|||
163173164|NCT00797966|589349816|FG005|Phase A+|Met withdrawal criteria|5|||
163173165|NCT00797966|589349811|FG000|Phase A+|Withdrawal by Subject|0|||
163173166|NCT00797966|589349812|FG001|Phase A+|Withdrawal by Subject|0|||
163173167|NCT00797966|589349813|FG002|Phase A+|Withdrawal by Subject|0|||
163173168|NCT00797966|589349814|FG003|Phase A+|Withdrawal by Subject|0|||
163173169|NCT00797966|589349815|FG004|Phase A+|Withdrawal by Subject|0|||
163173170|NCT00797966|589349816|FG005|Phase A+|Withdrawal by Subject|6|||
163173171|NCT00797966|589349811|FG000|Phase A+|Adverse Event|0|||
163173172|NCT00797966|589349812|FG001|Phase A+|Adverse Event|0|||
162823282|NCT01236573|588064842|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823283|NCT01236573|588064843|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823284|NCT01236573|588064844|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823285|NCT01236573|588064845|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163173173|NCT00797966|589349813|FG002|Phase A+|Adverse Event|0|||
162823286|NCT01236573|588064846|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163173174|NCT00797966|589349814|FG003|Phase A+|Adverse Event|0|||
163173175|NCT00797966|589349815|FG004|Phase A+|Adverse Event|0|||
163173176|NCT00797966|589349816|FG005|Phase A+|Adverse Event|4|||
163173177|NCT00797966|589349811|FG000|Phase A+|Protocol deviation|0|||
163173178|NCT00797966|589349812|FG001|Phase A+|Protocol deviation|0|||
163173179|NCT00797966|589349813|FG002|Phase A+|Protocol deviation|0|||
163173180|NCT00797966|589349814|FG003|Phase A+|Protocol deviation|0|||
163173181|NCT00797966|589349815|FG004|Phase A+|Protocol deviation|0|||
163173182|NCT00797966|589349816|FG005|Phase A+|Protocol deviation|4|||
163173183|NCT01002820|589349818|FG000|Overall Study|Adverse Event|1|||
162930056|NCT03118765|588448861|FG000|Overall Study|COPD Exacerbation|1|||
162930057|NCT03118765|588448862|FG001|Overall Study|COPD Exacerbation|0|||
162930058|NCT03118765|588448863|FG002|Overall Study|COPD Exacerbation|0|||
162930059|NCT03118765|588448864|FG003|Overall Study|COPD Exacerbation|1|||
162930060|NCT03118765|588448865|FG004|Overall Study|COPD Exacerbation|0|||
162930061|NCT03118765|588448861|FG000|Overall Study|Lost to Follow-up|1|||
162930062|NCT03118765|588448862|FG001|Overall Study|Lost to Follow-up|0|||
162930063|NCT03118765|588448863|FG002|Overall Study|Lost to Follow-up|1|||
162930064|NCT03118765|588448864|FG003|Overall Study|Lost to Follow-up|0|||
162930065|NCT03118765|588448865|FG004|Overall Study|Lost to Follow-up|0|||
162930066|NCT03118765|588448861|FG000|Overall Study|Sponsor Decision|1|||
162930067|NCT03118765|588448862|FG001|Overall Study|Sponsor Decision|0|||
162930068|NCT03118765|588448863|FG002|Overall Study|Sponsor Decision|1|||
162930069|NCT03118765|588448864|FG003|Overall Study|Sponsor Decision|0|||
162930070|NCT03118765|588448865|FG004|Overall Study|Sponsor Decision|1|||
162930071|NCT02643966|588448866|FG000|First Screening Round|ineligible|1|||
162930072|NCT02643966|588448866|FG000|First Screening Round|excluded from analysis|2|||
162930073|NCT02643966|588448866|FG000|First Screening Round|Lost to Follow-up|56|||
162930074|NCT02643966|588448866|FG000|First Screening Round|Withdrawal by Subject|28|||
162930075|NCT02643966|588448866|FG000|First Screening Round|Death|1|||
162930076|NCT02643966|588448866|FG000|Between First and Second Screening|Lost to Follow-up|65|||
162930077|NCT02643966|588448866|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
162930078|NCT02643966|588448866|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
162930079|NCT02643966|588448866|FG000|Second Screening Round|Withdrawal by Subject|20|||
162930080|NCT02643966|588448866|FG000|Second Screening Round|Lost to Follow-up|57|||
162930081|NCT02643966|588448866|FG000|Second Screening Round|Physician Decision|2|||
162930082|NCT02643966|588448866|FG000|Second Screening Round|Death|4|||
162930083|NCT02643966|588448866|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
162930084|NCT02643966|588448866|FG000|Between Second and Third Screening|Death|1|||
162930085|NCT02643966|588448866|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
162930086|NCT02643966|588448866|FG000|Third Screening Round|PI excluded|2|||
162930087|NCT02643966|588448866|FG000|Third Screening Round|Lost to Follow-up|241|||
162930088|NCT01493531|588448867|FG000|Overall Study|Adverse Event|4|||
162930089|NCT01493531|588448868|FG001|Overall Study|Adverse Event|12|||
162930090|NCT01493531|588448869|FG002|Overall Study|Adverse Event|9|||
162930091|NCT01493531|588448867|FG000|Overall Study|Gout flare|3|||
162930092|NCT01493531|588448868|FG001|Overall Study|Gout flare|0|||
162930093|NCT01493531|588448869|FG002|Overall Study|Gout flare|2|||
162930094|NCT01493531|588448867|FG000|Overall Study|Protocol Violation|8|||
162930095|NCT01493531|588448868|FG001|Overall Study|Protocol Violation|15|||
162930096|NCT01493531|588448869|FG002|Overall Study|Protocol Violation|12|||
162930097|NCT01493531|588448867|FG000|Overall Study|Sponsor terminated study|5|||
162930098|NCT01493531|588448868|FG001|Overall Study|Sponsor terminated study|2|||
162930099|NCT01493531|588448869|FG002|Overall Study|Sponsor terminated study|3|||
162930100|NCT01493531|588448867|FG000|Overall Study|Lost to Follow-up|5|||
162930101|NCT01493531|588448868|FG001|Overall Study|Lost to Follow-up|7|||
162930102|NCT01493531|588448869|FG002|Overall Study|Lost to Follow-up|11|||
162930103|NCT01493531|588448867|FG000|Overall Study|Withdrawal by Subject|16|||
162930104|NCT01493531|588448868|FG001|Overall Study|Withdrawal by Subject|13|||
162930105|NCT01493531|588448869|FG002|Overall Study|Withdrawal by Subject|11|||
162930106|NCT01493531|588448867|FG000|Overall Study|Death|0|||
162930107|NCT01493531|588448868|FG001|Overall Study|Death|1|||
162930108|NCT01493531|588448869|FG002|Overall Study|Death|0|||
162930109|NCT03835975|588448872|FG000|Overall Study|Lost to Follow-up|1|||
162930110|NCT03835975|588448873|FG001|Overall Study|Lost to Follow-up|1|||
162930111|NCT03835975|588448874|FG002|Overall Study|Lost to Follow-up|0|||
162930112|NCT03835975|588448875|FG003|Overall Study|Lost to Follow-up|0|||
162930113|NCT03835975|588448876|FG004|Overall Study|Lost to Follow-up|0|||
162930114|NCT03835975|588448872|FG000|Overall Study|No longer met eligibility criteria|0|||
162930115|NCT03835975|588448873|FG001|Overall Study|No longer met eligibility criteria|1|||
162930116|NCT03835975|588448874|FG002|Overall Study|No longer met eligibility criteria|0|||
162930117|NCT03835975|588448875|FG003|Overall Study|No longer met eligibility criteria|0|||
162930118|NCT03835975|588448876|FG004|Overall Study|No longer met eligibility criteria|0|||
162930119|NCT03835975|588448872|FG000|Overall Study|Protocol Violation|1|||
162930120|NCT03835975|588448873|FG001|Overall Study|Protocol Violation|1|||
162930121|NCT03835975|588448874|FG002|Overall Study|Protocol Violation|2|||
162930122|NCT03835975|588448875|FG003|Overall Study|Protocol Violation|0|||
162930123|NCT03835975|588448876|FG004|Overall Study|Protocol Violation|0|||
162930124|NCT03835975|588448872|FG000|Overall Study|Withdrawal by Subject|1|||
162930125|NCT03835975|588448873|FG001|Overall Study|Withdrawal by Subject|0|||
162930126|NCT03835975|588448874|FG002|Overall Study|Withdrawal by Subject|1|||
162930127|NCT03835975|588448875|FG003|Overall Study|Withdrawal by Subject|1|||
162930128|NCT03835975|588448876|FG004|Overall Study|Withdrawal by Subject|0|||
162930129|NCT01612702|588448879|FG000|Overall Study|Protocol Violation|11|||
162930130|NCT01612702|588448880|FG001|Overall Study|Protocol Violation|11|||
162698427|NCT03881059|587605505|FG002|Treatment Period - Part B|Adverse Event|3|||
162930131|NCT03070431|588448881|FG000|Overall Study|Withdrawal by Subject|2|||
162930132|NCT03070431|588448881|FG000|Overall Study|Lost to Follow-up|2|||
162930133|NCT00370396|588448882|FG000|Overall Study|Withdrawal by Subject|0|||
162930134|NCT00370396|588448883|FG001|Overall Study|Withdrawal by Subject|0|||
162930135|NCT00370396|588448884|FG002|Overall Study|Withdrawal by Subject|1|||
162930136|NCT00370396|588448882|FG000|Overall Study|Lost to Follow-up|11|||
162930137|NCT00370396|588448883|FG001|Overall Study|Lost to Follow-up|1|||
162930138|NCT00370396|588448884|FG002|Overall Study|Lost to Follow-up|0|||
162930139|NCT00995488|588448886|FG000|Overall Study|Withdrawal by Subject|1|||
162930140|NCT00051636|588448887|FG000|Period 1 - Core|Adverse Event|2|||
162930141|NCT00051636|588448888|FG001|Period 1 - Core|Adverse Event|2|||
162930142|NCT00051636|588448887|FG000|Period 1 - Core|Protocol Violation|1|||
162930143|NCT00051636|588448888|FG001|Period 1 - Core|Protocol Violation|0|||
162930144|NCT00051636|588448887|FG000|Period 1 - Core|Withdrawal by Subject|1|||
162930145|NCT00051636|588448888|FG001|Period 1 - Core|Withdrawal by Subject|2|||
162930146|NCT00051636|588448887|FG000|Period 1 - Core|Lost to Follow-up|0|||
162930147|NCT00051636|588448888|FG001|Period 1 - Core|Lost to Follow-up|2|||
162930148|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
162930149|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
162930150|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
162930151|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
162930152|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
162930153|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
162930154|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Death|4|||
162930155|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Death|5|||
162930156|NCT00051636|588448887|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
162930157|NCT00051636|588448888|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
162930158|NCT02340078|588448889|FG000|Overall Study|Protocol Violation|1|||
162930159|NCT00944125|588448892|FG000|3 to 6 Months|Withdrawal by Subject|0|||
162930160|NCT00944125|588448893|FG001|3 to 6 Months|Withdrawal by Subject|2|||
162930161|NCT00944125|588448892|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
162930162|NCT00944125|588448893|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
162930163|NCT03338673|588448896|FG000|Overall Study|Lost to Follow-up|1|||
162930164|NCT03338673|588448897|FG001|Overall Study|Lost to Follow-up|1|||
162930165|NCT01170364|588450347|FG000|Overall Study|Protocol Violation|4|||
162930166|NCT01170364|588450348|FG001|Overall Study|Protocol Violation|1|||
162930167|NCT00368537|588450350|FG000|Randomization|No study drug dosed|13|||
162930168|NCT00368537|588450351|FG001|Randomization|No study drug dosed|6|||
162930169|NCT00368537|588450350|FG000|Baseline Participants|Lost to Follow-up|16|||
162930170|NCT00368537|588450351|FG001|Baseline Participants|Lost to Follow-up|17|||
162930171|NCT00368537|588450350|FG000|Baseline Participants|Withdrawal by Subject|6|||
162930172|NCT00368537|588450351|FG001|Baseline Participants|Withdrawal by Subject|4|||
162930173|NCT00368537|588450350|FG000|Baseline Participants|Death|1|||
162930174|NCT00368537|588450351|FG001|Baseline Participants|Death|2|||
162930175|NCT00368537|588450350|FG000|Baseline Participants|No susceptibility|1|||
162930176|NCT00368537|588450351|FG001|Baseline Participants|No susceptibility|0|||
162930177|NCT00368537|588450350|FG000|Baseline Participants|Patient uncompliant|0|||
162930178|NCT00368537|588450351|FG001|Baseline Participants|Patient uncompliant|1|||
162930179|NCT01368276|588450361|FG000|Overall Study|Death|1|||
162930180|NCT01368276|588450362|FG001|Overall Study|Death|10|||
162930181|NCT01427920|588450365|FG000|Overall Study|Adverse Event|1|||
162930182|NCT01427920|588450366|FG001|Overall Study|Adverse Event|2|||
162930183|NCT01427920|588450365|FG000|Overall Study|Lack of Efficacy|1|||
162930184|NCT01427920|588450366|FG001|Overall Study|Lack of Efficacy|0|||
162930185|NCT01427920|588450365|FG000|Overall Study|Protocol Violation|1|||
162930186|NCT01427920|588450366|FG001|Overall Study|Protocol Violation|3|||
162930187|NCT01427920|588450365|FG000|Overall Study|Withdrawal Criteria|4|||
162930188|NCT01427920|588450366|FG001|Overall Study|Withdrawal Criteria|4|||
162930189|NCT01427920|588450365|FG000|Overall Study|Unclassified|2|||
162930190|NCT01427920|588450366|FG001|Overall Study|Unclassified|8|||
162930191|NCT03341273|588450367|FG000|Overall Study|Lost to Follow-up|7|||
162930192|NCT03341273|588450368|FG001|Overall Study|Lost to Follow-up|7|||
162930193|NCT03341273|588450367|FG000|Overall Study|Withdrawal by Subject|4|||
162930194|NCT03341273|588450368|FG001|Overall Study|Withdrawal by Subject|2|||
162930195|NCT03341273|588450367|FG000|Overall Study|Physician Decision|1|||
162930196|NCT03341273|588450368|FG001|Overall Study|Physician Decision|0|||
162930197|NCT03341273|588450367|FG000|Overall Study|Protocol Violation|0|||
162930198|NCT03341273|588450368|FG001|Overall Study|Protocol Violation|1|||
162930199|NCT03341273|588450367|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
162930200|NCT03341273|588450368|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
162930201|NCT03341273|588450367|FG000|Overall Study|Became ineligible after enrollment|1|||
162930202|NCT03341273|588450368|FG001|Overall Study|Became ineligible after enrollment|0|||
162930203|NCT03341273|588450367|FG000|Overall Study|Not Eligible at Enrollment|0|||
162930204|NCT03341273|588450368|FG001|Overall Study|Not Eligible at Enrollment|1|||
162930205|NCT03341273|588450367|FG000|Overall Study|Participant incarcerated|1|||
162930206|NCT03341273|588450368|FG001|Overall Study|Participant incarcerated|0|||
162930207|NCT01717456|588450375|FG000|End of Treatment|Physician Decision|0|||
162823287|NCT01236573|588064847|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823288|NCT01236573|588064848|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
162823289|NCT01236573|588064849|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
162823290|NCT01236573|588064850|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
162823291|NCT01236573|588064840|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823292|NCT01236573|588064841|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823293|NCT01236573|588064842|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823294|NCT01236573|588064843|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823295|NCT01236573|588064844|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823296|NCT01236573|588064845|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823297|NCT01236573|588064846|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823298|NCT01236573|588064847|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823299|NCT01236573|588064848|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
162823300|NCT01236573|588064849|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823301|NCT01236573|588064850|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162823302|NCT01236573|588064840|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823303|NCT01236573|588064841|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823304|NCT01236573|588064842|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823305|NCT01236573|588064843|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823306|NCT01236573|588064844|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823307|NCT01236573|588064845|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823308|NCT01236573|588064846|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823309|NCT01236573|588064847|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823310|NCT01236573|588064848|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823311|NCT01236573|588064849|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162823312|NCT01236573|588064850|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
162823313|NCT05418673|588064853|FG000|Overall Study|Study Terminated by Sponsor|2|||
162823314|NCT05418673|588064854|FG001|Overall Study|Study Terminated by Sponsor|4|||
162823315|NCT05418673|588064853|FG000|Overall Study|Lost to Follow-up|1|||
162823316|NCT05418673|588064854|FG001|Overall Study|Lost to Follow-up|0|||
162823317|NCT02665052|588064855|FG000|Overall Study|Lost to Follow-up|1|||
162823318|NCT02665052|588064856|FG001|Overall Study|Lost to Follow-up|0|||
162823319|NCT02665052|588064857|FG002|Overall Study|Lost to Follow-up|0|||
162823320|NCT02665052|588064858|FG003|Overall Study|Lost to Follow-up|0|||
162823321|NCT02665052|588064855|FG000|Overall Study|Withdrawal by Subject|1|||
162823322|NCT02665052|588064856|FG001|Overall Study|Withdrawal by Subject|1|||
162823323|NCT02665052|588064857|FG002|Overall Study|Withdrawal by Subject|0|||
162823324|NCT02665052|588064858|FG003|Overall Study|Withdrawal by Subject|5|||
162823325|NCT02665052|588064855|FG000|Overall Study|Adverse Event|1|||
162823326|NCT02665052|588064856|FG001|Overall Study|Adverse Event|1|||
162823327|NCT02665052|588064857|FG002|Overall Study|Adverse Event|0|||
162823328|NCT02665052|588064858|FG003|Overall Study|Adverse Event|0|||
162823329|NCT02234284|588064859|FG000|Overall Study|Death|4|||
162823330|NCT02234284|588064860|FG001|Overall Study|Death|2|||
162823331|NCT02234284|588064859|FG000|Overall Study|Withdrawal by Subject|1|||
162823332|NCT02234284|588064860|FG001|Overall Study|Withdrawal by Subject|0|||
162823333|NCT02234284|588064859|FG000|Overall Study|Lost to Follow-up|20|||
162823334|NCT02234284|588064860|FG001|Overall Study|Lost to Follow-up|7|||
162823335|NCT01986920|588064863|FG000|A- 101 25%|Withdrawal by Subject|1|||
162823336|NCT01986920|588064864|FG001|A- 101 25%|Withdrawal by Subject|0|||
162823337|NCT01986920|588064865|FG002|A- 101 25%|Withdrawal by Subject|0|||
162823338|NCT01986920|588064866|FG003|A- 101 25%|Withdrawal by Subject|0|||
162823339|NCT01986920|588064863|FG000|A-101 32.5%|Withdrawal by Subject|0|||
162823340|NCT01986920|588064864|FG001|A-101 32.5%|Withdrawal by Subject|1|||
162823341|NCT01986920|588064865|FG002|A-101 32.5%|Withdrawal by Subject|0|||
162823342|NCT01986920|588064866|FG003|A-101 32.5%|Withdrawal by Subject|0|||
162823343|NCT01986920|588064863|FG000|A-101 40%|Withdrawal by Subject|0|||
162823344|NCT01986920|588064864|FG001|A-101 40%|Withdrawal by Subject|0|||
162823345|NCT01986920|588064865|FG002|A-101 40%|Withdrawal by Subject|1|||
162823346|NCT01986920|588064866|FG003|A-101 40%|Withdrawal by Subject|0|||
162823347|NCT01986920|588064863|FG000|Placebo|Withdrawal by Subject|0|||
162823348|NCT01986920|588064864|FG001|Placebo|Withdrawal by Subject|0|||
162823349|NCT01986920|588064865|FG002|Placebo|Withdrawal by Subject|0|||
162823350|NCT01986920|588064866|FG003|Placebo|Withdrawal by Subject|1|||
162823351|NCT03023059|588064869|FG000|Overall Study|Withdrawal by Subject|5|||
162823352|NCT01338415|588064870|FG000|Core + Extension|Adverse Event|8|||
162823353|NCT01338415|588064871|FG001|Core + Extension|Adverse Event|6|||
162823354|NCT01338415|588064872|FG002|Core + Extension|Adverse Event|0|||
162823355|NCT01338415|588064870|FG000|Core + Extension|Withdrawal by Subject|1|||
162823356|NCT01338415|588064871|FG001|Core + Extension|Withdrawal by Subject|1|||
162823357|NCT01338415|588064872|FG002|Core + Extension|Withdrawal by Subject|0|||
162823358|NCT01338415|588064870|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
162823359|NCT01338415|588064871|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
162930208|NCT01717456|588450376|FG001|End of Treatment|Physician Decision|1|||
162930209|NCT01717456|588450375|FG000|End of Treatment|Lost to Follow-up|0|||
162930210|NCT01717456|588450376|FG001|End of Treatment|Lost to Follow-up|1|||
162930211|NCT01717456|588450375|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
162930212|NCT01717456|588450376|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
162930213|NCT02732561|588450377|FG000|Overall Study|Lost to Follow-up|1|||
162930214|NCT02732561|588450378|FG001|Overall Study|Lost to Follow-up|1|||
162930215|NCT02732561|588450377|FG000|Overall Study|Withdrawal by Subject|1|||
162930216|NCT02732561|588450378|FG001|Overall Study|Withdrawal by Subject|0|||
162930217|NCT03066440|588450381|FG000|Overall Study|Physician Decision|1|||
162930218|NCT03066440|588450382|FG001|Overall Study|Physician Decision|1|||
162930219|NCT03066440|588450381|FG000|Overall Study|Protocol Violation|0|||
162930220|NCT03066440|588450382|FG001|Overall Study|Protocol Violation|2|||
162930221|NCT00736333|588450383|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
162930222|NCT00736333|588450383|FG000|Overall Study|Data Missing|2|||
162930223|NCT00736333|588450383|FG000|Overall Study|Tumor Progression|75|||
162930224|NCT00736333|588450383|FG000|Overall Study|Toxicity|6|||
162930225|NCT00736333|588450383|FG000|Overall Study|Withdrawal by Subject|10|||
162930226|NCT00736333|588450383|FG000|Overall Study|Death|7|||
162930227|NCT00736333|588450383|FG000|Overall Study|Other|4|||
162930228|NCT04991311|588450385|FG000|Overall Study|Adverse Event|1|||
162930229|NCT00054275|588450387|FG000|Overall Study|Withdrawal by Subject|4|||
162930230|NCT00054275|588450387|FG000|Overall Study|Adverse Event|5|||
162930231|NCT00054275|588450387|FG000|Overall Study|Progressive disease in cycle 1|1|||
162930232|NCT00054275|588450387|FG000|Overall Study|Physician Decision|1|||
162930233|NCT01106352|588450388|FG000|Overall Study|Subjects untreated|0|||
162930234|NCT01106352|588450389|FG001|Overall Study|Subjects untreated|0|||
162930235|NCT01106352|588450390|FG002|Overall Study|Subjects untreated|0|||
162930236|NCT01106352|588450391|FG003|Overall Study|Subjects untreated|3|||
162930237|NCT01106352|588450392|FG004|Overall Study|Subjects untreated|4|||
162930238|NCT01106352|588450388|FG000|Overall Study|Sponsor Decision|1|||
162930239|NCT01106352|588450389|FG001|Overall Study|Sponsor Decision|0|||
162930240|NCT01106352|588450390|FG002|Overall Study|Sponsor Decision|0|||
162930241|NCT01106352|588450391|FG003|Overall Study|Sponsor Decision|0|||
162930242|NCT01106352|588450392|FG004|Overall Study|Sponsor Decision|0|||
162930243|NCT01106352|588450388|FG000|Overall Study|Too ill to come in for the visit|0|||
162930244|NCT01106352|588450389|FG001|Overall Study|Too ill to come in for the visit|0|||
162930245|NCT01106352|588450390|FG002|Overall Study|Too ill to come in for the visit|1|||
162930246|NCT01106352|588450391|FG003|Overall Study|Too ill to come in for the visit|0|||
162930247|NCT01106352|588450392|FG004|Overall Study|Too ill to come in for the visit|0|||
162930248|NCT01106352|588450388|FG000|Overall Study|Lost to Follow-up|0|||
162930249|NCT01106352|588450389|FG001|Overall Study|Lost to Follow-up|0|||
162930250|NCT01106352|588450390|FG002|Overall Study|Lost to Follow-up|0|||
162930251|NCT01106352|588450391|FG003|Overall Study|Lost to Follow-up|0|||
162930252|NCT01106352|588450392|FG004|Overall Study|Lost to Follow-up|1|||
162930253|NCT01106352|588450388|FG000|Overall Study|Death|0|||
162930254|NCT01106352|588450389|FG001|Overall Study|Death|0|||
162930255|NCT01106352|588450390|FG002|Overall Study|Death|1|||
162930256|NCT01106352|588450391|FG003|Overall Study|Death|3|||
162930257|NCT01106352|588450392|FG004|Overall Study|Death|1|||
162930258|NCT01106352|588450388|FG000|Overall Study|Disease progression|0|||
162930259|NCT01106352|588450389|FG001|Overall Study|Disease progression|0|||
162930260|NCT01106352|588450390|FG002|Overall Study|Disease progression|0|||
162930261|NCT01106352|588450391|FG003|Overall Study|Disease progression|1|||
162930262|NCT01106352|588450392|FG004|Overall Study|Disease progression|0|||
162930263|NCT01106352|588450388|FG000|Overall Study|Withdrawal by Subject|0|||
162930264|NCT01106352|588450389|FG001|Overall Study|Withdrawal by Subject|0|||
162930265|NCT01106352|588450390|FG002|Overall Study|Withdrawal by Subject|0|||
162930266|NCT01106352|588450391|FG003|Overall Study|Withdrawal by Subject|3|||
162930267|NCT01106352|588450392|FG004|Overall Study|Withdrawal by Subject|2|||
162930268|NCT01106352|588450388|FG000|Overall Study|Went on hospice|0|||
162930269|NCT01106352|588450389|FG001|Overall Study|Went on hospice|0|||
162930270|NCT01106352|588450390|FG002|Overall Study|Went on hospice|0|||
162930271|NCT01106352|588450391|FG003|Overall Study|Went on hospice|1|||
162930272|NCT01106352|588450392|FG004|Overall Study|Went on hospice|0|||
162930273|NCT01106352|588450388|FG000|Overall Study|Subject entered hospice|0|||
162930274|NCT01106352|588450389|FG001|Overall Study|Subject entered hospice|0|||
162930275|NCT01106352|588450390|FG002|Overall Study|Subject entered hospice|0|||
162930276|NCT01106352|588450391|FG003|Overall Study|Subject entered hospice|1|||
162930277|NCT01106352|588450392|FG004|Overall Study|Subject entered hospice|0|||
162930278|NCT01106352|588450388|FG000|Overall Study|Home hospice since July 2013|0|||
162930279|NCT01106352|588450389|FG001|Overall Study|Home hospice since July 2013|0|||
162930280|NCT01106352|588450390|FG002|Overall Study|Home hospice since July 2013|0|||
162930281|NCT01106352|588450391|FG003|Overall Study|Home hospice since July 2013|1|||
162930282|NCT01106352|588450392|FG004|Overall Study|Home hospice since July 2013|0|||
162930283|NCT03944707|588450393|FG000|Overall Study|Adverse Event|0|||
162930284|NCT03944707|588450394|FG001|Overall Study|Adverse Event|2|||
162930285|NCT03944707|588450393|FG000|Overall Study|Study terminated by sponsor|12|||
162930286|NCT03944707|588450394|FG001|Overall Study|Study terminated by sponsor|7|||
162930287|NCT03944707|588450393|FG000|Overall Study|Subject decision|0|||
162930288|NCT03944707|588450394|FG001|Overall Study|Subject decision|1|||
162930289|NCT02444182|588450396|FG000|Overall Study|non-compliance|2|||
162930290|NCT02444182|588450397|FG001|Overall Study|non-compliance|1|||
162930291|NCT02444182|588450396|FG000|Overall Study|Lost to Follow-up|0|||
162930292|NCT02444182|588450397|FG001|Overall Study|Lost to Follow-up|4|||
162930293|NCT01959230|588450398|FG000|Overall Study|Failure to follow study procedures|0|||
162930294|NCT01959230|588450399|FG001|Overall Study|Failure to follow study procedures|1|||
162930295|NCT01959230|588450398|FG000|Overall Study|Administrative reasons|2|||
162930296|NCT01959230|588450399|FG001|Overall Study|Administrative reasons|0|||
162930297|NCT01959230|588450398|FG000|Overall Study|Withdrawal by Subject|2|||
162930298|NCT01959230|588450399|FG001|Overall Study|Withdrawal by Subject|0|||
162930299|NCT01453374|588450400|FG000|Overall Study|Adverse Event|7|||
162930300|NCT01453374|588450400|FG000|Overall Study|Lack of Efficacy|1|||
162930301|NCT01453374|588450400|FG000|Overall Study|Lost to Follow-up|3|||
162930302|NCT01453374|588450400|FG000|Overall Study|Withdrawal by Subject|5|||
162930303|NCT01453374|588450400|FG000|Overall Study|Incarcerated|2|||
162930304|NCT00751998|588450401|FG000|Overall Study|Lost to Follow-up|7|||
162930305|NCT00751998|588450401|FG000|Overall Study|Death|11|||
162930306|NCT00751998|588450401|FG000|Overall Study|Withdrawal by Subject|2|||
162930307|NCT00996918|588450405|FG000|Overall Study|Lack of Efficacy|1|||
162930308|NCT00996918|588450406|FG001|Overall Study|Lack of Efficacy|1|||
162930309|NCT00996918|588450407|FG002|Overall Study|Lack of Efficacy|2|||
162930310|NCT00996918|588450408|FG003|Overall Study|Lack of Efficacy|2|||
162930311|NCT00996918|588450409|FG004|Overall Study|Lack of Efficacy|0|||
162930312|NCT00996918|588450405|FG000|Overall Study|Adverse Event|2|||
162930313|NCT00996918|588450406|FG001|Overall Study|Adverse Event|5|||
162930314|NCT00996918|588450407|FG002|Overall Study|Adverse Event|2|||
162930315|NCT00996918|588450408|FG003|Overall Study|Adverse Event|6|||
162930316|NCT00996918|588450409|FG004|Overall Study|Adverse Event|0|||
162930317|NCT00996918|588450405|FG000|Overall Study|Withdrawal by Subject|1|||
162930318|NCT00996918|588450406|FG001|Overall Study|Withdrawal by Subject|4|||
162930319|NCT00996918|588450407|FG002|Overall Study|Withdrawal by Subject|3|||
162930320|NCT00996918|588450408|FG003|Overall Study|Withdrawal by Subject|3|||
162930321|NCT00996918|588450409|FG004|Overall Study|Withdrawal by Subject|2|||
162930322|NCT00996918|588450405|FG000|Overall Study|Physician Decision|1|||
162930323|NCT00996918|588450406|FG001|Overall Study|Physician Decision|0|||
162930324|NCT00996918|588450407|FG002|Overall Study|Physician Decision|0|||
162930325|NCT00996918|588450408|FG003|Overall Study|Physician Decision|0|||
162930326|NCT00996918|588450409|FG004|Overall Study|Physician Decision|0|||
162930327|NCT00996918|588450405|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
162930328|NCT00996918|588450406|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
162930329|NCT00996918|588450407|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
162930330|NCT00996918|588450408|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
162930331|NCT00996918|588450409|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
162930332|NCT00996918|588450405|FG000|Overall Study|Loss of Caregiver|0|||
162930333|NCT00996918|588450406|FG001|Overall Study|Loss of Caregiver|1|||
162930334|NCT00996918|588450407|FG002|Overall Study|Loss of Caregiver|0|||
162930335|NCT00996918|588450408|FG003|Overall Study|Loss of Caregiver|0|||
162930336|NCT00996918|588450409|FG004|Overall Study|Loss of Caregiver|0|||
162930337|NCT00996918|588450405|FG000|Overall Study|Other|3|||
162930338|NCT00996918|588450406|FG001|Overall Study|Other|1|||
162930339|NCT00996918|588450407|FG002|Overall Study|Other|0|||
162930340|NCT00996918|588450408|FG003|Overall Study|Other|0|||
162930341|NCT00996918|588450409|FG004|Overall Study|Other|0|||
162930342|NCT01965535|588450412|FG000|Overall Study|Lack of Efficacy|2|||
162930343|NCT01965535|588450413|FG001|Overall Study|Lack of Efficacy|1|||
162930344|NCT00829439|588450415|FG000|Overall Study|Adverse Event|0|||
162930345|NCT00829439|588450416|FG001|Overall Study|Adverse Event|0|||
162930346|NCT00829439|588450417|FG002|Overall Study|Adverse Event|1|||
162930347|NCT00829439|588450418|FG003|Overall Study|Adverse Event|0|||
162930348|NCT02525562|588450419|FG000|Overall Study|Death|9|||
162930349|NCT02525562|588450420|FG001|Overall Study|Death|0|||
162930350|NCT02525562|588450421|FG002|Overall Study|Death|0|||
162930351|NCT02525562|588450419|FG000|Overall Study|Lost to Follow-up|19|||
162930352|NCT02525562|588450420|FG001|Overall Study|Lost to Follow-up|0|||
162930353|NCT02525562|588450421|FG002|Overall Study|Lost to Follow-up|0|||
162930354|NCT02525562|588450419|FG000|Overall Study|Withdrawal by Subject|37|||
162930355|NCT02525562|588450420|FG001|Overall Study|Withdrawal by Subject|0|||
162930356|NCT02525562|588450421|FG002|Overall Study|Withdrawal by Subject|0|||
162930357|NCT02525562|588450419|FG000|Overall Study|Revision/Removal of Study Device|4|||
162930358|NCT02525562|588450420|FG001|Overall Study|Revision/Removal of Study Device|0|||
162930359|NCT02525562|588450421|FG002|Overall Study|Revision/Removal of Study Device|0|||
162930360|NCT02525562|588450419|FG000|Overall Study|Study Closed by Sponsor|154|||
162930361|NCT02525562|588450420|FG001|Overall Study|Study Closed by Sponsor|0|||
162930362|NCT02525562|588450421|FG002|Overall Study|Study Closed by Sponsor|0|||
162930363|NCT00886782|588450422|FG000|Overall Study|Disease progression|3|||
162930364|NCT00886782|588450423|FG001|Overall Study|Disease progression|3|||
162930365|NCT00886782|588450424|FG002|Overall Study|Disease progression|3|||
162930366|NCT00886782|588450422|FG000|Overall Study|Study drug toxicity|0|||
162930367|NCT00886782|588450423|FG001|Overall Study|Study drug toxicity|0|||
162930368|NCT00886782|588450424|FG002|Overall Study|Study drug toxicity|1|||
162930369|NCT00886782|588450422|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
162930370|NCT00886782|588450423|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
162930371|NCT00886782|588450424|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
162930372|NCT01946282|588450425|FG000|Year 1|Did not return FIT kit|4186|||
162930373|NCT01946282|588450426|FG001|Year 1|Did not return FIT kit|608|||
162930374|NCT01946282|588450427|FG002|Year 1|Did not return FIT kit|654|||
162930375|NCT01946282|588450425|FG000|Year 2|Did not return FIT kit|803|||
162930376|NCT01946282|588450426|FG001|Year 2|Did not return FIT kit|131|||
162930377|NCT01946282|588450427|FG002|Year 2|Did not return FIT kit|115|||
162930378|NCT01946282|588450425|FG000|Year 3|Did not return FIT kit|288|||
162930379|NCT01946282|588450426|FG001|Year 3|Did not return FIT kit|43|||
162930380|NCT01946282|588450427|FG002|Year 3|Did not return FIT kit|30|||
162930381|NCT03031431|588450428|FG000|Overall Study|Infant removed by maternal request|1|||
162930382|NCT00078819|588450429|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930383|NCT00078819|588450430|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
162930384|NCT00078819|588450431|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930385|NCT00078819|588450432|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
162930386|NCT00078819|588450429|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
162930387|NCT00078819|588450430|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930388|NCT00078819|588450431|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930389|NCT00078819|588450432|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
162930390|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
162930391|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
162930392|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
162930393|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
162930394|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
162930395|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
162930396|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
162930397|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
162930398|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
162930399|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
162930400|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
162930401|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
162930402|NCT00078819|588450429|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
162930403|NCT00078819|588450430|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
162930404|NCT00078819|588450431|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
162930405|NCT00078819|588450432|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
162930406|NCT00078819|588450429|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
162930407|NCT00078819|588450430|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
162930408|NCT00078819|588450431|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
162930409|NCT00078819|588450432|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
162930410|NCT00078819|588450429|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930411|NCT00078819|588450430|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930412|NCT00078819|588450431|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
162930413|NCT00078819|588450432|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
162930414|NCT04130919|588450433|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930415|NCT04130919|588450434|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930416|NCT04130919|588450435|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
162930417|NCT04130919|588450436|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930418|NCT04130919|588450437|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930419|NCT04130919|588450438|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
162930420|NCT04130919|588450433|FG000|Blinded Treatment Phase|Adverse Event|0|||
162930421|NCT04130919|588450434|FG001|Blinded Treatment Phase|Adverse Event|0|||
162930422|NCT04130919|588450435|FG002|Blinded Treatment Phase|Adverse Event|1|||
162930423|NCT04130919|588450436|FG003|Blinded Treatment Phase|Adverse Event|0|||
162930424|NCT04130919|588450437|FG004|Blinded Treatment Phase|Adverse Event|0|||
162930425|NCT04130919|588450438|FG005|Blinded Treatment Phase|Adverse Event|0|||
162930426|NCT04130919|588450433|FG000|Blinded Treatment Phase|Disease worsening|0|||
162930427|NCT04130919|588450434|FG001|Blinded Treatment Phase|Disease worsening|0|||
162930428|NCT04130919|588450435|FG002|Blinded Treatment Phase|Disease worsening|1|||
162930429|NCT04130919|588450436|FG003|Blinded Treatment Phase|Disease worsening|0|||
162930430|NCT04130919|588450437|FG004|Blinded Treatment Phase|Disease worsening|0|||
162930431|NCT04130919|588450438|FG005|Blinded Treatment Phase|Disease worsening|0|||
162930432|NCT04130919|588450433|FG000|Blinded Treatment Phase|Investigator's decision|0|||
162930433|NCT04130919|588450434|FG001|Blinded Treatment Phase|Investigator's decision|1|||
162930434|NCT04130919|588450435|FG002|Blinded Treatment Phase|Investigator's decision|0|||
162930435|NCT04130919|588450436|FG003|Blinded Treatment Phase|Investigator's decision|0|||
162930436|NCT04130919|588450437|FG004|Blinded Treatment Phase|Investigator's decision|0|||
162930437|NCT04130919|588450438|FG005|Blinded Treatment Phase|Investigator's decision|0|||
162930438|NCT04130919|588450433|FG000|Blinded Treatment Phase|Withdrew consent|1|||
162930439|NCT04130919|588450434|FG001|Blinded Treatment Phase|Withdrew consent|0|||
162930440|NCT04130919|588450435|FG002|Blinded Treatment Phase|Withdrew consent|0|||
162930441|NCT04130919|588450436|FG003|Blinded Treatment Phase|Withdrew consent|0|||
162930442|NCT04130919|588450437|FG004|Blinded Treatment Phase|Withdrew consent|0|||
162930443|NCT04130919|588450438|FG005|Blinded Treatment Phase|Withdrew consent|0|||
162930444|NCT04130919|588450433|FG000|Open-label Treatment Phase|Withdrew consent|0|||
162930445|NCT04130919|588450434|FG001|Open-label Treatment Phase|Withdrew consent|0|||
162930446|NCT04130919|588450435|FG002|Open-label Treatment Phase|Withdrew consent|0|||
162930447|NCT04130919|588450436|FG003|Open-label Treatment Phase|Withdrew consent|1|||
162930448|NCT04130919|588450437|FG004|Open-label Treatment Phase|Withdrew consent|1|||
162930449|NCT04130919|588450438|FG005|Open-label Treatment Phase|Withdrew consent|1|||
162930450|NCT04130919|588450433|FG000|Open-label Treatment Phase|Disease worsening|0|||
162930451|NCT04130919|588450434|FG001|Open-label Treatment Phase|Disease worsening|0|||
162930452|NCT04130919|588450435|FG002|Open-label Treatment Phase|Disease worsening|0|||
162930453|NCT04130919|588450436|FG003|Open-label Treatment Phase|Disease worsening|1|||
162930454|NCT04130919|588450437|FG004|Open-label Treatment Phase|Disease worsening|0|||
162930455|NCT04130919|588450438|FG005|Open-label Treatment Phase|Disease worsening|1|||
162930456|NCT04130919|588450433|FG000|Open-label Treatment Phase|Investigator's decision|0|||
162930457|NCT04130919|588450434|FG001|Open-label Treatment Phase|Investigator's decision|0|||
162930458|NCT04130919|588450435|FG002|Open-label Treatment Phase|Investigator's decision|0|||
162930459|NCT04130919|588450436|FG003|Open-label Treatment Phase|Investigator's decision|1|||
162930460|NCT04130919|588450437|FG004|Open-label Treatment Phase|Investigator's decision|0|||
162930461|NCT04130919|588450438|FG005|Open-label Treatment Phase|Investigator's decision|0|||
162930462|NCT04130919|588450433|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
162930463|NCT04130919|588450434|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
162930464|NCT04130919|588450435|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
162930465|NCT04130919|588450436|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
162930466|NCT04130919|588450437|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
162930467|NCT04130919|588450438|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
162930468|NCT04130919|588450433|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930469|NCT04130919|588450434|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930470|NCT04130919|588450435|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930471|NCT04130919|588450436|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930472|NCT04130919|588450437|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
162930473|NCT04130919|588450438|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
162930474|NCT03012815|588450439|FG000|Overall Study|Lost to Follow-up|1|||
162930475|NCT03012815|588450440|FG001|Overall Study|Lost to Follow-up|0|||
162930476|NCT03012815|588450439|FG000|Overall Study|Physician Decision|3|||
162930477|NCT03012815|588450440|FG001|Overall Study|Physician Decision|2|||
162930478|NCT03012815|588450439|FG000|Overall Study|Adverse Event|1|||
162930479|NCT03012815|588450440|FG001|Overall Study|Adverse Event|0|||
162930480|NCT01462695|588450442|FG000|Overall Study|Adverse Event|1|||
162930481|NCT01462695|588450443|FG001|Overall Study|Adverse Event|1|||
162930482|NCT01462695|588450442|FG000|Overall Study|Death|2|||
162930483|NCT01462695|588450443|FG001|Overall Study|Death|0|||
162930484|NCT01462695|588450442|FG000|Overall Study|Lack of Efficacy|6|||
162930485|NCT01462695|588450443|FG001|Overall Study|Lack of Efficacy|12|||
162930486|NCT01462695|588450442|FG000|Overall Study|Physician Decision|5|||
162930487|NCT01462695|588450443|FG001|Overall Study|Physician Decision|0|||
162930488|NCT01462695|588450442|FG000|Overall Study|Withdrawal by Subject|2|||
162930489|NCT01462695|588450443|FG001|Overall Study|Withdrawal by Subject|0|||
162930490|NCT01462695|588450442|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
162930491|NCT01462695|588450443|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
162930492|NCT02400905|588450444|FG000|Overall Study|Death|24|||
162930493|NCT02400905|588450444|FG000|Overall Study|Lost to Follow-up|18|||
162930494|NCT02400905|588450444|FG000|Overall Study|Withdrawal by Subject|16|||
162930495|NCT02400905|588450444|FG000|Overall Study|Physician Decision|4|||
162930496|NCT02400905|588450444|FG000|Overall Study|Other|1|||
162823360|NCT01338415|588064872|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
162823361|NCT01338415|588064870|FG000|Core + Extension|Other (administrative reason)|1|||
162823362|NCT01338415|588064871|FG001|Core + Extension|Other (administrative reason)|0|||
162823363|NCT01338415|588064872|FG002|Core + Extension|Other (administrative reason)|0|||
162823364|NCT01338415|588064870|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
162823365|NCT01338415|588064871|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
162823366|NCT01338415|588064872|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
162823367|NCT01338415|588064870|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
162823368|NCT01338415|588064871|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
162823369|NCT01338415|588064872|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
162823370|NCT01338415|588064870|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
162823371|NCT01338415|588064871|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
162823372|NCT01338415|588064872|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
162823373|NCT01338415|588064870|FG000|Exceptional Use Treatment Period|Death|0|||
162823374|NCT01338415|588064871|FG001|Exceptional Use Treatment Period|Death|0|||
162823375|NCT01338415|588064872|FG002|Exceptional Use Treatment Period|Death|1|||
162823376|NCT00536809|588064873|FG000|Phase II|Adverse Event|1|||
162823377|NCT00536809|588064873|FG000|Phase II|Referred for surgical resection|1|||
162823378|NCT01526551|588064876|FG000|Overall Study|Lack of returned parental consent form|424|||
162823379|NCT00874770|588064877|FG000|Overall Study|Lack of Efficacy|2|||
162823380|NCT00874770|588064878|FG001|Overall Study|Lack of Efficacy|0|||
162823381|NCT00874770|588064879|FG002|Overall Study|Lack of Efficacy|0|||
162823382|NCT00874770|588064880|FG003|Overall Study|Lack of Efficacy|2|||
162823383|NCT00874770|588064877|FG000|Overall Study|Adverse Event|1|||
162823384|NCT00874770|588064878|FG001|Overall Study|Adverse Event|1|||
162823385|NCT00874770|588064879|FG002|Overall Study|Adverse Event|4|||
162823386|NCT00874770|588064880|FG003|Overall Study|Adverse Event|2|||
162823387|NCT00874770|588064877|FG000|Overall Study|Lost to Follow-up|1|||
162823388|NCT00874770|588064878|FG001|Overall Study|Lost to Follow-up|0|||
162823389|NCT00874770|588064879|FG002|Overall Study|Lost to Follow-up|0|||
162823390|NCT00874770|588064880|FG003|Overall Study|Lost to Follow-up|1|||
162823391|NCT00874770|588064877|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
162823392|NCT00874770|588064878|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
162823393|NCT00874770|588064879|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
162823394|NCT00874770|588064880|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
162823395|NCT01353508|588064881|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
162823396|NCT01353508|588064882|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
162823397|NCT01353508|588064883|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
162823398|NCT01353508|588064884|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
162823399|NCT01353508|588064881|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
162823400|NCT01353508|588064882|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
162823401|NCT01353508|588064883|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
162823402|NCT01353508|588064884|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
162823403|NCT00873366|588064885|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
162823404|NCT00873366|588064885|FG000|Overall Study|Off tamoxifen due to side effects|2|||
162823405|NCT00873366|588064885|FG000|Overall Study|Refused to continue DM-BT testing|3|||
162823406|NCT01576172|588064886|FG000|Overall Study|Ineligible|2|||
162823407|NCT01576172|588064887|FG001|Overall Study|Ineligible|1|||
162823408|NCT01576172|588064886|FG000|Overall Study|Withdrawal by Subject|2|||
162823409|NCT01576172|588064887|FG001|Overall Study|Withdrawal by Subject|0|||
162823410|NCT01576172|588064886|FG000|Overall Study|Insurance issue|1|||
162823411|NCT01576172|588064887|FG001|Overall Study|Insurance issue|0|||
162823412|NCT02092350|588064892|FG000|Overall Study|Adverse Event|0|||
162823413|NCT02092350|588064893|FG001|Overall Study|Adverse Event|3|||
162823414|NCT02092350|588064892|FG000|Overall Study|Death|2|||
162823415|NCT02092350|588064893|FG001|Overall Study|Death|5|||
162823416|NCT02092350|588064892|FG000|Overall Study|Lost to Follow-up|3|||
162823417|NCT02092350|588064893|FG001|Overall Study|Lost to Follow-up|1|||
162823418|NCT02092350|588064892|FG000|Overall Study|Protocol Violation|1|||
162823419|NCT02092350|588064893|FG001|Overall Study|Protocol Violation|0|||
162823420|NCT02092350|588064892|FG000|Overall Study|Physician Decision|1|||
162823421|NCT02092350|588064893|FG001|Overall Study|Physician Decision|1|||
162823422|NCT02092350|588064892|FG000|Overall Study|Screen Failure|1|||
162823423|NCT02092350|588064893|FG001|Overall Study|Screen Failure|0|||
162823424|NCT02092350|588064892|FG000|Overall Study|Withdrawal by Subject|2|||
162823425|NCT02092350|588064893|FG001|Overall Study|Withdrawal by Subject|2|||
162823426|NCT00646906|588064895|FG000|Crossover Period 1|Withdrawal by Subject|1|||
162823427|NCT00646906|588064896|FG001|Crossover Period 1|Withdrawal by Subject|0|||
162823428|NCT00646906|588064897|FG002|Crossover Period 1|Withdrawal by Subject|0|||
162823429|NCT00646906|588064898|FG003|Crossover Period 1|Withdrawal by Subject|0|||
162823430|NCT00646906|588064899|FG004|Crossover Period 1|Withdrawal by Subject|0|||
162823431|NCT00646906|588064900|FG005|Crossover Period 1|Withdrawal by Subject|1|||
162823432|NCT00646906|588064901|FG006|Crossover Period 1|Withdrawal by Subject|0|||
162930497|NCT03196791|588450447|FG000|Overall Study|Protocol Violation|7|||
162930498|NCT03196791|588450448|FG001|Overall Study|Protocol Violation|3|||
162930499|NCT03196791|588450447|FG000|Overall Study|Withdrawal by Subject|3|||
162930500|NCT03196791|588450448|FG001|Overall Study|Withdrawal by Subject|2|||
162930501|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
162930502|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
162930503|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
162930504|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
162930505|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
162930506|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
162930507|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930508|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
162930509|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930510|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
162930511|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Death|2|||
162930512|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Death|1|||
162930513|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Death|0|||
162930514|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Death|0|||
162930515|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Death|0|||
162930516|NCT00879970|588450449|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
162930517|NCT00879970|588450450|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930518|NCT00879970|588450451|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
162930519|NCT00879970|588450452|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930520|NCT00879970|588450453|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
162930521|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930522|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930523|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
162930524|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
162930525|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
162930526|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930527|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930528|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930529|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
162930530|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
162930531|NCT00879970|588450449|FG000|Period 2 Vitamin D Randomization|Death|0|||
162930532|NCT00879970|588450450|FG001|Period 2 Vitamin D Randomization|Death|0|||
162930533|NCT00879970|588450451|FG002|Period 2 Vitamin D Randomization|Death|0|||
162930534|NCT00879970|588450452|FG003|Period 2 Vitamin D Randomization|Death|2|||
162930535|NCT00879970|588450453|FG004|Period 2 Vitamin D Randomization|Death|0|||
162930536|NCT01749033|588450457|FG000|Overall Study|Did not receive allocated intervention|3|||
162930537|NCT01749033|588450458|FG001|Overall Study|Did not receive allocated intervention|3|||
162930538|NCT01749033|588450459|FG002|Overall Study|Did not receive allocated intervention|0|||
162930539|NCT01749033|588450457|FG000|Overall Study|Lost to Follow-up|0|||
162930540|NCT01749033|588450458|FG001|Overall Study|Lost to Follow-up|2|||
162930541|NCT01749033|588450459|FG002|Overall Study|Lost to Follow-up|1|||
162930542|NCT01256398|588450461|FG000|Overall Study|Withdrawal by Subject|1|||
162930543|NCT01039584|588450462|FG000|Overall Study|Withdrawal by Subject|4|||
162930544|NCT01039584|588450463|FG001|Overall Study|Withdrawal by Subject|2|||
162930545|NCT01039584|588450464|FG002|Overall Study|Withdrawal by Subject|1|||
162930546|NCT01039584|588450462|FG000|Overall Study|Protocol Violation|10|||
162930547|NCT01039584|588450463|FG001|Overall Study|Protocol Violation|4|||
162930548|NCT01039584|588450464|FG002|Overall Study|Protocol Violation|6|||
162930549|NCT01039584|588450462|FG000|Overall Study|Lost to Follow-up|5|||
162930550|NCT01039584|588450463|FG001|Overall Study|Lost to Follow-up|3|||
162930551|NCT01039584|588450464|FG002|Overall Study|Lost to Follow-up|4|||
162930552|NCT01039584|588450462|FG000|Overall Study|Negative Baseline culture for Candida|59|||
162930553|NCT01039584|588450463|FG001|Overall Study|Negative Baseline culture for Candida|59|||
162930554|NCT01039584|588450464|FG002|Overall Study|Negative Baseline culture for Candida|24|||
162930555|NCT01039584|588450462|FG000|Overall Study|Lack of Efficacy|7|||
162930556|NCT01039584|588450463|FG001|Overall Study|Lack of Efficacy|6|||
162930557|NCT01039584|588450464|FG002|Overall Study|Lack of Efficacy|10|||
162930558|NCT01039584|588450462|FG000|Overall Study|other|1|||
162698428|NCT03881059|587605503|FG000|Treatment Period - Part B|Death|0|||
162698429|NCT03881059|587605504|FG001|Treatment Period - Part B|Death|1|||
162930559|NCT01039584|588450463|FG001|Overall Study|other|3|||
162930560|NCT01039584|588450464|FG002|Overall Study|other|1|||
162930561|NCT01039584|588450462|FG000|Overall Study|Pap smear with significant pathology|10|||
162930562|NCT01039584|588450463|FG001|Overall Study|Pap smear with significant pathology|10|||
162930563|NCT01039584|588450464|FG002|Overall Study|Pap smear with significant pathology|3|||
162930564|NCT01039584|588450462|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
162930565|NCT01039584|588450463|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
162930566|NCT01039584|588450464|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
162930567|NCT01174368|588450467|FG000|Overall Study|Withdrawal by Subject|1|||
162930568|NCT00479765|588450468|FG000|Overall Study|study terminated|4|||
162930569|NCT03550794|588450471|FG000|Overall Study|No longer met inclusion criteria|1|||
162930570|NCT03550794|588450472|FG001|Overall Study|No longer met inclusion criteria|2|||
162930571|NCT03550794|588450471|FG000|Overall Study|Goals of care changed|1|||
162930572|NCT03550794|588450472|FG001|Overall Study|Goals of care changed|0|||
162930573|NCT03550794|588450471|FG000|Overall Study|Withdrawal by Subject|2|||
162930574|NCT03550794|588450472|FG001|Overall Study|Withdrawal by Subject|0|||
162930575|NCT03550794|588450471|FG000|Overall Study|Death|0|||
162930576|NCT03550794|588450472|FG001|Overall Study|Death|1|||
162930577|NCT01864525|588450473|FG000|Overall Study|Adverse Event|1|||
162930578|NCT01864525|588450474|FG001|Overall Study|Adverse Event|0|||
162930579|NCT01890785|588450475|FG000|Third Intervention|Withdrawal by Subject|0|||
162930580|NCT01890785|588450476|FG001|Third Intervention|Withdrawal by Subject|1|||
162930581|NCT01890785|588450477|FG002|Third Intervention|Withdrawal by Subject|0|||
162930582|NCT01890785|588450478|FG003|Third Intervention|Withdrawal by Subject|0|||
162930583|NCT01890785|588450479|FG004|Third Intervention|Withdrawal by Subject|0|||
162930584|NCT01890785|588450480|FG005|Third Intervention|Withdrawal by Subject|0|||
162930585|NCT03296553|588450481|FG000|Overall Study|Withdrawal by Subject|1|||
162930586|NCT03296553|588450482|FG001|Overall Study|Withdrawal by Subject|1|||
162930587|NCT03296553|588450481|FG000|Overall Study|Death|1|||
162930588|NCT03296553|588450482|FG001|Overall Study|Death|0|||
162930589|NCT00558519|588450483|FG000|Overall Study|Ph+|20|||
162930590|NCT00558519|588450483|FG000|Overall Study|Ineligible|1|||
162930591|NCT00558519|588450483|FG000|Overall Study|Insufficient data|1|||
162930592|NCT00558519|588450483|FG000|Overall Study|Never received treatment|1|||
162930593|NCT03001011|588450484|FG000|Overall Study|Adverse Event|9|||
162930594|NCT03001011|588450485|FG001|Overall Study|Adverse Event|3|||
162930595|NCT03001011|588450484|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
162930596|NCT03001011|588450485|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
162930597|NCT03001011|588450484|FG000|Overall Study|Other than specified above|3|||
162930598|NCT03001011|588450485|FG001|Overall Study|Other than specified above|8|||
162930599|NCT03077828|588450487|FG000|Treatment Cycles|Death|1|||
162930600|NCT03077828|588450487|FG000|Treatment Cycles|Withdrawal by Subject|1|||
162930601|NCT03077828|588450487|FG000|Treatment Cycles|Screen Fail|2|||
162930602|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
162930603|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
162930604|NCT03077828|588450487|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
162930605|NCT03077828|588450487|FG000|Follow-up|Patients still in follow-up|15|||
162930606|NCT02392559|588450488|FG000|Overall Study|Withdrawal by Subject|0|||
162930607|NCT02392559|588450489|FG001|Overall Study|Withdrawal by Subject|1|||
162930608|NCT03125915|588450495|FG000|1 Month Follow up|Lost to Follow-up|3|||
162930609|NCT03125915|588450496|FG001|1 Month Follow up|Lost to Follow-up|3|||
162930610|NCT03125915|588450497|FG002|1 Month Follow up|Lost to Follow-up|2|||
162930611|NCT03125915|588450498|FG003|1 Month Follow up|Lost to Follow-up|3|||
162930612|NCT03125915|588450495|FG000|3 Month Follow-up|Lost to Follow-up|6|||
162930613|NCT03125915|588450496|FG001|3 Month Follow-up|Lost to Follow-up|4|||
162930614|NCT03125915|588450497|FG002|3 Month Follow-up|Lost to Follow-up|4|||
162930615|NCT03125915|588450498|FG003|3 Month Follow-up|Lost to Follow-up|2|||
162930616|NCT03125915|588450495|FG000|6 Month Follow-up|Lost to Follow-up|7|||
162930617|NCT03125915|588450496|FG001|6 Month Follow-up|Lost to Follow-up|3|||
162930618|NCT03125915|588450497|FG002|6 Month Follow-up|Lost to Follow-up|6|||
162930619|NCT03125915|588450498|FG003|6 Month Follow-up|Lost to Follow-up|3|||
162930620|NCT04816877|588450499|FG000|Overall Study|Withdrawal by Subject|1|||
162930621|NCT04816877|588450500|FG001|Overall Study|Withdrawal by Subject|0|||
162930622|NCT02176642|588450502|FG000|Overall Study|Withdrawal by Subject|0|||
162930623|NCT02176642|588450503|FG001|Overall Study|Withdrawal by Subject|1|||
162930624|NCT01309828|588450504|FG000|Overall Study|Adverse Event|10|||
162930625|NCT01309828|588450505|FG001|Overall Study|Adverse Event|11|||
162930626|NCT01309828|588450504|FG000|Overall Study|Voluntary Withdrawal|5|||
162930627|NCT01309828|588450505|FG001|Overall Study|Voluntary Withdrawal|4|||
162930628|NCT01309828|588450504|FG000|Overall Study|Major Protocol Deviation|0|||
162930629|NCT01309828|588450505|FG001|Overall Study|Major Protocol Deviation|1|||
162930630|NCT01309828|588450504|FG000|Overall Study|Other|1|||
162930631|NCT01309828|588450505|FG001|Overall Study|Other|0|||
162930632|NCT00295620|588450506|FG000|Overall Study|Lost to Follow-up|9|||
162930633|NCT00295620|588450507|FG001|Overall Study|Lost to Follow-up|5|||
162930634|NCT00295620|588450506|FG000|Overall Study|Withdrawal by Subject|37|||
162930635|NCT00295620|588450507|FG001|Overall Study|Withdrawal by Subject|50|||
162930636|NCT00295620|588450506|FG000|Overall Study|Death|206|||
162930637|NCT00295620|588450507|FG001|Overall Study|Death|207|||
162930638|NCT00295620|588450506|FG000|Overall Study|Other reasons|10|||
162930639|NCT00295620|588450507|FG001|Overall Study|Other reasons|9|||
162930640|NCT00295620|588450506|FG000|Overall Study|Discontinuation by sponsor|580|||
162930641|NCT00295620|588450507|FG001|Overall Study|Discontinuation by sponsor|593|||
162930642|NCT00295620|588450506|FG000|Overall Study|Protocol Violation|30|||
162930643|NCT00295620|588450507|FG001|Overall Study|Protocol Violation|32|||
162930644|NCT00217971|588450508|FG000|Overall Study|Adverse Event|1|||
162930645|NCT00217971|588450509|FG001|Overall Study|Adverse Event|1|||
162930646|NCT00217971|588450508|FG000|Overall Study|Lost to Follow-up|15|||
162930647|NCT00217971|588450509|FG001|Overall Study|Lost to Follow-up|19|||
162930648|NCT00217971|588450508|FG000|Overall Study|Physician Decision|0|||
162930649|NCT00217971|588450509|FG001|Overall Study|Physician Decision|1|||
162930650|NCT00217971|588450508|FG000|Overall Study|Withdrawal by Subject|7|||
162930651|NCT00217971|588450509|FG001|Overall Study|Withdrawal by Subject|12|||
162930652|NCT00217971|588450508|FG000|Overall Study|non compliant|1|||
162930653|NCT00217971|588450509|FG001|Overall Study|non compliant|0|||
162930654|NCT00808015|588450510|FG000|Overall Study|Death|1|||
162930655|NCT00808015|588450510|FG000|Overall Study|Lack of Efficacy|58|||
163173184|NCT01002820|589349818|FG000|Overall Study|Withdrawal by Subject|2|||
163173185|NCT01002820|589349818|FG000|Overall Study|Lack of Efficacy|1|||
163173186|NCT02478398|589349819|FG000|Overall Study|Adverse Event|20|||
162823433|NCT00646906|588064895|FG000|Crossover Period 2|Withdrawal by Subject|0|||
162823434|NCT00646906|588064896|FG001|Crossover Period 2|Withdrawal by Subject|1|||
162823435|NCT00646906|588064897|FG002|Crossover Period 2|Withdrawal by Subject|2|||
162823436|NCT00646906|588064898|FG003|Crossover Period 2|Withdrawal by Subject|1|||
162823437|NCT00646906|588064899|FG004|Crossover Period 2|Withdrawal by Subject|0|||
162823438|NCT00646906|588064900|FG005|Crossover Period 2|Withdrawal by Subject|0|||
162823439|NCT00646906|588064901|FG006|Crossover Period 2|Withdrawal by Subject|0|||
162823440|NCT00646906|588064895|FG000|Crossover Period 2|Physician Decision|0|||
162823441|NCT00646906|588064896|FG001|Crossover Period 2|Physician Decision|0|||
162823442|NCT00646906|588064897|FG002|Crossover Period 2|Physician Decision|0|||
162823443|NCT00646906|588064898|FG003|Crossover Period 2|Physician Decision|0|||
162823444|NCT00646906|588064899|FG004|Crossover Period 2|Physician Decision|0|||
162823445|NCT00646906|588064900|FG005|Crossover Period 2|Physician Decision|0|||
162823446|NCT00646906|588064901|FG006|Crossover Period 2|Physician Decision|1|||
162823447|NCT02844920|588064913|FG000|Overall Study|Lost to Follow-up|2|||
162823448|NCT04534491|588064914|FG000|Overall Study|Not completed end-of-study interview|24|||
162823449|NCT04534491|588064914|FG000|Overall Study|Non-users|70|||
162823450|NCT04534491|588064914|FG000|Overall Study|Non-verifiable users|58|||
162823451|NCT00369785|588064920|FG000|Overall Study|Physician Decision|3|||
162823452|NCT00369785|588064921|FG001|Overall Study|Physician Decision|2|||
162823453|NCT00369785|588064920|FG000|Overall Study|Death|1|||
162823454|NCT00369785|588064921|FG001|Overall Study|Death|2|||
162823455|NCT00369785|588064920|FG000|Overall Study|Withdrawal by Subject|7|||
162823456|NCT00369785|588064921|FG001|Overall Study|Withdrawal by Subject|6|||
162823457|NCT00369785|588064920|FG000|Overall Study|Toxicity|6|||
162823458|NCT00369785|588064921|FG001|Overall Study|Toxicity|4|||
162823459|NCT00369785|588064920|FG000|Overall Study|Never started|0|||
162823460|NCT00369785|588064921|FG001|Overall Study|Never started|2|||
162823461|NCT00369785|588064920|FG000|Overall Study|Progression|4|||
162823462|NCT00369785|588064921|FG001|Overall Study|Progression|4|||
162823463|NCT00369785|588064920|FG000|Overall Study|Multiple reasons|6|||
162823464|NCT00369785|588064921|FG001|Overall Study|Multiple reasons|5|||
162823465|NCT00800683|588064922|FG000|Overall Study|Adverse Event|11|||
162823466|NCT00800683|588064923|FG001|Overall Study|Adverse Event|8|||
162823467|NCT00800683|588064922|FG000|Overall Study|Lost to Follow-up|3|||
162823468|NCT00800683|588064923|FG001|Overall Study|Lost to Follow-up|1|||
162823469|NCT00800683|588064922|FG000|Overall Study|Withdrawal by Subject|1|||
162823470|NCT00800683|588064923|FG001|Overall Study|Withdrawal by Subject|7|||
162823471|NCT00800683|588064922|FG000|Overall Study|Lack of Efficacy|1|||
162823472|NCT00800683|588064923|FG001|Overall Study|Lack of Efficacy|1|||
162823473|NCT00800683|588064922|FG000|Overall Study|Other|1|||
162823474|NCT00800683|588064923|FG001|Overall Study|Other|2|||
162823475|NCT02247960|588064925|FG000|Patient Consent and Randomization|Physician Decision|2|||
162823476|NCT02247960|588064926|FG001|Patient Consent and Randomization|Physician Decision|2|||
162823477|NCT02247960|588064925|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
162823478|NCT02247960|588064926|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
162823479|NCT02247960|588064925|FG000|Catheter Removed|Lost to Follow-up|7|||
162823480|NCT02247960|588064926|FG001|Catheter Removed|Lost to Follow-up|10|||
162823481|NCT02678416|588064927|FG000|Part 1|Withdrawal by Subject|1|||
162823482|NCT02678416|588064927|FG000|Part 2|Adverse Event|2|||
162823483|NCT02678416|588064927|FG000|Part 2|Withdrawal by Subject|1|||
162823484|NCT01848353|588064928|FG000|Phase 1|Withdrawal by Subject|3|||
162823485|NCT01848353|588064929|FG001|Phase 1|Withdrawal by Subject|1|||
162823486|NCT01848353|588064930|FG002|Phase 1|Withdrawal by Subject|0|||
162823487|NCT01848353|588064931|FG003|Phase 1|Withdrawal by Subject|0|||
162823488|NCT01848353|588064928|FG000|Phase 2|Withdrawal by Subject|3|||
162823489|NCT01848353|588064929|FG001|Phase 2|Withdrawal by Subject|2|||
162823490|NCT01848353|588064930|FG002|Phase 2|Withdrawal by Subject|0|||
162930656|NCT00808015|588450510|FG000|Overall Study|Lost to Follow-up|76|||
162930657|NCT00808015|588450510|FG000|Overall Study|Participants not willing to participate|158|||
162930658|NCT00808015|588450510|FG000|Overall Study|Adverse Event|22|||
162930659|NCT00808015|588450510|FG000|Overall Study|Other|25|||
162930660|NCT00808015|588450510|FG000|Overall Study|Enrolled but not treated|4|||
162930661|NCT00084617|588450513|FG000|Overall Study|Withdrawal by Subject|7|||
162930662|NCT00084617|588450513|FG000|Overall Study|Lack of Efficacy|1|||
162930663|NCT00084617|588450513|FG000|Overall Study|Protocol Violation|1|||
162930664|NCT01625286|588450514|FG000|Overall Study|Adverse Event|0|||
162930665|NCT01625286|588450515|FG001|Overall Study|Adverse Event|0|||
162930666|NCT01625286|588450516|FG002|Overall Study|Adverse Event|0|||
162930667|NCT01625286|588450517|FG003|Overall Study|Adverse Event|0|||
162930668|NCT01625286|588450518|FG004|Overall Study|Adverse Event|1|||
162930669|NCT01625286|588450519|FG005|Overall Study|Adverse Event|2|||
162930670|NCT01625286|588450520|FG006|Overall Study|Adverse Event|1|||
162930671|NCT01625286|588450514|FG000|Overall Study|Death|0|||
162930672|NCT01625286|588450515|FG001|Overall Study|Death|0|||
162930673|NCT01625286|588450516|FG002|Overall Study|Death|1|||
162930674|NCT01625286|588450517|FG003|Overall Study|Death|1|||
162930675|NCT01625286|588450518|FG004|Overall Study|Death|0|||
162930676|NCT01625286|588450519|FG005|Overall Study|Death|11|||
162930677|NCT01625286|588450520|FG006|Overall Study|Death|16|||
162930678|NCT01625286|588450514|FG000|Overall Study|Withdrawal by Subject|0|||
162930679|NCT01625286|588450515|FG001|Overall Study|Withdrawal by Subject|1|||
162930680|NCT01625286|588450516|FG002|Overall Study|Withdrawal by Subject|0|||
162930681|NCT01625286|588450517|FG003|Overall Study|Withdrawal by Subject|1|||
162930682|NCT01625286|588450518|FG004|Overall Study|Withdrawal by Subject|0|||
162930683|NCT01625286|588450519|FG005|Overall Study|Withdrawal by Subject|0|||
162930684|NCT01625286|588450520|FG006|Overall Study|Withdrawal by Subject|1|||
162930685|NCT01625286|588450514|FG000|Overall Study|Any reason not specifically recorded|0|||
162930686|NCT01625286|588450515|FG001|Overall Study|Any reason not specifically recorded|0|||
162930687|NCT01625286|588450516|FG002|Overall Study|Any reason not specifically recorded|0|||
162930688|NCT01625286|588450517|FG003|Overall Study|Any reason not specifically recorded|0|||
162930689|NCT01625286|588450518|FG004|Overall Study|Any reason not specifically recorded|0|||
162930690|NCT01625286|588450519|FG005|Overall Study|Any reason not specifically recorded|1|||
162930691|NCT01625286|588450520|FG006|Overall Study|Any reason not specifically recorded|0|||
162930692|NCT01625286|588450514|FG000|Overall Study|Progressive disease|6|||
162930693|NCT01625286|588450515|FG001|Overall Study|Progressive disease|3|||
162930694|NCT01625286|588450516|FG002|Overall Study|Progressive disease|4|||
162930695|NCT01625286|588450517|FG003|Overall Study|Progressive disease|5|||
162930696|NCT01625286|588450518|FG004|Overall Study|Progressive disease|5|||
162930697|NCT01625286|588450519|FG005|Overall Study|Progressive disease|0|||
162930698|NCT01625286|588450520|FG006|Overall Study|Progressive disease|0|||
162930699|NCT01625286|588450514|FG000|Overall Study|Lost to Follow-up|0|||
162930700|NCT01625286|588450515|FG001|Overall Study|Lost to Follow-up|0|||
162930701|NCT01625286|588450516|FG002|Overall Study|Lost to Follow-up|0|||
162930702|NCT01625286|588450517|FG003|Overall Study|Lost to Follow-up|0|||
162930703|NCT01625286|588450518|FG004|Overall Study|Lost to Follow-up|0|||
162930704|NCT01625286|588450519|FG005|Overall Study|Lost to Follow-up|0|||
162930705|NCT01625286|588450520|FG006|Overall Study|Lost to Follow-up|1|||
162930706|NCT04523831|588450523|FG000|Overall Study|Lost to Follow-up|15|||
162930707|NCT04523831|588450524|FG001|Overall Study|Lost to Follow-up|17|||
162930708|NCT04523831|588450523|FG000|Overall Study|Death|0|||
162930709|NCT04523831|588450524|FG001|Overall Study|Death|3|||
162930710|NCT04523831|588450523|FG000|Overall Study|Adverse Event|2|||
162930711|NCT04523831|588450524|FG001|Overall Study|Adverse Event|0|||
162930712|NCT00995930|588450525|FG000|Overall Study|Protocol deviation|2|||
162930713|NCT00995930|588450526|FG001|Overall Study|Protocol deviation|5|||
162930714|NCT00995930|588450525|FG000|Overall Study|Death|0|||
162930715|NCT00995930|588450526|FG001|Overall Study|Death|1|||
162930716|NCT00995930|588450525|FG000|Overall Study|Administrative problems|4|||
162930717|NCT00995930|588450526|FG001|Overall Study|Administrative problems|2|||
162930718|NCT00995930|588450525|FG000|Overall Study|Lost to Follow-up|1|||
162930719|NCT00995930|588450526|FG001|Overall Study|Lost to Follow-up|2|||
162930720|NCT00995930|588450525|FG000|Overall Study|Withdrawal by Subject|3|||
162930721|NCT00995930|588450526|FG001|Overall Study|Withdrawal by Subject|4|||
162930722|NCT00995930|588450525|FG000|Overall Study|Adverse Event|11|||
162930723|NCT00995930|588450526|FG001|Overall Study|Adverse Event|14|||
162930724|NCT01963676|588452173|FG000|Overall Study|Withdrawal by Subject|1|||
162930725|NCT01963676|588452174|FG001|Overall Study|Withdrawal by Subject|0|||
162930726|NCT03627195|588452175|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
162930727|NCT03627195|588452176|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930728|NCT03627195|588452177|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930729|NCT03627195|588452178|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930730|NCT03627195|588452179|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930731|NCT03627195|588452180|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
162930732|NCT00096382|588452183|FG000|Overall Study|Not treated|1|||
162930733|NCT00096382|588452184|FG001|Overall Study|Not treated|0|||
162823491|NCT01848353|588064931|FG003|Phase 2|Withdrawal by Subject|0|||
162823492|NCT01848353|588064928|FG000|Phase 3|Withdrawal by Subject|1|||
162823493|NCT01848353|588064929|FG001|Phase 3|Withdrawal by Subject|1|||
162823494|NCT01848353|588064930|FG002|Phase 3|Withdrawal by Subject|0|||
162823495|NCT01848353|588064931|FG003|Phase 3|Withdrawal by Subject|0|||
162823496|NCT01910116|588064941|FG000|Overall Study|Adverse Event|0|||
162823497|NCT01910116|588064942|FG001|Overall Study|Adverse Event|3|||
162823498|NCT01910116|588064941|FG000|Overall Study|Lack of Efficacy|3|||
162930734|NCT00096382|588452183|FG000|Overall Study|Death during treatment|1|||
162930735|NCT00096382|588452184|FG001|Overall Study|Death during treatment|0|||
162930736|NCT01977352|588452185|FG000|Overall Study|Lost to Follow-up|1|||
162930737|NCT01977352|588452186|FG001|Overall Study|Lost to Follow-up|2|||
162930738|NCT00409188|588452192|FG000|Overall Study|Ongoing at data cut-off|383|||
162930739|NCT00409188|588452193|FG001|Overall Study|Ongoing at data cut-off|175|||
162930740|NCT01835132|588452194|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
162930741|NCT00856778|588452195|FG000|Overall Study|Adverse Event|7|||
162930742|NCT00856778|588452195|FG000|Overall Study|Withdrawal by Subject|10|||
162930743|NCT00856778|588452195|FG000|Overall Study|Study deviation|2|||
162930744|NCT00856778|588452195|FG000|Overall Study|Lost to Follow-up|5|||
162930745|NCT01681771|588452196|FG000|Overall Study|Lost to Follow-up|4|||
162930746|NCT01681771|588452197|FG001|Overall Study|Lost to Follow-up|2|||
162930747|NCT00265083|588452198|FG000|Overall Study|Adverse Event|5|||
162930748|NCT00265083|588452199|FG001|Overall Study|Adverse Event|13|||
162930749|NCT00265083|588452200|FG002|Overall Study|Adverse Event|15|||
162930750|NCT00265083|588452198|FG000|Overall Study|Lost to Follow-up|3|||
162930751|NCT00265083|588452199|FG001|Overall Study|Lost to Follow-up|4|||
162930752|NCT00265083|588452200|FG002|Overall Study|Lost to Follow-up|4|||
162930753|NCT00265083|588452198|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
162930754|NCT00265083|588452199|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162930755|NCT00265083|588452200|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
162930756|NCT00265083|588452198|FG000|Overall Study|Other|1|||
162930757|NCT00265083|588452199|FG001|Overall Study|Other|12|||
162930758|NCT00265083|588452200|FG002|Overall Study|Other|9|||
162930759|NCT03208933|588452204|FG000|Overall Study|Death|3|||
162930760|NCT03208933|588452204|FG000|Overall Study|Withdrawal by Subject|3|||
162930761|NCT03208933|588452204|FG000|Overall Study|Adverse Event|1|||
162930762|NCT03208933|588452204|FG000|Overall Study|Lost to Follow-up|2|||
162930763|NCT03208933|588452204|FG000|Overall Study|Physician Decision|3|||
162930764|NCT03208933|588452204|FG000|Overall Study|Protocol Violation|1|||
162930765|NCT00854620|588452207|FG000|Overall Study|Adverse Event|1|||
162930766|NCT04242186|588452213|FG000|Overall Study|Death|5|||
162930767|NCT00550420|588452215|FG000|Overall Study|Adverse Event|28|||
162930768|NCT00550420|588452215|FG000|Overall Study|Lost to Follow-up|8|||
162930769|NCT00550420|588452215|FG000|Overall Study|Protocol Violation|11|||
162930770|NCT00550420|588452215|FG000|Overall Study|Withdrawal by Subject|30|||
162823499|NCT01910116|588064942|FG001|Overall Study|Lack of Efficacy|4|||
162823500|NCT01910116|588064941|FG000|Overall Study|Lost to Follow-up|1|||
162823501|NCT01910116|588064942|FG001|Overall Study|Lost to Follow-up|0|||
162823502|NCT01910116|588064941|FG000|Overall Study|Protocol Violation|1|||
162930771|NCT00550420|588452215|FG000|Overall Study|Still in study at termination|206|||
162930772|NCT00550420|588452215|FG000|Overall Study|Missing|2|||
162930773|NCT00550420|588452215|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
162930774|NCT00550420|588452215|FG000|Overall Study|Investigators opinion|1|||
162930775|NCT00550420|588452215|FG000|Overall Study|Lack of curative effect|1|||
163173187|NCT02478398|589349820|FG001|Overall Study|Adverse Event|5|||
163173188|NCT02478398|589349819|FG000|Overall Study|Lost to Follow-up|5|||
163173189|NCT02478398|589349820|FG001|Overall Study|Lost to Follow-up|4|||
163173190|NCT02478398|589349819|FG000|Overall Study|Non-Compliance With Study Drug|5|||
163173191|NCT02478398|589349820|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163173192|NCT02478398|589349819|FG000|Overall Study|Protocol Violation|3|||
163173193|NCT02478398|589349820|FG001|Overall Study|Protocol Violation|1|||
163173194|NCT02478398|589349819|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
162698430|NCT03881059|587605505|FG002|Treatment Period - Part B|Death|1|||
162698431|NCT03881059|587605503|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
162698432|NCT03881059|587605504|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
162698433|NCT03881059|587605505|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
162698434|NCT03881059|587605503|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
162698435|NCT03881059|587605504|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
162698436|NCT03881059|587605505|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
162823503|NCT01910116|588064942|FG001|Overall Study|Protocol Violation|2|||
162930776|NCT00550420|588452215|FG000|Overall Study|Unethical stop of enrollment|2|||
162930777|NCT00550420|588452215|FG000|Overall Study|Caregiver's decision to withdraw|1|||
162930778|NCT00550420|588452215|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
162930779|NCT00550420|588452215|FG000|Overall Study|Exclusion criteria|1|||
162930780|NCT00550420|588452215|FG000|Overall Study|Prohibited medicine|1|||
162930781|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930782|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
162930783|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930784|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
162930785|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
162930786|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
162930787|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
162930788|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
162930789|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
162930790|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
162930791|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
162930792|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
162930793|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
162823504|NCT01910116|588064941|FG000|Overall Study|Withdrawal by Subject|8|||
162823505|NCT01910116|588064942|FG001|Overall Study|Withdrawal by Subject|3|||
162823506|NCT01910116|588064941|FG000|Overall Study|uncertain allocation|1|||
162823507|NCT01910116|588064942|FG001|Overall Study|uncertain allocation|3|||
162823508|NCT01910116|588064941|FG000|Overall Study|incomplete data|0|||
162823509|NCT01910116|588064942|FG001|Overall Study|incomplete data|1|||
162823510|NCT02289352|588064945|FG000|Overall Study|Withdrawal by Subject|1|||
162823511|NCT02289352|588064946|FG001|Overall Study|Withdrawal by Subject|1|||
162823512|NCT02289352|588064947|FG002|Overall Study|Withdrawal by Subject|0|||
162823513|NCT03606980|588064948|FG000|Overall Study|Lost to Follow-up|3|||
162823514|NCT03606980|588064949|FG001|Overall Study|Lost to Follow-up|2|||
162823515|NCT03606980|588064950|FG002|Overall Study|Lost to Follow-up|3|||
162823516|NCT03606980|588064948|FG000|Overall Study|Withdrawal by Subject|1|||
162823517|NCT03606980|588064949|FG001|Overall Study|Withdrawal by Subject|0|||
162823518|NCT03606980|588064950|FG002|Overall Study|Withdrawal by Subject|4|||
162823519|NCT02374021|588064952|FG000|Overall Study|Adverse Event|1|||
162823520|NCT02374021|588064953|FG001|Overall Study|Adverse Event|0|||
162823521|NCT02374021|588064952|FG000|Overall Study|Lost to Follow-up|3|||
162823522|NCT02374021|588064953|FG001|Overall Study|Lost to Follow-up|2|||
162823523|NCT02374021|588064952|FG000|Overall Study|Physician Decision|0|||
162823524|NCT02374021|588064953|FG001|Overall Study|Physician Decision|3|||
162823525|NCT02374021|588064952|FG000|Overall Study|Withdrawal by Subject|6|||
162823526|NCT02374021|588064953|FG001|Overall Study|Withdrawal by Subject|5|||
162823527|NCT02374021|588064952|FG000|Overall Study|Poor Adherence|0|||
162823528|NCT02374021|588064953|FG001|Overall Study|Poor Adherence|1|||
162823529|NCT02374021|588064952|FG000|Overall Study|Scan protocol not followed|0|||
162823530|NCT02374021|588064953|FG001|Overall Study|Scan protocol not followed|1|||
162823531|NCT02374021|588064952|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
162823532|NCT02374021|588064953|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
162823533|NCT00732251|588064954|FG000|Overall Study|Lost to Follow-up|3|||
162823534|NCT00732251|588064954|FG000|Overall Study|Withdrawal by Subject|3|||
162823535|NCT00732251|588064954|FG000|Overall Study|Early Term due to Site Closure|1|||
162823536|NCT02737852|588066914|FG000|Overall Study|Withdrawal by Subject|2|||
162823537|NCT03688880|588066915|FG000|Overall Study|Withdrawal by Subject|0|||
162823538|NCT03688880|588066916|FG001|Overall Study|Withdrawal by Subject|2|||
162823539|NCT03688880|588066915|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
162823540|NCT03688880|588066916|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
162823541|NCT03688880|588066915|FG000|Overall Study|Lost to Follow-up|4|||
162823542|NCT03688880|588066916|FG001|Overall Study|Lost to Follow-up|7|||
162823543|NCT03688880|588066915|FG000|Overall Study|Adverse Event|0|||
162823544|NCT03688880|588066916|FG001|Overall Study|Adverse Event|2|||
162823545|NCT03688880|588066915|FG000|Overall Study|Device deficiencies|0|||
162823546|NCT03688880|588066916|FG001|Overall Study|Device deficiencies|2|||
162823547|NCT03688880|588066915|FG000|Overall Study|Other|10|||
162823548|NCT03688880|588066916|FG001|Overall Study|Other|16|||
162823549|NCT02807480|588066920|FG000|Overall Study|Withdrawal by Subject|14|||
162823550|NCT02807480|588066921|FG001|Overall Study|Withdrawal by Subject|10|||
162823551|NCT02163187|588066922|FG000|Overall Study|Device removed|1|||
162823552|NCT02163187|588066923|FG001|Overall Study|Device removed|0|||
162823553|NCT02163187|588066922|FG000|Overall Study|Progressive disease|1|||
162823554|NCT02163187|588066923|FG001|Overall Study|Progressive disease|0|||
162823555|NCT02369848|588066924|FG000|Overall Study|Death|1|||
162930794|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
162930795|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
162823556|NCT02369848|588066924|FG000|Overall Study|Withdrawal by Subject|2|||
162823557|NCT02369848|588066924|FG000|Overall Study|Lost to Follow-up|1|||
162823558|NCT02081534|588066929|FG000|Overall Study|Adverse Event|5|||
162823559|NCT02081534|588066930|FG001|Overall Study|Adverse Event|4|||
162823560|NCT02081534|588066931|FG002|Overall Study|Adverse Event|3|||
162823561|NCT02081534|588066932|FG003|Overall Study|Adverse Event|10|||
162823562|NCT02081534|588066933|FG004|Overall Study|Adverse Event|2|||
163173195|NCT02478398|589349820|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
163173196|NCT02478398|589349819|FG000|Overall Study|Withdrawal By Participant|10|||
162823563|NCT02081534|588066934|FG005|Overall Study|Adverse Event|8|||
162823564|NCT02081534|588066935|FG006|Overall Study|Adverse Event|2|||
162823565|NCT02081534|588066929|FG000|Overall Study|Withdrawal by Subject|0|||
162823566|NCT02081534|588066930|FG001|Overall Study|Withdrawal by Subject|1|||
162823567|NCT02081534|588066931|FG002|Overall Study|Withdrawal by Subject|1|||
162823568|NCT02081534|588066932|FG003|Overall Study|Withdrawal by Subject|1|||
162823569|NCT02081534|588066933|FG004|Overall Study|Withdrawal by Subject|1|||
162823570|NCT02081534|588066934|FG005|Overall Study|Withdrawal by Subject|0|||
162823571|NCT02081534|588066935|FG006|Overall Study|Withdrawal by Subject|1|||
162823572|NCT02081534|588066929|FG000|Overall Study|Protocol Violation|0|||
162823573|NCT02081534|588066930|FG001|Overall Study|Protocol Violation|3|||
162823574|NCT02081534|588066931|FG002|Overall Study|Protocol Violation|0|||
162823575|NCT02081534|588066932|FG003|Overall Study|Protocol Violation|0|||
162823576|NCT02081534|588066933|FG004|Overall Study|Protocol Violation|0|||
162823577|NCT02081534|588066934|FG005|Overall Study|Protocol Violation|0|||
162823578|NCT02081534|588066935|FG006|Overall Study|Protocol Violation|1|||
162823579|NCT02081534|588066929|FG000|Overall Study|Lost to Follow-up|0|||
162823580|NCT02081534|588066930|FG001|Overall Study|Lost to Follow-up|0|||
162823581|NCT02081534|588066931|FG002|Overall Study|Lost to Follow-up|0|||
162823582|NCT02081534|588066932|FG003|Overall Study|Lost to Follow-up|2|||
162823583|NCT02081534|588066933|FG004|Overall Study|Lost to Follow-up|1|||
162823584|NCT02081534|588066934|FG005|Overall Study|Lost to Follow-up|1|||
162823585|NCT02081534|588066935|FG006|Overall Study|Lost to Follow-up|0|||
162823586|NCT01848288|588066940|FG000|Overall Study|Death|1|||
162823587|NCT01848288|588066940|FG000|Overall Study|Protocol Violation|1|||
162823588|NCT01848288|588066940|FG000|Overall Study|Withdrawal by Subject|1|||
162823589|NCT01007032|588066942|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
162823590|NCT01007032|588066943|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
162823591|NCT01007032|588066944|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
162823592|NCT01007032|588066945|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
162823593|NCT01007032|588066942|FG000|Overall Study|Withdrawal by Subject|0|||
162823594|NCT01007032|588066943|FG001|Overall Study|Withdrawal by Subject|0|||
162823595|NCT01007032|588066944|FG002|Overall Study|Withdrawal by Subject|0|||
162823596|NCT01007032|588066945|FG003|Overall Study|Withdrawal by Subject|1|||
162823597|NCT01841749|588066946|FG000|Overall Study|Protocol Violation|1|||
162823598|NCT02285920|588066947|FG000|Overall Study|Kidney transplantation|2|||
162823599|NCT02285920|588066948|FG001|Overall Study|Kidney transplantation|2|||
162823600|NCT02285920|588066949|FG002|Overall Study|Kidney transplantation|2|||
162823601|NCT02285920|588066950|FG003|Overall Study|Kidney transplantation|0|||
162823602|NCT02285920|588066947|FG000|Overall Study|Change to peritoneal dialysis|0|||
162823603|NCT02285920|588066948|FG001|Overall Study|Change to peritoneal dialysis|0|||
162823604|NCT02285920|588066949|FG002|Overall Study|Change to peritoneal dialysis|1|||
162823605|NCT02285920|588066950|FG003|Overall Study|Change to peritoneal dialysis|0|||
162823606|NCT02285920|588066947|FG000|Overall Study|Transfer to non-participating unit|0|||
162823607|NCT02285920|588066948|FG001|Overall Study|Transfer to non-participating unit|1|||
162823608|NCT02285920|588066949|FG002|Overall Study|Transfer to non-participating unit|0|||
162823609|NCT02285920|588066950|FG003|Overall Study|Transfer to non-participating unit|0|||
162823610|NCT02285920|588066947|FG000|Overall Study|Dialysis discontinuation|0|||
162823611|NCT02285920|588066948|FG001|Overall Study|Dialysis discontinuation|1|||
162823612|NCT02285920|588066949|FG002|Overall Study|Dialysis discontinuation|0|||
162823613|NCT02285920|588066950|FG003|Overall Study|Dialysis discontinuation|0|||
162823614|NCT02285920|588066947|FG000|Overall Study|Death|2|||
162823615|NCT02285920|588066948|FG001|Overall Study|Death|0|||
162823616|NCT02285920|588066949|FG002|Overall Study|Death|2|||
162823617|NCT02285920|588066950|FG003|Overall Study|Death|1|||
162823618|NCT00677820|588066951|FG000|Overall Study|Lost to Follow-up|1|||
162823619|NCT00677820|588066952|FG001|Overall Study|Lost to Follow-up|0|||
162823620|NCT00066742|588066953|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
162823621|NCT00066742|588066953|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
162823622|NCT00066742|588066953|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
162823623|NCT00066742|588066953|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
162823624|NCT00066742|588066953|FG000|Induction Chemoradiotherapy|Ineligible|3|||
162823625|NCT00066742|588066953|FG000|Consolidation Chemotherapy|not protocol specified|1|||
162823626|NCT00066742|588066953|FG000|Consolidation Chemotherapy|Ineligible|2|||
162823627|NCT02357134|588066954|FG000|Overall Study|Lost to Follow-up|1|||
162823628|NCT02357134|588066955|FG001|Overall Study|Lost to Follow-up|0|||
162823629|NCT02357134|588066956|FG002|Overall Study|Lost to Follow-up|0|||
162823630|NCT02357134|588066957|FG003|Overall Study|Lost to Follow-up|0|||
162823631|NCT02716675|588066958|FG000|Overall Study|Death|2|||
162823632|NCT02716675|588066959|FG001|Overall Study|Death|3|||
162823633|NCT02716675|588066960|FG002|Overall Study|Death|0|||
162823634|NCT02716675|588066958|FG000|Overall Study|Physician Decision|2|||
162823635|NCT02716675|588066959|FG001|Overall Study|Physician Decision|1|||
162823636|NCT02716675|588066960|FG002|Overall Study|Physician Decision|1|||
162823637|NCT02716675|588066958|FG000|Overall Study|Lost to Follow-up|100|||
162930796|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
162930797|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
162823638|NCT02716675|588066959|FG001|Overall Study|Lost to Follow-up|87|||
162823639|NCT02716675|588066960|FG002|Overall Study|Lost to Follow-up|99|||
162823640|NCT02716675|588066958|FG000|Overall Study|Withdrawal by Subject|22|||
162823641|NCT02716675|588066959|FG001|Overall Study|Withdrawal by Subject|25|||
162823642|NCT02716675|588066960|FG002|Overall Study|Withdrawal by Subject|20|||
162823643|NCT02716675|588066958|FG000|Overall Study|Protocol Violation|0|||
162823644|NCT02716675|588066959|FG001|Overall Study|Protocol Violation|3|||
162823645|NCT02716675|588066960|FG002|Overall Study|Protocol Violation|1|||
162823646|NCT02716675|588066958|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
162823647|NCT02716675|588066959|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
162823648|NCT02716675|588066960|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
162823649|NCT02716675|588066958|FG000|Overall Study|Other|38|||
162823650|NCT02716675|588066959|FG001|Overall Study|Other|47|||
162823651|NCT02716675|588066960|FG002|Overall Study|Other|48|||
162823652|NCT00290290|588066967|FG000|Overall Study|Death|3|||
162823653|NCT00290290|588066968|FG001|Overall Study|Death|4|||
162823654|NCT00290290|588066967|FG000|Overall Study|Withdrawal by Subject|2|||
162823655|NCT00290290|588066968|FG001|Overall Study|Withdrawal by Subject|2|||
162823656|NCT00290290|588066967|FG000|Overall Study|Underwent clean surgical procedure|13|||
162823657|NCT00290290|588066968|FG001|Overall Study|Underwent clean surgical procedure|12|||
162823658|NCT00003895|588066971|FG000|Overall Study|Adverse Event|4|||
162823659|NCT00003895|588066972|FG001|Overall Study|Adverse Event|0|||
162823660|NCT00003895|588066971|FG000|Overall Study|Lack of Efficacy|1|||
162823661|NCT00003895|588066972|FG001|Overall Study|Lack of Efficacy|1|||
162823662|NCT00003895|588066971|FG000|Overall Study|Patient Vacation|2|||
162823663|NCT00003895|588066972|FG001|Overall Study|Patient Vacation|0|||
162823664|NCT00003895|588066971|FG000|Overall Study|Withdrawal by Subject|0|||
162823665|NCT00003895|588066972|FG001|Overall Study|Withdrawal by Subject|3|||
162823666|NCT01380730|588066973|FG000|Overall Study|Death|0|||
162823667|NCT01380730|588066974|FG001|Overall Study|Death|0|||
162823668|NCT01380730|588066975|FG002|Overall Study|Death|0|||
162823669|NCT01380730|588066976|FG003|Overall Study|Death|0|||
162823670|NCT01380730|588066977|FG004|Overall Study|Death|1|||
162823671|NCT01380730|588066978|FG005|Overall Study|Death|0|||
162823672|NCT01380730|588066979|FG006|Overall Study|Death|0|||
162823673|NCT01380730|588066980|FG007|Overall Study|Death|0|||
162823674|NCT00962390|588066981|FG000|Overall Study|Adverse Event|0|||
162823675|NCT00962390|588066982|FG001|Overall Study|Adverse Event|0|||
162823676|NCT00962390|588066983|FG002|Overall Study|Adverse Event|3|||
162823677|NCT00962390|588066984|FG003|Overall Study|Adverse Event|1|||
162823678|NCT00962390|588066981|FG000|Overall Study|Lost to Follow-up|2|||
162823679|NCT00962390|588066982|FG001|Overall Study|Lost to Follow-up|2|||
162823680|NCT00962390|588066983|FG002|Overall Study|Lost to Follow-up|0|||
162823681|NCT00962390|588066984|FG003|Overall Study|Lost to Follow-up|0|||
162823682|NCT00962390|588066981|FG000|Overall Study|Protocol Violation|1|||
162823683|NCT00962390|588066982|FG001|Overall Study|Protocol Violation|0|||
162823684|NCT00962390|588066983|FG002|Overall Study|Protocol Violation|0|||
162823685|NCT00962390|588066984|FG003|Overall Study|Protocol Violation|0|||
162823686|NCT00962390|588066981|FG000|Overall Study|Withdrawal by Subject|1|||
162823687|NCT00962390|588066982|FG001|Overall Study|Withdrawal by Subject|1|||
162823688|NCT00962390|588066983|FG002|Overall Study|Withdrawal by Subject|1|||
162823689|NCT00962390|588066984|FG003|Overall Study|Withdrawal by Subject|0|||
162823690|NCT02613884|588066985|FG000|Overall Study|Death|1|||
162823691|NCT02613884|588066985|FG000|Overall Study|Lost to Follow-up|1|||
162823692|NCT00433914|588066991|FG000|Overall Study|Withdrawal by Subject|0|||
162823693|NCT00433914|588066992|FG001|Overall Study|Withdrawal by Subject|2|||
162823694|NCT00433914|588066991|FG000|Overall Study|Lost to Follow-up|0|||
162823695|NCT00433914|588066992|FG001|Overall Study|Lost to Follow-up|1|||
162823696|NCT00766090|588066993|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823697|NCT00766090|588066994|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823698|NCT00766090|588066995|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823699|NCT00766090|588066996|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823700|NCT00766090|588066997|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823701|NCT00766090|588066998|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823702|NCT00766090|588066999|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162930798|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
162823703|NCT00766090|588067000|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823704|NCT00766090|588067001|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
162823705|NCT00766090|588067002|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162930799|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
162823706|NCT00766090|588067003|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823707|NCT00766090|588067004|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162823708|NCT00766090|588066993|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
162823709|NCT00766090|588066994|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823710|NCT00766090|588066995|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823711|NCT00766090|588066996|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823712|NCT00766090|588066997|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823713|NCT00766090|588066998|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823714|NCT00766090|588066999|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823715|NCT00766090|588067000|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823716|NCT00766090|588067001|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823717|NCT00766090|588067002|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823718|NCT00766090|588067003|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823719|NCT00766090|588067004|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162823720|NCT00766090|588066993|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162823721|NCT00766090|588066994|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823722|NCT00766090|588066995|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823723|NCT00766090|588066996|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162823724|NCT00766090|588066997|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823725|NCT00766090|588066998|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823726|NCT00766090|588066999|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162930800|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
162930801|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
162930802|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
162930803|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
162930804|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
162930805|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
162930806|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
162930807|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
162930808|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
162930809|NCT01872689|588452221|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
162930810|NCT01872689|588452222|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
162930811|NCT01872689|588452223|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
162930812|NCT01872689|588452224|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
162930813|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
162930814|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
162930815|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
162930816|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
162930817|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
162930818|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
162930819|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
162930820|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
162930821|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162930822|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
162930823|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162823727|NCT00766090|588067000|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823728|NCT00766090|588067001|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823729|NCT00766090|588067002|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823730|NCT00766090|588067003|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823731|NCT00766090|588067004|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162823732|NCT00766090|588066993|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823733|NCT00766090|588066994|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823734|NCT00766090|588066995|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
162823735|NCT00766090|588066996|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823736|NCT00766090|588066997|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823737|NCT00766090|588066998|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823738|NCT00766090|588066999|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823739|NCT00766090|588067000|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823740|NCT00766090|588067001|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823741|NCT00766090|588067002|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823742|NCT00766090|588067003|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823743|NCT00766090|588067004|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
162823744|NCT00766090|588066993|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823745|NCT00766090|588066994|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823746|NCT00766090|588066995|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823747|NCT00766090|588066996|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823748|NCT00766090|588066997|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
162930824|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
162930825|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
162930826|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
162930827|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
162930828|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
162930829|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
162930830|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
162930831|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
162930832|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
162930833|NCT01872689|588452221|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
162930834|NCT01872689|588452222|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
162930835|NCT01872689|588452223|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
162930836|NCT01872689|588452224|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
162930837|NCT01456052|588452225|FG000|Overall Study|Adverse Event|1|||
162930838|NCT01456052|588452226|FG001|Overall Study|Adverse Event|1|||
162930839|NCT01456052|588452227|FG002|Overall Study|Adverse Event|2|||
162930840|NCT01456052|588452225|FG000|Overall Study|Consent withdrawn|0|||
162930841|NCT01456052|588452226|FG001|Overall Study|Consent withdrawn|2|||
162930842|NCT01456052|588452227|FG002|Overall Study|Consent withdrawn|1|||
162930843|NCT01456052|588452225|FG000|Overall Study|Protocol Violation|0|||
162930844|NCT01456052|588452226|FG001|Overall Study|Protocol Violation|1|||
162930845|NCT01456052|588452227|FG002|Overall Study|Protocol Violation|0|||
162930846|NCT01456052|588452225|FG000|Overall Study|Physician Decision|1|||
162930847|NCT01456052|588452226|FG001|Overall Study|Physician Decision|0|||
162930848|NCT01456052|588452227|FG002|Overall Study|Physician Decision|1|||
162930849|NCT01456052|588452225|FG000|Overall Study|Treatment Failure|0|||
162930850|NCT01456052|588452226|FG001|Overall Study|Treatment Failure|1|||
162930851|NCT01456052|588452227|FG002|Overall Study|Treatment Failure|1|||
162930852|NCT02762565|588452230|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
162930853|NCT01113710|588452231|FG000|Overall Study|Adverse Event|64|||
162930854|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy|41|||
162930855|NCT01113710|588452231|FG000|Overall Study|No Information Available|40|||
162930856|NCT01113710|588452231|FG000|Overall Study|Withdrawal by Subject|28|||
162930857|NCT01113710|588452231|FG000|Overall Study|Lost to Follow-up|20|||
162930858|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
162930859|NCT01113710|588452231|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
162930860|NCT01113710|588452231|FG000|Overall Study|Lack of Patient's Compliance|8|||
162930861|NCT01113710|588452231|FG000|Overall Study|Other|7|||
162930862|NCT01113710|588452231|FG000|Overall Study|Adverse Event/Other|5|||
162930863|NCT01113710|588452231|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
162930864|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Other|4|||
162930865|NCT01113710|588452231|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
162930866|NCT01113710|588452231|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
162930867|NCT01113710|588452231|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
162930868|NCT01113710|588452231|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
162930869|NCT01113710|588452231|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
162930870|NCT01113710|588452231|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
162930871|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
162930872|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
162930873|NCT01113710|588452231|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
162930874|NCT01113710|588452231|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
162930875|NCT01113710|588452231|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
162930876|NCT01113710|588452231|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
162930877|NCT01113710|588452231|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
162930878|NCT02770716|588452233|FG000|Overall Study|Death|101|||
162930879|NCT02770716|588452234|FG001|Overall Study|Death|45|||
162930880|NCT02770716|588452233|FG000|Overall Study|Withdrawal by Subject|4|||
162930881|NCT02770716|588452234|FG001|Overall Study|Withdrawal by Subject|2|||
162930882|NCT02770716|588452233|FG000|Overall Study|Lost to Follow-up|1|||
162930883|NCT02770716|588452234|FG001|Overall Study|Lost to Follow-up|0|||
162930884|NCT02770716|588452233|FG000|Overall Study|Various reasons|6|||
162930885|NCT02770716|588452234|FG001|Overall Study|Various reasons|2|||
162930886|NCT01042977|588452235|FG000|Overall Study|Adverse Event|4|||
162930887|NCT01042977|588452236|FG001|Overall Study|Adverse Event|12|||
162930888|NCT01042977|588452235|FG000|Overall Study|Death|2|||
162930889|NCT01042977|588452236|FG001|Overall Study|Death|1|||
162930890|NCT01042977|588452235|FG000|Overall Study|Withdrawal by Subject|8|||
162930891|NCT01042977|588452236|FG001|Overall Study|Withdrawal by Subject|16|||
162930892|NCT01042977|588452235|FG000|Overall Study|Lost to Follow-up|0|||
163173197|NCT02478398|589349820|FG001|Overall Study|Withdrawal By Participant|4|||
163173198|NCT01475071|589349827|FG000|Overall Study|Physician Decision|1|||
162930893|NCT01042977|588452236|FG001|Overall Study|Lost to Follow-up|2|||
162930894|NCT01042977|588452235|FG000|Overall Study|Poor/non-compliance|3|||
162930895|NCT01042977|588452236|FG001|Overall Study|Poor/non-compliance|4|||
162823749|NCT00766090|588066998|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823750|NCT00766090|588066999|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823751|NCT00766090|588067000|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823752|NCT00766090|588067001|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823753|NCT00766090|588067002|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823754|NCT00766090|588067003|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823755|NCT00766090|588067004|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162823756|NCT00766090|588066993|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823757|NCT00766090|588066994|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823758|NCT00766090|588066995|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
162823759|NCT00766090|588066996|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823760|NCT00766090|588066997|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823761|NCT00766090|588066998|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823762|NCT00766090|588066999|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823763|NCT00766090|588067000|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823764|NCT00766090|588067001|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823765|NCT00766090|588067002|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823766|NCT00766090|588067003|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823767|NCT00766090|588067004|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162823768|NCT00766090|588066993|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
162823769|NCT00766090|588066994|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
162823770|NCT00766090|588066995|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
162823771|NCT00766090|588066996|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
162823772|NCT00766090|588066997|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
162823773|NCT00766090|588066998|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
162823774|NCT00766090|588066999|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
162823775|NCT00766090|588067000|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
162823776|NCT00766090|588067001|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
162823777|NCT00766090|588067002|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
162823778|NCT00766090|588067003|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
162823779|NCT00766090|588067004|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
162823780|NCT00766090|588066993|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823781|NCT00766090|588066994|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823782|NCT00766090|588066995|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823783|NCT00766090|588066996|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823784|NCT00766090|588066997|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823785|NCT00766090|588066998|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
162823786|NCT00766090|588066999|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823787|NCT00766090|588067000|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823788|NCT00766090|588067001|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823789|NCT00766090|588067002|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823790|NCT00766090|588067003|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823791|NCT00766090|588067004|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162823792|NCT00766090|588066993|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823793|NCT00766090|588066994|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
162823794|NCT00766090|588066995|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823795|NCT00766090|588066996|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
162823796|NCT00766090|588066997|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823797|NCT00766090|588066998|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823798|NCT00766090|588066999|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823799|NCT00766090|588067000|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823800|NCT00766090|588067001|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823801|NCT00766090|588067002|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823802|NCT00766090|588067003|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
162823803|NCT00766090|588067004|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
162823804|NCT00766090|588066993|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823805|NCT00766090|588066994|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823806|NCT00766090|588066995|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823807|NCT00766090|588066996|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823808|NCT00766090|588066997|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
162823809|NCT00766090|588066998|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823810|NCT00766090|588066999|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823811|NCT00766090|588067000|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823812|NCT00766090|588067001|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823813|NCT00766090|588067002|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823814|NCT00766090|588067003|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823815|NCT00766090|588067004|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162823816|NCT03024970|588067007|FG000|First Intervention|Adverse Event|1|||
162823817|NCT03024970|588067008|FG001|First Intervention|Adverse Event|0|||
162823818|NCT03024970|588067007|FG000|Second Intervention|Lost to Follow-up|1|||
162930896|NCT01042977|588452235|FG000|Overall Study|Subject no longer meets study criteria|15|||
162930897|NCT01042977|588452236|FG001|Overall Study|Subject no longer meets study criteria|13|||
162930898|NCT01042977|588452235|FG000|Overall Study|Incorrect enrollment|6|||
162930899|NCT01042977|588452236|FG001|Overall Study|Incorrect enrollment|4|||
162930900|NCT01042977|588452235|FG000|Overall Study|Safety|0|||
162930901|NCT01042977|588452236|FG001|Overall Study|Safety|2|||
162930902|NCT01042977|588452235|FG000|Overall Study|Administrative reason by sponsor|0|||
162930903|NCT01042977|588452236|FG001|Overall Study|Administrative reason by sponsor|1|||
162930904|NCT01042977|588452235|FG000|Overall Study|Various|3|||
162930905|NCT01042977|588452236|FG001|Overall Study|Various|0|||
162930906|NCT02499354|588452237|FG000|Overall Study|Withdrawal by Subject|1|||
162930907|NCT02499354|588452238|FG001|Overall Study|Withdrawal by Subject|0|||
162930908|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Adverse Event|6|||
162930909|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162930910|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Adverse Event|3|||
162930911|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162930912|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Physician Decision|0|||
162930913|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Physician Decision|0|||
162930914|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Physician Decision|1|||
162930915|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162930916|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
162930917|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
162930918|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
162930919|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
162930920|NCT01677910|588452240|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
162930921|NCT01677910|588452241|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
162930922|NCT01677910|588452242|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
162930923|NCT01677910|588452243|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
162930924|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930925|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930926|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
162930927|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
162930928|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930929|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930930|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162930931|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
162930932|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930933|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930934|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162930935|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
162930936|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930937|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930938|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162930939|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
162930940|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930941|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930942|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
162930943|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
162930944|NCT01677910|588452240|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930945|NCT01677910|588452241|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930946|NCT01677910|588452242|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
162930947|NCT01677910|588452243|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
162930948|NCT01703741|588452245|FG000|Overall Study|Withdrawal by Subject|6|||
162930949|NCT01703741|588452245|FG000|Overall Study|Adverse Event|2|||
162930950|NCT01703741|588452245|FG000|Overall Study|Physician Decision|2|||
162930951|NCT01703741|588452245|FG000|Overall Study|Protocol Violation|1|||
162930952|NCT01703741|588452245|FG000|Overall Study|Lost to Follow-up|3|||
162930953|NCT01703741|588452245|FG000|Overall Study|Subject did not want to continue|2|||
162930954|NCT01703741|588452245|FG000|Overall Study|Subject cannot comply with study visits|1|||
162930955|NCT01703741|588452245|FG000|Overall Study|Subject started testosterone injections|1|||
162930956|NCT04132232|588452246|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
162930957|NCT04132232|588452247|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
162930958|NCT04132232|588452246|FG000|Overall Study|Lost to Follow-up|6|||
162930959|NCT04132232|588452247|FG001|Overall Study|Lost to Follow-up|7|||
162930960|NCT00755937|588452248|FG000|Recruitment|Unknown if infliximab received|164|||
162930961|NCT00755937|588452248|FG000|Observational Follow-up|Lost to Follow-up|148|||
162930962|NCT03876873|588452249|FG000|Overall Study|Physician Decision|0|||
162930963|NCT03876873|588452250|FG001|Overall Study|Physician Decision|1|||
162930964|NCT03547531|588452251|FG000|Overall Study|not coming in data collection : sick|2|||
162930965|NCT03547531|588452252|FG001|Overall Study|not coming in data collection : sick|2|||
162930966|NCT03547531|588452251|FG000|Overall Study|having family occasion|0|||
162930967|NCT03547531|588452252|FG001|Overall Study|having family occasion|2|||
162930968|NCT02117479|588452262|FG000|Overall Study|Death|13|||
162930969|NCT02117479|588452263|FG001|Overall Study|Death|8|||
162930970|NCT02117479|588452262|FG000|Overall Study|Adverse Event|8|||
162930971|NCT02117479|588452263|FG001|Overall Study|Adverse Event|16|||
162930972|NCT02117479|588452262|FG000|Overall Study|Subject decision|8|||
162930973|NCT02117479|588452263|FG001|Overall Study|Subject decision|9|||
162930974|NCT02117479|588452262|FG000|Overall Study|Disease progression|104|||
162930975|NCT02117479|588452263|FG001|Overall Study|Disease progression|108|||
162930976|NCT02117479|588452262|FG000|Overall Study|Noncompliance with study treatment|1|||
162930977|NCT02117479|588452263|FG001|Overall Study|Noncompliance with study treatment|0|||
162930978|NCT02117479|588452262|FG000|Overall Study|Study terminated by the sponsor|4|||
162930979|NCT02117479|588452263|FG001|Overall Study|Study terminated by the sponsor|6|||
162930980|NCT02117479|588452262|FG000|Overall Study|Physician Decision|7|||
162930981|NCT02117479|588452263|FG001|Overall Study|Physician Decision|2|||
162930982|NCT02117479|588452262|FG000|Overall Study|Other unspecified|11|||
162930983|NCT02117479|588452263|FG001|Overall Study|Other unspecified|7|||
162930984|NCT01223196|588452269|FG000|Overall Study|Lost to Follow-up|2|||
162930985|NCT01223196|588452270|FG001|Overall Study|Lost to Follow-up|0|||
162930986|NCT01223196|588452269|FG000|Overall Study|Physician Decision|1|||
162930987|NCT01223196|588452270|FG001|Overall Study|Physician Decision|0|||
162930988|NCT01223196|588452269|FG000|Overall Study|Withdrawal by Subject|1|||
162930989|NCT01223196|588452270|FG001|Overall Study|Withdrawal by Subject|0|||
162930990|NCT02629133|588452271|FG000|Overall Study|Lost to Follow-up|3|||
162930991|NCT02629133|588452272|FG001|Overall Study|Lost to Follow-up|1|||
162930992|NCT02629133|588452271|FG000|Overall Study|Withdrawal by Subject|1|||
162930993|NCT02629133|588452272|FG001|Overall Study|Withdrawal by Subject|1|||
162930994|NCT01238822|588452273|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
162930995|NCT02598193|588452274|FG000|Overall Study|Adverse Event|13|||
162930996|NCT02598193|588452274|FG000|Overall Study|Withdrawal by Subject|1|||
162930997|NCT02598193|588452274|FG000|Overall Study|Listed in active lung transplant list|1|||
162930998|NCT02598193|588452274|FG000|Overall Study|Does not want to take Nintedanib|1|||
162930999|NCT00447694|588452277|FG000|Overall Study|Adverse Event|2|||
162931000|NCT00447694|588452277|FG000|Overall Study|Abnormal laboratory value|1|||
162931001|NCT00447694|588452277|FG000|Overall Study|Abnormal test procedure result|1|||
162931002|NCT00447694|588452277|FG000|Overall Study|Withdrawal by Subject|2|||
162931003|NCT01169987|588452278|FG000|Overall Study|Withdrawal by Subject|3|||
162931004|NCT01169987|588452278|FG000|Overall Study|Lost to Follow-up|24|||
162931005|NCT01169987|588452278|FG000|Overall Study|Other|4|||
162931006|NCT00386100|588452280|FG000|Overall Study|Did not receive study medication|6|||
162931007|NCT00386100|588452281|FG001|Overall Study|Did not receive study medication|4|||
162931008|NCT00386100|588452280|FG000|Overall Study|Adverse Event|15|||
162931009|NCT00386100|588452281|FG001|Overall Study|Adverse Event|25|||
162931010|NCT00386100|588452280|FG000|Overall Study|Death|0|||
162931011|NCT00386100|588452281|FG001|Overall Study|Death|1|||
162931012|NCT00386100|588452280|FG000|Overall Study|Insufficient therapeutic effect|30|||
162931013|NCT00386100|588452281|FG001|Overall Study|Insufficient therapeutic effect|6|||
162931014|NCT00386100|588452280|FG000|Overall Study|Lost to Follow-up|29|||
162931015|NCT00386100|588452281|FG001|Overall Study|Lost to Follow-up|29|||
162931016|NCT00386100|588452280|FG000|Overall Study|Non-compliance|18|||
162931017|NCT00386100|588452281|FG001|Overall Study|Non-compliance|19|||
162931018|NCT00386100|588452280|FG000|Overall Study|Protocol Violation|5|||
162931019|NCT00386100|588452281|FG001|Overall Study|Protocol Violation|3|||
162931020|NCT00386100|588452280|FG000|Overall Study|Withdrawal by Subject|32|||
162931021|NCT00386100|588452281|FG001|Overall Study|Withdrawal by Subject|31|||
162931022|NCT00386100|588452280|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
162931023|NCT00386100|588452281|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
162931024|NCT00386100|588452280|FG000|Overall Study|BMD <2.5|1|||
162931025|NCT00386100|588452281|FG001|Overall Study|BMD <2.5|0|||
162931026|NCT00386100|588452280|FG000|Overall Study|Consecutive elevated Hba1C|1|||
162931027|NCT00386100|588452281|FG001|Overall Study|Consecutive elevated Hba1C|0|||
162931028|NCT00386100|588452280|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
162931029|NCT00386100|588452281|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
162931030|NCT00386100|588452280|FG000|Overall Study|Laboratory findings|1|||
162931031|NCT00386100|588452281|FG001|Overall Study|Laboratory findings|0|||
162931032|NCT00386100|588452280|FG000|Overall Study|Participant's concern due to CPK levels|1|||
162931033|NCT00386100|588452281|FG001|Overall Study|Participant's concern due to CPK levels|0|||
162931034|NCT00386100|588452280|FG000|Overall Study|Participant moving out of state|2|||
162931035|NCT00386100|588452281|FG001|Overall Study|Participant moving out of state|0|||
162931036|NCT00386100|588452280|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
162931037|NCT00386100|588452281|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
162931038|NCT00386100|588452280|FG000|Overall Study|Didn't meet entry criteria|1|||
162931039|NCT00386100|588452281|FG001|Overall Study|Didn't meet entry criteria|1|||
162931040|NCT00386100|588452280|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
162931041|NCT00386100|588452281|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
162823819|NCT03024970|588067008|FG001|Second Intervention|Lost to Follow-up|0|||
162823820|NCT00131469|588067010|FG000|Overall Study|Withdrawal by Subject|3|||
162823821|NCT00131469|588067011|FG001|Overall Study|Withdrawal by Subject|4|||
162823822|NCT00131469|588067010|FG000|Overall Study|Protocol Violation|3|||
162823823|NCT00131469|588067011|FG001|Overall Study|Protocol Violation|1|||
162823824|NCT00131469|588067010|FG000|Overall Study|Death|0|||
162823825|NCT00131469|588067011|FG001|Overall Study|Death|1|||
162823826|NCT00131469|588067010|FG000|Overall Study|Lost to Follow-up|0|||
162823827|NCT00131469|588067011|FG001|Overall Study|Lost to Follow-up|1|||
162823828|NCT00131469|588067010|FG000|Overall Study|scan not analyzable|3|||
162823829|NCT00131469|588067011|FG001|Overall Study|scan not analyzable|6|||
162823830|NCT00574288|588067012|FG000|Overall Study|Adverse Event|2|||
162823831|NCT00574288|588067013|FG001|Overall Study|Adverse Event|0|||
162823832|NCT00574288|588067014|FG002|Overall Study|Adverse Event|0|||
162823833|NCT00574288|588067015|FG003|Overall Study|Adverse Event|0|||
162823834|NCT00574288|588067016|FG004|Overall Study|Adverse Event|1|||
162823835|NCT00574288|588067017|FG005|Overall Study|Adverse Event|0|||
162823836|NCT00574288|588067018|FG006|Overall Study|Adverse Event|0|||
162823837|NCT00574288|588067012|FG000|Overall Study|Death|0|||
162823838|NCT00574288|588067013|FG001|Overall Study|Death|0|||
162823839|NCT00574288|588067014|FG002|Overall Study|Death|0|||
162823840|NCT00574288|588067015|FG003|Overall Study|Death|0|||
162823841|NCT00574288|588067016|FG004|Overall Study|Death|0|||
162823842|NCT00574288|588067017|FG005|Overall Study|Death|25|||
162823843|NCT00574288|588067018|FG006|Overall Study|Death|21|||
162823844|NCT00574288|588067012|FG000|Overall Study|Lost to Follow-up|0|||
162823845|NCT00574288|588067013|FG001|Overall Study|Lost to Follow-up|0|||
162823846|NCT00574288|588067014|FG002|Overall Study|Lost to Follow-up|0|||
162823847|NCT00574288|588067015|FG003|Overall Study|Lost to Follow-up|0|||
162823848|NCT00574288|588067016|FG004|Overall Study|Lost to Follow-up|0|||
162823849|NCT00574288|588067017|FG005|Overall Study|Lost to Follow-up|1|||
162823850|NCT00574288|588067018|FG006|Overall Study|Lost to Follow-up|2|||
162823851|NCT00574288|588067012|FG000|Overall Study|Study Terminated By Sponsor|0|||
162823852|NCT00574288|588067013|FG001|Overall Study|Study Terminated By Sponsor|0|||
162823853|NCT00574288|588067014|FG002|Overall Study|Study Terminated By Sponsor|0|||
162823854|NCT00574288|588067015|FG003|Overall Study|Study Terminated By Sponsor|0|||
162823855|NCT00574288|588067016|FG004|Overall Study|Study Terminated By Sponsor|0|||
162823856|NCT00574288|588067017|FG005|Overall Study|Study Terminated By Sponsor|0|||
162823857|NCT00574288|588067018|FG006|Overall Study|Study Terminated By Sponsor|5|||
162823858|NCT00574288|588067012|FG000|Overall Study|Progressive Disease|17|||
162823859|NCT00574288|588067013|FG001|Overall Study|Progressive Disease|2|||
162823860|NCT00574288|588067014|FG002|Overall Study|Progressive Disease|3|||
162823861|NCT00574288|588067015|FG003|Overall Study|Progressive Disease|2|||
162823862|NCT00574288|588067016|FG004|Overall Study|Progressive Disease|1|||
162823863|NCT00574288|588067017|FG005|Overall Study|Progressive Disease|0|||
162823864|NCT00574288|588067018|FG006|Overall Study|Progressive Disease|0|||
162823865|NCT00574288|588067012|FG000|Overall Study|Other|1|||
162823866|NCT00574288|588067013|FG001|Overall Study|Other|1|||
162823867|NCT00574288|588067014|FG002|Overall Study|Other|0|||
162823868|NCT00574288|588067015|FG003|Overall Study|Other|0|||
162823869|NCT00574288|588067016|FG004|Overall Study|Other|0|||
162823870|NCT00574288|588067017|FG005|Overall Study|Other|0|||
162823871|NCT00574288|588067018|FG006|Overall Study|Other|0|||
162823872|NCT01106027|588067019|FG000|Overall Study|Lost graft early, discontinued|1|||
162823873|NCT00356889|588067020|FG000|Overall Study|Protocol Violation|2|||
162823874|NCT00356889|588067020|FG000|Overall Study|Adverse Event|1|||
162823875|NCT00736034|588067021|FG000|Overall Study|Adverse Event|2|||
162823876|NCT03123250|588067022|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
162823877|NCT02361944|588067023|FG000|Overall Study|surgery cancellation|0|||
162823878|NCT02361944|588067024|FG001|Overall Study|surgery cancellation|1|||
162823879|NCT00773136|588067051|FG000|Overall Study|Physician Decision|2|||
162823880|NCT02463071|588067058|FG000|Overall Study|Adverse Event|3|||
162823881|NCT02463071|588067059|FG001|Overall Study|Adverse Event|5|||
162823882|NCT02463071|588067060|FG002|Overall Study|Adverse Event|1|||
162823883|NCT02463071|588067058|FG000|Overall Study|Death|1|||
162823884|NCT02463071|588067059|FG001|Overall Study|Death|0|||
162823885|NCT02463071|588067060|FG002|Overall Study|Death|0|||
162823886|NCT02463071|588067058|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
162823887|NCT02463071|588067059|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162823888|NCT02463071|588067060|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
162823889|NCT02463071|588067058|FG000|Overall Study|Reason not specified|7|||
162823890|NCT02463071|588067059|FG001|Overall Study|Reason not specified|9|||
162823891|NCT02463071|588067060|FG002|Overall Study|Reason not specified|4|||
162823892|NCT02463071|588067058|FG000|Overall Study|Protocol Violation|0|||
162823893|NCT02463071|588067059|FG001|Overall Study|Protocol Violation|2|||
162823894|NCT02463071|588067060|FG002|Overall Study|Protocol Violation|0|||
162823895|NCT02463071|588067058|FG000|Overall Study|Lost to Follow-up|0|||
162823896|NCT02463071|588067059|FG001|Overall Study|Lost to Follow-up|0|||
162823897|NCT02463071|588067060|FG002|Overall Study|Lost to Follow-up|1|||
162823898|NCT00175877|588067076|FG000|Overall Study|Adverse Event|136|||
162823899|NCT00175877|588067076|FG000|Overall Study|Withdrawal by Subject|141|||
163173199|NCT01475071|589349827|FG000|Overall Study|Withdrawal by Subject|6|||
163173200|NCT01475071|589349827|FG000|Overall Study|Lost to Follow-up|1|||
163173201|NCT01205581|589349831|FG000|Overall Study|Withdrawal by Subject|1|||
163173202|NCT01205581|589349832|FG001|Overall Study|Withdrawal by Subject|0|||
163173203|NCT01205581|589349833|FG002|Overall Study|Withdrawal by Subject|0|||
163173204|NCT01205581|589349834|FG003|Overall Study|Withdrawal by Subject|0|||
162823900|NCT00175877|588067076|FG000|Overall Study|Lost to Follow-up|9|||
162823901|NCT00175877|588067076|FG000|Overall Study|Lack of Efficacy|26|||
162823902|NCT00175877|588067076|FG000|Overall Study|Protocol Violation|15|||
162823903|NCT00175877|588067076|FG000|Overall Study|Other Reason|20|||
162823904|NCT00175877|588067076|FG000|Overall Study|AE & Other|1|||
162823905|NCT00175877|588067076|FG000|Overall Study|Withdrawal by subject & Other|1|||
162823906|NCT02054325|588067080|FG000|Overall Study|Lost to Follow-up|8|||
162823907|NCT02054325|588067081|FG001|Overall Study|Lost to Follow-up|5|||
162823908|NCT02003014|588067082|FG000|Overall Study|Case report forms uncollected|9|||
162823909|NCT02003014|588067082|FG000|Overall Study|Treatment started after contract period|1|||
162823910|NCT02003014|588067082|FG000|Overall Study|Patient did not visit the study site|5|||
162823911|NCT02003014|588067082|FG000|Overall Study|Investigator's transfer|4|||
162823912|NCT03007979|588067085|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
162823913|NCT03734016|588067086|FG000|Overall Study|Sponsor Ended Study|225|||
162823914|NCT03734016|588067087|FG001|Overall Study|Sponsor Ended Study|200|||
162823915|NCT03734016|588067086|FG000|Overall Study|Death|69|||
162823916|NCT03734016|588067087|FG001|Overall Study|Death|83|||
162823917|NCT03734016|588067086|FG000|Overall Study|Withdrawal by Subject|21|||
162823918|NCT03734016|588067087|FG001|Overall Study|Withdrawal by Subject|27|||
162823919|NCT03734016|588067086|FG000|Overall Study|Physician Decision|1|||
162823920|NCT03734016|588067087|FG001|Overall Study|Physician Decision|12|||
162823921|NCT03734016|588067086|FG000|Overall Study|Lost to Follow-up|6|||
162823922|NCT03734016|588067087|FG001|Overall Study|Lost to Follow-up|2|||
162823923|NCT03734016|588067086|FG000|Overall Study|Miscellaneous|5|||
162823924|NCT03734016|588067087|FG001|Overall Study|Miscellaneous|1|||
162823925|NCT01624259|588067090|FG000|Overall Study|Adverse Event|18|||
162823926|NCT01624259|588067091|FG001|Overall Study|Adverse Event|18|||
162823927|NCT01624259|588067090|FG000|Overall Study|Protocol Violation|1|||
162823928|NCT01624259|588067091|FG001|Overall Study|Protocol Violation|2|||
162823929|NCT01624259|588067090|FG000|Overall Study|Withdrawal by Subject|5|||
162823930|NCT01624259|588067091|FG001|Overall Study|Withdrawal by Subject|7|||
162823931|NCT01624259|588067090|FG000|Overall Study|Physician Decision|1|||
162823932|NCT01624259|588067091|FG001|Overall Study|Physician Decision|1|||
162823933|NCT01624259|588067090|FG000|Overall Study|Lost to Follow-up|2|||
162823934|NCT01624259|588067091|FG001|Overall Study|Lost to Follow-up|3|||
162823935|NCT01624259|588067090|FG000|Overall Study|Abnormal laboratory measure|3|||
162823936|NCT01624259|588067091|FG001|Overall Study|Abnormal laboratory measure|0|||
162823937|NCT01298518|588067092|FG000|Overall Study|Withdrawal by Subject|0|||
162823938|NCT01298518|588067093|FG001|Overall Study|Withdrawal by Subject|0|||
162823939|NCT01298518|588067094|FG002|Overall Study|Withdrawal by Subject|1|||
162823940|NCT02273726|588067095|FG000|Overall Study|Death|70|||
162823941|NCT02273726|588067096|FG001|Overall Study|Death|62|||
162823942|NCT02273726|588067095|FG000|Overall Study|Withdrawal by Subject|41|||
162823943|NCT02273726|588067096|FG001|Overall Study|Withdrawal by Subject|29|||
162823944|NCT02273726|588067095|FG000|Overall Study|Kidney transplant|31|||
162823945|NCT02273726|588067096|FG001|Overall Study|Kidney transplant|39|||
162823946|NCT02273726|588067095|FG000|Overall Study|Physician Decision|30|||
162823947|NCT02273726|588067096|FG001|Overall Study|Physician Decision|15|||
162823948|NCT02273726|588067095|FG000|Overall Study|Adverse Event|27|||
162823949|NCT02273726|588067096|FG001|Overall Study|Adverse Event|9|||
162823950|NCT02273726|588067095|FG000|Overall Study|Lost to Follow-up|6|||
162823951|NCT02273726|588067096|FG001|Overall Study|Lost to Follow-up|3|||
162823952|NCT02273726|588067095|FG000|Overall Study|Lack of Efficacy|6|||
162823953|NCT02273726|588067096|FG001|Overall Study|Lack of Efficacy|1|||
162823954|NCT02273726|588067095|FG000|Overall Study|Protocol Violation|4|||
162823955|NCT02273726|588067096|FG001|Overall Study|Protocol Violation|0|||
162823956|NCT02273726|588067095|FG000|Overall Study|Other than specified|28|||
162823957|NCT02273726|588067096|FG001|Overall Study|Other than specified|30|||
162823958|NCT01979835|588067097|FG000|Primary Outcome SA Measurment|failed insertion|18|||
162823959|NCT01979835|588067097|FG000|Follow-up|Lost to Follow-up|32|||
162823960|NCT03697720|588068794|FG000|Overall Study|Lost to Follow-up|7|||
162823961|NCT00382720|588068799|FG000|Overall Study|Adverse Event|21|||
162823962|NCT00382720|588068800|FG001|Overall Study|Adverse Event|23|||
162823963|NCT00382720|588068801|FG002|Overall Study|Adverse Event|15|||
162823964|NCT00382720|588068799|FG000|Overall Study|Protocol Violation|2|||
162823965|NCT00382720|588068800|FG001|Overall Study|Protocol Violation|5|||
162823966|NCT00382720|588068801|FG002|Overall Study|Protocol Violation|1|||
162823967|NCT00382720|588068799|FG000|Overall Study|Death|0|||
162823968|NCT00382720|588068800|FG001|Overall Study|Death|1|||
162823969|NCT00382720|588068801|FG002|Overall Study|Death|2|||
162823970|NCT00382720|588068799|FG000|Overall Study|Progressive disease|37|||
162823971|NCT00382720|588068800|FG001|Overall Study|Progressive disease|28|||
162823972|NCT00382720|588068801|FG002|Overall Study|Progressive disease|38|||
162931042|NCT00386100|588452280|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
162931043|NCT00386100|588452281|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
162931044|NCT00386100|588452280|FG000|Overall Study|Bad metabolic control & patient security|1|||
162931045|NCT00386100|588452281|FG001|Overall Study|Bad metabolic control & patient security|0|||
162931046|NCT00386100|588452280|FG000|Overall Study|Bone loss by DXA bone scan|1|||
162931047|NCT00386100|588452281|FG001|Overall Study|Bone loss by DXA bone scan|0|||
162931048|NCT00386100|588452280|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
162931049|NCT00386100|588452281|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
162931050|NCT00386100|588452280|FG000|Overall Study|7.6% bone loss|1|||
162931051|NCT00386100|588452281|FG001|Overall Study|7.6% bone loss|0|||
162931052|NCT00386100|588452280|FG000|Overall Study|Osteoporosis|0|||
162931053|NCT00386100|588452281|FG001|Overall Study|Osteoporosis|1|||
162931054|NCT00386100|588452280|FG000|Overall Study|Positive pregnancy test|1|||
162931055|NCT00386100|588452281|FG001|Overall Study|Positive pregnancy test|3|||
162931056|NCT00386100|588452280|FG000|Overall Study|Out of country for 5 months|1|||
162931057|NCT00386100|588452281|FG001|Overall Study|Out of country for 5 months|0|||
162931058|NCT00386100|588452280|FG000|Overall Study|Hb1Ac >8%|0|||
162931059|NCT00386100|588452281|FG001|Overall Study|Hb1Ac >8%|1|||
162931060|NCT00386100|588452280|FG000|Overall Study|Participant randomized in error|1|||
162931061|NCT00386100|588452281|FG001|Overall Study|Participant randomized in error|0|||
162931062|NCT03672396|588452283|FG000|Overall Study|Withdrawal by Subject|4|||
162931063|NCT03672396|588452283|FG000|Overall Study|Physician Decision|1|||
162931064|NCT03672396|588452283|FG000|Overall Study|Adverse Event|1|||
162931065|NCT04380701|588452288|FG000|Overall Study|Pregnancy|0|||
162931066|NCT04380701|588452289|FG001|Overall Study|Pregnancy|0|||
162931067|NCT04380701|588452290|FG002|Overall Study|Pregnancy|0|||
162931068|NCT04380701|588452291|FG003|Overall Study|Pregnancy|0|||
162931069|NCT04380701|588452292|FG004|Overall Study|Pregnancy|0|||
162931070|NCT04380701|588452293|FG005|Overall Study|Pregnancy|0|||
162931071|NCT04380701|588452294|FG006|Overall Study|Pregnancy|0|||
162931072|NCT04380701|588452295|FG007|Overall Study|Pregnancy|0|||
162931073|NCT04380701|588452296|FG008|Overall Study|Pregnancy|0|||
162931074|NCT04380701|588452297|FG009|Overall Study|Pregnancy|0|||
162931075|NCT04380701|588452298|FG010|Overall Study|Pregnancy|0|||
162931076|NCT04380701|588452299|FG011|Overall Study|Pregnancy|0|||
162931077|NCT04380701|588452300|FG012|Overall Study|Pregnancy|0|||
162931078|NCT04380701|588452301|FG013|Overall Study|Pregnancy|0|||
162931079|NCT04380701|588452302|FG014|Overall Study|Pregnancy|0|||
162931080|NCT04380701|588452303|FG015|Overall Study|Pregnancy|0|||
162931081|NCT04380701|588452304|FG016|Overall Study|Pregnancy|0|||
162931082|NCT04380701|588452305|FG017|Overall Study|Pregnancy|0|||
162931083|NCT04380701|588452306|FG018|Overall Study|Pregnancy|0|||
162931084|NCT04380701|588452307|FG019|Overall Study|Pregnancy|0|||
162931085|NCT04380701|588452308|FG020|Overall Study|Pregnancy|0|||
162931086|NCT04380701|588452309|FG021|Overall Study|Pregnancy|0|||
162931087|NCT04380701|588452310|FG022|Overall Study|Pregnancy|0|||
162931088|NCT04380701|588452311|FG023|Overall Study|Pregnancy|0|||
162931089|NCT04380701|588452312|FG024|Overall Study|Pregnancy|0|||
162931090|NCT04380701|588452313|FG025|Overall Study|Pregnancy|0|||
162931091|NCT04380701|588452314|FG026|Overall Study|Pregnancy|0|||
162931092|NCT04380701|588452315|FG027|Overall Study|Pregnancy|0|||
162931093|NCT04380701|588452316|FG028|Overall Study|Pregnancy|0|||
162931094|NCT04380701|588452317|FG029|Overall Study|Pregnancy|0|||
162931095|NCT04380701|588452318|FG030|Overall Study|Pregnancy|0|||
162931096|NCT04380701|588452319|FG031|Overall Study|Pregnancy|0|||
162931097|NCT04380701|588452320|FG032|Overall Study|Pregnancy|1|||
162931098|NCT04380701|588452321|FG033|Overall Study|Pregnancy|0|||
162931099|NCT04380701|588452288|FG000|Overall Study|Lost to Follow-up|0|||
162931100|NCT04380701|588452289|FG001|Overall Study|Lost to Follow-up|0|||
162931101|NCT04380701|588452290|FG002|Overall Study|Lost to Follow-up|0|||
162931102|NCT04380701|588452291|FG003|Overall Study|Lost to Follow-up|0|||
162931103|NCT04380701|588452292|FG004|Overall Study|Lost to Follow-up|0|||
162931104|NCT04380701|588452293|FG005|Overall Study|Lost to Follow-up|0|||
162931105|NCT04380701|588452294|FG006|Overall Study|Lost to Follow-up|0|||
162931106|NCT04380701|588452295|FG007|Overall Study|Lost to Follow-up|0|||
162931107|NCT04380701|588452296|FG008|Overall Study|Lost to Follow-up|0|||
162931108|NCT04380701|588452297|FG009|Overall Study|Lost to Follow-up|0|||
162931109|NCT04380701|588452298|FG010|Overall Study|Lost to Follow-up|0|||
162931110|NCT04380701|588452299|FG011|Overall Study|Lost to Follow-up|0|||
163173205|NCT01205581|589349835|FG004|Overall Study|Withdrawal by Subject|0|||
162931111|NCT04380701|588452300|FG012|Overall Study|Lost to Follow-up|0|||
162931112|NCT04380701|588452301|FG013|Overall Study|Lost to Follow-up|0|||
162931113|NCT04380701|588452302|FG014|Overall Study|Lost to Follow-up|0|||
162931114|NCT04380701|588452303|FG015|Overall Study|Lost to Follow-up|0|||
162931115|NCT04380701|588452304|FG016|Overall Study|Lost to Follow-up|0|||
162931116|NCT04380701|588452305|FG017|Overall Study|Lost to Follow-up|0|||
162931117|NCT04380701|588452306|FG018|Overall Study|Lost to Follow-up|0|||
163173206|NCT01205581|589349836|FG005|Overall Study|Withdrawal by Subject|0|||
162931118|NCT04380701|588452307|FG019|Overall Study|Lost to Follow-up|0|||
162931119|NCT04380701|588452308|FG020|Overall Study|Lost to Follow-up|1|||
162931120|NCT04380701|588452309|FG021|Overall Study|Lost to Follow-up|0|||
162931121|NCT04380701|588452310|FG022|Overall Study|Lost to Follow-up|0|||
162931122|NCT04380701|588452311|FG023|Overall Study|Lost to Follow-up|1|||
162931123|NCT04380701|588452312|FG024|Overall Study|Lost to Follow-up|0|||
162931124|NCT04380701|588452313|FG025|Overall Study|Lost to Follow-up|0|||
162931125|NCT04380701|588452314|FG026|Overall Study|Lost to Follow-up|0|||
162931126|NCT04380701|588452315|FG027|Overall Study|Lost to Follow-up|0|||
162931127|NCT04380701|588452316|FG028|Overall Study|Lost to Follow-up|0|||
162931128|NCT04380701|588452317|FG029|Overall Study|Lost to Follow-up|1|||
162931129|NCT04380701|588452318|FG030|Overall Study|Lost to Follow-up|0|||
162931130|NCT04380701|588452319|FG031|Overall Study|Lost to Follow-up|0|||
162931131|NCT04380701|588452320|FG032|Overall Study|Lost to Follow-up|0|||
162931132|NCT04380701|588452321|FG033|Overall Study|Lost to Follow-up|1|||
162931133|NCT04380701|588452288|FG000|Overall Study|Private reason(s)|0|||
162931134|NCT04380701|588452289|FG001|Overall Study|Private reason(s)|0|||
162931135|NCT04380701|588452290|FG002|Overall Study|Private reason(s)|0|||
162931136|NCT04380701|588452291|FG003|Overall Study|Private reason(s)|0|||
162931137|NCT04380701|588452292|FG004|Overall Study|Private reason(s)|0|||
162931138|NCT04380701|588452293|FG005|Overall Study|Private reason(s)|0|||
162931139|NCT04380701|588452294|FG006|Overall Study|Private reason(s)|1|||
162931140|NCT04380701|588452295|FG007|Overall Study|Private reason(s)|0|||
162931141|NCT04380701|588452296|FG008|Overall Study|Private reason(s)|1|||
162931142|NCT04380701|588452297|FG009|Overall Study|Private reason(s)|1|||
162931143|NCT04380701|588452298|FG010|Overall Study|Private reason(s)|0|||
162931144|NCT04380701|588452299|FG011|Overall Study|Private reason(s)|0|||
162931145|NCT04380701|588452300|FG012|Overall Study|Private reason(s)|0|||
162931146|NCT04380701|588452301|FG013|Overall Study|Private reason(s)|0|||
162931147|NCT04380701|588452302|FG014|Overall Study|Private reason(s)|0|||
162931148|NCT04380701|588452303|FG015|Overall Study|Private reason(s)|0|||
162931149|NCT04380701|588452304|FG016|Overall Study|Private reason(s)|0|||
162931150|NCT04380701|588452305|FG017|Overall Study|Private reason(s)|0|||
162931151|NCT04380701|588452306|FG018|Overall Study|Private reason(s)|0|||
162931152|NCT04380701|588452307|FG019|Overall Study|Private reason(s)|0|||
162931153|NCT04380701|588452308|FG020|Overall Study|Private reason(s)|0|||
162931154|NCT04380701|588452309|FG021|Overall Study|Private reason(s)|0|||
162931155|NCT04380701|588452310|FG022|Overall Study|Private reason(s)|0|||
162931156|NCT04380701|588452311|FG023|Overall Study|Private reason(s)|1|||
162931157|NCT04380701|588452312|FG024|Overall Study|Private reason(s)|0|||
162931158|NCT04380701|588452313|FG025|Overall Study|Private reason(s)|0|||
162931159|NCT04380701|588452314|FG026|Overall Study|Private reason(s)|0|||
162931160|NCT04380701|588452315|FG027|Overall Study|Private reason(s)|0|||
162931161|NCT04380701|588452316|FG028|Overall Study|Private reason(s)|0|||
162931162|NCT04380701|588452317|FG029|Overall Study|Private reason(s)|1|||
162931163|NCT04380701|588452318|FG030|Overall Study|Private reason(s)|0|||
162931164|NCT04380701|588452319|FG031|Overall Study|Private reason(s)|0|||
162931165|NCT04380701|588452320|FG032|Overall Study|Private reason(s)|0|||
162931166|NCT04380701|588452321|FG033|Overall Study|Private reason(s)|0|||
162931167|NCT04380701|588452288|FG000|Overall Study|Withdrawal by Subject|0|||
162931168|NCT04380701|588452289|FG001|Overall Study|Withdrawal by Subject|0|||
162931169|NCT04380701|588452290|FG002|Overall Study|Withdrawal by Subject|0|||
162931170|NCT04380701|588452291|FG003|Overall Study|Withdrawal by Subject|0|||
162931171|NCT04380701|588452292|FG004|Overall Study|Withdrawal by Subject|0|||
162931172|NCT04380701|588452293|FG005|Overall Study|Withdrawal by Subject|0|||
162931173|NCT04380701|588452294|FG006|Overall Study|Withdrawal by Subject|1|||
162931174|NCT04380701|588452295|FG007|Overall Study|Withdrawal by Subject|1|||
162931175|NCT04380701|588452296|FG008|Overall Study|Withdrawal by Subject|0|||
162931176|NCT04380701|588452297|FG009|Overall Study|Withdrawal by Subject|0|||
162931177|NCT04380701|588452298|FG010|Overall Study|Withdrawal by Subject|0|||
162931178|NCT04380701|588452299|FG011|Overall Study|Withdrawal by Subject|1|||
162931179|NCT04380701|588452300|FG012|Overall Study|Withdrawal by Subject|0|||
162931180|NCT04380701|588452301|FG013|Overall Study|Withdrawal by Subject|1|||
162931181|NCT04380701|588452302|FG014|Overall Study|Withdrawal by Subject|0|||
162931182|NCT04380701|588452303|FG015|Overall Study|Withdrawal by Subject|0|||
162931183|NCT04380701|588452304|FG016|Overall Study|Withdrawal by Subject|1|||
162931184|NCT04380701|588452305|FG017|Overall Study|Withdrawal by Subject|0|||
162931185|NCT04380701|588452306|FG018|Overall Study|Withdrawal by Subject|0|||
162931186|NCT04380701|588452307|FG019|Overall Study|Withdrawal by Subject|0|||
162931187|NCT04380701|588452308|FG020|Overall Study|Withdrawal by Subject|0|||
162931188|NCT04380701|588452309|FG021|Overall Study|Withdrawal by Subject|0|||
162931189|NCT04380701|588452310|FG022|Overall Study|Withdrawal by Subject|2|||
162931190|NCT04380701|588452311|FG023|Overall Study|Withdrawal by Subject|2|||
162931191|NCT04380701|588452312|FG024|Overall Study|Withdrawal by Subject|1|||
162931192|NCT04380701|588452313|FG025|Overall Study|Withdrawal by Subject|1|||
162931193|NCT04380701|588452314|FG026|Overall Study|Withdrawal by Subject|0|||
162931194|NCT04380701|588452315|FG027|Overall Study|Withdrawal by Subject|0|||
162931195|NCT04380701|588452316|FG028|Overall Study|Withdrawal by Subject|0|||
162931196|NCT04380701|588452317|FG029|Overall Study|Withdrawal by Subject|0|||
162931197|NCT04380701|588452318|FG030|Overall Study|Withdrawal by Subject|0|||
162931198|NCT04380701|588452319|FG031|Overall Study|Withdrawal by Subject|0|||
162931199|NCT04380701|588452320|FG032|Overall Study|Withdrawal by Subject|0|||
162823973|NCT00382720|588068799|FG000|Overall Study|Withdrew consent|1|||
162823974|NCT00382720|588068800|FG001|Overall Study|Withdrew consent|1|||
162823975|NCT00382720|588068801|FG002|Overall Study|Withdrew consent|2|||
162823976|NCT00382720|588068799|FG000|Overall Study|Withdrawal by Subject|11|||
162823977|NCT00382720|588068800|FG001|Overall Study|Withdrawal by Subject|20|||
162823978|NCT00382720|588068801|FG002|Overall Study|Withdrawal by Subject|12|||
162823979|NCT00382720|588068799|FG000|Overall Study|Surgery|1|||
162823980|NCT00382720|588068800|FG001|Overall Study|Surgery|1|||
162823981|NCT00382720|588068801|FG002|Overall Study|Surgery|4|||
162823982|NCT00382720|588068799|FG000|Overall Study|Patient did not receive study medication|1|||
162823983|NCT00382720|588068800|FG001|Overall Study|Patient did not receive study medication|1|||
162823984|NCT00382720|588068801|FG002|Overall Study|Patient did not receive study medication|4|||
162823985|NCT00382720|588068799|FG000|Overall Study|Clinically progressive disease|0|||
162823986|NCT00382720|588068800|FG001|Overall Study|Clinically progressive disease|1|||
162823987|NCT00382720|588068801|FG002|Overall Study|Clinically progressive disease|0|||
162823988|NCT00382720|588068799|FG000|Overall Study|Good prognosis|0|||
162823989|NCT00382720|588068800|FG001|Overall Study|Good prognosis|1|||
162823990|NCT00382720|588068801|FG002|Overall Study|Good prognosis|0|||
162823991|NCT00382720|588068799|FG000|Overall Study|Investigator/Clinical decision|5|||
162823992|NCT00382720|588068800|FG001|Overall Study|Investigator/Clinical decision|6|||
162823993|NCT00382720|588068801|FG002|Overall Study|Investigator/Clinical decision|6|||
162823994|NCT00382720|588068799|FG000|Overall Study|Discontinued at end of study|0|||
162823995|NCT00382720|588068800|FG001|Overall Study|Discontinued at end of study|1|||
162823996|NCT00382720|588068801|FG002|Overall Study|Discontinued at end of study|2|||
162823997|NCT01183143|588068804|FG000|Overall Study|Protocol Violation|115|||
162823998|NCT01183143|588068804|FG000|Overall Study|Withdrawal by Subject|19|||
162823999|NCT01183143|588068804|FG000|Overall Study|Subject Questionnaires not returned|5|||
162824000|NCT01183143|588068804|FG000|Overall Study|Subjects enrolled, but not treated|11|||
162824001|NCT01704287|588068806|FG000|Initial Treatment Period|Death|139|||
162824002|NCT01704287|588068807|FG001|Initial Treatment Period|Death|129|||
162824003|NCT01704287|588068808|FG002|Initial Treatment Period|Death|71|||
162824004|NCT01704287|588068809|FG003|Initial Treatment Period|Death|0|||
162824005|NCT01704287|588068810|FG004|Initial Treatment Period|Death|0|||
162824006|NCT01704287|588068806|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
162824007|NCT01704287|588068807|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
162824008|NCT01704287|588068808|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
162824009|NCT01704287|588068809|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
162824010|NCT01704287|588068810|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
162824011|NCT01704287|588068806|FG000|Initial Treatment Period|Lost to Follow-up|5|||
162824012|NCT01704287|588068807|FG001|Initial Treatment Period|Lost to Follow-up|3|||
162824013|NCT01704287|588068808|FG002|Initial Treatment Period|Lost to Follow-up|0|||
162824014|NCT01704287|588068809|FG003|Initial Treatment Period|Lost to Follow-up|0|||
162824015|NCT01704287|588068810|FG004|Initial Treatment Period|Lost to Follow-up|0|||
162824016|NCT01704287|588068806|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
162824017|NCT01704287|588068807|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
162824018|NCT01704287|588068808|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
162824019|NCT01704287|588068809|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
162824020|NCT01704287|588068810|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
162824021|NCT01704287|588068806|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
162824022|NCT01704287|588068807|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
162824023|NCT01704287|588068808|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
162824024|NCT01704287|588068809|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
162824025|NCT01704287|588068810|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
162824026|NCT01704287|588068806|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
162824027|NCT01704287|588068807|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
162824028|NCT01704287|588068808|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
162824029|NCT01704287|588068809|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
162824030|NCT01704287|588068810|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
162824031|NCT01704287|588068806|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
162824032|NCT01704287|588068807|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
162824033|NCT01704287|588068808|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
162824034|NCT01704287|588068809|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
162824035|NCT01704287|588068810|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
162824036|NCT04042740|588068811|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
162824037|NCT04042740|588068811|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
162824038|NCT01717287|588068812|FG000|Overall Study|Lost to Follow-up|0|||
162824039|NCT01717287|588068813|FG001|Overall Study|Lost to Follow-up|2|||
162824040|NCT01717287|588068812|FG000|Overall Study|Protocol Violation|0|||
162824041|NCT01717287|588068813|FG001|Overall Study|Protocol Violation|1|||
162824042|NCT04024228|588068814|FG000|Overall Study|Adverse Event|1|||
162824043|NCT04024228|588068815|FG001|Overall Study|Adverse Event|0|||
162931200|NCT04380701|588452321|FG033|Overall Study|Withdrawal by Subject|0|||
162931201|NCT04380701|588452288|FG000|Overall Study|Adverse Event|0|||
162931202|NCT04380701|588452289|FG001|Overall Study|Adverse Event|0|||
162931203|NCT04380701|588452290|FG002|Overall Study|Adverse Event|0|||
162931204|NCT04380701|588452291|FG003|Overall Study|Adverse Event|0|||
162931205|NCT04380701|588452292|FG004|Overall Study|Adverse Event|0|||
162931206|NCT04380701|588452293|FG005|Overall Study|Adverse Event|1|||
162931207|NCT04380701|588452294|FG006|Overall Study|Adverse Event|0|||
162931208|NCT04380701|588452295|FG007|Overall Study|Adverse Event|0|||
162931209|NCT04380701|588452296|FG008|Overall Study|Adverse Event|0|||
162931210|NCT04380701|588452297|FG009|Overall Study|Adverse Event|0|||
162931211|NCT04380701|588452298|FG010|Overall Study|Adverse Event|0|||
162931212|NCT04380701|588452299|FG011|Overall Study|Adverse Event|0|||
162931213|NCT04380701|588452300|FG012|Overall Study|Adverse Event|0|||
162931214|NCT04380701|588452301|FG013|Overall Study|Adverse Event|0|||
162931215|NCT04380701|588452302|FG014|Overall Study|Adverse Event|0|||
162931216|NCT04380701|588452303|FG015|Overall Study|Adverse Event|1|||
162931217|NCT04380701|588452304|FG016|Overall Study|Adverse Event|0|||
162931218|NCT04380701|588452305|FG017|Overall Study|Adverse Event|0|||
162931219|NCT04380701|588452306|FG018|Overall Study|Adverse Event|0|||
162931220|NCT04380701|588452307|FG019|Overall Study|Adverse Event|1|||
162931221|NCT04380701|588452308|FG020|Overall Study|Adverse Event|0|||
162931222|NCT04380701|588452309|FG021|Overall Study|Adverse Event|0|||
162931223|NCT04380701|588452310|FG022|Overall Study|Adverse Event|0|||
162931224|NCT04380701|588452311|FG023|Overall Study|Adverse Event|0|||
162931225|NCT04380701|588452312|FG024|Overall Study|Adverse Event|0|||
162931226|NCT04380701|588452313|FG025|Overall Study|Adverse Event|0|||
162931227|NCT04380701|588452314|FG026|Overall Study|Adverse Event|0|||
162931228|NCT04380701|588452315|FG027|Overall Study|Adverse Event|0|||
162931229|NCT04380701|588452316|FG028|Overall Study|Adverse Event|0|||
162931230|NCT04380701|588452317|FG029|Overall Study|Adverse Event|0|||
162931231|NCT04380701|588452318|FG030|Overall Study|Adverse Event|0|||
162931232|NCT04380701|588452319|FG031|Overall Study|Adverse Event|0|||
162931233|NCT04380701|588452320|FG032|Overall Study|Adverse Event|0|||
162931234|NCT04380701|588452321|FG033|Overall Study|Adverse Event|0|||
162931235|NCT04380701|588452288|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
162931236|NCT04380701|588452289|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
162931237|NCT04380701|588452290|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
162931238|NCT04380701|588452291|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
162931239|NCT04380701|588452292|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
162931240|NCT04380701|588452293|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
162931241|NCT04380701|588452294|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
162931242|NCT04380701|588452295|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
162931243|NCT04380701|588452296|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
162931244|NCT04380701|588452297|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
162931245|NCT04380701|588452298|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
162931246|NCT04380701|588452299|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
162931247|NCT04380701|588452300|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
162931248|NCT04380701|588452301|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
162931249|NCT04380701|588452302|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
162931250|NCT04380701|588452303|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
162931251|NCT04380701|588452304|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
162931252|NCT04380701|588452305|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
162931253|NCT04380701|588452306|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
162931254|NCT04380701|588452307|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
162931255|NCT04380701|588452308|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
162931256|NCT04380701|588452309|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
162931257|NCT04380701|588452310|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
162931258|NCT04380701|588452311|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
162931259|NCT04380701|588452312|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
162931260|NCT04380701|588452313|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
162931261|NCT04380701|588452314|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
162931262|NCT04380701|588452315|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
162931263|NCT04380701|588452316|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
162931264|NCT04380701|588452317|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
162931265|NCT04380701|588452318|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
162931266|NCT04380701|588452319|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
162931267|NCT04380701|588452320|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
162931268|NCT04380701|588452321|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
162931269|NCT04380701|588452288|FG000|Overall Study|Physician Decision|0|||
162931270|NCT04380701|588452289|FG001|Overall Study|Physician Decision|0|||
162931271|NCT04380701|588452290|FG002|Overall Study|Physician Decision|0|||
162931272|NCT04380701|588452291|FG003|Overall Study|Physician Decision|0|||
162824044|NCT04024228|588068814|FG000|Overall Study|Protocol Deviation|0|||
162824045|NCT04024228|588068815|FG001|Overall Study|Protocol Deviation|2|||
162824046|NCT04024228|588068814|FG000|Overall Study|Withdrawal by Subject|3|||
162824047|NCT04024228|588068815|FG001|Overall Study|Withdrawal by Subject|4|||
162824048|NCT04490395|588068819|FG000|Overall Study|Lost to Follow-up|0|||
162824049|NCT04490395|588068820|FG001|Overall Study|Lost to Follow-up|1|||
162824050|NCT00938717|588068821|FG000|Overall Study|Adverse Event|10|||
162824051|NCT00938717|588068822|FG001|Overall Study|Adverse Event|41|||
162824052|NCT00938717|588068821|FG000|Overall Study|Protocol Violation|11|||
162824053|NCT00938717|588068822|FG001|Overall Study|Protocol Violation|8|||
162824054|NCT00938717|588068821|FG000|Overall Study|Withdrawal by Subject|26|||
162824055|NCT00938717|588068822|FG001|Overall Study|Withdrawal by Subject|24|||
162824056|NCT00938717|588068821|FG000|Overall Study|Lost to Follow-up|13|||
162824057|NCT00938717|588068822|FG001|Overall Study|Lost to Follow-up|18|||
162824058|NCT00938717|588068821|FG000|Overall Study|Lack of Efficacy|33|||
162824059|NCT00938717|588068822|FG001|Overall Study|Lack of Efficacy|15|||
162824060|NCT00938717|588068821|FG000|Overall Study|Other reason|5|||
162824061|NCT00938717|588068822|FG001|Overall Study|Other reason|2|||
162824062|NCT01942148|588068827|FG000|Overall Study|Adverse Event|4|||
162824063|NCT01942148|588068827|FG000|Overall Study|Lack of Efficacy|2|||
162824064|NCT01942148|588068827|FG000|Overall Study|Physician Decision|11|||
162824065|NCT01942148|588068827|FG000|Overall Study|Protocol Violation|1|||
162824066|NCT01942148|588068827|FG000|Overall Study|Withdrawal by Subject|8|||
162824067|NCT01942148|588068827|FG000|Overall Study|Use of the prohibition medicine|1|||
162824068|NCT03281668|588068834|FG000|Overall Study|Physician Decision|1|||
162824069|NCT03281668|588068834|FG000|Overall Study|scheduling conflict, family circumstance|2|||
162824070|NCT03281668|588068834|FG000|Overall Study|Withdrawal by Subject|4|||
162824071|NCT03281668|588068834|FG000|Overall Study|Lost to Follow-up|1|||
162824072|NCT01838616|588068837|FG000|Titration Period|Adverse Event|18|||
162824073|NCT01838616|588068838|FG001|Titration Period|Adverse Event|48|||
162824074|NCT01838616|588068837|FG000|Titration Period|Lack of Efficacy|5|||
162824075|NCT01838616|588068838|FG001|Titration Period|Lack of Efficacy|12|||
162824076|NCT01838616|588068837|FG000|Titration Period|Withdrawal by Subject|5|||
162824077|NCT01838616|588068838|FG001|Titration Period|Withdrawal by Subject|5|||
162824078|NCT01838616|588068837|FG000|Titration Period|Technical problems|1|||
162824079|NCT01838616|588068838|FG001|Titration Period|Technical problems|0|||
162824080|NCT01838616|588068837|FG000|Titration Period|Other|1|||
162824081|NCT01838616|588068838|FG001|Titration Period|Other|0|||
162824082|NCT01838616|588068837|FG000|Titration Period|Protocol Violation|0|||
162824083|NCT01838616|588068838|FG001|Titration Period|Protocol Violation|1|||
162824084|NCT01838616|588068837|FG000|Continuation Period|Lack of Efficacy|3|||
162824085|NCT01838616|588068838|FG001|Continuation Period|Lack of Efficacy|5|||
162824086|NCT01838616|588068837|FG000|Continuation Period|Adverse Event|8|||
162824087|NCT01838616|588068838|FG001|Continuation Period|Adverse Event|4|||
162824088|NCT01838616|588068837|FG000|Continuation Period|Protocol Violation|2|||
162824089|NCT01838616|588068838|FG001|Continuation Period|Protocol Violation|0|||
162824090|NCT01838616|588068837|FG000|Continuation Period|Lost to Follow-up|1|||
162824091|NCT01838616|588068838|FG001|Continuation Period|Lost to Follow-up|0|||
162824092|NCT01838616|588068837|FG000|Continuation Period|Withdrawal by Subject|0|||
162824093|NCT01838616|588068838|FG001|Continuation Period|Withdrawal by Subject|4|||
162824094|NCT01838616|588068837|FG000|Continuation Period|Technical problems|0|||
162824095|NCT01838616|588068838|FG001|Continuation Period|Technical problems|1|||
162824096|NCT01838616|588068837|FG000|Pick-up Arm|Lack of Efficacy|4|||
162824097|NCT01838616|588068838|FG001|Pick-up Arm|Lack of Efficacy|0|||
162824098|NCT01838616|588068837|FG000|Pick-up Arm|Adverse Event|9|||
162824099|NCT01838616|588068838|FG001|Pick-up Arm|Adverse Event|0|||
162824100|NCT01838616|588068837|FG000|Pick-up Arm|Withdrawal by Subject|1|||
162824101|NCT01838616|588068838|FG001|Pick-up Arm|Withdrawal by Subject|0|||
162824102|NCT01838616|588068837|FG000|Pick-up Arm|Technical problems|1|||
162824103|NCT01838616|588068838|FG001|Pick-up Arm|Technical problems|0|||
162824104|NCT02573870|588068839|FG000|Overall Study|Adverse Event|0|||
162824105|NCT02573870|588068840|FG001|Overall Study|Adverse Event|2|||
162824106|NCT02573870|588068839|FG000|Overall Study|Lack of Efficacy|0|||
162824107|NCT02573870|588068840|FG001|Overall Study|Lack of Efficacy|1|||
163173207|NCT01238588|589349852|FG000|Overall Study|Withdrawal by Subject|1|||
162824108|NCT02573870|588068839|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
162824109|NCT02573870|588068840|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
162824110|NCT02573870|588068839|FG000|Overall Study|Lost to Follow-up|0|||
162824111|NCT02573870|588068840|FG001|Overall Study|Lost to Follow-up|1|||
163173208|NCT01238588|589349852|FG000|Overall Study|Physician Decision|2|||
162824112|NCT02573870|588068839|FG000|Overall Study|Other: Fail to Meet Visit|0|||
162824113|NCT02573870|588068840|FG001|Overall Study|Other: Fail to Meet Visit|2|||
162824114|NCT00257725|588068841|FG000|Overall Study|Adverse Event|3|||
162824115|NCT01858532|588068842|FG000|Overall Study|Adverse Event|58|||
162824116|NCT01858532|588068843|FG001|Overall Study|Adverse Event|50|||
162824117|NCT01858532|588068844|FG002|Overall Study|Adverse Event|23|||
162824118|NCT01858532|588068845|FG003|Overall Study|Adverse Event|28|||
162824119|NCT01858532|588068842|FG000|Overall Study|Withdrew consent|71|||
162824120|NCT01858532|588068843|FG001|Overall Study|Withdrew consent|93|||
162824121|NCT01858532|588068844|FG002|Overall Study|Withdrew consent|46|||
162824122|NCT01858532|588068845|FG003|Overall Study|Withdrew consent|27|||
162824123|NCT01858532|588068842|FG000|Overall Study|Lost to Follow-up|17|||
162824124|NCT01858532|588068843|FG001|Overall Study|Lost to Follow-up|26|||
162824125|NCT01858532|588068844|FG002|Overall Study|Lost to Follow-up|11|||
162824126|NCT01858532|588068845|FG003|Overall Study|Lost to Follow-up|14|||
162824127|NCT01858532|588068842|FG000|Overall Study|Deterioration of medical status|3|||
162824128|NCT01858532|588068843|FG001|Overall Study|Deterioration of medical status|4|||
162824129|NCT01858532|588068844|FG002|Overall Study|Deterioration of medical status|3|||
162824130|NCT01858532|588068845|FG003|Overall Study|Deterioration of medical status|7|||
162824131|NCT01858532|588068842|FG000|Overall Study|Investigator request|3|||
162824132|NCT01858532|588068843|FG001|Overall Study|Investigator request|4|||
162824133|NCT01858532|588068844|FG002|Overall Study|Investigator request|2|||
162824134|NCT01858532|588068845|FG003|Overall Study|Investigator request|6|||
162824135|NCT01858532|588068842|FG000|Overall Study|Other, not specified|29|||
162824136|NCT01858532|588068843|FG001|Overall Study|Other, not specified|15|||
162824137|NCT01858532|588068844|FG002|Overall Study|Other, not specified|13|||
162824138|NCT01858532|588068845|FG003|Overall Study|Other, not specified|11|||
162824139|NCT00514514|588068846|FG000|Pre-phase|Death|10|||
162824140|NCT00514514|588068847|FG001|Pre-phase|Death|0|||
162824141|NCT00514514|588068848|FG002|Pre-phase|Death|0|||
162824142|NCT00514514|588068846|FG000|Pre-phase|administrative problems|2|||
162824143|NCT00514514|588068847|FG001|Pre-phase|administrative problems|0|||
162824144|NCT00514514|588068848|FG002|Pre-phase|administrative problems|0|||
162824145|NCT00514514|588068846|FG000|Pre-phase|Protocol Violation|6|||
162824146|NCT00514514|588068847|FG001|Pre-phase|Protocol Violation|0|||
162824147|NCT00514514|588068848|FG002|Pre-phase|Protocol Violation|0|||
162824148|NCT00514514|588068846|FG000|Pre-phase|condition no longer requires study drug|7|||
162824149|NCT00514514|588068847|FG001|Pre-phase|condition no longer requires study drug|0|||
162824150|NCT00514514|588068848|FG002|Pre-phase|condition no longer requires study drug|0|||
162824151|NCT00514514|588068846|FG000|Pre-phase|abnormal test procedure results|15|||
162824152|NCT00514514|588068847|FG001|Pre-phase|abnormal test procedure results|0|||
162824153|NCT00514514|588068848|FG002|Pre-phase|abnormal test procedure results|0|||
162824154|NCT00514514|588068846|FG000|Pre-phase|Lost to Follow-up|2|||
162824155|NCT00514514|588068847|FG001|Pre-phase|Lost to Follow-up|0|||
162824156|NCT00514514|588068848|FG002|Pre-phase|Lost to Follow-up|0|||
162824157|NCT00514514|588068846|FG000|Pre-phase|abnormal lab values|23|||
162824158|NCT00514514|588068847|FG001|Pre-phase|abnormal lab values|0|||
162824159|NCT00514514|588068848|FG002|Pre-phase|abnormal lab values|0|||
162824160|NCT00514514|588068846|FG000|Pre-phase|Lack of Efficacy|35|||
162824161|NCT00514514|588068847|FG001|Pre-phase|Lack of Efficacy|0|||
162824162|NCT00514514|588068848|FG002|Pre-phase|Lack of Efficacy|0|||
162824163|NCT00514514|588068846|FG000|Pre-phase|Adverse Event|137|||
162824164|NCT00514514|588068847|FG001|Pre-phase|Adverse Event|0|||
162824165|NCT00514514|588068848|FG002|Pre-phase|Adverse Event|0|||
162824166|NCT00514514|588068846|FG000|Pre-phase|Withdrawal by Subject|66|||
162824167|NCT00514514|588068847|FG001|Pre-phase|Withdrawal by Subject|0|||
162824168|NCT00514514|588068848|FG002|Pre-phase|Withdrawal by Subject|0|||
162824169|NCT00514514|588068846|FG000|Randomized - 9 Month|Death|3|||
162824170|NCT00514514|588068847|FG001|Randomized - 9 Month|Death|2|||
162824171|NCT00514514|588068848|FG002|Randomized - 9 Month|Death|2|||
162824172|NCT00514514|588068846|FG000|Randomized - 9 Month|Administrative problems|1|||
162824173|NCT00514514|588068847|FG001|Randomized - 9 Month|Administrative problems|1|||
162824174|NCT00514514|588068848|FG002|Randomized - 9 Month|Administrative problems|2|||
162824175|NCT00514514|588068846|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
162824176|NCT00514514|588068847|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
162824177|NCT00514514|588068848|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
162824178|NCT00514514|588068846|FG000|Randomized - 9 Month|Protocol Violation|1|||
162824179|NCT00514514|588068847|FG001|Randomized - 9 Month|Protocol Violation|1|||
162824180|NCT00514514|588068848|FG002|Randomized - 9 Month|Protocol Violation|0|||
162824181|NCT00514514|588068846|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
162824182|NCT00514514|588068847|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
162824183|NCT00514514|588068848|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
162824184|NCT00514514|588068846|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
162824185|NCT00514514|588068847|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
162824186|NCT00514514|588068848|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
162824187|NCT00514514|588068846|FG000|Randomized - 9 Month|Adverse Event|25|||
162824188|NCT00514514|588068847|FG001|Randomized - 9 Month|Adverse Event|44|||
162824189|NCT00514514|588068848|FG002|Randomized - 9 Month|Adverse Event|27|||
162824190|NCT00514514|588068846|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
162824191|NCT00514514|588068847|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
162824192|NCT00514514|588068848|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
162824193|NCT00514514|588068846|FG000|Extension - 4 Years|Lost to Follow-up|12|||
162824194|NCT00514514|588068847|FG001|Extension - 4 Years|Lost to Follow-up|10|||
162824195|NCT00514514|588068848|FG002|Extension - 4 Years|Lost to Follow-up|9|||
162824196|NCT00514514|588068846|FG000|Extension - 4 Years|Administrative problems|3|||
162824197|NCT00514514|588068847|FG001|Extension - 4 Years|Administrative problems|1|||
162824198|NCT00514514|588068848|FG002|Extension - 4 Years|Administrative problems|1|||
162824199|NCT00514514|588068846|FG000|Extension - 4 Years|Death|8|||
162824200|NCT00514514|588068847|FG001|Extension - 4 Years|Death|3|||
162824201|NCT00514514|588068848|FG002|Extension - 4 Years|Death|6|||
162824202|NCT00514514|588068846|FG000|Extension - 4 Years|Adverse Event|9|||
162824203|NCT00514514|588068847|FG001|Extension - 4 Years|Adverse Event|6|||
162824204|NCT00514514|588068848|FG002|Extension - 4 Years|Adverse Event|3|||
162824205|NCT02234479|588068851|FG000|Overall Study|Withdrawal by Subject|1|||
162824206|NCT02234479|588068852|FG001|Overall Study|Withdrawal by Subject|3|||
162824207|NCT01480284|588068853|FG000|Overall Study|Withdrawal by Subject|2|||
162824208|NCT01480284|588068854|FG001|Overall Study|Withdrawal by Subject|0|||
162824209|NCT01480284|588068853|FG000|Overall Study|Adverse Event|1|||
162824210|NCT01480284|588068854|FG001|Overall Study|Adverse Event|0|||
162824211|NCT01480284|588068853|FG000|Overall Study|Study closed/terminated|3|||
162824212|NCT01480284|588068854|FG001|Overall Study|Study closed/terminated|0|||
162824213|NCT01480284|588068853|FG000|Overall Study|Lost to Follow-up|1|||
162824214|NCT01480284|588068854|FG001|Overall Study|Lost to Follow-up|0|||
162824215|NCT01480284|588068853|FG000|Overall Study|Physician Decision|1|||
162824216|NCT01480284|588068854|FG001|Overall Study|Physician Decision|0|||
162824217|NCT03374995|588068858|FG000|Overall Study|Withdrawal by Subject|0|||
162824218|NCT03374995|588068859|FG001|Overall Study|Withdrawal by Subject|1|||
162824219|NCT01383096|588068862|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
162824220|NCT01383096|588068863|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
162824221|NCT01383096|588068864|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
162824222|NCT01383096|588068862|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
162824223|NCT01383096|588068863|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
162824224|NCT01383096|588068864|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
162824225|NCT01383096|588068862|FG000|Third Intervention (8 Days)|Elevated AST|0|||
162824226|NCT01383096|588068863|FG001|Third Intervention (8 Days)|Elevated AST|1|||
162824227|NCT01383096|588068864|FG002|Third Intervention (8 Days)|Elevated AST|0|||
162824228|NCT01383096|588068862|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
162824229|NCT01383096|588068863|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
162824230|NCT01383096|588068864|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
162824231|NCT01383096|588068862|FG000|Third Intervention (8 Days)|Adverse Event|1|||
162824232|NCT01383096|588068863|FG001|Third Intervention (8 Days)|Adverse Event|0|||
162824233|NCT01383096|588068864|FG002|Third Intervention (8 Days)|Adverse Event|0|||
162824234|NCT01383096|588068862|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
162824235|NCT01383096|588068863|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
162824236|NCT01383096|588068864|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
162824237|NCT01383096|588068862|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
162824238|NCT01383096|588068863|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
162824239|NCT01383096|588068864|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
162824240|NCT01383096|588068862|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
162824241|NCT01383096|588068863|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
162824242|NCT01383096|588068864|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
162824243|NCT01383096|588068862|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
162824244|NCT01383096|588068863|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
162824245|NCT01383096|588068864|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
162824246|NCT01383096|588068862|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
162824247|NCT01383096|588068863|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
162824248|NCT01383096|588068864|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
162824249|NCT01383096|588068862|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
162824250|NCT01383096|588068863|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
162824251|NCT01383096|588068864|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
162824252|NCT01211535|588068865|FG000|Overall Study|Adverse Event|0|||
162824253|NCT01211535|588068866|FG001|Overall Study|Adverse Event|1|||
162824254|NCT03593850|588068872|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
162824255|NCT03593850|588068873|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
162824256|NCT02490475|588068874|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
162824257|NCT02490475|588068875|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
162824258|NCT02490475|588068876|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
162824259|NCT02490475|588068877|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
162824260|NCT02490475|588068874|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
162824261|NCT02490475|588068875|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
162824262|NCT02490475|588068876|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
162824263|NCT02490475|588068877|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
162824264|NCT02490475|588068874|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
162824265|NCT02490475|588068875|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
162824266|NCT02490475|588068876|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
162824267|NCT02490475|588068877|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
162824268|NCT02490475|588068874|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
162824269|NCT02490475|588068875|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
162824270|NCT02490475|588068876|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
162824271|NCT02490475|588068877|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
162824272|NCT02490475|588068874|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
162824273|NCT02490475|588068875|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
162824274|NCT02490475|588068876|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
162824275|NCT02490475|588068877|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
162824276|NCT02490475|588068874|FG000|Period 2: Extension Phase|Refused Treatment|0|||
162824277|NCT02490475|588068875|FG001|Period 2: Extension Phase|Refused Treatment|0|||
162824278|NCT02490475|588068876|FG002|Period 2: Extension Phase|Refused Treatment|0|||
162824279|NCT02490475|588068877|FG003|Period 2: Extension Phase|Refused Treatment|1|||
162824280|NCT02490475|588068874|FG000|Period 2: Extension Phase|Adverse Event|0|||
162824281|NCT02490475|588068875|FG001|Period 2: Extension Phase|Adverse Event|0|||
162824282|NCT02490475|588068876|FG002|Period 2: Extension Phase|Adverse Event|1|||
162824283|NCT02490475|588068877|FG003|Period 2: Extension Phase|Adverse Event|0|||
162824284|NCT00616434|588068879|FG000|Overall Study|Adverse Event|5|||
162824285|NCT00616434|588068880|FG001|Overall Study|Adverse Event|2|||
162824286|NCT00616434|588068879|FG000|Overall Study|Physician Decision|0|||
162824287|NCT00616434|588068880|FG001|Overall Study|Physician Decision|4|||
162824288|NCT00616434|588068879|FG000|Overall Study|Withdrawal by Subject|1|||
162824289|NCT00616434|588068880|FG001|Overall Study|Withdrawal by Subject|1|||
162824290|NCT00616434|588068879|FG000|Overall Study|Protocol deviation|0|||
162824291|NCT00616434|588068880|FG001|Overall Study|Protocol deviation|1|||
162824292|NCT04784897|588068886|FG000|Overall Study|Death|4|||
162824293|NCT04784897|588068887|FG001|Overall Study|Death|2|||
162824294|NCT04784897|588068888|FG002|Overall Study|Death|1|||
162824295|NCT04784897|588068886|FG000|Overall Study|Withdrawal by Subject|0|||
162824296|NCT04784897|588068887|FG001|Overall Study|Withdrawal by Subject|0|||
162824297|NCT04784897|588068888|FG002|Overall Study|Withdrawal by Subject|1|||
162824298|NCT02319668|588068889|FG000|Overall Study|Other (Not specified)|0|||
162824299|NCT02319668|588068890|FG001|Overall Study|Other (Not specified)|2|||
162824300|NCT01161043|588068891|FG000|Overall Study|Withdrawal by Subject|3|||
162824301|NCT02164929|588068892|FG000|Overall Study|Converted to open procedure|1|||
162824302|NCT02164929|588068893|FG001|Overall Study|Converted to open procedure|0|||
162824303|NCT02164929|588068894|FG002|Overall Study|Converted to open procedure|0|||
162824304|NCT02164929|588068895|FG003|Overall Study|Converted to open procedure|2|||
162824305|NCT02164929|588068892|FG000|Overall Study|Failed regional block|0|||
162824306|NCT02164929|588068893|FG001|Overall Study|Failed regional block|0|||
162824307|NCT02164929|588068894|FG002|Overall Study|Failed regional block|1|||
162824308|NCT02164929|588068895|FG003|Overall Study|Failed regional block|0|||
162824309|NCT00365456|588068899|FG000|Trial Period I (12 Months)|Adverse Event|84|||
162824310|NCT00365456|588068900|FG001|Trial Period I (12 Months)|Adverse Event|0|||
162824311|NCT00365456|588068899|FG000|Trial Period I (12 Months)|Non-compliance|3|||
162824312|NCT00365456|588068900|FG001|Trial Period I (12 Months)|Non-compliance|0|||
162824313|NCT00365456|588068899|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
162824314|NCT00365456|588068900|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
162824315|NCT00365456|588068899|FG000|Trial Period I (12 Months)|Other|11|||
162824316|NCT00365456|588068900|FG001|Trial Period I (12 Months)|Other|0|||
162824317|NCT00365456|588068899|FG000|Trial Period II (12 Months)|Adverse Event|0|||
162824318|NCT00365456|588068900|FG001|Trial Period II (12 Months)|Adverse Event|6|||
162824319|NCT00365456|588068899|FG000|Trial Period II (12 Months)|Non-compliance|0|||
162931273|NCT04380701|588452292|FG004|Overall Study|Physician Decision|0|||
162824320|NCT00365456|588068900|FG001|Trial Period II (12 Months)|Non-compliance|2|||
162824321|NCT00365456|588068899|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
162824322|NCT00365456|588068900|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
162824323|NCT00365456|588068899|FG000|Trial Period II (12 Months)|Other|0|||
162824324|NCT00365456|588068900|FG001|Trial Period II (12 Months)|Other|1|||
162824325|NCT00365456|588068899|FG000|Trial Period III (12 Months)|Adverse Event|13|||
162824326|NCT00365456|588068900|FG001|Trial Period III (12 Months)|Adverse Event|3|||
162824327|NCT00365456|588068899|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
162824328|NCT00365456|588068900|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
162824329|NCT00365456|588068899|FG000|Trial Period III (12 Months)|Other|1|||
162824330|NCT00365456|588068900|FG001|Trial Period III (12 Months)|Other|1|||
162824331|NCT04754802|588068903|FG000|Overall Study|Lost to Follow-up|0|||
162824332|NCT04754802|588068904|FG001|Overall Study|Lost to Follow-up|2|||
162824333|NCT04754802|588068903|FG000|Overall Study|Withdrawal by Subject|2|||
162824334|NCT04754802|588068904|FG001|Overall Study|Withdrawal by Subject|0|||
162824335|NCT00701090|588068905|FG000|Overall Study|Adverse Event|11|||
162824336|NCT00701090|588068906|FG001|Overall Study|Adverse Event|2|||
162824337|NCT00701090|588068905|FG000|Overall Study|Death|0|||
162824338|NCT00701090|588068906|FG001|Overall Study|Death|1|||
162824339|NCT00701090|588068905|FG000|Overall Study|Lack of Efficacy|5|||
162824340|NCT00701090|588068906|FG001|Overall Study|Lack of Efficacy|4|||
162824341|NCT00701090|588068905|FG000|Overall Study|Lost to Follow-up|9|||
162824342|NCT00701090|588068906|FG001|Overall Study|Lost to Follow-up|9|||
162824343|NCT00701090|588068905|FG000|Overall Study|Physician Decision|3|||
162824344|NCT00701090|588068906|FG001|Overall Study|Physician Decision|4|||
162824345|NCT00701090|588068905|FG000|Overall Study|Protocol Violation|2|||
162824346|NCT00701090|588068906|FG001|Overall Study|Protocol Violation|3|||
162824347|NCT00701090|588068905|FG000|Overall Study|Withdrawal by Subject|11|||
162824348|NCT00701090|588068906|FG001|Overall Study|Withdrawal by Subject|16|||
162824349|NCT00701090|588068905|FG000|Overall Study|Other|7|||
162824350|NCT00701090|588068906|FG001|Overall Study|Other|12|||
162824351|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
162824352|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
162824353|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
162824354|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
162824355|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
162824356|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
162824357|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
162824358|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
162824359|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
162824360|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
162824361|NCT01299376|588068910|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
162824362|NCT01299376|588068911|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
162824363|NCT01299376|588068910|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
162824364|NCT01299376|588068911|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
162824365|NCT01299376|588068910|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
162824366|NCT01299376|588068911|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
162824367|NCT01299376|588068910|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
162824368|NCT01299376|588068911|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
162824369|NCT01299376|588068910|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
162824370|NCT01299376|588068911|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
162824371|NCT01299376|588068910|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
162824372|NCT01299376|588068911|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
162824373|NCT00617604|588068913|FG000|Overall Study|Death|2|||
162824374|NCT00617604|588068914|FG001|Overall Study|Death|1|||
162824375|NCT00617604|588068913|FG000|Overall Study|Lost to Follow-up|1|||
162824376|NCT00617604|588068914|FG001|Overall Study|Lost to Follow-up|0|||
162824377|NCT00617604|588068913|FG000|Overall Study|Miscellaneous Reasons|8|||
162824378|NCT00617604|588068914|FG001|Overall Study|Miscellaneous Reasons|10|||
162824379|NCT00617604|588068913|FG000|Overall Study|Withdrawal by Subject|4|||
162824380|NCT00617604|588068914|FG001|Overall Study|Withdrawal by Subject|6|||
162824381|NCT00617604|588068913|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
162824382|NCT00617604|588068914|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
162824383|NCT04029961|588068916|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
162824384|NCT04029961|588068917|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
162824385|NCT04029961|588068916|FG000|Overall Study|Change in Treatment Course|0|||
162824386|NCT04029961|588068917|FG001|Overall Study|Change in Treatment Course|1|||
162824387|NCT01252810|588068920|FG000|Overall Study|Withdrawal by Subject|4|||
162824388|NCT01252810|588068921|FG001|Overall Study|Withdrawal by Subject|1|||
162824389|NCT01252810|588068920|FG000|Overall Study|Lost to Follow-up|0|||
162824390|NCT01252810|588068921|FG001|Overall Study|Lost to Follow-up|1|||
162824391|NCT01252810|588068920|FG000|Overall Study|Physician Decision|2|||
162824392|NCT01252810|588068921|FG001|Overall Study|Physician Decision|1|||
162824393|NCT01252810|588068920|FG000|Overall Study|Various reasons|8|||
162824394|NCT01252810|588068921|FG001|Overall Study|Various reasons|0|||
162824395|NCT00688155|588068923|FG000|Overall Study|Withdrawal by Subject|2|||
162931274|NCT04380701|588452293|FG005|Overall Study|Physician Decision|0|||
162824396|NCT00688155|588068924|FG001|Overall Study|Withdrawal by Subject|2|||
162824397|NCT00688155|588068925|FG002|Overall Study|Withdrawal by Subject|1|||
162931275|NCT04380701|588452294|FG006|Overall Study|Physician Decision|0|||
162931276|NCT04380701|588452295|FG007|Overall Study|Physician Decision|0|||
162931277|NCT04380701|588452296|FG008|Overall Study|Physician Decision|0|||
163173209|NCT05395091|589349853|FG000|Baseline to Month 12|Adverse Event|7|||
163173210|NCT05395091|589349854|FG001|Baseline to Month 12|Adverse Event|2|||
163173211|NCT05395091|589349855|FG002|Baseline to Month 12|Adverse Event|0|||
163173212|NCT05395091|589349853|FG000|Baseline to Month 12|Death|3|||
163173213|NCT05395091|589349854|FG001|Baseline to Month 12|Death|1|||
162824398|NCT00688155|588068926|FG003|Overall Study|Withdrawal by Subject|1|||
162824399|NCT00445224|588068929|FG000|Specific Exercises|Withdrawal by Subject|3|||
162824400|NCT00445224|588068930|FG001|Specific Exercises|Withdrawal by Subject|3|||
162824401|NCT00445224|588068929|FG000|Specific Exercises|Withdrawal by Subject|1|||
162824402|NCT00445224|588068930|FG001|Specific Exercises|Withdrawal by Subject|0|||
162824403|NCT03184077|588068933|FG000|Overall Study|Lost to Follow-up|21|||
162824404|NCT03184077|588068934|FG001|Overall Study|Lost to Follow-up|21|||
162824405|NCT04136184|588068935|FG000|Overall Study|Lost to Follow-up|0|||
162824406|NCT04136184|588068936|FG001|Overall Study|Lost to Follow-up|3|||
162824407|NCT04136184|588068935|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
162824408|NCT04136184|588068936|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
162824409|NCT03318978|588068940|FG000|Overall Study|Withdrawal by Subject|1|||
162824410|NCT02717754|588068943|FG000|Overall Study|Incorrect Infusion Duration|0|||
162824411|NCT02717754|588068944|FG001|Overall Study|Incorrect Infusion Duration|0|||
162824412|NCT02717754|588068945|FG002|Overall Study|Incorrect Infusion Duration|0|||
162824413|NCT02717754|588068946|FG003|Overall Study|Incorrect Infusion Duration|10|||
162824414|NCT02717754|588068947|FG004|Overall Study|Incorrect Infusion Duration|20|||
162824415|NCT02717754|588068948|FG005|Overall Study|Incorrect Infusion Duration|20|||
162824416|NCT01200238|588068949|FG000|Overall Study|Adverse Event|2|||
162824417|NCT01200238|588068950|FG001|Overall Study|Adverse Event|1|||
162824418|NCT01200238|588068949|FG000|Overall Study|Progressive Disease|5|||
162824419|NCT01200238|588068950|FG001|Overall Study|Progressive Disease|8|||
162824420|NCT01200238|588068949|FG000|Overall Study|Withdrawal by Subject|0|||
162824421|NCT01200238|588068950|FG001|Overall Study|Withdrawal by Subject|1|||
162824422|NCT00482703|588068951|FG000|Overall Study|Poor compliance|1|||
162824423|NCT00482703|588068952|FG001|Overall Study|Poor compliance|0|||
162824424|NCT00667823|588068954|FG000|Overall Study|Lost to Follow-up|5|||
162824425|NCT00667823|588068954|FG000|Overall Study|Adverse Event|7|||
162824426|NCT00667823|588068954|FG000|Overall Study|Death|182|||
162824427|NCT00667823|588068954|FG000|Overall Study|Withdrawal by Subject|12|||
162824428|NCT00667823|588068954|FG000|Overall Study|Other|8|||
162824429|NCT00667823|588068954|FG000|Overall Study|Missing (completion page missing)|2|||
162824430|NCT02322125|588070190|FG000|Overall Study|Withdrawal by Subject|2|||
162824431|NCT01524198|588070193|FG000|Overall Study|Protocol Violation|8|||
162824432|NCT01524198|588070194|FG001|Overall Study|Protocol Violation|6|||
162824433|NCT01524198|588070193|FG000|Overall Study|Withdrawal by Subject|15|||
162824434|NCT01524198|588070194|FG001|Overall Study|Withdrawal by Subject|10|||
162824435|NCT04096274|588070195|FG000|Phase I|Lost to Follow-up|5|||
162824436|NCT04096274|588070196|FG001|Phase I|Lost to Follow-up|5|||
162824437|NCT04096274|588070195|FG000|Phase II|Lost to Follow-up|11|||
162824438|NCT04096274|588070196|FG001|Phase II|Lost to Follow-up|11|||
162824439|NCT01462435|588070198|FG000|Overall Study|Lack of Efficacy|1|||
162824440|NCT01462435|588070199|FG001|Overall Study|Lack of Efficacy|0|||
162824441|NCT01462435|588070200|FG002|Overall Study|Lack of Efficacy|0|||
162824442|NCT01462435|588070201|FG003|Overall Study|Lack of Efficacy|3|||
162824443|NCT01462435|588070198|FG000|Overall Study|Physician Decision|0|||
162824444|NCT01462435|588070199|FG001|Overall Study|Physician Decision|0|||
162824445|NCT01462435|588070200|FG002|Overall Study|Physician Decision|1|||
162824446|NCT01462435|588070201|FG003|Overall Study|Physician Decision|0|||
162824447|NCT01462435|588070198|FG000|Overall Study|Withdrawal by Subject|0|||
162824448|NCT01462435|588070199|FG001|Overall Study|Withdrawal by Subject|0|||
162824449|NCT01462435|588070200|FG002|Overall Study|Withdrawal by Subject|0|||
162824450|NCT01462435|588070201|FG003|Overall Study|Withdrawal by Subject|1|||
162824451|NCT01462435|588070198|FG000|Overall Study|Lost to Follow-up|0|||
162824452|NCT01462435|588070199|FG001|Overall Study|Lost to Follow-up|0|||
162824453|NCT01462435|588070200|FG002|Overall Study|Lost to Follow-up|0|||
162824454|NCT01462435|588070201|FG003|Overall Study|Lost to Follow-up|1|||
162824455|NCT05092919|588070202|FG000|Overall Study|Lost to Follow-up|7|||
162824456|NCT05092919|588070202|FG000|Overall Study|Withdrawal by Subject|2|||
162824457|NCT02248259|588070204|FG000|Treatment Period 1|Adverse Event|0|||
162824458|NCT02248259|588070205|FG001|Treatment Period 1|Adverse Event|0|||
162824459|NCT02248259|588070206|FG002|Treatment Period 1|Adverse Event|1|||
162824460|NCT02248259|588070207|FG003|Treatment Period 1|Adverse Event|0|||
162824461|NCT01543152|588070208|FG000|Overall Study|Withdrawal by Subject|0|||
162824462|NCT01543152|588070209|FG001|Overall Study|Withdrawal by Subject|2|||
162824463|NCT01543152|588070210|FG002|Overall Study|Withdrawal by Subject|0|||
162824464|NCT01543152|588070211|FG003|Overall Study|Withdrawal by Subject|0|||
162824465|NCT01543152|588070212|FG004|Overall Study|Withdrawal by Subject|0|||
162824466|NCT00096785|588070213|FG000|Overall Study|Lost to Follow-up|1|||
162824467|NCT00096785|588070214|FG001|Overall Study|Lost to Follow-up|0|||
162824468|NCT00096785|588070213|FG000|Overall Study|Withdrawal by Subject|0|||
162824469|NCT00096785|588070214|FG001|Overall Study|Withdrawal by Subject|1|||
162824470|NCT00096785|588070213|FG000|Overall Study|Relocated|1|||
162931278|NCT04380701|588452297|FG009|Overall Study|Physician Decision|0|||
162931279|NCT04380701|588452298|FG010|Overall Study|Physician Decision|0|||
162931280|NCT04380701|588452299|FG011|Overall Study|Physician Decision|0|||
162931281|NCT04380701|588452300|FG012|Overall Study|Physician Decision|0|||
162931282|NCT04380701|588452301|FG013|Overall Study|Physician Decision|0|||
162931283|NCT04380701|588452302|FG014|Overall Study|Physician Decision|0|||
162931284|NCT04380701|588452303|FG015|Overall Study|Physician Decision|0|||
162931285|NCT04380701|588452304|FG016|Overall Study|Physician Decision|0|||
162931286|NCT04380701|588452305|FG017|Overall Study|Physician Decision|0|||
162931287|NCT04380701|588452306|FG018|Overall Study|Physician Decision|0|||
162931288|NCT04380701|588452307|FG019|Overall Study|Physician Decision|0|||
162931289|NCT04380701|588452308|FG020|Overall Study|Physician Decision|0|||
162824471|NCT00096785|588070214|FG001|Overall Study|Relocated|0|||
162824472|NCT00762892|588070216|FG000|Overall Study|Lost to Follow-up|2|||
162824473|NCT00762892|588070217|FG001|Overall Study|Lost to Follow-up|5|||
162824474|NCT00762892|588070216|FG000|Overall Study|Withdrawal by Subject|0|||
162824475|NCT00762892|588070217|FG001|Overall Study|Withdrawal by Subject|1|||
162824476|NCT00762892|588070216|FG000|Overall Study|Death|1|||
162824477|NCT00762892|588070217|FG001|Overall Study|Death|0|||
162824478|NCT00762892|588070216|FG000|Overall Study|Pregnancy|1|||
162824479|NCT00762892|588070217|FG001|Overall Study|Pregnancy|0|||
162824480|NCT00762892|588070216|FG000|Overall Study|Incarceration|1|||
162824481|NCT00762892|588070217|FG001|Overall Study|Incarceration|0|||
162824482|NCT00914927|588070218|FG000|Overall Study|Adverse Event|0|||
162824483|NCT00914927|588070219|FG001|Overall Study|Adverse Event|0|||
162824484|NCT00914927|588070220|FG002|Overall Study|Adverse Event|0|||
162824485|NCT00914927|588070221|FG003|Overall Study|Adverse Event|0|||
162824486|NCT00914927|588070222|FG004|Overall Study|Adverse Event|1|||
162824487|NCT00914927|588070223|FG005|Overall Study|Adverse Event|0|||
162824488|NCT00914927|588070224|FG006|Overall Study|Adverse Event|0|||
162824489|NCT00914927|588070218|FG000|Overall Study|Withdrawal by Subject|0|||
162824490|NCT00914927|588070219|FG001|Overall Study|Withdrawal by Subject|1|||
162824491|NCT00914927|588070220|FG002|Overall Study|Withdrawal by Subject|0|||
162824492|NCT00914927|588070221|FG003|Overall Study|Withdrawal by Subject|1|||
162824493|NCT00914927|588070222|FG004|Overall Study|Withdrawal by Subject|0|||
162824494|NCT00914927|588070223|FG005|Overall Study|Withdrawal by Subject|0|||
162824495|NCT00914927|588070224|FG006|Overall Study|Withdrawal by Subject|0|||
162824496|NCT00914927|588070218|FG000|Overall Study|Lost to Follow-up|0|||
162824497|NCT00914927|588070219|FG001|Overall Study|Lost to Follow-up|0|||
162824498|NCT00914927|588070220|FG002|Overall Study|Lost to Follow-up|0|||
162824499|NCT00914927|588070221|FG003|Overall Study|Lost to Follow-up|1|||
162824500|NCT00914927|588070222|FG004|Overall Study|Lost to Follow-up|0|||
162824501|NCT00914927|588070223|FG005|Overall Study|Lost to Follow-up|0|||
162824502|NCT00914927|588070224|FG006|Overall Study|Lost to Follow-up|0|||
162824503|NCT00914927|588070218|FG000|Overall Study|Administrative/Other|2|||
162824504|NCT00914927|588070219|FG001|Overall Study|Administrative/Other|1|||
162824505|NCT00914927|588070220|FG002|Overall Study|Administrative/Other|0|||
162824506|NCT00914927|588070221|FG003|Overall Study|Administrative/Other|0|||
162824507|NCT00914927|588070222|FG004|Overall Study|Administrative/Other|1|||
162824508|NCT00914927|588070223|FG005|Overall Study|Administrative/Other|0|||
162824509|NCT00914927|588070224|FG006|Overall Study|Administrative/Other|0|||
162824510|NCT01490814|588070225|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
162824511|NCT01490814|588070226|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
162824512|NCT01490814|588070225|FG000|Overall Study|Physician Decision|1|||
162824513|NCT01490814|588070226|FG001|Overall Study|Physician Decision|0|||
162824514|NCT01490814|588070225|FG000|Overall Study|Withdrawal by Subject|0|||
162824515|NCT01490814|588070226|FG001|Overall Study|Withdrawal by Subject|5|||
162824516|NCT01537198|588070227|FG000|Overall Study|RSV infection|2|||
162824517|NCT01537198|588070227|FG000|Overall Study|Adverse Event|4|||
162824518|NCT01537198|588070227|FG000|Overall Study|No Further Visits to the Clinic|37|||
162824519|NCT01537198|588070227|FG000|Overall Study|Other|111|||
162824520|NCT00496730|588070229|FG000|Overall Study|Lost to Follow-up|4|||
162824521|NCT00496730|588070230|FG001|Overall Study|Lost to Follow-up|3|||
162824522|NCT00496730|588070229|FG000|Overall Study|Withdrawal by Subject|2|||
162824523|NCT00496730|588070230|FG001|Overall Study|Withdrawal by Subject|2|||
162824524|NCT03962738|588070239|FG000|Overall Study|Protocol Deviation|3|||
162824525|NCT03962738|588070240|FG001|Overall Study|Protocol Deviation|0|||
162824526|NCT03962738|588070241|FG002|Overall Study|Protocol Deviation|1|||
162824527|NCT03962738|588070242|FG003|Overall Study|Protocol Deviation|1|||
162931290|NCT04380701|588452309|FG021|Overall Study|Physician Decision|0|||
162824528|NCT03962738|588070239|FG000|Overall Study|Withdrawal by Subject|4|||
162824529|NCT03962738|588070240|FG001|Overall Study|Withdrawal by Subject|0|||
162824530|NCT03962738|588070241|FG002|Overall Study|Withdrawal by Subject|0|||
162824531|NCT03962738|588070242|FG003|Overall Study|Withdrawal by Subject|0|||
162824532|NCT03962738|588070239|FG000|Overall Study|Lost to Follow-up|0|||
162931291|NCT04380701|588452310|FG022|Overall Study|Physician Decision|0|||
162931292|NCT04380701|588452311|FG023|Overall Study|Physician Decision|0|||
162931293|NCT04380701|588452312|FG024|Overall Study|Physician Decision|2|||
162931294|NCT04380701|588452313|FG025|Overall Study|Physician Decision|0|||
162931295|NCT04380701|588452314|FG026|Overall Study|Physician Decision|0|||
162931296|NCT04380701|588452315|FG027|Overall Study|Physician Decision|0|||
162931297|NCT04380701|588452316|FG028|Overall Study|Physician Decision|0|||
162931298|NCT04380701|588452317|FG029|Overall Study|Physician Decision|0|||
162931299|NCT04380701|588452318|FG030|Overall Study|Physician Decision|0|||
162931300|NCT04380701|588452319|FG031|Overall Study|Physician Decision|0|||
162931301|NCT04380701|588452320|FG032|Overall Study|Physician Decision|0|||
162931302|NCT04380701|588452321|FG033|Overall Study|Physician Decision|0|||
162931303|NCT04380701|588452288|FG000|Overall Study|Death|0|||
162931304|NCT04380701|588452289|FG001|Overall Study|Death|0|||
162931305|NCT04380701|588452290|FG002|Overall Study|Death|0|||
162931306|NCT04380701|588452291|FG003|Overall Study|Death|0|||
162931307|NCT04380701|588452292|FG004|Overall Study|Death|0|||
162931308|NCT04380701|588452293|FG005|Overall Study|Death|0|||
162931309|NCT04380701|588452294|FG006|Overall Study|Death|0|||
162931310|NCT04380701|588452295|FG007|Overall Study|Death|0|||
162931311|NCT04380701|588452296|FG008|Overall Study|Death|0|||
162931312|NCT04380701|588452297|FG009|Overall Study|Death|0|||
162931313|NCT04380701|588452298|FG010|Overall Study|Death|0|||
162931314|NCT04380701|588452299|FG011|Overall Study|Death|0|||
162931315|NCT04380701|588452300|FG012|Overall Study|Death|0|||
162931316|NCT04380701|588452301|FG013|Overall Study|Death|0|||
162931317|NCT04380701|588452302|FG014|Overall Study|Death|0|||
162931318|NCT04380701|588452303|FG015|Overall Study|Death|0|||
162931319|NCT04380701|588452304|FG016|Overall Study|Death|0|||
162931320|NCT04380701|588452305|FG017|Overall Study|Death|0|||
162931321|NCT04380701|588452306|FG018|Overall Study|Death|0|||
162931322|NCT04380701|588452307|FG019|Overall Study|Death|0|||
162931323|NCT04380701|588452308|FG020|Overall Study|Death|0|||
162931324|NCT04380701|588452309|FG021|Overall Study|Death|0|||
162931325|NCT04380701|588452310|FG022|Overall Study|Death|0|||
162931326|NCT04380701|588452311|FG023|Overall Study|Death|0|||
162931327|NCT04380701|588452312|FG024|Overall Study|Death|1|||
162931328|NCT04380701|588452313|FG025|Overall Study|Death|0|||
162931329|NCT04380701|588452314|FG026|Overall Study|Death|0|||
162931330|NCT04380701|588452315|FG027|Overall Study|Death|0|||
162931331|NCT04380701|588452316|FG028|Overall Study|Death|0|||
162931332|NCT04380701|588452317|FG029|Overall Study|Death|0|||
162931333|NCT04380701|588452318|FG030|Overall Study|Death|0|||
162931334|NCT04380701|588452319|FG031|Overall Study|Death|0|||
162931335|NCT04380701|588452320|FG032|Overall Study|Death|0|||
162931336|NCT04380701|588452321|FG033|Overall Study|Death|0|||
162931337|NCT04380701|588452288|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931338|NCT04380701|588452289|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931339|NCT04380701|588452290|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931340|NCT04380701|588452291|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931341|NCT04380701|588452292|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931342|NCT04380701|588452293|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931343|NCT04380701|588452294|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931344|NCT04380701|588452295|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931345|NCT04380701|588452296|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931346|NCT04380701|588452297|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931347|NCT04380701|588452298|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931348|NCT04380701|588452299|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931349|NCT04380701|588452300|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931350|NCT04380701|588452301|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931351|NCT04380701|588452302|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
163042821|NCT01990768|588863968|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
163042822|NCT01990768|588863969|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
162698437|NCT03881059|587605503|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
162931352|NCT04380701|588452303|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931353|NCT04380701|588452304|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931354|NCT04380701|588452305|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931355|NCT04380701|588452306|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931356|NCT04380701|588452307|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931357|NCT04380701|588452308|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931358|NCT04380701|588452309|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
162931359|NCT04380701|588452310|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
162931360|NCT04380701|588452311|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
162931361|NCT04380701|588452312|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
162931362|NCT04380701|588452313|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931363|NCT04380701|588452314|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931364|NCT04380701|588452315|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931365|NCT04380701|588452316|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931366|NCT04380701|588452317|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931367|NCT04380701|588452318|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931368|NCT04380701|588452319|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931369|NCT04380701|588452320|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931370|NCT04380701|588452321|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162931371|NCT00065065|588452322|FG000|Overall Study|Adverse Event|3|||
162931372|NCT00065065|588452323|FG001|Overall Study|Adverse Event|2|||
162931373|NCT00065065|588452322|FG000|Overall Study|Withdrawal by Subject|1|||
162931374|NCT00065065|588452323|FG001|Overall Study|Withdrawal by Subject|5|||
162931375|NCT00065065|588452322|FG000|Overall Study|Lack of Efficacy|4|||
162931376|NCT00065065|588452323|FG001|Overall Study|Lack of Efficacy|11|||
162931377|NCT00065065|588452322|FG000|Overall Study|Other|2|||
162931378|NCT00065065|588452323|FG001|Overall Study|Other|2|||
162931379|NCT01050673|588452324|FG000|Overall Study|Physician Decision|4|||
162931380|NCT01050673|588452325|FG001|Overall Study|Physician Decision|5|||
162931381|NCT04363736|588452326|FG000|Overall Study|Withdrawal by Subject|1|||
162931382|NCT04363736|588452327|FG001|Overall Study|Withdrawal by Subject|0|||
162931383|NCT04363736|588452326|FG000|Overall Study|Lost to Follow-up|10|||
162931384|NCT04363736|588452327|FG001|Overall Study|Lost to Follow-up|7|||
162931385|NCT04363736|588452326|FG000|Overall Study|Death|8|||
162931386|NCT04363736|588452327|FG001|Overall Study|Death|6|||
162931387|NCT03797222|588452328|FG000|Overall Study|Withdrawal by Subject|1|||
162931388|NCT02556632|588452335|FG000|Overall Study|Lost to Follow-up|1|||
162931389|NCT02556632|588452336|FG001|Overall Study|Lost to Follow-up|0|||
163173214|NCT05395091|589349855|FG002|Baseline to Month 12|Death|0|||
163173215|NCT05395091|589349853|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
163173216|NCT05395091|589349854|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
163173217|NCT05395091|589349855|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
163173218|NCT05395091|589349853|FG000|Baseline to Month 12|Protocol Violation|2|||
163173219|NCT05395091|589349854|FG001|Baseline to Month 12|Protocol Violation|3|||
163173220|NCT05395091|589349855|FG002|Baseline to Month 12|Protocol Violation|0|||
163173221|NCT05395091|589349853|FG000|Baseline to Month 12|Physician Decision|1|||
162824533|NCT03962738|588070240|FG001|Overall Study|Lost to Follow-up|0|||
162824534|NCT03962738|588070241|FG002|Overall Study|Lost to Follow-up|1|||
162824535|NCT03962738|588070242|FG003|Overall Study|Lost to Follow-up|0|||
162824536|NCT02170779|588070243|FG000|Overall Study|Withdrawal by Subject|1|||
162824537|NCT02170779|588070244|FG001|Overall Study|Withdrawal by Subject|0|||
162824538|NCT02170779|588070243|FG000|Overall Study|Lost to Follow-up|0|||
162824539|NCT02170779|588070244|FG001|Overall Study|Lost to Follow-up|1|||
162824540|NCT04556136|588070247|FG000|Overall Study|Lost to Follow-up|6|||
162824541|NCT04556136|588070248|FG001|Overall Study|Lost to Follow-up|6|||
162824542|NCT04556136|588070247|FG000|Overall Study|Physician Decision|2|||
162824543|NCT04556136|588070248|FG001|Overall Study|Physician Decision|1|||
162824544|NCT04556136|588070247|FG000|Overall Study|Withdrawal by Subject|2|||
162824545|NCT04556136|588070248|FG001|Overall Study|Withdrawal by Subject|1|||
162824546|NCT00935272|588070251|FG000|Overall Study|Lost to Follow-up|10|||
162824547|NCT00935272|588070252|FG001|Overall Study|Lost to Follow-up|3|||
162824548|NCT00935272|588070251|FG000|Overall Study|Withdrawal by Subject|8|||
162824549|NCT00935272|588070252|FG001|Overall Study|Withdrawal by Subject|2|||
162824550|NCT00935272|588070251|FG000|Overall Study|Physician Decision|1|||
162824551|NCT00935272|588070252|FG001|Overall Study|Physician Decision|0|||
162824552|NCT00935272|588070251|FG000|Overall Study|Protocol Violation|0|||
162824553|NCT00935272|588070252|FG001|Overall Study|Protocol Violation|1|||
162824554|NCT03492554|588070253|FG000|Overall Study|Protocol Violation|0|||
162824555|NCT03492554|588070254|FG001|Overall Study|Protocol Violation|14|||
162824556|NCT01478360|588070255|FG000|Overall Study|Lost to Follow-up|1|||
162824557|NCT01478360|588070256|FG001|Overall Study|Lost to Follow-up|0|||
162824558|NCT01478360|588070255|FG000|Overall Study|Adverse Event|0|||
162824559|NCT01478360|588070256|FG001|Overall Study|Adverse Event|1|||
162824560|NCT01478360|588070255|FG000|Overall Study|Administrative problems|1|||
162824561|NCT01478360|588070256|FG001|Overall Study|Administrative problems|2|||
162824562|NCT04340557|588070260|FG000|Overall Study|Transferred to ICU and/or death|1|||
162824563|NCT04340557|588070261|FG001|Overall Study|Transferred to ICU and/or death|2|||
162824564|NCT01221727|588070262|FG000|Overall Study|Physician Decision|2|||
162824565|NCT01221727|588070263|FG001|Overall Study|Physician Decision|0|||
162824566|NCT01221727|588070262|FG000|Overall Study|Withdrawal by Subject|1|||
162824567|NCT01221727|588070263|FG001|Overall Study|Withdrawal by Subject|1|||
162931390|NCT02556632|588452337|FG002|Overall Study|Lost to Follow-up|0|||
162931391|NCT02556632|588452335|FG000|Overall Study|Disliked Intervention|1|||
162931392|NCT02556632|588452336|FG001|Overall Study|Disliked Intervention|1|||
162931393|NCT02556632|588452337|FG002|Overall Study|Disliked Intervention|1|||
162931394|NCT02556632|588452335|FG000|Overall Study|No Reason|1|||
163173222|NCT05395091|589349854|FG001|Baseline to Month 12|Physician Decision|0|||
162931395|NCT02556632|588452336|FG001|Overall Study|No Reason|0|||
162931396|NCT02556632|588452337|FG002|Overall Study|No Reason|1|||
162931397|NCT02556632|588452335|FG000|Overall Study|Personal Issues|0|||
162931398|NCT02556632|588452336|FG001|Overall Study|Personal Issues|1|||
162931399|NCT02556632|588452337|FG002|Overall Study|Personal Issues|1|||
162931400|NCT02556632|588452335|FG000|Overall Study|Changed Mind|0|||
162931401|NCT02556632|588452336|FG001|Overall Study|Changed Mind|1|||
162931402|NCT02556632|588452337|FG002|Overall Study|Changed Mind|0|||
162931403|NCT02556632|588452335|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
162931404|NCT02556632|588452336|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
162931405|NCT02556632|588452337|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
162931406|NCT02556632|588452335|FG000|Overall Study|Unrelated Adverse Event|1|||
162931407|NCT02556632|588452336|FG001|Overall Study|Unrelated Adverse Event|0|||
162931408|NCT02556632|588452337|FG002|Overall Study|Unrelated Adverse Event|3|||
162931409|NCT02556632|588452335|FG000|Overall Study|Related Adverse Event|0|||
162931410|NCT02556632|588452336|FG001|Overall Study|Related Adverse Event|1|||
162931411|NCT02556632|588452337|FG002|Overall Study|Related Adverse Event|0|||
162931412|NCT02556632|588452335|FG000|Overall Study|Possibly Related Adverse Event|0|||
162931413|NCT02556632|588452336|FG001|Overall Study|Possibly Related Adverse Event|0|||
162931414|NCT02556632|588452337|FG002|Overall Study|Possibly Related Adverse Event|1|||
162931415|NCT02556632|588452335|FG000|Overall Study|Did Not Start RT|0|||
162931416|NCT02556632|588452336|FG001|Overall Study|Did Not Start RT|1|||
162931417|NCT02556632|588452337|FG002|Overall Study|Did Not Start RT|0|||
162931418|NCT02556632|588452335|FG000|Overall Study|Ineligible|0|||
162931419|NCT02556632|588452336|FG001|Overall Study|Ineligible|1|||
162931420|NCT02556632|588452337|FG002|Overall Study|Ineligible|0|||
162931421|NCT02556632|588452335|FG000|Overall Study|Disliked Study Procedures|0|||
162931422|NCT02556632|588452336|FG001|Overall Study|Disliked Study Procedures|0|||
162931423|NCT02556632|588452337|FG002|Overall Study|Disliked Study Procedures|1|||
162931424|NCT02556632|588452335|FG000|Overall Study|Treatment or Change Delay|0|||
162931425|NCT02556632|588452336|FG001|Overall Study|Treatment or Change Delay|0|||
162931426|NCT02556632|588452337|FG002|Overall Study|Treatment or Change Delay|1|||
162931427|NCT00928135|588452347|FG000|Overall Study|Withdrawal by Subject|1|||
162931428|NCT00928135|588452348|FG001|Overall Study|Withdrawal by Subject|0|||
162931429|NCT04355767|588452349|FG000|Overall Study|Withdrawal by Subject|2|||
162931430|NCT04355767|588452350|FG001|Overall Study|Withdrawal by Subject|2|||
162931431|NCT04355767|588452349|FG000|Overall Study|Death|5|||
162931432|NCT04355767|588452350|FG001|Overall Study|Death|1|||
162931433|NCT01999322|588452351|FG000|Overall Study|Adverse Event|1|||
162931434|NCT01999322|588452352|FG001|Overall Study|Adverse Event|0|||
162931435|NCT00766506|588454220|FG000|Overall Study|Use rescue medication after 3 hours|3|||
162931436|NCT00766506|588454221|FG001|Overall Study|Use rescue medication after 3 hours|0|||
162931437|NCT00766506|588454220|FG000|Overall Study|Other|2|||
162931438|NCT00766506|588454221|FG001|Overall Study|Other|2|||
162931439|NCT03053622|588454222|FG000|Overall Study|Lost to Follow-up|0|||
162931440|NCT03053622|588454223|FG001|Overall Study|Lost to Follow-up|0|||
162931441|NCT03053622|588454224|FG002|Overall Study|Lost to Follow-up|0|||
162931442|NCT03053622|588454225|FG003|Overall Study|Lost to Follow-up|1|||
162931443|NCT01246986|588454226|FG000|Overall Study|Lost to Follow-up|0|||
162931444|NCT01246986|588454227|FG001|Overall Study|Lost to Follow-up|1|||
162931445|NCT01246986|588454228|FG002|Overall Study|Lost to Follow-up|3|||
162931446|NCT01246986|588454229|FG003|Overall Study|Lost to Follow-up|0|||
162931447|NCT01246986|588454230|FG004|Overall Study|Lost to Follow-up|0|||
162931448|NCT01246986|588454231|FG005|Overall Study|Lost to Follow-up|1|||
162931449|NCT01246986|588454232|FG006|Overall Study|Lost to Follow-up|0|||
162931450|NCT01246986|588454226|FG000|Overall Study|Withdrawal by Subject|3|||
162931451|NCT01246986|588454227|FG001|Overall Study|Withdrawal by Subject|4|||
162931452|NCT01246986|588454228|FG002|Overall Study|Withdrawal by Subject|3|||
162931453|NCT01246986|588454229|FG003|Overall Study|Withdrawal by Subject|0|||
162931454|NCT01246986|588454230|FG004|Overall Study|Withdrawal by Subject|4|||
162931455|NCT01246986|588454231|FG005|Overall Study|Withdrawal by Subject|0|||
162931456|NCT01246986|588454232|FG006|Overall Study|Withdrawal by Subject|0|||
162931457|NCT01440647|588454237|FG000|Overall Study|Death|2|||
162931458|NCT01440647|588454238|FG001|Overall Study|Death|3|||
162931459|NCT01406873|588454252|FG000|Overall Study|Withdrawal by Subject|1|||
162931460|NCT01406873|588454253|FG001|Overall Study|Withdrawal by Subject|1|||
162931461|NCT03990389|588454254|FG000|Overall Study|Lost to Follow-up|3|||
162931462|NCT03990389|588454255|FG001|Overall Study|Lost to Follow-up|0|||
162931463|NCT00207714|588454256|FG000|Overall Study|Adverse Event|6|||
162931464|NCT00207714|588454257|FG001|Overall Study|Adverse Event|2|||
162931465|NCT00207714|588454258|FG002|Overall Study|Adverse Event|4|||
162931466|NCT00207714|588454259|FG003|Overall Study|Adverse Event|3|||
162931467|NCT00207714|588454260|FG004|Overall Study|Adverse Event|1|||
162931468|NCT00207714|588454256|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
162931469|NCT00207714|588454257|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162931470|NCT00207714|588454258|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
162931471|NCT00207714|588454259|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
162931472|NCT00207714|588454260|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
162931473|NCT00207714|588454256|FG000|Overall Study|Other|3|||
162931474|NCT00207714|588454257|FG001|Overall Study|Other|2|||
162931475|NCT00207714|588454258|FG002|Overall Study|Other|5|||
162931476|NCT00207714|588454259|FG003|Overall Study|Other|1|||
162931477|NCT00207714|588454260|FG004|Overall Study|Other|0|||
162931478|NCT02595528|588454261|FG000|Overall Study|Withdrawal by Subject|1|||
162931479|NCT02595528|588454262|FG001|Overall Study|Withdrawal by Subject|2|||
162931480|NCT02595528|588454263|FG002|Overall Study|Withdrawal by Subject|1|||
162931481|NCT02595528|588454264|FG003|Overall Study|Withdrawal by Subject|3|||
162931482|NCT02595528|588454261|FG000|Overall Study|Lost to Follow-up|1|||
162931483|NCT02595528|588454262|FG001|Overall Study|Lost to Follow-up|1|||
162931484|NCT02595528|588454263|FG002|Overall Study|Lost to Follow-up|0|||
162931485|NCT02595528|588454264|FG003|Overall Study|Lost to Follow-up|1|||
162931486|NCT03202511|588454265|FG000|Overall Study|Withdrawal by Subject|1|||
162931487|NCT03202511|588454266|FG001|Overall Study|Withdrawal by Subject|0|||
162931488|NCT00686790|588454267|FG000|Overall Study|Adverse Event|2|||
162931489|NCT00686790|588454267|FG000|Overall Study|Withdrawal by Subject|1|||
162931490|NCT00686790|588454267|FG000|Overall Study|Death|1|||
162931491|NCT00686790|588454267|FG000|Overall Study|Lost to Follow-up|12|||
162931492|NCT03862625|588454270|FG000|Overall Study|Lost to Follow-up|0|||
162931493|NCT03862625|588454271|FG001|Overall Study|Lost to Follow-up|1|||
162931494|NCT02082912|588454272|FG000|Overall Study|Physician Decision|0|||
162931495|NCT02082912|588454273|FG001|Overall Study|Physician Decision|1|||
162931496|NCT02614703|588454274|FG000|Overall Study|Withdrawal by Subject|7|||
162931497|NCT02614703|588454275|FG001|Overall Study|Withdrawal by Subject|1|||
162931498|NCT00782275|588454285|FG000|Overall Study|Adverse Event|11|||
162931499|NCT00782275|588454285|FG000|Overall Study|Withdrawal by Subject|1|||
162931500|NCT00782275|588454285|FG000|Overall Study|Progressive Disease|21|||
162931501|NCT00782275|588454285|FG000|Overall Study|Physician Decision|4|||
162931502|NCT00782275|588454285|FG000|Overall Study|Not started treatment|1|||
162931503|NCT00782275|588454285|FG000|Overall Study|Other|3|||
162931504|NCT04378010|588454286|FG000|Overall Study|Adverse Event|8|||
162931505|NCT04378010|588454287|FG001|Overall Study|Adverse Event|14|||
162931506|NCT04378010|588454288|FG002|Overall Study|Adverse Event|4|||
162931507|NCT04378010|588454286|FG000|Overall Study|Withdrawal by Subject|0|||
162931508|NCT04378010|588454287|FG001|Overall Study|Withdrawal by Subject|2|||
162931509|NCT04378010|588454288|FG002|Overall Study|Withdrawal by Subject|1|||
162931510|NCT04378010|588454286|FG000|Overall Study|Protocol Violation|2|||
162931511|NCT04378010|588454287|FG001|Overall Study|Protocol Violation|1|||
162931512|NCT04378010|588454288|FG002|Overall Study|Protocol Violation|4|||
162931513|NCT04378010|588454286|FG000|Overall Study|Study terminated by Sponsor|22|||
162931514|NCT04378010|588454287|FG001|Overall Study|Study terminated by Sponsor|16|||
162931515|NCT04378010|588454288|FG002|Overall Study|Study terminated by Sponsor|22|||
162931516|NCT04378010|588454286|FG000|Overall Study|Subject inability to complete study visit|0|||
162931517|NCT04378010|588454287|FG001|Overall Study|Subject inability to complete study visit|0|||
162931518|NCT04378010|588454288|FG002|Overall Study|Subject inability to complete study visit|1|||
162931519|NCT04378010|588454286|FG000|Overall Study|Subject never dosed|0|||
162931520|NCT04378010|588454287|FG001|Overall Study|Subject never dosed|1|||
162931521|NCT04378010|588454288|FG002|Overall Study|Subject never dosed|0|||
162931522|NCT01792284|588454289|FG000|Lead-in Period|Adverse Event|15|||
162931523|NCT01792284|588454290|FG001|Lead-in Period|Adverse Event|0|||
162931524|NCT01792284|588454291|FG002|Lead-in Period|Adverse Event|0|||
162931525|NCT01792284|588454289|FG000|Lead-in Period|Lost to Follow-up|2|||
162931526|NCT01792284|588454290|FG001|Lead-in Period|Lost to Follow-up|0|||
162931527|NCT01792284|588454291|FG002|Lead-in Period|Lost to Follow-up|0|||
162931528|NCT01792284|588454289|FG000|Lead-in Period|Protocol Violation|1|||
162931529|NCT01792284|588454290|FG001|Lead-in Period|Protocol Violation|0|||
162931530|NCT01792284|588454291|FG002|Lead-in Period|Protocol Violation|0|||
162931531|NCT01792284|588454289|FG000|Lead-in Period|Withdrawal by Subject|10|||
162931532|NCT01792284|588454290|FG001|Lead-in Period|Withdrawal by Subject|0|||
162931533|NCT01792284|588454291|FG002|Lead-in Period|Withdrawal by Subject|0|||
162698438|NCT03881059|587605504|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
162931534|NCT01792284|588454289|FG000|Lead-in Period|Physician Decision|1|||
162931535|NCT01792284|588454290|FG001|Lead-in Period|Physician Decision|0|||
162931536|NCT01792284|588454291|FG002|Lead-in Period|Physician Decision|0|||
162931537|NCT01792284|588454289|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
162931538|NCT01792284|588454290|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
162931539|NCT01792284|588454291|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
162931540|NCT01792284|588454289|FG000|Randomization Period 1|Withdrawal by Subject|0|||
162931541|NCT01792284|588454290|FG001|Randomization Period 1|Withdrawal by Subject|1|||
162931542|NCT01792284|588454291|FG002|Randomization Period 1|Withdrawal by Subject|1|||
162931543|NCT01792284|588454289|FG000|Randomization Period 1|Physician Decision|0|||
162931544|NCT01792284|588454290|FG001|Randomization Period 1|Physician Decision|1|||
162931545|NCT01792284|588454291|FG002|Randomization Period 1|Physician Decision|1|||
162931546|NCT01792284|588454289|FG000|Randomization Period 1|Adverse Event|0|||
162931547|NCT01792284|588454290|FG001|Randomization Period 1|Adverse Event|0|||
162931548|NCT01792284|588454291|FG002|Randomization Period 1|Adverse Event|2|||
162931549|NCT01792284|588454289|FG000|Randomization Period 1|Lost to Follow-up|0|||
163173223|NCT05395091|589349855|FG002|Baseline to Month 12|Physician Decision|0|||
163173224|NCT05395091|589349853|FG000|Month 12 to Month 18|Death|1|||
163173225|NCT05395091|589349854|FG001|Month 12 to Month 18|Death|0|||
163173226|NCT05395091|589349855|FG002|Month 12 to Month 18|Death|0|||
163173227|NCT05395091|589349853|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
163173228|NCT05395091|589349854|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
163173229|NCT05395091|589349855|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
163173230|NCT05395091|589349853|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
163173231|NCT05395091|589349854|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
163173232|NCT05395091|589349855|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
163173233|NCT05395091|589349853|FG000|Month 12 to Month 18|Other reasons|0|||
163173234|NCT05395091|589349854|FG001|Month 12 to Month 18|Other reasons|0|||
163173235|NCT05395091|589349855|FG002|Month 12 to Month 18|Other reasons|1|||
163173236|NCT01915303|589349862|FG000|Core Phase|Adverse Event|7|||
163173237|NCT01915303|589349862|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
163173238|NCT01915303|589349862|FG000|Core Phase|Death|2|||
163173239|NCT01915303|589349862|FG000|Core Phase|Protocol Violation|2|||
163173240|NCT01915303|589349862|FG000|Core Phase|Abnormal lab value|1|||
162824568|NCT00529451|588070264|FG000|Overall Study|Subject withdrew consent|16|||
163173241|NCT01915303|589349862|FG000|Core Phase|Withdrawal by Subject|1|||
163173242|NCT01915303|589349862|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
163173243|NCT01915303|589349862|FG000|Extension Phase|Withdrawal by Subject|4|||
163173244|NCT01915303|589349862|FG000|Extension Phase|Adverse Event|3|||
163173245|NCT01915303|589349862|FG000|Extension Phase|Death|1|||
163173246|NCT01915303|589349862|FG000|Extension Phase|Protocol Violation|1|||
163173247|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173248|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
163173249|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173250|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173251|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173252|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173253|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162824569|NCT00529451|588070265|FG001|Overall Study|Subject withdrew consent|21|||
162824570|NCT00529451|588070266|FG002|Overall Study|Subject withdrew consent|13|||
162824571|NCT00529451|588070267|FG003|Overall Study|Subject withdrew consent|12|||
162824572|NCT00529451|588070264|FG000|Overall Study|Adverse Event|9|||
162824573|NCT00529451|588070265|FG001|Overall Study|Adverse Event|16|||
162824574|NCT00529451|588070266|FG002|Overall Study|Adverse Event|14|||
162824575|NCT00529451|588070267|FG003|Overall Study|Adverse Event|8|||
162824576|NCT00529451|588070264|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
162824577|NCT00529451|588070265|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
162824578|NCT00529451|588070266|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
162824579|NCT00529451|588070267|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
162824580|NCT00529451|588070264|FG000|Overall Study|Lost to Follow-up|4|||
162824581|NCT00529451|588070265|FG001|Overall Study|Lost to Follow-up|7|||
162824582|NCT00529451|588070266|FG002|Overall Study|Lost to Follow-up|4|||
162824583|NCT00529451|588070267|FG003|Overall Study|Lost to Follow-up|4|||
162824584|NCT00529451|588070264|FG000|Overall Study|Protocol deviation|1|||
162824585|NCT00529451|588070265|FG001|Overall Study|Protocol deviation|1|||
162824586|NCT00529451|588070266|FG002|Overall Study|Protocol deviation|4|||
162824587|NCT00529451|588070267|FG003|Overall Study|Protocol deviation|1|||
162824588|NCT00529451|588070264|FG000|Overall Study|Administrative problems|1|||
162824589|NCT00529451|588070265|FG001|Overall Study|Administrative problems|1|||
162824590|NCT00529451|588070266|FG002|Overall Study|Administrative problems|0|||
162824591|NCT00529451|588070267|FG003|Overall Study|Administrative problems|2|||
162824592|NCT02566577|588070268|FG000|Overall Study|Withdrawal by Subject|1|||
162824593|NCT02566577|588070269|FG001|Overall Study|Withdrawal by Subject|1|||
162824594|NCT02566577|588070268|FG000|Overall Study|Equipment failure|1|||
162824595|NCT02566577|588070269|FG001|Overall Study|Equipment failure|1|||
162824596|NCT02566577|588070268|FG000|Overall Study|Physical limitation|1|||
162824597|NCT02566577|588070269|FG001|Overall Study|Physical limitation|0|||
162824598|NCT01010633|588070270|FG000|Overall Study|Adverse Event|1|||
162824599|NCT01010633|588070271|FG001|Overall Study|Adverse Event|1|||
162824600|NCT01010633|588070270|FG000|Overall Study|Protocol Violation|1|||
162824601|NCT01010633|588070271|FG001|Overall Study|Protocol Violation|2|||
162824602|NCT01010633|588070270|FG000|Overall Study|Withdrawal by Subject|2|||
162824603|NCT01010633|588070271|FG001|Overall Study|Withdrawal by Subject|1|||
162824604|NCT01010633|588070270|FG000|Overall Study|Investigator decision|0|||
162824605|NCT01010633|588070271|FG001|Overall Study|Investigator decision|1|||
163173254|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173255|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
163173256|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162824606|NCT02941926|588070272|FG000|Core Phase|Progressive disease|1109|||
162824607|NCT02941926|588070272|FG000|Core Phase|Adverse Event|504|||
163173257|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162931550|NCT01792284|588454290|FG001|Randomization Period 1|Lost to Follow-up|0|||
162931551|NCT01792284|588454291|FG002|Randomization Period 1|Lost to Follow-up|1|||
162931552|NCT01792284|588454289|FG000|Randomization Period 2|Protocol Violation|0|||
162931553|NCT01792284|588454290|FG001|Randomization Period 2|Protocol Violation|1|||
162931554|NCT01792284|588454291|FG002|Randomization Period 2|Protocol Violation|0|||
162931555|NCT01792284|588454289|FG000|Randomization Period 2|Withdrawal by Subject|0|||
162931556|NCT01792284|588454290|FG001|Randomization Period 2|Withdrawal by Subject|2|||
162931557|NCT01792284|588454291|FG002|Randomization Period 2|Withdrawal by Subject|0|||
162931558|NCT02019979|588454292|FG000|Overall Study|study terminated|14|||
162931559|NCT00379587|588454294|FG000|Overall Study|Lost to Follow-up|2|||
162931560|NCT03237611|588454295|FG000|Overall Study|Withdrawal by Subject|1|||
162931561|NCT03237611|588454295|FG000|Overall Study|Ineligible|1|||
162931562|NCT01169649|588454300|FG000|Overall Study|Patient Not Treated|3|||
162931563|NCT00534092|588454301|FG000|Overall Study|Lost to Follow-up|1|||
162931564|NCT00534092|588454302|FG001|Overall Study|Lost to Follow-up|0|||
162931565|NCT00534092|588454301|FG000|Overall Study|personal reasons/family concerns|1|||
162931566|NCT00534092|588454302|FG001|Overall Study|personal reasons/family concerns|0|||
162931567|NCT02919475|588454303|FG000|Overall Study|Adverse Event|3|||
162931568|NCT02919475|588454304|FG001|Overall Study|Adverse Event|3|||
162931569|NCT02919475|588454305|FG002|Overall Study|Adverse Event|3|||
162931570|NCT02919475|588454306|FG003|Overall Study|Adverse Event|9|||
162931571|NCT02919475|588454307|FG004|Overall Study|Adverse Event|2|||
162931572|NCT02919475|588454303|FG000|Overall Study|Death|0|||
162931573|NCT02919475|588454304|FG001|Overall Study|Death|1|||
162931574|NCT02919475|588454305|FG002|Overall Study|Death|0|||
162931575|NCT02919475|588454306|FG003|Overall Study|Death|0|||
162931576|NCT02919475|588454307|FG004|Overall Study|Death|0|||
162931577|NCT02919475|588454303|FG000|Overall Study|Lost to Follow-up|0|||
162931578|NCT02919475|588454304|FG001|Overall Study|Lost to Follow-up|0|||
162931579|NCT02919475|588454305|FG002|Overall Study|Lost to Follow-up|0|||
162931580|NCT02919475|588454306|FG003|Overall Study|Lost to Follow-up|1|||
162931581|NCT02919475|588454307|FG004|Overall Study|Lost to Follow-up|0|||
162931582|NCT02919475|588454303|FG000|Overall Study|Withdrawal by Subject|2|||
162931583|NCT02919475|588454304|FG001|Overall Study|Withdrawal by Subject|3|||
162931584|NCT02919475|588454305|FG002|Overall Study|Withdrawal by Subject|1|||
162931585|NCT02919475|588454306|FG003|Overall Study|Withdrawal by Subject|2|||
162931586|NCT02919475|588454307|FG004|Overall Study|Withdrawal by Subject|2|||
162931587|NCT02919475|588454303|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931588|NCT02919475|588454304|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931589|NCT02919475|588454305|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931590|NCT02919475|588454306|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162931591|NCT02919475|588454307|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162931592|NCT00275028|588454310|FG000|Overall Study|Withdrew consent before treatment began|1|||
162931593|NCT00275028|588454310|FG000|Overall Study|Withdrawal by Subject|5|||
162931594|NCT00275028|588454310|FG000|Overall Study|Adverse Event|9|||
162931595|NCT00275028|588454310|FG000|Overall Study|Progressive Disease|30|||
162931596|NCT00275028|588454310|FG000|Overall Study|Physician Decision|2|||
162931597|NCT02323295|588454316|FG000|Overall Study|Adverse Event|0|||
162931598|NCT02323295|588454317|FG001|Overall Study|Adverse Event|1|||
162931599|NCT02323295|588454316|FG000|Overall Study|Withdrawal by Subject|0|||
162931600|NCT02323295|588454317|FG001|Overall Study|Withdrawal by Subject|1|||
162931601|NCT02323295|588454316|FG000|Overall Study|Patient did not have surgery as planned.|0|||
162931602|NCT02323295|588454317|FG001|Overall Study|Patient did not have surgery as planned.|1|||
162931603|NCT02370784|588454320|FG000|Overall Study|Patient started prohibited medication|0|||
162931604|NCT02370784|588454321|FG001|Overall Study|Patient started prohibited medication|1|||
162931605|NCT04356573|588454325|FG000|Overall Study|Didn't Qualify|1|||
162931606|NCT04356573|588454326|FG001|Overall Study|Didn't Qualify|0|||
162931607|NCT01244815|588454329|FG000|Overall Study|Not Treated|0|||
162931608|NCT01244815|588454330|FG001|Overall Study|Not Treated|1|||
162698439|NCT03881059|587605505|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
162931609|NCT01244815|588454331|FG002|Overall Study|Not Treated|0|||
162931610|NCT01244815|588454332|FG003|Overall Study|Not Treated|0|||
162931611|NCT01244815|588454329|FG000|Overall Study|Adverse Event|4|||
162931612|NCT01244815|588454330|FG001|Overall Study|Adverse Event|7|||
162931613|NCT01244815|588454331|FG002|Overall Study|Adverse Event|5|||
162931614|NCT01244815|588454332|FG003|Overall Study|Adverse Event|5|||
162931615|NCT01244815|588454329|FG000|Overall Study|Treatment Failure|0|||
162931616|NCT01244815|588454330|FG001|Overall Study|Treatment Failure|0|||
162931617|NCT01244815|588454331|FG002|Overall Study|Treatment Failure|0|||
162931618|NCT01244815|588454332|FG003|Overall Study|Treatment Failure|1|||
162931619|NCT01244815|588454329|FG000|Overall Study|Lost to Follow-up|3|||
162931620|NCT01244815|588454330|FG001|Overall Study|Lost to Follow-up|2|||
162931621|NCT01244815|588454331|FG002|Overall Study|Lost to Follow-up|3|||
162931622|NCT01244815|588454332|FG003|Overall Study|Lost to Follow-up|2|||
162931623|NCT01244815|588454329|FG000|Overall Study|Withdrawal by Subject|0|||
162931624|NCT01244815|588454330|FG001|Overall Study|Withdrawal by Subject|2|||
162931625|NCT01244815|588454331|FG002|Overall Study|Withdrawal by Subject|0|||
162931626|NCT01244815|588454332|FG003|Overall Study|Withdrawal by Subject|3|||
162931627|NCT01244815|588454329|FG000|Overall Study|Protocol Violation|7|||
162931628|NCT01244815|588454330|FG001|Overall Study|Protocol Violation|4|||
162931629|NCT01244815|588454331|FG002|Overall Study|Protocol Violation|3|||
162931630|NCT01244815|588454332|FG003|Overall Study|Protocol Violation|1|||
162931631|NCT01244815|588454329|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931632|NCT01244815|588454330|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
162931633|NCT01244815|588454331|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931634|NCT01244815|588454332|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
162931635|NCT02041494|588454334|FG000|Overall Study|Death|1|||
162931636|NCT02041494|588454335|FG001|Overall Study|Death|3|||
162931637|NCT02041494|588454334|FG000|Overall Study|Lost to Follow-up|2|||
162931638|NCT02041494|588454335|FG001|Overall Study|Lost to Follow-up|6|||
162931639|NCT02041494|588454334|FG000|Overall Study|study terminated|16|||
162931640|NCT02041494|588454335|FG001|Overall Study|study terminated|11|||
162931641|NCT02487979|588454340|FG000|Overall Study|Physician Decision|2|||
162931642|NCT02487979|588454340|FG000|Overall Study|Withdrawal by Subject|2|||
162931643|NCT02487979|588454340|FG000|Overall Study|Progressive Disease|17|||
162931644|NCT02410837|588454341|FG000|Overall Study|Death|387|||
162931645|NCT02410837|588454341|FG000|Overall Study|Lost to Follow-up|50|||
162931646|NCT02410837|588454341|FG000|Overall Study|Withdrawal by Subject|44|||
162931647|NCT02410837|588454341|FG000|Overall Study|Physician Decision|6|||
162931648|NCT02410837|588454341|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
162931649|NCT00849524|588454348|FG000|Overall Study|Lack of Efficacy|3|||
162931650|NCT01825876|588454351|FG000|Period 2|Withdrawal by Subject|0|||
162931651|NCT01825876|588454352|FG001|Period 2|Withdrawal by Subject|1|||
162931652|NCT01027884|588454356|FG000|Overall Study|Adverse Event|2|||
162931653|NCT01027884|588454357|FG001|Overall Study|Adverse Event|1|||
162931654|NCT01027884|588454356|FG000|Overall Study|Protocol Violation|1|||
162931655|NCT01027884|588454357|FG001|Overall Study|Protocol Violation|0|||
162931656|NCT01027884|588454356|FG000|Overall Study|Non-compliance|1|||
162931657|NCT01027884|588454357|FG001|Overall Study|Non-compliance|1|||
162931658|NCT01027884|588454356|FG000|Overall Study|Withdrawal by Subject|0|||
162931659|NCT01027884|588454357|FG001|Overall Study|Withdrawal by Subject|1|||
162931660|NCT01027884|588454356|FG000|Overall Study|Lost to Follow-up|0|||
162931661|NCT01027884|588454357|FG001|Overall Study|Lost to Follow-up|1|||
162931662|NCT01027884|588454356|FG000|Overall Study|Spinal fixation surgery|0|||
162931663|NCT01027884|588454357|FG001|Overall Study|Spinal fixation surgery|3|||
162931664|NCT03670537|588454359|FG000|Overall Study|Protocol Violation|1|||
162931665|NCT03636542|588454360|FG000|Overall Study|Lost to Follow-up|1|||
162931666|NCT03636542|588454361|FG001|Overall Study|Lost to Follow-up|1|||
162931667|NCT03636542|588454360|FG000|Overall Study|Physician Decision|0|||
162931668|NCT03636542|588454361|FG001|Overall Study|Physician Decision|1|||
162931669|NCT03636542|588454360|FG000|Overall Study|Withdrawal by Subject|1|||
162931670|NCT03636542|588454361|FG001|Overall Study|Withdrawal by Subject|0|||
162931671|NCT02059187|588454364|FG000|Overall Study|Adverse Event|0|||
162931672|NCT02059187|588454365|FG001|Overall Study|Adverse Event|3|||
162931673|NCT02059187|588454364|FG000|Overall Study|Death|1|||
162931674|NCT02059187|588454365|FG001|Overall Study|Death|1|||
162931675|NCT02059187|588454364|FG000|Overall Study|Lost to Follow-up|9|||
162931676|NCT02059187|588454365|FG001|Overall Study|Lost to Follow-up|8|||
162931677|NCT02059187|588454364|FG000|Overall Study|Non-compliance with study drug|1|||
162931678|NCT02059187|588454365|FG001|Overall Study|Non-compliance with study drug|0|||
162931679|NCT02059187|588454364|FG000|Overall Study|Physician Decision|1|||
162931680|NCT02059187|588454365|FG001|Overall Study|Physician Decision|2|||
162931681|NCT02059187|588454364|FG000|Overall Study|Protocol Violation|1|||
162931682|NCT02059187|588454365|FG001|Overall Study|Protocol Violation|0|||
162931683|NCT02059187|588454364|FG000|Overall Study|Withdrawal by Subject|12|||
162931684|NCT02059187|588454365|FG001|Overall Study|Withdrawal by Subject|8|||
162931685|NCT03751020|588454366|FG000|Overall Study|Withdrawal by Subject|2|||
162931686|NCT03751020|588454367|FG001|Overall Study|Withdrawal by Subject|0|||
162931687|NCT03751020|588454368|FG002|Overall Study|Withdrawal by Subject|0|||
162931688|NCT03751020|588454366|FG000|Overall Study|Lost to Follow-up|7|||
162931689|NCT03751020|588454367|FG001|Overall Study|Lost to Follow-up|4|||
162931690|NCT03751020|588454368|FG002|Overall Study|Lost to Follow-up|10|||
162931691|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
162931692|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162931693|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
162931694|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162931695|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931696|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931697|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
162931698|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
162931699|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
162931700|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
162931701|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
162931702|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
162931703|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
162931704|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162931705|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162931706|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
162931707|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931708|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931709|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
162931710|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
162931711|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
162931712|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
162931713|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
162931714|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
162931715|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931716|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931717|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
162931718|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
162931719|NCT00528879|588454369|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
162931720|NCT00528879|588454370|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
162931721|NCT00528879|588454371|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
162931722|NCT00528879|588454372|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
162931723|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
162931724|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
162931725|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
162931726|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
162931727|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
162931728|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
162931729|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
162931730|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
162931731|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
162931732|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
162931733|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
162931734|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
162931735|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
163173258|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173259|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173260|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173261|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173262|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173263|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173264|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173265|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
163173266|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
163173267|NCT02509117|589349864|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162824608|NCT02941926|588070272|FG000|Core Phase|Subject/guardian decision|127|||
162824609|NCT02941926|588070272|FG000|Core Phase|Physician Decision|112|||
162824610|NCT02941926|588070272|FG000|Core Phase|Death|46|||
162824611|NCT02941926|588070272|FG000|Core Phase|Protocol deviation|34|||
162824612|NCT02941926|588070272|FG000|Core Phase|Lost to Follow-up|8|||
162824613|NCT02941926|588070272|FG000|Core Phase|Technical problems|5|||
162824614|NCT02941926|588070272|FG000|Extension Phase|Physician Decision|155|||
162824615|NCT02941926|588070272|FG000|Extension Phase|Progressive disease|115|||
162824616|NCT02941926|588070272|FG000|Extension Phase|Adverse Event|13|||
162824617|NCT02941926|588070272|FG000|Extension Phase|Subject/Guardian decision|12|||
162824618|NCT02941926|588070272|FG000|Extension Phase|Death|6|||
162824619|NCT00097773|588070273|FG000|Overall Study|Lost to Follow-up|2|||
162824620|NCT00097773|588070274|FG001|Overall Study|Lost to Follow-up|2|||
162824621|NCT00097773|588070275|FG002|Overall Study|Lost to Follow-up|0|||
162824622|NCT00097773|588070276|FG003|Overall Study|Lost to Follow-up|1|||
162824623|NCT00097773|588070273|FG000|Overall Study|Physician Decision|2|||
162824624|NCT00097773|588070274|FG001|Overall Study|Physician Decision|2|||
162824625|NCT00097773|588070275|FG002|Overall Study|Physician Decision|3|||
162824626|NCT00097773|588070276|FG003|Overall Study|Physician Decision|1|||
162824627|NCT00097773|588070273|FG000|Overall Study|Withdrawal by Subject|3|||
162824628|NCT00097773|588070274|FG001|Overall Study|Withdrawal by Subject|3|||
162824629|NCT00097773|588070275|FG002|Overall Study|Withdrawal by Subject|3|||
162824630|NCT00097773|588070276|FG003|Overall Study|Withdrawal by Subject|1|||
162824631|NCT00097773|588070273|FG000|Overall Study|Adverse Event|0|||
162824632|NCT00097773|588070274|FG001|Overall Study|Adverse Event|1|||
162824633|NCT00097773|588070275|FG002|Overall Study|Adverse Event|0|||
162824634|NCT00097773|588070276|FG003|Overall Study|Adverse Event|0|||
162824635|NCT00097773|588070273|FG000|Overall Study|Other|1|||
162824636|NCT00097773|588070274|FG001|Overall Study|Other|0|||
162824637|NCT00097773|588070275|FG002|Overall Study|Other|2|||
163173268|NCT02509117|589349865|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173269|NCT02509117|589349866|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173270|NCT02509117|589349867|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173271|NCT02509117|589349868|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173272|NCT02509117|589349869|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173273|NCT02509117|589349870|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173274|NCT02509117|589349871|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173275|NCT02509117|589349872|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
163173276|NCT02509117|589349873|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
163173277|NCT00832624|589349874|FG000|Overall Study|Study Terminated|10|||
163173278|NCT00548184|589349877|FG000|Overall Study|Adverse Event|3|||
163173279|NCT00548184|589349877|FG000|Overall Study|took other drug|1|||
163173280|NCT00548184|589349877|FG000|Overall Study|Found Her2 negative|1|||
163173281|NCT00280748|589349884|FG000|Overall Study|Decline in performance|3|||
163173282|NCT00280748|589349884|FG000|Overall Study|Extra-cranial disease progression|1|||
163173283|NCT01433250|589349885|FG000|Overall Study|Protocol Violation|0|||
163173284|NCT01433250|589349886|FG001|Overall Study|Protocol Violation|1|||
163173285|NCT01433250|589349885|FG000|Overall Study|Withdrawal by Subject|3|||
163173286|NCT01433250|589349886|FG001|Overall Study|Withdrawal by Subject|2|||
163173287|NCT00796523|589349889|FG000|Overall Study|Lost to Follow-up|9|||
163173288|NCT00796523|589349890|FG001|Overall Study|Lost to Follow-up|7|||
163173289|NCT03288142|589349893|FG000|Overall Study|Lost to Follow-up|22|||
163173290|NCT03288142|589349894|FG001|Overall Study|Lost to Follow-up|15|||
163173291|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
163173292|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
163173293|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
163173294|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
163173295|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
163173296|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
163173297|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
163173298|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
163173299|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
163173300|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
162698440|NCT03881059|587605503|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
162824638|NCT00097773|588070276|FG003|Overall Study|Other|0|||
162824639|NCT01494350|588070277|FG000|Overall Study|Worsening of lesion|1|||
162824640|NCT00474708|588070278|FG000|Overall Study|Lack of Efficacy|11|||
162824641|NCT00474708|588070279|FG001|Overall Study|Lack of Efficacy|5|||
162824642|NCT00474708|588070278|FG000|Overall Study|Suicide ideation/behavior|0|||
162824643|NCT00474708|588070279|FG001|Overall Study|Suicide ideation/behavior|1|||
162824644|NCT00474708|588070278|FG000|Overall Study|Withdrawal by Subject|7|||
162931736|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
162931737|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
163173301|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
162931738|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
162931739|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
162931740|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
162931741|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
162931742|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
162931743|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
162931744|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
162931745|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
162931746|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
162931747|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
162931748|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
162931749|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
162931750|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
163173302|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
163173303|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
163173304|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
163173305|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
163173306|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
163173307|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
163173308|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
163173309|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
163173310|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
163173311|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
163173312|NCT01227824|589349895|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
163173313|NCT01227824|589349896|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
163173314|NCT01227824|589349897|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
163173315|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
163173316|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
163173317|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
163173318|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
163173319|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
163173320|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
163173321|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
163173322|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
163173323|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
163173324|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
163173325|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
163173326|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
163173327|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
163173328|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
163173329|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
163173330|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
163173331|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
163173332|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
163173333|NCT01227824|589349895|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
163173334|NCT01227824|589349896|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
163173335|NCT01227824|589349897|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
163173336|NCT02576145|589349898|FG000|Overall Study|Adverse Event|1|||
163173337|NCT02576145|589349899|FG001|Overall Study|Adverse Event|0|||
163173338|NCT02576145|589349898|FG000|Overall Study|Withdrawal by Subject|1|||
163173339|NCT02576145|589349899|FG001|Overall Study|Withdrawal by Subject|0|||
163173340|NCT02576145|589349898|FG000|Overall Study|Acute rejection|1|||
163173341|NCT02576145|589349899|FG001|Overall Study|Acute rejection|0|||
163173342|NCT02576145|589349898|FG000|Overall Study|Tetanus Titers Decreased|0|||
163173343|NCT02576145|589349899|FG001|Overall Study|Tetanus Titers Decreased|1|||
163173344|NCT00384111|589349905|FG000|Overall Study|Disease Progression|3|||
163173345|NCT00384111|589349905|FG000|Overall Study|Adverse Event|1|||
163173346|NCT00384111|589349905|FG000|Overall Study|Investigator Decision|3|||
163173347|NCT00384111|589349905|FG000|Overall Study|Study Terminated by the Sponsor|19|||
163173348|NCT00821509|589349906|FG000|Overall Study|Withdrawal by Subject|12|||
162931751|NCT00528879|588454369|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
162931752|NCT00528879|588454370|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
162931753|NCT00528879|588454371|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
163173349|NCT00821509|589349907|FG001|Overall Study|Withdrawal by Subject|11|||
163173350|NCT00821509|589349908|FG002|Overall Study|Withdrawal by Subject|34|||
162824645|NCT00474708|588070279|FG001|Overall Study|Withdrawal by Subject|0|||
162824646|NCT00474708|588070278|FG000|Overall Study|Lack of compliance|12|||
162824647|NCT00474708|588070279|FG001|Overall Study|Lack of compliance|4|||
162824648|NCT00474708|588070278|FG000|Overall Study|Lost to Follow-up|18|||
162824649|NCT00474708|588070279|FG001|Overall Study|Lost to Follow-up|9|||
162824650|NCT00474708|588070278|FG000|Overall Study|Physician Decision|9|||
162824651|NCT00474708|588070279|FG001|Overall Study|Physician Decision|6|||
162824652|NCT03700320|588070280|FG000|Overall Study|Adverse Event|5|||
162824653|NCT03700320|588070281|FG001|Overall Study|Adverse Event|31|||
162824654|NCT03700320|588070280|FG000|Overall Study|Lack of Efficacy|2|||
162824655|NCT03700320|588070281|FG001|Overall Study|Lack of Efficacy|5|||
162824656|NCT03700320|588070280|FG000|Overall Study|Withdrawal by Subject|29|||
162824657|NCT03700320|588070281|FG001|Overall Study|Withdrawal by Subject|75|||
162824658|NCT03700320|588070280|FG000|Overall Study|Lost to Follow-up|16|||
162824659|NCT03700320|588070281|FG001|Overall Study|Lost to Follow-up|23|||
162824660|NCT03700320|588070280|FG000|Overall Study|Pregnancy|2|||
162824661|NCT03700320|588070281|FG001|Overall Study|Pregnancy|4|||
162824662|NCT03700320|588070280|FG000|Overall Study|Protocol Deviation|7|||
162824663|NCT03700320|588070281|FG001|Overall Study|Protocol Deviation|31|||
162824664|NCT03700320|588070280|FG000|Overall Study|Non-compliance with Study Drug|1|||
162824665|NCT03700320|588070281|FG001|Overall Study|Non-compliance with Study Drug|3|||
162824666|NCT03700320|588070280|FG000|Overall Study|Reason not Specified|0|||
162824667|NCT03700320|588070281|FG001|Overall Study|Reason not Specified|1|||
162824668|NCT04305275|588070282|FG000|Overall Study|Adverse Event|4|||
162824669|NCT04305275|588070283|FG001|Overall Study|Adverse Event|0|||
162824670|NCT04305275|588070282|FG000|Overall Study|Lost to Follow-up|1|||
162824671|NCT04305275|588070283|FG001|Overall Study|Lost to Follow-up|1|||
162824672|NCT04305275|588070282|FG000|Overall Study|Withdrawal by Participant|8|||
162824673|NCT04305275|588070283|FG001|Overall Study|Withdrawal by Participant|1|||
162824674|NCT00199836|588070284|FG000|Overall Study|Progressive Disease|5|||
162824675|NCT00199836|588070284|FG000|Overall Study|Death|1|||
162824676|NCT03061175|588070287|FG000|Baseline|Participant was deemed ineligible|1|||
162824677|NCT03061175|588070288|FG001|Baseline|Participant was deemed ineligible|0|||
162824678|NCT03061175|588070287|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
162824679|NCT03061175|588070288|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
162824680|NCT03061175|588070287|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
162824681|NCT03061175|588070288|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
162824682|NCT03061175|588070287|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
162824683|NCT03061175|588070288|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
162824684|NCT00760669|588070289|FG000|Overall Study|Not assessed for overall improvement|18|||
162824685|NCT00760669|588070289|FG000|Overall Study|Participants missing efficacy assessment|6|||
162824686|NCT00760669|588070289|FG000|Overall Study|Participants with overlapping cases|1|||
162824687|NCT00760669|588070289|FG000|Overall Study|Took drug before entering in contract|5|||
162824688|NCT02456662|588070300|FG000|Overall Study|Lost to Follow-up|2|||
162824689|NCT02456662|588070301|FG001|Overall Study|Lost to Follow-up|1|||
162824690|NCT00504153|588070306|FG000|Overall Study|Withdrawal by Subject|1|||
162824691|NCT00504153|588070306|FG000|Overall Study|Adverse Event|4|||
162824692|NCT00504153|588070306|FG000|Overall Study|Death|1|||
162824693|NCT02303704|588070307|FG000|Overall Study|Protocol Violation|5|||
162824694|NCT02303704|588070308|FG001|Overall Study|Protocol Violation|9|||
162824695|NCT01034540|588070309|FG000|Overall Study|Adverse Event|0|||
162824696|NCT01034540|588070310|FG001|Overall Study|Adverse Event|1|||
162824697|NCT00805025|588070311|FG000|Overall Study|Screened but not enrolled/treated|42|||
162824698|NCT00805025|588070311|FG000|Overall Study|Adverse Event|4|||
162824699|NCT00805025|588070311|FG000|Overall Study|Withdrawal by Subject|2|||
162824700|NCT00805025|588070311|FG000|Overall Study|Physician Decision|1|||
162824701|NCT00932425|588070318|FG000|Overall Study|Lost to Follow-up|0|||
162824702|NCT00932425|588070319|FG001|Overall Study|Lost to Follow-up|1|||
162824703|NCT00932425|588070318|FG000|Overall Study|Withdrawal by Subject|0|||
162698441|NCT03881059|587605504|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
162824704|NCT00932425|588070319|FG001|Overall Study|Withdrawal by Subject|1|||
162824705|NCT01721876|588070320|FG000|Overall Study|Not treated|1|||
162824706|NCT01721876|588070321|FG001|Overall Study|Not treated|4|||
162824707|NCT01721876|588070320|FG000|Overall Study|Disease progression / relapse|123|||
162824708|NCT01721876|588070321|FG001|Overall Study|Disease progression / relapse|156|||
162824709|NCT01721876|588070320|FG000|Overall Study|Death|6|||
162824710|NCT01721876|588070321|FG001|Overall Study|Death|13|||
162824711|NCT01721876|588070320|FG000|Overall Study|Adverse Event|41|||
162824712|NCT01721876|588070321|FG001|Overall Study|Adverse Event|165|||
162824713|NCT01721876|588070320|FG000|Overall Study|Protocol Violation|2|||
162824714|NCT01721876|588070321|FG001|Overall Study|Protocol Violation|1|||
162824715|NCT01721876|588070320|FG000|Overall Study|Withdrawal by Subject|15|||
162824716|NCT01721876|588070321|FG001|Overall Study|Withdrawal by Subject|38|||
162824717|NCT01721876|588070320|FG000|Overall Study|Reason not listed|34|||
162824718|NCT01721876|588070321|FG001|Overall Study|Reason not listed|63|||
162824719|NCT01721876|588070320|FG000|Overall Study|Sponsor terminated trial|0|||
162824720|NCT01721876|588070321|FG001|Overall Study|Sponsor terminated trial|4|||
162931754|NCT00528879|588454372|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
162931755|NCT01159769|588454373|FG000|Overall Study|Adverse Event|1|||
162931756|NCT02555618|588454374|FG000|Overall Study|Sponsor's Circumstances|1|||
162931757|NCT02555618|588454375|FG001|Overall Study|Sponsor's Circumstances|0|||
162931758|NCT02217345|588454376|FG000|Overall Study|Lost to Follow-up|2|||
162931759|NCT02217345|588454377|FG001|Overall Study|Lost to Follow-up|1|||
162931760|NCT02217345|588454376|FG000|Overall Study|Withdrawal by Subject|3|||
162931761|NCT02217345|588454377|FG001|Overall Study|Withdrawal by Subject|2|||
162931762|NCT02217345|588454376|FG000|Overall Study|Adverse Event|2|||
162931763|NCT02217345|588454377|FG001|Overall Study|Adverse Event|1|||
162931764|NCT02217345|588454376|FG000|Overall Study|Physician Decision|0|||
162931765|NCT02217345|588454377|FG001|Overall Study|Physician Decision|1|||
162931766|NCT00845026|588454378|FG000|Study Period III|Adverse Event|23|||
162931767|NCT00845026|588454379|FG001|Study Period III|Adverse Event|19|||
162931768|NCT00845026|588454378|FG000|Study Period III|Perceived lack of efficacy|27|||
162931769|NCT00845026|588454379|FG001|Study Period III|Perceived lack of efficacy|15|||
162931770|NCT00845026|588454378|FG000|Study Period III|Withdrawal by Subject|19|||
162931771|NCT00845026|588454379|FG001|Study Period III|Withdrawal by Subject|15|||
162931772|NCT00845026|588454378|FG000|Study Period III|Entry Criteria not met|8|||
162931773|NCT00845026|588454379|FG001|Study Period III|Entry Criteria not met|11|||
162931774|NCT00845026|588454378|FG000|Study Period III|Lost to Follow-up|4|||
162931775|NCT00845026|588454379|FG001|Study Period III|Lost to Follow-up|5|||
162931776|NCT00845026|588454378|FG000|Study Period III|Protocol Violation|8|||
162931777|NCT00845026|588454379|FG001|Study Period III|Protocol Violation|1|||
162931778|NCT00845026|588454378|FG000|Study Period III|Scheduled conflict|3|||
162931779|NCT00845026|588454379|FG001|Study Period III|Scheduled conflict|1|||
162931780|NCT00845026|588454378|FG000|Study Period III|Subject is moving or has moved|2|||
162931781|NCT00845026|588454379|FG001|Study Period III|Subject is moving or has moved|4|||
162931782|NCT00845026|588454378|FG000|Study Period III|Transportation issues|1|||
162931783|NCT00845026|588454379|FG001|Study Period III|Transportation issues|1|||
162931784|NCT00845026|588454378|FG000|Study Period IV|Adverse Event|4|||
162931785|NCT00845026|588454379|FG001|Study Period IV|Adverse Event|0|||
162931786|NCT00845026|588454378|FG000|Study Period IV|Perceived lack of efficacy|2|||
162931787|NCT00845026|588454379|FG001|Study Period IV|Perceived lack of efficacy|1|||
162931788|NCT00845026|588454378|FG000|Study Period IV|Protocol Violation|3|||
162931789|NCT00845026|588454379|FG001|Study Period IV|Protocol Violation|1|||
162931790|NCT00845026|588454378|FG000|Study Period IV|Lost to Follow-up|1|||
162931791|NCT00845026|588454379|FG001|Study Period IV|Lost to Follow-up|0|||
162931792|NCT00845026|588454378|FG000|Study Period IV|Withdrawal by Subject|4|||
162931793|NCT00845026|588454379|FG001|Study Period IV|Withdrawal by Subject|1|||
162931794|NCT00845026|588454378|FG000|Study Period IV|Entry Criteria Not Met|1|||
162931795|NCT00845026|588454379|FG001|Study Period IV|Entry Criteria Not Met|0|||
162931796|NCT00845026|588454378|FG000|Study Period IV|Subject is moving or has moved|0|||
162931797|NCT00845026|588454379|FG001|Study Period IV|Subject is moving or has moved|1|||
162931798|NCT00845026|588454378|FG000|Study Period IV|Scheduling conflict|1|||
162931799|NCT00845026|588454379|FG001|Study Period IV|Scheduling conflict|0|||
162931800|NCT01325532|588454380|FG000|Overall Study|Withdrawal by Subject|2|||
162931801|NCT01325532|588454381|FG001|Overall Study|Withdrawal by Subject|0|||
162931802|NCT00061945|588454388|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
162931803|NCT00061945|588454389|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
162931804|NCT00061945|588454388|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
162931805|NCT00061945|588454389|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
162931806|NCT00061945|588454388|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
162931807|NCT00061945|588454389|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
162931808|NCT00061945|588454388|FG000|Course IV: Alemtuzumab|Early exits|6|||
162931809|NCT00061945|588454389|FG001|Course IV: Alemtuzumab|Early exits|15|||
162931810|NCT03712228|588454390|FG000|Treatment Period 1|Lack of Efficacy|0|||
162931811|NCT03712228|588454391|FG001|Treatment Period 1|Lack of Efficacy|0|||
162931812|NCT03712228|588454392|FG002|Treatment Period 1|Lack of Efficacy|0|||
162931813|NCT03712228|588454393|FG003|Treatment Period 1|Lack of Efficacy|0|||
162931814|NCT03712228|588454394|FG004|Treatment Period 1|Lack of Efficacy|0|||
162931815|NCT03712228|588454395|FG005|Treatment Period 1|Lack of Efficacy|1|||
162931816|NCT03712228|588454390|FG000|Treatment Period 2|Pregnancy|0|||
162931817|NCT03712228|588454391|FG001|Treatment Period 2|Pregnancy|0|||
162931818|NCT03712228|588454392|FG002|Treatment Period 2|Pregnancy|0|||
162931819|NCT03712228|588454393|FG003|Treatment Period 2|Pregnancy|1|||
162931820|NCT03712228|588454394|FG004|Treatment Period 2|Pregnancy|0|||
162931821|NCT03712228|588454395|FG005|Treatment Period 2|Pregnancy|0|||
162931822|NCT03712228|588454390|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162931823|NCT03712228|588454391|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162931824|NCT03712228|588454392|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162931825|NCT03712228|588454393|FG003|Treatment Period 2|Withdrawal by Subject|1|||
162931826|NCT03712228|588454394|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162931827|NCT03712228|588454395|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162931828|NCT01964105|588454396|FG000|Overall Study|Lost to Follow-up|2|||
162931829|NCT01964105|588454397|FG001|Overall Study|Lost to Follow-up|13|||
162931830|NCT01964105|588454398|FG002|Overall Study|Lost to Follow-up|0|||
162931831|NCT01254045|588454401|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
162931832|NCT01254045|588454402|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931833|NCT01254045|588454403|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931834|NCT01254045|588454404|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931835|NCT01254045|588454405|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931836|NCT01254045|588454406|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
162931837|NCT00597207|588454407|FG000|Overall Study|Lost to Follow-up|5|||
162931838|NCT00597207|588454408|FG001|Overall Study|Lost to Follow-up|7|||
162931839|NCT00520351|588454409|FG000|First Intervention|Withdrawal by Subject|1|||
162931840|NCT00520351|588454410|FG001|First Intervention|Withdrawal by Subject|1|||
162931841|NCT01021137|588454413|FG000|Overall Study|Lost to Follow-up|9|||
162931842|NCT01021137|588454414|FG001|Overall Study|Lost to Follow-up|4|||
162931843|NCT01021137|588454415|FG002|Overall Study|Lost to Follow-up|2|||
162931844|NCT01021137|588454416|FG003|Overall Study|Lost to Follow-up|6|||
162931845|NCT01021137|588454413|FG000|Overall Study|Withdrawal by Subject|1|||
162931846|NCT01021137|588454414|FG001|Overall Study|Withdrawal by Subject|0|||
162931847|NCT01021137|588454415|FG002|Overall Study|Withdrawal by Subject|0|||
162931848|NCT01021137|588454416|FG003|Overall Study|Withdrawal by Subject|3|||
162931849|NCT00725725|588454417|FG000|Overall Study|Adverse Event|1|||
162931850|NCT00725725|588454418|FG001|Overall Study|Adverse Event|3|||
162931851|NCT00725725|588454419|FG002|Overall Study|Adverse Event|2|||
162931852|NCT00725725|588454417|FG000|Overall Study|Lost to Follow-up|2|||
162931853|NCT00725725|588454418|FG001|Overall Study|Lost to Follow-up|0|||
162931854|NCT00725725|588454419|FG002|Overall Study|Lost to Follow-up|2|||
162931855|NCT00725725|588454417|FG000|Overall Study|Withdrawal by Subject|1|||
162931856|NCT00725725|588454418|FG001|Overall Study|Withdrawal by Subject|0|||
162931857|NCT00725725|588454419|FG002|Overall Study|Withdrawal by Subject|1|||
162931858|NCT00725725|588454417|FG000|Overall Study|Protocol Violation|0|||
162931859|NCT00725725|588454418|FG001|Overall Study|Protocol Violation|1|||
162931860|NCT00725725|588454419|FG002|Overall Study|Protocol Violation|0|||
162931861|NCT04288115|588454421|FG000|Overall Study|Withdrawal by Subject|0|||
162931862|NCT04288115|588454422|FG001|Overall Study|Withdrawal by Subject|1|||
162931863|NCT04288115|588454421|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
162931864|NCT04288115|588454422|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
162931865|NCT00729365|588454423|FG000|Overall Study|Physician Decision|33|||
162931866|NCT00729365|588454424|FG001|Overall Study|Physician Decision|6|||
162931867|NCT00729365|588454425|FG002|Overall Study|Physician Decision|7|||
162931868|NCT04556838|588454426|FG000|Overall Study|Withdrawal by Subject|3|||
162931869|NCT04556838|588454427|FG001|Overall Study|Withdrawal by Subject|1|||
162931870|NCT04556838|588454428|FG002|Overall Study|Withdrawal by Subject|2|||
162931871|NCT04556838|588454426|FG000|Overall Study|Adverse Event|0|||
162931872|NCT04556838|588454427|FG001|Overall Study|Adverse Event|1|||
162931873|NCT04556838|588454428|FG002|Overall Study|Adverse Event|1|||
162931874|NCT04556838|588454426|FG000|Overall Study|Lost to Follow-up|0|||
162931875|NCT04556838|588454427|FG001|Overall Study|Lost to Follow-up|0|||
162931876|NCT04556838|588454428|FG002|Overall Study|Lost to Follow-up|2|||
162931877|NCT04556838|588454426|FG000|Overall Study|Subject travel|0|||
162931878|NCT04556838|588454427|FG001|Overall Study|Subject travel|1|||
162931879|NCT04556838|588454428|FG002|Overall Study|Subject travel|0|||
162931880|NCT04556838|588454426|FG000|Overall Study|Physician Decision|1|||
162931881|NCT04556838|588454427|FG001|Overall Study|Physician Decision|0|||
162931882|NCT04556838|588454428|FG002|Overall Study|Physician Decision|0|||
162931883|NCT00382291|588456426|FG000|Overall Study|Adverse Event|1|||
162931884|NCT00382291|588456427|FG001|Overall Study|Adverse Event|2|||
162931885|NCT00382291|588456428|FG002|Overall Study|Adverse Event|2|||
162931886|NCT00382291|588456426|FG000|Overall Study|Protocol Violation|1|||
163173351|NCT01551420|589349909|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
163173352|NCT01551420|589349910|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
162931887|NCT00382291|588456427|FG001|Overall Study|Protocol Violation|0|||
162931888|NCT00382291|588456428|FG002|Overall Study|Protocol Violation|0|||
162931889|NCT00382291|588456426|FG000|Overall Study|Temporary study suspension|2|||
162931890|NCT00382291|588456427|FG001|Overall Study|Temporary study suspension|2|||
162931891|NCT00382291|588456428|FG002|Overall Study|Temporary study suspension|5|||
162931892|NCT00382291|588456426|FG000|Overall Study|Withdrawal by Subject|0|||
162698442|NCT03881059|587605505|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
162931893|NCT00382291|588456427|FG001|Overall Study|Withdrawal by Subject|2|||
162931894|NCT00382291|588456428|FG002|Overall Study|Withdrawal by Subject|0|||
162931895|NCT00382291|588456426|FG000|Overall Study|Physician Decision|0|||
162931896|NCT00382291|588456427|FG001|Overall Study|Physician Decision|1|||
162824721|NCT03805750|588070322|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
162824722|NCT03805750|588070323|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
162824723|NCT02811549|588070324|FG000|Overall Study|Lost to Follow-up|1|||
162824724|NCT02811549|588070324|FG000|Overall Study|Withdrawal by Subject|3|||
162824725|NCT02811549|588070324|FG000|Overall Study|Subject screen failed|4|||
162824726|NCT02811549|588070324|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
162824727|NCT05293743|588070325|FG000|Overall Study|Withdrawal by Subject|1|||
162824728|NCT05293743|588070326|FG001|Overall Study|Withdrawal by Subject|0|||
162824729|NCT00493220|588070327|FG000|Third Intervention|Withdrawal by Subject|1|||
162824730|NCT00493220|588070328|FG001|Third Intervention|Withdrawal by Subject|0|||
162824731|NCT00493220|588070329|FG002|Third Intervention|Withdrawal by Subject|0|||
162824732|NCT00493220|588070330|FG003|Third Intervention|Withdrawal by Subject|0|||
162824733|NCT00493220|588070331|FG004|Third Intervention|Withdrawal by Subject|0|||
162824734|NCT00493220|588070332|FG005|Third Intervention|Withdrawal by Subject|0|||
162824735|NCT00310804|588070333|FG000|Overall Study|Lost to Follow-up|2|||
162824736|NCT00310804|588070334|FG001|Overall Study|Lost to Follow-up|0|||
162824737|NCT00310804|588070333|FG000|Overall Study|Withdrawal by Subject|3|||
162824738|NCT00310804|588070334|FG001|Overall Study|Withdrawal by Subject|0|||
162824739|NCT01889238|588070337|FG000|Overall Study|Death|1|||
162824740|NCT01889238|588070337|FG000|Overall Study|Withdrawal by Subject|1|||
162824741|NCT01889238|588070337|FG000|Overall Study|Adverse Event|6|||
162824742|NCT01889238|588070337|FG000|Overall Study|Disease Progression|104|||
162824743|NCT01889238|588070337|FG000|Overall Study|Other|6|||
162824744|NCT02844816|588070338|FG000|Overall Study|No protocol treatment received|5|||
162824745|NCT02844816|588070339|FG001|Overall Study|No protocol treatment received|1|||
162824746|NCT02844816|588070338|FG000|Overall Study|Ineligible|22|||
162824747|NCT02844816|588070339|FG001|Overall Study|Ineligible|15|||
162824748|NCT02844816|588070338|FG000|Overall Study|Participant refusal|5|||
162824749|NCT02844816|588070339|FG001|Overall Study|Participant refusal|5|||
162824750|NCT02844816|588070338|FG000|Overall Study|Adverse Event|5|||
162824751|NCT02844816|588070339|FG001|Overall Study|Adverse Event|4|||
162824752|NCT02844816|588070338|FG000|Overall Study|Death|0|||
162824753|NCT02844816|588070339|FG001|Overall Study|Death|1|||
162824754|NCT02844816|588070338|FG000|Overall Study|Disease progression/recurrence|50|||
162824755|NCT02844816|588070339|FG001|Overall Study|Disease progression/recurrence|24|||
162824756|NCT02844816|588070338|FG000|Overall Study|Physician Decision|1|||
162824757|NCT02844816|588070339|FG001|Overall Study|Physician Decision|1|||
162824758|NCT04360551|588072257|FG000|Overall Study|Withdrawal by Subject|1|||
162824759|NCT04360551|588072258|FG001|Overall Study|Withdrawal by Subject|0|||
162824760|NCT03496012|588072259|FG000|Overall Study|Withdrawal by Subject|2|||
162824761|NCT03496012|588072260|FG001|Overall Study|Withdrawal by Subject|0|||
162824762|NCT03496012|588072261|FG002|Overall Study|Withdrawal by Subject|2|||
162824763|NCT03496012|588072259|FG000|Overall Study|Adverse Event|0|||
162824764|NCT03496012|588072260|FG001|Overall Study|Adverse Event|0|||
162824765|NCT03496012|588072261|FG002|Overall Study|Adverse Event|1|||
162824766|NCT03496012|588072259|FG000|Overall Study|Reason Not Specified|2|||
162824767|NCT03496012|588072260|FG001|Overall Study|Reason Not Specified|0|||
162824768|NCT03496012|588072261|FG002|Overall Study|Reason Not Specified|1|||
162824769|NCT02232802|588072269|FG000|Period 1|Sponsor request|1|||
162824770|NCT02232802|588072270|FG001|Period 1|Sponsor request|0|||
162824771|NCT02232802|588072269|FG000|Period 1|Adverse Event|1|||
162824772|NCT02232802|588072270|FG001|Period 1|Adverse Event|1|||
162824773|NCT00885703|588072275|FG000|Overall Study|Death|9|||
162824774|NCT00885703|588072276|FG001|Overall Study|Death|7|||
162824775|NCT00885703|588072277|FG002|Overall Study|Death|8|||
162824776|NCT00885703|588072278|FG003|Overall Study|Death|7|||
162824777|NCT00885703|588072279|FG004|Overall Study|Death|7|||
162824778|NCT00885703|588072280|FG005|Overall Study|Death|8|||
162824779|NCT00885703|588072281|FG006|Overall Study|Death|4|||
162824780|NCT00885703|588072275|FG000|Overall Study|Lost to Follow-up|0|||
162824781|NCT00885703|588072276|FG001|Overall Study|Lost to Follow-up|0|||
162824782|NCT00885703|588072277|FG002|Overall Study|Lost to Follow-up|1|||
162824783|NCT00885703|588072278|FG003|Overall Study|Lost to Follow-up|0|||
162824784|NCT00885703|588072279|FG004|Overall Study|Lost to Follow-up|0|||
162824785|NCT00885703|588072280|FG005|Overall Study|Lost to Follow-up|1|||
162824786|NCT00885703|588072281|FG006|Overall Study|Lost to Follow-up|0|||
162824787|NCT00885703|588072275|FG000|Overall Study|Withdrawal by Subject|0|||
162824788|NCT00885703|588072276|FG001|Overall Study|Withdrawal by Subject|0|||
163173353|NCT01551420|589349909|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
163173354|NCT01551420|589349910|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
163173355|NCT01551420|589349909|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
163173356|NCT01551420|589349910|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
163173357|NCT01551420|589349909|FG000|Screened for Part B Eligibility|Declined participation|8|||
163173358|NCT01551420|589349910|FG001|Screened for Part B Eligibility|Declined participation|1|||
163173359|NCT01551420|589349909|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
163173360|NCT01551420|589349910|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
163173361|NCT01551420|589349909|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
163173362|NCT01551420|589349910|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
163173363|NCT01551420|589349909|FG000|Home Use (Part B)|Withdrawal by staff|0|||
163173364|NCT01551420|589349910|FG001|Home Use (Part B)|Withdrawal by staff|1|||
163173365|NCT03612856|589349911|FG000|Pre-dose Period|Physician Decision|0|||
163173366|NCT03612856|589349912|FG001|Pre-dose Period|Physician Decision|1|||
163173367|NCT03612856|589349913|FG002|Pre-dose Period|Physician Decision|1|||
163173368|NCT03612856|589349911|FG000|Pre-dose Period|Withdrawal by Subject|0|||
163173369|NCT03612856|589349912|FG001|Pre-dose Period|Withdrawal by Subject|1|||
163173370|NCT03612856|589349913|FG002|Pre-dose Period|Withdrawal by Subject|0|||
163173371|NCT01576159|589349914|FG000|Overall Study|Withdrawal by Subject|0|||
163173372|NCT01576159|589349915|FG001|Overall Study|Withdrawal by Subject|1|||
163173373|NCT01576159|589349916|FG002|Overall Study|Withdrawal by Subject|0|||
163173374|NCT01576159|589349917|FG003|Overall Study|Withdrawal by Subject|0|||
163173375|NCT01576159|589349914|FG000|Overall Study|Physician Decision|0|||
163173376|NCT01576159|589349915|FG001|Overall Study|Physician Decision|0|||
163173377|NCT01576159|589349916|FG002|Overall Study|Physician Decision|1|||
163173378|NCT01576159|589349917|FG003|Overall Study|Physician Decision|0|||
162824789|NCT00885703|588072277|FG002|Overall Study|Withdrawal by Subject|0|||
162824790|NCT00885703|588072278|FG003|Overall Study|Withdrawal by Subject|1|||
162824791|NCT00885703|588072279|FG004|Overall Study|Withdrawal by Subject|3|||
162824792|NCT00885703|588072280|FG005|Overall Study|Withdrawal by Subject|1|||
162824793|NCT00885703|588072281|FG006|Overall Study|Withdrawal by Subject|1|||
162824794|NCT00885703|588072275|FG000|Overall Study|Ineligible (no CM)|1|||
162824795|NCT00885703|588072276|FG001|Overall Study|Ineligible (no CM)|3|||
162824796|NCT00885703|588072277|FG002|Overall Study|Ineligible (no CM)|2|||
162824797|NCT00885703|588072278|FG003|Overall Study|Ineligible (no CM)|1|||
162824798|NCT00885703|588072279|FG004|Overall Study|Ineligible (no CM)|2|||
162824799|NCT00885703|588072280|FG005|Overall Study|Ineligible (no CM)|3|||
162824800|NCT00885703|588072281|FG006|Overall Study|Ineligible (no CM)|1|||
162824801|NCT00346073|588072282|FG000|Overall Study|Serious Adverse Event|2|||
162824802|NCT00346073|588072283|FG001|Overall Study|Serious Adverse Event|0|||
162824803|NCT00346073|588072282|FG000|Overall Study|Lost to Follow-up|39|||
162824804|NCT00346073|588072283|FG001|Overall Study|Lost to Follow-up|24|||
162824805|NCT01490450|588072286|FG000|Period 1|Lack of Efficacy|2|||
162824806|NCT01490450|588072287|FG001|Period 1|Lack of Efficacy|0|||
162824807|NCT01490450|588072288|FG002|Period 1|Lack of Efficacy|3|||
162824808|NCT01490450|588072289|FG003|Period 1|Lack of Efficacy|0|||
162824809|NCT01490450|588072286|FG000|Period 1|Adverse Event|0|||
162824810|NCT01490450|588072287|FG001|Period 1|Adverse Event|0|||
162824811|NCT01490450|588072288|FG002|Period 1|Adverse Event|0|||
162824812|NCT01490450|588072289|FG003|Period 1|Adverse Event|5|||
162824813|NCT01490450|588072286|FG000|Period 1|Request to discontinue treatment|1|||
162824814|NCT01490450|588072287|FG001|Period 1|Request to discontinue treatment|0|||
162824815|NCT01490450|588072288|FG002|Period 1|Request to discontinue treatment|0|||
162824816|NCT01490450|588072289|FG003|Period 1|Request to discontinue treatment|0|||
162824817|NCT01490450|588072286|FG000|Period 1|Withdrawal by Subject|0|||
162824818|NCT01490450|588072287|FG001|Period 1|Withdrawal by Subject|0|||
162824819|NCT01490450|588072288|FG002|Period 1|Withdrawal by Subject|0|||
162824820|NCT01490450|588072289|FG003|Period 1|Withdrawal by Subject|3|||
162824821|NCT01490450|588072286|FG000|Period 1|No longer met study criteria|0|||
162824822|NCT01490450|588072287|FG001|Period 1|No longer met study criteria|1|||
162824823|NCT01490450|588072288|FG002|Period 1|No longer met study criteria|1|||
162824824|NCT01490450|588072289|FG003|Period 1|No longer met study criteria|0|||
162824825|NCT01490450|588072286|FG000|Period 2|Lack of Efficacy|0|||
162824826|NCT01490450|588072287|FG001|Period 2|Lack of Efficacy|0|||
162824827|NCT01490450|588072288|FG002|Period 2|Lack of Efficacy|0|||
162824828|NCT01490450|588072289|FG003|Period 2|Lack of Efficacy|1|||
162824829|NCT01490450|588072286|FG000|Period 2|Adverse Event|1|||
162824830|NCT01490450|588072287|FG001|Period 2|Adverse Event|1|||
162824831|NCT01490450|588072288|FG002|Period 2|Adverse Event|0|||
163173379|NCT01576159|589349914|FG000|Overall Study|Lost to Follow-up|0|||
163173380|NCT01576159|589349915|FG001|Overall Study|Lost to Follow-up|0|||
163173381|NCT01576159|589349916|FG002|Overall Study|Lost to Follow-up|0|||
162824832|NCT01490450|588072289|FG003|Period 2|Adverse Event|1|||
162824833|NCT01490450|588072286|FG000|Period 2|Withdrawal by Subject|1|||
162824834|NCT01490450|588072287|FG001|Period 2|Withdrawal by Subject|0|||
162824835|NCT01490450|588072288|FG002|Period 2|Withdrawal by Subject|0|||
162824836|NCT01490450|588072289|FG003|Period 2|Withdrawal by Subject|0|||
162824837|NCT01490450|588072286|FG000|Period 2|Lost to Follow-up|0|||
162824838|NCT01490450|588072287|FG001|Period 2|Lost to Follow-up|0|||
162824839|NCT01490450|588072288|FG002|Period 2|Lost to Follow-up|0|||
162824840|NCT01490450|588072289|FG003|Period 2|Lost to Follow-up|2|||
162824841|NCT00404820|588072290|FG000|Overall Study|Adverse Event|4|||
162824842|NCT00404820|588072291|FG001|Overall Study|Adverse Event|16|||
162824843|NCT00404820|588072290|FG000|Overall Study|Withdrawal by Subject|5|||
162824844|NCT00404820|588072291|FG001|Overall Study|Withdrawal by Subject|3|||
162824845|NCT00404820|588072290|FG000|Overall Study|Lost to Follow-up|7|||
162824846|NCT00404820|588072291|FG001|Overall Study|Lost to Follow-up|3|||
162824847|NCT00404820|588072290|FG000|Overall Study|Administrative problems|2|||
162824848|NCT00404820|588072291|FG001|Overall Study|Administrative problems|0|||
162824849|NCT00404820|588072290|FG000|Overall Study|Death|1|||
162824850|NCT00404820|588072291|FG001|Overall Study|Death|0|||
162824851|NCT00404820|588072290|FG000|Overall Study|Other|0|||
162824852|NCT00404820|588072291|FG001|Overall Study|Other|2|||
162824853|NCT02053168|588072296|FG000|Overall Study|Withdrawal by Subject|1|||
162824854|NCT02053168|588072296|FG000|Overall Study|Physician Decision|1|||
162824855|NCT02053168|588072296|FG000|Overall Study|Lost to Follow-up|1|||
162824856|NCT02687542|588072299|FG000|Overall Study|Medication error without associated AEs|0|||
162824857|NCT02687542|588072300|FG001|Overall Study|Medication error without associated AEs|0|||
162824858|NCT02687542|588072301|FG002|Overall Study|Medication error without associated AEs|0|||
162824859|NCT02687542|588072302|FG003|Overall Study|Medication error without associated AEs|0|||
162824860|NCT02687542|588072303|FG004|Overall Study|Medication error without associated AEs|1|||
162824861|NCT02687542|588072299|FG000|Overall Study|Lost to Follow-up|0|||
162824862|NCT02687542|588072300|FG001|Overall Study|Lost to Follow-up|0|||
162824863|NCT02687542|588072301|FG002|Overall Study|Lost to Follow-up|0|||
162824864|NCT02687542|588072302|FG003|Overall Study|Lost to Follow-up|0|||
162824865|NCT02687542|588072303|FG004|Overall Study|Lost to Follow-up|1|||
162824866|NCT02687542|588072299|FG000|Overall Study|Protocol Violation|0|||
162824867|NCT02687542|588072300|FG001|Overall Study|Protocol Violation|1|||
162824868|NCT02687542|588072301|FG002|Overall Study|Protocol Violation|0|||
162824869|NCT02687542|588072302|FG003|Overall Study|Protocol Violation|0|||
162824870|NCT02687542|588072303|FG004|Overall Study|Protocol Violation|0|||
162824871|NCT02687542|588072299|FG000|Overall Study|Other|5|||
162824872|NCT02687542|588072300|FG001|Overall Study|Other|9|||
162824873|NCT02687542|588072301|FG002|Overall Study|Other|10|||
162824874|NCT02687542|588072302|FG003|Overall Study|Other|6|||
162824875|NCT02687542|588072303|FG004|Overall Study|Other|5|||
162824876|NCT02687542|588072299|FG000|Overall Study|Adverse Event|3|||
162824877|NCT02687542|588072300|FG001|Overall Study|Adverse Event|1|||
162824878|NCT02687542|588072301|FG002|Overall Study|Adverse Event|3|||
162824879|NCT02687542|588072302|FG003|Overall Study|Adverse Event|2|||
162824880|NCT02687542|588072303|FG004|Overall Study|Adverse Event|9|||
162824881|NCT02687542|588072299|FG000|Overall Study|Withdrawal by Subject|0|||
162824882|NCT02687542|588072300|FG001|Overall Study|Withdrawal by Subject|1|||
162824883|NCT02687542|588072301|FG002|Overall Study|Withdrawal by Subject|1|||
162824884|NCT02687542|588072302|FG003|Overall Study|Withdrawal by Subject|2|||
162824885|NCT02687542|588072303|FG004|Overall Study|Withdrawal by Subject|4|||
162824886|NCT00636675|588072305|FG000|Overall Study|Lost to Follow-up|121|||
162824887|NCT00636675|588072306|FG001|Overall Study|Lost to Follow-up|31|||
162824888|NCT00636675|588072305|FG000|Overall Study|Withdrawal by Subject|19|||
162824889|NCT00636675|588072306|FG001|Overall Study|Withdrawal by Subject|10|||
162824890|NCT00176605|588072308|FG000|Overall Study|Withdrawal by Subject|2|||
162824891|NCT03785925|588072309|FG000|Overall Study|Withdrawal by Subject|15|||
162824892|NCT03785925|588072309|FG000|Overall Study|Lost to Follow-up|1|||
162931897|NCT00382291|588456428|FG002|Overall Study|Physician Decision|0|||
162824893|NCT01227187|588072310|FG000|Overall Study|Physician Decision|0|||
162824894|NCT01227187|588072311|FG001|Overall Study|Physician Decision|0|||
162824895|NCT01227187|588072312|FG002|Overall Study|Physician Decision|0|||
162824896|NCT01227187|588072313|FG003|Overall Study|Physician Decision|1|||
162931898|NCT00382291|588456426|FG000|Overall Study|Lack of Efficacy|0|||
162931899|NCT00382291|588456427|FG001|Overall Study|Lack of Efficacy|0|||
162824897|NCT01566773|588072315|FG000|Overall Study|Protocol specified criteria|4|||
162824898|NCT01566773|588072315|FG000|Overall Study|Protocol Violation|4|||
162824899|NCT01566773|588072315|FG000|Overall Study|Withdrawal by Subject|9|||
162824900|NCT01566773|588072315|FG000|Overall Study|Administrative reason|1|||
162824901|NCT01566773|588072315|FG000|Overall Study|Adverse Event|10|||
162931900|NCT00382291|588456428|FG002|Overall Study|Lack of Efficacy|1|||
162824902|NCT01566773|588072315|FG000|Overall Study|Physician Decision|2|||
162824903|NCT00833053|588072316|FG000|Overall Study|Adverse Event|4|||
162931901|NCT01326702|588456429|FG000|Overall Study|Other|1|||
162824904|NCT00833053|588072317|FG001|Overall Study|Adverse Event|0|||
162824905|NCT00833053|588072316|FG000|Overall Study|Treatment Failure|3|||
162824906|NCT00833053|588072317|FG001|Overall Study|Treatment Failure|1|||
162824907|NCT00833053|588072316|FG000|Overall Study|Withdrawal by Subject|0|||
162824908|NCT00833053|588072317|FG001|Overall Study|Withdrawal by Subject|1|||
162824909|NCT00833053|588072316|FG000|Overall Study|Protocol Violation|2|||
162824910|NCT00833053|588072317|FG001|Overall Study|Protocol Violation|1|||
162824911|NCT02187471|588072318|FG000|Overall Study|Protocol Violation|4|||
162824912|NCT02187471|588072319|FG001|Overall Study|Protocol Violation|5|||
162824913|NCT02187471|588072320|FG002|Overall Study|Protocol Violation|4|||
162824914|NCT02187471|588072321|FG003|Overall Study|Protocol Violation|4|||
162824915|NCT02187471|588072318|FG000|Overall Study|Missing|0|||
162824916|NCT02187471|588072319|FG001|Overall Study|Missing|0|||
162824917|NCT02187471|588072320|FG002|Overall Study|Missing|0|||
162824918|NCT02187471|588072321|FG003|Overall Study|Missing|1|||
162824919|NCT02187471|588072318|FG000|Overall Study|Lack of Efficacy|18|||
162824920|NCT02187471|588072319|FG001|Overall Study|Lack of Efficacy|9|||
162824921|NCT02187471|588072320|FG002|Overall Study|Lack of Efficacy|13|||
162824922|NCT02187471|588072321|FG003|Overall Study|Lack of Efficacy|11|||
162824923|NCT02187471|588072318|FG000|Overall Study|Adverse Event|24|||
162824924|NCT02187471|588072319|FG001|Overall Study|Adverse Event|34|||
162824925|NCT02187471|588072320|FG002|Overall Study|Adverse Event|44|||
162824926|NCT02187471|588072321|FG003|Overall Study|Adverse Event|36|||
162824927|NCT02187471|588072318|FG000|Overall Study|Withdrawal by Subject|23|||
162824928|NCT02187471|588072319|FG001|Overall Study|Withdrawal by Subject|29|||
162824929|NCT02187471|588072320|FG002|Overall Study|Withdrawal by Subject|22|||
162824930|NCT02187471|588072321|FG003|Overall Study|Withdrawal by Subject|24|||
162824931|NCT02187471|588072318|FG000|Overall Study|Other|7|||
162824932|NCT02187471|588072319|FG001|Overall Study|Other|5|||
162824933|NCT02187471|588072320|FG002|Overall Study|Other|3|||
162824934|NCT02187471|588072321|FG003|Overall Study|Other|4|||
162824935|NCT00957528|588072324|FG000|Overall Study|Protocol Violation|0|||
162824936|NCT00957528|588072325|FG001|Overall Study|Protocol Violation|1|||
162824937|NCT00957528|588072326|FG002|Overall Study|Protocol Violation|0|||
162824938|NCT00957528|588072324|FG000|Overall Study|Withdrawal by Subject|0|||
162824939|NCT00957528|588072325|FG001|Overall Study|Withdrawal by Subject|0|||
162824940|NCT00957528|588072326|FG002|Overall Study|Withdrawal by Subject|1|||
162824941|NCT02318667|588072327|FG000|Overall Study|Adverse Event|1|||
162824942|NCT02318667|588072327|FG000|Overall Study|Lack of Efficacy|6|||
162824943|NCT02318667|588072327|FG000|Overall Study|Protocol Violation|2|||
162824944|NCT01101438|588072329|FG000|Overall Study|Withdrawal by Subject|8|||
162824945|NCT01101438|588072330|FG001|Overall Study|Withdrawal by Subject|9|||
162824946|NCT02289742|588072339|FG000|First Wear Period|Adverse event prior to treatment|0|||
162824947|NCT02289742|588072340|FG001|First Wear Period|Adverse event prior to treatment|1|||
162824948|NCT02289742|588072341|FG002|First Wear Period|Adverse event prior to treatment|0|||
163173382|NCT01576159|589349917|FG003|Overall Study|Lost to Follow-up|1|||
163173383|NCT01576159|589349914|FG000|Overall Study|Protocol Violation|1|||
163173384|NCT01576159|589349915|FG001|Overall Study|Protocol Violation|0|||
163173385|NCT01576159|589349916|FG002|Overall Study|Protocol Violation|0|||
163173386|NCT01576159|589349917|FG003|Overall Study|Protocol Violation|0|||
163173387|NCT04463069|589349918|FG000|Overall Study|Withdrawal by Subject|2|||
163173388|NCT04463069|589349919|FG001|Overall Study|Withdrawal by Subject|10|||
163173389|NCT04463069|589349918|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
163173390|NCT04463069|589349919|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
163173391|NCT00311584|589349920|FG000|Overall Study|Death|1|||
163173392|NCT00311584|589349921|FG001|Overall Study|Death|0|||
163173393|NCT00311584|589349920|FG000|Overall Study|Lack of Efficacy|12|||
163173394|NCT00311584|589349921|FG001|Overall Study|Lack of Efficacy|15|||
163173395|NCT00311584|589349920|FG000|Overall Study|Physician Decision|4|||
163173396|NCT00311584|589349921|FG001|Overall Study|Physician Decision|5|||
162824949|NCT02289742|588072342|FG003|First Wear Period|Adverse event prior to treatment|0|||
162824950|NCT02289742|588072339|FG000|First Wear Period|Adverse Event|0|||
163173397|NCT00311584|589349920|FG000|Overall Study|Withdrawal by Subject|1|||
162824951|NCT02289742|588072340|FG001|First Wear Period|Adverse Event|0|||
162824952|NCT02289742|588072341|FG002|First Wear Period|Adverse Event|1|||
162824953|NCT02289742|588072342|FG003|First Wear Period|Adverse Event|0|||
162824954|NCT02289742|588072339|FG000|First Wear Period|Other prior to treatment|0|||
163173398|NCT00311584|589349921|FG001|Overall Study|Withdrawal by Subject|1|||
163173399|NCT00311584|589349920|FG000|Overall Study|ineligible|2|||
163173400|NCT00311584|589349921|FG001|Overall Study|ineligible|2|||
163173401|NCT03073733|589349922|FG000|Overall Study|Lost to Follow-up|1|||
162931902|NCT01326702|588456430|FG001|Overall Study|Other|0|||
162931903|NCT01326702|588456431|FG002|Overall Study|Other|0|||
162931904|NCT01326702|588456432|FG003|Overall Study|Other|0|||
162931905|NCT01326702|588456433|FG004|Overall Study|Other|0|||
162931906|NCT01326702|588456434|FG005|Overall Study|Other|1|||
162931907|NCT01326702|588456435|FG006|Overall Study|Other|0|||
162931908|NCT01326702|588456429|FG000|Overall Study|progressive disease|1|||
162931909|NCT01326702|588456430|FG001|Overall Study|progressive disease|1|||
162931910|NCT01326702|588456431|FG002|Overall Study|progressive disease|3|||
162931911|NCT01326702|588456432|FG003|Overall Study|progressive disease|1|||
162931912|NCT01326702|588456433|FG004|Overall Study|progressive disease|3|||
162931913|NCT01326702|588456434|FG005|Overall Study|progressive disease|2|||
162931914|NCT01326702|588456435|FG006|Overall Study|progressive disease|3|||
162931915|NCT01326702|588456429|FG000|Overall Study|Death|0|||
162931916|NCT01326702|588456430|FG001|Overall Study|Death|1|||
162931917|NCT01326702|588456431|FG002|Overall Study|Death|0|||
162931918|NCT01326702|588456432|FG003|Overall Study|Death|0|||
162931919|NCT01326702|588456433|FG004|Overall Study|Death|0|||
162931920|NCT01326702|588456434|FG005|Overall Study|Death|0|||
162931921|NCT01326702|588456435|FG006|Overall Study|Death|0|||
162931922|NCT01326702|588456429|FG000|Overall Study|Adverse Event|0|||
162931923|NCT01326702|588456430|FG001|Overall Study|Adverse Event|0|||
162931924|NCT01326702|588456431|FG002|Overall Study|Adverse Event|1|||
162931925|NCT01326702|588456432|FG003|Overall Study|Adverse Event|1|||
162931926|NCT01326702|588456433|FG004|Overall Study|Adverse Event|0|||
162931927|NCT01326702|588456434|FG005|Overall Study|Adverse Event|3|||
162931928|NCT01326702|588456435|FG006|Overall Study|Adverse Event|1|||
162931929|NCT01326702|588456429|FG000|Overall Study|Withdrawal by Subject|0|||
162931930|NCT01326702|588456430|FG001|Overall Study|Withdrawal by Subject|0|||
163173402|NCT03073733|589349923|FG001|Overall Study|Lost to Follow-up|0|||
163173403|NCT03073733|589349924|FG002|Overall Study|Lost to Follow-up|0|||
163173404|NCT03073733|589349922|FG000|Overall Study|Physician Decision|0|||
163173405|NCT03073733|589349923|FG001|Overall Study|Physician Decision|1|||
163173406|NCT03073733|589349924|FG002|Overall Study|Physician Decision|0|||
163173407|NCT03073733|589349922|FG000|Overall Study|Withdrawal by Subject|0|||
163173408|NCT03073733|589349923|FG001|Overall Study|Withdrawal by Subject|0|||
163173409|NCT03073733|589349924|FG002|Overall Study|Withdrawal by Subject|1|||
163173410|NCT01454778|589349925|FG000|Overall Study|Lost to Follow-up|2|||
163173411|NCT01454778|589349925|FG000|Overall Study|Death|1|||
163173412|NCT01227629|589349926|FG000|Overall Study|Adverse Event|2|||
163173413|NCT01227629|589349927|FG001|Overall Study|Adverse Event|2|||
163173414|NCT01227629|589349928|FG002|Overall Study|Adverse Event|1|||
163173415|NCT01227629|589349929|FG003|Overall Study|Adverse Event|6|||
163173416|NCT01227629|589349930|FG004|Overall Study|Adverse Event|1|||
163173417|NCT01227629|589349931|FG005|Overall Study|Adverse Event|1|||
163173418|NCT01227629|589349932|FG006|Overall Study|Adverse Event|6|||
163173419|NCT01227629|589349933|FG007|Overall Study|Adverse Event|6|||
163173420|NCT01227629|589349934|FG008|Overall Study|Adverse Event|4|||
163173421|NCT01227629|589349935|FG009|Overall Study|Adverse Event|0|||
163173422|NCT01227629|589349926|FG000|Overall Study|Protocol Violation|0|||
163173423|NCT01227629|589349927|FG001|Overall Study|Protocol Violation|0|||
163173424|NCT01227629|589349928|FG002|Overall Study|Protocol Violation|0|||
163173425|NCT01227629|589349929|FG003|Overall Study|Protocol Violation|1|||
163173426|NCT01227629|589349930|FG004|Overall Study|Protocol Violation|0|||
163173427|NCT01227629|589349931|FG005|Overall Study|Protocol Violation|0|||
163173428|NCT01227629|589349932|FG006|Overall Study|Protocol Violation|0|||
163173429|NCT01227629|589349933|FG007|Overall Study|Protocol Violation|0|||
163173430|NCT01227629|589349934|FG008|Overall Study|Protocol Violation|0|||
163173431|NCT01227629|589349935|FG009|Overall Study|Protocol Violation|0|||
163173432|NCT01227629|589349926|FG000|Overall Study|Lost to Follow-up|0|||
162698443|NCT03881059|587605503|FG000|Treatment Period - Part B|Other reasons|4|||
162931931|NCT01326702|588456431|FG002|Overall Study|Withdrawal by Subject|1|||
162931932|NCT01326702|588456432|FG003|Overall Study|Withdrawal by Subject|0|||
162931933|NCT01326702|588456433|FG004|Overall Study|Withdrawal by Subject|1|||
162931934|NCT01326702|588456434|FG005|Overall Study|Withdrawal by Subject|1|||
162931935|NCT01326702|588456435|FG006|Overall Study|Withdrawal by Subject|3|||
162931936|NCT01326702|588456429|FG000|Overall Study|Not Treated|0|||
162931937|NCT01326702|588456430|FG001|Overall Study|Not Treated|0|||
162931938|NCT01326702|588456431|FG002|Overall Study|Not Treated|0|||
162931939|NCT01326702|588456432|FG003|Overall Study|Not Treated|1|||
162931940|NCT01326702|588456433|FG004|Overall Study|Not Treated|0|||
163173433|NCT01227629|589349927|FG001|Overall Study|Lost to Follow-up|0|||
163173434|NCT01227629|589349928|FG002|Overall Study|Lost to Follow-up|0|||
163173435|NCT01227629|589349929|FG003|Overall Study|Lost to Follow-up|0|||
163173436|NCT01227629|589349930|FG004|Overall Study|Lost to Follow-up|1|||
162931941|NCT01326702|588456434|FG005|Overall Study|Not Treated|1|||
163173437|NCT01227629|589349931|FG005|Overall Study|Lost to Follow-up|0|||
163173438|NCT01227629|589349932|FG006|Overall Study|Lost to Follow-up|0|||
163173439|NCT01227629|589349933|FG007|Overall Study|Lost to Follow-up|0|||
163173440|NCT01227629|589349934|FG008|Overall Study|Lost to Follow-up|0|||
163173441|NCT01227629|589349935|FG009|Overall Study|Lost to Follow-up|0|||
163173442|NCT01227629|589349926|FG000|Overall Study|Withdrawal by Subject|0|||
162931942|NCT01326702|588456435|FG006|Overall Study|Not Treated|0|||
162931943|NCT02266706|588456436|FG000|Overall Study|Withdrawal by Subject|0|||
162931944|NCT02266706|588456437|FG001|Overall Study|Withdrawal by Subject|1|||
162931945|NCT02266706|588456438|FG002|Overall Study|Withdrawal by Subject|1|||
162931946|NCT02266706|588456439|FG003|Overall Study|Withdrawal by Subject|0|||
162931947|NCT02266706|588456440|FG004|Overall Study|Withdrawal by Subject|0|||
162931948|NCT02266706|588456441|FG005|Overall Study|Withdrawal by Subject|1|||
162931949|NCT02266706|588456442|FG006|Overall Study|Withdrawal by Subject|0|||
162931950|NCT02266706|588456443|FG007|Overall Study|Withdrawal by Subject|0|||
162931951|NCT02266706|588456444|FG008|Overall Study|Withdrawal by Subject|0|||
162931952|NCT02266706|588456436|FG000|Overall Study|Screen failure|0|||
162931953|NCT02266706|588456437|FG001|Overall Study|Screen failure|0|||
162931954|NCT02266706|588456438|FG002|Overall Study|Screen failure|0|||
162931955|NCT02266706|588456439|FG003|Overall Study|Screen failure|0|||
162931956|NCT02266706|588456440|FG004|Overall Study|Screen failure|0|||
162931957|NCT02266706|588456441|FG005|Overall Study|Screen failure|1|||
162931958|NCT02266706|588456442|FG006|Overall Study|Screen failure|1|||
162931959|NCT02266706|588456443|FG007|Overall Study|Screen failure|0|||
162931960|NCT02266706|588456444|FG008|Overall Study|Screen failure|0|||
162931961|NCT02266706|588456436|FG000|Overall Study|Enrollment in another study|0|||
162931962|NCT02266706|588456437|FG001|Overall Study|Enrollment in another study|0|||
162931963|NCT02266706|588456438|FG002|Overall Study|Enrollment in another study|0|||
162931964|NCT02266706|588456439|FG003|Overall Study|Enrollment in another study|1|||
162931965|NCT02266706|588456440|FG004|Overall Study|Enrollment in another study|0|||
162931966|NCT02266706|588456441|FG005|Overall Study|Enrollment in another study|0|||
162931967|NCT02266706|588456442|FG006|Overall Study|Enrollment in another study|0|||
162931968|NCT02266706|588456443|FG007|Overall Study|Enrollment in another study|0|||
162931969|NCT02266706|588456444|FG008|Overall Study|Enrollment in another study|0|||
162931970|NCT02270983|588456446|FG000|Overall Study|Adverse Event|3|||
162931971|NCT02270983|588456447|FG001|Overall Study|Adverse Event|2|||
162931972|NCT02270983|588456448|FG002|Overall Study|Adverse Event|6|||
162931973|NCT02270983|588456446|FG000|Overall Study|Lack of Efficacy|2|||
162931974|NCT02270983|588456447|FG001|Overall Study|Lack of Efficacy|1|||
162931975|NCT02270983|588456448|FG002|Overall Study|Lack of Efficacy|1|||
162931976|NCT02270983|588456446|FG000|Overall Study|Withdrawal by Subject|1|||
162931977|NCT02270983|588456447|FG001|Overall Study|Withdrawal by Subject|0|||
162931978|NCT02270983|588456448|FG002|Overall Study|Withdrawal by Subject|2|||
162931979|NCT02270983|588456446|FG000|Overall Study|Lost to Follow-up|1|||
162931980|NCT02270983|588456447|FG001|Overall Study|Lost to Follow-up|1|||
162931981|NCT02270983|588456448|FG002|Overall Study|Lost to Follow-up|2|||
162931982|NCT02270983|588456446|FG000|Overall Study|Protocol Violation|1|||
162931983|NCT02270983|588456447|FG001|Overall Study|Protocol Violation|1|||
162931984|NCT02270983|588456448|FG002|Overall Study|Protocol Violation|1|||
162931985|NCT02270983|588456446|FG000|Overall Study|family emergency|0|||
162931986|NCT02270983|588456447|FG001|Overall Study|family emergency|1|||
162931987|NCT02270983|588456448|FG002|Overall Study|family emergency|0|||
162931988|NCT02270983|588456446|FG000|Overall Study|study procedure non-compliance|1|||
162931989|NCT02270983|588456447|FG001|Overall Study|study procedure non-compliance|0|||
162931990|NCT02270983|588456448|FG002|Overall Study|study procedure non-compliance|0|||
162931991|NCT02270983|588456446|FG000|Overall Study|moved away from study site|0|||
162931992|NCT02270983|588456447|FG001|Overall Study|moved away from study site|1|||
162931993|NCT02270983|588456448|FG002|Overall Study|moved away from study site|0|||
162931994|NCT01059071|588456450|FG000|Overall Study|Lack of Efficacy|1|||
162931995|NCT01059071|588456451|FG001|Overall Study|Lack of Efficacy|4|||
162931996|NCT01059071|588456452|FG002|Overall Study|Lack of Efficacy|2|||
162931997|NCT01059071|588456453|FG003|Overall Study|Lack of Efficacy|3|||
162931998|NCT01059071|588456450|FG000|Overall Study|Withdrawal by Subject|1|||
162931999|NCT01059071|588456451|FG001|Overall Study|Withdrawal by Subject|0|||
162932000|NCT01059071|588456452|FG002|Overall Study|Withdrawal by Subject|0|||
162932001|NCT01059071|588456453|FG003|Overall Study|Withdrawal by Subject|2|||
162932002|NCT01059071|588456450|FG000|Overall Study|Physician Decision|0|||
162932003|NCT01059071|588456451|FG001|Overall Study|Physician Decision|0|||
162932004|NCT01059071|588456452|FG002|Overall Study|Physician Decision|0|||
162932005|NCT01059071|588456453|FG003|Overall Study|Physician Decision|1|||
162932006|NCT02962882|588456454|FG000|Overall Study|Adverse Event|2|||
162932007|NCT02962882|588456454|FG000|Overall Study|Withdrawal by Subject|2|||
162932008|NCT02962882|588456454|FG000|Overall Study|Transfer from ICU|32|||
162932009|NCT04741503|588456455|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
162932010|NCT04741503|588456456|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
162932011|NCT04741503|588456457|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
162932012|NCT04741503|588456455|FG000|Initial Enrollment|Overquotas removed|0|||
162932013|NCT04741503|588456456|FG001|Initial Enrollment|Overquotas removed|0|||
162932014|NCT04741503|588456457|FG002|Initial Enrollment|Overquotas removed|186|||
162932015|NCT04741503|588456455|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
162932016|NCT04741503|588456456|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
162932017|NCT04741503|588456457|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
162932018|NCT02791659|588456465|FG000|Overall Study|Protocol Violation|0|||
162932019|NCT02791659|588456466|FG001|Overall Study|Protocol Violation|1|||
162932020|NCT00881959|588456467|FG000|Overall Study|Lost to Follow-up|2|||
162932021|NCT00881959|588456468|FG001|Overall Study|Lost to Follow-up|4|||
162932022|NCT03840811|588456469|FG000|Overall Study|Lost to Follow-up|0|||
162932023|NCT03840811|588456470|FG001|Overall Study|Lost to Follow-up|0|||
163173443|NCT01227629|589349927|FG001|Overall Study|Withdrawal by Subject|0|||
163173444|NCT01227629|589349928|FG002|Overall Study|Withdrawal by Subject|0|||
163173445|NCT01227629|589349929|FG003|Overall Study|Withdrawal by Subject|0|||
163173446|NCT01227629|589349930|FG004|Overall Study|Withdrawal by Subject|0|||
163173447|NCT01227629|589349931|FG005|Overall Study|Withdrawal by Subject|0|||
163173448|NCT01227629|589349932|FG006|Overall Study|Withdrawal by Subject|2|||
163173449|NCT01227629|589349933|FG007|Overall Study|Withdrawal by Subject|0|||
163173450|NCT01227629|589349934|FG008|Overall Study|Withdrawal by Subject|0|||
163173451|NCT01227629|589349935|FG009|Overall Study|Withdrawal by Subject|1|||
163173452|NCT01227629|589349926|FG000|Overall Study|Other|0|||
163173453|NCT01227629|589349927|FG001|Overall Study|Other|0|||
163173454|NCT01227629|589349928|FG002|Overall Study|Other|0|||
163173455|NCT01227629|589349929|FG003|Overall Study|Other|1|||
163173456|NCT01227629|589349930|FG004|Overall Study|Other|0|||
163173457|NCT01227629|589349931|FG005|Overall Study|Other|0|||
163173458|NCT01227629|589349932|FG006|Overall Study|Other|0|||
163173459|NCT01227629|589349933|FG007|Overall Study|Other|0|||
163173460|NCT01227629|589349934|FG008|Overall Study|Other|2|||
163173461|NCT01227629|589349935|FG009|Overall Study|Other|1|||
163173462|NCT02276027|589351549|FG000|Overall Study|Death|1|||
163173463|NCT02276027|589351550|FG001|Overall Study|Death|0|||
163173464|NCT02276027|589351551|FG002|Overall Study|Death|0|||
163173465|NCT02276027|589351552|FG003|Overall Study|Death|2|||
163173466|NCT02276027|589351549|FG000|Overall Study|Physician Decision|0|||
163173467|NCT02276027|589351550|FG001|Overall Study|Physician Decision|0|||
163173468|NCT02276027|589351551|FG002|Overall Study|Physician Decision|0|||
163173469|NCT02276027|589351552|FG003|Overall Study|Physician Decision|1|||
163173470|NCT02276027|589351549|FG000|Overall Study|Progressive disease|1|||
163173471|NCT02276027|589351550|FG001|Overall Study|Progressive disease|13|||
163173472|NCT02276027|589351551|FG002|Overall Study|Progressive disease|12|||
163173473|NCT02276027|589351552|FG003|Overall Study|Progressive disease|14|||
163173474|NCT02276027|589351549|FG000|Overall Study|Subject/guardian decision|0|||
163173475|NCT02276027|589351550|FG001|Overall Study|Subject/guardian decision|1|||
163173476|NCT02276027|589351551|FG002|Overall Study|Subject/guardian decision|0|||
163173477|NCT02276027|589351552|FG003|Overall Study|Subject/guardian decision|3|||
163173478|NCT02276027|589351549|FG000|Overall Study|Adverse Event|0|||
163173479|NCT02276027|589351550|FG001|Overall Study|Adverse Event|2|||
163173480|NCT02276027|589351551|FG002|Overall Study|Adverse Event|8|||
163173481|NCT02276027|589351552|FG003|Overall Study|Adverse Event|2|||
163173482|NCT02446171|589351553|FG000|Overall Study|Withdrawal by Subject|0|||
163173483|NCT02446171|589351554|FG001|Overall Study|Withdrawal by Subject|0|||
163173484|NCT02446171|589351555|FG002|Overall Study|Withdrawal by Subject|2|||
163173485|NCT02446171|589351556|FG003|Overall Study|Withdrawal by Subject|0|||
163173486|NCT01264081|589351557|FG000|Participants Screened|Screening failures|30|||
163173487|NCT01264081|589351557|FG000|Started Treatment|Withdrawal by Subject|1|||
163173488|NCT01264081|589351557|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
163173489|NCT02320903|589351560|FG000|Overall Study|Withdrawal by Subject|0|||
163173490|NCT02320903|589351561|FG001|Overall Study|Withdrawal by Subject|9|||
163173491|NCT02320903|589351562|FG002|Overall Study|Withdrawal by Subject|9|||
163173492|NCT02320903|589351560|FG000|Overall Study|Exited therapy; no longer eligible|8|||
163173493|NCT02320903|589351561|FG001|Overall Study|Exited therapy; no longer eligible|2|||
163173494|NCT02320903|589351562|FG002|Overall Study|Exited therapy; no longer eligible|2|||
163173495|NCT02320903|589351560|FG000|Overall Study|Lost to Follow-up|0|||
163173496|NCT02320903|589351561|FG001|Overall Study|Lost to Follow-up|5|||
163173497|NCT02320903|589351562|FG002|Overall Study|Lost to Follow-up|5|||
163173498|NCT00773383|589351563|FG000|Overall Study|Adverse Event|4|||
163173499|NCT00773383|589351563|FG000|Overall Study|Death|1|||
163173500|NCT00773383|589351563|FG000|Overall Study|Progression of Disease|23|||
163173501|NCT00773383|589351563|FG000|Overall Study|Other|2|||
163173502|NCT00773383|589351563|FG000|Overall Study|No study dose received|1|||
163173503|NCT01012219|589351566|FG000|Period 1|Withdrawal by Subject|1|||
163173504|NCT01012219|589351566|FG000|Period 2|Withdrawal by Subject|1|||
163173505|NCT03811093|589351569|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
163173506|NCT03811093|589351570|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
163173507|NCT03811093|589351569|FG000|Overall Study|Unable to measure body fat percentage|2|||
163173508|NCT03811093|589351570|FG001|Overall Study|Unable to measure body fat percentage|0|||
163173509|NCT00464490|589351574|FG000|Overall Study|Physician Decision|11|||
163173510|NCT00464490|589351575|FG001|Overall Study|Physician Decision|11|||
163173511|NCT03188042|589351578|FG000|Overall Study|Withdrawal by Subject|1|||
163173512|NCT03188042|589351579|FG001|Overall Study|Withdrawal by Subject|1|||
163173513|NCT01328366|589351583|FG000|Overall Study|Death|1|||
163173514|NCT01328366|589351583|FG000|Overall Study|Withdrawal by Subject|2|||
163173515|NCT01328366|589351583|FG000|Overall Study|Lost to Follow-up|7|||
162824955|NCT02289742|588072340|FG001|First Wear Period|Other prior to treatment|0|||
162824956|NCT02289742|588072341|FG002|First Wear Period|Other prior to treatment|0|||
162824957|NCT02289742|588072342|FG003|First Wear Period|Other prior to treatment|1|||
162824958|NCT02289742|588072339|FG000|Third Wear Period|Adverse Event|0|||
162824959|NCT02289742|588072340|FG001|Third Wear Period|Adverse Event|1|||
162824960|NCT02289742|588072341|FG002|Third Wear Period|Adverse Event|0|||
162824961|NCT02289742|588072342|FG003|Third Wear Period|Adverse Event|0|||
162824962|NCT02289742|588072339|FG000|Third Wear Period|Reason not given|0|||
162824963|NCT02289742|588072340|FG001|Third Wear Period|Reason not given|0|||
162824964|NCT02289742|588072341|FG002|Third Wear Period|Reason not given|0|||
162824965|NCT02289742|588072342|FG003|Third Wear Period|Reason not given|1|||
162824966|NCT00709111|588072343|FG000|Overall Study|Withdrawal by Subject|1|||
162824967|NCT00709111|588072343|FG000|Overall Study|Unable to attend clinic visits|1|||
162824968|NCT02865018|588072344|FG000|Overall Study|Withdrawal by Subject|1|||
162824969|NCT01735279|588072347|FG000|Overall Study|Lost to Follow-up|11|||
162824970|NCT01735279|588072348|FG001|Overall Study|Lost to Follow-up|8|||
162824971|NCT00806195|588072349|FG000|Overall Study|Death|6|||
162824972|NCT00806195|588072350|FG001|Overall Study|Death|0|||
162824973|NCT00806195|588072351|FG002|Overall Study|Death|1|||
162824974|NCT00806195|588072352|FG003|Overall Study|Death|0|||
162824975|NCT00806195|588072349|FG000|Overall Study|Adverse Event|25|||
162824976|NCT00806195|588072350|FG001|Overall Study|Adverse Event|5|||
162824977|NCT00806195|588072351|FG002|Overall Study|Adverse Event|11|||
162824978|NCT00806195|588072352|FG003|Overall Study|Adverse Event|2|||
162824979|NCT00806195|588072349|FG000|Overall Study|Withdrawal by Subject|119|||
162824980|NCT00806195|588072350|FG001|Overall Study|Withdrawal by Subject|31|||
162824981|NCT00806195|588072351|FG002|Overall Study|Withdrawal by Subject|76|||
162824982|NCT00806195|588072352|FG003|Overall Study|Withdrawal by Subject|35|||
162824983|NCT00806195|588072349|FG000|Overall Study|Lost to Follow-up|217|||
162824984|NCT00806195|588072350|FG001|Overall Study|Lost to Follow-up|66|||
162824985|NCT00806195|588072351|FG002|Overall Study|Lost to Follow-up|90|||
162824986|NCT00806195|588072352|FG003|Overall Study|Lost to Follow-up|34|||
162824987|NCT00806195|588072349|FG000|Overall Study|Inappropriate Enrollment|0|||
162824988|NCT00806195|588072350|FG001|Overall Study|Inappropriate Enrollment|1|||
162824989|NCT00806195|588072351|FG002|Overall Study|Inappropriate Enrollment|0|||
162824990|NCT00806195|588072352|FG003|Overall Study|Inappropriate Enrollment|0|||
162824991|NCT00806195|588072349|FG000|Overall Study|Administrative Reason|113|||
162824992|NCT00806195|588072350|FG001|Overall Study|Administrative Reason|35|||
162824993|NCT00806195|588072351|FG002|Overall Study|Administrative Reason|66|||
162824994|NCT00806195|588072352|FG003|Overall Study|Administrative Reason|26|||
162824995|NCT00806195|588072349|FG000|Overall Study|Protocol Violation|34|||
162824996|NCT00806195|588072350|FG001|Overall Study|Protocol Violation|24|||
162824997|NCT00806195|588072351|FG002|Overall Study|Protocol Violation|26|||
162824998|NCT00806195|588072352|FG003|Overall Study|Protocol Violation|9|||
162824999|NCT01519934|588072358|FG000|Overall Study|Lost to Follow-up|3|||
162825000|NCT00922480|588072359|FG000|Main Study|Protocol Violation|3|||
162825001|NCT00922480|588072360|FG001|Main Study|Protocol Violation|6|||
162825002|NCT00922480|588072359|FG000|Main Study|Adverse Event|6|||
162825003|NCT00922480|588072360|FG001|Main Study|Adverse Event|7|||
162825004|NCT00922480|588072359|FG000|Main Study|Lack of Efficacy|3|||
162825005|NCT00922480|588072360|FG001|Main Study|Lack of Efficacy|0|||
162825006|NCT00922480|588072359|FG000|Main Study|Withdrawal by Subject|20|||
162825007|NCT00922480|588072360|FG001|Main Study|Withdrawal by Subject|15|||
162825008|NCT00922480|588072359|FG000|Main Study|Lost to Follow-up|5|||
162825009|NCT00922480|588072360|FG001|Main Study|Lost to Follow-up|0|||
162825010|NCT00922480|588072359|FG000|Main Study|Physician Decision|0|||
162825011|NCT00922480|588072360|FG001|Main Study|Physician Decision|1|||
162825012|NCT00922480|588072359|FG000|Extension Study|Protocol Violation|3|||
162825013|NCT00922480|588072360|FG001|Extension Study|Protocol Violation|0|||
162825014|NCT00922480|588072359|FG000|Extension Study|Adverse Event|1|||
162825015|NCT00922480|588072360|FG001|Extension Study|Adverse Event|1|||
162825016|NCT00922480|588072359|FG000|Extension Study|Withdrawal by Subject|1|||
162825017|NCT00922480|588072360|FG001|Extension Study|Withdrawal by Subject|1|||
162825018|NCT00922480|588072359|FG000|Extension Study|Others|0|||
162825019|NCT00922480|588072360|FG001|Extension Study|Others|1|||
162825020|NCT02161575|588072363|FG000|Overall Study|Protocol Violation|8|||
162825021|NCT02161575|588072363|FG000|Overall Study|Lack of Efficacy|1|||
162825022|NCT02161575|588072363|FG000|Overall Study|Adverse Event|2|||
162825023|NCT00326209|588072368|FG000|Overall Study|Adverse Event|28|||
162825024|NCT00326209|588072368|FG000|Overall Study|Withdrawal by Subject|22|||
162825025|NCT00326209|588072368|FG000|Overall Study|Lack of Efficacy|31|||
162825026|NCT00326209|588072368|FG000|Overall Study|Lost to Follow-up|18|||
162825027|NCT00326209|588072368|FG000|Overall Study|Participant non-compliant|6|||
162825028|NCT00326209|588072368|FG000|Overall Study|Sponsor closed study|173|||
162825029|NCT00326209|588072368|FG000|Overall Study|Prohibited medication use|1|||
162932024|NCT03840811|588456471|FG002|Overall Study|Lost to Follow-up|1|||
162932025|NCT01904383|588456472|FG000|Overall Study|CRF not collected|117|||
162932026|NCT01904383|588456472|FG000|Overall Study|Reason not listed|147|||
162932027|NCT01904383|588456472|FG000|Overall Study|Lost to Follow-up|674|||
162932028|NCT01904383|588456472|FG000|Overall Study|Lack of Efficacy|370|||
162932029|NCT01904383|588456472|FG000|Overall Study|Improvement|141|||
162932030|NCT01904383|588456472|FG000|Overall Study|Adverse Event|271|||
162932031|NCT01904383|588456472|FG000|Overall Study|No patient visit after entry|54|||
162932032|NCT04313283|588456475|FG000|Overall Study|did not complete intervention|4|||
162932033|NCT00472446|588456476|FG000|Overall Study|Protocol Violation|0|||
162932034|NCT00472446|588456477|FG001|Overall Study|Protocol Violation|0|||
162932035|NCT00472446|588456478|FG002|Overall Study|Protocol Violation|0|||
162932036|NCT00472446|588456479|FG003|Overall Study|Protocol Violation|1|||
162932037|NCT00472446|588456476|FG000|Overall Study|Reintervention|0|||
162932038|NCT00472446|588456477|FG001|Overall Study|Reintervention|0|||
162932039|NCT00472446|588456478|FG002|Overall Study|Reintervention|1|||
162932040|NCT00472446|588456479|FG003|Overall Study|Reintervention|1|||
162932041|NCT00472446|588456476|FG000|Overall Study|Questionnaires not returned|5|||
162932042|NCT00472446|588456477|FG001|Overall Study|Questionnaires not returned|6|||
162932043|NCT00472446|588456478|FG002|Overall Study|Questionnaires not returned|6|||
162932044|NCT00472446|588456479|FG003|Overall Study|Questionnaires not returned|4|||
162932045|NCT03211156|588456480|FG000|Overall Study|Withdrawal by Subject|0|||
162932046|NCT03211156|588456481|FG001|Overall Study|Withdrawal by Subject|2|||
162932047|NCT03211156|588456480|FG000|Overall Study|Lost to Follow-up|1|||
162932048|NCT03211156|588456481|FG001|Overall Study|Lost to Follow-up|1|||
162932049|NCT03211156|588456480|FG000|Overall Study|Adverse Event|1|||
162932050|NCT03211156|588456481|FG001|Overall Study|Adverse Event|0|||
162932051|NCT04126733|588456495|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
162932052|NCT04126733|588456495|FG000|Treatment Period|Adverse Event|8|||
162932053|NCT04126733|588456495|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
162932054|NCT04126733|588456495|FG000|Treatment Period|Physician Decision|5|||
162932055|NCT04126733|588456495|FG000|Treatment Period|Death|1|||
162932056|NCT04126733|588456495|FG000|Treatment Period|Other Reasons|2|||
162932057|NCT04126733|588456495|FG000|Active Follow-up Period|Death|13|||
162932058|NCT04126733|588456495|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
162932059|NCT04126733|588456495|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
162932060|NCT04126733|588456495|FG000|Active Follow-up Period|Other Reasons|1|||
162932061|NCT04126733|588456495|FG000|Long-term Follow-up Period|Death|22|||
162932062|NCT04126733|588456495|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
162932063|NCT04126733|588456495|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
162932064|NCT00837577|588456496|FG000|Double-blind Period|Clinical Adverse Event|1|||
162932065|NCT00837577|588456497|FG001|Double-blind Period|Clinical Adverse Event|0|||
162932066|NCT00837577|588456496|FG000|Double-blind Period|Withdrawal by Subject|1|||
162932067|NCT00837577|588456497|FG001|Double-blind Period|Withdrawal by Subject|0|||
162932068|NCT00837577|588456496|FG000|Open-label Period|Clinical Adverse Event|2|||
163173516|NCT01009840|589351584|FG000|Overall Study|Lost to Follow-up|1|||
163173517|NCT01009840|589351584|FG000|Overall Study|Adverse Event|4|||
163173518|NCT01009840|589351584|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
163173519|NCT01009840|589351584|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
163173520|NCT01009840|589351584|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
163173521|NCT03739242|589351589|FG000|Overall Study|Withdrawal by Subject|1|||
163173522|NCT03739242|589351590|FG001|Overall Study|Withdrawal by Subject|1|||
163173523|NCT03739242|589351589|FG000|Overall Study|Protocol Violation|0|||
163173524|NCT03739242|589351590|FG001|Overall Study|Protocol Violation|1|||
163173525|NCT01122394|589351591|FG000|Overall Study|Withdrawal by Subject|1|||
163173526|NCT01122394|589351592|FG001|Overall Study|Withdrawal by Subject|1|||
163173527|NCT01122394|589351591|FG000|Overall Study|Lost to Follow-up|2|||
163173528|NCT01122394|589351592|FG001|Overall Study|Lost to Follow-up|2|||
163173529|NCT01122394|589351591|FG000|Overall Study|Adverse Event|0|||
163173530|NCT01122394|589351592|FG001|Overall Study|Adverse Event|1|||
163173531|NCT00039871|589351593|FG000|Overall Study|Adverse Event|165|||
163173532|NCT00039871|589351593|FG000|Overall Study|Lost to Follow-up|18|||
163173533|NCT00039871|589351593|FG000|Overall Study|Protocol Violation|24|||
163173534|NCT00039871|589351593|FG000|Overall Study|Withdrawal by Subject|97|||
163173535|NCT00039871|589351593|FG000|Overall Study|Did not meet eligibility criteria|11|||
163173536|NCT00039871|589351593|FG000|Overall Study|Administrative|1|||
163173537|NCT00039871|589351593|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
163173538|NCT00039871|589351593|FG000|Overall Study|Never entered follow-up|7|||
163173539|NCT02446743|589351594|FG000|Overall Study|Withdrawal by Subject|1|||
163173540|NCT02446743|589351595|FG001|Overall Study|Withdrawal by Subject|1|||
163173541|NCT02446743|589351594|FG000|Overall Study|Lost to Follow-up|1|||
163173542|NCT02446743|589351595|FG001|Overall Study|Lost to Follow-up|0|||
163173543|NCT02446743|589351594|FG000|Overall Study|Adverse Event|1|||
163173544|NCT02446743|589351595|FG001|Overall Study|Adverse Event|1|||
163173545|NCT02446743|589351594|FG000|Overall Study|Other|2|||
163173546|NCT02446743|589351595|FG001|Overall Study|Other|3|||
163173547|NCT03086967|589351596|FG000|Overall Study|Screen Failure|2|||
163173548|NCT03086967|589351597|FG001|Overall Study|Screen Failure|2|||
163173549|NCT02230527|589351601|FG000|Overall Study|Withdrawal by Subject|1|||
163173550|NCT02230527|589351602|FG001|Overall Study|Withdrawal by Subject|1|||
163173551|NCT02230527|589351601|FG000|Overall Study|Death|1|||
163173552|NCT02230527|589351602|FG001|Overall Study|Death|0|||
162932069|NCT00837577|588456497|FG001|Open-label Period|Clinical Adverse Event|2|||
162932070|NCT00837577|588456496|FG000|Open-label Period|Laboratory Adverse Event|0|||
162932071|NCT00837577|588456497|FG001|Open-label Period|Laboratory Adverse Event|1|||
162932072|NCT00837577|588456496|FG000|Open-label Period|Lack of Efficacy|4|||
162932073|NCT00837577|588456497|FG001|Open-label Period|Lack of Efficacy|3|||
162932074|NCT00837577|588456496|FG000|Open-label Period|Withdrawal by Subject|1|||
162932075|NCT00837577|588456497|FG001|Open-label Period|Withdrawal by Subject|2|||
162932076|NCT00837577|588456496|FG000|Open-label Period|Other Reason|1|||
162932077|NCT00837577|588456497|FG001|Open-label Period|Other Reason|1|||
162932078|NCT00971204|588456498|FG000|Overall Study|Did not meet all criteria-not treated|14|||
162932079|NCT00971204|588456498|FG000|Overall Study|Lost to Follow-up|10|||
162932080|NCT02624518|588456499|FG000|Overall Study|Physician Decision|1|||
162932081|NCT02729194|588456500|FG000|Overall Study|Withdrawal by Subject|3|||
162932082|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
162932083|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932084|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932085|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932086|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
162932087|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
162932088|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932089|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932090|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932091|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
162932092|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
162932093|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932094|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932095|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932096|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
162932097|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
162932098|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932099|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932100|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932101|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
162932102|NCT00272961|588456501|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
162932103|NCT00272961|588456502|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932104|NCT00272961|588456503|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932105|NCT00272961|588456504|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932106|NCT00272961|588456505|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
162932107|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
162932108|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
162932109|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
162932110|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
163173553|NCT02230527|589351601|FG000|Overall Study|Lost to Follow-up|2|||
163173554|NCT02230527|589351602|FG001|Overall Study|Lost to Follow-up|1|||
163173555|NCT02230527|589351601|FG000|Overall Study|Other|1|||
163173556|NCT02230527|589351602|FG001|Overall Study|Other|0|||
163173557|NCT01752036|589351603|FG000|Overall Study|Death|2|||
163173558|NCT01011478|589351604|FG000|Overall Study|No follow up data|12|||
163173559|NCT01011478|589351605|FG001|Overall Study|No follow up data|7|||
163173560|NCT04418661|589351608|FG000|Overall Study|Adverse Event|0|||
163173561|NCT04418661|589351609|FG001|Overall Study|Adverse Event|1|||
163173562|NCT04418661|589351610|FG002|Overall Study|Adverse Event|5|||
163173563|NCT04418661|589351611|FG003|Overall Study|Adverse Event|3|||
163173564|NCT04418661|589351612|FG004|Overall Study|Adverse Event|0|||
163173565|NCT04418661|589351613|FG005|Overall Study|Adverse Event|2|||
163173566|NCT04418661|589351608|FG000|Overall Study|Progressive disease|4|||
163173567|NCT04418661|589351609|FG001|Overall Study|Progressive disease|11|||
163173568|NCT04418661|589351610|FG002|Overall Study|Progressive disease|6|||
163173569|NCT04418661|589351611|FG003|Overall Study|Progressive disease|11|||
163173570|NCT04418661|589351612|FG004|Overall Study|Progressive disease|1|||
163173571|NCT04418661|589351613|FG005|Overall Study|Progressive disease|12|||
163173572|NCT04418661|589351608|FG000|Overall Study|Withdrawal by Subject|0|||
163173573|NCT04418661|589351609|FG001|Overall Study|Withdrawal by Subject|1|||
163173574|NCT04418661|589351610|FG002|Overall Study|Withdrawal by Subject|0|||
163173575|NCT04418661|589351611|FG003|Overall Study|Withdrawal by Subject|1|||
163173576|NCT04418661|589351612|FG004|Overall Study|Withdrawal by Subject|0|||
163173577|NCT04418661|589351613|FG005|Overall Study|Withdrawal by Subject|0|||
163173578|NCT04418661|589351608|FG000|Overall Study|Other|0|||
163173579|NCT04418661|589351609|FG001|Overall Study|Other|0|||
163173580|NCT04418661|589351610|FG002|Overall Study|Other|1|||
163173581|NCT04418661|589351611|FG003|Overall Study|Other|3|||
163173582|NCT04418661|589351612|FG004|Overall Study|Other|0|||
163173583|NCT04418661|589351613|FG005|Overall Study|Other|1|||
163173584|NCT03337490|589351614|FG000|Overall Study|Withdrawal by Subject|1|||
163173585|NCT03337490|589351615|FG001|Overall Study|Withdrawal by Subject|0|||
163173586|NCT03337490|589351616|FG002|Overall Study|Withdrawal by Subject|0|||
163173587|NCT03337490|589351614|FG000|Overall Study|Lack of Efficacy|10|||
163173588|NCT03337490|589351615|FG001|Overall Study|Lack of Efficacy|12|||
163173589|NCT03337490|589351616|FG002|Overall Study|Lack of Efficacy|35|||
163173590|NCT03337490|589351614|FG000|Overall Study|Physician Decision|0|||
163173591|NCT03337490|589351615|FG001|Overall Study|Physician Decision|1|||
163173592|NCT03337490|589351616|FG002|Overall Study|Physician Decision|0|||
163173593|NCT03337490|589351614|FG000|Overall Study|Lost to Follow-up|0|||
163173594|NCT03337490|589351615|FG001|Overall Study|Lost to Follow-up|1|||
163173595|NCT03337490|589351616|FG002|Overall Study|Lost to Follow-up|0|||
163173596|NCT00917644|589351617|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
163173597|NCT00917644|589351618|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
163173598|NCT00917644|589351617|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
163173599|NCT00917644|589351618|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
163173600|NCT00917644|589351617|FG000|Period 2: Second Intervention|family emergency|1|||
163173601|NCT00917644|589351618|FG001|Period 2: Second Intervention|family emergency|0|||
163173602|NCT02108262|589351629|FG000|Overall Study|Non-compliance|0|||
163173603|NCT02108262|589351630|FG001|Overall Study|Non-compliance|2|||
163173604|NCT02108262|589351631|FG002|Overall Study|Non-compliance|1|||
163173605|NCT02108262|589351632|FG003|Overall Study|Non-compliance|1|||
163173606|NCT02108262|589351629|FG000|Overall Study|Randomized by error/screen failure|0|||
163173607|NCT02108262|589351630|FG001|Overall Study|Randomized by error/screen failure|0|||
163173608|NCT02108262|589351631|FG002|Overall Study|Randomized by error/screen failure|1|||
163173609|NCT02108262|589351632|FG003|Overall Study|Randomized by error/screen failure|0|||
163173610|NCT02108262|589351629|FG000|Overall Study|Distance to center|0|||
163173611|NCT02108262|589351630|FG001|Overall Study|Distance to center|1|||
163173612|NCT02108262|589351631|FG002|Overall Study|Distance to center|1|||
163173613|NCT02108262|589351632|FG003|Overall Study|Distance to center|0|||
163173614|NCT02108262|589351629|FG000|Overall Study|Adverse Event|0|||
163173615|NCT02108262|589351630|FG001|Overall Study|Adverse Event|11|||
163173616|NCT02108262|589351631|FG002|Overall Study|Adverse Event|6|||
163173617|NCT02108262|589351632|FG003|Overall Study|Adverse Event|12|||
163173618|NCT02108262|589351629|FG000|Overall Study|Death|0|||
163173619|NCT02108262|589351630|FG001|Overall Study|Death|2|||
163173620|NCT02108262|589351631|FG002|Overall Study|Death|2|||
163173621|NCT02108262|589351632|FG003|Overall Study|Death|1|||
163173622|NCT02108262|589351629|FG000|Overall Study|Lost to Follow-up|0|||
163173623|NCT02108262|589351630|FG001|Overall Study|Lost to Follow-up|0|||
163173624|NCT02108262|589351631|FG002|Overall Study|Lost to Follow-up|1|||
163173625|NCT02108262|589351632|FG003|Overall Study|Lost to Follow-up|0|||
162698444|NCT03881059|587605504|FG001|Treatment Period - Part B|Other reasons|3|||
163173626|NCT02108262|589351629|FG000|Overall Study|Physician Decision|0|||
163173627|NCT02108262|589351630|FG001|Overall Study|Physician Decision|0|||
163173628|NCT02108262|589351631|FG002|Overall Study|Physician Decision|2|||
163173629|NCT02108262|589351632|FG003|Overall Study|Physician Decision|0|||
163173630|NCT02108262|589351629|FG000|Overall Study|Withdrawal by Subject|0|||
163173631|NCT02108262|589351630|FG001|Overall Study|Withdrawal by Subject|7|||
163173632|NCT02108262|589351631|FG002|Overall Study|Withdrawal by Subject|3|||
163173633|NCT02108262|589351632|FG003|Overall Study|Withdrawal by Subject|4|||
163173634|NCT02108262|589351629|FG000|Overall Study|Due to key hepatic values|0|||
163173635|NCT02108262|589351630|FG001|Overall Study|Due to key hepatic values|1|||
163173636|NCT02108262|589351631|FG002|Overall Study|Due to key hepatic values|0|||
163173637|NCT02108262|589351632|FG003|Overall Study|Due to key hepatic values|0|||
163173638|NCT02108262|589351629|FG000|Overall Study|Unable to contact patient|0|||
163173639|NCT02108262|589351630|FG001|Overall Study|Unable to contact patient|3|||
163173640|NCT02108262|589351631|FG002|Overall Study|Unable to contact patient|1|||
163173641|NCT02108262|589351632|FG003|Overall Study|Unable to contact patient|2|||
163173642|NCT02108262|589351629|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
163173643|NCT02108262|589351630|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
162825030|NCT00326209|588072368|FG000|Overall Study|Violation of entry criteria|1|||
162825031|NCT00326209|588072368|FG000|Overall Study|Withdrawn in error|1|||
162825032|NCT00326209|588072368|FG000|Overall Study|Pregnancy|1|||
162825033|NCT02138617|588072369|FG000|Overall Study|Death|1|||
162825034|NCT02138617|588072370|FG001|Overall Study|Death|2|||
162825035|NCT02138617|588072371|FG002|Overall Study|Death|2|||
162825036|NCT02138617|588072369|FG000|Overall Study|Adverse Event|8|||
162825037|NCT02138617|588072370|FG001|Overall Study|Adverse Event|5|||
162825038|NCT02138617|588072371|FG002|Overall Study|Adverse Event|2|||
162825039|NCT02138617|588072369|FG000|Overall Study|Disease Progression|20|||
162825040|NCT02138617|588072370|FG001|Overall Study|Disease Progression|13|||
162825041|NCT02138617|588072371|FG002|Overall Study|Disease Progression|4|||
162825042|NCT02138617|588072369|FG000|Overall Study|Withdrawal by Subject|7|||
162825043|NCT02138617|588072370|FG001|Overall Study|Withdrawal by Subject|10|||
162825044|NCT02138617|588072371|FG002|Overall Study|Withdrawal by Subject|2|||
162825045|NCT02138617|588072369|FG000|Overall Study|other complicating disease|0|||
162825046|NCT02138617|588072370|FG001|Overall Study|other complicating disease|2|||
162825047|NCT02138617|588072371|FG002|Overall Study|other complicating disease|0|||
162825048|NCT02138617|588072369|FG000|Overall Study|Protocol Violation|1|||
162825049|NCT02138617|588072370|FG001|Overall Study|Protocol Violation|0|||
162825050|NCT02138617|588072371|FG002|Overall Study|Protocol Violation|0|||
162825051|NCT02138617|588072369|FG000|Overall Study|Physician Decision|7|||
162825052|NCT02138617|588072370|FG001|Overall Study|Physician Decision|6|||
162825053|NCT02138617|588072371|FG002|Overall Study|Physician Decision|0|||
162825054|NCT02138617|588072369|FG000|Overall Study|financial reason|0|||
162825055|NCT02138617|588072370|FG001|Overall Study|financial reason|1|||
162825056|NCT02138617|588072371|FG002|Overall Study|financial reason|0|||
162825057|NCT02138617|588072369|FG000|Overall Study|other therapy|3|||
162825058|NCT02138617|588072370|FG001|Overall Study|other therapy|4|||
162825059|NCT02138617|588072371|FG002|Overall Study|other therapy|0|||
162825060|NCT01671111|588072373|FG000|Overall Study|Adverse Event|2|||
162825061|NCT01671111|588072373|FG000|Overall Study|Lack of Efficacy|1|||
162825062|NCT01671111|588072373|FG000|Overall Study|Withdrawal by Subject|2|||
162825063|NCT01671111|588072373|FG000|Overall Study|Physician Decision|1|||
162825064|NCT01671111|588072373|FG000|Overall Study|Other|24|||
162825065|NCT00113074|588072383|FG000|Overall Study|Lost to Follow-up|10|||
162825066|NCT00113074|588072384|FG001|Overall Study|Lost to Follow-up|10|||
162825067|NCT00113074|588072385|FG002|Overall Study|Lost to Follow-up|14|||
162825068|NCT03680911|588072386|FG000|At Home Treatment|Study Termination|3|||
162825069|NCT03680911|588072387|FG001|At Home Treatment|Study Termination|0|||
162825070|NCT03680911|588072386|FG000|At Home Treatment|Lost to Follow-up|0|||
162825071|NCT03680911|588072387|FG001|At Home Treatment|Lost to Follow-up|1|||
162825072|NCT03680911|588072386|FG000|At Home Treatment|Withdrawal by Subject|0|||
162825073|NCT03680911|588072387|FG001|At Home Treatment|Withdrawal by Subject|2|||
162825074|NCT03680911|588072386|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
162825075|NCT03680911|588072387|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
162825076|NCT01009034|588072391|FG000|Overall Study|Lost to Follow-up|2|||
162825077|NCT01009034|588072391|FG000|Overall Study|Withdrawal by Subject|2|||
162825078|NCT00545064|588072392|FG000|Overall Study|Lost to Follow-up|3|||
162825079|NCT00545064|588072392|FG000|Overall Study|Withdrawal by Subject|2|||
162825080|NCT00545064|588072392|FG000|Overall Study|did not complete course of treatment|1|||
162825081|NCT00545064|588072392|FG000|Overall Study|cancel all appointments, no rebooking|1|||
162825082|NCT00545064|588072392|FG000|Overall Study|inclement weather|1|||
162825083|NCT05093322|588072393|FG000|Overall Study|Death|6|||
162825084|NCT05093322|588072394|FG001|Overall Study|Death|2|||
162825085|NCT05093322|588072393|FG000|Overall Study|Other|4|||
162825086|NCT05093322|588072394|FG001|Overall Study|Other|1|||
162825087|NCT00898443|588072395|FG000|Overall Study|Withdrawal by Subject|1|||
162825088|NCT00898443|588072396|FG001|Overall Study|Withdrawal by Subject|0|||
162825089|NCT03250832|588072398|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
162825090|NCT03250832|588072399|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
162825091|NCT03250832|588072400|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
162825092|NCT03250832|588072401|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
162825093|NCT03250832|588072402|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
162825094|NCT03250832|588072403|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
162825095|NCT03250832|588072404|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
162932111|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
162932112|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
162825096|NCT03250832|588072405|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
162825097|NCT03250832|588072406|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
162825098|NCT03250832|588072407|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
162825099|NCT03250832|588072408|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
162825100|NCT03250832|588072409|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
162825101|NCT03250832|588072398|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
162825102|NCT03250832|588072399|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
162932113|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932114|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
162932115|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932116|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
162932117|NCT00272961|588456501|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
162932118|NCT00272961|588456502|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
162932119|NCT00272961|588456503|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
162932120|NCT00272961|588456504|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
162932121|NCT00272961|588456505|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
162932122|NCT01507831|588456506|FG000|Overall Study|Randomized but not treated|0|||
162932123|NCT01507831|588456507|FG001|Overall Study|Randomized but not treated|3|||
162932124|NCT01507831|588456506|FG000|Overall Study|Adverse Event|48|||
162932125|NCT01507831|588456507|FG001|Overall Study|Adverse Event|113|||
162932126|NCT01507831|588456506|FG000|Overall Study|Death|6|||
162932127|NCT01507831|588456507|FG001|Overall Study|Death|2|||
162932128|NCT01507831|588456506|FG000|Overall Study|Poor compliance to protocol|38|||
162932129|NCT01507831|588456507|FG001|Overall Study|Poor compliance to protocol|60|||
162932130|NCT01507831|588456506|FG000|Overall Study|Physician Decision|0|||
162932131|NCT01507831|588456507|FG001|Overall Study|Physician Decision|4|||
162932132|NCT01507831|588456506|FG000|Overall Study|Participant moved|5|||
162932133|NCT01507831|588456507|FG001|Overall Study|Participant moved|19|||
162932134|NCT01507831|588456506|FG000|Overall Study|Consent withdrawn by participant|34|||
162932135|NCT01507831|588456507|FG001|Overall Study|Consent withdrawn by participant|72|||
162932136|NCT01507831|588456506|FG000|Overall Study|Related to study drug administration|5|||
162932137|NCT01507831|588456507|FG001|Overall Study|Related to study drug administration|14|||
162932138|NCT01507831|588456506|FG000|Overall Study|Last visit outside protocol visit window|51|||
162932139|NCT01507831|588456507|FG001|Overall Study|Last visit outside protocol visit window|143|||
162932140|NCT01507831|588456506|FG000|Overall Study|Selection criteria finally not met|0|||
162932141|NCT01507831|588456507|FG001|Overall Study|Selection criteria finally not met|1|||
162932142|NCT01507831|588456506|FG000|Overall Study|Site closure|0|||
162932143|NCT01507831|588456507|FG001|Overall Study|Site closure|3|||
162932144|NCT01507831|588456506|FG000|Overall Study|Potential lost to follow-up|3|||
162932145|NCT01507831|588456507|FG001|Overall Study|Potential lost to follow-up|0|||
162932146|NCT01507831|588456506|FG000|Overall Study|Other|3|||
162932147|NCT01507831|588456507|FG001|Overall Study|Other|6|||
162932148|NCT03652961|588456508|FG000|Overall Study|Lost to Follow-up|3|||
162932149|NCT03652961|588456508|FG000|Overall Study|Screen Failure|1|||
162932150|NCT01280981|588456511|FG000|Overall Study|Withdrawal by Subject|11|||
162932151|NCT01280981|588456511|FG000|Overall Study|Protocol Violation|2|||
162932152|NCT01280981|588456511|FG000|Overall Study|Lack of Efficacy|13|||
162932153|NCT01280981|588456511|FG000|Overall Study|Lost to Follow-up|3|||
162932154|NCT01280981|588456511|FG000|Overall Study|Adverse Event|6|||
162932155|NCT01280981|588456511|FG000|Overall Study|Irregular or discontinued menses|3|||
162932156|NCT01280981|588456511|FG000|Overall Study|Failed to return|45|||
162932157|NCT01280981|588456511|FG000|Overall Study|Non-compliance with protocol|3|||
162932158|NCT01280981|588456511|FG000|Overall Study|Withdrawal of consent|3|||
162932159|NCT01280981|588456511|FG000|Overall Study|Elective surgery|2|||
162932160|NCT01280981|588456511|FG000|Overall Study|Study site closure|1|||
162932161|NCT01610167|588456514|FG000|Overall Study|Scheduling conflict.|0|||
162932162|NCT01610167|588456515|FG001|Overall Study|Scheduling conflict.|0|||
162932163|NCT01610167|588456516|FG002|Overall Study|Scheduling conflict.|2|||
162932164|NCT03276962|588456521|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
162932165|NCT03276962|588456522|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
162932166|NCT03276962|588456523|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
162932167|NCT03276962|588456524|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
162932168|NCT03276962|588456525|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
162932169|NCT03276962|588456521|FG000|Overall Study|Protocol Deviation|2|||
162932170|NCT03276962|588456522|FG001|Overall Study|Protocol Deviation|0|||
162932171|NCT03276962|588456523|FG002|Overall Study|Protocol Deviation|1|||
162932172|NCT03276962|588456524|FG003|Overall Study|Protocol Deviation|2|||
162932173|NCT03276962|588456525|FG004|Overall Study|Protocol Deviation|1|||
162932174|NCT03276962|588456521|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
162932175|NCT03276962|588456522|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162932176|NCT03276962|588456523|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
162932177|NCT03276962|588456524|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162932178|NCT03276962|588456525|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
162932179|NCT03276962|588456521|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
162932180|NCT03276962|588456522|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
162932181|NCT03276962|588456523|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
162932182|NCT03276962|588456524|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
162932183|NCT03276962|588456525|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
162932184|NCT03276962|588456521|FG000|Overall Study|Lost to Follow-up|10|||
162932185|NCT03276962|588456522|FG001|Overall Study|Lost to Follow-up|10|||
162932186|NCT03276962|588456523|FG002|Overall Study|Lost to Follow-up|4|||
162932187|NCT03276962|588456524|FG003|Overall Study|Lost to Follow-up|6|||
162932188|NCT03276962|588456525|FG004|Overall Study|Lost to Follow-up|10|||
162932189|NCT03276962|588456521|FG000|Overall Study|Other|0|||
162932190|NCT03276962|588456522|FG001|Overall Study|Other|2|||
162932191|NCT03276962|588456523|FG002|Overall Study|Other|0|||
162932192|NCT03276962|588456524|FG003|Overall Study|Other|2|||
162932193|NCT03276962|588456525|FG004|Overall Study|Other|1|||
162932194|NCT01358708|588456526|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
162932195|NCT01358708|588456527|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162932196|NCT01358708|588456526|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
162932197|NCT01358708|588456527|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
162932198|NCT03056001|588456531|FG000|Overall Study|Death|24|||
162932199|NCT01364298|588456532|FG000|Overall Study|Adverse Event|3|||
162932200|NCT01364298|588456533|FG001|Overall Study|Adverse Event|4|||
162932201|NCT01364298|588456532|FG000|Overall Study|Lack of adherence to treatment|1|||
162932202|NCT01364298|588456533|FG001|Overall Study|Lack of adherence to treatment|3|||
162932203|NCT01364298|588456532|FG000|Overall Study|Lack of Efficacy|1|||
162932204|NCT01364298|588456533|FG001|Overall Study|Lack of Efficacy|0|||
162932205|NCT01364298|588456532|FG000|Overall Study|Lost to Follow-up|5|||
162932206|NCT01364298|588456533|FG001|Overall Study|Lost to Follow-up|10|||
162932207|NCT01364298|588456532|FG000|Overall Study|Withdrawal by Subject|3|||
162932208|NCT01364298|588456533|FG001|Overall Study|Withdrawal by Subject|3|||
162932209|NCT01364298|588456532|FG000|Overall Study|Other|1|||
162932210|NCT01364298|588456533|FG001|Overall Study|Other|3|||
162932211|NCT02766400|588456549|FG000|Overall Study|Death|1|||
162932212|NCT02766400|588456550|FG001|Overall Study|Death|2|||
162932213|NCT02766400|588456549|FG000|Overall Study|Withdrawal by Subject|1|||
162932214|NCT02766400|588456550|FG001|Overall Study|Withdrawal by Subject|0|||
162932215|NCT03499249|588456556|FG000|Overall Study|Physician Decision|1|||
162932216|NCT01374906|588456557|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162932217|NCT01374906|588456558|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162932218|NCT01374906|588456557|FG000|Overall Study|Administrative problems|2|||
162932219|NCT01374906|588456558|FG001|Overall Study|Administrative problems|2|||
162932220|NCT01374906|588456557|FG000|Overall Study|Adverse Event|10|||
162932221|NCT01374906|588456558|FG001|Overall Study|Adverse Event|11|||
162932222|NCT01374906|588456557|FG000|Overall Study|Death|0|||
162932223|NCT01374906|588456558|FG001|Overall Study|Death|2|||
162932224|NCT01374906|588456557|FG000|Overall Study|Protocol Violation|2|||
162932225|NCT01374906|588456558|FG001|Overall Study|Protocol Violation|2|||
162932226|NCT01374906|588456557|FG000|Overall Study|Withdrawal by Subject|15|||
162932227|NCT01374906|588456558|FG001|Overall Study|Withdrawal by Subject|9|||
162932228|NCT01374906|588456557|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
162932229|NCT01374906|588456558|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
162932230|NCT02475980|588456563|FG000|Overall Study|Lost to Follow-up|4|||
162932231|NCT02475980|588456563|FG000|Overall Study|Withdrawal by Subject|1|||
162932232|NCT01458119|588456571|FG000|Overall Study|Physician Decision|4|||
162932233|NCT01458119|588456571|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
162932234|NCT01458119|588456571|FG000|Overall Study|Pregnancy|1|||
162932235|NCT01458119|588456571|FG000|Overall Study|Death|2|||
162932236|NCT01458119|588456571|FG000|Overall Study|Adverse Event|1|||
162932237|NCT01458119|588456571|FG000|Overall Study|Consent Withdrawn by Participant|8|||
162932238|NCT01458119|588456571|FG000|Overall Study|Non-compliance With Study Drug|3|||
162932239|NCT03033069|588456572|FG000|Overall Study|Adverse Event|6|||
162932240|NCT03033069|588456573|FG001|Overall Study|Adverse Event|7|||
162932241|NCT03033069|588456574|FG002|Overall Study|Adverse Event|4|||
162932242|NCT03033069|588456575|FG003|Overall Study|Adverse Event|6|||
162932243|NCT03033069|588456572|FG000|Overall Study|Lack of Efficacy|0|||
162932244|NCT03033069|588456573|FG001|Overall Study|Lack of Efficacy|0|||
162932245|NCT03033069|588456574|FG002|Overall Study|Lack of Efficacy|1|||
162932246|NCT03033069|588456575|FG003|Overall Study|Lack of Efficacy|0|||
162932247|NCT03033069|588456572|FG000|Overall Study|Lost to Follow-up|6|||
162932248|NCT03033069|588456573|FG001|Overall Study|Lost to Follow-up|5|||
162932249|NCT03033069|588456574|FG002|Overall Study|Lost to Follow-up|5|||
162932250|NCT03033069|588456575|FG003|Overall Study|Lost to Follow-up|6|||
162932251|NCT03033069|588456572|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162932252|NCT03033069|588456573|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162932253|NCT03033069|588456574|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163173644|NCT02108262|589351631|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
163173645|NCT02108262|589351632|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
162932254|NCT03033069|588456575|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162932255|NCT03033069|588456572|FG000|Overall Study|Protocol Deviation|0|||
162932256|NCT03033069|588456573|FG001|Overall Study|Protocol Deviation|1|||
162932257|NCT03033069|588456574|FG002|Overall Study|Protocol Deviation|0|||
162932258|NCT03033069|588456575|FG003|Overall Study|Protocol Deviation|0|||
163173646|NCT02108262|589351629|FG000|Overall Study|Patient did not want another infusion|0|||
162932259|NCT03033069|588456572|FG000|Overall Study|Withdrawal by Subject|10|||
162932260|NCT03033069|588456573|FG001|Overall Study|Withdrawal by Subject|10|||
162825103|NCT03250832|588072400|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
162825104|NCT03250832|588072401|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
162825105|NCT03250832|588072402|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
162825106|NCT03250832|588072403|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
162825107|NCT03250832|588072404|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
162825108|NCT03250832|588072405|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
162825109|NCT03250832|588072406|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
162825110|NCT03250832|588072407|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
162825111|NCT03250832|588072408|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
162825112|NCT03250832|588072409|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
162825113|NCT03250832|588072398|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825114|NCT03250832|588072399|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825115|NCT03250832|588072400|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
162825116|NCT03250832|588072401|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825117|NCT03250832|588072402|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825118|NCT03250832|588072403|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825119|NCT03250832|588072404|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825120|NCT03250832|588072405|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825121|NCT03250832|588072406|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825122|NCT03250832|588072407|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825123|NCT03250832|588072408|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825124|NCT03250832|588072409|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162825125|NCT03250832|588072398|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825126|NCT03250832|588072399|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825127|NCT03250832|588072400|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825128|NCT03250832|588072401|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825129|NCT03250832|588072402|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825130|NCT03250832|588072403|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825131|NCT03250832|588072404|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825132|NCT03250832|588072405|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
162825133|NCT03250832|588072406|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825134|NCT03250832|588072407|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825135|NCT03250832|588072408|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825136|NCT03250832|588072409|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
162825137|NCT03250832|588072398|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825138|NCT03250832|588072399|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825139|NCT03250832|588072400|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825140|NCT03250832|588072401|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825141|NCT03250832|588072402|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825142|NCT03250832|588072403|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825143|NCT03250832|588072404|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825144|NCT03250832|588072405|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
162825145|NCT03250832|588072406|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825146|NCT03250832|588072407|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825147|NCT03250832|588072408|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825148|NCT03250832|588072409|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
162825149|NCT03250832|588072398|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825150|NCT03250832|588072399|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825151|NCT03250832|588072400|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825152|NCT03250832|588072401|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825153|NCT03250832|588072402|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825154|NCT03250832|588072403|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825155|NCT03250832|588072404|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825156|NCT03250832|588072405|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
162825157|NCT03250832|588072406|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163173647|NCT02108262|589351630|FG001|Overall Study|Patient did not want another infusion|3|||
163173648|NCT02108262|589351631|FG002|Overall Study|Patient did not want another infusion|3|||
162825158|NCT03250832|588072407|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825159|NCT03250832|588072408|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
162825160|NCT03250832|588072409|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163173649|NCT02108262|589351632|FG003|Overall Study|Patient did not want another infusion|2|||
163173650|NCT02108262|589351629|FG000|Overall Study|Vacation|0|||
163173651|NCT02108262|589351630|FG001|Overall Study|Vacation|1|||
163173652|NCT02108262|589351631|FG002|Overall Study|Vacation|0|||
163173653|NCT02108262|589351632|FG003|Overall Study|Vacation|0|||
163173654|NCT02108262|589351629|FG000|Overall Study|Patient decision|0|||
163173655|NCT02108262|589351630|FG001|Overall Study|Patient decision|7|||
163173656|NCT02108262|589351631|FG002|Overall Study|Patient decision|9|||
163173657|NCT02108262|589351632|FG003|Overall Study|Patient decision|14|||
163173658|NCT02108262|589351629|FG000|Overall Study|Missed IV due to pharmacy error|0|||
163173659|NCT02108262|589351630|FG001|Overall Study|Missed IV due to pharmacy error|0|||
163173660|NCT02108262|589351631|FG002|Overall Study|Missed IV due to pharmacy error|1|||
163173661|NCT02108262|589351632|FG003|Overall Study|Missed IV due to pharmacy error|0|||
163173662|NCT04449029|589351637|FG000|Overall Study|Adverse Event|0|||
163173663|NCT04449029|589351638|FG001|Overall Study|Adverse Event|1|||
163173664|NCT04449029|589351639|FG002|Overall Study|Adverse Event|1|||
163173665|NCT04449029|589351640|FG003|Overall Study|Adverse Event|0|||
163173666|NCT04449029|589351641|FG004|Overall Study|Adverse Event|1|||
163173667|NCT04449029|589351642|FG005|Overall Study|Adverse Event|0|||
162932261|NCT03033069|588456574|FG002|Overall Study|Withdrawal by Subject|11|||
163173668|NCT04449029|589351643|FG006|Overall Study|Adverse Event|1|||
163173669|NCT04449029|589351644|FG007|Overall Study|Adverse Event|0|||
163173670|NCT04449029|589351637|FG000|Overall Study|Lost to Follow-up|0|||
163173671|NCT04449029|589351638|FG001|Overall Study|Lost to Follow-up|1|||
163173672|NCT04449029|589351639|FG002|Overall Study|Lost to Follow-up|0|||
163173673|NCT04449029|589351640|FG003|Overall Study|Lost to Follow-up|0|||
163173674|NCT04449029|589351641|FG004|Overall Study|Lost to Follow-up|0|||
163173675|NCT04449029|589351642|FG005|Overall Study|Lost to Follow-up|0|||
163173676|NCT04449029|589351643|FG006|Overall Study|Lost to Follow-up|0|||
163173677|NCT04449029|589351644|FG007|Overall Study|Lost to Follow-up|0|||
163173678|NCT04449029|589351637|FG000|Overall Study|Protocol Violation|0|||
163173679|NCT04449029|589351638|FG001|Overall Study|Protocol Violation|1|||
163173680|NCT04449029|589351639|FG002|Overall Study|Protocol Violation|0|||
163173681|NCT04449029|589351640|FG003|Overall Study|Protocol Violation|0|||
163173682|NCT04449029|589351641|FG004|Overall Study|Protocol Violation|0|||
163173683|NCT04449029|589351642|FG005|Overall Study|Protocol Violation|0|||
163173684|NCT04449029|589351643|FG006|Overall Study|Protocol Violation|0|||
163173685|NCT04449029|589351644|FG007|Overall Study|Protocol Violation|0|||
163173686|NCT04449029|589351637|FG000|Overall Study|Physician Decision|0|||
163173687|NCT04449029|589351638|FG001|Overall Study|Physician Decision|0|||
163173688|NCT04449029|589351639|FG002|Overall Study|Physician Decision|0|||
163173689|NCT04449029|589351640|FG003|Overall Study|Physician Decision|0|||
163173690|NCT04449029|589351641|FG004|Overall Study|Physician Decision|0|||
163173691|NCT04449029|589351642|FG005|Overall Study|Physician Decision|1|||
163173692|NCT04449029|589351643|FG006|Overall Study|Physician Decision|0|||
163173693|NCT04449029|589351644|FG007|Overall Study|Physician Decision|0|||
163173694|NCT04449029|589351637|FG000|Overall Study|Withdrawal by Subject|3|||
163173695|NCT04449029|589351638|FG001|Overall Study|Withdrawal by Subject|0|||
163173696|NCT04449029|589351639|FG002|Overall Study|Withdrawal by Subject|1|||
163173697|NCT04449029|589351640|FG003|Overall Study|Withdrawal by Subject|1|||
163173698|NCT04449029|589351641|FG004|Overall Study|Withdrawal by Subject|5|||
163173699|NCT04449029|589351642|FG005|Overall Study|Withdrawal by Subject|1|||
163173700|NCT04449029|589351643|FG006|Overall Study|Withdrawal by Subject|4|||
163173701|NCT04449029|589351644|FG007|Overall Study|Withdrawal by Subject|0|||
163173702|NCT01073462|589351645|FG000|Overall Study|Death|14|||
163173703|NCT01073462|589351645|FG000|Overall Study|Kidney transplant|10|||
163173704|NCT01073462|589351645|FG000|Overall Study|Low parathyroid hormone levels|8|||
163173705|NCT01073462|589351645|FG000|Overall Study|Serious adverse event|2|||
163173706|NCT01073462|589351645|FG000|Overall Study|Lost to Follow-up|7|||
163173707|NCT00247611|589351648|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
163173708|NCT00247611|589351649|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
163173709|NCT00247611|589351648|FG000|Baselined|Completed baseline only|9|||
163173710|NCT00247611|589351649|FG001|Baselined|Completed baseline only|8|||
163173711|NCT00392379|589351653|FG000|Overall Study|Withdrawal by Subject|17|||
163173712|NCT00392379|589351654|FG001|Overall Study|Withdrawal by Subject|28|||
163173713|NCT00392379|589351653|FG000|Overall Study|Lost to Follow-up|4|||
163173714|NCT00392379|589351654|FG001|Overall Study|Lost to Follow-up|9|||
163173715|NCT00392379|589351653|FG000|Overall Study|Adverse Event|1|||
163173716|NCT00392379|589351654|FG001|Overall Study|Adverse Event|1|||
163173717|NCT01700387|589351660|FG000|Overall Study|Withdrawal by Subject|1|||
163173718|NCT01700387|589351661|FG001|Overall Study|Withdrawal by Subject|2|||
163173719|NCT01700387|589351660|FG000|Overall Study|Adverse Event|1|||
163173720|NCT01700387|589351661|FG001|Overall Study|Adverse Event|1|||
163173721|NCT01700387|589351660|FG000|Overall Study|Lost to Follow-up|2|||
163173722|NCT01700387|589351661|FG001|Overall Study|Lost to Follow-up|1|||
163173723|NCT02730793|589351664|FG000|Overall Study|Physician Decision|0|||
163173724|NCT02730793|589351665|FG001|Overall Study|Physician Decision|1|||
163173725|NCT02730793|589351664|FG000|Overall Study|Withdrawal by Subject|0|||
163173726|NCT02730793|589351665|FG001|Overall Study|Withdrawal by Subject|1|||
163173727|NCT02365233|589351666|FG000|Overall Study|IRB withheld the data|1|||
163173728|NCT02365233|589351667|FG001|Overall Study|IRB withheld the data|2|||
163173729|NCT02365233|589351668|FG002|Overall Study|IRB withheld the data|2|||
163173730|NCT00934843|589351669|FG000|Overall Study|Protocol Violation|0|||
163173731|NCT00934843|589351670|FG001|Overall Study|Protocol Violation|1|||
163173732|NCT00160667|589351671|FG000|Overall Study|Adverse Event|3|||
163173733|NCT00160667|589351672|FG001|Overall Study|Adverse Event|1|||
163173734|NCT00160667|589351673|FG002|Overall Study|Adverse Event|4|||
163173735|NCT00160667|589351671|FG000|Overall Study|Withdrawal by Subject|2|||
163173736|NCT00160667|589351672|FG001|Overall Study|Withdrawal by Subject|0|||
163173737|NCT00160667|589351673|FG002|Overall Study|Withdrawal by Subject|1|||
163173738|NCT00160667|589351671|FG000|Overall Study|Lack of Efficacy|0|||
163173739|NCT00160667|589351672|FG001|Overall Study|Lack of Efficacy|1|||
163173740|NCT00160667|589351673|FG002|Overall Study|Lack of Efficacy|0|||
163173741|NCT00160667|589351671|FG000|Overall Study|Protocol Violation|0|||
163173742|NCT00160667|589351672|FG001|Overall Study|Protocol Violation|1|||
163173743|NCT00160667|589351673|FG002|Overall Study|Protocol Violation|0|||
163173744|NCT00160667|589351671|FG000|Overall Study|Patient decision|0|||
163173745|NCT00160667|589351672|FG001|Overall Study|Patient decision|0|||
162825161|NCT03250832|588072398|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825162|NCT03250832|588072399|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825163|NCT03250832|588072400|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162932262|NCT03033069|588456575|FG003|Overall Study|Withdrawal by Subject|6|||
162698445|NCT03881059|587605505|FG002|Treatment Period - Part B|Other reasons|3|||
162698446|NCT02065570|587605506|FG000|Induction Study|Adverse Event|5|||
163173746|NCT00160667|589351673|FG002|Overall Study|Patient decision|1|||
163173747|NCT00995566|589351681|FG000|Overall Study|Adverse Event|2|||
163173748|NCT00995566|589351681|FG000|Overall Study|Early study termination|52|||
163173749|NCT00336583|589352910|FG000|Overall Study|Lost to Follow-up|1|||
163173750|NCT00336583|589352910|FG000|Overall Study|Death|1|||
163173751|NCT03224598|589352913|FG000|Overall Study|Lost to Follow-up|0|||
163173752|NCT03224598|589352914|FG001|Overall Study|Lost to Follow-up|2|||
163173753|NCT03224598|589352915|FG002|Overall Study|Lost to Follow-up|0|||
163173754|NCT03224598|589352913|FG000|Overall Study|Other|0|||
163173755|NCT03224598|589352914|FG001|Overall Study|Other|1|||
163173756|NCT03224598|589352915|FG002|Overall Study|Other|0|||
163173757|NCT03328182|589352918|FG000|Overall Study|Withdrawal by Subject|1|||
163173758|NCT03328182|589352918|FG000|Overall Study|Protocol Violation|2|||
163173759|NCT03328182|589352918|FG000|Overall Study|No Product Evaluated|1|||
163173760|NCT01095094|589352919|FG000|Overall Study|Withdrawal by Subject|1|||
163173761|NCT01095094|589352919|FG000|Overall Study|Death|1|||
163173762|NCT01095094|589352919|FG000|Overall Study|Physician Decision|1|||
163173763|NCT00137839|589352923|FG000|Overall Study|Adverse Event|7|||
163173764|NCT00137839|589352923|FG000|Overall Study|Physician Decision|7|||
163173765|NCT00137839|589352923|FG000|Overall Study|Death|8|||
163173766|NCT00137839|589352923|FG000|Overall Study|Disease Progression|60|||
163173767|NCT00137839|589352923|FG000|Overall Study|Not Start Treatment|1|||
163173768|NCT00137839|589352923|FG000|Overall Study|Prolonged Treatment Delay|1|||
163173769|NCT03860935|589352928|FG000|Overall Study|Withdrawal of Consent|15|||
163173770|NCT03860935|589352929|FG001|Overall Study|Withdrawal of Consent|6|||
163173771|NCT03860935|589352928|FG000|Overall Study|Death|75|||
163173772|NCT03860935|589352929|FG001|Overall Study|Death|51|||
163173773|NCT03361176|589352933|FG000|Overall Study|Lost to Follow-up|1|||
163173774|NCT03361176|589352934|FG001|Overall Study|Lost to Follow-up|2|||
163173775|NCT03361176|589352933|FG000|Overall Study|Adverse Event|0|||
163173776|NCT03361176|589352934|FG001|Overall Study|Adverse Event|2|||
163173777|NCT03361176|589352933|FG000|Overall Study|Withdrawal by Subject|0|||
163173778|NCT03361176|589352934|FG001|Overall Study|Withdrawal by Subject|1|||
163173779|NCT04461600|589352935|FG000|Overall Study|Death|6|||
163173780|NCT04461600|589352936|FG001|Overall Study|Death|5|||
163173781|NCT04461600|589352935|FG000|Overall Study|Withdrawal by Subject|0|||
163173782|NCT04461600|589352936|FG001|Overall Study|Withdrawal by Subject|1|||
163173783|NCT01437995|589352938|FG000|Overall Study|Lost to Follow-up|11|||
163173784|NCT01437995|589352939|FG001|Overall Study|Lost to Follow-up|18|||
163173785|NCT01437995|589352940|FG002|Overall Study|Lost to Follow-up|20|||
163173786|NCT04456673|589352941|FG000|Overall Study|Adverse Event|7|||
163173787|NCT04456673|589352942|FG001|Overall Study|Adverse Event|14|||
163173788|NCT04456673|589352941|FG000|Overall Study|Poor compliance to protocol|1|||
163173789|NCT04456673|589352942|FG001|Overall Study|Poor compliance to protocol|0|||
163173790|NCT04456673|589352941|FG000|Overall Study|Withdrawal by Subject|31|||
163173791|NCT04456673|589352942|FG001|Overall Study|Withdrawal by Subject|23|||
163173792|NCT04456673|589352941|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
163173793|NCT04456673|589352942|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
163173794|NCT02160002|589352943|FG000|Overall Study|Withdrawal by Subject|2|||
163173795|NCT02160002|589352944|FG001|Overall Study|Withdrawal by Subject|1|||
163173796|NCT04395001|589352946|FG000|Overall Study|Lost to Follow-up|8|||
163173797|NCT04395001|589352947|FG001|Overall Study|Lost to Follow-up|9|||
163173798|NCT04395001|589352948|FG002|Overall Study|Lost to Follow-up|5|||
163173799|NCT04395001|589352946|FG000|Overall Study|Withdrawal by Subject|3|||
163173800|NCT04395001|589352947|FG001|Overall Study|Withdrawal by Subject|1|||
163173801|NCT04395001|589352948|FG002|Overall Study|Withdrawal by Subject|3|||
163173802|NCT04395001|589352946|FG000|Overall Study|missed appointment|7|||
163173803|NCT04395001|589352947|FG001|Overall Study|missed appointment|4|||
163173804|NCT04395001|589352948|FG002|Overall Study|missed appointment|1|||
163173805|NCT01689532|589352949|FG000|Overall Study|Adverse Event|9|||
163173806|NCT01689532|589352950|FG001|Overall Study|Adverse Event|5|||
163173807|NCT01689532|589352949|FG000|Overall Study|Lack of Efficacy|2|||
163173808|NCT01689532|589352950|FG001|Overall Study|Lack of Efficacy|2|||
163173809|NCT01689532|589352949|FG000|Overall Study|Withdrawal by Subject|1|||
163173810|NCT01689532|589352950|FG001|Overall Study|Withdrawal by Subject|2|||
163173811|NCT01689532|589352949|FG000|Overall Study|Physician Decision|2|||
162932263|NCT03033069|588456572|FG000|Overall Study|Withdrawal By Caregiver|1|||
162932264|NCT03033069|588456573|FG001|Overall Study|Withdrawal By Caregiver|0|||
162932265|NCT03033069|588456574|FG002|Overall Study|Withdrawal By Caregiver|0|||
162932266|NCT03033069|588456575|FG003|Overall Study|Withdrawal By Caregiver|0|||
163173812|NCT01689532|589352950|FG001|Overall Study|Physician Decision|0|||
163173813|NCT01363349|589352951|FG000|Overall Study|Adverse Event|6|||
163173814|NCT01363349|589352952|FG001|Overall Study|Adverse Event|7|||
163173815|NCT01363349|589352951|FG000|Overall Study|Lack of Efficacy|3|||
163173816|NCT01363349|589352952|FG001|Overall Study|Lack of Efficacy|10|||
163173817|NCT01363349|589352951|FG000|Overall Study|Non compliance/Protocol deviations|2|||
163173818|NCT01363349|589352952|FG001|Overall Study|Non compliance/Protocol deviations|2|||
163173819|NCT01363349|589352951|FG000|Overall Study|Withdrawal by Subject|14|||
163173820|NCT01363349|589352952|FG001|Overall Study|Withdrawal by Subject|6|||
163173821|NCT01363349|589352951|FG000|Overall Study|Lost to Follow-up|5|||
163173822|NCT01363349|589352952|FG001|Overall Study|Lost to Follow-up|6|||
163173823|NCT01363349|589352951|FG000|Overall Study|Not reported|36|||
163173824|NCT01363349|589352952|FG001|Overall Study|Not reported|37|||
163173825|NCT01363349|589352951|FG000|Overall Study|missing|1|||
163173826|NCT01363349|589352952|FG001|Overall Study|missing|2|||
163173827|NCT05508074|589352953|FG000|Overall Study|Death|2|||
163173828|NCT05508074|589352954|FG001|Overall Study|Death|5|||
163173829|NCT05508074|589352953|FG000|Overall Study|Withdrawal by Subject|1|||
163173830|NCT05508074|589352954|FG001|Overall Study|Withdrawal by Subject|2|||
163173831|NCT05508074|589352953|FG000|Overall Study|Adverse Event|0|||
163173832|NCT05508074|589352954|FG001|Overall Study|Adverse Event|1|||
163173833|NCT05508074|589352953|FG000|Overall Study|Physician Decision|0|||
163173834|NCT05508074|589352954|FG001|Overall Study|Physician Decision|1|||
163173835|NCT05508074|589352953|FG000|Overall Study|wrongly randomized|0|||
163173836|NCT05508074|589352954|FG001|Overall Study|wrongly randomized|1|||
163173837|NCT05508074|589352953|FG000|Overall Study|non-compliance|0|||
163173838|NCT05508074|589352954|FG001|Overall Study|non-compliance|1|||
163173839|NCT02142387|589352955|FG000|Overall Study|<19 years old|49|||
163173840|NCT02142387|589352956|FG001|Overall Study|<19 years old|326|||
163173841|NCT02142387|589352955|FG000|Overall Study|non-cardiac etiology|504|||
163173842|NCT02142387|589352956|FG001|Overall Study|non-cardiac etiology|3431|||
163173843|NCT02142387|589352955|FG000|Overall Study|CPR not performed|74|||
163173844|NCT02142387|589352956|FG001|Overall Study|CPR not performed|473|||
163173845|NCT02142387|589352955|FG000|Overall Study|witnessed by paramedic|139|||
163173846|NCT02142387|589352956|FG001|Overall Study|witnessed by paramedic|917|||
163173847|NCT02142387|589352955|FG000|Overall Study|incomplete data|1|||
163173848|NCT02142387|589352956|FG001|Overall Study|incomplete data|9|||
163173849|NCT02142387|589352955|FG000|Overall Study|occurred not at home|298|||
163173850|NCT02142387|589352956|FG001|Overall Study|occurred not at home|2474|||
163173851|NCT01101308|589352957|FG000|Period 1|Adverse Event|2|||
163173852|NCT01101308|589352958|FG001|Period 1|Adverse Event|1|||
163173853|NCT01101308|589352957|FG000|Period 1|Positive for cotinine|1|||
163173854|NCT01101308|589352958|FG001|Period 1|Positive for cotinine|0|||
163173855|NCT02984943|589352959|FG000|Overall Study|Withdrawal by Subject|3|||
163173856|NCT02984943|589352959|FG000|Overall Study|Physician Decision|1|||
163173857|NCT02282345|589352962|FG000|Overall Study|Progression|0|||
163173858|NCT02282345|589352963|FG001|Overall Study|Progression|1|||
163173859|NCT02296138|589352964|FG000|Overall Study|Adverse Event|348|||
163173860|NCT02296138|589352965|FG001|Overall Study|Adverse Event|259|||
163173861|NCT02296138|589352964|FG000|Overall Study|Lack of Efficacy|59|||
163173862|NCT02296138|589352965|FG001|Overall Study|Lack of Efficacy|37|||
163173863|NCT02296138|589352964|FG000|Overall Study|Protocol Violation|35|||
163173864|NCT02296138|589352965|FG001|Overall Study|Protocol Violation|36|||
163173865|NCT02296138|589352964|FG000|Overall Study|Lost to Follow-up|9|||
163173866|NCT02296138|589352965|FG001|Overall Study|Lost to Follow-up|12|||
163173867|NCT02296138|589352964|FG000|Overall Study|Withdrawal by Subject|184|||
163173868|NCT02296138|589352965|FG001|Overall Study|Withdrawal by Subject|131|||
162932267|NCT03033069|588456572|FG000|Overall Study|Reason not Specified|0|||
163173869|NCT02296138|589352964|FG000|Overall Study|Not Treated|1|||
162932268|NCT03033069|588456573|FG001|Overall Study|Reason not Specified|1|||
162932269|NCT03033069|588456574|FG002|Overall Study|Reason not Specified|0|||
163173870|NCT02296138|589352965|FG001|Overall Study|Not Treated|1|||
163173871|NCT02296138|589352964|FG000|Overall Study|Patients with data irregularities|10|||
163173872|NCT02296138|589352965|FG001|Overall Study|Patients with data irregularities|11|||
163173873|NCT02296138|589352964|FG000|Overall Study|Other than specified|15|||
163173874|NCT02296138|589352965|FG001|Overall Study|Other than specified|13|||
163173875|NCT00711516|589352966|FG000|Overall Study|Adverse Event|1|||
163173876|NCT00711516|589352967|FG001|Overall Study|Adverse Event|1|||
163173877|NCT00711516|589352966|FG000|Overall Study|Withdrawal by Subject|0|||
163173878|NCT00711516|589352967|FG001|Overall Study|Withdrawal by Subject|1|||
163173879|NCT00711516|589352966|FG000|Overall Study|Protocol Violation|0|||
163173880|NCT00711516|589352967|FG001|Overall Study|Protocol Violation|1|||
163173881|NCT02692651|589352968|FG000|Study Treatment|Death|7|||
163173882|NCT02692651|589352969|FG001|Study Treatment|Death|3|||
163173883|NCT02692651|589352968|FG000|Study Treatment|comfort care|1|||
163173884|NCT02692651|589352969|FG001|Study Treatment|comfort care|1|||
163173885|NCT02692651|589352968|FG000|Study Treatment|Protocol violation per treating team preference|8|||
163173886|NCT02692651|589352969|FG001|Study Treatment|Protocol violation per treating team preference|6|||
163173887|NCT02692651|589352968|FG000|Post Study Treatment Follow-up|Death|4|||
163173888|NCT02692651|589352969|FG001|Post Study Treatment Follow-up|Death|4|||
163173889|NCT03490981|589352970|FG000|Overall Study|Lost to Follow-up|1|||
163173890|NCT03490981|589352971|FG001|Overall Study|Lost to Follow-up|2|||
163173891|NCT02480712|589352972|FG000|Overall Study|Enrolled but Never Treated|1|||
163173892|NCT02480712|589352972|FG000|Overall Study|Lost to Follow-up|5|||
163173893|NCT02480712|589352972|FG000|Overall Study|Withdrew Consent|3|||
163173894|NCT02480712|589352972|FG000|Overall Study|Death|1|||
163173895|NCT02480712|589352972|FG000|Overall Study|Lack of Efficacy|1|||
163173896|NCT01860846|589352979|FG000|Overall Study|Lost to Follow-up|33|||
163173897|NCT00466687|589352980|FG000|Overall Study|Adverse Event|1|||
163173898|NCT00466687|589352980|FG000|Overall Study|Other complicating illness|3|||
163173899|NCT00466687|589352980|FG000|Overall Study|Withdrawal by Subject|1|||
163173900|NCT00466687|589352980|FG000|Overall Study|Disease progression|29|||
163173901|NCT02586506|589352981|FG000|Overall Study|Protocol Violation|6|||
163173902|NCT02586506|589352981|FG000|Overall Study|Lost to Follow-up|1|||
163173903|NCT02586506|589352981|FG000|Overall Study|Other Reason|2|||
163173904|NCT00770146|589352982|FG000|Treatment Period|Withdrawal by Subject|6|||
163173905|NCT00770146|589352983|FG001|Treatment Period|Withdrawal by Subject|13|||
163173906|NCT00770146|589352982|FG000|Treatment Period|Adverse Event|2|||
163173907|NCT00770146|589352983|FG001|Treatment Period|Adverse Event|26|||
163173908|NCT00770146|589352982|FG000|Treatment Period|Other|1|||
163173909|NCT00770146|589352983|FG001|Treatment Period|Other|5|||
163173910|NCT00770146|589352982|FG000|Treatment Period|Protocol non-compliance|0|||
163173911|NCT00770146|589352983|FG001|Treatment Period|Protocol non-compliance|1|||
163173912|NCT00770146|589352982|FG000|Follow-up Period|Withdrawal by Subject|7|||
163173913|NCT00770146|589352983|FG001|Follow-up Period|Withdrawal by Subject|13|||
163173914|NCT00770146|589352982|FG000|Follow-up Period|Adverse Event|0|||
163173915|NCT00770146|589352983|FG001|Follow-up Period|Adverse Event|2|||
163173916|NCT00770146|589352982|FG000|Follow-up Period|Other|4|||
163173917|NCT00770146|589352983|FG001|Follow-up Period|Other|5|||
163173918|NCT01525901|589352984|FG000|Period 2: 12 Weeks|Adverse Event|0|||
163173919|NCT01525901|589352985|FG001|Period 2: 12 Weeks|Adverse Event|1|||
163173920|NCT01525901|589352986|FG002|Period 2: 12 Weeks|Adverse Event|0|||
163173921|NCT01525901|589352987|FG003|Period 2: 12 Weeks|Adverse Event|0|||
163173922|NCT01509053|589352988|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
163173923|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
163173924|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
163173925|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
163173926|NCT01509053|589352988|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
163173927|NCT01509053|589352988|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
163173928|NCT00834080|589352989|FG000|Overall Study|Adverse Event|7|||
163173929|NCT00834080|589352989|FG000|Overall Study|Lost to Follow-up|7|||
163173930|NCT00834080|589352989|FG000|Overall Study|Withdrawal by Subject|5|||
163173931|NCT00834080|589352989|FG000|Overall Study|Other - Pregnancy|1|||
163173932|NCT00834080|589352989|FG000|Overall Study|Other - False positive tests of the UDS|1|||
163173933|NCT00834080|589352989|FG000|Overall Study|Physician Decision|1|||
163173934|NCT00834080|589352989|FG000|Overall Study|Subject Relocated|1|||
163173935|NCT04345367|589352991|FG000|Overall Study|Other|3|||
163173936|NCT04345367|589352992|FG001|Overall Study|Other|4|||
163173937|NCT04345367|589352991|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
163173938|NCT04345367|589352992|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
163173939|NCT04345367|589352991|FG000|Overall Study|Withdrawal by Subject|11|||
163173940|NCT04345367|589352992|FG001|Overall Study|Withdrawal by Subject|11|||
163173941|NCT04345367|589352991|FG000|Overall Study|Protocol Violation|4|||
163173942|NCT04345367|589352992|FG001|Overall Study|Protocol Violation|3|||
163173943|NCT04345367|589352991|FG000|Overall Study|Lost to Follow-up|2|||
163173944|NCT04345367|589352992|FG001|Overall Study|Lost to Follow-up|4|||
163173945|NCT04345367|589352991|FG000|Overall Study|Lack of Efficacy|2|||
163173946|NCT04345367|589352992|FG001|Overall Study|Lack of Efficacy|0|||
163173947|NCT04345367|589352991|FG000|Overall Study|Death|2|||
163173948|NCT04345367|589352992|FG001|Overall Study|Death|0|||
163173949|NCT04345367|589352991|FG000|Overall Study|Adverse Event|10|||
163173950|NCT04345367|589352992|FG001|Overall Study|Adverse Event|9|||
163173951|NCT00439738|589352996|FG000|Overall Study|Withdrawal by Subject|16|||
163173952|NCT00439738|589352997|FG001|Overall Study|Withdrawal by Subject|13|||
163173953|NCT00439738|589352996|FG000|Overall Study|Adverse Event|6|||
163173954|NCT00439738|589352997|FG001|Overall Study|Adverse Event|4|||
163173955|NCT00439738|589352996|FG000|Overall Study|Lost to Follow-up|5|||
163173956|NCT00439738|589352997|FG001|Overall Study|Lost to Follow-up|6|||
163173957|NCT00439738|589352996|FG000|Overall Study|Protocol Violation|6|||
163173958|NCT00439738|589352997|FG001|Overall Study|Protocol Violation|3|||
163173959|NCT00439738|589352996|FG000|Overall Study|Lack of Efficacy|2|||
163173960|NCT00439738|589352997|FG001|Overall Study|Lack of Efficacy|2|||
163173961|NCT00439738|589352996|FG000|Overall Study|Abnormal Lab Values|1|||
163173962|NCT00439738|589352997|FG001|Overall Study|Abnormal Lab Values|0|||
163173963|NCT00781885|589353000|FG000|Overall Study|Physician Decision|1|||
163173964|NCT01755026|589353001|FG000|Overall Study|Adverse Event|1|||
163173965|NCT01755026|589353002|FG001|Overall Study|Adverse Event|0|||
163173966|NCT01755026|589353001|FG000|Overall Study|Withdrawal by Subject|1|||
163173967|NCT01755026|589353002|FG001|Overall Study|Withdrawal by Subject|1|||
163173968|NCT03836001|589353003|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
163173969|NCT03836001|589353004|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
163173970|NCT03836001|589353005|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
163173971|NCT03836001|589353003|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
163173972|NCT03836001|589353004|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
163173973|NCT03836001|589353005|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
163173974|NCT03836001|589353003|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
163173975|NCT03836001|589353004|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
163173976|NCT03836001|589353005|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
163173977|NCT03836001|589353003|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
163173978|NCT03836001|589353004|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
163173979|NCT03836001|589353005|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
163173980|NCT01284491|589353006|FG000|Overall Study|Study termination|13|||
163173981|NCT01978938|589353007|FG000|Overall Study|Lost to Follow-up|12|||
163173982|NCT01978938|589353008|FG001|Overall Study|Lost to Follow-up|6|||
163173983|NCT01978938|589353007|FG000|Overall Study|Withdrawal by Subject|8|||
163173984|NCT01978938|589353008|FG001|Overall Study|Withdrawal by Subject|4|||
163173985|NCT01978938|589353007|FG000|Overall Study|Adverse Event, non-fatal|2|||
163173986|NCT01978938|589353008|FG001|Overall Study|Adverse Event, non-fatal|1|||
163173987|NCT01978938|589353007|FG000|Overall Study|Participant noncompliance|1|||
163173988|NCT01978938|589353008|FG001|Overall Study|Participant noncompliance|1|||
163173989|NCT01978938|589353007|FG000|Overall Study|Did not meet inclusion criteria|0|||
163173990|NCT01978938|589353008|FG001|Overall Study|Did not meet inclusion criteria|1|||
163173991|NCT01978938|589353007|FG000|Overall Study|Previously scheduled procedure|0|||
163173992|NCT01978938|589353008|FG001|Overall Study|Previously scheduled procedure|1|||
163173993|NCT02694757|589353009|FG000|Overall Study|Lack of Efficacy|3|||
163173994|NCT02650921|589353010|FG000|Overall Study|Withdrawal by Subject|4|||
163173995|NCT02650921|589353010|FG000|Overall Study|Lost to Follow-up|2|||
163173996|NCT02650921|589353010|FG000|Overall Study|Adverse Event|1|||
163173997|NCT02650921|589353010|FG000|Overall Study|Due to Medical Condition|1|||
163173998|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
163173999|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
163174000|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
163174001|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
163174002|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
163174003|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
163174004|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
163174005|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
163174006|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
163174007|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
163174008|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
163174009|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
163174010|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
163174011|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
163174012|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
163174013|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
163174014|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
163174015|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
163174016|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
163174017|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
163174018|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
163174019|NCT01087788|589353011|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
163174020|NCT01087788|589353012|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
163174021|NCT01087788|589353013|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
163174022|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
163174023|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
163174024|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
163174025|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
163174026|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
163174027|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
163174028|NCT01087788|589353011|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
163174029|NCT01087788|589353012|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
163174030|NCT01087788|589353013|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
163174031|NCT01087788|589353011|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
163174032|NCT01087788|589353012|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
163174033|NCT01087788|589353013|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
163174034|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
163174035|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
163174036|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
163174037|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
163174038|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
163174039|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
163174040|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
163174041|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
163174042|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
163174043|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
163174044|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
163174045|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
163174046|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
163174047|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
163174048|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
163174049|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
163174050|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
163174051|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
163174052|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
163174053|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
163174054|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
163174055|NCT01087788|589353011|FG000|24-weeks Dose-blind Period|Patient moved|0|||
163174056|NCT01087788|589353012|FG001|24-weeks Dose-blind Period|Patient moved|0|||
163174057|NCT01087788|589353013|FG002|24-weeks Dose-blind Period|Patient moved|1|||
163174058|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
163174059|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
163174060|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
163174061|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
163174062|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
163174063|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
163174064|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
163174065|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
163174066|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
163174067|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
163174068|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
163174069|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
163174070|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
163174071|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
163174072|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
163174073|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
163174074|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
163174075|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
163174076|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
163174077|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
163174078|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
163174079|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
163174080|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
163174081|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
163174082|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
163174083|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
163174084|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
163174085|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
163174086|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
163174087|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
163174088|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
163174089|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
163174090|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
163174091|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
163174092|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
163174093|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
163174094|NCT01087788|589353011|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
163174095|NCT01087788|589353012|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
163174096|NCT01087788|589353013|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
163174097|NCT00783302|589353014|FG000|Overall Study|Lost to Follow-up|17|||
163174098|NCT00783302|589353014|FG000|Overall Study|Technical Problems|11|||
163174099|NCT00783302|589353014|FG000|Overall Study|Protocol Violation|3|||
163174100|NCT00783302|589353014|FG000|Overall Study|Physician Decision|1|||
163174101|NCT00783302|589353014|FG000|Overall Study|Withdrawal by Subject|3|||
163174102|NCT01806662|589353015|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
163174103|NCT01806662|589353016|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
163174104|NCT01806662|589353015|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
163174105|NCT01806662|589353016|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
163174106|NCT01806662|589353015|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
163174107|NCT01806662|589353016|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
163174108|NCT01806662|589353015|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
163174109|NCT01806662|589353016|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
163174110|NCT00043550|589353017|FG000|Overall Study|Withdrawal by Subject|22|||
163174111|NCT00043550|589353018|FG001|Overall Study|Withdrawal by Subject|12|||
163174112|NCT00043550|589353019|FG002|Overall Study|Withdrawal by Subject|20|||
163174113|NCT01917656|589353020|FG000|Overall Study|Adverse Event|11|||
163174114|NCT01917656|589353021|FG001|Overall Study|Adverse Event|0|||
163174115|NCT01917656|589353020|FG000|Overall Study|Withdrawal criteria|8|||
163174116|NCT01917656|589353021|FG001|Overall Study|Withdrawal criteria|14|||
163174117|NCT01917656|589353020|FG000|Overall Study|Unclassified|0|||
163174118|NCT01917656|589353021|FG001|Overall Study|Unclassified|3|||
163174119|NCT01917656|589353020|FG000|Overall Study|Withdrawal by Subject|4|||
163174120|NCT01917656|589353021|FG001|Overall Study|Withdrawal by Subject|3|||
163174121|NCT01917656|589353020|FG000|Overall Study|Lost to Follow-up|3|||
163174122|NCT01917656|589353021|FG001|Overall Study|Lost to Follow-up|4|||
163174123|NCT02285062|589353022|FG000|Pre-Treatment Period|Protocol Violation|0|||
163174124|NCT02285062|589353023|FG001|Pre-Treatment Period|Protocol Violation|2|||
163174125|NCT02285062|589353022|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
163174126|NCT02285062|589353023|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163174127|NCT00545129|589353024|FG000|Overall Study|Lack of Efficacy|2|||
163174128|NCT00545129|589353025|FG001|Overall Study|Lack of Efficacy|5|||
163174129|NCT00545129|589353024|FG000|Overall Study|Death|2|||
163174130|NCT00545129|589353025|FG001|Overall Study|Death|1|||
163174131|NCT00545129|589353024|FG000|Overall Study|Adverse Event|1|||
163174132|NCT00545129|589353025|FG001|Overall Study|Adverse Event|1|||
163174133|NCT00545129|589353024|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
163174134|NCT00545129|589353025|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
163174135|NCT00545129|589353024|FG000|Overall Study|Other|3|||
163174136|NCT00545129|589353025|FG001|Overall Study|Other|3|||
163174137|NCT03678870|589353026|FG000|Overall Study|prescribed non- protocol medications|10|||
163174138|NCT03678870|589353027|FG001|Overall Study|prescribed non- protocol medications|6|||
163174139|NCT03678870|589353026|FG000|Overall Study|Lost to Follow-up|3|||
163174140|NCT03678870|589353027|FG001|Overall Study|Lost to Follow-up|2|||
163174141|NCT03104816|589353029|FG000|Overall Study|Lack of Efficacy|0|||
163174142|NCT03104816|589353030|FG001|Overall Study|Lack of Efficacy|2|||
163174143|NCT03104816|589353031|FG002|Overall Study|Lack of Efficacy|0|||
163174144|NCT03104816|589353029|FG000|Overall Study|Protocol Violation|2|||
163174145|NCT03104816|589353030|FG001|Overall Study|Protocol Violation|0|||
163174146|NCT03104816|589353031|FG002|Overall Study|Protocol Violation|2|||
163174147|NCT01426789|589353032|FG000|Part 1|Protocol deviation|0|||
163174148|NCT01426789|589353033|FG001|Part 1|Protocol deviation|1|||
163174149|NCT01426789|589353034|FG002|Part 1|Protocol deviation|0|||
163174150|NCT01426789|589353035|FG003|Part 1|Protocol deviation|0|||
163174151|NCT01426789|589353036|FG004|Part 1|Protocol deviation|0|||
163174152|NCT01426789|589353037|FG005|Part 1|Protocol deviation|0|||
163174153|NCT01426789|589353032|FG000|Part 1|Lost to Follow-up|1|||
163174154|NCT01426789|589353033|FG001|Part 1|Lost to Follow-up|2|||
163174155|NCT01426789|589353034|FG002|Part 1|Lost to Follow-up|0|||
163174156|NCT01426789|589353035|FG003|Part 1|Lost to Follow-up|0|||
163174157|NCT01426789|589353036|FG004|Part 1|Lost to Follow-up|0|||
163174158|NCT01426789|589353037|FG005|Part 1|Lost to Follow-up|0|||
163174159|NCT01426789|589353032|FG000|Part 1|Lack of Efficacy|2|||
163174160|NCT01426789|589353033|FG001|Part 1|Lack of Efficacy|1|||
163174161|NCT01426789|589353034|FG002|Part 1|Lack of Efficacy|0|||
163174162|NCT01426789|589353035|FG003|Part 1|Lack of Efficacy|0|||
163174163|NCT01426789|589353036|FG004|Part 1|Lack of Efficacy|0|||
163174164|NCT01426789|589353037|FG005|Part 1|Lack of Efficacy|0|||
163174165|NCT01426789|589353032|FG000|Part 1|Adverse Event|3|||
163174166|NCT01426789|589353033|FG001|Part 1|Adverse Event|0|||
163174167|NCT01426789|589353034|FG002|Part 1|Adverse Event|0|||
162932270|NCT03033069|588456575|FG003|Overall Study|Reason not Specified|1|||
162932271|NCT00430638|588456576|FG000|Overall Study|Adverse Event|15|||
162932272|NCT00430638|588456577|FG001|Overall Study|Adverse Event|15|||
162932273|NCT00430638|588456576|FG000|Overall Study|Uncontrolled blood pressure|48|||
162932274|NCT00430638|588456577|FG001|Overall Study|Uncontrolled blood pressure|13|||
162932275|NCT00430638|588456576|FG000|Overall Study|Lost to Follow-up|1|||
162932276|NCT00430638|588456577|FG001|Overall Study|Lost to Follow-up|7|||
162932277|NCT00430638|588456576|FG000|Overall Study|Protocol Violation|6|||
162932278|NCT00430638|588456577|FG001|Overall Study|Protocol Violation|4|||
162932279|NCT00430638|588456576|FG000|Overall Study|Withdrawal by Subject|4|||
162932280|NCT00430638|588456577|FG001|Overall Study|Withdrawal by Subject|6|||
163174168|NCT01426789|589353035|FG003|Part 1|Adverse Event|0|||
163174169|NCT01426789|589353036|FG004|Part 1|Adverse Event|0|||
163174170|NCT01426789|589353037|FG005|Part 1|Adverse Event|0|||
163174171|NCT01426789|589353032|FG000|Part 2|Protocol deviation|0|||
163174172|NCT01426789|589353033|FG001|Part 2|Protocol deviation|0|||
163174173|NCT01426789|589353034|FG002|Part 2|Protocol deviation|1|||
163174174|NCT01426789|589353035|FG003|Part 2|Protocol deviation|0|||
163174175|NCT01426789|589353036|FG004|Part 2|Protocol deviation|0|||
163174176|NCT01426789|589353037|FG005|Part 2|Protocol deviation|0|||
163174177|NCT01426789|589353032|FG000|Part 2|Death|0|||
163174178|NCT01426789|589353033|FG001|Part 2|Death|0|||
163174179|NCT01426789|589353034|FG002|Part 2|Death|1|||
163174180|NCT01426789|589353035|FG003|Part 2|Death|0|||
163174181|NCT01426789|589353036|FG004|Part 2|Death|1|||
163174182|NCT01426789|589353037|FG005|Part 2|Death|0|||
163174183|NCT01426789|589353032|FG000|Part 2|Administrative problems|0|||
163174184|NCT01426789|589353033|FG001|Part 2|Administrative problems|0|||
163174185|NCT01426789|589353034|FG002|Part 2|Administrative problems|2|||
163174186|NCT01426789|589353035|FG003|Part 2|Administrative problems|0|||
163174187|NCT01426789|589353036|FG004|Part 2|Administrative problems|1|||
163174188|NCT01426789|589353037|FG005|Part 2|Administrative problems|0|||
163174189|NCT01426789|589353032|FG000|Part 2|Lost to Follow-up|0|||
163174190|NCT01426789|589353033|FG001|Part 2|Lost to Follow-up|0|||
163174191|NCT01426789|589353034|FG002|Part 2|Lost to Follow-up|4|||
163174192|NCT01426789|589353035|FG003|Part 2|Lost to Follow-up|0|||
163174193|NCT01426789|589353036|FG004|Part 2|Lost to Follow-up|1|||
163174194|NCT01426789|589353037|FG005|Part 2|Lost to Follow-up|0|||
163174195|NCT01426789|589353032|FG000|Part 2|Withdrawal by Subject|0|||
163174196|NCT01426789|589353033|FG001|Part 2|Withdrawal by Subject|0|||
163174197|NCT01426789|589353034|FG002|Part 2|Withdrawal by Subject|0|||
163174198|NCT01426789|589353035|FG003|Part 2|Withdrawal by Subject|1|||
163174199|NCT01426789|589353036|FG004|Part 2|Withdrawal by Subject|2|||
163174200|NCT01426789|589353037|FG005|Part 2|Withdrawal by Subject|0|||
163174201|NCT01426789|589353032|FG000|Part 2|Lack of Efficacy|0|||
163174202|NCT01426789|589353033|FG001|Part 2|Lack of Efficacy|0|||
163174203|NCT01426789|589353034|FG002|Part 2|Lack of Efficacy|5|||
163174204|NCT01426789|589353035|FG003|Part 2|Lack of Efficacy|0|||
163174205|NCT01426789|589353036|FG004|Part 2|Lack of Efficacy|2|||
163174206|NCT01426789|589353037|FG005|Part 2|Lack of Efficacy|0|||
163174207|NCT01426789|589353032|FG000|Part 2|Adverse Event|0|||
163174208|NCT01426789|589353033|FG001|Part 2|Adverse Event|0|||
163174209|NCT01426789|589353034|FG002|Part 2|Adverse Event|2|||
163174210|NCT01426789|589353035|FG003|Part 2|Adverse Event|0|||
163174211|NCT01426789|589353036|FG004|Part 2|Adverse Event|1|||
163174212|NCT01426789|589353037|FG005|Part 2|Adverse Event|0|||
163174213|NCT00003830|589354835|FG000|Overall Study|No follow up data|3|||
163174214|NCT00003830|589354836|FG001|Overall Study|No follow up data|0|||
163174215|NCT00003830|589354835|FG000|Overall Study|Sentinel node positive patients|829|||
163174216|NCT00003830|589354836|FG001|Overall Study|Sentinel node positive patients|793|||
163174217|NCT00883688|589354837|FG000|Overall Study|Ineligible|2|||
163174218|NCT00704522|589354838|FG000|Overall Study|Lack of Efficacy|65|||
163174219|NCT00704522|589354839|FG001|Overall Study|Lack of Efficacy|17|||
162932281|NCT00430638|588456576|FG000|Overall Study|Non-compliant|2|||
162932282|NCT00430638|588456577|FG001|Overall Study|Non-compliant|1|||
163174220|NCT00704522|589354838|FG000|Overall Study|Failure to appear again at hospital|56|||
163174221|NCT00704522|589354839|FG001|Overall Study|Failure to appear again at hospital|10|||
163174222|NCT00704522|589354838|FG000|Overall Study|Withdrawal by Subject|17|||
163174223|NCT00704522|589354839|FG001|Overall Study|Withdrawal by Subject|8|||
163174224|NCT00704522|589354838|FG000|Overall Study|Adverse Event|9|||
163174225|NCT00704522|589354839|FG001|Overall Study|Adverse Event|1|||
163174226|NCT00704522|589354838|FG000|Overall Study|Undefined causes|9|||
162932283|NCT00430638|588456576|FG000|Overall Study|Other|2|||
163174227|NCT00704522|589354839|FG001|Overall Study|Undefined causes|7|||
163174228|NCT00704522|589354838|FG000|Overall Study|No information on therapy end|27|||
163174229|NCT00704522|589354839|FG001|Overall Study|No information on therapy end|2|||
163174230|NCT04896229|589354840|FG000|Overall Study|Lost to Follow-up|113|||
163174231|NCT04896229|589354841|FG001|Overall Study|Lost to Follow-up|113|||
163174232|NCT00635024|589354842|FG000|Overall Study|Adverse Event|1|||
163174233|NCT01958489|589354843|FG000|Period 2|Adverse Event|0|||
163174234|NCT01958489|589354844|FG001|Period 2|Adverse Event|1|||
163174235|NCT00992589|589354845|FG000|Open-Label Phase|Adverse Event|4|||
163174236|NCT00992589|589354846|FG001|Open-Label Phase|Adverse Event|0|||
163174237|NCT00992589|589354847|FG002|Open-Label Phase|Adverse Event|0|||
163174238|NCT00992589|589354848|FG003|Open-Label Phase|Adverse Event|0|||
163174239|NCT00992589|589354845|FG000|Open-Label Phase|Withdrawal by Subject|20|||
163174240|NCT00992589|589354846|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163174241|NCT00992589|589354847|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163174242|NCT00992589|589354848|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163174243|NCT00992589|589354845|FG000|Open-Label Phase|Lost to Follow-up|1|||
163174244|NCT00992589|589354846|FG001|Open-Label Phase|Lost to Follow-up|0|||
163174245|NCT00992589|589354847|FG002|Open-Label Phase|Lost to Follow-up|0|||
163174246|NCT00992589|589354848|FG003|Open-Label Phase|Lost to Follow-up|0|||
163174247|NCT00992589|589354845|FG000|Open-Label Phase|Protocol Violation|3|||
163174248|NCT00992589|589354846|FG001|Open-Label Phase|Protocol Violation|0|||
163174249|NCT00992589|589354847|FG002|Open-Label Phase|Protocol Violation|0|||
163174250|NCT00992589|589354848|FG003|Open-Label Phase|Protocol Violation|0|||
163174251|NCT00992589|589354845|FG000|Open-Label Phase|Physician Decision|4|||
163174252|NCT00992589|589354846|FG001|Open-Label Phase|Physician Decision|0|||
163174253|NCT00992589|589354847|FG002|Open-Label Phase|Physician Decision|0|||
163174254|NCT00992589|589354848|FG003|Open-Label Phase|Physician Decision|0|||
163174255|NCT00992589|589354845|FG000|Open-Label Phase|Other|45|||
163174256|NCT00992589|589354846|FG001|Open-Label Phase|Other|0|||
163174257|NCT00992589|589354847|FG002|Open-Label Phase|Other|0|||
163174258|NCT00992589|589354848|FG003|Open-Label Phase|Other|0|||
163174259|NCT00992589|589354845|FG000|Double-Blind Phase|Adverse Event|0|||
163174260|NCT00992589|589354846|FG001|Double-Blind Phase|Adverse Event|6|||
163174261|NCT00992589|589354847|FG002|Double-Blind Phase|Adverse Event|2|||
163174262|NCT00992589|589354848|FG003|Double-Blind Phase|Adverse Event|3|||
163174263|NCT00992589|589354845|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163174264|NCT00992589|589354846|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
163174265|NCT00992589|589354847|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
163174266|NCT00992589|589354848|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
163174267|NCT00992589|589354845|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163174268|NCT00992589|589354846|FG001|Double-Blind Phase|Lost to Follow-up|0|||
163174269|NCT00992589|589354847|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163174270|NCT00992589|589354848|FG003|Double-Blind Phase|Lost to Follow-up|2|||
163174271|NCT00992589|589354845|FG000|Double-Blind Phase|Other|0|||
163174272|NCT00992589|589354846|FG001|Double-Blind Phase|Other|1|||
163174273|NCT00992589|589354847|FG002|Double-Blind Phase|Other|6|||
163174274|NCT00992589|589354848|FG003|Double-Blind Phase|Other|3|||
163174275|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
163174276|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174277|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174278|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174279|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174280|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174281|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174282|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174283|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
163174284|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Adverse Event|5|||
163174285|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Adverse Event|0|||
163174286|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Adverse Event|0|||
163174287|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Adverse Event|0|||
163174288|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Adverse Event|0|||
163174289|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Adverse Event|0|||
163174290|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Adverse Event|0|||
163174291|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Adverse Event|0|||
163174292|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Adverse Event|0|||
163174293|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
163174294|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174295|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174296|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
162825164|NCT03250832|588072401|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163174297|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174298|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174299|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174300|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174301|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
163174302|NCT00045942|589354849|FG000|PKC412A2104 (Core)|Death|1|||
163174303|NCT00045942|589354850|FG001|PKC412A2104 (Core)|Death|0|||
163174304|NCT00045942|589354851|FG002|PKC412A2104 (Core)|Death|0|||
163174305|NCT00045942|589354852|FG003|PKC412A2104 (Core)|Death|0|||
162825165|NCT03250832|588072402|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163174306|NCT00045942|589354853|FG004|PKC412A2104 (Core)|Death|0|||
163174307|NCT00045942|589354854|FG005|PKC412A2104 (Core)|Death|0|||
163174308|NCT00045942|589354855|FG006|PKC412A2104 (Core)|Death|0|||
163174309|NCT00045942|589354856|FG007|PKC412A2104 (Core)|Death|0|||
163174310|NCT00045942|589354857|FG008|PKC412A2104 (Core)|Death|0|||
163174311|NCT00045942|589354849|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
163174312|NCT00045942|589354850|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
162932284|NCT00430638|588456577|FG001|Overall Study|Other|2|||
162932285|NCT01529749|588456578|FG000|Overall Study|Lost to Follow-up|0|||
162932286|NCT01529749|588456579|FG001|Overall Study|Lost to Follow-up|1|||
162932287|NCT01529749|588456580|FG002|Overall Study|Lost to Follow-up|1|||
162932288|NCT01529749|588456581|FG003|Overall Study|Lost to Follow-up|0|||
162932289|NCT01529749|588456578|FG000|Overall Study|Physician Decision|0|||
162932290|NCT01529749|588456579|FG001|Overall Study|Physician Decision|0|||
162932291|NCT01529749|588456580|FG002|Overall Study|Physician Decision|0|||
162932292|NCT01529749|588456581|FG003|Overall Study|Physician Decision|1|||
162932293|NCT01529749|588456578|FG000|Overall Study|Withdrawal by Subject|0|||
162932294|NCT01529749|588456579|FG001|Overall Study|Withdrawal by Subject|1|||
162932295|NCT01529749|588456580|FG002|Overall Study|Withdrawal by Subject|1|||
163174313|NCT00045942|589354851|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
163174314|NCT00045942|589354852|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
163174315|NCT00045942|589354853|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
163174316|NCT00045942|589354854|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
163174317|NCT00045942|589354855|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
163174318|NCT00045942|589354856|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
163174319|NCT00045942|589354857|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
163174320|NCT00045942|589354849|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
163174321|NCT00045942|589354850|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
163174322|NCT00045942|589354851|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
163174323|NCT00045942|589354852|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
163174324|NCT00045942|589354853|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
163174325|NCT00045942|589354854|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
163174326|NCT00045942|589354855|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
163174327|NCT00045942|589354856|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
163174328|NCT00045942|589354857|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
163174329|NCT00045942|589354849|FG000|PKC412A2104E1|Lack of Efficacy|0|||
163174330|NCT00045942|589354850|FG001|PKC412A2104E1|Lack of Efficacy|11|||
163174331|NCT00045942|589354851|FG002|PKC412A2104E1|Lack of Efficacy|11|||
163174332|NCT00045942|589354852|FG003|PKC412A2104E1|Lack of Efficacy|23|||
163174333|NCT00045942|589354853|FG004|PKC412A2104E1|Lack of Efficacy|17|||
163174334|NCT00045942|589354854|FG005|PKC412A2104E1|Lack of Efficacy|0|||
163174335|NCT00045942|589354855|FG006|PKC412A2104E1|Lack of Efficacy|0|||
163174336|NCT00045942|589354856|FG007|PKC412A2104E1|Lack of Efficacy|0|||
163174337|NCT00045942|589354857|FG008|PKC412A2104E1|Lack of Efficacy|0|||
163174338|NCT00045942|589354849|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
163174339|NCT00045942|589354850|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
163174340|NCT00045942|589354851|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
163174341|NCT00045942|589354852|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
163174342|NCT00045942|589354853|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
163174343|NCT00045942|589354854|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
163174344|NCT00045942|589354855|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
163174345|NCT00045942|589354856|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
163174346|NCT00045942|589354857|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
163174347|NCT00045942|589354849|FG000|PKC412A2104E1|Adverse Event|0|||
163174348|NCT00045942|589354850|FG001|PKC412A2104E1|Adverse Event|1|||
163174349|NCT00045942|589354851|FG002|PKC412A2104E1|Adverse Event|1|||
163174350|NCT00045942|589354852|FG003|PKC412A2104E1|Adverse Event|3|||
163174351|NCT00045942|589354853|FG004|PKC412A2104E1|Adverse Event|6|||
163174352|NCT00045942|589354854|FG005|PKC412A2104E1|Adverse Event|0|||
163174353|NCT00045942|589354855|FG006|PKC412A2104E1|Adverse Event|0|||
163174354|NCT00045942|589354856|FG007|PKC412A2104E1|Adverse Event|0|||
163174355|NCT00045942|589354857|FG008|PKC412A2104E1|Adverse Event|0|||
163174356|NCT00045942|589354849|FG000|PKC412A2104E1|Death|0|||
163174357|NCT00045942|589354850|FG001|PKC412A2104E1|Death|4|||
163174358|NCT00045942|589354851|FG002|PKC412A2104E1|Death|1|||
163174359|NCT00045942|589354852|FG003|PKC412A2104E1|Death|1|||
162932296|NCT01529749|588456581|FG003|Overall Study|Withdrawal by Subject|0|||
162932297|NCT01529749|588456578|FG000|Overall Study|Protocol Violation|0|||
162932298|NCT01529749|588456579|FG001|Overall Study|Protocol Violation|0|||
162932299|NCT01529749|588456580|FG002|Overall Study|Protocol Violation|0|||
163174360|NCT00045942|589354853|FG004|PKC412A2104E1|Death|1|||
163174361|NCT00045942|589354854|FG005|PKC412A2104E1|Death|0|||
163174362|NCT00045942|589354855|FG006|PKC412A2104E1|Death|0|||
163174363|NCT00045942|589354856|FG007|PKC412A2104E1|Death|0|||
163174364|NCT00045942|589354857|FG008|PKC412A2104E1|Death|0|||
163174365|NCT00045942|589354849|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174366|NCT00045942|589354850|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174367|NCT00045942|589354851|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
163174368|NCT00045942|589354852|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
162932300|NCT01529749|588456581|FG003|Overall Study|Protocol Violation|1|||
163174369|NCT00045942|589354853|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174370|NCT00045942|589354854|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162698447|NCT02065570|587605507|FG001|Induction Study|Adverse Event|12|||
162932301|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Administrative problems|0|||
163174371|NCT00045942|589354855|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162698448|NCT02065570|587605508|FG002|Induction Study|Adverse Event|0|||
162698449|NCT02065570|587605509|FG003|Induction Study|Adverse Event|0|||
162932302|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Administrative problems|1|||
162932303|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
163174372|NCT00045942|589354856|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174373|NCT00045942|589354857|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
163174374|NCT00045942|589354849|FG000|PKC412A2104E2|Lost to Follow-up|0|||
163174375|NCT00045942|589354850|FG001|PKC412A2104E2|Lost to Follow-up|0|||
163174376|NCT00045942|589354851|FG002|PKC412A2104E2|Lost to Follow-up|0|||
163174377|NCT00045942|589354852|FG003|PKC412A2104E2|Lost to Follow-up|0|||
163174378|NCT00045942|589354853|FG004|PKC412A2104E2|Lost to Follow-up|0|||
163174379|NCT00045942|589354854|FG005|PKC412A2104E2|Lost to Follow-up|0|||
163174380|NCT00045942|589354855|FG006|PKC412A2104E2|Lost to Follow-up|0|||
163174381|NCT00045942|589354856|FG007|PKC412A2104E2|Lost to Follow-up|3|||
163174382|NCT00045942|589354857|FG008|PKC412A2104E2|Lost to Follow-up|0|||
163174383|NCT00045942|589354849|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
163174384|NCT00045942|589354850|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
163174385|NCT00045942|589354851|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
163174386|NCT00045942|589354852|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
163174387|NCT00045942|589354853|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
163174388|NCT00045942|589354854|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
163174389|NCT00045942|589354855|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
163174390|NCT00045942|589354856|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
163174391|NCT00045942|589354857|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
163174392|NCT00045942|589354849|FG000|PKC412A2104E2|Lack of Efficacy|0|||
163174393|NCT00045942|589354850|FG001|PKC412A2104E2|Lack of Efficacy|0|||
163174394|NCT00045942|589354851|FG002|PKC412A2104E2|Lack of Efficacy|0|||
163174395|NCT00045942|589354852|FG003|PKC412A2104E2|Lack of Efficacy|0|||
163174396|NCT00045942|589354853|FG004|PKC412A2104E2|Lack of Efficacy|0|||
163174397|NCT00045942|589354854|FG005|PKC412A2104E2|Lack of Efficacy|3|||
163174398|NCT00045942|589354855|FG006|PKC412A2104E2|Lack of Efficacy|2|||
163174399|NCT00045942|589354856|FG007|PKC412A2104E2|Lack of Efficacy|2|||
163174400|NCT00045942|589354857|FG008|PKC412A2104E2|Lack of Efficacy|6|||
163174401|NCT00045942|589354849|FG000|PKC412A2104E2|Adverse Event|0|||
163174402|NCT00045942|589354850|FG001|PKC412A2104E2|Adverse Event|0|||
163174403|NCT00045942|589354851|FG002|PKC412A2104E2|Adverse Event|0|||
163174404|NCT00045942|589354852|FG003|PKC412A2104E2|Adverse Event|0|||
163174405|NCT00045942|589354853|FG004|PKC412A2104E2|Adverse Event|0|||
163174406|NCT00045942|589354854|FG005|PKC412A2104E2|Adverse Event|4|||
163174407|NCT00045942|589354855|FG006|PKC412A2104E2|Adverse Event|3|||
163174408|NCT00045942|589354856|FG007|PKC412A2104E2|Adverse Event|1|||
163174409|NCT00045942|589354857|FG008|PKC412A2104E2|Adverse Event|0|||
163174410|NCT00045942|589354849|FG000|PKC412A2104E2|Death|0|||
163174411|NCT00045942|589354850|FG001|PKC412A2104E2|Death|0|||
163174412|NCT00045942|589354851|FG002|PKC412A2104E2|Death|0|||
163174413|NCT00045942|589354852|FG003|PKC412A2104E2|Death|0|||
163174414|NCT00045942|589354853|FG004|PKC412A2104E2|Death|0|||
163174415|NCT00045942|589354854|FG005|PKC412A2104E2|Death|1|||
163174416|NCT00045942|589354855|FG006|PKC412A2104E2|Death|2|||
163174417|NCT00045942|589354856|FG007|PKC412A2104E2|Death|0|||
163174418|NCT00045942|589354857|FG008|PKC412A2104E2|Death|0|||
163174419|NCT04575597|589354858|FG000|Overall Study|Death|0|||
163174420|NCT04575597|589354859|FG001|Overall Study|Death|0|||
163174421|NCT04575597|589354860|FG002|Overall Study|Death|0|||
163174422|NCT04575597|589354861|FG003|Overall Study|Death|1|||
163174423|NCT04575597|589354862|FG004|Overall Study|Death|3|||
163174424|NCT04575597|589354863|FG005|Overall Study|Death|14|||
163174425|NCT04575597|589354858|FG000|Overall Study|Lost to Follow-up|2|||
163174426|NCT04575597|589354859|FG001|Overall Study|Lost to Follow-up|1|||
163174427|NCT04575597|589354860|FG002|Overall Study|Lost to Follow-up|1|||
163174428|NCT04575597|589354861|FG003|Overall Study|Lost to Follow-up|2|||
163174429|NCT04575597|589354862|FG004|Overall Study|Lost to Follow-up|10|||
163174430|NCT04575597|589354863|FG005|Overall Study|Lost to Follow-up|8|||
163174431|NCT04575597|589354858|FG000|Overall Study|Withdrawal by Subject|2|||
163174432|NCT04575597|589354859|FG001|Overall Study|Withdrawal by Subject|2|||
163174433|NCT04575597|589354860|FG002|Overall Study|Withdrawal by Subject|4|||
163174434|NCT04575597|589354861|FG003|Overall Study|Withdrawal by Subject|2|||
163174435|NCT04575597|589354862|FG004|Overall Study|Withdrawal by Subject|25|||
163174436|NCT04575597|589354863|FG005|Overall Study|Withdrawal by Subject|28|||
163174437|NCT04575597|589354858|FG000|Overall Study|Not Recorded|0|||
163174438|NCT04575597|589354859|FG001|Overall Study|Not Recorded|0|||
163174439|NCT04575597|589354860|FG002|Overall Study|Not Recorded|0|||
163174440|NCT04575597|589354861|FG003|Overall Study|Not Recorded|0|||
163174441|NCT04575597|589354862|FG004|Overall Study|Not Recorded|0|||
163174442|NCT04575597|589354863|FG005|Overall Study|Not Recorded|2|||
163174443|NCT04575597|589354858|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174444|NCT04575597|589354859|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174445|NCT04575597|589354860|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174446|NCT04575597|589354861|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163174447|NCT04575597|589354862|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
163174448|NCT04575597|589354863|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163174449|NCT02095132|589354865|FG000|Overall Study|Adverse Event|0|||
163174450|NCT02095132|589354866|FG001|Overall Study|Adverse Event|0|||
163174451|NCT02095132|589354867|FG002|Overall Study|Adverse Event|0|||
163174452|NCT02095132|589354868|FG003|Overall Study|Adverse Event|0|||
163174453|NCT02095132|589354869|FG004|Overall Study|Adverse Event|1|||
163174454|NCT02095132|589354870|FG005|Overall Study|Adverse Event|0|||
163174455|NCT02095132|589354871|FG006|Overall Study|Adverse Event|1|||
163174456|NCT02095132|589354872|FG007|Overall Study|Adverse Event|0|||
163174457|NCT02095132|589354873|FG008|Overall Study|Adverse Event|0|||
163174458|NCT02095132|589354865|FG000|Overall Study|Death|0|||
163174459|NCT02095132|589354866|FG001|Overall Study|Death|0|||
163174460|NCT02095132|589354867|FG002|Overall Study|Death|0|||
163174461|NCT02095132|589354868|FG003|Overall Study|Death|0|||
163174462|NCT02095132|589354869|FG004|Overall Study|Death|0|||
163174463|NCT02095132|589354870|FG005|Overall Study|Death|0|||
163174464|NCT02095132|589354871|FG006|Overall Study|Death|1|||
163174465|NCT02095132|589354872|FG007|Overall Study|Death|0|||
163174466|NCT02095132|589354873|FG008|Overall Study|Death|0|||
163174467|NCT02095132|589354865|FG000|Overall Study|Lack of Efficacy|3|||
163174468|NCT02095132|589354866|FG001|Overall Study|Lack of Efficacy|5|||
163174469|NCT02095132|589354867|FG002|Overall Study|Lack of Efficacy|2|||
163174470|NCT02095132|589354868|FG003|Overall Study|Lack of Efficacy|8|||
163174471|NCT02095132|589354869|FG004|Overall Study|Lack of Efficacy|3|||
163174472|NCT02095132|589354870|FG005|Overall Study|Lack of Efficacy|6|||
162825166|NCT03250832|588072403|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825167|NCT03250832|588072404|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825168|NCT03250832|588072405|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
162825169|NCT03250832|588072406|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825170|NCT03250832|588072407|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163174473|NCT02095132|589354871|FG006|Overall Study|Lack of Efficacy|10|||
163174474|NCT02095132|589354872|FG007|Overall Study|Lack of Efficacy|9|||
163174475|NCT02095132|589354873|FG008|Overall Study|Lack of Efficacy|8|||
163174476|NCT02095132|589354865|FG000|Overall Study|Physician Decision|1|||
163174477|NCT02095132|589354866|FG001|Overall Study|Physician Decision|0|||
163174478|NCT02095132|589354867|FG002|Overall Study|Physician Decision|0|||
163174479|NCT02095132|589354868|FG003|Overall Study|Physician Decision|0|||
163174480|NCT02095132|589354869|FG004|Overall Study|Physician Decision|0|||
163174481|NCT02095132|589354870|FG005|Overall Study|Physician Decision|0|||
162825171|NCT03250832|588072408|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163174482|NCT02095132|589354871|FG006|Overall Study|Physician Decision|1|||
163174483|NCT02095132|589354872|FG007|Overall Study|Physician Decision|0|||
163174484|NCT02095132|589354873|FG008|Overall Study|Physician Decision|2|||
163174485|NCT02095132|589354865|FG000|Overall Study|Withdrawal by Subject|0|||
163174486|NCT02095132|589354866|FG001|Overall Study|Withdrawal by Subject|0|||
163174487|NCT02095132|589354867|FG002|Overall Study|Withdrawal by Subject|2|||
163174488|NCT02095132|589354868|FG003|Overall Study|Withdrawal by Subject|2|||
163174489|NCT02095132|589354869|FG004|Overall Study|Withdrawal by Subject|3|||
163174490|NCT02095132|589354870|FG005|Overall Study|Withdrawal by Subject|0|||
163174491|NCT02095132|589354871|FG006|Overall Study|Withdrawal by Subject|5|||
163174492|NCT02095132|589354872|FG007|Overall Study|Withdrawal by Subject|0|||
163174493|NCT02095132|589354873|FG008|Overall Study|Withdrawal by Subject|0|||
163174494|NCT04905498|589354876|FG000|Overall Study|Lost to Follow-up|0|||
163174495|NCT04905498|589354877|FG001|Overall Study|Lost to Follow-up|2|||
163174496|NCT04905498|589354876|FG000|Overall Study|COVID lockdown|1|||
163174497|NCT04905498|589354877|FG001|Overall Study|COVID lockdown|0|||
163174498|NCT01029405|589354878|FG000|Overall Study|Withdrawal by Subject|0|||
163174499|NCT01029405|589354879|FG001|Overall Study|Withdrawal by Subject|1|||
163174500|NCT01029405|589354880|FG002|Overall Study|Withdrawal by Subject|2|||
163174501|NCT01029405|589354881|FG003|Overall Study|Withdrawal by Subject|0|||
163174502|NCT01029405|589354878|FG000|Overall Study|Protocol Violation|0|||
163174503|NCT01029405|589354879|FG001|Overall Study|Protocol Violation|0|||
163174504|NCT01029405|589354880|FG002|Overall Study|Protocol Violation|0|||
163174505|NCT01029405|589354881|FG003|Overall Study|Protocol Violation|1|||
163174506|NCT01029405|589354878|FG000|Overall Study|Adverse Event|0|||
163174507|NCT01029405|589354879|FG001|Overall Study|Adverse Event|0|||
163174508|NCT01029405|589354880|FG002|Overall Study|Adverse Event|1|||
163174509|NCT01029405|589354881|FG003|Overall Study|Adverse Event|1|||
163174510|NCT01029405|589354878|FG000|Overall Study|Lost to Follow-up|2|||
163174511|NCT01029405|589354879|FG001|Overall Study|Lost to Follow-up|1|||
163174512|NCT01029405|589354880|FG002|Overall Study|Lost to Follow-up|1|||
163174513|NCT01029405|589354881|FG003|Overall Study|Lost to Follow-up|2|||
163174514|NCT01029405|589354878|FG000|Overall Study|Other|0|||
163174515|NCT01029405|589354879|FG001|Overall Study|Other|1|||
163174516|NCT01029405|589354880|FG002|Overall Study|Other|0|||
163174517|NCT01029405|589354881|FG003|Overall Study|Other|1|||
163174518|NCT01268579|589354882|FG000|Overall Study|Adverse Event|1|||
163174519|NCT01268579|589354882|FG000|Overall Study|Withdrawal by Subject|2|||
163174520|NCT03312751|589354883|FG000|Overall Study|Death|7|||
163174521|NCT03312751|589354884|FG001|Overall Study|Death|9|||
163174522|NCT03312751|589354883|FG000|Overall Study|Study discontinuation due to other reason|0|||
163174523|NCT03312751|589354884|FG001|Overall Study|Study discontinuation due to other reason|1|||
162825172|NCT03250832|588072409|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
162825173|NCT03250832|588072398|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825174|NCT03250832|588072399|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825175|NCT03250832|588072400|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825176|NCT03250832|588072401|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
163174524|NCT05463198|589354885|FG000|Overall Study|Withdrawal by Subject|19|||
163174525|NCT05463198|589354885|FG000|Overall Study|Procedure Notes Missing|18|||
163174526|NCT00420641|589354888|FG000|Overall Study|Adverse Event|3|||
163174527|NCT00420641|589354889|FG001|Overall Study|Adverse Event|25|||
163174528|NCT00420641|589354890|FG002|Overall Study|Adverse Event|10|||
163174529|NCT00420641|589354888|FG000|Overall Study|Lost to Follow-up|2|||
163174530|NCT00420641|589354889|FG001|Overall Study|Lost to Follow-up|4|||
163174531|NCT00420641|589354890|FG002|Overall Study|Lost to Follow-up|2|||
163174532|NCT00420641|589354888|FG000|Overall Study|Protocol Violation|8|||
162825177|NCT03250832|588072402|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825178|NCT03250832|588072403|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825179|NCT03250832|588072404|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825180|NCT03250832|588072405|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
162825181|NCT03250832|588072406|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825182|NCT03250832|588072407|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825183|NCT03250832|588072408|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825184|NCT03250832|588072409|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
162825185|NCT03250832|588072398|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825186|NCT03250832|588072399|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825187|NCT03250832|588072400|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825188|NCT03250832|588072401|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
163174533|NCT00420641|589354889|FG001|Overall Study|Protocol Violation|8|||
163174534|NCT00420641|589354890|FG002|Overall Study|Protocol Violation|7|||
163174535|NCT00420641|589354888|FG000|Overall Study|Withdrawal by Subject|15|||
163174536|NCT00420641|589354889|FG001|Overall Study|Withdrawal by Subject|21|||
163174537|NCT00420641|589354890|FG002|Overall Study|Withdrawal by Subject|14|||
163174538|NCT00420641|589354888|FG000|Overall Study|Lack of Efficacy|6|||
163174539|NCT00420641|589354889|FG001|Overall Study|Lack of Efficacy|5|||
163174540|NCT00420641|589354890|FG002|Overall Study|Lack of Efficacy|4|||
163174541|NCT00420641|589354888|FG000|Overall Study|Non-compliance|7|||
163174542|NCT00420641|589354889|FG001|Overall Study|Non-compliance|5|||
163174543|NCT00420641|589354890|FG002|Overall Study|Non-compliance|4|||
162932304|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
162932305|NCT00789828|588456582|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
162932306|NCT00789828|588456583|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
162932307|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
162932308|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
162932309|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
162932310|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
162932311|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
162932312|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
162932313|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
162932314|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
162932315|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Death|1|||
162932316|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Death|0|||
162932317|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
162932318|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
162932319|NCT00789828|588456582|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
162932320|NCT00789828|588456583|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
162932321|NCT02623426|588456584|FG000|Overall Study|Lost to Follow-up|0|||
162932322|NCT02623426|588456585|FG001|Overall Study|Lost to Follow-up|0|||
162932323|NCT02623426|588456586|FG002|Overall Study|Lost to Follow-up|1|||
162932324|NCT02623426|588456584|FG000|Overall Study|Withdrawal by Subject|1|||
162932325|NCT02623426|588456585|FG001|Overall Study|Withdrawal by Subject|2|||
162932326|NCT02623426|588456586|FG002|Overall Study|Withdrawal by Subject|2|||
162932327|NCT02094937|588456587|FG000|8 Weeks in Period 1|Adverse Event|9|||
162932328|NCT02094937|588456588|FG001|8 Weeks in Period 1|Adverse Event|0|||
162932329|NCT02094937|588456589|FG002|8 Weeks in Period 1|Adverse Event|0|||
162932330|NCT02094937|588456590|FG003|8 Weeks in Period 1|Adverse Event|0|||
162932331|NCT02094937|588456587|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
162932332|NCT02094937|588456588|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
162932333|NCT02094937|588456589|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
162932334|NCT02094937|588456590|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
162932335|NCT02094937|588456587|FG000|8 Weeks in Period 1|Protocol Violation|2|||
162932336|NCT02094937|588456588|FG001|8 Weeks in Period 1|Protocol Violation|0|||
162932337|NCT02094937|588456589|FG002|8 Weeks in Period 1|Protocol Violation|0|||
162932338|NCT02094937|588456590|FG003|8 Weeks in Period 1|Protocol Violation|0|||
162932339|NCT02094937|588456587|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
162932340|NCT02094937|588456588|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932341|NCT02094937|588456589|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932342|NCT02094937|588456590|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
162932343|NCT02094937|588456587|FG000|8 Weeks in Period 1|Physician Decision|1|||
162932344|NCT02094937|588456588|FG001|8 Weeks in Period 1|Physician Decision|0|||
162932345|NCT02094937|588456589|FG002|8 Weeks in Period 1|Physician Decision|0|||
162932346|NCT02094937|588456590|FG003|8 Weeks in Period 1|Physician Decision|0|||
162932347|NCT02094937|588456587|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
162932348|NCT02094937|588456588|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932349|NCT02094937|588456589|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932350|NCT02094937|588456590|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
162932351|NCT02094937|588456587|FG000|12 Weeks in Period 2|Adverse Event|0|||
162932352|NCT02094937|588456588|FG001|12 Weeks in Period 2|Adverse Event|2|||
162932353|NCT02094937|588456589|FG002|12 Weeks in Period 2|Adverse Event|4|||
162932354|NCT02094937|588456590|FG003|12 Weeks in Period 2|Adverse Event|1|||
162932355|NCT02094937|588456587|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
162932356|NCT02094937|588456588|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
162932357|NCT02094937|588456589|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
162932358|NCT02094937|588456590|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
162932359|NCT02094937|588456587|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
162932360|NCT02094937|588456588|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
162932361|NCT02094937|588456589|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
162932362|NCT02094937|588456590|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
163174544|NCT00420641|589354888|FG000|Overall Study|Other|4|||
163174545|NCT00420641|589354889|FG001|Overall Study|Other|4|||
163174546|NCT00420641|589354890|FG002|Overall Study|Other|3|||
163174547|NCT02815280|589354898|FG000|Double-Blind Phase|Adverse Event|1|||
162932363|NCT02094937|588456587|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
162932364|NCT02094937|588456588|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
162932365|NCT02094937|588456589|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
162932366|NCT02094937|588456590|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
162932367|NCT02094937|588456587|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
163174548|NCT02815280|589354899|FG001|Double-Blind Phase|Adverse Event|1|||
162932368|NCT02094937|588456588|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
162932369|NCT02094937|588456589|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
163174549|NCT02815280|589354898|FG000|Double-Blind Phase|Lost to Follow-up|10|||
163174550|NCT02815280|589354899|FG001|Double-Blind Phase|Lost to Follow-up|9|||
163174551|NCT02815280|589354898|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
163174552|NCT02815280|589354899|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
163174553|NCT02815280|589354898|FG000|Double-Blind Phase|Protocol Violation|2|||
163174554|NCT02815280|589354899|FG001|Double-Blind Phase|Protocol Violation|2|||
163174555|NCT02815280|589354898|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
163174556|NCT02815280|589354899|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
163174557|NCT02815280|589354898|FG000|Open-Label Phase|Adverse Event|2|||
163174558|NCT02815280|589354899|FG001|Open-Label Phase|Adverse Event|3|||
163174559|NCT02815280|589354898|FG000|Open-Label Phase|Lost to Follow-up|18|||
163174560|NCT02815280|589354899|FG001|Open-Label Phase|Lost to Follow-up|9|||
163174561|NCT02815280|589354898|FG000|Open-Label Phase|Withdrawal by Subject|33|||
163174562|NCT02815280|589354899|FG001|Open-Label Phase|Withdrawal by Subject|18|||
163174563|NCT02815280|589354898|FG000|Open-Label Phase|Protocol Violation|3|||
163174564|NCT02815280|589354899|FG001|Open-Label Phase|Protocol Violation|0|||
163174565|NCT02815280|589354898|FG000|Open-Label Phase|Administrative|26|||
163174566|NCT02815280|589354899|FG001|Open-Label Phase|Administrative|12|||
163174567|NCT02815280|589354898|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
163174568|NCT02815280|589354899|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
163174569|NCT01944839|589354902|FG000|Overall Study|Physician Decision|2|||
163174570|NCT01944839|589354903|FG001|Overall Study|Physician Decision|2|||
163174571|NCT01944839|589354902|FG000|Overall Study|Protocol Violation|0|||
163174572|NCT01944839|589354903|FG001|Overall Study|Protocol Violation|1|||
163174573|NCT01944839|589354902|FG000|Overall Study|Adverse Event|10|||
163174574|NCT01944839|589354903|FG001|Overall Study|Adverse Event|5|||
163174575|NCT01944839|589354902|FG000|Overall Study|Withdrawal by Subject|9|||
163174576|NCT01944839|589354903|FG001|Overall Study|Withdrawal by Subject|17|||
163174577|NCT01944839|589354902|FG000|Overall Study|Lost to Follow-up|1|||
163174578|NCT01944839|589354903|FG001|Overall Study|Lost to Follow-up|0|||
163174579|NCT01944839|589354902|FG000|Overall Study|Subject non-compliance|0|||
163174580|NCT01944839|589354903|FG001|Overall Study|Subject non-compliance|3|||
163174581|NCT00609362|589354904|FG000|Overall Study|Withdrawal by Subject|2|||
163174582|NCT00609362|589354905|FG001|Overall Study|Withdrawal by Subject|1|||
163174583|NCT00609362|589354904|FG000|Overall Study|Adverse Event|1|||
163174584|NCT00609362|589354905|FG001|Overall Study|Adverse Event|0|||
163174585|NCT05093790|589354906|FG000|Overall Study|Failure to meet continuation criteria|0|||
163174586|NCT05093790|589354907|FG001|Overall Study|Failure to meet continuation criteria|0|||
163174587|NCT05093790|589354908|FG002|Overall Study|Failure to meet continuation criteria|1|||
163174588|NCT05093790|589354909|FG003|Overall Study|Failure to meet continuation criteria|0|||
163174589|NCT05093790|589354906|FG000|Overall Study|Adverse Event|1|||
163174590|NCT05093790|589354907|FG001|Overall Study|Adverse Event|0|||
163174591|NCT05093790|589354908|FG002|Overall Study|Adverse Event|0|||
163174592|NCT05093790|589354909|FG003|Overall Study|Adverse Event|0|||
163174593|NCT05027971|589354919|FG000|Overall Study|Physician Decision|7|||
163174594|NCT05027971|589354920|FG001|Overall Study|Physician Decision|3|||
163174595|NCT05027971|589354919|FG000|Overall Study|Lost to Follow-up|1|||
163174596|NCT05027971|589354920|FG001|Overall Study|Lost to Follow-up|1|||
163174597|NCT05027971|589354919|FG000|Overall Study|Withdrawal by Subject|0|||
163174598|NCT05027971|589354920|FG001|Overall Study|Withdrawal by Subject|2|||
162698450|NCT02065570|587605506|FG000|Induction Study|Withdrawal by Subject|2|||
162698451|NCT02065570|587605507|FG001|Induction Study|Withdrawal by Subject|3|||
162932370|NCT02094937|588456590|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
162932371|NCT05458895|588456591|FG000|Overall Study|Withdrawal by Subject|8|||
163174599|NCT05027971|589354919|FG000|Overall Study|Non-study fiber used.|0|||
163174600|NCT05027971|589354920|FG001|Overall Study|Non-study fiber used.|1|||
163174601|NCT05027971|589354919|FG000|Overall Study|Protocol Violation|0|||
163174602|NCT05027971|589354920|FG001|Overall Study|Protocol Violation|2|||
163174603|NCT02025556|589354921|FG000|Overall Study|Adverse Event|0|||
163174604|NCT02025556|589354922|FG001|Overall Study|Adverse Event|4|||
163174605|NCT02025556|589354923|FG002|Overall Study|Adverse Event|2|||
163174606|NCT02025556|589354921|FG000|Overall Study|Lack of Efficacy|2|||
163174607|NCT02025556|589354922|FG001|Overall Study|Lack of Efficacy|1|||
163174608|NCT02025556|589354923|FG002|Overall Study|Lack of Efficacy|0|||
163174609|NCT02025556|589354921|FG000|Overall Study|Protocol Violation|2|||
163174610|NCT02025556|589354922|FG001|Overall Study|Protocol Violation|1|||
163174611|NCT02025556|589354923|FG002|Overall Study|Protocol Violation|0|||
163174612|NCT02025556|589354921|FG000|Overall Study|Withdrawal by Subject|0|||
163174613|NCT02025556|589354922|FG001|Overall Study|Withdrawal by Subject|3|||
163174614|NCT02025556|589354923|FG002|Overall Study|Withdrawal by Subject|6|||
163174615|NCT02025556|589354921|FG000|Overall Study|Lost to Follow-up|2|||
163174616|NCT02025556|589354922|FG001|Overall Study|Lost to Follow-up|4|||
163174617|NCT02025556|589354923|FG002|Overall Study|Lost to Follow-up|0|||
163174618|NCT02025556|589354921|FG000|Overall Study|Reason not reported|0|||
163174619|NCT02025556|589354922|FG001|Overall Study|Reason not reported|0|||
163174620|NCT02025556|589354923|FG002|Overall Study|Reason not reported|1|||
163174621|NCT02582684|589354925|FG000|Overall Study|Unable to contact subject/parent|4|||
163174622|NCT02582684|589354925|FG000|Overall Study|Subject not able to get to clinic|10|||
163174623|NCT02582684|589354925|FG000|Overall Study|Subject withdrew consent|1|||
163174624|NCT02582684|589354925|FG000|Overall Study|Found to be ineligible after enrollment|2|||
163174625|NCT01587898|589354926|FG000|Overall Study|Adverse Event|1|||
163174626|NCT01587898|589354927|FG001|Overall Study|Adverse Event|1|||
163174627|NCT01587898|589354928|FG002|Overall Study|Adverse Event|0|||
163174628|NCT01587898|589354929|FG003|Overall Study|Adverse Event|0|||
163174629|NCT01587898|589354926|FG000|Overall Study|Protocol Violation|0|||
163174630|NCT01587898|589354927|FG001|Overall Study|Protocol Violation|2|||
163174631|NCT01587898|589354928|FG002|Overall Study|Protocol Violation|1|||
163174632|NCT01587898|589354929|FG003|Overall Study|Protocol Violation|1|||
163174633|NCT01587898|589354926|FG000|Overall Study|Lost to Follow-up|0|||
163174634|NCT01587898|589354927|FG001|Overall Study|Lost to Follow-up|0|||
163174635|NCT01587898|589354928|FG002|Overall Study|Lost to Follow-up|0|||
163174636|NCT01587898|589354929|FG003|Overall Study|Lost to Follow-up|1|||
163174637|NCT01587898|589354926|FG000|Overall Study|Withdrawal by Subject|2|||
163174638|NCT01587898|589354927|FG001|Overall Study|Withdrawal by Subject|1|||
163174639|NCT01587898|589354928|FG002|Overall Study|Withdrawal by Subject|0|||
163174640|NCT01587898|589354929|FG003|Overall Study|Withdrawal by Subject|0|||
163174641|NCT01587898|589354926|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
163174642|NCT01587898|589354927|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
163174643|NCT01587898|589354928|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
163174644|NCT01587898|589354929|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
163174645|NCT00796991|589354931|FG000|Overall Study|Adverse Event|0|||
162825189|NCT03250832|588072402|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825190|NCT03250832|588072403|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825191|NCT03250832|588072404|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825192|NCT03250832|588072405|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825193|NCT03250832|588072406|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
162825194|NCT03250832|588072407|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
162825195|NCT03250832|588072408|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825196|NCT03250832|588072409|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
162825197|NCT03250832|588072398|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825198|NCT03250832|588072399|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825199|NCT03250832|588072400|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162932372|NCT05458895|588456591|FG000|Overall Study|Lost to Follow-up|17|||
162932373|NCT05458895|588456591|FG000|Overall Study|Pregnancy|2|||
162932374|NCT05458895|588456591|FG000|Overall Study|Withdrawal by Study Team|1|||
163174646|NCT00796991|589354932|FG001|Overall Study|Adverse Event|0|||
163174647|NCT00796991|589354933|FG002|Overall Study|Adverse Event|1|||
163174648|NCT00796991|589354931|FG000|Overall Study|Death|2|||
163174649|NCT00796991|589354932|FG001|Overall Study|Death|0|||
163174650|NCT00796991|589354933|FG002|Overall Study|Death|0|||
163174651|NCT00796991|589354931|FG000|Overall Study|Disease Progression|10|||
163174652|NCT00796991|589354932|FG001|Overall Study|Disease Progression|9|||
163174653|NCT00796991|589354933|FG002|Overall Study|Disease Progression|7|||
163174654|NCT00796991|589354931|FG000|Overall Study|Study Drug Toxicity|3|||
163174655|NCT00796991|589354932|FG001|Overall Study|Study Drug Toxicity|3|||
163174656|NCT00796991|589354933|FG002|Overall Study|Study Drug Toxicity|5|||
163174657|NCT00796991|589354931|FG000|Overall Study|Withdrawal by Subject|0|||
163174658|NCT00796991|589354932|FG001|Overall Study|Withdrawal by Subject|0|||
163174659|NCT00796991|589354933|FG002|Overall Study|Withdrawal by Subject|1|||
162932375|NCT04639310|588456592|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
162932376|NCT04639310|588456593|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
162932377|NCT05166421|588456594|FG000|Overall Study|Other|3|||
162932378|NCT05166421|588456595|FG001|Overall Study|Other|1|||
162932379|NCT05166421|588456596|FG002|Overall Study|Other|1|||
162932380|NCT05166421|588456594|FG000|Overall Study|Withdrawal by Subject|5|||
162932381|NCT05166421|588456595|FG001|Overall Study|Withdrawal by Subject|3|||
162932382|NCT05166421|588456596|FG002|Overall Study|Withdrawal by Subject|6|||
162932383|NCT05166421|588456594|FG000|Overall Study|Lost to Follow-up|4|||
162932384|NCT05166421|588456595|FG001|Overall Study|Lost to Follow-up|1|||
162932385|NCT05166421|588456596|FG002|Overall Study|Lost to Follow-up|7|||
162932386|NCT03262233|588458471|FG000|Overall Study|Withdrawal by Subject|12|||
162932387|NCT03262233|588458472|FG001|Overall Study|Withdrawal by Subject|8|||
163174660|NCT02437110|589354935|FG000|Screening|Lost to Follow-up|3|||
163174661|NCT02437110|589354935|FG000|Screening|Physician Decision|1|||
163174662|NCT02437110|589354935|FG000|ART|Adverse Event|3|||
163174663|NCT02437110|589354935|FG000|ART|Protocol Violation|3|||
163174664|NCT02437110|589354935|FG000|ART|Withdrawal by Subject|4|||
163174665|NCT02437110|589354935|FG000|ART|Lost to follow-up prior to start of intervention|1|||
163174666|NCT02437110|589354935|FG000|ART|Physician decision prior to start of intervention|2|||
163174667|NCT02437110|589354935|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
163174668|NCT02437110|589354935|FG000|Post-ART|Lost to Follow-up|3|||
163174669|NCT02437110|589354935|FG000|Post-ART|Protocol Violation|4|||
163174670|NCT02437110|589354935|FG000|Post-ART|Withdrawal by Subject|3|||
163174671|NCT00171834|589354936|FG000|Overall Study|Adverse Event|2|||
163174672|NCT00171834|589354937|FG001|Overall Study|Adverse Event|1|||
163174673|NCT00171834|589354938|FG002|Overall Study|Adverse Event|3|||
163174674|NCT00171834|589354939|FG003|Overall Study|Adverse Event|2|||
163174675|NCT00171834|589354940|FG004|Overall Study|Adverse Event|2|||
163174676|NCT00171834|589354941|FG005|Overall Study|Adverse Event|15|||
163174677|NCT00171834|589354942|FG006|Overall Study|Adverse Event|1|||
163174678|NCT00171834|589354936|FG000|Overall Study|Withdrawal by Subject|0|||
163174679|NCT00171834|589354937|FG001|Overall Study|Withdrawal by Subject|2|||
163174680|NCT00171834|589354938|FG002|Overall Study|Withdrawal by Subject|0|||
163174681|NCT00171834|589354939|FG003|Overall Study|Withdrawal by Subject|1|||
163174682|NCT00171834|589354940|FG004|Overall Study|Withdrawal by Subject|1|||
163174683|NCT00171834|589354941|FG005|Overall Study|Withdrawal by Subject|1|||
163174684|NCT00171834|589354942|FG006|Overall Study|Withdrawal by Subject|0|||
163174685|NCT00171834|589354936|FG000|Overall Study|Death from study indication|0|||
163174686|NCT00171834|589354937|FG001|Overall Study|Death from study indication|1|||
163174687|NCT00171834|589354938|FG002|Overall Study|Death from study indication|0|||
163174688|NCT00171834|589354939|FG003|Overall Study|Death from study indication|0|||
163174689|NCT00171834|589354940|FG004|Overall Study|Death from study indication|1|||
163174690|NCT00171834|589354941|FG005|Overall Study|Death from study indication|0|||
163174691|NCT00171834|589354942|FG006|Overall Study|Death from study indication|0|||
163174692|NCT00171834|589354936|FG000|Overall Study|Disease Progression|4|||
163174693|NCT00171834|589354937|FG001|Overall Study|Disease Progression|8|||
163174694|NCT00171834|589354938|FG002|Overall Study|Disease Progression|8|||
163174695|NCT00171834|589354939|FG003|Overall Study|Disease Progression|9|||
163174696|NCT00171834|589354940|FG004|Overall Study|Disease Progression|2|||
163174697|NCT00171834|589354941|FG005|Overall Study|Disease Progression|18|||
163174698|NCT00171834|589354942|FG006|Overall Study|Disease Progression|3|||
163174699|NCT00171834|589354936|FG000|Overall Study|Treatment Duration Completed|0|||
163174700|NCT00171834|589354937|FG001|Overall Study|Treatment Duration Completed|0|||
163174701|NCT00171834|589354938|FG002|Overall Study|Treatment Duration Completed|1|||
163174702|NCT00171834|589354939|FG003|Overall Study|Treatment Duration Completed|0|||
163174703|NCT00171834|589354940|FG004|Overall Study|Treatment Duration Completed|2|||
163174704|NCT00171834|589354941|FG005|Overall Study|Treatment Duration Completed|1|||
163174705|NCT00171834|589354942|FG006|Overall Study|Treatment Duration Completed|0|||
163174706|NCT01261780|589354943|FG000|Overall Study|Withdrawal by Subject|1|||
163174707|NCT01261780|589354944|FG001|Overall Study|Withdrawal by Subject|0|||
163174708|NCT01261780|589354943|FG000|Overall Study|Event not related to subject|1|||
163174709|NCT01261780|589354944|FG001|Overall Study|Event not related to subject|2|||
163174710|NCT01239732|589354945|FG000|Overall Study|Termination of study per protocol|667|||
163174711|NCT01239732|589354945|FG000|Overall Study|Death|226|||
163174712|NCT01239732|589354945|FG000|Overall Study|Withdrawal by Subject|87|||
163174713|NCT01239732|589354945|FG000|Overall Study|Adverse Event|6|||
163174714|NCT01239732|589354945|FG000|Overall Study|Protocol Violation|3|||
163174715|NCT01239732|589354945|FG000|Overall Study|Participant non compliance|5|||
163174716|NCT01239732|589354945|FG000|Overall Study|Study termination by sponsor|2|||
163174717|NCT01239732|589354945|FG000|Overall Study|Investigator's decision|4|||
163174718|NCT01239732|589354945|FG000|Overall Study|Treatment failure|2|||
163174719|NCT01239732|589354945|FG000|Overall Study|Other|19|||
162932388|NCT03262233|588458473|FG002|Overall Study|Withdrawal by Subject|21|||
162932389|NCT03262233|588458474|FG003|Overall Study|Withdrawal by Subject|13|||
163174720|NCT02015221|589354948|FG000|Overall Study|Withdrawal by Subject|8|||
162932390|NCT03262233|588458471|FG000|Overall Study|Declined due to shock|1|||
162932391|NCT03262233|588458472|FG001|Overall Study|Declined due to shock|2|||
162932392|NCT03262233|588458473|FG002|Overall Study|Declined due to shock|2|||
162932393|NCT03262233|588458474|FG003|Overall Study|Declined due to shock|3|||
162932394|NCT03262233|588458471|FG000|Overall Study|Protocol Violation|5|||
162932395|NCT03262233|588458472|FG001|Overall Study|Protocol Violation|10|||
162932396|NCT03262233|588458473|FG002|Overall Study|Protocol Violation|2|||
162932397|NCT03262233|588458474|FG003|Overall Study|Protocol Violation|13|||
163174721|NCT02015221|589354949|FG001|Overall Study|Withdrawal by Subject|6|||
163174722|NCT02015221|589354948|FG000|Overall Study|Lost to Follow-up|1|||
163174723|NCT02015221|589354949|FG001|Overall Study|Lost to Follow-up|0|||
163174724|NCT01306929|589354950|FG000|Overall Study|Withdrawal by Subject|23|||
163174725|NCT01306929|589354950|FG000|Overall Study|Adverse Event|21|||
163174726|NCT01306929|589354950|FG000|Overall Study|Physician Decision|13|||
163174727|NCT01306929|589354950|FG000|Overall Study|Death|8|||
163174728|NCT01306929|589354950|FG000|Overall Study|Withdrawal by parent/guardian|5|||
163174729|NCT01306929|589354950|FG000|Overall Study|Protocol Violation|3|||
163174730|NCT01306929|589354950|FG000|Overall Study|Non-compliance with study drug|2|||
163174731|NCT01306929|589354950|FG000|Overall Study|Lost to Follow-up|2|||
163174732|NCT01306929|589354950|FG000|Overall Study|Various|17|||
163174733|NCT01870076|589354951|FG000|Overall Study|Withdrawal by Subject|1|||
163174734|NCT01870076|589354952|FG001|Overall Study|Withdrawal by Subject|0|||
163174735|NCT01870076|589354953|FG002|Overall Study|Withdrawal by Subject|1|||
163174736|NCT01870076|589354954|FG003|Overall Study|Withdrawal by Subject|0|||
163174737|NCT03041129|589354955|FG000|Overall Study|Withdrawal by Subject|2|||
163174738|NCT03041129|589354956|FG001|Overall Study|Withdrawal by Subject|0|||
163174739|NCT03041129|589354957|FG002|Overall Study|Withdrawal by Subject|0|||
163174740|NCT03041129|589354958|FG003|Overall Study|Withdrawal by Subject|0|||
163174741|NCT00436501|589354963|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
163174742|NCT00436501|589354964|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
163174743|NCT00436501|589354963|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
163174744|NCT00436501|589354964|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
163174745|NCT00608569|589354977|FG000|Overall Study|Death|4|||
163174746|NCT00608569|589354978|FG001|Overall Study|Death|3|||
163174747|NCT00608569|589354977|FG000|Overall Study|Lost to Follow-up|4|||
163174748|NCT00608569|589354978|FG001|Overall Study|Lost to Follow-up|5|||
163174749|NCT00608569|589354977|FG000|Overall Study|Withdrawal by Subject|1|||
163174750|NCT00608569|589354978|FG001|Overall Study|Withdrawal by Subject|0|||
163174751|NCT00608569|589354977|FG000|Overall Study|Adverse Event|1|||
163174752|NCT00608569|589354978|FG001|Overall Study|Adverse Event|0|||
163174753|NCT00608569|589354977|FG000|Overall Study|Unable to adhere with study requirements|0|||
163174754|NCT00608569|589354978|FG001|Overall Study|Unable to adhere with study requirements|1|||
163174755|NCT03011892|589354979|FG000|Double Blind (DB) Period|Adverse Event|0|||
163174756|NCT03011892|589354980|FG001|Double Blind (DB) Period|Adverse Event|1|||
163174757|NCT03011892|589354981|FG002|Double Blind (DB) Period|Adverse Event|1|||
163174758|NCT03011892|589354982|FG003|Double Blind (DB) Period|Adverse Event|0|||
163174759|NCT03011892|589354983|FG004|Double Blind (DB) Period|Adverse Event|0|||
163174760|NCT03011892|589354984|FG005|Double Blind (DB) Period|Adverse Event|0|||
163174761|NCT03011892|589354985|FG006|Double Blind (DB) Period|Adverse Event|0|||
163174762|NCT03011892|589354986|FG007|Double Blind (DB) Period|Adverse Event|0|||
163174763|NCT03011892|589354987|FG008|Double Blind (DB) Period|Adverse Event|0|||
163174764|NCT03011892|589354988|FG009|Double Blind (DB) Period|Adverse Event|0|||
163174765|NCT03011892|589354989|FG010|Double Blind (DB) Period|Adverse Event|0|||
163174766|NCT03011892|589354990|FG011|Double Blind (DB) Period|Adverse Event|0|||
163174767|NCT03011892|589354979|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
163174768|NCT03011892|589354980|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
163174769|NCT03011892|589354981|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
163174770|NCT03011892|589354982|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
163174771|NCT03011892|589354983|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
163174772|NCT03011892|589354984|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
163174773|NCT03011892|589354985|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
163174774|NCT03011892|589354986|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
163174775|NCT03011892|589354987|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
163174776|NCT03011892|589354988|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
163174777|NCT03011892|589354989|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
163174778|NCT03011892|589354990|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
163174779|NCT03011892|589354979|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
163174780|NCT03011892|589354980|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
163174781|NCT03011892|589354981|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
163174782|NCT03011892|589354982|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
163174783|NCT03011892|589354983|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
163174784|NCT03011892|589354984|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
163174785|NCT03011892|589354985|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
163174786|NCT03011892|589354986|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
162932398|NCT03262233|588458471|FG000|Overall Study|data collection artifact|0|||
162698452|NCT02065570|587605508|FG002|Induction Study|Withdrawal by Subject|0|||
162698453|NCT02065570|587605509|FG003|Induction Study|Withdrawal by Subject|0|||
162698454|NCT02065570|587605506|FG000|Induction Study|Lost to Follow-up|1|||
162698455|NCT02065570|587605507|FG001|Induction Study|Lost to Follow-up|1|||
162698456|NCT02065570|587605508|FG002|Induction Study|Lost to Follow-up|0|||
162698457|NCT02065570|587605509|FG003|Induction Study|Lost to Follow-up|0|||
162698458|NCT02065570|587605506|FG000|Induction Study|Other, Not Specified|6|||
162698459|NCT02065570|587605507|FG001|Induction Study|Other, Not Specified|5|||
162698460|NCT02065570|587605508|FG002|Induction Study|Other, Not Specified|0|||
162698461|NCT02065570|587605509|FG003|Induction Study|Other, Not Specified|0|||
162698462|NCT02065570|587605506|FG000|Maintenance Study|Adverse Event|0|||
162698463|NCT02065570|587605507|FG001|Maintenance Study|Adverse Event|0|||
162825200|NCT03250832|588072401|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825201|NCT03250832|588072402|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825202|NCT03250832|588072403|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825203|NCT03250832|588072404|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825204|NCT03250832|588072405|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825205|NCT03250832|588072406|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
162825206|NCT03250832|588072407|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
162825207|NCT03250832|588072408|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825208|NCT03250832|588072409|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162825209|NCT03250832|588072398|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825210|NCT03250832|588072399|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825211|NCT03250832|588072400|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825212|NCT03250832|588072401|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825213|NCT03250832|588072402|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825214|NCT03250832|588072403|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825215|NCT03250832|588072404|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825216|NCT03250832|588072405|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825217|NCT03250832|588072406|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
162825218|NCT03250832|588072407|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
162825219|NCT03250832|588072408|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825220|NCT03250832|588072409|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
162825221|NCT03250832|588072398|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825222|NCT03250832|588072399|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825223|NCT03250832|588072400|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825224|NCT03250832|588072401|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825225|NCT03250832|588072402|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825226|NCT03250832|588072403|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825227|NCT03250832|588072404|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163174787|NCT03011892|589354987|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
163174788|NCT03011892|589354988|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
163174789|NCT03011892|589354989|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
163174790|NCT03011892|589354990|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
163174791|NCT03011892|589354979|FG000|Double Blind (DB) Period|Other|1|||
163174792|NCT03011892|589354980|FG001|Double Blind (DB) Period|Other|1|||
163174793|NCT03011892|589354981|FG002|Double Blind (DB) Period|Other|1|||
163174794|NCT03011892|589354982|FG003|Double Blind (DB) Period|Other|0|||
163174795|NCT03011892|589354983|FG004|Double Blind (DB) Period|Other|1|||
163174796|NCT03011892|589354984|FG005|Double Blind (DB) Period|Other|0|||
163174797|NCT03011892|589354985|FG006|Double Blind (DB) Period|Other|0|||
163174798|NCT03011892|589354986|FG007|Double Blind (DB) Period|Other|0|||
163174799|NCT03011892|589354987|FG008|Double Blind (DB) Period|Other|0|||
163174800|NCT03011892|589354988|FG009|Double Blind (DB) Period|Other|0|||
163174801|NCT03011892|589354989|FG010|Double Blind (DB) Period|Other|0|||
163174802|NCT03011892|589354990|FG011|Double Blind (DB) Period|Other|0|||
163174803|NCT03011892|589354979|FG000|Double Blind (DB) Period|Physician Decision|1|||
163174804|NCT03011892|589354980|FG001|Double Blind (DB) Period|Physician Decision|0|||
163174805|NCT03011892|589354981|FG002|Double Blind (DB) Period|Physician Decision|1|||
163174806|NCT03011892|589354982|FG003|Double Blind (DB) Period|Physician Decision|0|||
163174807|NCT03011892|589354983|FG004|Double Blind (DB) Period|Physician Decision|0|||
163174808|NCT03011892|589354984|FG005|Double Blind (DB) Period|Physician Decision|0|||
163174809|NCT03011892|589354985|FG006|Double Blind (DB) Period|Physician Decision|0|||
163174810|NCT03011892|589354986|FG007|Double Blind (DB) Period|Physician Decision|0|||
163174811|NCT03011892|589354987|FG008|Double Blind (DB) Period|Physician Decision|0|||
163174812|NCT03011892|589354988|FG009|Double Blind (DB) Period|Physician Decision|0|||
163174813|NCT03011892|589354989|FG010|Double Blind (DB) Period|Physician Decision|0|||
163174814|NCT03011892|589354990|FG011|Double Blind (DB) Period|Physician Decision|0|||
163174815|NCT03011892|589354979|FG000|Double Blind (DB) Period|Pregnancy|0|||
163174816|NCT03011892|589354980|FG001|Double Blind (DB) Period|Pregnancy|0|||
163174817|NCT03011892|589354981|FG002|Double Blind (DB) Period|Pregnancy|0|||
163174818|NCT03011892|589354982|FG003|Double Blind (DB) Period|Pregnancy|0|||
163174819|NCT03011892|589354983|FG004|Double Blind (DB) Period|Pregnancy|1|||
163174820|NCT03011892|589354984|FG005|Double Blind (DB) Period|Pregnancy|0|||
163174821|NCT03011892|589354985|FG006|Double Blind (DB) Period|Pregnancy|0|||
163174822|NCT03011892|589354986|FG007|Double Blind (DB) Period|Pregnancy|0|||
163174823|NCT03011892|589354987|FG008|Double Blind (DB) Period|Pregnancy|0|||
163174824|NCT03011892|589354988|FG009|Double Blind (DB) Period|Pregnancy|0|||
163174825|NCT03011892|589354989|FG010|Double Blind (DB) Period|Pregnancy|0|||
163174826|NCT03011892|589354990|FG011|Double Blind (DB) Period|Pregnancy|0|||
163174827|NCT03011892|589354979|FG000|Double Blind (DB) Period|Protocol Violation|1|||
163174828|NCT03011892|589354980|FG001|Double Blind (DB) Period|Protocol Violation|0|||
163174829|NCT03011892|589354981|FG002|Double Blind (DB) Period|Protocol Violation|0|||
163174830|NCT03011892|589354982|FG003|Double Blind (DB) Period|Protocol Violation|0|||
163174831|NCT03011892|589354983|FG004|Double Blind (DB) Period|Protocol Violation|0|||
163174832|NCT03011892|589354984|FG005|Double Blind (DB) Period|Protocol Violation|0|||
163174833|NCT03011892|589354985|FG006|Double Blind (DB) Period|Protocol Violation|0|||
163174834|NCT03011892|589354986|FG007|Double Blind (DB) Period|Protocol Violation|0|||
163174835|NCT03011892|589354987|FG008|Double Blind (DB) Period|Protocol Violation|0|||
163174836|NCT03011892|589354988|FG009|Double Blind (DB) Period|Protocol Violation|0|||
162825228|NCT03250832|588072405|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825229|NCT03250832|588072406|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825230|NCT03250832|588072407|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825231|NCT03250832|588072408|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
162825232|NCT03250832|588072409|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
162825233|NCT04411628|588072411|FG000|Overall Study|Withdrawal by Subject|1|||
162825234|NCT04411628|588072412|FG001|Overall Study|Withdrawal by Subject|1|||
162825235|NCT04411628|588072413|FG002|Overall Study|Withdrawal by Subject|2|||
162825236|NCT04411628|588072414|FG003|Overall Study|Withdrawal by Subject|0|||
162825237|NCT04411628|588072411|FG000|Overall Study|Lost to Follow-up|0|||
162825238|NCT04411628|588072412|FG001|Overall Study|Lost to Follow-up|1|||
162825239|NCT04411628|588072413|FG002|Overall Study|Lost to Follow-up|0|||
162825240|NCT04411628|588072414|FG003|Overall Study|Lost to Follow-up|0|||
162825241|NCT01428661|588072415|FG000|Double-Masked Phase|Protocol Violation|9|||
162825242|NCT01428661|588072416|FG001|Double-Masked Phase|Protocol Violation|4|||
162825243|NCT01428661|588072417|FG002|Double-Masked Phase|Protocol Violation|0|||
162825244|NCT01428661|588072415|FG000|Double-Masked Phase|Adverse Event|13|||
162825245|NCT01428661|588072416|FG001|Double-Masked Phase|Adverse Event|4|||
162825246|NCT01428661|588072417|FG002|Double-Masked Phase|Adverse Event|0|||
162825247|NCT01428661|588072415|FG000|Double-Masked Phase|Lost to Follow-up|14|||
162825248|NCT01428661|588072416|FG001|Double-Masked Phase|Lost to Follow-up|14|||
162825249|NCT01428661|588072417|FG002|Double-Masked Phase|Lost to Follow-up|0|||
162825250|NCT01428661|588072415|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
162825251|NCT01428661|588072416|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
162825252|NCT01428661|588072417|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
162825253|NCT01428661|588072415|FG000|Double-Masked Phase|Lack of Efficacy|2|||
162825254|NCT01428661|588072416|FG001|Double-Masked Phase|Lack of Efficacy|1|||
162825255|NCT01428661|588072417|FG002|Double-Masked Phase|Lack of Efficacy|0|||
162825256|NCT01428661|588072415|FG000|Double-Masked Phase|*Various|1|||
162825257|NCT01428661|588072416|FG001|Double-Masked Phase|*Various|6|||
162825258|NCT01428661|588072417|FG002|Double-Masked Phase|*Various|0|||
162825259|NCT01428661|588072415|FG000|Open Label Extension|Protocol Violation|0|||
162825260|NCT01428661|588072416|FG001|Open Label Extension|Protocol Violation|0|||
162825261|NCT01428661|588072417|FG002|Open Label Extension|Protocol Violation|9|||
162825262|NCT01428661|588072415|FG000|Open Label Extension|Adverse Event|0|||
162825263|NCT01428661|588072416|FG001|Open Label Extension|Adverse Event|0|||
162825264|NCT01428661|588072417|FG002|Open Label Extension|Adverse Event|15|||
162825265|NCT01428661|588072415|FG000|Open Label Extension|Lost to Follow-up|0|||
162825266|NCT01428661|588072416|FG001|Open Label Extension|Lost to Follow-up|0|||
162825267|NCT01428661|588072417|FG002|Open Label Extension|Lost to Follow-up|38|||
162825268|NCT01428661|588072415|FG000|Open Label Extension|Withdrawal by Subject|0|||
162825269|NCT01428661|588072416|FG001|Open Label Extension|Withdrawal by Subject|0|||
162825270|NCT01428661|588072417|FG002|Open Label Extension|Withdrawal by Subject|49|||
162825271|NCT01428661|588072415|FG000|Open Label Extension|Lack of Efficacy|0|||
162825272|NCT01428661|588072416|FG001|Open Label Extension|Lack of Efficacy|0|||
162825273|NCT01428661|588072417|FG002|Open Label Extension|Lack of Efficacy|24|||
162825274|NCT01428661|588072415|FG000|Open Label Extension|**Various|0|||
162825275|NCT01428661|588072416|FG001|Open Label Extension|**Various|0|||
162825276|NCT01428661|588072417|FG002|Open Label Extension|**Various|185|||
162825277|NCT06156215|588072418|FG000|Overall Study|Withdrawal by Subject|2|||
162825278|NCT06156215|588072419|FG001|Overall Study|Withdrawal by Subject|4|||
162825279|NCT06156215|588072420|FG002|Overall Study|Withdrawal by Subject|4|||
162825280|NCT06156215|588072421|FG003|Overall Study|Withdrawal by Subject|0|||
162825281|NCT06156215|588072422|FG004|Overall Study|Withdrawal by Subject|2|||
162825282|NCT06156215|588072423|FG005|Overall Study|Withdrawal by Subject|2|||
162825283|NCT06156215|588072418|FG000|Overall Study|Left ED without completing study|9|||
162825284|NCT06156215|588072419|FG001|Overall Study|Left ED without completing study|3|||
162825285|NCT06156215|588072420|FG002|Overall Study|Left ED without completing study|9|||
162825286|NCT06156215|588072421|FG003|Overall Study|Left ED without completing study|0|||
162825287|NCT06156215|588072422|FG004|Overall Study|Left ED without completing study|8|||
162825288|NCT06156215|588072423|FG005|Overall Study|Left ED without completing study|16|||
162825289|NCT06156215|588072418|FG000|Overall Study|Physician Decision|1|||
162825290|NCT06156215|588072419|FG001|Overall Study|Physician Decision|0|||
163174837|NCT03011892|589354989|FG010|Double Blind (DB) Period|Protocol Violation|0|||
163174838|NCT03011892|589354990|FG011|Double Blind (DB) Period|Protocol Violation|0|||
162825291|NCT06156215|588072420|FG002|Overall Study|Physician Decision|0|||
162825292|NCT06156215|588072421|FG003|Overall Study|Physician Decision|0|||
162825293|NCT06156215|588072422|FG004|Overall Study|Physician Decision|0|||
162825294|NCT06156215|588072423|FG005|Overall Study|Physician Decision|0|||
162825295|NCT06156215|588072418|FG000|Overall Study|Became or found ineligible|2|||
162825296|NCT06156215|588072419|FG001|Overall Study|Became or found ineligible|0|||
162825297|NCT06156215|588072420|FG002|Overall Study|Became or found ineligible|2|||
162825298|NCT06156215|588072421|FG003|Overall Study|Became or found ineligible|0|||
162825299|NCT06156215|588072422|FG004|Overall Study|Became or found ineligible|1|||
162825300|NCT06156215|588072423|FG005|Overall Study|Became or found ineligible|2|||
162825301|NCT04376827|588072424|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
162825302|NCT04376827|588072425|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
162825303|NCT04376827|588072424|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
162825304|NCT04376827|588072425|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
162825305|NCT04376827|588072424|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
162825306|NCT04376827|588072425|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
162825307|NCT04376827|588072424|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
162825308|NCT04376827|588072425|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
162825309|NCT04376827|588072424|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
162825310|NCT04376827|588072425|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
162825311|NCT00294060|588073884|FG000|Overall Study|Death|225|||
162825312|NCT00294060|588073884|FG000|Overall Study|Other|59|||
162825313|NCT00294060|588073884|FG000|Overall Study|Lost to Follow-up|55|||
162825314|NCT00294060|588073884|FG000|Overall Study|Withdrawal by Subject|11|||
162825315|NCT00294060|588073884|FG000|Overall Study|Physician Decision|797|||
162825316|NCT00294060|588073884|FG000|Overall Study|Medical condition|3|||
162825317|NCT00294060|588073884|FG000|Overall Study|Device explanted/not replaced|23|||
162825318|NCT00139776|588073885|FG000|Period I|Did not enter Period II|575|||
162825319|NCT00139776|588073886|FG001|Period I|Did not enter Period II|0|||
162825320|NCT00139776|588073887|FG002|Period I|Did not enter Period II|0|||
163174839|NCT03011892|589354979|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
163174840|NCT03011892|589354980|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
163174841|NCT03011892|589354981|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
163174842|NCT03011892|589354982|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
163174843|NCT03011892|589354983|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
163174844|NCT03011892|589354984|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
163174845|NCT03011892|589354985|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174846|NCT03011892|589354986|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174847|NCT03011892|589354987|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174848|NCT03011892|589354988|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174849|NCT03011892|589354989|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174850|NCT03011892|589354990|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
163174851|NCT03011892|589354979|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
163174852|NCT03011892|589354980|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
163174853|NCT03011892|589354981|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
163174854|NCT03011892|589354982|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
163174855|NCT03011892|589354983|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
163174856|NCT03011892|589354984|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
163174857|NCT03011892|589354985|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
163174858|NCT03011892|589354986|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
163174859|NCT03011892|589354987|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
163174860|NCT03011892|589354988|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
163174861|NCT03011892|589354989|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
163174862|NCT03011892|589354990|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
163174863|NCT03011892|589354979|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
163174864|NCT03011892|589354980|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
163174865|NCT03011892|589354981|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
163174866|NCT03011892|589354982|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
163174867|NCT03011892|589354983|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
163174868|NCT03011892|589354984|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
163174869|NCT03011892|589354985|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
163174870|NCT03011892|589354986|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
163174871|NCT03011892|589354987|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
163174872|NCT03011892|589354988|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
163174873|NCT03011892|589354989|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
163174874|NCT03011892|589354990|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
163174875|NCT03011892|589354979|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
163174876|NCT03011892|589354980|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
163174877|NCT03011892|589354981|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
163174878|NCT03011892|589354982|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
163174879|NCT03011892|589354983|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
163174880|NCT03011892|589354984|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
163174881|NCT03011892|589354985|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
163174882|NCT03011892|589354986|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
163174883|NCT03011892|589354987|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
163174884|NCT03011892|589354988|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
163174885|NCT03011892|589354989|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
163174886|NCT03011892|589354990|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
163174887|NCT03011892|589354979|FG000|Open Label (OL) Period|Reason not specified|0|||
163174888|NCT03011892|589354980|FG001|Open Label (OL) Period|Reason not specified|0|||
163174889|NCT03011892|589354981|FG002|Open Label (OL) Period|Reason not specified|0|||
163174890|NCT03011892|589354982|FG003|Open Label (OL) Period|Reason not specified|0|||
163174891|NCT03011892|589354983|FG004|Open Label (OL) Period|Reason not specified|0|||
163174892|NCT03011892|589354984|FG005|Open Label (OL) Period|Reason not specified|0|||
163174893|NCT03011892|589354985|FG006|Open Label (OL) Period|Reason not specified|0|||
163174894|NCT03011892|589354986|FG007|Open Label (OL) Period|Reason not specified|1|||
163174895|NCT03011892|589354987|FG008|Open Label (OL) Period|Reason not specified|0|||
163174896|NCT03011892|589354988|FG009|Open Label (OL) Period|Reason not specified|0|||
163174897|NCT03011892|589354989|FG010|Open Label (OL) Period|Reason not specified|0|||
163174898|NCT03011892|589354990|FG011|Open Label (OL) Period|Reason not specified|0|||
163174899|NCT02312687|589355004|FG000|Overall Study|Other, Not Specified|1|||
163174900|NCT00906971|589355007|FG000|Overall Study|Withdrawal by Subject|8|||
163174901|NCT00906971|589355008|FG001|Overall Study|Withdrawal by Subject|2|||
163174902|NCT00906971|589355007|FG000|Overall Study|Lost to Follow-up|0|||
163174903|NCT00906971|589355008|FG001|Overall Study|Lost to Follow-up|1|||
163174904|NCT01007253|589355015|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
163174905|NCT01007253|589355016|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174906|NCT01007253|589355017|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174907|NCT01007253|589355018|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163174908|NCT01159431|589355021|FG000|Overall Study|Adverse Event|1|||
163174909|NCT01159431|589355022|FG001|Overall Study|Adverse Event|2|||
163174910|NCT01159431|589355021|FG000|Overall Study|non-compliance|1|||
163174911|NCT01159431|589355022|FG001|Overall Study|non-compliance|1|||
163174912|NCT01159431|589355021|FG000|Overall Study|Lack of Efficacy|0|||
163174913|NCT01159431|589355022|FG001|Overall Study|Lack of Efficacy|3|||
163174914|NCT00884377|589357290|FG000|Overall Study|Withdrawal by Subject|1|||
163174915|NCT00884377|589357291|FG001|Overall Study|Withdrawal by Subject|0|||
163174916|NCT00884377|589357290|FG000|Overall Study|Could not confirm diagnosis|1|||
163174917|NCT00884377|589357291|FG001|Overall Study|Could not confirm diagnosis|0|||
163174918|NCT00884377|589357290|FG000|Overall Study|Physician Decision|0|||
163174919|NCT00884377|589357291|FG001|Overall Study|Physician Decision|1|||
163174920|NCT05347147|589357292|FG000|Overall Study|Lost to Follow-up|0|||
163174921|NCT05347147|589357293|FG001|Overall Study|Lost to Follow-up|1|||
163174922|NCT05347147|589357292|FG000|Overall Study|Sponsor request|3|||
163174923|NCT05347147|589357293|FG001|Overall Study|Sponsor request|3|||
163174924|NCT05347147|589357292|FG000|Overall Study|Study termination|2|||
163174925|NCT05347147|589357293|FG001|Overall Study|Study termination|1|||
163174926|NCT02677324|589357299|FG000|Overall Study|Disease Progression|6|||
163174927|NCT02677324|589357299|FG000|Overall Study|Inability to Swallow pills|1|||
163174928|NCT02677324|589357299|FG000|Overall Study|Non-compliance|1|||
163174929|NCT02677324|589357299|FG000|Overall Study|Lack of Efficacy|1|||
163174930|NCT02677324|589357299|FG000|Overall Study|Medical insurance coverage|1|||
163174931|NCT02677324|589357299|FG000|Overall Study|Adverse Event|1|||
163174932|NCT02677324|589357299|FG000|Overall Study|IgM Myeloma diagnosis|1|||
163174933|NCT01895361|589357300|FG000|Overall Study|Adverse Event|1|||
163174934|NCT01895361|589357301|FG001|Overall Study|Adverse Event|1|||
163174935|NCT01895361|589357302|FG002|Overall Study|Adverse Event|3|||
163174936|NCT01895361|589357300|FG000|Overall Study|Death|2|||
163174937|NCT01895361|589357301|FG001|Overall Study|Death|1|||
163174938|NCT01895361|589357302|FG002|Overall Study|Death|2|||
163174939|NCT01895361|589357300|FG000|Overall Study|Lost to Follow-up|4|||
163174940|NCT01895361|589357301|FG001|Overall Study|Lost to Follow-up|4|||
163174941|NCT01895361|589357302|FG002|Overall Study|Lost to Follow-up|6|||
163174942|NCT01895361|589357300|FG000|Overall Study|Non-compliance with study|1|||
163174943|NCT01895361|589357301|FG001|Overall Study|Non-compliance with study|3|||
163174944|NCT01895361|589357302|FG002|Overall Study|Non-compliance with study|1|||
163174945|NCT01895361|589357300|FG000|Overall Study|Physician Decision|2|||
163174946|NCT01895361|589357301|FG001|Overall Study|Physician Decision|2|||
163174947|NCT01895361|589357302|FG002|Overall Study|Physician Decision|2|||
163174948|NCT01895361|589357300|FG000|Overall Study|Withdrawal by Subject|7|||
163174949|NCT01895361|589357301|FG001|Overall Study|Withdrawal by Subject|6|||
163174950|NCT01895361|589357302|FG002|Overall Study|Withdrawal by Subject|6|||
163174951|NCT01895361|589357300|FG000|Overall Study|Lack of Efficacy|0|||
163174952|NCT01895361|589357301|FG001|Overall Study|Lack of Efficacy|1|||
163174953|NCT01895361|589357302|FG002|Overall Study|Lack of Efficacy|0|||
163174954|NCT01895361|589357300|FG000|Overall Study|Reasons different from categories above|7|||
163174955|NCT01895361|589357301|FG001|Overall Study|Reasons different from categories above|3|||
163174956|NCT01895361|589357302|FG002|Overall Study|Reasons different from categories above|4|||
163174957|NCT00282464|589357303|FG000|Overall Study|Adverse Event|26|||
163174958|NCT00282464|589357304|FG001|Overall Study|Adverse Event|20|||
163174959|NCT00282464|589357303|FG000|Overall Study|Lack of Efficacy|8|||
163174960|NCT00282464|589357304|FG001|Overall Study|Lack of Efficacy|8|||
163174961|NCT00282464|589357303|FG000|Overall Study|Lost to Follow-up|10|||
163174962|NCT00282464|589357304|FG001|Overall Study|Lost to Follow-up|10|||
163174963|NCT00282464|589357303|FG000|Overall Study|Withdrawal by Subject|24|||
162825321|NCT00139776|588073888|FG003|Period I|Did not enter Period II|0|||
162825322|NCT00139776|588073885|FG000|Period II|Not Randomized into Period III|0|||
162825323|NCT00139776|588073886|FG001|Period II|Not Randomized into Period III|322|||
162825324|NCT00139776|588073887|FG002|Period II|Not Randomized into Period III|0|||
162825325|NCT00139776|588073888|FG003|Period II|Not Randomized into Period III|0|||
163174964|NCT00282464|589357304|FG001|Overall Study|Withdrawal by Subject|10|||
163174965|NCT00282464|589357303|FG000|Overall Study|laboratory abnormality|1|||
163174966|NCT00282464|589357304|FG001|Overall Study|laboratory abnormality|2|||
163174967|NCT00282464|589357303|FG000|Overall Study|Protocol Violation|0|||
163174968|NCT00282464|589357304|FG001|Overall Study|Protocol Violation|7|||
163174969|NCT00282464|589357303|FG000|Overall Study|Patient moved|1|||
163174970|NCT00282464|589357304|FG001|Overall Study|Patient moved|0|||
163174971|NCT00282464|589357303|FG000|Overall Study|patient non-compliant|3|||
163174972|NCT00282464|589357304|FG001|Overall Study|patient non-compliant|0|||
163174973|NCT00282464|589357303|FG000|Overall Study|patient no show|0|||
163174974|NCT00282464|589357304|FG001|Overall Study|patient no show|1|||
163174975|NCT00282464|589357303|FG000|Overall Study|patient incarcerated|0|||
163174976|NCT00282464|589357304|FG001|Overall Study|patient incarcerated|1|||
162825326|NCT00139776|588073885|FG000|Period III|Adverse Event|0|||
163174977|NCT00282464|589357303|FG000|Overall Study|family crisis|0|||
163174978|NCT00282464|589357304|FG001|Overall Study|family crisis|1|||
163174979|NCT00282464|589357303|FG000|Overall Study|dispensed wrong kit|0|||
163174980|NCT00282464|589357304|FG001|Overall Study|dispensed wrong kit|1|||
163174981|NCT00282464|589357303|FG000|Overall Study|dropped due to missed visits|0|||
162932399|NCT03262233|588458472|FG001|Overall Study|data collection artifact|1|||
162932400|NCT03262233|588458473|FG002|Overall Study|data collection artifact|0|||
162932401|NCT03262233|588458474|FG003|Overall Study|data collection artifact|0|||
162932402|NCT03770000|588458475|FG000|Overall Study|Premature discontinuation due to PD|0|||
162932403|NCT03770000|588458476|FG001|Overall Study|Premature discontinuation due to PD|0|||
162932404|NCT03770000|588458477|FG002|Overall Study|Premature discontinuation due to PD|1|||
162932405|NCT03770000|588458478|FG003|Overall Study|Premature discontinuation due to PD|3|||
162932406|NCT03770000|588458479|FG004|Overall Study|Premature discontinuation due to PD|2|||
162932407|NCT03877237|588458480|FG000|Overall Study|Adverse Event|1|||
162932408|NCT03877237|588458481|FG001|Overall Study|Adverse Event|2|||
162932409|NCT03877237|588458480|FG000|Overall Study|Death|3|||
162932410|NCT03877237|588458481|FG001|Overall Study|Death|2|||
162932411|NCT03877237|588458480|FG000|Overall Study|Physician Decision|1|||
162932412|NCT03877237|588458481|FG001|Overall Study|Physician Decision|0|||
162932413|NCT03877237|588458480|FG000|Overall Study|Withdrawal by Subject|0|||
162932414|NCT03877237|588458481|FG001|Overall Study|Withdrawal by Subject|2|||
162932415|NCT02290028|588458483|FG000|Overall Study|Death|217|||
162932416|NCT02290028|588458483|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
162932417|NCT02290028|588458483|FG000|Overall Study|No longer under care of study physician|76|||
162932418|NCT02290028|588458483|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
162932419|NCT02290028|588458483|FG000|Overall Study|Withdrawal by Subject|52|||
162932420|NCT02290028|588458483|FG000|Overall Study|Study site closure|44|||
162932421|NCT02290028|588458483|FG000|Overall Study|Lost to Follow-up|34|||
162932422|NCT02290028|588458483|FG000|Overall Study|Miscellaneous|10|||
162825327|NCT00139776|588073886|FG001|Period III|Adverse Event|0|||
162825328|NCT00139776|588073887|FG002|Period III|Adverse Event|22|||
162825329|NCT00139776|588073888|FG003|Period III|Adverse Event|23|||
162825330|NCT00139776|588073885|FG000|Period III|Other|0|||
162825331|NCT00139776|588073886|FG001|Period III|Other|0|||
162825332|NCT00139776|588073887|FG002|Period III|Other|23|||
162825333|NCT00139776|588073888|FG003|Period III|Other|34|||
162825334|NCT00139776|588073885|FG000|Period III|Lack of Efficacy|0|||
162825335|NCT00139776|588073886|FG001|Period III|Lack of Efficacy|0|||
162825336|NCT00139776|588073887|FG002|Period III|Lack of Efficacy|10|||
162825337|NCT00139776|588073888|FG003|Period III|Lack of Efficacy|24|||
162825338|NCT00139776|588073885|FG000|Period III|Lost to Follow-up|0|||
162825339|NCT00139776|588073886|FG001|Period III|Lost to Follow-up|0|||
162825340|NCT00139776|588073887|FG002|Period III|Lost to Follow-up|5|||
162825341|NCT00139776|588073888|FG003|Period III|Lost to Follow-up|4|||
162825342|NCT00139776|588073885|FG000|Period III|Withdrawal by Subject|0|||
162825343|NCT00139776|588073886|FG001|Period III|Withdrawal by Subject|0|||
162825344|NCT00139776|588073887|FG002|Period III|Withdrawal by Subject|16|||
162825345|NCT00139776|588073888|FG003|Period III|Withdrawal by Subject|21|||
162825346|NCT00187096|588073889|FG000|Overall Study|unacceptable toxicity|0|||
162932423|NCT02290028|588458483|FG000|Overall Study|Transition to EP PASSION|1295|||
162825347|NCT00187096|588073890|FG001|Overall Study|unacceptable toxicity|0|||
162825348|NCT00187096|588073891|FG002|Overall Study|unacceptable toxicity|1|||
162825349|NCT00971178|588073902|FG000|Overall Study|Lost to Follow-up|2|||
162825350|NCT00971178|588073903|FG001|Overall Study|Lost to Follow-up|2|||
162932424|NCT02290028|588458483|FG000|Overall Study|Planned study completion at 12 months|257|||
162825351|NCT00971178|588073904|FG002|Overall Study|Lost to Follow-up|2|||
162932425|NCT00833547|588458484|FG000|Overall Study|Withdrawal by Subject|2|||
162932426|NCT00833547|588458485|FG001|Overall Study|Withdrawal by Subject|2|||
163174982|NCT00282464|589357304|FG001|Overall Study|dropped due to missed visits|1|||
163174983|NCT00475423|589357305|FG000|Overall Study|Protocol Violation|5|||
163174984|NCT00475423|589357305|FG000|Overall Study|Adverse Event|4|||
163174985|NCT00475423|589357305|FG000|Overall Study|Withdrawal by Subject|6|||
163174986|NCT00475423|589357305|FG000|Overall Study|Lack of Efficacy|8|||
163174987|NCT00475423|589357305|FG000|Overall Study|Death|1|||
163174988|NCT00475423|589357305|FG000|Overall Study|Reason not specified|1|||
163174989|NCT00475423|589357305|FG000|Overall Study|Lost to Follow-up|7|||
163174990|NCT01214174|589357306|FG000|Overall Study|Withdrawal by Subject|0|||
163174991|NCT01214174|589357307|FG001|Overall Study|Withdrawal by Subject|0|||
163174992|NCT01214174|589357308|FG002|Overall Study|Withdrawal by Subject|1|||
163174993|NCT02239120|589357309|FG000|Overall Study|Death|56|||
163174994|NCT02239120|589357310|FG001|Overall Study|Death|58|||
163174995|NCT02239120|589357309|FG000|Overall Study|Lost to Follow-up|19|||
163174996|NCT02239120|589357310|FG001|Overall Study|Lost to Follow-up|14|||
163174997|NCT00548405|589357331|FG000|Overall Study|Adverse Event|6|||
163174998|NCT00548405|589357332|FG001|Overall Study|Adverse Event|2|||
163174999|NCT00548405|589357333|FG002|Overall Study|Adverse Event|0|||
163175000|NCT00548405|589357331|FG000|Overall Study|Lack of Efficacy|6|||
163175001|NCT00548405|589357332|FG001|Overall Study|Lack of Efficacy|0|||
163175002|NCT00548405|589357333|FG002|Overall Study|Lack of Efficacy|0|||
163175003|NCT00548405|589357331|FG000|Overall Study|Physician Decision|3|||
163175004|NCT00548405|589357332|FG001|Overall Study|Physician Decision|4|||
163175005|NCT00548405|589357333|FG002|Overall Study|Physician Decision|1|||
163175006|NCT00548405|589357331|FG000|Overall Study|Pregnancy|1|||
163175007|NCT00548405|589357332|FG001|Overall Study|Pregnancy|0|||
163175008|NCT00548405|589357333|FG002|Overall Study|Pregnancy|0|||
163175009|NCT00548405|589357331|FG000|Overall Study|Protocol Violation|1|||
163175010|NCT00548405|589357332|FG001|Overall Study|Protocol Violation|0|||
163175011|NCT00548405|589357333|FG002|Overall Study|Protocol Violation|0|||
163175012|NCT00548405|589357331|FG000|Overall Study|Withdrawal by Subject|36|||
163175013|NCT00548405|589357332|FG001|Overall Study|Withdrawal by Subject|12|||
163175014|NCT00548405|589357333|FG002|Overall Study|Withdrawal by Subject|5|||
163175015|NCT00548405|589357331|FG000|Overall Study|Lost to Follow-up|1|||
163175016|NCT00548405|589357332|FG001|Overall Study|Lost to Follow-up|1|||
163175017|NCT00548405|589357333|FG002|Overall Study|Lost to Follow-up|2|||
163175018|NCT00548405|589357331|FG000|Overall Study|Death|0|||
163175019|NCT00548405|589357332|FG001|Overall Study|Death|1|||
163175020|NCT00548405|589357333|FG002|Overall Study|Death|1|||
163175021|NCT00548405|589357331|FG000|Overall Study|Sponsor decision|1|||
163175022|NCT00548405|589357332|FG001|Overall Study|Sponsor decision|0|||
163175023|NCT00548405|589357333|FG002|Overall Study|Sponsor decision|0|||
163175024|NCT00548405|589357331|FG000|Overall Study|Randomized but not treated|1|||
163175025|NCT00548405|589357332|FG001|Overall Study|Randomized but not treated|0|||
163175026|NCT00548405|589357333|FG002|Overall Study|Randomized but not treated|0|||
163175027|NCT01624870|589357334|FG000|Overall Study|Death|19|||
163175028|NCT01624870|589357334|FG000|Overall Study|Withdrawal by Subject|1|||
163175029|NCT01624870|589357334|FG000|Overall Study|CoreValve not implanted|6|||
163175030|NCT01624870|589357334|FG000|Overall Study|Lost to follow up|1|||
163175031|NCT01878149|589357335|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
163175032|NCT01878149|589357336|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
163175033|NCT04672252|589357339|FG000|Overall Study|Protocol Violation|1|||
163175034|NCT04672252|589357340|FG001|Overall Study|Protocol Violation|0|||
163175035|NCT03735238|589357344|FG000|Overall Study|Did not want to participate in research|3|||
163175036|NCT03735238|589357344|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
163175037|NCT02660138|589357345|FG000|Overall Study|Adverse Event|0|||
163175038|NCT02660138|589357346|FG001|Overall Study|Adverse Event|3|||
163175039|NCT02660138|589357347|FG002|Overall Study|Adverse Event|2|||
163175040|NCT02660138|589357345|FG000|Overall Study|Lack of Efficacy|1|||
163175041|NCT02660138|589357346|FG001|Overall Study|Lack of Efficacy|2|||
163175042|NCT02660138|589357347|FG002|Overall Study|Lack of Efficacy|1|||
163175043|NCT02660138|589357345|FG000|Overall Study|Withdrawal by Subject|7|||
163175044|NCT02660138|589357346|FG001|Overall Study|Withdrawal by Subject|6|||
162698464|NCT02065570|587605508|FG002|Maintenance Study|Adverse Event|8|||
163175045|NCT02660138|589357347|FG002|Overall Study|Withdrawal by Subject|6|||
163175046|NCT02660138|589357345|FG000|Overall Study|Lost to Follow-up|4|||
162698465|NCT02065570|587605509|FG003|Maintenance Study|Adverse Event|8|||
163175047|NCT02660138|589357346|FG001|Overall Study|Lost to Follow-up|4|||
163175048|NCT02660138|589357347|FG002|Overall Study|Lost to Follow-up|1|||
163175049|NCT02660138|589357345|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
163175050|NCT02660138|589357346|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
163175051|NCT02660138|589357347|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
163175052|NCT02660138|589357345|FG000|Overall Study|Other|1|||
163175053|NCT02660138|589357346|FG001|Overall Study|Other|1|||
163175054|NCT02660138|589357347|FG002|Overall Study|Other|0|||
163175055|NCT02660138|589357345|FG000|Overall Study|Not treated|0|||
163175056|NCT02660138|589357346|FG001|Overall Study|Not treated|1|||
163175057|NCT02660138|589357347|FG002|Overall Study|Not treated|0|||
163175058|NCT00308581|589357348|FG000|Induction Phase|Adverse Event|0|||
162825352|NCT01970488|588073906|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
162825353|NCT01970488|588073907|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
162825354|NCT01970488|588073908|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
162825355|NCT01970488|588073909|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163175059|NCT00308581|589357349|FG001|Induction Phase|Adverse Event|0|||
163175060|NCT00308581|589357350|FG002|Induction Phase|Adverse Event|37|||
163175061|NCT00308581|589357348|FG000|Induction Phase|Lack of Efficacy|0|||
163175062|NCT00308581|589357349|FG001|Induction Phase|Lack of Efficacy|0|||
163175063|NCT00308581|589357350|FG002|Induction Phase|Lack of Efficacy|121|||
163175064|NCT00308581|589357348|FG000|Induction Phase|Withdrawal by Subject|0|||
163175065|NCT00308581|589357349|FG001|Induction Phase|Withdrawal by Subject|0|||
163175066|NCT00308581|589357350|FG002|Induction Phase|Withdrawal by Subject|5|||
163175067|NCT00308581|589357348|FG000|Induction Phase|Unknown reason|0|||
163175068|NCT00308581|589357349|FG001|Induction Phase|Unknown reason|0|||
163175069|NCT00308581|589357350|FG002|Induction Phase|Unknown reason|3|||
163175070|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Adverse Event|10|||
163175071|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Adverse Event|17|||
163175072|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Adverse Event|0|||
163175073|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
163175074|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
163175075|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
163175076|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
163175077|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
163175078|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
163175079|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
163175080|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
163175081|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
162698466|NCT02065570|587605506|FG000|Maintenance Study|Withdrawal by Subject|0|||
162825356|NCT01970488|588073910|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
162825357|NCT01970488|588073906|FG000|Part 1: Through Week 16|Protocol Violation|1|||
162825358|NCT01970488|588073907|FG001|Part 1: Through Week 16|Protocol Violation|2|||
162825359|NCT01970488|588073908|FG002|Part 1: Through Week 16|Protocol Violation|0|||
162825360|NCT01970488|588073909|FG003|Part 1: Through Week 16|Protocol Violation|0|||
162825361|NCT01970488|588073910|FG004|Part 1: Through Week 16|Protocol Violation|0|||
162825362|NCT01970488|588073906|FG000|Part 1: Through Week 16|Adverse Event|6|||
162825363|NCT01970488|588073907|FG001|Part 1: Through Week 16|Adverse Event|5|||
162825364|NCT01970488|588073908|FG002|Part 1: Through Week 16|Adverse Event|0|||
162825365|NCT01970488|588073909|FG003|Part 1: Through Week 16|Adverse Event|0|||
162825366|NCT01970488|588073910|FG004|Part 1: Through Week 16|Adverse Event|0|||
162825367|NCT01970488|588073906|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
162825368|NCT01970488|588073907|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
162825369|NCT01970488|588073908|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
162825370|NCT01970488|588073909|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
162825371|NCT01970488|588073910|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
162825372|NCT01970488|588073906|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
162825373|NCT01970488|588073907|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
162825374|NCT01970488|588073908|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
162825375|NCT01970488|588073909|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
162825376|NCT01970488|588073910|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
162825377|NCT01970488|588073906|FG000|Part 2: Post Week 16|Physician Decision|0|||
162825378|NCT01970488|588073907|FG001|Part 2: Post Week 16|Physician Decision|0|||
162825379|NCT01970488|588073908|FG002|Part 2: Post Week 16|Physician Decision|0|||
162825380|NCT01970488|588073909|FG003|Part 2: Post Week 16|Physician Decision|0|||
162932427|NCT00566098|588458488|FG000|Collection of MILs|Withdrawal by Subject|1|||
162698467|NCT02065570|587605507|FG001|Maintenance Study|Withdrawal by Subject|0|||
162825381|NCT01970488|588073910|FG004|Part 2: Post Week 16|Physician Decision|1|||
162825382|NCT01970488|588073906|FG000|Part 2: Post Week 16|Non-compliance|0|||
162825383|NCT01970488|588073907|FG001|Part 2: Post Week 16|Non-compliance|0|||
162825384|NCT01970488|588073908|FG002|Part 2: Post Week 16|Non-compliance|1|||
162825385|NCT01970488|588073909|FG003|Part 2: Post Week 16|Non-compliance|0|||
162825386|NCT01970488|588073910|FG004|Part 2: Post Week 16|Non-compliance|0|||
162825387|NCT01970488|588073906|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
162825388|NCT01970488|588073907|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
162932428|NCT00566098|588458488|FG000|Collection of MILs|Relapsed|1|||
162932429|NCT00566098|588458488|FG000|Generation of MILs Product|Relapsed|1|||
162825389|NCT01970488|588073908|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
162825390|NCT01970488|588073909|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
162825391|NCT01970488|588073910|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
162825392|NCT01970488|588073906|FG000|Part 2: Post Week 16|Adverse Event|0|||
162932430|NCT00566098|588458488|FG000|Administration of ASCT+MILs|Death|10|||
162932431|NCT00566098|588458488|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
162932432|NCT02236754|588458489|FG000|Overall Study|Withdrawal by Subject|1|||
162932433|NCT02236754|588458490|FG001|Overall Study|Withdrawal by Subject|0|||
162932434|NCT01270841|588458491|FG000|Overall Study|Adverse Event|0|||
162932435|NCT01270841|588458492|FG001|Overall Study|Adverse Event|1|||
162932436|NCT01270841|588458493|FG002|Overall Study|Adverse Event|0|||
162932437|NCT01270841|588458494|FG003|Overall Study|Adverse Event|3|||
162932438|NCT01270841|588458491|FG000|Overall Study|Withdrawal by Subject|3|||
162932439|NCT01270841|588458492|FG001|Overall Study|Withdrawal by Subject|2|||
163175082|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
163175083|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
163175084|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
163175085|NCT00308581|589357348|FG000|Randomized Maintenance Phase|Unknown reason|3|||
163175086|NCT00308581|589357349|FG001|Randomized Maintenance Phase|Unknown reason|0|||
163175087|NCT00308581|589357350|FG002|Randomized Maintenance Phase|Unknown reason|0|||
163175088|NCT00899353|589357351|FG000|Overall Study|Adverse Event|2|||
163175089|NCT00899353|589357351|FG000|Overall Study|Lost to Follow-up|1|||
163175090|NCT00899353|589357351|FG000|Overall Study|Withdrawal by Subject|2|||
163175091|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
163175092|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
163175093|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
163175094|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
163175095|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
163175096|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
163175097|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
163175098|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
163175099|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
163175100|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
163175101|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
163175102|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
163175103|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
163175104|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
163175105|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
163175106|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
163175107|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
163175108|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175109|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175110|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163175111|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
163175112|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175113|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
163175114|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175115|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
163175116|NCT00095147|589357362|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
163175117|NCT00095147|589357363|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
163175118|NCT00095147|589357364|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
162932440|NCT01270841|588458493|FG002|Overall Study|Withdrawal by Subject|3|||
163175119|NCT00095147|589357365|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
163175120|NCT00095147|589357366|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
163175121|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
162932441|NCT01270841|588458494|FG003|Overall Study|Withdrawal by Subject|3|||
162932442|NCT01270841|588458491|FG000|Overall Study|Lost to Follow-up|3|||
162825393|NCT01970488|588073907|FG001|Part 2: Post Week 16|Adverse Event|0|||
162825394|NCT01970488|588073908|FG002|Part 2: Post Week 16|Adverse Event|5|||
162825395|NCT01970488|588073909|FG003|Part 2: Post Week 16|Adverse Event|1|||
162825396|NCT01970488|588073910|FG004|Part 2: Post Week 16|Adverse Event|1|||
162825397|NCT01970488|588073906|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
162825398|NCT01970488|588073907|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
162825399|NCT01970488|588073908|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
162825400|NCT01970488|588073909|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
163175122|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
163175123|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
163175124|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
163175125|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
163175126|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
163175127|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
163175128|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175129|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175130|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
163175131|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
163175132|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
162825401|NCT01970488|588073910|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
163175133|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
163175134|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
163175135|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
162825402|NCT01970488|588073906|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
162825403|NCT01970488|588073907|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
162825404|NCT01970488|588073908|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
163042823|NCT01990768|588863970|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
163175136|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
163175137|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
163175138|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175139|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175140|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
163175141|NCT00095147|589357362|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
163175142|NCT00095147|589357363|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175143|NCT00095147|589357364|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175144|NCT00095147|589357365|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
163175145|NCT00095147|589357366|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
163175146|NCT00095147|589357362|FG000|Long-term Extension Period|Death|0|||
163175147|NCT00095147|589357363|FG001|Long-term Extension Period|Death|0|||
163175148|NCT00095147|589357364|FG002|Long-term Extension Period|Death|0|||
163175149|NCT00095147|589357365|FG003|Long-term Extension Period|Death|0|||
163175150|NCT00095147|589357366|FG004|Long-term Extension Period|Death|3|||
163175151|NCT00095147|589357362|FG000|Long-term Extension Period|Adverse Event|0|||
163175152|NCT00095147|589357363|FG001|Long-term Extension Period|Adverse Event|0|||
163175153|NCT00095147|589357364|FG002|Long-term Extension Period|Adverse Event|0|||
163175154|NCT00095147|589357365|FG003|Long-term Extension Period|Adverse Event|0|||
163175155|NCT00095147|589357366|FG004|Long-term Extension Period|Adverse Event|11|||
163175156|NCT00095147|589357362|FG000|Long-term Extension Period|Lack of Efficacy|0|||
163175157|NCT00095147|589357363|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163175158|NCT00095147|589357364|FG002|Long-term Extension Period|Lack of Efficacy|0|||
163175159|NCT00095147|589357365|FG003|Long-term Extension Period|Lack of Efficacy|0|||
163175160|NCT00095147|589357366|FG004|Long-term Extension Period|Lack of Efficacy|9|||
163175161|NCT00095147|589357362|FG000|Long-term Extension Period|Lost to Follow-up|0|||
163175162|NCT00095147|589357363|FG001|Long-term Extension Period|Lost to Follow-up|0|||
163175163|NCT00095147|589357364|FG002|Long-term Extension Period|Lost to Follow-up|0|||
163175164|NCT00095147|589357365|FG003|Long-term Extension Period|Lost to Follow-up|0|||
163175165|NCT00095147|589357366|FG004|Long-term Extension Period|Lost to Follow-up|6|||
163175166|NCT00095147|589357362|FG000|Long-term Extension Period|Withdrawal of consent|0|||
163175167|NCT00095147|589357363|FG001|Long-term Extension Period|Withdrawal of consent|0|||
163175168|NCT00095147|589357364|FG002|Long-term Extension Period|Withdrawal of consent|0|||
163175169|NCT00095147|589357365|FG003|Long-term Extension Period|Withdrawal of consent|0|||
163175170|NCT00095147|589357366|FG004|Long-term Extension Period|Withdrawal of consent|12|||
163175171|NCT00095147|589357362|FG000|Long-term Extension Period|Pregnancy|0|||
163175172|NCT00095147|589357363|FG001|Long-term Extension Period|Pregnancy|0|||
163175173|NCT00095147|589357364|FG002|Long-term Extension Period|Pregnancy|0|||
163175174|NCT00095147|589357365|FG003|Long-term Extension Period|Pregnancy|0|||
163175175|NCT00095147|589357366|FG004|Long-term Extension Period|Pregnancy|1|||
163175176|NCT00095147|589357362|FG000|Long-term Extension Period|No longer meets study criteria|0|||
163175177|NCT00095147|589357363|FG001|Long-term Extension Period|No longer meets study criteria|0|||
163175178|NCT00095147|589357364|FG002|Long-term Extension Period|No longer meets study criteria|0|||
163175179|NCT00095147|589357365|FG003|Long-term Extension Period|No longer meets study criteria|0|||
163175180|NCT00095147|589357366|FG004|Long-term Extension Period|No longer meets study criteria|1|||
163175181|NCT00095147|589357362|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
163175182|NCT00095147|589357363|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
163175183|NCT00095147|589357364|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
163175184|NCT00095147|589357365|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
163175185|NCT00095147|589357366|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
163175186|NCT00095147|589357362|FG000|Long-term Extension Period|Leaving country|0|||
163175187|NCT00095147|589357363|FG001|Long-term Extension Period|Leaving country|0|||
163175188|NCT00095147|589357364|FG002|Long-term Extension Period|Leaving country|0|||
163175189|NCT00095147|589357365|FG003|Long-term Extension Period|Leaving country|0|||
163175190|NCT00095147|589357366|FG004|Long-term Extension Period|Leaving country|1|||
163175191|NCT02395302|589357367|FG000|Overall Study|Screen Failure|3|||
163175192|NCT02395302|589357367|FG000|Overall Study|Run In Failure|7|||
163175193|NCT02395302|589357367|FG000|Overall Study|Withdrawal by Subject|2|||
163175194|NCT02395302|589357367|FG000|Overall Study|Physician Decision|2|||
163175195|NCT04604132|589357368|FG000|Overall Study|Adverse Event|2|||
163175196|NCT04604132|589357369|FG001|Overall Study|Adverse Event|0|||
163175197|NCT04604132|589357370|FG002|Overall Study|Adverse Event|0|||
163175198|NCT04604132|589357371|FG003|Overall Study|Adverse Event|1|||
163175199|NCT04604132|589357372|FG004|Overall Study|Adverse Event|2|||
163175200|NCT04604132|589357368|FG000|Overall Study|Study terminated by sponsor|0|||
163175201|NCT04604132|589357369|FG001|Overall Study|Study terminated by sponsor|0|||
163175202|NCT04604132|589357370|FG002|Overall Study|Study terminated by sponsor|0|||
163175203|NCT04604132|589357371|FG003|Overall Study|Study terminated by sponsor|0|||
163175204|NCT04604132|589357372|FG004|Overall Study|Study terminated by sponsor|1|||
163175205|NCT04604132|589357368|FG000|Overall Study|Progressive disease: Clinical progression|0|||
163175206|NCT04604132|589357369|FG001|Overall Study|Progressive disease: Clinical progression|0|||
163175207|NCT04604132|589357370|FG002|Overall Study|Progressive disease: Clinical progression|1|||
163175208|NCT04604132|589357371|FG003|Overall Study|Progressive disease: Clinical progression|0|||
163175209|NCT04604132|589357372|FG004|Overall Study|Progressive disease: Clinical progression|0|||
163175210|NCT04604132|589357368|FG000|Overall Study|Progressive disease: Radiological progression|8|||
163175211|NCT04604132|589357369|FG001|Overall Study|Progressive disease: Radiological progression|7|||
163175212|NCT04604132|589357370|FG002|Overall Study|Progressive disease: Radiological progression|10|||
163175213|NCT04604132|589357371|FG003|Overall Study|Progressive disease: Radiological progression|4|||
163175214|NCT04604132|589357372|FG004|Overall Study|Progressive disease: Radiological progression|3|||
163175215|NCT04604132|589357368|FG000|Overall Study|Death|3|||
163175216|NCT04604132|589357369|FG001|Overall Study|Death|1|||
163175217|NCT04604132|589357370|FG002|Overall Study|Death|2|||
163175218|NCT04604132|589357371|FG003|Overall Study|Death|1|||
163175219|NCT04604132|589357372|FG004|Overall Study|Death|0|||
163175220|NCT00952380|589357373|FG000|Overall Study|Other|0|||
163175221|NCT00952380|589357374|FG001|Overall Study|Other|0|||
163175222|NCT00952380|589357375|FG002|Overall Study|Other|0|||
163175223|NCT00952380|589357376|FG003|Overall Study|Other|0|||
163175224|NCT00952380|589357377|FG004|Overall Study|Other|1|||
163175225|NCT00952380|589357373|FG000|Overall Study|Withdrawal by Subject|0|||
163175226|NCT00952380|589357374|FG001|Overall Study|Withdrawal by Subject|0|||
163175227|NCT00952380|589357375|FG002|Overall Study|Withdrawal by Subject|1|||
163175228|NCT00952380|589357376|FG003|Overall Study|Withdrawal by Subject|0|||
163175229|NCT00952380|589357377|FG004|Overall Study|Withdrawal by Subject|2|||
163175230|NCT00952380|589357373|FG000|Overall Study|Adverse Event|0|||
163175231|NCT00952380|589357374|FG001|Overall Study|Adverse Event|1|||
163175232|NCT00952380|589357375|FG002|Overall Study|Adverse Event|0|||
163175233|NCT00952380|589357376|FG003|Overall Study|Adverse Event|0|||
163175234|NCT00952380|589357377|FG004|Overall Study|Adverse Event|3|||
163175235|NCT00952380|589357373|FG000|Overall Study|Physician Decision|0|||
163175236|NCT00952380|589357374|FG001|Overall Study|Physician Decision|0|||
163175237|NCT00952380|589357375|FG002|Overall Study|Physician Decision|1|||
163175238|NCT00952380|589357376|FG003|Overall Study|Physician Decision|2|||
163175239|NCT00952380|589357377|FG004|Overall Study|Physician Decision|0|||
163175240|NCT00952380|589357373|FG000|Overall Study|Non-compliant to protocol|0|||
163175241|NCT00952380|589357374|FG001|Overall Study|Non-compliant to protocol|0|||
163175242|NCT00952380|589357375|FG002|Overall Study|Non-compliant to protocol|0|||
163175243|NCT00952380|589357376|FG003|Overall Study|Non-compliant to protocol|1|||
163175244|NCT00952380|589357377|FG004|Overall Study|Non-compliant to protocol|0|||
163175245|NCT02048241|589357379|FG000|Overall Study|Withdrawal by Subject|0|||
163175246|NCT02048241|589357380|FG001|Overall Study|Withdrawal by Subject|1|||
163175247|NCT00534313|589357381|FG000|Short-term Period|Adverse Event|1|||
163175248|NCT00534313|589357382|FG001|Short-term Period|Adverse Event|2|||
163175249|NCT00534313|589357383|FG002|Short-term Period|Adverse Event|1|||
163175250|NCT00534313|589357384|FG003|Short-term Period|Adverse Event|3|||
163175251|NCT00534313|589357381|FG000|Short-term Period|Lack of Efficacy|3|||
163175252|NCT00534313|589357382|FG001|Short-term Period|Lack of Efficacy|4|||
163175253|NCT00534313|589357383|FG002|Short-term Period|Lack of Efficacy|0|||
163175254|NCT00534313|589357384|FG003|Short-term Period|Lack of Efficacy|3|||
163175255|NCT00534313|589357381|FG000|Short-term Period|Participant not meeting study criteria|0|||
163175256|NCT00534313|589357382|FG001|Short-term Period|Participant not meeting study criteria|0|||
163175257|NCT00534313|589357383|FG002|Short-term Period|Participant not meeting study criteria|0|||
163175258|NCT00534313|589357384|FG003|Short-term Period|Participant not meeting study criteria|1|||
163175259|NCT00534313|589357381|FG000|Short-term Period|Participant withdrew consent|2|||
163175260|NCT00534313|589357382|FG001|Short-term Period|Participant withdrew consent|0|||
163175261|NCT00534313|589357383|FG002|Short-term Period|Participant withdrew consent|0|||
163175262|NCT00534313|589357384|FG003|Short-term Period|Participant withdrew consent|2|||
162932443|NCT01270841|588458492|FG001|Overall Study|Lost to Follow-up|1|||
163175263|NCT00534313|589357381|FG000|Short-term Period|Pregnancy|0|||
163175264|NCT00534313|589357382|FG001|Short-term Period|Pregnancy|0|||
163175265|NCT00534313|589357383|FG002|Short-term Period|Pregnancy|1|||
163175266|NCT00534313|589357384|FG003|Short-term Period|Pregnancy|0|||
163175267|NCT00534313|589357381|FG000|Long-term Period|Adverse Event|2|||
163175268|NCT00534313|589357382|FG001|Long-term Period|Adverse Event|1|||
163175269|NCT00534313|589357383|FG002|Long-term Period|Adverse Event|0|||
163175270|NCT00534313|589357384|FG003|Long-term Period|Adverse Event|1|||
163175271|NCT00534313|589357381|FG000|Long-term Period|Lack of Efficacy|14|||
163175272|NCT00534313|589357382|FG001|Long-term Period|Lack of Efficacy|10|||
163175273|NCT00534313|589357383|FG002|Long-term Period|Lack of Efficacy|14|||
163175274|NCT00534313|589357384|FG003|Long-term Period|Lack of Efficacy|12|||
163175275|NCT00534313|589357381|FG000|Long-term Period|Lost to Follow-up|1|||
163175276|NCT00534313|589357382|FG001|Long-term Period|Lost to Follow-up|2|||
163175277|NCT00534313|589357383|FG002|Long-term Period|Lost to Follow-up|0|||
163175278|NCT00534313|589357384|FG003|Long-term Period|Lost to Follow-up|0|||
163175279|NCT00534313|589357381|FG000|Long-term Period|Withdrawal by Subject|2|||
163175280|NCT00534313|589357382|FG001|Long-term Period|Withdrawal by Subject|2|||
163175281|NCT00534313|589357383|FG002|Long-term Period|Withdrawal by Subject|0|||
163175282|NCT00534313|589357384|FG003|Long-term Period|Withdrawal by Subject|0|||
163175283|NCT00534313|589357381|FG000|Long-term Period|No longer meets study criteria|0|||
163175284|NCT00534313|589357382|FG001|Long-term Period|No longer meets study criteria|1|||
163175285|NCT00534313|589357383|FG002|Long-term Period|No longer meets study criteria|0|||
163175286|NCT00534313|589357384|FG003|Long-term Period|No longer meets study criteria|0|||
163175287|NCT00534313|589357381|FG000|Long-term Period|Poor compliance/noncompliance|0|||
163175288|NCT00534313|589357382|FG001|Long-term Period|Poor compliance/noncompliance|1|||
163175289|NCT00534313|589357383|FG002|Long-term Period|Poor compliance/noncompliance|1|||
163175290|NCT00534313|589357384|FG003|Long-term Period|Poor compliance/noncompliance|0|||
163175291|NCT00534313|589357381|FG000|Long-term Period|Administrative reason by sponsor|17|||
163175292|NCT00534313|589357382|FG001|Long-term Period|Administrative reason by sponsor|15|||
163175293|NCT00534313|589357383|FG002|Long-term Period|Administrative reason by sponsor|26|||
163175294|NCT00534313|589357384|FG003|Long-term Period|Administrative reason by sponsor|18|||
163175295|NCT00534313|589357381|FG000|Long-term Period|Other|1|||
163175296|NCT00534313|589357382|FG001|Long-term Period|Other|2|||
163175297|NCT00534313|589357383|FG002|Long-term Period|Other|2|||
163175298|NCT00534313|589357384|FG003|Long-term Period|Other|2|||
163175299|NCT00402233|589357385|FG000|Overall Study|Adverse Event|1|||
163175300|NCT00402233|589357386|FG001|Overall Study|Adverse Event|7|||
163175301|NCT00402233|589357387|FG002|Overall Study|Adverse Event|9|||
163175302|NCT00402233|589357388|FG003|Overall Study|Adverse Event|9|||
163175303|NCT00402233|589357385|FG000|Overall Study|Protocol Violation|0|||
163175304|NCT00402233|589357386|FG001|Overall Study|Protocol Violation|1|||
163175305|NCT00402233|589357387|FG002|Overall Study|Protocol Violation|0|||
163175306|NCT00402233|589357388|FG003|Overall Study|Protocol Violation|0|||
163175307|NCT00402233|589357385|FG000|Overall Study|Withdrawal by Subject|2|||
163175308|NCT00402233|589357386|FG001|Overall Study|Withdrawal by Subject|1|||
163175309|NCT00402233|589357387|FG002|Overall Study|Withdrawal by Subject|2|||
163175310|NCT00402233|589357388|FG003|Overall Study|Withdrawal by Subject|2|||
163175311|NCT00402233|589357385|FG000|Overall Study|Worsening of disease under study|2|||
163175312|NCT00402233|589357386|FG001|Overall Study|Worsening of disease under study|0|||
163175313|NCT00402233|589357387|FG002|Overall Study|Worsening of disease under study|0|||
163175314|NCT00402233|589357388|FG003|Overall Study|Worsening of disease under study|0|||
163175315|NCT00402233|589357385|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163175316|NCT00402233|589357386|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163175317|NCT00402233|589357387|FG002|Overall Study|Worsening of other pre-existing disease|0|||
163175318|NCT00402233|589357388|FG003|Overall Study|Worsening of other pre-existing disease|0|||
163175319|NCT03007888|589357389|FG000|First Intervention (14 Days)|Adverse Event|1|||
163175320|NCT03007888|589357390|FG001|First Intervention (14 Days)|Adverse Event|0|||
163175321|NCT00927940|589357392|FG000|Overall Study|Death|1|||
163175322|NCT04658940|589357393|FG000|Overall Study|Withdrawal by Subject|1|||
163175323|NCT00827931|589357395|FG000|Overall Study|Death|3|||
163175324|NCT00827931|589357396|FG001|Overall Study|Death|5|||
163175325|NCT00827931|589357395|FG000|Overall Study|Adverse Event|1|||
163175326|NCT00827931|589357396|FG001|Overall Study|Adverse Event|0|||
163175327|NCT00827931|589357395|FG000|Overall Study|Lost to Follow-up|1|||
163175328|NCT00827931|589357396|FG001|Overall Study|Lost to Follow-up|0|||
163175329|NCT00827931|589357395|FG000|Overall Study|Withdrawal by Subject|0|||
163175330|NCT00827931|589357396|FG001|Overall Study|Withdrawal by Subject|1|||
163175331|NCT00827931|589357395|FG000|Overall Study|Other|1|||
163175332|NCT00827931|589357396|FG001|Overall Study|Other|0|||
163175333|NCT03579602|589357400|FG000|Overall Study|Subject unable to receive study drug|0|||
163175334|NCT03579602|589357401|FG001|Overall Study|Subject unable to receive study drug|2|||
163175335|NCT03579602|589357400|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
163175336|NCT03579602|589357401|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
163175337|NCT00483756|589357402|FG000|Overall Study|Death|2|||
163175338|NCT00483756|589357403|FG001|Overall Study|Death|0|||
163175339|NCT00483756|589357404|FG002|Overall Study|Death|1|||
163175340|NCT00483756|589357402|FG000|Overall Study|Adverse Event|19|||
163175341|NCT00483756|589357403|FG001|Overall Study|Adverse Event|38|||
163175342|NCT00483756|589357404|FG002|Overall Study|Adverse Event|40|||
163175343|NCT00483756|589357402|FG000|Overall Study|Lack of Efficacy|1|||
163175344|NCT00483756|589357403|FG001|Overall Study|Lack of Efficacy|0|||
163175345|NCT00483756|589357404|FG002|Overall Study|Lack of Efficacy|0|||
163175346|NCT00483756|589357402|FG000|Overall Study|Lost to Follow-up|3|||
163175347|NCT00483756|589357403|FG001|Overall Study|Lost to Follow-up|1|||
163175348|NCT00483756|589357404|FG002|Overall Study|Lost to Follow-up|0|||
163175349|NCT00483756|589357402|FG000|Overall Study|Withdrawal by Subject|5|||
163175350|NCT00483756|589357403|FG001|Overall Study|Withdrawal by Subject|3|||
163175351|NCT00483756|589357404|FG002|Overall Study|Withdrawal by Subject|4|||
163175352|NCT00483756|589357402|FG000|Overall Study|Other|2|||
163175353|NCT00483756|589357403|FG001|Overall Study|Other|4|||
163175354|NCT00483756|589357404|FG002|Overall Study|Other|3|||
163175355|NCT00483756|589357402|FG000|Overall Study|Randomized, Not Treated|1|||
163175356|NCT00483756|589357403|FG001|Overall Study|Randomized, Not Treated|4|||
163175357|NCT00483756|589357404|FG002|Overall Study|Randomized, Not Treated|4|||
163175358|NCT00495040|589357405|FG000|Overall Study|Withdrawal by Subject|3|||
163175359|NCT01829243|589357406|FG000|First Intervention|Screen Failure|4|||
163175360|NCT01829243|589357407|FG001|First Intervention|Screen Failure|2|||
163175361|NCT02282293|589357410|FG000|Overall Study|Lost to Follow-up|2|||
163175362|NCT02282293|589357411|FG001|Overall Study|Lost to Follow-up|2|||
163175363|NCT02282293|589357410|FG000|Overall Study|Unable to comply with study procedures|1|||
163175364|NCT02282293|589357411|FG001|Overall Study|Unable to comply with study procedures|0|||
163175365|NCT02282293|589357410|FG000|Overall Study|Moved out of study area|0|||
163175366|NCT02282293|589357411|FG001|Overall Study|Moved out of study area|1|||
163175367|NCT01894568|589357414|FG000|Overall Study|Adverse Event|2|||
163175368|NCT01894568|589357415|FG001|Overall Study|Adverse Event|3|||
163175369|NCT01894568|589357414|FG000|Overall Study|Protocol required discontinuation|2|||
163175370|NCT01894568|589357415|FG001|Overall Study|Protocol required discontinuation|1|||
163175371|NCT01894568|589357414|FG000|Overall Study|Withdrawal by Subject|5|||
163175372|NCT01894568|589357415|FG001|Overall Study|Withdrawal by Subject|5|||
163175373|NCT01894568|589357414|FG000|Overall Study|Physician Decision|1|||
163175374|NCT01894568|589357415|FG001|Overall Study|Physician Decision|0|||
163175375|NCT01894568|589357414|FG000|Overall Study|Lost to Follow-up|0|||
163175376|NCT01894568|589357415|FG001|Overall Study|Lost to Follow-up|1|||
163175377|NCT00807573|589357416|FG000|Overall Study|Withdrawal by Subject|1|||
163175378|NCT00807573|589357416|FG000|Overall Study|Adverse Event|1|||
163175379|NCT01514370|589357419|FG000|Overall Study|Protocol Violation|2|||
163175380|NCT01514370|589357420|FG001|Overall Study|Protocol Violation|3|||
163175381|NCT01514370|589357419|FG000|Overall Study|Lost to Follow-up|0|||
163175382|NCT01514370|589357420|FG001|Overall Study|Lost to Follow-up|2|||
163175383|NCT01514370|589357419|FG000|Overall Study|Withdrawal by Subject|2|||
163175384|NCT01514370|589357420|FG001|Overall Study|Withdrawal by Subject|1|||
163175385|NCT01514370|589357419|FG000|Overall Study|Adverse Event|1|||
163175386|NCT01514370|589357420|FG001|Overall Study|Adverse Event|3|||
163175387|NCT01514370|589357419|FG000|Overall Study|Other|6|||
163175388|NCT01514370|589357420|FG001|Overall Study|Other|7|||
163175389|NCT01089361|589357421|FG000|Overall Study|Death|1|||
163175390|NCT01089361|589357422|FG001|Overall Study|Death|0|||
163175391|NCT00169442|589357423|FG000|Overall Study|Withdrawal by Subject|0|||
163175392|NCT00169442|589357424|FG001|Overall Study|Withdrawal by Subject|0|||
162825405|NCT01970488|588073909|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
162825406|NCT01970488|588073910|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
162825407|NCT01816061|588073911|FG000|Overall Study|Lost to Follow-up|13|||
162825408|NCT01816061|588073912|FG001|Overall Study|Lost to Follow-up|24|||
162825409|NCT05525689|588073914|FG000|Overall Study|Lost to Follow-up|1|||
162825410|NCT05525689|588073915|FG001|Overall Study|Lost to Follow-up|0|||
162825411|NCT01231659|588073916|FG000|Overall Study|Adverse Event|9|||
162825412|NCT01231659|588073916|FG000|Overall Study|Disease Progression|48|||
162825413|NCT01231659|588073916|FG000|Overall Study|Death|2|||
162825414|NCT01231659|588073916|FG000|Overall Study|Patient refused to complete study visit|1|||
162825415|NCT01231659|588073916|FG000|Overall Study|Other protocol defined criteria|12|||
162825416|NCT01075412|588073917|FG000|Overall Study|Withdrawal by Subject|0|||
162825417|NCT01075412|588073918|FG001|Overall Study|Withdrawal by Subject|1|||
162825418|NCT00509067|588073919|FG000|Overall Study|Lost to Follow-up|1|||
162825419|NCT00509067|588073920|FG001|Overall Study|Lost to Follow-up|1|||
162825420|NCT00509067|588073919|FG000|Overall Study|Adverse Event|3|||
162825421|NCT00509067|588073920|FG001|Overall Study|Adverse Event|1|||
162825422|NCT00509067|588073919|FG000|Overall Study|Protocol Violation|0|||
162825423|NCT00509067|588073920|FG001|Overall Study|Protocol Violation|3|||
162825424|NCT00702325|588073934|FG000|Overall Study|Adverse Event|1|||
162825425|NCT00702325|588073935|FG001|Overall Study|Adverse Event|0|||
162825426|NCT00702325|588073934|FG000|Overall Study|Withdrawal by Subject|7|||
162825427|NCT00702325|588073935|FG001|Overall Study|Withdrawal by Subject|7|||
163175393|NCT00169442|589357425|FG002|Overall Study|Withdrawal by Subject|1|||
163175394|NCT00169442|589357426|FG003|Overall Study|Withdrawal by Subject|0|||
163175395|NCT00169442|589357427|FG004|Overall Study|Withdrawal by Subject|0|||
163175396|NCT00169442|589357428|FG005|Overall Study|Withdrawal by Subject|0|||
163175397|NCT00169442|589357423|FG000|Overall Study|Migrated/moved from study area|0|||
163175398|NCT00169442|589357424|FG001|Overall Study|Migrated/moved from study area|0|||
162825428|NCT00702325|588073934|FG000|Overall Study|Lost to Follow-up|3|||
162825429|NCT00702325|588073935|FG001|Overall Study|Lost to Follow-up|4|||
163175399|NCT00169442|589357425|FG002|Overall Study|Migrated/moved from study area|0|||
163175400|NCT00169442|589357426|FG003|Overall Study|Migrated/moved from study area|0|||
162825430|NCT00702325|588073934|FG000|Overall Study|Incorrect enrollment|5|||
162825431|NCT00702325|588073935|FG001|Overall Study|Incorrect enrollment|7|||
162932444|NCT01270841|588458493|FG002|Overall Study|Lost to Follow-up|4|||
162825432|NCT00702325|588073934|FG000|Overall Study|Developed study discontinuation criteria|18|||
162932445|NCT01270841|588458494|FG003|Overall Study|Lost to Follow-up|2|||
163175401|NCT00169442|589357427|FG004|Overall Study|Migrated/moved from study area|0|||
163175402|NCT00169442|589357428|FG005|Overall Study|Migrated/moved from study area|2|||
163175403|NCT00169442|589357423|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175404|NCT00169442|589357424|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175405|NCT00169442|589357425|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175406|NCT00169442|589357426|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175407|NCT00169442|589357427|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
163175408|NCT00169442|589357428|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
163175409|NCT00169442|589357423|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175410|NCT00169442|589357424|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
163175411|NCT00169442|589357425|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175412|NCT00169442|589357426|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175413|NCT00169442|589357427|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175414|NCT00169442|589357428|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163175415|NCT03353740|589357431|FG000|Overall Study|Images for these participants not viable|52|||
163175416|NCT02232880|589357433|FG000|Overall Study|study stopped prior to randomization|1|||
163175417|NCT03976648|589357436|FG000|Overall Study|Adverse Event|0|||
163175418|NCT03976648|589357437|FG001|Overall Study|Adverse Event|2|||
163175419|NCT03976648|589357436|FG000|Overall Study|Study terminated by sponsor|21|||
163175420|NCT03976648|589357437|FG001|Overall Study|Study terminated by sponsor|8|||
163175421|NCT03645434|589357438|FG000|Period 1|Adverse Event|0|||
163175422|NCT03645434|589357439|FG001|Period 1|Adverse Event|0|||
163175423|NCT03645434|589357440|FG002|Period 1|Adverse Event|0|||
163175424|NCT03645434|589357441|FG003|Period 1|Adverse Event|1|||
163175425|NCT03645434|589357442|FG004|Period 1|Adverse Event|0|||
163175426|NCT03645434|589357443|FG005|Period 1|Adverse Event|0|||
163175427|NCT03645434|589357438|FG000|Period 1|COPD exacerbation|0|||
163175428|NCT03645434|589357439|FG001|Period 1|COPD exacerbation|0|||
163175429|NCT03645434|589357440|FG002|Period 1|COPD exacerbation|0|||
163175430|NCT03645434|589357441|FG003|Period 1|COPD exacerbation|0|||
163175431|NCT03645434|589357442|FG004|Period 1|COPD exacerbation|1|||
163175432|NCT03645434|589357443|FG005|Period 1|COPD exacerbation|0|||
163175433|NCT00881868|589357444|FG000|Overall Study|Adverse Event|0|||
163175434|NCT00881868|589357445|FG001|Overall Study|Adverse Event|1|||
163175435|NCT00881868|589357444|FG000|Overall Study|Lost to Follow-up|2|||
163175436|NCT00881868|589357445|FG001|Overall Study|Lost to Follow-up|1|||
163175437|NCT00881868|589357444|FG000|Overall Study|Physician Decision|4|||
163175438|NCT00881868|589357445|FG001|Overall Study|Physician Decision|0|||
163175439|NCT00881868|589357444|FG000|Overall Study|Protocol Violation|2|||
163175440|NCT00881868|589357445|FG001|Overall Study|Protocol Violation|0|||
163175441|NCT02880956|589357448|FG000|Overall Study|Adverse Event|3|||
163175442|NCT02880956|589357449|FG001|Overall Study|Adverse Event|6|||
163175443|NCT02880956|589357450|FG002|Overall Study|Adverse Event|5|||
163175444|NCT02880956|589357451|FG003|Overall Study|Adverse Event|4|||
163175445|NCT02880956|589357448|FG000|Overall Study|Withdrawal by Subject|9|||
163175446|NCT02880956|589357449|FG001|Overall Study|Withdrawal by Subject|4|||
163175447|NCT02880956|589357450|FG002|Overall Study|Withdrawal by Subject|6|||
163175448|NCT02880956|589357451|FG003|Overall Study|Withdrawal by Subject|11|||
163175449|NCT02880956|589357448|FG000|Overall Study|Lost to Follow-up|0|||
163175450|NCT02880956|589357449|FG001|Overall Study|Lost to Follow-up|1|||
163175451|NCT02880956|589357450|FG002|Overall Study|Lost to Follow-up|0|||
163175452|NCT02880956|589357451|FG003|Overall Study|Lost to Follow-up|0|||
163175453|NCT02880956|589357448|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163175454|NCT02880956|589357449|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
163175455|NCT02880956|589357450|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163175456|NCT02880956|589357451|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
163175457|NCT02880956|589357448|FG000|Overall Study|Other, Not Specified|4|||
163175458|NCT02880956|589357449|FG001|Overall Study|Other, Not Specified|2|||
163175459|NCT02880956|589357450|FG002|Overall Study|Other, Not Specified|0|||
163175460|NCT02880956|589357451|FG003|Overall Study|Other, Not Specified|3|||
163175461|NCT02081859|589357452|FG000|Overall Study|No fertilization|2|||
163175462|NCT02081859|589357453|FG001|Overall Study|No fertilization|2|||
163175463|NCT02081859|589357452|FG000|Overall Study|No sperm|1|||
163175464|NCT02081859|589357453|FG001|Overall Study|No sperm|0|||
163175465|NCT02081859|589357452|FG000|Overall Study|Unanticipated freeze all cycle|2|||
163175466|NCT02081859|589357453|FG001|Overall Study|Unanticipated freeze all cycle|6|||
163175467|NCT02081859|589357452|FG000|Overall Study|< 4 embryos|27|||
163175468|NCT02081859|589357453|FG001|Overall Study|< 4 embryos|23|||
163175469|NCT02081859|589357452|FG000|Overall Study|Other reasons|2|||
163175470|NCT02081859|589357453|FG001|Overall Study|Other reasons|0|||
163175471|NCT03718299|589358760|FG000|Overall Study|Adverse Event|1|||
163175472|NCT03718299|589358760|FG000|Overall Study|Withdrawal by Subject|6|||
163175473|NCT03718299|589358760|FG000|Overall Study|Physician Decision|2|||
163175474|NCT03718299|589358760|FG000|Overall Study|Lost to Follow-up|1|||
163175475|NCT04389970|589358762|FG000|Overall Study|Lost to Follow-up|1|||
163175476|NCT03123185|589358763|FG000|Overall Study|Withdrawal by Subject|0|||
163175477|NCT03123185|589358764|FG001|Overall Study|Withdrawal by Subject|0|||
163175478|NCT03123185|589358765|FG002|Overall Study|Withdrawal by Subject|0|||
163175479|NCT03123185|589358766|FG003|Overall Study|Withdrawal by Subject|0|||
163175480|NCT03123185|589358767|FG004|Overall Study|Withdrawal by Subject|0|||
163175481|NCT03123185|589358768|FG005|Overall Study|Withdrawal by Subject|0|||
163175482|NCT03123185|589358769|FG006|Overall Study|Withdrawal by Subject|0|||
163175483|NCT03123185|589358770|FG007|Overall Study|Withdrawal by Subject|0|||
163175484|NCT03123185|589358771|FG008|Overall Study|Withdrawal by Subject|0|||
163175485|NCT03123185|589358772|FG009|Overall Study|Withdrawal by Subject|0|||
163175486|NCT03123185|589358773|FG010|Overall Study|Withdrawal by Subject|0|||
163175487|NCT03123185|589358774|FG011|Overall Study|Withdrawal by Subject|0|||
163175488|NCT03123185|589358775|FG012|Overall Study|Withdrawal by Subject|1|||
163175489|NCT03123185|589358776|FG013|Overall Study|Withdrawal by Subject|0|||
163175490|NCT00686634|589358781|FG000|Overall Study|Protocol Violation|6|||
163175491|NCT04369924|589358783|FG000|Overall Study|Lost to Follow-up|302|||
163175492|NCT04369924|589358784|FG001|Overall Study|Lost to Follow-up|339|||
163175493|NCT01653132|589358787|FG000|First Intervention|Protocol Violation|1|||
163175494|NCT01653132|589358788|FG001|First Intervention|Protocol Violation|0|||
163175495|NCT03828370|589358789|FG000|3 Month Follow-up|Lost to Follow-up|4|||
163175496|NCT03828370|589358790|FG001|3 Month Follow-up|Lost to Follow-up|12|||
163175497|NCT03828370|589358789|FG000|9 Month Follow up|Lost to Follow-up|12|||
163175498|NCT03828370|589358790|FG001|9 Month Follow up|Lost to Follow-up|20|||
163175499|NCT01209832|589358791|FG000|Period 1|Sponsor Decision and was not dosed|1|||
163175500|NCT01209832|589358791|FG000|Period 2|Sponsor Decision|1|||
163175501|NCT00761150|589358792|FG000|Open-label Period|Adverse Event|36|||
163175502|NCT00761150|589358793|FG001|Open-label Period|Adverse Event|0|||
163175503|NCT00761150|589358794|FG002|Open-label Period|Adverse Event|0|||
163175504|NCT00761150|589358792|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
163175505|NCT00761150|589358793|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
163175506|NCT00761150|589358794|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
163175507|NCT00761150|589358792|FG000|Open-label Period|Lost to Follow-up|7|||
163175508|NCT00761150|589358793|FG001|Open-label Period|Lost to Follow-up|0|||
163175509|NCT00761150|589358794|FG002|Open-label Period|Lost to Follow-up|0|||
163175510|NCT00761150|589358792|FG000|Open-label Period|Lack of Efficacy|4|||
163175511|NCT00761150|589358793|FG001|Open-label Period|Lack of Efficacy|0|||
163175512|NCT00761150|589358794|FG002|Open-label Period|Lack of Efficacy|0|||
163175513|NCT00761150|589358792|FG000|Open-label Period|Withdrawal by Subject|5|||
163175514|NCT00761150|589358793|FG001|Open-label Period|Withdrawal by Subject|0|||
163175515|NCT00761150|589358794|FG002|Open-label Period|Withdrawal by Subject|0|||
163175516|NCT00761150|589358792|FG000|Open-label Period|Noncompliance|2|||
163175517|NCT00761150|589358793|FG001|Open-label Period|Noncompliance|0|||
163175518|NCT00761150|589358794|FG002|Open-label Period|Noncompliance|0|||
163175519|NCT00761150|589358792|FG000|Open-label Period|Other|5|||
163175520|NCT00761150|589358793|FG001|Open-label Period|Other|0|||
163175521|NCT00761150|589358794|FG002|Open-label Period|Other|0|||
163175522|NCT00761150|589358792|FG000|Double-blind Period|Lack of Efficacy|0|||
163175523|NCT00761150|589358793|FG001|Double-blind Period|Lack of Efficacy|2|||
163175524|NCT00761150|589358794|FG002|Double-blind Period|Lack of Efficacy|19|||
163175525|NCT00761150|589358792|FG000|Double-blind Period|Adverse Event|0|||
163175526|NCT00761150|589358793|FG001|Double-blind Period|Adverse Event|3|||
163175527|NCT00761150|589358794|FG002|Double-blind Period|Adverse Event|3|||
163175528|NCT00761150|589358792|FG000|Double-blind Period|Withdrawal by Subject|0|||
163175529|NCT00761150|589358793|FG001|Double-blind Period|Withdrawal by Subject|3|||
163175530|NCT00761150|589358794|FG002|Double-blind Period|Withdrawal by Subject|2|||
163175531|NCT00761150|589358792|FG000|Double-blind Period|Lost to Follow-up|0|||
163175532|NCT00761150|589358793|FG001|Double-blind Period|Lost to Follow-up|2|||
163175533|NCT00761150|589358794|FG002|Double-blind Period|Lost to Follow-up|1|||
163175534|NCT00761150|589358792|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
163175535|NCT00761150|589358793|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
163175536|NCT00761150|589358794|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
163175537|NCT00761150|589358792|FG000|Double-blind Period|Noncompliance|0|||
163175538|NCT00761150|589358793|FG001|Double-blind Period|Noncompliance|1|||
163175539|NCT00761150|589358794|FG002|Double-blind Period|Noncompliance|0|||
163175540|NCT00761150|589358792|FG000|Double-blind Period|Other|0|||
163175541|NCT00761150|589358793|FG001|Double-blind Period|Other|3|||
163175542|NCT00761150|589358794|FG002|Double-blind Period|Other|3|||
163175543|NCT00046891|589358797|FG000|Overall Study|Cancels|5|||
163175544|NCT00046891|589358798|FG001|Overall Study|Cancels|9|||
163175545|NCT00046891|589358797|FG000|Overall Study|Ineligible|1|||
163175546|NCT00046891|589358798|FG001|Overall Study|Ineligible|1|||
163175547|NCT00046891|589358797|FG000|Overall Study|Withdrawal by Subject|18|||
163175548|NCT00046891|589358798|FG001|Overall Study|Withdrawal by Subject|15|||
163175549|NCT00046891|589358797|FG000|Overall Study|Adverse Event|5|||
163175550|NCT00046891|589358798|FG001|Overall Study|Adverse Event|5|||
163175551|NCT06400251|589358802|FG000|Overall Study|Never Start Protocol Therapy|1|||
162932446|NCT01270841|588458491|FG000|Overall Study|Physician Decision|0|||
163175552|NCT06400251|589358802|FG000|Overall Study|Ineligible|2|||
163175553|NCT06400251|589358802|FG000|Overall Study|Mutation Status Not Confirmed|3|||
163175554|NCT06400251|589358802|FG000|Overall Study|Disease Progression|25|||
163175555|NCT06400251|589358802|FG000|Overall Study|Adverse Event|1|||
163175556|NCT06400251|589358802|FG000|Overall Study|Complicating Disease|1|||
163175557|NCT06400251|589358802|FG000|Overall Study|Physician Decision|2|||
162932447|NCT01270841|588458492|FG001|Overall Study|Physician Decision|1|||
163175558|NCT02217527|589358803|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
162825433|NCT00702325|588073935|FG001|Overall Study|Developed study discontinuation criteria|28|||
162825434|NCT00702325|588073934|FG000|Overall Study|Severe noncompliance to protocol|3|||
162825435|NCT00702325|588073935|FG001|Overall Study|Severe noncompliance to protocol|3|||
162825436|NCT00702325|588073934|FG000|Overall Study|Termination due to lab results|1|||
162825437|NCT00702325|588073935|FG001|Overall Study|Termination due to lab results|0|||
162825438|NCT00702325|588073934|FG000|Overall Study|Didn't follow study medication dosage|0|||
162825439|NCT00702325|588073935|FG001|Overall Study|Didn't follow study medication dosage|2|||
162825440|NCT00702325|588073934|FG000|Overall Study|Withdrew consent|0|||
162825441|NCT00702325|588073935|FG001|Overall Study|Withdrew consent|1|||
162825442|NCT00702325|588073934|FG000|Overall Study|Incorrectly Discontinued|0|||
162825443|NCT00702325|588073935|FG001|Overall Study|Incorrectly Discontinued|1|||
162698468|NCT02065570|587605508|FG002|Maintenance Study|Withdrawal by Subject|1|||
162825444|NCT03716050|588073936|FG000|Overall Study|Lost to Follow-up|0|||
162825445|NCT03716050|588073937|FG001|Overall Study|Lost to Follow-up|0|||
162825446|NCT03716050|588073938|FG002|Overall Study|Lost to Follow-up|1|||
162825447|NCT03716050|588073939|FG003|Overall Study|Lost to Follow-up|0|||
162825448|NCT03716050|588073940|FG004|Overall Study|Lost to Follow-up|0|||
162825449|NCT03716050|588073941|FG005|Overall Study|Lost to Follow-up|0|||
162825450|NCT03716050|588073942|FG006|Overall Study|Lost to Follow-up|0|||
162825451|NCT03716050|588073943|FG007|Overall Study|Lost to Follow-up|0|||
162825452|NCT03716050|588073936|FG000|Overall Study|Physician Decision|0|||
162825453|NCT03716050|588073937|FG001|Overall Study|Physician Decision|0|||
162825454|NCT03716050|588073938|FG002|Overall Study|Physician Decision|0|||
162825455|NCT03716050|588073939|FG003|Overall Study|Physician Decision|1|||
162825456|NCT03716050|588073940|FG004|Overall Study|Physician Decision|0|||
162825457|NCT03716050|588073941|FG005|Overall Study|Physician Decision|0|||
162825458|NCT03716050|588073942|FG006|Overall Study|Physician Decision|0|||
162825459|NCT03716050|588073943|FG007|Overall Study|Physician Decision|0|||
162825460|NCT03716050|588073936|FG000|Overall Study|Protocol Violation|0|||
162825461|NCT03716050|588073937|FG001|Overall Study|Protocol Violation|0|||
162825462|NCT03716050|588073938|FG002|Overall Study|Protocol Violation|0|||
162825463|NCT03716050|588073939|FG003|Overall Study|Protocol Violation|1|||
162825464|NCT03716050|588073940|FG004|Overall Study|Protocol Violation|0|||
162825465|NCT03716050|588073941|FG005|Overall Study|Protocol Violation|0|||
162825466|NCT03716050|588073942|FG006|Overall Study|Protocol Violation|0|||
162825467|NCT03716050|588073943|FG007|Overall Study|Protocol Violation|2|||
162825468|NCT01289821|588073944|FG000|Treatment Period|Withdrawal by Subject|1|||
162825469|NCT01289821|588073944|FG000|Treatment Period|Physician Decision|3|||
162825470|NCT01289821|588073944|FG000|Treatment Period|Adverse Event|4|||
162825471|NCT01289821|588073944|FG000|Treatment Period|Radiological Progression|43|||
163175559|NCT02217527|589358804|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
163175560|NCT02217527|589358803|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
163175561|NCT02217527|589358804|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
163175562|NCT06390839|589358810|FG000|Overall Study|Ineligible|2|||
163175563|NCT06390839|589358810|FG000|Overall Study|Never start protocol therapy|3|||
163175564|NCT06390839|589358810|FG000|Overall Study|Adverse Event|1|||
163175565|NCT06390839|589358810|FG000|Overall Study|Alternative therapy|2|||
163175566|NCT06390839|589358810|FG000|Overall Study|Death|3|||
163175567|NCT06390839|589358810|FG000|Overall Study|Disease progression|28|||
163175568|NCT06390839|589358810|FG000|Overall Study|Withdrawal by Subject|2|||
163175569|NCT06390839|589358810|FG000|Overall Study|Complicating disease|1|||
163175570|NCT06390839|589358810|FG000|Overall Study|Noncompliance|1|||
162932448|NCT01270841|588458493|FG002|Overall Study|Physician Decision|0|||
162932449|NCT01270841|588458494|FG003|Overall Study|Physician Decision|0|||
162932450|NCT01270841|588458491|FG000|Overall Study|Did not qualify|6|||
162932451|NCT01270841|588458492|FG001|Overall Study|Did not qualify|3|||
162932452|NCT01270841|588458493|FG002|Overall Study|Did not qualify|4|||
162932453|NCT01270841|588458494|FG003|Overall Study|Did not qualify|5|||
162932454|NCT01270841|588458491|FG000|Overall Study|Protocol Violation|1|||
162932455|NCT01270841|588458492|FG001|Overall Study|Protocol Violation|5|||
162932456|NCT01270841|588458493|FG002|Overall Study|Protocol Violation|0|||
162932457|NCT01270841|588458494|FG003|Overall Study|Protocol Violation|0|||
162932458|NCT01270841|588458491|FG000|Overall Study|Enrolled in error|0|||
162932459|NCT01270841|588458492|FG001|Overall Study|Enrolled in error|1|||
162698469|NCT02065570|587605509|FG003|Maintenance Study|Withdrawal by Subject|4|||
162698470|NCT02065570|587605506|FG000|Maintenance Study|Lost to Follow-up|0|||
162932460|NCT01270841|588458493|FG002|Overall Study|Enrolled in error|0|||
162932461|NCT01270841|588458494|FG003|Overall Study|Enrolled in error|0|||
162932462|NCT01375010|588458495|FG000|Overall Study|Lost to Follow-up|8|||
163175571|NCT01738477|589358815|FG000|Overall Study|Lost to Follow-up|1|||
163175572|NCT01738477|589358816|FG001|Overall Study|Lost to Follow-up|4|||
163175573|NCT00502203|589358817|FG000|Overall Study|Inevaluable|1|||
163175574|NCT02720094|589358818|FG000|Overall Study|Ongoing|2210|||
163175575|NCT02720094|589358819|FG001|Overall Study|Ongoing|2203|||
163175576|NCT02720094|589358818|FG000|Overall Study|Scheduled exit visit/end of study|2|||
163175577|NCT02720094|589358819|FG001|Overall Study|Scheduled exit visit/end of study|1|||
163175578|NCT02720094|589358818|FG000|Overall Study|Death|4|||
163175579|NCT02720094|589358819|FG001|Overall Study|Death|7|||
163175580|NCT02720094|589358818|FG000|Overall Study|Withdrawal by Subject|55|||
163175581|NCT02720094|589358819|FG001|Overall Study|Withdrawal by Subject|56|||
163175582|NCT02720094|589358818|FG000|Overall Study|Lost to Follow-up|2|||
163175583|NCT02720094|589358819|FG001|Overall Study|Lost to Follow-up|7|||
163175584|NCT02720094|589358818|FG000|Overall Study|Physician Decision|1|||
163175585|NCT02720094|589358819|FG001|Overall Study|Physician Decision|3|||
163175586|NCT02720094|589358818|FG000|Overall Study|Inappropriate enrollment|1|||
163175587|NCT02720094|589358819|FG001|Overall Study|Inappropriate enrollment|3|||
163175588|NCT02720094|589358818|FG000|Overall Study|Relocation|1|||
163175589|NCT02720094|589358819|FG001|Overall Study|Relocation|1|||
162698471|NCT02065570|587605507|FG001|Maintenance Study|Lost to Follow-up|0|||
162932463|NCT01375010|588458496|FG001|Overall Study|Lost to Follow-up|2|||
162932464|NCT01375010|588458495|FG000|Overall Study|Withdrawal by Subject|4|||
162932465|NCT01375010|588458496|FG001|Overall Study|Withdrawal by Subject|2|||
162932466|NCT02402933|588458497|FG000|Overall Study|Withdrawal by Subject|4|||
162932467|NCT02402933|588458497|FG000|Overall Study|Discontinued; Site Termination|10|||
163175590|NCT01431638|589358822|FG000|Overall Study|Adverse Event|1|||
163175591|NCT01431638|589358823|FG001|Overall Study|Adverse Event|3|||
163175592|NCT01431638|589358824|FG002|Overall Study|Adverse Event|1|||
163175593|NCT01431638|589358822|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162932468|NCT00830063|588458500|FG000|Overall Study|Adverse Event|7|||
162932469|NCT00830063|588458501|FG001|Overall Study|Adverse Event|13|||
162932470|NCT00830063|588458502|FG002|Overall Study|Adverse Event|16|||
162932471|NCT00830063|588458503|FG003|Overall Study|Adverse Event|13|||
162932472|NCT00830063|588458500|FG000|Overall Study|Death|1|||
162932473|NCT00830063|588458501|FG001|Overall Study|Death|0|||
162932474|NCT00830063|588458502|FG002|Overall Study|Death|0|||
162932475|NCT00830063|588458503|FG003|Overall Study|Death|0|||
162932476|NCT00830063|588458500|FG000|Overall Study|Lost to Follow-up|0|||
162932477|NCT00830063|588458501|FG001|Overall Study|Lost to Follow-up|0|||
162932478|NCT00830063|588458502|FG002|Overall Study|Lost to Follow-up|3|||
162932479|NCT00830063|588458503|FG003|Overall Study|Lost to Follow-up|1|||
162932480|NCT00830063|588458500|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
162932481|NCT00830063|588458501|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
162932482|NCT00830063|588458502|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
162932483|NCT00830063|588458503|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
162825472|NCT01289821|588073944|FG000|Treatment Period|Clinical Progression|2|||
162825473|NCT01289821|588073944|FG000|Treatment Period|Therapeutic procedure required|1|||
162825474|NCT01289821|588073944|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
162825475|NCT01289821|588073944|FG000|Safety Follow-up Period|Protocol Violation|3|||
162825476|NCT01289821|588073944|FG000|Safety Follow-up Period|Unspecified reason|1|||
162825477|NCT01289821|588073944|FG000|Survival Follow-up Period|Protocol Violation|1|||
162825478|NCT01289821|588073944|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
162825479|NCT01289821|588073944|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
162932484|NCT00830063|588458500|FG000|Overall Study|Lack of Efficacy|51|||
162932485|NCT00830063|588458501|FG001|Overall Study|Lack of Efficacy|23|||
162932486|NCT00830063|588458502|FG002|Overall Study|Lack of Efficacy|25|||
162825480|NCT03086057|588073945|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
162825481|NCT03086057|588073946|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
162825482|NCT03086057|588073947|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
162825483|NCT03086057|588073948|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
162698472|NCT02065570|587605508|FG002|Maintenance Study|Lost to Follow-up|2|||
162825484|NCT03086057|588073945|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
162932487|NCT00830063|588458503|FG003|Overall Study|Lack of Efficacy|32|||
162932488|NCT00830063|588458500|FG000|Overall Study|Other|5|||
162932489|NCT00830063|588458501|FG001|Overall Study|Other|5|||
162932490|NCT00830063|588458502|FG002|Overall Study|Other|8|||
162932491|NCT00830063|588458503|FG003|Overall Study|Other|6|||
162932492|NCT00830063|588458500|FG000|Overall Study|Withdrawal by Subject|16|||
162932493|NCT00830063|588458501|FG001|Overall Study|Withdrawal by Subject|10|||
162932494|NCT00830063|588458502|FG002|Overall Study|Withdrawal by Subject|16|||
162932495|NCT00830063|588458503|FG003|Overall Study|Withdrawal by Subject|13|||
162932496|NCT00830063|588458500|FG000|Overall Study|Protocol Violation|1|||
162932497|NCT00830063|588458501|FG001|Overall Study|Protocol Violation|0|||
162932498|NCT00830063|588458502|FG002|Overall Study|Protocol Violation|3|||
162932499|NCT00830063|588458503|FG003|Overall Study|Protocol Violation|2|||
162932500|NCT00830063|588458500|FG000|Overall Study|Randomized But Not Treated|0|||
162932501|NCT00830063|588458501|FG001|Overall Study|Randomized But Not Treated|2|||
162932502|NCT00830063|588458502|FG002|Overall Study|Randomized But Not Treated|0|||
162932503|NCT00830063|588458503|FG003|Overall Study|Randomized But Not Treated|2|||
162932504|NCT01847313|588458504|FG000|Overall Study|Death|0|||
162932505|NCT01847313|588458505|FG001|Overall Study|Death|1|||
162932506|NCT01847313|588458504|FG000|Overall Study|Withdrawal by Subject|0|||
162932507|NCT01847313|588458505|FG001|Overall Study|Withdrawal by Subject|1|||
162932508|NCT00598559|588458506|FG000|Overall Study|Adverse Event|11|||
162932509|NCT00598559|588458507|FG001|Overall Study|Adverse Event|7|||
162932510|NCT00598559|588458508|FG002|Overall Study|Adverse Event|0|||
162932511|NCT00598559|588458506|FG000|Overall Study|Withdrawal by Subject|2|||
162932512|NCT00598559|588458507|FG001|Overall Study|Withdrawal by Subject|2|||
162932513|NCT00598559|588458508|FG002|Overall Study|Withdrawal by Subject|0|||
162932514|NCT00598559|588458506|FG000|Overall Study|Protocol Non-compliance|1|||
162932515|NCT00598559|588458507|FG001|Overall Study|Protocol Non-compliance|0|||
162932516|NCT00598559|588458508|FG002|Overall Study|Protocol Non-compliance|0|||
162932517|NCT00598559|588458506|FG000|Overall Study|Early discharge from hospital|9|||
162932518|NCT00598559|588458507|FG001|Overall Study|Early discharge from hospital|12|||
162932519|NCT00598559|588458508|FG002|Overall Study|Early discharge from hospital|3|||
162932520|NCT00598559|588458506|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
162932521|NCT00598559|588458507|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
162932522|NCT00598559|588458508|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
162932523|NCT03763331|588458513|FG000|Overall Study|Lost to Follow-up|1|||
162932524|NCT03763331|588458514|FG001|Overall Study|Lost to Follow-up|0|||
162932525|NCT03763331|588458513|FG000|Overall Study|Withdrawal by Subject|1|||
162932526|NCT03763331|588458514|FG001|Overall Study|Withdrawal by Subject|0|||
162932527|NCT03763331|588458513|FG000|Overall Study|Non-compliance|0|||
162932528|NCT03763331|588458514|FG001|Overall Study|Non-compliance|3|||
162932529|NCT01155063|588458515|FG000|Overall Study|Adverse Event|1|||
162932530|NCT01155063|588458515|FG000|Overall Study|Withdrawal by Subject|1|||
162932531|NCT01155063|588458515|FG000|Overall Study|Study terminated by sponsor|87|||
162932532|NCT00936884|588458516|FG000|Double-blind|Withdrawal by Subject|6|||
162932533|NCT00936884|588458517|FG001|Double-blind|Withdrawal by Subject|4|||
162932534|NCT00936884|588458518|FG002|Double-blind|Withdrawal by Subject|0|||
162932535|NCT00936884|588458516|FG000|Double-blind|Death|2|||
162932536|NCT00936884|588458517|FG001|Double-blind|Death|1|||
162932537|NCT00936884|588458518|FG002|Double-blind|Death|0|||
162698473|NCT02065570|587605509|FG003|Maintenance Study|Lost to Follow-up|2|||
162698474|NCT02065570|587605506|FG000|Maintenance Study|Other, Not Specified|0|||
162932538|NCT00936884|588458516|FG000|Double-blind|Lack of Efficacy|1|||
162932539|NCT00936884|588458517|FG001|Double-blind|Lack of Efficacy|1|||
162932540|NCT00936884|588458518|FG002|Double-blind|Lack of Efficacy|0|||
162932541|NCT00936884|588458516|FG000|Double-blind|Adverse Event|1|||
162932542|NCT00936884|588458517|FG001|Double-blind|Adverse Event|0|||
162932543|NCT00936884|588458518|FG002|Double-blind|Adverse Event|0|||
162932544|NCT00936884|588458516|FG000|Double-blind|Physician Decision|1|||
162932545|NCT00936884|588458517|FG001|Double-blind|Physician Decision|0|||
162932546|NCT00936884|588458518|FG002|Double-blind|Physician Decision|0|||
162932547|NCT00936884|588458516|FG000|Double-blind|No post baseline diary entry|1|||
162932548|NCT00936884|588458517|FG001|Double-blind|No post baseline diary entry|0|||
162932549|NCT00936884|588458518|FG002|Double-blind|No post baseline diary entry|0|||
162932550|NCT00936884|588458516|FG000|Double-blind|Did not receive study drug|0|||
162932551|NCT00936884|588458517|FG001|Double-blind|Did not receive study drug|1|||
162932552|NCT00936884|588458518|FG002|Double-blind|Did not receive study drug|0|||
162932553|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
162932554|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
162932555|NCT01663714|588458519|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
162932556|NCT01663714|588458519|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
162932557|NCT01663714|588458519|FG000|Long-Term Follow-Up|Death|4|||
162932558|NCT01663714|588458519|FG000|Long-Term Follow-Up|Non-compliance|1|||
162932559|NCT00597584|588458520|FG000|Overall Study|Adverse Event|4|||
163175594|NCT01431638|589358823|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163175595|NCT01431638|589358824|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
163175596|NCT01431638|589358822|FG000|Overall Study|Participants condition no longer requires study drug|0|||
163175597|NCT01431638|589358823|FG001|Overall Study|Participants condition no longer requires study drug|1|||
163175598|NCT01431638|589358824|FG002|Overall Study|Participants condition no longer requires study drug|0|||
163175599|NCT01431638|589358822|FG000|Overall Study|Participant withdrew consent|14|||
163175600|NCT01431638|589358823|FG001|Overall Study|Participant withdrew consent|5|||
163175601|NCT01431638|589358824|FG002|Overall Study|Participant withdrew consent|8|||
163175602|NCT01431638|589358822|FG000|Overall Study|Lost to Follow-up|7|||
163175603|NCT01431638|589358823|FG001|Overall Study|Lost to Follow-up|9|||
163175604|NCT01431638|589358824|FG002|Overall Study|Lost to Follow-up|7|||
163175605|NCT01431638|589358822|FG000|Overall Study|Administrative problems|1|||
163175606|NCT01431638|589358823|FG001|Overall Study|Administrative problems|4|||
163175607|NCT01431638|589358824|FG002|Overall Study|Administrative problems|6|||
163175608|NCT01431638|589358822|FG000|Overall Study|Death|1|||
163175609|NCT01431638|589358823|FG001|Overall Study|Death|0|||
163175610|NCT01431638|589358824|FG002|Overall Study|Death|0|||
163175611|NCT01431638|589358822|FG000|Overall Study|Protocol deviation|1|||
163175612|NCT01431638|589358823|FG001|Overall Study|Protocol deviation|1|||
163175613|NCT01431638|589358824|FG002|Overall Study|Protocol deviation|4|||
163175614|NCT01431638|589358822|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
163175615|NCT01431638|589358823|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
163175616|NCT01431638|589358824|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
163175617|NCT01381562|589358825|FG000|Overall Study|Adverse Event|0|||
163175618|NCT01381562|589358826|FG001|Overall Study|Adverse Event|1|||
163175619|NCT01381562|589358827|FG002|Overall Study|Adverse Event|0|||
163175620|NCT03400956|589358832|FG000|Treatment Period 1|Adverse Event|0|||
163175621|NCT03400956|589358833|FG001|Treatment Period 1|Adverse Event|1|||
163175622|NCT03400956|589358834|FG002|Treatment Period 1|Adverse Event|0|||
163175623|NCT03400956|589358832|FG000|Treatment Period 1|Lost to Follow-up|0|||
163175624|NCT03400956|589358833|FG001|Treatment Period 1|Lost to Follow-up|0|||
163175625|NCT03400956|589358834|FG002|Treatment Period 1|Lost to Follow-up|1|||
163175626|NCT03400956|589358832|FG000|Treatment Period 1|Protocol Violation|0|||
163175627|NCT03400956|589358833|FG001|Treatment Period 1|Protocol Violation|2|||
163175628|NCT03400956|589358834|FG002|Treatment Period 1|Protocol Violation|0|||
163175629|NCT03400956|589358832|FG000|Treatment Period 1|Study terminated by sponsor|3|||
163175630|NCT03400956|589358833|FG001|Treatment Period 1|Study terminated by sponsor|1|||
163175631|NCT03400956|589358834|FG002|Treatment Period 1|Study terminated by sponsor|1|||
163175632|NCT03400956|589358832|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163175633|NCT03400956|589358833|FG001|Treatment Period 1|Withdrawal by Subject|2|||
163175634|NCT03400956|589358834|FG002|Treatment Period 1|Withdrawal by Subject|4|||
163175635|NCT03400956|589358832|FG000|Treatment Period 1|Other|1|||
163175636|NCT03400956|589358833|FG001|Treatment Period 1|Other|2|||
163175637|NCT03400956|589358834|FG002|Treatment Period 1|Other|3|||
163175638|NCT03400956|589358832|FG000|Post-treatment Period 1|Adverse Event|0|||
163175639|NCT03400956|589358833|FG001|Post-treatment Period 1|Adverse Event|0|||
163175640|NCT03400956|589358834|FG002|Post-treatment Period 1|Adverse Event|1|||
163175641|NCT03400956|589358832|FG000|Post-treatment Period 1|Physician Decision|2|||
163175642|NCT03400956|589358833|FG001|Post-treatment Period 1|Physician Decision|3|||
163175643|NCT03400956|589358834|FG002|Post-treatment Period 1|Physician Decision|0|||
163175644|NCT03400956|589358832|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
163175645|NCT03400956|589358833|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
163175646|NCT03400956|589358834|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
163175647|NCT03400956|589358832|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
163175648|NCT03400956|589358833|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
163175649|NCT03400956|589358834|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
163175650|NCT03400956|589358832|FG000|Post-treatment Period 1|Other|4|||
163175651|NCT03400956|589358833|FG001|Post-treatment Period 1|Other|3|||
163175652|NCT03400956|589358834|FG002|Post-treatment Period 1|Other|4|||
163175653|NCT03400956|589358832|FG000|Treatment Period 2|Adverse Event|2|||
163175654|NCT03400956|589358833|FG001|Treatment Period 2|Adverse Event|1|||
163175655|NCT03400956|589358834|FG002|Treatment Period 2|Adverse Event|1|||
162932560|NCT00597584|588458521|FG001|Overall Study|Adverse Event|2|||
163175656|NCT03400956|589358832|FG000|Treatment Period 2|Lost to Follow-up|1|||
163175657|NCT03400956|589358833|FG001|Treatment Period 2|Lost to Follow-up|1|||
163175658|NCT03400956|589358834|FG002|Treatment Period 2|Lost to Follow-up|0|||
163175659|NCT03400956|589358832|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163175660|NCT03400956|589358833|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163175661|NCT03400956|589358834|FG002|Treatment Period 2|Withdrawal by Subject|3|||
163175662|NCT03400956|589358832|FG000|Treatment Period 2|Other|1|||
163175663|NCT03400956|589358833|FG001|Treatment Period 2|Other|1|||
163175664|NCT03400956|589358834|FG002|Treatment Period 2|Other|0|||
163175665|NCT03400956|589358832|FG000|Follow-up Period|Withdrawal by Subject|0|||
163175666|NCT03400956|589358833|FG001|Follow-up Period|Withdrawal by Subject|0|||
163175667|NCT03400956|589358834|FG002|Follow-up Period|Withdrawal by Subject|1|||
163175668|NCT03400956|589358832|FG000|Follow-up Period|Other|0|||
163175669|NCT03400956|589358833|FG001|Follow-up Period|Other|0|||
163175670|NCT03400956|589358834|FG002|Follow-up Period|Other|1|||
163175671|NCT00492063|589358835|FG000|Overall Study|Death|0|||
163175672|NCT00492063|589358836|FG001|Overall Study|Death|0|||
163175673|NCT00492063|589358837|FG002|Overall Study|Death|1|||
163175674|NCT00492063|589358838|FG003|Overall Study|Death|2|||
163175675|NCT00492063|589358835|FG000|Overall Study|Withdrawal by Subject|4|||
163175676|NCT00492063|589358836|FG001|Overall Study|Withdrawal by Subject|3|||
163175677|NCT00492063|589358837|FG002|Overall Study|Withdrawal by Subject|5|||
163175678|NCT00492063|589358838|FG003|Overall Study|Withdrawal by Subject|4|||
163175679|NCT00492063|589358835|FG000|Overall Study|Lost to Follow-up|6|||
163175680|NCT00492063|589358836|FG001|Overall Study|Lost to Follow-up|11|||
163175681|NCT00492063|589358837|FG002|Overall Study|Lost to Follow-up|5|||
163175682|NCT00492063|589358838|FG003|Overall Study|Lost to Follow-up|3|||
163175683|NCT00492063|589358835|FG000|Overall Study|Protocol Violation|0|||
163175684|NCT00492063|589358836|FG001|Overall Study|Protocol Violation|0|||
163175685|NCT00492063|589358837|FG002|Overall Study|Protocol Violation|0|||
163175686|NCT00492063|589358838|FG003|Overall Study|Protocol Violation|1|||
163175687|NCT01947855|589358844|FG000|Overall Study|Withdrawal by Subject|1|||
163175688|NCT01947855|589358845|FG001|Overall Study|Withdrawal by Subject|0|||
163175689|NCT01947855|589358846|FG002|Overall Study|Withdrawal by Subject|0|||
163175690|NCT00710762|589358847|FG000|Overall Study|Progressive disease|27|||
163175691|NCT00710762|589358848|FG001|Overall Study|Progressive disease|30|||
163175692|NCT00710762|589358847|FG000|Overall Study|Adverse Event other disease worsening|2|||
163175693|NCT00710762|589358848|FG001|Overall Study|Adverse Event other disease worsening|1|||
163175694|NCT00710762|589358847|FG000|Overall Study|Other Adverse Event|7|||
163175695|NCT00710762|589358848|FG001|Overall Study|Other Adverse Event|7|||
163175696|NCT00710762|589358847|FG000|Overall Study|Lost to Follow-up|1|||
163175697|NCT00710762|589358848|FG001|Overall Study|Lost to Follow-up|0|||
163175698|NCT00710762|589358847|FG000|Overall Study|Reason other than listed above|2|||
163175699|NCT00710762|589358848|FG001|Overall Study|Reason other than listed above|2|||
163175700|NCT01700439|589358852|FG000|Overall Study|Lost to Follow-up|47|||
163175701|NCT01700439|589358852|FG000|Overall Study|Withdrawal by Subject|183|||
163175702|NCT01700439|589358852|FG000|Overall Study|Death|186|||
163175703|NCT00592774|589358853|FG000|Overall Study|Adverse Event|5|||
163175704|NCT00592774|589358854|FG001|Overall Study|Adverse Event|19|||
163175705|NCT00592774|589358855|FG002|Overall Study|Adverse Event|2|||
163175706|NCT00592774|589358856|FG003|Overall Study|Adverse Event|14|||
163175707|NCT00592774|589358857|FG004|Overall Study|Adverse Event|8|||
163175708|NCT00592774|589358853|FG000|Overall Study|Protocol Violation|0|||
163175709|NCT00592774|589358854|FG001|Overall Study|Protocol Violation|1|||
163175710|NCT00592774|589358855|FG002|Overall Study|Protocol Violation|0|||
163175711|NCT00592774|589358856|FG003|Overall Study|Protocol Violation|0|||
163175712|NCT00592774|589358857|FG004|Overall Study|Protocol Violation|1|||
163175713|NCT00592774|589358853|FG000|Overall Study|Withdrawal by Subject|3|||
163175714|NCT00592774|589358854|FG001|Overall Study|Withdrawal by Subject|7|||
163175715|NCT00592774|589358855|FG002|Overall Study|Withdrawal by Subject|0|||
163175716|NCT00592774|589358856|FG003|Overall Study|Withdrawal by Subject|0|||
163175717|NCT00592774|589358857|FG004|Overall Study|Withdrawal by Subject|0|||
163175718|NCT00592774|589358853|FG000|Overall Study|Lack of Efficacy|3|||
162825485|NCT03086057|588073946|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
163175719|NCT00592774|589358854|FG001|Overall Study|Lack of Efficacy|3|||
163175720|NCT00592774|589358855|FG002|Overall Study|Lack of Efficacy|0|||
163175721|NCT00592774|589358856|FG003|Overall Study|Lack of Efficacy|0|||
162825486|NCT03086057|588073947|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
162825487|NCT03086057|588073948|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
162825488|NCT03086057|588073945|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
162825489|NCT03086057|588073946|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
163042824|NCT01990768|588863968|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
163175722|NCT00592774|589358857|FG004|Overall Study|Lack of Efficacy|2|||
163175723|NCT00592774|589358853|FG000|Overall Study|Physician Decision|0|||
163175724|NCT00592774|589358854|FG001|Overall Study|Physician Decision|1|||
163175725|NCT00592774|589358855|FG002|Overall Study|Physician Decision|1|||
163175726|NCT00592774|589358856|FG003|Overall Study|Physician Decision|0|||
163175727|NCT00592774|589358857|FG004|Overall Study|Physician Decision|1|||
163175728|NCT00592774|589358853|FG000|Overall Study|Other|0|||
163175729|NCT00592774|589358854|FG001|Overall Study|Other|1|||
163175730|NCT00592774|589358855|FG002|Overall Study|Other|1|||
162932561|NCT00597584|588458520|FG000|Overall Study|Death|53|||
162932562|NCT00597584|588458521|FG001|Overall Study|Death|30|||
162825490|NCT03086057|588073947|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
162825491|NCT03086057|588073948|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
162825492|NCT03086057|588073945|FG000|Stage 1: PrEP Uptake|Death|1|||
162825493|NCT03086057|588073946|FG001|Stage 1: PrEP Uptake|Death|0|||
162825494|NCT03086057|588073947|FG002|Stage 1: PrEP Uptake|Death|0|||
162825495|NCT03086057|588073948|FG003|Stage 1: PrEP Uptake|Death|0|||
162825496|NCT03086057|588073945|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
162825497|NCT03086057|588073946|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
162825498|NCT03086057|588073947|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
162825499|NCT03086057|588073948|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
162825500|NCT03086057|588073945|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
162825501|NCT03086057|588073946|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
162825502|NCT03086057|588073947|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
162825503|NCT03086057|588073948|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
162825504|NCT03086057|588073945|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
162825505|NCT03086057|588073946|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
162825506|NCT03086057|588073947|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
162825507|NCT03086057|588073948|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
162825508|NCT02243865|588073953|FG000|Overall Study|Protocol Violation|1|||
162825509|NCT02243865|588073954|FG001|Overall Study|Protocol Violation|3|||
162825510|NCT02243865|588073953|FG000|Overall Study|Lost to Follow-up|1|||
162825511|NCT02243865|588073954|FG001|Overall Study|Lost to Follow-up|1|||
162825512|NCT02243865|588073953|FG000|Overall Study|Withdrawal by Subject|1|||
162825513|NCT02243865|588073954|FG001|Overall Study|Withdrawal by Subject|0|||
162825514|NCT02243865|588073953|FG000|Overall Study|Adverse Event|1|||
162825515|NCT02243865|588073954|FG001|Overall Study|Adverse Event|1|||
162825516|NCT03654976|588073955|FG000|Overall Study|Withdrawal by Subject|12|||
162825517|NCT03654976|588073956|FG001|Overall Study|Withdrawal by Subject|11|||
162825518|NCT03654976|588073955|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
162825519|NCT03654976|588073956|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
162825520|NCT03654976|588073955|FG000|Overall Study|Adverse Event|5|||
162825521|NCT03654976|588073956|FG001|Overall Study|Adverse Event|0|||
162825522|NCT03654976|588073955|FG000|Overall Study|Lost to Follow-up|2|||
162825523|NCT03654976|588073956|FG001|Overall Study|Lost to Follow-up|0|||
162825524|NCT03654976|588073955|FG000|Overall Study|Lack of Efficacy|0|||
162825525|NCT03654976|588073956|FG001|Overall Study|Lack of Efficacy|1|||
162825526|NCT00117598|588073957|FG000|Prior to Treatment Cross Over|Death|40|||
162825527|NCT00117598|588073958|FG001|Prior to Treatment Cross Over|Death|41|||
162825528|NCT00117598|588073959|FG002|Prior to Treatment Cross Over|Death|37|||
162825529|NCT00117598|588073960|FG003|Prior to Treatment Cross Over|Death|0|||
162825530|NCT00117598|588073961|FG004|Prior to Treatment Cross Over|Death|0|||
162825531|NCT00117598|588073957|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
162825532|NCT00117598|588073958|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
162825533|NCT00117598|588073959|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
162825534|NCT00117598|588073960|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
162825535|NCT00117598|588073961|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
162825536|NCT00117598|588073957|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
162825537|NCT00117598|588073958|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
162825538|NCT00117598|588073959|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
162825539|NCT00117598|588073960|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
162825540|NCT00117598|588073961|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
163175731|NCT00592774|589358856|FG003|Overall Study|Other|0|||
163175732|NCT00592774|589358857|FG004|Overall Study|Other|2|||
163175733|NCT01892384|589358858|FG000|Overall Study|Withdrawal by Subject|1|||
163175734|NCT01892384|589358859|FG001|Overall Study|Withdrawal by Subject|1|||
163175735|NCT01892384|589358860|FG002|Overall Study|Withdrawal by Subject|0|||
163175736|NCT01892384|589358861|FG003|Overall Study|Withdrawal by Subject|0|||
163175737|NCT00621621|589358862|FG000|Overall Study|Subjects were exited at EP study|30|||
163175738|NCT00621621|589358863|FG001|Overall Study|Subjects were exited at EP study|0|||
163175739|NCT00053898|589358867|FG000|Overall Study|No follow-up data from any source|9|||
163175740|NCT00053898|589358868|FG001|Overall Study|No follow-up data from any source|12|||
163175741|NCT00053898|589358867|FG000|Overall Study|Follow-up from telephone contact only|5|||
163175742|NCT00053898|589358868|FG001|Overall Study|Follow-up from telephone contact only|1|||
163175743|NCT03985878|589358872|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
163175744|NCT03985878|589358872|FG000|Overall Study|Study Terminated by Sponsor|12|||
163175745|NCT03985878|589358872|FG000|Overall Study|Withdrawal by Subject|1|||
163175746|NCT02889562|589358873|FG000|Overall Study|Physician Decision|0|||
163175747|NCT02889562|589358874|FG001|Overall Study|Physician Decision|1|||
163175748|NCT02889562|589358873|FG000|Overall Study|Withdrawal by Subject|0|||
163175749|NCT02889562|589358874|FG001|Overall Study|Withdrawal by Subject|1|||
163175750|NCT04054947|589358878|FG000|Overall Study|Withdrawal by Subject|1|||
163175751|NCT04054947|589358879|FG001|Overall Study|Withdrawal by Subject|0|||
163175752|NCT04054947|589358878|FG000|Overall Study|Lost to Follow-up|2|||
163175753|NCT04054947|589358879|FG001|Overall Study|Lost to Follow-up|5|||
163175754|NCT01606878|589358880|FG000|Overall Study|Adverse Event|1|||
162825541|NCT00117598|588073957|FG000|Prior to Treatment Cross Over|Other|15|||
162825542|NCT00117598|588073958|FG001|Prior to Treatment Cross Over|Other|9|||
162825543|NCT00117598|588073959|FG002|Prior to Treatment Cross Over|Other|9|||
162825544|NCT00117598|588073960|FG003|Prior to Treatment Cross Over|Other|0|||
162825545|NCT00117598|588073961|FG004|Prior to Treatment Cross Over|Other|0|||
162825546|NCT00117598|588073957|FG000|After Treament Cross Over|Death|0|||
162825547|NCT00117598|588073958|FG001|After Treament Cross Over|Death|0|||
162825548|NCT00117598|588073959|FG002|After Treament Cross Over|Death|0|||
162825549|NCT00117598|588073960|FG003|After Treament Cross Over|Death|1|||
162825550|NCT00117598|588073961|FG004|After Treament Cross Over|Death|2|||
162825551|NCT00117598|588073957|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
162825552|NCT00117598|588073958|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
162825553|NCT00117598|588073959|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
162825554|NCT00117598|588073960|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
162825555|NCT00117598|588073961|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
162825556|NCT00117598|588073957|FG000|After Treament Cross Over|Other|0|||
162825557|NCT00117598|588073958|FG001|After Treament Cross Over|Other|0|||
162825558|NCT00117598|588073959|FG002|After Treament Cross Over|Other|0|||
162825559|NCT00117598|588073960|FG003|After Treament Cross Over|Other|1|||
162825560|NCT00117598|588073961|FG004|After Treament Cross Over|Other|2|||
162825561|NCT01235793|588073962|FG000|Overall Study|Death|6|||
162825562|NCT03098836|588073963|FG000|Overall Study|Adverse Event|1|||
162825563|NCT03098836|588073964|FG001|Overall Study|Adverse Event|3|||
162825564|NCT03098836|588073963|FG000|Overall Study|Lack of Efficacy|30|||
163175755|NCT01606878|589358881|FG001|Overall Study|Adverse Event|1|||
163175756|NCT01606878|589358882|FG002|Overall Study|Adverse Event|0|||
163175757|NCT01606878|589358883|FG003|Overall Study|Adverse Event|0|||
163175758|NCT01606878|589358884|FG004|Overall Study|Adverse Event|0|||
163175759|NCT01606878|589358885|FG005|Overall Study|Adverse Event|0|||
163175760|NCT01606878|589358886|FG006|Overall Study|Adverse Event|1|||
163175761|NCT01606878|589358887|FG007|Overall Study|Adverse Event|0|||
163175762|NCT01606878|589358888|FG008|Overall Study|Adverse Event|1|||
163175763|NCT01606878|589358889|FG009|Overall Study|Adverse Event|3|||
163175764|NCT01606878|589358890|FG010|Overall Study|Adverse Event|0|||
163175765|NCT01606878|589358880|FG000|Overall Study|Lack of Efficacy|1|||
163175766|NCT01606878|589358881|FG001|Overall Study|Lack of Efficacy|1|||
163175767|NCT01606878|589358882|FG002|Overall Study|Lack of Efficacy|1|||
163175768|NCT01606878|589358883|FG003|Overall Study|Lack of Efficacy|2|||
163175769|NCT01606878|589358884|FG004|Overall Study|Lack of Efficacy|1|||
163175770|NCT01606878|589358885|FG005|Overall Study|Lack of Efficacy|2|||
163175771|NCT01606878|589358886|FG006|Overall Study|Lack of Efficacy|1|||
163175772|NCT01606878|589358887|FG007|Overall Study|Lack of Efficacy|2|||
163175773|NCT01606878|589358888|FG008|Overall Study|Lack of Efficacy|2|||
163175774|NCT01606878|589358889|FG009|Overall Study|Lack of Efficacy|0|||
163175775|NCT01606878|589358890|FG010|Overall Study|Lack of Efficacy|1|||
163175776|NCT01606878|589358880|FG000|Overall Study|Physician Decision|1|||
163175777|NCT01606878|589358881|FG001|Overall Study|Physician Decision|0|||
163175778|NCT01606878|589358882|FG002|Overall Study|Physician Decision|2|||
163175779|NCT01606878|589358883|FG003|Overall Study|Physician Decision|1|||
163175780|NCT01606878|589358884|FG004|Overall Study|Physician Decision|1|||
163175781|NCT01606878|589358885|FG005|Overall Study|Physician Decision|1|||
163175782|NCT01606878|589358886|FG006|Overall Study|Physician Decision|2|||
163175783|NCT01606878|589358887|FG007|Overall Study|Physician Decision|0|||
163175784|NCT01606878|589358888|FG008|Overall Study|Physician Decision|1|||
163175785|NCT01606878|589358889|FG009|Overall Study|Physician Decision|0|||
163175786|NCT01606878|589358890|FG010|Overall Study|Physician Decision|0|||
163175787|NCT01606878|589358880|FG000|Overall Study|Withdrawal by Subject|3|||
163175788|NCT01606878|589358881|FG001|Overall Study|Withdrawal by Subject|2|||
163175789|NCT01606878|589358882|FG002|Overall Study|Withdrawal by Subject|2|||
163175790|NCT01606878|589358883|FG003|Overall Study|Withdrawal by Subject|0|||
163175791|NCT01606878|589358884|FG004|Overall Study|Withdrawal by Subject|1|||
163175792|NCT01606878|589358885|FG005|Overall Study|Withdrawal by Subject|1|||
163175793|NCT01606878|589358886|FG006|Overall Study|Withdrawal by Subject|2|||
163175794|NCT01606878|589358887|FG007|Overall Study|Withdrawal by Subject|1|||
163175795|NCT01606878|589358888|FG008|Overall Study|Withdrawal by Subject|2|||
163175796|NCT01606878|589358889|FG009|Overall Study|Withdrawal by Subject|0|||
163175797|NCT01606878|589358890|FG010|Overall Study|Withdrawal by Subject|2|||
163175798|NCT03720652|589358891|FG000|Overall Study|Withdrawal by Subject|2|||
163175799|NCT03720652|589358892|FG001|Overall Study|Withdrawal by Subject|7|||
163175800|NCT03720652|589358891|FG000|Overall Study|Lost to Follow-up|0|||
163175801|NCT03720652|589358892|FG001|Overall Study|Lost to Follow-up|4|||
163175802|NCT01155167|589358896|FG000|Overall Study|Insufficient ultrasound data|2|||
163175803|NCT01155167|589358897|FG001|Overall Study|Insufficient ultrasound data|0|||
163175804|NCT01155167|589358896|FG000|Overall Study|Access site changed to femoral artery|1|||
163175805|NCT01155167|589358897|FG001|Overall Study|Access site changed to femoral artery|0|||
162825565|NCT03098836|588073964|FG001|Overall Study|Lack of Efficacy|15|||
163175806|NCT00167778|589358898|FG000|Overall Study|Withdrawal by Subject|1|||
163175807|NCT02654717|589358899|FG000|Overall Study|Adverse Event|2|||
163175808|NCT02654717|589358900|FG001|Overall Study|Adverse Event|2|||
163175809|NCT02654717|589358899|FG000|Overall Study|Protocol Violation|1|||
163175810|NCT02654717|589358900|FG001|Overall Study|Protocol Violation|2|||
163175811|NCT02654717|589358899|FG000|Overall Study|Withdrawal by Subject|0|||
163175812|NCT02654717|589358900|FG001|Overall Study|Withdrawal by Subject|1|||
163175813|NCT02654717|589358899|FG000|Overall Study|Non-permitted medication|3|||
163175814|NCT02654717|589358900|FG001|Overall Study|Non-permitted medication|0|||
163175815|NCT00960570|589358901|FG000|21 Day Washout Period|Adverse Event|1|||
163175816|NCT00960570|589358901|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
163175817|NCT00960570|589358901|FG000|1 Day Period Between Dosing|Adverse Event|2|||
163175818|NCT00960570|589358901|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
163175819|NCT00853970|589358905|FG000|Overall Study|Withdrawal by Subject|2|||
163175820|NCT00853970|589358906|FG001|Overall Study|Withdrawal by Subject|1|||
163175821|NCT00853970|589358905|FG000|Overall Study|Cancelled surgery|4|||
163175822|NCT00853970|589358906|FG001|Overall Study|Cancelled surgery|2|||
163175823|NCT02519855|589360126|FG000|Overall Study|Adverse Event|0|||
163175824|NCT02519855|589360127|FG001|Overall Study|Adverse Event|1|||
163175825|NCT02519855|589360126|FG000|Overall Study|Lost to Follow-up|3|||
163175826|NCT02519855|589360127|FG001|Overall Study|Lost to Follow-up|3|||
163175827|NCT01842633|589360128|FG000|Overall Study|Screen Failure|1|||
163175828|NCT01842633|589360129|FG001|Overall Study|Screen Failure|0|||
163175829|NCT01842633|589360130|FG002|Overall Study|Screen Failure|0|||
163175830|NCT01842633|589360128|FG000|Overall Study|Adverse Event|1|||
163175831|NCT01842633|589360129|FG001|Overall Study|Adverse Event|1|||
163175832|NCT01842633|589360130|FG002|Overall Study|Adverse Event|0|||
163175833|NCT01842633|589360128|FG000|Overall Study|Withdrawal by Subject|0|||
163175834|NCT01842633|589360129|FG001|Overall Study|Withdrawal by Subject|1|||
163175835|NCT01842633|589360130|FG002|Overall Study|Withdrawal by Subject|0|||
163175836|NCT01842633|589360128|FG000|Overall Study|Technical issues|1|||
163175837|NCT01842633|589360129|FG001|Overall Study|Technical issues|0|||
163175838|NCT01842633|589360130|FG002|Overall Study|Technical issues|0|||
163175839|NCT02093351|589360131|FG000|Part A|Adverse Event|0|||
163175840|NCT02093351|589360132|FG001|Part A|Adverse Event|1|||
163175841|NCT02093351|589360133|FG002|Part A|Adverse Event|1|||
163175842|NCT02093351|589360134|FG003|Part A|Adverse Event|0|||
163175843|NCT02093351|589360131|FG000|Part A|Condition under investigation worsened|2|||
163175844|NCT02093351|589360132|FG001|Part A|Condition under investigation worsened|0|||
163175845|NCT02093351|589360133|FG002|Part A|Condition under investigation worsened|2|||
163175846|NCT02093351|589360134|FG003|Part A|Condition under investigation worsened|0|||
163175847|NCT02093351|589360131|FG000|Part A|Death|0|||
163175848|NCT02093351|589360132|FG001|Part A|Death|1|||
163175849|NCT02093351|589360133|FG002|Part A|Death|0|||
163175850|NCT02093351|589360134|FG003|Part A|Death|0|||
163175851|NCT02093351|589360131|FG000|Part B|Patient decision|0|||
163175852|NCT02093351|589360132|FG001|Part B|Patient decision|0|||
163175853|NCT02093351|589360133|FG002|Part B|Patient decision|0|||
163175854|NCT02093351|589360134|FG003|Part B|Patient decision|3|||
163175855|NCT02093351|589360131|FG000|Part B|Disease progression|0|||
163175856|NCT02093351|589360132|FG001|Part B|Disease progression|0|||
163175857|NCT02093351|589360133|FG002|Part B|Disease progression|0|||
163175858|NCT02093351|589360134|FG003|Part B|Disease progression|4|||
163175859|NCT02093351|589360131|FG000|Part B|Complete response|0|||
163175860|NCT02093351|589360132|FG001|Part B|Complete response|0|||
163175861|NCT02093351|589360133|FG002|Part B|Complete response|0|||
163175862|NCT02093351|589360134|FG003|Part B|Complete response|1|||
163175863|NCT02093351|589360131|FG000|Part B|Adverse event + disease progression|0|||
162825566|NCT03098836|588073963|FG000|Overall Study|Physician Decision|2|||
162825567|NCT03098836|588073964|FG001|Overall Study|Physician Decision|1|||
162825568|NCT03098836|588073963|FG000|Overall Study|Withdrawal by Subject|3|||
162825569|NCT03098836|588073964|FG001|Overall Study|Withdrawal by Subject|2|||
162825570|NCT03986866|588073965|FG000|Overall Study|Withdrawal by Subject|0|||
162825571|NCT03986866|588073966|FG001|Overall Study|Withdrawal by Subject|3|||
162825572|NCT03986866|588073965|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
162825573|NCT03986866|588073966|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
162825574|NCT01660451|588073969|FG000|Overall Study|Protocol Violation|0|||
163175864|NCT02093351|589360132|FG001|Part B|Adverse event + disease progression|0|||
163175865|NCT02093351|589360133|FG002|Part B|Adverse event + disease progression|0|||
163175866|NCT02093351|589360134|FG003|Part B|Adverse event + disease progression|1|||
163175867|NCT02093351|589360131|FG000|Part B|Lack of therapeutic response|0|||
163175868|NCT02093351|589360132|FG001|Part B|Lack of therapeutic response|0|||
163175869|NCT02093351|589360133|FG002|Part B|Lack of therapeutic response|0|||
163175870|NCT02093351|589360134|FG003|Part B|Lack of therapeutic response|12|||
163175871|NCT02093351|589360131|FG000|Part B|Condition under investigation worsened|0|||
163175872|NCT02093351|589360132|FG001|Part B|Condition under investigation worsened|0|||
163175873|NCT02093351|589360133|FG002|Part B|Condition under investigation worsened|0|||
162932563|NCT00597584|588458520|FG000|Overall Study|Lack of Efficacy|1|||
162932564|NCT00597584|588458521|FG001|Overall Study|Lack of Efficacy|0|||
162932565|NCT00597584|588458520|FG000|Overall Study|Lost to Follow-up|2|||
162932566|NCT00597584|588458521|FG001|Overall Study|Lost to Follow-up|4|||
162932567|NCT00597584|588458520|FG000|Overall Study|Physician Decision|3|||
162932568|NCT00597584|588458521|FG001|Overall Study|Physician Decision|0|||
162932569|NCT00597584|588458520|FG000|Overall Study|Pregnancy|2|||
163175874|NCT02093351|589360134|FG003|Part B|Condition under investigation worsened|39|||
163175875|NCT02093351|589360131|FG000|Part B|Adverse Event|0|||
163175876|NCT02093351|589360132|FG001|Part B|Adverse Event|0|||
163175877|NCT02093351|589360133|FG002|Part B|Adverse Event|0|||
163175878|NCT02093351|589360134|FG003|Part B|Adverse Event|2|||
163175879|NCT02093351|589360131|FG000|Part B|Death|0|||
163175880|NCT02093351|589360132|FG001|Part B|Death|0|||
163175881|NCT02093351|589360133|FG002|Part B|Death|0|||
163175882|NCT02093351|589360134|FG003|Part B|Death|1|||
163175883|NCT03565367|589360135|FG000|Overall Study|No scan due to technical issues|4|||
163175884|NCT03565367|589360136|FG001|Overall Study|No scan due to technical issues|0|||
163175885|NCT01099709|589360137|FG000|Period 1|Withdrawal by Subject|0|||
163175886|NCT01099709|589360138|FG001|Period 1|Withdrawal by Subject|1|||
163175887|NCT01099709|589360137|FG000|Period 1|Positive cotinine test|0|||
163175888|NCT01099709|589360138|FG001|Period 1|Positive cotinine test|1|||
163175889|NCT01099709|589360137|FG000|Period 1|Adverse Event|1|||
163175890|NCT01099709|589360138|FG001|Period 1|Adverse Event|0|||
163175891|NCT00706849|589360139|FG000|Treatment Period|Adverse Event|0|||
163175892|NCT00706849|589360140|FG001|Treatment Period|Adverse Event|9|||
163175893|NCT00706849|589360139|FG000|Treatment Period|Other|0|||
163175894|NCT00706849|589360140|FG001|Treatment Period|Other|1|||
163175895|NCT00706849|589360139|FG000|Follow-up Period|Withdrawal by Subject|0|||
163175896|NCT00706849|589360140|FG001|Follow-up Period|Withdrawal by Subject|2|||
163175897|NCT00706849|589360139|FG000|Follow-up Period|Protocol non-compliance|0|||
163175898|NCT00706849|589360140|FG001|Follow-up Period|Protocol non-compliance|1|||
163175899|NCT01611454|589360142|FG000|Overall Study|Lack of Efficacy|18|||
163175900|NCT01611454|589360143|FG001|Overall Study|Lack of Efficacy|10|||
163175901|NCT01275339|589360144|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
163175902|NCT01275339|589360145|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
163175903|NCT01275339|589360146|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
163175904|NCT01275339|589360147|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
163175905|NCT01275339|589360144|FG000|Overall Study|Withdrawal by Subject|0|||
163175906|NCT01275339|589360145|FG001|Overall Study|Withdrawal by Subject|0|||
163175907|NCT01275339|589360146|FG002|Overall Study|Withdrawal by Subject|1|||
163175908|NCT01275339|589360147|FG003|Overall Study|Withdrawal by Subject|0|||
163175909|NCT03023046|589360152|FG000|Overall Study|Withdrawal by Subject|1|||
163175910|NCT00640835|589360158|FG000|Overall Study|Adverse Event|5|||
163175911|NCT00640835|589360159|FG001|Overall Study|Adverse Event|3|||
163175912|NCT00640835|589360158|FG000|Overall Study|Withdrawal by Subject|12|||
163175913|NCT00640835|589360159|FG001|Overall Study|Withdrawal by Subject|14|||
163175914|NCT00640835|589360158|FG000|Overall Study|Physician Decision|10|||
163175915|NCT00640835|589360159|FG001|Overall Study|Physician Decision|14|||
162932570|NCT00597584|588458521|FG001|Overall Study|Pregnancy|0|||
162932571|NCT00597584|588458520|FG000|Overall Study|Withdrawal by Subject|44|||
162932572|NCT00597584|588458521|FG001|Overall Study|Withdrawal by Subject|12|||
162932573|NCT00597584|588458520|FG000|Overall Study|Discontinued Dialysis|0|||
162932574|NCT00597584|588458521|FG001|Overall Study|Discontinued Dialysis|1|||
162932575|NCT00597584|588458520|FG000|Overall Study|Lost ability to consent|1|||
162932576|NCT00597584|588458521|FG001|Overall Study|Lost ability to consent|1|||
162932577|NCT00597584|588458520|FG000|Overall Study|Never dosed|1|||
162932578|NCT00597584|588458521|FG001|Overall Study|Never dosed|0|||
162932579|NCT00597584|588458520|FG000|Overall Study|Relocation|8|||
162932580|NCT00597584|588458521|FG001|Overall Study|Relocation|6|||
162932581|NCT00597584|588458520|FG000|Overall Study|Renal transplant|9|||
163175916|NCT00640835|589360158|FG000|Overall Study|Sponsor's Decision|11|||
163175917|NCT00640835|589360159|FG001|Overall Study|Sponsor's Decision|7|||
163175918|NCT00640835|589360158|FG000|Overall Study|Protocol Violation|2|||
163175919|NCT00640835|589360159|FG001|Overall Study|Protocol Violation|2|||
163175920|NCT00640835|589360158|FG000|Overall Study|Lost to Follow-up|17|||
163175921|NCT00640835|589360159|FG001|Overall Study|Lost to Follow-up|13|||
163175922|NCT00640835|589360158|FG000|Overall Study|Other Reason|19|||
162932582|NCT00597584|588458521|FG001|Overall Study|Renal transplant|7|||
162932583|NCT02280421|588458522|FG000|Washout (2 Weeks)|Adverse Event|0|||
162932584|NCT02280421|588458523|FG001|Washout (2 Weeks)|Adverse Event|1|||
162932585|NCT02280421|588458522|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162932586|NCT02280421|588458523|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163175923|NCT00640835|589360159|FG001|Overall Study|Other Reason|4|||
163175924|NCT05954143|589360164|FG000|Overall Study|Progressive Disease|1|||
163175925|NCT05954143|589360165|FG001|Overall Study|Progressive Disease|0|||
163175926|NCT05954143|589360164|FG000|Overall Study|Physician Decision|1|||
163175927|NCT05954143|589360165|FG001|Overall Study|Physician Decision|0|||
163175928|NCT05954143|589360164|FG000|Overall Study|Study Terminated by Sponsor|2|||
163175929|NCT05954143|589360165|FG001|Overall Study|Study Terminated by Sponsor|4|||
163175930|NCT05954143|589360164|FG000|Overall Study|Death|1|||
163175931|NCT05954143|589360165|FG001|Overall Study|Death|0|||
163175932|NCT05954143|589360164|FG000|Overall Study|Withdrawal by Subject|0|||
163175933|NCT05954143|589360165|FG001|Overall Study|Withdrawal by Subject|1|||
163175934|NCT05954143|589360164|FG000|Overall Study|Other|1|||
163175935|NCT05954143|589360165|FG001|Overall Study|Other|0|||
163175936|NCT00713310|589360166|FG000|Overall Study|Adverse Event|5|||
163175937|NCT00713310|589360167|FG001|Overall Study|Adverse Event|2|||
163175938|NCT00713310|589360166|FG000|Overall Study|Lack of Efficacy|0|||
163175939|NCT00713310|589360167|FG001|Overall Study|Lack of Efficacy|2|||
163175940|NCT00713310|589360166|FG000|Overall Study|Withdrawal by Subject|0|||
163175941|NCT00713310|589360167|FG001|Overall Study|Withdrawal by Subject|2|||
163175942|NCT05028361|589360168|FG000|Overall Study|Withdrawal by Subject|1|||
163175943|NCT05028361|589360169|FG001|Overall Study|Withdrawal by Subject|0|||
163175944|NCT01993836|589360170|FG000|Overall Study|Surgery Cancelled|3|||
163175945|NCT01993836|589360171|FG001|Overall Study|Surgery Cancelled|0|||
163175946|NCT01993836|589360172|FG002|Overall Study|Surgery Cancelled|0|||
163175947|NCT01993836|589360170|FG000|Overall Study|Physician Decision|2|||
163175948|NCT01993836|589360171|FG001|Overall Study|Physician Decision|1|||
163175949|NCT01993836|589360172|FG002|Overall Study|Physician Decision|0|||
163175950|NCT01993836|589360170|FG000|Overall Study|Death|0|||
163175951|NCT01993836|589360171|FG001|Overall Study|Death|2|||
163175952|NCT01993836|589360172|FG002|Overall Study|Death|0|||
163175953|NCT01993836|589360170|FG000|Overall Study|Withdrawal by Subject|12|||
163175954|NCT01993836|589360171|FG001|Overall Study|Withdrawal by Subject|10|||
163175955|NCT01993836|589360172|FG002|Overall Study|Withdrawal by Subject|5|||
163175956|NCT02195687|589360173|FG000|Overall Study|Personal Reasons|1|||
163175957|NCT02195687|589360174|FG001|Overall Study|Personal Reasons|1|||
163175958|NCT02195687|589360173|FG000|Overall Study|Lost to Follow-up|4|||
163175959|NCT02195687|589360174|FG001|Overall Study|Lost to Follow-up|1|||
163175960|NCT00779259|589360175|FG000|Quinine Alone|Adverse Event|2|||
163175961|NCT01925989|589360181|FG000|Period 1|Sponsor Decision|1|||
163175962|NCT01925989|589360182|FG001|Period 1|Sponsor Decision|1|||
163175963|NCT01925989|589360183|FG002|Period 1|Sponsor Decision|0|||
163175964|NCT01925989|589360181|FG000|Period 1|Withdrawal by Subject|0|||
163175965|NCT01925989|589360182|FG001|Period 1|Withdrawal by Subject|1|||
163175966|NCT01925989|589360183|FG002|Period 1|Withdrawal by Subject|0|||
163175967|NCT02496676|589360185|FG000|Phase 1 - Period 1|Adverse Event|0|||
163175968|NCT02496676|589360186|FG001|Phase 1 - Period 1|Adverse Event|1|||
163175969|NCT02496676|589360185|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
163175970|NCT02496676|589360186|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
163175971|NCT03459690|589360187|FG000|Overall Study|Lost to Follow-up|0|||
163175972|NCT03459690|589360188|FG001|Overall Study|Lost to Follow-up|1|||
163175973|NCT03459690|589360187|FG000|Overall Study|Withdrawal by Subject|1|||
163175974|NCT03459690|589360188|FG001|Overall Study|Withdrawal by Subject|1|||
163175975|NCT02963831|589360189|FG000|Overall Study|Progressive Disease|3|||
163175976|NCT02963831|589360190|FG001|Overall Study|Progressive Disease|3|||
163175977|NCT02963831|589360191|FG002|Overall Study|Progressive Disease|16|||
163175978|NCT02963831|589360192|FG003|Overall Study|Progressive Disease|27|||
163175979|NCT02963831|589360189|FG000|Overall Study|Withdrawal by Subject|1|||
163175980|NCT02963831|589360190|FG001|Overall Study|Withdrawal by Subject|0|||
163175981|NCT02963831|589360191|FG002|Overall Study|Withdrawal by Subject|2|||
163175982|NCT02963831|589360192|FG003|Overall Study|Withdrawal by Subject|4|||
163175983|NCT02963831|589360189|FG000|Overall Study|Adverse Event|0|||
163175984|NCT02963831|589360190|FG001|Overall Study|Adverse Event|1|||
163175985|NCT02963831|589360191|FG002|Overall Study|Adverse Event|1|||
163175986|NCT02963831|589360192|FG003|Overall Study|Adverse Event|2|||
163175987|NCT02963831|589360189|FG000|Overall Study|Death|0|||
163175988|NCT02963831|589360190|FG001|Overall Study|Death|0|||
163175989|NCT02963831|589360191|FG002|Overall Study|Death|0|||
163175990|NCT02963831|589360192|FG003|Overall Study|Death|2|||
163175991|NCT02536404|589360196|FG000|Overall Study|Adverse Event|5|||
163175992|NCT02536404|589360197|FG001|Overall Study|Adverse Event|0|||
163175993|NCT02536404|589360196|FG000|Overall Study|Withdrawal by Subject|4|||
163175994|NCT02536404|589360197|FG001|Overall Study|Withdrawal by Subject|1|||
163175995|NCT02536404|589360196|FG000|Overall Study|Physician Decision|10|||
163175996|NCT02536404|589360197|FG001|Overall Study|Physician Decision|0|||
163175997|NCT02536404|589360196|FG000|Overall Study|Sponsor decision|1|||
163175998|NCT02536404|589360197|FG001|Overall Study|Sponsor decision|0|||
163175999|NCT02514473|589360198|FG000|Overall Study|Adverse Event|0|||
163176000|NCT02514473|589360199|FG001|Overall Study|Adverse Event|2|||
163176001|NCT02514473|589360198|FG000|Overall Study|Withdrawal by Subject|2|||
163176002|NCT02514473|589360199|FG001|Overall Study|Withdrawal by Subject|1|||
163176003|NCT02514473|589360198|FG000|Overall Study|Lost to Follow-up|0|||
163176004|NCT02514473|589360199|FG001|Overall Study|Lost to Follow-up|1|||
163176005|NCT02514473|589360198|FG000|Overall Study|Other|1|||
163176006|NCT02514473|589360199|FG001|Overall Study|Other|1|||
163176007|NCT04381988|589360200|FG000|Overall Study|The study was terminated|4|||
163176008|NCT04381988|589360201|FG001|Overall Study|The study was terminated|0|||
163176009|NCT02106923|589360202|FG000|Overall Study|Protocol Violation|0|||
163176010|NCT02106923|589360203|FG001|Overall Study|Protocol Violation|0|||
163176011|NCT02106923|589360204|FG002|Overall Study|Protocol Violation|0|||
163176012|NCT02106923|589360205|FG003|Overall Study|Protocol Violation|0|||
163176013|NCT02106923|589360206|FG004|Overall Study|Protocol Violation|0|||
162825575|NCT01660451|588073970|FG001|Overall Study|Protocol Violation|1|||
162825576|NCT01660451|588073971|FG002|Overall Study|Protocol Violation|1|||
162825577|NCT01660451|588073969|FG000|Overall Study|AE not associated with clinical disease progression|13|||
162825578|NCT01660451|588073970|FG001|Overall Study|AE not associated with clinical disease progression|10|||
162825579|NCT01660451|588073971|FG002|Overall Study|AE not associated with clinical disease progression|40|||
162825580|NCT01660451|588073969|FG000|Overall Study|AE associated with clinical disease progression|1|||
162825581|NCT01660451|588073970|FG001|Overall Study|AE associated with clinical disease progression|3|||
162825582|NCT01660451|588073971|FG002|Overall Study|AE associated with clinical disease progression|11|||
162825583|NCT01660451|588073969|FG000|Overall Study|Sponsor Decision|0|||
162825584|NCT01660451|588073970|FG001|Overall Study|Sponsor Decision|0|||
162825585|NCT01660451|588073971|FG002|Overall Study|Sponsor Decision|1|||
162825586|NCT01660451|588073969|FG000|Overall Study|Protocol Deviation|0|||
162825587|NCT01660451|588073970|FG001|Overall Study|Protocol Deviation|0|||
162825588|NCT01660451|588073971|FG002|Overall Study|Protocol Deviation|1|||
162825589|NCT01660451|588073969|FG000|Overall Study|Physician Decision|1|||
162825590|NCT01660451|588073970|FG001|Overall Study|Physician Decision|2|||
162825591|NCT01660451|588073971|FG002|Overall Study|Physician Decision|5|||
162825592|NCT01660451|588073969|FG000|Overall Study|Withdrawal by Subject|1|||
162825593|NCT01660451|588073970|FG001|Overall Study|Withdrawal by Subject|1|||
162825594|NCT01660451|588073971|FG002|Overall Study|Withdrawal by Subject|20|||
162825595|NCT01660451|588073969|FG000|Overall Study|Trial closure.|0|||
162825596|NCT01660451|588073970|FG001|Overall Study|Trial closure.|0|||
162825597|NCT01660451|588073971|FG002|Overall Study|Trial closure.|1|||
162825598|NCT01660451|588073969|FG000|Overall Study|Switching to other therapy|0|||
162825599|NCT01660451|588073970|FG001|Overall Study|Switching to other therapy|1|||
162825600|NCT01660451|588073971|FG002|Overall Study|Switching to other therapy|1|||
162825601|NCT01660451|588073969|FG000|Overall Study|Progressive disease - clinical progression|4|||
162825602|NCT01660451|588073970|FG001|Overall Study|Progressive disease - clinical progression|10|||
162825603|NCT01660451|588073971|FG002|Overall Study|Progressive disease - clinical progression|9|||
162825604|NCT01660451|588073969|FG000|Overall Study|Progressive disease - radiological progression|12|||
162825605|NCT01660451|588073970|FG001|Overall Study|Progressive disease - radiological progression|23|||
162825606|NCT01660451|588073971|FG002|Overall Study|Progressive disease - radiological progression|50|||
162825607|NCT01660451|588073969|FG000|Overall Study|Death|1|||
162825608|NCT01660451|588073970|FG001|Overall Study|Death|0|||
162825609|NCT01660451|588073971|FG002|Overall Study|Death|1|||
162825610|NCT01660451|588073969|FG000|Overall Study|Other|0|||
162825611|NCT01660451|588073970|FG001|Overall Study|Other|0|||
162825612|NCT01660451|588073971|FG002|Overall Study|Other|1|||
162825613|NCT04688775|588073972|FG000|Placebo-controlled Period|Randomized, not treated|1|||
162825614|NCT04688775|588073973|FG001|Placebo-controlled Period|Randomized, not treated|1|||
162825615|NCT04688775|588073974|FG002|Placebo-controlled Period|Randomized, not treated|0|||
162825616|NCT04688775|588073975|FG003|Placebo-controlled Period|Randomized, not treated|0|||
162825617|NCT04688775|588073972|FG000|Placebo-controlled Period|Adverse Event|2|||
163042825|NCT01990768|588863969|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
163176014|NCT02106923|589360207|FG005|Overall Study|Protocol Violation|1|||
163176015|NCT03485495|589360208|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
163176016|NCT03485495|589360209|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
163176017|NCT03915860|589360210|FG000|Overall Study|Adverse Event|3|||
163176018|NCT03915860|589360210|FG000|Overall Study|Withdrawal by Subject|6|||
163176019|NCT03915860|589360210|FG000|Overall Study|Lost to Follow-up|2|||
163176020|NCT03915860|589360210|FG000|Overall Study|Other than specified|3|||
163176021|NCT01107379|589360214|FG000|Overall Study|Withdrawal by Subject|18|||
163176022|NCT01107379|589360214|FG000|Overall Study|Lost to Follow-up|3|||
163176023|NCT04559529|589360215|FG000|First Intervention (1 Day)|Adverse Event|0|||
163176024|NCT04559529|589360216|FG001|First Intervention (1 Day)|Adverse Event|0|||
163176025|NCT04559529|589360217|FG002|First Intervention (1 Day)|Adverse Event|0|||
163176026|NCT04559529|589360218|FG003|First Intervention (1 Day)|Adverse Event|1|||
163176027|NCT04559529|589360215|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176028|NCT04559529|589360216|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176029|NCT04559529|589360217|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
163176030|NCT04559529|589360218|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
163176031|NCT04559529|589360215|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176032|NCT04559529|589360216|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176033|NCT04559529|589360217|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
163176034|NCT04559529|589360218|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
163176035|NCT01009281|589360219|FG000|Overall Study|Administrative problems|7|||
163176036|NCT00924170|589360220|FG000|Overall Study|Refused further treatment|0|||
163176037|NCT00924170|589360221|FG001|Overall Study|Refused further treatment|1|||
163176038|NCT00924170|589360220|FG000|Overall Study|Physician Decision|0|||
163176039|NCT00924170|589360221|FG001|Overall Study|Physician Decision|1|||
163176040|NCT00924170|589360220|FG000|Overall Study|Progressive disease|3|||
163176041|NCT00924170|589360221|FG001|Overall Study|Progressive disease|6|||
163176042|NCT00924170|589360220|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
163176043|NCT00924170|589360221|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
163176044|NCT00924170|589360220|FG000|Overall Study|Death|1|||
163176045|NCT00924170|589360221|FG001|Overall Study|Death|0|||
163176046|NCT03901456|589360224|FG000|Overall Study|Withdrawal by Subject|0|||
163176047|NCT03901456|589360225|FG001|Overall Study|Withdrawal by Subject|0|||
163176048|NCT03901456|589360226|FG002|Overall Study|Withdrawal by Subject|1|||
163176049|NCT03901456|589360224|FG000|Overall Study|Lost to Follow-up|0|||
163176050|NCT03901456|589360225|FG001|Overall Study|Lost to Follow-up|1|||
163176051|NCT03901456|589360226|FG002|Overall Study|Lost to Follow-up|0|||
163176052|NCT05318183|589360227|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
163176053|NCT05318183|589360228|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
163176054|NCT05318183|589360227|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
163176055|NCT05318183|589360228|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
163176056|NCT05318183|589360227|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
163176057|NCT05318183|589360228|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
163176058|NCT05318183|589360227|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
163176059|NCT05318183|589360228|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
163176060|NCT04098224|589360229|FG000|Overall Study|Adverse Event|1|||
163176061|NCT04098224|589360230|FG001|Overall Study|Adverse Event|0|||
163176062|NCT04098224|589360229|FG000|Overall Study|Physician Decision|1|||
163176063|NCT04098224|589360230|FG001|Overall Study|Physician Decision|0|||
163176064|NCT04098224|589360229|FG000|Overall Study|Patient not required enteral feeding|1|||
163176065|NCT04098224|589360230|FG001|Overall Study|Patient not required enteral feeding|0|||
163176066|NCT04098224|589360229|FG000|Overall Study|Patient failure nasogastric tube|1|||
163176067|NCT04098224|589360230|FG001|Overall Study|Patient failure nasogastric tube|0|||
163176068|NCT04098224|589360229|FG000|Overall Study|Patient early extubation|1|||
163176069|NCT04098224|589360230|FG001|Overall Study|Patient early extubation|3|||
163176070|NCT01203852|589360234|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
163176071|NCT01203852|589360234|FG000|Washout 2 Weeks|Physician Decision|46|||
163176072|NCT00899392|589360235|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
163176073|NCT00899392|589360236|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
163176074|NCT03709576|589360239|FG000|Overall Study|progression prior to enrollment|1|||
163176075|NCT00890045|589360249|FG000|Overall Study|Death|0|||
163176076|NCT00890045|589360250|FG001|Overall Study|Death|1|||
163176077|NCT00890045|589360249|FG000|Overall Study|Did not receive HeRO Graft|0|||
163176078|NCT00890045|589360250|FG001|Overall Study|Did not receive HeRO Graft|2|||
163176079|NCT00890045|589360249|FG000|Overall Study|Lost to Follow-up|5|||
163176080|NCT00890045|589360250|FG001|Overall Study|Lost to Follow-up|7|||
163176081|NCT00510653|589360251|FG000|Overall Study|Withdrawal by Subject|8|||
163176082|NCT00510653|589360251|FG000|Overall Study|Monetary|3|||
163176083|NCT02520089|589360254|FG000|Overall Study|Lost to Follow-up|3|||
163176084|NCT02520089|589360255|FG001|Overall Study|Lost to Follow-up|4|||
163176085|NCT01981551|589360258|FG000|Overall Study|Refused further treatment|8|||
163176086|NCT01981551|589360258|FG000|Overall Study|Adverse Event|1|||
163176087|NCT01451437|589360261|FG000|Overall Study|Adverse Event|0|||
163176088|NCT01451437|589360262|FG001|Overall Study|Adverse Event|0|||
162932587|NCT03870997|588458530|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
162932588|NCT03870997|588458531|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
162932589|NCT03870997|588458532|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
162932590|NCT03870997|588458533|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
162932591|NCT03870997|588458534|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
162932592|NCT03870997|588458535|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
162932593|NCT03726437|588458536|FG000|Overall Study|Lost to Follow-up|85|||
162932594|NCT03726437|588458537|FG001|Overall Study|Lost to Follow-up|76|||
162932595|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
162932596|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932597|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932598|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932599|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
162932600|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
162932601|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932602|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932603|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
162932604|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
163176089|NCT01451437|589360263|FG002|Overall Study|Adverse Event|0|||
163176090|NCT01451437|589360264|FG003|Overall Study|Adverse Event|0|||
163176091|NCT01451437|589360265|FG004|Overall Study|Adverse Event|0|||
163176092|NCT01451437|589360266|FG005|Overall Study|Adverse Event|1|||
163176093|NCT01451437|589360267|FG006|Overall Study|Adverse Event|1|||
163176094|NCT01451437|589360268|FG007|Overall Study|Adverse Event|2|||
163176095|NCT01451437|589360269|FG008|Overall Study|Adverse Event|1|||
163176096|NCT01451437|589360261|FG000|Overall Study|Physician Decision|1|||
163176097|NCT01451437|589360262|FG001|Overall Study|Physician Decision|1|||
163176098|NCT01451437|589360263|FG002|Overall Study|Physician Decision|2|||
163176099|NCT01451437|589360264|FG003|Overall Study|Physician Decision|0|||
163176100|NCT01451437|589360265|FG004|Overall Study|Physician Decision|0|||
163176101|NCT01451437|589360266|FG005|Overall Study|Physician Decision|0|||
163176102|NCT01451437|589360267|FG006|Overall Study|Physician Decision|0|||
163176103|NCT01451437|589360268|FG007|Overall Study|Physician Decision|0|||
163176104|NCT01451437|589360269|FG008|Overall Study|Physician Decision|0|||
163176105|NCT01451437|589360261|FG000|Overall Study|Disease Progression|0|||
163176106|NCT01451437|589360262|FG001|Overall Study|Disease Progression|0|||
163176107|NCT01451437|589360263|FG002|Overall Study|Disease Progression|1|||
163176108|NCT01451437|589360264|FG003|Overall Study|Disease Progression|1|||
163176109|NCT01451437|589360265|FG004|Overall Study|Disease Progression|3|||
163176110|NCT01451437|589360266|FG005|Overall Study|Disease Progression|2|||
163176111|NCT01451437|589360267|FG006|Overall Study|Disease Progression|3|||
163176112|NCT01451437|589360268|FG007|Overall Study|Disease Progression|1|||
163176113|NCT01451437|589360269|FG008|Overall Study|Disease Progression|3|||
163176114|NCT01451437|589360261|FG000|Overall Study|Protocol Violation|0|||
163176115|NCT01451437|589360262|FG001|Overall Study|Protocol Violation|0|||
163176116|NCT01451437|589360263|FG002|Overall Study|Protocol Violation|0|||
163176117|NCT01451437|589360264|FG003|Overall Study|Protocol Violation|0|||
163176118|NCT01451437|589360265|FG004|Overall Study|Protocol Violation|0|||
163176119|NCT01451437|589360266|FG005|Overall Study|Protocol Violation|0|||
163176120|NCT01451437|589360267|FG006|Overall Study|Protocol Violation|1|||
163176121|NCT01451437|589360268|FG007|Overall Study|Protocol Violation|0|||
163176122|NCT01451437|589360269|FG008|Overall Study|Protocol Violation|0|||
163176123|NCT01451437|589360261|FG000|Overall Study|Withdrawal by Subject|0|||
163176124|NCT01451437|589360262|FG001|Overall Study|Withdrawal by Subject|0|||
163176125|NCT01451437|589360263|FG002|Overall Study|Withdrawal by Subject|0|||
163176126|NCT01451437|589360264|FG003|Overall Study|Withdrawal by Subject|0|||
163176127|NCT01451437|589360265|FG004|Overall Study|Withdrawal by Subject|1|||
163176128|NCT01451437|589360266|FG005|Overall Study|Withdrawal by Subject|0|||
163176129|NCT01451437|589360267|FG006|Overall Study|Withdrawal by Subject|1|||
163176130|NCT01451437|589360268|FG007|Overall Study|Withdrawal by Subject|0|||
163176131|NCT01451437|589360269|FG008|Overall Study|Withdrawal by Subject|0|||
163176132|NCT04085367|589362055|FG000|Overall Study|Adverse Event|1|||
163176133|NCT04085367|589362056|FG001|Overall Study|Adverse Event|1|||
163176134|NCT04085367|589362055|FG000|Overall Study|Withdrawal by Subject|13|||
163176135|NCT04085367|589362056|FG001|Overall Study|Withdrawal by Subject|4|||
163176136|NCT04085367|589362055|FG000|Overall Study|Lost to Follow-up|3|||
163176137|NCT04085367|589362056|FG001|Overall Study|Lost to Follow-up|1|||
163176138|NCT04085367|589362055|FG000|Overall Study|Other unspecified|2|||
163176139|NCT04085367|589362056|FG001|Overall Study|Other unspecified|1|||
163176140|NCT04085367|589362055|FG000|Overall Study|Status Unknown|1|||
163176141|NCT04085367|589362056|FG001|Overall Study|Status Unknown|1|||
162932605|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
163176142|NCT00130442|589362060|FG000|Overall Study|Withdrawal by Subject|0|||
163176143|NCT00130442|589362061|FG001|Overall Study|Withdrawal by Subject|1|||
163176144|NCT00130442|589362060|FG000|Overall Study|did not meet criteria|1|||
163176145|NCT00130442|589362061|FG001|Overall Study|did not meet criteria|1|||
163176146|NCT00814333|589362062|FG000|Enrollment|Lost to Follow-up|1|||
163176147|NCT00814333|589362063|FG001|Enrollment|Lost to Follow-up|0|||
163176148|NCT01527357|589362064|FG000|Overall Study|Death|8|||
163176149|NCT01527357|589362065|FG001|Overall Study|Death|2|||
163176150|NCT01527357|589362064|FG000|Overall Study|Lost to Follow-up|6|||
163176151|NCT01527357|589362065|FG001|Overall Study|Lost to Follow-up|4|||
163176152|NCT01527357|589362064|FG000|Overall Study|Withdrew Consent|1|||
163176153|NCT01527357|589362065|FG001|Overall Study|Withdrew Consent|1|||
163176154|NCT01527357|589362064|FG000|Overall Study|Non-compliance|0|||
163176155|NCT01527357|589362065|FG001|Overall Study|Non-compliance|1|||
163176156|NCT01527357|589362064|FG000|Overall Study|No Day 29 Visit|0|||
163176157|NCT01527357|589362065|FG001|Overall Study|No Day 29 Visit|1|||
163176158|NCT01527357|589362064|FG000|Overall Study|Did Not Receive Treatment|2|||
163176159|NCT01527357|589362065|FG001|Overall Study|Did Not Receive Treatment|0|||
163176160|NCT02233946|589362066|FG000|Baseline|Withdrawal by Subject|2|||
163176161|NCT02233946|589362067|FG001|Baseline|Withdrawal by Subject|0|||
163176162|NCT02233946|589362066|FG000|3-months Follow-up|Lost to Follow-up|53|||
163176163|NCT02233946|589362067|FG001|3-months Follow-up|Lost to Follow-up|29|||
162825618|NCT04688775|588073973|FG001|Placebo-controlled Period|Adverse Event|0|||
162825619|NCT04688775|588073974|FG002|Placebo-controlled Period|Adverse Event|0|||
162825620|NCT04688775|588073975|FG003|Placebo-controlled Period|Adverse Event|0|||
162825621|NCT04688775|588073972|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
162825622|NCT04688775|588073973|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
162825623|NCT04688775|588073974|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
162825624|NCT04688775|588073975|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
162825625|NCT04688775|588073972|FG000|Placebo-controlled Period|Protocol Violation|0|||
162825626|NCT04688775|588073973|FG001|Placebo-controlled Period|Protocol Violation|1|||
162825627|NCT04688775|588073974|FG002|Placebo-controlled Period|Protocol Violation|0|||
162825628|NCT04688775|588073975|FG003|Placebo-controlled Period|Protocol Violation|0|||
162825629|NCT04688775|588073972|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
162825630|NCT04688775|588073973|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
162825631|NCT04688775|588073974|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
162825632|NCT04688775|588073975|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
162825633|NCT04688775|588073972|FG000|Placebo-controlled Period|Other reasons|0|||
162825634|NCT04688775|588073973|FG001|Placebo-controlled Period|Other reasons|1|||
162825635|NCT04688775|588073974|FG002|Placebo-controlled Period|Other reasons|0|||
162825636|NCT04688775|588073975|FG003|Placebo-controlled Period|Other reasons|0|||
162825637|NCT04688775|588073972|FG000|Delayed Start Period|Adverse Event|0|||
162825638|NCT04688775|588073973|FG001|Delayed Start Period|Adverse Event|0|||
162825639|NCT04688775|588073974|FG002|Delayed Start Period|Adverse Event|1|||
162825640|NCT04688775|588073975|FG003|Delayed Start Period|Adverse Event|0|||
162825641|NCT04688775|588073972|FG000|Delayed Start Period|Lack of Efficacy|0|||
162825642|NCT04688775|588073973|FG001|Delayed Start Period|Lack of Efficacy|0|||
162825643|NCT04688775|588073974|FG002|Delayed Start Period|Lack of Efficacy|0|||
162825644|NCT04688775|588073975|FG003|Delayed Start Period|Lack of Efficacy|3|||
162825645|NCT04688775|588073972|FG000|Delayed Start Period|Withdrawal by Subject|0|||
162825646|NCT04688775|588073973|FG001|Delayed Start Period|Withdrawal by Subject|0|||
162825647|NCT04688775|588073974|FG002|Delayed Start Period|Withdrawal by Subject|2|||
162825648|NCT04688775|588073975|FG003|Delayed Start Period|Withdrawal by Subject|4|||
162825649|NCT04688775|588073972|FG000|Delayed Start Period|Lost to Follow-up|0|||
162825650|NCT04688775|588073973|FG001|Delayed Start Period|Lost to Follow-up|0|||
162825651|NCT04688775|588073974|FG002|Delayed Start Period|Lost to Follow-up|2|||
162825652|NCT04688775|588073975|FG003|Delayed Start Period|Lost to Follow-up|1|||
162825653|NCT04688775|588073972|FG000|Delayed Start Period|other reasons|0|||
162825654|NCT04688775|588073973|FG001|Delayed Start Period|other reasons|0|||
162825655|NCT04688775|588073974|FG002|Delayed Start Period|other reasons|1|||
162825656|NCT04688775|588073975|FG003|Delayed Start Period|other reasons|0|||
162825657|NCT00074581|588073978|FG000|Overall Study|Death|15|||
162825658|NCT00074581|588073979|FG001|Overall Study|Death|16|||
162825659|NCT00074581|588073978|FG000|Overall Study|Withdrawal by Subject|50|||
162825660|NCT00074581|588073979|FG001|Overall Study|Withdrawal by Subject|49|||
162825661|NCT00074581|588073978|FG000|Overall Study|Unable to adhere to visit schedule|13|||
162825662|NCT00074581|588073979|FG001|Overall Study|Unable to adhere to visit schedule|14|||
162825663|NCT00074581|588073978|FG000|Overall Study|Relocated|14|||
162825664|NCT00074581|588073979|FG001|Overall Study|Relocated|9|||
162825665|NCT00074581|588073978|FG000|Overall Study|Were withdrawn by investigator|5|||
162825666|NCT00074581|588073979|FG001|Overall Study|Were withdrawn by investigator|2|||
163176164|NCT02233946|589362066|FG000|6-months Follow-up|Lost to Follow-up|21|||
163176165|NCT02233946|589362067|FG001|6-months Follow-up|Lost to Follow-up|2|||
163176166|NCT02233946|589362066|FG000|9-month Follow-up|Lost to Follow-up|20|||
163176167|NCT02233946|589362067|FG001|9-month Follow-up|Lost to Follow-up|11|||
163176168|NCT02233946|589362066|FG000|12-month Follow-up|Lost to Follow-up|28|||
162825667|NCT00074581|588073978|FG000|Overall Study|Lost to Follow-up|16|||
162825668|NCT00074581|588073979|FG001|Overall Study|Lost to Follow-up|11|||
163176169|NCT02233946|589362067|FG001|12-month Follow-up|Lost to Follow-up|11|||
163176170|NCT00910247|589362068|FG000|Overall Study|Adverse Event|15|||
162825669|NCT00074581|588073978|FG000|Overall Study|Ended relationship w. index participant|117|||
162825670|NCT00074581|588073979|FG001|Overall Study|Ended relationship w. index participant|106|||
162825671|NCT00074581|588073978|FG000|Overall Study|Other|14|||
162825672|NCT00074581|588073979|FG001|Overall Study|Other|19|||
162825673|NCT01770912|588073980|FG000|Overall Study|Lost to Follow-up|2|||
162825674|NCT01770912|588073981|FG001|Overall Study|Lost to Follow-up|0|||
162825675|NCT01708291|588073983|FG000|Overall Study|fighting|2|||
162825676|NCT01708291|588073984|FG001|Overall Study|fighting|1|||
162932606|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932607|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932608|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932609|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
162932610|NCT01889862|588458546|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
162932611|NCT01889862|588458547|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932612|NCT01889862|588458548|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932613|NCT01889862|588458549|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932614|NCT01889862|588458550|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
162932615|NCT01889862|588458546|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932616|NCT01889862|588458547|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932617|NCT01889862|588458548|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
162932618|NCT01889862|588458549|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932619|NCT01889862|588458550|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
162932620|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
162932621|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
162932622|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
163176171|NCT00910247|589362068|FG000|Overall Study|Death|2|||
163176172|NCT00910247|589362068|FG000|Overall Study|Lost to Follow-up|10|||
163176173|NCT00910247|589362068|FG000|Overall Study|Physician Decision|3|||
163176174|NCT00910247|589362068|FG000|Overall Study|Protocol Violation|10|||
163176175|NCT00910247|589362068|FG000|Overall Study|Withdrawal by Subject|25|||
163176176|NCT00910247|589362068|FG000|Overall Study|Not collected|4|||
163176177|NCT02927067|589362069|FG000|Overall Study|Withdrawn Consent|20|||
163176178|NCT02927067|589362070|FG001|Overall Study|Withdrawn Consent|12|||
163176179|NCT02927067|589362069|FG000|Overall Study|Death|18|||
163176180|NCT02927067|589362070|FG001|Overall Study|Death|31|||
163176181|NCT02927067|589362069|FG000|Overall Study|Adverse Event|13|||
163176182|NCT02927067|589362070|FG001|Overall Study|Adverse Event|10|||
163176183|NCT02927067|589362069|FG000|Overall Study|Noncompliance|5|||
163176184|NCT02927067|589362070|FG001|Overall Study|Noncompliance|2|||
163176185|NCT02927067|589362069|FG000|Overall Study|Reason not Specified|4|||
163176186|NCT02927067|589362070|FG001|Overall Study|Reason not Specified|6|||
163176187|NCT02292784|589362071|FG000|Overall Study|Lost to Follow-up|1|||
163176188|NCT02292784|589362072|FG001|Overall Study|Lost to Follow-up|17|||
163176189|NCT02292784|589362073|FG002|Overall Study|Lost to Follow-up|18|||
163176190|NCT02292784|589362071|FG000|Overall Study|Withdrawal by Subject|0|||
163176191|NCT02292784|589362072|FG001|Overall Study|Withdrawal by Subject|3|||
163176192|NCT02292784|589362073|FG002|Overall Study|Withdrawal by Subject|3|||
163176193|NCT00622739|589362074|FG000|Overall Study|Physician Decision|1|||
163176194|NCT00622739|589362075|FG001|Overall Study|Physician Decision|0|||
163176195|NCT00622739|589362074|FG000|Overall Study|Adverse Event|1|||
163176196|NCT00622739|589362075|FG001|Overall Study|Adverse Event|2|||
163176197|NCT00622739|589362074|FG000|Overall Study|Lack of Efficacy|0|||
163176198|NCT00622739|589362075|FG001|Overall Study|Lack of Efficacy|2|||
163176199|NCT00622739|589362074|FG000|Overall Study|Withdrawal by Subject|0|||
163176200|NCT00622739|589362075|FG001|Overall Study|Withdrawal by Subject|1|||
163176201|NCT00622739|589362074|FG000|Overall Study|Lost to Follow-up|0|||
163176202|NCT00622739|589362075|FG001|Overall Study|Lost to Follow-up|1|||
163176203|NCT00134784|589362076|FG000|Overall Study|Withdrawal by Subject|2|||
163176204|NCT00134784|589362077|FG001|Overall Study|Withdrawal by Subject|2|||
163176205|NCT00134784|589362078|FG002|Overall Study|Withdrawal by Subject|2|||
163176206|NCT00134784|589362079|FG003|Overall Study|Withdrawal by Subject|1|||
163176207|NCT00625742|589362080|FG000|Overall Study|Disease Progression|2|||
163176208|NCT00625742|589362080|FG000|Overall Study|Withdrawal by Subject|1|||
163176209|NCT00625742|589362080|FG000|Overall Study|Adverse Event|4|||
163176210|NCT00625742|589362080|FG000|Overall Study|Lost to Follow-up|4|||
163176211|NCT00625742|589362080|FG000|Overall Study|Ineligible|1|||
163176212|NCT03384693|589362081|FG000|Overall Study|Adverse Event|3|||
163176213|NCT03387150|589362082|FG000|Overall Study|Withdrawal by Subject|3|||
163176214|NCT03387150|589362083|FG001|Overall Study|Withdrawal by Subject|0|||
163176215|NCT03387150|589362084|FG002|Overall Study|Withdrawal by Subject|3|||
163176216|NCT03387150|589362085|FG003|Overall Study|Withdrawal by Subject|4|||
163176217|NCT03387150|589362086|FG004|Overall Study|Withdrawal by Subject|1|||
162932623|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
163176218|NCT03387150|589362087|FG005|Overall Study|Withdrawal by Subject|2|||
163176219|NCT03387150|589362088|FG006|Overall Study|Withdrawal by Subject|0|||
162932624|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
163176220|NCT03387150|589362082|FG000|Overall Study|Lost to Follow-up|3|||
163176221|NCT03387150|589362083|FG001|Overall Study|Lost to Follow-up|2|||
162932625|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
163176222|NCT03387150|589362084|FG002|Overall Study|Lost to Follow-up|2|||
163176223|NCT03387150|589362085|FG003|Overall Study|Lost to Follow-up|3|||
163176224|NCT03387150|589362086|FG004|Overall Study|Lost to Follow-up|3|||
163176225|NCT03387150|589362087|FG005|Overall Study|Lost to Follow-up|3|||
162932626|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
162932627|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
163176226|NCT03387150|589362088|FG006|Overall Study|Lost to Follow-up|0|||
162825677|NCT01536951|588073988|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825678|NCT01536951|588073989|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825679|NCT01536951|588073990|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
162825680|NCT01536951|588073991|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825681|NCT01536951|588073992|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825682|NCT01536951|588073993|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825683|NCT01536951|588073994|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825684|NCT01536951|588073995|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825685|NCT01536951|588073996|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
162825686|NCT01536951|588073988|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
162825687|NCT01536951|588073989|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
162825688|NCT01536951|588073990|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
162825689|NCT01536951|588073991|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
162825690|NCT01536951|588073992|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
162825691|NCT01536951|588073993|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
162825692|NCT01536951|588073994|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
162825693|NCT01536951|588073995|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
162825694|NCT01536951|588073996|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
162825695|NCT01843972|588073999|FG000|Overall Study|Withdrawal by Subject|0|||
162825696|NCT01843972|588074000|FG001|Overall Study|Withdrawal by Subject|0|||
162825697|NCT01843972|588074001|FG002|Overall Study|Withdrawal by Subject|0|||
162825698|NCT01843972|588074002|FG003|Overall Study|Withdrawal by Subject|0|||
162825699|NCT01843972|588074003|FG004|Overall Study|Withdrawal by Subject|1|||
162825700|NCT01843972|588074004|FG005|Overall Study|Withdrawal by Subject|0|||
162825701|NCT01843972|588074005|FG006|Overall Study|Withdrawal by Subject|0|||
162825702|NCT01843972|588074006|FG007|Overall Study|Withdrawal by Subject|0|||
162825703|NCT01843972|588074007|FG008|Overall Study|Withdrawal by Subject|0|||
162825704|NCT01843972|588074008|FG009|Overall Study|Withdrawal by Subject|0|||
162825705|NCT01817751|588074014|FG000|Overall Study|Physician Decision|1|||
162825706|NCT00545402|588074015|FG000|Overall Study|Discontinuation of treatment|17|||
162825707|NCT00545402|588074016|FG001|Overall Study|Discontinuation of treatment|9|||
162825708|NCT00545402|588074015|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
162825709|NCT00545402|588074016|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
162825710|NCT00545402|588074015|FG000|Overall Study|Death|5|||
162825711|NCT00545402|588074016|FG001|Overall Study|Death|7|||
162825712|NCT00545402|588074015|FG000|Overall Study|Graft loss|2|||
162825713|NCT00545402|588074016|FG001|Overall Study|Graft loss|4|||
162825714|NCT00545402|588074015|FG000|Overall Study|Withdrawal by Subject|0|||
162825715|NCT00545402|588074016|FG001|Overall Study|Withdrawal by Subject|1|||
162825716|NCT00545402|588074015|FG000|Overall Study|Protocol Violation|1|||
162825717|NCT00545402|588074016|FG001|Overall Study|Protocol Violation|0|||
162825718|NCT00545402|588074015|FG000|Overall Study|Reason not specified|1|||
162825719|NCT00545402|588074016|FG001|Overall Study|Reason not specified|1|||
162825720|NCT00382018|588074017|FG000|Overall Study|Progression|0|||
162825721|NCT00382018|588074018|FG001|Overall Study|Progression|136|||
162825722|NCT00382018|588074019|FG002|Overall Study|Progression|51|||
162825723|NCT00382018|588074020|FG003|Overall Study|Progression|43|||
162825724|NCT00382018|588074017|FG000|Overall Study|Death|0|||
162825725|NCT00382018|588074018|FG001|Overall Study|Death|9|||
162825726|NCT00382018|588074019|FG002|Overall Study|Death|7|||
162825727|NCT00382018|588074020|FG003|Overall Study|Death|11|||
163176227|NCT03387150|589362082|FG000|Overall Study|Participant unable to adhere to visit|0|||
163176228|NCT03387150|589362083|FG001|Overall Study|Participant unable to adhere to visit|1|||
163176229|NCT03387150|589362084|FG002|Overall Study|Participant unable to adhere to visit|0|||
163176230|NCT03387150|589362085|FG003|Overall Study|Participant unable to adhere to visit|0|||
163176231|NCT03387150|589362086|FG004|Overall Study|Participant unable to adhere to visit|2|||
163176232|NCT03387150|589362087|FG005|Overall Study|Participant unable to adhere to visit|2|||
163176233|NCT03387150|589362088|FG006|Overall Study|Participant unable to adhere to visit|0|||
163176234|NCT04006119|589362089|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
163176235|NCT04006119|589362089|FG000|End of Treatment Veledimex|Adverse Event|2|||
163176236|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
163176237|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
163176238|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
163176239|NCT04006119|589362089|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
163176240|NCT02919969|589362090|FG000|Overall Study|Lack of Efficacy|22|||
163176241|NCT02919969|589362090|FG000|Overall Study|Death|4|||
163176242|NCT02919969|589362090|FG000|Overall Study|Physician Decision|3|||
163176243|NCT02919969|589362090|FG000|Overall Study|Withdrawal by Subject|2|||
163176244|NCT03621475|589362091|FG000|Overall Study|No longer required restraints at initiation|0|||
163176245|NCT03621475|589362092|FG001|Overall Study|No longer required restraints at initiation|1|||
163176246|NCT00920907|589362098|FG000|Induction Period|Adverse Event|0|||
163176247|NCT00920907|589362099|FG001|Induction Period|Adverse Event|2|||
163176248|NCT00920907|589362098|FG000|Induction Period|Death|1|||
163176249|NCT00920907|589362099|FG001|Induction Period|Death|1|||
163176250|NCT00920907|589362098|FG000|Induction Period|Disease Progression|12|||
163176251|NCT00920907|589362099|FG001|Induction Period|Disease Progression|11|||
163176252|NCT00920907|589362098|FG000|Induction Period|Study Drug Toxicity|8|||
163176253|NCT00920907|589362099|FG001|Induction Period|Study Drug Toxicity|6|||
163176254|NCT00920907|589362098|FG000|Induction Period|No longer meets study criteria|0|||
163176255|NCT00920907|589362099|FG001|Induction Period|No longer meets study criteria|1|||
163176256|NCT00920907|589362098|FG000|Induction Period|Withdrawal by Subject|1|||
163176257|NCT00920907|589362099|FG001|Induction Period|Withdrawal by Subject|1|||
163176258|NCT00920907|589362098|FG000|Maintenance Period|Disease Progression|3|||
163176259|NCT00920907|589362099|FG001|Maintenance Period|Disease Progression|7|||
163176260|NCT00920907|589362098|FG000|Maintenance Period|Administrative (study closure)|7|||
163176261|NCT00920907|589362099|FG001|Maintenance Period|Administrative (study closure)|2|||
163176262|NCT00920907|589362098|FG000|Maintenance Period|Study Drug Toxicity|0|||
163176263|NCT00920907|589362099|FG001|Maintenance Period|Study Drug Toxicity|2|||
163176264|NCT00920907|589362098|FG000|Maintenance Period|Death|1|||
163176265|NCT00920907|589362099|FG001|Maintenance Period|Death|1|||
163176266|NCT00920907|589362098|FG000|Maintenance Period|Withdrawal by Subject|1|||
163176267|NCT00920907|589362099|FG001|Maintenance Period|Withdrawal by Subject|0|||
163176268|NCT00920907|589362098|FG000|Maintenance Period|Adverse Event|0|||
163176269|NCT00920907|589362099|FG001|Maintenance Period|Adverse Event|1|||
163176270|NCT02616601|589362100|FG000|Overall Study|Withdrawal by Subject|4|||
163176271|NCT02616601|589362101|FG001|Overall Study|Withdrawal by Subject|4|||
162825728|NCT00382018|588074017|FG000|Overall Study|Withdrawal by Subject|0|||
162825729|NCT00382018|588074018|FG001|Overall Study|Withdrawal by Subject|4|||
163176272|NCT02616601|589362102|FG002|Overall Study|Withdrawal by Subject|3|||
163176273|NCT02616601|589362100|FG000|Overall Study|Adverse Event|2|||
163176274|NCT02616601|589362101|FG001|Overall Study|Adverse Event|0|||
163176275|NCT02616601|589362102|FG002|Overall Study|Adverse Event|2|||
163176276|NCT02616601|589362100|FG000|Overall Study|Death|1|||
163176277|NCT02616601|589362101|FG001|Overall Study|Death|0|||
163176278|NCT02616601|589362102|FG002|Overall Study|Death|0|||
163176279|NCT02616601|589362100|FG000|Overall Study|Lost to Follow-up|1|||
163176280|NCT02616601|589362101|FG001|Overall Study|Lost to Follow-up|0|||
163176281|NCT02616601|589362102|FG002|Overall Study|Lost to Follow-up|1|||
162825730|NCT00382018|588074019|FG002|Overall Study|Withdrawal by Subject|3|||
162825731|NCT00382018|588074020|FG003|Overall Study|Withdrawal by Subject|4|||
162825732|NCT00382018|588074017|FG000|Overall Study|Other, not protocol specified|0|||
162825733|NCT00382018|588074018|FG001|Overall Study|Other, not protocol specified|16|||
162825734|NCT00382018|588074019|FG002|Overall Study|Other, not protocol specified|3|||
162825735|NCT00382018|588074020|FG003|Overall Study|Other, not protocol specified|1|||
162825736|NCT01984164|588074021|FG000|Overall Study|Withdrawal by Subject|4|||
162825737|NCT01984164|588074022|FG001|Overall Study|Withdrawal by Subject|3|||
162825738|NCT01984164|588074021|FG000|Overall Study|Adverse Event|5|||
162825739|NCT01984164|588074022|FG001|Overall Study|Adverse Event|19|||
162825740|NCT01984164|588074021|FG000|Overall Study|Lost to Follow-up|1|||
162825741|NCT01984164|588074022|FG001|Overall Study|Lost to Follow-up|3|||
162825742|NCT00427349|588074025|FG000|Overall Study|Lack of Efficacy|23|||
162825743|NCT00427349|588074025|FG000|Overall Study|Adverse Event|14|||
162825744|NCT00427349|588074025|FG000|Overall Study|Death|1|||
162825745|NCT00427349|588074025|FG000|Overall Study|Withdrawal by Subject|3|||
162825746|NCT00427349|588074025|FG000|Overall Study|Alternative therapy|1|||
162825747|NCT00427349|588074025|FG000|Overall Study|Other|2|||
162825748|NCT00427349|588074025|FG000|Overall Study|Ineligible|1|||
162825749|NCT00427349|588074025|FG000|Overall Study|Never started therapy|1|||
162825750|NCT00916279|588074029|FG000|Overall Study|Death|2|||
162825751|NCT00916279|588074029|FG000|Overall Study|Lost to Follow-up|2|||
162825752|NCT02592018|588074034|FG000|Overall Study|Adverse Event|1|||
162825753|NCT02592018|588074034|FG000|Overall Study|Lost to Follow-up|1|||
162825754|NCT03828292|588074037|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
162825755|NCT03828292|588074038|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
163176282|NCT02616601|589362100|FG000|Overall Study|Non-Compliance with Test Article|1|||
163176283|NCT02616601|589362101|FG001|Overall Study|Non-Compliance with Test Article|0|||
163176284|NCT02616601|589362102|FG002|Overall Study|Non-Compliance with Test Article|1|||
163176285|NCT00371761|589362103|FG000|Overall Study|Adverse Event|1|||
163176286|NCT00371761|589362104|FG001|Overall Study|Adverse Event|1|||
163176287|NCT00371761|589362103|FG000|Overall Study|Withdrawal by Subject|1|||
163176288|NCT00371761|589362104|FG001|Overall Study|Withdrawal by Subject|3|||
163176289|NCT00371761|589362103|FG000|Overall Study|Investigator Judgment|2|||
163176290|NCT00371761|589362104|FG001|Overall Study|Investigator Judgment|3|||
163176291|NCT00371761|589362103|FG000|Overall Study|Study termination|4|||
163176292|NCT00371761|589362104|FG001|Overall Study|Study termination|3|||
163176293|NCT00718081|589362106|FG000|Overall Study|Adverse Event|0|||
163176294|NCT00718081|589362107|FG001|Overall Study|Adverse Event|1|||
163176295|NCT00718081|589362108|FG002|Overall Study|Adverse Event|0|||
163176296|NCT00718081|589362106|FG000|Overall Study|Lack of Efficacy|7|||
163176297|NCT00718081|589362107|FG001|Overall Study|Lack of Efficacy|3|||
163176298|NCT00718081|589362108|FG002|Overall Study|Lack of Efficacy|21|||
163176299|NCT00923364|589362109|FG000|Overall Study|Death|3|||
163176300|NCT00923364|589362110|FG001|Overall Study|Death|0|||
163176301|NCT00923364|589362109|FG000|Overall Study|Did not go to transplant|1|||
163176302|NCT00923364|589362110|FG001|Overall Study|Did not go to transplant|0|||
163176303|NCT01397825|589362111|FG000|Overall Study|Progressive Disease|10|||
163176304|NCT01397825|589362112|FG001|Overall Study|Progressive Disease|3|||
163176305|NCT01397825|589362113|FG002|Overall Study|Progressive Disease|11|||
163176306|NCT01397825|589362114|FG003|Overall Study|Progressive Disease|1|||
163176307|NCT01397825|589362115|FG004|Overall Study|Progressive Disease|0|||
163176308|NCT01397825|589362111|FG000|Overall Study|Symptomatic Deterioration|2|||
163176309|NCT01397825|589362112|FG001|Overall Study|Symptomatic Deterioration|0|||
163176310|NCT01397825|589362113|FG002|Overall Study|Symptomatic Deterioration|4|||
163176311|NCT01397825|589362114|FG003|Overall Study|Symptomatic Deterioration|0|||
163176312|NCT01397825|589362115|FG004|Overall Study|Symptomatic Deterioration|0|||
163176313|NCT01397825|589362111|FG000|Overall Study|Adverse Event|0|||
163176314|NCT01397825|589362112|FG001|Overall Study|Adverse Event|1|||
163176315|NCT01397825|589362113|FG002|Overall Study|Adverse Event|5|||
163176316|NCT01397825|589362114|FG003|Overall Study|Adverse Event|1|||
163176317|NCT01397825|589362115|FG004|Overall Study|Adverse Event|0|||
163176318|NCT01397825|589362111|FG000|Overall Study|Withdrawal by Subject|1|||
163176319|NCT01397825|589362112|FG001|Overall Study|Withdrawal by Subject|0|||
163176320|NCT01397825|589362113|FG002|Overall Study|Withdrawal by Subject|5|||
163176321|NCT01397825|589362114|FG003|Overall Study|Withdrawal by Subject|1|||
163176322|NCT01397825|589362115|FG004|Overall Study|Withdrawal by Subject|0|||
163176323|NCT01931670|589362117|FG000|Treatment Period|Exclusionary Medication Received|1|||
163176324|NCT01931670|589362118|FG001|Treatment Period|Exclusionary Medication Received|1|||
163176325|NCT01931670|589362119|FG002|Treatment Period|Exclusionary Medication Received|1|||
163176326|NCT01931670|589362117|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
163176327|NCT01931670|589362118|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
163176328|NCT01931670|589362119|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
163176329|NCT01931670|589362117|FG000|Treatment Period|Subject Noncompliant|4|||
163176330|NCT01931670|589362118|FG001|Treatment Period|Subject Noncompliant|9|||
162825756|NCT03828292|588074039|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
162825757|NCT03828292|588074040|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
162825758|NCT03828292|588074041|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
162825759|NCT03828292|588074042|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
162825760|NCT03828292|588074037|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
162825761|NCT03828292|588074038|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
162825762|NCT03828292|588074039|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
162825763|NCT03828292|588074040|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
162825764|NCT03828292|588074041|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
162825765|NCT03828292|588074042|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
162825766|NCT03828292|588074037|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162825767|NCT03828292|588074038|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162825768|NCT03828292|588074039|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162825769|NCT03828292|588074040|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
163176331|NCT01931670|589362119|FG002|Treatment Period|Subject Noncompliant|5|||
163176332|NCT01931670|589362117|FG000|Treatment Period|Adverse Event|19|||
163176333|NCT01931670|589362118|FG001|Treatment Period|Adverse Event|8|||
163176334|NCT01931670|589362119|FG002|Treatment Period|Adverse Event|21|||
163176335|NCT01931670|589362117|FG000|Treatment Period|Lack of Efficacy|11|||
163176336|NCT01931670|589362118|FG001|Treatment Period|Lack of Efficacy|2|||
163176337|NCT01931670|589362119|FG002|Treatment Period|Lack of Efficacy|2|||
163176338|NCT01931670|589362117|FG000|Treatment Period|Pregnancy|7|||
163176339|NCT01931670|589362118|FG001|Treatment Period|Pregnancy|2|||
162825770|NCT03828292|588074041|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162825771|NCT03828292|588074042|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162825772|NCT03828292|588074037|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
162825773|NCT03828292|588074038|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
162932628|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
162932629|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
162932630|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932631|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932632|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932633|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
162932634|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
162932635|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932636|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932637|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932638|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
162932639|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
162932640|NCT01889862|588458546|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932641|NCT01889862|588458547|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932642|NCT01889862|588458548|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932643|NCT01889862|588458549|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
162932644|NCT01889862|588458550|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
162932645|NCT00033631|588458551|FG000|Overall Study|Protocol Violation|14|||
162932646|NCT00033631|588458552|FG001|Overall Study|Protocol Violation|11|||
162932647|NCT00033631|588458551|FG000|Overall Study|Withdrawal by Subject|4|||
162932648|NCT00033631|588458552|FG001|Overall Study|Withdrawal by Subject|4|||
162932649|NCT00667719|588458553|FG000|Overall Study|Adverse Event|39|||
162932650|NCT00667719|588458553|FG000|Overall Study|Abnormal Test Procedure|1|||
162932651|NCT00667719|588458553|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162932652|NCT00667719|588458553|FG000|Overall Study|Protocol Violation|3|||
162932653|NCT00667719|588458553|FG000|Overall Study|Withdrawal by Subject|17|||
162932654|NCT00667719|588458553|FG000|Overall Study|Lost to Follow-up|8|||
162932655|NCT01827371|588458554|FG000|Overall Study|Adverse Event|0|||
162932656|NCT01827371|588458555|FG001|Overall Study|Adverse Event|0|||
162932657|NCT01827371|588458556|FG002|Overall Study|Adverse Event|4|||
162932658|NCT01827371|588458557|FG003|Overall Study|Adverse Event|2|||
162932659|NCT01827371|588458554|FG000|Overall Study|Lost to Follow-up|0|||
162932660|NCT01827371|588458555|FG001|Overall Study|Lost to Follow-up|2|||
162932661|NCT01827371|588458556|FG002|Overall Study|Lost to Follow-up|0|||
162932662|NCT01827371|588458557|FG003|Overall Study|Lost to Follow-up|4|||
162932663|NCT01827371|588458554|FG000|Overall Study|Protocol Violation|1|||
163176340|NCT01931670|589362119|FG002|Treatment Period|Pregnancy|0|||
163176341|NCT01931670|589362117|FG000|Treatment Period|Other|8|||
163176342|NCT01931670|589362118|FG001|Treatment Period|Other|7|||
163176343|NCT01931670|589362119|FG002|Treatment Period|Other|2|||
163176344|NCT01931670|589362117|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
163176345|NCT01931670|589362118|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
163176346|NCT01931670|589362119|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
163176347|NCT01931670|589362117|FG000|Treatment Period|Lost to Follow-up|19|||
163176348|NCT01931670|589362118|FG001|Treatment Period|Lost to Follow-up|5|||
163176349|NCT01931670|589362119|FG002|Treatment Period|Lost to Follow-up|7|||
163176350|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
163176351|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
163176352|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
163176353|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
163176354|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
163176355|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
163176356|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
163176357|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
163176358|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
163176359|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
163176360|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
163176361|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
163176362|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
163176363|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
163176364|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
162932664|NCT01827371|588458555|FG001|Overall Study|Protocol Violation|0|||
162932665|NCT01827371|588458556|FG002|Overall Study|Protocol Violation|0|||
162932666|NCT01827371|588458557|FG003|Overall Study|Protocol Violation|0|||
163176365|NCT01931670|589362117|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
163176366|NCT01931670|589362118|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
163176367|NCT01931670|589362119|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
163176368|NCT00976508|589362122|FG000|Overall Study|Death|7|||
162932667|NCT01827371|588458554|FG000|Overall Study|Withdrawal by Subject|1|||
162932668|NCT01827371|588458555|FG001|Overall Study|Withdrawal by Subject|2|||
162932669|NCT01827371|588458556|FG002|Overall Study|Withdrawal by Subject|2|||
162932670|NCT01827371|588458557|FG003|Overall Study|Withdrawal by Subject|3|||
162825774|NCT03828292|588074039|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
162825775|NCT03828292|588074040|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
162825776|NCT03828292|588074041|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
162932671|NCT01827371|588458554|FG000|Overall Study|Physician Decision|0|||
162932672|NCT01827371|588458555|FG001|Overall Study|Physician Decision|1|||
162932673|NCT01827371|588458556|FG002|Overall Study|Physician Decision|0|||
162932674|NCT01827371|588458557|FG003|Overall Study|Physician Decision|1|||
162932675|NCT01827371|588458554|FG000|Overall Study|Temporary study halt to vaccinations|11|||
162932676|NCT01827371|588458555|FG001|Overall Study|Temporary study halt to vaccinations|2|||
162932677|NCT01827371|588458556|FG002|Overall Study|Temporary study halt to vaccinations|5|||
162932678|NCT01827371|588458557|FG003|Overall Study|Temporary study halt to vaccinations|13|||
162932679|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932680|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932681|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932682|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
162932683|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932684|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932685|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932686|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932687|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932688|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
162932689|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162932690|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162932691|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Adverse Event|1|||
162932692|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Adverse Event|1|||
162932693|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Adverse Event|1|||
162932694|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Adverse Event|1|||
162932695|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Adverse Event|0|||
162932696|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Adverse Event|0|||
162932697|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Adverse Event|0|||
162932698|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Adverse Event|0|||
162932699|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
162932700|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
163176369|NCT00976508|589362123|FG001|Overall Study|Death|1|||
163176370|NCT00976508|589362122|FG000|Overall Study|Lost to Follow-up|1|||
163176371|NCT00976508|589362123|FG001|Overall Study|Lost to Follow-up|0|||
163176372|NCT00976508|589362122|FG000|Overall Study|Withdrawal by Subject|1|||
163176373|NCT00976508|589362123|FG001|Overall Study|Withdrawal by Subject|0|||
163176374|NCT00976508|589362122|FG000|Overall Study|Disease Progression|4|||
163176375|NCT00976508|589362123|FG001|Overall Study|Disease Progression|4|||
163176376|NCT00976508|589362122|FG000|Overall Study|Subject Enrolled in Hospice|1|||
163176377|NCT00976508|589362123|FG001|Overall Study|Subject Enrolled in Hospice|0|||
163176378|NCT00976508|589362122|FG000|Overall Study|Terminated by the Sponsor|0|||
163176379|NCT00976508|589362123|FG001|Overall Study|Terminated by the Sponsor|1|||
163176380|NCT04352127|589362124|FG000|Overall Study|Unable to obtain readings|4|||
163176381|NCT04352127|589362125|FG001|Overall Study|Unable to obtain readings|1|||
163176382|NCT00470158|589362126|FG000|Overall Study|Death|0|||
163176383|NCT00470158|589362127|FG001|Overall Study|Death|0|||
163176384|NCT00470158|589362128|FG002|Overall Study|Death|0|||
163176385|NCT00470158|589362129|FG003|Overall Study|Death|0|||
163176386|NCT00470158|589362130|FG004|Overall Study|Death|2|||
163176387|NCT00470158|589362126|FG000|Overall Study|Lost to Follow-up|7|||
163176388|NCT00470158|589362127|FG001|Overall Study|Lost to Follow-up|8|||
163176389|NCT00470158|589362128|FG002|Overall Study|Lost to Follow-up|8|||
163176390|NCT00470158|589362129|FG003|Overall Study|Lost to Follow-up|5|||
163176391|NCT00470158|589362130|FG004|Overall Study|Lost to Follow-up|4|||
163176392|NCT00470158|589362126|FG000|Overall Study|Protocol Violation|1|||
163176393|NCT00470158|589362127|FG001|Overall Study|Protocol Violation|0|||
163176394|NCT00470158|589362128|FG002|Overall Study|Protocol Violation|0|||
163176395|NCT00470158|589362129|FG003|Overall Study|Protocol Violation|0|||
163176396|NCT00470158|589362130|FG004|Overall Study|Protocol Violation|0|||
163176397|NCT01249118|589362131|FG000|First Washout Period|Physician Decision|0|||
163176398|NCT01249118|589362132|FG001|First Washout Period|Physician Decision|1|||
163176399|NCT01249118|589362133|FG002|First Washout Period|Physician Decision|0|||
163176400|NCT00880685|589362134|FG000|Memantine 10mg|Lost to Follow-up|2|||
163176401|NCT00880685|589362134|FG000|Memantine 20mg|Withdrawal by Subject|1|||
163176402|NCT04179890|589362135|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
163176403|NCT04179890|589362136|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
163176404|NCT04179890|589362135|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
163176405|NCT04179890|589362136|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
163176406|NCT04179890|589362135|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
163176407|NCT04179890|589362136|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
162932701|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
162932702|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
162932703|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
162932704|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
162932705|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932706|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
162932707|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932708|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
162932709|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932710|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932711|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932712|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932713|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932714|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
162932715|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932716|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
162932717|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932718|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
162932719|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932720|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932721|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932722|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932723|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932724|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932725|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932726|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
162932727|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932728|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
162932729|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932730|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932731|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932732|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932733|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
162932734|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
162932735|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932736|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932737|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932738|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
162932739|NCT00950599|588458558|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
162932740|NCT00950599|588458559|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932741|NCT00950599|588458560|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932742|NCT00950599|588458561|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
162932743|NCT00950599|588458562|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
162932744|NCT00950599|588458563|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
162932745|NCT00950599|588458564|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932746|NCT00950599|588458565|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
162932747|NCT00950599|588458566|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932748|NCT00950599|588458567|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
162932749|NCT00950599|588458558|FG000|Follow-Up Period|Adverse Event|0|||
162932750|NCT00950599|588458559|FG001|Follow-Up Period|Adverse Event|0|||
162932751|NCT00950599|588458560|FG002|Follow-Up Period|Adverse Event|0|||
162932752|NCT00950599|588458561|FG003|Follow-Up Period|Adverse Event|0|||
162932753|NCT00950599|588458562|FG004|Follow-Up Period|Adverse Event|0|||
162932754|NCT00950599|588458563|FG005|Follow-Up Period|Adverse Event|0|||
162932755|NCT00950599|588458564|FG006|Follow-Up Period|Adverse Event|0|||
162932756|NCT00950599|588458565|FG007|Follow-Up Period|Adverse Event|0|||
162932757|NCT00950599|588458566|FG008|Follow-Up Period|Adverse Event|1|||
162932758|NCT00950599|588458567|FG009|Follow-Up Period|Adverse Event|0|||
162932759|NCT00950599|588458558|FG000|Follow-Up Period|Lack of Efficacy|0|||
162932760|NCT00950599|588458559|FG001|Follow-Up Period|Lack of Efficacy|0|||
162932761|NCT00950599|588458560|FG002|Follow-Up Period|Lack of Efficacy|0|||
162932762|NCT00950599|588458561|FG003|Follow-Up Period|Lack of Efficacy|0|||
162932763|NCT00950599|588458562|FG004|Follow-Up Period|Lack of Efficacy|0|||
162932764|NCT00950599|588458563|FG005|Follow-Up Period|Lack of Efficacy|0|||
162932765|NCT00950599|588458564|FG006|Follow-Up Period|Lack of Efficacy|0|||
162932766|NCT00950599|588458565|FG007|Follow-Up Period|Lack of Efficacy|0|||
162932767|NCT00950599|588458566|FG008|Follow-Up Period|Lack of Efficacy|3|||
162932768|NCT00950599|588458567|FG009|Follow-Up Period|Lack of Efficacy|0|||
162932769|NCT00950599|588458558|FG000|Follow-Up Period|Lost to Follow-up|0|||
162932770|NCT00950599|588458559|FG001|Follow-Up Period|Lost to Follow-up|0|||
162932771|NCT00950599|588458560|FG002|Follow-Up Period|Lost to Follow-up|0|||
162932772|NCT00950599|588458561|FG003|Follow-Up Period|Lost to Follow-up|0|||
162932773|NCT00950599|588458562|FG004|Follow-Up Period|Lost to Follow-up|0|||
162932774|NCT00950599|588458563|FG005|Follow-Up Period|Lost to Follow-up|0|||
162932775|NCT00950599|588458564|FG006|Follow-Up Period|Lost to Follow-up|0|||
162932776|NCT00950599|588458565|FG007|Follow-Up Period|Lost to Follow-up|0|||
162932777|NCT00950599|588458566|FG008|Follow-Up Period|Lost to Follow-up|5|||
162932778|NCT00950599|588458567|FG009|Follow-Up Period|Lost to Follow-up|1|||
162932779|NCT00950599|588458558|FG000|Follow-Up Period|Physician Decision|0|||
162932780|NCT00950599|588458559|FG001|Follow-Up Period|Physician Decision|0|||
162932781|NCT00950599|588458560|FG002|Follow-Up Period|Physician Decision|0|||
162932782|NCT00950599|588458561|FG003|Follow-Up Period|Physician Decision|0|||
162932783|NCT00950599|588458562|FG004|Follow-Up Period|Physician Decision|0|||
162932784|NCT00950599|588458563|FG005|Follow-Up Period|Physician Decision|0|||
162932785|NCT00950599|588458564|FG006|Follow-Up Period|Physician Decision|0|||
162932786|NCT00950599|588458565|FG007|Follow-Up Period|Physician Decision|0|||
162932787|NCT00950599|588458566|FG008|Follow-Up Period|Physician Decision|1|||
162932788|NCT00950599|588458567|FG009|Follow-Up Period|Physician Decision|0|||
162932789|NCT00950599|588458558|FG000|Follow-Up Period|Poor/Noncompliance|0|||
162932790|NCT00950599|588458559|FG001|Follow-Up Period|Poor/Noncompliance|0|||
162932791|NCT00950599|588458560|FG002|Follow-Up Period|Poor/Noncompliance|0|||
162932792|NCT00950599|588458561|FG003|Follow-Up Period|Poor/Noncompliance|0|||
162932793|NCT00950599|588458562|FG004|Follow-Up Period|Poor/Noncompliance|0|||
162932794|NCT00950599|588458563|FG005|Follow-Up Period|Poor/Noncompliance|0|||
162932795|NCT00950599|588458564|FG006|Follow-Up Period|Poor/Noncompliance|0|||
162932796|NCT00950599|588458565|FG007|Follow-Up Period|Poor/Noncompliance|0|||
162932797|NCT00950599|588458566|FG008|Follow-Up Period|Poor/Noncompliance|1|||
162932798|NCT00950599|588458567|FG009|Follow-Up Period|Poor/Noncompliance|0|||
162932799|NCT00950599|588458558|FG000|Follow-Up Period|Subject withdrew Consent|0|||
162932800|NCT00950599|588458559|FG001|Follow-Up Period|Subject withdrew Consent|0|||
162932801|NCT00950599|588458560|FG002|Follow-Up Period|Subject withdrew Consent|0|||
162932802|NCT00950599|588458561|FG003|Follow-Up Period|Subject withdrew Consent|0|||
162932803|NCT00950599|588458562|FG004|Follow-Up Period|Subject withdrew Consent|0|||
162932804|NCT00950599|588458563|FG005|Follow-Up Period|Subject withdrew Consent|0|||
162932805|NCT00950599|588458564|FG006|Follow-Up Period|Subject withdrew Consent|0|||
162932806|NCT00950599|588458565|FG007|Follow-Up Period|Subject withdrew Consent|0|||
162932807|NCT00950599|588458566|FG008|Follow-Up Period|Subject withdrew Consent|2|||
163176408|NCT04179890|589362135|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
163176409|NCT04179890|589362136|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
163176410|NCT04179890|589362135|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
163176411|NCT04179890|589362136|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
163176412|NCT04179890|589362135|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
163176413|NCT04179890|589362136|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
163176414|NCT04179890|589362135|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
163176415|NCT04179890|589362136|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
163176416|NCT04179890|589362135|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
163176417|NCT04179890|589362136|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
163176418|NCT04179890|589362135|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
163176419|NCT04179890|589362136|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
163176420|NCT00997438|589362138|FG000|Overall Study|Blood draw difficulty|2|||
163176421|NCT00997438|589362139|FG001|Overall Study|Blood draw difficulty|0|||
163176422|NCT00997438|589362140|FG002|Overall Study|Blood draw difficulty|1|||
163176423|NCT00997438|589362138|FG000|Overall Study|Withdrawal by Subject|1|||
163176424|NCT00997438|589362139|FG001|Overall Study|Withdrawal by Subject|1|||
163176425|NCT00997438|589362140|FG002|Overall Study|Withdrawal by Subject|0|||
163176426|NCT00997438|589362138|FG000|Overall Study|Exclusion criteria at visit 1|2|||
163176427|NCT00997438|589362139|FG001|Overall Study|Exclusion criteria at visit 1|2|||
163176428|NCT00997438|589362140|FG002|Overall Study|Exclusion criteria at visit 1|3|||
163176429|NCT01236118|589362141|FG000|Overall Study|Adverse Event|2|||
163176430|NCT01236118|589362142|FG001|Overall Study|Adverse Event|0|||
163176431|NCT01236118|589362143|FG002|Overall Study|Adverse Event|2|||
163176432|NCT01236118|589362141|FG000|Overall Study|Physician Decision|0|||
163176433|NCT01236118|589362142|FG001|Overall Study|Physician Decision|1|||
163176434|NCT01236118|589362143|FG002|Overall Study|Physician Decision|0|||
163176435|NCT01236118|589362141|FG000|Overall Study|Withdrawal by Subject|0|||
163176436|NCT01236118|589362142|FG001|Overall Study|Withdrawal by Subject|0|||
163176437|NCT01236118|589362143|FG002|Overall Study|Withdrawal by Subject|1|||
163176438|NCT04535167|589362144|FG000|Treatment|Adverse Event|0|||
163176439|NCT04535167|589362145|FG001|Treatment|Adverse Event|0|||
163176440|NCT04535167|589362146|FG002|Treatment|Adverse Event|0|||
163176441|NCT04535167|589362147|FG003|Treatment|Adverse Event|0|||
163176442|NCT04535167|589362148|FG004|Treatment|Adverse Event|0|||
163176443|NCT04535167|589362149|FG005|Treatment|Adverse Event|0|||
163176444|NCT04535167|589362150|FG006|Treatment|Adverse Event|1|||
163176445|NCT04535167|589362144|FG000|Follow-Up|Death|0|||
163176446|NCT04535167|589362145|FG001|Follow-Up|Death|0|||
163176447|NCT04535167|589362146|FG002|Follow-Up|Death|0|||
163176448|NCT04535167|589362147|FG003|Follow-Up|Death|0|||
163176449|NCT04535167|589362148|FG004|Follow-Up|Death|0|||
163176450|NCT04535167|589362149|FG005|Follow-Up|Death|0|||
163176451|NCT04535167|589362150|FG006|Follow-Up|Death|1|||
163176452|NCT04535167|589362144|FG000|Follow-Up|Lost to Follow-up|0|||
163176453|NCT04535167|589362145|FG001|Follow-Up|Lost to Follow-up|0|||
163176454|NCT04535167|589362146|FG002|Follow-Up|Lost to Follow-up|0|||
163176455|NCT04535167|589362147|FG003|Follow-Up|Lost to Follow-up|1|||
163176456|NCT04535167|589362148|FG004|Follow-Up|Lost to Follow-up|0|||
163176457|NCT04535167|589362149|FG005|Follow-Up|Lost to Follow-up|0|||
163176458|NCT04535167|589362150|FG006|Follow-Up|Lost to Follow-up|0|||
163176459|NCT00978432|589362151|FG000|Overall Study|Withdrawal by Subject|0|||
163176460|NCT00978432|589362152|FG001|Overall Study|Withdrawal by Subject|0|||
163176461|NCT00978432|589362153|FG002|Overall Study|Withdrawal by Subject|1|||
163176462|NCT00978432|589362151|FG000|Overall Study|Lack of Efficacy|1|||
163176463|NCT00978432|589362152|FG001|Overall Study|Lack of Efficacy|1|||
163176464|NCT00978432|589362153|FG002|Overall Study|Lack of Efficacy|3|||
163176465|NCT00978432|589362151|FG000|Overall Study|Adverse Event|2|||
163176466|NCT00978432|589362152|FG001|Overall Study|Adverse Event|0|||
163176467|NCT00978432|589362153|FG002|Overall Study|Adverse Event|1|||
163176468|NCT02579928|589362154|FG000|Overall Study|Withdrawal by Subject|1|||
163176469|NCT02579928|589362155|FG001|Overall Study|Withdrawal by Subject|0|||
163176470|NCT04300751|589362158|FG000|Overall Study|Withdrawal by Subject|1|||
163176471|NCT04656275|589362164|FG000|Overall Study|Study terminated by sponsor|2|||
163176472|NCT04656275|589362165|FG001|Overall Study|Study terminated by sponsor|4|||
163176473|NCT00329901|589362167|FG000|Overall Study|Withdrawal by Subject|4|||
162825777|NCT03828292|588074042|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
162825778|NCT03828292|588074037|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
162825779|NCT03828292|588074038|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
162825780|NCT03828292|588074039|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
162825781|NCT03828292|588074040|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
162825782|NCT03828292|588074041|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
162825783|NCT03828292|588074042|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
162825784|NCT00574145|588075209|FG000|Overall Study|Withdrawal by Subject|2|||
162825785|NCT00574145|588075210|FG001|Overall Study|Withdrawal by Subject|1|||
162825786|NCT03227471|588075211|FG000|Overall Study|Withdrawal by Subject|0|||
162825787|NCT03227471|588075212|FG001|Overall Study|Withdrawal by Subject|0|||
162825788|NCT03227471|588075213|FG002|Overall Study|Withdrawal by Subject|0|||
162825789|NCT03227471|588075214|FG003|Overall Study|Withdrawal by Subject|0|||
162825790|NCT03227471|588075215|FG004|Overall Study|Withdrawal by Subject|1|||
162825791|NCT03227471|588075216|FG005|Overall Study|Withdrawal by Subject|0|||
162825792|NCT03227471|588075217|FG006|Overall Study|Withdrawal by Subject|0|||
162825793|NCT03227471|588075218|FG007|Overall Study|Withdrawal by Subject|0|||
162825794|NCT03227471|588075219|FG008|Overall Study|Withdrawal by Subject|0|||
162825795|NCT03227471|588075220|FG009|Overall Study|Withdrawal by Subject|0|||
162825796|NCT03227471|588075221|FG010|Overall Study|Withdrawal by Subject|0|||
162825797|NCT03227471|588075222|FG011|Overall Study|Withdrawal by Subject|0|||
162825798|NCT03227471|588075223|FG012|Overall Study|Withdrawal by Subject|1|||
162825799|NCT03227471|588075224|FG013|Overall Study|Withdrawal by Subject|0|||
162825800|NCT03227471|588075225|FG014|Overall Study|Withdrawal by Subject|0|||
162825801|NCT03227471|588075211|FG000|Overall Study|Randomized, Never Dosed|0|||
162825802|NCT03227471|588075212|FG001|Overall Study|Randomized, Never Dosed|0|||
162825803|NCT03227471|588075213|FG002|Overall Study|Randomized, Never Dosed|0|||
162825804|NCT03227471|588075214|FG003|Overall Study|Randomized, Never Dosed|0|||
162825805|NCT03227471|588075215|FG004|Overall Study|Randomized, Never Dosed|0|||
162825806|NCT03227471|588075216|FG005|Overall Study|Randomized, Never Dosed|0|||
162825807|NCT03227471|588075217|FG006|Overall Study|Randomized, Never Dosed|0|||
162825808|NCT03227471|588075218|FG007|Overall Study|Randomized, Never Dosed|0|||
162825809|NCT03227471|588075219|FG008|Overall Study|Randomized, Never Dosed|0|||
162825810|NCT03227471|588075220|FG009|Overall Study|Randomized, Never Dosed|0|||
162825811|NCT03227471|588075221|FG010|Overall Study|Randomized, Never Dosed|0|||
162825812|NCT03227471|588075222|FG011|Overall Study|Randomized, Never Dosed|0|||
162825813|NCT03227471|588075223|FG012|Overall Study|Randomized, Never Dosed|0|||
162825814|NCT03227471|588075224|FG013|Overall Study|Randomized, Never Dosed|0|||
162825815|NCT03227471|588075225|FG014|Overall Study|Randomized, Never Dosed|1|||
162825816|NCT00736255|588075229|FG000|Overall Study|Adverse Event|1|||
162825817|NCT00736255|588075230|FG001|Overall Study|Adverse Event|0|||
162825818|NCT00736255|588075229|FG000|Overall Study|Physician Decision|1|||
162825819|NCT00736255|588075230|FG001|Overall Study|Physician Decision|0|||
162932808|NCT00950599|588458567|FG009|Follow-Up Period|Subject withdrew Consent|1|||
162932809|NCT01361607|588458568|FG000|Overall Study|Adverse Event|38|||
162932810|NCT01361607|588458569|FG001|Overall Study|Adverse Event|29|||
162932811|NCT01361607|588458568|FG000|Overall Study|Withdrawal by Subject|19|||
162932812|NCT01361607|588458569|FG001|Overall Study|Withdrawal by Subject|8|||
162932813|NCT01361607|588458568|FG000|Overall Study|Withdrawal by Investigator|5|||
162932814|NCT01361607|588458569|FG001|Overall Study|Withdrawal by Investigator|3|||
162932815|NCT01361607|588458568|FG000|Overall Study|Lost to Follow-up|1|||
162932816|NCT01361607|588458569|FG001|Overall Study|Lost to Follow-up|0|||
162932817|NCT01361607|588458568|FG000|Overall Study|Met Withdrawal Criteria|1|||
162932818|NCT01361607|588458569|FG001|Overall Study|Met Withdrawal Criteria|1|||
162932819|NCT02741271|588458580|FG000|Overall Study|Lost to Follow-up|2|||
162932820|NCT02741271|588458581|FG001|Overall Study|Lost to Follow-up|0|||
162932821|NCT02741271|588458580|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162932822|NCT02741271|588458581|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162932823|NCT00373685|588458582|FG000|Overall Study|Death|2|||
162932824|NCT00373685|588458583|FG001|Overall Study|Death|1|||
163176474|NCT00329901|589362168|FG001|Overall Study|Withdrawal by Subject|3|||
163176475|NCT00329901|589362169|FG002|Overall Study|Withdrawal by Subject|2|||
163176476|NCT00329901|589362167|FG000|Overall Study|Lost to Follow-up|2|||
163176477|NCT00329901|589362168|FG001|Overall Study|Lost to Follow-up|0|||
163176478|NCT00329901|589362169|FG002|Overall Study|Lost to Follow-up|1|||
163176479|NCT00329901|589362167|FG000|Overall Study|Protocol Violation|1|||
163176480|NCT00329901|589362168|FG001|Overall Study|Protocol Violation|0|||
163176481|NCT00329901|589362169|FG002|Overall Study|Protocol Violation|1|||
163176482|NCT00329901|589362167|FG000|Overall Study|Unable to classify|2|||
163176483|NCT00329901|589362168|FG001|Overall Study|Unable to classify|2|||
163176484|NCT00329901|589362169|FG002|Overall Study|Unable to classify|0|||
163176485|NCT00924781|589362170|FG000|Overall Study|Study terminated by sponsor|12|||
163176486|NCT00924781|589362171|FG001|Overall Study|Study terminated by sponsor|10|||
163176487|NCT00868517|589362182|FG000|Overall Study|Withdrawal by Subject|3|||
163176488|NCT00868517|589362183|FG001|Overall Study|Withdrawal by Subject|3|||
163176489|NCT00868517|589362184|FG002|Overall Study|Withdrawal by Subject|2|||
163176490|NCT00868517|589362182|FG000|Overall Study|Protocol Violation|1|||
163176491|NCT00868517|589362183|FG001|Overall Study|Protocol Violation|1|||
163176492|NCT00868517|589362184|FG002|Overall Study|Protocol Violation|0|||
163176493|NCT01721577|589362185|FG000|Overall Study|Lack of Efficacy|1|||
163176494|NCT01721577|589362186|FG001|Overall Study|Lack of Efficacy|0|||
163176495|NCT01721577|589362185|FG000|Overall Study|Death|1|||
163176496|NCT01721577|589362186|FG001|Overall Study|Death|0|||
163176497|NCT01721577|589362185|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
163176498|NCT01721577|589362186|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
163176499|NCT01721577|589362185|FG000|Overall Study|Adverse Event|0|||
163176500|NCT01721577|589362186|FG001|Overall Study|Adverse Event|2|||
163176501|NCT01055496|589362188|FG000|Overall Study|Withdrawal by Subject|2|||
163176502|NCT01055496|589362189|FG001|Overall Study|Withdrawal by Subject|4|||
163176503|NCT01055496|589362188|FG000|Overall Study|Death|13|||
163176504|NCT01055496|589362189|FG001|Overall Study|Death|23|||
163176505|NCT01055496|589362188|FG000|Overall Study|Lost to Follow-up|0|||
163176506|NCT01055496|589362189|FG001|Overall Study|Lost to Follow-up|2|||
163176507|NCT01055496|589362188|FG000|Overall Study|Other - Unspecified|0|||
163176508|NCT01055496|589362189|FG001|Overall Study|Other - Unspecified|1|||
163176509|NCT00584740|589362190|FG000|Overall Study|Adverse Event|1|||
163176510|NCT00584740|589362191|FG001|Overall Study|Adverse Event|1|||
163176511|NCT00584740|589362190|FG000|Overall Study|Lack of Efficacy|8|||
163176512|NCT00584740|589362191|FG001|Overall Study|Lack of Efficacy|2|||
163176513|NCT00584740|589362190|FG000|Overall Study|Withdrawal by Subject|3|||
163176514|NCT00584740|589362191|FG001|Overall Study|Withdrawal by Subject|2|||
163176515|NCT00584740|589362190|FG000|Overall Study|Lost to Follow-up|0|||
163176516|NCT00584740|589362191|FG001|Overall Study|Lost to Follow-up|1|||
163176517|NCT02158364|589362193|FG000|Overall Study|Case report forms uncollected|10|||
163176518|NCT02158364|589362193|FG000|Overall Study|Protocol Deviation|50|||
163176519|NCT00732940|589362197|FG000|Overall Study|Withdrawal by Subject|1|||
163176520|NCT00732940|589362198|FG001|Overall Study|Withdrawal by Subject|2|||
163176521|NCT00732940|589362197|FG000|Overall Study|Adverse Event|0|||
163176522|NCT00732940|589362198|FG001|Overall Study|Adverse Event|1|||
163176523|NCT00732940|589362197|FG000|Overall Study|Lost to Follow-up|1|||
163176524|NCT00732940|589362198|FG001|Overall Study|Lost to Follow-up|0|||
163176525|NCT01642732|589362199|FG000|Overall Study|Withdrawal by Subject|1|||
163176526|NCT01589770|589362204|FG000|Overall Study|EGFR <60ml/min|6|||
163176527|NCT01589770|589362205|FG001|Overall Study|EGFR <60ml/min|4|||
163176528|NCT01589770|589362204|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
162932825|NCT00373685|588458582|FG000|Overall Study|Adverse Event|278|||
163176529|NCT01589770|589362205|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
163176530|NCT01077375|589362209|FG000|Overall Study|Adverse Event|2|||
163176531|NCT01077375|589362210|FG001|Overall Study|Adverse Event|15|||
163176532|NCT01077375|589362209|FG000|Overall Study|Lack of Efficacy|6|||
163176533|NCT01077375|589362210|FG001|Overall Study|Lack of Efficacy|8|||
162825820|NCT00736255|588075229|FG000|Overall Study|Non-compliance|1|||
162825821|NCT00736255|588075230|FG001|Overall Study|Non-compliance|1|||
162825822|NCT00980200|588075235|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
162825823|NCT00980200|588075236|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
162825824|NCT00980200|588075237|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
162825825|NCT00980200|588075238|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
162825826|NCT00980200|588075239|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
162825827|NCT00980200|588075235|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
162825828|NCT00980200|588075236|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
162825829|NCT00980200|588075237|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
162825830|NCT00980200|588075238|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
162825831|NCT00980200|588075239|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
162825832|NCT01617460|588075240|FG000|Overall Study|Adverse Event|10|||
162825833|NCT01617460|588075240|FG000|Overall Study|Physician Decision|16|||
162825834|NCT01617460|588075240|FG000|Overall Study|Protocol Violation|5|||
162825835|NCT01617460|588075240|FG000|Overall Study|Withdrawal by Subject|9|||
162825836|NCT00457015|588075242|FG000|Overall Study|Left study site against medical advice|0|||
162825837|NCT00457015|588075243|FG001|Overall Study|Left study site against medical advice|1|||
162825838|NCT03670953|588075244|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
162825839|NCT03670953|588075245|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
162825840|NCT03670953|588075246|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
162825841|NCT03670953|588075247|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
162825842|NCT03670953|588075244|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
162825843|NCT03670953|588075245|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
162825844|NCT03670953|588075246|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
162825845|NCT03670953|588075247|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
162825846|NCT03670953|588075244|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
162825847|NCT03670953|588075245|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
162825848|NCT03670953|588075246|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
162825849|NCT03670953|588075247|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
162825850|NCT03670953|588075244|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
162825851|NCT03670953|588075245|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
162825852|NCT03670953|588075246|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
162825853|NCT03670953|588075247|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
162825854|NCT03670953|588075244|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
162631058|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
162932826|NCT00373685|588458583|FG001|Overall Study|Adverse Event|253|||
162932827|NCT00373685|588458582|FG000|Overall Study|Insufficient clinical response|169|||
162932828|NCT00373685|588458583|FG001|Overall Study|Insufficient clinical response|119|||
162932829|NCT00373685|588458582|FG000|Overall Study|Did not meet entrance criteria|167|||
162932830|NCT00373685|588458583|FG001|Overall Study|Did not meet entrance criteria|184|||
162932831|NCT00373685|588458582|FG000|Overall Study|Lost to follow up|83|||
162932832|NCT00373685|588458583|FG001|Overall Study|Lost to follow up|103|||
162932833|NCT00373685|588458582|FG000|Overall Study|No longer willing to participate|337|||
162932834|NCT00373685|588458583|FG001|Overall Study|No longer willing to participate|352|||
162932835|NCT00373685|588458582|FG000|Overall Study|Other|149|||
162932836|NCT00373685|588458583|FG001|Overall Study|Other|146|||
162932837|NCT00373685|588458582|FG000|Overall Study|Protocol Violation|191|||
162932838|NCT00373685|588458583|FG001|Overall Study|Protocol Violation|182|||
162932839|NCT00373685|588458582|FG000|Overall Study|Final Status Unknown|12|||
162932840|NCT00373685|588458583|FG001|Overall Study|Final Status Unknown|4|||
162932841|NCT00373685|588458582|FG000|Overall Study|Randomized, not treated|51|||
162932842|NCT00373685|588458583|FG001|Overall Study|Randomized, not treated|77|||
162932843|NCT02570165|588458584|FG000|Overall Study|Adverse Event|1|||
162932844|NCT02570165|588458585|FG001|Overall Study|Adverse Event|0|||
162932845|NCT02570165|588458586|FG002|Overall Study|Adverse Event|2|||
162932846|NCT02570165|588458587|FG003|Overall Study|Adverse Event|0|||
162932847|NCT02570165|588458588|FG004|Overall Study|Adverse Event|0|||
162932848|NCT02570165|588458589|FG005|Overall Study|Adverse Event|0|||
162932849|NCT02570165|588458590|FG006|Overall Study|Adverse Event|0|||
162932850|NCT02570165|588458584|FG000|Overall Study|Lack of Efficacy|0|||
162932851|NCT02570165|588458585|FG001|Overall Study|Lack of Efficacy|1|||
162932852|NCT02570165|588458586|FG002|Overall Study|Lack of Efficacy|0|||
162932853|NCT02570165|588458587|FG003|Overall Study|Lack of Efficacy|0|||
162932854|NCT02570165|588458588|FG004|Overall Study|Lack of Efficacy|4|||
162932855|NCT02570165|588458589|FG005|Overall Study|Lack of Efficacy|0|||
162932856|NCT02570165|588458590|FG006|Overall Study|Lack of Efficacy|0|||
162932857|NCT02570165|588458584|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
162932858|NCT02570165|588458585|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
162932859|NCT02570165|588458586|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
162932860|NCT02570165|588458587|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
162932861|NCT02570165|588458588|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
162932862|NCT02570165|588458589|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
162932863|NCT02570165|588458590|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
163176534|NCT01077375|589362209|FG000|Overall Study|Withdrawal by Subject|0|||
163176535|NCT01077375|589362210|FG001|Overall Study|Withdrawal by Subject|6|||
163176536|NCT01077375|589362209|FG000|Overall Study|Lost to Follow-up|2|||
163176537|NCT01077375|589362210|FG001|Overall Study|Lost to Follow-up|5|||
163176538|NCT01077375|589362209|FG000|Overall Study|Other Reason|0|||
163176539|NCT01077375|589362210|FG001|Overall Study|Other Reason|1|||
163176540|NCT03021564|589362214|FG000|Overall Study|Death|84|||
163176541|NCT03021564|589362215|FG001|Overall Study|Death|466|||
163176542|NCT03021564|589362214|FG000|Overall Study|Lost to Follow-up|0|||
163176543|NCT03021564|589362215|FG001|Overall Study|Lost to Follow-up|2|||
163176544|NCT00969280|589362216|FG000|Overall Study|Protocol Violation|2|||
163176545|NCT00969280|589362217|FG001|Overall Study|Protocol Violation|1|||
163176546|NCT00969280|589362216|FG000|Overall Study|Withdrawal by Subject|0|||
163176547|NCT00969280|589362217|FG001|Overall Study|Withdrawal by Subject|1|||
163176548|NCT00969280|589362216|FG000|Overall Study|infection of influenza A(H1N1)|0|||
163176549|NCT00969280|589362217|FG001|Overall Study|infection of influenza A(H1N1)|1|||
163176550|NCT00821327|589362218|FG000|Overall Study|Adverse Event|13|||
163176551|NCT00821327|589362218|FG000|Overall Study|Patient Request|1|||
163176552|NCT00821327|589362218|FG000|Overall Study|Investigator Request|2|||
163176553|NCT00821327|589362218|FG000|Overall Study|Sponsor Request|1|||
162932864|NCT02570165|588458584|FG000|Overall Study|Lost to Follow-up|0|||
162932865|NCT02570165|588458585|FG001|Overall Study|Lost to Follow-up|0|||
162932866|NCT02570165|588458586|FG002|Overall Study|Lost to Follow-up|1|||
162932867|NCT02570165|588458587|FG003|Overall Study|Lost to Follow-up|1|||
162932868|NCT02570165|588458588|FG004|Overall Study|Lost to Follow-up|0|||
162932869|NCT02570165|588458589|FG005|Overall Study|Lost to Follow-up|0|||
162932870|NCT02570165|588458590|FG006|Overall Study|Lost to Follow-up|0|||
162932871|NCT02570165|588458584|FG000|Overall Study|Physician Decision|0|||
162932872|NCT02570165|588458585|FG001|Overall Study|Physician Decision|1|||
163176554|NCT00821327|589362218|FG000|Overall Study|Disease Progression|13|||
163176555|NCT00821327|589362218|FG000|Overall Study|Other/Unknown|5|||
163176556|NCT00217464|589362219|FG000|Overall Study|Progression|15|||
163176557|NCT00217464|589362219|FG000|Overall Study|Other|2|||
162932873|NCT02570165|588458586|FG002|Overall Study|Physician Decision|0|||
162932874|NCT02570165|588458587|FG003|Overall Study|Physician Decision|0|||
162932875|NCT02570165|588458588|FG004|Overall Study|Physician Decision|0|||
162932876|NCT02570165|588458589|FG005|Overall Study|Physician Decision|0|||
162932877|NCT02570165|588458590|FG006|Overall Study|Physician Decision|0|||
162932878|NCT02570165|588458584|FG000|Overall Study|Withdrawal by Subject|0|||
163176558|NCT00459979|589362220|FG000|Overall Study|Withdrawal by Subject|1|||
162932879|NCT02570165|588458585|FG001|Overall Study|Withdrawal by Subject|0|||
162932880|NCT02570165|588458586|FG002|Overall Study|Withdrawal by Subject|0|||
162932881|NCT02570165|588458587|FG003|Overall Study|Withdrawal by Subject|2|||
162932882|NCT02570165|588458588|FG004|Overall Study|Withdrawal by Subject|1|||
162932883|NCT02570165|588458589|FG005|Overall Study|Withdrawal by Subject|0|||
162932884|NCT02570165|588458590|FG006|Overall Study|Withdrawal by Subject|0|||
162932885|NCT02570165|588458584|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932886|NCT02570165|588458585|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932887|NCT02570165|588458586|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932888|NCT02570165|588458587|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932889|NCT02570165|588458588|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932890|NCT02570165|588458589|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
162932891|NCT02570165|588458590|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
162932892|NCT02570165|588458584|FG000|Overall Study|Withdrawal Request by GSK|0|||
162932893|NCT02570165|588458585|FG001|Overall Study|Withdrawal Request by GSK|0|||
162932894|NCT02570165|588458586|FG002|Overall Study|Withdrawal Request by GSK|2|||
162932895|NCT02570165|588458587|FG003|Overall Study|Withdrawal Request by GSK|0|||
162932896|NCT02570165|588458588|FG004|Overall Study|Withdrawal Request by GSK|0|||
162932897|NCT02570165|588458589|FG005|Overall Study|Withdrawal Request by GSK|0|||
162932898|NCT02570165|588458590|FG006|Overall Study|Withdrawal Request by GSK|0|||
162932899|NCT01953783|588458591|FG000|Overall Study|Progressive disease|2|||
162932900|NCT01789281|588458592|FG000|Overall Study|Disease progression|15|||
162932901|NCT01789281|588458593|FG001|Overall Study|Disease progression|4|||
162932902|NCT01789281|588458592|FG000|Overall Study|Adverse Event|5|||
162932903|NCT01789281|588458593|FG001|Overall Study|Adverse Event|5|||
162932904|NCT01789281|588458592|FG000|Overall Study|Withdrawal by Subject|1|||
162932905|NCT01789281|588458593|FG001|Overall Study|Withdrawal by Subject|0|||
162932906|NCT01789281|588458592|FG000|Overall Study|Lost to Follow-up|1|||
162932907|NCT01789281|588458593|FG001|Overall Study|Lost to Follow-up|0|||
162932908|NCT01789281|588458592|FG000|Overall Study|Administrative problems|0|||
162932909|NCT01789281|588458593|FG001|Overall Study|Administrative problems|1|||
162932910|NCT01252238|588458594|FG000|Overall Study|Sponsor terminated study|4|||
162932911|NCT01252238|588458595|FG001|Overall Study|Sponsor terminated study|4|||
162932912|NCT01252238|588458596|FG002|Overall Study|Sponsor terminated study|4|||
162932913|NCT00411762|588458598|FG000|Overall Study|Withdrawal by Subject|5|||
162932914|NCT04428502|588458599|FG000|Overall Study|Did not meet entrance criteria|14|||
162932915|NCT02295280|588458601|FG000|Overall Study|Adverse Event|0|||
162932916|NCT02295280|588458602|FG001|Overall Study|Adverse Event|1|||
162932917|NCT02875067|588458603|FG000|Overall Study|Withdrawal by Subject|1|||
162932918|NCT02875067|588458603|FG000|Overall Study|Withdrawal by Termination of Study|5|||
162932919|NCT01430104|588458604|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
162932920|NCT02713243|588458606|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
162932921|NCT02713243|588458607|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
162932922|NCT02713243|588458606|FG000|Overall Study|Administrative problems|0|||
162932923|NCT02713243|588458607|FG001|Overall Study|Administrative problems|1|||
162932924|NCT02713243|588458606|FG000|Overall Study|Protocol deviation|0|||
162932925|NCT02713243|588458607|FG001|Overall Study|Protocol deviation|1|||
162932926|NCT01133392|588458608|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
162932927|NCT01133392|588458609|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
162932928|NCT01133392|588458608|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
162932929|NCT01133392|588458609|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
163176559|NCT00459979|589362220|FG000|Overall Study|Protocol Violation|1|||
163176560|NCT00278915|589362221|FG000|Overall Study|Disease progression|1|||
163176561|NCT05214573|589362222|FG000|Overall Study|Physician Decision|5924|||
163176562|NCT05214573|589362223|FG001|Overall Study|Physician Decision|0|||
163176563|NCT00814801|589362224|FG000|Overall Study|Adverse Event|15|||
163176564|NCT00814801|589362225|FG001|Overall Study|Adverse Event|16|||
163176565|NCT00814801|589362226|FG002|Overall Study|Adverse Event|19|||
163176566|NCT00814801|589362224|FG000|Overall Study|Withdrawal by Subject|9|||
163176567|NCT00814801|589362225|FG001|Overall Study|Withdrawal by Subject|11|||
163176568|NCT00814801|589362226|FG002|Overall Study|Withdrawal by Subject|14|||
163176569|NCT00814801|589362224|FG000|Overall Study|Inappropriate as a subject|1|||
163176570|NCT00814801|589362225|FG001|Overall Study|Inappropriate as a subject|1|||
163176571|NCT00814801|589362226|FG002|Overall Study|Inappropriate as a subject|1|||
162932930|NCT03751124|588458610|FG000|Overall Study|Adverse Event|4|||
162932931|NCT03751124|588458611|FG001|Overall Study|Adverse Event|3|||
162932932|NCT03751124|588458610|FG000|Overall Study|Protocol Deviation|0|||
162932933|NCT03751124|588458611|FG001|Overall Study|Protocol Deviation|1|||
162932934|NCT03751124|588458610|FG000|Overall Study|Lost to Follow-up|6|||
162932935|NCT03751124|588458611|FG001|Overall Study|Lost to Follow-up|4|||
163176572|NCT00814801|589362224|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
163176573|NCT00814801|589362225|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
163176574|NCT00814801|589362226|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
163176575|NCT00814801|589362224|FG000|Overall Study|Missing or change of caregiver|6|||
163176576|NCT00814801|589362225|FG001|Overall Study|Missing or change of caregiver|2|||
163176577|NCT00814801|589362226|FG002|Overall Study|Missing or change of caregiver|4|||
163176578|NCT00814801|589362224|FG000|Overall Study|Non-compliance|0|||
163176579|NCT00814801|589362225|FG001|Overall Study|Non-compliance|1|||
163176580|NCT00814801|589362226|FG002|Overall Study|Non-compliance|1|||
163176581|NCT00814801|589362224|FG000|Overall Study|Other|2|||
163176582|NCT00814801|589362225|FG001|Overall Study|Other|6|||
163176583|NCT00814801|589362226|FG002|Overall Study|Other|4|||
163176584|NCT01037088|589362232|FG000|Overall Study|Withdrawal by Subject|3|||
163176585|NCT00604214|589362233|FG000|Baseline to Day 28|Death|223|||
163176586|NCT00604214|589362234|FG001|Baseline to Day 28|Death|202|||
163176587|NCT00604214|589362233|FG000|Baseline to Day 28|Lost to Follow-up|2|||
163176588|NCT00604214|589362234|FG001|Baseline to Day 28|Lost to Follow-up|4|||
163176589|NCT00604214|589362233|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
163176590|NCT00604214|589362234|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
163176591|NCT00604214|589362233|FG000|Day 29 to Day 90|Death|64|||
163176592|NCT00604214|589362234|FG001|Day 29 to Day 90|Death|67|||
163176593|NCT00604214|589362233|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
163176594|NCT00604214|589362234|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
163176595|NCT00604214|589362233|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
163176596|NCT00604214|589362234|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
163176597|NCT00604214|589362233|FG000|Day 91 to Day 180|Death|19|||
163176598|NCT00604214|589362234|FG001|Day 91 to Day 180|Death|23|||
163176599|NCT00604214|589362233|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
163176600|NCT00604214|589362234|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
163176601|NCT00604214|589362233|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
163176602|NCT00604214|589362234|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
163176603|NCT00534599|589362235|FG000|Overall Study|Adverse Event|25|||
163176604|NCT00534599|589362236|FG001|Overall Study|Adverse Event|4|||
163176605|NCT00534599|589362235|FG000|Overall Study|Incorrect enrollment|2|||
163176606|NCT00534599|589362236|FG001|Overall Study|Incorrect enrollment|1|||
163176607|NCT00534599|589362235|FG000|Overall Study|Mis-randomization|2|||
163176608|NCT00534599|589362236|FG001|Overall Study|Mis-randomization|2|||
163176609|NCT00534599|589362235|FG000|Overall Study|Developed study-specific d/c criteria|5|||
163176610|NCT00534599|589362236|FG001|Overall Study|Developed study-specific d/c criteria|0|||
163176611|NCT00534599|589362235|FG000|Overall Study|Lack of Efficacy|0|||
163176612|NCT00534599|589362236|FG001|Overall Study|Lack of Efficacy|1|||
163176613|NCT00534599|589362235|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
163176614|NCT00534599|589362236|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
163176615|NCT00534599|589362235|FG000|Overall Study|Protocol Violation|1|||
163176616|NCT00534599|589362236|FG001|Overall Study|Protocol Violation|3|||
163176617|NCT00534599|589362235|FG000|Overall Study|Lost to Follow-up|11|||
163176618|NCT00534599|589362236|FG001|Overall Study|Lost to Follow-up|14|||
163176619|NCT00534599|589362235|FG000|Overall Study|Withdrawal by Subject|4|||
163176620|NCT00534599|589362236|FG001|Overall Study|Withdrawal by Subject|6|||
163176621|NCT00534599|589362235|FG000|Overall Study|Other|7|||
163176622|NCT00534599|589362236|FG001|Overall Study|Other|0|||
163176623|NCT01879579|589363654|FG000|Overall Study|Phone incompatible with texting platform|3|||
163176624|NCT01879579|589363655|FG001|Overall Study|Phone incompatible with texting platform|0|||
163176625|NCT01879579|589363654|FG000|Overall Study|Did not enroll in texting platform|1|||
163176626|NCT01879579|589363655|FG001|Overall Study|Did not enroll in texting platform|0|||
163176627|NCT01879579|589363654|FG000|Overall Study|Did not initiate insulin treatment|1|||
163176628|NCT01879579|589363655|FG001|Overall Study|Did not initiate insulin treatment|0|||
163176629|NCT01879579|589363654|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
163176630|NCT01879579|589363655|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
163176631|NCT01879579|589363654|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
163176632|NCT01879579|589363655|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
163176633|NCT00815516|589363662|FG000|Overall Study|Death|3|||
163176634|NCT00815516|589363663|FG001|Overall Study|Death|1|||
163176635|NCT00815516|589363662|FG000|Overall Study|Physician Decision|1|||
163176636|NCT00815516|589363663|FG001|Overall Study|Physician Decision|0|||
163176637|NCT01992159|589363669|FG000|Overall Study|Withdrawal by Subject|4|||
163176638|NCT01992159|589363670|FG001|Overall Study|Withdrawal by Subject|7|||
163176639|NCT01992159|589363671|FG002|Overall Study|Withdrawal by Subject|0|||
163176640|NCT01992159|589363672|FG003|Overall Study|Withdrawal by Subject|3|||
163176641|NCT01992159|589363669|FG000|Overall Study|Adverse Event|0|||
163176642|NCT01992159|589363670|FG001|Overall Study|Adverse Event|1|||
163176643|NCT01992159|589363671|FG002|Overall Study|Adverse Event|0|||
163176644|NCT01992159|589363672|FG003|Overall Study|Adverse Event|1|||
163176645|NCT01992159|589363669|FG000|Overall Study|Death|0|||
163176646|NCT01992159|589363670|FG001|Overall Study|Death|0|||
163176647|NCT01992159|589363671|FG002|Overall Study|Death|1|||
163176648|NCT01992159|589363672|FG003|Overall Study|Death|0|||
163176649|NCT00095238|589363673|FG000|Overall Study|Lack of Efficacy|9|||
163176650|NCT00095238|589363674|FG001|Overall Study|Lack of Efficacy|9|||
163176651|NCT00095238|589363673|FG000|Overall Study|Adverse Event|331|||
163176652|NCT00095238|589363674|FG001|Overall Study|Adverse Event|287|||
162932936|NCT03751124|588458610|FG000|Overall Study|Withdrawal by Subject|6|||
162932937|NCT03751124|588458611|FG001|Overall Study|Withdrawal by Subject|8|||
162932938|NCT03751124|588458610|FG000|Overall Study|Lack of Efficacy|1|||
162932939|NCT03751124|588458611|FG001|Overall Study|Lack of Efficacy|1|||
162932940|NCT03751124|588458610|FG000|Overall Study|Pregnancy|0|||
163176653|NCT00095238|589363673|FG000|Overall Study|Subject Withdrew Consent|208|||
163176654|NCT00095238|589363674|FG001|Overall Study|Subject Withdrew Consent|223|||
163176655|NCT00095238|589363673|FG000|Overall Study|Death|154|||
163176656|NCT00095238|589363674|FG001|Overall Study|Death|170|||
163176657|NCT00095238|589363673|FG000|Overall Study|Lost to Follow-up|19|||
163176658|NCT00095238|589363674|FG001|Overall Study|Lost to Follow-up|24|||
163176659|NCT00095238|589363673|FG000|Overall Study|Noncompliance|44|||
163176660|NCT00095238|589363674|FG001|Overall Study|Noncompliance|45|||
163176661|NCT00095238|589363673|FG000|Overall Study|No longer met study criteria|4|||
163176662|NCT00095238|589363674|FG001|Overall Study|No longer met study criteria|5|||
163176663|NCT00095238|589363673|FG000|Overall Study|Study terminated by sponsor|0|||
163176664|NCT00095238|589363674|FG001|Overall Study|Study terminated by sponsor|1|||
163176665|NCT00095238|589363673|FG000|Overall Study|Missing|1|||
163176666|NCT00095238|589363674|FG001|Overall Study|Missing|0|||
163176667|NCT00095238|589363673|FG000|Overall Study|Other Reasons|87|||
163176668|NCT00095238|589363674|FG001|Overall Study|Other Reasons|88|||
163176669|NCT03754972|589363675|FG000|Overall Study|Protocol Violation|25|||
163176670|NCT02311582|589363676|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176671|NCT02311582|589363677|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176672|NCT02311582|589363678|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
163176673|NCT02311582|589363679|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
163176674|NCT02311582|589363680|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
163176675|NCT03404960|589363682|FG000|Overall Study|Adverse Event|0|||
163176676|NCT03404960|589363683|FG001|Overall Study|Adverse Event|2|||
163176677|NCT03404960|589363682|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
163176678|NCT03404960|589363683|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
163176679|NCT03404960|589363682|FG000|Overall Study|Bowel obstruction|0|||
163176680|NCT03404960|589363683|FG001|Overall Study|Bowel obstruction|1|||
163176681|NCT03404960|589363682|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
163176682|NCT03404960|589363683|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
163176683|NCT06460493|589363686|FG000|Overall Study|Withdrawal by Subject|2|||
163176684|NCT00075270|589363691|FG000|Overall Study|Withdrawal by Subject|28|||
163176685|NCT00075270|589363692|FG001|Overall Study|Withdrawal by Subject|21|||
163176686|NCT00075270|589363691|FG000|Overall Study|Lost to Follow-up|25|||
163176687|NCT00075270|589363692|FG001|Overall Study|Lost to Follow-up|28|||
162932941|NCT03751124|588458611|FG001|Overall Study|Pregnancy|1|||
162932942|NCT03751124|588458610|FG000|Overall Study|Other|9|||
163176688|NCT00075270|589363691|FG000|Overall Study|Protocol Violation|0|||
163176689|NCT00075270|589363692|FG001|Overall Study|Protocol Violation|2|||
163176690|NCT00075270|589363691|FG000|Overall Study|Death|198|||
163176691|NCT00075270|589363692|FG001|Overall Study|Death|215|||
163176692|NCT00075270|589363691|FG000|Overall Study|Other/Unknown|9|||
163176693|NCT00075270|589363692|FG001|Overall Study|Other/Unknown|5|||
163176694|NCT00075270|589363691|FG000|Overall Study|Missing|26|||
163176695|NCT00075270|589363692|FG001|Overall Study|Missing|13|||
163176696|NCT00246571|589363693|FG000|Overall Study|Adverse Event|7|||
163176697|NCT00246571|589363694|FG001|Overall Study|Adverse Event|0|||
163176698|NCT00246571|589363693|FG000|Overall Study|Protocol Violation|0|||
163176699|NCT00246571|589363694|FG001|Overall Study|Protocol Violation|1|||
163176700|NCT00246571|589363693|FG000|Overall Study|Withdrawal by Subject|2|||
163176701|NCT00246571|589363694|FG001|Overall Study|Withdrawal by Subject|3|||
163176702|NCT00246571|589363693|FG000|Overall Study|Lack of Efficacy|84|||
163176703|NCT00246571|589363694|FG001|Overall Study|Lack of Efficacy|21|||
163176704|NCT00246571|589363693|FG000|Overall Study|Death|17|||
163176705|NCT00246571|589363694|FG001|Overall Study|Death|3|||
163176706|NCT00246571|589363693|FG000|Overall Study|Sponsor|0|||
163176707|NCT00246571|589363694|FG001|Overall Study|Sponsor|1|||
163176708|NCT00246571|589363693|FG000|Overall Study|Did not meet entrance criteria|2|||
163176709|NCT00246571|589363694|FG001|Overall Study|Did not meet entrance criteria|1|||
163176710|NCT00246571|589363693|FG000|Overall Study|Laboratory abnormalities|1|||
163176711|NCT00246571|589363694|FG001|Overall Study|Laboratory abnormalities|0|||
163176712|NCT00246571|589363693|FG000|Overall Study|Crossover participants|0|||
163176713|NCT00246571|589363694|FG001|Overall Study|Crossover participants|74|||
163176714|NCT00775203|589363695|FG000|Overall Study|Adverse Event|25|||
163176715|NCT00775203|589363696|FG001|Overall Study|Adverse Event|6|||
163176716|NCT00775203|589363695|FG000|Overall Study|Lack of Efficacy|8|||
163176717|NCT00775203|589363696|FG001|Overall Study|Lack of Efficacy|9|||
163176718|NCT00775203|589363695|FG000|Overall Study|Withdrawal by Subject|11|||
163176719|NCT00775203|589363696|FG001|Overall Study|Withdrawal by Subject|9|||
163176720|NCT00775203|589363695|FG000|Overall Study|Lost to Follow-up|11|||
163176721|NCT00775203|589363696|FG001|Overall Study|Lost to Follow-up|15|||
163176722|NCT00775203|589363695|FG000|Overall Study|Administrative reason|2|||
163176723|NCT00775203|589363696|FG001|Overall Study|Administrative reason|0|||
163176724|NCT00775203|589363695|FG000|Overall Study|Noncompliance|4|||
163176725|NCT00775203|589363696|FG001|Overall Study|Noncompliance|2|||
163176726|NCT00775203|589363695|FG000|Overall Study|Protocol Violation|0|||
163176727|NCT00775203|589363696|FG001|Overall Study|Protocol Violation|1|||
163176728|NCT00775203|589363695|FG000|Overall Study|Entered other study|1|||
163176729|NCT00775203|589363696|FG001|Overall Study|Entered other study|0|||
163176730|NCT00775203|589363695|FG000|Overall Study|Physician Decision|0|||
163176731|NCT00775203|589363696|FG001|Overall Study|Physician Decision|1|||
163176732|NCT02987660|589363697|FG000|Overall Study|Study terminated by sponsor|10|||
163176733|NCT02987660|589363698|FG001|Overall Study|Study terminated by sponsor|10|||
163176734|NCT05247398|589363699|FG000|Overall Study|Withdrawal by Subject|1|||
163176735|NCT05171816|589363700|FG000|Overall Study|Death|18|||
163176736|NCT05171816|589363701|FG001|Overall Study|Death|16|||
163176737|NCT02937571|589363702|FG000|Overall Study|Adverse Event|0|||
163176738|NCT02937571|589363703|FG001|Overall Study|Adverse Event|0|||
163176739|NCT02937571|589363704|FG002|Overall Study|Adverse Event|4|||
163176740|NCT02937571|589363702|FG000|Overall Study|Withdrawal by Subject|0|||
163176741|NCT02937571|589363703|FG001|Overall Study|Withdrawal by Subject|0|||
162825855|NCT03670953|588075245|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
162825856|NCT03670953|588075246|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
162825857|NCT03670953|588075247|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
162825858|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
162825859|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
162825860|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
162825861|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
162825862|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
162825863|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
162825864|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
162825865|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
162825866|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
162825867|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
162825868|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
162825869|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
162932943|NCT03751124|588458611|FG001|Overall Study|Other|9|||
163176742|NCT02937571|589363704|FG002|Overall Study|Withdrawal by Subject|3|||
163176743|NCT04902326|589363705|FG000|Overall Study|Withdrawal by Subject|1|||
163176744|NCT04902326|589363706|FG001|Overall Study|Withdrawal by Subject|3|||
163176745|NCT04902326|589363707|FG002|Overall Study|Withdrawal by Subject|0|||
163176746|NCT04902326|589363708|FG003|Overall Study|Withdrawal by Subject|1|||
163176747|NCT04902326|589363705|FG000|Overall Study|Lost to Follow-up|14|||
163176748|NCT04902326|589363706|FG001|Overall Study|Lost to Follow-up|14|||
163176749|NCT04902326|589363707|FG002|Overall Study|Lost to Follow-up|14|||
163176750|NCT04902326|589363708|FG003|Overall Study|Lost to Follow-up|6|||
163176751|NCT01155479|589363713|FG000|Part I|Adverse Event|13|||
163176752|NCT01155479|589363714|FG001|Part I|Adverse Event|8|||
163176753|NCT01155479|589363715|FG002|Part I|Adverse Event|18|||
163176754|NCT01155479|589363716|FG003|Part I|Adverse Event|7|||
162825870|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
162825871|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
162825872|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
162825873|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
162825874|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
162825875|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
162825876|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
162932944|NCT03751124|588458610|FG000|Overall Study|Participants who did not receive any study drug|0|||
162932945|NCT03751124|588458611|FG001|Overall Study|Participants who did not receive any study drug|1|||
162932946|NCT00555399|588458614|FG000|Overall Study|Withdrawal by Subject|0|||
162932947|NCT00555399|588458615|FG001|Overall Study|Withdrawal by Subject|0|||
162932948|NCT00555399|588458616|FG002|Overall Study|Withdrawal by Subject|1|||
162932949|NCT00555399|588458617|FG003|Overall Study|Withdrawal by Subject|0|||
163176755|NCT01155479|589363717|FG004|Part I|Adverse Event|6|||
163176756|NCT01155479|589363713|FG000|Part I|Administrative|2|||
163176757|NCT01155479|589363714|FG001|Part I|Administrative|2|||
163176758|NCT01155479|589363715|FG002|Part I|Administrative|2|||
163176759|NCT01155479|589363716|FG003|Part I|Administrative|0|||
163176760|NCT01155479|589363717|FG004|Part I|Administrative|0|||
163176761|NCT01155479|589363713|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
163176762|NCT01155479|589363714|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
163176763|NCT01155479|589363715|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
163176764|NCT01155479|589363716|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
163176765|NCT01155479|589363717|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
163176766|NCT01155479|589363713|FG000|Part I|Withdrawal by Subject|11|||
163176767|NCT01155479|589363714|FG001|Part I|Withdrawal by Subject|13|||
163176768|NCT01155479|589363715|FG002|Part I|Withdrawal by Subject|8|||
163176769|NCT01155479|589363716|FG003|Part I|Withdrawal by Subject|8|||
163176770|NCT01155479|589363717|FG004|Part I|Withdrawal by Subject|9|||
163176771|NCT01155479|589363713|FG000|Part I|Lost to Follow-up|0|||
163176772|NCT01155479|589363714|FG001|Part I|Lost to Follow-up|0|||
163176773|NCT01155479|589363715|FG002|Part I|Lost to Follow-up|1|||
163176774|NCT01155479|589363716|FG003|Part I|Lost to Follow-up|1|||
163176775|NCT01155479|589363717|FG004|Part I|Lost to Follow-up|0|||
163176776|NCT01155479|589363713|FG000|Part I|Treatment Failure|3|||
163176777|NCT01155479|589363714|FG001|Part I|Treatment Failure|0|||
163176778|NCT01155479|589363715|FG002|Part I|Treatment Failure|3|||
163176779|NCT01155479|589363716|FG003|Part I|Treatment Failure|1|||
163176780|NCT01155479|589363717|FG004|Part I|Treatment Failure|2|||
163176781|NCT01155479|589363713|FG000|Part I|Did Not Receive Treatment|4|||
163176782|NCT01155479|589363714|FG001|Part I|Did Not Receive Treatment|2|||
163176783|NCT01155479|589363715|FG002|Part I|Did Not Receive Treatment|2|||
163176784|NCT01155479|589363716|FG003|Part I|Did Not Receive Treatment|6|||
163176785|NCT01155479|589363717|FG004|Part I|Did Not Receive Treatment|1|||
163176786|NCT01155479|589363713|FG000|Part I|Non-Compliance with Protocol|2|||
163176787|NCT01155479|589363714|FG001|Part I|Non-Compliance with Protocol|1|||
163176788|NCT01155479|589363715|FG002|Part I|Non-Compliance with Protocol|3|||
163176789|NCT01155479|589363716|FG003|Part I|Non-Compliance with Protocol|3|||
163176790|NCT01155479|589363717|FG004|Part I|Non-Compliance with Protocol|2|||
163176791|NCT01155479|589363713|FG000|Part II|Adverse Event|7|||
163176792|NCT01155479|589363714|FG001|Part II|Adverse Event|6|||
163176793|NCT01155479|589363715|FG002|Part II|Adverse Event|8|||
163176794|NCT01155479|589363716|FG003|Part II|Adverse Event|3|||
163176795|NCT01155479|589363717|FG004|Part II|Adverse Event|4|||
163176796|NCT01155479|589363713|FG000|Part II|Administrative|43|||
163176797|NCT01155479|589363714|FG001|Part II|Administrative|49|||
163176798|NCT01155479|589363715|FG002|Part II|Administrative|36|||
163176799|NCT01155479|589363716|FG003|Part II|Administrative|38|||
163176800|NCT01155479|589363717|FG004|Part II|Administrative|46|||
163176801|NCT01155479|589363713|FG000|Part II|Withdrawal by Subject|8|||
163176802|NCT01155479|589363714|FG001|Part II|Withdrawal by Subject|4|||
163176803|NCT01155479|589363715|FG002|Part II|Withdrawal by Subject|12|||
163176804|NCT01155479|589363716|FG003|Part II|Withdrawal by Subject|7|||
163176805|NCT01155479|589363717|FG004|Part II|Withdrawal by Subject|3|||
163176806|NCT01155479|589363713|FG000|Part II|Lost to Follow-up|1|||
163176807|NCT01155479|589363714|FG001|Part II|Lost to Follow-up|0|||
163176808|NCT01155479|589363715|FG002|Part II|Lost to Follow-up|0|||
163176809|NCT01155479|589363716|FG003|Part II|Lost to Follow-up|0|||
162698475|NCT02065570|587605507|FG001|Maintenance Study|Other, Not Specified|0|||
162932950|NCT00555399|588458618|FG004|Overall Study|Withdrawal by Subject|0|||
162932951|NCT00555399|588458619|FG005|Overall Study|Withdrawal by Subject|0|||
162932952|NCT00555399|588458620|FG006|Overall Study|Withdrawal by Subject|0|||
163176810|NCT01155479|589363717|FG004|Part II|Lost to Follow-up|1|||
163176811|NCT01155479|589363713|FG000|Part II|Treatment Failure|0|||
163176812|NCT01155479|589363714|FG001|Part II|Treatment Failure|1|||
163176813|NCT01155479|589363715|FG002|Part II|Treatment Failure|2|||
163176814|NCT01155479|589363716|FG003|Part II|Treatment Failure|0|||
163176815|NCT01155479|589363717|FG004|Part II|Treatment Failure|1|||
163176816|NCT01155479|589363713|FG000|Part II|Non-Compliance with Protocol|0|||
163176817|NCT01155479|589363714|FG001|Part II|Non-Compliance with Protocol|1|||
163176818|NCT01155479|589363715|FG002|Part II|Non-Compliance with Protocol|0|||
163176819|NCT01155479|589363716|FG003|Part II|Non-Compliance with Protocol|2|||
163176820|NCT01155479|589363717|FG004|Part II|Non-Compliance with Protocol|0|||
163176821|NCT01857310|589363718|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
163176822|NCT01857310|589363719|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
163176823|NCT02360605|589363720|FG000|Overall Study|Withdrawal by Subject|4|||
163176824|NCT02360605|589363721|FG001|Overall Study|Withdrawal by Subject|9|||
163176825|NCT02360605|589363720|FG000|Overall Study|Lost to Follow-up|7|||
162932953|NCT00555399|588458621|FG007|Overall Study|Withdrawal by Subject|0|||
162932954|NCT00555399|588458622|FG008|Overall Study|Withdrawal by Subject|0|||
162932955|NCT00555399|588458623|FG009|Overall Study|Withdrawal by Subject|0|||
162932956|NCT00555399|588458624|FG010|Overall Study|Withdrawal by Subject|0|||
162932957|NCT00555399|588458625|FG011|Overall Study|Withdrawal by Subject|1|||
162932958|NCT00555399|588458614|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
162932959|NCT00555399|588458615|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
162932960|NCT00555399|588458616|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
162932961|NCT00555399|588458617|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
162932962|NCT00555399|588458618|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
162932963|NCT00555399|588458619|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
162932964|NCT00555399|588458620|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
162932965|NCT00555399|588458621|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
162932966|NCT00555399|588458622|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
163176826|NCT02360605|589363721|FG001|Overall Study|Lost to Follow-up|8|||
163176827|NCT02360605|589363720|FG000|Overall Study|Death|0|||
163176828|NCT02360605|589363721|FG001|Overall Study|Death|1|||
163176829|NCT00290407|589363722|FG000|Overall Study|Physician Decision|2|||
163176830|NCT05442775|589363725|FG000|Overall Study|Trial terminated|61|||
163176831|NCT05442775|589363725|FG000|Overall Study|Lack of Efficacy|4|||
163176832|NCT05442775|589363725|FG000|Overall Study|Withdrawal by Subject|4|||
163176833|NCT05442775|589363725|FG000|Overall Study|Death|1|||
163176834|NCT05442775|589363725|FG000|Overall Study|Participant removed at Sponsor request|1|||
163176835|NCT01966432|589363727|FG000|Overall Study|Lost to Follow-up|3|||
163176836|NCT01966432|589363728|FG001|Overall Study|Lost to Follow-up|2|||
163176837|NCT01966432|589363729|FG002|Overall Study|Lost to Follow-up|5|||
163176838|NCT01966432|589363727|FG000|Overall Study|Withdrawal by Subject|1|||
163176839|NCT01966432|589363728|FG001|Overall Study|Withdrawal by Subject|3|||
163176840|NCT01966432|589363729|FG002|Overall Study|Withdrawal by Subject|0|||
163176841|NCT01966432|589363727|FG000|Overall Study|Subject Incarcerated|0|||
163176842|NCT01966432|589363728|FG001|Overall Study|Subject Incarcerated|0|||
163176843|NCT01966432|589363729|FG002|Overall Study|Subject Incarcerated|1|||
163176844|NCT01966432|589363727|FG000|Overall Study|SBIRT program ended|1|||
163176845|NCT01966432|589363728|FG001|Overall Study|SBIRT program ended|8|||
163176846|NCT01966432|589363729|FG002|Overall Study|SBIRT program ended|20|||
163176847|NCT01120067|589363731|FG000|Overall Study|Lost to Follow-up|3|||
163176848|NCT01120067|589363732|FG001|Overall Study|Lost to Follow-up|1|||
163176849|NCT01120067|589363731|FG000|Overall Study|fail to engage >3 sessions|2|||
163176850|NCT01120067|589363732|FG001|Overall Study|fail to engage >3 sessions|0|||
163176851|NCT02216812|589363735|FG000|Overall Study|Lost to Follow-up|10|||
163176852|NCT02216812|589363736|FG001|Overall Study|Lost to Follow-up|5|||
163176853|NCT00527488|589363737|FG000|Overall Study|Withdrawn prior to dosing|0|||
163176854|NCT00527488|589363738|FG001|Overall Study|Withdrawn prior to dosing|1|||
163176855|NCT00527488|589363739|FG002|Overall Study|Withdrawn prior to dosing|1|||
163176856|NCT00527488|589363740|FG003|Overall Study|Withdrawn prior to dosing|0|||
163176857|NCT03036800|589363741|FG000|Overall Study|Protocol Violation|1|||
163176858|NCT03036800|589363742|FG001|Overall Study|Protocol Violation|0|||
163176859|NCT03036800|589363741|FG000|Overall Study|Non-compliance|1|||
163176860|NCT03036800|589363742|FG001|Overall Study|Non-compliance|0|||
163176861|NCT03036800|589363741|FG000|Overall Study|Lost to Follow-up|1|||
163176862|NCT03036800|589363742|FG001|Overall Study|Lost to Follow-up|0|||
163176863|NCT03036800|589363741|FG000|Overall Study|Death|1|||
163176864|NCT03036800|589363742|FG001|Overall Study|Death|0|||
163176865|NCT03036800|589363741|FG000|Overall Study|Tolerance|5|||
163176866|NCT03036800|589363742|FG001|Overall Study|Tolerance|0|||
163176867|NCT03036800|589363741|FG000|Overall Study|Unknown/no reason given|50|||
163176868|NCT03036800|589363742|FG001|Overall Study|Unknown/no reason given|39|||
163176869|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
163176870|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
163176871|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
163176872|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
163176873|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
163176874|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
163176875|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176876|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176877|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
163176878|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
163176879|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
163176880|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
163176881|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
163176882|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
163176883|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
163176884|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176885|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
163176886|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176887|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
163176888|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
163176889|NCT01986933|589363743|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176890|NCT01986933|589363744|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176891|NCT01986933|589363745|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176892|NCT01986933|589363746|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
163176893|NCT01986933|589363747|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
163176894|NCT01986933|589363743|FG000|Active-to-active (Part B)|Adverse Event|0|||
163176895|NCT01986933|589363744|FG001|Active-to-active (Part B)|Adverse Event|2|||
163176896|NCT01986933|589363745|FG002|Active-to-active (Part B)|Adverse Event|0|||
162698476|NCT02065570|587605508|FG002|Maintenance Study|Other, Not Specified|11|||
163176897|NCT01986933|589363746|FG003|Active-to-active (Part B)|Adverse Event|1|||
163176898|NCT01986933|589363747|FG004|Active-to-active (Part B)|Adverse Event|3|||
163176899|NCT01986933|589363743|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
163176900|NCT01986933|589363744|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
163176901|NCT01986933|589363745|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
163176902|NCT01986933|589363746|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
163176903|NCT01986933|589363747|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
163176904|NCT01986933|589363743|FG000|Active-to-active (Part B)|Pregnancy|0|||
163176905|NCT01986933|589363744|FG001|Active-to-active (Part B)|Pregnancy|0|||
163176906|NCT01986933|589363745|FG002|Active-to-active (Part B)|Pregnancy|0|||
163176907|NCT01986933|589363746|FG003|Active-to-active (Part B)|Pregnancy|0|||
163176908|NCT01986933|589363747|FG004|Active-to-active (Part B)|Pregnancy|1|||
163176909|NCT01986933|589363743|FG000|Active-to-active (Part B)|Physician Decision|0|||
163176910|NCT01986933|589363744|FG001|Active-to-active (Part B)|Physician Decision|0|||
163176911|NCT01986933|589363745|FG002|Active-to-active (Part B)|Physician Decision|1|||
162932967|NCT00555399|588458623|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
162932968|NCT00555399|588458624|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
162932969|NCT00555399|588458625|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
162932970|NCT00343642|588460059|FG000|Overall Study|Lost to Follow-up|0|||
162932971|NCT00343642|588460060|FG001|Overall Study|Lost to Follow-up|1|||
162932972|NCT00343642|588460061|FG002|Overall Study|Lost to Follow-up|0|||
162932973|NCT00343642|588460059|FG000|Overall Study|Pregnancy|1|||
162932974|NCT00343642|588460060|FG001|Overall Study|Pregnancy|0|||
162932975|NCT00343642|588460061|FG002|Overall Study|Pregnancy|2|||
162932976|NCT00343642|588460059|FG000|Overall Study|Withdrawal by Subject|2|||
162932977|NCT00343642|588460060|FG001|Overall Study|Withdrawal by Subject|3|||
162932978|NCT00343642|588460061|FG002|Overall Study|Withdrawal by Subject|4|||
162932979|NCT00343642|588460059|FG000|Overall Study|Adverse Event|0|||
162932980|NCT00343642|588460060|FG001|Overall Study|Adverse Event|0|||
162932981|NCT00343642|588460061|FG002|Overall Study|Adverse Event|1|||
162932982|NCT00343642|588460059|FG000|Overall Study|Flare up|6|||
162932983|NCT00343642|588460060|FG001|Overall Study|Flare up|4|||
162932984|NCT00343642|588460061|FG002|Overall Study|Flare up|0|||
162932985|NCT00860574|588460064|FG000|Overall Study|Death|2|||
162932986|NCT00860574|588460064|FG000|Overall Study|Relapse|1|||
162932987|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
162932988|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
162932989|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
162932990|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
162932991|NCT02496221|588460065|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
162932992|NCT02496221|588460066|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
162932993|NCT01335399|588460067|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
162932994|NCT01335399|588460068|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
162932995|NCT01335399|588460067|FG000|Pre-treatment Period|Participant request to discontinue|0|||
162932996|NCT01335399|588460068|FG001|Pre-treatment Period|Participant request to discontinue|1|||
162932997|NCT01335399|588460067|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
162932998|NCT01335399|588460068|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
162932999|NCT01335399|588460067|FG000|Pre-treatment Period|Consent withdrawal|3|||
162933000|NCT01335399|588460068|FG001|Pre-treatment Period|Consent withdrawal|0|||
162933001|NCT01335399|588460067|FG000|Treatment Period|Disease progression|117|||
162933002|NCT01335399|588460068|FG001|Treatment Period|Disease progression|145|||
162933003|NCT01335399|588460067|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
162933004|NCT01335399|588460068|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
163176912|NCT01986933|589363746|FG003|Active-to-active (Part B)|Physician Decision|1|||
163176913|NCT01986933|589363747|FG004|Active-to-active (Part B)|Physician Decision|0|||
163176914|NCT01986933|589363743|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
163176915|NCT01986933|589363744|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
163176916|NCT01986933|589363745|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
163176917|NCT01986933|589363746|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
163176918|NCT01986933|589363747|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
163176919|NCT01986933|589363743|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
163176920|NCT01986933|589363744|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
163176921|NCT01986933|589363745|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
163176922|NCT01986933|589363746|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
163176923|NCT01986933|589363747|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
163176924|NCT01986933|589363743|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
163176925|NCT01986933|589363744|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176926|NCT01986933|589363745|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
163176927|NCT01986933|589363746|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176928|NCT01986933|589363747|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
163176929|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
163176930|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
163176931|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
163176932|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
163176933|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
163176934|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176935|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176936|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176937|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
163176938|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
163176939|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
163176940|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
163176941|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
163176942|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
163176943|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
163176944|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
163176945|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
163176946|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
163176947|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
163176948|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
163176949|NCT01986933|589363743|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176950|NCT01986933|589363744|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
163176951|NCT01986933|589363745|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176952|NCT01986933|589363746|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176953|NCT01986933|589363747|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
163176954|NCT01077154|589363748|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
163176955|NCT01077154|589363749|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
163176956|NCT01077154|589363748|FG000|Overall Study|Withdrawal by Subject|369|||
163176957|NCT01077154|589363749|FG001|Overall Study|Withdrawal by Subject|385|||
163176958|NCT01077154|589363748|FG000|Overall Study|Death|215|||
163176959|NCT01077154|589363749|FG001|Overall Study|Death|214|||
163176960|NCT01077154|589363748|FG000|Overall Study|Lost to Follow-up|43|||
163176961|NCT01077154|589363749|FG001|Overall Study|Lost to Follow-up|35|||
163176962|NCT01077154|589363748|FG000|Overall Study|Noncompliance|22|||
163176963|NCT01077154|589363749|FG001|Overall Study|Noncompliance|20|||
163176964|NCT01077154|589363748|FG000|Overall Study|Disease Progression|18|||
163176965|NCT01077154|589363749|FG001|Overall Study|Disease Progression|20|||
163176966|NCT01077154|589363748|FG000|Overall Study|Ineligibility Determined|10|||
163176967|NCT01077154|589363749|FG001|Overall Study|Ineligibility Determined|14|||
163176968|NCT01077154|589363748|FG000|Overall Study|Other|14|||
163176969|NCT01077154|589363749|FG001|Overall Study|Other|11|||
163176970|NCT01077154|589363748|FG000|Overall Study|Adverse Event|9|||
162825877|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
162825878|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
162825879|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
162825880|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
162825881|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
162825882|NCT03670953|588075244|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
162825883|NCT03670953|588075245|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
162825884|NCT03670953|588075246|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
162825885|NCT03670953|588075247|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
162825886|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
162825887|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
162825888|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
162825889|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
162825890|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
162825891|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
162825892|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
162825893|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
162825894|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
162825895|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
162825896|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
162825897|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
162825898|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
162825899|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
162825900|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
162825901|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
162825902|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
162825903|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
162825904|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
162825905|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
162825906|NCT03670953|588075244|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
162825907|NCT03670953|588075245|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
162825908|NCT03670953|588075246|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
162825909|NCT03670953|588075247|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
162825910|NCT04179734|588075248|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
162933005|NCT01335399|588460067|FG000|Treatment Period|Study drug toxicity|52|||
162933006|NCT01335399|588460068|FG001|Treatment Period|Study drug toxicity|64|||
162933007|NCT01335399|588460067|FG000|Treatment Period|Participant request to discontinue|30|||
163176971|NCT01077154|589363749|FG001|Overall Study|Adverse Event|9|||
162933008|NCT01335399|588460068|FG001|Treatment Period|Participant request to discontinue|22|||
163176972|NCT01077154|589363748|FG000|Overall Study|Administrative Decision|1|||
163176973|NCT01077154|589363749|FG001|Overall Study|Administrative Decision|6|||
163176974|NCT01077154|589363748|FG000|Overall Study|Protocol Deviation|1|||
163176975|NCT01077154|589363749|FG001|Overall Study|Protocol Deviation|0|||
163176976|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
163176977|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
162698477|NCT02065570|587605509|FG003|Maintenance Study|Other, Not Specified|5|||
162933009|NCT01335399|588460067|FG000|Treatment Period|Other reasons|30|||
162933010|NCT01335399|588460068|FG001|Treatment Period|Other reasons|30|||
162933011|NCT01335399|588460067|FG000|Treatment Period|Consent withdrawal|10|||
162933012|NCT01335399|588460068|FG001|Treatment Period|Consent withdrawal|7|||
162933013|NCT01335399|588460067|FG000|Treatment Period|Death|7|||
162933014|NCT01335399|588460068|FG001|Treatment Period|Death|6|||
162933015|NCT01335399|588460067|FG000|Treatment Period|Poor/Non-compliance|3|||
162933016|NCT01335399|588460068|FG001|Treatment Period|Poor/Non-compliance|4|||
162933017|NCT01335399|588460067|FG000|Treatment Period|Lost to Follow-up|2|||
162933018|NCT01335399|588460068|FG001|Treatment Period|Lost to Follow-up|2|||
162933019|NCT01335399|588460067|FG000|Treatment Period|Maximum clinical benefit|1|||
162933020|NCT01335399|588460068|FG001|Treatment Period|Maximum clinical benefit|1|||
162933021|NCT01335399|588460067|FG000|Treatment Period|No longer meet study criteria|1|||
162933022|NCT01335399|588460068|FG001|Treatment Period|No longer meet study criteria|1|||
162933023|NCT01335399|588460067|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
162933024|NCT01335399|588460068|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
162933025|NCT01120600|588460071|FG000|Overall Study|Adverse Event|7|||
162933026|NCT01120600|588460072|FG001|Overall Study|Adverse Event|7|||
162933027|NCT01120600|588460071|FG000|Overall Study|Excessive Bone Loss|0|||
162933028|NCT01120600|588460072|FG001|Overall Study|Excessive Bone Loss|4|||
162933029|NCT01120600|588460071|FG000|Overall Study|Lost to Follow-up|1|||
162933030|NCT01120600|588460072|FG001|Overall Study|Lost to Follow-up|3|||
162933031|NCT01120600|588460071|FG000|Overall Study|Physician Decision|1|||
162933032|NCT01120600|588460072|FG001|Overall Study|Physician Decision|3|||
162933033|NCT01120600|588460071|FG000|Overall Study|Protocol Violation|0|||
162933034|NCT01120600|588460072|FG001|Overall Study|Protocol Violation|4|||
162933035|NCT01120600|588460071|FG000|Overall Study|Withdrawal by Subject|10|||
162933036|NCT01120600|588460072|FG001|Overall Study|Withdrawal by Subject|11|||
162933037|NCT01165242|588460075|FG000|Overall Study|Unreachable Subjects|1|||
162933038|NCT01165242|588460076|FG001|Overall Study|Unreachable Subjects|0|||
162933039|NCT01165242|588460077|FG002|Overall Study|Unreachable Subjects|0|||
162933040|NCT01165242|588460075|FG000|Overall Study|Incarcerated Subjects|0|||
162933041|NCT01165242|588460076|FG001|Overall Study|Incarcerated Subjects|1|||
162933042|NCT01165242|588460077|FG002|Overall Study|Incarcerated Subjects|0|||
162933043|NCT01165242|588460075|FG000|Overall Study|Visit 2 Declined by Subject|0|||
162933044|NCT01165242|588460076|FG001|Overall Study|Visit 2 Declined by Subject|0|||
162933045|NCT01165242|588460077|FG002|Overall Study|Visit 2 Declined by Subject|1|||
162933046|NCT01165242|588460075|FG000|Overall Study|Withdrawal by Subject|0|||
162933047|NCT01165242|588460076|FG001|Overall Study|Withdrawal by Subject|2|||
163176978|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
163176979|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
163176980|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
163176981|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
163176982|NCT04030026|589363750|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
163176983|NCT04030026|589363751|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
163176984|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
163176985|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
163176986|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
163176987|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
163176988|NCT04030026|589363750|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
163176989|NCT04030026|589363751|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
163176990|NCT02545543|589363752|FG000|Overall Study|Lost to Follow-up|67|||
163176991|NCT02545543|589363753|FG001|Overall Study|Lost to Follow-up|25|||
163176992|NCT02545543|589363752|FG000|Overall Study|Physician Decision|3|||
163176993|NCT02545543|589363753|FG001|Overall Study|Physician Decision|0|||
163176994|NCT02545543|589363752|FG000|Overall Study|Withdrawal by Subject|9|||
163176995|NCT02545543|589363753|FG001|Overall Study|Withdrawal by Subject|8|||
163176996|NCT02545543|589363752|FG000|Overall Study|Noncomplaince|1|||
163176997|NCT02545543|589363753|FG001|Overall Study|Noncomplaince|0|||
163176998|NCT02545543|589363752|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
163176999|NCT02545543|589363753|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
163177000|NCT00811642|589363754|FG000|Overall Study|Adverse Event|3|||
163177001|NCT00811642|589363754|FG000|Overall Study|Protocol Violation|1|||
163177002|NCT00811642|589363754|FG000|Overall Study|Death|2|||
163177003|NCT00811642|589363754|FG000|Overall Study|Withdrawal by Subject|7|||
163177004|NCT00811642|589363754|FG000|Overall Study|Cumulative use of antifungal agent|2|||
163177005|NCT04285580|589365104|FG000|Overall Study|Protocol Violation|0|||
163177006|NCT04285580|589365105|FG001|Overall Study|Protocol Violation|1|||
163177007|NCT00562627|589365106|FG000|Overall Study|Protocol Violation|1|||
163177008|NCT00562627|589365107|FG001|Overall Study|Protocol Violation|1|||
163177009|NCT00562627|589365108|FG002|Overall Study|Protocol Violation|1|||
163177010|NCT02316548|589365112|FG000|Overall Study|Protocol Violation|0|||
163177011|NCT02316548|589365113|FG001|Overall Study|Protocol Violation|1|||
163177012|NCT03422627|589365118|FG000|Overall Study|Protocol-specified Criteria|1|||
163177013|NCT03422627|589365119|FG001|Overall Study|Protocol-specified Criteria|1|||
163177014|NCT03422627|589365120|FG002|Overall Study|Protocol-specified Criteria|0|||
163177015|NCT03422627|589365121|FG003|Overall Study|Protocol-specified Criteria|0|||
163177016|NCT03422627|589365122|FG004|Overall Study|Protocol-specified Criteria|2|||
163177017|NCT03422627|589365118|FG000|Overall Study|Requirement for Alternative Therapy|1|||
163177018|NCT03422627|589365119|FG001|Overall Study|Requirement for Alternative Therapy|1|||
163177019|NCT03422627|589365120|FG002|Overall Study|Requirement for Alternative Therapy|2|||
163177020|NCT03422627|589365121|FG003|Overall Study|Requirement for Alternative Therapy|0|||
163177021|NCT03422627|589365122|FG004|Overall Study|Requirement for Alternative Therapy|0|||
163177022|NCT03422627|589365118|FG000|Overall Study|Disease Progression|1|||
163177023|NCT03422627|589365119|FG001|Overall Study|Disease Progression|0|||
163177024|NCT03422627|589365120|FG002|Overall Study|Disease Progression|1|||
163177025|NCT03422627|589365121|FG003|Overall Study|Disease Progression|2|||
163177026|NCT03422627|589365122|FG004|Overall Study|Disease Progression|0|||
163177027|NCT03422627|589365118|FG000|Overall Study|Adverse Event|2|||
163177028|NCT03422627|589365119|FG001|Overall Study|Adverse Event|1|||
163177029|NCT03422627|589365120|FG002|Overall Study|Adverse Event|0|||
163177030|NCT03422627|589365121|FG003|Overall Study|Adverse Event|0|||
162825911|NCT04179734|588075249|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
162825912|NCT04179734|588075248|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
162825913|NCT04179734|588075249|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
162825914|NCT00937937|588075250|FG000|Overall Study|Adverse Event|6|||
162825915|NCT00937937|588075250|FG000|Overall Study|Withdrawal by Subject|2|||
162825916|NCT00937937|588075250|FG000|Overall Study|Progression/relapse|61|||
162825917|NCT00937937|588075250|FG000|Overall Study|Death|1|||
162825918|NCT00937937|588075250|FG000|Overall Study|Other|2|||
162825919|NCT00054704|588075252|FG000|Overall Study|Lack of Efficacy|2|||
162825920|NCT00054704|588075253|FG001|Overall Study|Lack of Efficacy|3|||
162825921|NCT00054704|588075252|FG000|Overall Study|Adverse Event|3|||
162825922|NCT00054704|588075253|FG001|Overall Study|Adverse Event|1|||
163177031|NCT03422627|589365122|FG004|Overall Study|Adverse Event|2|||
163177032|NCT03422627|589365118|FG000|Overall Study|Ineligibility Determined|0|||
163177033|NCT03422627|589365119|FG001|Overall Study|Ineligibility Determined|1|||
163177034|NCT03422627|589365120|FG002|Overall Study|Ineligibility Determined|0|||
163177035|NCT03422627|589365121|FG003|Overall Study|Ineligibility Determined|0|||
163177036|NCT03422627|589365122|FG004|Overall Study|Ineligibility Determined|0|||
163177037|NCT03422627|589365118|FG000|Overall Study|Death|0|||
163177038|NCT03422627|589365119|FG001|Overall Study|Death|1|||
163177039|NCT03422627|589365120|FG002|Overall Study|Death|1|||
162825923|NCT00054704|588075252|FG000|Overall Study|Lost to Follow-up|0|||
162933048|NCT01165242|588460077|FG002|Overall Study|Withdrawal by Subject|2|||
162933049|NCT01165242|588460075|FG000|Overall Study|Extended Holiday|0|||
162933050|NCT01165242|588460076|FG001|Overall Study|Extended Holiday|0|||
162933051|NCT01165242|588460077|FG002|Overall Study|Extended Holiday|1|||
162933052|NCT01165242|588460075|FG000|Overall Study|Lost to Follow-up|9|||
162933053|NCT01165242|588460076|FG001|Overall Study|Lost to Follow-up|7|||
162933054|NCT01165242|588460077|FG002|Overall Study|Lost to Follow-up|10|||
162933055|NCT03372083|588460078|FG000|Overall Study|Adverse Event|3|||
162933056|NCT03372083|588460078|FG000|Overall Study|Physician Decision|1|||
162933057|NCT03372083|588460078|FG000|Overall Study|Withdrawal by Subject|1|||
162933058|NCT01690520|588460079|FG000|Overall Study|Death|25|||
162933059|NCT01690520|588460080|FG001|Overall Study|Death|21|||
162933060|NCT01690520|588460079|FG000|Overall Study|Lost to Follow-up|2|||
162933061|NCT01690520|588460080|FG001|Overall Study|Lost to Follow-up|3|||
162933062|NCT01690520|588460079|FG000|Overall Study|Withdrawal by Subject|2|||
162933063|NCT01690520|588460080|FG001|Overall Study|Withdrawal by Subject|0|||
162933064|NCT01690520|588460079|FG000|Overall Study|Relapse|0|||
162933065|NCT01690520|588460080|FG001|Overall Study|Relapse|1|||
162933066|NCT01690520|588460079|FG000|Overall Study|Other|0|||
162933067|NCT01690520|588460080|FG001|Overall Study|Other|1|||
162933068|NCT01690520|588460079|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
162933069|NCT01690520|588460080|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
162933070|NCT02544633|588460083|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
162933071|NCT02544633|588460084|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
162933072|NCT02544633|588460085|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
162933073|NCT02544633|588460086|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
162933074|NCT02544633|588460083|FG000|Treatment Period|Adverse Event|7|||
162933075|NCT02544633|588460084|FG001|Treatment Period|Adverse Event|4|||
162933076|NCT02544633|588460085|FG002|Treatment Period|Adverse Event|0|||
162933077|NCT02544633|588460086|FG003|Treatment Period|Adverse Event|5|||
162933078|NCT02544633|588460083|FG000|Treatment Period|Lack of Efficacy|17|||
162933079|NCT02544633|588460084|FG001|Treatment Period|Lack of Efficacy|11|||
162933080|NCT02544633|588460085|FG002|Treatment Period|Lack of Efficacy|5|||
162933081|NCT02544633|588460086|FG003|Treatment Period|Lack of Efficacy|5|||
162933082|NCT02544633|588460083|FG000|Treatment Period|Global Deterioration of Health|3|||
163177040|NCT03422627|589365121|FG003|Overall Study|Death|0|||
163177041|NCT03422627|589365122|FG004|Overall Study|Death|0|||
163177042|NCT03422627|589365118|FG000|Overall Study|Withdrawal by Subject|0|||
163177043|NCT03422627|589365119|FG001|Overall Study|Withdrawal by Subject|0|||
163177044|NCT03422627|589365120|FG002|Overall Study|Withdrawal by Subject|0|||
163177045|NCT03422627|589365121|FG003|Overall Study|Withdrawal by Subject|1|||
163177046|NCT03422627|589365122|FG004|Overall Study|Withdrawal by Subject|0|||
163177047|NCT04251156|589365123|FG000|Overall Study|Lost to Follow-up|1|||
163177048|NCT04251156|589365124|FG001|Overall Study|Lost to Follow-up|1|||
163177049|NCT04251156|589365123|FG000|Overall Study|Withdrawal by Subject|4|||
163177050|NCT04251156|589365124|FG001|Overall Study|Withdrawal by Subject|4|||
163177051|NCT03675321|589365125|FG000|Overall Study|Lack of Efficacy|2|||
163177052|NCT03675321|589365126|FG001|Overall Study|Lack of Efficacy|2|||
163177053|NCT03675321|589365125|FG000|Overall Study|Withdrawal by Subject|1|||
163177054|NCT03675321|589365126|FG001|Overall Study|Withdrawal by Subject|3|||
163177055|NCT00934648|589365132|FG000|Overall Study|Failure to return|8|||
163177056|NCT00934648|589365132|FG000|Overall Study|Withdrawal by Subject|1|||
163177057|NCT01479985|589365135|FG000|Overall Study|Tablet malfunction, no data saved|1|||
163177058|NCT01479985|589365136|FG001|Overall Study|Tablet malfunction, no data saved|1|||
163177059|NCT01479985|589365135|FG000|Overall Study|No decisional conflict scale responses|0|||
163177060|NCT01479985|589365136|FG001|Overall Study|No decisional conflict scale responses|2|||
163177061|NCT01479985|589365135|FG000|Overall Study|No post-visit survey|5|||
163177062|NCT01479985|589365136|FG001|Overall Study|No post-visit survey|3|||
163177063|NCT00708201|589365137|FG000|Overall Study|Adverse Event|4|||
163177064|NCT00708201|589365138|FG001|Overall Study|Adverse Event|4|||
163177065|NCT00708201|589365137|FG000|Overall Study|Withdrawal by Subject|1|||
163177066|NCT00708201|589365138|FG001|Overall Study|Withdrawal by Subject|1|||
163177067|NCT00708201|589365137|FG000|Overall Study|Lost to Follow-up|2|||
163177068|NCT00708201|589365138|FG001|Overall Study|Lost to Follow-up|0|||
163177069|NCT00708201|589365137|FG000|Overall Study|Protocol Violation|0|||
163177070|NCT00708201|589365138|FG001|Overall Study|Protocol Violation|1|||
163177071|NCT01933789|589365141|FG000|Overall Study|Death|0|||
163177072|NCT01933789|589365142|FG001|Overall Study|Death|0|||
163177073|NCT01933789|589365143|FG002|Overall Study|Death|0|||
162933083|NCT02544633|588460084|FG001|Treatment Period|Global Deterioration of Health|3|||
162933084|NCT02544633|588460085|FG002|Treatment Period|Global Deterioration of Health|0|||
162933085|NCT02544633|588460086|FG003|Treatment Period|Global Deterioration of Health|1|||
162933086|NCT02544633|588460083|FG000|Treatment Period|Withdrawal by Subject|1|||
163177074|NCT01933789|589365144|FG003|Overall Study|Death|0|||
163177075|NCT01933789|589365145|FG004|Overall Study|Death|21|||
163177076|NCT01933789|589365146|FG005|Overall Study|Death|32|||
163177077|NCT01933789|589365147|FG006|Overall Study|Death|0|||
162933087|NCT02544633|588460084|FG001|Treatment Period|Withdrawal by Subject|0|||
162825924|NCT00054704|588075253|FG001|Overall Study|Lost to Follow-up|1|||
162825925|NCT00362414|588075254|FG000|Overall Study|Death|2|||
162825926|NCT00362414|588075254|FG000|Overall Study|Adverse Event|1|||
162825927|NCT00915772|588075264|FG000|Overall Study|Adverse Event|12|||
162825928|NCT00915772|588075265|FG001|Overall Study|Adverse Event|13|||
162825929|NCT00915772|588075266|FG002|Overall Study|Adverse Event|11|||
162825930|NCT00915772|588075264|FG000|Overall Study|Protocol Violation|4|||
162825931|NCT00915772|588075265|FG001|Overall Study|Protocol Violation|1|||
162825932|NCT00915772|588075266|FG002|Overall Study|Protocol Violation|2|||
162825933|NCT00915772|588075264|FG000|Overall Study|Lost to Follow-up|1|||
162825934|NCT00915772|588075265|FG001|Overall Study|Lost to Follow-up|2|||
162825935|NCT00915772|588075266|FG002|Overall Study|Lost to Follow-up|2|||
162825936|NCT00915772|588075264|FG000|Overall Study|Lack of Efficacy|9|||
162825937|NCT00915772|588075265|FG001|Overall Study|Lack of Efficacy|15|||
162825938|NCT00915772|588075266|FG002|Overall Study|Lack of Efficacy|3|||
162825939|NCT00915772|588075264|FG000|Overall Study|Refused to continue trial medication|6|||
162825940|NCT00915772|588075265|FG001|Overall Study|Refused to continue trial medication|8|||
162825941|NCT00915772|588075266|FG002|Overall Study|Refused to continue trial medication|4|||
162825942|NCT00915772|588075264|FG000|Overall Study|Any other reason|4|||
162825943|NCT00915772|588075265|FG001|Overall Study|Any other reason|7|||
162825944|NCT00915772|588075266|FG002|Overall Study|Any other reason|7|||
162825945|NCT01365039|588075267|FG000|Overall Study|Study related symptoms and complaints|1|||
162825946|NCT01365039|588075268|FG001|Overall Study|Study related symptoms and complaints|0|||
162825947|NCT01911442|588075275|FG000|Overall Study|Adverse Event|2|||
162933088|NCT02544633|588460085|FG002|Treatment Period|Withdrawal by Subject|0|||
162933089|NCT02544633|588460086|FG003|Treatment Period|Withdrawal by Subject|0|||
162933090|NCT02544633|588460083|FG000|Treatment Period|Lost to Follow-up|0|||
162933091|NCT02544633|588460084|FG001|Treatment Period|Lost to Follow-up|1|||
162933092|NCT02544633|588460085|FG002|Treatment Period|Lost to Follow-up|0|||
162933093|NCT02544633|588460086|FG003|Treatment Period|Lost to Follow-up|0|||
163177078|NCT01933789|589365148|FG007|Overall Study|Death|0|||
163177079|NCT01933789|589365149|FG008|Overall Study|Death|0|||
163177080|NCT01933789|589365141|FG000|Overall Study|Lost to Follow-up|0|||
163177081|NCT01933789|589365142|FG001|Overall Study|Lost to Follow-up|0|||
163177082|NCT01933789|589365143|FG002|Overall Study|Lost to Follow-up|0|||
163177083|NCT01933789|589365144|FG003|Overall Study|Lost to Follow-up|1|||
163177084|NCT01933789|589365145|FG004|Overall Study|Lost to Follow-up|8|||
163177085|NCT01933789|589365146|FG005|Overall Study|Lost to Follow-up|9|||
163177086|NCT01933789|589365147|FG006|Overall Study|Lost to Follow-up|1|||
163177087|NCT01933789|589365148|FG007|Overall Study|Lost to Follow-up|4|||
163177088|NCT01933789|589365149|FG008|Overall Study|Lost to Follow-up|0|||
163177089|NCT01933789|589365141|FG000|Overall Study|Withdrawal by Subject|2|||
163177090|NCT01933789|589365142|FG001|Overall Study|Withdrawal by Subject|1|||
163177091|NCT01933789|589365143|FG002|Overall Study|Withdrawal by Subject|0|||
163177092|NCT01933789|589365144|FG003|Overall Study|Withdrawal by Subject|0|||
163177093|NCT01933789|589365145|FG004|Overall Study|Withdrawal by Subject|17|||
163177094|NCT01933789|589365146|FG005|Overall Study|Withdrawal by Subject|16|||
163177095|NCT01933789|589365147|FG006|Overall Study|Withdrawal by Subject|1|||
163177096|NCT01933789|589365148|FG007|Overall Study|Withdrawal by Subject|4|||
163177097|NCT01933789|589365149|FG008|Overall Study|Withdrawal by Subject|0|||
163177098|NCT01933789|589365141|FG000|Overall Study|Became Ineligible|4|||
163177099|NCT01933789|589365142|FG001|Overall Study|Became Ineligible|0|||
163177100|NCT01933789|589365143|FG002|Overall Study|Became Ineligible|0|||
163177101|NCT01933789|589365144|FG003|Overall Study|Became Ineligible|0|||
163177102|NCT01933789|589365145|FG004|Overall Study|Became Ineligible|13|||
163177103|NCT01933789|589365146|FG005|Overall Study|Became Ineligible|10|||
163177104|NCT01933789|589365147|FG006|Overall Study|Became Ineligible|13|||
163177105|NCT01933789|589365148|FG007|Overall Study|Became Ineligible|6|||
163177106|NCT01933789|589365149|FG008|Overall Study|Became Ineligible|0|||
163177107|NCT03562767|589365154|FG000|Overall Study|Physician Decision|2|||
163177108|NCT03562767|589365155|FG001|Overall Study|Physician Decision|0|||
163177109|NCT03562767|589365156|FG002|Overall Study|Physician Decision|0|||
163177110|NCT03562767|589365154|FG000|Overall Study|Logistic Reason|1|||
163177111|NCT03562767|589365155|FG001|Overall Study|Logistic Reason|3|||
163177112|NCT03562767|589365156|FG002|Overall Study|Logistic Reason|0|||
163177113|NCT02518464|589365159|FG000|Overall Study|Adverse Event|2|||
163177114|NCT03761797|589365160|FG000|Overall Study|Changing hospital|11|||
163177115|NCT03761797|589365160|FG000|Overall Study|Improvement/remission|6|||
163177116|NCT03761797|589365160|FG000|Overall Study|Withdrawal by Subject|19|||
163177117|NCT03761797|589365160|FG000|Overall Study|Lost to Follow-up|33|||
163177118|NCT03761797|589365160|FG000|Overall Study|Adverse Event|37|||
163177119|NCT03761797|589365160|FG000|Overall Study|Case report form (CRF) not collected|5|||
163177120|NCT03761797|589365160|FG000|Overall Study|No patient visit after entry|13|||
163177121|NCT03761797|589365160|FG000|Overall Study|Switch to other diabetes medication|10|||
163177122|NCT03761797|589365160|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
163177123|NCT03761797|589365160|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
163177124|NCT03761797|589365160|FG000|Overall Study|Insufficient effectives|2|||
163177125|NCT03761797|589365160|FG000|Overall Study|Excessive alcohol intake|1|||
163177126|NCT00266877|589365161|FG000|Overall Study|Death|1|||
163177127|NCT00266877|589365162|FG001|Overall Study|Death|1|||
163177128|NCT00266877|589365163|FG002|Overall Study|Death|1|||
163177129|NCT00266877|589365161|FG000|Overall Study|Adverse Event|6|||
163177130|NCT00266877|589365162|FG001|Overall Study|Adverse Event|4|||
163177131|NCT00266877|589365163|FG002|Overall Study|Adverse Event|1|||
163177132|NCT00266877|589365161|FG000|Overall Study|Physician Decision|2|||
163177133|NCT00266877|589365162|FG001|Overall Study|Physician Decision|1|||
163177134|NCT00266877|589365163|FG002|Overall Study|Physician Decision|1|||
163177135|NCT00266877|589365161|FG000|Overall Study|Withdrawal by Subject|3|||
163177136|NCT00266877|589365162|FG001|Overall Study|Withdrawal by Subject|1|||
163177137|NCT00266877|589365163|FG002|Overall Study|Withdrawal by Subject|1|||
163177138|NCT00266877|589365161|FG000|Overall Study|Disease Progression|72|||
163177139|NCT00266877|589365162|FG001|Overall Study|Disease Progression|37|||
163177140|NCT00266877|589365163|FG002|Overall Study|Disease Progression|23|||
163177141|NCT00266877|589365161|FG000|Overall Study|Symptomatic Deterioration|6|||
163177142|NCT00266877|589365162|FG001|Overall Study|Symptomatic Deterioration|3|||
163177143|NCT00266877|589365163|FG002|Overall Study|Symptomatic Deterioration|1|||
162933094|NCT02544633|588460083|FG000|Treatment Period|Death|0|||
162933095|NCT02544633|588460084|FG001|Treatment Period|Death|0|||
163177144|NCT00266877|589365161|FG000|Overall Study|Hospitalization|1|||
162933096|NCT02544633|588460085|FG002|Treatment Period|Death|1|||
163177145|NCT00266877|589365162|FG001|Overall Study|Hospitalization|0|||
163177146|NCT00266877|589365163|FG002|Overall Study|Hospitalization|0|||
163177147|NCT00266877|589365161|FG000|Overall Study|Concomitant Radiotherapy|0|||
163177148|NCT00266877|589365162|FG001|Overall Study|Concomitant Radiotherapy|1|||
163177149|NCT00266877|589365163|FG002|Overall Study|Concomitant Radiotherapy|0|||
163177150|NCT01150474|589365167|FG000|Overall Study|Withdrawal by Subject|5|||
163177151|NCT01150474|589365168|FG001|Overall Study|Withdrawal by Subject|2|||
163177152|NCT01150474|589365167|FG000|Overall Study|Cancer found|1|||
163177153|NCT01150474|589365168|FG001|Overall Study|Cancer found|0|||
163177154|NCT01150474|589365167|FG000|Overall Study|Multiple Studies|0|||
163177155|NCT01150474|589365168|FG001|Overall Study|Multiple Studies|1|||
163177156|NCT01150474|589365167|FG000|Overall Study|Rectotomy|1|||
163177157|NCT01150474|589365168|FG001|Overall Study|Rectotomy|0|||
163177158|NCT01150474|589365167|FG000|Overall Study|Drug did not arrive in time|1|||
163177159|NCT01150474|589365168|FG001|Overall Study|Drug did not arrive in time|0|||
163177160|NCT01150474|589365167|FG000|Overall Study|Drug not administered|1|||
163177161|NCT01150474|589365168|FG001|Overall Study|Drug not administered|0|||
163177162|NCT01150474|589365167|FG000|Overall Study|Surgery Changed|1|||
163177163|NCT01150474|589365168|FG001|Overall Study|Surgery Changed|0|||
163177164|NCT04231981|589365169|FG000|Overall Study|Adverse Event|1|||
163177165|NCT04231981|589365169|FG000|Overall Study|Death|16|||
163177166|NCT04231981|589365169|FG000|Overall Study|Lost to Follow-up|1|||
163177167|NCT02581943|589365170|FG000|Overall Study|Death|5|||
163177168|NCT02581943|589365171|FG001|Overall Study|Death|2|||
163177169|NCT02581943|589365170|FG000|Overall Study|Disease Progression|12|||
163177170|NCT02581943|589365171|FG001|Overall Study|Disease Progression|15|||
163177171|NCT02581943|589365170|FG000|Overall Study|Withdrawal by Subject|1|||
163177172|NCT02581943|589365171|FG001|Overall Study|Withdrawal by Subject|2|||
163177173|NCT01470989|589365172|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
163177174|NCT01470989|589365173|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
163177175|NCT01470989|589365172|FG000|Overall Study|Adverse Event|2|||
163177176|NCT01470989|589365173|FG001|Overall Study|Adverse Event|5|||
163177177|NCT01470989|589365172|FG000|Overall Study|Abnormal laboratory value|1|||
163177178|NCT01470989|589365173|FG001|Overall Study|Abnormal laboratory value|1|||
163177179|NCT01470989|589365172|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163177180|NCT01470989|589365173|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163177181|NCT01470989|589365172|FG000|Overall Study|Withdrawal by Subject|19|||
163177182|NCT01470989|589365173|FG001|Overall Study|Withdrawal by Subject|17|||
163177183|NCT01470989|589365172|FG000|Overall Study|Lost to Follow-up|18|||
163177184|NCT01470989|589365173|FG001|Overall Study|Lost to Follow-up|13|||
163177185|NCT01470989|589365172|FG000|Overall Study|Administrative problems|2|||
163177186|NCT01470989|589365173|FG001|Overall Study|Administrative problems|4|||
163177187|NCT01470989|589365172|FG000|Overall Study|Death|2|||
163177188|NCT01470989|589365173|FG001|Overall Study|Death|2|||
163177189|NCT01470989|589365172|FG000|Overall Study|Protocol deviation|1|||
163177190|NCT01470989|589365173|FG001|Overall Study|Protocol deviation|2|||
163177191|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
163177192|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
163177193|NCT01233687|589365174|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
163177194|NCT02197234|589365177|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
163177195|NCT02197234|589365177|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
163177196|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
163177197|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
163177198|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
163177199|NCT02197234|589365177|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
163177200|NCT03783702|589365178|FG000|Overall Study|Lost to Follow-up|6|||
163177201|NCT03783702|589365179|FG001|Overall Study|Lost to Follow-up|8|||
163177202|NCT03783702|589365178|FG000|Overall Study|Protocol Violation|1|||
163177203|NCT03783702|589365179|FG001|Overall Study|Protocol Violation|3|||
163177204|NCT02119676|589365180|FG000|Overall Study|Adverse Event|9|||
163177205|NCT02119676|589365181|FG001|Overall Study|Adverse Event|17|||
163177206|NCT02119676|589365182|FG002|Overall Study|Adverse Event|10|||
163177207|NCT02119676|589365183|FG003|Overall Study|Adverse Event|10|||
163177208|NCT02119676|589365180|FG000|Overall Study|Disease progression|53|||
163177209|NCT02119676|589365181|FG001|Overall Study|Disease progression|55|||
163177210|NCT02119676|589365182|FG002|Overall Study|Disease progression|68|||
163177211|NCT02119676|589365183|FG003|Overall Study|Disease progression|73|||
163177212|NCT02119676|589365180|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
163177213|NCT02119676|589365181|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
163177214|NCT02119676|589365182|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
163177215|NCT02119676|589365183|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
163177216|NCT02119676|589365180|FG000|Overall Study|Physician Decision|4|||
163177217|NCT02119676|589365181|FG001|Overall Study|Physician Decision|2|||
163177218|NCT02119676|589365182|FG002|Overall Study|Physician Decision|3|||
163177219|NCT02119676|589365183|FG003|Overall Study|Physician Decision|2|||
163177220|NCT02119676|589365180|FG000|Overall Study|Death|9|||
163177221|NCT02119676|589365181|FG001|Overall Study|Death|3|||
162933097|NCT02544633|588460086|FG003|Treatment Period|Death|0|||
162933098|NCT02544633|588460083|FG000|Treatment Period|Non-compliance|0|||
162933099|NCT02544633|588460084|FG001|Treatment Period|Non-compliance|0|||
162933100|NCT02544633|588460085|FG002|Treatment Period|Non-compliance|1|||
162933101|NCT02544633|588460086|FG003|Treatment Period|Non-compliance|0|||
162933102|NCT02544633|588460083|FG000|Treatment Period|Clinical Disease Progression|0|||
162933103|NCT02544633|588460084|FG001|Treatment Period|Clinical Disease Progression|0|||
162933104|NCT02544633|588460085|FG002|Treatment Period|Clinical Disease Progression|0|||
162933105|NCT02544633|588460086|FG003|Treatment Period|Clinical Disease Progression|1|||
162933106|NCT02544633|588460083|FG000|Survival Follow-up Period|Death|12|||
162933107|NCT02544633|588460084|FG001|Survival Follow-up Period|Death|14|||
162933108|NCT02544633|588460085|FG002|Survival Follow-up Period|Death|3|||
162933109|NCT02544633|588460086|FG003|Survival Follow-up Period|Death|9|||
162933110|NCT02544633|588460083|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
162933111|NCT02544633|588460084|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
162933112|NCT02544633|588460085|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
162933113|NCT02544633|588460086|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
162933114|NCT02544633|588460083|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
162933115|NCT02544633|588460084|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
162933116|NCT02544633|588460085|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
162933117|NCT02544633|588460086|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
162933118|NCT02544633|588460083|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
162933119|NCT02544633|588460084|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
162933120|NCT02544633|588460085|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
162933121|NCT02544633|588460086|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
162933122|NCT02092961|588460087|FG000|Overall Study|Not reported|1|||
162933123|NCT02092961|588460088|FG001|Overall Study|Not reported|0|||
162933124|NCT02092961|588460089|FG002|Overall Study|Not reported|1|||
162933125|NCT02092961|588460087|FG000|Overall Study|Study stopped|13|||
162933126|NCT02092961|588460088|FG001|Overall Study|Study stopped|9|||
162933127|NCT02092961|588460089|FG002|Overall Study|Study stopped|12|||
162698478|NCT02743793|587605510|FG000|Overall Study|Death|1|||
162933128|NCT02092961|588460087|FG000|Overall Study|Lack of therapeutic response|2|||
163177222|NCT02119676|589365182|FG002|Overall Study|Death|2|||
163177223|NCT02119676|589365183|FG003|Overall Study|Death|1|||
163177224|NCT02119676|589365180|FG000|Overall Study|Noncompliance|0|||
163177225|NCT02119676|589365181|FG001|Overall Study|Noncompliance|1|||
163177226|NCT02119676|589365182|FG002|Overall Study|Noncompliance|0|||
163177227|NCT02119676|589365183|FG003|Overall Study|Noncompliance|0|||
163177228|NCT02119676|589365180|FG000|Overall Study|Lost to Follow-up|0|||
163177229|NCT02119676|589365181|FG001|Overall Study|Lost to Follow-up|0|||
163177230|NCT02119676|589365182|FG002|Overall Study|Lost to Follow-up|1|||
163177231|NCT02119676|589365183|FG003|Overall Study|Lost to Follow-up|0|||
163177232|NCT02119676|589365180|FG000|Overall Study|Protocol deviation|0|||
163177233|NCT02119676|589365181|FG001|Overall Study|Protocol deviation|0|||
163177234|NCT02119676|589365182|FG002|Overall Study|Protocol deviation|1|||
163177235|NCT02119676|589365183|FG003|Overall Study|Protocol deviation|0|||
163177236|NCT02119676|589365180|FG000|Overall Study|Other, unspecified|2|||
163177237|NCT02119676|589365181|FG001|Overall Study|Other, unspecified|1|||
163177238|NCT02119676|589365182|FG002|Overall Study|Other, unspecified|3|||
163177239|NCT02119676|589365183|FG003|Overall Study|Other, unspecified|4|||
163177240|NCT02119676|589365180|FG000|Overall Study|Did not receive study med|2|||
163177241|NCT02119676|589365181|FG001|Overall Study|Did not receive study med|2|||
163177242|NCT02119676|589365182|FG002|Overall Study|Did not receive study med|4|||
163177243|NCT02119676|589365183|FG003|Overall Study|Did not receive study med|5|||
163177244|NCT00219544|589365184|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
163177245|NCT00219544|589365185|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
163177246|NCT00219544|589365184|FG000|Single Blind Treatment Period|Adverse Event|9|||
163177247|NCT00219544|589365185|FG001|Single Blind Treatment Period|Adverse Event|0|||
163177248|NCT00219544|589365184|FG000|Single Blind Treatment Period|Protocol Violation|4|||
163177249|NCT00219544|589365185|FG001|Single Blind Treatment Period|Protocol Violation|0|||
163177250|NCT00219544|589365184|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
163177251|NCT00219544|589365185|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
163177252|NCT00219544|589365184|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
163177253|NCT00219544|589365185|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
163177254|NCT00219544|589365184|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
163177255|NCT00219544|589365185|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
163177256|NCT00989573|589365186|FG000|Overall Study|Adverse Event|8|||
163177257|NCT00989573|589365187|FG001|Overall Study|Adverse Event|12|||
163177258|NCT00989573|589365188|FG002|Overall Study|Adverse Event|4|||
163177259|NCT00989573|589365186|FG000|Overall Study|Physician Decision|0|||
163177260|NCT00989573|589365187|FG001|Overall Study|Physician Decision|2|||
163177261|NCT00989573|589365188|FG002|Overall Study|Physician Decision|0|||
163177262|NCT00989573|589365186|FG000|Overall Study|Protocol Violation|1|||
163177263|NCT00989573|589365187|FG001|Overall Study|Protocol Violation|1|||
163177264|NCT00989573|589365188|FG002|Overall Study|Protocol Violation|1|||
163177265|NCT00989573|589365186|FG000|Overall Study|Withdrawal by Subject|4|||
163177266|NCT00989573|589365187|FG001|Overall Study|Withdrawal by Subject|7|||
163177267|NCT00989573|589365188|FG002|Overall Study|Withdrawal by Subject|3|||
163177268|NCT03473548|589365190|FG000|Overall Study|Did not attempt HST testing|3|||
163177269|NCT03473548|589365191|FG001|Overall Study|Did not attempt HST testing|0|||
163177270|NCT02207946|589365198|FG000|Overall Study|Lost to Follow-up|1|||
163177271|NCT02207946|589365199|FG001|Overall Study|Lost to Follow-up|0|||
163177272|NCT02207946|589365198|FG000|Overall Study|Adverse Event|0|||
163177273|NCT02207946|589365199|FG001|Overall Study|Adverse Event|1|||
163177274|NCT02829944|589365200|FG000|Overall Study|Physician Decision|0|||
163177275|NCT02829944|589365201|FG001|Overall Study|Physician Decision|1|||
163177276|NCT02829944|589365200|FG000|Overall Study|Screen Failure|2|||
163177277|NCT02829944|589365201|FG001|Overall Study|Screen Failure|2|||
163177278|NCT02829944|589365200|FG000|Overall Study|Inadequate Neuraxial Block|1|||
163177279|NCT02829944|589365201|FG001|Overall Study|Inadequate Neuraxial Block|1|||
163177280|NCT02829944|589365200|FG000|Overall Study|Withdrawal by Subject|2|||
163177281|NCT02829944|589365201|FG001|Overall Study|Withdrawal by Subject|1|||
163177282|NCT02829944|589365200|FG000|Overall Study|Catheter Displacement|1|||
163177283|NCT02829944|589365201|FG001|Overall Study|Catheter Displacement|0|||
163177284|NCT02829944|589365200|FG000|Overall Study|Catheter broke|0|||
163177285|NCT02829944|589365201|FG001|Overall Study|Catheter broke|1|||
163177286|NCT02829944|589365200|FG000|Overall Study|Staff unavailable|0|||
163177287|NCT02829944|589365201|FG001|Overall Study|Staff unavailable|1|||
163177288|NCT05856760|589365202|FG000|Overall Study|Adverse Event|2|||
163177289|NCT05856760|589365202|FG000|Overall Study|Physician Decision|1|||
163177290|NCT05856760|589365202|FG000|Overall Study|Protocol Violation|1|||
163177291|NCT05856760|589365202|FG000|Overall Study|Withdrawal by Subject|3|||
163177292|NCT04675151|589365203|FG000|Overall Study|Protocol Violation|1|||
163177293|NCT04675151|589365204|FG001|Overall Study|Protocol Violation|0|||
163177294|NCT04675151|589365205|FG002|Overall Study|Protocol Violation|0|||
163177295|NCT04675151|589365206|FG003|Overall Study|Protocol Violation|1|||
163177296|NCT04035486|589365207|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
163177297|NCT04035486|589365208|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
163177298|NCT04035486|589365209|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
163177299|NCT04035486|589365210|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
163177300|NCT04035486|589365207|FG000|Overall Study|Death|6|||
163177301|NCT04035486|589365208|FG001|Overall Study|Death|3|||
163177302|NCT04035486|589365209|FG002|Overall Study|Death|70|||
163177303|NCT04035486|589365210|FG003|Overall Study|Death|77|||
163177304|NCT04035486|589365207|FG000|Overall Study|Screen Failure|0|||
163177305|NCT04035486|589365208|FG001|Overall Study|Screen Failure|0|||
163177306|NCT04035486|589365209|FG002|Overall Study|Screen Failure|1|||
163177307|NCT04035486|589365210|FG003|Overall Study|Screen Failure|1|||
163177308|NCT04035486|589365207|FG000|Overall Study|Withdrawal by Subject|1|||
163177309|NCT04035486|589365208|FG001|Overall Study|Withdrawal by Subject|1|||
163177310|NCT04035486|589365209|FG002|Overall Study|Withdrawal by Subject|11|||
163177311|NCT04035486|589365210|FG003|Overall Study|Withdrawal by Subject|9|||
163177312|NCT01730937|589365211|FG000|Overall Study|Protocol Violation|5|||
163177313|NCT01730937|589365212|FG001|Overall Study|Protocol Violation|11|||
163177314|NCT03947684|589365213|FG000|Overall Study|Lost to Follow-up|13|||
163177315|NCT03947684|589365214|FG001|Overall Study|Lost to Follow-up|5|||
163177316|NCT03947684|589365215|FG002|Overall Study|Lost to Follow-up|1|||
163177317|NCT03947684|589365213|FG000|Overall Study|Withdrawal by Subject|11|||
163177318|NCT03947684|589365214|FG001|Overall Study|Withdrawal by Subject|4|||
163177319|NCT03947684|589365215|FG002|Overall Study|Withdrawal by Subject|0|||
163177320|NCT03947684|589365213|FG000|Overall Study|Physician Decision|1|||
163177321|NCT03947684|589365214|FG001|Overall Study|Physician Decision|0|||
163177322|NCT03947684|589365215|FG002|Overall Study|Physician Decision|0|||
163177323|NCT03947684|589365213|FG000|Overall Study|Lack of adherence to study protocol|2|||
163177324|NCT03947684|589365214|FG001|Overall Study|Lack of adherence to study protocol|0|||
163177325|NCT03947684|589365215|FG002|Overall Study|Lack of adherence to study protocol|0|||
163177326|NCT01395784|589365217|FG000|Overall Study|Lost to Follow-up|7|||
163177327|NCT01395784|589365217|FG000|Overall Study|Withdrawal by Subject|3|||
163177328|NCT01395784|589365217|FG000|Overall Study|Physician Decision|5|||
163177329|NCT05772702|589365218|FG000|Overall Study|Adverse Event|1|||
163177330|NCT01107418|589366539|FG000|Overall Study|Disease Progression|45|||
163177331|NCT01107418|589366539|FG000|Overall Study|Adverse Event|3|||
163177332|NCT01107418|589366539|FG000|Overall Study|Withdrawal by Subject|1|||
163177333|NCT01107418|589366539|FG000|Overall Study|Study Closing|1|||
163177334|NCT01107418|589366539|FG000|Overall Study|Started Other Therapy|1|||
163177335|NCT01107418|589366539|FG000|Overall Study|Entered Extension Study|1|||
163177336|NCT05710185|589366540|FG000|Overall Study|Adverse Event|1|||
163177337|NCT05710185|589366540|FG000|Overall Study|Lack of Efficacy|1|||
163177338|NCT03269552|589366541|FG000|Overall Study|Adverse Event|2|||
163177339|NCT01343823|589366542|FG000|Overall Study|Study Terminated|1|||
163177340|NCT01343823|589366543|FG001|Overall Study|Study Terminated|0|||
163177341|NCT01343823|589366544|FG002|Overall Study|Study Terminated|0|||
163177342|NCT01343823|589366545|FG003|Overall Study|Study Terminated|1|||
163177343|NCT01343823|589366542|FG000|Overall Study|Withdrawal by Subject|1|||
163177344|NCT01343823|589366543|FG001|Overall Study|Withdrawal by Subject|0|||
163177345|NCT01343823|589366544|FG002|Overall Study|Withdrawal by Subject|0|||
163177346|NCT01343823|589366545|FG003|Overall Study|Withdrawal by Subject|0|||
163177347|NCT03468543|589366548|FG000|Overall Study|Protocol stopping rules met|3|||
163177348|NCT04972630|589366549|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
163177349|NCT04972630|589366550|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
163177350|NCT04972630|589366551|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
163177351|NCT04214288|589366554|FG000|Overall Study|Ongoing in the study|41|||
162825948|NCT01911442|588075276|FG001|Overall Study|Adverse Event|2|||
163177352|NCT04214288|589366555|FG001|Overall Study|Ongoing in the study|51|||
163177353|NCT04214288|589366556|FG002|Overall Study|Ongoing in the study|12|||
163177354|NCT04214288|589366557|FG003|Overall Study|Ongoing in the study|39|||
163177355|NCT04214288|589366554|FG000|Overall Study|Adverse Event|1|||
163177356|NCT04214288|589366555|FG001|Overall Study|Adverse Event|0|||
163177357|NCT04214288|589366556|FG002|Overall Study|Adverse Event|0|||
163177358|NCT04214288|589366557|FG003|Overall Study|Adverse Event|0|||
163177359|NCT04214288|589366554|FG000|Overall Study|Death|22|||
163177360|NCT04214288|589366555|FG001|Overall Study|Death|13|||
163177361|NCT04214288|589366556|FG002|Overall Study|Death|7|||
163177362|NCT04214288|589366557|FG003|Overall Study|Death|19|||
163177363|NCT04214288|589366554|FG000|Overall Study|Lost to Follow-up|1|||
163177364|NCT04214288|589366555|FG001|Overall Study|Lost to Follow-up|2|||
162933129|NCT02092961|588460088|FG001|Overall Study|Lack of therapeutic response|1|||
162933130|NCT02092961|588460089|FG002|Overall Study|Lack of therapeutic response|3|||
162933131|NCT02092961|588460087|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
162933132|NCT02092961|588460088|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
162933133|NCT02092961|588460089|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
162933134|NCT02092961|588460087|FG000|Overall Study|Adverse Event|2|||
162933135|NCT02092961|588460088|FG001|Overall Study|Adverse Event|4|||
163177365|NCT04214288|589366556|FG002|Overall Study|Lost to Follow-up|1|||
163177366|NCT04214288|589366557|FG003|Overall Study|Lost to Follow-up|0|||
163177367|NCT04214288|589366554|FG000|Overall Study|Other|1|||
163177368|NCT04214288|589366555|FG001|Overall Study|Other|2|||
163177369|NCT04214288|589366556|FG002|Overall Study|Other|0|||
163177370|NCT04214288|589366557|FG003|Overall Study|Other|6|||
163177371|NCT04214288|589366554|FG000|Overall Study|Protocol Violation|0|||
163177372|NCT04214288|589366555|FG001|Overall Study|Protocol Violation|1|||
163177373|NCT04214288|589366556|FG002|Overall Study|Protocol Violation|0|||
163177374|NCT04214288|589366557|FG003|Overall Study|Protocol Violation|0|||
163177375|NCT04214288|589366554|FG000|Overall Study|Withdrawal by Subject|8|||
163177376|NCT04214288|589366555|FG001|Overall Study|Withdrawal by Subject|4|||
163177377|NCT04214288|589366556|FG002|Overall Study|Withdrawal by Subject|0|||
163177378|NCT04214288|589366557|FG003|Overall Study|Withdrawal by Subject|9|||
163177379|NCT02455557|589366559|FG000|Overall Study|Withdrawal by Subject|2|||
163177380|NCT02278341|589366560|FG000|Overall Study|Randomized but never received study drug|1|||
163177381|NCT02278341|589366561|FG001|Overall Study|Randomized but never received study drug|1|||
163177382|NCT02278341|589366560|FG000|Overall Study|Adverse Event|3|||
163177383|NCT02278341|589366561|FG001|Overall Study|Adverse Event|0|||
163177384|NCT02278341|589366560|FG000|Overall Study|Death|68|||
163177385|NCT02278341|589366561|FG001|Overall Study|Death|56|||
163177386|NCT02278341|589366560|FG000|Overall Study|Withdrawal by Subject|30|||
163177387|NCT02278341|589366561|FG001|Overall Study|Withdrawal by Subject|19|||
163177388|NCT02278341|589366560|FG000|Overall Study|Lost to Follow-up|0|||
163177389|NCT02278341|589366561|FG001|Overall Study|Lost to Follow-up|1|||
163177390|NCT02278341|589366560|FG000|Overall Study|Physician Decision|1|||
163177391|NCT02278341|589366561|FG001|Overall Study|Physician Decision|1|||
163177392|NCT02278341|589366560|FG000|Overall Study|Miscellaneous|15|||
163177393|NCT02278341|589366561|FG001|Overall Study|Miscellaneous|14|||
163177394|NCT01129024|589366562|FG000|Overall Study|Physician Decision|5|||
163177395|NCT01129024|589366562|FG000|Overall Study|Study Terminated by Sponsor|8|||
163177396|NCT01129024|589366562|FG000|Overall Study|Withdrawal by Subject|2|||
163177397|NCT01129024|589366562|FG000|Overall Study|Lack of Efficacy|3|||
163177398|NCT01129024|589366562|FG000|Overall Study|Needed a Platelet Transfusion|1|||
163177399|NCT02361580|589366564|FG000|Overall Study|Lost to Follow-up|6|||
163177400|NCT02361580|589366565|FG001|Overall Study|Lost to Follow-up|3|||
163177401|NCT02047318|589366566|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
163177402|NCT02047318|589366566|FG000|Core Study Period|Adverse Event|1|||
163177403|NCT02047318|589366566|FG000|Core Study Period|Withdrawal by caregiver|3|||
163177404|NCT02047318|589366566|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
163177405|NCT01487577|589366567|FG000|Overall Study|Became ineligible after signing consent|1|||
163177406|NCT00761748|589366568|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
163177407|NCT00761748|589366569|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
163177408|NCT00761748|589366568|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
163177409|NCT00761748|589366569|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
163177410|NCT02554279|589366570|FG000|Overall Study|Adverse Event|2|||
163177411|NCT02554279|589366571|FG001|Overall Study|Adverse Event|5|||
163177412|NCT02554279|589366570|FG000|Overall Study|Lost to Follow-up|3|||
163177413|NCT02554279|589366571|FG001|Overall Study|Lost to Follow-up|2|||
163177414|NCT02554279|589366570|FG000|Overall Study|Withdrawal by Subject|6|||
163177415|NCT02554279|589366571|FG001|Overall Study|Withdrawal by Subject|4|||
163177416|NCT02554279|589366570|FG000|Overall Study|Protocol Violation|2|||
163177417|NCT02554279|589366571|FG001|Overall Study|Protocol Violation|1|||
163177418|NCT02554279|589366570|FG000|Overall Study|Other reason|19|||
163177419|NCT02554279|589366571|FG001|Overall Study|Other reason|6|||
163177420|NCT00812487|589366572|FG000|Overall Study|Lost to Follow-up|2|||
163177421|NCT00812487|589366573|FG001|Overall Study|Lost to Follow-up|0|||
163177422|NCT00812487|589366572|FG000|Overall Study|Withdrawal by Subject|3|||
163177423|NCT00812487|589366573|FG001|Overall Study|Withdrawal by Subject|2|||
163177424|NCT00812487|589366572|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
163177425|NCT00812487|589366573|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
163177426|NCT00812487|589366572|FG000|Overall Study|Protocol Violation|0|||
163177427|NCT00812487|589366573|FG001|Overall Study|Protocol Violation|1|||
163177428|NCT00998764|589366574|FG000|Overall Study|Lack of Efficacy|3|||
163177429|NCT00998764|589366575|FG001|Overall Study|Lack of Efficacy|6|||
163177430|NCT00998764|589366574|FG000|Overall Study|Adverse Event|17|||
163177431|NCT00998764|589366575|FG001|Overall Study|Adverse Event|12|||
162933136|NCT02092961|588460089|FG002|Overall Study|Adverse Event|0|||
163177432|NCT00998764|589366574|FG000|Overall Study|Withdrawal by Subject|19|||
163177433|NCT00998764|589366575|FG001|Overall Study|Withdrawal by Subject|25|||
163177434|NCT00998764|589366574|FG000|Overall Study|Physician Decision|3|||
163177435|NCT00998764|589366575|FG001|Overall Study|Physician Decision|3|||
163177436|NCT00998764|589366574|FG000|Overall Study|Death|3|||
163177437|NCT00998764|589366575|FG001|Overall Study|Death|1|||
163177438|NCT00998764|589366574|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
163177439|NCT00998764|589366575|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
163177440|NCT00998764|589366574|FG000|Overall Study|Protocol Violation|0|||
163177441|NCT00998764|589366575|FG001|Overall Study|Protocol Violation|1|||
163177442|NCT00998764|589366574|FG000|Overall Study|Failed to Return|1|||
163177443|NCT00998764|589366575|FG001|Overall Study|Failed to Return|1|||
163177444|NCT00998764|589366574|FG000|Overall Study|Lost to Follow-up|1|||
163177445|NCT00998764|589366575|FG001|Overall Study|Lost to Follow-up|1|||
163177446|NCT00998764|589366574|FG000|Overall Study|Loss of Caregiver|0|||
163177447|NCT00998764|589366575|FG001|Overall Study|Loss of Caregiver|3|||
163177448|NCT00998764|589366574|FG000|Overall Study|Other|4|||
163177449|NCT00998764|589366575|FG001|Overall Study|Other|4|||
163177450|NCT00998764|589366574|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
163177451|NCT00998764|589366575|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
163177452|NCT04761627|589366578|FG000|Run-in Period|Death|1|||
163177453|NCT04761627|589366579|FG001|Run-in Period|Death|0|||
163177454|NCT04761627|589366580|FG002|Run-in Period|Death|0|||
163177455|NCT04761627|589366578|FG000|Run-in Period|Required alternative therapy|2|||
163177456|NCT04761627|589366579|FG001|Run-in Period|Required alternative therapy|0|||
163177457|NCT04761627|589366580|FG002|Run-in Period|Required alternative therapy|0|||
163177458|NCT04761627|589366578|FG000|Run-in Period|Lost to Follow-up|2|||
163177459|NCT04761627|589366579|FG001|Run-in Period|Lost to Follow-up|0|||
163177460|NCT04761627|589366580|FG002|Run-in Period|Lost to Follow-up|0|||
163177461|NCT04761627|589366578|FG000|Run-in Period|Protocol Violation|3|||
163177462|NCT04761627|589366579|FG001|Run-in Period|Protocol Violation|0|||
163177463|NCT04761627|589366580|FG002|Run-in Period|Protocol Violation|0|||
163177464|NCT04761627|589366578|FG000|Run-in Period|Abnormal liver function|1|||
163177465|NCT04761627|589366579|FG001|Run-in Period|Abnormal liver function|0|||
163177466|NCT04761627|589366580|FG002|Run-in Period|Abnormal liver function|0|||
163177467|NCT04761627|589366578|FG000|Run-in Period|Adverse Event|6|||
163177468|NCT04761627|589366579|FG001|Run-in Period|Adverse Event|0|||
163177469|NCT04761627|589366580|FG002|Run-in Period|Adverse Event|0|||
163177470|NCT04761627|589366578|FG000|Run-in Period|Withdrawal by Subject|7|||
163177471|NCT04761627|589366579|FG001|Run-in Period|Withdrawal by Subject|0|||
163177472|NCT04761627|589366580|FG002|Run-in Period|Withdrawal by Subject|0|||
163177473|NCT04761627|589366578|FG000|Run-in Period|Did not meet PASI 50|15|||
163177474|NCT04761627|589366579|FG001|Run-in Period|Did not meet PASI 50|0|||
163177475|NCT04761627|589366580|FG002|Run-in Period|Did not meet PASI 50|0|||
163177476|NCT04761627|589366578|FG000|Run-in Period|Study site closure|2|||
163177477|NCT04761627|589366579|FG001|Run-in Period|Study site closure|0|||
163177478|NCT04761627|589366580|FG002|Run-in Period|Study site closure|0|||
163177479|NCT04761627|589366578|FG000|Run-in Period|Pregnancy|2|||
163177480|NCT04761627|589366579|FG001|Run-in Period|Pregnancy|0|||
163177481|NCT04761627|589366580|FG002|Run-in Period|Pregnancy|0|||
163177482|NCT04761627|589366578|FG000|Post-randomization Period|Military service|0|||
163177483|NCT04761627|589366579|FG001|Post-randomization Period|Military service|1|||
163177484|NCT04761627|589366580|FG002|Post-randomization Period|Military service|0|||
163177485|NCT04761627|589366578|FG000|Post-randomization Period|Adverse Event|0|||
163177486|NCT04761627|589366579|FG001|Post-randomization Period|Adverse Event|4|||
163177487|NCT04761627|589366580|FG002|Post-randomization Period|Adverse Event|2|||
163177488|NCT04761627|589366578|FG000|Post-randomization Period|Lost to Follow-up|0|||
163177489|NCT04761627|589366579|FG001|Post-randomization Period|Lost to Follow-up|6|||
163177490|NCT04761627|589366580|FG002|Post-randomization Period|Lost to Follow-up|6|||
163177491|NCT04761627|589366578|FG000|Post-randomization Period|Withdrawal by Subject|0|||
163177492|NCT04761627|589366579|FG001|Post-randomization Period|Withdrawal by Subject|7|||
163177493|NCT04761627|589366580|FG002|Post-randomization Period|Withdrawal by Subject|6|||
162933137|NCT01623830|588460092|FG000|Overall Study|Withdrawal by Subject|6|||
162933138|NCT01623830|588460093|FG001|Overall Study|Withdrawal by Subject|7|||
162933139|NCT01623830|588460092|FG000|Overall Study|Exclusion from Study|1|||
162933140|NCT01623830|588460093|FG001|Overall Study|Exclusion from Study|2|||
163177494|NCT04761627|589366578|FG000|Post-randomization Period|Pregnancy|0|||
163177495|NCT04761627|589366579|FG001|Post-randomization Period|Pregnancy|0|||
163177496|NCT04761627|589366580|FG002|Post-randomization Period|Pregnancy|1|||
163177497|NCT04761627|589366578|FG000|Post-randomization Period|Study site closure|0|||
163177498|NCT04761627|589366579|FG001|Post-randomization Period|Study site closure|0|||
163177499|NCT04761627|589366580|FG002|Post-randomization Period|Study site closure|1|||
163177500|NCT04761627|589366578|FG000|Post-randomization Period|Family planning|0|||
163177501|NCT04761627|589366579|FG001|Post-randomization Period|Family planning|1|||
163177502|NCT04761627|589366580|FG002|Post-randomization Period|Family planning|0|||
163177503|NCT01634178|589366581|FG000|Treatment Period 1|Adverse Event|0|||
163177504|NCT01634178|589366582|FG001|Treatment Period 1|Adverse Event|1|||
163177505|NCT01634178|589366581|FG000|Treatment Period 2|Adverse Event|1|||
163177506|NCT01634178|589366582|FG001|Treatment Period 2|Adverse Event|0|||
163177507|NCT01117792|589366583|FG000|Overall Study|Death|1|||
163177508|NCT01117792|589366583|FG000|Overall Study|Adverse Event|3|||
163177509|NCT05867342|589366584|FG000|Overall Study|Investigator Decision|3|||
163177510|NCT05867342|589366585|FG001|Overall Study|Investigator Decision|3|||
163177511|NCT00723203|589366586|FG000|Overall Study|Withdrawal by Subject|3|||
163177512|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
163177513|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
163177514|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
163177515|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
163177516|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
163177517|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
163177518|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
163177519|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
163177520|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
163177521|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
163177522|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
163177523|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
163177524|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
163177525|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
163177526|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
163177527|NCT00274924|589366587|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
163177528|NCT00274924|589366588|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
163177529|NCT00274924|589366589|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
163177530|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
163177531|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
163177532|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
163177533|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
163177534|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
163177535|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
163177536|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
163177537|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
163177538|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
163177539|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
163177540|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
163177541|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
163177542|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
163177543|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
163177544|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
163177545|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
163177546|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
163177547|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
163177548|NCT00274924|589366587|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
163177549|NCT00274924|589366588|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
163177550|NCT00274924|589366589|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
163177551|NCT01903525|589366592|FG000|Overall Study|Lost to Follow-up|5|||
163177552|NCT01903525|589366593|FG001|Overall Study|Lost to Follow-up|9|||
163177553|NCT01903525|589366592|FG000|Overall Study|Adverse Event|0|||
163177554|NCT01903525|589366593|FG001|Overall Study|Adverse Event|1|||
163177555|NCT04365257|589366594|FG000|Overall Study|Physician Decision|1|||
163177556|NCT04365257|589366595|FG001|Overall Study|Physician Decision|0|||
163177557|NCT04365257|589366594|FG000|Overall Study|Patient Noncompliance|1|||
162933141|NCT02468557|588460094|FG000|Overall Study|Adverse Event|1|||
163177558|NCT04365257|589366595|FG001|Overall Study|Patient Noncompliance|0|||
163177559|NCT04365257|589366594|FG000|Overall Study|Withdrawal by Subject|0|||
162933142|NCT02468557|588460094|FG000|Overall Study|Death|1|||
162933143|NCT02468557|588460094|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
162933144|NCT02468557|588460094|FG000|Overall Study|All Enrolled but Never Dosed|4|||
162933145|NCT01605461|588460095|FG000|Overall Study|Lost to Follow-up|3|||
162933146|NCT01605461|588460095|FG000|Overall Study|Withdrawal by Subject|1|||
162933147|NCT02024698|588460096|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
162933148|NCT02024698|588460097|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
162933149|NCT03322462|588460098|FG000|Overall Study|Technical difficulties|2|||
162933150|NCT03322462|588460098|FG000|Overall Study|Other|1|||
162933151|NCT00515073|588460099|FG000|Overall Study|Withdrawal by Subject|1|||
162933152|NCT00515073|588460099|FG000|Overall Study|Physician Decision|1|||
162933153|NCT02764489|588460100|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
162933154|NCT02764489|588460101|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
162933155|NCT02764489|588460100|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
162933156|NCT02764489|588460101|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
162933157|NCT02764489|588460100|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
162933158|NCT02764489|588460101|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
162933159|NCT02764489|588460100|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
162933160|NCT02764489|588460101|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
163177560|NCT04365257|589366595|FG001|Overall Study|Withdrawal by Subject|1|||
163177561|NCT02129777|589366600|FG000|Double-Blind Period|Adverse Event|0|||
163177562|NCT02129777|589366601|FG001|Double-Blind Period|Adverse Event|0|||
163177563|NCT02129777|589366602|FG002|Double-Blind Period|Adverse Event|0|||
163177564|NCT02129777|589366603|FG003|Double-Blind Period|Adverse Event|0|||
163177565|NCT02129777|589366604|FG004|Double-Blind Period|Adverse Event|1|||
163177566|NCT02129777|589366605|FG005|Double-Blind Period|Adverse Event|0|||
163177567|NCT02129777|589366606|FG006|Double-Blind Period|Adverse Event|0|||
163177568|NCT02129777|589366600|FG000|Double-Blind Period|Lost to Follow-up|1|||
163177569|NCT02129777|589366601|FG001|Double-Blind Period|Lost to Follow-up|1|||
163177570|NCT02129777|589366602|FG002|Double-Blind Period|Lost to Follow-up|1|||
163177571|NCT02129777|589366603|FG003|Double-Blind Period|Lost to Follow-up|2|||
163177572|NCT02129777|589366604|FG004|Double-Blind Period|Lost to Follow-up|0|||
163177573|NCT02129777|589366605|FG005|Double-Blind Period|Lost to Follow-up|0|||
163177574|NCT02129777|589366606|FG006|Double-Blind Period|Lost to Follow-up|0|||
163177575|NCT02129777|589366600|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163177576|NCT02129777|589366601|FG001|Double-Blind Period|Withdrawal by Subject|4|||
163177577|NCT02129777|589366602|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163177578|NCT02129777|589366603|FG003|Double-Blind Period|Withdrawal by Subject|2|||
163177579|NCT02129777|589366604|FG004|Double-Blind Period|Withdrawal by Subject|3|||
163177580|NCT02129777|589366605|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163177581|NCT02129777|589366606|FG006|Double-Blind Period|Withdrawal by Subject|0|||
163177582|NCT02129777|589366600|FG000|Double-Blind Period|Pregnancy|0|||
163177583|NCT02129777|589366601|FG001|Double-Blind Period|Pregnancy|0|||
163177584|NCT02129777|589366602|FG002|Double-Blind Period|Pregnancy|0|||
163177585|NCT02129777|589366603|FG003|Double-Blind Period|Pregnancy|0|||
163177586|NCT02129777|589366604|FG004|Double-Blind Period|Pregnancy|1|||
163177587|NCT02129777|589366605|FG005|Double-Blind Period|Pregnancy|0|||
163177588|NCT02129777|589366606|FG006|Double-Blind Period|Pregnancy|0|||
163177589|NCT02129777|589366600|FG000|Double-Blind Period|Lack of Efficacy|3|||
163177590|NCT02129777|589366601|FG001|Double-Blind Period|Lack of Efficacy|1|||
163177591|NCT02129777|589366602|FG002|Double-Blind Period|Lack of Efficacy|0|||
163177592|NCT02129777|589366603|FG003|Double-Blind Period|Lack of Efficacy|3|||
163177593|NCT02129777|589366604|FG004|Double-Blind Period|Lack of Efficacy|2|||
163177594|NCT02129777|589366605|FG005|Double-Blind Period|Lack of Efficacy|0|||
163177595|NCT02129777|589366606|FG006|Double-Blind Period|Lack of Efficacy|0|||
163177596|NCT02129777|589366600|FG000|Double-Blind Period|Other|1|||
163177597|NCT02129777|589366601|FG001|Double-Blind Period|Other|2|||
163177598|NCT02129777|589366602|FG002|Double-Blind Period|Other|0|||
163177599|NCT02129777|589366603|FG003|Double-Blind Period|Other|0|||
163177600|NCT02129777|589366604|FG004|Double-Blind Period|Other|0|||
163177601|NCT02129777|589366605|FG005|Double-Blind Period|Other|0|||
163177602|NCT02129777|589366606|FG006|Double-Blind Period|Other|0|||
163177603|NCT02129777|589366600|FG000|Open-Label Period|Lack of Efficacy|0|||
163177604|NCT02129777|589366601|FG001|Open-Label Period|Lack of Efficacy|0|||
163177605|NCT02129777|589366602|FG002|Open-Label Period|Lack of Efficacy|0|||
163177606|NCT02129777|589366603|FG003|Open-Label Period|Lack of Efficacy|0|||
162933161|NCT01625845|588460102|FG000|Overall Study|Adverse Event|1|||
162933162|NCT01625845|588460103|FG001|Overall Study|Adverse Event|2|||
162933163|NCT01625845|588460102|FG000|Overall Study|Lost to Follow-up|2|||
163177607|NCT02129777|589366604|FG004|Open-Label Period|Lack of Efficacy|0|||
163177608|NCT02129777|589366605|FG005|Open-Label Period|Lack of Efficacy|0|||
163177609|NCT02129777|589366606|FG006|Open-Label Period|Lack of Efficacy|5|||
163177610|NCT02129777|589366600|FG000|Open-Label Period|Lost to Follow-up|0|||
163177611|NCT02129777|589366601|FG001|Open-Label Period|Lost to Follow-up|0|||
163177612|NCT02129777|589366602|FG002|Open-Label Period|Lost to Follow-up|0|||
163177613|NCT02129777|589366603|FG003|Open-Label Period|Lost to Follow-up|0|||
163177614|NCT02129777|589366604|FG004|Open-Label Period|Lost to Follow-up|0|||
163177615|NCT02129777|589366605|FG005|Open-Label Period|Lost to Follow-up|1|||
163177616|NCT02129777|589366606|FG006|Open-Label Period|Lost to Follow-up|1|||
163177617|NCT02129777|589366600|FG000|Open-Label Period|Withdrawal by Subject|0|||
163177618|NCT02129777|589366601|FG001|Open-Label Period|Withdrawal by Subject|0|||
163177619|NCT02129777|589366602|FG002|Open-Label Period|Withdrawal by Subject|0|||
163177620|NCT02129777|589366603|FG003|Open-Label Period|Withdrawal by Subject|0|||
163177621|NCT02129777|589366604|FG004|Open-Label Period|Withdrawal by Subject|0|||
163177622|NCT02129777|589366605|FG005|Open-Label Period|Withdrawal by Subject|1|||
163177623|NCT02129777|589366606|FG006|Open-Label Period|Withdrawal by Subject|3|||
163177624|NCT02129777|589366600|FG000|Open-Label Period|Study Termination|0|||
163177625|NCT02129777|589366601|FG001|Open-Label Period|Study Termination|0|||
163177626|NCT02129777|589366602|FG002|Open-Label Period|Study Termination|0|||
163177627|NCT02129777|589366603|FG003|Open-Label Period|Study Termination|0|||
163177628|NCT02129777|589366604|FG004|Open-Label Period|Study Termination|0|||
163177629|NCT02129777|589366605|FG005|Open-Label Period|Study Termination|10|||
163177630|NCT02129777|589366606|FG006|Open-Label Period|Study Termination|39|||
163177631|NCT02915874|589366607|FG000|Overall Study|Lost to Follow-up|5|||
163177632|NCT02915874|589366608|FG001|Overall Study|Lost to Follow-up|4|||
163177633|NCT02915874|589366607|FG000|Overall Study|Withdrawal by Subject|1|||
163177634|NCT02915874|589366608|FG001|Overall Study|Withdrawal by Subject|1|||
163177635|NCT02915874|589366607|FG000|Overall Study|Started New Anxiety Medication|0|||
163177636|NCT02915874|589366608|FG001|Overall Study|Started New Anxiety Medication|1|||
163177637|NCT01609478|589366616|FG000|Overall Study|Adverse Event|3|||
163177638|NCT01609478|589366617|FG001|Overall Study|Adverse Event|1|||
163177639|NCT01609478|589366618|FG002|Overall Study|Adverse Event|5|||
163177640|NCT01609478|589366616|FG000|Overall Study|Protocol Deviation|0|||
163177641|NCT01609478|589366617|FG001|Overall Study|Protocol Deviation|1|||
163177642|NCT01609478|589366618|FG002|Overall Study|Protocol Deviation|1|||
163177643|NCT01609478|589366616|FG000|Overall Study|Non-Compliance with study treatment|1|||
163177644|NCT01609478|589366617|FG001|Overall Study|Non-Compliance with study treatment|0|||
163177645|NCT01609478|589366618|FG002|Overall Study|Non-Compliance with study treatment|0|||
163177646|NCT01609478|589366616|FG000|Overall Study|Physician Decision|1|||
163177647|NCT01609478|589366617|FG001|Overall Study|Physician Decision|0|||
163177648|NCT01609478|589366618|FG002|Overall Study|Physician Decision|1|||
163177649|NCT01609478|589366616|FG000|Overall Study|Withdrawal by Subject|2|||
163177650|NCT01609478|589366617|FG001|Overall Study|Withdrawal by Subject|0|||
163177651|NCT01609478|589366618|FG002|Overall Study|Withdrawal by Subject|2|||
163177652|NCT04973137|589366619|FG000|Double Blind Phase|Adverse Event|4|||
163177653|NCT04973137|589366620|FG001|Double Blind Phase|Adverse Event|0|||
163177654|NCT04973137|589366619|FG000|Double Blind Phase|Death|25|||
163177655|NCT04973137|589366620|FG001|Double Blind Phase|Death|15|||
163177656|NCT04973137|589366619|FG000|Double Blind Phase|Physician Decision|5|||
163177657|NCT04973137|589366620|FG001|Double Blind Phase|Physician Decision|1|||
163177658|NCT04973137|589366619|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163177659|NCT04973137|589366620|FG001|Double Blind Phase|Withdrawal by Subject|1|||
163177660|NCT04973137|589366619|FG000|Double Blind Phase|Other|2|||
163177661|NCT04973137|589366620|FG001|Double Blind Phase|Other|2|||
163177662|NCT04973137|589366619|FG000|Open Label Extension Phase|Death|3|||
163177663|NCT04973137|589366620|FG001|Open Label Extension Phase|Death|0|||
163177664|NCT04973137|589366619|FG000|Open Label Extension Phase|Physician Decision|0|||
163177665|NCT04973137|589366620|FG001|Open Label Extension Phase|Physician Decision|1|||
163177666|NCT04973137|589366619|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
163177667|NCT04973137|589366620|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163177668|NCT04973137|589366619|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
163177669|NCT04973137|589366620|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
163177670|NCT04973137|589366619|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
163177671|NCT04973137|589366620|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
163177672|NCT04391569|589366623|FG000|Overall Study|Death|15|||
163177673|NCT04391569|589366624|FG001|Overall Study|Death|10|||
163177674|NCT04391569|589366623|FG000|Overall Study|Withdrawal by Subject|1|||
163177675|NCT04391569|589366624|FG001|Overall Study|Withdrawal by Subject|0|||
163177676|NCT04391569|589366623|FG000|Overall Study|Lost to Follow-up|3|||
163177677|NCT04391569|589366624|FG001|Overall Study|Lost to Follow-up|2|||
163177678|NCT04391569|589366623|FG000|Overall Study|Lack of Efficacy|0|||
163177679|NCT04391569|589366624|FG001|Overall Study|Lack of Efficacy|1|||
163177680|NCT04391569|589366623|FG000|Overall Study|Participant discharged to hospice facility|0|||
163177681|NCT04391569|589366624|FG001|Overall Study|Participant discharged to hospice facility|1|||
163177682|NCT04391569|589366623|FG000|Overall Study|Participant family decision|1|||
163177683|NCT04391569|589366624|FG001|Overall Study|Participant family decision|0|||
163177684|NCT04391569|589366623|FG000|Overall Study|Participant discharged prematurely|1|||
163177685|NCT04391569|589366624|FG001|Overall Study|Participant discharged prematurely|0|||
163177686|NCT01903252|589366641|FG000|Double-Blind Induction|Adverse Event|20|||
163177687|NCT01903252|589366642|FG001|Double-Blind Induction|Adverse Event|18|||
163177688|NCT01903252|589366643|FG002|Double-Blind Induction|Adverse Event|0|||
162933164|NCT01625845|588460103|FG001|Overall Study|Lost to Follow-up|1|||
162933165|NCT01625845|588460102|FG000|Overall Study|Withdrawal by Subject|2|||
162933166|NCT01625845|588460103|FG001|Overall Study|Withdrawal by Subject|0|||
162933167|NCT01294592|588460104|FG000|Overall Study|Adverse Event|28|||
162933168|NCT01294592|588460105|FG001|Overall Study|Adverse Event|13|||
162933169|NCT01294592|588460104|FG000|Overall Study|Lack of Efficacy|7|||
162933170|NCT01294592|588460105|FG001|Overall Study|Lack of Efficacy|5|||
162933171|NCT01294592|588460104|FG000|Overall Study|Protocol Violation|1|||
162933172|NCT01294592|588460105|FG001|Overall Study|Protocol Violation|7|||
162933173|NCT01294592|588460104|FG000|Overall Study|Lost to Follow-up|7|||
162933174|NCT01294592|588460105|FG001|Overall Study|Lost to Follow-up|9|||
162933175|NCT01294592|588460104|FG000|Overall Study|Physician Decision|6|||
162933176|NCT01294592|588460105|FG001|Overall Study|Physician Decision|11|||
162933177|NCT01294592|588460104|FG000|Overall Study|Withdrawal by Subject|28|||
162933178|NCT01294592|588460105|FG001|Overall Study|Withdrawal by Subject|28|||
162933179|NCT02853929|588460106|FG000|Overall Study|Lost to Follow-up|3|||
162933180|NCT02853929|588460107|FG001|Overall Study|Lost to Follow-up|0|||
162933181|NCT02853929|588460106|FG000|Overall Study|Withdrawal by Subject|1|||
162933182|NCT02853929|588460107|FG001|Overall Study|Withdrawal by Subject|0|||
162933183|NCT02853929|588460106|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
162933184|NCT02853929|588460107|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
162933185|NCT00623623|588460108|FG000|Overall Study|Previous enrolment into this study|1|||
162933186|NCT00623623|588460109|FG001|Overall Study|Previous enrolment into this study|1|||
162933187|NCT00693784|588460110|FG000|Overall Study|Lost to Follow-up|2|||
162933188|NCT00693784|588460110|FG000|Overall Study|Withdrawal by Subject|2|||
162933189|NCT02265952|588460111|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
162933190|NCT02265952|588460112|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
162933191|NCT02265952|588460111|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
162933192|NCT02265952|588460112|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
162933193|NCT00326885|588460115|FG000|Overall Study|Adverse Event|1|||
162933194|NCT00326885|588460115|FG000|Overall Study|Withdrawal by Subject|3|||
162933195|NCT00326885|588460115|FG000|Overall Study|Physician Decision|1|||
162933196|NCT00326885|588460115|FG000|Overall Study|Hospice withdrew consent|2|||
162933197|NCT00738673|588460127|FG000|Overall Study|Adverse Event|1|||
162933198|NCT00738673|588460128|FG001|Overall Study|Adverse Event|0|||
162933199|NCT00738673|588460127|FG000|Overall Study|Lack of Efficacy|19|||
162933200|NCT00738673|588460128|FG001|Overall Study|Lack of Efficacy|8|||
162933201|NCT00738673|588460127|FG000|Overall Study|Protocol Violation|1|||
162933202|NCT00738673|588460128|FG001|Overall Study|Protocol Violation|2|||
162933203|NCT00738673|588460127|FG000|Overall Study|Withdrawal by Subject|3|||
163177689|NCT01903252|589366644|FG003|Double-Blind Induction|Adverse Event|0|||
163177690|NCT01903252|589366645|FG004|Double-Blind Induction|Adverse Event|0|||
163177691|NCT01903252|589366646|FG005|Double-Blind Induction|Adverse Event|0|||
163177692|NCT01903252|589366641|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
163177693|NCT01903252|589366642|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
163177694|NCT01903252|589366643|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
163177695|NCT01903252|589366644|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
163177696|NCT01903252|589366645|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
163177697|NCT01903252|589366646|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
163177698|NCT01903252|589366641|FG000|Double-Blind Induction|Physician Decision|2|||
163177699|NCT01903252|589366642|FG001|Double-Blind Induction|Physician Decision|3|||
163177700|NCT01903252|589366643|FG002|Double-Blind Induction|Physician Decision|0|||
163177701|NCT01903252|589366644|FG003|Double-Blind Induction|Physician Decision|0|||
163177702|NCT01903252|589366645|FG004|Double-Blind Induction|Physician Decision|0|||
163177703|NCT01903252|589366646|FG005|Double-Blind Induction|Physician Decision|0|||
163177704|NCT01903252|589366641|FG000|Double-Blind Induction|non-compliance,|7|||
163177705|NCT01903252|589366642|FG001|Double-Blind Induction|non-compliance,|7|||
163177706|NCT01903252|589366643|FG002|Double-Blind Induction|non-compliance,|0|||
163177707|NCT01903252|589366644|FG003|Double-Blind Induction|non-compliance,|0|||
162933204|NCT00738673|588460128|FG001|Overall Study|Withdrawal by Subject|1|||
162933205|NCT02736227|588460129|FG000|Overall Study|Withdrawal by Subject|0|||
162933206|NCT02736227|588460130|FG001|Overall Study|Withdrawal by Subject|0|||
162933207|NCT02736227|588460131|FG002|Overall Study|Withdrawal by Subject|1|||
162933208|NCT02736227|588460129|FG000|Overall Study|Physician Decision|0|||
162933209|NCT02736227|588460130|FG001|Overall Study|Physician Decision|0|||
162933210|NCT02736227|588460131|FG002|Overall Study|Physician Decision|5|||
162933211|NCT02736227|588460129|FG000|Overall Study|Non Compliant|0|||
162933212|NCT02736227|588460130|FG001|Overall Study|Non Compliant|0|||
162933213|NCT02736227|588460131|FG002|Overall Study|Non Compliant|2|||
162933214|NCT01205529|588460132|FG000|Overall Study|Procedure Cancelled|4|||
162933215|NCT01205529|588460132|FG000|Overall Study|Withdrawal by Subject|2|||
162933216|NCT01205529|588460132|FG000|Overall Study|Physician Decision|4|||
162933217|NCT01205529|588460132|FG000|Overall Study|Unstable post op|15|||
163177708|NCT01903252|589366645|FG004|Double-Blind Induction|non-compliance,|0|||
163177709|NCT01903252|589366646|FG005|Double-Blind Induction|non-compliance,|0|||
163177710|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Adverse Event|0|||
163177711|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Adverse Event|0|||
163177712|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Adverse Event|17|||
163177713|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Adverse Event|0|||
163177714|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Adverse Event|0|||
163177715|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Adverse Event|0|||
163177716|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177717|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177718|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
163177719|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177720|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177721|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
163177722|NCT01903252|589366641|FG000|Extended Induction, Open-Label|Physician Decision|0|||
163177723|NCT01903252|589366642|FG001|Extended Induction, Open-Label|Physician Decision|0|||
163177724|NCT01903252|589366643|FG002|Extended Induction, Open-Label|Physician Decision|1|||
163177725|NCT01903252|589366644|FG003|Extended Induction, Open-Label|Physician Decision|0|||
163177726|NCT01903252|589366645|FG004|Extended Induction, Open-Label|Physician Decision|0|||
163177727|NCT01903252|589366646|FG005|Extended Induction, Open-Label|Physician Decision|0|||
163177728|NCT01903252|589366641|FG000|Maintenance, Open-Label|Adverse Event|0|||
163177729|NCT01903252|589366642|FG001|Maintenance, Open-Label|Adverse Event|0|||
163177730|NCT01903252|589366643|FG002|Maintenance, Open-Label|Adverse Event|0|||
163177731|NCT01903252|589366644|FG003|Maintenance, Open-Label|Adverse Event|3|||
163177732|NCT01903252|589366645|FG004|Maintenance, Open-Label|Adverse Event|9|||
163177733|NCT01903252|589366646|FG005|Maintenance, Open-Label|Adverse Event|14|||
163177734|NCT01903252|589366641|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177735|NCT01903252|589366642|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177736|NCT01903252|589366643|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
163177737|NCT01903252|589366644|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
163177738|NCT01903252|589366645|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
163177739|NCT01903252|589366646|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
163177740|NCT01903252|589366641|FG000|Maintenance, Open-Label|Other|0|||
163177741|NCT01903252|589366642|FG001|Maintenance, Open-Label|Other|0|||
163177742|NCT01903252|589366643|FG002|Maintenance, Open-Label|Other|0|||
163177743|NCT01903252|589366644|FG003|Maintenance, Open-Label|Other|2|||
163177744|NCT01903252|589366645|FG004|Maintenance, Open-Label|Other|6|||
163177745|NCT01903252|589366646|FG005|Maintenance, Open-Label|Other|2|||
163177746|NCT00645788|589366658|FG000|Overall Study|Did not receive study drug|1|||
163177747|NCT00645788|589366659|FG001|Overall Study|Did not receive study drug|1|||
163177748|NCT00645788|589366660|FG002|Overall Study|Did not receive study drug|0|||
163177749|NCT00645788|589366661|FG003|Overall Study|Did not receive study drug|0|||
163177750|NCT00645788|589366658|FG000|Overall Study|Adverse Event|4|||
163177751|NCT00645788|589366659|FG001|Overall Study|Adverse Event|9|||
163177752|NCT00645788|589366660|FG002|Overall Study|Adverse Event|5|||
163177753|NCT00645788|589366661|FG003|Overall Study|Adverse Event|3|||
163177754|NCT00645788|589366658|FG000|Overall Study|Lost to Follow-up|1|||
163177755|NCT00645788|589366659|FG001|Overall Study|Lost to Follow-up|0|||
163177756|NCT00645788|589366660|FG002|Overall Study|Lost to Follow-up|0|||
163177757|NCT00645788|589366661|FG003|Overall Study|Lost to Follow-up|0|||
163177758|NCT00645788|589366658|FG000|Overall Study|Protocol Violation|1|||
162825949|NCT01911442|588075277|FG002|Overall Study|Adverse Event|4|||
162825950|NCT01911442|588075275|FG000|Overall Study|Lack of Efficacy|1|||
162825951|NCT01911442|588075276|FG001|Overall Study|Lack of Efficacy|1|||
162825952|NCT01911442|588075277|FG002|Overall Study|Lack of Efficacy|1|||
162825953|NCT01911442|588075275|FG000|Overall Study|Lost to Follow-up|2|||
162825954|NCT01911442|588075276|FG001|Overall Study|Lost to Follow-up|0|||
162825955|NCT01911442|588075277|FG002|Overall Study|Lost to Follow-up|1|||
162825956|NCT01911442|588075275|FG000|Overall Study|Withdrawal by Subject|1|||
162825957|NCT01911442|588075276|FG001|Overall Study|Withdrawal by Subject|0|||
162825958|NCT01911442|588075277|FG002|Overall Study|Withdrawal by Subject|6|||
162825959|NCT01911442|588075275|FG000|Overall Study|Mother's Work Schedule|0|||
162825960|NCT01911442|588075276|FG001|Overall Study|Mother's Work Schedule|1|||
162825961|NCT01911442|588075277|FG002|Overall Study|Mother's Work Schedule|0|||
162825962|NCT00714285|588075285|FG000|Overall Study|Lost to Follow-up|0|||
162825963|NCT00714285|588075286|FG001|Overall Study|Lost to Follow-up|2|||
163177759|NCT00645788|589366659|FG001|Overall Study|Protocol Violation|0|||
163177760|NCT00645788|589366660|FG002|Overall Study|Protocol Violation|2|||
163177761|NCT00645788|589366661|FG003|Overall Study|Protocol Violation|0|||
163177762|NCT00645788|589366658|FG000|Overall Study|Withdrawal by Subject|0|||
163177763|NCT00645788|589366659|FG001|Overall Study|Withdrawal by Subject|1|||
163177764|NCT00645788|589366660|FG002|Overall Study|Withdrawal by Subject|0|||
163177765|NCT00645788|589366661|FG003|Overall Study|Withdrawal by Subject|2|||
163177766|NCT00645788|589366658|FG000|Overall Study|Pulmonary exacerbation|13|||
162825964|NCT00714285|588075287|FG002|Overall Study|Lost to Follow-up|0|||
162825965|NCT00714285|588075288|FG003|Overall Study|Lost to Follow-up|1|||
162825966|NCT00714285|588075285|FG000|Overall Study|Migrated/moved from study area|0|||
162933218|NCT01205529|588460132|FG000|Overall Study|No longer met criteria|30|||
162933219|NCT03840135|588460135|FG000|Overall Study|Protocol Violation|6|||
162933220|NCT03840135|588460136|FG001|Overall Study|Protocol Violation|1|||
162933221|NCT03840135|588460135|FG000|Overall Study|Withdrawal by Subject|1|||
162933222|NCT03840135|588460136|FG001|Overall Study|Withdrawal by Subject|0|||
162933223|NCT04133519|588460137|FG000|Overall Study|Withdrawal by Subject|5|||
162933224|NCT04133519|588460138|FG001|Overall Study|Withdrawal by Subject|4|||
162825967|NCT00714285|588075286|FG001|Overall Study|Migrated/moved from study area|1|||
162825968|NCT00714285|588075287|FG002|Overall Study|Migrated/moved from study area|0|||
163177767|NCT00645788|589366659|FG001|Overall Study|Pulmonary exacerbation|16|||
163177768|NCT00645788|589366660|FG002|Overall Study|Pulmonary exacerbation|11|||
163177769|NCT00645788|589366661|FG003|Overall Study|Pulmonary exacerbation|9|||
163177770|NCT01924429|589366662|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
163177771|NCT01924429|589366663|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
163177772|NCT01445886|589366666|FG000|Overall Study|Lost to Follow-up|2|||
163177773|NCT01445886|589366666|FG000|Overall Study|Protocol Violation|3|||
163177774|NCT04268823|589366672|FG000|Overall Study|Adverse Event|1|||
163177775|NCT04268823|589366673|FG001|Overall Study|Adverse Event|0|||
163177776|NCT04268823|589366672|FG000|Overall Study|Participant Decision|1|||
163177777|NCT04268823|589366673|FG001|Overall Study|Participant Decision|0|||
163177778|NCT05313009|589368051|FG000|Overall Study|Death|1|||
163177779|NCT05313009|589368052|FG001|Overall Study|Death|0|||
163177780|NCT02186301|589368053|FG000|Overall Study|Progressive Disease|7|||
163177781|NCT02186301|589368054|FG001|Overall Study|Progressive Disease|22|||
163177782|NCT02186301|589368055|FG002|Overall Study|Progressive Disease|27|||
163177783|NCT02186301|589368053|FG000|Overall Study|Adverse Event|5|||
163177784|NCT02186301|589368054|FG001|Overall Study|Adverse Event|5|||
163177785|NCT02186301|589368055|FG002|Overall Study|Adverse Event|5|||
163177786|NCT02186301|589368053|FG000|Overall Study|Death|1|||
163177787|NCT02186301|589368054|FG001|Overall Study|Death|0|||
163177788|NCT02186301|589368055|FG002|Overall Study|Death|0|||
163177789|NCT02186301|589368053|FG000|Overall Study|Withdrawal by Subject|5|||
163177790|NCT02186301|589368054|FG001|Overall Study|Withdrawal by Subject|1|||
163177791|NCT02186301|589368055|FG002|Overall Study|Withdrawal by Subject|3|||
163177792|NCT02186301|589368053|FG000|Overall Study|Physician Decision|1|||
163177793|NCT02186301|589368054|FG001|Overall Study|Physician Decision|0|||
163177794|NCT02186301|589368055|FG002|Overall Study|Physician Decision|1|||
163177795|NCT02186301|589368053|FG000|Overall Study|Study Terminated by Sponsor|1|||
163177796|NCT02186301|589368054|FG001|Overall Study|Study Terminated by Sponsor|0|||
163177797|NCT02186301|589368055|FG002|Overall Study|Study Terminated by Sponsor|11|||
163177798|NCT02186301|589368053|FG000|Overall Study|Protocol Deviation|0|||
163177799|NCT02186301|589368054|FG001|Overall Study|Protocol Deviation|2|||
163177800|NCT02186301|589368055|FG002|Overall Study|Protocol Deviation|0|||
163177801|NCT02186301|589368053|FG000|Overall Study|Missing|0|||
163177802|NCT02186301|589368054|FG001|Overall Study|Missing|0|||
163177803|NCT02186301|589368055|FG002|Overall Study|Missing|2|||
163177804|NCT02186301|589368053|FG000|Overall Study|Other|0|||
163177805|NCT02186301|589368054|FG001|Overall Study|Other|0|||
163177806|NCT02186301|589368055|FG002|Overall Study|Other|1|||
163177807|NCT00749580|589368056|FG000|Overall Study|Lost to Follow-up|4|||
163177808|NCT00749580|589368057|FG001|Overall Study|Lost to Follow-up|8|||
163177809|NCT00749580|589368056|FG000|Overall Study|Adverse Event|0|||
163177810|NCT00749580|589368057|FG001|Overall Study|Adverse Event|1|||
163177811|NCT05128929|589368058|FG000|Overall Study|Adverse Event|0|||
163177812|NCT05128929|589368059|FG001|Overall Study|Adverse Event|1|||
163177813|NCT03553836|589368060|FG000|Overall Study|Ongoing in Study|460|||
163177814|NCT03553836|589368061|FG001|Overall Study|Ongoing in Study|459|||
163177815|NCT03553836|589368060|FG000|Overall Study|Withdrawal by Subject|9|||
163177816|NCT03553836|589368061|FG001|Overall Study|Withdrawal by Subject|10|||
163177817|NCT03553836|589368060|FG000|Overall Study|Lost to Follow-up|1|||
163177818|NCT03553836|589368061|FG001|Overall Study|Lost to Follow-up|3|||
163177819|NCT03553836|589368060|FG000|Overall Study|Death|17|||
163177820|NCT03553836|589368061|FG001|Overall Study|Death|17|||
163177821|NCT00807027|589368062|FG000|Overall Study|Withdrawal by Subject|13|||
163177822|NCT00807027|589368063|FG001|Overall Study|Withdrawal by Subject|14|||
163177823|NCT00807027|589368062|FG000|Overall Study|Protocol Violation|1|||
163177824|NCT00807027|589368063|FG001|Overall Study|Protocol Violation|1|||
163177825|NCT00807027|589368062|FG000|Overall Study|Adverse Event|2|||
163177826|NCT00807027|589368063|FG001|Overall Study|Adverse Event|2|||
163177827|NCT05660850|589368064|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
163177828|NCT05660850|589368065|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
163177829|NCT05660850|589368066|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
163177830|NCT05660850|589368067|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
163177831|NCT02604017|589368068|FG000|Overall Study|Withdrew Consent|0|||
163177832|NCT02604017|589368069|FG001|Overall Study|Withdrew Consent|2|||
163177833|NCT02604017|589368068|FG000|Overall Study|Lost to Follow-up|5|||
163177834|NCT02604017|589368069|FG001|Overall Study|Lost to Follow-up|6|||
163177835|NCT02604017|589368068|FG000|Overall Study|Other|1|||
163177836|NCT02604017|589368069|FG001|Overall Study|Other|0|||
163177837|NCT01653782|589368075|FG000|Overall Study|Withdrawal by Subject|9|||
162825969|NCT00714285|588075288|FG003|Overall Study|Migrated/moved from study area|0|||
163177838|NCT01653782|589368076|FG001|Overall Study|Withdrawal by Subject|15|||
163177839|NCT01653782|589368077|FG002|Overall Study|Withdrawal by Subject|4|||
162933225|NCT04133519|588460137|FG000|Overall Study|Protocol Violation|0|||
162933226|NCT04133519|588460138|FG001|Overall Study|Protocol Violation|1|||
162933227|NCT04133519|588460137|FG000|Overall Study|Never started treatment|1|||
162933228|NCT04133519|588460138|FG001|Overall Study|Never started treatment|1|||
162933229|NCT00323609|588460139|FG000|Overall Study|Death|16|||
162933230|NCT00323609|588460140|FG001|Overall Study|Death|21|||
162933231|NCT00323609|588460141|FG002|Overall Study|Death|0|||
162933232|NCT00323609|588460142|FG003|Overall Study|Death|0|||
162933233|NCT00323609|588460139|FG000|Overall Study|Lost to Follow-up|9|||
162933234|NCT00323609|588460140|FG001|Overall Study|Lost to Follow-up|10|||
162933235|NCT00323609|588460141|FG002|Overall Study|Lost to Follow-up|0|||
162933236|NCT00323609|588460142|FG003|Overall Study|Lost to Follow-up|0|||
162933237|NCT00323609|588460139|FG000|Overall Study|Physician Decision|2|||
162933238|NCT00323609|588460140|FG001|Overall Study|Physician Decision|0|||
162933239|NCT00323609|588460141|FG002|Overall Study|Physician Decision|0|||
162933240|NCT00323609|588460142|FG003|Overall Study|Physician Decision|1|||
162933241|NCT00323609|588460139|FG000|Overall Study|Withdrawal by Subject|11|||
162933242|NCT00323609|588460140|FG001|Overall Study|Withdrawal by Subject|23|||
162933243|NCT00323609|588460141|FG002|Overall Study|Withdrawal by Subject|4|||
162933244|NCT00323609|588460142|FG003|Overall Study|Withdrawal by Subject|4|||
162933245|NCT00323609|588460139|FG000|Overall Study|Other non-VCF-related medical condition|3|||
162933246|NCT00323609|588460140|FG001|Overall Study|Other non-VCF-related medical condition|2|||
163177840|NCT01653782|589368075|FG000|Overall Study|Lost to Follow-up|7|||
163177841|NCT01653782|589368076|FG001|Overall Study|Lost to Follow-up|3|||
163177842|NCT01653782|589368077|FG002|Overall Study|Lost to Follow-up|2|||
163177843|NCT02497976|589368083|FG000|Overall Study|Withdrawal by Subject|2|||
163177844|NCT02497976|589368084|FG001|Overall Study|Withdrawal by Subject|0|||
163177845|NCT02497976|589368083|FG000|Overall Study|Moved out of area|0|||
163177846|NCT02497976|589368084|FG001|Overall Study|Moved out of area|1|||
163177847|NCT00058539|589368088|FG000|Overall Study|Disease progression|24|||
163177848|NCT00058539|589368088|FG000|Overall Study|Adverse Event|3|||
163177849|NCT00058539|589368088|FG000|Overall Study|Withdrawal by Subject|5|||
163177850|NCT00058539|589368088|FG000|Overall Study|Physician Decision|9|||
163177851|NCT00058539|589368088|FG000|Overall Study|Death|1|||
163177852|NCT01673282|589368089|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
163177853|NCT01673282|589368090|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
163177854|NCT01673282|589368089|FG000|Overall Study|Lack of Efficacy|9|||
163177855|NCT01673282|589368090|FG001|Overall Study|Lack of Efficacy|2|||
163177856|NCT01673282|589368089|FG000|Overall Study|Lost to Follow-up|11|||
163177857|NCT01673282|589368090|FG001|Overall Study|Lost to Follow-up|10|||
163177858|NCT01673282|589368089|FG000|Overall Study|Withdrawal by Subject|3|||
163177859|NCT01673282|589368090|FG001|Overall Study|Withdrawal by Subject|3|||
163177860|NCT01673282|589368089|FG000|Overall Study|Other|1|||
163177861|NCT01673282|589368090|FG001|Overall Study|Other|6|||
163177862|NCT02483533|589368091|FG000|Overall Study|Lack of Efficacy|50|||
162933247|NCT00323609|588460141|FG002|Overall Study|Other non-VCF-related medical condition|0|||
163177863|NCT02483533|589368092|FG001|Overall Study|Lack of Efficacy|50|||
163177864|NCT01323920|589368093|FG000|Overall Study|Death|5|||
163177865|NCT01323920|589368093|FG000|Overall Study|Withdrawal by Subject|1|||
163177866|NCT00768469|589368094|FG000|Overall Study|Adverse Event|0|||
163177867|NCT00768469|589368095|FG001|Overall Study|Adverse Event|2|||
163177868|NCT00768469|589368094|FG000|Overall Study|Disease Progression|3|||
163177869|NCT00768469|589368095|FG001|Overall Study|Disease Progression|4|||
163177870|NCT00768469|589368094|FG000|Overall Study|Withdrawal by Subject|0|||
163177871|NCT00768469|589368095|FG001|Overall Study|Withdrawal by Subject|1|||
163177872|NCT05040971|589368096|FG000|Overall Study|Withdrawal by Subject|0|||
163177873|NCT05040971|589368097|FG001|Overall Study|Withdrawal by Subject|2|||
163177874|NCT05040971|589368096|FG000|Overall Study|Lost to Follow-up|8|||
163177875|NCT05040971|589368097|FG001|Overall Study|Lost to Follow-up|3|||
163177876|NCT05040971|589368096|FG000|Overall Study|Death|2|||
163177877|NCT05040971|589368097|FG001|Overall Study|Death|0|||
163177878|NCT01293799|589368101|FG000|Overall Study|Kidney transplantation|109|||
163177879|NCT01293799|589368102|FG001|Overall Study|Kidney transplantation|96|||
163177880|NCT01293799|589368101|FG000|Overall Study|Transfer to hemodialysis|70|||
163177881|NCT01293799|589368102|FG001|Overall Study|Transfer to hemodialysis|90|||
163177882|NCT01293799|589368101|FG000|Overall Study|Death|27|||
163177883|NCT01293799|589368102|FG001|Overall Study|Death|29|||
163177884|NCT01293799|589368101|FG000|Overall Study|Transfer to assisted PD|24|||
163177885|NCT01293799|589368102|FG001|Overall Study|Transfer to assisted PD|18|||
163177886|NCT01293799|589368101|FG000|Overall Study|Withdrawal by Subject|26|||
163177887|NCT01293799|589368102|FG001|Overall Study|Withdrawal by Subject|0|||
163177888|NCT01293799|589368101|FG000|Overall Study|Investigator decision|5|||
163177889|NCT01293799|589368102|FG001|Overall Study|Investigator decision|2|||
162933248|NCT00323609|588460142|FG003|Overall Study|Other non-VCF-related medical condition|0|||
162933249|NCT00323609|588460139|FG000|Overall Study|Sponsor discontinued trial|29|||
162933250|NCT00323609|588460140|FG001|Overall Study|Sponsor discontinued trial|29|||
162933251|NCT00323609|588460141|FG002|Overall Study|Sponsor discontinued trial|0|||
162933252|NCT00323609|588460142|FG003|Overall Study|Sponsor discontinued trial|0|||
163177890|NCT01293799|589368101|FG000|Overall Study|Kidney function improved|6|||
163177891|NCT01293799|589368102|FG001|Overall Study|Kidney function improved|7|||
163177892|NCT01293799|589368101|FG000|Overall Study|Other causes|6|||
163177893|NCT01293799|589368102|FG001|Overall Study|Other causes|3|||
163177894|NCT00938886|589368108|FG000|Overall Study|Death|0|||
163177895|NCT00938886|589368109|FG001|Overall Study|Death|1|||
163177896|NCT00938886|589368108|FG000|Overall Study|Withdrawal by Subject|4|||
163177897|NCT00938886|589368109|FG001|Overall Study|Withdrawal by Subject|7|||
163177898|NCT00938886|589368108|FG000|Overall Study|Lost to Follow-up|3|||
163177899|NCT00938886|589368109|FG001|Overall Study|Lost to Follow-up|2|||
163177900|NCT02283177|589368110|FG000|Overall Study|Withdrawal by Subject|1|||
163177901|NCT02283177|589368111|FG001|Overall Study|Withdrawal by Subject|1|||
163177902|NCT03044574|589368112|FG000|Overall Study|Lost to Follow-up|37|||
163177903|NCT03044574|589368113|FG001|Overall Study|Lost to Follow-up|45|||
163177904|NCT02635646|589368115|FG000|Overall Study|Lost to Follow-up|24|||
163177905|NCT02635646|589368116|FG001|Overall Study|Lost to Follow-up|25|||
163177906|NCT02635646|589368115|FG000|Overall Study|Pregnancy|1|||
163177907|NCT02635646|589368116|FG001|Overall Study|Pregnancy|1|||
163177908|NCT00327470|589368125|FG000|Overall Study|Randomized, but not treated|0|||
163177909|NCT00327470|589368126|FG001|Overall Study|Randomized, but not treated|2|||
163177910|NCT00327470|589368125|FG000|Overall Study|Adverse Event|9|||
163177911|NCT00327470|589368126|FG001|Overall Study|Adverse Event|14|||
163177912|NCT00327470|589368125|FG000|Overall Study|Lack of Efficacy|7|||
163177913|NCT00327470|589368126|FG001|Overall Study|Lack of Efficacy|19|||
163177914|NCT00327470|589368125|FG000|Overall Study|Other|5|||
163177915|NCT00327470|589368126|FG001|Overall Study|Other|9|||
163177916|NCT00327470|589368125|FG000|Overall Study|Lost to Follow-up|1|||
163177917|NCT00327470|589368126|FG001|Overall Study|Lost to Follow-up|3|||
163177918|NCT00327470|589368125|FG000|Overall Study|Withdrawal by Subject|6|||
163177919|NCT00327470|589368126|FG001|Overall Study|Withdrawal by Subject|12|||
163177920|NCT00327470|589368125|FG000|Overall Study|Death|1|||
163177921|NCT00327470|589368126|FG001|Overall Study|Death|4|||
163177922|NCT01163032|589368136|FG000|Randomization Phase|Withdrawal by Subject|2|||
163177923|NCT01163032|589368137|FG001|Randomization Phase|Withdrawal by Subject|3|||
163177924|NCT01163032|589368138|FG002|Randomization Phase|Withdrawal by Subject|0|||
163177925|NCT01163032|589368136|FG000|Randomization Phase|Adverse Event|3|||
163177926|NCT01163032|589368137|FG001|Randomization Phase|Adverse Event|3|||
163177927|NCT01163032|589368138|FG002|Randomization Phase|Adverse Event|0|||
163177928|NCT01163032|589368136|FG000|Randomization Phase|Protocol Violation|0|||
163177929|NCT01163032|589368137|FG001|Randomization Phase|Protocol Violation|1|||
163177930|NCT01163032|589368138|FG002|Randomization Phase|Protocol Violation|0|||
163177931|NCT01163032|589368136|FG000|Randomization Phase|Various*|5|||
163177932|NCT01163032|589368137|FG001|Randomization Phase|Various*|4|||
163177933|NCT01163032|589368138|FG002|Randomization Phase|Various*|0|||
163177934|NCT01163032|589368136|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
163177935|NCT01163032|589368137|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
163177936|NCT01163032|589368138|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
163177937|NCT01163032|589368136|FG000|Open Label Extension Phase|Adverse Event|0|||
163177938|NCT01163032|589368137|FG001|Open Label Extension Phase|Adverse Event|0|||
163177939|NCT01163032|589368138|FG002|Open Label Extension Phase|Adverse Event|3|||
163177940|NCT01163032|589368136|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
163177941|NCT01163032|589368137|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163177942|NCT01163032|589368138|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
163177943|NCT01163032|589368136|FG000|Open Label Extension Phase|Protocol Violation|0|||
163177944|NCT01163032|589368137|FG001|Open Label Extension Phase|Protocol Violation|0|||
163177945|NCT01163032|589368138|FG002|Open Label Extension Phase|Protocol Violation|1|||
163177946|NCT01163032|589368136|FG000|Open Label Extension Phase|Study Termination|0|||
163177947|NCT01163032|589368137|FG001|Open Label Extension Phase|Study Termination|0|||
163177948|NCT01163032|589368138|FG002|Open Label Extension Phase|Study Termination|7|||
163177949|NCT01163032|589368136|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
163177950|NCT01163032|589368137|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
163177951|NCT01163032|589368138|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
162825970|NCT01022502|588075289|FG000|Overall Study|Adverse Event|1|||
163177952|NCT02751931|589368140|FG000|Overall Study|Adverse Event|3|||
163177953|NCT02751931|589368141|FG001|Overall Study|Adverse Event|0|||
163177954|NCT02751931|589368140|FG000|Overall Study|Other: Miscelleneous|10|||
163177955|NCT02751931|589368141|FG001|Overall Study|Other: Miscelleneous|8|||
163177956|NCT04090411|589368142|FG000|Induction Period|Adverse Event|3|||
163177957|NCT04090411|589368143|FG001|Induction Period|Adverse Event|1|||
163177958|NCT04090411|589368144|FG002|Induction Period|Adverse Event|1|||
163177959|NCT04090411|589368145|FG003|Induction Period|Adverse Event|1|||
163177960|NCT04090411|589368146|FG004|Induction Period|Adverse Event|0|||
163177961|NCT04090411|589368147|FG005|Induction Period|Adverse Event|0|||
163177962|NCT04090411|589368148|FG006|Induction Period|Adverse Event|0|||
163177963|NCT04090411|589368149|FG007|Induction Period|Adverse Event|0|||
162825971|NCT01022502|588075289|FG000|Overall Study|employment related reasons|1|||
162933253|NCT00323609|588460139|FG000|Overall Study|Unrelenting or severe back pain|1|||
162933254|NCT00323609|588460140|FG001|Overall Study|Unrelenting or severe back pain|1|||
162933255|NCT00323609|588460141|FG002|Overall Study|Unrelenting or severe back pain|0|||
162933256|NCT00323609|588460142|FG003|Overall Study|Unrelenting or severe back pain|0|||
162933257|NCT00323609|588460139|FG000|Overall Study|Logistical withdrawal|9|||
162933258|NCT00323609|588460140|FG001|Overall Study|Logistical withdrawal|5|||
162933259|NCT00323609|588460141|FG002|Overall Study|Logistical withdrawal|0|||
162933260|NCT00323609|588460142|FG003|Overall Study|Logistical withdrawal|1|||
162933261|NCT00323609|588460139|FG000|Overall Study|Other reason|11|||
162933262|NCT00323609|588460140|FG001|Overall Study|Other reason|8|||
162933263|NCT00323609|588460141|FG002|Overall Study|Other reason|4|||
162933264|NCT00323609|588460142|FG003|Overall Study|Other reason|9|||
162933265|NCT00068237|588460145|FG000|Overall Study|Ineligible|3|||
162933266|NCT00068237|588460145|FG000|Overall Study|No protocol treatment received|2|||
162933267|NCT05288673|588460146|FG000|Overall Study|Consent withdrawn by subject|0|||
162933268|NCT05288673|588460147|FG001|Overall Study|Consent withdrawn by subject|0|||
162933269|NCT05288673|588460148|FG002|Overall Study|Consent withdrawn by subject|1|||
162933270|NCT03056352|588460149|FG000|Overall Study|Lost to Follow-up|1|||
162933271|NCT00571922|588460150|FG000|Overall Study|Completion unknown|36|||
162933272|NCT00571922|588460151|FG001|Overall Study|Completion unknown|36|||
162933273|NCT02971605|588460152|FG000|Overall Study|Withdrawal by Subject|1|||
162933274|NCT01154153|588460155|FG000|Overall Study|Poor compliance to protocol|2|||
162933275|NCT01154153|588460156|FG001|Overall Study|Poor compliance to protocol|0|||
162933276|NCT01154153|588460155|FG000|Overall Study|Unable to use labs|2|||
162933277|NCT01154153|588460156|FG001|Overall Study|Unable to use labs|3|||
163177964|NCT04090411|589368150|FG008|Induction Period|Adverse Event|0|||
163177965|NCT04090411|589368151|FG009|Induction Period|Adverse Event|0|||
163177966|NCT04090411|589368152|FG010|Induction Period|Adverse Event|0|||
163177967|NCT04090411|589368153|FG011|Induction Period|Adverse Event|0|||
163177968|NCT04090411|589368154|FG012|Induction Period|Adverse Event|0|||
163177969|NCT04090411|589368142|FG000|Induction Period|Lack of Efficacy|0|||
163177970|NCT04090411|589368143|FG001|Induction Period|Lack of Efficacy|0|||
163177971|NCT04090411|589368144|FG002|Induction Period|Lack of Efficacy|1|||
163177972|NCT04090411|589368145|FG003|Induction Period|Lack of Efficacy|1|||
163177973|NCT04090411|589368146|FG004|Induction Period|Lack of Efficacy|0|||
163177974|NCT04090411|589368147|FG005|Induction Period|Lack of Efficacy|0|||
163177975|NCT04090411|589368148|FG006|Induction Period|Lack of Efficacy|0|||
163177976|NCT04090411|589368149|FG007|Induction Period|Lack of Efficacy|0|||
162825972|NCT01022502|588075289|FG000|Overall Study|Withdrawal by Subject|1|||
162825973|NCT02790138|588075293|FG000|Overall Study|Adverse Event|5|||
162825974|NCT02790138|588075294|FG001|Overall Study|Adverse Event|2|||
162825975|NCT02790138|588075293|FG000|Overall Study|Significant Protocol Deviation|0|||
162825976|NCT02790138|588075294|FG001|Overall Study|Significant Protocol Deviation|1|||
162825977|NCT02790138|588075293|FG000|Overall Study|Lost to Follow-up|1|||
162825978|NCT02790138|588075294|FG001|Overall Study|Lost to Follow-up|0|||
162825979|NCT02790138|588075293|FG000|Overall Study|Voluntary Withdrawal|8|||
162825980|NCT02790138|588075294|FG001|Overall Study|Voluntary Withdrawal|9|||
162825981|NCT02790138|588075293|FG000|Overall Study|Lack of Efficacy|6|||
162825982|NCT02790138|588075294|FG001|Overall Study|Lack of Efficacy|7|||
162825983|NCT02790138|588075293|FG000|Overall Study|Reason not Specified|1|||
162825984|NCT02790138|588075294|FG001|Overall Study|Reason not Specified|0|||
162825985|NCT03199040|588075295|FG000|Overall Study|Lack of Efficacy|2|||
162825986|NCT03199040|588075296|FG001|Overall Study|Lack of Efficacy|0|||
162825987|NCT03199040|588075295|FG000|Overall Study|Withdrawal by Subject|2|||
162933278|NCT01154153|588460155|FG000|Overall Study|Withdrew consent|1|||
162933279|NCT01154153|588460156|FG001|Overall Study|Withdrew consent|0|||
162933280|NCT00964223|588460157|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
162933281|NCT03439293|588460158|FG000|Overall Study|Death|22|||
162933282|NCT03439293|588460158|FG000|Overall Study|Withdrawal by Subject|8|||
163177977|NCT04090411|589368150|FG008|Induction Period|Lack of Efficacy|0|||
163177978|NCT04090411|589368151|FG009|Induction Period|Lack of Efficacy|0|||
163177979|NCT04090411|589368152|FG010|Induction Period|Lack of Efficacy|0|||
163177980|NCT04090411|589368153|FG011|Induction Period|Lack of Efficacy|0|||
163177981|NCT04090411|589368154|FG012|Induction Period|Lack of Efficacy|0|||
163042826|NCT01990768|588863970|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
163177982|NCT04090411|589368142|FG000|Induction Period|Physician Decision|0|||
162825988|NCT03199040|588075296|FG001|Overall Study|Withdrawal by Subject|0|||
162825989|NCT03199040|588075295|FG000|Overall Study|Adverse Event|0|||
162825990|NCT03199040|588075296|FG001|Overall Study|Adverse Event|1|||
162825991|NCT03199040|588075295|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
163177983|NCT04090411|589368143|FG001|Induction Period|Physician Decision|0|||
162825992|NCT03199040|588075296|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
163177984|NCT04090411|589368144|FG002|Induction Period|Physician Decision|1|||
163177985|NCT04090411|589368145|FG003|Induction Period|Physician Decision|0|||
163177986|NCT04090411|589368146|FG004|Induction Period|Physician Decision|0|||
163177987|NCT04090411|589368147|FG005|Induction Period|Physician Decision|0|||
163177988|NCT04090411|589368148|FG006|Induction Period|Physician Decision|0|||
163177989|NCT04090411|589368149|FG007|Induction Period|Physician Decision|0|||
163177990|NCT04090411|589368150|FG008|Induction Period|Physician Decision|0|||
163177991|NCT04090411|589368151|FG009|Induction Period|Physician Decision|0|||
163177992|NCT04090411|589368152|FG010|Induction Period|Physician Decision|0|||
163177993|NCT04090411|589368153|FG011|Induction Period|Physician Decision|0|||
163177994|NCT04090411|589368154|FG012|Induction Period|Physician Decision|0|||
163177995|NCT04090411|589368142|FG000|Induction Period|Protocol Violation|0|||
163177996|NCT04090411|589368143|FG001|Induction Period|Protocol Violation|0|||
163177997|NCT04090411|589368144|FG002|Induction Period|Protocol Violation|0|||
163177998|NCT04090411|589368145|FG003|Induction Period|Protocol Violation|1|||
163177999|NCT04090411|589368146|FG004|Induction Period|Protocol Violation|0|||
163178000|NCT04090411|589368147|FG005|Induction Period|Protocol Violation|0|||
163178001|NCT04090411|589368148|FG006|Induction Period|Protocol Violation|0|||
163178002|NCT04090411|589368149|FG007|Induction Period|Protocol Violation|0|||
163178003|NCT04090411|589368150|FG008|Induction Period|Protocol Violation|0|||
163178004|NCT04090411|589368151|FG009|Induction Period|Protocol Violation|0|||
163178005|NCT04090411|589368152|FG010|Induction Period|Protocol Violation|0|||
163178006|NCT04090411|589368153|FG011|Induction Period|Protocol Violation|0|||
163178007|NCT04090411|589368154|FG012|Induction Period|Protocol Violation|0|||
163178008|NCT04090411|589368142|FG000|Induction Period|Withdrawal by Subject|2|||
163178009|NCT04090411|589368143|FG001|Induction Period|Withdrawal by Subject|0|||
163178010|NCT04090411|589368144|FG002|Induction Period|Withdrawal by Subject|1|||
163178011|NCT04090411|589368145|FG003|Induction Period|Withdrawal by Subject|5|||
163178012|NCT04090411|589368146|FG004|Induction Period|Withdrawal by Subject|0|||
163178013|NCT04090411|589368147|FG005|Induction Period|Withdrawal by Subject|0|||
163178014|NCT04090411|589368148|FG006|Induction Period|Withdrawal by Subject|0|||
163178015|NCT04090411|589368149|FG007|Induction Period|Withdrawal by Subject|0|||
163178016|NCT04090411|589368150|FG008|Induction Period|Withdrawal by Subject|0|||
163178017|NCT04090411|589368151|FG009|Induction Period|Withdrawal by Subject|0|||
163178018|NCT04090411|589368152|FG010|Induction Period|Withdrawal by Subject|0|||
162825993|NCT01786603|588075297|FG000|Overall Study|Death|5|||
162825994|NCT01786603|588075298|FG001|Overall Study|Death|1|||
162825995|NCT01786603|588075297|FG000|Overall Study|Adverse Event|6|||
162825996|NCT01786603|588075298|FG001|Overall Study|Adverse Event|2|||
162825997|NCT01786603|588075297|FG000|Overall Study|Physician decision to withdraw|6|||
162825998|NCT01786603|588075298|FG001|Overall Study|Physician decision to withdraw|7|||
162825999|NCT01786603|588075297|FG000|Overall Study|Lost to Follow-up|1|||
162826000|NCT01786603|588075298|FG001|Overall Study|Lost to Follow-up|2|||
162826001|NCT01226459|588075299|FG000|Overall Study|Adverse Event|2|||
162826002|NCT01226459|588075300|FG001|Overall Study|Adverse Event|8|||
162826003|NCT01226459|588075299|FG000|Overall Study|Protocol Violation|4|||
162826004|NCT01226459|588075300|FG001|Overall Study|Protocol Violation|3|||
162826005|NCT01226459|588075299|FG000|Overall Study|Withdrawal by Subject|10|||
162826006|NCT01226459|588075300|FG001|Overall Study|Withdrawal by Subject|13|||
162826007|NCT01226459|588075299|FG000|Overall Study|Lost to Follow-up|4|||
162826008|NCT01226459|588075300|FG001|Overall Study|Lost to Follow-up|8|||
162826009|NCT01226459|588075299|FG000|Overall Study|Pregnancy|1|||
162826010|NCT01226459|588075300|FG001|Overall Study|Pregnancy|0|||
162826011|NCT01092143|588075306|FG000|Overall Study|Adverse Event|10|||
162826012|NCT01092143|588075307|FG001|Overall Study|Adverse Event|5|||
162826013|NCT01092143|588075308|FG002|Overall Study|Adverse Event|1|||
162826014|NCT01092143|588075309|FG003|Overall Study|Adverse Event|4|||
162826015|NCT01092143|588075310|FG004|Overall Study|Adverse Event|3|||
162826016|NCT01092143|588075306|FG000|Overall Study|Lost to Follow-up|1|||
162826017|NCT01092143|588075307|FG001|Overall Study|Lost to Follow-up|0|||
162826018|NCT01092143|588075308|FG002|Overall Study|Lost to Follow-up|1|||
163178019|NCT04090411|589368153|FG011|Induction Period|Withdrawal by Subject|0|||
162826019|NCT01092143|588075309|FG003|Overall Study|Lost to Follow-up|0|||
162826020|NCT01092143|588075310|FG004|Overall Study|Lost to Follow-up|0|||
162826021|NCT01092143|588075306|FG000|Overall Study|Consent withdrawn|2|||
162826022|NCT01092143|588075307|FG001|Overall Study|Consent withdrawn|1|||
162826023|NCT01092143|588075308|FG002|Overall Study|Consent withdrawn|0|||
163178020|NCT04090411|589368154|FG012|Induction Period|Withdrawal by Subject|0|||
163178021|NCT04090411|589368142|FG000|Chronic Period|Adverse Event|0|||
163178022|NCT04090411|589368143|FG001|Chronic Period|Adverse Event|0|||
162826024|NCT01092143|588075309|FG003|Overall Study|Consent withdrawn|1|||
162826025|NCT01092143|588075310|FG004|Overall Study|Consent withdrawn|3|||
162826026|NCT01092143|588075306|FG000|Overall Study|Not treated|0|||
162826027|NCT01092143|588075307|FG001|Overall Study|Not treated|0|||
162826028|NCT01092143|588075308|FG002|Overall Study|Not treated|1|||
162826029|NCT01092143|588075309|FG003|Overall Study|Not treated|0|||
162826030|NCT01092143|588075310|FG004|Overall Study|Not treated|0|||
163178023|NCT04090411|589368144|FG002|Chronic Period|Adverse Event|0|||
163178024|NCT04090411|589368145|FG003|Chronic Period|Adverse Event|0|||
163178025|NCT04090411|589368146|FG004|Chronic Period|Adverse Event|0|||
163178026|NCT04090411|589368147|FG005|Chronic Period|Adverse Event|1|||
163178027|NCT04090411|589368148|FG006|Chronic Period|Adverse Event|0|||
163178028|NCT04090411|589368149|FG007|Chronic Period|Adverse Event|3|||
163178029|NCT04090411|589368150|FG008|Chronic Period|Adverse Event|0|||
163178030|NCT04090411|589368151|FG009|Chronic Period|Adverse Event|0|||
163178031|NCT04090411|589368152|FG010|Chronic Period|Adverse Event|5|||
163178032|NCT04090411|589368153|FG011|Chronic Period|Adverse Event|1|||
163178033|NCT04090411|589368154|FG012|Chronic Period|Adverse Event|1|||
163178034|NCT04090411|589368142|FG000|Chronic Period|Lack of Efficacy|0|||
163178035|NCT04090411|589368143|FG001|Chronic Period|Lack of Efficacy|0|||
163178036|NCT04090411|589368144|FG002|Chronic Period|Lack of Efficacy|0|||
163178037|NCT04090411|589368145|FG003|Chronic Period|Lack of Efficacy|0|||
163178038|NCT04090411|589368146|FG004|Chronic Period|Lack of Efficacy|0|||
163178039|NCT04090411|589368147|FG005|Chronic Period|Lack of Efficacy|0|||
163178040|NCT04090411|589368148|FG006|Chronic Period|Lack of Efficacy|1|||
163178041|NCT04090411|589368149|FG007|Chronic Period|Lack of Efficacy|4|||
163178042|NCT04090411|589368150|FG008|Chronic Period|Lack of Efficacy|2|||
163178043|NCT04090411|589368151|FG009|Chronic Period|Lack of Efficacy|2|||
163178044|NCT04090411|589368152|FG010|Chronic Period|Lack of Efficacy|2|||
163178045|NCT04090411|589368153|FG011|Chronic Period|Lack of Efficacy|1|||
163178046|NCT04090411|589368154|FG012|Chronic Period|Lack of Efficacy|2|||
163178047|NCT04090411|589368142|FG000|Chronic Period|Relocation|0|||
163178048|NCT04090411|589368143|FG001|Chronic Period|Relocation|0|||
163178049|NCT04090411|589368144|FG002|Chronic Period|Relocation|0|||
163178050|NCT04090411|589368145|FG003|Chronic Period|Relocation|0|||
163178051|NCT04090411|589368146|FG004|Chronic Period|Relocation|0|||
163178052|NCT04090411|589368147|FG005|Chronic Period|Relocation|0|||
163178053|NCT04090411|589368148|FG006|Chronic Period|Relocation|0|||
163178054|NCT04090411|589368149|FG007|Chronic Period|Relocation|1|||
163178055|NCT04090411|589368150|FG008|Chronic Period|Relocation|0|||
163178056|NCT04090411|589368151|FG009|Chronic Period|Relocation|0|||
163178057|NCT04090411|589368152|FG010|Chronic Period|Relocation|0|||
163178058|NCT04090411|589368153|FG011|Chronic Period|Relocation|0|||
163178059|NCT04090411|589368154|FG012|Chronic Period|Relocation|0|||
163178060|NCT04090411|589368142|FG000|Chronic Period|Physician Decision|0|||
163178061|NCT04090411|589368143|FG001|Chronic Period|Physician Decision|0|||
163178062|NCT04090411|589368144|FG002|Chronic Period|Physician Decision|0|||
163178063|NCT04090411|589368145|FG003|Chronic Period|Physician Decision|0|||
163178064|NCT04090411|589368146|FG004|Chronic Period|Physician Decision|1|||
163178065|NCT04090411|589368147|FG005|Chronic Period|Physician Decision|0|||
163178066|NCT04090411|589368148|FG006|Chronic Period|Physician Decision|0|||
163178067|NCT04090411|589368149|FG007|Chronic Period|Physician Decision|1|||
163178068|NCT04090411|589368150|FG008|Chronic Period|Physician Decision|0|||
163178069|NCT04090411|589368151|FG009|Chronic Period|Physician Decision|0|||
163178070|NCT04090411|589368152|FG010|Chronic Period|Physician Decision|0|||
163178071|NCT04090411|589368153|FG011|Chronic Period|Physician Decision|1|||
163178072|NCT04090411|589368154|FG012|Chronic Period|Physician Decision|1|||
163178073|NCT04090411|589368142|FG000|Chronic Period|Protocol Violation|0|||
163178074|NCT04090411|589368143|FG001|Chronic Period|Protocol Violation|0|||
163178075|NCT04090411|589368144|FG002|Chronic Period|Protocol Violation|0|||
163178076|NCT04090411|589368145|FG003|Chronic Period|Protocol Violation|0|||
163178077|NCT04090411|589368146|FG004|Chronic Period|Protocol Violation|0|||
163178078|NCT04090411|589368147|FG005|Chronic Period|Protocol Violation|0|||
163178079|NCT04090411|589368148|FG006|Chronic Period|Protocol Violation|0|||
163178080|NCT04090411|589368149|FG007|Chronic Period|Protocol Violation|0|||
163178081|NCT04090411|589368150|FG008|Chronic Period|Protocol Violation|0|||
163178082|NCT04090411|589368151|FG009|Chronic Period|Protocol Violation|0|||
163178083|NCT04090411|589368152|FG010|Chronic Period|Protocol Violation|0|||
163178084|NCT04090411|589368153|FG011|Chronic Period|Protocol Violation|0|||
163178085|NCT04090411|589368154|FG012|Chronic Period|Protocol Violation|1|||
163178086|NCT04090411|589368142|FG000|Chronic Period|Withdrawal by Subject|0|||
163178087|NCT04090411|589368143|FG001|Chronic Period|Withdrawal by Subject|0|||
163178088|NCT04090411|589368144|FG002|Chronic Period|Withdrawal by Subject|0|||
163178089|NCT04090411|589368145|FG003|Chronic Period|Withdrawal by Subject|0|||
163178090|NCT04090411|589368146|FG004|Chronic Period|Withdrawal by Subject|0|||
163178091|NCT04090411|589368147|FG005|Chronic Period|Withdrawal by Subject|1|||
163178092|NCT04090411|589368148|FG006|Chronic Period|Withdrawal by Subject|1|||
163178093|NCT04090411|589368149|FG007|Chronic Period|Withdrawal by Subject|3|||
163178094|NCT04090411|589368150|FG008|Chronic Period|Withdrawal by Subject|3|||
163178095|NCT04090411|589368151|FG009|Chronic Period|Withdrawal by Subject|3|||
163178096|NCT04090411|589368152|FG010|Chronic Period|Withdrawal by Subject|1|||
163178097|NCT04090411|589368153|FG011|Chronic Period|Withdrawal by Subject|3|||
163178098|NCT04090411|589368154|FG012|Chronic Period|Withdrawal by Subject|0|||
163178099|NCT03764033|589368165|FG000|Treatment Phase|Withdrawal by Subject|8|||
163178100|NCT03764033|589368166|FG001|Treatment Phase|Withdrawal by Subject|3|||
163178101|NCT03764033|589368165|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
163178102|NCT03764033|589368166|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
162933283|NCT03439293|588460158|FG000|Overall Study|Lost to Follow-up|2|||
162933284|NCT03439293|588460158|FG000|Overall Study|Reason Not Specified|28|||
162933285|NCT03439293|588460158|FG000|Overall Study|Missing|1|||
162933286|NCT03404206|588460161|FG000|Overall Study|Withdrawal by Subject|1|||
162933287|NCT03404206|588460162|FG001|Overall Study|Withdrawal by Subject|1|||
162933288|NCT03404206|588460163|FG002|Overall Study|Withdrawal by Subject|0|||
162933289|NCT03404206|588460161|FG000|Overall Study|Lost to Follow-up|3|||
163178103|NCT03764033|589368165|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
163178104|NCT03764033|589368166|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
163178105|NCT04594369|589368167|FG000|Overall Study|Adverse Event|10|||
163178106|NCT04594369|589368168|FG001|Overall Study|Adverse Event|10|||
163178107|NCT04594369|589368169|FG002|Overall Study|Adverse Event|9|||
163178108|NCT04594369|589368167|FG000|Overall Study|Death|2|||
163178109|NCT04594369|589368168|FG001|Overall Study|Death|4|||
163178110|NCT04594369|589368169|FG002|Overall Study|Death|8|||
163178111|NCT04594369|589368167|FG000|Overall Study|Lost to Follow-up|10|||
163178112|NCT04594369|589368168|FG001|Overall Study|Lost to Follow-up|2|||
163178113|NCT04594369|589368169|FG002|Overall Study|Lost to Follow-up|4|||
163178114|NCT04594369|589368167|FG000|Overall Study|Physician Decision|2|||
163178115|NCT04594369|589368168|FG001|Overall Study|Physician Decision|2|||
163178116|NCT04594369|589368169|FG002|Overall Study|Physician Decision|3|||
163178117|NCT04594369|589368167|FG000|Overall Study|Protocol deviation|1|||
163178118|NCT04594369|589368168|FG001|Overall Study|Protocol deviation|3|||
163178119|NCT04594369|589368169|FG002|Overall Study|Protocol deviation|2|||
163178120|NCT04594369|589368167|FG000|Overall Study|Withdrawal by Subject|40|||
163178121|NCT04594369|589368168|FG001|Overall Study|Withdrawal by Subject|32|||
163178122|NCT04594369|589368169|FG002|Overall Study|Withdrawal by Subject|37|||
163178123|NCT04594369|589368167|FG000|Overall Study|Reason not specified|60|||
163178124|NCT04594369|589368168|FG001|Overall Study|Reason not specified|56|||
163178125|NCT04594369|589368169|FG002|Overall Study|Reason not specified|43|||
163178126|NCT01006603|589368170|FG000|Overall Study|Withdrawal by Subject|17|||
163178127|NCT01006603|589368171|FG001|Overall Study|Withdrawal by Subject|19|||
163178128|NCT01006603|589368170|FG000|Overall Study|Lost to Follow-up|0|||
163178129|NCT01006603|589368171|FG001|Overall Study|Lost to Follow-up|1|||
163178130|NCT01006603|589368170|FG000|Overall Study|Safety reason|1|||
163178131|NCT01006603|589368171|FG001|Overall Study|Safety reason|1|||
163178132|NCT01006603|589368170|FG000|Overall Study|Protocol Violation|1|||
163178133|NCT01006603|589368171|FG001|Overall Study|Protocol Violation|3|||
163178134|NCT01006603|589368170|FG000|Overall Study|Incorrect enrolment|0|||
163178135|NCT01006603|589368171|FG001|Overall Study|Incorrect enrolment|2|||
163178136|NCT01006603|589368170|FG000|Overall Study|Adverse Event|15|||
163178137|NCT01006603|589368171|FG001|Overall Study|Adverse Event|7|||
163178138|NCT01006603|589368170|FG000|Overall Study|Death|1|||
163178139|NCT01006603|589368171|FG001|Overall Study|Death|1|||
163178140|NCT01006603|589368170|FG000|Overall Study|Study specific discontinuation criteria|33|||
163178141|NCT01006603|589368171|FG001|Overall Study|Study specific discontinuation criteria|34|||
163178142|NCT01006603|589368170|FG000|Overall Study|Other|3|||
163178143|NCT01006603|589368171|FG001|Overall Study|Other|7|||
163178144|NCT03875235|589368172|FG000|Overall Study|Ongoing study treatment|63|||
163178145|NCT03875235|589368173|FG001|Overall Study|Ongoing study treatment|20|||
163178146|NCT03875235|589368172|FG000|Overall Study|Off treatment|77|||
163178147|NCT03875235|589368173|FG001|Overall Study|Off treatment|91|||
163178148|NCT03875235|589368172|FG000|Overall Study|Withdrawal by Subject|3|||
163178149|NCT03875235|589368173|FG001|Overall Study|Withdrawal by Subject|10|||
163178150|NCT03875235|589368172|FG000|Overall Study|Death|198|||
163178151|NCT03875235|589368173|FG001|Overall Study|Death|223|||
163178152|NCT02477696|589368178|FG000|Overall Study|Death|89|||
163178153|NCT02477696|589368179|FG001|Overall Study|Death|106|||
163178154|NCT02477696|589368178|FG000|Overall Study|Lost to Follow-up|7|||
162933290|NCT03404206|588460162|FG001|Overall Study|Lost to Follow-up|1|||
162933291|NCT03404206|588460163|FG002|Overall Study|Lost to Follow-up|0|||
162933292|NCT05478603|588460164|FG000|Overall Study|Withdrawal by Subject|0|||
162933293|NCT05478603|588460165|FG001|Overall Study|Withdrawal by Subject|1|||
162933294|NCT05478603|588460166|FG002|Overall Study|Withdrawal by Subject|0|||
162933295|NCT05478603|588460167|FG003|Overall Study|Withdrawal by Subject|0|||
163178155|NCT02477696|589368179|FG001|Overall Study|Lost to Follow-up|5|||
163178156|NCT02477696|589368178|FG000|Overall Study|Withdrawal by Subject|37|||
163178157|NCT02477696|589368179|FG001|Overall Study|Withdrawal by Subject|34|||
163178158|NCT02477696|589368178|FG000|Overall Study|Physician Decision|7|||
163178159|NCT02477696|589368179|FG001|Overall Study|Physician Decision|9|||
163178160|NCT02477696|589368178|FG000|Overall Study|Study terminated by sponsor|103|||
163178161|NCT02477696|589368179|FG001|Overall Study|Study terminated by sponsor|99|||
163178162|NCT02477696|589368178|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
163178163|NCT02477696|589368179|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
163178164|NCT02477696|589368178|FG000|Overall Study|Missing/Unknown|2|||
163178165|NCT02477696|589368179|FG001|Overall Study|Missing/Unknown|0|||
163178166|NCT02003365|589369158|FG000|Overall Study|Lost to Follow-up|0|||
163178167|NCT02003365|589369159|FG001|Overall Study|Lost to Follow-up|0|||
163178168|NCT02003365|589369160|FG002|Overall Study|Lost to Follow-up|1|||
163178169|NCT02582255|589369165|FG000|Overall Study|Protocol Violation|0|||
163178170|NCT02582255|589369166|FG001|Overall Study|Protocol Violation|3|||
162826031|NCT01092143|588075306|FG000|Overall Study|did not reversibility criteria|0|||
163178171|NCT01709578|589369167|FG000|Overall Study|Rescued and entered in long term safety|63|||
163178172|NCT01709578|589369168|FG001|Overall Study|Rescued and entered in long term safety|25|||
163178173|NCT01709578|589369169|FG002|Overall Study|Rescued and entered in long term safety|26|||
163178174|NCT01709578|589369167|FG000|Overall Study|Adverse Event|9|||
163178175|NCT01709578|589369168|FG001|Overall Study|Adverse Event|18|||
163178176|NCT01709578|589369169|FG002|Overall Study|Adverse Event|17|||
163178177|NCT01709578|589369167|FG000|Overall Study|Lack of Efficacy|5|||
163178178|NCT01709578|589369168|FG001|Overall Study|Lack of Efficacy|4|||
163178179|NCT01709578|589369169|FG002|Overall Study|Lack of Efficacy|2|||
163178180|NCT01709578|589369167|FG000|Overall Study|Poor compliance to protocol|1|||
163178181|NCT01709578|589369168|FG001|Overall Study|Poor compliance to protocol|2|||
163178182|NCT01709578|589369169|FG002|Overall Study|Poor compliance to protocol|1|||
163178183|NCT01709578|589369167|FG000|Overall Study|Other, not related to safety or efficacy|2|||
163178184|NCT01709578|589369168|FG001|Overall Study|Other, not related to safety or efficacy|7|||
163178185|NCT01709578|589369169|FG002|Overall Study|Other, not related to safety or efficacy|5|||
163178186|NCT04050371|589369170|FG000|Overall Study|Withdrawal by Subject|1|||
163178187|NCT04050371|589369171|FG001|Overall Study|Withdrawal by Subject|0|||
163178188|NCT00597701|589369172|FG000|Overall Study|Withdrawal by Subject|5|||
163178189|NCT00597701|589369173|FG001|Overall Study|Withdrawal by Subject|5|||
163178190|NCT00597701|589369172|FG000|Overall Study|Death|0|||
163178191|NCT00597701|589369173|FG001|Overall Study|Death|1|||
163178192|NCT00597701|589369172|FG000|Overall Study|Physician Decision|2|||
162826032|NCT01092143|588075307|FG001|Overall Study|did not reversibility criteria|0|||
162826033|NCT01092143|588075308|FG002|Overall Study|did not reversibility criteria|1|||
162826034|NCT01092143|588075309|FG003|Overall Study|did not reversibility criteria|0|||
162826035|NCT01092143|588075310|FG004|Overall Study|did not reversibility criteria|0|||
162826036|NCT01092143|588075306|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
162826037|NCT01092143|588075307|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
162826038|NCT01092143|588075308|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
162826039|NCT01092143|588075309|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
162826040|NCT01092143|588075310|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
162826041|NCT01092143|588075306|FG000|Overall Study|Ineligible patient|1|||
162826042|NCT01092143|588075307|FG001|Overall Study|Ineligible patient|0|||
162826043|NCT01092143|588075308|FG002|Overall Study|Ineligible patient|0|||
162826044|NCT01092143|588075309|FG003|Overall Study|Ineligible patient|0|||
162826045|NCT01092143|588075310|FG004|Overall Study|Ineligible patient|0|||
162826046|NCT01092143|588075306|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
162826047|NCT01092143|588075307|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
162826048|NCT01092143|588075308|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
162826049|NCT01092143|588075309|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
162826050|NCT01092143|588075310|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
162826051|NCT01092143|588075306|FG000|Overall Study|Patient travel|0|||
162826052|NCT01092143|588075307|FG001|Overall Study|Patient travel|0|||
162826053|NCT01092143|588075308|FG002|Overall Study|Patient travel|0|||
162826054|NCT01092143|588075309|FG003|Overall Study|Patient travel|0|||
162826055|NCT01092143|588075310|FG004|Overall Study|Patient travel|1|||
162826056|NCT01092143|588075306|FG000|Overall Study|Non compliance with study medication|0|||
162826057|NCT01092143|588075307|FG001|Overall Study|Non compliance with study medication|0|||
162826058|NCT01092143|588075308|FG002|Overall Study|Non compliance with study medication|0|||
162826059|NCT01092143|588075309|FG003|Overall Study|Non compliance with study medication|0|||
162826060|NCT01092143|588075310|FG004|Overall Study|Non compliance with study medication|1|||
162826061|NCT01092143|588075306|FG000|Overall Study|Randomized by mistake|0|||
162826062|NCT01092143|588075307|FG001|Overall Study|Randomized by mistake|0|||
162826063|NCT01092143|588075308|FG002|Overall Study|Randomized by mistake|0|||
162826064|NCT01092143|588075309|FG003|Overall Study|Randomized by mistake|1|||
162826065|NCT01092143|588075310|FG004|Overall Study|Randomized by mistake|0|||
162826066|NCT01092143|588075306|FG000|Overall Study|Pregnancy|0|||
162826067|NCT01092143|588075307|FG001|Overall Study|Pregnancy|0|||
162826068|NCT01092143|588075308|FG002|Overall Study|Pregnancy|0|||
162826069|NCT01092143|588075309|FG003|Overall Study|Pregnancy|1|||
162826070|NCT01092143|588075310|FG004|Overall Study|Pregnancy|0|||
162826071|NCT00555477|588075314|FG000|Overall Study|Adverse Event|0|||
162826072|NCT00555477|588075315|FG001|Overall Study|Adverse Event|9|||
162826073|NCT00555477|588075314|FG000|Overall Study|Withdrawal by Subject|1|||
162826074|NCT00555477|588075315|FG001|Overall Study|Withdrawal by Subject|2|||
162826075|NCT00555477|588075314|FG000|Overall Study|Physician Decision|1|||
162933296|NCT03634488|588460170|FG000|Overall Study|Death|1|||
163178193|NCT00597701|589369173|FG001|Overall Study|Physician Decision|0|||
163178194|NCT00597701|589369172|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
163178195|NCT00597701|589369173|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
162826076|NCT00555477|588075315|FG001|Overall Study|Physician Decision|2|||
162826077|NCT04702737|588075316|FG000|Overall Study|Decision by Sponsor|1|||
162826078|NCT04702737|588075316|FG000|Overall Study|Withdrawal of Consent from Study|3|||
162826079|NCT04702737|588075316|FG000|Overall Study|Lost to Follow-up|1|||
162826080|NCT04702737|588075316|FG000|Overall Study|Death|35|||
162698479|NCT02743793|587605511|FG001|Overall Study|Death|1|||
162826081|NCT01977820|588075319|FG000|Overall Study|Sponsor terminated the study|1|||
162933297|NCT03634488|588460171|FG001|Overall Study|Death|0|||
162933298|NCT03634488|588460172|FG002|Overall Study|Death|0|||
162933299|NCT03634488|588460170|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
162933300|NCT03634488|588460171|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
162933301|NCT03634488|588460172|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
162933302|NCT00869089|588460173|FG000|Overall Study|Lost to Follow-up|1|||
162933303|NCT00869089|588460173|FG000|Overall Study|Withdrawal by Subject|1|||
162933304|NCT00869089|588460173|FG000|Overall Study|Screen Fail|1|||
162933305|NCT01169844|588460181|FG000|Overall Study|Adverse Event|0|||
162933306|NCT01169844|588460182|FG001|Overall Study|Adverse Event|1|||
162933307|NCT01169844|588460181|FG000|Overall Study|Patient withdrew consent|4|||
162933308|NCT01169844|588460182|FG001|Overall Study|Patient withdrew consent|0|||
162933309|NCT01169844|588460181|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162933310|NCT01169844|588460182|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162933311|NCT00435825|588460186|FG000|Overall Study|Abnormality of Laboratory Test|0|||
162933312|NCT00435825|588460187|FG001|Overall Study|Abnormality of Laboratory Test|1|||
162933313|NCT00435825|588460188|FG002|Overall Study|Abnormality of Laboratory Test|0|||
162933314|NCT00435825|588460189|FG003|Overall Study|Abnormality of Laboratory Test|0|||
162933315|NCT00435825|588460186|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162933316|NCT00435825|588460187|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162933317|NCT00435825|588460188|FG002|Overall Study|Insufficient Therapeutic Response|0|||
162933318|NCT00435825|588460189|FG003|Overall Study|Insufficient Therapeutic Response|3|||
162933319|NCT00435825|588460186|FG000|Overall Study|Other Protocol Violation|1|||
162933320|NCT00435825|588460187|FG001|Overall Study|Other Protocol Violation|0|||
162933321|NCT00435825|588460188|FG002|Overall Study|Other Protocol Violation|0|||
162933322|NCT00435825|588460189|FG003|Overall Study|Other Protocol Violation|0|||
162933323|NCT00435825|588460186|FG000|Overall Study|Refused treatment|2|||
162933324|NCT00435825|588460187|FG001|Overall Study|Refused treatment|0|||
162933325|NCT00435825|588460188|FG002|Overall Study|Refused treatment|0|||
162933326|NCT00435825|588460189|FG003|Overall Study|Refused treatment|5|||
162933327|NCT00435825|588460186|FG000|Overall Study|Failure to return|5|||
162933328|NCT00435825|588460187|FG001|Overall Study|Failure to return|0|||
162933329|NCT00435825|588460188|FG002|Overall Study|Failure to return|4|||
162933330|NCT00435825|588460189|FG003|Overall Study|Failure to return|0|||
162933331|NCT00435825|588460186|FG000|Overall Study|Did not receive study drug|1|||
162933332|NCT00435825|588460187|FG001|Overall Study|Did not receive study drug|0|||
162933333|NCT00435825|588460188|FG002|Overall Study|Did not receive study drug|2|||
162933334|NCT00435825|588460189|FG003|Overall Study|Did not receive study drug|0|||
162933335|NCT00435825|588460186|FG000|Overall Study|Did not enter follow-up|0|||
162933336|NCT00435825|588460187|FG001|Overall Study|Did not enter follow-up|4|||
162933337|NCT00435825|588460188|FG002|Overall Study|Did not enter follow-up|1|||
162933338|NCT00435825|588460189|FG003|Overall Study|Did not enter follow-up|3|||
162933339|NCT00435825|588460186|FG000|Overall Study|Did not complete full follow-up period|6|||
162933340|NCT00435825|588460187|FG001|Overall Study|Did not complete full follow-up period|6|||
162933341|NCT00435825|588460188|FG002|Overall Study|Did not complete full follow-up period|4|||
162933342|NCT00435825|588460189|FG003|Overall Study|Did not complete full follow-up period|5|||
162933343|NCT05003167|588460190|FG000|Overall Study|Withdrawal by Subject|1|||
162933344|NCT01010230|588460191|FG000|Overall Study|Withdrawal by Subject|6|||
162933345|NCT01010230|588460192|FG001|Overall Study|Withdrawal by Subject|5|||
162933346|NCT01010230|588460191|FG000|Overall Study|Lost to Follow-up|4|||
162933347|NCT01010230|588460192|FG001|Overall Study|Lost to Follow-up|2|||
162933348|NCT00530439|588460193|FG000|Overall Study|GDM|9|||
162933349|NCT00530439|588460194|FG001|Overall Study|GDM|3|||
163178196|NCT04078178|589369178|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
163178197|NCT04078178|589369179|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
163178198|NCT04078178|589369178|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
163178199|NCT04078178|589369179|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
163178200|NCT04078178|589369178|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
163178201|NCT04078178|589369179|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
163178202|NCT04078178|589369178|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
162933350|NCT00530439|588460193|FG000|Overall Study|Withdraw|18|||
162933351|NCT00530439|588460194|FG001|Overall Study|Withdraw|14|||
162933352|NCT00530439|588460193|FG000|Overall Study|Missed abortion|1|||
162933353|NCT00530439|588460194|FG001|Overall Study|Missed abortion|4|||
162933354|NCT00530439|588460193|FG000|Overall Study|Misclassification|2|||
162933355|NCT00530439|588460194|FG001|Overall Study|Misclassification|0|||
162933356|NCT00530439|588460193|FG000|Overall Study|Twin pregnancy|0|||
162933357|NCT00530439|588460194|FG001|Overall Study|Twin pregnancy|2|||
162933358|NCT00530439|588460193|FG000|Overall Study|Severe malformation/abortion|0|||
162933359|NCT00530439|588460194|FG001|Overall Study|Severe malformation/abortion|3|||
162933360|NCT02367781|588460197|FG000|Overall Study|Withdrawal by Subject|20|||
162933361|NCT02367781|588460198|FG001|Overall Study|Withdrawal by Subject|13|||
162933362|NCT02367781|588460197|FG000|Overall Study|Protocol Violation|0|||
162933363|NCT02367781|588460198|FG001|Overall Study|Protocol Violation|1|||
162933364|NCT02367781|588460197|FG000|Overall Study|Physician Decision|7|||
162933365|NCT02367781|588460198|FG001|Overall Study|Physician Decision|0|||
162933366|NCT02367781|588460197|FG000|Overall Study|Randomized in Error|5|||
162933367|NCT02367781|588460198|FG001|Overall Study|Randomized in Error|4|||
162933368|NCT02367781|588460197|FG000|Overall Study|Non-Compliance|1|||
162933369|NCT02367781|588460198|FG001|Overall Study|Non-Compliance|0|||
162933370|NCT02367781|588460197|FG000|Overall Study|Lost to Follow-up|1|||
162933371|NCT02367781|588460198|FG001|Overall Study|Lost to Follow-up|2|||
162933372|NCT02367781|588460197|FG000|Overall Study|Death|330|||
162933373|NCT02367781|588460198|FG001|Overall Study|Death|176|||
162933374|NCT02367781|588460197|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
162933375|NCT02367781|588460198|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
162933376|NCT02367781|588460197|FG000|Overall Study|Prolonged Hospitalization|1|||
162933377|NCT02367781|588460198|FG001|Overall Study|Prolonged Hospitalization|0|||
162933378|NCT02367781|588460197|FG000|Overall Study|Death Prior First Dose|1|||
162933379|NCT02367781|588460198|FG001|Overall Study|Death Prior First Dose|0|||
162933380|NCT02367781|588460197|FG000|Overall Study|Administrative-Change Facility|1|||
162933381|NCT02367781|588460198|FG001|Overall Study|Administrative-Change Facility|0|||
162933382|NCT02367781|588460197|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
162933383|NCT02367781|588460198|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
162933384|NCT02367781|588460197|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
162933385|NCT02367781|588460198|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
162933386|NCT02367781|588460197|FG000|Overall Study|Study Terminated by Sponsor|3|||
162933387|NCT02367781|588460198|FG001|Overall Study|Study Terminated by Sponsor|1|||
162933388|NCT02367781|588460197|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
162933389|NCT02367781|588460198|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
162933390|NCT02367781|588460197|FG000|Overall Study|Sponsor Decision|2|||
162933391|NCT02367781|588460198|FG001|Overall Study|Sponsor Decision|0|||
162933392|NCT02367781|588460197|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
162933393|NCT02367781|588460198|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
162933394|NCT01393990|588462186|FG000|Overall Study|Adverse Event|0|||
162933395|NCT01393990|588462187|FG001|Overall Study|Adverse Event|0|||
162933396|NCT01393990|588462188|FG002|Overall Study|Adverse Event|0|||
162933397|NCT01393990|588462189|FG003|Overall Study|Adverse Event|0|||
162933398|NCT01393990|588462190|FG004|Overall Study|Adverse Event|0|||
162933399|NCT01393990|588462191|FG005|Overall Study|Adverse Event|0|||
162933400|NCT01393990|588462192|FG006|Overall Study|Adverse Event|0|||
162933401|NCT01393990|588462193|FG007|Overall Study|Adverse Event|0|||
162933402|NCT01393990|588462194|FG008|Overall Study|Adverse Event|0|||
162933403|NCT01393990|588462195|FG009|Overall Study|Adverse Event|0|||
162933404|NCT01393990|588462196|FG010|Overall Study|Adverse Event|0|||
162933405|NCT01393990|588462197|FG011|Overall Study|Adverse Event|0|||
162933406|NCT01393990|588462198|FG012|Overall Study|Adverse Event|0|||
162933407|NCT01393990|588462199|FG013|Overall Study|Adverse Event|0|||
162933408|NCT01393990|588462200|FG014|Overall Study|Adverse Event|1|||
162933409|NCT01393990|588462201|FG015|Overall Study|Adverse Event|1|||
162933410|NCT01393990|588462202|FG016|Overall Study|Adverse Event|0|||
162933411|NCT01393990|588462203|FG017|Overall Study|Adverse Event|0|||
162933412|NCT01393990|588462186|FG000|Overall Study|Progressive Disease|1|||
162933413|NCT01393990|588462187|FG001|Overall Study|Progressive Disease|0|||
162933414|NCT01393990|588462188|FG002|Overall Study|Progressive Disease|0|||
162933415|NCT01393990|588462189|FG003|Overall Study|Progressive Disease|1|||
162933416|NCT01393990|588462190|FG004|Overall Study|Progressive Disease|1|||
162933417|NCT01393990|588462191|FG005|Overall Study|Progressive Disease|1|||
162933418|NCT01393990|588462192|FG006|Overall Study|Progressive Disease|1|||
162933419|NCT01393990|588462193|FG007|Overall Study|Progressive Disease|1|||
162933420|NCT01393990|588462194|FG008|Overall Study|Progressive Disease|3|||
162933421|NCT01393990|588462195|FG009|Overall Study|Progressive Disease|1|||
162933422|NCT01393990|588462196|FG010|Overall Study|Progressive Disease|0|||
162933423|NCT01393990|588462197|FG011|Overall Study|Progressive Disease|0|||
162933424|NCT01393990|588462198|FG012|Overall Study|Progressive Disease|0|||
162933425|NCT01393990|588462199|FG013|Overall Study|Progressive Disease|1|||
162933426|NCT01393990|588462200|FG014|Overall Study|Progressive Disease|6|||
162933427|NCT01393990|588462201|FG015|Overall Study|Progressive Disease|1|||
162933428|NCT01393990|588462202|FG016|Overall Study|Progressive Disease|0|||
162933429|NCT01393990|588462203|FG017|Overall Study|Progressive Disease|0|||
162933430|NCT01393990|588462186|FG000|Overall Study|Death|0|||
162933431|NCT01393990|588462187|FG001|Overall Study|Death|0|||
162933432|NCT01393990|588462188|FG002|Overall Study|Death|0|||
162933433|NCT01393990|588462189|FG003|Overall Study|Death|0|||
162933434|NCT01393990|588462190|FG004|Overall Study|Death|1|||
162933435|NCT01393990|588462191|FG005|Overall Study|Death|0|||
162933436|NCT01393990|588462192|FG006|Overall Study|Death|0|||
162933437|NCT01393990|588462193|FG007|Overall Study|Death|0|||
162933438|NCT01393990|588462194|FG008|Overall Study|Death|0|||
162933439|NCT01393990|588462195|FG009|Overall Study|Death|0|||
162933440|NCT01393990|588462196|FG010|Overall Study|Death|0|||
162933441|NCT01393990|588462197|FG011|Overall Study|Death|0|||
162933442|NCT01393990|588462198|FG012|Overall Study|Death|0|||
162933443|NCT01393990|588462199|FG013|Overall Study|Death|1|||
162933444|NCT01393990|588462200|FG014|Overall Study|Death|1|||
162933445|NCT01393990|588462201|FG015|Overall Study|Death|0|||
162933446|NCT01393990|588462202|FG016|Overall Study|Death|0|||
162933447|NCT01393990|588462203|FG017|Overall Study|Death|0|||
162933448|NCT01393990|588462186|FG000|Overall Study|Withdrawal by Subject|0|||
162933449|NCT01393990|588462187|FG001|Overall Study|Withdrawal by Subject|0|||
162933450|NCT01393990|588462188|FG002|Overall Study|Withdrawal by Subject|0|||
162933451|NCT01393990|588462189|FG003|Overall Study|Withdrawal by Subject|0|||
162933452|NCT01393990|588462190|FG004|Overall Study|Withdrawal by Subject|0|||
162933453|NCT01393990|588462191|FG005|Overall Study|Withdrawal by Subject|0|||
162933454|NCT01393990|588462192|FG006|Overall Study|Withdrawal by Subject|0|||
162933455|NCT01393990|588462193|FG007|Overall Study|Withdrawal by Subject|0|||
162933456|NCT01393990|588462194|FG008|Overall Study|Withdrawal by Subject|0|||
162933457|NCT01393990|588462195|FG009|Overall Study|Withdrawal by Subject|0|||
162933458|NCT01393990|588462196|FG010|Overall Study|Withdrawal by Subject|0|||
162933459|NCT01393990|588462197|FG011|Overall Study|Withdrawal by Subject|0|||
162933460|NCT01393990|588462198|FG012|Overall Study|Withdrawal by Subject|0|||
162933461|NCT01393990|588462199|FG013|Overall Study|Withdrawal by Subject|0|||
162933462|NCT01393990|588462200|FG014|Overall Study|Withdrawal by Subject|1|||
162933463|NCT01393990|588462201|FG015|Overall Study|Withdrawal by Subject|1|||
162933464|NCT01393990|588462202|FG016|Overall Study|Withdrawal by Subject|0|||
162933465|NCT01393990|588462203|FG017|Overall Study|Withdrawal by Subject|0|||
162933466|NCT00331630|588462213|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
162933467|NCT00331630|588462213|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
162933468|NCT00331630|588462213|FG000|Follow up for 5 Years|Death|5|||
162933469|NCT00331630|588462213|FG000|Follow up for 5 Years|Data collection was stopped|24|||
162933470|NCT01859390|588462217|FG000|Overall Study|Insufficient Sputum Collected|1|||
162933471|NCT01859390|588462218|FG001|Overall Study|Insufficient Sputum Collected|3|||
162933472|NCT01859390|588462217|FG000|Overall Study|Sample Missing Collection Date|0|||
162826082|NCT01977820|588075320|FG001|Overall Study|Sponsor terminated the study|1|||
162826083|NCT00698997|588075321|FG000|Overall Study|Lost to Follow-up|3|||
162826084|NCT00698997|588075322|FG001|Overall Study|Lost to Follow-up|0|||
162933473|NCT01859390|588462218|FG001|Overall Study|Sample Missing Collection Date|1|||
162933474|NCT01859390|588462217|FG000|Overall Study|Tube Cracked|0|||
162933475|NCT01859390|588462218|FG001|Overall Study|Tube Cracked|2|||
162933476|NCT01859390|588462217|FG000|Overall Study|Shipment Error|0|||
162933477|NCT01859390|588462218|FG001|Overall Study|Shipment Error|1|||
162933478|NCT02451670|588462219|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
162933479|NCT02451670|588462220|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
162933480|NCT00463866|588462224|FG000|Overall Study|Adverse Event|70|||
162933481|NCT00463866|588462225|FG001|Overall Study|Adverse Event|93|||
162933482|NCT00463866|588462224|FG000|Overall Study|Withdrawal by Subject|81|||
162933483|NCT00463866|588462225|FG001|Overall Study|Withdrawal by Subject|79|||
162933484|NCT00463866|588462224|FG000|Overall Study|Lost to Follow-up|46|||
162933485|NCT00463866|588462225|FG001|Overall Study|Lost to Follow-up|55|||
162933486|NCT00463866|588462224|FG000|Overall Study|Incorrect Enrolment|64|||
162933487|NCT00463866|588462225|FG001|Overall Study|Incorrect Enrolment|66|||
162933488|NCT00463866|588462224|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
162933489|NCT00463866|588462225|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
162933490|NCT00463866|588462224|FG000|Overall Study|Safety Reason|1|||
162933491|NCT00463866|588462225|FG001|Overall Study|Safety Reason|3|||
162933492|NCT00463866|588462224|FG000|Overall Study|Mis-Randomization of subject|0|||
162933493|NCT00463866|588462225|FG001|Overall Study|Mis-Randomization of subject|1|||
162933494|NCT00463866|588462224|FG000|Overall Study|Other|22|||
162933495|NCT00463866|588462225|FG001|Overall Study|Other|22|||
162933496|NCT01084005|588462226|FG000|Overall Study|Adverse Event|1|||
162933497|NCT01084005|588462227|FG001|Overall Study|Adverse Event|8|||
162933498|NCT01084005|588462226|FG000|Overall Study|Protocol Violation|3|||
162933499|NCT01084005|588462227|FG001|Overall Study|Protocol Violation|7|||
162933500|NCT01084005|588462226|FG000|Overall Study|Withdrawal by Subject|1|||
162933501|NCT01084005|588462227|FG001|Overall Study|Withdrawal by Subject|1|||
162933502|NCT02480010|588462232|FG000|Overall Study|Adverse Event|3|||
162933503|NCT02480010|588462233|FG001|Overall Study|Adverse Event|1|||
162933504|NCT02480010|588462232|FG000|Overall Study|Death|1|||
162933505|NCT02480010|588462233|FG001|Overall Study|Death|0|||
162933506|NCT02480010|588462232|FG000|Overall Study|Insufficient therapeutic response|31|||
162933507|NCT02480010|588462233|FG001|Overall Study|Insufficient therapeutic response|29|||
162933508|NCT02480010|588462232|FG000|Overall Study|Refused Treatment|0|||
162933509|NCT02480010|588462233|FG001|Overall Study|Refused Treatment|3|||
162933510|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
162933511|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933512|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933513|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933514|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933515|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933516|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
162933517|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
162933518|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933519|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933520|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933521|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933522|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933523|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
162933524|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
162933525|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933526|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933527|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933528|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933529|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933530|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
162933531|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
162933532|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933533|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933534|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933535|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933536|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933537|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
162933538|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
162933539|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933540|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933541|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933542|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933543|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933544|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
162933545|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
162933546|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933547|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933548|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933549|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933550|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933551|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
162933552|NCT00606684|588462234|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
162933553|NCT00606684|588462235|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933554|NCT00606684|588462236|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933555|NCT00606684|588462237|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933556|NCT00606684|588462238|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933557|NCT00606684|588462239|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933558|NCT00606684|588462240|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
162933559|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162933560|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Adverse Event|3|||
162933561|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Adverse Event|2|||
163178203|NCT04078178|589369179|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
163178204|NCT04078178|589369178|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
163178205|NCT04078178|589369179|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
163178206|NCT04617795|589369180|FG000|Main Study|Lost to Follow-up|1|||
163178207|NCT04617795|589369181|FG001|Main Study|Lost to Follow-up|0|||
163178208|NCT04850313|589369182|FG000|Overall Study|Withdrawal by Subject|0|||
163178209|NCT04850313|589369183|FG001|Overall Study|Withdrawal by Subject|1|||
163178210|NCT03505671|589369188|FG000|Overall Study|Withdrawal by Subject|2|||
163178211|NCT03505671|589369189|FG001|Overall Study|Withdrawal by Subject|1|||
163178212|NCT03505671|589369188|FG000|Overall Study|Lost to Follow-up|1|||
163178213|NCT03505671|589369189|FG001|Overall Study|Lost to Follow-up|0|||
163178214|NCT02038829|589369190|FG000|Washout Period 1|Death|0|||
163178215|NCT02038829|589369191|FG001|Washout Period 1|Death|0|||
163178216|NCT02038829|589369192|FG002|Washout Period 1|Death|0|||
163178217|NCT02038829|589369193|FG003|Washout Period 1|Death|0|||
163178218|NCT02038829|589369194|FG004|Washout Period 1|Death|1|||
163178219|NCT02038829|589369195|FG005|Washout Period 1|Death|0|||
163178220|NCT02038829|589369196|FG006|Washout Period 1|Death|0|||
163178221|NCT02038829|589369197|FG007|Washout Period 1|Death|0|||
163178222|NCT02038829|589369198|FG008|Washout Period 1|Death|0|||
163178223|NCT02038829|589369199|FG009|Washout Period 1|Death|0|||
163178224|NCT02038829|589369200|FG010|Washout Period 1|Death|0|||
163178225|NCT02038829|589369201|FG011|Washout Period 1|Death|0|||
163178226|NCT02038829|589369190|FG000|Treatment Period 2|Adverse Event|0|||
163178227|NCT02038829|589369191|FG001|Treatment Period 2|Adverse Event|0|||
163178228|NCT02038829|589369192|FG002|Treatment Period 2|Adverse Event|0|||
163178229|NCT02038829|589369193|FG003|Treatment Period 2|Adverse Event|0|||
163178230|NCT02038829|589369194|FG004|Treatment Period 2|Adverse Event|0|||
163178231|NCT02038829|589369195|FG005|Treatment Period 2|Adverse Event|0|||
163178232|NCT02038829|589369196|FG006|Treatment Period 2|Adverse Event|0|||
163178233|NCT02038829|589369197|FG007|Treatment Period 2|Adverse Event|0|||
163178234|NCT02038829|589369198|FG008|Treatment Period 2|Adverse Event|0|||
163178235|NCT02038829|589369199|FG009|Treatment Period 2|Adverse Event|0|||
163178236|NCT02038829|589369200|FG010|Treatment Period 2|Adverse Event|1|||
163178237|NCT02038829|589369201|FG011|Treatment Period 2|Adverse Event|0|||
163178238|NCT02038829|589369190|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163178239|NCT02038829|589369191|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163178240|NCT02038829|589369192|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163178241|NCT02038829|589369193|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163178242|NCT02038829|589369194|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163178243|NCT02038829|589369195|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163178244|NCT02038829|589369196|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163178245|NCT02038829|589369197|FG007|Treatment Period 2|Withdrawal by Subject|0|||
163178246|NCT02038829|589369198|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162933562|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Adverse Event|4|||
162933563|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Adverse Event|2|||
162933564|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Adverse Event|0|||
162933565|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Adverse Event|1|||
162933566|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933567|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
162933568|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933569|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933570|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
162933571|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933572|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
162933573|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162933574|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
162933575|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
162933576|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
162933577|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
162933578|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
162933579|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
162933580|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
162933581|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933582|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
162933583|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933584|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
162933585|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
162933586|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
162933587|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Physician Decision|0|||
162933588|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Physician Decision|5|||
162933589|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Physician Decision|1|||
162933590|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162933591|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Physician Decision|3|||
162933592|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Physician Decision|1|||
162933593|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Physician Decision|2|||
162933594|NCT00606684|588462234|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162933595|NCT00606684|588462235|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162933596|NCT00606684|588462236|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162933597|NCT00606684|588462237|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162933598|NCT00606684|588462238|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162933599|NCT00606684|588462239|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162933600|NCT00606684|588462240|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162933601|NCT03568500|588462241|FG000|Overall Study|Lost to Follow-up|1|||
162933602|NCT03568500|588462242|FG001|Overall Study|Lost to Follow-up|1|||
162933603|NCT03568500|588462243|FG002|Overall Study|Lost to Follow-up|2|||
162933604|NCT03568500|588462241|FG000|Overall Study|Adverse Event|1|||
162933605|NCT03568500|588462242|FG001|Overall Study|Adverse Event|1|||
162933606|NCT03568500|588462243|FG002|Overall Study|Adverse Event|2|||
162933607|NCT03568500|588462241|FG000|Overall Study|Physician Decision|1|||
162933608|NCT03568500|588462242|FG001|Overall Study|Physician Decision|0|||
162933609|NCT03568500|588462243|FG002|Overall Study|Physician Decision|0|||
162933610|NCT03568500|588462241|FG000|Overall Study|Withdrawal by Subject|4|||
162933611|NCT03568500|588462242|FG001|Overall Study|Withdrawal by Subject|2|||
162933612|NCT03568500|588462243|FG002|Overall Study|Withdrawal by Subject|0|||
162933613|NCT03568500|588462241|FG000|Overall Study|Technical Problems|2|||
162933614|NCT03568500|588462242|FG001|Overall Study|Technical Problems|1|||
162933615|NCT03568500|588462243|FG002|Overall Study|Technical Problems|0|||
162933616|NCT03568500|588462241|FG000|Overall Study|Participant Noncompliance|1|||
162933617|NCT03568500|588462242|FG001|Overall Study|Participant Noncompliance|1|||
162933618|NCT03568500|588462243|FG002|Overall Study|Participant Noncompliance|0|||
162933619|NCT01759381|588462252|FG000|Overall Study|Death|1|||
162933620|NCT01759381|588462253|FG001|Overall Study|Death|0|||
162933621|NCT03377556|588462258|FG000|Overall Study|Adverse Event|5|||
162933622|NCT03377556|588462258|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162933623|NCT03377556|588462258|FG000|Overall Study|Progression/relapse|38|||
162933624|NCT03377556|588462258|FG000|Overall Study|Death|3|||
162933625|NCT00910858|588462259|FG000|Pharmacokinetic Phase|Adverse Event|1|||
162933626|NCT00910858|588462260|FG001|Pharmacokinetic Phase|Adverse Event|0|||
162933627|NCT00910858|588462261|FG002|Pharmacokinetic Phase|Adverse Event|0|||
162933628|NCT00910858|588462259|FG000|Monotherapy Phase|Adverse Event|3|||
162933629|NCT00910858|588462260|FG001|Monotherapy Phase|Adverse Event|2|||
162933630|NCT00910858|588462261|FG002|Monotherapy Phase|Adverse Event|0|||
162933631|NCT00910858|588462259|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
162933632|NCT00910858|588462260|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
162933633|NCT00910858|588462261|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
162933634|NCT00910858|588462259|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
162933635|NCT00910858|588462260|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
162933636|NCT00910858|588462261|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
162933637|NCT00910858|588462259|FG000|Monotherapy Phase|Protocol Violation|1|||
162933638|NCT00910858|588462260|FG001|Monotherapy Phase|Protocol Violation|0|||
162933639|NCT00910858|588462261|FG002|Monotherapy Phase|Protocol Violation|0|||
162933640|NCT00910858|588462259|FG000|Monotherapy Phase|Other|3|||
162933641|NCT00910858|588462260|FG001|Monotherapy Phase|Other|4|||
162933642|NCT00910858|588462261|FG002|Monotherapy Phase|Other|2|||
162933643|NCT00910858|588462259|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
162933644|NCT00910858|588462260|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
162933645|NCT00910858|588462261|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
162933646|NCT00910858|588462259|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
162933647|NCT00910858|588462260|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
162933648|NCT00910858|588462261|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
162933649|NCT00910858|588462259|FG000|Combined Treatment Phase|Protocol Violation|1|||
162933650|NCT00910858|588462260|FG001|Combined Treatment Phase|Protocol Violation|0|||
163178247|NCT02038829|589369199|FG009|Treatment Period 2|Withdrawal by Subject|0|||
163178248|NCT02038829|589369200|FG010|Treatment Period 2|Withdrawal by Subject|0|||
163178249|NCT02038829|589369201|FG011|Treatment Period 2|Withdrawal by Subject|0|||
163178250|NCT02038829|589369190|FG000|Washout Period 2|Adverse Event|0|||
163178251|NCT02038829|589369191|FG001|Washout Period 2|Adverse Event|0|||
163178252|NCT02038829|589369192|FG002|Washout Period 2|Adverse Event|0|||
163178253|NCT02038829|589369193|FG003|Washout Period 2|Adverse Event|0|||
163178254|NCT02038829|589369194|FG004|Washout Period 2|Adverse Event|0|||
163178255|NCT02038829|589369195|FG005|Washout Period 2|Adverse Event|0|||
163178256|NCT02038829|589369196|FG006|Washout Period 2|Adverse Event|0|||
163178257|NCT02038829|589369197|FG007|Washout Period 2|Adverse Event|0|||
163178258|NCT02038829|589369198|FG008|Washout Period 2|Adverse Event|1|||
163178259|NCT02038829|589369199|FG009|Washout Period 2|Adverse Event|0|||
163178260|NCT02038829|589369200|FG010|Washout Period 2|Adverse Event|0|||
163178261|NCT02038829|589369201|FG011|Washout Period 2|Adverse Event|0|||
163178262|NCT02038829|589369190|FG000|Washout Period 2|Withdrawal by Subject|0|||
163178263|NCT02038829|589369191|FG001|Washout Period 2|Withdrawal by Subject|0|||
163178264|NCT02038829|589369192|FG002|Washout Period 2|Withdrawal by Subject|0|||
163178265|NCT02038829|589369193|FG003|Washout Period 2|Withdrawal by Subject|0|||
163178266|NCT02038829|589369194|FG004|Washout Period 2|Withdrawal by Subject|0|||
163178267|NCT02038829|589369195|FG005|Washout Period 2|Withdrawal by Subject|1|||
163178268|NCT02038829|589369196|FG006|Washout Period 2|Withdrawal by Subject|0|||
163178269|NCT02038829|589369197|FG007|Washout Period 2|Withdrawal by Subject|0|||
163178270|NCT02038829|589369198|FG008|Washout Period 2|Withdrawal by Subject|0|||
163178271|NCT02038829|589369199|FG009|Washout Period 2|Withdrawal by Subject|0|||
163178272|NCT02038829|589369200|FG010|Washout Period 2|Withdrawal by Subject|0|||
163178273|NCT02038829|589369201|FG011|Washout Period 2|Withdrawal by Subject|0|||
163178274|NCT02038829|589369190|FG000|Treatment Period 4|Adverse Event|0|||
163178275|NCT02038829|589369191|FG001|Treatment Period 4|Adverse Event|1|||
163178276|NCT02038829|589369192|FG002|Treatment Period 4|Adverse Event|0|||
163178277|NCT02038829|589369193|FG003|Treatment Period 4|Adverse Event|0|||
163178278|NCT02038829|589369194|FG004|Treatment Period 4|Adverse Event|0|||
163178279|NCT02038829|589369195|FG005|Treatment Period 4|Adverse Event|0|||
163178280|NCT02038829|589369196|FG006|Treatment Period 4|Adverse Event|0|||
163178281|NCT02038829|589369197|FG007|Treatment Period 4|Adverse Event|0|||
163178282|NCT02038829|589369198|FG008|Treatment Period 4|Adverse Event|0|||
163178283|NCT02038829|589369199|FG009|Treatment Period 4|Adverse Event|0|||
163178284|NCT02038829|589369200|FG010|Treatment Period 4|Adverse Event|0|||
163178285|NCT02038829|589369201|FG011|Treatment Period 4|Adverse Event|0|||
163178286|NCT02038829|589369190|FG000|Washout Period 4|Adverse Event|0|||
163178287|NCT02038829|589369191|FG001|Washout Period 4|Adverse Event|0|||
163178288|NCT02038829|589369192|FG002|Washout Period 4|Adverse Event|0|||
163178289|NCT02038829|589369193|FG003|Washout Period 4|Adverse Event|0|||
163178290|NCT02038829|589369194|FG004|Washout Period 4|Adverse Event|0|||
163178291|NCT02038829|589369195|FG005|Washout Period 4|Adverse Event|0|||
163178292|NCT02038829|589369196|FG006|Washout Period 4|Adverse Event|1|||
163178293|NCT02038829|589369197|FG007|Washout Period 4|Adverse Event|0|||
163178294|NCT02038829|589369198|FG008|Washout Period 4|Adverse Event|0|||
163178295|NCT02038829|589369199|FG009|Washout Period 4|Adverse Event|0|||
163178296|NCT02038829|589369200|FG010|Washout Period 4|Adverse Event|0|||
163178297|NCT02038829|589369201|FG011|Washout Period 4|Adverse Event|0|||
163178298|NCT02038829|589369190|FG000|Treatment Period 6|Adverse Event|0|||
163178299|NCT02038829|589369191|FG001|Treatment Period 6|Adverse Event|0|||
163178300|NCT02038829|589369192|FG002|Treatment Period 6|Adverse Event|1|||
163178301|NCT02038829|589369193|FG003|Treatment Period 6|Adverse Event|0|||
163178302|NCT02038829|589369194|FG004|Treatment Period 6|Adverse Event|0|||
163178303|NCT02038829|589369195|FG005|Treatment Period 6|Adverse Event|0|||
163178304|NCT02038829|589369196|FG006|Treatment Period 6|Adverse Event|0|||
163178305|NCT02038829|589369197|FG007|Treatment Period 6|Adverse Event|0|||
163178306|NCT02038829|589369198|FG008|Treatment Period 6|Adverse Event|0|||
163178307|NCT02038829|589369199|FG009|Treatment Period 6|Adverse Event|0|||
163178308|NCT02038829|589369200|FG010|Treatment Period 6|Adverse Event|0|||
163178309|NCT02038829|589369201|FG011|Treatment Period 6|Adverse Event|0|||
163178310|NCT04393298|589369202|FG000|Overall Study|Adverse Event|0|||
163178311|NCT04393298|589369203|FG001|Overall Study|Adverse Event|0|||
163178312|NCT04393298|589369204|FG002|Overall Study|Adverse Event|0|||
163178313|NCT04393298|589369205|FG003|Overall Study|Adverse Event|0|||
163178314|NCT04393298|589369206|FG004|Overall Study|Adverse Event|1|||
163178315|NCT04393298|589369207|FG005|Overall Study|Adverse Event|0|||
163178316|NCT04393298|589369208|FG006|Overall Study|Adverse Event|0|||
163178317|NCT04393298|589369209|FG007|Overall Study|Adverse Event|0|||
163178318|NCT04393298|589369210|FG008|Overall Study|Adverse Event|2|||
163178319|NCT04393298|589369211|FG009|Overall Study|Adverse Event|0|||
163178320|NCT04393298|589369212|FG010|Overall Study|Adverse Event|0|||
163178321|NCT04393298|589369213|FG011|Overall Study|Adverse Event|0|||
163178322|NCT04393298|589369214|FG012|Overall Study|Adverse Event|1|||
163178323|NCT04393298|589369215|FG013|Overall Study|Adverse Event|1|||
162933651|NCT00910858|588462261|FG002|Combined Treatment Phase|Protocol Violation|0|||
162933652|NCT00910858|588462259|FG000|Combined Treatment Phase|Other|0|||
162933653|NCT00910858|588462260|FG001|Combined Treatment Phase|Other|2|||
163178324|NCT04393298|589369216|FG014|Overall Study|Adverse Event|0|||
163178325|NCT04393298|589369202|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178326|NCT04393298|589369203|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178327|NCT04393298|589369204|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
163178328|NCT04393298|589369205|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178329|NCT04393298|589369206|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178330|NCT04393298|589369207|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178331|NCT04393298|589369208|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178332|NCT04393298|589369209|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178333|NCT04393298|589369210|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178334|NCT04393298|589369211|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178335|NCT04393298|589369212|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178336|NCT04393298|589369213|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178337|NCT04393298|589369214|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178338|NCT04393298|589369215|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
163178339|NCT04393298|589369216|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
163178340|NCT04393298|589369202|FG000|Overall Study|Lack of Efficacy|0|||
163178341|NCT04393298|589369203|FG001|Overall Study|Lack of Efficacy|0|||
163178342|NCT04393298|589369204|FG002|Overall Study|Lack of Efficacy|0|||
163178343|NCT04393298|589369205|FG003|Overall Study|Lack of Efficacy|0|||
163178344|NCT04393298|589369206|FG004|Overall Study|Lack of Efficacy|0|||
163178345|NCT04393298|589369207|FG005|Overall Study|Lack of Efficacy|0|||
163178346|NCT04393298|589369208|FG006|Overall Study|Lack of Efficacy|0|||
163178347|NCT04393298|589369209|FG007|Overall Study|Lack of Efficacy|0|||
163178348|NCT04393298|589369210|FG008|Overall Study|Lack of Efficacy|0|||
163178349|NCT04393298|589369211|FG009|Overall Study|Lack of Efficacy|0|||
163178350|NCT04393298|589369212|FG010|Overall Study|Lack of Efficacy|0|||
163178351|NCT04393298|589369213|FG011|Overall Study|Lack of Efficacy|0|||
163178352|NCT04393298|589369214|FG012|Overall Study|Lack of Efficacy|0|||
163178353|NCT04393298|589369215|FG013|Overall Study|Lack of Efficacy|0|||
163178354|NCT04393298|589369216|FG014|Overall Study|Lack of Efficacy|1|||
163178355|NCT04393298|589369202|FG000|Overall Study|Progression|1|||
163178356|NCT04393298|589369203|FG001|Overall Study|Progression|0|||
163178357|NCT04393298|589369204|FG002|Overall Study|Progression|0|||
163178358|NCT04393298|589369205|FG003|Overall Study|Progression|0|||
163178359|NCT04393298|589369206|FG004|Overall Study|Progression|0|||
163178360|NCT04393298|589369207|FG005|Overall Study|Progression|0|||
163178361|NCT04393298|589369208|FG006|Overall Study|Progression|0|||
163178362|NCT04393298|589369209|FG007|Overall Study|Progression|0|||
163178363|NCT04393298|589369210|FG008|Overall Study|Progression|0|||
163178364|NCT04393298|589369211|FG009|Overall Study|Progression|0|||
163178365|NCT04393298|589369212|FG010|Overall Study|Progression|1|||
163178366|NCT04393298|589369213|FG011|Overall Study|Progression|1|||
163178367|NCT04393298|589369214|FG012|Overall Study|Progression|0|||
163178368|NCT04393298|589369215|FG013|Overall Study|Progression|0|||
163178369|NCT04393298|589369216|FG014|Overall Study|Progression|0|||
163178370|NCT04393298|589369202|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
163178371|NCT04393298|589369203|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178372|NCT04393298|589369204|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178373|NCT04393298|589369205|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178374|NCT04393298|589369206|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178375|NCT04393298|589369207|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178376|NCT04393298|589369208|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178377|NCT04393298|589369209|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178378|NCT04393298|589369210|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178379|NCT04393298|589369211|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178380|NCT04393298|589369212|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
162933654|NCT00910858|588462261|FG002|Combined Treatment Phase|Other|1|||
162933655|NCT00827827|588462262|FG000|Overall Study|Lost to Follow-up|3|||
163178381|NCT04393298|589369213|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178382|NCT04393298|589369214|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178383|NCT04393298|589369215|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178384|NCT04393298|589369216|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
163178385|NCT04393298|589369202|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178386|NCT04393298|589369203|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
163178387|NCT04393298|589369204|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162933656|NCT00827827|588462263|FG001|Overall Study|Lost to Follow-up|0|||
163178388|NCT04393298|589369205|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162933657|NCT00827827|588462262|FG000|Overall Study|Fall at home- hospitalization|1|||
162933658|NCT00827827|588462263|FG001|Overall Study|Fall at home- hospitalization|0|||
162933659|NCT00827827|588462262|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
163178389|NCT04393298|589369206|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178390|NCT04393298|589369207|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178391|NCT04393298|589369208|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178392|NCT04393298|589369209|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178393|NCT04393298|589369210|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178394|NCT04393298|589369211|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178395|NCT04393298|589369212|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178396|NCT04393298|589369213|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178397|NCT04393298|589369214|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178398|NCT04393298|589369215|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178399|NCT04393298|589369216|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163178400|NCT04393298|589369202|FG000|Overall Study|Clinical Progression|0|||
163178401|NCT04393298|589369203|FG001|Overall Study|Clinical Progression|2|||
163178402|NCT04393298|589369204|FG002|Overall Study|Clinical Progression|0|||
163178403|NCT04393298|589369205|FG003|Overall Study|Clinical Progression|0|||
163178404|NCT04393298|589369206|FG004|Overall Study|Clinical Progression|0|||
163178405|NCT04393298|589369207|FG005|Overall Study|Clinical Progression|0|||
163178406|NCT04393298|589369208|FG006|Overall Study|Clinical Progression|0|||
163178407|NCT04393298|589369209|FG007|Overall Study|Clinical Progression|0|||
163178408|NCT04393298|589369210|FG008|Overall Study|Clinical Progression|0|||
163178409|NCT04393298|589369211|FG009|Overall Study|Clinical Progression|0|||
163178410|NCT04393298|589369212|FG010|Overall Study|Clinical Progression|0|||
163178411|NCT04393298|589369213|FG011|Overall Study|Clinical Progression|0|||
163178412|NCT04393298|589369214|FG012|Overall Study|Clinical Progression|0|||
163178413|NCT04393298|589369215|FG013|Overall Study|Clinical Progression|0|||
163178414|NCT04393298|589369216|FG014|Overall Study|Clinical Progression|0|||
163178415|NCT04393298|589369202|FG000|Overall Study|Disease Progression|0|||
163178416|NCT04393298|589369203|FG001|Overall Study|Disease Progression|1|||
163178417|NCT04393298|589369204|FG002|Overall Study|Disease Progression|0|||
163178418|NCT04393298|589369205|FG003|Overall Study|Disease Progression|0|||
163178419|NCT04393298|589369206|FG004|Overall Study|Disease Progression|0|||
163178420|NCT04393298|589369207|FG005|Overall Study|Disease Progression|3|||
163178421|NCT04393298|589369208|FG006|Overall Study|Disease Progression|2|||
163178422|NCT04393298|589369209|FG007|Overall Study|Disease Progression|1|||
163178423|NCT04393298|589369210|FG008|Overall Study|Disease Progression|2|||
163178424|NCT04393298|589369211|FG009|Overall Study|Disease Progression|1|||
163178425|NCT04393298|589369212|FG010|Overall Study|Disease Progression|0|||
163178426|NCT04393298|589369213|FG011|Overall Study|Disease Progression|3|||
163178427|NCT04393298|589369214|FG012|Overall Study|Disease Progression|0|||
163178428|NCT04393298|589369215|FG013|Overall Study|Disease Progression|0|||
163178429|NCT04393298|589369216|FG014|Overall Study|Disease Progression|1|||
163178430|NCT04393298|589369202|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178431|NCT04393298|589369203|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178432|NCT04393298|589369204|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
163178433|NCT04393298|589369205|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178434|NCT04393298|589369206|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178435|NCT04393298|589369207|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178436|NCT04393298|589369208|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178437|NCT04393298|589369209|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178438|NCT04393298|589369210|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178439|NCT04393298|589369211|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178440|NCT04393298|589369212|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178441|NCT04393298|589369213|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178442|NCT04393298|589369214|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178443|NCT04393298|589369215|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178444|NCT04393298|589369216|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163178445|NCT04393298|589369202|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178446|NCT04393298|589369203|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178447|NCT04393298|589369204|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
163178448|NCT04393298|589369205|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178449|NCT04393298|589369206|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178450|NCT04393298|589369207|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178451|NCT04393298|589369208|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178452|NCT04393298|589369209|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178453|NCT04393298|589369210|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178454|NCT04393298|589369211|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
162933660|NCT00827827|588462263|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
162933661|NCT00827827|588462262|FG000|Overall Study|Gout|1|||
162933662|NCT00827827|588462263|FG001|Overall Study|Gout|0|||
162933663|NCT00827827|588462262|FG000|Overall Study|Transportation issues|1|||
162933664|NCT00827827|588462263|FG001|Overall Study|Transportation issues|0|||
162933665|NCT00827827|588462262|FG000|Overall Study|Burned with water at home|1|||
162933666|NCT00827827|588462263|FG001|Overall Study|Burned with water at home|0|||
162933667|NCT01907737|588462275|FG000|Overall Study|Withdrawal by Subject|1|||
162933668|NCT01165684|588462276|FG000|Overall Study|Adverse Event|1|||
162933669|NCT01165684|588462277|FG001|Overall Study|Adverse Event|1|||
162933670|NCT01165684|588462276|FG000|Overall Study|Lack of Efficacy|2|||
162933671|NCT01165684|588462277|FG001|Overall Study|Lack of Efficacy|1|||
162933672|NCT01165684|588462276|FG000|Overall Study|Protocol Violation|7|||
162933673|NCT01165684|588462277|FG001|Overall Study|Protocol Violation|15|||
162933674|NCT01165684|588462276|FG000|Overall Study|Withdrawal Criteria|2|||
162933675|NCT01165684|588462277|FG001|Overall Study|Withdrawal Criteria|13|||
162933676|NCT01165684|588462276|FG000|Overall Study|Unclassified|16|||
162933677|NCT01165684|588462277|FG001|Overall Study|Unclassified|22|||
162933678|NCT01886300|588462298|FG000|Overall Study|Trial terminated by sponsor|16|||
162933679|NCT00901628|588462299|FG000|Overall Study|disconnection of catheter|4|||
162933680|NCT00901628|588462300|FG001|Overall Study|disconnection of catheter|8|||
162933681|NCT00901628|588462299|FG000|Overall Study|disconnection of drain|0|||
162933682|NCT00901628|588462300|FG001|Overall Study|disconnection of drain|1|||
162933683|NCT00901628|588462299|FG000|Overall Study|peroneal nerve palsy|0|||
162933684|NCT00901628|588462300|FG001|Overall Study|peroneal nerve palsy|1|||
162933685|NCT00608205|588462301|FG000|Overall Study|Adverse Event|3|||
162933686|NCT00608205|588462302|FG001|Overall Study|Adverse Event|2|||
162933687|NCT00608205|588462301|FG000|Overall Study|Patient non-compliant|0|||
162933688|NCT00608205|588462302|FG001|Overall Study|Patient non-compliant|1|||
162933689|NCT02008721|588462305|FG000|Overall Study|Withdrawal by Subject|5|||
162933690|NCT02008721|588462306|FG001|Overall Study|Withdrawal by Subject|1|||
162933691|NCT02008721|588462305|FG000|Overall Study|Death|4|||
162933692|NCT02008721|588462306|FG001|Overall Study|Death|2|||
162933693|NCT02008721|588462305|FG000|Overall Study|Adverse Event|3|||
162933694|NCT02008721|588462306|FG001|Overall Study|Adverse Event|5|||
162933695|NCT02008721|588462305|FG000|Overall Study|Protocol Violation|3|||
162933696|NCT02008721|588462306|FG001|Overall Study|Protocol Violation|2|||
162933697|NCT00295854|588462307|FG000|Overall Study|Adverse Event|7|||
162933698|NCT00295854|588462308|FG001|Overall Study|Adverse Event|7|||
162933699|NCT00295854|588462309|FG002|Overall Study|Adverse Event|6|||
162933700|NCT00295854|588462307|FG000|Overall Study|Protocol Violation|1|||
162933701|NCT00295854|588462308|FG001|Overall Study|Protocol Violation|1|||
162933702|NCT00295854|588462309|FG002|Overall Study|Protocol Violation|1|||
162933703|NCT00295854|588462307|FG000|Overall Study|Lost to Follow-up|2|||
162933704|NCT00295854|588462308|FG001|Overall Study|Lost to Follow-up|0|||
162933705|NCT00295854|588462309|FG002|Overall Study|Lost to Follow-up|1|||
162933706|NCT00295854|588462307|FG000|Overall Study|Withdrawal by Subject|3|||
162933707|NCT00295854|588462308|FG001|Overall Study|Withdrawal by Subject|7|||
162933708|NCT00295854|588462309|FG002|Overall Study|Withdrawal by Subject|4|||
162933709|NCT00295854|588462307|FG000|Overall Study|did not continue to meet criteria|1|||
162933710|NCT00295854|588462308|FG001|Overall Study|did not continue to meet criteria|1|||
162933711|NCT00295854|588462309|FG002|Overall Study|did not continue to meet criteria|2|||
162933712|NCT00295854|588462307|FG000|Overall Study|required a prohibited medication|1|||
162933713|NCT00295854|588462308|FG001|Overall Study|required a prohibited medication|0|||
162933714|NCT00295854|588462309|FG002|Overall Study|required a prohibited medication|0|||
162933715|NCT00295854|588462307|FG000|Overall Study|Other|3|||
162933716|NCT00295854|588462308|FG001|Overall Study|Other|5|||
162933717|NCT00295854|588462309|FG002|Overall Study|Other|1|||
162933718|NCT01967888|588462311|FG000|Overall Study|Lost to Follow-up|6|||
162933719|NCT01967888|588462312|FG001|Overall Study|Lost to Follow-up|4|||
163178455|NCT04393298|589369212|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178456|NCT04393298|589369213|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178457|NCT04393298|589369214|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178458|NCT04393298|589369215|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178459|NCT04393298|589369216|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
163178460|NCT04393298|589369202|FG000|Overall Study|Progressive Disease (PD)|0|||
163178461|NCT04393298|589369203|FG001|Overall Study|Progressive Disease (PD)|0|||
163178462|NCT04393298|589369204|FG002|Overall Study|Progressive Disease (PD)|0|||
163178463|NCT04393298|589369205|FG003|Overall Study|Progressive Disease (PD)|3|||
163178464|NCT04393298|589369206|FG004|Overall Study|Progressive Disease (PD)|0|||
163178465|NCT04393298|589369207|FG005|Overall Study|Progressive Disease (PD)|0|||
163178466|NCT04393298|589369208|FG006|Overall Study|Progressive Disease (PD)|0|||
163178467|NCT04393298|589369209|FG007|Overall Study|Progressive Disease (PD)|0|||
163178468|NCT04393298|589369210|FG008|Overall Study|Progressive Disease (PD)|0|||
163178469|NCT04393298|589369211|FG009|Overall Study|Progressive Disease (PD)|0|||
163178470|NCT04393298|589369212|FG010|Overall Study|Progressive Disease (PD)|0|||
163178471|NCT04393298|589369213|FG011|Overall Study|Progressive Disease (PD)|0|||
163178472|NCT04393298|589369214|FG012|Overall Study|Progressive Disease (PD)|0|||
162933720|NCT01967888|588462311|FG000|Overall Study|Withdrawal by Subject|1|||
162933721|NCT01967888|588462312|FG001|Overall Study|Withdrawal by Subject|1|||
162933722|NCT01967888|588462311|FG000|Overall Study|Did Not Have Transplant|1|||
162933723|NCT01967888|588462312|FG001|Overall Study|Did Not Have Transplant|0|||
162933724|NCT01967888|588462311|FG000|Overall Study|Research visit not done, data recorded|1|||
162933725|NCT01967888|588462312|FG001|Overall Study|Research visit not done, data recorded|0|||
162933726|NCT01967888|588462311|FG000|Overall Study|Subject excluded after randomization|1|||
162933727|NCT01967888|588462312|FG001|Overall Study|Subject excluded after randomization|0|||
162933728|NCT01967888|588462311|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
162933729|NCT01967888|588462312|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
162933730|NCT01967888|588462311|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
162933731|NCT01967888|588462312|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
162933732|NCT03175120|588462316|FG000|Overall Study|Adverse Event|2|||
162933733|NCT03175120|588462317|FG001|Overall Study|Adverse Event|2|||
162933734|NCT03175120|588462316|FG000|Overall Study|Protocol Violation|5|||
162933735|NCT03175120|588462317|FG001|Overall Study|Protocol Violation|2|||
162933736|NCT03175120|588462316|FG000|Overall Study|Lost to Follow-up|1|||
162933737|NCT03175120|588462317|FG001|Overall Study|Lost to Follow-up|0|||
162933738|NCT03175120|588462316|FG000|Overall Study|Withdrawal by Subject|2|||
162933739|NCT03175120|588462317|FG001|Overall Study|Withdrawal by Subject|5|||
162933740|NCT03175120|588462316|FG000|Overall Study|Other|2|||
162933741|NCT03175120|588462317|FG001|Overall Study|Other|3|||
162933742|NCT04120194|588462318|FG000|Overall Study|Lost to Follow-up|11|||
162933743|NCT04120194|588462319|FG001|Overall Study|Lost to Follow-up|8|||
162933744|NCT04120194|588462318|FG000|Overall Study|Adverse Event|4|||
162933745|NCT04120194|588462319|FG001|Overall Study|Adverse Event|5|||
162933746|NCT04120194|588462318|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
162933747|NCT04120194|588462319|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
162933748|NCT04120194|588462318|FG000|Overall Study|Miscellaneous|4|||
162933749|NCT04120194|588462319|FG001|Overall Study|Miscellaneous|5|||
162933750|NCT02622074|588462320|FG000|Overall Study|Death|4|||
162933751|NCT02622074|588462321|FG001|Overall Study|Death|0|||
162933752|NCT02622074|588462322|FG002|Overall Study|Death|0|||
162933753|NCT02622074|588462323|FG003|Overall Study|Death|1|||
162933754|NCT02622074|588462324|FG004|Overall Study|Death|1|||
162933755|NCT02622074|588462325|FG005|Overall Study|Death|0|||
162933756|NCT02622074|588462320|FG000|Overall Study|Withdrawal by Subject|0|||
162933757|NCT02622074|588462321|FG001|Overall Study|Withdrawal by Subject|1|||
162933758|NCT02622074|588462322|FG002|Overall Study|Withdrawal by Subject|0|||
162933759|NCT02622074|588462323|FG003|Overall Study|Withdrawal by Subject|0|||
162933760|NCT02622074|588462324|FG004|Overall Study|Withdrawal by Subject|0|||
162933761|NCT02622074|588462325|FG005|Overall Study|Withdrawal by Subject|0|||
162933762|NCT02114931|588462326|FG000|Overall Study|Withdrawal by Subject|15|||
162933763|NCT02114931|588462327|FG001|Overall Study|Withdrawal by Subject|18|||
162933764|NCT02114931|588462326|FG000|Overall Study|Adverse Event|4|||
162933765|NCT02114931|588462327|FG001|Overall Study|Adverse Event|6|||
162933766|NCT02114931|588462326|FG000|Overall Study|Lost to Follow-up|3|||
162933767|NCT02114931|588462327|FG001|Overall Study|Lost to Follow-up|3|||
162933768|NCT02114931|588462326|FG000|Overall Study|Physician Decision|1|||
162933769|NCT02114931|588462327|FG001|Overall Study|Physician Decision|2|||
162933770|NCT02114931|588462326|FG000|Overall Study|Other|2|||
162933771|NCT02114931|588462327|FG001|Overall Study|Other|1|||
162933772|NCT03565211|588462331|FG000|Overall Study|Withdrawal by Subject|2|||
162933773|NCT03565211|588462331|FG000|Overall Study|Lost to Follow-up|1|||
162933774|NCT03565211|588462331|FG000|Overall Study|Adverse Event|44|||
162933775|NCT03565211|588462331|FG000|Overall Study|Personal issues|1|||
162933776|NCT00986154|588462332|FG000|Overall Study|Death|136|||
162933777|NCT00986154|588462333|FG001|Overall Study|Death|127|||
162933778|NCT00986154|588462332|FG000|Overall Study|Lost to Follow-up|7|||
162933779|NCT00986154|588462333|FG001|Overall Study|Lost to Follow-up|4|||
162933780|NCT00986154|588462332|FG000|Overall Study|Withdrawal by Subject|32|||
162933781|NCT00986154|588462333|FG001|Overall Study|Withdrawal by Subject|33|||
162933782|NCT00986154|588462332|FG000|Overall Study|investigator/subject decide not continue|6|||
162933783|NCT00986154|588462333|FG001|Overall Study|investigator/subject decide not continue|3|||
162933784|NCT00986154|588462332|FG000|Overall Study|never received study drug|25|||
162933785|NCT00986154|588462333|FG001|Overall Study|never received study drug|27|||
162933786|NCT00267007|588462334|FG000|Overall Study|Withdrawal by Subject|6|||
162933787|NCT00267007|588462335|FG001|Overall Study|Withdrawal by Subject|0|||
162933788|NCT00267007|588462334|FG000|Overall Study|Lost to Follow-up|1|||
162933789|NCT00267007|588462335|FG001|Overall Study|Lost to Follow-up|0|||
162933790|NCT00267007|588462334|FG000|Overall Study|Non-compliance|0|||
162933791|NCT00267007|588462335|FG001|Overall Study|Non-compliance|1|||
162933792|NCT00267007|588462334|FG000|Overall Study|Adverse Event|1|||
162933793|NCT00267007|588462335|FG001|Overall Study|Adverse Event|0|||
162933794|NCT01684722|588462342|FG000|Overall Study|Lost to Follow-up|78|||
162933795|NCT01684722|588462343|FG001|Overall Study|Lost to Follow-up|56|||
162933796|NCT01684722|588462344|FG002|Overall Study|Lost to Follow-up|75|||
162933797|NCT01684722|588462345|FG003|Overall Study|Lost to Follow-up|89|||
162933798|NCT01684722|588462342|FG000|Overall Study|Death|19|||
162933799|NCT01684722|588462343|FG001|Overall Study|Death|21|||
162933800|NCT01684722|588462344|FG002|Overall Study|Death|19|||
162933801|NCT01684722|588462345|FG003|Overall Study|Death|21|||
162933802|NCT01664494|588462346|FG000|Overall Study|Withdrawal by Subject|27|||
162933803|NCT01664494|588462346|FG000|Overall Study|Death|18|||
162933804|NCT01664494|588462346|FG000|Overall Study|Other|49|||
162933805|NCT01664494|588462346|FG000|Overall Study|Lost to Follow-up|99|||
162933806|NCT00219557|588462347|FG000|Phase 1|Lack of Efficacy|3|||
162933807|NCT00219557|588462348|FG001|Phase 1|Lack of Efficacy|0|||
162933808|NCT00219557|588462349|FG002|Phase 1|Lack of Efficacy|0|||
162933809|NCT00219557|588462347|FG000|Phase 1|Adverse Event|2|||
162933810|NCT00219557|588462348|FG001|Phase 1|Adverse Event|0|||
162933811|NCT00219557|588462349|FG002|Phase 1|Adverse Event|0|||
162933812|NCT00219557|588462347|FG000|Phase 1|Withdrawal by Subject|1|||
162933813|NCT00219557|588462348|FG001|Phase 1|Withdrawal by Subject|0|||
162933814|NCT00219557|588462349|FG002|Phase 1|Withdrawal by Subject|0|||
162933815|NCT00219557|588462347|FG000|Phase 1|Started chemotherapy at other institute|1|||
162933816|NCT00219557|588462348|FG001|Phase 1|Started chemotherapy at other institute|0|||
162933817|NCT00219557|588462349|FG002|Phase 1|Started chemotherapy at other institute|0|||
162933818|NCT00219557|588462347|FG000|Phase 2|Lack of Efficacy|0|||
162933819|NCT00219557|588462348|FG001|Phase 2|Lack of Efficacy|21|||
162933820|NCT00219557|588462349|FG002|Phase 2|Lack of Efficacy|15|||
162933821|NCT00219557|588462347|FG000|Phase 2|Adverse Event|0|||
162933822|NCT00219557|588462348|FG001|Phase 2|Adverse Event|22|||
162933823|NCT00219557|588462349|FG002|Phase 2|Adverse Event|2|||
162933824|NCT00219557|588462347|FG000|Phase 2|Death|0|||
162933825|NCT00219557|588462348|FG001|Phase 2|Death|8|||
162933826|NCT00219557|588462349|FG002|Phase 2|Death|2|||
162933827|NCT00219557|588462347|FG000|Phase 2|Other|0|||
162933828|NCT00219557|588462348|FG001|Phase 2|Other|8|||
162933829|NCT00219557|588462349|FG002|Phase 2|Other|6|||
162933830|NCT00219557|588462347|FG000|Phase 2|Withdrawal by Subject|0|||
162933831|NCT00219557|588462348|FG001|Phase 2|Withdrawal by Subject|9|||
162933832|NCT00219557|588462349|FG002|Phase 2|Withdrawal by Subject|5|||
162933833|NCT00219557|588462347|FG000|Phase 2|Treatment not received|0|||
162933834|NCT00219557|588462348|FG001|Phase 2|Treatment not received|1|||
162933835|NCT00219557|588462349|FG002|Phase 2|Treatment not received|3|||
162933836|NCT03063632|588462350|FG000|Overall Study|Death|4|||
162933837|NCT03063632|588462351|FG001|Overall Study|Death|6|||
162933838|NCT03063632|588462350|FG000|Overall Study|Lost to Follow-up|0|||
162933839|NCT03063632|588462351|FG001|Overall Study|Lost to Follow-up|1|||
162933840|NCT03063632|588462350|FG000|Overall Study|Withdrawal by Subject|0|||
162933841|NCT03063632|588462351|FG001|Overall Study|Withdrawal by Subject|2|||
162933842|NCT03063632|588462350|FG000|Overall Study|Physician Decision|2|||
162933843|NCT03063632|588462351|FG001|Overall Study|Physician Decision|0|||
162933844|NCT03063632|588462350|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
162933845|NCT03063632|588462351|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
162933846|NCT01612156|588462352|FG000|Overall Study|Protocol Violation|2|||
162933847|NCT01612156|588462353|FG001|Overall Study|Protocol Violation|0|||
162933848|NCT00410410|588462354|FG000|Induction Period (IP)|Death|1|||
162933849|NCT00410410|588462355|FG001|Induction Period (IP)|Death|0|||
162933850|NCT00410410|588462356|FG002|Induction Period (IP)|Death|0|||
162933851|NCT00410410|588462357|FG003|Induction Period (IP)|Death|0|||
162933852|NCT00410410|588462358|FG004|Induction Period (IP)|Death|0|||
162933853|NCT00410410|588462359|FG005|Induction Period (IP)|Death|0|||
163178473|NCT04393298|589369215|FG013|Overall Study|Progressive Disease (PD)|0|||
163178474|NCT04393298|589369216|FG014|Overall Study|Progressive Disease (PD)|0|||
163178475|NCT04393298|589369202|FG000|Overall Study|Started a New Cancer Treatment|0|||
163178476|NCT04393298|589369203|FG001|Overall Study|Started a New Cancer Treatment|0|||
163178477|NCT04393298|589369204|FG002|Overall Study|Started a New Cancer Treatment|0|||
163178478|NCT04393298|589369205|FG003|Overall Study|Started a New Cancer Treatment|0|||
163178479|NCT04393298|589369206|FG004|Overall Study|Started a New Cancer Treatment|1|||
163178480|NCT04393298|589369207|FG005|Overall Study|Started a New Cancer Treatment|0|||
163178481|NCT04393298|589369208|FG006|Overall Study|Started a New Cancer Treatment|0|||
163178482|NCT04393298|589369209|FG007|Overall Study|Started a New Cancer Treatment|0|||
162933854|NCT00410410|588462360|FG006|Induction Period (IP)|Death|0|||
163178483|NCT04393298|589369210|FG008|Overall Study|Started a New Cancer Treatment|0|||
162933855|NCT00410410|588462361|FG007|Induction Period (IP)|Death|0|||
162933856|NCT00410410|588462362|FG008|Induction Period (IP)|Death|0|||
162933857|NCT00410410|588462354|FG000|Induction Period (IP)|Adverse Event|3|||
162933858|NCT00410410|588462355|FG001|Induction Period (IP)|Adverse Event|4|||
162933859|NCT00410410|588462356|FG002|Induction Period (IP)|Adverse Event|2|||
162933860|NCT00410410|588462357|FG003|Induction Period (IP)|Adverse Event|4|||
162933861|NCT00410410|588462358|FG004|Induction Period (IP)|Adverse Event|1|||
162933862|NCT00410410|588462359|FG005|Induction Period (IP)|Adverse Event|0|||
162933863|NCT00410410|588462360|FG006|Induction Period (IP)|Adverse Event|0|||
162933864|NCT00410410|588462361|FG007|Induction Period (IP)|Adverse Event|0|||
162933865|NCT00410410|588462362|FG008|Induction Period (IP)|Adverse Event|0|||
162933866|NCT00410410|588462354|FG000|Induction Period (IP)|Lack of Efficacy|26|||
162933867|NCT00410410|588462355|FG001|Induction Period (IP)|Lack of Efficacy|24|||
162933868|NCT00410410|588462356|FG002|Induction Period (IP)|Lack of Efficacy|8|||
162933869|NCT00410410|588462357|FG003|Induction Period (IP)|Lack of Efficacy|8|||
162933870|NCT00410410|588462358|FG004|Induction Period (IP)|Lack of Efficacy|7|||
162933871|NCT00410410|588462359|FG005|Induction Period (IP)|Lack of Efficacy|7|||
162933872|NCT00410410|588462360|FG006|Induction Period (IP)|Lack of Efficacy|0|||
162933873|NCT00410410|588462361|FG007|Induction Period (IP)|Lack of Efficacy|0|||
162933874|NCT00410410|588462362|FG008|Induction Period (IP)|Lack of Efficacy|0|||
162933875|NCT00410410|588462354|FG000|Induction Period (IP)|Lost to Follow-up|2|||
162933876|NCT00410410|588462355|FG001|Induction Period (IP)|Lost to Follow-up|2|||
162933877|NCT00410410|588462356|FG002|Induction Period (IP)|Lost to Follow-up|2|||
162933878|NCT00410410|588462357|FG003|Induction Period (IP)|Lost to Follow-up|3|||
162933879|NCT00410410|588462358|FG004|Induction Period (IP)|Lost to Follow-up|0|||
162933880|NCT00410410|588462359|FG005|Induction Period (IP)|Lost to Follow-up|1|||
162933881|NCT00410410|588462360|FG006|Induction Period (IP)|Lost to Follow-up|0|||
162933882|NCT00410410|588462361|FG007|Induction Period (IP)|Lost to Follow-up|0|||
162933883|NCT00410410|588462362|FG008|Induction Period (IP)|Lost to Follow-up|0|||
162933884|NCT00410410|588462354|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
162933885|NCT00410410|588462355|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
162933886|NCT00410410|588462356|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
162933887|NCT00410410|588462357|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
162933888|NCT00410410|588462358|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
162933889|NCT00410410|588462359|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
162933890|NCT00410410|588462360|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
162933891|NCT00410410|588462361|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
162933892|NCT00410410|588462362|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
162933893|NCT00410410|588462354|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933894|NCT00410410|588462355|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933895|NCT00410410|588462356|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
162933896|NCT00410410|588462357|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933897|NCT00410410|588462358|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933898|NCT00410410|588462359|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933899|NCT00410410|588462360|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933900|NCT00410410|588462361|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933901|NCT00410410|588462362|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
162933902|NCT00410410|588462354|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933903|NCT00410410|588462355|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933904|NCT00410410|588462356|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933905|NCT00410410|588462357|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933906|NCT00410410|588462358|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
162933907|NCT00410410|588462359|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
162933908|NCT00410410|588462360|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933909|NCT00410410|588462361|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933910|NCT00410410|588462362|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
162933911|NCT00410410|588462354|FG000|Induction Period (IP)|Other|0|||
162933912|NCT00410410|588462355|FG001|Induction Period (IP)|Other|0|||
162933913|NCT00410410|588462356|FG002|Induction Period (IP)|Other|1|||
162933914|NCT00410410|588462357|FG003|Induction Period (IP)|Other|0|||
162933915|NCT00410410|588462358|FG004|Induction Period (IP)|Other|0|||
162933916|NCT00410410|588462359|FG005|Induction Period (IP)|Other|0|||
162933917|NCT00410410|588462360|FG006|Induction Period (IP)|Other|0|||
162933918|NCT00410410|588462361|FG007|Induction Period (IP)|Other|0|||
162933919|NCT00410410|588462362|FG008|Induction Period (IP)|Other|0|||
162933920|NCT00410410|588462354|FG000|Maintenance Period (MP)|Death|0|||
162933921|NCT00410410|588462355|FG001|Maintenance Period (MP)|Death|0|||
162933922|NCT00410410|588462356|FG002|Maintenance Period (MP)|Death|0|||
162933923|NCT00410410|588462357|FG003|Maintenance Period (MP)|Death|0|||
162933924|NCT00410410|588462358|FG004|Maintenance Period (MP)|Death|0|||
162933925|NCT00410410|588462359|FG005|Maintenance Period (MP)|Death|0|||
162933926|NCT00410410|588462360|FG006|Maintenance Period (MP)|Death|1|||
162933927|NCT00410410|588462361|FG007|Maintenance Period (MP)|Death|0|||
162933928|NCT00410410|588462362|FG008|Maintenance Period (MP)|Death|0|||
162933929|NCT00410410|588462354|FG000|Maintenance Period (MP)|Adverse Event|0|||
162933930|NCT00410410|588462355|FG001|Maintenance Period (MP)|Adverse Event|0|||
163178484|NCT04393298|589369211|FG009|Overall Study|Started a New Cancer Treatment|0|||
162933931|NCT00410410|588462356|FG002|Maintenance Period (MP)|Adverse Event|0|||
162933932|NCT00410410|588462357|FG003|Maintenance Period (MP)|Adverse Event|0|||
162933933|NCT00410410|588462358|FG004|Maintenance Period (MP)|Adverse Event|0|||
163178485|NCT04393298|589369212|FG010|Overall Study|Started a New Cancer Treatment|0|||
163178486|NCT04393298|589369213|FG011|Overall Study|Started a New Cancer Treatment|0|||
162933934|NCT00410410|588462359|FG005|Maintenance Period (MP)|Adverse Event|0|||
162933935|NCT00410410|588462360|FG006|Maintenance Period (MP)|Adverse Event|1|||
162933936|NCT00410410|588462361|FG007|Maintenance Period (MP)|Adverse Event|3|||
162933937|NCT00410410|588462362|FG008|Maintenance Period (MP)|Adverse Event|0|||
162933938|NCT00410410|588462354|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
162933939|NCT00410410|588462355|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
162933940|NCT00410410|588462356|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
162933941|NCT00410410|588462357|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
162933942|NCT00410410|588462358|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
162933943|NCT00410410|588462359|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
162933944|NCT00410410|588462360|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
162933945|NCT00410410|588462361|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
162933946|NCT00410410|588462362|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
162933947|NCT00410410|588462354|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
162933948|NCT00410410|588462355|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
162933949|NCT00410410|588462356|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
162933950|NCT00410410|588462357|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
162933951|NCT00410410|588462358|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
162933952|NCT00410410|588462359|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
162933953|NCT00410410|588462360|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
162933954|NCT00410410|588462361|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
162933955|NCT00410410|588462362|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
162933956|NCT00410410|588462354|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933957|NCT00410410|588462355|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933958|NCT00410410|588462356|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933959|NCT00410410|588462357|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933960|NCT00410410|588462358|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933961|NCT00410410|588462359|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933962|NCT00410410|588462360|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
162933963|NCT00410410|588462361|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
162933964|NCT00410410|588462362|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
162933965|NCT00410410|588462354|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933966|NCT00410410|588462355|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933967|NCT00410410|588462356|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933968|NCT00410410|588462357|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933969|NCT00410410|588462358|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933970|NCT00410410|588462359|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933971|NCT00410410|588462360|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
162933972|NCT00410410|588462361|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
162933973|NCT00410410|588462362|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
162933974|NCT00410410|588462354|FG000|Open-Label Period (OL)|Death|0|||
162933975|NCT00410410|588462355|FG001|Open-Label Period (OL)|Death|0|||
162933976|NCT00410410|588462356|FG002|Open-Label Period (OL)|Death|0|||
162933977|NCT00410410|588462357|FG003|Open-Label Period (OL)|Death|0|||
162933978|NCT00410410|588462358|FG004|Open-Label Period (OL)|Death|0|||
162933979|NCT00410410|588462359|FG005|Open-Label Period (OL)|Death|0|||
162933980|NCT00410410|588462360|FG006|Open-Label Period (OL)|Death|0|||
162933981|NCT00410410|588462361|FG007|Open-Label Period (OL)|Death|0|||
162933982|NCT00410410|588462362|FG008|Open-Label Period (OL)|Death|1|||
162933983|NCT00410410|588462354|FG000|Open-Label Period (OL)|Adverse Event|0|||
162933984|NCT00410410|588462355|FG001|Open-Label Period (OL)|Adverse Event|0|||
162933985|NCT00410410|588462356|FG002|Open-Label Period (OL)|Adverse Event|0|||
162933986|NCT00410410|588462357|FG003|Open-Label Period (OL)|Adverse Event|0|||
162933987|NCT00410410|588462358|FG004|Open-Label Period (OL)|Adverse Event|0|||
162933988|NCT00410410|588462359|FG005|Open-Label Period (OL)|Adverse Event|0|||
162933989|NCT00410410|588462360|FG006|Open-Label Period (OL)|Adverse Event|0|||
162933990|NCT00410410|588462361|FG007|Open-Label Period (OL)|Adverse Event|0|||
162933991|NCT00410410|588462362|FG008|Open-Label Period (OL)|Adverse Event|10|||
162933992|NCT00410410|588462354|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
162933993|NCT00410410|588462355|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
162933994|NCT00410410|588462356|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
162933995|NCT00410410|588462357|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
162933996|NCT00410410|588462358|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
162933997|NCT00410410|588462359|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
162933998|NCT00410410|588462360|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
162933999|NCT00410410|588462361|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
162934000|NCT00410410|588462362|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
162934001|NCT00410410|588462354|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
162934002|NCT00410410|588462355|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
162934003|NCT00410410|588462356|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
162934004|NCT00410410|588462357|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
162934005|NCT00410410|588462358|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
162934006|NCT00410410|588462359|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
162934007|NCT00410410|588462360|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
162934008|NCT00410410|588462361|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
162934009|NCT00410410|588462362|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
162934010|NCT00410410|588462354|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934011|NCT00410410|588462355|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934012|NCT00410410|588462356|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934013|NCT00410410|588462357|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934014|NCT00410410|588462358|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934015|NCT00410410|588462359|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934016|NCT00410410|588462360|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934017|NCT00410410|588462361|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
162934018|NCT00410410|588462362|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
162934019|NCT00410410|588462354|FG000|Open-Label Period (OL)|Pregnancy|0|||
162934020|NCT00410410|588462355|FG001|Open-Label Period (OL)|Pregnancy|0|||
162934021|NCT00410410|588462356|FG002|Open-Label Period (OL)|Pregnancy|0|||
162934022|NCT00410410|588462357|FG003|Open-Label Period (OL)|Pregnancy|0|||
162934023|NCT00410410|588462358|FG004|Open-Label Period (OL)|Pregnancy|0|||
162934024|NCT00410410|588462359|FG005|Open-Label Period (OL)|Pregnancy|0|||
162934025|NCT00410410|588462360|FG006|Open-Label Period (OL)|Pregnancy|0|||
162934026|NCT00410410|588462361|FG007|Open-Label Period (OL)|Pregnancy|0|||
162934027|NCT00410410|588462362|FG008|Open-Label Period (OL)|Pregnancy|1|||
162934028|NCT00410410|588462354|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934029|NCT00410410|588462355|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934030|NCT00410410|588462356|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934031|NCT00410410|588462357|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934032|NCT00410410|588462358|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934033|NCT00410410|588462359|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934034|NCT00410410|588462360|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934035|NCT00410410|588462361|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
162934036|NCT00410410|588462362|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
162934037|NCT00410410|588462354|FG000|Open-Label Period (OL)|Other|0|||
162934038|NCT00410410|588462355|FG001|Open-Label Period (OL)|Other|0|||
162934039|NCT00410410|588462356|FG002|Open-Label Period (OL)|Other|0|||
162934040|NCT00410410|588462357|FG003|Open-Label Period (OL)|Other|0|||
162934041|NCT00410410|588462358|FG004|Open-Label Period (OL)|Other|0|||
162934042|NCT00410410|588462359|FG005|Open-Label Period (OL)|Other|0|||
162934043|NCT00410410|588462360|FG006|Open-Label Period (OL)|Other|0|||
162934044|NCT00410410|588462361|FG007|Open-Label Period (OL)|Other|0|||
162934045|NCT00410410|588462362|FG008|Open-Label Period (OL)|Other|7|||
162934046|NCT01783496|588462363|FG000|Overall Study|Lost to Follow-up|0|||
162934047|NCT01783496|588462364|FG001|Overall Study|Lost to Follow-up|0|||
162934048|NCT01783496|588462365|FG002|Overall Study|Lost to Follow-up|0|||
162934049|NCT01783496|588462366|FG003|Overall Study|Lost to Follow-up|2|||
162934050|NCT01783496|588462367|FG004|Overall Study|Lost to Follow-up|0|||
162934051|NCT01783496|588462368|FG005|Overall Study|Lost to Follow-up|1|||
162934052|NCT01783496|588462363|FG000|Overall Study|Withdrawal by Subject|1|||
162934053|NCT01783496|588462364|FG001|Overall Study|Withdrawal by Subject|0|||
162934054|NCT01783496|588462365|FG002|Overall Study|Withdrawal by Subject|0|||
162934055|NCT01783496|588462366|FG003|Overall Study|Withdrawal by Subject|0|||
162934056|NCT01783496|588462367|FG004|Overall Study|Withdrawal by Subject|0|||
162934057|NCT01783496|588462368|FG005|Overall Study|Withdrawal by Subject|0|||
162934058|NCT01023269|588462369|FG000|Overall Study|early termination of the study|2|||
162934059|NCT01023269|588462370|FG001|Overall Study|early termination of the study|0|||
162934060|NCT00106028|588462371|FG000|Overall Study|Adverse Event|3|||
162934061|NCT00106028|588462372|FG001|Overall Study|Adverse Event|2|||
162934062|NCT00106028|588462371|FG000|Overall Study|Protocol Violation|1|||
162934063|NCT00106028|588462372|FG001|Overall Study|Protocol Violation|1|||
162934064|NCT00106028|588462371|FG000|Overall Study|Withdrawal by Subject|2|||
162934065|NCT00106028|588462372|FG001|Overall Study|Withdrawal by Subject|8|||
162934066|NCT00106028|588462371|FG000|Overall Study|Lost to Follow-up|0|||
162934067|NCT00106028|588462372|FG001|Overall Study|Lost to Follow-up|1|||
162934068|NCT00947011|588462373|FG000|Overall Study|Study was terminated,PI left institution|12|||
162934069|NCT05266456|588462376|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
162934070|NCT05266456|588462377|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
162934071|NCT05266456|588462378|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
162934072|NCT05266456|588462379|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
162934073|NCT05266456|588462376|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934074|NCT05266456|588462377|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934075|NCT05266456|588462378|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
162934076|NCT05266456|588462379|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
162934077|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
162934078|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
162934079|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
162934080|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
162934081|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934082|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934083|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
162934084|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
162934085|NCT05266456|588462376|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
163178487|NCT04393298|589369214|FG012|Overall Study|Started a New Cancer Treatment|0|||
163178488|NCT04393298|589369215|FG013|Overall Study|Started a New Cancer Treatment|0|||
163178489|NCT04393298|589369216|FG014|Overall Study|Started a New Cancer Treatment|0|||
163178490|NCT04393298|589369202|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178491|NCT04393298|589369203|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178492|NCT04393298|589369204|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178493|NCT04393298|589369205|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178494|NCT04393298|589369206|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
163178495|NCT04393298|589369207|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162698480|NCT02743793|587605510|FG000|Overall Study|Withdrawal by Subject|0|||
162826085|NCT00698997|588075321|FG000|Overall Study|Withdrawal by Subject|7|||
162826086|NCT00698997|588075322|FG001|Overall Study|Withdrawal by Subject|27|||
162826087|NCT00475722|588075323|FG000|Overall Study|Withdrawal by Subject|12|||
162826088|NCT00475722|588075324|FG001|Overall Study|Withdrawal by Subject|12|||
162826089|NCT00475722|588075323|FG000|Overall Study|Protocol Violation|3|||
162826090|NCT00475722|588075324|FG001|Overall Study|Protocol Violation|0|||
162826091|NCT05082376|588075327|FG000|Overall Study|Lost to Follow-up|2|||
162826092|NCT02568475|588075328|FG000|Overall Study|Lost to Follow-up|40|||
162826093|NCT02568475|588075329|FG001|Overall Study|Lost to Follow-up|39|||
162826094|NCT02568475|588075328|FG000|Overall Study|Withdrawal by Subject|2|||
162826095|NCT02568475|588075329|FG001|Overall Study|Withdrawal by Subject|0|||
162826096|NCT02568475|588075328|FG000|Overall Study|Discharged home|4|||
162826097|NCT02568475|588075329|FG001|Overall Study|Discharged home|4|||
162826098|NCT02568475|588075328|FG000|Overall Study|Short-term: Discharge location unknown|4|||
162826099|NCT02568475|588075329|FG001|Overall Study|Short-term: Discharge location unknown|0|||
162826100|NCT02568475|588075328|FG000|Overall Study|Transferred to another facility|1|||
162826101|NCT02568475|588075329|FG001|Overall Study|Transferred to another facility|0|||
162826102|NCT02625233|588075330|FG000|Overall Study|Adverse Event|2|||
162826103|NCT02625233|588075331|FG001|Overall Study|Adverse Event|0|||
162826104|NCT00290186|588075334|FG000|Overall Study|Adverse Event|1|||
162826105|NCT00290186|588075335|FG001|Overall Study|Adverse Event|1|||
162826106|NCT00290186|588075334|FG000|Overall Study|Lost to Follow-up|3|||
162826107|NCT00290186|588075335|FG001|Overall Study|Lost to Follow-up|2|||
162826108|NCT00290186|588075334|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
162826109|NCT00290186|588075335|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
162826110|NCT00290186|588075334|FG000|Overall Study|Withdrawal by Subject|0|||
162826111|NCT00290186|588075335|FG001|Overall Study|Withdrawal by Subject|1|||
162826112|NCT02710136|588075336|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
162826113|NCT02710136|588075337|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
162826114|NCT02269787|588075338|FG000|Overall Study|Lost to Follow-up|20|||
162826115|NCT02269787|588075339|FG001|Overall Study|Lost to Follow-up|6|||
162826116|NCT02269787|588075338|FG000|Overall Study|Death|2|||
162826117|NCT02269787|588075339|FG001|Overall Study|Death|3|||
162826118|NCT02269787|588075338|FG000|Overall Study|Incapacitated|0|||
162826119|NCT02269787|588075339|FG001|Overall Study|Incapacitated|1|||
162826120|NCT00798135|588075340|FG000|Overall Study|Disease progression, relapse|11|||
162826121|NCT00798135|588075340|FG000|Overall Study|Disease progression, refractory|1|||
162826122|NCT00798135|588075340|FG000|Overall Study|Physician Decision|1|||
162826123|NCT02228720|588075341|FG000|Open Label - Day 30|Lost to Follow-up|1|||
162826124|NCT00282295|588075342|FG000|Overall Study|Adverse Event|0|||
162826125|NCT00282295|588075343|FG001|Overall Study|Adverse Event|1|||
162826126|NCT00282295|588075344|FG002|Overall Study|Adverse Event|0|||
162826127|NCT00282295|588075342|FG000|Overall Study|Serious Adverse Events|0|||
162826128|NCT00282295|588075343|FG001|Overall Study|Serious Adverse Events|0|||
162826129|NCT00282295|588075344|FG002|Overall Study|Serious Adverse Events|1|||
162826130|NCT00282295|588075342|FG000|Overall Study|Protocol Violation|0|||
162826131|NCT00282295|588075343|FG001|Overall Study|Protocol Violation|2|||
162826132|NCT00282295|588075344|FG002|Overall Study|Protocol Violation|1|||
162826133|NCT00282295|588075342|FG000|Overall Study|Withdrawal by Subject|2|||
162826134|NCT00282295|588075343|FG001|Overall Study|Withdrawal by Subject|6|||
162826135|NCT00282295|588075344|FG002|Overall Study|Withdrawal by Subject|4|||
162826136|NCT00282295|588075342|FG000|Overall Study|Lost to Follow-up|1|||
162826137|NCT00282295|588075343|FG001|Overall Study|Lost to Follow-up|7|||
162826138|NCT00282295|588075344|FG002|Overall Study|Lost to Follow-up|2|||
162826139|NCT00282295|588075342|FG000|Overall Study|Other|0|||
162826140|NCT00282295|588075343|FG001|Overall Study|Other|1|||
162826141|NCT00282295|588075344|FG002|Overall Study|Other|0|||
162826142|NCT03337542|588075345|FG000|Overall Study|Withdrew Consent|17|||
162826143|NCT03337542|588075345|FG000|Overall Study|Allergic Adverse Event|1|||
162826144|NCT03337542|588075345|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
162826145|NCT03337542|588075345|FG000|Overall Study|Lost to Follow-up|1|||
162826146|NCT03337542|588075345|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
162826147|NCT01401842|588075346|FG000|Overall Study|Withdrawal by Subject|3|||
162826148|NCT01401842|588075347|FG001|Overall Study|Withdrawal by Subject|2|||
162826149|NCT01401842|588075346|FG000|Overall Study|academic reason|4|||
162826150|NCT01401842|588075347|FG001|Overall Study|academic reason|1|||
162826151|NCT01401842|588075346|FG000|Overall Study|changed companies|20|||
162826152|NCT01401842|588075347|FG001|Overall Study|changed companies|34|||
162826153|NCT01401842|588075346|FG000|Overall Study|discharged from US Army|3|||
162826154|NCT01401842|588075347|FG001|Overall Study|discharged from US Army|4|||
162826155|NCT01401842|588075346|FG000|Overall Study|invalid follow-up strength data|1|||
162826156|NCT01401842|588075347|FG001|Overall Study|invalid follow-up strength data|4|||
162826157|NCT01401842|588075346|FG000|Overall Study|on profile|9|||
162826158|NCT01401842|588075347|FG001|Overall Study|on profile|5|||
162826159|NCT01401842|588075346|FG000|Overall Study|other/unknown|28|||
162826160|NCT01401842|588075347|FG001|Overall Study|other/unknown|17|||
162826161|NCT04198623|588077210|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
162826162|NCT04183790|588077211|FG000|Overall Study|Participants did not rollover to Part B|12|||
162826163|NCT04183790|588077212|FG001|Overall Study|Participants did not rollover to Part B|0|||
162826164|NCT04183790|588077211|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
162826165|NCT04183790|588077212|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
162826166|NCT04183790|588077211|FG000|Overall Study|Commercial drug is available for participant|6|||
162826167|NCT04183790|588077212|FG001|Overall Study|Commercial drug is available for participant|0|||
162826168|NCT04183790|588077211|FG000|Overall Study|Adverse Event|1|||
162826169|NCT04183790|588077212|FG001|Overall Study|Adverse Event|0|||
162826170|NCT04183790|588077211|FG000|Overall Study|Not enrolled in 107 study|0|||
162826171|NCT04183790|588077212|FG001|Overall Study|Not enrolled in 107 study|2|||
162826172|NCT01251653|588077213|FG000|Overall Study|Progressive Disease|1|||
162826173|NCT01251653|588077214|FG001|Overall Study|Progressive Disease|7|||
162826174|NCT01251653|588077215|FG002|Overall Study|Progressive Disease|16|||
162826175|NCT01251653|588077216|FG003|Overall Study|Progressive Disease|4|||
162826176|NCT01251653|588077217|FG004|Overall Study|Progressive Disease|0|||
162826177|NCT01251653|588077218|FG005|Overall Study|Progressive Disease|17|||
162826178|NCT01251653|588077219|FG006|Overall Study|Progressive Disease|14|||
162826179|NCT01251653|588077220|FG007|Overall Study|Progressive Disease|7|||
162826180|NCT01251653|588077221|FG008|Overall Study|Progressive Disease|5|||
162826181|NCT01251653|588077213|FG000|Overall Study|Dose-limiting toxicity|0|||
162826182|NCT01251653|588077214|FG001|Overall Study|Dose-limiting toxicity|1|||
162826183|NCT01251653|588077215|FG002|Overall Study|Dose-limiting toxicity|1|||
162826184|NCT01251653|588077216|FG003|Overall Study|Dose-limiting toxicity|1|||
162826185|NCT01251653|588077217|FG004|Overall Study|Dose-limiting toxicity|0|||
162826186|NCT01251653|588077218|FG005|Overall Study|Dose-limiting toxicity|0|||
162826187|NCT01251653|588077219|FG006|Overall Study|Dose-limiting toxicity|2|||
162826188|NCT01251653|588077220|FG007|Overall Study|Dose-limiting toxicity|0|||
162826189|NCT01251653|588077221|FG008|Overall Study|Dose-limiting toxicity|0|||
162826190|NCT01251653|588077213|FG000|Overall Study|Adverse Event|1|||
162826191|NCT01251653|588077214|FG001|Overall Study|Adverse Event|0|||
162826192|NCT01251653|588077215|FG002|Overall Study|Adverse Event|2|||
162826193|NCT01251653|588077216|FG003|Overall Study|Adverse Event|1|||
162826194|NCT01251653|588077217|FG004|Overall Study|Adverse Event|1|||
162826195|NCT01251653|588077218|FG005|Overall Study|Adverse Event|0|||
162826196|NCT01251653|588077219|FG006|Overall Study|Adverse Event|2|||
162826197|NCT01251653|588077220|FG007|Overall Study|Adverse Event|2|||
162826198|NCT01251653|588077221|FG008|Overall Study|Adverse Event|1|||
162826199|NCT01251653|588077213|FG000|Overall Study|Withdrawal by Subject|1|||
162826200|NCT01251653|588077214|FG001|Overall Study|Withdrawal by Subject|0|||
162826201|NCT01251653|588077215|FG002|Overall Study|Withdrawal by Subject|1|||
162826202|NCT01251653|588077216|FG003|Overall Study|Withdrawal by Subject|0|||
162826203|NCT01251653|588077217|FG004|Overall Study|Withdrawal by Subject|1|||
162826204|NCT01251653|588077218|FG005|Overall Study|Withdrawal by Subject|1|||
162826205|NCT01251653|588077219|FG006|Overall Study|Withdrawal by Subject|0|||
162826206|NCT01251653|588077220|FG007|Overall Study|Withdrawal by Subject|1|||
162826207|NCT01251653|588077221|FG008|Overall Study|Withdrawal by Subject|0|||
162826208|NCT01251653|588077213|FG000|Overall Study|Other reason not mentioned above|0|||
162826209|NCT01251653|588077214|FG001|Overall Study|Other reason not mentioned above|0|||
162934086|NCT05266456|588462377|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
162934087|NCT05266456|588462378|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
162934088|NCT05266456|588462379|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
162934089|NCT02746705|588462386|FG000|Overall Study|Physician Decision|1|||
162934090|NCT02746705|588462387|FG001|Overall Study|Physician Decision|1|||
162934091|NCT02746705|588462386|FG000|Overall Study|Lost to Follow-up|1|||
162934092|NCT02746705|588462387|FG001|Overall Study|Lost to Follow-up|0|||
162934093|NCT02746705|588462386|FG000|Overall Study|outlier scores deemed not valid|0|||
162934094|NCT02746705|588462387|FG001|Overall Study|outlier scores deemed not valid|1|||
162934095|NCT00479401|588462388|FG000|Overall Study|Adverse Event|24|||
162934096|NCT00479401|588462389|FG001|Overall Study|Adverse Event|20|||
162934097|NCT00479401|588462390|FG002|Overall Study|Adverse Event|4|||
162934098|NCT00479401|588462388|FG000|Overall Study|Lack of Efficacy|2|||
162934099|NCT00479401|588462389|FG001|Overall Study|Lack of Efficacy|2|||
162934100|NCT00479401|588462390|FG002|Overall Study|Lack of Efficacy|4|||
162934101|NCT00479401|588462388|FG000|Overall Study|Protocol Violation|2|||
162934102|NCT00479401|588462389|FG001|Overall Study|Protocol Violation|1|||
162934103|NCT00479401|588462390|FG002|Overall Study|Protocol Violation|1|||
162934104|NCT00479401|588462388|FG000|Overall Study|Lost to Follow-up|1|||
162934105|NCT00479401|588462389|FG001|Overall Study|Lost to Follow-up|1|||
162934106|NCT00479401|588462390|FG002|Overall Study|Lost to Follow-up|1|||
162934107|NCT00479401|588462388|FG000|Overall Study|Withdrawal by Subject|16|||
162934108|NCT00479401|588462389|FG001|Overall Study|Withdrawal by Subject|10|||
162934109|NCT00479401|588462390|FG002|Overall Study|Withdrawal by Subject|2|||
162934110|NCT00479401|588462388|FG000|Overall Study|Exclusion criteria, relocation|4|||
162934111|NCT00479401|588462389|FG001|Overall Study|Exclusion criteria, relocation|3|||
162934112|NCT00479401|588462390|FG002|Overall Study|Exclusion criteria, relocation|0|||
162934113|NCT01504867|588462391|FG000|Overall Study|Inclusion criteria not met|2|||
162934114|NCT01504867|588462392|FG001|Overall Study|Inclusion criteria not met|2|||
162934115|NCT01504867|588462391|FG000|Overall Study|Consent revoked|5|||
162934116|NCT01504867|588462392|FG001|Overall Study|Consent revoked|1|||
162934117|NCT00378482|588462399|FG000|Overall Study|Lost to Follow-up|1|||
162934118|NCT00378482|588462399|FG000|Overall Study|Lack of Efficacy|8|||
162934119|NCT00378482|588462399|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
162934120|NCT00378482|588462399|FG000|Overall Study|Withdrawal by Subject|4|||
162934121|NCT00378482|588462399|FG000|Overall Study|Adverse Event|9|||
162934122|NCT00928252|588464275|FG000|Overall Study|Physician Decision|3|||
162934123|NCT02257632|588464276|FG000|Overall Study|Withdrawal by Subject|0|||
162934124|NCT02257632|588464277|FG001|Overall Study|Withdrawal by Subject|1|||
162934125|NCT02257632|588464276|FG000|Overall Study|Adverse Event|1|||
162934126|NCT02257632|588464277|FG001|Overall Study|Adverse Event|2|||
162934127|NCT00720798|588464281|FG000|Overall Study|Adverse Event|304|||
162934128|NCT00720798|588464281|FG000|Overall Study|Death|39|||
162934129|NCT00720798|588464281|FG000|Overall Study|Insufficient Therapeutic Response|129|||
162934130|NCT00720798|588464281|FG000|Overall Study|Protocol Violation|4|||
163178496|NCT04393298|589369208|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178497|NCT04393298|589369209|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178498|NCT04393298|589369210|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178499|NCT04393298|589369211|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178500|NCT04393298|589369212|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178501|NCT04393298|589369213|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178502|NCT04393298|589369214|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178503|NCT04393298|589369215|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178504|NCT04393298|589369216|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
163178505|NCT04393298|589369202|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178506|NCT04393298|589369203|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178507|NCT04393298|589369204|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178508|NCT04393298|589369205|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178509|NCT04393298|589369206|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178510|NCT04393298|589369207|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
163178511|NCT04393298|589369208|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178512|NCT04393298|589369209|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178513|NCT04393298|589369210|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162934131|NCT00720798|588464281|FG000|Overall Study|Refused Treatment|151|||
163178514|NCT04393298|589369211|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162934132|NCT00720798|588464281|FG000|Overall Study|Failure to Return|46|||
162934133|NCT00720798|588464281|FG000|Overall Study|Reason not Specified|83|||
162934134|NCT02806232|588464284|FG000|Overall Study|Lost to Follow-up|1|||
162934135|NCT02806232|588464285|FG001|Overall Study|Lost to Follow-up|2|||
162934136|NCT02806232|588464286|FG002|Overall Study|Lost to Follow-up|1|||
162934137|NCT02806232|588464287|FG003|Overall Study|Lost to Follow-up|0|||
162934138|NCT02806232|588464288|FG004|Overall Study|Lost to Follow-up|0|||
162934139|NCT02806232|588464289|FG005|Overall Study|Lost to Follow-up|1|||
162934140|NCT02806232|588464290|FG006|Overall Study|Lost to Follow-up|0|||
162934141|NCT02806232|588464291|FG007|Overall Study|Lost to Follow-up|0|||
162934142|NCT02806232|588464292|FG008|Overall Study|Lost to Follow-up|0|||
162934143|NCT02806232|588464284|FG000|Overall Study|Withdrawal by Subject|0|||
162934144|NCT02806232|588464285|FG001|Overall Study|Withdrawal by Subject|2|||
162934145|NCT02806232|588464286|FG002|Overall Study|Withdrawal by Subject|0|||
162934146|NCT02806232|588464287|FG003|Overall Study|Withdrawal by Subject|0|||
162934147|NCT02806232|588464288|FG004|Overall Study|Withdrawal by Subject|2|||
162934148|NCT02806232|588464289|FG005|Overall Study|Withdrawal by Subject|1|||
162934149|NCT02806232|588464290|FG006|Overall Study|Withdrawal by Subject|0|||
162934150|NCT02806232|588464291|FG007|Overall Study|Withdrawal by Subject|0|||
162934151|NCT02806232|588464292|FG008|Overall Study|Withdrawal by Subject|0|||
162934152|NCT01133821|588464293|FG000|Overall Study|Lost to Follow-up|8|||
162934153|NCT01133821|588464294|FG001|Overall Study|Lost to Follow-up|11|||
162934154|NCT01133821|588464293|FG000|Overall Study|Withdrawal by Subject|8|||
162934155|NCT01133821|588464294|FG001|Overall Study|Withdrawal by Subject|3|||
162934156|NCT01133821|588464293|FG000|Overall Study|preferred other treatment|1|||
162934157|NCT01133821|588464294|FG001|Overall Study|preferred other treatment|1|||
162934158|NCT01133821|588464293|FG000|Overall Study|Protocol Violation|0|||
162934159|NCT01133821|588464294|FG001|Overall Study|Protocol Violation|1|||
162934160|NCT01133821|588464293|FG000|Overall Study|Refused participation|1|||
162934161|NCT01133821|588464294|FG001|Overall Study|Refused participation|3|||
162934162|NCT00434161|588464295|FG000|Overall Study|Adverse Event|5|||
162934163|NCT00434161|588464296|FG001|Overall Study|Adverse Event|1|||
162934164|NCT00434161|588464297|FG002|Overall Study|Adverse Event|4|||
162934165|NCT00434161|588464295|FG000|Overall Study|Lost to Follow-up|0|||
162934166|NCT00434161|588464296|FG001|Overall Study|Lost to Follow-up|1|||
162934167|NCT00434161|588464297|FG002|Overall Study|Lost to Follow-up|0|||
162934168|NCT00434161|588464295|FG000|Overall Study|Death|1|||
162934169|NCT00434161|588464296|FG001|Overall Study|Death|0|||
162934170|NCT00434161|588464297|FG002|Overall Study|Death|1|||
162934171|NCT00434161|588464295|FG000|Overall Study|Non-Compliance|1|||
162934172|NCT00434161|588464296|FG001|Overall Study|Non-Compliance|1|||
162934173|NCT00434161|588464297|FG002|Overall Study|Non-Compliance|0|||
162934174|NCT00434161|588464295|FG000|Overall Study|Withdrawal by Subject|2|||
162934175|NCT00434161|588464296|FG001|Overall Study|Withdrawal by Subject|0|||
162934176|NCT00434161|588464297|FG002|Overall Study|Withdrawal by Subject|3|||
162934177|NCT00434161|588464295|FG000|Overall Study|Logistical error study assessments|1|||
162934178|NCT00434161|588464296|FG001|Overall Study|Logistical error study assessments|0|||
162934179|NCT00434161|588464297|FG002|Overall Study|Logistical error study assessments|3|||
162934180|NCT03342898|588464298|FG000|Overall Study|Adverse Event|3|||
162934181|NCT03342898|588464299|FG001|Overall Study|Adverse Event|1|||
162934182|NCT03342898|588464300|FG002|Overall Study|Adverse Event|0|||
162934183|NCT03342898|588464298|FG000|Overall Study|Lost to Follow-up|44|||
162934184|NCT03342898|588464299|FG001|Overall Study|Lost to Follow-up|40|||
162934185|NCT03342898|588464300|FG002|Overall Study|Lost to Follow-up|42|||
162934186|NCT03342898|588464298|FG000|Overall Study|Withdrawal of Consent|5|||
163042827|NCT01990768|588863968|FG000|6-Month Follow-up|No contact information|5|||
162934187|NCT03342898|588464299|FG001|Overall Study|Withdrawal of Consent|9|||
162934188|NCT03342898|588464300|FG002|Overall Study|Withdrawal of Consent|11|||
162934189|NCT03342898|588464298|FG000|Overall Study|Death|0|||
162934190|NCT03342898|588464299|FG001|Overall Study|Death|1|||
162934191|NCT03342898|588464300|FG002|Overall Study|Death|1|||
162934192|NCT03342898|588464298|FG000|Overall Study|Reason not Specified|2|||
162934193|NCT03342898|588464299|FG001|Overall Study|Reason not Specified|2|||
162934194|NCT03342898|588464300|FG002|Overall Study|Reason not Specified|0|||
162934195|NCT03997448|588464301|FG000|Study Treatment|Disease Progression|1|||
162934196|NCT03997448|588464301|FG000|Study Treatment|Symptomatic Deterioration|1|||
162934197|NCT03997448|588464301|FG000|Follow up|Death|2|||
162934198|NCT03997448|588464301|FG000|Follow up|study terminated|1|||
162934199|NCT01312779|588464302|FG000|Overall Study|Withdrawal by Subject|2|||
162934200|NCT01312779|588464302|FG000|Overall Study|Death|3|||
162934201|NCT01312779|588464302|FG000|Overall Study|Not Implanted with Device|27|||
162934202|NCT01621490|588464303|FG000|Overall Study|Subject no longer meets study criteria|0|||
162934203|NCT01621490|588464304|FG001|Overall Study|Subject no longer meets study criteria|0|||
162934204|NCT01621490|588464305|FG002|Overall Study|Subject no longer meets study criteria|0|||
162934205|NCT01621490|588464306|FG003|Overall Study|Subject no longer meets study criteria|0|||
162934206|NCT01621490|588464307|FG004|Overall Study|Subject no longer meets study criteria|1|||
162934207|NCT01621490|588464308|FG005|Overall Study|Subject no longer meets study criteria|0|||
162934208|NCT01621490|588464309|FG006|Overall Study|Subject no longer meets study criteria|0|||
162934209|NCT01621490|588464310|FG007|Overall Study|Subject no longer meets study criteria|0|||
162934210|NCT01621490|588464311|FG008|Overall Study|Subject no longer meets study criteria|0|||
162934211|NCT01621490|588464312|FG009|Overall Study|Subject no longer meets study criteria|0|||
162934212|NCT01621490|588464313|FG010|Overall Study|Subject no longer meets study criteria|0|||
162934213|NCT01621490|588464303|FG000|Overall Study|Maximum clinical benefit|3|||
162934214|NCT01621490|588464304|FG001|Overall Study|Maximum clinical benefit|2|||
162934215|NCT01621490|588464305|FG002|Overall Study|Maximum clinical benefit|0|||
162934216|NCT01621490|588464306|FG003|Overall Study|Maximum clinical benefit|0|||
162934217|NCT01621490|588464307|FG004|Overall Study|Maximum clinical benefit|0|||
162934218|NCT01621490|588464308|FG005|Overall Study|Maximum clinical benefit|0|||
162934219|NCT01621490|588464309|FG006|Overall Study|Maximum clinical benefit|1|||
162934220|NCT01621490|588464310|FG007|Overall Study|Maximum clinical benefit|2|||
162934221|NCT01621490|588464311|FG008|Overall Study|Maximum clinical benefit|2|||
162934222|NCT01621490|588464312|FG009|Overall Study|Maximum clinical benefit|0|||
162934223|NCT01621490|588464313|FG010|Overall Study|Maximum clinical benefit|0|||
162934224|NCT01621490|588464303|FG000|Overall Study|Withdrawal by Subject|1|||
162934225|NCT01621490|588464304|FG001|Overall Study|Withdrawal by Subject|0|||
162934226|NCT01621490|588464305|FG002|Overall Study|Withdrawal by Subject|0|||
162934227|NCT01621490|588464306|FG003|Overall Study|Withdrawal by Subject|0|||
162934228|NCT01621490|588464307|FG004|Overall Study|Withdrawal by Subject|0|||
162934229|NCT01621490|588464308|FG005|Overall Study|Withdrawal by Subject|1|||
162934230|NCT01621490|588464309|FG006|Overall Study|Withdrawal by Subject|0|||
162934231|NCT01621490|588464310|FG007|Overall Study|Withdrawal by Subject|0|||
162934232|NCT01621490|588464311|FG008|Overall Study|Withdrawal by Subject|0|||
162934233|NCT01621490|588464312|FG009|Overall Study|Withdrawal by Subject|0|||
162934234|NCT01621490|588464313|FG010|Overall Study|Withdrawal by Subject|0|||
162934235|NCT01621490|588464303|FG000|Overall Study|Subject request to discontinue study|1|||
162934236|NCT01621490|588464304|FG001|Overall Study|Subject request to discontinue study|3|||
162934237|NCT01621490|588464305|FG002|Overall Study|Subject request to discontinue study|1|||
162934238|NCT01621490|588464306|FG003|Overall Study|Subject request to discontinue study|1|||
162934239|NCT01621490|588464307|FG004|Overall Study|Subject request to discontinue study|0|||
162934240|NCT01621490|588464308|FG005|Overall Study|Subject request to discontinue study|2|||
162934241|NCT01621490|588464309|FG006|Overall Study|Subject request to discontinue study|1|||
162934242|NCT01621490|588464310|FG007|Overall Study|Subject request to discontinue study|0|||
162934243|NCT01621490|588464311|FG008|Overall Study|Subject request to discontinue study|1|||
162934244|NCT01621490|588464312|FG009|Overall Study|Subject request to discontinue study|0|||
162934245|NCT01621490|588464313|FG010|Overall Study|Subject request to discontinue study|0|||
162934246|NCT01621490|588464303|FG000|Overall Study|Adverse event unrelated to study drug|1|||
162934247|NCT01621490|588464304|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162934248|NCT01621490|588464305|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162934249|NCT01621490|588464306|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162934250|NCT01621490|588464307|FG004|Overall Study|Adverse event unrelated to study drug|0|||
162934251|NCT01621490|588464308|FG005|Overall Study|Adverse event unrelated to study drug|0|||
162934252|NCT01621490|588464309|FG006|Overall Study|Adverse event unrelated to study drug|0|||
162934253|NCT01621490|588464310|FG007|Overall Study|Adverse event unrelated to study drug|2|||
162934254|NCT01621490|588464311|FG008|Overall Study|Adverse event unrelated to study drug|0|||
162934255|NCT01621490|588464312|FG009|Overall Study|Adverse event unrelated to study drug|0|||
162934256|NCT01621490|588464313|FG010|Overall Study|Adverse event unrelated to study drug|0|||
162934257|NCT01621490|588464303|FG000|Overall Study|Disease progression|27|||
162934258|NCT01621490|588464304|FG001|Overall Study|Disease progression|28|||
162934259|NCT01621490|588464305|FG002|Overall Study|Disease progression|1|||
162934260|NCT01621490|588464306|FG003|Overall Study|Disease progression|5|||
162934261|NCT01621490|588464307|FG004|Overall Study|Disease progression|3|||
162934262|NCT01621490|588464308|FG005|Overall Study|Disease progression|8|||
162934263|NCT01621490|588464309|FG006|Overall Study|Disease progression|7|||
162934264|NCT01621490|588464310|FG007|Overall Study|Disease progression|1|||
162934265|NCT01621490|588464311|FG008|Overall Study|Disease progression|4|||
163178515|NCT04393298|589369212|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178516|NCT04393298|589369213|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178517|NCT04393298|589369214|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178518|NCT04393298|589369215|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178519|NCT04393298|589369216|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
163178520|NCT04393298|589369202|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178521|NCT04393298|589369203|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178522|NCT04393298|589369204|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178523|NCT04393298|589369205|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178524|NCT04393298|589369206|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178525|NCT04393298|589369207|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
163178526|NCT04393298|589369208|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178527|NCT04393298|589369209|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178528|NCT04393298|589369210|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178529|NCT04393298|589369211|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178530|NCT04393298|589369212|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178531|NCT04393298|589369213|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178532|NCT04393298|589369214|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178533|NCT04393298|589369215|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163178534|NCT04393298|589369216|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
163178535|NCT04393298|589369202|FG000|Overall Study|Death|0|||
163178536|NCT04393298|589369203|FG001|Overall Study|Death|0|||
163178537|NCT04393298|589369204|FG002|Overall Study|Death|0|||
163178538|NCT04393298|589369205|FG003|Overall Study|Death|0|||
163178539|NCT04393298|589369206|FG004|Overall Study|Death|0|||
163178540|NCT04393298|589369207|FG005|Overall Study|Death|1|||
163178541|NCT04393298|589369208|FG006|Overall Study|Death|1|||
163178542|NCT04393298|589369209|FG007|Overall Study|Death|0|||
163178543|NCT04393298|589369210|FG008|Overall Study|Death|1|||
163178544|NCT04393298|589369211|FG009|Overall Study|Death|1|||
163178545|NCT04393298|589369212|FG010|Overall Study|Death|0|||
163178546|NCT04393298|589369213|FG011|Overall Study|Death|1|||
163178547|NCT04393298|589369214|FG012|Overall Study|Death|1|||
163178548|NCT04393298|589369215|FG013|Overall Study|Death|0|||
163178549|NCT04393298|589369216|FG014|Overall Study|Death|1|||
163178550|NCT04393298|589369202|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178551|NCT04393298|589369203|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178552|NCT04393298|589369204|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178553|NCT04393298|589369205|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178554|NCT04393298|589369206|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178555|NCT04393298|589369207|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
163178556|NCT04393298|589369208|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178557|NCT04393298|589369209|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178558|NCT04393298|589369210|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178559|NCT04393298|589369211|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178560|NCT04393298|589369212|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178561|NCT04393298|589369213|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178562|NCT04393298|589369214|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178563|NCT04393298|589369215|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178564|NCT04393298|589369216|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163178565|NCT04393298|589369202|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
163178566|NCT04393298|589369203|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
163178567|NCT04393298|589369204|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
163178568|NCT04393298|589369205|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
163178569|NCT04393298|589369206|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
163178570|NCT04393298|589369207|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
162934266|NCT01621490|588464312|FG009|Overall Study|Disease progression|1|||
162934267|NCT01621490|588464313|FG010|Overall Study|Disease progression|1|||
162934268|NCT01621490|588464303|FG000|Overall Study|Study drug toxicity|1|||
162934269|NCT01621490|588464304|FG001|Overall Study|Study drug toxicity|4|||
162934270|NCT01621490|588464305|FG002|Overall Study|Study drug toxicity|5|||
162934271|NCT01621490|588464306|FG003|Overall Study|Study drug toxicity|3|||
162934272|NCT01621490|588464307|FG004|Overall Study|Study drug toxicity|1|||
162934273|NCT01621490|588464308|FG005|Overall Study|Study drug toxicity|10|||
162934274|NCT01621490|588464309|FG006|Overall Study|Study drug toxicity|1|||
162934275|NCT01621490|588464310|FG007|Overall Study|Study drug toxicity|4|||
162934276|NCT01621490|588464311|FG008|Overall Study|Study drug toxicity|1|||
162934277|NCT01621490|588464312|FG009|Overall Study|Study drug toxicity|0|||
162934278|NCT01621490|588464313|FG010|Overall Study|Study drug toxicity|0|||
162934279|NCT01621490|588464303|FG000|Overall Study|Death|0|||
162934280|NCT01621490|588464304|FG001|Overall Study|Death|0|||
162934281|NCT01621490|588464305|FG002|Overall Study|Death|0|||
162934282|NCT01621490|588464306|FG003|Overall Study|Death|0|||
162934283|NCT01621490|588464307|FG004|Overall Study|Death|0|||
162934284|NCT01621490|588464308|FG005|Overall Study|Death|0|||
162934285|NCT01621490|588464309|FG006|Overall Study|Death|0|||
162934286|NCT01621490|588464310|FG007|Overall Study|Death|0|||
162934287|NCT01621490|588464311|FG008|Overall Study|Death|1|||
162934288|NCT01621490|588464312|FG009|Overall Study|Death|0|||
162934289|NCT01621490|588464313|FG010|Overall Study|Death|0|||
162934290|NCT01621490|588464303|FG000|Overall Study|Other reasons|7|||
162934291|NCT01621490|588464304|FG001|Overall Study|Other reasons|6|||
162934292|NCT01621490|588464305|FG002|Overall Study|Other reasons|4|||
162934293|NCT01621490|588464306|FG003|Overall Study|Other reasons|1|||
162934294|NCT01621490|588464307|FG004|Overall Study|Other reasons|1|||
162934295|NCT01621490|588464308|FG005|Overall Study|Other reasons|3|||
162934296|NCT01621490|588464309|FG006|Overall Study|Other reasons|1|||
162934297|NCT01621490|588464310|FG007|Overall Study|Other reasons|1|||
162934298|NCT01621490|588464311|FG008|Overall Study|Other reasons|1|||
162934299|NCT01621490|588464312|FG009|Overall Study|Other reasons|0|||
162934300|NCT01621490|588464313|FG010|Overall Study|Other reasons|0|||
162934301|NCT00506753|588464314|FG000|Overall Study|Lost to Follow-up|21|||
162934302|NCT00506753|588464315|FG001|Overall Study|Lost to Follow-up|15|||
162934303|NCT00461500|588464316|FG000|Overall Study|Adverse Event|1|||
162934304|NCT00461500|588464317|FG001|Overall Study|Adverse Event|0|||
162934305|NCT00461500|588464316|FG000|Overall Study|Lack of Efficacy|0|||
162934306|NCT00461500|588464317|FG001|Overall Study|Lack of Efficacy|1|||
162934307|NCT00461500|588464316|FG000|Overall Study|Expired Drug Treatment|1|||
162934308|NCT00461500|588464317|FG001|Overall Study|Expired Drug Treatment|1|||
162934309|NCT00461500|588464316|FG000|Overall Study|Study Stopped|1|||
162934310|NCT00461500|588464317|FG001|Overall Study|Study Stopped|2|||
162934311|NCT00461500|588464316|FG000|Overall Study|Drug Treatment Misuse|1|||
162934312|NCT00461500|588464317|FG001|Overall Study|Drug Treatment Misuse|0|||
162934313|NCT00461500|588464316|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
162934314|NCT00461500|588464317|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
162934315|NCT00461500|588464316|FG000|Overall Study|Lost to Follow-up|2|||
162934316|NCT00461500|588464317|FG001|Overall Study|Lost to Follow-up|2|||
162934317|NCT02482805|588464323|FG000|Overall Study|Lost to Follow-up|4|||
162934318|NCT02482805|588464324|FG001|Overall Study|Lost to Follow-up|4|||
162934319|NCT02482805|588464325|FG002|Overall Study|Lost to Follow-up|0|||
162934320|NCT01144663|588464326|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
162934321|NCT01144663|588464327|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
162934322|NCT01144663|588464328|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
162934323|NCT01144663|588464329|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
162934324|NCT01144663|588464326|FG000|Primary Vaccination Phase|Adverse Event|1|||
162934325|NCT01144663|588464327|FG001|Primary Vaccination Phase|Adverse Event|0|||
162934326|NCT01144663|588464328|FG002|Primary Vaccination Phase|Adverse Event|0|||
162934327|NCT01144663|588464329|FG003|Primary Vaccination Phase|Adverse Event|1|||
162934328|NCT01144663|588464326|FG000|Primary Vaccination Phase|Protocol Violation|2|||
163178571|NCT04393298|589369208|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
162934329|NCT01144663|588464327|FG001|Primary Vaccination Phase|Protocol Violation|0|||
162934330|NCT01144663|588464328|FG002|Primary Vaccination Phase|Protocol Violation|1|||
162934331|NCT01144663|588464329|FG003|Primary Vaccination Phase|Protocol Violation|0|||
162934332|NCT01144663|588464326|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
162934333|NCT01144663|588464327|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
162934334|NCT01144663|588464328|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
162934335|NCT01144663|588464329|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
162934336|NCT01144663|588464326|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
162934337|NCT01144663|588464327|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
163178572|NCT04393298|589369209|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
162934338|NCT01144663|588464328|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
162934339|NCT01144663|588464329|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
162934340|NCT01144663|588464326|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
162934341|NCT01144663|588464327|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
162934342|NCT01144663|588464328|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
162934343|NCT01144663|588464329|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
162934344|NCT01144663|588464326|FG000|Primary Vaccination Phase|Other|0|||
162934345|NCT01144663|588464327|FG001|Primary Vaccination Phase|Other|1|||
162934346|NCT01144663|588464328|FG002|Primary Vaccination Phase|Other|0|||
162934347|NCT01144663|588464329|FG003|Primary Vaccination Phase|Other|2|||
162934348|NCT01144663|588464326|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
162934349|NCT01144663|588464327|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162934350|NCT01144663|588464328|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
162934351|NCT01144663|588464329|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
162934352|NCT01144663|588464326|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934353|NCT01144663|588464327|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934354|NCT01144663|588464328|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
162934355|NCT01144663|588464329|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
162934356|NCT01144663|588464326|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
162934357|NCT01144663|588464327|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
162934358|NCT01144663|588464328|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
162934359|NCT01144663|588464329|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
162934360|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
162934361|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
162934362|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
162934363|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
162934364|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
162934365|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
162934366|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
162934367|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
162934368|NCT01144663|588464326|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
162934369|NCT01144663|588464327|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
162934370|NCT01144663|588464328|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
162934371|NCT01144663|588464329|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
162934372|NCT01267266|588464332|FG000|Enrollment Phase|Withdrawal by Subject|2|||
162934373|NCT01267266|588464333|FG001|Enrollment Phase|Withdrawal by Subject|0|||
162934374|NCT01267266|588464332|FG000|Lead-in Phase|Lack of Efficacy|20|||
162934375|NCT01267266|588464333|FG001|Lead-in Phase|Lack of Efficacy|0|||
162934376|NCT01267266|588464332|FG000|Lead-in Phase|Adverse Event|2|||
162934377|NCT01267266|588464333|FG001|Lead-in Phase|Adverse Event|0|||
162934378|NCT01267266|588464332|FG000|Lead-in Phase|Withdrawal by Subject|1|||
162826210|NCT01251653|588077215|FG002|Overall Study|Other reason not mentioned above|0|||
162826211|NCT01251653|588077216|FG003|Overall Study|Other reason not mentioned above|0|||
162826212|NCT01251653|588077217|FG004|Overall Study|Other reason not mentioned above|0|||
162826213|NCT01251653|588077218|FG005|Overall Study|Other reason not mentioned above|0|||
162826214|NCT01251653|588077219|FG006|Overall Study|Other reason not mentioned above|0|||
162826215|NCT01251653|588077220|FG007|Overall Study|Other reason not mentioned above|2|||
162826216|NCT01251653|588077221|FG008|Overall Study|Other reason not mentioned above|0|||
162826217|NCT00847145|588077222|FG000|Overall Study|AE or Death|0|||
162826218|NCT00847145|588077223|FG001|Overall Study|AE or Death|1|||
162826219|NCT00847145|588077224|FG002|Overall Study|AE or Death|1|||
162934379|NCT01267266|588464333|FG001|Lead-in Phase|Withdrawal by Subject|0|||
162934380|NCT01335477|588464335|FG000|Overall Study|Adverse Event|30|||
162826220|NCT00847145|588077225|FG003|Overall Study|AE or Death|0|||
162826221|NCT00847145|588077226|FG004|Overall Study|AE or Death|0|||
162934381|NCT01335477|588464336|FG001|Overall Study|Adverse Event|42|||
162826222|NCT00847145|588077227|FG005|Overall Study|AE or Death|0|||
162826223|NCT00847145|588077228|FG006|Overall Study|AE or Death|0|||
162826224|NCT00847145|588077229|FG007|Overall Study|AE or Death|0|||
162826225|NCT00847145|588077222|FG000|Overall Study|Withdrawal by Subject|3|||
162826226|NCT00847145|588077223|FG001|Overall Study|Withdrawal by Subject|4|||
162826227|NCT00847145|588077224|FG002|Overall Study|Withdrawal by Subject|6|||
162826228|NCT00847145|588077225|FG003|Overall Study|Withdrawal by Subject|1|||
162826229|NCT00847145|588077226|FG004|Overall Study|Withdrawal by Subject|0|||
162826230|NCT00847145|588077227|FG005|Overall Study|Withdrawal by Subject|0|||
162826231|NCT00847145|588077228|FG006|Overall Study|Withdrawal by Subject|1|||
162826232|NCT00847145|588077229|FG007|Overall Study|Withdrawal by Subject|1|||
162826233|NCT00847145|588077222|FG000|Overall Study|Lost to Follow-up|3|||
162826234|NCT00847145|588077223|FG001|Overall Study|Lost to Follow-up|1|||
162826235|NCT00847145|588077224|FG002|Overall Study|Lost to Follow-up|1|||
162826236|NCT00847145|588077225|FG003|Overall Study|Lost to Follow-up|0|||
162826237|NCT00847145|588077226|FG004|Overall Study|Lost to Follow-up|4|||
162826238|NCT00847145|588077227|FG005|Overall Study|Lost to Follow-up|4|||
162826239|NCT00847145|588077228|FG006|Overall Study|Lost to Follow-up|8|||
162826240|NCT00847145|588077229|FG007|Overall Study|Lost to Follow-up|2|||
162826241|NCT00847145|588077222|FG000|Overall Study|Inappropriate enrollment|0|||
162826242|NCT00847145|588077223|FG001|Overall Study|Inappropriate enrollment|0|||
162826243|NCT00847145|588077224|FG002|Overall Study|Inappropriate enrollment|0|||
162826244|NCT00847145|588077225|FG003|Overall Study|Inappropriate enrollment|0|||
162826245|NCT00847145|588077226|FG004|Overall Study|Inappropriate enrollment|1|||
162826246|NCT00847145|588077227|FG005|Overall Study|Inappropriate enrollment|0|||
162826247|NCT00847145|588077228|FG006|Overall Study|Inappropriate enrollment|0|||
162826248|NCT00847145|588077229|FG007|Overall Study|Inappropriate enrollment|0|||
162826249|NCT00847145|588077222|FG000|Overall Study|Protocol Violation|0|||
162826250|NCT00847145|588077223|FG001|Overall Study|Protocol Violation|0|||
162826251|NCT00847145|588077224|FG002|Overall Study|Protocol Violation|3|||
162826252|NCT00847145|588077225|FG003|Overall Study|Protocol Violation|0|||
162826253|NCT00847145|588077226|FG004|Overall Study|Protocol Violation|1|||
162826254|NCT00847145|588077227|FG005|Overall Study|Protocol Violation|0|||
162826255|NCT00847145|588077228|FG006|Overall Study|Protocol Violation|0|||
162826256|NCT00847145|588077229|FG007|Overall Study|Protocol Violation|1|||
162826257|NCT02833974|588077230|FG000|Overall Study|Lost to Follow-up|1|||
162826258|NCT02833974|588077231|FG001|Overall Study|Lost to Follow-up|0|||
162826259|NCT02833974|588077230|FG000|Overall Study|Adverse Event|0|||
162826260|NCT02833974|588077231|FG001|Overall Study|Adverse Event|3|||
162826261|NCT04419610|588077232|FG000|Overall Study|Withdrawal by Subject|3|||
162826262|NCT04419610|588077233|FG001|Overall Study|Withdrawal by Subject|1|||
162826263|NCT04419610|588077232|FG000|Overall Study|Adverse Event|1|||
162826264|NCT04419610|588077233|FG001|Overall Study|Adverse Event|0|||
162826265|NCT04419610|588077232|FG000|Overall Study|discharged early|1|||
162826266|NCT04419610|588077233|FG001|Overall Study|discharged early|1|||
162826267|NCT01439282|588077234|FG000|Overall Study|Adverse Event|5|||
162826268|NCT01439282|588077235|FG001|Overall Study|Adverse Event|0|||
163178573|NCT04393298|589369210|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
163178574|NCT04393298|589369211|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
163178575|NCT04393298|589369212|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
163178576|NCT04393298|589369213|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
163178577|NCT04393298|589369214|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
163178578|NCT04393298|589369215|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
163178579|NCT04393298|589369216|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
163178580|NCT04393298|589369202|FG000|Overall Study|Patient Passed Away|0|||
163178581|NCT04393298|589369203|FG001|Overall Study|Patient Passed Away|0|||
163178582|NCT04393298|589369204|FG002|Overall Study|Patient Passed Away|0|||
163178583|NCT04393298|589369205|FG003|Overall Study|Patient Passed Away|0|||
163178584|NCT04393298|589369206|FG004|Overall Study|Patient Passed Away|0|||
163178585|NCT04393298|589369207|FG005|Overall Study|Patient Passed Away|0|||
163178586|NCT04393298|589369208|FG006|Overall Study|Patient Passed Away|0|||
163178587|NCT04393298|589369209|FG007|Overall Study|Patient Passed Away|1|||
163178588|NCT04393298|589369210|FG008|Overall Study|Patient Passed Away|0|||
163178589|NCT04393298|589369211|FG009|Overall Study|Patient Passed Away|0|||
163178590|NCT04393298|589369212|FG010|Overall Study|Patient Passed Away|0|||
163178591|NCT04393298|589369213|FG011|Overall Study|Patient Passed Away|0|||
163178592|NCT04393298|589369214|FG012|Overall Study|Patient Passed Away|0|||
163178593|NCT04393298|589369215|FG013|Overall Study|Patient Passed Away|0|||
163178594|NCT04393298|589369216|FG014|Overall Study|Patient Passed Away|0|||
162826269|NCT01439282|588077234|FG000|Overall Study|Withdrawal by Subject|2|||
162826270|NCT01439282|588077235|FG001|Overall Study|Withdrawal by Subject|0|||
162826271|NCT01439282|588077234|FG000|Overall Study|Other|1|||
162826272|NCT01439282|588077235|FG001|Overall Study|Other|1|||
162826273|NCT03197493|588077239|FG000|Overall Study|Withdrawal by Subject|5|||
162826274|NCT01469182|588077240|FG000|Overall Study|Adverse Event|21|||
163178595|NCT04393298|589369202|FG000|Overall Study|Patient Deceased|0|||
163178596|NCT04393298|589369203|FG001|Overall Study|Patient Deceased|0|||
163178597|NCT04393298|589369204|FG002|Overall Study|Patient Deceased|0|||
162934382|NCT01335477|588464335|FG000|Overall Study|Non compliant with protocol|0|||
162934383|NCT01335477|588464336|FG001|Overall Study|Non compliant with protocol|2|||
162934384|NCT01335477|588464335|FG000|Overall Study|Lost to Follow-up|1|||
162934385|NCT01335477|588464336|FG001|Overall Study|Lost to Follow-up|2|||
162934386|NCT01335477|588464335|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
162934387|NCT01335477|588464336|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
162934388|NCT01335477|588464335|FG000|Overall Study|Not treated|1|||
162934389|NCT01335477|588464336|FG001|Overall Study|Not treated|2|||
162934390|NCT01335477|588464335|FG000|Overall Study|Reason other than those stated above|2|||
162934391|NCT01335477|588464336|FG001|Overall Study|Reason other than those stated above|2|||
162934392|NCT03549130|588464338|FG000|Overall Study|Adverse Event|0|||
162934393|NCT03549130|588464339|FG001|Overall Study|Adverse Event|1|||
162934394|NCT03549130|588464338|FG000|Overall Study|Lost to Follow-up|0|||
162934395|NCT03549130|588464339|FG001|Overall Study|Lost to Follow-up|1|||
162934396|NCT01078623|588464340|FG000|Treatment Period 1|Adverse Event|1|||
162934397|NCT01078623|588464341|FG001|Treatment Period 1|Adverse Event|1|||
162934398|NCT01078623|588464342|FG002|Treatment Period 1|Adverse Event|1|||
162934399|NCT01078623|588464343|FG003|Treatment Period 1|Adverse Event|0|||
162934400|NCT01078623|588464344|FG004|Treatment Period 1|Adverse Event|0|||
162934401|NCT01078623|588464345|FG005|Treatment Period 1|Adverse Event|0|||
162934402|NCT01078623|588464346|FG006|Treatment Period 1|Adverse Event|1|||
162934403|NCT01078623|588464347|FG007|Treatment Period 1|Adverse Event|0|||
162934404|NCT01078623|588464348|FG008|Treatment Period 1|Adverse Event|1|||
162934405|NCT01078623|588464349|FG009|Treatment Period 1|Adverse Event|1|||
162934406|NCT01078623|588464350|FG010|Treatment Period 1|Adverse Event|0|||
162934407|NCT01078623|588464351|FG011|Treatment Period 1|Adverse Event|0|||
163178598|NCT04393298|589369205|FG003|Overall Study|Patient Deceased|0|||
163178599|NCT04393298|589369206|FG004|Overall Study|Patient Deceased|0|||
163178600|NCT04393298|589369207|FG005|Overall Study|Patient Deceased|0|||
163178601|NCT04393298|589369208|FG006|Overall Study|Patient Deceased|0|||
163178602|NCT04393298|589369209|FG007|Overall Study|Patient Deceased|1|||
163178603|NCT04393298|589369210|FG008|Overall Study|Patient Deceased|0|||
163178604|NCT04393298|589369211|FG009|Overall Study|Patient Deceased|0|||
163178605|NCT04393298|589369212|FG010|Overall Study|Patient Deceased|0|||
163178606|NCT04393298|589369213|FG011|Overall Study|Patient Deceased|0|||
163178607|NCT04393298|589369214|FG012|Overall Study|Patient Deceased|0|||
163178608|NCT04393298|589369215|FG013|Overall Study|Patient Deceased|0|||
163178609|NCT04393298|589369216|FG014|Overall Study|Patient Deceased|0|||
163178610|NCT04393298|589369202|FG000|Overall Study|Patient Discharged to Hospice|0|||
163178611|NCT04393298|589369203|FG001|Overall Study|Patient Discharged to Hospice|0|||
163178612|NCT04393298|589369204|FG002|Overall Study|Patient Discharged to Hospice|0|||
163178613|NCT04393298|589369205|FG003|Overall Study|Patient Discharged to Hospice|0|||
163178614|NCT04393298|589369206|FG004|Overall Study|Patient Discharged to Hospice|0|||
163178615|NCT04393298|589369207|FG005|Overall Study|Patient Discharged to Hospice|0|||
163178616|NCT04393298|589369208|FG006|Overall Study|Patient Discharged to Hospice|0|||
163178617|NCT04393298|589369209|FG007|Overall Study|Patient Discharged to Hospice|0|||
163178618|NCT04393298|589369210|FG008|Overall Study|Patient Discharged to Hospice|1|||
163178619|NCT04393298|589369211|FG009|Overall Study|Patient Discharged to Hospice|0|||
163178620|NCT04393298|589369212|FG010|Overall Study|Patient Discharged to Hospice|0|||
163178621|NCT04393298|589369213|FG011|Overall Study|Patient Discharged to Hospice|0|||
163178622|NCT04393298|589369214|FG012|Overall Study|Patient Discharged to Hospice|0|||
163178623|NCT04393298|589369215|FG013|Overall Study|Patient Discharged to Hospice|0|||
163178624|NCT04393298|589369216|FG014|Overall Study|Patient Discharged to Hospice|0|||
163178625|NCT04393298|589369202|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178626|NCT04393298|589369203|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178627|NCT04393298|589369204|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178628|NCT04393298|589369205|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178629|NCT04393298|589369206|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178630|NCT04393298|589369207|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162934408|NCT01078623|588464352|FG012|Treatment Period 1|Adverse Event|0|||
162934409|NCT01078623|588464353|FG013|Treatment Period 1|Adverse Event|0|||
162934410|NCT01078623|588464354|FG014|Treatment Period 1|Adverse Event|0|||
162934411|NCT01078623|588464355|FG015|Treatment Period 1|Adverse Event|0|||
162934412|NCT01078623|588464356|FG016|Treatment Period 1|Adverse Event|0|||
162934413|NCT01078623|588464357|FG017|Treatment Period 1|Adverse Event|0|||
162934414|NCT01078623|588464358|FG018|Treatment Period 1|Adverse Event|0|||
162934415|NCT01078623|588464359|FG019|Treatment Period 1|Adverse Event|0|||
162934416|NCT01078623|588464340|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162934417|NCT01078623|588464341|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163178631|NCT04393298|589369208|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162934418|NCT01078623|588464342|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162934419|NCT01078623|588464343|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162934420|NCT01078623|588464344|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162934421|NCT01078623|588464345|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162934422|NCT01078623|588464346|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162934423|NCT01078623|588464347|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162934424|NCT01078623|588464348|FG008|Treatment Period 1|Withdrawal by Subject|0|||
162934425|NCT01078623|588464349|FG009|Treatment Period 1|Withdrawal by Subject|0|||
162934426|NCT01078623|588464350|FG010|Treatment Period 1|Withdrawal by Subject|1|||
162934427|NCT01078623|588464351|FG011|Treatment Period 1|Withdrawal by Subject|0|||
162934428|NCT01078623|588464352|FG012|Treatment Period 1|Withdrawal by Subject|0|||
162934429|NCT01078623|588464353|FG013|Treatment Period 1|Withdrawal by Subject|0|||
162934430|NCT01078623|588464354|FG014|Treatment Period 1|Withdrawal by Subject|0|||
162934431|NCT01078623|588464355|FG015|Treatment Period 1|Withdrawal by Subject|0|||
162934432|NCT01078623|588464356|FG016|Treatment Period 1|Withdrawal by Subject|0|||
162934433|NCT01078623|588464357|FG017|Treatment Period 1|Withdrawal by Subject|0|||
162934434|NCT01078623|588464358|FG018|Treatment Period 1|Withdrawal by Subject|0|||
162934435|NCT01078623|588464359|FG019|Treatment Period 1|Withdrawal by Subject|0|||
162934436|NCT01078623|588464340|FG000|Treatment Period 1|Protocol Violation|0|||
162934437|NCT01078623|588464341|FG001|Treatment Period 1|Protocol Violation|0|||
162934438|NCT01078623|588464342|FG002|Treatment Period 1|Protocol Violation|0|||
162934439|NCT01078623|588464343|FG003|Treatment Period 1|Protocol Violation|0|||
162934440|NCT01078623|588464344|FG004|Treatment Period 1|Protocol Violation|0|||
162934441|NCT01078623|588464345|FG005|Treatment Period 1|Protocol Violation|1|||
162934442|NCT01078623|588464346|FG006|Treatment Period 1|Protocol Violation|0|||
162934443|NCT01078623|588464347|FG007|Treatment Period 1|Protocol Violation|0|||
162934444|NCT01078623|588464348|FG008|Treatment Period 1|Protocol Violation|0|||
162934445|NCT01078623|588464349|FG009|Treatment Period 1|Protocol Violation|0|||
162934446|NCT01078623|588464350|FG010|Treatment Period 1|Protocol Violation|0|||
162934447|NCT01078623|588464351|FG011|Treatment Period 1|Protocol Violation|0|||
162934448|NCT01078623|588464352|FG012|Treatment Period 1|Protocol Violation|0|||
162934449|NCT01078623|588464353|FG013|Treatment Period 1|Protocol Violation|0|||
162934450|NCT01078623|588464354|FG014|Treatment Period 1|Protocol Violation|0|||
162934451|NCT01078623|588464355|FG015|Treatment Period 1|Protocol Violation|0|||
162934452|NCT01078623|588464356|FG016|Treatment Period 1|Protocol Violation|0|||
162934453|NCT01078623|588464357|FG017|Treatment Period 1|Protocol Violation|0|||
162934454|NCT01078623|588464358|FG018|Treatment Period 1|Protocol Violation|0|||
162934455|NCT01078623|588464359|FG019|Treatment Period 1|Protocol Violation|0|||
162934456|NCT01078623|588464340|FG000|Treatment Period 2|Adverse Event|0|||
162934457|NCT01078623|588464341|FG001|Treatment Period 2|Adverse Event|0|||
162934458|NCT01078623|588464342|FG002|Treatment Period 2|Adverse Event|0|||
162934459|NCT01078623|588464343|FG003|Treatment Period 2|Adverse Event|0|||
162934460|NCT01078623|588464344|FG004|Treatment Period 2|Adverse Event|0|||
162934461|NCT01078623|588464345|FG005|Treatment Period 2|Adverse Event|0|||
162934462|NCT01078623|588464346|FG006|Treatment Period 2|Adverse Event|1|||
162934463|NCT01078623|588464347|FG007|Treatment Period 2|Adverse Event|0|||
162934464|NCT01078623|588464348|FG008|Treatment Period 2|Adverse Event|0|||
162934465|NCT01078623|588464349|FG009|Treatment Period 2|Adverse Event|0|||
162934466|NCT01078623|588464350|FG010|Treatment Period 2|Adverse Event|0|||
162934467|NCT01078623|588464351|FG011|Treatment Period 2|Adverse Event|0|||
162934468|NCT01078623|588464352|FG012|Treatment Period 2|Adverse Event|0|||
162934469|NCT01078623|588464353|FG013|Treatment Period 2|Adverse Event|0|||
162934470|NCT01078623|588464354|FG014|Treatment Period 2|Adverse Event|0|||
162934471|NCT01078623|588464355|FG015|Treatment Period 2|Adverse Event|0|||
162934472|NCT01078623|588464356|FG016|Treatment Period 2|Adverse Event|0|||
162934473|NCT01078623|588464357|FG017|Treatment Period 2|Adverse Event|0|||
162934474|NCT01078623|588464358|FG018|Treatment Period 2|Adverse Event|1|||
162934475|NCT01078623|588464359|FG019|Treatment Period 2|Adverse Event|0|||
162826275|NCT01469182|588077241|FG001|Overall Study|Adverse Event|3|||
162826276|NCT01469182|588077240|FG000|Overall Study|Lost to Follow-up|3|||
162826277|NCT01469182|588077241|FG001|Overall Study|Lost to Follow-up|0|||
162826278|NCT01469182|588077240|FG000|Overall Study|Withdrawal by Subject|4|||
162826279|NCT01469182|588077241|FG001|Overall Study|Withdrawal by Subject|1|||
162826280|NCT01469182|588077240|FG000|Overall Study|Protocol Violation|4|||
162826281|NCT01469182|588077241|FG001|Overall Study|Protocol Violation|2|||
162826282|NCT01469182|588077240|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
162826283|NCT01469182|588077241|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
162826284|NCT02236520|588077243|FG000|Overall Study|Physician Decision|0|||
162826285|NCT02236520|588077244|FG001|Overall Study|Physician Decision|5|||
162826286|NCT02236520|588077245|FG002|Overall Study|Physician Decision|0|||
162826287|NCT02236520|588077246|FG003|Overall Study|Physician Decision|0|||
162826288|NCT02236520|588077243|FG000|Overall Study|Withdrawal by Subject|1|||
162826289|NCT02236520|588077244|FG001|Overall Study|Withdrawal by Subject|0|||
162826290|NCT02236520|588077245|FG002|Overall Study|Withdrawal by Subject|0|||
162826291|NCT02236520|588077246|FG003|Overall Study|Withdrawal by Subject|1|||
162826292|NCT02236520|588077243|FG000|Overall Study|Pregnancy|1|||
162826293|NCT02236520|588077244|FG001|Overall Study|Pregnancy|0|||
162826294|NCT02236520|588077245|FG002|Overall Study|Pregnancy|0|||
162826295|NCT02236520|588077246|FG003|Overall Study|Pregnancy|0|||
162826296|NCT01785160|588077247|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
162826297|NCT01785160|588077247|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
162826298|NCT01033734|588077248|FG000|Overall Study|Withdrawal by Subject|1|||
162826299|NCT00549939|588077252|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
162826300|NCT00549939|588077253|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
162826301|NCT00549939|588077254|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
162826302|NCT00549939|588077252|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
162826303|NCT00549939|588077253|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
162826304|NCT00549939|588077254|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
162826305|NCT00549939|588077252|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
162826306|NCT00549939|588077253|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
162826307|NCT00549939|588077254|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
162826308|NCT00549939|588077252|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
162826309|NCT00549939|588077253|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
162826310|NCT00549939|588077254|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
162826311|NCT00549939|588077252|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
162826312|NCT00549939|588077253|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
162826313|NCT00549939|588077254|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
162826314|NCT00549939|588077252|FG000|40-week Open Label Treatment Period|Other|0|||
162826315|NCT00549939|588077253|FG001|40-week Open Label Treatment Period|Other|1|||
162826316|NCT00549939|588077254|FG002|40-week Open Label Treatment Period|Other|4|||
162826317|NCT03677596|588077255|FG000|Overall Study|Adverse Event|0|||
162826318|NCT03677596|588077256|FG001|Overall Study|Adverse Event|1|||
162826319|NCT03677596|588077255|FG000|Overall Study|Death|10|||
162826320|NCT03677596|588077256|FG001|Overall Study|Death|6|||
162826321|NCT03677596|588077255|FG000|Overall Study|Lost to Follow-up|0|||
162826322|NCT03677596|588077256|FG001|Overall Study|Lost to Follow-up|1|||
162826323|NCT03677596|588077255|FG000|Overall Study|Progressive Disease|8|||
162826324|NCT03677596|588077256|FG001|Overall Study|Progressive Disease|8|||
162826325|NCT03677596|588077255|FG000|Overall Study|Withdrawal by Subject|3|||
162826326|NCT03677596|588077256|FG001|Overall Study|Withdrawal by Subject|0|||
162826327|NCT03677596|588077255|FG000|Overall Study|Disease Relapse|2|||
162826328|NCT03677596|588077256|FG001|Overall Study|Disease Relapse|2|||
162826329|NCT03677596|588077255|FG000|Overall Study|Other|0|||
162826330|NCT03677596|588077256|FG001|Overall Study|Other|1|||
162826331|NCT01360554|588077257|FG000|Overall Study|Death|359|||
162826332|NCT01360554|588077258|FG001|Overall Study|Death|371|||
162826333|NCT01360554|588077257|FG000|Overall Study|Lost to Follow-up|4|||
162826334|NCT01360554|588077258|FG001|Overall Study|Lost to Follow-up|4|||
162826335|NCT01360554|588077257|FG000|Overall Study|Withdrawal by Subject|23|||
162826336|NCT01360554|588077258|FG001|Overall Study|Withdrawal by Subject|24|||
162826337|NCT01360554|588077257|FG000|Overall Study|Study terminated by sponsor|49|||
162826338|NCT01360554|588077258|FG001|Overall Study|Study terminated by sponsor|37|||
162826339|NCT01360554|588077257|FG000|Overall Study|Other, not specified|1|||
162826340|NCT01360554|588077258|FG001|Overall Study|Other, not specified|0|||
162826341|NCT01360554|588077257|FG000|Overall Study|Randomized but not treated.|3|||
162826342|NCT01360554|588077258|FG001|Overall Study|Randomized but not treated.|3|||
162826343|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
162826344|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
162826345|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
162826346|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
162826347|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
162826348|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
162934476|NCT01078623|588464340|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162934477|NCT01078623|588464341|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162934478|NCT01078623|588464342|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162934479|NCT01078623|588464343|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162934480|NCT01078623|588464344|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162934481|NCT01078623|588464345|FG005|Treatment Period 2|Withdrawal by Subject|1|||
162934482|NCT01078623|588464346|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162934483|NCT01078623|588464347|FG007|Treatment Period 2|Withdrawal by Subject|0|||
162934484|NCT01078623|588464348|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162934485|NCT01078623|588464349|FG009|Treatment Period 2|Withdrawal by Subject|0|||
162934486|NCT01078623|588464350|FG010|Treatment Period 2|Withdrawal by Subject|0|||
162934487|NCT01078623|588464351|FG011|Treatment Period 2|Withdrawal by Subject|0|||
162934488|NCT01078623|588464352|FG012|Treatment Period 2|Withdrawal by Subject|0|||
162934489|NCT01078623|588464353|FG013|Treatment Period 2|Withdrawal by Subject|0|||
162934490|NCT01078623|588464354|FG014|Treatment Period 2|Withdrawal by Subject|0|||
162934491|NCT01078623|588464355|FG015|Treatment Period 2|Withdrawal by Subject|0|||
162934492|NCT01078623|588464356|FG016|Treatment Period 2|Withdrawal by Subject|0|||
162934493|NCT01078623|588464357|FG017|Treatment Period 2|Withdrawal by Subject|0|||
162934494|NCT01078623|588464358|FG018|Treatment Period 2|Withdrawal by Subject|0|||
162934495|NCT01078623|588464359|FG019|Treatment Period 2|Withdrawal by Subject|0|||
162934496|NCT01078623|588464340|FG000|Treatment Period 3|Adverse Event|0|||
162934497|NCT01078623|588464341|FG001|Treatment Period 3|Adverse Event|0|||
162934498|NCT01078623|588464342|FG002|Treatment Period 3|Adverse Event|0|||
162934499|NCT01078623|588464343|FG003|Treatment Period 3|Adverse Event|0|||
162934500|NCT01078623|588464344|FG004|Treatment Period 3|Adverse Event|1|||
162934501|NCT01078623|588464345|FG005|Treatment Period 3|Adverse Event|0|||
162934502|NCT01078623|588464346|FG006|Treatment Period 3|Adverse Event|0|||
162934503|NCT01078623|588464347|FG007|Treatment Period 3|Adverse Event|0|||
162934504|NCT01078623|588464348|FG008|Treatment Period 3|Adverse Event|0|||
162934505|NCT01078623|588464349|FG009|Treatment Period 3|Adverse Event|0|||
162934506|NCT01078623|588464350|FG010|Treatment Period 3|Adverse Event|0|||
162934507|NCT01078623|588464351|FG011|Treatment Period 3|Adverse Event|0|||
162934508|NCT01078623|588464352|FG012|Treatment Period 3|Adverse Event|0|||
162934509|NCT01078623|588464353|FG013|Treatment Period 3|Adverse Event|1|||
162934510|NCT01078623|588464354|FG014|Treatment Period 3|Adverse Event|0|||
162934511|NCT01078623|588464355|FG015|Treatment Period 3|Adverse Event|0|||
162934512|NCT01078623|588464356|FG016|Treatment Period 3|Adverse Event|0|||
162934513|NCT01078623|588464357|FG017|Treatment Period 3|Adverse Event|0|||
162934514|NCT01078623|588464358|FG018|Treatment Period 3|Adverse Event|0|||
162934515|NCT01078623|588464359|FG019|Treatment Period 3|Adverse Event|0|||
162934516|NCT01078623|588464340|FG000|Treatment Period 4|Adverse Event|0|||
162934517|NCT01078623|588464341|FG001|Treatment Period 4|Adverse Event|0|||
162934518|NCT01078623|588464342|FG002|Treatment Period 4|Adverse Event|1|||
162934519|NCT01078623|588464343|FG003|Treatment Period 4|Adverse Event|0|||
162934520|NCT01078623|588464344|FG004|Treatment Period 4|Adverse Event|0|||
162934521|NCT01078623|588464345|FG005|Treatment Period 4|Adverse Event|0|||
162934522|NCT01078623|588464346|FG006|Treatment Period 4|Adverse Event|0|||
162934523|NCT01078623|588464347|FG007|Treatment Period 4|Adverse Event|0|||
162934524|NCT01078623|588464348|FG008|Treatment Period 4|Adverse Event|0|||
162934525|NCT01078623|588464349|FG009|Treatment Period 4|Adverse Event|0|||
162934526|NCT01078623|588464350|FG010|Treatment Period 4|Adverse Event|0|||
162934527|NCT01078623|588464351|FG011|Treatment Period 4|Adverse Event|0|||
162934528|NCT01078623|588464352|FG012|Treatment Period 4|Adverse Event|0|||
162934529|NCT01078623|588464353|FG013|Treatment Period 4|Adverse Event|0|||
162934530|NCT01078623|588464354|FG014|Treatment Period 4|Adverse Event|0|||
162934531|NCT01078623|588464355|FG015|Treatment Period 4|Adverse Event|0|||
162934532|NCT01078623|588464356|FG016|Treatment Period 4|Adverse Event|0|||
162934533|NCT01078623|588464357|FG017|Treatment Period 4|Adverse Event|0|||
162934534|NCT01078623|588464358|FG018|Treatment Period 4|Adverse Event|0|||
163178632|NCT04393298|589369209|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178633|NCT04393298|589369210|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178634|NCT04393298|589369211|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
163178635|NCT04393298|589369212|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162934535|NCT01078623|588464359|FG019|Treatment Period 4|Adverse Event|0|||
162934536|NCT01078623|588464340|FG000|Treatment Period 4|Withdrawal by Subject|0|||
162934537|NCT01078623|588464341|FG001|Treatment Period 4|Withdrawal by Subject|0|||
162934538|NCT01078623|588464342|FG002|Treatment Period 4|Withdrawal by Subject|0|||
162934539|NCT01078623|588464343|FG003|Treatment Period 4|Withdrawal by Subject|0|||
162934540|NCT01078623|588464344|FG004|Treatment Period 4|Withdrawal by Subject|0|||
162934541|NCT01078623|588464345|FG005|Treatment Period 4|Withdrawal by Subject|0|||
162934542|NCT01078623|588464346|FG006|Treatment Period 4|Withdrawal by Subject|0|||
162934543|NCT01078623|588464347|FG007|Treatment Period 4|Withdrawal by Subject|0|||
162934544|NCT01078623|588464348|FG008|Treatment Period 4|Withdrawal by Subject|0|||
162934545|NCT01078623|588464349|FG009|Treatment Period 4|Withdrawal by Subject|0|||
162934546|NCT01078623|588464350|FG010|Treatment Period 4|Withdrawal by Subject|0|||
162934547|NCT01078623|588464351|FG011|Treatment Period 4|Withdrawal by Subject|0|||
162934548|NCT01078623|588464352|FG012|Treatment Period 4|Withdrawal by Subject|0|||
162826349|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
162826350|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
162826351|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
162826352|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
162826353|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
162826354|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
162826355|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
162826356|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
162826357|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
162826358|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
162826359|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
162826360|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
162826361|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
162826362|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
162826363|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
162826364|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
162826365|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
162826366|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
162826367|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
162826368|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
162826369|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
162826370|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
162826371|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
162826372|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
162826373|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826374|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
162826375|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
162826376|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
162826377|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826378|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
162826379|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
162826380|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
162826381|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
162826382|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
162826383|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
162934549|NCT01078623|588464353|FG013|Treatment Period 4|Withdrawal by Subject|0|||
162934550|NCT01078623|588464354|FG014|Treatment Period 4|Withdrawal by Subject|0|||
163178636|NCT04393298|589369213|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178637|NCT04393298|589369214|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178638|NCT04393298|589369215|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178639|NCT04393298|589369216|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
163178640|NCT04393298|589369202|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
163178641|NCT04393298|589369203|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
163178642|NCT04393298|589369204|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
163178643|NCT04393298|589369205|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
163178644|NCT04393298|589369206|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
163178645|NCT04393298|589369207|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
163178646|NCT04393298|589369208|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
163178647|NCT04393298|589369209|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
163178648|NCT04393298|589369210|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
163178649|NCT04393298|589369211|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
163178650|NCT04393298|589369212|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
163178651|NCT04393298|589369213|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
163178652|NCT04393298|589369214|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
163178653|NCT04393298|589369215|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
163178654|NCT04393298|589369216|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
163178655|NCT01315236|589369227|FG000|Double-blind Phase|Death|1|||
163178656|NCT01315236|589369228|FG001|Double-blind Phase|Death|0|||
163178657|NCT01315236|589369227|FG000|Double-blind Phase|Adverse Event|1|||
163178658|NCT01315236|589369228|FG001|Double-blind Phase|Adverse Event|0|||
163178659|NCT01315236|589369227|FG000|Double-blind Phase|Withdrawal of Consent|1|||
163178660|NCT01315236|589369228|FG001|Double-blind Phase|Withdrawal of Consent|0|||
163178661|NCT01315236|589369227|FG000|Double-blind Phase|Lost to Follow-up|1|||
163178662|NCT01315236|589369228|FG001|Double-blind Phase|Lost to Follow-up|0|||
163178663|NCT01315236|589369227|FG000|Open-label Phase|Death|1|||
163178664|NCT01315236|589369228|FG001|Open-label Phase|Death|0|||
163178665|NCT01315236|589369227|FG000|Open-label Phase|Adverse Event|0|||
163178666|NCT01315236|589369228|FG001|Open-label Phase|Adverse Event|1|||
163178667|NCT01315236|589369227|FG000|Open-label Phase|Other|0|||
163178668|NCT01315236|589369228|FG001|Open-label Phase|Other|1|||
163178669|NCT01315236|589369227|FG000|12-Month Follow-up Period|Death|0|||
163178670|NCT01315236|589369228|FG001|12-Month Follow-up Period|Death|1|||
163178671|NCT01315236|589369227|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
163178672|NCT01315236|589369228|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
163178673|NCT01101191|589369236|FG000|Period 1|Withdrawal by Subject|1|||
163178674|NCT01101191|589369237|FG001|Period 1|Withdrawal by Subject|0|||
163178675|NCT01101191|589369236|FG000|Period 1|Adverse Event|1|||
163178676|NCT01101191|589369237|FG001|Period 1|Adverse Event|2|||
163178677|NCT01146860|589369238|FG000|Overall Study|Withdrawal by Subject|0|||
163178678|NCT01146860|589369239|FG001|Overall Study|Withdrawal by Subject|1|||
163178679|NCT04779216|589369240|FG000|Overall Study|Lost to Follow-up|1|||
163178680|NCT04779216|589369241|FG001|Overall Study|Lost to Follow-up|0|||
163178681|NCT04779216|589369240|FG000|Overall Study|Withdrawal by Subject|1|||
163178682|NCT04779216|589369241|FG001|Overall Study|Withdrawal by Subject|0|||
163178683|NCT02674854|589369246|FG000|Overall Study|Adverse Event|17|||
163178684|NCT02674854|589369247|FG001|Overall Study|Adverse Event|15|||
163178685|NCT02674854|589369248|FG002|Overall Study|Adverse Event|5|||
163178686|NCT02674854|589369246|FG000|Overall Study|Withdrawal by Subject|1|||
163178687|NCT02674854|589369247|FG001|Overall Study|Withdrawal by Subject|5|||
163178688|NCT02674854|589369248|FG002|Overall Study|Withdrawal by Subject|4|||
163178689|NCT02674854|589369246|FG000|Overall Study|No-compliant subject|1|||
162826384|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
162826385|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
162826386|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
162826387|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
162826388|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
162826389|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
162826390|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
162924223|NCT00077766|588423833|FG000|Overall Study|Participant's decision|1|||
163178690|NCT02674854|589369247|FG001|Overall Study|No-compliant subject|0|||
163178691|NCT02674854|589369248|FG002|Overall Study|No-compliant subject|1|||
163178692|NCT02674854|589369246|FG000|Overall Study|Lost to Follow-up|1|||
163178693|NCT02674854|589369247|FG001|Overall Study|Lost to Follow-up|0|||
163178694|NCT02674854|589369248|FG002|Overall Study|Lost to Follow-up|2|||
163178695|NCT02674854|589369246|FG000|Overall Study|Lack of Efficacy|0|||
163178696|NCT02674854|589369247|FG001|Overall Study|Lack of Efficacy|3|||
163178697|NCT02674854|589369248|FG002|Overall Study|Lack of Efficacy|0|||
163178698|NCT02674854|589369246|FG000|Overall Study|Disallowed Concurrent Medication|2|||
163178699|NCT02674854|589369247|FG001|Overall Study|Disallowed Concurrent Medication|2|||
162934551|NCT01078623|588464355|FG015|Treatment Period 4|Withdrawal by Subject|1|||
162934552|NCT01078623|588464356|FG016|Treatment Period 4|Withdrawal by Subject|0|||
162934553|NCT01078623|588464357|FG017|Treatment Period 4|Withdrawal by Subject|0|||
162934554|NCT01078623|588464358|FG018|Treatment Period 4|Withdrawal by Subject|0|||
162934555|NCT01078623|588464359|FG019|Treatment Period 4|Withdrawal by Subject|0|||
162934556|NCT00447603|588464377|FG000|Screening|Withdrawal by Subject|1|||
162934557|NCT00447603|588464378|FG001|Screening|Withdrawal by Subject|0|||
162934558|NCT00447603|588464379|FG002|Screening|Withdrawal by Subject|0|||
162934559|NCT00447603|588464377|FG000|Screening|Protocol Violation|1|||
162934560|NCT00447603|588464378|FG001|Screening|Protocol Violation|0|||
162934561|NCT00447603|588464379|FG002|Screening|Protocol Violation|0|||
162934562|NCT00447603|588464377|FG000|Screening|Screen Failure|4|||
162934563|NCT00447603|588464378|FG001|Screening|Screen Failure|0|||
162934564|NCT00447603|588464379|FG002|Screening|Screen Failure|0|||
162934565|NCT00447603|588464377|FG000|Screening|Study Terminated by Sponsor|15|||
162934566|NCT00447603|588464378|FG001|Screening|Study Terminated by Sponsor|0|||
162934567|NCT00447603|588464379|FG002|Screening|Study Terminated by Sponsor|0|||
162934568|NCT00447603|588464377|FG000|Filter Period|Adverse Event|0|||
162934569|NCT00447603|588464378|FG001|Filter Period|Adverse Event|0|||
162934570|NCT00447603|588464379|FG002|Filter Period|Adverse Event|1|||
162934571|NCT00447603|588464377|FG000|Filter Period|Screen Failure|0|||
162934572|NCT00447603|588464378|FG001|Filter Period|Screen Failure|3|||
162934573|NCT00447603|588464379|FG002|Filter Period|Screen Failure|4|||
162934574|NCT00447603|588464377|FG000|Filter Period|Study terminated by Sponsor|0|||
162934575|NCT00447603|588464378|FG001|Filter Period|Study terminated by Sponsor|1|||
162934576|NCT00447603|588464379|FG002|Filter Period|Study terminated by Sponsor|10|||
162934577|NCT01797120|588464382|FG000|Overall Study|Disesae progression|37|||
162934578|NCT01797120|588464383|FG001|Overall Study|Disesae progression|49|||
162934579|NCT01797120|588464382|FG000|Overall Study|Adverse Event|13|||
162934580|NCT01797120|588464383|FG001|Overall Study|Adverse Event|5|||
162934581|NCT01797120|588464382|FG000|Overall Study|Withdrawal by Subject|6|||
162934582|NCT01797120|588464383|FG001|Overall Study|Withdrawal by Subject|6|||
162934583|NCT01797120|588464382|FG000|Overall Study|Symptomatic progression|2|||
162934584|NCT01797120|588464383|FG001|Overall Study|Symptomatic progression|1|||
162934585|NCT01797120|588464382|FG000|Overall Study|Non-compliance|1|||
162934586|NCT01797120|588464383|FG001|Overall Study|Non-compliance|0|||
162934587|NCT01797120|588464382|FG000|Overall Study|Physician Decision|3|||
162934588|NCT01797120|588464383|FG001|Overall Study|Physician Decision|0|||
162934589|NCT01797120|588464382|FG000|Overall Study|still on treatment|2|||
162934590|NCT01797120|588464383|FG001|Overall Study|still on treatment|4|||
162934591|NCT01797120|588464382|FG000|Overall Study|never start protocol therapy|2|||
162934592|NCT01797120|588464383|FG001|Overall Study|never start protocol therapy|0|||
162934593|NCT01003886|588464384|FG000|Overall Study|Lack of Efficacy|5|||
162934594|NCT01003886|588464384|FG000|Overall Study|Lost to Follow-up|169|||
162934595|NCT01003886|588464384|FG000|Overall Study|Withdrawal by Subject|39|||
162934596|NCT01003886|588464384|FG000|Overall Study|Other|14|||
162934597|NCT01003886|588464384|FG000|Overall Study|Adverse Event|3|||
162934598|NCT00909727|588464402|FG000|Overall Study|Adverse Event|1|||
162934599|NCT00909727|588464403|FG001|Overall Study|Adverse Event|0|||
162934600|NCT00909727|588464402|FG000|Overall Study|Wrong Genotype|1|||
162934601|NCT00909727|588464403|FG001|Overall Study|Wrong Genotype|0|||
162934602|NCT00909727|588464402|FG000|Overall Study|Withdrawal of Consent|1|||
162934603|NCT00909727|588464403|FG001|Overall Study|Withdrawal of Consent|0|||
162934604|NCT00909727|588464402|FG000|Overall Study|Prohibited Medication|1|||
162934605|NCT00909727|588464403|FG001|Overall Study|Prohibited Medication|0|||
162934606|NCT05751629|588464404|FG000|Overall Study|Withdrawal by Subject|6|||
162934607|NCT05751629|588464404|FG000|Overall Study|Death|25|||
162934608|NCT05751629|588464404|FG000|Overall Study|Study Site Closed|9|||
162934609|NCT05751629|588464404|FG000|Overall Study|Physician Decision|1|||
162934610|NCT01909466|588464406|FG000|Overall Study|Lost to Follow-up|5|||
162934611|NCT01909466|588464407|FG001|Overall Study|Lost to Follow-up|7|||
162934612|NCT01909466|588464406|FG000|Overall Study|Adverse Event|3|||
163178700|NCT02674854|589369248|FG002|Overall Study|Disallowed Concurrent Medication|0|||
163178701|NCT02674854|589369246|FG000|Overall Study|Protocol Violation|1|||
163178702|NCT02674854|589369247|FG001|Overall Study|Protocol Violation|1|||
163178703|NCT02674854|589369248|FG002|Overall Study|Protocol Violation|2|||
163178704|NCT02674854|589369246|FG000|Overall Study|Death|0|||
162934613|NCT01909466|588464407|FG001|Overall Study|Adverse Event|4|||
162934614|NCT01909466|588464406|FG000|Overall Study|Met Withdrawal Criteria|0|||
162934615|NCT01909466|588464407|FG001|Overall Study|Met Withdrawal Criteria|3|||
162934616|NCT01909466|588464406|FG000|Overall Study|Physician Decision|2|||
162934617|NCT01909466|588464407|FG001|Overall Study|Physician Decision|0|||
162934618|NCT01909466|588464406|FG000|Overall Study|Withdrawal by Subject|11|||
162934619|NCT01909466|588464407|FG001|Overall Study|Withdrawal by Subject|9|||
162934620|NCT01909466|588464406|FG000|Overall Study|Lack of Efficacy|1|||
162934621|NCT01909466|588464407|FG001|Overall Study|Lack of Efficacy|0|||
162934622|NCT00672620|588464413|FG000|Overall Study|Adverse Event|7|||
162934623|NCT00672620|588464414|FG001|Overall Study|Adverse Event|7|||
162934624|NCT00672620|588464415|FG002|Overall Study|Adverse Event|12|||
162826391|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
162826392|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
162826393|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
162826394|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
162826395|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
162826396|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
162826397|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
162826398|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
162826399|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
162826400|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
162826401|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
162826402|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
162826403|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
162826404|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
162826405|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
162826406|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
162826407|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
162826408|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
162826409|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
162826410|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
162826411|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163178705|NCT02674854|589369247|FG001|Overall Study|Death|1|||
163178706|NCT02674854|589369248|FG002|Overall Study|Death|0|||
163178707|NCT02674854|589369246|FG000|Overall Study|Subject missed V6.2|1|||
163178708|NCT02674854|589369247|FG001|Overall Study|Subject missed V6.2|0|||
163178709|NCT02674854|589369248|FG002|Overall Study|Subject missed V6.2|0|||
163178710|NCT00879879|589369249|FG000|Overall Study|Death|1|||
163178711|NCT00879879|589369249|FG000|Overall Study|Withdrawal by Subject|1|||
163178712|NCT00879879|589369249|FG000|Overall Study|Physician Decision|1|||
163178713|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
163178714|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
163178715|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178716|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
163178717|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178718|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163178719|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178720|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
163178721|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178722|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178723|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178724|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
163178725|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
163178726|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
163178727|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162826412|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
162826413|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
162826414|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
162826415|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
162826416|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
162826417|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
162826418|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
162826419|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
162826420|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
162826421|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
162826422|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
162826423|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
162826424|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
162826425|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
162826426|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
162826427|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162826428|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162934625|NCT00672620|588464416|FG003|Overall Study|Adverse Event|17|||
162934626|NCT00672620|588464413|FG000|Overall Study|Lack of Efficacy|1|||
163178728|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162934627|NCT00672620|588464414|FG001|Overall Study|Lack of Efficacy|2|||
162934628|NCT00672620|588464415|FG002|Overall Study|Lack of Efficacy|2|||
162934629|NCT00672620|588464416|FG003|Overall Study|Lack of Efficacy|0|||
162934630|NCT00672620|588464413|FG000|Overall Study|Noncompliance with Study Drug|3|||
162934631|NCT00672620|588464414|FG001|Overall Study|Noncompliance with Study Drug|4|||
162934632|NCT00672620|588464415|FG002|Overall Study|Noncompliance with Study Drug|0|||
162934633|NCT00672620|588464416|FG003|Overall Study|Noncompliance with Study Drug|2|||
162934634|NCT00672620|588464413|FG000|Overall Study|Protocol Deviations|5|||
162934635|NCT00672620|588464414|FG001|Overall Study|Protocol Deviations|7|||
162934636|NCT00672620|588464415|FG002|Overall Study|Protocol Deviations|2|||
162934637|NCT00672620|588464416|FG003|Overall Study|Protocol Deviations|5|||
162934638|NCT00672620|588464413|FG000|Overall Study|Withdrawal of Consent|6|||
162934639|NCT00672620|588464414|FG001|Overall Study|Withdrawal of Consent|12|||
162934640|NCT00672620|588464415|FG002|Overall Study|Withdrawal of Consent|5|||
162934641|NCT00672620|588464416|FG003|Overall Study|Withdrawal of Consent|6|||
162934642|NCT00672620|588464413|FG000|Overall Study|Lost to Follow-up|8|||
162934643|NCT00672620|588464414|FG001|Overall Study|Lost to Follow-up|19|||
162934644|NCT00672620|588464415|FG002|Overall Study|Lost to Follow-up|8|||
162934645|NCT00672620|588464416|FG003|Overall Study|Lost to Follow-up|11|||
162934646|NCT00672620|588464413|FG000|Overall Study|Reason not Specified|3|||
162934647|NCT00672620|588464414|FG001|Overall Study|Reason not Specified|3|||
162934648|NCT00672620|588464415|FG002|Overall Study|Reason not Specified|2|||
162934649|NCT00672620|588464416|FG003|Overall Study|Reason not Specified|1|||
162934650|NCT00772577|588464417|FG000|Overall Study|Adverse Event|6|||
162934651|NCT00772577|588464418|FG001|Overall Study|Adverse Event|3|||
162934652|NCT00772577|588464417|FG000|Overall Study|Abnormal laboratory values|0|||
162934653|NCT00772577|588464418|FG001|Overall Study|Abnormal laboratory values|1|||
162934654|NCT00772577|588464417|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162934655|NCT00772577|588464418|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162934656|NCT00772577|588464417|FG000|Overall Study|Patient withdrew consent|8|||
162934657|NCT00772577|588464418|FG001|Overall Study|Patient withdrew consent|5|||
162934658|NCT00772577|588464417|FG000|Overall Study|Lost to Follow-up|4|||
162934659|NCT00772577|588464418|FG001|Overall Study|Lost to Follow-up|3|||
162934660|NCT00772577|588464417|FG000|Overall Study|Administrative problems|2|||
162934661|NCT00772577|588464418|FG001|Overall Study|Administrative problems|1|||
162934662|NCT00772577|588464417|FG000|Overall Study|Protocol Deviation|3|||
162934663|NCT00772577|588464418|FG001|Overall Study|Protocol Deviation|2|||
162934664|NCT02965820|588464419|FG000|Period 2, Second 30 Days|Adverse Event|1|||
162934665|NCT02965820|588464420|FG001|Period 2, Second 30 Days|Adverse Event|1|||
162934666|NCT01567306|588464421|FG000|Overall Study|Protocol Violation|2|||
162934667|NCT01567306|588464422|FG001|Overall Study|Protocol Violation|2|||
162934668|NCT01567306|588464423|FG002|Overall Study|Protocol Violation|0|||
162934669|NCT01567306|588464424|FG003|Overall Study|Protocol Violation|3|||
162934670|NCT01567306|588464425|FG004|Overall Study|Protocol Violation|1|||
162934671|NCT01567306|588464426|FG005|Overall Study|Protocol Violation|1|||
162934672|NCT01567306|588464421|FG000|Overall Study|Change site living|1|||
162934673|NCT01567306|588464422|FG001|Overall Study|Change site living|0|||
162934674|NCT01567306|588464423|FG002|Overall Study|Change site living|0|||
162934675|NCT01567306|588464424|FG003|Overall Study|Change site living|0|||
163178729|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
163178730|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
163178731|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178732|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
163178733|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162826429|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162826430|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
162826431|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162826432|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
162826433|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
162826434|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
162826435|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
162826436|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
162826437|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
162826438|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
162826439|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
162826440|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
162826441|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
162826442|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
162826443|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
162826444|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
162826445|NCT00111800|588077261|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
162826446|NCT00111800|588077262|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
162826447|NCT00111800|588077263|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
162826448|NCT00111800|588077264|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
162826449|NCT00111800|588077265|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
162826450|NCT00111800|588077266|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
162826451|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
162826452|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
162826453|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
162826454|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
162826455|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
162826456|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
162826457|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
162826458|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
162826459|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
162826460|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
162826461|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
162826462|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
162826463|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
162826464|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
162826465|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
162826466|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
162826467|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
162826468|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
162826469|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
162826470|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
162826471|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
162826472|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
162826473|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
162826474|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
162826475|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826476|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826477|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
162826478|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826479|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826480|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
162826481|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
162826482|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
162826483|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
162826484|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163178734|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162934676|NCT01567306|588464425|FG004|Overall Study|Change site living|0|||
162934677|NCT01567306|588464426|FG005|Overall Study|Change site living|0|||
162934678|NCT01567306|588464421|FG000|Overall Study|Adverse Event|0|||
162934679|NCT01567306|588464422|FG001|Overall Study|Adverse Event|0|||
162934680|NCT01567306|588464423|FG002|Overall Study|Adverse Event|0|||
162934681|NCT01567306|588464424|FG003|Overall Study|Adverse Event|2|||
162934682|NCT01567306|588464425|FG004|Overall Study|Adverse Event|4|||
162934683|NCT01567306|588464426|FG005|Overall Study|Adverse Event|1|||
162934684|NCT01567306|588464421|FG000|Overall Study|Lost to Follow-up|0|||
162934685|NCT01567306|588464422|FG001|Overall Study|Lost to Follow-up|0|||
162934686|NCT01567306|588464423|FG002|Overall Study|Lost to Follow-up|0|||
162934687|NCT01567306|588464424|FG003|Overall Study|Lost to Follow-up|0|||
162934688|NCT01567306|588464425|FG004|Overall Study|Lost to Follow-up|2|||
162934689|NCT01567306|588464426|FG005|Overall Study|Lost to Follow-up|0|||
162934690|NCT01567306|588464421|FG000|Overall Study|Withdrawal by Subject|0|||
162934691|NCT01567306|588464422|FG001|Overall Study|Withdrawal by Subject|0|||
162934692|NCT01567306|588464423|FG002|Overall Study|Withdrawal by Subject|0|||
162934693|NCT01567306|588464424|FG003|Overall Study|Withdrawal by Subject|0|||
162934694|NCT01567306|588464425|FG004|Overall Study|Withdrawal by Subject|0|||
162934695|NCT01567306|588464426|FG005|Overall Study|Withdrawal by Subject|1|||
162934696|NCT04272775|588464434|FG000|Overall Study|Study Terminated by Sponsor|1|||
162934697|NCT04272775|588464435|FG001|Overall Study|Study Terminated by Sponsor|0|||
162934698|NCT04272775|588464434|FG000|Overall Study|Protocol Violation|0|||
162934699|NCT04272775|588464435|FG001|Overall Study|Protocol Violation|1|||
162934700|NCT04272775|588464434|FG000|Overall Study|Symptomatic Deterioration|1|||
162934701|NCT04272775|588464435|FG001|Overall Study|Symptomatic Deterioration|1|||
162934702|NCT04272775|588464434|FG000|Overall Study|Withdrawal by Subject|1|||
162934703|NCT04272775|588464435|FG001|Overall Study|Withdrawal by Subject|2|||
162934704|NCT04272775|588464434|FG000|Overall Study|Adverse Event|1|||
162934705|NCT04272775|588464435|FG001|Overall Study|Adverse Event|2|||
162934706|NCT04272775|588464434|FG000|Overall Study|Progressive Disease|3|||
162934707|NCT04272775|588464435|FG001|Overall Study|Progressive Disease|1|||
162934708|NCT02063698|588464438|FG000|Overall Study|did not complete booklet for days 2-8|1|||
162934709|NCT02063698|588464439|FG001|Overall Study|did not complete booklet for days 2-8|2|||
162934710|NCT01092702|588464440|FG000|Overall Study|Withdrawal by Subject|7|||
162934711|NCT01092702|588464440|FG000|Overall Study|Lost to Follow-up|2|||
162934712|NCT00449930|588464441|FG000|Overall Study|Adverse Event|9|||
162934713|NCT00449930|588464442|FG001|Overall Study|Adverse Event|19|||
162934714|NCT00449930|588464441|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
162934715|NCT00449930|588464442|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
162934716|NCT00449930|588464441|FG000|Overall Study|Lack of Efficacy|10|||
162934717|NCT00449930|588464442|FG001|Overall Study|Lack of Efficacy|1|||
162934718|NCT00449930|588464441|FG000|Overall Study|Lost to Follow-up|9|||
162934719|NCT00449930|588464442|FG001|Overall Study|Lost to Follow-up|14|||
162934720|NCT00449930|588464441|FG000|Overall Study|Physician Decision|1|||
162934721|NCT00449930|588464442|FG001|Overall Study|Physician Decision|2|||
162934722|NCT00449930|588464441|FG000|Overall Study|Protocol Violation|14|||
162934723|NCT00449930|588464442|FG001|Overall Study|Protocol Violation|15|||
162934724|NCT00449930|588464441|FG000|Overall Study|Withdrawal by Subject|16|||
162934725|NCT00449930|588464442|FG001|Overall Study|Withdrawal by Subject|23|||
162934726|NCT00449930|588464441|FG000|Overall Study|Glycemic discontinuation criteria|1|||
162934727|NCT00449930|588464442|FG001|Overall Study|Glycemic discontinuation criteria|1|||
162934728|NCT00575328|588464444|FG000|Overall Study|Adverse Event|1|||
162934729|NCT00575328|588464445|FG001|Overall Study|Adverse Event|1|||
163178735|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178736|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
163178737|NCT00745615|589369250|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178738|NCT00745615|589369251|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
163178739|NCT00745615|589369252|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178740|NCT00745615|589369253|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178741|NCT00745615|589369254|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178742|NCT00745615|589369255|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
163178743|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163178744|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163178745|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
163042828|NCT01990768|588863969|FG001|6-Month Follow-up|No contact information|6|||
163042829|NCT01990768|588863970|FG002|6-Month Follow-up|No contact information|5|||
163042830|NCT01990768|588863968|FG000|6-Month Follow-up|Homeless|4|||
163042831|NCT01990768|588863969|FG001|6-Month Follow-up|Homeless|3|||
163178746|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162934730|NCT00575328|588464444|FG000|Overall Study|Lost to Follow-up|2|||
162934731|NCT00575328|588464445|FG001|Overall Study|Lost to Follow-up|1|||
162934732|NCT02124746|588464446|FG000|Overall Study|Adverse Event|2|||
162934733|NCT02124746|588464447|FG001|Overall Study|Adverse Event|1|||
162934734|NCT02124746|588464448|FG002|Overall Study|Adverse Event|2|||
162934735|NCT02124746|588464446|FG000|Overall Study|Death|2|||
162934736|NCT02124746|588464447|FG001|Overall Study|Death|1|||
162934737|NCT02124746|588464448|FG002|Overall Study|Death|3|||
162934738|NCT02124746|588464446|FG000|Overall Study|Lack of Efficacy|3|||
162934739|NCT02124746|588464447|FG001|Overall Study|Lack of Efficacy|2|||
162934740|NCT02124746|588464448|FG002|Overall Study|Lack of Efficacy|2|||
162934741|NCT02124746|588464446|FG000|Overall Study|Physician Decision|6|||
162934742|NCT02124746|588464447|FG001|Overall Study|Physician Decision|4|||
162934743|NCT02124746|588464448|FG002|Overall Study|Physician Decision|5|||
162934744|NCT02124746|588464446|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162934745|NCT02124746|588464447|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162934746|NCT02124746|588464448|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162934747|NCT02124746|588464446|FG000|Overall Study|Withdrawal by Subject|3|||
162934748|NCT02124746|588464447|FG001|Overall Study|Withdrawal by Subject|3|||
162934749|NCT02124746|588464448|FG002|Overall Study|Withdrawal by Subject|0|||
162934750|NCT02124746|588464446|FG000|Overall Study|Study Terminated by Sponsor|0|||
162934751|NCT02124746|588464447|FG001|Overall Study|Study Terminated by Sponsor|0|||
162934752|NCT02124746|588464448|FG002|Overall Study|Study Terminated by Sponsor|6|||
162934753|NCT02124746|588464446|FG000|Overall Study|Disease Progression|3|||
162934754|NCT02124746|588464447|FG001|Overall Study|Disease Progression|6|||
162934755|NCT02124746|588464448|FG002|Overall Study|Disease Progression|4|||
162934756|NCT01722266|588464453|FG000|Overall Study|Withdrawal by Subject|1|||
162934757|NCT01722266|588464454|FG001|Overall Study|Withdrawal by Subject|2|||
162934758|NCT01722266|588464455|FG002|Overall Study|Withdrawal by Subject|0|||
162934759|NCT01722266|588464456|FG003|Overall Study|Withdrawal by Subject|0|||
162934760|NCT01722266|588464453|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
162934761|NCT01722266|588464454|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
162934762|NCT01722266|588464455|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
162934763|NCT01722266|588464456|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
162934764|NCT01722266|588464453|FG000|Overall Study|Dropped out due to Nausea|0|||
162934765|NCT01722266|588464454|FG001|Overall Study|Dropped out due to Nausea|0|||
162934766|NCT01722266|588464455|FG002|Overall Study|Dropped out due to Nausea|2|||
162934767|NCT01722266|588464456|FG003|Overall Study|Dropped out due to Nausea|0|||
162934768|NCT03811249|588464457|FG000|Overall Study|Withdrawal by Subject|44|||
163178747|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
163178748|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
163178749|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178750|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178751|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178752|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
163178753|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
163178754|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
163178755|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178756|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178757|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178758|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
163178759|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
163178760|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
163178761|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178762|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178763|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178764|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
163178765|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
163178766|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
163178767|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178768|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178769|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178770|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163178771|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
162934769|NCT03811249|588464457|FG000|Overall Study|Missed Visit|24|||
163178772|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
163178773|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178774|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178775|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178776|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
163178777|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
163178778|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
162934770|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
162934771|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
162934772|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
162934773|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
162934774|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
162934775|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
162934776|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
162934777|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
162934778|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
162934779|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
162934780|NCT00124449|588464458|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
162934781|NCT00124449|588464459|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
162934782|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
162934783|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
162934784|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
162934785|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
162934786|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
162934787|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
162934788|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
162934789|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
162934790|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
162934791|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
162934792|NCT00124449|588464458|FG000|18-Month Untreated Observation Period|Relocated|1|||
162934793|NCT00124449|588464459|FG001|18-Month Untreated Observation Period|Relocated|0|||
162934794|NCT03124381|588464468|FG000|Overall Study|Lost to Follow-up|1|||
162934795|NCT03124381|588464469|FG001|Overall Study|Lost to Follow-up|1|||
162934796|NCT03124381|588464468|FG000|Overall Study|Withdrawal by Subject|6|||
162934797|NCT03124381|588464469|FG001|Overall Study|Withdrawal by Subject|3|||
162934798|NCT03124381|588464468|FG000|Overall Study|Protocol Violation|0|||
162934799|NCT03124381|588464469|FG001|Overall Study|Protocol Violation|1|||
162934800|NCT03124381|588464468|FG000|Overall Study|Adverse Event|1|||
162934801|NCT03124381|588464469|FG001|Overall Study|Adverse Event|1|||
162934802|NCT03124381|588464468|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
162934803|NCT03124381|588464469|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
162934804|NCT02473510|588464470|FG000|Overall Study|Lost to Follow-up|1|||
162934805|NCT02473510|588464471|FG001|Overall Study|Lost to Follow-up|2|||
162934806|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
162934807|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
162934808|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
162934809|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
162934810|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Other|1|||
162934811|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Other|0|||
162934812|NCT00990093|588464472|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
162934813|NCT00990093|588464473|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
162934814|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
162934815|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
162934816|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
163042832|NCT01990768|588863970|FG002|6-Month Follow-up|Homeless|6|||
162826485|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
162826486|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
162826487|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162826488|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162826489|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
162826490|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162826491|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162826492|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162826493|NCT00111800|588077261|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163178779|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178780|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178781|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178782|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162826494|NCT00111800|588077262|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
162826495|NCT00111800|588077263|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
162826496|NCT00111800|588077264|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
162826497|NCT00111800|588077265|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
162826498|NCT00111800|588077266|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
162826499|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
162826500|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
162826501|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
163178783|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
163178784|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
163178785|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178786|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178787|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178788|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178789|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
163178790|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
163178791|NCT00745615|589369250|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162826502|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
162826503|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
162826504|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
162826505|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
162934817|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
162934818|NCT00990093|588464472|FG000|Test Period 2 (15-28 Days)|Other|0|||
162934819|NCT00990093|588464473|FG001|Test Period 2 (15-28 Days)|Other|1|||
162934820|NCT03185949|588464474|FG000|ITT Analysis|Withdrawal by Subject|4|||
162934821|NCT03185949|588464475|FG001|ITT Analysis|Withdrawal by Subject|3|||
162934822|NCT03185949|588464474|FG000|PP Analysis|Protocol Violation|2|||
162934823|NCT03185949|588464475|FG001|PP Analysis|Protocol Violation|2|||
162934824|NCT03185949|588464474|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
162934825|NCT03185949|588464475|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
162934826|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
162934827|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
162934828|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
162934829|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
162934830|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
163178792|NCT00745615|589369251|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178793|NCT00745615|589369252|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178794|NCT00745615|589369253|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
163178795|NCT00745615|589369254|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
163178796|NCT00745615|589369255|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
163178797|NCT00570232|589369256|FG000|Overall Study|Adverse Event|10|||
163178798|NCT00570232|589369256|FG000|Overall Study|discontinued due to medical condition|3|||
163178799|NCT00570232|589369256|FG000|Overall Study|discontinued due to recurrence|8|||
163178800|NCT00570232|589369256|FG000|Overall Study|discontinued due to noncompliance|2|||
163178801|NCT01076075|589369257|FG000|Overall Study|Adverse Event|3|||
163178802|NCT01076075|589369258|FG001|Overall Study|Adverse Event|9|||
163178803|NCT01076075|589369257|FG000|Overall Study|Lack of Efficacy|5|||
163178804|NCT01076075|589369258|FG001|Overall Study|Lack of Efficacy|4|||
163178805|NCT01076075|589369257|FG000|Overall Study|Lost to Follow-up|6|||
162934831|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
163178806|NCT01076075|589369258|FG001|Overall Study|Lost to Follow-up|5|||
163178807|NCT01076075|589369257|FG000|Overall Study|other|19|||
163178808|NCT01076075|589369258|FG001|Overall Study|other|9|||
163178809|NCT01076075|589369257|FG000|Overall Study|Protocol Violation|0|||
163178810|NCT01076075|589369258|FG001|Overall Study|Protocol Violation|1|||
163178811|NCT01076075|589369257|FG000|Overall Study|Withdrawal by Subject|8|||
162934832|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
162934833|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934834|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934835|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934836|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
162934837|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
162934838|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934839|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
162934840|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934841|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934842|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934843|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
162934844|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
162934845|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
162934846|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934847|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934848|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
162934849|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
162934850|NCT01806597|588466078|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934851|NCT01806597|588466079|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
162934852|NCT01806597|588466080|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934853|NCT01806597|588466081|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934854|NCT01806597|588466082|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934855|NCT01806597|588466083|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
162934856|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
162934857|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
162934858|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
162934859|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
162934860|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
162934861|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
162934862|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
162934863|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
162934864|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
162934865|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
162934866|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
162934867|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
162934868|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
162934869|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934870|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934871|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934872|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934873|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
162934874|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
162934875|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
162934876|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934877|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934878|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934879|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
162934880|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
162934881|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934882|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934883|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934884|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934885|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
162934886|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934887|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
162934888|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934889|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
162934890|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934891|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
162934892|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
162934893|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
162934894|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
162934895|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
162934896|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
162934897|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
162934898|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
162934899|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
162934900|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
162934901|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
162934902|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
162934903|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
162934904|NCT01806597|588466078|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
162934905|NCT01806597|588466079|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934906|NCT01806597|588466080|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934907|NCT01806597|588466081|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934908|NCT01806597|588466082|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934909|NCT01806597|588466083|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
162934910|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934911|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934912|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934913|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934914|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
162934915|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
162934916|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934917|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934918|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934919|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934920|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
162934921|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
162934922|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934923|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934924|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934925|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934926|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
162934927|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
162934928|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934929|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934930|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934931|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934932|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
162934933|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
162934934|NCT01806597|588466078|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934935|NCT01806597|588466079|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934936|NCT01806597|588466080|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934937|NCT01806597|588466081|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934938|NCT01806597|588466082|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
162934939|NCT01806597|588466083|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
162934940|NCT01473758|588466085|FG000|Cycle 1|Adverse Event|10|||
162934941|NCT01473758|588466086|FG001|Cycle 1|Adverse Event|2|||
162934942|NCT01473758|588466087|FG002|Cycle 1|Adverse Event|0|||
162934943|NCT01473758|588466088|FG003|Cycle 1|Adverse Event|0|||
162934944|NCT01473758|588466085|FG000|Cycle 1|Withdrawal by Subject|1|||
162934945|NCT01473758|588466086|FG001|Cycle 1|Withdrawal by Subject|1|||
162934946|NCT01473758|588466087|FG002|Cycle 1|Withdrawal by Subject|0|||
162934947|NCT01473758|588466088|FG003|Cycle 1|Withdrawal by Subject|0|||
162934948|NCT01473758|588466085|FG000|Cycle 2|Adverse Event|0|||
162934949|NCT01473758|588466086|FG001|Cycle 2|Adverse Event|0|||
162934950|NCT01473758|588466087|FG002|Cycle 2|Adverse Event|5|||
162934951|NCT01473758|588466088|FG003|Cycle 2|Adverse Event|0|||
162934952|NCT02763579|588466089|FG000|Global Period|Death|167|||
162934953|NCT02763579|588466090|FG001|Global Period|Death|151|||
162934954|NCT02763579|588466091|FG002|Global Period|Death|0|||
162934955|NCT02763579|588466092|FG003|Global Period|Death|0|||
162934956|NCT02763579|588466089|FG000|Global Period|Lost to Follow-up|2|||
162934957|NCT02763579|588466090|FG001|Global Period|Lost to Follow-up|4|||
162934958|NCT02763579|588466091|FG002|Global Period|Lost to Follow-up|0|||
162934959|NCT02763579|588466092|FG003|Global Period|Lost to Follow-up|0|||
162934960|NCT02763579|588466089|FG000|Global Period|Physician Decision|0|||
162934961|NCT02763579|588466090|FG001|Global Period|Physician Decision|2|||
162631059|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
162934962|NCT02763579|588466091|FG002|Global Period|Physician Decision|0|||
162934963|NCT02763579|588466092|FG003|Global Period|Physician Decision|0|||
162934964|NCT02763579|588466089|FG000|Global Period|Study Terminated By Sponsor|21|||
162934965|NCT02763579|588466090|FG001|Global Period|Study Terminated By Sponsor|26|||
162934966|NCT02763579|588466091|FG002|Global Period|Study Terminated By Sponsor|0|||
162934967|NCT02763579|588466092|FG003|Global Period|Study Terminated By Sponsor|0|||
162934968|NCT02763579|588466089|FG000|Global Period|Withdrawal by Subject|12|||
162934969|NCT02763579|588466090|FG001|Global Period|Withdrawal by Subject|18|||
162934970|NCT02763579|588466091|FG002|Global Period|Withdrawal by Subject|0|||
162934971|NCT02763579|588466092|FG003|Global Period|Withdrawal by Subject|0|||
162934972|NCT02763579|588466089|FG000|China Period|Death|0|||
162934973|NCT02763579|588466090|FG001|China Period|Death|0|||
162934974|NCT02763579|588466091|FG002|China Period|Death|46|||
162934975|NCT02763579|588466092|FG003|China Period|Death|48|||
162934976|NCT02763579|588466089|FG000|China Period|Lost to Follow-up|0|||
162934977|NCT02763579|588466090|FG001|China Period|Lost to Follow-up|0|||
162934978|NCT02763579|588466091|FG002|China Period|Lost to Follow-up|1|||
162934979|NCT02763579|588466092|FG003|China Period|Lost to Follow-up|1|||
162934980|NCT02763579|588466089|FG000|China Period|Physician Decision|0|||
162934981|NCT02763579|588466090|FG001|China Period|Physician Decision|0|||
162934982|NCT02763579|588466091|FG002|China Period|Physician Decision|0|||
162934983|NCT02763579|588466092|FG003|China Period|Physician Decision|1|||
162934984|NCT02763579|588466089|FG000|China Period|Study Terminated By Sponsor|0|||
162934985|NCT02763579|588466090|FG001|China Period|Study Terminated By Sponsor|0|||
162934986|NCT02763579|588466091|FG002|China Period|Study Terminated By Sponsor|3|||
162934987|NCT02763579|588466092|FG003|China Period|Study Terminated By Sponsor|4|||
162934988|NCT02763579|588466089|FG000|China Period|Withdrawal by Subject|0|||
162934989|NCT02763579|588466090|FG001|China Period|Withdrawal by Subject|0|||
162934990|NCT02763579|588466091|FG002|China Period|Withdrawal by Subject|3|||
162934991|NCT02763579|588466092|FG003|China Period|Withdrawal by Subject|3|||
162934992|NCT00829413|588466096|FG000|Overall Study|No study drug admimnistered|13|||
162934993|NCT00829413|588466096|FG000|Overall Study|Training Patients|67|||
162934994|NCT00829413|588466096|FG000|Overall Study|No truth standard procedure available|9|||
162934995|NCT00829413|588466096|FG000|Overall Study|Technically inadequate truth standard|2|||
162934996|NCT00829413|588466096|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
162934997|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
162934998|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
162934999|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
162935000|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
162935001|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
162935002|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
162935003|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
162935004|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
162935005|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
162935006|NCT00294723|588466100|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
162935007|NCT00294723|588466101|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
162935008|NCT00294723|588466102|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
162935009|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
162935010|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
162935011|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
162935012|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
162935013|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
162935014|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
163178812|NCT01076075|589369258|FG001|Overall Study|Withdrawal by Subject|19|||
163178813|NCT03326206|589369265|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
163178814|NCT03326206|589369266|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
163178815|NCT03326206|589369265|FG000|Overall Study - 24 months|Death|8|||
163178816|NCT03326206|589369266|FG001|Overall Study - 24 months|Death|92|||
163178817|NCT03326206|589369265|FG000|Overall Study - 24 months|Observational data not available|43|||
163178818|NCT03326206|589369266|FG001|Overall Study - 24 months|Observational data not available|2879|||
163178819|NCT03326206|589369265|FG000|12 months|Unable to match cases with controls|17|||
163178820|NCT03326206|589369266|FG001|12 months|Unable to match cases with controls|22721|||
162698481|NCT02743793|587605511|FG001|Overall Study|Withdrawal by Subject|1|||
162935015|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
162935016|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
162935017|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
162935018|NCT00294723|588466100|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
162698482|NCT02743793|587605510|FG000|Overall Study|Screen Failure|4|||
162935019|NCT00294723|588466101|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
162935020|NCT00294723|588466102|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
162935021|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
163178821|NCT03326206|589369265|FG000|12 months|Death|2|||
163178822|NCT03326206|589369266|FG001|12 months|Death|50|||
163178823|NCT03326206|589369265|FG000|12 months|Observational data not available|49|||
162935022|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
162935023|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
162935024|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
162935025|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
162935026|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
162935027|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935028|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935029|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
162935030|NCT00294723|588466100|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
162935031|NCT00294723|588466101|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
162935032|NCT00294723|588466102|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
162935033|NCT00891774|588466107|FG000|Overall Study|Lost to Follow-up|5|||
162935034|NCT00891774|588466107|FG000|Overall Study|Illness (Self/Mother)|3|||
162935035|NCT00891774|588466107|FG000|Overall Study|Withdrawal by Subject|2|||
162935036|NCT00891774|588466107|FG000|Overall Study|Protocol Violation|4|||
162935037|NCT03255031|588466112|FG000|Overall Study|Adverse Event|5|||
162935038|NCT03255031|588466113|FG001|Overall Study|Adverse Event|3|||
162935039|NCT03255031|588466112|FG000|Overall Study|Physician Decision|2|||
162935040|NCT03255031|588466113|FG001|Overall Study|Physician Decision|1|||
162935041|NCT03255031|588466112|FG000|Overall Study|Withdrawal by Subject|9|||
162935042|NCT03255031|588466113|FG001|Overall Study|Withdrawal by Subject|3|||
162935043|NCT01809314|588466114|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
162935044|NCT01809314|588466114|FG000|Overall Study|Adverse Event|6|||
162935045|NCT01809314|588466114|FG000|Overall Study|Insufficient Therapeutic Response|14|||
162935046|NCT01809314|588466114|FG000|Overall Study|Lost to Follow-up|724|||
162935047|NCT00863057|588466117|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935048|NCT00863057|588466118|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935049|NCT00863057|588466119|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
162935050|NCT00863057|588466120|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
162935051|NCT00863057|588466117|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935052|NCT00863057|588466118|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
162935053|NCT00863057|588466119|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935054|NCT00863057|588466120|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
162935055|NCT00863057|588466117|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
162935056|NCT00863057|588466118|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
162935057|NCT00863057|588466119|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
163178824|NCT03326206|589369266|FG001|12 months|Observational data not available|2921|||
163178825|NCT01958827|589369267|FG000|Overall Study|Adverse Event|3|||
163178826|NCT01958827|589369267|FG000|Overall Study|Lack of Efficacy|6|||
163178827|NCT01958827|589369267|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
163178828|NCT01163318|589369268|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
163178829|NCT01163318|589369268|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
163178830|NCT01163318|589369268|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
163178831|NCT01163318|589369268|FG000|Overall Study|Participants Without Case Report Form|7|||
163178832|NCT01163318|589369268|FG000|Overall Study|Multiple Reasons Per Participant|224|||
163178833|NCT03587727|589369269|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
163178834|NCT03587727|589369269|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
163178835|NCT04770753|589370466|FG000|Overall Study|Randomized, never treated|1|||
163178836|NCT04770753|589370467|FG001|Overall Study|Randomized, never treated|1|||
163178837|NCT04770753|589370466|FG000|Overall Study|Withdrawal by Subject|3|||
163178838|NCT04770753|589370467|FG001|Overall Study|Withdrawal by Subject|1|||
163178839|NCT04770753|589370466|FG000|Overall Study|Adverse Event|2|||
163178840|NCT04770753|589370467|FG001|Overall Study|Adverse Event|0|||
163178841|NCT04770753|589370466|FG000|Overall Study|Pregnancy|1|||
163178842|NCT04770753|589370467|FG001|Overall Study|Pregnancy|0|||
163178843|NCT04770753|589370466|FG000|Overall Study|Other un-specified|1|||
163178844|NCT04770753|589370467|FG001|Overall Study|Other un-specified|0|||
163178845|NCT04562480|589370468|FG000|Overall Study|Withdrawal by Subject|1|||
163178846|NCT03563716|589370473|FG000|Overall Study|Death|20|||
163178847|NCT03563716|589370474|FG001|Overall Study|Death|14|||
163178848|NCT03563716|589370473|FG000|Overall Study|Withdrawal by Subject|3|||
163178849|NCT03563716|589370474|FG001|Overall Study|Withdrawal by Subject|3|||
163178850|NCT03563716|589370473|FG000|Overall Study|Still on Study|45|||
163178851|NCT03563716|589370474|FG001|Overall Study|Still on Study|50|||
163178852|NCT04001829|589370477|FG000|Overall Study|Never start protocol therapy|5|||
163178853|NCT04001829|589370478|FG001|Overall Study|Never start protocol therapy|5|||
163178854|NCT04001829|589370477|FG000|Overall Study|Adverse Event|11|||
163178855|NCT04001829|589370478|FG001|Overall Study|Adverse Event|7|||
163178856|NCT04001829|589370477|FG000|Overall Study|Alternative therapy|1|||
163178857|NCT04001829|589370478|FG001|Overall Study|Alternative therapy|2|||
163178858|NCT04001829|589370477|FG000|Overall Study|Disease progression/relapse|2|||
163178859|NCT04001829|589370478|FG001|Overall Study|Disease progression/relapse|1|||
162935058|NCT00863057|588466120|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
162935059|NCT00863057|588466117|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935060|NCT00863057|588466118|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935061|NCT00863057|588466119|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
162935062|NCT00863057|588466120|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
162935063|NCT02974114|588466124|FG000|Overall Study|Other (Not specified)|0|||
162935064|NCT02974114|588466125|FG001|Overall Study|Other (Not specified)|1|||
162935065|NCT02974114|588466126|FG002|Overall Study|Other (Not specified)|2|||
162935066|NCT00545233|588466129|FG000|Overall Study|Adverse Event|10|||
162935067|NCT00545233|588466130|FG001|Overall Study|Adverse Event|5|||
162935068|NCT00545233|588466129|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
162935069|NCT00545233|588466130|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162935070|NCT00545233|588466129|FG000|Overall Study|Protocol Violation|2|||
162935071|NCT00545233|588466130|FG001|Overall Study|Protocol Violation|0|||
162935072|NCT00545233|588466129|FG000|Overall Study|Refused Treatment|9|||
162935073|NCT00545233|588466130|FG001|Overall Study|Refused Treatment|7|||
162935074|NCT00545233|588466129|FG000|Overall Study|Failure to Return|4|||
162935075|NCT00545233|588466130|FG001|Overall Study|Failure to Return|6|||
162935076|NCT00545233|588466129|FG000|Overall Study|Insufficient response|14|||
162935077|NCT00545233|588466130|FG001|Overall Study|Insufficient response|15|||
162935078|NCT00545233|588466129|FG000|Overall Study|Physician Decision|2|||
162935079|NCT00545233|588466130|FG001|Overall Study|Physician Decision|1|||
162935080|NCT06371079|588466131|FG000|Overall Study|Missing data|88|||
162935081|NCT06371079|588466132|FG001|Overall Study|Missing data|247|||
162935082|NCT01238211|588466133|FG000|Overall Study|Continues active treatment|31|||
162935083|NCT01238211|588466133|FG000|Overall Study|Adverse Event|7|||
162935084|NCT01238211|588466133|FG000|Overall Study|Death|4|||
162935085|NCT01238211|588466133|FG000|Overall Study|Relapse/Progression|2|||
163178860|NCT04001829|589370477|FG000|Overall Study|Other complicating disease|1|||
163178861|NCT04001829|589370478|FG001|Overall Study|Other complicating disease|0|||
163178862|NCT04001829|589370477|FG000|Overall Study|Withdrawal by Subject|1|||
163178863|NCT04001829|589370478|FG001|Overall Study|Withdrawal by Subject|4|||
163178864|NCT04001829|589370477|FG000|Overall Study|Ineligible|2|||
163178865|NCT04001829|589370478|FG001|Overall Study|Ineligible|2|||
163178866|NCT04001829|589370477|FG000|Overall Study|Reason missing due to delinquent data|1|||
163178867|NCT04001829|589370478|FG001|Overall Study|Reason missing due to delinquent data|0|||
163178868|NCT05859698|589370479|FG000|Overall Study|Adverse Event|1|||
163178869|NCT05859698|589370479|FG000|Overall Study|Death|1|||
163178870|NCT05859698|589370479|FG000|Overall Study|Physician Decision|1|||
163178871|NCT05859698|589370479|FG000|Overall Study|Lost to Follow-up|2|||
163178872|NCT05859698|589370479|FG000|Overall Study|Other Than Specified|2|||
163178873|NCT05859698|589370479|FG000|Overall Study|Withdrawal by Subject|1|||
163178874|NCT05900999|589370480|FG000|Overall Study|Withdrawal by Subject|9|||
163178875|NCT05900999|589370480|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
163178876|NCT00364286|589370482|FG000|Overall Study|Withdrawal by Subject|1|||
163178877|NCT00364286|589370482|FG000|Overall Study|Adverse Event|2|||
163178878|NCT05388058|589370484|FG000|Initial Treatment|Withdrawal by Subject|0|||
163178879|NCT05388058|589370485|FG001|Initial Treatment|Withdrawal by Subject|1|||
163178880|NCT05388058|589370484|FG000|Initial Treatment|Ineligible|0|||
163178881|NCT05388058|589370485|FG001|Initial Treatment|Ineligible|1|||
163178882|NCT00430989|589370487|FG000|Overall Study|Lost to Follow-up|2|||
162826506|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
162826507|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
162826508|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
162826509|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
162826510|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
162826511|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
162826512|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
162826513|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
162826514|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
162826515|NCT00094770|588077267|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
162826516|NCT00094770|588077268|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
162826517|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
162826518|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
162826519|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
162826520|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
162826521|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
162935086|NCT01238211|588466133|FG000|Overall Study|Withdrawal by Subject|7|||
163178883|NCT00430989|589370488|FG001|Overall Study|Lost to Follow-up|3|||
163178884|NCT00430989|589370487|FG000|Overall Study|Withdrawal by Subject|15|||
163178885|NCT00430989|589370488|FG001|Overall Study|Withdrawal by Subject|14|||
163178886|NCT00430989|589370487|FG000|Overall Study|Protocol Violation|30|||
163178887|NCT00430989|589370488|FG001|Overall Study|Protocol Violation|37|||
163178888|NCT00430989|589370487|FG000|Overall Study|Not eligible|13|||
163178889|NCT00430989|589370488|FG001|Overall Study|Not eligible|6|||
163178890|NCT04527549|589370492|FG000|Overall Study|Withdrawal by Subject|1|||
163178891|NCT04527549|589370493|FG001|Overall Study|Withdrawal by Subject|1|||
163178892|NCT04831216|589370498|FG000|Overall Study|Lost to Follow-up|32|||
163178893|NCT05297786|589370500|FG000|Overall Study|Withdrawal by Subject|3|||
163178894|NCT05297786|589370501|FG001|Overall Study|Withdrawal by Subject|0|||
163178895|NCT05297786|589370500|FG000|Overall Study|Renal transplantation|1|||
163178896|NCT05297786|589370501|FG001|Overall Study|Renal transplantation|0|||
163178897|NCT05297786|589370500|FG000|Overall Study|Physician Decision|1|||
163178898|NCT05297786|589370501|FG001|Overall Study|Physician Decision|0|||
163178899|NCT05297786|589370500|FG000|Overall Study|Adverse Event|0|||
163178900|NCT05297786|589370501|FG001|Overall Study|Adverse Event|1|||
163178901|NCT05297786|589370500|FG000|Overall Study|Withdrawal by Subject|0|||
163178902|NCT05297786|589370501|FG001|Overall Study|Withdrawal by Subject|1|||
163178903|NCT05402137|589370502|FG000|Overall Study|Lost to Follow-up|42|||
163178904|NCT05402137|589370503|FG001|Overall Study|Lost to Follow-up|40|||
163178905|NCT03470441|589370504|FG000|Overall Study|Death|0|||
163178906|NCT03470441|589370505|FG001|Overall Study|Death|1|||
163178907|NCT03470441|589370506|FG002|Overall Study|Death|1|||
163178908|NCT03470441|589370507|FG003|Overall Study|Death|0|||
163178909|NCT03470441|589370504|FG000|Overall Study|Adverse Event|0|||
163178910|NCT03470441|589370505|FG001|Overall Study|Adverse Event|0|||
163178911|NCT03470441|589370506|FG002|Overall Study|Adverse Event|0|||
163178912|NCT03470441|589370507|FG003|Overall Study|Adverse Event|1|||
163178913|NCT03470441|589370504|FG000|Overall Study|Withdrawal by Subject|1|||
163178914|NCT03470441|589370505|FG001|Overall Study|Withdrawal by Subject|4|||
163178915|NCT03470441|589370506|FG002|Overall Study|Withdrawal by Subject|1|||
163178916|NCT03470441|589370507|FG003|Overall Study|Withdrawal by Subject|3|||
163178917|NCT06269484|589370508|FG000|Overall Study|Withdrawal by Subject|3|||
163178918|NCT06269484|589370509|FG001|Overall Study|Withdrawal by Subject|0|||
163178919|NCT06269484|589370510|FG002|Overall Study|Withdrawal by Subject|2|||
163178920|NCT06269484|589370508|FG000|Overall Study|All other reasons apart from specified|1|||
163178921|NCT06269484|589370509|FG001|Overall Study|All other reasons apart from specified|0|||
163178922|NCT06269484|589370510|FG002|Overall Study|All other reasons apart from specified|0|||
163178923|NCT06269484|589370508|FG000|Overall Study|Randomised but not started treatment|0|||
163178924|NCT06269484|589370509|FG001|Overall Study|Randomised but not started treatment|1|||
163178925|NCT06269484|589370510|FG002|Overall Study|Randomised but not started treatment|0|||
163178926|NCT05411367|589370512|FG000|Overall Study|Adverse Event|9|||
163178927|NCT05411367|589370513|FG001|Overall Study|Adverse Event|3|||
163178928|NCT05411367|589370512|FG000|Overall Study|Protocol Violation|0|||
163178929|NCT05411367|589370513|FG001|Overall Study|Protocol Violation|2|||
163178930|NCT05411367|589370512|FG000|Overall Study|Administrative Reasons|2|||
163178931|NCT05411367|589370513|FG001|Overall Study|Administrative Reasons|1|||
163178932|NCT05411367|589370512|FG000|Overall Study|Withdrawal by Subject|3|||
163178933|NCT05411367|589370513|FG001|Overall Study|Withdrawal by Subject|4|||
163178934|NCT05411367|589370512|FG000|Overall Study|Inclusion Criteria Not Met|0|||
163178935|NCT05411367|589370513|FG001|Overall Study|Inclusion Criteria Not Met|1|||
163178936|NCT02032823|589370516|FG000|Overall Study|Death|75|||
163178937|NCT02032823|589370517|FG001|Overall Study|Death|109|||
163178938|NCT02032823|589370516|FG000|Overall Study|Lost to Follow-up|18|||
163178939|NCT02032823|589370517|FG001|Overall Study|Lost to Follow-up|17|||
163178940|NCT02032823|589370516|FG000|Overall Study|Withdrawal by Subject|70|||
163178941|NCT02032823|589370517|FG001|Overall Study|Withdrawal by Subject|53|||
163178942|NCT02032823|589370516|FG000|Overall Study|Ongoing study at data cut-off|755|||
163178943|NCT02032823|589370517|FG001|Overall Study|Ongoing study at data cut-off|731|||
163178944|NCT02032823|589370516|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
163178945|NCT02032823|589370517|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
163178946|NCT03994601|589370518|FG000|Overall Study|Adverse Event|0|||
163178947|NCT03994601|589370519|FG001|Overall Study|Adverse Event|0|||
163178948|NCT03994601|589370520|FG002|Overall Study|Adverse Event|0|||
163178949|NCT03994601|589370521|FG003|Overall Study|Adverse Event|0|||
162698483|NCT02743793|587605511|FG001|Overall Study|Screen Failure|0|||
162935087|NCT01238211|588466133|FG000|Overall Study|Non-protocol treatment|4|||
162935088|NCT01238211|588466133|FG000|Overall Study|Investigator/Patient Decision|3|||
162935089|NCT02868281|588466134|FG000|Overall Study|Adverse Event|2|||
163178950|NCT03994601|589370522|FG004|Overall Study|Adverse Event|0|||
163178951|NCT03994601|589370523|FG005|Overall Study|Adverse Event|0|||
163178952|NCT03994601|589370524|FG006|Overall Study|Adverse Event|0|||
163178953|NCT03994601|589370525|FG007|Overall Study|Adverse Event|2|||
163178954|NCT03994601|589370526|FG008|Overall Study|Adverse Event|2|||
163178955|NCT03994601|589370527|FG009|Overall Study|Adverse Event|7|||
163178956|NCT03994601|589370528|FG010|Overall Study|Adverse Event|4|||
163178957|NCT03994601|589370529|FG011|Overall Study|Adverse Event|1|||
163178958|NCT03994601|589370530|FG012|Overall Study|Adverse Event|0|||
163178959|NCT03994601|589370518|FG000|Overall Study|Withdrew Consent|0|||
163178960|NCT03994601|589370519|FG001|Overall Study|Withdrew Consent|0|||
163178961|NCT03994601|589370520|FG002|Overall Study|Withdrew Consent|0|||
163178962|NCT03994601|589370521|FG003|Overall Study|Withdrew Consent|0|||
163178963|NCT03994601|589370522|FG004|Overall Study|Withdrew Consent|0|||
162935090|NCT02868281|588466135|FG001|Overall Study|Adverse Event|2|||
162935091|NCT02868281|588466134|FG000|Overall Study|Protocol Violation|13|||
162935092|NCT02868281|588466135|FG001|Overall Study|Protocol Violation|10|||
162935093|NCT02868281|588466134|FG000|Overall Study|Lost to Follow-up|3|||
162935094|NCT02868281|588466135|FG001|Overall Study|Lost to Follow-up|6|||
162935095|NCT02868281|588466134|FG000|Overall Study|Withdrawal by Subject|11|||
162935096|NCT02868281|588466135|FG001|Overall Study|Withdrawal by Subject|15|||
162935097|NCT02868281|588466134|FG000|Overall Study|Physician Decision|2|||
162935098|NCT02868281|588466135|FG001|Overall Study|Physician Decision|0|||
162935099|NCT02868281|588466134|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
162935100|NCT02868281|588466135|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
162935101|NCT02868281|588466134|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
162935102|NCT02868281|588466135|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
162935103|NCT02868281|588466134|FG000|Overall Study|Long journey/moving away|1|||
162935104|NCT02868281|588466135|FG001|Overall Study|Long journey/moving away|1|||
162935105|NCT01335464|588466136|FG000|Overall Study|Adverse Event|15|||
162935106|NCT01335464|588466137|FG001|Overall Study|Adverse Event|25|||
162935107|NCT01335464|588466136|FG000|Overall Study|Non compliant with protocol|2|||
162935108|NCT01335464|588466137|FG001|Overall Study|Non compliant with protocol|0|||
162935109|NCT01335464|588466136|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
162935110|NCT01335464|588466137|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
162935111|NCT01335464|588466136|FG000|Overall Study|Not treated|2|||
162935112|NCT01335464|588466137|FG001|Overall Study|Not treated|0|||
162935113|NCT01335464|588466136|FG000|Overall Study|Reason other than those stated above|1|||
162935114|NCT01335464|588466137|FG001|Overall Study|Reason other than those stated above|1|||
162935115|NCT02533999|588466144|FG000|Overall Study|Lost to Follow-up|3|||
162935116|NCT02533999|588466145|FG001|Overall Study|Lost to Follow-up|5|||
162935117|NCT02533999|588466144|FG000|Overall Study|Protocol Violation|3|||
162935118|NCT02533999|588466145|FG001|Overall Study|Protocol Violation|0|||
162935119|NCT02533999|588466144|FG000|Overall Study|Adverse Event|0|||
162935120|NCT02533999|588466145|FG001|Overall Study|Adverse Event|1|||
162935121|NCT02533999|588466144|FG000|Overall Study|Randomized but intervention not received|0|||
162935122|NCT02533999|588466145|FG001|Overall Study|Randomized but intervention not received|1|||
162935123|NCT03210259|588466146|FG000|12-Week Run-in Period|Adverse Event|1|||
162935124|NCT03210259|588466147|FG001|12-Week Run-in Period|Adverse Event|0|||
162935125|NCT03210259|588466148|FG002|12-Week Run-in Period|Adverse Event|0|||
162935126|NCT03210259|588466146|FG000|12-Week Run-in Period|Death|1|||
162935127|NCT03210259|588466147|FG001|12-Week Run-in Period|Death|0|||
162935128|NCT03210259|588466148|FG002|12-Week Run-in Period|Death|0|||
162935129|NCT03210259|588466146|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
162935130|NCT03210259|588466147|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
162935131|NCT03210259|588466148|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
162935132|NCT03210259|588466146|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
162935133|NCT03210259|588466147|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
162935134|NCT03210259|588466148|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
162935135|NCT03210259|588466146|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
162935136|NCT03210259|588466147|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
162935137|NCT03210259|588466148|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
162935138|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
162935139|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
162935140|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
162935141|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
162935142|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
162935143|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
162935144|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
162935145|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
162935146|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
162935147|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
162935148|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
162935149|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
162935150|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
162935151|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
162935152|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
162935153|NCT03210259|588466146|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
162935154|NCT03210259|588466147|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
162935155|NCT03210259|588466148|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
162935156|NCT05017493|588466149|FG000|Overall Study|Withdrawal by Subject|26|||
162935157|NCT05017493|588466150|FG001|Overall Study|Withdrawal by Subject|0|||
162935158|NCT05017493|588466149|FG000|Overall Study|Physician Decision|15|||
162935159|NCT05017493|588466150|FG001|Overall Study|Physician Decision|0|||
162935160|NCT05017493|588466149|FG000|Overall Study|Protocol Violation|81|||
162935161|NCT05017493|588466150|FG001|Overall Study|Protocol Violation|0|||
162935162|NCT03940586|588466154|FG000|Overall Study|Death|3|||
162935163|NCT03940586|588466155|FG001|Overall Study|Death|2|||
162935164|NCT03940586|588466156|FG002|Overall Study|Death|0|||
162935165|NCT03940586|588466154|FG000|Overall Study|Physician Decision|1|||
162935166|NCT03940586|588466155|FG001|Overall Study|Physician Decision|0|||
162935167|NCT03940586|588466156|FG002|Overall Study|Physician Decision|1|||
162935168|NCT03940586|588466154|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
162935169|NCT03940586|588466155|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
162935170|NCT03940586|588466156|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162935171|NCT03940586|588466154|FG000|Overall Study|Not Treated|0|||
162935172|NCT03940586|588466155|FG001|Overall Study|Not Treated|2|||
162935173|NCT03940586|588466156|FG002|Overall Study|Not Treated|0|||
162935174|NCT04304950|588466157|FG000|Overall Study|Lost to Follow-up|1|||
162935175|NCT04304950|588466158|FG001|Overall Study|Lost to Follow-up|1|||
162935176|NCT02006147|588466159|FG000|Overall Study|Protocol Violation|1|||
162935177|NCT02006147|588466160|FG001|Overall Study|Protocol Violation|1|||
162935178|NCT02006147|588466161|FG002|Overall Study|Protocol Violation|0|||
162935179|NCT02006147|588466162|FG003|Overall Study|Protocol Violation|0|||
162935180|NCT02006147|588466159|FG000|Overall Study|Withdrawal by Subject|0|||
162935181|NCT02006147|588466160|FG001|Overall Study|Withdrawal by Subject|1|||
162935182|NCT02006147|588466161|FG002|Overall Study|Withdrawal by Subject|0|||
162935183|NCT02006147|588466162|FG003|Overall Study|Withdrawal by Subject|0|||
162935184|NCT02006147|588466159|FG000|Overall Study|Withdrawal by Sponsor|1|||
162935185|NCT02006147|588466160|FG001|Overall Study|Withdrawal by Sponsor|0|||
162935186|NCT02006147|588466161|FG002|Overall Study|Withdrawal by Sponsor|0|||
162935187|NCT02006147|588466162|FG003|Overall Study|Withdrawal by Sponsor|0|||
162935188|NCT00345683|588466167|FG000|Overall Study|Lost to Follow-up|19|||
162935189|NCT00345683|588466168|FG001|Overall Study|Lost to Follow-up|7|||
162935190|NCT00345683|588466167|FG000|Overall Study|Other|6|||
162935191|NCT00345683|588466168|FG001|Overall Study|Other|2|||
162935192|NCT03182686|588466169|FG000|Overall Study|Lost to Follow-up|2|||
162935193|NCT03182686|588466170|FG001|Overall Study|Lost to Follow-up|0|||
162935194|NCT03182686|588466169|FG000|Overall Study|Adverse Event|2|||
162935195|NCT03182686|588466170|FG001|Overall Study|Adverse Event|0|||
162935196|NCT03182686|588466169|FG000|Overall Study|Withdrawal by Subject|3|||
162935197|NCT03182686|588466170|FG001|Overall Study|Withdrawal by Subject|0|||
162935198|NCT01154127|588466171|FG000|Period 1 (21 Days)|Adverse Event|3|||
162935199|NCT01154127|588466172|FG001|Period 1 (21 Days)|Adverse Event|4|||
162935200|NCT01154127|588466171|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
162935201|NCT01154127|588466172|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
162935202|NCT01154127|588466171|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
162935203|NCT01154127|588466172|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
162935204|NCT01154127|588466171|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
162935205|NCT01154127|588466172|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
162935206|NCT01154127|588466171|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
162935207|NCT01154127|588466172|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
162935208|NCT01697449|588466173|FG000|Overall Study|Disease progression|47|||
162935209|NCT01697449|588466173|FG000|Overall Study|Adverse Event|7|||
162935210|NCT01697449|588466173|FG000|Overall Study|Lost to Follow-up|5|||
162935211|NCT01697449|588466173|FG000|Overall Study|Withdrawal by Subject|2|||
162935212|NCT01697449|588466173|FG000|Overall Study|Physician Decision|1|||
162935213|NCT01697449|588466173|FG000|Overall Study|Death|2|||
163178964|NCT03994601|589370523|FG005|Overall Study|Withdrew Consent|0|||
162935214|NCT01697449|588466173|FG000|Overall Study|Other|1|||
162935215|NCT01697449|588466173|FG000|Overall Study|Missing|25|||
162935216|NCT01337050|588466174|FG000|Overall Study|Death|0|||
162935217|NCT01337050|588466175|FG001|Overall Study|Death|0|||
162935218|NCT01337050|588466176|FG002|Overall Study|Death|4|||
162935219|NCT01337050|588466174|FG000|Overall Study|Other|4|||
162935220|NCT01337050|588466175|FG001|Overall Study|Other|6|||
162935221|NCT01337050|588466176|FG002|Overall Study|Other|8|||
162935222|NCT01337050|588466174|FG000|Overall Study|Participants refused further follow-up|0|||
162935223|NCT01337050|588466175|FG001|Overall Study|Participants refused further follow-up|7|||
162935224|NCT01337050|588466176|FG002|Overall Study|Participants refused further follow-up|7|||
162935225|NCT00003102|588466177|FG000|Overall Study|Physician Decision|1|||
162935226|NCT00003102|588466178|FG001|Overall Study|Physician Decision|1|||
162935227|NCT00003102|588466179|FG002|Overall Study|Physician Decision|0|||
162935228|NCT00003102|588466177|FG000|Overall Study|Progressive Disease|0|||
162935229|NCT00003102|588466178|FG001|Overall Study|Progressive Disease|1|||
162935230|NCT00003102|588466179|FG002|Overall Study|Progressive Disease|0|||
162935231|NCT00003102|588466177|FG000|Overall Study|Adverse Event|0|||
162935232|NCT00003102|588466178|FG001|Overall Study|Adverse Event|1|||
162935233|NCT00003102|588466179|FG002|Overall Study|Adverse Event|1|||
162935234|NCT00003102|588466177|FG000|Overall Study|Death|0|||
163178965|NCT03994601|589370524|FG006|Overall Study|Withdrew Consent|1|||
162935235|NCT00003102|588466178|FG001|Overall Study|Death|0|||
162935236|NCT00003102|588466179|FG002|Overall Study|Death|1|||
162935237|NCT05037409|588466180|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
162935238|NCT05037409|588466181|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
162935239|NCT05037409|588466182|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
162935240|NCT00096486|588466185|FG000|Overall Study|Withdrawal by Subject|0|||
163178966|NCT03994601|589370525|FG007|Overall Study|Withdrew Consent|2|||
163178967|NCT03994601|589370526|FG008|Overall Study|Withdrew Consent|0|||
163178968|NCT03994601|589370527|FG009|Overall Study|Withdrew Consent|3|||
163178969|NCT03994601|589370528|FG010|Overall Study|Withdrew Consent|0|||
163178970|NCT03994601|589370529|FG011|Overall Study|Withdrew Consent|0|||
163178971|NCT03994601|589370530|FG012|Overall Study|Withdrew Consent|0|||
163178972|NCT03994601|589370518|FG000|Overall Study|Death|1|||
163178973|NCT03994601|589370519|FG001|Overall Study|Death|0|||
163178974|NCT03994601|589370520|FG002|Overall Study|Death|0|||
163178975|NCT03994601|589370521|FG003|Overall Study|Death|0|||
163178976|NCT03994601|589370522|FG004|Overall Study|Death|0|||
163178977|NCT03994601|589370523|FG005|Overall Study|Death|0|||
163178978|NCT03994601|589370524|FG006|Overall Study|Death|1|||
163178979|NCT03994601|589370525|FG007|Overall Study|Death|2|||
163178980|NCT03994601|589370526|FG008|Overall Study|Death|0|||
163178981|NCT03994601|589370527|FG009|Overall Study|Death|5|||
163178982|NCT03994601|589370528|FG010|Overall Study|Death|4|||
163178983|NCT03994601|589370529|FG011|Overall Study|Death|1|||
163178984|NCT03994601|589370530|FG012|Overall Study|Death|3|||
163178985|NCT03994601|589370518|FG000|Overall Study|Other Reasons|0|||
163178986|NCT03994601|589370519|FG001|Overall Study|Other Reasons|1|||
163178987|NCT03994601|589370520|FG002|Overall Study|Other Reasons|0|||
163178988|NCT03994601|589370521|FG003|Overall Study|Other Reasons|0|||
163178989|NCT03994601|589370522|FG004|Overall Study|Other Reasons|1|||
163178990|NCT03994601|589370523|FG005|Overall Study|Other Reasons|0|||
163178991|NCT03994601|589370524|FG006|Overall Study|Other Reasons|0|||
163178992|NCT03994601|589370525|FG007|Overall Study|Other Reasons|4|||
163178993|NCT03994601|589370526|FG008|Overall Study|Other Reasons|0|||
163178994|NCT03994601|589370527|FG009|Overall Study|Other Reasons|4|||
163178995|NCT03994601|589370528|FG010|Overall Study|Other Reasons|3|||
163178996|NCT03994601|589370529|FG011|Overall Study|Other Reasons|4|||
163178997|NCT03994601|589370530|FG012|Overall Study|Other Reasons|2|||
163178998|NCT03994601|589370518|FG000|Overall Study|Disease Progression|3|||
163178999|NCT03994601|589370519|FG001|Overall Study|Disease Progression|3|||
163179000|NCT03994601|589370520|FG002|Overall Study|Disease Progression|4|||
163179001|NCT03994601|589370521|FG003|Overall Study|Disease Progression|6|||
163179002|NCT03994601|589370522|FG004|Overall Study|Disease Progression|3|||
163179003|NCT03994601|589370523|FG005|Overall Study|Disease Progression|5|||
163179004|NCT03994601|589370524|FG006|Overall Study|Disease Progression|7|||
163179005|NCT03994601|589370525|FG007|Overall Study|Disease Progression|25|||
163179006|NCT03994601|589370526|FG008|Overall Study|Disease Progression|1|||
163179007|NCT03994601|589370527|FG009|Overall Study|Disease Progression|24|||
163179008|NCT03994601|589370528|FG010|Overall Study|Disease Progression|20|||
163179009|NCT03994601|589370529|FG011|Overall Study|Disease Progression|24|||
163179010|NCT03994601|589370530|FG012|Overall Study|Disease Progression|7|||
163179011|NCT03994601|589370518|FG000|Overall Study|Study Drug Toxicity|0|||
163179012|NCT03994601|589370519|FG001|Overall Study|Study Drug Toxicity|0|||
163179013|NCT03994601|589370520|FG002|Overall Study|Study Drug Toxicity|0|||
163179014|NCT03994601|589370521|FG003|Overall Study|Study Drug Toxicity|0|||
163179015|NCT03994601|589370522|FG004|Overall Study|Study Drug Toxicity|1|||
163179016|NCT03994601|589370523|FG005|Overall Study|Study Drug Toxicity|0|||
162935241|NCT00096486|588466186|FG001|Overall Study|Withdrawal by Subject|0|||
162935242|NCT00096486|588466187|FG002|Overall Study|Withdrawal by Subject|1|||
162935243|NCT00096486|588466188|FG003|Overall Study|Withdrawal by Subject|1|||
162935244|NCT00096486|588466185|FG000|Overall Study|Not Treated|0|||
162935245|NCT00096486|588466186|FG001|Overall Study|Not Treated|0|||
162935246|NCT00096486|588466187|FG002|Overall Study|Not Treated|1|||
162935247|NCT00096486|588466188|FG003|Overall Study|Not Treated|1|||
163179017|NCT03994601|589370524|FG006|Overall Study|Study Drug Toxicity|0|||
163179018|NCT03994601|589370525|FG007|Overall Study|Study Drug Toxicity|3|||
163179019|NCT03994601|589370526|FG008|Overall Study|Study Drug Toxicity|0|||
163179020|NCT03994601|589370527|FG009|Overall Study|Study Drug Toxicity|0|||
163179021|NCT03994601|589370528|FG010|Overall Study|Study Drug Toxicity|3|||
163179022|NCT03994601|589370529|FG011|Overall Study|Study Drug Toxicity|3|||
163179023|NCT03994601|589370530|FG012|Overall Study|Study Drug Toxicity|0|||
163179024|NCT03994601|589370518|FG000|Overall Study|AE Unrelated to Study Drug|0|||
163179025|NCT03994601|589370519|FG001|Overall Study|AE Unrelated to Study Drug|0|||
163179026|NCT03994601|589370520|FG002|Overall Study|AE Unrelated to Study Drug|1|||
163179027|NCT03994601|589370521|FG003|Overall Study|AE Unrelated to Study Drug|0|||
163179028|NCT03994601|589370522|FG004|Overall Study|AE Unrelated to Study Drug|0|||
163179029|NCT03994601|589370523|FG005|Overall Study|AE Unrelated to Study Drug|0|||
163179030|NCT03994601|589370524|FG006|Overall Study|AE Unrelated to Study Drug|0|||
163179031|NCT03994601|589370525|FG007|Overall Study|AE Unrelated to Study Drug|1|||
163179032|NCT03994601|589370526|FG008|Overall Study|AE Unrelated to Study Drug|0|||
163179033|NCT03994601|589370527|FG009|Overall Study|AE Unrelated to Study Drug|4|||
162935248|NCT01559818|588466189|FG000|Overall Study|Physician Decision|1|||
162935249|NCT01559818|588466189|FG000|Overall Study|Pregnancy|1|||
162935250|NCT01559818|588466189|FG000|Overall Study|Study terminated by Sponsor|4|||
162935251|NCT01559818|588466189|FG000|Overall Study|Withdrawal by Subject|1|||
162935252|NCT01512979|588466191|FG000|Overall Study|Adverse Event|2|||
162935253|NCT01512979|588466192|FG001|Overall Study|Adverse Event|2|||
162935254|NCT01512979|588466191|FG000|Overall Study|Protocol Violation|1|||
162935255|NCT01512979|588466192|FG001|Overall Study|Protocol Violation|4|||
162935256|NCT01512979|588466191|FG000|Overall Study|Lost to Follow-up|2|||
162935257|NCT01512979|588466192|FG001|Overall Study|Lost to Follow-up|5|||
162935258|NCT01512979|588466191|FG000|Overall Study|Withdrawal by Subject|1|||
162935259|NCT01512979|588466192|FG001|Overall Study|Withdrawal by Subject|2|||
162935260|NCT01512979|588466191|FG000|Overall Study|Reason other than stated above|13|||
162935261|NCT01512979|588466192|FG001|Overall Study|Reason other than stated above|9|||
162935262|NCT00125359|588466193|FG000|Overall Study|Death|4|||
162935263|NCT00125359|588466193|FG000|Overall Study|Adverse Event|5|||
162935264|NCT00125359|588466193|FG000|Overall Study|Physician Decision|14|||
162935265|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
162935266|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
162935267|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
162935268|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
162935269|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
162935270|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
162935271|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
162935272|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
162935273|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
162935274|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
162935275|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
162935276|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
162935277|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
162935278|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
162935279|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
162935280|NCT00529568|588466194|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
162935281|NCT00529568|588466195|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935282|NCT00529568|588466196|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935283|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
162935284|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
162935285|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
162935286|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
162935287|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
162935288|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
162935289|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
162935290|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
162935291|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
162935292|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
162935293|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
162935294|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
162935295|NCT00529568|588466194|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
162935296|NCT00529568|588466195|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
162935297|NCT00529568|588466196|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
162935298|NCT04049552|588466197|FG000|Overall Study|Lost to Follow-up|1|||
162935299|NCT00738920|588466199|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
162935300|NCT00738920|588466200|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
162935301|NCT00738920|588466201|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
162935302|NCT00738920|588466199|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
162935303|NCT00738920|588466200|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
162935304|NCT00738920|588466201|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
162935305|NCT00738920|588466199|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
162935306|NCT00738920|588466200|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
162935307|NCT00738920|588466201|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
162935308|NCT00738920|588466199|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
162935309|NCT00738920|588466200|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
162935310|NCT00738920|588466201|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
162935311|NCT00738920|588466199|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
162935312|NCT00738920|588466200|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
162935313|NCT00738920|588466201|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
162935314|NCT00738920|588466199|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
162935315|NCT00738920|588466200|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
162935316|NCT00738920|588466201|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
162935317|NCT00738920|588466199|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
162935318|NCT00738920|588466200|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
162935319|NCT00738920|588466201|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
162935320|NCT00738920|588466199|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
162935321|NCT00738920|588466200|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
162935322|NCT00738920|588466201|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
162935323|NCT00738920|588466199|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
162935324|NCT00738920|588466200|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
162935325|NCT00738920|588466201|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
162935326|NCT00738920|588466199|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
162935327|NCT00738920|588466200|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
162935328|NCT00738920|588466201|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
162935329|NCT04147611|588466205|FG000|Overall Study|Physician Decision|0|||
162935330|NCT04147611|588466206|FG001|Overall Study|Physician Decision|1|||
162935331|NCT01123980|588466211|FG000|Overall Study|Adverse Event|1|||
162935332|NCT01123980|588466212|FG001|Overall Study|Adverse Event|1|||
162935333|NCT01123980|588466211|FG000|Overall Study|Lack of Efficacy|1|||
162935334|NCT01123980|588466212|FG001|Overall Study|Lack of Efficacy|0|||
162935335|NCT01123980|588466211|FG000|Overall Study|Physician Decision|0|||
162935336|NCT01123980|588466212|FG001|Overall Study|Physician Decision|1|||
162935337|NCT01123980|588466211|FG000|Overall Study|Lost to Follow-up|0|||
162935338|NCT01123980|588466212|FG001|Overall Study|Lost to Follow-up|6|||
162935339|NCT01123980|588466211|FG000|Overall Study|Protocol Violation|6|||
162935340|NCT01123980|588466212|FG001|Overall Study|Protocol Violation|6|||
162935341|NCT01123980|588466211|FG000|Overall Study|Withdrawal by Subject|5|||
162935342|NCT01123980|588466212|FG001|Overall Study|Withdrawal by Subject|3|||
162935343|NCT01123980|588466211|FG000|Overall Study|Unclassified|6|||
162935344|NCT01123980|588466212|FG001|Overall Study|Unclassified|7|||
162935345|NCT04385199|588466213|FG000|Overall Study|Withdrawal by Subject|1|||
162935346|NCT04385199|588466214|FG001|Overall Study|Withdrawal by Subject|0|||
162935347|NCT02557672|588466215|FG000|Overall Study|Withdrawal by Subject|4|||
162935348|NCT02557672|588466216|FG001|Overall Study|Withdrawal by Subject|2|||
162935349|NCT03705169|588466217|FG000|Overall Study|Lost to Follow-up|0|||
162935350|NCT03705169|588466218|FG001|Overall Study|Lost to Follow-up|0|||
162935351|NCT03705169|588466219|FG002|Overall Study|Lost to Follow-up|0|||
162935352|NCT03705169|588466220|FG003|Overall Study|Lost to Follow-up|2|||
162935353|NCT03705169|588466221|FG004|Overall Study|Lost to Follow-up|0|||
162935354|NCT03705169|588466222|FG005|Overall Study|Lost to Follow-up|2|||
162935355|NCT03705169|588466223|FG006|Overall Study|Lost to Follow-up|1|||
162935356|NCT03705169|588466224|FG007|Overall Study|Lost to Follow-up|0|||
162935357|NCT03705169|588466225|FG008|Overall Study|Lost to Follow-up|0|||
162935358|NCT03705169|588466226|FG009|Overall Study|Lost to Follow-up|1|||
162935359|NCT03705169|588466217|FG000|Overall Study|Adverse Event|0|||
162935360|NCT03705169|588466218|FG001|Overall Study|Adverse Event|0|||
162935361|NCT03705169|588466219|FG002|Overall Study|Adverse Event|0|||
162935362|NCT03705169|588466220|FG003|Overall Study|Adverse Event|1|||
162935363|NCT03705169|588466221|FG004|Overall Study|Adverse Event|0|||
162935364|NCT03705169|588466222|FG005|Overall Study|Adverse Event|0|||
162935365|NCT03705169|588466223|FG006|Overall Study|Adverse Event|0|||
162935366|NCT03705169|588466224|FG007|Overall Study|Adverse Event|0|||
162935367|NCT03705169|588466225|FG008|Overall Study|Adverse Event|0|||
162935368|NCT03705169|588466226|FG009|Overall Study|Adverse Event|0|||
162935369|NCT03705169|588466217|FG000|Overall Study|Site Closure|0|||
162935370|NCT03705169|588466218|FG001|Overall Study|Site Closure|0|||
162935371|NCT03705169|588466219|FG002|Overall Study|Site Closure|0|||
162935372|NCT03705169|588466220|FG003|Overall Study|Site Closure|1|||
162935373|NCT03705169|588466221|FG004|Overall Study|Site Closure|0|||
162935374|NCT03705169|588466222|FG005|Overall Study|Site Closure|0|||
163179034|NCT03994601|589370528|FG010|Overall Study|AE Unrelated to Study Drug|5|||
163179035|NCT03994601|589370529|FG011|Overall Study|AE Unrelated to Study Drug|0|||
163179036|NCT03994601|589370530|FG012|Overall Study|AE Unrelated to Study Drug|0|||
163179037|NCT03994601|589370518|FG000|Overall Study|Request to Discontinue|0|||
163179038|NCT03994601|589370519|FG001|Overall Study|Request to Discontinue|0|||
163179039|NCT03994601|589370520|FG002|Overall Study|Request to Discontinue|0|||
162935375|NCT03705169|588466223|FG006|Overall Study|Site Closure|0|||
162935376|NCT03705169|588466224|FG007|Overall Study|Site Closure|0|||
162935377|NCT03705169|588466225|FG008|Overall Study|Site Closure|0|||
162935378|NCT03705169|588466226|FG009|Overall Study|Site Closure|0|||
162935379|NCT03705169|588466217|FG000|Overall Study|Did not receive study treatment|0|||
162935380|NCT03705169|588466218|FG001|Overall Study|Did not receive study treatment|0|||
162935381|NCT03705169|588466219|FG002|Overall Study|Did not receive study treatment|0|||
162935382|NCT03705169|588466220|FG003|Overall Study|Did not receive study treatment|1|||
162935383|NCT03705169|588466221|FG004|Overall Study|Did not receive study treatment|0|||
162935384|NCT03705169|588466222|FG005|Overall Study|Did not receive study treatment|0|||
162935385|NCT03705169|588466223|FG006|Overall Study|Did not receive study treatment|0|||
162935386|NCT03705169|588466224|FG007|Overall Study|Did not receive study treatment|0|||
163179040|NCT03994601|589370521|FG003|Overall Study|Request to Discontinue|0|||
163179041|NCT03994601|589370522|FG004|Overall Study|Request to Discontinue|0|||
162935387|NCT03705169|588466225|FG008|Overall Study|Did not receive study treatment|0|||
162935388|NCT03705169|588466226|FG009|Overall Study|Did not receive study treatment|0|||
162935389|NCT03705169|588466217|FG000|Overall Study|Concerns about study visit compliance|0|||
162935390|NCT03705169|588466218|FG001|Overall Study|Concerns about study visit compliance|0|||
162935391|NCT03705169|588466219|FG002|Overall Study|Concerns about study visit compliance|0|||
162935392|NCT03705169|588466220|FG003|Overall Study|Concerns about study visit compliance|1|||
162935393|NCT03705169|588466221|FG004|Overall Study|Concerns about study visit compliance|0|||
162935394|NCT03705169|588466222|FG005|Overall Study|Concerns about study visit compliance|0|||
162935395|NCT03705169|588466223|FG006|Overall Study|Concerns about study visit compliance|0|||
162935396|NCT03705169|588466224|FG007|Overall Study|Concerns about study visit compliance|0|||
162935397|NCT03705169|588466225|FG008|Overall Study|Concerns about study visit compliance|0|||
162935398|NCT03705169|588466226|FG009|Overall Study|Concerns about study visit compliance|0|||
162935399|NCT00458302|588468000|FG000|Overall Study|Adverse Event|4|||
162935400|NCT00458302|588468001|FG001|Overall Study|Adverse Event|14|||
162935401|NCT00458302|588468000|FG000|Overall Study|Pregnancy|2|||
162935402|NCT00458302|588468001|FG001|Overall Study|Pregnancy|1|||
162935403|NCT00458302|588468000|FG000|Overall Study|Protocol Violation|0|||
162935404|NCT00458302|588468001|FG001|Overall Study|Protocol Violation|2|||
162935405|NCT00458302|588468000|FG000|Overall Study|Withdrawal by Subject|6|||
162935406|NCT00458302|588468001|FG001|Overall Study|Withdrawal by Subject|4|||
162935407|NCT00458302|588468000|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
162935408|NCT00458302|588468001|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
162935409|NCT00458302|588468000|FG000|Overall Study|Study Termination By Sponsor|1|||
162935410|NCT00458302|588468001|FG001|Overall Study|Study Termination By Sponsor|0|||
162935411|NCT00458302|588468000|FG000|Overall Study|Lost to Follow-up|2|||
162935412|NCT00458302|588468001|FG001|Overall Study|Lost to Follow-up|0|||
162935413|NCT00458302|588468000|FG000|Overall Study|Other|4|||
162935414|NCT00458302|588468001|FG001|Overall Study|Other|2|||
162935415|NCT01513551|588468004|FG000|Overall Study|Death|0|||
162935416|NCT01513551|588468005|FG001|Overall Study|Death|1|||
162935417|NCT01513551|588468006|FG002|Overall Study|Death|0|||
162935418|NCT01513551|588468004|FG000|Overall Study|Lost to Follow-up|3|||
162935419|NCT01513551|588468005|FG001|Overall Study|Lost to Follow-up|5|||
162935420|NCT01513551|588468006|FG002|Overall Study|Lost to Follow-up|2|||
162935421|NCT01513551|588468004|FG000|Overall Study|Withdrawal by Subject|1|||
162935422|NCT01513551|588468005|FG001|Overall Study|Withdrawal by Subject|0|||
162935423|NCT01513551|588468006|FG002|Overall Study|Withdrawal by Subject|2|||
162935424|NCT01513551|588468004|FG000|Overall Study|Randomized but not vaccinated|0|||
162935425|NCT01513551|588468005|FG001|Overall Study|Randomized but not vaccinated|0|||
162935426|NCT01513551|588468006|FG002|Overall Study|Randomized but not vaccinated|1|||
162935427|NCT02038634|588468009|FG000|Overall Study|Lost to Follow-up|0|||
162935428|NCT02038634|588468010|FG001|Overall Study|Lost to Follow-up|1|||
162935429|NCT01706198|588468011|FG000|Overall Study|Adverse Event|12|||
162935430|NCT01706198|588468012|FG001|Overall Study|Adverse Event|15|||
162935431|NCT01706198|588468011|FG000|Overall Study|Protocol Violation|7|||
162935432|NCT01706198|588468012|FG001|Overall Study|Protocol Violation|5|||
162935433|NCT01706198|588468011|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
162935434|NCT01706198|588468012|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
162935435|NCT01706198|588468011|FG000|Overall Study|Lost to Follow-up|97|||
162935436|NCT01706198|588468012|FG001|Overall Study|Lost to Follow-up|93|||
162935437|NCT01706198|588468011|FG000|Overall Study|Physician Decision|23|||
162935438|NCT01706198|588468012|FG001|Overall Study|Physician Decision|37|||
162935439|NCT01706198|588468011|FG000|Overall Study|Withdrawal by Subject|23|||
162935440|NCT01706198|588468012|FG001|Overall Study|Withdrawal by Subject|31|||
162935441|NCT00549198|588468013|FG000|Overall Study|Adverse Event|28|||
162935442|NCT00549198|588468014|FG001|Overall Study|Adverse Event|26|||
162935443|NCT00549198|588468013|FG000|Overall Study|Insufficient Viral Load Response|4|||
162935444|NCT00549198|588468014|FG001|Overall Study|Insufficient Viral Load Response|2|||
162935445|NCT00549198|588468013|FG000|Overall Study|Protocol-defined Virological Failure|7|||
162935446|NCT00549198|588468014|FG001|Overall Study|Protocol-defined Virological Failure|0|||
162935447|NCT00549198|588468013|FG000|Overall Study|Non-compliance|2|||
162935448|NCT00549198|588468014|FG001|Overall Study|Non-compliance|4|||
162935449|NCT00549198|588468013|FG000|Overall Study|Lost to Follow-up|7|||
162935450|NCT00549198|588468014|FG001|Overall Study|Lost to Follow-up|8|||
162935451|NCT00549198|588468013|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
162935452|NCT00549198|588468014|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162935453|NCT00549198|588468013|FG000|Overall Study|Protocol Violation|7|||
162935454|NCT00549198|588468014|FG001|Overall Study|Protocol Violation|2|||
162935455|NCT00549198|588468013|FG000|Overall Study|Investigator Decision|4|||
162935456|NCT00549198|588468014|FG001|Overall Study|Investigator Decision|3|||
162935457|NCT00549198|588468013|FG000|Overall Study|Withdrawal by Subject|7|||
162935458|NCT00549198|588468014|FG001|Overall Study|Withdrawal by Subject|7|||
162935459|NCT00549198|588468013|FG000|Overall Study|Disease Progression|1|||
162935460|NCT00549198|588468014|FG001|Overall Study|Disease Progression|0|||
163179042|NCT03994601|589370523|FG005|Overall Study|Request to Discontinue|0|||
163179043|NCT03994601|589370524|FG006|Overall Study|Request to Discontinue|0|||
163179044|NCT03994601|589370525|FG007|Overall Study|Request to Discontinue|1|||
163179045|NCT03994601|589370526|FG008|Overall Study|Request to Discontinue|0|||
163179046|NCT03994601|589370527|FG009|Overall Study|Request to Discontinue|0|||
163179047|NCT03994601|589370528|FG010|Overall Study|Request to Discontinue|0|||
163179048|NCT03994601|589370529|FG011|Overall Study|Request to Discontinue|0|||
163179049|NCT03994601|589370530|FG012|Overall Study|Request to Discontinue|0|||
163179050|NCT04221438|589370531|FG000|Overall Study|Adverse Event|1|||
163179051|NCT04221438|589370531|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
163179052|NCT02411448|589370532|FG000|Overall Study|Withdrawal by Subject|1|||
163179053|NCT02411448|589370533|FG001|Overall Study|Withdrawal by Subject|14|||
163179054|NCT02411448|589370534|FG002|Overall Study|Withdrawal by Subject|9|||
163179055|NCT02411448|589370532|FG000|Overall Study|Other|0|||
163179056|NCT02411448|589370533|FG001|Overall Study|Other|2|||
163179057|NCT02411448|589370534|FG002|Overall Study|Other|0|||
163179058|NCT02411448|589370532|FG000|Overall Study|Did not receive study treatment|0|||
163179059|NCT02411448|589370533|FG001|Overall Study|Did not receive study treatment|3|||
163179060|NCT02411448|589370534|FG002|Overall Study|Did not receive study treatment|0|||
163179061|NCT02411448|589370532|FG000|Overall Study|Alive on study treatment|3|||
163179062|NCT02411448|589370533|FG001|Overall Study|Alive on study treatment|64|||
163179063|NCT02411448|589370534|FG002|Overall Study|Alive on study treatment|43|||
163179064|NCT06379893|589370548|FG000|Overall Study|Withdrawal by Subject|1|||
163179065|NCT06379893|589370548|FG000|Overall Study|Sponsors' decision|1|||
163179066|NCT06066697|589370549|FG000|Overall Study|Lost to Follow-up|5|||
163179067|NCT06066697|589370550|FG001|Overall Study|Lost to Follow-up|0|||
163179068|NCT02616562|589370552|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179069|NCT02616562|589370553|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
163179070|NCT02616562|589370554|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179071|NCT02616562|589370555|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179072|NCT02616562|589370556|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179073|NCT02616562|589370557|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179074|NCT02616562|589370558|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179075|NCT02616562|589370559|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179076|NCT02616562|589370560|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179077|NCT02616562|589370561|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179078|NCT02616562|589370562|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179079|NCT02616562|589370563|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179080|NCT02616562|589370564|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179081|NCT02616562|589370565|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179082|NCT02616562|589370566|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179083|NCT02616562|589370567|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179084|NCT02616562|589370568|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
163179085|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179086|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179087|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179088|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179089|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179090|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179091|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179092|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179093|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179094|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
163179095|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179096|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179097|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179098|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179099|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179100|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179101|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
163179102|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179103|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179104|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162935461|NCT00549198|588468013|FG000|Overall Study|Participant Moved|2|||
162935462|NCT00549198|588468014|FG001|Overall Study|Participant Moved|0|||
162935463|NCT00549198|588468013|FG000|Overall Study|Participant not able to perform Week 96|1|||
162935464|NCT00549198|588468014|FG001|Overall Study|Participant not able to perform Week 96|0|||
162935465|NCT00549198|588468013|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
162935466|NCT00549198|588468014|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
162935467|NCT00549198|588468013|FG000|Overall Study|Prohibited Medication|1|||
162935468|NCT00549198|588468014|FG001|Overall Study|Prohibited Medication|2|||
162935469|NCT00549198|588468013|FG000|Overall Study|Participant planning pregnancy|1|||
162935470|NCT00549198|588468014|FG001|Overall Study|Participant planning pregnancy|0|||
162935471|NCT00549198|588468013|FG000|Overall Study|Participant overweight, no scan possible|1|||
162935472|NCT00549198|588468014|FG001|Overall Study|Participant overweight, no scan possible|0|||
162935473|NCT00549198|588468013|FG000|Overall Study|No scan facilities|0|||
162935474|NCT00549198|588468014|FG001|Overall Study|No scan facilities|2|||
162935475|NCT00549198|588468013|FG000|Overall Study|Pregnancy|0|||
162935476|NCT00549198|588468014|FG001|Overall Study|Pregnancy|3|||
162935477|NCT00549198|588468013|FG000|Overall Study|Not Exposed to Study Drug|3|||
162935478|NCT00549198|588468014|FG001|Overall Study|Not Exposed to Study Drug|4|||
162935479|NCT03572933|588468025|FG000|Overall Study|Adverse Event|4|||
162935480|NCT03572933|588468026|FG001|Overall Study|Adverse Event|1|||
162935481|NCT03572933|588468025|FG000|Overall Study|Withdrawal by Subject|0|||
162935482|NCT03572933|588468026|FG001|Overall Study|Withdrawal by Subject|1|||
162935483|NCT01764854|588468027|FG000|Overall Study|Adverse Event|0|||
162935484|NCT01764854|588468028|FG001|Overall Study|Adverse Event|0|||
162935485|NCT01764854|588468029|FG002|Overall Study|Adverse Event|2|||
162935486|NCT01764854|588468030|FG003|Overall Study|Adverse Event|0|||
162935487|NCT01764854|588468027|FG000|Overall Study|Withdrawal by Subject|0|||
162935488|NCT01764854|588468028|FG001|Overall Study|Withdrawal by Subject|0|||
162935489|NCT01764854|588468029|FG002|Overall Study|Withdrawal by Subject|1|||
162935490|NCT01764854|588468030|FG003|Overall Study|Withdrawal by Subject|0|||
162935491|NCT01764854|588468027|FG000|Overall Study|relocation|0|||
162935492|NCT01764854|588468028|FG001|Overall Study|relocation|0|||
162935493|NCT01764854|588468029|FG002|Overall Study|relocation|2|||
162935494|NCT01764854|588468030|FG003|Overall Study|relocation|0|||
162935495|NCT01764854|588468027|FG000|Overall Study|Protocol Violation|0|||
162935496|NCT01764854|588468028|FG001|Overall Study|Protocol Violation|0|||
162935497|NCT01764854|588468029|FG002|Overall Study|Protocol Violation|1|||
162935498|NCT01764854|588468030|FG003|Overall Study|Protocol Violation|2|||
162935499|NCT03273387|588468031|FG000|Overall Study|Death|2|||
162935500|NCT03273387|588468032|FG001|Overall Study|Death|2|||
162935501|NCT03273387|588468031|FG000|Overall Study|Withdrawal by Subject|1|||
162935502|NCT03273387|588468032|FG001|Overall Study|Withdrawal by Subject|1|||
162935503|NCT02668783|588468033|FG000|Overall Study|Pregnancy|0|||
162935504|NCT02668783|588468034|FG001|Overall Study|Pregnancy|1|||
162935505|NCT02668783|588468033|FG000|Overall Study|Protocol Violation|2|||
162935506|NCT02668783|588468034|FG001|Overall Study|Protocol Violation|1|||
162935507|NCT02668783|588468033|FG000|Overall Study|Study terminated by sponsor|9|||
162935508|NCT02668783|588468034|FG001|Overall Study|Study terminated by sponsor|10|||
162935509|NCT02668783|588468033|FG000|Overall Study|Subject moved|1|||
162935510|NCT02668783|588468034|FG001|Overall Study|Subject moved|0|||
162935511|NCT02668783|588468033|FG000|Overall Study|Withdrawal by Subject|1|||
162935512|NCT02668783|588468034|FG001|Overall Study|Withdrawal by Subject|0|||
162935513|NCT04480463|588468035|FG000|Overall Study|Death|0|||
162935514|NCT04480463|588468036|FG001|Overall Study|Death|1|||
162935515|NCT04480463|588468035|FG000|Overall Study|Adverse Event|6|||
162935516|NCT04480463|588468036|FG001|Overall Study|Adverse Event|8|||
162935517|NCT04480463|588468035|FG000|Overall Study|Lost to Follow-up|3|||
162935518|NCT04480463|588468036|FG001|Overall Study|Lost to Follow-up|2|||
162935519|NCT04480463|588468035|FG000|Overall Study|Physician Decision|2|||
162935520|NCT04480463|588468036|FG001|Overall Study|Physician Decision|5|||
162935521|NCT04480463|588468035|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
162935522|NCT04480463|588468036|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
162935523|NCT04480463|588468035|FG000|Overall Study|Protocol Violation|2|||
162935524|NCT04480463|588468036|FG001|Overall Study|Protocol Violation|1|||
162935525|NCT04480463|588468035|FG000|Overall Study|Withdrawal by Subject|6|||
162935526|NCT04480463|588468036|FG001|Overall Study|Withdrawal by Subject|7|||
162935527|NCT04480463|588468035|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
162935528|NCT04480463|588468036|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
162935529|NCT04480463|588468035|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
162935530|NCT04480463|588468036|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
163179105|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179106|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179107|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162826522|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
162826523|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
162826524|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
162826525|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
163179108|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179109|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179110|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
163179111|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
163179112|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179113|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179114|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179115|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179116|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179117|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179118|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
163179119|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179120|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179121|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179122|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179123|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179124|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179125|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179126|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179127|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179128|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
163179129|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179130|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179131|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179132|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179133|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179134|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179135|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
163179136|NCT02616562|589370552|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179137|NCT02616562|589370553|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179138|NCT02616562|589370554|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179139|NCT02616562|589370555|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179140|NCT02616562|589370556|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179141|NCT02616562|589370557|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179142|NCT02616562|589370558|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179143|NCT02616562|589370559|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179144|NCT02616562|589370560|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
163179145|NCT02616562|589370561|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179146|NCT02616562|589370562|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179147|NCT02616562|589370563|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179148|NCT02616562|589370564|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179149|NCT02616562|589370565|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179150|NCT02616562|589370566|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179151|NCT02616562|589370567|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162826526|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
162826527|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
162826528|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
162826529|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
162826530|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
162826531|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
162826532|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
162826533|NCT00094770|588077267|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
162826534|NCT00094770|588077268|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
162826535|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
162826536|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
162826537|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
162826538|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
162826539|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
162826540|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
162826541|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
163179152|NCT02616562|589370568|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
163179153|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162826542|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
162826543|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
162826544|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
163179154|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179155|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179156|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179157|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179158|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179159|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179160|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179161|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179162|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162826545|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
162935531|NCT04480463|588468035|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
162935532|NCT04480463|588468036|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
162935533|NCT04480463|588468035|FG000|Overall Study|Other|6|||
162935534|NCT04480463|588468036|FG001|Overall Study|Other|4|||
162935535|NCT02231710|588468037|FG000|Overall Study|Physician Decision|1|||
162935536|NCT01399723|588468038|FG000|Overall Study|Lost to Follow-up|0|||
162935537|NCT01399723|588468039|FG001|Overall Study|Lost to Follow-up|1|||
163042833|NCT01990768|588863968|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
163179163|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179164|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
163179165|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179166|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179167|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
163179168|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179169|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
163179170|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179171|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179172|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179173|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179174|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179175|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179176|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179177|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179178|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179179|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179180|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179181|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
163179182|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179183|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179184|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179185|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179186|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
163179187|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179188|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179189|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179190|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179191|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179192|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179193|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179194|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179195|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179196|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179197|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179198|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
163179199|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179200|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179201|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179202|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179203|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
163179204|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179205|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179206|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179207|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179208|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179209|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179210|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179211|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179212|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179213|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179214|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
163179215|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179216|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179217|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
163179218|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
162935538|NCT00673361|588468040|FG000|Overall Study|Screen Failure|2|||
162935539|NCT01799590|588468042|FG000|Overall Study|Adverse Event|13|||
162935540|NCT01799590|588468043|FG001|Overall Study|Adverse Event|7|||
162935541|NCT01799590|588468044|FG002|Overall Study|Adverse Event|5|||
162826546|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
162935542|NCT01799590|588468042|FG000|Overall Study|Pregnancy|2|||
162935543|NCT01799590|588468043|FG001|Overall Study|Pregnancy|0|||
162935544|NCT01799590|588468044|FG002|Overall Study|Pregnancy|0|||
163179219|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162826547|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
162826548|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
162826549|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
162826550|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
162826551|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
162826552|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
162826553|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
162826554|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
162826555|NCT02752035|588077269|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
162826556|NCT02752035|588077270|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
162826557|NCT02752035|588077271|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
162826558|NCT02752035|588077272|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
162826559|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
162826560|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
162826561|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
162826562|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
162826563|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
162826564|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
162826565|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
162826566|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
162826567|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
162826568|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
162826569|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
162826570|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
162826571|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
162826572|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
162826573|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
162826574|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
162826575|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
162826576|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
162826577|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
162826578|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
162826579|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Death|0|||
162826580|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Death|25|||
162826581|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Death|13|||
162826582|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Death|4|||
162826583|NCT02752035|588077269|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
162826584|NCT02752035|588077270|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
162826585|NCT02752035|588077271|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
162826586|NCT02752035|588077272|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
162826587|NCT02752035|588077269|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
162826588|NCT02752035|588077270|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
162826589|NCT02752035|588077271|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
162826590|NCT02752035|588077272|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
162826591|NCT02752035|588077269|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
162826592|NCT02752035|588077270|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
162826593|NCT02752035|588077271|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
162826594|NCT02752035|588077272|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
162826595|NCT02752035|588077269|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
162826596|NCT02752035|588077270|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
162826597|NCT02752035|588077271|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
162935545|NCT01799590|588468042|FG000|Overall Study|Lack of Efficacy|3|||
163179220|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
163179221|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179222|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179223|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179224|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162935546|NCT01799590|588468043|FG001|Overall Study|Lack of Efficacy|1|||
162935547|NCT01799590|588468044|FG002|Overall Study|Lack of Efficacy|3|||
162935548|NCT01799590|588468042|FG000|Overall Study|Participants convenience|4|||
162935549|NCT01799590|588468043|FG001|Overall Study|Participants convenience|4|||
162935550|NCT01799590|588468044|FG002|Overall Study|Participants convenience|2|||
162935551|NCT01799590|588468042|FG000|Overall Study|Aggravation of complications|0|||
162935552|NCT01799590|588468043|FG001|Overall Study|Aggravation of complications|1|||
162935553|NCT01799590|588468044|FG002|Overall Study|Aggravation of complications|1|||
162935554|NCT01799590|588468042|FG000|Overall Study|Using drugs with restricted days of use|0|||
162935555|NCT01799590|588468043|FG001|Overall Study|Using drugs with restricted days of use|3|||
162935556|NCT01799590|588468044|FG002|Overall Study|Using drugs with restricted days of use|2|||
162935557|NCT01799590|588468042|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
162935558|NCT01799590|588468043|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
162935559|NCT01799590|588468044|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
162935560|NCT01799590|588468042|FG000|Overall Study|Other|3|||
162935561|NCT01799590|588468043|FG001|Overall Study|Other|0|||
162935562|NCT01799590|588468044|FG002|Overall Study|Other|1|||
162935563|NCT00752791|588468047|FG000|Overall Study|Adverse Event|7|||
162935564|NCT00752791|588468047|FG000|Overall Study|Withdrawal by Subject|1|||
162935565|NCT00752791|588468047|FG000|Overall Study|Physician Decision|1|||
162935566|NCT00752791|588468047|FG000|Overall Study|Death|1|||
162935567|NCT00752791|588468047|FG000|Overall Study|Renal transplant|3|||
162935568|NCT00752791|588468047|FG000|Overall Study|Switched to hemodialysis|2|||
162935569|NCT00752791|588468047|FG000|Overall Study|Protocol deviation|1|||
162935570|NCT01769378|588468052|FG000|Overall Study|Adverse Event|10|||
162935571|NCT01769378|588468053|FG001|Overall Study|Adverse Event|0|||
163179225|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179226|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179227|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179228|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179229|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179230|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179231|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
163179232|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179233|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179234|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179235|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179236|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179237|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
163179238|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179239|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179240|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179241|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179242|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179243|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179244|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179245|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179246|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179247|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179248|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179249|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
163179250|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179251|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179252|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179253|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179254|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163179255|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179256|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935572|NCT01769378|588468052|FG000|Overall Study|Entry criteria not met|1|||
162935573|NCT01769378|588468053|FG001|Overall Study|Entry criteria not met|0|||
162935574|NCT01769378|588468052|FG000|Overall Study|Protocol Violation|1|||
162935575|NCT01769378|588468053|FG001|Overall Study|Protocol Violation|1|||
162935576|NCT01769378|588468052|FG000|Overall Study|Withdrawal by Subject|10|||
162935577|NCT01769378|588468053|FG001|Overall Study|Withdrawal by Subject|3|||
162935578|NCT01769378|588468052|FG000|Overall Study|Sponsor Decision|1|||
162935579|NCT01769378|588468053|FG001|Overall Study|Sponsor Decision|0|||
162935580|NCT01769378|588468052|FG000|Overall Study|Lost to Follow-up|2|||
162935581|NCT01769378|588468053|FG001|Overall Study|Lost to Follow-up|0|||
162935582|NCT01977092|588468054|FG000|Overall Study|Death|3|||
162935583|NCT01977092|588468055|FG001|Overall Study|Death|4|||
162935584|NCT01977092|588468054|FG000|Overall Study|Lost to Follow-up|23|||
162935585|NCT01977092|588468055|FG001|Overall Study|Lost to Follow-up|14|||
162935586|NCT01977092|588468054|FG000|Overall Study|Withdrawal by Subject|2|||
162935587|NCT01977092|588468055|FG001|Overall Study|Withdrawal by Subject|1|||
162935588|NCT01977092|588468054|FG000|Overall Study|In prison|3|||
162935589|NCT01977092|588468055|FG001|Overall Study|In prison|11|||
162935590|NCT01958281|588468056|FG000|Overall Study|Lack of Efficacy|5|||
162935591|NCT01958281|588468057|FG001|Overall Study|Lack of Efficacy|2|||
162935592|NCT01958281|588468058|FG002|Overall Study|Lack of Efficacy|0|||
162935593|NCT01958281|588468056|FG000|Overall Study|Adverse Event|0|||
162935594|NCT01958281|588468057|FG001|Overall Study|Adverse Event|2|||
162935595|NCT01958281|588468058|FG002|Overall Study|Adverse Event|0|||
162935596|NCT01958281|588468056|FG000|Overall Study|Withdrew Consent|1|||
162935597|NCT01958281|588468057|FG001|Overall Study|Withdrew Consent|0|||
162935598|NCT01958281|588468058|FG002|Overall Study|Withdrew Consent|0|||
162935599|NCT03038113|588468059|FG000|Overall Study|Withdrawal by Subject|0|||
162935600|NCT03038113|588468060|FG001|Overall Study|Withdrawal by Subject|0|||
162935601|NCT03038113|588468061|FG002|Overall Study|Withdrawal by Subject|1|||
162935602|NCT03038113|588468062|FG003|Overall Study|Withdrawal by Subject|0|||
162935603|NCT03038113|588468063|FG004|Overall Study|Withdrawal by Subject|0|||
162935604|NCT03038113|588468064|FG005|Overall Study|Withdrawal by Subject|0|||
162935605|NCT03038113|588468065|FG006|Overall Study|Withdrawal by Subject|0|||
162935606|NCT03038113|588468066|FG007|Overall Study|Withdrawal by Subject|0|||
162935607|NCT03038113|588468067|FG008|Overall Study|Withdrawal by Subject|0|||
162935608|NCT03038113|588468068|FG009|Overall Study|Withdrawal by Subject|0|||
162935609|NCT03038113|588468069|FG010|Overall Study|Withdrawal by Subject|0|||
162935610|NCT03038113|588468070|FG011|Overall Study|Withdrawal by Subject|0|||
162935611|NCT03038113|588468071|FG012|Overall Study|Withdrawal by Subject|0|||
162935612|NCT03038113|588468072|FG013|Overall Study|Withdrawal by Subject|1|||
162935613|NCT03038113|588468059|FG000|Overall Study|Lost to Follow-up|0|||
162935614|NCT03038113|588468060|FG001|Overall Study|Lost to Follow-up|0|||
162935615|NCT03038113|588468061|FG002|Overall Study|Lost to Follow-up|0|||
162935616|NCT03038113|588468062|FG003|Overall Study|Lost to Follow-up|0|||
162935617|NCT03038113|588468063|FG004|Overall Study|Lost to Follow-up|0|||
162935618|NCT03038113|588468064|FG005|Overall Study|Lost to Follow-up|0|||
162935619|NCT03038113|588468065|FG006|Overall Study|Lost to Follow-up|1|||
162935620|NCT03038113|588468066|FG007|Overall Study|Lost to Follow-up|0|||
162935621|NCT03038113|588468067|FG008|Overall Study|Lost to Follow-up|0|||
162935622|NCT03038113|588468068|FG009|Overall Study|Lost to Follow-up|0|||
162935623|NCT03038113|588468069|FG010|Overall Study|Lost to Follow-up|0|||
162935624|NCT03038113|588468070|FG011|Overall Study|Lost to Follow-up|0|||
162935625|NCT03038113|588468071|FG012|Overall Study|Lost to Follow-up|0|||
162935626|NCT03038113|588468072|FG013|Overall Study|Lost to Follow-up|0|||
162935627|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
162935628|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
162935629|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162935630|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162935631|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
162935632|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
162935633|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162935634|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162935635|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
162935636|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
162935637|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
162935638|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
162935639|NCT02784106|588468073|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
162935640|NCT02784106|588468074|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935641|NCT02784106|588468075|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935642|NCT02784106|588468076|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162935643|NCT02784106|588468073|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
162935644|NCT02784106|588468074|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
162935645|NCT02784106|588468075|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
162935646|NCT02784106|588468076|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
162935647|NCT02784106|588468073|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
162935648|NCT02784106|588468074|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
162935649|NCT02784106|588468075|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
162935650|NCT02784106|588468076|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
162935651|NCT02927847|588468078|FG000|Overall Study|Lost to Follow-up|1|||
162935652|NCT02927847|588468079|FG001|Overall Study|Lost to Follow-up|0|||
162935653|NCT02927847|588468078|FG000|Overall Study|Withdrawal by Subject|4|||
162935654|NCT02927847|588468079|FG001|Overall Study|Withdrawal by Subject|2|||
162935655|NCT02927847|588468078|FG000|Overall Study|PI withdrawn due to missed visits|1|||
162935656|NCT02927847|588468079|FG001|Overall Study|PI withdrawn due to missed visits|1|||
162935657|NCT00553540|588468080|FG000|Overall Study|discharged after first visit|2|||
162935658|NCT00553540|588468081|FG001|Overall Study|discharged after first visit|5|||
162935659|NCT01755858|588468084|FG000|Overall Study|Adverse Event|1|||
162935660|NCT01755858|588468085|FG001|Overall Study|Adverse Event|1|||
162935661|NCT03882047|588468086|FG000|Overall Study|Adverse Event|0|||
162935662|NCT03882047|588468087|FG001|Overall Study|Adverse Event|2|||
162935663|NCT03882047|588468088|FG002|Overall Study|Adverse Event|2|||
162935664|NCT03882047|588468086|FG000|Overall Study|Treatment Failure|3|||
162935665|NCT03882047|588468087|FG001|Overall Study|Treatment Failure|3|||
162935666|NCT03882047|588468088|FG002|Overall Study|Treatment Failure|12|||
162935667|NCT03882047|588468086|FG000|Overall Study|Lost to Follow-up|0|||
162935668|NCT03882047|588468087|FG001|Overall Study|Lost to Follow-up|1|||
162935669|NCT03882047|588468088|FG002|Overall Study|Lost to Follow-up|0|||
162935670|NCT03882047|588468086|FG000|Overall Study|Did Not Wish to Continue|1|||
162935671|NCT03882047|588468087|FG001|Overall Study|Did Not Wish to Continue|4|||
162935672|NCT03882047|588468088|FG002|Overall Study|Did Not Wish to Continue|1|||
162935673|NCT03882047|588468086|FG000|Overall Study|Noncompliance With Protocol|2|||
162935674|NCT03882047|588468087|FG001|Overall Study|Noncompliance With Protocol|0|||
162935675|NCT03882047|588468088|FG002|Overall Study|Noncompliance With Protocol|0|||
162935676|NCT03882047|588468086|FG000|Overall Study|Did Not Meet Eligibility|0|||
162935677|NCT03882047|588468087|FG001|Overall Study|Did Not Meet Eligibility|0|||
162935678|NCT03882047|588468088|FG002|Overall Study|Did Not Meet Eligibility|1|||
162935679|NCT00175019|588468090|FG000|Overall Study|Adverse Event|54|||
162935680|NCT00175019|588468091|FG001|Overall Study|Adverse Event|22|||
162935681|NCT00175019|588468092|FG002|Overall Study|Adverse Event|2|||
162935682|NCT00175019|588468090|FG000|Overall Study|Protocol Violation|6|||
162935683|NCT00175019|588468091|FG001|Overall Study|Protocol Violation|3|||
162935684|NCT00175019|588468092|FG002|Overall Study|Protocol Violation|3|||
162935685|NCT00175019|588468090|FG000|Overall Study|Lost to Follow-up|42|||
162935686|NCT00175019|588468091|FG001|Overall Study|Lost to Follow-up|39|||
162935687|NCT00175019|588468092|FG002|Overall Study|Lost to Follow-up|9|||
162935688|NCT00175019|588468090|FG000|Overall Study|Did not continue under Amendment 4|1|||
162935689|NCT00175019|588468091|FG001|Overall Study|Did not continue under Amendment 4|1|||
162935690|NCT00175019|588468092|FG002|Overall Study|Did not continue under Amendment 4|2|||
162935691|NCT00175019|588468090|FG000|Overall Study|Personal Reason(s)|39|||
162935692|NCT00175019|588468091|FG001|Overall Study|Personal Reason(s)|31|||
162935693|NCT00175019|588468092|FG002|Overall Study|Personal Reason(s)|8|||
162935694|NCT00175019|588468090|FG000|Overall Study|Therapeutic Failure|10|||
162935695|NCT00175019|588468091|FG001|Overall Study|Therapeutic Failure|38|||
162935696|NCT00175019|588468092|FG002|Overall Study|Therapeutic Failure|22|||
162935697|NCT00175019|588468090|FG000|Overall Study|Gout Flare|2|||
162935698|NCT00175019|588468091|FG001|Overall Study|Gout Flare|3|||
162935699|NCT00175019|588468092|FG002|Overall Study|Gout Flare|0|||
162935700|NCT00175019|588468090|FG000|Overall Study|Reason Not Specified|40|||
162935701|NCT00175019|588468091|FG001|Overall Study|Reason Not Specified|34|||
162935702|NCT00175019|588468092|FG002|Overall Study|Reason Not Specified|11|||
163179257|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179258|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935703|NCT00475852|588468096|FG000|Overall Study|Death|444|||
162935704|NCT00475852|588468097|FG001|Overall Study|Death|456|||
162935705|NCT00475852|588468096|FG000|Overall Study|Withdrawal by Subject|19|||
162935706|NCT00475852|588468097|FG001|Overall Study|Withdrawal by Subject|24|||
162935707|NCT00475852|588468096|FG000|Overall Study|Lost to Follow-up|54|||
162935708|NCT00475852|588468097|FG001|Overall Study|Lost to Follow-up|68|||
162935709|NCT00297479|588468098|FG000|Overall Study|Lost to Follow-up|37|||
163179259|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162935710|NCT00297479|588468099|FG001|Overall Study|Lost to Follow-up|54|||
162826598|NCT02752035|588077272|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
162826599|NCT02752035|588077269|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
162826600|NCT02752035|588077270|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
162826601|NCT02752035|588077271|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
162826602|NCT02752035|588077272|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
162826603|NCT03668600|588077275|FG000|Overall Study|Study Terminated by the Sponsor|157|||
162826604|NCT03668600|588077275|FG000|Overall Study|Protocol Violation|1|||
162826605|NCT03668600|588077275|FG000|Overall Study|Pregnancy|1|||
162826606|NCT03668600|588077275|FG000|Overall Study|Lost to Follow-up|7|||
162826607|NCT03668600|588077275|FG000|Overall Study|Withdrawal by Subject|56|||
162826608|NCT03668600|588077275|FG000|Overall Study|Lack of Efficacy|7|||
162826609|NCT03668600|588077275|FG000|Overall Study|Adverse Event|1|||
162826610|NCT00424749|588077277|FG000|Overall Study|Withdrawal by Subject|1|||
162826611|NCT01263483|588077278|FG000|Overall Study|Adverse Event|4|||
162826612|NCT01263483|588077279|FG001|Overall Study|Adverse Event|0|||
162826613|NCT01263483|588077280|FG002|Overall Study|Adverse Event|3|||
162826614|NCT01263483|588077278|FG000|Overall Study|Withdrawal by Subject|1|||
162826615|NCT01263483|588077279|FG001|Overall Study|Withdrawal by Subject|0|||
162826616|NCT01263483|588077280|FG002|Overall Study|Withdrawal by Subject|0|||
162826617|NCT01263483|588077278|FG000|Overall Study|Lack of Efficacy|2|||
162826618|NCT01263483|588077279|FG001|Overall Study|Lack of Efficacy|0|||
162826619|NCT01263483|588077280|FG002|Overall Study|Lack of Efficacy|0|||
162826620|NCT01263483|588077278|FG000|Overall Study|Protocol Violation|0|||
162826621|NCT01263483|588077279|FG001|Overall Study|Protocol Violation|1|||
162826622|NCT01263483|588077280|FG002|Overall Study|Protocol Violation|1|||
162826623|NCT01263483|588077278|FG000|Overall Study|Participant Unavailability|0|||
162826624|NCT01263483|588077279|FG001|Overall Study|Participant Unavailability|1|||
163179260|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179261|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179262|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179263|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179264|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179265|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179266|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
163179267|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179268|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179269|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179270|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179271|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
163179272|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179273|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179274|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179275|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179276|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179277|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179278|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179279|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179280|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179281|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179282|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179283|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179284|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179285|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
163179286|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179287|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179288|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
163179289|NCT02616562|589370552|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179290|NCT02616562|589370553|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179291|NCT02616562|589370554|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179292|NCT02616562|589370555|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179293|NCT02616562|589370556|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179294|NCT02616562|589370557|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162698484|NCT02743793|587605510|FG000|Overall Study|No Primary Care Physician|0|||
162698485|NCT02743793|587605511|FG001|Overall Study|No Primary Care Physician|1|||
162826625|NCT01263483|588077280|FG002|Overall Study|Participant Unavailability|1|||
162826626|NCT01131676|588077285|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
162826627|NCT01131676|588077286|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
162826628|NCT01131676|588077287|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
162935711|NCT00297479|588468100|FG002|Overall Study|Lost to Follow-up|51|||
162935712|NCT03263819|588468101|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
162935713|NCT03263819|588468102|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
162935714|NCT00686920|588468107|FG000|Overall Study|Death|45|||
162935715|NCT00686920|588468108|FG001|Overall Study|Death|14|||
162935716|NCT00686920|588468107|FG000|Overall Study|Liver Transplant|23|||
162935717|NCT00686920|588468108|FG001|Overall Study|Liver Transplant|8|||
162935718|NCT00686920|588468107|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
162935719|NCT00686920|588468108|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
162935720|NCT00686920|588468107|FG000|Overall Study|Withdrawal by Subject|23|||
162935721|NCT00686920|588468108|FG001|Overall Study|Withdrawal by Subject|5|||
162935722|NCT00686920|588468107|FG000|Overall Study|Protocol Violation|2|||
162935723|NCT00686920|588468108|FG001|Overall Study|Protocol Violation|1|||
162935724|NCT00686920|588468107|FG000|Overall Study|Adverse Event|10|||
162935725|NCT00686920|588468108|FG001|Overall Study|Adverse Event|2|||
162935726|NCT00686920|588468107|FG000|Overall Study|Personal Reason|0|||
162935727|NCT00686920|588468108|FG001|Overall Study|Personal Reason|1|||
162935728|NCT00686920|588468107|FG000|Overall Study|Lost to Follow-up|15|||
162935729|NCT00686920|588468108|FG001|Overall Study|Lost to Follow-up|3|||
162935730|NCT00686920|588468107|FG000|Overall Study|Moved to Another State|1|||
162935731|NCT00686920|588468108|FG001|Overall Study|Moved to Another State|0|||
162935732|NCT00686920|588468107|FG000|Overall Study|Transferred to Nursing Home|1|||
162935733|NCT00686920|588468108|FG001|Overall Study|Transferred to Nursing Home|0|||
162935734|NCT00686920|588468107|FG000|Overall Study|Noncompliance|9|||
162935735|NCT00686920|588468108|FG001|Overall Study|Noncompliance|0|||
162935736|NCT00686920|588468107|FG000|Overall Study|Principal Investigator Decision|2|||
162935737|NCT00686920|588468108|FG001|Overall Study|Principal Investigator Decision|0|||
162935738|NCT00814658|588468112|FG000|Overall Study|Lost to Follow-up|0|||
162935739|NCT00814658|588468113|FG001|Overall Study|Lost to Follow-up|1|||
162935740|NCT00814658|588468112|FG000|Overall Study|Physician Decision|1|||
162935741|NCT00814658|588468113|FG001|Overall Study|Physician Decision|0|||
162935742|NCT00814658|588468112|FG000|Overall Study|Adverse Event|3|||
162935743|NCT00814658|588468113|FG001|Overall Study|Adverse Event|3|||
162935744|NCT02087046|588468114|FG000|Overall Study|Adverse Event|4|||
162935745|NCT02087046|588468114|FG000|Overall Study|Death|1|||
162935746|NCT02087046|588468114|FG000|Overall Study|Lost to Follow-up|3|||
162935747|NCT02087046|588468114|FG000|Overall Study|Withdrawal by Subject|2|||
162935748|NCT02087046|588468114|FG000|Overall Study|Physician Decision|1|||
162935749|NCT02444533|588468115|FG000|Overall Study|Not able to complete forms|0|||
162935750|NCT02444533|588468116|FG001|Overall Study|Not able to complete forms|2|||
162935751|NCT02444533|588468115|FG000|Overall Study|Only gave post-procedure complications|2|||
162935752|NCT02444533|588468116|FG001|Overall Study|Only gave post-procedure complications|2|||
162935753|NCT01141283|588468117|FG000|Overall Study|Adverse Event|56|||
162935754|NCT01141283|588468117|FG000|Overall Study|Lost to Follow-up|4|||
162935755|NCT01141283|588468117|FG000|Overall Study|Withdrawal by Subject|14|||
162935756|NCT01141283|588468117|FG000|Overall Study|Administrative|4|||
162935757|NCT01141283|588468117|FG000|Overall Study|Lack of Efficacy|10|||
162935758|NCT01208402|588468122|FG000|Overall Study|Withdrawal by Subject|1|||
162935759|NCT01208402|588468123|FG001|Overall Study|Withdrawal by Subject|0|||
162935760|NCT01571635|588468124|FG000|Overall Study|Adverse Event|3|||
162935761|NCT01571635|588468125|FG001|Overall Study|Adverse Event|0|||
162935762|NCT01571635|588468126|FG002|Overall Study|Adverse Event|2|||
162935763|NCT01571635|588468127|FG003|Overall Study|Adverse Event|3|||
163179295|NCT02616562|589370558|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179296|NCT02616562|589370559|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179297|NCT02616562|589370560|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179298|NCT02616562|589370561|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179299|NCT02616562|589370562|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179300|NCT02616562|589370563|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179301|NCT02616562|589370564|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179302|NCT02616562|589370565|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163042834|NCT01990768|588863969|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
163179303|NCT02616562|589370566|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
163179304|NCT02616562|589370567|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162935764|NCT01571635|588468128|FG004|Overall Study|Adverse Event|5|||
162935765|NCT01571635|588468124|FG000|Overall Study|Other reasons|2|||
162935766|NCT01571635|588468125|FG001|Overall Study|Other reasons|1|||
162935767|NCT01571635|588468126|FG002|Overall Study|Other reasons|2|||
162935768|NCT01571635|588468127|FG003|Overall Study|Other reasons|2|||
162935769|NCT01571635|588468128|FG004|Overall Study|Other reasons|1|||
162935770|NCT01571635|588468124|FG000|Overall Study|Study terminated by sponsor|0|||
162935771|NCT01571635|588468125|FG001|Overall Study|Study terminated by sponsor|4|||
162935772|NCT01571635|588468126|FG002|Overall Study|Study terminated by sponsor|1|||
162935773|NCT01571635|588468127|FG003|Overall Study|Study terminated by sponsor|3|||
162935774|NCT01571635|588468128|FG004|Overall Study|Study terminated by sponsor|1|||
162935775|NCT01571635|588468124|FG000|Overall Study|Withdrew consent|1|||
162935776|NCT01571635|588468125|FG001|Overall Study|Withdrew consent|1|||
162935777|NCT01571635|588468126|FG002|Overall Study|Withdrew consent|2|||
162935778|NCT01571635|588468127|FG003|Overall Study|Withdrew consent|3|||
162935779|NCT01571635|588468128|FG004|Overall Study|Withdrew consent|0|||
162935780|NCT01571635|588468124|FG000|Overall Study|Lack of Efficacy|0|||
162935781|NCT01571635|588468125|FG001|Overall Study|Lack of Efficacy|2|||
162935782|NCT01571635|588468126|FG002|Overall Study|Lack of Efficacy|0|||
162935783|NCT01571635|588468127|FG003|Overall Study|Lack of Efficacy|1|||
162935784|NCT01571635|588468128|FG004|Overall Study|Lack of Efficacy|2|||
162935785|NCT01201356|588468133|FG000|Overall Study|Adverse Event|170|||
162935786|NCT01201356|588468133|FG000|Overall Study|Abnormal laboratory value(s)|51|||
162935787|NCT01201356|588468133|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162935788|NCT01201356|588468133|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
162935789|NCT01201356|588468133|FG000|Overall Study|Condition no longer requires study drug|12|||
162935790|NCT01201356|588468133|FG000|Overall Study|Withdrawal by Subject|144|||
162935791|NCT01201356|588468133|FG000|Overall Study|Lost to Follow-up|50|||
162935792|NCT01201356|588468133|FG000|Overall Study|administrative problems|74|||
162935793|NCT01201356|588468133|FG000|Overall Study|Death|16|||
162935794|NCT01201356|588468133|FG000|Overall Study|Protocol Violation|12|||
162935795|NCT00585039|588468134|FG000|Overall Study|medication spilled|2|||
162935796|NCT00585039|588468135|FG001|Overall Study|medication spilled|0|||
162935797|NCT02173301|588468136|FG000|Overall Study|Adverse Event|7|||
162935798|NCT02173301|588468137|FG001|Overall Study|Adverse Event|8|||
162935799|NCT02173301|588468138|FG002|Overall Study|Adverse Event|13|||
162935800|NCT02173301|588468139|FG003|Overall Study|Adverse Event|5|||
162935801|NCT02173301|588468136|FG000|Overall Study|Withdrawal by Subject|8|||
162935802|NCT02173301|588468137|FG001|Overall Study|Withdrawal by Subject|10|||
162935803|NCT02173301|588468138|FG002|Overall Study|Withdrawal by Subject|4|||
162935804|NCT02173301|588468139|FG003|Overall Study|Withdrawal by Subject|8|||
162935805|NCT02173301|588468136|FG000|Overall Study|Lost to Follow-up|4|||
162935806|NCT02173301|588468137|FG001|Overall Study|Lost to Follow-up|4|||
162935807|NCT02173301|588468138|FG002|Overall Study|Lost to Follow-up|2|||
162935808|NCT02173301|588468139|FG003|Overall Study|Lost to Follow-up|2|||
162935809|NCT02173301|588468136|FG000|Overall Study|Protocol Violation|0|||
162935810|NCT02173301|588468137|FG001|Overall Study|Protocol Violation|1|||
162935811|NCT02173301|588468138|FG002|Overall Study|Protocol Violation|0|||
162935812|NCT02173301|588468139|FG003|Overall Study|Protocol Violation|0|||
162935813|NCT02173301|588468136|FG000|Overall Study|Physician Decision|0|||
162935814|NCT02173301|588468137|FG001|Overall Study|Physician Decision|0|||
162935815|NCT02173301|588468138|FG002|Overall Study|Physician Decision|1|||
162935816|NCT02173301|588468139|FG003|Overall Study|Physician Decision|0|||
162935817|NCT02173301|588468136|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
162935818|NCT02173301|588468137|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935819|NCT02173301|588468138|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935820|NCT02173301|588468139|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
162935821|NCT01585831|588468140|FG000|Overall Study|Physician Decision|0|||
162935822|NCT01585831|588468141|FG001|Overall Study|Physician Decision|1|||
162935823|NCT01585831|588468140|FG000|Overall Study|Withdrawal by Subject|2|||
162935824|NCT01585831|588468141|FG001|Overall Study|Withdrawal by Subject|1|||
162935825|NCT01225991|588468142|FG000|Overall Study|Withdrawal by Subject|6|||
162935826|NCT04079842|588468143|FG000|Overall Study|Request of subject|2|||
162935827|NCT04079842|588468143|FG000|Overall Study|Unable to draw Arterial samples|1|||
162935828|NCT02904200|588468144|FG000|Overall Study|Withdrawal by Subject|1|||
163179305|NCT02616562|589370568|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
163179306|NCT02616562|589370552|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179307|NCT02616562|589370553|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179308|NCT02616562|589370554|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179309|NCT02616562|589370555|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179310|NCT02616562|589370556|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179311|NCT02616562|589370557|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179312|NCT02616562|589370558|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179313|NCT02616562|589370559|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162935829|NCT02904200|588468145|FG001|Overall Study|Withdrawal by Subject|0|||
162935830|NCT02133352|588468146|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
162935831|NCT04444752|588468147|FG000|Overall Study|Adverse Event|1|||
162935832|NCT04444752|588468148|FG001|Overall Study|Adverse Event|0|||
162935833|NCT04444752|588468149|FG002|Overall Study|Adverse Event|0|||
162935834|NCT04444752|588468150|FG003|Overall Study|Adverse Event|2|||
162935835|NCT04444752|588468147|FG000|Overall Study|Lost to Follow-up|2|||
163179314|NCT02616562|589370560|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179315|NCT02616562|589370561|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179316|NCT02616562|589370562|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179317|NCT02616562|589370563|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179318|NCT02616562|589370564|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179319|NCT02616562|589370565|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162826629|NCT01131676|588077285|FG000|Discontinuation From Treatment|Not treated|4|||
162826630|NCT01131676|588077286|FG001|Discontinuation From Treatment|Not treated|2|||
162826631|NCT01131676|588077287|FG002|Discontinuation From Treatment|Not treated|2|||
162826632|NCT01131676|588077285|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
162826633|NCT01131676|588077286|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
162826634|NCT01131676|588077287|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
162826635|NCT01131676|588077285|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
162826636|NCT01131676|588077286|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
162826637|NCT01131676|588077287|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
162826638|NCT01131676|588077285|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
162826639|NCT01131676|588077286|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
162826640|NCT01131676|588077287|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
162826641|NCT01131676|588077285|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
162826642|NCT01131676|588077286|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
162826643|NCT01131676|588077287|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
162826644|NCT01131676|588077285|FG000|Discontinuation From Treatment|Other than those specified|162|||
162826645|NCT01131676|588077286|FG001|Discontinuation From Treatment|Other than those specified|142|||
162826646|NCT01131676|588077287|FG002|Discontinuation From Treatment|Other than those specified|125|||
162826647|NCT01131676|588077285|FG000|Discontinuation From Treatment|Adverse Event|303|||
162826648|NCT01131676|588077286|FG001|Discontinuation From Treatment|Adverse Event|267|||
162826649|NCT01131676|588077287|FG002|Discontinuation From Treatment|Adverse Event|273|||
162826650|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
162826651|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
162826652|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
162826653|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
162826654|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
162826655|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
162826656|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
162826657|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
162826658|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
162826659|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
162826660|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
162826661|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
162826662|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
162826663|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
162826664|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
162826665|NCT01131676|588077285|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
162826666|NCT01131676|588077286|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
162826667|NCT01131676|588077287|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
162826668|NCT04109222|588077288|FG000|Overall Study|Adverse Event|1|||
162826669|NCT04109222|588077289|FG001|Overall Study|Adverse Event|0|||
162826670|NCT04109222|588077290|FG002|Overall Study|Adverse Event|0|||
162826671|NCT02577406|588077291|FG000|Randomized Period|Death|1|||
162826672|NCT02577406|588077292|FG001|Randomized Period|Death|0|||
162826673|NCT02577406|588077291|FG000|Randomized Period|Other reasons|0|||
162826674|NCT02577406|588077292|FG001|Randomized Period|Other reasons|20|||
162826675|NCT02577406|588077291|FG000|Treatment Period|Death|38|||
162826676|NCT02577406|588077292|FG001|Treatment Period|Death|23|||
162826677|NCT02577406|588077291|FG000|Treatment Period|Adverse Event|17|||
162826678|NCT02577406|588077292|FG001|Treatment Period|Adverse Event|12|||
162826679|NCT02577406|588077291|FG000|Treatment Period|Progressive Disease|53|||
162826680|NCT02577406|588077292|FG001|Treatment Period|Progressive Disease|37|||
162826681|NCT02577406|588077291|FG000|Treatment Period|Withdrawal by Subject|10|||
162826682|NCT02577406|588077292|FG001|Treatment Period|Withdrawal by Subject|24|||
162826683|NCT02577406|588077291|FG000|Treatment Period|Lost to Follow-up|0|||
162826684|NCT02577406|588077292|FG001|Treatment Period|Lost to Follow-up|1|||
162826685|NCT02577406|588077291|FG000|Treatment Period|Transition to commercially available treatment|1|||
162826686|NCT02577406|588077292|FG001|Treatment Period|Transition to commercially available treatment|1|||
162935836|NCT04444752|588468148|FG001|Overall Study|Lost to Follow-up|6|||
162935837|NCT04444752|588468149|FG002|Overall Study|Lost to Follow-up|2|||
162935838|NCT04444752|588468150|FG003|Overall Study|Lost to Follow-up|5|||
162935839|NCT04444752|588468147|FG000|Overall Study|Physician Decision|0|||
162935840|NCT04444752|588468148|FG001|Overall Study|Physician Decision|0|||
162935841|NCT04444752|588468149|FG002|Overall Study|Physician Decision|0|||
162935842|NCT04444752|588468150|FG003|Overall Study|Physician Decision|2|||
162935843|NCT04444752|588468147|FG000|Overall Study|Pregnancy|0|||
162935844|NCT04444752|588468148|FG001|Overall Study|Pregnancy|0|||
162935845|NCT04444752|588468149|FG002|Overall Study|Pregnancy|0|||
162935846|NCT04444752|588468150|FG003|Overall Study|Pregnancy|1|||
162935847|NCT04444752|588468147|FG000|Overall Study|Withdrawal by Subject|6|||
162935848|NCT04444752|588468148|FG001|Overall Study|Withdrawal by Subject|5|||
162935849|NCT04444752|588468149|FG002|Overall Study|Withdrawal by Subject|3|||
162935850|NCT04444752|588468150|FG003|Overall Study|Withdrawal by Subject|4|||
162935851|NCT04444752|588468147|FG000|Overall Study|Protocol Violation|1|||
162935852|NCT04444752|588468148|FG001|Overall Study|Protocol Violation|1|||
162935853|NCT04444752|588468149|FG002|Overall Study|Protocol Violation|0|||
162935854|NCT04444752|588468150|FG003|Overall Study|Protocol Violation|0|||
162935855|NCT04444752|588468147|FG000|Overall Study|Patient moving out of town|1|||
162935856|NCT04444752|588468148|FG001|Overall Study|Patient moving out of town|0|||
162935857|NCT04444752|588468149|FG002|Overall Study|Patient moving out of town|0|||
162935858|NCT04444752|588468150|FG003|Overall Study|Patient moving out of town|1|||
162935859|NCT04444752|588468147|FG000|Overall Study|Lack of Efficacy|0|||
162935860|NCT04444752|588468148|FG001|Overall Study|Lack of Efficacy|0|||
162935861|NCT04444752|588468149|FG002|Overall Study|Lack of Efficacy|0|||
162935862|NCT04444752|588468150|FG003|Overall Study|Lack of Efficacy|1|||
162935863|NCT04444752|588468147|FG000|Overall Study|Death|0|||
162935864|NCT04444752|588468148|FG001|Overall Study|Death|0|||
162935865|NCT04444752|588468149|FG002|Overall Study|Death|1|||
162935866|NCT04444752|588468150|FG003|Overall Study|Death|0|||
162935867|NCT00579254|588468151|FG000|Overall Study|Lost to Follow-up|39|||
162935868|NCT00579254|588468151|FG000|Overall Study|Discontinued when study terminated|73|||
162935869|NCT00433381|588470235|FG000|Overall Study|Ineligible / no protocol treatment|3|||
162935870|NCT00433381|588470236|FG001|Overall Study|Ineligible / no protocol treatment|3|||
162935871|NCT01387282|588470237|FG000|Overall Study|Death|47|||
162935872|NCT01387282|588470238|FG001|Overall Study|Death|16|||
162935873|NCT01387282|588470237|FG000|Overall Study|Other|5|||
162935874|NCT01387282|588470238|FG001|Overall Study|Other|1|||
162935875|NCT01387282|588470237|FG000|Overall Study|Unrelated AE|6|||
162935876|NCT01387282|588470238|FG001|Overall Study|Unrelated AE|4|||
162935877|NCT01387282|588470237|FG000|Overall Study|Withdrawal by patient|33|||
162935878|NCT01387282|588470238|FG001|Overall Study|Withdrawal by patient|23|||
162935879|NCT01387282|588470237|FG000|Overall Study|Study drug-related AE|2|||
162935880|NCT01387282|588470238|FG001|Overall Study|Study drug-related AE|2|||
162935881|NCT01387282|588470237|FG000|Overall Study|Lost to Follow-up|4|||
162935882|NCT01387282|588470238|FG001|Overall Study|Lost to Follow-up|1|||
162935883|NCT04582266|588470239|FG000|Overall Study|Lost to Follow-up|7|||
162935884|NCT04582266|588470240|FG001|Overall Study|Lost to Follow-up|5|||
162935885|NCT04582266|588470239|FG000|Overall Study|Withdrawal by Subject|1|||
162935886|NCT04582266|588470240|FG001|Overall Study|Withdrawal by Subject|0|||
162935887|NCT04582266|588470239|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
162935888|NCT04582266|588470240|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
162935889|NCT01034137|588470242|FG000|Overall Study|Adverse Event|9|||
162935890|NCT01034137|588470243|FG001|Overall Study|Adverse Event|10|||
162935891|NCT01034137|588470244|FG002|Overall Study|Adverse Event|8|||
162935892|NCT01034137|588470242|FG000|Overall Study|Withdrawal by Subject|4|||
162935893|NCT01034137|588470243|FG001|Overall Study|Withdrawal by Subject|3|||
162935894|NCT01034137|588470244|FG002|Overall Study|Withdrawal by Subject|3|||
162935895|NCT01034137|588470242|FG000|Overall Study|Lack of Efficacy|9|||
162935896|NCT01034137|588470243|FG001|Overall Study|Lack of Efficacy|4|||
162935897|NCT01034137|588470244|FG002|Overall Study|Lack of Efficacy|13|||
162935898|NCT01034137|588470242|FG000|Overall Study|Protocol Violation|2|||
162935899|NCT01034137|588470243|FG001|Overall Study|Protocol Violation|2|||
162935900|NCT01034137|588470244|FG002|Overall Study|Protocol Violation|1|||
162935901|NCT01034137|588470242|FG000|Overall Study|Refused treatment or did not cooperate|2|||
162935902|NCT01034137|588470243|FG001|Overall Study|Refused treatment or did not cooperate|0|||
162935903|NCT01034137|588470244|FG002|Overall Study|Refused treatment or did not cooperate|1|||
162935904|NCT01034137|588470242|FG000|Overall Study|Administrative or other|2|||
162935905|NCT01034137|588470243|FG001|Overall Study|Administrative or other|3|||
162935906|NCT01034137|588470244|FG002|Overall Study|Administrative or other|4|||
162935907|NCT01466686|588470245|FG000|Overall Study|Withdrawal by Subject|1|||
162935908|NCT01405950|588470246|FG000|Overall Study|Withdrawal by Subject|1|||
162935909|NCT01405950|588470247|FG001|Overall Study|Withdrawal by Subject|0|||
162935910|NCT01405950|588470248|FG002|Overall Study|Withdrawal by Subject|0|||
162935911|NCT01405950|588470249|FG003|Overall Study|Withdrawal by Subject|0|||
162935912|NCT01381900|588470250|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
162935913|NCT01381900|588470251|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
162935914|NCT01381900|588470252|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
162935915|NCT01381900|588470250|FG000|Overall Study|Adverse Event|4|||
162935916|NCT01381900|588470251|FG001|Overall Study|Adverse Event|6|||
162935917|NCT01381900|588470252|FG002|Overall Study|Adverse Event|7|||
162935918|NCT01381900|588470250|FG000|Overall Study|Noncompliance with study drug|0|||
162935919|NCT01381900|588470251|FG001|Overall Study|Noncompliance with study drug|0|||
162935920|NCT01381900|588470252|FG002|Overall Study|Noncompliance with study drug|1|||
162935921|NCT01381900|588470250|FG000|Overall Study|Physician Decision|0|||
162935922|NCT01381900|588470251|FG001|Overall Study|Physician Decision|1|||
162935923|NCT01381900|588470252|FG002|Overall Study|Physician Decision|1|||
162935924|NCT01381900|588470250|FG000|Overall Study|Protocol Violation|0|||
162935925|NCT01381900|588470251|FG001|Overall Study|Protocol Violation|1|||
162935926|NCT01381900|588470252|FG002|Overall Study|Protocol Violation|1|||
162935927|NCT01381900|588470250|FG000|Overall Study|Withdrawal by Subject|0|||
162935928|NCT01381900|588470251|FG001|Overall Study|Withdrawal by Subject|0|||
162935929|NCT01381900|588470252|FG002|Overall Study|Withdrawal by Subject|1|||
162935930|NCT01381900|588470250|FG000|Overall Study|Early withdraw|3|||
162935931|NCT01381900|588470251|FG001|Overall Study|Early withdraw|1|||
162935932|NCT01381900|588470252|FG002|Overall Study|Early withdraw|1|||
162935933|NCT01772368|588470253|FG000|Overall Study|Adverse Event|1|||
162935934|NCT01772368|588470253|FG000|Overall Study|Withdrawal by Subject|3|||
162935935|NCT01772368|588470253|FG000|Overall Study|Protocol Violation|2|||
162935936|NCT01772368|588470253|FG000|Overall Study|Other|1|||
162935937|NCT00112489|588470257|FG000|Overall Study|Refused further treatment|8|||
162935938|NCT00112489|588470257|FG000|Overall Study|Adverse Event|12|||
162935939|NCT00112489|588470257|FG000|Overall Study|Death|2|||
162935940|NCT00112489|588470257|FG000|Overall Study|Other, Not Specified|9|||
162935941|NCT00112489|588470257|FG000|Overall Study|Patient never treated|2|||
162935942|NCT00112489|588470257|FG000|Overall Study|Ineligible|7|||
162935943|NCT02891200|588470262|FG000|Overall Study|Lost to Follow-up|31|||
162935944|NCT02891200|588470263|FG001|Overall Study|Lost to Follow-up|36|||
162935945|NCT02891200|588470262|FG000|Overall Study|Death|10|||
162935946|NCT02891200|588470263|FG001|Overall Study|Death|9|||
162935947|NCT02891200|588470262|FG000|Overall Study|Withdrawal by Subject|1|||
162935948|NCT02891200|588470263|FG001|Overall Study|Withdrawal by Subject|4|||
162935949|NCT01339910|588470264|FG000|Overall Study|Withdrawal by Subject|1|||
162935950|NCT01339910|588470265|FG001|Overall Study|Withdrawal by Subject|0|||
162935951|NCT01339910|588470264|FG000|Overall Study|Physician Decision|1|||
162935952|NCT01339910|588470265|FG001|Overall Study|Physician Decision|0|||
162935953|NCT01339910|588470264|FG000|Overall Study|Disease relapse|1|||
162935954|NCT01339910|588470265|FG001|Overall Study|Disease relapse|4|||
162935955|NCT02322879|588470266|FG000|First Intervention|Physician Decision|1|||
162935956|NCT02322879|588470267|FG001|First Intervention|Physician Decision|0|||
162935957|NCT00124020|588470274|FG000|Overall Study|Death|67|||
162935958|NCT00124020|588470275|FG001|Overall Study|Death|71|||
162935959|NCT00124020|588470274|FG000|Overall Study|Withdrawal by Subject|13|||
162935960|NCT00124020|588470275|FG001|Overall Study|Withdrawal by Subject|11|||
163179320|NCT02616562|589370566|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
163179321|NCT02616562|589370567|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
163179322|NCT02616562|589370568|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
163179323|NCT04770779|589370570|FG000|Overall Study|Randomized, never treated|0|||
162935961|NCT00124020|588470274|FG000|Overall Study|Lost to Follow-up|5|||
162935962|NCT00124020|588470275|FG001|Overall Study|Lost to Follow-up|8|||
162935963|NCT00124020|588470274|FG000|Overall Study|Other|1|||
163179324|NCT04770779|589370571|FG001|Overall Study|Randomized, never treated|1|||
163179325|NCT04770779|589370570|FG000|Overall Study|Adverse Event|9|||
162935964|NCT00124020|588470275|FG001|Overall Study|Other|1|||
162935965|NCT00124020|588470274|FG000|Overall Study|Transfer to another hospital|2|||
162935966|NCT00124020|588470275|FG001|Overall Study|Transfer to another hospital|0|||
162935967|NCT01155583|588470278|FG000|Phase I|Screen failure - did not start treatment|0|||
162935968|NCT01155583|588470279|FG001|Phase I|Screen failure - did not start treatment|0|||
162935969|NCT01155583|588470280|FG002|Phase I|Screen failure - did not start treatment|0|||
163179326|NCT04770779|589370571|FG001|Overall Study|Adverse Event|1|||
162935970|NCT01155583|588470281|FG003|Phase I|Screen failure - did not start treatment|0|||
162935971|NCT01155583|588470282|FG004|Phase I|Screen failure - did not start treatment|1|||
162935972|NCT01155583|588470283|FG005|Phase I|Screen failure - did not start treatment|0|||
162935973|NCT01155583|588470284|FG006|Phase I|Screen failure - did not start treatment|0|||
162935974|NCT01155583|588470285|FG007|Phase I|Screen failure - did not start treatment|2|||
162935975|NCT01155583|588470286|FG008|Phase I|Screen failure - did not start treatment|0|||
162935976|NCT01155583|588470278|FG000|Phase I|Withdrawal by Subject|0|||
162935977|NCT01155583|588470279|FG001|Phase I|Withdrawal by Subject|0|||
162935978|NCT01155583|588470280|FG002|Phase I|Withdrawal by Subject|0|||
162935979|NCT01155583|588470281|FG003|Phase I|Withdrawal by Subject|0|||
162935980|NCT01155583|588470282|FG004|Phase I|Withdrawal by Subject|0|||
162935981|NCT01155583|588470283|FG005|Phase I|Withdrawal by Subject|0|||
162935982|NCT01155583|588470284|FG006|Phase I|Withdrawal by Subject|0|||
162935983|NCT01155583|588470285|FG007|Phase I|Withdrawal by Subject|1|||
162935984|NCT01155583|588470286|FG008|Phase I|Withdrawal by Subject|0|||
162935985|NCT00886483|588470293|FG000|Overall Study|Lost to Follow-up|0|||
162935986|NCT00886483|588470294|FG001|Overall Study|Lost to Follow-up|1|||
162935987|NCT00886483|588470293|FG000|Overall Study|Pursue medications|1|||
162935988|NCT00886483|588470294|FG001|Overall Study|Pursue medications|2|||
162935989|NCT00886483|588470293|FG000|Overall Study|Distance to center, poor grades|1|||
162935990|NCT00886483|588470294|FG001|Overall Study|Distance to center, poor grades|0|||
162935991|NCT01001169|588470295|FG000|Overall Study|Withdrawal by Subject|2|||
162935992|NCT01001169|588470296|FG001|Overall Study|Withdrawal by Subject|1|||
162935993|NCT00602030|588470297|FG000|Lead-in Phase|Disease Progression|2|||
162935994|NCT00602030|588470298|FG001|Lead-in Phase|Disease Progression|3|||
162935995|NCT00602030|588470299|FG002|Lead-in Phase|Disease Progression|0|||
162935996|NCT00602030|588470300|FG003|Lead-in Phase|Disease Progression|0|||
162935997|NCT00602030|588470301|FG004|Lead-in Phase|Disease Progression|0|||
162935998|NCT00602030|588470297|FG000|Lead-in Phase|Adverse Event|0|||
162935999|NCT00602030|588470298|FG001|Lead-in Phase|Adverse Event|2|||
162936000|NCT00602030|588470299|FG002|Lead-in Phase|Adverse Event|0|||
162936001|NCT00602030|588470300|FG003|Lead-in Phase|Adverse Event|0|||
162936002|NCT00602030|588470301|FG004|Lead-in Phase|Adverse Event|0|||
162936003|NCT00602030|588470297|FG000|Double-blind Phase|Disease progression|0|||
162936004|NCT00602030|588470298|FG001|Double-blind Phase|Disease progression|0|||
162936005|NCT00602030|588470299|FG002|Double-blind Phase|Disease progression|33|||
162936006|NCT00602030|588470300|FG003|Double-blind Phase|Disease progression|30|||
162936007|NCT00602030|588470301|FG004|Double-blind Phase|Disease progression|0|||
162936008|NCT00602030|588470297|FG000|Double-blind Phase|Adverse Event|0|||
162936009|NCT00602030|588470298|FG001|Double-blind Phase|Adverse Event|0|||
162936010|NCT00602030|588470299|FG002|Double-blind Phase|Adverse Event|9|||
162936011|NCT00602030|588470300|FG003|Double-blind Phase|Adverse Event|18|||
162936012|NCT00602030|588470301|FG004|Double-blind Phase|Adverse Event|0|||
162936013|NCT00602030|588470297|FG000|Double-blind Phase|Consent withdrawal|0|||
162936014|NCT00602030|588470298|FG001|Double-blind Phase|Consent withdrawal|0|||
162936015|NCT00602030|588470299|FG002|Double-blind Phase|Consent withdrawal|4|||
162936016|NCT00602030|588470300|FG003|Double-blind Phase|Consent withdrawal|3|||
162936017|NCT00602030|588470301|FG004|Double-blind Phase|Consent withdrawal|0|||
162936018|NCT00602030|588470297|FG000|Double-blind Phase|Death|0|||
162936019|NCT00602030|588470298|FG001|Double-blind Phase|Death|0|||
162936020|NCT00602030|588470299|FG002|Double-blind Phase|Death|3|||
162936021|NCT00602030|588470300|FG003|Double-blind Phase|Death|3|||
162936022|NCT00602030|588470301|FG004|Double-blind Phase|Death|0|||
162936023|NCT00602030|588470297|FG000|Double-blind Phase|Administrative decision|0|||
162936024|NCT00602030|588470298|FG001|Double-blind Phase|Administrative decision|0|||
162936025|NCT00602030|588470299|FG002|Double-blind Phase|Administrative decision|0|||
162936026|NCT00602030|588470300|FG003|Double-blind Phase|Administrative decision|2|||
162936027|NCT00602030|588470301|FG004|Double-blind Phase|Administrative decision|0|||
162936028|NCT00602030|588470297|FG000|Double-blind Phase|Ineligibility|0|||
162936029|NCT00602030|588470298|FG001|Double-blind Phase|Ineligibility|0|||
162936030|NCT00602030|588470299|FG002|Double-blind Phase|Ineligibility|0|||
162936031|NCT00602030|588470300|FG003|Double-blind Phase|Ineligibility|1|||
162936032|NCT00602030|588470301|FG004|Double-blind Phase|Ineligibility|0|||
162936033|NCT00602030|588470297|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936034|NCT00602030|588470298|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936035|NCT00602030|588470299|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
162936036|NCT00602030|588470300|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936037|NCT00602030|588470301|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
162936038|NCT00602030|588470297|FG000|Double-blind Phase|Reason not specified|0|||
162936039|NCT00602030|588470298|FG001|Double-blind Phase|Reason not specified|0|||
162936040|NCT00602030|588470299|FG002|Double-blind Phase|Reason not specified|4|||
162936041|NCT00602030|588470300|FG003|Double-blind Phase|Reason not specified|2|||
162936042|NCT00602030|588470301|FG004|Double-blind Phase|Reason not specified|0|||
162936043|NCT00602030|588470297|FG000|Crossover Phase|Disease Progression|0|||
162936044|NCT00602030|588470298|FG001|Crossover Phase|Disease Progression|0|||
162936045|NCT00602030|588470299|FG002|Crossover Phase|Disease Progression|0|||
162936046|NCT00602030|588470300|FG003|Crossover Phase|Disease Progression|0|||
162936047|NCT00602030|588470301|FG004|Crossover Phase|Disease Progression|11|||
162936048|NCT00602030|588470297|FG000|Crossover Phase|Adverse Event|0|||
162936049|NCT00602030|588470298|FG001|Crossover Phase|Adverse Event|0|||
162936050|NCT00602030|588470299|FG002|Crossover Phase|Adverse Event|0|||
162936051|NCT00602030|588470300|FG003|Crossover Phase|Adverse Event|0|||
162936052|NCT00602030|588470301|FG004|Crossover Phase|Adverse Event|3|||
162936053|NCT00602030|588470297|FG000|Crossover Phase|Consent withdrawal|0|||
162936054|NCT00602030|588470298|FG001|Crossover Phase|Consent withdrawal|0|||
162936055|NCT00602030|588470299|FG002|Crossover Phase|Consent withdrawal|0|||
162936056|NCT00602030|588470300|FG003|Crossover Phase|Consent withdrawal|0|||
162936057|NCT00602030|588470301|FG004|Crossover Phase|Consent withdrawal|2|||
162936058|NCT01138150|588470302|FG000|Overall Study|blood unable to be processed|0|||
162936059|NCT01138150|588470303|FG001|Overall Study|blood unable to be processed|1|||
162936060|NCT01138150|588470302|FG000|Overall Study|Physician Decision|1|||
162936061|NCT01138150|588470303|FG001|Overall Study|Physician Decision|0|||
162936062|NCT01580020|588470304|FG000|Overall Study|Lack of Efficacy|0|||
162936063|NCT01580020|588470305|FG001|Overall Study|Lack of Efficacy|5|||
162936064|NCT01580020|588470306|FG002|Overall Study|Lack of Efficacy|0|||
162936065|NCT01580020|588470307|FG003|Overall Study|Lack of Efficacy|1|||
162936066|NCT01580020|588470304|FG000|Overall Study|Withdrawal by Subject|0|||
162936067|NCT01580020|588470305|FG001|Overall Study|Withdrawal by Subject|1|||
162936068|NCT01580020|588470306|FG002|Overall Study|Withdrawal by Subject|1|||
162936069|NCT01580020|588470307|FG003|Overall Study|Withdrawal by Subject|0|||
162936070|NCT01580020|588470304|FG000|Overall Study|Adverse Event|1|||
162936071|NCT01580020|588470305|FG001|Overall Study|Adverse Event|1|||
162936072|NCT01580020|588470306|FG002|Overall Study|Adverse Event|1|||
162936073|NCT01580020|588470307|FG003|Overall Study|Adverse Event|1|||
162936074|NCT01580020|588470304|FG000|Overall Study|Administrative Problems|0|||
162936075|NCT01580020|588470305|FG001|Overall Study|Administrative Problems|0|||
162936076|NCT01580020|588470306|FG002|Overall Study|Administrative Problems|1|||
162936077|NCT01580020|588470307|FG003|Overall Study|Administrative Problems|0|||
162936078|NCT01580020|588470304|FG000|Overall Study|Lost to Follow-up|0|||
162936079|NCT01580020|588470305|FG001|Overall Study|Lost to Follow-up|0|||
162936080|NCT01580020|588470306|FG002|Overall Study|Lost to Follow-up|1|||
162936081|NCT01580020|588470307|FG003|Overall Study|Lost to Follow-up|0|||
162936082|NCT01724359|588470308|FG000|Overall Study|Adverse Event|10|||
162936083|NCT01724359|588470308|FG000|Overall Study|Death|1|||
162936084|NCT01724359|588470308|FG000|Overall Study|Other|20|||
162936085|NCT02151461|588470315|FG000|Overall Study|Adverse Event|5|||
162936086|NCT02151461|588470316|FG001|Overall Study|Adverse Event|1|||
162936087|NCT02151461|588470317|FG002|Overall Study|Adverse Event|0|||
162936088|NCT02151461|588470318|FG003|Overall Study|Adverse Event|2|||
162936089|NCT02151461|588470315|FG000|Overall Study|Lost to Follow-up|0|||
162936090|NCT02151461|588470316|FG001|Overall Study|Lost to Follow-up|0|||
162936091|NCT02151461|588470317|FG002|Overall Study|Lost to Follow-up|1|||
162936092|NCT02151461|588470318|FG003|Overall Study|Lost to Follow-up|1|||
162936093|NCT02151461|588470315|FG000|Overall Study|Withdrawal by Subject|1|||
162936094|NCT02151461|588470316|FG001|Overall Study|Withdrawal by Subject|0|||
162936095|NCT02151461|588470317|FG002|Overall Study|Withdrawal by Subject|1|||
163179327|NCT04770779|589370570|FG000|Overall Study|Withdrawal by Subject|7|||
163179328|NCT04770779|589370571|FG001|Overall Study|Withdrawal by Subject|1|||
163179329|NCT04770779|589370570|FG000|Overall Study|Pregnancy|0|||
162826687|NCT02577406|588077291|FG000|Treatment Period|Physician Decision|1|||
162826688|NCT02577406|588077292|FG001|Treatment Period|Physician Decision|0|||
162826689|NCT02577406|588077291|FG000|Treatment Period|Disease Relapse|28|||
162826690|NCT02577406|588077292|FG001|Treatment Period|Disease Relapse|1|||
162826691|NCT02577406|588077291|FG000|Treatment Period|Protocol Violation|0|||
162826692|NCT02577406|588077292|FG001|Treatment Period|Protocol Violation|1|||
162826693|NCT02577406|588077291|FG000|Treatment Period|Other Reasons|3|||
162826694|NCT02577406|588077292|FG001|Treatment Period|Other Reasons|39|||
162826695|NCT02577406|588077291|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
162936096|NCT02151461|588470318|FG003|Overall Study|Withdrawal by Subject|1|||
162936097|NCT02151461|588470315|FG000|Overall Study|Treatment discontinuation|0|||
162936098|NCT02151461|588470316|FG001|Overall Study|Treatment discontinuation|0|||
162936099|NCT02151461|588470317|FG002|Overall Study|Treatment discontinuation|1|||
162936100|NCT02151461|588470318|FG003|Overall Study|Treatment discontinuation|0|||
162936101|NCT02168270|588470319|FG000|Overall Study|Lack of Efficacy|4|||
162936102|NCT01738581|588470320|FG000|Overall Study|Lost to Follow-up|1|||
162936103|NCT01738581|588470321|FG001|Overall Study|Lost to Follow-up|0|||
162936104|NCT02191579|588470328|FG000|Treatment 1|Multiple Reasons Specified|27|||
162936105|NCT02191579|588470329|FG001|Treatment 1|Multiple Reasons Specified|58|||
162936106|NCT02191579|588470328|FG000|Treatment 2|Multiple Reasons Specified|0|||
162936107|NCT02191579|588470329|FG001|Treatment 2|Multiple Reasons Specified|25|||
162936108|NCT02862535|588470330|FG000|Overall Study|Death|7|||
162936109|NCT02862535|588470331|FG001|Overall Study|Death|3|||
162936110|NCT02862535|588470332|FG002|Overall Study|Death|2|||
163179330|NCT04770779|589370571|FG001|Overall Study|Pregnancy|1|||
162936111|NCT02862535|588470333|FG003|Overall Study|Death|5|||
162936112|NCT02862535|588470330|FG000|Overall Study|Study Terminated by Sponsor|1|||
162936113|NCT02862535|588470331|FG001|Overall Study|Study Terminated by Sponsor|3|||
162936114|NCT02862535|588470332|FG002|Overall Study|Study Terminated by Sponsor|8|||
162936115|NCT02862535|588470333|FG003|Overall Study|Study Terminated by Sponsor|5|||
162936116|NCT02862535|588470330|FG000|Overall Study|Enrolled, not Treated|1|||
162936117|NCT02862535|588470331|FG001|Overall Study|Enrolled, not Treated|0|||
162936118|NCT02862535|588470332|FG002|Overall Study|Enrolled, not Treated|0|||
162936119|NCT02862535|588470333|FG003|Overall Study|Enrolled, not Treated|1|||
162936120|NCT02280356|588470334|FG000|Overall Study|Not Treated|2|||
162936121|NCT02280356|588470334|FG000|Overall Study|Withdrawal by Subject|1|||
162936122|NCT02280356|588470334|FG000|Overall Study|Not evaluable|2|||
162936123|NCT01086215|588470338|FG000|Overall Study|Death|14|||
162936124|NCT01086215|588470339|FG001|Overall Study|Death|8|||
162936125|NCT01086215|588470340|FG002|Overall Study|Death|8|||
162936126|NCT01086215|588470341|FG003|Overall Study|Death|1|||
162936127|NCT01086215|588470338|FG000|Overall Study|Lost to Follow-up|22|||
162936128|NCT01086215|588470339|FG001|Overall Study|Lost to Follow-up|39|||
162936129|NCT01086215|588470340|FG002|Overall Study|Lost to Follow-up|18|||
162936130|NCT01086215|588470341|FG003|Overall Study|Lost to Follow-up|2|||
162936131|NCT01965652|588470342|FG000|Overall Study|Adverse Event|40|||
162936132|NCT01965652|588470343|FG001|Overall Study|Adverse Event|37|||
162936133|NCT01965652|588470342|FG000|Overall Study|Withdrawal by Subject|62|||
162936134|NCT01965652|588470343|FG001|Overall Study|Withdrawal by Subject|69|||
162936135|NCT01965652|588470342|FG000|Overall Study|Lost to Follow-up|53|||
162936136|NCT01965652|588470343|FG001|Overall Study|Lost to Follow-up|40|||
162936137|NCT01965652|588470342|FG000|Overall Study|Protocol Violation|34|||
162936138|NCT01965652|588470343|FG001|Overall Study|Protocol Violation|38|||
162936139|NCT01965652|588470342|FG000|Overall Study|Death|3|||
162936140|NCT01965652|588470343|FG001|Overall Study|Death|4|||
162936141|NCT01965652|588470342|FG000|Overall Study|Other - Miscellaneous|18|||
162936142|NCT01965652|588470343|FG001|Overall Study|Other - Miscellaneous|21|||
162936143|NCT01965652|588470342|FG000|Overall Study|Pregnancy|0|||
162936144|NCT01965652|588470343|FG001|Overall Study|Pregnancy|1|||
162936145|NCT01121900|588470348|FG000|First Intervention Period|Adverse Event|1|||
162936146|NCT01121900|588470349|FG001|First Intervention Period|Adverse Event|1|||
162936147|NCT01121900|588470348|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162936148|NCT01121900|588470349|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162936149|NCT03493698|588470350|FG000|Treatment Period C|Adverse Event|1|||
162936150|NCT03493698|588470350|FG000|Treatment Period C|Withdrawal by Subject|1|||
162936151|NCT00408876|588470351|FG000|Overall Study|Adverse Event|9|||
162936152|NCT00408876|588470352|FG001|Overall Study|Adverse Event|17|||
162936153|NCT00408876|588470353|FG002|Overall Study|Adverse Event|27|||
162936154|NCT00408876|588470354|FG003|Overall Study|Adverse Event|10|||
162936155|NCT00408876|588470351|FG000|Overall Study|Withdrawal by Subject|3|||
162936156|NCT00408876|588470352|FG001|Overall Study|Withdrawal by Subject|6|||
162936157|NCT00408876|588470353|FG002|Overall Study|Withdrawal by Subject|6|||
162936158|NCT00408876|588470354|FG003|Overall Study|Withdrawal by Subject|14|||
162936159|NCT00408876|588470351|FG000|Overall Study|Lack of Efficacy|2|||
162936160|NCT00408876|588470352|FG001|Overall Study|Lack of Efficacy|4|||
162936161|NCT00408876|588470353|FG002|Overall Study|Lack of Efficacy|5|||
162936162|NCT00408876|588470354|FG003|Overall Study|Lack of Efficacy|6|||
162936163|NCT00408876|588470351|FG000|Overall Study|Lost to Follow-up|1|||
162936164|NCT00408876|588470352|FG001|Overall Study|Lost to Follow-up|6|||
162936165|NCT00408876|588470353|FG002|Overall Study|Lost to Follow-up|5|||
162936166|NCT00408876|588470354|FG003|Overall Study|Lost to Follow-up|2|||
162936167|NCT00408876|588470351|FG000|Overall Study|Protocol Violation|0|||
162936168|NCT00408876|588470352|FG001|Overall Study|Protocol Violation|3|||
162936169|NCT00408876|588470353|FG002|Overall Study|Protocol Violation|4|||
162936170|NCT00408876|588470354|FG003|Overall Study|Protocol Violation|3|||
162936171|NCT00408876|588470351|FG000|Overall Study|Physician Decision|1|||
162936172|NCT00408876|588470352|FG001|Overall Study|Physician Decision|0|||
162936173|NCT00408876|588470353|FG002|Overall Study|Physician Decision|3|||
162936174|NCT00408876|588470354|FG003|Overall Study|Physician Decision|0|||
162936175|NCT00291330|588470355|FG000|Overall Study|Adverse Event|47|||
162936176|NCT00291330|588470356|FG001|Overall Study|Adverse Event|40|||
162936177|NCT00291330|588470355|FG000|Overall Study|Protocol Violation|13|||
162936178|NCT00291330|588470356|FG001|Overall Study|Protocol Violation|20|||
162936179|NCT00291330|588470355|FG000|Overall Study|Lost to Follow-up|16|||
162936180|NCT00291330|588470356|FG001|Overall Study|Lost to Follow-up|11|||
162936181|NCT00291330|588470355|FG000|Overall Study|Withdrawal by Subject|22|||
162936182|NCT00291330|588470356|FG001|Overall Study|Withdrawal by Subject|25|||
162936183|NCT00291330|588470355|FG000|Overall Study|Other|3|||
162936184|NCT00291330|588470356|FG001|Overall Study|Other|1|||
162936185|NCT00566709|588470357|FG000|Overall Study|Protocol Violation|5|||
162936186|NCT00566709|588470358|FG001|Overall Study|Protocol Violation|0|||
162936187|NCT03443869|588470359|FG000|Overall Study|Death|3|||
162826696|NCT02577406|588077292|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
162826697|NCT01111851|588077298|FG000|Overall Study|All planned PET scans were not obtained.|2|||
162826698|NCT01111851|588077299|FG001|Overall Study|All planned PET scans were not obtained.|0|||
162826699|NCT05500274|588077300|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
162826700|NCT05500274|588077301|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
162826701|NCT05500274|588077300|FG000|Overall Study|Lost to Follow-up|76|||
162826702|NCT05500274|588077301|FG001|Overall Study|Lost to Follow-up|51|||
162826703|NCT01555151|588077302|FG000|Overall Study|Withdrawal by Subject|6|||
162826704|NCT01555151|588077303|FG001|Overall Study|Withdrawal by Subject|2|||
162826705|NCT01555151|588077304|FG002|Overall Study|Withdrawal by Subject|0|||
162826706|NCT01555151|588077305|FG003|Overall Study|Withdrawal by Subject|2|||
162826707|NCT01555151|588077302|FG000|Overall Study|Administrative|3|||
162826708|NCT01555151|588077303|FG001|Overall Study|Administrative|1|||
162826709|NCT01555151|588077304|FG002|Overall Study|Administrative|2|||
162826710|NCT01555151|588077305|FG003|Overall Study|Administrative|0|||
162826711|NCT01555151|588077302|FG000|Overall Study|Protocol Violation|3|||
162826712|NCT01555151|588077303|FG001|Overall Study|Protocol Violation|3|||
162826713|NCT01555151|588077304|FG002|Overall Study|Protocol Violation|3|||
162826714|NCT01555151|588077305|FG003|Overall Study|Protocol Violation|5|||
162826715|NCT01555151|588077302|FG000|Overall Study|Adverse Event|1|||
162826716|NCT01555151|588077303|FG001|Overall Study|Adverse Event|2|||
162826717|NCT01555151|588077304|FG002|Overall Study|Adverse Event|1|||
162826718|NCT01555151|588077305|FG003|Overall Study|Adverse Event|2|||
162826719|NCT01555151|588077302|FG000|Overall Study|Lost to Follow-up|0|||
162826720|NCT01555151|588077303|FG001|Overall Study|Lost to Follow-up|0|||
162826721|NCT01555151|588077304|FG002|Overall Study|Lost to Follow-up|0|||
162826722|NCT01555151|588077305|FG003|Overall Study|Lost to Follow-up|1|||
162826723|NCT01961349|588077306|FG000|Overall Study|Withdrawal by Subject|1|||
162826724|NCT01961349|588077307|FG001|Overall Study|Withdrawal by Subject|4|||
162826725|NCT01961349|588077308|FG002|Overall Study|Withdrawal by Subject|0|||
162826726|NCT01961349|588077306|FG000|Overall Study|Adverse Event|0|||
162826727|NCT01961349|588077307|FG001|Overall Study|Adverse Event|0|||
162826728|NCT01961349|588077308|FG002|Overall Study|Adverse Event|1|||
162826729|NCT01961349|588077306|FG000|Overall Study|registration error, personal reason etc|2|||
162826730|NCT01961349|588077307|FG001|Overall Study|registration error, personal reason etc|2|||
162826731|NCT01961349|588077308|FG002|Overall Study|registration error, personal reason etc|1|||
162826732|NCT02343159|588077314|FG000|Overall Study|Early Study Termination|16|||
162826733|NCT02343159|588077315|FG001|Overall Study|Early Study Termination|19|||
162936188|NCT03443869|588470360|FG001|Overall Study|Death|3|||
162826734|NCT02343159|588077316|FG002|Overall Study|Early Study Termination|23|||
162826735|NCT02343159|588077314|FG000|Overall Study|Physician Decision|2|||
162826736|NCT02343159|588077315|FG001|Overall Study|Physician Decision|0|||
162826737|NCT02343159|588077316|FG002|Overall Study|Physician Decision|1|||
162826738|NCT02343159|588077314|FG000|Overall Study|Withdrawal by Subject|3|||
162826739|NCT02343159|588077315|FG001|Overall Study|Withdrawal by Subject|0|||
162826740|NCT02343159|588077316|FG002|Overall Study|Withdrawal by Subject|2|||
162826741|NCT02343159|588077314|FG000|Overall Study|Lost to Follow-up|0|||
162826742|NCT02343159|588077315|FG001|Overall Study|Lost to Follow-up|2|||
162826743|NCT02343159|588077316|FG002|Overall Study|Lost to Follow-up|2|||
162936189|NCT03443869|588470359|FG000|Overall Study|Withdrawal by Subject|34|||
162936190|NCT03443869|588470360|FG001|Overall Study|Withdrawal by Subject|22|||
162936191|NCT03443869|588470359|FG000|Overall Study|Lost to Follow-up|1|||
162936192|NCT03443869|588470360|FG001|Overall Study|Lost to Follow-up|2|||
162936193|NCT03443869|588470359|FG000|Overall Study|Physician Decision|3|||
162936194|NCT03443869|588470360|FG001|Overall Study|Physician Decision|3|||
162936195|NCT03443869|588470359|FG000|Overall Study|Other|4|||
162936196|NCT03443869|588470360|FG001|Overall Study|Other|4|||
162936197|NCT02390219|588470361|FG000|Overall Study|Death|1|||
163179331|NCT03575793|589370572|FG000|Overall Study|Withdrawal by Subject|0|||
163179332|NCT03575793|589370573|FG001|Overall Study|Withdrawal by Subject|1|||
163179333|NCT03575793|589370572|FG000|Overall Study|Never Treated|0|||
163179334|NCT03575793|589370573|FG001|Overall Study|Never Treated|2|||
163179335|NCT03692052|589370574|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
163179336|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
163179337|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
163179338|NCT03692052|589370574|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
163179339|NCT02656706|589371030|FG000|Overall Study|Insurance Denial|1|||
163179340|NCT03659916|589371031|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
163179341|NCT03659916|589371032|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
163179342|NCT03659916|589371033|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
163179343|NCT03659916|589371031|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
163179344|NCT03659916|589371032|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
163179345|NCT03659916|589371033|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
163179346|NCT03659916|589371031|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
163179347|NCT03659916|589371032|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
163179348|NCT03659916|589371033|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
163179349|NCT03659916|589371031|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
163179350|NCT03659916|589371032|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
163179351|NCT03659916|589371033|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
163179352|NCT03659916|589371031|FG000|Treatment Period (72 Weeks)|Other|1|||
163179353|NCT03659916|589371032|FG001|Treatment Period (72 Weeks)|Other|3|||
163179354|NCT03659916|589371033|FG002|Treatment Period (72 Weeks)|Other|9|||
163179355|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
163179356|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
163179357|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
163179358|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
163179359|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
163179360|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
163179361|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
163179362|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
163179363|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
163179364|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
163179365|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
163179366|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
163179367|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
163179368|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
163179369|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
163179370|NCT03659916|589371031|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
163179371|NCT03659916|589371032|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
163179372|NCT03659916|589371033|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
163179373|NCT05076266|589371034|FG000|Overall Study|Survey not complete - Participant refusal|2|||
163179374|NCT05076266|589371035|FG001|Overall Study|Survey not complete - Participant refusal|0|||
163179375|NCT05169567|589371036|FG000|Overall Study|On study treatment|116|||
163179376|NCT05169567|589371037|FG001|Overall Study|On study treatment|128|||
163179377|NCT05169567|589371036|FG000|Overall Study|Lost to Follow-up|1|||
163179378|NCT05169567|589371037|FG001|Overall Study|Lost to Follow-up|0|||
163179379|NCT05169567|589371036|FG000|Overall Study|Withdrawal by Subject|25|||
163179380|NCT05169567|589371037|FG001|Overall Study|Withdrawal by Subject|21|||
163179381|NCT04576455|589371040|FG000|Overall Study|Ongoing in the Study|48|||
163179382|NCT04576455|589371041|FG001|Overall Study|Ongoing in the Study|58|||
163179383|NCT04576455|589371040|FG000|Overall Study|Death|83|||
163179384|NCT04576455|589371041|FG001|Overall Study|Death|77|||
162936198|NCT02390219|588470361|FG000|Overall Study|Physician Decision|1|||
162936199|NCT02390219|588470361|FG000|Overall Study|Adverse Event|6|||
163179385|NCT04576455|589371040|FG000|Overall Study|Lost to Follow-up|4|||
163179386|NCT04576455|589371041|FG001|Overall Study|Lost to Follow-up|5|||
162936200|NCT02390219|588470361|FG000|Overall Study|Withdrawal by Subject|1|||
162936201|NCT02390219|588470361|FG000|Overall Study|Lost to Follow-up|2|||
162936202|NCT02390219|588470361|FG000|Overall Study|Other|2|||
162936203|NCT00299728|588470362|FG000|Overall Study|Lost to Follow-up|0|||
162936204|NCT00299728|588470363|FG001|Overall Study|Lost to Follow-up|1|||
162936205|NCT00299728|588470362|FG000|Overall Study|Withdrawal by Subject|0|||
162936206|NCT00299728|588470363|FG001|Overall Study|Withdrawal by Subject|1|||
162936207|NCT00299728|588470362|FG000|Overall Study|Progressive disease|0|||
162936208|NCT00299728|588470363|FG001|Overall Study|Progressive disease|1|||
162936209|NCT04071626|588470367|FG000|Overall Study|Withdrawal by Subject|1|||
162936210|NCT04071626|588470368|FG001|Overall Study|Withdrawal by Subject|1|||
162936211|NCT04071626|588470367|FG000|Overall Study|Protocol Violation|0|||
162936212|NCT04071626|588470368|FG001|Overall Study|Protocol Violation|1|||
162936213|NCT00931385|588470369|FG000|Overall Study|Adverse Event|2|||
162936214|NCT00931385|588470370|FG001|Overall Study|Adverse Event|1|||
162936215|NCT00931385|588470371|FG002|Overall Study|Adverse Event|0|||
162936216|NCT00931385|588470372|FG003|Overall Study|Adverse Event|3|||
162936217|NCT00931385|588470369|FG000|Overall Study|Protocol Violation|0|||
162936218|NCT00931385|588470370|FG001|Overall Study|Protocol Violation|0|||
162936219|NCT00931385|588470371|FG002|Overall Study|Protocol Violation|1|||
162936220|NCT00931385|588470372|FG003|Overall Study|Protocol Violation|0|||
162936221|NCT00931385|588470369|FG000|Overall Study|Withdrawal by Subject|0|||
162936222|NCT00931385|588470370|FG001|Overall Study|Withdrawal by Subject|1|||
162936223|NCT00931385|588470371|FG002|Overall Study|Withdrawal by Subject|0|||
162936224|NCT00931385|588470372|FG003|Overall Study|Withdrawal by Subject|1|||
162936225|NCT00931385|588470369|FG000|Overall Study|Lost to Follow-up|0|||
162936226|NCT00931385|588470370|FG001|Overall Study|Lost to Follow-up|0|||
162936227|NCT00931385|588470371|FG002|Overall Study|Lost to Follow-up|0|||
162936228|NCT00931385|588470372|FG003|Overall Study|Lost to Follow-up|1|||
162936229|NCT02230085|588470375|FG000|Overall Study|Physician Decision|1|||
162936230|NCT02230085|588470375|FG000|Overall Study|Withdrawal by Subject|3|||
162936231|NCT00580983|588470376|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
162936232|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
162936233|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936234|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936235|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936236|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
162936237|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Adverse Event|60|||
162936238|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Adverse Event|0|||
162936239|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Adverse Event|0|||
162936240|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Adverse Event|0|||
162936241|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Adverse Event|0|||
163179387|NCT04576455|589371040|FG000|Overall Study|Withdrawal by Subject|16|||
163179388|NCT04576455|589371041|FG001|Overall Study|Withdrawal by Subject|12|||
163179389|NCT04449055|589371042|FG000|Overall Study|Lost to Follow-up|2|||
163179390|NCT04449055|589371043|FG001|Overall Study|Lost to Follow-up|1|||
163179391|NCT04449055|589371042|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
163179392|NCT04449055|589371043|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
163179393|NCT04449055|589371042|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
163179394|NCT04449055|589371043|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
163179395|NCT04449055|589371042|FG000|Overall Study|Incarcerated|1|||
163179396|NCT04449055|589371043|FG001|Overall Study|Incarcerated|0|||
163179397|NCT03003468|589371044|FG000|Overall Study|Withdrawal by Subject|0|||
163179398|NCT03003468|589371045|FG001|Overall Study|Withdrawal by Subject|0|||
163179399|NCT03003468|589371046|FG002|Overall Study|Withdrawal by Subject|1|||
163179400|NCT03003468|589371044|FG000|Overall Study|No measurable lesions|0|||
163179401|NCT03003468|589371045|FG001|Overall Study|No measurable lesions|0|||
163179402|NCT03003468|589371046|FG002|Overall Study|No measurable lesions|1|||
163179403|NCT06286332|589371047|FG000|Overall Study|Death|1|||
163179404|NCT06286332|589371048|FG001|Overall Study|Death|2|||
163179405|NCT06286332|589371047|FG000|Overall Study|Transfer to ICU|2|||
162936242|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
162936243|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936244|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936245|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936246|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
162936247|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Physician Decision|10|||
162936248|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Physician Decision|0|||
162936249|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Physician Decision|0|||
162936250|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Physician Decision|0|||
162936251|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Physician Decision|0|||
162936252|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
162936253|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936254|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
163179406|NCT06286332|589371048|FG001|Overall Study|Transfer to ICU|0|||
163179407|NCT06070987|589371050|FG000|first treatment|Withdrawal by Subject|1|||
162936255|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936256|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
162936257|NCT01360632|588470377|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
162936258|NCT01360632|588470378|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
162936259|NCT01360632|588470379|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
162936260|NCT01360632|588470380|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
162936261|NCT01360632|588470381|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
162936262|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936263|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
162936264|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
162936265|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936266|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
162936267|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Adverse Event|0|||
162936268|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Adverse Event|3|||
162936269|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Adverse Event|9|||
162936270|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Adverse Event|3|||
162936271|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Adverse Event|0|||
162936272|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936273|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936274|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
162936275|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
162936276|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162936277|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Physician Decision|0|||
162936278|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Physician Decision|0|||
162936279|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Physician Decision|0|||
162936280|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Physician Decision|1|||
162936281|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Physician Decision|0|||
162936282|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162936283|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
162936284|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
162936285|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
162936286|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162936287|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
162936288|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
162936289|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
162936290|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
162936291|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
162936292|NCT01360632|588470377|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936293|NCT01360632|588470378|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
162936294|NCT01360632|588470379|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936295|NCT01360632|588470380|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936296|NCT01360632|588470381|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
162936297|NCT01360632|588470377|FG000|Phase A+|Lost to Follow-up|0|||
162936298|NCT01360632|588470378|FG001|Phase A+|Lost to Follow-up|0|||
162936299|NCT01360632|588470379|FG002|Phase A+|Lost to Follow-up|0|||
162936300|NCT01360632|588470380|FG003|Phase A+|Lost to Follow-up|0|||
162936301|NCT01360632|588470381|FG004|Phase A+|Lost to Follow-up|2|||
162936302|NCT01360632|588470377|FG000|Phase A+|Adverse Event|0|||
162936303|NCT01360632|588470378|FG001|Phase A+|Adverse Event|0|||
162936304|NCT01360632|588470379|FG002|Phase A+|Adverse Event|0|||
162936305|NCT01360632|588470380|FG003|Phase A+|Adverse Event|0|||
162936306|NCT01360632|588470381|FG004|Phase A+|Adverse Event|2|||
162936307|NCT01360632|588470377|FG000|Phase A+|Met Withdrawal Criteria|0|||
162936308|NCT01360632|588470378|FG001|Phase A+|Met Withdrawal Criteria|0|||
162936309|NCT01360632|588470379|FG002|Phase A+|Met Withdrawal Criteria|0|||
163179408|NCT06070987|589371051|FG001|first treatment|Withdrawal by Subject|0|||
163179409|NCT06070987|589371050|FG000|first treatment|Lost to Follow-up|1|||
163179410|NCT06070987|589371051|FG001|first treatment|Lost to Follow-up|1|||
163179411|NCT06070987|589371050|FG000|first treatment|Protocol Violation|1|||
163179412|NCT06070987|589371051|FG001|first treatment|Protocol Violation|1|||
163179413|NCT06070987|589371050|FG000|wash out|did not participate in second treatment|2|||
162936310|NCT01360632|588470380|FG003|Phase A+|Met Withdrawal Criteria|0|||
162936311|NCT01360632|588470381|FG004|Phase A+|Met Withdrawal Criteria|7|||
162936312|NCT01360632|588470377|FG000|Phase A+|Physician Decision|0|||
162936313|NCT01360632|588470378|FG001|Phase A+|Physician Decision|0|||
162936314|NCT01360632|588470379|FG002|Phase A+|Physician Decision|0|||
162936315|NCT01360632|588470380|FG003|Phase A+|Physician Decision|0|||
162936316|NCT01360632|588470381|FG004|Phase A+|Physician Decision|3|||
162936317|NCT01360632|588470377|FG000|Phase A+|Withdrawal by Subject|0|||
162936318|NCT01360632|588470378|FG001|Phase A+|Withdrawal by Subject|0|||
162936319|NCT01360632|588470379|FG002|Phase A+|Withdrawal by Subject|0|||
162936320|NCT01360632|588470380|FG003|Phase A+|Withdrawal by Subject|0|||
162936321|NCT01360632|588470381|FG004|Phase A+|Withdrawal by Subject|8|||
162936322|NCT01360632|588470377|FG000|Phase A+|Protocol Deviation|0|||
162936323|NCT01360632|588470378|FG001|Phase A+|Protocol Deviation|0|||
162936324|NCT01360632|588470379|FG002|Phase A+|Protocol Deviation|0|||
162936325|NCT01360632|588470380|FG003|Phase A+|Protocol Deviation|0|||
162936326|NCT01360632|588470381|FG004|Phase A+|Protocol Deviation|3|||
162936327|NCT00811070|588470382|FG000|Overall Study|Death|0|||
162936328|NCT00811070|588470383|FG001|Overall Study|Death|0|||
162936329|NCT00811070|588470384|FG002|Overall Study|Death|0|||
162936330|NCT00811070|588470385|FG003|Overall Study|Death|2|||
162936331|NCT00811070|588470386|FG004|Overall Study|Death|5|||
162936332|NCT00811070|588470387|FG005|Overall Study|Death|0|||
162936333|NCT00811070|588470382|FG000|Overall Study|Other|1|||
162936334|NCT00811070|588470383|FG001|Overall Study|Other|0|||
162936335|NCT00811070|588470384|FG002|Overall Study|Other|0|||
163179414|NCT06070987|589371051|FG001|wash out|did not participate in second treatment|2|||
163179415|NCT06070987|589371050|FG000|second treatment|Withdrawal by Subject|1|||
163179416|NCT06070987|589371051|FG001|second treatment|Withdrawal by Subject|0|||
163179417|NCT06070987|589371050|FG000|second treatment|Lost to Follow-up|1|||
163179418|NCT06070987|589371051|FG001|second treatment|Lost to Follow-up|1|||
163179419|NCT06596005|589371052|FG000|Overall Study|Withdrawal by Subject|2|||
163179420|NCT06596005|589371053|FG001|Overall Study|Withdrawal by Subject|2|||
163179421|NCT06596005|589371054|FG002|Overall Study|Withdrawal by Subject|1|||
162936336|NCT00811070|588470385|FG003|Overall Study|Other|0|||
162936337|NCT00811070|588470386|FG004|Overall Study|Other|0|||
162936338|NCT00811070|588470387|FG005|Overall Study|Other|0|||
162936339|NCT00811070|588470382|FG000|Overall Study|Withdrawal by Subject|0|||
162936340|NCT00811070|588470383|FG001|Overall Study|Withdrawal by Subject|1|||
162936341|NCT00811070|588470384|FG002|Overall Study|Withdrawal by Subject|0|||
162936342|NCT00811070|588470385|FG003|Overall Study|Withdrawal by Subject|0|||
162936343|NCT00811070|588470386|FG004|Overall Study|Withdrawal by Subject|0|||
162936344|NCT00811070|588470387|FG005|Overall Study|Withdrawal by Subject|0|||
162936345|NCT00811070|588470382|FG000|Overall Study|Physician Decision|0|||
162936346|NCT00811070|588470383|FG001|Overall Study|Physician Decision|0|||
162936347|NCT00811070|588470384|FG002|Overall Study|Physician Decision|0|||
162936348|NCT00811070|588470385|FG003|Overall Study|Physician Decision|0|||
162936349|NCT00811070|588470386|FG004|Overall Study|Physician Decision|0|||
162936350|NCT00811070|588470387|FG005|Overall Study|Physician Decision|1|||
162936351|NCT00665626|588470390|FG000|Overall Study|Lack of Efficacy|8|||
162936352|NCT00665626|588470391|FG001|Overall Study|Lack of Efficacy|5|||
162936353|NCT00665626|588470390|FG000|Overall Study|Lost to Follow-up|0|||
163179422|NCT06596005|589371052|FG000|Overall Study|Other|0|||
163179423|NCT06596005|589371053|FG001|Overall Study|Other|2|||
163179424|NCT06596005|589371054|FG002|Overall Study|Other|0|||
163179425|NCT02445391|589371055|FG000|Overall Study|No active protocol treatment|3|||
163179426|NCT02445391|589371056|FG001|Overall Study|No active protocol treatment|0|||
162936354|NCT00665626|588470391|FG001|Overall Study|Lost to Follow-up|2|||
162936355|NCT00665626|588470390|FG000|Overall Study|Withdrawal by Subject|0|||
162936356|NCT00665626|588470391|FG001|Overall Study|Withdrawal by Subject|1|||
162936357|NCT00665626|588470390|FG000|Overall Study|Protocol Violation|0|||
162936358|NCT00665626|588470391|FG001|Overall Study|Protocol Violation|2|||
162936359|NCT00665626|588470390|FG000|Overall Study|Adverse Event|1|||
162936360|NCT00665626|588470391|FG001|Overall Study|Adverse Event|9|||
162936361|NCT00665626|588470390|FG000|Overall Study|Due to exclusion criteria|0|||
162936362|NCT00665626|588470391|FG001|Overall Study|Due to exclusion criteria|1|||
162936363|NCT00665626|588470390|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
162936364|NCT00665626|588470391|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
162936365|NCT00665626|588470390|FG000|Overall Study|Unably to comply with dosing regimen|0|||
162936366|NCT00665626|588470391|FG001|Overall Study|Unably to comply with dosing regimen|1|||
162936367|NCT00665626|588470390|FG000|Overall Study|Death|1|||
162936368|NCT00665626|588470391|FG001|Overall Study|Death|0|||
162936369|NCT02046369|588470392|FG000|Overall Study|Adverse Event|3|||
162936370|NCT02046369|588470393|FG001|Overall Study|Adverse Event|3|||
162936371|NCT02046369|588470392|FG000|Overall Study|Lack of Efficacy|3|||
162936372|NCT02046369|588470393|FG001|Overall Study|Lack of Efficacy|3|||
162936373|NCT02046369|588470392|FG000|Overall Study|Lost to Follow-up|3|||
162936374|NCT02046369|588470393|FG001|Overall Study|Lost to Follow-up|3|||
162936375|NCT02046369|588470392|FG000|Overall Study|Protocol Violation|1|||
162936376|NCT02046369|588470393|FG001|Overall Study|Protocol Violation|2|||
162936377|NCT02046369|588470392|FG000|Overall Study|Withdrawal by Subject|3|||
162936378|NCT02046369|588470393|FG001|Overall Study|Withdrawal by Subject|6|||
162936379|NCT02046369|588470392|FG000|Overall Study|never received study drug|0|||
162936380|NCT02046369|588470393|FG001|Overall Study|never received study drug|1|||
162936381|NCT02046369|588470392|FG000|Overall Study|non compliance|1|||
162936382|NCT02046369|588470393|FG001|Overall Study|non compliance|0|||
162936383|NCT03120520|588470394|FG000|Overall Study|Lost to Follow-up|1|||
162936384|NCT03120520|588470395|FG001|Overall Study|Lost to Follow-up|1|||
162936385|NCT03120520|588470396|FG002|Overall Study|Lost to Follow-up|1|||
162936386|NCT03120520|588470397|FG003|Overall Study|Lost to Follow-up|1|||
162936387|NCT03120520|588470394|FG000|Overall Study|Withdrawal by Subject|3|||
162936388|NCT03120520|588470395|FG001|Overall Study|Withdrawal by Subject|2|||
162936389|NCT03120520|588470396|FG002|Overall Study|Withdrawal by Subject|3|||
162936390|NCT03120520|588470397|FG003|Overall Study|Withdrawal by Subject|2|||
162936391|NCT03120520|588470394|FG000|Overall Study|Other|0|||
162936392|NCT03120520|588470395|FG001|Overall Study|Other|1|||
162936393|NCT03120520|588470396|FG002|Overall Study|Other|0|||
162936394|NCT03120520|588470397|FG003|Overall Study|Other|0|||
162936395|NCT01025193|588470399|FG000|Overall Study|Protocol Violation|1|||
162936396|NCT01025193|588470399|FG000|Overall Study|Adverse Event|3|||
162936397|NCT04345471|588470400|FG000|Overall Study|Adverse Event|8|||
162936398|NCT04345471|588470401|FG001|Overall Study|Adverse Event|5|||
162936399|NCT04345471|588470402|FG002|Overall Study|Adverse Event|6|||
162936400|NCT04345471|588470400|FG000|Overall Study|Lack of Efficacy|1|||
162936401|NCT04345471|588470401|FG001|Overall Study|Lack of Efficacy|1|||
162936402|NCT04345471|588470402|FG002|Overall Study|Lack of Efficacy|0|||
162936403|NCT04345471|588470400|FG000|Overall Study|Protocol Violation|0|||
162936404|NCT04345471|588470401|FG001|Overall Study|Protocol Violation|1|||
162936405|NCT04345471|588470402|FG002|Overall Study|Protocol Violation|2|||
162936406|NCT04345471|588470400|FG000|Overall Study|Withdrawal by Subject|10|||
162936407|NCT04345471|588470401|FG001|Overall Study|Withdrawal by Subject|5|||
162936408|NCT04345471|588470402|FG002|Overall Study|Withdrawal by Subject|10|||
162936409|NCT02378506|588470407|FG000|Overall Study|Lack of Efficacy|3|||
162936410|NCT02378506|588470407|FG000|Overall Study|Withdrawal by Subject|4|||
162936411|NCT02378506|588470407|FG000|Overall Study|Protocol Violation|2|||
162936412|NCT02378506|588470407|FG000|Overall Study|Death|1|||
162936413|NCT02378506|588470407|FG000|Overall Study|Adverse Event|14|||
162936414|NCT02378506|588470407|FG000|Overall Study|Randomized But Not Treated|1|||
163042835|NCT01990768|588863970|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
162936415|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
162936416|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
162936417|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
162936418|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
162936419|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
162936420|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
162936421|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
162936422|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
162936423|NCT00185211|588470408|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
162936424|NCT00185211|588470409|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
162936425|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
162936426|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
162936427|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
162936428|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
162936429|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
162936430|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
162936431|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
162936432|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
162936433|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
162936434|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
162936435|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
162936436|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
162936437|NCT00185211|588470408|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
162936438|NCT00185211|588470409|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
162936439|NCT01759537|588470410|FG000|Overall Study|Death|1|||
162936440|NCT01759537|588470411|FG001|Overall Study|Death|1|||
162936441|NCT01759537|588470410|FG000|Overall Study|Pregnancy|1|||
162936442|NCT01759537|588470411|FG001|Overall Study|Pregnancy|1|||
162936443|NCT01759537|588470410|FG000|Overall Study|Lost to Follow-up|9|||
162936444|NCT01759537|588470411|FG001|Overall Study|Lost to Follow-up|9|||
162936445|NCT01759537|588470410|FG000|Overall Study|Accident involving jaw fracture|1|||
162936446|NCT01759537|588470411|FG001|Overall Study|Accident involving jaw fracture|1|||
162936447|NCT01759537|588470410|FG000|Overall Study|Subcrestal implant too coronal|1|||
162936448|NCT01759537|588470411|FG001|Overall Study|Subcrestal implant too coronal|1|||
162936449|NCT01015612|588470412|FG000|Overall Study|Death|113|||
162936450|NCT01015612|588470412|FG000|Overall Study|Withdrawal by Subject|40|||
162936451|NCT00420290|588470413|FG000|Overall Study|Adverse Event|3|||
162936452|NCT00420290|588470414|FG001|Overall Study|Adverse Event|1|||
162936453|NCT00420290|588470413|FG000|Overall Study|Withdrawal by Subject|0|||
162936454|NCT00420290|588470414|FG001|Overall Study|Withdrawal by Subject|2|||
162936455|NCT00420290|588470413|FG000|Overall Study|did not meet inclusion/exclusion|1|||
162936456|NCT00420290|588470414|FG001|Overall Study|did not meet inclusion/exclusion|1|||
162936457|NCT00972153|588470417|FG000|Overall Study|Equipment malfunction during case|0|||
162936458|NCT00972153|588470418|FG001|Overall Study|Equipment malfunction during case|1|||
162936459|NCT00972153|588470419|FG002|Overall Study|Equipment malfunction during case|0|||
162936460|NCT01077713|588470420|FG000|Overall Study|Withdrawal by Subject|1|||
162936461|NCT01077713|588470421|FG001|Overall Study|Withdrawal by Subject|2|||
162936462|NCT01077713|588470420|FG000|Overall Study|Progressive Disease (PD)|0|||
162936463|NCT01077713|588470421|FG001|Overall Study|Progressive Disease (PD)|1|||
162936464|NCT01077713|588470420|FG000|Overall Study|Death|28|||
162936465|NCT01077713|588470421|FG001|Overall Study|Death|29|||
162936466|NCT01077713|588470420|FG000|Overall Study|Lost to Follow-up|1|||
162936467|NCT01077713|588470421|FG001|Overall Study|Lost to Follow-up|1|||
162936468|NCT01077713|588470420|FG000|Overall Study|Adverse Event|2|||
162936469|NCT01077713|588470421|FG001|Overall Study|Adverse Event|1|||
162936470|NCT01077713|588470420|FG000|Overall Study|Other|4|||
162936471|NCT01077713|588470421|FG001|Overall Study|Other|2|||
162936472|NCT04136626|588470422|FG000|Treatment Phase|Withdrawal by Subject|1|||
162936473|NCT04136626|588470423|FG001|Treatment Phase|Withdrawal by Subject|9|||
162936474|NCT04136626|588470422|FG000|Treatment Phase|Adverse Event|1|||
162936475|NCT04136626|588470423|FG001|Treatment Phase|Adverse Event|0|||
162936476|NCT04136626|588470422|FG000|Treatment Phase|Lost to Follow-up|1|||
162936477|NCT04136626|588470423|FG001|Treatment Phase|Lost to Follow-up|5|||
162936478|NCT04136626|588470422|FG000|12-month Follow-up|Lost to Follow-up|8|||
162936479|NCT04136626|588470423|FG001|12-month Follow-up|Lost to Follow-up|7|||
162936480|NCT02049359|588471697|FG000|Overall Study|Lost to Follow-up|26|||
163179427|NCT02445391|589371057|FG002|Overall Study|No active protocol treatment|0|||
163179428|NCT02445391|589371055|FG000|Overall Study|Adverse Event|0|||
162936481|NCT02049359|588471698|FG001|Overall Study|Lost to Follow-up|19|||
162936482|NCT00658320|588471699|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
162936483|NCT00658320|588471700|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
162936484|NCT00658320|588471699|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
162936485|NCT00658320|588471700|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
162936486|NCT00658320|588471699|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
163179429|NCT02445391|589371056|FG001|Overall Study|Adverse Event|21|||
162936487|NCT00658320|588471700|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
162936488|NCT00658320|588471699|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
162936489|NCT00658320|588471700|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
162936490|NCT02410252|588471702|FG000|Overall Study|Withdrawal by Subject|4|||
162936491|NCT02410252|588471702|FG000|Overall Study|Physician Decision|2|||
162936492|NCT01007916|588471706|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
162936493|NCT01007916|588471707|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
162936494|NCT01007916|588471706|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
162936495|NCT01007916|588471707|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
162936496|NCT00387712|588471710|FG000|Overall Study|Physician Decision|6|||
162936497|NCT00387712|588471711|FG001|Overall Study|Physician Decision|4|||
162936498|NCT00387712|588471710|FG000|Overall Study|Lost to Follow-up|17|||
162936499|NCT00387712|588471711|FG001|Overall Study|Lost to Follow-up|20|||
162936500|NCT00387712|588471710|FG000|Overall Study|Withdrawal by Subject|6|||
162936501|NCT00387712|588471711|FG001|Overall Study|Withdrawal by Subject|12|||
162936502|NCT00268346|588471728|FG000|Overall Study|Adverse Event|0|||
162936503|NCT00268346|588471729|FG001|Overall Study|Adverse Event|1|||
162936504|NCT00268346|588471728|FG000|Overall Study|Death|0|||
162936505|NCT00268346|588471729|FG001|Overall Study|Death|1|||
162936506|NCT00268346|588471728|FG000|Overall Study|Withdrawal by Subject|0|||
162936507|NCT00268346|588471729|FG001|Overall Study|Withdrawal by Subject|1|||
162936508|NCT02043366|588471732|FG000|Overall Study|Lost to Follow-up|2|||
162936509|NCT02043366|588471733|FG001|Overall Study|Lost to Follow-up|2|||
162936510|NCT02043366|588471734|FG002|Overall Study|Lost to Follow-up|2|||
162936511|NCT02043366|588471735|FG003|Overall Study|Lost to Follow-up|2|||
162936512|NCT02043366|588471736|FG004|Overall Study|Lost to Follow-up|2|||
162936513|NCT02043366|588471737|FG005|Overall Study|Lost to Follow-up|2|||
162936514|NCT01489956|588471738|FG000|Overall Study|Lost to Follow-up|1|||
162936515|NCT01489956|588471739|FG001|Overall Study|Lost to Follow-up|0|||
162936516|NCT01489956|588471740|FG002|Overall Study|Lost to Follow-up|0|||
162936517|NCT01489956|588471738|FG000|Overall Study|Withdrawal by Subject|0|||
162936518|NCT01489956|588471739|FG001|Overall Study|Withdrawal by Subject|0|||
162936519|NCT01489956|588471740|FG002|Overall Study|Withdrawal by Subject|1|||
162936520|NCT00723554|588471742|FG000|Overall Study|Adverse Event|12|||
162936521|NCT00723554|588471742|FG000|Overall Study|Investigator's judgement|5|||
162936522|NCT00723554|588471742|FG000|Overall Study|Inhaled medication other than iloprost|4|||
162936523|NCT00723554|588471742|FG000|Overall Study|Withdrawal of consent|3|||
162936524|NCT00723554|588471742|FG000|Overall Study|Other|3|||
162936525|NCT00723554|588471742|FG000|Overall Study|Lost to Follow-up|1|||
162936526|NCT00723554|588471742|FG000|Overall Study|Non-compliance|1|||
162936527|NCT01405820|588471743|FG000|Randomized Treatment Period|Adverse Event|3|||
162936528|NCT01405820|588471744|FG001|Randomized Treatment Period|Adverse Event|3|||
162936529|NCT01405820|588471745|FG002|Randomized Treatment Period|Adverse Event|3|||
162936530|NCT01405820|588471746|FG003|Randomized Treatment Period|Adverse Event|0|||
162936531|NCT01405820|588471747|FG004|Randomized Treatment Period|Adverse Event|2|||
162936532|NCT01405820|588471748|FG005|Randomized Treatment Period|Adverse Event|1|||
162936533|NCT01405820|588471743|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
162936534|NCT01405820|588471744|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
162936535|NCT01405820|588471745|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
162936536|NCT01405820|588471746|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
162936537|NCT01405820|588471747|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
162936538|NCT01405820|588471748|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
162936539|NCT01405820|588471743|FG000|Randomized Treatment Period|Other|2|||
162936540|NCT01405820|588471744|FG001|Randomized Treatment Period|Other|2|||
162936541|NCT01405820|588471745|FG002|Randomized Treatment Period|Other|1|||
162936542|NCT01405820|588471746|FG003|Randomized Treatment Period|Other|1|||
162936543|NCT01405820|588471747|FG004|Randomized Treatment Period|Other|0|||
162936544|NCT01405820|588471748|FG005|Randomized Treatment Period|Other|0|||
162936545|NCT01405820|588471743|FG000|Randomized Treatment Period|Physician Decision|0|||
162936546|NCT01405820|588471744|FG001|Randomized Treatment Period|Physician Decision|2|||
162936547|NCT01405820|588471745|FG002|Randomized Treatment Period|Physician Decision|1|||
162936548|NCT01405820|588471746|FG003|Randomized Treatment Period|Physician Decision|0|||
163042836|NCT01990768|588863968|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
162936549|NCT01405820|588471747|FG004|Randomized Treatment Period|Physician Decision|0|||
162936550|NCT01405820|588471748|FG005|Randomized Treatment Period|Physician Decision|0|||
162936551|NCT01405820|588471743|FG000|Randomized Treatment Period|Rescue|0|||
162936552|NCT01405820|588471744|FG001|Randomized Treatment Period|Rescue|1|||
162936553|NCT01405820|588471745|FG002|Randomized Treatment Period|Rescue|13|||
162936554|NCT01405820|588471746|FG003|Randomized Treatment Period|Rescue|10|||
162936555|NCT01405820|588471747|FG004|Randomized Treatment Period|Rescue|8|||
162936556|NCT01405820|588471748|FG005|Randomized Treatment Period|Rescue|8|||
162936557|NCT01405820|588471743|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
163042837|NCT01990768|588863969|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
162936558|NCT01405820|588471744|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936559|NCT01405820|588471745|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
162936560|NCT01405820|588471746|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936561|NCT01405820|588471747|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
162936562|NCT01405820|588471748|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
162936563|NCT01405820|588471743|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
162936564|NCT01405820|588471744|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
162936565|NCT01405820|588471745|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
162936566|NCT01405820|588471746|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
162936567|NCT01405820|588471747|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
162936568|NCT01405820|588471748|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
162936569|NCT01405820|588471743|FG000|Randomized Treatment Period|Death|0|||
162936570|NCT01405820|588471744|FG001|Randomized Treatment Period|Death|0|||
162936571|NCT01405820|588471745|FG002|Randomized Treatment Period|Death|0|||
162936572|NCT01405820|588471746|FG003|Randomized Treatment Period|Death|1|||
162936573|NCT01405820|588471747|FG004|Randomized Treatment Period|Death|0|||
162936574|NCT01405820|588471748|FG005|Randomized Treatment Period|Death|0|||
162936575|NCT01405820|588471743|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936576|NCT01405820|588471744|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936577|NCT01405820|588471745|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936578|NCT01405820|588471746|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
162936579|NCT01405820|588471747|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936580|NCT01405820|588471748|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
162936581|NCT01405820|588471743|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
162936582|NCT01405820|588471744|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936583|NCT01405820|588471745|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936584|NCT01405820|588471746|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936585|NCT01405820|588471747|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
162936586|NCT01405820|588471748|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
162936587|NCT01405820|588471743|FG000|Open-Label Treatment Period|Other|1|||
162936588|NCT01405820|588471744|FG001|Open-Label Treatment Period|Other|1|||
162936589|NCT01405820|588471745|FG002|Open-Label Treatment Period|Other|1|||
162936590|NCT01405820|588471746|FG003|Open-Label Treatment Period|Other|1|||
162936591|NCT01405820|588471747|FG004|Open-Label Treatment Period|Other|1|||
162936592|NCT01405820|588471748|FG005|Open-Label Treatment Period|Other|1|||
162936593|NCT01405820|588471743|FG000|Open-Label Treatment Period|Physician Decision|0|||
162936594|NCT01405820|588471744|FG001|Open-Label Treatment Period|Physician Decision|0|||
162936595|NCT01405820|588471745|FG002|Open-Label Treatment Period|Physician Decision|1|||
162936596|NCT01405820|588471746|FG003|Open-Label Treatment Period|Physician Decision|2|||
162936597|NCT01405820|588471747|FG004|Open-Label Treatment Period|Physician Decision|1|||
162936598|NCT01405820|588471748|FG005|Open-Label Treatment Period|Physician Decision|0|||
162936599|NCT01405820|588471743|FG000|Open-Label Treatment Period|Adverse Event|0|||
162936600|NCT01405820|588471744|FG001|Open-Label Treatment Period|Adverse Event|0|||
162936601|NCT01405820|588471745|FG002|Open-Label Treatment Period|Adverse Event|0|||
162936602|NCT01405820|588471746|FG003|Open-Label Treatment Period|Adverse Event|1|||
162936603|NCT01405820|588471747|FG004|Open-Label Treatment Period|Adverse Event|0|||
162936604|NCT01405820|588471748|FG005|Open-Label Treatment Period|Adverse Event|0|||
162936605|NCT03222141|588471751|FG000|Overall Study|Death|15|||
162936606|NCT03222141|588471751|FG000|Overall Study|Lost to Follow-up|3|||
162936607|NCT01894984|588471755|FG000|Overall Study|Other|314|||
162936608|NCT01894984|588471756|FG001|Overall Study|Other|175|||
162936609|NCT00827359|588471757|FG000|Overall Study|Progressive Diseas|19|||
162936610|NCT00827359|588471757|FG000|Overall Study|Unacceptable Toxicity|5|||
162936611|NCT00827359|588471757|FG000|Overall Study|Ineligible|1|||
162936612|NCT02436135|588471758|FG000|Overall Study|Progressive Disease|3|||
162936613|NCT02436135|588471759|FG001|Overall Study|Progressive Disease|1|||
162936614|NCT02436135|588471758|FG000|Overall Study|Investigator Discretion|1|||
162936615|NCT02436135|588471759|FG001|Overall Study|Investigator Discretion|2|||
162936616|NCT02436135|588471758|FG000|Overall Study|Adverse Event|1|||
162936617|NCT02436135|588471759|FG001|Overall Study|Adverse Event|0|||
162936618|NCT02436135|588471758|FG000|Overall Study|Withdrawal by Participant|1|||
162936619|NCT02436135|588471759|FG001|Overall Study|Withdrawal by Participant|0|||
162936620|NCT02436135|588471758|FG000|Overall Study|Study Terminated By Sponsor|0|||
162936621|NCT02436135|588471759|FG001|Overall Study|Study Terminated By Sponsor|1|||
162936622|NCT01427803|588471760|FG000|Overall Study|Lost to Follow-up|32|||
162936623|NCT01427803|588471761|FG001|Overall Study|Lost to Follow-up|26|||
162936624|NCT01427803|588471760|FG000|Overall Study|Withdrawal by Subject|20|||
162936625|NCT01427803|588471761|FG001|Overall Study|Withdrawal by Subject|0|||
162936626|NCT01427803|588471760|FG000|Overall Study|Unable to complete full treatment period|6|||
162936627|NCT01427803|588471761|FG001|Overall Study|Unable to complete full treatment period|0|||
162936628|NCT01427803|588471760|FG000|Overall Study|Protocol Violation|1|||
162936629|NCT01427803|588471761|FG001|Overall Study|Protocol Violation|0|||
162936630|NCT01427803|588471760|FG000|Overall Study|Physician Decision|3|||
162936631|NCT01427803|588471761|FG001|Overall Study|Physician Decision|0|||
162936632|NCT01427803|588471760|FG000|Overall Study|did not take product|1|||
162936633|NCT01427803|588471761|FG001|Overall Study|did not take product|0|||
162936634|NCT03412019|588471764|FG000|Overall Study|Withdrawal by Subject|1|||
162936635|NCT03412019|588471765|FG001|Overall Study|Withdrawal by Subject|1|||
162936636|NCT00415532|588471767|FG000|Treatment Period|Adverse Event|2|||
162936637|NCT00415532|588471768|FG001|Treatment Period|Adverse Event|3|||
162936638|NCT00415532|588471767|FG000|Treatment Period|Death|2|||
162936639|NCT00415532|588471768|FG001|Treatment Period|Death|1|||
162936640|NCT00415532|588471767|FG000|Treatment Period|Lost to Follow-up|1|||
162936641|NCT00415532|588471768|FG001|Treatment Period|Lost to Follow-up|1|||
162936642|NCT00415532|588471767|FG000|Treatment Period|Protocol Violation|1|||
162936643|NCT00415532|588471768|FG001|Treatment Period|Protocol Violation|0|||
162936644|NCT00415532|588471767|FG000|Treatment Period|Withdrawal by Subject|6|||
162936645|NCT00415532|588471768|FG001|Treatment Period|Withdrawal by Subject|6|||
162936646|NCT00415532|588471767|FG000|Treatment Period|Other|2|||
162936647|NCT00415532|588471768|FG001|Treatment Period|Other|2|||
162936648|NCT00415532|588471767|FG000|Treatment Period|Ineligibility determined|1|||
162936649|NCT00415532|588471768|FG001|Treatment Period|Ineligibility determined|1|||
162936650|NCT00415532|588471767|FG000|Treatment Period|Noncompliance|1|||
162936651|NCT00415532|588471768|FG001|Treatment Period|Noncompliance|1|||
162936652|NCT00415532|588471767|FG000|Treatment Period|Requirement for alternative therapy|1|||
162936653|NCT00415532|588471768|FG001|Treatment Period|Requirement for alternative therapy|0|||
162936654|NCT00415532|588471767|FG000|Safety Follow Up Period|Adverse Event|1|||
162936655|NCT00415532|588471768|FG001|Safety Follow Up Period|Adverse Event|3|||
162936656|NCT00415532|588471767|FG000|Safety Follow Up Period|Death|3|||
162936657|NCT00415532|588471768|FG001|Safety Follow Up Period|Death|0|||
162936658|NCT00415532|588471767|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
162936659|NCT00415532|588471768|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
162936660|NCT00415532|588471767|FG000|Safety Follow Up Period|Other|1|||
162936661|NCT00415532|588471768|FG001|Safety Follow Up Period|Other|4|||
162936662|NCT00415532|588471767|FG000|Safety Follow Up Period|Ineligibility determined|1|||
162936663|NCT00415532|588471768|FG001|Safety Follow Up Period|Ineligibility determined|1|||
162936664|NCT00415532|588471767|FG000|Safety Follow Up Period|Noncompliance|1|||
162936665|NCT00415532|588471768|FG001|Safety Follow Up Period|Noncompliance|0|||
162936666|NCT00415532|588471767|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
162936667|NCT00415532|588471768|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
162936668|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
162936669|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
162936670|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
162936671|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
162936672|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
162936673|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
162936674|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
162936675|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
162936676|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
162936677|NCT01698320|588471769|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
162936678|NCT01698320|588471770|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
162936679|NCT01698320|588471771|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
162936680|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Adverse Event|0|||
162936681|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Adverse Event|1|||
162936682|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Adverse Event|1|||
162936683|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
162936684|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
162936685|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
162936686|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
162936687|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
162936688|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
162936689|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Pregnancy|0|||
162936690|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Pregnancy|1|||
162936691|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Pregnancy|1|||
162936692|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
162936693|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
162936694|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
162936695|NCT01698320|588471769|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
162936696|NCT01698320|588471770|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
162936697|NCT01698320|588471771|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
162936698|NCT01698320|588471769|FG000|40-Week Open-Label Period|Adverse Event|0|||
162936699|NCT01698320|588471770|FG001|40-Week Open-Label Period|Adverse Event|3|||
162936700|NCT01698320|588471771|FG002|40-Week Open-Label Period|Adverse Event|2|||
162936701|NCT01698320|588471769|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
162936702|NCT01698320|588471770|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
162936703|NCT01698320|588471771|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
162936704|NCT01698320|588471769|FG000|40-Week Open-Label Period|Pregnancy|0|||
162936705|NCT01698320|588471770|FG001|40-Week Open-Label Period|Pregnancy|2|||
162936706|NCT01698320|588471771|FG002|40-Week Open-Label Period|Pregnancy|1|||
162936707|NCT01698320|588471769|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
162936708|NCT01698320|588471770|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
162936709|NCT01698320|588471771|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
162936710|NCT01698320|588471769|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
162936711|NCT01698320|588471770|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
162936712|NCT01698320|588471771|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
162936713|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
162936714|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
162936715|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
162936716|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
162936717|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936718|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936719|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162936720|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
163179430|NCT02445391|589371057|FG002|Overall Study|Adverse Event|12|||
163179431|NCT02445391|589371055|FG000|Overall Study|Alternative therapy|0|||
163179432|NCT02445391|589371056|FG001|Overall Study|Alternative therapy|0|||
163179433|NCT02445391|589371057|FG002|Overall Study|Alternative therapy|1|||
163179434|NCT02445391|589371055|FG000|Overall Study|Disease progression|0|||
163179435|NCT02445391|589371056|FG001|Overall Study|Disease progression|7|||
163179436|NCT02445391|589371057|FG002|Overall Study|Disease progression|22|||
163179437|NCT02445391|589371055|FG000|Overall Study|Complicating disease|0|||
163179438|NCT02445391|589371056|FG001|Overall Study|Complicating disease|2|||
163179439|NCT02445391|589371057|FG002|Overall Study|Complicating disease|1|||
163179440|NCT02445391|589371055|FG000|Overall Study|Withdrawal by Subject|0|||
163179441|NCT02445391|589371056|FG001|Overall Study|Withdrawal by Subject|4|||
163179442|NCT02445391|589371057|FG002|Overall Study|Withdrawal by Subject|9|||
163179443|NCT02445391|589371055|FG000|Overall Study|Financial issue|0|||
163179444|NCT02445391|589371056|FG001|Overall Study|Financial issue|0|||
163179445|NCT02445391|589371057|FG002|Overall Study|Financial issue|2|||
162936721|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
162936722|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
162936723|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
162936724|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
162936725|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
163179446|NCT02445391|589371055|FG000|Overall Study|Still on treatment|0|||
163179447|NCT02445391|589371056|FG001|Overall Study|Still on treatment|7|||
163179448|NCT02445391|589371057|FG002|Overall Study|Still on treatment|16|||
163179449|NCT02445391|589371055|FG000|Overall Study|Not start protocol therapy|0|||
163179450|NCT02445391|589371056|FG001|Overall Study|Not start protocol therapy|12|||
163179451|NCT02445391|589371057|FG002|Overall Study|Not start protocol therapy|9|||
163179452|NCT04814654|589371064|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
163179453|NCT04814654|589371065|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
163179454|NCT04814654|589371066|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
163179455|NCT00826540|589371068|FG000|Overall Study|ineligible|3|||
163179456|NCT00826540|589371068|FG000|Overall Study|Withdrawal by Subject|1|||
163179457|NCT03222609|589371266|FG000|Overall Study|Withdrew consent|3|||
163179458|NCT03222609|589371267|FG001|Overall Study|Withdrew consent|9|||
163179459|NCT03222609|589371268|FG002|Overall Study|Withdrew consent|4|||
163179460|NCT03222609|589371269|FG003|Overall Study|Withdrew consent|2|||
162826744|NCT02343159|588077314|FG000|Overall Study|Adverse Event|4|||
162826745|NCT02343159|588077315|FG001|Overall Study|Adverse Event|4|||
162826746|NCT02343159|588077316|FG002|Overall Study|Adverse Event|2|||
162826747|NCT02343159|588077314|FG000|Overall Study|Sponsor Decision|0|||
162826748|NCT02343159|588077315|FG001|Overall Study|Sponsor Decision|1|||
162826749|NCT02343159|588077316|FG002|Overall Study|Sponsor Decision|0|||
162826750|NCT02343159|588077314|FG000|Overall Study|Enrollment Error|1|||
162826751|NCT02343159|588077315|FG001|Overall Study|Enrollment Error|0|||
162826752|NCT02343159|588077316|FG002|Overall Study|Enrollment Error|0|||
162826753|NCT02114268|588077319|FG000|Overall Study|Lost to Follow-up|4|||
162826754|NCT02114268|588077320|FG001|Overall Study|Lost to Follow-up|1|||
162826755|NCT02114268|588077321|FG002|Overall Study|Lost to Follow-up|1|||
162826756|NCT02114268|588077322|FG003|Overall Study|Lost to Follow-up|0|||
162826757|NCT02114268|588077323|FG004|Overall Study|Lost to Follow-up|0|||
162826758|NCT02114268|588077324|FG005|Overall Study|Lost to Follow-up|2|||
162826759|NCT02114268|588077319|FG000|Overall Study|Withdrawal by Subject|1|||
162826760|NCT02114268|588077320|FG001|Overall Study|Withdrawal by Subject|0|||
162826761|NCT02114268|588077321|FG002|Overall Study|Withdrawal by Subject|0|||
162826762|NCT02114268|588077322|FG003|Overall Study|Withdrawal by Subject|0|||
162826763|NCT02114268|588077323|FG004|Overall Study|Withdrawal by Subject|0|||
162826764|NCT02114268|588077324|FG005|Overall Study|Withdrawal by Subject|1|||
162826765|NCT02114268|588077319|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
162826766|NCT02114268|588077320|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
162826767|NCT02114268|588077321|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
162826768|NCT02114268|588077322|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
162826769|NCT02114268|588077323|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
162826770|NCT02114268|588077324|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
162826771|NCT00073528|588077331|FG000|Overall Study|Death|488|||
162826772|NCT00073528|588077332|FG001|Overall Study|Death|473|||
162826773|NCT00073528|588077331|FG000|Overall Study|Lost to Follow-up|52|||
162826774|NCT00073528|588077332|FG001|Overall Study|Lost to Follow-up|45|||
162826775|NCT00073528|588077331|FG000|Overall Study|Withdrawal by Subject|50|||
162826776|NCT00073528|588077332|FG001|Overall Study|Withdrawal by Subject|45|||
162826777|NCT00073528|588077331|FG000|Overall Study|Study terminated by Sponsor|10|||
162826778|NCT00073528|588077332|FG001|Overall Study|Study terminated by Sponsor|29|||
162826779|NCT00073528|588077331|FG000|Overall Study|Other|18|||
162826780|NCT00073528|588077332|FG001|Overall Study|Other|19|||
162826781|NCT00073528|588077331|FG000|Overall Study|Other|9|||
162826782|NCT00073528|588077332|FG001|Overall Study|Other|12|||
162826783|NCT00073528|588077331|FG000|Overall Study|Protocol Violation|3|||
162826784|NCT00073528|588077332|FG001|Overall Study|Protocol Violation|5|||
162826785|NCT04037748|588077337|FG000|Treatment Period 1|Withdrawal by Subject|3|||
162826786|NCT04037748|588077338|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162826787|NCT04037748|588077337|FG000|Treatment Period 1|Adverse Event|1|||
162826788|NCT04037748|588077338|FG001|Treatment Period 1|Adverse Event|1|||
162826789|NCT04037748|588077337|FG000|Treatment Period 1|Protocol Violation|4|||
162826790|NCT04037748|588077338|FG001|Treatment Period 1|Protocol Violation|5|||
162826791|NCT04037748|588077337|FG000|Treatment Period 2|Adverse Event|0|||
162826792|NCT04037748|588077338|FG001|Treatment Period 2|Adverse Event|1|||
162826793|NCT04037748|588077337|FG000|Treatment Period 2|Protocol Violation|2|||
162826794|NCT04037748|588077338|FG001|Treatment Period 2|Protocol Violation|0|||
162826795|NCT01854645|588077339|FG000|Overall Study|Protocol-Specified Criteria|13|||
162826796|NCT01854645|588077340|FG001|Overall Study|Protocol-Specified Criteria|10|||
162826797|NCT01854645|588077341|FG002|Overall Study|Protocol-Specified Criteria|8|||
162826798|NCT01854645|588077342|FG003|Overall Study|Protocol-Specified Criteria|5|||
162826799|NCT01854645|588077343|FG004|Overall Study|Protocol-Specified Criteria|7|||
162826800|NCT01854645|588077339|FG000|Overall Study|Administrative Reasons / Missing|0|||
163042838|NCT01990768|588863970|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
162826801|NCT01854645|588077340|FG001|Overall Study|Administrative Reasons / Missing|0|||
162826802|NCT01854645|588077341|FG002|Overall Study|Administrative Reasons / Missing|0|||
162826803|NCT01854645|588077342|FG003|Overall Study|Administrative Reasons / Missing|1|||
162826804|NCT01854645|588077343|FG004|Overall Study|Administrative Reasons / Missing|1|||
162826805|NCT01854645|588077339|FG000|Overall Study|Protocol Violation|3|||
163179461|NCT03222609|589371266|FG000|Overall Study|Lost to Follow-up|2|||
163179462|NCT03222609|589371267|FG001|Overall Study|Lost to Follow-up|2|||
163179463|NCT03222609|589371268|FG002|Overall Study|Lost to Follow-up|1|||
163179464|NCT03222609|589371269|FG003|Overall Study|Lost to Follow-up|0|||
163179465|NCT03222609|589371266|FG000|Overall Study|Death|20|||
163179466|NCT03222609|589371267|FG001|Overall Study|Death|38|||
163179467|NCT03222609|589371268|FG002|Overall Study|Death|18|||
163179468|NCT03222609|589371269|FG003|Overall Study|Death|10|||
163179469|NCT03222609|589371266|FG000|Overall Study|Other, not specified|9|||
163179470|NCT03222609|589371267|FG001|Overall Study|Other, not specified|42|||
163179471|NCT03222609|589371268|FG002|Overall Study|Other, not specified|11|||
163179472|NCT03222609|589371269|FG003|Overall Study|Other, not specified|20|||
163179473|NCT03961555|589371270|FG000|Overall Study|Lost to Follow-up|0|||
163179474|NCT03961555|589371271|FG001|Overall Study|Lost to Follow-up|0|||
163179475|NCT03961555|589371272|FG002|Overall Study|Lost to Follow-up|1|||
163179476|NCT03961555|589371273|FG003|Overall Study|Lost to Follow-up|0|||
163179477|NCT03961555|589371270|FG000|Overall Study|Withdrawal by Subject|0|||
163179478|NCT03961555|589371271|FG001|Overall Study|Withdrawal by Subject|0|||
162826806|NCT01854645|588077340|FG001|Overall Study|Protocol Violation|0|||
162826807|NCT01854645|588077341|FG002|Overall Study|Protocol Violation|5|||
162826808|NCT01854645|588077342|FG003|Overall Study|Protocol Violation|4|||
162826809|NCT01854645|588077343|FG004|Overall Study|Protocol Violation|1|||
162826810|NCT01854645|588077339|FG000|Overall Study|Lost to Follow-up|10|||
162826811|NCT01854645|588077340|FG001|Overall Study|Lost to Follow-up|7|||
162826812|NCT01854645|588077341|FG002|Overall Study|Lost to Follow-up|8|||
162826813|NCT01854645|588077342|FG003|Overall Study|Lost to Follow-up|5|||
162826814|NCT01854645|588077343|FG004|Overall Study|Lost to Follow-up|0|||
162826815|NCT01854645|588077339|FG000|Overall Study|Physician Decision|1|||
162826816|NCT01854645|588077340|FG001|Overall Study|Physician Decision|5|||
162826817|NCT01854645|588077341|FG002|Overall Study|Physician Decision|3|||
162826818|NCT01854645|588077342|FG003|Overall Study|Physician Decision|3|||
162826819|NCT01854645|588077343|FG004|Overall Study|Physician Decision|7|||
162826820|NCT01854645|588077339|FG000|Overall Study|Withdrawal by Subject|31|||
162826821|NCT01854645|588077340|FG001|Overall Study|Withdrawal by Subject|41|||
162826822|NCT01854645|588077341|FG002|Overall Study|Withdrawal by Subject|30|||
162826823|NCT01854645|588077342|FG003|Overall Study|Withdrawal by Subject|21|||
162826824|NCT01854645|588077343|FG004|Overall Study|Withdrawal by Subject|24|||
162826825|NCT01854645|588077339|FG000|Overall Study|Lack of Efficacy|7|||
162826826|NCT01854645|588077340|FG001|Overall Study|Lack of Efficacy|12|||
162826827|NCT01854645|588077341|FG002|Overall Study|Lack of Efficacy|9|||
162826828|NCT01854645|588077342|FG003|Overall Study|Lack of Efficacy|3|||
162826829|NCT01854645|588077343|FG004|Overall Study|Lack of Efficacy|9|||
162826830|NCT01854645|588077339|FG000|Overall Study|Adverse Event|33|||
162826831|NCT01854645|588077340|FG001|Overall Study|Adverse Event|31|||
162826832|NCT01854645|588077341|FG002|Overall Study|Adverse Event|19|||
162826833|NCT01854645|588077342|FG003|Overall Study|Adverse Event|20|||
162826834|NCT01854645|588077343|FG004|Overall Study|Adverse Event|11|||
162826835|NCT02064920|588077344|FG000|Overall Study|Adverse Event|0|||
162826836|NCT02064920|588077345|FG001|Overall Study|Adverse Event|4|||
162826837|NCT02064920|588077344|FG000|Overall Study|Physician Decision|0|||
162826838|NCT02064920|588077345|FG001|Overall Study|Physician Decision|1|||
162826839|NCT02064920|588077344|FG000|Overall Study|Technical Problems|0|||
162826840|NCT02064920|588077345|FG001|Overall Study|Technical Problems|1|||
162826841|NCT02064920|588077344|FG000|Overall Study|Withdrawal by Subject|1|||
162826842|NCT02064920|588077345|FG001|Overall Study|Withdrawal by Subject|3|||
162826843|NCT02109562|588077346|FG000|Overall Study|Insufficient clinical response|2|||
162826844|NCT02109562|588077347|FG001|Overall Study|Insufficient clinical response|0|||
162826845|NCT02109562|588077348|FG002|Overall Study|Insufficient clinical response|4|||
162826846|NCT02109562|588077346|FG000|Overall Study|Adverse Event|0|||
162826847|NCT02109562|588077347|FG001|Overall Study|Adverse Event|2|||
162826848|NCT02109562|588077348|FG002|Overall Study|Adverse Event|3|||
162826849|NCT02109562|588077346|FG000|Overall Study|Lost to Follow-up|1|||
162826850|NCT02109562|588077347|FG001|Overall Study|Lost to Follow-up|0|||
162826851|NCT02109562|588077348|FG002|Overall Study|Lost to Follow-up|1|||
163179479|NCT03961555|589371272|FG002|Overall Study|Withdrawal by Subject|2|||
163179480|NCT03961555|589371273|FG003|Overall Study|Withdrawal by Subject|4|||
163179481|NCT03961555|589371270|FG000|Overall Study|Death|0|||
163179482|NCT03961555|589371271|FG001|Overall Study|Death|1|||
162826852|NCT02109562|588077346|FG000|Overall Study|Protocol Violation|0|||
162826853|NCT02109562|588077347|FG001|Overall Study|Protocol Violation|3|||
162826854|NCT02109562|588077348|FG002|Overall Study|Protocol Violation|1|||
162826855|NCT02109562|588077346|FG000|Overall Study|Withdrawal by Subject|20|||
163179483|NCT03961555|589371272|FG002|Overall Study|Death|0|||
162826856|NCT02109562|588077347|FG001|Overall Study|Withdrawal by Subject|25|||
162826857|NCT02109562|588077348|FG002|Overall Study|Withdrawal by Subject|21|||
162826858|NCT02109562|588077346|FG000|Overall Study|Physician Decision|3|||
162826859|NCT02109562|588077347|FG001|Overall Study|Physician Decision|4|||
162826860|NCT02109562|588077348|FG002|Overall Study|Physician Decision|5|||
162826861|NCT00262522|588077360|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
163179484|NCT03961555|589371273|FG003|Overall Study|Death|0|||
163179485|NCT03961555|589371270|FG000|Overall Study|Other|0|||
162936726|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
162936727|NCT01952574|588471772|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
162936728|NCT01952574|588471773|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936729|NCT01952574|588471774|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
162936730|NCT01952574|588471775|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936731|NCT01952574|588471776|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936732|NCT01952574|588471777|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936733|NCT01952574|588471778|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
162936734|NCT01952574|588471772|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936735|NCT01952574|588471773|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936736|NCT01952574|588471774|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936737|NCT01952574|588471775|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936738|NCT01952574|588471776|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
162936739|NCT01952574|588471777|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936740|NCT01952574|588471778|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
162936741|NCT01952574|588471772|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
162936742|NCT01952574|588471773|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
162936743|NCT01952574|588471774|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
162936744|NCT01952574|588471775|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
162936745|NCT01952574|588471776|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
162936746|NCT01952574|588471777|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
162936747|NCT01952574|588471778|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
162936748|NCT01952574|588471772|FG000|Open-label Treatment Phase|Missing|0|||
162936749|NCT01952574|588471773|FG001|Open-label Treatment Phase|Missing|0|||
162936750|NCT01952574|588471774|FG002|Open-label Treatment Phase|Missing|0|||
162936751|NCT01952574|588471775|FG003|Open-label Treatment Phase|Missing|0|||
162936752|NCT01952574|588471776|FG004|Open-label Treatment Phase|Missing|4|||
162936753|NCT01952574|588471777|FG005|Open-label Treatment Phase|Missing|0|||
162936754|NCT01952574|588471778|FG006|Open-label Treatment Phase|Missing|0|||
162936755|NCT01952574|588471772|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
162936756|NCT01952574|588471773|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
162936757|NCT01952574|588471774|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
162936758|NCT01952574|588471775|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
162936759|NCT01952574|588471776|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
162936760|NCT01952574|588471777|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
162936761|NCT01952574|588471778|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
162936762|NCT01952574|588471772|FG000|Open-label Treatment Phase|Death|0|||
162936763|NCT01952574|588471773|FG001|Open-label Treatment Phase|Death|0|||
162936764|NCT01952574|588471774|FG002|Open-label Treatment Phase|Death|0|||
162936765|NCT01952574|588471775|FG003|Open-label Treatment Phase|Death|0|||
162936766|NCT01952574|588471776|FG004|Open-label Treatment Phase|Death|1|||
162936767|NCT01952574|588471777|FG005|Open-label Treatment Phase|Death|0|||
162936768|NCT01952574|588471778|FG006|Open-label Treatment Phase|Death|0|||
162936769|NCT01952574|588471772|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
163179486|NCT03961555|589371271|FG001|Overall Study|Other|0|||
163179487|NCT03961555|589371272|FG002|Overall Study|Other|2|||
163179488|NCT03961555|589371273|FG003|Overall Study|Other|2|||
163179489|NCT03961555|589371270|FG000|Overall Study|No treatment received|0|||
163179490|NCT03961555|589371271|FG001|Overall Study|No treatment received|0|||
163179491|NCT03961555|589371272|FG002|Overall Study|No treatment received|1|||
163179492|NCT03961555|589371273|FG003|Overall Study|No treatment received|0|||
163179493|NCT00756509|589371276|FG000|Core Phase|Adverse Event|2|||
163179494|NCT00756509|589371276|FG000|Core Phase|Lack of Efficacy|2|||
163179495|NCT00756509|589371276|FG000|Core Phase|Disease progression|6|||
163179496|NCT00756509|589371276|FG000|Follow-Up Phase|Missing values|2|||
163179497|NCT00756509|589371276|FG000|Follow-Up Phase|Disease progression|9|||
163179498|NCT00756509|589371276|FG000|Follow-Up Phase|Administrative problems|3|||
163179499|NCT00756509|589371276|FG000|Follow-Up Phase|Lost to Follow-up|1|||
163179500|NCT00756509|589371276|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163179501|NCT00756509|589371276|FG000|Follow-Up Phase|Subject's condition no longer requires study drug|1|||
162936770|NCT01952574|588471773|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936771|NCT01952574|588471774|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936772|NCT01952574|588471775|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936773|NCT01952574|588471776|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
163179502|NCT00756509|589371276|FG000|Follow-Up Phase|Adverse Event|7|||
162936774|NCT01952574|588471777|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
163179503|NCT05222555|589371277|FG000|Overall Study|Ongoing|2|||
163179504|NCT05222555|589371278|FG001|Overall Study|Ongoing|18|||
163179505|NCT05222555|589371277|FG000|Overall Study|Adverse Event|1|||
162936775|NCT01952574|588471778|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
162936776|NCT01952574|588471772|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936777|NCT01952574|588471773|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936778|NCT01952574|588471774|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936779|NCT01952574|588471775|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936780|NCT01952574|588471776|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
162936781|NCT01952574|588471777|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
162936782|NCT01952574|588471778|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
162936783|NCT01107535|588471782|FG000|Overall Study|Death|5|||
162936784|NCT03567057|588471783|FG000|Overall Study|Adverse Event|56|||
162936785|NCT03567057|588471784|FG001|Overall Study|Adverse Event|53|||
162936786|NCT03567057|588471785|FG002|Overall Study|Adverse Event|28|||
162936787|NCT03567057|588471783|FG000|Overall Study|Withdrawal by Subject|22|||
162936788|NCT03567057|588471784|FG001|Overall Study|Withdrawal by Subject|24|||
162936789|NCT03567057|588471785|FG002|Overall Study|Withdrawal by Subject|13|||
162936790|NCT03567057|588471783|FG000|Overall Study|Lost to Follow-up|3|||
162936791|NCT03567057|588471784|FG001|Overall Study|Lost to Follow-up|5|||
162936792|NCT03567057|588471785|FG002|Overall Study|Lost to Follow-up|2|||
162936793|NCT03567057|588471783|FG000|Overall Study|COVID-19 pandemic|4|||
162936794|NCT03567057|588471784|FG001|Overall Study|COVID-19 pandemic|3|||
162936795|NCT03567057|588471785|FG002|Overall Study|COVID-19 pandemic|0|||
162936796|NCT03567057|588471783|FG000|Overall Study|Non-compliance with study drug|4|||
162936797|NCT03567057|588471784|FG001|Overall Study|Non-compliance with study drug|2|||
162936798|NCT03567057|588471785|FG002|Overall Study|Non-compliance with study drug|0|||
162936799|NCT03567057|588471783|FG000|Overall Study|Lack of Efficacy|3|||
162936800|NCT03567057|588471784|FG001|Overall Study|Lack of Efficacy|0|||
162936801|NCT03567057|588471785|FG002|Overall Study|Lack of Efficacy|1|||
162936802|NCT03567057|588471783|FG000|Overall Study|Death|1|||
162936803|NCT03567057|588471784|FG001|Overall Study|Death|0|||
162936804|NCT03567057|588471785|FG002|Overall Study|Death|0|||
162936805|NCT03567057|588471783|FG000|Overall Study|Physician Decision|1|||
162936806|NCT03567057|588471784|FG001|Overall Study|Physician Decision|0|||
162936807|NCT03567057|588471785|FG002|Overall Study|Physician Decision|0|||
162936808|NCT03567057|588471783|FG000|Overall Study|Unstable medical condition|1|||
162936809|NCT03567057|588471784|FG001|Overall Study|Unstable medical condition|0|||
162936810|NCT03567057|588471785|FG002|Overall Study|Unstable medical condition|0|||
162936811|NCT03567057|588471783|FG000|Overall Study|Medical history event|0|||
162936812|NCT03567057|588471784|FG001|Overall Study|Medical history event|0|||
162936813|NCT03567057|588471785|FG002|Overall Study|Medical history event|1|||
162936814|NCT03567057|588471783|FG000|Overall Study|Other|0|||
162936815|NCT03567057|588471784|FG001|Overall Study|Other|0|||
162936816|NCT03567057|588471785|FG002|Overall Study|Other|1|||
162936817|NCT01271933|588471786|FG000|Single-Blind Phase|Lack of Efficacy|37|||
162936818|NCT01271933|588471787|FG001|Single-Blind Phase|Lack of Efficacy|0|||
162936819|NCT01271933|588471788|FG002|Single-Blind Phase|Lack of Efficacy|0|||
162936820|NCT01271933|588471786|FG000|Single-Blind Phase|Lost to Follow-up|10|||
162936821|NCT01271933|588471787|FG001|Single-Blind Phase|Lost to Follow-up|0|||
162936822|NCT01271933|588471788|FG002|Single-Blind Phase|Lost to Follow-up|0|||
162936823|NCT01271933|588471786|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
162936824|NCT01271933|588471787|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
162936825|NCT01271933|588471788|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
162936826|NCT01271933|588471786|FG000|Single-Blind Phase|Protocol Violation|3|||
162936827|NCT01271933|588471787|FG001|Single-Blind Phase|Protocol Violation|0|||
162936828|NCT01271933|588471788|FG002|Single-Blind Phase|Protocol Violation|0|||
162936829|NCT01271933|588471786|FG000|Single-Blind Phase|Adverse Event|52|||
162936830|NCT01271933|588471787|FG001|Single-Blind Phase|Adverse Event|0|||
162936831|NCT01271933|588471788|FG002|Single-Blind Phase|Adverse Event|0|||
162936832|NCT01271933|588471786|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
162936833|NCT01271933|588471787|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
162936834|NCT01271933|588471788|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
162936835|NCT01271933|588471786|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
162936836|NCT01271933|588471787|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
162936837|NCT01271933|588471788|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
162936838|NCT01271933|588471786|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
162936839|NCT01271933|588471787|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
162936840|NCT01271933|588471788|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
162936841|NCT01271933|588471786|FG000|Double-Blind Phase|Randomized but not treated|0|||
163179506|NCT05222555|589371278|FG001|Overall Study|Adverse Event|1|||
163179507|NCT05222555|589371277|FG000|Overall Study|Death|0|||
163179508|NCT05222555|589371278|FG001|Overall Study|Death|6|||
163179509|NCT05222555|589371277|FG000|Overall Study|Withdrawal by Subject|0|||
163179510|NCT05222555|589371278|FG001|Overall Study|Withdrawal by Subject|11|||
163179511|NCT03516942|589371285|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
163179512|NCT03516942|589371285|FG000|Registration through baseline survey com|Death|8|||
163179513|NCT03516942|589371285|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
162936842|NCT01271933|588471787|FG001|Double-Blind Phase|Randomized but not treated|0|||
162936843|NCT01271933|588471788|FG002|Double-Blind Phase|Randomized but not treated|1|||
162936844|NCT01271933|588471786|FG000|Double-Blind Phase|Lack of Efficacy|0|||
162936845|NCT01271933|588471787|FG001|Double-Blind Phase|Lack of Efficacy|6|||
162936846|NCT01271933|588471788|FG002|Double-Blind Phase|Lack of Efficacy|9|||
162936847|NCT01271933|588471786|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162936848|NCT01271933|588471787|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162936849|NCT01271933|588471788|FG002|Double-Blind Phase|Lost to Follow-up|1|||
162936850|NCT01271933|588471786|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162936851|NCT01271933|588471787|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
162936852|NCT01271933|588471788|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
162936853|NCT01271933|588471786|FG000|Double-Blind Phase|Adverse Event|0|||
162936854|NCT01271933|588471787|FG001|Double-Blind Phase|Adverse Event|3|||
162936855|NCT01271933|588471788|FG002|Double-Blind Phase|Adverse Event|0|||
162936856|NCT01271933|588471786|FG000|Double-Blind Phase|Participant request-personal reason|0|||
162936857|NCT01271933|588471787|FG001|Double-Blind Phase|Participant request-personal reason|1|||
162936858|NCT01271933|588471788|FG002|Double-Blind Phase|Participant request-personal reason|0|||
162936859|NCT01620983|588471789|FG000|Overall Study|Lost to Follow-up|8|||
162936860|NCT01620983|588471790|FG001|Overall Study|Lost to Follow-up|4|||
162936861|NCT01620983|588471791|FG002|Overall Study|Lost to Follow-up|9|||
162936862|NCT01620983|588471789|FG000|Overall Study|Withdrawal by Subject|6|||
162936863|NCT01620983|588471790|FG001|Overall Study|Withdrawal by Subject|8|||
162936864|NCT01620983|588471791|FG002|Overall Study|Withdrawal by Subject|1|||
162936865|NCT01620983|588471789|FG000|Overall Study|Death|2|||
162936866|NCT01620983|588471790|FG001|Overall Study|Death|0|||
162936867|NCT01620983|588471791|FG002|Overall Study|Death|0|||
162936868|NCT01620983|588471789|FG000|Overall Study|Physician Decision|3|||
162936869|NCT01620983|588471790|FG001|Overall Study|Physician Decision|10|||
162936870|NCT01620983|588471791|FG002|Overall Study|Physician Decision|5|||
162936871|NCT03156270|588471794|FG000|Overall Study|Failed pre-treatment screening|1|||
162936872|NCT03156270|588471794|FG000|Overall Study|Lost to Follow-up|1|||
162936873|NCT00591253|588471795|FG000|Overall Study|Adverse Event|3|||
162936874|NCT00591253|588471796|FG001|Overall Study|Adverse Event|3|||
162936875|NCT00591253|588471797|FG002|Overall Study|Adverse Event|1|||
162936876|NCT00591253|588471795|FG000|Overall Study|Protocol Violation|2|||
162936877|NCT00591253|588471796|FG001|Overall Study|Protocol Violation|2|||
162936878|NCT00591253|588471797|FG002|Overall Study|Protocol Violation|2|||
162936879|NCT00591253|588471795|FG000|Overall Study|Lost to Follow-up|2|||
162936880|NCT00591253|588471796|FG001|Overall Study|Lost to Follow-up|4|||
162936881|NCT00591253|588471797|FG002|Overall Study|Lost to Follow-up|0|||
162936882|NCT00591253|588471795|FG000|Overall Study|Withdrawal by Subject|1|||
162936883|NCT00591253|588471796|FG001|Overall Study|Withdrawal by Subject|7|||
162936884|NCT00591253|588471797|FG002|Overall Study|Withdrawal by Subject|6|||
162936885|NCT00591253|588471795|FG000|Overall Study|Lack of Efficacy|1|||
162936886|NCT00591253|588471796|FG001|Overall Study|Lack of Efficacy|0|||
162936887|NCT00591253|588471797|FG002|Overall Study|Lack of Efficacy|3|||
162936888|NCT00591253|588471795|FG000|Overall Study|Other|5|||
162936889|NCT00591253|588471796|FG001|Overall Study|Other|5|||
162936890|NCT00591253|588471797|FG002|Overall Study|Other|3|||
162936891|NCT01783730|588471801|FG000|Overall Study|Failed to meet inclusion criteria|6|||
162936892|NCT01841359|588471802|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
162936893|NCT01841359|588471802|FG000|Overall Study|Concommitant medical issues|2|||
162936894|NCT01841359|588471802|FG000|Overall Study|Adverse Event|3|||
163179514|NCT03516942|589371285|FG000|T0: Baseline|LOST|13|||
163179515|NCT03516942|589371285|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
163179516|NCT03516942|589371285|FG000|T1: 3 Months Survey|Death|10|||
163179517|NCT03516942|589371285|FG000|T1: 3 Months Survey|Lost|163|||
163179518|NCT03516942|589371285|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
163179519|NCT03516942|589371285|FG000|T2: 6 Month Survey|Death|14|||
163179520|NCT03516942|589371285|FG000|T2: 6 Month Survey|Lost|180|||
163179521|NCT03516942|589371285|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
163179522|NCT03516942|589371285|FG000|T3: 12 Month Survey|Death|19|||
163179523|NCT03516942|589371285|FG000|T3: 12 Month Survey|Lost|209|||
162936895|NCT01841359|588471802|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
162936896|NCT00871169|588471803|FG000|Overall Study|Protocol Violation|1|||
162936897|NCT00871169|588471803|FG000|Overall Study|Patient did not receive study treatment|2|||
162936898|NCT00252187|588471804|FG000|Overall Study|Adverse Event|3|||
162936899|NCT00252187|588471805|FG001|Overall Study|Adverse Event|1|||
162936900|NCT00252187|588471804|FG000|Overall Study|Withdrawal by Subject|1|||
162826862|NCT00262522|588077361|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
162826863|NCT00262522|588077362|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
162826864|NCT00262522|588077363|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
162826865|NCT00262522|588077360|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
162826866|NCT00262522|588077361|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
162826867|NCT00262522|588077362|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
162826868|NCT00262522|588077363|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
162826869|NCT00262522|588077360|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
162826870|NCT00262522|588077361|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
162826871|NCT00262522|588077362|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
162826872|NCT00262522|588077363|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
162826873|NCT00262522|588077360|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
162826874|NCT00262522|588077361|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
162826875|NCT00262522|588077362|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
162826876|NCT00262522|588077363|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
162826877|NCT00262522|588077360|FG000|Study Start Through 8 Weeks|Death|1|||
162826878|NCT00262522|588077361|FG001|Study Start Through 8 Weeks|Death|0|||
162826879|NCT00262522|588077362|FG002|Study Start Through 8 Weeks|Death|0|||
162826880|NCT00262522|588077363|FG003|Study Start Through 8 Weeks|Death|0|||
162826881|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
162826882|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
162826883|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
162826884|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
162826885|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
162826886|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
162826887|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
162826888|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
162826889|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
162826890|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
162826891|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
162826892|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
162826893|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
162826894|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
162826895|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
162826896|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
162826897|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Death|2|||
162826898|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Death|0|||
162826899|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Death|1|||
162826900|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Death|0|||
162826901|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
162826902|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
162826903|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
162826904|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
162826905|NCT00262522|588077360|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
162826906|NCT00262522|588077361|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
162826907|NCT00262522|588077362|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
162826908|NCT00262522|588077363|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
162826909|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
162826910|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
162826911|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
162826912|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
162826913|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
162826914|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
162826915|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
162826916|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
162826917|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
162826918|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
162826919|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
162826920|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
162826921|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
162826922|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
162826923|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
162826924|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
162826925|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Death|2|||
162826926|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Death|0|||
162826927|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Death|2|||
162826928|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Death|0|||
162826929|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
162826930|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
162826931|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
162826932|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
162826933|NCT00262522|588077360|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
162826934|NCT00262522|588077361|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
162826935|NCT00262522|588077362|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
162826936|NCT00262522|588077363|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
162826937|NCT05318937|588077368|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162826938|NCT05318937|588077369|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162826939|NCT05318937|588077368|FG000|Overall Study|Lost to Follow-up|0|||
162826940|NCT05318937|588077369|FG001|Overall Study|Lost to Follow-up|1|||
162826941|NCT05318937|588077368|FG000|Overall Study|Withdrawal by Subject|0|||
162826942|NCT05318937|588077369|FG001|Overall Study|Withdrawal by Subject|2|||
162826943|NCT05318937|588077368|FG000|Overall Study|Protocol Violation|0|||
162826944|NCT05318937|588077369|FG001|Overall Study|Protocol Violation|1|||
162826945|NCT04722042|588077370|FG000|Overall Study|Withdrawal by Subject|2|||
162826946|NCT04722042|588077371|FG001|Overall Study|Withdrawal by Subject|1|||
162826947|NCT04722042|588077372|FG002|Overall Study|Withdrawal by Subject|0|||
162826948|NCT01877915|588077380|FG000|Overall Study|Lost to Follow-up|10|||
162826949|NCT01877915|588077381|FG001|Overall Study|Lost to Follow-up|9|||
162826950|NCT01877915|588077380|FG000|Overall Study|Withdrawal by Subject|42|||
162826951|NCT01877915|588077381|FG001|Overall Study|Withdrawal by Subject|55|||
162826952|NCT01877915|588077380|FG000|Overall Study|Other|2|||
162826953|NCT01877915|588077381|FG001|Overall Study|Other|4|||
162826954|NCT01045798|588077386|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
162826955|NCT01045798|588077387|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
162826956|NCT01045798|588077386|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
162826957|NCT01045798|588077387|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
162826958|NCT01045798|588077386|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
162826959|NCT01045798|588077387|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
162826960|NCT01045798|588077386|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
162826961|NCT01045798|588077387|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
162826962|NCT01449461|588077388|FG000|Overall Study|Adverse Event|0|||
162826963|NCT01449461|588077389|FG001|Overall Study|Adverse Event|3|||
162826964|NCT01449461|588077390|FG002|Overall Study|Adverse Event|2|||
162826965|NCT01449461|588077391|FG003|Overall Study|Adverse Event|3|||
162826966|NCT01449461|588077392|FG004|Overall Study|Adverse Event|4|||
162826967|NCT01449461|588077393|FG005|Overall Study|Adverse Event|4|||
162826968|NCT01449461|588077388|FG000|Overall Study|Death|0|||
162826969|NCT01449461|588077389|FG001|Overall Study|Death|2|||
162826970|NCT01449461|588077390|FG002|Overall Study|Death|0|||
162826971|NCT01449461|588077391|FG003|Overall Study|Death|0|||
162826972|NCT01449461|588077392|FG004|Overall Study|Death|7|||
162826973|NCT01449461|588077393|FG005|Overall Study|Death|1|||
162826974|NCT01449461|588077388|FG000|Overall Study|Physician Decision|0|||
162826975|NCT01449461|588077389|FG001|Overall Study|Physician Decision|1|||
162826976|NCT01449461|588077390|FG002|Overall Study|Physician Decision|0|||
162826977|NCT01449461|588077391|FG003|Overall Study|Physician Decision|4|||
162826978|NCT01449461|588077392|FG004|Overall Study|Physician Decision|1|||
162826979|NCT01449461|588077393|FG005|Overall Study|Physician Decision|0|||
162826980|NCT01449461|588077388|FG000|Overall Study|Documented Progressive Disease|4|||
162826981|NCT01449461|588077389|FG001|Overall Study|Documented Progressive Disease|7|||
162826982|NCT01449461|588077390|FG002|Overall Study|Documented Progressive Disease|14|||
162826983|NCT01449461|588077391|FG003|Overall Study|Documented Progressive Disease|15|||
162826984|NCT01449461|588077392|FG004|Overall Study|Documented Progressive Disease|24|||
162826985|NCT01449461|588077393|FG005|Overall Study|Documented Progressive Disease|5|||
162826986|NCT01449461|588077388|FG000|Overall Study|Clinical Progressive Disease|2|||
162826987|NCT01449461|588077389|FG001|Overall Study|Clinical Progressive Disease|2|||
162826988|NCT01449461|588077390|FG002|Overall Study|Clinical Progressive Disease|0|||
162826989|NCT01449461|588077391|FG003|Overall Study|Clinical Progressive Disease|3|||
162826990|NCT01449461|588077392|FG004|Overall Study|Clinical Progressive Disease|4|||
162826991|NCT01449461|588077393|FG005|Overall Study|Clinical Progressive Disease|2|||
162826992|NCT01449461|588077388|FG000|Overall Study|Protocol Violation|0|||
162826993|NCT01449461|588077389|FG001|Overall Study|Protocol Violation|0|||
162826994|NCT01449461|588077390|FG002|Overall Study|Protocol Violation|0|||
162826995|NCT01449461|588077391|FG003|Overall Study|Protocol Violation|1|||
162826996|NCT01449461|588077392|FG004|Overall Study|Protocol Violation|0|||
162826997|NCT01449461|588077393|FG005|Overall Study|Protocol Violation|0|||
162826998|NCT01449461|588077388|FG000|Overall Study|Site Terminated by Sponsor|0|||
162826999|NCT01449461|588077389|FG001|Overall Study|Site Terminated by Sponsor|1|||
162827000|NCT01449461|588077390|FG002|Overall Study|Site Terminated by Sponsor|2|||
162827001|NCT01449461|588077391|FG003|Overall Study|Site Terminated by Sponsor|3|||
162827002|NCT01449461|588077392|FG004|Overall Study|Site Terminated by Sponsor|4|||
162827003|NCT01449461|588077393|FG005|Overall Study|Site Terminated by Sponsor|1|||
162827004|NCT01449461|588077388|FG000|Overall Study|Withdrawal by Subject|0|||
162827005|NCT01449461|588077389|FG001|Overall Study|Withdrawal by Subject|1|||
162827006|NCT01449461|588077390|FG002|Overall Study|Withdrawal by Subject|0|||
162827007|NCT01449461|588077391|FG003|Overall Study|Withdrawal by Subject|0|||
162827008|NCT01449461|588077392|FG004|Overall Study|Withdrawal by Subject|2|||
162827009|NCT01449461|588077393|FG005|Overall Study|Withdrawal by Subject|1|||
162827010|NCT01449461|588077388|FG000|Overall Study|Reason not Specified|0|||
162827011|NCT01449461|588077389|FG001|Overall Study|Reason not Specified|1|||
162827012|NCT01449461|588077390|FG002|Overall Study|Reason not Specified|0|||
162827013|NCT01449461|588077391|FG003|Overall Study|Reason not Specified|3|||
162827014|NCT01449461|588077392|FG004|Overall Study|Reason not Specified|2|||
162827015|NCT01449461|588077393|FG005|Overall Study|Reason not Specified|1|||
162827016|NCT05314517|588077394|FG000|Double-blind Period|Adverse Event|4|||
162827017|NCT05314517|588077395|FG001|Double-blind Period|Adverse Event|0|||
162827018|NCT05314517|588077396|FG002|Double-blind Period|Adverse Event|0|||
162827019|NCT05314517|588077397|FG003|Double-blind Period|Adverse Event|0|||
162827020|NCT05314517|588077394|FG000|Double-blind Period|Noncompliance|0|||
162827021|NCT05314517|588077395|FG001|Double-blind Period|Noncompliance|1|||
162827022|NCT05314517|588077396|FG002|Double-blind Period|Noncompliance|0|||
162827023|NCT05314517|588077397|FG003|Double-blind Period|Noncompliance|0|||
162827024|NCT05314517|588077394|FG000|Double-blind Period|Randomized, not treated|1|||
162827025|NCT05314517|588077395|FG001|Double-blind Period|Randomized, not treated|0|||
162827026|NCT05314517|588077396|FG002|Double-blind Period|Randomized, not treated|0|||
162827027|NCT05314517|588077397|FG003|Double-blind Period|Randomized, not treated|0|||
162827028|NCT05314517|588077394|FG000|Open-label Extension|Adverse Event|0|||
162827029|NCT05314517|588077395|FG001|Open-label Extension|Adverse Event|0|||
162827030|NCT05314517|588077396|FG002|Open-label Extension|Adverse Event|1|||
162827031|NCT05314517|588077397|FG003|Open-label Extension|Adverse Event|2|||
162827032|NCT05314517|588077394|FG000|Open-label Extension|Investigator decision|0|||
162827033|NCT05314517|588077395|FG001|Open-label Extension|Investigator decision|0|||
162827034|NCT05314517|588077396|FG002|Open-label Extension|Investigator decision|1|||
162827035|NCT05314517|588077397|FG003|Open-label Extension|Investigator decision|0|||
162936901|NCT00252187|588471805|FG001|Overall Study|Withdrawal by Subject|0|||
162827036|NCT05314517|588077394|FG000|Open-label Extension|Lost to Follow-up|0|||
162827037|NCT05314517|588077395|FG001|Open-label Extension|Lost to Follow-up|0|||
162827038|NCT05314517|588077396|FG002|Open-label Extension|Lost to Follow-up|0|||
162827039|NCT05314517|588077397|FG003|Open-label Extension|Lost to Follow-up|1|||
162827040|NCT05314517|588077394|FG000|Open-label Extension|Withdrawal by Subject|0|||
162827041|NCT05314517|588077395|FG001|Open-label Extension|Withdrawal by Subject|0|||
162827042|NCT05314517|588077396|FG002|Open-label Extension|Withdrawal by Subject|1|||
162827043|NCT05314517|588077397|FG003|Open-label Extension|Withdrawal by Subject|2|||
162827044|NCT05314517|588077394|FG000|Open-label Extension|Use of prohibited medication|0|||
162827045|NCT05314517|588077395|FG001|Open-label Extension|Use of prohibited medication|0|||
162827046|NCT05314517|588077396|FG002|Open-label Extension|Use of prohibited medication|1|||
162827047|NCT05314517|588077397|FG003|Open-label Extension|Use of prohibited medication|0|||
162827048|NCT05314517|588077394|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
162827049|NCT05314517|588077395|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
162827050|NCT05314517|588077396|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
162827051|NCT05314517|588077397|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
162827052|NCT05050318|588078472|FG000|Overall Study|Protocol Deviation|1|||
162827053|NCT05050318|588078473|FG001|Overall Study|Protocol Deviation|0|||
162827054|NCT05050318|588078474|FG002|Overall Study|Protocol Deviation|0|||
162827055|NCT04259411|588078475|FG000|Overall Study|Death|1|||
162827056|NCT04259411|588078475|FG000|Overall Study|Missed visit|2|||
162827057|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
162827058|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
162827059|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
162827060|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
162827061|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
162827062|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
162827063|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Death|2|||
162827064|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Death|0|||
162827065|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
162827066|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
162827067|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
162827068|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
162827069|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
162827070|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
162827071|NCT02603120|588078481|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
162827072|NCT02603120|588078482|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
162827073|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
162827074|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
162827075|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
162827076|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
162827077|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
162827078|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
162827079|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
162827080|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
162827081|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
162827082|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
162827083|NCT02603120|588078481|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
162827084|NCT02603120|588078482|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
162827085|NCT00916357|588078484|FG000|Period 1|Withdrawal by Subject|1|||
162827086|NCT00916357|588078485|FG001|Period 1|Withdrawal by Subject|0|||
162827087|NCT00916357|588078486|FG002|Period 1|Withdrawal by Subject|0|||
162827088|NCT00916357|588078487|FG003|Period 1|Withdrawal by Subject|0|||
162827089|NCT00916357|588078488|FG004|Period 1|Withdrawal by Subject|0|||
162827090|NCT00916357|588078489|FG005|Period 1|Withdrawal by Subject|0|||
162827091|NCT00916357|588078484|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
162827092|NCT00916357|588078485|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
162827093|NCT00916357|588078486|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
162827094|NCT00916357|588078487|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
162936902|NCT00593333|588471808|FG000|Overall Study|Lost to Follow-up|10|||
162936903|NCT00593333|588471809|FG001|Overall Study|Lost to Follow-up|11|||
162936904|NCT01752920|588471810|FG000|Overall Study|Adverse Event|1|||
162936905|NCT01752920|588471811|FG001|Overall Study|Adverse Event|0|||
162936906|NCT01752920|588471812|FG002|Overall Study|Adverse Event|5|||
162936907|NCT01752920|588471813|FG003|Overall Study|Adverse Event|10|||
162936908|NCT01752920|588471810|FG000|Overall Study|Clinical Disease Progression|6|||
162936909|NCT01752920|588471811|FG001|Overall Study|Clinical Disease Progression|4|||
162936910|NCT01752920|588471812|FG002|Overall Study|Clinical Disease Progression|1|||
162936911|NCT01752920|588471813|FG003|Overall Study|Clinical Disease Progression|13|||
162936912|NCT01752920|588471810|FG000|Overall Study|Physician Decision|1|||
162936913|NCT01752920|588471811|FG001|Overall Study|Physician Decision|0|||
162936914|NCT01752920|588471812|FG002|Overall Study|Physician Decision|0|||
162936915|NCT01752920|588471813|FG003|Overall Study|Physician Decision|3|||
162936916|NCT01752920|588471810|FG000|Overall Study|Radiographic Disease Progression|20|||
162936917|NCT01752920|588471811|FG001|Overall Study|Radiographic Disease Progression|7|||
162936918|NCT01752920|588471812|FG002|Overall Study|Radiographic Disease Progression|12|||
162936919|NCT01752920|588471813|FG003|Overall Study|Radiographic Disease Progression|29|||
162936920|NCT01752920|588471810|FG000|Overall Study|Study Terminated by Sponsor|0|||
162936921|NCT01752920|588471811|FG001|Overall Study|Study Terminated by Sponsor|0|||
162936922|NCT01752920|588471812|FG002|Overall Study|Study Terminated by Sponsor|0|||
162936923|NCT01752920|588471813|FG003|Overall Study|Study Terminated by Sponsor|1|||
162936924|NCT01752920|588471810|FG000|Overall Study|Withdrawal by Subject|0|||
162936925|NCT01752920|588471811|FG001|Overall Study|Withdrawal by Subject|1|||
162936926|NCT01752920|588471812|FG002|Overall Study|Withdrawal by Subject|0|||
162936927|NCT01752920|588471813|FG003|Overall Study|Withdrawal by Subject|1|||
162936928|NCT01752920|588471810|FG000|Overall Study|Lack of clinical benefit|1|||
162936929|NCT01752920|588471811|FG001|Overall Study|Lack of clinical benefit|1|||
162936930|NCT01752920|588471812|FG002|Overall Study|Lack of clinical benefit|1|||
162936931|NCT01752920|588471813|FG003|Overall Study|Lack of clinical benefit|1|||
162936932|NCT00947856|588471814|FG000|Treatment Period|Progressive Disease|33|||
162936933|NCT00947856|588471815|FG001|Treatment Period|Progressive Disease|12|||
162936934|NCT00947856|588471814|FG000|Treatment Period|Adverse Event|15|||
162936935|NCT00947856|588471815|FG001|Treatment Period|Adverse Event|9|||
162936936|NCT00947856|588471814|FG000|Treatment Period|Physician Decision|14|||
162936937|NCT00947856|588471815|FG001|Treatment Period|Physician Decision|6|||
162936938|NCT00947856|588471814|FG000|Treatment Period|Study Stopped by Sponsor|4|||
162936939|NCT00947856|588471815|FG001|Treatment Period|Study Stopped by Sponsor|4|||
162936940|NCT00947856|588471814|FG000|Treatment Period|Withdrawal by Subject|12|||
162936941|NCT00947856|588471815|FG001|Treatment Period|Withdrawal by Subject|1|||
162936942|NCT00947856|588471814|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
162936943|NCT00947856|588471815|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
162936944|NCT00947856|588471814|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
162936945|NCT00947856|588471815|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
162936946|NCT00947856|588471814|FG000|Follow-up Period|Lost to Follow-up|7|||
162936947|NCT00947856|588471815|FG001|Follow-up Period|Lost to Follow-up|0|||
162936948|NCT00947856|588471814|FG000|Follow-up Period|Patient unavailable for site visits|1|||
162936949|NCT00947856|588471815|FG001|Follow-up Period|Patient unavailable for site visits|0|||
162936950|NCT00947856|588471814|FG000|Follow-up Period|Withdrawal by Subject|1|||
162936951|NCT00947856|588471815|FG001|Follow-up Period|Withdrawal by Subject|0|||
162936952|NCT00771901|588471818|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
162936953|NCT00771901|588471819|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
162936954|NCT00771901|588471820|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
162936955|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
162936956|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
162936957|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
162936958|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
162936959|NCT01328054|588471823|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
162936960|NCT01328054|588471824|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
162936961|NCT01855126|588471825|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
162936962|NCT01855126|588471826|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
162936963|NCT01855126|588471825|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162936964|NCT01855126|588471826|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162936965|NCT01298596|588471829|FG000|Overall Study|Withdrawal by Subject|1|||
162936966|NCT01298596|588471830|FG001|Overall Study|Withdrawal by Subject|1|||
162936967|NCT01298596|588471829|FG000|Overall Study|Death|5|||
162936968|NCT01298596|588471830|FG001|Overall Study|Death|3|||
162936969|NCT01298596|588471829|FG000|Overall Study|Lost to Follow-up|6|||
162936970|NCT01298596|588471830|FG001|Overall Study|Lost to Follow-up|14|||
162936971|NCT01298596|588471829|FG000|Overall Study|Referred for further management|16|||
162936972|NCT01298596|588471830|FG001|Overall Study|Referred for further management|15|||
162936973|NCT01629693|588471831|FG000|Overall Study|Lost to Follow-up|2|||
162936974|NCT01629693|588471832|FG001|Overall Study|Lost to Follow-up|4|||
162936975|NCT01629693|588471831|FG000|Overall Study|Withdrawal by Subject|2|||
162936976|NCT01629693|588471832|FG001|Overall Study|Withdrawal by Subject|2|||
162936977|NCT01629693|588471831|FG000|Overall Study|Adverse Event|1|||
162936978|NCT01629693|588471832|FG001|Overall Study|Adverse Event|0|||
162936979|NCT01629693|588471831|FG000|Overall Study|Investigator decision|0|||
162936980|NCT01629693|588471832|FG001|Overall Study|Investigator decision|1|||
162936981|NCT01629693|588471831|FG000|Overall Study|Poor comfort of study lenses|0|||
162936982|NCT01629693|588471832|FG001|Overall Study|Poor comfort of study lenses|2|||
162936983|NCT01629693|588471831|FG000|Overall Study|Subject decision unrelated to AE|0|||
162936984|NCT01629693|588471832|FG001|Overall Study|Subject decision unrelated to AE|1|||
162936985|NCT03740100|588471833|FG000|Overall Study|Adverse Event|1|||
162936986|NCT03740100|588471833|FG000|Overall Study|Death|1|||
162936987|NCT00254397|588471839|FG000|Overall Study|Disease Progression|4|||
162936988|NCT00254397|588471840|FG001|Overall Study|Disease Progression|1|||
162936989|NCT00254397|588471841|FG002|Overall Study|Disease Progression|16|||
162936990|NCT00254397|588471842|FG003|Overall Study|Disease Progression|23|||
162936991|NCT00254397|588471839|FG000|Overall Study|Non-Compliant|0|||
162936992|NCT00254397|588471840|FG001|Overall Study|Non-Compliant|0|||
162936993|NCT00254397|588471841|FG002|Overall Study|Non-Compliant|0|||
162936994|NCT00254397|588471842|FG003|Overall Study|Non-Compliant|1|||
162936995|NCT00254397|588471839|FG000|Overall Study|Adverse Event|2|||
162936996|NCT00254397|588471840|FG001|Overall Study|Adverse Event|0|||
162936997|NCT00254397|588471841|FG002|Overall Study|Adverse Event|3|||
162936998|NCT00254397|588471842|FG003|Overall Study|Adverse Event|1|||
162936999|NCT01715415|588471846|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
162937000|NCT01715415|588471847|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
162937001|NCT01715415|588471846|FG000|Double-blind Treatment|Adverse Event|3|||
162937002|NCT01715415|588471847|FG001|Double-blind Treatment|Adverse Event|0|||
162937003|NCT01715415|588471846|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
162937004|NCT01715415|588471847|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
162937005|NCT01715415|588471846|FG000|Double-blind Treatment|Other|1|||
162937006|NCT01715415|588471847|FG001|Double-blind Treatment|Other|0|||
162937007|NCT01715415|588471846|FG000|Open-label Treatment|Adverse Event|0|||
162937008|NCT01715415|588471847|FG001|Open-label Treatment|Adverse Event|1|||
162937009|NCT01715415|588471846|FG000|Open-label Treatment|Subject Noncompliant|0|||
162937010|NCT01715415|588471847|FG001|Open-label Treatment|Subject Noncompliant|1|||
162937011|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162937012|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162937013|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
162937014|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
162937015|NCT04578548|588471848|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
162937016|NCT04578548|588471849|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162937017|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
162937018|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
162937019|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
162937020|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162937021|NCT04578548|588471848|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
162937022|NCT04578548|588471849|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
162937023|NCT02224456|588473473|FG000|Overall Study|Lack of Efficacy|1|||
162937024|NCT02224456|588473473|FG000|Overall Study|Lost to Follow-up|15|||
162937025|NCT02224456|588473473|FG000|Overall Study|Withdrawal by Subject|9|||
162937026|NCT02224456|588473473|FG000|Overall Study|Physician Decision|3|||
162937027|NCT02224456|588473473|FG000|Overall Study|Death|2|||
162937028|NCT02224456|588473473|FG000|Overall Study|Pregnancy|4|||
162937029|NCT02224456|588473473|FG000|Overall Study|Protocol Violation|1|||
162937030|NCT02224456|588473473|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
162937031|NCT01241461|588473474|FG000|Overall Study|Progressive Disease|3|||
162937032|NCT01241461|588473475|FG001|Overall Study|Progressive Disease|6|||
162937033|NCT01379781|588473476|FG000|Overall Study|Lost to Follow-up|11|||
162937034|NCT01379781|588473477|FG001|Overall Study|Lost to Follow-up|8|||
162937035|NCT02247479|588473478|FG000|Overall Study|Adverse Event|8|||
162937036|NCT02247479|588473479|FG001|Overall Study|Adverse Event|9|||
162937037|NCT02247479|588473480|FG002|Overall Study|Adverse Event|8|||
162937038|NCT02247479|588473478|FG000|Overall Study|Death|5|||
162937039|NCT02247479|588473479|FG001|Overall Study|Death|4|||
162937040|NCT02247479|588473480|FG002|Overall Study|Death|6|||
162937041|NCT02247479|588473478|FG000|Overall Study|Lost to Follow-up|3|||
162937042|NCT02247479|588473479|FG001|Overall Study|Lost to Follow-up|3|||
162937043|NCT02247479|588473480|FG002|Overall Study|Lost to Follow-up|1|||
162827095|NCT00916357|588078488|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
162827096|NCT00916357|588078489|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
162827097|NCT03807349|588078492|FG000|Overall Study|Early Study Termination|9|||
162827098|NCT05807464|588078495|FG000|Overall Study|Adverse Event|1|||
162827099|NCT04451161|588078496|FG000|Overall Study|Lost to Follow-up|28|||
162827100|NCT04451161|588078497|FG001|Overall Study|Lost to Follow-up|37|||
162827101|NCT04451161|588078498|FG002|Overall Study|Lost to Follow-up|22|||
162827102|NCT04451161|588078499|FG003|Overall Study|Lost to Follow-up|13|||
162827103|NCT04451161|588078500|FG004|Overall Study|Lost to Follow-up|11|||
162827104|NCT04451161|588078501|FG005|Overall Study|Lost to Follow-up|14|||
162827105|NCT04451161|588078496|FG000|Overall Study|Withdrawal by Subject|3|||
162827106|NCT04451161|588078497|FG001|Overall Study|Withdrawal by Subject|0|||
162827107|NCT04451161|588078498|FG002|Overall Study|Withdrawal by Subject|0|||
162827108|NCT04451161|588078499|FG003|Overall Study|Withdrawal by Subject|0|||
162827109|NCT04451161|588078500|FG004|Overall Study|Withdrawal by Subject|2|||
162827110|NCT04451161|588078501|FG005|Overall Study|Withdrawal by Subject|4|||
162827111|NCT00596947|588078502|FG000|Overall Study|study halted due to low enrollment|5|||
162827112|NCT00596947|588078503|FG001|Overall Study|study halted due to low enrollment|3|||
162827113|NCT00596947|588078502|FG000|Overall Study|Lost to Follow-up|1|||
162827114|NCT00596947|588078503|FG001|Overall Study|Lost to Follow-up|0|||
162827115|NCT03000179|588078504|FG000|Overall Study|Lost to Follow-up|2|||
162827116|NCT01431274|588078510|FG000|Overall Study|Adverse Event|51|||
162827117|NCT01431274|588078511|FG001|Overall Study|Adverse Event|37|||
162827118|NCT01431274|588078512|FG002|Overall Study|Adverse Event|43|||
162827119|NCT01431274|588078513|FG003|Overall Study|Adverse Event|30|||
162827120|NCT01431274|588078514|FG004|Overall Study|Adverse Event|37|||
162827121|NCT01431274|588078510|FG000|Overall Study|Consent withdrawn not due to AE|29|||
162827122|NCT01431274|588078511|FG001|Overall Study|Consent withdrawn not due to AE|20|||
162827123|NCT01431274|588078512|FG002|Overall Study|Consent withdrawn not due to AE|17|||
162827124|NCT01431274|588078513|FG003|Overall Study|Consent withdrawn not due to AE|20|||
162827125|NCT01431274|588078514|FG004|Overall Study|Consent withdrawn not due to AE|11|||
162827126|NCT01431274|588078510|FG000|Overall Study|Non compliant with protocol|5|||
162827127|NCT01431274|588078511|FG001|Overall Study|Non compliant with protocol|8|||
162827128|NCT01431274|588078512|FG002|Overall Study|Non compliant with protocol|4|||
162827129|NCT01431274|588078513|FG003|Overall Study|Non compliant with protocol|4|||
162827130|NCT01431274|588078514|FG004|Overall Study|Non compliant with protocol|4|||
162827131|NCT01431274|588078510|FG000|Overall Study|Lost to Follow-up|6|||
162698486|NCT02743793|587605510|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
162698487|NCT02743793|587605511|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
162698488|NCT02743793|587605510|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
162698489|NCT02743793|587605511|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
162698490|NCT00786474|587605516|FG000|Overall Study|Death|5|||
162698491|NCT00786474|587605517|FG001|Overall Study|Death|4|||
162698492|NCT00786474|587605516|FG000|Overall Study|Withdrawal by Subject|23|||
162698493|NCT00786474|587605517|FG001|Overall Study|Withdrawal by Subject|31|||
162698494|NCT00786474|587605516|FG000|Overall Study|Lost to Follow-up|3|||
162698495|NCT00786474|587605517|FG001|Overall Study|Lost to Follow-up|3|||
162698496|NCT00786474|587605516|FG000|Overall Study|Physician Decision|2|||
162698497|NCT00786474|587605517|FG001|Overall Study|Physician Decision|1|||
162698498|NCT00786474|587605516|FG000|Overall Study|Other|4|||
162698499|NCT00786474|587605517|FG001|Overall Study|Other|4|||
162698500|NCT04642469|587605518|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
162698501|NCT04642469|587605519|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
162698502|NCT04642469|587605518|FG000|Overall Study|Death|1|||
162698503|NCT04642469|587605519|FG001|Overall Study|Death|2|||
162698504|NCT04642469|587605518|FG000|Overall Study|Study/site closed following amendment 1|11|||
162698505|NCT04642469|587605519|FG001|Overall Study|Study/site closed following amendment 1|11|||
162698506|NCT04642469|587605518|FG000|Overall Study|Other|1|||
162698507|NCT04642469|587605519|FG001|Overall Study|Other|1|||
162698508|NCT04642469|587605518|FG000|Overall Study|Withdrawal by Subject|1|||
162698509|NCT04642469|587605519|FG001|Overall Study|Withdrawal by Subject|0|||
162827132|NCT01431274|588078511|FG001|Overall Study|Lost to Follow-up|7|||
162698510|NCT02733042|587605520|FG000|Overall Study|Adverse Event|1|||
162698511|NCT02733042|587605521|FG001|Overall Study|Adverse Event|0|||
162698512|NCT02733042|587605522|FG002|Overall Study|Adverse Event|1|||
162698513|NCT02733042|587605523|FG003|Overall Study|Adverse Event|1|||
162698514|NCT02733042|587605524|FG004|Overall Study|Adverse Event|0|||
162827133|NCT01431274|588078512|FG002|Overall Study|Lost to Follow-up|1|||
162827134|NCT01431274|588078513|FG003|Overall Study|Lost to Follow-up|4|||
162827135|NCT01431274|588078514|FG004|Overall Study|Lost to Follow-up|0|||
162937044|NCT02247479|588473478|FG000|Overall Study|Non-compliance|0|||
162937045|NCT02247479|588473479|FG001|Overall Study|Non-compliance|0|||
162937046|NCT02247479|588473480|FG002|Overall Study|Non-compliance|1|||
162937047|NCT02247479|588473478|FG000|Overall Study|Withdrawal by Subject|25|||
162937048|NCT02247479|588473479|FG001|Overall Study|Withdrawal by Subject|29|||
162937049|NCT02247479|588473480|FG002|Overall Study|Withdrawal by Subject|24|||
162937050|NCT02247479|588473478|FG000|Overall Study|Study Terminated by Sponsor|98|||
162937051|NCT02247479|588473479|FG001|Overall Study|Study Terminated by Sponsor|88|||
162937052|NCT02247479|588473480|FG002|Overall Study|Study Terminated by Sponsor|94|||
162937053|NCT02247479|588473478|FG000|Overall Study|Physician Decision|1|||
162937054|NCT02247479|588473479|FG001|Overall Study|Physician Decision|0|||
162937055|NCT02247479|588473480|FG002|Overall Study|Physician Decision|2|||
162937056|NCT02247479|588473478|FG000|Overall Study|Unspecified Reason|2|||
162937057|NCT02247479|588473479|FG001|Overall Study|Unspecified Reason|5|||
162937058|NCT02247479|588473480|FG002|Overall Study|Unspecified Reason|2|||
162937059|NCT03740698|588473481|FG000|Overall Study|Physician Decision|0|||
162937060|NCT03740698|588473482|FG001|Overall Study|Physician Decision|1|||
162937061|NCT03740698|588473483|FG002|Overall Study|Physician Decision|1|||
162937062|NCT05216978|588473493|FG000|Overall Study|Withdrawal by Subject|3|||
162937063|NCT05216978|588473493|FG000|Overall Study|Lost to Follow-up|5|||
162937064|NCT03433001|588473512|FG000|Overall Study|Lack of Efficacy|109|||
162937065|NCT03433001|588473512|FG000|Overall Study|Adverse Event|69|||
162937066|NCT03433001|588473512|FG000|Overall Study|Withdrawal by Subject|10|||
162937067|NCT03433001|588473512|FG000|Overall Study|Death|12|||
162937068|NCT03433001|588473512|FG000|Overall Study|Lost to Follow-up|4|||
162937069|NCT03433001|588473512|FG000|Overall Study|Other|25|||
162937070|NCT01299038|588473513|FG000|Overall Study|Withdrawal by Subject|1|||
162937071|NCT01299038|588473514|FG001|Overall Study|Withdrawal by Subject|0|||
162937072|NCT01162499|588473515|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
162937073|NCT01162499|588473516|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
162937074|NCT00322556|588473517|FG000|Overall Study|Adverse Event|1|||
162937075|NCT00322556|588473517|FG000|Overall Study|Withdrawal by Subject|1|||
162937076|NCT00322556|588473517|FG000|Overall Study|Lost to Follow-up|3|||
162937077|NCT00322556|588473517|FG000|Overall Study|Other Reason|7|||
162937078|NCT01506323|588473518|FG000|Overall Study|Lost to Follow-up|5|||
162937079|NCT01506323|588473519|FG001|Overall Study|Lost to Follow-up|4|||
162937080|NCT01506323|588473518|FG000|Overall Study|Withdrawal by Subject|4|||
162937081|NCT01506323|588473519|FG001|Overall Study|Withdrawal by Subject|4|||
162937082|NCT01506323|588473518|FG000|Overall Study|Lack of Efficacy|1|||
162937083|NCT01506323|588473519|FG001|Overall Study|Lack of Efficacy|3|||
162937084|NCT01506323|588473518|FG000|Overall Study|Moved out of area|5|||
162937085|NCT01506323|588473519|FG001|Overall Study|Moved out of area|2|||
162937086|NCT01506323|588473518|FG000|Overall Study|Schedule or Transportation conflict|8|||
162937087|NCT01506323|588473519|FG001|Overall Study|Schedule or Transportation conflict|0|||
162937088|NCT01506323|588473518|FG000|Overall Study|Started another treatment|1|||
162937089|NCT01506323|588473519|FG001|Overall Study|Started another treatment|0|||
162937090|NCT04467697|588473520|FG000|Overall Study|Adverse Event|2|||
162937091|NCT04467697|588473520|FG000|Overall Study|Lost to Follow-up|6|||
162937092|NCT04467697|588473520|FG000|Overall Study|Withdrawal by Subject|9|||
162937093|NCT04467697|588473520|FG000|Overall Study|Protocol Violation|3|||
162937094|NCT03907280|588473521|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
162937095|NCT03907280|588473522|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
162937096|NCT03907280|588473523|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
162937097|NCT02637076|588473527|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
162937098|NCT02637076|588473528|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
162937099|NCT02637076|588473527|FG000|Overall Study|Withdrawal by Subject|0|||
162937100|NCT02637076|588473528|FG001|Overall Study|Withdrawal by Subject|4|||
162937101|NCT00130520|588473529|FG000|Overall Study|Adverse Event|11|||
162937102|NCT00130520|588473529|FG000|Overall Study|Death|1|||
162937103|NCT00130520|588473529|FG000|Overall Study|Physician Decision|1|||
162937104|NCT00130520|588473529|FG000|Overall Study|Withdrawal by Subject|1|||
162937105|NCT00130520|588473529|FG000|Overall Study|Disease Progression|23|||
162937106|NCT00130520|588473529|FG000|Overall Study|Protocol non-compliance|1|||
162827136|NCT01431274|588078510|FG000|Overall Study|Other reason not stated above|6|||
162827137|NCT01431274|588078511|FG001|Overall Study|Other reason not stated above|5|||
162827138|NCT01431274|588078512|FG002|Overall Study|Other reason not stated above|7|||
162827139|NCT01431274|588078513|FG003|Overall Study|Other reason not stated above|2|||
162827140|NCT01431274|588078514|FG004|Overall Study|Other reason not stated above|4|||
162827141|NCT01358760|588078519|FG000|Overall Study|Adverse Event|3|||
162827142|NCT01358760|588078520|FG001|Overall Study|Adverse Event|4|||
162827143|NCT01358760|588078521|FG002|Overall Study|Adverse Event|3|||
162827144|NCT01358760|588078519|FG000|Overall Study|Lost to Follow-up|1|||
162827145|NCT01358760|588078520|FG001|Overall Study|Lost to Follow-up|1|||
162827146|NCT01358760|588078521|FG002|Overall Study|Lost to Follow-up|3|||
162827147|NCT01358760|588078519|FG000|Overall Study|Withdrawal by Subject|5|||
162827148|NCT01358760|588078520|FG001|Overall Study|Withdrawal by Subject|3|||
162827149|NCT01358760|588078521|FG002|Overall Study|Withdrawal by Subject|2|||
162827150|NCT01358760|588078519|FG000|Overall Study|Physician Decision|1|||
162827151|NCT01358760|588078520|FG001|Overall Study|Physician Decision|0|||
162827152|NCT01358760|588078521|FG002|Overall Study|Physician Decision|1|||
162827153|NCT01358760|588078519|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
162827154|NCT01358760|588078520|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
162827155|NCT01358760|588078521|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
162827156|NCT01506960|588078524|FG000|Overall Study|Did not meet angiographic criteria|47|||
162827157|NCT00397033|588078525|FG000|Overall Study|Adverse Event|7|||
162827158|NCT00397033|588078526|FG001|Overall Study|Adverse Event|10|||
162827159|NCT00397033|588078527|FG002|Overall Study|Adverse Event|4|||
162827160|NCT00397033|588078525|FG000|Overall Study|Lack of Efficacy|22|||
162827161|NCT00397033|588078526|FG001|Overall Study|Lack of Efficacy|12|||
162827162|NCT00397033|588078527|FG002|Overall Study|Lack of Efficacy|9|||
162827163|NCT00397033|588078525|FG000|Overall Study|Lost to Follow-up|3|||
162827164|NCT00397033|588078526|FG001|Overall Study|Lost to Follow-up|3|||
162827165|NCT00397033|588078527|FG002|Overall Study|Lost to Follow-up|3|||
162827166|NCT00397033|588078525|FG000|Overall Study|Withdrawal by Subject|12|||
162827167|NCT00397033|588078526|FG001|Overall Study|Withdrawal by Subject|7|||
162827168|NCT00397033|588078527|FG002|Overall Study|Withdrawal by Subject|5|||
162827169|NCT00397033|588078525|FG000|Overall Study|Other|0|||
162827170|NCT00397033|588078526|FG001|Overall Study|Other|5|||
162827171|NCT00397033|588078527|FG002|Overall Study|Other|2|||
162827172|NCT03519867|588078528|FG000|Overall Study|Adverse Event|1|||
162827173|NCT03519867|588078529|FG001|Overall Study|Adverse Event|1|||
162827174|NCT03519867|588078530|FG002|Overall Study|Adverse Event|0|||
162827175|NCT03519867|588078531|FG003|Overall Study|Adverse Event|0|||
162827176|NCT03519867|588078532|FG004|Overall Study|Adverse Event|0|||
162827177|NCT03519867|588078533|FG005|Overall Study|Adverse Event|0|||
162827178|NCT03519867|588078534|FG006|Overall Study|Adverse Event|0|||
162827179|NCT03519867|588078535|FG007|Overall Study|Adverse Event|0|||
162827180|NCT03519867|588078536|FG008|Overall Study|Adverse Event|0|||
162827181|NCT03519867|588078537|FG009|Overall Study|Adverse Event|0|||
162827182|NCT03519867|588078528|FG000|Overall Study|Protocol Violation|0|||
162827183|NCT03519867|588078529|FG001|Overall Study|Protocol Violation|0|||
162827184|NCT03519867|588078530|FG002|Overall Study|Protocol Violation|0|||
162827185|NCT03519867|588078531|FG003|Overall Study|Protocol Violation|0|||
162827186|NCT03519867|588078532|FG004|Overall Study|Protocol Violation|0|||
162827187|NCT03519867|588078533|FG005|Overall Study|Protocol Violation|1|||
162827188|NCT03519867|588078534|FG006|Overall Study|Protocol Violation|0|||
162827189|NCT03519867|588078535|FG007|Overall Study|Protocol Violation|0|||
162827190|NCT03519867|588078536|FG008|Overall Study|Protocol Violation|0|||
162827191|NCT03519867|588078537|FG009|Overall Study|Protocol Violation|0|||
162827192|NCT03519867|588078528|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827193|NCT03519867|588078529|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827194|NCT03519867|588078530|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827195|NCT03519867|588078531|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827196|NCT03519867|588078532|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827197|NCT03519867|588078533|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827198|NCT03519867|588078534|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
162827199|NCT03519867|588078535|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827200|NCT03519867|588078536|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827201|NCT03519867|588078537|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
162827202|NCT03519867|588078528|FG000|Overall Study|Admin. of other reversal agent|1|||
162827203|NCT03519867|588078529|FG001|Overall Study|Admin. of other reversal agent|1|||
162827204|NCT03519867|588078530|FG002|Overall Study|Admin. of other reversal agent|0|||
162827205|NCT03519867|588078531|FG003|Overall Study|Admin. of other reversal agent|0|||
162827206|NCT03519867|588078532|FG004|Overall Study|Admin. of other reversal agent|0|||
162827207|NCT03519867|588078533|FG005|Overall Study|Admin. of other reversal agent|1|||
162827208|NCT03519867|588078534|FG006|Overall Study|Admin. of other reversal agent|0|||
162827209|NCT03519867|588078535|FG007|Overall Study|Admin. of other reversal agent|0|||
162827210|NCT03519867|588078536|FG008|Overall Study|Admin. of other reversal agent|0|||
162827211|NCT03519867|588078537|FG009|Overall Study|Admin. of other reversal agent|0|||
162827212|NCT03519867|588078528|FG000|Overall Study|Reason not provided|1|||
162827213|NCT03519867|588078529|FG001|Overall Study|Reason not provided|1|||
162827214|NCT03519867|588078530|FG002|Overall Study|Reason not provided|1|||
162827215|NCT03519867|588078531|FG003|Overall Study|Reason not provided|1|||
162827216|NCT03519867|588078532|FG004|Overall Study|Reason not provided|0|||
162827217|NCT03519867|588078533|FG005|Overall Study|Reason not provided|1|||
162827218|NCT03519867|588078534|FG006|Overall Study|Reason not provided|0|||
162827219|NCT03519867|588078535|FG007|Overall Study|Reason not provided|1|||
162827220|NCT03519867|588078536|FG008|Overall Study|Reason not provided|1|||
162827221|NCT03519867|588078537|FG009|Overall Study|Reason not provided|0|||
162827222|NCT01846624|588078538|FG000|Overall Study|Died during induction, no midostaurin|1|||
162827223|NCT03472924|588078541|FG000|Overall Study|Adverse Event|1|||
162827224|NCT03472924|588078542|FG001|Overall Study|Adverse Event|0|||
162827225|NCT02546765|588078544|FG000|Overall Study|Withdrawal by Subject|0|||
162827226|NCT02546765|588078545|FG001|Overall Study|Withdrawal by Subject|1|||
162827227|NCT02546765|588078546|FG002|Overall Study|Withdrawal by Subject|0|||
162827228|NCT02546765|588078547|FG003|Overall Study|Withdrawal by Subject|0|||
162827229|NCT04425720|588078550|FG000|Overall Study|Withdrawal by Subject|0|||
162827230|NCT04425720|588078551|FG001|Overall Study|Withdrawal by Subject|20|||
162827231|NCT00807742|588078552|FG000|Overall Study|Death|9|||
162827232|NCT00807742|588078553|FG001|Overall Study|Death|2|||
162827233|NCT00807742|588078552|FG000|Overall Study|Withdrawal by Subject|2|||
162827234|NCT00807742|588078553|FG001|Overall Study|Withdrawal by Subject|1|||
162827235|NCT00807742|588078552|FG000|Overall Study|Lost to Follow-up|35|||
162827236|NCT00807742|588078553|FG001|Overall Study|Lost to Follow-up|51|||
162827237|NCT04814823|588078554|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
162827238|NCT05678257|588078555|FG000|Overall Study|Withdrawal by Subject|2|||
162827239|NCT05678257|588078556|FG001|Overall Study|Withdrawal by Subject|0|||
162827240|NCT05678257|588078557|FG002|Overall Study|Withdrawal by Subject|5|||
162827241|NCT05678257|588078555|FG000|Overall Study|Physician Decision|1|||
162827242|NCT05678257|588078556|FG001|Overall Study|Physician Decision|0|||
162827243|NCT05678257|588078557|FG002|Overall Study|Physician Decision|1|||
162827244|NCT05678257|588078555|FG000|Overall Study|Adverse Event|1|||
162827245|NCT05678257|588078556|FG001|Overall Study|Adverse Event|3|||
162827246|NCT05678257|588078557|FG002|Overall Study|Adverse Event|1|||
162827247|NCT05678257|588078555|FG000|Overall Study|Progressive disease|11|||
162827248|NCT05678257|588078556|FG001|Overall Study|Progressive disease|18|||
162827249|NCT05678257|588078557|FG002|Overall Study|Progressive disease|7|||
162827250|NCT05678257|588078555|FG000|Overall Study|No longer clinically benefitting|2|||
162827251|NCT05678257|588078556|FG001|Overall Study|No longer clinically benefitting|1|||
162827252|NCT05678257|588078557|FG002|Overall Study|No longer clinically benefitting|0|||
162827253|NCT05678257|588078555|FG000|Overall Study|Sponsor decision|5|||
162827254|NCT05678257|588078556|FG001|Overall Study|Sponsor decision|9|||
162827255|NCT05678257|588078557|FG002|Overall Study|Sponsor decision|8|||
162827256|NCT05678257|588078555|FG000|Overall Study|Protocol Violation|0|||
162827257|NCT05678257|588078556|FG001|Overall Study|Protocol Violation|0|||
162827258|NCT05678257|588078557|FG002|Overall Study|Protocol Violation|1|||
162827259|NCT05678257|588078555|FG000|Overall Study|Patient non-compliance|0|||
162827260|NCT05678257|588078556|FG001|Overall Study|Patient non-compliance|0|||
162827261|NCT05678257|588078557|FG002|Overall Study|Patient non-compliance|3|||
162827262|NCT00430482|588078567|FG000|Completed Treatment|Insufficient Treatment|7|||
162827263|NCT00430482|588078568|FG001|Completed Treatment|Insufficient Treatment|11|||
162827264|NCT00583024|588078571|FG000|Overall Study|Lost to Follow-up|4|||
162827265|NCT00766038|588079954|FG000|Overall Study|Lost to Follow-up|15|||
162827266|NCT00766038|588079955|FG001|Overall Study|Lost to Follow-up|14|||
162827267|NCT00449670|588079956|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
162827268|NCT00449670|588079957|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
162827269|NCT00449670|588079956|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
162827270|NCT00449670|588079957|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
162827271|NCT00449670|588079956|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
162827272|NCT00449670|588079957|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
162827273|NCT00449670|588079956|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
162827274|NCT00449670|588079957|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
162937107|NCT00130520|588473529|FG000|Overall Study|Did not meet re-treatment criteria|1|||
162937108|NCT03487796|588473530|FG000|Overall Study|Lost to Follow-up|18|||
162827275|NCT00449670|588079956|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
162827276|NCT00449670|588079957|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
162827277|NCT00449670|588079956|FG000|Booster Phase (Study no.109873)|Other|0|||
162827278|NCT00449670|588079957|FG001|Booster Phase (Study no.109873)|Other|2|||
162827279|NCT01502709|588079958|FG000|Overall Study|Lost to Follow-up|4|||
162827280|NCT01502709|588079959|FG001|Overall Study|Lost to Follow-up|0|||
162827281|NCT03703882|588079960|FG000|Overall Study|Adverse Event|1|||
162827282|NCT03703882|588079961|FG001|Overall Study|Adverse Event|0|||
162827283|NCT03703882|588079960|FG000|Overall Study|Lost to Follow-up|0|||
162827284|NCT03703882|588079961|FG001|Overall Study|Lost to Follow-up|2|||
162827285|NCT03703882|588079960|FG000|Overall Study|Non-compliance with study drug|0|||
162827286|NCT03703882|588079961|FG001|Overall Study|Non-compliance with study drug|1|||
162827287|NCT03703882|588079960|FG000|Overall Study|Physician Decision|0|||
162827288|NCT03703882|588079961|FG001|Overall Study|Physician Decision|1|||
162827289|NCT03703882|588079960|FG000|Overall Study|Progressive disease|1|||
162827290|NCT03703882|588079961|FG001|Overall Study|Progressive disease|0|||
162827291|NCT03703882|588079960|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162827292|NCT03703882|588079961|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162827293|NCT03703882|588079960|FG000|Overall Study|Starting another treatment|0|||
162827294|NCT03703882|588079961|FG001|Overall Study|Starting another treatment|1|||
162827295|NCT03703882|588079960|FG000|Overall Study|noncompliance with study procedures|0|||
162827296|NCT03703882|588079961|FG001|Overall Study|noncompliance with study procedures|1|||
162827297|NCT02966509|588079967|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
162827298|NCT02966509|588079968|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
162827299|NCT02966509|588079967|FG000|Baseline Satisfaction Survey|Death|0|||
162827300|NCT02966509|588079968|FG001|Baseline Satisfaction Survey|Death|1|||
162827301|NCT02966509|588079967|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
162827302|NCT02966509|588079968|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
162827303|NCT02966509|588079967|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
162827304|NCT02966509|588079968|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
162827305|NCT02966509|588079967|FG000|6 Month Satisfaction Decision Survey|Death|22|||
162827306|NCT02966509|588079968|FG001|6 Month Satisfaction Decision Survey|Death|25|||
162827307|NCT02966509|588079967|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
162827308|NCT02966509|588079968|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
162827309|NCT02966509|588079967|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
162827310|NCT02966509|588079968|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
162827311|NCT02966509|588079967|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
162827312|NCT02966509|588079968|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
162827313|NCT02966509|588079967|FG000|6 Month Satisfaction Survey|Death|36|||
162827314|NCT02966509|588079968|FG001|6 Month Satisfaction Survey|Death|33|||
162827315|NCT02966509|588079967|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
162827316|NCT02966509|588079968|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
162827317|NCT02966509|588079967|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
162827318|NCT02966509|588079968|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
162827319|NCT02966509|588079967|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
162827320|NCT02966509|588079968|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
162827321|NCT02966509|588079967|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
162827322|NCT02966509|588079968|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
162827323|NCT02966509|588079967|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
162827324|NCT02966509|588079968|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
162827325|NCT02982954|588079969|FG000|Overall Study|Death|55|||
162827326|NCT02982954|588079970|FG001|Overall Study|Death|29|||
162827327|NCT02982954|588079971|FG002|Overall Study|Death|15|||
162827328|NCT02982954|588079972|FG003|Overall Study|Death|20|||
162827329|NCT02982954|588079969|FG000|Overall Study|Lost to Follow-up|2|||
162827330|NCT02982954|588079970|FG001|Overall Study|Lost to Follow-up|1|||
162827331|NCT02982954|588079971|FG002|Overall Study|Lost to Follow-up|0|||
162827332|NCT02982954|588079972|FG003|Overall Study|Lost to Follow-up|0|||
162827333|NCT02982954|588079969|FG000|Overall Study|Participant withdrew consent|7|||
162827334|NCT02982954|588079970|FG001|Overall Study|Participant withdrew consent|5|||
162827335|NCT02982954|588079971|FG002|Overall Study|Participant withdrew consent|1|||
162827336|NCT02982954|588079972|FG003|Overall Study|Participant withdrew consent|1|||
162827337|NCT02982954|588079969|FG000|Overall Study|Other reasons|42|||
162827338|NCT02982954|588079970|FG001|Overall Study|Other reasons|17|||
162827339|NCT02982954|588079971|FG002|Overall Study|Other reasons|12|||
162827340|NCT02982954|588079972|FG003|Overall Study|Other reasons|3|||
162827341|NCT02982954|588079969|FG000|Overall Study|Premature site closure|0|||
162827342|NCT02982954|588079970|FG001|Overall Study|Premature site closure|0|||
162827343|NCT02982954|588079971|FG002|Overall Study|Premature site closure|0|||
162827344|NCT02982954|588079972|FG003|Overall Study|Premature site closure|1|||
162827345|NCT03577730|588079973|FG000|Overall Study|Physician Decision|3|||
162827346|NCT03577730|588079974|FG001|Overall Study|Physician Decision|1|||
162827347|NCT03577730|588079973|FG000|Overall Study|Did not receive allocated intervention|1|||
162937109|NCT03487796|588473531|FG001|Overall Study|Lost to Follow-up|6|||
162937110|NCT00613574|588473535|FG000|Overall Study|Adverse Event|3|||
162937111|NCT00613574|588473535|FG000|Overall Study|Lost to Follow-up|2|||
162937112|NCT00613574|588473535|FG000|Overall Study|Other|1|||
162937113|NCT04604184|588473539|FG000|Overall Study|Adverse Event|5|||
162937114|NCT04604184|588473540|FG001|Overall Study|Adverse Event|5|||
162937115|NCT04604184|588473539|FG000|Overall Study|Death|2|||
162937116|NCT04604184|588473540|FG001|Overall Study|Death|1|||
162937117|NCT04604184|588473539|FG000|Overall Study|Withdrawal by Subject|1|||
162937118|NCT04604184|588473540|FG001|Overall Study|Withdrawal by Subject|3|||
162937119|NCT04604184|588473539|FG000|Overall Study|Not treated|2|||
162937120|NCT04604184|588473540|FG001|Overall Study|Not treated|2|||
162937121|NCT04604184|588473539|FG000|Overall Study|Due to sponsor decision|9|||
162937122|NCT04604184|588473540|FG001|Overall Study|Due to sponsor decision|7|||
162937123|NCT04604184|588473539|FG000|Overall Study|Physician Decision|0|||
162937124|NCT04604184|588473540|FG001|Overall Study|Physician Decision|1|||
162937125|NCT04604184|588473539|FG000|Overall Study|Transfer to healthcare|1|||
162937126|NCT04604184|588473540|FG001|Overall Study|Transfer to healthcare|0|||
162937127|NCT01751412|588473541|FG000|Overall Study|Disease Progression Before Treatment|1|||
162937128|NCT00582036|588473542|FG000|Overall Study|Withdrawal by Subject|0|||
162937129|NCT00582036|588473543|FG001|Overall Study|Withdrawal by Subject|1|||
162937130|NCT03734237|588473544|FG000|Overall Study|Lost to Follow-up|1|||
162937131|NCT03734237|588473545|FG001|Overall Study|Lost to Follow-up|3|||
162937132|NCT03734237|588473546|FG002|Overall Study|Lost to Follow-up|0|||
162937133|NCT03734237|588473544|FG000|Overall Study|Withdrawal by Subject|7|||
162937134|NCT03734237|588473545|FG001|Overall Study|Withdrawal by Subject|9|||
162937135|NCT03734237|588473546|FG002|Overall Study|Withdrawal by Subject|10|||
162937136|NCT02711956|588473547|FG000|Overall Study|Adverse Event|0|||
162937137|NCT02711956|588473548|FG001|Overall Study|Adverse Event|0|||
162937138|NCT02711956|588473549|FG002|Overall Study|Adverse Event|0|||
162937139|NCT02711956|588473550|FG003|Overall Study|Adverse Event|1|||
162937140|NCT02711956|588473551|FG004|Overall Study|Adverse Event|2|||
162937141|NCT02711956|588473552|FG005|Overall Study|Adverse Event|0|||
162937142|NCT02711956|588473553|FG006|Overall Study|Adverse Event|0|||
162937143|NCT02711956|588473554|FG007|Overall Study|Adverse Event|1|||
162937144|NCT02711956|588473555|FG008|Overall Study|Adverse Event|1|||
162937145|NCT02711956|588473556|FG009|Overall Study|Adverse Event|1|||
162937146|NCT02711956|588473557|FG010|Overall Study|Adverse Event|1|||
162937147|NCT02711956|588473558|FG011|Overall Study|Adverse Event|0|||
162937148|NCT02711956|588473559|FG012|Overall Study|Adverse Event|0|||
162937149|NCT02711956|588473560|FG013|Overall Study|Adverse Event|0|||
162937150|NCT02711956|588473561|FG014|Overall Study|Adverse Event|2|||
162937151|NCT02711956|588473547|FG000|Overall Study|Physician Decision|0|||
162937152|NCT02711956|588473548|FG001|Overall Study|Physician Decision|0|||
162698515|NCT02733042|587605525|FG005|Overall Study|Adverse Event|0|||
162937153|NCT02711956|588473549|FG002|Overall Study|Physician Decision|0|||
162937154|NCT02711956|588473550|FG003|Overall Study|Physician Decision|2|||
162937155|NCT02711956|588473551|FG004|Overall Study|Physician Decision|0|||
162937156|NCT02711956|588473552|FG005|Overall Study|Physician Decision|0|||
162937157|NCT02711956|588473553|FG006|Overall Study|Physician Decision|0|||
162937158|NCT02711956|588473554|FG007|Overall Study|Physician Decision|0|||
162937159|NCT02711956|588473555|FG008|Overall Study|Physician Decision|0|||
162827348|NCT03577730|588079974|FG001|Overall Study|Did not receive allocated intervention|0|||
162827349|NCT03810781|588079976|FG000|Overall Study|COVID shut down|2|||
162827350|NCT00253643|588079981|FG000|Overall Study|Withdrawal by Subject|0|||
162827351|NCT00253643|588079982|FG001|Overall Study|Withdrawal by Subject|0|||
162827352|NCT00253643|588079983|FG002|Overall Study|Withdrawal by Subject|1|||
162827353|NCT00253643|588079984|FG003|Overall Study|Withdrawal by Subject|1|||
162827354|NCT00253643|588079981|FG000|Overall Study|Non-Compliance|0|||
162827355|NCT00253643|588079982|FG001|Overall Study|Non-Compliance|0|||
162827356|NCT00253643|588079983|FG002|Overall Study|Non-Compliance|0|||
162827357|NCT00253643|588079984|FG003|Overall Study|Non-Compliance|2|||
162827358|NCT01368536|588079985|FG000|Overall Study|Adverse Event|5|||
162827359|NCT01368536|588079986|FG001|Overall Study|Adverse Event|6|||
162827360|NCT01368536|588079987|FG002|Overall Study|Adverse Event|8|||
162827361|NCT01368536|588079985|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162827362|NCT01368536|588079986|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162827363|NCT01368536|588079987|FG002|Overall Study|Abnormal laboratory value(s)|2|||
162827364|NCT01368536|588079985|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162827365|NCT01368536|588079986|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162827366|NCT01368536|588079987|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162827367|NCT01368536|588079985|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
162827368|NCT01368536|588079986|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162827369|NCT01368536|588079987|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162827370|NCT01368536|588079985|FG000|Overall Study|No longer required study medication|0|||
162827371|NCT01368536|588079986|FG001|Overall Study|No longer required study medication|0|||
162827372|NCT01368536|588079987|FG002|Overall Study|No longer required study medication|1|||
162827373|NCT01368536|588079985|FG000|Overall Study|Withdrawal by Subject|2|||
162827374|NCT01368536|588079986|FG001|Overall Study|Withdrawal by Subject|5|||
162827375|NCT01368536|588079987|FG002|Overall Study|Withdrawal by Subject|4|||
162827376|NCT01368536|588079985|FG000|Overall Study|Lost to Follow-up|3|||
162827377|NCT01368536|588079986|FG001|Overall Study|Lost to Follow-up|3|||
162827378|NCT01368536|588079987|FG002|Overall Study|Lost to Follow-up|5|||
162827379|NCT01368536|588079985|FG000|Overall Study|Administrative problems|34|||
162827380|NCT01368536|588079986|FG001|Overall Study|Administrative problems|39|||
162827381|NCT01368536|588079987|FG002|Overall Study|Administrative problems|35|||
162827382|NCT01368536|588079985|FG000|Overall Study|Protocol deviation|0|||
162827383|NCT01368536|588079986|FG001|Overall Study|Protocol deviation|3|||
162827384|NCT01368536|588079987|FG002|Overall Study|Protocol deviation|1|||
162827385|NCT03596866|588079991|FG000|Overall Study|Site terminated by Sponsor|64|||
162827386|NCT03596866|588079992|FG001|Overall Study|Site terminated by Sponsor|65|||
162827387|NCT03596866|588079991|FG000|Overall Study|Death|37|||
162827388|NCT03596866|588079992|FG001|Overall Study|Death|24|||
162827389|NCT03596866|588079991|FG000|Overall Study|Withdrawal by Subject|4|||
162827390|NCT03596866|588079992|FG001|Overall Study|Withdrawal by Subject|6|||
162827391|NCT03596866|588079991|FG000|Overall Study|Missing|0|||
162827392|NCT03596866|588079992|FG001|Overall Study|Missing|6|||
162827393|NCT03596866|588079991|FG000|Overall Study|Lost to Follow-up|2|||
162827394|NCT03596866|588079992|FG001|Overall Study|Lost to Follow-up|3|||
162827395|NCT03596866|588079991|FG000|Overall Study|Protocol Violation|1|||
162827396|NCT03596866|588079992|FG001|Overall Study|Protocol Violation|0|||
162827397|NCT03596866|588079991|FG000|Overall Study|Reason Not Specified|14|||
162827398|NCT03596866|588079992|FG001|Overall Study|Reason Not Specified|13|||
162827399|NCT04770532|588079993|FG000|Overall Study|Withdrawal by Subject|0|||
162827400|NCT04770532|588079994|FG001|Overall Study|Withdrawal by Subject|3|||
162827401|NCT04770532|588079993|FG000|Overall Study|Physician Decision|1|||
162827402|NCT04770532|588079994|FG001|Overall Study|Physician Decision|0|||
162827403|NCT04770532|588079993|FG000|Overall Study|Death|2|||
162827404|NCT04770532|588079994|FG001|Overall Study|Death|2|||
162827405|NCT00454857|588079998|FG000|Overall Study|Withdrawal by Subject|15|||
162827406|NCT00454857|588079998|FG000|Overall Study|Lost to Follow-up|16|||
162827407|NCT00454857|588079998|FG000|Overall Study|Noncompliance|6|||
162827408|NCT00454857|588079998|FG000|Overall Study|Death|5|||
162827409|NCT00454857|588079998|FG000|Overall Study|Other|11|||
162827410|NCT00454857|588079998|FG000|Overall Study|Reason unknown|1|||
162827411|NCT04707157|588079999|FG000|Overall Study|Adverse Event|12|||
162827412|NCT04707157|588080000|FG001|Overall Study|Adverse Event|3|||
162827413|NCT04707157|588079999|FG000|Overall Study|Lost to Follow-up|2|||
162827414|NCT04707157|588080000|FG001|Overall Study|Lost to Follow-up|0|||
162827415|NCT04707157|588079999|FG000|Overall Study|Sponsor's decision|1|||
162827416|NCT04707157|588080000|FG001|Overall Study|Sponsor's decision|0|||
162827417|NCT04707157|588079999|FG000|Overall Study|Physician Decision|8|||
162827418|NCT04707157|588080000|FG001|Overall Study|Physician Decision|5|||
162827419|NCT04707157|588079999|FG000|Overall Study|Protocol Deviation|1|||
162827420|NCT04707157|588080000|FG001|Overall Study|Protocol Deviation|0|||
162827421|NCT04707157|588079999|FG000|Overall Study|Withdrawal by Subject|1|||
162827422|NCT04707157|588080000|FG001|Overall Study|Withdrawal by Subject|1|||
162827423|NCT00003702|588080001|FG000|Overall Study|Ineligible cell types|2|||
162827424|NCT00003702|588080002|FG001|Overall Study|Ineligible cell types|2|||
162827425|NCT00003702|588080001|FG000|Overall Study|Did not meet criteria for persistence|8|||
162827426|NCT00003702|588080002|FG001|Overall Study|Did not meet criteria for persistence|5|||
162827427|NCT00003702|588080001|FG000|Overall Study|WHO score > 6|2|||
162827428|NCT00003702|588080002|FG001|Overall Study|WHO score > 6|1|||
162827429|NCT00003702|588080001|FG000|Overall Study|Inadequate documentation of disease|1|||
162827430|NCT00003702|588080002|FG001|Overall Study|Inadequate documentation of disease|3|||
162827431|NCT00827606|588080003|FG000|Overall Study|Protocol Violation|4|||
162827432|NCT00827606|588080004|FG001|Overall Study|Protocol Violation|3|||
162827433|NCT00827606|588080003|FG000|Overall Study|Lost to Follow-up|3|||
162827434|NCT00827606|588080004|FG001|Overall Study|Lost to Follow-up|1|||
162827435|NCT00827606|588080003|FG000|Overall Study|Withdrawal by Subject|7|||
162827436|NCT00827606|588080004|FG001|Overall Study|Withdrawal by Subject|6|||
162827437|NCT00827606|588080003|FG000|Overall Study|Pregnancy|0|||
162827438|NCT00827606|588080004|FG001|Overall Study|Pregnancy|1|||
162827439|NCT00827606|588080003|FG000|Overall Study|Other|5|||
162827440|NCT00827606|588080004|FG001|Overall Study|Other|13|||
162827441|NCT00827606|588080003|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
162827442|NCT00827606|588080004|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
162827443|NCT00827606|588080003|FG000|Overall Study|Adverse Event|4|||
162827444|NCT00827606|588080004|FG001|Overall Study|Adverse Event|2|||
162827445|NCT00243386|588080009|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
162827446|NCT00243386|588080010|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
162827447|NCT00243386|588080011|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
162827448|NCT00243386|588080009|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
162827449|NCT00243386|588080010|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
162827450|NCT00243386|588080011|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
162827451|NCT00243386|588080009|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
162827452|NCT00243386|588080010|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
162827453|NCT00243386|588080011|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
162827454|NCT00243386|588080009|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
162827455|NCT00243386|588080010|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
162827456|NCT00243386|588080011|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
162827457|NCT00243386|588080009|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
162827458|NCT00243386|588080010|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
162827459|NCT00243386|588080011|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
162827460|NCT00243386|588080009|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
162827461|NCT00243386|588080010|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
162827462|NCT00243386|588080011|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
162827463|NCT00243386|588080009|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
162827464|NCT00243386|588080010|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
162827465|NCT00243386|588080011|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
162827466|NCT00243386|588080009|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
162827467|NCT00243386|588080010|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
162827468|NCT00243386|588080011|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
162827469|NCT00133991|588080012|FG000|Overall Study|Death|4|||
162827470|NCT04995055|588080016|FG000|Period 1|COVID-19 Related|1|||
162827471|NCT04995055|588080017|FG001|Period 1|COVID-19 Related|0|||
162827472|NCT04995055|588080016|FG000|Period 1|Withdrawal by Subject|0|||
162827473|NCT04995055|588080017|FG001|Period 1|Withdrawal by Subject|1|||
162827474|NCT04995055|588080016|FG000|Period 1|Subject discontinued due to timing|4|||
162827475|NCT04995055|588080017|FG001|Period 1|Subject discontinued due to timing|4|||
162827476|NCT03418129|588080018|FG000|Overall Study|Lost to Follow-up|11|||
162827477|NCT03418129|588080019|FG001|Overall Study|Lost to Follow-up|20|||
162827478|NCT03418129|588080020|FG002|Overall Study|Lost to Follow-up|15|||
162827479|NCT03418129|588080018|FG000|Overall Study|Withdrawal by Subject|3|||
162827480|NCT03418129|588080019|FG001|Overall Study|Withdrawal by Subject|6|||
162827481|NCT03418129|588080020|FG002|Overall Study|Withdrawal by Subject|4|||
162827482|NCT01378858|588080023|FG000|Overall Study|Withdrawal by Subject|4|||
162827483|NCT01378858|588080024|FG001|Overall Study|Withdrawal by Subject|4|||
162827484|NCT02664272|588080025|FG000|Overall Study|Fluoroscopic images not made available|2|||
162827485|NCT03073980|588080026|FG000|Overall Study|Lost to Follow-up|10|||
162827486|NCT03073980|588080027|FG001|Overall Study|Lost to Follow-up|2|||
162827487|NCT03073980|588080028|FG002|Overall Study|Lost to Follow-up|9|||
162827488|NCT03073980|588080026|FG000|Overall Study|No post-procedure data|0|||
162827489|NCT03073980|588080027|FG001|Overall Study|No post-procedure data|0|||
162827490|NCT03073980|588080028|FG002|Overall Study|No post-procedure data|2|||
162827491|NCT04810689|588080029|FG000|Overall Study|Withdrawal by Subject|0|||
162827492|NCT04810689|588080030|FG001|Overall Study|Withdrawal by Subject|1|||
162827493|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
162827494|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
162827495|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
162827496|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
163042839|NCT01990768|588863968|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
162827497|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
162827498|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
162827499|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162827500|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162827501|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
162827502|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
162827503|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162827504|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162827505|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
162827506|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
162827507|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
162827508|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
162827509|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
162827510|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
162827511|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
162827512|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
162827513|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
162827514|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
162827515|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
162827516|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
162827517|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Death|2|||
162827518|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Death|1|||
162827519|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Death|0|||
162827520|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Death|0|||
162827521|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
162827522|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
162827523|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
162827524|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
162827525|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
162827526|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
162827527|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
162827528|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
162827529|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
162827530|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
162827531|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162827532|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162827533|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
162827534|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
162827535|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
162827536|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
162827537|NCT01940471|588080031|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
162827538|NCT01940471|588080032|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
162827539|NCT01940471|588080033|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
162827540|NCT01940471|588080034|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
162827541|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162827542|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162827543|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
162827544|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
162827545|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162827546|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162827547|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
162827548|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
162827549|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162827550|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162827551|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
162827552|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
162827553|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
162827554|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
162827555|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
162827556|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
162827557|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162827558|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162827559|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
162827560|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
162827561|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162937160|NCT02711956|588473556|FG009|Overall Study|Physician Decision|0|||
162937161|NCT02711956|588473557|FG010|Overall Study|Physician Decision|0|||
162937162|NCT02711956|588473558|FG011|Overall Study|Physician Decision|0|||
162937163|NCT02711956|588473559|FG012|Overall Study|Physician Decision|0|||
162937164|NCT02711956|588473560|FG013|Overall Study|Physician Decision|0|||
162937165|NCT02711956|588473561|FG014|Overall Study|Physician Decision|0|||
162937166|NCT02711956|588473547|FG000|Overall Study|Withdrawal by Subject|0|||
162937167|NCT02711956|588473548|FG001|Overall Study|Withdrawal by Subject|0|||
162937168|NCT02711956|588473549|FG002|Overall Study|Withdrawal by Subject|0|||
162937169|NCT02711956|588473550|FG003|Overall Study|Withdrawal by Subject|0|||
162937170|NCT02711956|588473551|FG004|Overall Study|Withdrawal by Subject|0|||
162937171|NCT02711956|588473552|FG005|Overall Study|Withdrawal by Subject|0|||
162937172|NCT02711956|588473553|FG006|Overall Study|Withdrawal by Subject|1|||
162937173|NCT02711956|588473554|FG007|Overall Study|Withdrawal by Subject|0|||
162937174|NCT02711956|588473555|FG008|Overall Study|Withdrawal by Subject|0|||
162937175|NCT02711956|588473556|FG009|Overall Study|Withdrawal by Subject|0|||
162937176|NCT02711956|588473557|FG010|Overall Study|Withdrawal by Subject|0|||
162937177|NCT02711956|588473558|FG011|Overall Study|Withdrawal by Subject|1|||
162937178|NCT02711956|588473559|FG012|Overall Study|Withdrawal by Subject|6|||
162937179|NCT02711956|588473560|FG013|Overall Study|Withdrawal by Subject|0|||
162937180|NCT02711956|588473561|FG014|Overall Study|Withdrawal by Subject|1|||
162937181|NCT02711956|588473547|FG000|Overall Study|Clinical progression|1|||
162937182|NCT02711956|588473548|FG001|Overall Study|Clinical progression|0|||
162937183|NCT02711956|588473549|FG002|Overall Study|Clinical progression|0|||
162937184|NCT02711956|588473550|FG003|Overall Study|Clinical progression|0|||
162937185|NCT02711956|588473551|FG004|Overall Study|Clinical progression|0|||
162937186|NCT02711956|588473552|FG005|Overall Study|Clinical progression|0|||
162937187|NCT02711956|588473553|FG006|Overall Study|Clinical progression|1|||
162937188|NCT02711956|588473554|FG007|Overall Study|Clinical progression|0|||
162937189|NCT02711956|588473555|FG008|Overall Study|Clinical progression|1|||
162937190|NCT02711956|588473556|FG009|Overall Study|Clinical progression|0|||
162937191|NCT02711956|588473557|FG010|Overall Study|Clinical progression|0|||
162937192|NCT02711956|588473558|FG011|Overall Study|Clinical progression|2|||
162937193|NCT02711956|588473559|FG012|Overall Study|Clinical progression|4|||
162937194|NCT02711956|588473560|FG013|Overall Study|Clinical progression|1|||
162937195|NCT02711956|588473561|FG014|Overall Study|Clinical progression|1|||
162827562|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162827563|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
162827564|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
162827565|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162827566|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162827567|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
162827568|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162827569|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
162827570|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
162827571|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
162827572|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
162937196|NCT02711956|588473547|FG000|Overall Study|Radiographic progression|1|||
162937197|NCT02711956|588473548|FG001|Overall Study|Radiographic progression|1|||
162937198|NCT02711956|588473549|FG002|Overall Study|Radiographic progression|2|||
162937199|NCT02711956|588473550|FG003|Overall Study|Radiographic progression|0|||
162937200|NCT02711956|588473551|FG004|Overall Study|Radiographic progression|1|||
162937201|NCT02711956|588473552|FG005|Overall Study|Radiographic progression|0|||
162937202|NCT02711956|588473553|FG006|Overall Study|Radiographic progression|0|||
162937203|NCT02711956|588473554|FG007|Overall Study|Radiographic progression|0|||
162937204|NCT02711956|588473555|FG008|Overall Study|Radiographic progression|2|||
162937205|NCT02711956|588473556|FG009|Overall Study|Radiographic progression|1|||
162937206|NCT02711956|588473557|FG010|Overall Study|Radiographic progression|0|||
162937207|NCT02711956|588473558|FG011|Overall Study|Radiographic progression|5|||
162937208|NCT02711956|588473559|FG012|Overall Study|Radiographic progression|3|||
162937209|NCT02711956|588473560|FG013|Overall Study|Radiographic progression|0|||
162937210|NCT02711956|588473561|FG014|Overall Study|Radiographic progression|1|||
162937211|NCT02711956|588473547|FG000|Overall Study|PSA progression with clinical progression|0|||
162937212|NCT02711956|588473548|FG001|Overall Study|PSA progression with clinical progression|0|||
162937213|NCT02711956|588473549|FG002|Overall Study|PSA progression with clinical progression|0|||
162937214|NCT02711956|588473550|FG003|Overall Study|PSA progression with clinical progression|0|||
162937215|NCT02711956|588473551|FG004|Overall Study|PSA progression with clinical progression|1|||
162937216|NCT02711956|588473552|FG005|Overall Study|PSA progression with clinical progression|0|||
162937217|NCT02711956|588473553|FG006|Overall Study|PSA progression with clinical progression|0|||
162937218|NCT02711956|588473554|FG007|Overall Study|PSA progression with clinical progression|0|||
162937219|NCT02711956|588473555|FG008|Overall Study|PSA progression with clinical progression|0|||
162937220|NCT02711956|588473556|FG009|Overall Study|PSA progression with clinical progression|0|||
162937221|NCT02711956|588473557|FG010|Overall Study|PSA progression with clinical progression|0|||
162937222|NCT02711956|588473558|FG011|Overall Study|PSA progression with clinical progression|0|||
162937223|NCT02711956|588473559|FG012|Overall Study|PSA progression with clinical progression|1|||
162937224|NCT02711956|588473560|FG013|Overall Study|PSA progression with clinical progression|1|||
162937225|NCT02711956|588473561|FG014|Overall Study|PSA progression with clinical progression|0|||
162937226|NCT02711956|588473547|FG000|Overall Study|PSA progression with radiographic progression|0|||
162937227|NCT02711956|588473548|FG001|Overall Study|PSA progression with radiographic progression|1|||
162937228|NCT02711956|588473549|FG002|Overall Study|PSA progression with radiographic progression|0|||
162937229|NCT02711956|588473550|FG003|Overall Study|PSA progression with radiographic progression|0|||
162937230|NCT02711956|588473551|FG004|Overall Study|PSA progression with radiographic progression|0|||
162937231|NCT02711956|588473552|FG005|Overall Study|PSA progression with radiographic progression|2|||
162937232|NCT02711956|588473553|FG006|Overall Study|PSA progression with radiographic progression|2|||
162937233|NCT02711956|588473554|FG007|Overall Study|PSA progression with radiographic progression|1|||
162937234|NCT02711956|588473555|FG008|Overall Study|PSA progression with radiographic progression|0|||
162937235|NCT02711956|588473556|FG009|Overall Study|PSA progression with radiographic progression|1|||
162937236|NCT02711956|588473557|FG010|Overall Study|PSA progression with radiographic progression|0|||
162937237|NCT02711956|588473558|FG011|Overall Study|PSA progression with radiographic progression|1|||
162937238|NCT02711956|588473559|FG012|Overall Study|PSA progression with radiographic progression|2|||
162937239|NCT02711956|588473560|FG013|Overall Study|PSA progression with radiographic progression|3|||
162937240|NCT02711956|588473561|FG014|Overall Study|PSA progression with radiographic progression|3|||
162937241|NCT01844583|588473562|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
162937242|NCT01844583|588473563|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
162937243|NCT01625377|588473564|FG000|Overall Study|Death|1|||
162937244|NCT01625377|588473565|FG001|Overall Study|Death|1|||
162937245|NCT01625377|588473564|FG000|Overall Study|Administrative Problem|1|||
162937246|NCT01625377|588473565|FG001|Overall Study|Administrative Problem|1|||
162937247|NCT01625377|588473564|FG000|Overall Study|Protocol Violation|0|||
162937248|NCT01625377|588473565|FG001|Overall Study|Protocol Violation|3|||
162937249|NCT01625377|588473564|FG000|Overall Study|Adverse Event|3|||
162937250|NCT01625377|588473565|FG001|Overall Study|Adverse Event|16|||
162937251|NCT01625377|588473564|FG000|Overall Study|Graft loss|1|||
162937252|NCT01625377|588473565|FG001|Overall Study|Graft loss|0|||
162937253|NCT01625377|588473564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162937254|NCT01625377|588473565|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162937255|NCT01625377|588473564|FG000|Overall Study|Abnormal laboratory values|1|||
162937256|NCT01625377|588473565|FG001|Overall Study|Abnormal laboratory values|0|||
162937257|NCT03294538|588473570|FG000|Overall Study|Adverse Event|0|||
162937258|NCT03294538|588473571|FG001|Overall Study|Adverse Event|1|||
162937259|NCT03294538|588473572|FG002|Overall Study|Adverse Event|1|||
162937260|NCT03294538|588473570|FG000|Overall Study|Lost to Follow-up|1|||
162937261|NCT03294538|588473571|FG001|Overall Study|Lost to Follow-up|0|||
162937262|NCT03294538|588473572|FG002|Overall Study|Lost to Follow-up|0|||
162937263|NCT03294538|588473570|FG000|Overall Study|Outside of Visit Window|4|||
162937264|NCT03294538|588473571|FG001|Overall Study|Outside of Visit Window|4|||
162937265|NCT03294538|588473572|FG002|Overall Study|Outside of Visit Window|1|||
162937266|NCT01090765|588473574|FG000|Overall Study|Patient withdrew consent|0|||
162937267|NCT01090765|588473575|FG001|Overall Study|Patient withdrew consent|0|||
162937268|NCT01090765|588473576|FG002|Overall Study|Patient withdrew consent|0|||
162937269|NCT01090765|588473577|FG003|Overall Study|Patient withdrew consent|0|||
162937270|NCT01090765|588473578|FG004|Overall Study|Patient withdrew consent|1|||
162937271|NCT01090765|588473579|FG005|Overall Study|Patient withdrew consent|1|||
162937272|NCT01090765|588473574|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937273|NCT01090765|588473575|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937274|NCT01090765|588473576|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937275|NCT01090765|588473577|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
162937276|NCT01090765|588473578|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937277|NCT01090765|588473579|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
162937278|NCT01090765|588473574|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
162937279|NCT01090765|588473575|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
162937280|NCT01090765|588473576|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
162937281|NCT01090765|588473577|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
162937282|NCT01090765|588473578|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
162937283|NCT01090765|588473579|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
162937284|NCT01787825|588473580|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
162937285|NCT01787825|588473581|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
162827573|NCT01940471|588080031|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162937286|NCT01787825|588473580|FG000|Overall Study|Data Not Analyzable|5|||
162937287|NCT01787825|588473581|FG001|Overall Study|Data Not Analyzable|1|||
162937288|NCT00718159|588473586|FG000|Overall Study|Progressive Disease|3|||
162937289|NCT00718159|588473587|FG001|Overall Study|Progressive Disease|3|||
162937290|NCT00718159|588473588|FG002|Overall Study|Progressive Disease|2|||
162937291|NCT00718159|588473589|FG003|Overall Study|Progressive Disease|0|||
162937292|NCT00718159|588473590|FG004|Overall Study|Progressive Disease|6|||
162937293|NCT00718159|588473591|FG005|Overall Study|Progressive Disease|0|||
162937294|NCT00718159|588473592|FG006|Overall Study|Progressive Disease|0|||
162937295|NCT00718159|588473586|FG000|Overall Study|Death due to Adverse Event|0|||
162937296|NCT00718159|588473587|FG001|Overall Study|Death due to Adverse Event|0|||
162937297|NCT00718159|588473588|FG002|Overall Study|Death due to Adverse Event|0|||
162937298|NCT00718159|588473589|FG003|Overall Study|Death due to Adverse Event|2|||
162937299|NCT00718159|588473590|FG004|Overall Study|Death due to Adverse Event|2|||
162937300|NCT00718159|588473591|FG005|Overall Study|Death due to Adverse Event|0|||
162937301|NCT00718159|588473592|FG006|Overall Study|Death due to Adverse Event|0|||
162937302|NCT00718159|588473586|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
162937303|NCT00718159|588473587|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
162937304|NCT00718159|588473588|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
162937305|NCT00718159|588473589|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
162937306|NCT00718159|588473590|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
162937307|NCT00718159|588473591|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
162937308|NCT00718159|588473592|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
162937309|NCT00718159|588473586|FG000|Overall Study|Investigator Decision|0|||
162937310|NCT00718159|588473587|FG001|Overall Study|Investigator Decision|0|||
162827574|NCT01940471|588080032|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162827575|NCT01940471|588080033|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
162827576|NCT01940471|588080034|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162827577|NCT04695392|588080035|FG000|Overall Study|Withdrawn by parent/guardian|0|||
162827578|NCT04695392|588080036|FG001|Overall Study|Withdrawn by parent/guardian|1|||
162827579|NCT04695392|588080035|FG000|Overall Study|Withdrawn by physician|0|||
162827580|NCT04695392|588080036|FG001|Overall Study|Withdrawn by physician|1|||
162827581|NCT00450723|588080037|FG000|Overall Study|Physician Decision|5|||
162827582|NCT01721057|588080040|FG000|Treatment Period|Withdrawal by Subject|11|||
162827583|NCT01721057|588080041|FG001|Treatment Period|Withdrawal by Subject|5|||
162827584|NCT01721057|588080042|FG002|Treatment Period|Withdrawal by Subject|8|||
162827585|NCT01721057|588080043|FG003|Treatment Period|Withdrawal by Subject|0|||
162827586|NCT01721057|588080044|FG004|Treatment Period|Withdrawal by Subject|0|||
162827587|NCT01721057|588080045|FG005|Treatment Period|Withdrawal by Subject|0|||
162827588|NCT01721057|588080046|FG006|Treatment Period|Withdrawal by Subject|0|||
162827589|NCT01721057|588080040|FG000|Treatment Period|Adverse Event|7|||
162827590|NCT01721057|588080041|FG001|Treatment Period|Adverse Event|10|||
162827591|NCT01721057|588080042|FG002|Treatment Period|Adverse Event|12|||
162827592|NCT01721057|588080043|FG003|Treatment Period|Adverse Event|0|||
162827593|NCT01721057|588080044|FG004|Treatment Period|Adverse Event|0|||
162827594|NCT01721057|588080045|FG005|Treatment Period|Adverse Event|0|||
162827595|NCT01721057|588080046|FG006|Treatment Period|Adverse Event|0|||
162827596|NCT01721057|588080040|FG000|Treatment Period|Lack of Efficacy|7|||
162937311|NCT00718159|588473588|FG002|Overall Study|Investigator Decision|0|||
162937312|NCT00718159|588473589|FG003|Overall Study|Investigator Decision|0|||
162937313|NCT00718159|588473590|FG004|Overall Study|Investigator Decision|0|||
162937314|NCT00718159|588473591|FG005|Overall Study|Investigator Decision|1|||
162827597|NCT01721057|588080041|FG001|Treatment Period|Lack of Efficacy|3|||
162827598|NCT01721057|588080042|FG002|Treatment Period|Lack of Efficacy|0|||
162827599|NCT01721057|588080043|FG003|Treatment Period|Lack of Efficacy|0|||
162827600|NCT01721057|588080044|FG004|Treatment Period|Lack of Efficacy|0|||
162827601|NCT01721057|588080045|FG005|Treatment Period|Lack of Efficacy|0|||
162827602|NCT01721057|588080046|FG006|Treatment Period|Lack of Efficacy|0|||
162937315|NCT00718159|588473592|FG006|Overall Study|Investigator Decision|1|||
162937316|NCT01238848|588473594|FG000|Overall Study|Physician Decision|13|||
162937317|NCT01238848|588473595|FG001|Overall Study|Physician Decision|5|||
162937318|NCT02040766|588473596|FG000|Overall Study|Adverse Event|1|||
162937319|NCT02040766|588473597|FG001|Overall Study|Adverse Event|1|||
162937320|NCT02040766|588473598|FG002|Overall Study|Adverse Event|1|||
162937321|NCT02040766|588473599|FG003|Overall Study|Adverse Event|0|||
162937322|NCT02040766|588473600|FG004|Overall Study|Adverse Event|2|||
162937323|NCT02040766|588473596|FG000|Overall Study|Withdrawal by Subject|4|||
162937324|NCT02040766|588473597|FG001|Overall Study|Withdrawal by Subject|3|||
162937325|NCT02040766|588473598|FG002|Overall Study|Withdrawal by Subject|2|||
162937326|NCT02040766|588473599|FG003|Overall Study|Withdrawal by Subject|3|||
162937327|NCT02040766|588473600|FG004|Overall Study|Withdrawal by Subject|2|||
162937328|NCT02040766|588473596|FG000|Overall Study|Non-compliance|0|||
162937329|NCT02040766|588473597|FG001|Overall Study|Non-compliance|1|||
162937330|NCT02040766|588473598|FG002|Overall Study|Non-compliance|0|||
162937331|NCT02040766|588473599|FG003|Overall Study|Non-compliance|0|||
162937332|NCT02040766|588473600|FG004|Overall Study|Non-compliance|0|||
162937333|NCT02040766|588473596|FG000|Overall Study|Protocol Violation|2|||
162937334|NCT02040766|588473597|FG001|Overall Study|Protocol Violation|1|||
162937335|NCT02040766|588473598|FG002|Overall Study|Protocol Violation|2|||
162937336|NCT02040766|588473599|FG003|Overall Study|Protocol Violation|3|||
162937337|NCT02040766|588473600|FG004|Overall Study|Protocol Violation|0|||
162937338|NCT02040766|588473596|FG000|Overall Study|Lost to Follow-up|4|||
162937339|NCT02040766|588473597|FG001|Overall Study|Lost to Follow-up|1|||
162937340|NCT02040766|588473598|FG002|Overall Study|Lost to Follow-up|3|||
162937341|NCT02040766|588473599|FG003|Overall Study|Lost to Follow-up|1|||
162937342|NCT02040766|588473600|FG004|Overall Study|Lost to Follow-up|4|||
162937343|NCT02040766|588473596|FG000|Overall Study|Not reported|1|||
162937344|NCT02040766|588473597|FG001|Overall Study|Not reported|0|||
162937345|NCT02040766|588473598|FG002|Overall Study|Not reported|0|||
162937346|NCT02040766|588473599|FG003|Overall Study|Not reported|0|||
162937347|NCT02040766|588473600|FG004|Overall Study|Not reported|0|||
162937348|NCT02040766|588473596|FG000|Overall Study|Lack of Efficacy|6|||
162937349|NCT02040766|588473597|FG001|Overall Study|Lack of Efficacy|3|||
162937350|NCT02040766|588473598|FG002|Overall Study|Lack of Efficacy|4|||
162937351|NCT02040766|588473599|FG003|Overall Study|Lack of Efficacy|6|||
162937352|NCT02040766|588473600|FG004|Overall Study|Lack of Efficacy|5|||
162937353|NCT00798889|588473606|FG000|Overall Study|Adverse Event|53|||
162937354|NCT00798889|588473606|FG000|Overall Study|Protocol Violation|2|||
162937355|NCT00798889|588473606|FG000|Overall Study|Withdrawal by Subject|31|||
162937356|NCT00798889|588473606|FG000|Overall Study|Lost to Follow-up|1|||
162937357|NCT00798889|588473606|FG000|Overall Study|Lack of Efficacy|213|||
162937358|NCT00798889|588473606|FG000|Overall Study|Decision of Sponsor|11|||
162937359|NCT00798889|588473606|FG000|Overall Study|Enrolled, Not treated|3|||
162937360|NCT00617461|588473607|FG000|First Treatment Intervention Period|Adverse Event|2|||
162937361|NCT00617461|588473608|FG001|First Treatment Intervention Period|Adverse Event|0|||
162937362|NCT00617461|588473607|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
162937363|NCT00617461|588473608|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
162937364|NCT00617461|588473607|FG000|First Treatment Intervention Period|Protocol Violation|2|||
162937365|NCT00617461|588473608|FG001|First Treatment Intervention Period|Protocol Violation|1|||
162937366|NCT00617461|588473607|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
162937367|NCT00617461|588473608|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
162937368|NCT00617461|588473607|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
162937369|NCT00617461|588473608|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
162827603|NCT01721057|588080040|FG000|Treatment Period|Lost to Follow-up|1|||
162827604|NCT01721057|588080041|FG001|Treatment Period|Lost to Follow-up|0|||
162827605|NCT01721057|588080042|FG002|Treatment Period|Lost to Follow-up|0|||
162827606|NCT01721057|588080043|FG003|Treatment Period|Lost to Follow-up|0|||
162827607|NCT01721057|588080044|FG004|Treatment Period|Lost to Follow-up|0|||
162827608|NCT01721057|588080045|FG005|Treatment Period|Lost to Follow-up|0|||
162827609|NCT01721057|588080046|FG006|Treatment Period|Lost to Follow-up|0|||
162827610|NCT01721057|588080040|FG000|Treatment Period|Physician Decision|0|||
162827611|NCT01721057|588080041|FG001|Treatment Period|Physician Decision|1|||
162827612|NCT01721057|588080042|FG002|Treatment Period|Physician Decision|3|||
162827613|NCT01721057|588080043|FG003|Treatment Period|Physician Decision|0|||
162827614|NCT01721057|588080044|FG004|Treatment Period|Physician Decision|0|||
162827615|NCT01721057|588080045|FG005|Treatment Period|Physician Decision|0|||
162827616|NCT01721057|588080046|FG006|Treatment Period|Physician Decision|0|||
162827617|NCT01721057|588080040|FG000|Treatment Period|Death|2|||
162827618|NCT01721057|588080041|FG001|Treatment Period|Death|0|||
162827619|NCT01721057|588080042|FG002|Treatment Period|Death|0|||
162827620|NCT01721057|588080043|FG003|Treatment Period|Death|0|||
162827621|NCT01721057|588080044|FG004|Treatment Period|Death|0|||
162827622|NCT01721057|588080045|FG005|Treatment Period|Death|0|||
162827623|NCT01721057|588080046|FG006|Treatment Period|Death|0|||
162827624|NCT01721057|588080040|FG000|Rescue Period|Adverse Event|0|||
162827625|NCT01721057|588080041|FG001|Rescue Period|Adverse Event|0|||
162827626|NCT01721057|588080042|FG002|Rescue Period|Adverse Event|0|||
162827627|NCT01721057|588080043|FG003|Rescue Period|Adverse Event|1|||
162827628|NCT01721057|588080044|FG004|Rescue Period|Adverse Event|0|||
162827629|NCT01721057|588080045|FG005|Rescue Period|Adverse Event|0|||
162827630|NCT01721057|588080046|FG006|Rescue Period|Adverse Event|0|||
162827631|NCT01721057|588080040|FG000|Rescue Period|Lack of Efficacy|0|||
162827632|NCT01721057|588080041|FG001|Rescue Period|Lack of Efficacy|0|||
162827633|NCT01721057|588080042|FG002|Rescue Period|Lack of Efficacy|0|||
162827634|NCT01721057|588080043|FG003|Rescue Period|Lack of Efficacy|2|||
162827635|NCT01721057|588080044|FG004|Rescue Period|Lack of Efficacy|0|||
162827636|NCT01721057|588080045|FG005|Rescue Period|Lack of Efficacy|0|||
162827637|NCT01721057|588080046|FG006|Rescue Period|Lack of Efficacy|0|||
162827638|NCT01202279|588080047|FG000|Overall Study|Adverse Event|8|||
162827639|NCT01202279|588080048|FG001|Overall Study|Adverse Event|6|||
162827640|NCT01202279|588080047|FG000|Overall Study|Withdrawal by Subject|13|||
162827641|NCT01202279|588080048|FG001|Overall Study|Withdrawal by Subject|10|||
162827642|NCT01202279|588080047|FG000|Overall Study|Physician Decision|0|||
162827643|NCT01202279|588080048|FG001|Overall Study|Physician Decision|1|||
162827644|NCT01202279|588080047|FG000|Overall Study|Lost to Follow-up|10|||
162827645|NCT01202279|588080048|FG001|Overall Study|Lost to Follow-up|7|||
162827646|NCT01202279|588080047|FG000|Overall Study|Protocol Violation|1|||
162827647|NCT01202279|588080048|FG001|Overall Study|Protocol Violation|1|||
162827648|NCT01202279|588080047|FG000|Overall Study|study compliance|5|||
163042840|NCT01990768|588863969|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
162937370|NCT00617461|588473607|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
162937371|NCT00617461|588473608|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
162937372|NCT00617461|588473607|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
162937373|NCT00617461|588473608|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
162827649|NCT01202279|588080048|FG001|Overall Study|study compliance|2|||
162827650|NCT02047253|588080049|FG000|Overall Study|Lost to Follow-up|8|||
162827651|NCT03574753|588080050|FG000|Overall Study|Adverse Event|3|||
162827652|NCT03574753|588080050|FG000|Overall Study|Progression/relapse|19|||
162827653|NCT03574753|588080050|FG000|Overall Study|Death|1|||
162827654|NCT01987960|588080052|FG000|Period 1|Adverse Event|24|||
162827655|NCT01987960|588080053|FG001|Period 1|Adverse Event|0|||
162827656|NCT01987960|588080054|FG002|Period 1|Adverse Event|0|||
162827657|NCT01987960|588080055|FG003|Period 1|Adverse Event|0|||
162827658|NCT01987960|588080052|FG000|Period 1|Lack of Efficacy|4|||
162827659|NCT01987960|588080053|FG001|Period 1|Lack of Efficacy|0|||
162827660|NCT01987960|588080054|FG002|Period 1|Lack of Efficacy|0|||
162827661|NCT01987960|588080055|FG003|Period 1|Lack of Efficacy|0|||
162827662|NCT01987960|588080052|FG000|Period 1|Non-compliance with IMP|6|||
162827663|NCT01987960|588080053|FG001|Period 1|Non-compliance with IMP|0|||
162827664|NCT01987960|588080054|FG002|Period 1|Non-compliance with IMP|0|||
162827665|NCT01987960|588080055|FG003|Period 1|Non-compliance with IMP|0|||
162827666|NCT01987960|588080052|FG000|Period 1|Protocol Violation|12|||
162827667|NCT01987960|588080053|FG001|Period 1|Protocol Violation|0|||
162827668|NCT01987960|588080054|FG002|Period 1|Protocol Violation|0|||
162827669|NCT01987960|588080055|FG003|Period 1|Protocol Violation|0|||
162827670|NCT01987960|588080052|FG000|Period 1|Withdrawal by Subject|21|||
162827671|NCT01987960|588080053|FG001|Period 1|Withdrawal by Subject|0|||
162827672|NCT01987960|588080054|FG002|Period 1|Withdrawal by Subject|0|||
162827673|NCT01987960|588080055|FG003|Period 1|Withdrawal by Subject|0|||
162827674|NCT01987960|588080052|FG000|Period 1|Lost to Follow-up|40|||
162827675|NCT01987960|588080053|FG001|Period 1|Lost to Follow-up|0|||
162827676|NCT01987960|588080054|FG002|Period 1|Lost to Follow-up|0|||
162827677|NCT01987960|588080055|FG003|Period 1|Lost to Follow-up|0|||
162827678|NCT01987960|588080052|FG000|Period 1|administrative or other reason|75|||
162827679|NCT01987960|588080053|FG001|Period 1|administrative or other reason|0|||
162827680|NCT01987960|588080054|FG002|Period 1|administrative or other reason|0|||
162827681|NCT01987960|588080055|FG003|Period 1|administrative or other reason|0|||
162827682|NCT01987960|588080052|FG000|Period 1|Withdrawal of consent before treatment|4|||
162827683|NCT01987960|588080053|FG001|Period 1|Withdrawal of consent before treatment|0|||
162827684|NCT01987960|588080054|FG002|Period 1|Withdrawal of consent before treatment|0|||
162827685|NCT01987960|588080055|FG003|Period 1|Withdrawal of consent before treatment|0|||
162827686|NCT01987960|588080052|FG000|Period 2|Adverse Event|0|||
162827687|NCT01987960|588080053|FG001|Period 2|Adverse Event|0|||
162827688|NCT01987960|588080054|FG002|Period 2|Adverse Event|1|||
162827689|NCT01987960|588080055|FG003|Period 2|Adverse Event|0|||
162827690|NCT01987960|588080052|FG000|Period 2|Withdrawal by Subject|0|||
162827691|NCT01987960|588080053|FG001|Period 2|Withdrawal by Subject|0|||
162827692|NCT01987960|588080054|FG002|Period 2|Withdrawal by Subject|1|||
162827693|NCT01987960|588080055|FG003|Period 2|Withdrawal by Subject|0|||
162827694|NCT01987960|588080052|FG000|Period 2|Administrative or other reason|0|||
162827695|NCT01987960|588080053|FG001|Period 2|Administrative or other reason|5|||
162827696|NCT01987960|588080054|FG002|Period 2|Administrative or other reason|7|||
162827697|NCT01987960|588080055|FG003|Period 2|Administrative or other reason|0|||
162827698|NCT01987960|588080052|FG000|Period 3|Adverse Event|0|||
162827699|NCT01987960|588080053|FG001|Period 3|Adverse Event|0|||
162827700|NCT01987960|588080054|FG002|Period 3|Adverse Event|0|||
162827701|NCT01987960|588080055|FG003|Period 3|Adverse Event|7|||
162827702|NCT01987960|588080052|FG000|Period 3|Non-compliance with IMP|0|||
162827703|NCT01987960|588080053|FG001|Period 3|Non-compliance with IMP|0|||
162827704|NCT01987960|588080054|FG002|Period 3|Non-compliance with IMP|0|||
162827705|NCT01987960|588080055|FG003|Period 3|Non-compliance with IMP|1|||
162937374|NCT00617461|588473607|FG000|Second Treatment Intervention Period|Adverse Event|0|||
162937375|NCT00617461|588473608|FG001|Second Treatment Intervention Period|Adverse Event|1|||
162827706|NCT01987960|588080052|FG000|Period 3|Protocol Violation|0|||
162827707|NCT01987960|588080053|FG001|Period 3|Protocol Violation|0|||
162827708|NCT01987960|588080054|FG002|Period 3|Protocol Violation|0|||
162827709|NCT01987960|588080055|FG003|Period 3|Protocol Violation|6|||
162827710|NCT01987960|588080052|FG000|Period 3|Withdrawal by Subject|0|||
162827711|NCT01987960|588080053|FG001|Period 3|Withdrawal by Subject|0|||
162827712|NCT01987960|588080054|FG002|Period 3|Withdrawal by Subject|0|||
162827713|NCT01987960|588080055|FG003|Period 3|Withdrawal by Subject|9|||
162827714|NCT01987960|588080052|FG000|Period 3|Lost to Follow-up|0|||
162827715|NCT01987960|588080053|FG001|Period 3|Lost to Follow-up|0|||
162937376|NCT00617461|588473607|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
162827716|NCT01987960|588080054|FG002|Period 3|Lost to Follow-up|0|||
162827717|NCT01987960|588080055|FG003|Period 3|Lost to Follow-up|5|||
162827718|NCT01987960|588080052|FG000|Period 3|Administrative or other reason|0|||
162827719|NCT01987960|588080053|FG001|Period 3|Administrative or other reason|0|||
162827720|NCT01987960|588080054|FG002|Period 3|Administrative or other reason|0|||
162827721|NCT01987960|588080055|FG003|Period 3|Administrative or other reason|43|||
162827722|NCT00789880|588080057|FG000|Overall Study|Adverse Event|0|||
162937377|NCT00617461|588473608|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
162698516|NCT02733042|587605526|FG006|Overall Study|Adverse Event|0|||
162937378|NCT00617461|588473607|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
162827723|NCT00789880|588080058|FG001|Overall Study|Adverse Event|0|||
162827724|NCT00789880|588080059|FG002|Overall Study|Adverse Event|0|||
162827725|NCT00789880|588080060|FG003|Overall Study|Adverse Event|0|||
162827726|NCT00789880|588080061|FG004|Overall Study|Adverse Event|1|||
162827727|NCT00789880|588080062|FG005|Overall Study|Adverse Event|0|||
162827728|NCT00789880|588080057|FG000|Overall Study|Protocol Violation|0|||
162827729|NCT00789880|588080058|FG001|Overall Study|Protocol Violation|1|||
162827730|NCT00789880|588080059|FG002|Overall Study|Protocol Violation|0|||
162827731|NCT00789880|588080060|FG003|Overall Study|Protocol Violation|1|||
162827732|NCT00789880|588080061|FG004|Overall Study|Protocol Violation|0|||
162827733|NCT00789880|588080062|FG005|Overall Study|Protocol Violation|0|||
162827734|NCT00789880|588080057|FG000|Overall Study|Withdrawal by Subject|1|||
162827735|NCT00789880|588080058|FG001|Overall Study|Withdrawal by Subject|0|||
162827736|NCT00789880|588080059|FG002|Overall Study|Withdrawal by Subject|0|||
162827737|NCT00789880|588080060|FG003|Overall Study|Withdrawal by Subject|0|||
162827738|NCT00789880|588080061|FG004|Overall Study|Withdrawal by Subject|2|||
162827739|NCT00789880|588080062|FG005|Overall Study|Withdrawal by Subject|0|||
162937379|NCT00617461|588473608|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
162937380|NCT00617461|588473607|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
162827740|NCT01177683|588080063|FG000|Study Treatment|Disease Progressions during treatment|2|||
162827741|NCT01177683|588080064|FG001|Study Treatment|Disease Progressions during treatment|0|||
162827742|NCT01177683|588080065|FG002|Study Treatment|Disease Progressions during treatment|3|||
162827743|NCT01177683|588080063|FG000|Study Treatment|Adverse Event|0|||
162827744|NCT01177683|588080064|FG001|Study Treatment|Adverse Event|1|||
162827745|NCT01177683|588080065|FG002|Study Treatment|Adverse Event|12|||
162827746|NCT01177683|588080063|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162827747|NCT01177683|588080064|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
162827748|NCT01177683|588080065|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
162827749|NCT01177683|588080063|FG000|Study Treatment|Alternative therapy|0|||
162827750|NCT01177683|588080064|FG001|Study Treatment|Alternative therapy|0|||
162827751|NCT01177683|588080065|FG002|Study Treatment|Alternative therapy|4|||
162827752|NCT01177683|588080063|FG000|Study Treatment|Physician Decision|1|||
162827753|NCT01177683|588080064|FG001|Study Treatment|Physician Decision|0|||
162827754|NCT01177683|588080065|FG002|Study Treatment|Physician Decision|1|||
162827755|NCT01177683|588080063|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
162827756|NCT01177683|588080064|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
162827757|NCT01177683|588080065|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
162827758|NCT01177683|588080063|FG000|Study Treatment|Symptomatic Deterioration|0|||
162827759|NCT01177683|588080064|FG001|Study Treatment|Symptomatic Deterioration|0|||
162827760|NCT01177683|588080065|FG002|Study Treatment|Symptomatic Deterioration|1|||
162827761|NCT01177683|588080063|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
162827762|NCT01177683|588080064|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
162827763|NCT01177683|588080065|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
162827764|NCT01177683|588080063|FG000|Follow up|Patient lost to follow up|0|||
162827765|NCT01177683|588080064|FG001|Follow up|Patient lost to follow up|0|||
162827766|NCT01177683|588080065|FG002|Follow up|Patient lost to follow up|2|||
162827767|NCT01177683|588080063|FG000|Follow up|Death|2|||
162827768|NCT01177683|588080064|FG001|Follow up|Death|1|||
162827769|NCT01177683|588080065|FG002|Follow up|Death|7|||
162827770|NCT01177683|588080063|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
162698517|NCT02733042|587605527|FG007|Overall Study|Adverse Event|0|||
162827771|NCT01177683|588080064|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
162698518|NCT02733042|587605528|FG008|Overall Study|Adverse Event|0|||
162937381|NCT00617461|588473608|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
162937382|NCT05085964|588473609|FG000|Overall Study|Premature termination of study|21|||
162937383|NCT05085964|588473610|FG001|Overall Study|Premature termination of study|0|||
162937384|NCT01821625|588473611|FG000|Overall Study|Withdrawal by Subject|2|||
162937385|NCT01821625|588473611|FG000|Overall Study|Lack of Efficacy|2|||
162937386|NCT01821625|588473611|FG000|Overall Study|Adverse Event|1|||
162698519|NCT02733042|587605529|FG009|Overall Study|Adverse Event|0|||
162827772|NCT01177683|588080065|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
162827773|NCT06347731|588080066|FG000|Overall Study|Death|1|||
162827774|NCT06347731|588080066|FG000|Overall Study|Protocol Violation|1|||
162827775|NCT06347731|588080066|FG000|Overall Study|Withdrawal by Subject|2|||
163042841|NCT01990768|588863970|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
162827776|NCT00609986|588080072|FG000|Overall Study|Did not receive transplant or treatment|8|||
162827777|NCT00609986|588080073|FG001|Overall Study|Did not receive transplant or treatment|3|||
162937387|NCT01821625|588473611|FG000|Overall Study|Medical contraindication|1|||
162937388|NCT01620489|588473613|FG000|Overall Study|Adverse Event|17|||
162698520|NCT02733042|587605530|FG010|Overall Study|Adverse Event|2|||
162937389|NCT01620489|588473614|FG001|Overall Study|Adverse Event|4|||
162827778|NCT03159091|588080074|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
162937390|NCT01620489|588473613|FG000|Overall Study|Protocol Violation|0|||
162698521|NCT02733042|587605531|FG011|Overall Study|Adverse Event|2|||
162698522|NCT02733042|587605532|FG012|Overall Study|Adverse Event|0|||
162698523|NCT02733042|587605533|FG013|Overall Study|Adverse Event|2|||
162827779|NCT03159091|588080075|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
162937391|NCT01620489|588473614|FG001|Overall Study|Protocol Violation|3|||
162937392|NCT01620489|588473613|FG000|Overall Study|Withdrawal Criteria|17|||
162937393|NCT01620489|588473614|FG001|Overall Study|Withdrawal Criteria|25|||
162937394|NCT01620489|588473613|FG000|Overall Study|Unclassified|1|||
162827780|NCT03159091|588080074|FG000|Overall Study|Patient has taken no dose of study drug|0|||
162827781|NCT03159091|588080075|FG001|Overall Study|Patient has taken no dose of study drug|1|||
162827782|NCT02044133|588080079|FG000|Overall Study|Lost to Follow-up|1|||
162827783|NCT02044133|588080080|FG001|Overall Study|Lost to Follow-up|1|||
162827784|NCT02044133|588080079|FG000|Overall Study|Death|1|||
162827785|NCT02044133|588080080|FG001|Overall Study|Death|0|||
162827786|NCT02044133|588080079|FG000|Overall Study|Release|3|||
162827787|NCT02044133|588080080|FG001|Overall Study|Release|4|||
162937395|NCT01620489|588473614|FG001|Overall Study|Unclassified|2|||
162937396|NCT01829295|588473615|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
162937397|NCT01829295|588473616|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
162937398|NCT01829295|588473617|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
162937399|NCT01829295|588473618|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
162937400|NCT01829295|588473615|FG000|6-12 Months|Adverse Event|0|||
162937401|NCT01829295|588473616|FG001|6-12 Months|Adverse Event|0|||
162937402|NCT01829295|588473617|FG002|6-12 Months|Adverse Event|3|||
162937403|NCT01829295|588473618|FG003|6-12 Months|Adverse Event|2|||
162937404|NCT01829295|588473615|FG000|6-12 Months|Lost to Follow-up|2|||
162937405|NCT01829295|588473616|FG001|6-12 Months|Lost to Follow-up|0|||
162937406|NCT01829295|588473617|FG002|6-12 Months|Lost to Follow-up|0|||
162937407|NCT01829295|588473618|FG003|6-12 Months|Lost to Follow-up|0|||
162937408|NCT01829295|588473615|FG000|6-12 Months|Withdrawal by Subject|2|||
162937409|NCT01829295|588473616|FG001|6-12 Months|Withdrawal by Subject|2|||
162937410|NCT01829295|588473617|FG002|6-12 Months|Withdrawal by Subject|0|||
162937411|NCT01829295|588473618|FG003|6-12 Months|Withdrawal by Subject|0|||
162937412|NCT02629965|588473621|FG000|Period 1|Adverse Event|1|||
162937413|NCT02629965|588473622|FG001|Period 1|Adverse Event|0|||
162937414|NCT02629965|588473621|FG000|Period 1|Unexpected worsening of disease|2|||
162827788|NCT02044133|588080079|FG000|Overall Study|Transfer|1|||
162937415|NCT02629965|588473622|FG001|Period 1|Unexpected worsening of disease|0|||
162827789|NCT02044133|588080080|FG001|Overall Study|Transfer|0|||
162827790|NCT02044133|588080079|FG000|Overall Study|refusal of blood sampling|0|||
162827791|NCT02044133|588080080|FG001|Overall Study|refusal of blood sampling|1|||
162827792|NCT04085523|588080081|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
162827793|NCT04085523|588080082|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
162827794|NCT04085523|588080083|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
162827795|NCT04085523|588080084|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
162827796|NCT04085523|588080085|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
162827797|NCT04085523|588080086|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
162827798|NCT02046096|588080087|FG000|Overall Study|Death|28|||
162827799|NCT02046096|588080088|FG001|Overall Study|Death|45|||
162827800|NCT02046096|588080087|FG000|Overall Study|Lost to Follow-up|9|||
162827801|NCT02046096|588080088|FG001|Overall Study|Lost to Follow-up|20|||
162827802|NCT02046096|588080087|FG000|Overall Study|Withdrawal by Subject|5|||
162827803|NCT02046096|588080088|FG001|Overall Study|Withdrawal by Subject|17|||
162827804|NCT02046096|588080087|FG000|Overall Study|Other endpoint|2|||
162827805|NCT02046096|588080088|FG001|Overall Study|Other endpoint|19|||
162827806|NCT03520959|588080089|FG000|Overall Study|Study terminated by Sponsor|0|||
162827807|NCT03520959|588080090|FG001|Overall Study|Study terminated by Sponsor|1|||
162827808|NCT04969276|588080092|FG000|Overall Study|Protocol Deviation|0|||
162827809|NCT04969276|588080093|FG001|Overall Study|Protocol Deviation|1|||
162827810|NCT04969276|588080094|FG002|Overall Study|Protocol Deviation|0|||
162827811|NCT04969276|588080092|FG000|Overall Study|Withdrawal by Subject|1|||
162827812|NCT04969276|588080093|FG001|Overall Study|Withdrawal by Subject|10|||
162827813|NCT04969276|588080094|FG002|Overall Study|Withdrawal by Subject|0|||
162827814|NCT04969276|588080092|FG000|Overall Study|Lost to Follow-up|0|||
162827815|NCT04969276|588080093|FG001|Overall Study|Lost to Follow-up|1|||
162827816|NCT04969276|588080094|FG002|Overall Study|Lost to Follow-up|0|||
162827817|NCT00943579|588080100|FG000|Overall Study|Adverse Event|4|||
162827818|NCT00943579|588080101|FG001|Overall Study|Adverse Event|3|||
162937416|NCT02629965|588473621|FG000|Period 1|Other than listed above|1|||
162937417|NCT02629965|588473622|FG001|Period 1|Other than listed above|2|||
162937418|NCT02629965|588473621|FG000|Period 2|Adverse Event|1|||
162937419|NCT02629965|588473622|FG001|Period 2|Adverse Event|0|||
162937420|NCT03387059|588473626|FG000|Overall Study|Study termination|5|||
162937421|NCT03387059|588473627|FG001|Overall Study|Study termination|4|||
162827819|NCT00943579|588080100|FG000|Overall Study|Lack of Efficacy|2|||
162827820|NCT00943579|588080101|FG001|Overall Study|Lack of Efficacy|2|||
162827821|NCT00418665|588080104|FG000|Treatment Period|Ineligibility determined|1|||
162827822|NCT00418665|588080105|FG001|Treatment Period|Ineligibility determined|1|||
162827823|NCT00418665|588080106|FG002|Treatment Period|Ineligibility determined|0|||
162827824|NCT00418665|588080104|FG000|Treatment Period|Adverse Event|2|||
162827825|NCT00418665|588080105|FG001|Treatment Period|Adverse Event|2|||
162827826|NCT00418665|588080106|FG002|Treatment Period|Adverse Event|0|||
162827827|NCT00418665|588080104|FG000|Treatment Period|Withdrawal by Subject|0|||
162827828|NCT00418665|588080105|FG001|Treatment Period|Withdrawal by Subject|3|||
162827829|NCT00418665|588080106|FG002|Treatment Period|Withdrawal by Subject|1|||
162827830|NCT00418665|588080104|FG000|Treatment Period|Requirement for alternative therapy|1|||
162937422|NCT01606137|588473628|FG000|Overall Study|Adverse Event|85|||
162937423|NCT01606137|588473628|FG000|Overall Study|Withdrawal by Subject|74|||
162937424|NCT01606137|588473628|FG000|Overall Study|Lack of Efficacy|56|||
162937425|NCT01606137|588473628|FG000|Overall Study|Lost to Follow-up|15|||
162937426|NCT01606137|588473628|FG000|Overall Study|Protocol Violation|1|||
162937427|NCT01606137|588473628|FG000|Overall Study|Patient non-compliance|9|||
162937428|NCT01606137|588473628|FG000|Overall Study|Death|1|||
162937429|NCT01606137|588473628|FG000|Overall Study|Decreased/no pain|4|||
162937430|NCT01606137|588473628|FG000|Overall Study|Issues with driving|4|||
162827831|NCT00418665|588080105|FG001|Treatment Period|Requirement for alternative therapy|0|||
162827832|NCT00418665|588080106|FG002|Treatment Period|Requirement for alternative therapy|0|||
162827833|NCT00418665|588080104|FG000|Treatment Period|Physician Decision|1|||
162827834|NCT00418665|588080105|FG001|Treatment Period|Physician Decision|0|||
162827835|NCT00418665|588080106|FG002|Treatment Period|Physician Decision|3|||
162827836|NCT00418665|588080104|FG000|Treatment Extension|Adverse Event|1|||
162827837|NCT00418665|588080105|FG001|Treatment Extension|Adverse Event|0|||
162827838|NCT00418665|588080106|FG002|Treatment Extension|Adverse Event|0|||
162937431|NCT01606137|588473628|FG000|Overall Study|multiple sclerosis less stable|1|||
162698524|NCT02733042|587605534|FG014|Overall Study|Adverse Event|0|||
162937432|NCT01606137|588473628|FG000|Overall Study|Increased bilirubin|1|||
162698525|NCT02733042|587605535|FG015|Overall Study|Adverse Event|0|||
162698526|NCT02733042|587605536|FG016|Overall Study|Adverse Event|0|||
162698527|NCT02733042|587605537|FG017|Overall Study|Adverse Event|1|||
162937433|NCT01606137|588473628|FG000|Overall Study|Spray causes nausea|1|||
162937434|NCT01606137|588473628|FG000|Overall Study|Not enough improvement|4|||
162937435|NCT01606137|588473628|FG000|Overall Study|Wanted to try another treatment|1|||
162937436|NCT01606137|588473628|FG000|Overall Study|Patient leaving country|1|||
162937437|NCT01606137|588473628|FG000|Overall Study|Personal reasons|1|||
162937438|NCT01606137|588473628|FG000|Overall Study|Unable to tolerate study med. taste|1|||
162937439|NCT01606137|588473628|FG000|Overall Study|Patient moving|1|||
162698528|NCT02733042|587605538|FG018|Overall Study|Adverse Event|0|||
162937440|NCT01606137|588473628|FG000|Overall Study|Unable to collect consistent data|1|||
162937441|NCT05028751|588473638|FG000|Overall Study|Study Terminated by Sponsor|3|||
162937442|NCT05028751|588473639|FG001|Overall Study|Study Terminated by Sponsor|0|||
162937443|NCT05028751|588473640|FG002|Overall Study|Study Terminated by Sponsor|0|||
162937444|NCT05028751|588473641|FG003|Overall Study|Study Terminated by Sponsor|0|||
162937445|NCT05028751|588473638|FG000|Overall Study|Death|9|||
162937446|NCT05028751|588473639|FG001|Overall Study|Death|3|||
162937447|NCT05028751|588473640|FG002|Overall Study|Death|2|||
162827839|NCT00418665|588080104|FG000|Treatment Extension|Withdrawal by Subject|1|||
162827840|NCT00418665|588080105|FG001|Treatment Extension|Withdrawal by Subject|0|||
162827841|NCT00418665|588080106|FG002|Treatment Extension|Withdrawal by Subject|0|||
162698529|NCT02733042|587605520|FG000|Overall Study|Progressive Disease|2|||
162698530|NCT02733042|587605521|FG001|Overall Study|Progressive Disease|1|||
162937448|NCT05028751|588473641|FG003|Overall Study|Death|4|||
162937449|NCT05028751|588473638|FG000|Overall Study|Withdrawal by Subject|0|||
162937450|NCT05028751|588473639|FG001|Overall Study|Withdrawal by Subject|0|||
162937451|NCT05028751|588473640|FG002|Overall Study|Withdrawal by Subject|1|||
162937452|NCT05028751|588473641|FG003|Overall Study|Withdrawal by Subject|0|||
162937453|NCT05028751|588473638|FG000|Overall Study|Miscellaneous|2|||
162937454|NCT05028751|588473639|FG001|Overall Study|Miscellaneous|0|||
162937455|NCT05028751|588473640|FG002|Overall Study|Miscellaneous|0|||
162937456|NCT05028751|588473641|FG003|Overall Study|Miscellaneous|0|||
162937457|NCT03586830|588473643|FG000|Overall Study|Site terminated by Sponsor|1|||
162937458|NCT03586830|588473644|FG001|Overall Study|Site terminated by Sponsor|4|||
162937459|NCT03586830|588473645|FG002|Overall Study|Site terminated by Sponsor|3|||
162698531|NCT02733042|587605522|FG002|Overall Study|Progressive Disease|3|||
162937460|NCT03586830|588473646|FG003|Overall Study|Site terminated by Sponsor|3|||
162937461|NCT03586830|588473643|FG000|Overall Study|Lost to Follow-up|0|||
162937462|NCT03586830|588473644|FG001|Overall Study|Lost to Follow-up|2|||
162937463|NCT03586830|588473645|FG002|Overall Study|Lost to Follow-up|2|||
162937464|NCT03586830|588473646|FG003|Overall Study|Lost to Follow-up|1|||
162937465|NCT03586830|588473643|FG000|Overall Study|Withdrawal by Subject|1|||
162937466|NCT03586830|588473644|FG001|Overall Study|Withdrawal by Subject|0|||
162937467|NCT03586830|588473645|FG002|Overall Study|Withdrawal by Subject|3|||
162937468|NCT03586830|588473646|FG003|Overall Study|Withdrawal by Subject|1|||
162698532|NCT02733042|587605523|FG003|Overall Study|Progressive Disease|1|||
162937469|NCT00395083|588473647|FG000|Overall Study|Withdrawal by Subject|6|||
162937470|NCT00395083|588473648|FG001|Overall Study|Withdrawal by Subject|5|||
162937471|NCT00395083|588473647|FG000|Overall Study|Developed another disease|4|||
162937472|NCT00395083|588473648|FG001|Overall Study|Developed another disease|3|||
162937473|NCT00628745|588473653|FG000|Overall Study|Withdrawal by Subject|63|||
162937474|NCT00628745|588473654|FG001|Overall Study|Withdrawal by Subject|3|||
162937475|NCT00628745|588473655|FG002|Overall Study|Withdrawal by Subject|9|||
162937476|NCT00628745|588473656|FG003|Overall Study|Withdrawal by Subject|2|||
162937477|NCT00628745|588473657|FG004|Overall Study|Withdrawal by Subject|69|||
162937478|NCT00628745|588473653|FG000|Overall Study|Does not meet inclusion criteria|0|||
162937479|NCT00628745|588473654|FG001|Overall Study|Does not meet inclusion criteria|12|||
162937480|NCT00628745|588473655|FG002|Overall Study|Does not meet inclusion criteria|0|||
162937481|NCT00628745|588473656|FG003|Overall Study|Does not meet inclusion criteria|0|||
162937482|NCT00628745|588473657|FG004|Overall Study|Does not meet inclusion criteria|18|||
162937483|NCT00628745|588473653|FG000|Overall Study|Participation in an interventional clinical trial|81|||
162937484|NCT00628745|588473654|FG001|Overall Study|Participation in an interventional clinical trial|4|||
162937485|NCT00628745|588473655|FG002|Overall Study|Participation in an interventional clinical trial|7|||
162937486|NCT00628745|588473656|FG003|Overall Study|Participation in an interventional clinical trial|0|||
162937487|NCT00628745|588473657|FG004|Overall Study|Participation in an interventional clinical trial|63|||
162937488|NCT00628745|588473653|FG000|Overall Study|Physician Decision|8|||
162937489|NCT00628745|588473654|FG001|Overall Study|Physician Decision|4|||
162937490|NCT00628745|588473655|FG002|Overall Study|Physician Decision|3|||
162937491|NCT00628745|588473656|FG003|Overall Study|Physician Decision|0|||
162937492|NCT00628745|588473657|FG004|Overall Study|Physician Decision|30|||
162937493|NCT00628745|588473653|FG000|Overall Study|Lost to Follow-up|109|||
162937494|NCT00628745|588473654|FG001|Overall Study|Lost to Follow-up|7|||
162937495|NCT00628745|588473655|FG002|Overall Study|Lost to Follow-up|7|||
162698533|NCT02733042|587605524|FG004|Overall Study|Progressive Disease|2|||
162698534|NCT02733042|587605525|FG005|Overall Study|Progressive Disease|3|||
162698535|NCT02733042|587605526|FG006|Overall Study|Progressive Disease|0|||
162698536|NCT02733042|587605527|FG007|Overall Study|Progressive Disease|3|||
162698537|NCT02733042|587605528|FG008|Overall Study|Progressive Disease|3|||
162698538|NCT02733042|587605529|FG009|Overall Study|Progressive Disease|2|||
162698539|NCT02733042|587605530|FG010|Overall Study|Progressive Disease|2|||
162698540|NCT02733042|587605531|FG011|Overall Study|Progressive Disease|2|||
162698541|NCT02733042|587605532|FG012|Overall Study|Progressive Disease|8|||
162698542|NCT02733042|587605533|FG013|Overall Study|Progressive Disease|1|||
162698543|NCT02733042|587605534|FG014|Overall Study|Progressive Disease|4|||
162698544|NCT02733042|587605535|FG015|Overall Study|Progressive Disease|7|||
162698545|NCT02733042|587605536|FG016|Overall Study|Progressive Disease|2|||
162698546|NCT02733042|587605537|FG017|Overall Study|Progressive Disease|3|||
162698547|NCT02733042|587605538|FG018|Overall Study|Progressive Disease|4|||
162698548|NCT02733042|587605520|FG000|Overall Study|Withdrawal by Subject|0|||
162698549|NCT02733042|587605521|FG001|Overall Study|Withdrawal by Subject|1|||
162698550|NCT02733042|587605522|FG002|Overall Study|Withdrawal by Subject|2|||
162698551|NCT02733042|587605523|FG003|Overall Study|Withdrawal by Subject|1|||
162698552|NCT02733042|587605524|FG004|Overall Study|Withdrawal by Subject|1|||
162698553|NCT02733042|587605525|FG005|Overall Study|Withdrawal by Subject|0|||
162698554|NCT02733042|587605526|FG006|Overall Study|Withdrawal by Subject|0|||
162698555|NCT02733042|587605527|FG007|Overall Study|Withdrawal by Subject|0|||
162698556|NCT02733042|587605528|FG008|Overall Study|Withdrawal by Subject|1|||
162698557|NCT02733042|587605529|FG009|Overall Study|Withdrawal by Subject|1|||
162698558|NCT02733042|587605530|FG010|Overall Study|Withdrawal by Subject|0|||
162698559|NCT02733042|587605531|FG011|Overall Study|Withdrawal by Subject|2|||
162698560|NCT02733042|587605532|FG012|Overall Study|Withdrawal by Subject|1|||
162698561|NCT02733042|587605533|FG013|Overall Study|Withdrawal by Subject|1|||
162698562|NCT02733042|587605534|FG014|Overall Study|Withdrawal by Subject|0|||
162698563|NCT02733042|587605535|FG015|Overall Study|Withdrawal by Subject|0|||
162698564|NCT02733042|587605536|FG016|Overall Study|Withdrawal by Subject|0|||
162698565|NCT02733042|587605537|FG017|Overall Study|Withdrawal by Subject|0|||
162698566|NCT02733042|587605538|FG018|Overall Study|Withdrawal by Subject|0|||
162698567|NCT02733042|587605520|FG000|Overall Study|Other Reasons|0|||
162698568|NCT02733042|587605521|FG001|Overall Study|Other Reasons|0|||
162698569|NCT02733042|587605522|FG002|Overall Study|Other Reasons|1|||
162698570|NCT02733042|587605523|FG003|Overall Study|Other Reasons|0|||
162698571|NCT02733042|587605524|FG004|Overall Study|Other Reasons|0|||
162698572|NCT02733042|587605525|FG005|Overall Study|Other Reasons|0|||
162698573|NCT02733042|587605526|FG006|Overall Study|Other Reasons|0|||
162698574|NCT02733042|587605527|FG007|Overall Study|Other Reasons|0|||
162698575|NCT02733042|587605528|FG008|Overall Study|Other Reasons|0|||
162698576|NCT02733042|587605529|FG009|Overall Study|Other Reasons|1|||
162698577|NCT02733042|587605530|FG010|Overall Study|Other Reasons|1|||
162698578|NCT02733042|587605531|FG011|Overall Study|Other Reasons|0|||
162698579|NCT02733042|587605532|FG012|Overall Study|Other Reasons|0|||
162698580|NCT02733042|587605533|FG013|Overall Study|Other Reasons|0|||
162698581|NCT02733042|587605534|FG014|Overall Study|Other Reasons|0|||
162698582|NCT02733042|587605535|FG015|Overall Study|Other Reasons|1|||
162937496|NCT00628745|588473656|FG003|Overall Study|Lost to Follow-up|0|||
162827842|NCT00418665|588080104|FG000|Treatment Extension|Requirement for alternative therapy|2|||
162827843|NCT00418665|588080105|FG001|Treatment Extension|Requirement for alternative therapy|2|||
162827844|NCT00418665|588080106|FG002|Treatment Extension|Requirement for alternative therapy|0|||
162827845|NCT00418665|588080104|FG000|Treatment Extension|Physician Decision|2|||
162827846|NCT00418665|588080105|FG001|Treatment Extension|Physician Decision|2|||
162827847|NCT00418665|588080106|FG002|Treatment Extension|Physician Decision|1|||
162827848|NCT00418665|588080104|FG000|Treatment Extension|Death|0|||
162827849|NCT00418665|588080105|FG001|Treatment Extension|Death|0|||
162827850|NCT00418665|588080106|FG002|Treatment Extension|Death|1|||
162827851|NCT00853749|588080107|FG000|Overall Study|Lost to Follow-up|0|||
162827852|NCT00853749|588080108|FG001|Overall Study|Lost to Follow-up|1|||
162698583|NCT02733042|587605536|FG016|Overall Study|Other Reasons|0|||
162827853|NCT00687440|588080109|FG000|Overall Study|Adverse Event|3|||
162698584|NCT02733042|587605537|FG017|Overall Study|Other Reasons|1|||
162698585|NCT02733042|587605538|FG018|Overall Study|Other Reasons|0|||
162827854|NCT00687440|588080109|FG000|Overall Study|Lost to Follow-up|3|||
162827855|NCT00687440|588080109|FG000|Overall Study|Lack of Efficacy|2|||
162827856|NCT00687440|588080109|FG000|Overall Study|Death|2|||
162937497|NCT00628745|588473657|FG004|Overall Study|Lost to Follow-up|498|||
162937498|NCT00628745|588473653|FG000|Overall Study|Death|197|||
162937499|NCT00628745|588473654|FG001|Overall Study|Death|81|||
162937500|NCT00628745|588473655|FG002|Overall Study|Death|12|||
162937501|NCT00628745|588473656|FG003|Overall Study|Death|4|||
162937502|NCT00628745|588473657|FG004|Overall Study|Death|939|||
162937503|NCT00628745|588473653|FG000|Overall Study|Participant transferred to another THAOS site|6|||
162937504|NCT00628745|588473654|FG001|Overall Study|Participant transferred to another THAOS site|0|||
162937505|NCT00628745|588473655|FG002|Overall Study|Participant transferred to another THAOS site|0|||
162937506|NCT00628745|588473656|FG003|Overall Study|Participant transferred to another THAOS site|0|||
162937507|NCT00628745|588473657|FG004|Overall Study|Participant transferred to another THAOS site|7|||
162937508|NCT00628745|588473653|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
162937509|NCT00628745|588473654|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
162937510|NCT00628745|588473655|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
162937511|NCT00628745|588473656|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
162937512|NCT00628745|588473657|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
162937513|NCT00628745|588473653|FG000|Overall Study|Site closure|152|||
162937514|NCT00628745|588473654|FG001|Overall Study|Site closure|146|||
162937515|NCT00628745|588473655|FG002|Overall Study|Site closure|6|||
162937516|NCT00628745|588473656|FG003|Overall Study|Site closure|8|||
162937517|NCT00628745|588473657|FG004|Overall Study|Site closure|691|||
162937518|NCT00628745|588473653|FG000|Overall Study|Duplicate participant|0|||
162937519|NCT00628745|588473654|FG001|Overall Study|Duplicate participant|0|||
162937520|NCT00628745|588473655|FG002|Overall Study|Duplicate participant|0|||
162937521|NCT00628745|588473656|FG003|Overall Study|Duplicate participant|0|||
162937522|NCT00628745|588473657|FG004|Overall Study|Duplicate participant|1|||
162937523|NCT00628745|588473653|FG000|Overall Study|Missing|4|||
162937524|NCT00628745|588473654|FG001|Overall Study|Missing|3|||
162937525|NCT00628745|588473655|FG002|Overall Study|Missing|0|||
162937526|NCT00628745|588473656|FG003|Overall Study|Missing|0|||
162937527|NCT00628745|588473657|FG004|Overall Study|Missing|10|||
162937528|NCT00628745|588473653|FG000|Overall Study|Othe reasons|987|||
162937529|NCT00628745|588473654|FG001|Overall Study|Othe reasons|373|||
162937530|NCT00628745|588473655|FG002|Overall Study|Othe reasons|105|||
162937531|NCT00628745|588473656|FG003|Overall Study|Othe reasons|1|||
162937532|NCT00628745|588473657|FG004|Overall Study|Othe reasons|1772|||
162937533|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
162937534|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
162937535|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
162937536|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
162937537|NCT00982410|588475473|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
162937538|NCT00982410|588475474|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
162937539|NCT00982410|588475473|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
162937540|NCT00982410|588475474|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
162937541|NCT00982410|588475473|FG000|6-month Follow-up Assessment|participant no transportation|1|||
162937542|NCT00982410|588475474|FG001|6-month Follow-up Assessment|participant no transportation|0|||
162937543|NCT00982410|588475473|FG000|6-month Follow-up Assessment|incarceration|0|||
162937544|NCT00982410|588475474|FG001|6-month Follow-up Assessment|incarceration|2|||
162937545|NCT00982410|588475473|FG000|6-month Follow-up Assessment|patent surgery|0|||
162937546|NCT00982410|588475474|FG001|6-month Follow-up Assessment|patent surgery|1|||
162937547|NCT00982410|588475473|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
162937548|NCT00982410|588475474|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
162937549|NCT00982410|588475473|FG000|12-month Follow-up Assessment|Death|0|||
162937550|NCT00982410|588475474|FG001|12-month Follow-up Assessment|Death|2|||
162937551|NCT00982410|588475473|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
162937552|NCT00982410|588475474|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
162937553|NCT00982410|588475473|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
162937554|NCT00982410|588475474|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
162937555|NCT00982410|588475473|FG000|12-month Follow-up Assessment|incarceration|2|||
162937556|NCT00982410|588475474|FG001|12-month Follow-up Assessment|incarceration|1|||
162937557|NCT00982410|588475473|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
162937558|NCT00982410|588475474|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
162937559|NCT02034799|588475477|FG000|Overall Study|Withdrawal by Subject|0|||
162937560|NCT02034799|588475478|FG001|Overall Study|Withdrawal by Subject|2|||
162937561|NCT02034799|588475477|FG000|Overall Study|Lost to Follow-up|0|||
162937562|NCT02034799|588475478|FG001|Overall Study|Lost to Follow-up|1|||
162937563|NCT02034799|588475477|FG000|Overall Study|Death|2|||
162937564|NCT02034799|588475478|FG001|Overall Study|Death|1|||
162937565|NCT03381248|588475482|FG000|0-6 Months|Withdrawal by Subject|4|||
162937566|NCT03381248|588475483|FG001|0-6 Months|Withdrawal by Subject|1|||
162937567|NCT03381248|588475482|FG000|0-6 Months|Lost to Follow-up|3|||
162937568|NCT03381248|588475483|FG001|0-6 Months|Lost to Follow-up|2|||
162937569|NCT03381248|588475482|FG000|0-6 Months|Lack of Efficacy|1|||
162937570|NCT03381248|588475483|FG001|0-6 Months|Lack of Efficacy|0|||
162937571|NCT03381248|588475482|FG000|0-6 Months|Adverse Event|1|||
162937572|NCT03381248|588475483|FG001|0-6 Months|Adverse Event|0|||
162937573|NCT03381248|588475482|FG000|0-6 Months|Protocol Violation|2|||
162937574|NCT03381248|588475483|FG001|0-6 Months|Protocol Violation|1|||
162937575|NCT03381248|588475482|FG000|0-6 Months|Physician Decision|1|||
162937576|NCT03381248|588475483|FG001|0-6 Months|Physician Decision|0|||
162937577|NCT03381248|588475482|FG000|0-6 Months|Planning another procedure|1|||
162937578|NCT03381248|588475483|FG001|0-6 Months|Planning another procedure|2|||
162937579|NCT03381248|588475482|FG000|6-12 Months|Withdrawal by Subject|1|||
162937580|NCT03381248|588475483|FG001|6-12 Months|Withdrawal by Subject|3|||
162937581|NCT03381248|588475482|FG000|6-12 Months|Lost to Follow-up|0|||
162937582|NCT03381248|588475483|FG001|6-12 Months|Lost to Follow-up|2|||
162937583|NCT03381248|588475482|FG000|6-12 Months|Protocol Violation|3|||
162937584|NCT03381248|588475483|FG001|6-12 Months|Protocol Violation|2|||
162937585|NCT03381248|588475482|FG000|6-12 Months|Planning another procedure|6|||
162937586|NCT03381248|588475483|FG001|6-12 Months|Planning another procedure|2|||
162937587|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
162937588|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
162937589|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
162937590|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
162937591|NCT03381248|588475482|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
162937592|NCT03381248|588475483|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
162937593|NCT05188521|588475488|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
162937594|NCT05188521|588475489|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
162937595|NCT01341639|588475490|FG000|Infant Series|Protocol Violation|1|||
162937596|NCT01341639|588475491|FG001|Infant Series|Protocol Violation|0|||
162937597|NCT01341639|588475490|FG000|Infant Series|Not Vaccinated|0|||
162937598|NCT01341639|588475491|FG001|Infant Series|Not Vaccinated|1|||
162937599|NCT01341639|588475490|FG000|Infant Series|Adverse Event|0|||
162937600|NCT01341639|588475491|FG001|Infant Series|Adverse Event|5|||
162937601|NCT01341639|588475490|FG000|Infant Series|Withdrawal by Subject|11|||
162937602|NCT01341639|588475491|FG001|Infant Series|Withdrawal by Subject|8|||
162937603|NCT01341639|588475490|FG000|Infant Series|Lost to Follow-up|0|||
162937604|NCT01341639|588475491|FG001|Infant Series|Lost to Follow-up|2|||
162937605|NCT01341639|588475490|FG000|Infant Series|Site 0048 Participants|17|||
162937606|NCT01341639|588475491|FG001|Infant Series|Site 0048 Participants|16|||
162937607|NCT01341639|588475490|FG000|Interim Period|Withdrawal by Subject|6|||
162937608|NCT01341639|588475491|FG001|Interim Period|Withdrawal by Subject|7|||
162937609|NCT01341639|588475490|FG000|Interim Period|Lost to Follow-up|2|||
162937610|NCT01341639|588475491|FG001|Interim Period|Lost to Follow-up|0|||
162937611|NCT01341639|588475490|FG000|Interim Period|Physician Decision|0|||
162827857|NCT00687440|588080109|FG000|Overall Study|Other|1|||
162827858|NCT00687440|588080109|FG000|Overall Study|Missing|1|||
162827859|NCT01538628|588080112|FG000|Overall Study|Withdrawal by Subject|1|||
162827860|NCT01538628|588080113|FG001|Overall Study|Withdrawal by Subject|1|||
162827861|NCT01538628|588080112|FG000|Overall Study|Lost to Follow-up|0|||
162827862|NCT01538628|588080113|FG001|Overall Study|Lost to Follow-up|1|||
162827863|NCT00307151|588081337|FG000|Overall Study|Death|4|||
162827864|NCT00307151|588081338|FG001|Overall Study|Death|3|||
162827865|NCT00307151|588081339|FG002|Overall Study|Death|10|||
162827866|NCT00307151|588081340|FG003|Overall Study|Death|3|||
162827867|NCT00307151|588081337|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162827868|NCT00307151|588081338|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162827869|NCT00307151|588081339|FG002|Overall Study|Severe debilitation, unable to continue|0|||
162827870|NCT00307151|588081340|FG003|Overall Study|Severe debilitation, unable to continue|0|||
162827871|NCT00307151|588081337|FG000|Overall Study|Subject unable to get to clinic|1|||
162827872|NCT00307151|588081338|FG001|Overall Study|Subject unable to get to clinic|0|||
162827873|NCT00307151|588081339|FG002|Overall Study|Subject unable to get to clinic|6|||
162827874|NCT00307151|588081340|FG003|Overall Study|Subject unable to get to clinic|2|||
162827875|NCT00307151|588081337|FG000|Overall Study|Withdrew consent|0|||
162827876|NCT00307151|588081338|FG001|Overall Study|Withdrew consent|1|||
162827877|NCT00307151|588081339|FG002|Overall Study|Withdrew consent|1|||
162827878|NCT00307151|588081340|FG003|Overall Study|Withdrew consent|3|||
162827879|NCT00307151|588081337|FG000|Overall Study|Not willing to adhere to study reqs|2|||
162827880|NCT00307151|588081338|FG001|Overall Study|Not willing to adhere to study reqs|0|||
162827881|NCT00307151|588081339|FG002|Overall Study|Not willing to adhere to study reqs|2|||
162827882|NCT00307151|588081340|FG003|Overall Study|Not willing to adhere to study reqs|2|||
162827883|NCT00307151|588081337|FG000|Overall Study|Clinic unable to contact subject|3|||
162827884|NCT00307151|588081338|FG001|Overall Study|Clinic unable to contact subject|3|||
162827885|NCT00307151|588081339|FG002|Overall Study|Clinic unable to contact subject|1|||
162827886|NCT00307151|588081340|FG003|Overall Study|Clinic unable to contact subject|1|||
162827887|NCT02263079|588081343|FG000|Overall Study|Physician Decision|1|||
162827888|NCT02263079|588081344|FG001|Overall Study|Physician Decision|0|||
162827889|NCT02263079|588081345|FG002|Overall Study|Physician Decision|0|||
162827890|NCT02263079|588081343|FG000|Overall Study|Withdrawal by Subject|2|||
162827891|NCT02263079|588081344|FG001|Overall Study|Withdrawal by Subject|8|||
162827892|NCT02263079|588081345|FG002|Overall Study|Withdrawal by Subject|0|||
162827893|NCT00402649|588081346|FG000|Overall Study|Lost to Follow-up|1|||
162827894|NCT00402649|588081346|FG000|Overall Study|Withdrawal by Subject|1|||
162827895|NCT01321710|588081352|FG000|Overall Study|Lost to Follow-up|4|||
162827896|NCT01321710|588081353|FG001|Overall Study|Lost to Follow-up|5|||
162827897|NCT01321710|588081354|FG002|Overall Study|Lost to Follow-up|0|||
162827898|NCT01761292|588081355|FG000|Part 1|Adverse Event|1|||
162827899|NCT01761292|588081355|FG000|Part 1|not receiving treatment in Part 1|1|||
162827900|NCT01761292|588081355|FG000|Extension 1|Withdrawal by Subject|1|||
162827901|NCT00840086|588081356|FG000|Overall Study|Adverse Event|1|||
162827902|NCT00840086|588081356|FG000|Overall Study|Protocol Violation|2|||
162827903|NCT00840086|588081356|FG000|Overall Study|Lost to Follow-up|1|||
162827904|NCT03332498|588081357|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
162827905|NCT03332498|588081358|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
162827906|NCT03332498|588081359|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
162827907|NCT05611671|588081360|FG000|Overall Study|Adverse Event|1|||
162827908|NCT05611671|588081361|FG001|Overall Study|Adverse Event|1|||
162827909|NCT05611671|588081362|FG002|Overall Study|Adverse Event|0|||
162827910|NCT05611671|588081363|FG003|Overall Study|Adverse Event|1|||
162827911|NCT05611671|588081360|FG000|Overall Study|Lack of Efficacy|1|||
162827912|NCT05611671|588081361|FG001|Overall Study|Lack of Efficacy|0|||
162827913|NCT05611671|588081362|FG002|Overall Study|Lack of Efficacy|1|||
162827914|NCT05611671|588081363|FG003|Overall Study|Lack of Efficacy|2|||
162827915|NCT05611671|588081360|FG000|Overall Study|Lost to Follow-up|0|||
162827916|NCT05611671|588081361|FG001|Overall Study|Lost to Follow-up|0|||
162827917|NCT05611671|588081362|FG002|Overall Study|Lost to Follow-up|0|||
162827918|NCT05611671|588081363|FG003|Overall Study|Lost to Follow-up|1|||
162827919|NCT05611671|588081360|FG000|Overall Study|Protocol Violation|0|||
162827920|NCT05611671|588081361|FG001|Overall Study|Protocol Violation|1|||
162827921|NCT05611671|588081362|FG002|Overall Study|Protocol Violation|0|||
162827922|NCT05611671|588081363|FG003|Overall Study|Protocol Violation|0|||
162827923|NCT05611671|588081360|FG000|Overall Study|Withdrawal by Subject|2|||
162827924|NCT05611671|588081361|FG001|Overall Study|Withdrawal by Subject|1|||
162827925|NCT05611671|588081362|FG002|Overall Study|Withdrawal by Subject|2|||
162827926|NCT05611671|588081363|FG003|Overall Study|Withdrawal by Subject|1|||
162827927|NCT03179891|588081364|FG000|First Intervention|Withdrawal by Subject|1|||
162827928|NCT03179891|588081365|FG001|First Intervention|Withdrawal by Subject|1|||
162827929|NCT03179891|588081364|FG000|First Intervention|Unspecified reason|1|||
162827930|NCT03179891|588081365|FG001|First Intervention|Unspecified reason|0|||
162827931|NCT03179891|588081364|FG000|First Intervention|Protocol Violation|0|||
162827932|NCT03179891|588081365|FG001|First Intervention|Protocol Violation|1|||
162827933|NCT00383084|588081372|FG000|Overall Study|Withdrawal by Subject|12|||
162827934|NCT00383084|588081373|FG001|Overall Study|Withdrawal by Subject|10|||
162827935|NCT02113436|588081374|FG000|Period 1: 8 Weeks|Adverse Event|1|||
162827936|NCT02113436|588081375|FG001|Period 1: 8 Weeks|Adverse Event|0|||
162827937|NCT02113436|588081376|FG002|Period 1: 8 Weeks|Adverse Event|0|||
162827938|NCT02113436|588081377|FG003|Period 1: 8 Weeks|Adverse Event|0|||
162827939|NCT02113436|588081374|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
162827940|NCT02113436|588081375|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
162827941|NCT02113436|588081376|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
162827942|NCT02113436|588081377|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
162827943|NCT02113436|588081374|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
162827944|NCT02113436|588081375|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
162827945|NCT02113436|588081376|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
162827946|NCT02113436|588081377|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
162827947|NCT02113436|588081374|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
162827948|NCT02113436|588081375|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
162827949|NCT02113436|588081376|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
162827950|NCT02113436|588081377|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
162827951|NCT02113436|588081374|FG000|Period 2: 16 Weeks|Adverse Event|0|||
162827952|NCT02113436|588081375|FG001|Period 2: 16 Weeks|Adverse Event|0|||
162827953|NCT02113436|588081376|FG002|Period 2: 16 Weeks|Adverse Event|4|||
162827954|NCT02113436|588081377|FG003|Period 2: 16 Weeks|Adverse Event|5|||
162827955|NCT02113436|588081374|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
162827956|NCT02113436|588081375|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
162827957|NCT02113436|588081376|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
162827958|NCT02113436|588081377|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
162827959|NCT02113436|588081374|FG000|Period 2: 16 Weeks|Physician Decision|0|||
162827960|NCT02113436|588081375|FG001|Period 2: 16 Weeks|Physician Decision|0|||
162827961|NCT02113436|588081376|FG002|Period 2: 16 Weeks|Physician Decision|2|||
162827962|NCT02113436|588081377|FG003|Period 2: 16 Weeks|Physician Decision|0|||
162827963|NCT02113436|588081374|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
162827964|NCT02113436|588081375|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
162827965|NCT02113436|588081376|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
162827966|NCT02113436|588081377|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
162827967|NCT01486927|588081378|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
162827968|NCT01486927|588081378|FG000|Overall Study|Physician Decision|1|||
162827969|NCT01486927|588081378|FG000|Overall Study|50 Exposure days not reached|2|||
162827970|NCT01486927|588081378|FG000|Overall Study|Withdrawal by Subject|8|||
162827971|NCT01486927|588081378|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
162827972|NCT02159729|588081379|FG000|Overall Study|Adverse Event|0|||
162827973|NCT02159729|588081380|FG001|Overall Study|Adverse Event|1|||
162827974|NCT02159729|588081379|FG000|Overall Study|Subject's Request|13|||
162827975|NCT02159729|588081380|FG001|Overall Study|Subject's Request|10|||
162827976|NCT02159729|588081379|FG000|Overall Study|Lost to Follow-up|24|||
162827977|NCT02159729|588081380|FG001|Overall Study|Lost to Follow-up|9|||
162827978|NCT02159729|588081379|FG000|Overall Study|Non compliance|2|||
162827979|NCT02159729|588081380|FG001|Overall Study|Non compliance|0|||
162827980|NCT02159729|588081379|FG000|Overall Study|Other Unspecified|3|||
162827981|NCT02159729|588081380|FG001|Overall Study|Other Unspecified|1|||
162827982|NCT02636582|588081381|FG000|Overall Study|Surgical Pathology|1|||
162827983|NCT02636582|588081382|FG001|Overall Study|Surgical Pathology|0|||
162827984|NCT00573430|588081383|FG000|Overall Study|Incorrect enrollment of randomization|0|||
162827985|NCT00573430|588081384|FG001|Overall Study|Incorrect enrollment of randomization|4|||
162827986|NCT00573430|588081385|FG002|Overall Study|Incorrect enrollment of randomization|3|||
162827987|NCT00573430|588081383|FG000|Overall Study|Adverse Event|0|||
162827988|NCT00573430|588081384|FG001|Overall Study|Adverse Event|0|||
162827989|NCT00573430|588081385|FG002|Overall Study|Adverse Event|2|||
162827990|NCT00573430|588081383|FG000|Overall Study|Withdrawal by Subject|1|||
162827991|NCT00573430|588081384|FG001|Overall Study|Withdrawal by Subject|0|||
162827992|NCT00573430|588081385|FG002|Overall Study|Withdrawal by Subject|1|||
162827993|NCT00573430|588081383|FG000|Overall Study|Protocol Violation|0|||
162827994|NCT00573430|588081384|FG001|Overall Study|Protocol Violation|1|||
162827995|NCT00573430|588081385|FG002|Overall Study|Protocol Violation|1|||
162827996|NCT00573430|588081383|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162827997|NCT00573430|588081384|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162827998|NCT00573430|588081385|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
162827999|NCT05895552|588081386|FG000|Overall Study|Adverse Event|2|||
162828000|NCT05895552|588081387|FG001|Overall Study|Adverse Event|2|||
162828001|NCT05895552|588081388|FG002|Overall Study|Adverse Event|1|||
162828002|NCT05895552|588081386|FG000|Overall Study|Lost to Follow-up|0|||
162828003|NCT05895552|588081387|FG001|Overall Study|Lost to Follow-up|1|||
162828004|NCT05895552|588081388|FG002|Overall Study|Lost to Follow-up|0|||
162828005|NCT05895552|588081386|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162828006|NCT05895552|588081387|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162828007|NCT05895552|588081388|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162828008|NCT05895552|588081386|FG000|Overall Study|Protocol Deviation|0|||
162828009|NCT05895552|588081387|FG001|Overall Study|Protocol Deviation|0|||
162828010|NCT05895552|588081388|FG002|Overall Study|Protocol Deviation|2|||
162828011|NCT05895552|588081386|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
162828012|NCT05895552|588081387|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
162828013|NCT05895552|588081388|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
162828014|NCT05895552|588081386|FG000|Overall Study|Withdrawal by Subject|2|||
162828015|NCT05895552|588081387|FG001|Overall Study|Withdrawal by Subject|2|||
162828016|NCT05895552|588081388|FG002|Overall Study|Withdrawal by Subject|4|||
162828017|NCT03810911|588081389|FG000|Overall Study|Death|1|||
162828018|NCT03810911|588081390|FG001|Overall Study|Death|1|||
162828019|NCT03810911|588081389|FG000|Overall Study|Withdrawal by Subject|1|||
162828020|NCT03810911|588081390|FG001|Overall Study|Withdrawal by Subject|1|||
162828021|NCT05374525|588081391|FG000|Overall Study|Adverse Event|5|||
162828022|NCT05374525|588081392|FG001|Overall Study|Adverse Event|6|||
162828023|NCT05374525|588081391|FG000|Overall Study|Lost to Follow-up|3|||
162828024|NCT05374525|588081392|FG001|Overall Study|Lost to Follow-up|3|||
162828025|NCT05374525|588081391|FG000|Overall Study|Physician Decision|2|||
162828026|NCT05374525|588081392|FG001|Overall Study|Physician Decision|2|||
162828027|NCT05374525|588081391|FG000|Overall Study|Withdrawal by Subject|26|||
162828028|NCT05374525|588081392|FG001|Overall Study|Withdrawal by Subject|8|||
162828029|NCT01349101|588081395|FG000|Overall Study|Disease Progression|1|||
162828030|NCT01349101|588081396|FG001|Overall Study|Disease Progression|1|||
162828031|NCT01349101|588081395|FG000|Overall Study|Death|3|||
162828032|NCT01349101|588081396|FG001|Overall Study|Death|8|||
162828033|NCT00829179|588081397|FG000|Overall Study|Withdrawal by Subject|1|||
162828034|NCT00271596|588081400|FG000|Overall Study|Protocol Violation|1|||
162828035|NCT00271596|588081401|FG001|Overall Study|Protocol Violation|0|||
162828036|NCT00271596|588081400|FG000|Overall Study|Withdrawal by Subject|0|||
162828037|NCT00271596|588081401|FG001|Overall Study|Withdrawal by Subject|1|||
162828038|NCT04232553|588081402|FG000|Overall Study|Adverse Event|3|||
162828039|NCT04232553|588081403|FG001|Overall Study|Adverse Event|2|||
162828040|NCT04232553|588081404|FG002|Overall Study|Adverse Event|1|||
162828041|NCT04232553|588081405|FG003|Overall Study|Adverse Event|2|||
162828042|NCT04232553|588081406|FG004|Overall Study|Adverse Event|1|||
162828043|NCT04232553|588081407|FG005|Overall Study|Adverse Event|1|||
162828044|NCT04232553|588081408|FG006|Overall Study|Adverse Event|0|||
162828045|NCT04232553|588081409|FG007|Overall Study|Adverse Event|0|||
162828046|NCT04232553|588081410|FG008|Overall Study|Adverse Event|0|||
162828047|NCT04232553|588081402|FG000|Overall Study|Death|0|||
162828048|NCT04232553|588081403|FG001|Overall Study|Death|1|||
162828049|NCT04232553|588081404|FG002|Overall Study|Death|0|||
162828050|NCT04232553|588081405|FG003|Overall Study|Death|1|||
162828051|NCT04232553|588081406|FG004|Overall Study|Death|0|||
162828052|NCT04232553|588081407|FG005|Overall Study|Death|0|||
162828053|NCT04232553|588081408|FG006|Overall Study|Death|0|||
162828054|NCT04232553|588081409|FG007|Overall Study|Death|0|||
162828055|NCT04232553|588081410|FG008|Overall Study|Death|0|||
162828056|NCT04232553|588081402|FG000|Overall Study|Lack of Efficacy|0|||
162828057|NCT04232553|588081403|FG001|Overall Study|Lack of Efficacy|2|||
162828058|NCT04232553|588081404|FG002|Overall Study|Lack of Efficacy|0|||
162828059|NCT04232553|588081405|FG003|Overall Study|Lack of Efficacy|0|||
162828060|NCT04232553|588081406|FG004|Overall Study|Lack of Efficacy|0|||
162828061|NCT04232553|588081407|FG005|Overall Study|Lack of Efficacy|0|||
162828062|NCT04232553|588081408|FG006|Overall Study|Lack of Efficacy|0|||
162828063|NCT04232553|588081409|FG007|Overall Study|Lack of Efficacy|0|||
162828064|NCT04232553|588081410|FG008|Overall Study|Lack of Efficacy|1|||
162828065|NCT04232553|588081402|FG000|Overall Study|Lost to Follow-up|0|||
162828066|NCT04232553|588081403|FG001|Overall Study|Lost to Follow-up|1|||
162828067|NCT04232553|588081404|FG002|Overall Study|Lost to Follow-up|0|||
162828068|NCT04232553|588081405|FG003|Overall Study|Lost to Follow-up|0|||
162828069|NCT04232553|588081406|FG004|Overall Study|Lost to Follow-up|1|||
162828070|NCT04232553|588081407|FG005|Overall Study|Lost to Follow-up|0|||
162828071|NCT04232553|588081408|FG006|Overall Study|Lost to Follow-up|0|||
162828072|NCT04232553|588081409|FG007|Overall Study|Lost to Follow-up|0|||
162828073|NCT04232553|588081410|FG008|Overall Study|Lost to Follow-up|1|||
162828074|NCT04232553|588081402|FG000|Overall Study|Other - As reported by the investigator|0|||
162828075|NCT04232553|588081403|FG001|Overall Study|Other - As reported by the investigator|1|||
162828076|NCT04232553|588081404|FG002|Overall Study|Other - As reported by the investigator|0|||
162828077|NCT04232553|588081405|FG003|Overall Study|Other - As reported by the investigator|0|||
162828078|NCT04232553|588081406|FG004|Overall Study|Other - As reported by the investigator|0|||
162828079|NCT04232553|588081407|FG005|Overall Study|Other - As reported by the investigator|0|||
162828080|NCT04232553|588081408|FG006|Overall Study|Other - As reported by the investigator|0|||
162828081|NCT04232553|588081409|FG007|Overall Study|Other - As reported by the investigator|0|||
162828082|NCT04232553|588081410|FG008|Overall Study|Other - As reported by the investigator|0|||
162828083|NCT04232553|588081402|FG000|Overall Study|Physician Decision|1|||
162828084|NCT04232553|588081403|FG001|Overall Study|Physician Decision|1|||
162828085|NCT04232553|588081404|FG002|Overall Study|Physician Decision|0|||
162828086|NCT04232553|588081405|FG003|Overall Study|Physician Decision|0|||
162828087|NCT04232553|588081406|FG004|Overall Study|Physician Decision|1|||
162828088|NCT04232553|588081407|FG005|Overall Study|Physician Decision|0|||
162937612|NCT01341639|588475491|FG001|Interim Period|Physician Decision|1|||
162937613|NCT01341639|588475490|FG000|Interim Period|Protocol Violation|0|||
162937614|NCT01341639|588475491|FG001|Interim Period|Protocol Violation|1|||
162937615|NCT01341639|588475490|FG000|Post-Treatment|Withdrawal by Subject|0|||
162937616|NCT01341639|588475491|FG001|Post-Treatment|Withdrawal by Subject|1|||
162937617|NCT01341639|588475490|FG000|Post-Treatment|Adverse Event|0|||
162937618|NCT01341639|588475491|FG001|Post-Treatment|Adverse Event|2|||
162937619|NCT01590433|588475492|FG000|Overall Study|Lost to Follow-up|20|||
162937620|NCT01590433|588475493|FG001|Overall Study|Lost to Follow-up|8|||
162937621|NCT01590433|588475492|FG000|Overall Study|Withdrawal by Subject|21|||
162937622|NCT01590433|588475493|FG001|Overall Study|Withdrawal by Subject|11|||
162937623|NCT01590433|588475492|FG000|Overall Study|Adverse Event|11|||
162937624|NCT01590433|588475493|FG001|Overall Study|Adverse Event|3|||
162937625|NCT00555009|588475494|FG000|Overall Study|Withdrawal by Subject|0|||
162937626|NCT00555009|588475495|FG001|Overall Study|Withdrawal by Subject|1|||
162937627|NCT00555009|588475494|FG000|Overall Study|Terminated by Sponsor|2|||
162698586|NCT02733042|587605520|FG000|Overall Study|Death|0|||
162698587|NCT02733042|587605521|FG001|Overall Study|Death|0|||
162937628|NCT00555009|588475495|FG001|Overall Study|Terminated by Sponsor|5|||
162937629|NCT02040428|588475496|FG000|Overall Study|Death|4|||
162937630|NCT02040428|588475497|FG001|Overall Study|Death|3|||
162937631|NCT02040428|588475496|FG000|Overall Study|Withdrawal by Subject|1|||
162937632|NCT02040428|588475497|FG001|Overall Study|Withdrawal by Subject|1|||
162937633|NCT02058628|588475498|FG000|Overall Study|Adverse Event|1|||
162937634|NCT02058628|588475499|FG001|Overall Study|Adverse Event|0|||
162937635|NCT02058628|588475498|FG000|Overall Study|Withdrawal by Subject|2|||
162937636|NCT02058628|588475499|FG001|Overall Study|Withdrawal by Subject|2|||
162937637|NCT02058628|588475498|FG000|Overall Study|Lost to Follow-up|2|||
162937638|NCT02058628|588475499|FG001|Overall Study|Lost to Follow-up|4|||
162937639|NCT02058628|588475498|FG000|Overall Study|Not in time schedule|0|||
162937640|NCT02058628|588475499|FG001|Overall Study|Not in time schedule|1|||
162937641|NCT02058628|588475498|FG000|Overall Study|The visit date was not in timeline|0|||
162937642|NCT02058628|588475499|FG001|Overall Study|The visit date was not in timeline|1|||
163042842|NCT01066871|588863974|FG000|Overall Study|Lost to Follow-up|0|||
162698588|NCT02733042|587605522|FG002|Overall Study|Death|0|||
162698589|NCT02733042|587605523|FG003|Overall Study|Death|0|||
162698590|NCT02733042|587605524|FG004|Overall Study|Death|0|||
162698591|NCT02733042|587605525|FG005|Overall Study|Death|0|||
162698592|NCT02733042|587605526|FG006|Overall Study|Death|1|||
162698593|NCT02733042|587605527|FG007|Overall Study|Death|0|||
162698594|NCT02733042|587605528|FG008|Overall Study|Death|1|||
162698595|NCT02733042|587605529|FG009|Overall Study|Death|0|||
162698596|NCT02733042|587605530|FG010|Overall Study|Death|1|||
162698597|NCT02733042|587605531|FG011|Overall Study|Death|0|||
162698598|NCT02733042|587605532|FG012|Overall Study|Death|0|||
162698599|NCT02733042|587605533|FG013|Overall Study|Death|0|||
162698600|NCT02733042|587605534|FG014|Overall Study|Death|1|||
162698601|NCT02733042|587605535|FG015|Overall Study|Death|2|||
162698602|NCT02733042|587605536|FG016|Overall Study|Death|0|||
162698603|NCT02733042|587605537|FG017|Overall Study|Death|0|||
162698604|NCT02733042|587605538|FG018|Overall Study|Death|0|||
162698605|NCT01088529|587605540|FG000|Overall Study|Did not receive study treatment|0|||
162698606|NCT01088529|587605541|FG001|Overall Study|Did not receive study treatment|1|||
162698607|NCT02838628|587605543|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
162698608|NCT02838628|587605544|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
162698609|NCT02838628|587605543|FG000|Recurrence Follow-up Period|Adverse Event|1|||
162698610|NCT02838628|587605544|FG001|Recurrence Follow-up Period|Adverse Event|0|||
162698611|NCT02838628|587605543|FG000|Recurrence Follow-up Period|Non-compliance|0|||
162698612|NCT02838628|587605544|FG001|Recurrence Follow-up Period|Non-compliance|1|||
162698613|NCT02838628|587605543|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
162698614|NCT02838628|587605544|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
162698615|NCT02838628|587605543|FG000|Recurrence Follow-up Period|Other un-specified|1|||
162698616|NCT02838628|587605544|FG001|Recurrence Follow-up Period|Other un-specified|1|||
162698617|NCT02303626|587605546|FG000|Overall Study|Lack of Efficacy|1|||
162698618|NCT02303626|587605547|FG001|Overall Study|Lack of Efficacy|0|||
162698619|NCT02303626|587605548|FG002|Overall Study|Lack of Efficacy|1|||
162698620|NCT02303626|587605546|FG000|Overall Study|Adverse Event|0|||
162698621|NCT02303626|587605547|FG001|Overall Study|Adverse Event|2|||
162698622|NCT02303626|587605548|FG002|Overall Study|Adverse Event|0|||
162698623|NCT02303626|587605546|FG000|Overall Study|Protocol Violation|0|||
162698624|NCT02303626|587605547|FG001|Overall Study|Protocol Violation|1|||
162698625|NCT02303626|587605548|FG002|Overall Study|Protocol Violation|0|||
162698626|NCT02303626|587605546|FG000|Overall Study|Pregnancy|0|||
162698627|NCT02303626|587605547|FG001|Overall Study|Pregnancy|0|||
162698628|NCT02303626|587605548|FG002|Overall Study|Pregnancy|1|||
162698629|NCT02303626|587605546|FG000|Overall Study|Subject Non-Compliance|0|||
162698630|NCT02303626|587605547|FG001|Overall Study|Subject Non-Compliance|0|||
162698631|NCT02303626|587605548|FG002|Overall Study|Subject Non-Compliance|1|||
162698632|NCT05832437|587605549|FG000|Overall Study|time off work|1|||
162698633|NCT05832437|587605550|FG001|Overall Study|time off work|0|||
162698634|NCT05832437|587605551|FG002|Overall Study|time off work|0|||
162698635|NCT05832437|587605552|FG003|Overall Study|time off work|0|||
162698636|NCT00337662|587605553|FG000|Study Period II|Lost to Follow-up|0|||
162698637|NCT00337662|587605554|FG001|Study Period II|Lost to Follow-up|0|||
162698638|NCT00337662|587605555|FG002|Study Period II|Lost to Follow-up|0|||
162698639|NCT00337662|587605556|FG003|Study Period II|Lost to Follow-up|35|||
162698640|NCT00337662|587605553|FG000|Study Period II|Withdrawal by Subject|0|||
162698641|NCT00337662|587605554|FG001|Study Period II|Withdrawal by Subject|0|||
162698642|NCT00337662|587605555|FG002|Study Period II|Withdrawal by Subject|0|||
162698643|NCT00337662|587605556|FG003|Study Period II|Withdrawal by Subject|20|||
162698644|NCT00337662|587605553|FG000|Study Period II|Adverse Event|0|||
162698645|NCT00337662|587605554|FG001|Study Period II|Adverse Event|0|||
162698646|NCT00337662|587605555|FG002|Study Period II|Adverse Event|0|||
162698647|NCT00337662|587605556|FG003|Study Period II|Adverse Event|16|||
162698648|NCT00337662|587605553|FG000|Study Period II|Physician Decision|0|||
162698649|NCT00337662|587605554|FG001|Study Period II|Physician Decision|0|||
162698650|NCT00337662|587605555|FG002|Study Period II|Physician Decision|0|||
162698651|NCT00337662|587605556|FG003|Study Period II|Physician Decision|13|||
162698652|NCT00337662|587605553|FG000|Study Period II|Entry Criteria Not Met|0|||
162698653|NCT00337662|587605554|FG001|Study Period II|Entry Criteria Not Met|0|||
162698654|NCT00337662|587605555|FG002|Study Period II|Entry Criteria Not Met|0|||
162698655|NCT00337662|587605556|FG003|Study Period II|Entry Criteria Not Met|6|||
162698656|NCT00337662|587605553|FG000|Study Period II|Protocol Violation|0|||
162698657|NCT00337662|587605554|FG001|Study Period II|Protocol Violation|0|||
162698658|NCT00337662|587605555|FG002|Study Period II|Protocol Violation|0|||
162698659|NCT00337662|587605556|FG003|Study Period II|Protocol Violation|6|||
162698660|NCT00337662|587605553|FG000|Study Period II|Lack of Efficacy|0|||
162937643|NCT02058628|588475498|FG000|Overall Study|A lot of time for study for participant|1|||
162937644|NCT02058628|588475499|FG001|Overall Study|A lot of time for study for participant|0|||
162937645|NCT02058628|588475498|FG000|Overall Study|Non compliance|1|||
162937646|NCT02058628|588475499|FG001|Overall Study|Non compliance|0|||
162937647|NCT00832078|588475500|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
162937648|NCT00832078|588475501|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
162937649|NCT00832078|588475500|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
162937650|NCT00832078|588475501|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
162937651|NCT02961920|588475502|FG000|Overall Study|did not achive stydy protocol schedule|1|||
162937652|NCT02961920|588475503|FG001|Overall Study|did not achive stydy protocol schedule|1|||
162937653|NCT01452529|588475506|FG000|Run-in Period|Adverse Event|96|||
162937654|NCT01452529|588475507|FG001|Run-in Period|Adverse Event|0|||
162937655|NCT01452529|588475508|FG002|Run-in Period|Adverse Event|0|||
162937656|NCT01452529|588475506|FG000|Run-in Period|Withdrawal by Subject|49|||
162937657|NCT01452529|588475507|FG001|Run-in Period|Withdrawal by Subject|0|||
162937658|NCT01452529|588475508|FG002|Run-in Period|Withdrawal by Subject|0|||
162937659|NCT01452529|588475506|FG000|Run-in Period|Lost to Follow-up|19|||
162937660|NCT01452529|588475507|FG001|Run-in Period|Lost to Follow-up|0|||
162937661|NCT01452529|588475508|FG002|Run-in Period|Lost to Follow-up|0|||
162937662|NCT01452529|588475506|FG000|Run-in Period|Lack of Efficacy|46|||
162937663|NCT01452529|588475507|FG001|Run-in Period|Lack of Efficacy|0|||
162937664|NCT01452529|588475508|FG002|Run-in Period|Lack of Efficacy|0|||
162937665|NCT01452529|588475506|FG000|Run-in Period|Confirmed or suspected diversion|23|||
162937666|NCT01452529|588475507|FG001|Run-in Period|Confirmed or suspected diversion|0|||
162937667|NCT01452529|588475508|FG002|Run-in Period|Confirmed or suspected diversion|0|||
162937668|NCT01452529|588475506|FG000|Run-in Period|Administrative|21|||
162937669|NCT01452529|588475507|FG001|Run-in Period|Administrative|0|||
162937670|NCT01452529|588475508|FG002|Run-in Period|Administrative|0|||
162937671|NCT01452529|588475506|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
162937672|NCT01452529|588475507|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
162937673|NCT01452529|588475508|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
162937674|NCT01452529|588475506|FG000|Double-blind (DB) Period|Adverse Event|0|||
162937675|NCT01452529|588475507|FG001|Double-blind (DB) Period|Adverse Event|18|||
162937676|NCT01452529|588475508|FG002|Double-blind (DB) Period|Adverse Event|11|||
162937677|NCT01452529|588475506|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
162937678|NCT01452529|588475507|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
162937679|NCT01452529|588475508|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
162937680|NCT01452529|588475506|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
162937681|NCT01452529|588475507|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
162937682|NCT01452529|588475508|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
162937683|NCT01452529|588475506|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
162937684|NCT01452529|588475507|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
162937685|NCT01452529|588475508|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
162937686|NCT01452529|588475506|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
162937687|NCT01452529|588475507|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
162698661|NCT00337662|587605554|FG001|Study Period II|Lack of Efficacy|0|||
162937688|NCT01452529|588475508|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
162937689|NCT01452529|588475506|FG000|Double-blind (DB) Period|Administrative|0|||
162937690|NCT01452529|588475507|FG001|Double-blind (DB) Period|Administrative|11|||
162937691|NCT01452529|588475508|FG002|Double-blind (DB) Period|Administrative|7|||
162937692|NCT03551730|588475509|FG000|Overall Study|Adverse Event|1|||
162937693|NCT03551730|588475510|FG001|Overall Study|Adverse Event|0|||
162937694|NCT03551730|588475511|FG002|Overall Study|Adverse Event|0|||
162937695|NCT03551730|588475512|FG003|Overall Study|Adverse Event|0|||
162937696|NCT03347695|588475519|FG000|Overall Study|Death|0|||
162698662|NCT00337662|587605555|FG002|Study Period II|Lack of Efficacy|0|||
162937697|NCT03347695|588475520|FG001|Overall Study|Death|4|||
162937698|NCT03347695|588475519|FG000|Overall Study|Lost to Follow-up|0|||
162937699|NCT03347695|588475520|FG001|Overall Study|Lost to Follow-up|1|||
162937700|NCT00671879|588475523|FG000|Overall Study|Withdrawal by Subject|0|||
162937701|NCT00671879|588475524|FG001|Overall Study|Withdrawal by Subject|4|||
162937702|NCT00671879|588475525|FG002|Overall Study|Withdrawal by Subject|6|||
162937703|NCT04633837|588475526|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
162937704|NCT04633837|588475527|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
162937705|NCT04527471|588475530|FG000|Overall Study|Adverse Event|1|||
162937706|NCT04527471|588475531|FG001|Overall Study|Adverse Event|0|||
162937707|NCT04527471|588475530|FG000|Overall Study|Lost to Follow-up|1|||
162937708|NCT04527471|588475531|FG001|Overall Study|Lost to Follow-up|0|||
162937709|NCT02884206|588475540|FG000|Valsartan Run-in Period|Death|1|||
162937710|NCT02884206|588475541|FG001|Valsartan Run-in Period|Death|0|||
162937711|NCT02884206|588475542|FG002|Valsartan Run-in Period|Death|0|||
162937712|NCT02884206|588475540|FG000|Valsartan Run-in Period|Adverse Event|31|||
162937713|NCT02884206|588475541|FG001|Valsartan Run-in Period|Adverse Event|0|||
162937714|NCT02884206|588475542|FG002|Valsartan Run-in Period|Adverse Event|0|||
162937715|NCT02884206|588475540|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
162937716|NCT02884206|588475541|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
162937717|NCT02884206|588475542|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
162937718|NCT02884206|588475540|FG000|Valsartan Run-in Period|Protocol deviation|4|||
162937719|NCT02884206|588475541|FG001|Valsartan Run-in Period|Protocol deviation|0|||
162937720|NCT02884206|588475542|FG002|Valsartan Run-in Period|Protocol deviation|0|||
162937721|NCT02884206|588475540|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
162937722|NCT02884206|588475541|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
162937723|NCT02884206|588475542|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
162937724|NCT02884206|588475540|FG000|Valsartan Run-in Period|Physician Decision|1|||
162937725|NCT02884206|588475541|FG001|Valsartan Run-in Period|Physician Decision|0|||
162937726|NCT02884206|588475542|FG002|Valsartan Run-in Period|Physician Decision|0|||
162937727|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Adverse Event|38|||
162937728|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Adverse Event|0|||
162937729|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Adverse Event|0|||
162937730|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Death|2|||
162937731|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Death|0|||
162698663|NCT00337662|587605556|FG003|Study Period II|Lack of Efficacy|7|||
162937732|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Death|0|||
162937733|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
162937734|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
162937735|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
162937736|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
162937737|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
162937738|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
162937739|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
162937740|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
162937741|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
162937742|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Physician Decision|1|||
162937743|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Physician Decision|0|||
162937744|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Physician Decision|0|||
162937745|NCT02884206|588475540|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
162937746|NCT02884206|588475541|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
162937747|NCT02884206|588475542|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
162937748|NCT02884206|588475540|FG000|Double-Blind Period|Death|0|||
162937749|NCT02884206|588475541|FG001|Double-Blind Period|Death|28|||
162937750|NCT02884206|588475542|FG002|Double-Blind Period|Death|39|||
162937751|NCT02884206|588475540|FG000|Double-Blind Period|Patient/guardian decision|0|||
162937752|NCT02884206|588475541|FG001|Double-Blind Period|Patient/guardian decision|10|||
162937753|NCT02884206|588475542|FG002|Double-Blind Period|Patient/guardian decision|13|||
162937754|NCT02884206|588475540|FG000|Double-Blind Period|Lost to Follow-up|0|||
162937755|NCT02884206|588475541|FG001|Double-Blind Period|Lost to Follow-up|4|||
162937756|NCT02884206|588475542|FG002|Double-Blind Period|Lost to Follow-up|4|||
162937757|NCT02884206|588475540|FG000|Double-Blind Period|Physician Decision|0|||
162937758|NCT02884206|588475541|FG001|Double-Blind Period|Physician Decision|2|||
162937759|NCT02884206|588475542|FG002|Double-Blind Period|Physician Decision|0|||
162937760|NCT02884206|588475540|FG000|Double-Blind Period|Adverse Event|0|||
162937761|NCT02884206|588475541|FG001|Double-Blind Period|Adverse Event|0|||
162937762|NCT02884206|588475542|FG002|Double-Blind Period|Adverse Event|3|||
162937763|NCT02884206|588475540|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
162937764|NCT02884206|588475541|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
162937765|NCT02884206|588475542|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
162937766|NCT01628120|588475547|FG000|Overall Study|Withdrawal by Subject|7|||
162937767|NCT01628120|588475547|FG000|Overall Study|Adverse Event|12|||
162937768|NCT01628120|588475547|FG000|Overall Study|Lost to Follow-up|1|||
162937769|NCT01628120|588475547|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
162937770|NCT01628120|588475547|FG000|Overall Study|Non-compliant with Study Procedures|1|||
162937771|NCT01628120|588475547|FG000|Overall Study|Not Treated|3|||
162937772|NCT01628120|588475547|FG000|Overall Study|Sponsor Decision|5|||
162937773|NCT01628120|588475547|FG000|Overall Study|Switched Dialysis Method|2|||
162937774|NCT01628120|588475547|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
162937775|NCT01628120|588475547|FG000|Overall Study|Moved or Relocated|5|||
162937776|NCT01628120|588475547|FG000|Overall Study|Kidney Transplant|2|||
162937777|NCT01628120|588475547|FG000|Overall Study|Use of Standard of Care|1|||
162937778|NCT01165996|588475548|FG000|Overall Study|Death|1|||
162937779|NCT01165996|588475548|FG000|Overall Study|Physician Decision|1|||
162937780|NCT00096265|588475549|FG000|Overall Study|Ineligible|1|||
162937781|NCT00096265|588475550|FG001|Overall Study|Ineligible|0|||
162937782|NCT00096265|588475551|FG002|Overall Study|Ineligible|0|||
162937783|NCT02232074|588475554|FG000|Overall Study|Withdrawal by Subject|5|||
162937784|NCT02232074|588475555|FG001|Overall Study|Withdrawal by Subject|3|||
162937785|NCT02232074|588475554|FG000|Overall Study|No legal concerns at baseline|36|||
162937786|NCT02232074|588475555|FG001|Overall Study|No legal concerns at baseline|41|||
162937787|NCT02232074|588475554|FG000|Overall Study|deemed ineligible|0|||
162937788|NCT02232074|588475555|FG001|Overall Study|deemed ineligible|1|||
162937789|NCT01927757|588475556|FG000|Overall Study|Withdrawal by Subject|14|||
162937790|NCT01927757|588475556|FG000|Overall Study|Lost to Follow-up|2|||
162937791|NCT01927757|588475556|FG000|Overall Study|Decision by Sponsor|2|||
162937792|NCT01927757|588475556|FG000|Overall Study|Other|1|||
162937793|NCT01927757|588475556|FG000|Overall Study|Ethical Reasons|4|||
162937794|NCT00444795|588475558|FG000|Overall Study|Not Treated|1|||
162937795|NCT00444795|588475558|FG000|Overall Study|Treated Prior to the Contract Date|2|||
162937796|NCT00988169|588475559|FG000|Overall Study|Withdrawal by Subject|1|||
162937797|NCT00704418|588475560|FG000|Overall Study|Withdrawal by Subject|2|||
162937798|NCT00704418|588475561|FG001|Overall Study|Withdrawal by Subject|0|||
162937799|NCT00704418|588475560|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
162937800|NCT00704418|588475561|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
162937801|NCT01464827|588475562|FG000|Overall Study|Adverse Event|0|||
162937802|NCT01464827|588475563|FG001|Overall Study|Adverse Event|0|||
162937803|NCT01464827|588475564|FG002|Overall Study|Adverse Event|0|||
162937804|NCT01464827|588475565|FG003|Overall Study|Adverse Event|0|||
162937805|NCT01464827|588475566|FG004|Overall Study|Adverse Event|0|||
162937806|NCT01464827|588475567|FG005|Overall Study|Adverse Event|0|||
162937807|NCT01464827|588475568|FG006|Overall Study|Adverse Event|0|||
162937808|NCT01464827|588475569|FG007|Overall Study|Adverse Event|0|||
162937809|NCT01464827|588475570|FG008|Overall Study|Adverse Event|0|||
162937810|NCT01464827|588475571|FG009|Overall Study|Adverse Event|0|||
162937811|NCT01464827|588475572|FG010|Overall Study|Adverse Event|0|||
162937812|NCT01464827|588475573|FG011|Overall Study|Adverse Event|0|||
162937813|NCT01464827|588475574|FG012|Overall Study|Adverse Event|1|||
162937814|NCT01464827|588475575|FG013|Overall Study|Adverse Event|0|||
162937815|NCT01464827|588475562|FG000|Overall Study|Withdrawal by Subject|1|||
162937816|NCT01464827|588475563|FG001|Overall Study|Withdrawal by Subject|0|||
162937817|NCT01464827|588475564|FG002|Overall Study|Withdrawal by Subject|0|||
162937818|NCT01464827|588475565|FG003|Overall Study|Withdrawal by Subject|0|||
162937819|NCT01464827|588475566|FG004|Overall Study|Withdrawal by Subject|1|||
162937820|NCT01464827|588475567|FG005|Overall Study|Withdrawal by Subject|0|||
162937821|NCT01464827|588475568|FG006|Overall Study|Withdrawal by Subject|0|||
162937822|NCT01464827|588475569|FG007|Overall Study|Withdrawal by Subject|1|||
162937823|NCT01464827|588475570|FG008|Overall Study|Withdrawal by Subject|0|||
162937824|NCT01464827|588475571|FG009|Overall Study|Withdrawal by Subject|0|||
162937825|NCT01464827|588475572|FG010|Overall Study|Withdrawal by Subject|0|||
162937826|NCT01464827|588475573|FG011|Overall Study|Withdrawal by Subject|0|||
162937827|NCT01464827|588475574|FG012|Overall Study|Withdrawal by Subject|0|||
162937828|NCT01464827|588475575|FG013|Overall Study|Withdrawal by Subject|0|||
162937829|NCT01464827|588475562|FG000|Overall Study|Lost to Follow-up|0|||
162937830|NCT01464827|588475563|FG001|Overall Study|Lost to Follow-up|2|||
162937831|NCT01464827|588475564|FG002|Overall Study|Lost to Follow-up|0|||
162937832|NCT01464827|588475565|FG003|Overall Study|Lost to Follow-up|2|||
162937833|NCT01464827|588475566|FG004|Overall Study|Lost to Follow-up|3|||
162937834|NCT01464827|588475567|FG005|Overall Study|Lost to Follow-up|1|||
162937835|NCT01464827|588475568|FG006|Overall Study|Lost to Follow-up|2|||
162937836|NCT01464827|588475569|FG007|Overall Study|Lost to Follow-up|2|||
162937837|NCT01464827|588475570|FG008|Overall Study|Lost to Follow-up|0|||
162937838|NCT01464827|588475571|FG009|Overall Study|Lost to Follow-up|0|||
162937839|NCT01464827|588475572|FG010|Overall Study|Lost to Follow-up|0|||
162937840|NCT01464827|588475573|FG011|Overall Study|Lost to Follow-up|1|||
162937841|NCT01464827|588475574|FG012|Overall Study|Lost to Follow-up|0|||
162937842|NCT01464827|588475575|FG013|Overall Study|Lost to Follow-up|1|||
162937843|NCT01464827|588475562|FG000|Overall Study|Other|2|||
162937844|NCT01464827|588475563|FG001|Overall Study|Other|3|||
162937845|NCT01464827|588475564|FG002|Overall Study|Other|0|||
162828089|NCT04232553|588081408|FG006|Overall Study|Physician Decision|0|||
162828090|NCT04232553|588081409|FG007|Overall Study|Physician Decision|0|||
162828091|NCT04232553|588081410|FG008|Overall Study|Physician Decision|0|||
162828092|NCT04232553|588081402|FG000|Overall Study|Pregnancy|1|||
162828093|NCT04232553|588081403|FG001|Overall Study|Pregnancy|0|||
162828094|NCT04232553|588081404|FG002|Overall Study|Pregnancy|0|||
162828095|NCT04232553|588081405|FG003|Overall Study|Pregnancy|0|||
162828096|NCT04232553|588081406|FG004|Overall Study|Pregnancy|0|||
162828097|NCT04232553|588081407|FG005|Overall Study|Pregnancy|0|||
162828098|NCT04232553|588081408|FG006|Overall Study|Pregnancy|0|||
162828099|NCT04232553|588081409|FG007|Overall Study|Pregnancy|0|||
162937846|NCT01464827|588475565|FG003|Overall Study|Other|2|||
162937847|NCT01464827|588475566|FG004|Overall Study|Other|3|||
162937848|NCT01464827|588475567|FG005|Overall Study|Other|0|||
162937849|NCT01464827|588475568|FG006|Overall Study|Other|1|||
162937850|NCT01464827|588475569|FG007|Overall Study|Other|0|||
162937851|NCT01464827|588475570|FG008|Overall Study|Other|3|||
162937852|NCT01464827|588475571|FG009|Overall Study|Other|1|||
162828100|NCT04232553|588081410|FG008|Overall Study|Pregnancy|0|||
162828101|NCT04232553|588081402|FG000|Overall Study|Withdrawal by Subject|7|||
162828102|NCT04232553|588081403|FG001|Overall Study|Withdrawal by Subject|5|||
162828103|NCT04232553|588081404|FG002|Overall Study|Withdrawal by Subject|0|||
162828104|NCT04232553|588081405|FG003|Overall Study|Withdrawal by Subject|0|||
162828105|NCT04232553|588081406|FG004|Overall Study|Withdrawal by Subject|2|||
162828106|NCT04232553|588081407|FG005|Overall Study|Withdrawal by Subject|2|||
162828107|NCT04232553|588081408|FG006|Overall Study|Withdrawal by Subject|0|||
162828108|NCT04232553|588081409|FG007|Overall Study|Withdrawal by Subject|2|||
162828109|NCT04232553|588081410|FG008|Overall Study|Withdrawal by Subject|0|||
162828110|NCT02969915|588081411|FG000|Overall Study|Death|104|||
162828111|NCT02969915|588081412|FG001|Overall Study|Death|125|||
162828112|NCT02969915|588081411|FG000|Overall Study|Lost to Follow-up|108|||
162828113|NCT02969915|588081412|FG001|Overall Study|Lost to Follow-up|112|||
162828114|NCT02969915|588081411|FG000|Overall Study|Censored due to COVID-19|481|||
162828115|NCT02969915|588081412|FG001|Overall Study|Censored due to COVID-19|471|||
162828116|NCT03625687|588081413|FG000|Overall Study|Death|1|||
162828117|NCT01069172|588081414|FG000|Overall Study|Withdrawal by Subject|1|||
162828118|NCT01069172|588081415|FG001|Overall Study|Withdrawal by Subject|0|||
162828119|NCT04206605|588081418|FG000|Overall Study|Adverse Event|0|||
162828120|NCT04206605|588081419|FG001|Overall Study|Adverse Event|1|||
162828121|NCT04206605|588081418|FG000|Overall Study|Withdrawal by Subject|1|||
162828122|NCT04206605|588081419|FG001|Overall Study|Withdrawal by Subject|0|||
162828123|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
162828124|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
162828125|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Death|0|||
162828126|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Death|1|||
162828127|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
162828128|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
162828129|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
162828130|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
162828131|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
162828132|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
162828133|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
162828134|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
162828135|NCT00843518|588081427|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
162828136|NCT00843518|588081428|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
162828137|NCT01131520|588081429|FG000|Overall Study|Computer problem|1|||
162828138|NCT01131520|588081430|FG001|Overall Study|Computer problem|0|||
162828139|NCT01131520|588081429|FG000|Overall Study|Counselor not available|0|||
162828140|NCT01131520|588081430|FG001|Overall Study|Counselor not available|3|||
162828141|NCT01131520|588081429|FG000|Overall Study|Subject changed history after enrollment|0|||
162828142|NCT01131520|588081430|FG001|Overall Study|Subject changed history after enrollment|1|||
162828143|NCT04066491|588081436|FG000|Overall Study|Randomized, not treated|0|||
162828144|NCT04066491|588081437|FG001|Overall Study|Randomized, not treated|0|||
162828145|NCT04066491|588081438|FG002|Overall Study|Randomized, not treated|2|||
162828146|NCT01392677|588081441|FG000|Overall Study|Adverse Event|3|||
162828147|NCT01392677|588081442|FG001|Overall Study|Adverse Event|1|||
162828148|NCT01392677|588081441|FG000|Overall Study|Withdrawal by Subject|0|||
162828149|NCT01392677|588081442|FG001|Overall Study|Withdrawal by Subject|2|||
162828150|NCT01392677|588081441|FG000|Overall Study|Incorrect enrollment|2|||
162828151|NCT01392677|588081442|FG001|Overall Study|Incorrect enrollment|3|||
162828152|NCT01392677|588081441|FG000|Overall Study|Other reason|3|||
162828153|NCT01392677|588081442|FG001|Overall Study|Other reason|2|||
162828154|NCT01357577|588081445|FG000|Overall Study|Lost to Follow-up|20|||
162828155|NCT01357577|588081446|FG001|Overall Study|Lost to Follow-up|16|||
162828156|NCT01357577|588081445|FG000|Overall Study|Withdrawal by Subject|16|||
162828157|NCT01357577|588081446|FG001|Overall Study|Withdrawal by Subject|8|||
162828158|NCT01357577|588081445|FG000|Overall Study|look at data in database?|1|||
162828159|NCT01357577|588081446|FG001|Overall Study|look at data in database?|2|||
162828160|NCT05493280|588081447|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
162828161|NCT05493280|588081448|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
162828162|NCT00666458|588082272|FG000|Overall Study|Adverse Event|8|||
162828163|NCT00666458|588082273|FG001|Overall Study|Adverse Event|7|||
162828164|NCT00666458|588082272|FG000|Overall Study|Withdrawal by Subject|5|||
162937853|NCT01464827|588475572|FG010|Overall Study|Other|2|||
162937854|NCT01464827|588475573|FG011|Overall Study|Other|0|||
162937855|NCT01464827|588475574|FG012|Overall Study|Other|1|||
162937856|NCT01464827|588475575|FG013|Overall Study|Other|0|||
162937857|NCT01464827|588475562|FG000|Overall Study|Not Treated|0|||
162937858|NCT01464827|588475563|FG001|Overall Study|Not Treated|2|||
162937859|NCT01464827|588475564|FG002|Overall Study|Not Treated|0|||
162937860|NCT01464827|588475565|FG003|Overall Study|Not Treated|0|||
162937861|NCT01464827|588475566|FG004|Overall Study|Not Treated|1|||
162937862|NCT01464827|588475567|FG005|Overall Study|Not Treated|0|||
162937863|NCT01464827|588475568|FG006|Overall Study|Not Treated|1|||
162937864|NCT01464827|588475569|FG007|Overall Study|Not Treated|0|||
162937865|NCT01464827|588475570|FG008|Overall Study|Not Treated|0|||
162937866|NCT01464827|588475571|FG009|Overall Study|Not Treated|2|||
162937867|NCT01464827|588475572|FG010|Overall Study|Not Treated|0|||
162937868|NCT01464827|588475573|FG011|Overall Study|Not Treated|1|||
162937869|NCT01464827|588475574|FG012|Overall Study|Not Treated|0|||
162937870|NCT01464827|588475575|FG013|Overall Study|Not Treated|2|||
162937871|NCT01075763|588475576|FG000|Overall Study|Lost to Follow-up|2|||
162937872|NCT01075763|588475577|FG001|Overall Study|Lost to Follow-up|1|||
162937873|NCT01075763|588475576|FG000|Overall Study|Lack of Efficacy|0|||
162937874|NCT01075763|588475577|FG001|Overall Study|Lack of Efficacy|1|||
162937875|NCT01075763|588475576|FG000|Overall Study|Withdrawal by Subject|2|||
162937876|NCT01075763|588475577|FG001|Overall Study|Withdrawal by Subject|2|||
162937877|NCT00586521|588475578|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
162937878|NCT03083483|588475582|FG000|Overall Study|Adverse Event|1|||
162937879|NCT03083483|588475583|FG001|Overall Study|Adverse Event|1|||
162937880|NCT03083483|588475584|FG002|Overall Study|Adverse Event|1|||
162937881|NCT03083483|588475582|FG000|Overall Study|Lost to Follow-up|2|||
162937882|NCT03083483|588475583|FG001|Overall Study|Lost to Follow-up|1|||
162937883|NCT03083483|588475584|FG002|Overall Study|Lost to Follow-up|1|||
162937884|NCT03083483|588475582|FG000|Overall Study|technological issues|1|||
162937885|NCT03083483|588475583|FG001|Overall Study|technological issues|0|||
162937886|NCT03083483|588475584|FG002|Overall Study|technological issues|1|||
162937887|NCT02710071|588475585|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
162828165|NCT00666458|588082273|FG001|Overall Study|Withdrawal by Subject|4|||
162937888|NCT02710071|588475586|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
162937889|NCT02710071|588475585|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
162937890|NCT02710071|588475586|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
162937891|NCT05487456|588475589|FG000|Overall Study|Withdrawal by Subject|0|||
162937892|NCT05487456|588475590|FG001|Overall Study|Withdrawal by Subject|0|||
162937893|NCT05487456|588475591|FG002|Overall Study|Withdrawal by Subject|1|||
162937894|NCT05487456|588475592|FG003|Overall Study|Withdrawal by Subject|0|||
162937895|NCT00958256|588475594|FG000|Overall Study|Adverse Event|3|||
162828166|NCT00666458|588082272|FG000|Overall Study|Lost to Follow-up|0|||
162828167|NCT00666458|588082273|FG001|Overall Study|Lost to Follow-up|3|||
162828168|NCT00666458|588082272|FG000|Overall Study|Administrative reason by sponsor|1|||
162828169|NCT00666458|588082273|FG001|Overall Study|Administrative reason by sponsor|1|||
162828170|NCT00666458|588082272|FG000|Overall Study|Incorrect enrollment|7|||
162828171|NCT00666458|588082273|FG001|Overall Study|Incorrect enrollment|1|||
162828172|NCT00666458|588082272|FG000|Overall Study|Study specific discontinuation criteria|14|||
162828173|NCT00666458|588082273|FG001|Overall Study|Study specific discontinuation criteria|7|||
162828174|NCT00666458|588082272|FG000|Overall Study|Severe non-compliance to the protocol|1|||
162828175|NCT00666458|588082273|FG001|Overall Study|Severe non-compliance to the protocol|1|||
162828176|NCT00666458|588082272|FG000|Overall Study|Safety reasons|1|||
162828177|NCT00666458|588082273|FG001|Overall Study|Safety reasons|0|||
162828178|NCT00666458|588082272|FG000|Overall Study|Medical history of anemia|1|||
162828179|NCT00666458|588082273|FG001|Overall Study|Medical history of anemia|0|||
162828180|NCT00516048|588082274|FG000|Overall Study|Death|0|||
162828181|NCT00516048|588082275|FG001|Overall Study|Death|0|||
162828182|NCT00516048|588082276|FG002|Overall Study|Death|1|||
162828183|NCT00516048|588082274|FG000|Overall Study|Subject Decision|0|||
162828184|NCT00516048|588082275|FG001|Overall Study|Subject Decision|2|||
162828185|NCT00516048|588082276|FG002|Overall Study|Subject Decision|0|||
162828186|NCT02554019|588082277|FG000|Overall Study|Withdrawal by Subject|1|||
162828187|NCT02554019|588082278|FG001|Overall Study|Withdrawal by Subject|0|||
162828188|NCT02554019|588082279|FG002|Overall Study|Withdrawal by Subject|2|||
162828189|NCT02554019|588082277|FG000|Overall Study|Adverse Event|1|||
162828190|NCT02554019|588082278|FG001|Overall Study|Adverse Event|0|||
162828191|NCT02554019|588082279|FG002|Overall Study|Adverse Event|0|||
162828192|NCT02463409|588082280|FG000|Overall Study|Withdrawal by Subject|1|||
162828193|NCT02463409|588082280|FG000|Overall Study|Screen failure|1|||
162828194|NCT01444742|588082281|FG000|Overall Study|Death|1|||
162828195|NCT01148537|588082289|FG000|Overall Study|Withdrawal by Subject|1|||
162828196|NCT01148537|588082290|FG001|Overall Study|Withdrawal by Subject|0|||
162828197|NCT01148537|588082291|FG002|Overall Study|Withdrawal by Subject|2|||
162828198|NCT01148537|588082289|FG000|Overall Study|Adverse Event|2|||
162937896|NCT05431153|588475595|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937897|NCT05431153|588475596|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162828199|NCT01148537|588082290|FG001|Overall Study|Adverse Event|0|||
162828200|NCT01148537|588082291|FG002|Overall Study|Adverse Event|1|||
162828201|NCT01843842|588082294|FG000|Overall Study|Do not meet inclusion criteria|1|||
162828202|NCT01843842|588082295|FG001|Overall Study|Do not meet inclusion criteria|1|||
162828203|NCT00632099|588082296|FG000|Overall Study|Lost to Follow-up|3|||
162828204|NCT00632099|588082297|FG001|Overall Study|Lost to Follow-up|3|||
162828205|NCT03374189|588082303|FG000|Overall Study|Lost to Follow-up|1|||
162828206|NCT03374189|588082304|FG001|Overall Study|Lost to Follow-up|0|||
162828207|NCT01517893|588082305|FG000|Overall Study|Withdrawal by Subject|3|||
162828208|NCT01517893|588082306|FG001|Overall Study|Withdrawal by Subject|0|||
162828209|NCT02018822|588082307|FG000|Overall Study|filling replaced by crown|0|||
162828210|NCT02018822|588082308|FG001|Overall Study|filling replaced by crown|1|||
162828211|NCT02018822|588082309|FG002|Overall Study|filling replaced by crown|0|||
162828212|NCT02018822|588082307|FG000|Overall Study|Physician Decision|0|||
162828213|NCT02018822|588082308|FG001|Overall Study|Physician Decision|1|||
162828214|NCT02018822|588082309|FG002|Overall Study|Physician Decision|1|||
162828215|NCT02018822|588082307|FG000|Overall Study|Lost to Follow-up|6|||
162828216|NCT02018822|588082308|FG001|Overall Study|Lost to Follow-up|6|||
162828217|NCT02018822|588082309|FG002|Overall Study|Lost to Follow-up|5|||
162828218|NCT03201458|588082310|FG000|Overall Study|No longer eligible|2|||
162828219|NCT03201458|588082311|FG001|Overall Study|No longer eligible|5|||
162828220|NCT03201458|588082310|FG000|Overall Study|Health event before starting|1|||
162828221|NCT03201458|588082311|FG001|Overall Study|Health event before starting|0|||
162828222|NCT03201458|588082310|FG000|Overall Study|Physician Decision|1|||
162828223|NCT03201458|588082311|FG001|Overall Study|Physician Decision|0|||
162828224|NCT02184195|588082320|FG000|Overall Study|Patient decision|5|||
162828225|NCT02184195|588082321|FG001|Overall Study|Patient decision|2|||
162828226|NCT02184195|588082320|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162828227|NCT02184195|588082321|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162828228|NCT02184195|588082320|FG000|Overall Study|Death|67|||
162828229|NCT02184195|588082321|FG001|Overall Study|Death|44|||
162828230|NCT02184195|588082320|FG000|Overall Study|Lost to Follow-up|1|||
162828231|NCT02184195|588082321|FG001|Overall Study|Lost to Follow-up|5|||
162828232|NCT02184195|588082320|FG000|Overall Study|Other|0|||
162828233|NCT02184195|588082321|FG001|Overall Study|Other|3|||
162698664|NCT00337662|587605553|FG000|Study Period II|Sponsor Decision|0|||
162828234|NCT00589420|588082322|FG000|Overall Study|screen failure|1|||
162828235|NCT00841568|588082323|FG000|Overall Study|Adverse Event|1|||
162828236|NCT00841568|588082323|FG000|Overall Study|Death|1|||
162828237|NCT00841568|588082323|FG000|Overall Study|Withdrawal by Subject|2|||
163042843|NCT01066871|588863975|FG001|Overall Study|Lost to Follow-up|2|||
162828238|NCT00841568|588082323|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
162828239|NCT03002155|588082324|FG000|Overall Study|Lost to Follow-up|1|||
162828240|NCT03002155|588082325|FG001|Overall Study|Lost to Follow-up|2|||
162828241|NCT03002155|588082324|FG000|Overall Study|Withdrawal by Subject|1|||
162828242|NCT03002155|588082325|FG001|Overall Study|Withdrawal by Subject|0|||
162937898|NCT05431153|588475597|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937899|NCT05431153|588475598|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937900|NCT05431153|588475599|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
162937901|NCT05431153|588475600|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162937902|NCT00678392|588475601|FG000|Overall Study|Adverse Event|0|||
162937903|NCT00678392|588475602|FG001|Overall Study|Adverse Event|6|||
162937904|NCT00678392|588475601|FG000|Overall Study|Death|280|||
162937905|NCT00678392|588475602|FG001|Overall Study|Death|269|||
162937906|NCT00678392|588475601|FG000|Overall Study|Lost to Follow-up|15|||
162937907|NCT00678392|588475602|FG001|Overall Study|Lost to Follow-up|13|||
162937908|NCT00678392|588475601|FG000|Overall Study|Objective Progression or Relapse|3|||
162937909|NCT00678392|588475602|FG001|Overall Study|Objective Progression or Relapse|8|||
162698665|NCT00337662|587605554|FG001|Study Period II|Sponsor Decision|0|||
162937910|NCT00678392|588475601|FG000|Overall Study|Sponsor's Decision|1|||
162828243|NCT03002155|588082324|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
162828244|NCT03002155|588082325|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
162828245|NCT00974675|588082328|FG000|Overall Study|Adverse Event|2|||
162828246|NCT00974675|588082329|FG001|Overall Study|Adverse Event|1|||
162828247|NCT00974675|588082330|FG002|Overall Study|Adverse Event|1|||
162828248|NCT00974675|588082331|FG003|Overall Study|Adverse Event|1|||
162828249|NCT00974675|588082328|FG000|Overall Study|Physician Decision|0|||
162828250|NCT00974675|588082329|FG001|Overall Study|Physician Decision|0|||
162828251|NCT00974675|588082330|FG002|Overall Study|Physician Decision|1|||
162828252|NCT00974675|588082331|FG003|Overall Study|Physician Decision|0|||
162828253|NCT00974675|588082328|FG000|Overall Study|Participant on holiday; unable to attend|0|||
162828254|NCT00974675|588082329|FG001|Overall Study|Participant on holiday; unable to attend|0|||
162828255|NCT00974675|588082330|FG002|Overall Study|Participant on holiday; unable to attend|0|||
162828256|NCT00974675|588082331|FG003|Overall Study|Participant on holiday; unable to attend|1|||
162828257|NCT03302975|588082335|FG000|Overall Study|Lost to Follow-up|4|||
162828258|NCT01436084|588082336|FG000|Overall Study|Disease Progression|2|||
162828259|NCT01436084|588082336|FG000|Overall Study|Withdrawal by Subject|1|||
162828260|NCT01436084|588082336|FG000|Overall Study|Early Closure of Study|1|||
162828261|NCT05998148|588082337|FG000|Allocation|Did not attend any appointments|1|||
162828262|NCT05998148|588082338|FG001|Allocation|Did not attend any appointments|4|||
162937911|NCT00678392|588475602|FG001|Overall Study|Sponsor's Decision|2|||
162828263|NCT05998148|588082337|FG000|Follow-Up|Lost to Follow-up|1|||
162828264|NCT05998148|588082338|FG001|Follow-Up|Lost to Follow-up|2|||
162937912|NCT00678392|588475601|FG000|Overall Study|Withdrawal by Subject|4|||
162937913|NCT00678392|588475602|FG001|Overall Study|Withdrawal by Subject|4|||
162937914|NCT00678392|588475601|FG000|Overall Study|Randomized But Not Treated|2|||
162937915|NCT00678392|588475602|FG001|Overall Study|Randomized But Not Treated|7|||
162937916|NCT00678392|588475601|FG000|Overall Study|Other|56|||
162937917|NCT00678392|588475602|FG001|Overall Study|Other|53|||
162937918|NCT03341507|588475603|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
162937919|NCT00989261|588475605|FG000|Overall Study|Still in follow up|12|||
162937920|NCT00989261|588475606|FG001|Overall Study|Still in follow up|21|||
162937921|NCT00989261|588475605|FG000|Overall Study|Withdrawal by Subject|0|||
162937922|NCT00989261|588475606|FG001|Overall Study|Withdrawal by Subject|1|||
162937923|NCT00989261|588475605|FG000|Overall Study|Lost to Follow-up|3|||
162937924|NCT00989261|588475606|FG001|Overall Study|Lost to Follow-up|0|||
162937925|NCT00782509|588475607|FG000|Overall Study|Adverse Event|20|||
162937926|NCT00782509|588475608|FG001|Overall Study|Adverse Event|10|||
162937927|NCT00782509|588475609|FG002|Overall Study|Adverse Event|20|||
162937928|NCT00782509|588475607|FG000|Overall Study|Lost to Follow-up|1|||
162937929|NCT00782509|588475608|FG001|Overall Study|Lost to Follow-up|2|||
162937930|NCT00782509|588475609|FG002|Overall Study|Lost to Follow-up|3|||
162937931|NCT00782509|588475607|FG000|Overall Study|Withdrawal by Subject|3|||
162828265|NCT05998148|588082337|FG000|Follow-Up|Change in insurance|1|||
162828266|NCT05998148|588082338|FG001|Follow-Up|Change in insurance|1|||
162828267|NCT03834519|588082340|FG000|Overall Study|Lost to Follow-up|2|||
162828268|NCT03834519|588082341|FG001|Overall Study|Lost to Follow-up|1|||
162828269|NCT03834519|588082340|FG000|Overall Study|Withdrawal by Subject|5|||
162828270|NCT03834519|588082341|FG001|Overall Study|Withdrawal by Subject|8|||
162828271|NCT03834519|588082340|FG000|Overall Study|Death|368|||
162828272|NCT03834519|588082341|FG001|Overall Study|Death|174|||
162828273|NCT03834519|588082340|FG000|Overall Study|Physician Decision|5|||
162828274|NCT03834519|588082341|FG001|Overall Study|Physician Decision|1|||
162828275|NCT03834519|588082340|FG000|Overall Study|Sponsor decision|149|||
162828276|NCT03834519|588082341|FG001|Overall Study|Sponsor decision|80|||
162828277|NCT04506086|588082342|FG000|Overall Study|Withdrawal by Subject|2|||
162937932|NCT00782509|588475608|FG001|Overall Study|Withdrawal by Subject|5|||
162937933|NCT00782509|588475609|FG002|Overall Study|Withdrawal by Subject|8|||
162937934|NCT00782509|588475607|FG000|Overall Study|Non compliance with protocol|2|||
162937935|NCT00782509|588475608|FG001|Overall Study|Non compliance with protocol|0|||
162937936|NCT00782509|588475609|FG002|Overall Study|Non compliance with protocol|0|||
162937937|NCT00782509|588475607|FG000|Overall Study|Other reasons not stated above|5|||
162937938|NCT00782509|588475608|FG001|Overall Study|Other reasons not stated above|2|||
162937939|NCT00782509|588475609|FG002|Overall Study|Other reasons not stated above|3|||
162937940|NCT00782509|588475607|FG000|Overall Study|Lack of Efficacy|10|||
162937941|NCT00782509|588475608|FG001|Overall Study|Lack of Efficacy|5|||
162937942|NCT00782509|588475609|FG002|Overall Study|Lack of Efficacy|2|||
162937943|NCT01401478|588475620|FG000|Overall Study|Study drug not available|6|||
162937944|NCT01401478|588475620|FG000|Overall Study|Adverse Event|5|||
162937945|NCT01401478|588475620|FG000|Overall Study|Hyperphosphatemia|5|||
162937946|NCT01401478|588475620|FG000|Overall Study|Lost to Follow-up|5|||
162937947|NCT01401478|588475620|FG000|Overall Study|Kidney transplantation|3|||
162937948|NCT01401478|588475620|FG000|Overall Study|Withdrawal by Subject|3|||
162937949|NCT01401478|588475620|FG000|Overall Study|Blood samples not available|1|||
162937950|NCT01401478|588475620|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
162937951|NCT01401478|588475620|FG000|Overall Study|Low intact parathyroid hormone|1|||
162937952|NCT01401478|588475620|FG000|Overall Study|Serious adverse event|1|||
162937953|NCT01814137|588475622|FG000|Overall Study|Adverse Event|0|||
162937954|NCT01814137|588475623|FG001|Overall Study|Adverse Event|1|||
162937955|NCT01814137|588475622|FG000|Overall Study|Withdrawal by Subject|2|||
162937956|NCT01814137|588475623|FG001|Overall Study|Withdrawal by Subject|2|||
162937957|NCT01814137|588475622|FG000|Overall Study|Physician Decision|1|||
162937958|NCT01814137|588475623|FG001|Overall Study|Physician Decision|1|||
162937959|NCT01814137|588475622|FG000|Overall Study|Unclassified|2|||
162937960|NCT01814137|588475623|FG001|Overall Study|Unclassified|1|||
162937961|NCT01798485|588475624|FG000|Overall Study|Adverse Event|32|||
162937962|NCT01798485|588475625|FG001|Overall Study|Adverse Event|40|||
162937963|NCT01798485|588475624|FG000|Overall Study|Withdrawal by Subject|27|||
162937964|NCT01798485|588475625|FG001|Overall Study|Withdrawal by Subject|31|||
162937965|NCT01798485|588475624|FG000|Overall Study|Lost to Follow-up|0|||
162937966|NCT01798485|588475625|FG001|Overall Study|Lost to Follow-up|3|||
162937967|NCT01798485|588475624|FG000|Overall Study|Physician Decision|14|||
162937968|NCT01798485|588475625|FG001|Overall Study|Physician Decision|10|||
162937969|NCT01798485|588475624|FG000|Overall Study|Objective Disease Progression|152|||
162937970|NCT01798485|588475625|FG001|Overall Study|Objective Disease Progression|106|||
162937971|NCT01798485|588475624|FG000|Overall Study|Death|25|||
162937972|NCT01798485|588475625|FG001|Overall Study|Death|22|||
162937973|NCT01798485|588475624|FG000|Overall Study|Sponsor Decision|61|||
162937974|NCT01798485|588475625|FG001|Overall Study|Sponsor Decision|54|||
162937975|NCT01798485|588475624|FG000|Overall Study|Clinical Progression|35|||
162937976|NCT01798485|588475625|FG001|Overall Study|Clinical Progression|24|||
162937977|NCT03687125|588475626|FG000|Overall Study|Progressive Disease|2|||
162937978|NCT03687125|588475627|FG001|Overall Study|Progressive Disease|1|||
162828278|NCT05937165|588082349|FG000|Overall Study|Withdrawal by Subject|0|||
162828279|NCT05937165|588082350|FG001|Overall Study|Withdrawal by Subject|1|||
162828280|NCT06608368|588082351|FG000|Overall Study|Family Emergency|0|||
162828281|NCT06608368|588082352|FG001|Overall Study|Family Emergency|1|||
162828282|NCT06608368|588082353|FG002|Overall Study|Family Emergency|0|||
162828283|NCT06608368|588082351|FG000|Overall Study|Scheduling Issues|0|||
162828284|NCT06608368|588082352|FG001|Overall Study|Scheduling Issues|1|||
162828285|NCT06608368|588082353|FG002|Overall Study|Scheduling Issues|0|||
162828286|NCT03977974|588082354|FG000|Period 2|Adverse Event|0|||
162828287|NCT03977974|588082355|FG001|Period 2|Adverse Event|0|||
162828288|NCT03977974|588082356|FG002|Period 2|Adverse Event|0|||
162828289|NCT03977974|588082357|FG003|Period 2|Adverse Event|0|||
162828290|NCT03977974|588082358|FG004|Period 2|Adverse Event|1|||
162828291|NCT03977974|588082359|FG005|Period 2|Adverse Event|0|||
162828292|NCT03977974|588082360|FG006|Period 2|Adverse Event|0|||
162828293|NCT03977974|588082361|FG007|Period 2|Adverse Event|0|||
162828294|NCT03977974|588082362|FG008|Period 2|Adverse Event|0|||
162828295|NCT03977974|588082363|FG009|Period 2|Adverse Event|0|||
162828296|NCT03977974|588082364|FG010|Period 2|Adverse Event|0|||
162828297|NCT03977974|588082365|FG011|Period 2|Adverse Event|0|||
162828298|NCT03977974|588082366|FG012|Period 2|Adverse Event|0|||
162828299|NCT03080883|588082367|FG000|Overall Study|Withdrawal by Subject|11|||
162828300|NCT03080883|588082368|FG001|Overall Study|Withdrawal by Subject|15|||
162828301|NCT03080883|588082367|FG000|Overall Study|Adverse Event|22|||
162828302|NCT03080883|588082368|FG001|Overall Study|Adverse Event|22|||
162828303|NCT03080883|588082367|FG000|Overall Study|Alternative Therapy|0|||
162828304|NCT03080883|588082368|FG001|Overall Study|Alternative Therapy|3|||
162828305|NCT03080883|588082367|FG000|Overall Study|Other Complicating Disease|9|||
162828306|NCT03080883|588082368|FG001|Overall Study|Other Complicating Disease|5|||
162937979|NCT03687125|588475626|FG000|Overall Study|Protocol Violation|1|||
162937980|NCT03687125|588475627|FG001|Overall Study|Protocol Violation|0|||
162937981|NCT00770991|588475628|FG000|Overall Study|Physician Decision|2|||
162937982|NCT00770991|588475629|FG001|Overall Study|Physician Decision|0|||
162937983|NCT00770991|588475628|FG000|Overall Study|Withdrawal by Subject|1|||
162937984|NCT00770991|588475629|FG001|Overall Study|Withdrawal by Subject|0|||
162828307|NCT03080883|588082367|FG000|Overall Study|Death|21|||
162828308|NCT03080883|588082368|FG001|Overall Study|Death|16|||
162828309|NCT03080883|588082367|FG000|Overall Study|Physician Decision|2|||
162828310|NCT03080883|588082368|FG001|Overall Study|Physician Decision|2|||
162828311|NCT03080883|588082367|FG000|Overall Study|Disease Progression|2|||
162828312|NCT03080883|588082368|FG001|Overall Study|Disease Progression|8|||
162828313|NCT03080883|588082367|FG000|Overall Study|Lost to Follow-up|1|||
162828314|NCT03080883|588082368|FG001|Overall Study|Lost to Follow-up|1|||
162828315|NCT00388973|588084020|FG000|Overall Study|Adverse Event|16|||
162828316|NCT00388973|588084021|FG001|Overall Study|Adverse Event|6|||
162828317|NCT00388973|588084020|FG000|Overall Study|Lack of Efficacy|1|||
162828318|NCT00388973|588084021|FG001|Overall Study|Lack of Efficacy|12|||
162828319|NCT00388973|588084020|FG000|Overall Study|Protocol Violation|3|||
162828320|NCT00388973|588084021|FG001|Overall Study|Protocol Violation|0|||
162828321|NCT00388973|588084020|FG000|Overall Study|Withdrawal by Subject|14|||
162828322|NCT00388973|588084021|FG001|Overall Study|Withdrawal by Subject|17|||
162828323|NCT00388973|588084020|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
162828324|NCT00388973|588084021|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
162828325|NCT00388973|588084020|FG000|Overall Study|Did not complete 61 days of treatment|5|||
162828326|NCT00388973|588084021|FG001|Overall Study|Did not complete 61 days of treatment|4|||
162828327|NCT00388973|588084020|FG000|Overall Study|Left region|0|||
162828328|NCT00388973|588084021|FG001|Overall Study|Left region|1|||
162828329|NCT00388973|588084020|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
162828330|NCT00388973|588084021|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
162828331|NCT00075400|588084031|FG000|Overall Study|Ineligible: wrong primary|1|||
162937985|NCT00770991|588475628|FG000|Overall Study|Adverse Event|1|||
162937986|NCT00770991|588475629|FG001|Overall Study|Adverse Event|5|||
162937987|NCT00770991|588475628|FG000|Overall Study|Pregnancy|1|||
162937988|NCT00770991|588475629|FG001|Overall Study|Pregnancy|0|||
162937989|NCT00490061|588475631|FG000|Overall Study|Physician Decision|1|||
162937990|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
162937991|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
162937992|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
162937993|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
162937994|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
162937995|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
162937996|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
162937997|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
162937998|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
162937999|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
162938000|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
162938001|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
162938002|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
163042844|NCT01066871|588863976|FG002|Overall Study|Lost to Follow-up|2|||
162938003|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
162938004|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
162938005|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
162938006|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
162938007|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
162938008|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
162938009|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
162938010|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
162938011|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
162938012|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
162938013|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
162938014|NCT00585351|588475634|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
162938015|NCT00585351|588475635|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
162938016|NCT00585351|588475636|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938017|NCT00585351|588475637|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938018|NCT00585351|588475638|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938019|NCT00585351|588475639|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938020|NCT00585351|588475640|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938021|NCT00585351|588475641|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162938022|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938023|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938024|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938025|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938026|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938027|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162938028|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
162938029|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
162938030|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Death|0|||
162938031|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Death|0|||
162938032|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Death|0|||
162938033|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Death|0|||
162938034|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Death|1|||
162938035|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Death|0|||
162938036|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Death|1|||
162938037|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Death|0|||
162938038|NCT00585351|588475634|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938039|NCT00585351|588475635|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938040|NCT00585351|588475636|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938041|NCT00585351|588475637|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938042|NCT00585351|588475638|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
162938043|NCT00585351|588475639|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
162938044|NCT00585351|588475640|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938045|NCT00585351|588475641|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
162938046|NCT00192296|588475642|FG000|Overall Study|Withdrawal by Subject|0|||
162938047|NCT00192296|588475643|FG001|Overall Study|Withdrawal by Subject|1|||
162938048|NCT00192296|588475644|FG002|Overall Study|Withdrawal by Subject|0|||
162938049|NCT00192296|588475645|FG003|Overall Study|Withdrawal by Subject|0|||
162938050|NCT02536378|588475650|FG000|Overall Study|Physician Decision|0|||
162938051|NCT02536378|588475651|FG001|Overall Study|Physician Decision|2|||
162938052|NCT02536378|588475650|FG000|Overall Study|Withdrawal by Subject|0|||
162938053|NCT02536378|588475651|FG001|Overall Study|Withdrawal by Subject|1|||
162938054|NCT02536378|588475650|FG000|Overall Study|Death|1|||
162938055|NCT02536378|588475651|FG001|Overall Study|Death|2|||
162938056|NCT02536378|588475650|FG000|Overall Study|Patient refused further follow up|6|||
162938057|NCT02536378|588475651|FG001|Overall Study|Patient refused further follow up|2|||
162938058|NCT02418910|588475652|FG000|Overall Study|Lost to Follow-up|3|||
162938059|NCT02418910|588475652|FG000|Overall Study|Withdrawal by Subject|4|||
162938060|NCT02472977|588475653|FG000|Overall Study|Disease progression|4|||
162938061|NCT02472977|588475654|FG001|Overall Study|Disease progression|25|||
162938062|NCT02472977|588475655|FG002|Overall Study|Disease progression|6|||
162938063|NCT02472977|588475653|FG000|Overall Study|Withdrawal by Subject|0|||
162938064|NCT02472977|588475654|FG001|Overall Study|Withdrawal by Subject|1|||
162938065|NCT02472977|588475655|FG002|Overall Study|Withdrawal by Subject|0|||
162938066|NCT02472977|588475653|FG000|Overall Study|Study drug toxicity|2|||
162938067|NCT02472977|588475654|FG001|Overall Study|Study drug toxicity|0|||
162938068|NCT02472977|588475655|FG002|Overall Study|Study drug toxicity|2|||
162938069|NCT02472977|588475653|FG000|Overall Study|Subject request to discontinue treatment|0|||
162938070|NCT02472977|588475654|FG001|Overall Study|Subject request to discontinue treatment|1|||
162828332|NCT00075400|588084031|FG000|Overall Study|Never treated|2|||
162828333|NCT01999465|588084032|FG000|Overall Study|Lost to Follow-up|0|||
162828334|NCT01999465|588084033|FG001|Overall Study|Lost to Follow-up|2|||
162828335|NCT01999465|588084032|FG000|Overall Study|Protocol Violation|0|||
162828336|NCT01999465|588084033|FG001|Overall Study|Protocol Violation|1|||
162828337|NCT00390546|588084034|FG000|Overall Study|Renal impairment|1|||
162828338|NCT00390546|588084035|FG001|Overall Study|Renal impairment|0|||
162828339|NCT00390546|588084034|FG000|Overall Study|Physician Decision|5|||
162828340|NCT00390546|588084035|FG001|Overall Study|Physician Decision|5|||
162828341|NCT01308008|588084036|FG000|4 Weeks|Illness, disinterest, time|9|||
162828342|NCT01308008|588084037|FG001|4 Weeks|Illness, disinterest, time|2|||
162828343|NCT02325219|588084038|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
162828344|NCT02325219|588084039|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
162828345|NCT02325219|588084040|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
162828346|NCT02325219|588084041|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
162828347|NCT02325219|588084042|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
162828348|NCT02325219|588084038|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
162828349|NCT02325219|588084039|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
162828350|NCT02325219|588084040|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162938071|NCT02472977|588475655|FG002|Overall Study|Subject request to discontinue treatment|0|||
162938072|NCT01132118|588477439|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
162828351|NCT02325219|588084041|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162828352|NCT02325219|588084042|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162828353|NCT02325219|588084038|FG000|Controlled Period (Week 0 - 16)|Other|0|||
162828354|NCT02325219|588084039|FG001|Controlled Period (Week 0 - 16)|Other|0|||
162828355|NCT02325219|588084040|FG002|Controlled Period (Week 0 - 16)|Other|1|||
162938073|NCT01132118|588477440|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
162938074|NCT01132118|588477439|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162938075|NCT01132118|588477440|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
162938076|NCT01132118|588477439|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
162938077|NCT01132118|588477440|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
162938078|NCT01644890|588477441|FG000|Overall Study|Adverse Event|7|||
162938079|NCT01644890|588477442|FG001|Overall Study|Adverse Event|20|||
162938080|NCT01644890|588477441|FG000|Overall Study|Death|1|||
162938081|NCT01644890|588477442|FG001|Overall Study|Death|3|||
162938082|NCT01644890|588477441|FG000|Overall Study|Physician Decision|3|||
162938083|NCT01644890|588477442|FG001|Overall Study|Physician Decision|9|||
162828356|NCT02325219|588084041|FG003|Controlled Period (Week 0 - 16)|Other|0|||
162828357|NCT02325219|588084042|FG004|Controlled Period (Week 0 - 16)|Other|0|||
162828358|NCT02325219|588084038|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162828359|NCT02325219|588084039|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162828360|NCT02325219|588084040|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162828361|NCT02325219|588084041|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162828362|NCT02325219|588084042|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
162938084|NCT01644890|588477441|FG000|Overall Study|Protocol Violation|6|||
162938085|NCT01644890|588477442|FG001|Overall Study|Protocol Violation|7|||
162938086|NCT01644890|588477441|FG000|Overall Study|Withdrawal by Subject|19|||
162938087|NCT01644890|588477442|FG001|Overall Study|Withdrawal by Subject|27|||
162938088|NCT01644890|588477441|FG000|Overall Study|Progression Disease|160|||
162938089|NCT01644890|588477442|FG001|Overall Study|Progression Disease|131|||
162938090|NCT01644890|588477441|FG000|Overall Study|Clinical Progression|6|||
162938091|NCT01644890|588477442|FG001|Overall Study|Clinical Progression|6|||
162938092|NCT01644890|588477441|FG000|Overall Study|> 28 days since last dose of study drug|6|||
162938093|NCT01644890|588477442|FG001|Overall Study|> 28 days since last dose of study drug|3|||
162938094|NCT01644890|588477441|FG000|Overall Study|Other|8|||
162938095|NCT01644890|588477442|FG001|Overall Study|Other|9|||
162938096|NCT01413204|588477445|FG000|Overall Study|Adverse Event|1|||
162938097|NCT01413204|588477446|FG001|Overall Study|Adverse Event|2|||
162938098|NCT01413204|588477447|FG002|Overall Study|Adverse Event|2|||
162938099|NCT01413204|588477445|FG000|Overall Study|Physician Decision|3|||
162938100|NCT01413204|588477446|FG001|Overall Study|Physician Decision|0|||
162938101|NCT01413204|588477447|FG002|Overall Study|Physician Decision|2|||
162938102|NCT01413204|588477445|FG000|Overall Study|Withdrawal by Subject|1|||
162938103|NCT01413204|588477446|FG001|Overall Study|Withdrawal by Subject|4|||
162938104|NCT01413204|588477447|FG002|Overall Study|Withdrawal by Subject|4|||
162938105|NCT01413204|588477445|FG000|Overall Study|Clearly not eligible for the study|0|||
162938106|NCT01413204|588477446|FG001|Overall Study|Clearly not eligible for the study|0|||
162938107|NCT01413204|588477447|FG002|Overall Study|Clearly not eligible for the study|1|||
162938108|NCT01413204|588477445|FG000|Overall Study|Fasting plasma glucose level increased|1|||
162938109|NCT01413204|588477446|FG001|Overall Study|Fasting plasma glucose level increased|0|||
162938110|NCT01413204|588477447|FG002|Overall Study|Fasting plasma glucose level increased|10|||
162938111|NCT00313703|588477449|FG000|Overall Study|Lost to Follow-up|11|||
162938112|NCT00313703|588477450|FG001|Overall Study|Lost to Follow-up|2|||
162938113|NCT00313703|588477451|FG002|Overall Study|Lost to Follow-up|5|||
162938114|NCT00313703|588477452|FG003|Overall Study|Lost to Follow-up|12|||
162938115|NCT02497391|588477453|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
162938116|NCT02497391|588477454|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938117|NCT02497391|588477455|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
162938118|NCT02497391|588477456|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938119|NCT02497391|588477457|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938120|NCT02497391|588477458|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
162938121|NCT02497391|588477453|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
162938122|NCT02497391|588477454|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
162938123|NCT02497391|588477455|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
162938124|NCT02497391|588477456|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
162938125|NCT02497391|588477457|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
162938126|NCT02497391|588477458|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
162938127|NCT02497391|588477453|FG000|Period 3 (14 Days)|Adverse Event|0|||
162938128|NCT02497391|588477454|FG001|Period 3 (14 Days)|Adverse Event|1|||
162938129|NCT02497391|588477455|FG002|Period 3 (14 Days)|Adverse Event|0|||
162938130|NCT02497391|588477456|FG003|Period 3 (14 Days)|Adverse Event|0|||
162938131|NCT02497391|588477457|FG004|Period 3 (14 Days)|Adverse Event|0|||
162938132|NCT02497391|588477458|FG005|Period 3 (14 Days)|Adverse Event|0|||
162938133|NCT02497391|588477453|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
162938134|NCT02497391|588477454|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
162938135|NCT02497391|588477455|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
162938136|NCT02497391|588477456|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
162938137|NCT02497391|588477457|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
162938138|NCT02497391|588477458|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
162938139|NCT02497391|588477453|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938140|NCT02497391|588477454|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938141|NCT02497391|588477455|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
162938142|NCT02497391|588477456|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938143|NCT02497391|588477457|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938144|NCT02497391|588477458|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
162938145|NCT03031899|588477461|FG000|Overall Study|Protocol Violation|1|||
162938146|NCT03031899|588477461|FG000|Overall Study|lesion disappeared after stopping habit|1|||
162938147|NCT01664052|588477462|FG000|Phase 1|No device placement|6|||
162938148|NCT01664052|588477463|FG001|Phase 1|No device placement|0|||
162938149|NCT01664052|588477462|FG000|Phase 1|No HSG 1 hr post placement|1|||
162938150|NCT01664052|588477463|FG001|Phase 1|No HSG 1 hr post placement|0|||
162938151|NCT01664052|588477462|FG000|Phase 2|No device placement|0|||
162938152|NCT01664052|588477463|FG001|Phase 2|No device placement|4|||
162938153|NCT01060670|588477464|FG000|Run In|screen failure|0|||
162938154|NCT01060670|588477465|FG001|Run In|screen failure|238|||
162938155|NCT03705351|588477471|FG000|Overall Study|Study termination|3|||
162938156|NCT03705351|588477471|FG000|Overall Study|Death|1|||
162938157|NCT03705351|588477471|FG000|Overall Study|Lack of Efficacy|2|||
162938158|NCT03705351|588477471|FG000|Overall Study|Withdrawal by Subject|1|||
162938159|NCT00633152|588477478|FG000|Overall Study|Adverse Event|1|||
162938160|NCT00633152|588477479|FG001|Overall Study|Adverse Event|0|||
162938161|NCT00633152|588477478|FG000|Overall Study|Randomized, did not receive study drug|5|||
162938162|NCT00633152|588477479|FG001|Overall Study|Randomized, did not receive study drug|2|||
162938163|NCT00633152|588477478|FG000|Overall Study|Withdrawal by Subject|1|||
162938164|NCT00633152|588477479|FG001|Overall Study|Withdrawal by Subject|1|||
162938165|NCT00633152|588477478|FG000|Overall Study|Lost to Follow-up|4|||
162938166|NCT00633152|588477479|FG001|Overall Study|Lost to Follow-up|1|||
162938167|NCT00633152|588477478|FG000|Overall Study|Miscellaneous Other|3|||
162938168|NCT00633152|588477479|FG001|Overall Study|Miscellaneous Other|2|||
162938169|NCT02180061|588477480|FG000|Overall Study|Adverse Event|4|||
162938170|NCT02180061|588477481|FG001|Overall Study|Adverse Event|2|||
162938171|NCT02180061|588477480|FG000|Overall Study|Clinical Progression|5|||
162938172|NCT02180061|588477481|FG001|Overall Study|Clinical Progression|1|||
162938173|NCT02180061|588477480|FG000|Overall Study|Progressive Disease|15|||
162938174|NCT02180061|588477481|FG001|Overall Study|Progressive Disease|5|||
162938175|NCT02180061|588477480|FG000|Overall Study|Physician Decision|1|||
162938176|NCT02180061|588477481|FG001|Overall Study|Physician Decision|0|||
162938177|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
162938178|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
162938179|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
162938180|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
162938181|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
162938182|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
162938183|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
162938184|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
162938185|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
162938186|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
162938187|NCT00056160|588477484|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
162938188|NCT00056160|588477485|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
162938189|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
162938190|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
162938191|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
162938192|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
162938193|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
162938194|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
162938195|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
162938196|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
162938197|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
162938198|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
162938199|NCT00056160|588477484|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
162938200|NCT00056160|588477485|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
162938201|NCT00056160|588477484|FG000|Final Follow-up|Transferred into expanded access study.|3|||
162938202|NCT00056160|588477485|FG001|Final Follow-up|Transferred into expanded access study.|0|||
162938203|NCT00056160|588477484|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
162938204|NCT00056160|588477485|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
162938205|NCT00056160|588477484|FG000|Final Follow-up|Adverse Event|1|||
162938206|NCT00056160|588477485|FG001|Final Follow-up|Adverse Event|0|||
162938207|NCT01469364|588477486|FG000|Overall Study|Adverse Event|1|||
162938208|NCT01469364|588477486|FG000|Overall Study|Withdrawal by Subject|1|||
162938209|NCT01579474|588477487|FG000|Overall Study|Adverse Event|1|||
162938210|NCT01579474|588477488|FG001|Overall Study|Adverse Event|13|||
162938211|NCT01579474|588477489|FG002|Overall Study|Adverse Event|2|||
162938212|NCT01579474|588477490|FG003|Overall Study|Adverse Event|0|||
162938213|NCT01579474|588477491|FG004|Overall Study|Adverse Event|0|||
162938214|NCT01579474|588477492|FG005|Overall Study|Adverse Event|1|||
162938215|NCT01579474|588477487|FG000|Overall Study|Lack of Efficacy|1|||
162938216|NCT01579474|588477488|FG001|Overall Study|Lack of Efficacy|0|||
162938217|NCT01579474|588477489|FG002|Overall Study|Lack of Efficacy|0|||
162938218|NCT01579474|588477490|FG003|Overall Study|Lack of Efficacy|0|||
162938219|NCT01579474|588477491|FG004|Overall Study|Lack of Efficacy|1|||
162938220|NCT01579474|588477492|FG005|Overall Study|Lack of Efficacy|0|||
162938221|NCT01579474|588477487|FG000|Overall Study|Withdrawal by Subject|1|||
162938222|NCT01579474|588477488|FG001|Overall Study|Withdrawal by Subject|0|||
162938223|NCT01579474|588477489|FG002|Overall Study|Withdrawal by Subject|0|||
162938224|NCT01579474|588477490|FG003|Overall Study|Withdrawal by Subject|0|||
162938225|NCT01579474|588477491|FG004|Overall Study|Withdrawal by Subject|0|||
162938226|NCT01579474|588477492|FG005|Overall Study|Withdrawal by Subject|0|||
162938227|NCT02295774|588477493|FG000|Overall Study|Physician Decision|1|||
162938228|NCT02295774|588477493|FG000|Overall Study|Withdrawal by Subject|2|||
162938229|NCT03532009|588477497|FG000|Overall Study|Other|1|||
162938230|NCT03532009|588477498|FG001|Overall Study|Other|1|||
162938231|NCT03532009|588477497|FG000|Overall Study|Death|1|||
162938232|NCT03532009|588477498|FG001|Overall Study|Death|1|||
162938233|NCT03532009|588477497|FG000|Overall Study|Withdrawal by Patient|0|||
162938234|NCT03532009|588477498|FG001|Overall Study|Withdrawal by Patient|2|||
162938235|NCT00368966|588477499|FG000|Infant Series|Withdrawal by Subject|11|||
162938236|NCT00368966|588477500|FG001|Infant Series|Withdrawal by Subject|6|||
162938237|NCT00368966|588477499|FG000|Infant Series|Protocol Violation|2|||
162938238|NCT00368966|588477500|FG001|Infant Series|Protocol Violation|1|||
162938239|NCT00368966|588477499|FG000|Infant Series|Lost to Follow-up|2|||
162938240|NCT00368966|588477500|FG001|Infant Series|Lost to Follow-up|0|||
162938241|NCT00368966|588477499|FG000|Infant Series|Randomization error|0|||
162938242|NCT00368966|588477500|FG001|Infant Series|Randomization error|1|||
162938243|NCT00368966|588477499|FG000|Infant Series|Failed to meet eligibility criteria|0|||
162938244|NCT00368966|588477500|FG001|Infant Series|Failed to meet eligibility criteria|1|||
162938245|NCT00368966|588477499|FG000|Infant Series|Adverse Event|0|||
162938246|NCT00368966|588477500|FG001|Infant Series|Adverse Event|1|||
162938247|NCT00368966|588477499|FG000|Infant Series|Failed to return|1|||
162938248|NCT00368966|588477500|FG001|Infant Series|Failed to return|0|||
162938249|NCT00368966|588477499|FG000|After Infant|Failed to return|3|||
162938250|NCT00368966|588477500|FG001|After Infant|Failed to return|1|||
162938251|NCT00368966|588477499|FG000|After Infant|Adverse Event|1|||
162938252|NCT00368966|588477500|FG001|After Infant|Adverse Event|2|||
162938253|NCT00368966|588477499|FG000|After Infant|Withdrawal by Subject|1|||
162938254|NCT00368966|588477500|FG001|After Infant|Withdrawal by Subject|1|||
162938255|NCT00368966|588477499|FG000|After Infant|Death|1|||
162938256|NCT00368966|588477500|FG001|After Infant|Death|0|||
162938257|NCT00368966|588477499|FG000|After Infant|Lost to Follow-up|0|||
162938258|NCT00368966|588477500|FG001|After Infant|Lost to Follow-up|1|||
162938259|NCT00368966|588477499|FG000|Toddler Dose|Withdrawal by Subject|1|||
162938260|NCT00368966|588477500|FG001|Toddler Dose|Withdrawal by Subject|1|||
162938261|NCT00368966|588477499|FG000|Toddler Dose|Lost to Follow-up|0|||
162938262|NCT00368966|588477500|FG001|Toddler Dose|Lost to Follow-up|2|||
162938263|NCT02866175|588477505|FG000|Overall Study|Adverse Event|56|||
162938264|NCT02866175|588477506|FG001|Overall Study|Adverse Event|54|||
162938265|NCT02866175|588477505|FG000|Overall Study|Withdrawal by Subject|31|||
162938266|NCT02866175|588477506|FG001|Overall Study|Withdrawal by Subject|52|||
162938267|NCT02866175|588477505|FG000|Overall Study|Death|30|||
162938268|NCT02866175|588477506|FG001|Overall Study|Death|23|||
162938269|NCT02866175|588477505|FG000|Overall Study|Other|7|||
162938270|NCT02866175|588477506|FG001|Overall Study|Other|14|||
162938271|NCT02866175|588477505|FG000|Overall Study|Progressive disease|1|||
162938272|NCT02866175|588477506|FG001|Overall Study|Progressive disease|1|||
162938273|NCT02866175|588477505|FG000|Overall Study|Lost to Follow-up|2|||
162938274|NCT02866175|588477506|FG001|Overall Study|Lost to Follow-up|0|||
162938275|NCT02866175|588477505|FG000|Overall Study|Lack of Efficacy|0|||
162938276|NCT02866175|588477506|FG001|Overall Study|Lack of Efficacy|1|||
162938277|NCT02866175|588477505|FG000|Overall Study|Physician Decision|3|||
162938278|NCT02866175|588477506|FG001|Overall Study|Physician Decision|15|||
162938279|NCT02866175|588477505|FG000|Overall Study|Did not receive treatment|5|||
162938280|NCT02866175|588477506|FG001|Overall Study|Did not receive treatment|15|||
162938281|NCT01694485|588477509|FG000|Overall Study|Withdrawal by Subject|20|||
162938282|NCT01694485|588477510|FG001|Overall Study|Withdrawal by Subject|6|||
162938283|NCT01694485|588477511|FG002|Overall Study|Withdrawal by Subject|7|||
162938284|NCT01694485|588477512|FG003|Overall Study|Withdrawal by Subject|25|||
162938285|NCT01694485|588477513|FG004|Overall Study|Withdrawal by Subject|18|||
162938286|NCT01694485|588477509|FG000|Overall Study|Sponsor Decision|3|||
162938287|NCT01694485|588477510|FG001|Overall Study|Sponsor Decision|0|||
162938288|NCT01694485|588477511|FG002|Overall Study|Sponsor Decision|0|||
162938289|NCT01694485|588477512|FG003|Overall Study|Sponsor Decision|2|||
162938290|NCT01694485|588477513|FG004|Overall Study|Sponsor Decision|0|||
162938291|NCT01694485|588477509|FG000|Overall Study|Lost to Follow-up|9|||
162938292|NCT01694485|588477510|FG001|Overall Study|Lost to Follow-up|1|||
162938293|NCT01694485|588477511|FG002|Overall Study|Lost to Follow-up|6|||
162938294|NCT01694485|588477512|FG003|Overall Study|Lost to Follow-up|10|||
162938295|NCT01694485|588477513|FG004|Overall Study|Lost to Follow-up|7|||
162938296|NCT01694485|588477509|FG000|Overall Study|Death|1|||
162938297|NCT01694485|588477510|FG001|Overall Study|Death|0|||
162938298|NCT01694485|588477511|FG002|Overall Study|Death|0|||
162938299|NCT01694485|588477512|FG003|Overall Study|Death|1|||
162938300|NCT01694485|588477513|FG004|Overall Study|Death|0|||
162938301|NCT02907203|588477514|FG000|Overall Study|Death|1|||
162938302|NCT02907203|588477514|FG000|Overall Study|Lost to Follow-up|3|||
162938303|NCT02907203|588477514|FG000|Overall Study|Withdrawal by Subject|3|||
162938304|NCT02907203|588477514|FG000|Overall Study|Surgical bypass|1|||
162938305|NCT00952484|588477515|FG000|Overall Study|Withdrawal by Subject|0|||
162938306|NCT00952484|588477516|FG001|Overall Study|Withdrawal by Subject|1|||
162938307|NCT00952484|588477517|FG002|Overall Study|Withdrawal by Subject|0|||
162938308|NCT02750306|588477518|FG000|Overall Study|Withdrawal by Subject|5|||
162938309|NCT02750306|588477519|FG001|Overall Study|Withdrawal by Subject|2|||
162938310|NCT02750306|588477518|FG000|Overall Study|Protocol Violation|1|||
162938311|NCT02750306|588477519|FG001|Overall Study|Protocol Violation|0|||
162938312|NCT02227849|588477525|FG000|Overall Study|Adverse Event|4|||
162938313|NCT02227849|588477525|FG000|Overall Study|Physician Decision|1|||
162938314|NCT02227849|588477525|FG000|Overall Study|Withdrawal by Subject|3|||
162938315|NCT00457665|588477528|FG000|12 Months|Drug allergy|1|||
162938316|NCT00457665|588477529|FG001|12 Months|Drug allergy|1|||
162938317|NCT00457665|588477528|FG000|12 Months|High HIV viral load|5|||
162938318|NCT00457665|588477529|FG001|12 Months|High HIV viral load|1|||
162938319|NCT00457665|588477528|FG000|12 Months|Lipodystrophy|2|||
162938320|NCT00457665|588477529|FG001|12 Months|Lipodystrophy|0|||
162938321|NCT00457665|588477528|FG000|12 Months|Withdrawal by Subject|0|||
162938322|NCT00457665|588477529|FG001|12 Months|Withdrawal by Subject|2|||
162938323|NCT00457665|588477528|FG000|12 Months|Abnormal Liver function tests|0|||
162938324|NCT00457665|588477529|FG001|12 Months|Abnormal Liver function tests|5|||
162938325|NCT00457665|588477528|FG000|24 Months|Withdrawal by Subject|3|||
162938326|NCT00457665|588477529|FG001|24 Months|Withdrawal by Subject|2|||
162938327|NCT00457665|588477528|FG000|24 Months|Lipodystrophy|1|||
162938328|NCT00457665|588477529|FG001|24 Months|Lipodystrophy|1|||
162938329|NCT00457665|588477528|FG000|24 Months|Abnormal liver function tests|1|||
162938330|NCT00457665|588477529|FG001|24 Months|Abnormal liver function tests|5|||
162938331|NCT02535000|588477531|FG000|Overall Study|Cancellation of surgery.|1|||
162938332|NCT02535000|588477532|FG001|Overall Study|Cancellation of surgery.|2|||
162938333|NCT04317781|588477533|FG000|Overall Study|Adverse Event|1|||
162938334|NCT04317781|588477533|FG000|Overall Study|Disease relapse|1|||
162938335|NCT04317781|588477533|FG000|Overall Study|Withdrawal by Subject|1|||
162938336|NCT01102777|588477539|FG000|Overall Study|Death|2|||
162938337|NCT01102777|588477540|FG001|Overall Study|Death|6|||
162938338|NCT01102777|588477539|FG000|Overall Study|Lost to Follow-up|7|||
162938339|NCT01102777|588477540|FG001|Overall Study|Lost to Follow-up|10|||
162938340|NCT00706706|588477541|FG000|Overall Study|Death|53|||
162938341|NCT00706706|588477541|FG000|Overall Study|Lost to Follow-up|7|||
162938342|NCT00706706|588477541|FG000|Overall Study|Study endpoint had reached|45|||
162938343|NCT02175966|588477546|FG000|Follow-up Period|Lack of Efficacy|10|||
162938344|NCT02175966|588477547|FG001|Follow-up Period|Lack of Efficacy|6|||
162938345|NCT00210626|588477548|FG000|Overall Study|Adverse Event|1|||
162938346|NCT00210626|588477549|FG001|Overall Study|Adverse Event|2|||
162938347|NCT00210626|588477548|FG000|Overall Study|Protocol Violation|1|||
162938348|NCT00210626|588477549|FG001|Overall Study|Protocol Violation|5|||
162938349|NCT00210626|588477548|FG000|Overall Study|Lost to Follow-up|11|||
162938350|NCT00210626|588477549|FG001|Overall Study|Lost to Follow-up|11|||
162938351|NCT00210626|588477548|FG000|Overall Study|Death|1|||
162938352|NCT00210626|588477549|FG001|Overall Study|Death|0|||
162938353|NCT00210626|588477548|FG000|Overall Study|Withdrawal by Subject|29|||
162938354|NCT00210626|588477549|FG001|Overall Study|Withdrawal by Subject|20|||
162938355|NCT00210626|588477548|FG000|Overall Study|Physician Decision|0|||
162938356|NCT00210626|588477549|FG001|Overall Study|Physician Decision|2|||
162938357|NCT00210626|588477548|FG000|Overall Study|Sponser Request|1|||
162938358|NCT00210626|588477549|FG001|Overall Study|Sponser Request|0|||
162938359|NCT00210626|588477548|FG000|Overall Study|Other|4|||
162938360|NCT00210626|588477549|FG001|Overall Study|Other|5|||
162938361|NCT03361956|588477550|FG000|Overall Study|Adverse Event|1|||
162938362|NCT03361956|588477551|FG001|Overall Study|Adverse Event|0|||
162938363|NCT03361956|588477552|FG002|Overall Study|Adverse Event|1|||
162938364|NCT03361956|588477553|FG003|Overall Study|Adverse Event|1|||
162828363|NCT02325219|588084038|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
162828364|NCT02325219|588084039|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
162828365|NCT02325219|588084040|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
162828366|NCT02325219|588084041|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
162828367|NCT02325219|588084042|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
162828368|NCT02325219|588084038|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162828369|NCT02325219|588084039|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
162828370|NCT02325219|588084040|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162828371|NCT02325219|588084041|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162828372|NCT02325219|588084042|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162828373|NCT02187172|588084043|FG000|Overall Study|Lost to Follow-up|1|||
162828374|NCT02187172|588084044|FG001|Overall Study|Lost to Follow-up|2|||
162828375|NCT02187172|588084043|FG000|Overall Study|Lack of Efficacy|1|||
162828376|NCT02187172|588084044|FG001|Overall Study|Lack of Efficacy|2|||
162828377|NCT02187172|588084043|FG000|Overall Study|Adverse Event|0|||
162828378|NCT02187172|588084044|FG001|Overall Study|Adverse Event|1|||
162828379|NCT02187172|588084043|FG000|Overall Study|Physician Decision|1|||
162828380|NCT02187172|588084044|FG001|Overall Study|Physician Decision|1|||
162828381|NCT00880399|588084045|FG000|Overall Study|Adverse Event|4|||
162828382|NCT00880399|588084046|FG001|Overall Study|Adverse Event|6|||
162828383|NCT00880399|588084047|FG002|Overall Study|Adverse Event|5|||
162828384|NCT00880399|588084045|FG000|Overall Study|Lack of Efficacy|1|||
162828385|NCT00880399|588084046|FG001|Overall Study|Lack of Efficacy|4|||
162828386|NCT00880399|588084047|FG002|Overall Study|Lack of Efficacy|2|||
162828387|NCT00880399|588084045|FG000|Overall Study|Protocol Violation|4|||
162828388|NCT00880399|588084046|FG001|Overall Study|Protocol Violation|4|||
162828389|NCT00880399|588084047|FG002|Overall Study|Protocol Violation|6|||
162828390|NCT00880399|588084045|FG000|Overall Study|Study closed/terminated|3|||
162828391|NCT00880399|588084046|FG001|Overall Study|Study closed/terminated|7|||
162828392|NCT00880399|588084047|FG002|Overall Study|Study closed/terminated|4|||
162828393|NCT00880399|588084045|FG000|Overall Study|Lost to Follow-up|8|||
162828394|NCT00880399|588084046|FG001|Overall Study|Lost to Follow-up|5|||
162828395|NCT00880399|588084047|FG002|Overall Study|Lost to Follow-up|3|||
162828396|NCT00880399|588084045|FG000|Overall Study|Physician Decision|5|||
162828397|NCT00880399|588084046|FG001|Overall Study|Physician Decision|0|||
162828398|NCT00880399|588084047|FG002|Overall Study|Physician Decision|3|||
162828399|NCT00880399|588084045|FG000|Overall Study|Withdrawal by Subject|6|||
162828400|NCT00880399|588084046|FG001|Overall Study|Withdrawal by Subject|3|||
162828401|NCT00880399|588084047|FG002|Overall Study|Withdrawal by Subject|3|||
162828402|NCT02181816|588084052|FG000|Overall Study|Case Report Forms Uncollected|38|||
162828403|NCT02181816|588084052|FG000|Overall Study|Protocol Deviation|21|||
162828404|NCT00909181|588084053|FG000|Overall Study|Lost to Follow-up|39|||
162828405|NCT00909181|588084054|FG001|Overall Study|Lost to Follow-up|18|||
162828406|NCT00909181|588084055|FG002|Overall Study|Lost to Follow-up|33|||
162828407|NCT02830880|588084056|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
162828408|NCT02830880|588084056|FG000|Overall Study|Death|1|||
162828409|NCT02830880|588084056|FG000|Overall Study|Physician Decision|1|||
162828410|NCT02349048|588084061|FG000|Overall Study|Withdrawal by Subject|4|||
162828411|NCT02349048|588084062|FG001|Overall Study|Withdrawal by Subject|0|||
162828412|NCT02349048|588084061|FG000|Overall Study|Lost to Follow-up|1|||
162828413|NCT02349048|588084062|FG001|Overall Study|Lost to Follow-up|0|||
162828414|NCT01648790|588084072|FG000|Treatment 3|Withdrawal by Subject|0|||
162828415|NCT01648790|588084073|FG001|Treatment 3|Withdrawal by Subject|0|||
162828416|NCT01648790|588084074|FG002|Treatment 3|Withdrawal by Subject|0|||
162828417|NCT01648790|588084075|FG003|Treatment 3|Withdrawal by Subject|1|||
162828418|NCT01648790|588084076|FG004|Treatment 3|Withdrawal by Subject|0|||
162828419|NCT02969187|588084077|FG000|Overall Study|Physician Decision|12|||
162828420|NCT02969187|588084078|FG001|Overall Study|Physician Decision|13|||
162938365|NCT03361956|588477554|FG004|Overall Study|Adverse Event|0|||
162828421|NCT03923426|588084082|FG000|Overall Study|Other|19|||
162828422|NCT03923426|588084082|FG000|Overall Study|Lost to Follow-up|16|||
162828423|NCT03923426|588084082|FG000|Overall Study|Death|107|||
162828424|NCT03923426|588084082|FG000|Overall Study|Incomplete response to question|13|||
162828425|NCT01278745|588084088|FG000|Overall Study|Death|2|||
162828426|NCT01278745|588084089|FG001|Overall Study|Death|5|||
162828427|NCT01278745|588084090|FG002|Overall Study|Death|7|||
162828428|NCT01278745|588084091|FG003|Overall Study|Death|0|||
162828429|NCT01278745|588084088|FG000|Overall Study|Physician Decision|1|||
162828430|NCT01278745|588084089|FG001|Overall Study|Physician Decision|0|||
162828431|NCT01278745|588084090|FG002|Overall Study|Physician Decision|0|||
162828432|NCT01278745|588084091|FG003|Overall Study|Physician Decision|9|||
162828433|NCT01278745|588084088|FG000|Overall Study|Withdrawal by Subject|1|||
162828434|NCT01278745|588084089|FG001|Overall Study|Withdrawal by Subject|1|||
162828435|NCT01278745|588084090|FG002|Overall Study|Withdrawal by Subject|5|||
162828436|NCT01278745|588084091|FG003|Overall Study|Withdrawal by Subject|1|||
162828437|NCT01278745|588084088|FG000|Overall Study|Sponsor Decision|1|||
162828438|NCT01278745|588084089|FG001|Overall Study|Sponsor Decision|0|||
162828439|NCT01278745|588084090|FG002|Overall Study|Sponsor Decision|62|||
162938366|NCT03361956|588477550|FG000|Overall Study|Other|0|||
162938367|NCT03361956|588477551|FG001|Overall Study|Other|0|||
162938368|NCT03361956|588477552|FG002|Overall Study|Other|0|||
162938369|NCT03361956|588477553|FG003|Overall Study|Other|1|||
162938370|NCT03361956|588477554|FG004|Overall Study|Other|0|||
162938371|NCT03361956|588477550|FG000|Overall Study|Withdrawal by Subject|2|||
162938372|NCT03361956|588477551|FG001|Overall Study|Withdrawal by Subject|2|||
162938373|NCT03361956|588477552|FG002|Overall Study|Withdrawal by Subject|2|||
162938374|NCT03361956|588477553|FG003|Overall Study|Withdrawal by Subject|0|||
162938375|NCT03361956|588477554|FG004|Overall Study|Withdrawal by Subject|3|||
162938376|NCT03361956|588477550|FG000|Overall Study|Disease Relapse|0|||
162938377|NCT03361956|588477551|FG001|Overall Study|Disease Relapse|0|||
162938378|NCT03361956|588477552|FG002|Overall Study|Disease Relapse|1|||
162938379|NCT03361956|588477553|FG003|Overall Study|Disease Relapse|0|||
162938380|NCT03361956|588477554|FG004|Overall Study|Disease Relapse|0|||
162938381|NCT03361956|588477550|FG000|Overall Study|Physician Decision|0|||
162938382|NCT03361956|588477551|FG001|Overall Study|Physician Decision|2|||
162938383|NCT03361956|588477552|FG002|Overall Study|Physician Decision|0|||
162938384|NCT03361956|588477553|FG003|Overall Study|Physician Decision|1|||
162938385|NCT03361956|588477554|FG004|Overall Study|Physician Decision|0|||
162938386|NCT03361956|588477550|FG000|Overall Study|Lost to Follow-up|0|||
162938387|NCT03361956|588477551|FG001|Overall Study|Lost to Follow-up|0|||
162938388|NCT03361956|588477552|FG002|Overall Study|Lost to Follow-up|1|||
162938389|NCT03361956|588477553|FG003|Overall Study|Lost to Follow-up|1|||
162938390|NCT03361956|588477554|FG004|Overall Study|Lost to Follow-up|2|||
162938391|NCT03760510|588477555|FG000|Overall Study|Not ventilated for 24 hours|105|||
162938392|NCT03760510|588477556|FG001|Overall Study|Not ventilated for 24 hours|97|||
162938393|NCT00871728|588477558|FG000|Overall Study|Adverse Event|1|||
162938394|NCT00871728|588477558|FG000|Overall Study|Protocol Violation|7|||
162938395|NCT00871728|588477558|FG000|Overall Study|Lost to Follow-up|2|||
162938396|NCT00871728|588477558|FG000|Overall Study|Failed to Visit Hospital|4|||
162938397|NCT00871728|588477558|FG000|Overall Study|Participant Non-compliance|1|||
162938398|NCT00871728|588477558|FG000|Overall Study|Withdrawal of Informed Consent|5|||
162938399|NCT04147715|588477559|FG000|Overall Study|Adverse Event|0|||
162938400|NCT04147715|588477560|FG001|Overall Study|Adverse Event|0|||
162938401|NCT04147715|588477561|FG002|Overall Study|Adverse Event|0|||
162938402|NCT04147715|588477562|FG003|Overall Study|Adverse Event|0|||
162938403|NCT04147715|588477563|FG004|Overall Study|Adverse Event|0|||
162938404|NCT04147715|588477564|FG005|Overall Study|Adverse Event|0|||
162938405|NCT04147715|588477565|FG006|Overall Study|Adverse Event|0|||
162938406|NCT04147715|588477566|FG007|Overall Study|Adverse Event|2|||
162938407|NCT04147715|588477567|FG008|Overall Study|Adverse Event|1|||
162938408|NCT04147715|588477568|FG009|Overall Study|Adverse Event|0|||
162938409|NCT04147715|588477569|FG010|Overall Study|Adverse Event|0|||
162938410|NCT04147715|588477570|FG011|Overall Study|Adverse Event|0|||
162938411|NCT02330081|588477582|FG000|Overall Study|Adverse Event|1|||
162938412|NCT02330081|588477582|FG000|Overall Study|Donation did not meet criteria|1|||
162938413|NCT02330081|588477582|FG000|Overall Study|Protocol Violation|6|||
162938414|NCT02277769|588477583|FG000|Overall Study|Protocol Violation|3|||
162938415|NCT02277769|588477584|FG001|Overall Study|Protocol Violation|3|||
162938416|NCT02277769|588477585|FG002|Overall Study|Protocol Violation|5|||
162938417|NCT02277769|588477583|FG000|Overall Study|Lack of Efficacy|17|||
162938418|NCT02277769|588477584|FG001|Overall Study|Lack of Efficacy|0|||
162938419|NCT02277769|588477585|FG002|Overall Study|Lack of Efficacy|4|||
162938420|NCT02277769|588477583|FG000|Overall Study|Adverse Event|14|||
162938421|NCT02277769|588477584|FG001|Overall Study|Adverse Event|2|||
162938422|NCT02277769|588477585|FG002|Overall Study|Adverse Event|4|||
162938423|NCT02277769|588477583|FG000|Overall Study|Other than specified above|12|||
162938424|NCT02277769|588477584|FG001|Overall Study|Other than specified above|8|||
162938425|NCT02277769|588477585|FG002|Overall Study|Other than specified above|5|||
162938426|NCT03775681|588477589|FG000|Overall Study|Physician Decision|3|||
162938427|NCT02123459|588477592|FG000|Washout Period (1 Day)|Adverse Event|1|||
162938428|NCT02123459|588477593|FG001|Washout Period (1 Day)|Adverse Event|0|||
162938429|NCT02196506|588477594|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
162938430|NCT02196506|588477595|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
162938431|NCT02196506|588477596|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
162938432|NCT02196506|588477597|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
162938433|NCT02196506|588477594|FG000|Phase A|Withdrawal by Subject|34|||
162938434|NCT02196506|588477595|FG001|Phase A|Withdrawal by Subject|0|||
162938435|NCT02196506|588477596|FG002|Phase A|Withdrawal by Subject|0|||
162938436|NCT02196506|588477597|FG003|Phase A|Withdrawal by Subject|0|||
162938437|NCT02196506|588477594|FG000|Phase A|Adverse Event|22|||
162938438|NCT02196506|588477595|FG001|Phase A|Adverse Event|0|||
162938439|NCT02196506|588477596|FG002|Phase A|Adverse Event|0|||
162938440|NCT02196506|588477597|FG003|Phase A|Adverse Event|0|||
162938441|NCT02196506|588477594|FG000|Phase A|Lost to Follow-up|9|||
162938442|NCT02196506|588477595|FG001|Phase A|Lost to Follow-up|0|||
162938443|NCT02196506|588477596|FG002|Phase A|Lost to Follow-up|0|||
162938444|NCT02196506|588477597|FG003|Phase A|Lost to Follow-up|0|||
162938445|NCT02196506|588477594|FG000|Phase A|Protocol deviation|12|||
162938446|NCT02196506|588477595|FG001|Phase A|Protocol deviation|0|||
162938447|NCT02196506|588477596|FG002|Phase A|Protocol deviation|0|||
162938448|NCT02196506|588477597|FG003|Phase A|Protocol deviation|0|||
162938449|NCT02196506|588477594|FG000|Phase A|Participant withdrawn by investigator|10|||
162938450|NCT02196506|588477595|FG001|Phase A|Participant withdrawn by investigator|0|||
162938451|NCT02196506|588477596|FG002|Phase A|Participant withdrawn by investigator|0|||
162938452|NCT02196506|588477597|FG003|Phase A|Participant withdrawn by investigator|0|||
162938453|NCT02196506|588477594|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
162938454|NCT02196506|588477595|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
162938455|NCT02196506|588477596|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
162938456|NCT02196506|588477597|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
162938457|NCT02196506|588477594|FG000|Phase B|Lack of Efficacy|0|||
162938458|NCT02196506|588477595|FG001|Phase B|Lack of Efficacy|1|||
162938459|NCT02196506|588477596|FG002|Phase B|Lack of Efficacy|2|||
162938460|NCT02196506|588477597|FG003|Phase B|Lack of Efficacy|0|||
162938461|NCT02196506|588477594|FG000|Phase B|Withdrawal by Participant|0|||
162938462|NCT02196506|588477595|FG001|Phase B|Withdrawal by Participant|8|||
162938463|NCT02196506|588477596|FG002|Phase B|Withdrawal by Participant|1|||
162938464|NCT02196506|588477597|FG003|Phase B|Withdrawal by Participant|0|||
162938465|NCT02196506|588477594|FG000|Phase B|Adverse Event|0|||
162938466|NCT02196506|588477595|FG001|Phase B|Adverse Event|4|||
162938467|NCT02196506|588477596|FG002|Phase B|Adverse Event|1|||
162938468|NCT02196506|588477597|FG003|Phase B|Adverse Event|0|||
162938469|NCT02196506|588477594|FG000|Phase B|Lost to Follow-up|0|||
162938470|NCT02196506|588477595|FG001|Phase B|Lost to Follow-up|2|||
162938471|NCT02196506|588477596|FG002|Phase B|Lost to Follow-up|1|||
162938472|NCT02196506|588477597|FG003|Phase B|Lost to Follow-up|0|||
162938473|NCT02196506|588477594|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
162938474|NCT02196506|588477595|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
162938475|NCT02196506|588477596|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
162938476|NCT02196506|588477597|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
162938477|NCT02196506|588477594|FG000|Phase A+|Withdrawal by Participant|0|||
162938478|NCT02196506|588477595|FG001|Phase A+|Withdrawal by Participant|0|||
162938479|NCT02196506|588477596|FG002|Phase A+|Withdrawal by Participant|0|||
162938480|NCT02196506|588477597|FG003|Phase A+|Withdrawal by Participant|5|||
162938481|NCT02196506|588477594|FG000|Phase A+|Adverse Event|0|||
162938482|NCT02196506|588477595|FG001|Phase A+|Adverse Event|0|||
162938483|NCT02196506|588477596|FG002|Phase A+|Adverse Event|0|||
162938484|NCT02196506|588477597|FG003|Phase A+|Adverse Event|1|||
162938485|NCT02196506|588477594|FG000|Phase A+|Lost to Follow-up|0|||
162938486|NCT02196506|588477595|FG001|Phase A+|Lost to Follow-up|0|||
162938487|NCT02196506|588477596|FG002|Phase A+|Lost to Follow-up|0|||
162938488|NCT02196506|588477597|FG003|Phase A+|Lost to Follow-up|6|||
162938489|NCT02196506|588477594|FG000|Phase A+|Participant withdrawn by investigator|0|||
162938490|NCT02196506|588477595|FG001|Phase A+|Participant withdrawn by investigator|0|||
163042845|NCT01066871|588863977|FG003|Overall Study|Lost to Follow-up|0|||
162938491|NCT02196506|588477596|FG002|Phase A+|Participant withdrawn by investigator|0|||
162938492|NCT02196506|588477597|FG003|Phase A+|Participant withdrawn by investigator|1|||
162938493|NCT01070394|588477598|FG000|Overall Study|Adverse Event|6|||
162938494|NCT01070394|588477598|FG000|Overall Study|Withdrawal by Subject|1|||
162938495|NCT01098240|588477599|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
162938496|NCT01098240|588477600|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
162938497|NCT01098240|588477601|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
162938498|NCT01098240|588477599|FG000|Open-Label Phase|Protocol Violation|4|||
162938499|NCT01098240|588477600|FG001|Open-Label Phase|Protocol Violation|0|||
162938500|NCT01098240|588477601|FG002|Open-Label Phase|Protocol Violation|0|||
162938501|NCT01098240|588477599|FG000|Open-Label Phase|Lost to Follow-up|13|||
162938502|NCT01098240|588477600|FG001|Open-Label Phase|Lost to Follow-up|0|||
162938503|NCT01098240|588477601|FG002|Open-Label Phase|Lost to Follow-up|0|||
162938504|NCT01098240|588477599|FG000|Open-Label Phase|Other|19|||
162938505|NCT01098240|588477600|FG001|Open-Label Phase|Other|0|||
162938506|NCT01098240|588477601|FG002|Open-Label Phase|Other|0|||
162938507|NCT01098240|588477599|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
162938508|NCT01098240|588477600|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
162938509|NCT01098240|588477601|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
162938510|NCT01098240|588477599|FG000|Open-Label Phase|Pregnancy|1|||
162938511|NCT01098240|588477600|FG001|Open-Label Phase|Pregnancy|0|||
162938512|NCT01098240|588477601|FG002|Open-Label Phase|Pregnancy|0|||
162938513|NCT01098240|588477599|FG000|Open-Label Phase|Withdrawal by Subject|9|||
162938514|NCT01098240|588477600|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162938515|NCT01098240|588477601|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162938516|NCT01098240|588477599|FG000|Open-Label Phase|Adverse Event|12|||
162938517|NCT01098240|588477600|FG001|Open-Label Phase|Adverse Event|0|||
162938518|NCT01098240|588477601|FG002|Open-Label Phase|Adverse Event|0|||
162938519|NCT01098240|588477599|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
162938520|NCT01098240|588477600|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
162938521|NCT01098240|588477601|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
162938522|NCT01098240|588477599|FG000|Double-Blind Phase|Protocol Violation|0|||
162938523|NCT01098240|588477600|FG001|Double-Blind Phase|Protocol Violation|2|||
162938524|NCT01098240|588477601|FG002|Double-Blind Phase|Protocol Violation|4|||
162938525|NCT01098240|588477599|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162938526|NCT01098240|588477600|FG001|Double-Blind Phase|Lost to Follow-up|2|||
162938527|NCT01098240|588477601|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162938528|NCT01098240|588477599|FG000|Double-Blind Phase|Other|0|||
162938529|NCT01098240|588477600|FG001|Double-Blind Phase|Other|2|||
162938530|NCT01098240|588477601|FG002|Double-Blind Phase|Other|2|||
162938531|NCT01098240|588477599|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
162938532|NCT01098240|588477600|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
162938533|NCT01098240|588477601|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
162938534|NCT01098240|588477599|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
162938535|NCT01098240|588477600|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
162938536|NCT01098240|588477601|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
162938537|NCT01098240|588477599|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162938538|NCT01098240|588477600|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
162938539|NCT01098240|588477601|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
162938540|NCT01098240|588477599|FG000|Double-Blind Phase|Adverse Event|0|||
162938541|NCT01098240|588477600|FG001|Double-Blind Phase|Adverse Event|3|||
162938542|NCT01098240|588477601|FG002|Double-Blind Phase|Adverse Event|3|||
162938543|NCT00066807|588477602|FG000|Overall Study|Study was terminated early|14|||
162938544|NCT00066807|588477603|FG001|Overall Study|Study was terminated early|15|||
162938545|NCT03507439|588477604|FG000|Overall Study|Other|2|||
162938546|NCT03507439|588477605|FG001|Overall Study|Other|1|||
162698666|NCT00337662|587605555|FG002|Study Period II|Sponsor Decision|0|||
162698667|NCT00337662|587605556|FG003|Study Period II|Sponsor Decision|2|||
162938547|NCT03507439|588477604|FG000|Overall Study|Withdrawal by Subject|1|||
162938548|NCT03507439|588477605|FG001|Overall Study|Withdrawal by Subject|0|||
162938549|NCT03507439|588477604|FG000|Overall Study|Death|1|||
162938550|NCT03507439|588477605|FG001|Overall Study|Death|1|||
162938551|NCT00874757|588477606|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
162938552|NCT03346538|588478999|FG000|Overall Study|Physician Decision|0|||
162938553|NCT03346538|588479000|FG001|Overall Study|Physician Decision|1|||
162938554|NCT03346538|588479001|FG002|Overall Study|Physician Decision|0|||
162938555|NCT03346538|588478999|FG000|Overall Study|Withdrawal by Subject|3|||
162938556|NCT03346538|588479000|FG001|Overall Study|Withdrawal by Subject|2|||
162938557|NCT03346538|588479001|FG002|Overall Study|Withdrawal by Subject|0|||
162938558|NCT03346538|588478999|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
162938559|NCT03346538|588479000|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
162938560|NCT03346538|588479001|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
162938561|NCT04014959|588479003|FG000|Baseline MRI and Assessments|Physician Decision|2|||
162938562|NCT04014959|588479003|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
162938563|NCT04014959|588479003|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
162938564|NCT02004847|588479005|FG000|Overall Study|Protocol Violation|1|||
162938565|NCT02004847|588479006|FG001|Overall Study|Protocol Violation|1|||
162938566|NCT02220920|588479007|FG000|Overall Study|Adverse Event|1|||
162938567|NCT02220920|588479008|FG001|Overall Study|Adverse Event|0|||
162938568|NCT02220920|588479007|FG000|Overall Study|Lack of Efficacy|0|||
162938569|NCT02220920|588479008|FG001|Overall Study|Lack of Efficacy|1|||
162938570|NCT02220920|588479007|FG000|Overall Study|Withdrawal by Subject|1|||
162938571|NCT02220920|588479008|FG001|Overall Study|Withdrawal by Subject|0|||
162938572|NCT02220920|588479007|FG000|Overall Study|Conflict with the stopping criteria|1|||
162938573|NCT02220920|588479008|FG001|Overall Study|Conflict with the stopping criteria|2|||
162938574|NCT02811861|588479015|FG000|Overall Study|Radiological Disease Progression|123|||
162938575|NCT02811861|588479016|FG001|Overall Study|Radiological Disease Progression|97|||
162938576|NCT02811861|588479017|FG002|Overall Study|Radiological Disease Progression|174|||
162938577|NCT02811861|588479015|FG000|Overall Study|Clinical Disease Progression|20|||
162938578|NCT02811861|588479016|FG001|Overall Study|Clinical Disease Progression|19|||
162938579|NCT02811861|588479017|FG002|Overall Study|Clinical Disease Progression|22|||
162938580|NCT02811861|588479015|FG000|Overall Study|Adverse Event|63|||
162938581|NCT02811861|588479016|FG001|Overall Study|Adverse Event|60|||
162938582|NCT02811861|588479017|FG002|Overall Study|Adverse Event|41|||
162938583|NCT02811861|588479015|FG000|Overall Study|Lost to Follow-up|0|||
162938584|NCT02811861|588479016|FG001|Overall Study|Lost to Follow-up|0|||
162938585|NCT02811861|588479017|FG002|Overall Study|Lost to Follow-up|1|||
162938586|NCT02811861|588479015|FG000|Overall Study|Subject Choice|29|||
162938587|NCT02811861|588479016|FG001|Overall Study|Subject Choice|17|||
162938588|NCT02811861|588479017|FG002|Overall Study|Subject Choice|23|||
162938589|NCT02811861|588479015|FG000|Overall Study|Withdrawal by Subject|4|||
162938590|NCT02811861|588479016|FG001|Overall Study|Withdrawal by Subject|4|||
162938591|NCT02811861|588479017|FG002|Overall Study|Withdrawal by Subject|9|||
162938592|NCT02811861|588479015|FG000|Overall Study|Other|4|||
162938593|NCT02811861|588479016|FG001|Overall Study|Other|13|||
162938594|NCT02811861|588479017|FG002|Overall Study|Other|3|||
162938595|NCT02811861|588479015|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
162938596|NCT02811861|588479016|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
162938597|NCT02811861|588479017|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
162938598|NCT02811861|588479015|FG000|Overall Study|Randomized but not treated|2|||
162938599|NCT02811861|588479016|FG001|Overall Study|Randomized but not treated|3|||
162938600|NCT02811861|588479017|FG002|Overall Study|Randomized but not treated|17|||
162938601|NCT04081337|588479021|FG000|Overall Study|Adverse Event|0|||
162938602|NCT04081337|588479022|FG001|Overall Study|Adverse Event|1|||
162938603|NCT04081337|588479021|FG000|Overall Study|Withdrawal by Subject|2|||
162938604|NCT04081337|588479022|FG001|Overall Study|Withdrawal by Subject|0|||
162938605|NCT04081337|588479021|FG000|Overall Study|Physician Decision|1|||
162938606|NCT04081337|588479022|FG001|Overall Study|Physician Decision|2|||
162938607|NCT04081337|588479021|FG000|Overall Study|Lost to Follow-up|1|||
162938608|NCT04081337|588479022|FG001|Overall Study|Lost to Follow-up|0|||
162938609|NCT06624072|588479023|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
162938610|NCT06624072|588479024|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
162938611|NCT06624072|588479025|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
162938612|NCT00416520|588479038|FG000|Open-label Period|Adverse Event|28|||
162938613|NCT00416520|588479039|FG001|Open-label Period|Adverse Event|10|||
162938614|NCT00416520|588479040|FG002|Open-label Period|Adverse Event|0|||
162938615|NCT00416520|588479041|FG003|Open-label Period|Adverse Event|0|||
162938616|NCT00416520|588479038|FG000|Open-label Period|Death|2|||
162938617|NCT00416520|588479039|FG001|Open-label Period|Death|1|||
162938618|NCT00416520|588479040|FG002|Open-label Period|Death|0|||
162938619|NCT00416520|588479041|FG003|Open-label Period|Death|0|||
162938620|NCT00416520|588479038|FG000|Open-label Period|Lack of Efficacy|8|||
162938621|NCT00416520|588479039|FG001|Open-label Period|Lack of Efficacy|1|||
162938622|NCT00416520|588479040|FG002|Open-label Period|Lack of Efficacy|0|||
162938623|NCT00416520|588479041|FG003|Open-label Period|Lack of Efficacy|0|||
162938624|NCT00416520|588479038|FG000|Open-label Period|Protocol Violation|3|||
162938625|NCT00416520|588479039|FG001|Open-label Period|Protocol Violation|3|||
162938626|NCT00416520|588479040|FG002|Open-label Period|Protocol Violation|0|||
162938627|NCT00416520|588479041|FG003|Open-label Period|Protocol Violation|0|||
162938628|NCT00416520|588479038|FG000|Open-label Period|Withdrawal by Subject|16|||
162938629|NCT00416520|588479039|FG001|Open-label Period|Withdrawal by Subject|5|||
162938630|NCT00416520|588479040|FG002|Open-label Period|Withdrawal by Subject|0|||
162938631|NCT00416520|588479041|FG003|Open-label Period|Withdrawal by Subject|0|||
162938632|NCT00416520|588479038|FG000|Open-label Period|Other Reasons|3|||
162938633|NCT00416520|588479039|FG001|Open-label Period|Other Reasons|12|||
162938634|NCT00416520|588479040|FG002|Open-label Period|Other Reasons|0|||
162938635|NCT00416520|588479041|FG003|Open-label Period|Other Reasons|0|||
162938636|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938637|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938638|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
162938639|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
162938640|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938641|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938642|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
162938643|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
162938644|NCT00416520|588479038|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
162938645|NCT00416520|588479039|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
162938646|NCT00416520|588479040|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
162938647|NCT00416520|588479041|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
162938648|NCT01387737|588479042|FG000|Overall Study|Adverse Event|20|||
162938649|NCT01387737|588479043|FG001|Overall Study|Adverse Event|30|||
162938650|NCT01387737|588479042|FG000|Overall Study|Lack of Efficacy|1|||
162938651|NCT01387737|588479043|FG001|Overall Study|Lack of Efficacy|0|||
162938652|NCT01387737|588479042|FG000|Overall Study|Physician Decision|3|||
162938653|NCT01387737|588479043|FG001|Overall Study|Physician Decision|10|||
162938654|NCT01387737|588479042|FG000|Overall Study|Withdrawal by Subject|27|||
162938655|NCT01387737|588479043|FG001|Overall Study|Withdrawal by Subject|31|||
162938656|NCT01387737|588479042|FG000|Overall Study|Clearly not eligible for the study|1|||
162938657|NCT01387737|588479043|FG001|Overall Study|Clearly not eligible for the study|3|||
162938658|NCT00707954|588479045|FG000|Overall Study|Physician Decision|0|||
162938659|NCT00707954|588479046|FG001|Overall Study|Physician Decision|0|||
162938660|NCT00707954|588479047|FG002|Overall Study|Physician Decision|0|||
162938661|NCT00707954|588479048|FG003|Overall Study|Physician Decision|0|||
162938662|NCT00707954|588479049|FG004|Overall Study|Physician Decision|1|||
162938663|NCT00449072|588479052|FG000|Overall Study|Adverse Event|3|||
162938664|NCT00449072|588479053|FG001|Overall Study|Adverse Event|1|||
162938665|NCT00449072|588479052|FG000|Overall Study|Protocol Violation|14|||
162938666|NCT00449072|588479053|FG001|Overall Study|Protocol Violation|12|||
162938667|NCT00449072|588479052|FG000|Overall Study|Lost to Follow-up|5|||
162938668|NCT00449072|588479053|FG001|Overall Study|Lost to Follow-up|7|||
162938669|NCT00449072|588479052|FG000|Overall Study|Withdrawal by Subject|11|||
162938670|NCT00449072|588479053|FG001|Overall Study|Withdrawal by Subject|8|||
162938671|NCT00449072|588479052|FG000|Overall Study|Lack of Efficacy|1|||
162938672|NCT00449072|588479053|FG001|Overall Study|Lack of Efficacy|1|||
162938673|NCT00449072|588479052|FG000|Overall Study|Physician Decision|1|||
162938674|NCT00449072|588479053|FG001|Overall Study|Physician Decision|0|||
162938675|NCT00449072|588479052|FG000|Overall Study|Not treated|0|||
162938676|NCT00449072|588479053|FG001|Overall Study|Not treated|1|||
162938677|NCT00449072|588479052|FG000|Overall Study|Excluded medication|0|||
162938678|NCT00449072|588479053|FG001|Overall Study|Excluded medication|2|||
162938679|NCT00449072|588479052|FG000|Overall Study|Non-compliance|2|||
162938680|NCT00449072|588479053|FG001|Overall Study|Non-compliance|5|||
162938681|NCT00449072|588479052|FG000|Overall Study|Sponsor decision|1|||
162938682|NCT00449072|588479053|FG001|Overall Study|Sponsor decision|3|||
162938683|NCT00449072|588479052|FG000|Overall Study|Relocation|3|||
162938684|NCT00449072|588479053|FG001|Overall Study|Relocation|2|||
162938685|NCT06509100|588479056|FG000|Overall Study|Withdrawal by Subject|1|||
162938686|NCT06509100|588479056|FG000|Overall Study|Lost to Follow-up|1|||
162938687|NCT05002569|588479059|FG000|Randomized|Withdrew Consent|3|||
162938688|NCT05002569|588479060|FG001|Randomized|Withdrew Consent|0|||
162938689|NCT05002569|588479059|FG000|Randomized|No longer meets study criteria|0|||
162938690|NCT05002569|588479060|FG001|Randomized|No longer meets study criteria|1|||
163042846|NCT01066871|588863974|FG000|Overall Study|Protocol Violation|1|||
162938691|NCT05002569|588479059|FG000|Randomized|AE unrelated to study drug|1|||
162938692|NCT05002569|588479060|FG001|Randomized|AE unrelated to study drug|0|||
162938693|NCT05002569|588479059|FG000|Treatment Period|Requested to Discontinue|26|||
162938694|NCT05002569|588479060|FG001|Treatment Period|Requested to Discontinue|5|||
162938695|NCT05002569|588479059|FG000|Treatment Period|Withdrew Consent|7|||
162938696|NCT05002569|588479060|FG001|Treatment Period|Withdrew Consent|1|||
162938697|NCT05002569|588479059|FG000|Treatment Period|Study Drug Toxicity|114|||
162938698|NCT05002569|588479060|FG001|Treatment Period|Study Drug Toxicity|64|||
162938699|NCT05002569|588479059|FG000|Treatment Period|AE unrelated to study drug|6|||
162938700|NCT05002569|588479060|FG001|Treatment Period|AE unrelated to study drug|12|||
162938701|NCT05002569|588479059|FG000|Treatment Period|Disease Recurrence|102|||
162938702|NCT05002569|588479060|FG001|Treatment Period|Disease Recurrence|128|||
162938703|NCT05002569|588479059|FG000|Treatment Period|Other Reasons|4|||
162938704|NCT05002569|588479060|FG001|Treatment Period|Other Reasons|7|||
162938705|NCT05002569|588479059|FG000|Treatment Period|Death|1|||
162938706|NCT05002569|588479060|FG001|Treatment Period|Death|1|||
162938707|NCT05002569|588479059|FG000|Follow Up|Death|78|||
162938708|NCT05002569|588479060|FG001|Follow Up|Death|69|||
162938709|NCT05002569|588479059|FG000|Follow Up|Lost to Follow-up|3|||
162938710|NCT05002569|588479060|FG001|Follow Up|Lost to Follow-up|3|||
162938711|NCT05002569|588479059|FG000|Follow Up|Withdrew consent|17|||
162938712|NCT05002569|588479060|FG001|Follow Up|Withdrew consent|16|||
162938713|NCT05002569|588479059|FG000|Follow Up|Other Reasons|444|||
162938714|NCT05002569|588479060|FG001|Follow Up|Other Reasons|452|||
162938715|NCT04041570|588479066|FG000|Overall Study|Moved from Area|0|||
162938716|NCT04041570|588479067|FG001|Overall Study|Moved from Area|2|||
162938717|NCT05211336|588479068|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
162938718|NCT05211336|588479069|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
162938719|NCT05211336|588479068|FG000|Overall Study|Progressive disease|0|||
162938720|NCT05211336|588479069|FG001|Overall Study|Progressive disease|4|||
162938721|NCT05211336|588479068|FG000|Overall Study|Death due to myocardial infarction|0|||
162938722|NCT05211336|588479069|FG001|Overall Study|Death due to myocardial infarction|1|||
162938723|NCT05211336|588479068|FG000|Overall Study|Death due to unknown cause|0|||
162938724|NCT05211336|588479069|FG001|Overall Study|Death due to unknown cause|1|||
162938725|NCT05211336|588479068|FG000|Overall Study|Worsening kidney function and quality of response|0|||
162938726|NCT05211336|588479069|FG001|Overall Study|Worsening kidney function and quality of response|1|||
162938727|NCT02337829|588479070|FG000|Overall Study|Death|0|||
162938728|NCT02337829|588479071|FG001|Overall Study|Death|1|||
162938729|NCT02337829|588479072|FG002|Overall Study|Death|0|||
162938730|NCT02337829|588479073|FG003|Overall Study|Death|0|||
162828440|NCT01278745|588084091|FG003|Overall Study|Sponsor Decision|6|||
162828441|NCT01278745|588084088|FG000|Overall Study|Ineligible|0|||
162828442|NCT01278745|588084089|FG001|Overall Study|Ineligible|0|||
162828443|NCT01278745|588084090|FG002|Overall Study|Ineligible|42|||
162828444|NCT01278745|588084091|FG003|Overall Study|Ineligible|61|||
162828445|NCT01278745|588084088|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
162828446|NCT01278745|588084089|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
162828447|NCT01278745|588084090|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
162828448|NCT01278745|588084091|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
162828449|NCT02953340|588084094|FG000|Overall Study|Death|0|||
162828450|NCT02953340|588084095|FG001|Overall Study|Death|1|||
162828451|NCT02953340|588084094|FG000|Overall Study|Investigator Decision|3|||
162828452|NCT02953340|588084095|FG001|Overall Study|Investigator Decision|3|||
162828453|NCT02953340|588084094|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
162828454|NCT02953340|588084095|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
162828455|NCT02953340|588084094|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
162828456|NCT02953340|588084095|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
162828457|NCT02953340|588084094|FG000|Overall Study|Withdrawal by Subject|9|||
162828458|NCT02953340|588084095|FG001|Overall Study|Withdrawal by Subject|9|||
162828459|NCT02953340|588084094|FG000|Overall Study|Sponsor decision|0|||
162828460|NCT02953340|588084095|FG001|Overall Study|Sponsor decision|2|||
162828461|NCT02953340|588084094|FG000|Overall Study|Lost to Follow-up|3|||
162828462|NCT02953340|588084095|FG001|Overall Study|Lost to Follow-up|2|||
162828463|NCT02953340|588084094|FG000|Overall Study|Reason not specified|2|||
162828464|NCT02953340|588084095|FG001|Overall Study|Reason not specified|2|||
162828465|NCT01376778|588084096|FG000|Overall Study|Lost to Follow-up|3|||
162828466|NCT01376778|588084097|FG001|Overall Study|Lost to Follow-up|2|||
162828467|NCT01923285|588084098|FG000|Overall Study|Withdrawal by Subject|7|||
162828468|NCT01923285|588084099|FG001|Overall Study|Withdrawal by Subject|6|||
162828469|NCT03462576|588084102|FG000|Overall Study|Protocol Violation|5|||
162828470|NCT03462576|588084103|FG001|Overall Study|Protocol Violation|11|||
162828471|NCT03462576|588084104|FG002|Overall Study|Protocol Violation|7|||
162938731|NCT02337829|588479070|FG000|Overall Study|Study terminated by sponsor|12|||
162938732|NCT02337829|588479071|FG001|Overall Study|Study terminated by sponsor|10|||
162938733|NCT02337829|588479072|FG002|Overall Study|Study terminated by sponsor|5|||
162938734|NCT02337829|588479073|FG003|Overall Study|Study terminated by sponsor|6|||
162938735|NCT02337829|588479070|FG000|Overall Study|discontinued for other reasons|6|||
162938736|NCT02337829|588479071|FG001|Overall Study|discontinued for other reasons|3|||
162938737|NCT02337829|588479072|FG002|Overall Study|discontinued for other reasons|1|||
162938738|NCT02337829|588479073|FG003|Overall Study|discontinued for other reasons|4|||
162938739|NCT01418352|588479074|FG000|Overall Study|Lost to Follow-up|2|||
162938740|NCT01418352|588479075|FG001|Overall Study|Lost to Follow-up|0|||
162938741|NCT01418352|588479076|FG002|Overall Study|Lost to Follow-up|0|||
162938742|NCT01418352|588479077|FG003|Overall Study|Lost to Follow-up|0|||
162938743|NCT01418352|588479074|FG000|Overall Study|Adverse Event|0|||
162938744|NCT01418352|588479075|FG001|Overall Study|Adverse Event|1|||
162938745|NCT01418352|588479076|FG002|Overall Study|Adverse Event|0|||
162938746|NCT01418352|588479077|FG003|Overall Study|Adverse Event|0|||
162938747|NCT01418352|588479074|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
162938748|NCT01418352|588479075|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
162938749|NCT01418352|588479076|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
162938750|NCT01418352|588479077|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
162938751|NCT01418352|588479074|FG000|Overall Study|Subject Withdrew Consent|0|||
162938752|NCT01418352|588479075|FG001|Overall Study|Subject Withdrew Consent|1|||
162938753|NCT01418352|588479076|FG002|Overall Study|Subject Withdrew Consent|2|||
162938754|NCT01418352|588479077|FG003|Overall Study|Subject Withdrew Consent|1|||
162938755|NCT01418352|588479074|FG000|Overall Study|Protocol Deviation|0|||
162938756|NCT01418352|588479075|FG001|Overall Study|Protocol Deviation|0|||
162938757|NCT01418352|588479076|FG002|Overall Study|Protocol Deviation|1|||
162938758|NCT01418352|588479077|FG003|Overall Study|Protocol Deviation|0|||
162938759|NCT01418352|588479074|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
162938760|NCT01418352|588479075|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938761|NCT01418352|588479076|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938762|NCT01418352|588479077|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
162938763|NCT00619619|588479078|FG000|Overall Study|Physician Decision|0|||
162938764|NCT00619619|588479079|FG001|Overall Study|Physician Decision|0|||
162938765|NCT00619619|588479080|FG002|Overall Study|Physician Decision|1|||
162938766|NCT00619619|588479081|FG003|Overall Study|Physician Decision|0|||
162938767|NCT00619619|588479082|FG004|Overall Study|Physician Decision|0|||
162938768|NCT00619619|588479083|FG005|Overall Study|Physician Decision|0|||
162938769|NCT00619619|588479084|FG006|Overall Study|Physician Decision|0|||
162938770|NCT00619619|588479085|FG007|Overall Study|Physician Decision|0|||
162938771|NCT00619619|588479078|FG000|Overall Study|Protocol Violation|0|||
162938772|NCT00619619|588479079|FG001|Overall Study|Protocol Violation|0|||
162938773|NCT00619619|588479080|FG002|Overall Study|Protocol Violation|0|||
162938774|NCT00619619|588479081|FG003|Overall Study|Protocol Violation|1|||
162938775|NCT00619619|588479082|FG004|Overall Study|Protocol Violation|0|||
162938776|NCT00619619|588479083|FG005|Overall Study|Protocol Violation|0|||
162938777|NCT00619619|588479084|FG006|Overall Study|Protocol Violation|1|||
162938778|NCT00619619|588479085|FG007|Overall Study|Protocol Violation|1|||
162938779|NCT00619619|588479078|FG000|Overall Study|Adverse Event|0|||
162938780|NCT00619619|588479079|FG001|Overall Study|Adverse Event|0|||
162938781|NCT00619619|588479080|FG002|Overall Study|Adverse Event|0|||
162938782|NCT00619619|588479081|FG003|Overall Study|Adverse Event|0|||
162938783|NCT00619619|588479082|FG004|Overall Study|Adverse Event|2|||
162938784|NCT00619619|588479083|FG005|Overall Study|Adverse Event|0|||
162938785|NCT00619619|588479084|FG006|Overall Study|Adverse Event|0|||
162938786|NCT00619619|588479085|FG007|Overall Study|Adverse Event|2|||
162938787|NCT01992107|588479088|FG000|Overall Study|Administrative reasons|2|||
162938788|NCT01992107|588479089|FG001|Overall Study|Administrative reasons|0|||
162938789|NCT01992107|588479090|FG002|Overall Study|Administrative reasons|0|||
162938790|NCT01992107|588479088|FG000|Overall Study|Adverse Event|0|||
162938791|NCT01992107|588479089|FG001|Overall Study|Adverse Event|1|||
162938792|NCT01992107|588479090|FG002|Overall Study|Adverse Event|0|||
162938793|NCT01992107|588479088|FG000|Overall Study|Lost to Follow-up|46|||
162938794|NCT01992107|588479089|FG001|Overall Study|Lost to Follow-up|22|||
162938795|NCT01992107|588479090|FG002|Overall Study|Lost to Follow-up|26|||
162938796|NCT01992107|588479088|FG000|Overall Study|noncompliance and were unavailable|7|||
162938797|NCT01992107|588479089|FG001|Overall Study|noncompliance and were unavailable|3|||
162938798|NCT01992107|588479090|FG002|Overall Study|noncompliance and were unavailable|2|||
162938799|NCT01992107|588479088|FG000|Overall Study|Withdrawal by Subject|13|||
162938800|NCT01992107|588479089|FG001|Overall Study|Withdrawal by Subject|7|||
162938801|NCT01992107|588479090|FG002|Overall Study|Withdrawal by Subject|8|||
162938802|NCT02022007|588479091|FG000|Overall Study|Withdrawal by Subject|1|||
162938803|NCT02022007|588479092|FG001|Overall Study|Withdrawal by Subject|1|||
162938804|NCT02022007|588479093|FG002|Overall Study|Withdrawal by Subject|1|||
162938805|NCT02022007|588479091|FG000|Overall Study|Noncompliant|0|||
162938806|NCT02022007|588479092|FG001|Overall Study|Noncompliant|0|||
162938807|NCT02022007|588479093|FG002|Overall Study|Noncompliant|1|||
162828472|NCT03462576|588084102|FG000|Overall Study|Device Malfunction|0|||
162828473|NCT03462576|588084103|FG001|Overall Study|Device Malfunction|0|||
162828474|NCT03462576|588084104|FG002|Overall Study|Device Malfunction|1|||
162828475|NCT00715026|588084105|FG000|Overall Study|Withdrawal by Subject|5|||
162828476|NCT00715026|588084105|FG000|Overall Study|Lost to Follow-up|3|||
162828477|NCT00715026|588084105|FG000|Overall Study|Protocol Violation|1|||
162828478|NCT00715026|588084105|FG000|Overall Study|Surgery done on non-study consented hip|1|||
162828479|NCT00750737|588084113|FG000|Overall Study|Withdrawal by Subject|3|||
162828480|NCT00750737|588084114|FG001|Overall Study|Withdrawal by Subject|3|||
162828481|NCT00865904|588084117|FG000|Overall Study|Randomized but not Treated|2|||
162828482|NCT00865904|588084118|FG001|Overall Study|Randomized but not Treated|0|||
162828483|NCT00865904|588084119|FG002|Overall Study|Randomized but not Treated|0|||
162828484|NCT00865904|588084120|FG003|Overall Study|Randomized but not Treated|1|||
162828485|NCT00865904|588084121|FG004|Overall Study|Randomized but not Treated|1|||
162828486|NCT01543828|588084122|FG000|Treatment 2|Lost to Follow-up|1|||
162828487|NCT01543828|588084123|FG001|Treatment 2|Lost to Follow-up|0|||
162828488|NCT00711425|588084126|FG000|Overall Study|Protocol Violation|1|||
162828489|NCT00711425|588084126|FG000|Overall Study|Death|2|||
162828490|NCT00711425|588084126|FG000|Overall Study|Lost to Follow-up|1|||
162828491|NCT00916149|588084127|FG000|Overall Study|Lost to Follow-up|3|||
162828492|NCT00916149|588084128|FG001|Overall Study|Lost to Follow-up|2|||
162828493|NCT00916149|588084129|FG002|Overall Study|Lost to Follow-up|0|||
162828494|NCT00916149|588084127|FG000|Overall Study|Unable to place scalp EEG leads|1|||
162828495|NCT00916149|588084128|FG001|Overall Study|Unable to place scalp EEG leads|0|||
162828496|NCT00916149|588084129|FG002|Overall Study|Unable to place scalp EEG leads|0|||
162828497|NCT00978029|588084130|FG000|Overall Study|Adverse Event|1|||
162828498|NCT00978029|588084131|FG001|Overall Study|Adverse Event|2|||
162828499|NCT00978029|588084132|FG002|Overall Study|Adverse Event|5|||
162828500|NCT00978029|588084130|FG000|Overall Study|Withdrawal by Subject|0|||
162828501|NCT00978029|588084131|FG001|Overall Study|Withdrawal by Subject|0|||
162828502|NCT00978029|588084132|FG002|Overall Study|Withdrawal by Subject|1|||
162828503|NCT00978029|588084130|FG000|Overall Study|Protocol Violation|0|||
162828504|NCT00978029|588084131|FG001|Overall Study|Protocol Violation|1|||
162828505|NCT00978029|588084132|FG002|Overall Study|Protocol Violation|0|||
162828506|NCT00545298|588084133|FG000|Overall Study|Issues with Standard of Care|2|||
162828507|NCT00545298|588084134|FG001|Overall Study|Issues with Standard of Care|0|||
162828508|NCT00545298|588084135|FG002|Overall Study|Issues with Standard of Care|1|||
162828509|NCT02090413|588084140|FG000|Overall Study|Adverse Event|11|||
162828510|NCT02090413|588084141|FG001|Overall Study|Adverse Event|15|||
162828511|NCT02090413|588084142|FG002|Overall Study|Adverse Event|20|||
162828512|NCT02090413|588084140|FG000|Overall Study|Flushing event|2|||
162828513|NCT02090413|588084141|FG001|Overall Study|Flushing event|0|||
162828514|NCT02090413|588084142|FG002|Overall Study|Flushing event|1|||
162828515|NCT02090413|588084140|FG000|Overall Study|Withdrawal by Subject|2|||
162828516|NCT02090413|588084141|FG001|Overall Study|Withdrawal by Subject|2|||
162828517|NCT02090413|588084142|FG002|Overall Study|Withdrawal by Subject|2|||
162828518|NCT02090413|588084140|FG000|Overall Study|Investigator Decision|1|||
162828519|NCT02090413|588084141|FG001|Overall Study|Investigator Decision|1|||
162828520|NCT02090413|588084142|FG002|Overall Study|Investigator Decision|0|||
162828521|NCT02090413|588084140|FG000|Overall Study|Other|2|||
162828522|NCT02090413|588084141|FG001|Overall Study|Other|1|||
162828523|NCT02090413|588084142|FG002|Overall Study|Other|0|||
162828524|NCT02090413|588084140|FG000|Overall Study|Lost to Follow-up|1|||
162828525|NCT02090413|588084141|FG001|Overall Study|Lost to Follow-up|1|||
162828526|NCT02090413|588084142|FG002|Overall Study|Lost to Follow-up|0|||
162828527|NCT05248295|588084143|FG000|Overall Study|found ineligible|4|||
162828528|NCT05248295|588084144|FG001|Overall Study|found ineligible|1|||
162828529|NCT05248295|588084143|FG000|Overall Study|Withdrawal by Subject|0|||
162828530|NCT05248295|588084144|FG001|Overall Study|Withdrawal by Subject|1|||
162828531|NCT05248295|588084143|FG000|Overall Study|Data loss: audio recording error|1|||
162828532|NCT05248295|588084144|FG001|Overall Study|Data loss: audio recording error|1|||
162828533|NCT04490018|588084145|FG000|Overall Study|Protocol Violation|0|||
162828534|NCT04490018|588084146|FG001|Overall Study|Protocol Violation|2|||
162828535|NCT04490018|588084147|FG002|Overall Study|Protocol Violation|1|||
162828536|NCT04490018|588084145|FG000|Overall Study|Lost to Follow-up|2|||
162828537|NCT04490018|588084146|FG001|Overall Study|Lost to Follow-up|2|||
162828538|NCT04490018|588084147|FG002|Overall Study|Lost to Follow-up|0|||
162828539|NCT04490018|588084145|FG000|Overall Study|Withdrawal by Subject|2|||
162938808|NCT01214603|588479094|FG000|Overall Study|Adverse Event|0|||
162938809|NCT01214603|588479095|FG001|Overall Study|Adverse Event|0|||
162938810|NCT01214603|588479096|FG002|Overall Study|Adverse Event|1|||
162938811|NCT01214603|588479094|FG000|Overall Study|Death|1|||
162938812|NCT01214603|588479095|FG001|Overall Study|Death|0|||
162938813|NCT01214603|588479096|FG002|Overall Study|Death|0|||
162938814|NCT01214603|588479094|FG000|Overall Study|Progressive Disease|4|||
162938815|NCT01214603|588479095|FG001|Overall Study|Progressive Disease|1|||
162938816|NCT01214603|588479096|FG002|Overall Study|Progressive Disease|3|||
162938817|NCT00542386|588479097|FG000|Overall Study|Adverse Event|1|||
162938818|NCT00542386|588479098|FG001|Overall Study|Adverse Event|7|||
162938819|NCT00542386|588479099|FG002|Overall Study|Adverse Event|7|||
162938820|NCT00542386|588479100|FG003|Overall Study|Adverse Event|8|||
162938821|NCT00542386|588479101|FG004|Overall Study|Adverse Event|13|||
162938822|NCT00542386|588479102|FG005|Overall Study|Adverse Event|4|||
162938823|NCT00542386|588479097|FG000|Overall Study|Death|0|||
162938824|NCT00542386|588479098|FG001|Overall Study|Death|0|||
162938825|NCT00542386|588479099|FG002|Overall Study|Death|1|||
162938826|NCT00542386|588479100|FG003|Overall Study|Death|2|||
162938827|NCT00542386|588479101|FG004|Overall Study|Death|1|||
162938828|NCT00542386|588479102|FG005|Overall Study|Death|2|||
162938829|NCT00542386|588479097|FG000|Overall Study|Lack of Efficacy|32|||
162938830|NCT00542386|588479098|FG001|Overall Study|Lack of Efficacy|12|||
162938831|NCT00542386|588479099|FG002|Overall Study|Lack of Efficacy|10|||
162938832|NCT00542386|588479100|FG003|Overall Study|Lack of Efficacy|13|||
162938833|NCT00542386|588479101|FG004|Overall Study|Lack of Efficacy|7|||
162938834|NCT00542386|588479102|FG005|Overall Study|Lack of Efficacy|31|||
162938835|NCT00542386|588479097|FG000|Overall Study|Physician Decision|1|||
162938836|NCT00542386|588479098|FG001|Overall Study|Physician Decision|0|||
162938837|NCT00542386|588479099|FG002|Overall Study|Physician Decision|0|||
162938838|NCT00542386|588479100|FG003|Overall Study|Physician Decision|1|||
162938839|NCT00542386|588479101|FG004|Overall Study|Physician Decision|0|||
162938840|NCT00542386|588479102|FG005|Overall Study|Physician Decision|0|||
162938841|NCT00542386|588479097|FG000|Overall Study|Protocol Violation|0|||
162938842|NCT00542386|588479098|FG001|Overall Study|Protocol Violation|0|||
162938843|NCT00542386|588479099|FG002|Overall Study|Protocol Violation|1|||
162938844|NCT00542386|588479100|FG003|Overall Study|Protocol Violation|0|||
162938845|NCT00542386|588479101|FG004|Overall Study|Protocol Violation|0|||
162938846|NCT00542386|588479102|FG005|Overall Study|Protocol Violation|4|||
162938847|NCT00542386|588479097|FG000|Overall Study|Withdrawal by Subject|5|||
162938848|NCT00542386|588479098|FG001|Overall Study|Withdrawal by Subject|8|||
162938849|NCT00542386|588479099|FG002|Overall Study|Withdrawal by Subject|10|||
162938850|NCT00542386|588479100|FG003|Overall Study|Withdrawal by Subject|11|||
162938851|NCT00542386|588479101|FG004|Overall Study|Withdrawal by Subject|15|||
162938852|NCT00542386|588479102|FG005|Overall Study|Withdrawal by Subject|7|||
162938853|NCT00542386|588479097|FG000|Overall Study|Other Reasons|4|||
162938854|NCT00542386|588479098|FG001|Overall Study|Other Reasons|1|||
162938855|NCT00542386|588479099|FG002|Overall Study|Other Reasons|4|||
162938856|NCT00542386|588479100|FG003|Overall Study|Other Reasons|3|||
162938857|NCT00542386|588479101|FG004|Overall Study|Other Reasons|4|||
162938858|NCT00542386|588479102|FG005|Overall Study|Other Reasons|2|||
162938859|NCT01507896|588479103|FG000|Overall Study|Withdrawal by Subject|1|||
162938860|NCT01507896|588479103|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
162938861|NCT00446654|588479111|FG000|Overall Study|Withdrawal by Subject|1|||
162938862|NCT00446654|588479112|FG001|Overall Study|Withdrawal by Subject|0|||
162938863|NCT00446654|588479111|FG000|Overall Study|Adverse Event|1|||
162938864|NCT00446654|588479112|FG001|Overall Study|Adverse Event|0|||
162938865|NCT01875445|588479113|FG000|Overall Study|Lost to Follow-up|5|||
162938866|NCT01875445|588479114|FG001|Overall Study|Lost to Follow-up|0|||
162938867|NCT01875445|588479113|FG000|Overall Study|Withdrawal by Subject|2|||
162938868|NCT01875445|588479114|FG001|Overall Study|Withdrawal by Subject|0|||
162938869|NCT04029090|588479115|FG000|Overall Study|Protocol Violation|1|||
162938870|NCT04029090|588479116|FG001|Overall Study|Protocol Violation|0|||
162938871|NCT04029090|588479117|FG002|Overall Study|Protocol Violation|0|||
162938872|NCT04029090|588479115|FG000|Overall Study|Withdrawal by Subject|0|||
162938873|NCT04029090|588479116|FG001|Overall Study|Withdrawal by Subject|1|||
162938874|NCT04029090|588479117|FG002|Overall Study|Withdrawal by Subject|0|||
162938875|NCT00506441|588479118|FG000|Period 1; Open-label Period|Adverse Event|21|||
162938876|NCT00506441|588479119|FG001|Period 1; Open-label Period|Adverse Event|0|||
162938877|NCT00506441|588479118|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
162938878|NCT00506441|588479119|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
162938879|NCT00506441|588479118|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
162938880|NCT00506441|588479119|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
162828540|NCT04490018|588084146|FG001|Overall Study|Withdrawal by Subject|1|||
162828541|NCT04490018|588084147|FG002|Overall Study|Withdrawal by Subject|0|||
162828542|NCT04490018|588084145|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162828543|NCT04490018|588084146|FG001|Overall Study|Withdrawal by parent/guardian|3|||
162828544|NCT04490018|588084147|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162828545|NCT02321930|588084148|FG000|Overall Study|Lost to Follow-up|1|||
162828546|NCT01293968|588084149|FG000|Overall Study|non-cooperation|3|||
162828547|NCT01293968|588084150|FG001|Overall Study|non-cooperation|3|||
162828548|NCT01484977|588084151|FG000|Overall Study|Adverse Event|8|||
162828549|NCT01484977|588084151|FG000|Overall Study|Lack of Efficacy|4|||
162828550|NCT01484977|588084151|FG000|Overall Study|Protocol Violation|6|||
162828551|NCT01484977|588084151|FG000|Overall Study|Lost to Follow-up|1|||
162828552|NCT01484977|588084151|FG000|Overall Study|Withdrawal by Subject|4|||
162828553|NCT01484977|588084151|FG000|Overall Study|Subject Protocol Non-compliant|1|||
162828554|NCT01484977|588084151|FG000|Overall Study|Moving Overseas|1|||
162828555|NCT01484977|588084151|FG000|Overall Study|Low White Blood Cell Count|1|||
162828556|NCT01484977|588084151|FG000|Overall Study|Lack of Compliance|1|||
162828557|NCT01133379|588084152|FG000|Overall Study|Withdrawal by Subject|0|||
162828558|NCT01133379|588084153|FG001|Overall Study|Withdrawal by Subject|1|||
162828559|NCT01133379|588084154|FG002|Overall Study|Withdrawal by Subject|1|||
162828560|NCT01133379|588084152|FG000|Overall Study|Lost to Follow-up|1|||
162828561|NCT01133379|588084153|FG001|Overall Study|Lost to Follow-up|1|||
162828562|NCT01133379|588084154|FG002|Overall Study|Lost to Follow-up|1|||
162828563|NCT01129921|588084157|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
162828564|NCT01129921|588084158|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
162828565|NCT01129921|588084157|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
162828566|NCT01129921|588084158|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
162938881|NCT00506441|588479118|FG000|Period 1; Open-label Period|Physician Decision|5|||
162938882|NCT00506441|588479119|FG001|Period 1; Open-label Period|Physician Decision|0|||
162938883|NCT00506441|588479118|FG000|Period 1; Open-label Period|Protocol Violation|9|||
162938884|NCT00506441|588479119|FG001|Period 1; Open-label Period|Protocol Violation|0|||
162938885|NCT00506441|588479118|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
162938886|NCT00506441|588479119|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
162938887|NCT00506441|588479118|FG000|Period 1; Open-label Period|Other Reasons|13|||
162938888|NCT00506441|588479119|FG001|Period 1; Open-label Period|Other Reasons|0|||
162938889|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Adverse Event|0|||
162938890|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Adverse Event|1|||
162938891|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
162938892|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
162938893|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Physician Decision|1|||
162938894|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Physician Decision|1|||
162938895|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
162938896|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
162938897|NCT00506441|588479118|FG000|Period 2; Double-blind Period|Other Reason|1|||
162938898|NCT00506441|588479119|FG001|Period 2; Double-blind Period|Other Reason|1|||
162938899|NCT00501046|588479120|FG000|Overall Study|Adverse Event|21|||
162938900|NCT00501046|588479121|FG001|Overall Study|Adverse Event|25|||
162938901|NCT00501046|588479120|FG000|Overall Study|Death|23|||
162938902|NCT00501046|588479121|FG001|Overall Study|Death|30|||
162938903|NCT00501046|588479120|FG000|Overall Study|Lost to Follow-up|14|||
162938904|NCT00501046|588479121|FG001|Overall Study|Lost to Follow-up|13|||
162938905|NCT00501046|588479120|FG000|Overall Study|Physician Decision|7|||
162938906|NCT00501046|588479121|FG001|Overall Study|Physician Decision|2|||
162938907|NCT00501046|588479120|FG000|Overall Study|Pregnancy|0|||
162938908|NCT00501046|588479121|FG001|Overall Study|Pregnancy|3|||
162938909|NCT00501046|588479120|FG000|Overall Study|Protocol Violation|2|||
162938910|NCT00501046|588479121|FG001|Overall Study|Protocol Violation|1|||
162938911|NCT00501046|588479120|FG000|Overall Study|Withdrawal by Subject|84|||
162938912|NCT00501046|588479121|FG001|Overall Study|Withdrawal by Subject|83|||
162938913|NCT00501046|588479120|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
162938914|NCT00501046|588479121|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
162938915|NCT05056727|588479122|FG000|Initiation Phase|Lost to Follow-up|1|||
162938916|NCT05056727|588479123|FG001|Initiation Phase|Lost to Follow-up|0|||
162938917|NCT05056727|588479124|FG002|Initiation Phase|Lost to Follow-up|0|||
162828567|NCT01129921|588084157|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
162828568|NCT01129921|588084158|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
162828569|NCT01129921|588084157|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
162828570|NCT01129921|588084158|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
162828571|NCT00121108|588084161|FG000|Overall Study|Lost to Follow-up|10|||
162828572|NCT00121108|588084162|FG001|Overall Study|Lost to Follow-up|22|||
162828573|NCT00121108|588084161|FG000|Overall Study|Withdrawal by Subject|106|||
162828574|NCT00121108|588084162|FG001|Overall Study|Withdrawal by Subject|195|||
162828575|NCT00121108|588084161|FG000|Overall Study|Death|5|||
162828576|NCT00121108|588084162|FG001|Overall Study|Death|8|||
162828577|NCT03996876|588084163|FG000|Overall Study|Incomplete Data|2|||
162828578|NCT03996876|588084164|FG001|Overall Study|Incomplete Data|4|||
162828579|NCT01380379|588084167|FG000|Overall Study|Pregnancy|1|||
162828580|NCT00597753|588084170|FG000|Overall Study|Adverse Event|6|||
162828581|NCT00597753|588084171|FG001|Overall Study|Adverse Event|2|||
162938918|NCT05056727|588479125|FG003|Initiation Phase|Lost to Follow-up|0|||
162938919|NCT05056727|588479122|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
162938920|NCT05056727|588479123|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
162938921|NCT05056727|588479124|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
162938922|NCT05056727|588479125|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
162938923|NCT05056727|588479122|FG000|Initiation Phase|Withdrawal by Subject|9|||
162938924|NCT05056727|588479123|FG001|Initiation Phase|Withdrawal by Subject|0|||
162938925|NCT05056727|588479124|FG002|Initiation Phase|Withdrawal by Subject|0|||
162938926|NCT05056727|588479125|FG003|Initiation Phase|Withdrawal by Subject|0|||
162938927|NCT05056727|588479122|FG000|Initiation Phase|Physician Decision|4|||
162828582|NCT00597753|588084170|FG000|Overall Study|Death|55|||
162828583|NCT00597753|588084171|FG001|Overall Study|Death|29|||
162828584|NCT00597753|588084170|FG000|Overall Study|Lack of Efficacy|2|||
162828585|NCT00597753|588084171|FG001|Overall Study|Lack of Efficacy|0|||
162828586|NCT00597753|588084170|FG000|Overall Study|Lost to Follow-up|10|||
162828587|NCT00597753|588084171|FG001|Overall Study|Lost to Follow-up|3|||
162828588|NCT00597753|588084170|FG000|Overall Study|Physician Decision|5|||
162828589|NCT00597753|588084171|FG001|Overall Study|Physician Decision|1|||
162828590|NCT00597753|588084170|FG000|Overall Study|Pregnancy|1|||
162938928|NCT05056727|588479123|FG001|Initiation Phase|Physician Decision|0|||
162938929|NCT05056727|588479124|FG002|Initiation Phase|Physician Decision|0|||
162938930|NCT05056727|588479125|FG003|Initiation Phase|Physician Decision|0|||
162938931|NCT05056727|588479122|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938932|NCT05056727|588479123|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
162938933|NCT05056727|588479124|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938934|NCT05056727|588479125|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
162938935|NCT05056727|588479122|FG000|Run-in Phase|Death|0|||
162938936|NCT05056727|588479123|FG001|Run-in Phase|Death|3|||
162938937|NCT05056727|588479124|FG002|Run-in Phase|Death|0|||
162938938|NCT05056727|588479125|FG003|Run-in Phase|Death|0|||
162938939|NCT05056727|588479122|FG000|Run-in Phase|Withdrawal by Subject|0|||
162938940|NCT05056727|588479123|FG001|Run-in Phase|Withdrawal by Subject|25|||
162938941|NCT05056727|588479124|FG002|Run-in Phase|Withdrawal by Subject|0|||
162938942|NCT05056727|588479125|FG003|Run-in Phase|Withdrawal by Subject|0|||
162938943|NCT05056727|588479122|FG000|Run-in Phase|Physician Decision|0|||
162938944|NCT05056727|588479123|FG001|Run-in Phase|Physician Decision|20|||
162938945|NCT05056727|588479124|FG002|Run-in Phase|Physician Decision|0|||
162938946|NCT05056727|588479125|FG003|Run-in Phase|Physician Decision|0|||
162938947|NCT05056727|588479122|FG000|Run-in Phase|Lost to Follow-up|0|||
162938948|NCT05056727|588479123|FG001|Run-in Phase|Lost to Follow-up|1|||
162938949|NCT05056727|588479124|FG002|Run-in Phase|Lost to Follow-up|0|||
162938950|NCT05056727|588479125|FG003|Run-in Phase|Lost to Follow-up|0|||
162938951|NCT05056727|588479122|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
162938952|NCT05056727|588479123|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
162938953|NCT05056727|588479124|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
162938954|NCT05056727|588479125|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
162938955|NCT05056727|588479122|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162938956|NCT05056727|588479123|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162938957|NCT05056727|588479124|FG002|Maintenance Phase|Withdrawal by Subject|19|||
162938958|NCT05056727|588479125|FG003|Maintenance Phase|Withdrawal by Subject|21|||
162938959|NCT05056727|588479122|FG000|Maintenance Phase|Physician Decision|0|||
162938960|NCT05056727|588479123|FG001|Maintenance Phase|Physician Decision|0|||
162938961|NCT05056727|588479124|FG002|Maintenance Phase|Physician Decision|4|||
162938962|NCT05056727|588479125|FG003|Maintenance Phase|Physician Decision|16|||
162938963|NCT05056727|588479122|FG000|Maintenance Phase|Lost to Follow-up|0|||
162938964|NCT05056727|588479123|FG001|Maintenance Phase|Lost to Follow-up|0|||
162938965|NCT05056727|588479124|FG002|Maintenance Phase|Lost to Follow-up|2|||
162938966|NCT05056727|588479125|FG003|Maintenance Phase|Lost to Follow-up|2|||
162938967|NCT05056727|588479122|FG000|Maintenance Phase|Death|0|||
162938968|NCT05056727|588479123|FG001|Maintenance Phase|Death|0|||
162938969|NCT05056727|588479124|FG002|Maintenance Phase|Death|4|||
162938970|NCT05056727|588479125|FG003|Maintenance Phase|Death|2|||
162938971|NCT02622113|588479126|FG000|Overall Study|Adverse Event|4|||
162938972|NCT02622113|588479127|FG001|Overall Study|Adverse Event|4|||
162938973|NCT02622113|588479126|FG000|Overall Study|Physician Decision|0|||
162938974|NCT02622113|588479127|FG001|Overall Study|Physician Decision|1|||
162938975|NCT02622113|588479126|FG000|Overall Study|Withdrawal by Subject|0|||
162938976|NCT02622113|588479127|FG001|Overall Study|Withdrawal by Subject|2|||
162938977|NCT02622113|588479126|FG000|Overall Study|Stopping Criteria|1|||
162938978|NCT02622113|588479127|FG001|Overall Study|Stopping Criteria|3|||
162938979|NCT03289208|588479129|FG000|Overall Study|Adverse Event|1|||
162938980|NCT03289208|588479130|FG001|Overall Study|Adverse Event|0|||
162828591|NCT00597753|588084171|FG001|Overall Study|Pregnancy|0|||
162828592|NCT00597753|588084170|FG000|Overall Study|Withdrawal by Subject|35|||
162828593|NCT00597753|588084171|FG001|Overall Study|Withdrawal by Subject|12|||
162938981|NCT03289208|588479131|FG002|Overall Study|Adverse Event|0|||
162938982|NCT01840605|588479133|FG000|Overall Study|Adverse Event|0|||
162938983|NCT01840605|588479134|FG001|Overall Study|Adverse Event|1|||
162938984|NCT01840605|588479133|FG000|Overall Study|Physician Decision|2|||
162828594|NCT00597753|588084170|FG000|Overall Study|Discontinued Dialysis|0|||
162828595|NCT00597753|588084171|FG001|Overall Study|Discontinued Dialysis|1|||
162828596|NCT00597753|588084170|FG000|Overall Study|Never dosed|2|||
162828597|NCT00597753|588084171|FG001|Overall Study|Never dosed|0|||
162828598|NCT00597753|588084170|FG000|Overall Study|Noncompliance|2|||
162828599|NCT00597753|588084171|FG001|Overall Study|Noncompliance|1|||
162828600|NCT00597753|588084170|FG000|Overall Study|Relocation|17|||
162828601|NCT00597753|588084171|FG001|Overall Study|Relocation|6|||
162828602|NCT00597753|588084170|FG000|Overall Study|Renal transplant|10|||
162828603|NCT00597753|588084171|FG001|Overall Study|Renal transplant|3|||
162828604|NCT00597753|588084170|FG000|Overall Study|Site closed by sponsor|19|||
162828605|NCT00597753|588084171|FG001|Overall Study|Site closed by sponsor|7|||
162828606|NCT00597753|588084170|FG000|Overall Study|Site elected to close|2|||
162828607|NCT00597753|588084171|FG001|Overall Study|Site elected to close|4|||
162828608|NCT01652885|588085761|FG000|Overall Study|Adverse Event|1|||
162828609|NCT03723707|588085762|FG000|Overall Study|Death|32|||
162828610|NCT03723707|588085763|FG001|Overall Study|Death|32|||
162828611|NCT03723707|588085762|FG000|Overall Study|Admitted to long term care|12|||
162828612|NCT03723707|588085763|FG001|Overall Study|Admitted to long term care|12|||
162828613|NCT03723707|588085762|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
162828614|NCT03723707|588085763|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
162938985|NCT01840605|588479134|FG001|Overall Study|Physician Decision|1|||
162938986|NCT05308472|588479135|FG000|Overall Study|Adverse Event|0|||
162938987|NCT05308472|588479136|FG001|Overall Study|Adverse Event|0|||
162938988|NCT05308472|588479137|FG002|Overall Study|Adverse Event|3|||
162938989|NCT03469271|588479138|FG000|Overall Study|Withdrawal by Subject|2|||
162938990|NCT03469271|588479139|FG001|Overall Study|Withdrawal by Subject|0|||
162938991|NCT03469271|588479140|FG002|Overall Study|Withdrawal by Subject|0|||
162938992|NCT03469271|588479141|FG003|Overall Study|Withdrawal by Subject|1|||
162938993|NCT00895583|588479143|FG000|Overall Study|Adverse Event|28|||
162938994|NCT00895583|588479144|FG001|Overall Study|Adverse Event|4|||
162938995|NCT00895583|588479143|FG000|Overall Study|Death|2|||
162938996|NCT00895583|588479144|FG001|Overall Study|Death|1|||
162938997|NCT00895583|588479143|FG000|Overall Study|Physician Decision|3|||
162938998|NCT00895583|588479144|FG001|Overall Study|Physician Decision|1|||
162938999|NCT00895583|588479143|FG000|Overall Study|Lost to Follow-up|1|||
162939000|NCT00895583|588479144|FG001|Overall Study|Lost to Follow-up|3|||
162939001|NCT00895583|588479143|FG000|Overall Study|Protocol Violation|1|||
162939002|NCT00895583|588479144|FG001|Overall Study|Protocol Violation|0|||
162939003|NCT00895583|588479143|FG000|Overall Study|Withdrawal by Subject|4|||
162939004|NCT00895583|588479144|FG001|Overall Study|Withdrawal by Subject|2|||
162939005|NCT00895583|588479143|FG000|Overall Study|Lack of Efficacy|5|||
162939006|NCT00895583|588479144|FG001|Overall Study|Lack of Efficacy|0|||
162939007|NCT00895583|588479143|FG000|Overall Study|Other|0|||
162939008|NCT00895583|588479144|FG001|Overall Study|Other|1|||
162939009|NCT04535583|588479147|FG000|Overall Study|Lost to Follow-up|1|||
162939010|NCT04535583|588479147|FG000|Overall Study|Physician Decision|1|||
162939011|NCT04535583|588479147|FG000|Overall Study|Withdrawal by Subject|1|||
162939012|NCT01078090|588479148|FG000|Overall Study|Lost to Follow-up|2363|||
162939013|NCT01078090|588479148|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
162939014|NCT01078090|588479148|FG000|Overall Study|Lack of Efficacy|1193|||
162939015|NCT01078090|588479148|FG000|Overall Study|ADR and lack of efficacy|61|||
162939016|NCT01078090|588479148|FG000|Overall Study|Other|523|||
162939017|NCT01748890|588479150|FG000|Overall Study|Insufficient recruitment for analysis|4|||
162939018|NCT03035227|588479151|FG000|Overall Study|study stopped due to PI leaving institut|1|||
162939019|NCT03035227|588479152|FG001|Overall Study|study stopped due to PI leaving institut|1|||
162939020|NCT02100956|588479153|FG000|At Least One Week Between Injections|Adverse Event|0|||
162939021|NCT02100956|588479154|FG001|At Least One Week Between Injections|Adverse Event|1|||
162939022|NCT03529955|588479155|FG000|Overall Study|Adverse Event|1|||
162939023|NCT03529955|588479155|FG000|Overall Study|Lack of Efficacy|1|||
162939024|NCT03016078|588479162|FG000|Overall Study|Protocol Violation|1|||
162939025|NCT03016078|588479162|FG000|Overall Study|Protocol Violation|1|||
162939026|NCT04526899|588479163|FG000|Overall Study|Withdrawal by Subject|3|||
162939027|NCT04526899|588479164|FG001|Overall Study|Withdrawal by Subject|2|||
162939028|NCT04526899|588479165|FG002|Overall Study|Withdrawal by Subject|2|||
162939029|NCT04526899|588479163|FG000|Overall Study|Lost to Follow-up|3|||
162939030|NCT04526899|588479164|FG001|Overall Study|Lost to Follow-up|3|||
162939031|NCT04526899|588479165|FG002|Overall Study|Lost to Follow-up|1|||
162939032|NCT04526899|588479163|FG000|Overall Study|Investigator's decision|1|||
162939033|NCT04526899|588479164|FG001|Overall Study|Investigator's decision|0|||
162939034|NCT04526899|588479165|FG002|Overall Study|Investigator's decision|0|||
162939035|NCT04526899|588479163|FG000|Overall Study|Death|33|||
162939036|NCT04526899|588479164|FG001|Overall Study|Death|17|||
162939037|NCT04526899|588479165|FG002|Overall Study|Death|13|||
162939038|NCT04526899|588479163|FG000|Overall Study|Other|1|||
162939039|NCT04526899|588479164|FG001|Overall Study|Other|0|||
162939040|NCT04526899|588479165|FG002|Overall Study|Other|0|||
162939041|NCT04526899|588479163|FG000|Overall Study|On-Treatment|19|||
162939042|NCT04526899|588479164|FG001|Overall Study|On-Treatment|10|||
162939043|NCT04526899|588479165|FG002|Overall Study|On-Treatment|12|||
162939044|NCT04526899|588479163|FG000|Overall Study|Survival Follow-up|34|||
162939045|NCT04526899|588479164|FG001|Overall Study|Survival Follow-up|14|||
162939046|NCT04526899|588479165|FG002|Overall Study|Survival Follow-up|16|||
162939047|NCT01259869|588480276|FG000|Overall Study|Duplicated registration|1|||
162939048|NCT00220701|588480278|FG000|Overall Study|Lost to Follow-up|5|||
162939049|NCT00220701|588480279|FG001|Overall Study|Lost to Follow-up|4|||
162939050|NCT05245617|588480280|FG000|Overall Study|Withdrawal by Subject|1|||
162939051|NCT01612000|588480284|FG000|Overall Study|Lost to Follow-up|6|||
162939052|NCT01612000|588480285|FG001|Overall Study|Lost to Follow-up|4|||
162939053|NCT01612000|588480286|FG002|Overall Study|Lost to Follow-up|4|||
162939054|NCT01612000|588480287|FG003|Overall Study|Lost to Follow-up|8|||
162698668|NCT00337662|587605553|FG000|Study Period II|Parent/Caregiver Decision|0|||
162939055|NCT01612000|588480284|FG000|Overall Study|Physician Decision|0|||
162939056|NCT01612000|588480285|FG001|Overall Study|Physician Decision|0|||
162939057|NCT01612000|588480286|FG002|Overall Study|Physician Decision|1|||
162939058|NCT01612000|588480287|FG003|Overall Study|Physician Decision|0|||
162828615|NCT03723707|588085762|FG000|Overall Study|Lost to Follow-up|40|||
162828616|NCT03723707|588085763|FG001|Overall Study|Lost to Follow-up|22|||
162828617|NCT03723707|588085762|FG000|Overall Study|Discontinued after study closure|24|||
162828618|NCT03723707|588085763|FG001|Overall Study|Discontinued after study closure|12|||
162828619|NCT00075023|588085764|FG000|Pilot Study|Physician Decision|1|||
162828620|NCT00075023|588085765|FG001|Pilot Study|Physician Decision|2|||
162828621|NCT00075023|588085764|FG000|Pilot Study|Withdrawal by Subject|1|||
162828622|NCT00075023|588085765|FG001|Pilot Study|Withdrawal by Subject|0|||
162828623|NCT04342871|588085766|FG000|Overall Study|Death|4|||
162828624|NCT04342871|588085766|FG000|Overall Study|Clinical deterioration/illness progression|2|||
162828625|NCT04342871|588085766|FG000|Overall Study|Did not complete baseline assessments|5|||
162828626|NCT04342871|588085766|FG000|Overall Study|Lost to Follow-up|13|||
162828627|NCT01429584|588085771|FG000|Overall Study|Withdrawal by Subject|1|||
162828628|NCT01429584|588085772|FG001|Overall Study|Withdrawal by Subject|0|||
162828629|NCT01429584|588085771|FG000|Overall Study|Protocol Violation|0|||
162828630|NCT01429584|588085772|FG001|Overall Study|Protocol Violation|1|||
162828631|NCT00750698|588085773|FG000|Overall Study|Withdrawal by Subject|1|||
162828632|NCT00750698|588085774|FG001|Overall Study|Withdrawal by Subject|0|||
162828633|NCT00750698|588085773|FG000|Overall Study|Progressive disease|5|||
162828634|NCT00750698|588085774|FG001|Overall Study|Progressive disease|2|||
162828635|NCT01417195|588085775|FG000|Overall Study|Stimulation failure|1|||
162828636|NCT01417195|588085776|FG001|Overall Study|Stimulation failure|0|||
162828637|NCT01417195|588085775|FG000|Overall Study|No embryos for transfer|0|||
162828638|NCT01417195|588085776|FG001|Overall Study|No embryos for transfer|1|||
162828639|NCT01417195|588085775|FG000|Overall Study|No transfer due to risk of OHSS|1|||
162828640|NCT01417195|588085776|FG001|Overall Study|No transfer due to risk of OHSS|0|||
162828641|NCT01417195|588085775|FG000|Overall Study|No transfer due to elevated progesterone|1|||
162828642|NCT01417195|588085776|FG001|Overall Study|No transfer due to elevated progesterone|0|||
162828643|NCT04766021|588085777|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
162828644|NCT04766021|588085777|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
162828645|NCT02257372|588085780|FG000|Overall Study|Adverse Event|3|||
162828646|NCT02257372|588085781|FG001|Overall Study|Adverse Event|7|||
162828647|NCT02257372|588085780|FG000|Overall Study|Lack of Efficacy|2|||
162828648|NCT02257372|588085781|FG001|Overall Study|Lack of Efficacy|1|||
162828649|NCT02257372|588085780|FG000|Overall Study|Protocol Violation|1|||
162828650|NCT02257372|588085781|FG001|Overall Study|Protocol Violation|1|||
162828651|NCT02257372|588085780|FG000|Overall Study|Lost to Follow-up|0|||
162828652|NCT02257372|588085781|FG001|Overall Study|Lost to Follow-up|1|||
162828653|NCT02257372|588085780|FG000|Overall Study|Withdrew consent|1|||
162828654|NCT02257372|588085781|FG001|Overall Study|Withdrew consent|0|||
162828655|NCT02634151|588085782|FG000|Overall Study|Withdrawal by Subject|1|||
162828656|NCT02634151|588085783|FG001|Overall Study|Withdrawal by Subject|0|||
162828657|NCT02634151|588085782|FG000|Overall Study|Non-Compliance|0|||
162828658|NCT02634151|588085783|FG001|Overall Study|Non-Compliance|1|||
162828659|NCT02634151|588085782|FG000|Overall Study|Other|0|||
162828660|NCT02634151|588085783|FG001|Overall Study|Other|1|||
162828661|NCT03709654|588085785|FG000|Overall Study|Lost to Follow-up|1|||
162828662|NCT03709654|588085786|FG001|Overall Study|Lost to Follow-up|1|||
162828663|NCT03709654|588085785|FG000|Overall Study|Withdrawal by Subject|1|||
162828664|NCT03709654|588085786|FG001|Overall Study|Withdrawal by Subject|1|||
162828665|NCT03709654|588085785|FG000|Overall Study|Adverse Event|1|||
162828666|NCT03709654|588085786|FG001|Overall Study|Adverse Event|0|||
162828667|NCT01040351|588085787|FG000|Overall Study|poor ovarian response|1|||
162828668|NCT01040351|588085788|FG001|Overall Study|poor ovarian response|2|||
162828669|NCT00530894|588085790|FG000|Overall Study|Death|84|||
162828670|NCT00530894|588085791|FG001|Overall Study|Death|89|||
162828671|NCT00530894|588085792|FG002|Overall Study|Death|55|||
162828672|NCT00530894|588085793|FG003|Overall Study|Death|89|||
162828673|NCT00530894|588085790|FG000|Overall Study|Lost to Follow-up|1|||
162828674|NCT00530894|588085791|FG001|Overall Study|Lost to Follow-up|3|||
162828675|NCT00530894|588085792|FG002|Overall Study|Lost to Follow-up|0|||
162828676|NCT00530894|588085793|FG003|Overall Study|Lost to Follow-up|0|||
162828677|NCT00530894|588085790|FG000|Overall Study|Withdrawal by Subject|1|||
162828678|NCT00530894|588085791|FG001|Overall Study|Withdrawal by Subject|23|||
162828679|NCT00530894|588085792|FG002|Overall Study|Withdrawal by Subject|0|||
162828680|NCT00530894|588085793|FG003|Overall Study|Withdrawal by Subject|5|||
162828681|NCT00530894|588085790|FG000|Overall Study|Alive and censored prior to 1 year|2|||
162828682|NCT00530894|588085791|FG001|Overall Study|Alive and censored prior to 1 year|0|||
162828683|NCT00530894|588085792|FG002|Overall Study|Alive and censored prior to 1 year|0|||
162828684|NCT00530894|588085793|FG003|Overall Study|Alive and censored prior to 1 year|0|||
162828685|NCT02256540|588085794|FG000|Overall Study|Withdrawal by Subject|0|||
162828686|NCT02256540|588085795|FG001|Overall Study|Withdrawal by Subject|1|||
162828687|NCT02256540|588085796|FG002|Overall Study|Withdrawal by Subject|1|||
162828688|NCT02256540|588085794|FG000|Overall Study|Back pain preventing exercise|0|||
162828689|NCT02256540|588085795|FG001|Overall Study|Back pain preventing exercise|0|||
162828690|NCT02256540|588085796|FG002|Overall Study|Back pain preventing exercise|1|||
162828691|NCT01230242|588085797|FG000|Overall Study|Physician Decision|2|||
162828692|NCT01230242|588085797|FG000|Overall Study|Withdrawal by Subject|1|||
162828693|NCT02576444|588085798|FG000|Overall Study|Death|1|||
162828694|NCT02576444|588085799|FG001|Overall Study|Death|1|||
162828695|NCT02576444|588085800|FG002|Overall Study|Death|0|||
162828696|NCT02576444|588085801|FG003|Overall Study|Death|0|||
162828697|NCT02576444|588085798|FG000|Overall Study|Withdrawal by Subject|0|||
162828698|NCT02576444|588085799|FG001|Overall Study|Withdrawal by Subject|0|||
162828699|NCT02576444|588085800|FG002|Overall Study|Withdrawal by Subject|2|||
162828700|NCT02576444|588085801|FG003|Overall Study|Withdrawal by Subject|0|||
162828701|NCT02576444|588085798|FG000|Overall Study|Adverse Event|0|||
162828702|NCT02576444|588085799|FG001|Overall Study|Adverse Event|0|||
162828703|NCT02576444|588085800|FG002|Overall Study|Adverse Event|1|||
162828704|NCT02576444|588085801|FG003|Overall Study|Adverse Event|0|||
162828705|NCT02576444|588085798|FG000|Overall Study|Physician Decision|0|||
162828706|NCT02576444|588085799|FG001|Overall Study|Physician Decision|0|||
162828707|NCT02576444|588085800|FG002|Overall Study|Physician Decision|1|||
162828708|NCT02576444|588085801|FG003|Overall Study|Physician Decision|0|||
162828709|NCT02700412|588085809|FG000|Overall Study|Adverse Event|6|||
162828710|NCT02700412|588085809|FG000|Overall Study|Death|1|||
162828711|NCT02700412|588085809|FG000|Overall Study|Lack of Efficacy|19|||
162828712|NCT02700412|588085809|FG000|Overall Study|Protocol Violation|5|||
162828713|NCT02700412|588085809|FG000|Overall Study|Withdrawal by Subject|2|||
162828714|NCT00928889|588085810|FG000|Overall Study|Lost to Follow-up|3|||
162828715|NCT00928889|588085811|FG001|Overall Study|Lost to Follow-up|1|||
162828716|NCT00928889|588085810|FG000|Overall Study|Protocol Violation|0|||
162828717|NCT00928889|588085811|FG001|Overall Study|Protocol Violation|1|||
162828718|NCT00928889|588085810|FG000|Overall Study|Adverse Event|1|||
162828719|NCT00928889|588085811|FG001|Overall Study|Adverse Event|0|||
162828720|NCT00928889|588085810|FG000|Overall Study|Other|1|||
162828721|NCT00928889|588085811|FG001|Overall Study|Other|0|||
162828722|NCT04416555|588085813|FG000|Overall Study|Withdrawal by Subject|0|||
162828723|NCT04416555|588085814|FG001|Overall Study|Withdrawal by Subject|3|||
162828724|NCT00530270|588085817|FG000|Overall Study|Protocol Violation|1|||
162828725|NCT00530270|588085818|FG001|Overall Study|Protocol Violation|0|||
162828726|NCT01197521|588085825|FG000|Overall Study|Not reported|24|||
162828727|NCT01197521|588085826|FG001|Overall Study|Not reported|25|||
162828728|NCT01197521|588085827|FG002|Overall Study|Not reported|21|||
162828729|NCT01197521|588085825|FG000|Overall Study|Enrolment in long term extension|42|||
162828730|NCT01197521|588085826|FG001|Overall Study|Enrolment in long term extension|36|||
162828731|NCT01197521|588085827|FG002|Overall Study|Enrolment in long term extension|87|||
162828732|NCT01197521|588085825|FG000|Overall Study|Severe non-compliance to protocol|1|||
162828733|NCT01197521|588085826|FG001|Overall Study|Severe non-compliance to protocol|3|||
162828734|NCT01197521|588085827|FG002|Overall Study|Severe non-compliance to protocol|3|||
162828735|NCT01197521|588085825|FG000|Overall Study|Lack of therapeutic response|2|||
162828736|NCT01197521|588085826|FG001|Overall Study|Lack of therapeutic response|3|||
162828737|NCT01197521|588085827|FG002|Overall Study|Lack of therapeutic response|4|||
162828738|NCT01197521|588085825|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
162828739|NCT01197521|588085826|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
162828740|NCT01197521|588085827|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
162828741|NCT01197521|588085825|FG000|Overall Study|Lost to Follow-up|3|||
162828742|NCT01197521|588085826|FG001|Overall Study|Lost to Follow-up|2|||
162828743|NCT01197521|588085827|FG002|Overall Study|Lost to Follow-up|2|||
162828744|NCT01197521|588085825|FG000|Overall Study|Adverse Event|25|||
162828745|NCT01197521|588085826|FG001|Overall Study|Adverse Event|28|||
162828746|NCT01197521|588085827|FG002|Overall Study|Adverse Event|24|||
162828747|NCT01309659|588085828|FG000|Overall Study|Protocol Violation|0|||
162828748|NCT01309659|588085829|FG001|Overall Study|Protocol Violation|1|||
162828749|NCT05879107|588085832|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
162828750|NCT05879107|588085833|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
162828751|NCT05879107|588085832|FG000|Overall Study|Migrated / moved from the study area|1|||
162828752|NCT05879107|588085833|FG001|Overall Study|Migrated / moved from the study area|1|||
162828753|NCT05879107|588085832|FG000|Overall Study|Lost to Follow-up|8|||
162828754|NCT05879107|588085833|FG001|Overall Study|Lost to Follow-up|13|||
162828755|NCT05879107|588085832|FG000|Overall Study|Death|0|||
162828756|NCT05879107|588085833|FG001|Overall Study|Death|2|||
162828757|NCT05879107|588085832|FG000|Overall Study|Other|0|||
162828758|NCT05879107|588085833|FG001|Overall Study|Other|3|||
162828759|NCT03901079|588085834|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
162828760|NCT04607148|588085835|FG000|Overall Study|Withdrawal by Subject|0|||
162828761|NCT04607148|588085836|FG001|Overall Study|Withdrawal by Subject|4|||
162828762|NCT04607148|588085837|FG002|Overall Study|Withdrawal by Subject|2|||
162828763|NCT04607148|588085838|FG003|Overall Study|Withdrawal by Subject|8|||
162828764|NCT04607148|588085835|FG000|Overall Study|Study Terminated by Sponsor|14|||
162828765|NCT04607148|588085836|FG001|Overall Study|Study Terminated by Sponsor|59|||
162828766|NCT04607148|588085837|FG002|Overall Study|Study Terminated by Sponsor|9|||
162939059|NCT01612000|588480284|FG000|Overall Study|Withdrawal by Subject|3|||
162939060|NCT01612000|588480285|FG001|Overall Study|Withdrawal by Subject|1|||
162939061|NCT01612000|588480286|FG002|Overall Study|Withdrawal by Subject|2|||
162939062|NCT01612000|588480287|FG003|Overall Study|Withdrawal by Subject|2|||
162939063|NCT03425331|588480288|FG000|Overall Study|Withdrawal by Subject|1|||
162939064|NCT03425331|588480288|FG000|Overall Study|Death|1|||
162939065|NCT03425331|588480288|FG000|Overall Study|Adverse Event|1|||
162939066|NCT03425331|588480288|FG000|Overall Study|Disease Progression|2|||
162939067|NCT03433274|588480289|FG000|Overall Study|Withdrawal by Subject|2|||
162939068|NCT03433274|588480289|FG000|Overall Study|Missed visit|5|||
162939069|NCT03433274|588480289|FG000|Overall Study|Death|23|||
162939070|NCT00441584|588480290|FG000|Overall Study|Lack of Efficacy|79|||
162939071|NCT00441584|588480290|FG000|Overall Study|Withdrawal by Subject|8|||
162939072|NCT00441584|588480290|FG000|Overall Study|Adverse Event|6|||
162939073|NCT00441584|588480290|FG000|Overall Study|Protocol Violation|5|||
162939074|NCT00441584|588480290|FG000|Overall Study|Lost to Follow-up|4|||
162939075|NCT00441584|588480290|FG000|Overall Study|Failure to meet eligibility criteria|3|||
162939076|NCT04864405|588480291|FG000|Overall Study|Withdrawal by Subject|4|||
162939077|NCT04864405|588480292|FG001|Overall Study|Withdrawal by Subject|6|||
162939078|NCT04864405|588480291|FG000|Overall Study|Did not want endocrine therapy|3|||
162939079|NCT04864405|588480292|FG001|Overall Study|Did not want endocrine therapy|5|||
162939080|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939081|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939082|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939083|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
162939084|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939085|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939086|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
162939087|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939088|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939089|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939090|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
162939091|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939092|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939093|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
162939094|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939095|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939096|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939097|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
162939098|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939099|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939100|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
162939101|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939102|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939103|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939104|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
162939105|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939106|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939107|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
162939108|NCT04969939|588480293|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939109|NCT04969939|588480294|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939110|NCT04969939|588480295|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939111|NCT04969939|588480296|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
162939112|NCT04969939|588480297|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939113|NCT04969939|588480298|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162828767|NCT04607148|588085838|FG003|Overall Study|Study Terminated by Sponsor|39|||
162828768|NCT04607148|588085835|FG000|Overall Study|Sponsor Decision|0|||
162828769|NCT04607148|588085836|FG001|Overall Study|Sponsor Decision|0|||
162828770|NCT04607148|588085837|FG002|Overall Study|Sponsor Decision|1|||
162828771|NCT04607148|588085838|FG003|Overall Study|Sponsor Decision|0|||
162828772|NCT04607148|588085835|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162828773|NCT04607148|588085836|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162828774|NCT04607148|588085837|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162828775|NCT04607148|588085838|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162828776|NCT04607148|588085835|FG000|Overall Study|Lost to Follow-up|0|||
162828777|NCT04607148|588085836|FG001|Overall Study|Lost to Follow-up|2|||
162828778|NCT04607148|588085837|FG002|Overall Study|Lost to Follow-up|0|||
162828779|NCT04607148|588085838|FG003|Overall Study|Lost to Follow-up|0|||
162828780|NCT04607148|588085835|FG000|Overall Study|Death|0|||
162828781|NCT04607148|588085836|FG001|Overall Study|Death|3|||
162828782|NCT04607148|588085837|FG002|Overall Study|Death|0|||
162828783|NCT04607148|588085838|FG003|Overall Study|Death|1|||
162828784|NCT04607148|588085835|FG000|Overall Study|Adverse Event|0|||
162828785|NCT04607148|588085836|FG001|Overall Study|Adverse Event|1|||
162828786|NCT04607148|588085837|FG002|Overall Study|Adverse Event|0|||
162828787|NCT04607148|588085838|FG003|Overall Study|Adverse Event|0|||
162828788|NCT01820364|588085841|FG000|Part I: LGX818|Death|1|||
162828789|NCT01820364|588085842|FG001|Part I: LGX818|Death|0|||
162828790|NCT01820364|588085841|FG000|Part I: LGX818|Administrative Problems|3|||
162828791|NCT01820364|588085842|FG001|Part I: LGX818|Administrative Problems|0|||
162828792|NCT01820364|588085841|FG000|Part I: LGX818|Adverse Event|6|||
162828793|NCT01820364|588085842|FG001|Part I: LGX818|Adverse Event|0|||
162828794|NCT01820364|588085841|FG000|Part I: LGX818|Disease Progression|4|||
162828795|NCT01820364|588085842|FG001|Part I: LGX818|Disease Progression|0|||
162828796|NCT01820364|588085841|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
162828797|NCT01820364|588085842|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
162828798|NCT03029143|588085843|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
162828799|NCT03029143|588085844|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
162828800|NCT03029143|588085845|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
162828801|NCT03029143|588085843|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
162828802|NCT03029143|588085844|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
162828803|NCT03029143|588085845|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
162828804|NCT03029143|588085843|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
162828805|NCT03029143|588085844|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
162828806|NCT03029143|588085845|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
162828807|NCT03029143|588085843|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
162828808|NCT03029143|588085844|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
162828809|NCT03029143|588085845|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
162828810|NCT03029143|588085843|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
162828811|NCT03029143|588085844|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
162828812|NCT03029143|588085845|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
162828813|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
162828814|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
162828815|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
162828816|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
162828817|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
162828818|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
162828819|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162828820|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162828821|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
162828822|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
162828823|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
162828824|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
162828825|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162828826|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
162828827|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
162828828|NCT03029143|588085843|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
162828829|NCT03029143|588085844|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
162828830|NCT03029143|588085845|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
162828831|NCT01087775|588085846|FG000|Overall Study|failed inclusion criteria|2|||
162828832|NCT04744207|588085847|FG000|Treatment|Withdrawal by Subject|2|||
162828833|NCT04744207|588085848|FG001|Treatment|Withdrawal by Subject|0|||
162828834|NCT04744207|588085847|FG000|Treatment|Adverse Event|1|||
162828835|NCT04744207|588085848|FG001|Treatment|Adverse Event|2|||
162828836|NCT00825162|588085855|FG000|Overall Study|Withdrawal by Subject|11|||
162828837|NCT00825162|588085856|FG001|Overall Study|Withdrawal by Subject|13|||
162939114|NCT04969939|588480299|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
162939115|NCT04969939|588480293|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939116|NCT04969939|588480294|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939117|NCT04969939|588480295|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939118|NCT04969939|588480296|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939119|NCT04969939|588480297|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
162939120|NCT04969939|588480298|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
162939121|NCT04969939|588480299|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162939122|NCT03843359|588480300|FG000|Escalation Phase|Lost to Follow-up|0|||
162939123|NCT03843359|588480301|FG001|Escalation Phase|Lost to Follow-up|0|||
162939124|NCT03843359|588480302|FG002|Escalation Phase|Lost to Follow-up|0|||
162939125|NCT03843359|588480303|FG003|Escalation Phase|Lost to Follow-up|0|||
162939126|NCT03843359|588480304|FG004|Escalation Phase|Lost to Follow-up|0|||
162939127|NCT03843359|588480305|FG005|Escalation Phase|Lost to Follow-up|0|||
162939128|NCT03843359|588480306|FG006|Escalation Phase|Lost to Follow-up|0|||
162939129|NCT03843359|588480307|FG007|Escalation Phase|Lost to Follow-up|0|||
162939130|NCT03843359|588480308|FG008|Escalation Phase|Lost to Follow-up|1|||
162939131|NCT03843359|588480309|FG009|Escalation Phase|Lost to Follow-up|0|||
162939132|NCT03843359|588480310|FG010|Escalation Phase|Lost to Follow-up|0|||
162939133|NCT03843359|588480311|FG011|Escalation Phase|Lost to Follow-up|0|||
162939134|NCT03843359|588480312|FG012|Escalation Phase|Lost to Follow-up|0|||
162939135|NCT03843359|588480313|FG013|Escalation Phase|Lost to Follow-up|0|||
162939136|NCT03843359|588480314|FG014|Escalation Phase|Lost to Follow-up|0|||
162939137|NCT03843359|588480315|FG015|Escalation Phase|Lost to Follow-up|0|||
162939138|NCT03843359|588480300|FG000|Escalation Phase|Physician Decision|0|||
162939139|NCT03843359|588480301|FG001|Escalation Phase|Physician Decision|0|||
162939140|NCT03843359|588480302|FG002|Escalation Phase|Physician Decision|1|||
162939141|NCT03843359|588480303|FG003|Escalation Phase|Physician Decision|0|||
162939142|NCT03843359|588480304|FG004|Escalation Phase|Physician Decision|0|||
162939143|NCT03843359|588480305|FG005|Escalation Phase|Physician Decision|1|||
162939144|NCT03843359|588480306|FG006|Escalation Phase|Physician Decision|0|||
162939145|NCT03843359|588480307|FG007|Escalation Phase|Physician Decision|0|||
162939146|NCT03843359|588480308|FG008|Escalation Phase|Physician Decision|0|||
162939147|NCT03843359|588480309|FG009|Escalation Phase|Physician Decision|0|||
162939148|NCT03843359|588480310|FG010|Escalation Phase|Physician Decision|0|||
162939149|NCT03843359|588480311|FG011|Escalation Phase|Physician Decision|0|||
162939150|NCT03843359|588480312|FG012|Escalation Phase|Physician Decision|0|||
162939151|NCT03843359|588480313|FG013|Escalation Phase|Physician Decision|0|||
162939152|NCT03843359|588480314|FG014|Escalation Phase|Physician Decision|0|||
162939153|NCT03843359|588480315|FG015|Escalation Phase|Physician Decision|0|||
162939154|NCT03843359|588480300|FG000|Escalation Phase|Investigator site closed|0|||
162939155|NCT03843359|588480301|FG001|Escalation Phase|Investigator site closed|1|||
162939156|NCT03843359|588480302|FG002|Escalation Phase|Investigator site closed|0|||
162939157|NCT03843359|588480303|FG003|Escalation Phase|Investigator site closed|1|||
162939158|NCT03843359|588480304|FG004|Escalation Phase|Investigator site closed|1|||
162939159|NCT03843359|588480305|FG005|Escalation Phase|Investigator site closed|0|||
162939160|NCT03843359|588480306|FG006|Escalation Phase|Investigator site closed|1|||
162939161|NCT03843359|588480307|FG007|Escalation Phase|Investigator site closed|0|||
162939162|NCT03843359|588480308|FG008|Escalation Phase|Investigator site closed|2|||
162939163|NCT03843359|588480309|FG009|Escalation Phase|Investigator site closed|0|||
162939164|NCT03843359|588480310|FG010|Escalation Phase|Investigator site closed|0|||
162939165|NCT03843359|588480311|FG011|Escalation Phase|Investigator site closed|0|||
162939166|NCT03843359|588480312|FG012|Escalation Phase|Investigator site closed|0|||
162939167|NCT03843359|588480313|FG013|Escalation Phase|Investigator site closed|0|||
162939168|NCT03843359|588480314|FG014|Escalation Phase|Investigator site closed|0|||
162939169|NCT03843359|588480315|FG015|Escalation Phase|Investigator site closed|0|||
162939170|NCT03843359|588480300|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
162939171|NCT03843359|588480301|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
162939172|NCT03843359|588480302|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
162939173|NCT03843359|588480303|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
162939174|NCT03843359|588480304|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
162939175|NCT03843359|588480305|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
162939176|NCT03843359|588480306|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
162939177|NCT03843359|588480307|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
162939178|NCT03843359|588480308|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
162939179|NCT03843359|588480309|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
162939180|NCT03843359|588480310|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
162939181|NCT03843359|588480311|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
162939182|NCT03843359|588480312|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
162939183|NCT03843359|588480313|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
162939184|NCT03843359|588480314|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
162939185|NCT03843359|588480315|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
162939186|NCT03843359|588480300|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939187|NCT03843359|588480301|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939188|NCT03843359|588480302|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
162939189|NCT03843359|588480303|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939190|NCT03843359|588480304|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
162939191|NCT03843359|588480305|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939192|NCT03843359|588480306|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939193|NCT03843359|588480307|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939194|NCT03843359|588480308|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939195|NCT03843359|588480309|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939196|NCT03843359|588480310|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939197|NCT03843359|588480311|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939198|NCT03843359|588480312|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939199|NCT03843359|588480313|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939200|NCT03843359|588480314|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939201|NCT03843359|588480315|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162939202|NCT03843359|588480300|FG000|Crossover|Withdrawal by Subject|0|||
162939203|NCT03843359|588480301|FG001|Crossover|Withdrawal by Subject|0|||
162939204|NCT03843359|588480302|FG002|Crossover|Withdrawal by Subject|0|||
162939205|NCT03843359|588480303|FG003|Crossover|Withdrawal by Subject|0|||
162939206|NCT03843359|588480304|FG004|Crossover|Withdrawal by Subject|0|||
162939207|NCT03843359|588480305|FG005|Crossover|Withdrawal by Subject|0|||
162939208|NCT03843359|588480306|FG006|Crossover|Withdrawal by Subject|0|||
162939209|NCT03843359|588480307|FG007|Crossover|Withdrawal by Subject|0|||
162939210|NCT03843359|588480308|FG008|Crossover|Withdrawal by Subject|0|||
162939211|NCT03843359|588480309|FG009|Crossover|Withdrawal by Subject|0|||
162939212|NCT03843359|588480310|FG010|Crossover|Withdrawal by Subject|0|||
162939213|NCT03843359|588480311|FG011|Crossover|Withdrawal by Subject|0|||
162939214|NCT03843359|588480312|FG012|Crossover|Withdrawal by Subject|0|||
162939215|NCT03843359|588480313|FG013|Crossover|Withdrawal by Subject|0|||
162939216|NCT03843359|588480314|FG014|Crossover|Withdrawal by Subject|0|||
162939217|NCT03843359|588480315|FG015|Crossover|Withdrawal by Subject|1|||
162939218|NCT03843359|588480300|FG000|Crossover|Investigator site closed|0|||
162939219|NCT03843359|588480301|FG001|Crossover|Investigator site closed|0|||
162939220|NCT03843359|588480302|FG002|Crossover|Investigator site closed|0|||
162939221|NCT03843359|588480303|FG003|Crossover|Investigator site closed|0|||
162939222|NCT03843359|588480304|FG004|Crossover|Investigator site closed|0|||
162939223|NCT03843359|588480305|FG005|Crossover|Investigator site closed|0|||
162939224|NCT03843359|588480306|FG006|Crossover|Investigator site closed|0|||
162939225|NCT03843359|588480307|FG007|Crossover|Investigator site closed|0|||
162939226|NCT03843359|588480308|FG008|Crossover|Investigator site closed|0|||
162939227|NCT03843359|588480309|FG009|Crossover|Investigator site closed|0|||
162939228|NCT03843359|588480310|FG010|Crossover|Investigator site closed|0|||
162939229|NCT03843359|588480311|FG011|Crossover|Investigator site closed|0|||
162939230|NCT03843359|588480312|FG012|Crossover|Investigator site closed|0|||
162939231|NCT03843359|588480313|FG013|Crossover|Investigator site closed|0|||
162939232|NCT03843359|588480314|FG014|Crossover|Investigator site closed|2|||
162939233|NCT03843359|588480315|FG015|Crossover|Investigator site closed|2|||
162939234|NCT03843359|588480300|FG000|Crossover|Ongoing at the time of analysis|0|||
162939235|NCT03843359|588480301|FG001|Crossover|Ongoing at the time of analysis|0|||
162939236|NCT03843359|588480302|FG002|Crossover|Ongoing at the time of analysis|0|||
162939237|NCT03843359|588480303|FG003|Crossover|Ongoing at the time of analysis|0|||
162939238|NCT03843359|588480304|FG004|Crossover|Ongoing at the time of analysis|0|||
162939239|NCT03843359|588480305|FG005|Crossover|Ongoing at the time of analysis|0|||
162828838|NCT00825162|588085857|FG002|Overall Study|Withdrawal by Subject|3|||
162828839|NCT00825162|588085855|FG000|Overall Study|Lost to Follow-up|9|||
162828840|NCT00825162|588085856|FG001|Overall Study|Lost to Follow-up|6|||
162828841|NCT00825162|588085857|FG002|Overall Study|Lost to Follow-up|3|||
162828842|NCT00825162|588085855|FG000|Overall Study|Physician Decision|2|||
162828843|NCT00825162|588085856|FG001|Overall Study|Physician Decision|0|||
162828844|NCT00825162|588085857|FG002|Overall Study|Physician Decision|0|||
162828845|NCT00825162|588085855|FG000|Overall Study|Move away from the study area|1|||
162828846|NCT00825162|588085856|FG001|Overall Study|Move away from the study area|0|||
162828847|NCT00825162|588085857|FG002|Overall Study|Move away from the study area|0|||
162828848|NCT00825162|588085855|FG000|Overall Study|Unable to attend the study visit|5|||
162828849|NCT00825162|588085856|FG001|Overall Study|Unable to attend the study visit|2|||
162828850|NCT00825162|588085857|FG002|Overall Study|Unable to attend the study visit|0|||
162828851|NCT00258674|588085862|FG000|Overall Study|Death|32|||
162828852|NCT00258674|588085863|FG001|Overall Study|Death|53|||
162828853|NCT00258674|588085864|FG002|Overall Study|Death|34|||
162828854|NCT02973087|588085865|FG000|Overall Study|Withdrawal by Subject|2|||
162828855|NCT02973087|588085866|FG001|Overall Study|Withdrawal by Subject|1|||
162828856|NCT02973087|588085865|FG000|Overall Study|Adverse Event|1|||
162828857|NCT02973087|588085866|FG001|Overall Study|Adverse Event|0|||
162828858|NCT02973087|588085865|FG000|Overall Study|other|1|||
162828859|NCT02973087|588085866|FG001|Overall Study|other|1|||
162828860|NCT03710486|588085867|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
162828861|NCT03710486|588085868|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
162828862|NCT03710486|588085867|FG000|Overall Study|Missing|0|||
162828863|NCT03710486|588085868|FG001|Overall Study|Missing|2|||
162828864|NCT01279850|588085873|FG000|Overall Study|Protocol Violation|50|||
162828865|NCT01279850|588085873|FG000|Overall Study|No Drug Administration Information|7|||
162828866|NCT01279850|588085873|FG000|Overall Study|No Visit After Treatment|34|||
162828867|NCT01147744|588085874|FG000|Overall Study|Protocol Violation|1|||
162828868|NCT01147744|588085875|FG001|Overall Study|Protocol Violation|0|||
162828869|NCT01147744|588085876|FG002|Overall Study|Protocol Violation|1|||
162828870|NCT01147744|588085877|FG003|Overall Study|Protocol Violation|0|||
162828871|NCT01147744|588085878|FG004|Overall Study|Protocol Violation|1|||
162828872|NCT01147744|588085879|FG005|Overall Study|Protocol Violation|3|||
162828873|NCT01147744|588085880|FG006|Overall Study|Protocol Violation|1|||
162828874|NCT01147744|588085874|FG000|Overall Study|Physician Decision|0|||
162828875|NCT01147744|588085875|FG001|Overall Study|Physician Decision|1|||
162828876|NCT01147744|588085876|FG002|Overall Study|Physician Decision|1|||
162828877|NCT01147744|588085877|FG003|Overall Study|Physician Decision|0|||
162828878|NCT01147744|588085878|FG004|Overall Study|Physician Decision|0|||
162828879|NCT01147744|588085879|FG005|Overall Study|Physician Decision|0|||
162828880|NCT01147744|588085880|FG006|Overall Study|Physician Decision|1|||
162828881|NCT01147744|588085874|FG000|Overall Study|Lack of Efficacy|11|||
162828882|NCT01147744|588085875|FG001|Overall Study|Lack of Efficacy|11|||
162828883|NCT01147744|588085876|FG002|Overall Study|Lack of Efficacy|9|||
162828884|NCT01147744|588085877|FG003|Overall Study|Lack of Efficacy|11|||
162828885|NCT01147744|588085878|FG004|Overall Study|Lack of Efficacy|13|||
162828886|NCT01147744|588085879|FG005|Overall Study|Lack of Efficacy|8|||
162828887|NCT01147744|588085880|FG006|Overall Study|Lack of Efficacy|7|||
162828888|NCT01147744|588085874|FG000|Overall Study|Adverse Event|1|||
162828889|NCT01147744|588085875|FG001|Overall Study|Adverse Event|2|||
162828890|NCT01147744|588085876|FG002|Overall Study|Adverse Event|3|||
162828891|NCT01147744|588085877|FG003|Overall Study|Adverse Event|0|||
162828892|NCT01147744|588085878|FG004|Overall Study|Adverse Event|2|||
162828893|NCT01147744|588085879|FG005|Overall Study|Adverse Event|1|||
162828894|NCT01147744|588085880|FG006|Overall Study|Adverse Event|2|||
162828895|NCT01147744|588085874|FG000|Overall Study|Withdrawal by Subject|8|||
162828896|NCT01147744|588085875|FG001|Overall Study|Withdrawal by Subject|4|||
162828897|NCT01147744|588085876|FG002|Overall Study|Withdrawal by Subject|2|||
162828898|NCT01147744|588085877|FG003|Overall Study|Withdrawal by Subject|2|||
162828899|NCT01147744|588085878|FG004|Overall Study|Withdrawal by Subject|2|||
162828900|NCT01147744|588085879|FG005|Overall Study|Withdrawal by Subject|5|||
162828901|NCT01147744|588085880|FG006|Overall Study|Withdrawal by Subject|2|||
162828902|NCT01147744|588085874|FG000|Overall Study|Lost to Follow-up|0|||
162828903|NCT01147744|588085875|FG001|Overall Study|Lost to Follow-up|1|||
162828904|NCT01147744|588085876|FG002|Overall Study|Lost to Follow-up|0|||
162828905|NCT01147744|588085877|FG003|Overall Study|Lost to Follow-up|0|||
162828906|NCT01147744|588085878|FG004|Overall Study|Lost to Follow-up|0|||
162828907|NCT01147744|588085879|FG005|Overall Study|Lost to Follow-up|0|||
162828908|NCT01147744|588085880|FG006|Overall Study|Lost to Follow-up|0|||
162828909|NCT01147744|588085874|FG000|Overall Study|Sponsor decision to amend protocol|7|||
162828910|NCT01147744|588085875|FG001|Overall Study|Sponsor decision to amend protocol|4|||
162828911|NCT01147744|588085876|FG002|Overall Study|Sponsor decision to amend protocol|2|||
162828912|NCT01147744|588085877|FG003|Overall Study|Sponsor decision to amend protocol|5|||
162828913|NCT01147744|588085878|FG004|Overall Study|Sponsor decision to amend protocol|7|||
162828914|NCT01147744|588085879|FG005|Overall Study|Sponsor decision to amend protocol|2|||
162828915|NCT01147744|588085880|FG006|Overall Study|Sponsor decision to amend protocol|6|||
162828916|NCT01147744|588085874|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162828917|NCT01147744|588085875|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162828918|NCT01147744|588085876|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162828919|NCT01147744|588085877|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162828920|NCT01147744|588085878|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162828921|NCT01147744|588085879|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162828922|NCT01147744|588085880|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162828923|NCT01342484|588085889|FG000|Overall Study|Other Reasons|1|||
162828924|NCT01342484|588085890|FG001|Overall Study|Other Reasons|0|||
162828925|NCT01342484|588085891|FG002|Overall Study|Other Reasons|0|||
162828926|NCT01342484|588085889|FG000|Overall Study|Protocol Violation|0|||
162828927|NCT01342484|588085890|FG001|Overall Study|Protocol Violation|0|||
162828928|NCT01342484|588085891|FG002|Overall Study|Protocol Violation|1|||
162828929|NCT01342484|588085889|FG000|Overall Study|Withdrawal by Subject|1|||
162828930|NCT01342484|588085890|FG001|Overall Study|Withdrawal by Subject|0|||
162828931|NCT01342484|588085891|FG002|Overall Study|Withdrawal by Subject|0|||
162828932|NCT00432042|588085892|FG000|Overall Study|Protocol Violation|2|||
162828933|NCT00432042|588085893|FG001|Overall Study|Protocol Violation|0|||
162828934|NCT00432042|588085894|FG002|Overall Study|Protocol Violation|0|||
162828935|NCT00432042|588085892|FG000|Overall Study|Withdrawal by Subject|0|||
162828936|NCT00432042|588085893|FG001|Overall Study|Withdrawal by Subject|0|||
162828937|NCT00432042|588085894|FG002|Overall Study|Withdrawal by Subject|2|||
162828938|NCT00432042|588085892|FG000|Overall Study|Lost to Follow-up|5|||
162828939|NCT00432042|588085893|FG001|Overall Study|Lost to Follow-up|1|||
162828940|NCT00432042|588085894|FG002|Overall Study|Lost to Follow-up|0|||
162828941|NCT01744665|588085896|FG000|Monitoring Phase|Adverse Event|4|||
162828942|NCT01744665|588085896|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
162828943|NCT01744665|588085896|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
162828944|NCT01744665|588085896|FG000|Monitoring Phase|Withdrawal by Subject|5|||
162828945|NCT01744665|588085896|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
162828946|NCT01744665|588085896|FG000|Consolidation Phase|Adverse Event|2|||
162828947|NCT01744665|588085896|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
162828948|NCT01744665|588085896|FG000|Consolidation Phase|Withdrawal by Subject|4|||
162828949|NCT01744665|588085896|FG000|Consolidation Phase|Administrative problems|9|||
162828950|NCT01744665|588085896|FG000|Re-initiation Phase|Administrative problems|10|||
162828951|NCT01744665|588085896|FG000|Re-initiation Phase|Adverse Event|1|||
162828952|NCT01744665|588085896|FG000|Re-initiation Phase|No longer required treatment|1|||
162828953|NCT01744665|588085896|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
162828954|NCT00492752|588085897|FG000|Double Blind Treatment|Death|13|||
162828955|NCT00492752|588085898|FG001|Double Blind Treatment|Death|0|||
162828956|NCT00492752|588085899|FG002|Double Blind Treatment|Death|2|||
162828957|NCT00492752|588085900|FG003|Double Blind Treatment|Death|0|||
162828958|NCT00492752|588085897|FG000|Double Blind Treatment|Adverse Event|1|||
162828959|NCT00492752|588085898|FG001|Double Blind Treatment|Adverse Event|0|||
162828960|NCT00492752|588085899|FG002|Double Blind Treatment|Adverse Event|0|||
162828961|NCT00492752|588085900|FG003|Double Blind Treatment|Adverse Event|0|||
162828962|NCT00492752|588085897|FG000|Double Blind Treatment|Protocol Violation|0|||
162828963|NCT00492752|588085898|FG001|Double Blind Treatment|Protocol Violation|0|||
162828964|NCT00492752|588085899|FG002|Double Blind Treatment|Protocol Violation|1|||
162828965|NCT00492752|588085900|FG003|Double Blind Treatment|Protocol Violation|0|||
162828966|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
162828967|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
162828968|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
162828969|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
162828970|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
162828971|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
162828972|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
162828973|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
162828974|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
162828975|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
162828976|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
162828977|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
162828978|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
162828979|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
163042847|NCT01066871|588863975|FG001|Overall Study|Protocol Violation|0|||
162939240|NCT03843359|588480306|FG006|Crossover|Ongoing at the time of analysis|0|||
162939241|NCT03843359|588480307|FG007|Crossover|Ongoing at the time of analysis|0|||
162939242|NCT03843359|588480308|FG008|Crossover|Ongoing at the time of analysis|0|||
162939243|NCT03843359|588480309|FG009|Crossover|Ongoing at the time of analysis|0|||
162939244|NCT03843359|588480310|FG010|Crossover|Ongoing at the time of analysis|0|||
162939245|NCT03843359|588480311|FG011|Crossover|Ongoing at the time of analysis|0|||
162939246|NCT03843359|588480312|FG012|Crossover|Ongoing at the time of analysis|0|||
162939247|NCT03843359|588480313|FG013|Crossover|Ongoing at the time of analysis|1|||
162939248|NCT03843359|588480314|FG014|Crossover|Ongoing at the time of analysis|0|||
162939249|NCT03843359|588480315|FG015|Crossover|Ongoing at the time of analysis|0|||
162939250|NCT03075527|588480316|FG000|Overall Study|Death|1|||
162939251|NCT03075527|588480316|FG000|Overall Study|Withdrawal by Subject|1|||
162939252|NCT03075527|588480316|FG000|Overall Study|Physician Decision|3|||
162939253|NCT03075527|588480316|FG000|Overall Study|Progression/Relapse|14|||
162939254|NCT05359003|588480321|FG000|Overall Study|Withdrawal by Subject|1|||
162939255|NCT05359003|588480322|FG001|Overall Study|Withdrawal by Subject|3|||
162939256|NCT06202521|588480325|FG000|Overall Study|Withdrawal by Subject|0|||
162939257|NCT06202521|588480326|FG001|Overall Study|Withdrawal by Subject|1|||
162939258|NCT06202521|588480327|FG002|Overall Study|Withdrawal by Subject|0|||
162939259|NCT06202521|588480328|FG003|Overall Study|Withdrawal by Subject|1|||
162939260|NCT06202521|588480325|FG000|Overall Study|Adverse Event|0|||
162939261|NCT06202521|588480326|FG001|Overall Study|Adverse Event|0|||
162939262|NCT06202521|588480327|FG002|Overall Study|Adverse Event|1|||
162939263|NCT06202521|588480328|FG003|Overall Study|Adverse Event|0|||
162939264|NCT02717611|588480331|FG000|Overall Study|Death|13|||
162939265|NCT02717611|588480331|FG000|Overall Study|Withdrawal by Subject|6|||
162939266|NCT02717611|588480331|FG000|Overall Study|Active, not recruiting|40|||
162939267|NCT02717611|588480331|FG000|Overall Study|Complicating disease|1|||
162939268|NCT00616928|588480334|FG000|Overall Study|Adverse Event|6|||
162939269|NCT00616928|588480335|FG001|Overall Study|Adverse Event|3|||
162939270|NCT00616928|588480336|FG002|Overall Study|Adverse Event|2|||
162939271|NCT00616928|588480337|FG003|Overall Study|Adverse Event|2|||
162939272|NCT00616928|588480334|FG000|Overall Study|Other|51|||
162939273|NCT00616928|588480335|FG001|Overall Study|Other|8|||
162939274|NCT00616928|588480336|FG002|Overall Study|Other|15|||
162939275|NCT00616928|588480337|FG003|Overall Study|Other|5|||
162939276|NCT00616928|588480334|FG000|Overall Study|Lost to Follow-up|5|||
162939277|NCT00616928|588480335|FG001|Overall Study|Lost to Follow-up|7|||
162939278|NCT00616928|588480336|FG002|Overall Study|Lost to Follow-up|0|||
162939279|NCT00616928|588480337|FG003|Overall Study|Lost to Follow-up|0|||
162939280|NCT05182606|588480340|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
162939281|NCT02669264|588480345|FG000|Overall Study|Death|5|||
162939282|NCT02669264|588480346|FG001|Overall Study|Death|5|||
162939283|NCT02669264|588480347|FG002|Overall Study|Death|3|||
162939284|NCT02669264|588480348|FG003|Overall Study|Death|3|||
162939285|NCT02669264|588480349|FG004|Overall Study|Death|3|||
162939286|NCT02669264|588480350|FG005|Overall Study|Death|6|||
162939287|NCT02669264|588480351|FG006|Overall Study|Death|3|||
162939288|NCT02669264|588480345|FG000|Overall Study|Withdrawal by Subject|0|||
162939289|NCT02669264|588480346|FG001|Overall Study|Withdrawal by Subject|1|||
162939290|NCT02669264|588480347|FG002|Overall Study|Withdrawal by Subject|0|||
162939291|NCT02669264|588480348|FG003|Overall Study|Withdrawal by Subject|0|||
162939292|NCT02669264|588480349|FG004|Overall Study|Withdrawal by Subject|1|||
162939293|NCT02669264|588480350|FG005|Overall Study|Withdrawal by Subject|0|||
162939294|NCT02669264|588480351|FG006|Overall Study|Withdrawal by Subject|0|||
162939295|NCT02669264|588480345|FG000|Overall Study|Lost to Follow-up|0|||
162939296|NCT02669264|588480346|FG001|Overall Study|Lost to Follow-up|0|||
162939297|NCT02669264|588480347|FG002|Overall Study|Lost to Follow-up|0|||
162939298|NCT02669264|588480348|FG003|Overall Study|Lost to Follow-up|0|||
162939299|NCT02669264|588480349|FG004|Overall Study|Lost to Follow-up|1|||
162939300|NCT02669264|588480350|FG005|Overall Study|Lost to Follow-up|0|||
162939301|NCT02669264|588480351|FG006|Overall Study|Lost to Follow-up|0|||
162939302|NCT02669264|588480345|FG000|Overall Study|Miscellaneous|0|||
162939303|NCT02669264|588480346|FG001|Overall Study|Miscellaneous|0|||
162939304|NCT02669264|588480347|FG002|Overall Study|Miscellaneous|0|||
162939305|NCT02669264|588480348|FG003|Overall Study|Miscellaneous|0|||
162939306|NCT02669264|588480349|FG004|Overall Study|Miscellaneous|0|||
162939307|NCT02669264|588480350|FG005|Overall Study|Miscellaneous|0|||
162939308|NCT02669264|588480351|FG006|Overall Study|Miscellaneous|2|||
162939309|NCT00500682|588480352|FG000|Overall Study|Adverse Event|37|||
162939310|NCT00500682|588480353|FG001|Overall Study|Adverse Event|29|||
162939311|NCT00500682|588480352|FG000|Overall Study|Death|25|||
162939312|NCT00500682|588480353|FG001|Overall Study|Death|16|||
162939313|NCT00500682|588480352|FG000|Overall Study|Lost to Follow-up|11|||
162939314|NCT00500682|588480353|FG001|Overall Study|Lost to Follow-up|11|||
162939315|NCT00500682|588480352|FG000|Overall Study|Physician Decision|6|||
162939316|NCT00500682|588480353|FG001|Overall Study|Physician Decision|10|||
162939317|NCT00500682|588480352|FG000|Overall Study|Pregnancy|2|||
162939318|NCT00500682|588480353|FG001|Overall Study|Pregnancy|0|||
162939319|NCT00500682|588480352|FG000|Overall Study|Protocol Violation|1|||
162939320|NCT00500682|588480353|FG001|Overall Study|Protocol Violation|3|||
162939321|NCT00500682|588480352|FG000|Overall Study|Withdrawal by Subject|80|||
162939322|NCT00500682|588480353|FG001|Overall Study|Withdrawal by Subject|74|||
162939323|NCT00500682|588480352|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
162939324|NCT00500682|588480353|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
162939325|NCT01680159|588480354|FG000|Screening Period|Not meet criteria for dose-up period|7|||
162939326|NCT01680159|588480354|FG000|Increased Dose Period|Adverse Event|6|||
162939327|NCT01680159|588480354|FG000|Increased Dose Period|Withdrawal by Subject|2|||
162939328|NCT00772382|588480355|FG000|Overall Study|Adverse Event|19|||
162939329|NCT00772382|588480355|FG000|Overall Study|Death|6|||
162939330|NCT00772382|588480355|FG000|Overall Study|Lack of Efficacy|4|||
162939331|NCT00772382|588480355|FG000|Overall Study|Physician Decision|5|||
162939332|NCT00772382|588480355|FG000|Overall Study|Protocol Violation|1|||
162939333|NCT00772382|588480355|FG000|Overall Study|Withdrawal by Subject|10|||
162939334|NCT00772382|588480355|FG000|Overall Study|Other Reasons|10|||
162939335|NCT05576012|588480360|FG000|Overall Study|Physician Decision|0|||
162939336|NCT05576012|588480361|FG001|Overall Study|Physician Decision|0|||
162939337|NCT05576012|588480362|FG002|Overall Study|Physician Decision|0|||
162939338|NCT05576012|588480363|FG003|Overall Study|Physician Decision|0|||
162939339|NCT05576012|588480364|FG004|Overall Study|Physician Decision|0|||
162939340|NCT05576012|588480365|FG005|Overall Study|Physician Decision|0|||
162939341|NCT05576012|588480366|FG006|Overall Study|Physician Decision|0|||
162939342|NCT05576012|588480367|FG007|Overall Study|Physician Decision|0|||
162939343|NCT05576012|588480368|FG008|Overall Study|Physician Decision|1|||
162939344|NCT05576012|588480369|FG009|Overall Study|Physician Decision|0|||
162939345|NCT03731182|588481530|FG000|Overall Study|Lost to Follow-up|2|||
162939346|NCT03731182|588481531|FG001|Overall Study|Lost to Follow-up|0|||
162939347|NCT03731182|588481530|FG000|Overall Study|Physician Decision|1|||
162939348|NCT03731182|588481531|FG001|Overall Study|Physician Decision|0|||
162939349|NCT03731182|588481530|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
162939350|NCT03731182|588481531|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
162939351|NCT03036579|588481538|FG000|2 Years|Lost to Follow-up|1|||
162939352|NCT03036579|588481539|FG001|2 Years|Lost to Follow-up|0|||
162939353|NCT03036579|588481538|FG000|3 Years|Lost to Follow-up|0|||
162939354|NCT03036579|588481539|FG001|3 Years|Lost to Follow-up|1|||
162939355|NCT02352337|588481540|FG000|Overall Study|Patients never treated|4|||
162939356|NCT02352337|588481541|FG001|Overall Study|Patients never treated|1|||
162939357|NCT02352337|588481542|FG002|Overall Study|Patients never treated|2|||
162939358|NCT02458638|588481545|FG000|Overall Study|Death|309|||
162939359|NCT02458638|588481545|FG000|Overall Study|End of Cohort/End of Study|67|||
162939360|NCT02458638|588481545|FG000|Overall Study|Lost to Follow-up|31|||
162939361|NCT02458638|588481545|FG000|Overall Study|Other Reasons|4|||
162939362|NCT02458638|588481545|FG000|Overall Study|Physician Decision|1|||
162939363|NCT02458638|588481545|FG000|Overall Study|Withdrawal by Subject|47|||
162939364|NCT00576901|588481557|FG000|Overall Study|Withdrawal by Subject|1|||
162939365|NCT00576901|588481557|FG000|Overall Study|Disease course|1|||
162939366|NCT00576901|588481557|FG000|Overall Study|Protocol Violation|1|||
162939367|NCT02398188|588481558|FG000|Overall Study|Adverse Event|2|||
162939368|NCT02398188|588481559|FG001|Overall Study|Adverse Event|3|||
162939369|NCT02398188|588481558|FG000|Overall Study|Lost to Follow-up|5|||
162939370|NCT02398188|588481559|FG001|Overall Study|Lost to Follow-up|0|||
162939371|NCT02398188|588481558|FG000|Overall Study|Non-compliance|4|||
162939372|NCT02398188|588481559|FG001|Overall Study|Non-compliance|4|||
162939373|NCT02398188|588481558|FG000|Overall Study|Protocol Violation|6|||
162939374|NCT02398188|588481559|FG001|Overall Study|Protocol Violation|10|||
162939375|NCT02398188|588481558|FG000|Overall Study|Sponsor Decision|2|||
162939376|NCT02398188|588481559|FG001|Overall Study|Sponsor Decision|1|||
162939377|NCT02398188|588481558|FG000|Overall Study|Pregnancy|1|||
162939378|NCT02398188|588481559|FG001|Overall Study|Pregnancy|0|||
162939379|NCT02398188|588481558|FG000|Overall Study|Withdrawal by Subject|7|||
162939380|NCT02398188|588481559|FG001|Overall Study|Withdrawal by Subject|16|||
162939381|NCT00620763|588481560|FG000|Period: First Intervention|Withdrawal by Subject|0|||
162939382|NCT00620763|588481561|FG001|Period: First Intervention|Withdrawal by Subject|2|||
162939383|NCT00620763|588481560|FG000|Period: First Intervention|Protocol Violation|0|||
162939384|NCT00620763|588481561|FG001|Period: First Intervention|Protocol Violation|3|||
162939385|NCT00620763|588481560|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
162939386|NCT00620763|588481561|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
162939387|NCT00729859|588481562|FG000|Overall Study|Adverse Event|0|||
162939388|NCT00729859|588481563|FG001|Overall Study|Adverse Event|1|||
162939389|NCT00729859|588481564|FG002|Overall Study|Adverse Event|0|||
162939390|NCT00729859|588481562|FG000|Overall Study|Withdrawal by Subject|0|||
162939391|NCT00729859|588481563|FG001|Overall Study|Withdrawal by Subject|1|||
162939392|NCT00729859|588481564|FG002|Overall Study|Withdrawal by Subject|0|||
162939393|NCT00760383|588481565|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
162939394|NCT00760383|588481566|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
162939395|NCT05034731|588481567|FG000|Overall Study|Screen fail|1|||
162939396|NCT05034731|588481568|FG001|Overall Study|Screen fail|1|||
162939397|NCT01725451|588481574|FG000|Period 1|Withdrawal by Subject|1|||
162828980|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
162828981|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
162828982|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
162828983|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
162828984|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
162828985|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
162828986|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
162828987|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
162828988|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
162828989|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
162828990|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
162828991|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
162828992|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
162828993|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
162828994|NCT00492752|588085897|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
162828995|NCT00492752|588085898|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
162828996|NCT00492752|588085899|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
162828997|NCT00492752|588085900|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
162828998|NCT04857996|588085901|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
162828999|NCT04857996|588085902|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
162829000|NCT04857996|588085901|FG000|Overall Study|Lost to Follow-up|1|||
162829001|NCT04857996|588085902|FG001|Overall Study|Lost to Follow-up|3|||
162829002|NCT04857996|588085901|FG000|Overall Study|Site Closure|1|||
162829003|NCT04857996|588085902|FG001|Overall Study|Site Closure|0|||
162829004|NCT04857996|588085901|FG000|Overall Study|Withdrawal by Subject|1|||
162829005|NCT04857996|588085902|FG001|Overall Study|Withdrawal by Subject|0|||
162829006|NCT02988661|588085903|FG000|Overall Study|Death|2|||
162829007|NCT02988661|588085904|FG001|Overall Study|Death|18|||
162829008|NCT02988661|588085903|FG000|Overall Study|Lost to Follow-up|0|||
162829009|NCT02988661|588085904|FG001|Overall Study|Lost to Follow-up|33|||
162829010|NCT02988661|588085903|FG000|Overall Study|Withdrawal by Subject|0|||
162829011|NCT02988661|588085904|FG001|Overall Study|Withdrawal by Subject|6|||
162829012|NCT02988661|588085903|FG000|Overall Study|Unable to complete the 18-month survey|1|||
162829013|NCT02988661|588085904|FG001|Overall Study|Unable to complete the 18-month survey|27|||
162829014|NCT04050982|588085905|FG000|Overall Study|Did not meet eligibility criteria|0|||
162829015|NCT04050982|588085906|FG001|Overall Study|Did not meet eligibility criteria|1|||
162829016|NCT04050982|588085907|FG002|Overall Study|Did not meet eligibility criteria|0|||
162829017|NCT04050982|588085905|FG000|Overall Study|Withdrawal by Subject|1|||
162829018|NCT04050982|588085906|FG001|Overall Study|Withdrawal by Subject|0|||
162829019|NCT04050982|588085907|FG002|Overall Study|Withdrawal by Subject|0|||
162829020|NCT04050982|588085905|FG000|Overall Study|Unable to enroll on platform|1|||
162829021|NCT04050982|588085906|FG001|Overall Study|Unable to enroll on platform|0|||
162829022|NCT04050982|588085907|FG002|Overall Study|Unable to enroll on platform|0|||
162829023|NCT04649255|588086959|FG000|Overall Study|Death|9|||
162829024|NCT04649255|588086959|FG000|Overall Study|Withdrawal by Subject|1|||
162829025|NCT04682405|588086963|FG000|Overall Study|Adverse Event|0|||
162829026|NCT04682405|588086964|FG001|Overall Study|Adverse Event|1|||
162829027|NCT00747643|588086965|FG000|Overall Study|Withdrawal by Subject|36|||
162829028|NCT00747643|588086966|FG001|Overall Study|Withdrawal by Subject|27|||
162829029|NCT03557281|588086967|FG000|Overall Study|Investigator discretion|0|||
162829030|NCT03557281|588086968|FG001|Overall Study|Investigator discretion|0|||
162829031|NCT03557281|588086969|FG002|Overall Study|Investigator discretion|1|||
162829032|NCT03557281|588086970|FG003|Overall Study|Investigator discretion|0|||
162829033|NCT03557281|588086971|FG004|Overall Study|Investigator discretion|0|||
162829034|NCT03557281|588086967|FG000|Overall Study|Withdrawal by Subject|0|||
162829035|NCT03557281|588086968|FG001|Overall Study|Withdrawal by Subject|1|||
162829036|NCT03557281|588086969|FG002|Overall Study|Withdrawal by Subject|1|||
162829037|NCT03557281|588086970|FG003|Overall Study|Withdrawal by Subject|1|||
162829038|NCT03557281|588086971|FG004|Overall Study|Withdrawal by Subject|2|||
162829039|NCT03557281|588086967|FG000|Overall Study|Randomized, but did not receive treatment|0|||
162829040|NCT03557281|588086968|FG001|Overall Study|Randomized, but did not receive treatment|0|||
162829041|NCT03557281|588086969|FG002|Overall Study|Randomized, but did not receive treatment|0|||
162829042|NCT03557281|588086970|FG003|Overall Study|Randomized, but did not receive treatment|0|||
162829043|NCT03557281|588086971|FG004|Overall Study|Randomized, but did not receive treatment|1|||
162829044|NCT01199042|588086972|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
162829045|NCT01199042|588086972|FG000|At Home (3 Months)|Lost to Follow-up|1|||
162829046|NCT03357731|588086977|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
162829047|NCT03357731|588086978|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
162829048|NCT03357731|588086979|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
162829049|NCT03357731|588086980|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
162829050|NCT03357731|588086981|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
162829051|NCT03357731|588086982|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
162829052|NCT03357731|588086977|FG000|Overall Study|Acute bradycardia and hypotension|0|||
162829053|NCT03357731|588086978|FG001|Overall Study|Acute bradycardia and hypotension|0|||
162829054|NCT03357731|588086979|FG002|Overall Study|Acute bradycardia and hypotension|0|||
162829055|NCT03357731|588086980|FG003|Overall Study|Acute bradycardia and hypotension|1|||
162829056|NCT03357731|588086981|FG004|Overall Study|Acute bradycardia and hypotension|0|||
162829057|NCT03357731|588086982|FG005|Overall Study|Acute bradycardia and hypotension|0|||
162829058|NCT03357731|588086977|FG000|Overall Study|Adverse Event|0|||
162829059|NCT03357731|588086978|FG001|Overall Study|Adverse Event|0|||
162829060|NCT03357731|588086979|FG002|Overall Study|Adverse Event|0|||
162829061|NCT03357731|588086980|FG003|Overall Study|Adverse Event|0|||
162829062|NCT03357731|588086981|FG004|Overall Study|Adverse Event|0|||
162829063|NCT03357731|588086982|FG005|Overall Study|Adverse Event|1|||
162829064|NCT03357731|588086977|FG000|Overall Study|Hypotension|0|||
162829065|NCT03357731|588086978|FG001|Overall Study|Hypotension|0|||
162829066|NCT03357731|588086979|FG002|Overall Study|Hypotension|1|||
162829067|NCT03357731|588086980|FG003|Overall Study|Hypotension|1|||
162829068|NCT03357731|588086981|FG004|Overall Study|Hypotension|0|||
162829069|NCT03357731|588086982|FG005|Overall Study|Hypotension|0|||
162829070|NCT03357731|588086977|FG000|Overall Study|Lost to Follow-up|0|||
162829071|NCT03357731|588086978|FG001|Overall Study|Lost to Follow-up|0|||
162829072|NCT03357731|588086979|FG002|Overall Study|Lost to Follow-up|0|||
162829073|NCT03357731|588086980|FG003|Overall Study|Lost to Follow-up|1|||
162829074|NCT03357731|588086981|FG004|Overall Study|Lost to Follow-up|0|||
162829075|NCT03357731|588086982|FG005|Overall Study|Lost to Follow-up|0|||
162829076|NCT01773109|588086983|FG000|Overall Study|Symptomatic Progression|2|||
162829077|NCT01773109|588086983|FG000|Overall Study|Death|1|||
162829078|NCT01239342|588086984|FG000|Overall Study|Adverse Event|1|||
162829079|NCT01239342|588086985|FG001|Overall Study|Adverse Event|0|||
162829080|NCT01239342|588086984|FG000|Overall Study|Withdrawal by Subject|1|||
162829081|NCT01239342|588086985|FG001|Overall Study|Withdrawal by Subject|5|||
162829082|NCT01239342|588086984|FG000|Overall Study|Reason Unknown|1|||
162829083|NCT01239342|588086985|FG001|Overall Study|Reason Unknown|1|||
162829084|NCT00003535|588086988|FG000|Overall Study|Not evaluable|5|||
162829085|NCT01849874|588086989|FG000|Overall Study|Death|89|||
162829086|NCT01849874|588086990|FG001|Overall Study|Death|42|||
162829087|NCT01849874|588086989|FG000|Overall Study|Withdrawal by Subject|17|||
162829088|NCT01849874|588086990|FG001|Overall Study|Withdrawal by Subject|16|||
162829089|NCT01849874|588086989|FG000|Overall Study|Lost to Follow-up|3|||
162829090|NCT01849874|588086990|FG001|Overall Study|Lost to Follow-up|2|||
162829091|NCT01849874|588086989|FG000|Overall Study|Study Termination By Sponsor|93|||
162829092|NCT01849874|588086990|FG001|Overall Study|Study Termination By Sponsor|48|||
162829093|NCT01849874|588086989|FG000|Overall Study|Completed as per protocol amendment 6|3|||
162829094|NCT01849874|588086990|FG001|Overall Study|Completed as per protocol amendment 6|0|||
162829095|NCT01849874|588086989|FG000|Overall Study|Physician Decision|7|||
162829096|NCT01849874|588086990|FG001|Overall Study|Physician Decision|1|||
162829097|NCT01849874|588086989|FG000|Overall Study|Other|16|||
162829098|NCT01849874|588086990|FG001|Overall Study|Other|4|||
162829099|NCT02347098|588086992|FG000|Overall Study|Death|1|||
162829100|NCT02347098|588086993|FG001|Overall Study|Death|0|||
162829101|NCT02347098|588086992|FG000|Overall Study|Withdrawal by Subject|1|||
162829102|NCT02347098|588086993|FG001|Overall Study|Withdrawal by Subject|0|||
162829103|NCT02347098|588086992|FG000|Overall Study|Lost to Follow-up|2|||
162829104|NCT02347098|588086993|FG001|Overall Study|Lost to Follow-up|2|||
162829105|NCT02347098|588086992|FG000|Overall Study|Refuse Follow-up Visit|1|||
162829106|NCT02347098|588086993|FG001|Overall Study|Refuse Follow-up Visit|5|||
162939398|NCT01725451|588481575|FG001|Period 1|Withdrawal by Subject|0|||
162939399|NCT01725451|588481576|FG002|Period 1|Withdrawal by Subject|0|||
162939400|NCT01725451|588481577|FG003|Period 1|Withdrawal by Subject|0|||
162939401|NCT01725451|588481574|FG000|Washout From Period 3|Protocol Violation|0|||
162939402|NCT01725451|588481575|FG001|Washout From Period 3|Protocol Violation|0|||
162939403|NCT01725451|588481576|FG002|Washout From Period 3|Protocol Violation|1|||
162939404|NCT01725451|588481577|FG003|Washout From Period 3|Protocol Violation|0|||
162939405|NCT01725451|588481574|FG000|Washout From Period 3|Adverse Event|0|||
162939406|NCT01725451|588481575|FG001|Washout From Period 3|Adverse Event|1|||
162939407|NCT01725451|588481576|FG002|Washout From Period 3|Adverse Event|0|||
162939408|NCT01725451|588481577|FG003|Washout From Period 3|Adverse Event|0|||
162939409|NCT01725451|588481574|FG000|Period 4|Adverse Event|0|||
162939410|NCT01725451|588481575|FG001|Period 4|Adverse Event|0|||
162939411|NCT01725451|588481576|FG002|Period 4|Adverse Event|1|||
162939412|NCT01725451|588481577|FG003|Period 4|Adverse Event|0|||
162939413|NCT00696709|588481579|FG000|Overall Study|Withdrawal by Subject|1|||
162939414|NCT00696709|588481580|FG001|Overall Study|Withdrawal by Subject|2|||
162939415|NCT00696709|588481581|FG002|Overall Study|Withdrawal by Subject|1|||
162939416|NCT00696709|588481582|FG003|Overall Study|Withdrawal by Subject|4|||
162939417|NCT00696709|588481583|FG004|Overall Study|Withdrawal by Subject|3|||
162939418|NCT00696709|588481579|FG000|Overall Study|Protocol Violation|1|||
162939419|NCT00696709|588481580|FG001|Overall Study|Protocol Violation|0|||
162939420|NCT00696709|588481581|FG002|Overall Study|Protocol Violation|0|||
162939421|NCT00696709|588481582|FG003|Overall Study|Protocol Violation|0|||
162939422|NCT00696709|588481583|FG004|Overall Study|Protocol Violation|0|||
162939423|NCT00696709|588481579|FG000|Overall Study|Lost to Follow-up|1|||
162939424|NCT00696709|588481580|FG001|Overall Study|Lost to Follow-up|1|||
162939425|NCT00696709|588481581|FG002|Overall Study|Lost to Follow-up|0|||
162939426|NCT00696709|588481582|FG003|Overall Study|Lost to Follow-up|0|||
162939427|NCT00696709|588481583|FG004|Overall Study|Lost to Follow-up|0|||
162939428|NCT00696709|588481579|FG000|Overall Study|Adverse Event|0|||
162939429|NCT00696709|588481580|FG001|Overall Study|Adverse Event|0|||
162939430|NCT00696709|588481581|FG002|Overall Study|Adverse Event|0|||
162939431|NCT00696709|588481582|FG003|Overall Study|Adverse Event|1|||
162939432|NCT00696709|588481583|FG004|Overall Study|Adverse Event|0|||
162939433|NCT00310856|588481584|FG000|Overall Study|Withdrawal by Subject|2|||
162939434|NCT00310856|588481585|FG001|Overall Study|Withdrawal by Subject|2|||
162939435|NCT00310856|588481586|FG002|Overall Study|Withdrawal by Subject|2|||
162939436|NCT00310856|588481584|FG000|Overall Study|Lost to Follow-up|1|||
162939437|NCT00310856|588481585|FG001|Overall Study|Lost to Follow-up|2|||
162939438|NCT00310856|588481586|FG002|Overall Study|Lost to Follow-up|6|||
162939439|NCT00310856|588481584|FG000|Overall Study|Inappropriate enrollment|1|||
162939440|NCT00310856|588481585|FG001|Overall Study|Inappropriate enrollment|1|||
162939441|NCT00310856|588481586|FG002|Overall Study|Inappropriate enrollment|0|||
162939442|NCT00310856|588481584|FG000|Overall Study|Unable to classify|1|||
162939443|NCT00310856|588481585|FG001|Overall Study|Unable to classify|0|||
162939444|NCT00310856|588481586|FG002|Overall Study|Unable to classify|0|||
162939445|NCT01306253|588481587|FG000|Overall Study|Lost to Follow-up|1|||
162939446|NCT01306253|588481588|FG001|Overall Study|Lost to Follow-up|1|||
162939447|NCT01261325|588481589|FG000|Overall Study|Lack of Efficacy|1|||
162939448|NCT01261325|588481590|FG001|Overall Study|Lack of Efficacy|1|||
162939449|NCT01261325|588481591|FG002|Overall Study|Lack of Efficacy|0|||
162939450|NCT01261325|588481589|FG000|Overall Study|Withdrawal by Subject|2|||
162939451|NCT01261325|588481590|FG001|Overall Study|Withdrawal by Subject|2|||
162939452|NCT01261325|588481591|FG002|Overall Study|Withdrawal by Subject|4|||
162939453|NCT01261325|588481589|FG000|Overall Study|SAE, non-fatal|1|||
162939454|NCT01261325|588481590|FG001|Overall Study|SAE, non-fatal|5|||
162939455|NCT01261325|588481591|FG002|Overall Study|SAE, non-fatal|1|||
162939456|NCT01261325|588481589|FG000|Overall Study|AE, non-serious non-fatal|9|||
162939457|NCT01261325|588481590|FG001|Overall Study|AE, non-serious non-fatal|15|||
162939458|NCT01261325|588481591|FG002|Overall Study|AE, non-serious non-fatal|13|||
162939459|NCT01261325|588481589|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162939460|NCT01261325|588481590|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162939461|NCT01261325|588481591|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162939462|NCT01261325|588481589|FG000|Overall Study|Non Compliance|2|||
162939463|NCT01261325|588481590|FG001|Overall Study|Non Compliance|0|||
162939464|NCT01261325|588481591|FG002|Overall Study|Non Compliance|0|||
162939465|NCT01261325|588481589|FG000|Overall Study|Patient Randomized by Mistake|0|||
162939466|NCT01261325|588481590|FG001|Overall Study|Patient Randomized by Mistake|1|||
162939467|NCT01261325|588481591|FG002|Overall Study|Patient Randomized by Mistake|0|||
162939468|NCT01261325|588481589|FG000|Overall Study|Erroneously Randomized|1|||
162939469|NCT01261325|588481590|FG001|Overall Study|Erroneously Randomized|0|||
162939470|NCT01261325|588481591|FG002|Overall Study|Erroneously Randomized|0|||
162939471|NCT01261325|588481589|FG000|Overall Study|Screen Failure|1|||
162939472|NCT01261325|588481590|FG001|Overall Study|Screen Failure|0|||
162939473|NCT01261325|588481591|FG002|Overall Study|Screen Failure|0|||
162939474|NCT01261325|588481589|FG000|Overall Study|Randomized in Error|0|||
162939475|NCT01261325|588481590|FG001|Overall Study|Randomized in Error|0|||
162829107|NCT02347098|588086992|FG000|Overall Study|no visit due to illness|2|||
162829108|NCT02347098|588086993|FG001|Overall Study|no visit due to illness|1|||
162829109|NCT04640272|588086994|FG000|Overall Study|Subject moved out of area|1|||
162829110|NCT02535715|588086998|FG000|Overall Study|Withdrawal by Subject|0|||
162829111|NCT02535715|588086999|FG001|Overall Study|Withdrawal by Subject|0|||
162829112|NCT02535715|588087000|FG002|Overall Study|Withdrawal by Subject|1|||
162829113|NCT04353284|588087001|FG000|Overall Study|Adverse Event|1|||
162829114|NCT04353284|588087002|FG001|Overall Study|Adverse Event|1|||
162829115|NCT04353284|588087001|FG000|Overall Study|Lost to Follow-up|1|||
162829116|NCT04353284|588087002|FG001|Overall Study|Lost to Follow-up|0|||
162829117|NCT01438489|588087006|FG000|Overall Study|Lost to Follow-up|4|||
162829118|NCT01438489|588087007|FG001|Overall Study|Lost to Follow-up|2|||
162829119|NCT01438489|588087008|FG002|Overall Study|Lost to Follow-up|2|||
162829120|NCT01438489|588087006|FG000|Overall Study|Withdrawal by Subject|11|||
162829121|NCT01438489|588087007|FG001|Overall Study|Withdrawal by Subject|3|||
162829122|NCT01438489|588087008|FG002|Overall Study|Withdrawal by Subject|8|||
162829123|NCT01438489|588087006|FG000|Overall Study|Death|0|||
162829124|NCT01438489|588087007|FG001|Overall Study|Death|0|||
162829125|NCT01438489|588087008|FG002|Overall Study|Death|1|||
162829126|NCT01438489|588087006|FG000|Overall Study|Sponsor decision|4|||
162829127|NCT01438489|588087007|FG001|Overall Study|Sponsor decision|1|||
162829128|NCT01438489|588087008|FG002|Overall Study|Sponsor decision|4|||
162829129|NCT01438489|588087006|FG000|Overall Study|Subject choice/Subject moved|2|||
162829130|NCT01438489|588087007|FG001|Overall Study|Subject choice/Subject moved|1|||
162829131|NCT01438489|588087008|FG002|Overall Study|Subject choice/Subject moved|1|||
162829132|NCT01438489|588087006|FG000|Overall Study|Investigator decision|0|||
162829133|NCT01438489|588087007|FG001|Overall Study|Investigator decision|1|||
162829134|NCT01438489|588087008|FG002|Overall Study|Investigator decision|0|||
162829135|NCT01438489|588087006|FG000|Overall Study|AE/SAEs|2|||
162829136|NCT01438489|588087007|FG001|Overall Study|AE/SAEs|1|||
162829137|NCT01438489|588087008|FG002|Overall Study|AE/SAEs|1|||
162829138|NCT01438489|588087006|FG000|Overall Study|Received prohibited medication|1|||
162829139|NCT01438489|588087007|FG001|Overall Study|Received prohibited medication|0|||
162829140|NCT01438489|588087008|FG002|Overall Study|Received prohibited medication|0|||
162829141|NCT01438489|588087006|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
162829142|NCT01438489|588087007|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
162829143|NCT01438489|588087008|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
162829144|NCT01438489|588087006|FG000|Overall Study|Inadequate venous access|0|||
162829145|NCT01438489|588087007|FG001|Overall Study|Inadequate venous access|2|||
162829146|NCT01438489|588087008|FG002|Overall Study|Inadequate venous access|0|||
162829147|NCT00766532|588087009|FG000|Overall Study|Protocol Violation|2|||
162829148|NCT03719690|588087011|FG000|Overall Study|Withdrawal by Subject|5|||
162829149|NCT03719690|588087012|FG001|Overall Study|Withdrawal by Subject|10|||
162829150|NCT03719690|588087011|FG000|Overall Study|Death|40|||
162829151|NCT03719690|588087012|FG001|Overall Study|Death|149|||
162829152|NCT03719690|588087011|FG000|Overall Study|Miscellaneous|12|||
162829153|NCT03719690|588087012|FG001|Overall Study|Miscellaneous|56|||
162829154|NCT03719690|588087011|FG000|Overall Study|Lost to Follow-up|2|||
162829155|NCT03719690|588087012|FG001|Overall Study|Lost to Follow-up|18|||
162829156|NCT03719690|588087011|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
162829157|NCT03719690|588087012|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
162829158|NCT03370120|588087022|FG000|Overall Study|Adverse event, non-fatal|24|||
162829159|NCT03370120|588087022|FG000|Overall Study|Withdrawal by Subject|6|||
162829160|NCT03370120|588087022|FG000|Overall Study|Lost to Follow-up|1|||
162829161|NCT03370120|588087022|FG000|Overall Study|Lack of Efficacy|37|||
162829162|NCT03370120|588087022|FG000|Overall Study|Per sponsor's instructions|1|||
162829163|NCT03370120|588087022|FG000|Overall Study|Study was terminated by parent company UCB|2|||
162829164|NCT03370120|588087022|FG000|Overall Study|The study was ended by the promoter|3|||
162829165|NCT03370120|588087022|FG000|Overall Study|Discontinuation of drug development|3|||
162829166|NCT03370120|588087022|FG000|Overall Study|End of project|2|||
162829167|NCT03370120|588087022|FG000|Overall Study|Premature study closure|2|||
162829168|NCT03370120|588087022|FG000|Overall Study|Premature program termination|1|||
162829169|NCT03370120|588087022|FG000|Overall Study|Premature study termination|7|||
162829170|NCT03370120|588087022|FG000|Overall Study|Trial terminated by sponsor|2|||
162829171|NCT03370120|588087022|FG000|Overall Study|Trial discontinued by sponsor|2|||
162829172|NCT03370120|588087022|FG000|Overall Study|Study ended|15|||
162829173|NCT03370120|588087022|FG000|Overall Study|Clinical trial has been cancelled|1|||
162829174|NCT03370120|588087022|FG000|Overall Study|End of study per sponsor decision|2|||
162829175|NCT03370120|588087022|FG000|Overall Study|Promoter's decision|2|||
162829176|NCT03370120|588087022|FG000|Overall Study|The trial has been suspended|3|||
162829177|NCT03370120|588087022|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
162939476|NCT01261325|588481591|FG002|Overall Study|Randomized in Error|1|||
162939477|NCT01261325|588481589|FG000|Overall Study|Protocol Violation|0|||
162939478|NCT01261325|588481590|FG001|Overall Study|Protocol Violation|3|||
162939479|NCT01261325|588481591|FG002|Overall Study|Protocol Violation|1|||
162939480|NCT01261325|588481589|FG000|Overall Study|Lost to Follow-up|0|||
162939481|NCT01261325|588481590|FG001|Overall Study|Lost to Follow-up|1|||
162939482|NCT01261325|588481591|FG002|Overall Study|Lost to Follow-up|3|||
162939483|NCT01261325|588481589|FG000|Overall Study|AE, serious fatal|0|||
162939484|NCT01261325|588481590|FG001|Overall Study|AE, serious fatal|0|||
162939485|NCT01261325|588481591|FG002|Overall Study|AE, serious fatal|2|||
162939486|NCT02668302|588481592|FG000|Overall Study|Withdrawal by Subject|1|||
162939487|NCT02668302|588481593|FG001|Overall Study|Withdrawal by Subject|0|||
162939488|NCT02619682|588481600|FG000|Overall Study|Withdrawal by Subject|3|||
162939489|NCT02619682|588481600|FG000|Overall Study|Lack of Efficacy|8|||
162939490|NCT02619682|588481600|FG000|Overall Study|new secondary cancer|1|||
162939491|NCT02619682|588481600|FG000|Overall Study|post surgery complications|2|||
162939492|NCT01861522|588481601|FG000|Overall Study|Adverse Event|1|||
162939493|NCT01861522|588481602|FG001|Overall Study|Adverse Event|0|||
162939494|NCT01861522|588481601|FG000|Overall Study|Withdrawal by Subject|2|||
162939495|NCT01861522|588481602|FG001|Overall Study|Withdrawal by Subject|0|||
162939496|NCT00526890|588481603|FG000|Overall Study|Adverse Event|2|||
162939497|NCT01995058|588481604|FG000|Overall Study|Sponsor Decision to terminate study|14|||
162939498|NCT01995058|588481605|FG001|Overall Study|Sponsor Decision to terminate study|12|||
162939499|NCT01995058|588481606|FG002|Overall Study|Sponsor Decision to terminate study|12|||
162939500|NCT01995058|588481607|FG003|Overall Study|Sponsor Decision to terminate study|10|||
162939501|NCT01995058|588481604|FG000|Overall Study|Progressive Disease|0|||
162939502|NCT01995058|588481605|FG001|Overall Study|Progressive Disease|1|||
162939503|NCT01995058|588481606|FG002|Overall Study|Progressive Disease|1|||
162939504|NCT01995058|588481607|FG003|Overall Study|Progressive Disease|1|||
162939505|NCT01995058|588481604|FG000|Overall Study|Adverse Event|0|||
162939506|NCT01995058|588481605|FG001|Overall Study|Adverse Event|0|||
162939507|NCT01995058|588481606|FG002|Overall Study|Adverse Event|0|||
162939508|NCT01995058|588481607|FG003|Overall Study|Adverse Event|1|||
162939509|NCT01995058|588481604|FG000|Overall Study|Lack of Efficacy|0|||
162939510|NCT01995058|588481605|FG001|Overall Study|Lack of Efficacy|0|||
162939511|NCT01995058|588481606|FG002|Overall Study|Lack of Efficacy|0|||
162939512|NCT01995058|588481607|FG003|Overall Study|Lack of Efficacy|1|||
162939513|NCT01995058|588481604|FG000|Overall Study|No Treatment Given|0|||
162939514|NCT01995058|588481605|FG001|Overall Study|No Treatment Given|0|||
162939515|NCT01995058|588481606|FG002|Overall Study|No Treatment Given|0|||
162939516|NCT01995058|588481607|FG003|Overall Study|No Treatment Given|1|||
162939517|NCT03611309|588481610|FG000|Overall Study|Lost to Follow-up|16|||
162939518|NCT03611309|588481611|FG001|Overall Study|Lost to Follow-up|8|||
162939519|NCT03611309|588481610|FG000|Overall Study|Withdrawal by Subject|5|||
162939520|NCT03611309|588481611|FG001|Overall Study|Withdrawal by Subject|5|||
162939521|NCT03611309|588481610|FG000|Overall Study|Physician Decision|0|||
162939522|NCT03611309|588481611|FG001|Overall Study|Physician Decision|2|||
162939523|NCT04128696|588481612|FG000|Overall Study|Lost to Follow-up|3|||
162939524|NCT04128696|588481613|FG001|Overall Study|Lost to Follow-up|7|||
162939525|NCT04128696|588481612|FG000|Overall Study|Withdrawal by Subject|12|||
162939526|NCT04128696|588481613|FG001|Overall Study|Withdrawal by Subject|11|||
162939527|NCT04128696|588481612|FG000|Overall Study|Study Closed/Terminated|26|||
162939528|NCT04128696|588481613|FG001|Overall Study|Study Closed/Terminated|38|||
162939529|NCT04128696|588481612|FG000|Overall Study|Physician Decision|2|||
162939530|NCT04128696|588481613|FG001|Overall Study|Physician Decision|3|||
162939531|NCT03280537|588481618|FG000|Overall Study|Withdrawal by Subject|2|||
162939532|NCT03280537|588481619|FG001|Overall Study|Withdrawal by Subject|4|||
162939533|NCT01588106|588481620|FG000|Overall Study|Withdrawal by Subject|5|||
162939534|NCT01588106|588481621|FG001|Overall Study|Withdrawal by Subject|4|||
162939535|NCT03083132|588481622|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
162939536|NCT03083132|588481623|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
162939537|NCT03083132|588481622|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
162939538|NCT03083132|588481623|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
162939539|NCT03083132|588481622|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
162939540|NCT03083132|588481623|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
162939541|NCT03118739|588481624|FG000|Overall Study|Physician Decision|0|||
162939542|NCT03118739|588481625|FG001|Overall Study|Physician Decision|1|||
162939543|NCT03118739|588481624|FG000|Overall Study|Withdrawal by Subject|5|||
162939544|NCT03118739|588481625|FG001|Overall Study|Withdrawal by Subject|3|||
162939545|NCT03118739|588481624|FG000|Overall Study|Lost to Follow-up|2|||
162939546|NCT03118739|588481625|FG001|Overall Study|Lost to Follow-up|0|||
162939547|NCT02995837|588481626|FG000|Overall Study|Lost to Follow-up|9|||
162939548|NCT02995837|588481627|FG001|Overall Study|Lost to Follow-up|8|||
162939549|NCT01859702|588481628|FG000|Overall Study|Protocol deviation|3|||
162939550|NCT01859702|588481628|FG000|Overall Study|Adverse Event|2|||
162939551|NCT01893138|588481629|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162939552|NCT01893138|588481630|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162939553|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
162939554|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
162939555|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
162939556|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
162939557|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
162939558|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
162939559|NCT01893138|588481629|FG000|Open Label - Unblinded Period|Adverse Event|1|||
162939560|NCT01893138|588481630|FG001|Open Label - Unblinded Period|Adverse Event|0|||
162939561|NCT01326026|588481631|FG000|Overall Study|Adverse Event|4|||
162939562|NCT01326026|588481632|FG001|Overall Study|Adverse Event|3|||
162939563|NCT01326026|588481631|FG000|Overall Study|Withdrawal Criteria|5|||
162939564|NCT01326026|588481632|FG001|Overall Study|Withdrawal Criteria|7|||
162939565|NCT01326026|588481631|FG000|Overall Study|Other|3|||
162939566|NCT01326026|588481632|FG001|Overall Study|Other|3|||
162939567|NCT03996005|588481635|FG000|Overall Study|Withdrawal by Subject|1|||
162939568|NCT00289458|588481636|FG000|Overall Study|Death|1|||
162939569|NCT00289458|588481637|FG001|Overall Study|Death|0|||
162939570|NCT00289458|588481638|FG002|Overall Study|Death|0|||
162939571|NCT00289458|588481636|FG000|Overall Study|Physician Decision|3|||
162939572|NCT00289458|588481637|FG001|Overall Study|Physician Decision|4|||
162939573|NCT00289458|588481638|FG002|Overall Study|Physician Decision|2|||
162939574|NCT00289458|588481636|FG000|Overall Study|Withdrawal by Subject|2|||
162939575|NCT00289458|588481637|FG001|Overall Study|Withdrawal by Subject|2|||
162939576|NCT00289458|588481638|FG002|Overall Study|Withdrawal by Subject|4|||
162939577|NCT04274192|588481639|FG000|Overall Study|Protocol Violation|1|||
162939578|NCT04274192|588481640|FG001|Overall Study|Protocol Violation|0|||
162939579|NCT07174544|588481641|FG000|Overall Study|Lost to Follow-up|43|||
162939580|NCT07174544|588481642|FG001|Overall Study|Lost to Follow-up|15|||
162939581|NCT03419234|588481643|FG000|Overall Study|Disease progression|37|||
162939582|NCT03419234|588481644|FG001|Overall Study|Disease progression|36|||
162939583|NCT03419234|588481643|FG000|Overall Study|Adverse Event|6|||
162939584|NCT03419234|588481644|FG001|Overall Study|Adverse Event|9|||
162939585|NCT03419234|588481643|FG000|Overall Study|Withdrawal by Subject|9|||
162939586|NCT03419234|588481644|FG001|Overall Study|Withdrawal by Subject|7|||
162939587|NCT03419234|588481643|FG000|Overall Study|Death|5|||
162939588|NCT03419234|588481644|FG001|Overall Study|Death|1|||
162939589|NCT03419234|588481643|FG000|Overall Study|Alternative therapy|4|||
162939590|NCT03419234|588481644|FG001|Overall Study|Alternative therapy|2|||
162939591|NCT03419234|588481643|FG000|Overall Study|PSA progression|8|||
162939592|NCT03419234|588481644|FG001|Overall Study|PSA progression|10|||
162939593|NCT03419234|588481643|FG000|Overall Study|Rising PSA and bone issues|3|||
162939594|NCT03419234|588481644|FG001|Overall Study|Rising PSA and bone issues|2|||
162939595|NCT03419234|588481643|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
162939596|NCT03419234|588481644|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
162939597|NCT03419234|588481643|FG000|Overall Study|Physician Decision|12|||
162939598|NCT03419234|588481644|FG001|Overall Study|Physician Decision|11|||
162939599|NCT03419234|588481643|FG000|Overall Study|Second malignancy|1|||
162939600|NCT03419234|588481644|FG001|Overall Study|Second malignancy|0|||
162939601|NCT03419234|588481643|FG000|Overall Study|Insurance status change/patient could not afford|2|||
162939602|NCT03419234|588481644|FG001|Overall Study|Insurance status change/patient could not afford|1|||
162939603|NCT03419234|588481643|FG000|Overall Study|Non-compliance|1|||
162939604|NCT03419234|588481644|FG001|Overall Study|Non-compliance|3|||
162939605|NCT03419234|588481643|FG000|Overall Study|Mistakenly off treatment|1|||
162939606|NCT03419234|588481644|FG001|Overall Study|Mistakenly off treatment|0|||
162939607|NCT03419234|588481643|FG000|Overall Study|Transition to hospice|1|||
162939608|NCT03419234|588481644|FG001|Overall Study|Transition to hospice|0|||
162939609|NCT03419234|588481643|FG000|Overall Study|Still on treatment|9|||
162939610|NCT03419234|588481644|FG001|Overall Study|Still on treatment|8|||
162939611|NCT03419234|588481643|FG000|Overall Study|Never received protocol therapy|2|||
162939612|NCT03419234|588481644|FG001|Overall Study|Never received protocol therapy|4|||
162939613|NCT03419234|588481643|FG000|Overall Study|Other complicating disease|0|||
162939614|NCT03419234|588481644|FG001|Overall Study|Other complicating disease|1|||
162939615|NCT03419234|588481643|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
162939616|NCT03419234|588481644|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
162939617|NCT00101582|588482938|FG000|Overall Study|Ineligibility determined|0|||
162939618|NCT00101582|588482939|FG001|Overall Study|Ineligibility determined|1|||
162939619|NCT00101582|588482938|FG000|Overall Study|Adverse Event|1|||
162939620|NCT00101582|588482939|FG001|Overall Study|Adverse Event|4|||
162939621|NCT00101582|588482938|FG000|Overall Study|Withdrawal by Subject|6|||
162939622|NCT00101582|588482939|FG001|Overall Study|Withdrawal by Subject|4|||
162939623|NCT00101582|588482938|FG000|Overall Study|Physician Decision|1|||
162939624|NCT00101582|588482939|FG001|Overall Study|Physician Decision|0|||
162939625|NCT00101582|588482938|FG000|Overall Study|Death|3|||
162939626|NCT00101582|588482939|FG001|Overall Study|Death|5|||
162939627|NCT00101582|588482938|FG000|Overall Study|Other|0|||
162939628|NCT00101582|588482939|FG001|Overall Study|Other|1|||
162939629|NCT01907087|588482940|FG000|Overall Study|Withdrawal by Subject|1|||
162939630|NCT01919190|588482941|FG000|Overall Study|Intra-op findings, etc.|3|||
162939631|NCT01919190|588482942|FG001|Overall Study|Intra-op findings, etc.|0|||
162939632|NCT03355742|588482943|FG000|Overall Study|Lost to Follow-up|4|||
162939633|NCT03355742|588482943|FG000|Overall Study|Withdrawal by Subject|29|||
162939634|NCT03355742|588482943|FG000|Overall Study|Physician Decision|6|||
162939635|NCT03355742|588482943|FG000|Overall Study|Death|55|||
162939636|NCT03355742|588482943|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
162939637|NCT02207621|588482945|FG000|Overall Study|Adverse Event|71|||
162939638|NCT02207621|588482946|FG001|Overall Study|Adverse Event|15|||
162939639|NCT02207621|588482947|FG002|Overall Study|Adverse Event|132|||
162939640|NCT02207621|588482945|FG000|Overall Study|Withdrawal by Subject|9|||
162939641|NCT02207621|588482946|FG001|Overall Study|Withdrawal by Subject|9|||
162939642|NCT02207621|588482947|FG002|Overall Study|Withdrawal by Subject|13|||
162939643|NCT02207621|588482945|FG000|Overall Study|Non-Compliant|3|||
162939644|NCT02207621|588482946|FG001|Overall Study|Non-Compliant|3|||
162939645|NCT02207621|588482947|FG002|Overall Study|Non-Compliant|1|||
162939646|NCT02207621|588482945|FG000|Overall Study|Lost to Follow-up|1|||
162939647|NCT02207621|588482946|FG001|Overall Study|Lost to Follow-up|0|||
162939648|NCT02207621|588482947|FG002|Overall Study|Lost to Follow-up|3|||
162939649|NCT02207621|588482945|FG000|Overall Study|Lack of Efficacy|10|||
162939650|NCT02207621|588482946|FG001|Overall Study|Lack of Efficacy|2|||
162939651|NCT02207621|588482947|FG002|Overall Study|Lack of Efficacy|4|||
162939652|NCT02207621|588482945|FG000|Overall Study|Disallowed Concurrent Medication|2|||
162939653|NCT02207621|588482946|FG001|Overall Study|Disallowed Concurrent Medication|5|||
162939654|NCT02207621|588482947|FG002|Overall Study|Disallowed Concurrent Medication|2|||
162939655|NCT02207621|588482945|FG000|Overall Study|Physician Decision|1|||
162939656|NCT02207621|588482946|FG001|Overall Study|Physician Decision|2|||
162939657|NCT02207621|588482947|FG002|Overall Study|Physician Decision|2|||
162939658|NCT02207621|588482945|FG000|Overall Study|Protocol Violation|4|||
162939659|NCT02207621|588482946|FG001|Overall Study|Protocol Violation|10|||
162939660|NCT02207621|588482947|FG002|Overall Study|Protocol Violation|6|||
162939661|NCT02207621|588482945|FG000|Overall Study|Death|2|||
162939662|NCT02207621|588482946|FG001|Overall Study|Death|0|||
162939663|NCT02207621|588482947|FG002|Overall Study|Death|0|||
162939664|NCT02207621|588482945|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
162939665|NCT02207621|588482946|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
162939666|NCT02207621|588482947|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
162939667|NCT02623959|588482948|FG000|Overall Study|Progression|0|||
162939668|NCT02623959|588482949|FG001|Overall Study|Progression|1|||
162939669|NCT00135707|588482950|FG000|Overall Study|Lost to Follow-up|94|||
162939670|NCT00135707|588482951|FG001|Overall Study|Lost to Follow-up|89|||
162939671|NCT00135707|588482950|FG000|Overall Study|Withdrawal by Subject|0|||
162939672|NCT00135707|588482951|FG001|Overall Study|Withdrawal by Subject|1|||
162939673|NCT00135707|588482950|FG000|Overall Study|Institutional review board request|1|||
162939674|NCT00135707|588482951|FG001|Overall Study|Institutional review board request|0|||
162939675|NCT00635778|588482955|FG000|Overall Study|Adverse Event|1|||
162939676|NCT00635778|588482956|FG001|Overall Study|Adverse Event|0|||
162939677|NCT00635778|588482957|FG002|Overall Study|Adverse Event|0|||
162939678|NCT00635778|588482958|FG003|Overall Study|Adverse Event|3|||
162939679|NCT00635778|588482959|FG004|Overall Study|Adverse Event|3|||
162939680|NCT00635778|588482960|FG005|Overall Study|Adverse Event|6|||
162939681|NCT00635778|588482961|FG006|Overall Study|Adverse Event|1|||
162939682|NCT00635778|588482955|FG000|Overall Study|Withdrawal by Subject|0|||
162939683|NCT00635778|588482956|FG001|Overall Study|Withdrawal by Subject|0|||
162939684|NCT00635778|588482957|FG002|Overall Study|Withdrawal by Subject|0|||
162939685|NCT00635778|588482958|FG003|Overall Study|Withdrawal by Subject|1|||
162939686|NCT00635778|588482959|FG004|Overall Study|Withdrawal by Subject|0|||
162939687|NCT00635778|588482960|FG005|Overall Study|Withdrawal by Subject|1|||
162939688|NCT00635778|588482961|FG006|Overall Study|Withdrawal by Subject|1|||
162939689|NCT00635778|588482955|FG000|Overall Study|Progressive disease|0|||
162939690|NCT00635778|588482956|FG001|Overall Study|Progressive disease|3|||
162939691|NCT00635778|588482957|FG002|Overall Study|Progressive disease|3|||
162939692|NCT00635778|588482958|FG003|Overall Study|Progressive disease|4|||
162939693|NCT00635778|588482959|FG004|Overall Study|Progressive disease|5|||
162939694|NCT00635778|588482960|FG005|Overall Study|Progressive disease|14|||
162939695|NCT00635778|588482961|FG006|Overall Study|Progressive disease|4|||
162939696|NCT00812253|588482962|FG000|Overall Study|Withdrawal by Subject|3|||
162939697|NCT00812253|588482963|FG001|Overall Study|Withdrawal by Subject|2|||
162939698|NCT00812253|588482962|FG000|Overall Study|Protocol Violation|1|||
162939699|NCT00812253|588482963|FG001|Overall Study|Protocol Violation|1|||
162939700|NCT00812253|588482962|FG000|Overall Study|Lost to Follow-up|2|||
162939701|NCT00812253|588482963|FG001|Overall Study|Lost to Follow-up|0|||
162939702|NCT04903288|588482964|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
162939703|NCT04903288|588482964|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
162939704|NCT04903288|588482964|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
162939705|NCT04903288|588482964|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
162939706|NCT00634907|588482974|FG000|Overall Study|Withdrawal by Subject|3|||
162939707|NCT00634907|588482975|FG001|Overall Study|Withdrawal by Subject|0|||
162939708|NCT00634907|588482974|FG000|Overall Study|Physician Decision|3|||
162939709|NCT00634907|588482975|FG001|Overall Study|Physician Decision|9|||
162939710|NCT00634907|588482974|FG000|Overall Study|Withdrawal by Subject|11|||
162939711|NCT00634907|588482975|FG001|Overall Study|Withdrawal by Subject|8|||
162939712|NCT01180244|588482982|FG000|Overall Study|Lack of Efficacy|0|||
162939713|NCT01180244|588482983|FG001|Overall Study|Lack of Efficacy|7|||
162939714|NCT01180244|588482982|FG000|Overall Study|Physician Decision|3|||
162939715|NCT01180244|588482983|FG001|Overall Study|Physician Decision|0|||
162939716|NCT01180244|588482982|FG000|Overall Study|Adverse Event|1|||
162939717|NCT01180244|588482983|FG001|Overall Study|Adverse Event|0|||
162939718|NCT01180244|588482982|FG000|Overall Study|Withdrawal by Subject|0|||
162939719|NCT01180244|588482983|FG001|Overall Study|Withdrawal by Subject|1|||
162939720|NCT01180244|588482982|FG000|Overall Study|Protocol Violation|1|||
162939721|NCT01180244|588482983|FG001|Overall Study|Protocol Violation|0|||
162939722|NCT01180244|588482982|FG000|Overall Study|Lost to Follow-up|1|||
162939723|NCT01180244|588482983|FG001|Overall Study|Lost to Follow-up|0|||
162939724|NCT01338636|588482984|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
162939725|NCT01689974|588482990|FG000|Overall Study|Termination of Study|5|||
162939726|NCT01689974|588482991|FG001|Overall Study|Termination of Study|5|||
162939727|NCT00681863|588482992|FG000|Overall Study|Adverse Event|1|||
162939728|NCT00681863|588482992|FG000|Overall Study|Lost to Follow-up|2|||
162939729|NCT00681863|588482992|FG000|Overall Study|Lack of Efficacy|2|||
162939730|NCT00681863|588482992|FG000|Overall Study|Other|18|||
162939731|NCT01388647|588482995|FG000|Overall Study|Adverse Event|1|||
162939732|NCT01388647|588482996|FG001|Overall Study|Adverse Event|2|||
162939733|NCT01006707|588482997|FG000|Study Session 1|Lost to Follow-up|2|||
162939734|NCT01006707|588482998|FG001|Study Session 1|Lost to Follow-up|0|||
162939735|NCT01006707|588482999|FG002|Study Session 1|Lost to Follow-up|0|||
162939736|NCT01006707|588482997|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
162939737|NCT01006707|588482998|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
162939738|NCT01006707|588482999|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
162939739|NCT01336894|588483002|FG000|Follow-up|Study terminated prematurely|2|||
162939740|NCT01336894|588483003|FG001|Follow-up|Study terminated prematurely|7|||
162939741|NCT03937466|588483004|FG000|Overall Study|not eligbile after the 2-week diary|9|||
162939742|NCT03937466|588483004|FG000|Overall Study|never returned their diary|6|||
162939743|NCT03937466|588483004|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
162939744|NCT03937466|588483004|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
162939745|NCT00622908|588483005|FG000|Overall Study|Protocol Violation|1|||
162939746|NCT00622908|588483006|FG001|Overall Study|Protocol Violation|0|||
162939747|NCT00622908|588483005|FG000|Overall Study|Adverse Event|0|||
162939748|NCT00622908|588483006|FG001|Overall Study|Adverse Event|1|||
162939749|NCT00622908|588483005|FG000|Overall Study|Lack of Efficacy|1|||
162939750|NCT00622908|588483006|FG001|Overall Study|Lack of Efficacy|7|||
162939751|NCT00622908|588483005|FG000|Overall Study|Lost to Follow-up|1|||
162939752|NCT00622908|588483006|FG001|Overall Study|Lost to Follow-up|0|||
162939753|NCT00622908|588483005|FG000|Overall Study|Refusal|0|||
162939754|NCT00622908|588483006|FG001|Overall Study|Refusal|1|||
162939755|NCT00622908|588483005|FG000|Overall Study|Termination by study sponser|0|||
162939756|NCT00622908|588483006|FG001|Overall Study|Termination by study sponser|1|||
162939757|NCT00358826|588483012|FG000|Core Study|Adverse Event|1|||
162939758|NCT00358826|588483013|FG001|Core Study|Adverse Event|3|||
162939759|NCT00358826|588483014|FG002|Core Study|Adverse Event|1|||
162939760|NCT00358826|588483015|FG003|Core Study|Adverse Event|1|||
162939761|NCT00358826|588483016|FG004|Core Study|Adverse Event|0|||
162939762|NCT00358826|588483017|FG005|Core Study|Adverse Event|0|||
162939763|NCT00358826|588483018|FG006|Core Study|Adverse Event|0|||
162939764|NCT00358826|588483019|FG007|Core Study|Adverse Event|0|||
162939765|NCT00358826|588483012|FG000|Core Study|Withdrawal by Subject|2|||
162939766|NCT00358826|588483013|FG001|Core Study|Withdrawal by Subject|2|||
162939767|NCT00358826|588483014|FG002|Core Study|Withdrawal by Subject|0|||
162939768|NCT00358826|588483015|FG003|Core Study|Withdrawal by Subject|0|||
162939769|NCT00358826|588483016|FG004|Core Study|Withdrawal by Subject|0|||
162939770|NCT00358826|588483017|FG005|Core Study|Withdrawal by Subject|0|||
162939771|NCT00358826|588483018|FG006|Core Study|Withdrawal by Subject|0|||
162939772|NCT00358826|588483019|FG007|Core Study|Withdrawal by Subject|0|||
162939773|NCT00358826|588483012|FG000|Core Study|Lost to Follow-up|0|||
162939774|NCT00358826|588483013|FG001|Core Study|Lost to Follow-up|0|||
162939775|NCT00358826|588483014|FG002|Core Study|Lost to Follow-up|0|||
162939776|NCT00358826|588483015|FG003|Core Study|Lost to Follow-up|1|||
162939777|NCT00358826|588483016|FG004|Core Study|Lost to Follow-up|0|||
162939778|NCT00358826|588483017|FG005|Core Study|Lost to Follow-up|0|||
162939779|NCT00358826|588483018|FG006|Core Study|Lost to Follow-up|0|||
162939780|NCT00358826|588483019|FG007|Core Study|Lost to Follow-up|0|||
162939781|NCT00358826|588483012|FG000|Core Study|Physician Decision|0|||
162939782|NCT00358826|588483013|FG001|Core Study|Physician Decision|0|||
162939783|NCT00358826|588483014|FG002|Core Study|Physician Decision|1|||
162939784|NCT00358826|588483015|FG003|Core Study|Physician Decision|0|||
162939785|NCT00358826|588483016|FG004|Core Study|Physician Decision|0|||
162939786|NCT00358826|588483017|FG005|Core Study|Physician Decision|0|||
162939787|NCT00358826|588483018|FG006|Core Study|Physician Decision|0|||
162939788|NCT00358826|588483019|FG007|Core Study|Physician Decision|0|||
162939789|NCT00358826|588483012|FG000|MDCT Substudy|Adverse Event|0|||
162939790|NCT00358826|588483013|FG001|MDCT Substudy|Adverse Event|0|||
162939791|NCT00358826|588483014|FG002|MDCT Substudy|Adverse Event|0|||
162939792|NCT00358826|588483015|FG003|MDCT Substudy|Adverse Event|0|||
162939793|NCT00358826|588483016|FG004|MDCT Substudy|Adverse Event|1|||
162939794|NCT00358826|588483017|FG005|MDCT Substudy|Adverse Event|0|||
162939795|NCT00358826|588483018|FG006|MDCT Substudy|Adverse Event|0|||
162939796|NCT00358826|588483019|FG007|MDCT Substudy|Adverse Event|0|||
162939797|NCT00358826|588483012|FG000|MDCT Substudy|Lost to Follow-up|0|||
162939798|NCT00358826|588483013|FG001|MDCT Substudy|Lost to Follow-up|0|||
162939799|NCT00358826|588483014|FG002|MDCT Substudy|Lost to Follow-up|0|||
162939800|NCT00358826|588483015|FG003|MDCT Substudy|Lost to Follow-up|0|||
162939801|NCT00358826|588483016|FG004|MDCT Substudy|Lost to Follow-up|0|||
162939802|NCT00358826|588483017|FG005|MDCT Substudy|Lost to Follow-up|1|||
162939803|NCT00358826|588483018|FG006|MDCT Substudy|Lost to Follow-up|0|||
162939804|NCT00358826|588483019|FG007|MDCT Substudy|Lost to Follow-up|0|||
162939805|NCT00358826|588483012|FG000|MDCT Substudy|Withdrawal by Subject|0|||
162939806|NCT00358826|588483013|FG001|MDCT Substudy|Withdrawal by Subject|0|||
162939807|NCT00358826|588483014|FG002|MDCT Substudy|Withdrawal by Subject|0|||
162939808|NCT00358826|588483015|FG003|MDCT Substudy|Withdrawal by Subject|0|||
162939809|NCT00358826|588483016|FG004|MDCT Substudy|Withdrawal by Subject|0|||
162939810|NCT00358826|588483017|FG005|MDCT Substudy|Withdrawal by Subject|1|||
162939811|NCT00358826|588483018|FG006|MDCT Substudy|Withdrawal by Subject|0|||
162939812|NCT00358826|588483019|FG007|MDCT Substudy|Withdrawal by Subject|0|||
162939813|NCT00283686|588483020|FG000|Overall Study|Death|1|||
162939814|NCT00283686|588483021|FG001|Overall Study|Death|1|||
162939815|NCT00283686|588483022|FG002|Overall Study|Death|1|||
162939816|NCT00283686|588483023|FG003|Overall Study|Death|0|||
162939817|NCT00283686|588483020|FG000|Overall Study|Lost to Follow-up|21|||
162939818|NCT00283686|588483021|FG001|Overall Study|Lost to Follow-up|31|||
162939819|NCT00283686|588483022|FG002|Overall Study|Lost to Follow-up|26|||
162939820|NCT00283686|588483023|FG003|Overall Study|Lost to Follow-up|20|||
162939821|NCT00283686|588483020|FG000|Overall Study|Less than full participation|7|||
162939822|NCT00283686|588483021|FG001|Overall Study|Less than full participation|9|||
162939823|NCT00283686|588483022|FG002|Overall Study|Less than full participation|6|||
162939824|NCT00283686|588483023|FG003|Overall Study|Less than full participation|12|||
162939825|NCT00543439|588483024|FG000|Period 1|Adverse Event|0|||
162939826|NCT00543439|588483025|FG001|Period 1|Adverse Event|2|||
162939827|NCT00543439|588483026|FG002|Period 1|Adverse Event|1|||
162939828|NCT00543439|588483024|FG000|Period 1|Withdrawal by Subject|1|||
162939829|NCT00543439|588483025|FG001|Period 1|Withdrawal by Subject|1|||
162939830|NCT00543439|588483026|FG002|Period 1|Withdrawal by Subject|0|||
162939831|NCT00543439|588483024|FG000|Period 1|Physician Decision|0|||
162939832|NCT00543439|588483025|FG001|Period 1|Physician Decision|0|||
162939833|NCT00543439|588483026|FG002|Period 1|Physician Decision|1|||
162939834|NCT00543439|588483024|FG000|Period 2|Protocol Violation|1|||
162939835|NCT00543439|588483025|FG001|Period 2|Protocol Violation|0|||
162939836|NCT00543439|588483026|FG002|Period 2|Protocol Violation|1|||
162939837|NCT00543439|588483024|FG000|Period 2|Adverse Event|0|||
162939838|NCT00543439|588483025|FG001|Period 2|Adverse Event|1|||
162939839|NCT00543439|588483026|FG002|Period 2|Adverse Event|1|||
162939840|NCT03264066|588483029|FG000|Overall Study|Adverse Event|1|||
162939841|NCT03264066|588483030|FG001|Overall Study|Adverse Event|1|||
162939842|NCT03264066|588483031|FG002|Overall Study|Adverse Event|0|||
162939843|NCT03264066|588483032|FG003|Overall Study|Adverse Event|0|||
162939844|NCT03264066|588483033|FG004|Overall Study|Adverse Event|0|||
162939845|NCT03264066|588483034|FG005|Overall Study|Adverse Event|0|||
162939846|NCT03264066|588483029|FG000|Overall Study|Death|12|||
162939847|NCT03264066|588483030|FG001|Overall Study|Death|12|||
162939848|NCT03264066|588483031|FG002|Overall Study|Death|8|||
162939849|NCT03264066|588483032|FG003|Overall Study|Death|10|||
162939850|NCT03264066|588483033|FG004|Overall Study|Death|6|||
162939851|NCT03264066|588483034|FG005|Overall Study|Death|1|||
162939852|NCT03264066|588483029|FG000|Overall Study|Lost to Follow-up|1|||
162939853|NCT03264066|588483030|FG001|Overall Study|Lost to Follow-up|0|||
162939854|NCT03264066|588483031|FG002|Overall Study|Lost to Follow-up|0|||
162939855|NCT03264066|588483032|FG003|Overall Study|Lost to Follow-up|0|||
162939856|NCT03264066|588483033|FG004|Overall Study|Lost to Follow-up|0|||
162939857|NCT03264066|588483034|FG005|Overall Study|Lost to Follow-up|0|||
162939858|NCT03264066|588483029|FG000|Overall Study|Progressive Disease|0|||
162939859|NCT03264066|588483030|FG001|Overall Study|Progressive Disease|2|||
162939860|NCT03264066|588483031|FG002|Overall Study|Progressive Disease|1|||
162939861|NCT03264066|588483032|FG003|Overall Study|Progressive Disease|0|||
162939862|NCT03264066|588483033|FG004|Overall Study|Progressive Disease|0|||
162939863|NCT03264066|588483034|FG005|Overall Study|Progressive Disease|0|||
162939864|NCT03264066|588483029|FG000|Overall Study|Study Terminated by Sponsor|5|||
162939865|NCT03264066|588483030|FG001|Overall Study|Study Terminated by Sponsor|5|||
162939866|NCT03264066|588483031|FG002|Overall Study|Study Terminated by Sponsor|8|||
162939867|NCT03264066|588483032|FG003|Overall Study|Study Terminated by Sponsor|5|||
162939868|NCT03264066|588483033|FG004|Overall Study|Study Terminated by Sponsor|1|||
162939869|NCT03264066|588483034|FG005|Overall Study|Study Terminated by Sponsor|2|||
162939870|NCT03264066|588483029|FG000|Overall Study|Withdrawal by Subject|1|||
162939871|NCT03264066|588483030|FG001|Overall Study|Withdrawal by Subject|0|||
162939872|NCT03264066|588483031|FG002|Overall Study|Withdrawal by Subject|0|||
162939873|NCT03264066|588483032|FG003|Overall Study|Withdrawal by Subject|5|||
162939874|NCT03264066|588483033|FG004|Overall Study|Withdrawal by Subject|0|||
162939875|NCT03264066|588483034|FG005|Overall Study|Withdrawal by Subject|0|||
162939876|NCT01484028|588483035|FG000|Period 1|Lost to Follow-up|0|||
162939877|NCT01484028|588483036|FG001|Period 1|Lost to Follow-up|1|||
162939878|NCT01484028|588483037|FG002|Period 1|Lost to Follow-up|0|||
162939879|NCT01484028|588483038|FG003|Period 1|Lost to Follow-up|0|||
162939880|NCT01484028|588483035|FG000|Period 1|Non-Compliance to Protocol|0|||
162939881|NCT01484028|588483036|FG001|Period 1|Non-Compliance to Protocol|1|||
162939882|NCT01484028|588483037|FG002|Period 1|Non-Compliance to Protocol|0|||
162939883|NCT01484028|588483038|FG003|Period 1|Non-Compliance to Protocol|1|||
162939884|NCT01484028|588483035|FG000|Period 1|Lens Discomfort|0|||
162939885|NCT01484028|588483036|FG001|Period 1|Lens Discomfort|1|||
162939886|NCT01484028|588483037|FG002|Period 1|Lens Discomfort|0|||
162939887|NCT01484028|588483038|FG003|Period 1|Lens Discomfort|0|||
162939888|NCT00146770|588483054|FG000|Overall Study|Adverse Event|2|||
162939889|NCT00146770|588483055|FG001|Overall Study|Adverse Event|0|||
162939890|NCT00146770|588483054|FG000|Overall Study|Pregnancy|1|||
162939891|NCT00146770|588483055|FG001|Overall Study|Pregnancy|0|||
162939892|NCT00146770|588483054|FG000|Overall Study|Withdrawal by Subject|2|||
162939893|NCT00146770|588483055|FG001|Overall Study|Withdrawal by Subject|0|||
162939894|NCT02826603|588483058|FG000|Overall Study|Adverse Event|17|||
162939895|NCT02826603|588483059|FG001|Overall Study|Adverse Event|9|||
162939896|NCT02826603|588483058|FG000|Overall Study|Lack of Efficacy|4|||
162939897|NCT02826603|588483059|FG001|Overall Study|Lack of Efficacy|9|||
162939898|NCT02826603|588483058|FG000|Overall Study|Lost to Follow-up|13|||
162939899|NCT02826603|588483059|FG001|Overall Study|Lost to Follow-up|12|||
162939900|NCT02826603|588483058|FG000|Overall Study|Noncompliance with treatment|0|||
162939901|NCT02826603|588483059|FG001|Overall Study|Noncompliance with treatment|2|||
162939902|NCT02826603|588483058|FG000|Overall Study|Physician Decision|1|||
162939903|NCT02826603|588483059|FG001|Overall Study|Physician Decision|7|||
162939904|NCT02826603|588483058|FG000|Overall Study|Pregnancy|1|||
162939905|NCT02826603|588483059|FG001|Overall Study|Pregnancy|2|||
162939906|NCT02826603|588483058|FG000|Overall Study|Protocol Violation|3|||
162939907|NCT02826603|588483059|FG001|Overall Study|Protocol Violation|3|||
162939908|NCT02826603|588483058|FG000|Overall Study|Withdrawal by Subject|20|||
162939909|NCT02826603|588483059|FG001|Overall Study|Withdrawal by Subject|19|||
162939910|NCT02826603|588483058|FG000|Overall Study|Death|2|||
162939911|NCT02826603|588483059|FG001|Overall Study|Death|0|||
162939912|NCT02826603|588483058|FG000|Overall Study|New therapy for study indication|0|||
162939913|NCT02826603|588483059|FG001|Overall Study|New therapy for study indication|1|||
162939914|NCT00905489|588483060|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
162939915|NCT00905489|588483060|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
162939916|NCT00905489|588483060|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
162939917|NCT00583596|588483061|FG000|Overall Study|Lost to Follow-up|110|||
162939918|NCT00583596|588483061|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
162939919|NCT00583596|588483061|FG000|Overall Study|Death|2|||
162939920|NCT00583596|588483061|FG000|Overall Study|Withdrawal by Subject|6|||
162939921|NCT00583596|588483061|FG000|Overall Study|Lost to Follow-up|94|||
162939922|NCT00583596|588483061|FG000|Overall Study|Data not complete|1|||
162939923|NCT00583596|588483061|FG000|Overall Study|Not consented|15|||
162939924|NCT00583596|588483061|FG000|Overall Study|Outside f-up window|26|||
162939925|NCT03558997|588483062|FG000|Overall Study|Adverse Event|0|||
162939926|NCT03558997|588483063|FG001|Overall Study|Adverse Event|2|||
162939927|NCT03558997|588483064|FG002|Overall Study|Adverse Event|5|||
162939928|NCT03558997|588483065|FG003|Overall Study|Adverse Event|1|||
162939929|NCT03558997|588483062|FG000|Overall Study|Physician Decision|0|||
162939930|NCT03558997|588483063|FG001|Overall Study|Physician Decision|0|||
162939931|NCT03558997|588483064|FG002|Overall Study|Physician Decision|1|||
162939932|NCT03558997|588483065|FG003|Overall Study|Physician Decision|0|||
162939933|NCT03558997|588483062|FG000|Overall Study|Withdrawal by Subject|1|||
162939934|NCT03558997|588483063|FG001|Overall Study|Withdrawal by Subject|0|||
162939935|NCT03558997|588483064|FG002|Overall Study|Withdrawal by Subject|1|||
162939936|NCT03558997|588483065|FG003|Overall Study|Withdrawal by Subject|1|||
162939937|NCT03558997|588483062|FG000|Overall Study|Lost to Follow-up|0|||
162939938|NCT03558997|588483063|FG001|Overall Study|Lost to Follow-up|0|||
162939939|NCT03558997|588483064|FG002|Overall Study|Lost to Follow-up|1|||
162939940|NCT03558997|588483065|FG003|Overall Study|Lost to Follow-up|0|||
162939941|NCT04567615|588483075|FG000|Randomization|Participant withdrew consent|1|||
162939942|NCT04567615|588483076|FG001|Randomization|Participant withdrew consent|0|||
162939943|NCT04567615|588483077|FG002|Randomization|Participant withdrew consent|0|||
162939944|NCT04567615|588483075|FG000|Randomization|Adverse event unrelated to study drug|0|||
162939945|NCT04567615|588483076|FG001|Randomization|Adverse event unrelated to study drug|1|||
162939946|NCT04567615|588483077|FG002|Randomization|Adverse event unrelated to study drug|0|||
162939947|NCT04567615|588483075|FG000|Treatment Period|Participant Withdrew Consent|2|||
162939948|NCT04567615|588483076|FG001|Treatment Period|Participant Withdrew Consent|5|||
162939949|NCT04567615|588483077|FG002|Treatment Period|Participant Withdrew Consent|1|||
162939950|NCT04567615|588483075|FG000|Treatment Period|Death|1|||
162939951|NCT04567615|588483076|FG001|Treatment Period|Death|2|||
162939952|NCT04567615|588483077|FG002|Treatment Period|Death|0|||
162939953|NCT04567615|588483075|FG000|Treatment Period|Lost to Follow-up|0|||
162939954|NCT04567615|588483076|FG001|Treatment Period|Lost to Follow-up|1|||
162939955|NCT04567615|588483077|FG002|Treatment Period|Lost to Follow-up|0|||
162939956|NCT04567615|588483075|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162939957|NCT04567615|588483076|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
162698669|NCT00337662|587605554|FG001|Study Period II|Parent/Caregiver Decision|0|||
162939958|NCT04567615|588483077|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162939959|NCT04567615|588483075|FG000|Treatment Period|Disease Progression|85|||
162939960|NCT04567615|588483076|FG001|Treatment Period|Disease Progression|63|||
162939961|NCT04567615|588483077|FG002|Treatment Period|Disease Progression|16|||
162939962|NCT04567615|588483075|FG000|Treatment Period|Study Drug Toxicity|3|||
162939963|NCT04567615|588483076|FG001|Treatment Period|Study Drug Toxicity|10|||
163042848|NCT01066871|588863976|FG002|Overall Study|Protocol Violation|3|||
162829178|NCT03370120|588087022|FG000|Overall Study|Early termination by order of sponsor|2|||
162829179|NCT03370120|588087022|FG000|Overall Study|Discontinuation of the study|5|||
162829180|NCT03370120|588087022|FG000|Overall Study|End of clinical trial discontinuation|1|||
162829181|NCT03370120|588087022|FG000|Overall Study|Because the clinical trial ended halfway|4|||
162829182|NCT03370120|588087022|FG000|Overall Study|Development discontinued|5|||
162829183|NCT03370120|588087022|FG000|Overall Study|Padsenovil program closed|3|||
162829184|NCT03370120|588087022|FG000|Overall Study|End of project|2|||
162829185|NCT03370120|588087022|FG000|Overall Study|Termination of project|1|||
162829186|NCT03370120|588087022|FG000|Overall Study|The study was interrupted by sponsor|4|||
162829187|NCT03370120|588087022|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
162829188|NCT03370120|588087022|FG000|Overall Study|End of sponsor decision|1|||
162829189|NCT03370120|588087022|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
162829190|NCT03370120|588087022|FG000|Overall Study|Early termination of studies|5|||
162829191|NCT03370120|588087022|FG000|Overall Study|This study is ended early|1|||
162829192|NCT03370120|588087022|FG000|Overall Study|End of padsevonil program|2|||
162829193|NCT03370120|588087022|FG000|Overall Study|Decision of sponsor|6|||
162829194|NCT03370120|588087022|FG000|Overall Study|Asked by the sponsor|3|||
162829195|NCT03370120|588087022|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
162829196|NCT03370120|588087022|FG000|Overall Study|PI decision poor compliance from participant|1|||
162829197|NCT03370120|588087022|FG000|Overall Study|Promoter ended the study|3|||
162829198|NCT03370120|588087022|FG000|Overall Study|Premature study close by sponsor's decision|4|||
162829199|NCT03370120|588087022|FG000|Overall Study|Study terminated by sponsor|33|||
162829200|NCT03370120|588087022|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
162829201|NCT03370120|588087022|FG000|Overall Study|Sponsor decision to terminate study|63|||
162829202|NCT03370120|588087022|FG000|Overall Study|Program closure|3|||
162829203|NCT03370120|588087022|FG000|Overall Study|Study ended prematurely|1|||
162829204|NCT03370120|588087022|FG000|Overall Study|Study stopped by sponsor|2|||
162829205|NCT03370120|588087022|FG000|Overall Study|Program termination|55|||
162829206|NCT03370120|588087022|FG000|Overall Study|Sponsor decision|62|||
162829207|NCT03370120|588087022|FG000|Overall Study|Sponsor study closure|10|||
162829208|NCT02375724|588087024|FG000|Overall Study|Lack of Efficacy|1|||
162829209|NCT02375724|588087025|FG001|Overall Study|Lack of Efficacy|1|||
162829210|NCT02375724|588087024|FG000|Overall Study|Withdrawal by Subject|1|||
162829211|NCT02375724|588087025|FG001|Overall Study|Withdrawal by Subject|1|||
162829212|NCT02375724|588087024|FG000|Overall Study|Lost to Follow-up|1|||
162829213|NCT02375724|588087025|FG001|Overall Study|Lost to Follow-up|0|||
162829214|NCT02375724|588087024|FG000|Overall Study|Protocol Violation|1|||
162829215|NCT02375724|588087025|FG001|Overall Study|Protocol Violation|0|||
162829216|NCT02375724|588087024|FG000|Overall Study|Adverse Event|2|||
162829217|NCT02375724|588087025|FG001|Overall Study|Adverse Event|4|||
162829218|NCT01356407|588087026|FG000|Overall Study|Lost to Follow-up|2|||
162829219|NCT01356407|588087027|FG001|Overall Study|Lost to Follow-up|0|||
162829220|NCT01356407|588087026|FG000|Overall Study|Patient Withdrew Consent|2|||
162829221|NCT01356407|588087027|FG001|Overall Study|Patient Withdrew Consent|1|||
162829222|NCT01356407|588087026|FG000|Overall Study|Could not afford IMP administration|0|||
162829223|NCT01356407|588087027|FG001|Overall Study|Could not afford IMP administration|1|||
162829224|NCT01356407|588087026|FG000|Overall Study|Not complete Endoscopy|2|||
162829225|NCT01356407|588087027|FG001|Overall Study|Not complete Endoscopy|2|||
162829226|NCT04712110|588087028|FG000|Overall Study|Lost to Follow-up|0|||
162829227|NCT04712110|588087029|FG001|Overall Study|Lost to Follow-up|1|||
162829228|NCT04712110|588087028|FG000|Overall Study|Withdrawal by Subject|0|||
162829229|NCT04712110|588087029|FG001|Overall Study|Withdrawal by Subject|4|||
162829230|NCT04712110|588087028|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
162829231|NCT04712110|588087029|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
162829232|NCT03962101|588087030|FG000|Overall Study|Adverse Event|1|||
162829233|NCT03962101|588087030|FG000|Overall Study|Physician Decision|2|||
162829234|NCT03962101|588087030|FG000|Overall Study|Not related to medical events|1|||
162829235|NCT00912028|588087031|FG000|Overall Study|Lost to Follow-up|2|||
162829236|NCT00912028|588087032|FG001|Overall Study|Lost to Follow-up|3|||
162939964|NCT04567615|588483077|FG002|Treatment Period|Study Drug Toxicity|4|||
162939965|NCT04567615|588483075|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
162939966|NCT04567615|588483076|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
162939967|NCT04567615|588483077|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
162939968|NCT04567615|588483075|FG000|Treatment Period|Other Reasons|1|||
162939969|NCT04567615|588483076|FG001|Treatment Period|Other Reasons|2|||
162939970|NCT04567615|588483077|FG002|Treatment Period|Other Reasons|0|||
162939971|NCT04567615|588483075|FG000|Treatment Period|Still On-going Treatment|21|||
162939972|NCT04567615|588483076|FG001|Treatment Period|Still On-going Treatment|22|||
162939973|NCT04567615|588483077|FG002|Treatment Period|Still On-going Treatment|2|||
162939974|NCT04317053|588483078|FG000|Overall Study|Withdrawn (screen failure)|4|||
162939975|NCT04317053|588483079|FG001|Overall Study|Withdrawn (screen failure)|2|||
162939976|NCT01022112|588483080|FG000|Overall Study|Adverse Event|1|||
162939977|NCT01022112|588483081|FG001|Overall Study|Adverse Event|2|||
162939978|NCT01022112|588483082|FG002|Overall Study|Adverse Event|0|||
162939979|NCT01022112|588483083|FG003|Overall Study|Adverse Event|1|||
162939980|NCT01022112|588483084|FG004|Overall Study|Adverse Event|0|||
162939981|NCT01022112|588483080|FG000|Overall Study|Lack of Efficacy|1|||
162939982|NCT01022112|588483081|FG001|Overall Study|Lack of Efficacy|0|||
162939983|NCT01022112|588483082|FG002|Overall Study|Lack of Efficacy|0|||
162939984|NCT01022112|588483083|FG003|Overall Study|Lack of Efficacy|0|||
162939985|NCT01022112|588483084|FG004|Overall Study|Lack of Efficacy|1|||
162939986|NCT01022112|588483080|FG000|Overall Study|Physician Decision|0|||
162939987|NCT01022112|588483081|FG001|Overall Study|Physician Decision|0|||
162939988|NCT01022112|588483082|FG002|Overall Study|Physician Decision|1|||
162939989|NCT01022112|588483083|FG003|Overall Study|Physician Decision|0|||
162939990|NCT01022112|588483084|FG004|Overall Study|Physician Decision|1|||
162939991|NCT01022112|588483080|FG000|Overall Study|Withdrawal by Subject|0|||
162939992|NCT01022112|588483081|FG001|Overall Study|Withdrawal by Subject|1|||
162939993|NCT01022112|588483082|FG002|Overall Study|Withdrawal by Subject|2|||
162939994|NCT01022112|588483083|FG003|Overall Study|Withdrawal by Subject|2|||
162939995|NCT01022112|588483084|FG004|Overall Study|Withdrawal by Subject|1|||
162939996|NCT01022112|588483080|FG000|Overall Study|Fasting plasma glucose level increased|1|||
162939997|NCT01022112|588483081|FG001|Overall Study|Fasting plasma glucose level increased|0|||
162939998|NCT01022112|588483082|FG002|Overall Study|Fasting plasma glucose level increased|0|||
162939999|NCT01022112|588483083|FG003|Overall Study|Fasting plasma glucose level increased|0|||
162940000|NCT01022112|588483084|FG004|Overall Study|Fasting plasma glucose level increased|7|||
162940001|NCT04680052|588484418|FG000|Overall Study|Ongoing|244|||
162940002|NCT04680052|588484419|FG001|Overall Study|Ongoing|229|||
162940003|NCT04680052|588484420|FG002|Overall Study|Ongoing|39|||
162940004|NCT04680052|588484421|FG003|Overall Study|Ongoing|46|||
162940005|NCT04680052|588484418|FG000|Overall Study|Death|15|||
162940006|NCT04680052|588484419|FG001|Overall Study|Death|22|||
162940007|NCT04680052|588484420|FG002|Overall Study|Death|7|||
162940008|NCT04680052|588484421|FG003|Overall Study|Death|1|||
162940009|NCT04680052|588484418|FG000|Overall Study|Lost to Follow-up|3|||
162940010|NCT04680052|588484419|FG001|Overall Study|Lost to Follow-up|2|||
162940011|NCT04680052|588484420|FG002|Overall Study|Lost to Follow-up|0|||
162940012|NCT04680052|588484421|FG003|Overall Study|Lost to Follow-up|1|||
162940013|NCT04680052|588484418|FG000|Overall Study|Withdrawal by Subject|11|||
162940014|NCT04680052|588484419|FG001|Overall Study|Withdrawal by Subject|19|||
162940015|NCT04680052|588484420|FG002|Overall Study|Withdrawal by Subject|7|||
162940016|NCT04680052|588484421|FG003|Overall Study|Withdrawal by Subject|5|||
162940017|NCT04680052|588484418|FG000|Overall Study|Missing|0|||
162940018|NCT04680052|588484419|FG001|Overall Study|Missing|1|||
162940019|NCT04680052|588484420|FG002|Overall Study|Missing|0|||
162940020|NCT04680052|588484421|FG003|Overall Study|Missing|0|||
162940021|NCT04680052|588484418|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940022|NCT04680052|588484419|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
162940023|NCT04680052|588484420|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940024|NCT04680052|588484421|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
162940025|NCT04680052|588484418|FG000|Overall Study|Physician Decision|0|||
162940026|NCT04680052|588484419|FG001|Overall Study|Physician Decision|1|||
162940027|NCT04680052|588484420|FG002|Overall Study|Physician Decision|0|||
162940028|NCT04680052|588484421|FG003|Overall Study|Physician Decision|0|||
162940029|NCT00759148|588484423|FG000|Overall Study|Adverse Event|1|||
162940030|NCT00759148|588484424|FG001|Overall Study|Adverse Event|6|||
162940031|NCT00759148|588484423|FG000|Overall Study|Withdrawal by Subject|3|||
162940032|NCT00759148|588484424|FG001|Overall Study|Withdrawal by Subject|7|||
162940033|NCT00759148|588484423|FG000|Overall Study|Lost to Follow-up|3|||
162940034|NCT00759148|588484424|FG001|Overall Study|Lost to Follow-up|9|||
162940035|NCT00759148|588484423|FG000|Overall Study|Treatment Failure|6|||
162940036|NCT00759148|588484424|FG001|Overall Study|Treatment Failure|10|||
162940037|NCT00759148|588484423|FG000|Overall Study|Reason not given|1|||
162940038|NCT00759148|588484424|FG001|Overall Study|Reason not given|0|||
162940039|NCT01073020|588484425|FG000|Overall Study|Withdrawal by Subject|6|||
162940040|NCT01073020|588484426|FG001|Overall Study|Withdrawal by Subject|4|||
162940041|NCT01073020|588484427|FG002|Overall Study|Withdrawal by Subject|1|||
162940042|NCT01073020|588484428|FG003|Overall Study|Withdrawal by Subject|2|||
162940043|NCT01073020|588484425|FG000|Overall Study|Physician Decision|1|||
162940044|NCT01073020|588484426|FG001|Overall Study|Physician Decision|0|||
162940045|NCT01073020|588484427|FG002|Overall Study|Physician Decision|2|||
162940046|NCT01073020|588484428|FG003|Overall Study|Physician Decision|0|||
162940047|NCT01073020|588484425|FG000|Overall Study|Death|0|||
162940048|NCT01073020|588484426|FG001|Overall Study|Death|1|||
162940049|NCT01073020|588484427|FG002|Overall Study|Death|0|||
162940050|NCT01073020|588484428|FG003|Overall Study|Death|0|||
162940051|NCT00094302|588484431|FG000|Overall Study|Lost to Follow-up|43|||
162940052|NCT00094302|588484432|FG001|Overall Study|Lost to Follow-up|41|||
162940053|NCT00094302|588484431|FG000|Overall Study|Physician Decision|5|||
162940054|NCT00094302|588484432|FG001|Overall Study|Physician Decision|8|||
162940055|NCT00094302|588484431|FG000|Overall Study|Withdrawal by Subject|103|||
162940056|NCT00094302|588484432|FG001|Overall Study|Withdrawal by Subject|111|||
162940057|NCT00094302|588484431|FG000|Overall Study|Death|266|||
162940058|NCT00094302|588484432|FG001|Overall Study|Death|246|||
162940059|NCT03329027|588484435|FG000|Overall Study|Lost to Follow-up|1|||
162940060|NCT03329027|588484436|FG001|Overall Study|Lost to Follow-up|0|||
162940061|NCT03329027|588484437|FG002|Overall Study|Lost to Follow-up|1|||
162940062|NCT03329027|588484435|FG000|Overall Study|Protocol Violation|9|||
162940063|NCT03329027|588484436|FG001|Overall Study|Protocol Violation|5|||
162940064|NCT03329027|588484437|FG002|Overall Study|Protocol Violation|7|||
162940065|NCT02761980|588484442|FG000|Overall Study|Adverse Event|4|||
162940066|NCT02761980|588484443|FG001|Overall Study|Adverse Event|6|||
162940067|NCT02761980|588484444|FG002|Overall Study|Adverse Event|5|||
162940068|NCT02761980|588484445|FG003|Overall Study|Adverse Event|6|||
162940069|NCT02761980|588484442|FG000|Overall Study|Withdrawal by Subject|0|||
162940070|NCT02761980|588484443|FG001|Overall Study|Withdrawal by Subject|1|||
162940071|NCT02761980|588484444|FG002|Overall Study|Withdrawal by Subject|0|||
162940072|NCT02761980|588484445|FG003|Overall Study|Withdrawal by Subject|0|||
162940073|NCT02761980|588484442|FG000|Overall Study|Other|0|||
162940074|NCT02761980|588484443|FG001|Overall Study|Other|0|||
162940075|NCT02761980|588484444|FG002|Overall Study|Other|1|||
162940076|NCT02761980|588484445|FG003|Overall Study|Other|0|||
162940077|NCT02848599|588484448|FG000|Overall Study|Protocol Violation|7|||
162940078|NCT02848599|588484449|FG001|Overall Study|Protocol Violation|9|||
162940079|NCT01829464|588484458|FG000|Overall Study|Adverse Event|1|||
162940080|NCT01829464|588484459|FG001|Overall Study|Adverse Event|0|||
162940081|NCT01829464|588484460|FG002|Overall Study|Adverse Event|0|||
162940082|NCT01829464|588484458|FG000|Overall Study|Lost to Follow-up|0|||
162940083|NCT01829464|588484459|FG001|Overall Study|Lost to Follow-up|0|||
162940084|NCT01829464|588484460|FG002|Overall Study|Lost to Follow-up|1|||
162940085|NCT01829464|588484458|FG000|Overall Study|Withdrawal by Subject|2|||
162940086|NCT01829464|588484459|FG001|Overall Study|Withdrawal by Subject|0|||
162940087|NCT01829464|588484460|FG002|Overall Study|Withdrawal by Subject|0|||
162940088|NCT01829464|588484458|FG000|Overall Study|Study terminated by sponsor|25|||
162940089|NCT01829464|588484459|FG001|Overall Study|Study terminated by sponsor|28|||
162940090|NCT01829464|588484460|FG002|Overall Study|Study terminated by sponsor|25|||
162940091|NCT01829464|588484458|FG000|Overall Study|Lack of Efficacy|0|||
162940092|NCT01829464|588484459|FG001|Overall Study|Lack of Efficacy|1|||
162940093|NCT01829464|588484460|FG002|Overall Study|Lack of Efficacy|0|||
162940094|NCT00755326|588484465|FG000|Overall Study|Lost to Follow-up|2|||
162940095|NCT00755326|588484466|FG001|Overall Study|Lost to Follow-up|3|||
162940096|NCT02385526|588484469|FG000|Overall Study|Withdrawal by Subject|0|||
162940097|NCT02385526|588484470|FG001|Overall Study|Withdrawal by Subject|2|||
162940098|NCT02385526|588484471|FG002|Overall Study|Withdrawal by Subject|0|||
162940099|NCT02385526|588484469|FG000|Overall Study|Lost to Follow-up|0|||
162940100|NCT02385526|588484470|FG001|Overall Study|Lost to Follow-up|1|||
162940101|NCT02385526|588484471|FG002|Overall Study|Lost to Follow-up|0|||
162940102|NCT02385526|588484469|FG000|Overall Study|Physician Decision|1|||
162940103|NCT02385526|588484470|FG001|Overall Study|Physician Decision|0|||
162940104|NCT02385526|588484471|FG002|Overall Study|Physician Decision|0|||
162940105|NCT02385526|588484469|FG000|Overall Study|Protocol Violation|1|||
162940106|NCT02385526|588484470|FG001|Overall Study|Protocol Violation|0|||
162940107|NCT02385526|588484471|FG002|Overall Study|Protocol Violation|0|||
162940108|NCT01595009|588484474|FG000|Core|Patients completed per protocol|85|||
162940109|NCT01595009|588484475|FG001|Core|Patients completed per protocol|44|||
162940110|NCT01595009|588484476|FG002|Core|Patients completed per protocol|0|||
162940111|NCT01595009|588484477|FG003|Core|Patients completed per protocol|0|||
162940112|NCT01595009|588484474|FG000|Core|Adverse Event|19|||
162940113|NCT01595009|588484475|FG001|Core|Adverse Event|23|||
162940114|NCT01595009|588484476|FG002|Core|Adverse Event|0|||
162940115|NCT01595009|588484477|FG003|Core|Adverse Event|0|||
162940116|NCT01595009|588484474|FG000|Core|Disease progression|14|||
162940117|NCT01595009|588484475|FG001|Core|Disease progression|26|||
162940118|NCT01595009|588484476|FG002|Core|Disease progression|0|||
162940119|NCT01595009|588484477|FG003|Core|Disease progression|0|||
162940120|NCT01595009|588484474|FG000|Core|Withdrawal by Subject|4|||
162940121|NCT01595009|588484475|FG001|Core|Withdrawal by Subject|17|||
162940122|NCT01595009|588484476|FG002|Core|Withdrawal by Subject|0|||
162940123|NCT01595009|588484477|FG003|Core|Withdrawal by Subject|0|||
162940124|NCT01595009|588484474|FG000|Core|Death|3|||
162940125|NCT01595009|588484475|FG001|Core|Death|6|||
162940126|NCT01595009|588484476|FG002|Core|Death|0|||
162940127|NCT01595009|588484477|FG003|Core|Death|0|||
162940128|NCT01595009|588484474|FG000|Core|Lost to Follow-up|1|||
162940129|NCT01595009|588484475|FG001|Core|Lost to Follow-up|2|||
162940130|NCT01595009|588484476|FG002|Core|Lost to Follow-up|0|||
162940131|NCT01595009|588484477|FG003|Core|Lost to Follow-up|0|||
162940132|NCT01595009|588484474|FG000|Core|Protocol deviation|0|||
162940133|NCT01595009|588484475|FG001|Core|Protocol deviation|1|||
162940134|NCT01595009|588484476|FG002|Core|Protocol deviation|0|||
162940135|NCT01595009|588484477|FG003|Core|Protocol deviation|0|||
162940136|NCT01595009|588484474|FG000|Core|Administrative problems|0|||
162940137|NCT01595009|588484475|FG001|Core|Administrative problems|1|||
162940138|NCT01595009|588484476|FG002|Core|Administrative problems|0|||
162940139|NCT01595009|588484477|FG003|Core|Administrative problems|0|||
162940140|NCT01595009|588484474|FG000|Extension|Administrative problems|0|||
162940141|NCT01595009|588484475|FG001|Extension|Administrative problems|0|||
162940142|NCT01595009|588484476|FG002|Extension|Administrative problems|0|||
162940143|NCT01595009|588484477|FG003|Extension|Administrative problems|1|||
162940144|NCT01595009|588484474|FG000|Extension|Patients completed per protocol|0|||
162940145|NCT01595009|588484475|FG001|Extension|Patients completed per protocol|0|||
162940146|NCT01595009|588484476|FG002|Extension|Patients completed per protocol|0|||
162940147|NCT01595009|588484477|FG003|Extension|Patients completed per protocol|2|||
162940148|NCT01595009|588484474|FG000|Extension|Disease progression|0|||
162940149|NCT01595009|588484475|FG001|Extension|Disease progression|0|||
162940150|NCT01595009|588484476|FG002|Extension|Disease progression|4|||
162940151|NCT01595009|588484477|FG003|Extension|Disease progression|7|||
162940152|NCT01595009|588484474|FG000|Extension|Adverse Event|0|||
162940153|NCT01595009|588484475|FG001|Extension|Adverse Event|0|||
162940154|NCT01595009|588484476|FG002|Extension|Adverse Event|0|||
162940155|NCT01595009|588484477|FG003|Extension|Adverse Event|1|||
162940156|NCT02623829|588484483|FG000|Overall Study|Lost to Follow-up|1|||
162940157|NCT02623829|588484484|FG001|Overall Study|Lost to Follow-up|1|||
162940158|NCT00662025|588484485|FG000|Overall Study|Objective progression or relapse|51|||
162940159|NCT00662025|588484485|FG000|Overall Study|Adverse Event|7|||
162940160|NCT00662025|588484485|FG000|Overall Study|Withdrawal by Subject|1|||
162940161|NCT00662025|588484485|FG000|Overall Study|Results of other clinical study|2|||
162940162|NCT00662025|588484485|FG000|Overall Study|Target lesion cannot be evaluated|1|||
162940163|NCT00662025|588484485|FG000|Overall Study|Domestic circumstances|1|||
162940164|NCT01333033|588484489|FG000|Overall Study|Ineligible|0|||
162940165|NCT01333033|588484490|FG001|Overall Study|Ineligible|0|||
162940166|NCT01333033|588484491|FG002|Overall Study|Ineligible|0|||
162940167|NCT01333033|588484492|FG003|Overall Study|Ineligible|0|||
162940168|NCT01333033|588484493|FG004|Overall Study|Ineligible|6|||
162940169|NCT01333033|588484494|FG005|Overall Study|Ineligible|8|||
162940170|NCT01333033|588484489|FG000|Overall Study|Withdrawal by Subject|0|||
162940171|NCT01333033|588484490|FG001|Overall Study|Withdrawal by Subject|0|||
162940172|NCT01333033|588484491|FG002|Overall Study|Withdrawal by Subject|0|||
162940173|NCT01333033|588484492|FG003|Overall Study|Withdrawal by Subject|0|||
162940174|NCT01333033|588484493|FG004|Overall Study|Withdrawal by Subject|4|||
162940175|NCT01333033|588484494|FG005|Overall Study|Withdrawal by Subject|2|||
162940176|NCT01333033|588484489|FG000|Overall Study|PET inevaluable|0|||
162940177|NCT01333033|588484490|FG001|Overall Study|PET inevaluable|0|||
162940178|NCT01333033|588484491|FG002|Overall Study|PET inevaluable|0|||
162940179|NCT01333033|588484492|FG003|Overall Study|PET inevaluable|0|||
162940180|NCT01333033|588484493|FG004|Overall Study|PET inevaluable|2|||
162940181|NCT01333033|588484494|FG005|Overall Study|PET inevaluable|4|||
162940182|NCT01333033|588484489|FG000|Overall Study|Adverse Event|0|||
162940183|NCT01333033|588484490|FG001|Overall Study|Adverse Event|0|||
162940184|NCT01333033|588484491|FG002|Overall Study|Adverse Event|0|||
162940185|NCT01333033|588484492|FG003|Overall Study|Adverse Event|0|||
162940186|NCT01333033|588484493|FG004|Overall Study|Adverse Event|2|||
162940187|NCT01333033|588484494|FG005|Overall Study|Adverse Event|1|||
162940188|NCT01333033|588484489|FG000|Overall Study|Progression|0|||
162940189|NCT01333033|588484490|FG001|Overall Study|Progression|0|||
162940190|NCT01333033|588484491|FG002|Overall Study|Progression|0|||
162940191|NCT01333033|588484492|FG003|Overall Study|Progression|0|||
162940192|NCT01333033|588484493|FG004|Overall Study|Progression|0|||
162940193|NCT01333033|588484494|FG005|Overall Study|Progression|1|||
162698670|NCT00337662|587605555|FG002|Study Period II|Parent/Caregiver Decision|0|||
162940194|NCT01333033|588484489|FG000|Overall Study|MD Decision|0|||
162940195|NCT01333033|588484490|FG001|Overall Study|MD Decision|0|||
162940196|NCT01333033|588484491|FG002|Overall Study|MD Decision|0|||
162940197|NCT01333033|588484492|FG003|Overall Study|MD Decision|0|||
162940198|NCT01333033|588484493|FG004|Overall Study|MD Decision|0|||
162940199|NCT01333033|588484494|FG005|Overall Study|MD Decision|2|||
162940200|NCT01842958|588484496|FG000|Overall Study|Lost to Follow-up|1|||
162940201|NCT01842958|588484497|FG001|Overall Study|Lost to Follow-up|1|||
162940202|NCT01829477|588484498|FG000|Overall Study|Study Terminated by Sponsor|15|||
162940203|NCT01829477|588484499|FG001|Overall Study|Study Terminated by Sponsor|15|||
162940204|NCT01829477|588484498|FG000|Overall Study|Withdrawal by Subject|1|||
162940205|NCT01829477|588484499|FG001|Overall Study|Withdrawal by Subject|0|||
162940206|NCT03465891|588484501|FG000|Overall Study|Withdrawal by Subject|0|||
162940207|NCT03465891|588484502|FG001|Overall Study|Withdrawal by Subject|1|||
162940208|NCT03465891|588484501|FG000|Overall Study|Disease progression|1|||
162940209|NCT03465891|588484502|FG001|Overall Study|Disease progression|0|||
162940210|NCT02737306|588484503|FG000|Overall Study|Adverse Event|3|||
162940211|NCT02737306|588484504|FG001|Overall Study|Adverse Event|0|||
162940212|NCT02737306|588484503|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
162940213|NCT02737306|588484504|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
162940214|NCT03361423|588484505|FG000|Overall Study|Withdrawal by Subject|4|||
162940215|NCT03361423|588484506|FG001|Overall Study|Withdrawal by Subject|3|||
162940216|NCT03361423|588484505|FG000|Overall Study|Did not treat|19|||
162940217|NCT03361423|588484506|FG001|Overall Study|Did not treat|18|||
162940218|NCT03361423|588484505|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
162940219|NCT03361423|588484506|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
162940220|NCT03361423|588484505|FG000|Overall Study|Missing data|4|||
162940221|NCT03361423|588484506|FG001|Overall Study|Missing data|1|||
162940222|NCT00818623|588484507|FG000|Overall Study|Adverse Event|1|||
162940223|NCT00818623|588484508|FG001|Overall Study|Adverse Event|0|||
162940224|NCT00818623|588484509|FG002|Overall Study|Adverse Event|1|||
162940225|NCT00818623|588484510|FG003|Overall Study|Adverse Event|0|||
162940226|NCT00818623|588484511|FG004|Overall Study|Adverse Event|0|||
162940227|NCT00818623|588484512|FG005|Overall Study|Adverse Event|1|||
162940228|NCT00818623|588484513|FG006|Overall Study|Adverse Event|0|||
162940229|NCT00818623|588484514|FG007|Overall Study|Adverse Event|0|||
162940230|NCT00818623|588484507|FG000|Overall Study|Bad prostate specific antigen response|0|||
162940231|NCT00818623|588484508|FG001|Overall Study|Bad prostate specific antigen response|3|||
162940232|NCT00818623|588484509|FG002|Overall Study|Bad prostate specific antigen response|2|||
162940233|NCT00818623|588484510|FG003|Overall Study|Bad prostate specific antigen response|5|||
162940234|NCT00818623|588484511|FG004|Overall Study|Bad prostate specific antigen response|0|||
162940235|NCT00818623|588484512|FG005|Overall Study|Bad prostate specific antigen response|1|||
162940236|NCT00818623|588484513|FG006|Overall Study|Bad prostate specific antigen response|0|||
162940237|NCT00818623|588484514|FG007|Overall Study|Bad prostate specific antigen response|0|||
162940238|NCT00818623|588484507|FG000|Overall Study|Withdrawal by Subject|0|||
162940239|NCT00818623|588484508|FG001|Overall Study|Withdrawal by Subject|1|||
162940240|NCT00818623|588484509|FG002|Overall Study|Withdrawal by Subject|1|||
162940241|NCT00818623|588484510|FG003|Overall Study|Withdrawal by Subject|0|||
162940242|NCT00818623|588484511|FG004|Overall Study|Withdrawal by Subject|0|||
162940243|NCT00818623|588484512|FG005|Overall Study|Withdrawal by Subject|1|||
162940244|NCT00818623|588484513|FG006|Overall Study|Withdrawal by Subject|1|||
162940245|NCT00818623|588484514|FG007|Overall Study|Withdrawal by Subject|1|||
162940246|NCT00818623|588484507|FG000|Overall Study|Protocol Violation|1|||
162940247|NCT00818623|588484508|FG001|Overall Study|Protocol Violation|0|||
162940248|NCT00818623|588484509|FG002|Overall Study|Protocol Violation|0|||
162940249|NCT00818623|588484510|FG003|Overall Study|Protocol Violation|0|||
162940250|NCT00818623|588484511|FG004|Overall Study|Protocol Violation|1|||
162940251|NCT00818623|588484512|FG005|Overall Study|Protocol Violation|0|||
162940252|NCT00818623|588484513|FG006|Overall Study|Protocol Violation|1|||
162940253|NCT00818623|588484514|FG007|Overall Study|Protocol Violation|0|||
162940254|NCT00818623|588484507|FG000|Overall Study|Need of additional treatment|0|||
162940255|NCT00818623|588484508|FG001|Overall Study|Need of additional treatment|0|||
162940256|NCT00818623|588484509|FG002|Overall Study|Need of additional treatment|0|||
162940257|NCT00818623|588484510|FG003|Overall Study|Need of additional treatment|0|||
162940258|NCT00818623|588484511|FG004|Overall Study|Need of additional treatment|1|||
162940259|NCT00818623|588484512|FG005|Overall Study|Need of additional treatment|0|||
162940260|NCT00818623|588484513|FG006|Overall Study|Need of additional treatment|0|||
162940261|NCT00818623|588484514|FG007|Overall Study|Need of additional treatment|0|||
162940262|NCT00818623|588484507|FG000|Overall Study|Lack of trial drug at site|0|||
162940263|NCT00818623|588484508|FG001|Overall Study|Lack of trial drug at site|0|||
162940264|NCT00818623|588484509|FG002|Overall Study|Lack of trial drug at site|0|||
162940265|NCT00818623|588484510|FG003|Overall Study|Lack of trial drug at site|0|||
162940266|NCT00818623|588484511|FG004|Overall Study|Lack of trial drug at site|2|||
162940267|NCT00818623|588484512|FG005|Overall Study|Lack of trial drug at site|0|||
162940268|NCT00818623|588484513|FG006|Overall Study|Lack of trial drug at site|1|||
162940269|NCT00818623|588484514|FG007|Overall Study|Lack of trial drug at site|0|||
162940270|NCT00818623|588484507|FG000|Overall Study|Disease progression|0|||
162940271|NCT00818623|588484508|FG001|Overall Study|Disease progression|0|||
162940272|NCT00818623|588484509|FG002|Overall Study|Disease progression|0|||
162940273|NCT00818623|588484510|FG003|Overall Study|Disease progression|0|||
162940274|NCT00818623|588484511|FG004|Overall Study|Disease progression|0|||
162940275|NCT00818623|588484512|FG005|Overall Study|Disease progression|0|||
162940276|NCT00818623|588484513|FG006|Overall Study|Disease progression|1|||
162940277|NCT00818623|588484514|FG007|Overall Study|Disease progression|0|||
162940278|NCT00299156|588484515|FG000|Period 2 (Randomized)|Screen Failure|0|||
162940279|NCT00299156|588484516|FG001|Period 2 (Randomized)|Screen Failure|1|||
162940280|NCT00299156|588484517|FG002|Period 2 (Randomized)|Screen Failure|0|||
162940281|NCT01166568|588484518|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
162940282|NCT01166568|588484519|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
162940283|NCT01166568|588484520|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
162940284|NCT01166568|588484518|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
162940285|NCT01166568|588484519|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
162940286|NCT01166568|588484520|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
162940287|NCT01166568|588484518|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
162940288|NCT01166568|588484519|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
162940289|NCT01166568|588484520|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
162940290|NCT00903383|588484521|FG000|Overall Study|Adverse Event|1|||
162940291|NCT00903383|588484522|FG001|Overall Study|Adverse Event|2|||
162940292|NCT00903383|588484523|FG002|Overall Study|Adverse Event|3|||
162940293|NCT00903383|588484524|FG003|Overall Study|Adverse Event|1|||
162940294|NCT00903383|588484521|FG000|Overall Study|Physician Decision|1|||
162940295|NCT00903383|588484522|FG001|Overall Study|Physician Decision|2|||
162940296|NCT00903383|588484523|FG002|Overall Study|Physician Decision|0|||
162940297|NCT00903383|588484524|FG003|Overall Study|Physician Decision|0|||
162940298|NCT00903383|588484521|FG000|Overall Study|Lost to Follow-up|0|||
162940299|NCT00903383|588484522|FG001|Overall Study|Lost to Follow-up|0|||
162940300|NCT00903383|588484523|FG002|Overall Study|Lost to Follow-up|0|||
162940301|NCT00903383|588484524|FG003|Overall Study|Lost to Follow-up|1|||
162940302|NCT00903383|588484521|FG000|Overall Study|Decision of Sponsor|1|||
162940303|NCT00903383|588484522|FG001|Overall Study|Decision of Sponsor|0|||
162940304|NCT00903383|588484523|FG002|Overall Study|Decision of Sponsor|0|||
162940305|NCT00903383|588484524|FG003|Overall Study|Decision of Sponsor|0|||
162940306|NCT00903383|588484521|FG000|Overall Study|Withdrawal by Subject|4|||
162940307|NCT00903383|588484522|FG001|Overall Study|Withdrawal by Subject|1|||
162940308|NCT00903383|588484523|FG002|Overall Study|Withdrawal by Subject|0|||
162940309|NCT00903383|588484524|FG003|Overall Study|Withdrawal by Subject|2|||
162940310|NCT00903383|588484521|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940311|NCT00903383|588484522|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
162940312|NCT00903383|588484523|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940313|NCT00903383|588484524|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
162940314|NCT00903383|588484521|FG000|Overall Study|Patient Decision|0|||
162940315|NCT00903383|588484522|FG001|Overall Study|Patient Decision|0|||
162940316|NCT00903383|588484523|FG002|Overall Study|Patient Decision|0|||
162940317|NCT00903383|588484524|FG003|Overall Study|Patient Decision|1|||
162940318|NCT02015793|588484532|FG000|Overall Study|Adverse Event|3|||
162940319|NCT02015793|588484533|FG001|Overall Study|Adverse Event|3|||
162940320|NCT02015793|588484532|FG000|Overall Study|Withdrawal by Subject|1|||
162940321|NCT02015793|588484533|FG001|Overall Study|Withdrawal by Subject|1|||
162940322|NCT00320593|588484534|FG000|Overall Study|Lost to Follow-up|3|||
162940323|NCT00320593|588484535|FG001|Overall Study|Lost to Follow-up|0|||
162940324|NCT00320593|588484534|FG000|Overall Study|Moved to another state|1|||
162940325|NCT00320593|588484535|FG001|Overall Study|Moved to another state|0|||
162940326|NCT00320593|588484534|FG000|Overall Study|Withdrawal by Subject|2|||
162940327|NCT00320593|588484535|FG001|Overall Study|Withdrawal by Subject|1|||
162940328|NCT00320593|588484534|FG000|Overall Study|Withdrawal by clinical center|1|||
162940329|NCT00320593|588484535|FG001|Overall Study|Withdrawal by clinical center|0|||
162940330|NCT01076166|588484536|FG000|Overall Study|Adverse Event|3|||
162940331|NCT01076166|588484536|FG000|Overall Study|Symptoms improved/resolved|6|||
162940332|NCT02087059|588484537|FG000|Overall Study|Disease Progression|1|||
162940333|NCT02087059|588484537|FG000|Overall Study|Adverse Event|5|||
162940334|NCT02087059|588484537|FG000|Overall Study|Lost to Follow-up|1|||
162940335|NCT01851590|588484538|FG000|Overall Study|Withdrawal by Subject|0|||
162940336|NCT01851590|588484539|FG001|Overall Study|Withdrawal by Subject|0|||
162940337|NCT01851590|588484540|FG002|Overall Study|Withdrawal by Subject|1|||
162940338|NCT01851590|588484538|FG000|Overall Study|Adverse Event|0|||
162940339|NCT01851590|588484539|FG001|Overall Study|Adverse Event|0|||
162940340|NCT01851590|588484540|FG002|Overall Study|Adverse Event|2|||
162940341|NCT01851590|588484538|FG000|Overall Study|Lack of Efficacy|0|||
162940342|NCT01851590|588484539|FG001|Overall Study|Lack of Efficacy|1|||
162940343|NCT01851590|588484540|FG002|Overall Study|Lack of Efficacy|0|||
162940344|NCT00321711|588484543|FG000|Part A|Adverse Event|3|||
162940345|NCT00321711|588484544|FG001|Part A|Adverse Event|3|||
162940346|NCT00321711|588484545|FG002|Part A|Adverse Event|2|||
162940347|NCT00321711|588484546|FG003|Part A|Adverse Event|0|||
162940348|NCT00321711|588484547|FG004|Part A|Adverse Event|0|||
162940349|NCT00321711|588484543|FG000|Part A|Withdrawal by Subject|1|||
162940350|NCT00321711|588484544|FG001|Part A|Withdrawal by Subject|1|||
162940351|NCT00321711|588484545|FG002|Part A|Withdrawal by Subject|1|||
162940352|NCT00321711|588484546|FG003|Part A|Withdrawal by Subject|0|||
162940353|NCT00321711|588484547|FG004|Part A|Withdrawal by Subject|0|||
162940354|NCT00321711|588484543|FG000|Part A|Disease progression|0|||
162940355|NCT00321711|588484544|FG001|Part A|Disease progression|1|||
162940356|NCT00321711|588484545|FG002|Part A|Disease progression|0|||
162940357|NCT00321711|588484546|FG003|Part A|Disease progression|0|||
162940358|NCT00321711|588484547|FG004|Part A|Disease progression|0|||
162940359|NCT00321711|588484543|FG000|Part A|Requirement for alternative therapy|0|||
162940360|NCT00321711|588484544|FG001|Part A|Requirement for alternative therapy|2|||
162940361|NCT00321711|588484545|FG002|Part A|Requirement for alternative therapy|1|||
162940362|NCT00321711|588484546|FG003|Part A|Requirement for alternative therapy|0|||
162940363|NCT00321711|588484547|FG004|Part A|Requirement for alternative therapy|0|||
162940364|NCT00321711|588484543|FG000|Part A|Physician Decision|0|||
162940365|NCT00321711|588484544|FG001|Part A|Physician Decision|1|||
162940366|NCT00321711|588484545|FG002|Part A|Physician Decision|3|||
162940367|NCT00321711|588484546|FG003|Part A|Physician Decision|0|||
162940368|NCT00321711|588484547|FG004|Part A|Physician Decision|0|||
162940369|NCT00321711|588484543|FG000|Part A|Other|1|||
162940370|NCT00321711|588484544|FG001|Part A|Other|2|||
162940371|NCT00321711|588484545|FG002|Part A|Other|3|||
162940372|NCT00321711|588484546|FG003|Part A|Other|0|||
162940373|NCT00321711|588484547|FG004|Part A|Other|0|||
162940374|NCT00321711|588484543|FG000|Part A|Protocol deviation|0|||
162940375|NCT00321711|588484544|FG001|Part A|Protocol deviation|0|||
162940376|NCT00321711|588484545|FG002|Part A|Protocol deviation|1|||
162940377|NCT00321711|588484546|FG003|Part A|Protocol deviation|0|||
162940378|NCT00321711|588484547|FG004|Part A|Protocol deviation|0|||
162940379|NCT00321711|588484543|FG000|Part B|Noncompliance|0|||
162940380|NCT00321711|588484544|FG001|Part B|Noncompliance|0|||
162940381|NCT00321711|588484545|FG002|Part B|Noncompliance|0|||
162940382|NCT00321711|588484546|FG003|Part B|Noncompliance|0|||
162940383|NCT00321711|588484547|FG004|Part B|Noncompliance|1|||
162940384|NCT00321711|588484543|FG000|Part B|Adverse Event|0|||
162940385|NCT00321711|588484544|FG001|Part B|Adverse Event|0|||
162940386|NCT00321711|588484545|FG002|Part B|Adverse Event|0|||
162940387|NCT00321711|588484546|FG003|Part B|Adverse Event|2|||
162940388|NCT00321711|588484547|FG004|Part B|Adverse Event|1|||
162829237|NCT00912028|588087033|FG002|Overall Study|Lost to Follow-up|0|||
162829238|NCT00912028|588087034|FG003|Overall Study|Lost to Follow-up|1|||
162829239|NCT00912028|588087035|FG004|Overall Study|Lost to Follow-up|3|||
162829240|NCT00912028|588087031|FG000|Overall Study|Withdrawal by Subject|3|||
162829241|NCT00912028|588087032|FG001|Overall Study|Withdrawal by Subject|0|||
162829242|NCT00912028|588087033|FG002|Overall Study|Withdrawal by Subject|0|||
162829243|NCT00912028|588087034|FG003|Overall Study|Withdrawal by Subject|0|||
162829244|NCT00912028|588087035|FG004|Overall Study|Withdrawal by Subject|0|||
162829245|NCT02285998|588087036|FG000|Overall Study|Adverse Event|9|||
162829246|NCT02285998|588087037|FG001|Overall Study|Adverse Event|8|||
162829247|NCT02285998|588087036|FG000|Overall Study|Physician Decision|1|||
162829248|NCT02285998|588087037|FG001|Overall Study|Physician Decision|2|||
162829249|NCT02285998|588087036|FG000|Overall Study|Lost to Follow-up|176|||
162829250|NCT02285998|588087037|FG001|Overall Study|Lost to Follow-up|172|||
162829251|NCT02285998|588087036|FG000|Overall Study|Withdrawal by Subject|53|||
162829252|NCT02285998|588087037|FG001|Overall Study|Withdrawal by Subject|61|||
162829253|NCT02285998|588087036|FG000|Overall Study|Other Reasons|7|||
162829254|NCT02285998|588087037|FG001|Overall Study|Other Reasons|10|||
162829255|NCT01793142|588087038|FG000|Overall Study|Randomized not treated|7|||
162829256|NCT02829138|588087039|FG000|Overall Study|Withdrawal by Subject|1|||
162829257|NCT02829138|588087040|FG001|Overall Study|Withdrawal by Subject|0|||
162829258|NCT01394627|588087041|FG000|First Intervention (1 Day)|poor intravenous access|0|||
162829259|NCT01394627|588087042|FG001|First Intervention (1 Day)|poor intravenous access|1|||
162829260|NCT01394627|588087041|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
162829261|NCT01394627|588087042|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
162829262|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
162829263|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
162829264|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
162940389|NCT00321711|588484543|FG000|Part B|Disease progression|0|||
162940390|NCT00321711|588484544|FG001|Part B|Disease progression|0|||
162940391|NCT00321711|588484545|FG002|Part B|Disease progression|0|||
162940392|NCT00321711|588484546|FG003|Part B|Disease progression|1|||
162940393|NCT00321711|588484547|FG004|Part B|Disease progression|0|||
162940394|NCT00321711|588484543|FG000|Part B|Physician Decision|0|||
162940395|NCT00321711|588484544|FG001|Part B|Physician Decision|0|||
162940396|NCT00321711|588484545|FG002|Part B|Physician Decision|0|||
162940397|NCT00321711|588484546|FG003|Part B|Physician Decision|1|||
162940398|NCT00321711|588484547|FG004|Part B|Physician Decision|2|||
162940399|NCT00321711|588484543|FG000|Part B|Death|0|||
162940400|NCT00321711|588484544|FG001|Part B|Death|0|||
162940401|NCT00321711|588484545|FG002|Part B|Death|0|||
162940402|NCT00321711|588484546|FG003|Part B|Death|2|||
162940403|NCT00321711|588484547|FG004|Part B|Death|1|||
162940404|NCT01211769|588484553|FG000|Overall Study|Lost to Follow-up|7|||
162940405|NCT01211769|588484554|FG001|Overall Study|Lost to Follow-up|9|||
162940406|NCT01211769|588484555|FG002|Overall Study|Lost to Follow-up|5|||
162940407|NCT01211769|588484556|FG003|Overall Study|Lost to Follow-up|9|||
162940408|NCT01211769|588484553|FG000|Overall Study|Physician Decision|2|||
162940409|NCT01211769|588484554|FG001|Overall Study|Physician Decision|0|||
162940410|NCT01211769|588484555|FG002|Overall Study|Physician Decision|2|||
162940411|NCT01211769|588484556|FG003|Overall Study|Physician Decision|1|||
162940412|NCT01211769|588484553|FG000|Overall Study|Adverse Event|0|||
162940413|NCT01211769|588484554|FG001|Overall Study|Adverse Event|1|||
162940414|NCT01211769|588484555|FG002|Overall Study|Adverse Event|1|||
162940415|NCT01211769|588484556|FG003|Overall Study|Adverse Event|1|||
162940416|NCT01709383|588484561|FG000|Overall Study|Lost to Follow-up|1|||
162940417|NCT01709383|588484562|FG001|Overall Study|Lost to Follow-up|0|||
162940418|NCT01193517|588484563|FG000|Overall Study|Early Progression|1|||
162940419|NCT01193517|588484564|FG001|Overall Study|Early Progression|0|||
162940420|NCT01193517|588484565|FG002|Overall Study|Early Progression|0|||
162940421|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
162940422|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
162940423|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
162940424|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
162940425|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
162940426|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
162940427|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
162940428|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
162940429|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
162940430|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
162940431|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
162940432|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
162940433|NCT01688037|588484566|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
162829265|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
162829266|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
162829267|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
162829268|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
162829269|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
162829270|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
162829271|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
162829272|NCT04041284|588087043|FG000|DB Phase (12 Weeks)|Other than specified|1|||
162829273|NCT04041284|588087044|FG001|DB Phase (12 Weeks)|Other than specified|0|||
162829274|NCT04041284|588087043|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
162829275|NCT04041284|588087044|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
162829276|NCT04041284|588087043|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
162829277|NCT04041284|588087044|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
162829278|NCT04041284|588087043|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
162829279|NCT04041284|588087044|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
162829280|NCT04041284|588087043|FG000|OL Phase (12 Weeks)|Other than specified|6|||
162829281|NCT04041284|588087044|FG001|OL Phase (12 Weeks)|Other than specified|2|||
162829282|NCT02016820|588087050|FG000|Overall Study|Lost to Follow-up|2|||
162829283|NCT02016820|588087051|FG001|Overall Study|Lost to Follow-up|4|||
162829284|NCT00884273|588087052|FG000|Overall Study|Adverse Event|0|||
162829285|NCT00884273|588087053|FG001|Overall Study|Adverse Event|2|||
162829286|NCT00884273|588087052|FG000|Overall Study|Protocol Violation|1|||
162829287|NCT00884273|588087053|FG001|Overall Study|Protocol Violation|3|||
162829288|NCT00884273|588087052|FG000|Overall Study|Practical reasons|1|||
162829289|NCT00884273|588087053|FG001|Overall Study|Practical reasons|0|||
162829290|NCT02437864|588087054|FG000|Overall Study|Protocol Violation|4|||
162829291|NCT02437864|588087055|FG001|Overall Study|Protocol Violation|0|||
162829292|NCT03803059|588087056|FG000|Overall Study|Protocol Violation|2|||
162829293|NCT03803059|588087056|FG000|Overall Study|Lost to Follow-up|1|||
162829294|NCT05419128|588087060|FG000|Overall Study|Withdrawal by Subject|1|||
162829295|NCT05419128|588087061|FG001|Overall Study|Withdrawal by Subject|1|||
162829296|NCT05419128|588087062|FG002|Overall Study|Withdrawal by Subject|0|||
162829297|NCT05419128|588087063|FG003|Overall Study|Withdrawal by Subject|1|||
162829298|NCT05419128|588087064|FG004|Overall Study|Withdrawal by Subject|1|||
162829299|NCT05419128|588087065|FG005|Overall Study|Withdrawal by Subject|0|||
162829300|NCT05419128|588087060|FG000|Overall Study|Lost to Follow-up|0|||
162829301|NCT05419128|588087061|FG001|Overall Study|Lost to Follow-up|0|||
162829302|NCT05419128|588087062|FG002|Overall Study|Lost to Follow-up|1|||
162829303|NCT05419128|588087063|FG003|Overall Study|Lost to Follow-up|0|||
162829304|NCT05419128|588087064|FG004|Overall Study|Lost to Follow-up|0|||
162829305|NCT05419128|588087065|FG005|Overall Study|Lost to Follow-up|1|||
162829306|NCT02581202|588087066|FG000|Overall Study|Lack of Efficacy|2|||
162829307|NCT02581202|588087066|FG000|Overall Study|Withdrawal by Subject|4|||
162829308|NCT02581202|588087066|FG000|Overall Study|Lost to Follow-up|5|||
162829309|NCT02581202|588087066|FG000|Overall Study|Pregnancy|3|||
162829310|NCT04218201|588089109|FG000|Overall Study|Death|0|||
162829311|NCT04218201|588089110|FG001|Overall Study|Death|0|||
162829312|NCT04218201|588089111|FG002|Overall Study|Death|2|||
162829313|NCT04218201|588089112|FG003|Overall Study|Death|0|||
162829314|NCT04218201|588089109|FG000|Overall Study|Unable to contact participant|4|||
162829315|NCT04218201|588089110|FG001|Overall Study|Unable to contact participant|0|||
162829316|NCT04218201|588089111|FG002|Overall Study|Unable to contact participant|3|||
162829317|NCT04218201|588089112|FG003|Overall Study|Unable to contact participant|0|||
162829318|NCT04218201|588089109|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
162829319|NCT04218201|588089110|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
162829320|NCT04218201|588089111|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
162829321|NCT04218201|588089112|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
162829322|NCT04218201|588089109|FG000|Overall Study|Withdrawal by Subject|2|||
162829323|NCT04218201|588089110|FG001|Overall Study|Withdrawal by Subject|0|||
162829324|NCT04218201|588089111|FG002|Overall Study|Withdrawal by Subject|0|||
162829325|NCT04218201|588089112|FG003|Overall Study|Withdrawal by Subject|0|||
162829326|NCT04218201|588089109|FG000|Overall Study|PCP plans to leave practice|0|||
162829327|NCT04218201|588089110|FG001|Overall Study|PCP plans to leave practice|8|||
162829328|NCT04218201|588089111|FG002|Overall Study|PCP plans to leave practice|0|||
162829329|NCT04218201|588089112|FG003|Overall Study|PCP plans to leave practice|5|||
162940434|NCT01688037|588484567|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
162940435|NCT01688037|588484568|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
162940436|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
162940437|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
162940438|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
162940439|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
162940440|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
162940441|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
162940442|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
162940443|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
162940444|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
162940445|NCT01688037|588484566|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
162940446|NCT01688037|588484567|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
162940447|NCT01688037|588484568|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
162940448|NCT01688037|588484566|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
162940449|NCT01688037|588484567|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
162940450|NCT01688037|588484568|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
162940451|NCT05440097|588485641|FG000|Overall Study|Withdrawal by Subject|154|||
162940452|NCT05440097|588485641|FG000|Overall Study|Death|2|||
162940453|NCT05440097|588485641|FG000|Overall Study|Physician Decision|2|||
162940454|NCT05440097|588485641|FG000|Overall Study|Lost to Follow-up|56|||
162940455|NCT05440097|588485641|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
162940456|NCT05590585|588485645|FG000|Overall Study|Lost to Follow-up|3|||
162940457|NCT05590585|588485645|FG000|Overall Study|Withdrawal by Subject|1|||
162940458|NCT01673009|588485646|FG000|Overall Study|Physician Decision|5|||
162940459|NCT01673009|588485646|FG000|Overall Study|Withdrawal by Subject|8|||
162940460|NCT04161144|588485648|FG000|Overall Study|Withdrawal by Subject|0|||
162940461|NCT04161144|588485649|FG001|Overall Study|Withdrawal by Subject|1|||
162940462|NCT04161144|588485648|FG000|Overall Study|Protocol Violation|1|||
162940463|NCT04161144|588485649|FG001|Overall Study|Protocol Violation|0|||
162940464|NCT04828161|588485650|FG000|Overall Study|Withdrawal by Subject|0|||
162940465|NCT04828161|588485651|FG001|Overall Study|Withdrawal by Subject|3|||
162940466|NCT04828161|588485652|FG002|Overall Study|Withdrawal by Subject|3|||
162940467|NCT04828161|588485653|FG003|Overall Study|Withdrawal by Subject|4|||
162940468|NCT04828161|588485650|FG000|Overall Study|Lost to Follow-up|1|||
162940469|NCT04828161|588485651|FG001|Overall Study|Lost to Follow-up|4|||
162940470|NCT04828161|588485652|FG002|Overall Study|Lost to Follow-up|2|||
162940471|NCT04828161|588485653|FG003|Overall Study|Lost to Follow-up|2|||
162940472|NCT04828161|588485650|FG000|Overall Study|Other|2|||
162940473|NCT04828161|588485651|FG001|Overall Study|Other|0|||
162940474|NCT04828161|588485652|FG002|Overall Study|Other|2|||
162940475|NCT04828161|588485653|FG003|Overall Study|Other|0|||
162940476|NCT04828161|588485650|FG000|Overall Study|Death|0|||
162940477|NCT04828161|588485651|FG001|Overall Study|Death|0|||
162940478|NCT04828161|588485652|FG002|Overall Study|Death|0|||
162940479|NCT04828161|588485653|FG003|Overall Study|Death|2|||
162940480|NCT03093454|588485654|FG000|Overall Study|Withdrawal by Subject|1|||
162940481|NCT03093454|588485655|FG001|Overall Study|Withdrawal by Subject|1|||
162940482|NCT03093454|588485654|FG000|Overall Study|Scheduling conflict|3|||
162940483|NCT03093454|588485655|FG001|Overall Study|Scheduling conflict|1|||
162940484|NCT03093454|588485654|FG000|Overall Study|Physician Decision|2|||
162940485|NCT03093454|588485655|FG001|Overall Study|Physician Decision|1|||
162940486|NCT02524379|588485656|FG000|Overall Study|Death|1|||
162940487|NCT01884025|588485657|FG000|Overall Study|Lost to Follow-up|3|||
162940488|NCT01884025|588485658|FG001|Overall Study|Lost to Follow-up|4|||
162940489|NCT02854436|588485660|FG000|Overall Study|Adverse Event|1|||
162940490|NCT02854436|588485660|FG000|Overall Study|Death|208|||
162940491|NCT02854436|588485660|FG000|Overall Study|Lost to Follow-up|5|||
162940492|NCT02854436|588485660|FG000|Overall Study|Withdrawal by Subject|24|||
162940493|NCT02854436|588485660|FG000|Overall Study|Other|45|||
162940494|NCT02854436|588485660|FG000|Overall Study|Physician Decision|6|||
162940495|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
162940496|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
162940497|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
162940498|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
162940499|NCT01700621|588485661|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
162940500|NCT01700621|588485662|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
162940501|NCT00384033|588485672|FG000|Overall Study|Adverse Event|10|||
162940502|NCT00384033|588485673|FG001|Overall Study|Adverse Event|8|||
162940503|NCT00384033|588485674|FG002|Overall Study|Adverse Event|11|||
162940504|NCT00384033|588485675|FG003|Overall Study|Adverse Event|20|||
162940505|NCT00384033|588485672|FG000|Overall Study|Failed to return|1|||
162940506|NCT00384033|588485673|FG001|Overall Study|Failed to return|3|||
162940507|NCT00384033|588485674|FG002|Overall Study|Failed to return|2|||
162940508|NCT00384033|588485675|FG003|Overall Study|Failed to return|2|||
162940509|NCT00384033|588485672|FG000|Overall Study|Physician Decision|1|||
162940510|NCT00384033|588485673|FG001|Overall Study|Physician Decision|0|||
162940511|NCT00384033|588485674|FG002|Overall Study|Physician Decision|0|||
162940512|NCT00384033|588485675|FG003|Overall Study|Physician Decision|0|||
162698671|NCT00337662|587605556|FG003|Study Period II|Parent/Caregiver Decision|1|||
162698672|NCT00337662|587605553|FG000|Study Period III|Lost to Follow-up|14|||
162940513|NCT00384033|588485672|FG000|Overall Study|Lost to Follow-up|6|||
162940514|NCT00384033|588485673|FG001|Overall Study|Lost to Follow-up|12|||
162940515|NCT00384033|588485674|FG002|Overall Study|Lost to Follow-up|7|||
162940516|NCT00384033|588485675|FG003|Overall Study|Lost to Follow-up|7|||
162940517|NCT00384033|588485672|FG000|Overall Study|Other|2|||
162940518|NCT00384033|588485673|FG001|Overall Study|Other|0|||
162940519|NCT00384033|588485674|FG002|Overall Study|Other|0|||
162940520|NCT00384033|588485675|FG003|Overall Study|Other|0|||
162940521|NCT00384033|588485672|FG000|Overall Study|Protocol Violation|5|||
162940522|NCT00384033|588485673|FG001|Overall Study|Protocol Violation|0|||
162940523|NCT00384033|588485674|FG002|Overall Study|Protocol Violation|5|||
162940524|NCT00384033|588485675|FG003|Overall Study|Protocol Violation|6|||
162940525|NCT00384033|588485672|FG000|Overall Study|Withdrawal by Subject|6|||
162940526|NCT00384033|588485673|FG001|Overall Study|Withdrawal by Subject|2|||
162940527|NCT00384033|588485674|FG002|Overall Study|Withdrawal by Subject|5|||
162940528|NCT00384033|588485675|FG003|Overall Study|Withdrawal by Subject|2|||
162940529|NCT00384033|588485672|FG000|Overall Study|Lack of Efficacy|7|||
162940530|NCT00384033|588485673|FG001|Overall Study|Lack of Efficacy|3|||
162940531|NCT00384033|588485674|FG002|Overall Study|Lack of Efficacy|3|||
162940532|NCT00384033|588485675|FG003|Overall Study|Lack of Efficacy|1|||
162940533|NCT00384033|588485672|FG000|Overall Study|Randomized but not treated|3|||
162940534|NCT00384033|588485673|FG001|Overall Study|Randomized but not treated|7|||
162940535|NCT00384033|588485674|FG002|Overall Study|Randomized but not treated|10|||
162940536|NCT00384033|588485675|FG003|Overall Study|Randomized but not treated|2|||
162940537|NCT02985151|588485676|FG000|Original Randomization|Withdrawal by Subject|0|||
162940538|NCT02985151|588485677|FG001|Original Randomization|Withdrawal by Subject|1|||
162940539|NCT02843074|588485687|FG000|Overall Study|Withdrawal by Subject|5|||
162940540|NCT02843074|588485687|FG000|Overall Study|Progressive disease|1|||
162940541|NCT02843074|588485687|FG000|Overall Study|Physician Decision|1|||
162940542|NCT02843074|588485687|FG000|Overall Study|Lost to Follow-up|1|||
162940543|NCT02843074|588485687|FG000|Overall Study|Death|9|||
162940544|NCT01564758|588485688|FG000|Overall Study|Death|8|||
162940545|NCT01564758|588485688|FG000|Overall Study|Adverse Event|3|||
162940546|NCT01564758|588485688|FG000|Overall Study|Other|3|||
162940547|NCT01186978|588485689|FG000|Overall Study|Withdrawal by Subject|1|||
162940548|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
162940549|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
162940550|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
162940551|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
162940552|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
162940553|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
162940554|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
162940555|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
162940556|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
162940557|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
162940558|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
162940559|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
162940560|NCT01227668|588485690|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
162940561|NCT01227668|588485691|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
162940562|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
162940563|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
162940564|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
162940565|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
162940566|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
162940567|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
162940568|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
162940569|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
162940570|NCT01227668|588485690|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
162940571|NCT01227668|588485691|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
162940572|NCT04281485|588485692|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
162940573|NCT04281485|588485693|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
162940574|NCT04281485|588485692|FG000|Overall Study|Ongoing (Safety data collection)|10|||
162940575|NCT04281485|588485693|FG001|Overall Study|Ongoing (Safety data collection)|5|||
162940576|NCT04317599|588485694|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
162940577|NCT04317599|588485694|FG000|Overall Study|treatment outside standard of care|4|||
162940578|NCT02115256|588485704|FG000|Overall Study|Withdrawal by Subject|0|||
162940579|NCT02115256|588485705|FG001|Overall Study|Withdrawal by Subject|1|||
162940580|NCT02427607|588485708|FG000|Overall Study|Withdrawal by Subject|1|||
162940581|NCT03211416|588485709|FG000|Overall Study|Adverse Event|7|||
162940582|NCT03211416|588485709|FG000|Overall Study|Lack of Efficacy|2|||
162940583|NCT03211416|588485709|FG000|Overall Study|Physician Decision|1|||
162940584|NCT01789320|588485710|FG000|Overall Study|Re-enrolled into study|1|||
162940585|NCT01789320|588485710|FG000|Overall Study|Lost to Follow-up|1|||
162940586|NCT03199274|588485713|FG000|Overall Study|Withdrawal by Subject|4|||
162940587|NCT03199274|588485714|FG001|Overall Study|Withdrawal by Subject|0|||
162940588|NCT03199274|588485713|FG000|Overall Study|Lost to Follow-up|0|||
162940589|NCT03199274|588485714|FG001|Overall Study|Lost to Follow-up|1|||
162940590|NCT03199274|588485713|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
162940591|NCT03199274|588485714|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
162940592|NCT01533428|588485725|FG000|Overall Study|Adverse Event|0|||
162940593|NCT01533428|588485726|FG001|Overall Study|Adverse Event|1|||
162940594|NCT01533428|588485725|FG000|Overall Study|Lost to Follow-up|2|||
162940595|NCT01533428|588485726|FG001|Overall Study|Lost to Follow-up|1|||
162940596|NCT01533428|588485725|FG000|Overall Study|Withdrawal by Subject|7|||
162940597|NCT01533428|588485726|FG001|Overall Study|Withdrawal by Subject|6|||
162940598|NCT02102490|588485727|FG000|Overall Study|Death|6|||
162940599|NCT02102490|588485727|FG000|Overall Study|Lost to Follow-up|1|||
162940600|NCT00095199|588485728|FG000|Overall Study|Adverse Event|40|||
162940601|NCT00095199|588485729|FG001|Overall Study|Adverse Event|22|||
162940602|NCT00095199|588485730|FG002|Overall Study|Adverse Event|26|||
162940603|NCT00095199|588485731|FG003|Overall Study|Adverse Event|11|||
162940604|NCT00095199|588485728|FG000|Overall Study|Progressive disease|213|||
162940605|NCT00095199|588485729|FG001|Overall Study|Progressive disease|179|||
162940606|NCT00095199|588485730|FG002|Overall Study|Progressive disease|105|||
162940607|NCT00095199|588485731|FG003|Overall Study|Progressive disease|98|||
162940608|NCT00095199|588485728|FG000|Overall Study|Death|10|||
162940609|NCT00095199|588485729|FG001|Overall Study|Death|6|||
162940610|NCT00095199|588485730|FG002|Overall Study|Death|11|||
162940611|NCT00095199|588485731|FG003|Overall Study|Death|9|||
162940612|NCT00095199|588485728|FG000|Overall Study|Withdrawal by Subject|21|||
162940613|NCT00095199|588485729|FG001|Overall Study|Withdrawal by Subject|16|||
162940614|NCT00095199|588485730|FG002|Overall Study|Withdrawal by Subject|13|||
162940615|NCT00095199|588485731|FG003|Overall Study|Withdrawal by Subject|22|||
162940616|NCT00095199|588485728|FG000|Overall Study|Protocol Violation|4|||
162940617|NCT00095199|588485729|FG001|Overall Study|Protocol Violation|4|||
162940618|NCT00095199|588485730|FG002|Overall Study|Protocol Violation|2|||
162940619|NCT00095199|588485731|FG003|Overall Study|Protocol Violation|0|||
162940620|NCT00095199|588485728|FG000|Overall Study|Liver function test results elevated|0|||
162940621|NCT00095199|588485729|FG001|Overall Study|Liver function test results elevated|0|||
162940622|NCT00095199|588485730|FG002|Overall Study|Liver function test results elevated|1|||
162940623|NCT00095199|588485731|FG003|Overall Study|Liver function test results elevated|1|||
162940624|NCT00095199|588485728|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
162940625|NCT00095199|588485729|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
162940626|NCT00095199|588485730|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
162940627|NCT00095199|588485731|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
162940628|NCT00095199|588485728|FG000|Overall Study|Physician Decision|5|||
162940629|NCT00095199|588485729|FG001|Overall Study|Physician Decision|6|||
162940630|NCT00095199|588485730|FG002|Overall Study|Physician Decision|1|||
162940631|NCT00095199|588485731|FG003|Overall Study|Physician Decision|1|||
162940632|NCT00095199|588485728|FG000|Overall Study|Not eligible|1|||
162940633|NCT00095199|588485729|FG001|Overall Study|Not eligible|7|||
162940634|NCT00095199|588485730|FG002|Overall Study|Not eligible|0|||
162940635|NCT00095199|588485731|FG003|Overall Study|Not eligible|1|||
162940636|NCT00095199|588485728|FG000|Overall Study|Started Palliative Radiotherapy|1|||
162940637|NCT00095199|588485729|FG001|Overall Study|Started Palliative Radiotherapy|0|||
162940638|NCT00095199|588485730|FG002|Overall Study|Started Palliative Radiotherapy|0|||
162940639|NCT00095199|588485731|FG003|Overall Study|Started Palliative Radiotherapy|0|||
162940640|NCT00095199|588485728|FG000|Overall Study|Started radiotherapy regimen|0|||
162940641|NCT00095199|588485729|FG001|Overall Study|Started radiotherapy regimen|1|||
162940642|NCT00095199|588485730|FG002|Overall Study|Started radiotherapy regimen|0|||
162940643|NCT00095199|588485731|FG003|Overall Study|Started radiotherapy regimen|0|||
162940644|NCT00095199|588485728|FG000|Overall Study|Primary tumor removed in other surgery|0|||
162940645|NCT00095199|588485729|FG001|Overall Study|Primary tumor removed in other surgery|1|||
162940646|NCT00095199|588485730|FG002|Overall Study|Primary tumor removed in other surgery|0|||
162940647|NCT00095199|588485731|FG003|Overall Study|Primary tumor removed in other surgery|0|||
162940648|NCT00095199|588485728|FG000|Overall Study|Data inadvertently lost by site|1|||
162940649|NCT00095199|588485729|FG001|Overall Study|Data inadvertently lost by site|0|||
162940650|NCT00095199|588485730|FG002|Overall Study|Data inadvertently lost by site|0|||
162940651|NCT00095199|588485731|FG003|Overall Study|Data inadvertently lost by site|0|||
162940652|NCT03896490|588485732|FG000|Overall Study|Withdrawal by Subject|1|||
162940653|NCT03896490|588485733|FG001|Overall Study|Withdrawal by Subject|1|||
162940654|NCT00385541|588485736|FG000|Overall Study|severe pain, clinician requested unblind|0|||
162940655|NCT00385541|588485737|FG001|Overall Study|severe pain, clinician requested unblind|1|||
162940656|NCT00929708|588485738|FG000|Overall Study|Protocol Violation|2|||
162940657|NCT00929708|588485739|FG001|Overall Study|Protocol Violation|1|||
162940658|NCT00929708|588485740|FG002|Overall Study|Protocol Violation|1|||
162940659|NCT00929708|588485741|FG003|Overall Study|Protocol Violation|1|||
162940660|NCT00929708|588485742|FG004|Overall Study|Protocol Violation|1|||
162940661|NCT00929708|588485738|FG000|Overall Study|Withdrawal by Subject|2|||
162940662|NCT00929708|588485739|FG001|Overall Study|Withdrawal by Subject|0|||
162940663|NCT00929708|588485740|FG002|Overall Study|Withdrawal by Subject|0|||
162940664|NCT00929708|588485741|FG003|Overall Study|Withdrawal by Subject|2|||
162940665|NCT00929708|588485742|FG004|Overall Study|Withdrawal by Subject|1|||
162940666|NCT00929708|588485738|FG000|Overall Study|Adverse Event|0|||
162940667|NCT00929708|588485739|FG001|Overall Study|Adverse Event|0|||
162940668|NCT00929708|588485740|FG002|Overall Study|Adverse Event|0|||
162940669|NCT00929708|588485741|FG003|Overall Study|Adverse Event|0|||
162940670|NCT00929708|588485742|FG004|Overall Study|Adverse Event|3|||
162940671|NCT00929708|588485738|FG000|Overall Study|Physician Decision|0|||
162940672|NCT00929708|588485739|FG001|Overall Study|Physician Decision|2|||
162940673|NCT00929708|588485740|FG002|Overall Study|Physician Decision|2|||
162940674|NCT00929708|588485741|FG003|Overall Study|Physician Decision|2|||
162940675|NCT00929708|588485742|FG004|Overall Study|Physician Decision|1|||
162940676|NCT00929708|588485738|FG000|Overall Study|Lost to Follow-up|0|||
162940677|NCT00929708|588485739|FG001|Overall Study|Lost to Follow-up|0|||
162940678|NCT00929708|588485740|FG002|Overall Study|Lost to Follow-up|0|||
162940679|NCT00929708|588485741|FG003|Overall Study|Lost to Follow-up|1|||
162940680|NCT00929708|588485742|FG004|Overall Study|Lost to Follow-up|0|||
162940681|NCT02154529|588485743|FG000|Overall Study|Death|1|||
162940682|NCT02154529|588485744|FG001|Overall Study|Death|1|||
162940683|NCT02154529|588485745|FG002|Overall Study|Death|5|||
162940684|NCT02154529|588485746|FG003|Overall Study|Death|1|||
162940685|NCT02154529|588485743|FG000|Overall Study|Termination of study by sponsor|2|||
162940686|NCT02154529|588485744|FG001|Overall Study|Termination of study by sponsor|2|||
162940687|NCT02154529|588485745|FG002|Overall Study|Termination of study by sponsor|3|||
162940688|NCT02154529|588485746|FG003|Overall Study|Termination of study by sponsor|1|||
162940689|NCT02154529|588485743|FG000|Overall Study|Lost to Follow-up|1|||
162940690|NCT02154529|588485744|FG001|Overall Study|Lost to Follow-up|0|||
162940691|NCT02154529|588485745|FG002|Overall Study|Lost to Follow-up|0|||
162940692|NCT02154529|588485746|FG003|Overall Study|Lost to Follow-up|0|||
162940693|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Adverse Event|3|||
162940694|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Adverse Event|0|||
162940695|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
162940696|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
162940697|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Physician Decision|1|||
162940698|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Physician Decision|0|||
162940699|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
162940700|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
162940701|NCT02081599|588486984|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
162940702|NCT02081599|588486985|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
162940703|NCT02081599|588486984|FG000|Period 1：Double-blind Period|stopping criteria|1|||
162940704|NCT02081599|588486985|FG001|Period 1：Double-blind Period|stopping criteria|0|||
162940705|NCT02081599|588486984|FG000|Period 2：Open-label Period|Adverse Event|1|||
162940706|NCT02081599|588486985|FG001|Period 2：Open-label Period|Adverse Event|0|||
162940707|NCT02081599|588486984|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
162940708|NCT02081599|588486985|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
162940709|NCT02081599|588486984|FG000|Period 2：Open-label Period|Physician Decision|1|||
162940710|NCT02081599|588486985|FG001|Period 2：Open-label Period|Physician Decision|0|||
162940711|NCT02081599|588486984|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
162940712|NCT02081599|588486985|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
162940713|NCT02146430|588486994|FG000|Overall Study|Protocol Violation|5|||
162940714|NCT02146430|588486995|FG001|Overall Study|Protocol Violation|4|||
162940715|NCT02146430|588486996|FG002|Overall Study|Protocol Violation|8|||
162940716|NCT02146430|588486997|FG003|Overall Study|Protocol Violation|6|||
162940717|NCT02146430|588486994|FG000|Overall Study|Lack of Efficacy|13|||
162940718|NCT02146430|588486995|FG001|Overall Study|Lack of Efficacy|11|||
162940719|NCT02146430|588486996|FG002|Overall Study|Lack of Efficacy|8|||
162940720|NCT02146430|588486997|FG003|Overall Study|Lack of Efficacy|5|||
162940721|NCT02146430|588486994|FG000|Overall Study|Adverse Event|20|||
162940722|NCT02146430|588486995|FG001|Overall Study|Adverse Event|40|||
162940723|NCT02146430|588486996|FG002|Overall Study|Adverse Event|32|||
162940724|NCT02146430|588486997|FG003|Overall Study|Adverse Event|49|||
162940725|NCT02146430|588486994|FG000|Overall Study|Reason missing or not reported|2|||
162940726|NCT02146430|588486995|FG001|Overall Study|Reason missing or not reported|3|||
162940727|NCT02146430|588486996|FG002|Overall Study|Reason missing or not reported|4|||
162940728|NCT02146430|588486997|FG003|Overall Study|Reason missing or not reported|5|||
162940729|NCT02146430|588486994|FG000|Overall Study|Withdrawal by Subject|27|||
162940730|NCT02146430|588486995|FG001|Overall Study|Withdrawal by Subject|29|||
162940731|NCT02146430|588486996|FG002|Overall Study|Withdrawal by Subject|30|||
162940732|NCT02146430|588486997|FG003|Overall Study|Withdrawal by Subject|34|||
162940733|NCT03093324|588486998|FG000|Overall Study|Adverse Event|4|||
162940734|NCT03093324|588486999|FG001|Overall Study|Adverse Event|15|||
162940735|NCT03093324|588486998|FG000|Overall Study|Lost to Follow-up|1|||
162940736|NCT03093324|588486999|FG001|Overall Study|Lost to Follow-up|0|||
162940737|NCT03093324|588486998|FG000|Overall Study|Protocol Deviation|2|||
162940738|NCT03093324|588486999|FG001|Overall Study|Protocol Deviation|2|||
162940739|NCT03093324|588486998|FG000|Overall Study|Withdrawal by Subject|2|||
162940740|NCT03093324|588486999|FG001|Overall Study|Withdrawal by Subject|2|||
162940741|NCT01767597|588487000|FG000|Overall Study|Incomplete intervention|3|||
162940742|NCT01767597|588487001|FG001|Overall Study|Incomplete intervention|1|||
162940743|NCT01767597|588487000|FG000|Overall Study|Withdrawal by Subject|1|||
162940744|NCT01767597|588487001|FG001|Overall Study|Withdrawal by Subject|0|||
162940745|NCT05342753|588487002|FG000|Overall Study|Withdrawal by Subject|6|||
162940746|NCT05342753|588487002|FG000|Overall Study|Lost to Follow-up|1|||
162940747|NCT00836927|588487003|FG000|Overall Study|Progressive disease|2|||
162940748|NCT00836927|588487004|FG001|Overall Study|Progressive disease|0|||
162940749|NCT00836927|588487005|FG002|Overall Study|Progressive disease|0|||
162940750|NCT00836927|588487006|FG003|Overall Study|Progressive disease|1|||
162940751|NCT00836927|588487007|FG004|Overall Study|Progressive disease|1|||
162940752|NCT00836927|588487003|FG000|Overall Study|Withdrawal by Subject|1|||
162940753|NCT00836927|588487004|FG001|Overall Study|Withdrawal by Subject|0|||
162940754|NCT00836927|588487005|FG002|Overall Study|Withdrawal by Subject|0|||
162940755|NCT00836927|588487006|FG003|Overall Study|Withdrawal by Subject|0|||
162940756|NCT00836927|588487007|FG004|Overall Study|Withdrawal by Subject|0|||
162940757|NCT04583579|588487010|FG000|Overall Study|Lost to Follow-up|4|||
162940758|NCT02006706|588487011|FG000|Overall Study|Lost to Follow-up|1|||
162940759|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
162940760|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
162940761|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
162940762|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
162940763|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940764|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
162940765|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940766|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
162940767|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940768|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940769|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
162940770|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
162940771|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
162940772|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940773|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940774|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
162940775|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
162940776|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
162940777|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
162940778|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
162940779|NCT04700449|588487014|FG000|Stage 1: Double-Blind Period|Other|0|||
162940780|NCT04700449|588487015|FG001|Stage 1: Double-Blind Period|Other|0|||
162940781|NCT04700449|588487016|FG002|Stage 1: Double-Blind Period|Other|1|||
162940782|NCT04700449|588487017|FG003|Stage 1: Double-Blind Period|Other|0|||
162940783|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
162940784|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
162829330|NCT04218201|588089109|FG000|Overall Study|Reduced panel|0|||
162829331|NCT04218201|588089110|FG001|Overall Study|Reduced panel|0|||
162829332|NCT04218201|588089111|FG002|Overall Study|Reduced panel|0|||
162829333|NCT04218201|588089112|FG003|Overall Study|Reduced panel|1|||
162829334|NCT04218201|588089109|FG000|Overall Study|No longer interested in participating|0|||
162829335|NCT04218201|588089110|FG001|Overall Study|No longer interested in participating|1|||
162829336|NCT04218201|588089111|FG002|Overall Study|No longer interested in participating|0|||
162829337|NCT04218201|588089112|FG003|Overall Study|No longer interested in participating|0|||
162829338|NCT02484911|588089115|FG000|Overall Study|Withdrawal by Subject|2|||
162829339|NCT02484911|588089116|FG001|Overall Study|Withdrawal by Subject|1|||
162829340|NCT02484911|588089115|FG000|Overall Study|Protocol Violation|2|||
162829341|NCT02484911|588089116|FG001|Overall Study|Protocol Violation|1|||
162829342|NCT02222207|588089120|FG000|Overall Study|Death|1|||
162829343|NCT02222207|588089120|FG000|Overall Study|Other reasons|2|||
162829344|NCT02222207|588089120|FG000|Overall Study|Adverse Event|1|||
162829345|NCT04036708|588089123|FG000|Overall Study|Lost to Follow-up|14|||
162829346|NCT04036708|588089124|FG001|Overall Study|Lost to Follow-up|4|||
162829347|NCT04036708|588089125|FG002|Overall Study|Lost to Follow-up|14|||
162829348|NCT04036708|588089126|FG003|Overall Study|Lost to Follow-up|4|||
162829349|NCT02918864|588089127|FG000|Overall Study|Withdrawal by Subject|1|||
162829350|NCT02918864|588089128|FG001|Overall Study|Withdrawal by Subject|1|||
162829351|NCT02918864|588089127|FG000|Overall Study|Lost to Follow-up|3|||
162829352|NCT02918864|588089128|FG001|Overall Study|Lost to Follow-up|2|||
162829353|NCT02104583|588089131|FG000|Overall Study|New ICD or CRT-D implanted|2|||
162829354|NCT02104583|588089132|FG001|Overall Study|New ICD or CRT-D implanted|0|||
162829355|NCT02104583|588089133|FG002|Overall Study|New ICD or CRT-D implanted|1|||
162829356|NCT02104583|588089134|FG003|Overall Study|New ICD or CRT-D implanted|0|||
162829357|NCT02104583|588089135|FG004|Overall Study|New ICD or CRT-D implanted|0|||
162829358|NCT02104583|588089131|FG000|Overall Study|Death|2|||
162940785|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
162940786|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
162940787|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940788|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940789|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
162940790|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
162940791|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940792|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940793|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
162940794|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
162940795|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940796|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940797|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
162940798|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
162940799|NCT04700449|588487014|FG000|Stage 2 Sub-study 1|Other|1|||
162940800|NCT04700449|588487015|FG001|Stage 2 Sub-study 1|Other|2|||
162940801|NCT04700449|588487016|FG002|Stage 2 Sub-study 1|Other|0|||
162940802|NCT04700449|588487017|FG003|Stage 2 Sub-study 1|Other|0|||
162940803|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
162940804|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
162940805|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
162940806|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
162940807|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940808|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940809|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
162940810|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
162940811|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940812|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940813|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
162940814|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
162940815|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
162829359|NCT02104583|588089132|FG001|Overall Study|Death|1|||
162829360|NCT02104583|588089133|FG002|Overall Study|Death|3|||
162829361|NCT02104583|588089134|FG003|Overall Study|Death|3|||
162829362|NCT02104583|588089135|FG004|Overall Study|Death|5|||
162829363|NCT02104583|588089131|FG000|Overall Study|Subject required cardiac ablation|6|||
162829364|NCT02104583|588089132|FG001|Overall Study|Subject required cardiac ablation|4|||
162829365|NCT02104583|588089133|FG002|Overall Study|Subject required cardiac ablation|4|||
162829366|NCT02104583|588089134|FG003|Overall Study|Subject required cardiac ablation|5|||
162940816|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
162940817|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
162829367|NCT02104583|588089135|FG004|Overall Study|Subject required cardiac ablation|4|||
162829368|NCT02104583|588089131|FG000|Overall Study|Subject required prohibited medication|0|||
162829369|NCT02104583|588089132|FG001|Overall Study|Subject required prohibited medication|1|||
162829370|NCT02104583|588089133|FG002|Overall Study|Subject required prohibited medication|1|||
162829371|NCT02104583|588089134|FG003|Overall Study|Subject required prohibited medication|0|||
162829372|NCT02104583|588089135|FG004|Overall Study|Subject required prohibited medication|1|||
162829373|NCT02104583|588089131|FG000|Overall Study|Withdrew Consent|3|||
162829374|NCT02104583|588089132|FG001|Overall Study|Withdrew Consent|2|||
162829375|NCT02104583|588089133|FG002|Overall Study|Withdrew Consent|0|||
162829376|NCT02104583|588089134|FG003|Overall Study|Withdrew Consent|2|||
162829377|NCT02104583|588089135|FG004|Overall Study|Withdrew Consent|1|||
162829378|NCT02104583|588089131|FG000|Overall Study|Investigator's Discretion|1|||
162829379|NCT02104583|588089132|FG001|Overall Study|Investigator's Discretion|0|||
162940818|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
162940819|NCT04700449|588487014|FG000|Stage 2 Sub-study 2|Other|0|||
162940820|NCT04700449|588487015|FG001|Stage 2 Sub-study 2|Other|0|||
162940821|NCT04700449|588487016|FG002|Stage 2 Sub-study 2|Other|0|||
162829380|NCT02104583|588089133|FG002|Overall Study|Investigator's Discretion|0|||
162829381|NCT02104583|588089134|FG003|Overall Study|Investigator's Discretion|0|||
162940822|NCT04700449|588487017|FG003|Stage 2 Sub-study 2|Other|5|||
162940823|NCT06041646|588487018|FG000|Overall Study|Withdrawal by Subject|1|||
162940824|NCT00356200|588487019|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
162940825|NCT00356200|588487020|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
162940826|NCT00356200|588487019|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
162940827|NCT00356200|588487020|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
162940828|NCT03209570|588487021|FG000|Overall Study|Death|1|||
162940829|NCT03209570|588487022|FG001|Overall Study|Death|0|||
162940830|NCT03209570|588487021|FG000|Overall Study|Incomplete Data|8|||
162698673|NCT00337662|587605554|FG001|Study Period III|Lost to Follow-up|16|||
162829382|NCT02104583|588089135|FG004|Overall Study|Investigator's Discretion|0|||
162829383|NCT02104583|588089131|FG000|Overall Study|Protocol Violation|0|||
162829384|NCT02104583|588089132|FG001|Overall Study|Protocol Violation|0|||
162829385|NCT02104583|588089133|FG002|Overall Study|Protocol Violation|1|||
162829386|NCT02104583|588089134|FG003|Overall Study|Protocol Violation|0|||
162829387|NCT02104583|588089135|FG004|Overall Study|Protocol Violation|0|||
162829388|NCT02104583|588089131|FG000|Overall Study|Adverse Event|3|||
162829389|NCT02104583|588089132|FG001|Overall Study|Adverse Event|3|||
162829390|NCT02104583|588089133|FG002|Overall Study|Adverse Event|6|||
162829391|NCT02104583|588089134|FG003|Overall Study|Adverse Event|6|||
162829392|NCT02104583|588089135|FG004|Overall Study|Adverse Event|1|||
162829393|NCT02104583|588089131|FG000|Overall Study|Lost to Follow-up|1|||
162829394|NCT02104583|588089132|FG001|Overall Study|Lost to Follow-up|0|||
162829395|NCT02104583|588089133|FG002|Overall Study|Lost to Follow-up|0|||
162829396|NCT02104583|588089134|FG003|Overall Study|Lost to Follow-up|0|||
162829397|NCT02104583|588089135|FG004|Overall Study|Lost to Follow-up|0|||
162829398|NCT02104583|588089131|FG000|Overall Study|Randomized but Never Treated|0|||
162829399|NCT02104583|588089132|FG001|Overall Study|Randomized but Never Treated|0|||
162829400|NCT02104583|588089133|FG002|Overall Study|Randomized but Never Treated|0|||
162829401|NCT02104583|588089134|FG003|Overall Study|Randomized but Never Treated|1|||
162829402|NCT02104583|588089135|FG004|Overall Study|Randomized but Never Treated|0|||
162829403|NCT00129766|588089136|FG000|Overall Study|Death|3|||
162829404|NCT00129766|588089137|FG001|Overall Study|Death|8|||
162829405|NCT00129766|588089136|FG000|Overall Study|Withdrawal of consent|31|||
162829406|NCT00129766|588089137|FG001|Overall Study|Withdrawal of consent|30|||
162829407|NCT00129766|588089136|FG000|Overall Study|Lost to Follow-up|26|||
162829408|NCT00129766|588089137|FG001|Overall Study|Lost to Follow-up|21|||
162829409|NCT01230307|588089138|FG000|Overall Study|LVAD Placement|0|||
162829410|NCT01230307|588089139|FG001|Overall Study|LVAD Placement|2|||
162829411|NCT04773106|588089140|FG000|Overall Study|Withdrawal by Subject|3|||
162829412|NCT04773106|588089140|FG000|Overall Study|Death|1|||
162829413|NCT02819635|588089144|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
162829414|NCT02819635|588089145|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
162829415|NCT02819635|588089146|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
162829416|NCT02819635|588089147|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
162829417|NCT02819635|588089148|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
162829418|NCT02819635|588089149|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
162829419|NCT02819635|588089150|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
162829420|NCT02819635|588089151|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
162829421|NCT02819635|588089152|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
162829422|NCT02819635|588089153|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
162829423|NCT02819635|588089154|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
162829424|NCT02819635|588089155|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
162829425|NCT02819635|588089144|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829426|NCT02819635|588089145|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829427|NCT02819635|588089146|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829428|NCT02819635|588089147|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829429|NCT02819635|588089148|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
162829430|NCT02819635|588089149|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
162829431|NCT02819635|588089150|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
162698674|NCT00337662|587605555|FG002|Study Period III|Lost to Follow-up|14|||
162698675|NCT00337662|587605556|FG003|Study Period III|Lost to Follow-up|0|||
162698676|NCT00337662|587605553|FG000|Study Period III|Withdrawal by Subject|18|||
162698677|NCT00337662|587605554|FG001|Study Period III|Withdrawal by Subject|14|||
162698678|NCT00337662|587605555|FG002|Study Period III|Withdrawal by Subject|12|||
162698679|NCT00337662|587605556|FG003|Study Period III|Withdrawal by Subject|0|||
162698680|NCT00337662|587605553|FG000|Study Period III|Adverse Event|9|||
162698681|NCT00337662|587605554|FG001|Study Period III|Adverse Event|10|||
162698682|NCT00337662|587605555|FG002|Study Period III|Adverse Event|8|||
162698683|NCT00337662|587605556|FG003|Study Period III|Adverse Event|0|||
162698684|NCT00337662|587605553|FG000|Study Period III|Protocol Violation|3|||
162698685|NCT00337662|587605554|FG001|Study Period III|Protocol Violation|8|||
162698686|NCT00337662|587605555|FG002|Study Period III|Protocol Violation|2|||
162698687|NCT00337662|587605556|FG003|Study Period III|Protocol Violation|0|||
162698688|NCT00337662|587605553|FG000|Study Period III|Physician Decision|6|||
162698689|NCT00337662|587605554|FG001|Study Period III|Physician Decision|5|||
162698690|NCT00337662|587605555|FG002|Study Period III|Physician Decision|0|||
162829432|NCT02819635|588089151|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829433|NCT02819635|588089152|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162698691|NCT00337662|587605556|FG003|Study Period III|Physician Decision|0|||
162829434|NCT02819635|588089153|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829435|NCT02819635|588089154|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162829436|NCT02819635|588089155|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
162940831|NCT03209570|588487022|FG001|Overall Study|Incomplete Data|10|||
162940832|NCT03209570|588487021|FG000|Overall Study|Protocol Violation|1|||
162940833|NCT03209570|588487022|FG001|Overall Study|Protocol Violation|0|||
162940834|NCT03209570|588487021|FG000|Overall Study|Withdrawal by Subject|0|||
162940835|NCT03209570|588487022|FG001|Overall Study|Withdrawal by Subject|3|||
162940836|NCT01000337|588487023|FG000|Overall Study|Lost to Follow-up|4|||
162940837|NCT01000337|588487024|FG001|Overall Study|Lost to Follow-up|3|||
162940838|NCT02173704|588487025|FG000|Overall Study|Adverse Event|1|||
162940839|NCT02173704|588487026|FG001|Overall Study|Adverse Event|0|||
162940840|NCT02173704|588487025|FG000|Overall Study|Lost to Follow-up|1|||
162940841|NCT02173704|588487026|FG001|Overall Study|Lost to Follow-up|0|||
162940842|NCT02173704|588487025|FG000|Overall Study|Other|1|||
162940843|NCT02173704|588487026|FG001|Overall Study|Other|0|||
162940844|NCT02173704|588487025|FG000|Overall Study|Protocol Violation|1|||
162940845|NCT02173704|588487026|FG001|Overall Study|Protocol Violation|0|||
162940846|NCT02173704|588487025|FG000|Overall Study|Withdrawal by Subject|9|||
162940847|NCT02173704|588487026|FG001|Overall Study|Withdrawal by Subject|4|||
162940848|NCT03901963|588487027|FG000|Overall Study|Lost to Follow-up|1|||
162940849|NCT03901963|588487028|FG001|Overall Study|Lost to Follow-up|1|||
162940850|NCT03901963|588487027|FG000|Overall Study|Physician Decision|1|||
162940851|NCT03901963|588487028|FG001|Overall Study|Physician Decision|2|||
162940852|NCT03901963|588487027|FG000|Overall Study|Protocol Violation|1|||
162940853|NCT03901963|588487028|FG001|Overall Study|Protocol Violation|1|||
162940854|NCT03901963|588487027|FG000|Overall Study|Withdrawal by Subject|4|||
162940855|NCT03901963|588487028|FG001|Overall Study|Withdrawal by Subject|11|||
162940856|NCT03901963|588487027|FG000|Overall Study|Ongoing|84|||
162940857|NCT03901963|588487028|FG001|Overall Study|Ongoing|73|||
162940858|NCT03901963|588487027|FG000|Overall Study|Randomized but not treated|3|||
162940859|NCT03901963|588487028|FG001|Overall Study|Randomized but not treated|3|||
162940860|NCT04956666|588487029|FG000|Overall Study|Adverse Event|18|||
162940861|NCT04956666|588487029|FG000|Overall Study|Physician Decision|5|||
162940862|NCT02909673|588487030|FG000|Overall Study|Did not meet inclusion criteria|129|||
162940863|NCT02909673|588487031|FG001|Overall Study|Did not meet inclusion criteria|29|||
162940864|NCT02909673|588487030|FG000|Overall Study|Surveys lost by scanner|95|||
162940865|NCT02909673|588487031|FG001|Overall Study|Surveys lost by scanner|2|||
162940866|NCT02909673|588487030|FG000|Overall Study|Tracking info missing|0|||
162940867|NCT02909673|588487031|FG001|Overall Study|Tracking info missing|5|||
162940868|NCT03349333|588487040|FG000|Overall Study|Progression of Disease|36|||
162940869|NCT03349333|588487040|FG000|Overall Study|Adverse Event|11|||
162940870|NCT03349333|588487040|FG000|Overall Study|Other|6|||
162940871|NCT03349333|588487040|FG000|Overall Study|Withdrawal by Subject|5|||
162940872|NCT03349333|588487040|FG000|Overall Study|Conditions interfere with participation|2|||
162940873|NCT03349333|588487040|FG000|Overall Study|Physician Decision|2|||
162940874|NCT03349333|588487040|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
162940875|NCT03349333|588487040|FG000|Overall Study|Patients in treatment less than 24 month|8|||
162940876|NCT00783796|588487041|FG000|Overall Study|Did not receive any stent|4|||
162940877|NCT00783796|588487041|FG000|Overall Study|Received non-XIENCE V stent|1|||
162940878|NCT00783796|588487041|FG000|Overall Study|Received commercial XIENCE V stent|1|||
162940879|NCT02752776|588487044|FG000|Overall Study|Adverse Event|15|||
162940880|NCT02752776|588487045|FG001|Overall Study|Adverse Event|23|||
162940881|NCT02752776|588487046|FG002|Overall Study|Adverse Event|11|||
162940882|NCT02752776|588487044|FG000|Overall Study|Lack of Efficacy|2|||
162940883|NCT02752776|588487045|FG001|Overall Study|Lack of Efficacy|6|||
162940884|NCT02752776|588487046|FG002|Overall Study|Lack of Efficacy|14|||
162940885|NCT02752776|588487044|FG000|Overall Study|Lost to Follow-up|11|||
162940886|NCT02752776|588487045|FG001|Overall Study|Lost to Follow-up|12|||
162940887|NCT02752776|588487046|FG002|Overall Study|Lost to Follow-up|4|||
162940888|NCT02752776|588487044|FG000|Overall Study|Non-compliance with study treatment|0|||
162940889|NCT02752776|588487045|FG001|Overall Study|Non-compliance with study treatment|0|||
162940890|NCT02752776|588487046|FG002|Overall Study|Non-compliance with study treatment|1|||
162940891|NCT02752776|588487044|FG000|Overall Study|Physician Decision|2|||
162940892|NCT02752776|588487045|FG001|Overall Study|Physician Decision|6|||
162940893|NCT02752776|588487046|FG002|Overall Study|Physician Decision|2|||
162940894|NCT02752776|588487044|FG000|Overall Study|Pregnancy|1|||
162940895|NCT02752776|588487045|FG001|Overall Study|Pregnancy|6|||
162940896|NCT02752776|588487046|FG002|Overall Study|Pregnancy|3|||
162940897|NCT02752776|588487044|FG000|Overall Study|Protocol Violation|10|||
162940898|NCT02752776|588487045|FG001|Overall Study|Protocol Violation|13|||
162940899|NCT02752776|588487046|FG002|Overall Study|Protocol Violation|6|||
162940900|NCT02752776|588487044|FG000|Overall Study|Subject/guardian decision|8|||
162940901|NCT02752776|588487045|FG001|Overall Study|Subject/guardian decision|6|||
162940902|NCT02752776|588487046|FG002|Overall Study|Subject/guardian decision|4|||
162940903|NCT02752776|588487044|FG000|Overall Study|Death|0|||
162940904|NCT02752776|588487045|FG001|Overall Study|Death|0|||
162940905|NCT02752776|588487046|FG002|Overall Study|Death|1|||
162940906|NCT02752776|588487044|FG000|Overall Study|Withdrawal by Subject|3|||
162940907|NCT02752776|588487045|FG001|Overall Study|Withdrawal by Subject|4|||
162940908|NCT02752776|588487046|FG002|Overall Study|Withdrawal by Subject|2|||
162940909|NCT01816477|588487047|FG000|Overall Study|Withdrawal by Subject|13|||
162940910|NCT01816477|588487048|FG001|Overall Study|Withdrawal by Subject|1|||
162940911|NCT01816477|588487047|FG000|Overall Study|Unable to tolerate catheter placement|3|||
162940912|NCT01816477|588487048|FG001|Overall Study|Unable to tolerate catheter placement|0|||
162940913|NCT02162758|588487049|FG000|Overall Study|Study termination|0|||
162940914|NCT02162758|588487050|FG001|Overall Study|Study termination|1|||
162940915|NCT02116803|588487051|FG000|Overall Study|Adverse Event|2|||
162940916|NCT02116803|588487052|FG001|Overall Study|Adverse Event|1|||
162940917|NCT02116803|588487051|FG000|Overall Study|Physician Decision|1|||
162940918|NCT02116803|588487052|FG001|Overall Study|Physician Decision|0|||
162940919|NCT02116803|588487051|FG000|Overall Study|Progressive disease|4|||
162940920|NCT02116803|588487052|FG001|Overall Study|Progressive disease|0|||
162940921|NCT02116803|588487051|FG000|Overall Study|Study terminated by sponsor|2|||
162940922|NCT02116803|588487052|FG001|Overall Study|Study terminated by sponsor|1|||
162940923|NCT02116803|588487051|FG000|Overall Study|Death|1|||
162940924|NCT02116803|588487052|FG001|Overall Study|Death|0|||
162940925|NCT03213210|588487053|FG000|Overall Study|Lost to Follow-up|2|||
162940926|NCT03213210|588487053|FG000|Overall Study|Study termination|3|||
162940927|NCT00684671|588487054|FG000|Overall Study|Adverse Event|1|||
162940928|NCT00684671|588487055|FG001|Overall Study|Adverse Event|0|||
162940929|NCT00684671|588487056|FG002|Overall Study|Adverse Event|0|||
162940930|NCT00684671|588487054|FG000|Overall Study|Lost to Follow-up|1|||
162940931|NCT00684671|588487055|FG001|Overall Study|Lost to Follow-up|0|||
162940932|NCT00684671|588487056|FG002|Overall Study|Lost to Follow-up|0|||
162940933|NCT00684671|588487054|FG000|Overall Study|Alcoholic dependance|1|||
162940934|NCT00684671|588487055|FG001|Overall Study|Alcoholic dependance|0|||
162940935|NCT00684671|588487056|FG002|Overall Study|Alcoholic dependance|0|||
162940936|NCT04128007|588487057|FG000|Overall Study|Withdrawal by Subject|9|||
162940937|NCT04128007|588487058|FG001|Overall Study|Withdrawal by Subject|6|||
162940938|NCT04128007|588487057|FG000|Overall Study|Protocol Violation|1|||
162940939|NCT04128007|588487058|FG001|Overall Study|Protocol Violation|0|||
162940940|NCT04128007|588487057|FG000|Overall Study|Lost to Follow-up|8|||
162940941|NCT04128007|588487058|FG001|Overall Study|Lost to Follow-up|7|||
162940942|NCT04128007|588487057|FG000|Overall Study|Adverse Event|5|||
162940943|NCT04128007|588487058|FG001|Overall Study|Adverse Event|2|||
162940944|NCT04128007|588487057|FG000|Overall Study|Not reported|0|||
162940945|NCT04128007|588487058|FG001|Overall Study|Not reported|2|||
162940946|NCT00481247|588487061|FG000|Overall Study|Death|0|||
162940947|NCT00481247|588487062|FG001|Overall Study|Death|1|||
162940948|NCT00481247|588487061|FG000|Overall Study|Disease progression|18|||
162940949|NCT00481247|588487062|FG001|Overall Study|Disease progression|22|||
162940950|NCT00481247|588487061|FG000|Overall Study|Intolerance|42|||
162940951|NCT00481247|588487062|FG001|Overall Study|Intolerance|17|||
162940952|NCT00481247|588487061|FG000|Overall Study|Treatment failure|10|||
162940953|NCT00481247|588487062|FG001|Overall Study|Treatment failure|14|||
162940954|NCT00481247|588487061|FG000|Overall Study|AE unrelated to study drug|13|||
162940955|NCT00481247|588487062|FG001|Overall Study|AE unrelated to study drug|4|||
162940956|NCT00481247|588487061|FG000|Overall Study|Withdrawal by Subject|8|||
162940957|NCT00481247|588487062|FG001|Overall Study|Withdrawal by Subject|13|||
162940958|NCT00481247|588487061|FG000|Overall Study|Pregnancy|2|||
162940959|NCT00481247|588487062|FG001|Overall Study|Pregnancy|1|||
162940960|NCT00481247|588487061|FG000|Overall Study|Lost to Follow-up|1|||
162940961|NCT00481247|588487062|FG001|Overall Study|Lost to Follow-up|2|||
162940962|NCT00481247|588487061|FG000|Overall Study|Poor compliance/noncompliance|1|||
162940963|NCT00481247|588487062|FG001|Overall Study|Poor compliance/noncompliance|7|||
162940964|NCT00481247|588487061|FG000|Overall Study|Administrative reason by sponsor|157|||
162940965|NCT00481247|588487062|FG001|Overall Study|Administrative reason by sponsor|162|||
162940966|NCT00481247|588487061|FG000|Overall Study|Varied|6|||
162940967|NCT00481247|588487062|FG001|Overall Study|Varied|15|||
162940968|NCT00481247|588487061|FG000|Overall Study|Did not receive treatment|1|||
162940969|NCT00481247|588487062|FG001|Overall Study|Did not receive treatment|2|||
162940970|NCT01716754|588487063|FG000|Overall Study|Death|0|||
162940971|NCT01716754|588487064|FG001|Overall Study|Death|0|||
162940972|NCT01716754|588487065|FG002|Overall Study|Death|0|||
162940973|NCT01716754|588487066|FG003|Overall Study|Death|1|||
162940974|NCT01716754|588487063|FG000|Overall Study|Protocol deviation|0|||
162940975|NCT01716754|588487064|FG001|Overall Study|Protocol deviation|2|||
162940976|NCT01716754|588487065|FG002|Overall Study|Protocol deviation|7|||
162940977|NCT01716754|588487066|FG003|Overall Study|Protocol deviation|2|||
162940978|NCT01716754|588487063|FG000|Overall Study|Non-compliance with study treatment|0|||
162940979|NCT01716754|588487064|FG001|Overall Study|Non-compliance with study treatment|0|||
162940980|NCT01716754|588487065|FG002|Overall Study|Non-compliance with study treatment|1|||
162940981|NCT01716754|588487066|FG003|Overall Study|Non-compliance with study treatment|0|||
162940982|NCT01716754|588487063|FG000|Overall Study|Physician Decision|1|||
162940983|NCT01716754|588487064|FG001|Overall Study|Physician Decision|0|||
162940984|NCT01716754|588487065|FG002|Overall Study|Physician Decision|0|||
162940985|NCT01716754|588487066|FG003|Overall Study|Physician Decision|0|||
162940986|NCT01716754|588487063|FG000|Overall Study|Lost to Follow-up|1|||
162940987|NCT01716754|588487064|FG001|Overall Study|Lost to Follow-up|0|||
162940988|NCT01716754|588487065|FG002|Overall Study|Lost to Follow-up|0|||
162940989|NCT01716754|588487066|FG003|Overall Study|Lost to Follow-up|1|||
162940990|NCT01716754|588487063|FG000|Overall Study|Adverse Event|4|||
162940991|NCT01716754|588487064|FG001|Overall Study|Adverse Event|2|||
162940992|NCT01716754|588487065|FG002|Overall Study|Adverse Event|2|||
162940993|NCT01716754|588487066|FG003|Overall Study|Adverse Event|1|||
162940994|NCT01716754|588487063|FG000|Overall Study|Withdrawal by Subject|5|||
162940995|NCT01716754|588487064|FG001|Overall Study|Withdrawal by Subject|0|||
162940996|NCT01716754|588487065|FG002|Overall Study|Withdrawal by Subject|4|||
162940997|NCT01716754|588487066|FG003|Overall Study|Withdrawal by Subject|3|||
162940998|NCT02110706|588487086|FG000|Overall Study|Adverse Event|2|||
162940999|NCT02110706|588487087|FG001|Overall Study|Adverse Event|3|||
162941000|NCT02110706|588487086|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
162941001|NCT02110706|588487087|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
162941002|NCT03521999|588487089|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
162941003|NCT03521999|588487090|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
162941004|NCT03521999|588487089|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
162941005|NCT03521999|588487090|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
162941006|NCT03521999|588487089|FG000|Completed 3 Month Follow up|Death|0|||
162941007|NCT03521999|588487090|FG001|Completed 3 Month Follow up|Death|1|||
162941008|NCT03521999|588487089|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
162941009|NCT03521999|588487090|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
162941010|NCT04182204|588487093|FG000|Safety Run-in|Lost to Follow-up|1|||
162941011|NCT04182204|588487094|FG001|Safety Run-in|Lost to Follow-up|0|||
162941012|NCT04182204|588487095|FG002|Safety Run-in|Lost to Follow-up|0|||
162941013|NCT04182204|588487093|FG000|Safety Run-in|Withdrawal by Subject|2|||
162941014|NCT04182204|588487094|FG001|Safety Run-in|Withdrawal by Subject|0|||
162941015|NCT04182204|588487095|FG002|Safety Run-in|Withdrawal by Subject|0|||
162941016|NCT04182204|588487093|FG000|Safety Run-in|Death|7|||
162941017|NCT04182204|588487094|FG001|Safety Run-in|Death|0|||
162941018|NCT04182204|588487095|FG002|Safety Run-in|Death|0|||
162941019|NCT04182204|588487093|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
162941020|NCT04182204|588487094|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
162829437|NCT02819635|588089144|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829438|NCT02819635|588089145|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829439|NCT02819635|588089146|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829440|NCT02819635|588089147|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829441|NCT02819635|588089148|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829442|NCT02819635|588089149|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
162829443|NCT02819635|588089150|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
162829444|NCT02819635|588089151|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829445|NCT02819635|588089152|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829446|NCT02819635|588089153|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829447|NCT02819635|588089154|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829448|NCT02819635|588089155|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
162829449|NCT02819635|588089144|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829450|NCT02819635|588089145|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829451|NCT02819635|588089146|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829452|NCT02819635|588089147|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829453|NCT02819635|588089148|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829454|NCT02819635|588089149|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829455|NCT02819635|588089150|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
162829456|NCT02819635|588089151|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829457|NCT02819635|588089152|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829458|NCT02819635|588089153|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829459|NCT02819635|588089154|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162941021|NCT04182204|588487095|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
162941022|NCT04182204|588487093|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
162941023|NCT04182204|588487094|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
162941024|NCT04182204|588487095|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
162941025|NCT04182204|588487093|FG000|Randomized Controlled Trial|Death|0|||
162941026|NCT04182204|588487094|FG001|Randomized Controlled Trial|Death|83|||
162941027|NCT04182204|588487095|FG002|Randomized Controlled Trial|Death|66|||
162941028|NCT03933202|588487096|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
162941029|NCT03933202|588487097|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
162941030|NCT03933202|588487096|FG000|Overall Study|Participant transferred care|1|||
162941031|NCT03933202|588487097|FG001|Overall Study|Participant transferred care|0|||
162941032|NCT03933202|588487096|FG000|Overall Study|Site research department closing|1|||
162941033|NCT03933202|588487097|FG001|Overall Study|Site research department closing|0|||
162941034|NCT03933202|588487096|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
162941035|NCT03933202|588487097|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
162941036|NCT03933202|588487096|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
162941037|NCT03933202|588487097|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
162941038|NCT03933202|588487096|FG000|Overall Study|Participant changed primary neurology provider|1|||
163042849|NCT01066871|588863977|FG003|Overall Study|Protocol Violation|2|||
162829460|NCT02819635|588089155|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
162829461|NCT02819635|588089144|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
162829462|NCT02819635|588089145|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
162829463|NCT02819635|588089146|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
162829464|NCT02819635|588089147|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
162829465|NCT02819635|588089148|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
162829466|NCT02819635|588089149|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
162829467|NCT02819635|588089150|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
162829468|NCT02819635|588089151|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
162829469|NCT02819635|588089152|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
162941039|NCT03933202|588487097|FG001|Overall Study|Participant changed primary neurology provider|0|||
162941040|NCT03933202|588487096|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
162941041|NCT03933202|588487097|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
162941042|NCT03933202|588487096|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
162941043|NCT03933202|588487097|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
162941044|NCT03933202|588487096|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
162941045|NCT03933202|588487097|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
162941046|NCT03933202|588487096|FG000|Overall Study|Missed visit|0|||
162941047|NCT03933202|588487097|FG001|Overall Study|Missed visit|1|||
162941048|NCT03933202|588487096|FG000|Overall Study|Investigator decision|4|||
162941049|NCT03933202|588487097|FG001|Overall Study|Investigator decision|0|||
162941050|NCT03933202|588487096|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
162941051|NCT03933202|588487097|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
162941052|NCT03933202|588487096|FG000|Overall Study|Withdrawal by Subject|10|||
162941053|NCT03933202|588487097|FG001|Overall Study|Withdrawal by Subject|8|||
162941054|NCT03933202|588487096|FG000|Overall Study|Death|2|||
162941055|NCT03933202|588487097|FG001|Overall Study|Death|0|||
162941056|NCT03933202|588487096|FG000|Overall Study|Progressive disease|0|||
162941057|NCT03933202|588487097|FG001|Overall Study|Progressive disease|3|||
162941058|NCT03933202|588487096|FG000|Overall Study|Protocol non-compliance|6|||
162941059|NCT03933202|588487097|FG001|Overall Study|Protocol non-compliance|3|||
162941060|NCT03933202|588487096|FG000|Overall Study|Lost to Follow-up|16|||
162941061|NCT03933202|588487097|FG001|Overall Study|Lost to Follow-up|8|||
162941062|NCT03933202|588487096|FG000|Overall Study|Adverse Event|3|||
162941063|NCT03933202|588487097|FG001|Overall Study|Adverse Event|0|||
162941064|NCT00947427|588487098|FG000|Overall Study|Withdrawal by Subject|1|||
162941065|NCT00947427|588487099|FG001|Overall Study|Withdrawal by Subject|3|||
162941066|NCT00947427|588487098|FG000|Overall Study|Protocol Violation|0|||
162941067|NCT00947427|588487099|FG001|Overall Study|Protocol Violation|1|||
162941068|NCT01348542|588487101|FG000|Overall Study|Withdrawal by Subject|3|||
162941069|NCT01348542|588487102|FG001|Overall Study|Withdrawal by Subject|0|||
162941070|NCT00686036|588487105|FG000|Overall Study|Adverse Event|3|||
162941071|NCT00686036|588487106|FG001|Overall Study|Adverse Event|0|||
162941072|NCT00686036|588487105|FG000|Overall Study|Withdrawal by Subject|3|||
162941073|NCT00686036|588487106|FG001|Overall Study|Withdrawal by Subject|1|||
162941074|NCT00686036|588487105|FG000|Overall Study|Study terminated by AstraZeneca|2|||
162941075|NCT00686036|588487106|FG001|Overall Study|Study terminated by AstraZeneca|1|||
162941076|NCT00686036|588487105|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
162941077|NCT00686036|588487106|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
162941078|NCT00686036|588487105|FG000|Overall Study|Other reasons not identified|0|||
162941079|NCT00686036|588487106|FG001|Overall Study|Other reasons not identified|4|||
162941080|NCT01411995|588487107|FG000|Overall Study|Failed IUD insertion|0|||
162941081|NCT01411995|588487108|FG001|Overall Study|Failed IUD insertion|1|||
162941082|NCT05658523|588487109|FG000|Baseline|No blood draw|1|||
162941083|NCT05658523|588487110|FG001|Baseline|No blood draw|0|||
162941084|NCT05658523|588487111|FG002|Baseline|No blood draw|0|||
162941085|NCT05658523|588487109|FG000|28 Days|Lost to Follow-up|1|||
162941086|NCT05658523|588487110|FG001|28 Days|Lost to Follow-up|0|||
162941087|NCT05658523|588487111|FG002|28 Days|Lost to Follow-up|0|||
162941088|NCT05658523|588487109|FG000|28 Days|Withdrawal by Subject|1|||
162941089|NCT05658523|588487110|FG001|28 Days|Withdrawal by Subject|1|||
162941090|NCT05658523|588487111|FG002|28 Days|Withdrawal by Subject|0|||
162941091|NCT05658523|588487109|FG000|28 Days|Visit missed|0|||
162941092|NCT05658523|588487110|FG001|28 Days|Visit missed|4|||
162941093|NCT05658523|588487111|FG002|28 Days|Visit missed|0|||
162941094|NCT05658523|588487109|FG000|6 Months|Lost to Follow-up|1|||
162941095|NCT05658523|588487110|FG001|6 Months|Lost to Follow-up|7|||
162941096|NCT05658523|588487111|FG002|6 Months|Lost to Follow-up|2|||
162941097|NCT05658523|588487109|FG000|6 Months|Withdrawal by Subject|1|||
162941098|NCT05658523|588487110|FG001|6 Months|Withdrawal by Subject|3|||
162941099|NCT05658523|588487111|FG002|6 Months|Withdrawal by Subject|4|||
162941100|NCT05658523|588487109|FG000|6 Months|Visit missed|5|||
162941101|NCT05658523|588487110|FG001|6 Months|Visit missed|7|||
162941102|NCT05658523|588487111|FG002|6 Months|Visit missed|0|||
162941103|NCT05658523|588487109|FG000|6 Months|No blood draw|0|||
162941104|NCT05658523|588487110|FG001|6 Months|No blood draw|0|||
162941105|NCT05658523|588487111|FG002|6 Months|No blood draw|1|||
162941106|NCT05658523|588487109|FG000|12 Months|Lost to Follow-up|2|||
162941107|NCT05658523|588487110|FG001|12 Months|Lost to Follow-up|6|||
162941108|NCT05658523|588487111|FG002|12 Months|Lost to Follow-up|3|||
162941109|NCT05658523|588487109|FG000|12 Months|Withdrawal by Subject|4|||
162941110|NCT05658523|588487110|FG001|12 Months|Withdrawal by Subject|4|||
162941111|NCT05658523|588487111|FG002|12 Months|Withdrawal by Subject|2|||
162941112|NCT05658523|588487109|FG000|12 Months|Visit missed|4|||
162941113|NCT05658523|588487110|FG001|12 Months|Visit missed|8|||
162941114|NCT05658523|588487111|FG002|12 Months|Visit missed|8|||
162941115|NCT05658523|588487109|FG000|18 Months|Lost to Follow-up|5|||
162941116|NCT05658523|588487110|FG001|18 Months|Lost to Follow-up|8|||
162941117|NCT05658523|588487111|FG002|18 Months|Lost to Follow-up|2|||
162829470|NCT02819635|588089153|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
162829471|NCT02819635|588089154|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
162829472|NCT02819635|588089155|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
162829473|NCT02819635|588089144|FG000|Substudy 2, Part 2|Adverse Event|0|||
162829474|NCT02819635|588089145|FG001|Substudy 2, Part 2|Adverse Event|0|||
162829475|NCT02819635|588089146|FG002|Substudy 2, Part 2|Adverse Event|0|||
162829476|NCT02819635|588089147|FG003|Substudy 2, Part 2|Adverse Event|0|||
162829477|NCT02819635|588089148|FG004|Substudy 2, Part 2|Adverse Event|0|||
162829478|NCT02819635|588089149|FG005|Substudy 2, Part 2|Adverse Event|4|||
162829479|NCT02819635|588089150|FG006|Substudy 2, Part 2|Adverse Event|0|||
162829480|NCT02819635|588089151|FG007|Substudy 2, Part 2|Adverse Event|0|||
162829481|NCT02819635|588089152|FG008|Substudy 2, Part 2|Adverse Event|0|||
162829482|NCT02819635|588089153|FG009|Substudy 2, Part 2|Adverse Event|0|||
162829483|NCT02819635|588089154|FG010|Substudy 2, Part 2|Adverse Event|0|||
162829484|NCT02819635|588089155|FG011|Substudy 2, Part 2|Adverse Event|0|||
162829485|NCT02819635|588089144|FG000|Substudy 2, Part 2|Withdrew consent|0|||
162829486|NCT02819635|588089145|FG001|Substudy 2, Part 2|Withdrew consent|0|||
162829487|NCT02819635|588089146|FG002|Substudy 2, Part 2|Withdrew consent|0|||
162829488|NCT02819635|588089147|FG003|Substudy 2, Part 2|Withdrew consent|0|||
162829489|NCT02819635|588089148|FG004|Substudy 2, Part 2|Withdrew consent|0|||
162829490|NCT02819635|588089149|FG005|Substudy 2, Part 2|Withdrew consent|3|||
162829491|NCT02819635|588089150|FG006|Substudy 2, Part 2|Withdrew consent|1|||
162829492|NCT02819635|588089151|FG007|Substudy 2, Part 2|Withdrew consent|0|||
162829493|NCT02819635|588089152|FG008|Substudy 2, Part 2|Withdrew consent|0|||
162829494|NCT02819635|588089153|FG009|Substudy 2, Part 2|Withdrew consent|0|||
162829495|NCT02819635|588089154|FG010|Substudy 2, Part 2|Withdrew consent|0|||
162829496|NCT02819635|588089155|FG011|Substudy 2, Part 2|Withdrew consent|0|||
162829497|NCT02819635|588089144|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
162941118|NCT05658523|588487109|FG000|18 Months|Withdrawal by Subject|17|||
162941119|NCT05658523|588487110|FG001|18 Months|Withdrawal by Subject|9|||
162941120|NCT05658523|588487111|FG002|18 Months|Withdrawal by Subject|16|||
162941121|NCT05658523|588487109|FG000|18 Months|Visit missed|12|||
162941122|NCT05658523|588487110|FG001|18 Months|Visit missed|14|||
162941123|NCT05658523|588487111|FG002|18 Months|Visit missed|6|||
162941124|NCT03212170|588487112|FG000|Overall Study|Withdrawal by Subject|1|||
162941125|NCT01937364|588487113|FG000|Overall Study|Adverse Event|2|||
162941126|NCT01937364|588487114|FG001|Overall Study|Adverse Event|1|||
162941127|NCT00628212|588487117|FG000|Overall Study|Adverse Event|2|||
162941128|NCT00628212|588487118|FG001|Overall Study|Adverse Event|0|||
162829498|NCT02819635|588089145|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
162829499|NCT02819635|588089146|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
162829500|NCT02819635|588089147|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
162829501|NCT02819635|588089148|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
162829502|NCT02819635|588089149|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
162829503|NCT02819635|588089150|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
162829504|NCT02819635|588089151|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
162829505|NCT02819635|588089152|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
162829506|NCT02819635|588089153|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
162829507|NCT02819635|588089154|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
162829508|NCT02819635|588089155|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
162829509|NCT02819635|588089144|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829510|NCT02819635|588089145|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829511|NCT02819635|588089146|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829512|NCT02819635|588089147|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162941129|NCT00628212|588487119|FG002|Overall Study|Adverse Event|1|||
162941130|NCT00628212|588487120|FG003|Overall Study|Adverse Event|2|||
162829513|NCT02819635|588089148|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829514|NCT02819635|588089149|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829515|NCT02819635|588089150|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
162829516|NCT02819635|588089151|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829517|NCT02819635|588089152|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829518|NCT02819635|588089153|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829519|NCT02819635|588089154|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829520|NCT02819635|588089155|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162829521|NCT02819635|588089144|FG000|Substudy 2, Part 2|Other, not specified|0|||
162829522|NCT02819635|588089145|FG001|Substudy 2, Part 2|Other, not specified|0|||
162829523|NCT02819635|588089146|FG002|Substudy 2, Part 2|Other, not specified|0|||
162829524|NCT02819635|588089147|FG003|Substudy 2, Part 2|Other, not specified|0|||
162829525|NCT02819635|588089148|FG004|Substudy 2, Part 2|Other, not specified|0|||
162829526|NCT02819635|588089149|FG005|Substudy 2, Part 2|Other, not specified|4|||
162829527|NCT02819635|588089150|FG006|Substudy 2, Part 2|Other, not specified|8|||
162829528|NCT02819635|588089151|FG007|Substudy 2, Part 2|Other, not specified|0|||
162829529|NCT02819635|588089152|FG008|Substudy 2, Part 2|Other, not specified|0|||
162829530|NCT02819635|588089153|FG009|Substudy 2, Part 2|Other, not specified|0|||
162829531|NCT02819635|588089154|FG010|Substudy 2, Part 2|Other, not specified|0|||
162829532|NCT02819635|588089155|FG011|Substudy 2, Part 2|Other, not specified|0|||
162829533|NCT02819635|588089144|FG000|Substudy 3|Adverse Event|0|||
162829534|NCT02819635|588089145|FG001|Substudy 3|Adverse Event|0|||
162829535|NCT02819635|588089146|FG002|Substudy 3|Adverse Event|0|||
162829536|NCT02819635|588089147|FG003|Substudy 3|Adverse Event|0|||
162829537|NCT02819635|588089148|FG004|Substudy 3|Adverse Event|0|||
162829538|NCT02819635|588089149|FG005|Substudy 3|Adverse Event|0|||
162829539|NCT02819635|588089150|FG006|Substudy 3|Adverse Event|0|||
162829540|NCT02819635|588089151|FG007|Substudy 3|Adverse Event|0|||
162829541|NCT02819635|588089152|FG008|Substudy 3|Adverse Event|32|||
162829542|NCT02819635|588089153|FG009|Substudy 3|Adverse Event|3|||
162829543|NCT02819635|588089154|FG010|Substudy 3|Adverse Event|12|||
162829544|NCT02819635|588089155|FG011|Substudy 3|Adverse Event|18|||
162829545|NCT02819635|588089144|FG000|Substudy 3|Withdrew consent|0|||
162829546|NCT02819635|588089145|FG001|Substudy 3|Withdrew consent|0|||
162829547|NCT02819635|588089146|FG002|Substudy 3|Withdrew consent|0|||
162829548|NCT02819635|588089147|FG003|Substudy 3|Withdrew consent|0|||
162829549|NCT02819635|588089148|FG004|Substudy 3|Withdrew consent|0|||
162829550|NCT02819635|588089149|FG005|Substudy 3|Withdrew consent|0|||
162829551|NCT02819635|588089150|FG006|Substudy 3|Withdrew consent|0|||
162829552|NCT02819635|588089151|FG007|Substudy 3|Withdrew consent|0|||
162829553|NCT02819635|588089152|FG008|Substudy 3|Withdrew consent|11|||
162829554|NCT02819635|588089153|FG009|Substudy 3|Withdrew consent|1|||
162829555|NCT02819635|588089154|FG010|Substudy 3|Withdrew consent|4|||
162829556|NCT02819635|588089155|FG011|Substudy 3|Withdrew consent|9|||
162829557|NCT02819635|588089144|FG000|Substudy 3|Lost to Follow-up|0|||
162829558|NCT02819635|588089145|FG001|Substudy 3|Lost to Follow-up|0|||
162829559|NCT02819635|588089146|FG002|Substudy 3|Lost to Follow-up|0|||
162829560|NCT02819635|588089147|FG003|Substudy 3|Lost to Follow-up|0|||
162829561|NCT02819635|588089148|FG004|Substudy 3|Lost to Follow-up|0|||
162829562|NCT02819635|588089149|FG005|Substudy 3|Lost to Follow-up|0|||
162829563|NCT02819635|588089150|FG006|Substudy 3|Lost to Follow-up|0|||
162829564|NCT02819635|588089151|FG007|Substudy 3|Lost to Follow-up|0|||
162829565|NCT02819635|588089152|FG008|Substudy 3|Lost to Follow-up|1|||
162829566|NCT02819635|588089153|FG009|Substudy 3|Lost to Follow-up|0|||
162829567|NCT02819635|588089154|FG010|Substudy 3|Lost to Follow-up|1|||
162829568|NCT02819635|588089155|FG011|Substudy 3|Lost to Follow-up|1|||
162941131|NCT00628212|588487117|FG000|Overall Study|Physician Decision|1|||
162941132|NCT00628212|588487118|FG001|Overall Study|Physician Decision|1|||
162941133|NCT00628212|588487119|FG002|Overall Study|Physician Decision|2|||
162941134|NCT00628212|588487120|FG003|Overall Study|Physician Decision|3|||
162941135|NCT02482571|588487121|FG000|Overall Study|Adverse Event|1|||
162941136|NCT02482571|588487121|FG000|Overall Study|Scanner or Respiract failure|3|||
162941137|NCT02482571|588487121|FG000|Overall Study|Withdrawal by Subject|4|||
162941138|NCT04071769|588487127|FG000|Overall Study|Lost to Follow-up|3|||
162941139|NCT04071769|588487127|FG000|Overall Study|Physician Decision|2|||
162941140|NCT04071769|588487127|FG000|Overall Study|Withdrawal by Subject|8|||
162941141|NCT01890707|588487128|FG000|Overall Study|Lost to Follow-up|1|||
162941142|NCT01890707|588487129|FG001|Overall Study|Lost to Follow-up|1|||
162941143|NCT00669955|588487130|FG000|Overall Study|Adverse Event|3|||
162941144|NCT00669955|588487131|FG001|Overall Study|Adverse Event|5|||
162941145|NCT00669955|588487130|FG000|Overall Study|Death|0|||
162941146|NCT00669955|588487131|FG001|Overall Study|Death|1|||
162941147|NCT00669955|588487130|FG000|Overall Study|Withdrawal by Subject|2|||
162941148|NCT00669955|588487131|FG001|Overall Study|Withdrawal by Subject|3|||
162941149|NCT00669955|588487130|FG000|Overall Study|Lost to Follow-up|5|||
162941150|NCT00669955|588487131|FG001|Overall Study|Lost to Follow-up|7|||
162941151|NCT00669955|588487130|FG000|Overall Study|Protocol Violation|2|||
162941152|NCT00669955|588487131|FG001|Overall Study|Protocol Violation|7|||
162941153|NCT00669955|588487130|FG000|Overall Study|Investigator Sponsor Judgement|0|||
162941154|NCT00669955|588487131|FG001|Overall Study|Investigator Sponsor Judgement|1|||
162941155|NCT00669955|588487130|FG000|Overall Study|not compliant with study drug/visit|2|||
162941156|NCT00669955|588487131|FG001|Overall Study|not compliant with study drug/visit|3|||
162941157|NCT03495869|588487132|FG000|Overall Study|Lost to Follow-up|4|||
162941158|NCT03495869|588487133|FG001|Overall Study|Lost to Follow-up|17|||
162941159|NCT03495869|588487134|FG002|Overall Study|Lost to Follow-up|8|||
162941160|NCT03495869|588487135|FG003|Overall Study|Lost to Follow-up|14|||
162941161|NCT03495869|588487132|FG000|Overall Study|Withdrawal by Subject|0|||
162941162|NCT03495869|588487133|FG001|Overall Study|Withdrawal by Subject|3|||
162941163|NCT03495869|588487134|FG002|Overall Study|Withdrawal by Subject|0|||
162941164|NCT03495869|588487135|FG003|Overall Study|Withdrawal by Subject|3|||
162941165|NCT03495869|588487132|FG000|Overall Study|Dropped from study|0|||
162941166|NCT03495869|588487133|FG001|Overall Study|Dropped from study|7|||
162941167|NCT03495869|588487134|FG002|Overall Study|Dropped from study|2|||
162941168|NCT03495869|588487135|FG003|Overall Study|Dropped from study|4|||
162941169|NCT03312530|588488531|FG000|Overall Study|Death|5|||
162941170|NCT03312530|588488532|FG001|Overall Study|Death|5|||
162941171|NCT03312530|588488533|FG002|Overall Study|Death|4|||
162941172|NCT03312530|588488534|FG003|Overall Study|Death|10|||
162941173|NCT03312530|588488535|FG004|Overall Study|Death|8|||
162941174|NCT03312530|588488531|FG000|Overall Study|Lost to Follow-up|0|||
162941175|NCT03312530|588488532|FG001|Overall Study|Lost to Follow-up|0|||
162941176|NCT03312530|588488533|FG002|Overall Study|Lost to Follow-up|0|||
162941177|NCT03312530|588488534|FG003|Overall Study|Lost to Follow-up|1|||
162941178|NCT03312530|588488535|FG004|Overall Study|Lost to Follow-up|0|||
162941179|NCT03312530|588488531|FG000|Overall Study|Participant in another sponsor study.|0|||
162941180|NCT03312530|588488532|FG001|Overall Study|Participant in another sponsor study.|0|||
162941181|NCT03312530|588488533|FG002|Overall Study|Participant in another sponsor study.|0|||
162941182|NCT03312530|588488534|FG003|Overall Study|Participant in another sponsor study.|1|||
162941183|NCT03312530|588488535|FG004|Overall Study|Participant in another sponsor study.|0|||
162941184|NCT03312530|588488531|FG000|Overall Study|Study terminated by sponsor|1|||
162941185|NCT03312530|588488532|FG001|Overall Study|Study terminated by sponsor|0|||
162941186|NCT03312530|588488533|FG002|Overall Study|Study terminated by sponsor|2|||
162941187|NCT03312530|588488534|FG003|Overall Study|Study terminated by sponsor|3|||
162941188|NCT03312530|588488535|FG004|Overall Study|Study terminated by sponsor|7|||
162941189|NCT03312530|588488531|FG000|Overall Study|Withdrawal by Subject|0|||
162941190|NCT03312530|588488532|FG001|Overall Study|Withdrawal by Subject|1|||
162941191|NCT03312530|588488533|FG002|Overall Study|Withdrawal by Subject|0|||
162941192|NCT03312530|588488534|FG003|Overall Study|Withdrawal by Subject|0|||
162941193|NCT03312530|588488535|FG004|Overall Study|Withdrawal by Subject|0|||
162941194|NCT03312530|588488531|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941195|NCT03312530|588488532|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941196|NCT03312530|588488533|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941197|NCT03312530|588488534|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
162941198|NCT03312530|588488535|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
162941199|NCT00614055|588488536|FG000|Overall Study|Adverse Event|1|||
162941200|NCT00614055|588488537|FG001|Overall Study|Adverse Event|0|||
162941201|NCT00614055|588488538|FG002|Overall Study|Adverse Event|0|||
162941202|NCT00614055|588488536|FG000|Overall Study|Protocol Violation|2|||
162941203|NCT00614055|588488537|FG001|Overall Study|Protocol Violation|2|||
162941204|NCT00614055|588488538|FG002|Overall Study|Protocol Violation|1|||
162941205|NCT00614055|588488536|FG000|Overall Study|Lack of Efficacy|0|||
162941206|NCT00614055|588488537|FG001|Overall Study|Lack of Efficacy|0|||
162941207|NCT00614055|588488538|FG002|Overall Study|Lack of Efficacy|2|||
162941208|NCT00614055|588488536|FG000|Overall Study|Unclassified|1|||
162941209|NCT00614055|588488537|FG001|Overall Study|Unclassified|4|||
162941210|NCT00614055|588488538|FG002|Overall Study|Unclassified|2|||
162941211|NCT02489318|588488541|FG000|Randomized|Withdrawal by Subject|0|||
162941212|NCT02489318|588488542|FG001|Randomized|Withdrawal by Subject|1|||
162941213|NCT02489318|588488541|FG000|Treated|Adverse Event|19|||
162941214|NCT02489318|588488542|FG001|Treated|Adverse Event|62|||
162941215|NCT02489318|588488541|FG000|Treated|Death|13|||
162941216|NCT02489318|588488542|FG001|Treated|Death|11|||
162941217|NCT02489318|588488541|FG000|Treated|Physician Decision|4|||
162941218|NCT02489318|588488542|FG001|Treated|Physician Decision|6|||
162941219|NCT02489318|588488541|FG000|Treated|Protocol Violation|1|||
162941220|NCT02489318|588488542|FG001|Treated|Protocol Violation|2|||
162941221|NCT02489318|588488541|FG000|Treated|Withdrawal by Subject|37|||
162941222|NCT02489318|588488542|FG001|Treated|Withdrawal by Subject|36|||
162941223|NCT02489318|588488541|FG000|Treated|Other: Progressive Disease|245|||
162941224|NCT02489318|588488542|FG001|Treated|Other: Progressive Disease|138|||
162941225|NCT02489318|588488541|FG000|Treated|Other|0|||
162941226|NCT02489318|588488542|FG001|Treated|Other|2|||
162941227|NCT02489318|588488541|FG000|Treated|Ongoing|0|||
162941228|NCT02489318|588488542|FG001|Treated|Ongoing|267|||
162941229|NCT03679741|588488545|FG000|Period 1|No longer meet eligibility criteria|1|||
162941230|NCT03679741|588488546|FG001|Period 1|No longer meet eligibility criteria|0|||
162941231|NCT03679741|588488545|FG000|Period 1|Lost to Follow-up|0|||
162941232|NCT03679741|588488546|FG001|Period 1|Lost to Follow-up|1|||
162941233|NCT03679741|588488545|FG000|Period 1|Adverse Event|1|||
162941234|NCT03679741|588488546|FG001|Period 1|Adverse Event|1|||
162941235|NCT03679741|588488545|FG000|Period 1|Withdrawal by Subject|0|||
162941236|NCT03679741|588488546|FG001|Period 1|Withdrawal by Subject|1|||
162941237|NCT03679741|588488545|FG000|Period 2|Adverse Event|2|||
162941238|NCT03679741|588488546|FG001|Period 2|Adverse Event|1|||
162941239|NCT03679741|588488545|FG000|Period 2|Withdrawal by Subject|1|||
162941240|NCT03679741|588488546|FG001|Period 2|Withdrawal by Subject|1|||
162941241|NCT02035137|588488548|FG000|Overall Study|Physician Decision|0|||
162941242|NCT02035137|588488549|FG001|Overall Study|Physician Decision|0|||
162941243|NCT02035137|588488550|FG002|Overall Study|Physician Decision|1|||
162941244|NCT02035137|588488548|FG000|Overall Study|Withdrawal by Subject|0|||
162941245|NCT02035137|588488549|FG001|Overall Study|Withdrawal by Subject|1|||
162941246|NCT02035137|588488550|FG002|Overall Study|Withdrawal by Subject|2|||
162941247|NCT02035137|588488548|FG000|Overall Study|Ineligible|0|||
162941248|NCT02035137|588488549|FG001|Overall Study|Ineligible|1|||
162941249|NCT02035137|588488550|FG002|Overall Study|Ineligible|2|||
162941250|NCT02035137|588488548|FG000|Overall Study|Disease progression prior to treatment start|2|||
162941251|NCT02035137|588488549|FG001|Overall Study|Disease progression prior to treatment start|0|||
162941252|NCT02035137|588488550|FG002|Overall Study|Disease progression prior to treatment start|0|||
162941253|NCT01215942|588488551|FG000|Treatment Period|Adverse Event|15|||
162941254|NCT01215942|588488552|FG001|Treatment Period|Adverse Event|26|||
162941255|NCT01215942|588488551|FG000|Treatment Period|Death|2|||
162941256|NCT01215942|588488552|FG001|Treatment Period|Death|4|||
162941257|NCT01215942|588488551|FG000|Treatment Period|Lack of Efficacy|23|||
162941258|NCT01215942|588488552|FG001|Treatment Period|Lack of Efficacy|62|||
162941259|NCT01215942|588488551|FG000|Treatment Period|Lost to Follow-up|3|||
162941260|NCT01215942|588488552|FG001|Treatment Period|Lost to Follow-up|4|||
162941261|NCT01215942|588488551|FG000|Treatment Period|Withdrawal by Subject|17|||
162941262|NCT01215942|588488552|FG001|Treatment Period|Withdrawal by Subject|40|||
162941263|NCT01215942|588488551|FG000|Treatment Period|Physician Decision|5|||
162941264|NCT01215942|588488552|FG001|Treatment Period|Physician Decision|5|||
162941265|NCT01215942|588488551|FG000|Treatment Period|Protocol Violation|0|||
162941266|NCT01215942|588488552|FG001|Treatment Period|Protocol Violation|1|||
162941267|NCT01215942|588488551|FG000|Treatment Period|Sponsor Decision|349|||
162941268|NCT01215942|588488552|FG001|Treatment Period|Sponsor Decision|530|||
162941269|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Death|0|||
162941270|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Death|1|||
162941271|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
162941272|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
162941273|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
162941274|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
162941275|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
162941276|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
162941277|NCT01215942|588488551|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
162829569|NCT02819635|588089144|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829570|NCT02819635|588089145|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829571|NCT02819635|588089146|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829572|NCT02819635|588089147|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829573|NCT02819635|588089148|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829574|NCT02819635|588089149|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829575|NCT02819635|588089150|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829576|NCT02819635|588089151|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829577|NCT02819635|588089152|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829578|NCT02819635|588089153|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829579|NCT02819635|588089154|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
162829580|NCT02819635|588089155|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
162829581|NCT02819635|588089144|FG000|Substudy 3|Other, not specified|0|||
162829582|NCT02819635|588089145|FG001|Substudy 3|Other, not specified|0|||
162829583|NCT02819635|588089146|FG002|Substudy 3|Other, not specified|0|||
162829584|NCT02819635|588089147|FG003|Substudy 3|Other, not specified|0|||
162829585|NCT02819635|588089148|FG004|Substudy 3|Other, not specified|0|||
162829586|NCT02819635|588089149|FG005|Substudy 3|Other, not specified|0|||
162829587|NCT02819635|588089150|FG006|Substudy 3|Other, not specified|0|||
162829588|NCT02819635|588089151|FG007|Substudy 3|Other, not specified|0|||
162829589|NCT02819635|588089152|FG008|Substudy 3|Other, not specified|202|||
162829590|NCT02819635|588089153|FG009|Substudy 3|Other, not specified|5|||
162829591|NCT02819635|588089154|FG010|Substudy 3|Other, not specified|89|||
162829592|NCT02819635|588089155|FG011|Substudy 3|Other, not specified|39|||
162829593|NCT01349465|588089157|FG000|Overall Study|Adverse Event|1|||
162829594|NCT01349465|588089158|FG001|Overall Study|Adverse Event|0|||
162829595|NCT01349465|588089157|FG000|Overall Study|Death|3|||
162829596|NCT01349465|588089158|FG001|Overall Study|Death|0|||
162829597|NCT01349465|588089157|FG000|Overall Study|Lost to Follow-up|10|||
162829598|NCT01349465|588089158|FG001|Overall Study|Lost to Follow-up|1|||
162829599|NCT01349465|588089157|FG000|Overall Study|Withdrawal by Subject|4|||
162829600|NCT01349465|588089158|FG001|Overall Study|Withdrawal by Subject|2|||
162829601|NCT01349465|588089157|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
162829602|NCT01349465|588089158|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
162829603|NCT04329702|588089161|FG000|Overall Study|illness|3|||
162829604|NCT04329702|588089162|FG001|Overall Study|illness|4|||
162829605|NCT04329702|588089163|FG002|Overall Study|illness|0|||
162829606|NCT04329702|588089161|FG000|Overall Study|Lost to Follow-up|0|||
162829607|NCT04329702|588089162|FG001|Overall Study|Lost to Follow-up|0|||
162829608|NCT04329702|588089163|FG002|Overall Study|Lost to Follow-up|2|||
162829609|NCT04329702|588089161|FG000|Overall Study|Death|0|||
162829610|NCT04329702|588089162|FG001|Overall Study|Death|2|||
162829611|NCT04329702|588089163|FG002|Overall Study|Death|0|||
162829612|NCT01476475|588089164|FG000|Overall Study|Adverse Event|6|||
162829613|NCT01476475|588089165|FG001|Overall Study|Adverse Event|0|||
162829614|NCT01476475|588089164|FG000|Overall Study|Poor compliance to protocol|1|||
162829615|NCT01476475|588089165|FG001|Overall Study|Poor compliance to protocol|1|||
162829616|NCT01476475|588089164|FG000|Overall Study|Other reasons|4|||
162829617|NCT01476475|588089165|FG001|Overall Study|Other reasons|2|||
162829618|NCT00751400|588089166|FG000|Overall Study|Lost to Follow-up|10|||
162829619|NCT01918007|588089170|FG000|Overall Study|Baseline oximetry not acceptable|11|||
162829620|NCT01918007|588089171|FG001|Overall Study|Baseline oximetry not acceptable|7|||
162829621|NCT01918007|588089170|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
162829622|NCT01918007|588089171|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
162829623|NCT01918007|588089170|FG000|Overall Study|Lost to Follow-up|4|||
162829624|NCT01918007|588089171|FG001|Overall Study|Lost to Follow-up|7|||
162829625|NCT01372384|588089172|FG000|Overall Study|Progression of disease|3|||
162829626|NCT00441974|588089173|FG000|Overall Study|Adverse Event|6|||
162829627|NCT00441974|588089173|FG000|Overall Study|Consent Withdrawn|35|||
162829628|NCT00441974|588089173|FG000|Overall Study|Lost to Follow-up|80|||
162829629|NCT00441974|588089173|FG000|Overall Study|Protocol Violation|7|||
162829630|NCT01471015|588089174|FG000|Overall Study|Death|0|||
162829631|NCT01471015|588089175|FG001|Overall Study|Death|1|||
162829632|NCT01471015|588089176|FG002|Overall Study|Death|1|||
162829633|NCT04206020|588089177|FG000|Overall Study|Adverse Event|1|||
162829634|NCT04206020|588089178|FG001|Overall Study|Adverse Event|4|||
162829635|NCT04206020|588089177|FG000|Overall Study|Protocol Violation|2|||
162829636|NCT04206020|588089178|FG001|Overall Study|Protocol Violation|0|||
162829637|NCT04206020|588089177|FG000|Overall Study|Withdrawal by Subject|2|||
162829638|NCT04206020|588089178|FG001|Overall Study|Withdrawal by Subject|0|||
162829639|NCT04206020|588089177|FG000|Overall Study|Lost to Follow-up|2|||
162829640|NCT04206020|588089178|FG001|Overall Study|Lost to Follow-up|0|||
162829641|NCT04206020|588089177|FG000|Overall Study|Pregnancy|0|||
162829642|NCT04206020|588089178|FG001|Overall Study|Pregnancy|1|||
162941278|NCT01215942|588488552|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
162941279|NCT03305055|588488553|FG000|Overall Study|Withdrawal by Subject|0|||
162941280|NCT03305055|588488554|FG001|Overall Study|Withdrawal by Subject|1|||
162941281|NCT03305055|588488553|FG000|Overall Study|Adverse Event|1|||
162941282|NCT03305055|588488554|FG001|Overall Study|Adverse Event|1|||
162941283|NCT04471935|588488555|FG000|Overall Study|Withdrawal by Subject|1|||
162941284|NCT04471935|588488555|FG000|Overall Study|Deemed ineligible to participate|1|||
162941285|NCT02540356|588488556|FG000|Overall Study|Terminated due to disease progression|1|||
162941286|NCT02540356|588488557|FG001|Overall Study|Terminated due to disease progression|0|||
162941287|NCT01399736|588488558|FG000|Overall Study|Withdrawal by Subject|4|||
162941288|NCT01399736|588488559|FG001|Overall Study|Withdrawal by Subject|2|||
162941289|NCT01399736|588488558|FG000|Overall Study|Lost to Follow-up|0|||
162941290|NCT01399736|588488559|FG001|Overall Study|Lost to Follow-up|2|||
162941291|NCT03500484|588488560|FG000|Overall Study|Adverse Event|2|||
162941292|NCT03500484|588488561|FG001|Overall Study|Adverse Event|0|||
162941293|NCT03500484|588488560|FG000|Overall Study|Physician Decision|1|||
162941294|NCT03500484|588488561|FG001|Overall Study|Physician Decision|0|||
162941295|NCT03500484|588488560|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
162941296|NCT03500484|588488561|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
162941297|NCT02795104|588488562|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
162941298|NCT02795104|588488563|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
162941299|NCT02795104|588488564|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
162941300|NCT02795104|588488562|FG000|Overall Study|Withdrawal by Subject|0|||
162941301|NCT02795104|588488563|FG001|Overall Study|Withdrawal by Subject|2|||
162941302|NCT02795104|588488564|FG002|Overall Study|Withdrawal by Subject|0|||
162941303|NCT02795104|588488562|FG000|Overall Study|Lost to Follow-up|0|||
162941304|NCT02795104|588488563|FG001|Overall Study|Lost to Follow-up|0|||
162941305|NCT02795104|588488564|FG002|Overall Study|Lost to Follow-up|1|||
162941306|NCT00948675|588488565|FG000|Overall Study|Lost to Follow-up|1|||
162941307|NCT00948675|588488566|FG001|Overall Study|Lost to Follow-up|0|||
162941308|NCT01654380|588488570|FG000|Part B, Period 1|Physician Decision|0|||
162941309|NCT01654380|588488571|FG001|Part B, Period 1|Physician Decision|0|||
162941310|NCT01654380|588488572|FG002|Part B, Period 1|Physician Decision|1|||
162941311|NCT01654380|588488573|FG003|Part B, Period 1|Physician Decision|0|||
162941312|NCT03335371|588488574|FG000|Overall Study|Lost to Follow-up|0|||
162941313|NCT03335371|588488575|FG001|Overall Study|Lost to Follow-up|0|||
162941314|NCT03335371|588488576|FG002|Overall Study|Lost to Follow-up|0|||
162941315|NCT03335371|588488577|FG003|Overall Study|Lost to Follow-up|0|||
162941316|NCT03335371|588488578|FG004|Overall Study|Lost to Follow-up|1|||
162941317|NCT03335371|588488574|FG000|Overall Study|Withdrawal by Subject|0|||
162941318|NCT03335371|588488575|FG001|Overall Study|Withdrawal by Subject|0|||
162941319|NCT03335371|588488576|FG002|Overall Study|Withdrawal by Subject|0|||
162941320|NCT03335371|588488577|FG003|Overall Study|Withdrawal by Subject|0|||
162941321|NCT03335371|588488578|FG004|Overall Study|Withdrawal by Subject|1|||
162941322|NCT03335371|588488574|FG000|Overall Study|Randomization Error|0|||
162941323|NCT03335371|588488575|FG001|Overall Study|Randomization Error|0|||
162941324|NCT03335371|588488576|FG002|Overall Study|Randomization Error|1|||
162941325|NCT03335371|588488577|FG003|Overall Study|Randomization Error|0|||
162941326|NCT03335371|588488578|FG004|Overall Study|Randomization Error|0|||
162941327|NCT06331156|588488580|FG000|Overall Study|Adverse Event|1|||
162941328|NCT06331156|588488581|FG001|Overall Study|Adverse Event|0|||
162941329|NCT06331156|588488580|FG000|Overall Study|Lost to Follow-up|1|||
162698692|NCT00337662|587605553|FG000|Study Period III|Entry Criteria Not Met|4|||
162941330|NCT06331156|588488581|FG001|Overall Study|Lost to Follow-up|0|||
162941331|NCT06331156|588488580|FG000|Overall Study|Migrated / Moved from the study area|4|||
162941332|NCT06331156|588488581|FG001|Overall Study|Migrated / Moved from the study area|3|||
162941333|NCT06331156|588488580|FG000|Overall Study|Other|7|||
162941334|NCT06331156|588488581|FG001|Overall Study|Other|0|||
162941335|NCT06331156|588488580|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
162941336|NCT06331156|588488581|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
162941337|NCT05845645|588488582|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941338|NCT05845645|588488583|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941339|NCT05845645|588488584|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
162941340|NCT05845645|588488585|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941341|NCT05845645|588488586|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941342|NCT05845645|588488587|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941343|NCT05845645|588488588|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941344|NCT05845645|588488589|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941345|NCT05845645|588488590|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941346|NCT05845645|588488591|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941347|NCT05845645|588488592|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941348|NCT05845645|588488593|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162941349|NCT05845645|588488582|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941350|NCT05845645|588488583|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941351|NCT05845645|588488584|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941352|NCT05845645|588488585|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941353|NCT05845645|588488586|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941354|NCT05845645|588488587|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941355|NCT05845645|588488588|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941356|NCT05845645|588488589|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941357|NCT05845645|588488590|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941358|NCT05845645|588488591|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
162941359|NCT05845645|588488592|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941360|NCT05845645|588488593|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
162941361|NCT00998881|588488598|FG000|Overall Study|Adverse Event|2|||
162941362|NCT00998881|588488599|FG001|Overall Study|Adverse Event|2|||
162941363|NCT00998881|588488598|FG000|Overall Study|Lack of Efficacy|1|||
162941364|NCT00998881|588488599|FG001|Overall Study|Lack of Efficacy|0|||
162941365|NCT00998881|588488598|FG000|Overall Study|Physician Decision|3|||
162941366|NCT00998881|588488599|FG001|Overall Study|Physician Decision|0|||
162941367|NCT00998881|588488598|FG000|Overall Study|Withdrawal by Subject|1|||
162941368|NCT00998881|588488599|FG001|Overall Study|Withdrawal by Subject|0|||
162941369|NCT00998881|588488598|FG000|Overall Study|Personal matter|1|||
162941370|NCT00998881|588488599|FG001|Overall Study|Personal matter|0|||
162941371|NCT02649231|588488600|FG000|Overall Study|Adverse Event|0|||
162941372|NCT02649231|588488601|FG001|Overall Study|Adverse Event|0|||
162941373|NCT02649231|588488602|FG002|Overall Study|Adverse Event|0|||
162941374|NCT02649231|588488603|FG003|Overall Study|Adverse Event|1|||
162941375|NCT02649231|588488600|FG000|Overall Study|Lost to Follow-up|2|||
162941376|NCT02649231|588488601|FG001|Overall Study|Lost to Follow-up|1|||
162941377|NCT02649231|588488602|FG002|Overall Study|Lost to Follow-up|1|||
162941378|NCT02649231|588488603|FG003|Overall Study|Lost to Follow-up|0|||
162941379|NCT02649231|588488600|FG000|Overall Study|Withdrawal by Subject|0|||
162941380|NCT02649231|588488601|FG001|Overall Study|Withdrawal by Subject|1|||
162941381|NCT02649231|588488602|FG002|Overall Study|Withdrawal by Subject|0|||
162941382|NCT02649231|588488603|FG003|Overall Study|Withdrawal by Subject|1|||
162941383|NCT02649231|588488600|FG000|Overall Study|Protocol Violation|2|||
162941384|NCT02649231|588488601|FG001|Overall Study|Protocol Violation|1|||
162941385|NCT02649231|588488602|FG002|Overall Study|Protocol Violation|1|||
162941386|NCT02649231|588488603|FG003|Overall Study|Protocol Violation|0|||
162941387|NCT02970669|588488606|FG000|Double-blind Period|Adverse Event|4|||
162941388|NCT02970669|588488607|FG001|Double-blind Period|Adverse Event|0|||
162941389|NCT02970669|588488606|FG000|Double-blind Period|Death|1|||
162941390|NCT02970669|588488607|FG001|Double-blind Period|Death|0|||
162941391|NCT02970669|588488606|FG000|Double-blind Period|Study terminated by sponsor|1|||
162941392|NCT02970669|588488607|FG001|Double-blind Period|Study terminated by sponsor|2|||
162941393|NCT02970669|588488606|FG000|Double-blind Period|Physician Decision|0|||
162941394|NCT02970669|588488607|FG001|Double-blind Period|Physician Decision|2|||
162941395|NCT02970669|588488606|FG000|Double-blind Period|Withdrawal by Subject|2|||
162941396|NCT02970669|588488607|FG001|Double-blind Period|Withdrawal by Subject|2|||
162941397|NCT02970669|588488606|FG000|Open-label Period|Withdrawal by Subject|2|||
162941398|NCT02970669|588488607|FG001|Open-label Period|Withdrawal by Subject|2|||
162941399|NCT02970669|588488606|FG000|Open-label Period|Adverse Event|1|||
162941400|NCT02970669|588488607|FG001|Open-label Period|Adverse Event|0|||
162941401|NCT02970669|588488606|FG000|Open-label Period|Physician Decision|1|||
162941402|NCT02970669|588488607|FG001|Open-label Period|Physician Decision|0|||
162941403|NCT00876733|588488608|FG000|Overall Study|Adverse Event|34|||
162941404|NCT00876733|588488609|FG001|Overall Study|Adverse Event|20|||
162941405|NCT00876733|588488610|FG002|Overall Study|Adverse Event|10|||
162941406|NCT00876733|588488611|FG003|Overall Study|Adverse Event|3|||
162941407|NCT00876733|588488608|FG000|Overall Study|Lack of Efficacy|17|||
162941408|NCT00876733|588488609|FG001|Overall Study|Lack of Efficacy|9|||
162941409|NCT00876733|588488610|FG002|Overall Study|Lack of Efficacy|10|||
162941410|NCT00876733|588488611|FG003|Overall Study|Lack of Efficacy|1|||
162941411|NCT00876733|588488608|FG000|Overall Study|Lost to Follow-up|26|||
162941412|NCT00876733|588488609|FG001|Overall Study|Lost to Follow-up|10|||
162941413|NCT00876733|588488610|FG002|Overall Study|Lost to Follow-up|3|||
162941414|NCT00876733|588488611|FG003|Overall Study|Lost to Follow-up|2|||
162941415|NCT00876733|588488608|FG000|Overall Study|Data not available|14|||
162941416|NCT00876733|588488609|FG001|Overall Study|Data not available|3|||
162941417|NCT00876733|588488610|FG002|Overall Study|Data not available|7|||
162941418|NCT00876733|588488611|FG003|Overall Study|Data not available|1|||
162941419|NCT02611752|588488614|FG000|Overall Study|Adverse Event|0|||
162941420|NCT02611752|588488615|FG001|Overall Study|Adverse Event|1|||
162941421|NCT03495986|588488616|FG000|Overall Study|Physician Decision|1|||
162941422|NCT03495986|588488617|FG001|Overall Study|Physician Decision|0|||
162941423|NCT03495986|588488616|FG000|Overall Study|Withdrawal by Subject|1|||
162941424|NCT03495986|588488617|FG001|Overall Study|Withdrawal by Subject|1|||
162941425|NCT03495986|588488616|FG000|Overall Study|Withdrawal by Subject|1|||
162941426|NCT03495986|588488617|FG001|Overall Study|Withdrawal by Subject|0|||
162941427|NCT05476679|588488618|FG000|Overall Study|Withdrawal by Subject|0|||
162941428|NCT05476679|588488619|FG001|Overall Study|Withdrawal by Subject|0|||
162941429|NCT05476679|588488620|FG002|Overall Study|Withdrawal by Subject|0|||
162941430|NCT05476679|588488621|FG003|Overall Study|Withdrawal by Subject|1|||
162941431|NCT05476679|588488622|FG004|Overall Study|Withdrawal by Subject|0|||
162941432|NCT05476679|588488618|FG000|Overall Study|Lost to Follow-up|0|||
162941433|NCT05476679|588488619|FG001|Overall Study|Lost to Follow-up|0|||
162941434|NCT05476679|588488620|FG002|Overall Study|Lost to Follow-up|0|||
162941435|NCT05476679|588488621|FG003|Overall Study|Lost to Follow-up|1|||
162941436|NCT05476679|588488622|FG004|Overall Study|Lost to Follow-up|0|||
162941437|NCT01214330|588488623|FG000|Overall Study|Withdrawal by Subject|2|||
162941438|NCT01214330|588488623|FG000|Overall Study|Withdrawal by Subject|2|||
162941439|NCT00249821|588488624|FG000|Overall Study|Technical problem|0|||
162941440|NCT00249821|588488625|FG001|Overall Study|Technical problem|1|||
162941441|NCT00467584|588488626|FG000|Overall Study|Withdrawal by Subject|4|||
162941442|NCT00467584|588488627|FG001|Overall Study|Withdrawal by Subject|5|||
162941443|NCT00467584|588488628|FG002|Overall Study|Withdrawal by Subject|1|||
162941444|NCT01498484|588488632|FG000|Overall Study|Death|6|||
162941445|NCT01498484|588488633|FG001|Overall Study|Death|3|||
162941446|NCT01498484|588488634|FG002|Overall Study|Death|1|||
162941447|NCT01498484|588488635|FG003|Overall Study|Death|1|||
162941448|NCT01498484|588488636|FG004|Overall Study|Death|0|||
162941449|NCT01498484|588488637|FG005|Overall Study|Death|0|||
162941450|NCT01498484|588488638|FG006|Overall Study|Death|10|||
162941451|NCT01498484|588488639|FG007|Overall Study|Death|1|||
162941452|NCT01498484|588488640|FG008|Overall Study|Death|0|||
162941453|NCT01498484|588488632|FG000|Overall Study|Physician Decision|3|||
162941454|NCT01498484|588488633|FG001|Overall Study|Physician Decision|2|||
162941455|NCT01498484|588488634|FG002|Overall Study|Physician Decision|1|||
162941456|NCT01498484|588488635|FG003|Overall Study|Physician Decision|1|||
162941457|NCT01498484|588488636|FG004|Overall Study|Physician Decision|0|||
162941458|NCT01498484|588488637|FG005|Overall Study|Physician Decision|0|||
162941459|NCT01498484|588488638|FG006|Overall Study|Physician Decision|8|||
162941460|NCT01498484|588488639|FG007|Overall Study|Physician Decision|13|||
162941461|NCT01498484|588488640|FG008|Overall Study|Physician Decision|1|||
162941462|NCT01498484|588488632|FG000|Overall Study|Adverse Event|0|||
162941463|NCT01498484|588488633|FG001|Overall Study|Adverse Event|0|||
162941464|NCT01498484|588488634|FG002|Overall Study|Adverse Event|0|||
162941465|NCT01498484|588488635|FG003|Overall Study|Adverse Event|0|||
162941466|NCT01498484|588488636|FG004|Overall Study|Adverse Event|0|||
162941467|NCT01498484|588488637|FG005|Overall Study|Adverse Event|1|||
162941468|NCT01498484|588488638|FG006|Overall Study|Adverse Event|0|||
162941469|NCT01498484|588488639|FG007|Overall Study|Adverse Event|0|||
162941470|NCT01498484|588488640|FG008|Overall Study|Adverse Event|0|||
162829643|NCT04206020|588089177|FG000|Overall Study|Unable to attend visits|1|||
162829644|NCT04206020|588089178|FG001|Overall Study|Unable to attend visits|2|||
162829645|NCT04962022|588089181|FG000|Period 1|Withdrawal by Subject|1|||
162829646|NCT04962022|588089182|FG001|Period 1|Withdrawal by Subject|0|||
162829647|NCT02055820|588089187|FG000|Phase I: Dose-Finding|Death|1|||
162829648|NCT02055820|588089188|FG001|Phase I: Dose-Finding|Death|0|||
162829649|NCT02055820|588089189|FG002|Phase I: Dose-Finding|Death|1|||
162829650|NCT02055820|588089190|FG003|Phase I: Dose-Finding|Death|2|||
162829651|NCT02055820|588089191|FG004|Phase I: Dose-Finding|Death|0|||
162829652|NCT02055820|588089192|FG005|Phase I: Dose-Finding|Death|1|||
162829653|NCT02055820|588089193|FG006|Phase I: Dose-Finding|Death|1|||
162829654|NCT02055820|588089194|FG007|Phase I: Dose-Finding|Death|0|||
162829655|NCT02055820|588089195|FG008|Phase I: Dose-Finding|Death|0|||
162829656|NCT02055820|588089196|FG009|Phase I: Dose-Finding|Death|0|||
162829657|NCT02055820|588089187|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829658|NCT02055820|588089188|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829659|NCT02055820|588089189|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829660|NCT02055820|588089190|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829661|NCT02055820|588089191|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829662|NCT02055820|588089192|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
162829663|NCT02055820|588089193|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829664|NCT02055820|588089194|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829665|NCT02055820|588089195|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829666|NCT02055820|588089196|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
162829667|NCT02055820|588089187|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829668|NCT02055820|588089188|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829669|NCT02055820|588089189|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829670|NCT02055820|588089190|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
162829671|NCT02055820|588089191|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829672|NCT02055820|588089192|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829673|NCT02055820|588089193|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
162829674|NCT02055820|588089194|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829675|NCT02055820|588089195|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
162941471|NCT01498484|588488632|FG000|Overall Study|Withdrawal by Subject|0|||
162941472|NCT01498484|588488633|FG001|Overall Study|Withdrawal by Subject|0|||
162941473|NCT01498484|588488634|FG002|Overall Study|Withdrawal by Subject|0|||
162941474|NCT01498484|588488635|FG003|Overall Study|Withdrawal by Subject|1|||
162941475|NCT01498484|588488636|FG004|Overall Study|Withdrawal by Subject|0|||
162941476|NCT01498484|588488637|FG005|Overall Study|Withdrawal by Subject|0|||
162941477|NCT01498484|588488638|FG006|Overall Study|Withdrawal by Subject|1|||
162941478|NCT01498484|588488639|FG007|Overall Study|Withdrawal by Subject|0|||
162941479|NCT01498484|588488640|FG008|Overall Study|Withdrawal by Subject|0|||
162941480|NCT01498484|588488632|FG000|Overall Study|Other|5|||
162941481|NCT01498484|588488633|FG001|Overall Study|Other|2|||
162941482|NCT01498484|588488634|FG002|Overall Study|Other|0|||
162941483|NCT01498484|588488635|FG003|Overall Study|Other|0|||
162941484|NCT01498484|588488636|FG004|Overall Study|Other|1|||
162941485|NCT01498484|588488637|FG005|Overall Study|Other|0|||
162941486|NCT01498484|588488638|FG006|Overall Study|Other|3|||
162941487|NCT01498484|588488639|FG007|Overall Study|Other|0|||
162941488|NCT01498484|588488640|FG008|Overall Study|Other|1|||
162941489|NCT00423800|588488641|FG000|Overall Study|Protocol Violation|0|||
162941490|NCT00423800|588488642|FG001|Overall Study|Protocol Violation|1|||
162941491|NCT00814320|588488643|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
162941492|NCT00814320|588488644|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
162941493|NCT00814320|588488643|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
162941494|NCT00814320|588488644|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
162941495|NCT00814320|588488643|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
162941496|NCT00814320|588488644|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
162941497|NCT00814320|588488643|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
162941498|NCT00814320|588488644|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
162941499|NCT00814320|588488643|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
162941500|NCT00814320|588488644|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
162941501|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
162941502|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
162941503|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
162941504|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
162941505|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
162941506|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
162941507|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
162941508|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
162941509|NCT00814320|588488643|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
162941510|NCT00814320|588488644|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
162941511|NCT00619385|588488645|FG000|Overall Study|Adverse Event|0|||
162941512|NCT00619385|588488646|FG001|Overall Study|Adverse Event|0|||
162941513|NCT00619385|588488647|FG002|Overall Study|Adverse Event|3|||
162941514|NCT00619385|588488645|FG000|Overall Study|Other|1|||
162941515|NCT00619385|588488646|FG001|Overall Study|Other|2|||
162941516|NCT00619385|588488647|FG002|Overall Study|Other|1|||
162941517|NCT00656019|588488648|FG000|Overall Study|Not Eligible|10|||
162941518|NCT00656019|588488649|FG001|Overall Study|Not Eligible|0|||
162941519|NCT00656019|588488650|FG002|Overall Study|Not Eligible|0|||
162698693|NCT00337662|587605554|FG001|Study Period III|Entry Criteria Not Met|1|||
162698694|NCT00337662|587605555|FG002|Study Period III|Entry Criteria Not Met|3|||
162698695|NCT00337662|587605556|FG003|Study Period III|Entry Criteria Not Met|0|||
162698696|NCT00337662|587605553|FG000|Study Period III|Lack of Efficacy|4|||
162698697|NCT00337662|587605554|FG001|Study Period III|Lack of Efficacy|4|||
162698698|NCT00337662|587605555|FG002|Study Period III|Lack of Efficacy|2|||
162698699|NCT00337662|587605556|FG003|Study Period III|Lack of Efficacy|0|||
162698700|NCT00337662|587605553|FG000|Study Period III|Parent/Caregiver Decision|0|||
162698701|NCT00337662|587605554|FG001|Study Period III|Parent/Caregiver Decision|0|||
162698702|NCT00337662|587605555|FG002|Study Period III|Parent/Caregiver Decision|2|||
162698703|NCT00337662|587605556|FG003|Study Period III|Parent/Caregiver Decision|0|||
162829676|NCT02055820|588089196|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
162829677|NCT02055820|588089187|FG000|Phase II: Expansion|Death|0|||
162829678|NCT02055820|588089188|FG001|Phase II: Expansion|Death|0|||
162829679|NCT02055820|588089189|FG002|Phase II: Expansion|Death|0|||
162829680|NCT02055820|588089190|FG003|Phase II: Expansion|Death|0|||
162829681|NCT02055820|588089191|FG004|Phase II: Expansion|Death|33|||
162829682|NCT02055820|588089192|FG005|Phase II: Expansion|Death|0|||
162829683|NCT02055820|588089193|FG006|Phase II: Expansion|Death|0|||
162829684|NCT02055820|588089194|FG007|Phase II: Expansion|Death|0|||
162829685|NCT02055820|588089195|FG008|Phase II: Expansion|Death|0|||
162829686|NCT02055820|588089196|FG009|Phase II: Expansion|Death|0|||
162829687|NCT02055820|588089187|FG000|Phase II: Expansion|Lost to Follow-up|0|||
162829688|NCT02055820|588089188|FG001|Phase II: Expansion|Lost to Follow-up|0|||
162829689|NCT02055820|588089189|FG002|Phase II: Expansion|Lost to Follow-up|0|||
162829690|NCT02055820|588089190|FG003|Phase II: Expansion|Lost to Follow-up|0|||
162829691|NCT02055820|588089191|FG004|Phase II: Expansion|Lost to Follow-up|4|||
162829692|NCT02055820|588089192|FG005|Phase II: Expansion|Lost to Follow-up|0|||
162829693|NCT02055820|588089193|FG006|Phase II: Expansion|Lost to Follow-up|0|||
162829694|NCT02055820|588089194|FG007|Phase II: Expansion|Lost to Follow-up|0|||
162941520|NCT00656019|588488651|FG003|Overall Study|Not Eligible|0|||
162941521|NCT00656019|588488648|FG000|Overall Study|Withdrawal by Subject|2|||
162941522|NCT00656019|588488649|FG001|Overall Study|Withdrawal by Subject|0|||
162941523|NCT00656019|588488650|FG002|Overall Study|Withdrawal by Subject|0|||
162941524|NCT00656019|588488651|FG003|Overall Study|Withdrawal by Subject|0|||
162941525|NCT00656019|588488648|FG000|Overall Study|Lost to Follow-up|2|||
162941526|NCT00656019|588488649|FG001|Overall Study|Lost to Follow-up|1|||
162941527|NCT00656019|588488650|FG002|Overall Study|Lost to Follow-up|0|||
162941528|NCT00656019|588488651|FG003|Overall Study|Lost to Follow-up|0|||
162941529|NCT01488578|588488652|FG000|Overall Study|Protocol Violation|1836|||
162941530|NCT05550532|588488657|FG000|Overall Study|Withdrawal by Subject|8|||
162941531|NCT05550532|588488658|FG001|Overall Study|Withdrawal by Subject|3|||
162941532|NCT05550532|588488657|FG000|Overall Study|Adverse Event|2|||
162941533|NCT05550532|588488658|FG001|Overall Study|Adverse Event|3|||
162941534|NCT05550532|588488657|FG000|Overall Study|Lost to Follow-up|4|||
162941535|NCT05550532|588488658|FG001|Overall Study|Lost to Follow-up|0|||
162941536|NCT05550532|588488657|FG000|Overall Study|Other|0|||
162941537|NCT05550532|588488658|FG001|Overall Study|Other|4|||
162941538|NCT00859469|588488659|FG000|Overall Study|Adverse Event|2|||
162941539|NCT00859469|588488659|FG000|Overall Study|Lack of Efficacy|9|||
162941540|NCT00859469|588488659|FG000|Overall Study|Withdrawal by Subject|1|||
162941541|NCT00859469|588488659|FG000|Overall Study|Death|16|||
162941542|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941543|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
162941544|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
162941545|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941546|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941547|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941548|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
162941549|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
162941550|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
162941551|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
162941552|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941553|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941554|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941555|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941556|NCT04820842|588490334|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941557|NCT04820842|588490335|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
162941558|NCT04820842|588490336|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941559|NCT04820842|588490337|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941560|NCT04820842|588490338|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941561|NCT04820842|588490339|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941562|NCT04820842|588490340|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162941563|NCT04820842|588490334|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941564|NCT04820842|588490335|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941565|NCT04820842|588490336|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941566|NCT04820842|588490337|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
162941567|NCT04820842|588490338|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941568|NCT04820842|588490339|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
162941569|NCT04820842|588490340|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
162941570|NCT01691508|588490341|FG000|Overall Study|Adverse Event|3|||
162941571|NCT01691508|588490342|FG001|Overall Study|Adverse Event|3|||
162941572|NCT01691508|588490341|FG000|Overall Study|Withdrawal by Subject|1|||
162941573|NCT01691508|588490342|FG001|Overall Study|Withdrawal by Subject|0|||
162941574|NCT01296932|588490343|FG000|Overall Study|Dose limiting toxicity|0|||
162941575|NCT01296932|588490344|FG001|Overall Study|Dose limiting toxicity|0|||
162941576|NCT01296932|588490345|FG002|Overall Study|Dose limiting toxicity|0|||
162941577|NCT01296932|588490346|FG003|Overall Study|Dose limiting toxicity|0|||
162941578|NCT01296932|588490347|FG004|Overall Study|Dose limiting toxicity|0|||
162941579|NCT01296932|588490348|FG005|Overall Study|Dose limiting toxicity|0|||
162941580|NCT01296932|588490349|FG006|Overall Study|Dose limiting toxicity|1|||
162941581|NCT01296932|588490350|FG007|Overall Study|Dose limiting toxicity|0|||
162941582|NCT01296932|588490351|FG008|Overall Study|Dose limiting toxicity|1|||
162941583|NCT01296932|588490343|FG000|Overall Study|Progressive disease|2|||
162941584|NCT01296932|588490344|FG001|Overall Study|Progressive disease|0|||
162941585|NCT01296932|588490345|FG002|Overall Study|Progressive disease|1|||
162941586|NCT01296932|588490346|FG003|Overall Study|Progressive disease|1|||
162941587|NCT01296932|588490347|FG004|Overall Study|Progressive disease|2|||
162941588|NCT01296932|588490348|FG005|Overall Study|Progressive disease|3|||
162941589|NCT01296932|588490349|FG006|Overall Study|Progressive disease|1|||
162941590|NCT01296932|588490350|FG007|Overall Study|Progressive disease|0|||
162941591|NCT01296932|588490351|FG008|Overall Study|Progressive disease|0|||
162941592|NCT01296932|588490343|FG000|Overall Study|Withdrawal by Subject|0|||
162941593|NCT01296932|588490344|FG001|Overall Study|Withdrawal by Subject|0|||
162941594|NCT01296932|588490345|FG002|Overall Study|Withdrawal by Subject|1|||
162941595|NCT01296932|588490346|FG003|Overall Study|Withdrawal by Subject|1|||
162941596|NCT01296932|588490347|FG004|Overall Study|Withdrawal by Subject|0|||
162941597|NCT01296932|588490348|FG005|Overall Study|Withdrawal by Subject|0|||
162941598|NCT01296932|588490349|FG006|Overall Study|Withdrawal by Subject|3|||
162941599|NCT01296932|588490350|FG007|Overall Study|Withdrawal by Subject|0|||
162941600|NCT01296932|588490351|FG008|Overall Study|Withdrawal by Subject|0|||
162941601|NCT01296932|588490343|FG000|Overall Study|Adverse Event|1|||
162941602|NCT01296932|588490344|FG001|Overall Study|Adverse Event|1|||
162941603|NCT01296932|588490345|FG002|Overall Study|Adverse Event|1|||
162829695|NCT02055820|588089195|FG008|Phase II: Expansion|Lost to Follow-up|0|||
162829696|NCT02055820|588089196|FG009|Phase II: Expansion|Lost to Follow-up|0|||
162829697|NCT02055820|588089187|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
162829698|NCT02055820|588089188|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
162829699|NCT02055820|588089189|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
162829700|NCT02055820|588089190|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
162829701|NCT02055820|588089191|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
162829702|NCT02055820|588089192|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
162829703|NCT02055820|588089193|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
162829704|NCT02055820|588089194|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
162829705|NCT02055820|588089195|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
162829706|NCT02055820|588089196|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
162829707|NCT02285777|588089197|FG000|Overall Study|Withdrawal by Subject|1|||
162829708|NCT02285777|588089198|FG001|Overall Study|Withdrawal by Subject|1|||
162829709|NCT02285777|588089197|FG000|Overall Study|Lost to Follow-up|4|||
162829710|NCT02285777|588089198|FG001|Overall Study|Lost to Follow-up|2|||
162829711|NCT00552175|588089199|FG000|Overall Study|Lack of Efficacy|2|||
162829712|NCT00552175|588089200|FG001|Overall Study|Lack of Efficacy|0|||
162829713|NCT00552175|588089201|FG002|Overall Study|Lack of Efficacy|1|||
162829714|NCT00552175|588089199|FG000|Overall Study|Adverse Event|9|||
162829715|NCT00552175|588089200|FG001|Overall Study|Adverse Event|9|||
162829716|NCT00552175|588089201|FG002|Overall Study|Adverse Event|10|||
162829717|NCT00552175|588089199|FG000|Overall Study|Withdrawal by Subject|2|||
162829718|NCT00552175|588089200|FG001|Overall Study|Withdrawal by Subject|2|||
162829719|NCT00552175|588089201|FG002|Overall Study|Withdrawal by Subject|1|||
162829720|NCT00552175|588089199|FG000|Overall Study|Lost to Follow-up|0|||
162829721|NCT00552175|588089200|FG001|Overall Study|Lost to Follow-up|0|||
162829722|NCT00552175|588089201|FG002|Overall Study|Lost to Follow-up|1|||
162829723|NCT00552175|588089199|FG000|Overall Study|Entry Criteria Not Met|1|||
162829724|NCT00552175|588089200|FG001|Overall Study|Entry Criteria Not Met|1|||
162829725|NCT00552175|588089201|FG002|Overall Study|Entry Criteria Not Met|0|||
162829726|NCT00552175|588089199|FG000|Overall Study|Reason Not Specified|3|||
162829727|NCT00552175|588089200|FG001|Overall Study|Reason Not Specified|1|||
162829728|NCT00552175|588089201|FG002|Overall Study|Reason Not Specified|1|||
162829729|NCT02614859|588089202|FG000|Overall Study|Physician Decision|0|||
162829730|NCT02614859|588089203|FG001|Overall Study|Physician Decision|1|||
162829731|NCT03548935|588089204|FG000|Overall Study|Withdrawal by Subject|26|||
162941604|NCT01296932|588490346|FG003|Overall Study|Adverse Event|2|||
162941605|NCT01296932|588490347|FG004|Overall Study|Adverse Event|1|||
162941606|NCT01296932|588490348|FG005|Overall Study|Adverse Event|0|||
162941607|NCT01296932|588490349|FG006|Overall Study|Adverse Event|0|||
162829732|NCT03548935|588089205|FG001|Overall Study|Withdrawal by Subject|17|||
162829733|NCT03548935|588089204|FG000|Overall Study|Lost to Follow-up|39|||
162829734|NCT03548935|588089205|FG001|Overall Study|Lost to Follow-up|28|||
162941608|NCT01296932|588490350|FG007|Overall Study|Adverse Event|0|||
162829735|NCT03548935|588089204|FG000|Overall Study|Death|1|||
162941609|NCT01296932|588490351|FG008|Overall Study|Adverse Event|1|||
162941610|NCT01296932|588490343|FG000|Overall Study|Investigator decision|0|||
162829736|NCT03548935|588089205|FG001|Overall Study|Death|1|||
162829737|NCT04677959|588089206|FG000|Overall Study|Adverse Event|1|||
162829738|NCT04677959|588089207|FG001|Overall Study|Adverse Event|9|||
162829739|NCT04677959|588089206|FG000|Overall Study|Withdrawal by Subject|2|||
162829740|NCT04677959|588089207|FG001|Overall Study|Withdrawal by Subject|15|||
162829741|NCT04677959|588089206|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162829742|NCT04677959|588089207|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162829743|NCT04677959|588089206|FG000|Overall Study|Non-compliance with study drug|0|||
162829744|NCT04677959|588089207|FG001|Overall Study|Non-compliance with study drug|2|||
162829745|NCT04677959|588089206|FG000|Overall Study|Protocol deviation|0|||
162829746|NCT04677959|588089207|FG001|Overall Study|Protocol deviation|11|||
162829747|NCT04677959|588089206|FG000|Overall Study|Lost to Follow-up|9|||
162829748|NCT04677959|588089207|FG001|Overall Study|Lost to Follow-up|13|||
162829749|NCT04677959|588089206|FG000|Overall Study|Other than specified|0|||
162829750|NCT04677959|588089207|FG001|Overall Study|Other than specified|8|||
162829751|NCT01074190|588089214|FG000|Overall Study|Emergency Cesarean Delivery|1|||
162829752|NCT01074190|588089215|FG001|Overall Study|Emergency Cesarean Delivery|2|||
162829753|NCT01074190|588089216|FG002|Overall Study|Emergency Cesarean Delivery|1|||
162829754|NCT01074190|588089214|FG000|Overall Study|Protocol Violation|2|||
162829755|NCT01074190|588089215|FG001|Overall Study|Protocol Violation|1|||
162829756|NCT01074190|588089216|FG002|Overall Study|Protocol Violation|0|||
162829757|NCT01074190|588089214|FG000|Overall Study|Delivered in under 90 minutes|0|||
162829758|NCT01074190|588089215|FG001|Overall Study|Delivered in under 90 minutes|2|||
162829759|NCT01074190|588089216|FG002|Overall Study|Delivered in under 90 minutes|1|||
162829760|NCT01074190|588089214|FG000|Overall Study|Subject withdrew consent|1|||
162829761|NCT01074190|588089215|FG001|Overall Study|Subject withdrew consent|1|||
162829762|NCT01074190|588089216|FG002|Overall Study|Subject withdrew consent|1|||
162829763|NCT00804570|588089217|FG000|Overall Study|Adverse Event|14|||
162829764|NCT00804570|588089218|FG001|Overall Study|Adverse Event|7|||
162829765|NCT00804570|588089217|FG000|Overall Study|Lack of Efficacy|0|||
162829766|NCT00804570|588089218|FG001|Overall Study|Lack of Efficacy|1|||
162829767|NCT00804570|588089217|FG000|Overall Study|Lost to Follow-up|18|||
162829768|NCT00804570|588089218|FG001|Overall Study|Lost to Follow-up|21|||
162829769|NCT00804570|588089217|FG000|Overall Study|Entry criteria not met|5|||
162829770|NCT00804570|588089218|FG001|Overall Study|Entry criteria not met|5|||
162829771|NCT00804570|588089217|FG000|Overall Study|Protocol Violation|12|||
162829772|NCT00804570|588089218|FG001|Overall Study|Protocol Violation|16|||
162829773|NCT00804570|588089217|FG000|Overall Study|Physician Decision|1|||
162829774|NCT00804570|588089218|FG001|Overall Study|Physician Decision|2|||
162829775|NCT00804570|588089217|FG000|Overall Study|Sponsor decision|1|||
162829776|NCT00804570|588089218|FG001|Overall Study|Sponsor decision|4|||
162829777|NCT00804570|588089217|FG000|Overall Study|Withdrawal by Subject|21|||
162829778|NCT00804570|588089218|FG001|Overall Study|Withdrawal by Subject|38|||
162829779|NCT00290342|588089219|FG000|Overall Study|Other|0|||
162829780|NCT00290342|588089220|FG001|Overall Study|Other|1|||
162829781|NCT00290342|588089219|FG000|Overall Study|Withdrawal by Subject|6|||
162829782|NCT00290342|588089220|FG001|Overall Study|Withdrawal by Subject|4|||
162829783|NCT00290342|588089219|FG000|Overall Study|Lost to Follow-up|1|||
162829784|NCT00290342|588089220|FG001|Overall Study|Lost to Follow-up|0|||
162829785|NCT02121262|588089227|FG000|Overall Study|Adverse Event|6|||
162829786|NCT02121262|588089228|FG001|Overall Study|Adverse Event|3|||
162829787|NCT02121262|588089227|FG000|Overall Study|Lack of Efficacy|3|||
162829788|NCT02121262|588089228|FG001|Overall Study|Lack of Efficacy|0|||
162829789|NCT02121262|588089227|FG000|Overall Study|Personal Reasons|19|||
162829790|NCT02121262|588089228|FG001|Overall Study|Personal Reasons|5|||
162829791|NCT02121262|588089227|FG000|Overall Study|Protocol Violation|1|||
162829792|NCT02121262|588089228|FG001|Overall Study|Protocol Violation|1|||
162829793|NCT02121262|588089227|FG000|Overall Study|Participant Dropped-out|0|||
162829794|NCT02121262|588089228|FG001|Overall Study|Participant Dropped-out|1|||
162829795|NCT02121262|588089227|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
162829796|NCT02121262|588089228|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
162829797|NCT02121262|588089227|FG000|Overall Study|Consent Withdrawn|1|||
162829798|NCT02121262|588089228|FG001|Overall Study|Consent Withdrawn|0|||
162829799|NCT01553188|588089229|FG000|Overall Study|Patient choice|1|||
162829800|NCT01553188|588089230|FG001|Overall Study|Patient choice|0|||
162829801|NCT01553188|588089231|FG002|Overall Study|Patient choice|0|||
162829802|NCT01553188|588089232|FG003|Overall Study|Patient choice|0|||
162829803|NCT01553188|588089229|FG000|Overall Study|Intercurrent illness and adverse event|0|||
162829804|NCT01553188|588089230|FG001|Overall Study|Intercurrent illness and adverse event|1|||
162829805|NCT01553188|588089231|FG002|Overall Study|Intercurrent illness and adverse event|2|||
162829806|NCT01553188|588089232|FG003|Overall Study|Intercurrent illness and adverse event|0|||
162829807|NCT02716987|588089233|FG000|Overall Study|Ligand synthesis failure|0|||
162829808|NCT02716987|588089234|FG001|Overall Study|Ligand synthesis failure|0|||
162829809|NCT02716987|588089235|FG002|Overall Study|Ligand synthesis failure|1|||
162829810|NCT02716987|588089236|FG003|Overall Study|Ligand synthesis failure|0|||
162829811|NCT02716987|588089237|FG004|Overall Study|Ligand synthesis failure|0|||
162829812|NCT02716987|588089238|FG005|Overall Study|Ligand synthesis failure|0|||
162829813|NCT02716987|588089233|FG000|Overall Study|Withdrawal by Subject|0|||
162829814|NCT02716987|588089234|FG001|Overall Study|Withdrawal by Subject|0|||
162829815|NCT02716987|588089235|FG002|Overall Study|Withdrawal by Subject|0|||
162829816|NCT02716987|588089236|FG003|Overall Study|Withdrawal by Subject|0|||
162829817|NCT02716987|588089237|FG004|Overall Study|Withdrawal by Subject|1|||
162829818|NCT02716987|588089238|FG005|Overall Study|Withdrawal by Subject|1|||
162829819|NCT01617070|588089240|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
162829820|NCT02230384|588089242|FG000|Phase 1|Lost to Follow-up|1|||
162829821|NCT02230384|588089243|FG001|Phase 1|Lost to Follow-up|0|||
162829822|NCT02230384|588089242|FG000|Phase 1|Physician Decision|0|||
162829823|NCT02230384|588089243|FG001|Phase 1|Physician Decision|1|||
162829824|NCT02230384|588089242|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
162829825|NCT02230384|588089243|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
162829826|NCT02230384|588089242|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
162829827|NCT02230384|588089243|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
162829828|NCT02230384|588089242|FG000|Phase 2 - Switch|Adverse Event|2|||
162829829|NCT02230384|588089243|FG001|Phase 2 - Switch|Adverse Event|0|||
162829830|NCT00808236|588089244|FG000|Overall Study|Was not resuscitated|50|||
162829831|NCT00808236|588089245|FG001|Overall Study|Was not resuscitated|56|||
162829832|NCT00808236|588089244|FG000|Overall Study|Pre-defined exclusion|13|||
162829833|NCT00808236|588089245|FG001|Overall Study|Pre-defined exclusion|3|||
162829834|NCT00808236|588089244|FG000|Overall Study|Lost to Follow-up|1|||
162829835|NCT00808236|588089245|FG001|Overall Study|Lost to Follow-up|1|||
162829836|NCT00808236|588089244|FG000|Overall Study|Physician Decision|0|||
162829837|NCT00808236|588089245|FG001|Overall Study|Physician Decision|1|||
162829838|NCT00808236|588089244|FG000|Overall Study|Death|18|||
162829839|NCT00808236|588089245|FG001|Overall Study|Death|30|||
162829840|NCT00961220|588089246|FG000|Overall Study|Adverse Event|3|||
162829841|NCT00961220|588089246|FG000|Overall Study|Lack of Efficacy|1|||
162829842|NCT00961220|588089246|FG000|Overall Study|No IV access for O6BG|1|||
162829843|NCT00961220|588089246|FG000|Overall Study|O6BG no longer supplied|1|||
162829844|NCT00961220|588089246|FG000|Overall Study|Complete Response prior to 12 courses|1|||
162829845|NCT05376215|588089247|FG000|Overall Study|Withdrawal by Subject|2|||
162941611|NCT01296932|588490344|FG001|Overall Study|Investigator decision|1|||
162941612|NCT01296932|588490345|FG002|Overall Study|Investigator decision|0|||
162829846|NCT05376215|588089248|FG001|Overall Study|Withdrawal by Subject|1|||
162829847|NCT05376215|588089247|FG000|Overall Study|Lost to Follow-up|0|||
162829848|NCT05376215|588089248|FG001|Overall Study|Lost to Follow-up|1|||
162829849|NCT01301950|588089249|FG000|Overall Study|Surgery was cancelled by patient|0|||
162829850|NCT01301950|588089250|FG001|Overall Study|Surgery was cancelled by patient|1|||
162829851|NCT00942175|588089253|FG000|Overall Study|Adverse Event|2|||
162829852|NCT00942175|588089254|FG001|Overall Study|Adverse Event|1|||
162829853|NCT00942175|588089255|FG002|Overall Study|Adverse Event|0|||
162829854|NCT00942175|588089256|FG003|Overall Study|Adverse Event|0|||
162829855|NCT00942175|588089253|FG000|Overall Study|Protocol Violation|0|||
162829856|NCT00942175|588089254|FG001|Overall Study|Protocol Violation|1|||
162829857|NCT00942175|588089255|FG002|Overall Study|Protocol Violation|2|||
162829858|NCT00942175|588089256|FG003|Overall Study|Protocol Violation|0|||
162829859|NCT00942175|588089253|FG000|Overall Study|Pregnancy|0|||
162829860|NCT00942175|588089254|FG001|Overall Study|Pregnancy|0|||
162829861|NCT00942175|588089255|FG002|Overall Study|Pregnancy|0|||
162829862|NCT00942175|588089256|FG003|Overall Study|Pregnancy|1|||
162829863|NCT00942175|588089253|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
162829864|NCT00942175|588089254|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
162829865|NCT00942175|588089255|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
162829866|NCT00942175|588089256|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
162829867|NCT00942175|588089253|FG000|Overall Study|Low Platelet Count|0|||
162829868|NCT00942175|588089254|FG001|Overall Study|Low Platelet Count|2|||
162829869|NCT00942175|588089255|FG002|Overall Study|Low Platelet Count|0|||
162829870|NCT00942175|588089256|FG003|Overall Study|Low Platelet Count|0|||
162829871|NCT01066585|588089257|FG000|Overall Study|Protocol Violation|1|||
162829872|NCT01066585|588089258|FG001|Overall Study|Protocol Violation|0|||
162829873|NCT01066585|588089257|FG000|Overall Study|Withdrawal by Subject|0|||
162829874|NCT01066585|588089258|FG001|Overall Study|Withdrawal by Subject|3|||
162829875|NCT00578136|588089265|FG000|Overall Study|Not given intervention|1|||
162829876|NCT00578136|588089266|FG001|Overall Study|Not given intervention|1|||
162829877|NCT01840579|588089271|FG000|Overall Study|Status not recorded|0|||
162829878|NCT01840579|588089272|FG001|Overall Study|Status not recorded|0|||
162829879|NCT01840579|588089273|FG002|Overall Study|Status not recorded|2|||
162829880|NCT01840579|588089274|FG003|Overall Study|Status not recorded|3|||
162829881|NCT01840579|588089275|FG004|Overall Study|Status not recorded|4|||
162829882|NCT01840579|588089276|FG005|Overall Study|Status not recorded|3|||
162829883|NCT01840579|588089277|FG006|Overall Study|Status not recorded|0|||
162829884|NCT01840579|588089278|FG007|Overall Study|Status not recorded|3|||
162829885|NCT01840579|588089279|FG008|Overall Study|Status not recorded|3|||
162829886|NCT01840579|588089280|FG009|Overall Study|Status not recorded|3|||
162829887|NCT01840579|588089271|FG000|Overall Study|Progressive disease|3|||
162829888|NCT01840579|588089272|FG001|Overall Study|Progressive disease|5|||
162829889|NCT01840579|588089273|FG002|Overall Study|Progressive disease|0|||
162829890|NCT01840579|588089274|FG003|Overall Study|Progressive disease|0|||
162829891|NCT01840579|588089275|FG004|Overall Study|Progressive disease|0|||
162829892|NCT01840579|588089276|FG005|Overall Study|Progressive disease|0|||
162829893|NCT01840579|588089277|FG006|Overall Study|Progressive disease|0|||
162829894|NCT01840579|588089278|FG007|Overall Study|Progressive disease|0|||
162829895|NCT01840579|588089279|FG008|Overall Study|Progressive disease|0|||
162829896|NCT01840579|588089280|FG009|Overall Study|Progressive disease|0|||
162829897|NCT01840579|588089271|FG000|Overall Study|Ongoing in study|0|||
162829898|NCT01840579|588089272|FG001|Overall Study|Ongoing in study|1|||
162829899|NCT01840579|588089273|FG002|Overall Study|Ongoing in study|0|||
162829900|NCT01840579|588089274|FG003|Overall Study|Ongoing in study|0|||
162829901|NCT01840579|588089275|FG004|Overall Study|Ongoing in study|0|||
162829902|NCT01840579|588089276|FG005|Overall Study|Ongoing in study|0|||
162829903|NCT01840579|588089277|FG006|Overall Study|Ongoing in study|0|||
162829904|NCT01840579|588089278|FG007|Overall Study|Ongoing in study|0|||
162829905|NCT01840579|588089279|FG008|Overall Study|Ongoing in study|0|||
162829906|NCT01840579|588089280|FG009|Overall Study|Ongoing in study|0|||
162829907|NCT01840579|588089271|FG000|Overall Study|Death|0|||
162829908|NCT01840579|588089272|FG001|Overall Study|Death|0|||
162829909|NCT01840579|588089273|FG002|Overall Study|Death|0|||
162829910|NCT01840579|588089274|FG003|Overall Study|Death|0|||
162829911|NCT01840579|588089275|FG004|Overall Study|Death|0|||
162829912|NCT01840579|588089276|FG005|Overall Study|Death|1|||
162829913|NCT01840579|588089277|FG006|Overall Study|Death|0|||
162829914|NCT01840579|588089278|FG007|Overall Study|Death|0|||
162829915|NCT01840579|588089279|FG008|Overall Study|Death|0|||
162829916|NCT01840579|588089280|FG009|Overall Study|Death|0|||
162829917|NCT01840579|588089271|FG000|Overall Study|Adverse Event|0|||
162829918|NCT01840579|588089272|FG001|Overall Study|Adverse Event|1|||
162829919|NCT01840579|588089273|FG002|Overall Study|Adverse Event|0|||
162829920|NCT01840579|588089274|FG003|Overall Study|Adverse Event|0|||
162829921|NCT01840579|588089275|FG004|Overall Study|Adverse Event|0|||
162829922|NCT01840579|588089276|FG005|Overall Study|Adverse Event|0|||
162829923|NCT01840579|588089277|FG006|Overall Study|Adverse Event|0|||
162829924|NCT01840579|588089278|FG007|Overall Study|Adverse Event|0|||
162829925|NCT01840579|588089279|FG008|Overall Study|Adverse Event|0|||
162829926|NCT01840579|588089280|FG009|Overall Study|Adverse Event|0|||
162829927|NCT01840579|588089271|FG000|Overall Study|Follow-up ended by Sponsor|0|||
162829928|NCT01840579|588089272|FG001|Overall Study|Follow-up ended by Sponsor|0|||
162829929|NCT01840579|588089273|FG002|Overall Study|Follow-up ended by Sponsor|0|||
162829930|NCT01840579|588089274|FG003|Overall Study|Follow-up ended by Sponsor|0|||
162829931|NCT01840579|588089275|FG004|Overall Study|Follow-up ended by Sponsor|0|||
162829932|NCT01840579|588089276|FG005|Overall Study|Follow-up ended by Sponsor|0|||
162829933|NCT01840579|588089277|FG006|Overall Study|Follow-up ended by Sponsor|2|||
162941613|NCT01296932|588490346|FG003|Overall Study|Investigator decision|1|||
162941614|NCT01296932|588490347|FG004|Overall Study|Investigator decision|0|||
162941615|NCT01296932|588490348|FG005|Overall Study|Investigator decision|0|||
162941616|NCT01296932|588490349|FG006|Overall Study|Investigator decision|1|||
162941617|NCT01296932|588490350|FG007|Overall Study|Investigator decision|0|||
162941618|NCT01296932|588490351|FG008|Overall Study|Investigator decision|1|||
162941619|NCT01296932|588490343|FG000|Overall Study|No clinical benefit anymore|0|||
162941620|NCT01296932|588490344|FG001|Overall Study|No clinical benefit anymore|1|||
162941621|NCT01296932|588490345|FG002|Overall Study|No clinical benefit anymore|0|||
162941622|NCT01296932|588490346|FG003|Overall Study|No clinical benefit anymore|0|||
162941623|NCT01296932|588490347|FG004|Overall Study|No clinical benefit anymore|0|||
162941624|NCT01296932|588490348|FG005|Overall Study|No clinical benefit anymore|0|||
162941625|NCT01296932|588490349|FG006|Overall Study|No clinical benefit anymore|0|||
162941626|NCT01296932|588490350|FG007|Overall Study|No clinical benefit anymore|0|||
162941627|NCT01296932|588490351|FG008|Overall Study|No clinical benefit anymore|0|||
162941628|NCT01296932|588490343|FG000|Overall Study|Physician Decision|0|||
162941629|NCT01296932|588490344|FG001|Overall Study|Physician Decision|0|||
162941630|NCT01296932|588490345|FG002|Overall Study|Physician Decision|1|||
162941631|NCT01296932|588490346|FG003|Overall Study|Physician Decision|0|||
162941632|NCT01296932|588490347|FG004|Overall Study|Physician Decision|0|||
162941633|NCT01296932|588490348|FG005|Overall Study|Physician Decision|0|||
162941634|NCT01296932|588490349|FG006|Overall Study|Physician Decision|0|||
162941635|NCT01296932|588490350|FG007|Overall Study|Physician Decision|0|||
162829934|NCT01840579|588089278|FG007|Overall Study|Follow-up ended by Sponsor|0|||
162829935|NCT01840579|588089279|FG008|Overall Study|Follow-up ended by Sponsor|0|||
162829936|NCT01840579|588089280|FG009|Overall Study|Follow-up ended by Sponsor|0|||
162829937|NCT01585272|588089285|FG000|Overall Study|Adverse Event|22|||
162829938|NCT01585272|588089285|FG000|Overall Study|Protocol Violation|7|||
162829939|NCT01585272|588089285|FG000|Overall Study|Withdrawal by Subject|10|||
162829940|NCT00645593|588089286|FG000|Overall Study|Later found to be ineligible|1|||
162829941|NCT00645593|588089287|FG001|Overall Study|Later found to be ineligible|0|||
162829942|NCT04013529|588089290|FG000|Overall Study|Withdrawal by Subject|1|||
162829943|NCT04013529|588089291|FG001|Overall Study|Withdrawal by Subject|1|||
162829944|NCT05885737|588089297|FG000|DB Period|Adverse Event|4|||
162829945|NCT05885737|588089298|FG001|DB Period|Adverse Event|4|||
162829946|NCT05885737|588089297|FG000|DB Period|Lost to Follow-up|0|||
162829947|NCT05885737|588089298|FG001|DB Period|Lost to Follow-up|1|||
162829948|NCT05885737|588089297|FG000|DB Period|Physician Decision|2|||
162829949|NCT05885737|588089298|FG001|DB Period|Physician Decision|0|||
162829950|NCT05885737|588089297|FG000|DB Period|Withdrawal by Subject|12|||
162829951|NCT05885737|588089298|FG001|DB Period|Withdrawal by Subject|6|||
162829952|NCT05885737|588089297|FG000|DB Period|Other: Unspecified|2|||
162829953|NCT05885737|588089298|FG001|DB Period|Other: Unspecified|2|||
162829954|NCT05885737|588089297|FG000|OLE Period|Adverse Event|3|||
162829955|NCT05885737|588089298|FG001|OLE Period|Adverse Event|2|||
162829956|NCT05885737|588089297|FG000|OLE Period|Physician Decision|1|||
162829957|NCT05885737|588089298|FG001|OLE Period|Physician Decision|0|||
162829958|NCT05885737|588089297|FG000|OLE Period|Withdrawal by Subject|5|||
162829959|NCT05885737|588089298|FG001|OLE Period|Withdrawal by Subject|5|||
162829960|NCT05885737|588089297|FG000|OLE Period|Other: Unspecified|2|||
162829961|NCT05885737|588089298|FG001|OLE Period|Other: Unspecified|1|||
162829962|NCT00609791|588090685|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
162829963|NCT04129528|588090689|FG000|Overall Study|Adverse Event|1|||
162829964|NCT04129528|588090690|FG001|Overall Study|Adverse Event|0|||
162829965|NCT04129528|588090689|FG000|Overall Study|Physician Decision|1|||
162941636|NCT01296932|588490351|FG008|Overall Study|Physician Decision|0|||
162829966|NCT04129528|588090690|FG001|Overall Study|Physician Decision|1|||
162829967|NCT04129528|588090689|FG000|Overall Study|Withdrawal by Subject|1|||
162829968|NCT04129528|588090690|FG001|Overall Study|Withdrawal by Subject|1|||
162829969|NCT00490568|588090693|FG000|Overall Study|Adverse Event|116|||
162829970|NCT00490568|588090693|FG000|Overall Study|Lost to Follow-up|13|||
162829971|NCT00490568|588090693|FG000|Overall Study|Protocol Violation|45|||
162829972|NCT00490568|588090693|FG000|Overall Study|Withdrawal by Subject|135|||
162829973|NCT00490568|588090693|FG000|Overall Study|Still in the study at termination|974|||
162829974|NCT00490568|588090693|FG000|Overall Study|Other|1|||
162829975|NCT00490568|588090693|FG000|Overall Study|Exclusion criteria met|1|||
162829976|NCT00490568|588090693|FG000|Overall Study|Caregiver related|20|||
162941637|NCT01296932|588490343|FG000|Overall Study|IV problems, administration not possible|0|||
162941638|NCT01296932|588490344|FG001|Overall Study|IV problems, administration not possible|0|||
162941639|NCT01296932|588490345|FG002|Overall Study|IV problems, administration not possible|1|||
162941640|NCT01296932|588490346|FG003|Overall Study|IV problems, administration not possible|0|||
162941641|NCT01296932|588490347|FG004|Overall Study|IV problems, administration not possible|0|||
162941642|NCT01296932|588490348|FG005|Overall Study|IV problems, administration not possible|0|||
162941643|NCT01296932|588490349|FG006|Overall Study|IV problems, administration not possible|0|||
162941644|NCT01296932|588490350|FG007|Overall Study|IV problems, administration not possible|0|||
162941645|NCT01296932|588490351|FG008|Overall Study|IV problems, administration not possible|0|||
162941646|NCT01296932|588490343|FG000|Overall Study|per protocol|0|||
162941647|NCT01296932|588490344|FG001|Overall Study|per protocol|0|||
162941648|NCT01296932|588490345|FG002|Overall Study|per protocol|1|||
162941649|NCT01296932|588490346|FG003|Overall Study|per protocol|1|||
162941650|NCT01296932|588490347|FG004|Overall Study|per protocol|0|||
162941651|NCT01296932|588490348|FG005|Overall Study|per protocol|0|||
162941652|NCT01296932|588490349|FG006|Overall Study|per protocol|0|||
162941653|NCT01296932|588490350|FG007|Overall Study|per protocol|0|||
162941654|NCT01296932|588490351|FG008|Overall Study|per protocol|0|||
162941655|NCT01296932|588490343|FG000|Overall Study|Low benefit and too many side effects|0|||
162941656|NCT01296932|588490344|FG001|Overall Study|Low benefit and too many side effects|0|||
162941657|NCT01296932|588490345|FG002|Overall Study|Low benefit and too many side effects|0|||
162941658|NCT01296932|588490346|FG003|Overall Study|Low benefit and too many side effects|0|||
162941659|NCT01296932|588490347|FG004|Overall Study|Low benefit and too many side effects|0|||
162941660|NCT01296932|588490348|FG005|Overall Study|Low benefit and too many side effects|0|||
162941661|NCT01296932|588490349|FG006|Overall Study|Low benefit and too many side effects|0|||
162941662|NCT01296932|588490350|FG007|Overall Study|Low benefit and too many side effects|1|||
162941663|NCT01296932|588490351|FG008|Overall Study|Low benefit and too many side effects|0|||
162941664|NCT01296932|588490343|FG000|Overall Study|No adequate treatment response|0|||
162941665|NCT01296932|588490344|FG001|Overall Study|No adequate treatment response|0|||
162941666|NCT01296932|588490345|FG002|Overall Study|No adequate treatment response|0|||
162941667|NCT01296932|588490346|FG003|Overall Study|No adequate treatment response|0|||
162941668|NCT01296932|588490347|FG004|Overall Study|No adequate treatment response|0|||
162941669|NCT01296932|588490348|FG005|Overall Study|No adequate treatment response|0|||
162941670|NCT01296932|588490349|FG006|Overall Study|No adequate treatment response|0|||
162941671|NCT01296932|588490350|FG007|Overall Study|No adequate treatment response|1|||
162941672|NCT01296932|588490351|FG008|Overall Study|No adequate treatment response|0|||
162941673|NCT01296932|588490343|FG000|Overall Study|Dosage already reduced, AE still present|0|||
162941674|NCT01296932|588490344|FG001|Overall Study|Dosage already reduced, AE still present|0|||
162941675|NCT01296932|588490345|FG002|Overall Study|Dosage already reduced, AE still present|0|||
162941676|NCT01296932|588490346|FG003|Overall Study|Dosage already reduced, AE still present|0|||
162941677|NCT01296932|588490347|FG004|Overall Study|Dosage already reduced, AE still present|0|||
162941678|NCT01296932|588490348|FG005|Overall Study|Dosage already reduced, AE still present|0|||
162941679|NCT01296932|588490349|FG006|Overall Study|Dosage already reduced, AE still present|0|||
162941680|NCT01296932|588490350|FG007|Overall Study|Dosage already reduced, AE still present|0|||
162941681|NCT01296932|588490351|FG008|Overall Study|Dosage already reduced, AE still present|1|||
162941682|NCT02918162|588490353|FG000|Overall Study|Withdrawal by Subject|1|||
162941683|NCT02918162|588490353|FG000|Overall Study|Omental Disease|1|||
162941684|NCT00395226|588490354|FG000|Overall Study|Adverse Event|4|||
162941685|NCT00395226|588490355|FG001|Overall Study|Adverse Event|3|||
162941686|NCT00395226|588490354|FG000|Overall Study|Withdrawal by Subject|0|||
162941687|NCT00395226|588490355|FG001|Overall Study|Withdrawal by Subject|1|||
162941688|NCT00395226|588490354|FG000|Overall Study|Lost to Follow-up|0|||
162941689|NCT00395226|588490355|FG001|Overall Study|Lost to Follow-up|1|||
162941690|NCT02655237|588490358|FG000|Overall Study|Adverse Event|10|||
162698704|NCT00337662|587605553|FG000|Study Period III|Sponsor Decision|1|||
162698705|NCT00337662|587605554|FG001|Study Period III|Sponsor Decision|0|||
162941691|NCT02655237|588490359|FG001|Overall Study|Adverse Event|7|||
162941692|NCT02655237|588490358|FG000|Overall Study|Protocol Deviation|2|||
162829977|NCT00490568|588090693|FG000|Overall Study|Abnormal ECG|25|||
162829978|NCT00490568|588090693|FG000|Overall Study|Participant refused follow-up|9|||
162829979|NCT00490568|588090693|FG000|Overall Study|Legal representative withdrew consent|1|||
162829980|NCT00490568|588090693|FG000|Overall Study|Disease progression|4|||
162829981|NCT00490568|588090693|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
162829982|NCT00490568|588090693|FG000|Overall Study|Investigator decision|3|||
162829983|NCT00490568|588090693|FG000|Overall Study|Non-Compliance|7|||
162829984|NCT00490568|588090693|FG000|Overall Study|Efficacy related|3|||
162829985|NCT00490568|588090693|FG000|Overall Study|Participant died|1|||
162829986|NCT00490568|588090693|FG000|Overall Study|Participant withdrawal due to surgery|1|||
162829987|NCT01081912|588090699|FG000|Conversion/Titration|Adverse Event|47|||
162829988|NCT01081912|588090700|FG001|Conversion/Titration|Adverse Event|0|||
162829989|NCT01081912|588090701|FG002|Conversion/Titration|Adverse Event|0|||
162829990|NCT01081912|588090699|FG000|Conversion/Titration|Lack of Efficacy|17|||
162829991|NCT01081912|588090700|FG001|Conversion/Titration|Lack of Efficacy|0|||
162829992|NCT01081912|588090701|FG002|Conversion/Titration|Lack of Efficacy|0|||
162829993|NCT01081912|588090699|FG000|Conversion/Titration|Lost to Follow-up|5|||
162829994|NCT01081912|588090700|FG001|Conversion/Titration|Lost to Follow-up|0|||
162829995|NCT01081912|588090701|FG002|Conversion/Titration|Lost to Follow-up|0|||
162829996|NCT01081912|588090699|FG000|Conversion/Titration|Physician Decision|2|||
162829997|NCT01081912|588090700|FG001|Conversion/Titration|Physician Decision|0|||
162829998|NCT01081912|588090701|FG002|Conversion/Titration|Physician Decision|0|||
162829999|NCT01081912|588090699|FG000|Conversion/Titration|Protocol Violation|67|||
162830000|NCT01081912|588090700|FG001|Conversion/Titration|Protocol Violation|0|||
162830001|NCT01081912|588090701|FG002|Conversion/Titration|Protocol Violation|0|||
162830002|NCT01081912|588090699|FG000|Conversion/Titration|Withdrawal by Subject|23|||
162830003|NCT01081912|588090700|FG001|Conversion/Titration|Withdrawal by Subject|0|||
162830004|NCT01081912|588090701|FG002|Conversion/Titration|Withdrawal by Subject|0|||
162830005|NCT01081912|588090699|FG000|Conversion/Titration|Non-Compliance|47|||
162830006|NCT01081912|588090700|FG001|Conversion/Titration|Non-Compliance|0|||
162830007|NCT01081912|588090701|FG002|Conversion/Titration|Non-Compliance|0|||
162830008|NCT01081912|588090699|FG000|Maintenance Treatment|Adverse Event|0|||
162830009|NCT01081912|588090700|FG001|Maintenance Treatment|Adverse Event|2|||
162830010|NCT01081912|588090701|FG002|Maintenance Treatment|Adverse Event|12|||
162830011|NCT01081912|588090699|FG000|Maintenance Treatment|Lack of Efficacy|0|||
162830012|NCT01081912|588090700|FG001|Maintenance Treatment|Lack of Efficacy|14|||
162830013|NCT01081912|588090701|FG002|Maintenance Treatment|Lack of Efficacy|64|||
162830014|NCT01081912|588090699|FG000|Maintenance Treatment|Lost to Follow-up|0|||
162830015|NCT01081912|588090700|FG001|Maintenance Treatment|Lost to Follow-up|1|||
162830016|NCT01081912|588090701|FG002|Maintenance Treatment|Lost to Follow-up|0|||
162830017|NCT01081912|588090699|FG000|Maintenance Treatment|Physician Decision|0|||
162830018|NCT01081912|588090700|FG001|Maintenance Treatment|Physician Decision|0|||
162830019|NCT01081912|588090701|FG002|Maintenance Treatment|Physician Decision|1|||
162830020|NCT01081912|588090699|FG000|Maintenance Treatment|Protocol Violation|0|||
162830021|NCT01081912|588090700|FG001|Maintenance Treatment|Protocol Violation|1|||
162830022|NCT01081912|588090701|FG002|Maintenance Treatment|Protocol Violation|2|||
162941693|NCT02655237|588490359|FG001|Overall Study|Protocol Deviation|0|||
162941694|NCT02655237|588490358|FG000|Overall Study|Withdrawal by Participant|1|||
162941695|NCT02655237|588490359|FG001|Overall Study|Withdrawal by Participant|2|||
162941696|NCT02655237|588490358|FG000|Overall Study|Lack of Efficacy|0|||
162941697|NCT02655237|588490359|FG001|Overall Study|Lack of Efficacy|1|||
162941698|NCT02655237|588490358|FG000|Overall Study|Recovery Leading to Surgery|2|||
162941699|NCT02655237|588490359|FG001|Overall Study|Recovery Leading to Surgery|1|||
162941700|NCT02655237|588490358|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
162830023|NCT01081912|588090699|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
162830024|NCT01081912|588090700|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
162830025|NCT01081912|588090701|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
162830026|NCT01081912|588090699|FG000|Maintenance Treatment|Non-Compliance|0|||
162830027|NCT01081912|588090700|FG001|Maintenance Treatment|Non-Compliance|4|||
162830028|NCT01081912|588090701|FG002|Maintenance Treatment|Non-Compliance|7|||
162830029|NCT01081912|588090699|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
162830030|NCT01081912|588090700|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
162941701|NCT02655237|588490359|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
162941702|NCT02655237|588490358|FG000|Overall Study|Randomized but Not Treated|1|||
162941703|NCT02655237|588490359|FG001|Overall Study|Randomized but Not Treated|0|||
162941704|NCT02227862|588490360|FG000|Overall Study|Protocol Violation|7|||
162941705|NCT02227862|588490361|FG001|Overall Study|Protocol Violation|9|||
162941706|NCT02227862|588490360|FG000|Overall Study|Other|0|||
162941707|NCT02227862|588490361|FG001|Overall Study|Other|2|||
162941708|NCT02227862|588490360|FG000|Overall Study|Adverse Event|4|||
162941709|NCT02227862|588490361|FG001|Overall Study|Adverse Event|3|||
162941710|NCT02227862|588490360|FG000|Overall Study|Withdrawal by Subject|7|||
162941711|NCT02227862|588490361|FG001|Overall Study|Withdrawal by Subject|6|||
162941712|NCT02227862|588490360|FG000|Overall Study|Lost to Follow-up|1|||
162941713|NCT02227862|588490361|FG001|Overall Study|Lost to Follow-up|2|||
162941714|NCT05014204|588490362|FG000|Overall Study|Withdrawal by Subject|1|||
162941715|NCT05014204|588490362|FG000|Overall Study|Physician Decision|1|||
162941716|NCT00819247|588490366|FG000|Overall Study|Adverse Event|0|||
162941717|NCT00819247|588490367|FG001|Overall Study|Adverse Event|5|||
162941718|NCT00819247|588490368|FG002|Overall Study|Adverse Event|3|||
162941719|NCT00819247|588490366|FG000|Overall Study|Insufficient testosterone response|5|||
162941720|NCT00819247|588490367|FG001|Overall Study|Insufficient testosterone response|8|||
162941721|NCT00819247|588490368|FG002|Overall Study|Insufficient testosterone response|10|||
162941722|NCT00819247|588490366|FG000|Overall Study|Withdrawal by Subject|1|||
162941723|NCT00819247|588490367|FG001|Overall Study|Withdrawal by Subject|0|||
162941724|NCT00819247|588490368|FG002|Overall Study|Withdrawal by Subject|0|||
162941725|NCT00819247|588490366|FG000|Overall Study|Protocol Violation|1|||
162941726|NCT00819247|588490367|FG001|Overall Study|Protocol Violation|0|||
162941727|NCT00819247|588490368|FG002|Overall Study|Protocol Violation|1|||
162941728|NCT00819247|588490366|FG000|Overall Study|Mistakenly withdrawn|0|||
162941729|NCT00819247|588490367|FG001|Overall Study|Mistakenly withdrawn|1|||
162941730|NCT00819247|588490368|FG002|Overall Study|Mistakenly withdrawn|0|||
162941731|NCT00819247|588490366|FG000|Overall Study|Bad prostate-specific antigen response|3|||
162941732|NCT00819247|588490367|FG001|Overall Study|Bad prostate-specific antigen response|2|||
162941733|NCT00819247|588490368|FG002|Overall Study|Bad prostate-specific antigen response|0|||
162941734|NCT00819247|588490366|FG000|Overall Study|Other|1|||
162941735|NCT00819247|588490367|FG001|Overall Study|Other|0|||
162941736|NCT00819247|588490368|FG002|Overall Study|Other|0|||
162941737|NCT03748641|588490372|FG000|Overall Study|Ongoing|155|||
162941738|NCT03748641|588490373|FG001|Overall Study|Ongoing|148|||
162941739|NCT03748641|588490374|FG002|Overall Study|Ongoing|66|||
162941740|NCT03748641|588490375|FG003|Overall Study|Ongoing|79|||
162941741|NCT03748641|588490376|FG004|Overall Study|Ongoing|84|||
162941742|NCT03748641|588490372|FG000|Overall Study|Death|54|||
162941743|NCT03748641|588490373|FG001|Overall Study|Death|59|||
162941744|NCT03748641|588490374|FG002|Overall Study|Death|51|||
162941745|NCT03748641|588490375|FG003|Overall Study|Death|42|||
162941746|NCT03748641|588490376|FG004|Overall Study|Death|9|||
162941747|NCT03748641|588490372|FG000|Overall Study|Lost to Follow-up|0|||
162941748|NCT03748641|588490373|FG001|Overall Study|Lost to Follow-up|2|||
162941749|NCT03748641|588490374|FG002|Overall Study|Lost to Follow-up|1|||
162941750|NCT03748641|588490375|FG003|Overall Study|Lost to Follow-up|0|||
162941751|NCT03748641|588490376|FG004|Overall Study|Lost to Follow-up|0|||
162941752|NCT03748641|588490372|FG000|Overall Study|Withdrawal by Subject|3|||
162941753|NCT03748641|588490373|FG001|Overall Study|Withdrawal by Subject|2|||
162941754|NCT03748641|588490374|FG002|Overall Study|Withdrawal by Subject|5|||
162941755|NCT03748641|588490375|FG003|Overall Study|Withdrawal by Subject|3|||
162941756|NCT03748641|588490376|FG004|Overall Study|Withdrawal by Subject|2|||
162941757|NCT00437281|588490377|FG000|Overall Study|Adverse Event|0|||
162941758|NCT00437281|588490378|FG001|Overall Study|Adverse Event|0|||
162941759|NCT00437281|588490379|FG002|Overall Study|Adverse Event|0|||
162941760|NCT00437281|588490380|FG003|Overall Study|Adverse Event|1|||
162941761|NCT00437281|588490381|FG004|Overall Study|Adverse Event|0|||
162941762|NCT00437281|588490382|FG005|Overall Study|Adverse Event|1|||
162941763|NCT00437281|588490383|FG006|Overall Study|Adverse Event|0|||
162941764|NCT00437281|588490384|FG007|Overall Study|Adverse Event|0|||
162941765|NCT00437281|588490385|FG008|Overall Study|Adverse Event|0|||
162941766|NCT00437281|588490386|FG009|Overall Study|Adverse Event|1|||
162941767|NCT00437281|588490387|FG010|Overall Study|Adverse Event|0|||
162941768|NCT00437281|588490388|FG011|Overall Study|Adverse Event|0|||
162941769|NCT00437281|588490389|FG012|Overall Study|Adverse Event|0|||
162941770|NCT00437281|588490390|FG013|Overall Study|Adverse Event|1|||
162941771|NCT00437281|588490391|FG014|Overall Study|Adverse Event|1|||
162941772|NCT00437281|588490392|FG015|Overall Study|Adverse Event|0|||
162941773|NCT00437281|588490393|FG016|Overall Study|Adverse Event|0|||
162941774|NCT00437281|588490394|FG017|Overall Study|Adverse Event|0|||
162941775|NCT00437281|588490395|FG018|Overall Study|Adverse Event|1|||
162941776|NCT00437281|588490396|FG019|Overall Study|Adverse Event|0|||
162941777|NCT00437281|588490377|FG000|Overall Study|Lost to Follow-up|0|||
162941778|NCT00437281|588490378|FG001|Overall Study|Lost to Follow-up|0|||
162941779|NCT00437281|588490379|FG002|Overall Study|Lost to Follow-up|0|||
162941780|NCT00437281|588490380|FG003|Overall Study|Lost to Follow-up|0|||
162941781|NCT00437281|588490381|FG004|Overall Study|Lost to Follow-up|0|||
162941782|NCT00437281|588490382|FG005|Overall Study|Lost to Follow-up|0|||
162941783|NCT00437281|588490383|FG006|Overall Study|Lost to Follow-up|0|||
162941784|NCT00437281|588490384|FG007|Overall Study|Lost to Follow-up|0|||
162941785|NCT00437281|588490385|FG008|Overall Study|Lost to Follow-up|0|||
162941786|NCT00437281|588490386|FG009|Overall Study|Lost to Follow-up|0|||
162941787|NCT00437281|588490387|FG010|Overall Study|Lost to Follow-up|0|||
162941788|NCT00437281|588490388|FG011|Overall Study|Lost to Follow-up|0|||
162941789|NCT00437281|588490389|FG012|Overall Study|Lost to Follow-up|0|||
162941790|NCT00437281|588490390|FG013|Overall Study|Lost to Follow-up|0|||
162941791|NCT00437281|588490391|FG014|Overall Study|Lost to Follow-up|0|||
162941792|NCT00437281|588490392|FG015|Overall Study|Lost to Follow-up|0|||
162941793|NCT00437281|588490393|FG016|Overall Study|Lost to Follow-up|0|||
162941794|NCT00437281|588490394|FG017|Overall Study|Lost to Follow-up|0|||
162941795|NCT00437281|588490395|FG018|Overall Study|Lost to Follow-up|0|||
162941796|NCT00437281|588490396|FG019|Overall Study|Lost to Follow-up|1|||
162941797|NCT00926289|588490397|FG000|Overall Study|Adverse Event|9|||
162941798|NCT00926289|588490398|FG001|Overall Study|Adverse Event|11|||
162941799|NCT00926289|588490397|FG000|Overall Study|Protocol Violation|8|||
162941800|NCT00926289|588490398|FG001|Overall Study|Protocol Violation|12|||
162941801|NCT00926289|588490397|FG000|Overall Study|Lost to Follow-up|3|||
162830031|NCT01081912|588090701|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
162830032|NCT01140451|588090702|FG000|Overall Study|Withdrawal by Subject|26|||
162830033|NCT01140451|588090703|FG001|Overall Study|Withdrawal by Subject|33|||
162941802|NCT00926289|588490398|FG001|Overall Study|Lost to Follow-up|6|||
162941803|NCT00926289|588490397|FG000|Overall Study|Withdrawal by Subject|4|||
162941804|NCT00926289|588490398|FG001|Overall Study|Withdrawal by Subject|4|||
162941805|NCT00926289|588490397|FG000|Overall Study|Other|1|||
162941806|NCT00926289|588490398|FG001|Overall Study|Other|3|||
162830034|NCT01140451|588090702|FG000|Overall Study|Adverse Event|2|||
162830035|NCT01140451|588090703|FG001|Overall Study|Adverse Event|6|||
162830036|NCT01140451|588090702|FG000|Overall Study|Physician Decision|5|||
162830037|NCT01140451|588090703|FG001|Overall Study|Physician Decision|3|||
162830038|NCT01140451|588090702|FG000|Overall Study|Lost to Follow-up|2|||
162830039|NCT01140451|588090703|FG001|Overall Study|Lost to Follow-up|0|||
162830040|NCT01140451|588090702|FG000|Overall Study|Participants Planning Pregnancy|3|||
162830041|NCT01140451|588090703|FG001|Overall Study|Participants Planning Pregnancy|0|||
162830042|NCT01146873|588090705|FG000|Overall Study|Transfer out|0|||
162830043|NCT01146873|588090706|FG001|Overall Study|Transfer out|6|||
162830044|NCT03200366|588090709|FG000|Patient Navigation Intervention Given|Death|0|||
162830045|NCT03200366|588090710|FG001|Patient Navigation Intervention Given|Death|2|||
162830046|NCT03200366|588090711|FG002|Patient Navigation Intervention Given|Death|0|||
162830047|NCT03200366|588090709|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
162830048|NCT03200366|588090710|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
162830049|NCT03200366|588090711|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
162830050|NCT03200366|588090709|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
162830051|NCT03200366|588090710|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
162830052|NCT03200366|588090711|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
162830053|NCT03200366|588090709|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
162830054|NCT03200366|588090710|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
162830055|NCT03200366|588090711|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
162830056|NCT03200366|588090709|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
162830057|NCT03200366|588090710|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
162830058|NCT03200366|588090711|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
162941807|NCT04104646|588490399|FG000|Overall Study|Withdrawal by Subject|1|||
162941808|NCT04104646|588490400|FG001|Overall Study|Withdrawal by Subject|1|||
162941809|NCT04104646|588490399|FG000|Overall Study|Lost to Follow-up|1|||
162941810|NCT04104646|588490400|FG001|Overall Study|Lost to Follow-up|0|||
162941811|NCT04104646|588490399|FG000|Overall Study|Physician Decision|2|||
162941812|NCT04104646|588490400|FG001|Overall Study|Physician Decision|0|||
162941813|NCT01199601|588490401|FG000|Overall Study|Lost to Follow-up|47|||
162941814|NCT01199601|588490402|FG001|Overall Study|Lost to Follow-up|66|||
162941815|NCT01199601|588490401|FG000|Overall Study|Withdrawal by Subject|15|||
162830059|NCT03200366|588090709|FG000|6 Month Post-Baseline Interview|Death|1|||
162830060|NCT03200366|588090710|FG001|6 Month Post-Baseline Interview|Death|1|||
162830061|NCT03200366|588090711|FG002|6 Month Post-Baseline Interview|Death|1|||
162830062|NCT03200366|588090709|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
162830063|NCT03200366|588090710|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
162830064|NCT03200366|588090711|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
162830065|NCT03200366|588090709|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
162830066|NCT03200366|588090710|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
162830067|NCT03200366|588090711|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
162830068|NCT03200366|588090709|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
162830069|NCT03200366|588090710|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
162830070|NCT03200366|588090711|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
162830071|NCT03200366|588090709|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
162830072|NCT03200366|588090710|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
162830073|NCT03200366|588090711|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
162830074|NCT03200366|588090709|FG000|9 Month Post-Baseline Interview|Death|1|||
162830075|NCT03200366|588090710|FG001|9 Month Post-Baseline Interview|Death|1|||
162830076|NCT03200366|588090711|FG002|9 Month Post-Baseline Interview|Death|1|||
162830077|NCT03200366|588090709|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
162941816|NCT01199601|588490402|FG001|Overall Study|Withdrawal by Subject|3|||
162941817|NCT01199601|588490401|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
162941818|NCT01199601|588490402|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
162941819|NCT00753714|588490403|FG000|Overall Study|Lack of Efficacy|21|||
162941820|NCT00753714|588490404|FG001|Overall Study|Lack of Efficacy|34|||
162941821|NCT00753714|588490403|FG000|Overall Study|Adverse Event|26|||
162941822|NCT00753714|588490404|FG001|Overall Study|Adverse Event|18|||
162941823|NCT00753714|588490403|FG000|Overall Study|Protocol Violation|1|||
162941824|NCT00753714|588490404|FG001|Overall Study|Protocol Violation|0|||
162941825|NCT00753714|588490403|FG000|Overall Study|Lost to Follow-up|0|||
162941826|NCT00753714|588490404|FG001|Overall Study|Lost to Follow-up|1|||
162941827|NCT00753714|588490403|FG000|Overall Study|Withdrawal by Subject|2|||
162941828|NCT00753714|588490404|FG001|Overall Study|Withdrawal by Subject|1|||
162941829|NCT00753714|588490403|FG000|Overall Study|Death|3|||
162941830|NCT00753714|588490404|FG001|Overall Study|Death|3|||
162941831|NCT00753714|588490403|FG000|Overall Study|Other|7|||
162941832|NCT00753714|588490404|FG001|Overall Study|Other|5|||
162941833|NCT03387098|588490405|FG000|Overall Study|progressive disease|1|||
162941834|NCT03387098|588490405|FG000|Overall Study|Withdrawal by Subject|2|||
162941835|NCT03387098|588490405|FG000|Overall Study|study terminated by sponsor|1|||
162941836|NCT00278512|588490406|FG000|Overall Study|Death|1|||
162941837|NCT00278512|588490407|FG001|Overall Study|Death|0|||
162941838|NCT01620177|588490408|FG000|Overall Study|Failure at Screening Visit|43|||
162941839|NCT01620177|588490408|FG000|Overall Study|Withdrawal by Subject|26|||
162941840|NCT01620177|588490408|FG000|Overall Study|Lost to Follow-up|7|||
162941841|NCT01620177|588490408|FG000|Overall Study|Physician Decision|2|||
162941842|NCT01620177|588490408|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
162941843|NCT02292238|588490409|FG000|Overall Study|Protocol Violation|1|||
162941844|NCT02292238|588490410|FG001|Overall Study|Protocol Violation|2|||
162941845|NCT02292238|588490409|FG000|Overall Study|Withdrawal by Subject|2|||
162941846|NCT02292238|588490410|FG001|Overall Study|Withdrawal by Subject|1|||
162941847|NCT02292238|588490409|FG000|Overall Study|Lost to Follow-up|1|||
162941848|NCT02292238|588490410|FG001|Overall Study|Lost to Follow-up|0|||
162941849|NCT02292238|588490409|FG000|Overall Study|Physician Decision|0|||
162941850|NCT02292238|588490410|FG001|Overall Study|Physician Decision|1|||
162941851|NCT04000009|588490411|FG000|Overall Study|Adverse Event|13|||
162941852|NCT04000009|588490411|FG000|Overall Study|Lack of Efficacy|7|||
162941853|NCT04000009|588490411|FG000|Overall Study|Lost to Follow-up|8|||
162941854|NCT04000009|588490411|FG000|Overall Study|Noncompliance with study drug|4|||
162941855|NCT04000009|588490411|FG000|Overall Study|Physician Decision|1|||
162941856|NCT04000009|588490411|FG000|Overall Study|Use of prohibited medication|3|||
162830078|NCT03200366|588090710|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
162830079|NCT03200366|588090711|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
162830080|NCT03200366|588090709|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
162941857|NCT04000009|588490411|FG000|Overall Study|Pregnancy|1|||
162941858|NCT04000009|588490411|FG000|Overall Study|Withdrawal by Subject|22|||
162941859|NCT04000009|588490411|FG000|Overall Study|Study terminated by sponsor|98|||
162941860|NCT04000009|588490411|FG000|Overall Study|Not further specified|8|||
162941861|NCT01754259|588490414|FG000|Overall Study|Withdrawal by Subject|2|||
162941862|NCT01754259|588490415|FG001|Overall Study|Withdrawal by Subject|4|||
162941863|NCT01754259|588490414|FG000|Overall Study|Adverse Event|3|||
162941864|NCT01754259|588490415|FG001|Overall Study|Adverse Event|1|||
162830081|NCT03200366|588090710|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
162830082|NCT03200366|588090711|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
162830083|NCT03200366|588090709|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
162830084|NCT03200366|588090710|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
162830085|NCT03200366|588090711|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
162830086|NCT00405067|588090712|FG000|Overall Study|Adverse Event|4|||
162830087|NCT00405067|588090713|FG001|Overall Study|Adverse Event|9|||
162830088|NCT00405067|588090714|FG002|Overall Study|Adverse Event|4|||
162830089|NCT00405067|588090712|FG000|Overall Study|Lost to Follow-up|0|||
162830090|NCT00405067|588090713|FG001|Overall Study|Lost to Follow-up|0|||
162830091|NCT00405067|588090714|FG002|Overall Study|Lost to Follow-up|1|||
162830092|NCT00631020|588090715|FG000|Overall Study|Lost to Follow-up|7|||
162830093|NCT00631020|588090715|FG000|Overall Study|Incarcerated|1|||
162830094|NCT00732303|588090717|FG000|Overall Study|Study Terminated|2|||
162830095|NCT01399788|588090718|FG000|First Intervention Period|Adverse Event|1|||
162830096|NCT01399788|588090719|FG001|First Intervention Period|Adverse Event|0|||
162830097|NCT02919436|588090720|FG000|Overall Study|Did not undergo surgery|16|||
162830098|NCT02919436|588090721|FG001|Overall Study|Did not undergo surgery|20|||
162830099|NCT02919436|588090720|FG000|Overall Study|Enrolled before trial registration|44|||
162830100|NCT02919436|588090721|FG001|Overall Study|Enrolled before trial registration|33|||
162830101|NCT01389752|588090722|FG000|Study Period 1|Sponsor decision|0|||
162830102|NCT01389752|588090723|FG001|Study Period 1|Sponsor decision|2|||
162830103|NCT01389752|588090722|FG000|Study Period 2|Sponsor decision|1|||
162830104|NCT01389752|588090723|FG001|Study Period 2|Sponsor decision|0|||
162830105|NCT01576549|588090734|FG000|Overall Study|Sponsor Decision|2|||
162830106|NCT00053417|588090735|FG000|Overall Study|Adverse Event|1|||
162830107|NCT00053417|588090736|FG001|Overall Study|Adverse Event|0|||
162830108|NCT00053417|588090737|FG002|Overall Study|Adverse Event|1|||
162830109|NCT00053417|588090738|FG003|Overall Study|Adverse Event|5|||
162830110|NCT00053417|588090735|FG000|Overall Study|Non-Compliance|0|||
162830111|NCT00053417|588090736|FG001|Overall Study|Non-Compliance|0|||
162830112|NCT00053417|588090737|FG002|Overall Study|Non-Compliance|0|||
162830113|NCT00053417|588090738|FG003|Overall Study|Non-Compliance|1|||
162830114|NCT00053417|588090735|FG000|Overall Study|Withdrawal by Subject|0|||
162830115|NCT00053417|588090736|FG001|Overall Study|Withdrawal by Subject|1|||
162830116|NCT00053417|588090737|FG002|Overall Study|Withdrawal by Subject|0|||
162830117|NCT00053417|588090738|FG003|Overall Study|Withdrawal by Subject|0|||
162830118|NCT00053417|588090735|FG000|Overall Study|Lost to Follow-up|1|||
162830119|NCT00053417|588090736|FG001|Overall Study|Lost to Follow-up|1|||
162830120|NCT00053417|588090737|FG002|Overall Study|Lost to Follow-up|0|||
162830121|NCT00053417|588090738|FG003|Overall Study|Lost to Follow-up|0|||
162830122|NCT04081363|588090739|FG000|Overall Study|Withdrawal by Subject|1|||
162830123|NCT04081363|588090740|FG001|Overall Study|Withdrawal by Subject|0|||
162830124|NCT02409290|588090741|FG000|Overall Study|Protocol Violation|3|||
162830125|NCT02409290|588090742|FG001|Overall Study|Protocol Violation|6|||
162830126|NCT02409290|588090743|FG002|Overall Study|Protocol Violation|9|||
162830127|NCT02409290|588090744|FG003|Overall Study|Protocol Violation|4|||
162830128|NCT02409290|588090741|FG000|Overall Study|No positive culture/no baseline sample|3|||
162830129|NCT02409290|588090742|FG001|Overall Study|No positive culture/no baseline sample|9|||
162830130|NCT02409290|588090743|FG002|Overall Study|No positive culture/no baseline sample|6|||
162830131|NCT02409290|588090744|FG003|Overall Study|No positive culture/no baseline sample|5|||
162830132|NCT02409290|588090741|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
162830133|NCT02409290|588090742|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
162830134|NCT02409290|588090743|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
162830135|NCT02409290|588090744|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
162830136|NCT04251910|588090749|FG000|Overall Study|Covid 19 lockdown|0|||
162830137|NCT04251910|588090750|FG001|Overall Study|Covid 19 lockdown|5|||
162830138|NCT04251910|588090751|FG002|Overall Study|Covid 19 lockdown|0|||
162830139|NCT04251910|588090752|FG003|Overall Study|Covid 19 lockdown|4|||
162830140|NCT04251910|588090753|FG004|Overall Study|Covid 19 lockdown|0|||
162830141|NCT04251910|588090754|FG005|Overall Study|Covid 19 lockdown|0|||
162830142|NCT04251910|588090749|FG000|Overall Study|Assisted living facility was closed|0|||
162830143|NCT04251910|588090750|FG001|Overall Study|Assisted living facility was closed|0|||
162830144|NCT04251910|588090751|FG002|Overall Study|Assisted living facility was closed|0|||
162830145|NCT04251910|588090752|FG003|Overall Study|Assisted living facility was closed|0|||
162830146|NCT04251910|588090753|FG004|Overall Study|Assisted living facility was closed|1|||
162830147|NCT04251910|588090754|FG005|Overall Study|Assisted living facility was closed|0|||
162830148|NCT01056510|588090757|FG000|Overall Study|Dropout Before Start of Treatment|1|||
162830149|NCT01056510|588090758|FG001|Overall Study|Dropout Before Start of Treatment|1|||
162830150|NCT01056510|588090757|FG000|Overall Study|Withdrawal by Subject|4|||
162830151|NCT01056510|588090758|FG001|Overall Study|Withdrawal by Subject|2|||
162830152|NCT01056510|588090757|FG000|Overall Study|Death|29|||
162830153|NCT01056510|588090758|FG001|Overall Study|Death|34|||
162830154|NCT01056510|588090757|FG000|Overall Study|Noncompliance|1|||
162830155|NCT01056510|588090758|FG001|Overall Study|Noncompliance|3|||
162830156|NCT01056510|588090757|FG000|Overall Study|Physician Decision|4|||
162830157|NCT01056510|588090758|FG001|Overall Study|Physician Decision|5|||
162830158|NCT01056510|588090757|FG000|Overall Study|Lost to Follow-up|5|||
162830159|NCT01056510|588090758|FG001|Overall Study|Lost to Follow-up|6|||
162830160|NCT01056510|588090757|FG000|Overall Study|Other|10|||
162830161|NCT01056510|588090758|FG001|Overall Study|Other|12|||
162830162|NCT01056510|588090757|FG000|Overall Study|Missing|0|||
162830163|NCT01056510|588090758|FG001|Overall Study|Missing|1|||
162830164|NCT02830776|588090759|FG000|Overall Study|Lost to Follow-up|1|||
162830165|NCT03451084|588090760|FG000|Overall Study|Withdrawal by Subject|2|||
162830166|NCT03451084|588090761|FG001|Overall Study|Withdrawal by Subject|1|||
162830167|NCT03451084|588090762|FG002|Overall Study|Withdrawal by Subject|2|||
162830168|NCT03451084|588090763|FG003|Overall Study|Withdrawal by Subject|1|||
162830169|NCT03451084|588090760|FG000|Overall Study|Disease recurrence|0|||
162830170|NCT03451084|588090761|FG001|Overall Study|Disease recurrence|2|||
162830171|NCT03451084|588090762|FG002|Overall Study|Disease recurrence|0|||
162830172|NCT03451084|588090763|FG003|Overall Study|Disease recurrence|0|||
162830173|NCT03451084|588090760|FG000|Overall Study|Lack of Efficacy|0|||
162830174|NCT03451084|588090761|FG001|Overall Study|Lack of Efficacy|3|||
162830175|NCT03451084|588090762|FG002|Overall Study|Lack of Efficacy|0|||
162830176|NCT03451084|588090763|FG003|Overall Study|Lack of Efficacy|1|||
162830177|NCT03451084|588090760|FG000|Overall Study|Death|1|||
162830178|NCT03451084|588090761|FG001|Overall Study|Death|0|||
162830179|NCT03451084|588090762|FG002|Overall Study|Death|2|||
162830180|NCT03451084|588090763|FG003|Overall Study|Death|0|||
162830181|NCT03451084|588090760|FG000|Overall Study|Physician Decision|0|||
162941865|NCT01754259|588490414|FG000|Overall Study|Lost to Follow-up|0|||
162941866|NCT01754259|588490415|FG001|Overall Study|Lost to Follow-up|1|||
162941867|NCT02829918|588490416|FG000|Overall Study|Death|2|||
162941868|NCT02829918|588490416|FG000|Overall Study|Withdrawal by Subject|4|||
162941869|NCT02829918|588490416|FG000|Overall Study|Adverse Event|1|||
162941870|NCT02829918|588490416|FG000|Overall Study|Progression|1|||
162941871|NCT00491504|588490419|FG000|Overall Study|Adverse Event|0|||
162941872|NCT00491504|588490420|FG001|Overall Study|Adverse Event|1|||
162941873|NCT00491504|588490421|FG002|Overall Study|Adverse Event|0|||
162941874|NCT00491504|588490422|FG003|Overall Study|Adverse Event|0|||
162941875|NCT00491504|588490419|FG000|Overall Study|Withdrawal by Subject|0|||
162941876|NCT00491504|588490420|FG001|Overall Study|Withdrawal by Subject|0|||
162941877|NCT00491504|588490421|FG002|Overall Study|Withdrawal by Subject|1|||
162941878|NCT00491504|588490422|FG003|Overall Study|Withdrawal by Subject|2|||
162941879|NCT00491504|588490419|FG000|Overall Study|Protocol Violation|0|||
162941880|NCT00491504|588490420|FG001|Overall Study|Protocol Violation|0|||
162941881|NCT00491504|588490421|FG002|Overall Study|Protocol Violation|3|||
162941882|NCT00491504|588490422|FG003|Overall Study|Protocol Violation|2|||
162941883|NCT02041702|588490427|FG000|Overall Study|Lost to Follow-up|1|||
162941884|NCT02041702|588490428|FG001|Overall Study|Lost to Follow-up|6|||
162941885|NCT02041702|588490427|FG000|Overall Study|Death|4|||
162941886|NCT02041702|588490428|FG001|Overall Study|Death|0|||
162941887|NCT02041702|588490427|FG000|Overall Study|Withdrawal by Subject|4|||
162941888|NCT02041702|588490428|FG001|Overall Study|Withdrawal by Subject|3|||
162941889|NCT02041702|588490427|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
162941890|NCT02041702|588490428|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
162941891|NCT02041702|588490427|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
162941892|NCT02041702|588490428|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
162941893|NCT00203307|588490429|FG000|First Intervention|Adverse Event|2|||
162941894|NCT00203307|588490430|FG001|First Intervention|Adverse Event|0|||
162941895|NCT03730103|588490431|FG000|Overall Study|Did not meet inclusion criteria|0|||
162941896|NCT03730103|588490432|FG001|Overall Study|Did not meet inclusion criteria|5|||
162941897|NCT02789111|588490433|FG000|Overall Study|Withdrawal by Subject|1|||
162941898|NCT02789111|588490434|FG001|Overall Study|Withdrawal by Subject|4|||
162941899|NCT02308111|588490435|FG000|Overall Study|Adverse Event|31|||
162941900|NCT02308111|588490436|FG001|Overall Study|Adverse Event|19|||
162941901|NCT02308111|588490435|FG000|Overall Study|Death|9|||
162941902|NCT02308111|588490436|FG001|Overall Study|Death|6|||
162941903|NCT02308111|588490435|FG000|Overall Study|Lost to Follow-up|2|||
162941904|NCT02308111|588490436|FG001|Overall Study|Lost to Follow-up|7|||
162941905|NCT02308111|588490435|FG000|Overall Study|Physician Decision|6|||
162830182|NCT03451084|588090761|FG001|Overall Study|Physician Decision|0|||
162830183|NCT03451084|588090762|FG002|Overall Study|Physician Decision|2|||
162830184|NCT03451084|588090763|FG003|Overall Study|Physician Decision|2|||
162830185|NCT03451084|588090760|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
162830186|NCT03451084|588090761|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
162941906|NCT02308111|588490436|FG001|Overall Study|Physician Decision|17|||
162941907|NCT02308111|588490435|FG000|Overall Study|Protocol Violation|0|||
162941908|NCT02308111|588490436|FG001|Overall Study|Protocol Violation|1|||
162941909|NCT02308111|588490435|FG000|Overall Study|Withdrawal by Subject|28|||
162941910|NCT02308111|588490436|FG001|Overall Study|Withdrawal by Subject|38|||
162941911|NCT02308111|588490435|FG000|Overall Study|Study Terminated by Sponsor|72|||
162941912|NCT02308111|588490436|FG001|Overall Study|Study Terminated by Sponsor|61|||
162941913|NCT02308111|588490435|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
162941914|NCT02308111|588490436|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
162941915|NCT02308111|588490435|FG000|Overall Study|Site Closure|3|||
162941916|NCT02308111|588490436|FG001|Overall Study|Site Closure|3|||
162941917|NCT02308111|588490435|FG000|Overall Study|Non-compliance with Study Drug|3|||
162941918|NCT02308111|588490436|FG001|Overall Study|Non-compliance with Study Drug|1|||
162941919|NCT02308111|588490435|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
162941920|NCT02308111|588490436|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
162941921|NCT02308111|588490435|FG000|Overall Study|Liver Transplant|3|||
162941922|NCT02308111|588490436|FG001|Overall Study|Liver Transplant|3|||
162941923|NCT02308111|588490435|FG000|Overall Study|Liver Transplant Waitlist|2|||
162941924|NCT02308111|588490436|FG001|Overall Study|Liver Transplant Waitlist|2|||
162941925|NCT02308111|588490435|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
162941926|NCT02308111|588490436|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
162941927|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
162941928|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
162941929|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
162941930|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
162941931|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
162941932|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
162941933|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
162941934|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
162941935|NCT03271528|588490438|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
162941936|NCT03271528|588490439|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
162941937|NCT03271528|588490438|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
162941938|NCT03271528|588490439|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
162941939|NCT03271528|588490438|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
162941940|NCT03271528|588490439|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
162941941|NCT03977584|588490442|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
162941942|NCT03977584|588490443|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
162941943|NCT03977584|588490444|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
162941944|NCT02257736|588490448|FG000|Overall Study|Progressive disease|365|||
162941945|NCT02257736|588490449|FG001|Overall Study|Progressive disease|327|||
162941946|NCT02257736|588490448|FG000|Overall Study|Adverse Event|45|||
162941947|NCT02257736|588490449|FG001|Overall Study|Adverse Event|56|||
162941948|NCT02257736|588490448|FG000|Overall Study|Withdrawal by Subject|21|||
162941949|NCT02257736|588490449|FG001|Overall Study|Withdrawal by Subject|38|||
162941950|NCT02257736|588490448|FG000|Overall Study|Death|11|||
162941951|NCT02257736|588490449|FG001|Overall Study|Death|6|||
162941952|NCT02257736|588490448|FG000|Overall Study|Physician Decision|5|||
162941953|NCT02257736|588490449|FG001|Overall Study|Physician Decision|9|||
162941954|NCT02257736|588490448|FG000|Overall Study|Non-Compliance with study drug|1|||
162941955|NCT02257736|588490449|FG001|Overall Study|Non-Compliance with study drug|2|||
162941956|NCT02257736|588490448|FG000|Overall Study|Protocol Violation|1|||
162941957|NCT02257736|588490449|FG001|Overall Study|Protocol Violation|0|||
162941958|NCT02257736|588490448|FG000|Overall Study|Other|1|||
162941959|NCT02257736|588490449|FG001|Overall Study|Other|7|||
162941960|NCT02257736|588490448|FG000|Overall Study|Randomized, not treated|1|||
162941961|NCT02257736|588490449|FG001|Overall Study|Randomized, not treated|2|||
162941962|NCT00745251|588490457|FG000|Overall Study|Adverse Event|1|||
162941963|NCT00745251|588490458|FG001|Overall Study|Adverse Event|2|||
162941964|NCT00745251|588490457|FG000|Overall Study|Withdrawal by Subject|1|||
162941965|NCT00745251|588490458|FG001|Overall Study|Withdrawal by Subject|1|||
162941966|NCT03390504|588490459|FG000|Overall Study|Lost to Follow-up|2|||
162941967|NCT03390504|588490460|FG001|Overall Study|Lost to Follow-up|4|||
162941968|NCT03390504|588490461|FG002|Overall Study|Lost to Follow-up|0|||
162941969|NCT03390504|588490462|FG003|Overall Study|Lost to Follow-up|1|||
162941970|NCT03390504|588490459|FG000|Overall Study|Withdrawal by Subject|3|||
162941971|NCT03390504|588490460|FG001|Overall Study|Withdrawal by Subject|15|||
162941972|NCT03390504|588490461|FG002|Overall Study|Withdrawal by Subject|5|||
162941973|NCT03390504|588490462|FG003|Overall Study|Withdrawal by Subject|2|||
162941974|NCT03390504|588490459|FG000|Overall Study|Other|1|||
162941975|NCT03390504|588490460|FG001|Overall Study|Other|2|||
162941976|NCT03390504|588490461|FG002|Overall Study|Other|2|||
162698706|NCT00337662|587605555|FG002|Study Period III|Sponsor Decision|1|||
162941977|NCT03390504|588490462|FG003|Overall Study|Other|6|||
162941978|NCT05431686|588490463|FG000|Overall Study|unable to schedule|10|||
162941979|NCT01118728|588490478|FG000|Overall Study|Adverse Event|17|||
162941980|NCT01118728|588490478|FG000|Overall Study|Lack of Efficacy|27|||
162941981|NCT01118728|588490478|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
162830187|NCT03451084|588090762|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
162830188|NCT03451084|588090763|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
162830189|NCT05289570|588090772|FG000|Overall Study|Physician Decision|1|||
162830190|NCT04544475|588090777|FG000|Overall Study|Withdrawal by Subject|1|||
162830191|NCT04544475|588090778|FG001|Overall Study|Withdrawal by Subject|3|||
162830192|NCT01765920|588090779|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
162830193|NCT01765920|588090780|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
162830194|NCT01765920|588090779|FG000|Overall Study|Patient code disclosure|0|||
162830195|NCT01765920|588090780|FG001|Overall Study|Patient code disclosure|1|||
162830196|NCT03223428|588090781|FG000|Overall Study|No longer taking Xermelo|27|||
162830197|NCT03223428|588090781|FG000|Overall Study|Declined Consent|1|||
162830198|NCT03223428|588090781|FG000|Overall Study|Non-responders|56|||
162830199|NCT03223428|588090781|FG000|Overall Study|Withdrawal by Subject|14|||
162830200|NCT00777101|588090782|FG000|Overall Study|Death|48|||
162830201|NCT00777101|588090783|FG001|Overall Study|Death|43|||
162830202|NCT00777101|588090782|FG000|Overall Study|Withdrawal by Subject|11|||
162830203|NCT00777101|588090783|FG001|Overall Study|Withdrawal by Subject|6|||
162830204|NCT00777101|588090782|FG000|Overall Study|Lost to Follow-up|2|||
162830205|NCT00777101|588090783|FG001|Overall Study|Lost to Follow-up|1|||
162830206|NCT00777101|588090782|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
162830207|NCT00777101|588090783|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162830208|NCT00777101|588090782|FG000|Overall Study|Failed to Return|0|||
162941982|NCT01118728|588490478|FG000|Overall Study|Withdrawal by Subject|3|||
162941983|NCT01118728|588490478|FG000|Overall Study|Lost to Follow-up|4|||
162941984|NCT01309919|588490482|FG000|Overall Study|Did not receive a postpartum IUD|17|||
162941985|NCT01309919|588490483|FG001|Overall Study|Did not receive a postpartum IUD|48|||
162830209|NCT00777101|588090783|FG001|Overall Study|Failed to Return|1|||
162830210|NCT00282334|588090787|FG000|Overall Study|Withdrawal by Subject|8|||
162830211|NCT00282334|588090788|FG001|Overall Study|Withdrawal by Subject|5|||
162830212|NCT00964743|588090796|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
162941986|NCT01736553|588490490|FG000|Overall Study|Death|12|||
162698707|NCT00337662|587605556|FG003|Study Period III|Sponsor Decision|0|||
162830213|NCT03317795|588090799|FG000|Overall Study|IUD Expulsion|1|||
162830214|NCT03317795|588090800|FG001|Overall Study|IUD Expulsion|0|||
162830215|NCT03317795|588090799|FG000|Overall Study|Lost to Follow-up|1|||
162830216|NCT03317795|588090800|FG001|Overall Study|Lost to Follow-up|3|||
162830217|NCT03317795|588090799|FG000|Overall Study|Treatment change|0|||
162830218|NCT03317795|588090800|FG001|Overall Study|Treatment change|3|||
162830219|NCT03317795|588090799|FG000|Overall Study|Intolerance of medication|0|||
162830220|NCT03317795|588090800|FG001|Overall Study|Intolerance of medication|1|||
162830221|NCT00886600|588090801|FG000|Double-blind Monotherapy|Adverse Event|1|||
162830222|NCT00886600|588090802|FG001|Double-blind Monotherapy|Adverse Event|1|||
162830223|NCT00886600|588090803|FG002|Double-blind Monotherapy|Adverse Event|1|||
162830224|NCT00886600|588090804|FG003|Double-blind Monotherapy|Adverse Event|1|||
162830225|NCT00886600|588090801|FG000|Double-blind Monotherapy|Protocol Violation|0|||
162830226|NCT00886600|588090802|FG001|Double-blind Monotherapy|Protocol Violation|0|||
162830227|NCT00886600|588090803|FG002|Double-blind Monotherapy|Protocol Violation|0|||
162830228|NCT00886600|588090804|FG003|Double-blind Monotherapy|Protocol Violation|1|||
162830229|NCT00886600|588090801|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
162830230|NCT00886600|588090802|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
162830231|NCT00886600|588090803|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
162830232|NCT00886600|588090804|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
162830233|NCT00886600|588090801|FG000|Combination Therapy Period|Adverse Event|0|||
162830234|NCT00886600|588090802|FG001|Combination Therapy Period|Adverse Event|0|||
162830235|NCT00886600|588090803|FG002|Combination Therapy Period|Adverse Event|1|||
162830236|NCT00886600|588090804|FG003|Combination Therapy Period|Adverse Event|0|||
162830237|NCT00886600|588090801|FG000|Combination Therapy Period|Protocol Violation|0|||
162830238|NCT00886600|588090802|FG001|Combination Therapy Period|Protocol Violation|0|||
162830239|NCT00886600|588090803|FG002|Combination Therapy Period|Protocol Violation|1|||
162830240|NCT00886600|588090804|FG003|Combination Therapy Period|Protocol Violation|0|||
162830241|NCT00501007|588090805|FG000|Overall Study|Inclusion criteria not met.|29|||
162830242|NCT00501007|588090806|FG001|Overall Study|Inclusion criteria not met.|25|||
162830243|NCT03917823|588090807|FG000|Overall Study|Lost to Follow-up|1|||
162830244|NCT03917823|588090808|FG001|Overall Study|Lost to Follow-up|1|||
162830245|NCT03917823|588090807|FG000|Overall Study|Withdrawal by Subject|0|||
162830246|NCT03917823|588090808|FG001|Overall Study|Withdrawal by Subject|1|||
162830247|NCT02424253|588090811|FG000|Overall Study|Other, unspecified|1|||
162830248|NCT02424253|588090812|FG001|Overall Study|Other, unspecified|0|||
162830249|NCT02424253|588090811|FG000|Overall Study|Compliance problems|1|||
162830250|NCT02424253|588090812|FG001|Overall Study|Compliance problems|0|||
162830251|NCT02424253|588090811|FG000|Overall Study|Physician Decision|2|||
162830252|NCT02424253|588090812|FG001|Overall Study|Physician Decision|0|||
162830253|NCT02424253|588090811|FG000|Overall Study|Lack of Efficacy|0|||
162830254|NCT02424253|588090812|FG001|Overall Study|Lack of Efficacy|7|||
162830255|NCT02424253|588090811|FG000|Overall Study|Adverse Event|2|||
162830256|NCT02424253|588090812|FG001|Overall Study|Adverse Event|0|||
162830257|NCT02424253|588090811|FG000|Overall Study|Consent withdrawn by subject|4|||
162830258|NCT02424253|588090812|FG001|Overall Study|Consent withdrawn by subject|1|||
162830259|NCT02424253|588090811|FG000|Overall Study|Lost to Follow-up|1|||
162830260|NCT02424253|588090812|FG001|Overall Study|Lost to Follow-up|1|||
162830261|NCT00473343|588090813|FG000|Overall Study|Adverse Event|9|||
162830262|NCT00473343|588090813|FG000|Overall Study|Lost to Follow-up|8|||
162830263|NCT00473343|588090813|FG000|Overall Study|Treatment failure|27|||
162830264|NCT00473343|588090813|FG000|Overall Study|Withdrew consent|3|||
162830265|NCT00473343|588090813|FG000|Overall Study|Other un-specified reason|3|||
162830266|NCT04126083|588090814|FG000|Overall Study|Withdrawal by Subject|1|||
162830267|NCT01892163|588090817|FG000|Overall Study|Death|1|||
162830268|NCT01892163|588090818|FG001|Overall Study|Death|1|||
162830269|NCT01892163|588090817|FG000|Overall Study|Lost to Follow-up|1|||
162830270|NCT01892163|588090818|FG001|Overall Study|Lost to Follow-up|0|||
162830271|NCT02577146|588090819|FG000|Overall Study|Lost to Follow-up|8|||
162830272|NCT02577146|588090819|FG000|Overall Study|Physician Decision|3|||
162830273|NCT02577146|588090819|FG000|Overall Study|Screen Failure|17|||
162830274|NCT03116698|588090820|FG000|Overall Study|Adverse Event|1|||
162830275|NCT03116698|588090821|FG001|Overall Study|Adverse Event|1|||
162830276|NCT03116698|588090822|FG002|Overall Study|Adverse Event|1|||
162830277|NCT03116698|588090823|FG003|Overall Study|Adverse Event|0|||
162830278|NCT03116698|588090820|FG000|Overall Study|Withdrawal by Subject|1|||
162830279|NCT03116698|588090821|FG001|Overall Study|Withdrawal by Subject|4|||
162830280|NCT03116698|588090822|FG002|Overall Study|Withdrawal by Subject|5|||
162830281|NCT03116698|588090823|FG003|Overall Study|Withdrawal by Subject|2|||
162830282|NCT03116698|588090820|FG000|Overall Study|Lost to Follow-up|2|||
162830283|NCT03116698|588090821|FG001|Overall Study|Lost to Follow-up|0|||
162830284|NCT03116698|588090822|FG002|Overall Study|Lost to Follow-up|0|||
162830285|NCT03116698|588090823|FG003|Overall Study|Lost to Follow-up|0|||
162830286|NCT03116698|588090820|FG000|Overall Study|Physician Decision|1|||
162830287|NCT03116698|588090821|FG001|Overall Study|Physician Decision|1|||
162830288|NCT03116698|588090822|FG002|Overall Study|Physician Decision|0|||
162830289|NCT03116698|588090823|FG003|Overall Study|Physician Decision|0|||
162830290|NCT03116698|588090820|FG000|Overall Study|Protocol Violation|1|||
162830291|NCT03116698|588090821|FG001|Overall Study|Protocol Violation|0|||
162830292|NCT03116698|588090822|FG002|Overall Study|Protocol Violation|0|||
162830293|NCT03116698|588090823|FG003|Overall Study|Protocol Violation|0|||
162830294|NCT03116698|588090820|FG000|Overall Study|Death|0|||
162830295|NCT03116698|588090821|FG001|Overall Study|Death|0|||
162830296|NCT03116698|588090822|FG002|Overall Study|Death|2|||
162830297|NCT03116698|588090823|FG003|Overall Study|Death|0|||
162830298|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
162830299|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
162830300|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
162830301|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
162830302|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
162830303|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
162830304|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
162830305|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
162830306|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to death|4|||
162830307|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to death|3|||
162830308|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
162830309|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
162830310|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
162830311|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
162830312|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
162830313|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
162830314|NCT02258451|588090824|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
162830315|NCT02258451|588090825|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
162830316|NCT02258451|588090824|FG000|Overall Study|Other reason|1|||
162830317|NCT02258451|588090825|FG001|Overall Study|Other reason|1|||
162830318|NCT02258451|588090824|FG000|Overall Study|Never treated|2|||
162830319|NCT02258451|588090825|FG001|Overall Study|Never treated|3|||
162830320|NCT00517751|588090830|FG000|Overall Study|Death|3|||
162830321|NCT00517751|588090830|FG000|Overall Study|Withdrawal by Subject|37|||
162830322|NCT00517751|588090830|FG000|Overall Study|Lost to Follow-up|4|||
162830323|NCT00517751|588090830|FG000|Overall Study|patient not over due|6|||
162830324|NCT00517751|588090830|FG000|Overall Study|Patient not due for visit|76|||
162830325|NCT00517751|588090830|FG000|Overall Study|Missing|3|||
162830326|NCT03021499|588090833|FG000|Overall Study|Adverse Event|1|||
162830327|NCT03021499|588090834|FG001|Overall Study|Adverse Event|0|||
162830328|NCT03021499|588090833|FG000|Overall Study|Death|1|||
162830329|NCT03021499|588090834|FG001|Overall Study|Death|5|||
162830330|NCT03021499|588090833|FG000|Overall Study|Lack of Efficacy|0|||
162830331|NCT03021499|588090834|FG001|Overall Study|Lack of Efficacy|1|||
162830332|NCT03021499|588090833|FG000|Overall Study|Lost to Follow-up|1|||
162830333|NCT03021499|588090834|FG001|Overall Study|Lost to Follow-up|3|||
162830334|NCT03021499|588090833|FG000|Overall Study|Physician Decision|2|||
162830335|NCT03021499|588090834|FG001|Overall Study|Physician Decision|3|||
162830336|NCT03021499|588090833|FG000|Overall Study|Pregnancy|1|||
162830337|NCT03021499|588090834|FG001|Overall Study|Pregnancy|0|||
162830338|NCT03021499|588090833|FG000|Overall Study|Withdrawal by Subject|7|||
162830339|NCT03021499|588090834|FG001|Overall Study|Withdrawal by Subject|14|||
162830340|NCT03021499|588090833|FG000|Overall Study|Prohibited medication required|1|||
162830341|NCT03021499|588090834|FG001|Overall Study|Prohibited medication required|0|||
162830342|NCT03021499|588090833|FG000|Overall Study|Protocol non-compliance|1|||
162698708|NCT00337662|587605553|FG000|Study Period III|Clinical Relapse|1|||
162941987|NCT01736553|588490491|FG001|Overall Study|Death|0|||
162941988|NCT01736553|588490490|FG000|Overall Study|Withdrawal by Subject|5|||
162941989|NCT01736553|588490491|FG001|Overall Study|Withdrawal by Subject|2|||
162941990|NCT01736553|588490490|FG000|Overall Study|Lost to Follow-up|2|||
162941991|NCT01736553|588490491|FG001|Overall Study|Lost to Follow-up|2|||
162941992|NCT01896297|588490492|FG000|Overall Study|Died in post treatment phase|1|||
162941993|NCT00003782|588490495|FG000|Overall Study|No follow up data|30|||
162941994|NCT00003782|588490496|FG001|Overall Study|No follow up data|31|||
162941995|NCT00003782|588490497|FG002|Overall Study|No follow up data|26|||
162941996|NCT03626857|588490500|FG000|Overall Study|Adverse Event|9|||
162941997|NCT03626857|588490501|FG001|Overall Study|Adverse Event|7|||
162941998|NCT03626857|588490500|FG000|Overall Study|Lost to Follow-up|8|||
162941999|NCT03626857|588490501|FG001|Overall Study|Lost to Follow-up|8|||
162942000|NCT03626857|588490500|FG000|Overall Study|Withdrawal by Subject|2|||
162942001|NCT03626857|588490501|FG001|Overall Study|Withdrawal by Subject|2|||
162942002|NCT03626857|588490500|FG000|Overall Study|Protocol Violation|1|||
162942003|NCT03626857|588490501|FG001|Overall Study|Protocol Violation|3|||
162942004|NCT01301833|588490502|FG000|Overall Study|Adverse Event|7|||
162942005|NCT01301833|588490503|FG001|Overall Study|Adverse Event|5|||
162830343|NCT03021499|588090834|FG001|Overall Study|Protocol non-compliance|1|||
162830344|NCT03021499|588090833|FG000|Overall Study|None of the above|0|||
162830345|NCT03021499|588090834|FG001|Overall Study|None of the above|4|||
162830346|NCT03021499|588090833|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
162830347|NCT03021499|588090834|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
162830348|NCT00495820|588090835|FG000|Overall Study|Adverse Event|1|||
162830349|NCT00495820|588090836|FG001|Overall Study|Adverse Event|1|||
162942006|NCT01301833|588490504|FG002|Overall Study|Adverse Event|5|||
162942007|NCT01301833|588490505|FG003|Overall Study|Adverse Event|5|||
162942008|NCT01301833|588490502|FG000|Overall Study|Lack of Efficacy|1|||
162942009|NCT01301833|588490503|FG001|Overall Study|Lack of Efficacy|1|||
162942010|NCT01301833|588490504|FG002|Overall Study|Lack of Efficacy|0|||
162942011|NCT01301833|588490505|FG003|Overall Study|Lack of Efficacy|0|||
162942012|NCT01301833|588490502|FG000|Overall Study|Physician Decision|3|||
162942013|NCT01301833|588490503|FG001|Overall Study|Physician Decision|1|||
162942014|NCT01301833|588490504|FG002|Overall Study|Physician Decision|1|||
162942015|NCT01301833|588490505|FG003|Overall Study|Physician Decision|0|||
162942016|NCT01301833|588490502|FG000|Overall Study|Withdrawal by Subject|3|||
162942017|NCT01301833|588490503|FG001|Overall Study|Withdrawal by Subject|1|||
162942018|NCT01301833|588490504|FG002|Overall Study|Withdrawal by Subject|1|||
162830350|NCT00820950|588090837|FG000|Overall Study|Scheduling Conflict|0|||
162830351|NCT00820950|588090838|FG001|Overall Study|Scheduling Conflict|0|||
162830352|NCT00820950|588090839|FG002|Overall Study|Scheduling Conflict|0|||
162830353|NCT00820950|588090840|FG003|Overall Study|Scheduling Conflict|0|||
162830354|NCT00820950|588090841|FG004|Overall Study|Scheduling Conflict|0|||
162830355|NCT00820950|588090842|FG005|Overall Study|Scheduling Conflict|0|||
162830356|NCT00820950|588090843|FG006|Overall Study|Scheduling Conflict|1|||
162830357|NCT00820950|588090844|FG007|Overall Study|Scheduling Conflict|1|||
162830358|NCT00820950|588090845|FG008|Overall Study|Scheduling Conflict|0|||
162830359|NCT00820950|588090846|FG009|Overall Study|Scheduling Conflict|0|||
162830360|NCT00820950|588090837|FG000|Overall Study|Protocol Violation|1|||
162830361|NCT00820950|588090838|FG001|Overall Study|Protocol Violation|1|||
162830362|NCT00820950|588090839|FG002|Overall Study|Protocol Violation|0|||
162830363|NCT00820950|588090840|FG003|Overall Study|Protocol Violation|0|||
162830364|NCT00820950|588090841|FG004|Overall Study|Protocol Violation|0|||
162830365|NCT00820950|588090842|FG005|Overall Study|Protocol Violation|0|||
162830366|NCT00820950|588090843|FG006|Overall Study|Protocol Violation|0|||
162830367|NCT00820950|588090844|FG007|Overall Study|Protocol Violation|0|||
162830368|NCT00820950|588090845|FG008|Overall Study|Protocol Violation|0|||
162830369|NCT00820950|588090846|FG009|Overall Study|Protocol Violation|0|||
162830370|NCT03927105|588093039|FG000|Overall Study|Death|1|||
162942019|NCT01301833|588490505|FG003|Overall Study|Withdrawal by Subject|2|||
162942020|NCT01301833|588490502|FG000|Overall Study|Personal matter|1|||
162830371|NCT03927105|588093039|FG000|Overall Study|In observation for potential re-treatment|2|||
162830372|NCT03927105|588093039|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
162830373|NCT00789529|588093040|FG000|Overall Study|Withdrawal by Subject|0|||
162830374|NCT00789529|588093041|FG001|Overall Study|Withdrawal by Subject|1|||
162830375|NCT00789529|588093040|FG000|Overall Study|Other Reason|1|||
162830376|NCT00789529|588093041|FG001|Overall Study|Other Reason|0|||
162830377|NCT01870401|588093042|FG000|Overall Study|Death|48|||
162830378|NCT01870401|588093043|FG001|Overall Study|Death|24|||
162942021|NCT01301833|588490503|FG001|Overall Study|Personal matter|0|||
162942022|NCT01301833|588490504|FG002|Overall Study|Personal matter|0|||
162942023|NCT01301833|588490505|FG003|Overall Study|Personal matter|0|||
162698709|NCT00337662|587605554|FG001|Study Period III|Clinical Relapse|0|||
162830379|NCT01870401|588093042|FG000|Overall Study|Withdrawal by Subject|39|||
162830380|NCT01870401|588093043|FG001|Overall Study|Withdrawal by Subject|26|||
162830381|NCT01870401|588093042|FG000|Overall Study|Lost to Follow-up|19|||
162830382|NCT01870401|588093043|FG001|Overall Study|Lost to Follow-up|14|||
162830383|NCT01870401|588093042|FG000|Overall Study|Other|9|||
162830384|NCT01870401|588093043|FG001|Overall Study|Other|7|||
162830385|NCT01870401|588093042|FG000|Overall Study|On-going in the Study|35|||
162830386|NCT01870401|588093043|FG001|Overall Study|On-going in the Study|25|||
162830387|NCT01135498|588093045|FG000|Overall Study|Adverse Event|20|||
162830388|NCT01135498|588093045|FG000|Overall Study|Progressive disease|38|||
162830389|NCT01135498|588093045|FG000|Overall Study|Investigator judgement|25|||
162830390|NCT01135498|588093045|FG000|Overall Study|Withdrawal by Subject|4|||
162830391|NCT01135498|588093045|FG000|Overall Study|Death|1|||
162830392|NCT01135498|588093045|FG000|Overall Study|Ongoing at time of analysis|2|||
162830393|NCT01192022|588093046|FG000|Overall Study|Withdrawal of Consent|3|||
162830394|NCT01192022|588093047|FG001|Overall Study|Withdrawal of Consent|1|||
162830395|NCT01192022|588093048|FG002|Overall Study|Withdrawal of Consent|0|||
162830396|NCT01192022|588093049|FG003|Overall Study|Withdrawal of Consent|0|||
162830397|NCT01192022|588093050|FG004|Overall Study|Withdrawal of Consent|0|||
162830398|NCT01192022|588093046|FG000|Overall Study|Lost to Follow-up|4|||
162830399|NCT01192022|588093047|FG001|Overall Study|Lost to Follow-up|2|||
162830400|NCT01192022|588093048|FG002|Overall Study|Lost to Follow-up|1|||
162830401|NCT01192022|588093049|FG003|Overall Study|Lost to Follow-up|1|||
162830402|NCT01192022|588093050|FG004|Overall Study|Lost to Follow-up|0|||
162830403|NCT01192022|588093046|FG000|Overall Study|Adverse Event|1|||
162830404|NCT01192022|588093047|FG001|Overall Study|Adverse Event|0|||
162830405|NCT01192022|588093048|FG002|Overall Study|Adverse Event|0|||
162830406|NCT01192022|588093049|FG003|Overall Study|Adverse Event|0|||
162830407|NCT01192022|588093050|FG004|Overall Study|Adverse Event|0|||
162830408|NCT01192022|588093046|FG000|Overall Study|Fatal Adverse Event|4|||
162830409|NCT01192022|588093047|FG001|Overall Study|Fatal Adverse Event|6|||
162830410|NCT01192022|588093048|FG002|Overall Study|Fatal Adverse Event|0|||
162830411|NCT01192022|588093049|FG003|Overall Study|Fatal Adverse Event|0|||
162830412|NCT01192022|588093050|FG004|Overall Study|Fatal Adverse Event|1|||
162830413|NCT01192022|588093046|FG000|Overall Study|Physician withdrew-patient hardship|1|||
162830414|NCT01192022|588093047|FG001|Overall Study|Physician withdrew-patient hardship|0|||
162830415|NCT01192022|588093048|FG002|Overall Study|Physician withdrew-patient hardship|0|||
162830416|NCT01192022|588093049|FG003|Overall Study|Physician withdrew-patient hardship|0|||
162830417|NCT01192022|588093050|FG004|Overall Study|Physician withdrew-patient hardship|0|||
162830418|NCT01192022|588093046|FG000|Overall Study|Patient too sick from chemotherapy|0|||
162830419|NCT01192022|588093047|FG001|Overall Study|Patient too sick from chemotherapy|1|||
162830420|NCT01192022|588093048|FG002|Overall Study|Patient too sick from chemotherapy|0|||
162830421|NCT01192022|588093049|FG003|Overall Study|Patient too sick from chemotherapy|0|||
162830422|NCT01192022|588093050|FG004|Overall Study|Patient too sick from chemotherapy|0|||
162830423|NCT01192022|588093046|FG000|Overall Study|Patient needed surgery|0|||
162830424|NCT01192022|588093047|FG001|Overall Study|Patient needed surgery|1|||
162942024|NCT02178709|588491659|FG000|Overall Study|Adverse Event|5|||
162830425|NCT01192022|588093048|FG002|Overall Study|Patient needed surgery|0|||
162830426|NCT01192022|588093049|FG003|Overall Study|Patient needed surgery|0|||
162830427|NCT01192022|588093050|FG004|Overall Study|Patient needed surgery|0|||
162830428|NCT01192022|588093046|FG000|Overall Study|Parents did not allow all follow up|0|||
162830429|NCT01192022|588093047|FG001|Overall Study|Parents did not allow all follow up|0|||
162830430|NCT01192022|588093048|FG002|Overall Study|Parents did not allow all follow up|0|||
162830431|NCT01192022|588093049|FG003|Overall Study|Parents did not allow all follow up|1|||
162830432|NCT01192022|588093050|FG004|Overall Study|Parents did not allow all follow up|0|||
162830433|NCT01351389|588093051|FG000|Overall Study|Withdrawal by Subject|7|||
162830434|NCT01351389|588093052|FG001|Overall Study|Withdrawal by Subject|0|||
162830435|NCT01351389|588093051|FG000|Overall Study|did not complete intervention|23|||
162830436|NCT01351389|588093052|FG001|Overall Study|did not complete intervention|15|||
162830437|NCT04839978|588093053|FG000|Overall Study|Lost to Follow-up|135|||
162830438|NCT04839978|588093054|FG001|Overall Study|Lost to Follow-up|147|||
162830439|NCT03551509|588093059|FG000|Overall Study|Lost to Follow-up|0|||
162830440|NCT03551509|588093060|FG001|Overall Study|Lost to Follow-up|1|||
162830441|NCT03551509|588093061|FG002|Overall Study|Lost to Follow-up|0|||
162830442|NCT01902966|588093062|FG000|Overall Study|Death|1|||
162830443|NCT01902966|588093062|FG000|Overall Study|Physician Decision|1|||
162830444|NCT01902966|588093062|FG000|Overall Study|Withdrawal by Subject|1|||
162830445|NCT01549275|588093063|FG000|Overall Study|Lost to Follow-up|1|||
162830446|NCT01549275|588093064|FG001|Overall Study|Lost to Follow-up|0|||
162830447|NCT00122681|588093065|FG000|Overall Study|Adverse Event|20|||
162830448|NCT00122681|588093066|FG001|Overall Study|Adverse Event|16|||
162942025|NCT02178709|588491659|FG000|Overall Study|Death|2|||
162942026|NCT02178709|588491659|FG000|Overall Study|Withdrawal by Subject|2|||
162942027|NCT02178709|588491659|FG000|Overall Study|Physician Decision|2|||
162942028|NCT02178709|588491659|FG000|Overall Study|Disease Progression|5|||
162942029|NCT02192905|588491662|FG000|Overall Study|Lost to Follow-up|1|||
162942030|NCT05218655|588491663|FG000|Overall Study|Adverse Event|6|||
162942031|NCT05218655|588491663|FG000|Overall Study|Sponsor's decision|85|||
162942032|NCT05218655|588491663|FG000|Overall Study|Death|1|||
162942033|NCT05218655|588491663|FG000|Overall Study|Lost to Follow-up|3|||
162942034|NCT05218655|588491663|FG000|Overall Study|Withdrawal by Subject|3|||
162942035|NCT05218655|588491663|FG000|Overall Study|Other than specified|3|||
162942036|NCT02228382|588491664|FG000|Overall Study|Death|5|||
162942037|NCT02228382|588491665|FG001|Overall Study|Death|7|||
162942038|NCT02228382|588491666|FG002|Overall Study|Death|5|||
162830449|NCT00122681|588093065|FG000|Overall Study|Lost to Follow-up|1080|||
162830450|NCT00122681|588093066|FG001|Overall Study|Lost to Follow-up|1097|||
162830451|NCT00122681|588093065|FG000|Overall Study|Protocol Violation|7|||
162830452|NCT00122681|588093066|FG001|Overall Study|Protocol Violation|10|||
162830453|NCT00122681|588093065|FG000|Overall Study|Withdrawal by Subject|257|||
162830454|NCT00122681|588093066|FG001|Overall Study|Withdrawal by Subject|251|||
162830455|NCT00122681|588093065|FG000|Overall Study|Personal reasons|150|||
162830456|NCT00122681|588093066|FG001|Overall Study|Personal reasons|147|||
162830457|NCT00783094|588093073|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
162830458|NCT00783094|588093074|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
162830459|NCT00783094|588093075|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
162830460|NCT00783094|588093073|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
162830461|NCT00783094|588093074|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
162830462|NCT00783094|588093075|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
162830463|NCT00783094|588093073|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
162830464|NCT00783094|588093074|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
162830465|NCT00783094|588093075|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
162830466|NCT00783094|588093073|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
162830467|NCT00783094|588093074|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
162942039|NCT02228382|588491667|FG003|Overall Study|Death|0|||
162942040|NCT02228382|588491668|FG004|Overall Study|Death|2|||
162942041|NCT02228382|588491664|FG000|Overall Study|Participant refused further follow-up|0|||
162830468|NCT00783094|588093075|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
162830469|NCT00783094|588093073|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
162830470|NCT00783094|588093074|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
162830471|NCT00783094|588093075|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
162830472|NCT00783094|588093073|FG000|Open-Label Extension Period|Adverse Event|12|||
162830473|NCT00783094|588093074|FG001|Open-Label Extension Period|Adverse Event|7|||
162942042|NCT02228382|588491665|FG001|Overall Study|Participant refused further follow-up|0|||
162942043|NCT02228382|588491666|FG002|Overall Study|Participant refused further follow-up|1|||
162942044|NCT02228382|588491667|FG003|Overall Study|Participant refused further follow-up|0|||
162942045|NCT02228382|588491668|FG004|Overall Study|Participant refused further follow-up|0|||
162942046|NCT02228382|588491664|FG000|Overall Study|Study terminated by sponsor|3|||
162942047|NCT02228382|588491665|FG001|Overall Study|Study terminated by sponsor|5|||
162942048|NCT02228382|588491666|FG002|Overall Study|Study terminated by sponsor|7|||
162942049|NCT02228382|588491667|FG003|Overall Study|Study terminated by sponsor|0|||
162830474|NCT00783094|588093075|FG002|Open-Label Extension Period|Adverse Event|16|||
162830475|NCT00783094|588093073|FG000|Open-Label Extension Period|Death|0|||
162830476|NCT00783094|588093074|FG001|Open-Label Extension Period|Death|0|||
162830477|NCT00783094|588093075|FG002|Open-Label Extension Period|Death|1|||
162830478|NCT00783094|588093073|FG000|Open-Label Extension Period|Protocol Violation|4|||
162830479|NCT00783094|588093074|FG001|Open-Label Extension Period|Protocol Violation|5|||
162830480|NCT00783094|588093075|FG002|Open-Label Extension Period|Protocol Violation|7|||
162830481|NCT00783094|588093073|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
162830482|NCT00783094|588093074|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
162830483|NCT00783094|588093075|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
162830484|NCT00783094|588093073|FG000|Open-Label Extension Period|Physician Decision|4|||
162942050|NCT02228382|588491668|FG004|Overall Study|Study terminated by sponsor|0|||
162942051|NCT02228382|588491664|FG000|Overall Study|Lost to Follow-up|0|||
162942052|NCT02228382|588491665|FG001|Overall Study|Lost to Follow-up|0|||
162942053|NCT02228382|588491666|FG002|Overall Study|Lost to Follow-up|3|||
162942054|NCT02228382|588491667|FG003|Overall Study|Lost to Follow-up|1|||
162942055|NCT02228382|588491668|FG004|Overall Study|Lost to Follow-up|0|||
162942056|NCT02228382|588491664|FG000|Overall Study|Withdrawal by Subject|0|||
162942057|NCT02228382|588491665|FG001|Overall Study|Withdrawal by Subject|3|||
162942058|NCT02228382|588491666|FG002|Overall Study|Withdrawal by Subject|2|||
162942059|NCT02228382|588491667|FG003|Overall Study|Withdrawal by Subject|1|||
162942060|NCT02228382|588491668|FG004|Overall Study|Withdrawal by Subject|0|||
162942061|NCT02228382|588491664|FG000|Overall Study|Other|2|||
162942062|NCT02228382|588491665|FG001|Overall Study|Other|3|||
162942063|NCT02228382|588491666|FG002|Overall Study|Other|3|||
162942064|NCT02228382|588491667|FG003|Overall Study|Other|0|||
162942065|NCT02228382|588491668|FG004|Overall Study|Other|0|||
162942066|NCT02396381|588491670|FG000|Overall Study|Adverse Event|3|||
162942067|NCT02396381|588491671|FG001|Overall Study|Adverse Event|2|||
162942068|NCT02396381|588491670|FG000|Overall Study|Withdrawal by Subject|33|||
162942069|NCT02396381|588491671|FG001|Overall Study|Withdrawal by Subject|24|||
162942070|NCT02396381|588491670|FG000|Overall Study|Lost to Follow-up|49|||
162942071|NCT02396381|588491671|FG001|Overall Study|Lost to Follow-up|31|||
162942072|NCT02396381|588491670|FG000|Overall Study|Protocol Violation|1|||
162942073|NCT02396381|588491671|FG001|Overall Study|Protocol Violation|0|||
162942074|NCT02396381|588491670|FG000|Overall Study|Site terminated by sponsor|7|||
162942075|NCT02396381|588491671|FG001|Overall Study|Site terminated by sponsor|8|||
162942076|NCT02396381|588491670|FG000|Overall Study|Physician Decision|5|||
162942077|NCT02396381|588491671|FG001|Overall Study|Physician Decision|5|||
162942078|NCT02396381|588491670|FG000|Overall Study|Pregnancy|2|||
162942079|NCT02396381|588491671|FG001|Overall Study|Pregnancy|0|||
162942080|NCT02396381|588491670|FG000|Overall Study|Non-compliance with study procedures|1|||
162942081|NCT02396381|588491671|FG001|Overall Study|Non-compliance with study procedures|0|||
162942082|NCT02396381|588491670|FG000|Overall Study|Moved out of town/state|1|||
162942083|NCT02396381|588491671|FG001|Overall Study|Moved out of town/state|3|||
162942084|NCT02396381|588491670|FG000|Overall Study|Could not complete visit|1|||
162942085|NCT02396381|588491671|FG001|Overall Study|Could not complete visit|0|||
162942086|NCT02396381|588491670|FG000|Overall Study|Possible conflict of interest|1|||
162942087|NCT02396381|588491671|FG001|Overall Study|Possible conflict of interest|0|||
162942088|NCT02396381|588491670|FG000|Overall Study|Randomization/Screening Error|3|||
162942089|NCT02396381|588491671|FG001|Overall Study|Randomization/Screening Error|1|||
162942090|NCT00275002|588491672|FG000|Overall Study|Death|1|||
162942091|NCT00275002|588491673|FG001|Overall Study|Death|0|||
162942092|NCT00275002|588491672|FG000|Overall Study|Disease progression|21|||
162942093|NCT00275002|588491673|FG001|Overall Study|Disease progression|15|||
162942094|NCT00275002|588491672|FG000|Overall Study|Adverse Event|0|||
162942095|NCT00275002|588491673|FG001|Overall Study|Adverse Event|1|||
162942096|NCT00113490|588491674|FG000|Overall Study|Withdrawal by Subject|1|||
162942097|NCT00113490|588491675|FG001|Overall Study|Withdrawal by Subject|3|||
162942098|NCT00113490|588491674|FG000|Overall Study|Lost to Follow-up|1|||
162942099|NCT00113490|588491675|FG001|Overall Study|Lost to Follow-up|0|||
162942100|NCT04652453|588491677|FG000|Overall Study|Death|8|||
162942101|NCT04652453|588491678|FG001|Overall Study|Death|2|||
162942102|NCT04652453|588491679|FG002|Overall Study|Death|0|||
162942103|NCT04652453|588491677|FG000|Overall Study|Hospice|5|||
162942104|NCT04652453|588491678|FG001|Overall Study|Hospice|5|||
162942105|NCT04652453|588491679|FG002|Overall Study|Hospice|0|||
162942106|NCT04652453|588491677|FG000|Overall Study|Withdrawal by Subject|2|||
162942107|NCT04652453|588491678|FG001|Overall Study|Withdrawal by Subject|0|||
162942108|NCT04652453|588491679|FG002|Overall Study|Withdrawal by Subject|0|||
162942109|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
162942110|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
162942111|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942112|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942113|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942114|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
162942115|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
162942116|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942117|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942118|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162698710|NCT00337662|587605555|FG002|Study Period III|Clinical Relapse|0|||
162942119|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942120|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942121|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942122|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162942123|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942124|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162830485|NCT00783094|588093074|FG001|Open-Label Extension Period|Physician Decision|2|||
162830486|NCT00783094|588093075|FG002|Open-Label Extension Period|Physician Decision|3|||
162830487|NCT00783094|588093073|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
162830488|NCT00783094|588093074|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
162830489|NCT00783094|588093075|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
162830490|NCT01324232|588093076|FG000|Overall Study|Protocol Violation|0|||
162830491|NCT01324232|588093077|FG001|Overall Study|Protocol Violation|0|||
162830492|NCT01324232|588093078|FG002|Overall Study|Protocol Violation|0|||
162830493|NCT01324232|588093079|FG003|Overall Study|Protocol Violation|2|||
162830494|NCT01324232|588093076|FG000|Overall Study|Missing|0|||
162830495|NCT01324232|588093077|FG001|Overall Study|Missing|0|||
162830496|NCT01324232|588093078|FG002|Overall Study|Missing|1|||
162830497|NCT01324232|588093079|FG003|Overall Study|Missing|0|||
162830498|NCT01324232|588093076|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
162830499|NCT01324232|588093077|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
162830500|NCT01324232|588093078|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
162830501|NCT01324232|588093079|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
162942125|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942126|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942127|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942128|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
162942129|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
162942130|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942131|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942132|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942133|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942134|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942135|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942136|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162942137|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
162942138|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942139|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942140|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942141|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942142|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942143|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
162942144|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942145|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942146|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162830502|NCT01324232|588093076|FG000|Overall Study|Lack of Efficacy|2|||
162830503|NCT01324232|588093077|FG001|Overall Study|Lack of Efficacy|1|||
162830504|NCT01324232|588093078|FG002|Overall Study|Lack of Efficacy|2|||
162830505|NCT01324232|588093079|FG003|Overall Study|Lack of Efficacy|2|||
162830506|NCT01324232|588093076|FG000|Overall Study|Participant Refused Medication|0|||
162830507|NCT01324232|588093077|FG001|Overall Study|Participant Refused Medication|1|||
162830508|NCT01324232|588093078|FG002|Overall Study|Participant Refused Medication|0|||
162830509|NCT01324232|588093079|FG003|Overall Study|Participant Refused Medication|0|||
162830510|NCT01324232|588093076|FG000|Overall Study|Intercurrent illness|0|||
162830511|NCT01324232|588093077|FG001|Overall Study|Intercurrent illness|0|||
162830512|NCT01324232|588093078|FG002|Overall Study|Intercurrent illness|0|||
162830513|NCT01324232|588093079|FG003|Overall Study|Intercurrent illness|1|||
162830514|NCT01324232|588093076|FG000|Overall Study|Adverse Event|2|||
162830515|NCT01324232|588093077|FG001|Overall Study|Adverse Event|5|||
162830516|NCT01324232|588093078|FG002|Overall Study|Adverse Event|6|||
162830517|NCT01324232|588093079|FG003|Overall Study|Adverse Event|6|||
162830518|NCT01324232|588093076|FG000|Overall Study|Withdrawal by Subject|0|||
162830519|NCT01324232|588093077|FG001|Overall Study|Withdrawal by Subject|3|||
162830520|NCT01324232|588093078|FG002|Overall Study|Withdrawal by Subject|4|||
162830521|NCT01324232|588093079|FG003|Overall Study|Withdrawal by Subject|0|||
162830522|NCT01324232|588093076|FG000|Overall Study|Lost to Follow-up|1|||
162830523|NCT01324232|588093077|FG001|Overall Study|Lost to Follow-up|0|||
162830524|NCT01324232|588093078|FG002|Overall Study|Lost to Follow-up|0|||
162830525|NCT01324232|588093079|FG003|Overall Study|Lost to Follow-up|0|||
162830526|NCT02513329|588093080|FG000|Overall Study|Lost to Follow-up|5|||
162830527|NCT02513329|588093081|FG001|Overall Study|Lost to Follow-up|2|||
162830528|NCT05440539|588093082|FG000|Overall Study|Lost to Follow-up|4|||
162830529|NCT05440539|588093083|FG001|Overall Study|Lost to Follow-up|4|||
162830530|NCT05440539|588093082|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
162830531|NCT05440539|588093083|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
162830532|NCT01265615|588093084|FG000|Overall Study|Protocol Violation|2|||
162830533|NCT01265615|588093085|FG001|Overall Study|Protocol Violation|2|||
162830534|NCT01265615|588093086|FG002|Overall Study|Protocol Violation|4|||
162830535|NCT01265615|588093087|FG003|Overall Study|Protocol Violation|3|||
162830536|NCT01732796|588093088|FG000|Overall Study|Adverse Event|16|||
162830537|NCT01732796|588093089|FG001|Overall Study|Adverse Event|16|||
162830538|NCT01732796|588093090|FG002|Overall Study|Adverse Event|4|||
162830539|NCT01732796|588093088|FG000|Overall Study|Lack of Efficacy|21|||
162830540|NCT01732796|588093089|FG001|Overall Study|Lack of Efficacy|18|||
162830541|NCT01732796|588093090|FG002|Overall Study|Lack of Efficacy|5|||
162830542|NCT01732796|588093088|FG000|Overall Study|Lost to Follow-up|2|||
162830543|NCT01732796|588093089|FG001|Overall Study|Lost to Follow-up|0|||
162830544|NCT01732796|588093090|FG002|Overall Study|Lost to Follow-up|0|||
162830545|NCT01732796|588093088|FG000|Overall Study|Withdrawal by Subject|6|||
162830546|NCT01732796|588093089|FG001|Overall Study|Withdrawal by Subject|8|||
162830547|NCT01732796|588093090|FG002|Overall Study|Withdrawal by Subject|2|||
162830548|NCT01732796|588093088|FG000|Overall Study|Other reason not defined above|1|||
162830549|NCT01732796|588093089|FG001|Overall Study|Other reason not defined above|0|||
162830550|NCT01732796|588093090|FG002|Overall Study|Other reason not defined above|2|||
162830551|NCT02004262|588093100|FG000|Overall Study|Death|67|||
162830552|NCT02004262|588093101|FG001|Overall Study|Death|64|||
162830553|NCT02004262|588093102|FG002|Overall Study|Death|66|||
162830554|NCT02004262|588093103|FG003|Overall Study|Death|28|||
162830555|NCT02004262|588093104|FG004|Overall Study|Death|29|||
162830556|NCT02004262|588093105|FG005|Overall Study|Death|22|||
162830557|NCT02004262|588093100|FG000|Overall Study|Withdrawal by Subject|1|||
162830558|NCT02004262|588093101|FG001|Overall Study|Withdrawal by Subject|0|||
162830559|NCT02004262|588093102|FG002|Overall Study|Withdrawal by Subject|4|||
162830560|NCT02004262|588093103|FG003|Overall Study|Withdrawal by Subject|0|||
162830561|NCT02004262|588093104|FG004|Overall Study|Withdrawal by Subject|1|||
162830562|NCT02004262|588093105|FG005|Overall Study|Withdrawal by Subject|3|||
162830563|NCT02004262|588093100|FG000|Overall Study|Lost to Follow-up|1|||
162830564|NCT02004262|588093101|FG001|Overall Study|Lost to Follow-up|1|||
162830565|NCT02004262|588093102|FG002|Overall Study|Lost to Follow-up|0|||
162830566|NCT02004262|588093103|FG003|Overall Study|Lost to Follow-up|0|||
162830567|NCT02004262|588093104|FG004|Overall Study|Lost to Follow-up|0|||
162830568|NCT02004262|588093105|FG005|Overall Study|Lost to Follow-up|0|||
162830569|NCT02004262|588093100|FG000|Overall Study|Study Terminated by Sponsor|4|||
162830570|NCT02004262|588093101|FG001|Overall Study|Study Terminated by Sponsor|3|||
162830571|NCT02004262|588093102|FG002|Overall Study|Study Terminated by Sponsor|2|||
162830572|NCT02004262|588093103|FG003|Overall Study|Study Terminated by Sponsor|1|||
162830573|NCT02004262|588093104|FG004|Overall Study|Study Terminated by Sponsor|1|||
162830574|NCT02004262|588093105|FG005|Overall Study|Study Terminated by Sponsor|5|||
162830575|NCT03703102|588093106|FG000|Overall Study|Adverse Event|4|||
162830576|NCT03703102|588093107|FG001|Overall Study|Adverse Event|3|||
162830577|NCT03703102|588093108|FG002|Overall Study|Adverse Event|7|||
162830578|NCT03703102|588093109|FG003|Overall Study|Adverse Event|3|||
162830579|NCT03703102|588093110|FG004|Overall Study|Adverse Event|13|||
162830580|NCT03703102|588093106|FG000|Overall Study|Lack of Efficacy|4|||
162830581|NCT03703102|588093107|FG001|Overall Study|Lack of Efficacy|0|||
162830582|NCT03703102|588093108|FG002|Overall Study|Lack of Efficacy|1|||
162830583|NCT03703102|588093109|FG003|Overall Study|Lack of Efficacy|4|||
162830584|NCT03703102|588093110|FG004|Overall Study|Lack of Efficacy|1|||
162830585|NCT03703102|588093106|FG000|Overall Study|Lost to Follow-up|0|||
162830586|NCT03703102|588093107|FG001|Overall Study|Lost to Follow-up|0|||
162830587|NCT03703102|588093108|FG002|Overall Study|Lost to Follow-up|1|||
162830588|NCT03703102|588093109|FG003|Overall Study|Lost to Follow-up|2|||
162830589|NCT03703102|588093110|FG004|Overall Study|Lost to Follow-up|2|||
162830590|NCT03703102|588093106|FG000|Overall Study|Physician Decision|2|||
162830591|NCT03703102|588093107|FG001|Overall Study|Physician Decision|2|||
162830592|NCT03703102|588093108|FG002|Overall Study|Physician Decision|2|||
162830593|NCT03703102|588093109|FG003|Overall Study|Physician Decision|2|||
162830594|NCT03703102|588093110|FG004|Overall Study|Physician Decision|4|||
162830595|NCT03703102|588093106|FG000|Overall Study|Withdrawal by Subject|7|||
162830596|NCT03703102|588093107|FG001|Overall Study|Withdrawal by Subject|5|||
162830597|NCT03703102|588093108|FG002|Overall Study|Withdrawal by Subject|5|||
162830598|NCT03703102|588093109|FG003|Overall Study|Withdrawal by Subject|5|||
162830599|NCT03703102|588093110|FG004|Overall Study|Withdrawal by Subject|9|||
162830600|NCT03703102|588093106|FG000|Overall Study|Ineligibility|0|||
162830601|NCT03703102|588093107|FG001|Overall Study|Ineligibility|0|||
162830602|NCT03703102|588093108|FG002|Overall Study|Ineligibility|1|||
162830603|NCT03703102|588093109|FG003|Overall Study|Ineligibility|0|||
162830604|NCT03703102|588093110|FG004|Overall Study|Ineligibility|0|||
162830605|NCT03703102|588093106|FG000|Overall Study|Protocol Deviation|4|||
162830606|NCT03703102|588093107|FG001|Overall Study|Protocol Deviation|4|||
162830607|NCT03703102|588093108|FG002|Overall Study|Protocol Deviation|3|||
162830608|NCT03703102|588093109|FG003|Overall Study|Protocol Deviation|0|||
162830609|NCT03703102|588093110|FG004|Overall Study|Protocol Deviation|0|||
162830610|NCT03703102|588093106|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162830611|NCT03703102|588093107|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162830612|NCT03703102|588093108|FG002|Overall Study|Non-Compliance with Study Drug|2|||
162830613|NCT03703102|588093109|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162830614|NCT03703102|588093110|FG004|Overall Study|Non-Compliance with Study Drug|4|||
162830615|NCT00876187|588093111|FG000|Overall Study|Adverse Event|14|||
162830616|NCT00876187|588093112|FG001|Overall Study|Adverse Event|12|||
162830617|NCT00876187|588093113|FG002|Overall Study|Adverse Event|19|||
162830618|NCT00876187|588093114|FG003|Overall Study|Adverse Event|29|||
162830619|NCT00876187|588093115|FG004|Overall Study|Adverse Event|10|||
162830620|NCT00876187|588093111|FG000|Overall Study|Lack of Efficacy|59|||
162830621|NCT00876187|588093112|FG001|Overall Study|Lack of Efficacy|34|||
162830622|NCT00876187|588093113|FG002|Overall Study|Lack of Efficacy|45|||
162830623|NCT00876187|588093114|FG003|Overall Study|Lack of Efficacy|34|||
162830624|NCT00876187|588093115|FG004|Overall Study|Lack of Efficacy|59|||
162830625|NCT00876187|588093111|FG000|Overall Study|Lost to Follow-up|9|||
162830626|NCT00876187|588093112|FG001|Overall Study|Lost to Follow-up|10|||
162830627|NCT00876187|588093113|FG002|Overall Study|Lost to Follow-up|8|||
162830628|NCT00876187|588093114|FG003|Overall Study|Lost to Follow-up|8|||
162830629|NCT00876187|588093115|FG004|Overall Study|Lost to Follow-up|11|||
162830630|NCT00876187|588093111|FG000|Overall Study|Protocol Violation|6|||
162830631|NCT00876187|588093112|FG001|Overall Study|Protocol Violation|7|||
162830632|NCT00876187|588093113|FG002|Overall Study|Protocol Violation|7|||
162830633|NCT00876187|588093114|FG003|Overall Study|Protocol Violation|6|||
162830634|NCT00876187|588093115|FG004|Overall Study|Protocol Violation|3|||
162830635|NCT00876187|588093111|FG000|Overall Study|Withdrawal by Subject|16|||
162830636|NCT00876187|588093112|FG001|Overall Study|Withdrawal by Subject|26|||
162830637|NCT00876187|588093113|FG002|Overall Study|Withdrawal by Subject|32|||
162942147|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162830638|NCT00876187|588093114|FG003|Overall Study|Withdrawal by Subject|38|||
162830639|NCT00876187|588093115|FG004|Overall Study|Withdrawal by Subject|37|||
162830640|NCT00876187|588093111|FG000|Overall Study|Entered extension study|101|||
162830641|NCT00876187|588093112|FG001|Overall Study|Entered extension study|120|||
162830642|NCT00876187|588093113|FG002|Overall Study|Entered extension study|156|||
162830643|NCT00876187|588093114|FG003|Overall Study|Entered extension study|151|||
162830644|NCT00876187|588093115|FG004|Overall Study|Entered extension study|144|||
162830645|NCT00876187|588093111|FG000|Overall Study|Randomized but not treated|3|||
162830646|NCT00876187|588093112|FG001|Overall Study|Randomized but not treated|1|||
162830647|NCT00876187|588093113|FG002|Overall Study|Randomized but not treated|3|||
162830648|NCT00876187|588093114|FG003|Overall Study|Randomized but not treated|2|||
162830649|NCT00876187|588093115|FG004|Overall Study|Randomized but not treated|3|||
162830650|NCT00876187|588093111|FG000|Overall Study|Other|2|||
162830651|NCT00876187|588093112|FG001|Overall Study|Other|5|||
162830652|NCT00876187|588093113|FG002|Overall Study|Other|9|||
162830653|NCT00876187|588093114|FG003|Overall Study|Other|7|||
162830654|NCT00876187|588093115|FG004|Overall Study|Other|4|||
162830655|NCT03571646|588093120|FG000|Overall Study|Adverse Event|1|||
162830656|NCT03571646|588093121|FG001|Overall Study|Adverse Event|0|||
162830657|NCT03571646|588093120|FG000|Overall Study|Withdrawal by Subject|1|||
162830658|NCT03571646|588093121|FG001|Overall Study|Withdrawal by Subject|1|||
162830659|NCT03972969|588093122|FG000|3-month Follow-up|Death|1|||
162830660|NCT03972969|588093123|FG001|3-month Follow-up|Death|1|||
162830661|NCT03972969|588093124|FG002|3-month Follow-up|Death|0|||
162830662|NCT03972969|588093122|FG000|6-month Follow-up|Death|1|||
162830663|NCT03972969|588093123|FG001|6-month Follow-up|Death|1|||
162830664|NCT03972969|588093124|FG002|6-month Follow-up|Death|1|||
162830665|NCT03972969|588093122|FG000|6-month Follow-up|Lost to Follow-up|2|||
162830666|NCT03972969|588093123|FG001|6-month Follow-up|Lost to Follow-up|2|||
162830667|NCT03972969|588093124|FG002|6-month Follow-up|Lost to Follow-up|2|||
162830668|NCT00283595|588093125|FG000|Overall Study|Withdrawal by Subject|1|||
162830669|NCT00283595|588093126|FG001|Overall Study|Withdrawal by Subject|2|||
162830670|NCT04718974|588093130|FG000|Overall Study|Death|0|||
162830671|NCT04718974|588093131|FG001|Overall Study|Death|2|||
162830672|NCT04718974|588093130|FG000|Overall Study|Lost to Follow-up|10|||
162830673|NCT04718974|588093131|FG001|Overall Study|Lost to Follow-up|20|||
162830674|NCT04718974|588093130|FG000|Overall Study|Transferred out|2|||
162830675|NCT04718974|588093131|FG001|Overall Study|Transferred out|4|||
162830676|NCT00845728|588093132|FG000|Overall Study|Abnormal laboratory value (s)|2|||
162830677|NCT00845728|588093133|FG001|Overall Study|Abnormal laboratory value (s)|2|||
162830678|NCT00845728|588093132|FG000|Overall Study|Patient's inability to use the device|4|||
162830679|NCT00845728|588093133|FG001|Overall Study|Patient's inability to use the device|6|||
162830680|NCT00845728|588093132|FG000|Overall Study|Abnormal test procedure result (s)|7|||
162830681|NCT00845728|588093133|FG001|Overall Study|Abnormal test procedure result (s)|2|||
162830682|NCT00845728|588093132|FG000|Overall Study|Lost to Follow-up|22|||
162830683|NCT00845728|588093133|FG001|Overall Study|Lost to Follow-up|13|||
162830684|NCT00845728|588093132|FG000|Overall Study|Death|24|||
162830685|NCT00845728|588093133|FG001|Overall Study|Death|26|||
162830686|NCT00845728|588093132|FG000|Overall Study|Administrative Problems|34|||
162830687|NCT00845728|588093133|FG001|Overall Study|Administrative Problems|26|||
162830688|NCT00845728|588093132|FG000|Overall Study|Protocol Violation|36|||
162830689|NCT00845728|588093133|FG001|Overall Study|Protocol Violation|24|||
162830690|NCT00845728|588093132|FG000|Overall Study|Lack of Efficacy|51|||
162830691|NCT00845728|588093133|FG001|Overall Study|Lack of Efficacy|39|||
162830692|NCT00845728|588093132|FG000|Overall Study|Adverse Event|101|||
162830693|NCT00845728|588093133|FG001|Overall Study|Adverse Event|96|||
162830694|NCT00845728|588093132|FG000|Overall Study|Withdrawal by Subject|105|||
162830695|NCT00845728|588093133|FG001|Overall Study|Withdrawal by Subject|108|||
162830696|NCT03259074|588093134|FG000|Overall Study|Adverse Event|9|||
162830697|NCT03259074|588093135|FG001|Overall Study|Adverse Event|12|||
162830698|NCT03259074|588093136|FG002|Overall Study|Adverse Event|8|||
162830699|NCT03259074|588093134|FG000|Overall Study|Death|1|||
162830700|NCT03259074|588093135|FG001|Overall Study|Death|1|||
162830701|NCT03259074|588093136|FG002|Overall Study|Death|3|||
162830702|NCT03259074|588093134|FG000|Overall Study|Lost to Follow-up|2|||
162830703|NCT03259074|588093135|FG001|Overall Study|Lost to Follow-up|4|||
162830704|NCT03259074|588093136|FG002|Overall Study|Lost to Follow-up|3|||
162830705|NCT03259074|588093134|FG000|Overall Study|New Therapy For Study Indication|1|||
162830706|NCT03259074|588093135|FG001|Overall Study|New Therapy For Study Indication|2|||
162830707|NCT03259074|588093136|FG002|Overall Study|New Therapy For Study Indication|2|||
162830708|NCT03259074|588093134|FG000|Overall Study|Physician Decision|4|||
162830709|NCT03259074|588093135|FG001|Overall Study|Physician Decision|12|||
162830710|NCT03259074|588093136|FG002|Overall Study|Physician Decision|10|||
162830711|NCT03259074|588093134|FG000|Overall Study|Pregnancy|1|||
162830712|NCT03259074|588093135|FG001|Overall Study|Pregnancy|1|||
162830713|NCT03259074|588093136|FG002|Overall Study|Pregnancy|0|||
162830714|NCT03259074|588093134|FG000|Overall Study|Progressive Disease|1|||
162830715|NCT03259074|588093135|FG001|Overall Study|Progressive Disease|0|||
162830716|NCT03259074|588093136|FG002|Overall Study|Progressive Disease|0|||
162830717|NCT03259074|588093134|FG000|Overall Study|Protocol Deviation|1|||
162830718|NCT03259074|588093135|FG001|Overall Study|Protocol Deviation|1|||
162830719|NCT03259074|588093136|FG002|Overall Study|Protocol Deviation|3|||
162830720|NCT03259074|588093134|FG000|Overall Study|Subject/Guardian Decision|13|||
162830721|NCT03259074|588093135|FG001|Overall Study|Subject/Guardian Decision|16|||
162830722|NCT03259074|588093136|FG002|Overall Study|Subject/Guardian Decision|14|||
162830723|NCT00705783|588093137|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
162830724|NCT00705783|588093138|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
162830725|NCT00705783|588093139|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
162830726|NCT00705783|588093137|FG000|Conversion Phase|Lost to Follow-up|13|||
162830727|NCT00705783|588093138|FG001|Conversion Phase|Lost to Follow-up|0|||
162830728|NCT00705783|588093139|FG002|Conversion Phase|Lost to Follow-up|0|||
162830729|NCT00705783|588093137|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
162830730|NCT00705783|588093138|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
162830731|NCT00705783|588093139|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
162830732|NCT00705783|588093137|FG000|Conversion Phase|Withdrawn by Investigator|4|||
162830733|NCT00705783|588093138|FG001|Conversion Phase|Withdrawn by Investigator|0|||
162830734|NCT00705783|588093139|FG002|Conversion Phase|Withdrawn by Investigator|0|||
162830735|NCT00705783|588093137|FG000|Conversion Phase|Withdrew Consent|24|||
162830736|NCT00705783|588093138|FG001|Conversion Phase|Withdrew Consent|0|||
162830737|NCT00705783|588093139|FG002|Conversion Phase|Withdrew Consent|0|||
162830738|NCT00705783|588093137|FG000|Conversion Phase|Protocol Deviation|2|||
162830739|NCT00705783|588093138|FG001|Conversion Phase|Protocol Deviation|0|||
162830740|NCT00705783|588093139|FG002|Conversion Phase|Protocol Deviation|0|||
162830741|NCT00705783|588093137|FG000|Conversion Phase|Adverse Event|11|||
162830742|NCT00705783|588093138|FG001|Conversion Phase|Adverse Event|0|||
162830743|NCT00705783|588093139|FG002|Conversion Phase|Adverse Event|0|||
162830744|NCT00705783|588093137|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
162830745|NCT00705783|588093138|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162830746|NCT00705783|588093139|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162830747|NCT00705783|588093137|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
162830748|NCT00705783|588093138|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162830749|NCT00705783|588093139|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162830750|NCT00705783|588093137|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
162830751|NCT00705783|588093138|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
162830752|NCT00705783|588093139|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
162830753|NCT00705783|588093137|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
162830754|NCT00705783|588093138|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
162830755|NCT00705783|588093139|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
162830756|NCT00705783|588093137|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
162830757|NCT00705783|588093138|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162830758|NCT00705783|588093139|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162830759|NCT00705783|588093137|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
162830760|NCT00705783|588093138|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162830761|NCT00705783|588093139|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162830762|NCT00705783|588093137|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
162830763|NCT00705783|588093138|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
162830764|NCT00705783|588093139|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
162830765|NCT00705783|588093137|FG000|Oral Stabilization Phase|Adverse Event|14|||
162830766|NCT00705783|588093138|FG001|Oral Stabilization Phase|Adverse Event|0|||
162830767|NCT00705783|588093139|FG002|Oral Stabilization Phase|Adverse Event|0|||
162830768|NCT00705783|588093137|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
162830769|NCT00705783|588093138|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162830770|NCT00705783|588093139|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162830771|NCT00705783|588093137|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
162830772|NCT00705783|588093138|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162830773|NCT00705783|588093139|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162830774|NCT00705783|588093137|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
162830775|NCT00705783|588093138|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
162830776|NCT00705783|588093139|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
162830777|NCT00705783|588093137|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
162830778|NCT00705783|588093138|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
162942148|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942149|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942150|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
162942151|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942152|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942153|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942154|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942155|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942156|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
162942157|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
162942158|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942159|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942160|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942161|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942162|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162698711|NCT00337662|587605556|FG003|Study Period III|Clinical Relapse|0|||
162942163|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
163042850|NCT01066871|588863974|FG000|Overall Study|Lack of Efficacy|0|||
162830779|NCT00705783|588093139|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
162830780|NCT00705783|588093137|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
162830781|NCT00705783|588093138|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
162830782|NCT00705783|588093139|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
162830783|NCT00705783|588093137|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
162830784|NCT00705783|588093138|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
162830785|NCT00705783|588093139|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
162830786|NCT00705783|588093137|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
162830787|NCT00705783|588093138|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
162830788|NCT00705783|588093139|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
162830789|NCT00705783|588093137|FG000|Depot Stabilization Phase|Adverse Event|17|||
162830790|NCT00705783|588093138|FG001|Depot Stabilization Phase|Adverse Event|0|||
162830791|NCT00705783|588093139|FG002|Depot Stabilization Phase|Adverse Event|0|||
162942164|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
162942165|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942166|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942167|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942168|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942169|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942170|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942171|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
162942172|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942173|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942174|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942175|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942176|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942177|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942178|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162942179|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942180|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942181|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
162942182|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942183|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942184|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
162942185|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
162830792|NCT00705783|588093137|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
162830793|NCT00705783|588093138|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162830794|NCT00705783|588093139|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162830795|NCT00705783|588093137|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
162830796|NCT00705783|588093138|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162830797|NCT00705783|588093139|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162830798|NCT00705783|588093137|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
162830799|NCT00705783|588093138|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
162830800|NCT00705783|588093139|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
162830801|NCT00705783|588093137|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
162830802|NCT00705783|588093138|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
162830803|NCT00705783|588093139|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
162830804|NCT00705783|588093137|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
162830805|NCT00705783|588093138|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
162830806|NCT00705783|588093139|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
162830807|NCT00705783|588093137|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
162830808|NCT00705783|588093138|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
162830809|NCT00705783|588093139|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
162830810|NCT00705783|588093137|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
162830811|NCT00705783|588093138|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
162830812|NCT00705783|588093139|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
162830813|NCT00705783|588093137|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
162830814|NCT00705783|588093138|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
162942186|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162830815|NCT00705783|588093139|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
162830816|NCT00705783|588093137|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
162942187|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162830817|NCT00705783|588093138|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
162942188|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942189|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942190|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942191|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942192|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162942193|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942194|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
162942195|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942196|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942197|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942198|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
162942199|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942200|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942201|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942202|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942203|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942204|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942205|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942206|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162942207|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
162942208|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942209|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942210|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942211|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942212|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
162942213|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942214|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942215|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942216|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942217|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942218|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942219|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942220|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
162942221|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942222|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942223|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942224|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
162942225|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
162942226|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942227|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942228|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
162942229|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
162942230|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942231|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942232|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942233|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942234|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
162942235|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942236|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942237|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942238|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942239|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942240|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942241|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942242|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
162942243|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
162942244|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942245|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942246|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942247|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942248|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162942249|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942250|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942251|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942252|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942253|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942254|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942255|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942256|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942257|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
162942258|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942259|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942260|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942261|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942262|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
162942263|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942264|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162698712|NCT00882921|587605557|FG000|Overall Study|Death|2|||
162942265|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942266|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
162942267|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942268|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942269|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942270|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942271|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942272|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942273|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942274|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942275|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942276|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
162942277|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942278|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942279|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942280|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942281|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942282|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942283|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942284|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
162942285|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
162942286|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942287|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942288|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942289|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942290|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162942291|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942292|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942293|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942294|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942295|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942296|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942297|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942298|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
162942299|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942300|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942301|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942302|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942303|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942304|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
162942305|NCT04033445|588491681|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942306|NCT04033445|588491682|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942307|NCT04033445|588491683|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942308|NCT04033445|588491684|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942309|NCT04033445|588491685|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942310|NCT04033445|588491686|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942311|NCT04033445|588491687|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942312|NCT04033445|588491688|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
162942313|NCT04033445|588491689|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942314|NCT04033445|588491690|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942315|NCT04033445|588491691|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942316|NCT04033445|588491692|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942317|NCT04033445|588491693|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942318|NCT04033445|588491694|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
162942319|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942320|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942321|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942322|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942323|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942324|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162830818|NCT00705783|588093139|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
162830819|NCT00705783|588093137|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
162830820|NCT00705783|588093138|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
162830821|NCT00705783|588093139|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
162830822|NCT00705783|588093137|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
162830823|NCT00705783|588093138|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
162830824|NCT00705783|588093139|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
162830825|NCT02182687|588093140|FG000|Overall Study|Withdrawal by Subject|4|||
162830826|NCT02182687|588093141|FG001|Overall Study|Withdrawal by Subject|0|||
162830827|NCT02182687|588093140|FG000|Overall Study|Adverse Event|1|||
162830828|NCT02182687|588093141|FG001|Overall Study|Adverse Event|0|||
162830829|NCT02182687|588093140|FG000|Overall Study|Lost to Follow-up|0|||
162830830|NCT02182687|588093141|FG001|Overall Study|Lost to Follow-up|1|||
162830831|NCT02025907|588093148|FG000|Overall Study|Lack of Efficacy|1|||
162830832|NCT02025907|588093149|FG001|Overall Study|Lack of Efficacy|0|||
162830833|NCT02025907|588093148|FG000|Overall Study|Withdrawal by Subject|15|||
162830834|NCT02025907|588093149|FG001|Overall Study|Withdrawal by Subject|8|||
162830835|NCT02025907|588093148|FG000|Overall Study|Protocol Violation|2|||
162830836|NCT02025907|588093149|FG001|Overall Study|Protocol Violation|0|||
162830837|NCT02025907|588093148|FG000|Overall Study|Physician Decision|2|||
162830838|NCT02025907|588093149|FG001|Overall Study|Physician Decision|0|||
162830839|NCT02025907|588093148|FG000|Overall Study|Lost to Follow-up|2|||
162830840|NCT02025907|588093149|FG001|Overall Study|Lost to Follow-up|2|||
162830841|NCT02025907|588093148|FG000|Overall Study|Adverse Event|3|||
162830842|NCT02025907|588093149|FG001|Overall Study|Adverse Event|1|||
162830843|NCT02025907|588093148|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
162830844|NCT02025907|588093149|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
162830845|NCT02411539|588093150|FG000|Overall Study|Lost to Follow-up|2|||
162830846|NCT02411539|588093151|FG001|Overall Study|Lost to Follow-up|0|||
162830847|NCT02411539|588093150|FG000|Overall Study|Confounding medical condition|0|||
162830848|NCT02411539|588093151|FG001|Overall Study|Confounding medical condition|1|||
162830849|NCT01422915|588093152|FG000|Overall Study|Adverse Event|1|||
162830850|NCT03631732|588093155|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
162830851|NCT03631732|588093156|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
162830852|NCT03631732|588093155|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
162942325|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942326|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942327|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162942328|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
162942329|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
162942330|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
162942331|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
162942332|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
162698713|NCT00882921|587605557|FG000|Overall Study|Other|3|||
162698714|NCT00882921|587605557|FG000|Overall Study|Lost to Follow-up|2|||
162698715|NCT00882921|587605557|FG000|Overall Study|Termination By Investigator|3|||
162698716|NCT00882921|587605557|FG000|Overall Study|Withdrawal Of Consent|1|||
162698717|NCT03391960|587605569|FG000|Overall Study|Protocol Violation|0|||
162698718|NCT03391960|587605570|FG001|Overall Study|Protocol Violation|0|||
162698719|NCT03390036|587606828|FG000|Overall Study|Lost to Follow-up|1|||
162698720|NCT03390036|587606829|FG001|Overall Study|Lost to Follow-up|0|||
162698721|NCT03390036|587606830|FG002|Overall Study|Lost to Follow-up|0|||
162698722|NCT03390036|587606828|FG000|Overall Study|Lack of Efficacy|1|||
162698723|NCT03390036|587606829|FG001|Overall Study|Lack of Efficacy|0|||
162698724|NCT03390036|587606830|FG002|Overall Study|Lack of Efficacy|0|||
162698725|NCT01681368|587606833|FG000|Overall Study|Refused further treatment|1|||
162698726|NCT01681368|587606833|FG000|Overall Study|Refused further follow up|1|||
162830853|NCT03631732|588093156|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
162830854|NCT03631732|588093155|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
162830855|NCT03631732|588093156|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
162942333|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942334|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942335|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942336|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942337|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942338|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942339|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942340|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942341|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
162942342|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
162942343|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
162942344|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
162942345|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
162942346|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
162942347|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942348|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942349|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942350|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942351|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942352|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942353|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942354|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942355|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942356|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942357|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942358|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942359|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162942360|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
162942361|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942362|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942363|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942364|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942365|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942366|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942367|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942368|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942369|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942370|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162942371|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
162942372|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
162942373|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
162942374|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
162942375|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942376|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942377|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942378|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942379|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942380|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942381|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
163042851|NCT01066871|588863975|FG001|Overall Study|Lack of Efficacy|0|||
162942382|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942383|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
162942384|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
162942385|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
162942386|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
162942387|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
162942388|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
162942389|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942390|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942391|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942392|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942393|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942394|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942395|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942396|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942397|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942398|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942399|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942400|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942401|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
162942402|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
162942403|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942404|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942405|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942406|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942407|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942408|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942409|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942410|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942411|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
162942412|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
162942413|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
162942414|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942415|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942416|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
162942417|NCT04033445|588491681|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942418|NCT04033445|588491682|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942419|NCT04033445|588491683|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942420|NCT04033445|588491684|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942421|NCT04033445|588491685|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942422|NCT04033445|588491686|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942423|NCT04033445|588491687|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942424|NCT04033445|588491688|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942425|NCT04033445|588491689|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942426|NCT04033445|588491690|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942427|NCT04033445|588491691|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942428|NCT04033445|588491692|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942429|NCT04033445|588491693|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
162942430|NCT04033445|588491694|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
162942431|NCT02985957|588491699|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942432|NCT02985957|588491700|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942433|NCT02985957|588491701|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942434|NCT02985957|588491702|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942435|NCT02985957|588491703|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162942436|NCT02985957|588491704|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942437|NCT02985957|588491705|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162942438|NCT02985957|588491699|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
162942439|NCT02985957|588491700|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
162942440|NCT02985957|588491701|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
162942441|NCT02985957|588491702|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
162942442|NCT02985957|588491703|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
162942443|NCT02985957|588491704|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
162942444|NCT02985957|588491705|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
162942445|NCT02985957|588491699|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942446|NCT02985957|588491700|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942447|NCT02985957|588491701|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942448|NCT02985957|588491702|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942449|NCT02985957|588491703|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942450|NCT02985957|588491704|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162942451|NCT02985957|588491705|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
162942452|NCT02985957|588491699|FG000|Treatment Period|Death|0|||
162942453|NCT02985957|588491700|FG001|Treatment Period|Death|0|||
162942454|NCT02985957|588491701|FG002|Treatment Period|Death|0|||
162942455|NCT02985957|588491702|FG003|Treatment Period|Death|0|||
162942456|NCT02985957|588491703|FG004|Treatment Period|Death|1|||
162942457|NCT02985957|588491704|FG005|Treatment Period|Death|0|||
162942458|NCT02985957|588491705|FG006|Treatment Period|Death|0|||
162942459|NCT02985957|588491699|FG000|Treatment Period|Participant withdrew consent|0|||
162942460|NCT02985957|588491700|FG001|Treatment Period|Participant withdrew consent|0|||
162942461|NCT02985957|588491701|FG002|Treatment Period|Participant withdrew consent|0|||
162942462|NCT02985957|588491702|FG003|Treatment Period|Participant withdrew consent|1|||
162942463|NCT02985957|588491703|FG004|Treatment Period|Participant withdrew consent|3|||
162942464|NCT02985957|588491704|FG005|Treatment Period|Participant withdrew consent|0|||
162942465|NCT02985957|588491705|FG006|Treatment Period|Participant withdrew consent|1|||
162942466|NCT02985957|588491699|FG000|Treatment Period|Lost to Follow-up|0|||
162942467|NCT02985957|588491700|FG001|Treatment Period|Lost to Follow-up|0|||
162942468|NCT02985957|588491701|FG002|Treatment Period|Lost to Follow-up|0|||
162942469|NCT02985957|588491702|FG003|Treatment Period|Lost to Follow-up|0|||
162942470|NCT02985957|588491703|FG004|Treatment Period|Lost to Follow-up|1|||
162942471|NCT02985957|588491704|FG005|Treatment Period|Lost to Follow-up|0|||
162942472|NCT02985957|588491705|FG006|Treatment Period|Lost to Follow-up|0|||
162942473|NCT02985957|588491699|FG000|Treatment Period|Other reasons|0|||
162942474|NCT02985957|588491700|FG001|Treatment Period|Other reasons|0|||
162942475|NCT02985957|588491701|FG002|Treatment Period|Other reasons|1|||
162942476|NCT02985957|588491702|FG003|Treatment Period|Other reasons|3|||
162942477|NCT02985957|588491703|FG004|Treatment Period|Other reasons|5|||
162942478|NCT02985957|588491704|FG005|Treatment Period|Other reasons|0|||
162942479|NCT02985957|588491705|FG006|Treatment Period|Other reasons|1|||
162942480|NCT02985957|588491699|FG000|Treatment Period|Not reported|0|||
162942481|NCT02985957|588491700|FG001|Treatment Period|Not reported|2|||
162942482|NCT02985957|588491701|FG002|Treatment Period|Not reported|2|||
162942483|NCT02985957|588491702|FG003|Treatment Period|Not reported|5|||
162942484|NCT02985957|588491703|FG004|Treatment Period|Not reported|0|||
162942485|NCT02985957|588491704|FG005|Treatment Period|Not reported|0|||
162942486|NCT02985957|588491705|FG006|Treatment Period|Not reported|0|||
162942487|NCT02985957|588491699|FG000|Treatment Period|Maximum clinical benefit|0|||
162942488|NCT02985957|588491700|FG001|Treatment Period|Maximum clinical benefit|0|||
162942489|NCT02985957|588491701|FG002|Treatment Period|Maximum clinical benefit|1|||
162942490|NCT02985957|588491702|FG003|Treatment Period|Maximum clinical benefit|1|||
162942491|NCT02985957|588491703|FG004|Treatment Period|Maximum clinical benefit|0|||
162942492|NCT02985957|588491704|FG005|Treatment Period|Maximum clinical benefit|0|||
162942493|NCT02985957|588491705|FG006|Treatment Period|Maximum clinical benefit|2|||
162942494|NCT02985957|588491699|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
162942495|NCT02985957|588491700|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
162942496|NCT02985957|588491701|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
162942497|NCT02985957|588491702|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
162942498|NCT02985957|588491703|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
162942499|NCT02985957|588491704|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
162942500|NCT02985957|588491705|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
162942501|NCT02985957|588491699|FG000|Treatment Period|Study drug toxicity|1|||
162942502|NCT02985957|588491700|FG001|Treatment Period|Study drug toxicity|23|||
162942503|NCT02985957|588491701|FG002|Treatment Period|Study drug toxicity|20|||
162942504|NCT02985957|588491702|FG003|Treatment Period|Study drug toxicity|12|||
162942505|NCT02985957|588491703|FG004|Treatment Period|Study drug toxicity|20|||
162942506|NCT02985957|588491704|FG005|Treatment Period|Study drug toxicity|3|||
162942507|NCT02985957|588491705|FG006|Treatment Period|Study drug toxicity|5|||
162942508|NCT02985957|588491699|FG000|Treatment Period|Disease progression|0|||
162942509|NCT02985957|588491700|FG001|Treatment Period|Disease progression|16|||
163042852|NCT01066871|588863976|FG002|Overall Study|Lack of Efficacy|0|||
162942510|NCT02985957|588491701|FG002|Treatment Period|Disease progression|20|||
162942511|NCT02985957|588491702|FG003|Treatment Period|Disease progression|40|||
162942512|NCT02985957|588491703|FG004|Treatment Period|Disease progression|29|||
162942513|NCT02985957|588491704|FG005|Treatment Period|Disease progression|11|||
162942514|NCT02985957|588491705|FG006|Treatment Period|Disease progression|28|||
162942515|NCT02985957|588491699|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
162942516|NCT02985957|588491700|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
162942517|NCT02985957|588491701|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
162942518|NCT02985957|588491702|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
162942519|NCT02985957|588491703|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
162942520|NCT02985957|588491704|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
162698727|NCT06017999|587606836|FG000|Overall Study|Withdrawal by Subject|0|||
162698728|NCT06017999|587606837|FG001|Overall Study|Withdrawal by Subject|4|||
162942521|NCT02985957|588491705|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
162942522|NCT02985957|588491699|FG000|Treatment Period|Poor/Non-Compliance|0|||
162942523|NCT02985957|588491700|FG001|Treatment Period|Poor/Non-Compliance|0|||
162942524|NCT02985957|588491701|FG002|Treatment Period|Poor/Non-Compliance|0|||
162942525|NCT02985957|588491702|FG003|Treatment Period|Poor/Non-Compliance|0|||
162942526|NCT02985957|588491703|FG004|Treatment Period|Poor/Non-Compliance|1|||
162942527|NCT02985957|588491704|FG005|Treatment Period|Poor/Non-Compliance|1|||
162942528|NCT02985957|588491705|FG006|Treatment Period|Poor/Non-Compliance|0|||
162942529|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
162942530|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
162942531|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
162942532|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
162942533|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
162942534|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
162942535|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
162942536|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
162942537|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
162942538|NCT02978326|588491707|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
162942539|NCT02978326|588491708|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
162942540|NCT02978326|588491709|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
162942541|NCT02365597|588491712|FG000|Overall Study|Lost to Follow-up|0|||
162942542|NCT02365597|588491713|FG001|Overall Study|Lost to Follow-up|1|||
162942543|NCT02365597|588491714|FG002|Overall Study|Lost to Follow-up|0|||
162942544|NCT02365597|588491715|FG003|Overall Study|Lost to Follow-up|1|||
162942545|NCT02365597|588491712|FG000|Overall Study|Withdrawal by Subject|1|||
162942546|NCT02365597|588491713|FG001|Overall Study|Withdrawal by Subject|8|||
162942547|NCT02365597|588491714|FG002|Overall Study|Withdrawal by Subject|5|||
162942548|NCT02365597|588491715|FG003|Overall Study|Withdrawal by Subject|1|||
162942549|NCT02365597|588491712|FG000|Overall Study|Sponsor's decision|1|||
162942550|NCT02365597|588491713|FG001|Overall Study|Sponsor's decision|3|||
162942551|NCT02365597|588491714|FG002|Overall Study|Sponsor's decision|13|||
162942552|NCT02365597|588491715|FG003|Overall Study|Sponsor's decision|0|||
162942553|NCT02365597|588491712|FG000|Overall Study|Other|0|||
162942554|NCT02365597|588491713|FG001|Overall Study|Other|4|||
162942555|NCT02365597|588491714|FG002|Overall Study|Other|0|||
162942556|NCT02365597|588491715|FG003|Overall Study|Other|0|||
162942557|NCT02365597|588491712|FG000|Overall Study|Enrolled but not treated|0|||
162942558|NCT02365597|588491713|FG001|Overall Study|Enrolled but not treated|1|||
162942559|NCT02365597|588491714|FG002|Overall Study|Enrolled but not treated|1|||
162942560|NCT02365597|588491715|FG003|Overall Study|Enrolled but not treated|0|||
162942561|NCT02365597|588491712|FG000|Overall Study|Ongoing|0|||
162942562|NCT02365597|588491713|FG001|Overall Study|Ongoing|0|||
162942563|NCT02365597|588491714|FG002|Overall Study|Ongoing|0|||
162942564|NCT02365597|588491715|FG003|Overall Study|Ongoing|17|||
162942565|NCT04309474|588491716|FG000|Overall Study|Randomized but not treated|0|||
162942566|NCT04309474|588491717|FG001|Overall Study|Randomized but not treated|2|||
162942567|NCT04309474|588491716|FG000|Overall Study|Adverse Event|4|||
162942568|NCT04309474|588491717|FG001|Overall Study|Adverse Event|1|||
162942569|NCT04309474|588491716|FG000|Overall Study|Withdrawal by Subject|6|||
162942570|NCT04309474|588491717|FG001|Overall Study|Withdrawal by Subject|9|||
162942571|NCT04309474|588491716|FG000|Overall Study|Lost to Follow-up|1|||
162942572|NCT04309474|588491717|FG001|Overall Study|Lost to Follow-up|2|||
162942573|NCT04309474|588491716|FG000|Overall Study|Not disclosed|10|||
162942574|NCT04309474|588491717|FG001|Overall Study|Not disclosed|6|||
162942575|NCT04670068|588491718|FG000|Overall Study|Progressive Disease|1|||
162942576|NCT04670068|588491719|FG001|Overall Study|Progressive Disease|1|||
162942577|NCT04670068|588491718|FG000|Overall Study|Withdrawal by Subject|1|||
162942578|NCT04670068|588491719|FG001|Overall Study|Withdrawal by Subject|0|||
162942579|NCT02974153|588491720|FG000|Overall Study|Adverse Event|6|||
162942580|NCT02974153|588491721|FG001|Overall Study|Adverse Event|0|||
162942581|NCT02974153|588491722|FG002|Overall Study|Adverse Event|1|||
162942582|NCT02974153|588491720|FG000|Overall Study|Lack of Efficacy|6|||
162942583|NCT02974153|588491721|FG001|Overall Study|Lack of Efficacy|5|||
162942584|NCT02974153|588491722|FG002|Overall Study|Lack of Efficacy|10|||
162942585|NCT02974153|588491720|FG000|Overall Study|Lost to Follow-up|9|||
162942586|NCT02974153|588491721|FG001|Overall Study|Lost to Follow-up|10|||
162942587|NCT02974153|588491722|FG002|Overall Study|Lost to Follow-up|17|||
162942588|NCT02974153|588491720|FG000|Overall Study|Physician Decision|0|||
162942589|NCT02974153|588491721|FG001|Overall Study|Physician Decision|2|||
162942590|NCT02974153|588491722|FG002|Overall Study|Physician Decision|1|||
162942591|NCT02974153|588491720|FG000|Overall Study|Withdrawal by Subject|9|||
162942592|NCT02974153|588491721|FG001|Overall Study|Withdrawal by Subject|16|||
162942593|NCT02974153|588491722|FG002|Overall Study|Withdrawal by Subject|11|||
162942594|NCT02974153|588491720|FG000|Overall Study|Study Burden|8|||
162942595|NCT02974153|588491721|FG001|Overall Study|Study Burden|7|||
162942596|NCT02974153|588491722|FG002|Overall Study|Study Burden|3|||
162942597|NCT02974153|588491720|FG000|Overall Study|Other|14|||
162942598|NCT02974153|588491721|FG001|Overall Study|Other|8|||
162942599|NCT02974153|588491722|FG002|Overall Study|Other|7|||
162942600|NCT02521948|588491723|FG000|Overall Study|Adverse Event|2|||
162942601|NCT02521948|588491723|FG000|Overall Study|Death|4|||
162942602|NCT02521948|588491723|FG000|Overall Study|Lost to Follow-up|1|||
162942603|NCT02521948|588491723|FG000|Overall Study|Did not attend one or both follow-ups|6|||
162942604|NCT00717756|588491726|FG000|Overall Study|Withdrawal by Subject|1|||
162942605|NCT00673790|588491727|FG000|Overall Study|Adverse Event|23|||
162942606|NCT00673790|588491728|FG001|Overall Study|Adverse Event|14|||
162942607|NCT00673790|588491729|FG002|Overall Study|Adverse Event|2|||
162942608|NCT00673790|588491727|FG000|Overall Study|Lack of Efficacy|2|||
162942609|NCT00673790|588491728|FG001|Overall Study|Lack of Efficacy|2|||
162942610|NCT00673790|588491729|FG002|Overall Study|Lack of Efficacy|2|||
162942611|NCT00673790|588491727|FG000|Overall Study|Protocol Violation|6|||
162942612|NCT00673790|588491728|FG001|Overall Study|Protocol Violation|9|||
162942613|NCT00673790|588491729|FG002|Overall Study|Protocol Violation|1|||
162942614|NCT00673790|588491727|FG000|Overall Study|Withdrawal by Subject|7|||
162942615|NCT00673790|588491728|FG001|Overall Study|Withdrawal by Subject|4|||
162942616|NCT00673790|588491729|FG002|Overall Study|Withdrawal by Subject|1|||
162942617|NCT00673790|588491727|FG000|Overall Study|Lost to Follow-up|6|||
162942618|NCT00673790|588491728|FG001|Overall Study|Lost to Follow-up|6|||
162942619|NCT00673790|588491729|FG002|Overall Study|Lost to Follow-up|5|||
162942620|NCT00673790|588491727|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
162942621|NCT00673790|588491728|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
162942622|NCT00673790|588491729|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
162942623|NCT00673790|588491727|FG000|Overall Study|Poor compliance|1|||
162942624|NCT00673790|588491728|FG001|Overall Study|Poor compliance|0|||
162942625|NCT00673790|588491729|FG002|Overall Study|Poor compliance|0|||
162942626|NCT00673790|588491727|FG000|Overall Study|Participated in two Nebivolol studies|0|||
162942627|NCT00673790|588491728|FG001|Overall Study|Participated in two Nebivolol studies|0|||
162942628|NCT00673790|588491729|FG002|Overall Study|Participated in two Nebivolol studies|1|||
162942629|NCT00673790|588491727|FG000|Overall Study|Unconfirmed pregnancy|0|||
162942630|NCT00673790|588491728|FG001|Overall Study|Unconfirmed pregnancy|1|||
162942631|NCT00673790|588491729|FG002|Overall Study|Unconfirmed pregnancy|0|||
162942632|NCT00673790|588491727|FG000|Overall Study|Randomization criteria not met|0|||
162942633|NCT00673790|588491728|FG001|Overall Study|Randomization criteria not met|1|||
162942634|NCT00673790|588491729|FG002|Overall Study|Randomization criteria not met|0|||
162942635|NCT01364870|588491730|FG000|Overall Study|Withdrawal by Subject|13|||
162942636|NCT01364870|588491731|FG001|Overall Study|Withdrawal by Subject|24|||
162942637|NCT01364870|588491732|FG002|Overall Study|Withdrawal by Subject|10|||
162942638|NCT01364870|588491730|FG000|Overall Study|Adverse Event|8|||
162942639|NCT01364870|588491731|FG001|Overall Study|Adverse Event|6|||
162942640|NCT01364870|588491732|FG002|Overall Study|Adverse Event|4|||
162942641|NCT01364870|588491730|FG000|Overall Study|Protocol Violation|1|||
162942642|NCT01364870|588491731|FG001|Overall Study|Protocol Violation|0|||
162942643|NCT01364870|588491732|FG002|Overall Study|Protocol Violation|0|||
162942644|NCT01873859|588491733|FG000|Overall Study|Withdrawal by Subject|0|||
162942645|NCT01873859|588491734|FG001|Overall Study|Withdrawal by Subject|4|||
162942646|NCT04471428|588491735|FG000|Overall Study|Withdrawal by Subject|29|||
162942647|NCT04471428|588491736|FG001|Overall Study|Withdrawal by Subject|4|||
162942648|NCT04471428|588491735|FG000|Overall Study|Physician Decision|0|||
162942649|NCT04471428|588491736|FG001|Overall Study|Physician Decision|1|||
162942650|NCT04471428|588491735|FG000|Overall Study|Reason Not Specified|0|||
162942651|NCT04471428|588491736|FG001|Overall Study|Reason Not Specified|2|||
162942652|NCT04471428|588491735|FG000|Overall Study|Death|131|||
162942653|NCT04471428|588491736|FG001|Overall Study|Death|147|||
162942654|NCT04471428|588491735|FG000|Overall Study|Lost to Follow-up|0|||
162942655|NCT04471428|588491736|FG001|Overall Study|Lost to Follow-up|3|||
162942656|NCT04471428|588491735|FG000|Overall Study|Study Terminated by Sponsor|20|||
162942657|NCT04471428|588491736|FG001|Overall Study|Study Terminated by Sponsor|29|||
162942658|NCT03504852|588491737|FG000|Overall Study|Withdrawal of informed consent|2|||
162942659|NCT03504852|588491738|FG001|Overall Study|Withdrawal of informed consent|1|||
162942660|NCT03504852|588491739|FG002|Overall Study|Withdrawal of informed consent|0|||
162942661|NCT03504852|588491737|FG000|Overall Study|Withdrawal by Subject|5|||
162942662|NCT03504852|588491738|FG001|Overall Study|Withdrawal by Subject|5|||
162942663|NCT03504852|588491739|FG002|Overall Study|Withdrawal by Subject|1|||
162942664|NCT03504852|588491737|FG000|Overall Study|Lost to Follow-up|4|||
162942665|NCT03504852|588491738|FG001|Overall Study|Lost to Follow-up|1|||
162942666|NCT03504852|588491739|FG002|Overall Study|Lost to Follow-up|0|||
162942667|NCT03504852|588491737|FG000|Overall Study|New therapy for study indication|1|||
162942668|NCT03504852|588491738|FG001|Overall Study|New therapy for study indication|0|||
162942669|NCT03504852|588491739|FG002|Overall Study|New therapy for study indication|0|||
162942670|NCT03504852|588491737|FG000|Overall Study|Lack of Efficacy|1|||
162942671|NCT03504852|588491738|FG001|Overall Study|Lack of Efficacy|2|||
162942672|NCT03504852|588491739|FG002|Overall Study|Lack of Efficacy|0|||
162942673|NCT03504852|588491737|FG000|Overall Study|Death|0|||
162942674|NCT03504852|588491738|FG001|Overall Study|Death|1|||
162942675|NCT03504852|588491739|FG002|Overall Study|Death|0|||
162942676|NCT03504852|588491737|FG000|Overall Study|Adverse Event|4|||
162942677|NCT03504852|588491738|FG001|Overall Study|Adverse Event|8|||
162942678|NCT03504852|588491739|FG002|Overall Study|Adverse Event|2|||
162942679|NCT03290079|588491740|FG000|Overall Study|Death|2|||
162942680|NCT03850509|588491741|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
162942681|NCT03850509|588491742|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
162942682|NCT02666430|588491743|FG000|Period 1|Lost to Follow-up|1|||
162942683|NCT02666430|588491744|FG001|Period 1|Lost to Follow-up|0|||
162942684|NCT02666430|588491743|FG000|Period 1|Adverse Event|0|||
162942685|NCT02666430|588491744|FG001|Period 1|Adverse Event|1|||
162942686|NCT02666430|588491743|FG000|Period 2|Withdrawal by Subject|1|||
162942687|NCT02666430|588491744|FG001|Period 2|Withdrawal by Subject|4|||
162942688|NCT02666430|588491743|FG000|Period 3|Lost to Follow-up|1|||
162942689|NCT02666430|588491744|FG001|Period 3|Lost to Follow-up|0|||
162942690|NCT03922477|588491745|FG000|Overall Study|Death|9|||
162942691|NCT03922477|588491745|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
162942692|NCT03922477|588491745|FG000|Overall Study|Physician Decision|1|||
162942693|NCT03922477|588491745|FG000|Overall Study|Withdrawal by Subject|2|||
162942694|NCT01618305|588491749|FG000|Overall Study|Death|0|||
162942695|NCT01618305|588491750|FG001|Overall Study|Death|1|||
162942696|NCT01618305|588491749|FG000|Overall Study|Lost to Follow-up|11|||
162942697|NCT01618305|588491750|FG001|Overall Study|Lost to Follow-up|7|||
162942698|NCT01618305|588491749|FG000|Overall Study|Protocol Violation|1|||
162942699|NCT01618305|588491750|FG001|Overall Study|Protocol Violation|0|||
162942700|NCT01618305|588491749|FG000|Overall Study|Withdrawal by Subject|3|||
162942701|NCT01618305|588491750|FG001|Overall Study|Withdrawal by Subject|2|||
162942702|NCT01565083|588491751|FG000|Overall Study|Withdrawal by Subject|6|||
162942703|NCT01565083|588491752|FG001|Overall Study|Withdrawal by Subject|4|||
162942704|NCT01565083|588491751|FG000|Overall Study|Lost to Follow-up|2|||
162942705|NCT01565083|588491752|FG001|Overall Study|Lost to Follow-up|7|||
162942706|NCT01565083|588491751|FG000|Overall Study|Death|22|||
162942707|NCT01565083|588491752|FG001|Overall Study|Death|23|||
162942708|NCT01565083|588491751|FG000|Overall Study|Other|3|||
162942709|NCT01565083|588491752|FG001|Overall Study|Other|5|||
162942710|NCT01960816|588491753|FG000|Overall Study|Lost to Follow-up|1|||
162942711|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
162942712|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
162942713|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
162942714|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
162942715|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
162698729|NCT06017999|587606838|FG002|Overall Study|Withdrawal by Subject|3|||
162942716|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
162942717|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
162942718|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
162942719|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
162942720|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
162942721|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
162942722|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
162942723|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
162942724|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
162942725|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
162942726|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
162942727|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
162942728|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
162942729|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
162942730|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
162942731|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
162942732|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
162942733|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
162942734|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
162942735|NCT00455533|588491754|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
162942736|NCT00455533|588491755|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
162942737|NCT00455533|588491756|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
162942738|NCT00455533|588491754|FG000|Period Two: Randomized Period|Death|0|||
162942739|NCT00455533|588491755|FG001|Period Two: Randomized Period|Death|0|||
162942740|NCT00455533|588491756|FG002|Period Two: Randomized Period|Death|3|||
162942741|NCT00455533|588491754|FG000|Period Two: Randomized Period|Disease Progression|0|||
162942742|NCT00455533|588491755|FG001|Period Two: Randomized Period|Disease Progression|1|||
162942743|NCT00455533|588491756|FG002|Period Two: Randomized Period|Disease Progression|1|||
162942744|NCT00455533|588491754|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
162942745|NCT00455533|588491755|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
162942746|NCT00455533|588491756|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
162942747|NCT00455533|588491754|FG000|Period Two: Randomized Period|Other - need reasons|0|||
162942748|NCT00455533|588491755|FG001|Period Two: Randomized Period|Other - need reasons|1|||
162942749|NCT00455533|588491756|FG002|Period Two: Randomized Period|Other - need reasons|0|||
162942750|NCT00455533|588491754|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
162942751|NCT00455533|588491755|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
162942752|NCT00455533|588491756|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
162942753|NCT00455533|588491754|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
162942754|NCT00455533|588491755|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
162942755|NCT00455533|588491756|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
162942756|NCT02415959|588491757|FG000|Overall Study|Adverse Event|0|||
162942757|NCT02415959|588491758|FG001|Overall Study|Adverse Event|1|||
162942758|NCT02415959|588491759|FG002|Overall Study|Adverse Event|0|||
162942759|NCT02415959|588491760|FG003|Overall Study|Adverse Event|0|||
162942760|NCT02415959|588491761|FG004|Overall Study|Adverse Event|0|||
162942761|NCT02415959|588491757|FG000|Overall Study|Protocol Violation|0|||
162942762|NCT02415959|588491758|FG001|Overall Study|Protocol Violation|0|||
162942763|NCT02415959|588491759|FG002|Overall Study|Protocol Violation|0|||
162942764|NCT02415959|588491760|FG003|Overall Study|Protocol Violation|1|||
162942765|NCT02415959|588491761|FG004|Overall Study|Protocol Violation|0|||
162942766|NCT01402908|588493172|FG000|Overall Study|Withdrawal by Subject|30|||
162942767|NCT01402908|588493173|FG001|Overall Study|Withdrawal by Subject|17|||
162942768|NCT01402908|588493172|FG000|Overall Study|Lost to Follow-up|3|||
162942769|NCT01402908|588493173|FG001|Overall Study|Lost to Follow-up|1|||
162942770|NCT01402908|588493172|FG000|Overall Study|Physician Decision|1|||
162942771|NCT01402908|588493173|FG001|Overall Study|Physician Decision|0|||
162942772|NCT01739790|588493174|FG000|Overall Study|Early Trial Termination|2|||
162942773|NCT01739790|588493175|FG001|Overall Study|Early Trial Termination|4|||
162942774|NCT01691859|588493177|FG000|Overall Study|Adverse Event|19|||
162942775|NCT01691859|588493177|FG000|Overall Study|Lack of Efficacy|11|||
162942776|NCT01691859|588493177|FG000|Overall Study|Protocol Violation|4|||
162942777|NCT01691859|588493177|FG000|Overall Study|Product commercially available|221|||
162942778|NCT01691859|588493177|FG000|Overall Study|Study closed/terminated|50|||
162942779|NCT01691859|588493177|FG000|Overall Study|Lost to Follow-up|5|||
162942780|NCT01691859|588493177|FG000|Overall Study|Physician Decision|6|||
162942781|NCT01691859|588493177|FG000|Overall Study|Withdrawal by Subject|31|||
162942782|NCT00862979|588493178|FG000|Overall Study|Adverse Event|6|||
162942783|NCT00862979|588493179|FG001|Overall Study|Adverse Event|3|||
162942784|NCT00862979|588493178|FG000|Overall Study|Protocol Violation|0|||
162942785|NCT00862979|588493179|FG001|Overall Study|Protocol Violation|1|||
162942786|NCT00862979|588493178|FG000|Overall Study|Patient withdrew consent|2|||
162698730|NCT06017999|587606836|FG000|Overall Study|Adverse Event|2|||
162942787|NCT00862979|588493179|FG001|Overall Study|Patient withdrew consent|1|||
162942788|NCT00862979|588493178|FG000|Overall Study|Administrative problems|0|||
162942789|NCT00862979|588493179|FG001|Overall Study|Administrative problems|1|||
162942790|NCT00862979|588493178|FG000|Overall Study|Death|0|||
162942791|NCT00862979|588493179|FG001|Overall Study|Death|1|||
162942792|NCT05568225|588493180|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
162942793|NCT05568225|588493181|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
162942794|NCT05568225|588493182|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
162942795|NCT05568225|588493180|FG000|Primary Treatment Period|Physician Decision|0|||
162942796|NCT05568225|588493181|FG001|Primary Treatment Period|Physician Decision|1|||
162942797|NCT05568225|588493182|FG002|Primary Treatment Period|Physician Decision|0|||
162942798|NCT05568225|588493180|FG000|Primary Treatment Period|Disease progression|0|||
162942799|NCT05568225|588493181|FG001|Primary Treatment Period|Disease progression|1|||
162942800|NCT05568225|588493182|FG002|Primary Treatment Period|Disease progression|0|||
162942801|NCT05568225|588493180|FG000|Primary Treatment Period|Lack of Efficacy|0|||
162942802|NCT05568225|588493181|FG001|Primary Treatment Period|Lack of Efficacy|1|||
162942803|NCT05568225|588493182|FG002|Primary Treatment Period|Lack of Efficacy|0|||
162942804|NCT05568225|588493180|FG000|Primary Treatment Period|Withdrawal of conset|1|||
162942805|NCT05568225|588493181|FG001|Primary Treatment Period|Withdrawal of conset|0|||
162942806|NCT05568225|588493182|FG002|Primary Treatment Period|Withdrawal of conset|4|||
162942807|NCT05568225|588493180|FG000|Primary Treatment Period|Adverse Event|1|||
162942808|NCT05568225|588493181|FG001|Primary Treatment Period|Adverse Event|0|||
162942809|NCT05568225|588493182|FG002|Primary Treatment Period|Adverse Event|0|||
162942810|NCT05568225|588493180|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
162942811|NCT05568225|588493181|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
162942812|NCT05568225|588493182|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
162942813|NCT05568225|588493180|FG000|Extension Treatment Period|Protocol Violation|0|||
162942814|NCT05568225|588493181|FG001|Extension Treatment Period|Protocol Violation|0|||
162942815|NCT05568225|588493182|FG002|Extension Treatment Period|Protocol Violation|1|||
162942816|NCT05568225|588493180|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162942817|NCT05568225|588493181|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162942818|NCT05568225|588493182|FG002|Extension Treatment Period|Lack of Efficacy|1|||
162942819|NCT01027143|588493185|FG000|Overall Study|Lost to Follow-up|9|||
162942820|NCT01027143|588493186|FG001|Overall Study|Lost to Follow-up|4|||
162942821|NCT02637557|588493191|FG000|Overall Study|Adverse Event|3|||
162942822|NCT02637557|588493192|FG001|Overall Study|Adverse Event|1|||
162942823|NCT02637557|588493193|FG002|Overall Study|Adverse Event|3|||
162942824|NCT02637557|588493194|FG003|Overall Study|Adverse Event|3|||
162942825|NCT02637557|588493191|FG000|Overall Study|Lost to Follow-up|1|||
162942826|NCT02637557|588493192|FG001|Overall Study|Lost to Follow-up|1|||
162942827|NCT02637557|588493193|FG002|Overall Study|Lost to Follow-up|0|||
162942828|NCT02637557|588493194|FG003|Overall Study|Lost to Follow-up|1|||
162942829|NCT02637557|588493191|FG000|Overall Study|Physician Decision|1|||
162942830|NCT02637557|588493192|FG001|Overall Study|Physician Decision|0|||
162942831|NCT02637557|588493193|FG002|Overall Study|Physician Decision|0|||
162942832|NCT02637557|588493194|FG003|Overall Study|Physician Decision|0|||
162942833|NCT02637557|588493191|FG000|Overall Study|Protocol Violation|2|||
162942834|NCT02637557|588493192|FG001|Overall Study|Protocol Violation|0|||
162942835|NCT02637557|588493193|FG002|Overall Study|Protocol Violation|2|||
162942836|NCT02637557|588493194|FG003|Overall Study|Protocol Violation|1|||
162942837|NCT02637557|588493191|FG000|Overall Study|Withdrawal by Subject|1|||
162942838|NCT02637557|588493192|FG001|Overall Study|Withdrawal by Subject|3|||
162942839|NCT02637557|588493193|FG002|Overall Study|Withdrawal by Subject|4|||
162942840|NCT02637557|588493194|FG003|Overall Study|Withdrawal by Subject|2|||
162942841|NCT00992407|588493195|FG000|Overall Study|Protocol Violation|2|||
162942842|NCT00992407|588493196|FG001|Overall Study|Protocol Violation|1|||
162942843|NCT00992407|588493195|FG000|Overall Study|Lost to Follow-up|3|||
162942844|NCT00992407|588493196|FG001|Overall Study|Lost to Follow-up|3|||
162942845|NCT00992407|588493195|FG000|Overall Study|Adverse Event|3|||
162942846|NCT00992407|588493196|FG001|Overall Study|Adverse Event|2|||
162942847|NCT00992407|588493195|FG000|Overall Study|protocol Violation & Adverse events|2|||
162942848|NCT00992407|588493196|FG001|Overall Study|protocol Violation & Adverse events|4|||
162942849|NCT00992407|588493195|FG000|Overall Study|Other|2|||
162942850|NCT00992407|588493196|FG001|Overall Study|Other|0|||
162942851|NCT00992407|588493195|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
162942852|NCT00992407|588493196|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
162942853|NCT00992407|588493195|FG000|Overall Study|Study medication not administered|17|||
162942854|NCT00992407|588493196|FG001|Overall Study|Study medication not administered|13|||
162942855|NCT03738332|588493199|FG000|Overall Study|Withdrawal by Subject|1|||
162942856|NCT01521559|588493200|FG000|Overall Study|Adverse Event|0|||
162942857|NCT01521559|588493201|FG001|Overall Study|Adverse Event|4|||
162942858|NCT01521559|588493200|FG000|Overall Study|Death|1|||
162942859|NCT01521559|588493201|FG001|Overall Study|Death|0|||
162942860|NCT01521559|588493200|FG000|Overall Study|Withdrawal by Subject|9|||
162942861|NCT01521559|588493201|FG001|Overall Study|Withdrawal by Subject|11|||
162942862|NCT01521559|588493200|FG000|Overall Study|Lost to Follow-up|3|||
162942863|NCT01521559|588493201|FG001|Overall Study|Lost to Follow-up|1|||
162942864|NCT01521559|588493200|FG000|Overall Study|Protocol Violation|1|||
162942865|NCT01521559|588493201|FG001|Overall Study|Protocol Violation|0|||
162942866|NCT01521559|588493200|FG000|Overall Study|Other|1|||
162942867|NCT01521559|588493201|FG001|Overall Study|Other|2|||
162942868|NCT02336737|588493202|FG000|Overall Study|Withdrawal by Subject|5|||
162942869|NCT02336737|588493202|FG000|Overall Study|Physician Decision|8|||
162942870|NCT00576381|588493207|FG000|Overall Study|Reoperation|3|||
162942871|NCT00576381|588493207|FG000|Overall Study|Adverse Event|4|||
162942872|NCT00287118|588493208|FG000|Overall Study|Adverse Event|30|||
162942873|NCT00287118|588493208|FG000|Overall Study|Death|1|||
162942874|NCT00287118|588493208|FG000|Overall Study|Lack of Efficacy|11|||
162942875|NCT00287118|588493208|FG000|Overall Study|Lost to Follow-up|1|||
162942876|NCT00287118|588493208|FG000|Overall Study|Protocol Violation|2|||
162942877|NCT00287118|588493208|FG000|Overall Study|Other|7|||
162942878|NCT02324465|588493209|FG000|Overall Study|device failure|0|||
162942879|NCT02324465|588493210|FG001|Overall Study|device failure|1|||
162942880|NCT01631864|588493211|FG000|Overall Study|Withdrawal by Subject|0|||
162942881|NCT01631864|588493212|FG001|Overall Study|Withdrawal by Subject|1|||
162942882|NCT01631864|588493211|FG000|Overall Study|Adverse Event|2|||
162942883|NCT01631864|588493212|FG001|Overall Study|Adverse Event|3|||
162942884|NCT04543136|588493225|FG000|Overall Study|Withdrawal by Subject|0|||
162942885|NCT04543136|588493226|FG001|Overall Study|Withdrawal by Subject|1|||
162942886|NCT04543136|588493227|FG002|Overall Study|Withdrawal by Subject|0|||
162942887|NCT04543136|588493228|FG003|Overall Study|Withdrawal by Subject|1|||
162942888|NCT04543136|588493229|FG004|Overall Study|Withdrawal by Subject|0|||
162942889|NCT04543136|588493230|FG005|Overall Study|Withdrawal by Subject|0|||
162942890|NCT00638157|588493234|FG000|Overall Study|Adverse Event|0|||
162942891|NCT00638157|588493235|FG001|Overall Study|Adverse Event|1|||
162942892|NCT00638157|588493234|FG000|Overall Study|Clinical (symptomatic) failure|1|||
162942893|NCT00638157|588493235|FG001|Overall Study|Clinical (symptomatic) failure|1|||
162942894|NCT00638157|588493234|FG000|Overall Study|Microbiological failure|1|||
162942895|NCT00638157|588493235|FG001|Overall Study|Microbiological failure|0|||
162942896|NCT00638157|588493234|FG000|Overall Study|Lost to Follow-up|1|||
162942897|NCT00638157|588493235|FG001|Overall Study|Lost to Follow-up|0|||
162942898|NCT00638157|588493234|FG000|Overall Study|Physician Decision|1|||
162942899|NCT00638157|588493235|FG001|Overall Study|Physician Decision|0|||
162942900|NCT00638157|588493234|FG000|Overall Study|Other|1|||
162942901|NCT00638157|588493235|FG001|Overall Study|Other|2|||
162942902|NCT00638157|588493234|FG000|Overall Study|Randomized, not treated|2|||
162942903|NCT00638157|588493235|FG001|Overall Study|Randomized, not treated|0|||
162942904|NCT04684524|588493236|FG000|Overall Study|Other|2|||
162942905|NCT04684524|588493237|FG001|Overall Study|Other|0|||
162942906|NCT04684524|588493236|FG000|Overall Study|Withdrawal by Subject|5|||
162942907|NCT04684524|588493237|FG001|Overall Study|Withdrawal by Subject|3|||
162942908|NCT04684524|588493236|FG000|Overall Study|Adverse Event|1|||
162942909|NCT04684524|588493237|FG001|Overall Study|Adverse Event|1|||
162942910|NCT00601354|588493241|FG000|Overall Study|Lost to Follow-up|4|||
162942911|NCT00601354|588493242|FG001|Overall Study|Lost to Follow-up|5|||
162942912|NCT05876091|588493243|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
162942913|NCT03402893|588493244|FG000|Overall Study|Withdrawal by Subject|1|||
162942914|NCT03466411|588493245|FG000|Overall Study|Lost to Follow-up|0|||
162942915|NCT03466411|588493246|FG001|Overall Study|Lost to Follow-up|1|||
162942916|NCT03466411|588493247|FG002|Overall Study|Lost to Follow-up|1|||
162942917|NCT03466411|588493248|FG003|Overall Study|Lost to Follow-up|0|||
162942918|NCT03466411|588493249|FG004|Overall Study|Lost to Follow-up|0|||
162942919|NCT03466411|588493250|FG005|Overall Study|Lost to Follow-up|0|||
162942920|NCT03466411|588493251|FG006|Overall Study|Lost to Follow-up|1|||
162942921|NCT03466411|588493252|FG007|Overall Study|Lost to Follow-up|1|||
162942922|NCT03466411|588493253|FG008|Overall Study|Lost to Follow-up|0|||
162942923|NCT03466411|588493254|FG009|Overall Study|Lost to Follow-up|1|||
162942924|NCT03466411|588493255|FG010|Overall Study|Lost to Follow-up|1|||
162942925|NCT03466411|588493256|FG011|Overall Study|Lost to Follow-up|1|||
162942926|NCT03466411|588493257|FG012|Overall Study|Lost to Follow-up|0|||
162942927|NCT03466411|588493245|FG000|Overall Study|Withdrawal by Subject|14|||
162942928|NCT03466411|588493246|FG001|Overall Study|Withdrawal by Subject|7|||
162942929|NCT03466411|588493247|FG002|Overall Study|Withdrawal by Subject|8|||
162942930|NCT03466411|588493248|FG003|Overall Study|Withdrawal by Subject|4|||
162942931|NCT03466411|588493249|FG004|Overall Study|Withdrawal by Subject|6|||
162942932|NCT03466411|588493250|FG005|Overall Study|Withdrawal by Subject|3|||
162942933|NCT03466411|588493251|FG006|Overall Study|Withdrawal by Subject|6|||
162942934|NCT03466411|588493252|FG007|Overall Study|Withdrawal by Subject|9|||
162942935|NCT03466411|588493253|FG008|Overall Study|Withdrawal by Subject|6|||
162942936|NCT03466411|588493254|FG009|Overall Study|Withdrawal by Subject|11|||
162942937|NCT03466411|588493255|FG010|Overall Study|Withdrawal by Subject|14|||
162942938|NCT03466411|588493256|FG011|Overall Study|Withdrawal by Subject|12|||
162942939|NCT03466411|588493257|FG012|Overall Study|Withdrawal by Subject|7|||
162942940|NCT03466411|588493245|FG000|Overall Study|Other|1|||
162942941|NCT03466411|588493246|FG001|Overall Study|Other|1|||
162942942|NCT03466411|588493247|FG002|Overall Study|Other|0|||
162942943|NCT03466411|588493248|FG003|Overall Study|Other|1|||
162942944|NCT03466411|588493249|FG004|Overall Study|Other|2|||
162942945|NCT03466411|588493250|FG005|Overall Study|Other|0|||
162942946|NCT03466411|588493251|FG006|Overall Study|Other|0|||
162942947|NCT03466411|588493252|FG007|Overall Study|Other|0|||
162942948|NCT03466411|588493253|FG008|Overall Study|Other|0|||
162942949|NCT03466411|588493254|FG009|Overall Study|Other|1|||
162942950|NCT03466411|588493255|FG010|Overall Study|Other|2|||
162942951|NCT03466411|588493256|FG011|Overall Study|Other|0|||
162942952|NCT03466411|588493257|FG012|Overall Study|Other|0|||
162942953|NCT03466411|588493245|FG000|Overall Study|Randomized but not Treated|0|||
162942954|NCT03466411|588493246|FG001|Overall Study|Randomized but not Treated|0|||
162830856|NCT03631732|588093155|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
162830857|NCT03631732|588093156|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
162830858|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
162830859|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
162830860|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
162830861|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
162830862|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
162830863|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
162830864|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
162830865|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
162830866|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
162830867|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
162830868|NCT03631732|588093155|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
162830869|NCT03631732|588093156|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
162830870|NCT01439204|588093157|FG000|Overall Study|Withdrawal by Subject|0|||
162830871|NCT01439204|588093158|FG001|Overall Study|Withdrawal by Subject|1|||
162830872|NCT01439204|588093157|FG000|Overall Study|Lost to Follow-up|0|||
162830873|NCT01439204|588093158|FG001|Overall Study|Lost to Follow-up|2|||
162830874|NCT01439204|588093157|FG000|Overall Study|No longer meets study criteria|1|||
162830875|NCT01439204|588093158|FG001|Overall Study|No longer meets study criteria|0|||
162830876|NCT01439204|588093157|FG000|Overall Study|poor/non-compliance|3|||
162830877|NCT01439204|588093158|FG001|Overall Study|poor/non-compliance|0|||
162830878|NCT01251367|588093159|FG000|Overall Study|Protocol Violation|1|||
162830879|NCT01251367|588093159|FG000|Overall Study|Lack of Efficacy|2|||
162830880|NCT01251367|588093159|FG000|Overall Study|Adverse Event|19|||
162830881|NCT01251367|588093159|FG000|Overall Study|Withdrawal by Subject|36|||
162830882|NCT01251367|588093159|FG000|Overall Study|Lost to Follow-up|5|||
162830883|NCT01251367|588093159|FG000|Overall Study|Subject Required Alternative Treatment|7|||
162830884|NCT01251367|588093159|FG000|Overall Study|No Study Drug Available|1|||
162830885|NCT01251367|588093159|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
162830886|NCT01251367|588093159|FG000|Overall Study|End of Study Visit Performed in Error|1|||
162830887|NCT02255409|588093160|FG000|Overall Study|Administrative Reason|3|||
162830888|NCT02255409|588093161|FG001|Overall Study|Administrative Reason|7|||
162830889|NCT02255409|588093160|FG000|Overall Study|Withdrawal by Subject|1|||
162830890|NCT02255409|588093161|FG001|Overall Study|Withdrawal by Subject|5|||
162830891|NCT02255409|588093160|FG000|Overall Study|Lost to Follow-up|10|||
162830892|NCT02255409|588093161|FG001|Overall Study|Lost to Follow-up|19|||
162830893|NCT00135668|588093162|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
162830894|NCT00135668|588093163|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
162830895|NCT00135668|588093164|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
162830896|NCT00135668|588093165|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
162830897|NCT02370615|588093168|FG000|Overall Study|Adverse Event|1|||
162830898|NCT02370615|588093169|FG001|Overall Study|Adverse Event|0|||
162830899|NCT02290873|588093170|FG000|Overall Study|Withdrawal by Subject|0|||
162830900|NCT02290873|588093171|FG001|Overall Study|Withdrawal by Subject|1|||
162830901|NCT02290873|588093172|FG002|Overall Study|Withdrawal by Subject|1|||
162830902|NCT02290873|588093170|FG000|Overall Study|Nellcor device error|1|||
162830903|NCT02290873|588093171|FG001|Overall Study|Nellcor device error|0|||
162830904|NCT02290873|588093172|FG002|Overall Study|Nellcor device error|0|||
162830905|NCT02290873|588093170|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
162830906|NCT02290873|588093171|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
162830907|NCT02290873|588093172|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
162830908|NCT02290873|588093170|FG000|Overall Study|Protocol Violation|0|||
162830909|NCT02290873|588093171|FG001|Overall Study|Protocol Violation|0|||
162830910|NCT02290873|588093172|FG002|Overall Study|Protocol Violation|1|||
162830911|NCT03715153|588093173|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
162830912|NCT03715153|588093174|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
162830913|NCT03715153|588093173|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
162830914|NCT03715153|588093174|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
162830915|NCT03715153|588093173|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
163042853|NCT01066871|588863977|FG003|Overall Study|Lack of Efficacy|1|||
162830916|NCT03715153|588093174|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
162830917|NCT03715153|588093173|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
162830918|NCT03715153|588093174|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
162830919|NCT03715153|588093173|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
162942955|NCT03466411|588493247|FG002|Overall Study|Randomized but not Treated|0|||
162942956|NCT03466411|588493248|FG003|Overall Study|Randomized but not Treated|0|||
162942957|NCT03466411|588493249|FG004|Overall Study|Randomized but not Treated|0|||
162942958|NCT03466411|588493250|FG005|Overall Study|Randomized but not Treated|0|||
162942959|NCT03466411|588493251|FG006|Overall Study|Randomized but not Treated|1|||
162942960|NCT03466411|588493252|FG007|Overall Study|Randomized but not Treated|0|||
162942961|NCT03466411|588493253|FG008|Overall Study|Randomized but not Treated|0|||
162942962|NCT03466411|588493254|FG009|Overall Study|Randomized but not Treated|0|||
162942963|NCT03466411|588493255|FG010|Overall Study|Randomized but not Treated|0|||
162942964|NCT03466411|588493256|FG011|Overall Study|Randomized but not Treated|0|||
162942965|NCT03466411|588493257|FG012|Overall Study|Randomized but not Treated|0|||
162942966|NCT03462719|588493258|FG000|Overall Study|Withdrawal by Subject|4|||
162942967|NCT03462719|588493259|FG001|Overall Study|Withdrawal by Subject|3|||
162942968|NCT03462719|588493258|FG000|Overall Study|Ongoing|87|||
162942969|NCT03462719|588493259|FG001|Overall Study|Ongoing|72|||
162942970|NCT04799158|588493260|FG000|Run-In Period|Adverse Event|6|||
162942971|NCT04799158|588493261|FG001|Run-In Period|Adverse Event|0|||
162942972|NCT04799158|588493262|FG002|Run-In Period|Adverse Event|0|||
162942973|NCT04799158|588493263|FG003|Run-In Period|Adverse Event|0|||
162942974|NCT04799158|588493264|FG004|Run-In Period|Adverse Event|0|||
162942975|NCT04799158|588493260|FG000|Run-In Period|Lost to Follow-up|4|||
162942976|NCT04799158|588493261|FG001|Run-In Period|Lost to Follow-up|0|||
162942977|NCT04799158|588493262|FG002|Run-In Period|Lost to Follow-up|0|||
162942978|NCT04799158|588493263|FG003|Run-In Period|Lost to Follow-up|0|||
162942979|NCT04799158|588493264|FG004|Run-In Period|Lost to Follow-up|0|||
162942980|NCT04799158|588493260|FG000|Run-In Period|Significant Protocol Deviation|1|||
162942981|NCT04799158|588493261|FG001|Run-In Period|Significant Protocol Deviation|0|||
162942982|NCT04799158|588493262|FG002|Run-In Period|Significant Protocol Deviation|0|||
162942983|NCT04799158|588493263|FG003|Run-In Period|Significant Protocol Deviation|0|||
162942984|NCT04799158|588493264|FG004|Run-In Period|Significant Protocol Deviation|0|||
162942985|NCT04799158|588493260|FG000|Run-In Period|Withdrawal by Subject|11|||
162942986|NCT04799158|588493261|FG001|Run-In Period|Withdrawal by Subject|0|||
162942987|NCT04799158|588493262|FG002|Run-In Period|Withdrawal by Subject|0|||
162942988|NCT04799158|588493263|FG003|Run-In Period|Withdrawal by Subject|0|||
162942989|NCT04799158|588493264|FG004|Run-In Period|Withdrawal by Subject|0|||
162942990|NCT04799158|588493260|FG000|Run-In Period|Miscellaneous|3|||
162942991|NCT04799158|588493261|FG001|Run-In Period|Miscellaneous|0|||
162942992|NCT04799158|588493262|FG002|Run-In Period|Miscellaneous|0|||
162942993|NCT04799158|588493263|FG003|Run-In Period|Miscellaneous|0|||
162942994|NCT04799158|588493264|FG004|Run-In Period|Miscellaneous|0|||
162942995|NCT04799158|588493260|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
162942996|NCT04799158|588493261|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942997|NCT04799158|588493262|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942998|NCT04799158|588493263|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162942999|NCT04799158|588493264|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
162943000|NCT04799158|588493260|FG000|On-Demand Treatment Period|Adverse Event|0|||
162943001|NCT04799158|588493261|FG001|On-Demand Treatment Period|Adverse Event|1|||
162943002|NCT04799158|588493262|FG002|On-Demand Treatment Period|Adverse Event|0|||
162943003|NCT04799158|588493263|FG003|On-Demand Treatment Period|Adverse Event|0|||
162943004|NCT04799158|588493264|FG004|On-Demand Treatment Period|Adverse Event|1|||
162943005|NCT04799158|588493260|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
162943006|NCT04799158|588493261|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
162943007|NCT04799158|588493262|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
162943008|NCT04799158|588493263|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
162943009|NCT04799158|588493264|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
162943010|NCT04799158|588493260|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943011|NCT04799158|588493261|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943012|NCT04799158|588493262|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943013|NCT04799158|588493263|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
162943014|NCT04799158|588493264|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
162943015|NCT04799158|588493260|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943016|NCT04799158|588493261|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943017|NCT04799158|588493262|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943018|NCT04799158|588493263|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
162943019|NCT04799158|588493264|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
162943020|NCT04799158|588493260|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
162943021|NCT04799158|588493261|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
162943022|NCT04799158|588493262|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
162943023|NCT04799158|588493263|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
162943024|NCT04799158|588493264|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
162943025|NCT04799158|588493260|FG000|On-Demand Treatment Period|Miscellaneous|0|||
162943026|NCT04799158|588493261|FG001|On-Demand Treatment Period|Miscellaneous|0|||
162943027|NCT04799158|588493262|FG002|On-Demand Treatment Period|Miscellaneous|0|||
162943028|NCT04799158|588493263|FG003|On-Demand Treatment Period|Miscellaneous|0|||
162943029|NCT04799158|588493264|FG004|On-Demand Treatment Period|Miscellaneous|1|||
162943030|NCT00319956|588493265|FG000|Overall Study|Death|20|||
162943031|NCT00319956|588493266|FG001|Overall Study|Death|24|||
162943032|NCT02607800|588493267|FG000|Overall Study|Lost to Follow-up|7|||
162943033|NCT02607800|588493268|FG001|Overall Study|Lost to Follow-up|10|||
162943034|NCT02607800|588493267|FG000|Overall Study|Withdrew Consent|2|||
162943035|NCT02607800|588493268|FG001|Overall Study|Withdrew Consent|0|||
162943036|NCT02607800|588493267|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
162943037|NCT02607800|588493268|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
162943038|NCT01185288|588493269|FG000|Overall Study|Adverse Event|7|||
162943039|NCT01185288|588493270|FG001|Overall Study|Adverse Event|6|||
162943040|NCT01185288|588493269|FG000|Overall Study|Withdrawal by Subject|6|||
162943041|NCT01185288|588493270|FG001|Overall Study|Withdrawal by Subject|4|||
162943042|NCT01185288|588493269|FG000|Overall Study|Lost to Follow-up|2|||
162943043|NCT01185288|588493270|FG001|Overall Study|Lost to Follow-up|5|||
162943044|NCT01185288|588493269|FG000|Overall Study|Lack of Efficacy|2|||
162943045|NCT01185288|588493270|FG001|Overall Study|Lack of Efficacy|0|||
162943046|NCT01185288|588493269|FG000|Overall Study|Investigator discretion|1|||
162943047|NCT01185288|588493270|FG001|Overall Study|Investigator discretion|0|||
162943048|NCT01185288|588493269|FG000|Overall Study|Did not meet inclusion criteria|1|||
162943049|NCT01185288|588493270|FG001|Overall Study|Did not meet inclusion criteria|0|||
162943050|NCT01185288|588493269|FG000|Overall Study|Noncompliance|0|||
162943051|NCT01185288|588493270|FG001|Overall Study|Noncompliance|1|||
162943052|NCT01202747|588493271|FG000|Overall Study|Withdrawal by Subject|1|||
162943053|NCT01446913|588493275|FG000|Overall Study|Significant illness|1|||
162943054|NCT01446913|588493276|FG001|Overall Study|Significant illness|1|||
162943055|NCT01446913|588493277|FG002|Overall Study|Significant illness|1|||
162943056|NCT01446913|588493275|FG000|Overall Study|Withdrawal by Subject|5|||
162943057|NCT01446913|588493276|FG001|Overall Study|Withdrawal by Subject|3|||
162943058|NCT01446913|588493277|FG002|Overall Study|Withdrawal by Subject|5|||
162943059|NCT01446913|588493275|FG000|Overall Study|Physician Decision|0|||
162943060|NCT01446913|588493276|FG001|Overall Study|Physician Decision|0|||
162943061|NCT01446913|588493277|FG002|Overall Study|Physician Decision|2|||
162943062|NCT01446913|588493275|FG000|Overall Study|Lost to Follow-up|3|||
162943063|NCT01446913|588493276|FG001|Overall Study|Lost to Follow-up|5|||
162943064|NCT01446913|588493277|FG002|Overall Study|Lost to Follow-up|3|||
162943065|NCT00679783|588493279|FG000|Overall Study|Adverse Event|0|||
162943066|NCT00679783|588493280|FG001|Overall Study|Adverse Event|0|||
162943067|NCT00679783|588493281|FG002|Overall Study|Adverse Event|0|||
162943068|NCT00679783|588493282|FG003|Overall Study|Adverse Event|3|||
162943069|NCT00679783|588493283|FG004|Overall Study|Adverse Event|0|||
162943070|NCT00679783|588493284|FG005|Overall Study|Adverse Event|0|||
162943071|NCT00679783|588493285|FG006|Overall Study|Adverse Event|1|||
162943072|NCT00679783|588493279|FG000|Overall Study|Lack of Efficacy|0|||
162943073|NCT00679783|588493280|FG001|Overall Study|Lack of Efficacy|1|||
162943074|NCT00679783|588493281|FG002|Overall Study|Lack of Efficacy|0|||
162943075|NCT00679783|588493282|FG003|Overall Study|Lack of Efficacy|2|||
162943076|NCT00679783|588493283|FG004|Overall Study|Lack of Efficacy|0|||
162943077|NCT00679783|588493284|FG005|Overall Study|Lack of Efficacy|0|||
162943078|NCT00679783|588493285|FG006|Overall Study|Lack of Efficacy|0|||
162943079|NCT00679783|588493279|FG000|Overall Study|Withdrawal by Subject|0|||
162943080|NCT00679783|588493280|FG001|Overall Study|Withdrawal by Subject|0|||
162943081|NCT00679783|588493281|FG002|Overall Study|Withdrawal by Subject|1|||
162943082|NCT00679783|588493282|FG003|Overall Study|Withdrawal by Subject|1|||
162943083|NCT00679783|588493283|FG004|Overall Study|Withdrawal by Subject|0|||
162943084|NCT00679783|588493284|FG005|Overall Study|Withdrawal by Subject|0|||
162943085|NCT00679783|588493285|FG006|Overall Study|Withdrawal by Subject|0|||
162943086|NCT00679783|588493279|FG000|Overall Study|Not Captured|0|||
162943087|NCT00679783|588493280|FG001|Overall Study|Not Captured|0|||
162943088|NCT00679783|588493281|FG002|Overall Study|Not Captured|0|||
162943089|NCT00679783|588493282|FG003|Overall Study|Not Captured|5|||
162943090|NCT00679783|588493283|FG004|Overall Study|Not Captured|0|||
162943091|NCT00679783|588493284|FG005|Overall Study|Not Captured|0|||
162943092|NCT00679783|588493285|FG006|Overall Study|Not Captured|0|||
162943093|NCT00679783|588493279|FG000|Overall Study|Ongoing at data cut-off|2|||
162943094|NCT00679783|588493280|FG001|Overall Study|Ongoing at data cut-off|2|||
162943095|NCT00679783|588493281|FG002|Overall Study|Ongoing at data cut-off|0|||
162943096|NCT00679783|588493282|FG003|Overall Study|Ongoing at data cut-off|9|||
162943097|NCT00679783|588493283|FG004|Overall Study|Ongoing at data cut-off|1|||
162943098|NCT00679783|588493284|FG005|Overall Study|Ongoing at data cut-off|0|||
162943099|NCT00679783|588493285|FG006|Overall Study|Ongoing at data cut-off|0|||
162943100|NCT01485536|588493286|FG000|Overall Study|Withdrawal by Subject|3|||
162943101|NCT01485536|588493286|FG000|Overall Study|Adverse Event|1|||
162943102|NCT02626949|588493287|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
162943103|NCT02626949|588493288|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
162943104|NCT02626949|588493287|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
162943105|NCT02626949|588493288|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
162943106|NCT02626949|588493287|FG000|Enrolled|Lost to Follow-up|7|||
162943107|NCT02626949|588493288|FG001|Enrolled|Lost to Follow-up|6|||
162943108|NCT02626949|588493287|FG000|Enrolled|Withdrawal by Subject|3|||
162943109|NCT02626949|588493288|FG001|Enrolled|Withdrawal by Subject|2|||
162943110|NCT00601484|588493289|FG000|Overall Study|Adverse Event|0|||
162943111|NCT00601484|588493290|FG001|Overall Study|Adverse Event|1|||
162943112|NCT00601484|588493289|FG000|Overall Study|Lost to Follow-up|4|||
162943113|NCT00601484|588493290|FG001|Overall Study|Lost to Follow-up|3|||
162943114|NCT00601484|588493289|FG000|Overall Study|Lack of Efficacy|0|||
162943115|NCT00601484|588493290|FG001|Overall Study|Lack of Efficacy|2|||
162943116|NCT00601484|588493289|FG000|Overall Study|Withdrawal by Subject|1|||
162943117|NCT00601484|588493290|FG001|Overall Study|Withdrawal by Subject|1|||
162943118|NCT00601484|588493289|FG000|Overall Study|Randomized, but not treated|0|||
162943119|NCT00601484|588493290|FG001|Overall Study|Randomized, but not treated|1|||
162943120|NCT02928848|588493291|FG000|Arm 2|Withdrawal by Subject|1|||
162943121|NCT02928848|588493292|FG001|Arm 2|Withdrawal by Subject|0|||
162943122|NCT00969332|588493293|FG000|Overall Study|Physician Decision|8|||
162943123|NCT00969332|588493293|FG000|Overall Study|Withdrawal by Subject|3|||
162943124|NCT03828461|588493294|FG000|Overall Study|Lost to Follow-up|1|||
162943125|NCT03828461|588493294|FG000|Overall Study|Withdrawal by Subject|3|||
162943126|NCT00576199|588493295|FG000|Overall Study|Adverse Event|12|||
162943127|NCT00576199|588493295|FG000|Overall Study|Insufficient Therapeutic Response|14|||
162943128|NCT00576199|588493295|FG000|Overall Study|Refused Treatment|2|||
162943129|NCT00576199|588493295|FG000|Overall Study|Reason Unspecified|2|||
162943130|NCT00663871|588493297|FG000|Overall Study|Lost to Follow-up|5|||
162943131|NCT00663871|588493298|FG001|Overall Study|Lost to Follow-up|5|||
162943132|NCT00663871|588493297|FG000|Overall Study|Withdrawal by Subject|5|||
162943133|NCT00663871|588493298|FG001|Overall Study|Withdrawal by Subject|2|||
162943134|NCT00582309|588493299|FG000|Overall Study|Protocol Violation|0|||
162943135|NCT00582309|588493300|FG001|Overall Study|Protocol Violation|0|||
162943136|NCT00582309|588493301|FG002|Overall Study|Protocol Violation|2|||
162943137|NCT03095352|588493305|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
162943138|NCT03095352|588493306|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
162943139|NCT00319449|588493309|FG000|Overall Study|Subject did not wish to continue|1|||
162943140|NCT00319449|588493310|FG001|Overall Study|Subject did not wish to continue|0|||
162943141|NCT00319449|588493309|FG000|Overall Study|Noncompliance with the protocol|1|||
162943142|NCT00319449|588493310|FG001|Overall Study|Noncompliance with the protocol|0|||
162943143|NCT01497938|588493313|FG000|Overall Study|Adverse Event|0|||
162943144|NCT01497938|588493314|FG001|Overall Study|Adverse Event|1|||
162943145|NCT01497938|588493313|FG000|Overall Study|Physician Decision|0|||
162943146|NCT01497938|588493314|FG001|Overall Study|Physician Decision|1|||
162943147|NCT01497938|588493313|FG000|Overall Study|Withdrawal by Subject|4|||
162943148|NCT01497938|588493314|FG001|Overall Study|Withdrawal by Subject|0|||
162943149|NCT01497938|588493313|FG000|Overall Study|Device Violation|1|||
162943150|NCT01497938|588493314|FG001|Overall Study|Device Violation|0|||
162943151|NCT03708211|588493315|FG000|Overall Study|Progressive Disease|10|||
162943152|NCT03708211|588493316|FG001|Overall Study|Progressive Disease|7|||
162943153|NCT03708211|588493315|FG000|Overall Study|Withdrawal by Subject|0|||
162943154|NCT03708211|588493316|FG001|Overall Study|Withdrawal by Subject|1|||
162943155|NCT03708211|588493315|FG000|Overall Study|Other|2|||
162943156|NCT03708211|588493316|FG001|Overall Study|Other|0|||
162943157|NCT00462982|588493321|FG000|Overall Study|Adverse Event|1|||
162943158|NCT00462982|588493321|FG000|Overall Study|Patient Not Treated|2|||
162943159|NCT05328375|588494386|FG000|Overall Study|Withdrawal by Subject|0|||
162943160|NCT05328375|588494387|FG001|Overall Study|Withdrawal by Subject|1|||
162943161|NCT05514119|588494392|FG000|Overall Study|Ineligible due to disease progression|1|||
162943162|NCT02946385|588494393|FG000|Overall Study|Lost to Follow-up|0|||
162943163|NCT02946385|588494394|FG001|Overall Study|Lost to Follow-up|0|||
162943164|NCT02946385|588494395|FG002|Overall Study|Lost to Follow-up|3|||
162943165|NCT02946385|588494396|FG003|Overall Study|Lost to Follow-up|0|||
162943166|NCT02946385|588494397|FG004|Overall Study|Lost to Follow-up|2|||
162943167|NCT02946385|588494398|FG005|Overall Study|Lost to Follow-up|1|||
162943168|NCT04849988|588494399|FG000|Overall Study|Lack of Efficacy|3|||
162943169|NCT04849988|588494400|FG001|Overall Study|Lack of Efficacy|4|||
162943170|NCT04849988|588494401|FG002|Overall Study|Lack of Efficacy|1|||
162943171|NCT04849988|588494402|FG003|Overall Study|Lack of Efficacy|4|||
162943172|NCT04849988|588494399|FG000|Overall Study|Other reasons|1|||
162943173|NCT04849988|588494400|FG001|Overall Study|Other reasons|2|||
162943174|NCT04849988|588494401|FG002|Overall Study|Other reasons|2|||
162943175|NCT04849988|588494402|FG003|Overall Study|Other reasons|1|||
162943176|NCT01893905|588494407|FG000|Overall Study|Withdrawal by Subject|1|||
162943177|NCT01893905|588494408|FG001|Overall Study|Withdrawal by Subject|0|||
162943178|NCT01893905|588494407|FG000|Overall Study|Adverse Event|9|||
162943179|NCT01893905|588494408|FG001|Overall Study|Adverse Event|3|||
162943180|NCT01893905|588494407|FG000|Overall Study|Lack of Efficacy|5|||
162943181|NCT01893905|588494408|FG001|Overall Study|Lack of Efficacy|7|||
162943182|NCT01893905|588494407|FG000|Overall Study|Lost to Follow-up|1|||
162943183|NCT01893905|588494408|FG001|Overall Study|Lost to Follow-up|0|||
162943184|NCT01893905|588494407|FG000|Overall Study|Protocol Violation|6|||
162943185|NCT01893905|588494408|FG001|Overall Study|Protocol Violation|1|||
162943186|NCT01893905|588494407|FG000|Overall Study|Lack of adherence to treatment|2|||
162943187|NCT01893905|588494408|FG001|Overall Study|Lack of adherence to treatment|0|||
162943188|NCT01893905|588494407|FG000|Overall Study|Other reason|1|||
162943189|NCT01893905|588494408|FG001|Overall Study|Other reason|3|||
162943190|NCT00278200|588494415|FG000|Overall Study|Death|1|||
162943191|NCT00278200|588494416|FG001|Overall Study|Death|3|||
162943192|NCT00278200|588494415|FG000|Overall Study|Physician Decision|0|||
162943193|NCT00278200|588494416|FG001|Overall Study|Physician Decision|1|||
162943194|NCT02688400|588494422|FG000|Overall Study|Protocol Violation|2|||
162943195|NCT02688400|588494423|FG001|Overall Study|Protocol Violation|5|||
162943196|NCT02688400|588494422|FG000|Overall Study|Lack of Efficacy|7|||
162943197|NCT02688400|588494423|FG001|Overall Study|Lack of Efficacy|7|||
162943198|NCT02688400|588494422|FG000|Overall Study|Adverse Event|21|||
162943199|NCT02688400|588494423|FG001|Overall Study|Adverse Event|12|||
162943200|NCT02688400|588494422|FG000|Overall Study|Withdrawal by Subject|15|||
162943201|NCT02688400|588494423|FG001|Overall Study|Withdrawal by Subject|13|||
162943202|NCT02688400|588494422|FG000|Overall Study|No study medication intake|1|||
162943203|NCT02688400|588494423|FG001|Overall Study|No study medication intake|4|||
162943204|NCT02688400|588494422|FG000|Overall Study|Lost to Follow-up|0|||
162943205|NCT02688400|588494423|FG001|Overall Study|Lost to Follow-up|3|||
162943206|NCT03519256|588494436|FG000|Overall Study|Disease recurrence|4|||
162943207|NCT03519256|588494437|FG001|Overall Study|Disease recurrence|4|||
162943208|NCT03519256|588494438|FG002|Overall Study|Disease recurrence|5|||
162943209|NCT03519256|588494439|FG003|Overall Study|Disease recurrence|2|||
162943210|NCT03519256|588494436|FG000|Overall Study|Study drug toxicity|0|||
162943211|NCT03519256|588494437|FG001|Overall Study|Study drug toxicity|2|||
162943212|NCT03519256|588494438|FG002|Overall Study|Study drug toxicity|5|||
162943213|NCT03519256|588494439|FG003|Overall Study|Study drug toxicity|2|||
162943214|NCT03519256|588494436|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162943215|NCT03519256|588494437|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162943216|NCT03519256|588494438|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162943217|NCT03519256|588494439|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162943218|NCT03519256|588494436|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162943219|NCT03519256|588494437|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162943220|NCT03519256|588494438|FG002|Overall Study|Participant request to discontinue study treatment|0|||
162943221|NCT03519256|588494439|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162943222|NCT03519256|588494436|FG000|Overall Study|Other reasons|0|||
162943223|NCT03519256|588494437|FG001|Overall Study|Other reasons|0|||
162943224|NCT03519256|588494438|FG002|Overall Study|Other reasons|2|||
162943225|NCT03519256|588494439|FG003|Overall Study|Other reasons|0|||
162943226|NCT03519256|588494436|FG000|Overall Study|Disease progression|6|||
162943227|NCT03519256|588494437|FG001|Overall Study|Disease progression|3|||
162943228|NCT03519256|588494438|FG002|Overall Study|Disease progression|2|||
162943229|NCT03519256|588494439|FG003|Overall Study|Disease progression|1|||
162943230|NCT03519256|588494436|FG000|Overall Study|Lost to Follow-up|0|||
162943231|NCT03519256|588494437|FG001|Overall Study|Lost to Follow-up|1|||
162943232|NCT03519256|588494438|FG002|Overall Study|Lost to Follow-up|0|||
162943233|NCT03519256|588494439|FG003|Overall Study|Lost to Follow-up|0|||
162943234|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
162943235|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
162943236|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
162943237|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
162943238|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
162943239|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
162943240|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
162943241|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
162943242|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943243|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943244|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
162943245|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
162943246|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
162943247|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
162943248|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
162943249|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
162943250|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943251|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943252|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
162943253|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
162943254|NCT02207231|588494440|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
162943255|NCT02207231|588494441|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
162943256|NCT02207231|588494442|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
162943257|NCT02207231|588494443|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
162943258|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
162943259|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
162943260|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
162943261|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
162943262|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943263|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943264|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
162943265|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
162943266|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
162943267|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
162943268|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
162943269|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
162943270|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
162943271|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
162943272|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
162943273|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
162943274|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
162943275|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
162943276|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
162943277|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
162943278|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943279|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
162943280|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943281|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
162943282|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
162943283|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
162943284|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
162943285|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
162943286|NCT02207231|588494440|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
162943287|NCT02207231|588494441|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
162943288|NCT02207231|588494442|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
162943289|NCT02207231|588494443|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
162943290|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
162943291|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
162943292|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
162943293|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
162943294|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
162943295|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
162943296|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
162943297|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
162943298|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
162943299|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
162943300|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
162698731|NCT06017999|587606837|FG001|Overall Study|Adverse Event|1|||
162698732|NCT06017999|587606838|FG002|Overall Study|Adverse Event|1|||
162943301|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
162943302|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
162943303|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
162943304|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
162943305|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
162943306|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
162943307|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
162943308|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
162943309|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
162943310|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
162943311|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
162943312|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
162943313|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
162943314|NCT02207231|588494440|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
162943315|NCT02207231|588494441|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
162943316|NCT02207231|588494442|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
162943317|NCT02207231|588494443|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
162943318|NCT00421174|588494444|FG000|Overall Study|Withdrawal by Subject|0|||
162943319|NCT00421174|588494445|FG001|Overall Study|Withdrawal by Subject|1|||
162943320|NCT00421174|588494444|FG000|Overall Study|Ineligible due to infection|2|||
162943321|NCT00421174|588494445|FG001|Overall Study|Ineligible due to infection|0|||
162943322|NCT01290263|588494448|FG000|Overall Study|Adverse Event|0|||
162943323|NCT01290263|588494449|FG001|Overall Study|Adverse Event|0|||
162943324|NCT01290263|588494450|FG002|Overall Study|Adverse Event|0|||
162943325|NCT01290263|588494451|FG003|Overall Study|Adverse Event|1|||
162943326|NCT01290263|588494452|FG004|Overall Study|Adverse Event|1|||
162943327|NCT01290263|588494448|FG000|Overall Study|Lack of Efficacy|8|||
162943328|NCT01290263|588494449|FG001|Overall Study|Lack of Efficacy|2|||
162943329|NCT01290263|588494450|FG002|Overall Study|Lack of Efficacy|7|||
162943330|NCT01290263|588494451|FG003|Overall Study|Lack of Efficacy|24|||
162943331|NCT01290263|588494452|FG004|Overall Study|Lack of Efficacy|33|||
162943332|NCT01290263|588494448|FG000|Overall Study|Withdrawal by Subject|3|||
162943333|NCT01290263|588494449|FG001|Overall Study|Withdrawal by Subject|1|||
162943334|NCT01290263|588494450|FG002|Overall Study|Withdrawal by Subject|0|||
162943335|NCT01290263|588494451|FG003|Overall Study|Withdrawal by Subject|1|||
162943336|NCT01290263|588494452|FG004|Overall Study|Withdrawal by Subject|2|||
162943337|NCT01290263|588494448|FG000|Overall Study|Participant Non-Compliance|0|||
162943338|NCT01290263|588494449|FG001|Overall Study|Participant Non-Compliance|0|||
162943339|NCT01290263|588494450|FG002|Overall Study|Participant Non-Compliance|0|||
162943340|NCT01290263|588494451|FG003|Overall Study|Participant Non-Compliance|1|||
162943341|NCT01290263|588494452|FG004|Overall Study|Participant Non-Compliance|1|||
162943342|NCT02309099|588494453|FG000|Overall Study|Adverse Event|2|||
162943343|NCT02309099|588494454|FG001|Overall Study|Adverse Event|0|||
162943344|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
162943345|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
162943346|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
162943347|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
162943348|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
162943349|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
162943350|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
162943351|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
162943352|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
162943353|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
162943354|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
162943355|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
162943356|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
162943357|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
162943358|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
162830920|NCT03715153|588093174|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
162830921|NCT03715153|588093173|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
162830922|NCT03715153|588093174|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
162830923|NCT03610724|588093175|FG000|Overall Study|Death|17|||
162830924|NCT03610724|588093175|FG000|Overall Study|Lost to Follow-up|1|||
162830925|NCT03610724|588093175|FG000|Overall Study|Physician Decision|1|||
162830926|NCT03610724|588093175|FG000|Overall Study|Died prior to infusion|1|||
162830927|NCT00078325|588093176|FG000|Overall Study|Adverse Event|15|||
162830928|NCT00078325|588093177|FG001|Overall Study|Adverse Event|10|||
162830929|NCT00078325|588093178|FG002|Overall Study|Adverse Event|5|||
162830930|NCT00078325|588093176|FG000|Overall Study|Protocol Violation|2|||
162830931|NCT00078325|588093177|FG001|Overall Study|Protocol Violation|2|||
162830932|NCT00078325|588093178|FG002|Overall Study|Protocol Violation|0|||
162830933|NCT00078325|588093176|FG000|Overall Study|Withdrawal by Subject|1|||
162830934|NCT00078325|588093177|FG001|Overall Study|Withdrawal by Subject|5|||
162830935|NCT00078325|588093178|FG002|Overall Study|Withdrawal by Subject|3|||
162830936|NCT00078325|588093176|FG000|Overall Study|Lost to Follow-up|0|||
162830937|NCT00078325|588093177|FG001|Overall Study|Lost to Follow-up|1|||
162830938|NCT00078325|588093178|FG002|Overall Study|Lost to Follow-up|1|||
162830939|NCT00078325|588093176|FG000|Overall Study|Physician Decision|2|||
162830940|NCT00078325|588093177|FG001|Overall Study|Physician Decision|0|||
162830941|NCT00078325|588093178|FG002|Overall Study|Physician Decision|1|||
162830942|NCT00078325|588093176|FG000|Overall Study|Miscellaneous|1|||
162830943|NCT00078325|588093177|FG001|Overall Study|Miscellaneous|1|||
162830944|NCT00078325|588093178|FG002|Overall Study|Miscellaneous|1|||
162830945|NCT01473563|588093179|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
162830946|NCT01519765|588093180|FG000|Overall Study|Adverse Event|0|||
162830947|NCT01519765|588093181|FG001|Overall Study|Adverse Event|1|||
162830948|NCT01519765|588093180|FG000|Overall Study|Lack of Efficacy|2|||
162830949|NCT01519765|588093181|FG001|Overall Study|Lack of Efficacy|0|||
162830950|NCT01519765|588093180|FG000|Overall Study|Protocol Violation|1|||
162830951|NCT01519765|588093181|FG001|Overall Study|Protocol Violation|0|||
162830952|NCT01519765|588093180|FG000|Overall Study|Withdrawal by Subject|0|||
162830953|NCT01519765|588093181|FG001|Overall Study|Withdrawal by Subject|1|||
162830954|NCT02943564|588093182|FG000|Overall Study|Miscellaneous Reasons|0|||
162830955|NCT02943564|588093183|FG001|Overall Study|Miscellaneous Reasons|0|||
162830956|NCT02943564|588093184|FG002|Overall Study|Miscellaneous Reasons|3|||
162830957|NCT02943564|588093182|FG000|Overall Study|Site terminated by sponsor|0|||
162830958|NCT02943564|588093183|FG001|Overall Study|Site terminated by sponsor|1|||
162830959|NCT02943564|588093184|FG002|Overall Study|Site terminated by sponsor|0|||
162830960|NCT02943564|588093182|FG000|Overall Study|Non-compliance with study drug|0|||
162830961|NCT02943564|588093183|FG001|Overall Study|Non-compliance with study drug|1|||
162830962|NCT02943564|588093184|FG002|Overall Study|Non-compliance with study drug|0|||
162830963|NCT02943564|588093182|FG000|Overall Study|Pregnancy|0|||
162830964|NCT02943564|588093183|FG001|Overall Study|Pregnancy|1|||
162830965|NCT02943564|588093184|FG002|Overall Study|Pregnancy|1|||
162830966|NCT02943564|588093182|FG000|Overall Study|Protocol Violation|2|||
162830967|NCT02943564|588093183|FG001|Overall Study|Protocol Violation|2|||
162830968|NCT02943564|588093184|FG002|Overall Study|Protocol Violation|2|||
162830969|NCT02943564|588093182|FG000|Overall Study|Lost to Follow-up|1|||
162830970|NCT02943564|588093183|FG001|Overall Study|Lost to Follow-up|0|||
162830971|NCT02943564|588093184|FG002|Overall Study|Lost to Follow-up|0|||
162830972|NCT02943564|588093182|FG000|Overall Study|Withdrawal by Subject|6|||
162830973|NCT02943564|588093183|FG001|Overall Study|Withdrawal by Subject|5|||
162830974|NCT02943564|588093184|FG002|Overall Study|Withdrawal by Subject|2|||
162830975|NCT02943564|588093182|FG000|Overall Study|Adverse Event|1|||
162830976|NCT02943564|588093183|FG001|Overall Study|Adverse Event|2|||
162830977|NCT02943564|588093184|FG002|Overall Study|Adverse Event|1|||
162830978|NCT02943564|588093182|FG000|Overall Study|Lack of Efficacy|0|||
162830979|NCT02943564|588093183|FG001|Overall Study|Lack of Efficacy|1|||
162943359|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
162830980|NCT02943564|588093184|FG002|Overall Study|Lack of Efficacy|0|||
162830981|NCT00932360|588093185|FG000|Washout (One Week)|Withdrawal by Subject|0|||
162830982|NCT00932360|588093186|FG001|Washout (One Week)|Withdrawal by Subject|0|||
162830983|NCT00932360|588093187|FG002|Washout (One Week)|Withdrawal by Subject|0|||
162830984|NCT00932360|588093188|FG003|Washout (One Week)|Withdrawal by Subject|0|||
162830985|NCT00932360|588093189|FG004|Washout (One Week)|Withdrawal by Subject|2|||
162830986|NCT00932360|588093190|FG005|Washout (One Week)|Withdrawal by Subject|0|||
162830987|NCT04143009|588093191|FG000|Pilot Trial|Lost to Follow-up|0|||
162830988|NCT04143009|588093192|FG001|Pilot Trial|Lost to Follow-up|1|||
162698733|NCT06017999|587606836|FG000|Overall Study|Lost to Follow-up|0|||
162830989|NCT04143009|588093193|FG002|Pilot Trial|Lost to Follow-up|1|||
162830990|NCT00781911|588093198|FG000|Overall Study|Adverse Event|4|||
162830991|NCT00781911|588093199|FG001|Overall Study|Adverse Event|4|||
162830992|NCT00781911|588093198|FG000|Overall Study|Withdrawal by Subject|1|||
162830993|NCT00781911|588093199|FG001|Overall Study|Withdrawal by Subject|2|||
162830994|NCT00781911|588093198|FG000|Overall Study|Physician Decision|0|||
162830995|NCT00781911|588093199|FG001|Overall Study|Physician Decision|2|||
162830996|NCT00781911|588093198|FG000|Overall Study|Sponsor Decision|1|||
162830997|NCT00781911|588093199|FG001|Overall Study|Sponsor Decision|0|||
162830998|NCT01357655|588093200|FG000|Overall Study|Administrative Reason by Sponsor|45|||
162830999|NCT01357655|588093201|FG001|Overall Study|Administrative Reason by Sponsor|0|||
162831000|NCT01357655|588093200|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
162831001|NCT01357655|588093201|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162831002|NCT01357655|588093200|FG000|Overall Study|Disease Progression|1|||
162831003|NCT01357655|588093201|FG001|Overall Study|Disease Progression|0|||
162831004|NCT01357655|588093200|FG000|Overall Study|Lost to Follow-up|2|||
162831005|NCT01357655|588093201|FG001|Overall Study|Lost to Follow-up|0|||
162831006|NCT01357655|588093200|FG000|Overall Study|Maximum Clinical Benefit|2|||
162831007|NCT01357655|588093201|FG001|Overall Study|Maximum Clinical Benefit|0|||
162831008|NCT01357655|588093200|FG000|Overall Study|Reason Unspecified|1|||
162831009|NCT01357655|588093201|FG001|Overall Study|Reason Unspecified|0|||
162831010|NCT01357655|588093200|FG000|Overall Study|Study Drug Toxicity|11|||
162831011|NCT01357655|588093201|FG001|Overall Study|Study Drug Toxicity|0|||
162831012|NCT01357655|588093200|FG000|Overall Study|Subject Withdrew Consent|1|||
162831013|NCT01357655|588093201|FG001|Overall Study|Subject Withdrew Consent|0|||
162831014|NCT01624662|588093205|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
162831015|NCT01624662|588093206|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
162831016|NCT01624662|588093207|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
162831017|NCT01624662|588093208|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
162831018|NCT01624662|588093205|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
162831019|NCT01624662|588093206|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
162831020|NCT01624662|588093207|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
162831021|NCT01624662|588093208|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
162831022|NCT01624662|588093205|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162831023|NCT01624662|588093206|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
162831024|NCT01624662|588093207|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162831025|NCT01624662|588093208|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162831026|NCT01624662|588093205|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
162831027|NCT01624662|588093206|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
162831028|NCT01624662|588093207|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
162831029|NCT01624662|588093208|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
162831030|NCT01624662|588093205|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
162831031|NCT01624662|588093206|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
162831032|NCT01624662|588093207|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
162831033|NCT01624662|588093208|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
162831034|NCT01624662|588093205|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162831035|NCT01624662|588093206|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
162831036|NCT01624662|588093207|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162831037|NCT01624662|588093208|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162831038|NCT01624662|588093205|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
162831039|NCT01624662|588093206|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
162831040|NCT01624662|588093207|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
162831041|NCT01624662|588093208|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
162831042|NCT00361270|588093209|FG000|Overall Study|Death|0|||
162831043|NCT00361270|588093210|FG001|Overall Study|Death|0|||
162831044|NCT00361270|588093211|FG002|Overall Study|Death|0|||
162831045|NCT00361270|588093212|FG003|Overall Study|Death|2|||
162831046|NCT00361270|588093209|FG000|Overall Study|Lost to Follow-up|4|||
162831047|NCT00361270|588093210|FG001|Overall Study|Lost to Follow-up|1|||
162831048|NCT00361270|588093211|FG002|Overall Study|Lost to Follow-up|0|||
162831049|NCT00361270|588093212|FG003|Overall Study|Lost to Follow-up|0|||
162831050|NCT00361270|588093209|FG000|Overall Study|Physician Decision|0|||
162831051|NCT00361270|588093210|FG001|Overall Study|Physician Decision|0|||
162831052|NCT00361270|588093211|FG002|Overall Study|Physician Decision|1|||
162831053|NCT00361270|588093212|FG003|Overall Study|Physician Decision|0|||
162831054|NCT00361270|588093209|FG000|Overall Study|Protocol Violation|9|||
162831055|NCT00361270|588093210|FG001|Overall Study|Protocol Violation|4|||
162831056|NCT00361270|588093211|FG002|Overall Study|Protocol Violation|5|||
162943360|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943361|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943362|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943363|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
162943364|NCT01545076|588494455|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
162943365|NCT01545076|588494456|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943366|NCT01545076|588494457|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943367|NCT01545076|588494458|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943368|NCT01545076|588494459|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
162943369|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943370|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943371|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943372|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
162943373|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
162943374|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
162943375|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
162943376|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
162943377|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
162943378|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
162943379|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943380|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
162943381|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
162943382|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943383|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162943384|NCT01545076|588494455|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
162943385|NCT01545076|588494456|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
162943386|NCT01545076|588494457|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
162943387|NCT01545076|588494458|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
162943388|NCT01545076|588494459|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
162943389|NCT00797108|588494463|FG000|Overall Study|Adverse Event|1|||
162943390|NCT00797108|588494464|FG001|Overall Study|Adverse Event|0|||
162943391|NCT00797108|588494465|FG002|Overall Study|Adverse Event|3|||
162943392|NCT00797108|588494463|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
162943393|NCT00797108|588494464|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
162943394|NCT00797108|588494465|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
162943395|NCT00797108|588494463|FG000|Overall Study|Global Deterioration of Health Status|0|||
162943396|NCT00797108|588494464|FG001|Overall Study|Global Deterioration of Health Status|1|||
162943397|NCT00797108|588494465|FG002|Overall Study|Global Deterioration of Health Status|0|||
162943398|NCT00797108|588494463|FG000|Overall Study|Lack of Efficacy|1|||
162943399|NCT00797108|588494464|FG001|Overall Study|Lack of Efficacy|0|||
162943400|NCT00797108|588494465|FG002|Overall Study|Lack of Efficacy|1|||
162943401|NCT00797108|588494463|FG000|Overall Study|Other|0|||
162943402|NCT00797108|588494464|FG001|Overall Study|Other|0|||
162943403|NCT00797108|588494465|FG002|Overall Study|Other|2|||
162943404|NCT00797108|588494463|FG000|Overall Study|Randomized but not Treated|2|||
162943405|NCT00797108|588494464|FG001|Overall Study|Randomized but not Treated|0|||
162943406|NCT00797108|588494465|FG002|Overall Study|Randomized but not Treated|0|||
162943407|NCT01031537|588494466|FG000|Overall Study|medical reasons not related to study|3|||
162943408|NCT01031537|588494466|FG000|Overall Study|Lack of Efficacy|1|||
162943409|NCT01031537|588494466|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
162943410|NCT01031537|588494466|FG000|Overall Study|moved, met exclusion criteria|10|||
162943411|NCT01031537|588494466|FG000|Overall Study|Withdrawal by Subject|5|||
162943412|NCT01031537|588494466|FG000|Overall Study|PI removal, no longer met eligibility|12|||
162943413|NCT00561730|588494475|FG000|Overall Study|Adverse Event|2|||
162943414|NCT00561730|588494475|FG000|Overall Study|Handling of the drug|1|||
162943415|NCT00561730|588494475|FG000|Overall Study|Lost to Follow-up|5|||
162943416|NCT00561730|588494475|FG000|Overall Study|Not specified reasons|1|||
162943417|NCT03194464|588494476|FG000|Overall Study|data not usable|2|||
162943418|NCT03594123|588494477|FG000|Overall Study|Lost to Follow-up|0|||
162943419|NCT03594123|588494478|FG001|Overall Study|Lost to Follow-up|1|||
162943420|NCT03594123|588494477|FG000|Overall Study|Adverse Event|8|||
162943421|NCT03594123|588494478|FG001|Overall Study|Adverse Event|5|||
162943422|NCT03594123|588494477|FG000|Overall Study|Site Terminated by Sponsor|4|||
162943423|NCT03594123|588494478|FG001|Overall Study|Site Terminated by Sponsor|1|||
162943424|NCT03594123|588494477|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
162943425|NCT03594123|588494478|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
162943426|NCT03594123|588494477|FG000|Overall Study|Lack of Efficacy|1|||
162831057|NCT00361270|588093212|FG003|Overall Study|Protocol Violation|4|||
162831058|NCT00361270|588093209|FG000|Overall Study|Withdrawal by Subject|6|||
162831059|NCT00361270|588093210|FG001|Overall Study|Withdrawal by Subject|6|||
162831060|NCT00361270|588093211|FG002|Overall Study|Withdrawal by Subject|3|||
162831061|NCT00361270|588093212|FG003|Overall Study|Withdrawal by Subject|7|||
162831062|NCT00361270|588093209|FG000|Overall Study|Afraid of Hypnosis|1|||
162831063|NCT00361270|588093210|FG001|Overall Study|Afraid of Hypnosis|2|||
162831064|NCT00361270|588093211|FG002|Overall Study|Afraid of Hypnosis|0|||
162831065|NCT00361270|588093212|FG003|Overall Study|Afraid of Hypnosis|0|||
162831066|NCT00361270|588093209|FG000|Overall Study|Problems with Transportation|4|||
162831067|NCT00361270|588093210|FG001|Overall Study|Problems with Transportation|0|||
162831068|NCT00361270|588093211|FG002|Overall Study|Problems with Transportation|0|||
162831069|NCT00361270|588093212|FG003|Overall Study|Problems with Transportation|0|||
162831070|NCT00361270|588093209|FG000|Overall Study|Adverse Event|0|||
162831071|NCT00361270|588093210|FG001|Overall Study|Adverse Event|1|||
162831072|NCT00361270|588093211|FG002|Overall Study|Adverse Event|1|||
162831073|NCT00361270|588093212|FG003|Overall Study|Adverse Event|0|||
162831074|NCT01423851|588093216|FG000|Whole Study|Disease progression|2|||
162831075|NCT01423851|588093217|FG001|Whole Study|Disease progression|1|||
162831076|NCT01423851|588093218|FG002|Whole Study|Disease progression|1|||
162831077|NCT01423851|588093219|FG003|Whole Study|Disease progression|4|||
162831078|NCT01423851|588093220|FG004|Whole Study|Disease progression|1|||
162831079|NCT01423851|588093221|FG005|Whole Study|Disease progression|3|||
162831080|NCT01423851|588093222|FG006|Whole Study|Disease progression|1|||
162831081|NCT01423851|588093223|FG007|Whole Study|Disease progression|4|||
162831082|NCT01423851|588093224|FG008|Whole Study|Disease progression|0|||
162831083|NCT01423851|588093225|FG009|Whole Study|Disease progression|2|||
162831084|NCT01423851|588093226|FG010|Whole Study|Disease progression|10|||
162831085|NCT01423851|588093216|FG000|Whole Study|Physician Decision|0|||
162831086|NCT01423851|588093217|FG001|Whole Study|Physician Decision|1|||
162831087|NCT01423851|588093218|FG002|Whole Study|Physician Decision|2|||
162831088|NCT01423851|588093219|FG003|Whole Study|Physician Decision|0|||
162831089|NCT01423851|588093220|FG004|Whole Study|Physician Decision|2|||
162831090|NCT01423851|588093221|FG005|Whole Study|Physician Decision|0|||
162831091|NCT01423851|588093222|FG006|Whole Study|Physician Decision|2|||
162831092|NCT01423851|588093223|FG007|Whole Study|Physician Decision|1|||
162831093|NCT01423851|588093224|FG008|Whole Study|Physician Decision|3|||
162831094|NCT01423851|588093225|FG009|Whole Study|Physician Decision|4|||
162831095|NCT01423851|588093226|FG010|Whole Study|Physician Decision|12|||
162831096|NCT01423851|588093216|FG000|Whole Study|Withdrawal by Subject|1|||
162831097|NCT01423851|588093217|FG001|Whole Study|Withdrawal by Subject|1|||
162831098|NCT01423851|588093218|FG002|Whole Study|Withdrawal by Subject|0|||
162831099|NCT01423851|588093219|FG003|Whole Study|Withdrawal by Subject|0|||
162831100|NCT01423851|588093220|FG004|Whole Study|Withdrawal by Subject|0|||
162831101|NCT01423851|588093221|FG005|Whole Study|Withdrawal by Subject|0|||
162831102|NCT01423851|588093222|FG006|Whole Study|Withdrawal by Subject|0|||
162831103|NCT01423851|588093223|FG007|Whole Study|Withdrawal by Subject|0|||
162831104|NCT01423851|588093224|FG008|Whole Study|Withdrawal by Subject|2|||
162831105|NCT01423851|588093225|FG009|Whole Study|Withdrawal by Subject|0|||
162831106|NCT01423851|588093226|FG010|Whole Study|Withdrawal by Subject|4|||
162831107|NCT01423851|588093216|FG000|Whole Study|Adverse Event|0|||
162831108|NCT01423851|588093217|FG001|Whole Study|Adverse Event|0|||
162831109|NCT01423851|588093218|FG002|Whole Study|Adverse Event|0|||
162831110|NCT01423851|588093219|FG003|Whole Study|Adverse Event|2|||
162831111|NCT01423851|588093220|FG004|Whole Study|Adverse Event|0|||
162831112|NCT01423851|588093221|FG005|Whole Study|Adverse Event|0|||
162831113|NCT01423851|588093222|FG006|Whole Study|Adverse Event|0|||
162831114|NCT01423851|588093223|FG007|Whole Study|Adverse Event|3|||
162831115|NCT01423851|588093224|FG008|Whole Study|Adverse Event|3|||
162831116|NCT01423851|588093225|FG009|Whole Study|Adverse Event|2|||
162831117|NCT01423851|588093226|FG010|Whole Study|Adverse Event|3|||
162831118|NCT00874120|588094501|FG000|First Intervention|Adverse Event|0|||
162831119|NCT00874120|588094502|FG001|First Intervention|Adverse Event|1|||
162831120|NCT00874120|588094501|FG000|First Intervention|Withdrawal by Subject|2|||
162831121|NCT00874120|588094502|FG001|First Intervention|Withdrawal by Subject|0|||
162831122|NCT00874120|588094501|FG000|First Intervention|Lost to Follow-up|0|||
162831123|NCT00874120|588094502|FG001|First Intervention|Lost to Follow-up|1|||
162831124|NCT00874120|588094501|FG000|First Intervention|Protocol Violation|3|||
162831125|NCT00874120|588094502|FG001|First Intervention|Protocol Violation|0|||
162831126|NCT00874120|588094501|FG000|First Intervention|positive drug test|1|||
162831127|NCT00874120|588094502|FG001|First Intervention|positive drug test|0|||
162831128|NCT00874120|588094501|FG000|Second Intervention|Withdrawal by Subject|1|||
162831129|NCT00874120|588094502|FG001|Second Intervention|Withdrawal by Subject|0|||
162831130|NCT00874120|588094501|FG000|Second Intervention|Protocol Violation|1|||
162831131|NCT00874120|588094502|FG001|Second Intervention|Protocol Violation|0|||
162831132|NCT00105443|588094508|FG000|Double-Blind Treatment|Adverse Event|1|||
162831133|NCT00105443|588094509|FG001|Double-Blind Treatment|Adverse Event|0|||
162831134|NCT00105443|588094510|FG002|Double-Blind Treatment|Adverse Event|0|||
162831135|NCT00105443|588094511|FG003|Double-Blind Treatment|Adverse Event|0|||
162831136|NCT00105443|588094508|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
162943427|NCT03594123|588494478|FG001|Overall Study|Lack of Efficacy|0|||
162943428|NCT03594123|588494477|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
162943429|NCT03594123|588494478|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
162943430|NCT01766921|588494479|FG000|Overall Study|Administrative Reason|5|||
162943431|NCT01766921|588494480|FG001|Overall Study|Administrative Reason|5|||
162943432|NCT01766921|588494479|FG000|Overall Study|Death|1|||
162943433|NCT01766921|588494480|FG001|Overall Study|Death|1|||
162943434|NCT01766921|588494479|FG000|Overall Study|Lost to Follow-up|1|||
162943435|NCT01766921|588494480|FG001|Overall Study|Lost to Follow-up|3|||
162943436|NCT01766921|588494479|FG000|Overall Study|Unclassified|2|||
162943437|NCT01766921|588494480|FG001|Overall Study|Unclassified|2|||
162943438|NCT01766921|588494479|FG000|Overall Study|Protocol Violation|1|||
162943439|NCT01766921|588494480|FG001|Overall Study|Protocol Violation|1|||
162943440|NCT01766921|588494479|FG000|Overall Study|Withdrawal by Subject|14|||
162943441|NCT01766921|588494480|FG001|Overall Study|Withdrawal by Subject|5|||
162943442|NCT02549495|588494486|FG000|Overall Study|Death|2|||
162943443|NCT02549495|588494486|FG000|Overall Study|Withdrawal by Subject|5|||
162943444|NCT02549495|588494486|FG000|Overall Study|Physician Decision|22|||
162943445|NCT02549495|588494486|FG000|Overall Study|Lost to Follow-up|6|||
162943446|NCT02549495|588494486|FG000|Overall Study|Protocol Violation|6|||
162943447|NCT03276975|588494489|FG000|Overall Study|Withdrawal by Subject|1|||
162943448|NCT03276975|588494490|FG001|Overall Study|Withdrawal by Subject|0|||
162943449|NCT01463683|588494491|FG000|Overall Study|Adverse Event|2|||
162943450|NCT01463683|588494492|FG001|Overall Study|Adverse Event|0|||
162943451|NCT01463683|588494493|FG002|Overall Study|Adverse Event|0|||
162943452|NCT01463683|588494491|FG000|Overall Study|Lost to Follow-up|10|||
162943453|NCT01463683|588494492|FG001|Overall Study|Lost to Follow-up|9|||
162943454|NCT01463683|588494493|FG002|Overall Study|Lost to Follow-up|7|||
162943455|NCT01463683|588494491|FG000|Overall Study|Physician Decision|0|||
162943456|NCT01463683|588494492|FG001|Overall Study|Physician Decision|3|||
162943457|NCT01463683|588494493|FG002|Overall Study|Physician Decision|1|||
162943458|NCT01463683|588494491|FG000|Overall Study|Pregnancy|2|||
162943459|NCT01463683|588494492|FG001|Overall Study|Pregnancy|2|||
162943460|NCT01463683|588494493|FG002|Overall Study|Pregnancy|1|||
162943461|NCT01463683|588494491|FG000|Overall Study|Withdrawal by Subject|5|||
162943462|NCT01463683|588494492|FG001|Overall Study|Withdrawal by Subject|17|||
162943463|NCT01463683|588494493|FG002|Overall Study|Withdrawal by Subject|2|||
162943464|NCT03111147|588494494|FG000|Overall Study|Lost to Follow-up|2|||
162943465|NCT03111147|588494495|FG001|Overall Study|Lost to Follow-up|5|||
162943466|NCT03111147|588494494|FG000|Overall Study|Withdrawal by Subject|4|||
162943467|NCT03111147|588494495|FG001|Overall Study|Withdrawal by Subject|3|||
162943468|NCT03111147|588494494|FG000|Overall Study|Protocol Violation|2|||
162943469|NCT03111147|588494495|FG001|Overall Study|Protocol Violation|1|||
162943470|NCT03111147|588494494|FG000|Overall Study|Death|1|||
162943471|NCT03111147|588494495|FG001|Overall Study|Death|1|||
162943472|NCT01058421|588494496|FG000|1 Month Outcomes|Death|10|||
162943473|NCT01058421|588494497|FG001|1 Month Outcomes|Death|6|||
162943474|NCT01058421|588494496|FG000|1 Month Outcomes|Lost to Follow-up|8|||
162943475|NCT01058421|588494497|FG001|1 Month Outcomes|Lost to Follow-up|7|||
162943476|NCT01058421|588494496|FG000|1 Month Outcomes|Remained in Hospital|5|||
162943477|NCT01058421|588494497|FG001|1 Month Outcomes|Remained in Hospital|12|||
162943478|NCT01058421|588494496|FG000|1 Month Outcomes|Remained in Other Facility|16|||
162943479|NCT01058421|588494497|FG001|1 Month Outcomes|Remained in Other Facility|17|||
162943480|NCT01058421|588494496|FG000|3 Month Outcomes|Death|3|||
162943481|NCT01058421|588494497|FG001|3 Month Outcomes|Death|5|||
162943482|NCT01058421|588494496|FG000|3 Month Outcomes|Lost to Follow-up|12|||
162943483|NCT01058421|588494497|FG001|3 Month Outcomes|Lost to Follow-up|11|||
162943484|NCT01058421|588494496|FG000|3 Month Outcomes|Remained in Hospital|0|||
162943485|NCT01058421|588494497|FG001|3 Month Outcomes|Remained in Hospital|2|||
162943486|NCT01058421|588494496|FG000|3 Month Outcomes|Remained in Other Facility|5|||
162943487|NCT01058421|588494497|FG001|3 Month Outcomes|Remained in Other Facility|8|||
162943488|NCT01058421|588494496|FG000|6 Month Outcomes|Death|2|||
162943489|NCT01058421|588494497|FG001|6 Month Outcomes|Death|2|||
162943490|NCT01058421|588494496|FG000|6 Month Outcomes|Lost to Follow-up|16|||
162943491|NCT01058421|588494497|FG001|6 Month Outcomes|Lost to Follow-up|21|||
162943492|NCT01058421|588494496|FG000|6 Month Outcomes|Remained in Other Facility|1|||
162943493|NCT01058421|588494497|FG001|6 Month Outcomes|Remained in Other Facility|3|||
162943494|NCT02779855|588494498|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
162943495|NCT02779855|588494499|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
162943496|NCT02779855|588494500|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
162943497|NCT00365352|588494507|FG000|Overall Study|Adverse Event|6|||
162943498|NCT00365352|588494508|FG001|Overall Study|Adverse Event|7|||
162943499|NCT00365352|588494509|FG002|Overall Study|Adverse Event|8|||
162943500|NCT00365352|588494507|FG000|Overall Study|Participant Withdrew Consent|8|||
162943501|NCT00365352|588494508|FG001|Overall Study|Participant Withdrew Consent|3|||
162943502|NCT00365352|588494509|FG002|Overall Study|Participant Withdrew Consent|4|||
162943503|NCT00365352|588494507|FG000|Overall Study|Lack of Efficacy|3|||
162943504|NCT00365352|588494508|FG001|Overall Study|Lack of Efficacy|0|||
162943505|NCT00365352|588494509|FG002|Overall Study|Lack of Efficacy|0|||
162943506|NCT00365352|588494507|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
162943507|NCT00365352|588494508|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
162943508|NCT00365352|588494509|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
162943509|NCT00365352|588494507|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
162943510|NCT00365352|588494508|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
162943511|NCT00365352|588494509|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
162943512|NCT00365352|588494507|FG000|Overall Study|Lost to Follow-up|1|||
162943513|NCT00365352|588494508|FG001|Overall Study|Lost to Follow-up|1|||
162943514|NCT00365352|588494509|FG002|Overall Study|Lost to Follow-up|0|||
162943515|NCT00365352|588494507|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
162943516|NCT00365352|588494508|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
162943517|NCT00365352|588494509|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
162943518|NCT02581345|588496170|FG000|Part 1: up to Week 16|Adverse Event|3|||
162943519|NCT02581345|588496171|FG001|Part 1: up to Week 16|Adverse Event|8|||
162943520|NCT02581345|588496172|FG002|Part 1: up to Week 16|Adverse Event|0|||
162943521|NCT02581345|588496173|FG003|Part 1: up to Week 16|Adverse Event|0|||
162943522|NCT02581345|588496170|FG000|Part 1: up to Week 16|Physician Decision|2|||
162943523|NCT02581345|588496171|FG001|Part 1: up to Week 16|Physician Decision|4|||
162943524|NCT02581345|588496172|FG002|Part 1: up to Week 16|Physician Decision|0|||
162943525|NCT02581345|588496173|FG003|Part 1: up to Week 16|Physician Decision|0|||
162943526|NCT02581345|588496170|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
162943527|NCT02581345|588496171|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
162943528|NCT02581345|588496172|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
162831137|NCT00105443|588094509|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
162831138|NCT00105443|588094510|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
162831139|NCT00105443|588094511|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
162831140|NCT00105443|588094508|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
162831141|NCT00105443|588094509|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
162831142|NCT00105443|588094510|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
162831143|NCT00105443|588094511|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
162831144|NCT00105443|588094508|FG000|Double-Blind Treatment|Physician Decision|1|||
162831145|NCT00105443|588094509|FG001|Double-Blind Treatment|Physician Decision|0|||
162831146|NCT00105443|588094510|FG002|Double-Blind Treatment|Physician Decision|2|||
162831147|NCT00105443|588094511|FG003|Double-Blind Treatment|Physician Decision|0|||
162831148|NCT00105443|588094508|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
162831149|NCT00105443|588094509|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
162831150|NCT00105443|588094510|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
162831151|NCT00105443|588094511|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
162831152|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
162831153|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
162831154|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
162831155|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
162831156|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
162831157|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
162831158|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
162831159|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
162831160|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
162831161|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
162831162|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
162831163|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
162831164|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
162831165|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
162831166|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
162831167|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
162831168|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
162831169|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
162831170|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
162831171|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
162831172|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
162831173|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
162831174|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
162831175|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
162831176|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
162831177|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
162831178|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
162831179|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
162831180|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
162831181|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
162831182|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
162831183|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
162831184|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
162831185|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
162831186|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
162831187|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
162831188|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
162831189|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
162831190|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
162831191|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
162831192|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
162831193|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
162831194|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
162831195|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
162831196|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
162831197|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
162831198|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
162831199|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
162831200|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
162831201|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
162831202|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
162831203|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
162831204|NCT00105443|588094508|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
162831205|NCT00105443|588094509|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
162831206|NCT00105443|588094510|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
162831207|NCT00105443|588094511|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
162831208|NCT01623271|588094514|FG000|Overall Study|Withdrawal by Subject|2|||
162831209|NCT02037295|588094517|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
162831210|NCT02037295|588094518|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
162831211|NCT02037295|588094519|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
162831212|NCT02037295|588094520|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
162943529|NCT02581345|588496173|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
162943530|NCT02581345|588496170|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
162943531|NCT02581345|588496171|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
162943532|NCT02581345|588496172|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
162943533|NCT02581345|588496173|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
162943534|NCT02581345|588496170|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
162943535|NCT02581345|588496171|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
162943536|NCT02581345|588496172|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
162943537|NCT02581345|588496173|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
162943538|NCT02581345|588496170|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
162943539|NCT02581345|588496171|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
162943540|NCT02581345|588496172|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
162943541|NCT02581345|588496173|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
162943542|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
162943543|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
162943544|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
162943545|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
162943546|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
162943547|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
162943548|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
162943549|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
162943550|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
162943551|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
162943552|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
162943553|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
162943554|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
162943555|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
162943556|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
162943557|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
162943558|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
162943559|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
162943560|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
162943561|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
162943562|NCT02581345|588496170|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
162943563|NCT02581345|588496171|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
162943564|NCT02581345|588496172|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
162943565|NCT02581345|588496173|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
162943566|NCT02819362|588496183|FG000|Overall Study|On-site MRI could not be performed|70|||
162943567|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
162943568|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
162943569|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
162943570|NCT05456529|588496184|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
162943571|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
162943572|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
162943573|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Physician Decision|2|||
162943574|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
162943575|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
162943576|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
162943577|NCT05456529|588496184|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
162943578|NCT02518113|588496185|FG000|Overall Study|Adverse Event|1|||
162943579|NCT02518113|588496186|FG001|Overall Study|Adverse Event|0|||
162943580|NCT02518113|588496187|FG002|Overall Study|Adverse Event|1|||
162943581|NCT02518113|588496188|FG003|Overall Study|Adverse Event|0|||
162943582|NCT02518113|588496185|FG000|Overall Study|Death|1|||
162943583|NCT02518113|588496186|FG001|Overall Study|Death|2|||
162943584|NCT02518113|588496187|FG002|Overall Study|Death|0|||
162943585|NCT02518113|588496188|FG003|Overall Study|Death|0|||
162943586|NCT02518113|588496185|FG000|Overall Study|Physician Decision|0|||
162943587|NCT02518113|588496186|FG001|Overall Study|Physician Decision|1|||
162943588|NCT02518113|588496187|FG002|Overall Study|Physician Decision|0|||
162943589|NCT02518113|588496188|FG003|Overall Study|Physician Decision|0|||
162943590|NCT02518113|588496185|FG000|Overall Study|Progressive Disease|1|||
162943591|NCT02518113|588496186|FG001|Overall Study|Progressive Disease|2|||
162943592|NCT02518113|588496187|FG002|Overall Study|Progressive Disease|3|||
162943593|NCT02518113|588496188|FG003|Overall Study|Progressive Disease|0|||
162943594|NCT02710123|588496189|FG000|Overall Study|Lost to Follow-up|3|||
162943595|NCT02710123|588496190|FG001|Overall Study|Lost to Follow-up|4|||
162943596|NCT02710123|588496189|FG000|Overall Study|Withdrawal by Subject|1|||
162943597|NCT02710123|588496190|FG001|Overall Study|Withdrawal by Subject|1|||
162943598|NCT02710123|588496189|FG000|Overall Study|Illness unrelated to study intervention|1|||
162943599|NCT02710123|588496190|FG001|Overall Study|Illness unrelated to study intervention|0|||
162943600|NCT02750761|588496196|FG000|Overall Study|Lost to Follow-up|0|||
162943601|NCT02750761|588496197|FG001|Overall Study|Lost to Follow-up|0|||
162943602|NCT02750761|588496198|FG002|Overall Study|Lost to Follow-up|1|||
162698734|NCT06017999|587606837|FG001|Overall Study|Lost to Follow-up|0|||
162943603|NCT02750761|588496199|FG003|Overall Study|Lost to Follow-up|0|||
162943604|NCT02750761|588496200|FG004|Overall Study|Lost to Follow-up|0|||
162943605|NCT02750761|588496201|FG005|Overall Study|Lost to Follow-up|0|||
162943606|NCT01860976|588496202|FG000|Blinded Treatment|Adverse Event|1|||
162943607|NCT01860976|588496203|FG001|Blinded Treatment|Adverse Event|3|||
162943608|NCT01860976|588496202|FG000|Blinded Treatment|Lack of Efficacy|5|||
162943609|NCT01860976|588496203|FG001|Blinded Treatment|Lack of Efficacy|12|||
162943610|NCT01860976|588496202|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
162943611|NCT01860976|588496203|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
162943612|NCT01860976|588496202|FG000|Blinded Treatment|Withdrawal by Subject|3|||
162943613|NCT01860976|588496203|FG001|Blinded Treatment|Withdrawal by Subject|5|||
162943614|NCT01860976|588496202|FG000|Blinded Treatment|Subject no longer met criteria|1|||
162943615|NCT01860976|588496203|FG001|Blinded Treatment|Subject no longer met criteria|0|||
162943616|NCT01860976|588496202|FG000|Blinded Treatment|Entered Open-Label in error|0|||
162943617|NCT01860976|588496203|FG001|Blinded Treatment|Entered Open-Label in error|1|||
162943618|NCT01860976|588496202|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
162943619|NCT01860976|588496203|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
162943620|NCT01860976|588496202|FG000|Open-Label|Adverse Event|2|||
162943621|NCT01860976|588496203|FG001|Open-Label|Adverse Event|4|||
162943622|NCT01860976|588496202|FG000|Open-Label|Lack of Efficacy|16|||
162943623|NCT01860976|588496203|FG001|Open-Label|Lack of Efficacy|8|||
162943624|NCT01860976|588496202|FG000|Open-Label|Lost to Follow-up|1|||
162943625|NCT01860976|588496203|FG001|Open-Label|Lost to Follow-up|2|||
162943626|NCT01860976|588496202|FG000|Open-Label|Subject request discontinue treatment|4|||
162943627|NCT01860976|588496203|FG001|Open-Label|Subject request discontinue treatment|3|||
162943628|NCT01860976|588496202|FG000|Open-Label|Withdrawal by Subject|4|||
162943629|NCT01860976|588496203|FG001|Open-Label|Withdrawal by Subject|1|||
162943630|NCT01860976|588496202|FG000|Open-Label|Other Reasons|1|||
162943631|NCT01860976|588496203|FG001|Open-Label|Other Reasons|1|||
162943632|NCT01860976|588496202|FG000|Long Term Extension|Adverse Event|4|||
162943633|NCT01860976|588496203|FG001|Long Term Extension|Adverse Event|0|||
162943634|NCT01860976|588496202|FG000|Long Term Extension|Lack of Efficacy|2|||
162943635|NCT01860976|588496203|FG001|Long Term Extension|Lack of Efficacy|0|||
162943636|NCT01860976|588496202|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
162943637|NCT01860976|588496203|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
162943638|NCT01860976|588496202|FG000|Long Term Extension|Lost to Follow-up|2|||
162943639|NCT01860976|588496203|FG001|Long Term Extension|Lost to Follow-up|0|||
162943640|NCT01860976|588496202|FG000|Long Term Extension|subject withdrew consent|7|||
162943641|NCT01860976|588496203|FG001|Long Term Extension|subject withdrew consent|0|||
162943642|NCT00419926|588496204|FG000|Overall Study|Withdrawal by Subject|7|||
162943643|NCT00419926|588496205|FG001|Overall Study|Withdrawal by Subject|3|||
162943644|NCT00419926|588496204|FG000|Overall Study|Administrative Problem|4|||
162943645|NCT00419926|588496205|FG001|Overall Study|Administrative Problem|4|||
162943646|NCT00419926|588496204|FG000|Overall Study|Lost to Follow-up|1|||
162943647|NCT00419926|588496205|FG001|Overall Study|Lost to Follow-up|2|||
162943648|NCT00419926|588496204|FG000|Overall Study|Death|2|||
162943649|NCT00419926|588496205|FG001|Overall Study|Death|1|||
162943650|NCT02153398|588496207|FG000|Overall Study|Withdrawal by Subject|1|||
162943651|NCT02153398|588496208|FG001|Overall Study|Withdrawal by Subject|0|||
162943652|NCT02153398|588496209|FG002|Overall Study|Withdrawal by Subject|0|||
162943653|NCT02153398|588496210|FG003|Overall Study|Withdrawal by Subject|0|||
162943654|NCT02153398|588496211|FG004|Overall Study|Withdrawal by Subject|0|||
162943655|NCT02153398|588496207|FG000|Overall Study|Adverse Event|0|||
162943656|NCT02153398|588496208|FG001|Overall Study|Adverse Event|0|||
162943657|NCT02153398|588496209|FG002|Overall Study|Adverse Event|1|||
162943658|NCT02153398|588496210|FG003|Overall Study|Adverse Event|1|||
162943659|NCT02153398|588496211|FG004|Overall Study|Adverse Event|0|||
162943660|NCT02374918|588496212|FG000|Overall Study|Protocol Violation|2|||
162943661|NCT02374918|588496213|FG001|Overall Study|Protocol Violation|0|||
162943662|NCT02374918|588496214|FG002|Overall Study|Protocol Violation|2|||
162943663|NCT02374918|588496215|FG003|Overall Study|Protocol Violation|1|||
162943664|NCT02374918|588496212|FG000|Overall Study|Withdrawal by Subject|1|||
162943665|NCT02374918|588496213|FG001|Overall Study|Withdrawal by Subject|1|||
162943666|NCT02374918|588496214|FG002|Overall Study|Withdrawal by Subject|1|||
162943667|NCT02374918|588496215|FG003|Overall Study|Withdrawal by Subject|0|||
162943668|NCT02374918|588496212|FG000|Overall Study|Lack of Efficacy|0|||
162943669|NCT02374918|588496213|FG001|Overall Study|Lack of Efficacy|0|||
162943670|NCT02374918|588496214|FG002|Overall Study|Lack of Efficacy|1|||
162943671|NCT02374918|588496215|FG003|Overall Study|Lack of Efficacy|1|||
162943672|NCT02204371|588496217|FG000|Overall Study|Adverse Event|1|||
162943673|NCT00810368|588496218|FG000|Overall Study|Lost to Follow-up|4|||
162943674|NCT00810368|588496219|FG001|Overall Study|Lost to Follow-up|2|||
162943675|NCT00810368|588496218|FG000|Overall Study|Lack of Efficacy|2|||
162943676|NCT00810368|588496219|FG001|Overall Study|Lack of Efficacy|0|||
162943677|NCT01506947|588496220|FG000|Overall Study|Lost to Follow-up|7|||
162943678|NCT01506947|588496220|FG000|Overall Study|Adverse Event|5|||
162943679|NCT01506947|588496220|FG000|Overall Study|Death|1|||
162943680|NCT01506947|588496220|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
162943681|NCT03803943|588496223|FG000|Overall Study|Withdrawal by Subject|2|||
162943682|NCT03803943|588496224|FG001|Overall Study|Withdrawal by Subject|2|||
162943683|NCT03803943|588496225|FG002|Overall Study|Withdrawal by Subject|2|||
162943684|NCT03803943|588496226|FG003|Overall Study|Withdrawal by Subject|2|||
162943685|NCT01781286|588496229|FG000|Overall Study|Lost to Follow-up|0|||
162943686|NCT01781286|588496230|FG001|Overall Study|Lost to Follow-up|0|||
162943687|NCT01781286|588496231|FG002|Overall Study|Lost to Follow-up|0|||
162943688|NCT01781286|588496232|FG003|Overall Study|Lost to Follow-up|0|||
162943689|NCT01781286|588496233|FG004|Overall Study|Lost to Follow-up|0|||
162943690|NCT01781286|588496234|FG005|Overall Study|Lost to Follow-up|1|||
162943691|NCT01781286|588496229|FG000|Overall Study|Time Constraints|2|||
162943692|NCT01781286|588496230|FG001|Overall Study|Time Constraints|0|||
162943693|NCT01781286|588496231|FG002|Overall Study|Time Constraints|2|||
162943694|NCT01781286|588496232|FG003|Overall Study|Time Constraints|0|||
162943695|NCT01781286|588496233|FG004|Overall Study|Time Constraints|0|||
162943696|NCT01781286|588496234|FG005|Overall Study|Time Constraints|0|||
162943697|NCT01781286|588496229|FG000|Overall Study|Noncompliance|0|||
162943698|NCT01781286|588496230|FG001|Overall Study|Noncompliance|0|||
162943699|NCT01781286|588496231|FG002|Overall Study|Noncompliance|0|||
162943700|NCT01781286|588496232|FG003|Overall Study|Noncompliance|1|||
162943701|NCT01781286|588496233|FG004|Overall Study|Noncompliance|0|||
162943702|NCT01781286|588496234|FG005|Overall Study|Noncompliance|0|||
162831213|NCT02770547|588094524|FG000|Overall Study|Patient non-compliant|1|||
162831214|NCT02770547|588094525|FG001|Overall Study|Patient non-compliant|0|||
162831215|NCT02770547|588094524|FG000|Overall Study|Adverse Event|0|||
162831216|NCT02770547|588094525|FG001|Overall Study|Adverse Event|1|||
162831217|NCT00661531|588094526|FG000|Overall Study|Withdrawal by Subject|3|||
162831218|NCT03134599|588094528|FG000|Week 1|Lost to Follow-up|0|||
162831219|NCT03134599|588094529|FG001|Week 1|Lost to Follow-up|0|||
162831220|NCT03134599|588094530|FG002|Week 1|Lost to Follow-up|0|||
162831221|NCT03134599|588094531|FG003|Week 1|Lost to Follow-up|0|||
162831222|NCT03134599|588094532|FG004|Week 1|Lost to Follow-up|1|||
162831223|NCT03134599|588094533|FG005|Week 1|Lost to Follow-up|0|||
162831224|NCT03134599|588094528|FG000|Week 2|Lost to Follow-up|1|||
162831225|NCT03134599|588094529|FG001|Week 2|Lost to Follow-up|0|||
162831226|NCT03134599|588094530|FG002|Week 2|Lost to Follow-up|0|||
162831227|NCT03134599|588094531|FG003|Week 2|Lost to Follow-up|1|||
162831228|NCT03134599|588094532|FG004|Week 2|Lost to Follow-up|1|||
162831229|NCT03134599|588094533|FG005|Week 2|Lost to Follow-up|0|||
162831230|NCT03134599|588094528|FG000|Week 3|Lost to Follow-up|0|||
162831231|NCT03134599|588094529|FG001|Week 3|Lost to Follow-up|0|||
162831232|NCT03134599|588094530|FG002|Week 3|Lost to Follow-up|0|||
162831233|NCT03134599|588094531|FG003|Week 3|Lost to Follow-up|1|||
162831234|NCT03134599|588094532|FG004|Week 3|Lost to Follow-up|0|||
162831235|NCT03134599|588094533|FG005|Week 3|Lost to Follow-up|1|||
162831236|NCT00393887|588094534|FG000|Overall Study|Physician Decision|5|||
162831237|NCT00393887|588094535|FG001|Overall Study|Physician Decision|0|||
162831238|NCT00393887|588094534|FG000|Overall Study|Lost to Follow-up|11|||
162831239|NCT00393887|588094535|FG001|Overall Study|Lost to Follow-up|9|||
162831240|NCT02311153|588094536|FG000|Overall Study|Lost to Follow-up|5|||
162831241|NCT02311153|588094537|FG001|Overall Study|Lost to Follow-up|7|||
162831242|NCT01967628|588094538|FG000|Overall Study|Withdrawal by Subject|2|||
162831243|NCT01967628|588094539|FG001|Overall Study|Withdrawal by Subject|0|||
162831244|NCT01967628|588094538|FG000|Overall Study|Unable to complete bronchoscopy|4|||
162831245|NCT01967628|588094539|FG001|Overall Study|Unable to complete bronchoscopy|6|||
162831246|NCT01967628|588094538|FG000|Overall Study|Lost to Follow-up|1|||
162831247|NCT01967628|588094539|FG001|Overall Study|Lost to Follow-up|0|||
162831248|NCT01967628|588094538|FG000|Overall Study|Low protein concentration in sample|20|||
162831249|NCT01967628|588094539|FG001|Overall Study|Low protein concentration in sample|25|||
162831250|NCT00838331|588094540|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
162831251|NCT01379274|588094541|FG000|Overall Study|funding withdrawn|1|||
162831252|NCT03287219|588094542|FG000|Overall Study|Protocol Violation|0|||
162831253|NCT03287219|588094543|FG001|Overall Study|Protocol Violation|2|||
162831254|NCT00957008|588094544|FG000|Overall Study|Withdrawal by Subject|13|||
162831255|NCT00957008|588094545|FG001|Overall Study|Withdrawal by Subject|10|||
162831256|NCT00957008|588094546|FG002|Overall Study|Withdrawal by Subject|12|||
162831257|NCT00957008|588094547|FG003|Overall Study|Withdrawal by Subject|16|||
162831258|NCT00957008|588094544|FG000|Overall Study|Lost to Follow-up|3|||
162831259|NCT00957008|588094545|FG001|Overall Study|Lost to Follow-up|1|||
162831260|NCT00957008|588094546|FG002|Overall Study|Lost to Follow-up|3|||
162831261|NCT00957008|588094547|FG003|Overall Study|Lost to Follow-up|4|||
162831262|NCT00957008|588094544|FG000|Overall Study|Physician Decision|1|||
162831263|NCT00957008|588094545|FG001|Overall Study|Physician Decision|0|||
162831264|NCT00957008|588094546|FG002|Overall Study|Physician Decision|1|||
162831265|NCT00957008|588094547|FG003|Overall Study|Physician Decision|1|||
162831266|NCT00957008|588094544|FG000|Overall Study|Relocated; Family conflict|4|||
162831267|NCT00957008|588094545|FG001|Overall Study|Relocated; Family conflict|1|||
162831268|NCT00957008|588094546|FG002|Overall Study|Relocated; Family conflict|1|||
162831269|NCT00957008|588094547|FG003|Overall Study|Relocated; Family conflict|3|||
162831270|NCT01118351|588094548|FG000|Overall Study|Adverse Event|3|||
162831271|NCT01118351|588094548|FG000|Overall Study|Withdrawal by Subject|1|||
162831272|NCT00811135|588094549|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
162831273|NCT00811135|588094549|FG000|Overall Study|Death|3|||
162831274|NCT00811135|588094549|FG000|Overall Study|Protocol Violation|2|||
162831275|NCT00811135|588094549|FG000|Overall Study|Violation of Selection Criteria|1|||
162831276|NCT00811135|588094549|FG000|Overall Study|Refused Treatment|1|||
162831277|NCT00811135|588094549|FG000|Overall Study|Withdrawal by Subject|3|||
162831278|NCT00811135|588094549|FG000|Overall Study|Administrative/Other Unspecified|11|||
162831279|NCT00811135|588094549|FG000|Overall Study|Ongoing|59|||
162831280|NCT02192827|588094557|FG000|Overall Study|Lost to Follow-up|25|||
162831281|NCT02192827|588094558|FG001|Overall Study|Lost to Follow-up|27|||
162831282|NCT02192827|588094557|FG000|Overall Study|Given additional steroids with admission|13|||
162831283|NCT02192827|588094558|FG001|Overall Study|Given additional steroids with admission|11|||
162831284|NCT01265797|588094565|FG000|Run-in Month|Withdrawal by Subject|0|||
162831285|NCT01265797|588094566|FG001|Run-in Month|Withdrawal by Subject|4|||
162831286|NCT01265797|588094565|FG000|Run-in Month|1st seizure during run-in month|0|||
162831287|NCT01265797|588094566|FG001|Run-in Month|1st seizure during run-in month|1|||
162831288|NCT01265797|588094565|FG000|Blinded Month|Lack of Efficacy|5|||
162831289|NCT01265797|588094566|FG001|Blinded Month|Lack of Efficacy|0|||
162831290|NCT01265797|588094565|FG000|Blinded Month|Lost to Follow-up|1|||
162831291|NCT01265797|588094566|FG001|Blinded Month|Lost to Follow-up|0|||
162943703|NCT00995410|588496235|FG000|Overall Study|Adverse Event|51|||
162943704|NCT00995410|588496235|FG000|Overall Study|Withdrawal by Subject|7|||
162943705|NCT00995410|588496235|FG000|Overall Study|Lost to Follow-up|2|||
162943706|NCT00995410|588496235|FG000|Overall Study|Misc|28|||
162943707|NCT03365375|588496236|FG000|Overall Study|Withdrawal by Subject|0|||
162943708|NCT03365375|588496237|FG001|Overall Study|Withdrawal by Subject|1|||
162943709|NCT03365375|588496236|FG000|Overall Study|Lost to Follow-up|0|||
162943710|NCT03365375|588496237|FG001|Overall Study|Lost to Follow-up|4|||
162943711|NCT02187042|588496238|FG000|Overall Study|Death|1|||
162943712|NCT02187042|588496239|FG001|Overall Study|Death|1|||
162943713|NCT02187042|588496238|FG000|Overall Study|Toxicity|6|||
162943714|NCT02187042|588496239|FG001|Overall Study|Toxicity|5|||
162943715|NCT02187042|588496238|FG000|Overall Study|Participant choice|1|||
162943716|NCT02187042|588496239|FG001|Overall Study|Participant choice|0|||
162943717|NCT02187042|588496238|FG000|Overall Study|Doctor choice|1|||
162943718|NCT02187042|588496239|FG001|Overall Study|Doctor choice|0|||
162943719|NCT02187042|588496238|FG000|Overall Study|Progressive disease|4|||
162943720|NCT02187042|588496239|FG001|Overall Study|Progressive disease|8|||
162943721|NCT03019965|588496246|FG000|Overall Study|Withdrawal by Subject|1|||
162943722|NCT03019965|588496247|FG001|Overall Study|Withdrawal by Subject|0|||
162943723|NCT03019965|588496246|FG000|Overall Study|Protocol Violation|1|||
162943724|NCT03019965|588496247|FG001|Overall Study|Protocol Violation|3|||
162943725|NCT03019965|588496246|FG000|Overall Study|viral or fungal infection|3|||
162943726|NCT03019965|588496247|FG001|Overall Study|viral or fungal infection|4|||
162943727|NCT03019965|588496246|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
162943728|NCT03019965|588496247|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
162943729|NCT03019965|588496246|FG000|Overall Study|Physician Decision|1|||
162943730|NCT03019965|588496247|FG001|Overall Study|Physician Decision|1|||
162943731|NCT00337571|588496248|FG000|Overall Study|Lack of Efficacy|3|||
162943732|NCT00337571|588496249|FG001|Overall Study|Lack of Efficacy|0|||
162943733|NCT00337571|588496250|FG002|Overall Study|Lack of Efficacy|0|||
162943734|NCT00337571|588496251|FG003|Overall Study|Lack of Efficacy|0|||
162943735|NCT00337571|588496248|FG000|Overall Study|Adverse Event|4|||
162943736|NCT00337571|588496249|FG001|Overall Study|Adverse Event|5|||
162943737|NCT00337571|588496250|FG002|Overall Study|Adverse Event|8|||
162943738|NCT00337571|588496251|FG003|Overall Study|Adverse Event|4|||
162943739|NCT00337571|588496248|FG000|Overall Study|Withdrawal by Subject|2|||
162943740|NCT00337571|588496249|FG001|Overall Study|Withdrawal by Subject|2|||
162943741|NCT00337571|588496250|FG002|Overall Study|Withdrawal by Subject|1|||
162943742|NCT00337571|588496251|FG003|Overall Study|Withdrawal by Subject|0|||
162943743|NCT00337571|588496248|FG000|Overall Study|Lost to Follow-up|3|||
162943744|NCT00337571|588496249|FG001|Overall Study|Lost to Follow-up|1|||
162943745|NCT00337571|588496250|FG002|Overall Study|Lost to Follow-up|0|||
162943746|NCT00337571|588496251|FG003|Overall Study|Lost to Follow-up|1|||
162943747|NCT00337571|588496248|FG000|Overall Study|Poor/noncompliance|1|||
162943748|NCT00337571|588496249|FG001|Overall Study|Poor/noncompliance|1|||
162943749|NCT00337571|588496250|FG002|Overall Study|Poor/noncompliance|1|||
162943750|NCT00337571|588496251|FG003|Overall Study|Poor/noncompliance|1|||
162943751|NCT00337571|588496248|FG000|Overall Study|No longer met study criteria|1|||
162943752|NCT00337571|588496249|FG001|Overall Study|No longer met study criteria|0|||
162943753|NCT00337571|588496250|FG002|Overall Study|No longer met study criteria|0|||
162943754|NCT00337571|588496251|FG003|Overall Study|No longer met study criteria|0|||
162943755|NCT00337571|588496248|FG000|Overall Study|High Potassium level|0|||
162943756|NCT00337571|588496249|FG001|Overall Study|High Potassium level|0|||
162943757|NCT00337571|588496250|FG002|Overall Study|High Potassium level|0|||
162943758|NCT00337571|588496251|FG003|Overall Study|High Potassium level|1|||
162943759|NCT01890915|588496258|FG000|Overall Study|Adverse Event|1|||
162943760|NCT01890915|588496259|FG001|Overall Study|Adverse Event|0|||
162943761|NCT01890915|588496258|FG000|Overall Study|Protocol Violation|2|||
162943762|NCT01890915|588496259|FG001|Overall Study|Protocol Violation|0|||
162943763|NCT01890915|588496258|FG000|Overall Study|Equipment Malfunction|0|||
162943764|NCT01890915|588496259|FG001|Overall Study|Equipment Malfunction|1|||
162943765|NCT01974895|588496260|FG000|Overall Study|Protocol Violation|1|||
162943766|NCT01974895|588496261|FG001|Overall Study|Protocol Violation|0|||
162943767|NCT01974895|588496260|FG000|Overall Study|Lost to Follow-up|4|||
162943768|NCT01974895|588496261|FG001|Overall Study|Lost to Follow-up|6|||
162943769|NCT01974895|588496260|FG000|Overall Study|Withdrawal by Subject|0|||
162943770|NCT01974895|588496261|FG001|Overall Study|Withdrawal by Subject|1|||
162943771|NCT01974895|588496260|FG000|Overall Study|Other (Missed Visit)|1|||
162943772|NCT01974895|588496261|FG001|Overall Study|Other (Missed Visit)|0|||
162943773|NCT01974895|588496260|FG000|Overall Study|Other (Reason unknown)|9|||
162943774|NCT01974895|588496261|FG001|Overall Study|Other (Reason unknown)|8|||
162943775|NCT01513148|588496262|FG000|Overall Study|Protocol Violation|2|||
162943776|NCT01513148|588496263|FG001|Overall Study|Protocol Violation|2|||
162943777|NCT03552757|588496264|FG000|Overall Study|Withdrawal by Subject|10|||
162943778|NCT03552757|588496265|FG001|Overall Study|Withdrawal by Subject|5|||
162943779|NCT03552757|588496266|FG002|Overall Study|Withdrawal by Subject|12|||
162943780|NCT03552757|588496264|FG000|Overall Study|Lost to Follow-up|2|||
162831292|NCT01265797|588094565|FG000|Blinded Month|Protocol Violation|2|||
162831293|NCT01265797|588094566|FG001|Blinded Month|Protocol Violation|1|||
162831294|NCT01265797|588094565|FG000|Blinded Month|Adverse Event|2|||
162831295|NCT01265797|588094566|FG001|Blinded Month|Adverse Event|0|||
162831296|NCT01265797|588094565|FG000|Blinded Month|Diary data incomplete|0|||
162831297|NCT01265797|588094566|FG001|Blinded Month|Diary data incomplete|1|||
162831298|NCT01265797|588094565|FG000|Open Label Month|Lost to Follow-up|0|||
162831299|NCT01265797|588094566|FG001|Open Label Month|Lost to Follow-up|1|||
162831300|NCT00939783|588094567|FG000|Overall Study|Death|6|||
162831301|NCT00939783|588094567|FG000|Overall Study|Adverse Event|39|||
162831302|NCT00939783|588094567|FG000|Overall Study|Study Terminated by Sponsor|498|||
162831303|NCT00939783|588094567|FG000|Overall Study|Withdrawal by Subject|78|||
162831304|NCT00939783|588094567|FG000|Overall Study|Other|16|||
162831305|NCT00939783|588094567|FG000|Overall Study|Lost to Follow-up|8|||
162831306|NCT00939783|588094567|FG000|Overall Study|Protocol Violation|3|||
162831307|NCT00939783|588094567|FG000|Overall Study|Enrolled but not treated|1|||
162831308|NCT01549002|588094574|FG000|Overall Study|Excessive pain|0|||
162831309|NCT01549002|588094575|FG001|Overall Study|Excessive pain|2|||
162831310|NCT01549002|588094574|FG000|Overall Study|Moderate sedation required|0|||
162831311|NCT01549002|588094575|FG001|Overall Study|Moderate sedation required|2|||
162831312|NCT02250274|588094579|FG000|Overall Study|Insufficient blood draw amount|7|||
162831313|NCT02250274|588094580|FG001|Overall Study|Insufficient blood draw amount|6|||
162831314|NCT00583362|588094581|FG000|Overall Study|Adverse Event|44|||
162831315|NCT00583362|588094581|FG000|Overall Study|Lack of Efficacy|22|||
162831316|NCT00583362|588094581|FG000|Overall Study|Lost to Follow-up|4|||
162831317|NCT00583362|588094581|FG000|Overall Study|Non-compliance with study drug|28|||
162831318|NCT00583362|588094581|FG000|Overall Study|Pregnancy|7|||
162831319|NCT00583362|588094581|FG000|Overall Study|Miscommunication of visit window|5|||
162831320|NCT00583362|588094581|FG000|Overall Study|Current site closed|7|||
162831321|NCT00583362|588094581|FG000|Overall Study|Subject not dosed in LBSL99|1|||
162831322|NCT00583362|588094581|FG000|Overall Study|Subject moved out of the country/state|2|||
162831323|NCT00583362|588094581|FG000|Overall Study|Missed visits due to staff changes|1|||
162831324|NCT00583362|588094581|FG000|Overall Study|Misunderstanding of protocol|1|||
162831325|NCT00583362|588094581|FG000|Overall Study|Behavioral problems and non-compliance|1|||
162831326|NCT00583362|588094581|FG000|Overall Study|Sponsor request due to missed doses|1|||
162831327|NCT00583362|588094581|FG000|Overall Study|Physician Decision|19|||
162831328|NCT00583362|588094581|FG000|Overall Study|Protocol Violation|2|||
162831329|NCT00583362|588094581|FG000|Overall Study|Withdrawal by Subject|57|||
162831330|NCT00506883|588094597|FG000|Overall Study|Lost to Follow-up|1|||
162831331|NCT00506883|588094598|FG001|Overall Study|Lost to Follow-up|1|||
162831332|NCT00506883|588094599|FG002|Overall Study|Lost to Follow-up|1|||
162831333|NCT00506883|588094597|FG000|Overall Study|Withdrawal by Subject|1|||
162831334|NCT00506883|588094598|FG001|Overall Study|Withdrawal by Subject|0|||
162831335|NCT00506883|588094599|FG002|Overall Study|Withdrawal by Subject|1|||
162831336|NCT00506883|588094597|FG000|Overall Study|Lack of Efficacy|0|||
162831337|NCT00506883|588094598|FG001|Overall Study|Lack of Efficacy|1|||
162831338|NCT00506883|588094599|FG002|Overall Study|Lack of Efficacy|1|||
162831339|NCT00506883|588094597|FG000|Overall Study|Other|5|||
162831340|NCT00506883|588094598|FG001|Overall Study|Other|1|||
162831341|NCT00506883|588094599|FG002|Overall Study|Other|1|||
162831342|NCT00455013|588094601|FG000|Short Term Period|Adverse Event|2|||
162831343|NCT00455013|588094602|FG001|Short Term Period|Adverse Event|5|||
162831344|NCT00455013|588094603|FG002|Short Term Period|Adverse Event|0|||
162831345|NCT00455013|588094601|FG000|Short Term Period|Withdrawal by Subject|0|||
162831346|NCT00455013|588094602|FG001|Short Term Period|Withdrawal by Subject|0|||
162831347|NCT00455013|588094603|FG002|Short Term Period|Withdrawal by Subject|1|||
162831348|NCT00455013|588094601|FG000|Short Term Period|Lack of Efficacy|4|||
162831349|NCT00455013|588094602|FG001|Short Term Period|Lack of Efficacy|0|||
162831350|NCT00455013|588094603|FG002|Short Term Period|Lack of Efficacy|0|||
162831351|NCT00455013|588094601|FG000|Short Term Period|Other|0|||
162831352|NCT00455013|588094602|FG001|Short Term Period|Other|0|||
162831353|NCT00455013|588094603|FG002|Short Term Period|Other|1|||
162831354|NCT00455013|588094601|FG000|Long Term Extension (LTE)|Adverse Event|0|||
162831355|NCT00455013|588094602|FG001|Long Term Extension (LTE)|Adverse Event|1|||
162831356|NCT00455013|588094603|FG002|Long Term Extension (LTE)|Adverse Event|1|||
162831357|NCT00455013|588094601|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
162831358|NCT00455013|588094602|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
162831359|NCT00455013|588094603|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
162831360|NCT00455013|588094601|FG000|Long Term Extension (LTE)|Death|1|||
162831361|NCT00455013|588094602|FG001|Long Term Extension (LTE)|Death|1|||
162831362|NCT00455013|588094603|FG002|Long Term Extension (LTE)|Death|0|||
162831363|NCT00455013|588094601|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
162831364|NCT00455013|588094602|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
162831365|NCT00455013|588094603|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
162831366|NCT00455013|588094601|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
162831367|NCT00455013|588094602|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
162831368|NCT00455013|588094603|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
162831369|NCT00455013|588094601|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
162943781|NCT03552757|588496265|FG001|Overall Study|Lost to Follow-up|7|||
162943782|NCT03552757|588496266|FG002|Overall Study|Lost to Follow-up|7|||
162943783|NCT03552757|588496264|FG000|Overall Study|Death|1|||
162943784|NCT03552757|588496265|FG001|Overall Study|Death|1|||
162943785|NCT03552757|588496266|FG002|Overall Study|Death|1|||
162943786|NCT02192099|588496269|FG000|Overall Study|Adverse Event|1|||
162943787|NCT02192099|588496269|FG000|Overall Study|Lost to Follow-up|2|||
162943788|NCT02192099|588496269|FG000|Overall Study|Physician Decision|1|||
162943789|NCT02192099|588496269|FG000|Overall Study|Pregnancy|1|||
162943790|NCT02192099|588496269|FG000|Overall Study|Protocol Violation|8|||
162943791|NCT02192099|588496269|FG000|Overall Study|Study Terminated by Sponsor|32|||
162943792|NCT02192099|588496269|FG000|Overall Study|Withdrawal by Subject|11|||
162943793|NCT02192099|588496269|FG000|Overall Study|Miscellaneous Reasons|5|||
162943794|NCT00386009|588496270|FG000|Overall Study|Adverse Event|0|||
162943795|NCT00386009|588496271|FG001|Overall Study|Adverse Event|2|||
162943796|NCT00386009|588496270|FG000|Overall Study|Death|1|||
162943797|NCT00386009|588496271|FG001|Overall Study|Death|0|||
162943798|NCT00386009|588496270|FG000|Overall Study|Entry Criteria Not Met|0|||
162943799|NCT00386009|588496271|FG001|Overall Study|Entry Criteria Not Met|2|||
162943800|NCT00386009|588496270|FG000|Overall Study|Lost to Follow-up|1|||
162943801|NCT00386009|588496271|FG001|Overall Study|Lost to Follow-up|1|||
162943802|NCT00386009|588496270|FG000|Overall Study|Protocol Violation|1|||
162943803|NCT00386009|588496271|FG001|Overall Study|Protocol Violation|0|||
162943804|NCT00386009|588496270|FG000|Overall Study|Sponsor Decision|1|||
162943805|NCT00386009|588496271|FG001|Overall Study|Sponsor Decision|1|||
162943806|NCT00386009|588496270|FG000|Overall Study|Withdrawal by Subject|5|||
162831370|NCT00455013|588094602|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
162831371|NCT00455013|588094603|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
162831372|NCT00455013|588094601|FG000|Long Term Extension (LTE)|non-specified|0|||
162831373|NCT00455013|588094602|FG001|Long Term Extension (LTE)|non-specified|0|||
162831374|NCT00455013|588094603|FG002|Long Term Extension (LTE)|non-specified|1|||
162831375|NCT00786565|588094607|FG000|Enrollment Prior to Surgery|Site Closed|3|||
162831376|NCT00786565|588094607|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
162831377|NCT00786565|588094607|FG000|Post Surgery|Abnormal macular pucker|1|||
162831378|NCT00786565|588094607|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
162831379|NCT05513625|588094610|FG000|Overall Study|Withdrawal by Subject|1|||
162831380|NCT00754793|588094612|FG000|Overall Study|voluntary withdrawn from study|0|||
162831381|NCT00754793|588094613|FG001|Overall Study|voluntary withdrawn from study|1|||
162831382|NCT02536313|588094615|FG000|Overall Study|Lack of Efficacy|0|||
162831383|NCT02536313|588094616|FG001|Overall Study|Lack of Efficacy|1|||
162831384|NCT00917150|588094621|FG000|Overall Study|Adverse Event|12|||
162831385|NCT00917150|588094622|FG001|Overall Study|Adverse Event|7|||
162831386|NCT00917150|588094623|FG002|Overall Study|Adverse Event|12|||
162831387|NCT00917150|588094624|FG003|Overall Study|Adverse Event|11|||
162831388|NCT00917150|588094621|FG000|Overall Study|Death|1|||
162831389|NCT00917150|588094622|FG001|Overall Study|Death|4|||
162831390|NCT00917150|588094623|FG002|Overall Study|Death|3|||
162831391|NCT00917150|588094624|FG003|Overall Study|Death|2|||
162831392|NCT00917150|588094621|FG000|Overall Study|Lost to Follow-up|1|||
162831393|NCT00917150|588094622|FG001|Overall Study|Lost to Follow-up|0|||
162831394|NCT00917150|588094623|FG002|Overall Study|Lost to Follow-up|4|||
162831395|NCT00917150|588094624|FG003|Overall Study|Lost to Follow-up|2|||
162831396|NCT00917150|588094621|FG000|Overall Study|Physician Decision|0|||
162831397|NCT00917150|588094622|FG001|Overall Study|Physician Decision|2|||
162831398|NCT00917150|588094623|FG002|Overall Study|Physician Decision|0|||
162831399|NCT00917150|588094624|FG003|Overall Study|Physician Decision|1|||
162831400|NCT00917150|588094621|FG000|Overall Study|Protocol Violation|5|||
162831401|NCT00917150|588094622|FG001|Overall Study|Protocol Violation|5|||
162831402|NCT00917150|588094623|FG002|Overall Study|Protocol Violation|3|||
162831403|NCT00917150|588094624|FG003|Overall Study|Protocol Violation|5|||
162831404|NCT00917150|588094621|FG000|Overall Study|Withdrawal by Subject|15|||
162831405|NCT00917150|588094622|FG001|Overall Study|Withdrawal by Subject|16|||
162831406|NCT00917150|588094623|FG002|Overall Study|Withdrawal by Subject|18|||
162943807|NCT00386009|588496271|FG001|Overall Study|Withdrawal by Subject|4|||
162831407|NCT00917150|588094624|FG003|Overall Study|Withdrawal by Subject|11|||
162831408|NCT00917150|588094621|FG000|Overall Study|Other than specified|3|||
162831409|NCT00917150|588094622|FG001|Overall Study|Other than specified|3|||
162831410|NCT00917150|588094623|FG002|Overall Study|Other than specified|2|||
162831411|NCT00917150|588094624|FG003|Overall Study|Other than specified|2|||
162831412|NCT03891264|588094626|FG000|Overall Study|Adverse Event|1|||
162831413|NCT03891264|588094626|FG000|Overall Study|Withdrawal by Subject|2|||
162943808|NCT00536575|588496274|FG000|Overall Study|Withdrawal by Subject|1|||
162943809|NCT00536575|588496274|FG000|Overall Study|Death|1|||
162943810|NCT01862328|588496281|FG000|Overall Study|Progressive Disease|3|||
162943811|NCT01862328|588496282|FG001|Overall Study|Progressive Disease|11|||
162943812|NCT01862328|588496283|FG002|Overall Study|Progressive Disease|5|||
162831414|NCT03891264|588094626|FG000|Overall Study|Physician Decision|2|||
162831415|NCT01924182|588094627|FG000|Overall Study|Withdrawal by Subject|1|||
162943813|NCT01862328|588496284|FG003|Overall Study|Progressive Disease|6|||
162943814|NCT01862328|588496285|FG004|Overall Study|Progressive Disease|7|||
162943815|NCT01862328|588496286|FG005|Overall Study|Progressive Disease|4|||
162943816|NCT01862328|588496287|FG006|Overall Study|Progressive Disease|3|||
162943817|NCT01862328|588496281|FG000|Overall Study|Adverse Event|0|||
162943818|NCT01862328|588496282|FG001|Overall Study|Adverse Event|4|||
162943819|NCT01862328|588496283|FG002|Overall Study|Adverse Event|0|||
162943820|NCT01862328|588496284|FG003|Overall Study|Adverse Event|1|||
162943821|NCT01862328|588496285|FG004|Overall Study|Adverse Event|0|||
162943822|NCT01862328|588496286|FG005|Overall Study|Adverse Event|2|||
162943823|NCT01862328|588496287|FG006|Overall Study|Adverse Event|4|||
162943824|NCT01862328|588496281|FG000|Overall Study|Other|0|||
162943825|NCT01862328|588496282|FG001|Overall Study|Other|2|||
162943826|NCT01862328|588496283|FG002|Overall Study|Other|1|||
162943827|NCT01862328|588496284|FG003|Overall Study|Other|0|||
162943828|NCT01862328|588496285|FG004|Overall Study|Other|4|||
162943829|NCT01862328|588496286|FG005|Overall Study|Other|0|||
162943830|NCT01862328|588496287|FG006|Overall Study|Other|1|||
162943831|NCT01862328|588496281|FG000|Overall Study|Withdrawal by Subject|1|||
162943832|NCT01862328|588496282|FG001|Overall Study|Withdrawal by Subject|1|||
162943833|NCT01862328|588496283|FG002|Overall Study|Withdrawal by Subject|0|||
162943834|NCT01862328|588496284|FG003|Overall Study|Withdrawal by Subject|0|||
162943835|NCT01862328|588496285|FG004|Overall Study|Withdrawal by Subject|1|||
162943836|NCT01862328|588496286|FG005|Overall Study|Withdrawal by Subject|1|||
162943837|NCT01862328|588496287|FG006|Overall Study|Withdrawal by Subject|1|||
162943838|NCT01862328|588496281|FG000|Overall Study|Symptomatic Deterioration|0|||
162943839|NCT01862328|588496282|FG001|Overall Study|Symptomatic Deterioration|0|||
162943840|NCT01862328|588496283|FG002|Overall Study|Symptomatic Deterioration|0|||
162943841|NCT01862328|588496284|FG003|Overall Study|Symptomatic Deterioration|0|||
162943842|NCT01862328|588496285|FG004|Overall Study|Symptomatic Deterioration|0|||
162943843|NCT01862328|588496286|FG005|Overall Study|Symptomatic Deterioration|0|||
162943844|NCT01862328|588496287|FG006|Overall Study|Symptomatic Deterioration|1|||
162943845|NCT00936975|588496288|FG000|Overall Study|Withdrawal by Subject|1|||
162943846|NCT00936975|588496288|FG000|Overall Study|Disease progression|3|||
162943847|NCT00936975|588496288|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
162943848|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
162943849|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
162943850|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Death|0|||
162943851|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Death|1|||
162943852|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
162943853|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
162943854|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
162943855|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
162943856|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
162943857|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
162943858|NCT01656889|588496292|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
162943859|NCT01656889|588496293|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
162943860|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
162943861|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
162943862|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
162943863|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
162943864|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
162943865|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
162943866|NCT01656889|588496292|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
162943867|NCT01656889|588496293|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
162943868|NCT02486796|588496294|FG000|Overall Study|Withdrawal by Subject|1|||
162943869|NCT02486796|588496295|FG001|Overall Study|Withdrawal by Subject|1|||
162943870|NCT02486796|588496294|FG000|Overall Study|Physician Decision|1|||
162943871|NCT02486796|588496295|FG001|Overall Study|Physician Decision|0|||
162943872|NCT00306384|588496298|FG000|Overall Study|Adverse Event|103|||
162943873|NCT00306384|588496299|FG001|Overall Study|Adverse Event|87|||
162943874|NCT00306384|588496300|FG002|Overall Study|Adverse Event|40|||
162943875|NCT00306384|588496298|FG000|Overall Study|Major protocol deviation|43|||
162943876|NCT00306384|588496299|FG001|Overall Study|Major protocol deviation|51|||
162943877|NCT00306384|588496300|FG002|Overall Study|Major protocol deviation|18|||
162943878|NCT00306384|588496298|FG000|Overall Study|Lost to Follow-up|57|||
162943879|NCT00306384|588496299|FG001|Overall Study|Lost to Follow-up|41|||
162943880|NCT00306384|588496300|FG002|Overall Study|Lost to Follow-up|35|||
162943881|NCT00306384|588496298|FG000|Overall Study|Voluntary withdrawal|199|||
162943882|NCT00306384|588496299|FG001|Overall Study|Voluntary withdrawal|187|||
162943883|NCT00306384|588496300|FG002|Overall Study|Voluntary withdrawal|91|||
162943884|NCT00306384|588496298|FG000|Overall Study|Study termination|1|||
162943885|NCT00306384|588496299|FG001|Overall Study|Study termination|0|||
162943886|NCT00306384|588496300|FG002|Overall Study|Study termination|1|||
162943887|NCT00306384|588496298|FG000|Overall Study|Pregnancy|3|||
162943888|NCT00306384|588496299|FG001|Overall Study|Pregnancy|1|||
162943889|NCT00306384|588496300|FG002|Overall Study|Pregnancy|1|||
162943890|NCT00306384|588496298|FG000|Overall Study|Lack of Efficacy|26|||
162943891|NCT00306384|588496299|FG001|Overall Study|Lack of Efficacy|40|||
162943892|NCT00306384|588496300|FG002|Overall Study|Lack of Efficacy|38|||
162943893|NCT00306384|588496298|FG000|Overall Study|Investigator discretion|28|||
162943894|NCT00306384|588496299|FG001|Overall Study|Investigator discretion|31|||
162943895|NCT00306384|588496300|FG002|Overall Study|Investigator discretion|21|||
162943896|NCT00306384|588496298|FG000|Overall Study|Other|80|||
162943897|NCT00306384|588496299|FG001|Overall Study|Other|70|||
162943898|NCT00306384|588496300|FG002|Overall Study|Other|32|||
162943899|NCT00306384|588496298|FG000|Overall Study|Site closure|2|||
162943900|NCT00306384|588496299|FG001|Overall Study|Site closure|0|||
162943901|NCT00306384|588496300|FG002|Overall Study|Site closure|0|||
162943902|NCT02275364|588496301|FG000|Period 1|Withdrawal by Subject|1|||
162943903|NCT02275364|588496302|FG001|Period 1|Withdrawal by Subject|0|||
162943904|NCT02275364|588496301|FG000|Period 1|Other reason|1|||
162943905|NCT02275364|588496302|FG001|Period 1|Other reason|0|||
162943906|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943907|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943908|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
162943909|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
162943910|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943911|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
162943912|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943913|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943914|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943915|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
162943916|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
162943917|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
162943918|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943919|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943920|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943921|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943922|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
162943923|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
162943924|NCT03384745|588496305|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943925|NCT03384745|588496306|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943926|NCT03384745|588496307|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
162943927|NCT03384745|588496308|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943928|NCT03384745|588496309|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943929|NCT03384745|588496310|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
162943930|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943931|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943932|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943933|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
162943934|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
162943935|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
162943936|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943937|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943938|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943939|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943940|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
162943941|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
162943942|NCT03384745|588496305|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943943|NCT03384745|588496306|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943944|NCT03384745|588496307|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
162943945|NCT03384745|588496308|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
162943946|NCT03384745|588496309|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943947|NCT03384745|588496310|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
162943948|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943949|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943950|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
162943951|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
162943952|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
162943953|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
162943954|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
162943955|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
162943956|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
162943957|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
162943958|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
162943959|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
162943960|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943961|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943962|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943963|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
162943964|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943965|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
162943966|NCT03384745|588496305|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943967|NCT03384745|588496306|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
162943968|NCT03384745|588496307|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943969|NCT03384745|588496308|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943970|NCT03384745|588496309|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
162943971|NCT03384745|588496310|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
162698735|NCT06017999|587606838|FG002|Overall Study|Lost to Follow-up|1|||
162698736|NCT06017999|587606836|FG000|Overall Study|Physician Decision|1|||
162698737|NCT06017999|587606837|FG001|Overall Study|Physician Decision|1|||
162698738|NCT06017999|587606838|FG002|Overall Study|Physician Decision|0|||
162698739|NCT06017999|587606836|FG000|Overall Study|Non-Compliance|0|||
162698740|NCT06017999|587606837|FG001|Overall Study|Non-Compliance|0|||
162698741|NCT06017999|587606838|FG002|Overall Study|Non-Compliance|1|||
162698742|NCT06017999|587606836|FG000|Overall Study|Lack of Efficacy|1|||
162698743|NCT06017999|587606837|FG001|Overall Study|Lack of Efficacy|0|||
162698744|NCT06017999|587606838|FG002|Overall Study|Lack of Efficacy|7|||
162698745|NCT06017999|587606836|FG000|Overall Study|COVID Positive|0|||
162698746|NCT06017999|587606837|FG001|Overall Study|COVID Positive|1|||
162698747|NCT06017999|587606838|FG002|Overall Study|COVID Positive|0|||
162698748|NCT06017999|587606836|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
162698749|NCT06017999|587606837|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
162698750|NCT06017999|587606838|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
162698751|NCT01155388|587606839|FG000|Overall Study|Adverse Event|1|||
162698752|NCT01155388|587606840|FG001|Overall Study|Adverse Event|0|||
162698753|NCT03943589|587606841|FG000|Overall Study|Death|1|||
162698754|NCT03943589|587606841|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
162698755|NCT04329104|587606842|FG000|Efficacy Study|Withdrawal by Subject|0|||
162698756|NCT04329104|587606843|FG001|Efficacy Study|Withdrawal by Subject|0|||
162698757|NCT04329104|587606844|FG002|Efficacy Study|Withdrawal by Subject|0|||
162698758|NCT04329104|587606845|FG003|Efficacy Study|Withdrawal by Subject|5|||
162698759|NCT04329104|587606846|FG004|Efficacy Study|Withdrawal by Subject|6|||
162698760|NCT04329104|587606847|FG005|Efficacy Study|Withdrawal by Subject|8|||
162698761|NCT01702428|587606848|FG000|Overall Study|Adverse Event|2|||
162698762|NCT01702428|587606849|FG001|Overall Study|Adverse Event|0|||
162698763|NCT01702428|587606850|FG002|Overall Study|Adverse Event|0|||
162698764|NCT01702428|587606851|FG003|Overall Study|Adverse Event|0|||
162698765|NCT01702428|587606848|FG000|Overall Study|Lost to Follow-up|33|||
162698766|NCT01702428|587606849|FG001|Overall Study|Lost to Follow-up|41|||
162698767|NCT01702428|587606850|FG002|Overall Study|Lost to Follow-up|37|||
162698768|NCT01702428|587606851|FG003|Overall Study|Lost to Follow-up|44|||
162698769|NCT01702428|587606848|FG000|Overall Study|Parents cannot assist to site|1|||
162698770|NCT01702428|587606849|FG001|Overall Study|Parents cannot assist to site|0|||
162698771|NCT01702428|587606850|FG002|Overall Study|Parents cannot assist to site|1|||
162698772|NCT01702428|587606851|FG003|Overall Study|Parents cannot assist to site|0|||
162698773|NCT01702428|587606848|FG000|Overall Study|Lost Coverage|0|||
162698774|NCT01702428|587606849|FG001|Overall Study|Lost Coverage|0|||
162698775|NCT01702428|587606850|FG002|Overall Study|Lost Coverage|0|||
162698776|NCT01702428|587606851|FG003|Overall Study|Lost Coverage|1|||
162698777|NCT01702428|587606848|FG000|Overall Study|Lost Health Plan|3|||
162698778|NCT01702428|587606849|FG001|Overall Study|Lost Health Plan|5|||
162698779|NCT01702428|587606850|FG002|Overall Study|Lost Health Plan|0|||
162698780|NCT01702428|587606851|FG003|Overall Study|Lost Health Plan|2|||
162698781|NCT01702428|587606848|FG000|Overall Study|Mother transferred care|0|||
162698782|NCT01702428|587606849|FG001|Overall Study|Mother transferred care|1|||
162698783|NCT01702428|587606850|FG002|Overall Study|Mother transferred care|0|||
162698784|NCT01702428|587606851|FG003|Overall Study|Mother transferred care|0|||
162698785|NCT01702428|587606848|FG000|Overall Study|Parents too busy|1|||
162698786|NCT01702428|587606849|FG001|Overall Study|Parents too busy|0|||
162698787|NCT01702428|587606850|FG002|Overall Study|Parents too busy|0|||
162698788|NCT01702428|587606851|FG003|Overall Study|Parents too busy|0|||
162943972|NCT02984683|588496313|FG000|Overall Study|Adverse Event|3|||
162831416|NCT01924182|588094628|FG001|Overall Study|Withdrawal by Subject|0|||
162831417|NCT00993265|588094630|FG000|Overall Study|Adverse Event|1|||
162831418|NCT00993265|588094631|FG001|Overall Study|Adverse Event|0|||
162831419|NCT00993265|588094630|FG000|Overall Study|Changed dose of concomitant drug|2|||
162831420|NCT00993265|588094631|FG001|Overall Study|Changed dose of concomitant drug|0|||
162831421|NCT00993265|588094630|FG000|Overall Study|Non-compliant with study medication|1|||
162831422|NCT00993265|588094631|FG001|Overall Study|Non-compliant with study medication|0|||
162831423|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
162831424|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
162831425|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
162831426|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
162831427|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
162831428|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
162831429|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
162831430|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
162831431|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
162831432|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
162831433|NCT00219284|588094632|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
162831434|NCT00219284|588094633|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
162831435|NCT00219284|588094632|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
162831436|NCT00219284|588094633|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
162831437|NCT00219284|588094632|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
162831438|NCT00219284|588094633|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
162831439|NCT00219284|588094632|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
162831440|NCT00219284|588094633|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
162831441|NCT05003622|588094634|FG000|Overall Study|Progressive disease|2|||
162831442|NCT05003622|588094634|FG000|Overall Study|Withdrawal by Subject|1|||
162831443|NCT01692275|588094636|FG000|Overall Study|Lost to Follow-up|57|||
162831444|NCT01692275|588094637|FG001|Overall Study|Lost to Follow-up|48|||
162831445|NCT01692275|588094636|FG000|Overall Study|Withdrawal by Subject|9|||
162831446|NCT01692275|588094637|FG001|Overall Study|Withdrawal by Subject|11|||
162831447|NCT05264740|588094645|FG000|Baseline|Withdrawal by Subject|0|||
162831448|NCT05264740|588094646|FG001|Baseline|Withdrawal by Subject|1|||
162831449|NCT05264740|588094645|FG000|Follow Up 1|Lost to Follow-up|1|||
162831450|NCT05264740|588094646|FG001|Follow Up 1|Lost to Follow-up|1|||
162831451|NCT05264740|588094645|FG000|Follow Up 1|Withdrawal by Subject|0|||
162831452|NCT05264740|588094646|FG001|Follow Up 1|Withdrawal by Subject|1|||
162831453|NCT05264740|588094645|FG000|Follow Up 2|Lost to Follow-up|1|||
162831454|NCT05264740|588094646|FG001|Follow Up 2|Lost to Follow-up|4|||
162831455|NCT05264740|588094645|FG000|Follow Up 3|Lost to Follow-up|7|||
162831456|NCT05264740|588094646|FG001|Follow Up 3|Lost to Follow-up|4|||
162831457|NCT01395394|588095990|FG000|Baseline Study Visit|Protocol Violation|1|||
162831458|NCT01395394|588095991|FG001|Baseline Study Visit|Protocol Violation|0|||
162831459|NCT01395394|588095992|FG002|Baseline Study Visit|Protocol Violation|0|||
162831460|NCT02356562|588095993|FG000|Overall Study|Withdrawal by Subject|0|||
162831461|NCT02356562|588095994|FG001|Overall Study|Withdrawal by Subject|1|||
162831462|NCT02356562|588095993|FG000|Overall Study|Re-entered treatment in a previous study|1|||
162831463|NCT02356562|588095994|FG001|Overall Study|Re-entered treatment in a previous study|0|||
162831464|NCT02356562|588095993|FG000|Overall Study|site closure|1|||
162831465|NCT02356562|588095994|FG001|Overall Study|site closure|0|||
162831466|NCT00412750|588095997|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162831467|NCT00412750|588095998|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162831468|NCT00412750|588095999|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162831469|NCT00412750|588095997|FG000|Overall Study|Administrative problems|21|||
162831470|NCT00412750|588095998|FG001|Overall Study|Administrative problems|17|||
162831471|NCT00412750|588095999|FG002|Overall Study|Administrative problems|14|||
162831472|NCT00412750|588095997|FG000|Overall Study|Adverse Event|8|||
162831473|NCT00412750|588095998|FG001|Overall Study|Adverse Event|3|||
162831474|NCT00412750|588095999|FG002|Overall Study|Adverse Event|3|||
162831475|NCT00412750|588095997|FG000|Overall Study|Lost to Follow-up|1|||
162831476|NCT00412750|588095998|FG001|Overall Study|Lost to Follow-up|0|||
162831477|NCT00412750|588095999|FG002|Overall Study|Lost to Follow-up|1|||
162831478|NCT00412750|588095997|FG000|Overall Study|Withdrawal by Subject|0|||
162831479|NCT00412750|588095998|FG001|Overall Study|Withdrawal by Subject|1|||
162831480|NCT00412750|588095999|FG002|Overall Study|Withdrawal by Subject|2|||
162831481|NCT00412750|588095997|FG000|Overall Study|Lack of Efficacy|0|||
162831482|NCT00412750|588095998|FG001|Overall Study|Lack of Efficacy|0|||
162831483|NCT00412750|588095999|FG002|Overall Study|Lack of Efficacy|3|||
162831484|NCT01611974|588096004|FG000|Overall Study|Death|10|||
162831485|NCT01611974|588096005|FG001|Overall Study|Death|12|||
162831486|NCT01611974|588096006|FG002|Overall Study|Death|10|||
162831487|NCT01611974|588096004|FG000|Overall Study|Lost to Follow-up|0|||
162831488|NCT01611974|588096005|FG001|Overall Study|Lost to Follow-up|1|||
162831489|NCT01611974|588096006|FG002|Overall Study|Lost to Follow-up|0|||
162831490|NCT01611974|588096004|FG000|Overall Study|Physician Decision|5|||
162831491|NCT01611974|588096005|FG001|Overall Study|Physician Decision|1|||
162943973|NCT02984683|588496314|FG001|Overall Study|Adverse Event|3|||
162943974|NCT02984683|588496313|FG000|Overall Study|Withdrawal by Subject|1|||
162943975|NCT02984683|588496314|FG001|Overall Study|Withdrawal by Subject|0|||
162943976|NCT02984683|588496313|FG000|Overall Study|Disease progression|7|||
162943977|NCT02984683|588496314|FG001|Overall Study|Disease progression|9|||
162943978|NCT03131999|588496315|FG000|Overall Study|Withdrawal by Subject|0|||
162943979|NCT03131999|588496316|FG001|Overall Study|Withdrawal by Subject|1|||
162943980|NCT02260492|588496317|FG000|Overall Study|Adverse Event|6|||
162943981|NCT02260492|588496318|FG001|Overall Study|Adverse Event|1|||
162943982|NCT02260492|588496319|FG002|Overall Study|Adverse Event|2|||
162943983|NCT02260492|588496317|FG000|Overall Study|Death|0|||
162943984|NCT02260492|588496318|FG001|Overall Study|Death|1|||
162943985|NCT02260492|588496319|FG002|Overall Study|Death|0|||
162943986|NCT02260492|588496317|FG000|Overall Study|Lost to Follow-up|12|||
162943987|NCT02260492|588496318|FG001|Overall Study|Lost to Follow-up|9|||
162943988|NCT02260492|588496319|FG002|Overall Study|Lost to Follow-up|0|||
162943989|NCT02260492|588496317|FG000|Overall Study|Physician Decision|2|||
162943990|NCT02260492|588496318|FG001|Overall Study|Physician Decision|0|||
162943991|NCT02260492|588496319|FG002|Overall Study|Physician Decision|1|||
162943992|NCT02260492|588496317|FG000|Overall Study|Withdrawal by Subject|3|||
162943993|NCT02260492|588496318|FG001|Overall Study|Withdrawal by Subject|2|||
162943994|NCT02260492|588496319|FG002|Overall Study|Withdrawal by Subject|2|||
162943995|NCT04634409|588496320|FG000|Overall Study|Death|0|||
162943996|NCT04634409|588496321|FG001|Overall Study|Death|0|||
162943997|NCT04634409|588496322|FG002|Overall Study|Death|0|||
162943998|NCT04634409|588496323|FG003|Overall Study|Death|0|||
162943999|NCT04634409|588496324|FG004|Overall Study|Death|0|||
162944000|NCT04634409|588496325|FG005|Overall Study|Death|0|||
162944001|NCT04634409|588496326|FG006|Overall Study|Death|0|||
162944002|NCT04634409|588496327|FG007|Overall Study|Death|0|||
162944003|NCT04634409|588496328|FG008|Overall Study|Death|0|||
162944004|NCT04634409|588496329|FG009|Overall Study|Death|0|||
162944005|NCT04634409|588496330|FG010|Overall Study|Death|1|||
162944006|NCT04634409|588496331|FG011|Overall Study|Death|0|||
162944007|NCT04634409|588496332|FG012|Overall Study|Death|1|||
162944008|NCT04634409|588496333|FG013|Overall Study|Death|0|||
162944009|NCT04634409|588496334|FG014|Overall Study|Death|0|||
162944010|NCT04634409|588496335|FG015|Overall Study|Death|0|||
162944011|NCT04634409|588496336|FG016|Overall Study|Death|0|||
162944012|NCT04634409|588496337|FG017|Overall Study|Death|0|||
162944013|NCT04634409|588496338|FG018|Overall Study|Death|0|||
162944014|NCT04634409|588496339|FG019|Overall Study|Death|0|||
162944015|NCT04634409|588496340|FG020|Overall Study|Death|0|||
162944016|NCT04634409|588496341|FG021|Overall Study|Death|0|||
162944017|NCT04634409|588496342|FG022|Overall Study|Death|0|||
162944018|NCT04634409|588496343|FG023|Overall Study|Death|0|||
162944019|NCT04634409|588496344|FG024|Overall Study|Death|0|||
162944020|NCT04634409|588496345|FG025|Overall Study|Death|0|||
162944021|NCT04634409|588496346|FG026|Overall Study|Death|0|||
162944022|NCT04634409|588496320|FG000|Overall Study|Adverse Event|0|||
162944023|NCT04634409|588496321|FG001|Overall Study|Adverse Event|0|||
162944024|NCT04634409|588496322|FG002|Overall Study|Adverse Event|1|||
162944025|NCT04634409|588496323|FG003|Overall Study|Adverse Event|0|||
162944026|NCT04634409|588496324|FG004|Overall Study|Adverse Event|0|||
162944027|NCT04634409|588496325|FG005|Overall Study|Adverse Event|1|||
162944028|NCT04634409|588496326|FG006|Overall Study|Adverse Event|0|||
162944029|NCT04634409|588496327|FG007|Overall Study|Adverse Event|0|||
162944030|NCT04634409|588496328|FG008|Overall Study|Adverse Event|0|||
162944031|NCT04634409|588496329|FG009|Overall Study|Adverse Event|0|||
162944032|NCT04634409|588496330|FG010|Overall Study|Adverse Event|0|||
162944033|NCT04634409|588496331|FG011|Overall Study|Adverse Event|0|||
162944034|NCT04634409|588496332|FG012|Overall Study|Adverse Event|0|||
162944035|NCT04634409|588496333|FG013|Overall Study|Adverse Event|0|||
162944036|NCT04634409|588496334|FG014|Overall Study|Adverse Event|0|||
162944037|NCT04634409|588496335|FG015|Overall Study|Adverse Event|0|||
162944038|NCT04634409|588496336|FG016|Overall Study|Adverse Event|0|||
162944039|NCT04634409|588496337|FG017|Overall Study|Adverse Event|0|||
162944040|NCT04634409|588496338|FG018|Overall Study|Adverse Event|0|||
162944041|NCT04634409|588496339|FG019|Overall Study|Adverse Event|0|||
162944042|NCT04634409|588496340|FG020|Overall Study|Adverse Event|0|||
162944043|NCT04634409|588496341|FG021|Overall Study|Adverse Event|0|||
162944044|NCT04634409|588496342|FG022|Overall Study|Adverse Event|0|||
162944045|NCT04634409|588496343|FG023|Overall Study|Adverse Event|0|||
162944046|NCT04634409|588496344|FG024|Overall Study|Adverse Event|0|||
162944047|NCT04634409|588496345|FG025|Overall Study|Adverse Event|0|||
162944048|NCT04634409|588496346|FG026|Overall Study|Adverse Event|0|||
162944049|NCT04634409|588496320|FG000|Overall Study|Lost to Follow-up|3|||
162944050|NCT04634409|588496321|FG001|Overall Study|Lost to Follow-up|1|||
162944051|NCT04634409|588496322|FG002|Overall Study|Lost to Follow-up|1|||
162944052|NCT04634409|588496323|FG003|Overall Study|Lost to Follow-up|3|||
162944053|NCT04634409|588496324|FG004|Overall Study|Lost to Follow-up|1|||
162944054|NCT04634409|588496325|FG005|Overall Study|Lost to Follow-up|1|||
162944055|NCT04634409|588496326|FG006|Overall Study|Lost to Follow-up|1|||
162944056|NCT04634409|588496327|FG007|Overall Study|Lost to Follow-up|3|||
162944057|NCT04634409|588496328|FG008|Overall Study|Lost to Follow-up|3|||
162944058|NCT04634409|588496329|FG009|Overall Study|Lost to Follow-up|11|||
162944059|NCT04634409|588496330|FG010|Overall Study|Lost to Follow-up|8|||
162944060|NCT04634409|588496331|FG011|Overall Study|Lost to Follow-up|15|||
162944061|NCT04634409|588496332|FG012|Overall Study|Lost to Follow-up|3|||
162944062|NCT04634409|588496333|FG013|Overall Study|Lost to Follow-up|2|||
162944063|NCT04634409|588496334|FG014|Overall Study|Lost to Follow-up|7|||
162944064|NCT04634409|588496335|FG015|Overall Study|Lost to Follow-up|0|||
162944065|NCT04634409|588496336|FG016|Overall Study|Lost to Follow-up|0|||
162944066|NCT04634409|588496337|FG017|Overall Study|Lost to Follow-up|0|||
162944067|NCT04634409|588496338|FG018|Overall Study|Lost to Follow-up|0|||
162944068|NCT04634409|588496339|FG019|Overall Study|Lost to Follow-up|0|||
162944069|NCT04634409|588496340|FG020|Overall Study|Lost to Follow-up|0|||
162944070|NCT04634409|588496341|FG021|Overall Study|Lost to Follow-up|0|||
162944071|NCT04634409|588496342|FG022|Overall Study|Lost to Follow-up|0|||
162944072|NCT04634409|588496343|FG023|Overall Study|Lost to Follow-up|0|||
162944073|NCT04634409|588496344|FG024|Overall Study|Lost to Follow-up|0|||
162944074|NCT04634409|588496345|FG025|Overall Study|Lost to Follow-up|0|||
162944075|NCT04634409|588496346|FG026|Overall Study|Lost to Follow-up|0|||
162944076|NCT04634409|588496320|FG000|Overall Study|Withdrawal by Subject|3|||
162944077|NCT04634409|588496321|FG001|Overall Study|Withdrawal by Subject|1|||
162944078|NCT04634409|588496322|FG002|Overall Study|Withdrawal by Subject|6|||
162944079|NCT04634409|588496323|FG003|Overall Study|Withdrawal by Subject|4|||
162944080|NCT04634409|588496324|FG004|Overall Study|Withdrawal by Subject|2|||
162944081|NCT04634409|588496325|FG005|Overall Study|Withdrawal by Subject|0|||
162944082|NCT04634409|588496326|FG006|Overall Study|Withdrawal by Subject|0|||
162944083|NCT04634409|588496327|FG007|Overall Study|Withdrawal by Subject|2|||
162944084|NCT04634409|588496328|FG008|Overall Study|Withdrawal by Subject|3|||
162944085|NCT04634409|588496329|FG009|Overall Study|Withdrawal by Subject|2|||
162944086|NCT04634409|588496330|FG010|Overall Study|Withdrawal by Subject|3|||
162944087|NCT04634409|588496331|FG011|Overall Study|Withdrawal by Subject|2|||
162944088|NCT04634409|588496332|FG012|Overall Study|Withdrawal by Subject|2|||
162944089|NCT04634409|588496333|FG013|Overall Study|Withdrawal by Subject|1|||
162944090|NCT04634409|588496334|FG014|Overall Study|Withdrawal by Subject|5|||
162944091|NCT04634409|588496335|FG015|Overall Study|Withdrawal by Subject|0|||
162944092|NCT04634409|588496336|FG016|Overall Study|Withdrawal by Subject|0|||
162944093|NCT04634409|588496337|FG017|Overall Study|Withdrawal by Subject|1|||
162944094|NCT04634409|588496338|FG018|Overall Study|Withdrawal by Subject|0|||
162944095|NCT04634409|588496339|FG019|Overall Study|Withdrawal by Subject|0|||
162944096|NCT04634409|588496340|FG020|Overall Study|Withdrawal by Subject|0|||
162944097|NCT04634409|588496341|FG021|Overall Study|Withdrawal by Subject|0|||
162944098|NCT04634409|588496342|FG022|Overall Study|Withdrawal by Subject|0|||
162944099|NCT04634409|588496343|FG023|Overall Study|Withdrawal by Subject|1|||
162944100|NCT04634409|588496344|FG024|Overall Study|Withdrawal by Subject|0|||
162944101|NCT04634409|588496345|FG025|Overall Study|Withdrawal by Subject|0|||
162944102|NCT04634409|588496346|FG026|Overall Study|Withdrawal by Subject|0|||
162944103|NCT04634409|588496320|FG000|Overall Study|Other - As reported by Investigator|1|||
162944104|NCT04634409|588496321|FG001|Overall Study|Other - As reported by Investigator|0|||
162944105|NCT04634409|588496322|FG002|Overall Study|Other - As reported by Investigator|0|||
162944106|NCT04634409|588496323|FG003|Overall Study|Other - As reported by Investigator|0|||
162944107|NCT04634409|588496324|FG004|Overall Study|Other - As reported by Investigator|0|||
162944108|NCT04634409|588496325|FG005|Overall Study|Other - As reported by Investigator|0|||
162944109|NCT04634409|588496326|FG006|Overall Study|Other - As reported by Investigator|0|||
162944110|NCT04634409|588496327|FG007|Overall Study|Other - As reported by Investigator|6|||
162944111|NCT04634409|588496328|FG008|Overall Study|Other - As reported by Investigator|4|||
162944112|NCT04634409|588496329|FG009|Overall Study|Other - As reported by Investigator|0|||
162944113|NCT04634409|588496330|FG010|Overall Study|Other - As reported by Investigator|1|||
162944114|NCT04634409|588496331|FG011|Overall Study|Other - As reported by Investigator|2|||
162944115|NCT04634409|588496332|FG012|Overall Study|Other - As reported by Investigator|2|||
162944116|NCT04634409|588496333|FG013|Overall Study|Other - As reported by Investigator|1|||
162944117|NCT04634409|588496334|FG014|Overall Study|Other - As reported by Investigator|0|||
162944118|NCT04634409|588496335|FG015|Overall Study|Other - As reported by Investigator|0|||
162944119|NCT04634409|588496336|FG016|Overall Study|Other - As reported by Investigator|0|||
162944120|NCT04634409|588496337|FG017|Overall Study|Other - As reported by Investigator|0|||
162944121|NCT04634409|588496338|FG018|Overall Study|Other - As reported by Investigator|0|||
162944122|NCT04634409|588496339|FG019|Overall Study|Other - As reported by Investigator|0|||
162944123|NCT04634409|588496340|FG020|Overall Study|Other - As reported by Investigator|0|||
162944124|NCT04634409|588496341|FG021|Overall Study|Other - As reported by Investigator|0|||
162944125|NCT04634409|588496342|FG022|Overall Study|Other - As reported by Investigator|0|||
162944126|NCT04634409|588496343|FG023|Overall Study|Other - As reported by Investigator|0|||
162944127|NCT04634409|588496344|FG024|Overall Study|Other - As reported by Investigator|0|||
162944128|NCT04634409|588496345|FG025|Overall Study|Other - As reported by Investigator|0|||
162944129|NCT04634409|588496346|FG026|Overall Study|Other - As reported by Investigator|0|||
162698789|NCT01702428|587606848|FG000|Overall Study|Protocol Violation|3|||
162698790|NCT01702428|587606849|FG001|Overall Study|Protocol Violation|0|||
162698791|NCT01702428|587606850|FG002|Overall Study|Protocol Violation|1|||
162698792|NCT01702428|587606851|FG003|Overall Study|Protocol Violation|0|||
162698793|NCT01702428|587606848|FG000|Overall Study|Withdrawal by Subject|21|||
162698794|NCT01702428|587606849|FG001|Overall Study|Withdrawal by Subject|23|||
162698795|NCT01702428|587606850|FG002|Overall Study|Withdrawal by Subject|14|||
162698796|NCT01702428|587606851|FG003|Overall Study|Withdrawal by Subject|10|||
162698797|NCT02091869|587606852|FG000|Overall Study|Withdrawal by Subject|0|||
162698798|NCT02091869|587606853|FG001|Overall Study|Withdrawal by Subject|3|||
162698799|NCT03685708|587606857|FG000|Overall Study|Withdrawal by Subject|0|||
162698800|NCT03685708|587606858|FG001|Overall Study|Withdrawal by Subject|0|||
162698801|NCT03685708|587606859|FG002|Overall Study|Withdrawal by Subject|1|||
162698802|NCT03685708|587606857|FG000|Overall Study|Screen Fail|0|||
162698803|NCT03685708|587606858|FG001|Overall Study|Screen Fail|1|||
162698804|NCT03685708|587606859|FG002|Overall Study|Screen Fail|1|||
162698805|NCT03685708|587606857|FG000|Overall Study|COVID 19 Pandemic|1|||
162698806|NCT03685708|587606858|FG001|Overall Study|COVID 19 Pandemic|1|||
162698807|NCT03685708|587606859|FG002|Overall Study|COVID 19 Pandemic|6|||
162698808|NCT03685708|587606857|FG000|Overall Study|Disease Progression|0|||
162698809|NCT03685708|587606858|FG001|Overall Study|Disease Progression|0|||
162698810|NCT03685708|587606859|FG002|Overall Study|Disease Progression|1|||
162698811|NCT02771210|587606861|FG000|Period 1|Adverse Event|5|||
162831492|NCT01611974|588096006|FG002|Overall Study|Physician Decision|2|||
162831493|NCT01611974|588096004|FG000|Overall Study|Withdrawal by Subject|0|||
162831494|NCT01611974|588096005|FG001|Overall Study|Withdrawal by Subject|1|||
162831495|NCT01611974|588096006|FG002|Overall Study|Withdrawal by Subject|4|||
162831496|NCT00522431|588096007|FG000|Overall Study|Adverse Event|5|||
162831497|NCT00522431|588096007|FG000|Overall Study|Protocol Violation|2|||
162831498|NCT00522431|588096007|FG000|Overall Study|Withdrawal by Subject|2|||
162831499|NCT00522431|588096007|FG000|Overall Study|Subject non-compliance|1|||
162831500|NCT00522431|588096007|FG000|Overall Study|Other/unknown|1|||
162831501|NCT00132132|588096008|FG000|Overall Study|Lost to Follow-up|7|||
162831502|NCT00132132|588096009|FG001|Overall Study|Lost to Follow-up|2|||
162831503|NCT03776175|588096010|FG000|Treatment Period (42 Days)|Adverse Event|0|||
162831504|NCT03776175|588096011|FG001|Treatment Period (42 Days)|Adverse Event|1|||
162831505|NCT03776175|588096012|FG002|Treatment Period (42 Days)|Adverse Event|1|||
162831506|NCT03776175|588096013|FG003|Treatment Period (42 Days)|Adverse Event|0|||
162831507|NCT03776175|588096010|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
162831508|NCT03776175|588096011|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
162831509|NCT03776175|588096012|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
162831510|NCT03776175|588096013|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
162831511|NCT03776175|588096010|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
162831512|NCT03776175|588096011|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
162831513|NCT03776175|588096012|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
162831514|NCT03776175|588096013|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
162831515|NCT03776175|588096010|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
162831516|NCT03776175|588096011|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
162831517|NCT03776175|588096012|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
162831518|NCT03776175|588096013|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
162831519|NCT03776175|588096010|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
162831520|NCT03776175|588096011|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
162831521|NCT03776175|588096012|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
162831522|NCT03776175|588096013|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
162831523|NCT03776175|588096010|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
162831524|NCT03776175|588096011|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
162831525|NCT03776175|588096012|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
162831526|NCT03776175|588096013|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
162831527|NCT03273166|588096014|FG000|Overall Study|Withdrawn prior to Completion|31|||
162831528|NCT03808077|588096015|FG000|Overall Study|Physician Decision|2|||
162831529|NCT03808077|588096016|FG001|Overall Study|Physician Decision|3|||
162831530|NCT03808077|588096015|FG000|Overall Study|Withdrawal by Subject|1|||
162831531|NCT03808077|588096016|FG001|Overall Study|Withdrawal by Subject|0|||
162831532|NCT03808077|588096015|FG000|Overall Study|Equipment Issues|2|||
162831533|NCT03808077|588096016|FG001|Overall Study|Equipment Issues|1|||
162831534|NCT00930761|588096021|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
162831535|NCT00930761|588096022|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
162831536|NCT00930761|588096021|FG000|Overall Study|less than 3 music therapy sessions|0|||
162831537|NCT00930761|588096022|FG001|Overall Study|less than 3 music therapy sessions|3|||
162698812|NCT02771210|587606862|FG001|Period 1|Adverse Event|3|||
162698813|NCT02771210|587606861|FG000|Period 1|Lack of Efficacy|3|||
162698814|NCT02771210|587606862|FG001|Period 1|Lack of Efficacy|6|||
162831538|NCT03699007|588096025|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
162944130|NCT02683187|588496347|FG000|Overall Study|Failed IV access|3|||
162698815|NCT02771210|587606861|FG000|Period 1|Lost to Follow-up|2|||
162944131|NCT02683187|588496347|FG000|Overall Study|Withdrawal by Subject|5|||
162944132|NCT05665595|588498692|FG000|Overall Study|Ongoing|692|||
162944133|NCT05665595|588498693|FG001|Overall Study|Ongoing|698|||
162944134|NCT05665595|588498692|FG000|Overall Study|Withdrawal by Subject|2|||
162944135|NCT05665595|588498693|FG001|Overall Study|Withdrawal by Subject|2|||
162944136|NCT05665595|588498692|FG000|Overall Study|Lost to Follow-up|1|||
162944137|NCT05665595|588498693|FG001|Overall Study|Lost to Follow-up|0|||
162944138|NCT05665595|588498692|FG000|Overall Study|Death|6|||
162944139|NCT05665595|588498693|FG001|Overall Study|Death|1|||
162944140|NCT01768858|588498694|FG000|Overall Study|Lost to Follow-up|9|||
162944141|NCT01768858|588498694|FG000|Overall Study|Lack of Efficacy|8|||
162944142|NCT01768858|588498694|FG000|Overall Study|Serious Adverse Event|1|||
162944143|NCT01768858|588498694|FG000|Overall Study|Participant moved to Germany|1|||
162944144|NCT01768858|588498694|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
162944145|NCT01768858|588498694|FG000|Overall Study|Exanthema|1|||
162944146|NCT01768858|588498694|FG000|Overall Study|Withdrawal by Subject|1|||
162944147|NCT03471078|588498702|FG000|Overall Study|Withdrawal by Subject|9|||
162944148|NCT03471078|588498703|FG001|Overall Study|Withdrawal by Subject|1|||
162944149|NCT03471078|588498702|FG000|Overall Study|Adverse Event|4|||
162944150|NCT03471078|588498703|FG001|Overall Study|Adverse Event|1|||
162944151|NCT03471078|588498702|FG000|Overall Study|Physician Decision|3|||
162944152|NCT03471078|588498703|FG001|Overall Study|Physician Decision|2|||
162944153|NCT03471078|588498702|FG000|Overall Study|Death|2|||
162944154|NCT03471078|588498703|FG001|Overall Study|Death|0|||
162944155|NCT03471078|588498702|FG000|Overall Study|Other|3|||
162944156|NCT03471078|588498703|FG001|Overall Study|Other|2|||
162944157|NCT00502775|588498704|FG000|Overall Study|Adverse Event|1|||
162944158|NCT00502775|588498705|FG001|Overall Study|Adverse Event|2|||
162944159|NCT00502775|588498706|FG002|Overall Study|Adverse Event|1|||
162944160|NCT00502775|588498704|FG000|Overall Study|Protocol Violation|1|||
162944161|NCT00502775|588498705|FG001|Overall Study|Protocol Violation|5|||
162944162|NCT00502775|588498706|FG002|Overall Study|Protocol Violation|2|||
162944163|NCT00502775|588498704|FG000|Overall Study|Withdrawal by Subject|1|||
162944164|NCT00502775|588498705|FG001|Overall Study|Withdrawal by Subject|1|||
162944165|NCT00502775|588498706|FG002|Overall Study|Withdrawal by Subject|2|||
162944166|NCT00502775|588498704|FG000|Overall Study|Sponsor Terminated Study|1|||
162944167|NCT00502775|588498705|FG001|Overall Study|Sponsor Terminated Study|0|||
162944168|NCT00502775|588498706|FG002|Overall Study|Sponsor Terminated Study|1|||
162944169|NCT00502775|588498704|FG000|Overall Study|Non-compliance with eDiary|4|||
162944170|NCT00502775|588498705|FG001|Overall Study|Non-compliance with eDiary|1|||
162944171|NCT00502775|588498706|FG002|Overall Study|Non-compliance with eDiary|1|||
162944172|NCT00502775|588498704|FG000|Overall Study|Subject unable to swallow capsule|1|||
162944173|NCT00502775|588498705|FG001|Overall Study|Subject unable to swallow capsule|0|||
162944174|NCT00502775|588498706|FG002|Overall Study|Subject unable to swallow capsule|1|||
162944175|NCT00502775|588498704|FG000|Overall Study|Logpad compliance <80%|1|||
162944176|NCT00502775|588498705|FG001|Overall Study|Logpad compliance <80%|0|||
162944177|NCT00502775|588498706|FG002|Overall Study|Logpad compliance <80%|0|||
162944178|NCT00502775|588498704|FG000|Overall Study|Randomized in error|0|||
162944179|NCT00502775|588498705|FG001|Overall Study|Randomized in error|1|||
162944180|NCT00502775|588498706|FG002|Overall Study|Randomized in error|1|||
162944181|NCT00502775|588498704|FG000|Overall Study|Non-compliance|0|||
162944182|NCT00502775|588498705|FG001|Overall Study|Non-compliance|2|||
162944183|NCT00502775|588498706|FG002|Overall Study|Non-compliance|2|||
162944184|NCT00502775|588498704|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
162944185|NCT00502775|588498705|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
162944186|NCT00502775|588498706|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
162944187|NCT00502775|588498704|FG000|Overall Study|Declining pollen counts|0|||
162944188|NCT00502775|588498705|FG001|Overall Study|Declining pollen counts|1|||
162944189|NCT00502775|588498706|FG002|Overall Study|Declining pollen counts|1|||
162944190|NCT00502775|588498704|FG000|Overall Study|Subject in jail|0|||
162944191|NCT00502775|588498705|FG001|Overall Study|Subject in jail|1|||
162944192|NCT00502775|588498706|FG002|Overall Study|Subject in jail|0|||
162944193|NCT00502775|588498704|FG000|Overall Study|Subject took disallowed drug|0|||
162944194|NCT00502775|588498705|FG001|Overall Study|Subject took disallowed drug|0|||
162944195|NCT00502775|588498706|FG002|Overall Study|Subject took disallowed drug|1|||
162944196|NCT05381948|588498709|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
162944197|NCT05381948|588498710|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
162944198|NCT05381948|588498711|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
162944199|NCT05381948|588498709|FG000|Overall Study|Adverse Event: Non-ocular|0|||
162944200|NCT05381948|588498710|FG001|Overall Study|Adverse Event: Non-ocular|1|||
162944201|NCT05381948|588498711|FG002|Overall Study|Adverse Event: Non-ocular|0|||
162944202|NCT05381948|588498709|FG000|Overall Study|Lost to Follow-up|1|||
162944203|NCT05381948|588498710|FG001|Overall Study|Lost to Follow-up|0|||
162944204|NCT05381948|588498711|FG002|Overall Study|Lost to Follow-up|0|||
162944205|NCT05381948|588498709|FG000|Overall Study|Protocol Deviation|0|||
162944206|NCT05381948|588498710|FG001|Overall Study|Protocol Deviation|2|||
162831539|NCT03699007|588096026|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
162831540|NCT03699007|588096025|FG000|6-month Follow Up|Lost to Follow-up|2|||
162831541|NCT03699007|588096026|FG001|6-month Follow Up|Lost to Follow-up|3|||
162831542|NCT01970995|588096027|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
162831543|NCT01970995|588096028|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
162944207|NCT05381948|588498711|FG002|Overall Study|Protocol Deviation|0|||
162944208|NCT05381948|588498709|FG000|Overall Study|Withdrawal by Subject|1|||
162944209|NCT05381948|588498710|FG001|Overall Study|Withdrawal by Subject|0|||
162944210|NCT05381948|588498711|FG002|Overall Study|Withdrawal by Subject|1|||
162944211|NCT05381948|588498709|FG000|Overall Study|Death|0|||
162944212|NCT05381948|588498710|FG001|Overall Study|Death|2|||
162944213|NCT05381948|588498711|FG002|Overall Study|Death|0|||
162944214|NCT05381948|588498709|FG000|Overall Study|Discontinued study without receiving study drug|0|||
162944215|NCT05381948|588498710|FG001|Overall Study|Discontinued study without receiving study drug|0|||
162944216|NCT05381948|588498711|FG002|Overall Study|Discontinued study without receiving study drug|1|||
162944217|NCT04471207|588498712|FG000|Overall Study|Lost to Follow-up|4|||
162944218|NCT04471207|588498713|FG001|Overall Study|Lost to Follow-up|1|||
162944219|NCT04471207|588498712|FG000|Overall Study|Medication Contraindication|0|||
162944220|NCT04471207|588498713|FG001|Overall Study|Medication Contraindication|1|||
162944221|NCT04471207|588498712|FG000|Overall Study|Loss of Interest|2|||
162944222|NCT04471207|588498713|FG001|Overall Study|Loss of Interest|1|||
162944223|NCT04471207|588498712|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
162944224|NCT04471207|588498713|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
162944225|NCT04471207|588498712|FG000|Overall Study|Scheduling Conflicts|3|||
162944226|NCT04471207|588498713|FG001|Overall Study|Scheduling Conflicts|1|||
162944227|NCT04471207|588498712|FG000|Overall Study|Physician Decision|1|||
162944228|NCT04471207|588498713|FG001|Overall Study|Physician Decision|0|||
162944229|NCT04471207|588498712|FG000|Overall Study|Unwilling to Use System|0|||
162944230|NCT04471207|588498713|FG001|Overall Study|Unwilling to Use System|1|||
162831544|NCT01970995|588096029|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
162831545|NCT01970995|588096027|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
162831546|NCT01970995|588096028|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
162831547|NCT01970995|588096029|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
162831548|NCT01709435|588096030|FG000|Overall Study|Adverse Event|1|||
162831549|NCT01709435|588096031|FG001|Overall Study|Adverse Event|1|||
162831550|NCT01709435|588096032|FG002|Overall Study|Adverse Event|1|||
162831551|NCT01709435|588096033|FG003|Overall Study|Adverse Event|0|||
162831552|NCT01709435|588096034|FG004|Overall Study|Adverse Event|0|||
162831553|NCT01709435|588096035|FG005|Overall Study|Adverse Event|1|||
162831554|NCT01709435|588096030|FG000|Overall Study|Lack of Efficacy|5|||
162831555|NCT01709435|588096031|FG001|Overall Study|Lack of Efficacy|7|||
162831556|NCT01709435|588096032|FG002|Overall Study|Lack of Efficacy|2|||
162831557|NCT01709435|588096033|FG003|Overall Study|Lack of Efficacy|2|||
162831558|NCT01709435|588096034|FG004|Overall Study|Lack of Efficacy|6|||
162831559|NCT01709435|588096035|FG005|Overall Study|Lack of Efficacy|3|||
162944231|NCT00520741|588498716|FG000|Overall Study|Adverse Event|16|||
162944232|NCT00520741|588498717|FG001|Overall Study|Adverse Event|56|||
162944233|NCT00520741|588498716|FG000|Overall Study|Lack of Efficacy|11|||
162944234|NCT00520741|588498717|FG001|Overall Study|Lack of Efficacy|30|||
162944235|NCT00520741|588498716|FG000|Overall Study|Withdrawal by Subject|0|||
162944236|NCT00520741|588498717|FG001|Overall Study|Withdrawal by Subject|11|||
162698816|NCT02771210|587606862|FG001|Period 1|Lost to Follow-up|0|||
162698817|NCT02771210|587606861|FG000|Period 1|Physician Decision|0|||
162944237|NCT00520741|588498716|FG000|Overall Study|Protocol Violation|2|||
162944238|NCT00520741|588498717|FG001|Overall Study|Protocol Violation|15|||
162944239|NCT00520741|588498716|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
162944240|NCT00520741|588498717|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
162944241|NCT00520741|588498716|FG000|Overall Study|Lost to Follow-up|4|||
162944242|NCT00520741|588498717|FG001|Overall Study|Lost to Follow-up|4|||
162944243|NCT00520741|588498716|FG000|Overall Study|Other reasons for premature termination|0|||
162698818|NCT02771210|587606862|FG001|Period 1|Physician Decision|1|||
162944244|NCT00520741|588498717|FG001|Overall Study|Other reasons for premature termination|6|||
162698819|NCT02771210|587606861|FG000|Period 1|Withdrawal by Subject|0|||
162831560|NCT01709435|588096030|FG000|Overall Study|Physician Decision|0|||
162831561|NCT01709435|588096031|FG001|Overall Study|Physician Decision|1|||
162831562|NCT01709435|588096032|FG002|Overall Study|Physician Decision|0|||
162831563|NCT01709435|588096033|FG003|Overall Study|Physician Decision|1|||
162831564|NCT01709435|588096034|FG004|Overall Study|Physician Decision|2|||
162831565|NCT01709435|588096035|FG005|Overall Study|Physician Decision|0|||
162831566|NCT01709435|588096030|FG000|Overall Study|Withdrawal by Subject|0|||
162831567|NCT01709435|588096031|FG001|Overall Study|Withdrawal by Subject|0|||
162831568|NCT01709435|588096032|FG002|Overall Study|Withdrawal by Subject|3|||
162831569|NCT01709435|588096033|FG003|Overall Study|Withdrawal by Subject|0|||
162831570|NCT01709435|588096034|FG004|Overall Study|Withdrawal by Subject|2|||
162831571|NCT01709435|588096035|FG005|Overall Study|Withdrawal by Subject|2|||
162831572|NCT01263639|588096036|FG000|Overall Study|Lost to Follow-up|66|||
162831573|NCT01263639|588096037|FG001|Overall Study|Lost to Follow-up|70|||
162831574|NCT01263639|588096036|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
162831575|NCT01263639|588096037|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
162831576|NCT01780662|588096038|FG000|Overall Study|Adverse Event|1|||
162831577|NCT01780662|588096039|FG001|Overall Study|Adverse Event|0|||
162831578|NCT01780662|588096040|FG002|Overall Study|Adverse Event|2|||
162831579|NCT01780662|588096038|FG000|Overall Study|Physician Decision|0|||
162831580|NCT01780662|588096039|FG001|Overall Study|Physician Decision|5|||
162831581|NCT01780662|588096040|FG002|Overall Study|Physician Decision|7|||
162831582|NCT01780662|588096038|FG000|Overall Study|Protocol Violation|0|||
162831583|NCT01780662|588096039|FG001|Overall Study|Protocol Violation|1|||
162831584|NCT01780662|588096040|FG002|Overall Study|Protocol Violation|0|||
162831585|NCT01780662|588096038|FG000|Overall Study|Ineligible|0|||
162944245|NCT03702621|588498718|FG000|Overall Study|Physician Decision|6|||
162944246|NCT03702621|588498719|FG001|Overall Study|Physician Decision|6|||
162831586|NCT01780662|588096039|FG001|Overall Study|Ineligible|0|||
162831587|NCT01780662|588096040|FG002|Overall Study|Ineligible|1|||
162831588|NCT03975920|588096041|FG000|Overall Study|Lost to Follow-up|1|||
162831589|NCT03975920|588096042|FG001|Overall Study|Lost to Follow-up|2|||
162831590|NCT03975920|588096041|FG000|Overall Study|Protocol Violation|1|||
162831591|NCT03975920|588096042|FG001|Overall Study|Protocol Violation|1|||
162831592|NCT03975920|588096041|FG000|Overall Study|Did not complete survey|2|||
162831593|NCT03975920|588096042|FG001|Overall Study|Did not complete survey|1|||
162831594|NCT03882970|588096043|FG000|Overall Study|Adverse Event|5|||
162831595|NCT03882970|588096044|FG001|Overall Study|Adverse Event|7|||
162831596|NCT03882970|588096045|FG002|Overall Study|Adverse Event|3|||
162831597|NCT03882970|588096046|FG003|Overall Study|Adverse Event|1|||
162698820|NCT02771210|587606862|FG001|Period 1|Withdrawal by Subject|3|||
162698821|NCT02771210|587606861|FG000|Period 1|Withdrawal of informed consent|1|||
162698822|NCT02771210|587606862|FG001|Period 1|Withdrawal of informed consent|5|||
162698823|NCT02771210|587606861|FG000|Period 2|Adverse Event|1|||
162698824|NCT02771210|587606862|FG001|Period 2|Adverse Event|0|||
162698825|NCT02771210|587606861|FG000|Period 2|Lack of Efficacy|0|||
162698826|NCT02771210|587606862|FG001|Period 2|Lack of Efficacy|1|||
162698827|NCT02771210|587606861|FG000|Period 2|Withdrawal by Subject|1|||
162698828|NCT02771210|587606862|FG001|Period 2|Withdrawal by Subject|0|||
162698829|NCT02771210|587606861|FG000|Period 2|Withdrawal of informed consent|0|||
162698830|NCT02771210|587606862|FG001|Period 2|Withdrawal of informed consent|2|||
162698831|NCT04397523|587606863|FG000|Overall Study|Lost to Follow-up|3|||
162698832|NCT04397523|587606863|FG000|Overall Study|Transfer from/to other hospital|8|||
162698833|NCT01275196|587606864|FG000|Overall Study|Adverse Event|3|||
162698834|NCT01275196|587606865|FG001|Overall Study|Adverse Event|5|||
162698835|NCT01275196|587606864|FG000|Overall Study|Withdrawal by Subject|4|||
162698836|NCT01275196|587606865|FG001|Overall Study|Withdrawal by Subject|5|||
162698837|NCT01275196|587606864|FG000|Overall Study|Lost to Follow-up|1|||
162698838|NCT01275196|587606865|FG001|Overall Study|Lost to Follow-up|0|||
162698839|NCT01275196|587606864|FG000|Overall Study|Disease Progression|6|||
162698840|NCT01275196|587606865|FG001|Overall Study|Disease Progression|5|||
162698841|NCT01275196|587606864|FG000|Overall Study|Protocol Violation|1|||
162698842|NCT01275196|587606865|FG001|Overall Study|Protocol Violation|0|||
162698843|NCT01275196|587606864|FG000|Overall Study|Suboptimal response/treatment failure|5|||
162698844|NCT01275196|587606865|FG001|Overall Study|Suboptimal response/treatment failure|6|||
162698845|NCT01744496|587606867|FG000|Titration Period|Adverse Event|2|||
162698846|NCT01744496|587606868|FG001|Titration Period|Adverse Event|1|||
162698847|NCT01744496|587606867|FG000|Titration Period|Personal reasons|0|||
162698848|NCT01744496|587606868|FG001|Titration Period|Personal reasons|1|||
162698849|NCT01744496|587606867|FG000|Maintenance Period|Adverse Event|1|||
162831598|NCT03882970|588096043|FG000|Overall Study|Death|1|||
162698850|NCT01744496|587606868|FG001|Maintenance Period|Adverse Event|3|||
162698851|NCT01744496|587606867|FG000|Maintenance Period|Protocol Violation|1|||
162698852|NCT01744496|587606868|FG001|Maintenance Period|Protocol Violation|0|||
162831599|NCT03882970|588096044|FG001|Overall Study|Death|2|||
162831600|NCT03882970|588096045|FG002|Overall Study|Death|1|||
162831601|NCT03882970|588096046|FG003|Overall Study|Death|1|||
162831602|NCT03882970|588096043|FG000|Overall Study|Lost to Follow-up|8|||
162831603|NCT03882970|588096044|FG001|Overall Study|Lost to Follow-up|9|||
162831604|NCT03882970|588096045|FG002|Overall Study|Lost to Follow-up|5|||
162831605|NCT03882970|588096046|FG003|Overall Study|Lost to Follow-up|5|||
162831606|NCT03882970|588096043|FG000|Overall Study|Physician Decision|0|||
162831607|NCT03882970|588096044|FG001|Overall Study|Physician Decision|2|||
162831608|NCT03882970|588096045|FG002|Overall Study|Physician Decision|2|||
162831609|NCT03882970|588096046|FG003|Overall Study|Physician Decision|2|||
162831610|NCT03882970|588096043|FG000|Overall Study|Protocol Violation|2|||
162831611|NCT03882970|588096044|FG001|Overall Study|Protocol Violation|0|||
162831612|NCT03882970|588096045|FG002|Overall Study|Protocol Violation|0|||
162831613|NCT03882970|588096046|FG003|Overall Study|Protocol Violation|0|||
162831614|NCT03882970|588096043|FG000|Overall Study|Withdrawal by Subject|8|||
162831615|NCT03882970|588096044|FG001|Overall Study|Withdrawal by Subject|17|||
162831616|NCT03882970|588096045|FG002|Overall Study|Withdrawal by Subject|7|||
162831617|NCT03882970|588096046|FG003|Overall Study|Withdrawal by Subject|22|||
162831618|NCT03882970|588096043|FG000|Overall Study|Personal Reason|2|||
162831619|NCT03882970|588096044|FG001|Overall Study|Personal Reason|3|||
162831620|NCT03882970|588096045|FG002|Overall Study|Personal Reason|1|||
162831621|NCT03882970|588096046|FG003|Overall Study|Personal Reason|3|||
162831622|NCT02863809|588096047|FG000|Overall Study|Adverse Event|8|||
162831623|NCT02863809|588096048|FG001|Overall Study|Adverse Event|8|||
162831624|NCT02863809|588096047|FG000|Overall Study|Withdrawal by Subject|0|||
162831625|NCT02863809|588096048|FG001|Overall Study|Withdrawal by Subject|1|||
162831626|NCT02863809|588096047|FG000|Overall Study|Lost to Follow-up|1|||
162831627|NCT02863809|588096048|FG001|Overall Study|Lost to Follow-up|1|||
162831628|NCT02863809|588096047|FG000|Overall Study|Death|1|||
162831629|NCT02863809|588096048|FG001|Overall Study|Death|0|||
162831630|NCT01081249|588096051|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
162831631|NCT01081249|588096052|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
162831632|NCT02813694|588096053|FG000|Overall Study|Physician Decision|0|||
162831633|NCT02813694|588096054|FG001|Overall Study|Physician Decision|1|||
162831634|NCT02813694|588096053|FG000|Overall Study|Withdrawal by Subject|10|||
162831635|NCT02813694|588096054|FG001|Overall Study|Withdrawal by Subject|9|||
162831636|NCT02813694|588096053|FG000|Overall Study|Lost to Follow-up|1|||
162831637|NCT02813694|588096054|FG001|Overall Study|Lost to Follow-up|1|||
162831638|NCT02813694|588096053|FG000|Overall Study|Death|3|||
162831639|NCT02813694|588096054|FG001|Overall Study|Death|3|||
162831640|NCT02813694|588096053|FG000|Overall Study|Randomized- did not receive study drug|2|||
162831641|NCT02813694|588096054|FG001|Overall Study|Randomized- did not receive study drug|0|||
162831642|NCT02813694|588096053|FG000|Overall Study|Patient hospitalized|1|||
162831643|NCT02813694|588096054|FG001|Overall Study|Patient hospitalized|0|||
162831644|NCT02980224|588096056|FG000|Overall Study|Adverse Event|4|||
162831645|NCT02980224|588096057|FG001|Overall Study|Adverse Event|1|||
162831646|NCT02980224|588096056|FG000|Overall Study|Withdrawal by Subject|0|||
162831647|NCT02980224|588096057|FG001|Overall Study|Withdrawal by Subject|2|||
162944247|NCT02402166|588498720|FG000|Overall Study|Adverse Event|2|||
162944248|NCT02402166|588498720|FG000|Overall Study|Withdrawal by Subject|2|||
162944249|NCT02402166|588498720|FG000|Overall Study|Lost to Follow-up|1|||
162944250|NCT00623103|588498721|FG000|Overall Study|Adverse Event|70|||
162944251|NCT00623103|588498722|FG001|Overall Study|Adverse Event|60|||
162944252|NCT00623103|588498721|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162944253|NCT00623103|588498722|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
162944254|NCT00623103|588498721|FG000|Overall Study|Withdrawal by Subject|18|||
162944255|NCT00623103|588498722|FG001|Overall Study|Withdrawal by Subject|24|||
162944256|NCT00623103|588498721|FG000|Overall Study|Lost to Follow-up|4|||
162944257|NCT00623103|588498722|FG001|Overall Study|Lost to Follow-up|1|||
162944258|NCT00623103|588498721|FG000|Overall Study|Administrative problems|2|||
162944259|NCT00623103|588498722|FG001|Overall Study|Administrative problems|4|||
162944260|NCT00623103|588498721|FG000|Overall Study|Death|11|||
162944261|NCT00623103|588498722|FG001|Overall Study|Death|11|||
162944262|NCT00623103|588498721|FG000|Overall Study|Protocol deviation|2|||
162944263|NCT00623103|588498722|FG001|Overall Study|Protocol deviation|1|||
162944264|NCT02433678|588498727|FG000|Overall Study|Lost to Follow-up|1|||
162944265|NCT02433678|588498728|FG001|Overall Study|Lost to Follow-up|2|||
162944266|NCT02684578|588498732|FG000|Overall Study|Withdrawal by Subject|10|||
162944267|NCT02684578|588498733|FG001|Overall Study|Withdrawal by Subject|7|||
162944268|NCT02684578|588498732|FG000|Overall Study|Lost to Follow-up|0|||
162944269|NCT02684578|588498733|FG001|Overall Study|Lost to Follow-up|3|||
162944270|NCT02684578|588498732|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
162944271|NCT02684578|588498733|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
162944272|NCT02684578|588498732|FG000|Overall Study|Missing follow-up data|0|||
162944273|NCT02684578|588498733|FG001|Overall Study|Missing follow-up data|1|||
162944274|NCT01505530|588498734|FG000|Overall Study|Progressive Disease|19|||
162944275|NCT01505530|588498735|FG001|Overall Study|Progressive Disease|17|||
162944276|NCT01505530|588498736|FG002|Overall Study|Progressive Disease|18|||
162944277|NCT01505530|588498734|FG000|Overall Study|Adverse Event|1|||
162944278|NCT01505530|588498735|FG001|Overall Study|Adverse Event|1|||
162698853|NCT01744496|587606867|FG000|Maintenance Period|Withdrawal by Subject|1|||
162698854|NCT01744496|587606868|FG001|Maintenance Period|Withdrawal by Subject|1|||
162698855|NCT01744496|587606867|FG000|Maintenance Period|Subject left town|1|||
162698856|NCT01744496|587606868|FG001|Maintenance Period|Subject left town|0|||
162831648|NCT00606320|588096060|FG000|Overall Study|Adverse Event|3|||
162831649|NCT00606320|588096060|FG000|Overall Study|Lack of Efficacy|5|||
162810673|NCT00887432|588018307|FG000|Overall Study|Start Excluded Therapy|3|||
162810674|NCT00887432|588018308|FG001|Overall Study|Start Excluded Therapy|0|||
162810675|NCT00887432|588018307|FG000|Overall Study|Did not complete treatment|6|||
162810676|NCT00887432|588018308|FG001|Overall Study|Did not complete treatment|8|||
162810677|NCT00887432|588018307|FG000|Overall Study|Protocol Violation|2|||
162810678|NCT00887432|588018308|FG001|Overall Study|Protocol Violation|3|||
162810679|NCT00887432|588018307|FG000|Overall Study|Withdrawal by Subject|3|||
162810680|NCT00887432|588018308|FG001|Overall Study|Withdrawal by Subject|2|||
162810681|NCT00887432|588018307|FG000|Overall Study|Lost to Follow-up|1|||
162810682|NCT00887432|588018308|FG001|Overall Study|Lost to Follow-up|0|||
162810683|NCT00887432|588018307|FG000|Overall Study|No reason provided|0|||
162810684|NCT00887432|588018308|FG001|Overall Study|No reason provided|1|||
162810685|NCT00899548|588018309|FG000|Overall Study|Physician Decision|3|||
162810686|NCT00551460|588018310|FG000|Overall Study|Adverse Event|1|||
162810687|NCT00551460|588018310|FG000|Overall Study|Withdrawal by Subject|1|||
162810688|NCT00551460|588018310|FG000|Overall Study|Physician Decision|1|||
162810689|NCT00551460|588018310|FG000|Overall Study|Death|7|||
162810690|NCT00551460|588018310|FG000|Overall Study|Ineligible|4|||
162810691|NCT00551460|588018310|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
162810692|NCT00448123|588018311|FG000|Overall Study|Lost to Follow-up|9|||
162810693|NCT00448123|588018312|FG001|Overall Study|Lost to Follow-up|6|||
162810694|NCT00448123|588018311|FG000|Overall Study|Physician Decision|6|||
162810695|NCT00448123|588018312|FG001|Overall Study|Physician Decision|6|||
162810696|NCT00818649|588018313|FG000|Overall Study|Declining performance status|2|||
162810697|NCT00818649|588018313|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
162810698|NCT00818649|588018313|FG000|Overall Study|Adverse Event|1|||
162810699|NCT02112708|588018317|FG000|Baseline|Physician Decision|16|||
162810700|NCT02112708|588018318|FG001|Baseline|Physician Decision|11|||
162810701|NCT02112708|588018317|FG000|Baseline|Lost to Follow-up|12|||
162810702|NCT02112708|588018318|FG001|Baseline|Lost to Follow-up|0|||
162810703|NCT02112708|588018317|FG000|4 Month|Death|0|||
162810704|NCT02112708|588018318|FG001|4 Month|Death|1|||
162810705|NCT02112708|588018317|FG000|4 Month|Withdrawal by Subject|12|||
162810706|NCT02112708|588018318|FG001|4 Month|Withdrawal by Subject|0|||
162810707|NCT00953745|588018319|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
162810708|NCT00953745|588018320|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
162810709|NCT00953745|588018319|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
162810710|NCT00953745|588018320|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
162810711|NCT00953745|588018319|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
162810712|NCT00953745|588018320|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
162810713|NCT00953745|588018319|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
162810714|NCT00953745|588018320|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
162810715|NCT00953745|588018319|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
162810716|NCT00953745|588018320|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
162810717|NCT00953745|588018319|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
162810718|NCT00953745|588018320|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
162810719|NCT03866473|588018322|FG000|Phase 1|Death|1|||
162810720|NCT03866473|588018323|FG001|Phase 1|Death|0|||
162810721|NCT03866473|588018322|FG000|Phase 2|Death|0|||
162810722|NCT03866473|588018323|FG001|Phase 2|Death|2|||
162810723|NCT03866473|588018322|FG000|Phase 2|Dropped|1|||
162810724|NCT03866473|588018323|FG001|Phase 2|Dropped|1|||
162810725|NCT03866473|588018322|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
162810726|NCT03866473|588018323|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
162810727|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
162810728|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
162810729|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
162810730|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
162810731|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
162810732|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
162810733|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
162810734|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
162810735|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
162810736|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
162944279|NCT01505530|588498736|FG002|Overall Study|Adverse Event|0|||
162944280|NCT01505530|588498734|FG000|Overall Study|Withdrawal by Subject|7|||
162944281|NCT01505530|588498735|FG001|Overall Study|Withdrawal by Subject|8|||
162944282|NCT01505530|588498736|FG002|Overall Study|Withdrawal by Subject|6|||
162944283|NCT01505530|588498734|FG000|Overall Study|Physician Decision|6|||
162944284|NCT01505530|588498735|FG001|Overall Study|Physician Decision|2|||
162944285|NCT01505530|588498736|FG002|Overall Study|Physician Decision|5|||
162944286|NCT01505530|588498734|FG000|Overall Study|Sponsor Decision|1|||
162944287|NCT01505530|588498735|FG001|Overall Study|Sponsor Decision|8|||
162944288|NCT01505530|588498736|FG002|Overall Study|Sponsor Decision|7|||
162944289|NCT01505530|588498734|FG000|Overall Study|Death|7|||
162944290|NCT01505530|588498735|FG001|Overall Study|Death|6|||
162944291|NCT01505530|588498736|FG002|Overall Study|Death|5|||
162944292|NCT01505530|588498734|FG000|Overall Study|entry criteria not met|0|||
162944293|NCT01505530|588498735|FG001|Overall Study|entry criteria not met|1|||
162944294|NCT01505530|588498736|FG002|Overall Study|entry criteria not met|0|||
162944295|NCT00626925|588498740|FG000|Overall Study|Lost to Follow-up|1|||
162944296|NCT00626925|588498741|FG001|Overall Study|Lost to Follow-up|2|||
162944297|NCT00626925|588498740|FG000|Overall Study|relapse|1|||
162944298|NCT00626925|588498741|FG001|Overall Study|relapse|0|||
162944299|NCT00626925|588498740|FG000|Overall Study|Adverse effect|6|||
162944300|NCT00626925|588498741|FG001|Overall Study|Adverse effect|2|||
162944301|NCT00626925|588498740|FG000|Overall Study|Lack of Efficacy|1|||
162944302|NCT00626925|588498741|FG001|Overall Study|Lack of Efficacy|4|||
162944303|NCT00626925|588498740|FG000|Overall Study|Time constraints|3|||
162944304|NCT00626925|588498741|FG001|Overall Study|Time constraints|1|||
162944305|NCT01966042|588498742|FG000|Overall Study|Death|2|||
162944306|NCT00625807|588498743|FG000|Overall Study|schedule conflict|2|||
162944307|NCT00625807|588498744|FG001|Overall Study|schedule conflict|8|||
162944308|NCT03267264|588498745|FG000|Overall Study|Withdrawal by Subject|1|||
162944309|NCT03267264|588498746|FG001|Overall Study|Withdrawal by Subject|0|||
162944310|NCT03267264|588498747|FG002|Overall Study|Withdrawal by Subject|2|||
162944311|NCT03267264|588498748|FG003|Overall Study|Withdrawal by Subject|4|||
162944312|NCT01802879|588498749|FG000|Overall Study|Administrative problems|2|||
162944313|NCT01802879|588498749|FG000|Overall Study|Disease progression|6|||
162944314|NCT00266409|588498750|FG000|Overall Study|Lack of Efficacy|2|||
162944315|NCT00266409|588498751|FG001|Overall Study|Lack of Efficacy|6|||
162944316|NCT00266409|588498752|FG002|Overall Study|Lack of Efficacy|1|||
162944317|NCT00266409|588498753|FG003|Overall Study|Lack of Efficacy|2|||
162944318|NCT00266409|588498750|FG000|Overall Study|Adverse Event|7|||
162944319|NCT00266409|588498751|FG001|Overall Study|Adverse Event|2|||
162944320|NCT00266409|588498752|FG002|Overall Study|Adverse Event|1|||
162944321|NCT00266409|588498753|FG003|Overall Study|Adverse Event|1|||
162944322|NCT00266409|588498750|FG000|Overall Study|Lost to Follow-up|18|||
162944323|NCT00266409|588498751|FG001|Overall Study|Lost to Follow-up|21|||
162944324|NCT00266409|588498752|FG002|Overall Study|Lost to Follow-up|6|||
162944325|NCT00266409|588498753|FG003|Overall Study|Lost to Follow-up|8|||
162944326|NCT00266409|588498750|FG000|Overall Study|Withdrawal by Subject|6|||
162944327|NCT00266409|588498751|FG001|Overall Study|Withdrawal by Subject|10|||
162944328|NCT00266409|588498752|FG002|Overall Study|Withdrawal by Subject|3|||
162944329|NCT00266409|588498753|FG003|Overall Study|Withdrawal by Subject|9|||
162944330|NCT00266409|588498750|FG000|Overall Study|Protocol Violation|5|||
162944331|NCT00266409|588498751|FG001|Overall Study|Protocol Violation|3|||
162944332|NCT00266409|588498752|FG002|Overall Study|Protocol Violation|4|||
162944333|NCT00266409|588498753|FG003|Overall Study|Protocol Violation|2|||
162944334|NCT00266409|588498750|FG000|Overall Study|Other|7|||
162944335|NCT00266409|588498751|FG001|Overall Study|Other|4|||
162944336|NCT00266409|588498752|FG002|Overall Study|Other|2|||
162944337|NCT00266409|588498753|FG003|Overall Study|Other|0|||
162944338|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
162944339|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
162944340|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
162944341|NCT00108732|588498761|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
162944342|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
162944343|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
162944344|NCT00108732|588498761|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
162944345|NCT01946165|588498763|FG000|Overall Study|Physician Decision|2|||
162944346|NCT01946165|588498764|FG001|Overall Study|Physician Decision|0|||
162944347|NCT01946165|588498763|FG000|Overall Study|Withdrawal by Subject|0|||
162944348|NCT01946165|588498764|FG001|Overall Study|Withdrawal by Subject|2|||
162944349|NCT01901055|588498765|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
162944350|NCT01901055|588498766|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
162944351|NCT01901055|588498765|FG000|Randomization But Not Titrated|Physician Decision|0|||
162944352|NCT01901055|588498766|FG001|Randomization But Not Titrated|Physician Decision|1|||
162944353|NCT01901055|588498765|FG000|Started Protocol to Week 6|Physician Decision|2|||
162944354|NCT01901055|588498766|FG001|Started Protocol to Week 6|Physician Decision|1|||
162944355|NCT01901055|588498765|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
162944356|NCT01901055|588498766|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
162944357|NCT01901055|588498765|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
162944358|NCT01901055|588498766|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
162944359|NCT01901055|588498765|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
162944360|NCT01901055|588498766|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
162944361|NCT01901055|588498765|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
162698857|NCT01284140|587606869|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
162698858|NCT01284140|587606870|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
162944362|NCT01901055|588498766|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
162944363|NCT01901055|588498765|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
162944364|NCT01901055|588498766|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
162944365|NCT01901055|588498765|FG000|Week 24|Withdrawal by Subject|13|||
162944366|NCT01901055|588498766|FG001|Week 24|Withdrawal by Subject|19|||
162944367|NCT01901055|588498765|FG000|Week 24|Physician Decision|1|||
162944368|NCT01901055|588498766|FG001|Week 24|Physician Decision|0|||
162944369|NCT01901055|588498765|FG000|Week 36|Withdrawal by Subject|0|||
162944370|NCT01901055|588498766|FG001|Week 36|Withdrawal by Subject|5|||
162944371|NCT01659567|588498767|FG000|Overall Study|Lack of Efficacy|22|||
162944372|NCT01659567|588498767|FG000|Overall Study|Switched to Pegferon|6|||
162944373|NCT01659567|588498767|FG000|Overall Study|Adverse Event|12|||
162944374|NCT01659567|588498767|FG000|Overall Study|Good result at early stage of treatment|5|||
162944375|NCT01659567|588498767|FG000|Overall Study|Withdrawal by Subject|64|||
162944376|NCT01659567|588498767|FG000|Overall Study|Progression of the main disease|1|||
162944377|NCT01659567|588498767|FG000|Overall Study|Other|13|||
162944378|NCT01179919|588498772|FG000|Overall Study|Protocol Violation|1|||
162944379|NCT01179919|588498772|FG000|Overall Study|Adverse Event|1|||
162944380|NCT01915732|588498781|FG000|Overall Study|Withdrawal by Subject|18|||
162944381|NCT01915732|588498782|FG001|Overall Study|Withdrawal by Subject|18|||
162944382|NCT01915732|588498781|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
162944383|NCT01915732|588498782|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162944384|NCT01915732|588498781|FG000|Overall Study|Adverse Event|12|||
162944385|NCT01915732|588498782|FG001|Overall Study|Adverse Event|4|||
162944386|NCT01915732|588498781|FG000|Overall Study|Protocol Violation|5|||
162944387|NCT01915732|588498782|FG001|Overall Study|Protocol Violation|5|||
162944388|NCT01915732|588498781|FG000|Overall Study|Lack of Efficacy|6|||
162944389|NCT01915732|588498782|FG001|Overall Study|Lack of Efficacy|11|||
162944390|NCT01915732|588498781|FG000|Overall Study|Lost to Follow-up|22|||
162944391|NCT01915732|588498782|FG001|Overall Study|Lost to Follow-up|26|||
162944392|NCT01915732|588498781|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
162831650|NCT00606320|588096060|FG000|Overall Study|Physician Decision|7|||
162698859|NCT01284140|587606869|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
162698860|NCT01284140|587606870|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
162831651|NCT00606320|588096060|FG000|Overall Study|Protocol Violation|8|||
162831652|NCT00606320|588096060|FG000|Overall Study|Withdrawal by Subject|10|||
162831653|NCT00606320|588096060|FG000|Overall Study|Progression to depressive phase|4|||
162831654|NCT04839380|588096061|FG000|Overall Study|Withdrawal by Subject|2|||
162831655|NCT04839380|588096061|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
162831656|NCT00879645|588096062|FG000|Overall Study|Adverse Event|1|||
162831657|NCT00879645|588096063|FG001|Overall Study|Adverse Event|0|||
162831658|NCT00879645|588096064|FG002|Overall Study|Adverse Event|0|||
162831659|NCT00879645|588096065|FG003|Overall Study|Adverse Event|0|||
162831660|NCT00749996|588096066|FG000|Overall Study|Lost to Follow-up|7|||
162831661|NCT00749996|588096067|FG001|Overall Study|Lost to Follow-up|4|||
162831662|NCT00749996|588096066|FG000|Overall Study|Withdrawal by Subject|5|||
162831663|NCT00749996|588096067|FG001|Overall Study|Withdrawal by Subject|4|||
162831664|NCT00749996|588096066|FG000|Overall Study|Protocol Violation|2|||
162831665|NCT00749996|588096067|FG001|Overall Study|Protocol Violation|3|||
162831666|NCT00749996|588096066|FG000|Overall Study|Physician Decision|2|||
162831667|NCT00749996|588096067|FG001|Overall Study|Physician Decision|0|||
162831668|NCT00749996|588096066|FG000|Overall Study|Pregnancy|0|||
162831669|NCT00749996|588096067|FG001|Overall Study|Pregnancy|2|||
162831670|NCT00749996|588096066|FG000|Overall Study|Adverse Event|1|||
162831671|NCT00749996|588096067|FG001|Overall Study|Adverse Event|0|||
162831672|NCT00749996|588096066|FG000|Overall Study|Death|1|||
162831673|NCT00749996|588096067|FG001|Overall Study|Death|0|||
162831674|NCT00996944|588096068|FG000|Double-blind Treatment Period|Adverse Event|2|||
162831675|NCT00996944|588096069|FG001|Double-blind Treatment Period|Adverse Event|1|||
162831676|NCT00996944|588096068|FG000|Double-blind Treatment Period|Protocol Violation|1|||
162944393|NCT01915732|588498782|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
162944394|NCT01915732|588498781|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
162944395|NCT01915732|588498782|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
162944396|NCT01915732|588498781|FG000|Overall Study|Drug Release Error|1|||
162944397|NCT01915732|588498782|FG001|Overall Study|Drug Release Error|0|||
162831677|NCT00996944|588096069|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162698861|NCT01551303|587606880|FG000|Overall Study|failed awareness check on vision test|4|||
162698862|NCT01551303|587606881|FG001|Overall Study|failed awareness check on vision test|7|||
162698863|NCT02589392|587606885|FG000|Overall Study|Adverse Event|1|||
162944398|NCT01915732|588498781|FG000|Overall Study|Recovered|1|||
162944399|NCT01915732|588498782|FG001|Overall Study|Recovered|0|||
162944400|NCT01915732|588498781|FG000|Overall Study|Pregnancy|1|||
162944401|NCT01915732|588498782|FG001|Overall Study|Pregnancy|0|||
162944402|NCT01915732|588498781|FG000|Overall Study|Poor Perceived Efficacy|1|||
162944403|NCT01915732|588498782|FG001|Overall Study|Poor Perceived Efficacy|0|||
162944404|NCT01915732|588498781|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
162944405|NCT01915732|588498782|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
162944406|NCT01915732|588498781|FG000|Overall Study|Got Well|0|||
162944407|NCT01915732|588498782|FG001|Overall Study|Got Well|1|||
162944408|NCT01915732|588498781|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
162944409|NCT01915732|588498782|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
162944410|NCT01915732|588498781|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
162944411|NCT01915732|588498782|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
162944412|NCT01915732|588498781|FG000|Overall Study|Job Transfer|0|||
162944413|NCT01915732|588498782|FG001|Overall Study|Job Transfer|1|||
162944414|NCT01915732|588498781|FG000|Overall Study|Improper Facial Procedure|0|||
162944415|NCT01915732|588498782|FG001|Overall Study|Improper Facial Procedure|1|||
162944416|NCT01915732|588498781|FG000|Overall Study|Poor Conscious Effect|0|||
162698864|NCT02589392|587606886|FG001|Overall Study|Adverse Event|1|||
162698865|NCT02589392|587606885|FG000|Overall Study|Withdrawal by Subject|1|||
162698866|NCT02589392|587606886|FG001|Overall Study|Withdrawal by Subject|2|||
162698867|NCT02589392|587606885|FG000|Overall Study|Protocol Violation|1|||
162698868|NCT02589392|587606886|FG001|Overall Study|Protocol Violation|1|||
162698869|NCT02589392|587606885|FG000|Overall Study|Lost to Follow-up|2|||
162698870|NCT02589392|587606886|FG001|Overall Study|Lost to Follow-up|2|||
162831678|NCT00996944|588096068|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
162831679|NCT00996944|588096069|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
162831680|NCT00996944|588096068|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
162831681|NCT00996944|588096069|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
162831682|NCT00996944|588096068|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
162831683|NCT00996944|588096069|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
162831684|NCT03775421|588096072|FG000|Overall Study|Lost to Follow-up|2|||
162831685|NCT03775421|588096072|FG000|Overall Study|Withdrawal by Subject|10|||
162831686|NCT03775421|588096072|FG000|Overall Study|Physician Decision|3|||
162831687|NCT03775421|588096072|FG000|Overall Study|Death|1|||
162831688|NCT03775421|588096072|FG000|Overall Study|Study Terminated by Sponsor|94|||
162831689|NCT01227044|588096075|FG000|Overall Study|Lost to Follow-up|5|||
162831690|NCT01227044|588096076|FG001|Overall Study|Lost to Follow-up|7|||
162831691|NCT01227044|588096075|FG000|Overall Study|Discontinued Intervention|1|||
162831692|NCT01227044|588096076|FG001|Overall Study|Discontinued Intervention|2|||
162831693|NCT04247061|588096077|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
162831694|NCT04247061|588096077|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
162831695|NCT04247061|588096077|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
162831696|NCT01378104|588096080|FG000|Overall Study|Adverse Event|8|||
162831697|NCT01378104|588096081|FG001|Overall Study|Adverse Event|8|||
162831698|NCT01378104|588096080|FG000|Overall Study|Lack of Efficacy|7|||
162831699|NCT01378104|588096081|FG001|Overall Study|Lack of Efficacy|5|||
162831700|NCT01378104|588096080|FG000|Overall Study|Withdrawal by Subject|12|||
162831701|NCT01378104|588096081|FG001|Overall Study|Withdrawal by Subject|13|||
162831702|NCT02287623|588096082|FG000|Overall Study|Protocol Violation|0|||
162831703|NCT02287623|588096083|FG001|Overall Study|Protocol Violation|1|||
162831704|NCT02700997|588096084|FG000|Overall Study|Did not undergo CT imaging|1|||
162831705|NCT02700997|588096084|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
162831706|NCT00205855|588096087|FG000|Overall Study|Only received temporary implants|16|||
162831707|NCT00205855|588096087|FG000|Overall Study|Withdrawal by Subject|5|||
162831708|NCT01445951|588096088|FG000|Overall Study|Adverse Event|16|||
162831709|NCT01445951|588096089|FG001|Overall Study|Adverse Event|9|||
162831710|NCT01445951|588096090|FG002|Overall Study|Adverse Event|0|||
162831711|NCT01445951|588096088|FG000|Overall Study|Protocol Violation|2|||
162831712|NCT01445951|588096089|FG001|Overall Study|Protocol Violation|2|||
162698871|NCT02589392|587606885|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
162698872|NCT02589392|587606886|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
162698873|NCT00322374|587606888|FG000|Starting Dose|Physician Decision|2|||
162944417|NCT01915732|588498782|FG001|Overall Study|Poor Conscious Effect|1|||
162698874|NCT00322374|587606889|FG001|Starting Dose|Physician Decision|0|||
162698875|NCT00322374|587606890|FG002|Starting Dose|Physician Decision|0|||
162698876|NCT00322374|587606891|FG003|Starting Dose|Physician Decision|0|||
162698877|NCT00322374|587606888|FG000|Starting Dose|Study Drug Toxicity|4|||
162698878|NCT00322374|587606889|FG001|Starting Dose|Study Drug Toxicity|0|||
162698879|NCT00322374|587606890|FG002|Starting Dose|Study Drug Toxicity|0|||
162698880|NCT00322374|587606891|FG003|Starting Dose|Study Drug Toxicity|0|||
162698881|NCT00322374|587606888|FG000|First Escalation|Documented Disease Progression|0|||
162698882|NCT00322374|587606889|FG001|First Escalation|Documented Disease Progression|6|||
162698883|NCT00322374|587606890|FG002|First Escalation|Documented Disease Progression|0|||
162698884|NCT00322374|587606891|FG003|First Escalation|Documented Disease Progression|0|||
162698885|NCT00322374|587606888|FG000|First Escalation|Physician Decision|0|||
162698886|NCT00322374|587606889|FG001|First Escalation|Physician Decision|12|||
162698887|NCT00322374|587606890|FG002|First Escalation|Physician Decision|0|||
162698888|NCT00322374|587606891|FG003|First Escalation|Physician Decision|0|||
162698889|NCT00322374|587606888|FG000|First Escalation|Study Drug Toxicity|0|||
162698890|NCT00322374|587606889|FG001|First Escalation|Study Drug Toxicity|11|||
162698891|NCT00322374|587606890|FG002|First Escalation|Study Drug Toxicity|0|||
162698892|NCT00322374|587606891|FG003|First Escalation|Study Drug Toxicity|0|||
162698893|NCT00322374|587606888|FG000|First Escalation|Participant Request|0|||
162698894|NCT00322374|587606889|FG001|First Escalation|Participant Request|1|||
162944418|NCT00698685|588498783|FG000|Overall Study|Sister withdrew as donor|1|||
162944419|NCT00698685|588498783|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
162944420|NCT01325207|588498784|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944421|NCT01325207|588498785|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944422|NCT01325207|588498786|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944423|NCT01325207|588498787|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944424|NCT01325207|588498788|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
162944425|NCT01325207|588498789|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
162944426|NCT01325207|588498784|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
162944427|NCT01325207|588498785|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
162944428|NCT01325207|588498786|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
162944429|NCT01325207|588498787|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
162944430|NCT01325207|588498788|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
162944431|NCT01325207|588498789|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
162944432|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944433|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944434|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944435|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
162944436|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
162944437|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
162944438|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944439|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
162944440|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944441|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944442|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944443|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
162944444|NCT01325207|588498784|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944445|NCT01325207|588498785|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944446|NCT01325207|588498786|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944447|NCT01325207|588498787|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944448|NCT01325207|588498788|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
162944449|NCT01325207|588498789|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
162944450|NCT01325207|588498784|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944451|NCT01325207|588498785|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944452|NCT01325207|588498786|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944453|NCT01325207|588498787|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944454|NCT01325207|588498788|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
162944455|NCT01325207|588498789|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
162944456|NCT01325207|588498784|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944457|NCT01325207|588498785|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944458|NCT01325207|588498786|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162978983|NCT01660022|588623540|FG002|First Sequence (7 Days)|Adverse Event|0|||
162698895|NCT00322374|587606890|FG002|First Escalation|Participant Request|0|||
162698896|NCT00322374|587606891|FG003|First Escalation|Participant Request|0|||
162698897|NCT00322374|587606888|FG000|Second Escalation|Physician Decision|0|||
162698898|NCT00322374|587606889|FG001|Second Escalation|Physician Decision|0|||
162698899|NCT00322374|587606890|FG002|Second Escalation|Physician Decision|5|||
162944459|NCT01325207|588498787|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944460|NCT01325207|588498788|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
162944461|NCT01325207|588498789|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
162944462|NCT00708422|588498790|FG000|Overall Study|Adverse Event|3|||
162944463|NCT00708422|588498791|FG001|Overall Study|Adverse Event|1|||
162944464|NCT00708422|588498790|FG000|Overall Study|Withdrawal by Subject|1|||
162944465|NCT00708422|588498791|FG001|Overall Study|Withdrawal by Subject|0|||
162944466|NCT01254409|588498792|FG000|Overall Study|Adverse Event|0|||
162944467|NCT01254409|588498793|FG001|Overall Study|Adverse Event|1|||
162944468|NCT01254409|588498794|FG002|Overall Study|Adverse Event|0|||
162944469|NCT01254409|588498795|FG003|Overall Study|Adverse Event|0|||
162944470|NCT00635154|588498802|FG000|Overall Study|Alternative Treatment|8|||
162944471|NCT00635154|588498802|FG000|Overall Study|Other|4|||
162944472|NCT00635154|588498802|FG000|Overall Study|Still on treatment|21|||
162944473|NCT02114697|588498803|FG000|Overall Study|Study terminated|5|||
162944474|NCT02114697|588498804|FG001|Overall Study|Study terminated|4|||
162944475|NCT02660242|588498809|FG000|Glucose Tabs|Lost to Follow-up|1|||
162944476|NCT02660242|588498809|FG000|Glucagon Injection|Lost to Follow-up|1|||
162944477|NCT02796664|588498812|FG000|Overall Study|Withdrawal by Subject|0|||
162944478|NCT02796664|588498813|FG001|Overall Study|Withdrawal by Subject|3|||
162944479|NCT02796664|588498812|FG000|Overall Study|Noncompliance|1|||
162944480|NCT02796664|588498813|FG001|Overall Study|Noncompliance|1|||
162944481|NCT02796664|588498812|FG000|Overall Study|Death|0|||
162944482|NCT02796664|588498813|FG001|Overall Study|Death|1|||
162944483|NCT02246478|588498814|FG000|Multiple-dose Phase|Protocol Violation|1|||
162944484|NCT02246478|588498815|FG001|Multiple-dose Phase|Protocol Violation|0|||
162944485|NCT02246478|588498816|FG002|Multiple-dose Phase|Protocol Violation|0|||
162944486|NCT02246478|588498817|FG003|Multiple-dose Phase|Protocol Violation|1|||
162944487|NCT00198029|588498818|FG000|Overall Study|Withdrawal by Subject|4|||
162944488|NCT01626079|588498819|FG000|Overall Study|Death|167|||
162944489|NCT01626079|588498820|FG001|Overall Study|Death|192|||
162944490|NCT01626079|588498821|FG002|Overall Study|Death|39|||
162944491|NCT01626079|588498819|FG000|Overall Study|Withdrawal by Subject|23|||
162944492|NCT01626079|588498820|FG001|Overall Study|Withdrawal by Subject|37|||
162944493|NCT01626079|588498821|FG002|Overall Study|Withdrawal by Subject|5|||
162944494|NCT01626079|588498819|FG000|Overall Study|Lost to Follow-up|7|||
162944495|NCT01626079|588498820|FG001|Overall Study|Lost to Follow-up|4|||
162944496|NCT01626079|588498821|FG002|Overall Study|Lost to Follow-up|2|||
162944497|NCT01626079|588498819|FG000|Overall Study|Missed Visits|1|||
162944498|NCT01626079|588498820|FG001|Overall Study|Missed Visits|4|||
162944499|NCT01626079|588498821|FG002|Overall Study|Missed Visits|6|||
162944500|NCT02430870|588498823|FG000|Part 2|Voluntary Withdrawal|0|||
162944501|NCT02430870|588498824|FG001|Part 2|Voluntary Withdrawal|0|||
162944502|NCT02430870|588498825|FG002|Part 2|Voluntary Withdrawal|0|||
162944503|NCT02430870|588498826|FG003|Part 2|Voluntary Withdrawal|0|||
162944504|NCT02430870|588498827|FG004|Part 2|Voluntary Withdrawal|0|||
162944505|NCT02430870|588498828|FG005|Part 2|Voluntary Withdrawal|0|||
162944506|NCT02430870|588498829|FG006|Part 2|Voluntary Withdrawal|1|||
162944507|NCT02430870|588498830|FG007|Part 2|Voluntary Withdrawal|0|||
162944508|NCT02430870|588498823|FG000|Part 2|Other Reason Not Specified|0|||
162944509|NCT02430870|588498824|FG001|Part 2|Other Reason Not Specified|0|||
162944510|NCT02430870|588498825|FG002|Part 2|Other Reason Not Specified|0|||
162944511|NCT02430870|588498826|FG003|Part 2|Other Reason Not Specified|0|||
162944512|NCT02430870|588498827|FG004|Part 2|Other Reason Not Specified|0|||
162944513|NCT02430870|588498828|FG005|Part 2|Other Reason Not Specified|0|||
162944514|NCT02430870|588498829|FG006|Part 2|Other Reason Not Specified|0|||
162944515|NCT02430870|588498830|FG007|Part 2|Other Reason Not Specified|1|||
162944516|NCT00865709|588498833|FG000|Treatment|Adverse Event|9|||
162944517|NCT00865709|588498834|FG001|Treatment|Adverse Event|6|||
162944518|NCT00865709|588498833|FG000|Treatment|Withdrawal by Subject|10|||
162944519|NCT00865709|588498834|FG001|Treatment|Withdrawal by Subject|7|||
162944520|NCT00865709|588498833|FG000|Treatment|Physician Decision|3|||
162944521|NCT00865709|588498834|FG001|Treatment|Physician Decision|2|||
162944522|NCT00865709|588498833|FG000|Treatment|Surgery|8|||
162944523|NCT00865709|588498834|FG001|Treatment|Surgery|3|||
162944524|NCT00429923|588498835|FG000|Overall Study|Adverse Event|0|||
162944525|NCT00429923|588498836|FG001|Overall Study|Adverse Event|2|||
162944526|NCT00429923|588498837|FG002|Overall Study|Adverse Event|3|||
162944527|NCT00429923|588498835|FG000|Overall Study|Lack of Efficacy|4|||
162944528|NCT00429923|588498836|FG001|Overall Study|Lack of Efficacy|1|||
162944529|NCT00429923|588498837|FG002|Overall Study|Lack of Efficacy|33|||
162944530|NCT00429923|588498835|FG000|Overall Study|Lost to Follow-up|0|||
162944531|NCT00429923|588498836|FG001|Overall Study|Lost to Follow-up|0|||
162944532|NCT00429923|588498837|FG002|Overall Study|Lost to Follow-up|2|||
162944533|NCT00429923|588498835|FG000|Overall Study|Withdrew Consent|1|||
162944534|NCT00429923|588498836|FG001|Overall Study|Withdrew Consent|0|||
162944535|NCT00429923|588498837|FG002|Overall Study|Withdrew Consent|1|||
162944536|NCT00429923|588498835|FG000|Overall Study|Early Termination|0|||
162831713|NCT01445951|588096090|FG002|Overall Study|Protocol Violation|2|||
162831714|NCT01445951|588096088|FG000|Overall Study|Withdrawal by Subject|21|||
162831715|NCT01445951|588096089|FG001|Overall Study|Withdrawal by Subject|16|||
162831716|NCT01445951|588096090|FG002|Overall Study|Withdrawal by Subject|8|||
162831717|NCT01445951|588096088|FG000|Overall Study|Physician Decision|3|||
162831718|NCT01445951|588096089|FG001|Overall Study|Physician Decision|1|||
162831719|NCT01445951|588096090|FG002|Overall Study|Physician Decision|0|||
162831720|NCT01445951|588096088|FG000|Overall Study|Lost to Follow-up|1|||
162831721|NCT01445951|588096089|FG001|Overall Study|Lost to Follow-up|2|||
162831722|NCT01445951|588096090|FG002|Overall Study|Lost to Follow-up|4|||
162831723|NCT01445951|588096088|FG000|Overall Study|Pregnancy|0|||
162831724|NCT01445951|588096089|FG001|Overall Study|Pregnancy|1|||
162831725|NCT01445951|588096090|FG002|Overall Study|Pregnancy|4|||
162831726|NCT01445951|588096088|FG000|Overall Study|Death|0|||
162831727|NCT01445951|588096089|FG001|Overall Study|Death|0|||
162831728|NCT01445951|588096090|FG002|Overall Study|Death|1|||
162831729|NCT01445951|588096088|FG000|Overall Study|Non-compliance with study drug|1|||
162831730|NCT01445951|588096089|FG001|Overall Study|Non-compliance with study drug|2|||
162831731|NCT01445951|588096090|FG002|Overall Study|Non-compliance with study drug|0|||
162831732|NCT01445951|588096088|FG000|Overall Study|Non-compliance with protocol|0|||
162831733|NCT01445951|588096089|FG001|Overall Study|Non-compliance with protocol|1|||
162831734|NCT01445951|588096090|FG002|Overall Study|Non-compliance with protocol|0|||
162831735|NCT01445951|588096088|FG000|Overall Study|Sponsor decision - subject travel|0|||
162831736|NCT01445951|588096089|FG001|Overall Study|Sponsor decision - subject travel|1|||
162831737|NCT01445951|588096090|FG002|Overall Study|Sponsor decision - subject travel|0|||
162831738|NCT01445951|588096088|FG000|Overall Study|Cough|0|||
162831739|NCT01445951|588096089|FG001|Overall Study|Cough|1|||
162831740|NCT01445951|588096090|FG002|Overall Study|Cough|0|||
162831741|NCT02739620|588096093|FG000|Overall Study|Lost to Follow-up|3|||
162831742|NCT02739620|588096094|FG001|Overall Study|Lost to Follow-up|1|||
162831743|NCT02739620|588096093|FG000|Overall Study|Adverse Event|0|||
162831744|NCT02739620|588096094|FG001|Overall Study|Adverse Event|1|||
162831745|NCT02039375|588096097|FG000|Overall Study|Lost to Follow-up|2|||
162831746|NCT03765138|588096098|FG000|Overall Study|Lost to Follow-up|1|||
162831747|NCT03099187|588096105|FG000|Double-blind Treatment|Adverse Event|19|||
162831748|NCT03099187|588096106|FG001|Double-blind Treatment|Adverse Event|1|||
162831749|NCT03099187|588096107|FG002|Double-blind Treatment|Adverse Event|0|||
162831750|NCT03099187|588096108|FG003|Double-blind Treatment|Adverse Event|0|||
162831751|NCT03099187|588096105|FG000|Double-blind Treatment|Death|1|||
162831752|NCT03099187|588096106|FG001|Double-blind Treatment|Death|3|||
162831753|NCT03099187|588096107|FG002|Double-blind Treatment|Death|0|||
162831754|NCT03099187|588096108|FG003|Double-blind Treatment|Death|0|||
162831755|NCT03099187|588096105|FG000|Double-blind Treatment|Lack of Efficacy|1|||
162831756|NCT03099187|588096106|FG001|Double-blind Treatment|Lack of Efficacy|0|||
162831757|NCT03099187|588096107|FG002|Double-blind Treatment|Lack of Efficacy|0|||
162831758|NCT03099187|588096108|FG003|Double-blind Treatment|Lack of Efficacy|0|||
162831759|NCT03099187|588096105|FG000|Double-blind Treatment|Physician Decision|2|||
162831760|NCT03099187|588096106|FG001|Double-blind Treatment|Physician Decision|1|||
162831761|NCT03099187|588096107|FG002|Double-blind Treatment|Physician Decision|0|||
162831762|NCT03099187|588096108|FG003|Double-blind Treatment|Physician Decision|0|||
162831763|NCT03099187|588096105|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
162831764|NCT03099187|588096106|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
162831765|NCT03099187|588096107|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
162831766|NCT03099187|588096108|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
162831767|NCT03099187|588096105|FG000|Double-blind Treatment|Lung transplantation|0|||
162831768|NCT03099187|588096106|FG001|Double-blind Treatment|Lung transplantation|1|||
162831769|NCT03099187|588096107|FG002|Double-blind Treatment|Lung transplantation|0|||
162831770|NCT03099187|588096108|FG003|Double-blind Treatment|Lung transplantation|0|||
162831771|NCT03099187|588096105|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
162831772|NCT03099187|588096106|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
162831773|NCT03099187|588096107|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
162831774|NCT03099187|588096108|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
162831775|NCT03099187|588096105|FG000|Double-blind Treatment|Disease progression|0|||
162831776|NCT03099187|588096106|FG001|Double-blind Treatment|Disease progression|1|||
162831777|NCT03099187|588096107|FG002|Double-blind Treatment|Disease progression|0|||
162831778|NCT03099187|588096108|FG003|Double-blind Treatment|Disease progression|0|||
162831779|NCT03099187|588096105|FG000|Double-blind Treatment|Randomization error|0|||
162831780|NCT03099187|588096106|FG001|Double-blind Treatment|Randomization error|2|||
162831781|NCT03099187|588096107|FG002|Double-blind Treatment|Randomization error|0|||
162831782|NCT03099187|588096108|FG003|Double-blind Treatment|Randomization error|0|||
162831783|NCT03099187|588096105|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
162831784|NCT03099187|588096106|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
162831785|NCT03099187|588096107|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
162944537|NCT00429923|588498836|FG001|Overall Study|Early Termination|1|||
162944538|NCT00429923|588498837|FG002|Overall Study|Early Termination|0|||
162944539|NCT01265784|588498838|FG000|Overall Study|Lost to Follow-up|5|||
162944540|NCT01265784|588498839|FG001|Overall Study|Lost to Follow-up|3|||
162944541|NCT01265784|588498840|FG002|Overall Study|Lost to Follow-up|2|||
162944542|NCT01265784|588498838|FG000|Overall Study|Withdrawal by Subject|0|||
162944543|NCT01265784|588498839|FG001|Overall Study|Withdrawal by Subject|5|||
162944544|NCT01265784|588498840|FG002|Overall Study|Withdrawal by Subject|0|||
162944545|NCT01265784|588498838|FG000|Overall Study|Physician Decision|1|||
162944546|NCT01265784|588498839|FG001|Overall Study|Physician Decision|0|||
162944547|NCT01265784|588498840|FG002|Overall Study|Physician Decision|1|||
162944548|NCT01265784|588498838|FG000|Overall Study|Adverse Event|1|||
162944549|NCT01265784|588498839|FG001|Overall Study|Adverse Event|0|||
162944550|NCT01265784|588498840|FG002|Overall Study|Adverse Event|0|||
162944551|NCT01265784|588498838|FG000|Overall Study|Death|3|||
162944552|NCT01265784|588498839|FG001|Overall Study|Death|0|||
162944553|NCT01265784|588498840|FG002|Overall Study|Death|0|||
162944554|NCT01265784|588498838|FG000|Overall Study|Protocol Violation|2|||
162944555|NCT01265784|588498839|FG001|Overall Study|Protocol Violation|0|||
162944556|NCT01265784|588498840|FG002|Overall Study|Protocol Violation|0|||
162944557|NCT01265784|588498838|FG000|Overall Study|Incorrectly Randomized|0|||
162944558|NCT01265784|588498839|FG001|Overall Study|Incorrectly Randomized|0|||
162944559|NCT01265784|588498840|FG002|Overall Study|Incorrectly Randomized|1|||
162944560|NCT03740165|588498843|FG000|Overall Study|Death|232|||
162944561|NCT03740165|588498844|FG001|Overall Study|Death|242|||
162944562|NCT03740165|588498845|FG002|Overall Study|Death|229|||
162944563|NCT03740165|588498843|FG000|Overall Study|Lost to Follow-up|0|||
162944564|NCT03740165|588498844|FG001|Overall Study|Lost to Follow-up|0|||
162944565|NCT03740165|588498845|FG002|Overall Study|Lost to Follow-up|1|||
162944566|NCT03740165|588498843|FG000|Overall Study|Withdrawal by Subject|7|||
162944567|NCT03740165|588498844|FG001|Overall Study|Withdrawal by Subject|4|||
162944568|NCT03740165|588498845|FG002|Overall Study|Withdrawal by Subject|3|||
162944569|NCT03740165|588498843|FG000|Overall Study|Ongoing in Study|216|||
162944570|NCT03740165|588498844|FG001|Overall Study|Ongoing in Study|212|||
162944571|NCT03740165|588498845|FG002|Overall Study|Ongoing in Study|221|||
162944572|NCT03049618|588498846|FG000|Overall Study|Death|1|||
162944573|NCT03049618|588498847|FG001|Overall Study|Death|0|||
162944574|NCT03049618|588498846|FG000|Overall Study|Lack of Efficacy|1|||
162944575|NCT03049618|588498847|FG001|Overall Study|Lack of Efficacy|2|||
162944576|NCT02785913|588500715|FG000|Overall Study|Adverse Event|5|||
162944577|NCT02785913|588500715|FG000|Overall Study|Death|2|||
162944578|NCT02785913|588500715|FG000|Overall Study|Progression|18|||
162944579|NCT02785913|588500715|FG000|Overall Study|Not protocol specified|1|||
162944580|NCT03717064|588500716|FG000|Period 2|Adverse Event|1|||
162944581|NCT01298570|588500717|FG000|Overall Study|Disease progression, relapse during acti|64|||
162944582|NCT01298570|588500718|FG001|Overall Study|Disease progression, relapse during acti|40|||
162944583|NCT01298570|588500717|FG000|Overall Study|Adverse Event|20|||
162944584|NCT01298570|588500718|FG001|Overall Study|Adverse Event|2|||
162944585|NCT01298570|588500717|FG000|Overall Study|Withdrawal by Subject|21|||
162944586|NCT01298570|588500718|FG001|Overall Study|Withdrawal by Subject|6|||
162944587|NCT01298570|588500717|FG000|Overall Study|Treatment delay > 4 weeks|4|||
162944588|NCT01298570|588500718|FG001|Overall Study|Treatment delay > 4 weeks|5|||
162944589|NCT01298570|588500717|FG000|Overall Study|Physician Decision|4|||
162944590|NCT01298570|588500718|FG001|Overall Study|Physician Decision|2|||
162944591|NCT01298570|588500717|FG000|Overall Study|Other complicating disease|2|||
162944592|NCT01298570|588500718|FG001|Overall Study|Other complicating disease|1|||
162944593|NCT01298570|588500717|FG000|Overall Study|Surgery|2|||
162944594|NCT01298570|588500718|FG001|Overall Study|Surgery|1|||
162944595|NCT01298570|588500717|FG000|Overall Study|Symptomatic progression/deterioration|3|||
162944596|NCT01298570|588500718|FG001|Overall Study|Symptomatic progression/deterioration|2|||
162944597|NCT01298570|588500717|FG000|Overall Study|Death|0|||
162944598|NCT01298570|588500718|FG001|Overall Study|Death|1|||
162944599|NCT01298570|588500717|FG000|Overall Study|Ineligibility|0|||
162944600|NCT01298570|588500718|FG001|Overall Study|Ineligibility|1|||
162944601|NCT01929109|588500719|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
162944602|NCT01929109|588500720|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
162944603|NCT01929109|588500721|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
162944604|NCT01929109|588500722|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
162944605|NCT01929109|588500723|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
162944606|NCT00076102|588500724|FG000|Overall Study|Clinical progression|1|||
162944607|NCT00076102|588500724|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
162944608|NCT00076102|588500724|FG000|Overall Study|plexiform neurofibroma surgery|1|||
162944609|NCT00076102|588500724|FG000|Overall Study|refusal of further therapy|2|||
162944610|NCT01052116|588500725|FG000|Overall Study|Lost to Follow-up|11|||
162944611|NCT01052116|588500726|FG001|Overall Study|Lost to Follow-up|17|||
162944612|NCT01052116|588500725|FG000|Overall Study|Withdrawal by Subject|3|||
162944613|NCT01052116|588500726|FG001|Overall Study|Withdrawal by Subject|6|||
162944614|NCT01052116|588500725|FG000|Overall Study|Spirometry not performed|0|||
162944615|NCT01052116|588500726|FG001|Overall Study|Spirometry not performed|4|||
162944616|NCT02180711|588500728|FG000|Overall Study|Death|0|||
162944617|NCT02180711|588500729|FG001|Overall Study|Death|1|||
162944618|NCT02180711|588500730|FG002|Overall Study|Death|0|||
162944619|NCT02180711|588500731|FG003|Overall Study|Death|0|||
162944620|NCT02180711|588500732|FG004|Overall Study|Death|7|||
162944621|NCT02180711|588500733|FG005|Overall Study|Death|0|||
162944622|NCT02180711|588500734|FG006|Overall Study|Death|1|||
162944623|NCT02180711|588500735|FG007|Overall Study|Death|3|||
162944624|NCT02180711|588500728|FG000|Overall Study|Lost to Follow-up|0|||
162944625|NCT02180711|588500729|FG001|Overall Study|Lost to Follow-up|1|||
162944626|NCT02180711|588500730|FG002|Overall Study|Lost to Follow-up|0|||
162944627|NCT02180711|588500731|FG003|Overall Study|Lost to Follow-up|0|||
162944628|NCT02180711|588500732|FG004|Overall Study|Lost to Follow-up|1|||
162944629|NCT02180711|588500733|FG005|Overall Study|Lost to Follow-up|1|||
162944630|NCT02180711|588500734|FG006|Overall Study|Lost to Follow-up|0|||
162944631|NCT02180711|588500735|FG007|Overall Study|Lost to Follow-up|3|||
162944632|NCT02180711|588500728|FG000|Overall Study|Withdrawal by Subject|2|||
162944633|NCT02180711|588500729|FG001|Overall Study|Withdrawal by Subject|1|||
162944634|NCT02180711|588500730|FG002|Overall Study|Withdrawal by Subject|0|||
162944635|NCT02180711|588500731|FG003|Overall Study|Withdrawal by Subject|4|||
162944636|NCT02180711|588500732|FG004|Overall Study|Withdrawal by Subject|3|||
162944637|NCT02180711|588500733|FG005|Overall Study|Withdrawal by Subject|0|||
162944638|NCT02180711|588500734|FG006|Overall Study|Withdrawal by Subject|3|||
162944639|NCT02180711|588500735|FG007|Overall Study|Withdrawal by Subject|2|||
162944640|NCT02180711|588500728|FG000|Overall Study|- Disease Progression|0|||
162944641|NCT02180711|588500729|FG001|Overall Study|- Disease Progression|1|||
162944642|NCT02180711|588500730|FG002|Overall Study|- Disease Progression|0|||
162944643|NCT02180711|588500731|FG003|Overall Study|- Disease Progression|0|||
162944644|NCT02180711|588500732|FG004|Overall Study|- Disease Progression|0|||
162944645|NCT02180711|588500733|FG005|Overall Study|- Disease Progression|0|||
162944646|NCT02180711|588500734|FG006|Overall Study|- Disease Progression|0|||
162831786|NCT03099187|588096108|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
162831787|NCT03099187|588096105|FG000|12-month Safety Follow-up|Adverse Event|0|||
162831788|NCT03099187|588096106|FG001|12-month Safety Follow-up|Adverse Event|0|||
162831789|NCT03099187|588096107|FG002|12-month Safety Follow-up|Adverse Event|5|||
162831790|NCT03099187|588096108|FG003|12-month Safety Follow-up|Adverse Event|12|||
162831791|NCT03099187|588096105|FG000|12-month Safety Follow-up|Death|0|||
162831792|NCT03099187|588096106|FG001|12-month Safety Follow-up|Death|0|||
162831793|NCT03099187|588096107|FG002|12-month Safety Follow-up|Death|7|||
162831794|NCT03099187|588096108|FG003|12-month Safety Follow-up|Death|9|||
162831795|NCT03099187|588096105|FG000|12-month Safety Follow-up|Lung transplantation|0|||
162831796|NCT03099187|588096106|FG001|12-month Safety Follow-up|Lung transplantation|0|||
162831797|NCT03099187|588096107|FG002|12-month Safety Follow-up|Lung transplantation|2|||
162831798|NCT03099187|588096108|FG003|12-month Safety Follow-up|Lung transplantation|1|||
162831799|NCT03099187|588096105|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
162831800|NCT03099187|588096106|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
162831801|NCT03099187|588096107|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
162831802|NCT03099187|588096108|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
162831803|NCT03099187|588096105|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
162831804|NCT03099187|588096106|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
162831805|NCT03099187|588096107|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
162831806|NCT03099187|588096108|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
162831807|NCT03099187|588096105|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
162831808|NCT03099187|588096106|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
162831809|NCT03099187|588096107|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
162831810|NCT03099187|588096108|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
162831811|NCT03099187|588096105|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
162831812|NCT03099187|588096106|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
162831813|NCT03099187|588096107|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
162831814|NCT03099187|588096108|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
162831815|NCT03885089|588096109|FG000|Overall Study|No informed consent for publication of study results|2|||
162831816|NCT00278993|588096110|FG000|Overall Study|Adverse Event|24|||
162831817|NCT00278993|588096110|FG000|Overall Study|Withdrawal by Subject|5|||
162831818|NCT00278993|588096110|FG000|Overall Study|Progressive Disease|65|||
162831819|NCT00278993|588096110|FG000|Overall Study|Physician Decision|9|||
162831820|NCT00278993|588096110|FG000|Overall Study|Not Otherwise Specified|4|||
162831821|NCT00470054|588096113|FG000|Overall Study|Ineligible|1|||
162831822|NCT01439555|588096114|FG000|Overall Study|Protocol Violation|1|||
162831823|NCT04869345|588096115|FG000|Overall Study|Lost to Follow-up|8|||
162831824|NCT04869345|588096116|FG001|Overall Study|Lost to Follow-up|3|||
162831825|NCT04194528|588096123|FG000|Overall Study|Adverse Event|1|||
162831826|NCT03921424|588096136|FG000|Overall Study|Lost to Follow-up|0|||
162831827|NCT03921424|588096137|FG001|Overall Study|Lost to Follow-up|1|||
162831828|NCT03921424|588096136|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
162831829|NCT03921424|588096137|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
162831830|NCT01246583|588096140|FG000|Overall Study|Lost to Follow-up|0|||
162831831|NCT01246583|588096141|FG001|Overall Study|Lost to Follow-up|0|||
162831832|NCT01246583|588096142|FG002|Overall Study|Lost to Follow-up|0|||
162831833|NCT01246583|588096143|FG003|Overall Study|Lost to Follow-up|1|||
162831834|NCT01246583|588096140|FG000|Overall Study|Protocol Violation|0|||
162831835|NCT01246583|588096141|FG001|Overall Study|Protocol Violation|0|||
162831836|NCT01246583|588096142|FG002|Overall Study|Protocol Violation|1|||
162831837|NCT01246583|588096143|FG003|Overall Study|Protocol Violation|0|||
162831838|NCT01246583|588096140|FG000|Overall Study|Withdrawal by Subject|1|||
162831839|NCT01246583|588096141|FG001|Overall Study|Withdrawal by Subject|0|||
162831840|NCT01246583|588096142|FG002|Overall Study|Withdrawal by Subject|0|||
162831841|NCT01246583|588096143|FG003|Overall Study|Withdrawal by Subject|0|||
162831842|NCT02595450|588096144|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
162831843|NCT02595450|588096144|FG000|Overall Study|Enrolled, but not treated|8|||
162831844|NCT00102960|588096150|FG000|Overall Study|Death|23|||
162831845|NCT00102960|588096151|FG001|Overall Study|Death|11|||
162831846|NCT00102960|588096152|FG002|Overall Study|Death|11|||
162831847|NCT00102960|588096150|FG000|Overall Study|Lost to Follow-up|6|||
162831848|NCT00102960|588096151|FG001|Overall Study|Lost to Follow-up|12|||
162831849|NCT00102960|588096152|FG002|Overall Study|Lost to Follow-up|16|||
162831850|NCT00102960|588096150|FG000|Overall Study|Withdrawal by Subject|1|||
162831851|NCT00102960|588096151|FG001|Overall Study|Withdrawal by Subject|0|||
162831852|NCT00102960|588096152|FG002|Overall Study|Withdrawal by Subject|1|||
162831853|NCT03040999|588098197|FG000|Overall Study|Lost to Follow-up|2|||
162831854|NCT03040999|588098198|FG001|Overall Study|Lost to Follow-up|2|||
162831855|NCT03040999|588098197|FG000|Overall Study|Withdrawal by Subject|12|||
162831856|NCT03040999|588098198|FG001|Overall Study|Withdrawal by Subject|13|||
162831857|NCT03040999|588098197|FG000|Overall Study|Death|155|||
162831858|NCT03040999|588098198|FG001|Overall Study|Death|171|||
162831859|NCT03040999|588098197|FG000|Overall Study|Physician Decision|0|||
162831860|NCT03040999|588098198|FG001|Overall Study|Physician Decision|3|||
162831861|NCT05121480|588098199|FG000|Overall Study|Lack of Efficacy|2|||
162831862|NCT05121480|588098200|FG001|Overall Study|Lack of Efficacy|2|||
162698900|NCT00322374|587606891|FG003|Second Escalation|Physician Decision|0|||
162698901|NCT00322374|587606888|FG000|Second Escalation|Study Drug Toxicity|0|||
162698902|NCT00322374|587606889|FG001|Second Escalation|Study Drug Toxicity|0|||
162698903|NCT00322374|587606890|FG002|Second Escalation|Study Drug Toxicity|1|||
162831863|NCT05121480|588098201|FG002|Overall Study|Lack of Efficacy|1|||
162831864|NCT05121480|588098202|FG003|Overall Study|Lack of Efficacy|4|||
162831865|NCT05121480|588098203|FG004|Overall Study|Lack of Efficacy|0|||
162831866|NCT05121480|588098204|FG005|Overall Study|Lack of Efficacy|1|||
162831867|NCT05121480|588098205|FG006|Overall Study|Lack of Efficacy|0|||
162831868|NCT05121480|588098206|FG007|Overall Study|Lack of Efficacy|2|||
162831869|NCT05121480|588098199|FG000|Overall Study|Treatment Failure|0|||
162831870|NCT05121480|588098200|FG001|Overall Study|Treatment Failure|2|||
162831871|NCT05121480|588098201|FG002|Overall Study|Treatment Failure|0|||
162831872|NCT05121480|588098202|FG003|Overall Study|Treatment Failure|1|||
162831873|NCT05121480|588098203|FG004|Overall Study|Treatment Failure|0|||
162831874|NCT05121480|588098204|FG005|Overall Study|Treatment Failure|0|||
162831875|NCT05121480|588098205|FG006|Overall Study|Treatment Failure|0|||
162831876|NCT05121480|588098206|FG007|Overall Study|Treatment Failure|0|||
162831877|NCT05121480|588098199|FG000|Overall Study|Adverse Event|0|||
162831878|NCT05121480|588098200|FG001|Overall Study|Adverse Event|1|||
162831879|NCT05121480|588098201|FG002|Overall Study|Adverse Event|0|||
162831880|NCT05121480|588098202|FG003|Overall Study|Adverse Event|5|||
162831881|NCT05121480|588098203|FG004|Overall Study|Adverse Event|3|||
162831882|NCT05121480|588098204|FG005|Overall Study|Adverse Event|2|||
162831883|NCT05121480|588098205|FG006|Overall Study|Adverse Event|0|||
162831884|NCT05121480|588098206|FG007|Overall Study|Adverse Event|4|||
162831885|NCT05121480|588098199|FG000|Overall Study|Withdrawal by Subject|4|||
162698904|NCT00322374|587606891|FG003|Second Escalation|Study Drug Toxicity|0|||
162831886|NCT05121480|588098200|FG001|Overall Study|Withdrawal by Subject|9|||
162831887|NCT05121480|588098201|FG002|Overall Study|Withdrawal by Subject|1|||
162831888|NCT05121480|588098202|FG003|Overall Study|Withdrawal by Subject|8|||
162831889|NCT05121480|588098203|FG004|Overall Study|Withdrawal by Subject|0|||
162831890|NCT05121480|588098204|FG005|Overall Study|Withdrawal by Subject|9|||
162831891|NCT05121480|588098205|FG006|Overall Study|Withdrawal by Subject|0|||
162831892|NCT05121480|588098206|FG007|Overall Study|Withdrawal by Subject|4|||
162831893|NCT05121480|588098199|FG000|Overall Study|Non-compliance with the protocol|0|||
162831894|NCT05121480|588098200|FG001|Overall Study|Non-compliance with the protocol|0|||
162831895|NCT05121480|588098201|FG002|Overall Study|Non-compliance with the protocol|0|||
162831896|NCT05121480|588098202|FG003|Overall Study|Non-compliance with the protocol|0|||
162831897|NCT05121480|588098203|FG004|Overall Study|Non-compliance with the protocol|1|||
162831898|NCT05121480|588098204|FG005|Overall Study|Non-compliance with the protocol|6|||
162831899|NCT05121480|588098205|FG006|Overall Study|Non-compliance with the protocol|0|||
162831900|NCT05121480|588098206|FG007|Overall Study|Non-compliance with the protocol|1|||
162831901|NCT05121480|588098199|FG000|Overall Study|Lost to Follow-up|0|||
162831902|NCT05121480|588098200|FG001|Overall Study|Lost to Follow-up|4|||
162831903|NCT05121480|588098201|FG002|Overall Study|Lost to Follow-up|1|||
162831904|NCT05121480|588098202|FG003|Overall Study|Lost to Follow-up|3|||
162831905|NCT05121480|588098203|FG004|Overall Study|Lost to Follow-up|1|||
162831906|NCT05121480|588098204|FG005|Overall Study|Lost to Follow-up|1|||
162831907|NCT05121480|588098205|FG006|Overall Study|Lost to Follow-up|1|||
162831908|NCT05121480|588098206|FG007|Overall Study|Lost to Follow-up|4|||
162831909|NCT05121480|588098199|FG000|Overall Study|Physician Decision|0|||
162831910|NCT05121480|588098200|FG001|Overall Study|Physician Decision|0|||
162831911|NCT05121480|588098201|FG002|Overall Study|Physician Decision|0|||
162831912|NCT05121480|588098202|FG003|Overall Study|Physician Decision|0|||
162831913|NCT05121480|588098203|FG004|Overall Study|Physician Decision|0|||
162831914|NCT05121480|588098204|FG005|Overall Study|Physician Decision|1|||
162831915|NCT05121480|588098205|FG006|Overall Study|Physician Decision|0|||
162831916|NCT05121480|588098206|FG007|Overall Study|Physician Decision|1|||
162831917|NCT05121480|588098199|FG000|Overall Study|Other Reason|0|||
162831918|NCT05121480|588098200|FG001|Overall Study|Other Reason|0|||
162831919|NCT05121480|588098201|FG002|Overall Study|Other Reason|0|||
162831920|NCT05121480|588098202|FG003|Overall Study|Other Reason|0|||
162831921|NCT05121480|588098203|FG004|Overall Study|Other Reason|0|||
162831922|NCT05121480|588098204|FG005|Overall Study|Other Reason|1|||
162831923|NCT05121480|588098205|FG006|Overall Study|Other Reason|1|||
162831924|NCT05121480|588098206|FG007|Overall Study|Other Reason|1|||
162831925|NCT01964352|588098213|FG000|Overall Study|Adverse Event|13|||
162831926|NCT01964352|588098214|FG001|Overall Study|Adverse Event|3|||
162831927|NCT01964352|588098215|FG002|Overall Study|Adverse Event|4|||
162831928|NCT01964352|588098216|FG003|Overall Study|Adverse Event|3|||
162831929|NCT01964352|588098213|FG000|Overall Study|Lack of Efficacy|6|||
162831930|NCT01964352|588098214|FG001|Overall Study|Lack of Efficacy|0|||
162831931|NCT01964352|588098215|FG002|Overall Study|Lack of Efficacy|0|||
162831932|NCT01964352|588098216|FG003|Overall Study|Lack of Efficacy|0|||
162831933|NCT01964352|588098213|FG000|Overall Study|Protocol Violation|2|||
162831934|NCT01964352|588098214|FG001|Overall Study|Protocol Violation|4|||
162831935|NCT01964352|588098215|FG002|Overall Study|Protocol Violation|0|||
162831936|NCT01964352|588098216|FG003|Overall Study|Protocol Violation|2|||
162831937|NCT01964352|588098213|FG000|Overall Study|Lost to Follow-up|1|||
162831938|NCT01964352|588098214|FG001|Overall Study|Lost to Follow-up|0|||
162831939|NCT01964352|588098215|FG002|Overall Study|Lost to Follow-up|0|||
162831940|NCT01964352|588098216|FG003|Overall Study|Lost to Follow-up|1|||
162831941|NCT01964352|588098213|FG000|Overall Study|Withdrawal by Subject|4|||
162831942|NCT01964352|588098214|FG001|Overall Study|Withdrawal by Subject|2|||
162831943|NCT01964352|588098215|FG002|Overall Study|Withdrawal by Subject|1|||
162831944|NCT01964352|588098216|FG003|Overall Study|Withdrawal by Subject|0|||
162831945|NCT01964352|588098213|FG000|Overall Study|Other than stated above|0|||
162831946|NCT01964352|588098214|FG001|Overall Study|Other than stated above|2|||
162831947|NCT01964352|588098215|FG002|Overall Study|Other than stated above|1|||
162831948|NCT01964352|588098216|FG003|Overall Study|Other than stated above|2|||
162831949|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
162831950|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
162831951|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
162831952|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
162831953|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
162831954|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
162831955|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
162831956|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
162831957|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
162831958|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
162831959|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
162831960|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
162831961|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
162831962|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
162831963|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
162944647|NCT02180711|588500735|FG007|Overall Study|- Disease Progression|0|||
162944648|NCT02180711|588500728|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
162944649|NCT02180711|588500729|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
162944650|NCT02180711|588500730|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
162944651|NCT02180711|588500731|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
162944652|NCT02180711|588500732|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944653|NCT02180711|588500733|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944654|NCT02180711|588500734|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944655|NCT02180711|588500735|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
162944656|NCT02180711|588500728|FG000|Overall Study|- Study Terminated by Sponsor|2|||
162698905|NCT03382600|587606892|FG000|Overall Study|Adverse Event|3|||
162698906|NCT03382600|587606893|FG001|Overall Study|Adverse Event|3|||
162698907|NCT03382600|587606892|FG000|Overall Study|Clinical Disease Progression|2|||
162698908|NCT03382600|587606893|FG001|Overall Study|Clinical Disease Progression|4|||
162698909|NCT03382600|587606892|FG000|Overall Study|Radiological Progression|40|||
162698910|NCT03382600|587606893|FG001|Overall Study|Radiological Progression|31|||
162698911|NCT03382600|587606892|FG000|Overall Study|Withdrawal by Subject|0|||
162698912|NCT03382600|587606893|FG001|Overall Study|Withdrawal by Subject|1|||
162698913|NCT03382600|587606892|FG000|Overall Study|Other|9|||
162698914|NCT03382600|587606893|FG001|Overall Study|Other|7|||
162698915|NCT02269943|587606894|FG000|Treatment Period|Death|0|||
162698916|NCT02269943|587606895|FG001|Treatment Period|Death|1|||
162698917|NCT02269943|587606894|FG000|Treatment Period|Adverse Event|1|||
162698918|NCT02269943|587606895|FG001|Treatment Period|Adverse Event|10|||
162698919|NCT02269943|587606894|FG000|Treatment Period|Progressive Disease|5|||
162698920|NCT02269943|587606895|FG001|Treatment Period|Progressive Disease|17|||
162698921|NCT02269943|587606894|FG000|Treatment Period|Symptomatic Deterioration|0|||
162698922|NCT02269943|587606895|FG001|Treatment Period|Symptomatic Deterioration|2|||
162698923|NCT02269943|587606894|FG000|Follow-Up Survival Period|Death|3|||
162698924|NCT02269943|587606895|FG001|Follow-Up Survival Period|Death|16|||
162698925|NCT02269943|587606894|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
162698926|NCT02269943|587606895|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
162698927|NCT02269943|587606894|FG000|Follow-Up Survival Period|Alive|2|||
162698928|NCT02269943|587606895|FG001|Follow-Up Survival Period|Alive|8|||
162698929|NCT02066532|587606900|FG000|Phase II|Withdrawal by Subject|1|||
162698930|NCT02066532|587606901|FG001|Phase II|Withdrawal by Subject|0|||
162698931|NCT02066532|587606902|FG002|Phase II|Withdrawal by Subject|0|||
162698932|NCT02066532|587606903|FG003|Phase II|Withdrawal by Subject|0|||
162698933|NCT05033080|587606904|FG000|Overall Study|Adverse Event|4|||
162698934|NCT05033080|587606905|FG001|Overall Study|Adverse Event|4|||
162698935|NCT05033080|587606904|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
162698936|NCT05033080|587606905|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
162944657|NCT02180711|588500729|FG001|Overall Study|- Study Terminated by Sponsor|3|||
162944658|NCT02180711|588500730|FG002|Overall Study|- Study Terminated by Sponsor|0|||
162944659|NCT02180711|588500731|FG003|Overall Study|- Study Terminated by Sponsor|5|||
162944660|NCT02180711|588500732|FG004|Overall Study|- Study Terminated by Sponsor|32|||
162944661|NCT02180711|588500733|FG005|Overall Study|- Study Terminated by Sponsor|0|||
162944662|NCT02180711|588500734|FG006|Overall Study|- Study Terminated by Sponsor|4|||
162944663|NCT02180711|588500735|FG007|Overall Study|- Study Terminated by Sponsor|13|||
162944664|NCT02180711|588500728|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
162944665|NCT02180711|588500729|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
162944666|NCT02180711|588500730|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
162944667|NCT02180711|588500731|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
162944668|NCT02180711|588500732|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
162944669|NCT02180711|588500733|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
162944670|NCT02180711|588500734|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
162944671|NCT02180711|588500735|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
162944672|NCT02180711|588500728|FG000|Overall Study|- Other|1|||
162944673|NCT02180711|588500729|FG001|Overall Study|- Other|0|||
162944674|NCT02180711|588500730|FG002|Overall Study|- Other|0|||
162944675|NCT02180711|588500731|FG003|Overall Study|- Other|1|||
162944676|NCT02180711|588500732|FG004|Overall Study|- Other|0|||
162944677|NCT02180711|588500733|FG005|Overall Study|- Other|0|||
162944678|NCT02180711|588500734|FG006|Overall Study|- Other|0|||
162944679|NCT02180711|588500735|FG007|Overall Study|- Other|0|||
162698937|NCT05033080|587606904|FG000|Overall Study|Lost to Follow-up|1|||
162698938|NCT05033080|587606905|FG001|Overall Study|Lost to Follow-up|0|||
162698939|NCT05033080|587606904|FG000|Overall Study|Other non-compliance|0|||
162698940|NCT05033080|587606905|FG001|Overall Study|Other non-compliance|1|||
162698941|NCT05033080|587606904|FG000|Overall Study|Physician Decision|0|||
162698942|NCT05033080|587606905|FG001|Overall Study|Physician Decision|1|||
162698943|NCT05033080|587606904|FG000|Overall Study|Other|1|||
162944680|NCT00444145|588500736|FG000|Overall Study|Withdrawal by Subject|2|||
162944681|NCT00444145|588500736|FG000|Overall Study|Lost to Follow-up|1|||
162944682|NCT00444145|588500736|FG000|Overall Study|non-compliant|11|||
162698944|NCT05033080|587606905|FG001|Overall Study|Other|1|||
162698945|NCT05376371|587606906|FG000|Overall Study|change in release date|10|||
162698946|NCT04159415|587606907|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698947|NCT04159415|587606908|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698948|NCT04159415|587606909|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698949|NCT04159415|587606910|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698950|NCT04159415|587606911|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698951|NCT04159415|587606912|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698952|NCT04159415|587606913|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
162698953|NCT04159415|587606914|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
162698954|NCT04159415|587606915|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698955|NCT04159415|587606916|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162698956|NCT04159415|587606907|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698957|NCT04159415|587606908|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698958|NCT04159415|587606909|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698959|NCT04159415|587606910|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698960|NCT04159415|587606911|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698961|NCT04159415|587606912|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698962|NCT04159415|587606913|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698963|NCT04159415|587606914|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
162698964|NCT04159415|587606915|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162698965|NCT04159415|587606916|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162831964|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
162831965|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
162831966|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
162831967|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
162831968|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
162831969|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
162831970|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
162831971|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
162831972|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
162831973|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
162831974|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
162831975|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
162831976|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
162831977|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
162831978|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
162831979|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
162831980|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
162831981|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
162831982|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
162831983|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
162831984|NCT02831673|588098217|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
162831985|NCT02831673|588098218|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
162831986|NCT02831673|588098219|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
162831987|NCT02831673|588098220|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
162831988|NCT02831673|588098221|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
162831989|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
162831990|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
162831991|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
162831992|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
162831993|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
162831994|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162831995|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162831996|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
162831997|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
162831998|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
162831999|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162832000|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162832001|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162832002|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
162832003|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
162832004|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
162832005|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
162832006|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
162832007|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
162832008|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
162832009|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
162832010|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
162832011|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
162832012|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
162832013|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
162832014|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
162832015|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
162832016|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
162832017|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
162832018|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
162832019|NCT02831673|588098217|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162832020|NCT02831673|588098218|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162832021|NCT02831673|588098219|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
162832022|NCT02831673|588098220|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
162832023|NCT02831673|588098221|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
162832024|NCT02831673|588098217|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162832025|NCT02831673|588098218|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162832026|NCT02831673|588098219|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162944683|NCT00444145|588500736|FG000|Overall Study|Screen Failures|5|||
162944684|NCT01619800|588500737|FG000|Overall Study|study terminated|2|||
162944685|NCT01619800|588500738|FG001|Overall Study|study terminated|0|||
162944686|NCT00414466|588500740|FG000|Overall Study|Adverse Event|0|||
162944687|NCT00414466|588500741|FG001|Overall Study|Adverse Event|0|||
162944688|NCT00414466|588500742|FG002|Overall Study|Adverse Event|1|||
162944689|NCT00414466|588500743|FG003|Overall Study|Adverse Event|1|||
162944690|NCT00414466|588500740|FG000|Overall Study|Lack of Efficacy|1|||
162944691|NCT00414466|588500741|FG001|Overall Study|Lack of Efficacy|0|||
162944692|NCT00414466|588500742|FG002|Overall Study|Lack of Efficacy|0|||
162944693|NCT00414466|588500743|FG003|Overall Study|Lack of Efficacy|0|||
162944694|NCT00414466|588500740|FG000|Overall Study|Withdrawn by Sponsor|1|||
162944695|NCT00414466|588500741|FG001|Overall Study|Withdrawn by Sponsor|0|||
162944696|NCT00414466|588500742|FG002|Overall Study|Withdrawn by Sponsor|0|||
162944697|NCT00414466|588500743|FG003|Overall Study|Withdrawn by Sponsor|0|||
162944698|NCT02742090|588500746|FG000|Overall Study|Adverse Event|10|||
162944699|NCT02742090|588500746|FG000|Overall Study|Death|3|||
162944700|NCT02742090|588500746|FG000|Overall Study|Disease Progression|25|||
162944701|NCT02742090|588500746|FG000|Overall Study|Investigator's Decision|1|||
162944702|NCT02742090|588500746|FG000|Overall Study|Lost to Follow-up|1|||
162944703|NCT02742090|588500746|FG000|Overall Study|Non-compliance with Study|1|||
162944704|NCT02742090|588500746|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
162944705|NCT02742090|588500746|FG000|Overall Study|Withdrawal by Subject|4|||
162944706|NCT02742090|588500746|FG000|Overall Study|Reason Not Specified|1|||
162944707|NCT02016300|588500751|FG000|Overall Study|Lost to Follow-up|0|||
162944708|NCT02016300|588500752|FG001|Overall Study|Lost to Follow-up|3|||
162944709|NCT05301751|588500757|FG000|Overall Study|Withdrawal by Subject|0|||
162944710|NCT05301751|588500758|FG001|Overall Study|Withdrawal by Subject|0|||
162944711|NCT05301751|588500759|FG002|Overall Study|Withdrawal by Subject|1|||
162944712|NCT05301751|588500760|FG003|Overall Study|Withdrawal by Subject|0|||
162944713|NCT06165744|588500763|FG000|Overall Study|Non device-related adverse event|1|||
162944714|NCT01546987|588500764|FG000|Overall Study|Protocol Violation|3|||
162698966|NCT04159415|587606907|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698967|NCT04159415|587606908|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698968|NCT04159415|587606909|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698969|NCT04159415|587606910|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698970|NCT04159415|587606911|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698971|NCT04159415|587606912|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698972|NCT04159415|587606913|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698973|NCT04159415|587606914|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
162944715|NCT01546987|588500765|FG001|Overall Study|Protocol Violation|4|||
162944716|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944717|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
162944718|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944719|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944720|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
162944721|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
162944722|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
162698974|NCT04159415|587606915|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698975|NCT04159415|587606916|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162698976|NCT04159415|587606907|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698977|NCT04159415|587606908|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698978|NCT04159415|587606909|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698979|NCT04159415|587606910|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698980|NCT04159415|587606911|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698981|NCT04159415|587606912|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162944723|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
162944724|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
162944725|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
162944726|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944727|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
162944728|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944729|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944730|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
162944731|NCT02270736|588500766|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944732|NCT02270736|588500767|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162832027|NCT02831673|588098220|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162832028|NCT02831673|588098221|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
162832029|NCT02831673|588098217|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162832030|NCT02831673|588098218|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162832031|NCT02831673|588098219|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162832032|NCT02831673|588098220|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
162832033|NCT02831673|588098221|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
162832034|NCT02831673|588098217|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
162832035|NCT02831673|588098218|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
162698982|NCT04159415|587606913|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162944733|NCT02270736|588500768|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
162944734|NCT02270736|588500769|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944735|NCT02270736|588500770|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
162944736|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944737|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944738|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944739|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
162944740|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
162944741|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944742|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944743|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944744|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
162944745|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
162944746|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944747|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944748|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944749|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
162944750|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
162944751|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944752|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944753|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944754|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
162944755|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
162944756|NCT02270736|588500766|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944757|NCT02270736|588500767|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944758|NCT02270736|588500768|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944759|NCT02270736|588500769|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
162944760|NCT02270736|588500770|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
162944761|NCT00262600|588500771|FG000|Overall Study|Lost to Follow-up|17|||
162944762|NCT00262600|588500772|FG001|Overall Study|Lost to Follow-up|31|||
162944763|NCT00262600|588500773|FG002|Overall Study|Lost to Follow-up|41|||
162944764|NCT00262600|588500771|FG000|Overall Study|Withdrawal by Subject|128|||
162944765|NCT00262600|588500772|FG001|Overall Study|Withdrawal by Subject|145|||
162944766|NCT00262600|588500773|FG002|Overall Study|Withdrawal by Subject|139|||
162944767|NCT00262600|588500771|FG000|Overall Study|Not Treated|32|||
162944768|NCT00262600|588500772|FG001|Overall Study|Not Treated|17|||
162944769|NCT00262600|588500773|FG002|Overall Study|Not Treated|24|||
162944770|NCT00262600|588500771|FG000|Overall Study|Other|58|||
162944771|NCT00262600|588500772|FG001|Overall Study|Other|59|||
162944772|NCT00262600|588500773|FG002|Overall Study|Other|62|||
162944773|NCT02132247|588500780|FG000|Overall Study|Protocol Violation|1|||
162944774|NCT02132247|588500781|FG001|Overall Study|Protocol Violation|0|||
162944775|NCT04373434|588500786|FG000|Overall Study|Lost to Follow-up|37|||
162944776|NCT04373434|588500787|FG001|Overall Study|Lost to Follow-up|32|||
162944777|NCT04373434|588500786|FG000|Overall Study|Refused at 9 months|1|||
162944778|NCT04373434|588500787|FG001|Overall Study|Refused at 9 months|2|||
162944779|NCT04373434|588500786|FG000|Overall Study|Refused at 4 months|7|||
162944780|NCT04373434|588500787|FG001|Overall Study|Refused at 4 months|3|||
162944781|NCT04373434|588500786|FG000|Overall Study|Excluded|2|||
162944782|NCT04373434|588500787|FG001|Overall Study|Excluded|0|||
162944783|NCT00527423|588500788|FG000|Overall Study|Protocol Violation|1|||
162944784|NCT00527423|588500788|FG000|Overall Study|Adverse Event|5|||
162944785|NCT00527423|588500788|FG000|Overall Study|Physician Decision|4|||
162944786|NCT00527423|588500788|FG000|Overall Study|Withdrawal by Subject|10|||
162944787|NCT00527423|588500788|FG000|Overall Study|Lost to Follow-up|4|||
162944788|NCT00527423|588500788|FG000|Overall Study|OTHER|4|||
162944789|NCT00527423|588500788|FG000|Overall Study|Death|9|||
162944790|NCT02446132|588500789|FG000|Overall Study|Adverse Event|10|||
162944791|NCT02446132|588500790|FG001|Overall Study|Adverse Event|27|||
162944792|NCT02446132|588500791|FG002|Overall Study|Adverse Event|27|||
162944793|NCT02446132|588500789|FG000|Overall Study|Death|2|||
162944794|NCT02446132|588500790|FG001|Overall Study|Death|13|||
162944795|NCT02446132|588500791|FG002|Overall Study|Death|10|||
162944796|NCT02446132|588500789|FG000|Overall Study|Lack of Efficacy|1|||
162944797|NCT02446132|588500790|FG001|Overall Study|Lack of Efficacy|10|||
162944798|NCT02446132|588500791|FG002|Overall Study|Lack of Efficacy|6|||
162944799|NCT02446132|588500789|FG000|Overall Study|Lost to Follow-up|2|||
162944800|NCT02446132|588500790|FG001|Overall Study|Lost to Follow-up|4|||
162944801|NCT02446132|588500791|FG002|Overall Study|Lost to Follow-up|5|||
162944802|NCT02446132|588500789|FG000|Overall Study|Non-compliance With Study Drug|2|||
162944803|NCT02446132|588500790|FG001|Overall Study|Non-compliance With Study Drug|2|||
162944804|NCT02446132|588500791|FG002|Overall Study|Non-compliance With Study Drug|3|||
162944805|NCT02446132|588500789|FG000|Overall Study|Physician Decision|1|||
162944806|NCT02446132|588500790|FG001|Overall Study|Physician Decision|8|||
162944807|NCT02446132|588500791|FG002|Overall Study|Physician Decision|13|||
162944808|NCT02446132|588500789|FG000|Overall Study|Protocol Deviation|0|||
162944809|NCT02446132|588500790|FG001|Overall Study|Protocol Deviation|0|||
162944810|NCT02446132|588500791|FG002|Overall Study|Protocol Deviation|1|||
162944811|NCT02446132|588500789|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
162944812|NCT02446132|588500790|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
162944813|NCT02446132|588500791|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
162944814|NCT02446132|588500789|FG000|Overall Study|Study Terminated by Sponsor|4|||
162944815|NCT02446132|588500790|FG001|Overall Study|Study Terminated by Sponsor|35|||
162698983|NCT04159415|587606914|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698984|NCT04159415|587606915|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162698985|NCT04159415|587606916|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
162698986|NCT03560245|587606917|FG000|Overall Study|Withdrawal by Subject|3|||
162698987|NCT03560245|587606918|FG001|Overall Study|Withdrawal by Subject|2|||
162698988|NCT03560245|587606917|FG000|Overall Study|Adverse Event|1|||
162698989|NCT03560245|587606918|FG001|Overall Study|Adverse Event|1|||
162698990|NCT03560245|587606917|FG000|Overall Study|Protocol Violation|1|||
162698991|NCT03560245|587606918|FG001|Overall Study|Protocol Violation|0|||
162698992|NCT03560245|587606917|FG000|Overall Study|Death|0|||
162698993|NCT03560245|587606918|FG001|Overall Study|Death|1|||
162698994|NCT03560245|587606917|FG000|Overall Study|Lost to Follow-up|0|||
162698995|NCT03560245|587606918|FG001|Overall Study|Lost to Follow-up|1|||
162698996|NCT03560245|587606917|FG000|Overall Study|Physician Decision|0|||
162698997|NCT03560245|587606918|FG001|Overall Study|Physician Decision|1|||
162698998|NCT03560245|587606917|FG000|Overall Study|Other|0|||
162698999|NCT03560245|587606918|FG001|Overall Study|Other|1|||
162699000|NCT00960752|587606924|FG000|Overall Study|Adverse Event|0|||
162699001|NCT00960752|587606925|FG001|Overall Study|Adverse Event|0|||
162699002|NCT00960752|587606926|FG002|Overall Study|Adverse Event|1|||
162944816|NCT02446132|588500791|FG002|Overall Study|Study Terminated by Sponsor|58|||
162944817|NCT02446132|588500789|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
162944818|NCT02446132|588500790|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
162944819|NCT02446132|588500791|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
162944820|NCT02446132|588500789|FG000|Overall Study|Withdrawal by Subject|11|||
162944821|NCT02446132|588500790|FG001|Overall Study|Withdrawal by Subject|29|||
162944822|NCT02446132|588500791|FG002|Overall Study|Withdrawal by Subject|25|||
162944823|NCT02446132|588500789|FG000|Overall Study|Reason not Specified|4|||
162944824|NCT02446132|588500790|FG001|Overall Study|Reason not Specified|16|||
162944825|NCT02446132|588500791|FG002|Overall Study|Reason not Specified|10|||
162944826|NCT02446132|588500789|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
162944827|NCT02446132|588500790|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
162944828|NCT02446132|588500791|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
162944829|NCT03444038|588500792|FG000|Overall Study|Adverse Event|12|||
162944830|NCT03444038|588500792|FG000|Overall Study|Withdrawal by Subject|7|||
162944831|NCT03444038|588500792|FG000|Overall Study|Lost to Follow-up|1|||
162944832|NCT03444038|588500792|FG000|Overall Study|Physician Decision|2|||
162944833|NCT03444038|588500792|FG000|Overall Study|Lack of Efficacy|7|||
162944834|NCT02354586|588500794|FG000|Overall Study|Death|230|||
162944835|NCT02354586|588500794|FG000|Overall Study|Withdrawal by Subject|59|||
162944836|NCT02354586|588500794|FG000|Overall Study|Lost to Follow-up|11|||
162944837|NCT02354586|588500794|FG000|Overall Study|Sponsor decision|51|||
162944838|NCT02354586|588500794|FG000|Overall Study|Site closure|2|||
162944839|NCT02354586|588500794|FG000|Overall Study|Intercurrent illness|1|||
162944840|NCT02354586|588500794|FG000|Overall Study|Protocol Violation|3|||
162944841|NCT02354586|588500794|FG000|Overall Study|Physician Decision|13|||
162944842|NCT02354586|588500794|FG000|Overall Study|Lack of Efficacy|86|||
162944843|NCT02354586|588500794|FG000|Overall Study|Adverse Event|7|||
162944844|NCT00436007|588500795|FG000|Overall Study|Withdrawal by Subject|5|||
162944845|NCT00436007|588500796|FG001|Overall Study|Withdrawal by Subject|3|||
162944846|NCT00436007|588500797|FG002|Overall Study|Withdrawal by Subject|4|||
162944847|NCT00436007|588500795|FG000|Overall Study|Lost to Follow-up|14|||
162944848|NCT00436007|588500796|FG001|Overall Study|Lost to Follow-up|10|||
162944849|NCT00436007|588500797|FG002|Overall Study|Lost to Follow-up|13|||
162944850|NCT00436007|588500795|FG000|Overall Study|Physician Decision|0|||
162944851|NCT00436007|588500796|FG001|Overall Study|Physician Decision|0|||
162944852|NCT00436007|588500797|FG002|Overall Study|Physician Decision|2|||
162944853|NCT00436007|588500795|FG000|Overall Study|Death|0|||
162944854|NCT00436007|588500796|FG001|Overall Study|Death|1|||
162944855|NCT00436007|588500797|FG002|Overall Study|Death|3|||
162944856|NCT00436007|588500795|FG000|Overall Study|Other|0|||
162944857|NCT00436007|588500796|FG001|Overall Study|Other|0|||
162944858|NCT00436007|588500797|FG002|Overall Study|Other|1|||
162944859|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
162699003|NCT00960752|587606924|FG000|Overall Study|Progression|0|||
162944860|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944861|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
162944862|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
162944863|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944864|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
162944865|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
163042854|NCT01066871|588863974|FG000|Overall Study|Withdrawal by Subject|3|||
163042855|NCT01066871|588863975|FG001|Overall Study|Withdrawal by Subject|1|||
163042856|NCT01066871|588863976|FG002|Overall Study|Withdrawal by Subject|0|||
163042857|NCT01066871|588863977|FG003|Overall Study|Withdrawal by Subject|0|||
163042858|NCT01066871|588863974|FG000|Overall Study|Other|0|||
163042859|NCT01066871|588863975|FG001|Overall Study|Other|2|||
162944866|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
162944867|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
162944868|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
162944869|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
162944870|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
162944871|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944872|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944873|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944874|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944875|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
162944876|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
162944877|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944878|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944879|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162944880|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162944881|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162944882|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
162944883|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944884|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944885|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944886|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944887|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
162944888|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
162944889|NCT01957488|588500798|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
162944890|NCT01957488|588500799|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
162944891|NCT01957488|588500800|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
162944892|NCT01957488|588500801|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
162944893|NCT01957488|588500802|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
162944894|NCT01957488|588500803|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
162944895|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
162944896|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944897|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
162944898|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
162944899|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944900|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
162944901|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Other|1|||
162944902|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Other|0|||
162944903|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Other|0|||
162944904|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Other|0|||
162944905|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Other|0|||
162944906|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Other|0|||
162944907|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944908|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
162944909|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944910|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944911|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944912|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
162944913|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944914|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944915|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944916|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944917|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
162944918|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
162944919|NCT01957488|588500798|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944920|NCT01957488|588500799|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162699004|NCT00960752|587606925|FG001|Overall Study|Progression|0|||
162944921|NCT01957488|588500800|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944922|NCT01957488|588500801|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
162944923|NCT01957488|588500802|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
163042860|NCT01066871|588863976|FG002|Overall Study|Other|1|||
162944924|NCT01957488|588500803|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
162944925|NCT01957488|588500798|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
162944926|NCT01957488|588500799|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944927|NCT01957488|588500800|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944928|NCT01957488|588500801|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944929|NCT01957488|588500802|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944930|NCT01957488|588500803|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
162944931|NCT01957488|588500798|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944932|NCT01957488|588500799|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
162944933|NCT01957488|588500800|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944934|NCT01957488|588500801|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944935|NCT01957488|588500802|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944936|NCT01957488|588500803|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
162944937|NCT00721409|588500804|FG000|Overall Study|Global deterioration of health status|2|||
162944938|NCT00721409|588500805|FG001|Overall Study|Global deterioration of health status|6|||
162944939|NCT00721409|588500806|FG002|Overall Study|Global deterioration of health status|3|||
162944940|NCT00721409|588500804|FG000|Overall Study|Death|0|||
162944941|NCT00721409|588500805|FG001|Overall Study|Death|1|||
162944942|NCT00721409|588500806|FG002|Overall Study|Death|0|||
162944943|NCT00721409|588500804|FG000|Overall Study|Randomized not Treated|0|||
162944944|NCT00721409|588500805|FG001|Overall Study|Randomized not Treated|1|||
162944945|NCT00721409|588500806|FG002|Overall Study|Randomized not Treated|4|||
162944946|NCT00721409|588500804|FG000|Overall Study|Reason not specified|1|||
162944947|NCT00721409|588500805|FG001|Overall Study|Reason not specified|0|||
162944948|NCT00721409|588500806|FG002|Overall Study|Reason not specified|2|||
162944949|NCT00721409|588500804|FG000|Overall Study|Adverse Event|0|||
162944950|NCT00721409|588500805|FG001|Overall Study|Adverse Event|13|||
162944951|NCT00721409|588500806|FG002|Overall Study|Adverse Event|2|||
162944952|NCT00721409|588500804|FG000|Overall Study|Lost to Follow-up|0|||
162944953|NCT00721409|588500805|FG001|Overall Study|Lost to Follow-up|0|||
162944954|NCT00721409|588500806|FG002|Overall Study|Lost to Follow-up|1|||
162944955|NCT00721409|588500804|FG000|Overall Study|Withdrawal by Subject|1|||
162944956|NCT00721409|588500805|FG001|Overall Study|Withdrawal by Subject|6|||
162944957|NCT00721409|588500806|FG002|Overall Study|Withdrawal by Subject|5|||
162944958|NCT00721409|588500804|FG000|Overall Study|Objective progression or relapse|8|||
162944959|NCT00721409|588500805|FG001|Overall Study|Objective progression or relapse|55|||
162944960|NCT00721409|588500806|FG002|Overall Study|Objective progression or relapse|62|||
162944961|NCT01424722|588500807|FG000|Overall Study|Sponsor terminated investigation|2258|||
162944962|NCT02483975|588500808|FG000|Overall Study|Adverse Event|0|||
162944963|NCT02483975|588500809|FG001|Overall Study|Adverse Event|1|||
162944964|NCT02483975|588500808|FG000|Overall Study|Lost to Follow-up|0|||
162944965|NCT02483975|588500809|FG001|Overall Study|Lost to Follow-up|1|||
162944966|NCT02483975|588500808|FG000|Overall Study|Physician Decision|2|||
162944967|NCT02483975|588500809|FG001|Overall Study|Physician Decision|0|||
162944968|NCT00818883|588500810|FG000|Overall Study|Adverse Event|28|||
162944969|NCT00818883|588500811|FG001|Overall Study|Adverse Event|19|||
162944970|NCT00818883|588500810|FG000|Overall Study|Protocol Violation|2|||
162944971|NCT00818883|588500811|FG001|Overall Study|Protocol Violation|2|||
162944972|NCT00818883|588500810|FG000|Overall Study|Lost to Follow-up|3|||
162944973|NCT00818883|588500811|FG001|Overall Study|Lost to Follow-up|2|||
162944974|NCT00818883|588500810|FG000|Overall Study|Withdrawal by Subject|16|||
162944975|NCT00818883|588500811|FG001|Overall Study|Withdrawal by Subject|14|||
162944976|NCT00818883|588500810|FG000|Overall Study|Lack of Efficacy|0|||
162944977|NCT00818883|588500811|FG001|Overall Study|Lack of Efficacy|2|||
162944978|NCT00818883|588500810|FG000|Overall Study|Other|2|||
162944979|NCT00818883|588500811|FG001|Overall Study|Other|7|||
162944980|NCT02166697|588500812|FG000|Overall Study|Protocol Violation|347|||
162944981|NCT01153984|588500819|FG000|Overall Study|Withdrawal by Subject|1|||
162944982|NCT01153984|588500819|FG000|Overall Study|Adverse Event|1|||
162944983|NCT00973700|588500820|FG000|Overall Study|Withdrawal by Subject|2|||
162944984|NCT00973700|588500821|FG001|Overall Study|Withdrawal by Subject|2|||
162944985|NCT00973700|588500822|FG002|Overall Study|Withdrawal by Subject|8|||
162944986|NCT00973700|588500823|FG003|Overall Study|Withdrawal by Subject|4|||
162944987|NCT00973700|588500824|FG004|Overall Study|Withdrawal by Subject|4|||
162944988|NCT00973700|588500820|FG000|Overall Study|Lost to Follow-up|5|||
162944989|NCT00973700|588500821|FG001|Overall Study|Lost to Follow-up|0|||
162944990|NCT00973700|588500822|FG002|Overall Study|Lost to Follow-up|1|||
162944991|NCT00973700|588500823|FG003|Overall Study|Lost to Follow-up|8|||
162944992|NCT00973700|588500824|FG004|Overall Study|Lost to Follow-up|5|||
162944993|NCT00973700|588500820|FG000|Overall Study|Inappropriate enrolment|0|||
162944994|NCT00973700|588500821|FG001|Overall Study|Inappropriate enrolment|0|||
162944995|NCT00973700|588500822|FG002|Overall Study|Inappropriate enrolment|0|||
162944996|NCT00973700|588500823|FG003|Overall Study|Inappropriate enrolment|4|||
162944997|NCT00973700|588500824|FG004|Overall Study|Inappropriate enrolment|0|||
162944998|NCT00973700|588500820|FG000|Overall Study|Unable to Classify|0|||
162944999|NCT00973700|588500821|FG001|Overall Study|Unable to Classify|0|||
162945000|NCT00973700|588500822|FG002|Overall Study|Unable to Classify|1|||
162945001|NCT00973700|588500823|FG003|Overall Study|Unable to Classify|2|||
162945002|NCT00973700|588500824|FG004|Overall Study|Unable to Classify|1|||
162945003|NCT01618266|588500833|FG000|Overall Study|Lost to Follow-up|9|||
162945004|NCT01618266|588500833|FG000|Overall Study|Treatment satisfaction|10|||
162945005|NCT01618266|588500833|FG000|Overall Study|Other reasons|11|||
162945006|NCT01618266|588500833|FG000|Overall Study|Lack of Efficacy|23|||
162945007|NCT01618266|588500833|FG000|Overall Study|Protocol Violation|43|||
162945008|NCT00290745|588500834|FG000|Overall Study|Withdrawal by Subject|4|||
162945009|NCT00290745|588500834|FG000|Overall Study|Physician Decision|2|||
162945010|NCT00290745|588500834|FG000|Overall Study|Surgery after 3 months for progression|3|||
162945011|NCT00290745|588500834|FG000|Overall Study|Baseline MRI not available|3|||
162945012|NCT02224391|588500839|FG000|Overall Study|Lost to Follow-up|26|||
162945013|NCT02224391|588500840|FG001|Overall Study|Lost to Follow-up|19|||
162945014|NCT02224391|588500839|FG000|Overall Study|Withdrawal by Subject|6|||
162945015|NCT02224391|588500840|FG001|Overall Study|Withdrawal by Subject|5|||
162945016|NCT02492958|588500841|FG000|Overall Study|Withdrawal by Subject|0|||
162945017|NCT02492958|588500842|FG001|Overall Study|Withdrawal by Subject|0|||
162945018|NCT02492958|588500843|FG002|Overall Study|Withdrawal by Subject|1|||
162945019|NCT02492958|588500844|FG003|Overall Study|Withdrawal by Subject|0|||
162945020|NCT02492958|588500841|FG000|Overall Study|Adverse Event|1|||
162945021|NCT02492958|588500842|FG001|Overall Study|Adverse Event|0|||
162945022|NCT02492958|588500843|FG002|Overall Study|Adverse Event|1|||
162945023|NCT02492958|588500844|FG003|Overall Study|Adverse Event|0|||
162945024|NCT03522948|588500845|FG000|Overall Study|Lost to Follow-up|1|||
162945025|NCT02236130|588500847|FG000|Overall Study|Lost to Follow-up|7|||
162945026|NCT02236130|588500848|FG001|Overall Study|Lost to Follow-up|12|||
162945027|NCT00424489|588500851|FG000|Overall Study|Death|3|||
162945028|NCT01984242|588500852|FG000|Overall Study|Death|52|||
162945029|NCT01984242|588500853|FG001|Overall Study|Death|50|||
162945030|NCT01984242|588500854|FG002|Overall Study|Death|52|||
162945031|NCT01984242|588500852|FG000|Overall Study|Withdrawal by Subject|5|||
162945032|NCT01984242|588500853|FG001|Overall Study|Withdrawal by Subject|3|||
162945033|NCT01984242|588500854|FG002|Overall Study|Withdrawal by Subject|10|||
162945034|NCT01984242|588500852|FG000|Overall Study|Physician Decision|0|||
162945035|NCT01984242|588500853|FG001|Overall Study|Physician Decision|0|||
162945036|NCT01984242|588500854|FG002|Overall Study|Physician Decision|1|||
162945037|NCT01984242|588500852|FG000|Overall Study|Lost to Follow-up|4|||
162945038|NCT01984242|588500853|FG001|Overall Study|Lost to Follow-up|0|||
162945039|NCT01984242|588500854|FG002|Overall Study|Lost to Follow-up|3|||
162945040|NCT01984242|588500852|FG000|Overall Study|Sponsor Decision|1|||
162945041|NCT01984242|588500853|FG001|Overall Study|Sponsor Decision|0|||
162945042|NCT01984242|588500854|FG002|Overall Study|Sponsor Decision|0|||
162945043|NCT01984242|588500852|FG000|Overall Study|Non-Compliance|1|||
162945044|NCT01984242|588500853|FG001|Overall Study|Non-Compliance|0|||
162945045|NCT01984242|588500854|FG002|Overall Study|Non-Compliance|0|||
162945046|NCT01984242|588500852|FG000|Overall Study|Study terminated by Sponsor|38|||
162945047|NCT01984242|588500853|FG001|Overall Study|Study terminated by Sponsor|50|||
162945048|NCT01984242|588500854|FG002|Overall Study|Study terminated by Sponsor|34|||
162945049|NCT01984242|588500852|FG000|Overall Study|Disease Progression|0|||
162945050|NCT01984242|588500853|FG001|Overall Study|Disease Progression|0|||
162945051|NCT01984242|588500854|FG002|Overall Study|Disease Progression|1|||
162945052|NCT00449150|588500857|FG000|Overall Study|Adverse Event|11|||
162945053|NCT00449150|588500858|FG001|Overall Study|Adverse Event|18|||
162945054|NCT00449150|588500859|FG002|Overall Study|Adverse Event|9|||
162945055|NCT00449150|588500857|FG000|Overall Study|Lack of Efficacy|1|||
162945056|NCT00449150|588500858|FG001|Overall Study|Lack of Efficacy|2|||
162945057|NCT00449150|588500859|FG002|Overall Study|Lack of Efficacy|2|||
162945058|NCT00449150|588500857|FG000|Overall Study|Other|16|||
162945059|NCT00449150|588500858|FG001|Overall Study|Other|13|||
162945060|NCT00449150|588500859|FG002|Overall Study|Other|14|||
162945061|NCT00449150|588500857|FG000|Overall Study|Withdrawal by Subject|17|||
162945062|NCT00449150|588500858|FG001|Overall Study|Withdrawal by Subject|18|||
162945063|NCT00449150|588500859|FG002|Overall Study|Withdrawal by Subject|21|||
162945064|NCT00449150|588500857|FG000|Overall Study|Protocol Violation|1|||
162945065|NCT00449150|588500858|FG001|Overall Study|Protocol Violation|2|||
162945066|NCT00449150|588500859|FG002|Overall Study|Protocol Violation|1|||
162945067|NCT00770510|588500860|FG000|Overall Study|Lost to Follow-up|2|||
162945068|NCT00770510|588500860|FG000|Overall Study|Pregnancy|1|||
162945069|NCT00770510|588500860|FG000|Overall Study|Withdrawal by Subject|2|||
162945070|NCT01089647|588500866|FG000|Overall Study|Lost to Follow-up|2|||
162945071|NCT01089647|588500867|FG001|Overall Study|Lost to Follow-up|2|||
162945072|NCT01089647|588500866|FG000|Overall Study|Withdrawal by Subject|2|||
162945073|NCT01089647|588500867|FG001|Overall Study|Withdrawal by Subject|1|||
162945074|NCT01089647|588500866|FG000|Overall Study|Adverse Event|0|||
162945075|NCT01089647|588500867|FG001|Overall Study|Adverse Event|1|||
162945076|NCT02001558|588500870|FG000|Overall Study|Lost to Follow-up|8|||
162945077|NCT02001558|588500871|FG001|Overall Study|Lost to Follow-up|14|||
162945078|NCT04117607|588500872|FG000|Overall Study|Early Termination|0|||
162945079|NCT04117607|588500873|FG001|Overall Study|Early Termination|1|||
162945080|NCT04117607|588500874|FG002|Overall Study|Early Termination|0|||
162945081|NCT04117607|588500875|FG003|Overall Study|Early Termination|0|||
162945082|NCT04117607|588500876|FG004|Overall Study|Early Termination|0|||
162945083|NCT04117607|588500877|FG005|Overall Study|Early Termination|0|||
162945084|NCT04117607|588500878|FG006|Overall Study|Early Termination|1|||
162945085|NCT04117607|588500879|FG007|Overall Study|Early Termination|0|||
162945086|NCT04117607|588500880|FG008|Overall Study|Early Termination|0|||
162945087|NCT04117607|588500881|FG009|Overall Study|Early Termination|0|||
162945088|NCT04117607|588500882|FG010|Overall Study|Early Termination|0|||
162945089|NCT04117607|588500883|FG011|Overall Study|Early Termination|0|||
162945090|NCT04117607|588500884|FG012|Overall Study|Early Termination|0|||
162945091|NCT04117607|588500885|FG013|Overall Study|Early Termination|0|||
162945092|NCT01457053|588500889|FG000|Overall Study|Unable to undergo selected treatment|1|||
162945093|NCT01457053|588500890|FG001|Overall Study|Unable to undergo selected treatment|1|||
162945094|NCT02073643|588500891|FG000|Overall Study|Lost to Follow-up|24|||
162945095|NCT04333095|588500894|FG000|Overall Study|Protocol Violation|4|||
162945096|NCT04333095|588500895|FG001|Overall Study|Protocol Violation|0|||
162945097|NCT04333095|588500894|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
162945098|NCT04333095|588500895|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
162945099|NCT04333095|588500894|FG000|Overall Study|Mini Sternotomy|4|||
162945100|NCT04333095|588500895|FG001|Overall Study|Mini Sternotomy|5|||
162945101|NCT02364557|588500896|FG000|Overall Study|Protocol Violation|3|||
162945102|NCT02364557|588500897|FG001|Overall Study|Protocol Violation|1|||
162945103|NCT04347239|588500898|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
162945104|NCT04347239|588500899|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
162945105|NCT04347239|588500900|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
162945106|NCT04347239|588500898|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
162945107|NCT04347239|588500899|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
162945108|NCT04347239|588500900|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
162945109|NCT00788957|588500909|FG000|Part 1|Death|8|||
162945110|NCT00788957|588500910|FG001|Part 1|Death|0|||
162945111|NCT00788957|588500911|FG002|Part 1|Death|0|||
162945112|NCT00788957|588500912|FG003|Part 1|Death|0|||
162945113|NCT00788957|588500913|FG004|Part 1|Death|0|||
162945114|NCT00788957|588500914|FG005|Part 1|Death|0|||
162945115|NCT00788957|588500909|FG000|Part 1|Lost to Follow-up|1|||
162945116|NCT00788957|588500910|FG001|Part 1|Lost to Follow-up|0|||
162945117|NCT00788957|588500911|FG002|Part 1|Lost to Follow-up|0|||
162945118|NCT00788957|588500912|FG003|Part 1|Lost to Follow-up|0|||
162945119|NCT00788957|588500913|FG004|Part 1|Lost to Follow-up|0|||
162945120|NCT00788957|588500914|FG005|Part 1|Lost to Follow-up|0|||
162945121|NCT00788957|588500909|FG000|Part 2|Withdrawal by Subject|0|||
162945122|NCT00788957|588500910|FG001|Part 2|Withdrawal by Subject|9|||
162945123|NCT00788957|588500911|FG002|Part 2|Withdrawal by Subject|5|||
162945124|NCT00788957|588500912|FG003|Part 2|Withdrawal by Subject|3|||
162945125|NCT00788957|588500913|FG004|Part 2|Withdrawal by Subject|0|||
162945126|NCT00788957|588500914|FG005|Part 2|Withdrawal by Subject|0|||
162945127|NCT00788957|588500909|FG000|Part 2|Death|0|||
162945128|NCT00788957|588500910|FG001|Part 2|Death|32|||
162945129|NCT00788957|588500911|FG002|Part 2|Death|35|||
162945130|NCT00788957|588500912|FG003|Part 2|Death|37|||
162945131|NCT00788957|588500913|FG004|Part 2|Death|0|||
162945132|NCT00788957|588500914|FG005|Part 2|Death|0|||
162945133|NCT00788957|588500909|FG000|Part 2|Lost to Follow-up|0|||
162945134|NCT00788957|588500910|FG001|Part 2|Lost to Follow-up|0|||
162945135|NCT00788957|588500911|FG002|Part 2|Lost to Follow-up|3|||
162945136|NCT00788957|588500912|FG003|Part 2|Lost to Follow-up|0|||
162945137|NCT00788957|588500913|FG004|Part 2|Lost to Follow-up|0|||
162945138|NCT00788957|588500914|FG005|Part 2|Lost to Follow-up|0|||
162945139|NCT00788957|588500909|FG000|Part 2|On-study at time of data cut-off|0|||
162945140|NCT00788957|588500910|FG001|Part 2|On-study at time of data cut-off|1|||
162945141|NCT00788957|588500911|FG002|Part 2|On-study at time of data cut-off|1|||
162945142|NCT00788957|588500912|FG003|Part 2|On-study at time of data cut-off|1|||
162699005|NCT00960752|587606926|FG002|Overall Study|Progression|1|||
162945143|NCT00788957|588500913|FG004|Part 2|On-study at time of data cut-off|0|||
162945144|NCT00788957|588500914|FG005|Part 2|On-study at time of data cut-off|0|||
162945145|NCT00788957|588500909|FG000|Part 3|Withdrawal by Subject|0|||
162945146|NCT00788957|588500910|FG001|Part 3|Withdrawal by Subject|0|||
162945147|NCT00788957|588500911|FG002|Part 3|Withdrawal by Subject|0|||
162945148|NCT00788957|588500912|FG003|Part 3|Withdrawal by Subject|0|||
162945149|NCT00788957|588500913|FG004|Part 3|Withdrawal by Subject|0|||
162945150|NCT00788957|588500914|FG005|Part 3|Withdrawal by Subject|2|||
162945151|NCT00788957|588500909|FG000|Part 3|Death|0|||
162945152|NCT00788957|588500910|FG001|Part 3|Death|0|||
162945153|NCT00788957|588500911|FG002|Part 3|Death|0|||
162945154|NCT00788957|588500912|FG003|Part 3|Death|0|||
162945155|NCT00788957|588500913|FG004|Part 3|Death|8|||
162699006|NCT02058290|587606930|FG000|Overall Study|Protocol Violation|2|||
162945156|NCT00788957|588500914|FG005|Part 3|Death|8|||
162945157|NCT00788957|588500909|FG000|Part 3|On-study at time of data cut-off|0|||
162945158|NCT00788957|588500910|FG001|Part 3|On-study at time of data cut-off|0|||
162945159|NCT00788957|588500911|FG002|Part 3|On-study at time of data cut-off|0|||
162945160|NCT00788957|588500912|FG003|Part 3|On-study at time of data cut-off|0|||
162945161|NCT00788957|588500913|FG004|Part 3|On-study at time of data cut-off|1|||
162945162|NCT00788957|588500914|FG005|Part 3|On-study at time of data cut-off|0|||
162945163|NCT00796510|588500923|FG000|Overall Study|Death|1|||
162945164|NCT00796510|588500924|FG001|Overall Study|Death|0|||
162945165|NCT00796510|588500923|FG000|Overall Study|Study Terminated|2|||
162945166|NCT00796510|588500924|FG001|Overall Study|Study Terminated|0|||
162945167|NCT02841709|588502842|FG000|5th Intervention|Adverse Event|2|||
162945168|NCT02841709|588502843|FG001|5th Intervention|Adverse Event|0|||
162945169|NCT02841709|588502844|FG002|5th Intervention|Adverse Event|0|||
162945170|NCT02841709|588502845|FG003|5th Intervention|Adverse Event|0|||
162945171|NCT02841709|588502846|FG004|5th Intervention|Adverse Event|2|||
162945172|NCT01210001|588502847|FG000|Overall Study|Not treated|1|||
162945173|NCT01210001|588502848|FG001|Overall Study|Not treated|0|||
162945174|NCT01210001|588502849|FG002|Overall Study|Not treated|0|||
162945175|NCT01210001|588502847|FG000|Overall Study|Adverse Event|4|||
162945176|NCT01210001|588502848|FG001|Overall Study|Adverse Event|2|||
162945177|NCT01210001|588502849|FG002|Overall Study|Adverse Event|5|||
162945178|NCT01210001|588502847|FG000|Overall Study|Non compliant with protocol|2|||
162945179|NCT01210001|588502848|FG001|Overall Study|Non compliant with protocol|2|||
162945180|NCT01210001|588502849|FG002|Overall Study|Non compliant with protocol|3|||
162945181|NCT01210001|588502847|FG000|Overall Study|Lost to Follow-up|4|||
162945182|NCT01210001|588502848|FG001|Overall Study|Lost to Follow-up|3|||
162945183|NCT01210001|588502849|FG002|Overall Study|Lost to Follow-up|2|||
162945184|NCT01210001|588502847|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
162945185|NCT01210001|588502848|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
162945186|NCT01210001|588502849|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
162945187|NCT01210001|588502847|FG000|Overall Study|Other reason not defined above|2|||
162945188|NCT01210001|588502848|FG001|Overall Study|Other reason not defined above|2|||
162945189|NCT01210001|588502849|FG002|Overall Study|Other reason not defined above|1|||
162945190|NCT00788125|588502850|FG000|Overall Study|Death|6|||
162945191|NCT04526210|588502854|FG000|Overall Study|Sponsor decision|7|||
162945192|NCT04526210|588502855|FG001|Overall Study|Sponsor decision|5|||
162945193|NCT04526210|588502854|FG000|Overall Study|Withdrawal by Subject|3|||
162945194|NCT04526210|588502855|FG001|Overall Study|Withdrawal by Subject|2|||
162945195|NCT01781637|588502856|FG000|Overall Study|Adverse Event|1|||
162945196|NCT01781637|588502857|FG001|Overall Study|Adverse Event|0|||
162945197|NCT01781637|588502856|FG000|Overall Study|Lack of Efficacy|2|||
162945198|NCT01781637|588502857|FG001|Overall Study|Lack of Efficacy|6|||
162945199|NCT01781637|588502856|FG000|Overall Study|Withdrawal by Subject|1|||
162945200|NCT01781637|588502857|FG001|Overall Study|Withdrawal by Subject|0|||
162945201|NCT02637232|588502858|FG000|Overall Study|Lost to Follow-up|42|||
162945202|NCT02637232|588502858|FG000|Overall Study|Adverse Event|11|||
162945203|NCT02637232|588502858|FG000|Overall Study|patient 's decision|2|||
162945204|NCT00090857|588502859|FG000|Overall Study|Lost to Follow-up|0|||
162945205|NCT00090857|588502860|FG001|Overall Study|Lost to Follow-up|1|||
162945206|NCT00090857|588502859|FG000|Overall Study|Withdrawal by Subject|2|||
162945207|NCT00090857|588502860|FG001|Overall Study|Withdrawal by Subject|0|||
162945208|NCT00090857|588502859|FG000|Overall Study|Adverse Event|2|||
162945209|NCT00090857|588502860|FG001|Overall Study|Adverse Event|2|||
162945210|NCT05097326|588502862|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
162945211|NCT05097326|588502863|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
162945212|NCT03480425|588502864|FG000|Overall Study|Force transducer technical failure|1|||
162945213|NCT02473640|588502874|FG000|Treatment Period 1|Adverse Event|1|||
162945214|NCT03292653|588502875|FG000|Overall Study|Adverse Event|0|||
162945215|NCT03292653|588502876|FG001|Overall Study|Adverse Event|0|||
162945216|NCT03292653|588502877|FG002|Overall Study|Adverse Event|1|||
162945217|NCT03292653|588502875|FG000|Overall Study|Did not Receive Treatment|1|||
162945218|NCT03292653|588502876|FG001|Overall Study|Did not Receive Treatment|0|||
162945219|NCT03292653|588502877|FG002|Overall Study|Did not Receive Treatment|0|||
162945220|NCT04720664|588502878|FG000|Overall Study|Adverse Event|2|||
162945221|NCT04720664|588502878|FG000|Overall Study|Lack of Efficacy|9|||
162945222|NCT03103100|588502881|FG000|Overall Study|Adverse Event|1|||
162945223|NCT03103100|588502882|FG001|Overall Study|Adverse Event|0|||
162945224|NCT03103100|588502883|FG002|Overall Study|Adverse Event|0|||
162945225|NCT03103100|588502881|FG000|Overall Study|Physician Decision|1|||
162945226|NCT03103100|588502882|FG001|Overall Study|Physician Decision|0|||
162945227|NCT03103100|588502883|FG002|Overall Study|Physician Decision|2|||
162945228|NCT02720510|588502893|FG000|Overall Study|Study Terminated by the sponsor|2|||
162945229|NCT02720510|588502894|FG001|Overall Study|Study Terminated by the sponsor|0|||
162945230|NCT02720510|588502893|FG000|Overall Study|Adverse Event|0|||
162945231|NCT02720510|588502894|FG001|Overall Study|Adverse Event|1|||
162945232|NCT02720510|588502893|FG000|Overall Study|Physician Decision|1|||
162945233|NCT02720510|588502894|FG001|Overall Study|Physician Decision|2|||
162945234|NCT02460159|588502895|FG000|Overall Study|Adverse Event|4|||
162945235|NCT02460159|588502896|FG001|Overall Study|Adverse Event|1|||
162945236|NCT02460159|588502895|FG000|Overall Study|Withdrawal by Subject|2|||
162945237|NCT02460159|588502896|FG001|Overall Study|Withdrawal by Subject|0|||
162945238|NCT00084084|588502897|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
162945239|NCT00084084|588502897|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
162945240|NCT01531205|588502901|FG000|Overall Study|Did not proceed to surgery|1|||
162945241|NCT02465567|588502902|FG000|Overall Study|Adverse Event|118|||
162945242|NCT02465567|588502903|FG001|Overall Study|Adverse Event|113|||
162945243|NCT02465567|588502904|FG002|Overall Study|Adverse Event|147|||
162945244|NCT02465567|588502905|FG003|Overall Study|Adverse Event|138|||
162945245|NCT02465567|588502902|FG000|Overall Study|Lack of Efficacy|103|||
162945246|NCT02465567|588502903|FG001|Overall Study|Lack of Efficacy|102|||
162945247|NCT02465567|588502904|FG002|Overall Study|Lack of Efficacy|171|||
162945248|NCT02465567|588502905|FG003|Overall Study|Lack of Efficacy|135|||
162945249|NCT02465567|588502902|FG000|Overall Study|Withdrawal by Subject|104|||
162945250|NCT02465567|588502903|FG001|Overall Study|Withdrawal by Subject|94|||
162945251|NCT02465567|588502904|FG002|Overall Study|Withdrawal by Subject|123|||
162945252|NCT02465567|588502905|FG003|Overall Study|Withdrawal by Subject|130|||
162945253|NCT02465567|588502902|FG000|Overall Study|Physician Decision|23|||
162945254|NCT02465567|588502903|FG001|Overall Study|Physician Decision|33|||
162945255|NCT02465567|588502904|FG002|Overall Study|Physician Decision|38|||
162945256|NCT02465567|588502905|FG003|Overall Study|Physician Decision|28|||
162945257|NCT02465567|588502902|FG000|Overall Study|Major Protocol Deviation|24|||
162945258|NCT02465567|588502903|FG001|Overall Study|Major Protocol Deviation|26|||
162945259|NCT02465567|588502904|FG002|Overall Study|Major Protocol Deviation|22|||
162945260|NCT02465567|588502905|FG003|Overall Study|Major Protocol Deviation|25|||
162945261|NCT02465567|588502902|FG000|Overall Study|Lost to Follow-up|25|||
162945262|NCT02465567|588502903|FG001|Overall Study|Lost to Follow-up|21|||
162945263|NCT02465567|588502904|FG002|Overall Study|Lost to Follow-up|19|||
162945264|NCT02465567|588502905|FG003|Overall Study|Lost to Follow-up|15|||
162945265|NCT02465567|588502902|FG000|Overall Study|Protocol Specified Criteria|20|||
162945266|NCT02465567|588502903|FG001|Overall Study|Protocol Specified Criteria|10|||
162945267|NCT02465567|588502904|FG002|Overall Study|Protocol Specified Criteria|9|||
162945268|NCT02465567|588502905|FG003|Overall Study|Protocol Specified Criteria|12|||
162945269|NCT02465567|588502902|FG000|Overall Study|Administrative Reasons|12|||
162945270|NCT02465567|588502903|FG001|Overall Study|Administrative Reasons|9|||
162945271|NCT02465567|588502904|FG002|Overall Study|Administrative Reasons|11|||
162945272|NCT02465567|588502905|FG003|Overall Study|Administrative Reasons|5|||
162945273|NCT02465567|588502902|FG000|Overall Study|Randomized but not treated|1|||
162945274|NCT02465567|588502903|FG001|Overall Study|Randomized but not treated|5|||
162945275|NCT02465567|588502904|FG002|Overall Study|Randomized but not treated|4|||
162945276|NCT02465567|588502905|FG003|Overall Study|Randomized but not treated|5|||
162945277|NCT02465567|588502902|FG000|Overall Study|enrolled in >1 studies|18|||
162945278|NCT02465567|588502903|FG001|Overall Study|enrolled in >1 studies|11|||
162945279|NCT02465567|588502904|FG002|Overall Study|enrolled in >1 studies|19|||
162945280|NCT02465567|588502905|FG003|Overall Study|enrolled in >1 studies|15|||
162945281|NCT02465567|588502902|FG000|Overall Study|missing PI Signature|1|||
162945282|NCT02465567|588502903|FG001|Overall Study|missing PI Signature|0|||
162945283|NCT02465567|588502904|FG002|Overall Study|missing PI Signature|0|||
162945284|NCT02465567|588502905|FG003|Overall Study|missing PI Signature|0|||
162945285|NCT00337077|588502909|FG000|Overall Study|Progressive disease|25|||
162945286|NCT00337077|588502910|FG001|Overall Study|Progressive disease|37|||
162945287|NCT00337077|588502911|FG002|Overall Study|Progressive disease|19|||
162945288|NCT00337077|588502909|FG000|Overall Study|Adverse Event|7|||
162945289|NCT00337077|588502910|FG001|Overall Study|Adverse Event|7|||
162945290|NCT00337077|588502911|FG002|Overall Study|Adverse Event|1|||
162945291|NCT00337077|588502909|FG000|Overall Study|Death|0|||
162945292|NCT00337077|588502910|FG001|Overall Study|Death|1|||
162945293|NCT00337077|588502911|FG002|Overall Study|Death|0|||
162945294|NCT00337077|588502909|FG000|Overall Study|Withdrawal by Subject|7|||
162945295|NCT00337077|588502910|FG001|Overall Study|Withdrawal by Subject|2|||
162945296|NCT00337077|588502911|FG002|Overall Study|Withdrawal by Subject|2|||
162945297|NCT00337077|588502909|FG000|Overall Study|Alternative therapy|1|||
162945298|NCT00337077|588502910|FG001|Overall Study|Alternative therapy|0|||
162945299|NCT00337077|588502911|FG002|Overall Study|Alternative therapy|0|||
162945300|NCT00337077|588502909|FG000|Overall Study|Physician Decision|1|||
162945301|NCT00337077|588502910|FG001|Overall Study|Physician Decision|4|||
162945302|NCT00337077|588502911|FG002|Overall Study|Physician Decision|2|||
162699007|NCT02058290|587606931|FG001|Overall Study|Protocol Violation|1|||
162945303|NCT00337077|588502909|FG000|Overall Study|Never started treatment|1|||
162945304|NCT00337077|588502910|FG001|Overall Study|Never started treatment|1|||
162945305|NCT00337077|588502911|FG002|Overall Study|Never started treatment|0|||
162945306|NCT00337077|588502909|FG000|Overall Study|Ineligible|1|||
162945307|NCT00337077|588502910|FG001|Overall Study|Ineligible|1|||
162945308|NCT00337077|588502911|FG002|Overall Study|Ineligible|1|||
162945309|NCT00984295|588502913|FG000|Overall Study|Lost to Follow-up|31|||
162945310|NCT00984295|588502914|FG001|Overall Study|Lost to Follow-up|12|||
162945311|NCT00984295|588502915|FG002|Overall Study|Lost to Follow-up|13|||
162945312|NCT00984295|588502913|FG000|Overall Study|Protocol Violation|2|||
162945313|NCT00984295|588502914|FG001|Overall Study|Protocol Violation|1|||
162699008|NCT02058290|587606930|FG000|Overall Study|Physician Decision|1|||
162699009|NCT02058290|587606931|FG001|Overall Study|Physician Decision|0|||
162699010|NCT02058290|587606930|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
162699011|NCT02058290|587606931|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
162945314|NCT00984295|588502915|FG002|Overall Study|Protocol Violation|4|||
162945315|NCT00984295|588502913|FG000|Overall Study|Withdrawal by Subject|18|||
162945316|NCT00984295|588502914|FG001|Overall Study|Withdrawal by Subject|9|||
162945317|NCT00984295|588502915|FG002|Overall Study|Withdrawal by Subject|12|||
162945318|NCT00984295|588502913|FG000|Overall Study|CAE - discontinued test vaccine|0|||
162945319|NCT00984295|588502914|FG001|Overall Study|CAE - discontinued test vaccine|1|||
162945320|NCT00984295|588502915|FG002|Overall Study|CAE - discontinued test vaccine|3|||
162945321|NCT00984295|588502913|FG000|Overall Study|Missed one or more blood samplings|3|||
162945322|NCT00984295|588502914|FG001|Overall Study|Missed one or more blood samplings|7|||
162945323|NCT00984295|588502915|FG002|Overall Study|Missed one or more blood samplings|2|||
162945324|NCT00984295|588502913|FG000|Overall Study|Incomplete safety follow-up|11|||
162945325|NCT00984295|588502914|FG001|Overall Study|Incomplete safety follow-up|2|||
162945326|NCT00984295|588502915|FG002|Overall Study|Incomplete safety follow-up|3|||
162945327|NCT04582539|588502916|FG000|Overall Study|Death|1|||
162945328|NCT04582539|588502917|FG001|Overall Study|Death|1|||
162945329|NCT04582539|588502918|FG002|Overall Study|Death|0|||
162945330|NCT04582539|588502919|FG003|Overall Study|Death|1|||
162945331|NCT04582539|588502920|FG004|Overall Study|Death|0|||
162945332|NCT04582539|588502916|FG000|Overall Study|Lost to Follow-up|1|||
162945333|NCT04582539|588502917|FG001|Overall Study|Lost to Follow-up|0|||
162945334|NCT04582539|588502918|FG002|Overall Study|Lost to Follow-up|0|||
162945335|NCT04582539|588502919|FG003|Overall Study|Lost to Follow-up|0|||
162945336|NCT04582539|588502920|FG004|Overall Study|Lost to Follow-up|0|||
162945337|NCT04582539|588502916|FG000|Overall Study|Study Terminated by Sponsor|1|||
162945338|NCT04582539|588502917|FG001|Overall Study|Study Terminated by Sponsor|3|||
162945339|NCT04582539|588502918|FG002|Overall Study|Study Terminated by Sponsor|2|||
162945340|NCT04582539|588502919|FG003|Overall Study|Study Terminated by Sponsor|2|||
162945341|NCT04582539|588502920|FG004|Overall Study|Study Terminated by Sponsor|3|||
162945342|NCT04582539|588502916|FG000|Overall Study|Physician Decision|0|||
162945343|NCT04582539|588502917|FG001|Overall Study|Physician Decision|1|||
162945344|NCT04582539|588502918|FG002|Overall Study|Physician Decision|0|||
162945345|NCT04582539|588502919|FG003|Overall Study|Physician Decision|0|||
162945346|NCT04582539|588502920|FG004|Overall Study|Physician Decision|0|||
162945347|NCT04582539|588502916|FG000|Overall Study|Withdrawal by Subject|1|||
162945348|NCT04582539|588502917|FG001|Overall Study|Withdrawal by Subject|0|||
162945349|NCT04582539|588502918|FG002|Overall Study|Withdrawal by Subject|2|||
162945350|NCT04582539|588502919|FG003|Overall Study|Withdrawal by Subject|1|||
162945351|NCT04582539|588502920|FG004|Overall Study|Withdrawal by Subject|0|||
162945352|NCT04582539|588502916|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945353|NCT04582539|588502917|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945354|NCT04582539|588502918|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945355|NCT04582539|588502919|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
162945356|NCT04582539|588502920|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
162945357|NCT00662129|588502921|FG000|Overall Study|Protocol Violation|1|||
162945358|NCT00662129|588502921|FG000|Overall Study|Cancel prior to beginning treatment|1|||
162945359|NCT00662129|588502921|FG000|Overall Study|Ineligible|1|||
162945360|NCT05030753|588502926|FG000|9-week|Lost to Follow-up|10|||
162945361|NCT05030753|588502927|FG001|9-week|Lost to Follow-up|7|||
162945362|NCT05030753|588502926|FG000|9-week|Withdrawal by Subject|1|||
162945363|NCT05030753|588502927|FG001|9-week|Withdrawal by Subject|0|||
162945364|NCT05030753|588502926|FG000|9-week|Excluded from analysis due to missing covariates|2|||
162945365|NCT05030753|588502927|FG001|9-week|Excluded from analysis due to missing covariates|1|||
162945366|NCT05030753|588502926|FG000|6-month post intervention|Lost to Follow-up|5|||
162945367|NCT05030753|588502927|FG001|6-month post intervention|Lost to Follow-up|4|||
162945368|NCT05030753|588502926|FG000|6-month post intervention|Withdrawal by Subject|4|||
162945369|NCT05030753|588502927|FG001|6-month post intervention|Withdrawal by Subject|0|||
162945370|NCT05030753|588502926|FG000|18-month post intervention|Lost to Follow-up|3|||
162945371|NCT05030753|588502927|FG001|18-month post intervention|Lost to Follow-up|1|||
162945372|NCT03072459|588502932|FG000|Overall Study|Device revised/removed|1|||
162945373|NCT03072459|588502932|FG000|Overall Study|Subject not able to return|1|||
162945374|NCT00329602|588502933|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
162945375|NCT00329602|588502934|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
162945376|NCT00329602|588502935|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
162699012|NCT02058290|587606930|FG000|Overall Study|Withdrawal by Subject|0|||
162699013|NCT02058290|587606931|FG001|Overall Study|Withdrawal by Subject|1|||
162945377|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
162945378|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
162945379|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
162945380|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
162945381|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
162945382|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
162945383|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
162945384|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
162945385|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
162945386|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
162945387|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
162945388|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
162945389|NCT00329602|588502933|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
162945390|NCT00329602|588502934|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
162945391|NCT00329602|588502935|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
162945392|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
162945393|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
162945394|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
162945395|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
162945396|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
162945397|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
162945398|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
162945399|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
162945400|NCT02579096|588502936|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
162945401|NCT02579096|588502937|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
162945402|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Death|2|||
162945403|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Death|4|||
162945404|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
162945405|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
162945406|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
162945407|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
162945408|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
162945409|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
162945410|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
162945411|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
162945412|NCT02579096|588502936|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
162945413|NCT02579096|588502937|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
162945414|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Death|3|||
162945415|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Death|2|||
162945416|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
162945417|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
162945418|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
162945419|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
162945420|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
162945421|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
162945422|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
162945423|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
162945424|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
163042861|NCT01066871|588863977|FG003|Overall Study|Other|2|||
162699014|NCT00105586|587606935|FG000|Overall Study|Adverse Event|4|||
162699015|NCT00105586|587606936|FG001|Overall Study|Adverse Event|3|||
162699016|NCT00105586|587606935|FG000|Overall Study|Physician Decision|13|||
162699017|NCT00105586|587606936|FG001|Overall Study|Physician Decision|13|||
162699018|NCT02262260|587606939|FG000|Overall Study|Adverse Event|4|||
162699019|NCT02262260|587606940|FG001|Overall Study|Adverse Event|1|||
162699020|NCT02262260|587606939|FG000|Overall Study|Withdrawal of consent|4|||
162699021|NCT02262260|587606940|FG001|Overall Study|Withdrawal of consent|2|||
162699022|NCT02262260|587606939|FG000|Overall Study|Lost to Follow-up|1|||
162699023|NCT02262260|587606940|FG001|Overall Study|Lost to Follow-up|2|||
162699024|NCT02262260|587606939|FG000|Overall Study|Protocol deviation|2|||
162699025|NCT02262260|587606940|FG001|Overall Study|Protocol deviation|5|||
162699026|NCT01794117|587606941|FG000|Overall Study|Adverse Event|1|||
162699027|NCT01794117|587606942|FG001|Overall Study|Adverse Event|0|||
162699028|NCT01794117|587606943|FG002|Overall Study|Adverse Event|0|||
162699029|NCT01794117|587606944|FG003|Overall Study|Adverse Event|0|||
162699030|NCT01794117|587606941|FG000|Overall Study|Participant noncompliance|0|||
162699031|NCT01794117|587606942|FG001|Overall Study|Participant noncompliance|1|||
162699032|NCT01794117|587606943|FG002|Overall Study|Participant noncompliance|0|||
162699033|NCT01794117|587606944|FG003|Overall Study|Participant noncompliance|0|||
162699034|NCT01794117|587606941|FG000|Overall Study|Refused further treatment|0|||
162699035|NCT01794117|587606942|FG001|Overall Study|Refused further treatment|2|||
162699036|NCT01794117|587606943|FG002|Overall Study|Refused further treatment|0|||
162699037|NCT01794117|587606944|FG003|Overall Study|Refused further treatment|0|||
162699038|NCT03406702|587606945|FG000|Overall Study|Missed Day 27 Dosing|1|||
162699039|NCT01233609|587606948|FG000|Overall Study|Death|1|||
162699040|NCT01233609|587606949|FG001|Overall Study|Death|0|||
162699041|NCT01233609|587606948|FG000|Overall Study|Lost to Follow-up|3|||
162699042|NCT01233609|587606949|FG001|Overall Study|Lost to Follow-up|1|||
162699043|NCT01233609|587606948|FG000|Overall Study|Adverse Event|2|||
162699044|NCT01233609|587606949|FG001|Overall Study|Adverse Event|1|||
162699045|NCT01233609|587606948|FG000|Overall Study|Withdrawal by Subject|3|||
162699046|NCT01233609|587606949|FG001|Overall Study|Withdrawal by Subject|0|||
162699047|NCT00581113|587608127|FG000|Overall Study|Withdrawal by Subject|0|||
162699048|NCT00581113|587608128|FG001|Overall Study|Withdrawal by Subject|1|||
162699049|NCT04834362|587608129|FG000|Overall Study|Death|1|||
162699050|NCT04834362|587608130|FG001|Overall Study|Death|2|||
162699051|NCT00329719|587608133|FG000|Overall Study|Lost to Follow-up|0|||
162699052|NCT00329719|587608134|FG001|Overall Study|Lost to Follow-up|0|||
162699053|NCT00329719|587608135|FG002|Overall Study|Lost to Follow-up|0|||
162699054|NCT00329719|587608136|FG003|Overall Study|Lost to Follow-up|1|||
162699055|NCT01668147|587608139|FG000|Overall Study|Withdrawal by Subject|6|||
162699056|NCT00224133|587608142|FG000|Overall Study|Adverse Event|93|||
162699057|NCT00224133|587608142|FG000|Overall Study|Protocol Violation|6|||
162699058|NCT00224133|587608142|FG000|Overall Study|Withdrawal by Subject|33|||
162699059|NCT00224133|587608142|FG000|Overall Study|Lack of Efficacy|58|||
162699060|NCT00224133|587608142|FG000|Overall Study|Lost to Follow-up|21|||
162945425|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
162945426|NCT02579096|588502936|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
162945427|NCT02579096|588502937|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
162945428|NCT02097121|588502942|FG000|Overall Study|Other, not specified|4|||
162945429|NCT02097121|588502943|FG001|Overall Study|Other, not specified|2|||
162945430|NCT02097121|588502944|FG002|Overall Study|Other, not specified|3|||
162945431|NCT02097121|588502942|FG000|Overall Study|Lack of Efficacy|2|||
162699061|NCT00224133|587608142|FG000|Overall Study|Physician Decision|1|||
162699062|NCT00224133|587608142|FG000|Overall Study|Other|14|||
162945432|NCT02097121|588502943|FG001|Overall Study|Lack of Efficacy|1|||
162945433|NCT02097121|588502944|FG002|Overall Study|Lack of Efficacy|3|||
162945434|NCT02097121|588502942|FG000|Overall Study|Withdrawal by Subject|0|||
162945435|NCT02097121|588502943|FG001|Overall Study|Withdrawal by Subject|1|||
162945436|NCT02097121|588502944|FG002|Overall Study|Withdrawal by Subject|2|||
162945437|NCT02097121|588502942|FG000|Overall Study|Adverse Event|0|||
162945438|NCT02097121|588502943|FG001|Overall Study|Adverse Event|1|||
162945439|NCT02097121|588502944|FG002|Overall Study|Adverse Event|0|||
162945440|NCT02097121|588502942|FG000|Overall Study|Lost to Follow-up|1|||
162945441|NCT02097121|588502943|FG001|Overall Study|Lost to Follow-up|1|||
162945442|NCT02097121|588502944|FG002|Overall Study|Lost to Follow-up|2|||
162945443|NCT00510510|588502945|FG000|Overall Study|Adverse Event|4|||
162945444|NCT00510510|588502946|FG001|Overall Study|Adverse Event|3|||
162945445|NCT00510510|588502947|FG002|Overall Study|Adverse Event|6|||
162945446|NCT00510510|588502945|FG000|Overall Study|Lack of Efficacy|0|||
162945447|NCT00510510|588502946|FG001|Overall Study|Lack of Efficacy|1|||
162945448|NCT00510510|588502947|FG002|Overall Study|Lack of Efficacy|1|||
162945449|NCT00510510|588502945|FG000|Overall Study|Subjects no longer requires study drug|0|||
162945450|NCT00510510|588502946|FG001|Overall Study|Subjects no longer requires study drug|0|||
162945451|NCT00510510|588502947|FG002|Overall Study|Subjects no longer requires study drug|2|||
162945452|NCT00510510|588502945|FG000|Overall Study|Withdrawal by Subject|1|||
162945453|NCT00510510|588502946|FG001|Overall Study|Withdrawal by Subject|2|||
162945454|NCT00510510|588502947|FG002|Overall Study|Withdrawal by Subject|3|||
162945455|NCT00510510|588502945|FG000|Overall Study|Lost to Follow-up|0|||
162945456|NCT00510510|588502946|FG001|Overall Study|Lost to Follow-up|0|||
162945457|NCT00510510|588502947|FG002|Overall Study|Lost to Follow-up|1|||
162945458|NCT00510510|588502945|FG000|Overall Study|Protocol Violation|0|||
162945459|NCT00510510|588502946|FG001|Overall Study|Protocol Violation|3|||
162945460|NCT00510510|588502947|FG002|Overall Study|Protocol Violation|4|||
162945461|NCT03595657|588502948|FG000|Overall Study|Adverse Event|14|||
162945462|NCT03595657|588502948|FG000|Overall Study|Death|1|||
162945463|NCT03595657|588502948|FG000|Overall Study|Lack of Efficacy|40|||
162945464|NCT03595657|588502948|FG000|Overall Study|Withdrawal by Subject|10|||
162945465|NCT03595657|588502948|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
162945466|NCT03595657|588502948|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
162945467|NCT01066052|588502949|FG000|Overall Study|Enrolled But Not Treated|3|||
162945468|NCT01066052|588502950|FG001|Overall Study|Enrolled But Not Treated|0|||
162945469|NCT03184441|588502951|FG000|Overall Study|Withdrawal by Subject|1|||
162945470|NCT01200394|588502952|FG000|Overall Study|Adverse Event|0|||
162945471|NCT01200394|588502953|FG001|Overall Study|Adverse Event|14|||
162945472|NCT01200394|588502952|FG000|Overall Study|Death|1|||
162945473|NCT01200394|588502953|FG001|Overall Study|Death|0|||
162945474|NCT01200394|588502952|FG000|Overall Study|Lost to Follow-up|0|||
162945475|NCT01200394|588502953|FG001|Overall Study|Lost to Follow-up|1|||
162945476|NCT01200394|588502952|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162945477|NCT01200394|588502953|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
162945478|NCT01200394|588502952|FG000|Overall Study|Protocol Violation|0|||
162945479|NCT01200394|588502953|FG001|Overall Study|Protocol Violation|3|||
162945480|NCT01200394|588502952|FG000|Overall Study|Withdrawal by Subject|0|||
162945481|NCT01200394|588502953|FG001|Overall Study|Withdrawal by Subject|5|||
162945482|NCT01200394|588502952|FG000|Overall Study|Other|0|||
162945483|NCT01200394|588502953|FG001|Overall Study|Other|1|||
162945484|NCT01835145|588502956|FG000|Overall Study|Ineligible prior to treatment|1|||
162945485|NCT01835145|588502957|FG001|Overall Study|Ineligible prior to treatment|0|||
162699063|NCT01238575|587608144|FG000|Overall Study|Lack of Efficacy|2|||
162832036|NCT02831673|588098219|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
162832037|NCT02831673|588098220|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
162832038|NCT02831673|588098221|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
162832039|NCT02831673|588098217|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162832040|NCT02831673|588098218|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162832041|NCT02831673|588098219|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162832042|NCT02831673|588098220|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
162832043|NCT02831673|588098221|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
162832044|NCT02831673|588098217|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162832045|NCT02831673|588098218|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162832046|NCT02831673|588098219|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162832047|NCT02831673|588098220|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
162832048|NCT02831673|588098221|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
162832049|NCT00150592|588098222|FG000|Overall Study|Adverse Event|4|||
162832050|NCT00150592|588098223|FG001|Overall Study|Adverse Event|1|||
162832051|NCT00150592|588098222|FG000|Overall Study|Protocol Violation|1|||
162832052|NCT00150592|588098223|FG001|Overall Study|Protocol Violation|0|||
162832053|NCT00150592|588098222|FG000|Overall Study|Withdrawal by Subject|1|||
162832054|NCT00150592|588098223|FG001|Overall Study|Withdrawal by Subject|2|||
162832055|NCT00150592|588098222|FG000|Overall Study|Non-compliance|1|||
162832056|NCT00150592|588098223|FG001|Overall Study|Non-compliance|0|||
162832057|NCT01823679|588098224|FG000|Overall Study|Death|1|||
162832058|NCT01157078|588098225|FG000|Overall Study|Withdrawal by Subject|12|||
162832059|NCT01157078|588098226|FG001|Overall Study|Withdrawal by Subject|14|||
162832060|NCT01157078|588098225|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162832061|NCT01157078|588098226|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162832062|NCT01157078|588098225|FG000|Overall Study|Adverse Event|6|||
162832063|NCT01157078|588098226|FG001|Overall Study|Adverse Event|6|||
162832064|NCT01157078|588098225|FG000|Overall Study|Severe non-compliance to protocol|2|||
162832065|NCT01157078|588098226|FG001|Overall Study|Severe non-compliance to protocol|4|||
162832066|NCT01157078|588098225|FG000|Overall Study|Condition under investigation worsened|0|||
162832067|NCT01157078|588098226|FG001|Overall Study|Condition under investigation worsened|1|||
162832068|NCT01157078|588098225|FG000|Overall Study|Lack of Efficacy|2|||
162832069|NCT01157078|588098226|FG001|Overall Study|Lack of Efficacy|0|||
162832070|NCT01157078|588098225|FG000|Overall Study|Study-specific withdrawal criteria|2|||
162832071|NCT01157078|588098226|FG001|Overall Study|Study-specific withdrawal criteria|2|||
162832072|NCT01157078|588098225|FG000|Overall Study|Lost to Follow-up|7|||
162832073|NCT01157078|588098226|FG001|Overall Study|Lost to Follow-up|5|||
162832074|NCT01157078|588098225|FG000|Overall Study|Other|2|||
162832075|NCT01157078|588098226|FG001|Overall Study|Other|4|||
162832076|NCT02145741|588098228|FG000|Overall Study|Progressive disease|3|||
162832077|NCT02145741|588098229|FG001|Overall Study|Progressive disease|6|||
162832078|NCT02145741|588098230|FG002|Overall Study|Progressive disease|6|||
162832079|NCT02145741|588098228|FG000|Overall Study|quality issue with the administered drug|3|||
162832080|NCT02145741|588098229|FG001|Overall Study|quality issue with the administered drug|0|||
162832081|NCT02145741|588098230|FG002|Overall Study|quality issue with the administered drug|0|||
162832082|NCT01496885|588098231|FG000|Overall Study|Lost to Follow-up|13|||
162832083|NCT01496885|588098231|FG000|Overall Study|Withdrawal by Subject|7|||
162832084|NCT01496885|588098231|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
162832085|NCT01496885|588098231|FG000|Overall Study|Death|1|||
162832086|NCT01294670|588098232|FG000|Overall Study|Not treated|1|||
162832087|NCT01294670|588098233|FG001|Overall Study|Not treated|0|||
162832088|NCT01294670|588098234|FG002|Overall Study|Not treated|0|||
162832089|NCT01294670|588098235|FG003|Overall Study|Not treated|0|||
162832090|NCT01294670|588098236|FG004|Overall Study|Not treated|0|||
162832091|NCT02412787|588098237|FG000|Overall Study|Withdrawal by Subject|9|||
162832092|NCT02412787|588098237|FG000|Overall Study|Participation Terminated by Investigator|1|||
162832093|NCT02412787|588098237|FG000|Overall Study|Site Terminated by Sponsor|21|||
162832094|NCT02412787|588098237|FG000|Overall Study|Technical Problems|1|||
162832095|NCT02412787|588098237|FG000|Overall Study|Reason Not Specified|1|||
162832096|NCT03246958|588098238|FG000|Overall Study|Withdrawal by Subject|0|||
162832097|NCT03246958|588098239|FG001|Overall Study|Withdrawal by Subject|1|||
162832098|NCT03246958|588098240|FG002|Overall Study|Withdrawal by Subject|0|||
162832099|NCT03246958|588098241|FG003|Overall Study|Withdrawal by Subject|0|||
162832100|NCT03246958|588098242|FG004|Overall Study|Withdrawal by Subject|0|||
162832101|NCT03246958|588098243|FG005|Overall Study|Withdrawal by Subject|1|||
162832102|NCT03246958|588098244|FG006|Overall Study|Withdrawal by Subject|0|||
162832103|NCT03246958|588098238|FG000|Overall Study|Progression|13|||
162832104|NCT03246958|588098239|FG001|Overall Study|Progression|9|||
162832105|NCT03246958|588098240|FG002|Overall Study|Progression|3|||
162832106|NCT03246958|588098241|FG003|Overall Study|Progression|2|||
162832107|NCT03246958|588098242|FG004|Overall Study|Progression|1|||
162832108|NCT03246958|588098243|FG005|Overall Study|Progression|2|||
162945486|NCT02729896|588502958|FG000|Overall Study|Death|0|||
162945487|NCT02729896|588502959|FG001|Overall Study|Death|2|||
162945488|NCT02729896|588502960|FG002|Overall Study|Death|13|||
162945489|NCT02729896|588502958|FG000|Overall Study|Lost to Follow-up|0|||
162945490|NCT02729896|588502959|FG001|Overall Study|Lost to Follow-up|2|||
162945491|NCT02729896|588502960|FG002|Overall Study|Lost to Follow-up|3|||
162945492|NCT02729896|588502958|FG000|Overall Study|Other|0|||
162945493|NCT02729896|588502959|FG001|Overall Study|Other|2|||
162945494|NCT02729896|588502960|FG002|Overall Study|Other|0|||
162945495|NCT02729896|588502958|FG000|Overall Study|Physician Decision|1|||
162945496|NCT02729896|588502959|FG001|Overall Study|Physician Decision|2|||
162945497|NCT02729896|588502960|FG002|Overall Study|Physician Decision|3|||
162945498|NCT02729896|588502958|FG000|Overall Study|Progressive Disease|0|||
162945499|NCT02729896|588502959|FG001|Overall Study|Progressive Disease|1|||
162945500|NCT02729896|588502960|FG002|Overall Study|Progressive Disease|0|||
162945501|NCT02729896|588502958|FG000|Overall Study|Withdrawal by Subject|1|||
162945502|NCT02729896|588502959|FG001|Overall Study|Withdrawal by Subject|0|||
162945503|NCT02729896|588502960|FG002|Overall Study|Withdrawal by Subject|3|||
162945504|NCT02199509|588502961|FG000|Overall Study|Suicidal Ideation|0|||
162945505|NCT02199509|588502962|FG001|Overall Study|Suicidal Ideation|1|||
162945506|NCT02199509|588502961|FG000|Overall Study|Misunderstood titration schedule|1|||
162945507|NCT02199509|588502962|FG001|Overall Study|Misunderstood titration schedule|0|||
162945508|NCT04094870|588502963|FG000|Overall Study|Lost to Follow-up|1|||
162945509|NCT04094870|588502964|FG001|Overall Study|Lost to Follow-up|1|||
162945510|NCT02708277|588502966|FG000|Overall Study|Lost to Follow-up|7|||
162945511|NCT02708277|588502967|FG001|Overall Study|Lost to Follow-up|4|||
162945512|NCT01592370|588502970|FG000|Overall Study|Disease Progression|62|||
162945513|NCT01592370|588502971|FG001|Overall Study|Disease Progression|16|||
162945514|NCT01592370|588502972|FG002|Overall Study|Disease Progression|52|||
162945515|NCT01592370|588502973|FG003|Overall Study|Disease Progression|3|||
162945516|NCT01592370|588502974|FG004|Overall Study|Disease Progression|3|||
162945517|NCT01592370|588502975|FG005|Overall Study|Disease Progression|31|||
162945518|NCT01592370|588502976|FG006|Overall Study|Disease Progression|14|||
162945519|NCT01592370|588502970|FG000|Overall Study|Study Drug Toxicity|14|||
162945520|NCT01592370|588502971|FG001|Overall Study|Study Drug Toxicity|3|||
162945521|NCT01592370|588502972|FG002|Overall Study|Study Drug Toxicity|0|||
162945522|NCT01592370|588502973|FG003|Overall Study|Study Drug Toxicity|0|||
162945523|NCT01592370|588502974|FG004|Overall Study|Study Drug Toxicity|0|||
162945524|NCT01592370|588502975|FG005|Overall Study|Study Drug Toxicity|0|||
162945525|NCT01592370|588502976|FG006|Overall Study|Study Drug Toxicity|1|||
162945526|NCT01592370|588502970|FG000|Overall Study|AE unrelated to study drug|4|||
162945527|NCT01592370|588502971|FG001|Overall Study|AE unrelated to study drug|3|||
162945528|NCT01592370|588502972|FG002|Overall Study|AE unrelated to study drug|0|||
162945529|NCT01592370|588502973|FG003|Overall Study|AE unrelated to study drug|0|||
162945530|NCT01592370|588502974|FG004|Overall Study|AE unrelated to study drug|0|||
162945531|NCT01592370|588502975|FG005|Overall Study|AE unrelated to study drug|0|||
162945532|NCT01592370|588502976|FG006|Overall Study|AE unrelated to study drug|1|||
162945533|NCT01592370|588502970|FG000|Overall Study|Request to discontinue study treatment|5|||
162945534|NCT01592370|588502971|FG001|Overall Study|Request to discontinue study treatment|0|||
162945535|NCT01592370|588502972|FG002|Overall Study|Request to discontinue study treatment|2|||
162945536|NCT01592370|588502973|FG003|Overall Study|Request to discontinue study treatment|0|||
162945537|NCT01592370|588502974|FG004|Overall Study|Request to discontinue study treatment|1|||
162945538|NCT01592370|588502975|FG005|Overall Study|Request to discontinue study treatment|2|||
162945539|NCT01592370|588502976|FG006|Overall Study|Request to discontinue study treatment|0|||
162945540|NCT01592370|588502970|FG000|Overall Study|Withdrew consent|1|||
162945541|NCT01592370|588502971|FG001|Overall Study|Withdrew consent|2|||
162945542|NCT01592370|588502972|FG002|Overall Study|Withdrew consent|1|||
162945543|NCT01592370|588502973|FG003|Overall Study|Withdrew consent|1|||
162945544|NCT01592370|588502974|FG004|Overall Study|Withdrew consent|0|||
162945545|NCT01592370|588502975|FG005|Overall Study|Withdrew consent|0|||
162945546|NCT01592370|588502976|FG006|Overall Study|Withdrew consent|0|||
162945547|NCT01592370|588502970|FG000|Overall Study|Maximum clinical benefit|11|||
162945548|NCT01592370|588502971|FG001|Overall Study|Maximum clinical benefit|1|||
162945549|NCT01592370|588502972|FG002|Overall Study|Maximum clinical benefit|7|||
162945550|NCT01592370|588502973|FG003|Overall Study|Maximum clinical benefit|1|||
162945551|NCT01592370|588502974|FG004|Overall Study|Maximum clinical benefit|0|||
162945552|NCT01592370|588502975|FG005|Overall Study|Maximum clinical benefit|0|||
162945553|NCT01592370|588502976|FG006|Overall Study|Maximum clinical benefit|0|||
162945554|NCT01592370|588502970|FG000|Overall Study|No longer meets study criteria|1|||
162945555|NCT01592370|588502971|FG001|Overall Study|No longer meets study criteria|0|||
162945556|NCT01592370|588502972|FG002|Overall Study|No longer meets study criteria|0|||
162945557|NCT01592370|588502973|FG003|Overall Study|No longer meets study criteria|0|||
162945558|NCT01592370|588502974|FG004|Overall Study|No longer meets study criteria|0|||
162945559|NCT01592370|588502975|FG005|Overall Study|No longer meets study criteria|0|||
162945560|NCT01592370|588502976|FG006|Overall Study|No longer meets study criteria|0|||
162945561|NCT01592370|588502970|FG000|Overall Study|Other Reasons|6|||
162945562|NCT01592370|588502971|FG001|Overall Study|Other Reasons|0|||
162945563|NCT01592370|588502972|FG002|Overall Study|Other Reasons|10|||
162945564|NCT01592370|588502973|FG003|Overall Study|Other Reasons|0|||
162945565|NCT01592370|588502974|FG004|Overall Study|Other Reasons|0|||
162945566|NCT01592370|588502975|FG005|Overall Study|Other Reasons|1|||
162945567|NCT01592370|588502976|FG006|Overall Study|Other Reasons|0|||
162945568|NCT01592370|588502970|FG000|Overall Study|Not Treated|0|||
162945569|NCT01592370|588502971|FG001|Overall Study|Not Treated|0|||
162945570|NCT01592370|588502972|FG002|Overall Study|Not Treated|0|||
162945571|NCT01592370|588502973|FG003|Overall Study|Not Treated|0|||
162945572|NCT01592370|588502974|FG004|Overall Study|Not Treated|2|||
162945573|NCT01592370|588502975|FG005|Overall Study|Not Treated|2|||
162945574|NCT01592370|588502976|FG006|Overall Study|Not Treated|0|||
162945575|NCT02742181|588502977|FG000|Overall Study|Physician Decision|1|||
162945576|NCT02742181|588502978|FG001|Overall Study|Physician Decision|0|||
162945577|NCT02739984|588502979|FG000|Overall Study|Sponsor Decision|1|||
162945578|NCT02739984|588502980|FG001|Overall Study|Sponsor Decision|0|||
162945579|NCT02739984|588502979|FG000|Overall Study|Withdrawal by Subject|1|||
162945580|NCT02739984|588502980|FG001|Overall Study|Withdrawal by Subject|1|||
162945581|NCT02739984|588502979|FG000|Overall Study|Death|0|||
162945582|NCT02739984|588502980|FG001|Overall Study|Death|1|||
162945583|NCT02739984|588502979|FG000|Overall Study|Lost to Follow-up|3|||
162945584|NCT02739984|588502980|FG001|Overall Study|Lost to Follow-up|0|||
162945585|NCT01048333|588502985|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945586|NCT01048333|588502986|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
162945587|NCT01048333|588502987|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945588|NCT01048333|588502988|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945589|NCT01048333|588502989|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945590|NCT01048333|588502990|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
162945591|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945592|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945593|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945594|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
162945595|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945596|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
162945597|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945598|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945599|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
162945600|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945601|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945602|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
162945603|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
162945604|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
162945605|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
162945606|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
162945607|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
162945608|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
162945609|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
162945610|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
162945611|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
162945612|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
162945613|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
162945614|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
162945615|NCT04947579|588502992|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
162945616|NCT04947579|588502993|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945617|NCT04947579|588502994|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945618|NCT04947579|588502995|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945619|NCT04947579|588502996|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945620|NCT04947579|588502997|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
162945621|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945622|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945623|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
162945624|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945625|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945626|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
162945627|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945628|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
162945629|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945630|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945631|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
162945632|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
162945633|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945634|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945635|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
162945636|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945637|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945638|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
162945639|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
162945640|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
162945641|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
162945642|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
162945643|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
162945644|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
162945645|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
162945646|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
162945647|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
162945648|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
162945649|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
162945650|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
162945651|NCT04947579|588502992|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945652|NCT04947579|588502993|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
162945653|NCT04947579|588502994|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
162945654|NCT04947579|588502995|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945655|NCT04947579|588502996|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
162945656|NCT04947579|588502997|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
162945657|NCT00634179|588502998|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
162945658|NCT00767325|588502999|FG000|Overall Study|Lack of Efficacy|2|||
162945659|NCT00767325|588502999|FG000|Overall Study|Adverse Event|7|||
162945660|NCT00767325|588502999|FG000|Overall Study|Lost to Follow-up|3|||
162945661|NCT00767325|588502999|FG000|Overall Study|No longer met study criteria|2|||
162945662|NCT00767325|588502999|FG000|Overall Study|Missed visit due to family reasons|1|||
162945663|NCT03538756|588503000|FG000|Long-Term Follow-up|Adverse Event|0|||
162945664|NCT03538756|588503001|FG001|Long-Term Follow-up|Adverse Event|0|||
162945665|NCT03538756|588503002|FG002|Long-Term Follow-up|Adverse Event|6|||
162945666|NCT03538756|588503000|FG000|Long-Term Follow-up|Death|0|||
162945667|NCT03538756|588503001|FG001|Long-Term Follow-up|Death|0|||
162945668|NCT03538756|588503002|FG002|Long-Term Follow-up|Death|1|||
162945669|NCT03538756|588503000|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
162945670|NCT03538756|588503001|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
162945671|NCT03538756|588503002|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
162945672|NCT03538756|588503000|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
162945673|NCT03538756|588503001|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
162945674|NCT03538756|588503002|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
162945675|NCT03538756|588503000|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
162945676|NCT03538756|588503001|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
162945677|NCT03538756|588503002|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
162945678|NCT00752856|588503003|FG000|Overall Study|randomized but did not do viral kinetics|0|||
162945679|NCT00752856|588503004|FG001|Overall Study|randomized but did not do viral kinetics|1|||
162945680|NCT00996736|588503005|FG000|Overall Study|Death|1|||
162945681|NCT00996736|588503006|FG001|Overall Study|Death|1|||
162945682|NCT00996736|588503005|FG000|Overall Study|Lost to Follow-up|15|||
162945683|NCT00996736|588503006|FG001|Overall Study|Lost to Follow-up|14|||
162945684|NCT00996736|588503005|FG000|Overall Study|Visit not within 3-month window|5|||
162945685|NCT00996736|588503006|FG001|Overall Study|Visit not within 3-month window|3|||
162945686|NCT02688608|588503007|FG000|Overall Study|Lost to Follow-up|1|||
162945687|NCT02346201|588503008|FG000|Overall Study|Adverse Event|3|||
162945688|NCT02346201|588503009|FG001|Overall Study|Adverse Event|2|||
162945689|NCT02346201|588503008|FG000|Overall Study|Lost to Follow-up|1|||
162945690|NCT02346201|588503009|FG001|Overall Study|Lost to Follow-up|0|||
162945691|NCT02346201|588503008|FG000|Overall Study|Withdrawal by Subject|6|||
162945692|NCT02346201|588503009|FG001|Overall Study|Withdrawal by Subject|3|||
162945693|NCT02346201|588503008|FG000|Overall Study|Unavailable for future follow-up|0|||
162945694|NCT02346201|588503009|FG001|Overall Study|Unavailable for future follow-up|1|||
162945695|NCT02346201|588503008|FG000|Overall Study|Physician Decision|0|||
162945696|NCT02346201|588503009|FG001|Overall Study|Physician Decision|1|||
162945697|NCT02346201|588503008|FG000|Overall Study|Missed final visit|0|||
162945698|NCT02346201|588503009|FG001|Overall Study|Missed final visit|2|||
162945699|NCT02109133|588503010|FG000|Overall Study|Lost to Follow-up|1|||
162945700|NCT02109133|588503011|FG001|Overall Study|Lost to Follow-up|0|||
162945701|NCT05200858|588503012|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
162945702|NCT05200858|588503013|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
162945703|NCT05200858|588503014|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
162945704|NCT05200858|588503015|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
162945705|NCT00409578|588503018|FG000|Overall Study|Adverse Event|27|||
162945706|NCT00409578|588503019|FG001|Overall Study|Adverse Event|37|||
162945707|NCT00409578|588503020|FG002|Overall Study|Adverse Event|25|||
162945708|NCT00409578|588503021|FG003|Overall Study|Adverse Event|33|||
162945709|NCT00409578|588503018|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162945710|NCT00409578|588503019|FG001|Overall Study|Abnormal laboratory value(s)|2|||
162945711|NCT00409578|588503020|FG002|Overall Study|Abnormal laboratory value(s)|2|||
162945712|NCT00409578|588503021|FG003|Overall Study|Abnormal laboratory value(s)|4|||
162945713|NCT00409578|588503018|FG000|Overall Study|Lack of Efficacy|0|||
162945714|NCT00409578|588503019|FG001|Overall Study|Lack of Efficacy|0|||
162945715|NCT00409578|588503020|FG002|Overall Study|Lack of Efficacy|0|||
162945716|NCT00409578|588503021|FG003|Overall Study|Lack of Efficacy|2|||
162945717|NCT00409578|588503018|FG000|Overall Study|Subject no longer requires study drug|0|||
162945718|NCT00409578|588503019|FG001|Overall Study|Subject no longer requires study drug|0|||
162945719|NCT00409578|588503020|FG002|Overall Study|Subject no longer requires study drug|0|||
162945720|NCT00409578|588503021|FG003|Overall Study|Subject no longer requires study drug|1|||
162945721|NCT00409578|588503018|FG000|Overall Study|Withdrawal by Subject|8|||
162945722|NCT00409578|588503019|FG001|Overall Study|Withdrawal by Subject|15|||
162945723|NCT00409578|588503020|FG002|Overall Study|Withdrawal by Subject|16|||
162945724|NCT00409578|588503021|FG003|Overall Study|Withdrawal by Subject|17|||
162945725|NCT00409578|588503018|FG000|Overall Study|Lost to Follow-up|2|||
162945726|NCT00409578|588503019|FG001|Overall Study|Lost to Follow-up|0|||
162945727|NCT00409578|588503020|FG002|Overall Study|Lost to Follow-up|2|||
162945728|NCT00409578|588503021|FG003|Overall Study|Lost to Follow-up|2|||
162945729|NCT00409578|588503018|FG000|Overall Study|Administrative problems|8|||
162945730|NCT00409578|588503019|FG001|Overall Study|Administrative problems|9|||
162945731|NCT00409578|588503020|FG002|Overall Study|Administrative problems|2|||
162945732|NCT00409578|588503021|FG003|Overall Study|Administrative problems|4|||
162945733|NCT00409578|588503018|FG000|Overall Study|Death|2|||
162945734|NCT00409578|588503019|FG001|Overall Study|Death|4|||
162945735|NCT00409578|588503020|FG002|Overall Study|Death|4|||
162945736|NCT00409578|588503021|FG003|Overall Study|Death|2|||
162945737|NCT00409578|588503018|FG000|Overall Study|Protocol Violation|3|||
162945738|NCT00409578|588503019|FG001|Overall Study|Protocol Violation|2|||
162945739|NCT00409578|588503020|FG002|Overall Study|Protocol Violation|3|||
162945740|NCT00409578|588503021|FG003|Overall Study|Protocol Violation|1|||
162945741|NCT00409578|588503018|FG000|Overall Study|Missing|0|||
162945742|NCT00409578|588503019|FG001|Overall Study|Missing|1|||
162945743|NCT00409578|588503020|FG002|Overall Study|Missing|0|||
162945744|NCT00409578|588503021|FG003|Overall Study|Missing|1|||
162945745|NCT02448771|588503022|FG000|Overall Study|Disease Progression|30|||
162945746|NCT02448771|588503022|FG000|Overall Study|Unacceptable Toxicity|1|||
162945747|NCT02448771|588503022|FG000|Overall Study|Physician Decision|3|||
162945748|NCT02448771|588503022|FG000|Overall Study|Started new therapy|2|||
162945749|NCT00770315|588503024|FG000|Overall Study|Adverse Event|11|||
162945750|NCT00770315|588503025|FG001|Overall Study|Adverse Event|17|||
162945751|NCT00770315|588503026|FG002|Overall Study|Adverse Event|16|||
162945752|NCT00770315|588503027|FG003|Overall Study|Adverse Event|6|||
162945753|NCT00770315|588503024|FG000|Overall Study|Lost to Follow-up|9|||
162945754|NCT00770315|588503025|FG001|Overall Study|Lost to Follow-up|5|||
162945755|NCT00770315|588503026|FG002|Overall Study|Lost to Follow-up|10|||
162945756|NCT00770315|588503027|FG003|Overall Study|Lost to Follow-up|3|||
162945757|NCT00770315|588503024|FG000|Overall Study|Withdrawal by Subject|13|||
162945758|NCT00770315|588503025|FG001|Overall Study|Withdrawal by Subject|17|||
162945759|NCT00770315|588503026|FG002|Overall Study|Withdrawal by Subject|24|||
162945760|NCT00770315|588503027|FG003|Overall Study|Withdrawal by Subject|20|||
162945761|NCT00770315|588503024|FG000|Overall Study|Noncompliance with Protocol|7|||
162945762|NCT00770315|588503025|FG001|Overall Study|Noncompliance with Protocol|4|||
162945763|NCT00770315|588503026|FG002|Overall Study|Noncompliance with Protocol|7|||
162945764|NCT00770315|588503027|FG003|Overall Study|Noncompliance with Protocol|9|||
162945765|NCT02999178|588504549|FG000|Overall Study|Adverse Event|85|||
162945766|NCT02999178|588504550|FG001|Overall Study|Adverse Event|62|||
162945767|NCT02999178|588504549|FG000|Overall Study|Protocol Violation|1|||
162945768|NCT02999178|588504550|FG001|Overall Study|Protocol Violation|2|||
162945769|NCT02999178|588504549|FG000|Overall Study|Lost to Follow-up|0|||
162945770|NCT02999178|588504550|FG001|Overall Study|Lost to Follow-up|2|||
162945771|NCT02999178|588504549|FG000|Overall Study|Withdrawal by Subject|21|||
162945772|NCT02999178|588504550|FG001|Overall Study|Withdrawal by Subject|21|||
162945773|NCT02999178|588504549|FG000|Overall Study|Other reason not defined above|7|||
162945774|NCT02999178|588504550|FG001|Overall Study|Other reason not defined above|13|||
162945775|NCT01244126|588504552|FG000|Overall Study|Protocol Violation|3|||
162945776|NCT01244126|588504553|FG001|Overall Study|Protocol Violation|3|||
162945777|NCT01244126|588504554|FG002|Overall Study|Protocol Violation|9|||
162945778|NCT00630305|588504555|FG000|Overall Study|Withdrawal by Subject|1|||
162945779|NCT00630305|588504555|FG000|Overall Study|Inability to insert contact lens|1|||
162945780|NCT01085045|588504556|FG000|Part A|Withdrawal by Subject|4|||
162945781|NCT01085045|588504556|FG000|Part A|Adverse Event|6|||
162945782|NCT01085045|588504556|FG000|Part A|Protocol Violation|1|||
162945783|NCT01085045|588504556|FG000|Part A|Protocol Specified Criteria|7|||
162945784|NCT01085045|588504556|FG000|Part B|Withdrawal by Subject|2|||
162945785|NCT01085045|588504556|FG000|Part B|Protocol Specified Criteria|6|||
162945786|NCT01085045|588504556|FG000|Part B|Lost to Follow-up|1|||
162945787|NCT01085045|588504556|FG000|Part B|Adverse Event|6|||
162945788|NCT00863746|588504557|FG000|Treatment|Not treated|4|||
162945789|NCT00863746|588504558|FG001|Treatment|Not treated|2|||
162945790|NCT00863746|588504557|FG000|Treatment|Adverse Event|41|||
162945791|NCT00863746|588504558|FG001|Treatment|Adverse Event|16|||
162945792|NCT00863746|588504557|FG000|Treatment|non-compliant with study medication|4|||
162945793|NCT00863746|588504558|FG001|Treatment|non-compliant with study medication|0|||
162945794|NCT00863746|588504557|FG000|Treatment|Consent withdrawn|15|||
162945795|NCT00863746|588504558|FG001|Treatment|Consent withdrawn|14|||
162945796|NCT00863746|588504557|FG000|Treatment|Lost to Follow-up|1|||
162945797|NCT00863746|588504558|FG001|Treatment|Lost to Follow-up|0|||
162945798|NCT00863746|588504557|FG000|Treatment|Protocol Violation|5|||
162945799|NCT00863746|588504558|FG001|Treatment|Protocol Violation|3|||
162945800|NCT00863746|588504557|FG000|Treatment|Other|1|||
162699064|NCT01238575|587608145|FG001|Overall Study|Lack of Efficacy|4|||
162945801|NCT00863746|588504558|FG001|Treatment|Other|0|||
162945802|NCT00863746|588504557|FG000|Survival Follow up|Death|244|||
162945803|NCT00863746|588504558|FG001|Survival Follow up|Death|271|||
162945804|NCT00863746|588504557|FG000|Survival Follow up|Lost to Follow-up|2|||
162945805|NCT00863746|588504558|FG001|Survival Follow up|Lost to Follow-up|1|||
162945806|NCT00863746|588504557|FG000|Survival Follow up|Consent Withdrawn|7|||
162945807|NCT00863746|588504558|FG001|Survival Follow up|Consent Withdrawn|8|||
162945808|NCT02924038|588504559|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
162945809|NCT02924038|588504560|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
162945810|NCT02395822|588504561|FG000|Overall Study|Withdrawal by Subject|1|||
162945811|NCT02395822|588504561|FG000|Overall Study|Death|1|||
162699065|NCT01238575|587608144|FG000|Overall Study|Adverse Event|2|||
162945812|NCT03311646|588504568|FG000|Overall Study|Physician Decision|1|||
162945813|NCT03311646|588504568|FG000|Overall Study|Withdrawal by Subject|5|||
162945814|NCT03311646|588504568|FG000|Overall Study|Lost to Follow-up|5|||
162945815|NCT03311646|588504568|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
162945816|NCT00531206|588504571|FG000|Overall Study|Adverse Event related|5|||
162945817|NCT00531206|588504571|FG000|Overall Study|Lack of Efficacy|2|||
162945818|NCT00531206|588504571|FG000|Overall Study|Lost to Follow-up|5|||
162945819|NCT00531206|588504571|FG000|Overall Study|including non-related adverse events|8|||
162945820|NCT01439165|588504582|FG000|Overall Study|Protocol Violation|3|||
162945821|NCT01439165|588504583|FG001|Overall Study|Protocol Violation|0|||
162945822|NCT01439165|588504582|FG000|Overall Study|Lost to Follow-up|11|||
162945823|NCT01439165|588504583|FG001|Overall Study|Lost to Follow-up|1|||
162945824|NCT01439165|588504582|FG000|Overall Study|Withdrawal by Subject|7|||
162945825|NCT01439165|588504583|FG001|Overall Study|Withdrawal by Subject|1|||
162945826|NCT03331042|588504584|FG000|Overall Study|Protocol Violation|1|||
162945827|NCT03331042|588504585|FG001|Overall Study|Protocol Violation|0|||
162945828|NCT03331042|588504586|FG002|Overall Study|Protocol Violation|0|||
162945829|NCT03331042|588504587|FG003|Overall Study|Protocol Violation|0|||
162945830|NCT03331042|588504584|FG000|Overall Study|Physician Decision|0|||
162945831|NCT03331042|588504585|FG001|Overall Study|Physician Decision|0|||
162945832|NCT03331042|588504586|FG002|Overall Study|Physician Decision|1|||
162945833|NCT03331042|588504587|FG003|Overall Study|Physician Decision|0|||
162945834|NCT03331042|588504584|FG000|Overall Study|Lost to Follow-up|0|||
162945835|NCT03331042|588504585|FG001|Overall Study|Lost to Follow-up|0|||
162945836|NCT03331042|588504586|FG002|Overall Study|Lost to Follow-up|0|||
162945837|NCT03331042|588504587|FG003|Overall Study|Lost to Follow-up|1|||
162945838|NCT03499964|588504590|FG000|Overall Study|Lack of Efficacy|6|||
162945839|NCT03499964|588504591|FG001|Overall Study|Lack of Efficacy|26|||
162945840|NCT03499964|588504590|FG000|Overall Study|Adverse Event|1|||
162945841|NCT03499964|588504591|FG001|Overall Study|Adverse Event|0|||
162945842|NCT03499964|588504590|FG000|Overall Study|Death|1|||
162945843|NCT03499964|588504591|FG001|Overall Study|Death|0|||
162945844|NCT03499964|588504590|FG000|Overall Study|Withdrawal by Subject|2|||
162945845|NCT03499964|588504591|FG001|Overall Study|Withdrawal by Subject|1|||
162945846|NCT03499964|588504590|FG000|Overall Study|Lost to Follow-up|1|||
162945847|NCT03499964|588504591|FG001|Overall Study|Lost to Follow-up|0|||
162945848|NCT01047345|588504592|FG000|Base Study|Adverse Event|3|||
162945849|NCT01047345|588504593|FG001|Base Study|Adverse Event|0|||
162945850|NCT01047345|588504594|FG002|Base Study|Adverse Event|0|||
162945851|NCT01047345|588504592|FG000|Base Study|Lost to Follow-up|4|||
162945852|NCT01047345|588504593|FG001|Base Study|Lost to Follow-up|1|||
162945853|NCT01047345|588504594|FG002|Base Study|Lost to Follow-up|0|||
162945854|NCT01047345|588504592|FG000|Base Study|Protocol Violation|3|||
162945855|NCT01047345|588504593|FG001|Base Study|Protocol Violation|1|||
162945856|NCT01047345|588504594|FG002|Base Study|Protocol Violation|0|||
162945857|NCT01047345|588504592|FG000|Base Study|Withdrawal by Subject|12|||
162945858|NCT01047345|588504593|FG001|Base Study|Withdrawal by Subject|4|||
162945859|NCT01047345|588504594|FG002|Base Study|Withdrawal by Subject|0|||
162945860|NCT01047345|588504592|FG000|Extension|Withdrawal by Subject|0|||
162945861|NCT01047345|588504593|FG001|Extension|Withdrawal by Subject|0|||
162945862|NCT01047345|588504594|FG002|Extension|Withdrawal by Subject|1|||
162945863|NCT01047345|588504592|FG000|Extension|Lost to Follow-up|0|||
162945864|NCT01047345|588504593|FG001|Extension|Lost to Follow-up|0|||
162945865|NCT01047345|588504594|FG002|Extension|Lost to Follow-up|5|||
162945866|NCT00712010|588504595|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
162945867|NCT00995553|588504596|FG000|Overall Study|Withdrawal by Subject|2|||
162945868|NCT00995553|588504597|FG001|Overall Study|Withdrawal by Subject|6|||
162945869|NCT00927810|588504598|FG000|Overall Study|Withdrawal by Subject|0|||
162945870|NCT00927810|588504599|FG001|Overall Study|Withdrawal by Subject|3|||
162945871|NCT00927810|588504600|FG002|Overall Study|Withdrawal by Subject|0|||
162945872|NCT00927810|588504601|FG003|Overall Study|Withdrawal by Subject|1|||
162945873|NCT00927810|588504598|FG000|Overall Study|Lost to Follow-up|0|||
162945874|NCT00927810|588504599|FG001|Overall Study|Lost to Follow-up|2|||
162945875|NCT00927810|588504600|FG002|Overall Study|Lost to Follow-up|1|||
162945876|NCT00927810|588504601|FG003|Overall Study|Lost to Follow-up|1|||
162832109|NCT03246958|588098244|FG006|Overall Study|Progression|1|||
162832110|NCT03246958|588098238|FG000|Overall Study|Adverse Event|2|||
162832111|NCT03246958|588098239|FG001|Overall Study|Adverse Event|2|||
162832112|NCT03246958|588098240|FG002|Overall Study|Adverse Event|0|||
162832113|NCT03246958|588098241|FG003|Overall Study|Adverse Event|1|||
162832114|NCT03246958|588098242|FG004|Overall Study|Adverse Event|1|||
162832115|NCT03246958|588098243|FG005|Overall Study|Adverse Event|0|||
162832116|NCT03246958|588098244|FG006|Overall Study|Adverse Event|2|||
162832117|NCT03246958|588098238|FG000|Overall Study|Death|0|||
162832118|NCT03246958|588098239|FG001|Overall Study|Death|1|||
162832119|NCT03246958|588098240|FG002|Overall Study|Death|0|||
162832120|NCT03246958|588098241|FG003|Overall Study|Death|0|||
162945877|NCT00927810|588504598|FG000|Overall Study|Death|0|||
162945878|NCT00927810|588504599|FG001|Overall Study|Death|2|||
162945879|NCT00927810|588504600|FG002|Overall Study|Death|0|||
162945880|NCT00927810|588504601|FG003|Overall Study|Death|0|||
162832121|NCT03246958|588098242|FG004|Overall Study|Death|0|||
162945881|NCT00927810|588504598|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162945882|NCT00927810|588504599|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162945883|NCT00927810|588504600|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162945884|NCT00927810|588504601|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162945885|NCT00950807|588504602|FG000|Treatment Period 1|Lack of Efficacy|1|||
162945886|NCT00950807|588504603|FG001|Treatment Period 1|Lack of Efficacy|0|||
162945887|NCT00950807|588504604|FG002|Treatment Period 1|Lack of Efficacy|0|||
162945888|NCT00950807|588504605|FG003|Treatment Period 1|Lack of Efficacy|0|||
162945889|NCT00950807|588504606|FG004|Treatment Period 1|Lack of Efficacy|0|||
162945890|NCT00950807|588504607|FG005|Treatment Period 1|Lack of Efficacy|1|||
162945891|NCT00950807|588504608|FG006|Treatment Period 1|Lack of Efficacy|0|||
162945892|NCT00950807|588504609|FG007|Treatment Period 1|Lack of Efficacy|0|||
162945893|NCT00950807|588504610|FG008|Treatment Period 1|Lack of Efficacy|0|||
162945894|NCT00950807|588504611|FG009|Treatment Period 1|Lack of Efficacy|0|||
162945895|NCT00950807|588504602|FG000|Treatment Period 1|Protocol Violation|1|||
162945896|NCT00950807|588504603|FG001|Treatment Period 1|Protocol Violation|0|||
162945897|NCT00950807|588504604|FG002|Treatment Period 1|Protocol Violation|0|||
162945898|NCT00950807|588504605|FG003|Treatment Period 1|Protocol Violation|0|||
162945899|NCT00950807|588504606|FG004|Treatment Period 1|Protocol Violation|0|||
162945900|NCT00950807|588504607|FG005|Treatment Period 1|Protocol Violation|0|||
162945901|NCT00950807|588504608|FG006|Treatment Period 1|Protocol Violation|0|||
162945902|NCT00950807|588504609|FG007|Treatment Period 1|Protocol Violation|0|||
162945903|NCT00950807|588504610|FG008|Treatment Period 1|Protocol Violation|0|||
162945904|NCT00950807|588504611|FG009|Treatment Period 1|Protocol Violation|0|||
162945905|NCT00950807|588504602|FG000|Treatment Period 1|Lost to Follow-up|0|||
162945906|NCT00950807|588504603|FG001|Treatment Period 1|Lost to Follow-up|0|||
162945907|NCT00950807|588504604|FG002|Treatment Period 1|Lost to Follow-up|1|||
162945908|NCT00950807|588504605|FG003|Treatment Period 1|Lost to Follow-up|0|||
162945909|NCT00950807|588504606|FG004|Treatment Period 1|Lost to Follow-up|0|||
162945910|NCT00950807|588504607|FG005|Treatment Period 1|Lost to Follow-up|0|||
162945911|NCT00950807|588504608|FG006|Treatment Period 1|Lost to Follow-up|0|||
162945912|NCT00950807|588504609|FG007|Treatment Period 1|Lost to Follow-up|0|||
162945913|NCT00950807|588504610|FG008|Treatment Period 1|Lost to Follow-up|0|||
162945914|NCT00950807|588504611|FG009|Treatment Period 1|Lost to Follow-up|0|||
162945915|NCT00950807|588504602|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162945916|NCT00950807|588504603|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162945917|NCT00950807|588504604|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162945918|NCT00950807|588504605|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162945919|NCT00950807|588504606|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162945920|NCT00950807|588504607|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162945921|NCT00950807|588504608|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162945922|NCT00950807|588504609|FG007|Treatment Period 1|Withdrawal by Subject|0|||
162945923|NCT00950807|588504610|FG008|Treatment Period 1|Withdrawal by Subject|1|||
162945924|NCT00950807|588504611|FG009|Treatment Period 1|Withdrawal by Subject|0|||
162945925|NCT00950807|588504602|FG000|Treatment Period 1|Adverse Event|0|||
162945926|NCT00950807|588504603|FG001|Treatment Period 1|Adverse Event|0|||
162945927|NCT00950807|588504604|FG002|Treatment Period 1|Adverse Event|0|||
162945928|NCT00950807|588504605|FG003|Treatment Period 1|Adverse Event|0|||
162945929|NCT00950807|588504606|FG004|Treatment Period 1|Adverse Event|0|||
162945930|NCT00950807|588504607|FG005|Treatment Period 1|Adverse Event|1|||
162945931|NCT00950807|588504608|FG006|Treatment Period 1|Adverse Event|0|||
162945932|NCT00950807|588504609|FG007|Treatment Period 1|Adverse Event|0|||
162945933|NCT00950807|588504610|FG008|Treatment Period 1|Adverse Event|0|||
162945934|NCT00950807|588504611|FG009|Treatment Period 1|Adverse Event|0|||
162945935|NCT00950807|588504602|FG000|Washout Period 1|Lack of Efficacy|0|||
162945936|NCT00950807|588504603|FG001|Washout Period 1|Lack of Efficacy|0|||
162945937|NCT00950807|588504604|FG002|Washout Period 1|Lack of Efficacy|0|||
162945938|NCT00950807|588504605|FG003|Washout Period 1|Lack of Efficacy|0|||
162945939|NCT00950807|588504606|FG004|Washout Period 1|Lack of Efficacy|0|||
162945940|NCT00950807|588504607|FG005|Washout Period 1|Lack of Efficacy|0|||
162945941|NCT00950807|588504608|FG006|Washout Period 1|Lack of Efficacy|1|||
162945942|NCT00950807|588504609|FG007|Washout Period 1|Lack of Efficacy|0|||
162945943|NCT00950807|588504610|FG008|Washout Period 1|Lack of Efficacy|0|||
162945944|NCT00950807|588504611|FG009|Washout Period 1|Lack of Efficacy|0|||
162945945|NCT00950807|588504602|FG000|Washout Period 1|Withdrawal by Subject|0|||
162945946|NCT00950807|588504603|FG001|Washout Period 1|Withdrawal by Subject|0|||
162945947|NCT00950807|588504604|FG002|Washout Period 1|Withdrawal by Subject|0|||
162945948|NCT00950807|588504605|FG003|Washout Period 1|Withdrawal by Subject|0|||
162945949|NCT00950807|588504606|FG004|Washout Period 1|Withdrawal by Subject|0|||
162945950|NCT00950807|588504607|FG005|Washout Period 1|Withdrawal by Subject|0|||
162945951|NCT00950807|588504608|FG006|Washout Period 1|Withdrawal by Subject|0|||
162945952|NCT00950807|588504609|FG007|Washout Period 1|Withdrawal by Subject|0|||
162945953|NCT00950807|588504610|FG008|Washout Period 1|Withdrawal by Subject|1|||
162945954|NCT00950807|588504611|FG009|Washout Period 1|Withdrawal by Subject|0|||
162945955|NCT00950807|588504602|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
162945956|NCT00950807|588504603|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945957|NCT00950807|588504604|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945958|NCT00950807|588504605|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945959|NCT00950807|588504606|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945960|NCT00950807|588504607|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945961|NCT00950807|588504608|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
162945962|NCT00950807|588504609|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
162945963|NCT00950807|588504610|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945964|NCT00950807|588504611|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
162945965|NCT00950807|588504602|FG000|Washout Period 1|Adverse Event|2|||
162945966|NCT00950807|588504603|FG001|Washout Period 1|Adverse Event|0|||
162945967|NCT00950807|588504604|FG002|Washout Period 1|Adverse Event|0|||
162945968|NCT00950807|588504605|FG003|Washout Period 1|Adverse Event|1|||
162945969|NCT00950807|588504606|FG004|Washout Period 1|Adverse Event|1|||
162945970|NCT00950807|588504607|FG005|Washout Period 1|Adverse Event|0|||
162945971|NCT00950807|588504608|FG006|Washout Period 1|Adverse Event|0|||
162945972|NCT00950807|588504609|FG007|Washout Period 1|Adverse Event|0|||
162945973|NCT00950807|588504610|FG008|Washout Period 1|Adverse Event|0|||
162945974|NCT00950807|588504611|FG009|Washout Period 1|Adverse Event|0|||
162945975|NCT00950807|588504602|FG000|Treatment Period 2|Lack of Efficacy|1|||
162945976|NCT00950807|588504603|FG001|Treatment Period 2|Lack of Efficacy|0|||
162945977|NCT00950807|588504604|FG002|Treatment Period 2|Lack of Efficacy|0|||
162945978|NCT00950807|588504605|FG003|Treatment Period 2|Lack of Efficacy|0|||
162945979|NCT00950807|588504606|FG004|Treatment Period 2|Lack of Efficacy|0|||
162945980|NCT00950807|588504607|FG005|Treatment Period 2|Lack of Efficacy|0|||
162945981|NCT00950807|588504608|FG006|Treatment Period 2|Lack of Efficacy|0|||
162945982|NCT00950807|588504609|FG007|Treatment Period 2|Lack of Efficacy|0|||
162945983|NCT00950807|588504610|FG008|Treatment Period 2|Lack of Efficacy|0|||
162945984|NCT00950807|588504611|FG009|Treatment Period 2|Lack of Efficacy|0|||
162945985|NCT00950807|588504602|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162945986|NCT00950807|588504603|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162945987|NCT00950807|588504604|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162945988|NCT00950807|588504605|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162945989|NCT00950807|588504606|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162945990|NCT00950807|588504607|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162945991|NCT00950807|588504608|FG006|Treatment Period 2|Withdrawal by Subject|1|||
162945992|NCT00950807|588504609|FG007|Treatment Period 2|Withdrawal by Subject|2|||
162945993|NCT00950807|588504610|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162945994|NCT00950807|588504611|FG009|Treatment Period 2|Withdrawal by Subject|0|||
162945995|NCT00950807|588504602|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
162945996|NCT00950807|588504603|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945997|NCT00950807|588504604|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945998|NCT00950807|588504605|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162945999|NCT00950807|588504606|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946000|NCT00950807|588504607|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946001|NCT00950807|588504608|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946002|NCT00950807|588504609|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946003|NCT00950807|588504610|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946004|NCT00950807|588504611|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162946005|NCT00950807|588504602|FG000|Treatment Period 2|Adverse Event|0|||
162946006|NCT00950807|588504603|FG001|Treatment Period 2|Adverse Event|1|||
162946007|NCT00950807|588504604|FG002|Treatment Period 2|Adverse Event|0|||
162946008|NCT00950807|588504605|FG003|Treatment Period 2|Adverse Event|1|||
162946009|NCT00950807|588504606|FG004|Treatment Period 2|Adverse Event|0|||
162946010|NCT00950807|588504607|FG005|Treatment Period 2|Adverse Event|1|||
162946011|NCT00950807|588504608|FG006|Treatment Period 2|Adverse Event|0|||
162946012|NCT00950807|588504609|FG007|Treatment Period 2|Adverse Event|1|||
162946013|NCT00950807|588504610|FG008|Treatment Period 2|Adverse Event|0|||
162946014|NCT00950807|588504611|FG009|Treatment Period 2|Adverse Event|0|||
162946015|NCT00950807|588504602|FG000|Washout Period 2|Lack of Efficacy|1|||
162946016|NCT00950807|588504603|FG001|Washout Period 2|Lack of Efficacy|0|||
162946017|NCT00950807|588504604|FG002|Washout Period 2|Lack of Efficacy|0|||
162946018|NCT00950807|588504605|FG003|Washout Period 2|Lack of Efficacy|0|||
162946019|NCT00950807|588504606|FG004|Washout Period 2|Lack of Efficacy|0|||
162946020|NCT00950807|588504607|FG005|Washout Period 2|Lack of Efficacy|0|||
162946021|NCT00950807|588504608|FG006|Washout Period 2|Lack of Efficacy|0|||
162946022|NCT00950807|588504609|FG007|Washout Period 2|Lack of Efficacy|0|||
162946023|NCT00950807|588504610|FG008|Washout Period 2|Lack of Efficacy|0|||
162946024|NCT00950807|588504611|FG009|Washout Period 2|Lack of Efficacy|0|||
162946025|NCT00950807|588504602|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946026|NCT00950807|588504603|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946027|NCT00950807|588504604|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946028|NCT00950807|588504605|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946029|NCT00950807|588504606|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946030|NCT00950807|588504607|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946031|NCT00950807|588504608|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946032|NCT00950807|588504609|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
162946033|NCT00950807|588504610|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946034|NCT00950807|588504611|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
162946035|NCT00950807|588504602|FG000|Washout Period 2|Adverse Event|3|||
162946036|NCT00950807|588504603|FG001|Washout Period 2|Adverse Event|0|||
162946037|NCT00950807|588504604|FG002|Washout Period 2|Adverse Event|0|||
162946038|NCT00950807|588504605|FG003|Washout Period 2|Adverse Event|1|||
162946039|NCT00950807|588504606|FG004|Washout Period 2|Adverse Event|0|||
162946040|NCT00950807|588504607|FG005|Washout Period 2|Adverse Event|0|||
162946041|NCT00950807|588504608|FG006|Washout Period 2|Adverse Event|0|||
162946042|NCT00950807|588504609|FG007|Washout Period 2|Adverse Event|0|||
162946043|NCT00950807|588504610|FG008|Washout Period 2|Adverse Event|0|||
162946044|NCT00950807|588504611|FG009|Washout Period 2|Adverse Event|0|||
162946045|NCT00950807|588504602|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162946046|NCT00950807|588504603|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162946047|NCT00950807|588504604|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162946048|NCT00950807|588504605|FG003|Treatment Period 3|Withdrawal by Subject|0|||
162946049|NCT00950807|588504606|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162946050|NCT00950807|588504607|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162946051|NCT00950807|588504608|FG006|Treatment Period 3|Withdrawal by Subject|0|||
162946052|NCT00950807|588504609|FG007|Treatment Period 3|Withdrawal by Subject|0|||
162946053|NCT00950807|588504610|FG008|Treatment Period 3|Withdrawal by Subject|0|||
162946054|NCT00950807|588504611|FG009|Treatment Period 3|Withdrawal by Subject|1|||
162946055|NCT00950807|588504602|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162946056|NCT00950807|588504603|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946057|NCT00950807|588504604|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946058|NCT00950807|588504605|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946059|NCT00950807|588504606|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946060|NCT00950807|588504607|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946061|NCT00950807|588504608|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946062|NCT00950807|588504609|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162946063|NCT00950807|588504610|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946064|NCT00950807|588504611|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162946065|NCT00950807|588504602|FG000|Treatment Period 3|Adverse Event|0|||
162946066|NCT00950807|588504603|FG001|Treatment Period 3|Adverse Event|0|||
162946067|NCT00950807|588504604|FG002|Treatment Period 3|Adverse Event|0|||
162946068|NCT00950807|588504605|FG003|Treatment Period 3|Adverse Event|0|||
162946069|NCT00950807|588504606|FG004|Treatment Period 3|Adverse Event|0|||
162946070|NCT00950807|588504607|FG005|Treatment Period 3|Adverse Event|0|||
162946071|NCT00950807|588504608|FG006|Treatment Period 3|Adverse Event|1|||
162946072|NCT00950807|588504609|FG007|Treatment Period 3|Adverse Event|0|||
162946073|NCT00950807|588504610|FG008|Treatment Period 3|Adverse Event|0|||
162946074|NCT00950807|588504611|FG009|Treatment Period 3|Adverse Event|0|||
162946075|NCT01492400|588504615|FG000|Overall Study|Miscellaneous Reasons|2|||
162946076|NCT01492400|588504616|FG001|Overall Study|Miscellaneous Reasons|3|||
162946077|NCT01492400|588504615|FG000|Overall Study|Personal Reasons|0|||
162946078|NCT01492400|588504616|FG001|Overall Study|Personal Reasons|5|||
162946079|NCT01492400|588504615|FG000|Overall Study|Lost to Follow-up|3|||
162946080|NCT01492400|588504616|FG001|Overall Study|Lost to Follow-up|1|||
162946081|NCT01492400|588504615|FG000|Overall Study|Pregnancy|0|||
162946082|NCT01492400|588504616|FG001|Overall Study|Pregnancy|1|||
162946083|NCT01492400|588504615|FG000|Overall Study|Lack of Efficacy|1|||
162946084|NCT01492400|588504616|FG001|Overall Study|Lack of Efficacy|1|||
162946085|NCT01492400|588504615|FG000|Overall Study|Adverse Event|10|||
162946086|NCT01492400|588504616|FG001|Overall Study|Adverse Event|5|||
162946087|NCT00659607|588504617|FG000|Overall Study|No blood pressure recorded|147|||
162946088|NCT00659607|588504617|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
162946089|NCT00659607|588504617|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
162946090|NCT00659607|588504617|FG000|Overall Study|No recorded efficacy data|15|||
162946091|NCT00659607|588504617|FG000|Overall Study|Inconsistent BP measuring date|2|||
162946092|NCT02153736|588504628|FG000|Overall Study|Lost to Follow-up|1|||
162946093|NCT02153736|588504629|FG001|Overall Study|Lost to Follow-up|0|||
162946094|NCT02153736|588504628|FG000|Overall Study|Medical status change made ineligible|1|||
162946095|NCT02153736|588504629|FG001|Overall Study|Medical status change made ineligible|0|||
162946096|NCT02153736|588504628|FG000|Overall Study|Death|0|||
162946097|NCT02153736|588504629|FG001|Overall Study|Death|1|||
162946098|NCT02153736|588504628|FG000|Overall Study|Withdrawal by Subject|0|||
162946099|NCT02153736|588504629|FG001|Overall Study|Withdrawal by Subject|1|||
162946100|NCT02568384|588504630|FG000|Overall Study|Mobile devices incompatible with App|2|||
162946101|NCT01734772|588504631|FG000|Overall Study|Adverse Event|1|||
162946102|NCT01734772|588504632|FG001|Overall Study|Adverse Event|2|||
162946103|NCT01734772|588504631|FG000|Overall Study|Withdrawal by Subject|0|||
162946104|NCT01734772|588504632|FG001|Overall Study|Withdrawal by Subject|1|||
162946105|NCT00720122|588504635|FG000|Overall Study|Lost to Follow-up|1|||
162946106|NCT00720122|588504635|FG000|Overall Study|Physician Decision|1|||
162946107|NCT00720122|588504635|FG000|Overall Study|Withdrawal by Subject|7|||
162946108|NCT03066999|588504636|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
162946109|NCT03066999|588504637|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
162946110|NCT00661999|588504638|FG000|Overall Study|Adverse Event|11|||
162946111|NCT00661999|588504639|FG001|Overall Study|Adverse Event|5|||
162946112|NCT00661999|588504640|FG002|Overall Study|Adverse Event|8|||
162946113|NCT00661999|588504638|FG000|Overall Study|Death|8|||
162946114|NCT00661999|588504639|FG001|Overall Study|Death|6|||
162946115|NCT00661999|588504640|FG002|Overall Study|Death|3|||
162946116|NCT00661999|588504638|FG000|Overall Study|Other Reasons|5|||
162946117|NCT00661999|588504639|FG001|Overall Study|Other Reasons|12|||
162946118|NCT00661999|588504640|FG002|Overall Study|Other Reasons|23|||
162946119|NCT00661999|588504638|FG000|Overall Study|Withdrawal by Subject|30|||
162946120|NCT00661999|588504639|FG001|Overall Study|Withdrawal by Subject|23|||
162946121|NCT00661999|588504640|FG002|Overall Study|Withdrawal by Subject|14|||
162946122|NCT00661999|588504638|FG000|Overall Study|Alternative Treatment|1|||
162946123|NCT00661999|588504639|FG001|Overall Study|Alternative Treatment|0|||
162946124|NCT00661999|588504640|FG002|Overall Study|Alternative Treatment|0|||
162946125|NCT00661999|588504638|FG000|Overall Study|Other Medical Problems|4|||
162946126|NCT00661999|588504639|FG001|Overall Study|Other Medical Problems|4|||
162946127|NCT00661999|588504640|FG002|Overall Study|Other Medical Problems|9|||
162946128|NCT01139164|588504643|FG000|Overall Study|Withdrawn prior to study start|0|||
162946129|NCT01139164|588504644|FG001|Overall Study|Withdrawn prior to study start|2|||
162946130|NCT01139164|588504645|FG002|Overall Study|Withdrawn prior to study start|0|||
162946131|NCT01790568|588504646|FG000|Overall Study|Progression prior to transplant|0|||
162946132|NCT01790568|588504647|FG001|Overall Study|Progression prior to transplant|1|||
162946133|NCT01361126|588504648|FG000|Overall Study|Sponsor decision|0|||
162946134|NCT01361126|588504649|FG001|Overall Study|Sponsor decision|2|||
162946135|NCT00264810|588504650|FG000|Baseline|Withdrawal by Subject|10|||
162946136|NCT00264810|588504651|FG001|Baseline|Withdrawal by Subject|10|||
162946137|NCT00264810|588504650|FG000|Baseline|Physician Decision|7|||
162946138|NCT00264810|588504651|FG001|Baseline|Physician Decision|8|||
162946139|NCT00264810|588504650|FG000|Baseline|Subject Compliance Failure|3|||
162946140|NCT00264810|588504651|FG001|Baseline|Subject Compliance Failure|3|||
162946141|NCT00264810|588504650|FG000|Baseline|Insufficient Seizure Frequency|2|||
162946142|NCT00264810|588504651|FG001|Baseline|Insufficient Seizure Frequency|2|||
162946143|NCT00264810|588504650|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
162946144|NCT00264810|588504651|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
162946145|NCT00264810|588504650|FG000|Baseline|Other|0|||
162946146|NCT00264810|588504651|FG001|Baseline|Other|1|||
162946147|NCT00264810|588504650|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
162946148|NCT00264810|588504651|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
162946149|NCT00264810|588504650|FG000|Stimulation Optimization Period|Death|0|||
162946150|NCT00264810|588504651|FG001|Stimulation Optimization Period|Death|1|||
162946151|NCT00264810|588504650|FG000|Blinded Evaluation Period|Explant due to infection|1|||
162946152|NCT00264810|588504651|FG001|Blinded Evaluation Period|Explant due to infection|1|||
162946153|NCT00264810|588504650|FG000|Open Label Evaluation Period|Explant due to infection|1|||
162946154|NCT00264810|588504651|FG001|Open Label Evaluation Period|Explant due to infection|1|||
162946155|NCT00264810|588504650|FG000|Open Label Evaluation Period|Death|3|||
162946156|NCT00264810|588504651|FG001|Open Label Evaluation Period|Death|2|||
162946157|NCT00264810|588504650|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
162946158|NCT00264810|588504651|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
162946159|NCT02994056|588504652|FG000|Overall Study|Death|8|||
162946160|NCT02994056|588504652|FG000|Overall Study|Withdrew Consent|1|||
162946161|NCT01658943|588504657|FG000|Overall Study|Adverse Event|6|||
162946162|NCT01658943|588504658|FG001|Overall Study|Adverse Event|13|||
162946163|NCT01658943|588504657|FG000|Overall Study|Withdrawal by Subject|9|||
162946164|NCT01658943|588504658|FG001|Overall Study|Withdrawal by Subject|2|||
162946165|NCT01658943|588504657|FG000|Overall Study|Progression/Relapse|39|||
162946166|NCT01658943|588504658|FG001|Overall Study|Progression/Relapse|40|||
162946167|NCT01658943|588504657|FG000|Overall Study|Death|4|||
162946168|NCT01658943|588504658|FG001|Overall Study|Death|2|||
162946169|NCT01658943|588504657|FG000|Overall Study|not protocol specified|4|||
162946170|NCT01658943|588504658|FG001|Overall Study|not protocol specified|1|||
162946171|NCT01658943|588504657|FG000|Overall Study|Not eligible|7|||
162946172|NCT01658943|588504658|FG001|Overall Study|Not eligible|9|||
162946173|NCT01658943|588504657|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
162946174|NCT01658943|588504658|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
162946175|NCT01346410|588504660|FG000|Overall Study|Death|1|||
162946176|NCT00979628|588504661|FG000|Overall Study|received regimen < 24 hours|7|||
162946177|NCT00979628|588504662|FG001|Overall Study|received regimen < 24 hours|6|||
162946178|NCT00979628|588504663|FG002|Overall Study|received regimen < 24 hours|5|||
162832122|NCT03246958|588098243|FG005|Overall Study|Death|0|||
162832123|NCT03246958|588098244|FG006|Overall Study|Death|0|||
162832124|NCT03246958|588098238|FG000|Overall Study|Physician Decision|0|||
162832125|NCT03246958|588098239|FG001|Overall Study|Physician Decision|0|||
162832126|NCT03246958|588098240|FG002|Overall Study|Physician Decision|0|||
162832127|NCT03246958|588098241|FG003|Overall Study|Physician Decision|1|||
162832128|NCT03246958|588098242|FG004|Overall Study|Physician Decision|0|||
162832129|NCT03246958|588098243|FG005|Overall Study|Physician Decision|0|||
162832130|NCT03246958|588098244|FG006|Overall Study|Physician Decision|0|||
162832131|NCT03246958|588098238|FG000|Overall Study|Never start treatment|1|||
162832132|NCT03246958|588098239|FG001|Overall Study|Never start treatment|0|||
162832133|NCT03246958|588098240|FG002|Overall Study|Never start treatment|0|||
162832134|NCT03246958|588098241|FG003|Overall Study|Never start treatment|0|||
162832135|NCT03246958|588098242|FG004|Overall Study|Never start treatment|0|||
162832136|NCT03246958|588098243|FG005|Overall Study|Never start treatment|0|||
162832137|NCT03246958|588098244|FG006|Overall Study|Never start treatment|0|||
162832138|NCT03246958|588098238|FG000|Overall Study|Over enrollment|0|||
162832139|NCT03246958|588098239|FG001|Overall Study|Over enrollment|2|||
162832140|NCT03246958|588098240|FG002|Overall Study|Over enrollment|0|||
162832141|NCT03246958|588098241|FG003|Overall Study|Over enrollment|0|||
162832142|NCT03246958|588098242|FG004|Overall Study|Over enrollment|0|||
162832143|NCT03246958|588098243|FG005|Overall Study|Over enrollment|0|||
162832144|NCT03246958|588098244|FG006|Overall Study|Over enrollment|0|||
162832145|NCT01650636|588098247|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
162832146|NCT01650636|588098248|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
162832147|NCT01650636|588098247|FG000|Washout up to 5 Months|Physician Decision|2|||
162832148|NCT01650636|588098248|FG001|Washout up to 5 Months|Physician Decision|2|||
162832149|NCT01650636|588098247|FG000|Washout up to 5 Months|Death|1|||
162832150|NCT01650636|588098248|FG001|Washout up to 5 Months|Death|0|||
162832151|NCT01650636|588098247|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
162832152|NCT01650636|588098248|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
162832153|NCT01650636|588098247|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
162832154|NCT01650636|588098248|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
162832155|NCT01650636|588098247|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
162832156|NCT01650636|588098248|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
162832157|NCT01560780|588098249|FG000|Overall Study|Death|2|||
162832158|NCT01560780|588098250|FG001|Overall Study|Death|1|||
162832159|NCT01560780|588098249|FG000|Overall Study|Patient Preference|11|||
162832160|NCT01560780|588098250|FG001|Overall Study|Patient Preference|11|||
162832161|NCT01500278|588098251|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
162832162|NCT01500278|588098252|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
162832163|NCT01500278|588098251|FG000|Week 0 - Week 12|Protocol Violation|10|||
162832164|NCT01500278|588098252|FG001|Week 0 - Week 12|Protocol Violation|16|||
162832165|NCT01500278|588098251|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
162832166|NCT01500278|588098252|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
162832167|NCT01500278|588098251|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
162832168|NCT01500278|588098252|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
162832169|NCT01500278|588098251|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
162832170|NCT01500278|588098252|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
162832171|NCT01500278|588098251|FG000|Week 0 - Week 12|Patient decision|1|||
162832172|NCT01500278|588098252|FG001|Week 0 - Week 12|Patient decision|0|||
162832173|NCT01500278|588098251|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
162832174|NCT01500278|588098252|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
162832175|NCT01500278|588098251|FG000|Week 0 - Week 12|Investigator decision|1|||
162832176|NCT01500278|588098252|FG001|Week 0 - Week 12|Investigator decision|0|||
162832177|NCT01500278|588098251|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
162832178|NCT01500278|588098252|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
162832179|NCT01500278|588098251|FG000|Week 0 - Week 12|Sponsor decision|1|||
162832180|NCT01500278|588098252|FG001|Week 0 - Week 12|Sponsor decision|0|||
162832181|NCT01500278|588098251|FG000|Week 0 - Week 12|Personal reason|0|||
162832182|NCT01500278|588098252|FG001|Week 0 - Week 12|Personal reason|1|||
162832183|NCT01500278|588098251|FG000|Week 0 - Week 12|Other serious disease|0|||
162832184|NCT01500278|588098252|FG001|Week 0 - Week 12|Other serious disease|1|||
162832185|NCT01500278|588098251|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
162832186|NCT01500278|588098252|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
162832187|NCT01500278|588098251|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
162832188|NCT01500278|588098252|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
162832189|NCT01500278|588098251|FG000|Week 13 - Week 104|Protocol Violation|6|||
162832190|NCT01500278|588098252|FG001|Week 13 - Week 104|Protocol Violation|6|||
162832191|NCT01500278|588098251|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
162832192|NCT01500278|588098252|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
162832193|NCT01500278|588098251|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
162832194|NCT01500278|588098252|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
162832195|NCT01500278|588098251|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
162832196|NCT01500278|588098252|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
162946179|NCT00979628|588504661|FG000|Overall Study|received steroids|1|||
162946180|NCT00979628|588504662|FG001|Overall Study|received steroids|1|||
162946181|NCT00979628|588504663|FG002|Overall Study|received steroids|0|||
162946182|NCT00979628|588504661|FG000|Overall Study|transferred to ICU|1|||
162946183|NCT00979628|588504662|FG001|Overall Study|transferred to ICU|2|||
162946184|NCT00979628|588504663|FG002|Overall Study|transferred to ICU|1|||
162946185|NCT05905783|588504664|FG000|Overall Study|Lost to Follow-up|12|||
162946186|NCT05905783|588504665|FG001|Overall Study|Lost to Follow-up|18|||
162946187|NCT05905783|588504664|FG000|Overall Study|Withdrawal by Subject|29|||
162946188|NCT05905783|588504665|FG001|Overall Study|Withdrawal by Subject|37|||
162946189|NCT05905783|588504664|FG000|Overall Study|Decision by sponsor|69|||
162946190|NCT05905783|588504665|FG001|Overall Study|Decision by sponsor|65|||
162946191|NCT00911859|588504666|FG000|Treatment Period|Adverse Event|3|||
162946192|NCT00911859|588504667|FG001|Treatment Period|Adverse Event|3|||
162946193|NCT00911859|588504668|FG002|Treatment Period|Adverse Event|7|||
162946194|NCT00911859|588504666|FG000|Treatment Period|Death|1|||
162946195|NCT00911859|588504667|FG001|Treatment Period|Death|3|||
162946196|NCT00911859|588504668|FG002|Treatment Period|Death|5|||
162946197|NCT00911859|588504666|FG000|Treatment Period|Lack of Efficacy|1|||
162946198|NCT00911859|588504667|FG001|Treatment Period|Lack of Efficacy|7|||
162946199|NCT00911859|588504668|FG002|Treatment Period|Lack of Efficacy|5|||
162946200|NCT00911859|588504666|FG000|Treatment Period|Physician Decision|3|||
162946201|NCT00911859|588504667|FG001|Treatment Period|Physician Decision|3|||
162946202|NCT00911859|588504668|FG002|Treatment Period|Physician Decision|3|||
162946203|NCT00911859|588504666|FG000|Treatment Period|Withdrawal by Subject|0|||
162946204|NCT00911859|588504667|FG001|Treatment Period|Withdrawal by Subject|4|||
162946205|NCT00911859|588504668|FG002|Treatment Period|Withdrawal by Subject|5|||
162946206|NCT00911859|588504666|FG000|Treatment Period|Did not receive study treatment|0|||
162946207|NCT00911859|588504667|FG001|Treatment Period|Did not receive study treatment|1|||
162946208|NCT00911859|588504668|FG002|Treatment Period|Did not receive study treatment|0|||
162946209|NCT00911859|588504666|FG000|Maintainance Period|Lack of Efficacy|0|||
162946210|NCT00911859|588504667|FG001|Maintainance Period|Lack of Efficacy|0|||
162946211|NCT00911859|588504668|FG002|Maintainance Period|Lack of Efficacy|9|||
162946212|NCT00911859|588504666|FG000|Maintainance Period|Physician Decision|0|||
162946213|NCT00911859|588504667|FG001|Maintainance Period|Physician Decision|0|||
162946214|NCT00911859|588504668|FG002|Maintainance Period|Physician Decision|9|||
162946215|NCT00911859|588504666|FG000|Maintainance Period|Withdrawal by Subject|0|||
162946216|NCT00911859|588504667|FG001|Maintainance Period|Withdrawal by Subject|0|||
162946217|NCT00911859|588504668|FG002|Maintainance Period|Withdrawal by Subject|3|||
162946218|NCT00911859|588504666|FG000|Follow-up Period|Death|5|||
162946219|NCT00911859|588504667|FG001|Follow-up Period|Death|8|||
162946220|NCT00911859|588504668|FG002|Follow-up Period|Death|10|||
162946221|NCT00911859|588504666|FG000|Follow-up Period|Lost to Follow-up|1|||
162946222|NCT00911859|588504667|FG001|Follow-up Period|Lost to Follow-up|1|||
162946223|NCT00911859|588504668|FG002|Follow-up Period|Lost to Follow-up|0|||
162946224|NCT00911859|588504666|FG000|Follow-up Period|Withdrawal by Subject|0|||
162946225|NCT00911859|588504667|FG001|Follow-up Period|Withdrawal by Subject|4|||
162946226|NCT00911859|588504668|FG002|Follow-up Period|Withdrawal by Subject|4|||
162946227|NCT00911859|588504666|FG000|Follow-up Period|Study terminated by sponsor|5|||
162946228|NCT00911859|588504667|FG001|Follow-up Period|Study terminated by sponsor|33|||
162946229|NCT00911859|588504668|FG002|Follow-up Period|Study terminated by sponsor|27|||
162946230|NCT03008460|588504673|FG000|Overall Study|Protocol deviation|0|||
162946231|NCT03008460|588504674|FG001|Overall Study|Protocol deviation|2|||
162946232|NCT03008460|588504673|FG000|Overall Study|Study drug not dispensed|0|||
162946233|NCT03008460|588504674|FG001|Overall Study|Study drug not dispensed|1|||
162946234|NCT03008460|588504673|FG000|Overall Study|Adverse Event|0|||
162946235|NCT03008460|588504674|FG001|Overall Study|Adverse Event|1|||
162946236|NCT03008460|588504673|FG000|Overall Study|Withdrawal by Subject|5|||
162946237|NCT03008460|588504674|FG001|Overall Study|Withdrawal by Subject|6|||
162946238|NCT03008460|588504673|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
162946239|NCT03008460|588504674|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
162946240|NCT03008460|588504673|FG000|Overall Study|End of study visit outside permitted time window|0|||
162946241|NCT03008460|588504674|FG001|Overall Study|End of study visit outside permitted time window|1|||
162946242|NCT03008460|588504673|FG000|Overall Study|Lost to Follow-up|1|||
162946243|NCT03008460|588504674|FG001|Overall Study|Lost to Follow-up|3|||
162946244|NCT04272801|588504680|FG000|Overall Study|Withdrawal by Subject|4|||
162946245|NCT04272801|588504680|FG000|Overall Study|Lost to Follow-up|4|||
162946246|NCT04272801|588504680|FG000|Overall Study|Ineligible|1|||
162699066|NCT01238575|587608145|FG001|Overall Study|Adverse Event|0|||
162946247|NCT02456909|588504681|FG000|Overall Study|Did not receive allocated intervention|24|||
162946248|NCT02456909|588504682|FG001|Overall Study|Did not receive allocated intervention|26|||
162946249|NCT02456909|588504681|FG000|Overall Study|Did not complete the primary outcome|0|||
162946250|NCT02456909|588504682|FG001|Overall Study|Did not complete the primary outcome|1|||
162946251|NCT02130466|588504683|FG000|Overall Study|Death|4|||
162946252|NCT02130466|588504684|FG001|Overall Study|Death|1|||
162946253|NCT02130466|588504685|FG002|Overall Study|Death|1|||
162946254|NCT02130466|588504686|FG003|Overall Study|Death|3|||
162946255|NCT02130466|588504687|FG004|Overall Study|Death|2|||
162946256|NCT02130466|588504688|FG005|Overall Study|Death|30|||
162946257|NCT02130466|588504689|FG006|Overall Study|Death|45|||
162946258|NCT02130466|588504690|FG007|Overall Study|Death|2|||
162946259|NCT02130466|588504691|FG008|Overall Study|Death|3|||
162946260|NCT02130466|588504692|FG009|Overall Study|Death|4|||
162946261|NCT02130466|588504693|FG010|Overall Study|Death|5|||
162946262|NCT02130466|588504694|FG011|Overall Study|Death|3|||
162946263|NCT02130466|588504695|FG012|Overall Study|Death|11|||
162946264|NCT02130466|588504696|FG013|Overall Study|Death|7|||
162946265|NCT02130466|588504683|FG000|Overall Study|Lost to Follow-up|1|||
162946266|NCT02130466|588504684|FG001|Overall Study|Lost to Follow-up|0|||
162946267|NCT02130466|588504685|FG002|Overall Study|Lost to Follow-up|0|||
162946268|NCT02130466|588504686|FG003|Overall Study|Lost to Follow-up|0|||
162946269|NCT02130466|588504687|FG004|Overall Study|Lost to Follow-up|0|||
162946270|NCT02130466|588504688|FG005|Overall Study|Lost to Follow-up|1|||
162946271|NCT02130466|588504689|FG006|Overall Study|Lost to Follow-up|0|||
162946272|NCT02130466|588504690|FG007|Overall Study|Lost to Follow-up|0|||
162946273|NCT02130466|588504691|FG008|Overall Study|Lost to Follow-up|0|||
162946274|NCT02130466|588504692|FG009|Overall Study|Lost to Follow-up|0|||
162946275|NCT02130466|588504693|FG010|Overall Study|Lost to Follow-up|0|||
162946276|NCT02130466|588504694|FG011|Overall Study|Lost to Follow-up|0|||
162946277|NCT02130466|588504695|FG012|Overall Study|Lost to Follow-up|1|||
162946278|NCT02130466|588504696|FG013|Overall Study|Lost to Follow-up|0|||
162946279|NCT02130466|588504683|FG000|Overall Study|Physician Decision|0|||
162946280|NCT02130466|588504684|FG001|Overall Study|Physician Decision|0|||
162946281|NCT02130466|588504685|FG002|Overall Study|Physician Decision|0|||
162946282|NCT02130466|588504686|FG003|Overall Study|Physician Decision|0|||
162946283|NCT02130466|588504687|FG004|Overall Study|Physician Decision|0|||
162946284|NCT02130466|588504688|FG005|Overall Study|Physician Decision|1|||
162946285|NCT02130466|588504689|FG006|Overall Study|Physician Decision|1|||
162946286|NCT02130466|588504690|FG007|Overall Study|Physician Decision|0|||
162946287|NCT02130466|588504691|FG008|Overall Study|Physician Decision|0|||
162946288|NCT02130466|588504692|FG009|Overall Study|Physician Decision|0|||
162946289|NCT02130466|588504693|FG010|Overall Study|Physician Decision|0|||
162946290|NCT02130466|588504694|FG011|Overall Study|Physician Decision|0|||
162946291|NCT02130466|588504695|FG012|Overall Study|Physician Decision|0|||
162946292|NCT02130466|588504696|FG013|Overall Study|Physician Decision|0|||
162946293|NCT02130466|588504683|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946294|NCT02130466|588504684|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
162946295|NCT02130466|588504685|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946296|NCT02130466|588504686|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
162946297|NCT02130466|588504687|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946298|NCT02130466|588504688|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
162946299|NCT02130466|588504689|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
162946300|NCT02130466|588504690|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946301|NCT02130466|588504691|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946302|NCT02130466|588504692|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946303|NCT02130466|588504693|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
162946304|NCT02130466|588504694|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946305|NCT02130466|588504695|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
162946306|NCT02130466|588504696|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
162946307|NCT02130466|588504683|FG000|Overall Study|Withdrawal by Subject|1|||
162946308|NCT02130466|588504684|FG001|Overall Study|Withdrawal by Subject|0|||
162946309|NCT02130466|588504685|FG002|Overall Study|Withdrawal by Subject|0|||
162946310|NCT02130466|588504686|FG003|Overall Study|Withdrawal by Subject|0|||
162946311|NCT02130466|588504687|FG004|Overall Study|Withdrawal by Subject|0|||
162946312|NCT02130466|588504688|FG005|Overall Study|Withdrawal by Subject|1|||
162946313|NCT02130466|588504689|FG006|Overall Study|Withdrawal by Subject|0|||
162946314|NCT02130466|588504690|FG007|Overall Study|Withdrawal by Subject|0|||
162946315|NCT02130466|588504691|FG008|Overall Study|Withdrawal by Subject|1|||
162946316|NCT02130466|588504692|FG009|Overall Study|Withdrawal by Subject|0|||
162946317|NCT02130466|588504693|FG010|Overall Study|Withdrawal by Subject|0|||
162946318|NCT02130466|588504694|FG011|Overall Study|Withdrawal by Subject|0|||
162946319|NCT02130466|588504695|FG012|Overall Study|Withdrawal by Subject|0|||
162946320|NCT02130466|588504696|FG013|Overall Study|Withdrawal by Subject|0|||
162946321|NCT04529109|588504698|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
162946322|NCT04529109|588504699|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
162946323|NCT01508936|588504701|FG000|Overall Study|Adverse Event|11|||
162946324|NCT01508936|588504702|FG001|Overall Study|Adverse Event|32|||
162946325|NCT01508936|588504701|FG000|Overall Study|Lack of Efficacy|0|||
162946326|NCT01508936|588504702|FG001|Overall Study|Lack of Efficacy|1|||
162946327|NCT01508936|588504701|FG000|Overall Study|Withdrawal by Subject|4|||
162946328|NCT01508936|588504702|FG001|Overall Study|Withdrawal by Subject|18|||
162946329|NCT01508936|588504701|FG000|Overall Study|Protocol Violation|2|||
162946330|NCT01508936|588504702|FG001|Overall Study|Protocol Violation|3|||
162946331|NCT01508936|588504701|FG000|Overall Study|Lost to Follow-up|2|||
162946332|NCT01508936|588504702|FG001|Overall Study|Lost to Follow-up|9|||
162946333|NCT01508936|588504701|FG000|Overall Study|Other|0|||
162946334|NCT01508936|588504702|FG001|Overall Study|Other|5|||
162946335|NCT01508936|588504701|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
162946336|NCT01508936|588504702|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
162946337|NCT00679367|588504703|FG000|Overall Study|Adverse Event|7|||
162946338|NCT00679367|588504703|FG000|Overall Study|inability to swallow oral drugs|1|||
162946339|NCT00679367|588504703|FG000|Overall Study|Lack of Efficacy|3|||
162946340|NCT00679367|588504703|FG000|Overall Study|Withdrawal by Subject|1|||
162946341|NCT00922779|588504704|FG000|Overall Study|Adverse Event|67|||
162946342|NCT00922779|588504704|FG000|Overall Study|Pregnancy|7|||
162946343|NCT00922779|588504704|FG000|Overall Study|Withdrawal by Subject|308|||
162946344|NCT00922779|588504704|FG000|Overall Study|Lost to Follow-up|44|||
162946345|NCT00922779|588504704|FG000|Overall Study|Other|27|||
162946346|NCT00922779|588504704|FG000|Overall Study|Missing|1874|||
162946347|NCT01611090|588504705|FG000|Randomized Period|Lost to Follow-up|8|||
162946348|NCT01611090|588504706|FG001|Randomized Period|Lost to Follow-up|3|||
162946349|NCT01611090|588504707|FG002|Randomized Period|Lost to Follow-up|0|||
162946350|NCT01611090|588504705|FG000|Randomized Period|Withdrawal by Subject|22|||
162946351|NCT01611090|588504706|FG001|Randomized Period|Withdrawal by Subject|26|||
162946352|NCT01611090|588504707|FG002|Randomized Period|Withdrawal by Subject|0|||
162946353|NCT01611090|588504705|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
162946354|NCT01611090|588504706|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
162946355|NCT01611090|588504707|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
162946356|NCT01611090|588504705|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
162946357|NCT01611090|588504706|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
162946358|NCT01611090|588504707|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
162946359|NCT03968224|588504708|FG000|Overall Study|Lost to Follow-up|11|||
162946360|NCT03968224|588504709|FG001|Overall Study|Lost to Follow-up|18|||
162946361|NCT05771428|588506363|FG000|Overall Study|Adverse Event|0|||
162946362|NCT05771428|588506364|FG001|Overall Study|Adverse Event|1|||
162946363|NCT05771428|588506365|FG002|Overall Study|Adverse Event|1|||
162946364|NCT05771428|588506366|FG003|Overall Study|Adverse Event|1|||
162946365|NCT05771428|588506363|FG000|Overall Study|Withdrawal by Subject|3|||
162946366|NCT05771428|588506364|FG001|Overall Study|Withdrawal by Subject|2|||
162946367|NCT05771428|588506365|FG002|Overall Study|Withdrawal by Subject|1|||
162946368|NCT05771428|588506366|FG003|Overall Study|Withdrawal by Subject|4|||
162946369|NCT05771428|588506363|FG000|Overall Study|Other|0|||
162946370|NCT05771428|588506364|FG001|Overall Study|Other|1|||
162946371|NCT05771428|588506365|FG002|Overall Study|Other|2|||
162946372|NCT05771428|588506366|FG003|Overall Study|Other|1|||
162946373|NCT05771428|588506363|FG000|Overall Study|Randomized but Not Treated|0|||
162946374|NCT05771428|588506364|FG001|Overall Study|Randomized but Not Treated|0|||
162946375|NCT05771428|588506365|FG002|Overall Study|Randomized but Not Treated|1|||
162946376|NCT05771428|588506366|FG003|Overall Study|Randomized but Not Treated|0|||
162946377|NCT04025229|588506367|FG000|Overall Study|Adverse Event|1|||
162946378|NCT04025229|588506368|FG001|Overall Study|Adverse Event|0|||
162946379|NCT04025229|588506367|FG000|Overall Study|Withdrawal by Subject|0|||
162946380|NCT04025229|588506368|FG001|Overall Study|Withdrawal by Subject|2|||
162946381|NCT04025229|588506367|FG000|Overall Study|Death|0|||
162946382|NCT04025229|588506368|FG001|Overall Study|Death|1|||
162946383|NCT04025229|588506367|FG000|Overall Study|Physician Decision|0|||
162946384|NCT04025229|588506368|FG001|Overall Study|Physician Decision|1|||
162946385|NCT03815942|588506369|FG000|Overall Study|Withdrawal by Subject|0|||
162946386|NCT03815942|588506370|FG001|Overall Study|Withdrawal by Subject|17|||
162946387|NCT01374919|588506371|FG000|Overall Study|Withdrawal by Subject|2|||
162946388|NCT00366899|588506372|FG000|Infant Series|Withdrawal by Subject|4|||
162946389|NCT00366899|588506373|FG001|Infant Series|Withdrawal by Subject|7|||
162946390|NCT00366899|588506372|FG000|Infant Series|Protocol Violation|2|||
162946391|NCT00366899|588506373|FG001|Infant Series|Protocol Violation|1|||
162946392|NCT00366899|588506372|FG000|Infant Series|Failed to return|1|||
162946393|NCT00366899|588506373|FG001|Infant Series|Failed to return|1|||
162946394|NCT00366899|588506372|FG000|Infant Series|Lost to Follow-up|0|||
162946395|NCT00366899|588506373|FG001|Infant Series|Lost to Follow-up|2|||
162946396|NCT00366899|588506372|FG000|Infant Series|Adverse Event|0|||
162946397|NCT00366899|588506373|FG001|Infant Series|Adverse Event|1|||
162946398|NCT00366899|588506372|FG000|Infant Series|Physician Decision|1|||
162946399|NCT00366899|588506373|FG001|Infant Series|Physician Decision|0|||
162946400|NCT00366899|588506372|FG000|Infant Series|Randomized but not consented|1|||
162946401|NCT00366899|588506373|FG001|Infant Series|Randomized but not consented|0|||
162946402|NCT00366899|588506372|FG000|After Infant Series|Lost to Follow-up|4|||
162946403|NCT00366899|588506373|FG001|After Infant Series|Lost to Follow-up|3|||
162946404|NCT00366899|588506372|FG000|After Infant Series|Withdrawal by Subject|1|||
162946405|NCT00366899|588506373|FG001|After Infant Series|Withdrawal by Subject|4|||
162946406|NCT00366899|588506372|FG000|After Infant Series|Adverse Event|1|||
162946407|NCT00366899|588506373|FG001|After Infant Series|Adverse Event|2|||
162946408|NCT00366899|588506372|FG000|After Infant Series|Protocol Violation|1|||
162946409|NCT00366899|588506373|FG001|After Infant Series|Protocol Violation|0|||
162946410|NCT00366899|588506372|FG000|Toddler Dose|Withdrawal by Subject|1|||
162946411|NCT00366899|588506373|FG001|Toddler Dose|Withdrawal by Subject|1|||
162946412|NCT00366899|588506372|FG000|Toddler Dose|Protocol Violation|1|||
162946413|NCT00366899|588506373|FG001|Toddler Dose|Protocol Violation|0|||
162946414|NCT03601637|588506374|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
162946415|NCT03601637|588506375|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
162946416|NCT03601637|588506374|FG000|Overall Study|Adverse Event|1|||
162946417|NCT03601637|588506375|FG001|Overall Study|Adverse Event|1|||
162946418|NCT03601637|588506374|FG000|Overall Study|Other|0|||
162946419|NCT03601637|588506375|FG001|Overall Study|Other|1|||
162946420|NCT02322047|588506377|FG000|Overall Study|Physician Decision|1|||
162946421|NCT02322047|588506378|FG001|Overall Study|Physician Decision|0|||
162946422|NCT02322047|588506379|FG002|Overall Study|Physician Decision|0|||
162946423|NCT02322047|588506380|FG003|Overall Study|Physician Decision|0|||
162946424|NCT02322047|588506377|FG000|Overall Study|Withdrawal by Subject|1|||
162946425|NCT02322047|588506378|FG001|Overall Study|Withdrawal by Subject|0|||
162946426|NCT02322047|588506379|FG002|Overall Study|Withdrawal by Subject|0|||
162946427|NCT02322047|588506380|FG003|Overall Study|Withdrawal by Subject|1|||
162946428|NCT02322047|588506377|FG000|Overall Study|Adverse Event|0|||
162946429|NCT02322047|588506378|FG001|Overall Study|Adverse Event|1|||
162946430|NCT02322047|588506379|FG002|Overall Study|Adverse Event|0|||
162946431|NCT02322047|588506380|FG003|Overall Study|Adverse Event|0|||
162946432|NCT02322047|588506377|FG000|Overall Study|Lost to Follow-up|0|||
162946433|NCT02322047|588506378|FG001|Overall Study|Lost to Follow-up|0|||
162946434|NCT02322047|588506379|FG002|Overall Study|Lost to Follow-up|1|||
162946435|NCT02322047|588506380|FG003|Overall Study|Lost to Follow-up|1|||
162946436|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
162946437|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
162946438|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946439|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946440|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
162946441|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
162946442|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
162946443|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946444|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946445|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
162946446|NCT00920140|588506383|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946447|NCT00920140|588506384|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
162946448|NCT00920140|588506385|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946449|NCT00920140|588506386|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946450|NCT00920140|588506387|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162946451|NCT00920140|588506383|FG000|Phase 2|Adverse Event|0|||
162946452|NCT00920140|588506384|FG001|Phase 2|Adverse Event|0|||
162946453|NCT00920140|588506385|FG002|Phase 2|Adverse Event|14|||
162946454|NCT00920140|588506386|FG003|Phase 2|Adverse Event|2|||
162946455|NCT00920140|588506387|FG004|Phase 2|Adverse Event|3|||
162946456|NCT00920140|588506383|FG000|Phase 2|Lack of Efficacy|0|||
162946457|NCT00920140|588506384|FG001|Phase 2|Lack of Efficacy|0|||
162946458|NCT00920140|588506385|FG002|Phase 2|Lack of Efficacy|29|||
162946459|NCT00920140|588506386|FG003|Phase 2|Lack of Efficacy|14|||
162946460|NCT00920140|588506387|FG004|Phase 2|Lack of Efficacy|5|||
162946461|NCT00920140|588506383|FG000|Phase 2|Lost to Follow-up|0|||
162946462|NCT00920140|588506384|FG001|Phase 2|Lost to Follow-up|0|||
162946463|NCT00920140|588506385|FG002|Phase 2|Lost to Follow-up|0|||
162946464|NCT00920140|588506386|FG003|Phase 2|Lost to Follow-up|1|||
162946465|NCT00920140|588506387|FG004|Phase 2|Lost to Follow-up|0|||
162946466|NCT00920140|588506383|FG000|Phase 2|Physician Decision|0|||
162946467|NCT00920140|588506384|FG001|Phase 2|Physician Decision|0|||
162946468|NCT00920140|588506385|FG002|Phase 2|Physician Decision|3|||
162946469|NCT00920140|588506386|FG003|Phase 2|Physician Decision|3|||
162946470|NCT00920140|588506387|FG004|Phase 2|Physician Decision|2|||
162946471|NCT00920140|588506383|FG000|Phase 2|Withdrawal by Subject|0|||
162946472|NCT00920140|588506384|FG001|Phase 2|Withdrawal by Subject|0|||
162946473|NCT00920140|588506385|FG002|Phase 2|Withdrawal by Subject|4|||
162946474|NCT00920140|588506386|FG003|Phase 2|Withdrawal by Subject|2|||
162946475|NCT00920140|588506387|FG004|Phase 2|Withdrawal by Subject|1|||
162946476|NCT01400425|588506388|FG000|Overall Study|Withdrawal by Subject|10|||
162946477|NCT00720096|588506390|FG000|Overall Study|Withdrawal by Subject|0|||
162946478|NCT00720096|588506391|FG001|Overall Study|Withdrawal by Subject|2|||
162832197|NCT01500278|588098251|FG000|Week 13 - Week 104|Non/bad compliance|7|||
162832198|NCT01500278|588098252|FG001|Week 13 - Week 104|Non/bad compliance|5|||
162832199|NCT01500278|588098251|FG000|Week 13 - Week 104|Recurrent infections|1|||
162832200|NCT01500278|588098252|FG001|Week 13 - Week 104|Recurrent infections|0|||
162832201|NCT01500278|588098251|FG000|Week 13 - Week 104|False positive test|1|||
162832202|NCT01500278|588098252|FG001|Week 13 - Week 104|False positive test|2|||
162832203|NCT01500278|588098251|FG000|Week 13 - Week 104|Sponsor request|4|||
162832204|NCT01500278|588098252|FG001|Week 13 - Week 104|Sponsor request|0|||
162832205|NCT01500278|588098251|FG000|Week 13 - Week 104|Withdrawn in error|1|||
162832206|NCT01500278|588098252|FG001|Week 13 - Week 104|Withdrawn in error|0|||
162832207|NCT01500278|588098251|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
162832208|NCT01500278|588098252|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
162832209|NCT01500278|588098251|FG000|Week 13 - Week 104|Protocol deviation|1|||
162832210|NCT01500278|588098252|FG001|Week 13 - Week 104|Protocol deviation|0|||
162832211|NCT01500278|588098251|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
162832212|NCT01500278|588098252|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
162832213|NCT01500278|588098251|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
162832214|NCT01500278|588098252|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
162832215|NCT01500278|588098251|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
162832216|NCT01500278|588098252|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
162832217|NCT01500278|588098251|FG000|Week 13 - Week 104|Relocation|0|||
162832218|NCT01500278|588098252|FG001|Week 13 - Week 104|Relocation|1|||
162832219|NCT01500278|588098251|FG000|Week 13 - Week 104|Sponsor decision|0|||
162832220|NCT01500278|588098252|FG001|Week 13 - Week 104|Sponsor decision|2|||
162832221|NCT01500278|588098251|FG000|Week 13 - Week 104|Medical monitor decision|0|||
162832222|NCT01500278|588098252|FG001|Week 13 - Week 104|Medical monitor decision|2|||
162832223|NCT01500278|588098251|FG000|Week 13 - Week 104|Personal reason|0|||
162832224|NCT01500278|588098252|FG001|Week 13 - Week 104|Personal reason|1|||
162832225|NCT01500278|588098251|FG000|Week 13 - Week 104|Not completed|0|||
162832226|NCT01500278|588098252|FG001|Week 13 - Week 104|Not completed|1|||
162832227|NCT01500278|588098251|FG000|Week 13 - Week 104|Death|2|||
162832228|NCT01500278|588098252|FG001|Week 13 - Week 104|Death|4|||
162832229|NCT01500278|588098251|FG000|Week 13 - Week 104|Adverse Event|54|||
162832230|NCT01500278|588098252|FG001|Week 13 - Week 104|Adverse Event|54|||
162832231|NCT00414453|588098253|FG000|Overall Study|Abnormal lab work|16|||
162832232|NCT01157364|588098254|FG000|Overall Study|Other Reasons|1|||
162832233|NCT01157364|588098255|FG001|Overall Study|Other Reasons|1|||
162832234|NCT01157364|588098256|FG002|Overall Study|Other Reasons|2|||
162832235|NCT01157364|588098257|FG003|Overall Study|Other Reasons|1|||
162832236|NCT01157364|588098258|FG004|Overall Study|Other Reasons|0|||
162832237|NCT01157364|588098259|FG005|Overall Study|Other Reasons|0|||
162832238|NCT01157364|588098254|FG000|Overall Study|Personal Reasons|0|||
162832239|NCT01157364|588098255|FG001|Overall Study|Personal Reasons|2|||
162832240|NCT01157364|588098256|FG002|Overall Study|Personal Reasons|0|||
162832241|NCT01157364|588098257|FG003|Overall Study|Personal Reasons|0|||
162832242|NCT01157364|588098258|FG004|Overall Study|Personal Reasons|1|||
162832243|NCT01157364|588098259|FG005|Overall Study|Personal Reasons|1|||
162832244|NCT01157364|588098254|FG000|Overall Study|Lost to Follow-up|1|||
162832245|NCT01157364|588098255|FG001|Overall Study|Lost to Follow-up|0|||
162832246|NCT01157364|588098256|FG002|Overall Study|Lost to Follow-up|1|||
162832247|NCT01157364|588098257|FG003|Overall Study|Lost to Follow-up|0|||
162832248|NCT01157364|588098258|FG004|Overall Study|Lost to Follow-up|0|||
162832249|NCT01157364|588098259|FG005|Overall Study|Lost to Follow-up|0|||
162832250|NCT01157364|588098254|FG000|Overall Study|Lack of Efficacy|0|||
162832251|NCT01157364|588098255|FG001|Overall Study|Lack of Efficacy|0|||
162832252|NCT01157364|588098256|FG002|Overall Study|Lack of Efficacy|0|||
162832253|NCT01157364|588098257|FG003|Overall Study|Lack of Efficacy|1|||
162832254|NCT01157364|588098258|FG004|Overall Study|Lack of Efficacy|0|||
162832255|NCT01157364|588098259|FG005|Overall Study|Lack of Efficacy|0|||
162832256|NCT01157364|588098254|FG000|Overall Study|Adverse Event|0|||
162832257|NCT01157364|588098255|FG001|Overall Study|Adverse Event|1|||
162832258|NCT01157364|588098256|FG002|Overall Study|Adverse Event|1|||
162832259|NCT01157364|588098257|FG003|Overall Study|Adverse Event|0|||
162832260|NCT01157364|588098258|FG004|Overall Study|Adverse Event|1|||
162832261|NCT01157364|588098259|FG005|Overall Study|Adverse Event|0|||
162832262|NCT00183274|588098262|FG000|Phase 1: Open-Label|Adverse Event|31|||
162832263|NCT00183274|588098263|FG001|Phase 1: Open-Label|Adverse Event|0|||
162832264|NCT00183274|588098264|FG002|Phase 1: Open-Label|Adverse Event|0|||
162832265|NCT00183274|588098265|FG003|Phase 1: Open-Label|Adverse Event|0|||
162832266|NCT00183274|588098266|FG004|Phase 1: Open-Label|Adverse Event|0|||
162832267|NCT00183274|588098267|FG005|Phase 1: Open-Label|Adverse Event|0|||
162832268|NCT00183274|588098262|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
162832269|NCT00183274|588098263|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
162832270|NCT00183274|588098264|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
162832271|NCT00183274|588098265|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
162832272|NCT00183274|588098266|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
162832273|NCT00183274|588098267|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
162832274|NCT00183274|588098262|FG000|Phase 1: Open-Label|Protocol Violation|11|||
162832275|NCT00183274|588098263|FG001|Phase 1: Open-Label|Protocol Violation|0|||
162832276|NCT00183274|588098264|FG002|Phase 1: Open-Label|Protocol Violation|0|||
162832277|NCT00183274|588098265|FG003|Phase 1: Open-Label|Protocol Violation|0|||
162832278|NCT00183274|588098266|FG004|Phase 1: Open-Label|Protocol Violation|0|||
162832279|NCT00183274|588098267|FG005|Phase 1: Open-Label|Protocol Violation|0|||
162832280|NCT00183274|588098262|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
162832281|NCT00183274|588098263|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
162832282|NCT00183274|588098264|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
162832283|NCT00183274|588098265|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
162832284|NCT00183274|588098266|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
162832285|NCT00183274|588098267|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
162832286|NCT00183274|588098262|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
162832287|NCT00183274|588098263|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
162832288|NCT00183274|588098264|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
162832289|NCT00183274|588098265|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
162832290|NCT00183274|588098266|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
162832291|NCT00183274|588098267|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
162832292|NCT00183274|588098262|FG000|Phase 1: Open-Label|Other|9|||
162832293|NCT00183274|588098263|FG001|Phase 1: Open-Label|Other|0|||
162832294|NCT00183274|588098264|FG002|Phase 1: Open-Label|Other|0|||
162832295|NCT00183274|588098265|FG003|Phase 1: Open-Label|Other|0|||
162832296|NCT00183274|588098266|FG004|Phase 1: Open-Label|Other|0|||
162832297|NCT00183274|588098267|FG005|Phase 1: Open-Label|Other|0|||
162832298|NCT00183274|588098262|FG000|Phase 2: Double-Blind|Relapsed|0|||
162832299|NCT00183274|588098263|FG001|Phase 2: Double-Blind|Relapsed|8|||
162832300|NCT00183274|588098264|FG002|Phase 2: Double-Blind|Relapsed|29|||
162832301|NCT00183274|588098265|FG003|Phase 2: Double-Blind|Relapsed|0|||
162832302|NCT00183274|588098266|FG004|Phase 2: Double-Blind|Relapsed|0|||
162832303|NCT00183274|588098267|FG005|Phase 2: Double-Blind|Relapsed|0|||
162832304|NCT00183274|588098262|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
162832305|NCT00183274|588098263|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
162832306|NCT00183274|588098264|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
162832307|NCT00183274|588098265|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
162832308|NCT00183274|588098266|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
162832309|NCT00183274|588098267|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
162832310|NCT00183274|588098262|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
162832311|NCT00183274|588098263|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
162832312|NCT00183274|588098264|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
162832313|NCT00183274|588098265|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
162832314|NCT00183274|588098266|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
162832315|NCT00183274|588098267|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
162832316|NCT00183274|588098262|FG000|Phase 3: Double-Blind|Relapsed|0|||
162832317|NCT00183274|588098263|FG001|Phase 3: Double-Blind|Relapsed|0|||
162832318|NCT00183274|588098264|FG002|Phase 3: Double-Blind|Relapsed|0|||
162832319|NCT00183274|588098265|FG003|Phase 3: Double-Blind|Relapsed|1|||
162832320|NCT00183274|588098266|FG004|Phase 3: Double-Blind|Relapsed|11|||
162832321|NCT00183274|588098267|FG005|Phase 3: Double-Blind|Relapsed|2|||
162832322|NCT00586495|588098272|FG000|Treatment Period|Adverse Event|11|||
162832323|NCT00586495|588098272|FG000|Treatment Period|Death|1|||
162832324|NCT00586495|588098272|FG000|Treatment Period|Protocol Violation|1|||
162832325|NCT00586495|588098272|FG000|Treatment Period|Withdrawal by Subject|1|||
162832326|NCT00586495|588098272|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
162832327|NCT00586495|588098272|FG000|Treatment Period|Switch to commercial drug|10|||
162832328|NCT00586495|588098272|FG000|Follow-up|Death|40|||
162832329|NCT00586495|588098272|FG000|Follow-up|Lost to Follow-up|1|||
162832330|NCT00586495|588098272|FG000|Follow-up|Withdrawal by Subject|4|||
162832331|NCT00586495|588098272|FG000|Follow-up|Protocol driven decision point|37|||
162832332|NCT00586495|588098272|FG000|Follow-up|Switch to commercial drug|10|||
162832333|NCT01046877|588098275|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
162832334|NCT01046877|588098275|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
162832335|NCT04770389|588098281|FG000|Overall Study|Adverse Event|1|||
162832336|NCT04770389|588098282|FG001|Overall Study|Adverse Event|2|||
162832337|NCT04770389|588098283|FG002|Overall Study|Adverse Event|0|||
162832338|NCT04770389|588098284|FG003|Overall Study|Adverse Event|1|||
162832339|NCT04770389|588098281|FG000|Overall Study|Withdrawal by Subject|0|||
162832340|NCT04770389|588098282|FG001|Overall Study|Withdrawal by Subject|2|||
162832341|NCT04770389|588098283|FG002|Overall Study|Withdrawal by Subject|1|||
162832342|NCT04770389|588098284|FG003|Overall Study|Withdrawal by Subject|0|||
162832343|NCT04770389|588098281|FG000|Overall Study|Failed attempt to draw blood|1|||
162832344|NCT04770389|588098282|FG001|Overall Study|Failed attempt to draw blood|0|||
162832345|NCT04770389|588098283|FG002|Overall Study|Failed attempt to draw blood|0|||
162832346|NCT04770389|588098284|FG003|Overall Study|Failed attempt to draw blood|0|||
162832347|NCT04770389|588098281|FG000|Overall Study|Left the country|0|||
162832348|NCT04770389|588098282|FG001|Overall Study|Left the country|0|||
162832349|NCT04770389|588098283|FG002|Overall Study|Left the country|1|||
162946479|NCT04557124|588506392|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
162946480|NCT04557124|588506393|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
162946481|NCT04557124|588506392|FG000|Mid-point (1 Month)|Missed testing|5|||
162946482|NCT04557124|588506393|FG001|Mid-point (1 Month)|Missed testing|4|||
162946483|NCT04557124|588506392|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
162946484|NCT04557124|588506393|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
162946485|NCT04557124|588506392|FG000|Post-testing (2 Months)|Missed testing|1|||
162946486|NCT04557124|588506393|FG001|Post-testing (2 Months)|Missed testing|5|||
162946487|NCT04557124|588506392|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
162946488|NCT04557124|588506393|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
162946489|NCT04557124|588506392|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
162946490|NCT04557124|588506393|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
162946491|NCT00001849|588506394|FG000|Overall Study|Death|4|||
162946492|NCT00001849|588506394|FG000|Overall Study|Lost to Follow-up|2|||
162946493|NCT00001849|588506394|FG000|Overall Study|Withdrawal by Subject|2|||
162946494|NCT00001849|588506394|FG000|Overall Study|tumor remained occult|6|||
162946495|NCT00442936|588506395|FG000|Overall Study|Protocol Violation|1|||
162946496|NCT00442936|588506396|FG001|Overall Study|Protocol Violation|0|||
162946497|NCT00442936|588506397|FG002|Overall Study|Protocol Violation|1|||
162946498|NCT00442936|588506398|FG003|Overall Study|Protocol Violation|1|||
162946499|NCT02428699|588506399|FG000|Washout Period 1|Screen Failure|1|||
162946500|NCT02428699|588506400|FG001|Washout Period 1|Screen Failure|2|||
162946501|NCT03127137|588506401|FG000|Overall Study|Requested sedation after consent|1|||
162946502|NCT03127137|588506402|FG001|Overall Study|Requested sedation after consent|0|||
162946503|NCT03127137|588506401|FG000|Overall Study|Malfunction in electronic data collection|1|||
162946504|NCT03127137|588506402|FG001|Overall Study|Malfunction in electronic data collection|0|||
162946505|NCT03127137|588506401|FG000|Overall Study|Post procedure testing could not be obtained|0|||
162946506|NCT03127137|588506402|FG001|Overall Study|Post procedure testing could not be obtained|1|||
162946507|NCT04424407|588506403|FG000|Overall Study|Withdrawal by Subject|2|||
162946508|NCT04424407|588506403|FG000|Overall Study|Lost to Follow-up|1|||
162946509|NCT00264797|588506404|FG000|Overall Study|Withdrawal by Subject|11|||
162946510|NCT00264797|588506405|FG001|Overall Study|Withdrawal by Subject|11|||
162946511|NCT00264797|588506404|FG000|Overall Study|Lost to Follow-up|9|||
162946512|NCT00264797|588506405|FG001|Overall Study|Lost to Follow-up|17|||
162946513|NCT00264797|588506404|FG000|Overall Study|Moved from area|3|||
162946514|NCT00264797|588506405|FG001|Overall Study|Moved from area|1|||
162946515|NCT00264797|588506404|FG000|Overall Study|Practical Problems|2|||
162946516|NCT00264797|588506405|FG001|Overall Study|Practical Problems|3|||
162946517|NCT00264797|588506404|FG000|Overall Study|Incarceration|4|||
162946518|NCT00264797|588506405|FG001|Overall Study|Incarceration|5|||
162946519|NCT00264797|588506404|FG000|Overall Study|Pressure/advice from Outsiders|1|||
162946520|NCT00264797|588506405|FG001|Overall Study|Pressure/advice from Outsiders|1|||
162946521|NCT00264797|588506404|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
162946522|NCT00264797|588506405|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
162946523|NCT00264797|588506404|FG000|Overall Study|Other|3|||
162946524|NCT00264797|588506405|FG001|Overall Study|Other|4|||
162946525|NCT03992196|588506406|FG000|Enrollment|lost to follow-up prior dosing|1|||
162946526|NCT03992196|588506407|FG001|Enrollment|lost to follow-up prior dosing|0|||
162946527|NCT03992196|588506408|FG002|Enrollment|lost to follow-up prior dosing|0|||
162946528|NCT03992196|588506406|FG000|Treatment|Protocol Violation|0|||
162946529|NCT03992196|588506407|FG001|Treatment|Protocol Violation|0|||
162946530|NCT03992196|588506408|FG002|Treatment|Protocol Violation|1|||
162946531|NCT03992196|588506406|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
162946532|NCT03992196|588506407|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
162946533|NCT03992196|588506408|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
162946534|NCT03992196|588506406|FG000|Treatment|Withdrawal due to non-compliance|0|||
162946535|NCT03992196|588506407|FG001|Treatment|Withdrawal due to non-compliance|0|||
162946536|NCT03992196|588506408|FG002|Treatment|Withdrawal due to non-compliance|1|||
162946537|NCT03992196|588506406|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
162946538|NCT03992196|588506407|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
162946539|NCT03992196|588506408|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
162946540|NCT03992196|588506406|FG000|Treatment|Withdrawal by parent/guardian|0|||
162946541|NCT03992196|588506407|FG001|Treatment|Withdrawal by parent/guardian|0|||
162946542|NCT03992196|588506408|FG002|Treatment|Withdrawal by parent/guardian|2|||
162946543|NCT00755196|588506410|FG000|Overall Study|Lost to Follow-up|1|||
162946544|NCT00755196|588506410|FG000|Overall Study|Lack of Efficiency|1|||
162946545|NCT02388763|588506411|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
162946546|NCT02388763|588506412|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
162946547|NCT02388763|588506411|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
162946548|NCT02388763|588506412|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
162946549|NCT01604850|588506413|FG000|Overall Study|Enrolled but never treated|0|||
162946550|NCT01604850|588506414|FG001|Overall Study|Enrolled but never treated|1|||
162946551|NCT01604850|588506413|FG000|Overall Study|Efficacy Failure|50|||
162946552|NCT01604850|588506414|FG001|Overall Study|Efficacy Failure|29|||
162946553|NCT01604850|588506413|FG000|Overall Study|Lost to Follow-up|1|||
162946554|NCT01604850|588506414|FG001|Overall Study|Lost to Follow-up|0|||
162946555|NCT01604850|588506413|FG000|Overall Study|Subject withdrew consent|1|||
162946556|NCT01604850|588506414|FG001|Overall Study|Subject withdrew consent|0|||
162946557|NCT01703832|588506415|FG000|Overall Study|Withdrawal by Subject|1|||
162946558|NCT01703832|588506416|FG001|Overall Study|Withdrawal by Subject|0|||
162946559|NCT00243932|588506417|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
162946560|NCT00243932|588506418|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
162946561|NCT00243932|588506419|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
162946562|NCT01458405|588506422|FG000|Phase 1 (up to 12 Months)|Other|0|||
162946563|NCT01458405|588506423|FG001|Phase 1 (up to 12 Months)|Other|1|||
162946564|NCT01458405|588506424|FG002|Phase 1 (up to 12 Months)|Other|0|||
162946565|NCT01458405|588506425|FG003|Phase 1 (up to 12 Months)|Other|0|||
162946566|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
162946567|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
162946568|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
162946569|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
162946570|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946571|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946572|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
162946573|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
162946574|NCT01458405|588506422|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946575|NCT01458405|588506423|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946576|NCT01458405|588506424|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
162946577|NCT01458405|588506425|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
162946578|NCT02497781|588506429|FG000|Overall Study|Withdrawal by Subject|2|||
162946579|NCT02497781|588506430|FG001|Overall Study|Withdrawal by Subject|0|||
162946580|NCT02497781|588506429|FG000|Overall Study|Lack of Efficacy|0|||
162946581|NCT02497781|588506430|FG001|Overall Study|Lack of Efficacy|1|||
162946582|NCT02497781|588506429|FG000|Overall Study|Randomised but not treated|1|||
162946583|NCT02497781|588506430|FG001|Overall Study|Randomised but not treated|1|||
162946584|NCT02497781|588506429|FG000|Overall Study|Lost to Follow-up|1|||
162946585|NCT02497781|588506430|FG001|Overall Study|Lost to Follow-up|1|||
162946586|NCT01193608|588506431|FG000|Overall Study|Other|0|||
162946587|NCT01193608|588506432|FG001|Overall Study|Other|1|||
162946588|NCT01193608|588506433|FG002|Overall Study|Other|0|||
162946589|NCT01193608|588506434|FG003|Overall Study|Other|0|||
162946590|NCT01193608|588506435|FG004|Overall Study|Other|0|||
162946591|NCT01193608|588506436|FG005|Overall Study|Other|0|||
162946592|NCT01193608|588506431|FG000|Overall Study|Withdrawal by Subject|0|||
162946593|NCT01193608|588506432|FG001|Overall Study|Withdrawal by Subject|1|||
162946594|NCT01193608|588506433|FG002|Overall Study|Withdrawal by Subject|2|||
162946595|NCT01193608|588506434|FG003|Overall Study|Withdrawal by Subject|3|||
162946596|NCT01193608|588506435|FG004|Overall Study|Withdrawal by Subject|3|||
162946597|NCT01193608|588506436|FG005|Overall Study|Withdrawal by Subject|0|||
162946598|NCT01193608|588506431|FG000|Overall Study|Lost to Follow-up|0|||
162946599|NCT01193608|588506432|FG001|Overall Study|Lost to Follow-up|0|||
162946600|NCT01193608|588506433|FG002|Overall Study|Lost to Follow-up|0|||
162946601|NCT01193608|588506434|FG003|Overall Study|Lost to Follow-up|0|||
162946602|NCT01193608|588506435|FG004|Overall Study|Lost to Follow-up|1|||
162946603|NCT01193608|588506436|FG005|Overall Study|Lost to Follow-up|2|||
162946604|NCT01193608|588506431|FG000|Overall Study|Adverse Event|0|||
162946605|NCT01193608|588506432|FG001|Overall Study|Adverse Event|0|||
162946606|NCT01193608|588506433|FG002|Overall Study|Adverse Event|0|||
162946607|NCT01193608|588506434|FG003|Overall Study|Adverse Event|0|||
162946608|NCT01193608|588506435|FG004|Overall Study|Adverse Event|1|||
162946609|NCT01193608|588506436|FG005|Overall Study|Adverse Event|0|||
162946610|NCT01249664|588506437|FG000|Overall Study|Withdrawal by Subject|5|||
162946611|NCT01249664|588506438|FG001|Overall Study|Withdrawal by Subject|0|||
162946612|NCT01249664|588506437|FG000|Overall Study|Adverse Event|1|||
162946613|NCT01249664|588506438|FG001|Overall Study|Adverse Event|0|||
162946614|NCT00454636|588506439|FG000|Overall Study|Adverse Event|10|||
162946615|NCT00454636|588506440|FG001|Overall Study|Adverse Event|6|||
162946616|NCT00454636|588506441|FG002|Overall Study|Adverse Event|9|||
162946617|NCT00454636|588506442|FG003|Overall Study|Adverse Event|15|||
162946618|NCT00454636|588506439|FG000|Overall Study|Disease Progression|11|||
162946619|NCT00454636|588506440|FG001|Overall Study|Disease Progression|12|||
162946620|NCT00454636|588506441|FG002|Overall Study|Disease Progression|4|||
162946621|NCT00454636|588506442|FG003|Overall Study|Disease Progression|11|||
162946622|NCT00454636|588506439|FG000|Overall Study|Protocol Violation|3|||
162946623|NCT00454636|588506440|FG001|Overall Study|Protocol Violation|2|||
162946624|NCT00454636|588506441|FG002|Overall Study|Protocol Violation|3|||
162946625|NCT00454636|588506442|FG003|Overall Study|Protocol Violation|3|||
162946626|NCT00454636|588506439|FG000|Overall Study|Death|6|||
162946627|NCT00454636|588506440|FG001|Overall Study|Death|1|||
162946628|NCT00454636|588506441|FG002|Overall Study|Death|1|||
162946629|NCT00454636|588506442|FG003|Overall Study|Death|1|||
162832350|NCT04770389|588098284|FG003|Overall Study|Left the country|2|||
162832351|NCT04770389|588098281|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
162832352|NCT04770389|588098282|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
162832353|NCT04770389|588098283|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
162832354|NCT04770389|588098284|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
162832355|NCT04770389|588098281|FG000|Overall Study|Lost to Follow-up|0|||
162832356|NCT04770389|588098282|FG001|Overall Study|Lost to Follow-up|0|||
162832357|NCT04770389|588098283|FG002|Overall Study|Lost to Follow-up|0|||
162832358|NCT04770389|588098284|FG003|Overall Study|Lost to Follow-up|1|||
162832359|NCT04770389|588098281|FG000|Overall Study|Moved away from study site|0|||
162832360|NCT04770389|588098282|FG001|Overall Study|Moved away from study site|1|||
162832361|NCT04770389|588098283|FG002|Overall Study|Moved away from study site|0|||
162832362|NCT04770389|588098284|FG003|Overall Study|Moved away from study site|0|||
162832363|NCT00794157|588098285|FG000|Overall Study|Adverse Event|4|||
162832364|NCT00794157|588098286|FG001|Overall Study|Adverse Event|1|||
162832365|NCT00794157|588098287|FG002|Overall Study|Adverse Event|8|||
162832366|NCT00794157|588098285|FG000|Overall Study|Subject withdrew consent|2|||
162832367|NCT00794157|588098286|FG001|Overall Study|Subject withdrew consent|0|||
162832368|NCT00794157|588098287|FG002|Overall Study|Subject withdrew consent|3|||
162832369|NCT00794157|588098285|FG000|Overall Study|Lost to Follow-up|2|||
162832370|NCT00794157|588098286|FG001|Overall Study|Lost to Follow-up|0|||
162832371|NCT00794157|588098287|FG002|Overall Study|Lost to Follow-up|1|||
162832372|NCT00794157|588098285|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162832373|NCT00794157|588098286|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162832374|NCT00794157|588098287|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162832375|NCT00794157|588098285|FG000|Overall Study|Administrative problems|1|||
162832376|NCT00794157|588098286|FG001|Overall Study|Administrative problems|7|||
162832377|NCT00794157|588098287|FG002|Overall Study|Administrative problems|4|||
162832378|NCT00794157|588098285|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162832379|NCT00794157|588098286|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162832380|NCT00794157|588098287|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162832381|NCT00794157|588098285|FG000|Overall Study|Protocol deviation|0|||
162832382|NCT00794157|588098286|FG001|Overall Study|Protocol deviation|1|||
162832383|NCT00794157|588098287|FG002|Overall Study|Protocol deviation|1|||
162832384|NCT00531752|588098295|FG000|First Double-blind Intervention Period|Adverse Event|2|||
162832385|NCT00531752|588098296|FG001|First Double-blind Intervention Period|Adverse Event|0|||
162832386|NCT00531752|588098297|FG002|First Double-blind Intervention Period|Adverse Event|1|||
162832387|NCT00531752|588098298|FG003|First Double-blind Intervention Period|Adverse Event|1|||
162832388|NCT00531752|588098295|FG000|First Double-blind Intervention Period|Other|1|||
162832389|NCT00531752|588098296|FG001|First Double-blind Intervention Period|Other|4|||
162832390|NCT00531752|588098297|FG002|First Double-blind Intervention Period|Other|4|||
162832391|NCT00531752|588098298|FG003|First Double-blind Intervention Period|Other|0|||
162832392|NCT00531752|588098295|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
162832393|NCT00531752|588098296|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
162832394|NCT00531752|588098297|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
162832395|NCT00531752|588098298|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
162832396|NCT00531752|588098295|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
162832397|NCT00531752|588098296|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
162832398|NCT00531752|588098297|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
162832399|NCT00531752|588098298|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
162832400|NCT00531752|588098295|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
162832401|NCT00531752|588098296|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
162832402|NCT00531752|588098297|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
162832403|NCT00531752|588098298|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
162832404|NCT00531752|588098295|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
162832405|NCT00531752|588098296|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
162832406|NCT00531752|588098297|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
162832407|NCT00531752|588098298|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
162832408|NCT00531752|588098295|FG000|Second Double-blind Intervention Period|Other|1|||
162832409|NCT00531752|588098296|FG001|Second Double-blind Intervention Period|Other|1|||
162832410|NCT00531752|588098297|FG002|Second Double-blind Intervention Period|Other|0|||
162832411|NCT00531752|588098298|FG003|Second Double-blind Intervention Period|Other|0|||
162832412|NCT00531752|588098295|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
162832413|NCT00531752|588098296|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
162832414|NCT00531752|588098297|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
162832415|NCT00531752|588098298|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
162832416|NCT00531752|588098295|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
162832417|NCT00531752|588098296|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
162832418|NCT00531752|588098297|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
162946630|NCT00454636|588506439|FG000|Overall Study|Patient refusal|1|||
162946631|NCT00454636|588506440|FG001|Overall Study|Patient refusal|1|||
162946632|NCT00454636|588506441|FG002|Overall Study|Patient refusal|3|||
162946633|NCT00454636|588506442|FG003|Overall Study|Patient refusal|2|||
162946634|NCT00454636|588506439|FG000|Overall Study|Lost to Follow-up|0|||
162946635|NCT00454636|588506440|FG001|Overall Study|Lost to Follow-up|1|||
162946636|NCT00454636|588506441|FG002|Overall Study|Lost to Follow-up|0|||
162946637|NCT00454636|588506442|FG003|Overall Study|Lost to Follow-up|0|||
162946638|NCT00806156|588506443|FG000|Overall Study|Death|35|||
162946639|NCT00806156|588506444|FG001|Overall Study|Death|95|||
162946640|NCT00806156|588506443|FG000|Overall Study|Did not meet eligibility criteria|1|||
162946641|NCT00806156|588506444|FG001|Overall Study|Did not meet eligibility criteria|0|||
162946642|NCT00806156|588506443|FG000|Overall Study|Study terminated by Sponsor|2|||
162946643|NCT00806156|588506444|FG001|Overall Study|Study terminated by Sponsor|40|||
162946644|NCT00806156|588506443|FG000|Overall Study|Consent withdrawn by subject|1|||
162946645|NCT00806156|588506444|FG001|Overall Study|Consent withdrawn by subject|3|||
162946646|NCT00806156|588506443|FG000|Overall Study|Lost to Follow-up|0|||
162946647|NCT00806156|588506444|FG001|Overall Study|Lost to Follow-up|1|||
162946648|NCT01025037|588506449|FG000|Overall Study|Adverse Event|3|||
162946649|NCT01025037|588506449|FG000|Overall Study|Lost to Follow-up|7|||
162946650|NCT01025037|588506449|FG000|Overall Study|Withdrawal by Subject|1|||
162946651|NCT02674334|588506454|FG000|Overall Study|Lost to Follow-up|5|||
162946652|NCT02674334|588506455|FG001|Overall Study|Lost to Follow-up|3|||
162946653|NCT02674334|588506454|FG000|Overall Study|participant difficulty breathing|1|||
162946654|NCT02674334|588506455|FG001|Overall Study|participant difficulty breathing|0|||
162946655|NCT02674334|588506454|FG000|Overall Study|NIRS not recording|1|||
162946656|NCT02674334|588506455|FG001|Overall Study|NIRS not recording|0|||
162946657|NCT00860405|588506466|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
162946658|NCT00860405|588506467|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
162946659|NCT00864097|588506468|FG000|Overall Study|Death|0|||
162946660|NCT00864097|588506469|FG001|Overall Study|Death|1|||
162946661|NCT00864097|588506470|FG002|Overall Study|Death|0|||
162946662|NCT00864097|588506471|FG003|Overall Study|Death|0|||
162946663|NCT00864097|588506468|FG000|Overall Study|Adverse Event|6|||
162946664|NCT00864097|588506469|FG001|Overall Study|Adverse Event|8|||
162946665|NCT00864097|588506470|FG002|Overall Study|Adverse Event|11|||
162946666|NCT00864097|588506471|FG003|Overall Study|Adverse Event|9|||
162946667|NCT00864097|588506468|FG000|Overall Study|Lack of Efficacy|9|||
162946668|NCT00864097|588506469|FG001|Overall Study|Lack of Efficacy|3|||
162946669|NCT00864097|588506470|FG002|Overall Study|Lack of Efficacy|7|||
162946670|NCT00864097|588506471|FG003|Overall Study|Lack of Efficacy|2|||
162946671|NCT00864097|588506468|FG000|Overall Study|Lost to Follow-up|0|||
162946672|NCT00864097|588506469|FG001|Overall Study|Lost to Follow-up|1|||
162946673|NCT00864097|588506470|FG002|Overall Study|Lost to Follow-up|0|||
162946674|NCT00864097|588506471|FG003|Overall Study|Lost to Follow-up|1|||
162946675|NCT00864097|588506468|FG000|Overall Study|Withdrawal by Subject|15|||
162946676|NCT00864097|588506469|FG001|Overall Study|Withdrawal by Subject|11|||
162946677|NCT00864097|588506470|FG002|Overall Study|Withdrawal by Subject|11|||
162946678|NCT00864097|588506471|FG003|Overall Study|Withdrawal by Subject|12|||
162946679|NCT00864097|588506468|FG000|Overall Study|Protocol Violation|2|||
162946680|NCT00864097|588506469|FG001|Overall Study|Protocol Violation|1|||
162946681|NCT00864097|588506470|FG002|Overall Study|Protocol Violation|0|||
162946682|NCT00864097|588506471|FG003|Overall Study|Protocol Violation|1|||
162946683|NCT00864097|588506468|FG000|Overall Study|Terminated by sponsor|105|||
162946684|NCT00864097|588506469|FG001|Overall Study|Terminated by sponsor|112|||
162946685|NCT00864097|588506470|FG002|Overall Study|Terminated by sponsor|102|||
162946686|NCT00864097|588506471|FG003|Overall Study|Terminated by sponsor|99|||
162946687|NCT00864097|588506468|FG000|Overall Study|Randomized but not treated|2|||
162946688|NCT00864097|588506469|FG001|Overall Study|Randomized but not treated|0|||
162946689|NCT00864097|588506470|FG002|Overall Study|Randomized but not treated|1|||
162946690|NCT00864097|588506471|FG003|Overall Study|Randomized but not treated|0|||
162946691|NCT00864097|588506468|FG000|Overall Study|Other|0|||
162946692|NCT00864097|588506469|FG001|Overall Study|Other|0|||
162946693|NCT00864097|588506470|FG002|Overall Study|Other|0|||
162946694|NCT00864097|588506471|FG003|Overall Study|Other|1|||
162946695|NCT00320112|588506474|FG000|Overall Study|Lost to Follow-up|3|||
162946696|NCT00320112|588506475|FG001|Overall Study|Lost to Follow-up|4|||
162946697|NCT00320112|588506474|FG000|Overall Study|Withdrawal by Subject|3|||
162946698|NCT00320112|588506475|FG001|Overall Study|Withdrawal by Subject|0|||
162946699|NCT00320112|588506474|FG000|Overall Study|Death|2|||
162946700|NCT00320112|588506475|FG001|Overall Study|Death|1|||
162946701|NCT02899338|588506476|FG000|Overall Study|Adverse Event|1|||
162946702|NCT02899338|588506477|FG001|Overall Study|Adverse Event|2|||
162946703|NCT02899338|588506476|FG000|Overall Study|Withdrawal by Subject|2|||
162946704|NCT02899338|588506477|FG001|Overall Study|Withdrawal by Subject|0|||
162946705|NCT06179108|588506478|FG000|Overall Study|Withdrawal by Subject|16|||
162946706|NCT06179108|588506479|FG001|Overall Study|Withdrawal by Subject|19|||
162946707|NCT06179108|588506480|FG002|Overall Study|Withdrawal by Subject|10|||
162946708|NCT06179108|588506481|FG003|Overall Study|Withdrawal by Subject|11|||
162946709|NCT06179108|588506478|FG000|Overall Study|Lost to Follow-up|12|||
162946710|NCT06179108|588506479|FG001|Overall Study|Lost to Follow-up|4|||
162946711|NCT06179108|588506480|FG002|Overall Study|Lost to Follow-up|1|||
162946712|NCT06179108|588506481|FG003|Overall Study|Lost to Follow-up|9|||
162946713|NCT06179108|588506478|FG000|Overall Study|Adverse Event|2|||
162946714|NCT06179108|588506479|FG001|Overall Study|Adverse Event|3|||
162946715|NCT06179108|588506480|FG002|Overall Study|Adverse Event|3|||
162946716|NCT06179108|588506481|FG003|Overall Study|Adverse Event|2|||
162946717|NCT06179108|588506478|FG000|Overall Study|Protocol Violation|0|||
162946718|NCT06179108|588506479|FG001|Overall Study|Protocol Violation|1|||
162946719|NCT06179108|588506480|FG002|Overall Study|Protocol Violation|0|||
162946720|NCT06179108|588506481|FG003|Overall Study|Protocol Violation|1|||
162946721|NCT06179108|588506478|FG000|Overall Study|Physician Decision|1|||
162946722|NCT06179108|588506479|FG001|Overall Study|Physician Decision|1|||
162946723|NCT06179108|588506480|FG002|Overall Study|Physician Decision|0|||
162946724|NCT06179108|588506481|FG003|Overall Study|Physician Decision|0|||
162946725|NCT06179108|588506478|FG000|Overall Study|Lack of Efficacy|0|||
162946726|NCT06179108|588506479|FG001|Overall Study|Lack of Efficacy|0|||
162946727|NCT06179108|588506480|FG002|Overall Study|Lack of Efficacy|0|||
162946728|NCT06179108|588506481|FG003|Overall Study|Lack of Efficacy|1|||
162946729|NCT06179108|588506478|FG000|Overall Study|Death|0|||
162946730|NCT06179108|588506479|FG001|Overall Study|Death|0|||
162946731|NCT06179108|588506480|FG002|Overall Study|Death|0|||
162946732|NCT06179108|588506481|FG003|Overall Study|Death|1|||
162946733|NCT00814463|588506482|FG000|Overall Study|Lost to Follow-up|1|||
162946734|NCT01370408|588506484|FG000|Overall Study|treatment failure|9|||
162946735|NCT02780687|588506489|FG000|Overall Study|Adverse Event|1|||
162946736|NCT02780687|588506490|FG001|Overall Study|Adverse Event|1|||
162946737|NCT02780687|588506489|FG000|Overall Study|Withdrawal by Subject|2|||
162946738|NCT02780687|588506490|FG001|Overall Study|Withdrawal by Subject|1|||
162946739|NCT02780687|588506489|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
162946740|NCT02780687|588506490|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
162946741|NCT02780687|588506489|FG000|Overall Study|progressive disease|29|||
162946742|NCT02780687|588506490|FG001|Overall Study|progressive disease|6|||
162946743|NCT00414765|588506492|FG000|Overall Study|Adverse Event|5|||
162946744|NCT00414765|588506493|FG001|Overall Study|Adverse Event|9|||
162946745|NCT00414765|588506492|FG000|Overall Study|Withdrawal by Subject|1|||
162946746|NCT00414765|588506493|FG001|Overall Study|Withdrawal by Subject|1|||
162946747|NCT00414765|588506492|FG000|Overall Study|Disease Progression|0|||
162946748|NCT00414765|588506493|FG001|Overall Study|Disease Progression|1|||
162946749|NCT05694013|588506495|FG000|Overall Study|Death|6|||
162946750|NCT05694013|588506496|FG001|Overall Study|Death|2|||
162946751|NCT05694013|588506495|FG000|Overall Study|Participant Decision|0|||
162946752|NCT05694013|588506496|FG001|Overall Study|Participant Decision|1|||
162946753|NCT05694013|588506495|FG000|Overall Study|Physician Decision|1|||
162946754|NCT05694013|588506496|FG001|Overall Study|Physician Decision|0|||
162946755|NCT05694013|588506495|FG000|Overall Study|Progressive Disease|0|||
162946756|NCT05694013|588506496|FG001|Overall Study|Progressive Disease|1|||
162946757|NCT05694013|588506495|FG000|Overall Study|Study Terminated by Sponsor|12|||
162946758|NCT05694013|588506496|FG001|Overall Study|Study Terminated by Sponsor|17|||
162946759|NCT05694013|588506495|FG000|Overall Study|Withdrawal by Subject|3|||
162946760|NCT05694013|588506496|FG001|Overall Study|Withdrawal by Subject|0|||
162946761|NCT01199861|588506497|FG000|Overall Study|Administrative problems|1|||
162946762|NCT01199861|588506498|FG001|Overall Study|Administrative problems|0|||
162946763|NCT01199861|588506497|FG000|Overall Study|Adverse Event|1|||
162946764|NCT01199861|588506498|FG001|Overall Study|Adverse Event|0|||
162946765|NCT04817891|588506499|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
162946766|NCT04817891|588506499|FG000|Overall Study|Adverse Event|1|||
162946767|NCT04817891|588506499|FG000|Overall Study|Withdrawal by Subject|1|||
162946768|NCT03982433|588506500|FG000|Overall Study|Lost to Follow-up|1|||
162946769|NCT04256421|588506503|FG000|Overall Study|Death|171|||
162946770|NCT04256421|588506504|FG001|Overall Study|Death|180|||
162946771|NCT04256421|588506503|FG000|Overall Study|Lost to Follow-up|1|||
162946772|NCT04256421|588506504|FG001|Overall Study|Lost to Follow-up|1|||
162946773|NCT04256421|588506503|FG000|Overall Study|Withdrawal by Subject|9|||
162946774|NCT04256421|588506504|FG001|Overall Study|Withdrawal by Subject|10|||
162946775|NCT04256421|588506503|FG000|Overall Study|Ongoing in Study|66|||
162946776|NCT04256421|588506504|FG001|Overall Study|Ongoing in Study|52|||
162946777|NCT00419770|588508090|FG000|Overall Study|Withdrawal by Subject|5|||
162946778|NCT00419770|588508091|FG001|Overall Study|Withdrawal by Subject|1|||
162946779|NCT02424188|588508099|FG000|Overall Study|Death|2|||
162946780|NCT02424188|588508100|FG001|Overall Study|Death|2|||
162946781|NCT02424188|588508099|FG000|Overall Study|Lost to Follow-up|1|||
162946782|NCT02424188|588508100|FG001|Overall Study|Lost to Follow-up|3|||
162832419|NCT00531752|588098298|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
162832420|NCT02821715|588098299|FG000|Overall Study|Protocol Violation|1|||
162832421|NCT02821715|588098300|FG001|Overall Study|Protocol Violation|0|||
162832422|NCT02821715|588098301|FG002|Overall Study|Protocol Violation|0|||
162832423|NCT02821715|588098302|FG003|Overall Study|Protocol Violation|0|||
162832424|NCT02821715|588098303|FG004|Overall Study|Protocol Violation|0|||
162832425|NCT02821715|588098304|FG005|Overall Study|Protocol Violation|0|||
162832426|NCT00640328|588098305|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
162832427|NCT00640328|588098306|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
162832428|NCT00640328|588098307|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
162832429|NCT00640328|588098308|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
162832430|NCT00640328|588098309|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
162832431|NCT00640328|588098310|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
162832432|NCT00640328|588098305|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
162832433|NCT00640328|588098306|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
162832434|NCT00640328|588098307|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
162832435|NCT00640328|588098308|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
162832436|NCT00640328|588098309|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
162832437|NCT00640328|588098310|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
162832438|NCT00640328|588098305|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
162832439|NCT00640328|588098306|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
162832440|NCT00640328|588098307|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
162832441|NCT00640328|588098308|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
162832442|NCT00640328|588098309|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
162832443|NCT00640328|588098310|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
162832444|NCT00640328|588098305|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
162832445|NCT00640328|588098306|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
162832446|NCT00640328|588098307|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
162832447|NCT00640328|588098308|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
162832448|NCT00640328|588098309|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
162832449|NCT00640328|588098310|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
162832450|NCT02374099|588098313|FG000|Overall Study|Adverse Event|1|||
162832451|NCT02374099|588098314|FG001|Overall Study|Adverse Event|0|||
162832452|NCT02374099|588098313|FG000|Overall Study|Progressive Disease|35|||
162832453|NCT02374099|588098314|FG001|Overall Study|Progressive Disease|40|||
162832454|NCT02374099|588098313|FG000|Overall Study|Withdrawal by Subject|5|||
162832455|NCT02374099|588098314|FG001|Overall Study|Withdrawal by Subject|1|||
162832456|NCT02374099|588098313|FG000|Overall Study|Miscellaneous|2|||
162832457|NCT02374099|588098314|FG001|Overall Study|Miscellaneous|3|||
162832458|NCT02374099|588098313|FG000|Overall Study|Randomized, but not treated|2|||
162832459|NCT02374099|588098314|FG001|Overall Study|Randomized, but not treated|1|||
162832460|NCT02374099|588098313|FG000|Overall Study|Study Terminated by Sponsor|3|||
162832461|NCT02374099|588098314|FG001|Overall Study|Study Terminated by Sponsor|4|||
162832462|NCT01033825|588098315|FG000|Overall Study|Withdrawal by Subject|2|||
162832463|NCT01033825|588098316|FG001|Overall Study|Withdrawal by Subject|3|||
162832464|NCT01033825|588098317|FG002|Overall Study|Withdrawal by Subject|2|||
162832465|NCT01033825|588098318|FG003|Overall Study|Withdrawal by Subject|1|||
162832466|NCT01033825|588098319|FG004|Overall Study|Withdrawal by Subject|1|||
162832467|NCT01033825|588098320|FG005|Overall Study|Withdrawal by Subject|0|||
162832468|NCT01033825|588098321|FG006|Overall Study|Withdrawal by Subject|0|||
162832469|NCT01033825|588098315|FG000|Overall Study|Adverse Event|0|||
162832470|NCT01033825|588098316|FG001|Overall Study|Adverse Event|0|||
162832471|NCT01033825|588098317|FG002|Overall Study|Adverse Event|0|||
162832472|NCT01033825|588098318|FG003|Overall Study|Adverse Event|1|||
162832473|NCT01033825|588098319|FG004|Overall Study|Adverse Event|0|||
162832474|NCT01033825|588098320|FG005|Overall Study|Adverse Event|0|||
162832475|NCT01033825|588098321|FG006|Overall Study|Adverse Event|0|||
162832476|NCT01033825|588098315|FG000|Overall Study|Protocol Violation|1|||
162832477|NCT01033825|588098316|FG001|Overall Study|Protocol Violation|0|||
162832478|NCT01033825|588098317|FG002|Overall Study|Protocol Violation|0|||
162832479|NCT01033825|588098318|FG003|Overall Study|Protocol Violation|0|||
162832480|NCT01033825|588098319|FG004|Overall Study|Protocol Violation|0|||
162832481|NCT01033825|588098320|FG005|Overall Study|Protocol Violation|0|||
162832482|NCT01033825|588098321|FG006|Overall Study|Protocol Violation|0|||
162832483|NCT01033825|588098315|FG000|Overall Study|Other|0|||
162832484|NCT01033825|588098316|FG001|Overall Study|Other|0|||
162832485|NCT01033825|588098317|FG002|Overall Study|Other|0|||
162832486|NCT01033825|588098318|FG003|Overall Study|Other|0|||
162832487|NCT01033825|588098319|FG004|Overall Study|Other|1|||
162832488|NCT01033825|588098320|FG005|Overall Study|Other|0|||
162832489|NCT01033825|588098321|FG006|Overall Study|Other|0|||
162832490|NCT04294719|588098322|FG000|Overall Study|Withdrawal by Subject|1|||
162832491|NCT01714687|588098323|FG000|Overall Study|Withdrawal by Subject|1|||
162946783|NCT02424188|588508099|FG000|Overall Study|Incarceration|1|||
162946784|NCT02424188|588508100|FG001|Overall Study|Incarceration|0|||
162946785|NCT00453362|588508105|FG000|Overall Study|Adverse Event|5|||
162946786|NCT00453362|588508105|FG000|Overall Study|Death|7|||
162946787|NCT00453362|588508105|FG000|Overall Study|Physician Decision|2|||
162946788|NCT00453362|588508105|FG000|Overall Study|Withdrawal by Subject|3|||
162946789|NCT00453362|588508105|FG000|Overall Study|Progression of disease|56|||
162946790|NCT00453362|588508105|FG000|Overall Study|Screening Failure|14|||
162946791|NCT04885296|588508106|FG000|Period 1|Covid-19 Related|1|||
162946792|NCT04885296|588508107|FG001|Period 1|Covid-19 Related|0|||
162946793|NCT04885296|588508106|FG000|Period 1|Adverse Event|0|||
162946794|NCT04885296|588508107|FG001|Period 1|Adverse Event|1|||
162946795|NCT04885296|588508106|FG000|Period 1|Withdrawal by Subject|1|||
162946796|NCT04885296|588508107|FG001|Period 1|Withdrawal by Subject|1|||
162946797|NCT04885296|588508106|FG000|Period 1|Test Article No Longer Available|1|||
162946798|NCT04885296|588508107|FG001|Period 1|Test Article No Longer Available|0|||
162946799|NCT04885296|588508106|FG000|Period 1|Dispensed Study lens in Error|1|||
162946800|NCT04885296|588508107|FG001|Period 1|Dispensed Study lens in Error|0|||
162946801|NCT04885296|588508106|FG000|Period 1|Lost to Follow-up|1|||
162946802|NCT04885296|588508107|FG001|Period 1|Lost to Follow-up|0|||
162946803|NCT04885296|588508106|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
162946804|NCT04885296|588508107|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
162946805|NCT00433147|588508108|FG000|Overall Study|Adverse Event|0|||
162946806|NCT00433147|588508109|FG001|Overall Study|Adverse Event|1|||
162946807|NCT00433147|588508110|FG002|Overall Study|Adverse Event|0|||
162946808|NCT00433147|588508111|FG003|Overall Study|Adverse Event|0|||
162946809|NCT04510857|588508115|FG000|Overall Study|Withdrawal by Subject|1|||
162946810|NCT04510857|588508116|FG001|Overall Study|Withdrawal by Subject|2|||
162946811|NCT01124149|588508119|FG000|Acute Phase|Withdrawal by Subject|22|||
162946812|NCT01124149|588508119|FG000|Acute Phase|Adverse Event|21|||
162946813|NCT01124149|588508119|FG000|Acute Phase|Lack of Efficacy|17|||
162946814|NCT01124149|588508119|FG000|Acute Phase|Protocol Violation|14|||
162946815|NCT01124149|588508119|FG000|Acute Phase|Lost to Follow-up|2|||
162946816|NCT01124149|588508119|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
162946817|NCT01124149|588508119|FG000|Acute Phase|Sponsor request|1|||
162946818|NCT01124149|588508119|FG000|Acute Phase|UC symptoms not ameliorated|1|||
162946819|NCT01124149|588508119|FG000|Acute Phase|Non-compliance|1|||
162946820|NCT01124149|588508119|FG000|Acute Phase|Low hemoglobin|1|||
162946821|NCT01124149|588508119|FG000|Acute Phase|Travelling to another country|1|||
162946822|NCT01124149|588508119|FG000|Acute Phase|Sponsor decision|1|||
162946823|NCT01124149|588508119|FG000|Maintenance Phase|Lack of Efficacy|40|||
162946824|NCT01124149|588508119|FG000|Maintenance Phase|Adverse Event|24|||
162946825|NCT01124149|588508119|FG000|Maintenance Phase|Lost to Follow-up|15|||
162946826|NCT01124149|588508119|FG000|Maintenance Phase|Withdrawal by Subject|10|||
162946827|NCT01124149|588508119|FG000|Maintenance Phase|Protocol Violation|5|||
162946828|NCT01124149|588508119|FG000|Maintenance Phase|Coordinator error|1|||
162946829|NCT01124149|588508119|FG000|Maintenance Phase|Non-compliance|1|||
162946830|NCT00977106|588508120|FG000|Overall Study|Adverse Event|5|||
162946831|NCT00977106|588508121|FG001|Overall Study|Adverse Event|6|||
162946832|NCT00977106|588508120|FG000|Overall Study|Withdrawal by Subject|2|||
162946833|NCT00977106|588508121|FG001|Overall Study|Withdrawal by Subject|2|||
162946834|NCT00977106|588508120|FG000|Overall Study|Lack of Efficacy|2|||
162946835|NCT00977106|588508121|FG001|Overall Study|Lack of Efficacy|2|||
162946836|NCT00977106|588508120|FG000|Overall Study|Protocol Violation|0|||
162946837|NCT00977106|588508121|FG001|Overall Study|Protocol Violation|1|||
162946838|NCT00977106|588508120|FG000|Overall Study|Other|1|||
162946839|NCT00977106|588508121|FG001|Overall Study|Other|0|||
162946840|NCT01644500|588508122|FG000|Overall Study|Adverse Event|6|||
162946841|NCT01644500|588508123|FG001|Overall Study|Adverse Event|1|||
162946842|NCT01644500|588508124|FG002|Overall Study|Adverse Event|2|||
162946843|NCT01644500|588508122|FG000|Overall Study|Death|0|||
162946844|NCT01644500|588508123|FG001|Overall Study|Death|1|||
162946845|NCT01644500|588508124|FG002|Overall Study|Death|0|||
162946846|NCT01644500|588508122|FG000|Overall Study|Lost to Follow-up|3|||
162946847|NCT01644500|588508123|FG001|Overall Study|Lost to Follow-up|8|||
162946848|NCT01644500|588508124|FG002|Overall Study|Lost to Follow-up|0|||
162946849|NCT01644500|588508122|FG000|Overall Study|Protocol Violation|1|||
162946850|NCT01644500|588508123|FG001|Overall Study|Protocol Violation|1|||
162946851|NCT01644500|588508124|FG002|Overall Study|Protocol Violation|0|||
162946852|NCT01644500|588508122|FG000|Overall Study|Withdrawal by Subject|11|||
162946853|NCT01644500|588508123|FG001|Overall Study|Withdrawal by Subject|12|||
162946854|NCT01644500|588508124|FG002|Overall Study|Withdrawal by Subject|12|||
162946855|NCT01644500|588508122|FG000|Overall Study|Physician Decision|1|||
162946856|NCT01644500|588508123|FG001|Overall Study|Physician Decision|1|||
162946857|NCT01644500|588508124|FG002|Overall Study|Physician Decision|1|||
162946858|NCT05518487|588508127|FG000|Overall Study|Withdrawal by Subject|3|||
162946859|NCT00543309|588508128|FG000|Overall Study|Physician Decision|0|||
162946860|NCT00543309|588508129|FG001|Overall Study|Physician Decision|1|||
162946861|NCT00543309|588508130|FG002|Overall Study|Physician Decision|0|||
162946862|NCT05014412|588508137|FG000|Overall Study|Death|11|||
162946863|NCT05014412|588508138|FG001|Overall Study|Death|7|||
162946864|NCT05014412|588508139|FG002|Overall Study|Death|4|||
162946865|NCT05014412|588508140|FG003|Overall Study|Death|7|||
162946866|NCT05014412|588508137|FG000|Overall Study|Withdrawal by Subject|1|||
162946867|NCT05014412|588508138|FG001|Overall Study|Withdrawal by Subject|1|||
162946868|NCT05014412|588508139|FG002|Overall Study|Withdrawal by Subject|1|||
162946869|NCT05014412|588508140|FG003|Overall Study|Withdrawal by Subject|2|||
162946870|NCT05014412|588508137|FG000|Overall Study|Ongoing|21|||
162946871|NCT05014412|588508138|FG001|Overall Study|Ongoing|4|||
162946872|NCT05014412|588508139|FG002|Overall Study|Ongoing|6|||
162946873|NCT05014412|588508140|FG003|Overall Study|Ongoing|20|||
162946874|NCT02353169|588508141|FG000|Overall Study|QTc > 450 msec|1|||
162946875|NCT02353169|588508142|FG001|Overall Study|QTc > 450 msec|1|||
162946876|NCT02353169|588508143|FG002|Overall Study|QTc > 450 msec|1|||
162946877|NCT02353169|588508144|FG003|Overall Study|QTc > 450 msec|1|||
162946878|NCT02353169|588508141|FG000|Overall Study|OR team declined|2|||
162946879|NCT02353169|588508142|FG001|Overall Study|OR team declined|0|||
162946880|NCT02353169|588508143|FG002|Overall Study|OR team declined|0|||
162946881|NCT02353169|588508144|FG003|Overall Study|OR team declined|0|||
162946882|NCT02353169|588508141|FG000|Overall Study|Inhalational induction|0|||
162946883|NCT02353169|588508142|FG001|Overall Study|Inhalational induction|2|||
162946884|NCT02353169|588508143|FG002|Overall Study|Inhalational induction|0|||
162946885|NCT02353169|588508144|FG003|Overall Study|Inhalational induction|0|||
162946886|NCT02353169|588508141|FG000|Overall Study|ECG data error|0|||
162946887|NCT02353169|588508142|FG001|Overall Study|ECG data error|3|||
162946888|NCT02353169|588508143|FG002|Overall Study|ECG data error|2|||
162832492|NCT01714687|588098324|FG001|Overall Study|Withdrawal by Subject|0|||
162832493|NCT01714687|588098323|FG000|Overall Study|Lost to Follow-up|2|||
162832494|NCT01714687|588098324|FG001|Overall Study|Lost to Follow-up|4|||
162832495|NCT00788372|588098325|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
162832496|NCT00788372|588098325|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
162832497|NCT00788372|588098325|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
162832498|NCT00788372|588098325|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
162832499|NCT00788372|588098325|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
162832500|NCT00788372|588098325|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
162832501|NCT00788372|588098325|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
162832502|NCT01464307|588098330|FG000|Main Period|Death|0|||
162832503|NCT01464307|588098331|FG001|Main Period|Death|1|||
162832504|NCT01464307|588098330|FG000|Main Period|Adverse Event|6|||
162832505|NCT01464307|588098331|FG001|Main Period|Adverse Event|1|||
162832506|NCT01464307|588098330|FG000|Main Period|Lack of Efficacy|2|||
162946889|NCT02353169|588508144|FG003|Overall Study|ECG data error|2|||
162946890|NCT02353169|588508141|FG000|Overall Study|Pre-op medication|0|||
162946891|NCT02353169|588508142|FG001|Overall Study|Pre-op medication|0|||
162946892|NCT02353169|588508143|FG002|Overall Study|Pre-op medication|1|||
162946893|NCT02353169|588508144|FG003|Overall Study|Pre-op medication|0|||
162946894|NCT00486837|588508145|FG000|Overall Study|Withdrawal by Subject|1|||
162946895|NCT00486837|588508146|FG001|Overall Study|Withdrawal by Subject|0|||
162946896|NCT00486837|588508145|FG000|Overall Study|Adverse Event|1|||
162946897|NCT00486837|588508146|FG001|Overall Study|Adverse Event|1|||
162946898|NCT00486837|588508145|FG000|Overall Study|Protocol Violation|4|||
162946899|NCT00486837|588508146|FG001|Overall Study|Protocol Violation|2|||
162946900|NCT00486837|588508145|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
162946901|NCT00486837|588508146|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
162946902|NCT05295953|588508147|FG000|Overall Study|Withdrawal by Subject|0|||
162946903|NCT05295953|588508148|FG001|Overall Study|Withdrawal by Subject|1|||
162946904|NCT04981912|588508150|FG000|Overall Study|Physician Decision|2|||
162946905|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946906|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
162946907|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946908|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
162946909|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
162946910|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
162946911|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
162946912|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
162946913|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946914|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
162946915|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946916|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
162946917|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
162946918|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
162946919|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
162946920|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
162946921|NCT05630547|588508153|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946922|NCT05630547|588508154|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
162946923|NCT05630547|588508155|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946924|NCT05630547|588508156|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
162946925|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
162946926|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
162946927|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
162946928|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
162946929|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946930|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946931|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
162946932|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
162946933|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
162832507|NCT01464307|588098331|FG001|Main Period|Lack of Efficacy|0|||
162832508|NCT01464307|588098330|FG000|Main Period|Withdrawal by Subject|5|||
162832509|NCT01464307|588098331|FG001|Main Period|Withdrawal by Subject|2|||
162832510|NCT01464307|588098330|FG000|Main Period|Predefined discontinuation criteria|2|||
162832511|NCT01464307|588098331|FG001|Main Period|Predefined discontinuation criteria|1|||
162832512|NCT01464307|588098330|FG000|Open-Label Extension Period|Adverse Event|15|||
162832513|NCT01464307|588098331|FG001|Open-Label Extension Period|Adverse Event|0|||
162699067|NCT00593554|587608147|FG000|Overall Study|Death|1|||
162699068|NCT00593554|587608148|FG001|Overall Study|Death|2|||
162699069|NCT00593554|587608147|FG000|Overall Study|Physician Decision|0|||
162699070|NCT00593554|587608148|FG001|Overall Study|Physician Decision|1|||
162832514|NCT01464307|588098330|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
162832515|NCT01464307|588098331|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
162832516|NCT01464307|588098330|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
162832517|NCT01464307|588098331|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
162832518|NCT01464307|588098330|FG000|Open-Label Extension Period|Death|1|||
162832519|NCT01464307|588098331|FG001|Open-Label Extension Period|Death|0|||
162832520|NCT01464307|588098330|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
162832521|NCT01464307|588098331|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
162832522|NCT01464307|588098330|FG000|Open-Label Extension Period|Non-compliance|9|||
162832523|NCT01464307|588098331|FG001|Open-Label Extension Period|Non-compliance|0|||
162832524|NCT01464307|588098330|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
162832525|NCT01464307|588098331|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
162832526|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Death|3|||
162832527|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Death|0|||
162832528|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Adverse Event|12|||
162832529|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Adverse Event|6|||
162832530|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
162832531|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
162832532|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
162832533|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
162832534|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
162832535|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
162832536|NCT00159861|588098334|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
162832537|NCT00159861|588098335|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
162832538|NCT00159861|588098334|FG000|Extension Study - up to 3 Years|Death|24|||
162832539|NCT00159861|588098335|FG001|Extension Study - up to 3 Years|Death|28|||
162832540|NCT00159861|588098334|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
162832541|NCT00159861|588098335|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
162832542|NCT00159861|588098334|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
162832543|NCT00159861|588098335|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
162832544|NCT00159861|588098334|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
162832545|NCT00159861|588098335|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
162832546|NCT00159861|588098334|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
162832547|NCT00159861|588098335|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
162832548|NCT03349099|588098336|FG000|Overall Study|Physician Decision|3|||
162832549|NCT03349099|588098337|FG001|Overall Study|Physician Decision|4|||
162832550|NCT03349099|588098336|FG000|Overall Study|Stone migrated from the kidney|1|||
162832551|NCT03349099|588098337|FG001|Overall Study|Stone migrated from the kidney|0|||
162832552|NCT01210690|588098339|FG000|Overall Study|Adverse Event|7|||
162832553|NCT01210690|588098339|FG000|Overall Study|Lack of Efficacy|12|||
162832554|NCT01210690|588098339|FG000|Overall Study|Lost to Follow-up|3|||
162832555|NCT01210690|588098339|FG000|Overall Study|Disease Remission|1|||
162832556|NCT01210690|588098339|FG000|Overall Study|Withdrawal by Subject|1|||
162832557|NCT01210690|588098339|FG000|Overall Study|Patient refused to swallow|1|||
162832558|NCT01210690|588098339|FG000|Overall Study|Patient could not take glucose|1|||
162832559|NCT00894556|588098340|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
162832560|NCT00894556|588098341|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
162832561|NCT00894556|588098342|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
162832562|NCT00894556|588098343|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
162832563|NCT00894556|588098340|FG000|Treatment Phase|Lost to Follow-up|2|||
162832564|NCT00894556|588098341|FG001|Treatment Phase|Lost to Follow-up|3|||
162832565|NCT00894556|588098342|FG002|Treatment Phase|Lost to Follow-up|1|||
162832566|NCT00894556|588098343|FG003|Treatment Phase|Lost to Follow-up|0|||
162832567|NCT00894556|588098340|FG000|Treatment Phase|Lack of Qualifying Event|2|||
162699071|NCT00593554|587608147|FG000|Overall Study|Withdrawal by Subject|1|||
162832568|NCT00894556|588098341|FG001|Treatment Phase|Lack of Qualifying Event|1|||
162832569|NCT00894556|588098342|FG002|Treatment Phase|Lack of Qualifying Event|0|||
162832570|NCT00894556|588098343|FG003|Treatment Phase|Lack of Qualifying Event|0|||
162832571|NCT00528021|588098347|FG000|Overall Study|Lack of Efficacy|17|||
162832572|NCT00528021|588098348|FG001|Overall Study|Lack of Efficacy|13|||
162832573|NCT00528021|588098349|FG002|Overall Study|Lack of Efficacy|7|||
162832574|NCT00528021|588098350|FG003|Overall Study|Lack of Efficacy|9|||
162832575|NCT05054114|588098354|FG000|Overall Study|Protocol Violation|13|||
162832576|NCT05054114|588098355|FG001|Overall Study|Protocol Violation|1|||
162699072|NCT00593554|587608148|FG001|Overall Study|Withdrawal by Subject|0|||
162699073|NCT00593554|587608147|FG000|Overall Study|Disease Progression|1|||
162699074|NCT00593554|587608148|FG001|Overall Study|Disease Progression|2|||
162946934|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
162946935|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
162946936|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
162946937|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
162946938|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
162946939|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
162946940|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
162946941|NCT05630547|588508153|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
162946942|NCT05630547|588508154|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
162946943|NCT05630547|588508155|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
162699075|NCT00795132|587608151|FG000|Overall Study|Death|1|||
162946944|NCT05630547|588508156|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
162946945|NCT05049460|588508157|FG000|Overall Study|Withdrawal by Subject|2|||
162946946|NCT05049460|588508158|FG001|Overall Study|Withdrawal by Subject|2|||
162946947|NCT05049460|588508157|FG000|Overall Study|Lost to Follow-up|2|||
162946948|NCT05049460|588508158|FG001|Overall Study|Lost to Follow-up|2|||
162946949|NCT00368277|588508161|FG000|Overall Study|Adverse Event|33|||
162946950|NCT00368277|588508162|FG001|Overall Study|Adverse Event|49|||
162946951|NCT00368277|588508161|FG000|Overall Study|Death|2|||
162946952|NCT00368277|588508162|FG001|Overall Study|Death|1|||
162946953|NCT00368277|588508161|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
162946954|NCT00368277|588508162|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
162946955|NCT00368277|588508161|FG000|Overall Study|Protocol deviation|7|||
162946956|NCT00368277|588508162|FG001|Overall Study|Protocol deviation|0|||
162946957|NCT00368277|588508161|FG000|Overall Study|Patient withdrew consent|32|||
162946958|NCT00368277|588508162|FG001|Overall Study|Patient withdrew consent|28|||
162946959|NCT00368277|588508161|FG000|Overall Study|Lost to Follow-up|8|||
162946960|NCT00368277|588508162|FG001|Overall Study|Lost to Follow-up|6|||
162946961|NCT00117949|588508165|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
162946962|NCT00117949|588508166|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
162946963|NCT00117949|588508167|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
162946964|NCT00117949|588508168|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
162946965|NCT00117949|588508165|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
162946966|NCT00117949|588508166|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
162946967|NCT00117949|588508167|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
162946968|NCT00117949|588508168|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
162946969|NCT00117949|588508165|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
162946970|NCT00117949|588508166|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
162946971|NCT00117949|588508167|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
162946972|NCT00117949|588508168|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
162946973|NCT00117949|588508165|FG000|Overall Study|PSA increase >=10ng/mL|0|||
162946974|NCT00117949|588508166|FG001|Overall Study|PSA increase >=10ng/mL|1|||
162946975|NCT00117949|588508167|FG002|Overall Study|PSA increase >=10ng/mL|1|||
162946976|NCT00117949|588508168|FG003|Overall Study|PSA increase >=10ng/mL|0|||
162946977|NCT00117949|588508165|FG000|Overall Study|PSA reduction <=50%|0|||
162946978|NCT00117949|588508166|FG001|Overall Study|PSA reduction <=50%|2|||
162946979|NCT00117949|588508167|FG002|Overall Study|PSA reduction <=50%|2|||
162946980|NCT00117949|588508168|FG003|Overall Study|PSA reduction <=50%|4|||
162946981|NCT00117949|588508165|FG000|Overall Study|Hepatic abnormalities|0|||
162946982|NCT00117949|588508166|FG001|Overall Study|Hepatic abnormalities|1|||
162946983|NCT00117949|588508167|FG002|Overall Study|Hepatic abnormalities|0|||
162946984|NCT00117949|588508168|FG003|Overall Study|Hepatic abnormalities|1|||
162946985|NCT01974141|588508169|FG000|Overall Study|Other Reasons|28|||
162946986|NCT01974141|588508170|FG001|Overall Study|Other Reasons|18|||
162946987|NCT01974141|588508169|FG000|Overall Study|Protocol Violation|2|||
162946988|NCT01974141|588508170|FG001|Overall Study|Protocol Violation|6|||
162946989|NCT01974141|588508169|FG000|Overall Study|Personal Reasons|21|||
162946990|NCT01974141|588508170|FG001|Overall Study|Personal Reasons|20|||
162946991|NCT01974141|588508169|FG000|Overall Study|Lost to Follow-up|38|||
162946992|NCT01974141|588508170|FG001|Overall Study|Lost to Follow-up|29|||
162946993|NCT01974141|588508169|FG000|Overall Study|Pregnancy|3|||
162946994|NCT01974141|588508170|FG001|Overall Study|Pregnancy|3|||
162946995|NCT01974141|588508169|FG000|Overall Study|Lack of Efficacy|0|||
162832577|NCT05054114|588098354|FG000|Overall Study|Pregnancy|0|||
162832578|NCT05054114|588098355|FG001|Overall Study|Pregnancy|1|||
162832579|NCT01806779|588098356|FG000|Overall Study|Physician Decision|2|||
162832580|NCT01806779|588098357|FG001|Overall Study|Physician Decision|0|||
162832581|NCT01806779|588098358|FG002|Overall Study|Physician Decision|1|||
162832582|NCT01806779|588098356|FG000|Overall Study|Lack of Efficacy|1|||
162832583|NCT01806779|588098357|FG001|Overall Study|Lack of Efficacy|1|||
162832584|NCT01806779|588098358|FG002|Overall Study|Lack of Efficacy|0|||
162832585|NCT01806779|588098356|FG000|Overall Study|Lost to Follow-up|19|||
162832586|NCT01806779|588098357|FG001|Overall Study|Lost to Follow-up|20|||
162832587|NCT01806779|588098358|FG002|Overall Study|Lost to Follow-up|0|||
162832588|NCT01806779|588098356|FG000|Overall Study|Withdrawal by Subject|20|||
162832589|NCT01806779|588098357|FG001|Overall Study|Withdrawal by Subject|23|||
162832590|NCT01806779|588098358|FG002|Overall Study|Withdrawal by Subject|22|||
162832591|NCT00805480|588098359|FG000|Overall Study|Withdrawal by Subject|13|||
162832592|NCT00805480|588098360|FG001|Overall Study|Withdrawal by Subject|5|||
162832593|NCT00805480|588098361|FG002|Overall Study|Withdrawal by Subject|11|||
162832594|NCT00805480|588098362|FG003|Overall Study|Withdrawal by Subject|5|||
162832595|NCT00805480|588098359|FG000|Overall Study|Lost to Follow-up|1|||
162832596|NCT00805480|588098360|FG001|Overall Study|Lost to Follow-up|2|||
162832597|NCT00805480|588098361|FG002|Overall Study|Lost to Follow-up|0|||
162832598|NCT00805480|588098362|FG003|Overall Study|Lost to Follow-up|0|||
162832599|NCT00805480|588098359|FG000|Overall Study|Adverse Event|0|||
162832600|NCT00805480|588098360|FG001|Overall Study|Adverse Event|0|||
162832601|NCT00805480|588098361|FG002|Overall Study|Adverse Event|1|||
162832602|NCT00805480|588098362|FG003|Overall Study|Adverse Event|0|||
162832603|NCT03077685|588098365|FG000|Overall Study|Lost to Follow-up|0|||
162832604|NCT03077685|588098366|FG001|Overall Study|Lost to Follow-up|0|||
162832605|NCT03077685|588098367|FG002|Overall Study|Lost to Follow-up|0|||
162832606|NCT03077685|588098368|FG003|Overall Study|Lost to Follow-up|0|||
162832607|NCT03077685|588098369|FG004|Overall Study|Lost to Follow-up|1|||
162832608|NCT03077685|588098365|FG000|Overall Study|Death|0|||
162832609|NCT03077685|588098366|FG001|Overall Study|Death|0|||
162832610|NCT03077685|588098367|FG002|Overall Study|Death|1|||
162832611|NCT03077685|588098368|FG003|Overall Study|Death|1|||
162832612|NCT03077685|588098369|FG004|Overall Study|Death|3|||
162832613|NCT03077685|588098365|FG000|Overall Study|Withdrawal by Subject|0|||
162832614|NCT03077685|588098366|FG001|Overall Study|Withdrawal by Subject|0|||
162832615|NCT03077685|588098367|FG002|Overall Study|Withdrawal by Subject|0|||
162832616|NCT03077685|588098368|FG003|Overall Study|Withdrawal by Subject|2|||
162832617|NCT03077685|588098369|FG004|Overall Study|Withdrawal by Subject|1|||
162832618|NCT03077685|588098365|FG000|Overall Study|Physician Decision|0|||
162832619|NCT03077685|588098366|FG001|Overall Study|Physician Decision|0|||
162946996|NCT01974141|588508170|FG001|Overall Study|Lack of Efficacy|1|||
162946997|NCT01974141|588508169|FG000|Overall Study|Adverse Event|4|||
162946998|NCT01974141|588508170|FG001|Overall Study|Adverse Event|5|||
162832620|NCT03077685|588098367|FG002|Overall Study|Physician Decision|1|||
162832621|NCT03077685|588098368|FG003|Overall Study|Physician Decision|0|||
162832622|NCT03077685|588098369|FG004|Overall Study|Physician Decision|3|||
162832623|NCT03077685|588098365|FG000|Overall Study|Disease Progression|1|||
162832624|NCT03077685|588098366|FG001|Overall Study|Disease Progression|0|||
162832625|NCT03077685|588098367|FG002|Overall Study|Disease Progression|0|||
162832626|NCT03077685|588098368|FG003|Overall Study|Disease Progression|2|||
162832627|NCT03077685|588098369|FG004|Overall Study|Disease Progression|1|||
162832628|NCT03077685|588098365|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
162946999|NCT04028843|588508171|FG000|Overall Study|Lost to Follow-up|32|||
162832629|NCT03077685|588098366|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
162832630|NCT03077685|588098367|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
162832631|NCT03077685|588098368|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
162832632|NCT03077685|588098369|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
162832633|NCT03077685|588098365|FG000|Overall Study|Subject entered hospice care|0|||
162832634|NCT03077685|588098366|FG001|Overall Study|Subject entered hospice care|0|||
162832635|NCT03077685|588098367|FG002|Overall Study|Subject entered hospice care|0|||
162832636|NCT03077685|588098368|FG003|Overall Study|Subject entered hospice care|0|||
162832637|NCT03077685|588098369|FG004|Overall Study|Subject entered hospice care|1|||
162832638|NCT02116777|588098370|FG000|Overall Study|Adverse Event|0|||
162832639|NCT02116777|588098371|FG001|Overall Study|Adverse Event|0|||
162832640|NCT02116777|588098372|FG002|Overall Study|Adverse Event|0|||
162832641|NCT02116777|588098373|FG003|Overall Study|Adverse Event|0|||
162832642|NCT02116777|588098374|FG004|Overall Study|Adverse Event|2|||
162832643|NCT02116777|588098375|FG005|Overall Study|Adverse Event|2|||
162832644|NCT02116777|588098376|FG006|Overall Study|Adverse Event|0|||
162832645|NCT02116777|588098370|FG000|Overall Study|Death|0|||
162832646|NCT02116777|588098371|FG001|Overall Study|Death|0|||
162832647|NCT02116777|588098372|FG002|Overall Study|Death|0|||
162832648|NCT02116777|588098373|FG003|Overall Study|Death|1|||
162832649|NCT02116777|588098374|FG004|Overall Study|Death|0|||
162832650|NCT02116777|588098375|FG005|Overall Study|Death|0|||
162832651|NCT02116777|588098376|FG006|Overall Study|Death|0|||
162832652|NCT02116777|588098370|FG000|Overall Study|Lack of Efficacy|3|||
162832653|NCT02116777|588098371|FG001|Overall Study|Lack of Efficacy|3|||
162832654|NCT02116777|588098372|FG002|Overall Study|Lack of Efficacy|3|||
162832655|NCT02116777|588098373|FG003|Overall Study|Lack of Efficacy|8|||
162832656|NCT02116777|588098374|FG004|Overall Study|Lack of Efficacy|4|||
162832657|NCT02116777|588098375|FG005|Overall Study|Lack of Efficacy|1|||
162832658|NCT02116777|588098376|FG006|Overall Study|Lack of Efficacy|9|||
162832659|NCT02116777|588098370|FG000|Overall Study|Physician Decision|0|||
162832660|NCT02116777|588098371|FG001|Overall Study|Physician Decision|0|||
162832661|NCT02116777|588098372|FG002|Overall Study|Physician Decision|0|||
162832662|NCT02116777|588098373|FG003|Overall Study|Physician Decision|2|||
162832663|NCT02116777|588098374|FG004|Overall Study|Physician Decision|0|||
162832664|NCT02116777|588098375|FG005|Overall Study|Physician Decision|0|||
162832665|NCT02116777|588098376|FG006|Overall Study|Physician Decision|0|||
162832666|NCT02116777|588098370|FG000|Overall Study|Protocol Violation|0|||
162832667|NCT02116777|588098371|FG001|Overall Study|Protocol Violation|0|||
162832668|NCT02116777|588098372|FG002|Overall Study|Protocol Violation|0|||
162832669|NCT02116777|588098373|FG003|Overall Study|Protocol Violation|1|||
162832670|NCT02116777|588098374|FG004|Overall Study|Protocol Violation|0|||
162832671|NCT02116777|588098375|FG005|Overall Study|Protocol Violation|0|||
162832672|NCT02116777|588098376|FG006|Overall Study|Protocol Violation|0|||
162832673|NCT02116777|588098370|FG000|Overall Study|Withdrawal by Subject|0|||
162832674|NCT02116777|588098371|FG001|Overall Study|Withdrawal by Subject|0|||
162832675|NCT02116777|588098372|FG002|Overall Study|Withdrawal by Subject|0|||
162832676|NCT02116777|588098373|FG003|Overall Study|Withdrawal by Subject|1|||
162832677|NCT02116777|588098374|FG004|Overall Study|Withdrawal by Subject|0|||
162699076|NCT00795132|587608151|FG000|Overall Study|Relapse|2|||
162832678|NCT02116777|588098375|FG005|Overall Study|Withdrawal by Subject|0|||
162832679|NCT02116777|588098376|FG006|Overall Study|Withdrawal by Subject|0|||
162832680|NCT00733954|588098377|FG000|Overall Study|Lost to Follow-up|5|||
162832681|NCT00733954|588098378|FG001|Overall Study|Lost to Follow-up|2|||
162832682|NCT00733954|588098377|FG000|Overall Study|Protocol Violation|1|||
162832683|NCT00733954|588098378|FG001|Overall Study|Protocol Violation|0|||
162832684|NCT00733954|588098377|FG000|Overall Study|Withdrawal by Subject|2|||
162832685|NCT00733954|588098378|FG001|Overall Study|Withdrawal by Subject|0|||
162832686|NCT02663453|588098379|FG000|Overall Study|Death|4|||
162832687|NCT02663453|588098380|FG001|Overall Study|Death|4|||
162832688|NCT02663453|588098379|FG000|Overall Study|Withdrawal by Subject|1|||
162832689|NCT02663453|588098380|FG001|Overall Study|Withdrawal by Subject|0|||
162832690|NCT03770260|588099450|FG000|Overall Study|Disease progression|0|||
162832691|NCT03770260|588099451|FG001|Overall Study|Disease progression|1|||
162832692|NCT03770260|588099452|FG002|Overall Study|Disease progression|0|||
162832693|NCT03770260|588099453|FG003|Overall Study|Disease progression|0|||
162832694|NCT00477165|588099457|FG000|Overall Study|Adverse Event|7|||
162832695|NCT00477165|588099458|FG001|Overall Study|Adverse Event|2|||
162832696|NCT02135692|588099462|FG000|Overall Study|Adverse Event|3|||
162832697|NCT02135692|588099462|FG000|Overall Study|Lack of Efficacy|2|||
162832698|NCT02135692|588099462|FG000|Overall Study|Protocol Violation|2|||
162832699|NCT02135692|588099462|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
162832700|NCT02135692|588099462|FG000|Overall Study|Product commercially available|159|||
162832701|NCT02135692|588099462|FG000|Overall Study|Study closed/terminated|153|||
162832702|NCT02135692|588099462|FG000|Overall Study|Lost to Follow-up|4|||
162832703|NCT02135692|588099462|FG000|Overall Study|Withdrawal by Subject|15|||
162832704|NCT01097746|588099464|FG000|Overall Study|Adverse Event|4|||
162832705|NCT01097746|588099464|FG000|Overall Study|taken off study before any treatment given|1|||
162832706|NCT02495844|588099465|FG000|Overall Study|Lack of Efficacy|1|||
162832707|NCT02495844|588099466|FG001|Overall Study|Lack of Efficacy|2|||
162832708|NCT02495844|588099465|FG000|Overall Study|AE, non-fatal|0|||
162832709|NCT02495844|588099466|FG001|Overall Study|AE, non-fatal|1|||
162832710|NCT02495844|588099465|FG000|Overall Study|Hepatitis Positivity|0|||
162832711|NCT02495844|588099466|FG001|Overall Study|Hepatitis Positivity|1|||
162832712|NCT01514682|588099468|FG000|Overall Study|Withdrawal by Subject|2|||
162832713|NCT01514682|588099469|FG001|Overall Study|Withdrawal by Subject|3|||
162832714|NCT01514682|588099468|FG000|Overall Study|Physician Decision|4|||
162832715|NCT01514682|588099469|FG001|Overall Study|Physician Decision|3|||
162832716|NCT00647556|588099470|FG000|Overall Study|Adverse Event|0|||
162832717|NCT00647556|588099471|FG001|Overall Study|Adverse Event|1|||
162832718|NCT00647556|588099470|FG000|Overall Study|Lost to Follow-up|1|||
162832719|NCT00647556|588099471|FG001|Overall Study|Lost to Follow-up|0|||
162832720|NCT00647556|588099470|FG000|Overall Study|Protocol Violation|0|||
162832721|NCT00647556|588099471|FG001|Overall Study|Protocol Violation|1|||
162832722|NCT00647556|588099470|FG000|Overall Study|Withdrawal by Subject|1|||
162832723|NCT00647556|588099471|FG001|Overall Study|Withdrawal by Subject|0|||
162832724|NCT00647556|588099470|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
162832725|NCT00647556|588099471|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
162832726|NCT00623480|588099472|FG000|Overall Study|Lost to Follow-up|0|||
162832727|NCT00623480|588099473|FG001|Overall Study|Lost to Follow-up|1|||
162832728|NCT00623480|588099472|FG000|Overall Study|Withdrawal by Subject|2|||
162832729|NCT00623480|588099473|FG001|Overall Study|Withdrawal by Subject|4|||
162832730|NCT00623480|588099472|FG000|Overall Study|Lack of Efficacy|1|||
162832731|NCT00623480|588099473|FG001|Overall Study|Lack of Efficacy|0|||
162832732|NCT00623480|588099472|FG000|Overall Study|Non-compliant with study medication|4|||
162832733|NCT00623480|588099473|FG001|Overall Study|Non-compliant with study medication|0|||
162832734|NCT00623480|588099472|FG000|Overall Study|Protocol Violation|0|||
162832735|NCT00623480|588099473|FG001|Overall Study|Protocol Violation|1|||
162832736|NCT00623480|588099472|FG000|Overall Study|Site closed by sponsor|0|||
162832737|NCT00623480|588099473|FG001|Overall Study|Site closed by sponsor|1|||
162832738|NCT01594853|588099474|FG000|Overall Study|Withdrawal by Subject|1|||
162832739|NCT01594853|588099475|FG001|Overall Study|Withdrawal by Subject|1|||
162832740|NCT01594853|588099474|FG000|Overall Study|Lost to Follow-up|1|||
162832741|NCT01594853|588099475|FG001|Overall Study|Lost to Follow-up|1|||
162832742|NCT01594853|588099474|FG000|Overall Study|noncompliance with exercise|0|||
162832743|NCT01594853|588099475|FG001|Overall Study|noncompliance with exercise|1|||
162832744|NCT00769002|588099476|FG000|Overall Study|Study was not completed, no data|9|||
162832745|NCT00769002|588099477|FG001|Overall Study|Study was not completed, no data|9|||
162832746|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
162832747|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
162832748|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
162832749|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
162832750|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
162832751|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
162832752|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
162832753|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
162832754|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
162832755|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
162947000|NCT04028843|588508172|FG001|Overall Study|Lost to Follow-up|39|||
162832756|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
162832757|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
162832758|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
162699077|NCT00358150|587608156|FG000|Overall Study|Adverse Event|3|||
162699078|NCT00358150|587608156|FG000|Overall Study|Withdrawal by Subject|1|||
162699079|NCT00358150|587608156|FG000|Overall Study|Undefined|3|||
162699080|NCT04254679|587608179|FG000|Overall Study|Protocol Violation|1|||
162699081|NCT04254679|587608180|FG001|Overall Study|Protocol Violation|1|||
162699082|NCT04254679|587608179|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
162699083|NCT04254679|587608180|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
162947001|NCT04028843|588508171|FG000|Overall Study|Adverse Event|1|||
162947002|NCT04028843|588508172|FG001|Overall Study|Adverse Event|0|||
162947003|NCT04028843|588508171|FG000|Overall Study|Non-viable Pregnancy|0|||
162947004|NCT04028843|588508172|FG001|Overall Study|Non-viable Pregnancy|1|||
162947005|NCT04028843|588508171|FG000|Overall Study|Withdrawal by Subject|4|||
162947006|NCT04028843|588508172|FG001|Overall Study|Withdrawal by Subject|2|||
162947007|NCT01867242|588508177|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
162947008|NCT01867242|588508178|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
162947009|NCT01867242|588508179|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
162947010|NCT00406848|588508180|FG000|Overall Study|Withdrawal by Subject|27|||
162947011|NCT00406848|588508181|FG001|Overall Study|Withdrawal by Subject|22|||
162947012|NCT00406848|588508180|FG000|Overall Study|Adverse Event|38|||
162947013|NCT00406848|588508181|FG001|Overall Study|Adverse Event|7|||
162947014|NCT00406848|588508180|FG000|Overall Study|Lack of Efficacy|9|||
162947015|NCT00406848|588508181|FG001|Overall Study|Lack of Efficacy|14|||
162947016|NCT00406848|588508180|FG000|Overall Study|Protocol Violation|10|||
162947017|NCT00406848|588508181|FG001|Overall Study|Protocol Violation|6|||
162947018|NCT00406848|588508180|FG000|Overall Study|Lost to Follow-up|6|||
162947019|NCT00406848|588508181|FG001|Overall Study|Lost to Follow-up|2|||
162947020|NCT00406848|588508180|FG000|Overall Study|Physician Decision|2|||
162947021|NCT00406848|588508181|FG001|Overall Study|Physician Decision|2|||
162947022|NCT00406848|588508180|FG000|Overall Study|Sponsor Decision|1|||
162947023|NCT00406848|588508181|FG001|Overall Study|Sponsor Decision|1|||
162947024|NCT04803357|588508182|FG000|Overall Study|Withdrawal by Subject|31|||
162947025|NCT04803357|588508183|FG001|Overall Study|Withdrawal by Subject|5|||
162947026|NCT02879643|588508185|FG000|Overall Study|Adverse Event|0|||
162832759|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
162832760|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
162832761|NCT00960661|588099478|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
162832762|NCT00960661|588099479|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
162832763|NCT00960661|588099480|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
162832764|NCT00960661|588099478|FG000|Interventional Phase|Adverse Event|0|||
162832765|NCT00960661|588099479|FG001|Interventional Phase|Adverse Event|17|||
162832766|NCT00960661|588099480|FG002|Interventional Phase|Adverse Event|8|||
162832767|NCT00960661|588099478|FG000|Interventional Phase|Death|0|||
162832768|NCT00960661|588099479|FG001|Interventional Phase|Death|1|||
162832769|NCT00960661|588099480|FG002|Interventional Phase|Death|0|||
162832770|NCT00960661|588099478|FG000|Interventional Phase|Lost to Follow-up|0|||
162832771|NCT00960661|588099479|FG001|Interventional Phase|Lost to Follow-up|0|||
162832772|NCT00960661|588099480|FG002|Interventional Phase|Lost to Follow-up|2|||
162832773|NCT00960661|588099478|FG000|Interventional Phase|entry criteria not met|0|||
162832774|NCT00960661|588099479|FG001|Interventional Phase|entry criteria not met|3|||
162832775|NCT00960661|588099480|FG002|Interventional Phase|entry criteria not met|0|||
162832776|NCT00960661|588099478|FG000|Interventional Phase|Protocol Violation|0|||
162832777|NCT00960661|588099479|FG001|Interventional Phase|Protocol Violation|7|||
162832778|NCT00960661|588099480|FG002|Interventional Phase|Protocol Violation|2|||
162832779|NCT00960661|588099478|FG000|Interventional Phase|Withdrawal by Subject|0|||
162832780|NCT00960661|588099479|FG001|Interventional Phase|Withdrawal by Subject|18|||
162832781|NCT00960661|588099480|FG002|Interventional Phase|Withdrawal by Subject|29|||
162832782|NCT00960661|588099478|FG000|Interventional Phase|Physician Decision|0|||
162832783|NCT00960661|588099479|FG001|Interventional Phase|Physician Decision|3|||
162832784|NCT00960661|588099480|FG002|Interventional Phase|Physician Decision|5|||
162832785|NCT00960661|588099478|FG000|Interventional Phase|sponsor decision|0|||
162832786|NCT00960661|588099479|FG001|Interventional Phase|sponsor decision|1|||
162832787|NCT00960661|588099480|FG002|Interventional Phase|sponsor decision|0|||
162832788|NCT00960661|588099478|FG000|Interventional Phase|Lack of Efficacy|0|||
162832789|NCT00960661|588099479|FG001|Interventional Phase|Lack of Efficacy|2|||
162832790|NCT00960661|588099480|FG002|Interventional Phase|Lack of Efficacy|0|||
162832791|NCT02699892|588099481|FG000|Overall Study|Other|36|||
162832792|NCT00711100|588099487|FG000|Overall Study|Lack of Efficacy|5|||
162832793|NCT00711100|588099487|FG000|Overall Study|Withdrawal by Subject|8|||
162832794|NCT00847912|588099488|FG000|Overall Study|Protocol Violation|6|||
162832795|NCT00847912|588099489|FG001|Overall Study|Protocol Violation|7|||
162832796|NCT00847912|588099488|FG000|Overall Study|Withdrawal by Subject|3|||
162832797|NCT00847912|588099489|FG001|Overall Study|Withdrawal by Subject|6|||
162832798|NCT02083380|588099490|FG000|Overall Study|Lack of Efficacy|68|||
162832799|NCT02083380|588099491|FG001|Overall Study|Lack of Efficacy|79|||
162832800|NCT02083380|588099492|FG002|Overall Study|Lack of Efficacy|64|||
162832801|NCT02083380|588099490|FG000|Overall Study|Withdrawal by Subject|9|||
162832802|NCT02083380|588099491|FG001|Overall Study|Withdrawal by Subject|3|||
162832803|NCT02083380|588099492|FG002|Overall Study|Withdrawal by Subject|7|||
162832804|NCT02083380|588099490|FG000|Overall Study|Physician Decision|1|||
162832805|NCT02083380|588099491|FG001|Overall Study|Physician Decision|6|||
162832806|NCT02083380|588099492|FG002|Overall Study|Physician Decision|3|||
162832807|NCT02083380|588099490|FG000|Overall Study|Adverse Event|0|||
162832808|NCT02083380|588099491|FG001|Overall Study|Adverse Event|0|||
162832809|NCT02083380|588099492|FG002|Overall Study|Adverse Event|1|||
162947027|NCT02879643|588508186|FG001|Overall Study|Adverse Event|0|||
162947028|NCT02879643|588508187|FG002|Overall Study|Adverse Event|1|||
162832810|NCT02083380|588099490|FG000|Overall Study|Lost to Follow-up|5|||
162832811|NCT02083380|588099491|FG001|Overall Study|Lost to Follow-up|3|||
162832812|NCT02083380|588099492|FG002|Overall Study|Lost to Follow-up|3|||
162832813|NCT02083380|588099490|FG000|Overall Study|Other|8|||
162832814|NCT02083380|588099491|FG001|Overall Study|Other|4|||
162832815|NCT02083380|588099492|FG002|Overall Study|Other|6|||
162832816|NCT00001379|588099493|FG000|Initial Treatment|Disease progression|21|||
162832817|NCT00001379|588099494|FG001|Initial Treatment|Disease progression|3|||
162832818|NCT00001379|588099495|FG002|Initial Treatment|Disease progression|0|||
162832819|NCT00001379|588099496|FG003|Initial Treatment|Disease progression|0|||
162832820|NCT00001379|588099493|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
162832821|NCT00001379|588099494|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
162832822|NCT00001379|588099495|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
162832823|NCT00001379|588099496|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
162947029|NCT02879643|588508188|FG003|Overall Study|Adverse Event|1|||
162832824|NCT00001379|588099493|FG000|Initial Treatment|Received alternative treatment|2|||
162832825|NCT00001379|588099494|FG001|Initial Treatment|Received alternative treatment|1|||
162832826|NCT00001379|588099495|FG002|Initial Treatment|Received alternative treatment|0|||
162832827|NCT00001379|588099496|FG003|Initial Treatment|Received alternative treatment|0|||
162832828|NCT00001379|588099493|FG000|Initial Treatment|Refused further treatment|2|||
162832829|NCT00001379|588099494|FG001|Initial Treatment|Refused further treatment|0|||
162832830|NCT00001379|588099495|FG002|Initial Treatment|Refused further treatment|0|||
162832831|NCT00001379|588099496|FG003|Initial Treatment|Refused further treatment|0|||
162832832|NCT00001379|588099493|FG000|Initial Treatment|Did not receive protocol treatment|0|||
162832833|NCT00001379|588099494|FG001|Initial Treatment|Did not receive protocol treatment|0|||
162832834|NCT00001379|588099495|FG002|Initial Treatment|Did not receive protocol treatment|5|||
162832835|NCT00001379|588099496|FG003|Initial Treatment|Did not receive protocol treatment|0|||
162832836|NCT00001379|588099493|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
162832837|NCT00001379|588099494|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
162832838|NCT00001379|588099495|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
162832839|NCT00001379|588099496|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
162832840|NCT00001379|588099493|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
162832841|NCT00001379|588099494|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
162832842|NCT00001379|588099495|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
162832843|NCT00001379|588099496|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
162832844|NCT00001379|588099493|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
162832845|NCT00001379|588099494|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
162832846|NCT00001379|588099495|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
162832847|NCT00001379|588099496|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
162832848|NCT00001379|588099493|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
162832849|NCT00001379|588099494|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
162832850|NCT00001379|588099495|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
162832851|NCT00001379|588099496|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
162832852|NCT00001379|588099493|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
162832853|NCT00001379|588099494|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
162832854|NCT00001379|588099495|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
162832855|NCT00001379|588099496|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
162832856|NCT01577186|588099499|FG000|Overall Study|Adverse Event|23|||
162832857|NCT01577186|588099499|FG000|Overall Study|Death|1|||
162832858|NCT01577186|588099499|FG000|Overall Study|Lost to Follow-up|28|||
162832859|NCT01577186|588099499|FG000|Overall Study|Withdrawal by Subject|35|||
162832860|NCT01577186|588099499|FG000|Overall Study|Insufficient Response|18|||
162832861|NCT01577186|588099499|FG000|Overall Study|Ineligible to Continue|15|||
162832862|NCT01577186|588099499|FG000|Overall Study|Non-Compliant|8|||
162832863|NCT01577186|588099499|FG000|Overall Study|Other|2|||
162832864|NCT01032915|588099500|FG000|Overall Study|Adverse Event|2|||
162832865|NCT01032915|588099501|FG001|Overall Study|Adverse Event|2|||
162832866|NCT01032915|588099502|FG002|Overall Study|Adverse Event|1|||
162832867|NCT01032915|588099503|FG003|Overall Study|Adverse Event|1|||
162832868|NCT01032915|588099500|FG000|Overall Study|Abnormal test procedure result|0|||
162832869|NCT01032915|588099501|FG001|Overall Study|Abnormal test procedure result|0|||
162832870|NCT01032915|588099502|FG002|Overall Study|Abnormal test procedure result|1|||
162832871|NCT01032915|588099503|FG003|Overall Study|Abnormal test procedure result|0|||
162832872|NCT01032915|588099500|FG000|Overall Study|Withdrawal by Subject|0|||
162832873|NCT01032915|588099501|FG001|Overall Study|Withdrawal by Subject|3|||
162832874|NCT01032915|588099502|FG002|Overall Study|Withdrawal by Subject|1|||
162832875|NCT01032915|588099503|FG003|Overall Study|Withdrawal by Subject|1|||
162832876|NCT01032915|588099500|FG000|Overall Study|Administrative reasons|5|||
162832877|NCT01032915|588099501|FG001|Overall Study|Administrative reasons|6|||
162832878|NCT01032915|588099502|FG002|Overall Study|Administrative reasons|4|||
162832879|NCT01032915|588099503|FG003|Overall Study|Administrative reasons|4|||
162832880|NCT01032915|588099500|FG000|Overall Study|Protocol Violation|1|||
162947030|NCT02879643|588508189|FG004|Overall Study|Adverse Event|0|||
162947031|NCT00182091|588508190|FG000|Overall Study|Withdrawal by Subject|1|||
162947032|NCT00182091|588508191|FG001|Overall Study|Withdrawal by Subject|0|||
162947033|NCT00182091|588508192|FG002|Overall Study|Withdrawal by Subject|0|||
162947034|NCT00182091|588508193|FG003|Overall Study|Withdrawal by Subject|0|||
162947035|NCT01046253|588508194|FG000|Second Intervention|Adverse Event|0|||
162947036|NCT01046253|588508195|FG001|Second Intervention|Adverse Event|1|||
162947037|NCT01046253|588508194|FG000|Second Intervention|Protocol Violation|0|||
162947038|NCT01046253|588508195|FG001|Second Intervention|Protocol Violation|1|||
162947039|NCT02339909|588508196|FG000|Overall Study|Became ineligible after randomisation|89|||
162947040|NCT02339909|588508197|FG001|Overall Study|Became ineligible after randomisation|63|||
162832881|NCT01032915|588099501|FG001|Overall Study|Protocol Violation|0|||
162832882|NCT01032915|588099502|FG002|Overall Study|Protocol Violation|0|||
162832883|NCT01032915|588099503|FG003|Overall Study|Protocol Violation|1|||
162832884|NCT02797808|588099505|FG000|Overall Study|Withdrawal by Subject|1|||
162832885|NCT02797808|588099506|FG001|Overall Study|Withdrawal by Subject|1|||
162832886|NCT02797808|588099505|FG000|Overall Study|Physician Decision|6|||
162832887|NCT02797808|588099506|FG001|Overall Study|Physician Decision|2|||
162832888|NCT00535132|588099509|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
162832889|NCT00535132|588099510|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
162832890|NCT00535132|588099509|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
162832891|NCT00535132|588099510|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
162832892|NCT00264875|588099511|FG000|Overall Study|Adverse Event|6|||
162832893|NCT00264875|588099511|FG000|Overall Study|Lost to Follow-up|6|||
162832894|NCT00264875|588099511|FG000|Overall Study|Protocol Violation|11|||
162832895|NCT00264875|588099511|FG000|Overall Study|Withdrawal by Subject|7|||
162832896|NCT00143312|588099524|FG000|Overall Study|Death|11|||
162832897|NCT00143312|588099524|FG000|Overall Study|Adverse Event|2|||
162832898|NCT00143312|588099524|FG000|Overall Study|Lost to Follow-up|1|||
162832899|NCT00143312|588099524|FG000|Overall Study|Other|1|||
162832900|NCT00143312|588099524|FG000|Overall Study|Withdrawal by Subject|1|||
162832901|NCT01029366|588099525|FG000|Overall Study|Withdrawal by Subject|1|||
162832902|NCT01029366|588099526|FG001|Overall Study|Withdrawal by Subject|0|||
162832903|NCT01029366|588099525|FG000|Overall Study|Death|1|||
162832904|NCT01029366|588099526|FG001|Overall Study|Death|1|||
162832905|NCT01029366|588099525|FG000|Overall Study|disease progression|2|||
162832906|NCT01029366|588099526|FG001|Overall Study|disease progression|0|||
162832907|NCT01029366|588099525|FG000|Overall Study|manufacturing failure|0|||
162832908|NCT01029366|588099526|FG001|Overall Study|manufacturing failure|1|||
162832909|NCT00607386|588099527|FG000|Overall Study|Physician Decision|1|||
162832910|NCT00563186|588099528|FG000|Overall Study|LOS<48 hours|97|||
162832911|NCT00563186|588099529|FG001|Overall Study|LOS<48 hours|74|||
162832912|NCT00563186|588099528|FG000|Overall Study|Incomplete data|1|||
162832913|NCT00563186|588099529|FG001|Overall Study|Incomplete data|1|||
162832914|NCT00446511|588099532|FG000|Overall Study|Adverse Event|7|||
162832915|NCT00446511|588099533|FG001|Overall Study|Adverse Event|2|||
162832916|NCT00446511|588099534|FG002|Overall Study|Adverse Event|3|||
162832917|NCT00446511|588099535|FG003|Overall Study|Adverse Event|1|||
162832918|NCT00446511|588099532|FG000|Overall Study|Protocol Violation|0|||
162832919|NCT00446511|588099533|FG001|Overall Study|Protocol Violation|0|||
162832920|NCT00446511|588099534|FG002|Overall Study|Protocol Violation|0|||
162832921|NCT00446511|588099535|FG003|Overall Study|Protocol Violation|1|||
162832922|NCT00446511|588099532|FG000|Overall Study|Withdrawal by Subject|0|||
162832923|NCT00446511|588099533|FG001|Overall Study|Withdrawal by Subject|0|||
162832924|NCT00446511|588099534|FG002|Overall Study|Withdrawal by Subject|0|||
162832925|NCT00446511|588099535|FG003|Overall Study|Withdrawal by Subject|3|||
162832926|NCT00446511|588099532|FG000|Overall Study|Administrative Problems|3|||
162832927|NCT00446511|588099533|FG001|Overall Study|Administrative Problems|0|||
162832928|NCT00446511|588099534|FG002|Overall Study|Administrative Problems|4|||
162832929|NCT00446511|588099535|FG003|Overall Study|Administrative Problems|1|||
162832930|NCT01136655|588099536|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
162832931|NCT01136655|588099536|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
162832932|NCT01136655|588099536|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
162832933|NCT01136655|588099536|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
162832934|NCT01073267|588099537|FG000|Overall Study|Disease Progression|3|||
162832935|NCT00708123|588099538|FG000|Period 1|Protocol Violation|0|||
162832936|NCT00708123|588099539|FG001|Period 1|Protocol Violation|1|||
162832937|NCT00708123|588099540|FG002|Period 1|Protocol Violation|0|||
162832938|NCT00708123|588099541|FG003|Period 1|Protocol Violation|1|||
162832939|NCT00708123|588099542|FG004|Period 1|Protocol Violation|0|||
162832940|NCT00708123|588099538|FG000|Period 1|Adverse Event|0|||
162832941|NCT00708123|588099539|FG001|Period 1|Adverse Event|0|||
162832942|NCT00708123|588099540|FG002|Period 1|Adverse Event|1|||
162832943|NCT00708123|588099541|FG003|Period 1|Adverse Event|0|||
162832944|NCT00708123|588099542|FG004|Period 1|Adverse Event|0|||
162832945|NCT00708123|588099538|FG000|Period 2|Protocol Violation|0|||
162832946|NCT00708123|588099539|FG001|Period 2|Protocol Violation|0|||
162832947|NCT00708123|588099540|FG002|Period 2|Protocol Violation|0|||
162832948|NCT00708123|588099541|FG003|Period 2|Protocol Violation|1|||
162832949|NCT00708123|588099542|FG004|Period 2|Protocol Violation|0|||
162832950|NCT00708123|588099538|FG000|Period 2|Other Reason|1|||
162832951|NCT00708123|588099539|FG001|Period 2|Other Reason|0|||
162832952|NCT00708123|588099540|FG002|Period 2|Other Reason|0|||
162832953|NCT00708123|588099541|FG003|Period 2|Other Reason|0|||
162832954|NCT00708123|588099542|FG004|Period 2|Other Reason|0|||
162832955|NCT00708123|588099538|FG000|Period 3|Lost to Follow-up|0|||
162832956|NCT00708123|588099539|FG001|Period 3|Lost to Follow-up|0|||
162832957|NCT00708123|588099540|FG002|Period 3|Lost to Follow-up|1|||
162832958|NCT00708123|588099541|FG003|Period 3|Lost to Follow-up|1|||
162832959|NCT00708123|588099542|FG004|Period 3|Lost to Follow-up|0|||
162832960|NCT00708123|588099538|FG000|Period 4|Protocol Violation|0|||
162832961|NCT00708123|588099539|FG001|Period 4|Protocol Violation|1|||
162832962|NCT00708123|588099540|FG002|Period 4|Protocol Violation|0|||
162832963|NCT00708123|588099541|FG003|Period 4|Protocol Violation|0|||
162832964|NCT00708123|588099542|FG004|Period 4|Protocol Violation|0|||
162832965|NCT02970292|588099543|FG000|Overall Study|Physician Decision|1|||
162832966|NCT02970292|588099544|FG001|Overall Study|Physician Decision|1|||
162832967|NCT02970292|588099543|FG000|Overall Study|Withdrawal by Subject|11|||
162832968|NCT02970292|588099544|FG001|Overall Study|Withdrawal by Subject|5|||
162832969|NCT02970292|588099543|FG000|Overall Study|Noncompliance with study drug|2|||
162832970|NCT02970292|588099544|FG001|Overall Study|Noncompliance with study drug|2|||
162832971|NCT02970292|588099543|FG000|Overall Study|Adverse Event|5|||
162832972|NCT02970292|588099544|FG001|Overall Study|Adverse Event|0|||
162832973|NCT02970292|588099543|FG000|Overall Study|Lack of Efficacy|1|||
162832974|NCT02970292|588099544|FG001|Overall Study|Lack of Efficacy|0|||
162832975|NCT02970292|588099543|FG000|Overall Study|Lost to Follow-up|1|||
162832976|NCT02970292|588099544|FG001|Overall Study|Lost to Follow-up|0|||
162832977|NCT02970292|588099543|FG000|Overall Study|Protocol Violation|2|||
162832978|NCT02970292|588099544|FG001|Overall Study|Protocol Violation|0|||
162832979|NCT02970292|588099543|FG000|Overall Study|Other|1|||
162832980|NCT02970292|588099544|FG001|Overall Study|Other|0|||
162832981|NCT00814892|588099545|FG000|Overall Study|Disease Progression|1|||
162832982|NCT00814892|588099545|FG000|Overall Study|Study Termination|1|||
162832983|NCT00845650|588099546|FG000|Overall Study|Withdrawal by Subject|0|||
162832984|NCT00845650|588099547|FG001|Overall Study|Withdrawal by Subject|0|||
162832985|NCT00845650|588099548|FG002|Overall Study|Withdrawal by Subject|0|||
162832986|NCT00845650|588099549|FG003|Overall Study|Withdrawal by Subject|0|||
162832987|NCT00845650|588099550|FG004|Overall Study|Withdrawal by Subject|2|||
162832988|NCT00845650|588099551|FG005|Overall Study|Withdrawal by Subject|0|||
162832989|NCT00845650|588099546|FG000|Overall Study|Lost to Follow-up|0|||
162832990|NCT00845650|588099547|FG001|Overall Study|Lost to Follow-up|0|||
162832991|NCT00845650|588099548|FG002|Overall Study|Lost to Follow-up|3|||
162832992|NCT00845650|588099549|FG003|Overall Study|Lost to Follow-up|1|||
162832993|NCT00845650|588099550|FG004|Overall Study|Lost to Follow-up|0|||
162832994|NCT00845650|588099551|FG005|Overall Study|Lost to Follow-up|1|||
162832995|NCT00845650|588099546|FG000|Overall Study|Sponsor hold on dosing|0|||
162832996|NCT00845650|588099547|FG001|Overall Study|Sponsor hold on dosing|0|||
162832997|NCT00845650|588099548|FG002|Overall Study|Sponsor hold on dosing|0|||
162832998|NCT00845650|588099549|FG003|Overall Study|Sponsor hold on dosing|0|||
162832999|NCT00845650|588099550|FG004|Overall Study|Sponsor hold on dosing|1|||
162833000|NCT00845650|588099551|FG005|Overall Study|Sponsor hold on dosing|1|||
162833001|NCT00845650|588099546|FG000|Overall Study|Unable to access IV line|1|||
162833002|NCT00845650|588099547|FG001|Overall Study|Unable to access IV line|0|||
162833003|NCT00845650|588099548|FG002|Overall Study|Unable to access IV line|0|||
162833004|NCT00845650|588099549|FG003|Overall Study|Unable to access IV line|0|||
162833005|NCT00845650|588099550|FG004|Overall Study|Unable to access IV line|0|||
162833006|NCT00845650|588099551|FG005|Overall Study|Unable to access IV line|0|||
162833007|NCT04486950|588099553|FG000|Overall Study|Lost to Follow-up|0|||
162833008|NCT04486950|588099554|FG001|Overall Study|Lost to Follow-up|0|||
162833009|NCT04486950|588099555|FG002|Overall Study|Lost to Follow-up|0|||
162833010|NCT04486950|588099556|FG003|Overall Study|Lost to Follow-up|0|||
162833011|NCT04486950|588099557|FG004|Overall Study|Lost to Follow-up|0|||
162833012|NCT04486950|588099558|FG005|Overall Study|Lost to Follow-up|1|||
162833013|NCT04486950|588099559|FG006|Overall Study|Lost to Follow-up|0|||
162833014|NCT01883635|588099560|FG000|Overall Study|Withdrawal by Subject|4|||
162833015|NCT01883635|588099561|FG001|Overall Study|Withdrawal by Subject|0|||
162833016|NCT00761514|588099562|FG000|Overall Study|Adverse Event|1|||
162833017|NCT00761514|588099562|FG000|Overall Study|Withdrawal by Subject|2|||
162833018|NCT00761514|588099562|FG000|Overall Study|Lost to Follow-up|1|||
162833019|NCT00761514|588099562|FG000|Overall Study|Health insurance didn't cover study drug|1|||
162833020|NCT00761514|588099562|FG000|Overall Study|Problem complying with study visit|1|||
162833021|NCT00761514|588099562|FG000|Overall Study|Unable to pay for medications|1|||
162833022|NCT01979536|588099565|FG000|Overall Study|Physician Decision|2|||
162833023|NCT01979536|588099566|FG001|Overall Study|Physician Decision|3|||
162833024|NCT01979536|588099565|FG000|Overall Study|Withdrawal by Subject|0|||
162833025|NCT01979536|588099566|FG001|Overall Study|Withdrawal by Subject|1|||
162833026|NCT01979536|588099565|FG000|Overall Study|Refusal|0|||
162833027|NCT01979536|588099566|FG001|Overall Study|Refusal|1|||
162833028|NCT01979536|588099565|FG000|Overall Study|Relapse|0|||
162833029|NCT01979536|588099566|FG001|Overall Study|Relapse|1|||
162833030|NCT01979536|588099565|FG000|Overall Study|Study terminated by Sponsor|0|||
162833031|NCT01979536|588099566|FG001|Overall Study|Study terminated by Sponsor|1|||
162833032|NCT01979536|588099565|FG000|Overall Study|Did not start treatment|0|||
162833033|NCT01979536|588099566|FG001|Overall Study|Did not start treatment|1|||
162833034|NCT04294901|588099567|FG000|Overall Study|Death|86|||
162833035|NCT04294901|588099568|FG001|Overall Study|Death|110|||
162833036|NCT04294901|588099567|FG000|Overall Study|Provider did not have historical control patients|581|||
162833037|NCT04294901|588099568|FG001|Overall Study|Provider did not have historical control patients|0|||
162833038|NCT04294901|588099567|FG000|Overall Study|Provider did not have intervention patients|0|||
162833039|NCT04294901|588099568|FG001|Overall Study|Provider did not have intervention patients|98|||
162833040|NCT01934556|588099571|FG000|Overall Study|Withdrawal by Subject|0|||
162833041|NCT01934556|588099572|FG001|Overall Study|Withdrawal by Subject|1|||
162833042|NCT01934556|588099573|FG002|Overall Study|Withdrawal by Subject|1|||
162833043|NCT01934556|588099571|FG000|Overall Study|Lost to Follow-up|4|||
162833044|NCT01934556|588099572|FG001|Overall Study|Lost to Follow-up|10|||
162833045|NCT01934556|588099573|FG002|Overall Study|Lost to Follow-up|7|||
162833046|NCT01934556|588099571|FG000|Overall Study|Death|1|||
162833047|NCT01934556|588099572|FG001|Overall Study|Death|5|||
162833048|NCT01934556|588099573|FG002|Overall Study|Death|2|||
162833049|NCT01908101|588100916|FG000|Overall Study|Physician Decision|1|||
162833050|NCT01908101|588100916|FG000|Overall Study|Withdrawal by Subject|1|||
162833051|NCT01908101|588100916|FG000|Overall Study|Incorrect Diagnosis|2|||
162833052|NCT01908101|588100916|FG000|Overall Study|Incorrect Starting Dose|1|||
162833053|NCT01908101|588100916|FG000|Overall Study|Did not complete the first cycle|4|||
162833054|NCT01394939|588100917|FG000|Overall Study|Adverse Event|1|||
162833055|NCT01394939|588100918|FG001|Overall Study|Adverse Event|3|||
162833056|NCT01394939|588100919|FG002|Overall Study|Adverse Event|0|||
162833057|NCT01394939|588100920|FG003|Overall Study|Adverse Event|2|||
162833058|NCT01394939|588100917|FG000|Overall Study|Death|0|||
162833059|NCT01394939|588100918|FG001|Overall Study|Death|2|||
162833060|NCT01394939|588100919|FG002|Overall Study|Death|0|||
162833061|NCT01394939|588100920|FG003|Overall Study|Death|0|||
162833062|NCT01394939|588100917|FG000|Overall Study|Physician Decision|0|||
162833063|NCT01394939|588100918|FG001|Overall Study|Physician Decision|1|||
162833064|NCT01394939|588100919|FG002|Overall Study|Physician Decision|0|||
162833065|NCT01394939|588100920|FG003|Overall Study|Physician Decision|0|||
162833066|NCT01394939|588100917|FG000|Overall Study|Withdrawal by Subject|0|||
162833067|NCT01394939|588100918|FG001|Overall Study|Withdrawal by Subject|2|||
162833068|NCT01394939|588100919|FG002|Overall Study|Withdrawal by Subject|0|||
162833069|NCT01394939|588100920|FG003|Overall Study|Withdrawal by Subject|2|||
162833070|NCT01394939|588100917|FG000|Overall Study|Others|0|||
162833071|NCT01394939|588100918|FG001|Overall Study|Others|2|||
162833072|NCT01394939|588100919|FG002|Overall Study|Others|0|||
162833073|NCT01394939|588100920|FG003|Overall Study|Others|3|||
162833074|NCT03657043|588100923|FG000|Overall Study|Withdrawal by Subject|1|||
162833075|NCT03657043|588100924|FG001|Overall Study|Withdrawal by Subject|1|||
162833076|NCT03657043|588100925|FG002|Overall Study|Withdrawal by Subject|0|||
162833077|NCT03657043|588100926|FG003|Overall Study|Withdrawal by Subject|0|||
162833078|NCT03657043|588100927|FG004|Overall Study|Withdrawal by Subject|4|||
162833079|NCT03657043|588100923|FG000|Overall Study|Study closure by Sponsor|0|||
162833080|NCT03657043|588100924|FG001|Overall Study|Study closure by Sponsor|2|||
162833081|NCT03657043|588100925|FG002|Overall Study|Study closure by Sponsor|0|||
162833082|NCT03657043|588100926|FG003|Overall Study|Study closure by Sponsor|0|||
162833083|NCT03657043|588100927|FG004|Overall Study|Study closure by Sponsor|17|||
162699084|NCT04076020|587608189|FG000|Overall Study|Death|4|||
162699085|NCT04076020|587608190|FG001|Overall Study|Death|6|||
162699086|NCT04076020|587608189|FG000|Overall Study|Withdrawal by Subject|12|||
162699087|NCT04076020|587608190|FG001|Overall Study|Withdrawal by Subject|8|||
162699088|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
162699089|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
162699090|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
162699091|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
162699092|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162699093|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
162699094|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162699095|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162699096|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
162699097|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
162699098|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
162699099|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
162699100|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
162699101|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
162699102|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
162699103|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
162699104|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
162699105|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
162699106|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
162699107|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
162699108|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
162699109|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
162699110|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
162699111|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
162699112|NCT03230864|587608192|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
162699113|NCT03230864|587608193|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162699114|NCT03230864|587608194|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162699115|NCT03230864|587608195|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162699116|NCT03230864|587608192|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
162699117|NCT03230864|587608193|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
162699118|NCT03230864|587608194|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
162699119|NCT03230864|587608195|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
162699120|NCT03230864|587608192|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162699121|NCT03230864|587608193|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162699122|NCT03230864|587608194|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
162699123|NCT03230864|587608195|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
162699124|NCT03230864|587608192|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162699125|NCT03230864|587608193|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162699126|NCT03230864|587608194|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
162699127|NCT03230864|587608195|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162699128|NCT00502996|587608210|FG000|Overall Study|Lost to Follow-up|9|||
162699129|NCT00502996|587608210|FG000|Overall Study|Protocol Violation|2|||
162699130|NCT00502996|587608210|FG000|Overall Study|Treatment failure|25|||
162699131|NCT00502996|587608210|FG000|Overall Study|Withdrawal Informed Consent|6|||
162699132|NCT00502996|587608210|FG000|Overall Study|Adverse Event|2|||
162699133|NCT01316692|587608211|FG000|Overall Study|Adverse Event|5|||
162699134|NCT01316692|587608211|FG000|Overall Study|Disease Progression|7|||
162699135|NCT02001974|587608220|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
162699136|NCT02001974|587608221|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
162699137|NCT02001974|587608222|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
162699138|NCT02001974|587608220|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
162699139|NCT02001974|587608221|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
162699140|NCT02001974|587608222|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
162699141|NCT02001974|587608220|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
162699142|NCT02001974|587608221|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
162699143|NCT02001974|587608222|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
162699144|NCT02001974|587608220|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
162699145|NCT02001974|587608221|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
162699146|NCT02001974|587608222|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
162699147|NCT00993317|587608223|FG000|Overall Study|Adverse Event|2|||
162833084|NCT03657043|588100923|FG000|Overall Study|Lost to Follow-up|0|||
162833085|NCT03657043|588100924|FG001|Overall Study|Lost to Follow-up|0|||
162833086|NCT03657043|588100925|FG002|Overall Study|Lost to Follow-up|0|||
162833087|NCT03657043|588100926|FG003|Overall Study|Lost to Follow-up|0|||
162833088|NCT03657043|588100927|FG004|Overall Study|Lost to Follow-up|4|||
162833089|NCT03657043|588100923|FG000|Overall Study|Death|6|||
162833090|NCT03657043|588100924|FG001|Overall Study|Death|5|||
162833091|NCT03657043|588100925|FG002|Overall Study|Death|0|||
162833092|NCT03657043|588100926|FG003|Overall Study|Death|0|||
162833093|NCT03657043|588100927|FG004|Overall Study|Death|53|||
162833094|NCT03657043|588100923|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
162833095|NCT03657043|588100924|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
162833096|NCT03657043|588100925|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
162833097|NCT03657043|588100926|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
162833098|NCT03657043|588100927|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
162833099|NCT03657043|588100923|FG000|Overall Study|Adverse Event|0|||
162833100|NCT03657043|588100924|FG001|Overall Study|Adverse Event|0|||
162833101|NCT03657043|588100925|FG002|Overall Study|Adverse Event|0|||
162833102|NCT03657043|588100926|FG003|Overall Study|Adverse Event|0|||
162833103|NCT03657043|588100927|FG004|Overall Study|Adverse Event|2|||
162833104|NCT03657043|588100923|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
162833105|NCT03657043|588100924|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
162833106|NCT03657043|588100925|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
162833107|NCT03657043|588100926|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
162833108|NCT03657043|588100927|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
162833109|NCT03657043|588100923|FG000|Overall Study|Withdrawal - declined follow-up|0|||
162833110|NCT03657043|588100924|FG001|Overall Study|Withdrawal - declined follow-up|0|||
162833111|NCT03657043|588100925|FG002|Overall Study|Withdrawal - declined follow-up|0|||
162833112|NCT03657043|588100926|FG003|Overall Study|Withdrawal - declined follow-up|0|||
162833113|NCT03657043|588100927|FG004|Overall Study|Withdrawal - declined follow-up|1|||
162833114|NCT01995071|588100928|FG000|Overall Study|Adverse Event|0|||
162833115|NCT01995071|588100929|FG001|Overall Study|Adverse Event|0|||
162833116|NCT01995071|588100930|FG002|Overall Study|Adverse Event|0|||
162833117|NCT01995071|588100931|FG003|Overall Study|Adverse Event|0|||
162833118|NCT01995071|588100932|FG004|Overall Study|Adverse Event|0|||
162833119|NCT01995071|588100933|FG005|Overall Study|Adverse Event|0|||
162833120|NCT01995071|588100934|FG006|Overall Study|Adverse Event|1|||
162833121|NCT01995071|588100935|FG007|Overall Study|Adverse Event|0|||
162833122|NCT01995071|588100936|FG008|Overall Study|Adverse Event|0|||
162833123|NCT01995071|588100937|FG009|Overall Study|Adverse Event|0|||
162833124|NCT01995071|588100938|FG010|Overall Study|Adverse Event|0|||
162833125|NCT01995071|588100939|FG011|Overall Study|Adverse Event|0|||
162833126|NCT01995071|588100928|FG000|Overall Study|Moved|0|||
162833127|NCT01995071|588100929|FG001|Overall Study|Moved|0|||
162833128|NCT01995071|588100930|FG002|Overall Study|Moved|1|||
162833129|NCT01995071|588100931|FG003|Overall Study|Moved|0|||
162833130|NCT01995071|588100932|FG004|Overall Study|Moved|1|||
162833131|NCT01995071|588100933|FG005|Overall Study|Moved|0|||
162833132|NCT01995071|588100934|FG006|Overall Study|Moved|0|||
162833133|NCT01995071|588100935|FG007|Overall Study|Moved|0|||
162833134|NCT01995071|588100936|FG008|Overall Study|Moved|0|||
162833135|NCT01995071|588100937|FG009|Overall Study|Moved|0|||
162833136|NCT01995071|588100938|FG010|Overall Study|Moved|1|||
162833137|NCT01995071|588100939|FG011|Overall Study|Moved|0|||
162833138|NCT01995071|588100928|FG000|Overall Study|Lost to Follow-up|1|||
162833139|NCT01995071|588100929|FG001|Overall Study|Lost to Follow-up|0|||
162833140|NCT01995071|588100930|FG002|Overall Study|Lost to Follow-up|0|||
162833141|NCT01995071|588100931|FG003|Overall Study|Lost to Follow-up|0|||
162833142|NCT01995071|588100932|FG004|Overall Study|Lost to Follow-up|0|||
162833143|NCT01995071|588100933|FG005|Overall Study|Lost to Follow-up|0|||
162833144|NCT01995071|588100934|FG006|Overall Study|Lost to Follow-up|0|||
162833145|NCT01995071|588100935|FG007|Overall Study|Lost to Follow-up|1|||
162833146|NCT01995071|588100936|FG008|Overall Study|Lost to Follow-up|1|||
162833147|NCT01995071|588100937|FG009|Overall Study|Lost to Follow-up|0|||
162833148|NCT01995071|588100938|FG010|Overall Study|Lost to Follow-up|0|||
162833149|NCT01995071|588100939|FG011|Overall Study|Lost to Follow-up|0|||
162833150|NCT01995071|588100928|FG000|Overall Study|Incarcerated|0|||
162699148|NCT00993317|587608224|FG001|Overall Study|Adverse Event|4|||
162699149|NCT00993317|587608223|FG000|Overall Study|Lack of Efficacy|18|||
162699150|NCT00993317|587608224|FG001|Overall Study|Lack of Efficacy|18|||
162699151|NCT00993317|587608223|FG000|Overall Study|Withdrawal by Subject|0|||
162699152|NCT00993317|587608224|FG001|Overall Study|Withdrawal by Subject|2|||
162699153|NCT00993317|587608223|FG000|Overall Study|Investigator's opinion|0|||
162699154|NCT00993317|587608224|FG001|Overall Study|Investigator's opinion|1|||
162699155|NCT00993317|587608223|FG000|Overall Study|Early study termination at the site|1|||
162699156|NCT00993317|587608224|FG001|Overall Study|Early study termination at the site|0|||
162699157|NCT01380990|587608225|FG000|Overall Study|Treatment Failure|1|||
162699158|NCT01380990|587608226|FG001|Overall Study|Treatment Failure|0|||
162699159|NCT01380990|587608225|FG000|Overall Study|Death|0|||
162699160|NCT01380990|587608226|FG001|Overall Study|Death|1|||
162699161|NCT04422639|587608227|FG000|Overall Study|Death|1|||
162699162|NCT04422639|587608228|FG001|Overall Study|Death|0|||
162699163|NCT04422639|587608227|FG000|Overall Study|study closed prior to completion of FU visits|0|||
162699164|NCT04422639|587608228|FG001|Overall Study|study closed prior to completion of FU visits|2|||
162699165|NCT01964521|587608229|FG000|Overall Study|Lost to Follow-up|4|||
162699166|NCT01463293|587608231|FG000|Overall Study|Lost to Follow-up|1|||
162699167|NCT01463293|587608232|FG001|Overall Study|Lost to Follow-up|4|||
162699168|NCT01463293|587608233|FG002|Overall Study|Lost to Follow-up|5|||
162699169|NCT01463293|587608231|FG000|Overall Study|Adverse Event|1|||
162699170|NCT01463293|587608232|FG001|Overall Study|Adverse Event|2|||
162699171|NCT01463293|587608233|FG002|Overall Study|Adverse Event|0|||
162699172|NCT01463293|587608231|FG000|Overall Study|Withdrawal by Subject|4|||
162699173|NCT01463293|587608232|FG001|Overall Study|Withdrawal by Subject|10|||
162699174|NCT01463293|587608233|FG002|Overall Study|Withdrawal by Subject|5|||
162699175|NCT01463293|587608231|FG000|Overall Study|Other|0|||
162699176|NCT01463293|587608232|FG001|Overall Study|Other|0|||
162699177|NCT01463293|587608233|FG002|Overall Study|Other|2|||
162699178|NCT02796963|587608234|FG000|Overall Study|Lost to Follow-up|89|||
162699179|NCT02796963|587608235|FG001|Overall Study|Lost to Follow-up|76|||
162699180|NCT02796963|587608236|FG002|Overall Study|Lost to Follow-up|69|||
162699181|NCT02796963|587608237|FG003|Overall Study|Lost to Follow-up|72|||
162699182|NCT03192215|587608238|FG000|Overall Study|Death|28|||
162699183|NCT03192215|587608239|FG001|Overall Study|Death|23|||
162699184|NCT03192215|587608238|FG000|Overall Study|Lost to Follow-up|10|||
162699185|NCT03192215|587608239|FG001|Overall Study|Lost to Follow-up|15|||
162699186|NCT03192215|587608238|FG000|Overall Study|Withdrawal by Subject|49|||
162699187|NCT03192215|587608239|FG001|Overall Study|Withdrawal by Subject|48|||
162699188|NCT03192215|587608238|FG000|Overall Study|Other as reported in analysis|4|||
162699189|NCT03192215|587608239|FG001|Overall Study|Other as reported in analysis|1|||
162699190|NCT00735644|587608250|FG000|Overall Study|Did not receive study vaccine|0|||
162699191|NCT00735644|587608251|FG001|Overall Study|Did not receive study vaccine|1|||
162699192|NCT00735644|587608252|FG002|Overall Study|Did not receive study vaccine|0|||
162699193|NCT00735644|587608253|FG003|Overall Study|Did not receive study vaccine|0|||
162699194|NCT00735644|587608254|FG004|Overall Study|Did not receive study vaccine|0|||
162699195|NCT00735644|587608250|FG000|Overall Study|Withdrawal by Subject|0|||
162699196|NCT00735644|587608251|FG001|Overall Study|Withdrawal by Subject|1|||
162699197|NCT00735644|587608252|FG002|Overall Study|Withdrawal by Subject|1|||
162699198|NCT00735644|587608253|FG003|Overall Study|Withdrawal by Subject|1|||
162699199|NCT00735644|587608254|FG004|Overall Study|Withdrawal by Subject|0|||
162699200|NCT00655551|587608255|FG000|All Periods Combined|Adverse Event|0|||
162699201|NCT00655551|587608256|FG001|All Periods Combined|Adverse Event|3|||
162699202|NCT00655551|587608257|FG002|All Periods Combined|Adverse Event|4|||
162699203|NCT00655551|587608255|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
162699204|NCT00655551|587608256|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
162699205|NCT00655551|587608257|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
162699206|NCT00655551|587608255|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
162699207|NCT00655551|587608256|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
162699208|NCT00655551|587608257|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
162699209|NCT00655551|587608255|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
162699210|NCT00655551|587608256|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
162699211|NCT00655551|587608257|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
162833151|NCT01995071|588100929|FG001|Overall Study|Incarcerated|0|||
162699212|NCT02855164|587608259|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162699213|NCT02855164|587608260|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162699214|NCT02855164|587608261|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
162699215|NCT02855164|587608262|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
162699216|NCT02855164|587608263|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
162699217|NCT02855164|587608264|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162699218|NCT02855164|587608265|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162699219|NCT02855164|587608266|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162699220|NCT02855164|587608259|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
162699221|NCT02855164|587608260|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
162833152|NCT01995071|588100930|FG002|Overall Study|Incarcerated|0|||
162833153|NCT01995071|588100931|FG003|Overall Study|Incarcerated|0|||
162833154|NCT01995071|588100932|FG004|Overall Study|Incarcerated|0|||
162833155|NCT01995071|588100933|FG005|Overall Study|Incarcerated|0|||
162833156|NCT01995071|588100934|FG006|Overall Study|Incarcerated|0|||
162833157|NCT01995071|588100935|FG007|Overall Study|Incarcerated|1|||
162833158|NCT01995071|588100936|FG008|Overall Study|Incarcerated|0|||
162833159|NCT01995071|588100937|FG009|Overall Study|Incarcerated|0|||
162833160|NCT01995071|588100938|FG010|Overall Study|Incarcerated|0|||
162833161|NCT01995071|588100939|FG011|Overall Study|Incarcerated|0|||
162833162|NCT01659320|588100944|FG000|Overall Study|Withdrawal by Subject|2|||
162833163|NCT01659320|588100944|FG000|Overall Study|Physician Decision|1|||
162833164|NCT00590590|588100945|FG000|Overall Study|Lack of Efficacy|1|||
162833165|NCT00590590|588100946|FG001|Overall Study|Lack of Efficacy|2|||
162833166|NCT00590590|588100947|FG002|Overall Study|Lack of Efficacy|0|||
162833167|NCT00590590|588100945|FG000|Overall Study|Adverse Event|1|||
162833168|NCT00590590|588100946|FG001|Overall Study|Adverse Event|0|||
162833169|NCT00590590|588100947|FG002|Overall Study|Adverse Event|0|||
162833170|NCT00590590|588100945|FG000|Overall Study|Protocol Violation|0|||
162833171|NCT00590590|588100946|FG001|Overall Study|Protocol Violation|0|||
162833172|NCT00590590|588100947|FG002|Overall Study|Protocol Violation|2|||
162833173|NCT00590590|588100945|FG000|Overall Study|Lost to Follow-up|4|||
162833174|NCT00590590|588100946|FG001|Overall Study|Lost to Follow-up|1|||
162833175|NCT00590590|588100947|FG002|Overall Study|Lost to Follow-up|2|||
162833176|NCT00590590|588100945|FG000|Overall Study|Withdrawal by Subject|0|||
162833177|NCT00590590|588100946|FG001|Overall Study|Withdrawal by Subject|1|||
162833178|NCT00590590|588100947|FG002|Overall Study|Withdrawal by Subject|1|||
162833179|NCT00590590|588100945|FG000|Overall Study|Did not complete due to study closure|1|||
162833180|NCT00590590|588100946|FG001|Overall Study|Did not complete due to study closure|1|||
162833181|NCT00590590|588100947|FG002|Overall Study|Did not complete due to study closure|1|||
162833182|NCT00590590|588100945|FG000|Overall Study|Did not complete study|0|||
162833183|NCT00590590|588100946|FG001|Overall Study|Did not complete study|1|||
162833184|NCT00590590|588100947|FG002|Overall Study|Did not complete study|0|||
162833185|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
162833186|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
162833187|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
162833188|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
162833189|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
162833190|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
162833191|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
162833192|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
162833193|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
162833194|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
162833195|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
162833196|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
162833197|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
162833198|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
162833199|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
162833200|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
162833201|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
162833202|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
162833203|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
162833204|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
162833205|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
162833206|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
162833207|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
162833208|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
162833209|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
162833210|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
162833211|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
162833212|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
162833213|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
162833214|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
162833215|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
162833216|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
162833217|NCT03605680|588100949|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
162833218|NCT03605680|588100950|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
162833219|NCT03605680|588100951|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
162833220|NCT03605680|588100952|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
162833221|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
162833222|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
162833223|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
162833224|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
162699222|NCT02855164|587608261|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
162699223|NCT02855164|587608262|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
162699224|NCT02855164|587608263|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
162699225|NCT02855164|587608264|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
162699226|NCT02855164|587608265|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
162699227|NCT02855164|587608266|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
162699228|NCT02855164|587608259|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
162699229|NCT02855164|587608260|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
162699230|NCT02855164|587608261|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
162699231|NCT02855164|587608262|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
162699232|NCT02855164|587608263|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
162699233|NCT02855164|587608264|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
162699234|NCT02855164|587608265|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
162699235|NCT02855164|587608266|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
162699236|NCT02855164|587608259|FG000|Part C (Randomized Set)|Adverse Event|0|||
162699237|NCT02855164|587608260|FG001|Part C (Randomized Set)|Adverse Event|0|||
162699238|NCT02855164|587608261|FG002|Part C (Randomized Set)|Adverse Event|0|||
162699239|NCT02855164|587608262|FG003|Part C (Randomized Set)|Adverse Event|0|||
162699240|NCT02855164|587608263|FG004|Part C (Randomized Set)|Adverse Event|0|||
162699241|NCT02855164|587608264|FG005|Part C (Randomized Set)|Adverse Event|5|||
162699242|NCT02855164|587608265|FG006|Part C (Randomized Set)|Adverse Event|9|||
162699243|NCT02855164|587608266|FG007|Part C (Randomized Set)|Adverse Event|2|||
162699244|NCT02855164|587608259|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
162699245|NCT02855164|587608260|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
162699246|NCT02855164|587608261|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
162699247|NCT02855164|587608262|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
162699248|NCT02855164|587608263|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
162699249|NCT02855164|587608264|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
162699250|NCT02855164|587608265|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
162699251|NCT02855164|587608266|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
162699252|NCT02855164|587608259|FG000|Part C (Randomized Set)|Physician Decision|0|||
162699253|NCT02855164|587608260|FG001|Part C (Randomized Set)|Physician Decision|0|||
162699254|NCT02855164|587608261|FG002|Part C (Randomized Set)|Physician Decision|0|||
162699255|NCT02855164|587608262|FG003|Part C (Randomized Set)|Physician Decision|0|||
162699256|NCT02855164|587608263|FG004|Part C (Randomized Set)|Physician Decision|0|||
162699257|NCT02855164|587608264|FG005|Part C (Randomized Set)|Physician Decision|1|||
162699258|NCT02855164|587608265|FG006|Part C (Randomized Set)|Physician Decision|0|||
162699259|NCT02855164|587608266|FG007|Part C (Randomized Set)|Physician Decision|1|||
162699260|NCT02855164|587608259|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
162699261|NCT02855164|587608260|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
162699262|NCT02855164|587608261|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
162699263|NCT02855164|587608262|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
162947041|NCT02339909|588508198|FG002|Overall Study|Became ineligible after randomisation|71|||
162947042|NCT00860028|588508199|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
162947043|NCT00860028|588508200|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
162699264|NCT02855164|587608263|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
162699265|NCT02855164|587608264|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
162699266|NCT02855164|587608265|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
162699267|NCT02855164|587608266|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
162699268|NCT01040780|587610325|FG000|Overall Study|Protocol Violation|1|||
162699269|NCT01040780|587610326|FG001|Overall Study|Protocol Violation|3|||
162699270|NCT03681639|587610327|FG000|Overall Study|Death|4|||
162699271|NCT03681639|587610327|FG000|Overall Study|Lost to Follow-up|2|||
162699272|NCT03681639|587610327|FG000|Overall Study|Withdrawal by Subject|1|||
162699273|NCT03681639|587610327|FG000|Overall Study|Adverse Event|2|||
162699274|NCT00654940|587610328|FG000|Period 1|Adverse Event|0|||
162699275|NCT00654940|587610329|FG001|Period 1|Adverse Event|1|||
162699276|NCT00654940|587610328|FG000|Period 1|Intolerable Pain Level|1|||
162699277|NCT00654940|587610329|FG001|Period 1|Intolerable Pain Level|0|||
162699278|NCT01818141|587610330|FG000|Overall Study|Withdrawal by Subject|2|||
162947044|NCT02576990|588508201|FG000|Overall Study|Death|29|||
162947045|NCT02576990|588508202|FG001|Overall Study|Death|18|||
162947046|NCT02576990|588508201|FG000|Overall Study|Physician Decision|1|||
162947047|NCT02576990|588508202|FG001|Overall Study|Physician Decision|0|||
162947048|NCT02576990|588508201|FG000|Overall Study|Screen failure|2|||
162947049|NCT02576990|588508202|FG001|Overall Study|Screen failure|0|||
162947050|NCT02576990|588508201|FG000|Overall Study|Sponsor's decision|24|||
162947051|NCT02576990|588508202|FG001|Overall Study|Sponsor's decision|4|||
162947052|NCT02576990|588508201|FG000|Overall Study|Withdrawal by Subject|0|||
162947053|NCT02576990|588508202|FG001|Overall Study|Withdrawal by Subject|2|||
162947054|NCT00936390|588508203|FG000|Overall Study|Protocol Violation|21|||
162947055|NCT00936390|588508204|FG001|Overall Study|Protocol Violation|25|||
162947056|NCT02093689|588508205|FG000|Overall Study|Physician Decision|4|||
162947057|NCT02093689|588508206|FG001|Overall Study|Physician Decision|0|||
162947058|NCT02093689|588508207|FG002|Overall Study|Physician Decision|0|||
162947059|NCT00475020|588508208|FG000|Overall Study|Physician Decision|3|||
162947060|NCT00475020|588508208|FG000|Overall Study|Insurance Denial|1|||
162947061|NCT00475020|588508208|FG000|Overall Study|Donor not able to donate the last minute|1|||
162947062|NCT01575054|588508209|FG000|Overall Study|Other Reasons|5|||
162947063|NCT01575054|588508210|FG001|Overall Study|Other Reasons|3|||
162947064|NCT01575054|588508209|FG000|Overall Study|Protocol Violation|2|||
162947065|NCT01575054|588508210|FG001|Overall Study|Protocol Violation|1|||
162947066|NCT01575054|588508209|FG000|Overall Study|Personal Reasons|10|||
162947067|NCT01575054|588508210|FG001|Overall Study|Personal Reasons|11|||
162947068|NCT01575054|588508209|FG000|Overall Study|Lost to Follow-up|3|||
162947069|NCT01575054|588508210|FG001|Overall Study|Lost to Follow-up|3|||
162947070|NCT01575054|588508209|FG000|Overall Study|Adverse Event|9|||
162947071|NCT01575054|588508210|FG001|Overall Study|Adverse Event|8|||
162947072|NCT03481309|588508211|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
162947073|NCT03481309|588508212|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947074|NCT03481309|588508213|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947075|NCT03481309|588508214|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947076|NCT03481309|588508215|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947077|NCT03481309|588508216|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
162947078|NCT03309956|588508219|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
162947079|NCT02768298|588508220|FG000|Overall Study|Adverse Event|1|||
162947080|NCT02768298|588508221|FG001|Overall Study|Adverse Event|4|||
162947081|NCT02768298|588508220|FG000|Overall Study|Death|2|||
162947082|NCT02768298|588508221|FG001|Overall Study|Death|1|||
162947083|NCT02768298|588508220|FG000|Overall Study|Non-compliance with study treatment|0|||
162947084|NCT02768298|588508221|FG001|Overall Study|Non-compliance with study treatment|1|||
162947085|NCT02768298|588508220|FG000|Overall Study|Subject/guardian decision|1|||
162947086|NCT02768298|588508221|FG001|Overall Study|Subject/guardian decision|0|||
162947087|NCT02768298|588508220|FG000|Overall Study|Withdrawal of informed consent|0|||
162947088|NCT02768298|588508221|FG001|Overall Study|Withdrawal of informed consent|1|||
162947089|NCT03365947|588508222|FG000|Overall Study|Lost to Follow-up|0|||
162947090|NCT03365947|588508223|FG001|Overall Study|Lost to Follow-up|0|||
162947091|NCT03365947|588508224|FG002|Overall Study|Lost to Follow-up|0|||
162947092|NCT03365947|588508225|FG003|Overall Study|Lost to Follow-up|0|||
162947093|NCT03365947|588508226|FG004|Overall Study|Lost to Follow-up|0|||
162947094|NCT03365947|588508227|FG005|Overall Study|Lost to Follow-up|1|||
162947095|NCT03365947|588508228|FG006|Overall Study|Lost to Follow-up|0|||
162947096|NCT03365947|588508229|FG007|Overall Study|Lost to Follow-up|0|||
162947097|NCT03365947|588508230|FG008|Overall Study|Lost to Follow-up|0|||
162947098|NCT03365947|588508231|FG009|Overall Study|Lost to Follow-up|0|||
162947099|NCT03365947|588508232|FG010|Overall Study|Lost to Follow-up|0|||
162947100|NCT03365947|588508233|FG011|Overall Study|Lost to Follow-up|0|||
162947101|NCT03365947|588508234|FG012|Overall Study|Lost to Follow-up|0|||
162947102|NCT03365947|588508235|FG013|Overall Study|Lost to Follow-up|0|||
162947103|NCT03365947|588508236|FG014|Overall Study|Lost to Follow-up|0|||
162947104|NCT03365947|588508237|FG015|Overall Study|Lost to Follow-up|0|||
162947105|NCT03365947|588508238|FG016|Overall Study|Lost to Follow-up|0|||
162947106|NCT03365947|588508239|FG017|Overall Study|Lost to Follow-up|0|||
162947107|NCT03365947|588508240|FG018|Overall Study|Lost to Follow-up|0|||
162947108|NCT02518685|588508241|FG000|Overall Study|Adverse Event|29|||
162947109|NCT02518685|588508242|FG001|Overall Study|Adverse Event|1|||
162947110|NCT02518685|588508241|FG000|Overall Study|Withdrawal by Subject|10|||
162947111|NCT02518685|588508242|FG001|Overall Study|Withdrawal by Subject|3|||
162947112|NCT02518685|588508241|FG000|Overall Study|relocation, study fatigue|7|||
162947113|NCT02518685|588508242|FG001|Overall Study|relocation, study fatigue|2|||
162947114|NCT02518685|588508241|FG000|Overall Study|Pregnancy|1|||
162833225|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
162833226|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
162833227|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
162833228|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
162833229|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162833230|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162833231|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162833232|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
162833233|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
162833234|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
162833235|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
162833236|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
162833237|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
162833238|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
162833239|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
162833240|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
162833241|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
162833242|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
162833243|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
162833244|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
162833245|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
162833246|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
162833247|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
162833248|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
162833249|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
162833250|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
162833251|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
162833252|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
162833253|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
162833254|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
162833255|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
162947115|NCT02518685|588508242|FG001|Overall Study|Pregnancy|0|||
162833256|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
162833257|NCT03605680|588100949|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
162833258|NCT03605680|588100950|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
162833259|NCT03605680|588100951|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
162833260|NCT03605680|588100952|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
162833261|NCT03865706|588100955|FG000|Overall Study|Death|0|||
162833262|NCT03865706|588100956|FG001|Overall Study|Death|3|||
162833263|NCT03865706|588100957|FG002|Overall Study|Death|1|||
162833264|NCT02095535|588100958|FG000|Recruitment|Protocol Violation|2|||
162833265|NCT02646982|588100959|FG000|Overall Study|Adverse Event|1|||
162833266|NCT02646982|588100960|FG001|Overall Study|Adverse Event|1|||
162833267|NCT02646982|588100959|FG000|Overall Study|Withdrawal by Subject|2|||
162833268|NCT02646982|588100960|FG001|Overall Study|Withdrawal by Subject|1|||
162833269|NCT01877187|588100961|FG000|Overall Study|Death|2|||
162833270|NCT01877187|588100961|FG000|Overall Study|Withdrawal by Subject|4|||
162833271|NCT01877187|588100961|FG000|Overall Study|Lost to Follow-up|3|||
162833272|NCT01877187|588100961|FG000|Overall Study|Declining clinical status|11|||
162833273|NCT01877187|588100961|FG000|Overall Study|Liver transplant|2|||
162833274|NCT04677712|588100963|FG000|Overall Study|Lost to Follow-up|0|||
162833275|NCT04677712|588100964|FG001|Overall Study|Lost to Follow-up|1|||
162833276|NCT04677712|588100965|FG002|Overall Study|Lost to Follow-up|0|||
162833277|NCT04677712|588100966|FG003|Overall Study|Lost to Follow-up|0|||
162833278|NCT04677712|588100967|FG004|Overall Study|Lost to Follow-up|0|||
162833279|NCT04677712|588100968|FG005|Overall Study|Lost to Follow-up|0|||
162833280|NCT02915523|588100973|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
162833281|NCT02915523|588100974|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
162833282|NCT02915523|588100975|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
162833283|NCT02915523|588100976|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
162833284|NCT02915523|588100973|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
162833285|NCT02915523|588100974|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
162833286|NCT02915523|588100975|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
162833287|NCT02915523|588100976|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
162833288|NCT02915523|588100973|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
162833289|NCT02915523|588100974|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
162833290|NCT02915523|588100975|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
162833291|NCT02915523|588100976|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
162833292|NCT02915523|588100973|FG000|Expansion Phase (Phase 2)|Death|0|||
162833293|NCT02915523|588100974|FG001|Expansion Phase (Phase 2)|Death|0|||
162833294|NCT02915523|588100975|FG002|Expansion Phase (Phase 2)|Death|26|||
162833295|NCT02915523|588100976|FG003|Expansion Phase (Phase 2)|Death|53|||
162833296|NCT02915523|588100973|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
162947116|NCT02518685|588508241|FG000|Overall Study|Physician Decision|1|||
162947117|NCT02518685|588508242|FG001|Overall Study|Physician Decision|0|||
162947118|NCT02518685|588508241|FG000|Overall Study|Lost to Follow-up|1|||
162833297|NCT02915523|588100974|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
162833298|NCT02915523|588100975|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
162833299|NCT02915523|588100976|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
162833300|NCT02915523|588100973|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
162833301|NCT02915523|588100974|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
162833302|NCT02915523|588100975|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
162833303|NCT02915523|588100976|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
162833304|NCT02915523|588100973|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
162833305|NCT02915523|588100974|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
162947119|NCT02518685|588508242|FG001|Overall Study|Lost to Follow-up|4|||
162833306|NCT02915523|588100975|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
162833307|NCT02915523|588100976|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
162833308|NCT00708500|588100979|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
162833309|NCT00708500|588100980|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
162833310|NCT00708500|588100981|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
162833311|NCT00708500|588100979|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
162833312|NCT00708500|588100980|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
162833313|NCT00708500|588100981|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
162833314|NCT00708500|588100979|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
162833315|NCT00708500|588100980|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
162833316|NCT00708500|588100981|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
162833317|NCT00708500|588100979|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
162833318|NCT00708500|588100980|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
162833319|NCT00708500|588100981|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
162833320|NCT00708500|588100979|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
162833321|NCT00708500|588100980|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
162833322|NCT00708500|588100981|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
162833323|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
162833324|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
162833325|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
162833326|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
162833327|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
162833328|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
162833329|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
162833330|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
162833331|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
162833332|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
162833333|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
162833334|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
162833335|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
162833336|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
162833337|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
162833338|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
162833339|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
162833340|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
162947120|NCT01922349|588508243|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162947121|NCT01922349|588508244|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162947122|NCT01922349|588508245|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
162833341|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
162833342|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
162833343|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
162833344|NCT00708500|588100979|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
162833345|NCT00708500|588100980|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
162833346|NCT00708500|588100981|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
162833347|NCT00708500|588100979|FG000|FOLLOWUP|Adverse Event|0|||
162833348|NCT00708500|588100980|FG001|FOLLOWUP|Adverse Event|1|||
162833349|NCT00708500|588100981|FG002|FOLLOWUP|Adverse Event|0|||
162833350|NCT00708500|588100979|FG000|FOLLOWUP|Lost to Follow-up|1|||
162833351|NCT00708500|588100980|FG001|FOLLOWUP|Lost to Follow-up|6|||
162833352|NCT00708500|588100981|FG002|FOLLOWUP|Lost to Follow-up|4|||
162833353|NCT00708500|588100979|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
162833354|NCT00708500|588100980|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
162833355|NCT00708500|588100981|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
162833356|NCT00708500|588100979|FG000|FOLLOWUP|Subject withdrew consent|31|||
162833357|NCT00708500|588100980|FG001|FOLLOWUP|Subject withdrew consent|4|||
162833358|NCT00708500|588100981|FG002|FOLLOWUP|Subject withdrew consent|5|||
162833359|NCT00708500|588100979|FG000|FOLLOWUP|Non-compliance with protocol|5|||
162833360|NCT00708500|588100980|FG001|FOLLOWUP|Non-compliance with protocol|0|||
162833361|NCT00708500|588100981|FG002|FOLLOWUP|Non-compliance with protocol|1|||
162833362|NCT00382993|588100991|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
162833363|NCT00382993|588100992|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
162833364|NCT00382993|588100991|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
162833365|NCT00382993|588100992|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
162833366|NCT00382993|588100991|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
162833367|NCT00382993|588100992|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
162833368|NCT00382993|588100991|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
162833369|NCT00382993|588100992|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
162833370|NCT00382993|588100991|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
162833371|NCT00382993|588100992|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
162833372|NCT00382993|588100991|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
162947123|NCT01922349|588508246|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
162833373|NCT00382993|588100992|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
162833374|NCT00382993|588100991|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
162833375|NCT00382993|588100992|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
162833376|NCT00382993|588100991|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
162833377|NCT00382993|588100992|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
162833378|NCT00382993|588100991|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
162833379|NCT00382993|588100992|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
162833380|NCT00382993|588100991|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
162833381|NCT00382993|588100992|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
162833382|NCT00794677|588100993|FG000|First Intervention|Withdrawal by Subject|2|||
162833383|NCT00794677|588100994|FG001|First Intervention|Withdrawal by Subject|0|||
162833384|NCT01965262|588101008|FG000|Second Intervention (7 Days)|Discontinued|0|||
162833385|NCT01965262|588101009|FG001|Second Intervention (7 Days)|Discontinued|1|||
162833386|NCT01965262|588101008|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
162833387|NCT01965262|588101009|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
162833388|NCT01965262|588101008|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
162833389|NCT01965262|588101009|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
162833390|NCT00906087|588101010|FG000|Initial Washout|Withdrawal by Subject|1|||
162833391|NCT00906087|588101010|FG000|Initial Washout|Physician Decision|1|||
162833392|NCT00440947|588101011|FG000|36-Week Induction Phase|Adverse Event|16|||
162833393|NCT00440947|588101012|FG001|36-Week Induction Phase|Adverse Event|0|||
162833394|NCT00440947|588101013|FG002|36-Week Induction Phase|Adverse Event|0|||
162833395|NCT00440947|588101014|FG003|36-Week Induction Phase|Adverse Event|0|||
162833396|NCT00440947|588101015|FG004|36-Week Induction Phase|Adverse Event|0|||
162833397|NCT00440947|588101011|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
162833398|NCT00440947|588101012|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
162833399|NCT00440947|588101013|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
162833400|NCT00440947|588101014|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
162833401|NCT00440947|588101015|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
162833402|NCT00440947|588101011|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
162833403|NCT00440947|588101012|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
162833404|NCT00440947|588101013|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
162833405|NCT00440947|588101014|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
162833406|NCT00440947|588101015|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
162833407|NCT00440947|588101011|FG000|36-Week Induction Phase|Non-compliance|10|||
162833408|NCT00440947|588101012|FG001|36-Week Induction Phase|Non-compliance|0|||
162833409|NCT00440947|588101013|FG002|36-Week Induction Phase|Non-compliance|0|||
162833410|NCT00440947|588101014|FG003|36-Week Induction Phase|Non-compliance|0|||
162833411|NCT00440947|588101015|FG004|36-Week Induction Phase|Non-compliance|0|||
162833412|NCT00440947|588101011|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
162833413|NCT00440947|588101012|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
162833414|NCT00440947|588101013|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
162833415|NCT00440947|588101014|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
162833416|NCT00440947|588101015|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
162833417|NCT00440947|588101011|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
162833418|NCT00440947|588101012|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
162833419|NCT00440947|588101013|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
162833420|NCT00440947|588101014|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
162833421|NCT00440947|588101015|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
162833422|NCT00440947|588101011|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
162833423|NCT00440947|588101012|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
162833424|NCT00440947|588101013|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
162833425|NCT00440947|588101014|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
162833426|NCT00440947|588101015|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
162833427|NCT00440947|588101011|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
162833428|NCT00440947|588101012|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
162833429|NCT00440947|588101013|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
162833430|NCT00440947|588101014|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
162833431|NCT00440947|588101015|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
162833432|NCT00440947|588101011|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
162833433|NCT00440947|588101012|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
162833434|NCT00440947|588101013|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
162833435|NCT00440947|588101014|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
162833436|NCT00440947|588101015|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
162833437|NCT00440947|588101011|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
162833438|NCT00440947|588101012|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
162833439|NCT00440947|588101013|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
162833440|NCT00440947|588101014|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
162833441|NCT00440947|588101015|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
162833442|NCT00440947|588101011|FG000|36-Week Induction Phase|Incarceration|3|||
162833443|NCT00440947|588101012|FG001|36-Week Induction Phase|Incarceration|0|||
162833444|NCT00440947|588101013|FG002|36-Week Induction Phase|Incarceration|0|||
162833445|NCT00440947|588101014|FG003|36-Week Induction Phase|Incarceration|0|||
162833446|NCT00440947|588101015|FG004|36-Week Induction Phase|Incarceration|0|||
162833447|NCT00440947|588101011|FG000|36-Week Induction Phase|Pregnancy|1|||
162833448|NCT00440947|588101012|FG001|36-Week Induction Phase|Pregnancy|0|||
162833449|NCT00440947|588101013|FG002|36-Week Induction Phase|Pregnancy|0|||
162833450|NCT00440947|588101014|FG003|36-Week Induction Phase|Pregnancy|0|||
162833451|NCT00440947|588101015|FG004|36-Week Induction Phase|Pregnancy|0|||
162833452|NCT00440947|588101011|FG000|48-Week Randomization Phase|Adverse Event|0|||
162833453|NCT00440947|588101012|FG001|48-Week Randomization Phase|Adverse Event|2|||
162833454|NCT00440947|588101013|FG002|48-Week Randomization Phase|Adverse Event|5|||
162833455|NCT00440947|588101014|FG003|48-Week Randomization Phase|Adverse Event|0|||
162833456|NCT00440947|588101015|FG004|48-Week Randomization Phase|Adverse Event|0|||
162833457|NCT00440947|588101011|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
162833458|NCT00440947|588101012|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
162833459|NCT00440947|588101013|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
162833460|NCT00440947|588101014|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
162833461|NCT00440947|588101015|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
162833462|NCT00440947|588101011|FG000|48-Week Randomization Phase|Non-compliance|0|||
162833463|NCT00440947|588101012|FG001|48-Week Randomization Phase|Non-compliance|3|||
162833464|NCT00440947|588101013|FG002|48-Week Randomization Phase|Non-compliance|4|||
162833465|NCT00440947|588101014|FG003|48-Week Randomization Phase|Non-compliance|0|||
162833466|NCT00440947|588101015|FG004|48-Week Randomization Phase|Non-compliance|0|||
162833467|NCT00440947|588101011|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
162833468|NCT00440947|588101012|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
162833469|NCT00440947|588101013|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
162833470|NCT00440947|588101014|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
162833471|NCT00440947|588101015|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
162833472|NCT00440947|588101011|FG000|48-Week Randomization Phase|Protocol Violation|0|||
162833473|NCT00440947|588101012|FG001|48-Week Randomization Phase|Protocol Violation|0|||
162833474|NCT00440947|588101013|FG002|48-Week Randomization Phase|Protocol Violation|1|||
162833475|NCT00440947|588101014|FG003|48-Week Randomization Phase|Protocol Violation|0|||
162833476|NCT00440947|588101015|FG004|48-Week Randomization Phase|Protocol Violation|0|||
162833477|NCT00440947|588101011|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
162833478|NCT00440947|588101012|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
162833479|NCT00440947|588101013|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
162833480|NCT00440947|588101014|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
162833481|NCT00440947|588101015|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
162833482|NCT00440947|588101011|FG000|48-Week Randomization Phase|Pregnancy|0|||
162833483|NCT00440947|588101012|FG001|48-Week Randomization Phase|Pregnancy|0|||
162833484|NCT00440947|588101013|FG002|48-Week Randomization Phase|Pregnancy|1|||
162833485|NCT00440947|588101014|FG003|48-Week Randomization Phase|Pregnancy|0|||
162833486|NCT00440947|588101015|FG004|48-Week Randomization Phase|Pregnancy|0|||
162833487|NCT00440947|588101011|FG000|48-Week Randomization Phase|Incarceration|0|||
162833488|NCT00440947|588101012|FG001|48-Week Randomization Phase|Incarceration|3|||
162833489|NCT00440947|588101013|FG002|48-Week Randomization Phase|Incarceration|0|||
162833490|NCT00440947|588101014|FG003|48-Week Randomization Phase|Incarceration|0|||
162833491|NCT00440947|588101015|FG004|48-Week Randomization Phase|Incarceration|0|||
162833492|NCT00440947|588101011|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
162833493|NCT00440947|588101012|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
162833494|NCT00440947|588101013|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
162833495|NCT00440947|588101014|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
162833496|NCT00440947|588101015|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
162833497|NCT00440947|588101011|FG000|48-Week Randomization Phase|Physician Decision|0|||
162833498|NCT00440947|588101012|FG001|48-Week Randomization Phase|Physician Decision|2|||
162833499|NCT00440947|588101013|FG002|48-Week Randomization Phase|Physician Decision|0|||
162833500|NCT00440947|588101014|FG003|48-Week Randomization Phase|Physician Decision|0|||
162833501|NCT00440947|588101015|FG004|48-Week Randomization Phase|Physician Decision|0|||
162833502|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
162833503|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
162833504|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
162833505|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
162833506|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
162833507|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
162833508|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
162833509|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
162833510|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
162833511|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
162833512|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
162833513|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
162833514|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
162833515|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
162833516|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
162699279|NCT01818141|587610331|FG001|Overall Study|Withdrawal by Subject|0|||
162699280|NCT01818141|587610330|FG000|Overall Study|No baseline C.diff colonies|1|||
162699281|NCT01818141|587610331|FG001|Overall Study|No baseline C.diff colonies|1|||
162699282|NCT01818141|587610330|FG000|Overall Study|Lost to Follow-up|0|||
162699283|NCT01818141|587610331|FG001|Overall Study|Lost to Follow-up|2|||
162699284|NCT02169830|587610335|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
162699285|NCT02169830|587610336|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
162699286|NCT02169830|587610337|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
162699287|NCT02169830|587610335|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
162699288|NCT02169830|587610336|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162699289|NCT02169830|587610337|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162699290|NCT02169830|587610335|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162699291|NCT02169830|587610336|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
162699292|NCT02169830|587610337|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
162699293|NCT02169830|587610335|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
162699294|NCT02169830|587610336|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
162699295|NCT02169830|587610337|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
162699296|NCT02169830|587610335|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
162699297|NCT02169830|587610336|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
162699298|NCT02169830|587610337|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
162699299|NCT03204695|587610338|FG000|Overall Study|Death|1|||
162699300|NCT03204695|587610338|FG000|Overall Study|Participant was treated with another device|1|||
162699301|NCT03204695|587610338|FG000|Overall Study|Physician Decision|2|||
162699302|NCT04781647|587610342|FG000|Overall Study|Study terminated by Sponsor|11|||
162699303|NCT04781647|587610343|FG001|Overall Study|Study terminated by Sponsor|9|||
162699304|NCT04781647|587610344|FG002|Overall Study|Study terminated by Sponsor|9|||
162699305|NCT04781647|587610342|FG000|Overall Study|Withdrawal by Subject|1|||
162699306|NCT04781647|587610343|FG001|Overall Study|Withdrawal by Subject|2|||
162833517|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
162833518|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
162833519|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
162833520|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
162699307|NCT04781647|587610344|FG002|Overall Study|Withdrawal by Subject|0|||
162699308|NCT04781647|587610342|FG000|Overall Study|Adverse Event|0|||
162699309|NCT04781647|587610343|FG001|Overall Study|Adverse Event|1|||
162699310|NCT04781647|587610344|FG002|Overall Study|Adverse Event|1|||
162699311|NCT04781647|587610342|FG000|Overall Study|Protocol Violation|1|||
162699312|NCT04781647|587610343|FG001|Overall Study|Protocol Violation|0|||
162699313|NCT04781647|587610344|FG002|Overall Study|Protocol Violation|0|||
162947124|NCT05109234|588508247|FG000|Overall Study|Adverse Event|2|||
162699314|NCT04781647|587610342|FG000|Overall Study|Pregnancy|0|||
162699315|NCT04781647|587610343|FG001|Overall Study|Pregnancy|0|||
162833521|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
162833522|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
162833523|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
162833524|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
162833525|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
162833526|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
162833527|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
162833528|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
162833529|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
162833530|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
162833531|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
162833532|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
162833533|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
162833534|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
162833535|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
162833536|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
162833537|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
162833538|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
162833539|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
162833540|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
162833541|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
162833542|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
162833543|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
162833544|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
162833545|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
162833546|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
162833547|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
162833548|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
162833549|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
162833550|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
162833551|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
162833552|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
162833553|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
162833554|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
162833555|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
162833556|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
162833557|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Other|0|||
162833558|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Other|0|||
162833559|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Other|0|||
162833560|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Other|1|||
162833561|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Other|0|||
162833562|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
162833563|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
162833564|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
162833565|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
162833566|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
162833567|NCT00440947|588101011|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
162833568|NCT00440947|588101012|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
162833569|NCT00440947|588101013|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
162833570|NCT00440947|588101014|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
162833571|NCT00440947|588101015|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
162833572|NCT01834274|588101016|FG000|Overall Study|Study Termination|41|||
162833573|NCT01834274|588101017|FG001|Overall Study|Study Termination|38|||
162833574|NCT01834274|588101016|FG000|Overall Study|Withdrawal by Subject|1|||
162833575|NCT01834274|588101017|FG001|Overall Study|Withdrawal by Subject|1|||
162699316|NCT04781647|587610344|FG002|Overall Study|Pregnancy|1|||
162699317|NCT04781647|587610342|FG000|Overall Study|Virology rebounded|1|||
162699318|NCT04781647|587610343|FG001|Overall Study|Virology rebounded|0|||
162699319|NCT04781647|587610344|FG002|Overall Study|Virology rebounded|0|||
162699320|NCT00777803|587610345|FG000|Overall Study|Lost to Follow-up|12|||
162699321|NCT00777803|587610346|FG001|Overall Study|Lost to Follow-up|5|||
162699322|NCT00777803|587610345|FG000|Overall Study|Adverse Event|1|||
162699323|NCT00777803|587610346|FG001|Overall Study|Adverse Event|0|||
162699324|NCT00777803|587610345|FG000|Overall Study|Non-compliance|2|||
162699325|NCT00777803|587610346|FG001|Overall Study|Non-compliance|2|||
162699326|NCT01755689|587610347|FG000|Overall Study|Withdrawal by Subject|1|||
162699327|NCT01755689|587610348|FG001|Overall Study|Withdrawal by Subject|3|||
162699328|NCT01755689|587610349|FG002|Overall Study|Withdrawal by Subject|2|||
162699329|NCT01755689|587610350|FG003|Overall Study|Withdrawal by Subject|1|||
162699330|NCT01755689|587610351|FG004|Overall Study|Withdrawal by Subject|1|||
162699331|NCT01755689|587610347|FG000|Overall Study|Migrated/moved from study area|0|||
162699332|NCT01755689|587610348|FG001|Overall Study|Migrated/moved from study area|1|||
162699333|NCT01755689|587610349|FG002|Overall Study|Migrated/moved from study area|1|||
162699334|NCT01755689|587610350|FG003|Overall Study|Migrated/moved from study area|1|||
162699335|NCT01755689|587610351|FG004|Overall Study|Migrated/moved from study area|1|||
162699336|NCT01755689|587610347|FG000|Overall Study|Lost to Follow-up|1|||
162699337|NCT01755689|587610348|FG001|Overall Study|Lost to Follow-up|0|||
162699338|NCT01755689|587610349|FG002|Overall Study|Lost to Follow-up|1|||
162699339|NCT01755689|587610350|FG003|Overall Study|Lost to Follow-up|0|||
162699340|NCT01755689|587610351|FG004|Overall Study|Lost to Follow-up|2|||
162699341|NCT01755689|587610347|FG000|Overall Study|Pregnancy|1|||
162699342|NCT01755689|587610348|FG001|Overall Study|Pregnancy|1|||
162699343|NCT01755689|587610349|FG002|Overall Study|Pregnancy|2|||
162699344|NCT01755689|587610350|FG003|Overall Study|Pregnancy|4|||
162699345|NCT01755689|587610351|FG004|Overall Study|Pregnancy|2|||
162699346|NCT02930122|587610354|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
162699347|NCT02930122|587610355|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
162699348|NCT01995357|587610356|FG000|Period 5|Lack of Efficacy|1|||
162699349|NCT01995357|587610357|FG001|Period 5|Lack of Efficacy|0|||
162699350|NCT01995357|587610358|FG002|Period 5|Lack of Efficacy|0|||
162699351|NCT01995357|587610359|FG003|Period 5|Lack of Efficacy|0|||
162699352|NCT01995357|587610360|FG004|Period 5|Lack of Efficacy|0|||
162699353|NCT01995357|587610361|FG005|Period 5|Lack of Efficacy|0|||
162699354|NCT01995357|587610356|FG000|Period 5|Adverse Event|1|||
162833576|NCT01834274|588101016|FG000|Overall Study|Lost to Follow-up|3|||
162833577|NCT01834274|588101017|FG001|Overall Study|Lost to Follow-up|1|||
162833578|NCT01834274|588101016|FG000|Overall Study|Other|2|||
162833579|NCT01834274|588101017|FG001|Overall Study|Other|1|||
162699355|NCT01995357|587610357|FG001|Period 5|Adverse Event|0|||
162699356|NCT01995357|587610358|FG002|Period 5|Adverse Event|1|||
162699357|NCT01995357|587610359|FG003|Period 5|Adverse Event|0|||
162699358|NCT01995357|587610360|FG004|Period 5|Adverse Event|0|||
162699359|NCT01995357|587610361|FG005|Period 5|Adverse Event|0|||
162699360|NCT02609659|587610362|FG000|Overall Study|Adverse Event|1|||
162699361|NCT02609659|587610362|FG000|Overall Study|Lost to Follow-up|6|||
162833580|NCT01827670|588101020|FG000|Overall Study|Withdrawal of Consent|3|||
162833581|NCT01827670|588101021|FG001|Overall Study|Withdrawal of Consent|2|||
162833582|NCT01827670|588101020|FG000|Overall Study|Lost to Follow-up|0|||
162833583|NCT01827670|588101021|FG001|Overall Study|Lost to Follow-up|1|||
162947125|NCT05109234|588508248|FG001|Overall Study|Adverse Event|2|||
162947126|NCT05109234|588508247|FG000|Overall Study|Lack of Efficacy|5|||
162947127|NCT05109234|588508248|FG001|Overall Study|Lack of Efficacy|0|||
162947128|NCT05109234|588508247|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
162833584|NCT03681119|588101026|FG000|Overall Study|No specific reason|4|||
162833585|NCT03681119|588101027|FG001|Overall Study|No specific reason|0|||
162833586|NCT03681119|588101026|FG000|Overall Study|Sickness|2|||
162833587|NCT03681119|588101027|FG001|Overall Study|Sickness|0|||
162833588|NCT02941627|588101036|FG000|Overall Study|Death|1|||
162833589|NCT02941627|588101036|FG000|Overall Study|Surgical failure|1|||
162833590|NCT02941627|588101036|FG000|Overall Study|cholesteatoma prevented implantation|1|||
162833591|NCT00517829|588101037|FG000|Overall Study|Adverse Event|22|||
162833592|NCT00517829|588101038|FG001|Overall Study|Adverse Event|34|||
162833593|NCT00517829|588101037|FG000|Overall Study|Disease Progression|39|||
162833594|NCT00517829|588101038|FG001|Overall Study|Disease Progression|32|||
162833595|NCT00517829|588101037|FG000|Overall Study|Patient Request|6|||
162833596|NCT00517829|588101038|FG001|Overall Study|Patient Request|5|||
162833597|NCT00517829|588101037|FG000|Overall Study|Investigator Request|5|||
162833598|NCT00517829|588101038|FG001|Overall Study|Investigator Request|3|||
162833599|NCT00517829|588101037|FG000|Overall Study|Other|3|||
162833600|NCT00517829|588101038|FG001|Overall Study|Other|1|||
162833601|NCT01265550|588101039|FG000|Pre Randomization|Withdrawal by Subject|0|||
162833602|NCT01265550|588101040|FG001|Pre Randomization|Withdrawal by Subject|0|||
162833603|NCT01265550|588101041|FG002|Pre Randomization|Withdrawal by Subject|0|||
162833604|NCT01265550|588101042|FG003|Pre Randomization|Withdrawal by Subject|70|||
162833605|NCT01265550|588101039|FG000|Pre Randomization|Technical Exclusions|0|||
162833606|NCT01265550|588101040|FG001|Pre Randomization|Technical Exclusions|0|||
162833607|NCT01265550|588101041|FG002|Pre Randomization|Technical Exclusions|0|||
162833608|NCT01265550|588101042|FG003|Pre Randomization|Technical Exclusions|54|||
162833609|NCT01265550|588101039|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
162833610|NCT01265550|588101040|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
162833611|NCT01265550|588101041|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
162833612|NCT01265550|588101042|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
162833613|NCT01265550|588101039|FG000|Pre Randomization|Non-GERD organic disorders|0|||
162833614|NCT01265550|588101040|FG001|Pre Randomization|Non-GERD organic disorders|0|||
162833615|NCT01265550|588101041|FG002|Pre Randomization|Non-GERD organic disorders|0|||
162833616|NCT01265550|588101042|FG003|Pre Randomization|Non-GERD organic disorders|23|||
162833617|NCT01265550|588101039|FG000|Pre Randomization|Functional heartburn|0|||
162833618|NCT01265550|588101040|FG001|Pre Randomization|Functional heartburn|0|||
162833619|NCT01265550|588101041|FG002|Pre Randomization|Functional heartburn|0|||
162833620|NCT01265550|588101042|FG003|Pre Randomization|Functional heartburn|99|||
162833621|NCT00606086|588101043|FG000|Overall Study|Adverse Event|1|||
162833622|NCT00606086|588101044|FG001|Overall Study|Adverse Event|1|||
162833623|NCT00606086|588101043|FG000|Overall Study|Lost to Follow-up|4|||
162833624|NCT00606086|588101044|FG001|Overall Study|Lost to Follow-up|8|||
162833625|NCT00606086|588101043|FG000|Overall Study|Protocol Violation|1|||
162833626|NCT00606086|588101044|FG001|Overall Study|Protocol Violation|0|||
162833627|NCT00606086|588101043|FG000|Overall Study|Withdrawal by Subject|5|||
162833628|NCT00606086|588101044|FG001|Overall Study|Withdrawal by Subject|3|||
162833629|NCT00606086|588101043|FG000|Overall Study|Non-compliance|0|||
162833630|NCT00606086|588101044|FG001|Overall Study|Non-compliance|1|||
162833631|NCT00606086|588101043|FG000|Overall Study|Randomized, not treated|1|||
162833632|NCT00606086|588101044|FG001|Overall Study|Randomized, not treated|2|||
162833633|NCT01929408|588101045|FG000|Overall Study|received HCT as initial treatment|8|||
162833634|NCT00652366|588101056|FG000|Overall Study|Adverse Event|8|||
162833635|NCT00652366|588101057|FG001|Overall Study|Adverse Event|4|||
162833636|NCT00652366|588101058|FG002|Overall Study|Adverse Event|7|||
162833637|NCT00652366|588101059|FG003|Overall Study|Adverse Event|17|||
162833638|NCT00652366|588101060|FG004|Overall Study|Adverse Event|13|||
162947129|NCT05109234|588508248|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
162947130|NCT05109234|588508247|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
162833639|NCT00652366|588101056|FG000|Overall Study|Death|5|||
162833640|NCT00652366|588101057|FG001|Overall Study|Death|4|||
162833641|NCT00652366|588101058|FG002|Overall Study|Death|1|||
162833642|NCT00652366|588101059|FG003|Overall Study|Death|8|||
162833643|NCT00652366|588101060|FG004|Overall Study|Death|5|||
162833644|NCT00652366|588101056|FG000|Overall Study|Lack of Efficacy|84|||
162833645|NCT00652366|588101057|FG001|Overall Study|Lack of Efficacy|58|||
162833646|NCT00652366|588101058|FG002|Overall Study|Lack of Efficacy|53|||
162833647|NCT00652366|588101059|FG003|Overall Study|Lack of Efficacy|133|||
162833648|NCT00652366|588101060|FG004|Overall Study|Lack of Efficacy|13|||
162833649|NCT00652366|588101056|FG000|Overall Study|Violation of Selection Criteria|0|||
162833650|NCT00652366|588101057|FG001|Overall Study|Violation of Selection Criteria|0|||
162833651|NCT00652366|588101058|FG002|Overall Study|Violation of Selection Criteria|1|||
162833652|NCT00652366|588101059|FG003|Overall Study|Violation of Selection Criteria|0|||
162833653|NCT00652366|588101060|FG004|Overall Study|Violation of Selection Criteria|0|||
162833654|NCT00652366|588101056|FG000|Overall Study|Protocol Violation|1|||
162833655|NCT00652366|588101057|FG001|Overall Study|Protocol Violation|0|||
162833656|NCT00652366|588101058|FG002|Overall Study|Protocol Violation|0|||
162833657|NCT00652366|588101059|FG003|Overall Study|Protocol Violation|0|||
162833658|NCT00652366|588101060|FG004|Overall Study|Protocol Violation|0|||
162833659|NCT00652366|588101056|FG000|Overall Study|Refused treatment|3|||
162833660|NCT00652366|588101057|FG001|Overall Study|Refused treatment|7|||
162833661|NCT00652366|588101058|FG002|Overall Study|Refused treatment|6|||
162833662|NCT00652366|588101059|FG003|Overall Study|Refused treatment|17|||
162833663|NCT00652366|588101060|FG004|Overall Study|Refused treatment|5|||
162833664|NCT00652366|588101056|FG000|Overall Study|Other|5|||
162833665|NCT00652366|588101057|FG001|Overall Study|Other|2|||
162833666|NCT00652366|588101058|FG002|Overall Study|Other|3|||
162833667|NCT00652366|588101059|FG003|Overall Study|Other|4|||
162833668|NCT00652366|588101060|FG004|Overall Study|Other|0|||
162833669|NCT03873714|588101061|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
162833670|NCT01970501|588101062|FG000|Overall Study|Discontinuation of study by sponsor|16|||
162833671|NCT01970501|588101063|FG001|Overall Study|Discontinuation of study by sponsor|14|||
162833672|NCT01970501|588101062|FG000|Overall Study|Withdrawal by Subject|6|||
162833673|NCT01970501|588101063|FG001|Overall Study|Withdrawal by Subject|7|||
162833674|NCT01970501|588101062|FG000|Overall Study|Adverse Event|2|||
162833675|NCT01970501|588101063|FG001|Overall Study|Adverse Event|4|||
162833676|NCT01970501|588101062|FG000|Overall Study|Death|1|||
162699362|NCT02609659|587610362|FG000|Overall Study|Other|1|||
162699363|NCT01004250|587610365|FG000|Induction Therapy Period|Adverse Event|10|||
162699364|NCT01004250|587610365|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
162699365|NCT01004250|587610365|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
162699366|NCT01004250|587610365|FG000|Induction Therapy Period|Physician Decision|2|||
162699367|NCT01004250|587610365|FG000|Maintenance Therapy Period|Adverse Event|15|||
162699368|NCT01004250|587610365|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
162699369|NCT01004250|587610365|FG000|Maintenance Therapy Period|Protocol Violation|1|||
162699370|NCT01004250|587610365|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
162699371|NCT01004250|587610365|FG000|Maintenance Therapy Period|Physician Decision|4|||
162699372|NCT01004250|587610365|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
162699373|NCT01853254|587610366|FG000|Overall Study|Abnormal Laboratory Test|1|||
162699374|NCT01853254|587610366|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
162699375|NCT01853254|587610366|FG000|Overall Study|Death|1|||
162699376|NCT01853254|587610366|FG000|Overall Study|Failure to Return|43|||
162699377|NCT01853254|587610366|FG000|Overall Study|Insufficient Therapeutic Response|22|||
162699378|NCT01853254|587610366|FG000|Overall Study|Refusal of Treatment|1|||
162699379|NCT01853254|587610366|FG000|Overall Study|Other Protocol Violation|1|||
162699380|NCT01853254|587610366|FG000|Overall Study|Withdrawal of Consent|16|||
162699381|NCT01853254|587610366|FG000|Overall Study|Administrative/Other|16|||
162699382|NCT02462083|587610367|FG000|Overall Study|Sponsor request|39|||
162699383|NCT02462083|587610367|FG000|Overall Study|Withdrawal by Subject|87|||
162699384|NCT02462083|587610367|FG000|Overall Study|Lost to Follow-up|41|||
162699385|NCT02462083|587610367|FG000|Overall Study|Lack of Efficacy|151|||
162699386|NCT02462083|587610367|FG000|Overall Study|Pregnancy|1|||
162699387|NCT02462083|587610367|FG000|Overall Study|Protocol Violation|6|||
162699388|NCT02462083|587610367|FG000|Overall Study|Adverse Event|33|||
162699389|NCT02462083|587610367|FG000|Overall Study|Worsening condition|16|||
162699390|NCT02462083|587610367|FG000|Overall Study|Other than specified|45|||
162699391|NCT02711995|587610370|FG000|Washout (90 Days)|Conflicting medication|1|||
162833677|NCT01970501|588101063|FG001|Overall Study|Death|3|||
162833678|NCT01970501|588101062|FG000|Overall Study|Physician Decision|2|||
162699392|NCT01809210|587610373|FG000|Overall Study|Withdrawal by Subject|0|||
162699393|NCT01809210|587610374|FG001|Overall Study|Withdrawal by Subject|0|||
162699394|NCT01809210|587610375|FG002|Overall Study|Withdrawal by Subject|1|||
162699395|NCT01809210|587610376|FG003|Overall Study|Withdrawal by Subject|1|||
162699396|NCT01809210|587610377|FG004|Overall Study|Withdrawal by Subject|1|||
162699397|NCT01809210|587610378|FG005|Overall Study|Withdrawal by Subject|0|||
162833679|NCT01970501|588101063|FG001|Overall Study|Physician Decision|0|||
162833680|NCT00677014|588101064|FG000|Overall Study|Lost to Follow-up|20|||
162833681|NCT00677014|588101065|FG001|Overall Study|Lost to Follow-up|12|||
162833682|NCT00677014|588101066|FG002|Overall Study|Lost to Follow-up|24|||
162833683|NCT00677014|588101064|FG000|Overall Study|Death|6|||
162833684|NCT00677014|588101065|FG001|Overall Study|Death|15|||
162833685|NCT00677014|588101066|FG002|Overall Study|Death|7|||
162833686|NCT00677014|588101064|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
162833687|NCT00677014|588101065|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
162833688|NCT00677014|588101066|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
162833689|NCT01326546|588101069|FG000|Overall Study|Lost to Follow-up|8|||
162833690|NCT01326546|588101070|FG001|Overall Study|Lost to Follow-up|7|||
162833691|NCT01326546|588101069|FG000|Overall Study|Protocol Violation|3|||
162833692|NCT01326546|588101070|FG001|Overall Study|Protocol Violation|4|||
162833693|NCT01326546|588101069|FG000|Overall Study|Pregnancy|0|||
162833694|NCT01326546|588101070|FG001|Overall Study|Pregnancy|1|||
162833695|NCT01326546|588101069|FG000|Overall Study|Adverse Event|1|||
162833696|NCT01326546|588101070|FG001|Overall Study|Adverse Event|0|||
162833697|NCT01326546|588101069|FG000|Overall Study|Withdrawal by Subject|5|||
162833698|NCT01326546|588101070|FG001|Overall Study|Withdrawal by Subject|1|||
162833699|NCT00081159|588101074|FG000|Overall Study|Withdrawal by Subject|0|||
162833700|NCT00081159|588101075|FG001|Overall Study|Withdrawal by Subject|3|||
162833701|NCT00081159|588101074|FG000|Overall Study|Myelosuppression prior to treatment|0|||
162833702|NCT00081159|588101075|FG001|Overall Study|Myelosuppression prior to treatment|1|||
162833703|NCT00081159|588101074|FG000|Overall Study|Lost to Follow-up|2|||
162833704|NCT00081159|588101075|FG001|Overall Study|Lost to Follow-up|1|||
162833705|NCT00923130|588101078|FG000|Overall Study|Stopped treatment due to progression|17|||
162833706|NCT00923130|588101078|FG000|Overall Study|Death|1|||
162833707|NCT00923130|588101078|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
162833708|NCT00923130|588101078|FG000|Overall Study|Switched to alternative treatment|2|||
162833709|NCT00923130|588101078|FG000|Overall Study|Refused further treatment|2|||
162833710|NCT03693625|588101079|FG000|Overall Study|Adverse Event|2|||
162833711|NCT03693625|588101080|FG001|Overall Study|Adverse Event|0|||
162833712|NCT03693625|588101079|FG000|Overall Study|Study Terminated By Sponsor|20|||
162833713|NCT03693625|588101080|FG001|Overall Study|Study Terminated By Sponsor|7|||
162833714|NCT03693625|588101079|FG000|Overall Study|Withdrawal by Subject|1|||
162833715|NCT03693625|588101080|FG001|Overall Study|Withdrawal by Subject|1|||
162833716|NCT02457637|588101081|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
162833717|NCT01035905|588101082|FG000|Overall Study|Lack of Efficacy|1|||
162833718|NCT01035905|588101083|FG001|Overall Study|Lack of Efficacy|1|||
162833719|NCT05038020|588101085|FG000|Overall Study|Early Termination|3|||
162833720|NCT05038020|588101086|FG001|Overall Study|Early Termination|0|||
162833721|NCT03416153|588101088|FG000|Overall Study|Physician Decision|1|||
162833722|NCT03416153|588101089|FG001|Overall Study|Physician Decision|1|||
162833723|NCT03416153|588101088|FG000|Overall Study|Withdrawal by Subject|1|||
162833724|NCT03416153|588101089|FG001|Overall Study|Withdrawal by Subject|0|||
162833725|NCT03468855|588102894|FG000|Overall Study|Adverse Event|2|||
162833726|NCT03468855|588102894|FG000|Overall Study|Lost to Follow-up|5|||
162833727|NCT03468855|588102894|FG000|Overall Study|Withdrawal by Subject|3|||
162833728|NCT03468855|588102894|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
162833729|NCT02068547|588102895|FG000|Overall Study|Lost to Follow-up|3|||
162833730|NCT02068547|588102896|FG001|Overall Study|Lost to Follow-up|3|||
162833731|NCT02068547|588102895|FG000|Overall Study|Physician Decision|1|||
162833732|NCT02068547|588102896|FG001|Overall Study|Physician Decision|0|||
162833733|NCT00880893|588102897|FG000|Overall Study|Protocol Violation|13|||
162833734|NCT00880893|588102898|FG001|Overall Study|Protocol Violation|1|||
162833735|NCT00880893|588102897|FG000|Overall Study|Withdrawal by Subject|15|||
162699398|NCT01809210|587610379|FG006|Overall Study|Withdrawal by Subject|4|||
162699399|NCT01809210|587610373|FG000|Overall Study|Death|1|||
162699400|NCT01809210|587610374|FG001|Overall Study|Death|1|||
162699401|NCT01809210|587610375|FG002|Overall Study|Death|2|||
162699402|NCT01809210|587610376|FG003|Overall Study|Death|0|||
162699403|NCT01809210|587610377|FG004|Overall Study|Death|1|||
162699404|NCT01809210|587610378|FG005|Overall Study|Death|3|||
162699405|NCT01809210|587610379|FG006|Overall Study|Death|1|||
162699406|NCT01115998|587610380|FG000|Overall Study|Lost to Follow-up|6|||
162699407|NCT01115998|587610381|FG001|Overall Study|Lost to Follow-up|6|||
162699408|NCT01383993|587610387|FG000|Overall Study|Adverse Event|1|||
162699409|NCT01383993|587610388|FG001|Overall Study|Adverse Event|1|||
162699410|NCT01383993|587610389|FG002|Overall Study|Adverse Event|0|||
162699411|NCT01383993|587610387|FG000|Overall Study|Withdrawal by Subject|0|||
162699412|NCT01383993|587610388|FG001|Overall Study|Withdrawal by Subject|0|||
162699413|NCT01383993|587610389|FG002|Overall Study|Withdrawal by Subject|1|||
162699414|NCT01383993|587610387|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
162699415|NCT01383993|587610388|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
162699416|NCT01383993|587610389|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
162699417|NCT01489020|587610394|FG000|Overall Study|Withdrawal by Subject|1|||
162699418|NCT01489020|587610395|FG001|Overall Study|Withdrawal by Subject|0|||
162699419|NCT01489020|587610396|FG002|Overall Study|Withdrawal by Subject|0|||
162699420|NCT01489020|587610397|FG003|Overall Study|Withdrawal by Subject|0|||
162699421|NCT01489020|587610398|FG004|Overall Study|Withdrawal by Subject|0|||
162699422|NCT01489020|587610399|FG005|Overall Study|Withdrawal by Subject|0|||
162699423|NCT01489020|587610394|FG000|Overall Study|Adverse Event|0|||
162699424|NCT01489020|587610395|FG001|Overall Study|Adverse Event|0|||
162699425|NCT01489020|587610396|FG002|Overall Study|Adverse Event|3|||
162699426|NCT01489020|587610397|FG003|Overall Study|Adverse Event|0|||
162699427|NCT01489020|587610398|FG004|Overall Study|Adverse Event|3|||
162699428|NCT01489020|587610399|FG005|Overall Study|Adverse Event|0|||
162699429|NCT01489020|587610394|FG000|Overall Study|Concomitant disease|0|||
162699430|NCT01489020|587610395|FG001|Overall Study|Concomitant disease|0|||
162699431|NCT01489020|587610396|FG002|Overall Study|Concomitant disease|0|||
162699432|NCT01489020|587610397|FG003|Overall Study|Concomitant disease|0|||
162699433|NCT01489020|587610398|FG004|Overall Study|Concomitant disease|3|||
162699434|NCT01489020|587610399|FG005|Overall Study|Concomitant disease|0|||
162699435|NCT00262743|587610401|FG000|Overall Study|Adverse Event|0|||
162699436|NCT00262743|587610402|FG001|Overall Study|Adverse Event|9|||
162699437|NCT00262743|587610401|FG000|Overall Study|Disease progression|0|||
162699438|NCT00262743|587610402|FG001|Overall Study|Disease progression|3|||
162699439|NCT02485353|587610405|FG000|Overall Study|Death|1|||
162699440|NCT02485353|587610405|FG000|Overall Study|Disease Progression|1|||
162699441|NCT04747275|587610408|FG000|Overall Study|Study terminated|0|||
162699442|NCT04747275|587610409|FG001|Overall Study|Study terminated|1|||
162699443|NCT03268590|587610412|FG000|Overall Study|Previously unknown exclusion criteria|1|||
162699444|NCT00531011|587610413|FG000|Overall Study|Withdrawal by Subject|2|||
162699445|NCT00531011|587610414|FG001|Overall Study|Withdrawal by Subject|4|||
162699446|NCT00531011|587610413|FG000|Overall Study|Death|1|||
162699447|NCT00531011|587610414|FG001|Overall Study|Death|0|||
162699448|NCT00531011|587610413|FG000|Overall Study|Lost to Follow-up|1|||
162699449|NCT00531011|587610414|FG001|Overall Study|Lost to Follow-up|0|||
162833736|NCT00880893|588102898|FG001|Overall Study|Withdrawal by Subject|11|||
162833737|NCT00880893|588102897|FG000|Overall Study|Lost to Follow-up|76|||
162833738|NCT00880893|588102898|FG001|Overall Study|Lost to Follow-up|33|||
162833739|NCT00880893|588102897|FG000|Overall Study|Serious adverse event|3|||
162833740|NCT00880893|588102898|FG001|Overall Study|Serious adverse event|0|||
162833741|NCT01736579|588102902|FG000|Overall Study|Termination of Study by Sponsor|2|||
162833742|NCT01736579|588102903|FG001|Overall Study|Termination of Study by Sponsor|2|||
162833743|NCT01979523|588102905|FG000|Overall Study|Withdrawal by Subject|1|||
162833744|NCT01979523|588102906|FG001|Overall Study|Withdrawal by Subject|0|||
162833745|NCT00772954|588102917|FG000|Overall Study|Adverse Event|0|||
162833746|NCT00772954|588102918|FG001|Overall Study|Adverse Event|0|||
162699450|NCT00531011|587610413|FG000|Overall Study|Physician Decision|0|||
162699451|NCT00531011|587610414|FG001|Overall Study|Physician Decision|3|||
162833747|NCT00772954|588102919|FG002|Overall Study|Adverse Event|1|||
162699452|NCT02823964|587610417|FG000|Overall Study|Adverse Event|2|||
162699453|NCT02823964|587610417|FG000|Overall Study|Physician Decision|1|||
162699454|NCT02823964|587610417|FG000|Overall Study|Lack of Efficacy|1|||
162699455|NCT02823964|587610417|FG000|Overall Study|Withdrawal by Subject|1|||
162699456|NCT03537261|587610418|FG000|Overall Study|Lost to Follow-up|4|||
162699457|NCT03537261|587610419|FG001|Overall Study|Lost to Follow-up|5|||
162699458|NCT03537261|587610418|FG000|Overall Study|Withdrawal by Subject|4|||
162699459|NCT03537261|587610419|FG001|Overall Study|Withdrawal by Subject|6|||
162699460|NCT03537261|587610418|FG000|Overall Study|Did not return study questionnaires|0|||
162699461|NCT03537261|587610419|FG001|Overall Study|Did not return study questionnaires|1|||
162699462|NCT01729728|587610422|FG000|Overall Study|Adverse Event|0|||
162699463|NCT01729728|587610423|FG001|Overall Study|Adverse Event|6|||
162833748|NCT01661140|588102920|FG000|Open-Label Period|Adverse Event|44|||
162833749|NCT01661140|588102921|FG001|Open-Label Period|Adverse Event|0|||
162833750|NCT01661140|588102922|FG002|Open-Label Period|Adverse Event|0|||
162833751|NCT01661140|588102920|FG000|Open-Label Period|Protocol Violation|3|||
162833752|NCT01661140|588102921|FG001|Open-Label Period|Protocol Violation|0|||
162833753|NCT01661140|588102922|FG002|Open-Label Period|Protocol Violation|0|||
162833754|NCT01661140|588102920|FG000|Open-Label Period|Withdrawal by Subject|5|||
162833755|NCT01661140|588102921|FG001|Open-Label Period|Withdrawal by Subject|0|||
162833756|NCT01661140|588102922|FG002|Open-Label Period|Withdrawal by Subject|0|||
162833757|NCT01661140|588102920|FG000|Open-Label Period|Investigator Decision|3|||
162833758|NCT01661140|588102921|FG001|Open-Label Period|Investigator Decision|0|||
162833759|NCT01661140|588102922|FG002|Open-Label Period|Investigator Decision|0|||
162833760|NCT01661140|588102920|FG000|Open-Label Period|Death|1|||
162833761|NCT01661140|588102921|FG001|Open-Label Period|Death|0|||
162833762|NCT01661140|588102922|FG002|Open-Label Period|Death|0|||
162699464|NCT01729728|587610424|FG002|Overall Study|Adverse Event|0|||
162699465|NCT01729728|587610422|FG000|Overall Study|Protocol Violation|1|||
162699466|NCT01729728|587610423|FG001|Overall Study|Protocol Violation|0|||
162833763|NCT01661140|588102920|FG000|Open-Label Period|Administrative/Other|1|||
162699467|NCT01729728|587610424|FG002|Overall Study|Protocol Violation|1|||
162699468|NCT00610675|587610425|FG000|Overall Study|Untreated|4|||
162699469|NCT00610675|587610425|FG000|Overall Study|Adverse Event|67|||
162699470|NCT00610675|587610425|FG000|Overall Study|Insufficient Effect|31|||
162699471|NCT00610675|587610425|FG000|Overall Study|Withdrawal by Subject|28|||
162833764|NCT01661140|588102921|FG001|Open-Label Period|Administrative/Other|0|||
162699472|NCT00610675|587610425|FG000|Overall Study|Reasons unrelated to trial|27|||
162699473|NCT00610675|587610425|FG000|Overall Study|Lack of Compliance|7|||
162833765|NCT01661140|588102922|FG002|Open-Label Period|Administrative/Other|0|||
162833766|NCT01661140|588102920|FG000|Open-Label Period|Sponsor termination|16|||
162833767|NCT01661140|588102921|FG001|Open-Label Period|Sponsor termination|0|||
162833768|NCT01661140|588102922|FG002|Open-Label Period|Sponsor termination|0|||
162833769|NCT01661140|588102920|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
162833770|NCT01661140|588102921|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
162833771|NCT01661140|588102922|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
162833772|NCT01661140|588102920|FG000|Open-Label Period|Lost to Follow-up|2|||
162833773|NCT01661140|588102921|FG001|Open-Label Period|Lost to Follow-up|0|||
162833774|NCT01661140|588102922|FG002|Open-Label Period|Lost to Follow-up|0|||
162833775|NCT01661140|588102920|FG000|Double-Blind Period|Refused Treatment|0|||
162833776|NCT01661140|588102921|FG001|Double-Blind Period|Refused Treatment|0|||
162833777|NCT01661140|588102922|FG002|Double-Blind Period|Refused Treatment|1|||
162833778|NCT01661140|588102920|FG000|Double-Blind Period|Adverse Event|0|||
162833779|NCT01661140|588102921|FG001|Double-Blind Period|Adverse Event|16|||
162833780|NCT01661140|588102922|FG002|Double-Blind Period|Adverse Event|18|||
162833781|NCT01661140|588102920|FG000|Double-Blind Period|Protocol Violation|0|||
162833782|NCT01661140|588102921|FG001|Double-Blind Period|Protocol Violation|2|||
162833783|NCT01661140|588102922|FG002|Double-Blind Period|Protocol Violation|3|||
162833784|NCT01661140|588102920|FG000|Double-Blind Period|Withdrawal by Subject|0|||
162833785|NCT01661140|588102921|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162833786|NCT01661140|588102922|FG002|Double-Blind Period|Withdrawal by Subject|3|||
162833787|NCT01661140|588102920|FG000|Double-Blind Period|Investigator's Decision|0|||
162833788|NCT01661140|588102921|FG001|Double-Blind Period|Investigator's Decision|1|||
162833789|NCT01661140|588102922|FG002|Double-Blind Period|Investigator's Decision|2|||
162833790|NCT01661140|588102920|FG000|Double-Blind Period|Sponsor Termination|0|||
162833791|NCT01661140|588102921|FG001|Double-Blind Period|Sponsor Termination|14|||
162833792|NCT01661140|588102922|FG002|Double-Blind Period|Sponsor Termination|17|||
162833793|NCT01661140|588102920|FG000|Double-Blind Period|Administrative/Other|0|||
162833794|NCT01661140|588102921|FG001|Double-Blind Period|Administrative/Other|7|||
162833795|NCT01661140|588102922|FG002|Double-Blind Period|Administrative/Other|6|||
162833796|NCT02239939|588102923|FG000|Overall Study|Adverse Event|1|||
162833797|NCT02239939|588102924|FG001|Overall Study|Adverse Event|0|||
162833798|NCT02239939|588102923|FG000|Overall Study|Withdrawal by Subject|1|||
162833799|NCT02239939|588102924|FG001|Overall Study|Withdrawal by Subject|1|||
162833800|NCT02239939|588102923|FG000|Overall Study|Lost to Follow-up|0|||
162833801|NCT02239939|588102924|FG001|Overall Study|Lost to Follow-up|1|||
162833802|NCT00493870|588102928|FG000|Overall Study|Lost to Follow-up|12|||
162833803|NCT00493870|588102929|FG001|Overall Study|Lost to Follow-up|15|||
162833804|NCT00272038|588102930|FG000|Overall Study|withdrew before they received 2 cycles|7|||
162833805|NCT05594173|588102931|FG000|Overall Study|Adverse Event|1|||
162833806|NCT05594173|588102931|FG000|Overall Study|COVID-19 Pandemic|2|||
162833807|NCT00763139|588102932|FG000|Overall Study|Adverse Event|4|||
162833808|NCT00763139|588102933|FG001|Overall Study|Adverse Event|2|||
162833809|NCT00763139|588102932|FG000|Overall Study|Withdrawal by Subject|0|||
162833810|NCT00763139|588102933|FG001|Overall Study|Withdrawal by Subject|1|||
162833811|NCT00763139|588102932|FG000|Overall Study|med change not allowed by protocol|1|||
162833812|NCT00763139|588102933|FG001|Overall Study|med change not allowed by protocol|0|||
162833813|NCT05634577|588102934|FG000|Overall Study|Lost to Follow-up|1|||
162833814|NCT05634577|588102934|FG000|Overall Study|Withdrawal by Subject|1|||
162833815|NCT03468309|588102935|FG000|Overall Study|Lost to Follow-up|4|||
162833816|NCT03468309|588102935|FG000|Overall Study|Withdrawal by Subject|2|||
162833817|NCT02631200|588102938|FG000|First Period|Death|1|||
162833818|NCT02631200|588102939|FG001|First Period|Death|2|||
162833819|NCT02631200|588102938|FG000|First Period|Patient ill-health|2|||
162833820|NCT02631200|588102939|FG001|First Period|Patient ill-health|4|||
162833821|NCT02631200|588102938|FG000|First Period|Withdrawal by Subject|4|||
162833822|NCT02631200|588102939|FG001|First Period|Withdrawal by Subject|1|||
162833823|NCT02631200|588102938|FG000|Deferred Period|Death|0|||
162833824|NCT02631200|588102939|FG001|Deferred Period|Death|1|||
162833825|NCT02631200|588102938|FG000|Deferred Period|Received kidney transplant|0|||
162833826|NCT02631200|588102939|FG001|Deferred Period|Received kidney transplant|1|||
162833827|NCT02631200|588102938|FG000|Deferred Period|Withdrawal by Subject|0|||
162833828|NCT02631200|588102939|FG001|Deferred Period|Withdrawal by Subject|2|||
162833829|NCT02631200|588102938|FG000|Deferred Period|Lost to Follow-up|0|||
162833830|NCT02631200|588102939|FG001|Deferred Period|Lost to Follow-up|1|||
162833831|NCT03363321|588102943|FG000|Overall Study|Withdrawal by Subject|0|||
162833832|NCT03363321|588102944|FG001|Overall Study|Withdrawal by Subject|1|||
162833833|NCT03363321|588102945|FG002|Overall Study|Withdrawal by Subject|0|||
162833834|NCT03363321|588102946|FG003|Overall Study|Withdrawal by Subject|1|||
162833835|NCT03363321|588102947|FG004|Overall Study|Withdrawal by Subject|0|||
162833836|NCT00915681|588102948|FG000|Overall Study|Screening failures|46|||
162833837|NCT03221751|588102953|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
162833838|NCT03221751|588102954|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
162833839|NCT02590588|588102957|FG000|Overall Study|Adverse Event|1|||
162833840|NCT01780831|588102965|FG000|Overall Study|Withdrawal by Subject|0|||
162833841|NCT01780831|588102966|FG001|Overall Study|Withdrawal by Subject|0|||
162833842|NCT01780831|588102967|FG002|Overall Study|Withdrawal by Subject|4|||
162833843|NCT01780831|588102968|FG003|Overall Study|Withdrawal by Subject|0|||
162833844|NCT01780831|588102965|FG000|Overall Study|Lost to Follow-up|0|||
162833845|NCT01780831|588102966|FG001|Overall Study|Lost to Follow-up|0|||
162833846|NCT01780831|588102967|FG002|Overall Study|Lost to Follow-up|0|||
162833847|NCT01780831|588102968|FG003|Overall Study|Lost to Follow-up|1|||
162833848|NCT01098071|588102974|FG000|Overall Study|Surgery (adenoidectomy)|2|||
162833849|NCT01098071|588102974|FG000|Overall Study|Lost to Follow-up|13|||
162699474|NCT00610675|587610425|FG000|Overall Study|Lost to Follow-up|31|||
162699475|NCT00610675|587610425|FG000|Overall Study|Other reason (not specified)|25|||
162699476|NCT00983619|587610432|FG000|Overall Study|Lost to Follow-up|0|||
162699477|NCT00983619|587610433|FG001|Overall Study|Lost to Follow-up|1|||
162699478|NCT00983619|587610434|FG002|Overall Study|Lost to Follow-up|0|||
162699479|NCT00983619|587610435|FG003|Overall Study|Lost to Follow-up|0|||
162699480|NCT00983619|587610436|FG004|Overall Study|Lost to Follow-up|0|||
162699481|NCT00983619|587610437|FG005|Overall Study|Lost to Follow-up|2|||
162699482|NCT00983619|587610438|FG006|Overall Study|Lost to Follow-up|0|||
162699483|NCT00983619|587610439|FG007|Overall Study|Lost to Follow-up|0|||
162699484|NCT00983619|587610440|FG008|Overall Study|Lost to Follow-up|0|||
162699485|NCT00983619|587610441|FG009|Overall Study|Lost to Follow-up|0|||
162699486|NCT00983619|587610442|FG010|Overall Study|Lost to Follow-up|0|||
162699487|NCT00983619|587610443|FG011|Overall Study|Lost to Follow-up|2|||
162699488|NCT00983619|587610432|FG000|Overall Study|Withdrawal by Subject|2|||
162699489|NCT00983619|587610433|FG001|Overall Study|Withdrawal by Subject|1|||
162699490|NCT00983619|587610434|FG002|Overall Study|Withdrawal by Subject|1|||
162699491|NCT00983619|587610435|FG003|Overall Study|Withdrawal by Subject|3|||
162699492|NCT00983619|587610436|FG004|Overall Study|Withdrawal by Subject|1|||
162699493|NCT00983619|587610437|FG005|Overall Study|Withdrawal by Subject|23|||
162699494|NCT00983619|587610438|FG006|Overall Study|Withdrawal by Subject|0|||
162699495|NCT00983619|587610439|FG007|Overall Study|Withdrawal by Subject|0|||
162699496|NCT00983619|587610440|FG008|Overall Study|Withdrawal by Subject|0|||
162699497|NCT00983619|587610441|FG009|Overall Study|Withdrawal by Subject|0|||
162699498|NCT00983619|587610442|FG010|Overall Study|Withdrawal by Subject|1|||
162699499|NCT00983619|587610443|FG011|Overall Study|Withdrawal by Subject|1|||
162699500|NCT00983619|587610432|FG000|Overall Study|Death|0|||
162699501|NCT00983619|587610433|FG001|Overall Study|Death|2|||
162699502|NCT00983619|587610434|FG002|Overall Study|Death|2|||
162699503|NCT00983619|587610435|FG003|Overall Study|Death|1|||
162699504|NCT00983619|587610436|FG004|Overall Study|Death|2|||
162699505|NCT00983619|587610437|FG005|Overall Study|Death|30|||
162699506|NCT00983619|587610438|FG006|Overall Study|Death|1|||
162699507|NCT00983619|587610439|FG007|Overall Study|Death|0|||
162699508|NCT00983619|587610440|FG008|Overall Study|Death|1|||
162699509|NCT00983619|587610441|FG009|Overall Study|Death|2|||
162699510|NCT00983619|587610442|FG010|Overall Study|Death|9|||
162699511|NCT00983619|587610443|FG011|Overall Study|Death|8|||
162699512|NCT00983619|587610432|FG000|Overall Study|Other|1|||
162833850|NCT01784861|588102975|FG000|Overall Study|Adverse Event|0|||
162833851|NCT01784861|588102976|FG001|Overall Study|Adverse Event|0|||
162833852|NCT01784861|588102977|FG002|Overall Study|Adverse Event|1|||
162833853|NCT01784861|588102978|FG003|Overall Study|Adverse Event|2|||
162833854|NCT01784861|588102979|FG004|Overall Study|Adverse Event|1|||
162833855|NCT01784861|588102980|FG005|Overall Study|Adverse Event|0|||
162833856|NCT01784861|588102975|FG000|Overall Study|Withdrawal by Subject|0|||
162699513|NCT00983619|587610433|FG001|Overall Study|Other|0|||
162833857|NCT01784861|588102976|FG001|Overall Study|Withdrawal by Subject|0|||
162833858|NCT01784861|588102977|FG002|Overall Study|Withdrawal by Subject|0|||
162833859|NCT01784861|588102978|FG003|Overall Study|Withdrawal by Subject|1|||
162833860|NCT01784861|588102979|FG004|Overall Study|Withdrawal by Subject|0|||
162833861|NCT01784861|588102980|FG005|Overall Study|Withdrawal by Subject|0|||
162699514|NCT00983619|587610434|FG002|Overall Study|Other|0|||
162699515|NCT00983619|587610435|FG003|Overall Study|Other|1|||
162699516|NCT00983619|587610436|FG004|Overall Study|Other|0|||
162699517|NCT00983619|587610437|FG005|Overall Study|Other|12|||
162699518|NCT00983619|587610438|FG006|Overall Study|Other|2|||
162699519|NCT00983619|587610439|FG007|Overall Study|Other|2|||
162699520|NCT00983619|587610440|FG008|Overall Study|Other|0|||
162699521|NCT00983619|587610441|FG009|Overall Study|Other|1|||
162699522|NCT00983619|587610442|FG010|Overall Study|Other|1|||
162699523|NCT00983619|587610443|FG011|Overall Study|Other|0|||
162833862|NCT01784861|588102975|FG000|Overall Study|Physician Decision|0|||
162947131|NCT05109234|588508248|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
162833863|NCT01784861|588102976|FG001|Overall Study|Physician Decision|0|||
162833864|NCT01784861|588102977|FG002|Overall Study|Physician Decision|0|||
162833865|NCT01784861|588102978|FG003|Overall Study|Physician Decision|2|||
162833866|NCT01784861|588102979|FG004|Overall Study|Physician Decision|0|||
162833867|NCT01784861|588102980|FG005|Overall Study|Physician Decision|1|||
162833868|NCT02898259|588102992|FG000|Overall Study|Adverse Event|0|||
162833869|NCT02898259|588102993|FG001|Overall Study|Adverse Event|0|||
162833870|NCT02898259|588102994|FG002|Overall Study|Adverse Event|1|||
162833871|NCT02898259|588102995|FG003|Overall Study|Adverse Event|0|||
162833872|NCT02898259|588102996|FG004|Overall Study|Adverse Event|0|||
162833873|NCT02898259|588102992|FG000|Overall Study|Lack of Efficacy|1|||
162833874|NCT02898259|588102993|FG001|Overall Study|Lack of Efficacy|1|||
162833875|NCT02898259|588102994|FG002|Overall Study|Lack of Efficacy|3|||
162833876|NCT02898259|588102995|FG003|Overall Study|Lack of Efficacy|0|||
162833877|NCT02898259|588102996|FG004|Overall Study|Lack of Efficacy|0|||
162833878|NCT02898259|588102992|FG000|Overall Study|Lost to Follow-up|0|||
162833879|NCT02898259|588102993|FG001|Overall Study|Lost to Follow-up|0|||
162833880|NCT02898259|588102994|FG002|Overall Study|Lost to Follow-up|1|||
162833881|NCT02898259|588102995|FG003|Overall Study|Lost to Follow-up|0|||
162833882|NCT02898259|588102996|FG004|Overall Study|Lost to Follow-up|0|||
162833883|NCT02898259|588102992|FG000|Overall Study|Transformation before study began|0|||
162833884|NCT02898259|588102993|FG001|Overall Study|Transformation before study began|0|||
162833885|NCT02898259|588102994|FG002|Overall Study|Transformation before study began|0|||
162833886|NCT02898259|588102995|FG003|Overall Study|Transformation before study began|1|||
162833887|NCT02898259|588102996|FG004|Overall Study|Transformation before study began|0|||
162833888|NCT03016325|588103003|FG000|Treatment Period|Participant withdrew consent|0|||
162833889|NCT03016325|588103004|FG001|Treatment Period|Participant withdrew consent|1|||
162833890|NCT03016325|588103005|FG002|Treatment Period|Participant withdrew consent|0|||
162833891|NCT03016325|588103006|FG003|Treatment Period|Participant withdrew consent|0|||
162833892|NCT03016325|588103007|FG004|Treatment Period|Participant withdrew consent|0|||
162833893|NCT03016325|588103008|FG005|Treatment Period|Participant withdrew consent|0|||
162833894|NCT03016325|588103009|FG006|Treatment Period|Participant withdrew consent|0|||
162833895|NCT03016325|588103010|FG007|Treatment Period|Participant withdrew consent|0|||
162833896|NCT03016325|588103003|FG000|Treatment Period|Death|0|||
162833897|NCT03016325|588103004|FG001|Treatment Period|Death|0|||
162833898|NCT03016325|588103005|FG002|Treatment Period|Death|0|||
162833899|NCT03016325|588103006|FG003|Treatment Period|Death|0|||
162833900|NCT03016325|588103007|FG004|Treatment Period|Death|2|||
162833901|NCT03016325|588103008|FG005|Treatment Period|Death|0|||
162833902|NCT03016325|588103009|FG006|Treatment Period|Death|0|||
162833903|NCT03016325|588103010|FG007|Treatment Period|Death|0|||
162833904|NCT03016325|588103003|FG000|Treatment Period|Participant refuses assessments|0|||
162833905|NCT03016325|588103004|FG001|Treatment Period|Participant refuses assessments|0|||
162833906|NCT03016325|588103005|FG002|Treatment Period|Participant refuses assessments|1|||
162833907|NCT03016325|588103006|FG003|Treatment Period|Participant refuses assessments|0|||
162833908|NCT03016325|588103007|FG004|Treatment Period|Participant refuses assessments|0|||
162833909|NCT03016325|588103008|FG005|Treatment Period|Participant refuses assessments|0|||
162833910|NCT03016325|588103009|FG006|Treatment Period|Participant refuses assessments|0|||
162833911|NCT03016325|588103010|FG007|Treatment Period|Participant refuses assessments|0|||
162833912|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Death|2|||
162833913|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Death|0|||
162833914|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Death|5|||
162833915|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Death|6|||
162833916|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Death|3|||
162833917|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Death|0|||
162833918|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Death|0|||
162833919|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Death|0|||
162833920|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
162833921|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
162833922|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
162833923|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
162833924|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
162833925|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
162833926|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
162833927|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
162833928|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
162833929|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
162833930|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
162833931|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
162833932|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
162833933|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
162833934|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
162833935|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
162833936|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
162833937|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
162833938|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
162833939|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
162833940|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
162833941|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
162833942|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
162833943|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
162833944|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833945|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833946|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833947|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833948|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
162833949|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833950|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
162833951|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
162833952|NCT03016325|588103003|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833953|NCT03016325|588103004|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833954|NCT03016325|588103005|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
162833955|NCT03016325|588103006|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833956|NCT03016325|588103007|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833957|NCT03016325|588103008|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833958|NCT03016325|588103009|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833959|NCT03016325|588103010|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
162833960|NCT03016325|588103003|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833961|NCT03016325|588103004|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
162833962|NCT03016325|588103005|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833963|NCT03016325|588103006|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833964|NCT03016325|588103007|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833965|NCT03016325|588103008|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833966|NCT03016325|588103009|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833967|NCT03016325|588103010|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
162833968|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Death|3|||
162833969|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Death|3|||
162833970|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Death|11|||
162833971|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Death|12|||
162833972|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Death|9|||
162833973|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Death|0|||
162833974|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Death|0|||
162947132|NCT05109234|588508247|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
162833975|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Death|1|||
162833976|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
162833977|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833978|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833979|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833980|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833981|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833982|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833983|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
162833984|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
162833985|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
162947133|NCT05109234|588508248|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
162833986|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
162833987|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
162833988|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
162833989|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
162833990|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
162833991|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
162833992|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833993|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833994|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833995|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833996|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
162833997|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833998|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162833999|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
162834000|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834001|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834002|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834003|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834004|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
162834005|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834006|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834007|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
162834008|NCT03016325|588103003|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834009|NCT03016325|588103004|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834010|NCT03016325|588103005|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834011|NCT03016325|588103006|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
162834012|NCT03016325|588103007|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834013|NCT03016325|588103008|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834014|NCT03016325|588103009|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834015|NCT03016325|588103010|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
162834016|NCT03016325|588103003|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834017|NCT03016325|588103004|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
162834018|NCT03016325|588103005|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834019|NCT03016325|588103006|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834020|NCT03016325|588103007|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834021|NCT03016325|588103008|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834022|NCT03016325|588103009|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834023|NCT03016325|588103010|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
162834024|NCT03016325|588103003|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
162834025|NCT03016325|588103004|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
162834026|NCT03016325|588103005|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
162834027|NCT03016325|588103006|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
162834028|NCT03016325|588103007|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
162834029|NCT03016325|588103008|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
162834030|NCT03016325|588103009|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
162834031|NCT03016325|588103010|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
162834032|NCT01152021|588103011|FG000|Overall Study|Adverse Event|4|||
162834033|NCT01152021|588103012|FG001|Overall Study|Adverse Event|4|||
162834034|NCT01152021|588103011|FG000|Overall Study|Study drug had expired|1|||
162834035|NCT01152021|588103012|FG001|Overall Study|Study drug had expired|0|||
162834036|NCT01152021|588103011|FG000|Overall Study|Physician Decision|1|||
162834037|NCT01152021|588103012|FG001|Overall Study|Physician Decision|1|||
162834038|NCT01152021|588103011|FG000|Overall Study|No access to study drug in Pharmacy|0|||
162834039|NCT01152021|588103012|FG001|Overall Study|No access to study drug in Pharmacy|1|||
162834040|NCT02595723|588103013|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
162834041|NCT02595723|588103014|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
162834042|NCT02595723|588103015|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
162834043|NCT02595723|588103013|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
162834044|NCT02595723|588103014|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
162834045|NCT02595723|588103015|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
162947134|NCT05109234|588508247|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
162947135|NCT05109234|588508248|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
162947136|NCT00336024|588508249|FG000|Overall Study|Death|2|||
162947137|NCT00336024|588508250|FG001|Overall Study|Death|1|||
162947138|NCT00336024|588508249|FG000|Overall Study|Physician Decision|4|||
162834046|NCT00513500|588103016|FG000|Overall Study|Lost to Follow-up|35|||
162834047|NCT00513500|588103017|FG001|Overall Study|Lost to Follow-up|39|||
162834048|NCT00513500|588103016|FG000|Overall Study|Death|2|||
162834049|NCT00513500|588103017|FG001|Overall Study|Death|1|||
162834050|NCT00513500|588103016|FG000|Overall Study|Hospitalized|4|||
162834051|NCT00513500|588103017|FG001|Overall Study|Hospitalized|14|||
162834052|NCT04288154|588103018|FG000|Overall Study|Withdrawal by Subject|9|||
162834053|NCT04288154|588103019|FG001|Overall Study|Withdrawal by Subject|9|||
162834054|NCT01902290|588103025|FG000|Overall Study|Withdrawal by Subject|19|||
162834055|NCT01902290|588103026|FG001|Overall Study|Withdrawal by Subject|27|||
162834056|NCT01902290|588103025|FG000|Overall Study|Lost to Follow-up|2|||
162834057|NCT01902290|588103026|FG001|Overall Study|Lost to Follow-up|2|||
162834058|NCT01902290|588103025|FG000|Overall Study|Death|1|||
162834059|NCT01902290|588103026|FG001|Overall Study|Death|0|||
162834060|NCT01902290|588103025|FG000|Overall Study|Sponsor Decision|26|||
162834061|NCT01902290|588103026|FG001|Overall Study|Sponsor Decision|24|||
162834062|NCT00769184|588103027|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
162834063|NCT00769184|588103028|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
162834064|NCT00769184|588103027|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
162834065|NCT00769184|588103028|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
162834066|NCT00769184|588103027|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
162834067|NCT00769184|588103028|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
162834068|NCT00385255|588103029|FG000|Overall Study|Serious Adverse Event|1|||
162834069|NCT00385255|588103030|FG001|Overall Study|Serious Adverse Event|2|||
162834070|NCT00385255|588103029|FG000|Overall Study|Protocol Violation|0|||
162834071|NCT00385255|588103030|FG001|Overall Study|Protocol Violation|4|||
162834072|NCT00385255|588103029|FG000|Overall Study|Withdrawal by Subject|0|||
162834073|NCT00385255|588103030|FG001|Overall Study|Withdrawal by Subject|8|||
162834074|NCT00385255|588103029|FG000|Overall Study|Migrated/moved from study area|0|||
162834075|NCT00385255|588103030|FG001|Overall Study|Migrated/moved from study area|1|||
162834076|NCT00385255|588103029|FG000|Overall Study|Lost to Follow-up|20|||
162834077|NCT00385255|588103030|FG001|Overall Study|Lost to Follow-up|58|||
162834078|NCT00835237|588103035|FG000|Overall Study|Lost to Follow-up|4|||
162834079|NCT00835237|588103036|FG001|Overall Study|Lost to Follow-up|0|||
162834080|NCT00835237|588103035|FG000|Overall Study|Withdrawal by Subject|2|||
162834081|NCT00835237|588103036|FG001|Overall Study|Withdrawal by Subject|0|||
162834082|NCT03436862|588103040|FG000|Overall Study|Adverse Event|4|||
162834083|NCT03436862|588103040|FG000|Overall Study|Progressive Disease|2|||
162834084|NCT00391222|588103043|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
162834085|NCT00391222|588103044|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
162834086|NCT00391222|588103045|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
162834087|NCT00391222|588103046|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
162834088|NCT00391222|588103043|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
162834089|NCT00391222|588103044|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
162834090|NCT00391222|588103045|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
162834091|NCT00391222|588103046|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
162834092|NCT00391222|588103043|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
162834093|NCT00391222|588103044|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
162834094|NCT00391222|588103045|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
162834095|NCT00391222|588103046|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
162834096|NCT00391222|588103043|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
162834097|NCT00391222|588103044|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
162834098|NCT00391222|588103045|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
162834099|NCT00391222|588103046|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
162834100|NCT00391222|588103043|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
162834101|NCT00391222|588103044|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
162834102|NCT00391222|588103045|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
162834103|NCT00391222|588103046|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
162834104|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
162834105|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
162834106|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
162834107|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
162834108|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
162834109|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
162834110|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
162834111|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
162834112|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
162834113|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
162834114|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
162834115|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
162834116|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
162947139|NCT00336024|588508250|FG001|Overall Study|Physician Decision|1|||
162947140|NCT00336024|588508249|FG000|Overall Study|Protocol Violation|1|||
162947141|NCT00336024|588508250|FG001|Overall Study|Protocol Violation|0|||
162699524|NCT00672958|587610444|FG000|Overall Study|Adverse Event|11|||
162699525|NCT00672958|587610445|FG001|Overall Study|Adverse Event|9|||
162699526|NCT00672958|587610444|FG000|Overall Study|Lack of Efficacy|6|||
162947142|NCT00336024|588508249|FG000|Overall Study|Withdrawal by Subject|1|||
162947143|NCT00336024|588508250|FG001|Overall Study|Withdrawal by Subject|2|||
162947144|NCT00336024|588508249|FG000|Overall Study|Failure to fulfill consolidation|1|||
162947145|NCT00336024|588508250|FG001|Overall Study|Failure to fulfill consolidation|1|||
162947146|NCT00336024|588508249|FG000|Overall Study|Progressive Disease|4|||
162947147|NCT00336024|588508250|FG001|Overall Study|Progressive Disease|7|||
162947148|NCT00336024|588508249|FG000|Overall Study|Ineligible|7|||
162947149|NCT00336024|588508250|FG001|Overall Study|Ineligible|7|||
162947150|NCT05067504|588508252|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
162947151|NCT05067504|588508253|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
162947152|NCT05067504|588508252|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
162947153|NCT05067504|588508253|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
162947154|NCT05067504|588508252|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
162947155|NCT05067504|588508253|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
162947156|NCT03805438|588510144|FG000|Overall Study|Lack of Efficacy|1|||
162947157|NCT03805438|588510144|FG000|Overall Study|Protocol Violation|1|||
162947158|NCT02684344|588510145|FG000|Overall Study|Withdrawal by Subject|0|||
162699527|NCT00672958|587610445|FG001|Overall Study|Lack of Efficacy|11|||
162699528|NCT00672958|587610444|FG000|Overall Study|Non-compliance with study drug|2|||
162699529|NCT00672958|587610445|FG001|Overall Study|Non-compliance with study drug|3|||
162699530|NCT00672958|587610444|FG000|Overall Study|Protocol deviations|11|||
162699531|NCT00672958|587610445|FG001|Overall Study|Protocol deviations|5|||
162699532|NCT00672958|587610444|FG000|Overall Study|Voluntary withdrawal|12|||
162699533|NCT00672958|587610445|FG001|Overall Study|Voluntary withdrawal|8|||
162699534|NCT00672958|587610444|FG000|Overall Study|Lost to Follow-up|22|||
162947159|NCT02684344|588510146|FG001|Overall Study|Withdrawal by Subject|1|||
162947160|NCT01494506|588510150|FG000|Overall Study|Lack of Efficacy|77|||
162947161|NCT01494506|588510151|FG001|Overall Study|Lack of Efficacy|83|||
162947162|NCT01494506|588510152|FG002|Overall Study|Lack of Efficacy|57|||
162947163|NCT01494506|588510150|FG000|Overall Study|Adverse Event|17|||
162947164|NCT01494506|588510151|FG001|Overall Study|Adverse Event|10|||
162947165|NCT01494506|588510152|FG002|Overall Study|Adverse Event|11|||
162947166|NCT01494506|588510150|FG000|Overall Study|Death|9|||
162947167|NCT01494506|588510151|FG001|Overall Study|Death|5|||
162947168|NCT01494506|588510152|FG002|Overall Study|Death|2|||
162947169|NCT01494506|588510150|FG000|Overall Study|Physician Decision|7|||
162947170|NCT01494506|588510151|FG001|Overall Study|Physician Decision|5|||
162947171|NCT01494506|588510152|FG002|Overall Study|Physician Decision|4|||
162947172|NCT01494506|588510150|FG000|Overall Study|Withdrawal by Subject|17|||
162947173|NCT01494506|588510151|FG001|Overall Study|Withdrawal by Subject|20|||
162947174|NCT01494506|588510152|FG002|Overall Study|Withdrawal by Subject|14|||
162947175|NCT01494506|588510150|FG000|Overall Study|Clinical Deterioration|21|||
162947176|NCT01494506|588510151|FG001|Overall Study|Clinical Deterioration|17|||
162947177|NCT01494506|588510152|FG002|Overall Study|Clinical Deterioration|13|||
162947178|NCT01494506|588510150|FG000|Overall Study|Sponsor Decision|0|||
162947179|NCT01494506|588510151|FG001|Overall Study|Sponsor Decision|0|||
162947180|NCT01494506|588510152|FG002|Overall Study|Sponsor Decision|1|||
162947181|NCT01494506|588510150|FG000|Overall Study|Other|0|||
162947182|NCT01494506|588510151|FG001|Overall Study|Other|3|||
162947183|NCT01494506|588510152|FG002|Overall Study|Other|1|||
162947184|NCT02777528|588510154|FG000|Overall Study|Still in study|24|||
162699535|NCT00672958|587610445|FG001|Overall Study|Lost to Follow-up|17|||
162699536|NCT00672958|587610444|FG000|Overall Study|Reason not specified|0|||
162947185|NCT02777528|588510155|FG001|Overall Study|Still in study|10|||
162947186|NCT02777528|588510156|FG002|Overall Study|Still in study|1|||
162699537|NCT00672958|587610445|FG001|Overall Study|Reason not specified|3|||
162699538|NCT02374593|587610446|FG000|Overall Study|non-compliant|2|||
162947187|NCT02777528|588510154|FG000|Overall Study|Study Device Explanted|1|||
162947188|NCT02777528|588510155|FG001|Overall Study|Study Device Explanted|0|||
162947189|NCT02777528|588510156|FG002|Overall Study|Study Device Explanted|0|||
162947190|NCT02777528|588510154|FG000|Overall Study|Death|14|||
162947191|NCT02777528|588510155|FG001|Overall Study|Death|7|||
162947192|NCT02777528|588510156|FG002|Overall Study|Death|1|||
162947193|NCT02777528|588510154|FG000|Overall Study|Withdrawal by Subject|2|||
162947194|NCT02777528|588510155|FG001|Overall Study|Withdrawal by Subject|2|||
162947195|NCT02777528|588510156|FG002|Overall Study|Withdrawal by Subject|1|||
162947196|NCT02777528|588510154|FG000|Overall Study|Physician Decision|2|||
162947197|NCT02777528|588510155|FG001|Overall Study|Physician Decision|1|||
162947198|NCT02777528|588510156|FG002|Overall Study|Physician Decision|0|||
162947199|NCT02777528|588510154|FG000|Overall Study|Lost to Follow-up|2|||
162834117|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
162834118|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
162834119|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
162834120|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
162834121|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
162834122|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
162834123|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
162834124|NCT00391222|588103043|FG000|Period III (Double-Blind Treatment)|Other|6|||
162834125|NCT00391222|588103044|FG001|Period III (Double-Blind Treatment)|Other|1|||
162834126|NCT00391222|588103045|FG002|Period III (Double-Blind Treatment)|Other|6|||
162834127|NCT00391222|588103046|FG003|Period III (Double-Blind Treatment)|Other|0|||
162834128|NCT01015768|588103047|FG000|Overall Study|Some subject data unuseable|4|||
162834129|NCT01015768|588103048|FG001|Overall Study|Some subject data unuseable|4|||
162834130|NCT01627860|588103049|FG000|Overall Study|Adverse Event|9|||
162834131|NCT01627860|588103050|FG001|Overall Study|Adverse Event|4|||
162834132|NCT01627860|588103049|FG000|Overall Study|Withdrawal by Subject|2|||
162834133|NCT01627860|588103050|FG001|Overall Study|Withdrawal by Subject|1|||
162834134|NCT01627860|588103049|FG000|Overall Study|Seizure frequency doubled|0|||
162834135|NCT01627860|588103050|FG001|Overall Study|Seizure frequency doubled|1|||
162834136|NCT01627860|588103049|FG000|Overall Study|Protocol Violation|1|||
162834137|NCT01627860|588103050|FG001|Overall Study|Protocol Violation|0|||
162834138|NCT01225731|588103051|FG000|Part 1|Did not meet eligibility criteria|1|||
162834139|NCT01225731|588103052|FG001|Part 1|Did not meet eligibility criteria|0|||
162834140|NCT01225731|588103053|FG002|Part 1|Did not meet eligibility criteria|0|||
162834141|NCT01225731|588103054|FG003|Part 1|Did not meet eligibility criteria|0|||
162834142|NCT01225731|588103055|FG004|Part 1|Did not meet eligibility criteria|1|||
162834143|NCT01225731|588103056|FG005|Part 1|Did not meet eligibility criteria|0|||
162834144|NCT01225731|588103057|FG006|Part 1|Did not meet eligibility criteria|0|||
162834145|NCT01225731|588103058|FG007|Part 1|Did not meet eligibility criteria|0|||
162834146|NCT01225731|588103059|FG008|Part 1|Did not meet eligibility criteria|0|||
162834147|NCT01225731|588103060|FG009|Part 1|Did not meet eligibility criteria|0|||
162834148|NCT01225731|588103061|FG010|Part 1|Did not meet eligibility criteria|0|||
162834149|NCT01225731|588103062|FG011|Part 1|Did not meet eligibility criteria|0|||
162834150|NCT01225731|588103063|FG012|Part 1|Did not meet eligibility criteria|0|||
162834151|NCT01225731|588103051|FG000|Part 1|Adverse Event|1|||
162834152|NCT01225731|588103052|FG001|Part 1|Adverse Event|2|||
162834153|NCT01225731|588103053|FG002|Part 1|Adverse Event|1|||
162834154|NCT01225731|588103054|FG003|Part 1|Adverse Event|1|||
162834155|NCT01225731|588103055|FG004|Part 1|Adverse Event|1|||
162834156|NCT01225731|588103056|FG005|Part 1|Adverse Event|0|||
162834157|NCT01225731|588103057|FG006|Part 1|Adverse Event|0|||
162834158|NCT01225731|588103058|FG007|Part 1|Adverse Event|0|||
162834159|NCT01225731|588103059|FG008|Part 1|Adverse Event|0|||
162834160|NCT01225731|588103060|FG009|Part 1|Adverse Event|0|||
162834161|NCT01225731|588103061|FG010|Part 1|Adverse Event|0|||
162834162|NCT01225731|588103062|FG011|Part 1|Adverse Event|0|||
162834163|NCT01225731|588103063|FG012|Part 1|Adverse Event|0|||
162834164|NCT01225731|588103051|FG000|Part 1|Withdrawal by Subject|0|||
162834165|NCT01225731|588103052|FG001|Part 1|Withdrawal by Subject|3|||
162834166|NCT01225731|588103053|FG002|Part 1|Withdrawal by Subject|0|||
162834167|NCT01225731|588103054|FG003|Part 1|Withdrawal by Subject|0|||
162834168|NCT01225731|588103055|FG004|Part 1|Withdrawal by Subject|4|||
162834169|NCT01225731|588103056|FG005|Part 1|Withdrawal by Subject|0|||
162834170|NCT01225731|588103057|FG006|Part 1|Withdrawal by Subject|0|||
162834171|NCT01225731|588103058|FG007|Part 1|Withdrawal by Subject|0|||
162834172|NCT01225731|588103059|FG008|Part 1|Withdrawal by Subject|0|||
162834173|NCT01225731|588103060|FG009|Part 1|Withdrawal by Subject|0|||
162834174|NCT01225731|588103061|FG010|Part 1|Withdrawal by Subject|0|||
162834175|NCT01225731|588103062|FG011|Part 1|Withdrawal by Subject|0|||
162834176|NCT01225731|588103063|FG012|Part 1|Withdrawal by Subject|0|||
162834177|NCT01225731|588103051|FG000|Part 1|Protocol Violation|0|||
162834178|NCT01225731|588103052|FG001|Part 1|Protocol Violation|0|||
162834179|NCT01225731|588103053|FG002|Part 1|Protocol Violation|0|||
162834180|NCT01225731|588103054|FG003|Part 1|Protocol Violation|1|||
162834181|NCT01225731|588103055|FG004|Part 1|Protocol Violation|0|||
162834182|NCT01225731|588103056|FG005|Part 1|Protocol Violation|0|||
162834183|NCT01225731|588103057|FG006|Part 1|Protocol Violation|0|||
162834184|NCT01225731|588103058|FG007|Part 1|Protocol Violation|0|||
162834185|NCT01225731|588103059|FG008|Part 1|Protocol Violation|0|||
162834186|NCT01225731|588103060|FG009|Part 1|Protocol Violation|0|||
162834187|NCT01225731|588103061|FG010|Part 1|Protocol Violation|0|||
162834188|NCT01225731|588103062|FG011|Part 1|Protocol Violation|0|||
162834189|NCT01225731|588103063|FG012|Part 1|Protocol Violation|0|||
162834190|NCT01225731|588103051|FG000|Part 2|Protocol Violation|0|||
162834191|NCT01225731|588103052|FG001|Part 2|Protocol Violation|0|||
162834192|NCT01225731|588103053|FG002|Part 2|Protocol Violation|0|||
162834193|NCT01225731|588103054|FG003|Part 2|Protocol Violation|0|||
162834194|NCT01225731|588103055|FG004|Part 2|Protocol Violation|0|||
162834195|NCT01225731|588103056|FG005|Part 2|Protocol Violation|1|||
162834196|NCT01225731|588103057|FG006|Part 2|Protocol Violation|0|||
162834197|NCT01225731|588103058|FG007|Part 2|Protocol Violation|0|||
162834198|NCT01225731|588103059|FG008|Part 2|Protocol Violation|1|||
162834199|NCT01225731|588103060|FG009|Part 2|Protocol Violation|0|||
162834200|NCT01225731|588103061|FG010|Part 2|Protocol Violation|0|||
162834201|NCT01225731|588103062|FG011|Part 2|Protocol Violation|0|||
162834202|NCT01225731|588103063|FG012|Part 2|Protocol Violation|0|||
162834203|NCT01225731|588103051|FG000|Part 2|Adverse Event|0|||
162834204|NCT01225731|588103052|FG001|Part 2|Adverse Event|0|||
162834205|NCT01225731|588103053|FG002|Part 2|Adverse Event|0|||
162834206|NCT01225731|588103054|FG003|Part 2|Adverse Event|0|||
162834207|NCT01225731|588103055|FG004|Part 2|Adverse Event|0|||
162834208|NCT01225731|588103056|FG005|Part 2|Adverse Event|0|||
162834209|NCT01225731|588103057|FG006|Part 2|Adverse Event|4|||
162834210|NCT01225731|588103058|FG007|Part 2|Adverse Event|4|||
162834211|NCT01225731|588103059|FG008|Part 2|Adverse Event|2|||
162834212|NCT01225731|588103060|FG009|Part 2|Adverse Event|0|||
162834213|NCT01225731|588103061|FG010|Part 2|Adverse Event|0|||
162834214|NCT01225731|588103062|FG011|Part 2|Adverse Event|0|||
162834215|NCT01225731|588103063|FG012|Part 2|Adverse Event|0|||
162834216|NCT01225731|588103051|FG000|Part 2|Lack of Efficacy|0|||
162834217|NCT01225731|588103052|FG001|Part 2|Lack of Efficacy|0|||
162834218|NCT01225731|588103053|FG002|Part 2|Lack of Efficacy|0|||
162834219|NCT01225731|588103054|FG003|Part 2|Lack of Efficacy|0|||
162834220|NCT01225731|588103055|FG004|Part 2|Lack of Efficacy|0|||
162834221|NCT01225731|588103056|FG005|Part 2|Lack of Efficacy|1|||
162834222|NCT01225731|588103057|FG006|Part 2|Lack of Efficacy|0|||
162834223|NCT01225731|588103058|FG007|Part 2|Lack of Efficacy|12|||
162834224|NCT01225731|588103059|FG008|Part 2|Lack of Efficacy|3|||
162834225|NCT01225731|588103060|FG009|Part 2|Lack of Efficacy|0|||
162834226|NCT01225731|588103061|FG010|Part 2|Lack of Efficacy|0|||
162834227|NCT01225731|588103062|FG011|Part 2|Lack of Efficacy|0|||
162834228|NCT01225731|588103063|FG012|Part 2|Lack of Efficacy|0|||
162834229|NCT01225731|588103051|FG000|Part 2|Pregnancy|0|||
162834230|NCT01225731|588103052|FG001|Part 2|Pregnancy|0|||
162834231|NCT01225731|588103053|FG002|Part 2|Pregnancy|0|||
162834232|NCT01225731|588103054|FG003|Part 2|Pregnancy|0|||
162834233|NCT01225731|588103055|FG004|Part 2|Pregnancy|0|||
162834234|NCT01225731|588103056|FG005|Part 2|Pregnancy|0|||
162834235|NCT01225731|588103057|FG006|Part 2|Pregnancy|1|||
162834236|NCT01225731|588103058|FG007|Part 2|Pregnancy|0|||
162834237|NCT01225731|588103059|FG008|Part 2|Pregnancy|1|||
162834238|NCT01225731|588103060|FG009|Part 2|Pregnancy|0|||
162834239|NCT01225731|588103061|FG010|Part 2|Pregnancy|0|||
162834240|NCT01225731|588103062|FG011|Part 2|Pregnancy|0|||
162834241|NCT01225731|588103063|FG012|Part 2|Pregnancy|0|||
162834242|NCT01225731|588103051|FG000|Part 2|Lost to Follow-up|0|||
162834243|NCT01225731|588103052|FG001|Part 2|Lost to Follow-up|0|||
162834244|NCT01225731|588103053|FG002|Part 2|Lost to Follow-up|0|||
162834245|NCT01225731|588103054|FG003|Part 2|Lost to Follow-up|0|||
162834246|NCT01225731|588103055|FG004|Part 2|Lost to Follow-up|0|||
162834247|NCT01225731|588103056|FG005|Part 2|Lost to Follow-up|0|||
162834248|NCT01225731|588103057|FG006|Part 2|Lost to Follow-up|0|||
162834249|NCT01225731|588103058|FG007|Part 2|Lost to Follow-up|3|||
162834250|NCT01225731|588103059|FG008|Part 2|Lost to Follow-up|1|||
162834251|NCT01225731|588103060|FG009|Part 2|Lost to Follow-up|0|||
162834252|NCT01225731|588103061|FG010|Part 2|Lost to Follow-up|0|||
162834253|NCT01225731|588103062|FG011|Part 2|Lost to Follow-up|0|||
162834254|NCT01225731|588103063|FG012|Part 2|Lost to Follow-up|0|||
162834255|NCT01225731|588103051|FG000|Part 2|Physician Decision|0|||
162834256|NCT01225731|588103052|FG001|Part 2|Physician Decision|0|||
162834257|NCT01225731|588103053|FG002|Part 2|Physician Decision|0|||
162834258|NCT01225731|588103054|FG003|Part 2|Physician Decision|0|||
162834259|NCT01225731|588103055|FG004|Part 2|Physician Decision|0|||
162834260|NCT01225731|588103056|FG005|Part 2|Physician Decision|0|||
162834261|NCT01225731|588103057|FG006|Part 2|Physician Decision|0|||
162834262|NCT01225731|588103058|FG007|Part 2|Physician Decision|2|||
162834263|NCT01225731|588103059|FG008|Part 2|Physician Decision|2|||
162834264|NCT01225731|588103060|FG009|Part 2|Physician Decision|0|||
162834265|NCT01225731|588103061|FG010|Part 2|Physician Decision|0|||
162834266|NCT01225731|588103062|FG011|Part 2|Physician Decision|0|||
162834267|NCT01225731|588103063|FG012|Part 2|Physician Decision|0|||
162834268|NCT01225731|588103051|FG000|Part 2|Withdrawal by Subject|0|||
162834269|NCT01225731|588103052|FG001|Part 2|Withdrawal by Subject|0|||
162834270|NCT01225731|588103053|FG002|Part 2|Withdrawal by Subject|0|||
162834271|NCT01225731|588103054|FG003|Part 2|Withdrawal by Subject|0|||
162834272|NCT01225731|588103055|FG004|Part 2|Withdrawal by Subject|0|||
162834273|NCT01225731|588103056|FG005|Part 2|Withdrawal by Subject|1|||
162834274|NCT01225731|588103057|FG006|Part 2|Withdrawal by Subject|3|||
162834275|NCT01225731|588103058|FG007|Part 2|Withdrawal by Subject|4|||
162834276|NCT01225731|588103059|FG008|Part 2|Withdrawal by Subject|1|||
162834277|NCT01225731|588103060|FG009|Part 2|Withdrawal by Subject|0|||
162834278|NCT01225731|588103061|FG010|Part 2|Withdrawal by Subject|0|||
162834279|NCT01225731|588103062|FG011|Part 2|Withdrawal by Subject|0|||
162834280|NCT01225731|588103063|FG012|Part 2|Withdrawal by Subject|0|||
162834281|NCT01225731|588103051|FG000|Part 3|Adverse Event|0|||
162834282|NCT01225731|588103052|FG001|Part 3|Adverse Event|0|||
162834283|NCT01225731|588103053|FG002|Part 3|Adverse Event|0|||
162834284|NCT01225731|588103054|FG003|Part 3|Adverse Event|0|||
162834285|NCT01225731|588103055|FG004|Part 3|Adverse Event|0|||
162834286|NCT01225731|588103056|FG005|Part 3|Adverse Event|0|||
162834287|NCT01225731|588103057|FG006|Part 3|Adverse Event|0|||
162834288|NCT01225731|588103058|FG007|Part 3|Adverse Event|0|||
162834289|NCT01225731|588103059|FG008|Part 3|Adverse Event|0|||
162834290|NCT01225731|588103060|FG009|Part 3|Adverse Event|0|||
162834291|NCT01225731|588103061|FG010|Part 3|Adverse Event|1|||
162834292|NCT01225731|588103062|FG011|Part 3|Adverse Event|1|||
162834293|NCT01225731|588103063|FG012|Part 3|Adverse Event|0|||
162834294|NCT01225731|588103051|FG000|Part 3|Lost to Follow-up|0|||
162834295|NCT01225731|588103052|FG001|Part 3|Lost to Follow-up|0|||
162834296|NCT01225731|588103053|FG002|Part 3|Lost to Follow-up|0|||
162834297|NCT01225731|588103054|FG003|Part 3|Lost to Follow-up|0|||
162834298|NCT01225731|588103055|FG004|Part 3|Lost to Follow-up|0|||
162834299|NCT01225731|588103056|FG005|Part 3|Lost to Follow-up|0|||
162834300|NCT01225731|588103057|FG006|Part 3|Lost to Follow-up|0|||
162834301|NCT01225731|588103058|FG007|Part 3|Lost to Follow-up|0|||
162834302|NCT01225731|588103059|FG008|Part 3|Lost to Follow-up|0|||
162834303|NCT01225731|588103060|FG009|Part 3|Lost to Follow-up|0|||
162834304|NCT01225731|588103061|FG010|Part 3|Lost to Follow-up|1|||
162834305|NCT01225731|588103062|FG011|Part 3|Lost to Follow-up|2|||
162834306|NCT01225731|588103063|FG012|Part 3|Lost to Follow-up|1|||
162834307|NCT01225731|588103051|FG000|Part 3|Physician Decision|0|||
162834308|NCT01225731|588103052|FG001|Part 3|Physician Decision|0|||
162834309|NCT01225731|588103053|FG002|Part 3|Physician Decision|0|||
162834310|NCT01225731|588103054|FG003|Part 3|Physician Decision|0|||
162834311|NCT01225731|588103055|FG004|Part 3|Physician Decision|0|||
162834312|NCT01225731|588103056|FG005|Part 3|Physician Decision|0|||
162834313|NCT01225731|588103057|FG006|Part 3|Physician Decision|0|||
162834314|NCT01225731|588103058|FG007|Part 3|Physician Decision|0|||
162834315|NCT01225731|588103059|FG008|Part 3|Physician Decision|0|||
162834316|NCT01225731|588103060|FG009|Part 3|Physician Decision|0|||
162834317|NCT01225731|588103061|FG010|Part 3|Physician Decision|0|||
162834318|NCT01225731|588103062|FG011|Part 3|Physician Decision|1|||
162834319|NCT01225731|588103063|FG012|Part 3|Physician Decision|2|||
162834320|NCT01225731|588103051|FG000|Part 3|Withdrawal by Subject|0|||
162834321|NCT01225731|588103052|FG001|Part 3|Withdrawal by Subject|0|||
162834322|NCT01225731|588103053|FG002|Part 3|Withdrawal by Subject|0|||
162834323|NCT01225731|588103054|FG003|Part 3|Withdrawal by Subject|0|||
162834324|NCT01225731|588103055|FG004|Part 3|Withdrawal by Subject|0|||
162947200|NCT02777528|588510155|FG001|Overall Study|Lost to Follow-up|0|||
162947201|NCT02777528|588510156|FG002|Overall Study|Lost to Follow-up|0|||
162947202|NCT02777528|588510154|FG000|Overall Study|Discontinued due to Other|1|||
162834325|NCT01225731|588103056|FG005|Part 3|Withdrawal by Subject|0|||
162834326|NCT01225731|588103057|FG006|Part 3|Withdrawal by Subject|0|||
162834327|NCT01225731|588103058|FG007|Part 3|Withdrawal by Subject|0|||
162834328|NCT01225731|588103059|FG008|Part 3|Withdrawal by Subject|0|||
162834329|NCT01225731|588103060|FG009|Part 3|Withdrawal by Subject|0|||
162834330|NCT01225731|588103061|FG010|Part 3|Withdrawal by Subject|4|||
162834331|NCT01225731|588103062|FG011|Part 3|Withdrawal by Subject|6|||
162834332|NCT01225731|588103063|FG012|Part 3|Withdrawal by Subject|4|||
162834333|NCT00577642|588103064|FG000|Overall Study|Clinical Disease Progression|1|||
162834334|NCT00542269|588103070|FG000|Overall Study|Adverse Event|10|||
162834335|NCT00542269|588103071|FG001|Overall Study|Adverse Event|4|||
162834336|NCT00542269|588103072|FG002|Overall Study|Adverse Event|5|||
162834337|NCT00542269|588103070|FG000|Overall Study|Protocol Violation|1|||
162834338|NCT00542269|588103071|FG001|Overall Study|Protocol Violation|1|||
162947203|NCT02777528|588510155|FG001|Overall Study|Discontinued due to Other|0|||
162947204|NCT02777528|588510156|FG002|Overall Study|Discontinued due to Other|0|||
162834339|NCT00542269|588103072|FG002|Overall Study|Protocol Violation|0|||
162834340|NCT00542269|588103070|FG000|Overall Study|Withdrawal by Subject|1|||
162834341|NCT00542269|588103071|FG001|Overall Study|Withdrawal by Subject|0|||
162834342|NCT00542269|588103072|FG002|Overall Study|Withdrawal by Subject|0|||
162834343|NCT00542269|588103070|FG000|Overall Study|Administrative problems|1|||
162834344|NCT00542269|588103071|FG001|Overall Study|Administrative problems|1|||
162834345|NCT00542269|588103072|FG002|Overall Study|Administrative problems|1|||
162947205|NCT02127281|588510157|FG000|Overall Study|Lost to Follow-up|1|||
162834346|NCT00490451|588103073|FG000|Overall Study|Adverse Event|3|||
162834347|NCT00490451|588103074|FG001|Overall Study|Adverse Event|3|||
162834348|NCT00490451|588103073|FG000|Overall Study|Death|3|||
162834349|NCT00490451|588103074|FG001|Overall Study|Death|1|||
162834350|NCT00490451|588103073|FG000|Overall Study|Withdrawal by Subject|2|||
162834351|NCT00490451|588103074|FG001|Overall Study|Withdrawal by Subject|0|||
162834352|NCT00490451|588103073|FG000|Overall Study|Investigator Decision|1|||
162834353|NCT00490451|588103074|FG001|Overall Study|Investigator Decision|0|||
162834354|NCT00490451|588103073|FG000|Overall Study|Protocol Violation|1|||
162834355|NCT00490451|588103074|FG001|Overall Study|Protocol Violation|0|||
162834356|NCT00490451|588103073|FG000|Overall Study|Progressive Disease|53|||
162834357|NCT00490451|588103074|FG001|Overall Study|Progressive Disease|34|||
162834358|NCT01181011|588103077|FG000|Overall Study|Adverse Event|2|||
162834359|NCT01181011|588103077|FG000|Overall Study|Lost to Follow-up|1|||
162834360|NCT00401375|588103078|FG000|Overall Study|Protocol Violation|2|||
162834361|NCT00401375|588103079|FG001|Overall Study|Protocol Violation|2|||
162834362|NCT00401375|588103080|FG002|Overall Study|Protocol Violation|1|||
162834363|NCT00401375|588103078|FG000|Overall Study|Adverse Event|6|||
162834364|NCT00401375|588103079|FG001|Overall Study|Adverse Event|11|||
162834365|NCT00401375|588103080|FG002|Overall Study|Adverse Event|10|||
162834366|NCT00401375|588103078|FG000|Overall Study|Withdrawal by Subject|9|||
162834367|NCT00401375|588103079|FG001|Overall Study|Withdrawal by Subject|7|||
162834368|NCT00401375|588103080|FG002|Overall Study|Withdrawal by Subject|7|||
162834369|NCT00401375|588103078|FG000|Overall Study|Lost to Follow-up|0|||
162834370|NCT00401375|588103079|FG001|Overall Study|Lost to Follow-up|1|||
162834371|NCT00401375|588103080|FG002|Overall Study|Lost to Follow-up|1|||
162834372|NCT00401375|588103078|FG000|Overall Study|Other than specified|2|||
162834373|NCT00401375|588103079|FG001|Overall Study|Other than specified|1|||
162834374|NCT00401375|588103080|FG002|Overall Study|Other than specified|3|||
162834375|NCT00401375|588103078|FG000|Overall Study|Randomized but not treated|3|||
162834376|NCT00401375|588103079|FG001|Overall Study|Randomized but not treated|3|||
162834377|NCT00401375|588103080|FG002|Overall Study|Randomized but not treated|3|||
162834378|NCT00950664|588103081|FG000|First Intervention|Lost to Follow-up|1|||
162834379|NCT00950664|588103082|FG001|First Intervention|Lost to Follow-up|3|||
162834380|NCT00950664|588103081|FG000|First Intervention|Withdrawal by Subject|2|||
162834381|NCT00950664|588103082|FG001|First Intervention|Withdrawal by Subject|2|||
162834382|NCT03152019|588103083|FG000|Overall Study|Adverse Event|0|||
162834383|NCT03152019|588103084|FG001|Overall Study|Adverse Event|1|||
162834384|NCT04703075|588103085|FG000|Overall Study|Adverse Event|11|||
162834385|NCT04703075|588103086|FG001|Overall Study|Adverse Event|7|||
162834386|NCT04703075|588103085|FG000|Overall Study|Lost to Follow-up|6|||
162834387|NCT04703075|588103086|FG001|Overall Study|Lost to Follow-up|12|||
162834388|NCT04703075|588103085|FG000|Overall Study|Physician Decision|3|||
162834389|NCT04703075|588103086|FG001|Overall Study|Physician Decision|0|||
162834390|NCT04703075|588103085|FG000|Overall Study|Moved|0|||
162834391|NCT04703075|588103086|FG001|Overall Study|Moved|2|||
162834392|NCT04703075|588103085|FG000|Overall Study|Index INH Resistant|0|||
162834393|NCT04703075|588103086|FG001|Overall Study|Index INH Resistant|1|||
162834394|NCT04703075|588103085|FG000|Overall Study|Lack of Efficacy|6|||
162834395|NCT04703075|588103086|FG001|Overall Study|Lack of Efficacy|18|||
162834396|NCT01187953|588103087|FG000|Overall Study|Death|11|||
162834397|NCT01187953|588103088|FG001|Overall Study|Death|13|||
162834398|NCT01187953|588103087|FG000|Overall Study|Adverse Event|1|||
162947206|NCT02127281|588510158|FG001|Overall Study|Lost to Follow-up|0|||
162699539|NCT02374593|587610447|FG001|Overall Study|non-compliant|0|||
162699540|NCT04844918|587610448|FG000|Overall Study|Adverse Event|7|||
162699541|NCT04844918|587610449|FG001|Overall Study|Adverse Event|8|||
162699542|NCT04844918|587610450|FG002|Overall Study|Adverse Event|5|||
162699543|NCT04844918|587610448|FG000|Overall Study|Physician Decision|0|||
162834399|NCT01187953|588103088|FG001|Overall Study|Adverse Event|2|||
162834400|NCT01187953|588103087|FG000|Overall Study|Lost to Follow-up|0|||
162834401|NCT01187953|588103088|FG001|Overall Study|Lost to Follow-up|3|||
162834402|NCT01187953|588103087|FG000|Overall Study|Withdrawal by Subject|3|||
162834403|NCT01187953|588103088|FG001|Overall Study|Withdrawal by Subject|3|||
162834404|NCT01783678|588104595|FG000|Overall Study|Randomized but Not Treated|0|||
162834405|NCT01783678|588104596|FG001|Overall Study|Randomized but Not Treated|0|||
162947207|NCT01882647|588510160|FG000|Overall Study|Lost to Follow-up|2|||
162947208|NCT01882647|588510161|FG001|Overall Study|Lost to Follow-up|2|||
162947209|NCT01882647|588510160|FG000|Overall Study|Withdrawal by Subject|0|||
162699544|NCT04844918|587610449|FG001|Overall Study|Physician Decision|1|||
162834406|NCT01783678|588104597|FG002|Overall Study|Randomized but Not Treated|0|||
162834407|NCT01783678|588104598|FG003|Overall Study|Randomized but Not Treated|1|||
162834408|NCT01783678|588104599|FG004|Overall Study|Randomized but Not Treated|0|||
162834409|NCT01783678|588104600|FG005|Overall Study|Randomized but Not Treated|0|||
162834410|NCT01783678|588104595|FG000|Overall Study|Lack of Efficacy|1|||
162834411|NCT01783678|588104596|FG001|Overall Study|Lack of Efficacy|13|||
162834412|NCT01783678|588104597|FG002|Overall Study|Lack of Efficacy|1|||
162834413|NCT01783678|588104598|FG003|Overall Study|Lack of Efficacy|3|||
162947210|NCT01882647|588510161|FG001|Overall Study|Withdrawal by Subject|4|||
162834414|NCT01783678|588104599|FG004|Overall Study|Lack of Efficacy|6|||
162834415|NCT01783678|588104600|FG005|Overall Study|Lack of Efficacy|5|||
162834416|NCT01783678|588104595|FG000|Overall Study|Lost to Follow-up|0|||
162834417|NCT01783678|588104596|FG001|Overall Study|Lost to Follow-up|4|||
162834418|NCT01783678|588104597|FG002|Overall Study|Lost to Follow-up|0|||
162834419|NCT01783678|588104598|FG003|Overall Study|Lost to Follow-up|2|||
162834420|NCT01783678|588104599|FG004|Overall Study|Lost to Follow-up|1|||
162834421|NCT01783678|588104600|FG005|Overall Study|Lost to Follow-up|0|||
162834422|NCT01783678|588104595|FG000|Overall Study|Withdrew Consent|1|||
162834423|NCT01783678|588104596|FG001|Overall Study|Withdrew Consent|1|||
162834424|NCT01783678|588104597|FG002|Overall Study|Withdrew Consent|0|||
162834425|NCT01783678|588104598|FG003|Overall Study|Withdrew Consent|2|||
162834426|NCT01783678|588104599|FG004|Overall Study|Withdrew Consent|0|||
162834427|NCT01783678|588104600|FG005|Overall Study|Withdrew Consent|0|||
162834428|NCT02404103|588104601|FG000|Overall Study|Adverse Event|1|||
162834429|NCT02404103|588104602|FG001|Overall Study|Adverse Event|0|||
162834430|NCT02404103|588104601|FG000|Overall Study|Lost to Follow-up|3|||
162834431|NCT02404103|588104602|FG001|Overall Study|Lost to Follow-up|3|||
162834432|NCT01408147|588104603|FG000|Overall Study|Withdrawal by Subject|0|||
162834433|NCT01408147|588104604|FG001|Overall Study|Withdrawal by Subject|1|||
162834434|NCT01042600|588104605|FG000|Overall Study|Ineligible|1|||
162834435|NCT01042600|588104606|FG001|Overall Study|Ineligible|0|||
162834436|NCT00621504|588104607|FG000|Overall Study|Adverse Event|1|||
162834437|NCT00621504|588104608|FG001|Overall Study|Adverse Event|3|||
162834438|NCT00621504|588104607|FG000|Overall Study|At the request of sponsor/investigator|1|||
162834439|NCT00621504|588104608|FG001|Overall Study|At the request of sponsor/investigator|0|||
162834440|NCT00621504|588104607|FG000|Overall Study|Withdrew consent|9|||
162834441|NCT00621504|588104608|FG001|Overall Study|Withdrew consent|6|||
162834442|NCT00621504|588104607|FG000|Overall Study|Lost to Follow-up|8|||
162834443|NCT00621504|588104608|FG001|Overall Study|Lost to Follow-up|10|||
162834444|NCT00621504|588104607|FG000|Overall Study|Other|1|||
162834445|NCT00621504|588104608|FG001|Overall Study|Other|0|||
162834446|NCT00621504|588104607|FG000|Overall Study|Death|6|||
162834447|NCT00621504|588104608|FG001|Overall Study|Death|6|||
162834448|NCT03311711|588104613|FG000|Overall Study|Death|1|||
162834449|NCT03311711|588104614|FG001|Overall Study|Death|0|||
162834450|NCT03311711|588104615|FG002|Overall Study|Death|0|||
162834451|NCT03311711|588104616|FG003|Overall Study|Death|0|||
162834452|NCT03311711|588104617|FG004|Overall Study|Death|0|||
162834453|NCT03311711|588104618|FG005|Overall Study|Death|0|||
162834454|NCT03311711|588104619|FG006|Overall Study|Death|1|||
162834455|NCT03311711|588104620|FG007|Overall Study|Death|0|||
162834456|NCT03311711|588104621|FG008|Overall Study|Death|1|||
162834457|NCT03311711|588104622|FG009|Overall Study|Death|0|||
162834458|NCT03311711|588104613|FG000|Overall Study|Death of dyad partner|0|||
162947211|NCT01108094|588510162|FG000|Overall Study|Adverse Event|2|||
162947212|NCT01108094|588510163|FG001|Overall Study|Adverse Event|0|||
162947213|NCT01108094|588510164|FG002|Overall Study|Adverse Event|0|||
162947214|NCT01108094|588510165|FG003|Overall Study|Adverse Event|0|||
162947215|NCT01108094|588510162|FG000|Overall Study|Withdrawal by Subject|1|||
162947216|NCT01108094|588510163|FG001|Overall Study|Withdrawal by Subject|0|||
162947217|NCT01108094|588510164|FG002|Overall Study|Withdrawal by Subject|0|||
162947218|NCT01108094|588510165|FG003|Overall Study|Withdrawal by Subject|0|||
162947219|NCT05037097|588510168|FG000|Overall Study|Withdrawal by Subject|0|||
162947220|NCT05037097|588510169|FG001|Overall Study|Withdrawal by Subject|1|||
162947221|NCT05037097|588510170|FG002|Overall Study|Withdrawal by Subject|0|||
162947222|NCT05037097|588510171|FG003|Overall Study|Withdrawal by Subject|1|||
162699545|NCT04844918|587610450|FG002|Overall Study|Physician Decision|0|||
162699546|NCT04844918|587610448|FG000|Overall Study|Withdrawal by Subject|6|||
162834459|NCT03311711|588104614|FG001|Overall Study|Death of dyad partner|1|||
162834460|NCT03311711|588104615|FG002|Overall Study|Death of dyad partner|0|||
162834461|NCT03311711|588104616|FG003|Overall Study|Death of dyad partner|0|||
162834462|NCT03311711|588104617|FG004|Overall Study|Death of dyad partner|0|||
162834463|NCT03311711|588104618|FG005|Overall Study|Death of dyad partner|0|||
162834464|NCT03311711|588104619|FG006|Overall Study|Death of dyad partner|0|||
162834465|NCT03311711|588104620|FG007|Overall Study|Death of dyad partner|1|||
162834466|NCT03311711|588104621|FG008|Overall Study|Death of dyad partner|0|||
162834467|NCT03311711|588104622|FG009|Overall Study|Death of dyad partner|1|||
162834468|NCT03311711|588104613|FG000|Overall Study|Lost to Follow-up|2|||
162834469|NCT03311711|588104614|FG001|Overall Study|Lost to Follow-up|2|||
162834470|NCT03311711|588104615|FG002|Overall Study|Lost to Follow-up|0|||
162834471|NCT03311711|588104616|FG003|Overall Study|Lost to Follow-up|0|||
162834472|NCT03311711|588104617|FG004|Overall Study|Lost to Follow-up|0|||
162834473|NCT03311711|588104618|FG005|Overall Study|Lost to Follow-up|0|||
162834474|NCT03311711|588104619|FG006|Overall Study|Lost to Follow-up|1|||
162834475|NCT03311711|588104620|FG007|Overall Study|Lost to Follow-up|1|||
162834476|NCT03311711|588104621|FG008|Overall Study|Lost to Follow-up|0|||
162834477|NCT03311711|588104622|FG009|Overall Study|Lost to Follow-up|0|||
162947223|NCT05037097|588510172|FG004|Overall Study|Withdrawal by Subject|0|||
162947224|NCT05037097|588510173|FG005|Overall Study|Withdrawal by Subject|2|||
162834478|NCT03311711|588104613|FG000|Overall Study|Withdrawal by Subject|1|||
162834479|NCT03311711|588104614|FG001|Overall Study|Withdrawal by Subject|1|||
162834480|NCT03311711|588104615|FG002|Overall Study|Withdrawal by Subject|0|||
162834481|NCT03311711|588104616|FG003|Overall Study|Withdrawal by Subject|0|||
162834482|NCT03311711|588104617|FG004|Overall Study|Withdrawal by Subject|0|||
162834483|NCT03311711|588104618|FG005|Overall Study|Withdrawal by Subject|0|||
162834484|NCT03311711|588104619|FG006|Overall Study|Withdrawal by Subject|3|||
162834485|NCT03311711|588104620|FG007|Overall Study|Withdrawal by Subject|3|||
162834486|NCT03311711|588104621|FG008|Overall Study|Withdrawal by Subject|0|||
162834487|NCT03311711|588104622|FG009|Overall Study|Withdrawal by Subject|0|||
162834488|NCT02229552|588104623|FG000|Baseline|Withdrawal by Subject|6|||
162834489|NCT02229552|588104623|FG000|1-year Follow up|Withdrawal by Subject|7|||
162834490|NCT02229552|588104623|FG000|1-year Follow up|Lost to Follow-up|18|||
162834491|NCT02229552|588104623|FG000|2-Year Follow up|Withdrawal by Subject|9|||
162834492|NCT02229552|588104623|FG000|2-Year Follow up|Lost to Follow-up|17|||
162834493|NCT00706134|588104624|FG000|Overall Study|Adverse Event|8|||
162834494|NCT00706134|588104625|FG001|Overall Study|Adverse Event|7|||
162834495|NCT00706134|588104626|FG002|Overall Study|Adverse Event|2|||
162834496|NCT00706134|588104627|FG003|Overall Study|Adverse Event|3|||
162834497|NCT00706134|588104624|FG000|Overall Study|Lost to Follow-up|0|||
162834498|NCT00706134|588104625|FG001|Overall Study|Lost to Follow-up|1|||
162834499|NCT00706134|588104626|FG002|Overall Study|Lost to Follow-up|0|||
162834500|NCT00706134|588104627|FG003|Overall Study|Lost to Follow-up|0|||
162834501|NCT00706134|588104624|FG000|Overall Study|Protocol Violation|0|||
162834502|NCT00706134|588104625|FG001|Overall Study|Protocol Violation|6|||
162834503|NCT00706134|588104626|FG002|Overall Study|Protocol Violation|0|||
162834504|NCT00706134|588104627|FG003|Overall Study|Protocol Violation|3|||
162834505|NCT00706134|588104624|FG000|Overall Study|Withdrawal by Subject|1|||
162834506|NCT00706134|588104625|FG001|Overall Study|Withdrawal by Subject|2|||
162834507|NCT00706134|588104626|FG002|Overall Study|Withdrawal by Subject|1|||
162834508|NCT00706134|588104627|FG003|Overall Study|Withdrawal by Subject|0|||
162834509|NCT00706134|588104624|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
162834510|NCT00706134|588104625|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162834511|NCT00706134|588104626|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
162834512|NCT00706134|588104627|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
162834513|NCT00706134|588104624|FG000|Overall Study|Did not meet study criteria|2|||
162834514|NCT00706134|588104625|FG001|Overall Study|Did not meet study criteria|0|||
162834515|NCT00706134|588104626|FG002|Overall Study|Did not meet study criteria|0|||
162834516|NCT00706134|588104627|FG003|Overall Study|Did not meet study criteria|0|||
162834517|NCT00631371|588104635|FG000|Overall Study|Lost to Follow-up|24|||
162834518|NCT00631371|588104636|FG001|Overall Study|Lost to Follow-up|19|||
162834519|NCT00631371|588104635|FG000|Overall Study|Other reason|5|||
162834520|NCT00631371|588104636|FG001|Overall Study|Other reason|12|||
162834521|NCT00631371|588104635|FG000|Overall Study|subject request|38|||
162834522|NCT00631371|588104636|FG001|Overall Study|subject request|45|||
162834523|NCT00631371|588104635|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
162834524|NCT00631371|588104636|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
162834525|NCT00631371|588104635|FG000|Overall Study|Death|263|||
162834526|NCT00631371|588104636|FG001|Overall Study|Death|239|||
162834527|NCT03354663|588104637|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
162834528|NCT03354663|588104637|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
162834529|NCT03354663|588104637|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
162834530|NCT03354663|588104637|FG000|Completed 30-day Visit|Missed Visit|1|||
162834531|NCT01391000|588104640|FG000|Overall Study|Lost to Follow-up|2|||
162834532|NCT01391000|588104641|FG001|Overall Study|Lost to Follow-up|0|||
162834533|NCT03860961|588104645|FG000|Overall Study|Withdrawal by Subject|6|||
162947225|NCT05037097|588510174|FG006|Overall Study|Withdrawal by Subject|0|||
162947226|NCT05037097|588510175|FG007|Overall Study|Withdrawal by Subject|0|||
162834534|NCT03860961|588104646|FG001|Overall Study|Withdrawal by Subject|11|||
162834535|NCT03860961|588104645|FG000|Overall Study|Death|10|||
162834536|NCT03860961|588104646|FG001|Overall Study|Death|6|||
162834537|NCT03860961|588104645|FG000|Overall Study|Incomplete two-year data|4|||
162834538|NCT03860961|588104646|FG001|Overall Study|Incomplete two-year data|0|||
162834539|NCT03189446|588104647|FG000|Overall Study|Adverse Event|2|||
162947227|NCT05037097|588510168|FG000|Overall Study|Lost to Follow-up|0|||
162947228|NCT05037097|588510169|FG001|Overall Study|Lost to Follow-up|1|||
162947229|NCT05037097|588510170|FG002|Overall Study|Lost to Follow-up|0|||
162834540|NCT03189446|588104647|FG000|Overall Study|Withdrawal by Subject|2|||
162834541|NCT03189446|588104647|FG000|Overall Study|Physician Decision|1|||
162834542|NCT00883337|588104648|FG000|Core Treatment Period|Adverse Event|9|||
162834543|NCT00883337|588104649|FG001|Core Treatment Period|Adverse Event|12|||
162834544|NCT00883337|588104650|FG002|Core Treatment Period|Adverse Event|22|||
162947230|NCT05037097|588510171|FG003|Overall Study|Lost to Follow-up|0|||
162834545|NCT00883337|588104648|FG000|Core Treatment Period|Lack of Efficacy|7|||
162834546|NCT00883337|588104649|FG001|Core Treatment Period|Lack of Efficacy|4|||
162834547|NCT00883337|588104650|FG002|Core Treatment Period|Lack of Efficacy|2|||
162834548|NCT00883337|588104648|FG000|Core Treatment Period|Lost to Follow-up|1|||
162834549|NCT00883337|588104649|FG001|Core Treatment Period|Lost to Follow-up|1|||
162834550|NCT00883337|588104650|FG002|Core Treatment Period|Lost to Follow-up|0|||
162834551|NCT00883337|588104648|FG000|Core Treatment Period|Withdrawal by Subject|2|||
162834552|NCT00883337|588104649|FG001|Core Treatment Period|Withdrawal by Subject|2|||
162834553|NCT00883337|588104650|FG002|Core Treatment Period|Withdrawal by Subject|6|||
162834554|NCT00883337|588104648|FG000|Core Treatment Period|Wish to be pregnant|1|||
162834555|NCT00883337|588104649|FG001|Core Treatment Period|Wish to be pregnant|2|||
162834556|NCT00883337|588104650|FG002|Core Treatment Period|Wish to be pregnant|1|||
162834557|NCT00883337|588104648|FG000|Core Treatment Period|Poor compliance to protocol|0|||
162834558|NCT00883337|588104649|FG001|Core Treatment Period|Poor compliance to protocol|0|||
162834559|NCT00883337|588104650|FG002|Core Treatment Period|Poor compliance to protocol|1|||
162834560|NCT00883337|588104648|FG000|Core Treatment Period|Other than above|0|||
162834561|NCT00883337|588104649|FG001|Core Treatment Period|Other than above|1|||
162834562|NCT00883337|588104650|FG002|Core Treatment Period|Other than above|1|||
162834563|NCT00883337|588104648|FG000|Extension Treatment Period|Adverse Event|8|||
162834564|NCT00883337|588104649|FG001|Extension Treatment Period|Adverse Event|5|||
162834565|NCT00883337|588104650|FG002|Extension Treatment Period|Adverse Event|5|||
162834566|NCT00883337|588104648|FG000|Extension Treatment Period|Lack of Efficacy|8|||
162834567|NCT00883337|588104649|FG001|Extension Treatment Period|Lack of Efficacy|8|||
162834568|NCT00883337|588104650|FG002|Extension Treatment Period|Lack of Efficacy|8|||
162834569|NCT00883337|588104648|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
162834570|NCT00883337|588104649|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
162834571|NCT00883337|588104650|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
162834572|NCT00883337|588104648|FG000|Extension Treatment Period|Lost to Follow-up|1|||
162834573|NCT00883337|588104649|FG001|Extension Treatment Period|Lost to Follow-up|0|||
162834574|NCT00883337|588104650|FG002|Extension Treatment Period|Lost to Follow-up|0|||
162834575|NCT00883337|588104648|FG000|Extension Treatment Period|Other than above|10|||
162834576|NCT00883337|588104649|FG001|Extension Treatment Period|Other than above|9|||
162834577|NCT00883337|588104650|FG002|Extension Treatment Period|Other than above|5|||
162834578|NCT00713700|588104652|FG000|Overall Study|Lost to Follow-up|3|||
162834579|NCT00713700|588104652|FG000|Overall Study|Withdrawal by Subject|1|||
162947231|NCT05037097|588510172|FG004|Overall Study|Lost to Follow-up|1|||
162947232|NCT05037097|588510173|FG005|Overall Study|Lost to Follow-up|1|||
162947233|NCT05037097|588510174|FG006|Overall Study|Lost to Follow-up|0|||
162947234|NCT05037097|588510175|FG007|Overall Study|Lost to Follow-up|0|||
162947235|NCT02918877|588510176|FG000|Overall Study|Withdrawal by Subject|2|||
162947236|NCT02918877|588510177|FG001|Overall Study|Withdrawal by Subject|2|||
162947237|NCT02918877|588510176|FG000|Overall Study|Surgery cancelled|1|||
162947238|NCT02918877|588510177|FG001|Overall Study|Surgery cancelled|0|||
162947239|NCT02918877|588510176|FG000|Overall Study|Physician Decision|1|||
162947240|NCT02918877|588510177|FG001|Overall Study|Physician Decision|0|||
162947241|NCT02918877|588510176|FG000|Overall Study|Received intraoperative steroids|1|||
162947242|NCT02918877|588510177|FG001|Overall Study|Received intraoperative steroids|0|||
162947243|NCT02918877|588510176|FG000|Overall Study|Unable to obtain lab samples|1|||
162947244|NCT02918877|588510177|FG001|Overall Study|Unable to obtain lab samples|0|||
162947245|NCT02918877|588510176|FG000|Overall Study|Unsafe to perform BAL|0|||
162947246|NCT02918877|588510177|FG001|Overall Study|Unsafe to perform BAL|1|||
162947247|NCT05346055|588510178|FG000|Overall Study|Withdrawal by Subject|1|||
162947248|NCT05346055|588510178|FG000|Overall Study|Protocol Violation|1|||
162947249|NCT05346055|588510178|FG000|Overall Study|Therapist decision|1|||
162947250|NCT00376220|588510179|FG000|Overall Study|Lost to Follow-up|7|||
162947251|NCT00376220|588510180|FG001|Overall Study|Lost to Follow-up|10|||
162834580|NCT00781456|588104653|FG000|Overall Study|Adverse Event|3|||
162834581|NCT00781456|588104654|FG001|Overall Study|Adverse Event|3|||
162834582|NCT00781456|588104653|FG000|Overall Study|Withdrawal by Subject|3|||
162947252|NCT00376220|588510179|FG000|Overall Study|Withdrawal by Subject|3|||
162834583|NCT00781456|588104654|FG001|Overall Study|Withdrawal by Subject|5|||
162834584|NCT00781456|588104653|FG000|Overall Study|Protocol Violation|4|||
162834585|NCT00781456|588104654|FG001|Overall Study|Protocol Violation|1|||
162947253|NCT00376220|588510180|FG001|Overall Study|Withdrawal by Subject|2|||
162947254|NCT02564263|588510181|FG000|Overall Study|Adverse Event|31|||
162947255|NCT02564263|588510182|FG001|Overall Study|Adverse Event|29|||
162947256|NCT02564263|588510181|FG000|Overall Study|Death|270|||
162834586|NCT00781456|588104653|FG000|Overall Study|Noncompliance With Protocol|1|||
162834587|NCT00781456|588104654|FG001|Overall Study|Noncompliance With Protocol|1|||
162834588|NCT00781456|588104653|FG000|Overall Study|Lost to Follow-up|10|||
162834589|NCT00781456|588104654|FG001|Overall Study|Lost to Follow-up|5|||
162834590|NCT00781456|588104653|FG000|Overall Study|Other Reason, Unknown|0|||
162834591|NCT00781456|588104654|FG001|Overall Study|Other Reason, Unknown|1|||
162834592|NCT03548558|588104656|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
162834593|NCT03548558|588104657|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
162834594|NCT03548558|588104658|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
162834595|NCT03548558|588104659|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
162834596|NCT03548558|588104660|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
162834597|NCT03548558|588104661|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
162834598|NCT03548558|588104662|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
162834599|NCT03548558|588104656|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
162834600|NCT03548558|588104657|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
162834601|NCT03548558|588104658|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
162834602|NCT03548558|588104659|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
162834603|NCT03548558|588104660|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
162834604|NCT03548558|588104661|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
162834605|NCT03548558|588104662|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
162834606|NCT03548558|588104656|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
162834607|NCT03548558|588104657|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
162834608|NCT03548558|588104658|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
162834609|NCT03548558|588104659|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
162834610|NCT03548558|588104660|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
162834611|NCT03548558|588104661|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
162834612|NCT03548558|588104662|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
162834613|NCT03548558|588104656|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
162834614|NCT03548558|588104657|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
162834615|NCT03548558|588104658|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
162834616|NCT03548558|588104659|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
162834617|NCT03548558|588104660|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
162834618|NCT03548558|588104661|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
162834619|NCT03548558|588104662|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
162834620|NCT03548558|588104656|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
162834621|NCT03548558|588104657|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
162834622|NCT03548558|588104658|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
162834623|NCT03548558|588104659|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
162834624|NCT03548558|588104660|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
162834625|NCT03548558|588104661|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
162834626|NCT03548558|588104662|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
162834627|NCT03548558|588104656|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
162834628|NCT03548558|588104657|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
162834629|NCT03548558|588104658|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
162834630|NCT03548558|588104659|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
162834631|NCT03548558|588104660|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
162834632|NCT03548558|588104661|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
162834633|NCT03548558|588104662|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
162834634|NCT02669017|588104665|FG000|Overall Study|Death|1|||
162834635|NCT02669017|588104666|FG001|Overall Study|Death|2|||
162834636|NCT02669017|588104667|FG002|Overall Study|Death|2|||
162834637|NCT02669017|588104668|FG003|Overall Study|Death|3|||
162834638|NCT02669017|588104669|FG004|Overall Study|Death|8|||
162834639|NCT02669017|588104670|FG005|Overall Study|Death|18|||
162834640|NCT02669017|588104671|FG006|Overall Study|Death|10|||
162834641|NCT02669017|588104672|FG007|Overall Study|Death|47|||
162834642|NCT02669017|588104673|FG008|Overall Study|Death|20|||
162834643|NCT02669017|588104665|FG000|Overall Study|Withdrawal by Subject|0|||
162834644|NCT02669017|588104666|FG001|Overall Study|Withdrawal by Subject|0|||
162834645|NCT02669017|588104667|FG002|Overall Study|Withdrawal by Subject|0|||
162947257|NCT02564263|588510182|FG001|Overall Study|Death|262|||
162834646|NCT02669017|588104668|FG003|Overall Study|Withdrawal by Subject|1|||
162834647|NCT02669017|588104669|FG004|Overall Study|Withdrawal by Subject|2|||
162834648|NCT02669017|588104670|FG005|Overall Study|Withdrawal by Subject|0|||
162834649|NCT02669017|588104671|FG006|Overall Study|Withdrawal by Subject|0|||
162834650|NCT02669017|588104672|FG007|Overall Study|Withdrawal by Subject|2|||
162834651|NCT02669017|588104673|FG008|Overall Study|Withdrawal by Subject|2|||
162834652|NCT02669017|588104665|FG000|Overall Study|Lost to Follow-up|0|||
162834653|NCT02669017|588104666|FG001|Overall Study|Lost to Follow-up|0|||
162834654|NCT02669017|588104667|FG002|Overall Study|Lost to Follow-up|0|||
162834655|NCT02669017|588104668|FG003|Overall Study|Lost to Follow-up|0|||
162834656|NCT02669017|588104669|FG004|Overall Study|Lost to Follow-up|0|||
162834657|NCT02669017|588104670|FG005|Overall Study|Lost to Follow-up|0|||
162834658|NCT02669017|588104671|FG006|Overall Study|Lost to Follow-up|0|||
162834659|NCT02669017|588104672|FG007|Overall Study|Lost to Follow-up|0|||
162834660|NCT02669017|588104673|FG008|Overall Study|Lost to Follow-up|1|||
162834661|NCT02669017|588104665|FG000|Overall Study|Miscellaneous|0|||
162834662|NCT02669017|588104666|FG001|Overall Study|Miscellaneous|0|||
162834663|NCT02669017|588104667|FG002|Overall Study|Miscellaneous|0|||
162834664|NCT02669017|588104668|FG003|Overall Study|Miscellaneous|0|||
162834665|NCT02669017|588104669|FG004|Overall Study|Miscellaneous|2|||
162834666|NCT02669017|588104670|FG005|Overall Study|Miscellaneous|1|||
162834667|NCT02669017|588104671|FG006|Overall Study|Miscellaneous|1|||
162834668|NCT02669017|588104672|FG007|Overall Study|Miscellaneous|13|||
162834669|NCT02669017|588104673|FG008|Overall Study|Miscellaneous|2|||
162947258|NCT02564263|588510181|FG000|Overall Study|Withdrawal by Subject|4|||
162947259|NCT02564263|588510182|FG001|Overall Study|Withdrawal by Subject|19|||
162947260|NCT02564263|588510181|FG000|Overall Study|Sponsor's decision|9|||
162947261|NCT02564263|588510182|FG001|Overall Study|Sponsor's decision|4|||
162947262|NCT02906709|588510183|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
162947263|NCT02906709|588510184|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
162947264|NCT02906709|588510183|FG000|Phase A (Week 0 to Week 16)|Death|0|||
162947265|NCT02906709|588510184|FG001|Phase A (Week 0 to Week 16)|Death|1|||
162947266|NCT02906709|588510183|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
162947267|NCT02906709|588510184|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
162947268|NCT02906709|588510183|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
162947269|NCT02906709|588510184|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
162947270|NCT02419313|588510185|FG000|First Intervention|Lost to Follow-up|2|||
162947271|NCT02419313|588510186|FG001|First Intervention|Lost to Follow-up|0|||
162947272|NCT02419313|588510185|FG000|Second Intervention|Lost to Follow-up|1|||
162947273|NCT02419313|588510186|FG001|Second Intervention|Lost to Follow-up|0|||
162947274|NCT00322491|588510193|FG000|Overall Study|Adverse Event|1|||
162947275|NCT00322491|588510194|FG001|Overall Study|Adverse Event|0|||
162947276|NCT00322491|588510193|FG000|Overall Study|Death|1|||
162947277|NCT00322491|588510194|FG001|Overall Study|Death|2|||
162947278|NCT00688064|588510195|FG000|Overall Study|Protocol Violation|0|||
162947279|NCT00688064|588510196|FG001|Overall Study|Protocol Violation|1|||
162947280|NCT00688064|588510195|FG000|Overall Study|Adverse Event|2|||
162947281|NCT00688064|588510196|FG001|Overall Study|Adverse Event|4|||
162947282|NCT00688064|588510195|FG000|Overall Study|Withdrawal by Subject|7|||
162947283|NCT00688064|588510196|FG001|Overall Study|Withdrawal by Subject|7|||
162947284|NCT00688064|588510195|FG000|Overall Study|Lost to Follow-up|10|||
162947285|NCT00688064|588510196|FG001|Overall Study|Lost to Follow-up|10|||
162947286|NCT00688064|588510195|FG000|Overall Study|Lack of Efficacy|0|||
162947287|NCT00688064|588510196|FG001|Overall Study|Lack of Efficacy|1|||
162947288|NCT00688064|588510195|FG000|Overall Study|Pregnancy|1|||
162947289|NCT00688064|588510196|FG001|Overall Study|Pregnancy|0|||
162947290|NCT00688064|588510195|FG000|Overall Study|Any other reasons|1|||
162947291|NCT00688064|588510196|FG001|Overall Study|Any other reasons|3|||
162947292|NCT00524459|588510200|FG000|Overall Study|Withdrawal by Subject|1|||
162834670|NCT04091087|588104674|FG000|Overall Study|Not treated|1|||
162834671|NCT04091087|588104675|FG001|Overall Study|Not treated|0|||
162947293|NCT00524459|588510200|FG000|Overall Study|Other|1|||
162947294|NCT00728949|588510201|FG000|Overall Study|Adverse Event|8|||
162834672|NCT04091087|588104674|FG000|Overall Study|Adverse Event|4|||
162834673|NCT04091087|588104675|FG001|Overall Study|Adverse Event|4|||
162834674|NCT04091087|588104674|FG000|Overall Study|Protocol Violation|0|||
162834675|NCT04091087|588104675|FG001|Overall Study|Protocol Violation|1|||
162834676|NCT04091087|588104674|FG000|Overall Study|Withdrawal by Subject|5|||
162834677|NCT04091087|588104675|FG001|Overall Study|Withdrawal by Subject|2|||
162834678|NCT04152161|588104676|FG000|Overall Study|Death|0|||
162947295|NCT00728949|588510202|FG001|Overall Study|Adverse Event|0|||
162947296|NCT00728949|588510201|FG000|Overall Study|Withdrawal by Subject|2|||
162947297|NCT00728949|588510202|FG001|Overall Study|Withdrawal by Subject|2|||
162947298|NCT00728949|588510201|FG000|Overall Study|Abnormal Lab Results|0|||
162947299|NCT00728949|588510202|FG001|Overall Study|Abnormal Lab Results|2|||
162947300|NCT00728949|588510201|FG000|Overall Study|On treatment at cutoff date|1|||
162947301|NCT00728949|588510202|FG001|Overall Study|On treatment at cutoff date|0|||
162947302|NCT02319148|588510207|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
162834679|NCT04152161|588104677|FG001|Overall Study|Death|1|||
162834680|NCT04152161|588104676|FG000|Overall Study|Physician Decision|0|||
162834681|NCT04152161|588104677|FG001|Overall Study|Physician Decision|1|||
162834682|NCT04152161|588104676|FG000|Overall Study|Lost to Follow-up|9|||
162834683|NCT04152161|588104677|FG001|Overall Study|Lost to Follow-up|3|||
162834684|NCT04152161|588104676|FG000|Overall Study|Protocol Violation|1|||
162834685|NCT04152161|588104677|FG001|Overall Study|Protocol Violation|0|||
162834686|NCT04152161|588104676|FG000|Overall Study|Withdrawal by Subject|29|||
162834687|NCT04152161|588104677|FG001|Overall Study|Withdrawal by Subject|28|||
162834688|NCT04152161|588104676|FG000|Overall Study|Sponsor termination of study|750|||
162834689|NCT04152161|588104677|FG001|Overall Study|Sponsor termination of study|755|||
162834690|NCT04152161|588104676|FG000|Overall Study|Other|20|||
162834691|NCT04152161|588104677|FG001|Overall Study|Other|18|||
162834692|NCT02559687|588104678|FG000|Overall Study|Death|112|||
162834693|NCT02559687|588104678|FG000|Overall Study|Sponsor Decision|5|||
162834694|NCT02559687|588104678|FG000|Overall Study|Withdrawal by Subject|4|||
162834695|NCT02599961|588104685|FG000|Overall Study|Withdrawal by Subject|1|||
162834696|NCT02599961|588104685|FG000|Overall Study|Subject Non-Compliance|2|||
162834697|NCT02599961|588104685|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
162834698|NCT02599961|588104685|FG000|Overall Study|Other, Not Specified|3|||
162834699|NCT00618410|588104686|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
162834700|NCT00618410|588104687|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
162834701|NCT00464334|588104688|FG000|Overall Study|Adverse Event|0|||
162834702|NCT00464334|588104689|FG001|Overall Study|Adverse Event|0|||
162834703|NCT00464334|588104690|FG002|Overall Study|Adverse Event|0|||
162834704|NCT00464334|588104691|FG003|Overall Study|Adverse Event|1|||
162834705|NCT00464334|588104692|FG004|Overall Study|Adverse Event|1|||
162834706|NCT00464334|588104693|FG005|Overall Study|Adverse Event|1|||
162834707|NCT00464334|588104694|FG006|Overall Study|Adverse Event|0|||
162834708|NCT00464334|588104695|FG007|Overall Study|Adverse Event|0|||
162834709|NCT00464334|588104696|FG008|Overall Study|Adverse Event|2|||
162834710|NCT00464334|588104697|FG009|Overall Study|Adverse Event|1|||
162834711|NCT00464334|588104698|FG010|Overall Study|Adverse Event|2|||
162834712|NCT00464334|588104688|FG000|Overall Study|Lack of Efficacy|0|||
162834713|NCT00464334|588104689|FG001|Overall Study|Lack of Efficacy|1|||
162834714|NCT00464334|588104690|FG002|Overall Study|Lack of Efficacy|0|||
162834715|NCT00464334|588104691|FG003|Overall Study|Lack of Efficacy|0|||
162834716|NCT00464334|588104692|FG004|Overall Study|Lack of Efficacy|0|||
162834717|NCT00464334|588104693|FG005|Overall Study|Lack of Efficacy|0|||
162834718|NCT00464334|588104694|FG006|Overall Study|Lack of Efficacy|0|||
162834719|NCT00464334|588104695|FG007|Overall Study|Lack of Efficacy|0|||
162947303|NCT02319148|588510208|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
162947304|NCT02319148|588510209|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
162947305|NCT02319148|588510210|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
162947306|NCT02319148|588510207|FG000|Second Intervention Period|No longer willing to participate|0|||
162947307|NCT02319148|588510208|FG001|Second Intervention Period|No longer willing to participate|1|||
162947308|NCT02319148|588510209|FG002|Second Intervention Period|No longer willing to participate|0|||
162947309|NCT02319148|588510210|FG003|Second Intervention Period|No longer willing to participate|0|||
162947310|NCT02319148|588510207|FG000|Second Intervention Period|Other|0|||
162947311|NCT02319148|588510208|FG001|Second Intervention Period|Other|0|||
162947312|NCT02319148|588510209|FG002|Second Intervention Period|Other|0|||
162947313|NCT02319148|588510210|FG003|Second Intervention Period|Other|1|||
162947314|NCT01574248|588510211|FG000|Overall Study|Withdrawal by Subject|2|||
162947315|NCT01574248|588510212|FG001|Overall Study|Withdrawal by Subject|0|||
162947316|NCT01574248|588510211|FG000|Overall Study|Missing primary endpoint data|1|||
162947317|NCT01574248|588510212|FG001|Overall Study|Missing primary endpoint data|0|||
162947318|NCT00048048|588510215|FG000|Core Treatment|Withdrawal by Subject|0|||
162947319|NCT00048048|588510216|FG001|Core Treatment|Withdrawal by Subject|0|||
162947320|NCT00048048|588510217|FG002|Core Treatment|Withdrawal by Subject|1|||
162947321|NCT00048048|588510218|FG003|Core Treatment|Withdrawal by Subject|0|||
162947322|NCT00048048|588510219|FG004|Core Treatment|Withdrawal by Subject|0|||
162834720|NCT00464334|588104696|FG008|Overall Study|Lack of Efficacy|0|||
162834721|NCT00464334|588104697|FG009|Overall Study|Lack of Efficacy|0|||
162947323|NCT00048048|588510220|FG005|Core Treatment|Withdrawal by Subject|0|||
162947324|NCT00048048|588510221|FG006|Core Treatment|Withdrawal by Subject|0|||
162947325|NCT00048048|588510222|FG007|Core Treatment|Withdrawal by Subject|0|||
162947326|NCT00048048|588510223|FG008|Core Treatment|Withdrawal by Subject|0|||
162947327|NCT00048048|588510224|FG009|Core Treatment|Withdrawal by Subject|0|||
162947328|NCT00048048|588510225|FG010|Core Treatment|Withdrawal by Subject|0|||
162834722|NCT00464334|588104698|FG010|Overall Study|Lack of Efficacy|0|||
162834723|NCT00464334|588104688|FG000|Overall Study|Lost to Follow-up|0|||
162947329|NCT00048048|588510226|FG011|Core Treatment|Withdrawal by Subject|0|||
162834724|NCT00464334|588104689|FG001|Overall Study|Lost to Follow-up|0|||
162834725|NCT00464334|588104690|FG002|Overall Study|Lost to Follow-up|1|||
162834726|NCT00464334|588104691|FG003|Overall Study|Lost to Follow-up|0|||
162834727|NCT00464334|588104692|FG004|Overall Study|Lost to Follow-up|1|||
162834728|NCT00464334|588104693|FG005|Overall Study|Lost to Follow-up|0|||
162834729|NCT00464334|588104694|FG006|Overall Study|Lost to Follow-up|1|||
162834730|NCT00464334|588104695|FG007|Overall Study|Lost to Follow-up|0|||
162834731|NCT00464334|588104696|FG008|Overall Study|Lost to Follow-up|0|||
162834732|NCT00464334|588104697|FG009|Overall Study|Lost to Follow-up|0|||
162834733|NCT00464334|588104698|FG010|Overall Study|Lost to Follow-up|2|||
162834734|NCT00464334|588104688|FG000|Overall Study|Progressive Disease|0|||
162834735|NCT00464334|588104689|FG001|Overall Study|Progressive Disease|0|||
162834736|NCT00464334|588104690|FG002|Overall Study|Progressive Disease|0|||
162834737|NCT00464334|588104691|FG003|Overall Study|Progressive Disease|0|||
162834738|NCT00464334|588104692|FG004|Overall Study|Progressive Disease|0|||
162834739|NCT00464334|588104693|FG005|Overall Study|Progressive Disease|1|||
162834740|NCT00464334|588104694|FG006|Overall Study|Progressive Disease|0|||
162834741|NCT00464334|588104695|FG007|Overall Study|Progressive Disease|0|||
162834742|NCT00464334|588104696|FG008|Overall Study|Progressive Disease|1|||
162834743|NCT00464334|588104697|FG009|Overall Study|Progressive Disease|0|||
162834744|NCT00464334|588104698|FG010|Overall Study|Progressive Disease|0|||
162834745|NCT00464334|588104688|FG000|Overall Study|Study Terminated by Sponsor|0|||
162834746|NCT00464334|588104689|FG001|Overall Study|Study Terminated by Sponsor|0|||
162834747|NCT00464334|588104690|FG002|Overall Study|Study Terminated by Sponsor|0|||
162834748|NCT00464334|588104691|FG003|Overall Study|Study Terminated by Sponsor|1|||
162834749|NCT00464334|588104692|FG004|Overall Study|Study Terminated by Sponsor|0|||
162834750|NCT00464334|588104693|FG005|Overall Study|Study Terminated by Sponsor|0|||
162834751|NCT00464334|588104694|FG006|Overall Study|Study Terminated by Sponsor|0|||
162834752|NCT00464334|588104695|FG007|Overall Study|Study Terminated by Sponsor|0|||
162834753|NCT00464334|588104696|FG008|Overall Study|Study Terminated by Sponsor|0|||
162834754|NCT00464334|588104697|FG009|Overall Study|Study Terminated by Sponsor|0|||
162834755|NCT00464334|588104698|FG010|Overall Study|Study Terminated by Sponsor|0|||
162834756|NCT00464334|588104688|FG000|Overall Study|Withdrawal by Subject|1|||
162834757|NCT00464334|588104689|FG001|Overall Study|Withdrawal by Subject|7|||
162834758|NCT00464334|588104690|FG002|Overall Study|Withdrawal by Subject|4|||
162834759|NCT00464334|588104691|FG003|Overall Study|Withdrawal by Subject|2|||
162834760|NCT00464334|588104692|FG004|Overall Study|Withdrawal by Subject|2|||
162834761|NCT00464334|588104693|FG005|Overall Study|Withdrawal by Subject|2|||
162834762|NCT00464334|588104694|FG006|Overall Study|Withdrawal by Subject|2|||
162834763|NCT00464334|588104695|FG007|Overall Study|Withdrawal by Subject|1|||
162834764|NCT00464334|588104696|FG008|Overall Study|Withdrawal by Subject|3|||
162834765|NCT00464334|588104697|FG009|Overall Study|Withdrawal by Subject|0|||
162834766|NCT00464334|588104698|FG010|Overall Study|Withdrawal by Subject|0|||
162834767|NCT01857869|588104699|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
162834768|NCT01857869|588104700|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
162834769|NCT01857869|588104701|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
162834770|NCT01857869|588104702|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
162834771|NCT01857869|588104703|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
162834772|NCT01857869|588104704|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
162834773|NCT01857869|588104705|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
162834774|NCT01857869|588104706|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
162834775|NCT01857869|588104707|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
162834776|NCT01857869|588104708|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
162834777|NCT01857869|588104699|FG000|Primary/Challenge Phase|Pregnancy|1|||
162834778|NCT01857869|588104700|FG001|Primary/Challenge Phase|Pregnancy|0|||
162834779|NCT01857869|588104701|FG002|Primary/Challenge Phase|Pregnancy|0|||
162947330|NCT00048048|588510215|FG000|Core Treatment|Adverse Event|0|||
162947331|NCT00048048|588510216|FG001|Core Treatment|Adverse Event|0|||
162947332|NCT00048048|588510217|FG002|Core Treatment|Adverse Event|0|||
162947333|NCT00048048|588510218|FG003|Core Treatment|Adverse Event|0|||
162947334|NCT00048048|588510219|FG004|Core Treatment|Adverse Event|0|||
162947335|NCT00048048|588510220|FG005|Core Treatment|Adverse Event|0|||
162947336|NCT00048048|588510221|FG006|Core Treatment|Adverse Event|0|||
162947337|NCT00048048|588510222|FG007|Core Treatment|Adverse Event|1|||
162947338|NCT00048048|588510223|FG008|Core Treatment|Adverse Event|0|||
162947339|NCT00048048|588510224|FG009|Core Treatment|Adverse Event|0|||
162947340|NCT00048048|588510225|FG010|Core Treatment|Adverse Event|0|||
162947341|NCT00048048|588510226|FG011|Core Treatment|Adverse Event|0|||
162947342|NCT00048048|588510215|FG000|Extension Year 1|Early withdrawals|0|||
162947343|NCT00048048|588510216|FG001|Extension Year 1|Early withdrawals|0|||
162947344|NCT00048048|588510217|FG002|Extension Year 1|Early withdrawals|0|||
162947345|NCT00048048|588510218|FG003|Extension Year 1|Early withdrawals|0|||
162947346|NCT00048048|588510219|FG004|Extension Year 1|Early withdrawals|0|||
162947347|NCT00048048|588510220|FG005|Extension Year 1|Early withdrawals|0|||
162947348|NCT00048048|588510221|FG006|Extension Year 1|Early withdrawals|0|||
162947349|NCT00048048|588510222|FG007|Extension Year 1|Early withdrawals|0|||
162947350|NCT00048048|588510223|FG008|Extension Year 1|Early withdrawals|0|||
162947351|NCT00048048|588510224|FG009|Extension Year 1|Early withdrawals|2|||
162947352|NCT00048048|588510225|FG010|Extension Year 1|Early withdrawals|2|||
162947353|NCT00048048|588510226|FG011|Extension Year 1|Early withdrawals|4|||
162947354|NCT00048048|588510215|FG000|Extension Year 2|Early withdrawals|0|||
162947355|NCT00048048|588510216|FG001|Extension Year 2|Early withdrawals|0|||
162947356|NCT00048048|588510217|FG002|Extension Year 2|Early withdrawals|0|||
162947357|NCT00048048|588510218|FG003|Extension Year 2|Early withdrawals|0|||
162947358|NCT00048048|588510219|FG004|Extension Year 2|Early withdrawals|0|||
162947359|NCT00048048|588510220|FG005|Extension Year 2|Early withdrawals|0|||
162947360|NCT00048048|588510221|FG006|Extension Year 2|Early withdrawals|0|||
162947361|NCT00048048|588510222|FG007|Extension Year 2|Early withdrawals|0|||
162947362|NCT00048048|588510223|FG008|Extension Year 2|Early withdrawals|0|||
162947363|NCT00048048|588510224|FG009|Extension Year 2|Early withdrawals|0|||
162947364|NCT00048048|588510225|FG010|Extension Year 2|Early withdrawals|4|||
162947365|NCT00048048|588510226|FG011|Extension Year 2|Early withdrawals|2|||
162947366|NCT02194998|588510245|FG000|On-HCV Treatment|Did not pick up study medication|0|||
162947367|NCT02194998|588510246|FG001|On-HCV Treatment|Did not pick up study medication|1|||
162947368|NCT02194998|588510247|FG002|On-HCV Treatment|Did not pick up study medication|0|||
162947369|NCT02194998|588510248|FG003|On-HCV Treatment|Did not pick up study medication|0|||
162947370|NCT02194998|588510245|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
162947371|NCT02194998|588510246|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
162947372|NCT02194998|588510247|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
162947373|NCT02194998|588510248|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
162947374|NCT01400113|588510249|FG000|Overall Study|Withdrawal by Subject|1|||
162947375|NCT01400113|588510250|FG001|Overall Study|Withdrawal by Subject|1|||
162947376|NCT00282256|588510251|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
162947377|NCT00282256|588510251|FG000|Extension Treatment Period|Adverse Event|2|||
162947378|NCT01345019|588510252|FG000|Blinded Treatment Phase|Death|147|||
162947379|NCT01345019|588510253|FG001|Blinded Treatment Phase|Death|137|||
162947380|NCT01345019|588510252|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
162947381|NCT01345019|588510253|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
162947382|NCT01345019|588510252|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
162947383|NCT01345019|588510253|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
162947384|NCT01345019|588510252|FG000|Blinded Treatment Phase|Disease Progression|12|||
162947385|NCT01345019|588510253|FG001|Blinded Treatment Phase|Disease Progression|10|||
162947386|NCT01345019|588510252|FG000|Blinded Treatment Phase|Adverse Event|6|||
162947387|NCT01345019|588510253|FG001|Blinded Treatment Phase|Adverse Event|13|||
162947388|NCT01345019|588510252|FG000|Blinded Treatment Phase|Administrative Decision|10|||
162947389|NCT01345019|588510253|FG001|Blinded Treatment Phase|Administrative Decision|8|||
162947390|NCT01345019|588510252|FG000|Blinded Treatment Phase|Noncompliance|5|||
162947391|NCT01345019|588510253|FG001|Blinded Treatment Phase|Noncompliance|3|||
162947392|NCT01345019|588510252|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
162947393|NCT01345019|588510253|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
162947394|NCT01345019|588510252|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
162947395|NCT01345019|588510253|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
162947396|NCT01345019|588510252|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
162947397|NCT01345019|588510253|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
162947398|NCT01345019|588510252|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
162947399|NCT01345019|588510253|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
162947400|NCT01345019|588510252|FG000|Open Label Treatment Phase|Death|49|||
162947401|NCT01345019|588510253|FG001|Open Label Treatment Phase|Death|48|||
162947402|NCT01345019|588510252|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
162947403|NCT01345019|588510253|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
162947404|NCT01345019|588510252|FG000|Open Label Treatment Phase|Adverse Event|30|||
162947405|NCT01345019|588510253|FG001|Open Label Treatment Phase|Adverse Event|51|||
162947406|NCT01345019|588510252|FG000|Open Label Treatment Phase|Administrative Decision|30|||
162947407|NCT01345019|588510253|FG001|Open Label Treatment Phase|Administrative Decision|15|||
162947408|NCT01345019|588510252|FG000|Open Label Treatment Phase|Disease Progression|17|||
162947409|NCT01345019|588510253|FG001|Open Label Treatment Phase|Disease Progression|18|||
162947410|NCT01345019|588510252|FG000|Open Label Treatment Phase|Noncompliance|5|||
162947411|NCT01345019|588510253|FG001|Open Label Treatment Phase|Noncompliance|4|||
162947412|NCT01345019|588510252|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
162947413|NCT01345019|588510253|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
162947414|NCT01345019|588510252|FG000|Open Label Treatment Phase|Pregnancy|1|||
162947415|NCT01345019|588510253|FG001|Open Label Treatment Phase|Pregnancy|0|||
162947416|NCT01345019|588510252|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
162947417|NCT01345019|588510253|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
162947418|NCT01345019|588510252|FG000|Open Label Treatment Phase|Protocol Violation|0|||
162947419|NCT01345019|588510253|FG001|Open Label Treatment Phase|Protocol Violation|1|||
162947420|NCT02636907|588510254|FG000|Autoinjector Assessment Period|Adverse Event|2|||
162947421|NCT02636907|588510254|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
162947422|NCT02636907|588510254|FG000|Extension Phase|Adverse Event|2|||
162947423|NCT02636907|588510254|FG000|Extension Phase|Withdrawal by Subject|4|||
162947424|NCT02636907|588510254|FG000|Extension Phase|Physician Decision|1|||
162947425|NCT02636907|588510254|FG000|Extension Phase|Lost to Follow-up|2|||
162947426|NCT02636907|588510254|FG000|Extension Phase|Lack of Efficacy|1|||
162947427|NCT00762086|588510255|FG000|Overall Study|Adverse Event|2|||
162947428|NCT00762086|588510256|FG001|Overall Study|Adverse Event|0|||
162947429|NCT00762086|588510255|FG000|Overall Study|Lost to Follow-up|0|||
162947430|NCT00762086|588510256|FG001|Overall Study|Lost to Follow-up|2|||
162947431|NCT00762086|588510255|FG000|Overall Study|Non compliance|1|||
162947432|NCT00762086|588510256|FG001|Overall Study|Non compliance|0|||
162947433|NCT00762086|588510255|FG000|Overall Study|Withdrawal by Subject|2|||
162947434|NCT00762086|588510256|FG001|Overall Study|Withdrawal by Subject|2|||
162947435|NCT00762086|588510255|FG000|Overall Study|Ineligible to participate in the study|1|||
162947436|NCT00762086|588510256|FG001|Overall Study|Ineligible to participate in the study|0|||
162947437|NCT01074554|588510266|FG000|Overall Study|Adverse Event|3|||
162947438|NCT01074554|588510267|FG001|Overall Study|Adverse Event|3|||
162947439|NCT01074554|588510266|FG000|Overall Study|Lost to Follow-up|0|||
162947440|NCT01074554|588510267|FG001|Overall Study|Lost to Follow-up|1|||
162947441|NCT00497796|588510268|FG000|Overall Study|Adverse event (not related)|9|||
162947442|NCT00497796|588510269|FG001|Overall Study|Adverse event (not related)|9|||
162947443|NCT00497796|588510268|FG000|Overall Study|Adverse event (related)|5|||
162947444|NCT00497796|588510269|FG001|Overall Study|Adverse event (related)|4|||
162947445|NCT00497796|588510268|FG000|Overall Study|CMV infection or disease treatment|30|||
162947446|NCT00497796|588510269|FG001|Overall Study|CMV infection or disease treatment|4|||
162947447|NCT00497796|588510268|FG000|Overall Study|Consent withdrawn|10|||
162947448|NCT00497796|588510269|FG001|Overall Study|Consent withdrawn|3|||
162947449|NCT00497796|588510268|FG000|Overall Study|Investigator/sponsor discretion|31|||
162947450|NCT00497796|588510269|FG001|Overall Study|Investigator/sponsor discretion|34|||
162947451|NCT00497796|588510268|FG000|Overall Study|Lost to Follow-up|0|||
162947452|NCT00497796|588510269|FG001|Overall Study|Lost to Follow-up|1|||
162947453|NCT00497796|588510268|FG000|Overall Study|Not applicable (randomized not treated)|0|||
162947454|NCT00497796|588510269|FG001|Overall Study|Not applicable (randomized not treated)|4|||
162947455|NCT01856309|588510271|FG000|Overall Study|Death|4|||
162947456|NCT01856309|588510272|FG001|Overall Study|Death|6|||
162947457|NCT01856309|588510273|FG002|Overall Study|Death|11|||
162947458|NCT01856309|588510274|FG003|Overall Study|Death|6|||
162947459|NCT01856309|588510271|FG000|Overall Study|Lost to Follow-up|6|||
162947460|NCT01856309|588510272|FG001|Overall Study|Lost to Follow-up|2|||
162947461|NCT01856309|588510273|FG002|Overall Study|Lost to Follow-up|4|||
162947462|NCT01856309|588510274|FG003|Overall Study|Lost to Follow-up|8|||
162947463|NCT01856309|588510271|FG000|Overall Study|Withdrawal by Subject|11|||
162947464|NCT01856309|588510272|FG001|Overall Study|Withdrawal by Subject|13|||
162947465|NCT01856309|588510273|FG002|Overall Study|Withdrawal by Subject|28|||
162947466|NCT01856309|588510274|FG003|Overall Study|Withdrawal by Subject|26|||
162947467|NCT01856309|588510271|FG000|Overall Study|Other|227|||
162947468|NCT01856309|588510272|FG001|Overall Study|Other|225|||
162947469|NCT01856309|588510273|FG002|Overall Study|Other|447|||
162947470|NCT01856309|588510274|FG003|Overall Study|Other|469|||
162947471|NCT01856309|588510271|FG000|Overall Study|Lack of Efficacy|14|||
162947472|NCT01856309|588510272|FG001|Overall Study|Lack of Efficacy|9|||
162947473|NCT01856309|588510273|FG002|Overall Study|Lack of Efficacy|40|||
162947474|NCT01856309|588510274|FG003|Overall Study|Lack of Efficacy|25|||
162947475|NCT01856309|588510271|FG000|Overall Study|Adverse Event|31|||
162947476|NCT01856309|588510272|FG001|Overall Study|Adverse Event|31|||
162947477|NCT01856309|588510273|FG002|Overall Study|Adverse Event|55|||
162947478|NCT01856309|588510274|FG003|Overall Study|Adverse Event|65|||
162947479|NCT01856309|588510271|FG000|Overall Study|Pregnancy|0|||
162947480|NCT01856309|588510272|FG001|Overall Study|Pregnancy|0|||
162947481|NCT01856309|588510273|FG002|Overall Study|Pregnancy|0|||
162947482|NCT01856309|588510274|FG003|Overall Study|Pregnancy|1|||
162947483|NCT01856309|588510271|FG000|Overall Study|Physician Decision|6|||
162947484|NCT01856309|588510272|FG001|Overall Study|Physician Decision|1|||
162947485|NCT01856309|588510273|FG002|Overall Study|Physician Decision|6|||
162947486|NCT01856309|588510274|FG003|Overall Study|Physician Decision|8|||
162947487|NCT01856309|588510271|FG000|Overall Study|Noncompliance With Study Drug|0|||
162947488|NCT01856309|588510272|FG001|Overall Study|Noncompliance With Study Drug|1|||
162947489|NCT01856309|588510273|FG002|Overall Study|Noncompliance With Study Drug|4|||
162947490|NCT01856309|588510274|FG003|Overall Study|Noncompliance With Study Drug|1|||
162947491|NCT00220337|588510275|FG000|Overall Study|Adverse Event|70|||
162947492|NCT00220337|588510275|FG000|Overall Study|Lack of Efficacy|17|||
162947493|NCT00220337|588510275|FG000|Overall Study|Withdrawal by Subject|68|||
162947494|NCT00220337|588510275|FG000|Overall Study|Protocol Violation|2|||
162947495|NCT00220337|588510275|FG000|Overall Study|Lost to Follow-up|5|||
162947496|NCT00220337|588510275|FG000|Overall Study|Other|12|||
162947497|NCT00220337|588510275|FG000|Overall Study|Unsatisfactory compliance|5|||
162947498|NCT00832377|588510276|FG000|Overall Study|Protocol Violation|1|||
162947499|NCT00944697|588510277|FG000|Overall Study|Withdrawal by Subject|1|||
162947500|NCT00944697|588510278|FG001|Overall Study|Withdrawal by Subject|1|||
162947501|NCT00944697|588510277|FG000|Overall Study|Adverse Event|0|||
162947502|NCT00944697|588510278|FG001|Overall Study|Adverse Event|3|||
162947503|NCT00944697|588510277|FG000|Overall Study|Administrative|1|||
162947504|NCT00944697|588510278|FG001|Overall Study|Administrative|1|||
162947505|NCT03661528|588510279|FG000|Overall Study|Death|1|||
162947506|NCT03661528|588510280|FG001|Overall Study|Death|0|||
162947507|NCT03661528|588510279|FG000|Overall Study|Physician Decision|3|||
162947508|NCT03661528|588510280|FG001|Overall Study|Physician Decision|1|||
162947509|NCT03661528|588510279|FG000|Overall Study|Other than Specified|5|||
162947510|NCT03661528|588510280|FG001|Overall Study|Other than Specified|2|||
162947511|NCT03661528|588510279|FG000|Overall Study|Withdrawal by Subject|5|||
162947512|NCT03661528|588510280|FG001|Overall Study|Withdrawal by Subject|3|||
162947513|NCT03661528|588510279|FG000|Overall Study|Disease Progression|8|||
162947514|NCT03661528|588510280|FG001|Overall Study|Disease Progression|13|||
162947515|NCT03661528|588510279|FG000|Overall Study|Adverse Event|61|||
162699547|NCT04844918|587610449|FG001|Overall Study|Withdrawal by Subject|3|||
162699548|NCT04844918|587610450|FG002|Overall Study|Withdrawal by Subject|3|||
162947516|NCT03661528|588510280|FG001|Overall Study|Adverse Event|55|||
162947517|NCT03130699|588510288|FG000|Overall Study|Lost to Follow-up|34|||
162947518|NCT03130699|588510289|FG001|Overall Study|Lost to Follow-up|37|||
162947519|NCT03130699|588510290|FG002|Overall Study|Lost to Follow-up|26|||
162947520|NCT03130699|588510288|FG000|Overall Study|Withdrawal by Subject|5|||
162947521|NCT03130699|588510289|FG001|Overall Study|Withdrawal by Subject|1|||
162947522|NCT03130699|588510290|FG002|Overall Study|Withdrawal by Subject|0|||
162947523|NCT03130699|588510288|FG000|Overall Study|Withdrawal by PI|1|||
162947524|NCT03130699|588510289|FG001|Overall Study|Withdrawal by PI|2|||
162947525|NCT03130699|588510290|FG002|Overall Study|Withdrawal by PI|5|||
162947526|NCT03130699|588510288|FG000|Overall Study|Death|0|||
162947527|NCT03130699|588510289|FG001|Overall Study|Death|0|||
162947528|NCT03130699|588510290|FG002|Overall Study|Death|1|||
162947529|NCT00661505|588510291|FG000|Overall Study|Adverse Event|3|||
162947530|NCT00661505|588510291|FG000|Overall Study|Protocol Violation|14|||
162947531|NCT00661505|588510291|FG000|Overall Study|Withdrawal by Subject|8|||
162947532|NCT00661505|588510291|FG000|Overall Study|Lost to Follow-up|3|||
162947533|NCT00661505|588510291|FG000|Overall Study|Other|2|||
162947534|NCT04534283|588510292|FG000|Overall Study|Physician Decision|2|||
162947535|NCT04534283|588510292|FG000|Overall Study|Withdrawal by Subject|1|||
162947536|NCT04534283|588510292|FG000|Overall Study|Disease Progression|12|||
162947537|NCT04534283|588510292|FG000|Overall Study|Adverse Event|1|||
162947538|NCT05956665|588510293|FG000|Overall Study|Death|1|||
162947539|NCT05956665|588510293|FG000|Overall Study|Withdrawal by Subject|1|||
162947540|NCT00977470|588510294|FG000|Overall Study|Lack of Efficacy|32|||
162947541|NCT00977470|588510295|FG001|Overall Study|Lack of Efficacy|30|||
162947542|NCT00977470|588510294|FG000|Overall Study|Physician Decision|2|||
162947543|NCT00977470|588510295|FG001|Overall Study|Physician Decision|0|||
162947544|NCT00977470|588510294|FG000|Overall Study|Adverse Event|1|||
162947545|NCT00977470|588510295|FG001|Overall Study|Adverse Event|2|||
162947546|NCT00977470|588510294|FG000|Overall Study|Protocol Violation|1|||
162947547|NCT00977470|588510295|FG001|Overall Study|Protocol Violation|0|||
162947548|NCT00977470|588510294|FG000|Overall Study|Withdrawal by Subject|0|||
162947549|NCT00977470|588510295|FG001|Overall Study|Withdrawal by Subject|2|||
162947550|NCT00977470|588510294|FG000|Overall Study|Death|0|||
162947551|NCT00977470|588510295|FG001|Overall Study|Death|2|||
162947552|NCT00977470|588510294|FG000|Overall Study|clinical decline|0|||
162947553|NCT00977470|588510295|FG001|Overall Study|clinical decline|1|||
162947554|NCT00977470|588510294|FG000|Overall Study|prolonged recovery post-surgery|0|||
162947555|NCT00977470|588510295|FG001|Overall Study|prolonged recovery post-surgery|1|||
162947556|NCT00977470|588510294|FG000|Overall Study|Still on-study|2|||
162947557|NCT00977470|588510295|FG001|Overall Study|Still on-study|0|||
162947558|NCT03257462|588510296|FG000|Cohort A|Lost to Follow-up|1|||
162947559|NCT03257462|588510297|FG001|Cohort A|Lost to Follow-up|0|||
162947560|NCT03257462|588510298|FG002|Cohort A|Lost to Follow-up|0|||
162947561|NCT03257462|588510299|FG003|Cohort A|Lost to Follow-up|0|||
162947562|NCT03257462|588510296|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
162947563|NCT03257462|588510297|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
162947564|NCT03257462|588510298|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
162947565|NCT03257462|588510299|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
162947566|NCT00796822|588510300|FG000|Overall Study|Lost to Follow-up|2|||
162947567|NCT00796822|588510301|FG001|Overall Study|Lost to Follow-up|0|||
162947568|NCT00796822|588510300|FG000|Overall Study|Adverse Event|1|||
162947569|NCT00796822|588510301|FG001|Overall Study|Adverse Event|0|||
162947570|NCT06354270|588510307|FG000|Overall Study|Withdrawal by Subject|1|||
162947571|NCT06354270|588510308|FG001|Overall Study|Withdrawal by Subject|0|||
162947572|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947573|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947574|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947575|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947576|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947577|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
162947578|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947579|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947580|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
162947581|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
162947582|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
162947583|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
162947584|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
162947585|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
162947586|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
162947587|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
162947588|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
162947589|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
162947590|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947591|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947592|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947593|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947594|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947595|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
162947596|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
162947597|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
162947598|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
162947599|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947600|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947601|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
162947602|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947603|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947604|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
162947605|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947606|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
162699549|NCT04844918|587610448|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
162699550|NCT04844918|587610449|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
162699551|NCT04844918|587610450|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
162699552|NCT01009047|587610451|FG000|Overall Study|Adverse Event|5|||
162699553|NCT01009047|587610452|FG001|Overall Study|Adverse Event|0|||
162699554|NCT01009047|587610451|FG000|Overall Study|Lost to Follow-up|0|||
162699555|NCT01009047|587610452|FG001|Overall Study|Lost to Follow-up|2|||
162699556|NCT01009047|587610451|FG000|Overall Study|Lack of Efficacy|4|||
162699557|NCT01009047|587610452|FG001|Overall Study|Lack of Efficacy|11|||
162699558|NCT01009047|587610451|FG000|Overall Study|Withdrawal by consent|16|||
162699559|NCT01009047|587610452|FG001|Overall Study|Withdrawal by consent|11|||
162699560|NCT01009047|587610451|FG000|Overall Study|Other|3|||
162699561|NCT01009047|587610452|FG001|Overall Study|Other|2|||
162699562|NCT02443103|587610454|FG000|Overall Study|Adverse Event|2|||
162947607|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162947608|NCT05097989|588510309|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947609|NCT05097989|588510310|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947610|NCT05097989|588510311|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
162947611|NCT05097989|588510312|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947612|NCT05097989|588510313|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947613|NCT05097989|588510314|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947614|NCT05097989|588510315|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947615|NCT05097989|588510316|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947616|NCT05097989|588510317|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
162947617|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947618|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
162947619|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162699563|NCT02443103|587610454|FG000|Overall Study|Noncompliance|1|||
162699564|NCT02366936|587610456|FG000|Overall Study|Withdrawal by Subject|2|||
162699565|NCT02366936|587610456|FG000|Overall Study|Lost to Follow-up|4|||
162699566|NCT02366936|587610456|FG000|Overall Study|Physician Decision|2|||
162699567|NCT02878213|587610457|FG000|Overall Study|Withdrawal by Subject|2|||
162699568|NCT02878213|587610457|FG000|Overall Study|Adverse Event|1|||
162699569|NCT01558674|587610458|FG000|Part 1|Study Terminated by Sponsor|10|||
162699570|NCT01558674|587610459|FG001|Part 1|Study Terminated by Sponsor|0|||
162699571|NCT01558674|587610458|FG000|Part 1|Withdrawal by Subject|1|||
162699572|NCT01558674|587610459|FG001|Part 1|Withdrawal by Subject|0|||
162699573|NCT01555021|587610460|FG000|Overall Study|Lost to Follow-up|1|||
162699574|NCT01555021|587610461|FG001|Overall Study|Lost to Follow-up|2|||
162699575|NCT01388530|587610462|FG000|Overall Study|Lost to Follow-up|5|||
162699576|NCT02420327|587610463|FG000|Overall Study|Adverse Event|7|||
162699577|NCT02420327|587610463|FG000|Overall Study|Pregnancy|1|||
162947620|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947621|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947622|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947623|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947624|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947625|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
162947626|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947627|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947628|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947629|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947630|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162947631|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162699578|NCT02420327|587610463|FG000|Overall Study|Withdrawal by Subject|6|||
162699579|NCT02420327|587610463|FG000|Overall Study|Lost to Follow-up|1|||
162699580|NCT02420327|587610463|FG000|Overall Study|Protocol Violation|1|||
162699581|NCT01225835|587610466|FG000|Overall Study|Completed protocol|2|||
162699582|NCT01225835|587610467|FG001|Overall Study|Completed protocol|1|||
162699583|NCT01225835|587610466|FG000|Overall Study|Did not meet hCG criterion|2|||
162699584|NCT01225835|587610467|FG001|Overall Study|Did not meet hCG criterion|0|||
162699585|NCT01225835|587610466|FG000|Overall Study|Adverse Event|2|||
162699586|NCT01225835|587610467|FG001|Overall Study|Adverse Event|1|||
162699587|NCT01225835|587610466|FG000|Overall Study|Other|1|||
162699588|NCT01225835|587610467|FG001|Overall Study|Other|1|||
162699589|NCT01146574|587610468|FG000|Overall Study|Death|0|||
162699590|NCT01146574|587610469|FG001|Overall Study|Death|1|||
162699591|NCT01146574|587610470|FG002|Overall Study|Death|1|||
162699592|NCT01146574|587610471|FG003|Overall Study|Death|0|||
162699593|NCT01146574|587610472|FG004|Overall Study|Death|0|||
162699594|NCT01146574|587610473|FG005|Overall Study|Death|0|||
162699595|NCT01146574|587610474|FG006|Overall Study|Death|0|||
162699596|NCT01146574|587610468|FG000|Overall Study|Other reasons|0|||
162699597|NCT01146574|587610469|FG001|Overall Study|Other reasons|0|||
162699598|NCT01146574|587610470|FG002|Overall Study|Other reasons|3|||
162699599|NCT01146574|587610471|FG003|Overall Study|Other reasons|0|||
162699600|NCT01146574|587610472|FG004|Overall Study|Other reasons|0|||
162699601|NCT01146574|587610473|FG005|Overall Study|Other reasons|0|||
162699602|NCT01146574|587610474|FG006|Overall Study|Other reasons|0|||
162699603|NCT01146574|587610468|FG000|Overall Study|Kidney transplant|0|||
162699604|NCT01146574|587610469|FG001|Overall Study|Kidney transplant|0|||
162699605|NCT01146574|587610470|FG002|Overall Study|Kidney transplant|1|||
162699606|NCT01146574|587610471|FG003|Overall Study|Kidney transplant|1|||
162699607|NCT01146574|587610472|FG004|Overall Study|Kidney transplant|0|||
162699608|NCT01146574|587610473|FG005|Overall Study|Kidney transplant|0|||
162699609|NCT01146574|587610474|FG006|Overall Study|Kidney transplant|0|||
162699610|NCT01146574|587610468|FG000|Overall Study|Withdrew consent|0|||
162699611|NCT01146574|587610469|FG001|Overall Study|Withdrew consent|0|||
162699612|NCT01146574|587610470|FG002|Overall Study|Withdrew consent|1|||
162699613|NCT01146574|587610471|FG003|Overall Study|Withdrew consent|1|||
162699614|NCT01146574|587610472|FG004|Overall Study|Withdrew consent|2|||
162699615|NCT01146574|587610473|FG005|Overall Study|Withdrew consent|1|||
162699616|NCT01146574|587610474|FG006|Overall Study|Withdrew consent|1|||
162699617|NCT01266993|587610475|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
162834780|NCT01857869|588104702|FG003|Primary/Challenge Phase|Pregnancy|0|||
162834781|NCT01857869|588104703|FG004|Primary/Challenge Phase|Pregnancy|0|||
162834782|NCT01857869|588104704|FG005|Primary/Challenge Phase|Pregnancy|0|||
162834783|NCT01857869|588104705|FG006|Primary/Challenge Phase|Pregnancy|0|||
162834784|NCT01857869|588104706|FG007|Primary/Challenge Phase|Pregnancy|0|||
162834785|NCT01857869|588104707|FG008|Primary/Challenge Phase|Pregnancy|0|||
162834786|NCT01857869|588104708|FG009|Primary/Challenge Phase|Pregnancy|0|||
162834787|NCT01857869|588104699|FG000|Primary/Challenge Phase|Protocol Violation|1|||
162834788|NCT01857869|588104700|FG001|Primary/Challenge Phase|Protocol Violation|0|||
162834789|NCT01857869|588104701|FG002|Primary/Challenge Phase|Protocol Violation|0|||
162834790|NCT01857869|588104702|FG003|Primary/Challenge Phase|Protocol Violation|0|||
162834791|NCT01857869|588104703|FG004|Primary/Challenge Phase|Protocol Violation|0|||
162834792|NCT01857869|588104704|FG005|Primary/Challenge Phase|Protocol Violation|0|||
162834793|NCT01857869|588104705|FG006|Primary/Challenge Phase|Protocol Violation|0|||
162834794|NCT01857869|588104706|FG007|Primary/Challenge Phase|Protocol Violation|0|||
162834795|NCT01857869|588104707|FG008|Primary/Challenge Phase|Protocol Violation|0|||
162834796|NCT01857869|588104708|FG009|Primary/Challenge Phase|Protocol Violation|0|||
162834797|NCT01857869|588104699|FG000|Primary/Challenge Phase|Other|1|||
162834798|NCT01857869|588104700|FG001|Primary/Challenge Phase|Other|1|||
162834799|NCT01857869|588104701|FG002|Primary/Challenge Phase|Other|0|||
162834800|NCT01857869|588104702|FG003|Primary/Challenge Phase|Other|0|||
162834801|NCT01857869|588104703|FG004|Primary/Challenge Phase|Other|0|||
162834802|NCT01857869|588104704|FG005|Primary/Challenge Phase|Other|0|||
162834803|NCT01857869|588104705|FG006|Primary/Challenge Phase|Other|0|||
162834804|NCT01857869|588104706|FG007|Primary/Challenge Phase|Other|0|||
162834805|NCT01857869|588104707|FG008|Primary/Challenge Phase|Other|0|||
162834806|NCT01857869|588104708|FG009|Primary/Challenge Phase|Other|0|||
162834807|NCT01857869|588104699|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834808|NCT01857869|588104700|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834809|NCT01857869|588104701|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834810|NCT01857869|588104702|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
162834811|NCT01857869|588104703|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834812|NCT01857869|588104704|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834813|NCT01857869|588104705|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834814|NCT01857869|588104706|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834815|NCT01857869|588104707|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834816|NCT01857869|588104708|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
162834817|NCT01857869|588104699|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834818|NCT01857869|588104700|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834819|NCT01857869|588104701|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834820|NCT01857869|588104702|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
162834821|NCT01857869|588104703|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162947632|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947633|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162947634|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162699618|NCT01266993|587610476|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
162699619|NCT01266993|587610475|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
162699620|NCT01266993|587610476|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
162699621|NCT00514046|587610483|FG000|Overall Study|transferred to another protocol|2|||
162699622|NCT00514046|587610484|FG001|Overall Study|transferred to another protocol|1|||
162699623|NCT00514046|587610485|FG002|Overall Study|transferred to another protocol|3|||
162699624|NCT00514046|587610486|FG003|Overall Study|transferred to another protocol|0|||
162699625|NCT00514046|587610487|FG004|Overall Study|transferred to another protocol|1|||
162699626|NCT00514046|587610488|FG005|Overall Study|transferred to another protocol|0|||
162699627|NCT00514046|587610489|FG006|Overall Study|transferred to another protocol|0|||
162699628|NCT00514046|587610490|FG007|Overall Study|transferred to another protocol|0|||
162699629|NCT00514046|587610491|FG008|Overall Study|transferred to another protocol|0|||
162699630|NCT00514046|587610483|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
162699631|NCT00514046|587610484|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
162699632|NCT00514046|587610485|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
162699633|NCT00514046|587610486|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
162699634|NCT00514046|587610487|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
162699635|NCT00514046|587610488|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
162699636|NCT00514046|587610489|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
162699637|NCT00514046|587610490|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
162699638|NCT00514046|587610491|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
162699639|NCT00514046|587610483|FG000|Overall Study|Disease progression on study|0|||
162699640|NCT00514046|587610484|FG001|Overall Study|Disease progression on study|0|||
162699641|NCT00514046|587610485|FG002|Overall Study|Disease progression on study|2|||
162699642|NCT00514046|587610486|FG003|Overall Study|Disease progression on study|0|||
162699643|NCT00514046|587610487|FG004|Overall Study|Disease progression on study|0|||
162699644|NCT00514046|587610488|FG005|Overall Study|Disease progression on study|1|||
162699645|NCT00514046|587610489|FG006|Overall Study|Disease progression on study|0|||
162699646|NCT00514046|587610490|FG007|Overall Study|Disease progression on study|0|||
162699647|NCT00514046|587610491|FG008|Overall Study|Disease progression on study|0|||
162699648|NCT00383240|587610496|FG000|Overall Study|Adverse Event|4|||
162699649|NCT00383240|587610497|FG001|Overall Study|Adverse Event|6|||
162699650|NCT00383240|587610498|FG002|Overall Study|Adverse Event|9|||
162699651|NCT00383240|587610499|FG003|Overall Study|Adverse Event|7|||
162699652|NCT00383240|587610496|FG000|Overall Study|Treatment Failure|8|||
162699653|NCT00383240|587610497|FG001|Overall Study|Treatment Failure|13|||
162699654|NCT00383240|587610498|FG002|Overall Study|Treatment Failure|47|||
162699655|NCT00383240|587610499|FG003|Overall Study|Treatment Failure|46|||
162699656|NCT00383240|587610496|FG000|Overall Study|Lost to Follow-up|3|||
162699657|NCT00383240|587610497|FG001|Overall Study|Lost to Follow-up|0|||
162699658|NCT00383240|587610498|FG002|Overall Study|Lost to Follow-up|0|||
162699659|NCT00383240|587610499|FG003|Overall Study|Lost to Follow-up|2|||
162699660|NCT00383240|587610496|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
162699661|NCT00383240|587610497|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
162699662|NCT00383240|587610498|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
162699663|NCT00383240|587610499|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
162699664|NCT00383240|587610496|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
162699665|NCT00383240|587610497|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
162947635|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947636|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947637|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947638|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947639|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
162947640|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947641|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947642|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947643|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
162947644|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947645|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162947646|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947647|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162947648|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947649|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947650|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947651|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947652|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162947653|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
162947654|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
162947655|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947656|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
162947657|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
162947658|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947659|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
162947660|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
162947661|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
162947662|NCT05097989|588510309|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
162947663|NCT05097989|588510310|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
162947664|NCT05097989|588510311|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
162947665|NCT05097989|588510312|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
162947666|NCT05097989|588510313|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
162947667|NCT05097989|588510314|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
162947668|NCT05097989|588510315|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
162947669|NCT05097989|588510316|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
162947670|NCT05097989|588510317|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
162947671|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947672|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947673|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947674|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947675|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
162947676|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947677|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947678|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947679|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
162947680|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
162947681|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
162947682|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947683|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947684|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947685|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947686|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947687|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947688|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
162947689|NCT05097989|588510309|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
162947690|NCT05097989|588510310|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
162947691|NCT05097989|588510311|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
162947692|NCT05097989|588510312|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
162947693|NCT05097989|588510313|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
162947694|NCT05097989|588510314|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
162699666|NCT00383240|587610498|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
162699667|NCT00383240|587610499|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
162699668|NCT00383240|587610496|FG000|Overall Study|Protocol Violation|4|||
162834822|NCT01857869|588104704|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834823|NCT01857869|588104705|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834824|NCT01857869|588104706|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834825|NCT01857869|588104707|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834826|NCT01857869|588104708|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
162834827|NCT02728830|588104733|FG000|Overall Study|Exclusionary Surgery|9|||
162834828|NCT02728830|588104733|FG000|Overall Study|Exclusionary Pathology|6|||
162834829|NCT02728830|588104733|FG000|Overall Study|Physician Decision|3|||
162834830|NCT02728830|588104733|FG000|Overall Study|Withdrawal by Subject|2|||
162834831|NCT02728830|588104733|FG000|Overall Study|Lost to Follow-up|1|||
162834832|NCT02728830|588104733|FG000|Overall Study|Exclusionary Lab Values|1|||
162834833|NCT02728830|588104733|FG000|Overall Study|Contraindicated Illness|1|||
162834834|NCT02728830|588104733|FG000|Overall Study|Language Barrier|1|||
162834835|NCT01087905|588104734|FG000|Overall Study|Lost to Follow-up|24|||
162834836|NCT01087905|588104735|FG001|Overall Study|Lost to Follow-up|28|||
162834837|NCT01087905|588104736|FG002|Overall Study|Lost to Follow-up|18|||
162834838|NCT01087905|588104737|FG003|Overall Study|Lost to Follow-up|31|||
162834839|NCT01087905|588104738|FG004|Overall Study|Lost to Follow-up|27|||
162834840|NCT01087905|588104739|FG005|Overall Study|Lost to Follow-up|25|||
162834841|NCT01087905|588104740|FG006|Overall Study|Lost to Follow-up|20|||
162834842|NCT01087905|588104741|FG007|Overall Study|Lost to Follow-up|24|||
162834843|NCT01087905|588104734|FG000|Overall Study|Withdrawal by Subject|5|||
162834844|NCT01087905|588104735|FG001|Overall Study|Withdrawal by Subject|4|||
162834845|NCT01087905|588104736|FG002|Overall Study|Withdrawal by Subject|4|||
162834846|NCT01087905|588104737|FG003|Overall Study|Withdrawal by Subject|5|||
162834847|NCT01087905|588104738|FG004|Overall Study|Withdrawal by Subject|4|||
162834848|NCT01087905|588104739|FG005|Overall Study|Withdrawal by Subject|3|||
162834849|NCT01087905|588104740|FG006|Overall Study|Withdrawal by Subject|3|||
162834850|NCT01087905|588104741|FG007|Overall Study|Withdrawal by Subject|5|||
162834851|NCT00790907|588104742|FG000|Overall Study|Adverse Event|9|||
162834852|NCT00790907|588104743|FG001|Overall Study|Adverse Event|7|||
162834853|NCT00790907|588104744|FG002|Overall Study|Adverse Event|6|||
162834854|NCT00790907|588104742|FG000|Overall Study|Physician Decision|304|||
162834855|NCT00790907|588104743|FG001|Overall Study|Physician Decision|271|||
162834856|NCT00790907|588104744|FG002|Overall Study|Physician Decision|255|||
162834857|NCT00790907|588104742|FG000|Overall Study|Withdrawal by Subject|1|||
162834858|NCT00790907|588104743|FG001|Overall Study|Withdrawal by Subject|7|||
162834859|NCT00790907|588104744|FG002|Overall Study|Withdrawal by Subject|5|||
162834860|NCT00790907|588104742|FG000|Overall Study|Bleeding Event|11|||
162834861|NCT00790907|588104743|FG001|Overall Study|Bleeding Event|16|||
162834862|NCT00790907|588104744|FG002|Overall Study|Bleeding Event|21|||
162834863|NCT00790907|588104742|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
162834864|NCT00790907|588104743|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
162834865|NCT00790907|588104744|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
162834866|NCT00790907|588104742|FG000|Overall Study|Qualifying Condition Not Present|29|||
162834867|NCT00790907|588104743|FG001|Overall Study|Qualifying Condition Not Present|14|||
162834868|NCT00790907|588104744|FG002|Overall Study|Qualifying Condition Not Present|16|||
162834869|NCT00790907|588104742|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
162834870|NCT00790907|588104743|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
162834871|NCT00790907|588104744|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
162834872|NCT00790907|588104742|FG000|Overall Study|Did Not Receive Study Drug|10|||
162834873|NCT00790907|588104743|FG001|Overall Study|Did Not Receive Study Drug|0|||
162834874|NCT00790907|588104744|FG002|Overall Study|Did Not Receive Study Drug|0|||
162834875|NCT00774345|588104745|FG000|Pre-treatment|Other reasons|2|||
162834876|NCT00774345|588104746|FG001|Pre-treatment|Other reasons|0|||
162834877|NCT00774345|588104745|FG000|Treatment|Adverse Event|61|||
162834878|NCT00774345|588104746|FG001|Treatment|Adverse Event|15|||
162834879|NCT00774345|588104745|FG000|Treatment|Progressive Disease without histologic transformation|51|||
162834880|NCT00774345|588104746|FG001|Treatment|Progressive Disease without histologic transformation|111|||
162834881|NCT00774345|588104745|FG000|Treatment|Progressive Disease with histologic transformation|4|||
162834882|NCT00774345|588104746|FG001|Treatment|Progressive Disease with histologic transformation|2|||
162947695|NCT05097989|588510315|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
162947696|NCT05097989|588510316|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
162947697|NCT05097989|588510317|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
162947698|NCT00918567|588510326|FG000|Overall Study|Lack of Efficacy|3|||
162947699|NCT00918567|588510327|FG001|Overall Study|Lack of Efficacy|1|||
162947700|NCT00918567|588510326|FG000|Overall Study|Withdrawal by Subject|1|||
162947701|NCT00918567|588510327|FG001|Overall Study|Withdrawal by Subject|1|||
162947702|NCT00918567|588510326|FG000|Overall Study|Adverse Event|1|||
162947703|NCT00918567|588510327|FG001|Overall Study|Adverse Event|0|||
162947704|NCT05275998|588510330|FG000|Overall Study|Adverse Event|0|||
162947705|NCT05275998|588510331|FG001|Overall Study|Adverse Event|0|||
162947706|NCT05275998|588510332|FG002|Overall Study|Adverse Event|0|||
162947707|NCT05275998|588510333|FG003|Overall Study|Adverse Event|1|||
162947708|NCT05275998|588510330|FG000|Overall Study|Withdrawal by Subject|0|||
162947709|NCT05275998|588510331|FG001|Overall Study|Withdrawal by Subject|0|||
162947710|NCT05275998|588510332|FG002|Overall Study|Withdrawal by Subject|0|||
162947711|NCT05275998|588510333|FG003|Overall Study|Withdrawal by Subject|1|||
162947712|NCT05275998|588510330|FG000|Overall Study|Physician Decision|0|||
162947713|NCT05275998|588510331|FG001|Overall Study|Physician Decision|0|||
162947714|NCT05275998|588510332|FG002|Overall Study|Physician Decision|0|||
162947715|NCT05275998|588510333|FG003|Overall Study|Physician Decision|1|||
162947716|NCT05275998|588510330|FG000|Overall Study|Protocol Violation|0|||
162947717|NCT05275998|588510331|FG001|Overall Study|Protocol Violation|0|||
162947718|NCT05275998|588510332|FG002|Overall Study|Protocol Violation|1|||
162947719|NCT05275998|588510333|FG003|Overall Study|Protocol Violation|0|||
162947720|NCT01936948|588510334|FG000|Overall Study|no 30-day follow-up data|0|||
162947721|NCT01936948|588510335|FG001|Overall Study|no 30-day follow-up data|3|||
162947722|NCT01936948|588510336|FG002|Overall Study|no 30-day follow-up data|3|||
162947723|NCT01936948|588510337|FG003|Overall Study|no 30-day follow-up data|3|||
162947724|NCT02327130|588510341|FG000|Overall Study|Discharged in less than 5 days|5|||
162947725|NCT02327130|588510341|FG000|Overall Study|Physician Decision|2|||
162947726|NCT02327130|588510341|FG000|Overall Study|Unable to provide breath sample|1|||
162947727|NCT02327130|588510341|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
162947728|NCT02327130|588510341|FG000|Overall Study|Met exclusion criteria|3|||
162947729|NCT01451762|588511596|FG000|Overall Study|Lost to Follow-up|3|||
162947730|NCT01451762|588511597|FG001|Overall Study|Lost to Follow-up|6|||
162947731|NCT01451762|588511598|FG002|Overall Study|Lost to Follow-up|6|||
162947732|NCT04349917|588511606|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
162947733|NCT04349917|588511607|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
162947734|NCT04349917|588511606|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
162947735|NCT04349917|588511607|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
162947736|NCT00088829|588511620|FG000|Overall Study|PI left institution and study was close|22|||
162947737|NCT02532764|588511621|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947738|NCT02532764|588511622|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947739|NCT02532764|588511623|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947740|NCT02532764|588511624|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947741|NCT02532764|588511625|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947742|NCT02532764|588511626|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947743|NCT02532764|588511627|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
162947744|NCT02532764|588511628|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947745|NCT02532764|588511629|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947746|NCT02532764|588511630|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
162947747|NCT00525590|588511637|FG000|Overall Study|Adverse Event|3|||
162947748|NCT00525590|588511637|FG000|Overall Study|Physician Decision|3|||
162947749|NCT00525590|588511637|FG000|Overall Study|Withdrawal by Subject|16|||
162947750|NCT00525590|588511637|FG000|Overall Study|Lost to Follow-up|1|||
162947751|NCT00525590|588511637|FG000|Overall Study|Death|9|||
162947752|NCT00525590|588511637|FG000|Overall Study|Other|13|||
162947753|NCT03830164|588511642|FG000|Overall Study|Adverse Event|0|||
162947754|NCT03830164|588511643|FG001|Overall Study|Adverse Event|2|||
162947755|NCT03830164|588511644|FG002|Overall Study|Adverse Event|0|||
162947756|NCT03830164|588511642|FG000|Overall Study|Lack of Efficacy|1|||
162947757|NCT03830164|588511643|FG001|Overall Study|Lack of Efficacy|5|||
162947758|NCT03830164|588511644|FG002|Overall Study|Lack of Efficacy|0|||
162947759|NCT03830164|588511642|FG000|Overall Study|Lost to Follow-up|0|||
162947760|NCT03830164|588511643|FG001|Overall Study|Lost to Follow-up|1|||
162699669|NCT00383240|587610497|FG001|Overall Study|Protocol Violation|5|||
162699670|NCT00383240|587610498|FG002|Overall Study|Protocol Violation|9|||
162699671|NCT00383240|587610499|FG003|Overall Study|Protocol Violation|6|||
162699672|NCT00383240|587610496|FG000|Overall Study|Did not meet protocol eligibility|9|||
162699673|NCT00383240|587610497|FG001|Overall Study|Did not meet protocol eligibility|4|||
162699674|NCT00383240|587610498|FG002|Overall Study|Did not meet protocol eligibility|9|||
162699675|NCT00383240|587610499|FG003|Overall Study|Did not meet protocol eligibility|3|||
162699676|NCT00383240|587610496|FG000|Overall Study|Administrative|1|||
162699677|NCT00383240|587610497|FG001|Overall Study|Administrative|1|||
162699678|NCT00383240|587610498|FG002|Overall Study|Administrative|0|||
162699679|NCT00383240|587610499|FG003|Overall Study|Administrative|0|||
162699680|NCT02049710|587610500|FG000|Overall Study|Lost to Follow-up|319|||
162699681|NCT02049710|587610501|FG001|Overall Study|Lost to Follow-up|324|||
162699682|NCT00003458|587610502|FG000|Overall Study|Not evaluable|4|||
162699683|NCT06385483|587610506|FG000|Overall Study|Withdrawal by Subject|2|||
162699684|NCT06385483|587610506|FG000|Overall Study|Never start protocol therapy|2|||
162699685|NCT06385483|587610506|FG000|Overall Study|Disease progression|15|||
162699686|NCT01216293|587610507|FG000|Main Study|Adverse Event|1|||
162699687|NCT01216293|587610508|FG001|Main Study|Adverse Event|4|||
162699688|NCT01216293|587610509|FG002|Main Study|Adverse Event|2|||
162699689|NCT01216293|587610507|FG000|Main Study|Major Protocol Deviation|1|||
162699690|NCT01216293|587610508|FG001|Main Study|Major Protocol Deviation|0|||
162699691|NCT01216293|587610509|FG002|Main Study|Major Protocol Deviation|1|||
162699692|NCT01216293|587610507|FG000|Main Study|Lost to Follow-up|3|||
162699693|NCT01216293|587610508|FG001|Main Study|Lost to Follow-up|1|||
162699694|NCT01216293|587610509|FG002|Main Study|Lost to Follow-up|0|||
162699695|NCT01216293|587610507|FG000|Main Study|Voluntary Withdrawal|2|||
162699696|NCT01216293|587610508|FG001|Main Study|Voluntary Withdrawal|2|||
162699697|NCT01216293|587610509|FG002|Main Study|Voluntary Withdrawal|2|||
162699698|NCT01216293|587610507|FG000|Main Study|Other Reason Not Specified|0|||
162699699|NCT01216293|587610508|FG001|Main Study|Other Reason Not Specified|1|||
162699700|NCT01216293|587610509|FG002|Main Study|Other Reason Not Specified|1|||
162699701|NCT01216293|587610507|FG000|Main Study|Randomized, Not Treated|1|||
162699702|NCT01216293|587610508|FG001|Main Study|Randomized, Not Treated|0|||
162699703|NCT01216293|587610509|FG002|Main Study|Randomized, Not Treated|0|||
162699704|NCT01216293|587610507|FG000|Calcium Absorption Substudy|Adverse Event|0|||
162699705|NCT01216293|587610508|FG001|Calcium Absorption Substudy|Adverse Event|2|||
162699706|NCT01216293|587610509|FG002|Calcium Absorption Substudy|Adverse Event|0|||
162699707|NCT01216293|587610507|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
162699708|NCT01216293|587610508|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
162699709|NCT01216293|587610509|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
162699710|NCT01216293|587610507|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
162699711|NCT01216293|587610508|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
162699712|NCT01216293|587610509|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
162699713|NCT04714216|587612345|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
162699714|NCT04714216|587612345|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
162699715|NCT01349829|587612346|FG000|Overall Study|Lost to Follow-up|4|||
162699716|NCT01349829|587612347|FG001|Overall Study|Lost to Follow-up|8|||
162699717|NCT01349829|587612346|FG000|Overall Study|Consent withdrawal|3|||
162699718|NCT01349829|587612347|FG001|Overall Study|Consent withdrawal|8|||
162699719|NCT01349829|587612346|FG000|Overall Study|Migrated/moved|2|||
162699720|NCT01349829|587612347|FG001|Overall Study|Migrated/moved|7|||
162699721|NCT02555371|587612348|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
162699722|NCT02555371|587612349|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162699723|NCT02555371|587612350|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162699724|NCT02555371|587612351|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162699725|NCT02555371|587612352|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162699726|NCT02555371|587612348|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
162699727|NCT02555371|587612349|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162699728|NCT02555371|587612350|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162699729|NCT02555371|587612351|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162699730|NCT02555371|587612352|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162699731|NCT02555371|587612348|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
162699732|NCT02555371|587612349|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162699733|NCT02555371|587612350|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162699734|NCT02555371|587612351|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162834883|NCT00774345|588104745|FG000|Treatment|Withdrawal by Subject|5|||
162834884|NCT00774345|588104746|FG001|Treatment|Withdrawal by Subject|2|||
162834885|NCT00774345|588104745|FG000|Treatment|Lost to Follow-up|1|||
162834886|NCT00774345|588104746|FG001|Treatment|Lost to Follow-up|1|||
162834887|NCT00774345|588104745|FG000|Treatment|Death|4|||
162834888|NCT00774345|588104746|FG001|Treatment|Death|0|||
162834889|NCT00774345|588104745|FG000|Treatment|Other Reasons|32|||
162834890|NCT00774345|588104746|FG001|Treatment|Other Reasons|26|||
162834891|NCT02069899|588104747|FG000|Overall Study|Adverse Event|6|||
162834892|NCT02069899|588104748|FG001|Overall Study|Adverse Event|0|||
162834893|NCT02069899|588104749|FG002|Overall Study|Adverse Event|1|||
162834894|NCT02069899|588104747|FG000|Overall Study|Withdrawal by Participant|2|||
162834895|NCT02069899|588104748|FG001|Overall Study|Withdrawal by Participant|0|||
162834896|NCT02069899|588104749|FG002|Overall Study|Withdrawal by Participant|0|||
162834897|NCT02069899|588104747|FG000|Overall Study|Lost to Follow-up|1|||
162834898|NCT02069899|588104748|FG001|Overall Study|Lost to Follow-up|0|||
162834899|NCT02069899|588104749|FG002|Overall Study|Lost to Follow-up|1|||
162834900|NCT02069899|588104747|FG000|Overall Study|Other|4|||
162834901|NCT02069899|588104748|FG001|Overall Study|Other|0|||
162834902|NCT02069899|588104749|FG002|Overall Study|Other|0|||
162834903|NCT02069899|588104747|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
162834904|NCT02069899|588104748|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
162834905|NCT02069899|588104749|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
162834906|NCT02069899|588104747|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
162834907|NCT02069899|588104748|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
162834908|NCT02069899|588104749|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
162834909|NCT01119248|588104750|FG000|Overall Study|Physician Decision|5|||
162834910|NCT00550680|588104751|FG000|Overall Study|Administrative Reasons|1|||
162834911|NCT00550680|588104751|FG000|Overall Study|Adverse Event|5|||
162834912|NCT00550680|588104751|FG000|Overall Study|Death|3|||
162834913|NCT00550680|588104751|FG000|Overall Study|Early Improvement|1|||
162834914|NCT00550680|588104751|FG000|Overall Study|Lost to Follow-up|3|||
162834915|NCT00550680|588104751|FG000|Overall Study|Lack of Efficacy|1|||
162834916|NCT00550680|588104751|FG000|Overall Study|Other|10|||
162834917|NCT00550680|588104751|FG000|Overall Study|Protocol Violation|7|||
162834918|NCT00550680|588104751|FG000|Overall Study|Refused Treatment|19|||
162834919|NCT00550680|588104751|FG000|Overall Study|Screen Failure|6|||
162834920|NCT01967550|588104752|FG000|Overall Study|Withdrawal by Subject|1|||
162834921|NCT01967550|588104753|FG001|Overall Study|Withdrawal by Subject|0|||
162834922|NCT01967550|588104752|FG000|Overall Study|Adverse Event|2|||
162834923|NCT01967550|588104753|FG001|Overall Study|Adverse Event|0|||
162834924|NCT01967550|588104752|FG000|Overall Study|Protocol Violation|2|||
162834925|NCT01967550|588104753|FG001|Overall Study|Protocol Violation|1|||
162834926|NCT01967550|588104752|FG000|Overall Study|Non Compliance|0|||
162834927|NCT01967550|588104753|FG001|Overall Study|Non Compliance|1|||
162834928|NCT01273883|588104755|FG000|First Intervention|Adverse Event|2|||
162834929|NCT01273883|588104756|FG001|First Intervention|Adverse Event|1|||
162834930|NCT01273883|588104755|FG000|Second Intervention|Lost to Follow-up|1|||
162834931|NCT01273883|588104756|FG001|Second Intervention|Lost to Follow-up|1|||
162834932|NCT01273883|588104755|FG000|Second Intervention|Lack of Efficacy|1|||
162834933|NCT01273883|588104756|FG001|Second Intervention|Lack of Efficacy|0|||
162834934|NCT01553136|588104758|FG000|Overall Study|Adverse Event|3|||
162834935|NCT01553136|588104759|FG001|Overall Study|Adverse Event|2|||
162834936|NCT01553136|588104758|FG000|Overall Study|Withdrawal by Subject|2|||
162834937|NCT01553136|588104759|FG001|Overall Study|Withdrawal by Subject|3|||
162834938|NCT01553136|588104758|FG000|Overall Study|Lost to Follow-up|4|||
162834939|NCT01553136|588104759|FG001|Overall Study|Lost to Follow-up|10|||
162834940|NCT01553136|588104758|FG000|Overall Study|Physician Decision|2|||
162834941|NCT01553136|588104759|FG001|Overall Study|Physician Decision|3|||
162834942|NCT01553136|588104758|FG000|Overall Study|Scheduling Difficulties|5|||
162834943|NCT01553136|588104759|FG001|Overall Study|Scheduling Difficulties|4|||
162834944|NCT00333359|588104764|FG000|Overall Study|Adverse Event|29|||
162834945|NCT00333359|588104765|FG001|Overall Study|Adverse Event|35|||
162834946|NCT00333359|588104764|FG000|Overall Study|Withdrawal by Subject|19|||
162834947|NCT00333359|588104765|FG001|Overall Study|Withdrawal by Subject|37|||
162834948|NCT00333359|588104764|FG000|Overall Study|Physician Decision|2|||
162834949|NCT00333359|588104765|FG001|Overall Study|Physician Decision|2|||
162834950|NCT00333359|588104764|FG000|Overall Study|Protocol Non-compliance|2|||
162834951|NCT00333359|588104765|FG001|Overall Study|Protocol Non-compliance|8|||
162834952|NCT00333359|588104764|FG000|Overall Study|Lost to Follow-up|15|||
162834953|NCT00333359|588104765|FG001|Overall Study|Lost to Follow-up|25|||
162834954|NCT00333359|588104764|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
162834955|NCT00333359|588104765|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
162834956|NCT00333359|588104764|FG000|Overall Study|Treatment Failure|3|||
162834957|NCT00333359|588104765|FG001|Overall Study|Treatment Failure|8|||
162834958|NCT00333359|588104764|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
162834959|NCT00333359|588104765|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
162834960|NCT01452152|588104768|FG000|Overall Study|Study termination by sponsor|5|||
162947761|NCT03830164|588511644|FG002|Overall Study|Lost to Follow-up|0|||
162947762|NCT03830164|588511642|FG000|Overall Study|Withdrawal by Subject|1|||
162947763|NCT03830164|588511643|FG001|Overall Study|Withdrawal by Subject|0|||
162947764|NCT03830164|588511644|FG002|Overall Study|Withdrawal by Subject|0|||
162947765|NCT04099888|588511645|FG000|Overall Study|Study terminated by sponsor|9|||
162947766|NCT04099888|588511646|FG001|Overall Study|Study terminated by sponsor|11|||
162947767|NCT04099888|588511645|FG000|Overall Study|Lost to Follow-up|1|||
162947768|NCT04099888|588511646|FG001|Overall Study|Lost to Follow-up|1|||
162947769|NCT04099888|588511645|FG000|Overall Study|Withdrawal by Subject|5|||
162947770|NCT04099888|588511646|FG001|Overall Study|Withdrawal by Subject|6|||
162947771|NCT04099888|588511645|FG000|Overall Study|Death|5|||
162947772|NCT04099888|588511646|FG001|Overall Study|Death|2|||
162947773|NCT04099888|588511645|FG000|Overall Study|Other|1|||
162947774|NCT04099888|588511646|FG001|Overall Study|Other|0|||
162947775|NCT01273181|588511652|FG000|Phase I, Dose 1|Study termination|1|||
162947776|NCT01273181|588511653|FG001|Phase I, Dose 1|Study termination|0|||
162947777|NCT01273181|588511654|FG002|Phase I, Dose 1|Study termination|0|||
162947778|NCT01273181|588511655|FG003|Phase I, Dose 1|Study termination|0|||
162947779|NCT01273181|588511652|FG000|Phase I, Dose 2|Death during treatment|0|||
162947780|NCT01273181|588511653|FG001|Phase I, Dose 2|Death during treatment|1|||
162947781|NCT01273181|588511654|FG002|Phase I, Dose 2|Death during treatment|0|||
162947782|NCT01273181|588511655|FG003|Phase I, Dose 2|Death during treatment|0|||
162947783|NCT01273181|588511652|FG000|Phase 2, Dose 1|Study termination|0|||
162947784|NCT01273181|588511653|FG001|Phase 2, Dose 1|Study termination|0|||
162947785|NCT01273181|588511654|FG002|Phase 2, Dose 1|Study termination|1|||
162947786|NCT01273181|588511655|FG003|Phase 2, Dose 1|Study termination|0|||
162947787|NCT01273181|588511652|FG000|Phase 2, Dose 2|Death during treatment|0|||
162947788|NCT01273181|588511653|FG001|Phase 2, Dose 2|Death during treatment|0|||
162947789|NCT01273181|588511654|FG002|Phase 2, Dose 2|Death during treatment|0|||
162947790|NCT01273181|588511655|FG003|Phase 2, Dose 2|Death during treatment|1|||
162947791|NCT04276883|588511656|FG000|Overall Study|Withdrawal by Subject|2|||
162947792|NCT04276883|588511657|FG001|Overall Study|Withdrawal by Subject|3|||
162947793|NCT04276883|588511658|FG002|Overall Study|Withdrawal by Subject|6|||
162947794|NCT04276883|588511656|FG000|Overall Study|Lost to Follow-up|1|||
162947795|NCT04276883|588511657|FG001|Overall Study|Lost to Follow-up|3|||
162947796|NCT04276883|588511658|FG002|Overall Study|Lost to Follow-up|0|||
162947797|NCT04276883|588511656|FG000|Overall Study|Adverse Event|0|||
162947798|NCT04276883|588511657|FG001|Overall Study|Adverse Event|1|||
162947799|NCT04276883|588511658|FG002|Overall Study|Adverse Event|0|||
162947800|NCT04276883|588511656|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
162947801|NCT04276883|588511657|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
162947802|NCT04276883|588511658|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
162947803|NCT02458469|588511660|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947804|NCT02458469|588511661|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947805|NCT02458469|588511662|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
162947806|NCT02458469|588511663|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947807|NCT02458469|588511664|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947808|NCT02458469|588511665|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162947809|NCT02458469|588511660|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
162947810|NCT02458469|588511661|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
162947811|NCT02458469|588511662|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
162699735|NCT02555371|587612352|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162699736|NCT02555371|587612348|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
162947812|NCT02458469|588511663|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
162947813|NCT02458469|588511664|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
162947814|NCT02458469|588511665|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
162947815|NCT02458469|588511660|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947816|NCT02458469|588511661|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947817|NCT02458469|588511662|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947818|NCT02458469|588511663|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162947819|NCT02458469|588511664|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162834961|NCT01452152|588104769|FG001|Overall Study|Study termination by sponsor|0|||
162834962|NCT01452152|588104770|FG002|Overall Study|Study termination by sponsor|4|||
162834963|NCT04099251|588106874|FG000|Pre-Treatment|Other reasons|1|||
162834964|NCT04099251|588106875|FG001|Pre-Treatment|Other reasons|0|||
162834965|NCT04099251|588106874|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
162834966|NCT04099251|588106875|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
162834967|NCT04099251|588106874|FG000|Blinded Treatment Phase|Other reasons|16|||
162834968|NCT04099251|588106875|FG001|Blinded Treatment Phase|Other reasons|7|||
162834969|NCT04099251|588106874|FG000|Blinded Treatment Phase|Disease recurrence|26|||
162834970|NCT04099251|588106875|FG001|Blinded Treatment Phase|Disease recurrence|41|||
162834971|NCT04099251|588106874|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
162834972|NCT04099251|588106875|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
162834973|NCT04099251|588106874|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
162834974|NCT04099251|588106875|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
162834975|NCT04099251|588106874|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
162834976|NCT04099251|588106875|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
162834977|NCT04099251|588106874|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
162834978|NCT04099251|588106875|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
162834979|NCT04099251|588106874|FG000|Blinded Treatment Phase|Death|6|||
162834980|NCT04099251|588106875|FG001|Blinded Treatment Phase|Death|2|||
162834981|NCT04099251|588106874|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
162834982|NCT04099251|588106875|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
162924224|NCT00077766|588423834|FG001|Overall Study|Participant's decision|0|||
162699737|NCT02555371|587612349|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162699738|NCT02555371|587612350|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162699739|NCT02555371|587612351|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162699740|NCT02555371|587612352|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162699741|NCT02555371|587612348|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
162699742|NCT02555371|587612349|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162699743|NCT02555371|587612350|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162699744|NCT02555371|587612351|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162699745|NCT02555371|587612352|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162699746|NCT02555371|587612348|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162699747|NCT02555371|587612349|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
162699748|NCT02555371|587612350|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
162699749|NCT02555371|587612351|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162699750|NCT02555371|587612352|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162699751|NCT02555371|587612348|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162699752|NCT02555371|587612349|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
162699753|NCT02555371|587612350|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
162699754|NCT02555371|587612351|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162699755|NCT02555371|587612352|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162699756|NCT02555371|587612348|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162699757|NCT02555371|587612349|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
162699758|NCT02555371|587612350|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162699759|NCT02555371|587612351|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162699760|NCT02555371|587612352|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162699761|NCT02555371|587612348|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162699762|NCT02555371|587612349|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
162699763|NCT02555371|587612350|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
162699764|NCT02555371|587612351|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162699765|NCT02555371|587612352|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162699766|NCT02555371|587612348|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162699767|NCT02555371|587612349|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162699768|NCT02555371|587612350|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162699769|NCT02555371|587612351|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
162699770|NCT02555371|587612352|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162699771|NCT02555371|587612348|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162699772|NCT02555371|587612349|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162699773|NCT02555371|587612350|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162699774|NCT02555371|587612351|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
162699775|NCT02555371|587612352|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162699776|NCT02555371|587612348|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162699777|NCT02555371|587612349|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162699778|NCT02555371|587612350|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162699779|NCT02555371|587612351|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162699780|NCT02555371|587612352|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
162699781|NCT02555371|587612348|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162699782|NCT02555371|587612349|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162699783|NCT02555371|587612350|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162699784|NCT02555371|587612351|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162699785|NCT02555371|587612352|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
162699786|NCT02555371|587612348|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162699787|NCT02555371|587612349|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162699788|NCT02555371|587612350|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162699789|NCT02555371|587612351|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
162699790|NCT02555371|587612352|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162699791|NCT03095599|587612353|FG000|Overall Study|Withdrawal by Subject|1|||
162699792|NCT03095599|587612354|FG001|Overall Study|Withdrawal by Subject|0|||
162699793|NCT03095599|587612353|FG000|Overall Study|Lost to Follow-up|1|||
162699794|NCT03095599|587612354|FG001|Overall Study|Lost to Follow-up|0|||
162699795|NCT03095599|587612353|FG000|Overall Study|Withdrawal prior to vaccination|1|||
162699796|NCT03095599|587612354|FG001|Overall Study|Withdrawal prior to vaccination|0|||
162699797|NCT00742885|587612355|FG000|Overall Study|Lost to Follow-up|1|||
162699798|NCT00742885|587612356|FG001|Overall Study|Lost to Follow-up|0|||
162699799|NCT03615482|587612359|FG000|Overall Study|Death|1|||
162699800|NCT03615482|587612360|FG001|Overall Study|Death|0|||
162699801|NCT03615482|587612359|FG000|Overall Study|Lost to Follow-up|7|||
162699802|NCT03615482|587612360|FG001|Overall Study|Lost to Follow-up|7|||
162699803|NCT03615482|587612359|FG000|Overall Study|Physician Decision|2|||
162947820|NCT02458469|588511665|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
162947821|NCT02603952|588511670|FG000|Overall Study|Withdrawal by Subject|1|||
162947822|NCT02603952|588511671|FG001|Overall Study|Withdrawal by Subject|0|||
162947823|NCT02603952|588511672|FG002|Overall Study|Withdrawal by Subject|0|||
162947824|NCT02603952|588511673|FG003|Overall Study|Withdrawal by Subject|0|||
162947825|NCT02603952|588511670|FG000|Overall Study|Received oseltamivir by error|0|||
162947826|NCT02603952|588511671|FG001|Overall Study|Received oseltamivir by error|0|||
162947827|NCT02603952|588511672|FG002|Overall Study|Received oseltamivir by error|0|||
162947828|NCT02603952|588511673|FG003|Overall Study|Received oseltamivir by error|1|||
162947829|NCT00958243|588511681|FG000|Overall Study|Withdrawal by Subject|0|||
162834983|NCT04099251|588106874|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
162834984|NCT04099251|588106875|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
162834985|NCT04099251|588106874|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
162834986|NCT04099251|588106875|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
162834987|NCT04099251|588106874|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
162834988|NCT04099251|588106875|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
162834989|NCT04099251|588106874|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
162834990|NCT04099251|588106875|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
162834991|NCT04099251|588106874|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
162834992|NCT04099251|588106875|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
162834993|NCT04099251|588106874|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
162834994|NCT04099251|588106875|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
162834995|NCT04099251|588106874|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
162834996|NCT04099251|588106875|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
162834997|NCT04099251|588106874|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
162834998|NCT04099251|588106875|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
162834999|NCT04311502|588106876|FG000|Overall Study|Death|1|||
162835000|NCT04311502|588106877|FG001|Overall Study|Death|1|||
162835001|NCT04311502|588106878|FG002|Overall Study|Death|1|||
162835002|NCT04311502|588106876|FG000|Overall Study|Lost to Follow-up|2|||
162835003|NCT04311502|588106877|FG001|Overall Study|Lost to Follow-up|3|||
162835004|NCT04311502|588106878|FG002|Overall Study|Lost to Follow-up|0|||
162835005|NCT04311502|588106876|FG000|Overall Study|Participant is in prison|1|||
162835006|NCT04311502|588106877|FG001|Overall Study|Participant is in prison|0|||
162835007|NCT04311502|588106878|FG002|Overall Study|Participant is in prison|0|||
162947830|NCT00958243|588511682|FG001|Overall Study|Withdrawal by Subject|1|||
162699804|NCT03615482|587612360|FG001|Overall Study|Physician Decision|3|||
162947831|NCT00958243|588511683|FG002|Overall Study|Withdrawal by Subject|3|||
162947832|NCT00958243|588511684|FG003|Overall Study|Withdrawal by Subject|1|||
162947833|NCT00958243|588511685|FG004|Overall Study|Withdrawal by Subject|1|||
162947834|NCT00958243|588511686|FG005|Overall Study|Withdrawal by Subject|5|||
162947835|NCT00958243|588511681|FG000|Overall Study|Lost to Follow-up|2|||
162947836|NCT00958243|588511682|FG001|Overall Study|Lost to Follow-up|5|||
162947837|NCT00958243|588511683|FG002|Overall Study|Lost to Follow-up|11|||
162947838|NCT00958243|588511684|FG003|Overall Study|Lost to Follow-up|2|||
162947839|NCT00958243|588511685|FG004|Overall Study|Lost to Follow-up|8|||
162947840|NCT00958243|588511686|FG005|Overall Study|Lost to Follow-up|5|||
162947841|NCT03283709|588511694|FG000|Overall Study|trial terminated|0|||
162947842|NCT03283709|588511695|FG001|Overall Study|trial terminated|1|||
162947843|NCT01347710|588511699|FG000|Overall Study|Withdrawal by Subject|2|||
162947844|NCT01347710|588511699|FG000|Overall Study|Adverse Event|4|||
162947845|NCT01347710|588511699|FG000|Overall Study|Angio or SPECT not completed|18|||
162947846|NCT01347710|588511699|FG000|Overall Study|issue with vitals prior to dosing|1|||
162947847|NCT01347710|588511699|FG000|Overall Study|Lost to Follow-up|1|||
162947848|NCT01347710|588511699|FG000|Overall Study|Physician Decision|2|||
162947849|NCT01347710|588511699|FG000|Overall Study|Other|3|||
162947850|NCT04591626|588511701|FG000|Overall Study|Adverse Event|4|||
162947851|NCT04591626|588511702|FG001|Overall Study|Adverse Event|0|||
162947852|NCT04591626|588511701|FG000|Overall Study|Withdrawal by Subject|5|||
162947853|NCT04591626|588511702|FG001|Overall Study|Withdrawal by Subject|3|||
162947854|NCT04591626|588511701|FG000|Overall Study|Physician Decision|0|||
162947855|NCT04591626|588511702|FG001|Overall Study|Physician Decision|1|||
162947856|NCT04591626|588511701|FG000|Overall Study|Death|0|||
162947857|NCT04591626|588511702|FG001|Overall Study|Death|1|||
162947858|NCT04591626|588511701|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162947859|NCT04591626|588511702|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162947860|NCT02003183|588511705|FG000|Overall Study|Lost to Follow-up|0|||
162947861|NCT02003183|588511706|FG001|Overall Study|Lost to Follow-up|2|||
162947862|NCT00841100|588511711|FG000|Phase 1 (28 Days)|Adverse Event|1|||
162947863|NCT00841100|588511711|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
162947864|NCT03338972|588511712|FG000|Overall Study|Death|1|||
162947865|NCT03338972|588511713|FG001|Overall Study|Death|1|||
162947866|NCT03338972|588511714|FG002|Overall Study|Death|0|||
162947867|NCT03338972|588511715|FG003|Overall Study|Death|0|||
162947868|NCT03338972|588511712|FG000|Overall Study|Withdrawal by Subject|1|||
162947869|NCT03338972|588511713|FG001|Overall Study|Withdrawal by Subject|0|||
162947870|NCT03338972|588511714|FG002|Overall Study|Withdrawal by Subject|0|||
162947871|NCT03338972|588511715|FG003|Overall Study|Withdrawal by Subject|0|||
162947872|NCT01355081|588511716|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
162947873|NCT01355081|588511717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
162947874|NCT01355081|588511718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
162947875|NCT01355081|588511716|FG000|Overall Study|Major Protocol Deviation|0|||
162947876|NCT01355081|588511717|FG001|Overall Study|Major Protocol Deviation|1|||
162947877|NCT01355081|588511718|FG002|Overall Study|Major Protocol Deviation|0|||
162947878|NCT01355081|588511716|FG000|Overall Study|Lost to Follow-up|0|||
162947879|NCT01355081|588511717|FG001|Overall Study|Lost to Follow-up|0|||
162947880|NCT01355081|588511718|FG002|Overall Study|Lost to Follow-up|1|||
162947881|NCT01355081|588511716|FG000|Overall Study|Withdrawal of Consent|2|||
162947882|NCT01355081|588511717|FG001|Overall Study|Withdrawal of Consent|3|||
162947883|NCT01355081|588511718|FG002|Overall Study|Withdrawal of Consent|3|||
162947884|NCT01355081|588511716|FG000|Overall Study|Lack of Efficacy|2|||
162947885|NCT01355081|588511717|FG001|Overall Study|Lack of Efficacy|1|||
162947886|NCT01355081|588511718|FG002|Overall Study|Lack of Efficacy|1|||
162947887|NCT01355081|588511716|FG000|Overall Study|Non Compliance with Study Medication|0|||
162947888|NCT01355081|588511717|FG001|Overall Study|Non Compliance with Study Medication|1|||
162947889|NCT01355081|588511718|FG002|Overall Study|Non Compliance with Study Medication|0|||
162947890|NCT02719522|588511721|FG000|Overall Study|Implant Failure|4|||
162947891|NCT02719522|588511721|FG000|Overall Study|Death|2|||
162947892|NCT02719522|588511721|FG000|Overall Study|Lost to Follow-up|5|||
162947893|NCT06096168|588511722|FG000|Overall Study|Death|30|||
162947894|NCT06096168|588511722|FG000|Overall Study|Revision|2|||
162947895|NCT01868009|588511723|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
162947896|NCT01868009|588511724|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
162947897|NCT01868009|588511723|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
162947898|NCT01868009|588511724|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
162947899|NCT01868009|588511723|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
162947900|NCT01868009|588511724|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
162947901|NCT04603937|588511725|FG000|Overall Study|Adverse Event|9|||
162947902|NCT04603937|588511726|FG001|Overall Study|Adverse Event|10|||
162947903|NCT04603937|588511725|FG000|Overall Study|Withdrawal by Subject|7|||
162947904|NCT04603937|588511726|FG001|Overall Study|Withdrawal by Subject|6|||
162947905|NCT04603937|588511725|FG000|Overall Study|Lost to Follow-up|5|||
162947906|NCT04603937|588511726|FG001|Overall Study|Lost to Follow-up|6|||
162947907|NCT04603937|588511725|FG000|Overall Study|Physician Decision|0|||
162947908|NCT04603937|588511726|FG001|Overall Study|Physician Decision|1|||
162835008|NCT04311502|588106876|FG000|Overall Study|Participant moved out of country|1|||
162835009|NCT04311502|588106877|FG001|Overall Study|Participant moved out of country|0|||
162835010|NCT04311502|588106878|FG002|Overall Study|Participant moved out of country|0|||
162835011|NCT04311502|588106876|FG000|Overall Study|Withdrawal by Subject|2|||
162835012|NCT04311502|588106877|FG001|Overall Study|Withdrawal by Subject|0|||
162835013|NCT04311502|588106878|FG002|Overall Study|Withdrawal by Subject|0|||
162835014|NCT04311502|588106876|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
162835015|NCT04311502|588106877|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
162835016|NCT04311502|588106878|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
162835017|NCT05032157|588106885|FG000|Overall Study|Adverse Event|12|||
162835018|NCT05032157|588106886|FG001|Overall Study|Adverse Event|7|||
162835019|NCT05032157|588106885|FG000|Overall Study|Pregnancy|0|||
162835020|NCT05032157|588106886|FG001|Overall Study|Pregnancy|2|||
162835021|NCT05032157|588106885|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162835022|NCT05032157|588106886|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
162835023|NCT05032157|588106885|FG000|Overall Study|Protocol Deviation|8|||
162835024|NCT05032157|588106886|FG001|Overall Study|Protocol Deviation|4|||
162835025|NCT05032157|588106885|FG000|Overall Study|Lost to Follow-up|1|||
162835026|NCT05032157|588106886|FG001|Overall Study|Lost to Follow-up|3|||
162835027|NCT05032157|588106885|FG000|Overall Study|Physician Decision|7|||
162835028|NCT05032157|588106886|FG001|Overall Study|Physician Decision|2|||
162835029|NCT05032157|588106885|FG000|Overall Study|Patient Decision|38|||
162835030|NCT05032157|588106886|FG001|Overall Study|Patient Decision|19|||
162835031|NCT03451773|588106887|FG000|Overall Study|Death on study|1|||
162835032|NCT03451773|588106888|FG001|Overall Study|Death on study|5|||
162835033|NCT03451773|588106887|FG000|Overall Study|Death during follow-up period|0|||
162835034|NCT03451773|588106888|FG001|Overall Study|Death during follow-up period|1|||
162835035|NCT02627495|588106889|FG000|Overall Study|Withdrawal by Subject|4|||
162835036|NCT02543528|588106890|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
162835037|NCT02543528|588106891|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
162835038|NCT02543528|588106892|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
162835039|NCT02543528|588106893|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
162835040|NCT02543528|588106894|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
162835041|NCT02543528|588106890|FG000|Adaptation Period|Lens Handling Difficultes|0|||
162835042|NCT02543528|588106891|FG001|Adaptation Period|Lens Handling Difficultes|0|||
162835043|NCT02543528|588106892|FG002|Adaptation Period|Lens Handling Difficultes|0|||
162835044|NCT02543528|588106893|FG003|Adaptation Period|Lens Handling Difficultes|0|||
162835045|NCT02543528|588106894|FG004|Adaptation Period|Lens Handling Difficultes|8|||
162835046|NCT02543528|588106890|FG000|Adaptation Period|Lost to Follow-up|0|||
162835047|NCT02543528|588106891|FG001|Adaptation Period|Lost to Follow-up|0|||
162835048|NCT02543528|588106892|FG002|Adaptation Period|Lost to Follow-up|0|||
162835049|NCT02543528|588106893|FG003|Adaptation Period|Lost to Follow-up|0|||
162835050|NCT02543528|588106894|FG004|Adaptation Period|Lost to Follow-up|14|||
162835051|NCT02543528|588106890|FG000|Adaptation Period|Adverse Event|0|||
162835052|NCT02543528|588106891|FG001|Adaptation Period|Adverse Event|0|||
162835053|NCT02543528|588106892|FG002|Adaptation Period|Adverse Event|0|||
162835054|NCT02543528|588106893|FG003|Adaptation Period|Adverse Event|0|||
162835055|NCT02543528|588106894|FG004|Adaptation Period|Adverse Event|2|||
162835056|NCT02543528|588106890|FG000|Extended Wear Period|Adverse Event|17|||
162835057|NCT02543528|588106891|FG001|Extended Wear Period|Adverse Event|11|||
162835058|NCT02543528|588106892|FG002|Extended Wear Period|Adverse Event|16|||
162835059|NCT02543528|588106893|FG003|Extended Wear Period|Adverse Event|3|||
162835060|NCT02543528|588106894|FG004|Extended Wear Period|Adverse Event|0|||
162835061|NCT02543528|588106890|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
162835062|NCT02543528|588106891|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
162835063|NCT02543528|588106892|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
162835064|NCT02543528|588106893|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
162835065|NCT02543528|588106894|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
162835066|NCT02543528|588106890|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
162947909|NCT04603937|588511725|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
162947910|NCT04603937|588511726|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
162947911|NCT02585258|588511727|FG000|Overall Study|Adverse Event|28|||
162947912|NCT02585258|588511728|FG001|Overall Study|Adverse Event|29|||
162835067|NCT02543528|588106891|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
162835068|NCT02543528|588106892|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
162835069|NCT02543528|588106893|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
162835070|NCT02543528|588106894|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
162835071|NCT02543528|588106890|FG000|Extended Wear Period|Lost to Follow-up|0|||
162835072|NCT02543528|588106891|FG001|Extended Wear Period|Lost to Follow-up|1|||
162835073|NCT02543528|588106892|FG002|Extended Wear Period|Lost to Follow-up|2|||
162835074|NCT02543528|588106893|FG003|Extended Wear Period|Lost to Follow-up|1|||
162835075|NCT02543528|588106894|FG004|Extended Wear Period|Lost to Follow-up|0|||
162835076|NCT02543528|588106890|FG000|Extended Wear Period|Withdrawal by Subject|10|||
162835077|NCT02543528|588106891|FG001|Extended Wear Period|Withdrawal by Subject|9|||
162835078|NCT02543528|588106892|FG002|Extended Wear Period|Withdrawal by Subject|4|||
162835079|NCT02543528|588106893|FG003|Extended Wear Period|Withdrawal by Subject|5|||
162835080|NCT02543528|588106894|FG004|Extended Wear Period|Withdrawal by Subject|0|||
162835081|NCT02049944|588106895|FG000|Overall Study|Protocol Violation|2|||
162835082|NCT01339559|588106897|FG000|Overall Study|Adverse Event|92|||
162835083|NCT01339559|588106897|FG000|Overall Study|Death|5|||
162835084|NCT01339559|588106897|FG000|Overall Study|Lack of Efficacy|164|||
162835085|NCT01339559|588106897|FG000|Overall Study|Lost to Follow-up|22|||
162835086|NCT01339559|588106897|FG000|Overall Study|Subject choice|89|||
162835087|NCT01339559|588106897|FG000|Overall Study|Protocol Violation|15|||
162835088|NCT01339559|588106897|FG000|Overall Study|Study closure at site|1|||
162835089|NCT01339559|588106897|FG000|Overall Study|Incarcerated|2|||
162835090|NCT01339559|588106897|FG000|Overall Study|Epilepsy surgery|1|||
162835091|NCT01339559|588106897|FG000|Overall Study|Pregnancy planned|2|||
162835092|NCT01339559|588106897|FG000|Overall Study|Left the country|1|||
162835093|NCT01339559|588106897|FG000|Overall Study|Investigator decision|2|||
162835094|NCT01339559|588106897|FG000|Overall Study|Patient didn't wish to continue|1|||
162835095|NCT01339559|588106897|FG000|Overall Study|PI decision|1|||
162835096|NCT00971945|588106898|FG000|Overall Study|Progressive Disease|3|||
162835097|NCT00971945|588106898|FG000|Overall Study|Change in treatment policy|1|||
162835098|NCT00971945|588106898|FG000|Overall Study|Other reasons|2|||
162835099|NCT03691974|588106899|FG000|Overall Study|Physician Decision|1|||
162835100|NCT03691974|588106900|FG001|Overall Study|Physician Decision|0|||
162835101|NCT03691974|588106899|FG000|Overall Study|Adverse Event|1|||
162835102|NCT03691974|588106900|FG001|Overall Study|Adverse Event|0|||
162835103|NCT03691974|588106899|FG000|Overall Study|Withdrawal by Subject|11|||
162835104|NCT03691974|588106900|FG001|Overall Study|Withdrawal by Subject|9|||
162835105|NCT03691974|588106899|FG000|Overall Study|Protocol Violation|1|||
162835106|NCT03691974|588106900|FG001|Overall Study|Protocol Violation|0|||
162835107|NCT03691974|588106899|FG000|Overall Study|Lost to Follow-up|8|||
162835108|NCT03691974|588106900|FG001|Overall Study|Lost to Follow-up|7|||
162835109|NCT00746252|588106904|FG000|Overall Study|weight gain >7.5 %|1|||
162835110|NCT00746252|588106905|FG001|Overall Study|weight gain >7.5 %|2|||
162835111|NCT01049035|588106906|FG000|Overall Study|Serious adverse event|0|||
162835112|NCT01049035|588106907|FG001|Overall Study|Serious adverse event|1|||
162835113|NCT01049035|588106908|FG002|Overall Study|Serious adverse event|1|||
162835114|NCT01049035|588106909|FG003|Overall Study|Serious adverse event|2|||
162835115|NCT01049035|588106910|FG004|Overall Study|Serious adverse event|0|||
162835116|NCT01049035|588106911|FG005|Overall Study|Serious adverse event|0|||
162835117|NCT01049035|588106912|FG006|Overall Study|Serious adverse event|0|||
162835118|NCT01049035|588106906|FG000|Overall Study|Other adverse event (AE)|0|||
162835119|NCT01049035|588106907|FG001|Overall Study|Other adverse event (AE)|0|||
162835120|NCT01049035|588106908|FG002|Overall Study|Other adverse event (AE)|0|||
162835121|NCT01049035|588106909|FG003|Overall Study|Other adverse event (AE)|1|||
162835122|NCT01049035|588106910|FG004|Overall Study|Other adverse event (AE)|0|||
162835123|NCT01049035|588106911|FG005|Overall Study|Other adverse event (AE)|0|||
162835124|NCT01049035|588106912|FG006|Overall Study|Other adverse event (AE)|0|||
162835125|NCT01049035|588106906|FG000|Overall Study|Non-compliance with the protocol|12|||
162835126|NCT01049035|588106907|FG001|Overall Study|Non-compliance with the protocol|6|||
162835127|NCT01049035|588106908|FG002|Overall Study|Non-compliance with the protocol|14|||
162835128|NCT01049035|588106909|FG003|Overall Study|Non-compliance with the protocol|5|||
162835129|NCT01049035|588106910|FG004|Overall Study|Non-compliance with the protocol|3|||
162835130|NCT01049035|588106911|FG005|Overall Study|Non-compliance with the protocol|4|||
162835131|NCT01049035|588106912|FG006|Overall Study|Non-compliance with the protocol|10|||
162835132|NCT01049035|588106906|FG000|Overall Study|Lost to Follow-up|5|||
162835133|NCT01049035|588106907|FG001|Overall Study|Lost to Follow-up|4|||
162835134|NCT01049035|588106908|FG002|Overall Study|Lost to Follow-up|4|||
162835135|NCT01049035|588106909|FG003|Overall Study|Lost to Follow-up|1|||
162835136|NCT01049035|588106910|FG004|Overall Study|Lost to Follow-up|0|||
162835137|NCT01049035|588106911|FG005|Overall Study|Lost to Follow-up|3|||
162835138|NCT01049035|588106912|FG006|Overall Study|Lost to Follow-up|3|||
162835139|NCT01049035|588106906|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
162947913|NCT02585258|588511727|FG000|Overall Study|Death|3|||
162947914|NCT02585258|588511728|FG001|Overall Study|Death|2|||
162835140|NCT01049035|588106907|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
162835141|NCT01049035|588106908|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
162835142|NCT01049035|588106909|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
162835143|NCT01049035|588106910|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
162835144|NCT01049035|588106911|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
162835145|NCT01049035|588106912|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
162835146|NCT01137773|588106913|FG000|Overall Study|Death|3|||
162835147|NCT01137773|588106914|FG001|Overall Study|Death|3|||
162835148|NCT01137773|588106913|FG000|Overall Study|Lost to Follow-up|6|||
162947915|NCT02585258|588511727|FG000|Overall Study|Lack of Efficacy|7|||
162835149|NCT01137773|588106914|FG001|Overall Study|Lost to Follow-up|0|||
162835150|NCT03548051|588106916|FG000|Overall Study|Death|1|||
162835151|NCT03548051|588106917|FG001|Overall Study|Death|1|||
162835152|NCT03548051|588106916|FG000|Overall Study|Withdrawal by Subject|1|||
162835153|NCT03548051|588106917|FG001|Overall Study|Withdrawal by Subject|0|||
162835154|NCT00082888|588106918|FG000|Overall Study|Ineligible|1|||
162835155|NCT00082888|588106919|FG001|Overall Study|Ineligible|0|||
162835156|NCT00082888|588106920|FG002|Overall Study|Ineligible|0|||
162835157|NCT00817531|588106922|FG000|Overall Study|Adverse Event|1|||
162835158|NCT00817531|588106922|FG000|Overall Study|Lack of Efficacy|1|||
162835159|NCT00812214|588106923|FG000|Overall Study|Lost to Follow-up|3|||
162835160|NCT00812214|588106924|FG001|Overall Study|Lost to Follow-up|1|||
162835161|NCT03325673|588106927|FG000|Overall Study|Adverse Event|4|||
162835162|NCT03325673|588106928|FG001|Overall Study|Adverse Event|0|||
162835163|NCT02684981|588106929|FG000|Overall Study|Permanently discontinued the treatment|157|||
162835164|NCT02684981|588106930|FG001|Overall Study|Permanently discontinued the treatment|161|||
162835165|NCT02684981|588106931|FG002|Overall Study|Permanently discontinued the treatment|110|||
162835166|NCT02684981|588106929|FG000|Overall Study|Other|83|||
162835167|NCT02684981|588106930|FG001|Overall Study|Other|49|||
162835168|NCT02684981|588106931|FG002|Overall Study|Other|17|||
162835169|NCT00820898|588106934|FG000|Overall Study|Inelgible - wrong primary site|1|||
162835170|NCT00452699|588106937|FG000|Overall Study|Adverse Event|10|||
162835171|NCT00452699|588106938|FG001|Overall Study|Adverse Event|3|||
162835172|NCT00452699|588106937|FG000|Overall Study|Lack of Efficacy|6|||
162835173|NCT00452699|588106938|FG001|Overall Study|Lack of Efficacy|4|||
162835174|NCT00452699|588106937|FG000|Overall Study|Lost to Follow-up|6|||
162947916|NCT02585258|588511728|FG001|Overall Study|Lack of Efficacy|9|||
162947917|NCT02585258|588511727|FG000|Overall Study|includes covid-related access problems|42|||
162947918|NCT02585258|588511728|FG001|Overall Study|includes covid-related access problems|46|||
162947919|NCT02585258|588511727|FG000|Overall Study|Lost to Follow-up|5|||
162947920|NCT02585258|588511728|FG001|Overall Study|Lost to Follow-up|2|||
162947921|NCT05125952|588511729|FG000|Overall Study|Physician Decision|1|||
162947922|NCT03946449|588511730|FG000|Treatment Extension II|Rolled over to another study|0|||
162947923|NCT03946449|588511731|FG001|Treatment Extension II|Rolled over to another study|0|||
162947924|NCT03946449|588511732|FG002|Treatment Extension II|Rolled over to another study|2|||
162947925|NCT03946449|588511730|FG000|Treatment Extension II|Withdrawal by Subject|0|||
162947926|NCT03946449|588511731|FG001|Treatment Extension II|Withdrawal by Subject|0|||
162947927|NCT03946449|588511732|FG002|Treatment Extension II|Withdrawal by Subject|1|||
162947928|NCT02848326|588513104|FG000|Treatment Period|Adverse Event|5|||
162947929|NCT02848326|588513105|FG001|Treatment Period|Adverse Event|4|||
162947930|NCT02848326|588513106|FG002|Treatment Period|Adverse Event|11|||
162947931|NCT02848326|588513107|FG003|Treatment Period|Adverse Event|6|||
162947932|NCT02848326|588513108|FG004|Treatment Period|Adverse Event|5|||
162947933|NCT02848326|588513109|FG005|Treatment Period|Adverse Event|7|||
162947934|NCT02848326|588513104|FG000|Treatment Period|Withdrawal of Consent|20|||
162947935|NCT02848326|588513105|FG001|Treatment Period|Withdrawal of Consent|6|||
162947936|NCT02848326|588513106|FG002|Treatment Period|Withdrawal of Consent|9|||
162947937|NCT02848326|588513107|FG003|Treatment Period|Withdrawal of Consent|6|||
162947938|NCT02848326|588513108|FG004|Treatment Period|Withdrawal of Consent|9|||
162947939|NCT02848326|588513109|FG005|Treatment Period|Withdrawal of Consent|6|||
162947940|NCT02848326|588513104|FG000|Treatment Period|Lost to Follow-up|5|||
162835175|NCT00452699|588106938|FG001|Overall Study|Lost to Follow-up|9|||
162835176|NCT00452699|588106937|FG000|Overall Study|Protocol Violation|21|||
162947941|NCT02848326|588513105|FG001|Treatment Period|Lost to Follow-up|1|||
162835177|NCT00452699|588106938|FG001|Overall Study|Protocol Violation|25|||
162835178|NCT00452699|588106937|FG000|Overall Study|Withdrawal by Subject|26|||
162835179|NCT00452699|588106938|FG001|Overall Study|Withdrawal by Subject|25|||
162947942|NCT02848326|588513106|FG002|Treatment Period|Lost to Follow-up|11|||
162947943|NCT02848326|588513107|FG003|Treatment Period|Lost to Follow-up|7|||
162947944|NCT02848326|588513108|FG004|Treatment Period|Lost to Follow-up|2|||
162835180|NCT00452699|588106937|FG000|Overall Study|Other|12|||
162835181|NCT00452699|588106938|FG001|Overall Study|Other|7|||
162835182|NCT00326898|588106941|FG000|Overall Study|Disease progression|52|||
162835183|NCT00326898|588106942|FG001|Overall Study|Disease progression|54|||
162947945|NCT02848326|588513109|FG005|Treatment Period|Lost to Follow-up|3|||
162947946|NCT02848326|588513104|FG000|Treatment Period|Pregnancy|0|||
162835184|NCT00326898|588106943|FG002|Overall Study|Disease progression|102|||
162835185|NCT00326898|588106941|FG000|Overall Study|Adverse Event|124|||
162835186|NCT00326898|588106942|FG001|Overall Study|Adverse Event|128|||
162947947|NCT02848326|588513105|FG001|Treatment Period|Pregnancy|0|||
162947948|NCT02848326|588513106|FG002|Treatment Period|Pregnancy|1|||
162947949|NCT02848326|588513107|FG003|Treatment Period|Pregnancy|1|||
162835187|NCT00326898|588106943|FG002|Overall Study|Adverse Event|33|||
162835188|NCT00326898|588106941|FG000|Overall Study|Death|2|||
162835189|NCT00326898|588106942|FG001|Overall Study|Death|0|||
162835190|NCT00326898|588106943|FG002|Overall Study|Death|0|||
162835191|NCT00326898|588106941|FG000|Overall Study|Withdrawal by Subject|134|||
162835192|NCT00326898|588106942|FG001|Overall Study|Withdrawal by Subject|128|||
162835193|NCT00326898|588106943|FG002|Overall Study|Withdrawal by Subject|32|||
162835194|NCT00326898|588106941|FG000|Overall Study|Alternative therapy|1|||
162835195|NCT00326898|588106942|FG001|Overall Study|Alternative therapy|0|||
162835196|NCT00326898|588106943|FG002|Overall Study|Alternative therapy|0|||
162835197|NCT00326898|588106941|FG000|Overall Study|Other complicating disease|5|||
162835198|NCT00326898|588106942|FG001|Overall Study|Other complicating disease|5|||
162835199|NCT00326898|588106943|FG002|Overall Study|Other complicating disease|4|||
162835200|NCT00326898|588106941|FG000|Overall Study|Other/Missing/Unknown|33|||
162835201|NCT00326898|588106942|FG001|Overall Study|Other/Missing/Unknown|28|||
162835202|NCT00326898|588106943|FG002|Overall Study|Other/Missing/Unknown|32|||
162835203|NCT03847987|588106944|FG000|Overall Study|Lost to Follow-up|1|||
162835204|NCT03847987|588106945|FG001|Overall Study|Lost to Follow-up|0|||
162835205|NCT03847987|588106944|FG000|Overall Study|Adverse Event|2|||
162835206|NCT03847987|588106945|FG001|Overall Study|Adverse Event|0|||
162835207|NCT01709149|588106951|FG000|Open-label Lead-in Phase|Adverse Event|109|||
162835208|NCT01709149|588106952|FG001|Open-label Lead-in Phase|Adverse Event|0|||
162835209|NCT01709149|588106953|FG002|Open-label Lead-in Phase|Adverse Event|0|||
162835210|NCT01709149|588106951|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
162835211|NCT01709149|588106952|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
162835212|NCT01709149|588106953|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
162835213|NCT01709149|588106951|FG000|Open-label Lead-in Phase|Death|1|||
162835214|NCT01709149|588106952|FG001|Open-label Lead-in Phase|Death|0|||
162835215|NCT01709149|588106953|FG002|Open-label Lead-in Phase|Death|0|||
162835216|NCT01709149|588106951|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
162835217|NCT01709149|588106952|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
162835218|NCT01709149|588106953|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
162835219|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162835220|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
162835221|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
162835222|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162835223|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
162835224|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
162835225|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162835226|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
162835227|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
162835228|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
162835229|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
162835230|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
162835231|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
162835232|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
162835233|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
162835234|NCT01709149|588106951|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162835235|NCT01709149|588106952|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
162835236|NCT01709149|588106953|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162835237|NCT03509350|588106954|FG000|Overall Study|Withdrawal by Subject|0|||
162835238|NCT03509350|588106955|FG001|Overall Study|Withdrawal by Subject|2|||
162835239|NCT00763815|588106956|FG000|Overall Study|Adverse Event|14|||
162835240|NCT00763815|588106957|FG001|Overall Study|Adverse Event|29|||
162835241|NCT00763815|588106956|FG000|Overall Study|Lack of Efficacy|10|||
162835242|NCT00763815|588106957|FG001|Overall Study|Lack of Efficacy|11|||
162835243|NCT00763815|588106956|FG000|Overall Study|Poor Compliance to Protocol|6|||
162835244|NCT00763815|588106957|FG001|Overall Study|Poor Compliance to Protocol|6|||
162835245|NCT00763815|588106956|FG000|Overall Study|Lost to Follow-up|2|||
162835246|NCT00763815|588106957|FG001|Overall Study|Lost to Follow-up|4|||
162835247|NCT00763815|588106956|FG000|Overall Study|Early Termination|1|||
162835248|NCT00763815|588106957|FG001|Overall Study|Early Termination|0|||
162835249|NCT00763815|588106956|FG000|Overall Study|Familial and Personal Reasons|9|||
162835250|NCT00763815|588106957|FG001|Overall Study|Familial and Personal Reasons|16|||
162835251|NCT00763815|588106956|FG000|Overall Study|Physician Decision|1|||
162835252|NCT00763815|588106957|FG001|Overall Study|Physician Decision|0|||
162835253|NCT00763815|588106956|FG000|Overall Study|Withdrawal by Subject|7|||
162835254|NCT00763815|588106957|FG001|Overall Study|Withdrawal by Subject|12|||
162835255|NCT00763815|588106956|FG000|Overall Study|Protocol Violation|2|||
162835256|NCT00763815|588106957|FG001|Overall Study|Protocol Violation|5|||
162835257|NCT00763815|588106956|FG000|Overall Study|Sponsor's Decision|0|||
162835258|NCT00763815|588106957|FG001|Overall Study|Sponsor's Decision|1|||
162835259|NCT04951037|588106958|FG000|Overall Study|Lost to Follow-up|16|||
162835260|NCT04951037|588106958|FG000|Overall Study|Withdrawal by Subject|5|||
162699805|NCT03615482|587612359|FG000|Overall Study|Withdrawal by Subject|7|||
162835261|NCT04951037|588106958|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
162835262|NCT05630937|588106959|FG000|Overall Study|Study terminated by sponsor|1|||
162835263|NCT05630937|588106960|FG001|Overall Study|Study terminated by sponsor|1|||
162835264|NCT05630937|588106961|FG002|Overall Study|Study terminated by sponsor|8|||
162835265|NCT05630937|588106962|FG003|Overall Study|Study terminated by sponsor|0|||
162835266|NCT05630937|588106959|FG000|Overall Study|Lost to Follow-up|0|||
162835267|NCT05630937|588106960|FG001|Overall Study|Lost to Follow-up|0|||
162835268|NCT05630937|588106961|FG002|Overall Study|Lost to Follow-up|1|||
162835269|NCT05630937|588106962|FG003|Overall Study|Lost to Follow-up|0|||
162835270|NCT05630937|588106959|FG000|Overall Study|Enrolled but not treated|0|||
162835271|NCT05630937|588106960|FG001|Overall Study|Enrolled but not treated|0|||
162835272|NCT05630937|588106961|FG002|Overall Study|Enrolled but not treated|0|||
162835273|NCT05630937|588106962|FG003|Overall Study|Enrolled but not treated|1|||
162835274|NCT03245450|588106963|FG000|Overall Study|Radiological disease progression|3|||
162835275|NCT03245450|588106964|FG001|Overall Study|Radiological disease progression|3|||
162835276|NCT03245450|588106965|FG002|Overall Study|Radiological disease progression|2|||
162835277|NCT03245450|588106966|FG003|Overall Study|Radiological disease progression|2|||
162835278|NCT03245450|588106967|FG004|Overall Study|Radiological disease progression|7|||
162835279|NCT03245450|588106968|FG005|Overall Study|Radiological disease progression|6|||
162835280|NCT03245450|588106969|FG006|Overall Study|Radiological disease progression|6|||
162835281|NCT03245450|588106963|FG000|Overall Study|Clinical disease progression|0|||
162835282|NCT03245450|588106964|FG001|Overall Study|Clinical disease progression|0|||
162835283|NCT03245450|588106965|FG002|Overall Study|Clinical disease progression|1|||
162835284|NCT03245450|588106966|FG003|Overall Study|Clinical disease progression|0|||
162835285|NCT03245450|588106967|FG004|Overall Study|Clinical disease progression|0|||
162835286|NCT03245450|588106968|FG005|Overall Study|Clinical disease progression|2|||
162835287|NCT03245450|588106969|FG006|Overall Study|Clinical disease progression|0|||
162835288|NCT03245450|588106963|FG000|Overall Study|Other|0|||
162835289|NCT03245450|588106964|FG001|Overall Study|Other|0|||
162835290|NCT03245450|588106965|FG002|Overall Study|Other|0|||
162835291|NCT03245450|588106966|FG003|Overall Study|Other|1|||
162835292|NCT03245450|588106967|FG004|Overall Study|Other|1|||
162835293|NCT03245450|588106968|FG005|Overall Study|Other|1|||
162835294|NCT03245450|588106969|FG006|Overall Study|Other|1|||
162835295|NCT03245450|588106963|FG000|Overall Study|Withdrawal by Subject|0|||
162835296|NCT03245450|588106964|FG001|Overall Study|Withdrawal by Subject|1|||
162835297|NCT03245450|588106965|FG002|Overall Study|Withdrawal by Subject|0|||
162835298|NCT03245450|588106966|FG003|Overall Study|Withdrawal by Subject|0|||
162835299|NCT03245450|588106967|FG004|Overall Study|Withdrawal by Subject|0|||
162835300|NCT03245450|588106968|FG005|Overall Study|Withdrawal by Subject|0|||
162835301|NCT03245450|588106969|FG006|Overall Study|Withdrawal by Subject|0|||
162835302|NCT03245450|588106963|FG000|Overall Study|Adverse Event|0|||
162835303|NCT03245450|588106964|FG001|Overall Study|Adverse Event|0|||
162835304|NCT03245450|588106965|FG002|Overall Study|Adverse Event|0|||
162835305|NCT03245450|588106966|FG003|Overall Study|Adverse Event|0|||
162835306|NCT03245450|588106967|FG004|Overall Study|Adverse Event|1|||
162835307|NCT03245450|588106968|FG005|Overall Study|Adverse Event|0|||
162835308|NCT03245450|588106969|FG006|Overall Study|Adverse Event|2|||
162835309|NCT02429414|588106970|FG000|Overall Study|Physician Decision|0|||
162835310|NCT02429414|588106971|FG001|Overall Study|Physician Decision|1|||
162835311|NCT01604265|588106974|FG000|Overall Study|Adverse Event|1|||
162835312|NCT01604265|588106975|FG001|Overall Study|Adverse Event|0|||
162835313|NCT01604265|588106974|FG000|Overall Study|Withdrawal by Subject|1|||
162835314|NCT01604265|588106975|FG001|Overall Study|Withdrawal by Subject|0|||
162835315|NCT01903837|588106978|FG000|Part A|Withdrawal by Subject|4|||
162835316|NCT01903837|588106979|FG001|Part A|Withdrawal by Subject|9|||
162835317|NCT01903837|588106980|FG002|Part A|Withdrawal by Subject|8|||
162835318|NCT01903837|588106981|FG003|Part A|Withdrawal by Subject|5|||
162835319|NCT01903837|588106978|FG000|Part A|Adverse Event|3|||
162835320|NCT01903837|588106979|FG001|Part A|Adverse Event|6|||
162835321|NCT01903837|588106980|FG002|Part A|Adverse Event|9|||
162835322|NCT01903837|588106981|FG003|Part A|Adverse Event|6|||
162835323|NCT01903837|588106978|FG000|Part A|Lost to Follow-up|9|||
162835324|NCT01903837|588106979|FG001|Part A|Lost to Follow-up|7|||
162835325|NCT01903837|588106980|FG002|Part A|Lost to Follow-up|7|||
162835326|NCT01903837|588106981|FG003|Part A|Lost to Follow-up|2|||
162835327|NCT01903837|588106978|FG000|Part A|Non-compliance with study drug|1|||
162835328|NCT01903837|588106979|FG001|Part A|Non-compliance with study drug|4|||
162835329|NCT01903837|588106980|FG002|Part A|Non-compliance with study drug|4|||
162835330|NCT01903837|588106981|FG003|Part A|Non-compliance with study drug|0|||
162835331|NCT01903837|588106978|FG000|Part A|Physician Decision|1|||
162699806|NCT03615482|587612360|FG001|Overall Study|Withdrawal by Subject|7|||
162835332|NCT01903837|588106979|FG001|Part A|Physician Decision|1|||
162835333|NCT01903837|588106980|FG002|Part A|Physician Decision|0|||
162835334|NCT01903837|588106981|FG003|Part A|Physician Decision|0|||
162835335|NCT01903837|588106978|FG000|Part A|Protocol Violation|1|||
162835336|NCT01903837|588106979|FG001|Part A|Protocol Violation|1|||
162835337|NCT01903837|588106980|FG002|Part A|Protocol Violation|0|||
162835338|NCT01903837|588106981|FG003|Part A|Protocol Violation|0|||
162835339|NCT01903837|588106978|FG000|Part B|Lost to Follow-up|0|||
162835340|NCT01903837|588106979|FG001|Part B|Lost to Follow-up|3|||
162835341|NCT01903837|588106980|FG002|Part B|Lost to Follow-up|3|||
162835342|NCT01903837|588106981|FG003|Part B|Lost to Follow-up|4|||
162835343|NCT01903837|588106978|FG000|Part B|Withdrawal by Subject|1|||
162835344|NCT01903837|588106979|FG001|Part B|Withdrawal by Subject|2|||
162835345|NCT01903837|588106980|FG002|Part B|Withdrawal by Subject|0|||
162835346|NCT01903837|588106981|FG003|Part B|Withdrawal by Subject|3|||
162835347|NCT01903837|588106978|FG000|Part B|Adverse Event|3|||
162835348|NCT01903837|588106979|FG001|Part B|Adverse Event|0|||
162835349|NCT01903837|588106980|FG002|Part B|Adverse Event|2|||
162835350|NCT01903837|588106981|FG003|Part B|Adverse Event|0|||
162835351|NCT01903837|588106978|FG000|Part B|Non-compliance with study drug|2|||
162835352|NCT01903837|588106979|FG001|Part B|Non-compliance with study drug|0|||
162835353|NCT01903837|588106980|FG002|Part B|Non-compliance with study drug|0|||
162835354|NCT01903837|588106981|FG003|Part B|Non-compliance with study drug|1|||
162835355|NCT01903837|588106978|FG000|Part B|Incarceration|2|||
162835356|NCT01903837|588106979|FG001|Part B|Incarceration|0|||
162835357|NCT01903837|588106980|FG002|Part B|Incarceration|0|||
162835358|NCT01903837|588106981|FG003|Part B|Incarceration|1|||
162835359|NCT01903837|588106978|FG000|Part B|Physician Decision|1|||
162835360|NCT01903837|588106979|FG001|Part B|Physician Decision|0|||
162835361|NCT01903837|588106980|FG002|Part B|Physician Decision|0|||
162835362|NCT01903837|588106981|FG003|Part B|Physician Decision|2|||
162835363|NCT01903837|588106978|FG000|Part B|Lack of Efficacy|0|||
162835364|NCT01903837|588106979|FG001|Part B|Lack of Efficacy|1|||
162835365|NCT01903837|588106980|FG002|Part B|Lack of Efficacy|0|||
162835366|NCT01903837|588106981|FG003|Part B|Lack of Efficacy|0|||
162835367|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
162835368|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
162835369|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
162835370|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
162835371|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
162835372|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
162835373|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
162835374|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
162835375|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
162835376|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
162835377|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
162835378|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
162835379|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
162835380|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
162835381|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
162835382|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
162835383|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
162835384|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
162835385|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
162835386|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
162835387|NCT02706873|588106982|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
162835388|NCT02706873|588106983|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
162835389|NCT02706873|588106984|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
162835390|NCT02706873|588106985|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
162835391|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
162835392|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
162835393|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
162835394|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
162835395|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
162835396|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
162835397|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
162835398|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
162835399|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
162835400|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
162835401|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
162835402|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
162699807|NCT00163215|587612365|FG000|Overall Study|Lack of Efficacy|3|||
162699808|NCT00163215|587612365|FG000|Overall Study|Withdrawal by Subject|5|||
162835403|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
162835404|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
162835405|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
162835406|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
162835407|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
162835408|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
162835409|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
162835410|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
162835411|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
162835412|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
162835413|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
162835414|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
162835415|NCT02706873|588106982|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
162835416|NCT02706873|588106983|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
162835417|NCT02706873|588106984|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
162835418|NCT02706873|588106985|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
162835419|NCT05098041|588106987|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
162835420|NCT00705939|588106989|FG000|Overall Study|Protocol Violation|0|||
162835421|NCT00705939|588106990|FG001|Overall Study|Protocol Violation|0|||
162835422|NCT00705939|588106991|FG002|Overall Study|Protocol Violation|1|||
162835423|NCT00705939|588106989|FG000|Overall Study|Withdrawal by Subject|0|||
162835424|NCT00705939|588106990|FG001|Overall Study|Withdrawal by Subject|1|||
162835425|NCT00705939|588106991|FG002|Overall Study|Withdrawal by Subject|3|||
162835426|NCT00705939|588106989|FG000|Overall Study|Physician Decision|0|||
162835427|NCT00705939|588106990|FG001|Overall Study|Physician Decision|1|||
162835428|NCT00705939|588106991|FG002|Overall Study|Physician Decision|0|||
162835429|NCT00797732|588106995|FG000|Overall Study|Withdrawal by Subject|3|||
162835430|NCT00797732|588106996|FG001|Overall Study|Withdrawal by Subject|3|||
162835431|NCT00797732|588106997|FG002|Overall Study|Withdrawal by Subject|0|||
162835432|NCT00797732|588106995|FG000|Overall Study|Lost to Follow-up|1|||
162835433|NCT00797732|588106996|FG001|Overall Study|Lost to Follow-up|0|||
162835434|NCT00797732|588106997|FG002|Overall Study|Lost to Follow-up|0|||
162835435|NCT00797732|588106995|FG000|Overall Study|Death|1|||
162835436|NCT00797732|588106996|FG001|Overall Study|Death|0|||
162835437|NCT00797732|588106997|FG002|Overall Study|Death|0|||
162835438|NCT00797732|588106995|FG000|Overall Study|Not meet inclusion criteria|0|||
162835439|NCT00797732|588106996|FG001|Overall Study|Not meet inclusion criteria|0|||
162835440|NCT00797732|588106997|FG002|Overall Study|Not meet inclusion criteria|7|||
162835441|NCT00797732|588106995|FG000|Overall Study|Excluded due to time constraints|0|||
162835442|NCT00797732|588106996|FG001|Overall Study|Excluded due to time constraints|0|||
162835443|NCT00797732|588106997|FG002|Overall Study|Excluded due to time constraints|24|||
162835444|NCT00797732|588106995|FG000|Overall Study|Refused to Participate|0|||
162835445|NCT00797732|588106996|FG001|Overall Study|Refused to Participate|0|||
162835446|NCT00797732|588106997|FG002|Overall Study|Refused to Participate|123|||
162835447|NCT03948178|588106998|FG000|Overall Study|Protocol Violation|1|||
162835448|NCT03948178|588106998|FG000|Overall Study|Lost to Follow-up|2|||
162835449|NCT03948178|588106998|FG000|Overall Study|Withdrawal by Subject|2|||
162835450|NCT03948178|588106998|FG000|Overall Study|Reason not known|2|||
162835451|NCT03948178|588106998|FG000|Overall Study|Personal reason|14|||
162835452|NCT03948178|588106998|FG000|Overall Study|Disease progression|30|||
162835453|NCT03948178|588106998|FG000|Overall Study|Adverse Event|12|||
162835454|NCT03948178|588106998|FG000|Overall Study|Sponsor terminated study|164|||
162835455|NCT01297270|588106999|FG000|Overall Study|Adverse Event|19|||
162835456|NCT01297270|588107000|FG001|Overall Study|Adverse Event|32|||
162835457|NCT01297270|588107001|FG002|Overall Study|Adverse Event|5|||
162835458|NCT01297270|588106999|FG000|Overall Study|Lack of Efficacy|15|||
162835459|NCT01297270|588107000|FG001|Overall Study|Lack of Efficacy|17|||
162835460|NCT01297270|588107001|FG002|Overall Study|Lack of Efficacy|15|||
162835461|NCT01297270|588106999|FG000|Overall Study|Lost to Follow-up|1|||
162835462|NCT01297270|588107000|FG001|Overall Study|Lost to Follow-up|2|||
162835463|NCT01297270|588107001|FG002|Overall Study|Lost to Follow-up|1|||
162835464|NCT01297270|588106999|FG000|Overall Study|Protocol Violation|0|||
162835465|NCT01297270|588107000|FG001|Overall Study|Protocol Violation|2|||
162835466|NCT01297270|588107001|FG002|Overall Study|Protocol Violation|0|||
162835467|NCT01297270|588106999|FG000|Overall Study|Withdrawal by Subject|7|||
162835468|NCT01297270|588107000|FG001|Overall Study|Withdrawal by Subject|15|||
162835469|NCT01297270|588107001|FG002|Overall Study|Withdrawal by Subject|7|||
162835470|NCT01297270|588106999|FG000|Overall Study|Other reason not defined above|3|||
162835471|NCT01297270|588107000|FG001|Overall Study|Other reason not defined above|3|||
162835472|NCT01297270|588107001|FG002|Overall Study|Other reason not defined above|1|||
162835473|NCT01297270|588106999|FG000|Overall Study|Not treated|0|||
162835474|NCT01297270|588107000|FG001|Overall Study|Not treated|1|||
162835475|NCT01297270|588107001|FG002|Overall Study|Not treated|0|||
162835476|NCT00401752|588107004|FG000|Overall Study|Adverse Event|2|||
162835477|NCT00401752|588107005|FG001|Overall Study|Adverse Event|5|||
162835478|NCT00401752|588107004|FG000|Overall Study|Withdrawal by Subject|2|||
162835479|NCT00401752|588107005|FG001|Overall Study|Withdrawal by Subject|6|||
162835480|NCT00401752|588107004|FG000|Overall Study|Lost to Follow-up|1|||
162835481|NCT00401752|588107005|FG001|Overall Study|Lost to Follow-up|4|||
162835482|NCT00401752|588107004|FG000|Overall Study|Development of any exclusion criteria|4|||
162835483|NCT00401752|588107005|FG001|Overall Study|Development of any exclusion criteria|2|||
162835484|NCT00401752|588107004|FG000|Overall Study|Physician Decision|1|||
162835485|NCT00401752|588107005|FG001|Overall Study|Physician Decision|1|||
162835486|NCT02432235|588107006|FG000|Overall Study|Death|1|||
162835487|NCT02432235|588107007|FG001|Overall Study|Death|1|||
162835488|NCT02432235|588107008|FG002|Overall Study|Death|2|||
162835489|NCT02432235|588107009|FG003|Overall Study|Death|2|||
162835490|NCT02432235|588107010|FG004|Overall Study|Death|1|||
162835491|NCT02432235|588107011|FG005|Overall Study|Death|3|||
162835492|NCT02432235|588107012|FG006|Overall Study|Death|11|||
162835493|NCT02432235|588107013|FG007|Overall Study|Death|15|||
162835494|NCT02432235|588107014|FG008|Overall Study|Death|15|||
162835495|NCT02432235|588107015|FG009|Overall Study|Death|3|||
162835496|NCT02432235|588107016|FG010|Overall Study|Death|1|||
162835497|NCT02432235|588107017|FG011|Overall Study|Death|0|||
162835498|NCT02432235|588107006|FG000|Overall Study|Withdrawal by Subject|0|||
162835499|NCT02432235|588107007|FG001|Overall Study|Withdrawal by Subject|1|||
162835500|NCT02432235|588107008|FG002|Overall Study|Withdrawal by Subject|0|||
162835501|NCT02432235|588107009|FG003|Overall Study|Withdrawal by Subject|0|||
162835502|NCT02432235|588107010|FG004|Overall Study|Withdrawal by Subject|0|||
162835503|NCT02432235|588107011|FG005|Overall Study|Withdrawal by Subject|2|||
162835504|NCT02432235|588107012|FG006|Overall Study|Withdrawal by Subject|5|||
162835505|NCT02432235|588107013|FG007|Overall Study|Withdrawal by Subject|3|||
162835506|NCT02432235|588107014|FG008|Overall Study|Withdrawal by Subject|1|||
162835507|NCT02432235|588107015|FG009|Overall Study|Withdrawal by Subject|0|||
162835508|NCT02432235|588107016|FG010|Overall Study|Withdrawal by Subject|0|||
162835509|NCT02432235|588107017|FG011|Overall Study|Withdrawal by Subject|0|||
162835510|NCT02432235|588107006|FG000|Overall Study|Lost to Follow-up|0|||
162835511|NCT02432235|588107007|FG001|Overall Study|Lost to Follow-up|0|||
162835512|NCT02432235|588107008|FG002|Overall Study|Lost to Follow-up|0|||
162835513|NCT02432235|588107009|FG003|Overall Study|Lost to Follow-up|0|||
162835514|NCT02432235|588107010|FG004|Overall Study|Lost to Follow-up|0|||
162835515|NCT02432235|588107011|FG005|Overall Study|Lost to Follow-up|1|||
162835516|NCT02432235|588107012|FG006|Overall Study|Lost to Follow-up|0|||
162835517|NCT02432235|588107013|FG007|Overall Study|Lost to Follow-up|0|||
162835518|NCT02432235|588107014|FG008|Overall Study|Lost to Follow-up|1|||
162835519|NCT02432235|588107015|FG009|Overall Study|Lost to Follow-up|0|||
162835520|NCT02432235|588107016|FG010|Overall Study|Lost to Follow-up|0|||
162835521|NCT02432235|588107017|FG011|Overall Study|Lost to Follow-up|0|||
162835522|NCT02432235|588107006|FG000|Overall Study|Miscellaneous|0|||
162835523|NCT02432235|588107007|FG001|Overall Study|Miscellaneous|0|||
162835524|NCT02432235|588107008|FG002|Overall Study|Miscellaneous|0|||
162835525|NCT02432235|588107009|FG003|Overall Study|Miscellaneous|0|||
162835526|NCT02432235|588107010|FG004|Overall Study|Miscellaneous|1|||
162835527|NCT02432235|588107011|FG005|Overall Study|Miscellaneous|6|||
162835528|NCT02432235|588107012|FG006|Overall Study|Miscellaneous|2|||
162835529|NCT02432235|588107013|FG007|Overall Study|Miscellaneous|2|||
162835530|NCT02432235|588107014|FG008|Overall Study|Miscellaneous|4|||
162835531|NCT02432235|588107015|FG009|Overall Study|Miscellaneous|0|||
162835532|NCT02432235|588107016|FG010|Overall Study|Miscellaneous|0|||
162835533|NCT02432235|588107017|FG011|Overall Study|Miscellaneous|1|||
162835534|NCT01895322|588107018|FG000|Overall Study|Adverse Event|1|||
162835535|NCT01895322|588107018|FG000|Overall Study|Withdrawal by Subject|2|||
162835536|NCT01895322|588107018|FG000|Overall Study|Protocol Violation|10|||
162835537|NCT01347554|588107019|FG000|Overall Study|Lack of Efficacy|7|||
162835538|NCT01347554|588107020|FG001|Overall Study|Lack of Efficacy|11|||
162835539|NCT02873936|588107022|FG000|Overall Study|Withdrew Consent|4|||
162835540|NCT02873936|588107023|FG001|Overall Study|Withdrew Consent|11|||
162835541|NCT02873936|588107024|FG002|Overall Study|Withdrew Consent|20|||
162835542|NCT02873936|588107022|FG000|Overall Study|Investigator's Discretion|3|||
162835543|NCT02873936|588107023|FG001|Overall Study|Investigator's Discretion|5|||
162835544|NCT02873936|588107024|FG002|Overall Study|Investigator's Discretion|4|||
162835545|NCT02873936|588107022|FG000|Overall Study|Adverse Event|3|||
162835546|NCT02873936|588107023|FG001|Overall Study|Adverse Event|5|||
162835547|NCT02873936|588107024|FG002|Overall Study|Adverse Event|3|||
162835548|NCT02873936|588107022|FG000|Overall Study|Protocol Violation|0|||
162835549|NCT02873936|588107023|FG001|Overall Study|Protocol Violation|1|||
162835550|NCT02873936|588107024|FG002|Overall Study|Protocol Violation|3|||
162835551|NCT02873936|588107022|FG000|Overall Study|Lost to Follow-up|1|||
162835552|NCT02873936|588107023|FG001|Overall Study|Lost to Follow-up|1|||
162835553|NCT02873936|588107024|FG002|Overall Study|Lost to Follow-up|1|||
162947950|NCT02848326|588513108|FG004|Treatment Period|Pregnancy|0|||
162835554|NCT02873936|588107022|FG000|Overall Study|Non-compliance With Study Drug|1|||
162947951|NCT02848326|588513109|FG005|Treatment Period|Pregnancy|1|||
162835555|NCT02873936|588107023|FG001|Overall Study|Non-compliance With Study Drug|0|||
162835556|NCT02873936|588107024|FG002|Overall Study|Non-compliance With Study Drug|1|||
162835557|NCT02873936|588107022|FG000|Overall Study|Randomized but not Dosed|1|||
162835558|NCT02873936|588107023|FG001|Overall Study|Randomized but not Dosed|0|||
162835559|NCT02873936|588107024|FG002|Overall Study|Randomized but not Dosed|0|||
162835560|NCT01505634|588107025|FG000|Overall Study|Withdrawal by Subject|2|||
162835561|NCT01505634|588107026|FG001|Overall Study|Withdrawal by Subject|5|||
162835562|NCT01505634|588107027|FG002|Overall Study|Withdrawal by Subject|1|||
162835563|NCT01505634|588107025|FG000|Overall Study|Physician Decision|1|||
162835564|NCT01505634|588107026|FG001|Overall Study|Physician Decision|1|||
162835565|NCT01505634|588107027|FG002|Overall Study|Physician Decision|0|||
162835566|NCT01505634|588107025|FG000|Overall Study|Adverse Event|1|||
162835567|NCT01505634|588107026|FG001|Overall Study|Adverse Event|0|||
162835568|NCT01505634|588107027|FG002|Overall Study|Adverse Event|0|||
162835569|NCT01505634|588107025|FG000|Overall Study|Insufficient supply of drug at site|1|||
162835570|NCT01505634|588107026|FG001|Overall Study|Insufficient supply of drug at site|0|||
162835571|NCT01505634|588107027|FG002|Overall Study|Insufficient supply of drug at site|0|||
162835572|NCT01505634|588107025|FG000|Overall Study|Protocol Violation|2|||
162835573|NCT01505634|588107026|FG001|Overall Study|Protocol Violation|0|||
162835574|NCT01505634|588107027|FG002|Overall Study|Protocol Violation|0|||
162835575|NCT01505634|588107025|FG000|Overall Study|Lost to Follow-up|1|||
162835576|NCT01505634|588107026|FG001|Overall Study|Lost to Follow-up|4|||
162835577|NCT01505634|588107027|FG002|Overall Study|Lost to Follow-up|4|||
162835578|NCT01505634|588107025|FG000|Overall Study|Death|1|||
162835579|NCT01505634|588107026|FG001|Overall Study|Death|0|||
162835580|NCT01505634|588107027|FG002|Overall Study|Death|0|||
162835581|NCT01505634|588107025|FG000|Overall Study|In a conflict zone|0|||
162835582|NCT01505634|588107026|FG001|Overall Study|In a conflict zone|0|||
162835583|NCT01505634|588107027|FG002|Overall Study|In a conflict zone|1|||
162835584|NCT02054897|588107028|FG000|Overall Study|Withdrawal by Subject|2|||
162835585|NCT02054897|588107029|FG001|Overall Study|Withdrawal by Subject|0|||
162835586|NCT02054897|588107030|FG002|Overall Study|Withdrawal by Subject|2|||
162835587|NCT02054897|588107028|FG000|Overall Study|Missing follow-up information|3|||
162835588|NCT02054897|588107029|FG001|Overall Study|Missing follow-up information|5|||
162835589|NCT02054897|588107030|FG002|Overall Study|Missing follow-up information|3|||
162835590|NCT02054897|588107028|FG000|Overall Study|Lost to Follow-up|4|||
162835591|NCT02054897|588107029|FG001|Overall Study|Lost to Follow-up|2|||
162835592|NCT02054897|588107030|FG002|Overall Study|Lost to Follow-up|7|||
162835593|NCT02054897|588107028|FG000|Overall Study|Randomized but not exposed|1|||
162835594|NCT02054897|588107029|FG001|Overall Study|Randomized but not exposed|0|||
162835595|NCT02054897|588107030|FG002|Overall Study|Randomized but not exposed|0|||
162835596|NCT00960843|588107031|FG000|Overall Study|Lost to Follow-up|2|||
162835597|NCT00960843|588107032|FG001|Overall Study|Lost to Follow-up|0|||
162835598|NCT00960843|588107031|FG000|Overall Study|Protocol Violation|0|||
162835599|NCT00960843|588107032|FG001|Overall Study|Protocol Violation|4|||
162835600|NCT00960843|588107031|FG000|Overall Study|Repeated needle dislodgment|0|||
162835601|NCT00960843|588107032|FG001|Overall Study|Repeated needle dislodgment|1|||
162835602|NCT00254501|588107033|FG000|Overall Study|Lost to Follow-up|1|||
162835603|NCT00254501|588107034|FG001|Overall Study|Lost to Follow-up|1|||
162835604|NCT00879697|588107036|FG000|Overall Study|Physician Decision|2|||
162835605|NCT00879697|588107037|FG001|Overall Study|Physician Decision|2|||
162835606|NCT01836783|588107040|FG000|Overall Study|Withdrawal by Subject|0|||
162835607|NCT01836783|588107041|FG001|Overall Study|Withdrawal by Subject|2|||
162835608|NCT01100437|588107047|FG000|Titration/Stabilization|Adverse Event|0|||
162835609|NCT01100437|588107048|FG001|Titration/Stabilization|Adverse Event|0|||
162835610|NCT01100437|588107049|FG002|Titration/Stabilization|Adverse Event|4|||
162835611|NCT01100437|588107047|FG000|Titration/Stabilization|Non-compliance|0|||
162835612|NCT01100437|588107048|FG001|Titration/Stabilization|Non-compliance|0|||
162835613|NCT01100437|588107049|FG002|Titration/Stabilization|Non-compliance|1|||
162835614|NCT01100437|588107047|FG000|Titration/Stabilization|Sponsor canceled study|0|||
162835615|NCT01100437|588107048|FG001|Titration/Stabilization|Sponsor canceled study|0|||
162835616|NCT01100437|588107049|FG002|Titration/Stabilization|Sponsor canceled study|1|||
162835617|NCT01100437|588107047|FG000|Maintenance|Withdrawal by Subject|0|||
162835618|NCT01100437|588107048|FG001|Maintenance|Withdrawal by Subject|0|||
162835619|NCT01100437|588107049|FG002|Maintenance|Withdrawal by Subject|1|||
162835620|NCT01100437|588107047|FG000|Maintenance|Sponsor termination of study|0|||
162835621|NCT01100437|588107048|FG001|Maintenance|Sponsor termination of study|0|||
162835622|NCT01100437|588107049|FG002|Maintenance|Sponsor termination of study|1|||
162835623|NCT02867995|588107051|FG000|Overall Study|Withdrawal by Subject|0|||
162835624|NCT02867995|588107052|FG001|Overall Study|Withdrawal by Subject|1|||
162835625|NCT02867995|588107051|FG000|Overall Study|Lost to Follow-up|0|||
162835626|NCT02867995|588107052|FG001|Overall Study|Lost to Follow-up|2|||
162835627|NCT01534533|588107053|FG000|Overall Study|Lost to Follow-up|3|||
162835628|NCT01534533|588107054|FG001|Overall Study|Lost to Follow-up|0|||
162835629|NCT01534533|588107055|FG002|Overall Study|Lost to Follow-up|4|||
162835630|NCT01534533|588107056|FG003|Overall Study|Lost to Follow-up|3|||
162835631|NCT01534533|588107053|FG000|Overall Study|Withdrawal by Subject|5|||
162835632|NCT01534533|588107054|FG001|Overall Study|Withdrawal by Subject|3|||
162835633|NCT01534533|588107055|FG002|Overall Study|Withdrawal by Subject|4|||
162835634|NCT01534533|588107056|FG003|Overall Study|Withdrawal by Subject|1|||
162835635|NCT03315871|588107057|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
162835636|NCT03315871|588107058|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
162835637|NCT03315871|588107059|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
162835638|NCT03315871|588107057|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
162835639|NCT03315871|588107058|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
162835640|NCT03315871|588107059|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
162835641|NCT03315871|588107057|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
162835642|NCT03315871|588107058|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
162835643|NCT03315871|588107059|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
162835644|NCT03315871|588107057|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
162835645|NCT03315871|588107058|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
162835646|NCT03315871|588107059|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
162835647|NCT03315871|588107057|FG000|PROSTVAC + CV301|Progressive disease|0|||
162835648|NCT03315871|588107058|FG001|PROSTVAC + CV301|Progressive disease|0|||
162835649|NCT03315871|588107059|FG002|PROSTVAC + CV301|Progressive disease|1|||
162835650|NCT03315871|588107057|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
162835651|NCT03315871|588107058|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
162835652|NCT03315871|588107059|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
162835653|NCT00328627|588109984|FG000|Overall Study|Hyperglycemic Rescue|41|||
162835654|NCT00328627|588109985|FG001|Overall Study|Hyperglycemic Rescue|18|||
162835655|NCT00328627|588109986|FG002|Overall Study|Hyperglycemic Rescue|16|||
162835656|NCT00328627|588109987|FG003|Overall Study|Hyperglycemic Rescue|13|||
162835657|NCT00328627|588109988|FG004|Overall Study|Hyperglycemic Rescue|6|||
162835658|NCT00328627|588109989|FG005|Overall Study|Hyperglycemic Rescue|5|||
162835659|NCT00328627|588109990|FG006|Overall Study|Hyperglycemic Rescue|19|||
162835660|NCT00328627|588109991|FG007|Overall Study|Hyperglycemic Rescue|6|||
162835661|NCT00328627|588109992|FG008|Overall Study|Hyperglycemic Rescue|6|||
162835662|NCT00328627|588109993|FG009|Overall Study|Hyperglycemic Rescue|11|||
162835663|NCT00328627|588109994|FG010|Overall Study|Hyperglycemic Rescue|3|||
162835664|NCT00328627|588109995|FG011|Overall Study|Hyperglycemic Rescue|2|||
162835665|NCT00328627|588109984|FG000|Overall Study|Adverse Event|3|||
162835666|NCT00328627|588109985|FG001|Overall Study|Adverse Event|1|||
162835667|NCT00328627|588109986|FG002|Overall Study|Adverse Event|2|||
162835668|NCT00328627|588109987|FG003|Overall Study|Adverse Event|3|||
162835669|NCT00328627|588109988|FG004|Overall Study|Adverse Event|1|||
162835670|NCT00328627|588109989|FG005|Overall Study|Adverse Event|2|||
162835671|NCT00328627|588109990|FG006|Overall Study|Adverse Event|1|||
162835672|NCT00328627|588109991|FG007|Overall Study|Adverse Event|2|||
162835673|NCT00328627|588109992|FG008|Overall Study|Adverse Event|0|||
162835674|NCT00328627|588109993|FG009|Overall Study|Adverse Event|7|||
162835675|NCT00328627|588109994|FG010|Overall Study|Adverse Event|5|||
162835676|NCT00328627|588109995|FG011|Overall Study|Adverse Event|4|||
162835677|NCT00328627|588109984|FG000|Overall Study|Protocol Violation|2|||
162835678|NCT00328627|588109985|FG001|Overall Study|Protocol Violation|2|||
162835679|NCT00328627|588109986|FG002|Overall Study|Protocol Violation|2|||
162835680|NCT00328627|588109987|FG003|Overall Study|Protocol Violation|8|||
162835681|NCT00328627|588109988|FG004|Overall Study|Protocol Violation|5|||
162835682|NCT00328627|588109989|FG005|Overall Study|Protocol Violation|5|||
162835683|NCT00328627|588109990|FG006|Overall Study|Protocol Violation|6|||
162835684|NCT00328627|588109991|FG007|Overall Study|Protocol Violation|2|||
162835685|NCT00328627|588109992|FG008|Overall Study|Protocol Violation|1|||
162835686|NCT00328627|588109993|FG009|Overall Study|Protocol Violation|4|||
162835687|NCT00328627|588109994|FG010|Overall Study|Protocol Violation|6|||
162835688|NCT00328627|588109995|FG011|Overall Study|Protocol Violation|2|||
162835689|NCT00328627|588109984|FG000|Overall Study|Lost to Follow-up|4|||
162835690|NCT00328627|588109985|FG001|Overall Study|Lost to Follow-up|2|||
162835691|NCT00328627|588109986|FG002|Overall Study|Lost to Follow-up|2|||
162835692|NCT00328627|588109987|FG003|Overall Study|Lost to Follow-up|4|||
162835693|NCT00328627|588109988|FG004|Overall Study|Lost to Follow-up|0|||
162835694|NCT00328627|588109989|FG005|Overall Study|Lost to Follow-up|2|||
162835695|NCT00328627|588109990|FG006|Overall Study|Lost to Follow-up|3|||
162835696|NCT00328627|588109991|FG007|Overall Study|Lost to Follow-up|0|||
162835697|NCT00328627|588109992|FG008|Overall Study|Lost to Follow-up|3|||
162835698|NCT00328627|588109993|FG009|Overall Study|Lost to Follow-up|2|||
162835699|NCT00328627|588109994|FG010|Overall Study|Lost to Follow-up|0|||
162835700|NCT00328627|588109995|FG011|Overall Study|Lost to Follow-up|1|||
162835701|NCT00328627|588109984|FG000|Overall Study|Withdrawal by Subject|5|||
162835702|NCT00328627|588109985|FG001|Overall Study|Withdrawal by Subject|4|||
162835703|NCT00328627|588109986|FG002|Overall Study|Withdrawal by Subject|5|||
162835704|NCT00328627|588109987|FG003|Overall Study|Withdrawal by Subject|6|||
162835705|NCT00328627|588109988|FG004|Overall Study|Withdrawal by Subject|2|||
162835706|NCT00328627|588109989|FG005|Overall Study|Withdrawal by Subject|5|||
162835707|NCT00328627|588109990|FG006|Overall Study|Withdrawal by Subject|4|||
162947952|NCT02848326|588513104|FG000|Treatment Period|Protocol Violation|4|||
162835708|NCT00328627|588109991|FG007|Overall Study|Withdrawal by Subject|4|||
162835709|NCT00328627|588109992|FG008|Overall Study|Withdrawal by Subject|4|||
162835710|NCT00328627|588109993|FG009|Overall Study|Withdrawal by Subject|5|||
162835711|NCT00328627|588109994|FG010|Overall Study|Withdrawal by Subject|2|||
162835712|NCT00328627|588109995|FG011|Overall Study|Withdrawal by Subject|7|||
162835713|NCT00328627|588109984|FG000|Overall Study|Pregnancy|0|||
162835714|NCT00328627|588109985|FG001|Overall Study|Pregnancy|1|||
162835715|NCT00328627|588109986|FG002|Overall Study|Pregnancy|0|||
162835716|NCT00328627|588109987|FG003|Overall Study|Pregnancy|0|||
162835717|NCT00328627|588109988|FG004|Overall Study|Pregnancy|0|||
162835718|NCT00328627|588109989|FG005|Overall Study|Pregnancy|0|||
162835719|NCT00328627|588109990|FG006|Overall Study|Pregnancy|0|||
162835720|NCT00328627|588109991|FG007|Overall Study|Pregnancy|0|||
162835721|NCT00328627|588109992|FG008|Overall Study|Pregnancy|0|||
162835722|NCT00328627|588109993|FG009|Overall Study|Pregnancy|0|||
162835723|NCT00328627|588109994|FG010|Overall Study|Pregnancy|0|||
162835724|NCT00328627|588109995|FG011|Overall Study|Pregnancy|0|||
162835725|NCT00328627|588109984|FG000|Overall Study|Physician Decision|4|||
162835726|NCT00328627|588109985|FG001|Overall Study|Physician Decision|3|||
162835727|NCT00328627|588109986|FG002|Overall Study|Physician Decision|1|||
162835728|NCT00328627|588109987|FG003|Overall Study|Physician Decision|2|||
162835729|NCT00328627|588109988|FG004|Overall Study|Physician Decision|1|||
162835730|NCT00328627|588109989|FG005|Overall Study|Physician Decision|1|||
162835731|NCT00328627|588109990|FG006|Overall Study|Physician Decision|1|||
162835732|NCT00328627|588109991|FG007|Overall Study|Physician Decision|0|||
162835733|NCT00328627|588109992|FG008|Overall Study|Physician Decision|3|||
162835734|NCT00328627|588109993|FG009|Overall Study|Physician Decision|2|||
162835735|NCT00328627|588109994|FG010|Overall Study|Physician Decision|1|||
162835736|NCT00328627|588109995|FG011|Overall Study|Physician Decision|0|||
162835737|NCT00328627|588109984|FG000|Overall Study|Other|0|||
162835738|NCT00328627|588109985|FG001|Overall Study|Other|0|||
162835739|NCT00328627|588109986|FG002|Overall Study|Other|0|||
162835740|NCT00328627|588109987|FG003|Overall Study|Other|1|||
162835741|NCT00328627|588109988|FG004|Overall Study|Other|0|||
162835742|NCT00328627|588109989|FG005|Overall Study|Other|0|||
162835743|NCT00328627|588109990|FG006|Overall Study|Other|1|||
162835744|NCT00328627|588109991|FG007|Overall Study|Other|0|||
162835745|NCT00328627|588109992|FG008|Overall Study|Other|0|||
162835746|NCT00328627|588109993|FG009|Overall Study|Other|1|||
162835747|NCT00328627|588109994|FG010|Overall Study|Other|1|||
162835748|NCT00328627|588109995|FG011|Overall Study|Other|0|||
162835749|NCT00513409|588109997|FG000|Overall Study|Adverse Event|0|||
162835750|NCT00513409|588109998|FG001|Overall Study|Adverse Event|1|||
162835751|NCT00513409|588109997|FG000|Overall Study|Withdrawal by Subject|0|||
162835752|NCT00513409|588109998|FG001|Overall Study|Withdrawal by Subject|2|||
162835753|NCT00513409|588109997|FG000|Overall Study|Lost to Follow-up|0|||
162835754|NCT00513409|588109998|FG001|Overall Study|Lost to Follow-up|1|||
162835755|NCT00513409|588109997|FG000|Overall Study|Physician Decision|1|||
162835756|NCT00513409|588109998|FG001|Overall Study|Physician Decision|0|||
162835757|NCT00513409|588109997|FG000|Overall Study|Visit 3 not done|1|||
162835758|NCT00513409|588109998|FG001|Overall Study|Visit 3 not done|2|||
162835759|NCT00691483|588109999|FG000|Overall Study|Adverse Event|14|||
162835760|NCT00691483|588110000|FG001|Overall Study|Adverse Event|6|||
162835761|NCT00691483|588109999|FG000|Overall Study|Lost to Follow-up|17|||
162835762|NCT00691483|588110000|FG001|Overall Study|Lost to Follow-up|10|||
162835763|NCT00691483|588109999|FG000|Overall Study|Withdrawal by Subject|24|||
162835764|NCT00691483|588110000|FG001|Overall Study|Withdrawal by Subject|7|||
162835765|NCT00691483|588109999|FG000|Overall Study|Other known cause|6|||
162835766|NCT00691483|588110000|FG001|Overall Study|Other known cause|1|||
162835767|NCT00691483|588109999|FG000|Overall Study|Randomized by not treated|7|||
162835768|NCT00691483|588110000|FG001|Overall Study|Randomized by not treated|1|||
162835769|NCT04623242|588110001|FG000|Overall Study|Withdrawal by Subject|7|||
162835770|NCT04623242|588110002|FG001|Overall Study|Withdrawal by Subject|12|||
162835771|NCT04623242|588110003|FG002|Overall Study|Withdrawal by Subject|5|||
162835772|NCT04623242|588110004|FG003|Overall Study|Withdrawal by Subject|7|||
162835773|NCT04623242|588110005|FG004|Overall Study|Withdrawal by Subject|0|||
162835774|NCT04623242|588110001|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
162835775|NCT04623242|588110002|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
162835776|NCT04623242|588110003|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
162835777|NCT04623242|588110004|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
162835778|NCT04623242|588110005|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
162835779|NCT04623242|588110001|FG000|Overall Study|Subject unblinded to mutation status|0|||
162835780|NCT04623242|588110002|FG001|Overall Study|Subject unblinded to mutation status|0|||
162835781|NCT04623242|588110003|FG002|Overall Study|Subject unblinded to mutation status|0|||
162835782|NCT04623242|588110004|FG003|Overall Study|Subject unblinded to mutation status|13|||
162835783|NCT04623242|588110005|FG004|Overall Study|Subject unblinded to mutation status|0|||
162835784|NCT02921971|588110008|FG000|Overall Study|Adverse Event|1|||
162835785|NCT02921971|588110009|FG001|Overall Study|Adverse Event|2|||
162835786|NCT02921971|588110008|FG000|Overall Study|Lack of Efficacy|3|||
162835787|NCT02921971|588110009|FG001|Overall Study|Lack of Efficacy|1|||
162835788|NCT02921971|588110008|FG000|Overall Study|Other than specified above|2|||
162835789|NCT02921971|588110009|FG001|Overall Study|Other than specified above|1|||
162835790|NCT02105454|588110010|FG000|Overall Study|Withdrawal by Subject|1|||
162835791|NCT02721355|588110013|FG000|Overall Study|Lost to Follow-up|6|||
162947953|NCT02848326|588513105|FG001|Treatment Period|Protocol Violation|3|||
162947954|NCT02848326|588513106|FG002|Treatment Period|Protocol Violation|4|||
162947955|NCT02848326|588513107|FG003|Treatment Period|Protocol Violation|2|||
162947956|NCT02848326|588513108|FG004|Treatment Period|Protocol Violation|3|||
162947957|NCT02848326|588513109|FG005|Treatment Period|Protocol Violation|3|||
162947958|NCT02848326|588513104|FG000|Treatment Period|Non-compliance with Study Drug|4|||
162947959|NCT02848326|588513105|FG001|Treatment Period|Non-compliance with Study Drug|0|||
162947960|NCT02848326|588513106|FG002|Treatment Period|Non-compliance with Study Drug|0|||
162947961|NCT02848326|588513107|FG003|Treatment Period|Non-compliance with Study Drug|1|||
162947962|NCT02848326|588513108|FG004|Treatment Period|Non-compliance with Study Drug|0|||
162947963|NCT02848326|588513109|FG005|Treatment Period|Non-compliance with Study Drug|0|||
162947964|NCT02848326|588513104|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
162947965|NCT02848326|588513105|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
162947966|NCT02848326|588513106|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
162947967|NCT02848326|588513107|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
162947968|NCT02848326|588513108|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
162947969|NCT02848326|588513109|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
162947970|NCT02848326|588513104|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
162947971|NCT02848326|588513105|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
162947972|NCT02848326|588513106|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
162947973|NCT02848326|588513107|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
162947974|NCT02848326|588513108|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
162947975|NCT02848326|588513109|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
162947976|NCT00441467|588513123|FG000|Overall Study|Adverse Event|6|||
162947977|NCT00441467|588513123|FG000|Overall Study|Withdrawal by Subject|3|||
162947978|NCT00441467|588513123|FG000|Overall Study|Progressive disease|9|||
162947979|NCT01042522|588513125|FG000|Overall Study|Adverse Event|1|||
162947980|NCT01042522|588513126|FG001|Overall Study|Adverse Event|2|||
162947981|NCT01042522|588513125|FG000|Overall Study|Disease Progression|5|||
162947982|NCT01042522|588513126|FG001|Overall Study|Disease Progression|0|||
162947983|NCT01042522|588513125|FG000|Overall Study|Death|1|||
162947984|NCT01042522|588513126|FG001|Overall Study|Death|0|||
162947985|NCT01042522|588513125|FG000|Overall Study|Patient Refused|0|||
162947986|NCT01042522|588513126|FG001|Overall Study|Patient Refused|3|||
162947987|NCT01042522|588513125|FG000|Overall Study|Withdrawal by Subject|1|||
162947988|NCT01042522|588513126|FG001|Overall Study|Withdrawal by Subject|1|||
162947989|NCT00745420|588513130|FG000|Overall Study|Ineligible|1|||
162947990|NCT01367275|588513131|FG000|Overall Study|Ineligible|1|||
162947991|NCT01367275|588513131|FG000|Overall Study|Disease Progression|2|||
162947992|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
162947993|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
162947994|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
162947995|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
162947996|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
162947997|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
162947998|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
162947999|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
162948000|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
162948001|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
162948002|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
162948003|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
162948004|NCT00048568|588513140|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
162948005|NCT00048568|588513141|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
162948006|NCT00048568|588513142|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
162948007|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Death|1|||
162948008|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Death|1|||
162948009|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Death|0|||
162948010|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
162948011|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
162948012|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
162948013|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
162948014|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
162948015|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
162948016|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
162948017|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
162948018|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
162948019|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
162948020|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
162699809|NCT00163215|587612365|FG000|Overall Study|Other|7|||
162948021|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
162948022|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
162948023|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
162835792|NCT02721355|588110014|FG001|Overall Study|Lost to Follow-up|1|||
162835793|NCT00356278|588110015|FG000|Overall Study|Withdrawal by Subject|25|||
162835794|NCT00356278|588110016|FG001|Overall Study|Withdrawal by Subject|15|||
162835795|NCT00356278|588110017|FG002|Overall Study|Withdrawal by Subject|19|||
162835796|NCT01268293|588110025|FG000|Overall Study|Disease progression|7|||
162835797|NCT01268293|588110025|FG000|Overall Study|Adverse Event|1|||
162835798|NCT01268293|588110025|FG000|Overall Study|Subject choice|1|||
162835799|NCT02597855|588110026|FG000|Overall Study|Lost to Follow-up|2|||
162835800|NCT02597855|588110027|FG001|Overall Study|Lost to Follow-up|1|||
162835801|NCT01777152|588110033|FG000|Overall Study|Withdrawal by Subject|22|||
162835802|NCT01777152|588110034|FG001|Overall Study|Withdrawal by Subject|16|||
162835803|NCT01777152|588110033|FG000|Overall Study|Lost to Follow-up|3|||
162835804|NCT01777152|588110034|FG001|Overall Study|Lost to Follow-up|5|||
162835805|NCT01777152|588110033|FG000|Overall Study|Death|68|||
162835806|NCT01777152|588110034|FG001|Overall Study|Death|89|||
162835807|NCT01777152|588110033|FG000|Overall Study|Not eligible, no study drug received|1|||
162835808|NCT01777152|588110034|FG001|Overall Study|Not eligible, no study drug received|0|||
162835809|NCT01777152|588110033|FG000|Overall Study|Change of diagnosis|1|||
162835810|NCT01777152|588110034|FG001|Overall Study|Change of diagnosis|0|||
162835811|NCT03446885|588110035|FG000|Overall Study|Lost to Follow-up|1|||
162835812|NCT03446885|588110036|FG001|Overall Study|Lost to Follow-up|0|||
162835813|NCT03446885|588110035|FG000|Overall Study|Did not complete entire visit|1|||
162835814|NCT03446885|588110036|FG001|Overall Study|Did not complete entire visit|0|||
162835815|NCT05882318|588110039|FG000|Overall Study|Withdrawal by Subject|1|||
162835816|NCT05882318|588110040|FG001|Overall Study|Withdrawal by Subject|0|||
162835817|NCT05882318|588110039|FG000|Overall Study|Protocol Violation|0|||
162835818|NCT05882318|588110040|FG001|Overall Study|Protocol Violation|1|||
162835819|NCT03042468|588110041|FG000|Overall Study|Death|0|||
162835820|NCT03042468|588110042|FG001|Overall Study|Death|1|||
162835821|NCT03042468|588110043|FG002|Overall Study|Death|1|||
162835822|NCT03042468|588110044|FG003|Overall Study|Death|0|||
162835823|NCT03042468|588110045|FG004|Overall Study|Death|0|||
162835824|NCT03042468|588110046|FG005|Overall Study|Death|0|||
162835825|NCT03042468|588110041|FG000|Overall Study|Withdrawal by Subject|0|||
162835826|NCT03042468|588110042|FG001|Overall Study|Withdrawal by Subject|0|||
162835827|NCT03042468|588110043|FG002|Overall Study|Withdrawal by Subject|0|||
162835828|NCT03042468|588110044|FG003|Overall Study|Withdrawal by Subject|0|||
162835829|NCT03042468|588110045|FG004|Overall Study|Withdrawal by Subject|0|||
162835830|NCT03042468|588110046|FG005|Overall Study|Withdrawal by Subject|1|||
162835831|NCT03042468|588110041|FG000|Overall Study|Lost to Follow-up|0|||
162835832|NCT03042468|588110042|FG001|Overall Study|Lost to Follow-up|0|||
162835833|NCT03042468|588110043|FG002|Overall Study|Lost to Follow-up|0|||
162835834|NCT03042468|588110044|FG003|Overall Study|Lost to Follow-up|0|||
162835835|NCT03042468|588110045|FG004|Overall Study|Lost to Follow-up|1|||
162835836|NCT03042468|588110046|FG005|Overall Study|Lost to Follow-up|1|||
162835837|NCT01485627|588110047|FG000|Overall Study|Patient withdrew|6|||
162835838|NCT01485627|588110048|FG001|Overall Study|Patient withdrew|5|||
162835839|NCT01485627|588110047|FG000|Overall Study|Patient died|3|||
162835840|NCT01485627|588110048|FG001|Overall Study|Patient died|1|||
162835841|NCT01485627|588110047|FG000|Overall Study|Patient lost to followup|0|||
162835842|NCT01485627|588110048|FG001|Overall Study|Patient lost to followup|1|||
162835843|NCT01485627|588110047|FG000|Overall Study|Caregiver withdrew|3|||
162835844|NCT01485627|588110048|FG001|Overall Study|Caregiver withdrew|3|||
162835845|NCT01485627|588110047|FG000|Overall Study|Caregiver lost to follow up|11|||
162835846|NCT01485627|588110048|FG001|Overall Study|Caregiver lost to follow up|12|||
162835847|NCT01485627|588110047|FG000|Overall Study|Caregiver died|1|||
162835848|NCT01485627|588110048|FG001|Overall Study|Caregiver died|0|||
162835849|NCT01485627|588110047|FG000|Overall Study|caregiver was not bereaved|42|||
162835850|NCT01485627|588110048|FG001|Overall Study|caregiver was not bereaved|35|||
162835851|NCT00267748|588110050|FG000|Non-randomized Period|Progressive disease|10|||
162835852|NCT00267748|588110051|FG001|Non-randomized Period|Progressive disease|0|||
162835853|NCT00267748|588110052|FG002|Non-randomized Period|Progressive disease|0|||
162835854|NCT00267748|588110050|FG000|Non-randomized Period|Adverse Event|8|||
162835855|NCT00267748|588110051|FG001|Non-randomized Period|Adverse Event|0|||
162835856|NCT00267748|588110052|FG002|Non-randomized Period|Adverse Event|0|||
162835857|NCT00267748|588110050|FG000|Non-randomized Period|Death|1|||
162948024|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
162948025|NCT00048568|588513140|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
162948026|NCT00048568|588513141|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
162835858|NCT00267748|588110051|FG001|Non-randomized Period|Death|0|||
162835859|NCT00267748|588110052|FG002|Non-randomized Period|Death|0|||
162948027|NCT00048568|588513142|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
162835860|NCT00267748|588110050|FG000|Non-randomized Period|Participant not willing to participate|1|||
162835861|NCT00267748|588110051|FG001|Non-randomized Period|Participant not willing to participate|0|||
162835862|NCT00267748|588110052|FG002|Non-randomized Period|Participant not willing to participate|0|||
162835863|NCT00267748|588110050|FG000|Non-randomized Period|Other|3|||
162948028|NCT00048568|588513140|FG000|Open-Label Period|Death|0|||
162835864|NCT00267748|588110051|FG001|Non-randomized Period|Other|0|||
162835865|NCT00267748|588110052|FG002|Non-randomized Period|Other|0|||
162835866|NCT00267748|588110050|FG000|Randomized Period|Death|0|||
162835867|NCT00267748|588110051|FG001|Randomized Period|Death|2|||
162835868|NCT00267748|588110052|FG002|Randomized Period|Death|3|||
162835869|NCT00267748|588110050|FG000|Randomized Period|Adverse Event|0|||
162835870|NCT00267748|588110051|FG001|Randomized Period|Adverse Event|23|||
162835871|NCT00267748|588110052|FG002|Randomized Period|Adverse Event|25|||
162835872|NCT00267748|588110050|FG000|Randomized Period|Global deterioration of health status|0|||
162835873|NCT00267748|588110051|FG001|Randomized Period|Global deterioration of health status|6|||
162835874|NCT00267748|588110052|FG002|Randomized Period|Global deterioration of health status|7|||
162835875|NCT00267748|588110050|FG000|Randomized Period|Lost to Follow-up|0|||
162835876|NCT00267748|588110051|FG001|Randomized Period|Lost to Follow-up|1|||
162835877|NCT00267748|588110052|FG002|Randomized Period|Lost to Follow-up|0|||
162835878|NCT00267748|588110050|FG000|Randomized Period|Objective progression or relapse|0|||
162835879|NCT00267748|588110051|FG001|Randomized Period|Objective progression or relapse|77|||
162835880|NCT00267748|588110052|FG002|Randomized Period|Objective progression or relapse|86|||
162835881|NCT00267748|588110050|FG000|Randomized Period|Withdrawal by Subject|0|||
162835882|NCT00267748|588110051|FG001|Randomized Period|Withdrawal by Subject|9|||
162835883|NCT00267748|588110052|FG002|Randomized Period|Withdrawal by Subject|2|||
162835884|NCT00267748|588110050|FG000|Randomized Period|Other|0|||
162835885|NCT00267748|588110051|FG001|Randomized Period|Other|9|||
162835886|NCT00267748|588110052|FG002|Randomized Period|Other|6|||
162835887|NCT00267748|588110050|FG000|Randomized Period|randomized but not treated|0|||
162835888|NCT00267748|588110051|FG001|Randomized Period|randomized but not treated|0|||
162835889|NCT00267748|588110052|FG002|Randomized Period|randomized but not treated|3|||
162835890|NCT00004259|588110056|FG000|Overall Study|Protocol Violation|1|||
162835891|NCT00004259|588110057|FG001|Overall Study|Protocol Violation|2|||
162835892|NCT00004259|588110058|FG002|Overall Study|Protocol Violation|0|||
162835893|NCT00004259|588110059|FG003|Overall Study|Protocol Violation|0|||
162835894|NCT00004259|588110056|FG000|Overall Study|Withdrawal by Subject|0|||
162835895|NCT00004259|588110057|FG001|Overall Study|Withdrawal by Subject|2|||
162835896|NCT00004259|588110058|FG002|Overall Study|Withdrawal by Subject|0|||
162835897|NCT00004259|588110059|FG003|Overall Study|Withdrawal by Subject|0|||
162835898|NCT03594227|588110060|FG000|Overall Study|Adverse Event|2|||
162835899|NCT03594227|588110061|FG001|Overall Study|Adverse Event|1|||
162835900|NCT03594227|588110062|FG002|Overall Study|Adverse Event|0|||
162835901|NCT03594227|588110063|FG003|Overall Study|Adverse Event|2|||
162835902|NCT03594227|588110060|FG000|Overall Study|Lost to Follow-up|1|||
162835903|NCT03594227|588110061|FG001|Overall Study|Lost to Follow-up|1|||
162835904|NCT03594227|588110062|FG002|Overall Study|Lost to Follow-up|1|||
162835905|NCT03594227|588110063|FG003|Overall Study|Lost to Follow-up|0|||
162835906|NCT03594227|588110060|FG000|Overall Study|Withdrawal by Subject|1|||
162835907|NCT03594227|588110061|FG001|Overall Study|Withdrawal by Subject|1|||
162835908|NCT03594227|588110062|FG002|Overall Study|Withdrawal by Subject|1|||
162835909|NCT03594227|588110063|FG003|Overall Study|Withdrawal by Subject|1|||
162835910|NCT03594227|588110060|FG000|Overall Study|Pregnancy|0|||
162835911|NCT03594227|588110061|FG001|Overall Study|Pregnancy|1|||
162835912|NCT03594227|588110062|FG002|Overall Study|Pregnancy|0|||
162835913|NCT03594227|588110063|FG003|Overall Study|Pregnancy|0|||
162835914|NCT03594227|588110060|FG000|Overall Study|Sponsor Decision|0|||
162835915|NCT03594227|588110061|FG001|Overall Study|Sponsor Decision|0|||
162835916|NCT03594227|588110062|FG002|Overall Study|Sponsor Decision|0|||
162835917|NCT03594227|588110063|FG003|Overall Study|Sponsor Decision|1|||
162835918|NCT03594227|588110060|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
162835919|NCT03594227|588110061|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
162835920|NCT03594227|588110062|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
162835921|NCT03594227|588110063|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
162835922|NCT01618214|588110069|FG000|Overall Study|Adverse Event|3|||
162835923|NCT01618214|588110070|FG001|Overall Study|Adverse Event|1|||
162835924|NCT01618214|588110069|FG000|Overall Study|Lack of Efficacy|1|||
162835925|NCT01618214|588110070|FG001|Overall Study|Lack of Efficacy|1|||
162835926|NCT01618214|588110069|FG000|Overall Study|Protocol Violation|1|||
162835927|NCT01618214|588110070|FG001|Overall Study|Protocol Violation|4|||
162835928|NCT01618214|588110069|FG000|Overall Study|Withdrawal Criteria|1|||
162835929|NCT01618214|588110070|FG001|Overall Study|Withdrawal Criteria|2|||
162835930|NCT01618214|588110069|FG000|Overall Study|Unclassified|4|||
162835931|NCT01618214|588110070|FG001|Overall Study|Unclassified|5|||
162835932|NCT02937818|588110071|FG000|Overall Study|Participants decision|2|||
162835933|NCT02937818|588110072|FG001|Overall Study|Participants decision|1|||
162835934|NCT02937818|588110073|FG002|Overall Study|Participants decision|1|||
162835935|NCT02937818|588110074|FG003|Overall Study|Participants decision|1|||
162835936|NCT02937818|588110071|FG000|Overall Study|Adverse Event|2|||
162835937|NCT02937818|588110072|FG001|Overall Study|Adverse Event|4|||
162835938|NCT02937818|588110073|FG002|Overall Study|Adverse Event|1|||
162835939|NCT02937818|588110074|FG003|Overall Study|Adverse Event|1|||
162835940|NCT02937818|588110071|FG000|Overall Study|Disease progression|17|||
162835941|NCT02937818|588110072|FG001|Overall Study|Disease progression|15|||
162835942|NCT02937818|588110073|FG002|Overall Study|Disease progression|7|||
162835943|NCT02937818|588110074|FG003|Overall Study|Disease progression|19|||
162835944|NCT02937818|588110071|FG000|Overall Study|Condition under investigation worsened|0|||
162835945|NCT02937818|588110072|FG001|Overall Study|Condition under investigation worsened|0|||
162948029|NCT00048568|588513141|FG001|Open-Label Period|Death|0|||
162948030|NCT00048568|588513142|FG002|Open-Label Period|Death|13|||
162948031|NCT00048568|588513140|FG000|Open-Label Period|Adverse Event|0|||
162948032|NCT00048568|588513141|FG001|Open-Label Period|Adverse Event|0|||
162948033|NCT00048568|588513142|FG002|Open-Label Period|Adverse Event|49|||
162948034|NCT00048568|588513140|FG000|Open-Label Period|Lack of Efficacy|0|||
162948035|NCT00048568|588513141|FG001|Open-Label Period|Lack of Efficacy|0|||
162948036|NCT00048568|588513142|FG002|Open-Label Period|Lack of Efficacy|32|||
162948037|NCT00048568|588513140|FG000|Open-Label Period|Withdrawal by Subject|0|||
162948038|NCT00048568|588513141|FG001|Open-Label Period|Withdrawal by Subject|0|||
162948039|NCT00048568|588513142|FG002|Open-Label Period|Withdrawal by Subject|26|||
162948040|NCT00048568|588513140|FG000|Open-Label Period|Pregnancy|0|||
162948041|NCT00048568|588513141|FG001|Open-Label Period|Pregnancy|0|||
162948042|NCT00048568|588513142|FG002|Open-Label Period|Pregnancy|5|||
162948043|NCT00048568|588513140|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
162948044|NCT00048568|588513141|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
162948045|NCT00048568|588513142|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
162948046|NCT00048568|588513140|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
162948047|NCT00048568|588513141|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
162948048|NCT00048568|588513142|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
162948049|NCT00048568|588513140|FG000|Open-Label Period|Unknown Reasons|0|||
162948050|NCT00048568|588513141|FG001|Open-Label Period|Unknown Reasons|0|||
162948051|NCT00048568|588513142|FG002|Open-Label Period|Unknown Reasons|25|||
162948052|NCT00048568|588513140|FG000|Open-Label Period|Lost to Follow-up|0|||
162948053|NCT00048568|588513141|FG001|Open-Label Period|Lost to Follow-up|0|||
162948054|NCT00048568|588513142|FG002|Open-Label Period|Lost to Follow-up|7|||
162948055|NCT01717976|588513143|FG000|Overall Study|Protocol Violation|0|||
162948056|NCT01717976|588513144|FG001|Overall Study|Protocol Violation|1|||
162948057|NCT03831048|588513145|FG000|Overall Study|Protocol Violation|9|||
162948058|NCT03831048|588513146|FG001|Overall Study|Protocol Violation|3|||
162948059|NCT03831048|588513145|FG000|Overall Study|Death|4|||
162948060|NCT03831048|588513146|FG001|Overall Study|Death|9|||
162948061|NCT03831048|588513145|FG000|Overall Study|Re-transplant|0|||
162948062|NCT03831048|588513146|FG001|Overall Study|Re-transplant|2|||
162948063|NCT03831048|588513145|FG000|Overall Study|Protocol violation and death|1|||
162948064|NCT03831048|588513146|FG001|Overall Study|Protocol violation and death|1|||
162948065|NCT01996033|588513149|FG000|Overall Study|Death|1|||
162948066|NCT01996033|588513149|FG000|Overall Study|Physician Decision|1|||
162948067|NCT01996033|588513149|FG000|Overall Study|Withdrawal by Subject|4|||
162948068|NCT01996033|588513149|FG000|Overall Study|Lost to Follow-up|3|||
162948069|NCT02896361|588513152|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
162948070|NCT02896361|588513153|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
162948071|NCT02896361|588513154|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
162948072|NCT02896361|588513152|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
162948073|NCT02896361|588513153|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
162948074|NCT02896361|588513154|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
162948075|NCT02143102|588513159|FG000|Overall Study|Lost to Follow-up|11|||
162948076|NCT02143102|588513160|FG001|Overall Study|Lost to Follow-up|0|||
162948077|NCT03164772|588513163|FG000|Overall Study|Death|4|||
162948078|NCT03164772|588513164|FG001|Overall Study|Death|2|||
162948079|NCT03164772|588513163|FG000|Overall Study|Adverse Event|1|||
162948080|NCT03164772|588513164|FG001|Overall Study|Adverse Event|4|||
162835946|NCT02937818|588110073|FG002|Overall Study|Condition under investigation worsened|1|||
162948081|NCT03164772|588513163|FG000|Overall Study|Progressive Disease|11|||
162835947|NCT02937818|588110074|FG003|Overall Study|Condition under investigation worsened|0|||
162948082|NCT03164772|588513164|FG001|Overall Study|Progressive Disease|21|||
162948083|NCT03164772|588513163|FG000|Overall Study|Physician Decision|2|||
162948084|NCT03164772|588513164|FG001|Overall Study|Physician Decision|0|||
162948085|NCT03164772|588513163|FG000|Overall Study|Withdrawal by Subject|0|||
162948086|NCT03164772|588513164|FG001|Overall Study|Withdrawal by Subject|4|||
162948087|NCT00324168|588513167|FG000|Overall Study|Lost to Follow-up|19|||
162948088|NCT00324168|588513168|FG001|Overall Study|Lost to Follow-up|18|||
162948089|NCT00324168|588513167|FG000|Overall Study|Death|3|||
162948090|NCT00324168|588513168|FG001|Overall Study|Death|3|||
162835948|NCT02228590|588110079|FG000|Overall Study|Withdrawal by Subject|1|||
162835949|NCT02111993|588110080|FG000|Overall Study|Physician Decision|5|||
162948091|NCT00324168|588513167|FG000|Overall Study|Patient did not visit in f/u window|6|||
162835950|NCT02111993|588110081|FG001|Overall Study|Physician Decision|4|||
162835951|NCT01400451|588110094|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
162835952|NCT01400451|588110095|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
162835953|NCT01400451|588110096|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
162835954|NCT01400451|588110094|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
162835955|NCT01400451|588110095|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
162835956|NCT01400451|588110096|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
162835957|NCT01400451|588110094|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
162835958|NCT01400451|588110095|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
162835959|NCT01400451|588110096|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
162835960|NCT01400451|588110094|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
162835961|NCT01400451|588110095|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
162835962|NCT01400451|588110096|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
162835963|NCT01400451|588110094|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
162835964|NCT01400451|588110095|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
162835965|NCT01400451|588110096|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
162835966|NCT00317109|588110100|FG000|Overall Study|Withdrawal by Subject|2|||
162835967|NCT00317109|588110101|FG001|Overall Study|Withdrawal by Subject|0|||
162835968|NCT00317109|588110100|FG000|Overall Study|Migated/moved from study area|1|||
162835969|NCT00317109|588110101|FG001|Overall Study|Migated/moved from study area|0|||
162835970|NCT01508702|588110104|FG000|Overall Study|Adverse Event|7|||
162835971|NCT01508702|588110105|FG001|Overall Study|Adverse Event|3|||
162835972|NCT01508702|588110104|FG000|Overall Study|Gout flare|2|||
162835973|NCT01508702|588110105|FG001|Overall Study|Gout flare|0|||
162835974|NCT01508702|588110104|FG000|Overall Study|Protocol Violation|2|||
162835975|NCT01508702|588110105|FG001|Overall Study|Protocol Violation|1|||
162835976|NCT01508702|588110104|FG000|Overall Study|Lost to Follow-up|1|||
162835977|NCT01508702|588110105|FG001|Overall Study|Lost to Follow-up|2|||
162835978|NCT01508702|588110104|FG000|Overall Study|Withdrawal by Subject|11|||
162835979|NCT01508702|588110105|FG001|Overall Study|Withdrawal by Subject|7|||
162835980|NCT04472429|588110106|FG000|Randomized Period|Ongoing|90|||
162835981|NCT04472429|588110107|FG001|Randomized Period|Ongoing|40|||
162835982|NCT04472429|588110108|FG002|Randomized Period|Ongoing|0|||
162835983|NCT04472429|588110106|FG000|Randomized Period|Death|52|||
162835984|NCT04472429|588110107|FG001|Randomized Period|Death|37|||
162835985|NCT04472429|588110108|FG002|Randomized Period|Death|0|||
162835986|NCT04472429|588110106|FG000|Randomized Period|Lost to Follow-up|4|||
162835987|NCT04472429|588110107|FG001|Randomized Period|Lost to Follow-up|0|||
162835988|NCT04472429|588110108|FG002|Randomized Period|Lost to Follow-up|0|||
162835989|NCT04472429|588110106|FG000|Randomized Period|Physician Decision|1|||
162835990|NCT04472429|588110107|FG001|Randomized Period|Physician Decision|2|||
162835991|NCT04472429|588110108|FG002|Randomized Period|Physician Decision|0|||
162835992|NCT04472429|588110106|FG000|Randomized Period|Withdrawal by Subject|6|||
162835993|NCT04472429|588110107|FG001|Randomized Period|Withdrawal by Subject|5|||
162835994|NCT04472429|588110108|FG002|Randomized Period|Withdrawal by Subject|0|||
162835995|NCT04472429|588110106|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
162835996|NCT04472429|588110107|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
162835997|NCT04472429|588110108|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
162835998|NCT04472429|588110106|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
162835999|NCT04472429|588110107|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
162836000|NCT04472429|588110108|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
162836001|NCT04472429|588110106|FG000|Open-label Monotherapy Period|Ongoing|0|||
162836002|NCT04472429|588110107|FG001|Open-label Monotherapy Period|Ongoing|0|||
162836003|NCT04472429|588110108|FG002|Open-label Monotherapy Period|Ongoing|32|||
162836004|NCT04472429|588110106|FG000|Open-label Monotherapy Period|Death|0|||
162836005|NCT04472429|588110107|FG001|Open-label Monotherapy Period|Death|0|||
162836006|NCT04472429|588110108|FG002|Open-label Monotherapy Period|Death|35|||
162836007|NCT04472429|588110106|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
162836008|NCT04472429|588110107|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
162836009|NCT04472429|588110108|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
162836010|NCT01180660|588110109|FG000|Overall Study|Changed to open surgery|1|||
162836011|NCT01180660|588110110|FG001|Overall Study|Changed to open surgery|0|||
162836012|NCT00250835|588110111|FG000|Overall Study|Withdrawal by Subject|1|||
162836013|NCT03461757|588110112|FG000|Overall Study|Adverse Event|1|||
162836014|NCT03461757|588110113|FG001|Overall Study|Adverse Event|0|||
162836015|NCT03461757|588110112|FG000|Overall Study|Lost to Follow-up|13|||
162836016|NCT03461757|588110113|FG001|Overall Study|Lost to Follow-up|7|||
162836017|NCT03461757|588110112|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
162836018|NCT03461757|588110113|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
162836019|NCT03461757|588110112|FG000|Overall Study|Non-compliance with study treatment|0|||
162836020|NCT03461757|588110113|FG001|Overall Study|Non-compliance with study treatment|1|||
162836021|NCT03461757|588110112|FG000|Overall Study|Pregnancy|2|||
162836022|NCT03461757|588110113|FG001|Overall Study|Pregnancy|0|||
162836023|NCT03461757|588110112|FG000|Overall Study|Protocol Violation|1|||
162948092|NCT00324168|588513168|FG001|Overall Study|Patient did not visit in f/u window|9|||
162948093|NCT01203878|588513169|FG000|Overall Study|Withdrawal by Subject|0|||
162948094|NCT01203878|588513170|FG001|Overall Study|Withdrawal by Subject|0|||
162948095|NCT01203878|588513171|FG002|Overall Study|Withdrawal by Subject|1|||
162948096|NCT01203878|588513169|FG000|Overall Study|Adverse Event|0|||
162948097|NCT01203878|588513170|FG001|Overall Study|Adverse Event|0|||
162948098|NCT01203878|588513171|FG002|Overall Study|Adverse Event|2|||
162948099|NCT00274937|588513172|FG000|Overall Study|Physician Decision|10|||
162836024|NCT03461757|588110113|FG001|Overall Study|Protocol Violation|1|||
162836025|NCT03461757|588110112|FG000|Overall Study|Withdrawal by Subject|7|||
162836026|NCT03461757|588110113|FG001|Overall Study|Withdrawal by Subject|7|||
162836027|NCT03461757|588110112|FG000|Overall Study|Other Reasons|1|||
162836028|NCT03461757|588110113|FG001|Overall Study|Other Reasons|4|||
162836029|NCT03861559|588110114|FG000|Overall Study|Adverse Event|0|||
162836030|NCT03861559|588110115|FG001|Overall Study|Adverse Event|2|||
162836031|NCT03861559|588110114|FG000|Overall Study|Treatment failure|0|||
162836032|NCT03861559|588110115|FG001|Overall Study|Treatment failure|2|||
162836033|NCT03861559|588110114|FG000|Overall Study|Noncompliance|1|||
162836034|NCT03861559|588110115|FG001|Overall Study|Noncompliance|1|||
162836035|NCT03861559|588110114|FG000|Overall Study|Did not meet eligibility requirements|1|||
162836036|NCT03861559|588110115|FG001|Overall Study|Did not meet eligibility requirements|0|||
162836037|NCT02500121|588110118|FG000|Overall Study|Lost to Follow-up|0|||
162836038|NCT02500121|588110119|FG001|Overall Study|Lost to Follow-up|1|||
162836039|NCT02500121|588110118|FG000|Overall Study|Withdrawal by Subject|1|||
162836040|NCT02500121|588110119|FG001|Overall Study|Withdrawal by Subject|1|||
162836041|NCT02500121|588110118|FG000|Overall Study|Death|26|||
162836042|NCT02500121|588110119|FG001|Overall Study|Death|24|||
162836043|NCT04942925|588110121|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
162836044|NCT04942925|588110122|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
162836045|NCT04942925|588110121|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
162836046|NCT04942925|588110122|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
162836047|NCT02124564|588110123|FG000|Treatment Period|Adverse Event|2|||
162836048|NCT02124564|588110123|FG000|Treatment Period|Lack of Efficacy|3|||
162836049|NCT02124564|588110123|FG000|Treatment Period|Withdrawal by Subject|2|||
162836050|NCT04489888|588110124|FG000|Overall Study|Death|75|||
162836051|NCT04489888|588110124|FG000|Overall Study|Sponsor Decision|26|||
162836052|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
162836053|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
162836054|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
162836055|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
162836056|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
162836057|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
162836058|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162836059|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162836060|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162836061|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162836062|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
162836063|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
162836064|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
162836065|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
162836066|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
162836067|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
162836068|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
162836069|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
162836070|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
162836071|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
162836072|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
162836073|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
162836074|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
162836075|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
162948100|NCT00274937|588513172|FG000|Overall Study|Withdrawal by Subject|6|||
162948101|NCT00274937|588513172|FG000|Overall Study|Progressive Disease|4|||
162948102|NCT01682083|588513173|FG000|Overall Study|Lost to Follow-up|11|||
162948103|NCT01682083|588513174|FG001|Overall Study|Lost to Follow-up|18|||
162948104|NCT01682083|588513173|FG000|Overall Study|Withdrawal by Subject|31|||
162948105|NCT01682083|588513174|FG001|Overall Study|Withdrawal by Subject|40|||
162948106|NCT01682083|588513173|FG000|Overall Study|Death|60|||
162948107|NCT01682083|588513174|FG001|Overall Study|Death|93|||
162948108|NCT01682083|588513173|FG000|Overall Study|Physician Decision|5|||
162948109|NCT01682083|588513174|FG001|Overall Study|Physician Decision|4|||
162948110|NCT02731157|588513175|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
162948111|NCT03657160|588513178|FG000|Overall Study|Adverse Event|5|||
162948112|NCT03657160|588513179|FG001|Overall Study|Adverse Event|6|||
162699810|NCT02451930|587612368|FG000|Overall Study|Death|0|||
162699811|NCT02451930|587612369|FG001|Overall Study|Death|15|||
162699812|NCT02451930|587612368|FG000|Overall Study|Lost to Follow-up|0|||
162699813|NCT02451930|587612369|FG001|Overall Study|Lost to Follow-up|3|||
162699814|NCT02451930|587612368|FG000|Overall Study|Sponsor Decision|2|||
162699815|NCT02451930|587612369|FG001|Overall Study|Sponsor Decision|10|||
162699816|NCT02451930|587612368|FG000|Overall Study|Withdrawal by Subject|0|||
162699817|NCT02451930|587612369|FG001|Overall Study|Withdrawal by Subject|1|||
162699818|NCT02451930|587612368|FG000|Overall Study|Other|0|||
162699819|NCT02451930|587612369|FG001|Overall Study|Other|1|||
162699820|NCT00962585|587612370|FG000|Overall Study|Adverse Event|0|||
162699821|NCT00962585|587612371|FG001|Overall Study|Adverse Event|2|||
162699822|NCT00962585|587612372|FG002|Overall Study|Adverse Event|1|||
162699823|NCT00962585|587612373|FG003|Overall Study|Adverse Event|0|||
162699824|NCT00962585|587612370|FG000|Overall Study|Lost to Follow-up|3|||
162699825|NCT00962585|587612371|FG001|Overall Study|Lost to Follow-up|0|||
162699826|NCT00962585|587612372|FG002|Overall Study|Lost to Follow-up|1|||
162948113|NCT03657160|588513178|FG000|Overall Study|Protocol Deviation|3|||
162948114|NCT03657160|588513179|FG001|Overall Study|Protocol Deviation|0|||
162948115|NCT03657160|588513178|FG000|Overall Study|Withdrawal by Subject|18|||
162948116|NCT03657160|588513179|FG001|Overall Study|Withdrawal by Subject|16|||
162948117|NCT03657160|588513178|FG000|Overall Study|Site Termination|1|||
162948118|NCT03657160|588513179|FG001|Overall Study|Site Termination|0|||
162948119|NCT03657160|588513178|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
162948120|NCT03657160|588513179|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
162948121|NCT03657160|588513178|FG000|Overall Study|Death|33|||
162948122|NCT03657160|588513179|FG001|Overall Study|Death|26|||
162948123|NCT03657160|588513178|FG000|Overall Study|Death (COVID-19-Related)|1|||
162948124|NCT03657160|588513179|FG001|Overall Study|Death (COVID-19-Related)|0|||
162948125|NCT03657160|588513178|FG000|Overall Study|Reason Not Specified|5|||
162948126|NCT03657160|588513179|FG001|Overall Study|Reason Not Specified|5|||
162948127|NCT03657160|588513178|FG000|Overall Study|Other (COVID-19-Related)|0|||
162948128|NCT03657160|588513179|FG001|Overall Study|Other (COVID-19-Related)|1|||
162948129|NCT02732210|588513181|FG000|Overall Study|Site Closed|0|||
162948130|NCT02732210|588513182|FG001|Overall Study|Site Closed|11|||
162948131|NCT02732210|588513181|FG000|Overall Study|Study Ended|13|||
162948132|NCT02732210|588513182|FG001|Overall Study|Study Ended|13|||
162948133|NCT02732210|588513181|FG000|Overall Study|Withdrawal by Subject|28|||
162948134|NCT02732210|588513182|FG001|Overall Study|Withdrawal by Subject|87|||
162948135|NCT02732210|588513181|FG000|Overall Study|Lost to Follow-up|5|||
162948136|NCT02732210|588513182|FG001|Overall Study|Lost to Follow-up|57|||
162948137|NCT02732210|588513181|FG000|Overall Study|Death|4|||
162948138|NCT02732210|588513182|FG001|Overall Study|Death|15|||
162948139|NCT02732210|588513181|FG000|Overall Study|Other|35|||
162948140|NCT02732210|588513182|FG001|Overall Study|Other|103|||
162948141|NCT02732210|588513181|FG000|Overall Study|Missing|0|||
162948142|NCT02732210|588513182|FG001|Overall Study|Missing|8|||
162948143|NCT00686959|588513183|FG000|Overall Study|Participants censored (no death events)|124|||
162948144|NCT00686959|588513184|FG001|Overall Study|Participants censored (no death events)|117|||
162948145|NCT01876706|588513185|FG000|Overall Study|BPH Intervention|9|||
162948146|NCT01876706|588513185|FG000|Overall Study|Lost to Follow-up|7|||
162948147|NCT01876706|588513185|FG000|Overall Study|Withdrawals|6|||
162948148|NCT01876706|588513185|FG000|Overall Study|Death|3|||
162948149|NCT00604500|588513186|FG000|Overall Study|Adverse Event|2|||
162948150|NCT00604500|588513186|FG000|Overall Study|Protocol Violation|2|||
162948151|NCT00604500|588513186|FG000|Overall Study|Treatment Failure|1|||
162699827|NCT00962585|587612373|FG003|Overall Study|Lost to Follow-up|0|||
162948152|NCT00604500|588513186|FG000|Overall Study|Withdrawal by Subject|4|||
162948153|NCT00604500|588513186|FG000|Overall Study|Administrative|1|||
162948154|NCT00604500|588513186|FG000|Overall Study|Did not meet protocol eligibility|1|||
162948155|NCT02191891|588513187|FG000|Overall Study|Withdrawal by Subject|0|||
162948156|NCT02191891|588513188|FG001|Overall Study|Withdrawal by Subject|1|||
162699828|NCT00962585|587612370|FG000|Overall Study|Protocol Violation|0|||
162699829|NCT00962585|587612371|FG001|Overall Study|Protocol Violation|0|||
162699830|NCT00962585|587612372|FG002|Overall Study|Protocol Violation|1|||
162948157|NCT02191891|588513189|FG002|Overall Study|Withdrawal by Subject|0|||
162948158|NCT02191891|588513190|FG003|Overall Study|Withdrawal by Subject|0|||
162948159|NCT02191891|588513191|FG004|Overall Study|Withdrawal by Subject|1|||
162836076|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
162836077|NCT03829657|588110134|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
162836078|NCT03829657|588110135|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
162836079|NCT03829657|588110136|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
162836080|NCT03829657|588110137|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
162836081|NCT03829657|588110138|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
162836082|NCT03829657|588110134|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
162836083|NCT03829657|588110135|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
162836084|NCT03829657|588110136|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
162836085|NCT03829657|588110137|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
162836086|NCT03829657|588110138|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
162836087|NCT03829657|588110134|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
162836088|NCT03829657|588110135|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
162836089|NCT03829657|588110136|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
162836090|NCT03829657|588110137|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
162836091|NCT03829657|588110138|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
162836092|NCT03829657|588110134|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
162836093|NCT03829657|588110135|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
162836094|NCT03829657|588110136|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
162836095|NCT03829657|588110137|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
162836096|NCT03829657|588110138|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
162836097|NCT03829657|588110134|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
162836098|NCT03829657|588110135|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
162836099|NCT03829657|588110136|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
162836100|NCT03829657|588110137|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
162836101|NCT03829657|588110138|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
162836102|NCT01014689|588110139|FG000|Overall Study|Lack of Efficacy|0|||
162836103|NCT01014689|588110140|FG001|Overall Study|Lack of Efficacy|1|||
162836104|NCT01014689|588110139|FG000|Overall Study|Adverse Event|3|||
162836105|NCT01014689|588110140|FG001|Overall Study|Adverse Event|0|||
162836106|NCT01014689|588110139|FG000|Overall Study|Withdrawal by Subject|5|||
162836107|NCT01014689|588110140|FG001|Overall Study|Withdrawal by Subject|4|||
162836108|NCT01014689|588110139|FG000|Overall Study|Protocol Violation|1|||
162836109|NCT01014689|588110140|FG001|Overall Study|Protocol Violation|1|||
162836110|NCT01014689|588110139|FG000|Overall Study|Lost to Follow-up|3|||
162836111|NCT01014689|588110140|FG001|Overall Study|Lost to Follow-up|7|||
162836112|NCT01014689|588110139|FG000|Overall Study|Pregnancy|1|||
162836113|NCT01014689|588110140|FG001|Overall Study|Pregnancy|0|||
162836114|NCT04418076|588110142|FG000|Overall Study|Death|1|||
162836115|NCT04418076|588110143|FG001|Overall Study|Death|0|||
162836116|NCT04418076|588110144|FG002|Overall Study|Death|0|||
162836117|NCT04418076|588110145|FG003|Overall Study|Death|0|||
162836118|NCT04418076|588110142|FG000|Overall Study|Lost to Follow-up|2|||
162836119|NCT04418076|588110143|FG001|Overall Study|Lost to Follow-up|5|||
162836120|NCT04418076|588110144|FG002|Overall Study|Lost to Follow-up|1|||
162836121|NCT04418076|588110145|FG003|Overall Study|Lost to Follow-up|2|||
162836122|NCT04418076|588110142|FG000|Overall Study|Withdrawal by Subject|1|||
162836123|NCT04418076|588110143|FG001|Overall Study|Withdrawal by Subject|0|||
162836124|NCT04418076|588110144|FG002|Overall Study|Withdrawal by Subject|1|||
162836125|NCT04418076|588110145|FG003|Overall Study|Withdrawal by Subject|1|||
162836126|NCT04418076|588110142|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
162836127|NCT04418076|588110143|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
162836128|NCT04418076|588110144|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
162836129|NCT04418076|588110145|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
162836130|NCT00562588|588110149|FG000|Overall Study|Adverse Event|40|||
162836131|NCT00562588|588110150|FG001|Overall Study|Adverse Event|58|||
162836132|NCT00562588|588110149|FG000|Overall Study|Protocol Violation|30|||
162836133|NCT00562588|588110150|FG001|Overall Study|Protocol Violation|26|||
162836134|NCT00562588|588110149|FG000|Overall Study|Lost to Follow-up|12|||
162836135|NCT00562588|588110150|FG001|Overall Study|Lost to Follow-up|4|||
162836136|NCT00562588|588110149|FG000|Overall Study|Withdrawal by Subject|10|||
162836137|NCT00562588|588110150|FG001|Overall Study|Withdrawal by Subject|9|||
162836138|NCT00562588|588110149|FG000|Overall Study|Other|0|||
162836139|NCT00562588|588110150|FG001|Overall Study|Other|2|||
162836140|NCT03257267|588111619|FG000|Overall Study|Adverse Event|17|||
162836141|NCT03257267|588111620|FG001|Overall Study|Adverse Event|7|||
162836142|NCT03257267|588111619|FG000|Overall Study|Death|96|||
162836143|NCT03257267|588111620|FG001|Overall Study|Death|98|||
162836144|NCT03257267|588111619|FG000|Overall Study|Lost to Follow-up|2|||
162836145|NCT03257267|588111620|FG001|Overall Study|Lost to Follow-up|2|||
162836146|NCT03257267|588111619|FG000|Overall Study|Non-compliance with Study Drug|0|||
162836147|NCT03257267|588111620|FG001|Overall Study|Non-compliance with Study Drug|2|||
162836148|NCT03257267|588111619|FG000|Overall Study|Participant Decision|35|||
162836149|NCT03257267|588111620|FG001|Overall Study|Participant Decision|43|||
162836150|NCT03257267|588111619|FG000|Overall Study|Sponsor Decision|1|||
162836151|NCT03257267|588111620|FG001|Overall Study|Sponsor Decision|0|||
162836152|NCT03257267|588111619|FG000|Overall Study|Physician Decision|1|||
162836153|NCT03257267|588111620|FG001|Overall Study|Physician Decision|3|||
162836154|NCT03257267|588111619|FG000|Overall Study|Disease Progression|109|||
162836155|NCT03257267|588111620|FG001|Overall Study|Disease Progression|121|||
162836156|NCT03257267|588111619|FG000|Overall Study|Withdrawal by Subject|8|||
162836157|NCT03257267|588111620|FG001|Overall Study|Withdrawal by Subject|26|||
162836158|NCT03257267|588111619|FG000|Overall Study|Other|0|||
162836159|NCT03257267|588111620|FG001|Overall Study|Other|2|||
162699831|NCT00962585|587612373|FG003|Overall Study|Protocol Violation|0|||
162699832|NCT00962585|587612370|FG000|Overall Study|Withdrawal by Subject|1|||
162699833|NCT00962585|587612371|FG001|Overall Study|Withdrawal by Subject|0|||
162699834|NCT00962585|587612372|FG002|Overall Study|Withdrawal by Subject|0|||
162699835|NCT00962585|587612373|FG003|Overall Study|Withdrawal by Subject|0|||
162699836|NCT00962585|587612370|FG000|Overall Study|Withdrew Consent|2|||
162699837|NCT00962585|587612371|FG001|Overall Study|Withdrew Consent|0|||
162699838|NCT00962585|587612372|FG002|Overall Study|Withdrew Consent|0|||
162699839|NCT00962585|587612373|FG003|Overall Study|Withdrew Consent|0|||
162699840|NCT01950273|587612384|FG000|Overall Study|Protocol Violation|1|||
162699841|NCT01950273|587612385|FG001|Overall Study|Protocol Violation|0|||
162699842|NCT01950273|587612384|FG000|Overall Study|Withdrawal by Subject|2|||
162699843|NCT01950273|587612385|FG001|Overall Study|Withdrawal by Subject|0|||
162699844|NCT01950273|587612384|FG000|Overall Study|Other not defined above|1|||
162699845|NCT01950273|587612385|FG001|Overall Study|Other not defined above|0|||
162699846|NCT04430335|587612388|FG000|Overall Study|Withdrawal by Subject|1|||
162699847|NCT00179010|587612391|FG000|Overall Study|Muscle probe defective|1|||
162699848|NCT00179010|587612392|FG001|Overall Study|Muscle probe defective|1|||
162699849|NCT00179010|587612391|FG000|Overall Study|Failure to place arterial line|0|||
162699850|NCT00179010|587612392|FG001|Overall Study|Failure to place arterial line|1|||
162699851|NCT03249376|587612407|FG000|Overall Study|Adverse Event|11|||
162699852|NCT03249376|587612408|FG001|Overall Study|Adverse Event|5|||
162699853|NCT03249376|587612407|FG000|Overall Study|Lack of Efficacy|2|||
162699854|NCT03249376|587612408|FG001|Overall Study|Lack of Efficacy|4|||
162699855|NCT03249376|587612407|FG000|Overall Study|Protocol Violation|3|||
162699856|NCT03249376|587612408|FG001|Overall Study|Protocol Violation|2|||
162699857|NCT03249376|587612407|FG000|Overall Study|Physician Decision|0|||
162699858|NCT03249376|587612408|FG001|Overall Study|Physician Decision|2|||
162699859|NCT03249376|587612407|FG000|Overall Study|Withdrawal by Subject|3|||
162699860|NCT03249376|587612408|FG001|Overall Study|Withdrawal by Subject|9|||
162699861|NCT03249376|587612407|FG000|Overall Study|LTFU|2|||
162699862|NCT03249376|587612408|FG001|Overall Study|LTFU|1|||
162699863|NCT00627042|587612412|FG000|Overall Study|Withdrawal by Subject|2|||
162699864|NCT00794820|587612420|FG000|Overall Study|Adverse Event|11|||
162699865|NCT00794820|587612420|FG000|Overall Study|Secondary Malignancies|2|||
162699866|NCT00794820|587612420|FG000|Overall Study|Resistant Disease|2|||
162699867|NCT00794820|587612420|FG000|Overall Study|Ineligible/Screen Failure|1|||
162836160|NCT03445000|588111621|FG000|Overall Study|Disease progression|8|||
162836161|NCT03445000|588111621|FG000|Overall Study|Adverse Event|3|||
162836162|NCT03445000|588111621|FG000|Overall Study|Death|2|||
162836163|NCT03445000|588111621|FG000|Overall Study|Physician Decision|1|||
162699868|NCT00432679|587612424|FG000|Overall Study|Adverse Event|2|||
162699869|NCT00432679|587612425|FG001|Overall Study|Adverse Event|1|||
162699870|NCT00432679|587612424|FG000|Overall Study|Withdrawal by Subject|3|||
162699871|NCT00432679|587612425|FG001|Overall Study|Withdrawal by Subject|2|||
162699872|NCT03405662|587612427|FG000|Overall Study|COVID-19 restriction|1|||
162699873|NCT03405662|587612428|FG001|Overall Study|COVID-19 restriction|0|||
162699874|NCT03405662|587612427|FG000|Overall Study|unblinding|0|||
162699875|NCT03405662|587612428|FG001|Overall Study|unblinding|1|||
162836164|NCT01982292|588111622|FG000|Overall Study|Adverse Event|2|||
162836165|NCT01982292|588111623|FG001|Overall Study|Adverse Event|0|||
162836166|NCT01982292|588111622|FG000|Overall Study|Death|1|||
162699876|NCT03405662|587612427|FG000|Overall Study|placement in memory care facility|0|||
162699877|NCT03405662|587612428|FG001|Overall Study|placement in memory care facility|2|||
162836167|NCT01982292|588111623|FG001|Overall Study|Death|0|||
162836168|NCT01982292|588111622|FG000|Overall Study|Lost to Follow-up|2|||
162836169|NCT01982292|588111623|FG001|Overall Study|Lost to Follow-up|0|||
162948160|NCT02191891|588513187|FG000|Overall Study|Adverse Event|0|||
162948161|NCT02191891|588513188|FG001|Overall Study|Adverse Event|1|||
162948162|NCT02191891|588513189|FG002|Overall Study|Adverse Event|0|||
162948163|NCT02191891|588513190|FG003|Overall Study|Adverse Event|0|||
162948164|NCT02191891|588513191|FG004|Overall Study|Adverse Event|2|||
162948165|NCT02191891|588513187|FG000|Overall Study|Disease Progression|4|||
162948166|NCT02191891|588513188|FG001|Overall Study|Disease Progression|10|||
162948167|NCT02191891|588513189|FG002|Overall Study|Disease Progression|4|||
162948168|NCT02191891|588513190|FG003|Overall Study|Disease Progression|2|||
162948169|NCT02191891|588513191|FG004|Overall Study|Disease Progression|7|||
162948170|NCT03099538|588513193|FG000|Overall Study|Lack of Efficacy|3|||
162948171|NCT01448057|588513194|FG000|Overall Study|Protocol Violation|3|||
162948172|NCT01448057|588513195|FG001|Overall Study|Protocol Violation|2|||
162948173|NCT01448057|588513194|FG000|Overall Study|Lost to Follow-up|3|||
162948174|NCT01448057|588513195|FG001|Overall Study|Lost to Follow-up|0|||
162948175|NCT01448057|588513194|FG000|Overall Study|Adverse Event|0|||
162948176|NCT01448057|588513195|FG001|Overall Study|Adverse Event|2|||
162948177|NCT01448057|588513194|FG000|Overall Study|Withdrawal by Subject|2|||
162948178|NCT01448057|588513195|FG001|Overall Study|Withdrawal by Subject|0|||
162948179|NCT02468778|588513198|FG000|Overall Study|Death|2|||
162948180|NCT02468778|588513199|FG001|Overall Study|Death|1|||
162948181|NCT02468778|588513200|FG002|Overall Study|Death|0|||
162948182|NCT02468778|588513198|FG000|Overall Study|Lost to Follow-up|1|||
162948183|NCT02468778|588513199|FG001|Overall Study|Lost to Follow-up|2|||
162948184|NCT02468778|588513200|FG002|Overall Study|Lost to Follow-up|2|||
162948185|NCT02468778|588513198|FG000|Overall Study|Withdrawal by Subject|0|||
162948186|NCT02468778|588513199|FG001|Overall Study|Withdrawal by Subject|1|||
162948187|NCT02468778|588513200|FG002|Overall Study|Withdrawal by Subject|1|||
162836170|NCT01982292|588111622|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
162836171|NCT01982292|588111623|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
162836172|NCT01982292|588111622|FG000|Overall Study|Protocol Deviation|1|||
162836173|NCT01982292|588111623|FG001|Overall Study|Protocol Deviation|0|||
162836174|NCT01982292|588111622|FG000|Overall Study|Patient/Guardian Decision|3|||
162836175|NCT01982292|588111623|FG001|Overall Study|Patient/Guardian Decision|1|||
162836176|NCT01982292|588111622|FG000|Overall Study|Technical Problems|2|||
162836177|NCT01982292|588111623|FG001|Overall Study|Technical Problems|0|||
162836178|NCT03409744|588111624|FG000|Overall Study|Death|2|||
162836179|NCT03409744|588111624|FG000|Overall Study|Physician Decision|5|||
162836180|NCT03409744|588111624|FG000|Overall Study|Pregnancy|1|||
162836181|NCT03409744|588111624|FG000|Overall Study|Lost to Follow-up|1|||
162836182|NCT03409744|588111624|FG000|Overall Study|Protocol Violation|1|||
162836183|NCT04872101|588111625|FG000|Overall Study|Withdrawal by Subject|10|||
162836184|NCT04872101|588111626|FG001|Overall Study|Withdrawal by Subject|16|||
162836185|NCT04872101|588111625|FG000|Overall Study|Lack of Efficacy|6|||
162836186|NCT04872101|588111626|FG001|Overall Study|Lack of Efficacy|14|||
162836187|NCT04872101|588111625|FG000|Overall Study|Adverse Event|1|||
162836188|NCT04872101|588111626|FG001|Overall Study|Adverse Event|6|||
162836189|NCT04872101|588111625|FG000|Overall Study|Lost to Follow-up|2|||
162836190|NCT04872101|588111626|FG001|Overall Study|Lost to Follow-up|1|||
162836191|NCT04872101|588111625|FG000|Overall Study|Pregnancy|2|||
162836192|NCT04872101|588111626|FG001|Overall Study|Pregnancy|0|||
162836193|NCT04872101|588111625|FG000|Overall Study|Prohibited Medication|1|||
162836194|NCT04872101|588111626|FG001|Overall Study|Prohibited Medication|0|||
162836195|NCT04872101|588111625|FG000|Overall Study|Not dosed|1|||
162948188|NCT03912337|588513205|FG000|Overall Study|Withdrawal of Consent From Study|1|||
162948189|NCT03912337|588513206|FG001|Overall Study|Withdrawal of Consent From Study|0|||
162948190|NCT03912337|588513205|FG000|Overall Study|Lost to Follow-up|1|||
162948191|NCT03912337|588513206|FG001|Overall Study|Lost to Follow-up|1|||
162699878|NCT00280293|587612429|FG000|Overall Study|Protocol Violation|3|||
162699879|NCT00280293|587612430|FG001|Overall Study|Protocol Violation|0|||
162836196|NCT04872101|588111626|FG001|Overall Study|Not dosed|0|||
162836197|NCT05804877|588111627|FG000|Overall Study|Lost to Follow-up|1|||
162836198|NCT05804877|588111628|FG001|Overall Study|Lost to Follow-up|3|||
162836199|NCT05804877|588111627|FG000|Overall Study|Withdrawal by Subject|1|||
162948192|NCT03978624|588513209|FG000|Overall Study|Protocol Violation|1|||
162948193|NCT03978624|588513210|FG001|Overall Study|Protocol Violation|0|||
162948194|NCT04646109|588513211|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
162836200|NCT05804877|588111628|FG001|Overall Study|Withdrawal by Subject|0|||
162836201|NCT05804877|588111627|FG000|Overall Study|Withdrawal by Subject|1|||
162836202|NCT05804877|588111628|FG001|Overall Study|Withdrawal by Subject|0|||
162836203|NCT00879229|588111629|FG000|Overall Study|Study terminated by Sponsor|13|||
162836204|NCT00879229|588111630|FG001|Overall Study|Study terminated by Sponsor|12|||
162948195|NCT04646109|588513212|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
162948196|NCT06176768|588513213|FG000|Overall Study|Adverse Event|1|||
162948197|NCT06176768|588513214|FG001|Overall Study|Adverse Event|0|||
162948198|NCT06176768|588513213|FG000|Overall Study|Assigned treatment by mistake|1|||
162948199|NCT06176768|588513214|FG001|Overall Study|Assigned treatment by mistake|0|||
162948200|NCT06176768|588513213|FG000|Overall Study|Lost to Follow-up|0|||
162948201|NCT06176768|588513214|FG001|Overall Study|Lost to Follow-up|3|||
162948202|NCT06176768|588513213|FG000|Overall Study|Physician Decision|1|||
162948203|NCT06176768|588513214|FG001|Overall Study|Physician Decision|0|||
162948204|NCT06176768|588513213|FG000|Overall Study|Protocol deviation|3|||
162948205|NCT06176768|588513214|FG001|Overall Study|Protocol deviation|1|||
162948206|NCT06176768|588513213|FG000|Overall Study|Other|1|||
162948207|NCT06176768|588513214|FG001|Overall Study|Other|0|||
162948208|NCT06176768|588513213|FG000|Overall Study|Withdrawal by Subject|6|||
162948209|NCT06176768|588513214|FG001|Overall Study|Withdrawal by Subject|9|||
162948210|NCT02672553|588513217|FG000|Overall Study|Death|3|||
162948211|NCT02672553|588513218|FG001|Overall Study|Death|5|||
162948212|NCT02672553|588513217|FG000|Overall Study|Valve Explant|1|||
162948213|NCT02672553|588513218|FG001|Overall Study|Valve Explant|0|||
162948214|NCT02672553|588513217|FG000|Overall Study|Conversion to Commercial Valve|3|||
162699880|NCT00280293|587612429|FG000|Overall Study|Physician Decision|5|||
162699881|NCT00280293|587612430|FG001|Overall Study|Physician Decision|4|||
162699882|NCT00280293|587612429|FG000|Overall Study|Lost to Follow-up|14|||
162699883|NCT00280293|587612430|FG001|Overall Study|Lost to Follow-up|12|||
162699884|NCT00280293|587612429|FG000|Overall Study|Withdrawal by Subject|3|||
162699885|NCT00280293|587612430|FG001|Overall Study|Withdrawal by Subject|5|||
162699886|NCT00280293|587612429|FG000|Overall Study|Incarceration/Legal Reasons|1|||
162699887|NCT00280293|587612430|FG001|Overall Study|Incarceration/Legal Reasons|1|||
162699888|NCT00280293|587612429|FG000|Overall Study|Adverse Event|0|||
162699889|NCT00280293|587612430|FG001|Overall Study|Adverse Event|1|||
162699890|NCT01177813|587612431|FG000|Overall Study|Adverse Event|8|||
162699891|NCT01177813|587612432|FG001|Overall Study|Adverse Event|2|||
162699892|NCT01177813|587612433|FG002|Overall Study|Adverse Event|4|||
162699893|NCT01177813|587612434|FG003|Overall Study|Adverse Event|6|||
162699894|NCT01177813|587612435|FG004|Overall Study|Adverse Event|3|||
162699895|NCT01177813|587612431|FG000|Overall Study|Lack of Efficacy|1|||
162699896|NCT01177813|587612432|FG001|Overall Study|Lack of Efficacy|0|||
162699897|NCT01177813|587612433|FG002|Overall Study|Lack of Efficacy|0|||
162699898|NCT01177813|587612434|FG003|Overall Study|Lack of Efficacy|0|||
162699899|NCT01177813|587612435|FG004|Overall Study|Lack of Efficacy|0|||
162699900|NCT01177813|587612431|FG000|Overall Study|Protocol Violation|3|||
162699901|NCT01177813|587612432|FG001|Overall Study|Protocol Violation|2|||
162699902|NCT01177813|587612433|FG002|Overall Study|Protocol Violation|2|||
162699903|NCT01177813|587612434|FG003|Overall Study|Protocol Violation|0|||
162699904|NCT01177813|587612435|FG004|Overall Study|Protocol Violation|1|||
162699905|NCT01177813|587612431|FG000|Overall Study|Lost to Follow-up|12|||
162699906|NCT01177813|587612432|FG001|Overall Study|Lost to Follow-up|5|||
162699907|NCT01177813|587612433|FG002|Overall Study|Lost to Follow-up|6|||
162699908|NCT01177813|587612434|FG003|Overall Study|Lost to Follow-up|3|||
162699909|NCT01177813|587612435|FG004|Overall Study|Lost to Follow-up|0|||
162699910|NCT01177813|587612431|FG000|Overall Study|Withdrawal by Subject|12|||
162699911|NCT01177813|587612432|FG001|Overall Study|Withdrawal by Subject|7|||
162699912|NCT01177813|587612433|FG002|Overall Study|Withdrawal by Subject|6|||
162699913|NCT01177813|587612434|FG003|Overall Study|Withdrawal by Subject|5|||
162699914|NCT01177813|587612435|FG004|Overall Study|Withdrawal by Subject|3|||
162699915|NCT01177813|587612431|FG000|Overall Study|Other reason not defined above|5|||
162699916|NCT01177813|587612432|FG001|Overall Study|Other reason not defined above|2|||
162699917|NCT01177813|587612433|FG002|Overall Study|Other reason not defined above|2|||
162699918|NCT01177813|587612434|FG003|Overall Study|Other reason not defined above|3|||
162699919|NCT01177813|587612435|FG004|Overall Study|Other reason not defined above|2|||
162699920|NCT01458249|587612438|FG000|Overall Study|Not treated|1|||
162699921|NCT01458249|587612438|FG000|Overall Study|Adverse Event|4|||
162699922|NCT01458249|587612438|FG000|Overall Study|Other|2|||
162699923|NCT01458249|587612438|FG000|Overall Study|Ongoing|1|||
162699924|NCT02056119|587612441|FG000|Overall Study|Death|1|||
162699925|NCT02056119|587612442|FG001|Overall Study|Death|2|||
162699926|NCT02056119|587612441|FG000|Overall Study|Intubated for less than 24 hrs|2|||
162699927|NCT02056119|587612442|FG001|Overall Study|Intubated for less than 24 hrs|7|||
162948215|NCT02672553|588513218|FG001|Overall Study|Conversion to Commercial Valve|0|||
162699928|NCT02056119|587612441|FG000|Overall Study|No aerosol treatments were given.|3|||
162699929|NCT02056119|587612442|FG001|Overall Study|No aerosol treatments were given.|2|||
162699930|NCT02056119|587612441|FG000|Overall Study|Received Metaneb treatment|0|||
162948216|NCT02672553|588513217|FG000|Overall Study|Withdrawal by Subject|3|||
162948217|NCT02672553|588513218|FG001|Overall Study|Withdrawal by Subject|3|||
162699931|NCT02056119|587612442|FG001|Overall Study|Received Metaneb treatment|2|||
162699932|NCT02056119|587612441|FG000|Overall Study|Protocol Violation|4|||
162699933|NCT02056119|587612442|FG001|Overall Study|Protocol Violation|7|||
162699934|NCT01348854|587612443|FG000|Overall Study|Lost to Follow-up|2|||
162699935|NCT01348854|587612444|FG001|Overall Study|Lost to Follow-up|1|||
162699936|NCT01348854|587612443|FG000|Overall Study|Withdrawal by Subject|1|||
162836205|NCT00879229|588111629|FG000|Overall Study|Death|4|||
162836206|NCT00879229|588111630|FG001|Overall Study|Death|2|||
162836207|NCT00879229|588111629|FG000|Overall Study|Adverse Event|2|||
162836208|NCT00879229|588111630|FG001|Overall Study|Adverse Event|0|||
162836209|NCT00879229|588111629|FG000|Overall Study|Withdrawal by Subject|1|||
162836210|NCT00879229|588111630|FG001|Overall Study|Withdrawal by Subject|0|||
162836211|NCT00879229|588111629|FG000|Overall Study|Clinical status did not improve|1|||
162836212|NCT00879229|588111630|FG001|Overall Study|Clinical status did not improve|0|||
162836213|NCT00879229|588111629|FG000|Overall Study|Other|1|||
162836214|NCT00879229|588111630|FG001|Overall Study|Other|0|||
162836215|NCT00264004|588111631|FG000|Overall Study|Adverse Event|2|||
162836216|NCT00264004|588111632|FG001|Overall Study|Adverse Event|3|||
162836217|NCT00264004|588111633|FG002|Overall Study|Adverse Event|6|||
162836218|NCT00264004|588111634|FG003|Overall Study|Adverse Event|4|||
162836219|NCT00264004|588111631|FG000|Overall Study|Withdrawal by Subject|0|||
162836220|NCT00264004|588111632|FG001|Overall Study|Withdrawal by Subject|1|||
162836221|NCT00264004|588111633|FG002|Overall Study|Withdrawal by Subject|2|||
162836222|NCT00264004|588111634|FG003|Overall Study|Withdrawal by Subject|2|||
162836223|NCT00264004|588111631|FG000|Overall Study|Other|2|||
162836224|NCT00264004|588111632|FG001|Overall Study|Other|2|||
162836225|NCT00264004|588111633|FG002|Overall Study|Other|0|||
162836226|NCT00264004|588111634|FG003|Overall Study|Other|3|||
162836227|NCT00264004|588111631|FG000|Overall Study|Development study specific disc. crit.|1|||
162836228|NCT00264004|588111632|FG001|Overall Study|Development study specific disc. crit.|0|||
162836229|NCT00264004|588111633|FG002|Overall Study|Development study specific disc. crit.|1|||
162836230|NCT00264004|588111634|FG003|Overall Study|Development study specific disc. crit.|0|||
162836231|NCT00264004|588111631|FG000|Overall Study|Cond. under inv. worsened|9|||
162836232|NCT00264004|588111632|FG001|Overall Study|Cond. under inv. worsened|5|||
162836233|NCT00264004|588111633|FG002|Overall Study|Cond. under inv. worsened|3|||
162836234|NCT00264004|588111634|FG003|Overall Study|Cond. under inv. worsened|4|||
162836235|NCT00264004|588111631|FG000|Overall Study|Not treated|3|||
162836236|NCT00264004|588111632|FG001|Overall Study|Not treated|0|||
162836237|NCT00264004|588111633|FG002|Overall Study|Not treated|2|||
162836238|NCT00264004|588111634|FG003|Overall Study|Not treated|2|||
162836239|NCT02475681|588111635|FG000|Overall Study|Death|16|||
162836240|NCT02475681|588111636|FG001|Overall Study|Death|6|||
162836241|NCT02475681|588111637|FG002|Overall Study|Death|9|||
162836242|NCT02475681|588111635|FG000|Overall Study|Physician Decision|0|||
162836243|NCT02475681|588111636|FG001|Overall Study|Physician Decision|3|||
162836244|NCT02475681|588111637|FG002|Overall Study|Physician Decision|1|||
162836245|NCT02475681|588111635|FG000|Overall Study|Withdrawal by Subject|12|||
162836246|NCT02475681|588111636|FG001|Overall Study|Withdrawal by Subject|6|||
162836247|NCT02475681|588111637|FG002|Overall Study|Withdrawal by Subject|9|||
162836248|NCT02475681|588111635|FG000|Overall Study|Lost to Follow-up|2|||
162836249|NCT02475681|588111636|FG001|Overall Study|Lost to Follow-up|1|||
162836250|NCT02475681|588111637|FG002|Overall Study|Lost to Follow-up|3|||
162836251|NCT02475681|588111635|FG000|Overall Study|Ongoing in Study|0|||
162836252|NCT02475681|588111636|FG001|Overall Study|Ongoing in Study|163|||
162836253|NCT02475681|588111637|FG002|Overall Study|Ongoing in Study|157|||
162836254|NCT02475681|588111635|FG000|Overall Study|Reasons other than above listed|2|||
162836255|NCT02475681|588111636|FG001|Overall Study|Reasons other than above listed|0|||
162836256|NCT02475681|588111637|FG002|Overall Study|Reasons other than above listed|0|||
162836257|NCT01262365|588111645|FG000|Overall Study|Lack of Efficacy|35|||
162836258|NCT01262365|588111646|FG001|Overall Study|Lack of Efficacy|30|||
162836259|NCT01262365|588111647|FG002|Overall Study|Lack of Efficacy|47|||
162836260|NCT01262365|588111645|FG000|Overall Study|Protocol Violation|3|||
162836261|NCT01262365|588111646|FG001|Overall Study|Protocol Violation|1|||
162836262|NCT01262365|588111647|FG002|Overall Study|Protocol Violation|1|||
162836263|NCT01262365|588111645|FG000|Overall Study|Lost to Follow-up|3|||
162836264|NCT01262365|588111646|FG001|Overall Study|Lost to Follow-up|7|||
162836265|NCT01262365|588111647|FG002|Overall Study|Lost to Follow-up|6|||
162836266|NCT01262365|588111645|FG000|Overall Study|Withdrawal by Subject|17|||
162836267|NCT01262365|588111646|FG001|Overall Study|Withdrawal by Subject|22|||
162836268|NCT01262365|588111647|FG002|Overall Study|Withdrawal by Subject|22|||
162836269|NCT01262365|588111645|FG000|Overall Study|Death|1|||
162836270|NCT01262365|588111646|FG001|Overall Study|Death|2|||
162836271|NCT01262365|588111647|FG002|Overall Study|Death|1|||
162836272|NCT01262365|588111645|FG000|Overall Study|Adverse Event|26|||
162836273|NCT01262365|588111646|FG001|Overall Study|Adverse Event|16|||
162836274|NCT01262365|588111647|FG002|Overall Study|Adverse Event|11|||
162836275|NCT01262365|588111645|FG000|Overall Study|sponsor decision|1|||
162836276|NCT01262365|588111646|FG001|Overall Study|sponsor decision|1|||
162836277|NCT01262365|588111647|FG002|Overall Study|sponsor decision|0|||
162836278|NCT01262365|588111645|FG000|Overall Study|Randomization error|1|||
162836279|NCT01262365|588111646|FG001|Overall Study|Randomization error|0|||
162836280|NCT01262365|588111647|FG002|Overall Study|Randomization error|2|||
162836281|NCT01262365|588111645|FG000|Overall Study|Non-compliance|1|||
162836282|NCT01262365|588111646|FG001|Overall Study|Non-compliance|0|||
162836283|NCT01262365|588111647|FG002|Overall Study|Non-compliance|2|||
162836284|NCT01262365|588111645|FG000|Overall Study|Suspected pregnancy|1|||
162836285|NCT01262365|588111646|FG001|Overall Study|Suspected pregnancy|0|||
162836286|NCT01262365|588111647|FG002|Overall Study|Suspected pregnancy|0|||
162836287|NCT01262365|588111645|FG000|Overall Study|Patient pregnant|1|||
162836288|NCT01262365|588111646|FG001|Overall Study|Patient pregnant|0|||
162836289|NCT01262365|588111647|FG002|Overall Study|Patient pregnant|1|||
162836290|NCT01262365|588111645|FG000|Overall Study|Toxicity related to study drug|0|||
162836291|NCT01262365|588111646|FG001|Overall Study|Toxicity related to study drug|1|||
162836292|NCT01262365|588111647|FG002|Overall Study|Toxicity related to study drug|0|||
162836293|NCT01262365|588111645|FG000|Overall Study|Cannot tolerate the protocol|0|||
162836294|NCT01262365|588111646|FG001|Overall Study|Cannot tolerate the protocol|1|||
162836295|NCT01262365|588111647|FG002|Overall Study|Cannot tolerate the protocol|0|||
162836296|NCT01262365|588111645|FG000|Overall Study|Patient unavailable|0|||
162836297|NCT01262365|588111646|FG001|Overall Study|Patient unavailable|0|||
162836298|NCT01262365|588111647|FG002|Overall Study|Patient unavailable|1|||
162836299|NCT00527605|588111648|FG000|Overall Study|Adverse Event|3|||
162836300|NCT00527605|588111649|FG001|Overall Study|Adverse Event|0|||
162836301|NCT00527605|588111648|FG000|Overall Study|Withdrawal by Subject|3|||
162836302|NCT00527605|588111649|FG001|Overall Study|Withdrawal by Subject|7|||
162836303|NCT00527605|588111648|FG000|Overall Study|Lost to Follow-up|6|||
162836304|NCT00527605|588111649|FG001|Overall Study|Lost to Follow-up|2|||
162836305|NCT00527605|588111648|FG000|Overall Study|Protocol Violation|1|||
162836306|NCT00527605|588111649|FG001|Overall Study|Protocol Violation|2|||
162836307|NCT01363986|588111655|FG000|Overall Study|Disease progression|1|||
162836308|NCT02605642|588111656|FG000|Overall Study|Other|11|||
162836309|NCT02605642|588111657|FG001|Overall Study|Other|1|||
162836310|NCT02605642|588111656|FG000|Overall Study|Participant non-compliance|2|||
162836311|NCT02605642|588111657|FG001|Overall Study|Participant non-compliance|4|||
162836312|NCT02605642|588111656|FG000|Overall Study|Physician Decision|10|||
162836313|NCT02605642|588111657|FG001|Overall Study|Physician Decision|0|||
162836314|NCT02605642|588111656|FG000|Overall Study|Lost to Follow-up|12|||
162836315|NCT02605642|588111657|FG001|Overall Study|Lost to Follow-up|1|||
162836316|NCT02605642|588111656|FG000|Overall Study|Adverse Event|14|||
162836317|NCT02605642|588111657|FG001|Overall Study|Adverse Event|2|||
162836318|NCT02605642|588111656|FG000|Overall Study|Withdrawal by Subject|23|||
162836319|NCT02605642|588111657|FG001|Overall Study|Withdrawal by Subject|2|||
162836320|NCT02605642|588111656|FG000|Overall Study|Lack of response|24|||
162836321|NCT02605642|588111657|FG001|Overall Study|Lack of response|11|||
162836322|NCT02111564|588111660|FG000|Overall Study|Death|109|||
162836323|NCT02111564|588111661|FG001|Overall Study|Death|120|||
162836324|NCT02111564|588111660|FG000|Overall Study|Lost to Follow-up|2|||
162836325|NCT02111564|588111661|FG001|Overall Study|Lost to Follow-up|3|||
162836326|NCT02111564|588111660|FG000|Overall Study|Withdrawal by Subject|20|||
162836327|NCT02111564|588111661|FG001|Overall Study|Withdrawal by Subject|20|||
162836328|NCT00687362|588111662|FG000|Overall Study|Protocol Violation|2|||
162836329|NCT00687362|588111662|FG000|Overall Study|Withdrawal by Subject|1|||
162836330|NCT03704194|588111672|FG000|Overall Study|Withdrawal by Subject|0|||
162836331|NCT03704194|588111673|FG001|Overall Study|Withdrawal by Subject|1|||
162836332|NCT00925015|588111674|FG000|Overall Study|Adverse Event|1|||
162836333|NCT00925015|588111675|FG001|Overall Study|Adverse Event|2|||
162836334|NCT00925015|588111676|FG002|Overall Study|Adverse Event|1|||
162836335|NCT00925015|588111674|FG000|Overall Study|Physician Decision|0|||
162836336|NCT00925015|588111675|FG001|Overall Study|Physician Decision|1|||
162836337|NCT00925015|588111676|FG002|Overall Study|Physician Decision|0|||
162836338|NCT00925015|588111674|FG000|Overall Study|Progressive Disease|7|||
162836339|NCT00925015|588111675|FG001|Overall Study|Progressive Disease|3|||
162836340|NCT00925015|588111676|FG002|Overall Study|Progressive Disease|4|||
162836341|NCT00925015|588111674|FG000|Overall Study|Withdrawal by Subject|0|||
162836342|NCT00925015|588111675|FG001|Overall Study|Withdrawal by Subject|0|||
162836343|NCT00925015|588111676|FG002|Overall Study|Withdrawal by Subject|1|||
162836344|NCT00179309|588111679|FG000|Treatment|Toxicity|2|||
162836345|NCT00179309|588111680|FG001|Treatment|Toxicity|3|||
162836346|NCT00179309|588111679|FG000|Treatment|Withdrawal by Subject|1|||
162836347|NCT00179309|588111680|FG001|Treatment|Withdrawal by Subject|2|||
162836348|NCT00179309|588111679|FG000|Treatment|Allergy|1|||
162836349|NCT00179309|588111680|FG001|Treatment|Allergy|0|||
162836350|NCT04986202|588111681|FG000|Overall Study|Death|10|||
162836351|NCT04986202|588111682|FG001|Overall Study|Death|3|||
162836352|NCT04986202|588111683|FG002|Overall Study|Death|10|||
162836353|NCT04986202|588111681|FG000|Overall Study|Physician Decision|3|||
162836354|NCT04986202|588111682|FG001|Overall Study|Physician Decision|1|||
162836355|NCT04986202|588111683|FG002|Overall Study|Physician Decision|2|||
162836356|NCT04986202|588111681|FG000|Overall Study|Withdrawal by Subject|4|||
162836357|NCT04986202|588111682|FG001|Overall Study|Withdrawal by Subject|2|||
162836358|NCT04986202|588111683|FG002|Overall Study|Withdrawal by Subject|4|||
162836359|NCT05131204|588111684|FG000|Overall Study|Sponsor request|2|||
162948218|NCT02672553|588513217|FG000|Overall Study|Intraoperative screen failure|2|||
162948219|NCT02672553|588513218|FG001|Overall Study|Intraoperative screen failure|0|||
162948220|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in CNS Only|16|||
162948221|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
162948222|NCT01004172|588513219|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
162948223|NCT01004172|588513219|FG000|Overall Study|Adverse Event|1|||
162948224|NCT01004172|588513219|FG000|Overall Study|Physician Decision|1|||
162948225|NCT01004172|588513219|FG000|Overall Study|Symptomatic Deterioration|2|||
162948226|NCT01606306|588513220|FG000|Overall Study|Lack of Efficacy|2|||
162948227|NCT01606306|588513221|FG001|Overall Study|Lack of Efficacy|1|||
162948228|NCT01606306|588513222|FG002|Overall Study|Lack of Efficacy|4|||
162948229|NCT01606306|588513223|FG003|Overall Study|Lack of Efficacy|4|||
162948230|NCT01606306|588513224|FG004|Overall Study|Lack of Efficacy|1|||
162948231|NCT01606306|588513225|FG005|Overall Study|Lack of Efficacy|2|||
162948232|NCT01606306|588513220|FG000|Overall Study|Adverse Event|1|||
162948233|NCT01606306|588513221|FG001|Overall Study|Adverse Event|0|||
162948234|NCT01606306|588513222|FG002|Overall Study|Adverse Event|1|||
162948235|NCT01606306|588513223|FG003|Overall Study|Adverse Event|1|||
162948236|NCT01606306|588513224|FG004|Overall Study|Adverse Event|2|||
162948237|NCT01606306|588513225|FG005|Overall Study|Adverse Event|0|||
162948238|NCT01606306|588513220|FG000|Overall Study|Lost to Follow-up|7|||
162948239|NCT01606306|588513221|FG001|Overall Study|Lost to Follow-up|4|||
162948240|NCT01606306|588513222|FG002|Overall Study|Lost to Follow-up|5|||
162948241|NCT01606306|588513223|FG003|Overall Study|Lost to Follow-up|4|||
162948242|NCT01606306|588513224|FG004|Overall Study|Lost to Follow-up|3|||
162948243|NCT01606306|588513225|FG005|Overall Study|Lost to Follow-up|5|||
162948244|NCT01606306|588513220|FG000|Overall Study|Withdrawal by Subject|4|||
162948245|NCT01606306|588513221|FG001|Overall Study|Withdrawal by Subject|3|||
162948246|NCT01606306|588513222|FG002|Overall Study|Withdrawal by Subject|4|||
162948247|NCT01606306|588513223|FG003|Overall Study|Withdrawal by Subject|4|||
162948248|NCT01606306|588513224|FG004|Overall Study|Withdrawal by Subject|5|||
162948249|NCT01606306|588513225|FG005|Overall Study|Withdrawal by Subject|4|||
162948250|NCT01606306|588513220|FG000|Overall Study|Physician Decision|1|||
162948251|NCT01606306|588513221|FG001|Overall Study|Physician Decision|2|||
162948252|NCT01606306|588513222|FG002|Overall Study|Physician Decision|0|||
162948253|NCT01606306|588513223|FG003|Overall Study|Physician Decision|0|||
162948254|NCT01606306|588513224|FG004|Overall Study|Physician Decision|0|||
162948255|NCT01606306|588513225|FG005|Overall Study|Physician Decision|0|||
162948256|NCT00950872|588513226|FG000|Overall Study|Withdrawal by Subject|1|||
162948257|NCT00950872|588513226|FG000|Overall Study|Did not have surgery|2|||
162948258|NCT00970281|588513227|FG000|Overall Study|Lack of Efficacy|1|||
162948259|NCT00970281|588513228|FG001|Overall Study|Lack of Efficacy|14|||
162948260|NCT00970281|588513227|FG000|Overall Study|Withdrawal by Subject|0|||
162948261|NCT00970281|588513228|FG001|Overall Study|Withdrawal by Subject|1|||
162948262|NCT00970281|588513227|FG000|Overall Study|Physician Decision|1|||
162948263|NCT00970281|588513228|FG001|Overall Study|Physician Decision|1|||
162948264|NCT00993616|588513241|FG000|Overall Study|No tumor at entry|1|||
162948265|NCT00993616|588513241|FG000|Overall Study|Never treated|1|||
162948266|NCT02937701|588515144|FG000|Day 1 to Week 22|Adverse Event|11|||
162948267|NCT02937701|588515145|FG001|Day 1 to Week 22|Adverse Event|14|||
162948268|NCT02937701|588515146|FG002|Day 1 to Week 22|Adverse Event|0|||
162948269|NCT02937701|588515147|FG003|Day 1 to Week 22|Adverse Event|0|||
162948270|NCT02937701|588515148|FG004|Day 1 to Week 22|Adverse Event|0|||
162948271|NCT02937701|588515144|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
162948272|NCT02937701|588515145|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
162948273|NCT02937701|588515146|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948274|NCT02937701|588515147|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948275|NCT02937701|588515148|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
162948276|NCT02937701|588515144|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
162948277|NCT02937701|588515145|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
162948278|NCT02937701|588515146|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948279|NCT02937701|588515147|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948280|NCT02937701|588515148|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
162948281|NCT02937701|588515144|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
162948282|NCT02937701|588515145|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
162948283|NCT02937701|588515146|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
162948284|NCT02937701|588515147|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
162948285|NCT02937701|588515148|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
162948286|NCT02937701|588515144|FG000|Day 1 to Week 22|Death|1|||
162948287|NCT02937701|588515145|FG001|Day 1 to Week 22|Death|1|||
162948288|NCT02937701|588515146|FG002|Day 1 to Week 22|Death|0|||
162948289|NCT02937701|588515147|FG003|Day 1 to Week 22|Death|0|||
162948290|NCT02937701|588515148|FG004|Day 1 to Week 22|Death|0|||
162948291|NCT02937701|588515144|FG000|Day 1 to Week 22|Protocol Violation|1|||
162948292|NCT02937701|588515145|FG001|Day 1 to Week 22|Protocol Violation|1|||
162948293|NCT02937701|588515146|FG002|Day 1 to Week 22|Protocol Violation|0|||
162948294|NCT02937701|588515147|FG003|Day 1 to Week 22|Protocol Violation|0|||
162836360|NCT05131204|588111685|FG001|Overall Study|Sponsor request|1|||
162836361|NCT02469090|588111687|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
162836362|NCT02469090|588111688|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
162836363|NCT02469090|588111689|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
162836364|NCT02469090|588111687|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
162836365|NCT02469090|588111688|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
162836366|NCT02469090|588111689|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
162836367|NCT02469090|588111687|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
162836368|NCT02469090|588111688|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
162836369|NCT02469090|588111689|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
162836370|NCT02469090|588111687|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
162836371|NCT02469090|588111688|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
162836372|NCT02469090|588111689|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
162836373|NCT02469090|588111687|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
162836374|NCT02469090|588111688|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
162836375|NCT02469090|588111689|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
162836376|NCT02469090|588111687|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
162836377|NCT02469090|588111688|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
162836378|NCT02469090|588111689|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
162836379|NCT02469090|588111687|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
162836380|NCT02469090|588111688|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
162836381|NCT02469090|588111689|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
162836382|NCT02469090|588111687|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
162836383|NCT02469090|588111688|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
162836384|NCT02469090|588111689|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
162836385|NCT03823391|588111693|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
162836386|NCT03823391|588111694|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
162836387|NCT03823391|588111693|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
162836388|NCT03823391|588111694|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
162836389|NCT05030311|588111696|FG000|Overall Study|Technical problems|0|||
162836390|NCT05030311|588111697|FG001|Overall Study|Technical problems|1|||
162836391|NCT05030311|588111696|FG000|Overall Study|Withdrawal by Subject|31|||
162836392|NCT05030311|588111697|FG001|Overall Study|Withdrawal by Subject|17|||
162836393|NCT05030311|588111696|FG000|Overall Study|Adverse Event|13|||
162836394|NCT05030311|588111697|FG001|Overall Study|Adverse Event|5|||
162836395|NCT05030311|588111696|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162836396|NCT05030311|588111697|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162836397|NCT05030311|588111696|FG000|Overall Study|Physician Decision|5|||
162836398|NCT05030311|588111697|FG001|Overall Study|Physician Decision|2|||
162836399|NCT05030311|588111696|FG000|Overall Study|Lost to Follow-up|5|||
162836400|NCT05030311|588111697|FG001|Overall Study|Lost to Follow-up|1|||
162836401|NCT05030311|588111696|FG000|Overall Study|Protocol Violation|4|||
162836402|NCT05030311|588111697|FG001|Overall Study|Protocol Violation|4|||
162836403|NCT01425203|588111698|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
162836404|NCT01425203|588111699|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
162836405|NCT01425203|588111700|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
162836406|NCT01425203|588111698|FG000|Treatment Phase|Failure at futility timepoint|8|||
162836407|NCT01425203|588111699|FG001|Treatment Phase|Failure at futility timepoint|27|||
162836408|NCT01425203|588111700|FG002|Treatment Phase|Failure at futility timepoint|0|||
162836409|NCT01425203|588111698|FG000|Treatment Phase|Other virologic failure criteria|5|||
162836410|NCT01425203|588111699|FG001|Treatment Phase|Other virologic failure criteria|3|||
162948295|NCT02937701|588515148|FG004|Day 1 to Week 22|Protocol Violation|0|||
162948296|NCT02937701|588515144|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
162836411|NCT01425203|588111700|FG002|Treatment Phase|Other virologic failure criteria|0|||
162836412|NCT01425203|588111698|FG000|Treatment Phase|Unidentified reasons|11|||
162836413|NCT01425203|588111699|FG001|Treatment Phase|Unidentified reasons|5|||
162836414|NCT01425203|588111700|FG002|Treatment Phase|Unidentified reasons|0|||
162836415|NCT01425203|588111698|FG000|Treatment Phase|Did not receive treatment|0|||
162836416|NCT01425203|588111699|FG001|Treatment Phase|Did not receive treatment|1|||
162836417|NCT01425203|588111700|FG002|Treatment Phase|Did not receive treatment|0|||
162836418|NCT01425203|588111698|FG000|Crossover Phase|Failure at futility timepoint|0|||
162836419|NCT01425203|588111699|FG001|Crossover Phase|Failure at futility timepoint|0|||
162836420|NCT01425203|588111700|FG002|Crossover Phase|Failure at futility timepoint|3|||
162836421|NCT01425203|588111698|FG000|Crossover Phase|Other virologic failure criteria|0|||
162836422|NCT01425203|588111699|FG001|Crossover Phase|Other virologic failure criteria|0|||
162836423|NCT01425203|588111700|FG002|Crossover Phase|Other virologic failure criteria|3|||
162836424|NCT00290433|588111703|FG000|Overall Study|Disease Progression|13|||
162836425|NCT00290433|588111703|FG000|Overall Study|Adverse Event|14|||
162836426|NCT00290433|588111703|FG000|Overall Study|Withdrawal by Subject|1|||
162836427|NCT00290433|588111703|FG000|Overall Study|Non-Compliance|1|||
162836428|NCT00290433|588111703|FG000|Overall Study|Congestive Heart Failure|1|||
162836429|NCT00290433|588111703|FG000|Overall Study|Transplant in CR|5|||
162836430|NCT00290433|588111703|FG000|Overall Study|Unrelated Infection/Death|1|||
162836431|NCT02264990|588111708|FG000|Overall Study|Death|255|||
162836432|NCT02264990|588111709|FG001|Overall Study|Death|250|||
162836433|NCT02264990|588111708|FG000|Overall Study|Withdrawal by Subject|4|||
162836434|NCT02264990|588111709|FG001|Overall Study|Withdrawal by Subject|5|||
162836435|NCT02264990|588111708|FG000|Overall Study|Lost to Follow-up|1|||
162836436|NCT02264990|588111709|FG001|Overall Study|Lost to Follow-up|3|||
162836437|NCT02264990|588111708|FG000|Overall Study|Other|0|||
162836438|NCT02264990|588111709|FG001|Overall Study|Other|1|||
162836439|NCT03031301|588111710|FG000|Overall Study|Protocol Violation|4|||
162836440|NCT03031301|588111711|FG001|Overall Study|Protocol Violation|8|||
162836441|NCT03031301|588111710|FG000|Overall Study|Withdrawal by Subject|7|||
162836442|NCT03031301|588111711|FG001|Overall Study|Withdrawal by Subject|4|||
162836443|NCT03031301|588111710|FG000|Overall Study|Lost to Follow-up|4|||
162836444|NCT03031301|588111711|FG001|Overall Study|Lost to Follow-up|12|||
162836445|NCT03031301|588111710|FG000|Overall Study|Noncompliance|1|||
162836446|NCT03031301|588111711|FG001|Overall Study|Noncompliance|3|||
162836447|NCT03031301|588111710|FG000|Overall Study|Technical issue|1|||
162836448|NCT03031301|588111711|FG001|Overall Study|Technical issue|1|||
162836449|NCT03031301|588111710|FG000|Overall Study|Adverse Event|1|||
162836450|NCT03031301|588111711|FG001|Overall Study|Adverse Event|0|||
162836451|NCT02275338|588111713|FG000|Overall Study|Adverse Event|15|||
162836452|NCT02275338|588111713|FG000|Overall Study|Lack of Efficacy|3|||
162836453|NCT02275338|588111713|FG000|Overall Study|Withdrawal by Subject|4|||
162836454|NCT02275338|588111713|FG000|Overall Study|Disease progression (death)|1|||
162836455|NCT02275338|588111713|FG000|Overall Study|Ineligible to start Phase 2|4|||
162836456|NCT02275338|588111713|FG000|Overall Study|Reason not specified|5|||
162836457|NCT02275338|588111713|FG000|Overall Study|Does not meet entry criteria|1|||
162836458|NCT01100944|588111714|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
162836459|NCT01100944|588111715|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
162836460|NCT01100944|588111716|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
162836461|NCT01100944|588111714|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
162836462|NCT01100944|588111715|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
162836463|NCT01100944|588111716|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
162836464|NCT01100944|588111714|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
162836465|NCT01100944|588111715|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
162836466|NCT01100944|588111716|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
162836467|NCT01100944|588111714|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
162836468|NCT01100944|588111715|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
162836469|NCT01100944|588111716|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
162836470|NCT01665807|588111720|FG000|Overall Study|Withdrawal by Subject|2|||
162836471|NCT01665807|588111721|FG001|Overall Study|Withdrawal by Subject|0|||
162836472|NCT01665807|588111722|FG002|Overall Study|Withdrawal by Subject|1|||
162836473|NCT03603496|588111724|FG000|Overall Study|Death|19|||
162836474|NCT03603496|588111725|FG001|Overall Study|Death|24|||
162836475|NCT03603496|588111724|FG000|Overall Study|Lost to Follow-up|141|||
162836476|NCT03603496|588111725|FG001|Overall Study|Lost to Follow-up|141|||
162836477|NCT03603496|588111724|FG000|Overall Study|Withdrawal by Subject|26|||
162836478|NCT03603496|588111725|FG001|Overall Study|Withdrawal by Subject|20|||
162836479|NCT00109707|588111727|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
162836480|NCT00109707|588111728|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
162836481|NCT00109707|588111729|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
162836482|NCT00109707|588111727|FG000|Overall Study|Abnormal laboratory values|1|||
162836483|NCT00109707|588111728|FG001|Overall Study|Abnormal laboratory values|0|||
162836484|NCT00109707|588111729|FG002|Overall Study|Abnormal laboratory values|0|||
162836485|NCT00109707|588111727|FG000|Overall Study|Administrative problems|2|||
162836486|NCT00109707|588111728|FG001|Overall Study|Administrative problems|0|||
162836487|NCT00109707|588111729|FG002|Overall Study|Administrative problems|1|||
162836488|NCT00109707|588111727|FG000|Overall Study|Adverse Event|10|||
162836489|NCT00109707|588111728|FG001|Overall Study|Adverse Event|2|||
162836490|NCT00109707|588111729|FG002|Overall Study|Adverse Event|3|||
162836491|NCT00109707|588111727|FG000|Overall Study|Death|4|||
162836492|NCT00109707|588111728|FG001|Overall Study|Death|0|||
162836493|NCT00109707|588111729|FG002|Overall Study|Death|0|||
162836494|NCT00109707|588111727|FG000|Overall Study|Disease progression|12|||
162836495|NCT00109707|588111728|FG001|Overall Study|Disease progression|4|||
162836496|NCT00109707|588111729|FG002|Overall Study|Disease progression|3|||
162836497|NCT00109707|588111727|FG000|Overall Study|Lost to Follow-up|3|||
162836498|NCT00109707|588111728|FG001|Overall Study|Lost to Follow-up|0|||
162836499|NCT00109707|588111729|FG002|Overall Study|Lost to Follow-up|0|||
162836500|NCT00109707|588111727|FG000|Overall Study|Protocol Violation|1|||
162836501|NCT00109707|588111728|FG001|Overall Study|Protocol Violation|0|||
162836502|NCT00109707|588111729|FG002|Overall Study|Protocol Violation|0|||
162836503|NCT00109707|588111727|FG000|Overall Study|Patient withdrew consent|6|||
162836504|NCT00109707|588111728|FG001|Overall Study|Patient withdrew consent|1|||
162836505|NCT00109707|588111729|FG002|Overall Study|Patient withdrew consent|0|||
162836506|NCT00623428|588111736|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
162836507|NCT00623428|588111737|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
162836508|NCT00623428|588111736|FG000|Treatment Period|Death|0|||
162836509|NCT00623428|588111737|FG001|Treatment Period|Death|1|||
162836510|NCT00623428|588111736|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
162836511|NCT00623428|588111737|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
162836512|NCT00623428|588111736|FG000|Treatment Period|Insufficient therapeutic response|0|||
162836513|NCT00623428|588111737|FG001|Treatment Period|Insufficient therapeutic response|2|||
162836514|NCT00623428|588111736|FG000|Treatment Period|Other|0|||
162836515|NCT00623428|588111737|FG001|Treatment Period|Other|1|||
162836516|NCT00623428|588111736|FG000|Treatment Period|Withdrawal by Subject|0|||
162836517|NCT00623428|588111737|FG001|Treatment Period|Withdrawal by Subject|1|||
162836518|NCT00623428|588111736|FG000|Follow-up Period|Relapse post-treatment|11|||
162836519|NCT00623428|588111737|FG001|Follow-up Period|Relapse post-treatment|3|||
162836520|NCT00623428|588111736|FG000|Follow-up Period|Failure to return|10|||
162836521|NCT00623428|588111737|FG001|Follow-up Period|Failure to return|2|||
162836522|NCT00623428|588111736|FG000|Follow-up Period|Patient withdrew consent|5|||
162836523|NCT00623428|588111737|FG001|Follow-up Period|Patient withdrew consent|4|||
162836524|NCT00623428|588111736|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
162836525|NCT00623428|588111737|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
162836526|NCT00623428|588111736|FG000|Follow-up Period|Did not cooperate|0|||
162836527|NCT00623428|588111737|FG001|Follow-up Period|Did not cooperate|3|||
162836528|NCT00623428|588111736|FG000|Follow-up Period|Reason not specified|1|||
162836529|NCT00623428|588111737|FG001|Follow-up Period|Reason not specified|1|||
162836530|NCT00623428|588111736|FG000|Follow-up Period|Death|0|||
162836531|NCT00623428|588111737|FG001|Follow-up Period|Death|1|||
162836532|NCT01692301|588111738|FG000|Overall Study|Adverse Event|15|||
162836533|NCT01692301|588111739|FG001|Overall Study|Adverse Event|12|||
162836534|NCT01692301|588111738|FG000|Overall Study|Death|1|||
162836535|NCT01692301|588111739|FG001|Overall Study|Death|2|||
162836536|NCT01692301|588111738|FG000|Overall Study|Lack of Efficacy|0|||
162836537|NCT01692301|588111739|FG001|Overall Study|Lack of Efficacy|5|||
162836538|NCT01692301|588111738|FG000|Overall Study|Non-compliance with study treatment|1|||
162948297|NCT02937701|588515145|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
162948298|NCT02937701|588515146|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
162948299|NCT02937701|588515147|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
162948300|NCT02937701|588515148|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
162948301|NCT02937701|588515144|FG000|Day 1 to Week 22|Physician Decision|2|||
162948302|NCT02937701|588515145|FG001|Day 1 to Week 22|Physician Decision|0|||
162836539|NCT01692301|588111739|FG001|Overall Study|Non-compliance with study treatment|2|||
162836540|NCT01692301|588111738|FG000|Overall Study|Protocol deviation|9|||
162836541|NCT01692301|588111739|FG001|Overall Study|Protocol deviation|2|||
162836542|NCT01692301|588111738|FG000|Overall Study|Patient/guardian decision|16|||
162836543|NCT01692301|588111739|FG001|Overall Study|Patient/guardian decision|15|||
162948303|NCT02937701|588515146|FG002|Day 1 to Week 22|Physician Decision|0|||
162948304|NCT02937701|588515147|FG003|Day 1 to Week 22|Physician Decision|0|||
162948305|NCT02937701|588515148|FG004|Day 1 to Week 22|Physician Decision|0|||
162836544|NCT01692301|588111738|FG000|Overall Study|Technical problems|0|||
162836545|NCT01692301|588111739|FG001|Overall Study|Technical problems|1|||
162836546|NCT01692301|588111738|FG000|Overall Study|Physician Decision|2|||
162836547|NCT01692301|588111739|FG001|Overall Study|Physician Decision|2|||
162836548|NCT01692301|588111738|FG000|Overall Study|Lost to Follow-up|1|||
162836549|NCT01692301|588111739|FG001|Overall Study|Lost to Follow-up|1|||
162836550|NCT00574275|588111740|FG000|Overall Study|Randomized but not treated|2|||
162836551|NCT00574275|588111741|FG001|Overall Study|Randomized but not treated|3|||
162836552|NCT00574275|588111740|FG000|Overall Study|Adverse Event|32|||
162836553|NCT00574275|588111741|FG001|Overall Study|Adverse Event|76|||
162948306|NCT02937701|588515144|FG000|Day 1 to Week 22|Other|1|||
162948307|NCT02937701|588515145|FG001|Day 1 to Week 22|Other|0|||
162948308|NCT02937701|588515146|FG002|Day 1 to Week 22|Other|0|||
162948309|NCT02937701|588515147|FG003|Day 1 to Week 22|Other|0|||
162948310|NCT02937701|588515148|FG004|Day 1 to Week 22|Other|0|||
162948311|NCT02937701|588515144|FG000|Week 22 to Week 50|Adverse Event|0|||
162948312|NCT02937701|588515145|FG001|Week 22 to Week 50|Adverse Event|0|||
162948313|NCT02937701|588515146|FG002|Week 22 to Week 50|Adverse Event|10|||
162948314|NCT02937701|588515147|FG003|Week 22 to Week 50|Adverse Event|3|||
162948315|NCT02937701|588515148|FG004|Week 22 to Week 50|Adverse Event|3|||
162948316|NCT02937701|588515144|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
162948317|NCT02937701|588515145|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
162948318|NCT02937701|588515146|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
162948319|NCT02937701|588515147|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
162948320|NCT02937701|588515148|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
162948321|NCT02937701|588515144|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
162948322|NCT02937701|588515145|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
162948323|NCT02937701|588515146|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
162948324|NCT02937701|588515147|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
162948325|NCT02937701|588515148|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
162948326|NCT02937701|588515144|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
162948327|NCT02937701|588515145|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
162948328|NCT02937701|588515146|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
162948329|NCT02937701|588515147|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
162948330|NCT02937701|588515148|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
162948331|NCT02937701|588515144|FG000|Week 22 to Week 50|Physician Decision|0|||
162948332|NCT02937701|588515145|FG001|Week 22 to Week 50|Physician Decision|0|||
162948333|NCT02937701|588515146|FG002|Week 22 to Week 50|Physician Decision|2|||
162948334|NCT02937701|588515147|FG003|Week 22 to Week 50|Physician Decision|0|||
162948335|NCT02937701|588515148|FG004|Week 22 to Week 50|Physician Decision|1|||
162948336|NCT02937701|588515144|FG000|Week 22 to Week 50|Other|0|||
162948337|NCT02937701|588515145|FG001|Week 22 to Week 50|Other|0|||
162948338|NCT02937701|588515146|FG002|Week 22 to Week 50|Other|0|||
162948339|NCT02937701|588515147|FG003|Week 22 to Week 50|Other|0|||
162948340|NCT02937701|588515148|FG004|Week 22 to Week 50|Other|1|||
162948341|NCT01507051|588515149|FG000|Overall Study|Withdrawal by Subject|1|||
162948342|NCT01507051|588515150|FG001|Overall Study|Withdrawal by Subject|3|||
162948343|NCT01507051|588515151|FG002|Overall Study|Withdrawal by Subject|1|||
162948344|NCT01507051|588515152|FG003|Overall Study|Withdrawal by Subject|6|||
162948345|NCT01507051|588515149|FG000|Overall Study|Physician Decision|0|||
162948346|NCT01507051|588515150|FG001|Overall Study|Physician Decision|0|||
162948347|NCT01507051|588515151|FG002|Overall Study|Physician Decision|0|||
162948348|NCT01507051|588515152|FG003|Overall Study|Physician Decision|1|||
162948349|NCT01507051|588515149|FG000|Overall Study|Adverse Event|1|||
162948350|NCT01507051|588515150|FG001|Overall Study|Adverse Event|0|||
162948351|NCT01507051|588515151|FG002|Overall Study|Adverse Event|0|||
162948352|NCT01507051|588515152|FG003|Overall Study|Adverse Event|0|||
162948353|NCT01101022|588515153|FG000|Overall Study|Adverse Event|6|||
162948354|NCT01101022|588515154|FG001|Overall Study|Adverse Event|2|||
162948355|NCT01101022|588515153|FG000|Overall Study|Protocol Violation|4|||
162948356|NCT01101022|588515154|FG001|Overall Study|Protocol Violation|3|||
162948357|NCT01101022|588515153|FG000|Overall Study|Withdrawal by Subject|3|||
162948358|NCT01101022|588515154|FG001|Overall Study|Withdrawal by Subject|8|||
162948359|NCT01101022|588515153|FG000|Overall Study|Lost to Follow-up|1|||
162948360|NCT01101022|588515154|FG001|Overall Study|Lost to Follow-up|4|||
162948361|NCT01101022|588515153|FG000|Overall Study|Lack of Efficacy|0|||
162948362|NCT01101022|588515154|FG001|Overall Study|Lack of Efficacy|7|||
162948363|NCT01101022|588515153|FG000|Overall Study|Sponsor decision|1|||
162948364|NCT01101022|588515154|FG001|Overall Study|Sponsor decision|1|||
162948365|NCT01101022|588515153|FG000|Overall Study|Non-compliance|1|||
162948366|NCT01101022|588515154|FG001|Overall Study|Non-compliance|0|||
162948367|NCT01101022|588515153|FG000|Overall Study|Work schedule|1|||
162948368|NCT01101022|588515154|FG001|Overall Study|Work schedule|1|||
162948369|NCT01101022|588515153|FG000|Overall Study|Vacation|0|||
162948370|NCT01101022|588515154|FG001|Overall Study|Vacation|1|||
162948371|NCT03075761|588515155|FG000|Overall Study|Lost to Follow-up|1|||
162948372|NCT03075761|588515156|FG001|Overall Study|Lost to Follow-up|6|||
162948373|NCT01139047|588515157|FG000|Overall Study|Withdrawal by Subject|1|||
162948374|NCT00420303|588515162|FG000|Overall Study|Serious Adverse Event|1|||
162948375|NCT00420303|588515163|FG001|Overall Study|Serious Adverse Event|0|||
162948376|NCT00420303|588515162|FG000|Overall Study|Lack of Efficacy|0|||
162948377|NCT00420303|588515163|FG001|Overall Study|Lack of Efficacy|3|||
162948378|NCT00420303|588515162|FG000|Overall Study|Physician Decision|0|||
162948379|NCT00420303|588515163|FG001|Overall Study|Physician Decision|1|||
162948380|NCT01941095|588515164|FG000|Overall Study|Insufficient therapeutic response|13|||
162948381|NCT01941095|588515164|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
162948382|NCT01941095|588515164|FG000|Overall Study|Adverse Event|11|||
162948383|NCT01941095|588515164|FG000|Overall Study|Physician Decision|3|||
162948384|NCT01941095|588515164|FG000|Overall Study|Withdrawal by Subject|17|||
162836554|NCT00574275|588111740|FG000|Overall Study|Disease progression|160|||
162836555|NCT00574275|588111741|FG001|Overall Study|Disease progression|146|||
162836556|NCT00574275|588111740|FG000|Overall Study|Lost to Follow-up|2|||
162836557|NCT00574275|588111741|FG001|Overall Study|Lost to Follow-up|1|||
162836558|NCT00574275|588111740|FG000|Overall Study|Study stopped based on DMC decision|62|||
162836559|NCT00574275|588111741|FG001|Overall Study|Study stopped based on DMC decision|23|||
162836560|NCT00574275|588111740|FG000|Overall Study|Withdrawal by Subject|15|||
162836561|NCT00574275|588111741|FG001|Overall Study|Withdrawal by Subject|17|||
162836562|NCT00574275|588111740|FG000|Overall Study|Error calculating tumor measurement|1|||
162836563|NCT00574275|588111741|FG001|Overall Study|Error calculating tumor measurement|0|||
162836564|NCT00574275|588111740|FG000|Overall Study|Physician Decision|1|||
162836565|NCT00574275|588111741|FG001|Overall Study|Physician Decision|1|||
162836566|NCT00574275|588111740|FG000|Overall Study|Protocol Violation|0|||
162836567|NCT00574275|588111741|FG001|Overall Study|Protocol Violation|1|||
162836568|NCT00574275|588111740|FG000|Overall Study|Patient and Investigator decision|0|||
162836569|NCT00574275|588111741|FG001|Overall Study|Patient and Investigator decision|1|||
162836570|NCT00574275|588111740|FG000|Overall Study|Insurance change|0|||
162836571|NCT00574275|588111741|FG001|Overall Study|Insurance change|1|||
162836572|NCT00574275|588111740|FG000|Overall Study|Operation for curative intent|0|||
162836573|NCT00574275|588111741|FG001|Overall Study|Operation for curative intent|1|||
162836574|NCT00889265|588111744|FG000|Overall Study|Adverse Event|1|||
162836575|NCT00889265|588111744|FG000|Overall Study|Lost to Follow-up|5|||
162836576|NCT00889265|588111744|FG000|Overall Study|Protocol Violation|1|||
162836577|NCT03028870|588111747|FG000|Overall Study|Adverse Event|7|||
162836578|NCT03028870|588111748|FG001|Overall Study|Adverse Event|4|||
162836579|NCT03028870|588111749|FG002|Overall Study|Adverse Event|3|||
162836580|NCT03028870|588111750|FG003|Overall Study|Adverse Event|3|||
162836581|NCT03028870|588111747|FG000|Overall Study|Withdrawal by Subject|1|||
162836582|NCT03028870|588111748|FG001|Overall Study|Withdrawal by Subject|1|||
162836583|NCT03028870|588111749|FG002|Overall Study|Withdrawal by Subject|1|||
162836584|NCT03028870|588111750|FG003|Overall Study|Withdrawal by Subject|2|||
162836585|NCT03028870|588111747|FG000|Overall Study|Lost to Follow-up|1|||
162836586|NCT03028870|588111748|FG001|Overall Study|Lost to Follow-up|0|||
162836587|NCT03028870|588111749|FG002|Overall Study|Lost to Follow-up|0|||
162836588|NCT03028870|588111750|FG003|Overall Study|Lost to Follow-up|0|||
162836589|NCT03028870|588111747|FG000|Overall Study|Lack of Efficacy|3|||
162836590|NCT03028870|588111748|FG001|Overall Study|Lack of Efficacy|0|||
162836591|NCT03028870|588111749|FG002|Overall Study|Lack of Efficacy|0|||
162836592|NCT03028870|588111750|FG003|Overall Study|Lack of Efficacy|0|||
162836593|NCT03028870|588111747|FG000|Overall Study|Administrative|5|||
162836594|NCT03028870|588111748|FG001|Overall Study|Administrative|5|||
162836595|NCT03028870|588111749|FG002|Overall Study|Administrative|12|||
162836596|NCT03028870|588111750|FG003|Overall Study|Administrative|4|||
162836597|NCT01967537|588111751|FG000|Overall Study|Withdrawal by Subject|52|||
162836598|NCT01967537|588111751|FG000|Overall Study|Refuse treatment|2|||
162836599|NCT01967537|588111751|FG000|Overall Study|Lost to Follow-up|6|||
162836600|NCT02425826|588111753|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
162836601|NCT02425826|588111754|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
162836602|NCT02425826|588111755|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
162836603|NCT02425826|588111753|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
162836604|NCT02425826|588111754|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
162836605|NCT02425826|588111755|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
162836606|NCT02425826|588111753|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
162836607|NCT02425826|588111754|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
162836608|NCT02425826|588111755|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
162836609|NCT02425826|588111753|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
162836610|NCT02425826|588111754|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
162836611|NCT02425826|588111755|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
162836612|NCT02425826|588111753|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
162836613|NCT02425826|588111754|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
162836614|NCT02425826|588111755|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
162836615|NCT02425826|588111753|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
162836616|NCT02425826|588111754|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
162836617|NCT02425826|588111755|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
162836618|NCT02425826|588111753|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
162836619|NCT02425826|588111754|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
162836620|NCT02425826|588111755|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
162948385|NCT01941095|588515164|FG000|Overall Study|Lost to Follow-up|10|||
162948386|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
162948387|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
162948388|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
162948389|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
162948390|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
162948391|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
162948392|NCT04455633|588515166|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
162948393|NCT04455633|588515167|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
162948394|NCT04455633|588515168|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
162948395|NCT04455633|588515166|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
162948396|NCT04455633|588515167|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
162948397|NCT04455633|588515168|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
162948398|NCT01648166|588515169|FG000|Overall Study|inadequate toenail samples|53|||
162948399|NCT01648166|588515170|FG001|Overall Study|inadequate toenail samples|100|||
162948400|NCT00883090|588515171|FG000|Overall Study|Sponsor's decision|1|||
162948401|NCT00883090|588515171|FG000|Overall Study|Withdrawal by Subject|1|||
162948402|NCT03527745|588515172|FG000|Overall Study|Lost to Follow-up|3|||
162948403|NCT03527745|588515173|FG001|Overall Study|Lost to Follow-up|6|||
162948404|NCT03527745|588515174|FG002|Overall Study|Lost to Follow-up|7|||
162948405|NCT03527745|588515175|FG003|Overall Study|Lost to Follow-up|9|||
162948406|NCT03527745|588515176|FG004|Overall Study|Lost to Follow-up|0|||
162948407|NCT03527745|588515177|FG005|Overall Study|Lost to Follow-up|2|||
162948408|NCT03527745|588515178|FG006|Overall Study|Lost to Follow-up|3|||
162948409|NCT03527745|588515179|FG007|Overall Study|Lost to Follow-up|2|||
162948410|NCT03527745|588515180|FG008|Overall Study|Lost to Follow-up|3|||
162948411|NCT03527745|588515181|FG009|Overall Study|Lost to Follow-up|2|||
162948412|NCT03527745|588515182|FG010|Overall Study|Lost to Follow-up|1|||
162948413|NCT03527745|588515183|FG011|Overall Study|Lost to Follow-up|1|||
162948414|NCT03527745|588515184|FG012|Overall Study|Lost to Follow-up|0|||
162948415|NCT03527745|588515185|FG013|Overall Study|Lost to Follow-up|0|||
162948416|NCT03527745|588515186|FG014|Overall Study|Lost to Follow-up|0|||
162948417|NCT03527745|588515187|FG015|Overall Study|Lost to Follow-up|0|||
162948418|NCT03527745|588515188|FG016|Overall Study|Lost to Follow-up|1|||
162948419|NCT03527745|588515189|FG017|Overall Study|Lost to Follow-up|0|||
162948420|NCT03527745|588515190|FG018|Overall Study|Lost to Follow-up|0|||
162948421|NCT03527745|588515191|FG019|Overall Study|Lost to Follow-up|1|||
162948422|NCT03527745|588515192|FG020|Overall Study|Lost to Follow-up|1|||
162948423|NCT03527745|588515193|FG021|Overall Study|Lost to Follow-up|5|||
162948424|NCT03527745|588515194|FG022|Overall Study|Lost to Follow-up|6|||
162948425|NCT03527745|588515195|FG023|Overall Study|Lost to Follow-up|8|||
162948426|NCT03527745|588515196|FG024|Overall Study|Lost to Follow-up|1|||
162948427|NCT03527745|588515197|FG025|Overall Study|Lost to Follow-up|3|||
162948428|NCT00560235|588515200|FG000|Phase 1|Discontinued|8|||
162948429|NCT00560235|588515201|FG001|Phase 1|Discontinued|0|||
162948430|NCT00560235|588515202|FG002|Phase 1|Discontinued|0|||
162948431|NCT00560235|588515200|FG000|Phase 1B|Discontinued|0|||
162948432|NCT00560235|588515201|FG001|Phase 1B|Discontinued|19|||
162948433|NCT00560235|588515202|FG002|Phase 1B|Discontinued|0|||
162948434|NCT00560235|588515200|FG000|Phase 2|Discontinued|0|||
162948435|NCT00560235|588515201|FG001|Phase 2|Discontinued|0|||
162948436|NCT00560235|588515202|FG002|Phase 2|Discontinued|96|||
162948437|NCT00560235|588515200|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
162948438|NCT00560235|588515201|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
162948439|NCT00560235|588515202|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
162948440|NCT04015232|588515203|FG000|Overall Study|Withdrawal by Subject|7|||
162948441|NCT04015232|588515204|FG001|Overall Study|Withdrawal by Subject|4|||
162948442|NCT04015232|588515203|FG000|Overall Study|Protocol Violation|1|||
162948443|NCT04015232|588515204|FG001|Overall Study|Protocol Violation|0|||
162836621|NCT02425826|588111753|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
162836622|NCT02425826|588111754|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
162836623|NCT02425826|588111755|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
162836624|NCT02425826|588111753|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
162836625|NCT02425826|588111754|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
162836626|NCT02425826|588111755|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
162836627|NCT02425826|588111753|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
162836628|NCT02425826|588111754|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
162836629|NCT02425826|588111755|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
162836630|NCT01344876|588111756|FG000|Overall Study|Adverse Event|0|||
162836631|NCT01344876|588111757|FG001|Overall Study|Adverse Event|0|||
162836632|NCT01344876|588111758|FG002|Overall Study|Adverse Event|0|||
162836633|NCT01344876|588111759|FG003|Overall Study|Adverse Event|0|||
162836634|NCT01344876|588111760|FG004|Overall Study|Adverse Event|1|||
162836635|NCT01344876|588111756|FG000|Overall Study|Withdrawal by Subject|0|||
162836636|NCT01344876|588111757|FG001|Overall Study|Withdrawal by Subject|0|||
162836637|NCT01344876|588111758|FG002|Overall Study|Withdrawal by Subject|1|||
162836638|NCT01344876|588111759|FG003|Overall Study|Withdrawal by Subject|0|||
162836639|NCT01344876|588111760|FG004|Overall Study|Withdrawal by Subject|0|||
162836640|NCT01344876|588111756|FG000|Overall Study|Definite progression of primary disease|1|||
162836641|NCT01344876|588111757|FG001|Overall Study|Definite progression of primary disease|0|||
162836642|NCT01344876|588111758|FG002|Overall Study|Definite progression of primary disease|0|||
162836643|NCT01344876|588111759|FG003|Overall Study|Definite progression of primary disease|3|||
162836644|NCT01344876|588111760|FG004|Overall Study|Definite progression of primary disease|0|||
162836645|NCT05107765|588111761|FG000|Overall Study|Lost to Follow-up|4|||
162836646|NCT05107765|588111762|FG001|Overall Study|Lost to Follow-up|1|||
162836647|NCT05107765|588111761|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
162836648|NCT05107765|588111762|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
162836649|NCT05107765|588111761|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
162948444|NCT04015232|588515203|FG000|Overall Study|Medical Grounds|3|||
162948445|NCT04015232|588515204|FG001|Overall Study|Medical Grounds|3|||
162948446|NCT01087970|588515207|FG000|Overall Study|Protocol Violation|2|||
162948447|NCT00365300|588515208|FG000|Open-label Phase|Adverse Event|4|||
162948448|NCT00365300|588515209|FG001|Open-label Phase|Adverse Event|0|||
162948449|NCT00365300|588515208|FG000|Open-label Phase|Failed to Return|1|||
162948450|NCT00365300|588515209|FG001|Open-label Phase|Failed to Return|0|||
162948451|NCT00365300|588515208|FG000|Open-label Phase|Physician Decision|1|||
162948452|NCT00365300|588515209|FG001|Open-label Phase|Physician Decision|0|||
162948453|NCT00365300|588515208|FG000|Open-label Phase|Noncompliance|9|||
162948454|NCT00365300|588515209|FG001|Open-label Phase|Noncompliance|0|||
162948455|NCT00365300|588515208|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
162948456|NCT00365300|588515209|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
162836650|NCT05107765|588111762|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
162836651|NCT03368170|588113252|FG000|Overall Study|Adverse Event|2|||
162836652|NCT03368170|588113253|FG001|Overall Study|Adverse Event|1|||
162836653|NCT03047980|588113254|FG000|Overall Study|Adverse Event|1|||
162836654|NCT02164981|588113255|FG000|Started|Withdrawal by Subject|2|||
162836655|NCT02164981|588113256|FG001|Started|Withdrawal by Subject|1|||
162836656|NCT02164981|588113257|FG002|Started|Withdrawal by Subject|0|||
162836657|NCT02164981|588113255|FG000|Started|Protocol Violation|2|||
162836658|NCT02164981|588113256|FG001|Started|Protocol Violation|0|||
162836659|NCT02164981|588113257|FG002|Started|Protocol Violation|0|||
162836660|NCT02164981|588113255|FG000|Started|Adverse Event|1|||
162836661|NCT02164981|588113256|FG001|Started|Adverse Event|2|||
162836662|NCT02164981|588113257|FG002|Started|Adverse Event|0|||
162836663|NCT02164981|588113255|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
162836664|NCT02164981|588113256|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
162836665|NCT02164981|588113257|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
162836666|NCT02164981|588113255|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
162836667|NCT02164981|588113256|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
162948457|NCT00365300|588515208|FG000|Open-label Phase|Protocol Violation|1|||
162836668|NCT02164981|588113257|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
162836669|NCT02164981|588113255|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
162836670|NCT02164981|588113256|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
162836671|NCT02164981|588113257|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
162836672|NCT01761266|588113258|FG000|Overall Study|Death|415|||
162948458|NCT00365300|588515209|FG001|Open-label Phase|Protocol Violation|0|||
162948459|NCT00365300|588515208|FG000|Open-label Phase|Lack of Efficacy|1|||
162836673|NCT01761266|588113259|FG001|Overall Study|Death|402|||
162836674|NCT01761266|588113258|FG000|Overall Study|Lost to Follow-up|8|||
162948460|NCT00365300|588515209|FG001|Open-label Phase|Lack of Efficacy|0|||
162948461|NCT00365300|588515208|FG000|Open-label Phase|Patient skipped open label phase|1|||
162948462|NCT00365300|588515209|FG001|Open-label Phase|Patient skipped open label phase|0|||
162948463|NCT00365300|588515208|FG000|Double-blind Phase|Failed to return|1|||
162836675|NCT01761266|588113259|FG001|Overall Study|Lost to Follow-up|12|||
162836676|NCT01761266|588113258|FG000|Overall Study|Withdrawal by Subject|14|||
162836677|NCT01761266|588113259|FG001|Overall Study|Withdrawal by Subject|10|||
162836678|NCT01761266|588113258|FG000|Overall Study|Sponsor Decision|41|||
162836679|NCT01761266|588113259|FG001|Overall Study|Sponsor Decision|52|||
162836680|NCT01662440|588113260|FG000|Overall Study|Adverse Event|1|||
162836681|NCT01662440|588113261|FG001|Overall Study|Adverse Event|0|||
162836682|NCT01662440|588113262|FG002|Overall Study|Adverse Event|0|||
162836683|NCT01662440|588113263|FG003|Overall Study|Adverse Event|1|||
162836684|NCT01662440|588113260|FG000|Overall Study|Death|0|||
162836685|NCT01662440|588113261|FG001|Overall Study|Death|1|||
162836686|NCT01662440|588113262|FG002|Overall Study|Death|0|||
162836687|NCT01662440|588113263|FG003|Overall Study|Death|0|||
162836688|NCT01662440|588113260|FG000|Overall Study|Lost to Follow-up|2|||
162836689|NCT01662440|588113261|FG001|Overall Study|Lost to Follow-up|2|||
162836690|NCT01662440|588113262|FG002|Overall Study|Lost to Follow-up|4|||
162836691|NCT01662440|588113263|FG003|Overall Study|Lost to Follow-up|1|||
162836692|NCT01662440|588113260|FG000|Overall Study|Subject moved to another country.|0|||
162836693|NCT01662440|588113261|FG001|Overall Study|Subject moved to another country.|1|||
162836694|NCT01662440|588113262|FG002|Overall Study|Subject moved to another country.|0|||
162836695|NCT01662440|588113263|FG003|Overall Study|Subject moved to another country.|0|||
162948464|NCT00365300|588515209|FG001|Double-blind Phase|Failed to return|0|||
162948465|NCT00365300|588515208|FG000|Double-blind Phase|Noncompliance|1|||
162948466|NCT00365300|588515209|FG001|Double-blind Phase|Noncompliance|1|||
162948467|NCT00365300|588515208|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162948468|NCT00365300|588515209|FG001|Double-blind Phase|Withdrawal by Subject|1|||
162948469|NCT00365300|588515208|FG000|Double-blind Phase|Protocol Violation|3|||
162948470|NCT00365300|588515209|FG001|Double-blind Phase|Protocol Violation|1|||
162948471|NCT00365300|588515208|FG000|Double-blind Phase|Lack of Efficacy|6|||
162948472|NCT00365300|588515209|FG001|Double-blind Phase|Lack of Efficacy|6|||
162948473|NCT01029353|588515210|FG000|Overall Study|Lost to Follow-up|4|||
162948474|NCT01029353|588515211|FG001|Overall Study|Lost to Follow-up|5|||
162948475|NCT01029353|588515212|FG002|Overall Study|Lost to Follow-up|5|||
162948476|NCT01029353|588515213|FG003|Overall Study|Lost to Follow-up|4|||
162948477|NCT01029353|588515210|FG000|Overall Study|Consent Withdrawn|2|||
162948478|NCT01029353|588515211|FG001|Overall Study|Consent Withdrawn|0|||
162948479|NCT01029353|588515212|FG002|Overall Study|Consent Withdrawn|0|||
162948480|NCT01029353|588515213|FG003|Overall Study|Consent Withdrawn|0|||
162948481|NCT01029353|588515210|FG000|Overall Study|Primary Outcome Indeterminate|1|||
162948482|NCT01029353|588515211|FG001|Overall Study|Primary Outcome Indeterminate|3|||
162948483|NCT01029353|588515212|FG002|Overall Study|Primary Outcome Indeterminate|2|||
162948484|NCT01029353|588515213|FG003|Overall Study|Primary Outcome Indeterminate|0|||
162948485|NCT04538170|588515216|FG000|Overall Study|Withdrawal by Subject|104|||
162948486|NCT04538170|588515217|FG001|Overall Study|Withdrawal by Subject|210|||
162948487|NCT02932878|588515221|FG000|Overall Study|Due to Lab Results|2|||
162948488|NCT02932878|588515222|FG001|Overall Study|Due to Lab Results|1|||
162948489|NCT01918397|588515224|FG000|Overall Study|Never started treatment|2|||
162948490|NCT01918397|588515225|FG001|Overall Study|Never started treatment|1|||
162948491|NCT01918397|588515226|FG002|Overall Study|Never started treatment|0|||
162948492|NCT01918397|588515227|FG003|Overall Study|Never started treatment|0|||
162948493|NCT01918397|588515224|FG000|Overall Study|Adverse Event|1|||
162948494|NCT01918397|588515225|FG001|Overall Study|Adverse Event|1|||
162948495|NCT01918397|588515226|FG002|Overall Study|Adverse Event|1|||
162836696|NCT01662440|588113260|FG000|Overall Study|Protocol Violation|1|||
162836697|NCT01662440|588113261|FG001|Overall Study|Protocol Violation|0|||
162836698|NCT01662440|588113262|FG002|Overall Study|Protocol Violation|0|||
162836699|NCT01662440|588113263|FG003|Overall Study|Protocol Violation|0|||
162836700|NCT01662440|588113260|FG000|Overall Study|Withdrawal by Subject|5|||
162836701|NCT01662440|588113261|FG001|Overall Study|Withdrawal by Subject|2|||
162948496|NCT01918397|588515227|FG003|Overall Study|Adverse Event|0|||
162836702|NCT01662440|588113262|FG002|Overall Study|Withdrawal by Subject|2|||
162836703|NCT01662440|588113263|FG003|Overall Study|Withdrawal by Subject|2|||
162948497|NCT01918397|588515224|FG000|Overall Study|Lack of compliance|2|||
162948498|NCT01918397|588515225|FG001|Overall Study|Lack of compliance|2|||
162948499|NCT01918397|588515226|FG002|Overall Study|Lack of compliance|3|||
162948500|NCT01918397|588515227|FG003|Overall Study|Lack of compliance|0|||
162948501|NCT01918397|588515224|FG000|Overall Study|Pregnancy|0|||
162948502|NCT01918397|588515225|FG001|Overall Study|Pregnancy|1|||
162948503|NCT01918397|588515226|FG002|Overall Study|Pregnancy|0|||
162948504|NCT01918397|588515227|FG003|Overall Study|Pregnancy|0|||
162948505|NCT01918397|588515224|FG000|Overall Study|Rifampin susceptible|0|||
162948506|NCT01918397|588515225|FG001|Overall Study|Rifampin susceptible|0|||
162948507|NCT01918397|588515226|FG002|Overall Study|Rifampin susceptible|0|||
162948508|NCT01918397|588515227|FG003|Overall Study|Rifampin susceptible|2|||
162948509|NCT01918397|588515224|FG000|Overall Study|Treatment failure|0|||
162948510|NCT01918397|588515225|FG001|Overall Study|Treatment failure|0|||
162948511|NCT01918397|588515226|FG002|Overall Study|Treatment failure|0|||
162948512|NCT01918397|588515227|FG003|Overall Study|Treatment failure|1|||
162948513|NCT01918397|588515224|FG000|Overall Study|Withdrawal by Subject|3|||
162948514|NCT01918397|588515225|FG001|Overall Study|Withdrawal by Subject|2|||
162948515|NCT01918397|588515226|FG002|Overall Study|Withdrawal by Subject|1|||
162948516|NCT01918397|588515227|FG003|Overall Study|Withdrawal by Subject|1|||
162948517|NCT01918397|588515224|FG000|Overall Study|XDR at baseline|0|||
162948518|NCT01918397|588515225|FG001|Overall Study|XDR at baseline|0|||
162948519|NCT01918397|588515226|FG002|Overall Study|XDR at baseline|1|||
162836704|NCT00112905|588113264|FG000|Overall Study|Adverse Event|4|||
162836705|NCT00112905|588113264|FG000|Overall Study|Death|1|||
162836706|NCT00112905|588113264|FG000|Overall Study|Ineligibility|5|||
162836707|NCT00112905|588113264|FG000|Overall Study|Alternative treatment|1|||
162836708|NCT00112905|588113264|FG000|Overall Study|performance status was deteiorating|1|||
162836709|NCT01765673|588113265|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
162836710|NCT04541004|588113270|FG000|Overall Study|Adverse Event|2|||
162836711|NCT00605085|588113271|FG000|Overall Study|Withdrawal by Subject|8|||
162836712|NCT00605085|588113272|FG001|Overall Study|Withdrawal by Subject|5|||
162836713|NCT00605085|588113271|FG000|Overall Study|Adverse Event|9|||
162836714|NCT00605085|588113272|FG001|Overall Study|Adverse Event|5|||
162836715|NCT00605085|588113271|FG000|Overall Study|Pregnancy|2|||
162836716|NCT00605085|588113272|FG001|Overall Study|Pregnancy|0|||
162836717|NCT00605085|588113271|FG000|Overall Study|Protocol Violation|3|||
162836718|NCT00605085|588113272|FG001|Overall Study|Protocol Violation|2|||
162836719|NCT00605085|588113271|FG000|Overall Study|Lost to Follow-up|10|||
162836720|NCT00605085|588113272|FG001|Overall Study|Lost to Follow-up|5|||
162836721|NCT00605085|588113271|FG000|Overall Study|administrative reasons|18|||
162836722|NCT00605085|588113272|FG001|Overall Study|administrative reasons|8|||
162836723|NCT01652287|588113278|FG000|Overall Study|Withdrawal by Subject|2|||
162836724|NCT01652287|588113279|FG001|Overall Study|Withdrawal by Subject|0|||
162836725|NCT01592760|588113281|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
162836726|NCT01592760|588113282|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
162836727|NCT01592760|588113283|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
162836728|NCT04312009|588113284|FG000|Overall Study|Withdrawal by Subject|2|||
162836729|NCT04312009|588113285|FG001|Overall Study|Withdrawal by Subject|1|||
162836730|NCT01637142|588113288|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
162836731|NCT00699348|588113292|FG000|Overall Study|Death|6|||
162836732|NCT00699348|588113292|FG000|Overall Study|Adverse Event|15|||
162836733|NCT00699348|588113292|FG000|Overall Study|Withdrawal by Subject|11|||
162836734|NCT00699348|588113292|FG000|Overall Study|Protocol Violation|10|||
162836735|NCT00699348|588113292|FG000|Overall Study|Lack of Efficacy|8|||
162836736|NCT00699348|588113292|FG000|Overall Study|Failure to return|1|||
162836737|NCT00699348|588113292|FG000|Overall Study|Blood transfusion|24|||
162836738|NCT00699348|588113292|FG000|Overall Study|Renal transplantation|10|||
162836739|NCT00699348|588113292|FG000|Overall Study|Other|5|||
162836740|NCT00122135|588113293|FG000|Overall Study|Withdrawal by Subject|3|||
162836741|NCT00122135|588113294|FG001|Overall Study|Withdrawal by Subject|0|||
162836742|NCT02468648|588113299|FG000|Overall Study|Death|1|||
162836743|NCT00488982|588113300|FG000|Course 1|Physician Decision|0|||
162836744|NCT00488982|588113301|FG001|Course 1|Physician Decision|2|||
162836745|NCT00488982|588113302|FG002|Course 1|Physician Decision|4|||
162836746|NCT00488982|588113300|FG000|Course 1|Withdrawal by Subject|0|||
162836747|NCT00488982|588113301|FG001|Course 1|Withdrawal by Subject|8|||
162836748|NCT00488982|588113302|FG002|Course 1|Withdrawal by Subject|2|||
162836749|NCT00488982|588113300|FG000|Course 1|nonprotocol therapy|0|||
162836750|NCT00488982|588113301|FG001|Course 1|nonprotocol therapy|2|||
162836751|NCT00488982|588113302|FG002|Course 1|nonprotocol therapy|2|||
162836752|NCT00488982|588113300|FG000|Course 1|Adverse Event|0|||
162836753|NCT00488982|588113301|FG001|Course 1|Adverse Event|0|||
162836754|NCT00488982|588113302|FG002|Course 1|Adverse Event|6|||
162836755|NCT01368835|588113303|FG000|Overall Study|Inclusion criteria/photography quality|22|||
162836756|NCT01368835|588113303|FG000|Overall Study|Lost to Follow-up|11|||
162836757|NCT02754726|588113304|FG000|Overall Study|Progressive Disease by RECIST|13|||
162836758|NCT02754726|588113304|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
162836759|NCT02754726|588113304|FG000|Overall Study|Clinical Disease Progression|5|||
162836760|NCT02754726|588113304|FG000|Overall Study|Adverse Event|3|||
162948520|NCT01918397|588515227|FG003|Overall Study|XDR at baseline|0|||
162836761|NCT02754726|588113304|FG000|Overall Study|Withdrawal by Subject|1|||
162836762|NCT02754726|588113304|FG000|Overall Study|Tolerability|1|||
162948521|NCT01918397|588515224|FG000|Overall Study|Lost to Follow-up|2|||
162836763|NCT03806127|588113316|FG000|Overall Study|Withdrawal by Subject|4|||
162836764|NCT03806127|588113317|FG001|Overall Study|Withdrawal by Subject|5|||
162836765|NCT03806127|588113316|FG000|Overall Study|Protocol Violation|3|||
162836766|NCT03806127|588113317|FG001|Overall Study|Protocol Violation|1|||
162836767|NCT03806127|588113316|FG000|Overall Study|Adverse Event|3|||
162836768|NCT03806127|588113317|FG001|Overall Study|Adverse Event|0|||
162836769|NCT03806127|588113316|FG000|Overall Study|Unable to Complete Procedures|0|||
162836770|NCT03806127|588113317|FG001|Overall Study|Unable to Complete Procedures|1|||
162836771|NCT03806127|588113316|FG000|Overall Study|Pregnancy|0|||
162836772|NCT03806127|588113317|FG001|Overall Study|Pregnancy|1|||
162836773|NCT03806127|588113316|FG000|Overall Study|Lost to Follow-up|5|||
162836774|NCT03806127|588113317|FG001|Overall Study|Lost to Follow-up|1|||
162836775|NCT03806127|588113316|FG000|Overall Study|Physician Decision|1|||
162836776|NCT03806127|588113317|FG001|Overall Study|Physician Decision|1|||
162836777|NCT03806127|588113316|FG000|Overall Study|Could Not Come Due to Covid|1|||
162836778|NCT03806127|588113317|FG001|Overall Study|Could Not Come Due to Covid|0|||
162836779|NCT03806127|588113316|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
162836780|NCT03806127|588113317|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
162836781|NCT03806127|588113316|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
162836782|NCT03806127|588113317|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
162836783|NCT03806127|588113316|FG000|Overall Study|Covid 19 Restrictions|2|||
162836784|NCT03806127|588113317|FG001|Overall Study|Covid 19 Restrictions|0|||
162836785|NCT03806127|588113316|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
162836786|NCT03806127|588113317|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
162836787|NCT03806127|588113316|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
162836788|NCT03806127|588113317|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
162836789|NCT01289015|588113323|FG000|Overall Study|Protocol Violation|12|||
162836790|NCT01289015|588113324|FG001|Overall Study|Protocol Violation|9|||
162836791|NCT01289015|588113323|FG000|Overall Study|Adverse Event|3|||
162836792|NCT01289015|588113324|FG001|Overall Study|Adverse Event|0|||
162836793|NCT01289015|588113323|FG000|Overall Study|Lost to Follow-up|33|||
162836794|NCT01289015|588113324|FG001|Overall Study|Lost to Follow-up|17|||
162836795|NCT01289015|588113323|FG000|Overall Study|Withdrawal by Subject|17|||
162836796|NCT01289015|588113324|FG001|Overall Study|Withdrawal by Subject|8|||
162836797|NCT01289015|588113323|FG000|Overall Study|Disease progression|1|||
162836798|NCT01289015|588113324|FG001|Overall Study|Disease progression|0|||
162836799|NCT01289015|588113323|FG000|Overall Study|Negative baseline culture and others|33|||
162836800|NCT01289015|588113324|FG001|Overall Study|Negative baseline culture and others|20|||
162836801|NCT05980299|588113329|FG000|Overall Study|Death|28|||
162836802|NCT05980299|588113330|FG001|Overall Study|Death|0|||
162836803|NCT05980299|588113329|FG000|Overall Study|Discharged from Nursing Home|9|||
162836804|NCT05980299|588113330|FG001|Overall Study|Discharged from Nursing Home|0|||
162836805|NCT05980299|588113329|FG000|Overall Study|Lost to Follow-up|0|||
162836806|NCT05980299|588113330|FG001|Overall Study|Lost to Follow-up|10|||
162836807|NCT01294800|588113338|FG000|Overall Study|Adverse Event|7|||
162836808|NCT01294800|588113339|FG001|Overall Study|Adverse Event|6|||
162836809|NCT01294800|588113340|FG002|Overall Study|Adverse Event|12|||
162836810|NCT01294800|588113341|FG003|Overall Study|Adverse Event|5|||
162836811|NCT01294800|588113338|FG000|Overall Study|Subject Withdrew Consent|2|||
162836812|NCT01294800|588113339|FG001|Overall Study|Subject Withdrew Consent|2|||
162836813|NCT01294800|588113340|FG002|Overall Study|Subject Withdrew Consent|2|||
162836814|NCT01294800|588113341|FG003|Overall Study|Subject Withdrew Consent|11|||
162836815|NCT01294800|588113338|FG000|Overall Study|Lost to Follow-up|0|||
162836816|NCT01294800|588113339|FG001|Overall Study|Lost to Follow-up|0|||
162836817|NCT01294800|588113340|FG002|Overall Study|Lost to Follow-up|1|||
162836818|NCT01294800|588113341|FG003|Overall Study|Lost to Follow-up|0|||
162836819|NCT01294800|588113338|FG000|Overall Study|Non-compliance With Protocol|0|||
162836820|NCT01294800|588113339|FG001|Overall Study|Non-compliance With Protocol|1|||
162836821|NCT01294800|588113340|FG002|Overall Study|Non-compliance With Protocol|1|||
162836822|NCT01294800|588113341|FG003|Overall Study|Non-compliance With Protocol|0|||
162836823|NCT01294800|588113338|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
162836824|NCT01294800|588113339|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
162836825|NCT01294800|588113340|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
162836826|NCT01294800|588113341|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
162836827|NCT01662895|588113342|FG000|Overall Study|Lost to Follow-up|0|||
162836828|NCT01662895|588113343|FG001|Overall Study|Lost to Follow-up|1|||
162836829|NCT05048342|588113344|FG000|Overall Study|Adverse Event|1|||
162836830|NCT05048342|588113344|FG000|Overall Study|Subject decision|2|||
162836831|NCT01441063|588113345|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
162836832|NCT01441063|588113345|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
162836833|NCT00493038|588113346|FG000|Treatment|Adverse Event|8|||
162836834|NCT00493038|588113347|FG001|Treatment|Adverse Event|4|||
162836835|NCT00493038|588113346|FG000|Treatment|Lost to Follow-up|5|||
162836836|NCT00493038|588113347|FG001|Treatment|Lost to Follow-up|3|||
162836837|NCT00493038|588113346|FG000|Treatment|Withdrawal by Subject|11|||
162948522|NCT01918397|588515225|FG001|Overall Study|Lost to Follow-up|1|||
162948523|NCT01918397|588515226|FG002|Overall Study|Lost to Follow-up|1|||
162948524|NCT01918397|588515227|FG003|Overall Study|Lost to Follow-up|1|||
162948525|NCT01918397|588515224|FG000|Overall Study|Increased QTc|1|||
162948526|NCT01918397|588515225|FG001|Overall Study|Increased QTc|0|||
162948527|NCT01918397|588515226|FG002|Overall Study|Increased QTc|0|||
162948528|NCT01918397|588515227|FG003|Overall Study|Increased QTc|1|||
162948529|NCT01918397|588515224|FG000|Overall Study|Death|0|||
162948530|NCT01918397|588515225|FG001|Overall Study|Death|0|||
162948531|NCT01918397|588515226|FG002|Overall Study|Death|1|||
162948532|NCT01918397|588515227|FG003|Overall Study|Death|0|||
162948533|NCT01918397|588515224|FG000|Overall Study|Involved in another investigative trial|0|||
162948534|NCT01918397|588515225|FG001|Overall Study|Involved in another investigative trial|0|||
162948535|NCT01918397|588515226|FG002|Overall Study|Involved in another investigative trial|0|||
162948536|NCT01918397|588515227|FG003|Overall Study|Involved in another investigative trial|1|||
162948537|NCT00849901|588515234|FG000|Acute Treatment Phase|Adverse Event|9|||
162948538|NCT00849901|588515235|FG001|Acute Treatment Phase|Adverse Event|1|||
162948539|NCT00849901|588515236|FG002|Acute Treatment Phase|Adverse Event|3|||
162948540|NCT00849901|588515234|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
162948541|NCT00849901|588515235|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
162948542|NCT00849901|588515236|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
162948543|NCT00849901|588515234|FG000|Acute Treatment Phase|Protocol Violation|0|||
162948544|NCT00849901|588515235|FG001|Acute Treatment Phase|Protocol Violation|2|||
162948545|NCT00849901|588515236|FG002|Acute Treatment Phase|Protocol Violation|1|||
162948546|NCT00849901|588515234|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
162948547|NCT00849901|588515235|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
162948548|NCT00849901|588515236|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
162948549|NCT00849901|588515234|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
162948550|NCT00849901|588515235|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
162948551|NCT00849901|588515236|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
162948552|NCT00849901|588515234|FG000|Acute Treatment Phase|Physician Decision|1|||
162948553|NCT00849901|588515235|FG001|Acute Treatment Phase|Physician Decision|1|||
162948554|NCT00849901|588515236|FG002|Acute Treatment Phase|Physician Decision|1|||
162948555|NCT00849901|588515234|FG000|Acute Treatment Phase|Sponsor Decision|1|||
162948556|NCT00849901|588515235|FG001|Acute Treatment Phase|Sponsor Decision|0|||
162948557|NCT00849901|588515236|FG002|Acute Treatment Phase|Sponsor Decision|0|||
162948558|NCT00849901|588515234|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
162948559|NCT00849901|588515235|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
162948560|NCT00849901|588515236|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
162948561|NCT00849901|588515234|FG000|Extension Phase|Adverse Event|2|||
162948562|NCT00849901|588515235|FG001|Extension Phase|Adverse Event|8|||
162948563|NCT00849901|588515236|FG002|Extension Phase|Adverse Event|4|||
162948564|NCT00849901|588515234|FG000|Extension Phase|Lost to Follow-up|3|||
162948565|NCT00849901|588515235|FG001|Extension Phase|Lost to Follow-up|0|||
162948566|NCT00849901|588515236|FG002|Extension Phase|Lost to Follow-up|1|||
162948567|NCT00849901|588515234|FG000|Extension Phase|Protocol Violation|2|||
162948568|NCT00849901|588515235|FG001|Extension Phase|Protocol Violation|2|||
162948569|NCT00849901|588515236|FG002|Extension Phase|Protocol Violation|4|||
162948570|NCT00849901|588515234|FG000|Extension Phase|Withdrawal by Subject|7|||
162948571|NCT00849901|588515235|FG001|Extension Phase|Withdrawal by Subject|6|||
162948572|NCT00849901|588515236|FG002|Extension Phase|Withdrawal by Subject|3|||
162948573|NCT00849901|588515234|FG000|Extension Phase|Parent or Caregiver Decision|10|||
162948574|NCT00849901|588515235|FG001|Extension Phase|Parent or Caregiver Decision|4|||
162948575|NCT00849901|588515236|FG002|Extension Phase|Parent or Caregiver Decision|4|||
162948576|NCT00849901|588515234|FG000|Extension Phase|Physician Decision|1|||
162948577|NCT00849901|588515235|FG001|Extension Phase|Physician Decision|2|||
162948578|NCT00849901|588515236|FG002|Extension Phase|Physician Decision|0|||
162948579|NCT00849901|588515234|FG000|Extension Phase|Lack of Efficacy|2|||
162948580|NCT00849901|588515235|FG001|Extension Phase|Lack of Efficacy|4|||
162948581|NCT00849901|588515236|FG002|Extension Phase|Lack of Efficacy|1|||
162948582|NCT00262223|588515237|FG000|Treatment Phase|Withdrawal by Subject|3|||
162948583|NCT00262223|588515238|FG001|Treatment Phase|Withdrawal by Subject|6|||
162948584|NCT00262223|588515237|FG000|Treatment Phase|Adverse Event|1|||
162948585|NCT00262223|588515238|FG001|Treatment Phase|Adverse Event|2|||
162948586|NCT00262223|588515237|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
162948587|NCT00262223|588515238|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
162948588|NCT00262223|588515237|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
162948589|NCT00262223|588515238|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
162948590|NCT00262223|588515237|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
162948591|NCT00262223|588515238|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
162948592|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
162948593|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
162948594|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
162948595|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
162836838|NCT00493038|588113347|FG001|Treatment|Withdrawal by Subject|12|||
162836839|NCT00493038|588113346|FG000|Treatment|Other|0|||
162836840|NCT00493038|588113347|FG001|Treatment|Other|1|||
162836841|NCT00493038|588113346|FG000|Follow-up|Lost to Follow-up|1|||
162836842|NCT00493038|588113347|FG001|Follow-up|Lost to Follow-up|0|||
162836843|NCT01639833|588113374|FG000|Overall Study|Death|4|||
162836844|NCT01639833|588113375|FG001|Overall Study|Death|2|||
162836845|NCT01639833|588113374|FG000|Overall Study|Withdrawal by Subject|2|||
162836846|NCT01639833|588113375|FG001|Overall Study|Withdrawal by Subject|2|||
162836847|NCT01888640|588113376|FG000|Overall Study|Lost to Follow-up|1|||
162836848|NCT01888640|588113377|FG001|Overall Study|Lost to Follow-up|2|||
162836849|NCT01888640|588113378|FG002|Overall Study|Lost to Follow-up|0|||
162836850|NCT01888640|588113376|FG000|Overall Study|Withdrawal by Subject|15|||
162836851|NCT01888640|588113377|FG001|Overall Study|Withdrawal by Subject|11|||
162836852|NCT01888640|588113378|FG002|Overall Study|Withdrawal by Subject|4|||
162836853|NCT01888640|588113376|FG000|Overall Study|Minimum dose not met|10|||
162836854|NCT01888640|588113377|FG001|Overall Study|Minimum dose not met|16|||
162836855|NCT01888640|588113378|FG002|Overall Study|Minimum dose not met|0|||
162836856|NCT01888640|588113376|FG000|Overall Study|Given wrong unit (placebo)|1|||
162836857|NCT01888640|588113377|FG001|Overall Study|Given wrong unit (placebo)|0|||
162836858|NCT01888640|588113378|FG002|Overall Study|Given wrong unit (placebo)|0|||
162836859|NCT01888640|588113376|FG000|Overall Study|Excluded for prior TENS|0|||
162836860|NCT01888640|588113377|FG001|Overall Study|Excluded for prior TENS|1|||
162836861|NCT01888640|588113378|FG002|Overall Study|Excluded for prior TENS|0|||
162836862|NCT01888640|588113376|FG000|Overall Study|Researcher Termination of Participant|0|||
162836863|NCT01888640|588113377|FG001|Overall Study|Researcher Termination of Participant|1|||
162836864|NCT01888640|588113378|FG002|Overall Study|Researcher Termination of Participant|1|||
162836865|NCT01277549|588113379|FG000|Overall Study|Failed to meet eligibility criteria|13|||
162836866|NCT01277549|588113380|FG001|Overall Study|Failed to meet eligibility criteria|9|||
162836867|NCT01277549|588113379|FG000|Overall Study|Withdrawal by Subject|1|||
162836868|NCT01277549|588113380|FG001|Overall Study|Withdrawal by Subject|3|||
162836869|NCT01277549|588113379|FG000|Overall Study|Protocol Violation|10|||
162836870|NCT01277549|588113380|FG001|Overall Study|Protocol Violation|1|||
162836871|NCT01277549|588113379|FG000|Overall Study|Physician Decision|2|||
162836872|NCT01277549|588113380|FG001|Overall Study|Physician Decision|1|||
162836873|NCT01142726|588113383|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
162836874|NCT01142726|588113384|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
162836875|NCT01142726|588113385|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
162836876|NCT01142726|588113383|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
162836877|NCT01142726|588113384|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
162836878|NCT01142726|588113385|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
162836879|NCT01142726|588113383|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
162836880|NCT01142726|588113384|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
162836881|NCT01142726|588113385|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
162836882|NCT01142726|588113383|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
162836883|NCT01142726|588113384|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
162836884|NCT01142726|588113385|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
162836885|NCT01142726|588113383|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
162836886|NCT01142726|588113384|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
162836887|NCT01142726|588113385|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
162836888|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
162836889|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
162836890|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
162836891|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
162836892|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
162836893|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
162836894|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
162836895|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
162836896|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
162836897|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
162836898|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
162836899|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
162836900|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
162836901|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
162836902|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
162836903|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
162836904|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
162836905|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
162836906|NCT01142726|588113383|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
162836907|NCT01142726|588113384|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
162836908|NCT01142726|588113385|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
162836909|NCT01142726|588113383|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
162836910|NCT01142726|588113384|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
162836911|NCT01142726|588113385|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
162836912|NCT01142726|588113383|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
162836913|NCT01142726|588113384|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
162836914|NCT01142726|588113385|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
162836915|NCT01142726|588113383|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
162836916|NCT01142726|588113384|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
162836917|NCT01142726|588113385|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
162836918|NCT01142726|588113383|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
162836919|NCT01142726|588113384|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
162836920|NCT01142726|588113385|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
162836921|NCT01568593|588113386|FG000|Overall Study|Lack of Efficacy|4|||
162836922|NCT01568593|588113387|FG001|Overall Study|Lack of Efficacy|1|||
162836923|NCT01568593|588113386|FG000|Overall Study|Adverse Event|3|||
162836924|NCT01568593|588113387|FG001|Overall Study|Adverse Event|2|||
162836925|NCT02109484|588113388|FG000|Overall Study|Lost to Follow-up|0|||
162836926|NCT02109484|588113389|FG001|Overall Study|Lost to Follow-up|0|||
162836927|NCT02109484|588113390|FG002|Overall Study|Lost to Follow-up|0|||
162836928|NCT02109484|588113391|FG003|Overall Study|Lost to Follow-up|1|||
162836929|NCT02109484|588113392|FG004|Overall Study|Lost to Follow-up|1|||
162836930|NCT02109484|588113393|FG005|Overall Study|Lost to Follow-up|0|||
162836931|NCT02109484|588113394|FG006|Overall Study|Lost to Follow-up|1|||
162836932|NCT02109484|588113395|FG007|Overall Study|Lost to Follow-up|0|||
162836933|NCT02109484|588113388|FG000|Overall Study|Withdrawal by Subject|0|||
162836934|NCT02109484|588113389|FG001|Overall Study|Withdrawal by Subject|0|||
162836935|NCT02109484|588113390|FG002|Overall Study|Withdrawal by Subject|0|||
162836936|NCT02109484|588113391|FG003|Overall Study|Withdrawal by Subject|0|||
162836937|NCT02109484|588113392|FG004|Overall Study|Withdrawal by Subject|1|||
162836938|NCT02109484|588113393|FG005|Overall Study|Withdrawal by Subject|1|||
162836939|NCT02109484|588113394|FG006|Overall Study|Withdrawal by Subject|1|||
162836940|NCT02109484|588113395|FG007|Overall Study|Withdrawal by Subject|0|||
162836941|NCT02109484|588113388|FG000|Overall Study|Physician Decision|0|||
162836942|NCT02109484|588113389|FG001|Overall Study|Physician Decision|0|||
162836943|NCT02109484|588113390|FG002|Overall Study|Physician Decision|0|||
162836944|NCT02109484|588113391|FG003|Overall Study|Physician Decision|0|||
162836945|NCT02109484|588113392|FG004|Overall Study|Physician Decision|2|||
162836946|NCT02109484|588113393|FG005|Overall Study|Physician Decision|0|||
162836947|NCT02109484|588113394|FG006|Overall Study|Physician Decision|0|||
162836948|NCT02109484|588113395|FG007|Overall Study|Physician Decision|0|||
162836949|NCT02109484|588113388|FG000|Overall Study|Death|0|||
162836950|NCT02109484|588113389|FG001|Overall Study|Death|0|||
162836951|NCT02109484|588113390|FG002|Overall Study|Death|0|||
162836952|NCT02109484|588113391|FG003|Overall Study|Death|0|||
162836953|NCT02109484|588113392|FG004|Overall Study|Death|0|||
162836954|NCT02109484|588113393|FG005|Overall Study|Death|0|||
162836955|NCT02109484|588113394|FG006|Overall Study|Death|0|||
162836956|NCT02109484|588113395|FG007|Overall Study|Death|2|||
162836957|NCT02109484|588113388|FG000|Overall Study|Moved away from study area|0|||
162836958|NCT02109484|588113389|FG001|Overall Study|Moved away from study area|0|||
162836959|NCT02109484|588113390|FG002|Overall Study|Moved away from study area|0|||
162836960|NCT02109484|588113391|FG003|Overall Study|Moved away from study area|0|||
162836961|NCT02109484|588113392|FG004|Overall Study|Moved away from study area|0|||
162836962|NCT02109484|588113393|FG005|Overall Study|Moved away from study area|0|||
162836963|NCT02109484|588113394|FG006|Overall Study|Moved away from study area|1|||
162836964|NCT02109484|588113395|FG007|Overall Study|Moved away from study area|1|||
162836965|NCT00796315|588113396|FG000|Overall Study|Protocol Violation|0|||
162836966|NCT00796315|588113397|FG001|Overall Study|Protocol Violation|1|||
162836967|NCT00796315|588113398|FG002|Overall Study|Protocol Violation|0|||
162836968|NCT01294579|588113404|FG000|Overall Study|Disease progression|12|||
162836969|NCT01294579|588113404|FG000|Overall Study|Adverse Event|11|||
162836970|NCT01294579|588113404|FG000|Overall Study|Study closed/terminated|3|||
162836971|NCT01294579|588113404|FG000|Overall Study|Lost to Follow-up|1|||
162836972|NCT01294579|588113404|FG000|Overall Study|Physician Decision|3|||
162836973|NCT01294579|588113404|FG000|Overall Study|Withdrawal by Subject|5|||
162836974|NCT02788747|588113405|FG000|Overall Study|Adverse Event|1|||
162836975|NCT02788747|588113406|FG001|Overall Study|Adverse Event|0|||
162836976|NCT02788747|588113407|FG002|Overall Study|Adverse Event|0|||
162836977|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
162836978|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
162836979|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
162836980|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
162836981|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
162836982|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
162836983|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
162836984|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
162836985|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
162836986|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
162836987|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
162836988|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
162836989|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
162836990|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
162836991|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
162836992|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
162836993|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
162836994|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
162836995|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
162836996|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
162836997|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
162836998|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
162836999|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
162837000|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
162837001|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
162837002|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
162837003|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
162837004|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
162837005|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
162837006|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
162837007|NCT00784654|588113410|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
162837008|NCT00784654|588113411|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
162837009|NCT00784654|588113412|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
162837010|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
162837011|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
162837012|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
162837013|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
162837014|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
162837015|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
162837016|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162837017|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
162837018|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
162837019|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
162837020|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
162837021|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
162837022|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Adverse Event|0|||
162837023|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Adverse Event|1|||
162837024|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Adverse Event|1|||
162837025|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
162837026|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
162837027|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
162837028|NCT00784654|588113410|FG000|Randomized Withdrawal Period|Family reasons|0|||
162837029|NCT00784654|588113411|FG001|Randomized Withdrawal Period|Family reasons|0|||
162837030|NCT00784654|588113412|FG002|Randomized Withdrawal Period|Family reasons|1|||
162837031|NCT00562354|588113413|FG000|Overall Study|Physician Decision|0|||
162837032|NCT00562354|588113414|FG001|Overall Study|Physician Decision|1|||
162837033|NCT00562354|588113413|FG000|Overall Study|Lost to Follow-up|0|||
162837034|NCT00562354|588113414|FG001|Overall Study|Lost to Follow-up|1|||
162837035|NCT01430455|588113430|FG000|Overall Study|Withdrawal by Subject|1|||
162837036|NCT01430455|588113430|FG000|Overall Study|Switched to follow-up phase|1|||
162837037|NCT05061719|588113431|FG000|Overall Study|Adverse Event|60|||
162837038|NCT05061719|588113431|FG000|Overall Study|Death|1|||
162837039|NCT05061719|588113431|FG000|Overall Study|Lack of Efficacy|7|||
162837040|NCT05061719|588113431|FG000|Overall Study|Lost to Follow-up|5|||
162837041|NCT05061719|588113431|FG000|Overall Study|Pregnancy|1|||
162837042|NCT05061719|588113431|FG000|Overall Study|Protocol Violation|8|||
162837043|NCT05061719|588113431|FG000|Overall Study|Withdrawal by Subject|41|||
162837044|NCT05061719|588113431|FG000|Overall Study|Site Closure|2|||
162837045|NCT02600507|588115210|FG000|Overall Study|Adverse Event|3|||
162837046|NCT02600507|588115211|FG001|Overall Study|Adverse Event|15|||
162837047|NCT02600507|588115212|FG002|Overall Study|Adverse Event|5|||
162837048|NCT02600507|588115210|FG000|Overall Study|Lack of Efficacy|3|||
162837049|NCT02600507|588115211|FG001|Overall Study|Lack of Efficacy|8|||
162837050|NCT02600507|588115212|FG002|Overall Study|Lack of Efficacy|5|||
162837051|NCT02600507|588115210|FG000|Overall Study|Lost to Follow-up|3|||
162837052|NCT02600507|588115211|FG001|Overall Study|Lost to Follow-up|5|||
162837053|NCT02600507|588115212|FG002|Overall Study|Lost to Follow-up|2|||
162837054|NCT02600507|588115210|FG000|Overall Study|Protocol Violation|12|||
162837055|NCT02600507|588115211|FG001|Overall Study|Protocol Violation|4|||
162837056|NCT02600507|588115212|FG002|Overall Study|Protocol Violation|4|||
162837057|NCT02600507|588115210|FG000|Overall Study|Physician Decision|1|||
162837058|NCT02600507|588115211|FG001|Overall Study|Physician Decision|0|||
162837059|NCT02600507|588115212|FG002|Overall Study|Physician Decision|1|||
162837060|NCT02600507|588115210|FG000|Overall Study|Withdrawal by Subject|7|||
162837061|NCT02600507|588115211|FG001|Overall Study|Withdrawal by Subject|11|||
162837062|NCT02600507|588115212|FG002|Overall Study|Withdrawal by Subject|7|||
162837063|NCT02600507|588115210|FG000|Overall Study|Other|0|||
162837064|NCT02600507|588115211|FG001|Overall Study|Other|1|||
162837065|NCT02600507|588115212|FG002|Overall Study|Other|1|||
162837066|NCT05048719|588115213|FG000|Overall Study|Withdrawal by Subject|2|||
162837067|NCT05048719|588115214|FG001|Overall Study|Withdrawal by Subject|1|||
162837068|NCT05048719|588115215|FG002|Overall Study|Withdrawal by Subject|3|||
162837069|NCT05048719|588115216|FG003|Overall Study|Withdrawal by Subject|1|||
162837070|NCT05048719|588115217|FG004|Overall Study|Withdrawal by Subject|0|||
162837071|NCT05048719|588115218|FG005|Overall Study|Withdrawal by Subject|2|||
162837072|NCT05048719|588115219|FG006|Overall Study|Withdrawal by Subject|1|||
162837073|NCT05048719|588115220|FG007|Overall Study|Withdrawal by Subject|1|||
162837074|NCT05048719|588115221|FG008|Overall Study|Withdrawal by Subject|0|||
162837075|NCT05048719|588115213|FG000|Overall Study|Death|1|||
162837076|NCT05048719|588115214|FG001|Overall Study|Death|0|||
162837077|NCT05048719|588115215|FG002|Overall Study|Death|0|||
162837078|NCT05048719|588115216|FG003|Overall Study|Death|0|||
162837079|NCT05048719|588115217|FG004|Overall Study|Death|0|||
162837080|NCT05048719|588115218|FG005|Overall Study|Death|0|||
162837081|NCT05048719|588115219|FG006|Overall Study|Death|0|||
162837082|NCT05048719|588115220|FG007|Overall Study|Death|0|||
162837083|NCT05048719|588115221|FG008|Overall Study|Death|0|||
162837084|NCT05048719|588115213|FG000|Overall Study|Adverse Event|0|||
162837085|NCT05048719|588115214|FG001|Overall Study|Adverse Event|1|||
162837086|NCT05048719|588115215|FG002|Overall Study|Adverse Event|2|||
162837087|NCT05048719|588115216|FG003|Overall Study|Adverse Event|0|||
162837088|NCT05048719|588115217|FG004|Overall Study|Adverse Event|1|||
162837089|NCT05048719|588115218|FG005|Overall Study|Adverse Event|0|||
162837090|NCT05048719|588115219|FG006|Overall Study|Adverse Event|0|||
162837091|NCT05048719|588115220|FG007|Overall Study|Adverse Event|0|||
162837092|NCT05048719|588115221|FG008|Overall Study|Adverse Event|0|||
162837093|NCT05048719|588115213|FG000|Overall Study|Lost to Follow-up|0|||
162837094|NCT05048719|588115214|FG001|Overall Study|Lost to Follow-up|0|||
162837095|NCT05048719|588115215|FG002|Overall Study|Lost to Follow-up|1|||
162837096|NCT05048719|588115216|FG003|Overall Study|Lost to Follow-up|3|||
162837097|NCT05048719|588115217|FG004|Overall Study|Lost to Follow-up|1|||
162837098|NCT05048719|588115218|FG005|Overall Study|Lost to Follow-up|1|||
162837099|NCT05048719|588115219|FG006|Overall Study|Lost to Follow-up|1|||
162837100|NCT05048719|588115220|FG007|Overall Study|Lost to Follow-up|1|||
162837101|NCT05048719|588115221|FG008|Overall Study|Lost to Follow-up|0|||
162837102|NCT05048719|588115213|FG000|Overall Study|Physician Decision|0|||
162837103|NCT05048719|588115214|FG001|Overall Study|Physician Decision|0|||
162837104|NCT05048719|588115215|FG002|Overall Study|Physician Decision|0|||
162837105|NCT05048719|588115216|FG003|Overall Study|Physician Decision|0|||
162837106|NCT05048719|588115217|FG004|Overall Study|Physician Decision|0|||
162837107|NCT05048719|588115218|FG005|Overall Study|Physician Decision|0|||
162837108|NCT05048719|588115219|FG006|Overall Study|Physician Decision|0|||
162837109|NCT05048719|588115220|FG007|Overall Study|Physician Decision|1|||
162837110|NCT05048719|588115221|FG008|Overall Study|Physician Decision|1|||
162837111|NCT05048719|588115213|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
162837112|NCT05048719|588115214|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837113|NCT05048719|588115215|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837114|NCT05048719|588115216|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837115|NCT05048719|588115217|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837116|NCT05048719|588115218|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837117|NCT05048719|588115219|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837118|NCT05048719|588115220|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837119|NCT05048719|588115221|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
162837120|NCT05048719|588115213|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837121|NCT05048719|588115214|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
162837122|NCT05048719|588115215|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837123|NCT05048719|588115216|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837124|NCT05048719|588115217|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837125|NCT05048719|588115218|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837126|NCT05048719|588115219|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837127|NCT05048719|588115220|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837128|NCT05048719|588115221|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
162837129|NCT05048719|588115213|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837130|NCT05048719|588115214|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
162837131|NCT05048719|588115215|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837132|NCT05048719|588115216|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837133|NCT05048719|588115217|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837134|NCT05048719|588115218|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837135|NCT05048719|588115219|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837136|NCT05048719|588115220|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837137|NCT05048719|588115221|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
162837138|NCT05048719|588115213|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837139|NCT05048719|588115214|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837140|NCT05048719|588115215|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837141|NCT05048719|588115216|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
162837142|NCT05048719|588115217|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837143|NCT05048719|588115218|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837144|NCT05048719|588115219|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837145|NCT05048719|588115220|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162948596|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
162948597|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
162948598|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
162948599|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
162837146|NCT05048719|588115221|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
162837147|NCT05048719|588115213|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837148|NCT05048719|588115214|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837149|NCT05048719|588115215|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837150|NCT05048719|588115216|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837151|NCT05048719|588115217|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837152|NCT05048719|588115218|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
162837153|NCT05048719|588115219|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837154|NCT05048719|588115220|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837155|NCT05048719|588115221|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
162837156|NCT00494091|588115222|FG000|Overall Study|Death|5|||
162837157|NCT00494091|588115223|FG001|Overall Study|Death|54|||
162837158|NCT00494091|588115222|FG000|Overall Study|Lost to Follow-up|0|||
162837159|NCT00494091|588115223|FG001|Overall Study|Lost to Follow-up|4|||
162837160|NCT00494091|588115222|FG000|Overall Study|Other|1|||
162837161|NCT00494091|588115223|FG001|Overall Study|Other|11|||
162837162|NCT00494091|588115222|FG000|Overall Study|Withdrawal by Subject|0|||
162837163|NCT00494091|588115223|FG001|Overall Study|Withdrawal by Subject|7|||
162837164|NCT02354703|588115231|FG000|Overall Study|Withdrawal by Subject|1|||
162837165|NCT02354703|588115232|FG001|Overall Study|Withdrawal by Subject|1|||
162837166|NCT02354703|588115233|FG002|Overall Study|Withdrawal by Subject|1|||
162837167|NCT02354703|588115234|FG003|Overall Study|Withdrawal by Subject|1|||
162837168|NCT02354703|588115231|FG000|Overall Study|Lost to Follow-up|2|||
162837169|NCT02354703|588115232|FG001|Overall Study|Lost to Follow-up|7|||
162837170|NCT02354703|588115233|FG002|Overall Study|Lost to Follow-up|9|||
162837171|NCT02354703|588115234|FG003|Overall Study|Lost to Follow-up|2|||
162837172|NCT02354703|588115231|FG000|Overall Study|Adverse Event|0|||
162837173|NCT02354703|588115232|FG001|Overall Study|Adverse Event|0|||
162837174|NCT02354703|588115233|FG002|Overall Study|Adverse Event|1|||
162837175|NCT02354703|588115234|FG003|Overall Study|Adverse Event|0|||
162837176|NCT00984204|588115235|FG000|Overall Study|Death|1|||
162837177|NCT00984204|588115235|FG000|Overall Study|Lost to Follow-up|4|||
162837178|NCT00984204|588115235|FG000|Overall Study|Lack of Efficacy|10|||
162837179|NCT03269344|588115237|FG000|Overall Study|Protocol Violation|4|||
162837180|NCT03269344|588115238|FG001|Overall Study|Protocol Violation|3|||
162837181|NCT04478708|588115241|FG000|Overall Study|Lost to Follow-up|0|||
162837182|NCT04478708|588115242|FG001|Overall Study|Lost to Follow-up|0|||
162837183|NCT04478708|588115243|FG002|Overall Study|Lost to Follow-up|0|||
162837184|NCT04478708|588115244|FG003|Overall Study|Lost to Follow-up|0|||
162837185|NCT04478708|588115245|FG004|Overall Study|Lost to Follow-up|0|||
162837186|NCT04478708|588115246|FG005|Overall Study|Lost to Follow-up|0|||
162837187|NCT04478708|588115247|FG006|Overall Study|Lost to Follow-up|0|||
162837188|NCT04478708|588115248|FG007|Overall Study|Lost to Follow-up|0|||
162837189|NCT04478708|588115249|FG008|Overall Study|Lost to Follow-up|1|||
162837190|NCT04478708|588115250|FG009|Overall Study|Lost to Follow-up|1|||
162837191|NCT04478708|588115251|FG010|Overall Study|Lost to Follow-up|1|||
162837192|NCT04478708|588115252|FG011|Overall Study|Lost to Follow-up|2|||
162837193|NCT04478708|588115253|FG012|Overall Study|Lost to Follow-up|1|||
162837194|NCT04478708|588115254|FG013|Overall Study|Lost to Follow-up|0|||
162837195|NCT04478708|588115255|FG014|Overall Study|Lost to Follow-up|0|||
162837196|NCT04478708|588115256|FG015|Overall Study|Lost to Follow-up|0|||
162837197|NCT04478708|588115257|FG016|Overall Study|Lost to Follow-up|0|||
162837198|NCT04478708|588115241|FG000|Overall Study|Withdrawal of consent from study|0|||
162837199|NCT04478708|588115242|FG001|Overall Study|Withdrawal of consent from study|1|||
162837200|NCT04478708|588115243|FG002|Overall Study|Withdrawal of consent from study|2|||
162837201|NCT04478708|588115244|FG003|Overall Study|Withdrawal of consent from study|0|||
162837202|NCT04478708|588115245|FG004|Overall Study|Withdrawal of consent from study|1|||
162837203|NCT04478708|588115246|FG005|Overall Study|Withdrawal of consent from study|1|||
162837204|NCT04478708|588115247|FG006|Overall Study|Withdrawal of consent from study|1|||
162837205|NCT04478708|588115248|FG007|Overall Study|Withdrawal of consent from study|0|||
162837206|NCT04478708|588115249|FG008|Overall Study|Withdrawal of consent from study|0|||
162837207|NCT04478708|588115250|FG009|Overall Study|Withdrawal of consent from study|0|||
162837208|NCT04478708|588115251|FG010|Overall Study|Withdrawal of consent from study|4|||
162837209|NCT04478708|588115252|FG011|Overall Study|Withdrawal of consent from study|3|||
162837210|NCT04478708|588115253|FG012|Overall Study|Withdrawal of consent from study|0|||
162837211|NCT04478708|588115254|FG013|Overall Study|Withdrawal of consent from study|0|||
162837212|NCT04478708|588115255|FG014|Overall Study|Withdrawal of consent from study|1|||
162837213|NCT04478708|588115256|FG015|Overall Study|Withdrawal of consent from study|0|||
162837214|NCT04478708|588115257|FG016|Overall Study|Withdrawal of consent from study|4|||
162837215|NCT01869114|588115258|FG000|Overall Study|Death|19|||
162837216|NCT01869114|588115259|FG001|Overall Study|Death|18|||
162837217|NCT01869114|588115260|FG002|Overall Study|Death|8|||
162837218|NCT01869114|588115258|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
162837219|NCT01869114|588115259|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
162837220|NCT01869114|588115260|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
162837221|NCT01869114|588115258|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
162837222|NCT01869114|588115259|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
162837223|NCT01869114|588115260|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
162837224|NCT01869114|588115258|FG000|Overall Study|Withdrawal by Subject|0|||
162837225|NCT01869114|588115259|FG001|Overall Study|Withdrawal by Subject|3|||
162837226|NCT01869114|588115260|FG002|Overall Study|Withdrawal by Subject|0|||
162837227|NCT01869114|588115258|FG000|Overall Study|Disease Progression|0|||
162837228|NCT01869114|588115259|FG001|Overall Study|Disease Progression|1|||
162837229|NCT01869114|588115260|FG002|Overall Study|Disease Progression|0|||
162837230|NCT00559507|588115261|FG000|Overall Study|Not treated, patient ineligible|3|||
162837231|NCT04681170|588115262|FG000|Stratified Enrolment & run-in|Death|1|||
162837232|NCT04681170|588115263|FG001|Stratified Enrolment & run-in|Death|0|||
162837233|NCT04681170|588115262|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
162837234|NCT04681170|588115263|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
162837235|NCT04681170|588115262|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
162837236|NCT04681170|588115263|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
162837237|NCT04681170|588115262|FG000|Open Label Efficacy Phase|Adverse Event|0|||
162837238|NCT04681170|588115263|FG001|Open Label Efficacy Phase|Adverse Event|2|||
162837239|NCT04681170|588115262|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
162837240|NCT04681170|588115263|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
162837241|NCT04681170|588115262|FG000|Open Label Safety Phase|AEs and none compliance|0|||
162837242|NCT04681170|588115263|FG001|Open Label Safety Phase|AEs and none compliance|1|||
162837243|NCT01407926|588115264|FG000|Overall Study|Lost to Follow-up|55|||
162837244|NCT02118792|588115265|FG000|Overall Study|Withdrawal by Subject|6|||
162837245|NCT02118792|588115266|FG001|Overall Study|Withdrawal by Subject|3|||
162837246|NCT02118792|588115265|FG000|Overall Study|Lost to Follow-up|4|||
162837247|NCT02118792|588115266|FG001|Overall Study|Lost to Follow-up|4|||
162837248|NCT02118792|588115265|FG000|Overall Study|Adverse Event|5|||
162837249|NCT02118792|588115266|FG001|Overall Study|Adverse Event|4|||
162837250|NCT02118792|588115265|FG000|Overall Study|Withdrawal by parent/guardian|14|||
162837251|NCT02118792|588115266|FG001|Overall Study|Withdrawal by parent/guardian|20|||
162837252|NCT02118792|588115265|FG000|Overall Study|Other|1|||
162837253|NCT02118792|588115266|FG001|Overall Study|Other|6|||
162837254|NCT02118792|588115265|FG000|Overall Study|Randomised but not treated|1|||
162837255|NCT02118792|588115266|FG001|Overall Study|Randomised but not treated|0|||
162837256|NCT04232696|588115268|FG000|Overall Study|Implant attempted but not completed|5|||
162837257|NCT04232696|588115269|FG001|Overall Study|Implant attempted but not completed|2|||
162837258|NCT04232696|588115268|FG000|Overall Study|Not satisfied with therapy outcome|0|||
162837259|NCT04232696|588115269|FG001|Overall Study|Not satisfied with therapy outcome|8|||
162837260|NCT04232696|588115268|FG000|Overall Study|Adverse Event|0|||
162837261|NCT04232696|588115269|FG001|Overall Study|Adverse Event|3|||
162837262|NCT04232696|588115268|FG000|Overall Study|Withdrawal by Subject|0|||
162837263|NCT04232696|588115269|FG001|Overall Study|Withdrawal by Subject|3|||
162837264|NCT04232696|588115268|FG000|Overall Study|Missed Visit|0|||
162837265|NCT04232696|588115269|FG001|Overall Study|Missed Visit|2|||
162837266|NCT04232696|588115268|FG000|Overall Study|Other reason|0|||
162837267|NCT04232696|588115269|FG001|Overall Study|Other reason|1|||
162837268|NCT01678144|588115270|FG000|Stage 1: MAR Classic|Adverse Event|1|||
162837269|NCT01885000|588115271|FG000|Overall Study|Adverse Event|1|||
162837270|NCT01885000|588115272|FG001|Overall Study|Adverse Event|0|||
162837271|NCT01885000|588115271|FG000|Overall Study|Withdrawal by Subject|1|||
162837272|NCT01885000|588115272|FG001|Overall Study|Withdrawal by Subject|1|||
162837273|NCT01885000|588115271|FG000|Overall Study|Protocol Violation|0|||
162837274|NCT01885000|588115272|FG001|Overall Study|Protocol Violation|1|||
162837275|NCT02792842|588115273|FG000|Overall Study|Adverse Event|4|||
162837276|NCT02792842|588115274|FG001|Overall Study|Adverse Event|2|||
162837277|NCT02792842|588115275|FG002|Overall Study|Adverse Event|3|||
162837278|NCT02792842|588115273|FG000|Overall Study|Withdrawal by Subject|0|||
162837279|NCT02792842|588115274|FG001|Overall Study|Withdrawal by Subject|1|||
162837280|NCT02792842|588115275|FG002|Overall Study|Withdrawal by Subject|2|||
162837281|NCT02792842|588115273|FG000|Overall Study|Lost to Follow-up|0|||
162837282|NCT02792842|588115274|FG001|Overall Study|Lost to Follow-up|0|||
162837283|NCT02792842|588115275|FG002|Overall Study|Lost to Follow-up|1|||
162837284|NCT02792842|588115273|FG000|Overall Study|Schedule delay|0|||
162837285|NCT02792842|588115274|FG001|Overall Study|Schedule delay|1|||
162837286|NCT02792842|588115275|FG002|Overall Study|Schedule delay|1|||
162837287|NCT05289830|588115282|FG000|Overall Study|Lost to Follow-up|1|||
162837288|NCT05289830|588115283|FG001|Overall Study|Lost to Follow-up|1|||
162837289|NCT05289830|588115282|FG000|Overall Study|Physician Decision|0|||
162837290|NCT05289830|588115283|FG001|Overall Study|Physician Decision|1|||
162837291|NCT01046825|588115284|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
162837292|NCT01046825|588115285|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
162837293|NCT01046825|588115286|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
162837294|NCT01046825|588115287|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
162837295|NCT01046825|588115288|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
162837296|NCT01046825|588115284|FG000|Overall Study|Physician Decision|0|||
162837297|NCT01046825|588115285|FG001|Overall Study|Physician Decision|1|||
162837298|NCT01046825|588115286|FG002|Overall Study|Physician Decision|2|||
162837299|NCT01046825|588115287|FG003|Overall Study|Physician Decision|0|||
162837300|NCT01046825|588115288|FG004|Overall Study|Physician Decision|0|||
162837301|NCT01046825|588115284|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
162837302|NCT01046825|588115285|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
162837303|NCT01046825|588115286|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
162837304|NCT01046825|588115287|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
162837305|NCT01046825|588115288|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
162837306|NCT01046825|588115284|FG000|Overall Study|Found to be ineligible|0|||
162837307|NCT01046825|588115285|FG001|Overall Study|Found to be ineligible|1|||
162837308|NCT01046825|588115286|FG002|Overall Study|Found to be ineligible|0|||
162837309|NCT01046825|588115287|FG003|Overall Study|Found to be ineligible|0|||
162837310|NCT01046825|588115288|FG004|Overall Study|Found to be ineligible|0|||
162837311|NCT01046825|588115284|FG000|Overall Study|Death|0|||
162837312|NCT01046825|588115285|FG001|Overall Study|Death|0|||
162837313|NCT01046825|588115286|FG002|Overall Study|Death|0|||
162837314|NCT01046825|588115287|FG003|Overall Study|Death|1|||
162837315|NCT01046825|588115288|FG004|Overall Study|Death|0|||
162837316|NCT01046825|588115284|FG000|Overall Study|Did not submit biology samples|0|||
162837317|NCT01046825|588115285|FG001|Overall Study|Did not submit biology samples|0|||
162837318|NCT01046825|588115286|FG002|Overall Study|Did not submit biology samples|0|||
162837319|NCT01046825|588115287|FG003|Overall Study|Did not submit biology samples|0|||
162837320|NCT01046825|588115288|FG004|Overall Study|Did not submit biology samples|13|||
162837321|NCT02872311|588115292|FG000|Overall Study|Death|2|||
162837322|NCT02872311|588115293|FG001|Overall Study|Death|0|||
162837323|NCT02872311|588115294|FG002|Overall Study|Death|0|||
162837324|NCT02872311|588115295|FG003|Overall Study|Death|0|||
162837325|NCT02872311|588115296|FG004|Overall Study|Death|0|||
162837326|NCT02872311|588115292|FG000|Overall Study|Lost to Follow-up|2|||
162837327|NCT02872311|588115293|FG001|Overall Study|Lost to Follow-up|0|||
162837328|NCT02872311|588115294|FG002|Overall Study|Lost to Follow-up|0|||
162837329|NCT02872311|588115295|FG003|Overall Study|Lost to Follow-up|0|||
162837330|NCT02872311|588115296|FG004|Overall Study|Lost to Follow-up|0|||
162837331|NCT02872311|588115292|FG000|Overall Study|Protocol Violation|0|||
162837332|NCT02872311|588115293|FG001|Overall Study|Protocol Violation|2|||
162837333|NCT02872311|588115294|FG002|Overall Study|Protocol Violation|1|||
162837334|NCT02872311|588115295|FG003|Overall Study|Protocol Violation|0|||
162837335|NCT02872311|588115296|FG004|Overall Study|Protocol Violation|0|||
162837336|NCT05617911|588115297|FG000|Overall Study|Withdrawal by Subject|1|||
162837337|NCT05617911|588115298|FG001|Overall Study|Withdrawal by Subject|0|||
162837338|NCT03557359|588115299|FG000|Dose 1: 240 mg|Adverse Event|1|||
162837339|NCT03557359|588115300|FG001|Dose 1: 240 mg|Adverse Event|0|||
162837340|NCT03975647|588115301|FG000|Overall Study|Death|71|||
162837341|NCT03975647|588115302|FG001|Overall Study|Death|63|||
162837342|NCT03975647|588115301|FG000|Overall Study|Lost to Follow-up|2|||
162837343|NCT03975647|588115302|FG001|Overall Study|Lost to Follow-up|2|||
162837344|NCT03975647|588115301|FG000|Overall Study|Subject withdrawal of consent|7|||
162837345|NCT03975647|588115302|FG001|Overall Study|Subject withdrawal of consent|11|||
162837346|NCT04868903|588115303|FG000|Overall Study|Adverse Event|0|||
162837347|NCT04868903|588115304|FG001|Overall Study|Adverse Event|0|||
162837348|NCT04868903|588115305|FG002|Overall Study|Adverse Event|0|||
162837349|NCT04868903|588115306|FG003|Overall Study|Adverse Event|1|||
162837350|NCT04868903|588115303|FG000|Overall Study|Withdrawal by Subject|29|||
162837351|NCT04868903|588115304|FG001|Overall Study|Withdrawal by Subject|44|||
162837352|NCT04868903|588115305|FG002|Overall Study|Withdrawal by Subject|17|||
162837353|NCT04868903|588115306|FG003|Overall Study|Withdrawal by Subject|12|||
162837354|NCT04868903|588115303|FG000|Overall Study|Hyperparathyroidism|3|||
162837355|NCT04868903|588115304|FG001|Overall Study|Hyperparathyroidism|5|||
162837356|NCT04868903|588115305|FG002|Overall Study|Hyperparathyroidism|2|||
162837357|NCT04868903|588115306|FG003|Overall Study|Hyperparathyroidism|3|||
162837358|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
162837359|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
162837360|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
162837361|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
162837362|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
162837363|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
162837364|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
162837365|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
162837366|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
162837367|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
162837368|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
162837369|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
162837370|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
162837371|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
162837372|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
162837373|NCT03735667|588115307|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
162837374|NCT03735667|588115308|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
162837375|NCT03735667|588115309|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
162837376|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
162837377|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
162837378|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
162837379|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
162837380|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
162837381|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
162837382|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
162837383|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
162837384|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
162837385|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
162699937|NCT01348854|587612444|FG001|Overall Study|Withdrawal by Subject|0|||
162837386|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
162837387|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
162837388|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
162837389|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
162837390|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
162837391|NCT03735667|588115307|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
162837392|NCT03735667|588115308|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
162837393|NCT03735667|588115309|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
162837394|NCT03092726|588115310|FG000|Overall Study|Adverse Event|3|||
162837395|NCT03092726|588115311|FG001|Overall Study|Adverse Event|10|||
162837396|NCT03092726|588115310|FG000|Overall Study|Lack of Efficacy|0|||
162837397|NCT03092726|588115311|FG001|Overall Study|Lack of Efficacy|1|||
162837398|NCT03092726|588115310|FG000|Overall Study|Lost to Follow-up|1|||
162837399|NCT03092726|588115311|FG001|Overall Study|Lost to Follow-up|0|||
162837400|NCT03092726|588115310|FG000|Overall Study|Withdrawal by Subject|5|||
162837401|NCT03092726|588115311|FG001|Overall Study|Withdrawal by Subject|3|||
162837402|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
162837403|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
162837404|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
162837405|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
162837406|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
162837407|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
162837408|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
162837409|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
162837410|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
162837411|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
162837412|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
162948600|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
162948601|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
162837413|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
162837414|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
162837415|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
162837416|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
162837417|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
162837418|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
162837419|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
162837420|NCT04418765|588115318|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
162837421|NCT04418765|588115319|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
162837422|NCT04418765|588115320|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
162837423|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
162837424|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
162837425|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
162837426|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
162837427|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
162837428|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
162837429|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
162837430|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
162837431|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
162837432|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
162837433|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
162837434|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
162837435|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
162837436|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
162837437|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
162837438|NCT04418765|588115318|FG000|Extension Period (48 Weeks)|Other than specified|0|||
162837439|NCT04418765|588115319|FG001|Extension Period (48 Weeks)|Other than specified|5|||
162837440|NCT04418765|588115320|FG002|Extension Period (48 Weeks)|Other than specified|2|||
162837441|NCT03345472|588115324|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
162837442|NCT03345472|588115324|FG000|Implant to 3 Months|Physician Decision|1|||
162837443|NCT03345472|588115324|FG000|Implant to 3 Months|Adverse Event|1|||
162837444|NCT03345472|588115324|FG000|3 Months to 12 Months|Physician Decision|3|||
162948602|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948603|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
162948604|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
162948605|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
162948606|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
162837445|NCT03345472|588115324|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
162837446|NCT03345472|588115324|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
162837447|NCT03345472|588115324|FG000|3 Months to 12 Months|Adverse Event|1|||
162837448|NCT03345472|588115324|FG000|3 Months to 12 Months|Death|1|||
162837449|NCT01926782|588115325|FG000|Overall Study|Participant moved|2|||
162948607|NCT00437658|588515241|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
162948608|NCT00437658|588515242|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
162948609|NCT00437658|588515243|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
162948610|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
162948611|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
162837450|NCT01926782|588115326|FG001|Overall Study|Participant moved|0|||
162837451|NCT01926782|588115327|FG002|Overall Study|Participant moved|1|||
162948612|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
162837452|NCT01926782|588115328|FG003|Overall Study|Participant moved|1|||
162837453|NCT01926782|588115329|FG004|Overall Study|Participant moved|0|||
162837454|NCT01926782|588115330|FG005|Overall Study|Participant moved|3|||
162837455|NCT01926782|588115325|FG000|Overall Study|Physician Decision|0|||
162837456|NCT01926782|588115326|FG001|Overall Study|Physician Decision|2|||
162837457|NCT01926782|588115327|FG002|Overall Study|Physician Decision|1|||
162837458|NCT01926782|588115328|FG003|Overall Study|Physician Decision|1|||
162837459|NCT01926782|588115329|FG004|Overall Study|Physician Decision|0|||
162837460|NCT01926782|588115330|FG005|Overall Study|Physician Decision|0|||
162837461|NCT01926782|588115325|FG000|Overall Study|Other than specified|2|||
162837462|NCT01926782|588115326|FG001|Overall Study|Other than specified|3|||
162837463|NCT01926782|588115327|FG002|Overall Study|Other than specified|5|||
162837464|NCT01926782|588115328|FG003|Overall Study|Other than specified|12|||
162837465|NCT01926782|588115329|FG004|Overall Study|Other than specified|4|||
162837466|NCT01926782|588115330|FG005|Overall Study|Other than specified|11|||
162837467|NCT01926782|588115325|FG000|Overall Study|Adverse Event|13|||
162837468|NCT01926782|588115326|FG001|Overall Study|Adverse Event|4|||
162837469|NCT01926782|588115327|FG002|Overall Study|Adverse Event|17|||
162837470|NCT01926782|588115328|FG003|Overall Study|Adverse Event|4|||
162837471|NCT01926782|588115329|FG004|Overall Study|Adverse Event|3|||
162837472|NCT01926782|588115330|FG005|Overall Study|Adverse Event|14|||
162837473|NCT01926782|588115325|FG000|Overall Study|Poor compliance to protocol|5|||
162837474|NCT01926782|588115326|FG001|Overall Study|Poor compliance to protocol|3|||
162837475|NCT01926782|588115327|FG002|Overall Study|Poor compliance to protocol|8|||
162837476|NCT01926782|588115328|FG003|Overall Study|Poor compliance to protocol|0|||
162837477|NCT01926782|588115329|FG004|Overall Study|Poor compliance to protocol|1|||
162837478|NCT01926782|588115330|FG005|Overall Study|Poor compliance to protocol|6|||
162837479|NCT01926782|588115325|FG000|Overall Study|Randomized and not treated|0|||
162837480|NCT01926782|588115326|FG001|Overall Study|Randomized and not treated|0|||
162837481|NCT01926782|588115327|FG002|Overall Study|Randomized and not treated|0|||
162837482|NCT01926782|588115328|FG003|Overall Study|Randomized and not treated|1|||
162837483|NCT01926782|588115329|FG004|Overall Study|Randomized and not treated|0|||
162837484|NCT01926782|588115330|FG005|Overall Study|Randomized and not treated|0|||
162837485|NCT01926782|588115325|FG000|Overall Study|Withdrawal by Subject|6|||
162837486|NCT01926782|588115326|FG001|Overall Study|Withdrawal by Subject|1|||
162837487|NCT01926782|588115327|FG002|Overall Study|Withdrawal by Subject|8|||
162837488|NCT01926782|588115328|FG003|Overall Study|Withdrawal by Subject|1|||
162837489|NCT01926782|588115329|FG004|Overall Study|Withdrawal by Subject|0|||
162837490|NCT01926782|588115330|FG005|Overall Study|Withdrawal by Subject|5|||
162837491|NCT01926782|588115325|FG000|Overall Study|Related to study drug administration|0|||
162837492|NCT01926782|588115326|FG001|Overall Study|Related to study drug administration|0|||
162837493|NCT01926782|588115327|FG002|Overall Study|Related to study drug administration|0|||
162837494|NCT01926782|588115328|FG003|Overall Study|Related to study drug administration|0|||
162837495|NCT01926782|588115329|FG004|Overall Study|Related to study drug administration|0|||
162837496|NCT01926782|588115330|FG005|Overall Study|Related to study drug administration|2|||
162837497|NCT04607733|588115333|FG000|Overall Study|Lost to Follow-up|1|||
162837498|NCT04607733|588115334|FG001|Overall Study|Lost to Follow-up|0|||
162837499|NCT04607733|588115335|FG002|Overall Study|Lost to Follow-up|0|||
162837500|NCT04607733|588115336|FG003|Overall Study|Lost to Follow-up|1|||
162837501|NCT04607733|588115337|FG004|Overall Study|Lost to Follow-up|1|||
162837502|NCT04607733|588115338|FG005|Overall Study|Lost to Follow-up|0|||
162837503|NCT04607733|588115333|FG000|Overall Study|Withdrawal by Subject|0|||
162837504|NCT04607733|588115334|FG001|Overall Study|Withdrawal by Subject|0|||
162837505|NCT04607733|588115335|FG002|Overall Study|Withdrawal by Subject|0|||
162837506|NCT04607733|588115336|FG003|Overall Study|Withdrawal by Subject|0|||
162837507|NCT04607733|588115337|FG004|Overall Study|Withdrawal by Subject|1|||
162837508|NCT04607733|588115338|FG005|Overall Study|Withdrawal by Subject|0|||
162837509|NCT02296242|588115339|FG000|Overall Study|Death|1|||
162837510|NCT02296242|588115340|FG001|Overall Study|Death|1|||
162837511|NCT02296242|588115341|FG002|Overall Study|Death|1|||
162837512|NCT02296242|588115342|FG003|Overall Study|Death|1|||
162837513|NCT02296242|588115343|FG004|Overall Study|Death|1|||
162837514|NCT02296242|588115339|FG000|Overall Study|Withdrawal by Subject|0|||
162837515|NCT02296242|588115340|FG001|Overall Study|Withdrawal by Subject|0|||
162837516|NCT02296242|588115341|FG002|Overall Study|Withdrawal by Subject|1|||
162837517|NCT02296242|588115342|FG003|Overall Study|Withdrawal by Subject|1|||
162837518|NCT02296242|588115343|FG004|Overall Study|Withdrawal by Subject|3|||
162837519|NCT02296242|588115339|FG000|Overall Study|Disease Progression|1|||
162837520|NCT02296242|588115340|FG001|Overall Study|Disease Progression|3|||
162837521|NCT02296242|588115341|FG002|Overall Study|Disease Progression|2|||
162837522|NCT02296242|588115342|FG003|Overall Study|Disease Progression|8|||
162837523|NCT02296242|588115343|FG004|Overall Study|Disease Progression|11|||
162837524|NCT02296242|588115339|FG000|Overall Study|Unacceptable Toxicity|0|||
162837525|NCT02296242|588115340|FG001|Overall Study|Unacceptable Toxicity|0|||
162837526|NCT02296242|588115341|FG002|Overall Study|Unacceptable Toxicity|0|||
162837527|NCT02296242|588115342|FG003|Overall Study|Unacceptable Toxicity|0|||
162837528|NCT02296242|588115343|FG004|Overall Study|Unacceptable Toxicity|1|||
162837529|NCT02296242|588115339|FG000|Overall Study|Patient Condition Changed|0|||
162837530|NCT02296242|588115340|FG001|Overall Study|Patient Condition Changed|0|||
162837531|NCT02296242|588115341|FG002|Overall Study|Patient Condition Changed|2|||
162837532|NCT02296242|588115342|FG003|Overall Study|Patient Condition Changed|0|||
162837533|NCT02296242|588115343|FG004|Overall Study|Patient Condition Changed|1|||
162837534|NCT02296242|588115339|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
162837535|NCT02296242|588115340|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
162837536|NCT02296242|588115341|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
162837537|NCT02296242|588115342|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
162837538|NCT02296242|588115343|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
162837539|NCT02296242|588115339|FG000|Overall Study|Lost to Follow-up|1|||
162837540|NCT02296242|588115340|FG001|Overall Study|Lost to Follow-up|0|||
162837541|NCT02296242|588115341|FG002|Overall Study|Lost to Follow-up|0|||
162837542|NCT02296242|588115342|FG003|Overall Study|Lost to Follow-up|0|||
162837543|NCT02296242|588115343|FG004|Overall Study|Lost to Follow-up|0|||
162837544|NCT02296242|588115339|FG000|Overall Study|Need for Hydroxyurea|2|||
162837545|NCT02296242|588115340|FG001|Overall Study|Need for Hydroxyurea|0|||
162948613|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
162948614|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
162948615|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
162948616|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
162948617|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
162948618|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
162948619|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
162948620|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948621|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
162948622|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
162948623|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
162948624|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
162948625|NCT00437658|588515241|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
162948626|NCT00437658|588515242|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
162948627|NCT00437658|588515243|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
162948628|NCT03952143|588515244|FG000|Lead-In Period|Adverse Event|2|||
162948629|NCT03952143|588515245|FG001|Lead-In Period|Adverse Event|0|||
162948630|NCT03952143|588515246|FG002|Lead-In Period|Adverse Event|0|||
162948631|NCT03952143|588515244|FG000|Lead-In Period|Lack of Efficacy|2|||
162948632|NCT03952143|588515245|FG001|Lead-In Period|Lack of Efficacy|0|||
162948633|NCT03952143|588515246|FG002|Lead-In Period|Lack of Efficacy|0|||
162948634|NCT03952143|588515244|FG000|Lead-In Period|Physician Decision|5|||
162948635|NCT03952143|588515245|FG001|Lead-In Period|Physician Decision|0|||
162948636|NCT03952143|588515246|FG002|Lead-In Period|Physician Decision|0|||
162948637|NCT03952143|588515244|FG000|Lead-In Period|Protocol Violation|5|||
162948638|NCT03952143|588515245|FG001|Lead-In Period|Protocol Violation|0|||
162948639|NCT03952143|588515246|FG002|Lead-In Period|Protocol Violation|0|||
162948640|NCT03952143|588515244|FG000|Lead-In Period|Withdrawal by Subject|19|||
162948641|NCT03952143|588515245|FG001|Lead-In Period|Withdrawal by Subject|0|||
162948642|NCT03952143|588515246|FG002|Lead-In Period|Withdrawal by Subject|0|||
162948643|NCT03952143|588515244|FG000|Treatment Period|Adverse Event|0|||
162948644|NCT03952143|588515245|FG001|Treatment Period|Adverse Event|0|||
162948645|NCT03952143|588515246|FG002|Treatment Period|Adverse Event|1|||
162948646|NCT03952143|588515244|FG000|Treatment Period|Lost to Follow-up|0|||
162948647|NCT03952143|588515245|FG001|Treatment Period|Lost to Follow-up|2|||
162837546|NCT02296242|588115341|FG002|Overall Study|Need for Hydroxyurea|0|||
162837547|NCT02296242|588115342|FG003|Overall Study|Need for Hydroxyurea|0|||
162837548|NCT02296242|588115343|FG004|Overall Study|Need for Hydroxyurea|0|||
162837549|NCT02296242|588115339|FG000|Overall Study|Screened for Other Protocol|0|||
162837550|NCT02296242|588115340|FG001|Overall Study|Screened for Other Protocol|1|||
162948648|NCT03952143|588515246|FG002|Treatment Period|Lost to Follow-up|0|||
162948649|NCT03952143|588515244|FG000|Treatment Period|Physician Decision|0|||
162948650|NCT03952143|588515245|FG001|Treatment Period|Physician Decision|0|||
162837551|NCT02296242|588115341|FG002|Overall Study|Screened for Other Protocol|0|||
162837552|NCT02296242|588115342|FG003|Overall Study|Screened for Other Protocol|0|||
162837553|NCT02296242|588115343|FG004|Overall Study|Screened for Other Protocol|0|||
162837554|NCT02296242|588115339|FG000|Overall Study|Physician Decision|0|||
162837555|NCT02296242|588115340|FG001|Overall Study|Physician Decision|1|||
162837556|NCT02296242|588115341|FG002|Overall Study|Physician Decision|0|||
162837557|NCT02296242|588115342|FG003|Overall Study|Physician Decision|1|||
162837558|NCT02296242|588115343|FG004|Overall Study|Physician Decision|0|||
162837559|NCT02296242|588115339|FG000|Overall Study|Alternative Treatment|0|||
162837560|NCT02296242|588115340|FG001|Overall Study|Alternative Treatment|0|||
162837561|NCT02296242|588115341|FG002|Overall Study|Alternative Treatment|0|||
162837562|NCT02296242|588115342|FG003|Overall Study|Alternative Treatment|1|||
162837563|NCT02296242|588115343|FG004|Overall Study|Alternative Treatment|0|||
162837564|NCT02296242|588115339|FG000|Overall Study|Adverse Event|0|||
162837565|NCT02296242|588115340|FG001|Overall Study|Adverse Event|0|||
162837566|NCT02296242|588115341|FG002|Overall Study|Adverse Event|0|||
162837567|NCT02296242|588115342|FG003|Overall Study|Adverse Event|1|||
162837568|NCT02296242|588115343|FG004|Overall Study|Adverse Event|0|||
162837569|NCT02296242|588115339|FG000|Overall Study|Lack of Efficacy|0|||
162837570|NCT02296242|588115340|FG001|Overall Study|Lack of Efficacy|0|||
162837571|NCT02296242|588115341|FG002|Overall Study|Lack of Efficacy|0|||
162837572|NCT02296242|588115342|FG003|Overall Study|Lack of Efficacy|0|||
162837573|NCT02296242|588115343|FG004|Overall Study|Lack of Efficacy|3|||
162837574|NCT03504397|588115349|FG000|Overall Study|Progressive Disease|151|||
162837575|NCT03504397|588115350|FG001|Overall Study|Progressive Disease|199|||
162837576|NCT03504397|588115349|FG000|Overall Study|Withdrawal by Subject|29|||
162837577|NCT03504397|588115350|FG001|Overall Study|Withdrawal by Subject|17|||
162837578|NCT03504397|588115349|FG000|Overall Study|Lost to Follow-up|1|||
162837579|NCT03504397|588115350|FG001|Overall Study|Lost to Follow-up|0|||
162837580|NCT03504397|588115349|FG000|Overall Study|Death|14|||
162837581|NCT03504397|588115350|FG001|Overall Study|Death|16|||
162837582|NCT03504397|588115349|FG000|Overall Study|Adverse Event|40|||
162837583|NCT03504397|588115350|FG001|Overall Study|Adverse Event|14|||
162837584|NCT03504397|588115349|FG000|Overall Study|miscellaneous|17|||
162837585|NCT03504397|588115350|FG001|Overall Study|miscellaneous|15|||
162837586|NCT03504397|588115349|FG000|Overall Study|Protocol deviation|1|||
162837587|NCT03504397|588115350|FG001|Overall Study|Protocol deviation|0|||
162837588|NCT03504397|588115349|FG000|Overall Study|Participants who did not take the study drug|4|||
162837589|NCT03504397|588115350|FG001|Overall Study|Participants who did not take the study drug|4|||
162837590|NCT00070941|588115351|FG000|Overall Study|Adverse Event|10|||
162837591|NCT00070941|588115352|FG001|Overall Study|Adverse Event|8|||
162837592|NCT00070941|588115353|FG002|Overall Study|Adverse Event|4|||
162837593|NCT02199080|588115354|FG000|Overall Study|Protocol Violation|12|||
162837594|NCT02443883|588115355|FG000|Overall Study|Adverse Event|0|||
162837595|NCT02443883|588115356|FG001|Overall Study|Adverse Event|1|||
162837596|NCT02443883|588115357|FG002|Overall Study|Adverse Event|0|||
162837597|NCT02443883|588115358|FG003|Overall Study|Adverse Event|0|||
162837598|NCT02443883|588115355|FG000|Overall Study|Lost to Follow-up|3|||
162837599|NCT02443883|588115356|FG001|Overall Study|Lost to Follow-up|2|||
162837600|NCT02443883|588115357|FG002|Overall Study|Lost to Follow-up|1|||
162837601|NCT02443883|588115358|FG003|Overall Study|Lost to Follow-up|0|||
162837602|NCT02443883|588115355|FG000|Overall Study|Physician Decision|1|||
162837603|NCT02443883|588115356|FG001|Overall Study|Physician Decision|1|||
162837604|NCT02443883|588115357|FG002|Overall Study|Physician Decision|0|||
162837605|NCT02443883|588115358|FG003|Overall Study|Physician Decision|3|||
162837606|NCT02443883|588115355|FG000|Overall Study|Withdrawal by Subject|1|||
162837607|NCT02443883|588115356|FG001|Overall Study|Withdrawal by Subject|0|||
162837608|NCT02443883|588115357|FG002|Overall Study|Withdrawal by Subject|0|||
162837609|NCT02443883|588115358|FG003|Overall Study|Withdrawal by Subject|2|||
162837610|NCT02443883|588115355|FG000|Overall Study|Randomized, but never treated|1|||
162837611|NCT02443883|588115356|FG001|Overall Study|Randomized, but never treated|0|||
162837612|NCT02443883|588115357|FG002|Overall Study|Randomized, but never treated|0|||
162837613|NCT02443883|588115358|FG003|Overall Study|Randomized, but never treated|0|||
162837614|NCT00999908|588115359|FG000|Treatment Period 1|Subject withdrew consent|2|||
162837615|NCT00999908|588115360|FG001|Treatment Period 1|Subject withdrew consent|0|||
162837616|NCT00999908|588115361|FG002|Treatment Period 1|Subject withdrew consent|0|||
162837617|NCT00999908|588115359|FG000|Treatment Period 2|Protocol Violation|1|||
162837618|NCT00999908|588115360|FG001|Treatment Period 2|Protocol Violation|0|||
162837619|NCT00999908|588115361|FG002|Treatment Period 2|Protocol Violation|0|||
162837620|NCT01097863|588115362|FG000|Overall Study|Discomfort|1|||
162837621|NCT01097863|588115363|FG001|Overall Study|Discomfort|0|||
162837622|NCT01097863|588115364|FG002|Overall Study|Discomfort|1|||
162837623|NCT01097863|588115362|FG000|Overall Study|Did not return for final visit|0|||
162837624|NCT01097863|588115363|FG001|Overall Study|Did not return for final visit|0|||
162837625|NCT01097863|588115364|FG002|Overall Study|Did not return for final visit|1|||
162948651|NCT03952143|588515246|FG002|Treatment Period|Physician Decision|2|||
162837626|NCT00419380|588115365|FG000|Overall Study|Lack of Efficacy|1|||
162837627|NCT00419380|588115366|FG001|Overall Study|Lack of Efficacy|7|||
162837628|NCT00419380|588115365|FG000|Overall Study|Physician Decision|0|||
162837629|NCT00419380|588115366|FG001|Overall Study|Physician Decision|1|||
162837630|NCT00419380|588115365|FG000|Overall Study|Lost to Follow-up|0|||
162837631|NCT00419380|588115366|FG001|Overall Study|Lost to Follow-up|1|||
162837632|NCT00419380|588115365|FG000|Overall Study|Withdrawal by Subject|0|||
162837633|NCT00419380|588115366|FG001|Overall Study|Withdrawal by Subject|1|||
162837634|NCT03099707|588115367|FG000|Overall Study|Withdrawal by Subject|0|||
162837635|NCT03099707|588115368|FG001|Overall Study|Withdrawal by Subject|3|||
162837636|NCT03099707|588115367|FG000|Overall Study|Lost to Follow-up|0|||
162837637|NCT03099707|588115368|FG001|Overall Study|Lost to Follow-up|1|||
162837638|NCT03167073|588115369|FG000|Overall Study|Stillbirth|1|||
162837639|NCT03167073|588115370|FG001|Overall Study|Stillbirth|0|||
162837640|NCT01026831|588115373|FG000|Overall Study|Adverse Event|4|||
162837641|NCT01026831|588115374|FG001|Overall Study|Adverse Event|3|||
162837642|NCT01026831|588115373|FG000|Overall Study|Lost to Follow-up|2|||
162837643|NCT01026831|588115374|FG001|Overall Study|Lost to Follow-up|0|||
162837644|NCT01026831|588115373|FG000|Overall Study|Physician Decision|1|||
162837645|NCT01026831|588115374|FG001|Overall Study|Physician Decision|1|||
162837646|NCT01026831|588115373|FG000|Overall Study|Protocol Violation|0|||
162837647|NCT01026831|588115374|FG001|Overall Study|Protocol Violation|2|||
162837648|NCT01026831|588115373|FG000|Overall Study|Withdrawal by Subject|7|||
162837649|NCT01026831|588115374|FG001|Overall Study|Withdrawal by Subject|5|||
162837650|NCT01079182|588115375|FG000|Overall Study|Lost to Follow-up|1634|||
162837651|NCT01079182|588115375|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
162837652|NCT01079182|588115375|FG000|Overall Study|Lack of Efficacy|514|||
162837653|NCT01079182|588115375|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
162837654|NCT01079182|588115375|FG000|Overall Study|Reasons not Evaluated|271|||
162837655|NCT04417894|588115376|FG000|Overall Study|Lost to Follow-up|3|||
162837656|NCT04417894|588115377|FG001|Overall Study|Lost to Follow-up|0|||
162948652|NCT03952143|588515244|FG000|Treatment Period|Protocol Violation|0|||
162948653|NCT03952143|588515245|FG001|Treatment Period|Protocol Violation|0|||
162948654|NCT03952143|588515246|FG002|Treatment Period|Protocol Violation|1|||
162948655|NCT03952143|588515244|FG000|Treatment Period|Withdrawal by Subject|0|||
162837657|NCT04417894|588115376|FG000|Overall Study|Withdrawal by Subject|7|||
162948656|NCT03952143|588515245|FG001|Treatment Period|Withdrawal by Subject|5|||
162948657|NCT03952143|588515246|FG002|Treatment Period|Withdrawal by Subject|26|||
162948658|NCT03952143|588515244|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
162948659|NCT03952143|588515245|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
162948660|NCT03952143|588515246|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
162948661|NCT03952143|588515244|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
162948662|NCT03952143|588515245|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
162948663|NCT03952143|588515246|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
162948664|NCT02152566|588515247|FG000|Overall Study|Lost to Follow-up|1|||
162948665|NCT02152566|588515247|FG000|Overall Study|Withdrawal by Subject|2|||
162948666|NCT01866319|588515248|FG000|Overall Study|Adverse Event|12|||
162948667|NCT01866319|588515249|FG001|Overall Study|Adverse Event|5|||
162948668|NCT01866319|588515250|FG002|Overall Study|Adverse Event|9|||
162948669|NCT01866319|588515248|FG000|Overall Study|Clinical progression|3|||
162948670|NCT01866319|588515249|FG001|Overall Study|Clinical progression|2|||
162948671|NCT01866319|588515250|FG002|Overall Study|Clinical progression|2|||
162948672|NCT01866319|588515248|FG000|Overall Study|Death|153|||
162948673|NCT01866319|588515249|FG001|Overall Study|Death|154|||
162948674|NCT01866319|588515250|FG002|Overall Study|Death|147|||
162948675|NCT01866319|588515248|FG000|Overall Study|Lost to Follow-up|6|||
162948676|NCT01866319|588515249|FG001|Overall Study|Lost to Follow-up|3|||
162948677|NCT01866319|588515250|FG002|Overall Study|Lost to Follow-up|8|||
162948678|NCT01866319|588515248|FG000|Overall Study|Physician Decision|1|||
162948679|NCT01866319|588515249|FG001|Overall Study|Physician Decision|0|||
162948680|NCT01866319|588515250|FG002|Overall Study|Physician Decision|1|||
162948681|NCT01866319|588515248|FG000|Overall Study|Protocol Violation|0|||
162837658|NCT04417894|588115377|FG001|Overall Study|Withdrawal by Subject|6|||
162837659|NCT04417894|588115376|FG000|Overall Study|Lack of Efficacy|3|||
162837660|NCT04417894|588115377|FG001|Overall Study|Lack of Efficacy|1|||
162837661|NCT00262873|588115378|FG000|Overall Study|Adverse Event|3|||
162837662|NCT00262873|588115378|FG000|Overall Study|Withdrawal by Subject|5|||
162837663|NCT00844753|588115379|FG000|Overall Study|Lack of Efficacy|1|||
162837664|NCT00844753|588115380|FG001|Overall Study|Lack of Efficacy|0|||
162837665|NCT00844753|588115381|FG002|Overall Study|Lack of Efficacy|2|||
162837666|NCT00844753|588115382|FG003|Overall Study|Lack of Efficacy|2|||
162948682|NCT01866319|588515249|FG001|Overall Study|Protocol Violation|0|||
162948683|NCT01866319|588515250|FG002|Overall Study|Protocol Violation|1|||
162948684|NCT01866319|588515248|FG000|Overall Study|Withdrawal by Subject|32|||
162948685|NCT01866319|588515249|FG001|Overall Study|Withdrawal by Subject|14|||
162948686|NCT01866319|588515250|FG002|Overall Study|Withdrawal by Subject|12|||
162948687|NCT00496964|588515251|FG000|Overall Study|Withdrawal by Subject|0|||
162948688|NCT00496964|588515252|FG001|Overall Study|Withdrawal by Subject|1|||
162948689|NCT02942264|588515253|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948690|NCT02942264|588515254|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
162948691|NCT02942264|588515255|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948692|NCT02942264|588515256|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948693|NCT02942264|588515257|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948694|NCT02942264|588515258|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948695|NCT02942264|588515259|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
162948696|NCT02942264|588515260|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948697|NCT02942264|588515261|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
162948698|NCT02942264|588515253|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948699|NCT02942264|588515254|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948700|NCT02942264|588515255|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948701|NCT02942264|588515256|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948702|NCT02942264|588515257|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948703|NCT02942264|588515258|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948704|NCT02942264|588515259|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948705|NCT02942264|588515260|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
162948706|NCT02942264|588515261|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
162948707|NCT01328093|588515262|FG000|Double-Blind Phase|Adverse Event|78|||
162948708|NCT01328093|588515263|FG001|Double-Blind Phase|Adverse Event|15|||
162948709|NCT01328093|588515262|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
162948710|NCT01328093|588515263|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
162948711|NCT01328093|588515262|FG000|Double-Blind Phase|Lost to Follow-up|39|||
162948712|NCT01328093|588515263|FG001|Double-Blind Phase|Lost to Follow-up|14|||
162948713|NCT01328093|588515262|FG000|Double-Blind Phase|Protocol Violation|30|||
162948714|NCT01328093|588515263|FG001|Double-Blind Phase|Protocol Violation|10|||
162948715|NCT01328093|588515262|FG000|Double-Blind Phase|Lack of Efficacy|55|||
162948716|NCT01328093|588515263|FG001|Double-Blind Phase|Lack of Efficacy|13|||
162948717|NCT01328093|588515262|FG000|Double-Blind Phase|Sponsor Decision|17|||
162948718|NCT01328093|588515263|FG001|Double-Blind Phase|Sponsor Decision|3|||
162948719|NCT01328093|588515262|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
162948720|NCT01328093|588515263|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
162948721|NCT01328093|588515262|FG000|Double-Blind Phase|Scheduling conflict|8|||
162948722|NCT01328093|588515263|FG001|Double-Blind Phase|Scheduling conflict|3|||
162948723|NCT01328093|588515262|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
162948724|NCT01328093|588515263|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
162948725|NCT01328093|588515262|FG000|Double-Blind Phase|Death|1|||
162948726|NCT01328093|588515263|FG001|Double-Blind Phase|Death|0|||
162948727|NCT01328093|588515262|FG000|Open-Label Phase|Sponsor Decision|98|||
162948728|NCT01328093|588515263|FG001|Open-Label Phase|Sponsor Decision|34|||
162948729|NCT01328093|588515262|FG000|Open-Label Phase|Protocol Violation|8|||
162948730|NCT01328093|588515263|FG001|Open-Label Phase|Protocol Violation|3|||
162948731|NCT01328093|588515262|FG000|Open-Label Phase|Lost to Follow-up|10|||
162948732|NCT01328093|588515263|FG001|Open-Label Phase|Lost to Follow-up|1|||
162948733|NCT01328093|588515262|FG000|Open-Label Phase|Adverse Event|10|||
162948734|NCT01328093|588515263|FG001|Open-Label Phase|Adverse Event|4|||
162948735|NCT01328093|588515262|FG000|Open-Label Phase|Lack of Efficacy|5|||
162948736|NCT01328093|588515263|FG001|Open-Label Phase|Lack of Efficacy|6|||
162948737|NCT01328093|588515262|FG000|Open-Label Phase|Withdrawal by Subject|4|||
162948738|NCT01328093|588515263|FG001|Open-Label Phase|Withdrawal by Subject|1|||
162948739|NCT01328093|588515262|FG000|Open-Label Phase|Scheduling conflict|2|||
162948740|NCT01328093|588515263|FG001|Open-Label Phase|Scheduling conflict|1|||
162948741|NCT01328093|588515262|FG000|Open-Label Phase|Subject is moving or has moved|2|||
162948742|NCT01328093|588515263|FG001|Open-Label Phase|Subject is moving or has moved|0|||
162948743|NCT01328093|588515262|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
162948744|NCT01328093|588515263|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
162948745|NCT03980483|588515266|FG000|Overall Study|Adverse Event|13|||
162948746|NCT03980483|588515267|FG001|Overall Study|Adverse Event|29|||
162948747|NCT03980483|588515268|FG002|Overall Study|Adverse Event|11|||
162948748|NCT03980483|588515269|FG003|Overall Study|Adverse Event|2|||
162948749|NCT03980483|588515270|FG004|Overall Study|Adverse Event|2|||
162948750|NCT03980483|588515271|FG005|Overall Study|Adverse Event|2|||
162948751|NCT03980483|588515266|FG000|Overall Study|Lack of Efficacy|7|||
162948752|NCT03980483|588515267|FG001|Overall Study|Lack of Efficacy|6|||
162948753|NCT03980483|588515268|FG002|Overall Study|Lack of Efficacy|0|||
162948754|NCT03980483|588515269|FG003|Overall Study|Lack of Efficacy|3|||
162948755|NCT03980483|588515270|FG004|Overall Study|Lack of Efficacy|1|||
162948756|NCT03980483|588515271|FG005|Overall Study|Lack of Efficacy|1|||
162948757|NCT03980483|588515266|FG000|Overall Study|Lost to Follow-up|2|||
162948758|NCT03980483|588515267|FG001|Overall Study|Lost to Follow-up|4|||
162948759|NCT03980483|588515268|FG002|Overall Study|Lost to Follow-up|2|||
162837667|NCT00844753|588115379|FG000|Overall Study|Adverse Event|3|||
162837668|NCT00844753|588115380|FG001|Overall Study|Adverse Event|2|||
162837669|NCT00844753|588115381|FG002|Overall Study|Adverse Event|5|||
162837670|NCT00844753|588115382|FG003|Overall Study|Adverse Event|5|||
162837671|NCT00844753|588115379|FG000|Overall Study|Lost to Follow-up|1|||
162837672|NCT00844753|588115380|FG001|Overall Study|Lost to Follow-up|1|||
162837673|NCT00844753|588115381|FG002|Overall Study|Lost to Follow-up|0|||
162837674|NCT00844753|588115382|FG003|Overall Study|Lost to Follow-up|1|||
162837675|NCT00844753|588115379|FG000|Overall Study|could not swallow medication|2|||
162837676|NCT00844753|588115380|FG001|Overall Study|could not swallow medication|0|||
162837677|NCT00844753|588115381|FG002|Overall Study|could not swallow medication|0|||
162837678|NCT00844753|588115382|FG003|Overall Study|could not swallow medication|0|||
162837679|NCT00844753|588115379|FG000|Overall Study|Withdrawal by Subject|1|||
162837680|NCT00844753|588115380|FG001|Overall Study|Withdrawal by Subject|0|||
162837681|NCT00844753|588115381|FG002|Overall Study|Withdrawal by Subject|0|||
162837682|NCT00844753|588115382|FG003|Overall Study|Withdrawal by Subject|3|||
162837683|NCT00903175|588115384|FG000|Period 1 - First Line|Adverse Event|36|||
162837684|NCT00903175|588115385|FG001|Period 1 - First Line|Adverse Event|50|||
162837685|NCT00903175|588115384|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
162837686|NCT00903175|588115385|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
162837687|NCT00903175|588115384|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
162837688|NCT00903175|588115385|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
162837689|NCT00903175|588115384|FG000|Period 1 - First Line|Protocol Violation|3|||
162837690|NCT00903175|588115385|FG001|Period 1 - First Line|Protocol Violation|3|||
162837691|NCT00903175|588115384|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
162837692|NCT00903175|588115385|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
162837693|NCT00903175|588115384|FG000|Period 1 - First Line|Administrative problems|12|||
162837694|NCT00903175|588115385|FG001|Period 1 - First Line|Administrative problems|13|||
162837695|NCT00903175|588115384|FG000|Period 1 - First Line|Death|17|||
162837696|NCT00903175|588115385|FG001|Period 1 - First Line|Death|10|||
162948760|NCT03980483|588515269|FG003|Overall Study|Lost to Follow-up|1|||
162948761|NCT03980483|588515270|FG004|Overall Study|Lost to Follow-up|2|||
162948762|NCT03980483|588515271|FG005|Overall Study|Lost to Follow-up|0|||
162948763|NCT03980483|588515266|FG000|Overall Study|Protocol Violation|4|||
162948764|NCT03980483|588515267|FG001|Overall Study|Protocol Violation|2|||
162837697|NCT00903175|588115384|FG000|Period 2 - Second Line|Missing|1|||
162837698|NCT00903175|588115385|FG001|Period 2 - Second Line|Missing|0|||
162837699|NCT00903175|588115384|FG000|Period 2 - Second Line|Adverse Event|16|||
162837700|NCT00903175|588115385|FG001|Period 2 - Second Line|Adverse Event|20|||
162837701|NCT00903175|588115384|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
162837702|NCT00903175|588115385|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
162948765|NCT03980483|588515268|FG002|Overall Study|Protocol Violation|1|||
162837703|NCT00903175|588115384|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
162837704|NCT00903175|588115385|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
162837705|NCT00903175|588115384|FG000|Period 2 - Second Line|Administrative problems|19|||
162837706|NCT00903175|588115385|FG001|Period 2 - Second Line|Administrative problems|9|||
162837707|NCT00903175|588115384|FG000|Period 2 - Second Line|Death|5|||
162837708|NCT00903175|588115385|FG001|Period 2 - Second Line|Death|2|||
162837709|NCT03074474|588115388|FG000|Overall Study|Lost to Follow-up|10|||
162837710|NCT03074474|588115388|FG000|Overall Study|Withdrawal by Subject|10|||
162837711|NCT03074474|588115388|FG000|Overall Study|Death|4|||
162837712|NCT03074474|588115388|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
162837713|NCT00371865|588115391|FG000|Overall Study|Lack of Efficacy|0|||
162837714|NCT00371865|588115392|FG001|Overall Study|Lack of Efficacy|2|||
162837715|NCT00371865|588115391|FG000|Overall Study|Protocol Violation|3|||
162837716|NCT00371865|588115392|FG001|Overall Study|Protocol Violation|2|||
162837717|NCT00371865|588115391|FG000|Overall Study|Withdrawal by Subject|12|||
162837718|NCT00371865|588115392|FG001|Overall Study|Withdrawal by Subject|10|||
162837719|NCT04179175|588117316|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
162837720|NCT04179175|588117317|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
162837721|NCT04179175|588117318|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
162837722|NCT04179175|588117319|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
162837723|NCT04179175|588117320|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
162837724|NCT04179175|588117321|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
162837725|NCT04179175|588117316|FG000|Overall Study|Adverse Event|5|||
162837726|NCT04179175|588117317|FG001|Overall Study|Adverse Event|3|||
162837727|NCT04179175|588117318|FG002|Overall Study|Adverse Event|3|||
162837728|NCT04179175|588117319|FG003|Overall Study|Adverse Event|4|||
162837729|NCT04179175|588117320|FG004|Overall Study|Adverse Event|6|||
162837730|NCT04179175|588117321|FG005|Overall Study|Adverse Event|6|||
162837731|NCT04179175|588117316|FG000|Overall Study|Lack of Efficacy|5|||
162837732|NCT04179175|588117317|FG001|Overall Study|Lack of Efficacy|1|||
162837733|NCT04179175|588117318|FG002|Overall Study|Lack of Efficacy|3|||
162837734|NCT04179175|588117319|FG003|Overall Study|Lack of Efficacy|2|||
162837735|NCT04179175|588117320|FG004|Overall Study|Lack of Efficacy|18|||
162837736|NCT04179175|588117321|FG005|Overall Study|Lack of Efficacy|7|||
162837737|NCT04179175|588117316|FG000|Overall Study|Lost to Follow-up|5|||
162837738|NCT04179175|588117317|FG001|Overall Study|Lost to Follow-up|3|||
162837739|NCT04179175|588117318|FG002|Overall Study|Lost to Follow-up|2|||
162837740|NCT04179175|588117319|FG003|Overall Study|Lost to Follow-up|2|||
162837741|NCT04179175|588117320|FG004|Overall Study|Lost to Follow-up|4|||
162837742|NCT04179175|588117321|FG005|Overall Study|Lost to Follow-up|5|||
162837743|NCT04179175|588117316|FG000|Overall Study|Physician Decision|2|||
162837744|NCT04179175|588117317|FG001|Overall Study|Physician Decision|0|||
162837745|NCT04179175|588117318|FG002|Overall Study|Physician Decision|2|||
162837746|NCT04179175|588117319|FG003|Overall Study|Physician Decision|3|||
162837747|NCT04179175|588117320|FG004|Overall Study|Physician Decision|1|||
162837748|NCT04179175|588117321|FG005|Overall Study|Physician Decision|1|||
162837749|NCT04179175|588117316|FG000|Overall Study|Pregnancy|3|||
162837750|NCT04179175|588117317|FG001|Overall Study|Pregnancy|0|||
162837751|NCT04179175|588117318|FG002|Overall Study|Pregnancy|3|||
162837752|NCT04179175|588117319|FG003|Overall Study|Pregnancy|0|||
162837753|NCT04179175|588117320|FG004|Overall Study|Pregnancy|1|||
162837754|NCT04179175|588117321|FG005|Overall Study|Pregnancy|2|||
162837755|NCT04179175|588117316|FG000|Overall Study|Withdrawal by Subject|22|||
162837756|NCT04179175|588117317|FG001|Overall Study|Withdrawal by Subject|10|||
162837757|NCT04179175|588117318|FG002|Overall Study|Withdrawal by Subject|12|||
162837758|NCT04179175|588117319|FG003|Overall Study|Withdrawal by Subject|8|||
162837759|NCT04179175|588117320|FG004|Overall Study|Withdrawal by Subject|23|||
162837760|NCT04179175|588117321|FG005|Overall Study|Withdrawal by Subject|31|||
162837761|NCT04179175|588117316|FG000|Overall Study|Technical problems|0|||
162837762|NCT04179175|588117317|FG001|Overall Study|Technical problems|0|||
162837763|NCT04179175|588117318|FG002|Overall Study|Technical problems|1|||
162837764|NCT04179175|588117319|FG003|Overall Study|Technical problems|1|||
162837765|NCT04179175|588117320|FG004|Overall Study|Technical problems|0|||
162837766|NCT04179175|588117321|FG005|Overall Study|Technical problems|0|||
162837767|NCT03215030|588117326|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
162837768|NCT03215030|588117327|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
162837769|NCT03215030|588117328|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837770|NCT03215030|588117329|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
162837771|NCT03215030|588117330|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837772|NCT03215030|588117331|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837773|NCT03215030|588117332|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837774|NCT03215030|588117333|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837775|NCT03215030|588117334|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837776|NCT03215030|588117335|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837777|NCT03215030|588117336|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837778|NCT03215030|588117337|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
162837779|NCT03215030|588117326|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162837780|NCT03215030|588117327|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837781|NCT03215030|588117328|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837782|NCT03215030|588117329|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162837783|NCT03215030|588117330|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837784|NCT03215030|588117331|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837785|NCT03215030|588117332|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837786|NCT03215030|588117333|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837787|NCT03215030|588117334|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837788|NCT03215030|588117335|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837789|NCT03215030|588117336|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837790|NCT03215030|588117337|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162837791|NCT03215030|588117326|FG000|Part 1: Dose Escalation|Death|15|||
162837792|NCT03215030|588117327|FG001|Part 1: Dose Escalation|Death|6|||
162837793|NCT03215030|588117328|FG002|Part 1: Dose Escalation|Death|6|||
162837794|NCT03215030|588117329|FG003|Part 1: Dose Escalation|Death|8|||
162837795|NCT03215030|588117330|FG004|Part 1: Dose Escalation|Death|0|||
162837796|NCT03215030|588117331|FG005|Part 1: Dose Escalation|Death|0|||
162837797|NCT03215030|588117332|FG006|Part 1: Dose Escalation|Death|0|||
162837798|NCT03215030|588117333|FG007|Part 1: Dose Escalation|Death|0|||
162837799|NCT03215030|588117334|FG008|Part 1: Dose Escalation|Death|0|||
162837800|NCT03215030|588117335|FG009|Part 1: Dose Escalation|Death|0|||
162837801|NCT03215030|588117336|FG010|Part 1: Dose Escalation|Death|0|||
162837802|NCT03215030|588117337|FG011|Part 1: Dose Escalation|Death|0|||
162837803|NCT03215030|588117326|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
162837804|NCT03215030|588117327|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
162837805|NCT03215030|588117328|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
162837806|NCT03215030|588117329|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
162837807|NCT03215030|588117330|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
162837808|NCT03215030|588117331|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
162837809|NCT03215030|588117332|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
162837810|NCT03215030|588117333|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
162837811|NCT03215030|588117334|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
162837812|NCT03215030|588117335|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
162837813|NCT03215030|588117336|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
162837814|NCT03215030|588117337|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
162837815|NCT03215030|588117326|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837816|NCT03215030|588117327|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837817|NCT03215030|588117328|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837818|NCT03215030|588117329|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837819|NCT03215030|588117330|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837820|NCT03215030|588117331|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837821|NCT03215030|588117332|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837822|NCT03215030|588117333|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
162837823|NCT03215030|588117334|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837824|NCT03215030|588117335|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837825|NCT03215030|588117336|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837826|NCT03215030|588117337|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
162837827|NCT03215030|588117326|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837828|NCT03215030|588117327|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837829|NCT03215030|588117328|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837830|NCT03215030|588117329|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837831|NCT03215030|588117330|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
162837832|NCT03215030|588117331|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
162837833|NCT03215030|588117332|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
162837834|NCT03215030|588117333|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
162837835|NCT03215030|588117334|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837836|NCT03215030|588117335|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837837|NCT03215030|588117336|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162948766|NCT03980483|588515269|FG003|Overall Study|Protocol Violation|1|||
162837838|NCT03215030|588117337|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162837839|NCT03215030|588117326|FG000|Part 2: Dose Expansion|Death|0|||
162837840|NCT03215030|588117327|FG001|Part 2: Dose Expansion|Death|0|||
162837841|NCT03215030|588117328|FG002|Part 2: Dose Expansion|Death|0|||
162837842|NCT03215030|588117329|FG003|Part 2: Dose Expansion|Death|0|||
162948767|NCT03980483|588515270|FG004|Overall Study|Protocol Violation|0|||
162837843|NCT03215030|588117330|FG004|Part 2: Dose Expansion|Death|3|||
162837844|NCT03215030|588117331|FG005|Part 2: Dose Expansion|Death|1|||
162837845|NCT03215030|588117332|FG006|Part 2: Dose Expansion|Death|5|||
162837846|NCT03215030|588117333|FG007|Part 2: Dose Expansion|Death|4|||
162837847|NCT03215030|588117334|FG008|Part 2: Dose Expansion|Death|0|||
162837848|NCT03215030|588117335|FG009|Part 2: Dose Expansion|Death|0|||
162837849|NCT03215030|588117336|FG010|Part 2: Dose Expansion|Death|0|||
162837850|NCT03215030|588117337|FG011|Part 2: Dose Expansion|Death|0|||
162837851|NCT03215030|588117326|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
162837852|NCT03215030|588117327|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
162837853|NCT03215030|588117328|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
162837854|NCT03215030|588117329|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
162837855|NCT03215030|588117330|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
162837856|NCT03215030|588117331|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
162837857|NCT03215030|588117332|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
162837858|NCT03215030|588117333|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
162837859|NCT03215030|588117334|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
162837860|NCT03215030|588117335|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
162837861|NCT03215030|588117336|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
162837862|NCT03215030|588117337|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
162837863|NCT03215030|588117326|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
162837864|NCT03215030|588117327|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
162837865|NCT03215030|588117328|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
162837866|NCT03215030|588117329|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
162837867|NCT03215030|588117330|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
162837868|NCT03215030|588117331|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
162837869|NCT03215030|588117332|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
162837870|NCT03215030|588117333|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
162837871|NCT03215030|588117334|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
162837872|NCT03215030|588117335|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
162837873|NCT03215030|588117336|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
162837874|NCT03215030|588117337|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
162837875|NCT03215030|588117326|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837876|NCT03215030|588117327|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837877|NCT03215030|588117328|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837878|NCT03215030|588117329|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837879|NCT03215030|588117330|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837880|NCT03215030|588117331|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837881|NCT03215030|588117332|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837882|NCT03215030|588117333|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837883|NCT03215030|588117334|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
162837884|NCT03215030|588117335|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
162837885|NCT03215030|588117336|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837886|NCT03215030|588117337|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
162837887|NCT03215030|588117326|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837888|NCT03215030|588117327|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837889|NCT03215030|588117328|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837890|NCT03215030|588117329|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837891|NCT03215030|588117330|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837892|NCT03215030|588117331|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837893|NCT03215030|588117332|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837894|NCT03215030|588117333|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837895|NCT03215030|588117334|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
162837896|NCT03215030|588117335|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
162837897|NCT03215030|588117336|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837898|NCT03215030|588117337|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
162837899|NCT03215030|588117326|FG000|Part 3: Dose Extension|Death|0|||
162837900|NCT03215030|588117327|FG001|Part 3: Dose Extension|Death|0|||
162837901|NCT03215030|588117328|FG002|Part 3: Dose Extension|Death|0|||
162837902|NCT03215030|588117329|FG003|Part 3: Dose Extension|Death|0|||
162837903|NCT03215030|588117330|FG004|Part 3: Dose Extension|Death|0|||
162837904|NCT03215030|588117331|FG005|Part 3: Dose Extension|Death|0|||
162837905|NCT03215030|588117332|FG006|Part 3: Dose Extension|Death|0|||
162837906|NCT03215030|588117333|FG007|Part 3: Dose Extension|Death|0|||
162837907|NCT03215030|588117334|FG008|Part 3: Dose Extension|Death|19|||
162948768|NCT03980483|588515271|FG005|Overall Study|Protocol Violation|0|||
162948769|NCT03980483|588515266|FG000|Overall Study|Physician Decision|14|||
162837908|NCT03215030|588117335|FG009|Part 3: Dose Extension|Death|20|||
162837909|NCT03215030|588117336|FG010|Part 3: Dose Extension|Death|0|||
162837910|NCT03215030|588117337|FG011|Part 3: Dose Extension|Death|0|||
162837911|NCT03215030|588117326|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
162837912|NCT03215030|588117327|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
162837913|NCT03215030|588117328|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
162837914|NCT03215030|588117329|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
162837915|NCT03215030|588117330|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
162837916|NCT03215030|588117331|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
162948770|NCT03980483|588515267|FG001|Overall Study|Physician Decision|10|||
162837917|NCT03215030|588117332|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
162837918|NCT03215030|588117333|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
162837919|NCT03215030|588117334|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
162837920|NCT03215030|588117335|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
162837921|NCT03215030|588117336|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
162837922|NCT03215030|588117337|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
162837923|NCT03215030|588117326|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837924|NCT03215030|588117327|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837925|NCT03215030|588117328|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837926|NCT03215030|588117329|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837927|NCT03215030|588117330|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837928|NCT03215030|588117331|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837929|NCT03215030|588117332|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837930|NCT03215030|588117333|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837931|NCT03215030|588117334|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837932|NCT03215030|588117335|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
162837933|NCT03215030|588117336|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
162837934|NCT03215030|588117337|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
162837935|NCT01745146|588117340|FG000|Overall Study|Withdrawal by Subject|1|||
162837936|NCT01745146|588117341|FG001|Overall Study|Withdrawal by Subject|3|||
162837937|NCT01745146|588117340|FG000|Overall Study|Lost to Follow-up|2|||
162837938|NCT01745146|588117341|FG001|Overall Study|Lost to Follow-up|0|||
162837939|NCT04316585|588117342|FG000|Overall Study|Adverse Event|2|||
162837940|NCT04316585|588117343|FG001|Overall Study|Adverse Event|1|||
162837941|NCT04316585|588117342|FG000|Overall Study|Lost to Follow-up|1|||
162837942|NCT04316585|588117343|FG001|Overall Study|Lost to Follow-up|0|||
162837943|NCT04316585|588117342|FG000|Overall Study|Withdrawal by Subject|2|||
162837944|NCT04316585|588117343|FG001|Overall Study|Withdrawal by Subject|3|||
162837945|NCT04316585|588117342|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
162837946|NCT04316585|588117343|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
162837947|NCT04316585|588117342|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
162837948|NCT04316585|588117343|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
162837949|NCT00130832|588117344|FG000|Overall Study|Adverse Event|1|||
162837950|NCT00130832|588117345|FG001|Overall Study|Adverse Event|1|||
162837951|NCT00130832|588117344|FG000|Overall Study|Lost to Follow-up|1|||
162837952|NCT00130832|588117345|FG001|Overall Study|Lost to Follow-up|2|||
162837953|NCT00130832|588117344|FG000|Overall Study|Protocol Violation|6|||
162837954|NCT00130832|588117345|FG001|Overall Study|Protocol Violation|8|||
162837955|NCT00130832|588117344|FG000|Overall Study|Withdrawal by Subject|6|||
162837956|NCT00130832|588117345|FG001|Overall Study|Withdrawal by Subject|1|||
162837957|NCT00130832|588117344|FG000|Overall Study|Moved|2|||
162837958|NCT00130832|588117345|FG001|Overall Study|Moved|2|||
162837959|NCT00130832|588117344|FG000|Overall Study|Other|0|||
162837960|NCT00130832|588117345|FG001|Overall Study|Other|3|||
162837961|NCT02770326|588117347|FG000|Overall Study|Death|3|||
162837962|NCT02770326|588117347|FG000|Overall Study|Lost to Follow-up|1|||
162837963|NCT03118297|588117348|FG000|Overall Study|Lost to Follow-up|0|||
162837964|NCT03118297|588117349|FG001|Overall Study|Lost to Follow-up|2|||
162837965|NCT02363686|588117350|FG000|Overall Study|Withdrawal by Subject|22|||
162837966|NCT02363686|588117350|FG000|Overall Study|incomplete FEES examinations|13|||
162837967|NCT01121393|588117355|FG000|Overall Study|Progressive disease|201|||
162837968|NCT01121393|588117356|FG001|Overall Study|Progressive disease|20|||
162837969|NCT01121393|588117355|FG000|Overall Study|Other Adverse events|24|||
162837970|NCT01121393|588117356|FG001|Overall Study|Other Adverse events|45|||
162837971|NCT01121393|588117355|FG000|Overall Study|Non-compliant with protocol|0|||
162837972|NCT01121393|588117356|FG001|Overall Study|Non-compliant with protocol|3|||
162837973|NCT01121393|588117355|FG000|Overall Study|Lost to Follow-up|1|||
162948771|NCT03980483|588515268|FG002|Overall Study|Physician Decision|7|||
162948772|NCT03980483|588515269|FG003|Overall Study|Physician Decision|4|||
162948773|NCT03980483|588515270|FG004|Overall Study|Physician Decision|4|||
162837974|NCT01121393|588117356|FG001|Overall Study|Lost to Follow-up|0|||
162837975|NCT01121393|588117355|FG000|Overall Study|Refused cont. medication|7|||
162837976|NCT01121393|588117356|FG001|Overall Study|Refused cont. medication|7|||
162837977|NCT01121393|588117355|FG000|Overall Study|Not treated|3|||
162837978|NCT01121393|588117356|FG001|Overall Study|Not treated|9|||
162948774|NCT03980483|588515271|FG005|Overall Study|Physician Decision|2|||
162837979|NCT01121393|588117355|FG000|Overall Study|Other than listed|6|||
162837980|NCT01121393|588117356|FG001|Overall Study|Other than listed|0|||
162837981|NCT00577993|588117362|FG000|Overall Study|Adverse Event|1|||
162837982|NCT00577993|588117363|FG001|Overall Study|Adverse Event|0|||
162837983|NCT00577993|588117364|FG002|Overall Study|Adverse Event|0|||
162837984|NCT00577993|588117362|FG000|Overall Study|Death|0|||
162837985|NCT00577993|588117363|FG001|Overall Study|Death|1|||
162837986|NCT00577993|588117364|FG002|Overall Study|Death|1|||
162837987|NCT00577993|588117362|FG000|Overall Study|Lack of Efficacy|0|||
162837988|NCT00577993|588117363|FG001|Overall Study|Lack of Efficacy|1|||
162948775|NCT03980483|588515266|FG000|Overall Study|Withdrawal by Subject|38|||
162837989|NCT00577993|588117364|FG002|Overall Study|Lack of Efficacy|0|||
162837990|NCT00577993|588117362|FG000|Overall Study|Protocol Violation|2|||
162837991|NCT00577993|588117363|FG001|Overall Study|Protocol Violation|3|||
162837992|NCT00577993|588117364|FG002|Overall Study|Protocol Violation|0|||
162837993|NCT00577993|588117362|FG000|Overall Study|Withdrawal by Subject|1|||
162837994|NCT00577993|588117363|FG001|Overall Study|Withdrawal by Subject|0|||
162837995|NCT00577993|588117364|FG002|Overall Study|Withdrawal by Subject|2|||
162837996|NCT00577993|588117362|FG000|Overall Study|Conversion|2|||
162837997|NCT00577993|588117363|FG001|Overall Study|Conversion|5|||
162837998|NCT00577993|588117364|FG002|Overall Study|Conversion|0|||
162837999|NCT00577993|588117362|FG000|Overall Study|Uninsured|1|||
162838000|NCT00577993|588117363|FG001|Overall Study|Uninsured|0|||
162838001|NCT00577993|588117364|FG002|Overall Study|Uninsured|0|||
162838002|NCT02217566|588117365|FG000|Overall Study|Lost to Follow-up|2|||
162838003|NCT02217566|588117365|FG000|Overall Study|Death|3|||
162838004|NCT02217566|588117365|FG000|Overall Study|Early study termination|6|||
162838005|NCT02064387|588117370|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838006|NCT02064387|588117371|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838007|NCT02064387|588117372|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838008|NCT02064387|588117373|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838009|NCT02064387|588117374|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838010|NCT02064387|588117375|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838011|NCT02064387|588117376|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838012|NCT02064387|588117377|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
162838013|NCT02064387|588117378|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838014|NCT02064387|588117379|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
162838015|NCT02064387|588117380|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838016|NCT02064387|588117381|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
162838017|NCT02064387|588117370|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838018|NCT02064387|588117371|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838019|NCT02064387|588117372|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838020|NCT02064387|588117373|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838021|NCT02064387|588117374|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838022|NCT02064387|588117375|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838023|NCT02064387|588117376|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838024|NCT02064387|588117377|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
162838025|NCT02064387|588117378|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838026|NCT02064387|588117379|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838027|NCT02064387|588117380|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838028|NCT02064387|588117381|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
162838029|NCT02064387|588117370|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838030|NCT02064387|588117371|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838031|NCT02064387|588117372|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838032|NCT02064387|588117373|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838033|NCT02064387|588117374|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838034|NCT02064387|588117375|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838035|NCT02064387|588117376|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838036|NCT02064387|588117377|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838037|NCT02064387|588117378|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
162838038|NCT02064387|588117379|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838039|NCT02064387|588117380|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838040|NCT02064387|588117381|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
162838041|NCT02064387|588117370|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
162838042|NCT02064387|588117371|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
162838043|NCT02064387|588117372|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
162838044|NCT02064387|588117373|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
162838045|NCT02064387|588117374|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
162838046|NCT02064387|588117375|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
162838047|NCT02064387|588117376|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
162838048|NCT02064387|588117377|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
162838049|NCT02064387|588117378|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
162838050|NCT02064387|588117379|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
162838051|NCT02064387|588117380|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
162838052|NCT02064387|588117381|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
162838053|NCT02064387|588117370|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838054|NCT02064387|588117371|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838055|NCT02064387|588117372|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838056|NCT02064387|588117373|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838057|NCT02064387|588117374|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838058|NCT02064387|588117375|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838059|NCT02064387|588117376|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838060|NCT02064387|588117377|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838061|NCT02064387|588117378|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838062|NCT02064387|588117379|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838063|NCT02064387|588117380|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
162838064|NCT02064387|588117381|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
162838065|NCT02436876|588117383|FG000|Overall Study|Lost to Follow-up|0|||
162838066|NCT02436876|588117384|FG001|Overall Study|Lost to Follow-up|1|||
162838067|NCT02436876|588117385|FG002|Overall Study|Lost to Follow-up|1|||
162838068|NCT02436876|588117386|FG003|Overall Study|Lost to Follow-up|1|||
162838069|NCT02436876|588117383|FG000|Overall Study|Withdrawal by Subject|1|||
162838070|NCT02436876|588117384|FG001|Overall Study|Withdrawal by Subject|0|||
162838071|NCT02436876|588117385|FG002|Overall Study|Withdrawal by Subject|0|||
162838072|NCT02436876|588117386|FG003|Overall Study|Withdrawal by Subject|1|||
162838073|NCT02436876|588117383|FG000|Overall Study|Physician Decision|0|||
162838074|NCT02436876|588117384|FG001|Overall Study|Physician Decision|2|||
162838075|NCT02436876|588117385|FG002|Overall Study|Physician Decision|1|||
162838076|NCT02436876|588117386|FG003|Overall Study|Physician Decision|0|||
162838077|NCT02436876|588117383|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
162838078|NCT02436876|588117384|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
162838079|NCT02436876|588117385|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
162838080|NCT02436876|588117386|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
162838081|NCT00075504|588117389|FG000|Overall Study|Withdrawal by Subject|9|||
162838082|NCT00075504|588117390|FG001|Overall Study|Withdrawal by Subject|7|||
162838083|NCT01290692|588117391|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
162838084|NCT02780648|588117392|FG000|Overall Study|Disease Progression|1|||
162838085|NCT02780648|588117393|FG001|Overall Study|Disease Progression|0|||
162838086|NCT03127384|588117405|FG000|Overall Study|Lost to Follow-up|4|||
162838087|NCT03127384|588117405|FG000|Overall Study|Subject request|2|||
162838088|NCT00689871|588117406|FG000|Overall Study|Lost to Follow-up|123|||
162838089|NCT00689871|588117407|FG001|Overall Study|Lost to Follow-up|13|||
162838090|NCT00689871|588117408|FG002|Overall Study|Lost to Follow-up|37|||
162838091|NCT00689871|588117409|FG003|Overall Study|Lost to Follow-up|1|||
162838092|NCT00689871|588117406|FG000|Overall Study|Explanted of All Study Devices|36|||
162838093|NCT00689871|588117407|FG001|Overall Study|Explanted of All Study Devices|25|||
162838094|NCT00689871|588117408|FG002|Overall Study|Explanted of All Study Devices|29|||
162838095|NCT00689871|588117409|FG003|Overall Study|Explanted of All Study Devices|3|||
162838096|NCT00689871|588117406|FG000|Overall Study|Withdrawal by Subject|13|||
162948776|NCT03980483|588515267|FG001|Overall Study|Withdrawal by Subject|21|||
162948777|NCT03980483|588515268|FG002|Overall Study|Withdrawal by Subject|15|||
162948778|NCT03980483|588515269|FG003|Overall Study|Withdrawal by Subject|5|||
162838097|NCT00689871|588117407|FG001|Overall Study|Withdrawal by Subject|3|||
162838098|NCT00689871|588117408|FG002|Overall Study|Withdrawal by Subject|4|||
162838099|NCT00689871|588117409|FG003|Overall Study|Withdrawal by Subject|1|||
162948779|NCT03980483|588515270|FG004|Overall Study|Withdrawal by Subject|3|||
162948780|NCT03980483|588515271|FG005|Overall Study|Withdrawal by Subject|4|||
162948781|NCT03980483|588515266|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
162948782|NCT03980483|588515267|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162948783|NCT03980483|588515268|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948784|NCT03980483|588515269|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162948785|NCT03980483|588515270|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948786|NCT03980483|588515271|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162948787|NCT03980483|588515266|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948788|NCT03980483|588515267|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
162948789|NCT03980483|588515268|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948790|NCT03980483|588515269|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948791|NCT03980483|588515270|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948792|NCT03980483|588515271|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
162948793|NCT03980483|588515266|FG000|Overall Study|Other|0|||
162838100|NCT00689871|588117406|FG000|Overall Study|Death|1|||
162838101|NCT00689871|588117407|FG001|Overall Study|Death|10|||
162838102|NCT00689871|588117408|FG002|Overall Study|Death|2|||
162838103|NCT00689871|588117409|FG003|Overall Study|Death|2|||
162838104|NCT00689871|588117406|FG000|Overall Study|Physician Decision|2|||
162838105|NCT00689871|588117407|FG001|Overall Study|Physician Decision|1|||
162838106|NCT00689871|588117408|FG002|Overall Study|Physician Decision|1|||
162948794|NCT03980483|588515267|FG001|Overall Study|Other|1|||
162948795|NCT03980483|588515268|FG002|Overall Study|Other|0|||
162838107|NCT00689871|588117409|FG003|Overall Study|Physician Decision|0|||
162838108|NCT01110200|588117419|FG000|Overall Study|Adverse Event|28|||
162838109|NCT01110200|588117420|FG001|Overall Study|Adverse Event|28|||
162838110|NCT01110200|588117419|FG000|Overall Study|Withdrawal by Subject|25|||
162838111|NCT01110200|588117420|FG001|Overall Study|Withdrawal by Subject|32|||
162838112|NCT01110200|588117419|FG000|Overall Study|Lack of Efficacy|16|||
162838113|NCT01110200|588117420|FG001|Overall Study|Lack of Efficacy|25|||
162838114|NCT01110200|588117419|FG000|Overall Study|Protocol Violation|14|||
162838115|NCT01110200|588117420|FG001|Overall Study|Protocol Violation|12|||
162838116|NCT01110200|588117419|FG000|Overall Study|Physician Decision|13|||
162838117|NCT01110200|588117420|FG001|Overall Study|Physician Decision|17|||
162838118|NCT01110200|588117419|FG000|Overall Study|Lost to Follow-up|10|||
162838119|NCT01110200|588117420|FG001|Overall Study|Lost to Follow-up|7|||
162838120|NCT05073458|588117425|FG000|24-week Double-blind Period|Adverse Event|1|||
162838121|NCT05073458|588117426|FG001|24-week Double-blind Period|Adverse Event|0|||
162838122|NCT05073458|588117425|FG000|24-week Double-blind Period|Physician Decision|1|||
162838123|NCT05073458|588117426|FG001|24-week Double-blind Period|Physician Decision|0|||
162838124|NCT05073458|588117425|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
162838125|NCT05073458|588117426|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
162838126|NCT05073458|588117425|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
162838127|NCT05073458|588117426|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
162838128|NCT05073458|588117425|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
162948796|NCT03980483|588515269|FG003|Overall Study|Other|0|||
162838129|NCT05073458|588117426|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
162838130|NCT05073458|588117425|FG000|24-week Open-label Period|Adverse Event|1|||
162838131|NCT05073458|588117426|FG001|24-week Open-label Period|Adverse Event|2|||
162838132|NCT05913232|588117427|FG000|Overall Study|Adverse Event|0|||
162838133|NCT05913232|588117428|FG001|Overall Study|Adverse Event|2|||
162838134|NCT05913232|588117429|FG002|Overall Study|Adverse Event|1|||
162838135|NCT05913232|588117430|FG003|Overall Study|Adverse Event|1|||
162838136|NCT01627899|588117433|FG000|Overall Study|Study terminated early by sponsor.|5|||
162838137|NCT05103332|588117434|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838138|NCT05103332|588117435|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
162838139|NCT05103332|588117436|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
162838140|NCT05103332|588117437|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838141|NCT05103332|588117438|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838142|NCT05103332|588117439|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
162838143|NCT05103332|588117440|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838144|NCT05103332|588117441|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838145|NCT05103332|588117442|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838146|NCT05103332|588117443|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838147|NCT05103332|588117444|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838148|NCT05103332|588117445|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838149|NCT05103332|588117446|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838150|NCT05103332|588117447|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838151|NCT05103332|588117448|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838152|NCT05103332|588117449|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838153|NCT05103332|588117450|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838154|NCT05103332|588117451|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838155|NCT05103332|588117434|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838156|NCT05103332|588117435|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
162838157|NCT05103332|588117436|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838158|NCT05103332|588117437|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
162838159|NCT05103332|588117438|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838160|NCT05103332|588117439|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838161|NCT05103332|588117440|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838162|NCT05103332|588117441|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838163|NCT05103332|588117442|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838164|NCT05103332|588117443|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838165|NCT05103332|588117444|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838166|NCT05103332|588117445|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838167|NCT05103332|588117446|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838168|NCT05103332|588117447|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838169|NCT05103332|588117448|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838170|NCT05103332|588117449|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838171|NCT05103332|588117450|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838172|NCT05103332|588117451|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
162838173|NCT05103332|588117434|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
162838174|NCT05103332|588117435|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
162838175|NCT05103332|588117436|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
162948797|NCT03980483|588515270|FG004|Overall Study|Other|0|||
162948798|NCT03980483|588515271|FG005|Overall Study|Other|0|||
162838176|NCT05103332|588117437|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
162838177|NCT05103332|588117438|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
162838178|NCT05103332|588117439|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
162838179|NCT05103332|588117440|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838180|NCT05103332|588117441|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838181|NCT05103332|588117442|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838182|NCT05103332|588117443|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838183|NCT05103332|588117444|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838184|NCT05103332|588117445|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838185|NCT05103332|588117446|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838186|NCT05103332|588117447|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838187|NCT05103332|588117448|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838188|NCT05103332|588117449|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838189|NCT05103332|588117450|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838190|NCT05103332|588117451|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838191|NCT05103332|588117434|FG000|DB Period (6 Months=168 Days)|Other|0|||
162699938|NCT03220737|587612445|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162838192|NCT05103332|588117435|FG001|DB Period (6 Months=168 Days)|Other|0|||
162838193|NCT05103332|588117436|FG002|DB Period (6 Months=168 Days)|Other|0|||
162838194|NCT05103332|588117437|FG003|DB Period (6 Months=168 Days)|Other|1|||
162838195|NCT05103332|588117438|FG004|DB Period (6 Months=168 Days)|Other|0|||
162838196|NCT05103332|588117439|FG005|DB Period (6 Months=168 Days)|Other|0|||
162838197|NCT05103332|588117440|FG006|DB Period (6 Months=168 Days)|Other|0|||
162838198|NCT05103332|588117441|FG007|DB Period (6 Months=168 Days)|Other|0|||
162838199|NCT05103332|588117442|FG008|DB Period (6 Months=168 Days)|Other|0|||
162838200|NCT05103332|588117443|FG009|DB Period (6 Months=168 Days)|Other|0|||
162838201|NCT05103332|588117444|FG010|DB Period (6 Months=168 Days)|Other|0|||
162838202|NCT05103332|588117445|FG011|DB Period (6 Months=168 Days)|Other|0|||
162838203|NCT05103332|588117446|FG012|DB Period (6 Months=168 Days)|Other|0|||
162838204|NCT05103332|588117447|FG013|DB Period (6 Months=168 Days)|Other|0|||
162838205|NCT05103332|588117448|FG014|DB Period (6 Months=168 Days)|Other|0|||
162838206|NCT05103332|588117449|FG015|DB Period (6 Months=168 Days)|Other|0|||
162838207|NCT05103332|588117450|FG016|DB Period (6 Months=168 Days)|Other|0|||
162838208|NCT05103332|588117451|FG017|DB Period (6 Months=168 Days)|Other|0|||
162838209|NCT05103332|588117434|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838210|NCT05103332|588117435|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838211|NCT05103332|588117436|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838212|NCT05103332|588117437|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838213|NCT05103332|588117438|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838214|NCT05103332|588117439|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838215|NCT05103332|588117440|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838216|NCT05103332|588117441|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838217|NCT05103332|588117442|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838218|NCT05103332|588117443|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838219|NCT05103332|588117444|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
162838220|NCT05103332|588117445|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838221|NCT05103332|588117446|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838222|NCT05103332|588117447|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838223|NCT05103332|588117448|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838224|NCT05103332|588117449|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838225|NCT05103332|588117450|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838226|NCT05103332|588117451|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
162838227|NCT05103332|588117434|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838228|NCT05103332|588117435|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838229|NCT05103332|588117436|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162948799|NCT05150964|588515272|FG000|Overall Study|Lost to Follow-up|2|||
162948800|NCT01062256|588515277|FG000|Overall Study|Adverse Event|1|||
162948801|NCT01062256|588515278|FG001|Overall Study|Adverse Event|0|||
162948802|NCT01062256|588515279|FG002|Overall Study|Adverse Event|0|||
162838230|NCT05103332|588117437|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838231|NCT05103332|588117438|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838232|NCT05103332|588117439|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838233|NCT05103332|588117440|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838234|NCT05103332|588117441|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162948803|NCT01062256|588515277|FG000|Overall Study|Withdrawal by Subject|1|||
162838235|NCT05103332|588117442|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
162838236|NCT05103332|588117443|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838237|NCT05103332|588117444|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838238|NCT05103332|588117445|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838239|NCT05103332|588117446|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838240|NCT05103332|588117447|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838241|NCT05103332|588117448|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838242|NCT05103332|588117449|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838243|NCT05103332|588117450|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838244|NCT05103332|588117451|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
162838245|NCT05103332|588117434|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838246|NCT05103332|588117435|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838247|NCT05103332|588117436|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838248|NCT05103332|588117437|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838249|NCT05103332|588117438|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838250|NCT05103332|588117439|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838251|NCT05103332|588117440|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838252|NCT05103332|588117441|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838253|NCT05103332|588117442|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838254|NCT05103332|588117443|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838255|NCT05103332|588117444|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838256|NCT05103332|588117445|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
162838257|NCT05103332|588117446|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838258|NCT05103332|588117447|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838259|NCT05103332|588117448|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838260|NCT05103332|588117449|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838261|NCT05103332|588117450|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838262|NCT05103332|588117451|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
162838263|NCT05103332|588117434|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838264|NCT05103332|588117435|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838265|NCT05103332|588117436|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838266|NCT05103332|588117437|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838267|NCT05103332|588117438|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838268|NCT05103332|588117439|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838269|NCT05103332|588117440|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
162838270|NCT05103332|588117441|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
162838271|NCT05103332|588117442|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838272|NCT05103332|588117443|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
162838273|NCT05103332|588117444|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
162838274|NCT05103332|588117445|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
162838275|NCT05103332|588117446|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838276|NCT05103332|588117447|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838277|NCT05103332|588117448|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838278|NCT05103332|588117449|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838279|NCT05103332|588117450|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838280|NCT05103332|588117451|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
162838281|NCT05103332|588117434|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838282|NCT05103332|588117435|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838283|NCT05103332|588117436|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838284|NCT05103332|588117437|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838285|NCT05103332|588117438|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838286|NCT05103332|588117439|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838287|NCT05103332|588117440|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838288|NCT05103332|588117441|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838289|NCT05103332|588117442|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838290|NCT05103332|588117443|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838291|NCT05103332|588117444|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838292|NCT05103332|588117445|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
162838293|NCT05103332|588117446|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
162838294|NCT05103332|588117447|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
162838295|NCT05103332|588117448|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
162838296|NCT05103332|588117449|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
162838297|NCT05103332|588117450|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
162838298|NCT05103332|588117451|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
162838299|NCT05103332|588117434|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838300|NCT05103332|588117435|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838301|NCT05103332|588117436|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838302|NCT05103332|588117437|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838303|NCT05103332|588117438|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838304|NCT05103332|588117439|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838305|NCT05103332|588117440|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838306|NCT05103332|588117441|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838307|NCT05103332|588117442|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838308|NCT05103332|588117443|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838309|NCT05103332|588117444|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838310|NCT05103332|588117445|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838311|NCT05103332|588117446|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838312|NCT05103332|588117447|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838313|NCT05103332|588117448|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838314|NCT05103332|588117449|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838315|NCT05103332|588117450|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
162838316|NCT05103332|588117451|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
162838317|NCT05103332|588117434|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838318|NCT05103332|588117435|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838319|NCT05103332|588117436|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838320|NCT05103332|588117437|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838321|NCT05103332|588117438|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838322|NCT05103332|588117439|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838323|NCT05103332|588117440|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838324|NCT05103332|588117441|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838325|NCT05103332|588117442|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838326|NCT05103332|588117443|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838327|NCT05103332|588117444|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838328|NCT05103332|588117445|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
162838329|NCT05103332|588117446|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
162838330|NCT05103332|588117447|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
162838331|NCT05103332|588117448|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
162838332|NCT05103332|588117449|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
162838333|NCT05103332|588117450|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
162838334|NCT05103332|588117451|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
162838335|NCT05103332|588117434|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838336|NCT05103332|588117435|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838337|NCT05103332|588117436|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838338|NCT05103332|588117437|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838339|NCT05103332|588117438|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838340|NCT05103332|588117439|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838341|NCT05103332|588117440|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838342|NCT05103332|588117441|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838343|NCT05103332|588117442|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838344|NCT05103332|588117443|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838345|NCT05103332|588117444|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838346|NCT05103332|588117445|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838347|NCT05103332|588117446|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838348|NCT05103332|588117447|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838349|NCT05103332|588117448|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
162838350|NCT05103332|588117449|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
162838351|NCT05103332|588117450|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
162838352|NCT05103332|588117451|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
162838353|NCT05103332|588117434|FG000|SFU Period (6 Months=168 Days)|Death|0|||
162838354|NCT05103332|588117435|FG001|SFU Period (6 Months=168 Days)|Death|0|||
162838355|NCT05103332|588117436|FG002|SFU Period (6 Months=168 Days)|Death|0|||
162838356|NCT05103332|588117437|FG003|SFU Period (6 Months=168 Days)|Death|0|||
162838357|NCT05103332|588117438|FG004|SFU Period (6 Months=168 Days)|Death|0|||
162838358|NCT05103332|588117439|FG005|SFU Period (6 Months=168 Days)|Death|0|||
162838359|NCT05103332|588117440|FG006|SFU Period (6 Months=168 Days)|Death|0|||
162838360|NCT05103332|588117441|FG007|SFU Period (6 Months=168 Days)|Death|0|||
162838361|NCT05103332|588117442|FG008|SFU Period (6 Months=168 Days)|Death|0|||
162838362|NCT05103332|588117443|FG009|SFU Period (6 Months=168 Days)|Death|0|||
162838363|NCT05103332|588117444|FG010|SFU Period (6 Months=168 Days)|Death|0|||
162838364|NCT05103332|588117445|FG011|SFU Period (6 Months=168 Days)|Death|0|||
162838365|NCT05103332|588117446|FG012|SFU Period (6 Months=168 Days)|Death|0|||
162838366|NCT05103332|588117447|FG013|SFU Period (6 Months=168 Days)|Death|0|||
162838367|NCT05103332|588117448|FG014|SFU Period (6 Months=168 Days)|Death|1|||
162838368|NCT05103332|588117449|FG015|SFU Period (6 Months=168 Days)|Death|0|||
162838369|NCT05103332|588117450|FG016|SFU Period (6 Months=168 Days)|Death|0|||
162838370|NCT05103332|588117451|FG017|SFU Period (6 Months=168 Days)|Death|1|||
162838371|NCT04428476|588117452|FG000|Overall Study|Withdrawal by Subject|1|||
162838372|NCT04428476|588117452|FG000|Overall Study|Still on treatment|12|||
162838373|NCT02043548|588117454|FG000|Overall Study|Lack of Efficacy|1|||
162838374|NCT02043548|588117455|FG001|Overall Study|Lack of Efficacy|0|||
162838375|NCT02043548|588117454|FG000|Overall Study|Adverse Event|0|||
162838376|NCT02043548|588117455|FG001|Overall Study|Adverse Event|1|||
162838377|NCT02289950|588117457|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
162838378|NCT02289950|588117458|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
162838379|NCT02289950|588117457|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
162838380|NCT02289950|588117458|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
162838381|NCT02289950|588117457|FG000|Overall Study|Lost to Follow-up|1|||
162838382|NCT02289950|588117458|FG001|Overall Study|Lost to Follow-up|0|||
162838383|NCT02289950|588117457|FG000|Overall Study|Physician Decision|9|||
162838384|NCT02289950|588117458|FG001|Overall Study|Physician Decision|3|||
162838385|NCT02289950|588117457|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
162838386|NCT02289950|588117458|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
162838387|NCT02289950|588117457|FG000|Overall Study|Withdrawal by Subject|1|||
162838388|NCT02289950|588117458|FG001|Overall Study|Withdrawal by Subject|3|||
162838389|NCT02289950|588117457|FG000|Overall Study|Test article held for greater than 28 days|0|||
162838390|NCT02289950|588117458|FG001|Overall Study|Test article held for greater than 28 days|1|||
162838391|NCT02289950|588117457|FG000|Overall Study|Adverse Event|11|||
162838392|NCT02289950|588117458|FG001|Overall Study|Adverse Event|3|||
162838393|NCT02289950|588117457|FG000|Overall Study|Death|1|||
162838394|NCT02289950|588117458|FG001|Overall Study|Death|1|||
162838395|NCT02289950|588117457|FG000|Overall Study|Other|5|||
162838396|NCT02289950|588117458|FG001|Overall Study|Other|2|||
162838397|NCT02289950|588117457|FG000|Overall Study|Not Treated|2|||
162838398|NCT02289950|588117458|FG001|Overall Study|Not Treated|1|||
162838399|NCT01425008|588117459|FG000|Dose Escalation Phase|Progressive Disease|2|||
162838400|NCT01425008|588117460|FG001|Dose Escalation Phase|Progressive Disease|3|||
162838401|NCT01425008|588117461|FG002|Dose Escalation Phase|Progressive Disease|2|||
162838402|NCT01425008|588117462|FG003|Dose Escalation Phase|Progressive Disease|3|||
162838403|NCT01425008|588117463|FG004|Dose Escalation Phase|Progressive Disease|5|||
162838404|NCT01425008|588117464|FG005|Dose Escalation Phase|Progressive Disease|4|||
162838405|NCT01425008|588117465|FG006|Dose Escalation Phase|Progressive Disease|0|||
162838406|NCT01425008|588117466|FG007|Dose Escalation Phase|Progressive Disease|2|||
162838407|NCT01425008|588117467|FG008|Dose Escalation Phase|Progressive Disease|6|||
162838408|NCT01425008|588117468|FG009|Dose Escalation Phase|Progressive Disease|2|||
162838409|NCT01425008|588117469|FG010|Dose Escalation Phase|Progressive Disease|0|||
162838410|NCT01425008|588117470|FG011|Dose Escalation Phase|Progressive Disease|0|||
162838411|NCT01425008|588117471|FG012|Dose Escalation Phase|Progressive Disease|0|||
162838412|NCT01425008|588117472|FG013|Dose Escalation Phase|Progressive Disease|0|||
162838413|NCT01425008|588117473|FG014|Dose Escalation Phase|Progressive Disease|0|||
162838414|NCT01425008|588117474|FG015|Dose Escalation Phase|Progressive Disease|0|||
162838415|NCT01425008|588117475|FG016|Dose Escalation Phase|Progressive Disease|0|||
162838416|NCT01425008|588117476|FG017|Dose Escalation Phase|Progressive Disease|0|||
162838417|NCT01425008|588117477|FG018|Dose Escalation Phase|Progressive Disease|0|||
162838418|NCT01425008|588117459|FG000|Dose Escalation Phase|Adverse Event|2|||
162838419|NCT01425008|588117460|FG001|Dose Escalation Phase|Adverse Event|0|||
162838420|NCT01425008|588117461|FG002|Dose Escalation Phase|Adverse Event|0|||
162838421|NCT01425008|588117462|FG003|Dose Escalation Phase|Adverse Event|0|||
162838422|NCT01425008|588117463|FG004|Dose Escalation Phase|Adverse Event|0|||
162838423|NCT01425008|588117464|FG005|Dose Escalation Phase|Adverse Event|2|||
162838424|NCT01425008|588117465|FG006|Dose Escalation Phase|Adverse Event|0|||
162838425|NCT01425008|588117466|FG007|Dose Escalation Phase|Adverse Event|0|||
162838426|NCT01425008|588117467|FG008|Dose Escalation Phase|Adverse Event|2|||
162838427|NCT01425008|588117468|FG009|Dose Escalation Phase|Adverse Event|0|||
162838428|NCT01425008|588117469|FG010|Dose Escalation Phase|Adverse Event|0|||
162838429|NCT01425008|588117470|FG011|Dose Escalation Phase|Adverse Event|0|||
162838430|NCT01425008|588117471|FG012|Dose Escalation Phase|Adverse Event|0|||
162838431|NCT01425008|588117472|FG013|Dose Escalation Phase|Adverse Event|0|||
162948804|NCT01062256|588515278|FG001|Overall Study|Withdrawal by Subject|1|||
162948805|NCT01062256|588515279|FG002|Overall Study|Withdrawal by Subject|1|||
162948806|NCT01062256|588515277|FG000|Overall Study|Ineligible|1|||
162948807|NCT01062256|588515278|FG001|Overall Study|Ineligible|4|||
162948808|NCT01062256|588515279|FG002|Overall Study|Ineligible|3|||
162948809|NCT01062256|588515277|FG000|Overall Study|Administrative|0|||
162948810|NCT01062256|588515278|FG001|Overall Study|Administrative|2|||
162948811|NCT01062256|588515279|FG002|Overall Study|Administrative|0|||
162948812|NCT03883906|588515282|FG000|Overall Study|Withdrawal by Subject|2|||
162948813|NCT03883906|588515282|FG000|Overall Study|Physician Decision|5|||
162948814|NCT03561883|588515295|FG000|Overall Study|Adverse Event|10|||
162948815|NCT03561883|588515296|FG001|Overall Study|Adverse Event|13|||
162948816|NCT03561883|588515295|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162948817|NCT03561883|588515296|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162948818|NCT03561883|588515295|FG000|Overall Study|Protocol Violation|2|||
162948819|NCT03561883|588515296|FG001|Overall Study|Protocol Violation|3|||
162948820|NCT03561883|588515295|FG000|Overall Study|Withdrawal by Subject|14|||
162948821|NCT03561883|588515296|FG001|Overall Study|Withdrawal by Subject|6|||
162948822|NCT03561883|588515295|FG000|Overall Study|Lost to Follow-up|2|||
162948823|NCT03561883|588515296|FG001|Overall Study|Lost to Follow-up|6|||
162948824|NCT03561883|588515295|FG000|Overall Study|Study Terminated by Sponsor|12|||
162838432|NCT01425008|588117473|FG014|Dose Escalation Phase|Adverse Event|0|||
162948825|NCT03561883|588515296|FG001|Overall Study|Study Terminated by Sponsor|11|||
162948826|NCT03561883|588515295|FG000|Overall Study|Physician Decision|1|||
162948827|NCT03561883|588515296|FG001|Overall Study|Physician Decision|0|||
162948828|NCT03561883|588515295|FG000|Overall Study|Randomized by Mistake|1|||
162948829|NCT03561883|588515296|FG001|Overall Study|Randomized by Mistake|0|||
162838433|NCT01425008|588117474|FG015|Dose Escalation Phase|Adverse Event|0|||
162838434|NCT01425008|588117475|FG016|Dose Escalation Phase|Adverse Event|0|||
162838435|NCT01425008|588117476|FG017|Dose Escalation Phase|Adverse Event|0|||
162838436|NCT01425008|588117477|FG018|Dose Escalation Phase|Adverse Event|0|||
162838437|NCT01425008|588117459|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838438|NCT01425008|588117460|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838439|NCT01425008|588117461|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838440|NCT01425008|588117462|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838441|NCT01425008|588117463|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
162838442|NCT01425008|588117464|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838443|NCT01425008|588117465|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
162838444|NCT01425008|588117466|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
162838445|NCT01425008|588117467|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
162838446|NCT01425008|588117468|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838447|NCT01425008|588117469|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838448|NCT01425008|588117470|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838449|NCT01425008|588117471|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838450|NCT01425008|588117472|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838451|NCT01425008|588117473|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838452|NCT01425008|588117474|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838453|NCT01425008|588117475|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838454|NCT01425008|588117476|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838455|NCT01425008|588117477|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162838456|NCT01425008|588117459|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
162838457|NCT01425008|588117460|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162838458|NCT01425008|588117461|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162838459|NCT01425008|588117462|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162838460|NCT01425008|588117463|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
162838461|NCT01425008|588117464|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
162838462|NCT01425008|588117465|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
162838463|NCT01425008|588117466|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
162838464|NCT01425008|588117467|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
162838465|NCT01425008|588117468|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
162838466|NCT01425008|588117469|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
162838467|NCT01425008|588117470|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
162838468|NCT01425008|588117471|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
162838469|NCT01425008|588117472|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
162838470|NCT01425008|588117473|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
162838471|NCT01425008|588117474|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
162838472|NCT01425008|588117475|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
162838473|NCT01425008|588117476|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
162838474|NCT01425008|588117477|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
162838475|NCT01425008|588117459|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
162948830|NCT03561883|588515295|FG000|Overall Study|Other, Not Specified|3|||
162948831|NCT03561883|588515296|FG001|Overall Study|Other, Not Specified|2|||
162948832|NCT02365207|588515301|FG000|Overall Study|Withdrawal by Subject|1|||
162948833|NCT02365207|588515301|FG000|Overall Study|Physician Decision|1|||
162948834|NCT01318499|588515304|FG000|Overall Study|Adverse Event|16|||
162948835|NCT01318499|588515305|FG001|Overall Study|Adverse Event|11|||
162948836|NCT01318499|588515306|FG002|Overall Study|Adverse Event|6|||
162948837|NCT01318499|588515304|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
162948838|NCT01318499|588515305|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
162948839|NCT01318499|588515306|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
162948840|NCT01318499|588515304|FG000|Overall Study|Noncompliance|2|||
162948841|NCT01318499|588515305|FG001|Overall Study|Noncompliance|3|||
162948842|NCT01318499|588515306|FG002|Overall Study|Noncompliance|0|||
162948843|NCT01318499|588515304|FG000|Overall Study|Treatment Failure|19|||
162948844|NCT01318499|588515305|FG001|Overall Study|Treatment Failure|19|||
162948845|NCT01318499|588515306|FG002|Overall Study|Treatment Failure|101|||
162948846|NCT01318499|588515304|FG000|Overall Study|Protocol Violation|2|||
162948847|NCT01318499|588515305|FG001|Overall Study|Protocol Violation|4|||
162838476|NCT01425008|588117460|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838477|NCT01425008|588117461|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
162838478|NCT01425008|588117462|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838479|NCT01425008|588117463|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838480|NCT01425008|588117464|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838481|NCT01425008|588117465|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838482|NCT01425008|588117466|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
162948848|NCT01318499|588515306|FG002|Overall Study|Protocol Violation|2|||
162838483|NCT01425008|588117467|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
162838484|NCT01425008|588117468|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
162838485|NCT01425008|588117469|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838486|NCT01425008|588117470|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838487|NCT01425008|588117471|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838488|NCT01425008|588117472|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838489|NCT01425008|588117473|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838490|NCT01425008|588117474|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838491|NCT01425008|588117475|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838492|NCT01425008|588117476|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838493|NCT01425008|588117477|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
162838494|NCT01425008|588117459|FG000|Dose Escalation Phase|Other|0|||
162838495|NCT01425008|588117460|FG001|Dose Escalation Phase|Other|0|||
162838496|NCT01425008|588117461|FG002|Dose Escalation Phase|Other|0|||
162838497|NCT01425008|588117462|FG003|Dose Escalation Phase|Other|0|||
162838498|NCT01425008|588117463|FG004|Dose Escalation Phase|Other|0|||
162838499|NCT01425008|588117464|FG005|Dose Escalation Phase|Other|0|||
162838500|NCT01425008|588117465|FG006|Dose Escalation Phase|Other|0|||
162838501|NCT01425008|588117466|FG007|Dose Escalation Phase|Other|0|||
162838502|NCT01425008|588117467|FG008|Dose Escalation Phase|Other|1|||
162838503|NCT01425008|588117468|FG009|Dose Escalation Phase|Other|0|||
162838504|NCT01425008|588117469|FG010|Dose Escalation Phase|Other|0|||
162838505|NCT01425008|588117470|FG011|Dose Escalation Phase|Other|0|||
162838506|NCT01425008|588117471|FG012|Dose Escalation Phase|Other|0|||
162838507|NCT01425008|588117472|FG013|Dose Escalation Phase|Other|0|||
162838508|NCT01425008|588117473|FG014|Dose Escalation Phase|Other|0|||
162838509|NCT01425008|588117474|FG015|Dose Escalation Phase|Other|0|||
162838510|NCT01425008|588117475|FG016|Dose Escalation Phase|Other|0|||
162838511|NCT01425008|588117476|FG017|Dose Escalation Phase|Other|0|||
162838512|NCT01425008|588117477|FG018|Dose Escalation Phase|Other|0|||
162838513|NCT01425008|588117459|FG000|Dose Expansion Phase|Progressive Disease|0|||
162838514|NCT01425008|588117460|FG001|Dose Expansion Phase|Progressive Disease|0|||
162838515|NCT01425008|588117461|FG002|Dose Expansion Phase|Progressive Disease|0|||
162838516|NCT01425008|588117462|FG003|Dose Expansion Phase|Progressive Disease|0|||
162838517|NCT01425008|588117463|FG004|Dose Expansion Phase|Progressive Disease|0|||
162838518|NCT01425008|588117464|FG005|Dose Expansion Phase|Progressive Disease|0|||
162838519|NCT01425008|588117465|FG006|Dose Expansion Phase|Progressive Disease|0|||
162838520|NCT01425008|588117466|FG007|Dose Expansion Phase|Progressive Disease|0|||
162838521|NCT01425008|588117467|FG008|Dose Expansion Phase|Progressive Disease|0|||
162838522|NCT01425008|588117468|FG009|Dose Expansion Phase|Progressive Disease|0|||
162838523|NCT01425008|588117469|FG010|Dose Expansion Phase|Progressive Disease|10|||
162838524|NCT01425008|588117470|FG011|Dose Expansion Phase|Progressive Disease|4|||
162838525|NCT01425008|588117471|FG012|Dose Expansion Phase|Progressive Disease|12|||
162838526|NCT01425008|588117472|FG013|Dose Expansion Phase|Progressive Disease|1|||
162838527|NCT01425008|588117473|FG014|Dose Expansion Phase|Progressive Disease|5|||
162838528|NCT01425008|588117474|FG015|Dose Expansion Phase|Progressive Disease|8|||
162838529|NCT01425008|588117475|FG016|Dose Expansion Phase|Progressive Disease|9|||
162838530|NCT01425008|588117476|FG017|Dose Expansion Phase|Progressive Disease|2|||
162838531|NCT01425008|588117477|FG018|Dose Expansion Phase|Progressive Disease|10|||
162838532|NCT01425008|588117459|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
162838533|NCT01425008|588117460|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
162838534|NCT01425008|588117461|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
162948849|NCT01318499|588515304|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
162838535|NCT01425008|588117462|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
162838536|NCT01425008|588117463|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
162838537|NCT01425008|588117464|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
162838538|NCT01425008|588117465|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
162838539|NCT01425008|588117466|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
162838540|NCT01425008|588117467|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
162838541|NCT01425008|588117468|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
162838542|NCT01425008|588117469|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
162838543|NCT01425008|588117470|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
162699939|NCT03220737|587612446|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
162838544|NCT01425008|588117471|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
162838545|NCT01425008|588117472|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
162838546|NCT01425008|588117473|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
162838547|NCT01425008|588117474|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
162838548|NCT01425008|588117475|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
162838549|NCT01425008|588117476|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
162838550|NCT01425008|588117477|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
162838551|NCT01425008|588117459|FG000|Dose Expansion Phase|Other|0|||
162838552|NCT01425008|588117460|FG001|Dose Expansion Phase|Other|0|||
162838553|NCT01425008|588117461|FG002|Dose Expansion Phase|Other|0|||
162838554|NCT01425008|588117462|FG003|Dose Expansion Phase|Other|0|||
162838555|NCT01425008|588117463|FG004|Dose Expansion Phase|Other|0|||
162838556|NCT01425008|588117464|FG005|Dose Expansion Phase|Other|0|||
162838557|NCT01425008|588117465|FG006|Dose Expansion Phase|Other|0|||
162838558|NCT01425008|588117466|FG007|Dose Expansion Phase|Other|0|||
162838559|NCT01425008|588117467|FG008|Dose Expansion Phase|Other|0|||
162838560|NCT01425008|588117468|FG009|Dose Expansion Phase|Other|0|||
162838561|NCT01425008|588117469|FG010|Dose Expansion Phase|Other|0|||
162838562|NCT01425008|588117470|FG011|Dose Expansion Phase|Other|0|||
162838563|NCT01425008|588117471|FG012|Dose Expansion Phase|Other|1|||
162838564|NCT01425008|588117472|FG013|Dose Expansion Phase|Other|0|||
162838565|NCT01425008|588117473|FG014|Dose Expansion Phase|Other|0|||
162838566|NCT01425008|588117474|FG015|Dose Expansion Phase|Other|0|||
162838567|NCT01425008|588117475|FG016|Dose Expansion Phase|Other|2|||
162838568|NCT01425008|588117476|FG017|Dose Expansion Phase|Other|0|||
162838569|NCT01425008|588117477|FG018|Dose Expansion Phase|Other|4|||
162838570|NCT01425008|588117459|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838571|NCT01425008|588117460|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838572|NCT01425008|588117461|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838573|NCT01425008|588117462|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838574|NCT01425008|588117463|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838575|NCT01425008|588117464|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838576|NCT01425008|588117465|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838577|NCT01425008|588117466|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838578|NCT01425008|588117467|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838579|NCT01425008|588117468|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838580|NCT01425008|588117469|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
162838581|NCT01425008|588117470|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
162838582|NCT01425008|588117471|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838583|NCT01425008|588117472|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838584|NCT01425008|588117473|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838585|NCT01425008|588117474|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
162838586|NCT01425008|588117475|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
162838587|NCT01425008|588117476|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
162838588|NCT01425008|588117477|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
162838589|NCT01425008|588117459|FG000|Dose Expansion Phase|Adverse Event|0|||
162838590|NCT01425008|588117460|FG001|Dose Expansion Phase|Adverse Event|0|||
162838591|NCT01425008|588117461|FG002|Dose Expansion Phase|Adverse Event|0|||
162838592|NCT01425008|588117462|FG003|Dose Expansion Phase|Adverse Event|0|||
162838593|NCT01425008|588117463|FG004|Dose Expansion Phase|Adverse Event|0|||
162838594|NCT01425008|588117464|FG005|Dose Expansion Phase|Adverse Event|0|||
162838595|NCT01425008|588117465|FG006|Dose Expansion Phase|Adverse Event|0|||
162838596|NCT01425008|588117466|FG007|Dose Expansion Phase|Adverse Event|0|||
162838597|NCT01425008|588117467|FG008|Dose Expansion Phase|Adverse Event|0|||
162838598|NCT01425008|588117468|FG009|Dose Expansion Phase|Adverse Event|0|||
162838599|NCT01425008|588117469|FG010|Dose Expansion Phase|Adverse Event|2|||
162838600|NCT01425008|588117470|FG011|Dose Expansion Phase|Adverse Event|3|||
162838601|NCT01425008|588117471|FG012|Dose Expansion Phase|Adverse Event|3|||
162838602|NCT01425008|588117472|FG013|Dose Expansion Phase|Adverse Event|0|||
162838603|NCT01425008|588117473|FG014|Dose Expansion Phase|Adverse Event|1|||
162838604|NCT01425008|588117474|FG015|Dose Expansion Phase|Adverse Event|1|||
162838605|NCT01425008|588117475|FG016|Dose Expansion Phase|Adverse Event|5|||
162838606|NCT01425008|588117476|FG017|Dose Expansion Phase|Adverse Event|0|||
162838607|NCT01425008|588117477|FG018|Dose Expansion Phase|Adverse Event|3|||
162838608|NCT01425008|588117459|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
162838609|NCT01425008|588117460|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
162838610|NCT01425008|588117461|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
162838611|NCT01425008|588117462|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
162838612|NCT01425008|588117463|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
162838613|NCT01425008|588117464|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
162838614|NCT01425008|588117465|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
162838615|NCT01425008|588117466|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
162838616|NCT01425008|588117467|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
162838617|NCT01425008|588117468|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
162838618|NCT01425008|588117469|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
162838619|NCT01425008|588117470|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
162838620|NCT01425008|588117471|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
162838621|NCT01425008|588117472|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
162838622|NCT01425008|588117473|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
162838623|NCT01425008|588117474|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
162838624|NCT01425008|588117475|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
162838625|NCT01425008|588117476|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
162838626|NCT01425008|588117477|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
162838627|NCT01425008|588117459|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838628|NCT01425008|588117460|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162948850|NCT01318499|588515305|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
162948851|NCT01318499|588515306|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
162699940|NCT03220737|587612447|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162699941|NCT03220737|587612448|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
162699942|NCT03220737|587612449|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162699943|NCT03220737|587612450|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
162699944|NCT03220737|587612451|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
162699945|NCT03220737|587612445|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
162699946|NCT03220737|587612446|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162699947|NCT03220737|587612447|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
162699948|NCT03220737|587612448|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162699949|NCT03220737|587612449|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
162699950|NCT03220737|587612450|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162699951|NCT03220737|587612451|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
162699952|NCT03220737|587612445|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
162699953|NCT03220737|587612446|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
162699954|NCT03220737|587612447|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
162699955|NCT03220737|587612448|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
162699956|NCT03220737|587612449|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
162699957|NCT03220737|587612450|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
162699958|NCT03220737|587612451|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
162699959|NCT03220737|587612445|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699960|NCT03220737|587612446|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699961|NCT03220737|587612447|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
162699962|NCT03220737|587612448|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699963|NCT03220737|587612449|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699964|NCT03220737|587612450|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699965|NCT03220737|587612451|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162699966|NCT03220737|587612445|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699967|NCT03220737|587612446|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699968|NCT03220737|587612447|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699969|NCT03220737|587612448|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699970|NCT03220737|587612449|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
162699971|NCT03220737|587612450|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699972|NCT03220737|587612451|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162699973|NCT03220737|587612445|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
162699974|NCT03220737|587612446|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699975|NCT03220737|587612447|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699976|NCT03220737|587612448|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699977|NCT03220737|587612449|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699978|NCT03220737|587612450|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699979|NCT03220737|587612451|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162699980|NCT03220737|587612445|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
162699981|NCT03220737|587612446|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699982|NCT03220737|587612447|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699983|NCT03220737|587612448|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699984|NCT03220737|587612449|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699985|NCT03220737|587612450|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699986|NCT03220737|587612451|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162699987|NCT03220737|587612445|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
162699988|NCT03220737|587612446|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699989|NCT03220737|587612447|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699990|NCT03220737|587612448|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699991|NCT03220737|587612449|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699992|NCT03220737|587612450|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699993|NCT03220737|587612451|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162699994|NCT04011384|587612457|FG000|Overall Study|Withdrawal by Subject|2|||
162699995|NCT04011384|587612458|FG001|Overall Study|Withdrawal by Subject|0|||
162699996|NCT04716881|587612461|FG000|Overall Study|Adverse Event|1|||
162948852|NCT01318499|588515304|FG000|Overall Study|Other|7|||
162838629|NCT01425008|588117461|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838630|NCT01425008|588117462|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838631|NCT01425008|588117463|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838632|NCT01425008|588117464|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838633|NCT01425008|588117465|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838634|NCT01425008|588117466|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838635|NCT01425008|588117467|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838636|NCT01425008|588117468|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838637|NCT01425008|588117469|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838638|NCT01425008|588117470|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838639|NCT01425008|588117471|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838640|NCT01425008|588117472|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838641|NCT01425008|588117473|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838642|NCT01425008|588117474|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838643|NCT01425008|588117475|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838644|NCT01425008|588117476|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162838645|NCT01425008|588117477|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
162838646|NCT00264238|588117478|FG000|Overall Study|Protocol Violation|1|||
162948853|NCT01318499|588515305|FG001|Overall Study|Other|10|||
162948854|NCT01318499|588515306|FG002|Overall Study|Other|22|||
162948855|NCT01395030|588515307|FG000|Overall Study|Did not complete FCH PET/CT|7|||
162948856|NCT01759290|588515308|FG000|Overall Study|Subjects withdrawn consent|5|||
162948857|NCT01759290|588515308|FG000|Overall Study|Physician Decision|2|||
162948858|NCT01759290|588515308|FG000|Overall Study|Death|17|||
162948859|NCT01759290|588515308|FG000|Overall Study|Lost to Follow-up|53|||
162948860|NCT01759290|588515308|FG000|Overall Study|Unknown reason|4|||
162948861|NCT01766778|588515312|FG000|Overall Study|Adverse Event|4|||
162948862|NCT01766778|588515313|FG001|Overall Study|Adverse Event|4|||
162699997|NCT04716881|587612461|FG000|Overall Study|Lost to Follow-up|1|||
162699998|NCT01630590|587612463|FG000|Overall Study|Adverse Event|9|||
162699999|NCT01630590|587612463|FG000|Overall Study|Lack of Efficacy|37|||
162700000|NCT01630590|587612463|FG000|Overall Study|Withdrawal by Subject|4|||
162700001|NCT01630590|587612463|FG000|Overall Study|2nd primary tumor|2|||
162700002|NCT01630590|587612463|FG000|Overall Study|Automobile accident|1|||
162700003|NCT01630590|587612463|FG000|Overall Study|Maximum benefit|4|||
162700004|NCT01751113|587612464|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162700005|NCT01751113|587612465|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162700006|NCT01751113|587612466|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162700007|NCT01751113|587612467|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
162700008|NCT01751113|587612468|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
162700009|NCT01751113|587612469|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162700010|NCT01751113|587612464|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162700011|NCT01751113|587612465|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162700012|NCT01751113|587612466|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162700013|NCT01751113|587612467|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162700014|NCT01751113|587612468|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162700015|NCT01751113|587612469|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
162700016|NCT00363896|587612470|FG000|Overall Study|Withdrawal by Subject|29|||
162700017|NCT00363896|587612471|FG001|Overall Study|Withdrawal by Subject|16|||
162700018|NCT00363896|587612470|FG000|Overall Study|Adverse Event|24|||
162700019|NCT00363896|587612471|FG001|Overall Study|Adverse Event|13|||
162700020|NCT00363896|587612470|FG000|Overall Study|COPD exacerbation|13|||
162700021|NCT00363896|587612471|FG001|Overall Study|COPD exacerbation|7|||
162700022|NCT00363896|587612470|FG000|Overall Study|Lack of Efficacy|12|||
162700023|NCT00363896|587612471|FG001|Overall Study|Lack of Efficacy|8|||
162700024|NCT00363896|587612470|FG000|Overall Study|Protocol Violation|6|||
162700025|NCT00363896|587612471|FG001|Overall Study|Protocol Violation|1|||
162700026|NCT00363896|587612470|FG000|Overall Study|Lost to Follow-up|3|||
162700027|NCT00363896|587612471|FG001|Overall Study|Lost to Follow-up|0|||
162700028|NCT00363896|587612470|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
162700029|NCT00363896|587612471|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
162700030|NCT00363896|587612470|FG000|Overall Study|Other|1|||
162700031|NCT00363896|587612471|FG001|Overall Study|Other|2|||
162700032|NCT04147260|587612474|FG000|Overall Study|Adverse Event|1|||
162700033|NCT04147260|587612475|FG001|Overall Study|Adverse Event|0|||
162700034|NCT04147260|587612476|FG002|Overall Study|Adverse Event|1|||
162700035|NCT04147260|587612477|FG003|Overall Study|Adverse Event|2|||
162700036|NCT04147260|587612478|FG004|Overall Study|Adverse Event|0|||
162700037|NCT04147260|587612474|FG000|Overall Study|Withdrawal by Subject|0|||
162700038|NCT04147260|587612475|FG001|Overall Study|Withdrawal by Subject|0|||
162948863|NCT01766778|588515312|FG000|Overall Study|Withdrawal by Subject|1|||
162948864|NCT01766778|588515313|FG001|Overall Study|Withdrawal by Subject|0|||
162948865|NCT01054599|588515314|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
162948866|NCT01054599|588515315|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
162838647|NCT03359759|588117479|FG000|Overall Study|Death|3|||
162838648|NCT03359759|588117479|FG000|Overall Study|Lost to Follow-up|2|||
162838649|NCT04818593|588117480|FG000|Overall Study|Low Oocyte Yield|8|||
162838650|NCT04818593|588117481|FG001|Overall Study|Low Oocyte Yield|8|||
162838651|NCT04818593|588117480|FG000|Overall Study|Not ICSI Insemination|7|||
162838652|NCT04818593|588117481|FG001|Overall Study|Not ICSI Insemination|7|||
162838653|NCT04818593|588117480|FG000|Overall Study|Poor Sperm Quality|2|||
162838654|NCT04818593|588117481|FG001|Overall Study|Poor Sperm Quality|2|||
162838655|NCT04818593|588117480|FG000|Overall Study|Withdrawal by Subject|2|||
162838656|NCT04818593|588117481|FG001|Overall Study|Withdrawal by Subject|2|||
162838657|NCT04818593|588117480|FG000|Overall Study|Conversion to IUI due to low response|1|||
162838658|NCT04818593|588117481|FG001|Overall Study|Conversion to IUI due to low response|1|||
162838659|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
162838660|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
162838661|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
162838662|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
162838663|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
162838664|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
162838665|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
162838666|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
162838667|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
162838668|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
162838669|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
162838670|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
162838671|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
162838672|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
162838673|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
162838674|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
162838675|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
162838676|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
162838677|NCT02600494|588117482|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
162838678|NCT02600494|588117483|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
162838679|NCT02600494|588117484|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
162838680|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
162838681|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
162838682|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
162838683|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
162838684|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
162838685|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
162838686|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
162838687|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
162838688|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
162838689|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
162838690|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
162838691|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
162838692|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
162838693|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
162838694|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
162838695|NCT02600494|588117482|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
162838696|NCT02600494|588117483|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
162838697|NCT02600494|588117484|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
162838698|NCT00661271|588119134|FG000|Overall Study|Lost to Follow-up|28|||
162838699|NCT00661271|588119135|FG001|Overall Study|Lost to Follow-up|25|||
162838700|NCT00953758|588119136|FG000|Overall Study|Death|2|||
162838701|NCT00953758|588119137|FG001|Overall Study|Death|0|||
162838702|NCT00953758|588119138|FG002|Overall Study|Death|1|||
162838703|NCT00953758|588119139|FG003|Overall Study|Death|1|||
162838704|NCT00953758|588119140|FG004|Overall Study|Death|1|||
162838705|NCT00953758|588119141|FG005|Overall Study|Death|1|||
162838706|NCT00953758|588119142|FG006|Overall Study|Death|1|||
162838707|NCT00953758|588119143|FG007|Overall Study|Death|3|||
162838708|NCT00953758|588119144|FG008|Overall Study|Death|1|||
162948867|NCT01054599|588515314|FG000|Overall Study|Protocol Violation|1|||
162948868|NCT01054599|588515315|FG001|Overall Study|Protocol Violation|0|||
162838709|NCT00953758|588119145|FG009|Overall Study|Death|0|||
162838710|NCT00953758|588119136|FG000|Overall Study|Participant refused further follow-up|0|||
162838711|NCT00953758|588119137|FG001|Overall Study|Participant refused further follow-up|0|||
162948869|NCT01054599|588515314|FG000|Overall Study|Spells/seizure-like episodes|1|||
162838712|NCT00953758|588119138|FG002|Overall Study|Participant refused further follow-up|1|||
162838713|NCT00953758|588119139|FG003|Overall Study|Participant refused further follow-up|0|||
162838714|NCT00953758|588119140|FG004|Overall Study|Participant refused further follow-up|3|||
162838715|NCT00953758|588119141|FG005|Overall Study|Participant refused further follow-up|0|||
162838716|NCT00953758|588119142|FG006|Overall Study|Participant refused further follow-up|0|||
162838717|NCT00953758|588119143|FG007|Overall Study|Participant refused further follow-up|0|||
162838718|NCT00953758|588119144|FG008|Overall Study|Participant refused further follow-up|1|||
162838719|NCT00953758|588119145|FG009|Overall Study|Participant refused further follow-up|0|||
162838720|NCT00953758|588119136|FG000|Overall Study|Lost to Follow-up|0|||
162838721|NCT00953758|588119137|FG001|Overall Study|Lost to Follow-up|0|||
162838722|NCT00953758|588119138|FG002|Overall Study|Lost to Follow-up|0|||
162838723|NCT00953758|588119139|FG003|Overall Study|Lost to Follow-up|1|||
162838724|NCT00953758|588119140|FG004|Overall Study|Lost to Follow-up|0|||
162838725|NCT00953758|588119141|FG005|Overall Study|Lost to Follow-up|0|||
162838726|NCT00953758|588119142|FG006|Overall Study|Lost to Follow-up|0|||
162838727|NCT00953758|588119143|FG007|Overall Study|Lost to Follow-up|1|||
162838728|NCT00953758|588119144|FG008|Overall Study|Lost to Follow-up|0|||
162838729|NCT00953758|588119145|FG009|Overall Study|Lost to Follow-up|1|||
162838730|NCT00953758|588119136|FG000|Overall Study|Physician Decision|0|||
162838731|NCT00953758|588119137|FG001|Overall Study|Physician Decision|0|||
162838732|NCT00953758|588119138|FG002|Overall Study|Physician Decision|0|||
162838733|NCT00953758|588119139|FG003|Overall Study|Physician Decision|0|||
162838734|NCT00953758|588119140|FG004|Overall Study|Physician Decision|1|||
162838735|NCT00953758|588119141|FG005|Overall Study|Physician Decision|0|||
162838736|NCT00953758|588119142|FG006|Overall Study|Physician Decision|0|||
162838737|NCT00953758|588119143|FG007|Overall Study|Physician Decision|0|||
162838738|NCT00953758|588119144|FG008|Overall Study|Physician Decision|0|||
162838739|NCT00953758|588119145|FG009|Overall Study|Physician Decision|0|||
162838740|NCT00953758|588119136|FG000|Overall Study|Disease progression|0|||
162838741|NCT00953758|588119137|FG001|Overall Study|Disease progression|0|||
162838742|NCT00953758|588119138|FG002|Overall Study|Disease progression|0|||
162838743|NCT00953758|588119139|FG003|Overall Study|Disease progression|0|||
162838744|NCT00953758|588119140|FG004|Overall Study|Disease progression|1|||
162838745|NCT00953758|588119141|FG005|Overall Study|Disease progression|0|||
162838746|NCT00953758|588119142|FG006|Overall Study|Disease progression|0|||
162838747|NCT00953758|588119143|FG007|Overall Study|Disease progression|0|||
162838748|NCT00953758|588119144|FG008|Overall Study|Disease progression|0|||
162838749|NCT00953758|588119145|FG009|Overall Study|Disease progression|0|||
162838750|NCT00953758|588119136|FG000|Overall Study|Participant went for transplant|0|||
162838751|NCT00953758|588119137|FG001|Overall Study|Participant went for transplant|0|||
162838752|NCT00953758|588119138|FG002|Overall Study|Participant went for transplant|0|||
162838753|NCT00953758|588119139|FG003|Overall Study|Participant went for transplant|0|||
162838754|NCT00953758|588119140|FG004|Overall Study|Participant went for transplant|0|||
162838755|NCT00953758|588119141|FG005|Overall Study|Participant went for transplant|0|||
162838756|NCT00953758|588119142|FG006|Overall Study|Participant went for transplant|0|||
162838757|NCT00953758|588119143|FG007|Overall Study|Participant went for transplant|0|||
162838758|NCT00953758|588119144|FG008|Overall Study|Participant went for transplant|1|||
162838759|NCT00953758|588119145|FG009|Overall Study|Participant went for transplant|0|||
162838760|NCT00293579|588119147|FG000|Overall Study|Withdrawal by Subject|1|||
162700039|NCT04147260|587612476|FG002|Overall Study|Withdrawal by Subject|1|||
162700040|NCT04147260|587612477|FG003|Overall Study|Withdrawal by Subject|1|||
162700041|NCT04147260|587612478|FG004|Overall Study|Withdrawal by Subject|0|||
162700042|NCT01313923|587612486|FG000|Overall Study|Physician Decision|3|||
162700043|NCT02471404|587612487|FG000|Overall Study|Adverse Event|7|||
162700044|NCT02471404|587612488|FG001|Overall Study|Adverse Event|1|||
162700045|NCT02471404|587612489|FG002|Overall Study|Adverse Event|2|||
162700046|NCT02471404|587612487|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
162700047|NCT02471404|587612488|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
162700048|NCT02471404|587612489|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
162700049|NCT02471404|587612487|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
162700050|NCT02471404|587612488|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162838761|NCT01276236|588119148|FG000|Overall Study|Lack of Efficacy|2|||
162838762|NCT01276236|588119148|FG000|Overall Study|Withdrawal by Subject|4|||
162838763|NCT02799069|588119149|FG000|Overall Study|Adverse Event|0|||
162838764|NCT02799069|588119150|FG001|Overall Study|Adverse Event|2|||
162838765|NCT02799069|588119151|FG002|Overall Study|Adverse Event|2|||
162838766|NCT02799069|588119149|FG000|Overall Study|Lack of Efficacy|2|||
162838767|NCT02799069|588119150|FG001|Overall Study|Lack of Efficacy|0|||
162838768|NCT02799069|588119151|FG002|Overall Study|Lack of Efficacy|0|||
162838769|NCT02799069|588119149|FG000|Overall Study|Lost to Follow-up|1|||
162838770|NCT02799069|588119150|FG001|Overall Study|Lost to Follow-up|1|||
162838771|NCT02799069|588119151|FG002|Overall Study|Lost to Follow-up|0|||
162948870|NCT01054599|588515315|FG001|Overall Study|Spells/seizure-like episodes|1|||
162948871|NCT01054599|588515314|FG000|Overall Study|Timing/scheduling difficulties|1|||
162838772|NCT02799069|588119149|FG000|Overall Study|Withdrawal by Subject|4|||
162700051|NCT02471404|587612489|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
162700052|NCT02471404|587612487|FG000|Overall Study|Lost to Follow-up|1|||
162700053|NCT02471404|587612488|FG001|Overall Study|Lost to Follow-up|1|||
162838773|NCT02799069|588119150|FG001|Overall Study|Withdrawal by Subject|4|||
162838774|NCT02799069|588119151|FG002|Overall Study|Withdrawal by Subject|3|||
162838775|NCT02799069|588119149|FG000|Overall Study|Protocol Violation|1|||
162838776|NCT02799069|588119150|FG001|Overall Study|Protocol Violation|0|||
162838777|NCT02799069|588119151|FG002|Overall Study|Protocol Violation|2|||
162838778|NCT03215771|588119152|FG000|Overall Study|Withdrawal by Subject|2|||
162838779|NCT03215771|588119152|FG000|Overall Study|Physician Decision|1|||
162838780|NCT02703311|588119159|FG000|Overall Study|Death|5|||
162838781|NCT02703311|588119159|FG000|Overall Study|Withdrawal by Subject|3|||
162838782|NCT00343889|588119162|FG000|Overall Study|Lost to Follow-up|2|||
162838783|NCT00343889|588119163|FG001|Overall Study|Lost to Follow-up|0|||
162838784|NCT00343889|588119162|FG000|Overall Study|Withdrawal by Subject|0|||
162838785|NCT00343889|588119163|FG001|Overall Study|Withdrawal by Subject|1|||
162838786|NCT00343889|588119162|FG000|Overall Study|Protocol Violation|1|||
162838787|NCT00343889|588119163|FG001|Overall Study|Protocol Violation|0|||
162838788|NCT00137111|588119164|FG000|Total Therapy|Death|35|||
162838789|NCT00137111|588119165|FG001|Total Therapy|Death|0|||
162838790|NCT00137111|588119166|FG002|Total Therapy|Death|0|||
162838791|NCT00137111|588119167|FG003|Total Therapy|Death|0|||
162838792|NCT00137111|588119164|FG000|Total Therapy|Non Compliance|5|||
162838793|NCT00137111|588119165|FG001|Total Therapy|Non Compliance|0|||
162838794|NCT00137111|588119166|FG002|Total Therapy|Non Compliance|0|||
162838795|NCT00137111|588119167|FG003|Total Therapy|Non Compliance|0|||
162838796|NCT00088374|588119168|FG000|Overall Study|patient did not receive any 17AAG|1|||
162838797|NCT00088374|588119168|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
162838798|NCT00852995|588119169|FG000|Overall Study|Adverse Event|1|||
162838799|NCT00852995|588119170|FG001|Overall Study|Adverse Event|0|||
162838800|NCT00852995|588119171|FG002|Overall Study|Adverse Event|4|||
162838801|NCT00852995|588119172|FG003|Overall Study|Adverse Event|0|||
162838802|NCT00852995|588119173|FG004|Overall Study|Adverse Event|0|||
162838803|NCT00852995|588119169|FG000|Overall Study|Lost to Follow-up|0|||
162838804|NCT00852995|588119170|FG001|Overall Study|Lost to Follow-up|1|||
162838805|NCT00852995|588119171|FG002|Overall Study|Lost to Follow-up|1|||
162838806|NCT00852995|588119172|FG003|Overall Study|Lost to Follow-up|0|||
162838807|NCT00852995|588119173|FG004|Overall Study|Lost to Follow-up|0|||
162838808|NCT00852995|588119169|FG000|Overall Study|Withdrawal by Subject|4|||
162838809|NCT00852995|588119170|FG001|Overall Study|Withdrawal by Subject|0|||
162838810|NCT00852995|588119171|FG002|Overall Study|Withdrawal by Subject|0|||
162838811|NCT00852995|588119172|FG003|Overall Study|Withdrawal by Subject|1|||
162838812|NCT00852995|588119173|FG004|Overall Study|Withdrawal by Subject|2|||
162838813|NCT00852995|588119169|FG000|Overall Study|Non-Compliance|0|||
162838814|NCT00852995|588119170|FG001|Overall Study|Non-Compliance|0|||
162838815|NCT00852995|588119171|FG002|Overall Study|Non-Compliance|0|||
162838816|NCT00852995|588119172|FG003|Overall Study|Non-Compliance|2|||
162838817|NCT00852995|588119173|FG004|Overall Study|Non-Compliance|0|||
162838818|NCT00852995|588119169|FG000|Overall Study|Progressive Disease|1|||
162838819|NCT00852995|588119170|FG001|Overall Study|Progressive Disease|0|||
162838820|NCT00852995|588119171|FG002|Overall Study|Progressive Disease|0|||
162838821|NCT00852995|588119172|FG003|Overall Study|Progressive Disease|2|||
162838822|NCT00852995|588119173|FG004|Overall Study|Progressive Disease|1|||
162838823|NCT00852995|588119169|FG000|Overall Study|Physician Decision|1|||
162838824|NCT00852995|588119170|FG001|Overall Study|Physician Decision|0|||
162838825|NCT00852995|588119171|FG002|Overall Study|Physician Decision|0|||
162838826|NCT00852995|588119172|FG003|Overall Study|Physician Decision|0|||
162838827|NCT00852995|588119173|FG004|Overall Study|Physician Decision|0|||
162838828|NCT00852995|588119169|FG000|Overall Study|Protocol Violation|0|||
162838829|NCT00852995|588119170|FG001|Overall Study|Protocol Violation|0|||
162838830|NCT00852995|588119171|FG002|Overall Study|Protocol Violation|0|||
162838831|NCT00852995|588119172|FG003|Overall Study|Protocol Violation|0|||
162838832|NCT00852995|588119173|FG004|Overall Study|Protocol Violation|1|||
162838833|NCT00852995|588119169|FG000|Overall Study|Moved Out of Area|1|||
162838834|NCT00852995|588119170|FG001|Overall Study|Moved Out of Area|0|||
162838835|NCT00852995|588119171|FG002|Overall Study|Moved Out of Area|0|||
162838836|NCT00852995|588119172|FG003|Overall Study|Moved Out of Area|0|||
162838837|NCT00852995|588119173|FG004|Overall Study|Moved Out of Area|0|||
162948872|NCT01054599|588515315|FG001|Overall Study|Timing/scheduling difficulties|1|||
162838838|NCT02508194|588119176|FG000|Overall Study|Death|5|||
162948873|NCT01054599|588515314|FG000|Overall Study|Visual impairment, WTAR <80|0|||
162838839|NCT02508194|588119177|FG001|Overall Study|Death|3|||
162838840|NCT02508194|588119176|FG000|Overall Study|Lost to Follow-up|25|||
162838841|NCT02508194|588119177|FG001|Overall Study|Lost to Follow-up|18|||
162838842|NCT02508194|588119176|FG000|Overall Study|Withdrawal by Subject|20|||
162838843|NCT02508194|588119177|FG001|Overall Study|Withdrawal by Subject|18|||
162838844|NCT02508194|588119176|FG000|Overall Study|Error in Randomization|1|||
162838845|NCT02508194|588119177|FG001|Overall Study|Error in Randomization|3|||
162838846|NCT02508194|588119176|FG000|Overall Study|Principal Investigator Decision|1|||
162948874|NCT01054599|588515315|FG001|Overall Study|Visual impairment, WTAR <80|1|||
162948875|NCT01054599|588515314|FG000|Overall Study|Lost to Follow-up|0|||
162948876|NCT01054599|588515315|FG001|Overall Study|Lost to Follow-up|2|||
162948877|NCT01054599|588515314|FG000|Overall Study|Adverse Event|0|||
162948878|NCT01054599|588515315|FG001|Overall Study|Adverse Event|1|||
162948879|NCT01054599|588515314|FG000|Overall Study|Withdrawal by Subject|0|||
162948880|NCT01054599|588515315|FG001|Overall Study|Withdrawal by Subject|1|||
162948881|NCT01104662|588515316|FG000|Overall Study|Adverse Event|2|||
162948882|NCT01104662|588515317|FG001|Overall Study|Adverse Event|2|||
162948883|NCT01104662|588515318|FG002|Overall Study|Adverse Event|0|||
162948884|NCT01104662|588515319|FG003|Overall Study|Adverse Event|1|||
162948885|NCT01104662|588515320|FG004|Overall Study|Adverse Event|1|||
162948886|NCT01104662|588515321|FG005|Overall Study|Adverse Event|1|||
162948887|NCT01104662|588515322|FG006|Overall Study|Adverse Event|0|||
162948888|NCT01104662|588515323|FG007|Overall Study|Adverse Event|0|||
162948889|NCT01104662|588515316|FG000|Overall Study|Clinical Failure|1|||
162948890|NCT01104662|588515317|FG001|Overall Study|Clinical Failure|0|||
162948891|NCT01104662|588515318|FG002|Overall Study|Clinical Failure|0|||
162948892|NCT01104662|588515319|FG003|Overall Study|Clinical Failure|0|||
162948893|NCT01104662|588515320|FG004|Overall Study|Clinical Failure|0|||
162948894|NCT01104662|588515321|FG005|Overall Study|Clinical Failure|1|||
162948895|NCT01104662|588515322|FG006|Overall Study|Clinical Failure|0|||
162948896|NCT01104662|588515323|FG007|Overall Study|Clinical Failure|0|||
162948897|NCT01104662|588515316|FG000|Overall Study|Participant left investigator's care|1|||
162948898|NCT01104662|588515317|FG001|Overall Study|Participant left investigator's care|1|||
162948899|NCT01104662|588515318|FG002|Overall Study|Participant left investigator's care|0|||
162948900|NCT01104662|588515319|FG003|Overall Study|Participant left investigator's care|0|||
162948901|NCT01104662|588515320|FG004|Overall Study|Participant left investigator's care|0|||
162948902|NCT01104662|588515321|FG005|Overall Study|Participant left investigator's care|0|||
162948903|NCT01104662|588515322|FG006|Overall Study|Participant left investigator's care|0|||
162948904|NCT01104662|588515323|FG007|Overall Study|Participant left investigator's care|0|||
162948905|NCT01104662|588515316|FG000|Overall Study|Reason not specified|3|||
162948906|NCT01104662|588515317|FG001|Overall Study|Reason not specified|3|||
162948907|NCT01104662|588515318|FG002|Overall Study|Reason not specified|0|||
162948908|NCT01104662|588515319|FG003|Overall Study|Reason not specified|0|||
162948909|NCT01104662|588515320|FG004|Overall Study|Reason not specified|0|||
162948910|NCT01104662|588515321|FG005|Overall Study|Reason not specified|1|||
162948911|NCT01104662|588515322|FG006|Overall Study|Reason not specified|0|||
162948912|NCT01104662|588515323|FG007|Overall Study|Reason not specified|0|||
162948913|NCT01104662|588515316|FG000|Overall Study|Randomized but not treated|3|||
162948914|NCT01104662|588515317|FG001|Overall Study|Randomized but not treated|4|||
162948915|NCT01104662|588515318|FG002|Overall Study|Randomized but not treated|1|||
162948916|NCT01104662|588515319|FG003|Overall Study|Randomized but not treated|0|||
162948917|NCT01104662|588515320|FG004|Overall Study|Randomized but not treated|0|||
162948918|NCT01104662|588515321|FG005|Overall Study|Randomized but not treated|1|||
162948919|NCT01104662|588515322|FG006|Overall Study|Randomized but not treated|0|||
162948920|NCT01104662|588515323|FG007|Overall Study|Randomized but not treated|0|||
162948921|NCT01478620|588515324|FG000|Overall Study|Lost to Follow-up|6|||
162948922|NCT02888171|588515330|FG000|Overall Study|Lost to Follow-up|2|||
162948923|NCT02888171|588515331|FG001|Overall Study|Lost to Follow-up|1|||
162948924|NCT02888171|588515330|FG000|Overall Study|Withdrawal by Subject|3|||
162948925|NCT02888171|588515331|FG001|Overall Study|Withdrawal by Subject|2|||
162948926|NCT02888171|588515330|FG000|Overall Study|Adverse Event|0|||
162948927|NCT02888171|588515331|FG001|Overall Study|Adverse Event|1|||
162948928|NCT02817841|588516901|FG000|Overall Study|Lost to Follow-up|287|||
162948929|NCT02817841|588516901|FG000|Overall Study|Withdrawal by Subject|183|||
162948930|NCT02817841|588516901|FG000|Overall Study|Adverse event not related to bleeding|131|||
162948931|NCT02817841|588516901|FG000|Overall Study|Adverse event related to bleeding|51|||
162948932|NCT02817841|588516901|FG000|Overall Study|Pregnancy|32|||
162948933|NCT02817841|588516901|FG000|Overall Study|Pregnancy wish|17|||
162838847|NCT02508194|588119177|FG001|Overall Study|Principal Investigator Decision|2|||
162838848|NCT00626093|588119178|FG000|Overall Study|Lost to Follow-up|5|||
162838849|NCT00626093|588119178|FG000|Overall Study|Death|1|||
162838850|NCT00626093|588119178|FG000|Overall Study|Physician Decision|4|||
162838851|NCT00626093|588119178|FG000|Overall Study|Withdrawal by Subject|6|||
162838852|NCT00626093|588119178|FG000|Overall Study|Protocol Violation|1|||
162838853|NCT00626093|588119178|FG000|Overall Study|One of the required devices not implante|6|||
162838854|NCT00511355|588119179|FG000|Overall Study|Adverse Event|4|||
162838855|NCT00511355|588119180|FG001|Overall Study|Adverse Event|4|||
162838856|NCT00511355|588119179|FG000|Overall Study|Pregnancy Wish|1|||
162838857|NCT00511355|588119180|FG001|Overall Study|Pregnancy Wish|0|||
162838858|NCT00511355|588119179|FG000|Overall Study|Lost to Follow-up|2|||
162838859|NCT00511355|588119180|FG001|Overall Study|Lost to Follow-up|1|||
162838860|NCT00511355|588119179|FG000|Overall Study|Other Reason|0|||
162838861|NCT00511355|588119180|FG001|Overall Study|Other Reason|1|||
162838862|NCT00511355|588119179|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
162838863|NCT00511355|588119180|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
162838864|NCT00511355|588119179|FG000|Overall Study|Withdrawal of informed consent|0|||
162838865|NCT00511355|588119180|FG001|Overall Study|Withdrawal of informed consent|1|||
162838866|NCT00511355|588119179|FG000|Overall Study|Other reason pre-treatment|0|||
162838867|NCT00511355|588119180|FG001|Overall Study|Other reason pre-treatment|1|||
162838868|NCT01632566|588119182|FG000|Overall Study|Withdrawal by Subject|0|||
162838869|NCT01632566|588119183|FG001|Overall Study|Withdrawal by Subject|1|||
162838870|NCT01632566|588119184|FG002|Overall Study|Withdrawal by Subject|0|||
162838871|NCT01632566|588119185|FG003|Overall Study|Withdrawal by Subject|0|||
162838872|NCT01632566|588119186|FG004|Overall Study|Withdrawal by Subject|0|||
162838873|NCT01632566|588119182|FG000|Overall Study|Sponsor Decision|0|||
162838874|NCT01632566|588119183|FG001|Overall Study|Sponsor Decision|2|||
162838875|NCT01632566|588119184|FG002|Overall Study|Sponsor Decision|9|||
162838876|NCT01632566|588119185|FG003|Overall Study|Sponsor Decision|2|||
162838877|NCT01632566|588119186|FG004|Overall Study|Sponsor Decision|2|||
162838878|NCT00454805|588119187|FG000|Overall Study|Withdrawal by Subject|9|||
162838879|NCT00454805|588119188|FG001|Overall Study|Withdrawal by Subject|2|||
162838880|NCT00454805|588119187|FG000|Overall Study|Death|0|||
162838881|NCT00454805|588119188|FG001|Overall Study|Death|2|||
162838882|NCT00454805|588119187|FG000|Overall Study|Disease progression|16|||
162838883|NCT00454805|588119188|FG001|Overall Study|Disease progression|19|||
162838884|NCT00454805|588119187|FG000|Overall Study|In order to begin radiotherapy|1|||
162838885|NCT00454805|588119188|FG001|Overall Study|In order to begin radiotherapy|0|||
162838886|NCT00217087|588119189|FG000|Overall Study|decided to have esophagectomy|1|||
162838887|NCT00217087|588119190|FG001|Overall Study|decided to have esophagectomy|2|||
162838888|NCT00217087|588119189|FG000|Overall Study|completed less than 12 months return|10|||
162838889|NCT00217087|588119190|FG001|Overall Study|completed less than 12 months return|18|||
162838890|NCT03208231|588119195|FG000|Overall Study|Death|1|||
162838891|NCT03208231|588119196|FG001|Overall Study|Death|2|||
162838892|NCT03208231|588119195|FG000|Overall Study|Moved and unable to get to clinic|1|||
162838893|NCT03208231|588119196|FG001|Overall Study|Moved and unable to get to clinic|0|||
162838894|NCT03208231|588119195|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
162838895|NCT03208231|588119196|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
162838896|NCT03205995|588119197|FG000|Overall Study|Adverse Event|1|||
162838897|NCT03205995|588119197|FG000|Overall Study|Death|1|||
162838898|NCT03205995|588119197|FG000|Overall Study|Physician Decision|2|||
162838899|NCT03205995|588119197|FG000|Overall Study|Protocol Violation|2|||
162838900|NCT03892746|588119200|FG000|Overall Study|Withdrawal by Subject|2|||
162838901|NCT03892746|588119201|FG001|Overall Study|Withdrawal by Subject|1|||
162838902|NCT03892746|588119200|FG000|Overall Study|Lost to Follow-up|2|||
162838903|NCT03892746|588119201|FG001|Overall Study|Lost to Follow-up|0|||
162838904|NCT03977467|588119202|FG000|Overall Study|Disease Progression|1|||
162838905|NCT03977467|588119203|FG001|Overall Study|Disease Progression|1|||
162838906|NCT03977467|588119204|FG002|Overall Study|Disease Progression|30|||
162838907|NCT03977467|588119205|FG003|Overall Study|Disease Progression|0|||
162838908|NCT03977467|588119202|FG000|Overall Study|Adverse Event|0|||
162838909|NCT03977467|588119203|FG001|Overall Study|Adverse Event|1|||
162838910|NCT03977467|588119204|FG002|Overall Study|Adverse Event|0|||
162838911|NCT03977467|588119205|FG003|Overall Study|Adverse Event|0|||
162838912|NCT03977467|588119202|FG000|Overall Study|Death|0|||
162700054|NCT02471404|587612489|FG002|Overall Study|Lost to Follow-up|3|||
162838913|NCT03977467|588119203|FG001|Overall Study|Death|0|||
162838914|NCT03977467|588119204|FG002|Overall Study|Death|3|||
162838915|NCT03977467|588119205|FG003|Overall Study|Death|0|||
162838916|NCT03977467|588119202|FG000|Overall Study|Lack of Efficacy|0|||
162838917|NCT03977467|588119203|FG001|Overall Study|Lack of Efficacy|0|||
162838918|NCT03977467|588119204|FG002|Overall Study|Lack of Efficacy|1|||
162838919|NCT03977467|588119205|FG003|Overall Study|Lack of Efficacy|0|||
162838920|NCT03977467|588119202|FG000|Overall Study|Withdrawal by Subject|2|||
162838921|NCT03977467|588119203|FG001|Overall Study|Withdrawal by Subject|1|||
162838922|NCT03977467|588119204|FG002|Overall Study|Withdrawal by Subject|4|||
162838923|NCT03977467|588119205|FG003|Overall Study|Withdrawal by Subject|0|||
162838924|NCT03977467|588119202|FG000|Overall Study|Study Terminated|1|||
162838925|NCT03977467|588119203|FG001|Overall Study|Study Terminated|0|||
162838926|NCT03977467|588119204|FG002|Overall Study|Study Terminated|0|||
162838927|NCT03977467|588119205|FG003|Overall Study|Study Terminated|1|||
162838928|NCT01328951|588119206|FG000|Overall Study|Disease Progression|17|||
162838929|NCT01328951|588119207|FG001|Overall Study|Disease Progression|14|||
162838930|NCT01328951|588119206|FG000|Overall Study|Adverse Event|2|||
162838931|NCT01328951|588119207|FG001|Overall Study|Adverse Event|0|||
162838932|NCT01328951|588119206|FG000|Overall Study|Death|243|||
162838933|NCT01328951|588119207|FG001|Overall Study|Death|258|||
162838934|NCT01328951|588119206|FG000|Overall Study|Lost to Follow-up|6|||
162838935|NCT01328951|588119207|FG001|Overall Study|Lost to Follow-up|7|||
162838936|NCT01328951|588119206|FG000|Overall Study|Withdrawal by Subject|6|||
162838937|NCT01328951|588119207|FG001|Overall Study|Withdrawal by Subject|6|||
162838938|NCT01328951|588119206|FG000|Overall Study|Study Closed by the Sponsor|36|||
162838939|NCT01328951|588119207|FG001|Overall Study|Study Closed by the Sponsor|31|||
162838940|NCT01328951|588119206|FG000|Overall Study|Other|11|||
162838941|NCT01328951|588119207|FG001|Overall Study|Other|6|||
162838942|NCT04042103|588119213|FG000|Overall Study|Lost to Follow-up|1|||
162838943|NCT04042103|588119213|FG000|Overall Study|Withdrawal by Subject|1|||
162838944|NCT04209855|588119214|FG000|Overall Study|Death|161|||
162838945|NCT04209855|588119215|FG001|Overall Study|Death|177|||
162838946|NCT04209855|588119214|FG000|Overall Study|PI Discretion|1|||
162838947|NCT04209855|588119215|FG001|Overall Study|PI Discretion|1|||
162838948|NCT04209855|588119214|FG000|Overall Study|Lost to Follow-up|5|||
162838949|NCT04209855|588119215|FG001|Overall Study|Lost to Follow-up|2|||
162838950|NCT04209855|588119214|FG000|Overall Study|Withdrew consent|10|||
162838951|NCT04209855|588119215|FG001|Overall Study|Withdrew consent|24|||
162838952|NCT04209855|588119214|FG000|Overall Study|Sponsor decision|44|||
162838953|NCT04209855|588119215|FG001|Overall Study|Sponsor decision|18|||
162838954|NCT04209855|588119214|FG000|Overall Study|Other than specified|6|||
162838955|NCT04209855|588119215|FG001|Overall Study|Other than specified|4|||
162838956|NCT00271817|588119216|FG000|Part 1|Adverse Event|68|||
162838957|NCT00271817|588119217|FG001|Part 1|Adverse Event|25|||
162838958|NCT00271817|588119218|FG002|Part 1|Adverse Event|156|||
162838959|NCT00271817|588119216|FG000|Part 1|Lost to Follow-up|6|||
162838960|NCT00271817|588119217|FG001|Part 1|Lost to Follow-up|8|||
162838961|NCT00271817|588119218|FG002|Part 1|Lost to Follow-up|24|||
162838962|NCT00271817|588119216|FG000|Part 1|Protocol Violation|5|||
162838963|NCT00271817|588119217|FG001|Part 1|Protocol Violation|4|||
162838964|NCT00271817|588119218|FG002|Part 1|Protocol Violation|7|||
162838965|NCT00271817|588119216|FG000|Part 1|Patient Moved|3|||
162838966|NCT00271817|588119217|FG001|Part 1|Patient Moved|1|||
162838967|NCT00271817|588119218|FG002|Part 1|Patient Moved|5|||
162838968|NCT00271817|588119216|FG000|Part 1|Withdrawal by Subject|23|||
162838969|NCT00271817|588119217|FG001|Part 1|Withdrawal by Subject|17|||
162838970|NCT00271817|588119218|FG002|Part 1|Withdrawal by Subject|45|||
162838971|NCT00271817|588119216|FG000|Part 1|LDL < 50 mg/dL|1|||
162838972|NCT00271817|588119217|FG001|Part 1|LDL < 50 mg/dL|4|||
162838973|NCT00271817|588119218|FG002|Part 1|LDL < 50 mg/dL|48|||
162838974|NCT00271817|588119216|FG000|Part 2|Adverse Event|0|||
162838975|NCT00271817|588119217|FG001|Part 2|Adverse Event|17|||
162838976|NCT00271817|588119218|FG002|Part 2|Adverse Event|33|||
162838977|NCT00271817|588119216|FG000|Part 2|Lack of Efficacy|0|||
162838978|NCT00271817|588119217|FG001|Part 2|Lack of Efficacy|1|||
162838979|NCT00271817|588119218|FG002|Part 2|Lack of Efficacy|6|||
162838980|NCT00271817|588119216|FG000|Part 2|Lost to Follow-up|0|||
162838981|NCT00271817|588119217|FG001|Part 2|Lost to Follow-up|6|||
162838982|NCT00271817|588119218|FG002|Part 2|Lost to Follow-up|18|||
162948934|NCT02817841|588516901|FG000|Overall Study|Other reasons|53|||
162948935|NCT02817841|588516901|FG000|Overall Study|Protocol Violation|94|||
162838983|NCT00271817|588119216|FG000|Part 2|Protocol Violation|0|||
162838984|NCT00271817|588119217|FG001|Part 2|Protocol Violation|3|||
162838985|NCT00271817|588119218|FG002|Part 2|Protocol Violation|5|||
162838986|NCT00271817|588119216|FG000|Part 2|Patient Moved|0|||
162838987|NCT00271817|588119217|FG001|Part 2|Patient Moved|0|||
162948936|NCT00705536|588516902|FG000|Start Period 1|Withdrawal by Subject|0|||
162948937|NCT00705536|588516903|FG001|Start Period 1|Withdrawal by Subject|0|||
162838988|NCT00271817|588119218|FG002|Part 2|Patient Moved|5|||
162838989|NCT00271817|588119216|FG000|Part 2|Withdrawal by Subject|0|||
162838990|NCT00271817|588119217|FG001|Part 2|Withdrawal by Subject|2|||
162838991|NCT00271817|588119218|FG002|Part 2|Withdrawal by Subject|13|||
162838992|NCT00271817|588119216|FG000|Part 2|LDL < 50 mg/dL|0|||
162838993|NCT00271817|588119217|FG001|Part 2|LDL < 50 mg/dL|3|||
162838994|NCT00271817|588119218|FG002|Part 2|LDL < 50 mg/dL|4|||
162838995|NCT01471782|588119222|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
162838996|NCT01471782|588119223|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
162838997|NCT01471782|588119224|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
162838998|NCT01471782|588119225|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
162838999|NCT01471782|588119226|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
162839000|NCT01471782|588119227|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
162839001|NCT01471782|588119222|FG000|Overall Study|Lack of Efficacy|1|||
162839002|NCT01471782|588119223|FG001|Overall Study|Lack of Efficacy|2|||
162839003|NCT01471782|588119224|FG002|Overall Study|Lack of Efficacy|1|||
162839004|NCT01471782|588119225|FG003|Overall Study|Lack of Efficacy|1|||
162839005|NCT01471782|588119226|FG004|Overall Study|Lack of Efficacy|5|||
162839006|NCT01471782|588119227|FG005|Overall Study|Lack of Efficacy|18|||
162839007|NCT01471782|588119222|FG000|Overall Study|Adverse Event|1|||
162839008|NCT01471782|588119223|FG001|Overall Study|Adverse Event|1|||
162839009|NCT01471782|588119224|FG002|Overall Study|Adverse Event|2|||
162839010|NCT01471782|588119225|FG003|Overall Study|Adverse Event|2|||
162839011|NCT01471782|588119226|FG004|Overall Study|Adverse Event|3|||
162839012|NCT01471782|588119227|FG005|Overall Study|Adverse Event|1|||
162839013|NCT01471782|588119222|FG000|Overall Study|Other|0|||
162839014|NCT01471782|588119223|FG001|Overall Study|Other|0|||
162839015|NCT01471782|588119224|FG002|Overall Study|Other|1|||
162839016|NCT01471782|588119225|FG003|Overall Study|Other|1|||
162839017|NCT01471782|588119226|FG004|Overall Study|Other|6|||
162839018|NCT01471782|588119227|FG005|Overall Study|Other|5|||
162839019|NCT01471782|588119222|FG000|Overall Study|Change of Chemotherapy|1|||
162839020|NCT01471782|588119223|FG001|Overall Study|Change of Chemotherapy|1|||
162839021|NCT01471782|588119224|FG002|Overall Study|Change of Chemotherapy|0|||
162839022|NCT01471782|588119225|FG003|Overall Study|Change of Chemotherapy|0|||
162839023|NCT01471782|588119226|FG004|Overall Study|Change of Chemotherapy|1|||
162839024|NCT01471782|588119227|FG005|Overall Study|Change of Chemotherapy|4|||
162839025|NCT01471782|588119222|FG000|Overall Study|Disease Relapse|0|||
162839026|NCT01471782|588119223|FG001|Overall Study|Disease Relapse|0|||
162839027|NCT01471782|588119224|FG002|Overall Study|Disease Relapse|0|||
162839028|NCT01471782|588119225|FG003|Overall Study|Disease Relapse|1|||
162839029|NCT01471782|588119226|FG004|Overall Study|Disease Relapse|2|||
162839030|NCT01471782|588119227|FG005|Overall Study|Disease Relapse|1|||
162839031|NCT01471782|588119222|FG000|Overall Study|Physician Decision|0|||
162839032|NCT01471782|588119223|FG001|Overall Study|Physician Decision|0|||
162839033|NCT01471782|588119224|FG002|Overall Study|Physician Decision|0|||
162839034|NCT01471782|588119225|FG003|Overall Study|Physician Decision|0|||
162839035|NCT01471782|588119226|FG004|Overall Study|Physician Decision|3|||
162839036|NCT01471782|588119227|FG005|Overall Study|Physician Decision|8|||
162839037|NCT01471782|588119222|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162839038|NCT01471782|588119223|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162839039|NCT01471782|588119224|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162839040|NCT01471782|588119225|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162839041|NCT01471782|588119226|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
162839042|NCT01471782|588119227|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162839043|NCT01471782|588119222|FG000|Overall Study|Death|0|||
162839044|NCT01471782|588119223|FG001|Overall Study|Death|0|||
162839045|NCT01471782|588119224|FG002|Overall Study|Death|0|||
162839046|NCT01471782|588119225|FG003|Overall Study|Death|0|||
162839047|NCT01471782|588119226|FG004|Overall Study|Death|0|||
162839048|NCT01471782|588119227|FG005|Overall Study|Death|1|||
162839049|NCT00936208|588119228|FG000|Overall Study|Protocol Violation|37|||
162839050|NCT00936208|588119229|FG001|Overall Study|Protocol Violation|22|||
162839051|NCT04428424|588119230|FG000|Overall Study|Does not meet entrance criteria|132|||
162839052|NCT04428424|588119230|FG000|Overall Study|Lost to Follow-up|115|||
162839053|NCT01411085|588119231|FG000|Overall Study|Physician Decision|1|||
162839054|NCT01411085|588119231|FG000|Overall Study|Protocol Violation|1|||
162839055|NCT01411085|588119231|FG000|Overall Study|Adverse Event|1|||
162839056|NCT01564862|588119232|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
162839057|NCT01564862|588119233|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
162839058|NCT01564862|588119234|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
162839059|NCT01564862|588119232|FG000|Overall Study|Major Protocol Deviation|3|||
162839060|NCT01564862|588119233|FG001|Overall Study|Major Protocol Deviation|3|||
162839061|NCT01564862|588119234|FG002|Overall Study|Major Protocol Deviation|4|||
162839062|NCT01564862|588119232|FG000|Overall Study|Lost to Follow-up|10|||
162839063|NCT01564862|588119233|FG001|Overall Study|Lost to Follow-up|8|||
162839064|NCT01564862|588119234|FG002|Overall Study|Lost to Follow-up|6|||
162839065|NCT01564862|588119232|FG000|Overall Study|Voluntary Withdrawal|9|||
162839066|NCT01564862|588119233|FG001|Overall Study|Voluntary Withdrawal|6|||
162839067|NCT01564862|588119234|FG002|Overall Study|Voluntary Withdrawal|8|||
162839068|NCT01564862|588119232|FG000|Overall Study|Lack of Efficacy|1|||
162839069|NCT01564862|588119233|FG001|Overall Study|Lack of Efficacy|5|||
162839070|NCT01564862|588119234|FG002|Overall Study|Lack of Efficacy|6|||
162948938|NCT00705536|588516904|FG002|Start Period 1|Withdrawal by Subject|0|||
162948939|NCT00705536|588516905|FG003|Start Period 1|Withdrawal by Subject|1|||
162948940|NCT04188106|588516906|FG000|Overall Study|Lost to Follow-up|5|||
162948941|NCT04188106|588516906|FG000|Overall Study|Non-Compliance|1|||
162700055|NCT02471404|587612487|FG000|Overall Study|Protocol Violation|1|||
162700056|NCT02471404|587612488|FG001|Overall Study|Protocol Violation|0|||
162700057|NCT02471404|587612489|FG002|Overall Study|Protocol Violation|0|||
162839071|NCT01564862|588119232|FG000|Overall Study|Other reason(s)|1|||
162839072|NCT01564862|588119233|FG001|Overall Study|Other reason(s)|0|||
162839073|NCT01564862|588119234|FG002|Overall Study|Other reason(s)|0|||
162839074|NCT03809611|588119235|FG000|Overall Study|Withdrawal by Subject|1|||
162839075|NCT03809611|588119236|FG001|Overall Study|Withdrawal by Subject|1|||
162839076|NCT02193074|588119239|FG000|Overall Study|Withdrawal by Subject|1|||
162839077|NCT02193074|588119240|FG001|Overall Study|Withdrawal by Subject|2|||
162839078|NCT02193074|588119239|FG000|Overall Study|Adverse Event|16|||
162839079|NCT02193074|588119240|FG001|Overall Study|Adverse Event|13|||
162839080|NCT03124563|588119242|FG000|Overall Study|Lost to Follow-up|1|||
162839081|NCT03124563|588119243|FG001|Overall Study|Lost to Follow-up|1|||
162839082|NCT03124563|588119242|FG000|Overall Study|Withdrawal by Subject|1|||
162839083|NCT03124563|588119243|FG001|Overall Study|Withdrawal by Subject|1|||
162839084|NCT04745689|588119244|FG000|Overall Study|Death|9|||
162839085|NCT04745689|588119245|FG001|Overall Study|Death|6|||
162839086|NCT04745689|588119244|FG000|Overall Study|Lost to Follow-up|1|||
162839087|NCT04745689|588119245|FG001|Overall Study|Lost to Follow-up|0|||
162839088|NCT04745689|588119244|FG000|Overall Study|Withdrawal by Subject|2|||
162839089|NCT04745689|588119245|FG001|Overall Study|Withdrawal by Subject|0|||
162839090|NCT04745689|588119244|FG000|Overall Study|Study terminated by sponsor|10|||
162839091|NCT04745689|588119245|FG001|Overall Study|Study terminated by sponsor|3|||
162839092|NCT02396589|588119248|FG000|Intervention|Lost to Follow-up|1|||
162839093|NCT02396589|588119249|FG001|Intervention|Lost to Follow-up|0|||
162839094|NCT02396589|588119248|FG000|6 Month Follow-up|change in health status|0|||
162839095|NCT02396589|588119249|FG001|6 Month Follow-up|change in health status|1|||
162839096|NCT02396589|588119248|FG000|9 Month Follow-up|Death|0|||
162839097|NCT02396589|588119249|FG001|9 Month Follow-up|Death|1|||
162839098|NCT02396589|588119248|FG000|12 Month Follow up|Lost to Follow-up|0|||
162839099|NCT02396589|588119249|FG001|12 Month Follow up|Lost to Follow-up|2|||
162839100|NCT04381650|588119250|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839101|NCT04381650|588119251|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839102|NCT04381650|588119252|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839103|NCT04381650|588119253|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
162839104|NCT04381650|588119254|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839105|NCT04381650|588119255|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839106|NCT04381650|588119256|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839107|NCT04381650|588119257|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839108|NCT04381650|588119258|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839109|NCT04381650|588119259|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839110|NCT04381650|588119260|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
162839111|NCT04381650|588119250|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839112|NCT04381650|588119251|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839113|NCT04381650|588119252|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839114|NCT04381650|588119253|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
162839115|NCT04381650|588119254|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839116|NCT04381650|588119255|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839117|NCT04381650|588119256|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839118|NCT04381650|588119257|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839119|NCT04381650|588119258|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839120|NCT04381650|588119259|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839121|NCT04381650|588119260|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
162839122|NCT04381650|588119250|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
162839123|NCT04381650|588119251|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
162839124|NCT04381650|588119252|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
162839125|NCT04381650|588119253|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
162839126|NCT04381650|588119254|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839127|NCT04381650|588119255|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839128|NCT04381650|588119256|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839129|NCT04381650|588119257|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839130|NCT04381650|588119258|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162700058|NCT02471404|587612487|FG000|Overall Study|Withdrawal by Subject|8|||
162839131|NCT04381650|588119259|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839132|NCT04381650|588119260|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
162839133|NCT04381650|588119250|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839134|NCT04381650|588119251|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839135|NCT04381650|588119252|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
162948942|NCT02289963|588516907|FG000|Overall Study|Adverse Event|1|||
162839136|NCT04381650|588119253|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
162839137|NCT04381650|588119254|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839138|NCT04381650|588119255|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839139|NCT04381650|588119256|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839140|NCT04381650|588119257|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839141|NCT04381650|588119258|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839142|NCT04381650|588119259|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839143|NCT04381650|588119260|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
162839144|NCT04381650|588119250|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839145|NCT04381650|588119251|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
162839146|NCT04381650|588119252|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
162839147|NCT04381650|588119253|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
162839148|NCT04381650|588119254|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839149|NCT04381650|588119255|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839150|NCT04381650|588119256|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839151|NCT04381650|588119257|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839152|NCT04381650|588119258|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839153|NCT04381650|588119259|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839154|NCT04381650|588119260|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
162839155|NCT04381650|588119250|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839156|NCT04381650|588119251|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839157|NCT04381650|588119252|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839158|NCT04381650|588119253|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839159|NCT04381650|588119254|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
162839160|NCT04381650|588119255|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
162839161|NCT04381650|588119256|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839162|NCT04381650|588119257|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839163|NCT04381650|588119258|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839164|NCT04381650|588119259|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
162839165|NCT04381650|588119260|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
162839166|NCT04381650|588119250|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839167|NCT04381650|588119251|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839168|NCT04381650|588119252|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839169|NCT04381650|588119253|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839170|NCT04381650|588119254|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839171|NCT04381650|588119255|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839172|NCT04381650|588119256|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839173|NCT04381650|588119257|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162839174|NCT04381650|588119258|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162839175|NCT04381650|588119259|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162839176|NCT04381650|588119260|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162839177|NCT04381650|588119250|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
162839178|NCT04381650|588119251|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
162839179|NCT04381650|588119252|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
162839180|NCT04381650|588119253|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
162839181|NCT04381650|588119254|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
162839182|NCT04381650|588119255|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
162839183|NCT04381650|588119256|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
162839184|NCT04381650|588119257|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
162839185|NCT04381650|588119258|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
162839186|NCT04381650|588119259|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
162839187|NCT04381650|588119260|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
162839188|NCT04381650|588119250|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
162839189|NCT04381650|588119251|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
162839190|NCT04381650|588119252|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
162839191|NCT04381650|588119253|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
162839192|NCT04381650|588119254|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
162839193|NCT04381650|588119255|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
162839194|NCT04381650|588119256|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
162839195|NCT04381650|588119257|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
162839196|NCT04381650|588119258|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
162839197|NCT04381650|588119259|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
162839198|NCT04381650|588119260|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
162839199|NCT04381650|588119250|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839200|NCT04381650|588119251|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839201|NCT04381650|588119252|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839202|NCT04381650|588119253|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162700059|NCT02471404|587612488|FG001|Overall Study|Withdrawal by Subject|4|||
162700060|NCT02471404|587612489|FG002|Overall Study|Withdrawal by Subject|5|||
162700061|NCT02471404|587612487|FG000|Overall Study|Other reasons not specified|10|||
162700062|NCT02471404|587612488|FG001|Overall Study|Other reasons not specified|7|||
162700063|NCT02471404|587612489|FG002|Overall Study|Other reasons not specified|12|||
162700064|NCT02204293|587612490|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
162700065|NCT02204293|587612491|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
162700066|NCT02204293|587612492|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
162700067|NCT02204293|587612493|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
162700068|NCT02204293|587612494|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
162700069|NCT02204293|587612495|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
162700070|NCT02204293|587612490|FG000|Core Study Part I|Adverse Event|1|||
162700071|NCT02204293|587612491|FG001|Core Study Part I|Adverse Event|0|||
162700072|NCT02204293|587612492|FG002|Core Study Part I|Adverse Event|0|||
162700073|NCT02204293|587612493|FG003|Core Study Part I|Adverse Event|0|||
162700074|NCT02204293|587612494|FG004|Core Study Part I|Adverse Event|0|||
162700075|NCT02204293|587612495|FG005|Core Study Part I|Adverse Event|0|||
162700076|NCT02204293|587612490|FG000|Core Study Part I|Physician Decision|0|||
162700077|NCT02204293|587612491|FG001|Core Study Part I|Physician Decision|3|||
162700078|NCT02204293|587612492|FG002|Core Study Part I|Physician Decision|0|||
162700079|NCT02204293|587612493|FG003|Core Study Part I|Physician Decision|0|||
162700080|NCT02204293|587612494|FG004|Core Study Part I|Physician Decision|0|||
162700081|NCT02204293|587612495|FG005|Core Study Part I|Physician Decision|0|||
162700082|NCT02204293|587612490|FG000|LTE Phase|Study Suspended|0|||
162700083|NCT02204293|587612491|FG001|LTE Phase|Study Suspended|0|||
162700084|NCT02204293|587612492|FG002|LTE Phase|Study Suspended|0|||
162700085|NCT02204293|587612493|FG003|LTE Phase|Study Suspended|0|||
162700086|NCT02204293|587612494|FG004|LTE Phase|Study Suspended|0|||
162700087|NCT02204293|587612495|FG005|LTE Phase|Study Suspended|7|||
162700088|NCT03051659|587612496|FG000|Treatment Period|Withdrawal by Subject|0|||
162700089|NCT03051659|587612497|FG001|Treatment Period|Withdrawal by Subject|2|||
162700090|NCT03051659|587612496|FG000|Survival Follow-up|Lost to Follow-up|23|||
162700091|NCT03051659|587612497|FG001|Survival Follow-up|Lost to Follow-up|22|||
162700092|NCT04779242|587612498|FG000|Overall Study|Adverse Event|1|||
162700093|NCT04779242|587612499|FG001|Overall Study|Adverse Event|1|||
162700094|NCT04779242|587612498|FG000|Overall Study|Lost to Follow-up|2|||
162700095|NCT04779242|587612499|FG001|Overall Study|Lost to Follow-up|4|||
162700096|NCT04779242|587612498|FG000|Overall Study|Withdrawal by Subject|7|||
162700097|NCT04779242|587612499|FG001|Overall Study|Withdrawal by Subject|9|||
162839203|NCT04381650|588119254|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839204|NCT04381650|588119255|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839205|NCT04381650|588119256|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839206|NCT04381650|588119257|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
162839207|NCT04381650|588119258|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839208|NCT04381650|588119259|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839209|NCT04381650|588119260|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
162839210|NCT05593016|588120952|FG000|Overall Study|Death|1|||
162839211|NCT05593016|588120953|FG001|Overall Study|Death|1|||
162839212|NCT05593016|588120954|FG002|Overall Study|Death|1|||
162839213|NCT05593016|588120955|FG003|Overall Study|Death|0|||
162839214|NCT05593016|588120956|FG004|Overall Study|Death|0|||
162839215|NCT05593016|588120952|FG000|Overall Study|Lost to Follow-up|1|||
162839216|NCT05593016|588120953|FG001|Overall Study|Lost to Follow-up|1|||
162839217|NCT05593016|588120954|FG002|Overall Study|Lost to Follow-up|1|||
162839218|NCT05593016|588120955|FG003|Overall Study|Lost to Follow-up|2|||
162839219|NCT05593016|588120956|FG004|Overall Study|Lost to Follow-up|0|||
162839220|NCT05416138|588120957|FG000|Overall Study|Withdrawal by Subject|2|||
162839221|NCT05416138|588120958|FG001|Overall Study|Withdrawal by Subject|1|||
162839222|NCT04705051|588120959|FG000|Overall Study|Enrolled but not treated|1|||
162839223|NCT04705051|588120959|FG000|Overall Study|Study terminated by sponsor|23|||
162839224|NCT03686397|588120960|FG000|Overall Study|Lack of Efficacy|3|||
162839225|NCT03686397|588120961|FG001|Overall Study|Lack of Efficacy|5|||
162839226|NCT03686397|588120960|FG000|Overall Study|Adverse Event|0|||
162839227|NCT03686397|588120961|FG001|Overall Study|Adverse Event|1|||
162839228|NCT03686397|588120960|FG000|Overall Study|Protocol Violation|0|||
162839229|NCT03686397|588120961|FG001|Overall Study|Protocol Violation|1|||
162839230|NCT03686397|588120960|FG000|Overall Study|Withdrawal by Subject|0|||
162839231|NCT03686397|588120961|FG001|Overall Study|Withdrawal by Subject|1|||
162839232|NCT03686397|588120960|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
162839233|NCT03686397|588120961|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
162839234|NCT03160560|588120964|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
162839235|NCT03160560|588120965|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162839236|NCT03160560|588120966|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162839237|NCT03160560|588120967|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
162700098|NCT04779242|587612498|FG000|Overall Study|Death|6|||
162700099|NCT04779242|587612499|FG001|Overall Study|Death|6|||
162700100|NCT04779242|587612498|FG000|Overall Study|COVID-19 related reasons|2|||
162700101|NCT04779242|587612499|FG001|Overall Study|COVID-19 related reasons|1|||
162700102|NCT04779242|587612498|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
162700103|NCT04779242|587612499|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
162700104|NCT04779242|587612498|FG000|Overall Study|Martial Law in Ukraine|2|||
162700105|NCT04779242|587612499|FG001|Overall Study|Martial Law in Ukraine|3|||
162700106|NCT00849680|587612502|FG000|Overall Study|Adverse Event|0|||
162700107|NCT00849680|587612503|FG001|Overall Study|Adverse Event|0|||
162700108|NCT00849680|587612504|FG002|Overall Study|Adverse Event|0|||
162700109|NCT00849680|587612505|FG003|Overall Study|Adverse Event|0|||
162700110|NCT00849680|587612506|FG004|Overall Study|Adverse Event|0|||
162700111|NCT00849680|587612507|FG005|Overall Study|Adverse Event|0|||
162700112|NCT00849680|587612508|FG006|Overall Study|Adverse Event|2|||
162700113|NCT00849680|587612509|FG007|Overall Study|Adverse Event|0|||
162700114|NCT00849680|587612502|FG000|Overall Study|Lost to Follow-up|7|||
162700115|NCT00849680|587612503|FG001|Overall Study|Lost to Follow-up|3|||
162700116|NCT00849680|587612504|FG002|Overall Study|Lost to Follow-up|12|||
162839238|NCT03160560|588120964|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
162839239|NCT03160560|588120965|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
162839240|NCT03160560|588120966|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
162839241|NCT03160560|588120967|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
162839242|NCT02814565|588120975|FG000|Overall Study|Lack of Efficacy|0|||
162839243|NCT02814565|588120976|FG001|Overall Study|Lack of Efficacy|1|||
162839244|NCT02814565|588120975|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
162839245|NCT02814565|588120976|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
162839246|NCT05587296|588120979|FG000|Overall Study|Adverse Event|15|||
162839247|NCT05587296|588120980|FG001|Overall Study|Adverse Event|7|||
162839248|NCT05587296|588120979|FG000|Overall Study|Lack of Efficacy|2|||
162839249|NCT05587296|588120980|FG001|Overall Study|Lack of Efficacy|0|||
162839250|NCT05587296|588120979|FG000|Overall Study|Lost to Follow-up|1|||
162839251|NCT05587296|588120980|FG001|Overall Study|Lost to Follow-up|0|||
162839252|NCT05587296|588120979|FG000|Overall Study|Withdrawal by Subject|14|||
162839253|NCT05587296|588120980|FG001|Overall Study|Withdrawal by Subject|4|||
162839254|NCT05587296|588120979|FG000|Overall Study|miscellaneous|3|||
162839255|NCT05587296|588120980|FG001|Overall Study|miscellaneous|6|||
162839256|NCT05587296|588120979|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
162839257|NCT05587296|588120980|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
162839258|NCT02847624|588120983|FG000|Overall Study|Lost to Follow-up|28|||
162839259|NCT02847624|588120983|FG000|Overall Study|Protocol Violation|98|||
162839260|NCT02847624|588120983|FG000|Overall Study|Case report failures|4|||
162839261|NCT04735653|588120984|FG000|Overall Study|Lost to Follow-up|17|||
162839262|NCT04735653|588120985|FG001|Overall Study|Lost to Follow-up|7|||
162839263|NCT04735653|588120984|FG000|Overall Study|Withdrawal by Subject|8|||
162839264|NCT04735653|588120985|FG001|Overall Study|Withdrawal by Subject|2|||
162839265|NCT04735653|588120984|FG000|Overall Study|Death|0|||
162839266|NCT04735653|588120985|FG001|Overall Study|Death|2|||
162839267|NCT04735653|588120984|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
162839268|NCT04735653|588120985|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
162839269|NCT00608985|588121000|FG000|Overall Study|Adverse Event|2|||
162839270|NCT00608985|588121001|FG001|Overall Study|Adverse Event|7|||
162839271|NCT00608985|588121002|FG002|Overall Study|Adverse Event|4|||
162839272|NCT00608985|588121003|FG003|Overall Study|Adverse Event|6|||
162839273|NCT00608985|588121000|FG000|Overall Study|Administrative/Other|7|||
162839274|NCT00608985|588121001|FG001|Overall Study|Administrative/Other|4|||
162839275|NCT00608985|588121002|FG002|Overall Study|Administrative/Other|1|||
162839276|NCT00608985|588121003|FG003|Overall Study|Administrative/Other|2|||
162839277|NCT00608985|588121000|FG000|Overall Study|Withdrawal of Consent|5|||
162839278|NCT00608985|588121001|FG001|Overall Study|Withdrawal of Consent|1|||
162839279|NCT00608985|588121002|FG002|Overall Study|Withdrawal of Consent|1|||
162839280|NCT00608985|588121003|FG003|Overall Study|Withdrawal of Consent|1|||
162839281|NCT00608985|588121000|FG000|Overall Study|Lost to Follow-up|2|||
162839282|NCT00608985|588121001|FG001|Overall Study|Lost to Follow-up|1|||
162839283|NCT00608985|588121002|FG002|Overall Study|Lost to Follow-up|0|||
162839284|NCT00608985|588121003|FG003|Overall Study|Lost to Follow-up|0|||
162839285|NCT00706030|588121004|FG000|Overall Study|Disease Progression|4|||
162839286|NCT00706030|588121005|FG001|Overall Study|Disease Progression|6|||
162839287|NCT00706030|588121006|FG002|Overall Study|Disease Progression|46|||
162839288|NCT00706030|588121007|FG003|Overall Study|Disease Progression|12|||
162839289|NCT00706030|588121004|FG000|Overall Study|Adverse Event|1|||
162839290|NCT00706030|588121005|FG001|Overall Study|Adverse Event|0|||
162839291|NCT00706030|588121006|FG002|Overall Study|Adverse Event|4|||
162839292|NCT00706030|588121007|FG003|Overall Study|Adverse Event|2|||
162839293|NCT00706030|588121004|FG000|Overall Study|Withdrawal by Subject|1|||
162839294|NCT00706030|588121005|FG001|Overall Study|Withdrawal by Subject|0|||
162839295|NCT00706030|588121006|FG002|Overall Study|Withdrawal by Subject|2|||
162839296|NCT00706030|588121007|FG003|Overall Study|Withdrawal by Subject|0|||
162839297|NCT00706030|588121004|FG000|Overall Study|Physician Decision|0|||
162839298|NCT00706030|588121005|FG001|Overall Study|Physician Decision|0|||
162839299|NCT00706030|588121006|FG002|Overall Study|Physician Decision|2|||
162839300|NCT00706030|588121007|FG003|Overall Study|Physician Decision|0|||
162839301|NCT00706030|588121004|FG000|Overall Study|Not recorded|0|||
162839302|NCT00706030|588121005|FG001|Overall Study|Not recorded|0|||
162839303|NCT00706030|588121006|FG002|Overall Study|Not recorded|2|||
162839304|NCT00706030|588121007|FG003|Overall Study|Not recorded|0|||
162839305|NCT00706030|588121004|FG000|Overall Study|Protocol Violation|0|||
162839306|NCT00706030|588121005|FG001|Overall Study|Protocol Violation|0|||
162839307|NCT00706030|588121006|FG002|Overall Study|Protocol Violation|1|||
162839308|NCT00706030|588121007|FG003|Overall Study|Protocol Violation|1|||
162839309|NCT00706030|588121004|FG000|Overall Study|Failed to return|0|||
162839310|NCT00706030|588121005|FG001|Overall Study|Failed to return|0|||
162839311|NCT00706030|588121006|FG002|Overall Study|Failed to return|1|||
162839312|NCT00706030|588121007|FG003|Overall Study|Failed to return|0|||
162839313|NCT00706030|588121004|FG000|Overall Study|Symptomatic Deterioration|0|||
162839314|NCT00706030|588121005|FG001|Overall Study|Symptomatic Deterioration|0|||
162839315|NCT00706030|588121006|FG002|Overall Study|Symptomatic Deterioration|1|||
162839316|NCT00706030|588121007|FG003|Overall Study|Symptomatic Deterioration|0|||
162839317|NCT00706030|588121004|FG000|Overall Study|No treatment received|0|||
162839318|NCT00706030|588121005|FG001|Overall Study|No treatment received|0|||
162839319|NCT00706030|588121006|FG002|Overall Study|No treatment received|0|||
162839320|NCT00706030|588121007|FG003|Overall Study|No treatment received|1|||
162839321|NCT00706030|588121004|FG000|Overall Study|Death|0|||
162839322|NCT00706030|588121005|FG001|Overall Study|Death|0|||
162839323|NCT00706030|588121006|FG002|Overall Study|Death|1|||
162839324|NCT00706030|588121007|FG003|Overall Study|Death|0|||
162839325|NCT05779072|588121008|FG000|Overall Study|Lost to Follow-up|0|||
162839326|NCT05779072|588121009|FG001|Overall Study|Lost to Follow-up|1|||
162839327|NCT05779072|588121008|FG000|Overall Study|Withdrawal by Subject|1|||
162839328|NCT05779072|588121009|FG001|Overall Study|Withdrawal by Subject|5|||
162839329|NCT03870555|588121010|FG000|Period 3 (2 Days)|Adverse Event|1|||
162839330|NCT03870555|588121011|FG001|Period 3 (2 Days)|Adverse Event|0|||
162839331|NCT03870555|588121012|FG002|Period 3 (2 Days)|Adverse Event|0|||
162839332|NCT03847610|588121013|FG000|Overall Study|Withdrawal by Subject|1|||
162839333|NCT02004873|588121014|FG000|Overall Study|Implant unsuccessful|6|||
162839334|NCT02004873|588121014|FG000|Overall Study|Awaiting 6-month visit|390|||
162839335|NCT02004873|588121014|FG000|Overall Study|Missed 6-month visit|4|||
162839336|NCT02004873|588121014|FG000|Overall Study|Death|23|||
162839337|NCT02004873|588121014|FG000|Overall Study|Withdrawal by Subject|1|||
162839338|NCT01445769|588121016|FG000|Overall Study|Consent Withdrawn|2|||
162839339|NCT01445769|588121016|FG000|Overall Study|Disease Progression|1|||
162839340|NCT01445769|588121016|FG000|Overall Study|Lost to Follow-up|5|||
162839341|NCT00044512|588121017|FG000|Follow Up|Lost to Follow-up|2|||
162839342|NCT03440814|588121022|FG000|Overall Study|Adverse Event|2|||
162839343|NCT03440814|588121023|FG001|Overall Study|Adverse Event|1|||
162839344|NCT03440814|588121022|FG000|Overall Study|Lost to Follow-up|2|||
162839345|NCT03440814|588121023|FG001|Overall Study|Lost to Follow-up|0|||
162839346|NCT03440814|588121022|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
162839347|NCT03440814|588121023|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
162839348|NCT01437397|588121024|FG000|Overall Study|Lost to Follow-up|9|||
162839349|NCT01437397|588121025|FG001|Overall Study|Lost to Follow-up|4|||
162839350|NCT01437397|588121026|FG002|Overall Study|Lost to Follow-up|2|||
162839351|NCT01437397|588121027|FG003|Overall Study|Lost to Follow-up|4|||
162839352|NCT01437397|588121028|FG004|Overall Study|Lost to Follow-up|5|||
162839353|NCT01437397|588121024|FG000|Overall Study|Withdrawal by Subject|11|||
162839354|NCT01437397|588121025|FG001|Overall Study|Withdrawal by Subject|12|||
162839355|NCT01437397|588121026|FG002|Overall Study|Withdrawal by Subject|24|||
162839356|NCT01437397|588121027|FG003|Overall Study|Withdrawal by Subject|11|||
162839357|NCT01437397|588121028|FG004|Overall Study|Withdrawal by Subject|22|||
162839358|NCT01437397|588121024|FG000|Overall Study|Protocol Violation|10|||
162839359|NCT01437397|588121025|FG001|Overall Study|Protocol Violation|12|||
162839360|NCT01437397|588121026|FG002|Overall Study|Protocol Violation|13|||
162839361|NCT01437397|588121027|FG003|Overall Study|Protocol Violation|21|||
162839362|NCT01437397|588121028|FG004|Overall Study|Protocol Violation|19|||
162839363|NCT01437397|588121024|FG000|Overall Study|Lack of Efficacy|5|||
162839364|NCT01437397|588121025|FG001|Overall Study|Lack of Efficacy|4|||
162839365|NCT01437397|588121026|FG002|Overall Study|Lack of Efficacy|8|||
162839366|NCT01437397|588121027|FG003|Overall Study|Lack of Efficacy|10|||
162839367|NCT01437397|588121028|FG004|Overall Study|Lack of Efficacy|20|||
162839368|NCT01437397|588121024|FG000|Overall Study|Adverse Event|21|||
162948943|NCT02289963|588516908|FG001|Overall Study|Adverse Event|2|||
162839369|NCT01437397|588121025|FG001|Overall Study|Adverse Event|22|||
162839370|NCT01437397|588121026|FG002|Overall Study|Adverse Event|16|||
162839371|NCT01437397|588121027|FG003|Overall Study|Adverse Event|14|||
162839372|NCT01437397|588121028|FG004|Overall Study|Adverse Event|21|||
162839373|NCT01437397|588121024|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
162839374|NCT01437397|588121025|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
162839375|NCT01437397|588121026|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
162839376|NCT01437397|588121027|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
162839377|NCT01437397|588121028|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
162839378|NCT00866307|588121030|FG000|Induction|Adverse Event|5|||
162839379|NCT00866307|588121031|FG001|Induction|Adverse Event|0|||
162839380|NCT00866307|588121032|FG002|Induction|Adverse Event|0|||
162839381|NCT00866307|588121030|FG000|Induction|Death|2|||
162839382|NCT00866307|588121031|FG001|Induction|Death|0|||
162839383|NCT00866307|588121032|FG002|Induction|Death|0|||
162839384|NCT00866307|588121030|FG000|Induction|Physician Decision|5|||
162839385|NCT00866307|588121031|FG001|Induction|Physician Decision|0|||
162839386|NCT00866307|588121032|FG002|Induction|Physician Decision|0|||
162839387|NCT00866307|588121030|FG000|Induction|Progressive Disease|1|||
162839388|NCT00866307|588121031|FG001|Induction|Progressive Disease|0|||
162839389|NCT00866307|588121032|FG002|Induction|Progressive Disease|0|||
162839390|NCT00866307|588121030|FG000|Induction|Identification of Patients with Day 29 M|3|||
162839391|NCT00866307|588121031|FG001|Induction|Identification of Patients with Day 29 M|0|||
162839392|NCT00866307|588121032|FG002|Induction|Identification of Patients with Day 29 M|0|||
162839393|NCT00866307|588121030|FG000|Induction|Inadequate cytognetic samples th|1|||
162839394|NCT00866307|588121031|FG001|Induction|Inadequate cytognetic samples th|0|||
162839395|NCT00866307|588121032|FG002|Induction|Inadequate cytognetic samples th|0|||
162839396|NCT00866307|588121030|FG000|Induction|Improper post-induction consent|2|||
162839397|NCT00866307|588121031|FG001|Induction|Improper post-induction consent|0|||
162839398|NCT00866307|588121032|FG002|Induction|Improper post-induction consent|0|||
162839399|NCT00866307|588121030|FG000|Induction|Study was closed at the time|1|||
162839400|NCT00866307|588121031|FG001|Induction|Study was closed at the time|0|||
162839401|NCT00866307|588121032|FG002|Induction|Study was closed at the time|0|||
162839402|NCT00866307|588121030|FG000|Consolidation/Maintenance|Adverse Event|0|||
162839403|NCT00866307|588121031|FG001|Consolidation/Maintenance|Adverse Event|0|||
162839404|NCT00866307|588121032|FG002|Consolidation/Maintenance|Adverse Event|8|||
162839405|NCT00866307|588121030|FG000|Consolidation/Maintenance|Death|0|||
162839406|NCT00866307|588121031|FG001|Consolidation/Maintenance|Death|0|||
162839407|NCT00866307|588121032|FG002|Consolidation/Maintenance|Death|1|||
162839408|NCT00866307|588121030|FG000|Consolidation/Maintenance|Physician Decision|0|||
162839409|NCT00866307|588121031|FG001|Consolidation/Maintenance|Physician Decision|3|||
162839410|NCT00866307|588121032|FG002|Consolidation/Maintenance|Physician Decision|2|||
162839411|NCT00866307|588121030|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
162839412|NCT00866307|588121031|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
162839413|NCT00866307|588121032|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
162839414|NCT00866307|588121030|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
162839415|NCT00866307|588121031|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
162839416|NCT00866307|588121032|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
162839417|NCT00866307|588121030|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
162839418|NCT00866307|588121031|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
162839419|NCT00866307|588121032|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
162839420|NCT00866307|588121030|FG000|Consolidation/Maintenance|Therapy error|0|||
162839421|NCT00866307|588121031|FG001|Consolidation/Maintenance|Therapy error|1|||
162839422|NCT00866307|588121032|FG002|Consolidation/Maintenance|Therapy error|0|||
162839423|NCT00866307|588121030|FG000|Consolidation/Maintenance|Non-compliance|0|||
162839424|NCT00866307|588121031|FG001|Consolidation/Maintenance|Non-compliance|0|||
162839425|NCT00866307|588121032|FG002|Consolidation/Maintenance|Non-compliance|1|||
162839426|NCT00866307|588121030|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
162839427|NCT00866307|588121031|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
162839428|NCT00866307|588121032|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
162839429|NCT02573155|588121035|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
162839430|NCT02573155|588121036|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
162839431|NCT02573155|588121035|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
162839432|NCT02573155|588121036|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
162839433|NCT02573155|588121035|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
162839434|NCT02573155|588121036|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
162839435|NCT02573155|588121035|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
162839436|NCT02573155|588121036|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
162839437|NCT02573155|588121035|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
162839438|NCT02573155|588121036|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
162839439|NCT02573155|588121035|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
162839440|NCT02573155|588121036|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
162839441|NCT02573155|588121035|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
162839442|NCT02573155|588121036|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
162839443|NCT02573155|588121035|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
162839444|NCT02573155|588121036|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
162839445|NCT01681433|588121037|FG000|Overall Study|Lack of Efficacy|23|||
162839446|NCT01681433|588121038|FG001|Overall Study|Lack of Efficacy|23|||
162839447|NCT01681433|588121037|FG000|Overall Study|Withdrawal by Subject|5|||
162839448|NCT01681433|588121038|FG001|Overall Study|Withdrawal by Subject|5|||
162839449|NCT01681433|588121037|FG000|Overall Study|Protocol Violation|2|||
162839450|NCT01681433|588121038|FG001|Overall Study|Protocol Violation|0|||
162839451|NCT01681433|588121037|FG000|Overall Study|Adverse Event|2|||
162839452|NCT01681433|588121038|FG001|Overall Study|Adverse Event|4|||
162839453|NCT01681433|588121037|FG000|Overall Study|Lost to Follow-up|0|||
162839454|NCT01681433|588121038|FG001|Overall Study|Lost to Follow-up|1|||
162839455|NCT00903929|588121039|FG000|Overall Study|Withdrawal by Subject|0|||
162839456|NCT00903929|588121040|FG001|Overall Study|Withdrawal by Subject|0|||
162839457|NCT00903929|588121041|FG002|Overall Study|Withdrawal by Subject|1|||
162839458|NCT00903929|588121042|FG003|Overall Study|Withdrawal by Subject|2|||
162839459|NCT00903929|588121039|FG000|Overall Study|Adverse Event|0|||
162839460|NCT00903929|588121040|FG001|Overall Study|Adverse Event|0|||
162839461|NCT00903929|588121041|FG002|Overall Study|Adverse Event|0|||
162839462|NCT00903929|588121042|FG003|Overall Study|Adverse Event|1|||
162839463|NCT04947800|588121046|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
162839464|NCT04947800|588121047|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
162839465|NCT04947800|588121048|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
162839466|NCT02158091|588121049|FG000|Overall Study|DLT|2|||
162839467|NCT02158091|588121050|FG001|Overall Study|DLT|1|||
162839468|NCT02158091|588121051|FG002|Overall Study|DLT|0|||
162839469|NCT01358864|588121056|FG000|Overall Study|Adverse Event|0|||
162839470|NCT01358864|588121057|FG001|Overall Study|Adverse Event|6|||
162839471|NCT01358864|588121058|FG002|Overall Study|Adverse Event|9|||
162839472|NCT01358864|588121059|FG003|Overall Study|Adverse Event|0|||
162839473|NCT01358864|588121060|FG004|Overall Study|Adverse Event|4|||
162839474|NCT01358864|588121061|FG005|Overall Study|Adverse Event|8|||
162839475|NCT01358864|588121062|FG006|Overall Study|Adverse Event|12|||
162839476|NCT01358864|588121063|FG007|Overall Study|Adverse Event|7|||
162839477|NCT01358864|588121056|FG000|Overall Study|Lack of Efficacy|26|||
162839478|NCT01358864|588121057|FG001|Overall Study|Lack of Efficacy|3|||
162839479|NCT01358864|588121058|FG002|Overall Study|Lack of Efficacy|4|||
162839480|NCT01358864|588121059|FG003|Overall Study|Lack of Efficacy|19|||
162839481|NCT01358864|588121060|FG004|Overall Study|Lack of Efficacy|7|||
162839482|NCT01358864|588121061|FG005|Overall Study|Lack of Efficacy|4|||
162839483|NCT01358864|588121062|FG006|Overall Study|Lack of Efficacy|49|||
162839484|NCT01358864|588121063|FG007|Overall Study|Lack of Efficacy|44|||
162839485|NCT01358864|588121056|FG000|Overall Study|Lost to Follow-up|0|||
162839486|NCT01358864|588121057|FG001|Overall Study|Lost to Follow-up|0|||
162839487|NCT01358864|588121058|FG002|Overall Study|Lost to Follow-up|1|||
162839488|NCT01358864|588121059|FG003|Overall Study|Lost to Follow-up|0|||
162948944|NCT02289963|588516907|FG000|Overall Study|Poor compliance to protocol|1|||
162948945|NCT02289963|588516908|FG001|Overall Study|Poor compliance to protocol|0|||
162948946|NCT02289963|588516907|FG000|Overall Study|Withdrawal by Subject|1|||
162948947|NCT02289963|588516908|FG001|Overall Study|Withdrawal by Subject|0|||
162948948|NCT02289963|588516907|FG000|Overall Study|Last injection missed|2|||
162948949|NCT02289963|588516908|FG001|Overall Study|Last injection missed|2|||
162948950|NCT02289963|588516907|FG000|Overall Study|End treatment visit outside visit window|0|||
162948951|NCT02289963|588516908|FG001|Overall Study|End treatment visit outside visit window|4|||
162948952|NCT02289963|588516907|FG000|Overall Study|Other than specified above|0|||
162948953|NCT02289963|588516908|FG001|Overall Study|Other than specified above|2|||
162948954|NCT01746017|588516910|FG000|Period 1|Withdrawal by Subject|0|||
162948955|NCT01746017|588516911|FG001|Period 1|Withdrawal by Subject|0|||
162948956|NCT01746017|588516912|FG002|Period 1|Withdrawal by Subject|0|||
162948957|NCT01746017|588516913|FG003|Period 1|Withdrawal by Subject|0|||
162948958|NCT01746017|588516914|FG004|Period 1|Withdrawal by Subject|0|||
162948959|NCT01746017|588516915|FG005|Period 1|Withdrawal by Subject|0|||
162948960|NCT01746017|588516916|FG006|Period 1|Withdrawal by Subject|1|||
162948961|NCT01746017|588516917|FG007|Period 1|Withdrawal by Subject|0|||
162948962|NCT01746017|588516918|FG008|Period 1|Withdrawal by Subject|0|||
162948963|NCT01746017|588516919|FG009|Period 1|Withdrawal by Subject|0|||
162948964|NCT01746017|588516920|FG010|Period 1|Withdrawal by Subject|0|||
162948965|NCT01746017|588516910|FG000|Period 3|Withdrawal by Subject|0|||
162948966|NCT01746017|588516911|FG001|Period 3|Withdrawal by Subject|0|||
162948967|NCT01746017|588516912|FG002|Period 3|Withdrawal by Subject|0|||
162948968|NCT01746017|588516913|FG003|Period 3|Withdrawal by Subject|0|||
162948969|NCT01746017|588516914|FG004|Period 3|Withdrawal by Subject|0|||
162948970|NCT01746017|588516915|FG005|Period 3|Withdrawal by Subject|1|||
162839489|NCT01358864|588121060|FG004|Overall Study|Lost to Follow-up|0|||
162839490|NCT01358864|588121061|FG005|Overall Study|Lost to Follow-up|0|||
162839491|NCT01358864|588121062|FG006|Overall Study|Lost to Follow-up|0|||
162839492|NCT01358864|588121063|FG007|Overall Study|Lost to Follow-up|1|||
162839493|NCT01358864|588121056|FG000|Overall Study|Withdrawal by Subject|3|||
162839494|NCT01358864|588121057|FG001|Overall Study|Withdrawal by Subject|4|||
162839495|NCT01358864|588121058|FG002|Overall Study|Withdrawal by Subject|2|||
162948971|NCT01746017|588516916|FG006|Period 3|Withdrawal by Subject|0|||
162948972|NCT01746017|588516917|FG007|Period 3|Withdrawal by Subject|0|||
162700117|NCT00849680|587612505|FG003|Overall Study|Lost to Follow-up|11|||
162700118|NCT00849680|587612506|FG004|Overall Study|Lost to Follow-up|8|||
162700119|NCT00849680|587612507|FG005|Overall Study|Lost to Follow-up|11|||
162700120|NCT00849680|587612508|FG006|Overall Study|Lost to Follow-up|12|||
162700121|NCT00849680|587612509|FG007|Overall Study|Lost to Follow-up|5|||
162700122|NCT00849680|587612502|FG000|Overall Study|Subject moved|1|||
162700123|NCT00849680|587612503|FG001|Overall Study|Subject moved|0|||
162700124|NCT00849680|587612504|FG002|Overall Study|Subject moved|3|||
162700125|NCT00849680|587612505|FG003|Overall Study|Subject moved|1|||
162700126|NCT00849680|587612506|FG004|Overall Study|Subject moved|0|||
162700127|NCT00849680|587612507|FG005|Overall Study|Subject moved|2|||
162700128|NCT00849680|587612508|FG006|Overall Study|Subject moved|2|||
162700129|NCT00849680|587612509|FG007|Overall Study|Subject moved|2|||
162700130|NCT00849680|587612502|FG000|Overall Study|Withdrawal by Subject|2|||
162700131|NCT00849680|587612503|FG001|Overall Study|Withdrawal by Subject|0|||
162700132|NCT00849680|587612504|FG002|Overall Study|Withdrawal by Subject|0|||
162700133|NCT00849680|587612505|FG003|Overall Study|Withdrawal by Subject|2|||
162700134|NCT00849680|587612506|FG004|Overall Study|Withdrawal by Subject|2|||
162700135|NCT00849680|587612507|FG005|Overall Study|Withdrawal by Subject|2|||
162700136|NCT00849680|587612508|FG006|Overall Study|Withdrawal by Subject|1|||
162700137|NCT00849680|587612509|FG007|Overall Study|Withdrawal by Subject|1|||
162700138|NCT00849680|587612502|FG000|Overall Study|Subject unable to comply with protocol|1|||
162700139|NCT00849680|587612503|FG001|Overall Study|Subject unable to comply with protocol|0|||
162700140|NCT00849680|587612504|FG002|Overall Study|Subject unable to comply with protocol|0|||
162700141|NCT00849680|587612505|FG003|Overall Study|Subject unable to comply with protocol|0|||
162700142|NCT00849680|587612506|FG004|Overall Study|Subject unable to comply with protocol|0|||
162700143|NCT00849680|587612507|FG005|Overall Study|Subject unable to comply with protocol|0|||
162700144|NCT00849680|587612508|FG006|Overall Study|Subject unable to comply with protocol|0|||
162700145|NCT00849680|587612509|FG007|Overall Study|Subject unable to comply with protocol|0|||
162700146|NCT02207374|587612512|FG000|Overall Study|Withdrawal by Subject|5|||
162700147|NCT02207374|587612513|FG001|Overall Study|Withdrawal by Subject|9|||
162700148|NCT02207374|587612514|FG002|Overall Study|Withdrawal by Subject|4|||
162700149|NCT02207374|587612512|FG000|Overall Study|Death|1|||
162700150|NCT02207374|587612513|FG001|Overall Study|Death|0|||
162700151|NCT02207374|587612514|FG002|Overall Study|Death|1|||
162700152|NCT02207374|587612512|FG000|Overall Study|Missing follow-up information|0|||
162700153|NCT02207374|587612513|FG001|Overall Study|Missing follow-up information|1|||
162700154|NCT02207374|587612514|FG002|Overall Study|Missing follow-up information|1|||
162700155|NCT02087150|587612515|FG000|Overall Study|Death|0|||
162700156|NCT02087150|587612516|FG001|Overall Study|Death|1|||
162700157|NCT02087150|587612517|FG002|Overall Study|Death|0|||
162700158|NCT02087150|587612515|FG000|Overall Study|Lost to Follow-up|6|||
162700159|NCT02087150|587612516|FG001|Overall Study|Lost to Follow-up|13|||
162700160|NCT02087150|587612517|FG002|Overall Study|Lost to Follow-up|7|||
162700161|NCT02087150|587612515|FG000|Overall Study|Withdrawal by Subject|2|||
162700162|NCT02087150|587612516|FG001|Overall Study|Withdrawal by Subject|5|||
162700163|NCT02087150|587612517|FG002|Overall Study|Withdrawal by Subject|3|||
162700164|NCT02087150|587612515|FG000|Overall Study|Physician Decision|0|||
162700165|NCT02087150|587612516|FG001|Overall Study|Physician Decision|1|||
162700166|NCT02087150|587612517|FG002|Overall Study|Physician Decision|0|||
162700167|NCT02087150|587612515|FG000|Overall Study|Procedure not done|1|||
162700168|NCT02087150|587612516|FG001|Overall Study|Procedure not done|13|||
162700169|NCT02087150|587612517|FG002|Overall Study|Procedure not done|0|||
162700170|NCT02087150|587612515|FG000|Overall Study|F/U not completed w/in study window|0|||
162700171|NCT02087150|587612516|FG001|Overall Study|F/U not completed w/in study window|0|||
162700172|NCT02087150|587612517|FG002|Overall Study|F/U not completed w/in study window|1|||
162700173|NCT02087150|587612515|FG000|Overall Study|Other|1|||
162700174|NCT02087150|587612516|FG001|Overall Study|Other|0|||
162700175|NCT02087150|587612517|FG002|Overall Study|Other|0|||
162700176|NCT02087150|587612515|FG000|Overall Study|Pt moved out of town|0|||
162700177|NCT02087150|587612516|FG001|Overall Study|Pt moved out of town|1|||
162700178|NCT02087150|587612517|FG002|Overall Study|Pt moved out of town|0|||
162700179|NCT00785538|587612518|FG000|Treatment Period|Adverse Event|1|||
162700180|NCT00785538|587612519|FG001|Treatment Period|Adverse Event|2|||
162700181|NCT00785538|587612520|FG002|Treatment Period|Adverse Event|2|||
162948973|NCT01746017|588516918|FG008|Period 3|Withdrawal by Subject|0|||
162700182|NCT00785538|587612521|FG003|Treatment Period|Adverse Event|0|||
162700183|NCT00785538|587612518|FG000|Treatment Period|Withdrawal by Subject|0|||
162700184|NCT00785538|587612519|FG001|Treatment Period|Withdrawal by Subject|0|||
162700185|NCT00785538|587612520|FG002|Treatment Period|Withdrawal by Subject|0|||
162700186|NCT00785538|587612521|FG003|Treatment Period|Withdrawal by Subject|1|||
162700187|NCT00683449|587612522|FG000|Overall Study|Lost to Follow-up|0|||
162700188|NCT00683449|587612523|FG001|Overall Study|Lost to Follow-up|1|||
162700189|NCT00683449|587612524|FG002|Overall Study|Lost to Follow-up|0|||
162700190|NCT00683449|587612525|FG003|Overall Study|Lost to Follow-up|0|||
162700191|NCT00683449|587612526|FG004|Overall Study|Lost to Follow-up|0|||
162700192|NCT01000376|587612532|FG000|Cycle 1 Day 1|Adverse Event|1|||
162700193|NCT01000376|587612533|FG001|Cycle 1 Day 1|Adverse Event|0|||
162700194|NCT01000376|587612532|FG000|Cycle 1 Day 1|Progressive Disease|1|||
162700195|NCT01000376|587612533|FG001|Cycle 1 Day 1|Progressive Disease|0|||
162700196|NCT00507026|587612534|FG000|Overall Study|Lack of Efficacy|6|||
162700197|NCT00507026|587612535|FG001|Overall Study|Lack of Efficacy|4|||
162700198|NCT00507026|587612536|FG002|Overall Study|Lack of Efficacy|21|||
162700199|NCT00507026|587612534|FG000|Overall Study|Withdrawal by Subject|2|||
162700200|NCT00507026|587612535|FG001|Overall Study|Withdrawal by Subject|0|||
162700201|NCT00507026|587612536|FG002|Overall Study|Withdrawal by Subject|0|||
162700202|NCT00507026|587612534|FG000|Overall Study|Investigator Decision|1|||
162700203|NCT00507026|587612535|FG001|Overall Study|Investigator Decision|0|||
162700204|NCT00507026|587612536|FG002|Overall Study|Investigator Decision|0|||
162700205|NCT00507026|587612534|FG000|Overall Study|Adverse Event|2|||
162700206|NCT00507026|587612535|FG001|Overall Study|Adverse Event|0|||
162700207|NCT00507026|587612536|FG002|Overall Study|Adverse Event|0|||
162700208|NCT00507026|587612534|FG000|Overall Study|Protocol Violation|1|||
162700209|NCT00507026|587612535|FG001|Overall Study|Protocol Violation|0|||
162700210|NCT00507026|587612536|FG002|Overall Study|Protocol Violation|0|||
162700211|NCT00507026|587612534|FG000|Overall Study|Other|1|||
162700212|NCT00507026|587612535|FG001|Overall Study|Other|0|||
162700213|NCT00507026|587612536|FG002|Overall Study|Other|0|||
162700214|NCT04230980|587612537|FG000|Overall Study|Lost to Follow-up|1|||
162700215|NCT04230980|587612538|FG001|Overall Study|Lost to Follow-up|2|||
162700216|NCT04230980|587612537|FG000|Overall Study|Adverse Event|0|||
162700217|NCT04230980|587612538|FG001|Overall Study|Adverse Event|1|||
162700218|NCT04285229|587612539|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162700219|NCT04285229|587612540|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162700220|NCT04285229|587612541|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162700221|NCT04285229|587612542|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162700222|NCT04285229|587612543|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162700223|NCT04285229|587612544|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162700224|NCT04285229|587612539|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
162700225|NCT04285229|587612540|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
162700226|NCT04285229|587612541|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
162700227|NCT04285229|587612542|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
162700228|NCT04285229|587612543|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
162700229|NCT04285229|587612544|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
162700230|NCT04285229|587612539|FG000|Extended Treatment Period|Adverse Event|0|||
162700231|NCT04285229|587612540|FG001|Extended Treatment Period|Adverse Event|0|||
162700232|NCT04285229|587612541|FG002|Extended Treatment Period|Adverse Event|0|||
162700233|NCT04285229|587612542|FG003|Extended Treatment Period|Adverse Event|1|||
162700234|NCT04285229|587612543|FG004|Extended Treatment Period|Adverse Event|0|||
162700235|NCT04285229|587612544|FG005|Extended Treatment Period|Adverse Event|0|||
162700236|NCT04285229|587612539|FG000|Extended Treatment Period|Physician Decision|0|||
162700237|NCT04285229|587612540|FG001|Extended Treatment Period|Physician Decision|0|||
162700238|NCT04285229|587612541|FG002|Extended Treatment Period|Physician Decision|1|||
162700239|NCT04285229|587612542|FG003|Extended Treatment Period|Physician Decision|0|||
162700240|NCT04285229|587612543|FG004|Extended Treatment Period|Physician Decision|0|||
162700241|NCT04285229|587612544|FG005|Extended Treatment Period|Physician Decision|0|||
162700242|NCT04285229|587612539|FG000|Follow-up Period|Adverse Event|0|||
162700243|NCT04285229|587612540|FG001|Follow-up Period|Adverse Event|0|||
162700244|NCT04285229|587612541|FG002|Follow-up Period|Adverse Event|0|||
162700245|NCT04285229|587612542|FG003|Follow-up Period|Adverse Event|0|||
162700246|NCT04285229|587612543|FG004|Follow-up Period|Adverse Event|1|||
162700247|NCT04285229|587612544|FG005|Follow-up Period|Adverse Event|4|||
162700248|NCT04285229|587612539|FG000|Follow-up Period|Withdrawal by Subject|0|||
162700249|NCT04285229|587612540|FG001|Follow-up Period|Withdrawal by Subject|0|||
162700250|NCT04285229|587612541|FG002|Follow-up Period|Withdrawal by Subject|0|||
162700251|NCT04285229|587612542|FG003|Follow-up Period|Withdrawal by Subject|0|||
162700252|NCT04285229|587612543|FG004|Follow-up Period|Withdrawal by Subject|0|||
162700253|NCT04285229|587612544|FG005|Follow-up Period|Withdrawal by Subject|5|||
162700254|NCT04285229|587612539|FG000|Follow-up Period|Covid-19|0|||
162700255|NCT04285229|587612540|FG001|Follow-up Period|Covid-19|0|||
162700256|NCT04285229|587612541|FG002|Follow-up Period|Covid-19|0|||
162700257|NCT04285229|587612542|FG003|Follow-up Period|Covid-19|0|||
162700258|NCT04285229|587612543|FG004|Follow-up Period|Covid-19|0|||
162700259|NCT04285229|587612544|FG005|Follow-up Period|Covid-19|2|||
162700260|NCT04285229|587612539|FG000|Follow-up Period|Physician Decision|0|||
162700261|NCT04285229|587612540|FG001|Follow-up Period|Physician Decision|0|||
162700262|NCT04285229|587612541|FG002|Follow-up Period|Physician Decision|0|||
162700263|NCT04285229|587612542|FG003|Follow-up Period|Physician Decision|0|||
162700264|NCT04285229|587612543|FG004|Follow-up Period|Physician Decision|0|||
162700265|NCT04285229|587612544|FG005|Follow-up Period|Physician Decision|1|||
162700266|NCT00876460|587612547|FG000|Combination Therapy Phase|Progressive disease|2|||
162700267|NCT00876460|587612548|FG001|Combination Therapy Phase|Progressive disease|3|||
162700268|NCT00876460|587612549|FG002|Combination Therapy Phase|Progressive disease|3|||
162839496|NCT01358864|588121059|FG003|Overall Study|Withdrawal by Subject|0|||
162839497|NCT01358864|588121060|FG004|Overall Study|Withdrawal by Subject|0|||
162839498|NCT01358864|588121061|FG005|Overall Study|Withdrawal by Subject|1|||
162839499|NCT01358864|588121062|FG006|Overall Study|Withdrawal by Subject|1|||
162839500|NCT01358864|588121063|FG007|Overall Study|Withdrawal by Subject|3|||
162839501|NCT01358864|588121056|FG000|Overall Study|Other reason not defined above|2|||
162839502|NCT01358864|588121057|FG001|Overall Study|Other reason not defined above|0|||
162839503|NCT01358864|588121058|FG002|Overall Study|Other reason not defined above|0|||
162839504|NCT01358864|588121059|FG003|Overall Study|Other reason not defined above|0|||
162839505|NCT01358864|588121060|FG004|Overall Study|Other reason not defined above|0|||
162839506|NCT01358864|588121061|FG005|Overall Study|Other reason not defined above|0|||
162839507|NCT01358864|588121062|FG006|Overall Study|Other reason not defined above|2|||
162839508|NCT01358864|588121063|FG007|Overall Study|Other reason not defined above|0|||
162839509|NCT01358864|588121056|FG000|Overall Study|Not treated|0|||
162839510|NCT01358864|588121057|FG001|Overall Study|Not treated|0|||
162839511|NCT01358864|588121058|FG002|Overall Study|Not treated|0|||
162839512|NCT01358864|588121059|FG003|Overall Study|Not treated|0|||
162839513|NCT01358864|588121060|FG004|Overall Study|Not treated|0|||
162839514|NCT01358864|588121061|FG005|Overall Study|Not treated|0|||
162839515|NCT01358864|588121062|FG006|Overall Study|Not treated|1|||
162839516|NCT01358864|588121063|FG007|Overall Study|Not treated|0|||
162839517|NCT04518462|588121069|FG000|Overall Study|Withdrawal by Subject|0|||
162839518|NCT04518462|588121070|FG001|Overall Study|Withdrawal by Subject|0|||
162839519|NCT04518462|588121071|FG002|Overall Study|Withdrawal by Subject|1|||
162839520|NCT04518462|588121069|FG000|Overall Study|Physician Decision|1|||
162839521|NCT04518462|588121070|FG001|Overall Study|Physician Decision|1|||
162839522|NCT04518462|588121071|FG002|Overall Study|Physician Decision|0|||
162839523|NCT01003210|588121072|FG000|Overall Study|Lost to Follow-up|1|||
162839524|NCT01003210|588121073|FG001|Overall Study|Lost to Follow-up|3|||
162839525|NCT00861744|588121076|FG000|Overall Study|Adverse Event|0|||
162839526|NCT00861744|588121077|FG001|Overall Study|Adverse Event|0|||
162839527|NCT00861744|588121078|FG002|Overall Study|Adverse Event|0|||
162839528|NCT00861744|588121079|FG003|Overall Study|Adverse Event|1|||
162839529|NCT00861744|588121076|FG000|Overall Study|Lost to Follow-up|7|||
162839530|NCT00861744|588121077|FG001|Overall Study|Lost to Follow-up|19|||
162839531|NCT00861744|588121078|FG002|Overall Study|Lost to Follow-up|17|||
162839532|NCT00861744|588121079|FG003|Overall Study|Lost to Follow-up|12|||
162839533|NCT00861744|588121076|FG000|Overall Study|Withdrawal by Subject|10|||
162839534|NCT00861744|588121077|FG001|Overall Study|Withdrawal by Subject|6|||
162839535|NCT00861744|588121078|FG002|Overall Study|Withdrawal by Subject|6|||
162839536|NCT00861744|588121079|FG003|Overall Study|Withdrawal by Subject|19|||
162839537|NCT00861744|588121076|FG000|Overall Study|Protocol Violation|0|||
162839538|NCT00861744|588121077|FG001|Overall Study|Protocol Violation|1|||
162839539|NCT00861744|588121078|FG002|Overall Study|Protocol Violation|0|||
162839540|NCT00861744|588121079|FG003|Overall Study|Protocol Violation|0|||
162839541|NCT00861744|588121076|FG000|Overall Study|Migration from study area|0|||
162839542|NCT00861744|588121077|FG001|Overall Study|Migration from study area|3|||
162839543|NCT00861744|588121078|FG002|Overall Study|Migration from study area|1|||
162839544|NCT00861744|588121079|FG003|Overall Study|Migration from study area|0|||
162839545|NCT00861744|588121076|FG000|Overall Study|Blood draws|0|||
162839546|NCT00861744|588121077|FG001|Overall Study|Blood draws|0|||
162839547|NCT00861744|588121078|FG002|Overall Study|Blood draws|0|||
162839548|NCT00861744|588121079|FG003|Overall Study|Blood draws|1|||
162839549|NCT05568888|588121080|FG000|Overall Study|Physician Decision|1|||
162839550|NCT05568888|588121081|FG001|Overall Study|Physician Decision|0|||
162839551|NCT05568888|588121080|FG000|Overall Study|Protocol Deviation|2|||
162839552|NCT05568888|588121081|FG001|Overall Study|Protocol Deviation|1|||
162839553|NCT05568888|588121080|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
162839554|NCT05568888|588121081|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
162839555|NCT05568888|588121080|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
162839556|NCT05568888|588121081|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
162948974|NCT01746017|588516919|FG009|Period 3|Withdrawal by Subject|0|||
162948975|NCT01746017|588516920|FG010|Period 3|Withdrawal by Subject|0|||
162839557|NCT05568888|588121080|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
162839558|NCT05568888|588121081|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
162839559|NCT05036083|588121089|FG000|Overall Study|Physician Decision|1|||
162839560|NCT05036083|588121089|FG000|Overall Study|Withdrawal by Subject|1|||
162839561|NCT05036083|588121089|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
162839562|NCT05036083|588121089|FG000|Overall Study|IV not sustainable|1|||
162839563|NCT01844986|588121090|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
162839564|NCT01844986|588121091|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
162948976|NCT02424097|588516923|FG000|Overall Study|Lost to Follow-up|1|||
162839565|NCT01844986|588121090|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
162839566|NCT01844986|588121091|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
162839567|NCT01844986|588121090|FG000|Overall Study (Global Cohort)|Death|55|||
162839568|NCT01844986|588121091|FG001|Overall Study (Global Cohort)|Death|26|||
162839569|NCT01844986|588121090|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
162839570|NCT01844986|588121091|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
162839571|NCT01844986|588121090|FG000|Overall Study (China Cohort)|Death|10|||
162839572|NCT01844986|588121091|FG001|Overall Study (China Cohort)|Death|6|||
162839573|NCT02028455|588121094|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839574|NCT02028455|588121095|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839575|NCT02028455|588121096|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839576|NCT02028455|588121097|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839577|NCT02028455|588121098|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839578|NCT02028455|588121099|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
162839579|NCT02028455|588121100|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
162839580|NCT02028455|588121101|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
162839581|NCT02028455|588121094|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
162839582|NCT02028455|588121095|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
162839583|NCT02028455|588121096|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
162839584|NCT02028455|588121097|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
162839585|NCT02028455|588121098|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
162839586|NCT02028455|588121099|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
162839587|NCT02028455|588121100|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
162839588|NCT02028455|588121101|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
162839589|NCT02028455|588121094|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839590|NCT02028455|588121095|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839591|NCT02028455|588121096|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839592|NCT02028455|588121097|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839593|NCT02028455|588121098|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839594|NCT02028455|588121099|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
162839595|NCT02028455|588121100|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
162839596|NCT02028455|588121101|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
162839597|NCT02028455|588121094|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
162839598|NCT02028455|588121095|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
162839599|NCT02028455|588121096|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
162839600|NCT02028455|588121097|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
162839601|NCT02028455|588121098|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
162839602|NCT02028455|588121099|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
162839603|NCT02028455|588121100|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
162839604|NCT02028455|588121101|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
162839605|NCT07099521|588121102|FG000|Overall Study|Incompeleted stimulus program|1|||
162839606|NCT07099521|588121103|FG001|Overall Study|Incompeleted stimulus program|0|||
162839607|NCT07099521|588121102|FG000|Overall Study|Non-social anxiety symtpoms|0|||
162948977|NCT02424097|588516924|FG001|Overall Study|Lost to Follow-up|2|||
162948978|NCT01675622|588516925|FG000|Overall Study|Withdrawal by Subject|2|||
162948979|NCT01675622|588516926|FG001|Overall Study|Withdrawal by Subject|2|||
162948980|NCT01675622|588516925|FG000|Overall Study|Adverse Event|12|||
162948981|NCT01675622|588516926|FG001|Overall Study|Adverse Event|10|||
162948982|NCT01675622|588516925|FG000|Overall Study|Protocol Violation|4|||
162948983|NCT01675622|588516926|FG001|Overall Study|Protocol Violation|1|||
162948984|NCT01675622|588516925|FG000|Overall Study|Lack of Efficacy|2|||
162948985|NCT01675622|588516926|FG001|Overall Study|Lack of Efficacy|4|||
162948986|NCT01675622|588516925|FG000|Overall Study|Lost to Follow-up|1|||
162948987|NCT01675622|588516926|FG001|Overall Study|Lost to Follow-up|3|||
162948988|NCT01675622|588516925|FG000|Overall Study|Other|5|||
162948989|NCT01675622|588516926|FG001|Overall Study|Other|4|||
162948990|NCT04032977|588516927|FG000|Overall Study|Withdrawal by Subject|6|||
162948991|NCT04032977|588516928|FG001|Overall Study|Withdrawal by Subject|1|||
162948992|NCT04032977|588516927|FG000|Overall Study|Lost to Follow-up|2|||
162948993|NCT04032977|588516928|FG001|Overall Study|Lost to Follow-up|7|||
162948994|NCT04032977|588516927|FG000|Overall Study|Pregnancy|1|||
162948995|NCT04032977|588516928|FG001|Overall Study|Pregnancy|0|||
162948996|NCT01519661|588516930|FG000|Overall Study|Protocol deviation|6|||
162948997|NCT01519661|588516930|FG000|Overall Study|Lost to Follow-up|3|||
162948998|NCT01519661|588516930|FG000|Overall Study|Withdrawal by Subject|17|||
162948999|NCT01519661|588516930|FG000|Overall Study|Lack of Efficacy|6|||
162949000|NCT01519661|588516930|FG000|Overall Study|Adverse Event|29|||
162949001|NCT00840632|588516932|FG000|First Intervention|Withdrawal by Subject|0|||
162949002|NCT00840632|588516933|FG001|First Intervention|Withdrawal by Subject|1|||
162700269|NCT00876460|587612550|FG003|Combination Therapy Phase|Progressive disease|3|||
162700270|NCT00876460|587612551|FG004|Combination Therapy Phase|Progressive disease|3|||
162700271|NCT00876460|587612552|FG005|Combination Therapy Phase|Progressive disease|1|||
162700272|NCT00876460|587612553|FG006|Combination Therapy Phase|Progressive disease|1|||
162700273|NCT00876460|587612554|FG007|Combination Therapy Phase|Progressive disease|1|||
162700274|NCT00876460|587612547|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
162700275|NCT00876460|587612548|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
162700276|NCT00876460|587612549|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
162700277|NCT00876460|587612550|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
162700278|NCT00876460|587612551|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
162700279|NCT00876460|587612552|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
162700280|NCT00876460|587612553|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
162700281|NCT00876460|587612554|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
162700282|NCT00876460|587612547|FG000|Combination Therapy Phase|Adverse Event|0|||
162700283|NCT00876460|587612548|FG001|Combination Therapy Phase|Adverse Event|2|||
162700284|NCT00876460|587612549|FG002|Combination Therapy Phase|Adverse Event|0|||
162700285|NCT00876460|587612550|FG003|Combination Therapy Phase|Adverse Event|2|||
162700286|NCT00876460|587612551|FG004|Combination Therapy Phase|Adverse Event|2|||
162700287|NCT00876460|587612552|FG005|Combination Therapy Phase|Adverse Event|0|||
162700288|NCT00876460|587612553|FG006|Combination Therapy Phase|Adverse Event|3|||
162700289|NCT00876460|587612554|FG007|Combination Therapy Phase|Adverse Event|2|||
162700290|NCT00876460|587612547|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
162700291|NCT00876460|587612548|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
162700292|NCT00876460|587612549|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
162700293|NCT00876460|587612550|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
162700294|NCT00876460|587612551|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
162700295|NCT00876460|587612552|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
162700296|NCT00876460|587612553|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
162700297|NCT00876460|587612554|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
162700298|NCT00876460|587612547|FG000|Combination Therapy Phase|Other reason not defined above|0|||
162700299|NCT00876460|587612548|FG001|Combination Therapy Phase|Other reason not defined above|0|||
162700300|NCT00876460|587612549|FG002|Combination Therapy Phase|Other reason not defined above|0|||
162700301|NCT00876460|587612550|FG003|Combination Therapy Phase|Other reason not defined above|0|||
162700302|NCT00876460|587612551|FG004|Combination Therapy Phase|Other reason not defined above|0|||
162700303|NCT00876460|587612552|FG005|Combination Therapy Phase|Other reason not defined above|0|||
162700304|NCT00876460|587612553|FG006|Combination Therapy Phase|Other reason not defined above|1|||
162700305|NCT00876460|587612554|FG007|Combination Therapy Phase|Other reason not defined above|2|||
162700306|NCT00876460|587612547|FG000|Combination Therapy Phase|Not treated|0|||
162700307|NCT00876460|587612548|FG001|Combination Therapy Phase|Not treated|0|||
162700308|NCT00876460|587612549|FG002|Combination Therapy Phase|Not treated|0|||
162700309|NCT00876460|587612550|FG003|Combination Therapy Phase|Not treated|0|||
162949003|NCT00840632|588516932|FG000|Washout|Withdrawal by Subject|1|||
162839608|NCT07099521|588121103|FG001|Overall Study|Non-social anxiety symtpoms|1|||
162839609|NCT07099521|588121102|FG000|Overall Study|Extreme values|2|||
162839610|NCT07099521|588121103|FG001|Overall Study|Extreme values|4|||
162839611|NCT00542997|588123249|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
162839612|NCT00542997|588123249|FG000|Wash in / Wash Out Period|Adverse Event|3|||
162839613|NCT00542997|588123249|FG000|Efficacy Period|Adverse Event|3|||
162839614|NCT00598975|588123250|FG000|Overall Study|Adverse Event|1|||
162839615|NCT00598975|588123251|FG001|Overall Study|Adverse Event|1|||
162839616|NCT00598975|588123250|FG000|Overall Study|Brain metastases|1|||
162839617|NCT00598975|588123251|FG001|Overall Study|Brain metastases|0|||
162839618|NCT00598975|588123250|FG000|Overall Study|Withdrawal by Subject|1|||
162839619|NCT00598975|588123251|FG001|Overall Study|Withdrawal by Subject|1|||
162839620|NCT00598975|588123250|FG000|Overall Study|Withdrawal of consent|0|||
162839621|NCT00598975|588123251|FG001|Overall Study|Withdrawal of consent|1|||
162839622|NCT00598975|588123250|FG000|Overall Study|Disease progression|8|||
162839623|NCT00598975|588123251|FG001|Overall Study|Disease progression|3|||
162839624|NCT00598975|588123250|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
162839625|NCT00598975|588123251|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
162839626|NCT01178138|588123254|FG000|Overall Study|Lost to Follow-up|8|||
162839627|NCT01178138|588123254|FG000|Overall Study|Withdrawal by Subject|7|||
162839628|NCT01178138|588123254|FG000|Overall Study|Physician Decision|8|||
162839629|NCT00403260|588123255|FG000|Overall Study|Adverse Event|5|||
162839630|NCT00403260|588123256|FG001|Overall Study|Adverse Event|4|||
162839631|NCT00403260|588123255|FG000|Overall Study|Withdrawal by Subject|5|||
162839632|NCT00403260|588123256|FG001|Overall Study|Withdrawal by Subject|6|||
162839633|NCT00403260|588123255|FG000|Overall Study|Lost to Follow-up|49|||
162839634|NCT00403260|588123256|FG001|Overall Study|Lost to Follow-up|25|||
162839635|NCT00403260|588123255|FG000|Overall Study|Re-appearance of P. falciparum|34|||
162839636|NCT00403260|588123256|FG001|Overall Study|Re-appearance of P. falciparum|25|||
162839637|NCT00403260|588123255|FG000|Overall Study|P. vivax infection|26|||
162839638|NCT00403260|588123256|FG001|Overall Study|P. vivax infection|4|||
162839639|NCT00403260|588123255|FG000|Overall Study|Mixed infection with P. vivax|2|||
162839640|NCT00403260|588123256|FG001|Overall Study|Mixed infection with P. vivax|0|||
162839641|NCT00403260|588123255|FG000|Overall Study|Mixed infection with P. falciparum|1|||
162839642|NCT00403260|588123256|FG001|Overall Study|Mixed infection with P. falciparum|0|||
162839643|NCT00403260|588123255|FG000|Overall Study|P. vivax infection at screening|1|||
162839644|NCT00403260|588123256|FG001|Overall Study|P. vivax infection at screening|0|||
162839645|NCT00403260|588123255|FG000|Overall Study|P. ovale infection|1|||
162839646|NCT00403260|588123256|FG001|Overall Study|P. ovale infection|0|||
162839647|NCT00403260|588123255|FG000|Overall Study|Gametocyte re-appearance|1|||
162839648|NCT00403260|588123256|FG001|Overall Study|Gametocyte re-appearance|1|||
162839649|NCT00403260|588123255|FG000|Overall Study|Withdrawn from study accidentally|0|||
162839650|NCT00403260|588123256|FG001|Overall Study|Withdrawn from study accidentally|1|||
162839651|NCT01241708|588123257|FG000|Overall Study|Withdrawal by Subject|6|||
162839652|NCT01241708|588123257|FG000|Overall Study|Screen Failure|6|||
162839653|NCT01241708|588123257|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
162839654|NCT01241708|588123257|FG000|Overall Study|Lost to Follow-up|5|||
162839655|NCT04137887|588123260|FG000|Overall Study|Death|102|||
162839656|NCT04137887|588123261|FG001|Overall Study|Death|92|||
162839657|NCT04137887|588123260|FG000|Overall Study|Withdrawal by Subject|2|||
162839658|NCT04137887|588123261|FG001|Overall Study|Withdrawal by Subject|3|||
162949004|NCT00840632|588516933|FG001|Washout|Withdrawal by Subject|1|||
162949005|NCT05017480|588516934|FG000|Stage 1 Study|Withdrawal by Subject|8|||
162949006|NCT05017480|588516935|FG001|Stage 1 Study|Withdrawal by Subject|6|||
162949007|NCT05017480|588516936|FG002|Stage 1 Study|Withdrawal by Subject|0|||
162949008|NCT05017480|588516937|FG003|Stage 1 Study|Withdrawal by Subject|0|||
162949009|NCT05017480|588516938|FG004|Stage 1 Study|Withdrawal by Subject|0|||
162949010|NCT05017480|588516934|FG000|Stage 1 Study|Adverse Event|1|||
162949011|NCT05017480|588516935|FG001|Stage 1 Study|Adverse Event|1|||
162949012|NCT05017480|588516936|FG002|Stage 1 Study|Adverse Event|0|||
162949013|NCT05017480|588516937|FG003|Stage 1 Study|Adverse Event|0|||
162949014|NCT05017480|588516938|FG004|Stage 1 Study|Adverse Event|0|||
162839659|NCT04137887|588123260|FG000|Overall Study|Randomized but not treated|0|||
162839660|NCT04137887|588123261|FG001|Overall Study|Randomized but not treated|1|||
162839661|NCT01790503|588123264|FG000|Overall Study|Adverse Event|1|||
162839662|NCT01790503|588123265|FG001|Overall Study|Adverse Event|0|||
162839663|NCT01790503|588123266|FG002|Overall Study|Adverse Event|0|||
162839664|NCT01790503|588123267|FG003|Overall Study|Adverse Event|0|||
162839665|NCT01790503|588123268|FG004|Overall Study|Adverse Event|0|||
162839666|NCT01790503|588123269|FG005|Overall Study|Adverse Event|2|||
162839667|NCT01790503|588123270|FG006|Overall Study|Adverse Event|0|||
162839668|NCT01790503|588123271|FG007|Overall Study|Adverse Event|0|||
162949015|NCT05017480|588516934|FG000|Stage 1 Study|Poor Compliance|1|||
162700310|NCT00876460|587612551|FG004|Combination Therapy Phase|Not treated|0|||
162700311|NCT00876460|587612552|FG005|Combination Therapy Phase|Not treated|0|||
162700312|NCT00876460|587612553|FG006|Combination Therapy Phase|Not treated|1|||
162700313|NCT00876460|587612554|FG007|Combination Therapy Phase|Not treated|0|||
162700314|NCT00876460|587612547|FG000|Mono Therapy Phase|Progressive disease|0|||
162700315|NCT00876460|587612548|FG001|Mono Therapy Phase|Progressive disease|0|||
162700316|NCT00876460|587612549|FG002|Mono Therapy Phase|Progressive disease|0|||
162700317|NCT00876460|587612550|FG003|Mono Therapy Phase|Progressive disease|0|||
162700318|NCT00876460|587612551|FG004|Mono Therapy Phase|Progressive disease|2|||
162700319|NCT00876460|587612552|FG005|Mono Therapy Phase|Progressive disease|0|||
162700320|NCT00876460|587612553|FG006|Mono Therapy Phase|Progressive disease|1|||
162700321|NCT00876460|587612554|FG007|Mono Therapy Phase|Progressive disease|3|||
162700322|NCT00876460|587612547|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
162700323|NCT00876460|587612548|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
162700324|NCT00876460|587612549|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
162700325|NCT00876460|587612550|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
162700326|NCT00876460|587612551|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
162700327|NCT00876460|587612552|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
162700328|NCT00876460|587612553|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
162700329|NCT00876460|587612554|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
162700330|NCT00876460|587612547|FG000|Mono Therapy Phase|Adverse Event|0|||
162700331|NCT00876460|587612548|FG001|Mono Therapy Phase|Adverse Event|0|||
162700332|NCT00876460|587612549|FG002|Mono Therapy Phase|Adverse Event|0|||
162700333|NCT00876460|587612550|FG003|Mono Therapy Phase|Adverse Event|1|||
162700334|NCT00876460|587612551|FG004|Mono Therapy Phase|Adverse Event|0|||
162700335|NCT00876460|587612552|FG005|Mono Therapy Phase|Adverse Event|0|||
162700336|NCT00876460|587612553|FG006|Mono Therapy Phase|Adverse Event|0|||
162700337|NCT00876460|587612554|FG007|Mono Therapy Phase|Adverse Event|0|||
162700338|NCT00513019|587615008|FG000|Overall Study|Adverse Event|1|||
162700339|NCT00513019|587615009|FG001|Overall Study|Adverse Event|0|||
162700340|NCT00513019|587615008|FG000|Overall Study|Withdrawal by Subject|4|||
162700341|NCT00513019|587615009|FG001|Overall Study|Withdrawal by Subject|5|||
162700342|NCT04129580|587615010|FG000|Overall Study|Lost to Follow-up|14|||
162700343|NCT04129580|587615011|FG001|Overall Study|Lost to Follow-up|25|||
162700344|NCT00322868|587615012|FG000|Overall Study|disease progression|1|||
162700345|NCT01852162|587615013|FG000|Overall Study|Adverse Event|1|||
162700346|NCT01852162|587615014|FG001|Overall Study|Adverse Event|0|||
162700347|NCT01852162|587615013|FG000|Overall Study|Withdrawal by Subject|3|||
162700348|NCT01852162|587615014|FG001|Overall Study|Withdrawal by Subject|1|||
162700349|NCT01500226|587615017|FG000|Overall Study|Adverse Event|31|||
162700350|NCT01500226|587615018|FG001|Overall Study|Adverse Event|38|||
162700351|NCT01500226|587615017|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
162700352|NCT01500226|587615018|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
162700353|NCT01500226|587615017|FG000|Overall Study|Withdrawal by Subject|93|||
162700354|NCT01500226|587615018|FG001|Overall Study|Withdrawal by Subject|96|||
162700355|NCT01500226|587615017|FG000|Overall Study|Death|12|||
162700356|NCT01500226|587615018|FG001|Overall Study|Death|4|||
162700357|NCT01500226|587615017|FG000|Overall Study|Disease Progression|16|||
162700358|NCT01500226|587615018|FG001|Overall Study|Disease Progression|14|||
162700359|NCT01500226|587615017|FG000|Overall Study|Protocol Violation|53|||
162700360|NCT01500226|587615018|FG001|Overall Study|Protocol Violation|39|||
162700361|NCT01500226|587615017|FG000|Overall Study|Physician Decision|17|||
162700362|NCT01500226|587615018|FG001|Overall Study|Physician Decision|15|||
162700363|NCT01500226|587615017|FG000|Overall Study|Lack of Efficacy|14|||
162700364|NCT01500226|587615018|FG001|Overall Study|Lack of Efficacy|30|||
162700365|NCT01500226|587615017|FG000|Overall Study|Lost to Follow-up|9|||
162700366|NCT01500226|587615018|FG001|Overall Study|Lost to Follow-up|5|||
162700367|NCT01500226|587615017|FG000|Overall Study|Other Reasons|19|||
162700368|NCT01500226|587615018|FG001|Overall Study|Other Reasons|16|||
162700369|NCT02955277|587615019|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
162700370|NCT02955277|587615020|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
162700371|NCT02955277|587615019|FG000|Post to Follow-up|Lost to Follow-up|8|||
162700372|NCT02955277|587615020|FG001|Post to Follow-up|Lost to Follow-up|11|||
162700373|NCT04212169|587615023|FG000|Overall Study|Adverse Event|0|||
162700374|NCT04212169|587615024|FG001|Overall Study|Adverse Event|0|||
162839669|NCT01790503|588123272|FG008|Overall Study|Adverse Event|2|||
162839670|NCT01790503|588123273|FG009|Overall Study|Adverse Event|4|||
162839671|NCT01790503|588123274|FG010|Overall Study|Adverse Event|7|||
162839672|NCT01790503|588123264|FG000|Overall Study|Withdrawal by Subject|0|||
162839673|NCT01790503|588123265|FG001|Overall Study|Withdrawal by Subject|0|||
162839674|NCT01790503|588123266|FG002|Overall Study|Withdrawal by Subject|1|||
162839675|NCT01790503|588123267|FG003|Overall Study|Withdrawal by Subject|1|||
162839676|NCT01790503|588123268|FG004|Overall Study|Withdrawal by Subject|1|||
162839677|NCT01790503|588123269|FG005|Overall Study|Withdrawal by Subject|2|||
162839678|NCT01790503|588123270|FG006|Overall Study|Withdrawal by Subject|1|||
162839679|NCT01790503|588123271|FG007|Overall Study|Withdrawal by Subject|0|||
162949016|NCT05017480|588516935|FG001|Stage 1 Study|Poor Compliance|1|||
162949017|NCT05017480|588516936|FG002|Stage 1 Study|Poor Compliance|0|||
162949018|NCT05017480|588516937|FG003|Stage 1 Study|Poor Compliance|0|||
162839680|NCT01790503|588123272|FG008|Overall Study|Withdrawal by Subject|0|||
162839681|NCT01790503|588123273|FG009|Overall Study|Withdrawal by Subject|0|||
162839682|NCT01790503|588123274|FG010|Overall Study|Withdrawal by Subject|1|||
162839683|NCT01790503|588123264|FG000|Overall Study|Disease progression|2|||
162839684|NCT01790503|588123265|FG001|Overall Study|Disease progression|1|||
162839685|NCT01790503|588123266|FG002|Overall Study|Disease progression|0|||
162839686|NCT01790503|588123267|FG003|Overall Study|Disease progression|1|||
162839687|NCT01790503|588123268|FG004|Overall Study|Disease progression|2|||
162839688|NCT01790503|588123269|FG005|Overall Study|Disease progression|1|||
162839689|NCT01790503|588123270|FG006|Overall Study|Disease progression|0|||
162839690|NCT01790503|588123271|FG007|Overall Study|Disease progression|1|||
162839691|NCT01790503|588123272|FG008|Overall Study|Disease progression|0|||
162839692|NCT01790503|588123273|FG009|Overall Study|Disease progression|17|||
162839693|NCT01790503|588123274|FG010|Overall Study|Disease progression|7|||
162839694|NCT01790503|588123264|FG000|Overall Study|Protocol Violation|0|||
162839695|NCT01790503|588123265|FG001|Overall Study|Protocol Violation|0|||
162839696|NCT01790503|588123266|FG002|Overall Study|Protocol Violation|0|||
162839697|NCT01790503|588123267|FG003|Overall Study|Protocol Violation|0|||
162839698|NCT01790503|588123268|FG004|Overall Study|Protocol Violation|0|||
162839699|NCT01790503|588123269|FG005|Overall Study|Protocol Violation|0|||
162839700|NCT01790503|588123270|FG006|Overall Study|Protocol Violation|0|||
162839701|NCT01790503|588123271|FG007|Overall Study|Protocol Violation|0|||
162839702|NCT01790503|588123272|FG008|Overall Study|Protocol Violation|0|||
162839703|NCT01790503|588123273|FG009|Overall Study|Protocol Violation|1|||
162839704|NCT01790503|588123274|FG010|Overall Study|Protocol Violation|0|||
162839705|NCT01790503|588123264|FG000|Overall Study|Physician Decision|0|||
162839706|NCT01790503|588123265|FG001|Overall Study|Physician Decision|0|||
162839707|NCT01790503|588123266|FG002|Overall Study|Physician Decision|0|||
162839708|NCT01790503|588123267|FG003|Overall Study|Physician Decision|0|||
162839709|NCT01790503|588123268|FG004|Overall Study|Physician Decision|0|||
162839710|NCT01790503|588123269|FG005|Overall Study|Physician Decision|0|||
162839711|NCT01790503|588123270|FG006|Overall Study|Physician Decision|0|||
162839712|NCT01790503|588123271|FG007|Overall Study|Physician Decision|0|||
162839713|NCT01790503|588123272|FG008|Overall Study|Physician Decision|0|||
162839714|NCT01790503|588123273|FG009|Overall Study|Physician Decision|1|||
162839715|NCT01790503|588123274|FG010|Overall Study|Physician Decision|1|||
162839716|NCT01790503|588123264|FG000|Overall Study|Death|0|||
162839717|NCT01790503|588123265|FG001|Overall Study|Death|0|||
162839718|NCT01790503|588123266|FG002|Overall Study|Death|0|||
162839719|NCT01790503|588123267|FG003|Overall Study|Death|0|||
162839720|NCT01790503|588123268|FG004|Overall Study|Death|0|||
162839721|NCT01790503|588123269|FG005|Overall Study|Death|0|||
162839722|NCT01790503|588123270|FG006|Overall Study|Death|0|||
162839723|NCT01790503|588123271|FG007|Overall Study|Death|0|||
162839724|NCT01790503|588123272|FG008|Overall Study|Death|0|||
162839725|NCT01790503|588123273|FG009|Overall Study|Death|1|||
162839726|NCT01790503|588123274|FG010|Overall Study|Death|0|||
162839727|NCT01790503|588123264|FG000|Overall Study|Non Compliance|0|||
162839728|NCT01790503|588123265|FG001|Overall Study|Non Compliance|0|||
162839729|NCT01790503|588123266|FG002|Overall Study|Non Compliance|0|||
162839730|NCT01790503|588123267|FG003|Overall Study|Non Compliance|0|||
162839731|NCT01790503|588123268|FG004|Overall Study|Non Compliance|1|||
162949019|NCT05017480|588516938|FG004|Stage 1 Study|Poor Compliance|0|||
162949020|NCT05017480|588516934|FG000|Stage 1 Study|Physician Decision|0|||
162949021|NCT05017480|588516935|FG001|Stage 1 Study|Physician Decision|1|||
162949022|NCT05017480|588516936|FG002|Stage 1 Study|Physician Decision|0|||
162949023|NCT05017480|588516937|FG003|Stage 1 Study|Physician Decision|0|||
162949024|NCT05017480|588516938|FG004|Stage 1 Study|Physician Decision|0|||
162949025|NCT05017480|588516934|FG000|Stage 2 Study|Withdrawal by Subject|0|||
162949026|NCT05017480|588516935|FG001|Stage 2 Study|Withdrawal by Subject|0|||
162949027|NCT05017480|588516936|FG002|Stage 2 Study|Withdrawal by Subject|6|||
162949028|NCT05017480|588516937|FG003|Stage 2 Study|Withdrawal by Subject|9|||
162949029|NCT05017480|588516938|FG004|Stage 2 Study|Withdrawal by Subject|11|||
162949030|NCT05017480|588516934|FG000|Stage 2 Study|Lost to Follow-up|0|||
162949031|NCT05017480|588516935|FG001|Stage 2 Study|Lost to Follow-up|0|||
162949032|NCT05017480|588516936|FG002|Stage 2 Study|Lost to Follow-up|0|||
162949033|NCT05017480|588516937|FG003|Stage 2 Study|Lost to Follow-up|2|||
162839732|NCT01790503|588123269|FG005|Overall Study|Non Compliance|0|||
162839733|NCT01790503|588123270|FG006|Overall Study|Non Compliance|0|||
162839734|NCT01790503|588123271|FG007|Overall Study|Non Compliance|0|||
162949034|NCT05017480|588516938|FG004|Stage 2 Study|Lost to Follow-up|1|||
162949035|NCT05017480|588516934|FG000|Stage 2 Study|Adverse Event|0|||
162839735|NCT01790503|588123272|FG008|Overall Study|Non Compliance|0|||
162839736|NCT01790503|588123273|FG009|Overall Study|Non Compliance|0|||
162839737|NCT01790503|588123274|FG010|Overall Study|Non Compliance|0|||
162839738|NCT01790503|588123264|FG000|Overall Study|Other|0|||
162839739|NCT01790503|588123265|FG001|Overall Study|Other|0|||
162839740|NCT01790503|588123266|FG002|Overall Study|Other|0|||
162839741|NCT01790503|588123267|FG003|Overall Study|Other|0|||
162839742|NCT01790503|588123268|FG004|Overall Study|Other|1|||
162839743|NCT01790503|588123269|FG005|Overall Study|Other|0|||
162949036|NCT05017480|588516935|FG001|Stage 2 Study|Adverse Event|0|||
162949037|NCT05017480|588516936|FG002|Stage 2 Study|Adverse Event|0|||
162949038|NCT05017480|588516937|FG003|Stage 2 Study|Adverse Event|1|||
162949039|NCT05017480|588516938|FG004|Stage 2 Study|Adverse Event|0|||
162949040|NCT05017480|588516934|FG000|Stage 2 Study|COVID-19|0|||
162949041|NCT05017480|588516935|FG001|Stage 2 Study|COVID-19|0|||
162949042|NCT05017480|588516936|FG002|Stage 2 Study|COVID-19|0|||
162949043|NCT05017480|588516937|FG003|Stage 2 Study|COVID-19|1|||
162949044|NCT05017480|588516938|FG004|Stage 2 Study|COVID-19|0|||
162949045|NCT05017480|588516934|FG000|Stage 2 Study|Pregnancy|0|||
162949046|NCT05017480|588516935|FG001|Stage 2 Study|Pregnancy|0|||
162949047|NCT05017480|588516936|FG002|Stage 2 Study|Pregnancy|0|||
162949048|NCT05017480|588516937|FG003|Stage 2 Study|Pregnancy|0|||
162949049|NCT05017480|588516938|FG004|Stage 2 Study|Pregnancy|1|||
162949050|NCT02311361|588516939|FG000|Overall Study|Did not receive treatment|0|||
162839744|NCT01790503|588123270|FG006|Overall Study|Other|0|||
162839745|NCT01790503|588123271|FG007|Overall Study|Other|0|||
162839746|NCT01790503|588123272|FG008|Overall Study|Other|1|||
162839747|NCT01790503|588123273|FG009|Overall Study|Other|2|||
162839748|NCT01790503|588123274|FG010|Overall Study|Other|0|||
162839749|NCT04183335|588123275|FG000|Overall Study|Adverse Event|1|||
162839750|NCT04183335|588123276|FG001|Overall Study|Adverse Event|0|||
162839751|NCT04183335|588123275|FG000|Overall Study|Withdrawal by Subject|12|||
162839752|NCT04183335|588123276|FG001|Overall Study|Withdrawal by Subject|3|||
162839753|NCT00049673|588123277|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
162839754|NCT00049673|588123278|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
162839755|NCT01535729|588123279|FG000|Overall Study|Withdrawal by Subject|2|||
162839756|NCT01535729|588123279|FG000|Overall Study|Disease progression|230|||
162839757|NCT01535729|588123279|FG000|Overall Study|Discontinued treatment|25|||
162839758|NCT01535729|588123279|FG000|Overall Study|Lost to Follow-up|8|||
162839759|NCT01535729|588123279|FG000|Overall Study|Death|52|||
162839760|NCT01535729|588123279|FG000|Overall Study|Other|19|||
162839761|NCT01535729|588123279|FG000|Overall Study|Did not sign informed consent|1|||
162839762|NCT01535729|588123279|FG000|Overall Study|No previous chemotherapy|33|||
162839763|NCT01535729|588123279|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
162839764|NCT01535729|588123279|FG000|Overall Study|Protocol Violation|11|||
162839765|NCT01535729|588123279|FG000|Overall Study|Screening failure|1|||
162839766|NCT01535729|588123279|FG000|Overall Study|Not treated|9|||
162839767|NCT01535729|588123279|FG000|Overall Study|No participant record available|5|||
162839768|NCT03733392|588123282|FG000|Overall Study|Withdrawal by Subject|11|||
162839769|NCT03733392|588123283|FG001|Overall Study|Withdrawal by Subject|1|||
162839770|NCT03733392|588123282|FG000|Overall Study|Death|1|||
162839771|NCT03733392|588123283|FG001|Overall Study|Death|0|||
162839772|NCT03733392|588123282|FG000|Overall Study|Lost to Follow-up|5|||
162839773|NCT03733392|588123283|FG001|Overall Study|Lost to Follow-up|0|||
162839774|NCT03733392|588123282|FG000|Overall Study|Protocol Violation|0|||
162839775|NCT03733392|588123283|FG001|Overall Study|Protocol Violation|1|||
162839776|NCT03733392|588123282|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
162839777|NCT03733392|588123283|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
162839778|NCT03733392|588123282|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
162839779|NCT03733392|588123283|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
162839780|NCT03733392|588123282|FG000|Overall Study|Patient Non-Compliance|2|||
162839781|NCT03733392|588123283|FG001|Overall Study|Patient Non-Compliance|1|||
162839782|NCT03733392|588123282|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
162839783|NCT03733392|588123283|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
162839784|NCT03733392|588123282|FG000|Overall Study|Withdrawal prior to procedure|5|||
162839785|NCT03733392|588123283|FG001|Overall Study|Withdrawal prior to procedure|2|||
162839786|NCT02740478|588123284|FG000|Overall Study|Withdrawal by Subject|1|||
162839787|NCT01934140|588123291|FG000|Persistence Phase (Year 6-10)|Other|24|||
162839788|NCT01934140|588123292|FG001|Persistence Phase (Year 6-10)|Other|6|||
162839789|NCT01934140|588123291|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
162839790|NCT01934140|588123292|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
162839791|NCT01934140|588123291|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
162839792|NCT01934140|588123292|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
162839793|NCT01934140|588123291|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
162839794|NCT01934140|588123292|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
162839795|NCT01934140|588123291|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
162839796|NCT01934140|588123292|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
162839797|NCT01934140|588123291|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
162839798|NCT01934140|588123292|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
162839799|NCT01934140|588123291|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
162839800|NCT01934140|588123292|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
162839801|NCT01934140|588123291|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
162839802|NCT01934140|588123292|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
162839803|NCT01461044|588123296|FG000|Overall Study|Death|58|||
162839804|NCT01461044|588123297|FG001|Overall Study|Death|35|||
162839805|NCT01461044|588123296|FG000|Overall Study|Lost to Follow-up|12|||
162839806|NCT01461044|588123297|FG001|Overall Study|Lost to Follow-up|5|||
162839807|NCT00618748|588123298|FG000|Overall Study|Adverse Event|4|||
162839808|NCT00618748|588123299|FG001|Overall Study|Adverse Event|3|||
162839809|NCT00618748|588123300|FG002|Overall Study|Adverse Event|8|||
162839810|NCT00618748|588123298|FG000|Overall Study|Physician Decision|3|||
162839811|NCT00618748|588123299|FG001|Overall Study|Physician Decision|1|||
162839812|NCT00618748|588123300|FG002|Overall Study|Physician Decision|1|||
162839813|NCT00618748|588123298|FG000|Overall Study|Withdrawal by Subject|4|||
162700375|NCT04212169|587615025|FG002|Overall Study|Adverse Event|0|||
162839814|NCT00618748|588123299|FG001|Overall Study|Withdrawal by Subject|1|||
162839815|NCT00618748|588123300|FG002|Overall Study|Withdrawal by Subject|5|||
162839816|NCT00200850|588123301|FG000|Overall Study|relocation|1|||
162839817|NCT00200850|588123302|FG001|Overall Study|relocation|0|||
162839818|NCT00200850|588123303|FG002|Overall Study|relocation|1|||
162839819|NCT00200850|588123301|FG000|Overall Study|too busy|1|||
162839820|NCT00200850|588123302|FG001|Overall Study|too busy|0|||
162839821|NCT00200850|588123303|FG002|Overall Study|too busy|0|||
162839822|NCT00200850|588123301|FG000|Overall Study|Pregnancy|0|||
162839823|NCT00200850|588123302|FG001|Overall Study|Pregnancy|0|||
162839824|NCT00200850|588123303|FG002|Overall Study|Pregnancy|1|||
162839825|NCT00200850|588123301|FG000|Overall Study|Poor adherence|0|||
162839826|NCT00200850|588123302|FG001|Overall Study|Poor adherence|0|||
162839827|NCT00200850|588123303|FG002|Overall Study|Poor adherence|1|||
162839828|NCT00200850|588123301|FG000|Overall Study|optic neuritis|0|||
162839829|NCT00200850|588123302|FG001|Overall Study|optic neuritis|0|||
162839830|NCT00200850|588123303|FG002|Overall Study|optic neuritis|1|||
162839831|NCT00200850|588123301|FG000|Overall Study|Adverse Event|1|||
162839832|NCT00200850|588123302|FG001|Overall Study|Adverse Event|1|||
162839833|NCT00200850|588123303|FG002|Overall Study|Adverse Event|2|||
162839834|NCT02889796|588123306|FG000|Overall Study|Withdrew Consent|18|||
162839835|NCT02889796|588123307|FG001|Overall Study|Withdrew Consent|29|||
162839836|NCT02889796|588123308|FG002|Overall Study|Withdrew Consent|20|||
162839837|NCT02889796|588123309|FG003|Overall Study|Withdrew Consent|1|||
162839838|NCT02889796|588123310|FG004|Overall Study|Withdrew Consent|2|||
162839839|NCT02889796|588123311|FG005|Overall Study|Withdrew Consent|35|||
162839840|NCT02889796|588123306|FG000|Overall Study|Investigator's Discretion|10|||
162839841|NCT02889796|588123307|FG001|Overall Study|Investigator's Discretion|9|||
162839842|NCT02889796|588123308|FG002|Overall Study|Investigator's Discretion|10|||
162839843|NCT02889796|588123309|FG003|Overall Study|Investigator's Discretion|3|||
162839844|NCT02889796|588123310|FG004|Overall Study|Investigator's Discretion|0|||
162839845|NCT02889796|588123311|FG005|Overall Study|Investigator's Discretion|15|||
162839846|NCT02889796|588123306|FG000|Overall Study|Adverse Event|17|||
162839847|NCT02889796|588123307|FG001|Overall Study|Adverse Event|8|||
162839848|NCT02889796|588123308|FG002|Overall Study|Adverse Event|8|||
162839849|NCT02889796|588123309|FG003|Overall Study|Adverse Event|4|||
162839850|NCT02889796|588123310|FG004|Overall Study|Adverse Event|1|||
162839851|NCT02889796|588123311|FG005|Overall Study|Adverse Event|7|||
162839852|NCT02889796|588123306|FG000|Overall Study|Lost to Follow-up|5|||
162839853|NCT02889796|588123307|FG001|Overall Study|Lost to Follow-up|7|||
162839854|NCT02889796|588123308|FG002|Overall Study|Lost to Follow-up|2|||
162839855|NCT02889796|588123309|FG003|Overall Study|Lost to Follow-up|0|||
162839856|NCT02889796|588123310|FG004|Overall Study|Lost to Follow-up|2|||
162839857|NCT02889796|588123311|FG005|Overall Study|Lost to Follow-up|6|||
162839858|NCT02889796|588123306|FG000|Overall Study|Protocol Violation|0|||
162839859|NCT02889796|588123307|FG001|Overall Study|Protocol Violation|1|||
162839860|NCT02889796|588123308|FG002|Overall Study|Protocol Violation|3|||
162839861|NCT02889796|588123309|FG003|Overall Study|Protocol Violation|0|||
162839862|NCT02889796|588123310|FG004|Overall Study|Protocol Violation|0|||
162839863|NCT02889796|588123311|FG005|Overall Study|Protocol Violation|4|||
162839864|NCT02889796|588123306|FG000|Overall Study|Non-compliance With Study Drug|0|||
162839865|NCT02889796|588123307|FG001|Overall Study|Non-compliance With Study Drug|2|||
162839866|NCT02889796|588123308|FG002|Overall Study|Non-compliance With Study Drug|0|||
162839867|NCT02889796|588123309|FG003|Overall Study|Non-compliance With Study Drug|0|||
162839868|NCT02889796|588123310|FG004|Overall Study|Non-compliance With Study Drug|1|||
162839869|NCT02889796|588123311|FG005|Overall Study|Non-compliance With Study Drug|2|||
162839870|NCT02889796|588123306|FG000|Overall Study|Death|1|||
162839871|NCT02889796|588123307|FG001|Overall Study|Death|1|||
162839872|NCT02889796|588123308|FG002|Overall Study|Death|0|||
162839873|NCT02889796|588123309|FG003|Overall Study|Death|1|||
162839874|NCT02889796|588123310|FG004|Overall Study|Death|0|||
162839875|NCT02889796|588123311|FG005|Overall Study|Death|1|||
162839876|NCT02889796|588123306|FG000|Overall Study|Pregnancy|0|||
162839877|NCT02889796|588123307|FG001|Overall Study|Pregnancy|1|||
162839878|NCT02889796|588123308|FG002|Overall Study|Pregnancy|1|||
162839879|NCT02889796|588123309|FG003|Overall Study|Pregnancy|0|||
162839880|NCT02889796|588123310|FG004|Overall Study|Pregnancy|0|||
162839881|NCT02889796|588123311|FG005|Overall Study|Pregnancy|0|||
162839882|NCT02889796|588123306|FG000|Overall Study|Randomized but not Dosed|2|||
162839883|NCT02889796|588123307|FG001|Overall Study|Randomized but not Dosed|0|||
162839884|NCT02889796|588123308|FG002|Overall Study|Randomized but not Dosed|0|||
162839885|NCT02889796|588123309|FG003|Overall Study|Randomized but not Dosed|0|||
162839886|NCT02889796|588123310|FG004|Overall Study|Randomized but not Dosed|0|||
162839887|NCT02889796|588123311|FG005|Overall Study|Randomized but not Dosed|2|||
162839888|NCT04294459|588123312|FG000|Overall Study|Adverse Event|0|||
162839889|NCT04294459|588123313|FG001|Overall Study|Adverse Event|1|||
162839890|NCT02787863|588123314|FG000|Overall Study|Death|1|||
162839891|NCT02787863|588123315|FG001|Overall Study|Death|0|||
162839892|NCT02787863|588123316|FG002|Overall Study|Death|1|||
162839893|NCT02787863|588123317|FG003|Overall Study|Death|0|||
162839894|NCT02787863|588123318|FG004|Overall Study|Death|0|||
162839895|NCT02787863|588123319|FG005|Overall Study|Death|0|||
162839896|NCT02787863|588123320|FG006|Overall Study|Death|0|||
162839897|NCT02787863|588123321|FG007|Overall Study|Death|0|||
162839898|NCT02787863|588123314|FG000|Overall Study|Withdrawal by Subject|0|||
162839899|NCT02787863|588123315|FG001|Overall Study|Withdrawal by Subject|1|||
162839900|NCT02787863|588123316|FG002|Overall Study|Withdrawal by Subject|1|||
162839901|NCT02787863|588123317|FG003|Overall Study|Withdrawal by Subject|0|||
162839902|NCT02787863|588123318|FG004|Overall Study|Withdrawal by Subject|0|||
162839903|NCT02787863|588123319|FG005|Overall Study|Withdrawal by Subject|0|||
162839904|NCT02787863|588123320|FG006|Overall Study|Withdrawal by Subject|0|||
162839905|NCT02787863|588123321|FG007|Overall Study|Withdrawal by Subject|0|||
162839906|NCT01414257|588123322|FG000|Overall Study|No Visit After First Day of Treatment|12|||
162839907|NCT01414257|588123322|FG000|Overall Study|Protocol Violation|10|||
162839908|NCT02479802|588123323|FG000|Overall Study|Lost to Follow-up|1|||
162839909|NCT02479802|588123323|FG000|Overall Study|Adverse Event|1|||
162839910|NCT01882907|588123324|FG000|Overall Study|Adverse Event|3|||
162839911|NCT01882907|588123325|FG001|Overall Study|Adverse Event|1|||
162839912|NCT01882907|588123324|FG000|Overall Study|Lack of Efficacy|0|||
162839913|NCT01882907|588123325|FG001|Overall Study|Lack of Efficacy|3|||
162839914|NCT01882907|588123324|FG000|Overall Study|Lost to Follow-up|1|||
162839915|NCT01882907|588123325|FG001|Overall Study|Lost to Follow-up|4|||
162839916|NCT01882907|588123324|FG000|Overall Study|Protocol Violation|10|||
162839917|NCT01882907|588123325|FG001|Overall Study|Protocol Violation|14|||
162839918|NCT01882907|588123324|FG000|Overall Study|Withdrawal by Subject|0|||
162839919|NCT01882907|588123325|FG001|Overall Study|Withdrawal by Subject|6|||
162839920|NCT01978093|588123326|FG000|Overall Study|Death|1|||
162839921|NCT01978093|588123327|FG001|Overall Study|Death|0|||
162839922|NCT01978093|588123326|FG000|Overall Study|Adverse Event|0|||
162839923|NCT01978093|588123327|FG001|Overall Study|Adverse Event|5|||
162839924|NCT01978093|588123326|FG000|Overall Study|Protocol Violation|8|||
162839925|NCT01978093|588123327|FG001|Overall Study|Protocol Violation|2|||
162839926|NCT01978093|588123326|FG000|Overall Study|Withdrawal by Subject|29|||
162839927|NCT01978093|588123327|FG001|Overall Study|Withdrawal by Subject|25|||
162839928|NCT01978093|588123326|FG000|Overall Study|Lost to Follow-up|11|||
162839929|NCT01978093|588123327|FG001|Overall Study|Lost to Follow-up|15|||
162839930|NCT01978093|588123326|FG000|Overall Study|Migrated/moved from study area|11|||
162839931|NCT01978093|588123327|FG001|Overall Study|Migrated/moved from study area|13|||
162949051|NCT02311361|588516940|FG001|Overall Study|Did not receive treatment|1|||
162949052|NCT02311361|588516941|FG002|Overall Study|Did not receive treatment|0|||
162949053|NCT02311361|588516942|FG003|Overall Study|Did not receive treatment|1|||
162949054|NCT05628675|588516947|FG000|Overall Study|Lost to Follow-up|2|||
162949055|NCT05628675|588516947|FG000|Overall Study|Withdrawal by Subject|1|||
162949056|NCT00633594|588516950|FG000|Overall Study|Adverse Event|0|||
162949057|NCT00633594|588516951|FG001|Overall Study|Adverse Event|4|||
162949058|NCT00633594|588516952|FG002|Overall Study|Adverse Event|7|||
162949059|NCT00633594|588516950|FG000|Overall Study|Death|0|||
162949060|NCT00633594|588516951|FG001|Overall Study|Death|1|||
162949061|NCT00633594|588516952|FG002|Overall Study|Death|2|||
162949062|NCT00633594|588516950|FG000|Overall Study|Disease Progression|0|||
162949063|NCT00633594|588516951|FG001|Overall Study|Disease Progression|0|||
162949064|NCT00633594|588516952|FG002|Overall Study|Disease Progression|1|||
162949065|NCT02028715|588516953|FG000|Overall Study|Adverse Event|2|||
162949066|NCT02028715|588516954|FG001|Overall Study|Adverse Event|2|||
162949067|NCT02028715|588516953|FG000|Overall Study|Physician Decision|1|||
162949068|NCT02028715|588516954|FG001|Overall Study|Physician Decision|0|||
162949069|NCT02028715|588516953|FG000|Overall Study|Did not complete satisfaction surveys|2|||
162949070|NCT02028715|588516954|FG001|Overall Study|Did not complete satisfaction surveys|2|||
162949071|NCT01492361|588516955|FG000|Overall Study|Withdrawal by Subject|281|||
162839932|NCT01978093|588123326|FG000|Overall Study|Loss of kaiser coverage|4|||
162839933|NCT01978093|588123327|FG001|Overall Study|Loss of kaiser coverage|10|||
162839934|NCT01978093|588123326|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
162839935|NCT01978093|588123327|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
162839936|NCT01978093|588123326|FG000|Overall Study|Mother lost custody of child|0|||
162839937|NCT01978093|588123327|FG001|Overall Study|Mother lost custody of child|1|||
162839938|NCT01978093|588123326|FG000|Overall Study|Child was in care of grandmother|0|||
162949072|NCT01492361|588516956|FG001|Overall Study|Withdrawal by Subject|297|||
162949073|NCT01492361|588516955|FG000|Overall Study|Physician Decision|12|||
162839939|NCT01978093|588123327|FG001|Overall Study|Child was in care of grandmother|1|||
162839940|NCT01978093|588123326|FG000|Overall Study|N/A for vaccine administration|0|||
162949074|NCT01492361|588516956|FG001|Overall Study|Physician Decision|12|||
162839941|NCT01978093|588123327|FG001|Overall Study|N/A for vaccine administration|1|||
162839942|NCT03124784|588123332|FG000|Overall Study|Adverse Event|1|||
162839943|NCT03124784|588123332|FG000|Overall Study|Computer/Equip Malfunction|1|||
162949075|NCT01492361|588516955|FG000|Overall Study|Lost to Follow-up|6|||
162949076|NCT01492361|588516956|FG001|Overall Study|Lost to Follow-up|13|||
162949077|NCT01492361|588516955|FG000|Overall Study|Other than specified above|106|||
162839944|NCT02162732|588123333|FG000|Overall Study|Biopsy not performed.|18|||
162839945|NCT01784965|588123334|FG000|Overall Study|Withdrawal by Subject|6|||
162839946|NCT01784965|588123335|FG001|Overall Study|Withdrawal by Subject|3|||
162839947|NCT01784965|588123334|FG000|Overall Study|Adverse Event|0|||
162839948|NCT01784965|588123335|FG001|Overall Study|Adverse Event|8|||
162839949|NCT03757988|588123336|FG000|Overall Study|Withdrawal by Subject|1|||
162839950|NCT02450487|588123337|FG000|Overall Study|Lost to Follow-up|3|||
162839951|NCT04269395|588123338|FG000|Overall Study|Lost to Follow-up|1|||
162839952|NCT04269395|588123339|FG001|Overall Study|Lost to Follow-up|0|||
162839953|NCT04269395|588123338|FG000|Overall Study|Study terminated by Sponsor|13|||
162839954|NCT04269395|588123339|FG001|Overall Study|Study terminated by Sponsor|10|||
162839955|NCT04161495|588123340|FG000|Overall Study|Withdrawal by Subject|3|||
162839956|NCT04161495|588123341|FG001|Overall Study|Withdrawal by Subject|0|||
162839957|NCT04161495|588123340|FG000|Overall Study|Protocol Violation|1|||
162839958|NCT04161495|588123341|FG001|Overall Study|Protocol Violation|0|||
162839959|NCT04161495|588123340|FG000|Overall Study|Prohibited concomitant medication|3|||
162839960|NCT04161495|588123341|FG001|Overall Study|Prohibited concomitant medication|0|||
162839961|NCT04161495|588123340|FG000|Overall Study|Adverse Event|1|||
162839962|NCT04161495|588123341|FG001|Overall Study|Adverse Event|0|||
162839963|NCT04161495|588123340|FG000|Overall Study|Other - Unspecified|1|||
162839964|NCT04161495|588123341|FG001|Overall Study|Other - Unspecified|0|||
162839965|NCT04161495|588123340|FG000|Overall Study|Death|0|||
162839966|NCT04161495|588123341|FG001|Overall Study|Death|1|||
162839967|NCT00252057|588123344|FG000|Overall Study|Withdrawal by Subject|2|||
162839968|NCT00252057|588123345|FG001|Overall Study|Withdrawal by Subject|5|||
162839969|NCT00252057|588123344|FG000|Overall Study|Death|1|||
162839970|NCT00252057|588123345|FG001|Overall Study|Death|2|||
162839971|NCT00252057|588123344|FG000|Overall Study|Participant previously enrolled|0|||
162839972|NCT00252057|588123345|FG001|Overall Study|Participant previously enrolled|1|||
162839973|NCT01764633|588123346|FG000|Overall Study|Withdrawal by Subject|105|||
162839974|NCT01764633|588123347|FG001|Overall Study|Withdrawal by Subject|88|||
162839975|NCT01764633|588123346|FG000|Overall Study|Lost to Follow-up|13|||
162839976|NCT01764633|588123347|FG001|Overall Study|Lost to Follow-up|5|||
162839977|NCT02268058|588123348|FG000|Overall Study|Protocol Violation|1|||
162839978|NCT02268058|588123349|FG001|Overall Study|Protocol Violation|0|||
162839979|NCT02268058|588123350|FG002|Overall Study|Protocol Violation|0|||
162949078|NCT01492361|588516956|FG001|Overall Study|Other than specified above|138|||
162949079|NCT01475838|588516957|FG000|Randomized Phase|Randomized but Not Treated|0|||
162949080|NCT01475838|588516958|FG001|Randomized Phase|Randomized but Not Treated|5|||
162949081|NCT01475838|588516957|FG000|Randomized Phase|Adverse Event|6|||
162949082|NCT01475838|588516958|FG001|Randomized Phase|Adverse Event|1|||
162949083|NCT01475838|588516957|FG000|Randomized Phase|Pregnancy|0|||
162949084|NCT01475838|588516958|FG001|Randomized Phase|Pregnancy|1|||
162949085|NCT01475838|588516957|FG000|Randomized Phase|Investigators Discretion|1|||
162949086|NCT01475838|588516958|FG001|Randomized Phase|Investigators Discretion|2|||
162949087|NCT01475838|588516957|FG000|Randomized Phase|Withdrew Consent|10|||
162949088|NCT01475838|588516958|FG001|Randomized Phase|Withdrew Consent|14|||
162949089|NCT01475838|588516957|FG000|Randomized Phase|Lost to Follow-up|3|||
162949090|NCT01475838|588516958|FG001|Randomized Phase|Lost to Follow-up|4|||
162949091|NCT01475838|588516957|FG000|Randomized Phase|Participant Noncompliance|1|||
162949092|NCT01475838|588516958|FG001|Randomized Phase|Participant Noncompliance|5|||
162949093|NCT01475838|588516957|FG000|Randomized Phase|Protocol Violation|9|||
162949094|NCT01475838|588516958|FG001|Randomized Phase|Protocol Violation|4|||
162949095|NCT01475838|588516957|FG000|Extension Phase|Participant Noncompliance|1|||
162949096|NCT01475838|588516958|FG001|Extension Phase|Participant Noncompliance|0|||
162949097|NCT01315249|588516964|FG000|Overall Study|Adverse Event|22|||
162949098|NCT01315249|588516965|FG001|Overall Study|Adverse Event|26|||
162949099|NCT01315249|588516964|FG000|Overall Study|Withdrawal by Subject|11|||
162949100|NCT01315249|588516965|FG001|Overall Study|Withdrawal by Subject|10|||
162949101|NCT01315249|588516964|FG000|Overall Study|Protocol Violation|8|||
162839980|NCT02268058|588123351|FG003|Overall Study|Protocol Violation|0|||
162949102|NCT01315249|588516965|FG001|Overall Study|Protocol Violation|5|||
162839981|NCT04142983|588123352|FG000|Overall Study|Lost to Follow-up|73|||
162839982|NCT04142983|588123352|FG000|Overall Study|Withdrawal by Subject|10|||
162839983|NCT04142983|588123352|FG000|Overall Study|Physician Decision|1|||
162839984|NCT04142983|588123352|FG000|Overall Study|Adverse Event|1|||
162839985|NCT04142983|588123352|FG000|Overall Study|No longer eligible|4|||
162839986|NCT04142983|588123352|FG000|Overall Study|Screen Failure|10|||
162839987|NCT04372927|588123357|FG000|Overall Study|Death|1|||
162949103|NCT01315249|588516964|FG000|Overall Study|Abnormal test results|1|||
162949104|NCT01315249|588516965|FG001|Overall Study|Abnormal test results|2|||
162949105|NCT01315249|588516964|FG000|Overall Study|Administrative problems|1|||
162949106|NCT01315249|588516965|FG001|Overall Study|Administrative problems|0|||
162839988|NCT01847885|588123361|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
162839989|NCT01847885|588123362|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
162839990|NCT01847885|588123363|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
162839991|NCT01847885|588123361|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
162839992|NCT01847885|588123362|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
162839993|NCT01847885|588123363|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
162839994|NCT01847885|588123361|FG000|Initial Enrollment (Consented)|Screen failure|39|||
162839995|NCT01847885|588123362|FG001|Initial Enrollment (Consented)|Screen failure|0|||
162839996|NCT01847885|588123363|FG002|Initial Enrollment (Consented)|Screen failure|0|||
162839997|NCT01847885|588123361|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
162949107|NCT01315249|588516964|FG000|Overall Study|inability to use device|1|||
162949108|NCT01315249|588516965|FG001|Overall Study|inability to use device|0|||
162949109|NCT01315249|588516964|FG000|Overall Study|Lack of Efficacy|0|||
162949110|NCT01315249|588516965|FG001|Overall Study|Lack of Efficacy|1|||
162839998|NCT01847885|588123362|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
162839999|NCT01847885|588123363|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
162840000|NCT01847885|588123361|FG000|Randomization|Protocol Violation|0|||
162840001|NCT01847885|588123362|FG001|Randomization|Protocol Violation|1|||
162840002|NCT01847885|588123363|FG002|Randomization|Protocol Violation|0|||
162840003|NCT01847885|588123361|FG000|Randomization|Withdrawal by Subject|0|||
162840004|NCT01847885|588123362|FG001|Randomization|Withdrawal by Subject|0|||
162840005|NCT01847885|588123363|FG002|Randomization|Withdrawal by Subject|2|||
162840006|NCT01847885|588123361|FG000|Randomization|Screen Failure|0|||
162840007|NCT01847885|588123362|FG001|Randomization|Screen Failure|3|||
162840008|NCT01847885|588123363|FG002|Randomization|Screen Failure|0|||
162840009|NCT03033745|588123366|FG000|Overall Study|Protocol Violation|0|||
162840010|NCT03033745|588123367|FG001|Overall Study|Protocol Violation|0|||
162840011|NCT03033745|588123368|FG002|Overall Study|Protocol Violation|1|||
162840012|NCT03033745|588123366|FG000|Overall Study|Adverse Event|1|||
162840013|NCT03033745|588123367|FG001|Overall Study|Adverse Event|0|||
162840014|NCT03033745|588123368|FG002|Overall Study|Adverse Event|1|||
162840015|NCT03033745|588123366|FG000|Overall Study|Withdrawal by Subject|0|||
162840016|NCT03033745|588123367|FG001|Overall Study|Withdrawal by Subject|1|||
162840017|NCT03033745|588123368|FG002|Overall Study|Withdrawal by Subject|0|||
162840018|NCT01999582|588123370|FG000|Overall Study|Withdrawal by Subject|0|||
162840019|NCT01999582|588123371|FG001|Overall Study|Withdrawal by Subject|0|||
162840020|NCT01999582|588123372|FG002|Overall Study|Withdrawal by Subject|0|||
162840021|NCT01999582|588123373|FG003|Overall Study|Withdrawal by Subject|1|||
162840022|NCT01999582|588123374|FG004|Overall Study|Withdrawal by Subject|0|||
162840023|NCT01999582|588123375|FG005|Overall Study|Withdrawal by Subject|0|||
162840024|NCT01999582|588123370|FG000|Overall Study|Adverse Event|0|||
162840025|NCT01999582|588123371|FG001|Overall Study|Adverse Event|0|||
162840026|NCT01999582|588123372|FG002|Overall Study|Adverse Event|3|||
162840027|NCT01999582|588123373|FG003|Overall Study|Adverse Event|0|||
162840028|NCT01999582|588123374|FG004|Overall Study|Adverse Event|1|||
162840029|NCT01999582|588123375|FG005|Overall Study|Adverse Event|0|||
162840030|NCT01999582|588123370|FG000|Overall Study|Other Reasons|1|||
162840031|NCT01999582|588123371|FG001|Overall Study|Other Reasons|0|||
162840032|NCT01999582|588123372|FG002|Overall Study|Other Reasons|3|||
162949111|NCT01315249|588516964|FG000|Overall Study|Lost to Follow-up|0|||
162949112|NCT01315249|588516965|FG001|Overall Study|Lost to Follow-up|2|||
162840033|NCT01999582|588123373|FG003|Overall Study|Other Reasons|1|||
162840034|NCT01999582|588123374|FG004|Overall Study|Other Reasons|1|||
162840035|NCT01999582|588123375|FG005|Overall Study|Other Reasons|2|||
162840036|NCT01999582|588123370|FG000|Overall Study|Protocol Violation|1|||
162949113|NCT01315249|588516964|FG000|Overall Study|Death|0|||
162840037|NCT01999582|588123371|FG001|Overall Study|Protocol Violation|0|||
162840038|NCT01999582|588123372|FG002|Overall Study|Protocol Violation|0|||
162840039|NCT01999582|588123373|FG003|Overall Study|Protocol Violation|0|||
162840040|NCT01999582|588123374|FG004|Overall Study|Protocol Violation|0|||
162840041|NCT01999582|588123375|FG005|Overall Study|Protocol Violation|1|||
162840042|NCT01999582|588123370|FG000|Overall Study|Lack of Efficacy|1|||
162840043|NCT01999582|588123371|FG001|Overall Study|Lack of Efficacy|3|||
162840044|NCT01999582|588123372|FG002|Overall Study|Lack of Efficacy|0|||
162840045|NCT01999582|588123373|FG003|Overall Study|Lack of Efficacy|1|||
162840046|NCT01999582|588123374|FG004|Overall Study|Lack of Efficacy|0|||
162840047|NCT01999582|588123375|FG005|Overall Study|Lack of Efficacy|0|||
162949114|NCT01315249|588516965|FG001|Overall Study|Death|1|||
162949115|NCT03655106|588516966|FG000|Overall Study|Withdrawal by Subject|3|||
162949116|NCT03655106|588516967|FG001|Overall Study|Withdrawal by Subject|2|||
162949117|NCT03655106|588516966|FG000|Overall Study|Lost to Follow-up|2|||
162949118|NCT03655106|588516967|FG001|Overall Study|Lost to Follow-up|1|||
162949119|NCT03655106|588516966|FG000|Overall Study|Duplicate Enrollment|1|||
162949120|NCT03655106|588516967|FG001|Overall Study|Duplicate Enrollment|1|||
162949121|NCT03655106|588516966|FG000|Overall Study|Protocol Violation|3|||
162949122|NCT03655106|588516967|FG001|Overall Study|Protocol Violation|0|||
162949123|NCT03227445|588516968|FG000|Period 1 (28 Days)|Adverse Event|1|||
162949124|NCT03227445|588516969|FG001|Period 1 (28 Days)|Adverse Event|2|||
162949125|NCT03227445|588516970|FG002|Period 1 (28 Days)|Adverse Event|0|||
162949126|NCT03227445|588516971|FG003|Period 1 (28 Days)|Adverse Event|1|||
162949127|NCT03227445|588516968|FG000|Period 1 (28 Days)|Protocol Violation|1|||
162949128|NCT03227445|588516969|FG001|Period 1 (28 Days)|Protocol Violation|0|||
162949129|NCT03227445|588516970|FG002|Period 1 (28 Days)|Protocol Violation|0|||
162949130|NCT03227445|588516971|FG003|Period 1 (28 Days)|Protocol Violation|0|||
162949131|NCT03227445|588516968|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
162949132|NCT03227445|588516969|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
162949133|NCT03227445|588516970|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
162949134|NCT03227445|588516971|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
162949135|NCT03227445|588516968|FG000|Period 2 (28 Days)|Adverse Event|1|||
162949136|NCT03227445|588516969|FG001|Period 2 (28 Days)|Adverse Event|0|||
162949137|NCT03227445|588516970|FG002|Period 2 (28 Days)|Adverse Event|2|||
162949138|NCT03227445|588516971|FG003|Period 2 (28 Days)|Adverse Event|1|||
162949139|NCT03227445|588516968|FG000|Period 2 (28 Days)|Protocol Violation|0|||
162949140|NCT03227445|588516969|FG001|Period 2 (28 Days)|Protocol Violation|0|||
162949141|NCT03227445|588516970|FG002|Period 2 (28 Days)|Protocol Violation|0|||
162949142|NCT03227445|588516971|FG003|Period 2 (28 Days)|Protocol Violation|1|||
162949143|NCT03227445|588516968|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
162949144|NCT03227445|588516969|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
162840048|NCT03728309|588123380|FG000|Overall Study|Randomized but not Treated|0|||
162949145|NCT03227445|588516970|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
162949146|NCT03227445|588516971|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
162949147|NCT01991470|588516972|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
162949148|NCT01991470|588516972|FG000|Enlite 1 Period|Adverse Event|1|||
162949149|NCT01991470|588516972|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
162949150|NCT01991470|588516972|FG000|Enlite 3 Period|Lost to Follow-up|1|||
162949151|NCT01991470|588516972|FG000|Enlite 3 Period|Physician Decision|2|||
162949152|NCT01991470|588516972|FG000|Enlite 3 Period|Physician Decision|8|||
162949153|NCT01991470|588516972|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
162949154|NCT01225146|588516975|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
162949155|NCT01225146|588516976|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
162949156|NCT00623779|588516977|FG000|Overall Study|Adverse Event|1|||
162949157|NCT00623779|588516978|FG001|Overall Study|Adverse Event|3|||
162949158|NCT00623779|588516979|FG002|Overall Study|Adverse Event|0|||
162840049|NCT03728309|588123381|FG001|Overall Study|Randomized but not Treated|1|||
162840050|NCT03728309|588123380|FG000|Overall Study|Adverse Event|0|||
162949159|NCT00623779|588516977|FG000|Overall Study|Criteria from CSR|2|||
162840051|NCT03728309|588123381|FG001|Overall Study|Adverse Event|1|||
162840052|NCT03728309|588123380|FG000|Overall Study|Withdrawal by Subject|2|||
162840053|NCT03728309|588123381|FG001|Overall Study|Withdrawal by Subject|8|||
162840054|NCT03728309|588123380|FG000|Overall Study|Lost to Follow-up|9|||
162840055|NCT03728309|588123381|FG001|Overall Study|Lost to Follow-up|10|||
162840056|NCT03728309|588123380|FG000|Overall Study|Protocol Deviation|0|||
162840057|NCT03728309|588123381|FG001|Overall Study|Protocol Deviation|1|||
162840058|NCT03728309|588123380|FG000|Overall Study|Due to COVID|1|||
162840059|NCT03728309|588123381|FG001|Overall Study|Due to COVID|3|||
162840060|NCT00927095|588123384|FG000|Overall Study|Adverse Event|3|||
162840061|NCT00927095|588123385|FG001|Overall Study|Adverse Event|1|||
162840062|NCT00927095|588123386|FG002|Overall Study|Adverse Event|0|||
162840063|NCT00927095|588123384|FG000|Overall Study|Withdrawal by Subject|2|||
162840064|NCT00927095|588123385|FG001|Overall Study|Withdrawal by Subject|1|||
162840065|NCT00927095|588123386|FG002|Overall Study|Withdrawal by Subject|1|||
162840066|NCT00927095|588123384|FG000|Overall Study|Physician Decision|1|||
162840067|NCT00927095|588123385|FG001|Overall Study|Physician Decision|2|||
162840068|NCT00927095|588123386|FG002|Overall Study|Physician Decision|1|||
162840069|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
162840070|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
162840071|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
162840072|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
162840073|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162840074|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162840075|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
162840076|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162840077|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
162840078|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162840079|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162840080|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162840081|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
162840082|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
162840083|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
162840084|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
162840085|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
162840086|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
162840087|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
162840088|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
162840089|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
162840090|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
162840091|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
162840092|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
162840093|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
162840094|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
162840095|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
162840096|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
162840097|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
162840098|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
162840099|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
162840100|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
162840101|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
162840102|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
162840103|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
162840104|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
162840105|NCT03403205|588123393|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
162840106|NCT03403205|588123394|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
162840107|NCT03403205|588123395|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
162840108|NCT03403205|588123396|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
162840109|NCT03403205|588123397|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
162840110|NCT03403205|588123398|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
162840111|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
162840112|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
162840113|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
162840114|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
162949160|NCT00623779|588516978|FG001|Overall Study|Criteria from CSR|0|||
162949161|NCT00623779|588516979|FG002|Overall Study|Criteria from CSR|1|||
162840115|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
162949162|NCT01629381|588516983|FG000|Overall Study|Withdrawal by Subject|2|||
162949163|NCT01629381|588516984|FG001|Overall Study|Withdrawal by Subject|5|||
162840116|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
162840117|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
162840118|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
162840119|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
162840120|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
162840121|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
162840122|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
162840123|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Death|1|||
162840124|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Death|0|||
162840125|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Death|0|||
162840126|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Death|0|||
162840127|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Death|0|||
162840128|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Death|0|||
162840129|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
162840130|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
162840131|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
162840132|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
162840133|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
162840134|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
162840135|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
162840136|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
162840137|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
162840138|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
162840139|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
162840140|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
162840141|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
162840142|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
162840143|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
162840144|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
162840145|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
162840146|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
162840147|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
162840148|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
162840149|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
162840150|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
162840151|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
162840152|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
162840153|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
162840154|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
162840155|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
162840156|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
162840157|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
162840158|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
162840159|NCT03403205|588123393|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
162840160|NCT03403205|588123394|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
162840161|NCT03403205|588123395|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
162840162|NCT03403205|588123396|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
162840163|NCT03403205|588123397|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
162840164|NCT03403205|588123398|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
162840165|NCT05130463|588123401|FG000|Overall Study|Unspecified reasons|2|||
162840166|NCT05130463|588123401|FG000|Overall Study|off-label indication dose|435|||
162840167|NCT03652662|588123405|FG000|Overall Study|Withdrawal by Subject|2|||
162840168|NCT03652662|588123406|FG001|Overall Study|Withdrawal by Subject|1|||
162840169|NCT03652662|588123405|FG000|Overall Study|Lost to Follow-up|1|||
162840170|NCT03652662|588123406|FG001|Overall Study|Lost to Follow-up|0|||
162840171|NCT00487539|588123407|FG000|Overall Study|Adverse Event|3|||
162840172|NCT00487539|588123408|FG001|Overall Study|Adverse Event|2|||
162840173|NCT00487539|588123409|FG002|Overall Study|Adverse Event|1|||
162840174|NCT00487539|588123410|FG003|Overall Study|Adverse Event|1|||
162840175|NCT00487539|588123407|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162840176|NCT00487539|588123408|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162840177|NCT00487539|588123409|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162840178|NCT00487539|588123410|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
162840179|NCT00487539|588123407|FG000|Overall Study|Other|3|||
162840180|NCT00487539|588123408|FG001|Overall Study|Other|1|||
162840181|NCT00487539|588123409|FG002|Overall Study|Other|2|||
162840182|NCT00487539|588123410|FG003|Overall Study|Other|2|||
162840183|NCT02695628|588123411|FG000|Overall Study|Withdrawal by Subject|1|||
162949164|NCT00906347|588516987|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
162949165|NCT00906347|588516988|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
162949166|NCT00906347|588516987|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
162949167|NCT00906347|588516988|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
162949168|NCT00906347|588516987|FG000|Received Study Drug|Refused study drug|1|||
162949169|NCT00906347|588516988|FG001|Received Study Drug|Refused study drug|0|||
162949170|NCT00906347|588516987|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
162949171|NCT00906347|588516988|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
162949172|NCT02545998|588516994|FG000|Overall Study|Lost to Follow-up|12|||
162949173|NCT02545998|588516995|FG001|Overall Study|Lost to Follow-up|3|||
162949174|NCT02545998|588516994|FG000|Overall Study|Withdrawal by Subject|3|||
162949175|NCT02545998|588516995|FG001|Overall Study|Withdrawal by Subject|2|||
162949176|NCT00472290|588516996|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
162949177|NCT00472290|588516996|FG000|Overall Study|Protocol Specified Criteria|7|||
162949178|NCT00472290|588516996|FG000|Overall Study|Administrative Decision|37|||
162949179|NCT00472290|588516996|FG000|Overall Study|Death|3|||
162949180|NCT00472290|588516996|FG000|Overall Study|Lost to Follow-up|1|||
162949181|NCT00472290|588516996|FG000|Overall Study|Lack of Efficacy|1|||
162949182|NCT00472290|588516996|FG000|Overall Study|Disease Progression|4|||
162949183|NCT00472290|588516996|FG000|Overall Study|Withdrawal by Subject|5|||
162949184|NCT00472290|588516996|FG000|Overall Study|Adverse Event|6|||
162949185|NCT00472290|588516996|FG000|Overall Study|Requirement for alternative therapy|7|||
162949186|NCT00777829|588516997|FG000|Overall Study|Withdrawal by Subject|0|||
162949187|NCT00777829|588516998|FG001|Overall Study|Withdrawal by Subject|2|||
162949188|NCT00745095|588517000|FG000|Overall Study|Declined to participate|1|||
162949189|NCT00745095|588517001|FG001|Overall Study|Declined to participate|0|||
162949190|NCT00745095|588517002|FG002|Overall Study|Declined to participate|0|||
162949191|NCT00745095|588517003|FG003|Overall Study|Declined to participate|0|||
162949192|NCT00745095|588517004|FG004|Overall Study|Declined to participate|92|||
162949193|NCT00745095|588517005|FG005|Overall Study|Declined to participate|95|||
162949194|NCT00745095|588517000|FG000|Overall Study|Ineligible due to GFR criteria|0|||
162949195|NCT00745095|588517001|FG001|Overall Study|Ineligible due to GFR criteria|2|||
162949196|NCT00745095|588517002|FG002|Overall Study|Ineligible due to GFR criteria|3|||
162949197|NCT00745095|588517003|FG003|Overall Study|Ineligible due to GFR criteria|3|||
162949198|NCT00745095|588517004|FG004|Overall Study|Ineligible due to GFR criteria|30|||
162949199|NCT00745095|588517005|FG005|Overall Study|Ineligible due to GFR criteria|28|||
162949200|NCT01226797|588517010|FG000|Overall Study|Adverse Event|1|||
162949201|NCT01226797|588517011|FG001|Overall Study|Adverse Event|0|||
162949202|NCT01226797|588517010|FG000|Overall Study|No longer willing to participate|1|||
162949203|NCT01226797|588517011|FG001|Overall Study|No longer willing to participate|0|||
162949204|NCT01226797|588517010|FG000|Overall Study|Protocol Violation|0|||
162949205|NCT01226797|588517011|FG001|Overall Study|Protocol Violation|1|||
162840184|NCT02751502|588123412|FG000|Overall Study|Lack of funding|4|||
162840185|NCT02678390|588123413|FG000|AE (1 Day)|Withdrawal by Subject|0|||
162840186|NCT02678390|588123414|FG001|AE (1 Day)|Withdrawal by Subject|1|||
162840187|NCT03499028|588123415|FG000|Overall Study|Lost to Follow-up|12|||
162840188|NCT03499028|588123416|FG001|Overall Study|Lost to Follow-up|9|||
162840189|NCT03499028|588123415|FG000|Overall Study|Withdrawal by Subject|5|||
162840190|NCT03499028|588123416|FG001|Overall Study|Withdrawal by Subject|8|||
162840191|NCT03499028|588123415|FG000|Overall Study|Unplanned SNF discharge|5|||
162840192|NCT03499028|588123416|FG001|Overall Study|Unplanned SNF discharge|8|||
162840193|NCT02925156|588123417|FG000|Overall Study|Lost to Follow-up|27|||
162840194|NCT02925156|588123418|FG001|Overall Study|Lost to Follow-up|53|||
162840195|NCT02925156|588123419|FG002|Overall Study|Lost to Follow-up|51|||
162840196|NCT02925156|588123420|FG003|Overall Study|Lost to Follow-up|59|||
162840197|NCT02925156|588123421|FG004|Overall Study|Lost to Follow-up|89|||
162840198|NCT02925156|588123422|FG005|Overall Study|Lost to Follow-up|107|||
162840199|NCT02925156|588123423|FG006|Overall Study|Lost to Follow-up|34|||
162840200|NCT02925156|588123424|FG007|Overall Study|Lost to Follow-up|36|||
162949206|NCT00577460|588517012|FG000|Overall Study|Adverse Event|11|||
162949207|NCT00577460|588517013|FG001|Overall Study|Adverse Event|7|||
162949208|NCT00577460|588517014|FG002|Overall Study|Adverse Event|14|||
162949209|NCT00577460|588517012|FG000|Overall Study|Protocol Violation|0|||
162949210|NCT00577460|588517013|FG001|Overall Study|Protocol Violation|1|||
162949211|NCT00577460|588517014|FG002|Overall Study|Protocol Violation|1|||
162949212|NCT00577460|588517012|FG000|Overall Study|Lost to Follow-up|0|||
162949213|NCT00577460|588517013|FG001|Overall Study|Lost to Follow-up|3|||
162949214|NCT00577460|588517014|FG002|Overall Study|Lost to Follow-up|4|||
162949215|NCT00577460|588517012|FG000|Overall Study|Withdrawal by Subject|5|||
162840201|NCT02925156|588123425|FG008|Overall Study|Lost to Follow-up|73|||
162949216|NCT00577460|588517013|FG001|Overall Study|Withdrawal by Subject|5|||
162949217|NCT00577460|588517014|FG002|Overall Study|Withdrawal by Subject|6|||
162949218|NCT00577460|588517012|FG000|Overall Study|Other|0|||
162949219|NCT00577460|588517013|FG001|Overall Study|Other|3|||
162949220|NCT00577460|588517014|FG002|Overall Study|Other|2|||
162949221|NCT00162123|588517015|FG000|Overall Study|Disease progression|27|||
162949222|NCT00162123|588517016|FG001|Overall Study|Disease progression|19|||
162840202|NCT02925156|588123426|FG009|Overall Study|Lost to Follow-up|34|||
162840203|NCT01844895|588123427|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
162840204|NCT01844895|588123427|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
162840205|NCT01844895|588123427|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
162840206|NCT01844895|588123427|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
162840207|NCT01844895|588123427|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
162840208|NCT01844895|588123427|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
162840209|NCT01844895|588123427|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
162840210|NCT01318109|588123428|FG000|Overall Study|Adverse Event|0|||
162840211|NCT01318109|588123429|FG001|Overall Study|Adverse Event|2|||
162840212|NCT01318109|588123430|FG002|Overall Study|Adverse Event|0|||
162840213|NCT01318109|588123428|FG000|Overall Study|Withdrawal by Subject|1|||
162840214|NCT01318109|588123429|FG001|Overall Study|Withdrawal by Subject|0|||
162840215|NCT01318109|588123430|FG002|Overall Study|Withdrawal by Subject|0|||
162840216|NCT01318109|588123428|FG000|Overall Study|Schedule Conflict|0|||
162840217|NCT01318109|588123429|FG001|Overall Study|Schedule Conflict|1|||
162840218|NCT01318109|588123430|FG002|Overall Study|Schedule Conflict|0|||
162840219|NCT04982250|588123438|FG000|Overall Study|Lost to Follow-up|0|||
162840220|NCT04982250|588123439|FG001|Overall Study|Lost to Follow-up|26|||
162840221|NCT04982250|588123440|FG002|Overall Study|Lost to Follow-up|0|||
162840222|NCT04982250|588123441|FG003|Overall Study|Lost to Follow-up|0|||
162840223|NCT04982250|588123442|FG004|Overall Study|Lost to Follow-up|72|||
162840224|NCT04982250|588123443|FG005|Overall Study|Lost to Follow-up|69|||
162840225|NCT04982250|588123438|FG000|Overall Study|Not Eligible to Enroll|0|||
162840226|NCT04982250|588123439|FG001|Overall Study|Not Eligible to Enroll|0|||
162840227|NCT04982250|588123440|FG002|Overall Study|Not Eligible to Enroll|0|||
162840228|NCT04982250|588123441|FG003|Overall Study|Not Eligible to Enroll|0|||
162840229|NCT04982250|588123442|FG004|Overall Study|Not Eligible to Enroll|10|||
162840230|NCT04982250|588123443|FG005|Overall Study|Not Eligible to Enroll|7|||
162840231|NCT02392429|588124964|FG000|Screening|Screen failure|15|||
162840232|NCT02392429|588124964|FG000|Enrolled Participants|Ineligible due to disease|3|||
162840233|NCT02392429|588124964|FG000|Enrolled Participants|Withdrawal by Subject|4|||
162840234|NCT02392429|588124964|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
162840235|NCT02392429|588124964|FG000|Evaluable|Death|5|||
162840236|NCT02392429|588124964|FG000|Evaluable|Withdrawal by Subject|1|||
162840237|NCT02392429|588124964|FG000|Evaluable|Adverse Event|1|||
162840238|NCT02392429|588124964|FG000|Evaluable|remission bone marrow biopsy|3|||
162840239|NCT00482014|588124965|FG000|Overall Study|Withdrawal by Subject|1|||
162840240|NCT00482014|588124966|FG001|Overall Study|Withdrawal by Subject|2|||
162840241|NCT00482014|588124967|FG002|Overall Study|Withdrawal by Subject|3|||
162840242|NCT00482014|588124968|FG003|Overall Study|Withdrawal by Subject|4|||
162840243|NCT00482014|588124965|FG000|Overall Study|Adverse Event|3|||
162840244|NCT00482014|588124966|FG001|Overall Study|Adverse Event|0|||
162840245|NCT00482014|588124967|FG002|Overall Study|Adverse Event|2|||
162840246|NCT00482014|588124968|FG003|Overall Study|Adverse Event|8|||
162840247|NCT00482014|588124965|FG000|Overall Study|Death|1|||
162840248|NCT00482014|588124966|FG001|Overall Study|Death|2|||
162840249|NCT00482014|588124967|FG002|Overall Study|Death|1|||
162840250|NCT00482014|588124968|FG003|Overall Study|Death|4|||
162840251|NCT00482014|588124965|FG000|Overall Study|Lack of Efficacy|1|||
162840252|NCT00482014|588124966|FG001|Overall Study|Lack of Efficacy|0|||
162840253|NCT00482014|588124967|FG002|Overall Study|Lack of Efficacy|4|||
162840254|NCT00482014|588124968|FG003|Overall Study|Lack of Efficacy|6|||
162840255|NCT00482014|588124965|FG000|Overall Study|Sponsor Decision|1|||
162840256|NCT00482014|588124966|FG001|Overall Study|Sponsor Decision|2|||
162840257|NCT00482014|588124967|FG002|Overall Study|Sponsor Decision|1|||
162840258|NCT00482014|588124968|FG003|Overall Study|Sponsor Decision|1|||
162840259|NCT01284114|588124971|FG000|Overall Study|viral infection|1|||
162840260|NCT01284114|588124971|FG000|Overall Study|From the results of ALLTITUDE study|1|||
162840261|NCT01284114|588124971|FG000|Overall Study|Symptomatic hypotension|1|||
162840262|NCT01284114|588124971|FG000|Overall Study|dizziness|1|||
162840263|NCT02322710|588124975|FG000|Overall Study|No efficacy assessment post-baseline|0|||
162840264|NCT02322710|588124976|FG001|Overall Study|No efficacy assessment post-baseline|1|||
162840265|NCT02322710|588124975|FG000|Overall Study|Protocol Violation|20|||
162840266|NCT02322710|588124976|FG001|Overall Study|Protocol Violation|25|||
162840267|NCT04161131|588124977|FG000|Overall Study|Ineligible|2|||
162840268|NCT04161131|588124977|FG000|Overall Study|Lost to Follow-up|4|||
162840269|NCT05064059|588124978|FG000|Overall Study|Death|199|||
162840270|NCT05064059|588124979|FG001|Overall Study|Death|196|||
162840271|NCT05064059|588124978|FG000|Overall Study|Physician Decision|4|||
162840272|NCT05064059|588124979|FG001|Overall Study|Physician Decision|2|||
162840273|NCT05064059|588124978|FG000|Overall Study|Sponsor Decision|14|||
162840274|NCT05064059|588124979|FG001|Overall Study|Sponsor Decision|11|||
162840275|NCT05064059|588124978|FG000|Overall Study|Withdrawal by Subject|4|||
162840276|NCT05064059|588124979|FG001|Overall Study|Withdrawal by Subject|11|||
162840277|NCT02615990|588124980|FG000|Overall Study|study terminated|1|||
162840278|NCT02615990|588124981|FG001|Overall Study|study terminated|1|||
162840279|NCT00808444|588124984|FG000|Overall Study|Withdrawal by Subject|1|||
162840280|NCT00808444|588124985|FG001|Overall Study|Withdrawal by Subject|0|||
162840281|NCT00808444|588124984|FG000|Overall Study|Lost to Follow-up|0|||
162840282|NCT00808444|588124985|FG001|Overall Study|Lost to Follow-up|1|||
162840283|NCT04401267|588124986|FG000|Overall Study|Death|0|||
162840284|NCT04401267|588124987|FG001|Overall Study|Death|1|||
162840285|NCT04401267|588124986|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
162840286|NCT04401267|588124987|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
162840287|NCT04401267|588124986|FG000|Overall Study|Found to be Ineligible|1|||
162840288|NCT04401267|588124987|FG001|Overall Study|Found to be Ineligible|0|||
162840289|NCT01449708|588124997|FG000|Overall Study|Protocol Violation|0|||
162840290|NCT01449708|588124998|FG001|Overall Study|Protocol Violation|1|||
162840291|NCT01449708|588124997|FG000|Overall Study|surgical complication|1|||
162840292|NCT01449708|588124998|FG001|Overall Study|surgical complication|2|||
162840293|NCT01449708|588124997|FG000|Overall Study|respiratory failure|1|||
162840294|NCT01449708|588124998|FG001|Overall Study|respiratory failure|0|||
162840295|NCT02421887|588125001|FG000|Overall Study|Lost to Follow-up|5|||
162840296|NCT02421887|588125002|FG001|Overall Study|Lost to Follow-up|0|||
162840297|NCT02421887|588125001|FG000|Overall Study|Withdrawal by Subject|8|||
162840298|NCT02421887|588125002|FG001|Overall Study|Withdrawal by Subject|5|||
162840299|NCT02421887|588125001|FG000|Overall Study|Physician Decision|2|||
162840300|NCT02421887|588125002|FG001|Overall Study|Physician Decision|4|||
162840301|NCT02421887|588125001|FG000|Overall Study|Adverse Event|2|||
162840302|NCT02421887|588125002|FG001|Overall Study|Adverse Event|0|||
162840303|NCT05702515|588125003|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
162840304|NCT01340209|588125009|FG000|Overall Study|Adverse Event|1|||
162840305|NCT01340209|588125010|FG001|Overall Study|Adverse Event|1|||
162840306|NCT01340209|588125011|FG002|Overall Study|Adverse Event|2|||
162840307|NCT01340209|588125009|FG000|Overall Study|Protocol Violation|1|||
162840308|NCT01340209|588125010|FG001|Overall Study|Protocol Violation|2|||
162840309|NCT01340209|588125011|FG002|Overall Study|Protocol Violation|1|||
162840310|NCT01340209|588125009|FG000|Overall Study|Withdrawal by Subject|0|||
162840311|NCT01340209|588125010|FG001|Overall Study|Withdrawal by Subject|0|||
162840312|NCT01340209|588125011|FG002|Overall Study|Withdrawal by Subject|1|||
162840313|NCT01340209|588125009|FG000|Overall Study|Other reason not defined above|3|||
162840314|NCT01340209|588125010|FG001|Overall Study|Other reason not defined above|5|||
162840315|NCT01340209|588125011|FG002|Overall Study|Other reason not defined above|4|||
162840316|NCT02926209|588125012|FG000|Study Cohort|Poor Bowel Preparation|1|||
162840317|NCT02926209|588125013|FG001|Study Cohort|Poor Bowel Preparation|0|||
162840318|NCT00429858|588125014|FG000|Overall Study|Withdrawal by Subject|1|||
162840319|NCT00429858|588125014|FG000|Overall Study|Study Termination|1|||
162840320|NCT01587079|588125015|FG000|Overall Study|Protocol-specified criteria|9|||
162840321|NCT01587079|588125015|FG000|Overall Study|Protocol Violation|5|||
162840322|NCT01587079|588125015|FG000|Overall Study|Lost to Follow-up|2|||
162840323|NCT01587079|588125015|FG000|Overall Study|Physician Decision|2|||
162840324|NCT01587079|588125015|FG000|Overall Study|Withdrawal by Subject|7|||
162840325|NCT01587079|588125015|FG000|Overall Study|Adverse Event|14|||
162840326|NCT01239160|588125016|FG000|Overall Study|Lost to Follow-up|3|||
162840327|NCT01239160|588125017|FG001|Overall Study|Lost to Follow-up|5|||
162840328|NCT01239160|588125018|FG002|Overall Study|Lost to Follow-up|0|||
162840329|NCT01239160|588125016|FG000|Overall Study|Withdrawal by Subject|17|||
162840330|NCT01239160|588125017|FG001|Overall Study|Withdrawal by Subject|6|||
162840331|NCT01239160|588125018|FG002|Overall Study|Withdrawal by Subject|2|||
162840332|NCT01239160|588125016|FG000|Overall Study|Physician Decision|5|||
162840333|NCT01239160|588125017|FG001|Overall Study|Physician Decision|7|||
162840334|NCT01239160|588125018|FG002|Overall Study|Physician Decision|2|||
162840335|NCT01239160|588125016|FG000|Overall Study|Early Termination Due to Study Closure|0|||
162840336|NCT01239160|588125017|FG001|Overall Study|Early Termination Due to Study Closure|1|||
162840337|NCT01239160|588125018|FG002|Overall Study|Early Termination Due to Study Closure|6|||
162840338|NCT04781816|588125023|FG000|Overall Study|Adverse Event|0|||
162840339|NCT04781816|588125024|FG001|Overall Study|Adverse Event|1|||
162840340|NCT04781816|588125023|FG000|Overall Study|Withdrawal by Subject|1|||
162840341|NCT04781816|588125024|FG001|Overall Study|Withdrawal by Subject|1|||
162840342|NCT04781816|588125023|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
162840343|NCT04781816|588125024|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
162840344|NCT01789970|588125025|FG000|Open-label Titration Period|Adverse Event|68|||
162840345|NCT01789970|588125026|FG001|Open-label Titration Period|Adverse Event|0|||
162840346|NCT01789970|588125027|FG002|Open-label Titration Period|Adverse Event|0|||
162840347|NCT01789970|588125025|FG000|Open-label Titration Period|Lack of Efficacy|31|||
162840348|NCT01789970|588125026|FG001|Open-label Titration Period|Lack of Efficacy|0|||
162840349|NCT01789970|588125027|FG002|Open-label Titration Period|Lack of Efficacy|0|||
162840350|NCT01789970|588125025|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
162840351|NCT01789970|588125026|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
162840352|NCT01789970|588125027|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
162840353|NCT01789970|588125025|FG000|Open-label Titration Period|Protocol Violation|18|||
162840354|NCT01789970|588125026|FG001|Open-label Titration Period|Protocol Violation|0|||
162949223|NCT00162123|588517017|FG002|Overall Study|Disease progression|10|||
162840355|NCT01789970|588125027|FG002|Open-label Titration Period|Protocol Violation|0|||
162840356|NCT01789970|588125025|FG000|Open-label Titration Period|Lost to Follow-up|5|||
162840357|NCT01789970|588125026|FG001|Open-label Titration Period|Lost to Follow-up|0|||
162840358|NCT01789970|588125027|FG002|Open-label Titration Period|Lost to Follow-up|0|||
162840359|NCT01789970|588125025|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
162840360|NCT01789970|588125026|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
162840361|NCT01789970|588125027|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
162840362|NCT01789970|588125025|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
162840363|NCT01789970|588125026|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
162840364|NCT01789970|588125027|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
162840365|NCT01789970|588125025|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
162840366|NCT01789970|588125026|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
162840367|NCT01789970|588125027|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
162840368|NCT01789970|588125025|FG000|Open-label Titration Period|Pregnancy|2|||
162840369|NCT01789970|588125026|FG001|Open-label Titration Period|Pregnancy|0|||
162840370|NCT01789970|588125027|FG002|Open-label Titration Period|Pregnancy|0|||
162840371|NCT01789970|588125025|FG000|Open-label Titration Period|Other|76|||
162840372|NCT01789970|588125026|FG001|Open-label Titration Period|Other|0|||
162840373|NCT01789970|588125027|FG002|Open-label Titration Period|Other|0|||
162840374|NCT01789970|588125025|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
162840375|NCT01789970|588125026|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
162840376|NCT01789970|588125027|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
162840377|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
162840378|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
162840379|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
162840380|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162840381|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
162840382|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
162840383|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162840384|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
162840385|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
162840386|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
162840387|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
162840388|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
162840389|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
162840390|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
162840391|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
162840392|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
162840393|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
162840394|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
162840395|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162840396|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162840397|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
162840398|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
162840399|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
162840400|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
162840401|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
162840402|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
162840403|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
162840404|NCT01789970|588125025|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
162840405|NCT01789970|588125026|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
162840406|NCT01789970|588125027|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
162840407|NCT00643994|588125028|FG000|Overall Study|Death|24|||
162840408|NCT00643994|588125028|FG000|Overall Study|Lost to Follow-up|72|||
162840409|NCT04016311|588125032|FG000|Overall Study|Withdrawal by Subject|1|||
162840410|NCT04016311|588125033|FG001|Overall Study|Withdrawal by Subject|0|||
162840411|NCT00662792|588125034|FG000|Period 1|Personal Reasons|0|||
162840412|NCT00662792|588125035|FG001|Period 1|Personal Reasons|0|||
162840413|NCT00662792|588125036|FG002|Period 1|Personal Reasons|1|||
162840414|NCT00662792|588125037|FG003|Period 1|Personal Reasons|0|||
162840415|NCT00662792|588125034|FG000|Period 1|Refused continuing medication|0|||
162840416|NCT00662792|588125035|FG001|Period 1|Refused continuing medication|1|||
162840417|NCT00662792|588125036|FG002|Period 1|Refused continuing medication|1|||
162840418|NCT00662792|588125037|FG003|Period 1|Refused continuing medication|0|||
162840419|NCT00662792|588125034|FG000|Period 1|Lost to Follow-up|1|||
162840420|NCT00662792|588125035|FG001|Period 1|Lost to Follow-up|0|||
162840421|NCT00662792|588125036|FG002|Period 1|Lost to Follow-up|0|||
162840422|NCT00662792|588125037|FG003|Period 1|Lost to Follow-up|0|||
162840423|NCT00662792|588125034|FG000|Period 1|Other adverse event (AE)|0|||
162840424|NCT00662792|588125035|FG001|Period 1|Other adverse event (AE)|2|||
162840425|NCT00662792|588125036|FG002|Period 1|Other adverse event (AE)|0|||
162840426|NCT00662792|588125037|FG003|Period 1|Other adverse event (AE)|0|||
162840427|NCT00662792|588125034|FG000|Period 1|Worsening of disease under study (AE)|1|||
162840428|NCT00662792|588125035|FG001|Period 1|Worsening of disease under study (AE)|3|||
162840429|NCT00662792|588125036|FG002|Period 1|Worsening of disease under study (AE)|2|||
162840430|NCT00662792|588125037|FG003|Period 1|Worsening of disease under study (AE)|0|||
162949224|NCT00162123|588517018|FG003|Overall Study|Disease progression|4|||
162949225|NCT00162123|588517019|FG004|Overall Study|Disease progression|8|||
162949226|NCT00162123|588517020|FG005|Overall Study|Disease progression|3|||
162949227|NCT00162123|588517021|FG006|Overall Study|Disease progression|1|||
162949228|NCT00162123|588517022|FG007|Overall Study|Disease progression|0|||
162949229|NCT00162123|588517015|FG000|Overall Study|Study drug toxicity|6|||
162949230|NCT00162123|588517016|FG001|Overall Study|Study drug toxicity|1|||
162949231|NCT00162123|588517017|FG002|Overall Study|Study drug toxicity|5|||
162949232|NCT00162123|588517018|FG003|Overall Study|Study drug toxicity|0|||
162949233|NCT00162123|588517019|FG004|Overall Study|Study drug toxicity|4|||
162949234|NCT00162123|588517020|FG005|Overall Study|Study drug toxicity|1|||
162949235|NCT00162123|588517021|FG006|Overall Study|Study drug toxicity|1|||
162949236|NCT00162123|588517022|FG007|Overall Study|Study drug toxicity|0|||
162949237|NCT00162123|588517015|FG000|Overall Study|Death|3|||
162949238|NCT00162123|588517016|FG001|Overall Study|Death|3|||
162949239|NCT00162123|588517017|FG002|Overall Study|Death|1|||
162949240|NCT00162123|588517018|FG003|Overall Study|Death|1|||
162949241|NCT00162123|588517019|FG004|Overall Study|Death|1|||
162949242|NCT00162123|588517020|FG005|Overall Study|Death|1|||
162949243|NCT00162123|588517021|FG006|Overall Study|Death|0|||
162949244|NCT00162123|588517022|FG007|Overall Study|Death|0|||
162949245|NCT00162123|588517015|FG000|Overall Study|Withdrawal by Subject|2|||
162949246|NCT00162123|588517016|FG001|Overall Study|Withdrawal by Subject|0|||
162949247|NCT00162123|588517017|FG002|Overall Study|Withdrawal by Subject|2|||
162949248|NCT00162123|588517018|FG003|Overall Study|Withdrawal by Subject|1|||
162949249|NCT00162123|588517019|FG004|Overall Study|Withdrawal by Subject|1|||
162949250|NCT00162123|588517020|FG005|Overall Study|Withdrawal by Subject|2|||
162949251|NCT00162123|588517021|FG006|Overall Study|Withdrawal by Subject|1|||
162949252|NCT00162123|588517022|FG007|Overall Study|Withdrawal by Subject|0|||
162949253|NCT00162123|588517015|FG000|Overall Study|Deterioration without progression|2|||
162949254|NCT00162123|588517016|FG001|Overall Study|Deterioration without progression|2|||
162949255|NCT00162123|588517017|FG002|Overall Study|Deterioration without progression|3|||
162949256|NCT00162123|588517018|FG003|Overall Study|Deterioration without progression|0|||
162949257|NCT00162123|588517019|FG004|Overall Study|Deterioration without progression|1|||
162949258|NCT00162123|588517020|FG005|Overall Study|Deterioration without progression|0|||
162949259|NCT00162123|588517021|FG006|Overall Study|Deterioration without progression|0|||
162949260|NCT00162123|588517022|FG007|Overall Study|Deterioration without progression|0|||
162949261|NCT00162123|588517015|FG000|Overall Study|Adverse Event|1|||
162949262|NCT00162123|588517016|FG001|Overall Study|Adverse Event|2|||
162949263|NCT00162123|588517017|FG002|Overall Study|Adverse Event|0|||
162949264|NCT00162123|588517018|FG003|Overall Study|Adverse Event|2|||
162949265|NCT00162123|588517019|FG004|Overall Study|Adverse Event|1|||
162949266|NCT00162123|588517020|FG005|Overall Study|Adverse Event|0|||
162949267|NCT00162123|588517021|FG006|Overall Study|Adverse Event|0|||
162949268|NCT00162123|588517022|FG007|Overall Study|Adverse Event|0|||
162949269|NCT00162123|588517015|FG000|Overall Study|Not specified (before treatment)|2|||
162840431|NCT00662792|588125034|FG000|Period 1|Not treated|0|||
162949270|NCT00162123|588517016|FG001|Overall Study|Not specified (before treatment)|0|||
162949271|NCT00162123|588517017|FG002|Overall Study|Not specified (before treatment)|0|||
162949272|NCT00162123|588517018|FG003|Overall Study|Not specified (before treatment)|0|||
162949273|NCT00162123|588517019|FG004|Overall Study|Not specified (before treatment)|12|||
162840432|NCT00662792|588125035|FG001|Period 1|Not treated|1|||
162949274|NCT00162123|588517020|FG005|Overall Study|Not specified (before treatment)|1|||
162949275|NCT00162123|588517021|FG006|Overall Study|Not specified (before treatment)|0|||
162949276|NCT00162123|588517022|FG007|Overall Study|Not specified (before treatment)|0|||
162949277|NCT00162123|588517015|FG000|Overall Study|Not specified (after start of treatment)|0|||
162949278|NCT00162123|588517016|FG001|Overall Study|Not specified (after start of treatment)|0|||
162949279|NCT00162123|588517017|FG002|Overall Study|Not specified (after start of treatment)|0|||
162949280|NCT00162123|588517018|FG003|Overall Study|Not specified (after start of treatment)|0|||
162949281|NCT00162123|588517019|FG004|Overall Study|Not specified (after start of treatment)|3|||
162949282|NCT00162123|588517020|FG005|Overall Study|Not specified (after start of treatment)|0|||
162949283|NCT00162123|588517021|FG006|Overall Study|Not specified (after start of treatment)|0|||
162949284|NCT00162123|588517022|FG007|Overall Study|Not specified (after start of treatment)|0|||
162949285|NCT00162123|588517015|FG000|Overall Study|Physician Decision|1|||
162949286|NCT00162123|588517016|FG001|Overall Study|Physician Decision|2|||
162949287|NCT00162123|588517017|FG002|Overall Study|Physician Decision|0|||
162949288|NCT00162123|588517018|FG003|Overall Study|Physician Decision|0|||
162949289|NCT00162123|588517019|FG004|Overall Study|Physician Decision|0|||
162949290|NCT00162123|588517020|FG005|Overall Study|Physician Decision|1|||
162949291|NCT00162123|588517021|FG006|Overall Study|Physician Decision|1|||
162949292|NCT00162123|588517022|FG007|Overall Study|Physician Decision|0|||
162949293|NCT00162123|588517015|FG000|Overall Study|Tumor assessment only (not treated)|0|||
162949294|NCT00162123|588517016|FG001|Overall Study|Tumor assessment only (not treated)|0|||
162949295|NCT00162123|588517017|FG002|Overall Study|Tumor assessment only (not treated)|0|||
162949296|NCT00162123|588517018|FG003|Overall Study|Tumor assessment only (not treated)|0|||
162949297|NCT00162123|588517019|FG004|Overall Study|Tumor assessment only (not treated)|0|||
162949298|NCT00162123|588517020|FG005|Overall Study|Tumor assessment only (not treated)|0|||
162949299|NCT00162123|588517021|FG006|Overall Study|Tumor assessment only (not treated)|0|||
162949300|NCT00162123|588517022|FG007|Overall Study|Tumor assessment only (not treated)|1|||
162949301|NCT00162123|588517015|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
162949302|NCT00162123|588517016|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
162949303|NCT00162123|588517017|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
162949304|NCT00162123|588517018|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
162949305|NCT00162123|588517019|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
162949306|NCT00162123|588517020|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
162949307|NCT00162123|588517021|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
162949308|NCT00162123|588517022|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
162949309|NCT02016170|588517023|FG000|Overall Study|Adverse Event|1|||
162949310|NCT02016170|588517024|FG001|Overall Study|Adverse Event|1|||
162949311|NCT02016170|588517025|FG002|Overall Study|Adverse Event|0|||
162949312|NCT02016170|588517023|FG000|Overall Study|Protocol Violation|1|||
162949313|NCT02016170|588517024|FG001|Overall Study|Protocol Violation|0|||
162949314|NCT02016170|588517025|FG002|Overall Study|Protocol Violation|0|||
162949315|NCT05214560|588517028|FG000|Overall Study|Screening Failure|1|||
162949316|NCT05214560|588517028|FG000|Overall Study|Physician Decision|4|||
162949317|NCT05214560|588517028|FG000|Overall Study|Withdrawal by Subject|1|||
162949318|NCT05214560|588517028|FG000|Overall Study|Lost to Follow-up|2|||
162949319|NCT05214560|588517028|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
162949320|NCT05214560|588517028|FG000|Overall Study|Study physician not available for the anesthesia|3|||
162949321|NCT05214560|588517028|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
162949322|NCT05214560|588517028|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
162949323|NCT05214560|588517028|FG000|Overall Study|Surgery not performed|3|||
162949324|NCT00878995|588517032|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
162949325|NCT00878995|588517033|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
162949326|NCT03629249|588517034|FG000|Overall Study|Study terminated by sponsor|197|||
162949327|NCT03629249|588517035|FG001|Overall Study|Study terminated by sponsor|197|||
162949328|NCT03629249|588517036|FG002|Overall Study|Study terminated by sponsor|194|||
162949329|NCT03629249|588517034|FG000|Overall Study|Protocol deviation|0|||
162949330|NCT03629249|588517035|FG001|Overall Study|Protocol deviation|2|||
162949331|NCT03629249|588517036|FG002|Overall Study|Protocol deviation|5|||
162949332|NCT03629249|588517034|FG000|Overall Study|Subject decision|1|||
162949333|NCT03629249|588517035|FG001|Overall Study|Subject decision|1|||
162949334|NCT03629249|588517036|FG002|Overall Study|Subject decision|3|||
162949335|NCT03629249|588517034|FG000|Overall Study|Adverse Event|1|||
162949336|NCT03629249|588517035|FG001|Overall Study|Adverse Event|1|||
162949337|NCT03629249|588517036|FG002|Overall Study|Adverse Event|0|||
162949338|NCT03629249|588517034|FG000|Overall Study|Death|1|||
162949339|NCT03629249|588517035|FG001|Overall Study|Death|0|||
162949340|NCT03629249|588517036|FG002|Overall Study|Death|0|||
162949341|NCT03629249|588517034|FG000|Overall Study|Physician Decision|1|||
162949342|NCT03629249|588517035|FG001|Overall Study|Physician Decision|0|||
162949343|NCT03629249|588517036|FG002|Overall Study|Physician Decision|0|||
162949344|NCT00352690|588517037|FG000|Overall Study|Determined to be ineligible|2|||
162949345|NCT00352690|588517038|FG001|Overall Study|Determined to be ineligible|0|||
162949346|NCT03633721|588517041|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
162949347|NCT03633721|588517042|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
162949348|NCT03633721|588517043|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
162949349|NCT03633721|588517044|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
162949350|NCT01475474|588517048|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
162949351|NCT01475474|588517048|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
162949352|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
162949353|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
162949354|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
162949355|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
162949356|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
162949357|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Death|1|||
162949358|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Death|2|||
162949359|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Death|2|||
162949360|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Death|2|||
162949361|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Death|1|||
162949362|NCT02343120|588517049|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
162949363|NCT02343120|588517050|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949364|NCT02343120|588517051|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949365|NCT02343120|588517052|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949366|NCT02343120|588517053|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
162949367|NCT02343120|588517049|FG000|Part 2: Expansion|Sponsor decision|0|||
162949368|NCT02343120|588517050|FG001|Part 2: Expansion|Sponsor decision|0|||
162949369|NCT02343120|588517051|FG002|Part 2: Expansion|Sponsor decision|0|||
162949370|NCT02343120|588517052|FG003|Part 2: Expansion|Sponsor decision|165|||
162949371|NCT02343120|588517053|FG004|Part 2: Expansion|Sponsor decision|67|||
162949372|NCT02343120|588517049|FG000|Part 2: Expansion|Death|0|||
162949373|NCT02343120|588517050|FG001|Part 2: Expansion|Death|0|||
162949374|NCT02343120|588517051|FG002|Part 2: Expansion|Death|0|||
162949375|NCT02343120|588517052|FG003|Part 2: Expansion|Death|74|||
162949376|NCT02343120|588517053|FG004|Part 2: Expansion|Death|17|||
162949377|NCT02343120|588517049|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
162949378|NCT02343120|588517050|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
162949379|NCT02343120|588517051|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
162949380|NCT02343120|588517052|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
162949381|NCT02343120|588517053|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
162949382|NCT02343120|588517049|FG000|Part 2: Expansion|Lost to Follow-up|0|||
162949383|NCT02343120|588517050|FG001|Part 2: Expansion|Lost to Follow-up|0|||
162949384|NCT02343120|588517051|FG002|Part 2: Expansion|Lost to Follow-up|0|||
162949385|NCT02343120|588517052|FG003|Part 2: Expansion|Lost to Follow-up|5|||
162949386|NCT02343120|588517053|FG004|Part 2: Expansion|Lost to Follow-up|2|||
162949387|NCT02343120|588517049|FG000|Part 2: Expansion|Other|0|||
162949388|NCT02343120|588517050|FG001|Part 2: Expansion|Other|0|||
162949389|NCT02343120|588517051|FG002|Part 2: Expansion|Other|0|||
162949390|NCT02343120|588517052|FG003|Part 2: Expansion|Other|1|||
162949391|NCT02343120|588517053|FG004|Part 2: Expansion|Other|5|||
162949392|NCT02343120|588517049|FG000|Part 2: Expansion|Adverse Event|0|||
162949393|NCT02343120|588517050|FG001|Part 2: Expansion|Adverse Event|0|||
162949394|NCT02343120|588517051|FG002|Part 2: Expansion|Adverse Event|0|||
162949395|NCT02343120|588517052|FG003|Part 2: Expansion|Adverse Event|1|||
162949396|NCT02343120|588517053|FG004|Part 2: Expansion|Adverse Event|1|||
162949397|NCT02534493|588517059|FG000|Overall Study|Lost to Follow-up|1|||
162949398|NCT02534493|588517059|FG000|Overall Study|Withdrawal by Subject|1|||
162949399|NCT01691248|588517060|FG000|Overall Study|Protocol Violation|43|||
162949400|NCT01691248|588517061|FG001|Overall Study|Protocol Violation|27|||
162949401|NCT01691248|588517060|FG000|Overall Study|Adverse Event|24|||
162949402|NCT01691248|588517061|FG001|Overall Study|Adverse Event|22|||
162949403|NCT01691248|588517060|FG000|Overall Study|Withdrawal by Subject|20|||
162949404|NCT01691248|588517061|FG001|Overall Study|Withdrawal by Subject|18|||
162949405|NCT01691248|588517060|FG000|Overall Study|Confirmed CDAD|14|||
162949406|NCT01691248|588517061|FG001|Overall Study|Confirmed CDAD|31|||
162949407|NCT01691248|588517060|FG000|Overall Study|Lost to Follow-up|2|||
162949408|NCT01691248|588517061|FG001|Overall Study|Lost to Follow-up|5|||
162949409|NCT01691248|588517060|FG000|Overall Study|Reason not provided|4|||
162949410|NCT01691248|588517061|FG001|Overall Study|Reason not provided|4|||
162949411|NCT01691248|588517060|FG000|Overall Study|Not Treated|4|||
162949412|NCT01691248|588517061|FG001|Overall Study|Not Treated|7|||
162949413|NCT00549718|588518704|FG000|Overall Study|Insufficient clinical response|20|||
162949414|NCT00549718|588518705|FG001|Overall Study|Insufficient clinical response|7|||
162949415|NCT00549718|588518706|FG002|Overall Study|Insufficient clinical response|18|||
162949416|NCT00549718|588518707|FG003|Overall Study|Insufficient clinical response|32|||
162949417|NCT00549718|588518704|FG000|Overall Study|Adverse Event|6|||
162949418|NCT00549718|588518705|FG001|Overall Study|Adverse Event|8|||
162949419|NCT00549718|588518706|FG002|Overall Study|Adverse Event|7|||
162949420|NCT00549718|588518707|FG003|Overall Study|Adverse Event|3|||
162949421|NCT00549718|588518704|FG000|Overall Study|Lost to Follow-up|4|||
162949422|NCT00549718|588518705|FG001|Overall Study|Lost to Follow-up|2|||
162949423|NCT00549718|588518706|FG002|Overall Study|Lost to Follow-up|0|||
162949424|NCT00549718|588518707|FG003|Overall Study|Lost to Follow-up|6|||
162949425|NCT00549718|588518704|FG000|Overall Study|Withdrawal by Subject|9|||
162949426|NCT00549718|588518705|FG001|Overall Study|Withdrawal by Subject|18|||
162949427|NCT00549718|588518706|FG002|Overall Study|Withdrawal by Subject|12|||
162949428|NCT00549718|588518707|FG003|Overall Study|Withdrawal by Subject|13|||
162949429|NCT00549718|588518704|FG000|Overall Study|Administrative|2|||
162949430|NCT00549718|588518705|FG001|Overall Study|Administrative|2|||
162949431|NCT00549718|588518706|FG002|Overall Study|Administrative|2|||
162949432|NCT00549718|588518707|FG003|Overall Study|Administrative|1|||
162949433|NCT00397488|588518708|FG000|Overall Study|Withdrawal by Subject|3|||
162949434|NCT00397488|588518708|FG000|Overall Study|Adverse Event|3|||
162949435|NCT00397488|588518708|FG000|Overall Study|Death|1|||
162949436|NCT02880761|588518712|FG000|Overall Study|Death|6|||
162949437|NCT02880761|588518713|FG001|Overall Study|Death|8|||
162949438|NCT02880761|588518712|FG000|Overall Study|Withdrawal by Subject|3|||
162949439|NCT02880761|588518713|FG001|Overall Study|Withdrawal by Subject|6|||
162949440|NCT02880761|588518712|FG000|Overall Study|Protocol Violation|4|||
162949441|NCT02880761|588518713|FG001|Overall Study|Protocol Violation|3|||
162949442|NCT02880761|588518712|FG000|Overall Study|Lost to Follow-up|3|||
162949443|NCT02880761|588518713|FG001|Overall Study|Lost to Follow-up|4|||
162949444|NCT02106156|588518714|FG000|Overall Study|Patient Died|19|||
162949445|NCT02106156|588518715|FG001|Overall Study|Patient Died|0|||
162949446|NCT02106156|588518716|FG002|Overall Study|Patient Died|0|||
162949447|NCT02106156|588518714|FG000|Overall Study|Lack of Tolerability|305|||
162949448|NCT02106156|588518715|FG001|Overall Study|Lack of Tolerability|3|||
162949449|NCT02106156|588518716|FG002|Overall Study|Lack of Tolerability|0|||
162949450|NCT02106156|588518714|FG000|Overall Study|Lack of Virological Response|1044|||
162949451|NCT02106156|588518715|FG001|Overall Study|Lack of Virological Response|8|||
162949452|NCT02106156|588518716|FG002|Overall Study|Lack of Virological Response|0|||
162949453|NCT02106156|588518714|FG000|Overall Study|Concomitant Disease|74|||
162949454|NCT02106156|588518715|FG001|Overall Study|Concomitant Disease|2|||
162949455|NCT02106156|588518716|FG002|Overall Study|Concomitant Disease|0|||
162949456|NCT02106156|588518714|FG000|Overall Study|Lack of Compliance|211|||
162949457|NCT02106156|588518715|FG001|Overall Study|Lack of Compliance|7|||
162949458|NCT02106156|588518716|FG002|Overall Study|Lack of Compliance|0|||
162949459|NCT02106156|588518714|FG000|Overall Study|Patients Request|307|||
162949460|NCT02106156|588518715|FG001|Overall Study|Patients Request|9|||
162949461|NCT02106156|588518716|FG002|Overall Study|Patients Request|0|||
162949462|NCT02106156|588518714|FG000|Overall Study|Lost to Follow-up|451|||
162949463|NCT02106156|588518715|FG001|Overall Study|Lost to Follow-up|8|||
162949464|NCT02106156|588518716|FG002|Overall Study|Lost to Follow-up|0|||
162949465|NCT02106156|588518714|FG000|Overall Study|Unplanned Event|82|||
162949466|NCT02106156|588518715|FG001|Overall Study|Unplanned Event|2|||
162949467|NCT02106156|588518716|FG002|Overall Study|Unplanned Event|0|||
162949468|NCT02106156|588518714|FG000|Overall Study|Change of Laboratory Parameter|10|||
162949469|NCT02106156|588518715|FG001|Overall Study|Change of Laboratory Parameter|0|||
162949470|NCT02106156|588518716|FG002|Overall Study|Change of Laboratory Parameter|0|||
162949471|NCT02106156|588518714|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
162949472|NCT02106156|588518715|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
162949473|NCT02106156|588518716|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
162949474|NCT02106156|588518714|FG000|Overall Study|Relocation/Change of Physician|40|||
162949475|NCT02106156|588518715|FG001|Overall Study|Relocation/Change of Physician|1|||
162949476|NCT02106156|588518716|FG002|Overall Study|Relocation/Change of Physician|0|||
162949477|NCT01136382|588518717|FG000|Overall Study|Other|8|||
162949478|NCT01136382|588518718|FG001|Overall Study|Other|3|||
162949479|NCT01136382|588518717|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
162949480|NCT01136382|588518718|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
162949481|NCT01136382|588518717|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
162949482|NCT01136382|588518718|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
162949483|NCT01136382|588518717|FG000|Overall Study|Withdrawal by Subject|4|||
162949484|NCT01136382|588518718|FG001|Overall Study|Withdrawal by Subject|1|||
162949485|NCT01287013|588518726|FG000|Overall Study|Non-evaluable|3|||
162949486|NCT01287013|588518727|FG001|Overall Study|Non-evaluable|5|||
162949487|NCT01287013|588518728|FG002|Overall Study|Non-evaluable|21|||
162949488|NCT00051025|588518729|FG000|Overall Study|Progressive Disease|1|||
162949489|NCT00051025|588518730|FG001|Overall Study|Progressive Disease|1|||
162949490|NCT00051025|588518729|FG000|Overall Study|Adverse Event|1|||
162949491|NCT00051025|588518730|FG001|Overall Study|Adverse Event|1|||
162949492|NCT00051025|588518729|FG000|Overall Study|Withdrawal by Subject|0|||
162949493|NCT00051025|588518730|FG001|Overall Study|Withdrawal by Subject|1|||
162949494|NCT00051025|588518729|FG000|Overall Study|Death|0|||
162949495|NCT00051025|588518730|FG001|Overall Study|Death|1|||
162949496|NCT01179048|588518731|FG000|Overall Study|Withdrawn - does not allow contact|4|||
162949497|NCT01179048|588518732|FG001|Overall Study|Withdrawn - does not allow contact|8|||
162949498|NCT01179048|588518731|FG000|Overall Study|Lost to Follow-up|8|||
162949499|NCT01179048|588518732|FG001|Overall Study|Lost to Follow-up|9|||
162949500|NCT01179048|588518731|FG000|Overall Study|Alive|127|||
162949501|NCT01179048|588518732|FG001|Overall Study|Alive|142|||
162840433|NCT00662792|588125036|FG002|Period 1|Not treated|0|||
162840434|NCT00662792|588125037|FG003|Period 1|Not treated|0|||
162840435|NCT00662792|588125034|FG000|Period 2|Worsening of disease under study|1|||
162840436|NCT00662792|588125035|FG001|Period 2|Worsening of disease under study|0|||
162840437|NCT00662792|588125036|FG002|Period 2|Worsening of disease under study|0|||
162700376|NCT04212169|587615026|FG003|Overall Study|Adverse Event|2|||
162700377|NCT04212169|587615023|FG000|Overall Study|Lost to Follow-up|1|||
162700378|NCT04212169|587615024|FG001|Overall Study|Lost to Follow-up|0|||
162700379|NCT04212169|587615025|FG002|Overall Study|Lost to Follow-up|0|||
162700380|NCT04212169|587615026|FG003|Overall Study|Lost to Follow-up|2|||
162840438|NCT00662792|588125037|FG003|Period 2|Worsening of disease under study|3|||
162840439|NCT00662792|588125034|FG000|Period 3|Refused continuing medication|1|||
162840440|NCT00662792|588125035|FG001|Period 3|Refused continuing medication|0|||
162840441|NCT00662792|588125036|FG002|Period 3|Refused continuing medication|1|||
162840442|NCT00662792|588125037|FG003|Period 3|Refused continuing medication|0|||
162840443|NCT00662792|588125034|FG000|Period 3|Other adverse event (AE)|0|||
162840444|NCT00662792|588125035|FG001|Period 3|Other adverse event (AE)|0|||
162840445|NCT00662792|588125036|FG002|Period 3|Other adverse event (AE)|1|||
162840446|NCT00662792|588125037|FG003|Period 3|Other adverse event (AE)|1|||
162840447|NCT00662792|588125034|FG000|Period 4|Refused continuing medication|0|||
162840448|NCT00662792|588125035|FG001|Period 4|Refused continuing medication|1|||
162840449|NCT00662792|588125036|FG002|Period 4|Refused continuing medication|0|||
162840450|NCT00662792|588125037|FG003|Period 4|Refused continuing medication|0|||
162840451|NCT00662792|588125034|FG000|Period 4|Other adverse event (AE)|1|||
162840452|NCT00662792|588125035|FG001|Period 4|Other adverse event (AE)|0|||
162840453|NCT00662792|588125036|FG002|Period 4|Other adverse event (AE)|0|||
162840454|NCT00662792|588125037|FG003|Period 4|Other adverse event (AE)|0|||
162840455|NCT00662792|588125034|FG000|Period 4|Worsening of disease under study (AE)|0|||
162840456|NCT00662792|588125035|FG001|Period 4|Worsening of disease under study (AE)|0|||
162840457|NCT00662792|588125036|FG002|Period 4|Worsening of disease under study (AE)|0|||
162840458|NCT00662792|588125037|FG003|Period 4|Worsening of disease under study (AE)|1|||
162840459|NCT04029519|588125039|FG000|Overall Study|Protocol Violation|1|||
162840460|NCT04029519|588125039|FG000|Overall Study|Withdrawal by Subject|3|||
162840461|NCT04029519|588125039|FG000|Overall Study|Lost to Follow-up|1|||
162840462|NCT02706730|588125040|FG000|Overall Study|Adverse Event|3|||
162840463|NCT02706730|588125040|FG000|Overall Study|Lack of Efficacy|5|||
162840464|NCT02706730|588125040|FG000|Overall Study|Withdrawal by Subject|11|||
162840465|NCT02706730|588125040|FG000|Overall Study|Study Terminated by Sponsor|11|||
162840466|NCT02706730|588125040|FG000|Overall Study|Subject chose not to receive injection|3|||
162840467|NCT02499029|588125041|FG000|Overall Study|Lost to Follow-up|2|||
162840468|NCT02499029|588125042|FG001|Overall Study|Lost to Follow-up|2|||
162840469|NCT02499029|588125041|FG000|Overall Study|Physician Decision|2|||
162840470|NCT02499029|588125042|FG001|Overall Study|Physician Decision|1|||
162840471|NCT02499029|588125041|FG000|Overall Study|Death|1|||
162840472|NCT02499029|588125042|FG001|Overall Study|Death|0|||
162840473|NCT00756938|588125043|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
162840474|NCT00756938|588125044|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
162840475|NCT00756938|588125045|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
162840476|NCT00756938|588125046|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
162840477|NCT00756938|588125043|FG000|12-week Base Study|Protocol Violation|0|||
162840478|NCT00756938|588125044|FG001|12-week Base Study|Protocol Violation|0|||
162840479|NCT00756938|588125045|FG002|12-week Base Study|Protocol Violation|1|||
162840480|NCT00756938|588125046|FG003|12-week Base Study|Protocol Violation|0|||
162840481|NCT00756938|588125043|FG000|12-week Base Study|Lost to Follow-up|1|||
162840482|NCT00756938|588125044|FG001|12-week Base Study|Lost to Follow-up|0|||
162840483|NCT00756938|588125045|FG002|12-week Base Study|Lost to Follow-up|0|||
162840484|NCT00756938|588125046|FG003|12-week Base Study|Lost to Follow-up|0|||
162840485|NCT00756938|588125043|FG000|Optional Extension|Lack of Efficacy|0|||
162840486|NCT00756938|588125044|FG001|Optional Extension|Lack of Efficacy|0|||
162840487|NCT00756938|588125045|FG002|Optional Extension|Lack of Efficacy|0|||
162840488|NCT00756938|588125046|FG003|Optional Extension|Lack of Efficacy|1|||
162840489|NCT00756938|588125043|FG000|Optional Extension|End of Study|0|||
162840490|NCT00756938|588125044|FG001|Optional Extension|End of Study|0|||
162840491|NCT00756938|588125045|FG002|Optional Extension|End of Study|0|||
162840492|NCT00756938|588125046|FG003|Optional Extension|End of Study|11|||
162840493|NCT00756938|588125043|FG000|Optional Extension|Protocol-specific criteria met|0|||
162840494|NCT00756938|588125044|FG001|Optional Extension|Protocol-specific criteria met|0|||
162840495|NCT00756938|588125045|FG002|Optional Extension|Protocol-specific criteria met|0|||
162840496|NCT00756938|588125046|FG003|Optional Extension|Protocol-specific criteria met|9|||
162840497|NCT00756938|588125043|FG000|Optional Extension|Physician Decision|0|||
162840498|NCT00756938|588125044|FG001|Optional Extension|Physician Decision|0|||
162840499|NCT00756938|588125045|FG002|Optional Extension|Physician Decision|0|||
162840500|NCT00756938|588125046|FG003|Optional Extension|Physician Decision|3|||
162840501|NCT00756938|588125043|FG000|Optional Extension|Lost to Follow-up|0|||
162840502|NCT00756938|588125044|FG001|Optional Extension|Lost to Follow-up|0|||
162840503|NCT00756938|588125045|FG002|Optional Extension|Lost to Follow-up|0|||
162700381|NCT04212169|587615023|FG000|Overall Study|Withdrawal by Subject|10|||
162949502|NCT01900730|588518733|FG000|Overall Study|Withdrawal by Subject|1|||
162949503|NCT01900730|588518734|FG001|Overall Study|Withdrawal by Subject|0|||
162949504|NCT01900730|588518733|FG000|Overall Study|Screen Failure|1|||
162949505|NCT01900730|588518734|FG001|Overall Study|Screen Failure|0|||
162949506|NCT02109042|588518735|FG000|Overall Study|Sponsor Decision|15|||
162949507|NCT03203447|588518736|FG000|Overall Study|Withdrawal by Subject|2|||
162949508|NCT03203447|588518737|FG001|Overall Study|Withdrawal by Subject|1|||
162949509|NCT03203447|588518736|FG000|Overall Study|Lost to Follow-up|1|||
162949510|NCT03203447|588518737|FG001|Overall Study|Lost to Follow-up|10|||
162949511|NCT03203447|588518736|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
162949512|NCT03203447|588518737|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
162949513|NCT02189941|588518742|FG000|Overall Study|Non-compliance|0|||
162949514|NCT02189941|588518743|FG001|Overall Study|Non-compliance|0|||
162949515|NCT02189941|588518744|FG002|Overall Study|Non-compliance|1|||
162949516|NCT00445003|588518745|FG000|Overall Study|Death|1|||
162949517|NCT00445003|588518746|FG001|Overall Study|Death|2|||
162949518|NCT00445003|588518747|FG002|Overall Study|Death|1|||
162949519|NCT00445003|588518745|FG000|Overall Study|Missed Visit|3|||
162949520|NCT00445003|588518746|FG001|Overall Study|Missed Visit|5|||
162949521|NCT00445003|588518747|FG002|Overall Study|Missed Visit|1|||
162949522|NCT00445003|588518745|FG000|Overall Study|Dropped|1|||
162949523|NCT00445003|588518746|FG001|Overall Study|Dropped|3|||
162949524|NCT00445003|588518747|FG002|Overall Study|Dropped|2|||
162949525|NCT01471093|588518750|FG000|Overall Study|Adverse Event|1|||
162949526|NCT01471093|588518751|FG001|Overall Study|Adverse Event|0|||
162949527|NCT01471093|588518752|FG002|Overall Study|Adverse Event|0|||
162949528|NCT01471093|588518753|FG003|Overall Study|Adverse Event|0|||
162949529|NCT00528606|588518754|FG000|Overall Study|Withdrew consent|4|||
162949530|NCT00528606|588518755|FG001|Overall Study|Withdrew consent|3|||
162949531|NCT00528606|588518754|FG000|Overall Study|Lost to Follow-up|4|||
162949532|NCT00528606|588518755|FG001|Overall Study|Lost to Follow-up|1|||
162949533|NCT00528606|588518754|FG000|Overall Study|Adverse Event|3|||
162949534|NCT00528606|588518755|FG001|Overall Study|Adverse Event|0|||
162949535|NCT00528606|588518754|FG000|Overall Study|Other|2|||
162949536|NCT00528606|588518755|FG001|Overall Study|Other|0|||
162949537|NCT02475954|588518756|FG000|Overall Study|Withdrawal by Subject|2|||
162949538|NCT02475954|588518757|FG001|Overall Study|Withdrawal by Subject|2|||
162949539|NCT02475954|588518756|FG000|Overall Study|Lost to Follow-up|11|||
162949540|NCT02475954|588518757|FG001|Overall Study|Lost to Follow-up|9|||
162949541|NCT02475954|588518756|FG000|Overall Study|Death|1|||
162949542|NCT02475954|588518757|FG001|Overall Study|Death|1|||
162949543|NCT00880568|588518759|FG000|Overall Study|Disease progression|3|||
162949544|NCT00880568|588518760|FG001|Overall Study|Disease progression|3|||
162949545|NCT00880568|588518761|FG002|Overall Study|Disease progression|3|||
162949546|NCT00880568|588518762|FG003|Overall Study|Disease progression|1|||
162949547|NCT00880568|588518763|FG004|Overall Study|Disease progression|3|||
162949548|NCT00880568|588518764|FG005|Overall Study|Disease progression|3|||
162949549|NCT00880568|588518765|FG006|Overall Study|Disease progression|5|||
162949550|NCT00880568|588518766|FG007|Overall Study|Disease progression|0|||
162949551|NCT00880568|588518767|FG008|Overall Study|Disease progression|3|||
162949552|NCT00880568|588518759|FG000|Overall Study|Adverse Event|0|||
162949553|NCT00880568|588518760|FG001|Overall Study|Adverse Event|0|||
162949554|NCT00880568|588518761|FG002|Overall Study|Adverse Event|0|||
162949555|NCT00880568|588518762|FG003|Overall Study|Adverse Event|0|||
162949556|NCT00880568|588518763|FG004|Overall Study|Adverse Event|0|||
162949557|NCT00880568|588518764|FG005|Overall Study|Adverse Event|0|||
162949558|NCT00880568|588518765|FG006|Overall Study|Adverse Event|1|||
162949559|NCT00880568|588518766|FG007|Overall Study|Adverse Event|1|||
162949560|NCT00880568|588518767|FG008|Overall Study|Adverse Event|0|||
162949561|NCT00880568|588518759|FG000|Overall Study|Withdrawal by Subject|0|||
162840504|NCT00756938|588125046|FG003|Optional Extension|Lost to Follow-up|1|||
162840505|NCT00756938|588125043|FG000|Optional Extension|Protocol Violation|0|||
162840506|NCT00756938|588125044|FG001|Optional Extension|Protocol Violation|0|||
162840507|NCT00756938|588125045|FG002|Optional Extension|Protocol Violation|0|||
162840508|NCT00756938|588125046|FG003|Optional Extension|Protocol Violation|1|||
162840509|NCT00756938|588125043|FG000|Optional Extension|Withdrawal by Subject|0|||
162840510|NCT00756938|588125044|FG001|Optional Extension|Withdrawal by Subject|0|||
162840511|NCT00756938|588125045|FG002|Optional Extension|Withdrawal by Subject|0|||
162840512|NCT00756938|588125046|FG003|Optional Extension|Withdrawal by Subject|10|||
162840513|NCT00756938|588125043|FG000|Optional Extension|Adverse Event|0|||
162840514|NCT00756938|588125044|FG001|Optional Extension|Adverse Event|0|||
162840515|NCT00756938|588125045|FG002|Optional Extension|Adverse Event|0|||
162840516|NCT00756938|588125046|FG003|Optional Extension|Adverse Event|1|||
162840517|NCT04823949|588125047|FG000|Overall Study|Withdrawal by Subject|0|||
162840518|NCT04823949|588125048|FG001|Overall Study|Withdrawal by Subject|4|||
162840519|NCT04823949|588125047|FG000|Overall Study|Physician Decision|0|||
162840520|NCT04823949|588125048|FG001|Overall Study|Physician Decision|1|||
162840521|NCT00094055|588125049|FG000|Overall Study|Adverse Event|11|||
162840522|NCT00094055|588125049|FG000|Overall Study|Death|4|||
162840523|NCT00094055|588125049|FG000|Overall Study|Lack of Efficacy|17|||
162840524|NCT00094055|588125049|FG000|Overall Study|Lost to Follow-up|2|||
162840525|NCT00094055|588125049|FG000|Overall Study|progressive disease|2|||
162840526|NCT00094055|588125049|FG000|Overall Study|clinical progression|1|||
162840527|NCT00094055|588125049|FG000|Overall Study|roll-over to another study|14|||
162840528|NCT00094055|588125049|FG000|Overall Study|Withdrawal by Subject|9|||
162840529|NCT00441545|588125050|FG000|First Intervention|Adverse Event|6|||
162840530|NCT00441545|588125051|FG001|First Intervention|Adverse Event|5|||
162840531|NCT00441545|588125050|FG000|First Intervention|Protocol Violation|2|||
162840532|NCT00441545|588125051|FG001|First Intervention|Protocol Violation|2|||
162840533|NCT00441545|588125050|FG000|First Intervention|Withdrawal by Subject|3|||
162840534|NCT00441545|588125051|FG001|First Intervention|Withdrawal by Subject|3|||
162840535|NCT00441545|588125050|FG000|First Intervention|Kidney transplant|1|||
162840536|NCT00441545|588125051|FG001|First Intervention|Kidney transplant|1|||
162840537|NCT00441545|588125050|FG000|First Intervention|Lack of Efficacy|2|||
162840538|NCT00441545|588125051|FG001|First Intervention|Lack of Efficacy|0|||
162840539|NCT00441545|588125050|FG000|First Intervention|Subject exceeded safety criteria|0|||
162840540|NCT00441545|588125051|FG001|First Intervention|Subject exceeded safety criteria|1|||
162840541|NCT00441545|588125050|FG000|First Intervention|Subject met an exclusionary criteria|1|||
162840542|NCT00441545|588125051|FG001|First Intervention|Subject met an exclusionary criteria|0|||
162840543|NCT00441545|588125050|FG000|First Intervention|Extended hospitalization|1|||
162840544|NCT00441545|588125051|FG001|First Intervention|Extended hospitalization|0|||
162840545|NCT00441545|588125050|FG000|First Intervention|Site error|1|||
162840546|NCT00441545|588125051|FG001|First Intervention|Site error|0|||
162840547|NCT00441545|588125050|FG000|First Intervention|Sponsor's request|1|||
162840548|NCT00441545|588125051|FG001|First Intervention|Sponsor's request|0|||
162840549|NCT00441545|588125050|FG000|Second Intervention|Adverse Event|5|||
162840550|NCT00441545|588125051|FG001|Second Intervention|Adverse Event|2|||
162840551|NCT00441545|588125050|FG000|Second Intervention|Protocol Violation|4|||
162840552|NCT00441545|588125051|FG001|Second Intervention|Protocol Violation|1|||
162840553|NCT00441545|588125050|FG000|Second Intervention|Withdrawal by Subject|1|||
162840554|NCT00441545|588125051|FG001|Second Intervention|Withdrawal by Subject|1|||
162840555|NCT00441545|588125050|FG000|Second Intervention|Kidney Transplant|1|||
162840556|NCT00441545|588125051|FG001|Second Intervention|Kidney Transplant|1|||
162840557|NCT00441545|588125050|FG000|Second Intervention|Lack of Efficacy|0|||
162840558|NCT00441545|588125051|FG001|Second Intervention|Lack of Efficacy|1|||
162840559|NCT00441545|588125050|FG000|Second Intervention|Subject exceeded safety criteria|1|||
162840560|NCT00441545|588125051|FG001|Second Intervention|Subject exceeded safety criteria|0|||
162840561|NCT00441545|588125050|FG000|Second Intervention|Subject moved|0|||
162840562|NCT00441545|588125051|FG001|Second Intervention|Subject moved|1|||
162840563|NCT02347176|588125052|FG000|Overall Study|Lost to Follow-up|2|||
162949562|NCT00880568|588518760|FG001|Overall Study|Withdrawal by Subject|0|||
162949563|NCT00880568|588518761|FG002|Overall Study|Withdrawal by Subject|0|||
162949564|NCT00880568|588518762|FG003|Overall Study|Withdrawal by Subject|0|||
162949565|NCT00880568|588518763|FG004|Overall Study|Withdrawal by Subject|0|||
162949566|NCT00880568|588518764|FG005|Overall Study|Withdrawal by Subject|0|||
162949567|NCT00880568|588518765|FG006|Overall Study|Withdrawal by Subject|0|||
162840564|NCT02347176|588125053|FG001|Overall Study|Lost to Follow-up|3|||
162840565|NCT02347176|588125054|FG002|Overall Study|Lost to Follow-up|1|||
162840566|NCT02347176|588125055|FG003|Overall Study|Lost to Follow-up|1|||
162840567|NCT02347176|588125052|FG000|Overall Study|Withdrawal by Subject|9|||
162840568|NCT02347176|588125053|FG001|Overall Study|Withdrawal by Subject|5|||
162840569|NCT02347176|588125054|FG002|Overall Study|Withdrawal by Subject|5|||
162840570|NCT02347176|588125055|FG003|Overall Study|Withdrawal by Subject|3|||
162840571|NCT02347176|588125052|FG000|Overall Study|Other|1|||
162840572|NCT02347176|588125053|FG001|Overall Study|Other|2|||
162840573|NCT02347176|588125054|FG002|Overall Study|Other|2|||
162949568|NCT00880568|588518766|FG007|Overall Study|Withdrawal by Subject|1|||
162949569|NCT00880568|588518767|FG008|Overall Study|Withdrawal by Subject|0|||
162949570|NCT00620022|588518768|FG000|Treatment Period 1|Adverse Event|4|||
162949571|NCT00620022|588518769|FG001|Treatment Period 1|Adverse Event|6|||
162949572|NCT00620022|588518768|FG000|Treatment Period 1|Subject withdrew consent|1|||
162949573|NCT00620022|588518769|FG001|Treatment Period 1|Subject withdrew consent|0|||
162949574|NCT00620022|588518768|FG000|Treatment Period 2|Adverse Event|2|||
162949575|NCT00620022|588518769|FG001|Treatment Period 2|Adverse Event|2|||
162949576|NCT00760266|588518771|FG000|Overall Study|Adverse Event|13|||
162949577|NCT00760266|588518772|FG001|Overall Study|Adverse Event|7|||
162949578|NCT00760266|588518771|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162949579|NCT00760266|588518772|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162949580|NCT00760266|588518771|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162949581|NCT00760266|588518772|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162949582|NCT00760266|588518771|FG000|Overall Study|Lack of Efficacy|2|||
162949583|NCT00760266|588518772|FG001|Overall Study|Lack of Efficacy|2|||
162949584|NCT00760266|588518771|FG000|Overall Study|Protocol deviation|2|||
162949585|NCT00760266|588518772|FG001|Overall Study|Protocol deviation|4|||
162949586|NCT00760266|588518771|FG000|Overall Study|Patient withdrew consent|3|||
162949587|NCT00760266|588518772|FG001|Overall Study|Patient withdrew consent|3|||
162949588|NCT00760266|588518771|FG000|Overall Study|Lost to Follow-up|2|||
162949589|NCT00760266|588518772|FG001|Overall Study|Lost to Follow-up|1|||
162949590|NCT00760266|588518771|FG000|Overall Study|Administrative Problems|0|||
162949591|NCT00760266|588518772|FG001|Overall Study|Administrative Problems|1|||
162840574|NCT02347176|588125055|FG003|Overall Study|Other|0|||
162840575|NCT00411554|588125058|FG000|Overall Study|Adverse Event|2|||
162840576|NCT00411554|588125059|FG001|Overall Study|Adverse Event|4|||
162840577|NCT00411554|588125058|FG000|Overall Study|Lack of Efficacy|2|||
162840578|NCT00411554|588125059|FG001|Overall Study|Lack of Efficacy|5|||
162840579|NCT00411554|588125058|FG000|Overall Study|Withdrawal by Subject|3|||
162840580|NCT00411554|588125059|FG001|Overall Study|Withdrawal by Subject|0|||
162840581|NCT00411554|588125058|FG000|Overall Study|Patient Moved|1|||
162840582|NCT00411554|588125059|FG001|Overall Study|Patient Moved|0|||
162840583|NCT00143455|588125062|FG000|Cohort 1|Adverse Event|8|||
162840584|NCT00143455|588125063|FG001|Cohort 1|Adverse Event|4|||
162840585|NCT00143455|588125064|FG002|Cohort 1|Adverse Event|0|||
162840586|NCT00143455|588125065|FG003|Cohort 1|Adverse Event|0|||
162840587|NCT00143455|588125062|FG000|Cohort 1|Death|5|||
162840588|NCT00143455|588125063|FG001|Cohort 1|Death|2|||
162840589|NCT00143455|588125064|FG002|Cohort 1|Death|0|||
162840590|NCT00143455|588125065|FG003|Cohort 1|Death|0|||
162840591|NCT00143455|588125062|FG000|Cohort 1|Progressive Disease|0|||
162840592|NCT00143455|588125063|FG001|Cohort 1|Progressive Disease|6|||
162840593|NCT00143455|588125064|FG002|Cohort 1|Progressive Disease|0|||
162840594|NCT00143455|588125065|FG003|Cohort 1|Progressive Disease|0|||
162840595|NCT00143455|588125062|FG000|Cohort 1|Withdrawal by Subject|1|||
162840596|NCT00143455|588125063|FG001|Cohort 1|Withdrawal by Subject|4|||
162840597|NCT00143455|588125064|FG002|Cohort 1|Withdrawal by Subject|0|||
162840598|NCT00143455|588125065|FG003|Cohort 1|Withdrawal by Subject|0|||
162840599|NCT00143455|588125062|FG000|Cohort 1|Randomized But Not Treated|0|||
162840600|NCT00143455|588125063|FG001|Cohort 1|Randomized But Not Treated|1|||
162840601|NCT00143455|588125064|FG002|Cohort 1|Randomized But Not Treated|0|||
162840602|NCT00143455|588125065|FG003|Cohort 1|Randomized But Not Treated|0|||
162840603|NCT00143455|588125062|FG000|Cohort 2|Adverse Event|0|||
162840604|NCT00143455|588125063|FG001|Cohort 2|Adverse Event|0|||
162840605|NCT00143455|588125064|FG002|Cohort 2|Adverse Event|42|||
162840606|NCT00143455|588125065|FG003|Cohort 2|Adverse Event|30|||
162840607|NCT00143455|588125062|FG000|Cohort 2|No Longer Required Study Treatment|0|||
162840608|NCT00143455|588125063|FG001|Cohort 2|No Longer Required Study Treatment|0|||
162840609|NCT00143455|588125064|FG002|Cohort 2|No Longer Required Study Treatment|1|||
162840610|NCT00143455|588125065|FG003|Cohort 2|No Longer Required Study Treatment|0|||
162840611|NCT00143455|588125062|FG000|Cohort 2|Protocol Violation|0|||
162840612|NCT00143455|588125063|FG001|Cohort 2|Protocol Violation|0|||
162840613|NCT00143455|588125064|FG002|Cohort 2|Protocol Violation|1|||
162840614|NCT00143455|588125065|FG003|Cohort 2|Protocol Violation|1|||
162840615|NCT00143455|588125062|FG000|Cohort 2|Lost to Follow-up|0|||
162840616|NCT00143455|588125063|FG001|Cohort 2|Lost to Follow-up|0|||
162840617|NCT00143455|588125064|FG002|Cohort 2|Lost to Follow-up|1|||
162840618|NCT00143455|588125065|FG003|Cohort 2|Lost to Follow-up|4|||
162840619|NCT00143455|588125062|FG000|Cohort 2|Death|0|||
162840620|NCT00143455|588125063|FG001|Cohort 2|Death|0|||
162840621|NCT00143455|588125064|FG002|Cohort 2|Death|20|||
162840622|NCT00143455|588125065|FG003|Cohort 2|Death|12|||
162840623|NCT00143455|588125062|FG000|Cohort 2|Progressive Disease|0|||
162949592|NCT01239121|588518773|FG000|Overall Study|Withdrawal by Subject|2|||
162840624|NCT00143455|588125063|FG001|Cohort 2|Progressive Disease|0|||
162840625|NCT00143455|588125064|FG002|Cohort 2|Progressive Disease|20|||
162840626|NCT00143455|588125065|FG003|Cohort 2|Progressive Disease|27|||
162840627|NCT00143455|588125062|FG000|Cohort 2|Withdrawal by Subject|0|||
162840628|NCT00143455|588125063|FG001|Cohort 2|Withdrawal by Subject|0|||
162840629|NCT00143455|588125064|FG002|Cohort 2|Withdrawal by Subject|13|||
162840630|NCT00143455|588125065|FG003|Cohort 2|Withdrawal by Subject|12|||
162840631|NCT00143455|588125062|FG000|Cohort 2|Other|0|||
162840632|NCT00143455|588125063|FG001|Cohort 2|Other|0|||
162840633|NCT00143455|588125064|FG002|Cohort 2|Other|7|||
162840634|NCT00143455|588125065|FG003|Cohort 2|Other|6|||
162840635|NCT00143455|588125062|FG000|Cohort 2|Randomized But Not Treated|0|||
162840636|NCT00143455|588125063|FG001|Cohort 2|Randomized But Not Treated|0|||
162840637|NCT00143455|588125064|FG002|Cohort 2|Randomized But Not Treated|1|||
162840638|NCT00143455|588125065|FG003|Cohort 2|Randomized But Not Treated|1|||
162840639|NCT02682901|588125066|FG000|Overall Study|Adverse Event|10|||
162840640|NCT02682901|588125067|FG001|Overall Study|Adverse Event|3|||
162949593|NCT01239121|588518774|FG001|Overall Study|Withdrawal by Subject|4|||
162840641|NCT02682901|588125066|FG000|Overall Study|Lack of Efficacy|0|||
162840642|NCT02682901|588125067|FG001|Overall Study|Lack of Efficacy|1|||
162840643|NCT00720109|588125082|FG000|Induction Period|Did not meet eligibility criteria|3|||
162840644|NCT00720109|588125083|FG001|Induction Period|Did not meet eligibility criteria|0|||
162840645|NCT00720109|588125084|FG002|Induction Period|Did not meet eligibility criteria|0|||
162840646|NCT00720109|588125082|FG000|Induction Period|Bone Marrow Transplant|2|||
162840647|NCT00720109|588125083|FG001|Induction Period|Bone Marrow Transplant|0|||
162840648|NCT00720109|588125084|FG002|Induction Period|Bone Marrow Transplant|0|||
162840649|NCT00720109|588125082|FG000|Induction Period|Physician Decision|1|||
162840650|NCT00720109|588125083|FG001|Induction Period|Physician Decision|0|||
162840651|NCT00720109|588125084|FG002|Induction Period|Physician Decision|0|||
162840652|NCT00720109|588125082|FG000|Risk Stratification Period|Adverse Event|0|||
162840653|NCT00720109|588125083|FG001|Risk Stratification Period|Adverse Event|1|||
162840654|NCT00720109|588125084|FG002|Risk Stratification Period|Adverse Event|0|||
162840655|NCT00720109|588125082|FG000|Risk Stratification Period|Physician Decision|0|||
162840656|NCT00720109|588125083|FG001|Risk Stratification Period|Physician Decision|2|||
162840657|NCT00720109|588125084|FG002|Risk Stratification Period|Physician Decision|1|||
162840658|NCT00720109|588125082|FG000|Risk Stratification Period|Bone marrow transplant|0|||
162840659|NCT00720109|588125083|FG001|Risk Stratification Period|Bone marrow transplant|9|||
162840660|NCT00720109|588125084|FG002|Risk Stratification Period|Bone marrow transplant|7|||
162840661|NCT00720109|588125082|FG000|Risk Stratification Period|Disease progression or relapse|0|||
162840662|NCT00720109|588125083|FG001|Risk Stratification Period|Disease progression or relapse|2|||
162840663|NCT00720109|588125084|FG002|Risk Stratification Period|Disease progression or relapse|0|||
162840664|NCT00720109|588125082|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
162840665|NCT00720109|588125083|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
162840666|NCT00720109|588125084|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
162840667|NCT02665286|588125087|FG000|Overall Study|Lost to Follow-up|3|||
162840668|NCT02665286|588125088|FG001|Overall Study|Lost to Follow-up|2|||
162840669|NCT02665286|588125089|FG002|Overall Study|Lost to Follow-up|1|||
162840670|NCT04153188|588125105|FG000|Overall Study|Lost to Follow-up|1|||
162840671|NCT04153188|588125106|FG001|Overall Study|Lost to Follow-up|1|||
162840672|NCT04153188|588125105|FG000|Overall Study|Withdrawal by Subject|2|||
162840673|NCT04153188|588125106|FG001|Overall Study|Withdrawal by Subject|0|||
162840674|NCT04153188|588125105|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
162840675|NCT04153188|588125106|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
162840676|NCT01489527|588125107|FG000|Overall Study|Pregnancy|9|||
162840677|NCT01489527|588125108|FG001|Overall Study|Pregnancy|14|||
162840678|NCT01489527|588125107|FG000|Overall Study|Participant moved|6|||
162840679|NCT01489527|588125108|FG001|Overall Study|Participant moved|7|||
162840680|NCT01489527|588125107|FG000|Overall Study|Withdrawal by Subject|0|||
162840681|NCT01489527|588125108|FG001|Overall Study|Withdrawal by Subject|4|||
162840682|NCT01489527|588125107|FG000|Overall Study|Lost to Follow-up|5|||
162840683|NCT01489527|588125108|FG001|Overall Study|Lost to Follow-up|1|||
162840684|NCT01489527|588125107|FG000|Overall Study|Procedures|1|||
162840685|NCT01489527|588125108|FG001|Overall Study|Procedures|0|||
162840686|NCT01489527|588125107|FG000|Overall Study|Not compliant|1|||
162840687|NCT01489527|588125108|FG001|Overall Study|Not compliant|0|||
162840688|NCT04899232|588125109|FG000|Screening Period|Physician Decision|1|||
162840689|NCT04899232|588125110|FG001|Screening Period|Physician Decision|0|||
162840690|NCT04899232|588125111|FG002|Screening Period|Physician Decision|0|||
162840691|NCT04899232|588125109|FG000|Screening Period|Withdrawal by Subject|1|||
162840692|NCT04899232|588125110|FG001|Screening Period|Withdrawal by Subject|0|||
162840693|NCT04899232|588125111|FG002|Screening Period|Withdrawal by Subject|0|||
162840694|NCT04899232|588125109|FG000|Screening Period|Participant discharged before receiving intervention|3|||
162840695|NCT04899232|588125110|FG001|Screening Period|Participant discharged before receiving intervention|0|||
162840696|NCT04899232|588125111|FG002|Screening Period|Participant discharged before receiving intervention|0|||
162840697|NCT00700271|588125112|FG000|Overall Study|Adverse Event|4|||
162840698|NCT00700271|588125113|FG001|Overall Study|Adverse Event|6|||
162840699|NCT00700271|588125112|FG000|Overall Study|Protocol Violation|1|||
162840700|NCT00700271|588125113|FG001|Overall Study|Protocol Violation|0|||
162840701|NCT00700271|588125112|FG000|Overall Study|Administrative Reasons|1|||
162840702|NCT00700271|588125113|FG001|Overall Study|Administrative Reasons|0|||
162949594|NCT01239121|588518775|FG002|Overall Study|Withdrawal by Subject|0|||
162949595|NCT04006171|588518778|FG000|Overall Study|Withdrawal by Subject|8|||
162949596|NCT04006171|588518779|FG001|Overall Study|Withdrawal by Subject|7|||
162949597|NCT04006171|588518778|FG000|Overall Study|missing serum samples|2|||
162949598|NCT04006171|588518779|FG001|Overall Study|missing serum samples|2|||
162949599|NCT04006171|588518778|FG000|Overall Study|insufficient sample volume|2|||
162949600|NCT04006171|588518779|FG001|Overall Study|insufficient sample volume|3|||
162949601|NCT03049488|588518780|FG000|Overall Study|Lost to Follow-up|1|||
162949602|NCT03049488|588518781|FG001|Overall Study|Lost to Follow-up|1|||
162949603|NCT03049488|588518782|FG002|Overall Study|Lost to Follow-up|0|||
162949604|NCT03049488|588518783|FG003|Overall Study|Lost to Follow-up|0|||
162949605|NCT03049488|588518784|FG004|Overall Study|Lost to Follow-up|0|||
162949606|NCT03049488|588518785|FG005|Overall Study|Lost to Follow-up|0|||
162949607|NCT03049488|588518780|FG000|Overall Study|Moved from Area|1|||
162840703|NCT00700271|588125112|FG000|Overall Study|Withdrawal by Subject|6|||
162949608|NCT03049488|588518781|FG001|Overall Study|Moved from Area|0|||
162840704|NCT00700271|588125113|FG001|Overall Study|Withdrawal by Subject|4|||
162840705|NCT00700271|588125112|FG000|Overall Study|Lost to Follow-up|2|||
162949609|NCT03049488|588518782|FG002|Overall Study|Moved from Area|0|||
162840706|NCT00700271|588125113|FG001|Overall Study|Lost to Follow-up|2|||
162949610|NCT03049488|588518783|FG003|Overall Study|Moved from Area|1|||
162949611|NCT03049488|588518784|FG004|Overall Study|Moved from Area|1|||
162949612|NCT03049488|588518785|FG005|Overall Study|Moved from Area|0|||
162949613|NCT03049488|588518780|FG000|Overall Study|Physician Decision|0|||
162949614|NCT03049488|588518781|FG001|Overall Study|Physician Decision|1|||
162840707|NCT02926950|588125114|FG000|Overall Study|Adverse Event|4|||
162840708|NCT02926950|588125115|FG001|Overall Study|Adverse Event|6|||
162840709|NCT02926950|588125114|FG000|Overall Study|At the participant's own request|21|||
162840710|NCT02926950|588125115|FG001|Overall Study|At the participant's own request|25|||
162840711|NCT02926950|588125114|FG000|Overall Study|Reason not Specified|17|||
162840712|NCT02926950|588125115|FG001|Overall Study|Reason not Specified|9|||
162840713|NCT02926950|588125114|FG000|Overall Study|Lost to Follow-up|7|||
162840714|NCT02926950|588125115|FG001|Overall Study|Lost to Follow-up|8|||
162840715|NCT02553460|588125116|FG000|Overall Study|Death|3|||
162840716|NCT02553460|588125116|FG000|Overall Study|Withdrawal by Subject|1|||
162840717|NCT02553460|588125116|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
162840718|NCT02553460|588125116|FG000|Overall Study|Relapse or Transplant|14|||
162840719|NCT02553460|588125116|FG000|Overall Study|No response to treatment|2|||
162840720|NCT02553460|588125116|FG000|Overall Study|CAR T cells|2|||
162924225|NCT00077766|588423833|FG000|Overall Study|Dialysis Discontinued|1|||
162924226|NCT00077766|588423834|FG001|Overall Study|Dialysis Discontinued|0|||
162924227|NCT00077766|588423833|FG000|Overall Study|Dialysis|0|||
162924228|NCT00077766|588423834|FG001|Overall Study|Dialysis|1|||
162924229|NCT00077766|588423833|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
162924230|NCT00077766|588423834|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
162924231|NCT00077766|588423833|FG000|Overall Study|Started Nocturnal Dialysis|0|||
162924232|NCT00077766|588423834|FG001|Overall Study|Started Nocturnal Dialysis|1|||
162924233|NCT00077766|588423833|FG000|Overall Study|Stop Dialysis|0|||
162924234|NCT00077766|588423834|FG001|Overall Study|Stop Dialysis|1|||
162924235|NCT00077766|588423833|FG000|Overall Study|Participants Vacation|2|||
162924236|NCT00077766|588423834|FG001|Overall Study|Participants Vacation|1|||
162924237|NCT00938015|588423835|FG000|Overall Study|Death|2|||
162924238|NCT00938015|588423835|FG000|Overall Study|Lost to Follow-up|32|||
162924239|NCT00938015|588423835|FG000|Overall Study|Adverse Event|32|||
162924240|NCT00938015|588423835|FG000|Overall Study|Non-responder|52|||
162924241|NCT00938015|588423835|FG000|Overall Study|Reason not related to Etanercept|29|||
162924242|NCT03186794|588423836|FG000|Overall Study|Physician Decision|2|||
162924243|NCT03186794|588423836|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
162924244|NCT01418365|588423840|FG000|First Intervention|Withdrawal by Subject|0|||
162924245|NCT01418365|588423841|FG001|First Intervention|Withdrawal by Subject|1|||
162924246|NCT01418365|588423840|FG000|First Intervention|Non-compliance|1|||
162924247|NCT01418365|588423841|FG001|First Intervention|Non-compliance|0|||
162924248|NCT01418365|588423840|FG000|Second Intervention|Withdrawal by Subject|0|||
162924249|NCT01418365|588423841|FG001|Second Intervention|Withdrawal by Subject|1|||
162924250|NCT02575807|588423846|FG000|Overall Study|Death|8|||
162924251|NCT02575807|588423847|FG001|Overall Study|Death|3|||
162924252|NCT02575807|588423848|FG002|Overall Study|Death|7|||
162924253|NCT02575807|588423849|FG003|Overall Study|Death|0|||
162924254|NCT02575807|588423850|FG004|Overall Study|Death|1|||
162949615|NCT03049488|588518782|FG002|Overall Study|Physician Decision|0|||
162949616|NCT03049488|588518783|FG003|Overall Study|Physician Decision|0|||
162949617|NCT03049488|588518784|FG004|Overall Study|Physician Decision|0|||
162949618|NCT03049488|588518785|FG005|Overall Study|Physician Decision|0|||
162924255|NCT02575807|588423846|FG000|Overall Study|Study terminated by Sponsor|0|||
162949619|NCT03049488|588518780|FG000|Overall Study|Withdrawal by Subject|0|||
162949620|NCT03049488|588518781|FG001|Overall Study|Withdrawal by Subject|0|||
162949621|NCT03049488|588518782|FG002|Overall Study|Withdrawal by Subject|0|||
162949622|NCT03049488|588518783|FG003|Overall Study|Withdrawal by Subject|1|||
162949623|NCT03049488|588518784|FG004|Overall Study|Withdrawal by Subject|1|||
162949624|NCT03049488|588518785|FG005|Overall Study|Withdrawal by Subject|0|||
162949625|NCT00440557|588518786|FG000|Overall Study|Withdrawal by Subject|10|||
162949626|NCT00440557|588518787|FG001|Overall Study|Withdrawal by Subject|5|||
162924256|NCT02575807|588423847|FG001|Overall Study|Study terminated by Sponsor|1|||
162924257|NCT02575807|588423848|FG002|Overall Study|Study terminated by Sponsor|7|||
162924258|NCT02575807|588423849|FG003|Overall Study|Study terminated by Sponsor|0|||
162949627|NCT00440557|588518788|FG002|Overall Study|Withdrawal by Subject|11|||
162949628|NCT00440557|588518786|FG000|Overall Study|Lost to Follow-up|1|||
162949629|NCT00440557|588518787|FG001|Overall Study|Lost to Follow-up|2|||
162949630|NCT00440557|588518788|FG002|Overall Study|Lost to Follow-up|6|||
162924259|NCT02575807|588423850|FG004|Overall Study|Study terminated by Sponsor|1|||
162924260|NCT02575807|588423846|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
162924261|NCT02575807|588423847|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
162949631|NCT00440557|588518786|FG000|Overall Study|Adverse Event|3|||
162949632|NCT00440557|588518787|FG001|Overall Study|Adverse Event|3|||
162924262|NCT02575807|588423848|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
162924263|NCT02575807|588423849|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
162924264|NCT02575807|588423850|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
162924265|NCT02575807|588423846|FG000|Overall Study|Terminated due to physician decision|0|||
162949633|NCT00440557|588518788|FG002|Overall Study|Adverse Event|5|||
162840721|NCT03266016|588127229|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
162840722|NCT03266016|588127230|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
162840723|NCT03266016|588127231|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
162840724|NCT03266016|588127232|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
162840725|NCT03266016|588127229|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
162840726|NCT03266016|588127230|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
162840727|NCT03266016|588127231|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
162840728|NCT03266016|588127232|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
162840729|NCT00768898|588127233|FG000|Overall Study|Unrelated injury|1|||
162840730|NCT00768898|588127233|FG000|Overall Study|Headache|1|||
162840731|NCT01777763|588127236|FG000|Overall Study|Adverse Event|2|||
162840732|NCT01777763|588127237|FG001|Overall Study|Adverse Event|32|||
162840733|NCT01777763|588127236|FG000|Overall Study|Protocol Violation|1|||
162840734|NCT01777763|588127237|FG001|Overall Study|Protocol Violation|7|||
162840735|NCT01777763|588127236|FG000|Overall Study|Withdrawal by Subject|0|||
162840736|NCT01777763|588127237|FG001|Overall Study|Withdrawal by Subject|2|||
162840737|NCT01777763|588127236|FG000|Overall Study|Treatment Failure|1|||
162840738|NCT01777763|588127237|FG001|Overall Study|Treatment Failure|6|||
162840739|NCT02787850|588127242|FG000|Overall Study|Withdrawal by Subject|0|||
162840740|NCT02787850|588127243|FG001|Overall Study|Withdrawal by Subject|1|||
162840741|NCT03718143|588127244|FG000|Overall Study|Death|1|||
162840742|NCT03718143|588127245|FG001|Overall Study|Death|0|||
162840743|NCT03718143|588127246|FG002|Overall Study|Death|0|||
162840744|NCT03718143|588127244|FG000|Overall Study|Progression of Disease|1|||
162840745|NCT03718143|588127245|FG001|Overall Study|Progression of Disease|0|||
162840746|NCT03718143|588127246|FG002|Overall Study|Progression of Disease|0|||
162840747|NCT03718143|588127244|FG000|Overall Study|Withdrawal of Informed Consent|1|||
162840748|NCT03718143|588127245|FG001|Overall Study|Withdrawal of Informed Consent|2|||
162840749|NCT03718143|588127246|FG002|Overall Study|Withdrawal of Informed Consent|1|||
162840750|NCT03905863|588127247|FG000|Overall Study|Adverse Event|2|||
162840751|NCT03905863|588127248|FG001|Overall Study|Adverse Event|4|||
162840752|NCT03905863|588127247|FG000|Overall Study|Withdrawal by Subject|2|||
162840753|NCT03905863|588127248|FG001|Overall Study|Withdrawal by Subject|2|||
162840754|NCT03905863|588127247|FG000|Overall Study|Physician Decision|0|||
162840755|NCT03905863|588127248|FG001|Overall Study|Physician Decision|3|||
162840756|NCT03905863|588127247|FG000|Overall Study|Lost to Follow-up|1|||
162840757|NCT03905863|588127248|FG001|Overall Study|Lost to Follow-up|0|||
162840758|NCT03905863|588127247|FG000|Overall Study|Protocol Violation|0|||
162840759|NCT03905863|588127248|FG001|Overall Study|Protocol Violation|2|||
162949634|NCT00440557|588518786|FG000|Overall Study|Death|2|||
162949635|NCT00440557|588518787|FG001|Overall Study|Death|6|||
162949636|NCT00440557|588518788|FG002|Overall Study|Death|3|||
162949637|NCT00440557|588518786|FG000|Overall Study|Began Dialysis|4|||
162949638|NCT00440557|588518787|FG001|Overall Study|Began Dialysis|1|||
162949639|NCT00440557|588518788|FG002|Overall Study|Began Dialysis|4|||
162949640|NCT00440557|588518786|FG000|Overall Study|Principal Investigator decision|0|||
162949641|NCT00440557|588518787|FG001|Overall Study|Principal Investigator decision|3|||
162949642|NCT00440557|588518788|FG002|Overall Study|Principal Investigator decision|1|||
162949643|NCT00440557|588518786|FG000|Overall Study|Patient moved|1|||
162949644|NCT00440557|588518787|FG001|Overall Study|Patient moved|2|||
162949645|NCT00440557|588518788|FG002|Overall Study|Patient moved|1|||
162949646|NCT00440557|588518786|FG000|Overall Study|Principal Investigator's office closed|3|||
162949647|NCT00440557|588518787|FG001|Overall Study|Principal Investigator's office closed|6|||
162949648|NCT00440557|588518788|FG002|Overall Study|Principal Investigator's office closed|4|||
162949649|NCT00440557|588518786|FG000|Overall Study|Patient transferred to nursing home|0|||
162949650|NCT00440557|588518787|FG001|Overall Study|Patient transferred to nursing home|1|||
162949651|NCT00440557|588518788|FG002|Overall Study|Patient transferred to nursing home|0|||
162949652|NCT00440557|588518786|FG000|Overall Study|Patient had surgery|1|||
162949653|NCT00440557|588518787|FG001|Overall Study|Patient had surgery|0|||
162949654|NCT00440557|588518788|FG002|Overall Study|Patient had surgery|0|||
162949655|NCT01939197|588518789|FG000|Overall Study|Withdrawal by Subject|1|||
162949656|NCT01939197|588518790|FG001|Overall Study|Withdrawal by Subject|0|||
162949657|NCT01939197|588518791|FG002|Overall Study|Withdrawal by Subject|0|||
162949658|NCT01939197|588518792|FG003|Overall Study|Withdrawal by Subject|0|||
162949659|NCT01939197|588518793|FG004|Overall Study|Withdrawal by Subject|1|||
162949660|NCT01939197|588518794|FG005|Overall Study|Withdrawal by Subject|0|||
162949661|NCT01939197|588518795|FG006|Overall Study|Withdrawal by Subject|0|||
162840760|NCT03905863|588127247|FG000|Overall Study|Death|0|||
162840761|NCT03905863|588127248|FG001|Overall Study|Death|1|||
162840762|NCT02944448|588127252|FG000|Overall Study|Adverse Event|37|||
162840763|NCT02944448|588127253|FG001|Overall Study|Adverse Event|6|||
162840764|NCT02944448|588127252|FG000|Overall Study|Lack of Efficacy|8|||
162840765|NCT02944448|588127253|FG001|Overall Study|Lack of Efficacy|5|||
162840766|NCT02944448|588127252|FG000|Overall Study|Lost to Follow-up|3|||
162949662|NCT01939197|588518789|FG000|Overall Study|Lost to Follow-up|0|||
162840767|NCT02944448|588127253|FG001|Overall Study|Lost to Follow-up|1|||
162949663|NCT01939197|588518790|FG001|Overall Study|Lost to Follow-up|1|||
162949664|NCT01939197|588518791|FG002|Overall Study|Lost to Follow-up|0|||
162840768|NCT02944448|588127252|FG000|Overall Study|Protocol Violation|25|||
162840769|NCT02944448|588127253|FG001|Overall Study|Protocol Violation|7|||
162840770|NCT02944448|588127252|FG000|Overall Study|Withdrawal by Subject|14|||
162840771|NCT02944448|588127253|FG001|Overall Study|Withdrawal by Subject|4|||
162840772|NCT02944448|588127252|FG000|Overall Study|Sponsor did not supply drug in time|0|||
162840773|NCT02944448|588127253|FG001|Overall Study|Sponsor did not supply drug in time|1|||
162840774|NCT02944448|588127252|FG000|Overall Study|Noncompliant with dosing|1|||
162840775|NCT02944448|588127253|FG001|Overall Study|Noncompliant with dosing|0|||
162840776|NCT02944448|588127252|FG000|Overall Study|Abnormal laboratory values|1|||
162840777|NCT02944448|588127253|FG001|Overall Study|Abnormal laboratory values|0|||
162840778|NCT01191697|588127256|FG000|Overall Study|Death|1|||
162840779|NCT01191697|588127256|FG000|Overall Study|Physician Decision|2|||
162840780|NCT01191697|588127256|FG000|Overall Study|Pursue chemoradiation|2|||
162840781|NCT01191697|588127256|FG000|Overall Study|Break from chemotherapy|2|||
162840782|NCT01191697|588127256|FG000|Overall Study|Withdrawal by Subject|1|||
162840783|NCT01191697|588127256|FG000|Overall Study|Surveillance|1|||
162840784|NCT01191697|588127256|FG000|Overall Study|Adverse Event|2|||
162840785|NCT01191697|588127256|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
162840786|NCT01191697|588127256|FG000|Overall Study|Not completed but analyzed|25|||
162840787|NCT01396005|588127257|FG000|Overall Study|Withdrawal by Subject|0|||
162840788|NCT01396005|588127258|FG001|Overall Study|Withdrawal by Subject|1|||
162840789|NCT01396005|588127257|FG000|Overall Study|Non-compliance with protocol|0|||
162840790|NCT01396005|588127258|FG001|Overall Study|Non-compliance with protocol|1|||
162840791|NCT02397473|588127259|FG000|Treatment Phase|Adverse Event|1|||
162840792|NCT02397473|588127260|FG001|Treatment Phase|Adverse Event|2|||
162840793|NCT02397473|588127259|FG000|Treatment Phase|Lack of Efficacy|8|||
162840794|NCT02397473|588127260|FG001|Treatment Phase|Lack of Efficacy|1|||
162840795|NCT02397473|588127259|FG000|Treatment Phase|Lost to Follow-up|1|||
162840796|NCT02397473|588127260|FG001|Treatment Phase|Lost to Follow-up|0|||
162840797|NCT02397473|588127259|FG000|Treatment Phase|Withdrawal by Subject|2|||
162840798|NCT02397473|588127260|FG001|Treatment Phase|Withdrawal by Subject|1|||
162840799|NCT02397473|588127259|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
162840800|NCT02397473|588127260|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
162840801|NCT02397473|588127259|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
162840802|NCT02397473|588127260|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
162840803|NCT02397473|588127259|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
162840804|NCT02397473|588127260|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
162840805|NCT02397473|588127259|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
162840806|NCT02397473|588127260|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
162840807|NCT02397473|588127259|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
162840808|NCT02397473|588127260|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
162840809|NCT01467492|588127261|FG000|Overall Study|Withdrawal by Subject|6|||
162840810|NCT01467492|588127262|FG001|Overall Study|Withdrawal by Subject|4|||
162840811|NCT01467492|588127261|FG000|Overall Study|Study Terminated by Sponsor|6|||
162840812|NCT01467492|588127262|FG001|Overall Study|Study Terminated by Sponsor|4|||
162840813|NCT01467492|588127261|FG000|Overall Study|Adverse Event|4|||
162840814|NCT01467492|588127262|FG001|Overall Study|Adverse Event|3|||
162949665|NCT01939197|588518792|FG003|Overall Study|Lost to Follow-up|1|||
162949666|NCT01939197|588518793|FG004|Overall Study|Lost to Follow-up|3|||
162949667|NCT01939197|588518794|FG005|Overall Study|Lost to Follow-up|1|||
162949668|NCT01939197|588518795|FG006|Overall Study|Lost to Follow-up|2|||
162949669|NCT00680121|588518796|FG000|Overall Study|Lost to Follow-up|27|||
162949670|NCT00680121|588518797|FG001|Overall Study|Lost to Follow-up|23|||
162840815|NCT01467492|588127261|FG000|Overall Study|Lost to Follow-up|3|||
162840816|NCT01467492|588127262|FG001|Overall Study|Lost to Follow-up|2|||
162840817|NCT01467492|588127261|FG000|Overall Study|Undefined|2|||
162840818|NCT01467492|588127262|FG001|Overall Study|Undefined|0|||
162840819|NCT01467492|588127261|FG000|Overall Study|Enrolled But Not Treated|1|||
162840820|NCT01467492|588127262|FG001|Overall Study|Enrolled But Not Treated|0|||
162949671|NCT02849652|588518798|FG000|Overall Study|Lost to Follow-up|104|||
162840821|NCT00491179|588127263|FG000|Overall Study|Adverse Event|5|||
162840822|NCT00491179|588127264|FG001|Overall Study|Adverse Event|1|||
162840823|NCT00491179|588127263|FG000|Overall Study|Withdrawal by Subject|2|||
162840824|NCT00491179|588127264|FG001|Overall Study|Withdrawal by Subject|1|||
162840825|NCT02009878|588127266|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
162840826|NCT02009878|588127267|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
162840827|NCT02009878|588127268|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
162840828|NCT01790048|588127269|FG000|Overall Study|Incorrect Age|9|||
162840829|NCT01790048|588127270|FG001|Overall Study|Incorrect Age|14|||
162840830|NCT01790048|588127269|FG000|Overall Study|data entry error|0|||
162840831|NCT01790048|588127270|FG001|Overall Study|data entry error|1|||
162840832|NCT01790048|588127269|FG000|Overall Study|Other|0|||
162840833|NCT01790048|588127270|FG001|Overall Study|Other|2|||
162840834|NCT01790048|588127269|FG000|Overall Study|SAM at Enrollment|2|||
162840835|NCT01790048|588127270|FG001|Overall Study|SAM at Enrollment|0|||
162840836|NCT01790048|588127269|FG000|Overall Study|Measurement error|1|||
162840837|NCT01790048|588127270|FG001|Overall Study|Measurement error|0|||
162840838|NCT01491178|588127271|FG000|Overall Study|Adverse Event|1016|||
162840839|NCT01491178|588127271|FG000|Overall Study|Improvement of NVAF|210|||
162840840|NCT01491178|588127271|FG000|Overall Study|To conduct invasive treatment|59|||
162840841|NCT01491178|588127271|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
162840842|NCT01491178|588127271|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
162840843|NCT01491178|588127271|FG000|Overall Study|To take a contraindication|20|||
162840844|NCT01491178|588127271|FG000|Overall Study|Other than specified above|657|||
162840845|NCT01604512|588127274|FG000|Overall Study|Withdrawal by Subject|3|||
162840846|NCT01604512|588127274|FG000|Overall Study|Not treated|4|||
162840847|NCT01415752|588127277|FG000|Induction (Step 1)|Ineligible|4|||
162840848|NCT01415752|588127278|FG001|Induction (Step 1)|Ineligible|3|||
162840849|NCT01415752|588127279|FG002|Induction (Step 1)|Ineligible|4|||
162840850|NCT01415752|588127280|FG003|Induction (Step 1)|Ineligible|4|||
162840851|NCT01415752|588127277|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
162840852|NCT01415752|588127278|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
162840853|NCT01415752|588127279|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
162840854|NCT01415752|588127280|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
162840855|NCT01415752|588127277|FG000|Maintenance (Step 2)|Adverse Event|3|||
162840856|NCT01415752|588127278|FG001|Maintenance (Step 2)|Adverse Event|4|||
162840857|NCT01415752|588127279|FG002|Maintenance (Step 2)|Adverse Event|9|||
162840858|NCT01415752|588127280|FG003|Maintenance (Step 2)|Adverse Event|6|||
162840859|NCT01415752|588127277|FG000|Maintenance (Step 2)|Death|1|||
162840860|NCT01415752|588127278|FG001|Maintenance (Step 2)|Death|1|||
162840861|NCT01415752|588127279|FG002|Maintenance (Step 2)|Death|2|||
162840862|NCT01415752|588127280|FG003|Maintenance (Step 2)|Death|0|||
162840863|NCT01415752|588127277|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
162840864|NCT01415752|588127278|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
162840865|NCT01415752|588127279|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
162840866|NCT01415752|588127280|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
162840867|NCT01415752|588127277|FG000|Maintenance (Step 2)|Alternative therapy|0|||
162840868|NCT01415752|588127278|FG001|Maintenance (Step 2)|Alternative therapy|1|||
162840869|NCT01415752|588127279|FG002|Maintenance (Step 2)|Alternative therapy|0|||
162840870|NCT01415752|588127280|FG003|Maintenance (Step 2)|Alternative therapy|0|||
162840871|NCT01415752|588127277|FG000|Maintenance (Step 2)|Other reasons|3|||
162840872|NCT01415752|588127278|FG001|Maintenance (Step 2)|Other reasons|6|||
162840873|NCT01415752|588127279|FG002|Maintenance (Step 2)|Other reasons|4|||
162840874|NCT01415752|588127280|FG003|Maintenance (Step 2)|Other reasons|6|||
162840875|NCT01415752|588127277|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
162700382|NCT04212169|587615024|FG001|Overall Study|Withdrawal by Subject|2|||
162700383|NCT04212169|587615025|FG002|Overall Study|Withdrawal by Subject|5|||
162700384|NCT04212169|587615026|FG003|Overall Study|Withdrawal by Subject|7|||
162840876|NCT01415752|588127278|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
162840877|NCT01415752|588127279|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
162840878|NCT01415752|588127280|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
162840879|NCT01415752|588127277|FG000|Maintenance (Step 2)|ineligible|1|||
162840880|NCT01415752|588127278|FG001|Maintenance (Step 2)|ineligible|1|||
162840881|NCT01415752|588127279|FG002|Maintenance (Step 2)|ineligible|1|||
162840882|NCT01415752|588127280|FG003|Maintenance (Step 2)|ineligible|0|||
162840883|NCT01415752|588127277|FG000|Maintenance (Step 2)|Missing|4|||
162840884|NCT01415752|588127278|FG001|Maintenance (Step 2)|Missing|1|||
162840885|NCT01415752|588127279|FG002|Maintenance (Step 2)|Missing|4|||
162840886|NCT01415752|588127280|FG003|Maintenance (Step 2)|Missing|3|||
162840887|NCT03083886|588127281|FG000|Overall Study|Withdrawal by Subject|51|||
162840888|NCT03083886|588127282|FG001|Overall Study|Withdrawal by Subject|73|||
162840889|NCT03083886|588127283|FG002|Overall Study|Withdrawal by Subject|104|||
162840890|NCT03083886|588127281|FG000|Overall Study|Missing Baseline data|43|||
162840891|NCT03083886|588127282|FG001|Overall Study|Missing Baseline data|42|||
162840892|NCT03083886|588127283|FG002|Overall Study|Missing Baseline data|31|||
162840893|NCT03083886|588127281|FG000|Overall Study|Investigator terminated|1|||
162840894|NCT03083886|588127282|FG001|Overall Study|Investigator terminated|6|||
162840895|NCT03083886|588127283|FG002|Overall Study|Investigator terminated|3|||
162840896|NCT01391507|588127284|FG000|Overall Study|Death|0|||
162840897|NCT01391507|588127285|FG001|Overall Study|Death|0|||
162840898|NCT01391507|588127286|FG002|Overall Study|Death|0|||
162840899|NCT01391507|588127287|FG003|Overall Study|Death|1|||
162840900|NCT01391507|588127284|FG000|Overall Study|Adverse Event|1|||
162840901|NCT01391507|588127285|FG001|Overall Study|Adverse Event|1|||
162840902|NCT01391507|588127286|FG002|Overall Study|Adverse Event|2|||
162840903|NCT01391507|588127287|FG003|Overall Study|Adverse Event|2|||
162840904|NCT01391507|588127284|FG000|Overall Study|Withdrawal by Subject|1|||
162840905|NCT01391507|588127285|FG001|Overall Study|Withdrawal by Subject|2|||
162840906|NCT01391507|588127286|FG002|Overall Study|Withdrawal by Subject|1|||
162840907|NCT01391507|588127287|FG003|Overall Study|Withdrawal by Subject|1|||
162840908|NCT01391507|588127284|FG000|Overall Study|Lack of Efficacy|0|||
162840909|NCT01391507|588127285|FG001|Overall Study|Lack of Efficacy|0|||
162840910|NCT01391507|588127286|FG002|Overall Study|Lack of Efficacy|0|||
162840911|NCT01391507|588127287|FG003|Overall Study|Lack of Efficacy|1|||
162840912|NCT01391507|588127284|FG000|Overall Study|Protocol Violation|2|||
162840913|NCT01391507|588127285|FG001|Overall Study|Protocol Violation|1|||
162840914|NCT01391507|588127286|FG002|Overall Study|Protocol Violation|1|||
162840915|NCT01391507|588127287|FG003|Overall Study|Protocol Violation|2|||
162840916|NCT01453855|588127288|FG000|Overall Study|Adverse Event|3|||
162840917|NCT01453855|588127289|FG001|Overall Study|Adverse Event|4|||
162840918|NCT01453855|588127288|FG000|Overall Study|Lost to Follow-up|2|||
162840919|NCT01453855|588127289|FG001|Overall Study|Lost to Follow-up|1|||
162840920|NCT01453855|588127288|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
162840921|NCT01453855|588127289|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
162840922|NCT01453855|588127288|FG000|Overall Study|Noncompliance|1|||
162840923|NCT01453855|588127289|FG001|Overall Study|Noncompliance|0|||
162840924|NCT01453855|588127288|FG000|Overall Study|Inadequate Control of IOP|1|||
162840925|NCT01453855|588127289|FG001|Overall Study|Inadequate Control of IOP|5|||
162840926|NCT01453855|588127288|FG000|Overall Study|Other|0|||
162840927|NCT01453855|588127289|FG001|Overall Study|Other|1|||
162840928|NCT03529773|588127292|FG000|Overall Study|Adverse Event|0|||
162840929|NCT03529773|588127293|FG001|Overall Study|Adverse Event|0|||
162840930|NCT03529773|588127294|FG002|Overall Study|Adverse Event|0|||
162840931|NCT03529773|588127295|FG003|Overall Study|Adverse Event|0|||
162840932|NCT03529773|588127296|FG004|Overall Study|Adverse Event|0|||
162840933|NCT03529773|588127297|FG005|Overall Study|Adverse Event|0|||
162840934|NCT03529773|588127298|FG006|Overall Study|Adverse Event|0|||
162840935|NCT03529773|588127299|FG007|Overall Study|Adverse Event|0|||
162840936|NCT03529773|588127300|FG008|Overall Study|Adverse Event|0|||
162840937|NCT03529773|588127301|FG009|Overall Study|Adverse Event|0|||
162840938|NCT03529773|588127302|FG010|Overall Study|Adverse Event|0|||
162840939|NCT03529773|588127303|FG011|Overall Study|Adverse Event|0|||
162840940|NCT03529773|588127304|FG012|Overall Study|Adverse Event|0|||
162840941|NCT03529773|588127305|FG013|Overall Study|Adverse Event|0|||
162840942|NCT03529773|588127306|FG014|Overall Study|Adverse Event|0|||
162840943|NCT03529773|588127307|FG015|Overall Study|Adverse Event|0|||
162840944|NCT03529773|588127308|FG016|Overall Study|Adverse Event|0|||
162840945|NCT03529773|588127309|FG017|Overall Study|Adverse Event|0|||
162840946|NCT03529773|588127310|FG018|Overall Study|Adverse Event|0|||
162840947|NCT03529773|588127311|FG019|Overall Study|Adverse Event|0|||
162840948|NCT03529773|588127312|FG020|Overall Study|Adverse Event|0|||
162840949|NCT03529773|588127313|FG021|Overall Study|Adverse Event|0|||
162840950|NCT03529773|588127314|FG022|Overall Study|Adverse Event|0|||
162840951|NCT03529773|588127315|FG023|Overall Study|Adverse Event|0|||
162840952|NCT03529773|588127316|FG024|Overall Study|Adverse Event|0|||
162840953|NCT03529773|588127317|FG025|Overall Study|Adverse Event|0|||
162840954|NCT03529773|588127318|FG026|Overall Study|Adverse Event|0|||
162840955|NCT03529773|588127319|FG027|Overall Study|Adverse Event|0|||
162840956|NCT03529773|588127320|FG028|Overall Study|Adverse Event|0|||
162840957|NCT03529773|588127321|FG029|Overall Study|Adverse Event|0|||
162840958|NCT03529773|588127322|FG030|Overall Study|Adverse Event|1|||
162840959|NCT03529773|588127323|FG031|Overall Study|Adverse Event|0|||
162840960|NCT03529773|588127324|FG032|Overall Study|Adverse Event|0|||
162840961|NCT03529773|588127325|FG033|Overall Study|Adverse Event|0|||
162840962|NCT03529773|588127326|FG034|Overall Study|Adverse Event|0|||
162840963|NCT03529773|588127327|FG035|Overall Study|Adverse Event|1|||
162840964|NCT03529773|588127328|FG036|Overall Study|Adverse Event|0|||
162840965|NCT03529773|588127329|FG037|Overall Study|Adverse Event|0|||
162840966|NCT03529773|588127330|FG038|Overall Study|Adverse Event|1|||
162840967|NCT03529773|588127331|FG039|Overall Study|Adverse Event|1|||
162840968|NCT03529773|588127292|FG000|Overall Study|Death|0|||
162840969|NCT03529773|588127293|FG001|Overall Study|Death|0|||
162840970|NCT03529773|588127294|FG002|Overall Study|Death|0|||
162840971|NCT03529773|588127295|FG003|Overall Study|Death|0|||
162840972|NCT03529773|588127296|FG004|Overall Study|Death|0|||
162840973|NCT03529773|588127297|FG005|Overall Study|Death|0|||
162840974|NCT03529773|588127298|FG006|Overall Study|Death|0|||
162840975|NCT03529773|588127299|FG007|Overall Study|Death|0|||
162840976|NCT03529773|588127300|FG008|Overall Study|Death|0|||
162840977|NCT03529773|588127301|FG009|Overall Study|Death|0|||
162840978|NCT03529773|588127302|FG010|Overall Study|Death|0|||
162840979|NCT03529773|588127303|FG011|Overall Study|Death|0|||
162840980|NCT03529773|588127304|FG012|Overall Study|Death|1|||
162840981|NCT03529773|588127305|FG013|Overall Study|Death|0|||
162840982|NCT03529773|588127306|FG014|Overall Study|Death|0|||
162840983|NCT03529773|588127307|FG015|Overall Study|Death|0|||
162840984|NCT03529773|588127308|FG016|Overall Study|Death|0|||
162840985|NCT03529773|588127309|FG017|Overall Study|Death|0|||
162840986|NCT03529773|588127310|FG018|Overall Study|Death|0|||
162840987|NCT03529773|588127311|FG019|Overall Study|Death|1|||
162840988|NCT03529773|588127312|FG020|Overall Study|Death|0|||
162840989|NCT03529773|588127313|FG021|Overall Study|Death|0|||
162840990|NCT03529773|588127314|FG022|Overall Study|Death|1|||
162840991|NCT03529773|588127315|FG023|Overall Study|Death|0|||
162840992|NCT03529773|588127316|FG024|Overall Study|Death|0|||
162840993|NCT03529773|588127317|FG025|Overall Study|Death|0|||
162840994|NCT03529773|588127318|FG026|Overall Study|Death|0|||
162840995|NCT03529773|588127319|FG027|Overall Study|Death|0|||
162840996|NCT03529773|588127320|FG028|Overall Study|Death|0|||
162840997|NCT03529773|588127321|FG029|Overall Study|Death|0|||
162840998|NCT03529773|588127322|FG030|Overall Study|Death|0|||
162840999|NCT03529773|588127323|FG031|Overall Study|Death|0|||
162841000|NCT03529773|588127324|FG032|Overall Study|Death|0|||
162841001|NCT03529773|588127325|FG033|Overall Study|Death|1|||
162841002|NCT03529773|588127326|FG034|Overall Study|Death|1|||
162841003|NCT03529773|588127327|FG035|Overall Study|Death|0|||
162841004|NCT03529773|588127328|FG036|Overall Study|Death|1|||
162841005|NCT03529773|588127329|FG037|Overall Study|Death|0|||
162841006|NCT03529773|588127330|FG038|Overall Study|Death|0|||
162841007|NCT03529773|588127331|FG039|Overall Study|Death|0|||
162841008|NCT03529773|588127292|FG000|Overall Study|Lost to Follow-up|0|||
162841009|NCT03529773|588127293|FG001|Overall Study|Lost to Follow-up|0|||
162841010|NCT03529773|588127294|FG002|Overall Study|Lost to Follow-up|1|||
162841011|NCT03529773|588127295|FG003|Overall Study|Lost to Follow-up|0|||
162841012|NCT03529773|588127296|FG004|Overall Study|Lost to Follow-up|1|||
162841013|NCT03529773|588127297|FG005|Overall Study|Lost to Follow-up|1|||
162841014|NCT03529773|588127298|FG006|Overall Study|Lost to Follow-up|0|||
162841015|NCT03529773|588127299|FG007|Overall Study|Lost to Follow-up|0|||
162841016|NCT03529773|588127300|FG008|Overall Study|Lost to Follow-up|0|||
162841017|NCT03529773|588127301|FG009|Overall Study|Lost to Follow-up|0|||
162841018|NCT03529773|588127302|FG010|Overall Study|Lost to Follow-up|0|||
162841019|NCT03529773|588127303|FG011|Overall Study|Lost to Follow-up|0|||
162841020|NCT03529773|588127304|FG012|Overall Study|Lost to Follow-up|0|||
162841021|NCT03529773|588127305|FG013|Overall Study|Lost to Follow-up|1|||
162841022|NCT03529773|588127306|FG014|Overall Study|Lost to Follow-up|4|||
162841023|NCT03529773|588127307|FG015|Overall Study|Lost to Follow-up|1|||
162841024|NCT03529773|588127308|FG016|Overall Study|Lost to Follow-up|1|||
162841025|NCT03529773|588127309|FG017|Overall Study|Lost to Follow-up|0|||
162841026|NCT03529773|588127310|FG018|Overall Study|Lost to Follow-up|1|||
162841027|NCT03529773|588127311|FG019|Overall Study|Lost to Follow-up|1|||
162841028|NCT03529773|588127312|FG020|Overall Study|Lost to Follow-up|2|||
162841029|NCT03529773|588127313|FG021|Overall Study|Lost to Follow-up|4|||
162841030|NCT03529773|588127314|FG022|Overall Study|Lost to Follow-up|3|||
162841031|NCT03529773|588127315|FG023|Overall Study|Lost to Follow-up|4|||
162841032|NCT03529773|588127316|FG024|Overall Study|Lost to Follow-up|3|||
162841033|NCT03529773|588127317|FG025|Overall Study|Lost to Follow-up|5|||
162841034|NCT03529773|588127318|FG026|Overall Study|Lost to Follow-up|5|||
162841035|NCT03529773|588127319|FG027|Overall Study|Lost to Follow-up|0|||
162841036|NCT03529773|588127320|FG028|Overall Study|Lost to Follow-up|0|||
162841037|NCT03529773|588127321|FG029|Overall Study|Lost to Follow-up|0|||
162841038|NCT03529773|588127322|FG030|Overall Study|Lost to Follow-up|1|||
162841039|NCT03529773|588127323|FG031|Overall Study|Lost to Follow-up|0|||
162841040|NCT03529773|588127324|FG032|Overall Study|Lost to Follow-up|0|||
162841041|NCT03529773|588127325|FG033|Overall Study|Lost to Follow-up|1|||
162841042|NCT03529773|588127326|FG034|Overall Study|Lost to Follow-up|1|||
162841043|NCT03529773|588127327|FG035|Overall Study|Lost to Follow-up|0|||
162841044|NCT03529773|588127328|FG036|Overall Study|Lost to Follow-up|0|||
162841045|NCT03529773|588127329|FG037|Overall Study|Lost to Follow-up|3|||
162841046|NCT03529773|588127330|FG038|Overall Study|Lost to Follow-up|1|||
162841047|NCT03529773|588127331|FG039|Overall Study|Lost to Follow-up|1|||
162841048|NCT03529773|588127292|FG000|Overall Study|No longer meets eligibility criteria|0|||
162841049|NCT03529773|588127293|FG001|Overall Study|No longer meets eligibility criteria|0|||
162841050|NCT03529773|588127294|FG002|Overall Study|No longer meets eligibility criteria|0|||
162841051|NCT03529773|588127295|FG003|Overall Study|No longer meets eligibility criteria|0|||
162841052|NCT03529773|588127296|FG004|Overall Study|No longer meets eligibility criteria|0|||
162841053|NCT03529773|588127297|FG005|Overall Study|No longer meets eligibility criteria|0|||
162841054|NCT03529773|588127298|FG006|Overall Study|No longer meets eligibility criteria|0|||
162841055|NCT03529773|588127299|FG007|Overall Study|No longer meets eligibility criteria|0|||
162841056|NCT03529773|588127300|FG008|Overall Study|No longer meets eligibility criteria|0|||
162841057|NCT03529773|588127301|FG009|Overall Study|No longer meets eligibility criteria|0|||
162841058|NCT03529773|588127302|FG010|Overall Study|No longer meets eligibility criteria|0|||
162841059|NCT03529773|588127303|FG011|Overall Study|No longer meets eligibility criteria|0|||
162841060|NCT03529773|588127304|FG012|Overall Study|No longer meets eligibility criteria|0|||
162841061|NCT03529773|588127305|FG013|Overall Study|No longer meets eligibility criteria|0|||
162841062|NCT03529773|588127306|FG014|Overall Study|No longer meets eligibility criteria|0|||
162841063|NCT03529773|588127307|FG015|Overall Study|No longer meets eligibility criteria|0|||
162841064|NCT03529773|588127308|FG016|Overall Study|No longer meets eligibility criteria|0|||
162841065|NCT03529773|588127309|FG017|Overall Study|No longer meets eligibility criteria|0|||
162841066|NCT03529773|588127310|FG018|Overall Study|No longer meets eligibility criteria|0|||
162841067|NCT03529773|588127311|FG019|Overall Study|No longer meets eligibility criteria|0|||
162841068|NCT03529773|588127312|FG020|Overall Study|No longer meets eligibility criteria|0|||
162841069|NCT03529773|588127313|FG021|Overall Study|No longer meets eligibility criteria|0|||
162841070|NCT03529773|588127314|FG022|Overall Study|No longer meets eligibility criteria|1|||
162841071|NCT03529773|588127315|FG023|Overall Study|No longer meets eligibility criteria|0|||
162841072|NCT03529773|588127316|FG024|Overall Study|No longer meets eligibility criteria|0|||
162841073|NCT03529773|588127317|FG025|Overall Study|No longer meets eligibility criteria|0|||
162841074|NCT03529773|588127318|FG026|Overall Study|No longer meets eligibility criteria|0|||
162841075|NCT03529773|588127319|FG027|Overall Study|No longer meets eligibility criteria|0|||
162841076|NCT03529773|588127320|FG028|Overall Study|No longer meets eligibility criteria|0|||
162841077|NCT03529773|588127321|FG029|Overall Study|No longer meets eligibility criteria|0|||
162841078|NCT03529773|588127322|FG030|Overall Study|No longer meets eligibility criteria|0|||
162841079|NCT03529773|588127323|FG031|Overall Study|No longer meets eligibility criteria|0|||
162841080|NCT03529773|588127324|FG032|Overall Study|No longer meets eligibility criteria|0|||
162841081|NCT03529773|588127325|FG033|Overall Study|No longer meets eligibility criteria|0|||
162841082|NCT03529773|588127326|FG034|Overall Study|No longer meets eligibility criteria|0|||
162841083|NCT03529773|588127327|FG035|Overall Study|No longer meets eligibility criteria|0|||
162841084|NCT03529773|588127328|FG036|Overall Study|No longer meets eligibility criteria|0|||
162841085|NCT03529773|588127329|FG037|Overall Study|No longer meets eligibility criteria|0|||
162841086|NCT03529773|588127330|FG038|Overall Study|No longer meets eligibility criteria|1|||
162841087|NCT03529773|588127331|FG039|Overall Study|No longer meets eligibility criteria|0|||
162841088|NCT03529773|588127292|FG000|Overall Study|Other|0|||
162841089|NCT03529773|588127293|FG001|Overall Study|Other|0|||
162841090|NCT03529773|588127294|FG002|Overall Study|Other|0|||
162841091|NCT03529773|588127295|FG003|Overall Study|Other|0|||
162841092|NCT03529773|588127296|FG004|Overall Study|Other|0|||
162841093|NCT03529773|588127297|FG005|Overall Study|Other|0|||
162841094|NCT03529773|588127298|FG006|Overall Study|Other|0|||
162841095|NCT03529773|588127299|FG007|Overall Study|Other|0|||
162841096|NCT03529773|588127300|FG008|Overall Study|Other|0|||
162841097|NCT03529773|588127301|FG009|Overall Study|Other|0|||
162841098|NCT03529773|588127302|FG010|Overall Study|Other|0|||
162841099|NCT03529773|588127303|FG011|Overall Study|Other|0|||
162841100|NCT03529773|588127304|FG012|Overall Study|Other|1|||
162841101|NCT03529773|588127305|FG013|Overall Study|Other|0|||
162841102|NCT03529773|588127306|FG014|Overall Study|Other|2|||
162841103|NCT03529773|588127307|FG015|Overall Study|Other|0|||
162841104|NCT03529773|588127308|FG016|Overall Study|Other|0|||
162841105|NCT03529773|588127309|FG017|Overall Study|Other|3|||
162841106|NCT03529773|588127310|FG018|Overall Study|Other|0|||
162841107|NCT03529773|588127311|FG019|Overall Study|Other|0|||
162841108|NCT03529773|588127312|FG020|Overall Study|Other|1|||
162841109|NCT03529773|588127313|FG021|Overall Study|Other|0|||
162841110|NCT03529773|588127314|FG022|Overall Study|Other|1|||
162841111|NCT03529773|588127315|FG023|Overall Study|Other|0|||
162841112|NCT03529773|588127316|FG024|Overall Study|Other|3|||
162841113|NCT03529773|588127317|FG025|Overall Study|Other|2|||
162841114|NCT03529773|588127318|FG026|Overall Study|Other|2|||
162841115|NCT03529773|588127319|FG027|Overall Study|Other|0|||
162841116|NCT03529773|588127320|FG028|Overall Study|Other|0|||
162841117|NCT03529773|588127321|FG029|Overall Study|Other|0|||
162841118|NCT03529773|588127322|FG030|Overall Study|Other|0|||
162841119|NCT03529773|588127323|FG031|Overall Study|Other|0|||
162841120|NCT03529773|588127324|FG032|Overall Study|Other|0|||
162841121|NCT03529773|588127325|FG033|Overall Study|Other|0|||
162841122|NCT03529773|588127326|FG034|Overall Study|Other|1|||
162841123|NCT03529773|588127327|FG035|Overall Study|Other|1|||
162841124|NCT03529773|588127328|FG036|Overall Study|Other|0|||
162841125|NCT03529773|588127329|FG037|Overall Study|Other|0|||
162841126|NCT03529773|588127330|FG038|Overall Study|Other|0|||
162841127|NCT03529773|588127331|FG039|Overall Study|Other|0|||
162841128|NCT03529773|588127292|FG000|Overall Study|Physician Decision|0|||
162841129|NCT03529773|588127293|FG001|Overall Study|Physician Decision|0|||
162841130|NCT03529773|588127294|FG002|Overall Study|Physician Decision|0|||
162841131|NCT03529773|588127295|FG003|Overall Study|Physician Decision|0|||
162841132|NCT03529773|588127296|FG004|Overall Study|Physician Decision|0|||
162841133|NCT03529773|588127297|FG005|Overall Study|Physician Decision|0|||
162841134|NCT03529773|588127298|FG006|Overall Study|Physician Decision|0|||
162841135|NCT03529773|588127299|FG007|Overall Study|Physician Decision|0|||
162841136|NCT03529773|588127300|FG008|Overall Study|Physician Decision|0|||
162841137|NCT03529773|588127301|FG009|Overall Study|Physician Decision|0|||
162841138|NCT03529773|588127302|FG010|Overall Study|Physician Decision|0|||
162841139|NCT03529773|588127303|FG011|Overall Study|Physician Decision|0|||
162841140|NCT03529773|588127304|FG012|Overall Study|Physician Decision|0|||
162841141|NCT03529773|588127305|FG013|Overall Study|Physician Decision|0|||
162841142|NCT03529773|588127306|FG014|Overall Study|Physician Decision|0|||
162841143|NCT03529773|588127307|FG015|Overall Study|Physician Decision|0|||
162841144|NCT03529773|588127308|FG016|Overall Study|Physician Decision|0|||
162841145|NCT03529773|588127309|FG017|Overall Study|Physician Decision|0|||
162841146|NCT03529773|588127310|FG018|Overall Study|Physician Decision|0|||
162841147|NCT03529773|588127311|FG019|Overall Study|Physician Decision|1|||
162841148|NCT03529773|588127312|FG020|Overall Study|Physician Decision|1|||
162841149|NCT03529773|588127313|FG021|Overall Study|Physician Decision|0|||
162841150|NCT03529773|588127314|FG022|Overall Study|Physician Decision|0|||
162841151|NCT03529773|588127315|FG023|Overall Study|Physician Decision|0|||
162841152|NCT03529773|588127316|FG024|Overall Study|Physician Decision|0|||
162841153|NCT03529773|588127317|FG025|Overall Study|Physician Decision|0|||
162841154|NCT03529773|588127318|FG026|Overall Study|Physician Decision|0|||
162841155|NCT03529773|588127319|FG027|Overall Study|Physician Decision|0|||
162841156|NCT03529773|588127320|FG028|Overall Study|Physician Decision|0|||
162841157|NCT03529773|588127321|FG029|Overall Study|Physician Decision|0|||
162841158|NCT03529773|588127322|FG030|Overall Study|Physician Decision|0|||
162841159|NCT03529773|588127323|FG031|Overall Study|Physician Decision|0|||
162841160|NCT03529773|588127324|FG032|Overall Study|Physician Decision|0|||
162841161|NCT03529773|588127325|FG033|Overall Study|Physician Decision|0|||
162841162|NCT03529773|588127326|FG034|Overall Study|Physician Decision|0|||
162841163|NCT03529773|588127327|FG035|Overall Study|Physician Decision|0|||
162841164|NCT03529773|588127328|FG036|Overall Study|Physician Decision|0|||
162841165|NCT03529773|588127329|FG037|Overall Study|Physician Decision|0|||
162841166|NCT03529773|588127330|FG038|Overall Study|Physician Decision|0|||
162841167|NCT03529773|588127331|FG039|Overall Study|Physician Decision|0|||
162841168|NCT03529773|588127292|FG000|Overall Study|Protocol Violation|0|||
162841169|NCT03529773|588127293|FG001|Overall Study|Protocol Violation|0|||
162841170|NCT03529773|588127294|FG002|Overall Study|Protocol Violation|0|||
162841171|NCT03529773|588127295|FG003|Overall Study|Protocol Violation|0|||
162841172|NCT03529773|588127296|FG004|Overall Study|Protocol Violation|0|||
162841173|NCT03529773|588127297|FG005|Overall Study|Protocol Violation|0|||
162841174|NCT03529773|588127298|FG006|Overall Study|Protocol Violation|0|||
162841175|NCT03529773|588127299|FG007|Overall Study|Protocol Violation|0|||
162841176|NCT03529773|588127300|FG008|Overall Study|Protocol Violation|0|||
162841177|NCT03529773|588127301|FG009|Overall Study|Protocol Violation|0|||
162841178|NCT03529773|588127302|FG010|Overall Study|Protocol Violation|0|||
162841179|NCT03529773|588127303|FG011|Overall Study|Protocol Violation|0|||
162841180|NCT03529773|588127304|FG012|Overall Study|Protocol Violation|0|||
162841181|NCT03529773|588127305|FG013|Overall Study|Protocol Violation|0|||
162841182|NCT03529773|588127306|FG014|Overall Study|Protocol Violation|0|||
162841183|NCT03529773|588127307|FG015|Overall Study|Protocol Violation|0|||
162841184|NCT03529773|588127308|FG016|Overall Study|Protocol Violation|0|||
162841185|NCT03529773|588127309|FG017|Overall Study|Protocol Violation|0|||
162841186|NCT03529773|588127310|FG018|Overall Study|Protocol Violation|0|||
162841187|NCT03529773|588127311|FG019|Overall Study|Protocol Violation|0|||
162841188|NCT03529773|588127312|FG020|Overall Study|Protocol Violation|0|||
162841189|NCT03529773|588127313|FG021|Overall Study|Protocol Violation|0|||
162841190|NCT03529773|588127314|FG022|Overall Study|Protocol Violation|0|||
162841191|NCT03529773|588127315|FG023|Overall Study|Protocol Violation|0|||
162841192|NCT03529773|588127316|FG024|Overall Study|Protocol Violation|0|||
162841193|NCT03529773|588127317|FG025|Overall Study|Protocol Violation|0|||
162841194|NCT03529773|588127318|FG026|Overall Study|Protocol Violation|0|||
162841195|NCT03529773|588127319|FG027|Overall Study|Protocol Violation|0|||
162841196|NCT03529773|588127320|FG028|Overall Study|Protocol Violation|0|||
162841197|NCT03529773|588127321|FG029|Overall Study|Protocol Violation|0|||
162841198|NCT03529773|588127322|FG030|Overall Study|Protocol Violation|1|||
162841199|NCT03529773|588127323|FG031|Overall Study|Protocol Violation|0|||
162841200|NCT03529773|588127324|FG032|Overall Study|Protocol Violation|0|||
162841201|NCT03529773|588127325|FG033|Overall Study|Protocol Violation|0|||
162841202|NCT03529773|588127326|FG034|Overall Study|Protocol Violation|0|||
162841203|NCT03529773|588127327|FG035|Overall Study|Protocol Violation|0|||
162841204|NCT03529773|588127328|FG036|Overall Study|Protocol Violation|0|||
162841205|NCT03529773|588127329|FG037|Overall Study|Protocol Violation|0|||
162841206|NCT03529773|588127330|FG038|Overall Study|Protocol Violation|0|||
162841207|NCT03529773|588127331|FG039|Overall Study|Protocol Violation|0|||
162841208|NCT03529773|588127292|FG000|Overall Study|Withdrawal by Subject|0|||
162841209|NCT03529773|588127293|FG001|Overall Study|Withdrawal by Subject|0|||
162841210|NCT03529773|588127294|FG002|Overall Study|Withdrawal by Subject|0|||
162841211|NCT03529773|588127295|FG003|Overall Study|Withdrawal by Subject|0|||
162841212|NCT03529773|588127296|FG004|Overall Study|Withdrawal by Subject|0|||
162841213|NCT03529773|588127297|FG005|Overall Study|Withdrawal by Subject|0|||
162841214|NCT03529773|588127298|FG006|Overall Study|Withdrawal by Subject|0|||
162841215|NCT03529773|588127299|FG007|Overall Study|Withdrawal by Subject|1|||
162841216|NCT03529773|588127300|FG008|Overall Study|Withdrawal by Subject|0|||
162841217|NCT03529773|588127301|FG009|Overall Study|Withdrawal by Subject|1|||
162841218|NCT03529773|588127302|FG010|Overall Study|Withdrawal by Subject|1|||
162841219|NCT03529773|588127303|FG011|Overall Study|Withdrawal by Subject|0|||
162841220|NCT03529773|588127304|FG012|Overall Study|Withdrawal by Subject|0|||
162841221|NCT03529773|588127305|FG013|Overall Study|Withdrawal by Subject|0|||
162841222|NCT03529773|588127306|FG014|Overall Study|Withdrawal by Subject|0|||
162841223|NCT03529773|588127307|FG015|Overall Study|Withdrawal by Subject|3|||
162841224|NCT03529773|588127308|FG016|Overall Study|Withdrawal by Subject|0|||
162841225|NCT03529773|588127309|FG017|Overall Study|Withdrawal by Subject|2|||
162841226|NCT03529773|588127310|FG018|Overall Study|Withdrawal by Subject|3|||
162841227|NCT03529773|588127311|FG019|Overall Study|Withdrawal by Subject|1|||
162841228|NCT03529773|588127312|FG020|Overall Study|Withdrawal by Subject|3|||
162841229|NCT03529773|588127313|FG021|Overall Study|Withdrawal by Subject|1|||
162841230|NCT03529773|588127314|FG022|Overall Study|Withdrawal by Subject|1|||
162841231|NCT03529773|588127315|FG023|Overall Study|Withdrawal by Subject|2|||
162841232|NCT03529773|588127316|FG024|Overall Study|Withdrawal by Subject|2|||
162841233|NCT03529773|588127317|FG025|Overall Study|Withdrawal by Subject|4|||
162841234|NCT03529773|588127318|FG026|Overall Study|Withdrawal by Subject|2|||
162841235|NCT03529773|588127319|FG027|Overall Study|Withdrawal by Subject|1|||
162841236|NCT03529773|588127320|FG028|Overall Study|Withdrawal by Subject|1|||
162841237|NCT03529773|588127321|FG029|Overall Study|Withdrawal by Subject|0|||
162841238|NCT03529773|588127322|FG030|Overall Study|Withdrawal by Subject|0|||
162841239|NCT03529773|588127323|FG031|Overall Study|Withdrawal by Subject|0|||
162841240|NCT03529773|588127324|FG032|Overall Study|Withdrawal by Subject|0|||
162841241|NCT03529773|588127325|FG033|Overall Study|Withdrawal by Subject|0|||
162841242|NCT03529773|588127326|FG034|Overall Study|Withdrawal by Subject|1|||
162841243|NCT03529773|588127327|FG035|Overall Study|Withdrawal by Subject|2|||
162841244|NCT03529773|588127328|FG036|Overall Study|Withdrawal by Subject|0|||
162841245|NCT03529773|588127329|FG037|Overall Study|Withdrawal by Subject|2|||
162841246|NCT03529773|588127330|FG038|Overall Study|Withdrawal by Subject|1|||
162841247|NCT03529773|588127331|FG039|Overall Study|Withdrawal by Subject|1|||
162949672|NCT02849652|588518799|FG001|Overall Study|Lost to Follow-up|35|||
162949673|NCT02849652|588518800|FG002|Overall Study|Lost to Follow-up|116|||
162841248|NCT03529773|588127292|FG000|Overall Study|Screen Failure|0|||
162841249|NCT03529773|588127293|FG001|Overall Study|Screen Failure|0|||
162841250|NCT03529773|588127294|FG002|Overall Study|Screen Failure|0|||
162841251|NCT03529773|588127295|FG003|Overall Study|Screen Failure|0|||
162841252|NCT03529773|588127296|FG004|Overall Study|Screen Failure|0|||
162841253|NCT03529773|588127297|FG005|Overall Study|Screen Failure|0|||
162841254|NCT03529773|588127298|FG006|Overall Study|Screen Failure|0|||
162841255|NCT03529773|588127299|FG007|Overall Study|Screen Failure|0|||
162841256|NCT03529773|588127300|FG008|Overall Study|Screen Failure|0|||
162841257|NCT03529773|588127301|FG009|Overall Study|Screen Failure|0|||
162841258|NCT03529773|588127302|FG010|Overall Study|Screen Failure|0|||
162841259|NCT03529773|588127303|FG011|Overall Study|Screen Failure|0|||
162841260|NCT03529773|588127304|FG012|Overall Study|Screen Failure|0|||
162841261|NCT03529773|588127305|FG013|Overall Study|Screen Failure|0|||
162841262|NCT03529773|588127306|FG014|Overall Study|Screen Failure|0|||
162841263|NCT03529773|588127307|FG015|Overall Study|Screen Failure|0|||
162841264|NCT03529773|588127308|FG016|Overall Study|Screen Failure|0|||
162841265|NCT03529773|588127309|FG017|Overall Study|Screen Failure|0|||
162841266|NCT03529773|588127310|FG018|Overall Study|Screen Failure|0|||
162841267|NCT03529773|588127311|FG019|Overall Study|Screen Failure|0|||
162841268|NCT03529773|588127312|FG020|Overall Study|Screen Failure|0|||
162841269|NCT03529773|588127313|FG021|Overall Study|Screen Failure|0|||
162841270|NCT03529773|588127314|FG022|Overall Study|Screen Failure|0|||
162841271|NCT03529773|588127315|FG023|Overall Study|Screen Failure|0|||
162841272|NCT03529773|588127316|FG024|Overall Study|Screen Failure|0|||
162841273|NCT03529773|588127317|FG025|Overall Study|Screen Failure|0|||
162841274|NCT03529773|588127318|FG026|Overall Study|Screen Failure|0|||
162841275|NCT03529773|588127319|FG027|Overall Study|Screen Failure|0|||
162841276|NCT03529773|588127320|FG028|Overall Study|Screen Failure|0|||
162841277|NCT03529773|588127321|FG029|Overall Study|Screen Failure|0|||
162841278|NCT03529773|588127322|FG030|Overall Study|Screen Failure|0|||
162841279|NCT03529773|588127323|FG031|Overall Study|Screen Failure|0|||
162841280|NCT03529773|588127324|FG032|Overall Study|Screen Failure|0|||
162841281|NCT03529773|588127325|FG033|Overall Study|Screen Failure|0|||
162841282|NCT03529773|588127326|FG034|Overall Study|Screen Failure|0|||
162841283|NCT03529773|588127327|FG035|Overall Study|Screen Failure|0|||
162841284|NCT03529773|588127328|FG036|Overall Study|Screen Failure|1|||
162841285|NCT03529773|588127329|FG037|Overall Study|Screen Failure|1|||
162841286|NCT03529773|588127330|FG038|Overall Study|Screen Failure|0|||
162841287|NCT03529773|588127331|FG039|Overall Study|Screen Failure|1|||
162841288|NCT03529773|588127292|FG000|Overall Study|Randomized but not vaccinated|0|||
162841289|NCT03529773|588127293|FG001|Overall Study|Randomized but not vaccinated|0|||
162841290|NCT03529773|588127294|FG002|Overall Study|Randomized but not vaccinated|0|||
162841291|NCT03529773|588127295|FG003|Overall Study|Randomized but not vaccinated|0|||
162841292|NCT03529773|588127296|FG004|Overall Study|Randomized but not vaccinated|0|||
162841293|NCT03529773|588127297|FG005|Overall Study|Randomized but not vaccinated|0|||
162841294|NCT03529773|588127298|FG006|Overall Study|Randomized but not vaccinated|0|||
162841295|NCT03529773|588127299|FG007|Overall Study|Randomized but not vaccinated|0|||
162841296|NCT03529773|588127300|FG008|Overall Study|Randomized but not vaccinated|0|||
162841297|NCT03529773|588127301|FG009|Overall Study|Randomized but not vaccinated|0|||
162841298|NCT03529773|588127302|FG010|Overall Study|Randomized but not vaccinated|0|||
162841299|NCT03529773|588127303|FG011|Overall Study|Randomized but not vaccinated|0|||
162841300|NCT03529773|588127304|FG012|Overall Study|Randomized but not vaccinated|0|||
162841301|NCT03529773|588127305|FG013|Overall Study|Randomized but not vaccinated|0|||
162841302|NCT03529773|588127306|FG014|Overall Study|Randomized but not vaccinated|0|||
162841303|NCT03529773|588127307|FG015|Overall Study|Randomized but not vaccinated|0|||
162841304|NCT03529773|588127308|FG016|Overall Study|Randomized but not vaccinated|0|||
162841305|NCT03529773|588127309|FG017|Overall Study|Randomized but not vaccinated|1|||
162841306|NCT03529773|588127310|FG018|Overall Study|Randomized but not vaccinated|0|||
162841307|NCT03529773|588127311|FG019|Overall Study|Randomized but not vaccinated|0|||
162841308|NCT03529773|588127312|FG020|Overall Study|Randomized but not vaccinated|0|||
162841309|NCT03529773|588127313|FG021|Overall Study|Randomized but not vaccinated|0|||
162841310|NCT03529773|588127314|FG022|Overall Study|Randomized but not vaccinated|0|||
162841311|NCT03529773|588127315|FG023|Overall Study|Randomized but not vaccinated|0|||
162841312|NCT03529773|588127316|FG024|Overall Study|Randomized but not vaccinated|0|||
162841313|NCT03529773|588127317|FG025|Overall Study|Randomized but not vaccinated|0|||
162841314|NCT03529773|588127318|FG026|Overall Study|Randomized but not vaccinated|0|||
162841315|NCT03529773|588127319|FG027|Overall Study|Randomized but not vaccinated|1|||
162841316|NCT03529773|588127320|FG028|Overall Study|Randomized but not vaccinated|0|||
162841317|NCT03529773|588127321|FG029|Overall Study|Randomized but not vaccinated|0|||
162841318|NCT03529773|588127322|FG030|Overall Study|Randomized but not vaccinated|0|||
162841319|NCT03529773|588127323|FG031|Overall Study|Randomized but not vaccinated|0|||
162841320|NCT03529773|588127324|FG032|Overall Study|Randomized but not vaccinated|0|||
162841321|NCT03529773|588127325|FG033|Overall Study|Randomized but not vaccinated|0|||
162841322|NCT03529773|588127326|FG034|Overall Study|Randomized but not vaccinated|0|||
162841323|NCT03529773|588127327|FG035|Overall Study|Randomized but not vaccinated|0|||
162841324|NCT03529773|588127328|FG036|Overall Study|Randomized but not vaccinated|0|||
162841325|NCT03529773|588127329|FG037|Overall Study|Randomized but not vaccinated|0|||
162841326|NCT03529773|588127330|FG038|Overall Study|Randomized but not vaccinated|0|||
162841327|NCT03529773|588127331|FG039|Overall Study|Randomized but not vaccinated|0|||
162841328|NCT01496066|588127333|FG000|Overall Study|Lost to Follow-up|8|||
162841329|NCT01496066|588127334|FG001|Overall Study|Lost to Follow-up|5|||
162841330|NCT01496066|588127333|FG000|Overall Study|Explant|3|||
162841331|NCT01496066|588127334|FG001|Overall Study|Explant|0|||
162841332|NCT01496066|588127333|FG000|Overall Study|Death|1|||
162841333|NCT01496066|588127334|FG001|Overall Study|Death|4|||
162841334|NCT00253630|588127335|FG000|Overall Study|ineligible|2|||
162841335|NCT03237065|588127336|FG000|Overall Study|Adverse Event|0|||
162841336|NCT03237065|588127337|FG001|Overall Study|Adverse Event|2|||
162841337|NCT03237065|588127336|FG000|Overall Study|Protocol Violation|0|||
162841338|NCT03237065|588127337|FG001|Overall Study|Protocol Violation|1|||
162841339|NCT03237065|588127336|FG000|Overall Study|Withdrawal by Subject|3|||
162841340|NCT03237065|588127337|FG001|Overall Study|Withdrawal by Subject|0|||
162841341|NCT03237065|588127336|FG000|Overall Study|Lost to Follow-up|1|||
162841342|NCT03237065|588127337|FG001|Overall Study|Lost to Follow-up|0|||
162841343|NCT03237065|588127336|FG000|Overall Study|Unable to obtain venous access|0|||
162841344|NCT03237065|588127337|FG001|Overall Study|Unable to obtain venous access|1|||
162841345|NCT00209339|588127338|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
162841346|NCT00209339|588127338|FG000|At 12 Months Follow-up|Death|1|||
162841347|NCT00209339|588127338|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
162841348|NCT00209339|588127338|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
162841349|NCT00209339|588127338|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
162841350|NCT00209339|588127338|FG000|At 24 Months Follow-up|Death|1|||
162841351|NCT00209339|588127338|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
162841352|NCT00209339|588127338|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
162841353|NCT00209339|588127338|FG000|At 4 Years Follow-up|Death|1|||
162841354|NCT00209339|588127338|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
162841355|NCT00209339|588127338|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
162841356|NCT00209339|588127338|FG000|At 5 Years Follow-up|Death|1|||
162841357|NCT02062658|588127340|FG000|Overall Study|Withdrawal by Subject|1|||
162841358|NCT02062658|588127340|FG000|Overall Study|Lack of Efficacy|1|||
162841359|NCT02475655|588127341|FG000|Overall Study|Lost to Follow-up|0|||
162841360|NCT02475655|588127342|FG001|Overall Study|Lost to Follow-up|1|||
162841361|NCT00257010|588127345|FG000|Overall Study|Lack of Efficacy|11|||
162841362|NCT00257010|588127345|FG000|Overall Study|Lost to Follow-up|53|||
162841363|NCT00257010|588127345|FG000|Overall Study|Withdrawal by Subject|34|||
162841364|NCT00257010|588127345|FG000|Overall Study|Adverse Event|10|||
162841365|NCT00257010|588127345|FG000|Overall Study|various|11|||
162841366|NCT00257010|588127345|FG000|Overall Study|no headache reported|9|||
162841367|NCT02574637|588127346|FG000|Double-blind Period|Adverse Event|1|||
162841368|NCT02574637|588127347|FG001|Double-blind Period|Adverse Event|0|||
162841369|NCT02574637|588127348|FG002|Double-blind Period|Adverse Event|0|||
162841370|NCT02574637|588127349|FG003|Double-blind Period|Adverse Event|0|||
162841371|NCT02574637|588127350|FG004|Double-blind Period|Adverse Event|0|||
162841372|NCT02574637|588127351|FG005|Double-blind Period|Adverse Event|0|||
162949674|NCT02849652|588518801|FG003|Overall Study|Lost to Follow-up|22|||
162949675|NCT02849652|588518798|FG000|Overall Study|Withdrawal by Subject|10|||
162949676|NCT02849652|588518799|FG001|Overall Study|Withdrawal by Subject|2|||
162949677|NCT02849652|588518800|FG002|Overall Study|Withdrawal by Subject|8|||
162949678|NCT02849652|588518801|FG003|Overall Study|Withdrawal by Subject|4|||
162949679|NCT04977336|588518804|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
162949680|NCT04977336|588518805|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
162949681|NCT04977336|588518806|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
162949682|NCT04977336|588518807|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
162949683|NCT04977336|588518808|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
162949684|NCT04977336|588518804|FG000|Overall Study|Lost to Follow-up|0|||
162949685|NCT04977336|588518805|FG001|Overall Study|Lost to Follow-up|0|||
162949686|NCT04977336|588518806|FG002|Overall Study|Lost to Follow-up|1|||
162949687|NCT04977336|588518807|FG003|Overall Study|Lost to Follow-up|0|||
162949688|NCT04977336|588518808|FG004|Overall Study|Lost to Follow-up|0|||
162949689|NCT00408902|588518810|FG000|Overall Study|Lack of Efficacy|7|||
162949690|NCT00408902|588518810|FG000|Overall Study|Adverse Event|3|||
162700385|NCT04212169|587615023|FG000|Overall Study|Other reason, unspecified|3|||
162700386|NCT04212169|587615024|FG001|Overall Study|Other reason, unspecified|1|||
162841373|NCT02574637|588127352|FG006|Double-blind Period|Adverse Event|0|||
162841374|NCT02574637|588127353|FG007|Double-blind Period|Adverse Event|0|||
162841375|NCT02574637|588127354|FG008|Double-blind Period|Adverse Event|0|||
162841376|NCT02574637|588127355|FG009|Double-blind Period|Adverse Event|0|||
162841377|NCT02574637|588127346|FG000|Double-blind Period|Lack of Efficacy|0|||
162841378|NCT02574637|588127347|FG001|Double-blind Period|Lack of Efficacy|0|||
162841379|NCT02574637|588127348|FG002|Double-blind Period|Lack of Efficacy|2|||
162841380|NCT02574637|588127349|FG003|Double-blind Period|Lack of Efficacy|0|||
162841381|NCT02574637|588127350|FG004|Double-blind Period|Lack of Efficacy|0|||
162841382|NCT02574637|588127351|FG005|Double-blind Period|Lack of Efficacy|0|||
162949691|NCT02480764|588518814|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162949692|NCT02480764|588518815|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
162949693|NCT02480764|588518816|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
162949694|NCT02480764|588518814|FG000|Overall Study|Major Protocol Deviation|1|||
162949695|NCT02480764|588518815|FG001|Overall Study|Major Protocol Deviation|4|||
162949696|NCT02480764|588518816|FG002|Overall Study|Major Protocol Deviation|3|||
162949697|NCT02480764|588518814|FG000|Overall Study|Lost to Follow-up|0|||
162949698|NCT02480764|588518815|FG001|Overall Study|Lost to Follow-up|1|||
162949699|NCT02480764|588518816|FG002|Overall Study|Lost to Follow-up|2|||
162949700|NCT02480764|588518814|FG000|Overall Study|Voluntary Withdrawal|6|||
162949701|NCT02480764|588518815|FG001|Overall Study|Voluntary Withdrawal|5|||
162949702|NCT02480764|588518816|FG002|Overall Study|Voluntary Withdrawal|10|||
162949703|NCT02480764|588518814|FG000|Overall Study|Lack of Efficacy|0|||
162949704|NCT02480764|588518815|FG001|Overall Study|Lack of Efficacy|3|||
162949705|NCT02480764|588518816|FG002|Overall Study|Lack of Efficacy|3|||
162949706|NCT02480764|588518814|FG000|Overall Study|Reason not Specified|0|||
162949707|NCT02480764|588518815|FG001|Overall Study|Reason not Specified|1|||
162949708|NCT02480764|588518816|FG002|Overall Study|Reason not Specified|0|||
162949709|NCT02457832|588518819|FG000|Training|Lost to Follow-up|10|||
162949710|NCT02457832|588518820|FG001|Training|Lost to Follow-up|6|||
162949711|NCT02457832|588518821|FG002|Training|Lost to Follow-up|3|||
162949712|NCT02457832|588518819|FG000|One Month Washout|Lost to Follow-up|0|||
162841383|NCT02574637|588127352|FG006|Double-blind Period|Lack of Efficacy|0|||
162841384|NCT02574637|588127353|FG007|Double-blind Period|Lack of Efficacy|0|||
162841385|NCT02574637|588127354|FG008|Double-blind Period|Lack of Efficacy|0|||
162841386|NCT02574637|588127355|FG009|Double-blind Period|Lack of Efficacy|0|||
162841387|NCT02574637|588127346|FG000|Double-blind Period|Protocol Deviation|1|||
162841388|NCT02574637|588127347|FG001|Double-blind Period|Protocol Deviation|0|||
162841389|NCT02574637|588127348|FG002|Double-blind Period|Protocol Deviation|0|||
162841390|NCT02574637|588127349|FG003|Double-blind Period|Protocol Deviation|0|||
162841391|NCT02574637|588127350|FG004|Double-blind Period|Protocol Deviation|0|||
162949713|NCT02457832|588518820|FG001|One Month Washout|Lost to Follow-up|1|||
162949714|NCT02457832|588518821|FG002|One Month Washout|Lost to Follow-up|1|||
162949715|NCT01044732|588518822|FG000|Overall Study|Lost to Follow-up|2|||
162949716|NCT01044732|588518823|FG001|Overall Study|Lost to Follow-up|1|||
162949717|NCT01044732|588518822|FG000|Overall Study|Physician Decision|5|||
162949718|NCT01044732|588518823|FG001|Overall Study|Physician Decision|3|||
162949719|NCT01044732|588518822|FG000|Overall Study|Protocol Violation|11|||
162949720|NCT01044732|588518823|FG001|Overall Study|Protocol Violation|12|||
162949721|NCT01044732|588518822|FG000|Overall Study|Withdrawal by Subject|0|||
162949722|NCT01044732|588518823|FG001|Overall Study|Withdrawal by Subject|1|||
162949723|NCT01044732|588518822|FG000|Overall Study|Inadequate bowel preparation|11|||
162949724|NCT01044732|588518823|FG001|Overall Study|Inadequate bowel preparation|17|||
162949725|NCT01044732|588518822|FG000|Overall Study|Inability to reach cecum|5|||
162949726|NCT01044732|588518823|FG001|Overall Study|Inability to reach cecum|2|||
162949727|NCT01044732|588518822|FG000|Overall Study|Technical error or malfunction|15|||
162949728|NCT01044732|588518823|FG001|Overall Study|Technical error or malfunction|14|||
162949729|NCT01030965|588518824|FG000|Overall Study|Lack of Efficacy|3|||
162949730|NCT01030965|588518825|FG001|Overall Study|Lack of Efficacy|2|||
162949731|NCT01030965|588518826|FG002|Overall Study|Lack of Efficacy|0|||
162949732|NCT01030965|588518827|FG003|Overall Study|Lack of Efficacy|3|||
162949733|NCT01030965|588518824|FG000|Overall Study|Protocol Violation|1|||
162949734|NCT01030965|588518825|FG001|Overall Study|Protocol Violation|1|||
162949735|NCT01030965|588518826|FG002|Overall Study|Protocol Violation|1|||
162949736|NCT01030965|588518827|FG003|Overall Study|Protocol Violation|1|||
162949737|NCT01030965|588518824|FG000|Overall Study|Adverse Event|0|||
162949738|NCT01030965|588518825|FG001|Overall Study|Adverse Event|1|||
162949739|NCT01030965|588518826|FG002|Overall Study|Adverse Event|2|||
162949740|NCT01030965|588518827|FG003|Overall Study|Adverse Event|1|||
162949741|NCT01030965|588518824|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
162949742|NCT01030965|588518825|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
162949743|NCT01030965|588518826|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
162949744|NCT01030965|588518827|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
162949745|NCT01030965|588518824|FG000|Overall Study|Withdrawal by Subject|0|||
162949746|NCT01030965|588518825|FG001|Overall Study|Withdrawal by Subject|1|||
162949747|NCT01030965|588518826|FG002|Overall Study|Withdrawal by Subject|0|||
162949748|NCT01030965|588518827|FG003|Overall Study|Withdrawal by Subject|2|||
162949749|NCT02097290|588518828|FG000|Overall Study|Death|6|||
162949750|NCT02097290|588518828|FG000|Overall Study|Total Withdrawals|3|||
162949751|NCT02097290|588518828|FG000|Overall Study|Attempt|8|||
162949752|NCT03991494|588518833|FG000|Overall Study|Progressive Disease|4|||
162949753|NCT05277389|588518834|FG000|Overall Study|Lost to Follow-up|1|||
162841392|NCT02574637|588127351|FG005|Double-blind Period|Protocol Deviation|0|||
162841393|NCT02574637|588127352|FG006|Double-blind Period|Protocol Deviation|0|||
162841394|NCT02574637|588127353|FG007|Double-blind Period|Protocol Deviation|0|||
162949754|NCT05277389|588518835|FG001|Overall Study|Lost to Follow-up|4|||
162949755|NCT03144687|588518839|FG000|Overall Study|Death|0|||
162949756|NCT03144687|588518840|FG001|Overall Study|Death|2|||
162949757|NCT03144687|588518839|FG000|Overall Study|Lost to Follow-up|0|||
162949758|NCT03144687|588518840|FG001|Overall Study|Lost to Follow-up|1|||
162841395|NCT02574637|588127354|FG008|Double-blind Period|Protocol Deviation|0|||
162841396|NCT02574637|588127355|FG009|Double-blind Period|Protocol Deviation|0|||
162841397|NCT02574637|588127346|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
162841398|NCT02574637|588127347|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
162841399|NCT02574637|588127348|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
162841400|NCT02574637|588127349|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
162841401|NCT02574637|588127350|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
162841402|NCT02574637|588127351|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
162841403|NCT02574637|588127352|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
162949759|NCT03144687|588518839|FG000|Overall Study|Physician Decision|0|||
162949760|NCT03144687|588518840|FG001|Overall Study|Physician Decision|1|||
162949761|NCT03144687|588518839|FG000|Overall Study|Withdrawal by Subject|1|||
162949762|NCT03144687|588518840|FG001|Overall Study|Withdrawal by Subject|3|||
162949763|NCT03144687|588518839|FG000|Overall Study|Not Reported|2|||
162949764|NCT03144687|588518840|FG001|Overall Study|Not Reported|0|||
162949765|NCT02514174|588518841|FG000|Overall Study|Patient refused to continue medication|1|||
162949766|NCT02514174|588518841|FG000|Overall Study|Adverse Event|2|||
162949767|NCT02514174|588518841|FG000|Overall Study|Study closed by sponsor|9|||
162949768|NCT02514174|588518841|FG000|Overall Study|Progressive disease|11|||
162949769|NCT02514174|588518841|FG000|Overall Study|Treatment change|1|||
162949770|NCT02514174|588518841|FG000|Overall Study|Treated off study with Afatinib.|1|||
162949771|NCT00824265|588518842|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
162949772|NCT00824265|588518843|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
162949773|NCT00824265|588518842|FG000|Treatment Phase|Protocol Violation|1|||
162949774|NCT00824265|588518843|FG001|Treatment Phase|Protocol Violation|0|||
162949775|NCT00824265|588518842|FG000|Treatment Phase|Lost to Follow-up|1|||
162949776|NCT00824265|588518843|FG001|Treatment Phase|Lost to Follow-up|1|||
162949777|NCT00824265|588518842|FG000|Treatment Phase|Physician Decision|6|||
162949778|NCT00824265|588518843|FG001|Treatment Phase|Physician Decision|12|||
162949779|NCT00824265|588518842|FG000|Treatment Phase|Withdrawal by Subject|6|||
162949780|NCT00824265|588518843|FG001|Treatment Phase|Withdrawal by Subject|15|||
162949781|NCT00824265|588518842|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
162949782|NCT00824265|588518843|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
162949783|NCT00824265|588518842|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
162949784|NCT00824265|588518843|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
162949785|NCT02170688|588518844|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
162949786|NCT02170688|588518845|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
162949787|NCT02170688|588518846|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
162949788|NCT02170688|588518847|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
162949789|NCT02170688|588518848|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
162949790|NCT02170688|588518844|FG000|Overall Study|Full dose not received|0|||
162949791|NCT02170688|588518845|FG001|Overall Study|Full dose not received|1|||
162949792|NCT02170688|588518846|FG002|Overall Study|Full dose not received|0|||
162949793|NCT02170688|588518847|FG003|Overall Study|Full dose not received|0|||
162949794|NCT02170688|588518848|FG004|Overall Study|Full dose not received|0|||
162949795|NCT02170688|588518844|FG000|Overall Study|Physician Decision|0|||
162949796|NCT02170688|588518845|FG001|Overall Study|Physician Decision|0|||
162949797|NCT02170688|588518846|FG002|Overall Study|Physician Decision|1|||
162949798|NCT02170688|588518847|FG003|Overall Study|Physician Decision|0|||
162949799|NCT02170688|588518848|FG004|Overall Study|Physician Decision|0|||
162949800|NCT02079532|588518851|FG000|Overall Study|Adverse Event|7|||
162949801|NCT02079532|588518851|FG000|Overall Study|Additional or changed therapy|2|||
162949802|NCT02079532|588518851|FG000|Overall Study|Lack of Efficacy|9|||
162949803|NCT02079532|588518851|FG000|Overall Study|Protocol Violation|3|||
162949804|NCT02079532|588518851|FG000|Overall Study|Withdrawal by Subject|1|||
162949805|NCT02079532|588518851|FG000|Overall Study|Administrative problems|1|||
162949806|NCT02079532|588518851|FG000|Overall Study|Inclusion into ReFIRST|3|||
162841404|NCT02574637|588127353|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
162841405|NCT02574637|588127354|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
162841406|NCT02574637|588127355|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
162841407|NCT02574637|588127346|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
162841408|NCT02574637|588127347|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
162949807|NCT02079532|588518851|FG000|Overall Study|Other|3|||
162949808|NCT02920996|588518852|FG000|Overall Study|Adverse Event|8|||
162949809|NCT02920996|588518853|FG001|Overall Study|Adverse Event|0|||
162949810|NCT02920996|588518852|FG000|Overall Study|Physician Decision|1|||
162949811|NCT02920996|588518853|FG001|Overall Study|Physician Decision|0|||
162949812|NCT02920996|588518852|FG000|Overall Study|Death|1|||
162949813|NCT02920996|588518853|FG001|Overall Study|Death|0|||
162949814|NCT02920996|588518852|FG000|Overall Study|Missing|1|||
162949815|NCT02920996|588518853|FG001|Overall Study|Missing|0|||
162949816|NCT02920996|588518852|FG000|Overall Study|Subject Non-Compliance|1|||
162949817|NCT02920996|588518853|FG001|Overall Study|Subject Non-Compliance|0|||
162841409|NCT02574637|588127348|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
162841410|NCT02574637|588127349|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
162841411|NCT02574637|588127350|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
162841412|NCT02574637|588127351|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
162841413|NCT02574637|588127352|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
162841414|NCT02574637|588127353|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
162841415|NCT02574637|588127354|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
162841416|NCT02574637|588127355|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
162841417|NCT02574637|588127346|FG000|Double-blind Period|Reason Not Specified|0|||
162841418|NCT02574637|588127347|FG001|Double-blind Period|Reason Not Specified|0|||
162841419|NCT02574637|588127348|FG002|Double-blind Period|Reason Not Specified|0|||
162841420|NCT02574637|588127349|FG003|Double-blind Period|Reason Not Specified|1|||
162841421|NCT02574637|588127350|FG004|Double-blind Period|Reason Not Specified|0|||
162841422|NCT02574637|588127351|FG005|Double-blind Period|Reason Not Specified|0|||
162841423|NCT02574637|588127352|FG006|Double-blind Period|Reason Not Specified|0|||
162841424|NCT02574637|588127353|FG007|Double-blind Period|Reason Not Specified|0|||
162841425|NCT02574637|588127354|FG008|Double-blind Period|Reason Not Specified|0|||
162841426|NCT02574637|588127355|FG009|Double-blind Period|Reason Not Specified|0|||
162841427|NCT02574637|588127346|FG000|Open-label (OL) Period|Adverse Event|0|||
162841428|NCT02574637|588127347|FG001|Open-label (OL) Period|Adverse Event|0|||
162841429|NCT02574637|588127348|FG002|Open-label (OL) Period|Adverse Event|0|||
162841430|NCT02574637|588127349|FG003|Open-label (OL) Period|Adverse Event|0|||
162841431|NCT02574637|588127350|FG004|Open-label (OL) Period|Adverse Event|0|||
162841432|NCT02574637|588127351|FG005|Open-label (OL) Period|Adverse Event|0|||
162841433|NCT02574637|588127352|FG006|Open-label (OL) Period|Adverse Event|0|||
162841434|NCT02574637|588127353|FG007|Open-label (OL) Period|Adverse Event|0|||
162841435|NCT02574637|588127354|FG008|Open-label (OL) Period|Adverse Event|1|||
162841436|NCT02574637|588127355|FG009|Open-label (OL) Period|Adverse Event|0|||
162841437|NCT02574637|588127346|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
162841438|NCT02574637|588127347|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
162841439|NCT02574637|588127348|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
162841440|NCT02574637|588127349|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
162841441|NCT02574637|588127350|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
162841442|NCT02574637|588127351|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
162841443|NCT02574637|588127352|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
162841444|NCT02574637|588127353|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
162841445|NCT02574637|588127354|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
162841446|NCT02574637|588127355|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
162841447|NCT02574637|588127346|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841448|NCT02574637|588127347|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841449|NCT02574637|588127348|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841450|NCT02574637|588127349|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841451|NCT02574637|588127350|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841452|NCT02574637|588127351|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
162841453|NCT02574637|588127352|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
162841454|NCT02574637|588127353|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
162841455|NCT02574637|588127354|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
162841456|NCT02574637|588127355|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
162841457|NCT00939692|588127368|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
162841458|NCT00939692|588127369|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
162841459|NCT00939692|588127368|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
162841460|NCT00939692|588127369|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
162841461|NCT00699907|588127374|FG000|Overall Study|Withdrawal by Subject|2|||
162841462|NCT00699907|588127375|FG001|Overall Study|Withdrawal by Subject|1|||
162841463|NCT00699907|588127376|FG002|Overall Study|Withdrawal by Subject|0|||
162949818|NCT01402947|588518854|FG000|First Intervention|Adverse Event|0|||
162949819|NCT01402947|588518855|FG001|First Intervention|Adverse Event|1|||
162949820|NCT00591630|588518856|FG000|Overall Study|Death|0|||
162949821|NCT00591630|588518857|FG001|Overall Study|Death|0|||
162949822|NCT00591630|588518858|FG002|Overall Study|Death|1|||
162949823|NCT00591630|588518859|FG003|Overall Study|Death|0|||
162949824|NCT01471522|588518863|FG000|Overall Study|Withdrawal by Subject|28|||
162949825|NCT01471522|588518864|FG001|Overall Study|Withdrawal by Subject|22|||
162949826|NCT01471522|588518863|FG000|Overall Study|Lost to Follow-up|36|||
162949827|NCT01471522|588518864|FG001|Overall Study|Lost to Follow-up|26|||
162949828|NCT01432171|588518866|FG000|Overall Study|Death|1|||
162949829|NCT01432171|588518867|FG001|Overall Study|Death|2|||
162949830|NCT01432171|588518866|FG000|Overall Study|Lost to Follow-up|6|||
162949831|NCT01432171|588518867|FG001|Overall Study|Lost to Follow-up|5|||
162949832|NCT01432171|588518866|FG000|Overall Study|Withdrawal by Subject|3|||
162949833|NCT01432171|588518867|FG001|Overall Study|Withdrawal by Subject|1|||
162949834|NCT01432171|588518866|FG000|Overall Study|Noncompliance|2|||
162949835|NCT01432171|588518867|FG001|Overall Study|Noncompliance|3|||
162949836|NCT01432171|588518866|FG000|Overall Study|Insurance denial trial coverage|1|||
162949837|NCT01432171|588518867|FG001|Overall Study|Insurance denial trial coverage|0|||
162949838|NCT01432171|588518866|FG000|Overall Study|Patient moved to palliative care|1|||
162949839|NCT01432171|588518867|FG001|Overall Study|Patient moved to palliative care|0|||
162949840|NCT02863575|588518868|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
162700387|NCT04212169|587615025|FG002|Overall Study|Other reason, unspecified|0|||
162949841|NCT02863575|588518869|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
162949842|NCT02863575|588518870|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
162949843|NCT02863575|588518868|FG000|Overall Study|Withdrawal by Subject|0|||
162949844|NCT02863575|588518869|FG001|Overall Study|Withdrawal by Subject|1|||
162949845|NCT02863575|588518870|FG002|Overall Study|Withdrawal by Subject|1|||
162949846|NCT02863575|588518868|FG000|Overall Study|Adverse Event|0|||
162949847|NCT02863575|588518869|FG001|Overall Study|Adverse Event|1|||
162949848|NCT02863575|588518870|FG002|Overall Study|Adverse Event|0|||
162700388|NCT04212169|587615026|FG003|Overall Study|Other reason, unspecified|2|||
162949849|NCT01706926|588518871|FG000|Overall Study|Lost to Follow-up|0|||
162949850|NCT01706926|588518872|FG001|Overall Study|Lost to Follow-up|0|||
162700389|NCT02176928|587615027|FG000|Overall Study|Lost to Follow-up|2|||
162949851|NCT01706926|588518873|FG002|Overall Study|Lost to Follow-up|1|||
162949852|NCT01706926|588518874|FG003|Overall Study|Lost to Follow-up|0|||
162841464|NCT00699907|588127374|FG000|Overall Study|No usable sample|0|||
162841465|NCT00699907|588127375|FG001|Overall Study|No usable sample|9|||
162841466|NCT00699907|588127376|FG002|Overall Study|No usable sample|8|||
162841467|NCT01081795|588127377|FG000|Overall Study|Adverse Event|18|||
162841468|NCT01081795|588127378|FG001|Overall Study|Adverse Event|23|||
162841469|NCT01081795|588127379|FG002|Overall Study|Adverse Event|6|||
162841470|NCT01081795|588127377|FG000|Overall Study|Lack of Efficacy|7|||
162841471|NCT01081795|588127378|FG001|Overall Study|Lack of Efficacy|5|||
162841472|NCT01081795|588127379|FG002|Overall Study|Lack of Efficacy|19|||
162841473|NCT01081795|588127377|FG000|Overall Study|Subject's schedule|1|||
162841474|NCT01081795|588127378|FG001|Overall Study|Subject's schedule|1|||
162841475|NCT01081795|588127379|FG002|Overall Study|Subject's schedule|2|||
162841476|NCT01081795|588127377|FG000|Overall Study|Revocation of informed consent|2|||
162949853|NCT01706926|588518871|FG000|Overall Study|Withdrawal by Subject|2|||
162949854|NCT01706926|588518872|FG001|Overall Study|Withdrawal by Subject|0|||
162949855|NCT01706926|588518873|FG002|Overall Study|Withdrawal by Subject|1|||
162949856|NCT01706926|588518874|FG003|Overall Study|Withdrawal by Subject|2|||
162949857|NCT01706926|588518871|FG000|Overall Study|Other|4|||
162949858|NCT01706926|588518872|FG001|Overall Study|Other|4|||
162949859|NCT01706926|588518873|FG002|Overall Study|Other|4|||
162949860|NCT01706926|588518874|FG003|Overall Study|Other|3|||
162949861|NCT01248247|588520202|FG000|Overall Study|Adverse Event|2|||
162949862|NCT01248247|588520203|FG001|Overall Study|Adverse Event|4|||
162949863|NCT01248247|588520204|FG002|Overall Study|Adverse Event|4|||
162949864|NCT01248247|588520205|FG003|Overall Study|Adverse Event|2|||
162949865|NCT01248247|588520202|FG000|Overall Study|Death|0|||
162949866|NCT01248247|588520203|FG001|Overall Study|Death|1|||
162949867|NCT01248247|588520204|FG002|Overall Study|Death|4|||
162949868|NCT01248247|588520205|FG003|Overall Study|Death|7|||
162949869|NCT01248247|588520202|FG000|Overall Study|Lost to Follow-up|0|||
162949870|NCT01248247|588520203|FG001|Overall Study|Lost to Follow-up|1|||
162949871|NCT01248247|588520204|FG002|Overall Study|Lost to Follow-up|1|||
162949872|NCT01248247|588520205|FG003|Overall Study|Lost to Follow-up|0|||
162949873|NCT01248247|588520202|FG000|Overall Study|Alternative treatment|0|||
162949874|NCT01248247|588520203|FG001|Overall Study|Alternative treatment|1|||
162949875|NCT01248247|588520204|FG002|Overall Study|Alternative treatment|0|||
162949876|NCT01248247|588520205|FG003|Overall Study|Alternative treatment|0|||
162949877|NCT01248247|588520202|FG000|Overall Study|Other|2|||
162949878|NCT01248247|588520203|FG001|Overall Study|Other|8|||
162949879|NCT01248247|588520204|FG002|Overall Study|Other|8|||
162949880|NCT01248247|588520205|FG003|Overall Study|Other|5|||
162949881|NCT01248247|588520202|FG000|Overall Study|Progression|18|||
162949882|NCT01248247|588520203|FG001|Overall Study|Progression|27|||
162949883|NCT01248247|588520204|FG002|Overall Study|Progression|56|||
162949884|NCT01248247|588520205|FG003|Overall Study|Progression|44|||
162949885|NCT01248247|588520202|FG000|Overall Study|Refuse further treatment|0|||
162949886|NCT01248247|588520203|FG001|Overall Study|Refuse further treatment|0|||
162949887|NCT01248247|588520204|FG002|Overall Study|Refuse further treatment|1|||
162949888|NCT01248247|588520205|FG003|Overall Study|Refuse further treatment|2|||
162949889|NCT01248247|588520202|FG000|Overall Study|Complicating disease|0|||
162949890|NCT01248247|588520203|FG001|Overall Study|Complicating disease|0|||
162949891|NCT01248247|588520204|FG002|Overall Study|Complicating disease|1|||
162949892|NCT01248247|588520205|FG003|Overall Study|Complicating disease|1|||
162949893|NCT03597256|588520206|FG000|Overall Study|Lost to Follow-up|3|||
162949894|NCT03597256|588520207|FG001|Overall Study|Lost to Follow-up|1|||
162949895|NCT03597256|588520206|FG000|Overall Study|Withdrawal by Subject|0|||
162949896|NCT03597256|588520207|FG001|Overall Study|Withdrawal by Subject|1|||
162949897|NCT03597256|588520206|FG000|Overall Study|Could not return for treatment|0|||
162949898|NCT03597256|588520207|FG001|Overall Study|Could not return for treatment|1|||
162841477|NCT01081795|588127378|FG001|Overall Study|Revocation of informed consent|0|||
162949899|NCT03597256|588520206|FG000|Overall Study|Moved from location|0|||
162949900|NCT03597256|588520207|FG001|Overall Study|Moved from location|1|||
162949901|NCT03597256|588520206|FG000|Overall Study|Not accepted the treatment|0|||
162841478|NCT01081795|588127379|FG002|Overall Study|Revocation of informed consent|0|||
162949902|NCT03597256|588520207|FG001|Overall Study|Not accepted the treatment|1|||
162949903|NCT02943447|588520208|FG000|Blinded Study Phase|Withdrew Consent|1|||
162949904|NCT02943447|588520209|FG001|Blinded Study Phase|Withdrew Consent|2|||
162949905|NCT02943447|588520210|FG002|Blinded Study Phase|Withdrew Consent|1|||
162949906|NCT02943447|588520208|FG000|Blinded Study Phase|Adverse Event|3|||
162949907|NCT02943447|588520209|FG001|Blinded Study Phase|Adverse Event|0|||
162949908|NCT02943447|588520210|FG002|Blinded Study Phase|Adverse Event|0|||
162949909|NCT02943447|588520208|FG000|Blinded Study Phase|Investigator's discretion|1|||
162949910|NCT02943447|588520209|FG001|Blinded Study Phase|Investigator's discretion|0|||
162949911|NCT02943447|588520210|FG002|Blinded Study Phase|Investigator's discretion|0|||
162841479|NCT01081795|588127377|FG000|Overall Study|Ineligible for participation|1|||
162841480|NCT01081795|588127378|FG001|Overall Study|Ineligible for participation|0|||
162841481|NCT01081795|588127379|FG002|Overall Study|Ineligible for participation|0|||
162841482|NCT01081795|588127377|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
162841483|NCT01081795|588127378|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
162841484|NCT01081795|588127379|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
162841485|NCT01081795|588127377|FG000|Overall Study|Using drug with restricted days of use|2|||
162841486|NCT01081795|588127378|FG001|Overall Study|Using drug with restricted days of use|3|||
162841487|NCT01081795|588127379|FG002|Overall Study|Using drug with restricted days of use|2|||
162841488|NCT01081795|588127377|FG000|Overall Study|Other|1|||
162841489|NCT01081795|588127378|FG001|Overall Study|Other|2|||
162841490|NCT01081795|588127379|FG002|Overall Study|Other|0|||
162841491|NCT02462473|588127380|FG000|Overall Study|Death|1|||
162841492|NCT02462473|588127380|FG000|Overall Study|Other|3|||
162841493|NCT01536860|588127382|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
162841494|NCT01536860|588127383|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
162841495|NCT01536860|588127384|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
162841496|NCT01164722|588127385|FG000|Overall Study|Adverse Event|0|||
162841497|NCT01164722|588127386|FG001|Overall Study|Adverse Event|1|||
162841498|NCT01164722|588127385|FG000|Overall Study|Withdrawal by Subject|3|||
162841499|NCT01164722|588127386|FG001|Overall Study|Withdrawal by Subject|4|||
162841500|NCT01164722|588127385|FG000|Overall Study|Lost to Follow-up|3|||
162841501|NCT01164722|588127386|FG001|Overall Study|Lost to Follow-up|6|||
162841502|NCT01164722|588127385|FG000|Overall Study|met protocol criteria for non-treatment|11|||
162841503|NCT01164722|588127386|FG001|Overall Study|met protocol criteria for non-treatment|1|||
162841504|NCT01164722|588127385|FG000|Overall Study|enrolled on other study, concomitant med|1|||
162841505|NCT01164722|588127386|FG001|Overall Study|enrolled on other study, concomitant med|3|||
162841506|NCT03889639|588127388|FG000|Overall Study|Withdrawal by Subject|0|||
162841507|NCT03889639|588127389|FG001|Overall Study|Withdrawal by Subject|0|||
162841508|NCT03889639|588127390|FG002|Overall Study|Withdrawal by Subject|0|||
162841509|NCT03889639|588127391|FG003|Overall Study|Withdrawal by Subject|0|||
162841510|NCT03889639|588127392|FG004|Overall Study|Withdrawal by Subject|0|||
162841511|NCT03889639|588127393|FG005|Overall Study|Withdrawal by Subject|0|||
162841512|NCT03889639|588127394|FG006|Overall Study|Withdrawal by Subject|0|||
162841513|NCT03889639|588127395|FG007|Overall Study|Withdrawal by Subject|1|||
162841514|NCT01707693|588127396|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
162841515|NCT01707693|588127397|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
162841516|NCT01707693|588127396|FG000|Overall Study Allocation|Protocol Violation|4|||
162841517|NCT01707693|588127397|FG001|Overall Study Allocation|Protocol Violation|3|||
162841518|NCT01707693|588127396|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
162841519|NCT01707693|588127397|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
162841520|NCT01707693|588127396|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
162841521|NCT01707693|588127397|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
162841522|NCT02556255|588127399|FG000|Overall Study|Lost to Follow-up|4|||
162841523|NCT00993031|588127400|FG000|Overall Study|Death|0|||
162841524|NCT00993031|588127401|FG001|Overall Study|Death|1|||
162841525|NCT00993031|588127400|FG000|Overall Study|Physician Decision|0|||
162841526|NCT00993031|588127401|FG001|Overall Study|Physician Decision|2|||
162841527|NCT00993031|588127400|FG000|Overall Study|Withdrawal by Subject|3|||
162841528|NCT00993031|588127401|FG001|Overall Study|Withdrawal by Subject|3|||
162841529|NCT00993031|588127400|FG000|Overall Study|Lost to Follow-up|19|||
162841530|NCT00993031|588127401|FG001|Overall Study|Lost to Follow-up|13|||
162841531|NCT03115151|588127402|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
162841532|NCT03115151|588127403|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
162841533|NCT03115151|588127402|FG000|Overall Study|Epidural catheter removal|1|||
162841534|NCT03115151|588127403|FG001|Overall Study|Epidural catheter removal|0|||
162949912|NCT02943447|588520208|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
162949913|NCT02943447|588520209|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
162949914|NCT02943447|588520210|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
162949915|NCT02943447|588520208|FG000|Open-Label Extension Phase|Adverse Event|4|||
162949916|NCT02943447|588520209|FG001|Open-Label Extension Phase|Adverse Event|7|||
162949917|NCT02943447|588520210|FG002|Open-Label Extension Phase|Adverse Event|3|||
162949918|NCT02943447|588520208|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
162949919|NCT02943447|588520209|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
162949920|NCT02943447|588520210|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
162949921|NCT02943447|588520208|FG000|Open-Label Extension Phase|Withdrew consent|1|||
162949922|NCT02943447|588520209|FG001|Open-Label Extension Phase|Withdrew consent|1|||
162949923|NCT02943447|588520210|FG002|Open-Label Extension Phase|Withdrew consent|1|||
162949924|NCT02943447|588520208|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162949925|NCT02943447|588520209|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
162949926|NCT02943447|588520210|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162949927|NCT01725529|588520221|FG000|Overall Study|Adverse Event|1|||
162949928|NCT01725529|588520222|FG001|Overall Study|Adverse Event|0|||
162949929|NCT01725529|588520223|FG002|Overall Study|Adverse Event|0|||
162949930|NCT01725529|588520221|FG000|Overall Study|Lost to Follow-up|2|||
162949931|NCT01725529|588520222|FG001|Overall Study|Lost to Follow-up|1|||
162949932|NCT01725529|588520223|FG002|Overall Study|Lost to Follow-up|1|||
162949933|NCT01725529|588520221|FG000|Overall Study|Protocol Violation|0|||
162949934|NCT01725529|588520222|FG001|Overall Study|Protocol Violation|1|||
162949935|NCT01725529|588520223|FG002|Overall Study|Protocol Violation|1|||
162949936|NCT01725529|588520221|FG000|Overall Study|Withdrawal by Subject|12|||
162949937|NCT01725529|588520222|FG001|Overall Study|Withdrawal by Subject|14|||
162841535|NCT03115151|588127402|FG000|Overall Study|Withdrawal by Subject|0|||
162841536|NCT03115151|588127403|FG001|Overall Study|Withdrawal by Subject|1|||
162841537|NCT03115151|588127402|FG000|Overall Study|Intervention not received according to the protocol.|1|||
162841538|NCT03115151|588127403|FG001|Overall Study|Intervention not received according to the protocol.|1|||
162949938|NCT01725529|588520223|FG002|Overall Study|Withdrawal by Subject|8|||
162949939|NCT00358449|588520225|FG000|Overall Study|Adverse Event|1|||
162949940|NCT00358449|588520226|FG001|Overall Study|Adverse Event|0|||
162949941|NCT00358449|588520227|FG002|Overall Study|Adverse Event|1|||
162949942|NCT00358449|588520225|FG000|Overall Study|Lost to Follow-up|1|||
162949943|NCT00358449|588520226|FG001|Overall Study|Lost to Follow-up|0|||
162949944|NCT00358449|588520227|FG002|Overall Study|Lost to Follow-up|0|||
162949945|NCT00358449|588520225|FG000|Overall Study|Withdrawal by Subject|2|||
162949946|NCT00358449|588520226|FG001|Overall Study|Withdrawal by Subject|0|||
162949947|NCT00358449|588520227|FG002|Overall Study|Withdrawal by Subject|0|||
162949948|NCT00358449|588520225|FG000|Overall Study|Lack of Efficacy|0|||
162949949|NCT00358449|588520226|FG001|Overall Study|Lack of Efficacy|1|||
162949950|NCT00358449|588520227|FG002|Overall Study|Lack of Efficacy|0|||
162949951|NCT00358449|588520225|FG000|Overall Study|Steriod Inhaler was Increased|0|||
162949952|NCT00358449|588520226|FG001|Overall Study|Steriod Inhaler was Increased|0|||
162949953|NCT00358449|588520227|FG002|Overall Study|Steriod Inhaler was Increased|1|||
162949954|NCT01804270|588520228|FG000|Overall Study|Withdrawal by Subject|1|||
162949955|NCT01804270|588520229|FG001|Overall Study|Withdrawal by Subject|1|||
162949956|NCT02334722|588520231|FG000|Overall Study|Lost to Follow-up|4|||
162949957|NCT02334722|588520232|FG001|Overall Study|Lost to Follow-up|0|||
162949958|NCT02334722|588520231|FG000|Overall Study|6 week questionnaire not completed|2|||
162841539|NCT03115151|588127402|FG000|Overall Study|Physician Decision|1|||
162841540|NCT03115151|588127403|FG001|Overall Study|Physician Decision|0|||
162841541|NCT03115151|588127402|FG000|Overall Study|Randomization not applied|1|||
162841542|NCT03115151|588127403|FG001|Overall Study|Randomization not applied|1|||
162841543|NCT01543087|588127407|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
162841544|NCT01543087|588127408|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
162841545|NCT01543087|588127409|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
162841546|NCT01543087|588127410|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
162841547|NCT01543087|588127411|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
162841548|NCT01543087|588127412|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
162841549|NCT01543087|588127407|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
162841550|NCT01543087|588127408|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
162841551|NCT01543087|588127409|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
162949959|NCT02334722|588520232|FG001|Overall Study|6 week questionnaire not completed|0|||
162949960|NCT02334722|588520231|FG000|Overall Study|Unable to obtain medication|1|||
162949961|NCT02334722|588520232|FG001|Overall Study|Unable to obtain medication|1|||
162841552|NCT01543087|588127410|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
162841553|NCT01543087|588127411|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
162841554|NCT01543087|588127412|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
162841555|NCT01543087|588127407|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
162841556|NCT01543087|588127408|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
162841557|NCT01543087|588127409|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
162841558|NCT01543087|588127410|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
162841559|NCT01543087|588127411|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
162841560|NCT01543087|588127412|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
162841561|NCT01543087|588127407|FG000|Stage 1 (48 Months)|Other than specified|5|||
162841562|NCT01543087|588127408|FG001|Stage 1 (48 Months)|Other than specified|0|||
162841563|NCT01543087|588127409|FG002|Stage 1 (48 Months)|Other than specified|9|||
162841564|NCT01543087|588127410|FG003|Stage 1 (48 Months)|Other than specified|0|||
162841565|NCT01543087|588127411|FG004|Stage 1 (48 Months)|Other than specified|0|||
162841566|NCT01543087|588127412|FG005|Stage 1 (48 Months)|Other than specified|0|||
162841567|NCT01543087|588127407|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
162841568|NCT01543087|588127408|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
162841569|NCT01543087|588127409|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
162841570|NCT01543087|588127410|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
162841571|NCT01543087|588127411|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
162841572|NCT01543087|588127412|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
162841573|NCT01543087|588127407|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
162841574|NCT01543087|588127408|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
162841575|NCT01543087|588127409|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
162841576|NCT01543087|588127410|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
162841577|NCT01543087|588127411|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
162949962|NCT02334722|588520231|FG000|Overall Study|Withdrawal by Subject|0|||
162949963|NCT02334722|588520232|FG001|Overall Study|Withdrawal by Subject|3|||
162949964|NCT02334722|588520231|FG000|Overall Study|Adverse Event|0|||
162949965|NCT02334722|588520232|FG001|Overall Study|Adverse Event|2|||
162949966|NCT02334722|588520231|FG000|Overall Study|Physician Decision|0|||
162949967|NCT02334722|588520232|FG001|Overall Study|Physician Decision|1|||
162949968|NCT03988803|588520233|FG000|Period 2|Prematurely discontinued from medication|2|||
162949969|NCT03988803|588520233|FG000|Period 2|Adverse Event|1|||
162949970|NCT00925769|588520234|FG000|Overall Study|Major toxicity|1|||
162949971|NCT00925769|588520235|FG001|Overall Study|Major toxicity|0|||
162949972|NCT00925769|588520236|FG002|Overall Study|Major toxicity|1|||
162949973|NCT00925769|588520237|FG003|Overall Study|Major toxicity|1|||
162949974|NCT00925769|588520238|FG004|Overall Study|Major toxicity|0|||
162949975|NCT00925769|588520239|FG005|Overall Study|Major toxicity|0|||
162949976|NCT00925769|588520234|FG000|Overall Study|Disease progression|4|||
162949977|NCT00925769|588520235|FG001|Overall Study|Disease progression|5|||
162949978|NCT00925769|588520236|FG002|Overall Study|Disease progression|3|||
162949979|NCT00925769|588520237|FG003|Overall Study|Disease progression|4|||
162949980|NCT00925769|588520238|FG004|Overall Study|Disease progression|2|||
162949981|NCT00925769|588520239|FG005|Overall Study|Disease progression|3|||
162949982|NCT00925769|588520234|FG000|Overall Study|Death|0|||
162949983|NCT00925769|588520235|FG001|Overall Study|Death|0|||
162949984|NCT00925769|588520236|FG002|Overall Study|Death|1|||
162949985|NCT00925769|588520237|FG003|Overall Study|Death|0|||
162949986|NCT00925769|588520238|FG004|Overall Study|Death|0|||
162949987|NCT00925769|588520239|FG005|Overall Study|Death|0|||
162949988|NCT00925769|588520234|FG000|Overall Study|Physician Decision|1|||
162949989|NCT00925769|588520235|FG001|Overall Study|Physician Decision|0|||
162949990|NCT00925769|588520236|FG002|Overall Study|Physician Decision|0|||
162949991|NCT00925769|588520237|FG003|Overall Study|Physician Decision|0|||
162949992|NCT00925769|588520238|FG004|Overall Study|Physician Decision|0|||
162949993|NCT00925769|588520239|FG005|Overall Study|Physician Decision|0|||
162949994|NCT00925769|588520234|FG000|Overall Study|Missing documentation|0|||
162949995|NCT00925769|588520235|FG001|Overall Study|Missing documentation|1|||
162949996|NCT00925769|588520236|FG002|Overall Study|Missing documentation|0|||
162949997|NCT00925769|588520237|FG003|Overall Study|Missing documentation|0|||
162949998|NCT00925769|588520238|FG004|Overall Study|Missing documentation|0|||
162949999|NCT00925769|588520239|FG005|Overall Study|Missing documentation|0|||
162950000|NCT00925769|588520234|FG000|Overall Study|End of study visit not done|0|||
162950001|NCT00925769|588520235|FG001|Overall Study|End of study visit not done|0|||
162950002|NCT00925769|588520236|FG002|Overall Study|End of study visit not done|1|||
162950003|NCT00925769|588520237|FG003|Overall Study|End of study visit not done|0|||
162841578|NCT01543087|588127412|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
162841579|NCT01543087|588127407|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
162950004|NCT00925769|588520238|FG004|Overall Study|End of study visit not done|0|||
162841580|NCT01543087|588127408|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
162841581|NCT01543087|588127409|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
162841582|NCT01543087|588127410|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
162841583|NCT01543087|588127411|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
162841584|NCT01543087|588127412|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
162841585|NCT03713944|588127413|FG000|Study Treatment|Patient non-compliance|1|||
162841586|NCT03713944|588127413|FG000|Study Treatment|Alternative Cancer Therapy|3|||
162841587|NCT03713944|588127413|FG000|Study Treatment|Disease Progression|18|||
162841588|NCT03713944|588127413|FG000|Study Treatment|AE/Side Effects/Complications|2|||
162841589|NCT03713944|588127413|FG000|Study Treatment|Death|2|||
162841590|NCT03713944|588127413|FG000|Study Treatment|Withdrawal by Subject|1|||
162841591|NCT03713944|588127413|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
162841592|NCT03713944|588127413|FG000|Study Treatment|Symptomatic Deterioration|2|||
162841593|NCT03713944|588127413|FG000|Follow up|Withdrawal by Subject|2|||
162841594|NCT03713944|588127413|FG000|Follow up|Death|11|||
162841595|NCT03713944|588127413|FG000|Follow up|Study Terminated|3|||
162841596|NCT00730639|588127416|FG000|Overall Study|Adverse Event|3|||
162841597|NCT00730639|588127417|FG001|Overall Study|Adverse Event|0|||
162841598|NCT00730639|588127418|FG002|Overall Study|Adverse Event|9|||
162841599|NCT00730639|588127419|FG003|Overall Study|Adverse Event|8|||
162841600|NCT00730639|588127420|FG004|Overall Study|Adverse Event|23|||
162841601|NCT00730639|588127416|FG000|Overall Study|Complete Response|0|||
162841602|NCT00730639|588127417|FG001|Overall Study|Complete Response|0|||
162841603|NCT00730639|588127418|FG002|Overall Study|Complete Response|2|||
162841604|NCT00730639|588127419|FG003|Overall Study|Complete Response|2|||
162841605|NCT00730639|588127420|FG004|Overall Study|Complete Response|1|||
162841606|NCT00730639|588127416|FG000|Overall Study|Completed Maximum Cycles|0|||
162841607|NCT00730639|588127417|FG001|Overall Study|Completed Maximum Cycles|0|||
162841608|NCT00730639|588127418|FG002|Overall Study|Completed Maximum Cycles|11|||
162841609|NCT00730639|588127419|FG003|Overall Study|Completed Maximum Cycles|3|||
162841610|NCT00730639|588127420|FG004|Overall Study|Completed Maximum Cycles|6|||
162841611|NCT00730639|588127416|FG000|Overall Study|Death|0|||
162841612|NCT00730639|588127417|FG001|Overall Study|Death|0|||
162841613|NCT00730639|588127418|FG002|Overall Study|Death|0|||
162841614|NCT00730639|588127419|FG003|Overall Study|Death|0|||
162841615|NCT00730639|588127420|FG004|Overall Study|Death|2|||
162841616|NCT00730639|588127416|FG000|Overall Study|Disease Progression|12|||
162841617|NCT00730639|588127417|FG001|Overall Study|Disease Progression|13|||
162841618|NCT00730639|588127418|FG002|Overall Study|Disease Progression|48|||
162841619|NCT00730639|588127419|FG003|Overall Study|Disease Progression|32|||
162841620|NCT00730639|588127420|FG004|Overall Study|Disease Progression|88|||
162841621|NCT00730639|588127416|FG000|Overall Study|non-specified|0|||
162841622|NCT00730639|588127417|FG001|Overall Study|non-specified|0|||
162841623|NCT00730639|588127418|FG002|Overall Study|non-specified|4|||
162841624|NCT00730639|588127419|FG003|Overall Study|non-specified|2|||
162841625|NCT00730639|588127420|FG004|Overall Study|non-specified|3|||
162841626|NCT00730639|588127416|FG000|Overall Study|Protocol Violation|0|||
162841627|NCT00730639|588127417|FG001|Overall Study|Protocol Violation|0|||
162841628|NCT00730639|588127418|FG002|Overall Study|Protocol Violation|1|||
162841629|NCT00730639|588127419|FG003|Overall Study|Protocol Violation|0|||
162841630|NCT00730639|588127420|FG004|Overall Study|Protocol Violation|0|||
162841631|NCT00730639|588127416|FG000|Overall Study|Withdrawal by Subject|0|||
162841632|NCT00730639|588127417|FG001|Overall Study|Withdrawal by Subject|0|||
162841633|NCT00730639|588127418|FG002|Overall Study|Withdrawal by Subject|6|||
162841634|NCT00730639|588127419|FG003|Overall Study|Withdrawal by Subject|3|||
162841635|NCT00730639|588127420|FG004|Overall Study|Withdrawal by Subject|4|||
162841636|NCT00730639|588127416|FG000|Overall Study|Treatment on-going|2|||
162841637|NCT00730639|588127417|FG001|Overall Study|Treatment on-going|5|||
162841638|NCT00730639|588127418|FG002|Overall Study|Treatment on-going|5|||
162841639|NCT00730639|588127419|FG003|Overall Study|Treatment on-going|4|||
162841640|NCT00730639|588127420|FG004|Overall Study|Treatment on-going|4|||
162841641|NCT00848354|588127422|FG000|Phase 1|Adverse Event|5|||
162841642|NCT00848354|588127423|FG001|Phase 1|Adverse Event|4|||
162841643|NCT00848354|588127422|FG000|Phase 1|Discontinuation of study by sponsor|2|||
162841644|NCT00848354|588127423|FG001|Phase 1|Discontinuation of study by sponsor|1|||
162841645|NCT00848354|588127422|FG000|Phase 1|Failed to return|0|||
162841646|NCT00848354|588127423|FG001|Phase 1|Failed to return|1|||
162841647|NCT00848354|588127422|FG000|Phase 1|Lost to Follow-up|1|||
162841648|NCT00848354|588127423|FG001|Phase 1|Lost to Follow-up|1|||
162841649|NCT00848354|588127422|FG000|Phase 1|Unspecified Reason|1|||
162950005|NCT00925769|588520239|FG005|Overall Study|End of study visit not done|0|||
162950006|NCT00925769|588520234|FG000|Overall Study|Participant is unable to swallow drug|0|||
162950007|NCT00925769|588520235|FG001|Overall Study|Participant is unable to swallow drug|0|||
162950008|NCT00925769|588520236|FG002|Overall Study|Participant is unable to swallow drug|0|||
162950009|NCT00925769|588520237|FG003|Overall Study|Participant is unable to swallow drug|1|||
162950010|NCT00925769|588520238|FG004|Overall Study|Participant is unable to swallow drug|0|||
162950011|NCT00925769|588520239|FG005|Overall Study|Participant is unable to swallow drug|0|||
162950012|NCT00925769|588520234|FG000|Overall Study|Adverse Event|0|||
162950013|NCT00925769|588520235|FG001|Overall Study|Adverse Event|0|||
162950014|NCT00925769|588520236|FG002|Overall Study|Adverse Event|0|||
162950015|NCT00925769|588520237|FG003|Overall Study|Adverse Event|0|||
162950016|NCT00925769|588520238|FG004|Overall Study|Adverse Event|1|||
162950017|NCT00925769|588520239|FG005|Overall Study|Adverse Event|0|||
162950018|NCT01666730|588520242|FG000|Overall Study|Adverse Event|16|||
162950019|NCT01666730|588520242|FG000|Overall Study|Death|2|||
162950020|NCT01666730|588520242|FG000|Overall Study|Physician Decision|5|||
162950021|NCT01666730|588520242|FG000|Overall Study|Withdrawal by Subject|9|||
162950022|NCT01666730|588520242|FG000|Overall Study|Disease progression/relapse|18|||
162950023|NCT01434693|588520243|FG000|Overall Study|Adverse Event|1|||
162950024|NCT01434693|588520244|FG001|Overall Study|Adverse Event|0|||
162950025|NCT01434693|588520245|FG002|Overall Study|Adverse Event|0|||
162950026|NCT01434693|588520246|FG003|Overall Study|Adverse Event|0|||
162950027|NCT01434693|588520243|FG000|Overall Study|Withdrawal by Subject|1|||
162950028|NCT01434693|588520244|FG001|Overall Study|Withdrawal by Subject|0|||
162950029|NCT01434693|588520245|FG002|Overall Study|Withdrawal by Subject|1|||
162950030|NCT01434693|588520246|FG003|Overall Study|Withdrawal by Subject|1|||
162950031|NCT01434693|588520243|FG000|Overall Study|Lost to Follow-up|1|||
162950032|NCT01434693|588520244|FG001|Overall Study|Lost to Follow-up|0|||
162950033|NCT01434693|588520245|FG002|Overall Study|Lost to Follow-up|0|||
162950034|NCT01434693|588520246|FG003|Overall Study|Lost to Follow-up|0|||
162950035|NCT02087904|588520248|FG000|Overall Study|Did Not Receive Study Drug|0|||
162950036|NCT02087904|588520249|FG001|Overall Study|Did Not Receive Study Drug|0|||
162950037|NCT02087904|588520250|FG002|Overall Study|Did Not Receive Study Drug|2|||
162950038|NCT02087904|588520251|FG003|Overall Study|Did Not Receive Study Drug|1|||
162950039|NCT02087904|588520248|FG000|Overall Study|Adverse Event|8|||
162950040|NCT02087904|588520249|FG001|Overall Study|Adverse Event|4|||
162950041|NCT02087904|588520250|FG002|Overall Study|Adverse Event|4|||
162950042|NCT02087904|588520251|FG003|Overall Study|Adverse Event|12|||
162950043|NCT02087904|588520248|FG000|Overall Study|Lack of Efficacy|3|||
162950044|NCT02087904|588520249|FG001|Overall Study|Lack of Efficacy|6|||
162950045|NCT02087904|588520250|FG002|Overall Study|Lack of Efficacy|3|||
162950046|NCT02087904|588520251|FG003|Overall Study|Lack of Efficacy|2|||
162950047|NCT02087904|588520248|FG000|Overall Study|Other|6|||
162950048|NCT02087904|588520249|FG001|Overall Study|Other|2|||
162950049|NCT02087904|588520250|FG002|Overall Study|Other|4|||
162841650|NCT00848354|588127423|FG001|Phase 1|Unspecified Reason|1|||
162841651|NCT00848354|588127422|FG000|Phase 1|Protocol Violation|1|||
162841652|NCT00848354|588127423|FG001|Phase 1|Protocol Violation|1|||
162841653|NCT00848354|588127422|FG000|Phase 1|Withdrawal by Subject|2|||
162841654|NCT00848354|588127423|FG001|Phase 1|Withdrawal by Subject|4|||
162841655|NCT00848354|588127422|FG000|Phase 1|Lack of Efficacy|0|||
162841656|NCT00848354|588127423|FG001|Phase 1|Lack of Efficacy|1|||
162950050|NCT02087904|588520251|FG003|Overall Study|Other|4|||
162950051|NCT02087904|588520248|FG000|Overall Study|Withdrawal by Subject|8|||
162950052|NCT02087904|588520249|FG001|Overall Study|Withdrawal by Subject|3|||
162950053|NCT02087904|588520250|FG002|Overall Study|Withdrawal by Subject|7|||
162841657|NCT00848354|588127422|FG000|Phase 2 Year 1|Adverse Event|7|||
162841658|NCT00848354|588127423|FG001|Phase 2 Year 1|Adverse Event|2|||
162841659|NCT00848354|588127422|FG000|Phase 2 Year 1|Death|1|||
162841660|NCT00848354|588127423|FG001|Phase 2 Year 1|Death|0|||
162841661|NCT00848354|588127422|FG000|Phase 2 Year 1|Failed to Return|1|||
162950054|NCT02087904|588520251|FG003|Overall Study|Withdrawal by Subject|4|||
162950055|NCT02087904|588520248|FG000|Overall Study|Lost to Follow-up|0|||
162950056|NCT02087904|588520249|FG001|Overall Study|Lost to Follow-up|4|||
162950057|NCT02087904|588520250|FG002|Overall Study|Lost to Follow-up|2|||
162950058|NCT02087904|588520251|FG003|Overall Study|Lost to Follow-up|2|||
162950059|NCT01735630|588520252|FG000|Overall Study|Adverse Event|8|||
162950060|NCT01735630|588520253|FG001|Overall Study|Adverse Event|7|||
162950061|NCT01735630|588520252|FG000|Overall Study|Lost to Follow-up|1|||
162950062|NCT01735630|588520253|FG001|Overall Study|Lost to Follow-up|0|||
162841662|NCT00848354|588127423|FG001|Phase 2 Year 1|Failed to Return|1|||
162841663|NCT00848354|588127422|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
162841664|NCT00848354|588127423|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
162950063|NCT01735630|588520252|FG000|Overall Study|Physician Decision|0|||
162950064|NCT01735630|588520253|FG001|Overall Study|Physician Decision|1|||
162950065|NCT01735630|588520252|FG000|Overall Study|Sponsor Decision|2|||
162950066|NCT01735630|588520253|FG001|Overall Study|Sponsor Decision|1|||
162950067|NCT01735630|588520252|FG000|Overall Study|Withdrawal by Subject|7|||
162950068|NCT01735630|588520253|FG001|Overall Study|Withdrawal by Subject|9|||
162841665|NCT00848354|588127422|FG000|Phase 2 Year 1|Unspecified Reason|3|||
162841666|NCT00848354|588127423|FG001|Phase 2 Year 1|Unspecified Reason|0|||
162841667|NCT00848354|588127422|FG000|Phase 2 Year 1|Protocol Violation|4|||
162841668|NCT00848354|588127423|FG001|Phase 2 Year 1|Protocol Violation|1|||
162841669|NCT00848354|588127422|FG000|Phase 2 Year 1|Subject Request|1|||
162841670|NCT00848354|588127423|FG001|Phase 2 Year 1|Subject Request|2|||
162841671|NCT00848354|588127422|FG000|Phase 2 Year 2|Adverse Event|12|||
162841672|NCT00848354|588127423|FG001|Phase 2 Year 2|Adverse Event|2|||
162841673|NCT00848354|588127422|FG000|Phase 2 Year 2|Death|2|||
162841674|NCT00848354|588127423|FG001|Phase 2 Year 2|Death|0|||
162841675|NCT00848354|588127422|FG000|Phase 2 Year 2|Failed to return|3|||
162841676|NCT00848354|588127423|FG001|Phase 2 Year 2|Failed to return|0|||
162841677|NCT00848354|588127422|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
162841678|NCT00848354|588127423|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
162841679|NCT00848354|588127422|FG000|Phase 2 Year 2|Unspecified Reason|1|||
162841680|NCT00848354|588127423|FG001|Phase 2 Year 2|Unspecified Reason|0|||
162950069|NCT00891293|588520255|FG000|Overall Study|Adverse Event|2|||
162950070|NCT00891293|588520255|FG000|Overall Study|Protocol Violation|2|||
162950071|NCT00891293|588520255|FG000|Overall Study|Laboratory abnormality|4|||
162950072|NCT00891293|588520255|FG000|Overall Study|Lost to Follow-up|7|||
162841681|NCT00848354|588127422|FG000|Phase 2 Year 2|Protocol Violation|1|||
162841682|NCT00848354|588127423|FG001|Phase 2 Year 2|Protocol Violation|1|||
162950073|NCT00891293|588520255|FG000|Overall Study|Subject withdrew consent|7|||
162950074|NCT00891293|588520255|FG000|Overall Study|Sponsor termination|62|||
162950075|NCT02178722|588520256|FG000|Overall Study|Withdrawal by Subject|0|||
162950076|NCT02178722|588520257|FG001|Overall Study|Withdrawal by Subject|0|||
162950077|NCT02178722|588520258|FG002|Overall Study|Withdrawal by Subject|0|||
162950078|NCT02178722|588520259|FG003|Overall Study|Withdrawal by Subject|2|||
162950079|NCT02178722|588520260|FG004|Overall Study|Withdrawal by Subject|33|||
162950080|NCT02178722|588520256|FG000|Overall Study|Death|2|||
162950081|NCT02178722|588520257|FG001|Overall Study|Death|13|||
162950082|NCT02178722|588520258|FG002|Overall Study|Death|12|||
162950083|NCT02178722|588520259|FG003|Overall Study|Death|12|||
162950084|NCT02178722|588520260|FG004|Overall Study|Death|205|||
162950085|NCT02178722|588520256|FG000|Overall Study|Lost to Follow-up|0|||
162950086|NCT02178722|588520257|FG001|Overall Study|Lost to Follow-up|0|||
162950087|NCT02178722|588520258|FG002|Overall Study|Lost to Follow-up|0|||
162950088|NCT02178722|588520259|FG003|Overall Study|Lost to Follow-up|2|||
162950089|NCT02178722|588520260|FG004|Overall Study|Lost to Follow-up|11|||
162950090|NCT02178722|588520256|FG000|Overall Study|Study terminated by Sponsor|2|||
162950091|NCT02178722|588520257|FG001|Overall Study|Study terminated by Sponsor|7|||
162950092|NCT02178722|588520258|FG002|Overall Study|Study terminated by Sponsor|6|||
162950093|NCT02178722|588520259|FG003|Overall Study|Study terminated by Sponsor|4|||
162950094|NCT02178722|588520260|FG004|Overall Study|Study terminated by Sponsor|128|||
162950095|NCT02178722|588520256|FG000|Overall Study|Physician Decision|0|||
162950096|NCT02178722|588520257|FG001|Overall Study|Physician Decision|0|||
162950097|NCT02178722|588520258|FG002|Overall Study|Physician Decision|0|||
162950098|NCT02178722|588520259|FG003|Overall Study|Physician Decision|0|||
162950099|NCT02178722|588520260|FG004|Overall Study|Physician Decision|3|||
162950100|NCT02178722|588520256|FG000|Overall Study|Other|0|||
162950101|NCT02178722|588520257|FG001|Overall Study|Other|0|||
162950102|NCT02178722|588520258|FG002|Overall Study|Other|0|||
162950103|NCT02178722|588520259|FG003|Overall Study|Other|0|||
162950104|NCT02178722|588520260|FG004|Overall Study|Other|2|||
162950105|NCT01572948|588520261|FG000|Overall Study|Lost to Follow-up|1|||
162950106|NCT01572948|588520262|FG001|Overall Study|Lost to Follow-up|0|||
162950107|NCT01572948|588520261|FG000|Overall Study|unable to contact|0|||
162950108|NCT01572948|588520262|FG001|Overall Study|unable to contact|1|||
162950109|NCT00877032|588520270|FG000|Overall Study|Did not meet entrance criteria|0|||
162950110|NCT00877032|588520271|FG001|Overall Study|Did not meet entrance criteria|0|||
162950111|NCT00877032|588520272|FG002|Overall Study|Did not meet entrance criteria|0|||
162950112|NCT00877032|588520273|FG003|Overall Study|Did not meet entrance criteria|1|||
162950113|NCT00877032|588520274|FG004|Overall Study|Did not meet entrance criteria|0|||
162950114|NCT00877032|588520275|FG005|Overall Study|Did not meet entrance criteria|0|||
162950115|NCT00877032|588520276|FG006|Overall Study|Did not meet entrance criteria|2|||
162950116|NCT02107092|588520278|FG000|Overall Study|Miscellaneous|3|||
162950117|NCT02107092|588520278|FG000|Overall Study|Subject compliance|3|||
162950118|NCT02107092|588520278|FG000|Overall Study|Hypo-or hyperkalemia|2|||
162950119|NCT02107092|588520278|FG000|Overall Study|Met ECG withdrawal criteria|3|||
162841683|NCT00848354|588127422|FG000|Phase 2 Year 2|Subject Request|1|||
162841684|NCT00848354|588127423|FG001|Phase 2 Year 2|Subject Request|1|||
162841685|NCT00848354|588127422|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
162841686|NCT00848354|588127423|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
162841687|NCT00915343|588127424|FG000|Part B - Open Label Period|Treatment switch|0|||
162841688|NCT00915343|588127425|FG001|Part B - Open Label Period|Treatment switch|0|||
162950120|NCT02107092|588520278|FG000|Overall Study|Physician Decision|3|||
162950121|NCT02107092|588520278|FG000|Overall Study|Lost to Follow-up|2|||
162950122|NCT02107092|588520278|FG000|Overall Study|Withdrawal by Subject|9|||
162950123|NCT02107092|588520278|FG000|Overall Study|Adverse Event|7|||
162950124|NCT02107092|588520278|FG000|Overall Study|Expected progression of CKD|12|||
162950125|NCT00537030|588520279|FG000|Overall Study|Physician Decision|2|||
162950126|NCT00537030|588520279|FG000|Overall Study|Withdrawal by Subject|2|||
162950127|NCT00537030|588520279|FG000|Overall Study|≥ Grade 2 allergy|7|||
162950128|NCT00537030|588520279|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
162950129|NCT00537030|588520279|FG000|Overall Study|Ineligible|2|||
162950130|NCT00537030|588520279|FG000|Overall Study|Inevaluable|2|||
162950131|NCT04213326|588520281|FG000|Overall Study|Consent withdrawn|51|||
162950132|NCT04213326|588520282|FG001|Overall Study|Consent withdrawn|241|||
162950133|NCT04213326|588520281|FG000|Overall Study|Lost to Follow-up|50|||
162950134|NCT04213326|588520282|FG001|Overall Study|Lost to Follow-up|902|||
162950135|NCT04213326|588520281|FG000|Overall Study|Protocol Violation|3|||
162950136|NCT04213326|588520282|FG001|Overall Study|Protocol Violation|25|||
162950137|NCT04213326|588520281|FG000|Overall Study|Participant eligibility changed|106|||
162950138|NCT04213326|588520282|FG001|Overall Study|Participant eligibility changed|19|||
162950139|NCT04213326|588520281|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
162950140|NCT04213326|588520282|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
162950141|NCT04213326|588520281|FG000|Overall Study|Incomplete study visit|0|||
162950142|NCT04213326|588520282|FG001|Overall Study|Incomplete study visit|367|||
162950143|NCT01496183|588520284|FG000|Overall Study|Physician Decision|3|||
162950144|NCT01496183|588520285|FG001|Overall Study|Physician Decision|1|||
162950145|NCT01496183|588520284|FG000|Overall Study|Withdrawal by Subject|0|||
162950146|NCT01496183|588520285|FG001|Overall Study|Withdrawal by Subject|1|||
162950147|NCT01173692|588520288|FG000|Overall Study|Adverse Event|1|||
162950148|NCT01173692|588520289|FG001|Overall Study|Adverse Event|2|||
162950149|NCT01173692|588520288|FG000|Overall Study|Withdrawal by Subject|1|||
162950150|NCT01173692|588520289|FG001|Overall Study|Withdrawal by Subject|3|||
162950151|NCT00669864|588520292|FG000|Overall Study|Lost to Follow-up|2|||
162950152|NCT00669864|588520292|FG000|Overall Study|Protocol Violation|2|||
162950153|NCT00669864|588520292|FG000|Overall Study|Withdrawal by Subject|3|||
162950154|NCT00669864|588520292|FG000|Overall Study|Other|2|||
162950155|NCT01941030|588520296|FG000|Overall Study|Death|3|||
162950156|NCT01941030|588520297|FG001|Overall Study|Death|2|||
162950157|NCT01941030|588520296|FG000|Overall Study|Lost to Follow-up|6|||
162950158|NCT01941030|588520297|FG001|Overall Study|Lost to Follow-up|5|||
162950159|NCT01941030|588520296|FG000|Overall Study|Withdrawal by Subject|4|||
162950160|NCT01941030|588520297|FG001|Overall Study|Withdrawal by Subject|6|||
162950161|NCT05067647|588520300|FG000|Overall Study|Lost to Follow-up|1|||
162950162|NCT02781727|588520302|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
162950163|NCT02781727|588520303|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
162950164|NCT02781727|588520302|FG000|Treatment Period|Withdrawal by Subject|1|||
162950165|NCT02781727|588520303|FG001|Treatment Period|Withdrawal by Subject|0|||
162950166|NCT02781727|588520302|FG000|Treatment Period|Lost to Follow-up|0|||
162950167|NCT02781727|588520303|FG001|Treatment Period|Lost to Follow-up|1|||
162950168|NCT03069937|588520305|FG000|Overall Study|Second primary malignancy noted|1|||
162950169|NCT01569152|588520309|FG000|Phase IIa, Period 1|Early Escape|5|||
162950170|NCT01569152|588520310|FG001|Phase IIa, Period 1|Early Escape|22|||
162950171|NCT01569152|588520311|FG002|Phase IIa, Period 1|Early Escape|0|||
162950172|NCT01569152|588520309|FG000|Phase IIa, Period 1|Adverse Event|4|||
162950173|NCT01569152|588520310|FG001|Phase IIa, Period 1|Adverse Event|0|||
162950174|NCT01569152|588520311|FG002|Phase IIa, Period 1|Adverse Event|0|||
162950175|NCT01569152|588520309|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
162950176|NCT01569152|588520310|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
162950177|NCT01569152|588520311|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
162950178|NCT01569152|588520309|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
162950179|NCT01569152|588520310|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
162950180|NCT01569152|588520311|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
162950181|NCT01569152|588520309|FG000|Phase IIa, Period 1|Protocol Violation|0|||
162950182|NCT01569152|588520310|FG001|Phase IIa, Period 1|Protocol Violation|1|||
162950183|NCT01569152|588520311|FG002|Phase IIa, Period 1|Protocol Violation|0|||
162950184|NCT01569152|588520309|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
162950185|NCT01569152|588520310|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
162950186|NCT01569152|588520311|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
162950187|NCT01569152|588520309|FG000|Safety Extension, Period 3|Adverse Event|0|||
162950188|NCT01569152|588520310|FG001|Safety Extension, Period 3|Adverse Event|0|||
162950189|NCT01569152|588520311|FG002|Safety Extension, Period 3|Adverse Event|4|||
162700390|NCT02176928|587615028|FG001|Overall Study|Lost to Follow-up|4|||
162950190|NCT01569152|588520309|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
162950191|NCT01569152|588520310|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
162950192|NCT01569152|588520311|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
162950193|NCT01569152|588520309|FG000|Safety Extension, Period 3|Physician Decision|0|||
162950194|NCT01569152|588520310|FG001|Safety Extension, Period 3|Physician Decision|0|||
162950195|NCT01569152|588520311|FG002|Safety Extension, Period 3|Physician Decision|2|||
162950196|NCT01569152|588520309|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
162950197|NCT01569152|588520310|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
162950198|NCT01569152|588520311|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
162841689|NCT00915343|588127426|FG002|Part B - Open Label Period|Treatment switch|1|||
162841690|NCT00915343|588127424|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
162841691|NCT00915343|588127425|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
162841692|NCT00915343|588127426|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
162841693|NCT02406781|588127427|FG000|Overall Study|Protocol Violation|2|||
162841694|NCT02406781|588127428|FG001|Overall Study|Protocol Violation|2|||
162841695|NCT02406781|588127429|FG002|Overall Study|Protocol Violation|2|||
162841696|NCT02406781|588127430|FG003|Overall Study|Protocol Violation|2|||
162950199|NCT00683293|588520318|FG000|Overall Study|Withdrawal by Subject|2|||
162950200|NCT00683293|588520319|FG001|Overall Study|Withdrawal by Subject|3|||
162950201|NCT00743197|588520322|FG000|Overall Study|Study terminated due to departure of PI.|1|||
162950202|NCT00743197|588520323|FG001|Overall Study|Study terminated due to departure of PI.|2|||
162950203|NCT01411332|588520328|FG000|Enrollment|Protocol Violation|0|||
162950204|NCT01411332|588520329|FG001|Enrollment|Protocol Violation|1|||
162950205|NCT01411332|588520328|FG000|Enrollment|Withdrawal by Subject|0|||
162950206|NCT01411332|588520329|FG001|Enrollment|Withdrawal by Subject|1|||
162950207|NCT01411332|588520328|FG000|Treatment|Lost to Follow-up|1|||
162950208|NCT01411332|588520329|FG001|Treatment|Lost to Follow-up|0|||
162950209|NCT02507375|588520330|FG000|Overall Study|Progressive Disease|4|||
162950210|NCT02507375|588520331|FG001|Overall Study|Progressive Disease|5|||
162950211|NCT02507375|588520330|FG000|Overall Study|Death|0|||
162950212|NCT02507375|588520331|FG001|Overall Study|Death|1|||
162950213|NCT02507375|588520330|FG000|Overall Study|Refused treatment|0|||
162950214|NCT02507375|588520331|FG001|Overall Study|Refused treatment|1|||
162950215|NCT02507375|588520330|FG000|Overall Study|Adverse Event|0|||
162950216|NCT02507375|588520331|FG001|Overall Study|Adverse Event|1|||
162950217|NCT01215981|588521644|FG000|Overall Study|Physician Decision|0|||
162950218|NCT01215981|588521645|FG001|Overall Study|Physician Decision|1|||
162950219|NCT01215981|588521644|FG000|Overall Study|Protocol Violation|1|||
162950220|NCT01215981|588521645|FG001|Overall Study|Protocol Violation|0|||
162950221|NCT01215981|588521644|FG000|Overall Study|Withdrawal by Subject|1|||
162950222|NCT01215981|588521645|FG001|Overall Study|Withdrawal by Subject|0|||
162950223|NCT02653664|588521650|FG000|Post-Treatment|Withdrawal by Subject|6|||
162950224|NCT02653664|588521651|FG001|Post-Treatment|Withdrawal by Subject|5|||
162950225|NCT02653664|588521652|FG002|Post-Treatment|Withdrawal by Subject|7|||
162950226|NCT02653664|588521650|FG000|Post-Treatment|Lost to Follow-up|8|||
162950227|NCT02653664|588521651|FG001|Post-Treatment|Lost to Follow-up|1|||
162950228|NCT02653664|588521652|FG002|Post-Treatment|Lost to Follow-up|7|||
162950229|NCT02653664|588521650|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
162950230|NCT02653664|588521651|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
162950231|NCT02653664|588521652|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
162950232|NCT02653664|588521650|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
162950233|NCT02653664|588521651|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
162950234|NCT02653664|588521652|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
162950235|NCT02653664|588521650|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950236|NCT02653664|588521651|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
162950237|NCT02653664|588521652|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950238|NCT02653664|588521650|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
162950239|NCT02653664|588521651|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
162841697|NCT02406781|588127431|FG004|Overall Study|Protocol Violation|1|||
162841698|NCT02406781|588127432|FG005|Overall Study|Protocol Violation|5|||
162841699|NCT02406781|588127433|FG006|Overall Study|Protocol Violation|3|||
162950240|NCT02653664|588521652|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
162950241|NCT02653664|588521650|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
162950242|NCT02653664|588521651|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
162950243|NCT02653664|588521652|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
162950244|NCT02653664|588521650|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
162950245|NCT02653664|588521651|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
162950246|NCT02653664|588521652|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
162950247|NCT02653664|588521650|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950248|NCT02653664|588521651|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
162950249|NCT02653664|588521652|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
162950250|NCT02653664|588521650|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
162950251|NCT02653664|588521651|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
162950252|NCT02653664|588521652|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
162950253|NCT04657770|588521653|FG000|Overall Study|Withdrawal by Subject|3|||
162950254|NCT04657770|588521653|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
162950255|NCT00485472|588521654|FG000|Overall Study|Adverse Event|8|||
162950256|NCT00485472|588521655|FG001|Overall Study|Adverse Event|5|||
162950257|NCT00485472|588521654|FG000|Overall Study|Lack of Efficacy|5|||
162950258|NCT00485472|588521655|FG001|Overall Study|Lack of Efficacy|4|||
162950259|NCT00485472|588521654|FG000|Overall Study|Withdrawal by Subject|1|||
162950260|NCT00485472|588521655|FG001|Overall Study|Withdrawal by Subject|0|||
162950261|NCT00485472|588521654|FG000|Overall Study|Protocol Violation|0|||
162950262|NCT00485472|588521655|FG001|Overall Study|Protocol Violation|1|||
162950263|NCT00485472|588521654|FG000|Overall Study|Other|2|||
162950264|NCT00485472|588521655|FG001|Overall Study|Other|1|||
162950265|NCT00485472|588521654|FG000|Overall Study|Lost to Follow-up|0|||
162950266|NCT00485472|588521655|FG001|Overall Study|Lost to Follow-up|1|||
162950267|NCT00746798|588521656|FG000|Overall Study|Protocol Violation|0|||
162950268|NCT00746798|588521657|FG001|Overall Study|Protocol Violation|1|||
162950269|NCT00746798|588521658|FG002|Overall Study|Protocol Violation|0|||
162950270|NCT00746798|588521659|FG003|Overall Study|Protocol Violation|0|||
162950271|NCT00746798|588521656|FG000|Overall Study|Withdrawal by Subject|0|||
162950272|NCT00746798|588521657|FG001|Overall Study|Withdrawal by Subject|1|||
162950273|NCT00746798|588521658|FG002|Overall Study|Withdrawal by Subject|1|||
162950274|NCT00746798|588521659|FG003|Overall Study|Withdrawal by Subject|0|||
162950275|NCT00746798|588521656|FG000|Overall Study|Death|0|||
162950276|NCT00746798|588521657|FG001|Overall Study|Death|0|||
162950277|NCT00746798|588521658|FG002|Overall Study|Death|2|||
162950278|NCT00746798|588521659|FG003|Overall Study|Death|0|||
162950279|NCT00746798|588521656|FG000|Overall Study|Participant unable to return for visit|1|||
162950280|NCT00746798|588521657|FG001|Overall Study|Participant unable to return for visit|0|||
162950281|NCT00746798|588521658|FG002|Overall Study|Participant unable to return for visit|0|||
162950282|NCT00746798|588521659|FG003|Overall Study|Participant unable to return for visit|0|||
162950283|NCT04915755|588521662|FG000|Overall Study|Physician Decision|3|||
162950284|NCT04915755|588521663|FG001|Overall Study|Physician Decision|2|||
162950285|NCT04915755|588521662|FG000|Overall Study|Withdrawal by Subject|1|||
162950286|NCT04915755|588521663|FG001|Overall Study|Withdrawal by Subject|1|||
162950287|NCT04915755|588521662|FG000|Overall Study|Ongoing for PACT|3|||
162950288|NCT04915755|588521663|FG001|Overall Study|Ongoing for PACT|2|||
162950289|NCT04915755|588521662|FG000|Overall Study|Other|7|||
162950290|NCT04915755|588521663|FG001|Overall Study|Other|11|||
162950291|NCT00727571|588521665|FG000|Overall Study|Ineligibility determined|1|||
162950292|NCT00727571|588521666|FG001|Overall Study|Ineligibility determined|1|||
162950293|NCT00727571|588521667|FG002|Overall Study|Ineligibility determined|1|||
162950294|NCT00727571|588521668|FG003|Overall Study|Ineligibility determined|0|||
162950295|NCT00727571|588521665|FG000|Overall Study|Death|0|||
162950296|NCT00727571|588521666|FG001|Overall Study|Death|19|||
162950297|NCT00727571|588521667|FG002|Overall Study|Death|5|||
162950298|NCT00727571|588521668|FG003|Overall Study|Death|1|||
162950299|NCT00727571|588521665|FG000|Overall Study|Physician Decision|0|||
162950300|NCT00727571|588521666|FG001|Overall Study|Physician Decision|5|||
162950301|NCT00727571|588521667|FG002|Overall Study|Physician Decision|0|||
162950302|NCT00727571|588521668|FG003|Overall Study|Physician Decision|0|||
162950303|NCT00727571|588521665|FG000|Overall Study|Withdrawal by Subject|0|||
162950304|NCT00727571|588521666|FG001|Overall Study|Withdrawal by Subject|10|||
162950305|NCT00727571|588521667|FG002|Overall Study|Withdrawal by Subject|11|||
162950306|NCT00727571|588521668|FG003|Overall Study|Withdrawal by Subject|0|||
162950307|NCT00727571|588521665|FG000|Overall Study|Subject Non Compliance|0|||
162950308|NCT00727571|588521666|FG001|Overall Study|Subject Non Compliance|6|||
162950309|NCT00727571|588521667|FG002|Overall Study|Subject Non Compliance|0|||
162950310|NCT00727571|588521668|FG003|Overall Study|Subject Non Compliance|4|||
162700391|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162950311|NCT00727571|588521665|FG000|Overall Study|Dismissed from nursing home|0|||
162950312|NCT00727571|588521666|FG001|Overall Study|Dismissed from nursing home|9|||
162950313|NCT00727571|588521667|FG002|Overall Study|Dismissed from nursing home|5|||
162950314|NCT00727571|588521668|FG003|Overall Study|Dismissed from nursing home|0|||
162950315|NCT00727571|588521665|FG000|Overall Study|Hospitalization|0|||
162950316|NCT00727571|588521666|FG001|Overall Study|Hospitalization|1|||
162950317|NCT00727571|588521667|FG002|Overall Study|Hospitalization|0|||
162950318|NCT00727571|588521668|FG003|Overall Study|Hospitalization|1|||
162950319|NCT00727571|588521665|FG000|Overall Study|AE not leading to hospitalization|0|||
162950320|NCT00727571|588521666|FG001|Overall Study|AE not leading to hospitalization|0|||
162950321|NCT00727571|588521667|FG002|Overall Study|AE not leading to hospitalization|2|||
162950322|NCT00727571|588521668|FG003|Overall Study|AE not leading to hospitalization|0|||
162950323|NCT00727571|588521665|FG000|Overall Study|Other|0|||
162950324|NCT00727571|588521666|FG001|Overall Study|Other|4|||
162950325|NCT00727571|588521667|FG002|Overall Study|Other|6|||
162950326|NCT00727571|588521668|FG003|Overall Study|Other|0|||
162950327|NCT03247556|588521669|FG000|Overall Study|Adverse Event|1|||
162950328|NCT03247556|588521670|FG001|Overall Study|Adverse Event|4|||
162950329|NCT03247556|588521671|FG002|Overall Study|Adverse Event|5|||
162950330|NCT03247556|588521669|FG000|Overall Study|Lost to Follow-up|5|||
162950331|NCT03247556|588521670|FG001|Overall Study|Lost to Follow-up|5|||
162950332|NCT03247556|588521671|FG002|Overall Study|Lost to Follow-up|4|||
162950333|NCT03247556|588521669|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
162950334|NCT03247556|588521670|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
162950335|NCT03247556|588521671|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
162950336|NCT03247556|588521669|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
162950337|NCT03247556|588521670|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
162950338|NCT03247556|588521671|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
162950339|NCT03247556|588521669|FG000|Overall Study|Protocol Violation|2|||
162950340|NCT03247556|588521670|FG001|Overall Study|Protocol Violation|0|||
162950341|NCT03247556|588521671|FG002|Overall Study|Protocol Violation|1|||
162950342|NCT03247556|588521669|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
162950343|NCT03247556|588521670|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
162950344|NCT03247556|588521671|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
162950345|NCT01710657|588521675|FG000|Overall Study|Lost to Follow-up|2|||
162950346|NCT01710657|588521676|FG001|Overall Study|Lost to Follow-up|0|||
162950347|NCT01710657|588521677|FG002|Overall Study|Lost to Follow-up|1|||
162950348|NCT01710657|588521675|FG000|Overall Study|Protocol Violation|2|||
162950349|NCT01710657|588521676|FG001|Overall Study|Protocol Violation|2|||
162950350|NCT01710657|588521677|FG002|Overall Study|Protocol Violation|0|||
162950351|NCT01710657|588521675|FG000|Overall Study|Adverse Event|14|||
162950352|NCT01710657|588521676|FG001|Overall Study|Adverse Event|8|||
162950353|NCT01710657|588521677|FG002|Overall Study|Adverse Event|28|||
162950354|NCT01710657|588521675|FG000|Overall Study|Withdrawal by Subject|0|||
162950355|NCT01710657|588521676|FG001|Overall Study|Withdrawal by Subject|1|||
162950356|NCT01710657|588521677|FG002|Overall Study|Withdrawal by Subject|2|||
162950357|NCT01710657|588521675|FG000|Overall Study|Lack of Efficacy|0|||
162950358|NCT01710657|588521676|FG001|Overall Study|Lack of Efficacy|1|||
162950359|NCT01710657|588521677|FG002|Overall Study|Lack of Efficacy|1|||
162950360|NCT02495857|588521685|FG000|Overall Study|Adverse Event|5|||
162950361|NCT02495857|588521686|FG001|Overall Study|Adverse Event|0|||
162950362|NCT02495857|588521687|FG002|Overall Study|Adverse Event|1|||
162950363|NCT02495857|588521685|FG000|Overall Study|Withdrawal by Subject|9|||
162950364|NCT02495857|588521686|FG001|Overall Study|Withdrawal by Subject|6|||
162950365|NCT02495857|588521687|FG002|Overall Study|Withdrawal by Subject|10|||
162950366|NCT02495857|588521685|FG000|Overall Study|Physician Decision|0|||
162950367|NCT02495857|588521686|FG001|Overall Study|Physician Decision|1|||
162950368|NCT02495857|588521687|FG002|Overall Study|Physician Decision|0|||
162950369|NCT02495857|588521685|FG000|Overall Study|Protocol Violation|1|||
162950370|NCT02495857|588521686|FG001|Overall Study|Protocol Violation|1|||
162950371|NCT02495857|588521687|FG002|Overall Study|Protocol Violation|2|||
162950372|NCT02495857|588521685|FG000|Overall Study|Lost to Follow-up|4|||
162950373|NCT02495857|588521686|FG001|Overall Study|Lost to Follow-up|5|||
162950374|NCT02495857|588521687|FG002|Overall Study|Lost to Follow-up|3|||
162950375|NCT02495857|588521685|FG000|Overall Study|Other|3|||
162841700|NCT03505021|588127434|FG000|Overall Study|Protocol Violation|1|||
162841701|NCT03505021|588127435|FG001|Overall Study|Protocol Violation|0|||
162841702|NCT03505021|588127434|FG000|Overall Study|Death|9|||
162841703|NCT03505021|588127435|FG001|Overall Study|Death|8|||
162841704|NCT03505021|588127434|FG000|Overall Study|Consent withdrawn by subject|6|||
162841705|NCT03505021|588127435|FG001|Overall Study|Consent withdrawn by subject|1|||
162841706|NCT03505021|588127434|FG000|Overall Study|Lost to Follow-up|5|||
162841707|NCT03505021|588127435|FG001|Overall Study|Lost to Follow-up|3|||
162841708|NCT03505021|588127434|FG000|Overall Study|Adverse Event|26|||
162841709|NCT03505021|588127435|FG001|Overall Study|Adverse Event|9|||
162841710|NCT03505021|588127434|FG000|Overall Study|Disease progression|33|||
162841711|NCT03505021|588127435|FG001|Overall Study|Disease progression|17|||
162841712|NCT03505021|588127434|FG000|Overall Study|Other|11|||
162841713|NCT03505021|588127435|FG001|Overall Study|Other|5|||
162841714|NCT03505021|588127434|FG000|Overall Study|Personal reason|21|||
162841715|NCT03505021|588127435|FG001|Overall Study|Personal reason|12|||
162841716|NCT03087955|588128901|FG000|Overall Study|Death|4|||
162841717|NCT03087955|588128902|FG001|Overall Study|Death|0|||
162841718|NCT03087955|588128901|FG000|Overall Study|Lack of Efficacy|2|||
162841719|NCT03087955|588128902|FG001|Overall Study|Lack of Efficacy|0|||
162841720|NCT03087955|588128901|FG000|Overall Study|Lost to Follow-up|1|||
162841721|NCT03087955|588128902|FG001|Overall Study|Lost to Follow-up|0|||
162841722|NCT04484285|588128903|FG000|Overall Study|Unable to operate stimulator|3|||
162950376|NCT02495857|588521686|FG001|Overall Study|Other|3|||
162950377|NCT02495857|588521687|FG002|Overall Study|Other|2|||
162950378|NCT01367457|588521688|FG000|Overall Study|Death|2|||
162950379|NCT01367457|588521689|FG001|Overall Study|Death|0|||
162950380|NCT01367457|588521690|FG002|Overall Study|Death|0|||
162950381|NCT01367457|588521688|FG000|Overall Study|Investigator's decision|2|||
162950382|NCT01367457|588521689|FG001|Overall Study|Investigator's decision|0|||
162950383|NCT01367457|588521690|FG002|Overall Study|Investigator's decision|0|||
162950384|NCT01367457|588521688|FG000|Overall Study|Clinical decline (CD)|2|||
162950385|NCT01367457|588521689|FG001|Overall Study|Clinical decline (CD)|0|||
162950386|NCT01367457|588521690|FG002|Overall Study|Clinical decline (CD)|0|||
162950387|NCT01367457|588521688|FG000|Overall Study|Progression and death|8|||
162950388|NCT01367457|588521689|FG001|Overall Study|Progression and death|0|||
162950389|NCT01367457|588521690|FG002|Overall Study|Progression and death|0|||
162950390|NCT01367457|588521688|FG000|Overall Study|Toxicity|16|||
162950391|NCT01367457|588521689|FG001|Overall Study|Toxicity|0|||
162950392|NCT01367457|588521690|FG002|Overall Study|Toxicity|0|||
162950393|NCT01367457|588521688|FG000|Overall Study|Progression|137|||
162950394|NCT01367457|588521689|FG001|Overall Study|Progression|0|||
162950395|NCT01367457|588521690|FG002|Overall Study|Progression|0|||
162950396|NCT01367457|588521688|FG000|Overall Study|Patient asks for rest + slow progression|1|||
162950397|NCT01367457|588521689|FG001|Overall Study|Patient asks for rest + slow progression|0|||
162950398|NCT01367457|588521690|FG002|Overall Study|Patient asks for rest + slow progression|0|||
162950399|NCT01367457|588521688|FG000|Overall Study|Investigator's opinion, stable disease|1|||
162950400|NCT01367457|588521689|FG001|Overall Study|Investigator's opinion, stable disease|0|||
162700392|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
162700393|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
162700394|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
162700395|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
162700396|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
162700397|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162700398|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162700399|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162700400|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162700401|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700402|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162841723|NCT04484285|588128904|FG001|Overall Study|Unable to operate stimulator|0|||
162841724|NCT06272370|588128905|FG000|Overall Study|Lost to Follow-up|0|||
162841725|NCT06272370|588128906|FG001|Overall Study|Lost to Follow-up|3|||
162841726|NCT06272370|588128907|FG002|Overall Study|Lost to Follow-up|1|||
162841727|NCT06272370|588128908|FG003|Overall Study|Lost to Follow-up|1|||
162841728|NCT05280756|588128915|FG000|Overall Study|Lost to Follow-up|1|||
162841729|NCT05280756|588128916|FG001|Overall Study|Lost to Follow-up|1|||
162950401|NCT01367457|588521690|FG002|Overall Study|Investigator's opinion, stable disease|0|||
162950402|NCT01367457|588521688|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
162950403|NCT01367457|588521689|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
162950404|NCT01367457|588521690|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
162950405|NCT01367457|588521688|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
162950406|NCT01367457|588521689|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
162950407|NCT01367457|588521690|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
162841730|NCT02527707|588128918|FG000|Overall Study|Adverse Event|1|||
162841731|NCT02527707|588128918|FG000|Overall Study|Adverse Event|1|||
162841732|NCT01299766|588128919|FG000|Overall Study|Death|5|||
162841733|NCT01299766|588128920|FG001|Overall Study|Death|4|||
162841734|NCT01299766|588128919|FG000|Overall Study|Withdrawal by Subject|29|||
162841735|NCT01299766|588128920|FG001|Overall Study|Withdrawal by Subject|19|||
162841736|NCT04002310|588128921|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
162841737|NCT04002310|588128922|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
162841738|NCT04002310|588128923|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
162841739|NCT04002310|588128924|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
162841740|NCT04002310|588128925|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
162841741|NCT00352534|588128926|FG000|Initial Staging|Ineligible|8|||
162841742|NCT00352534|588128927|FG001|Initial Staging|Ineligible|9|||
162841743|NCT00352534|588128928|FG002|Initial Staging|Ineligible|0|||
162841744|NCT00352534|588128929|FG003|Initial Staging|Ineligible|0|||
162841745|NCT00352534|588128930|FG004|Initial Staging|Ineligible|0|||
162841746|NCT00352534|588128931|FG005|Initial Staging|Ineligible|0|||
162841747|NCT00352534|588128932|FG006|Initial Staging|Ineligible|0|||
162841748|NCT00352534|588128926|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
162841749|NCT00352534|588128927|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
162841750|NCT00352534|588128928|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
162950408|NCT01367457|588521688|FG000|Overall Study|low grade toxicities + stable disease|1|||
162950409|NCT01367457|588521689|FG001|Overall Study|low grade toxicities + stable disease|0|||
162950410|NCT01367457|588521690|FG002|Overall Study|low grade toxicities + stable disease|0|||
162950411|NCT01367457|588521688|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
162950412|NCT01367457|588521689|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
162950413|NCT01367457|588521690|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
162950414|NCT01367457|588521688|FG000|Overall Study|Withdrawal by Subject|1|||
162950415|NCT01367457|588521689|FG001|Overall Study|Withdrawal by Subject|0|||
162950416|NCT01367457|588521690|FG002|Overall Study|Withdrawal by Subject|0|||
162950417|NCT01367457|588521688|FG000|Overall Study|CD, associated leukaemia|1|||
162950418|NCT01367457|588521689|FG001|Overall Study|CD, associated leukaemia|0|||
162950419|NCT01367457|588521690|FG002|Overall Study|CD, associated leukaemia|0|||
162841751|NCT00352534|588128929|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
162841752|NCT00352534|588128930|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
162841753|NCT00352534|588128931|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
162841754|NCT00352534|588128932|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
162841755|NCT00352534|588128926|FG000|Final Risk Group Assignment|Physician Decision|0|||
162841756|NCT00352534|588128927|FG001|Final Risk Group Assignment|Physician Decision|0|||
162841757|NCT00352534|588128928|FG002|Final Risk Group Assignment|Physician Decision|0|||
162841758|NCT00352534|588128929|FG003|Final Risk Group Assignment|Physician Decision|0|||
162841759|NCT00352534|588128930|FG004|Final Risk Group Assignment|Physician Decision|0|||
162950420|NCT01367457|588521688|FG000|Overall Study|Uncontrolled pain|1|||
162950421|NCT01367457|588521689|FG001|Overall Study|Uncontrolled pain|0|||
162950422|NCT01367457|588521690|FG002|Overall Study|Uncontrolled pain|0|||
162950423|NCT01367457|588521688|FG000|Overall Study|Overall status worsens to grade 4|1|||
162950424|NCT01367457|588521689|FG001|Overall Study|Overall status worsens to grade 4|0|||
162950425|NCT01367457|588521690|FG002|Overall Study|Overall status worsens to grade 4|0|||
162950426|NCT01367457|588521688|FG000|Overall Study|Stabilisation + frequent infections|1|||
162950427|NCT01367457|588521689|FG001|Overall Study|Stabilisation + frequent infections|0|||
162950428|NCT01367457|588521690|FG002|Overall Study|Stabilisation + frequent infections|0|||
162950429|NCT01367457|588521688|FG000|Overall Study|No clinical benefit|1|||
162950430|NCT01367457|588521689|FG001|Overall Study|No clinical benefit|0|||
162950431|NCT01367457|588521690|FG002|Overall Study|No clinical benefit|0|||
162950432|NCT01367457|588521688|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
162950433|NCT01367457|588521689|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
162950434|NCT01367457|588521690|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
162950435|NCT01367457|588521688|FG000|Overall Study|Overall decline|1|||
162950436|NCT01367457|588521689|FG001|Overall Study|Overall decline|0|||
162700403|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700404|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
162950437|NCT01367457|588521690|FG002|Overall Study|Overall decline|0|||
162950438|NCT01367457|588521688|FG000|Overall Study|Rejection of treatment|1|||
162950439|NCT01367457|588521689|FG001|Overall Study|Rejection of treatment|0|||
162950440|NCT01367457|588521690|FG002|Overall Study|Rejection of treatment|0|||
162841760|NCT00352534|588128931|FG005|Final Risk Group Assignment|Physician Decision|8|||
162841761|NCT00352534|588128932|FG006|Final Risk Group Assignment|Physician Decision|0|||
162841762|NCT00352534|588128926|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
162950441|NCT01367457|588521688|FG000|Overall Study|Lost to Follow-up|1|||
162950442|NCT01367457|588521689|FG001|Overall Study|Lost to Follow-up|0|||
162841763|NCT00352534|588128927|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
162841764|NCT00352534|588128928|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
162841765|NCT00352534|588128929|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
162950443|NCT01367457|588521690|FG002|Overall Study|Lost to Follow-up|0|||
162950444|NCT01367457|588521688|FG000|Overall Study|Death from septic shock|1|||
162950445|NCT01367457|588521689|FG001|Overall Study|Death from septic shock|0|||
162950446|NCT01367457|588521690|FG002|Overall Study|Death from septic shock|0|||
162950447|NCT01367457|588521688|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
162950448|NCT01367457|588521689|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
162950449|NCT01367457|588521690|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
162950450|NCT01367457|588521688|FG000|Overall Study|Patient's Wish|1|||
162950451|NCT01367457|588521689|FG001|Overall Study|Patient's Wish|0|||
162950452|NCT01367457|588521690|FG002|Overall Study|Patient's Wish|0|||
162950453|NCT01367457|588521688|FG000|Overall Study|Palliative. Overall decline|1|||
162950454|NCT01367457|588521689|FG001|Overall Study|Palliative. Overall decline|0|||
162950455|NCT01367457|588521690|FG002|Overall Study|Palliative. Overall decline|0|||
162950456|NCT01367457|588521688|FG000|Overall Study|Suspected DP/suspected active infection|1|||
162950457|NCT01367457|588521689|FG001|Overall Study|Suspected DP/suspected active infection|0|||
162950458|NCT01367457|588521690|FG002|Overall Study|Suspected DP/suspected active infection|0|||
162950459|NCT04407806|588521695|FG000|Overall Study|Withdrawal by Subject|1|||
162950460|NCT04407806|588521696|FG001|Overall Study|Withdrawal by Subject|2|||
162950461|NCT02058498|588521698|FG000|Overall Study|Withdrawal by Subject|4|||
162700405|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
162700406|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700407|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700408|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700409|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700410|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162700411|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162700412|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162700413|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162700414|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
162700415|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
162700416|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162700417|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162700418|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162700419|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162700420|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162700421|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
162700422|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700423|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700424|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
162700425|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
162700426|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700427|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700428|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700429|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700430|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162700431|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700432|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700433|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
162700434|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
162700435|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700436|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700437|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700438|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700439|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700440|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162700441|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700442|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700443|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700444|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700445|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
162700446|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700447|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162950462|NCT04605094|588521699|FG000|Overall Study|Adverse Event|2|||
162950463|NCT04605094|588521700|FG001|Overall Study|Adverse Event|2|||
162950464|NCT04605094|588521699|FG000|Overall Study|Lost to Follow-up|1|||
162950465|NCT04605094|588521700|FG001|Overall Study|Lost to Follow-up|4|||
162950466|NCT04605094|588521699|FG000|Overall Study|Physician Decision|2|||
162950467|NCT04605094|588521700|FG001|Overall Study|Physician Decision|2|||
162950468|NCT04605094|588521699|FG000|Overall Study|Study terminated by Sponsor|31|||
162950469|NCT04605094|588521700|FG001|Overall Study|Study terminated by Sponsor|33|||
162950470|NCT04605094|588521699|FG000|Overall Study|Withdrawal by Subject|22|||
162950471|NCT04605094|588521700|FG001|Overall Study|Withdrawal by Subject|19|||
162950472|NCT04605094|588521699|FG000|Overall Study|Other|1|||
162950473|NCT04605094|588521700|FG001|Overall Study|Other|1|||
162950474|NCT02724462|588521701|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
162950475|NCT02724462|588521702|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
162950476|NCT02724462|588521701|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950477|NCT02724462|588521702|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
162841766|NCT00352534|588128930|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
162841767|NCT00352534|588128931|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
162841768|NCT00352534|588128932|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
162841769|NCT00352534|588128926|FG000|Final Risk Group Assignment|Ineligible|0|||
162841770|NCT00352534|588128927|FG001|Final Risk Group Assignment|Ineligible|0|||
162841771|NCT00352534|588128928|FG002|Final Risk Group Assignment|Ineligible|3|||
162841772|NCT00352534|588128929|FG003|Final Risk Group Assignment|Ineligible|1|||
162841773|NCT00352534|588128930|FG004|Final Risk Group Assignment|Ineligible|0|||
162841774|NCT00352534|588128931|FG005|Final Risk Group Assignment|Ineligible|13|||
162841775|NCT00352534|588128932|FG006|Final Risk Group Assignment|Ineligible|0|||
162841776|NCT00352534|588128926|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841777|NCT00352534|588128927|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841778|NCT00352534|588128928|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841779|NCT00352534|588128929|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841780|NCT00352534|588128930|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841781|NCT00352534|588128931|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
162841782|NCT00352534|588128932|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
162841783|NCT00352534|588128926|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841784|NCT00352534|588128927|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841785|NCT00352534|588128928|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841786|NCT00352534|588128929|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841787|NCT00352534|588128930|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841788|NCT00352534|588128931|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
162841789|NCT00352534|588128932|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
162841790|NCT00352534|588128926|FG000|Final Risk Group Assignment|Death|0|||
162841791|NCT00352534|588128927|FG001|Final Risk Group Assignment|Death|0|||
162841792|NCT00352534|588128928|FG002|Final Risk Group Assignment|Death|0|||
162841793|NCT00352534|588128929|FG003|Final Risk Group Assignment|Death|0|||
162841794|NCT00352534|588128930|FG004|Final Risk Group Assignment|Death|0|||
162841795|NCT00352534|588128931|FG005|Final Risk Group Assignment|Death|2|||
162841796|NCT00352534|588128932|FG006|Final Risk Group Assignment|Death|0|||
162841797|NCT00544869|588128934|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
162841798|NCT00544869|588128935|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
162841799|NCT00544869|588128936|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
162841800|NCT00544869|588128934|FG000|Overall Study|Adverse Event|6|||
162841801|NCT00544869|588128935|FG001|Overall Study|Adverse Event|1|||
162841802|NCT00544869|588128936|FG002|Overall Study|Adverse Event|0|||
162841803|NCT00544869|588128934|FG000|Overall Study|Lack of Efficacy|1|||
162841804|NCT00544869|588128935|FG001|Overall Study|Lack of Efficacy|1|||
162841805|NCT00544869|588128936|FG002|Overall Study|Lack of Efficacy|0|||
162841806|NCT00544869|588128934|FG000|Overall Study|Physician Decision|2|||
162841807|NCT00544869|588128935|FG001|Overall Study|Physician Decision|0|||
162841808|NCT00544869|588128936|FG002|Overall Study|Physician Decision|0|||
162841809|NCT02968810|588128947|FG000|Overall Study|Lost to Follow-up|1|||
162841810|NCT02968810|588128948|FG001|Overall Study|Lost to Follow-up|0|||
162841811|NCT02968810|588128947|FG000|Overall Study|Physician Decision|1|||
162700448|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700449|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700450|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162700451|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162700452|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162950478|NCT02724462|588521701|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
162841812|NCT02968810|588128948|FG001|Overall Study|Physician Decision|0|||
162841813|NCT02968810|588128947|FG000|Overall Study|Withdrawal by Subject|1|||
162700453|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162841814|NCT02968810|588128948|FG001|Overall Study|Withdrawal by Subject|3|||
162841815|NCT02968810|588128947|FG000|Overall Study|Disease Progression|0|||
162841816|NCT02968810|588128948|FG001|Overall Study|Disease Progression|1|||
162841817|NCT01072344|588128949|FG000|Overall Study|Relasped-reached end point|7|||
162841818|NCT01072344|588128950|FG001|Overall Study|Relasped-reached end point|12|||
162841819|NCT01072344|588128949|FG000|Overall Study|Protocol Violation|1|||
162841820|NCT01072344|588128950|FG001|Overall Study|Protocol Violation|2|||
162841821|NCT01072344|588128949|FG000|Overall Study|Lost to Follow-up|3|||
162841822|NCT01072344|588128950|FG001|Overall Study|Lost to Follow-up|4|||
162841823|NCT00804687|588128951|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
162841824|NCT00804687|588128952|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
162841825|NCT00804687|588128953|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
162841826|NCT00804687|588128954|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
162841827|NCT00804687|588128955|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
162841828|NCT00804687|588128956|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
162841829|NCT00804687|588128951|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
162841830|NCT00804687|588128952|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
162841831|NCT00804687|588128953|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
162841832|NCT00804687|588128954|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
162841833|NCT00804687|588128955|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
162841834|NCT00804687|588128956|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
162841835|NCT00804687|588128951|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
162841836|NCT00804687|588128952|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
162841837|NCT00804687|588128953|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
162841838|NCT00804687|588128954|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
162841839|NCT00804687|588128955|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
162841840|NCT00804687|588128956|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
162841841|NCT00804687|588128951|FG000|Period 5: Treatment Period|Positive drug test|1|||
162841842|NCT00804687|588128952|FG001|Period 5: Treatment Period|Positive drug test|0|||
162841843|NCT00804687|588128953|FG002|Period 5: Treatment Period|Positive drug test|0|||
162841844|NCT00804687|588128954|FG003|Period 5: Treatment Period|Positive drug test|0|||
162841845|NCT00804687|588128955|FG004|Period 5: Treatment Period|Positive drug test|0|||
162841846|NCT00804687|588128956|FG005|Period 5: Treatment Period|Positive drug test|0|||
162841847|NCT00716976|588128959|FG000|Overall Study|Adverse Event|2|||
162841848|NCT00716976|588128960|FG001|Overall Study|Adverse Event|0|||
162841849|NCT00716976|588128959|FG000|Overall Study|Death|1|||
162841850|NCT00716976|588128960|FG001|Overall Study|Death|0|||
162841851|NCT00716976|588128959|FG000|Overall Study|Physician Decision|2|||
162841852|NCT00716976|588128960|FG001|Overall Study|Physician Decision|2|||
162841853|NCT00716976|588128959|FG000|Overall Study|Withdrawal by Subject|5|||
162841854|NCT00716976|588128960|FG001|Overall Study|Withdrawal by Subject|1|||
162841855|NCT00716976|588128959|FG000|Overall Study|Premature discontinuation cisplatin|5|||
162841856|NCT00716976|588128960|FG001|Overall Study|Premature discontinuation cisplatin|4|||
162841857|NCT00716976|588128959|FG000|Overall Study|Radiation during protocol|1|||
162841858|NCT00716976|588128960|FG001|Overall Study|Radiation during protocol|0|||
162841859|NCT00716976|588128959|FG000|Overall Study|Ineligibles|4|||
162841860|NCT00716976|588128960|FG001|Overall Study|Ineligibles|2|||
162841861|NCT00805740|588128962|FG000|Overall Study|Death|7|||
162841862|NCT00805740|588128963|FG001|Overall Study|Death|4|||
162841863|NCT00805740|588128962|FG000|Overall Study|Withdrawal by Subject|1|||
162841864|NCT00805740|588128963|FG001|Overall Study|Withdrawal by Subject|0|||
162841865|NCT00805740|588128962|FG000|Overall Study|Lost to Follow-up|1|||
162841866|NCT00805740|588128963|FG001|Overall Study|Lost to Follow-up|0|||
162841867|NCT00805740|588128962|FG000|Overall Study|Randomized, but not treated|2|||
162841868|NCT00805740|588128963|FG001|Overall Study|Randomized, but not treated|0|||
162841869|NCT05227690|588128971|FG000|Overall Study|Adverse Event|5|||
162841870|NCT05227690|588128972|FG001|Overall Study|Adverse Event|6|||
162841871|NCT05227690|588128973|FG002|Overall Study|Adverse Event|10|||
162841872|NCT05227690|588128971|FG000|Overall Study|Lack of Efficacy|2|||
162841873|NCT05227690|588128972|FG001|Overall Study|Lack of Efficacy|4|||
162841874|NCT05227690|588128973|FG002|Overall Study|Lack of Efficacy|1|||
162841875|NCT05227690|588128971|FG000|Overall Study|Physician Decision|6|||
162841876|NCT05227690|588128972|FG001|Overall Study|Physician Decision|0|||
162841877|NCT05227690|588128973|FG002|Overall Study|Physician Decision|4|||
162950479|NCT02724462|588521702|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
162950480|NCT02724462|588521701|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950481|NCT02724462|588521702|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
162841878|NCT05227690|588128971|FG000|Overall Study|Withdrawal of consent|28|||
162841879|NCT05227690|588128972|FG001|Overall Study|Withdrawal of consent|27|||
162841880|NCT05227690|588128973|FG002|Overall Study|Withdrawal of consent|21|||
162841881|NCT05227690|588128971|FG000|Overall Study|Other, not specified|2|||
162841882|NCT05227690|588128972|FG001|Overall Study|Other, not specified|2|||
162950482|NCT02724462|588521701|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
162841883|NCT05227690|588128973|FG002|Overall Study|Other, not specified|1|||
162841884|NCT00975156|588128974|FG000|Overall Study|Protocol Violation|0|||
162841885|NCT00975156|588128975|FG001|Overall Study|Protocol Violation|1|||
162841886|NCT01534676|588128981|FG000|Overall Study|Study closed due to poor enrollment|2|||
162841887|NCT01534676|588128982|FG001|Overall Study|Study closed due to poor enrollment|1|||
162841888|NCT02634580|588128983|FG000|Double-blind Treatment Period|Subject Request|1|||
162841889|NCT02634580|588128984|FG001|Double-blind Treatment Period|Subject Request|0|||
162841890|NCT02634580|588128985|FG002|Double-blind Treatment Period|Subject Request|1|||
162841891|NCT02634580|588128986|FG003|Double-blind Treatment Period|Subject Request|1|||
162841892|NCT02634580|588128983|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162841893|NCT02634580|588128984|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
162841894|NCT02634580|588128985|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
162841895|NCT02634580|588128986|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
162841896|NCT02908880|588128988|FG000|Overall Study|Lost to Follow-up|4|||
162841897|NCT02908880|588128988|FG000|Overall Study|Explantation of the device|1|||
162841898|NCT02908880|588128988|FG000|Overall Study|Withdrawal by Subject|17|||
162841899|NCT02908880|588128988|FG000|Overall Study|Death|5|||
162841900|NCT00424827|588128993|FG000|Overall Study|Adverse Event|1|||
162841901|NCT05689047|588128996|FG000|Overall Study|Lost to Follow-up|0|||
162841902|NCT05689047|588128997|FG001|Overall Study|Lost to Follow-up|1|||
162841903|NCT05689047|588128996|FG000|Overall Study|Protocol Deviation|1|||
162841904|NCT05689047|588128997|FG001|Overall Study|Protocol Deviation|0|||
162841905|NCT03132636|588128998|FG000|Overall Study|Adverse Event|1|||
162841906|NCT03132636|588128999|FG001|Overall Study|Adverse Event|2|||
162841907|NCT03132636|588128998|FG000|Overall Study|Death|4|||
162841908|NCT03132636|588128999|FG001|Overall Study|Death|7|||
162841909|NCT03132636|588128998|FG000|Overall Study|Lost to Follow-up|3|||
162841910|NCT03132636|588128999|FG001|Overall Study|Lost to Follow-up|2|||
162841911|NCT03132636|588128998|FG000|Overall Study|Non compliance with protocol by participant|1|||
162841912|NCT03132636|588128999|FG001|Overall Study|Non compliance with protocol by participant|1|||
162841913|NCT03132636|588128998|FG000|Overall Study|Subject decision|1|||
162841914|NCT03132636|588128999|FG001|Overall Study|Subject decision|9|||
162841915|NCT03132636|588128998|FG000|Overall Study|Sponsor decision|0|||
162841916|NCT03132636|588128999|FG001|Overall Study|Sponsor decision|1|||
162841917|NCT03132636|588128998|FG000|Overall Study|Physician Decision|1|||
162841918|NCT03132636|588128999|FG001|Overall Study|Physician Decision|0|||
162841919|NCT03132636|588128998|FG000|Overall Study|Progressive disease|33|||
162841920|NCT03132636|588128999|FG001|Overall Study|Progressive disease|36|||
162841921|NCT03132636|588128998|FG000|Overall Study|Withdrawal of consent|2|||
162841922|NCT03132636|588128999|FG001|Overall Study|Withdrawal of consent|5|||
162841923|NCT03132636|588128998|FG000|Overall Study|Did not re-consent|1|||
162841924|NCT03132636|588128999|FG001|Overall Study|Did not re-consent|0|||
162841925|NCT03132636|588128998|FG000|Overall Study|Lost insurance coverage|1|||
162841926|NCT03132636|588128999|FG001|Overall Study|Lost insurance coverage|0|||
162841927|NCT03132636|588128998|FG000|Overall Study|Related to radiological outcomes|0|||
162841928|NCT03132636|588128999|FG001|Overall Study|Related to radiological outcomes|1|||
162841929|NCT03132636|588128998|FG000|Overall Study|Unable to come to site for continued visits|0|||
162841930|NCT03132636|588128999|FG001|Overall Study|Unable to come to site for continued visits|1|||
162841931|NCT01285908|588129000|FG000|Baseline Measurement|unable to insert catheter|1|||
162841932|NCT01285908|588129001|FG001|Baseline Measurement|unable to insert catheter|0|||
162841933|NCT01285908|588129002|FG002|Baseline Measurement|unable to insert catheter|0|||
162841934|NCT01285908|588129000|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
162841935|NCT01285908|588129001|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
162841936|NCT01285908|588129002|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
162841937|NCT01285908|588129000|FG000|Baseline Measurement|unable to tolerate procedure|1|||
162841938|NCT01285908|588129001|FG001|Baseline Measurement|unable to tolerate procedure|0|||
162841939|NCT01285908|588129002|FG002|Baseline Measurement|unable to tolerate procedure|0|||
162841940|NCT01562548|588129003|FG000|Overall Study|Lost to Follow-up|0|||
162841941|NCT01562548|588129004|FG001|Overall Study|Lost to Follow-up|0|||
162841942|NCT01562548|588129005|FG002|Overall Study|Lost to Follow-up|1|||
162841943|NCT01562548|588129006|FG003|Overall Study|Lost to Follow-up|0|||
162841944|NCT03655756|588129007|FG000|Overall Study|Death|1|||
162841945|NCT02161211|588129010|FG000|Overall Study|Lost to Follow-up|21|||
162841946|NCT02161211|588129011|FG001|Overall Study|Lost to Follow-up|27|||
162841947|NCT02161211|588129012|FG002|Overall Study|Lost to Follow-up|21|||
162841948|NCT02161211|588129010|FG000|Overall Study|Dropped|12|||
162841949|NCT02161211|588129011|FG001|Overall Study|Dropped|5|||
162841950|NCT02161211|588129012|FG002|Overall Study|Dropped|9|||
162841951|NCT01703858|588129013|FG000|Overall Study|Withdrawal by Subject|0|||
162841952|NCT01703858|588129014|FG001|Overall Study|Withdrawal by Subject|1|||
162841953|NCT01703858|588129015|FG002|Overall Study|Withdrawal by Subject|0|||
162841954|NCT01834729|588129018|FG000|Overall Study|Did not return bowel diaries|0|||
162841955|NCT01834729|588129019|FG001|Overall Study|Did not return bowel diaries|0|||
162841956|NCT01834729|588129020|FG002|Overall Study|Did not return bowel diaries|3|||
162841957|NCT01834729|588129021|FG003|Overall Study|Did not return bowel diaries|0|||
162841958|NCT01834729|588129018|FG000|Overall Study|Withdrawal by Subject|1|||
162841959|NCT01834729|588129019|FG001|Overall Study|Withdrawal by Subject|1|||
162841960|NCT01834729|588129020|FG002|Overall Study|Withdrawal by Subject|0|||
162841961|NCT01834729|588129021|FG003|Overall Study|Withdrawal by Subject|0|||
162841962|NCT01834729|588129018|FG000|Overall Study|Adverse Event|0|||
162841963|NCT01834729|588129019|FG001|Overall Study|Adverse Event|0|||
162841964|NCT01834729|588129020|FG002|Overall Study|Adverse Event|0|||
162841965|NCT01834729|588129021|FG003|Overall Study|Adverse Event|2|||
162841966|NCT03403192|588129022|FG000|Overall Study|Lost to Follow-up|1|||
162841967|NCT03403192|588129023|FG001|Overall Study|Lost to Follow-up|2|||
162841968|NCT03403192|588129024|FG002|Overall Study|Lost to Follow-up|0|||
162841969|NCT03403192|588129025|FG003|Overall Study|Lost to Follow-up|0|||
162841970|NCT03403192|588129022|FG000|Overall Study|Unable to respond|0|||
162841971|NCT03403192|588129023|FG001|Overall Study|Unable to respond|1|||
162841972|NCT03403192|588129024|FG002|Overall Study|Unable to respond|0|||
162841973|NCT03403192|588129025|FG003|Overall Study|Unable to respond|0|||
162841974|NCT03403192|588129022|FG000|Overall Study|Incomplete|3|||
162841975|NCT03403192|588129023|FG001|Overall Study|Incomplete|1|||
162841976|NCT03403192|588129024|FG002|Overall Study|Incomplete|3|||
162841977|NCT03403192|588129025|FG003|Overall Study|Incomplete|6|||
162841978|NCT04673786|588129028|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
162841979|NCT04673786|588129029|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
162841980|NCT04673786|588129030|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
162841981|NCT04673786|588129028|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
162841982|NCT04673786|588129029|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
162841983|NCT04673786|588129030|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
162841984|NCT04673786|588129028|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
162841985|NCT04673786|588129029|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
162841986|NCT04673786|588129030|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
162841987|NCT04673786|588129028|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
162841988|NCT04673786|588129029|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
162841989|NCT04673786|588129030|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
162841990|NCT04673786|588129028|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
162841991|NCT04673786|588129029|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
162841992|NCT04673786|588129030|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
162841993|NCT04673786|588129028|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
162841994|NCT04673786|588129029|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
162841995|NCT04673786|588129030|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
162841996|NCT01325428|588129031|FG000|Part A|Progressive disease according to RECIST|9|||
162841997|NCT01325428|588129031|FG000|Part A|Clinical signs, symptoms of progression|2|||
162841998|NCT01325428|588129031|FG000|Part A|Other adverse event|1|||
162841999|NCT01325428|588129031|FG000|Part A|Refused continue taking trial medication|2|||
162842000|NCT01325428|588129031|FG000|Part A|Other reason not defined above|2|||
162842001|NCT01325428|588129031|FG000|Part B|Refused continue taking trial medication|2|||
162842002|NCT01325428|588129031|FG000|Part B|Other reason not defined above|1|||
162842003|NCT04849780|588129032|FG000|Period 1|Covid-19 Related|1|||
162842004|NCT04849780|588129033|FG001|Period 1|Covid-19 Related|0|||
162842005|NCT04849780|588129032|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
162842006|NCT04849780|588129033|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
162842007|NCT04849780|588129032|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
162842008|NCT04849780|588129033|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
162842009|NCT00725075|588129034|FG000|Overall Study|Use of Excluded Medication|0|||
162842010|NCT00725075|588129035|FG001|Overall Study|Use of Excluded Medication|1|||
162842011|NCT00725075|588129036|FG002|Overall Study|Use of Excluded Medication|0|||
162842012|NCT00725075|588129034|FG000|Overall Study|Protocol Violation|0|||
162842013|NCT00725075|588129035|FG001|Overall Study|Protocol Violation|0|||
162842014|NCT00725075|588129036|FG002|Overall Study|Protocol Violation|1|||
162842015|NCT00725075|588129034|FG000|Overall Study|Lost to Follow-up|1|||
162842016|NCT00725075|588129035|FG001|Overall Study|Lost to Follow-up|0|||
162842017|NCT00725075|588129036|FG002|Overall Study|Lost to Follow-up|0|||
162842018|NCT00725075|588129034|FG000|Overall Study|Withdrawal by Subject|4|||
162842019|NCT00725075|588129035|FG001|Overall Study|Withdrawal by Subject|5|||
162842020|NCT00725075|588129036|FG002|Overall Study|Withdrawal by Subject|4|||
162842021|NCT00725075|588129034|FG000|Overall Study|Adverse Event|2|||
162842022|NCT00725075|588129035|FG001|Overall Study|Adverse Event|1|||
162842023|NCT00725075|588129036|FG002|Overall Study|Adverse Event|1|||
162842024|NCT00725075|588129034|FG000|Overall Study|Worsening of Disease|2|||
162842025|NCT00725075|588129035|FG001|Overall Study|Worsening of Disease|1|||
162842026|NCT00725075|588129036|FG002|Overall Study|Worsening of Disease|2|||
162842027|NCT00725075|588129034|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
162842028|NCT00725075|588129035|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
162842029|NCT00725075|588129036|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
162842030|NCT00725075|588129034|FG000|Overall Study|Other|1|||
162842031|NCT00725075|588129035|FG001|Overall Study|Other|0|||
162842032|NCT00725075|588129036|FG002|Overall Study|Other|0|||
162842033|NCT01298492|588129037|FG000|Overall Study|Death|2|||
162842034|NCT01298492|588129037|FG000|Overall Study|Insufficient Clinical Response|22|||
162842035|NCT01298492|588129037|FG000|Overall Study|Lost to Follow-up|12|||
162842036|NCT01298492|588129037|FG000|Overall Study|Withdrawal by Subject|47|||
162842037|NCT01298492|588129037|FG000|Overall Study|Other (Unspecified)|7|||
162842038|NCT01298492|588129037|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
162842039|NCT01298492|588129037|FG000|Overall Study|Protocol Violation|2|||
162842040|NCT01298492|588129037|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
162842041|NCT01298492|588129037|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
162842042|NCT02340663|588129038|FG000|Overall Study|Lost to Follow-up|1|||
162842043|NCT02340663|588129039|FG001|Overall Study|Lost to Follow-up|0|||
162842044|NCT02340663|588129038|FG000|Overall Study|Protocol Violation|1|||
162842045|NCT02340663|588129039|FG001|Overall Study|Protocol Violation|0|||
162842046|NCT02340663|588129038|FG000|Overall Study|Withdrawal by Subject|3|||
162842047|NCT02340663|588129039|FG001|Overall Study|Withdrawal by Subject|1|||
162842048|NCT02902120|588129041|FG000|Overall Study|Lack of Efficacy|1|||
162842049|NCT01353703|588129042|FG000|Overall Study|Migrated/moved from study area|1|||
162842050|NCT01353703|588129043|FG001|Overall Study|Migrated/moved from study area|0|||
162842051|NCT03298022|588129044|FG000|Overall Study|Lack of Efficacy|4|||
162842052|NCT03298022|588129044|FG000|Overall Study|Withdrawal by Subject|7|||
162842053|NCT03298022|588129044|FG000|Overall Study|Adverse Event|1|||
162842054|NCT03298022|588129044|FG000|Overall Study|disease relapse|1|||
162842055|NCT03694925|588129045|FG000|Overall Study|Inadequate laboratory testing|0|||
162842056|NCT03694925|588129046|FG001|Overall Study|Inadequate laboratory testing|3|||
162842057|NCT03694925|588129047|FG002|Overall Study|Inadequate laboratory testing|0|||
162842058|NCT01422239|588129048|FG000|Overall Study|Lost to Follow-up|4|||
162842059|NCT01422239|588129049|FG001|Overall Study|Lost to Follow-up|3|||
162842060|NCT03033875|588129053|FG000|Overall Study|Withdrawal by Subject|5|||
162842061|NCT03033875|588129054|FG001|Overall Study|Withdrawal by Subject|9|||
162842062|NCT03033875|588129055|FG002|Overall Study|Withdrawal by Subject|4|||
162842063|NCT03033875|588129053|FG000|Overall Study|Other|14|||
162842064|NCT03033875|588129054|FG001|Overall Study|Other|15|||
162842065|NCT03033875|588129055|FG002|Overall Study|Other|8|||
162842066|NCT03595553|588129059|FG000|Overall Study|Withdrawal by Subject|20|||
162842067|NCT03595553|588129060|FG001|Overall Study|Withdrawal by Subject|8|||
162842068|NCT03595553|588129059|FG000|Overall Study|Physician Decision|3|||
162842069|NCT03595553|588129060|FG001|Overall Study|Physician Decision|2|||
162842070|NCT03595553|588129059|FG000|Overall Study|Adverse Event|2|||
162842071|NCT03595553|588129060|FG001|Overall Study|Adverse Event|5|||
162842072|NCT03595553|588129059|FG000|Overall Study|Death|24|||
162842073|NCT03595553|588129060|FG001|Overall Study|Death|22|||
162842074|NCT03595553|588129059|FG000|Overall Study|Lost to Follow-up|6|||
162842075|NCT03595553|588129060|FG001|Overall Study|Lost to Follow-up|7|||
162842076|NCT03595553|588129059|FG000|Overall Study|Other as indicated in CSR|3|||
162842077|NCT03595553|588129060|FG001|Overall Study|Other as indicated in CSR|3|||
162842078|NCT03595553|588129059|FG000|Overall Study|Sponsor Decision|0|||
162842079|NCT03595553|588129060|FG001|Overall Study|Sponsor Decision|1|||
162842080|NCT03467958|588129061|FG000|Overall Study|Adverse Event|20|||
162842081|NCT03467958|588129062|FG001|Overall Study|Adverse Event|32|||
162842082|NCT03467958|588129063|FG002|Overall Study|Adverse Event|5|||
162842083|NCT03467958|588129064|FG003|Overall Study|Adverse Event|3|||
162700454|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
162700455|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
162700456|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
162700457|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162842084|NCT03467958|588129065|FG004|Overall Study|Adverse Event|3|||
162842085|NCT03467958|588129066|FG005|Overall Study|Adverse Event|3|||
162842086|NCT03467958|588129067|FG006|Overall Study|Adverse Event|6|||
162842087|NCT03467958|588129068|FG007|Overall Study|Adverse Event|5|||
162842088|NCT03467958|588129069|FG008|Overall Study|Adverse Event|0|||
162842089|NCT03467958|588129061|FG000|Overall Study|Lack of Efficacy|59|||
162700458|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162700459|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162700460|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162700461|NCT02018861|587615033|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700462|NCT02018861|587615034|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700463|NCT02018861|587615035|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162842090|NCT03467958|588129062|FG001|Overall Study|Lack of Efficacy|120|||
162842091|NCT03467958|588129063|FG002|Overall Study|Lack of Efficacy|6|||
162842092|NCT03467958|588129064|FG003|Overall Study|Lack of Efficacy|9|||
162842093|NCT03467958|588129065|FG004|Overall Study|Lack of Efficacy|8|||
162842094|NCT03467958|588129066|FG005|Overall Study|Lack of Efficacy|9|||
162842095|NCT03467958|588129067|FG006|Overall Study|Lack of Efficacy|11|||
162842096|NCT03467958|588129068|FG007|Overall Study|Lack of Efficacy|9|||
162842097|NCT03467958|588129069|FG008|Overall Study|Lack of Efficacy|3|||
162842098|NCT03467958|588129061|FG000|Overall Study|Lost to Follow-up|1|||
162842099|NCT03467958|588129062|FG001|Overall Study|Lost to Follow-up|2|||
162842100|NCT03467958|588129063|FG002|Overall Study|Lost to Follow-up|1|||
162842101|NCT03467958|588129064|FG003|Overall Study|Lost to Follow-up|0|||
162842102|NCT03467958|588129065|FG004|Overall Study|Lost to Follow-up|4|||
162842103|NCT03467958|588129066|FG005|Overall Study|Lost to Follow-up|0|||
162842104|NCT03467958|588129067|FG006|Overall Study|Lost to Follow-up|0|||
162842105|NCT03467958|588129068|FG007|Overall Study|Lost to Follow-up|0|||
162842106|NCT03467958|588129069|FG008|Overall Study|Lost to Follow-up|0|||
162842107|NCT03467958|588129061|FG000|Overall Study|Other reasons|8|||
162950483|NCT02724462|588521702|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
162950484|NCT02724462|588521701|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
162950485|NCT02724462|588521702|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
162950486|NCT00469417|588521703|FG000|Overall Study|Treatment failure all lesions|18|||
162950487|NCT00469417|588521704|FG001|Overall Study|Treatment failure all lesions|11|||
162950488|NCT00469417|588521703|FG000|Overall Study|Consent withdrawn|1|||
162950489|NCT00469417|588521704|FG001|Overall Study|Consent withdrawn|1|||
162950490|NCT00469417|588521703|FG000|Overall Study|Adverse Event|8|||
162950491|NCT00469417|588521704|FG001|Overall Study|Adverse Event|2|||
162950492|NCT00469417|588521703|FG000|Overall Study|Lost to Follow-up|1|||
162950493|NCT00469417|588521704|FG001|Overall Study|Lost to Follow-up|2|||
162950494|NCT00469417|588521703|FG000|Overall Study|Intercurrent disease|0|||
162950495|NCT00469417|588521704|FG001|Overall Study|Intercurrent disease|1|||
162950496|NCT00469417|588521703|FG000|Overall Study|Randomized but not treated|2|||
162950497|NCT00469417|588521704|FG001|Overall Study|Randomized but not treated|0|||
162950498|NCT02188303|588521709|FG000|Overall Study|Adverse Event|0|||
162950499|NCT02188303|588521710|FG001|Overall Study|Adverse Event|0|||
162950500|NCT02188303|588521711|FG002|Overall Study|Adverse Event|0|||
162950501|NCT02188303|588521712|FG003|Overall Study|Adverse Event|0|||
162950502|NCT02188303|588521713|FG004|Overall Study|Adverse Event|0|||
162950503|NCT02188303|588521714|FG005|Overall Study|Adverse Event|2|||
162950504|NCT02188303|588521715|FG006|Overall Study|Adverse Event|0|||
162950505|NCT02188303|588521716|FG007|Overall Study|Adverse Event|2|||
162950506|NCT02188303|588521709|FG000|Overall Study|Dose Termination Criteria Met|0|||
162950507|NCT02188303|588521710|FG001|Overall Study|Dose Termination Criteria Met|0|||
162950508|NCT02188303|588521711|FG002|Overall Study|Dose Termination Criteria Met|0|||
162950509|NCT02188303|588521712|FG003|Overall Study|Dose Termination Criteria Met|0|||
162950510|NCT02188303|588521713|FG004|Overall Study|Dose Termination Criteria Met|0|||
162950511|NCT02188303|588521714|FG005|Overall Study|Dose Termination Criteria Met|0|||
162950512|NCT02188303|588521715|FG006|Overall Study|Dose Termination Criteria Met|2|||
162950513|NCT02188303|588521716|FG007|Overall Study|Dose Termination Criteria Met|4|||
162950514|NCT04206332|588521718|FG000|Part A|Lost to Follow-up|0|||
162950515|NCT04206332|588521719|FG001|Part A|Lost to Follow-up|1|||
162950516|NCT04206332|588521720|FG002|Part A|Lost to Follow-up|0|||
162842108|NCT03467958|588129062|FG001|Overall Study|Other reasons|14|||
162842109|NCT03467958|588129063|FG002|Overall Study|Other reasons|2|||
162842110|NCT03467958|588129064|FG003|Overall Study|Other reasons|1|||
162842111|NCT03467958|588129065|FG004|Overall Study|Other reasons|4|||
162842112|NCT03467958|588129066|FG005|Overall Study|Other reasons|0|||
162842113|NCT03467958|588129067|FG006|Overall Study|Other reasons|1|||
162842114|NCT03467958|588129068|FG007|Overall Study|Other reasons|0|||
162842115|NCT03467958|588129069|FG008|Overall Study|Other reasons|1|||
162842116|NCT03467958|588129061|FG000|Overall Study|Pregnancy|1|||
162842117|NCT03467958|588129062|FG001|Overall Study|Pregnancy|0|||
162842118|NCT03467958|588129063|FG002|Overall Study|Pregnancy|0|||
162842119|NCT03467958|588129064|FG003|Overall Study|Pregnancy|0|||
162842120|NCT03467958|588129065|FG004|Overall Study|Pregnancy|0|||
162950517|NCT04206332|588521721|FG003|Part A|Lost to Follow-up|0|||
162950518|NCT04206332|588521722|FG004|Part A|Lost to Follow-up|0|||
162950519|NCT04206332|588521723|FG005|Part A|Lost to Follow-up|0|||
162950520|NCT04206332|588521724|FG006|Part A|Lost to Follow-up|0|||
162950521|NCT04206332|588521725|FG007|Part A|Lost to Follow-up|0|||
162842121|NCT03467958|588129066|FG005|Overall Study|Pregnancy|1|||
162842122|NCT03467958|588129067|FG006|Overall Study|Pregnancy|0|||
162842123|NCT03467958|588129068|FG007|Overall Study|Pregnancy|0|||
162950522|NCT04206332|588521726|FG008|Part A|Lost to Follow-up|0|||
162950523|NCT04206332|588521727|FG009|Part A|Lost to Follow-up|0|||
162950524|NCT04206332|588521728|FG010|Part A|Lost to Follow-up|0|||
162950525|NCT04206332|588521729|FG011|Part A|Lost to Follow-up|0|||
162950526|NCT04206332|588521730|FG012|Part A|Lost to Follow-up|0|||
162950527|NCT04206332|588521731|FG013|Part A|Lost to Follow-up|0|||
162950528|NCT04206332|588521732|FG014|Part A|Lost to Follow-up|0|||
162950529|NCT04206332|588521733|FG015|Part A|Lost to Follow-up|0|||
162950530|NCT04206332|588521734|FG016|Part A|Lost to Follow-up|0|||
162950531|NCT04206332|588521718|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950532|NCT04206332|588521719|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950533|NCT04206332|588521720|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950534|NCT04206332|588521721|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950535|NCT04206332|588521722|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950536|NCT04206332|588521723|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
162950537|NCT04206332|588521724|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162700464|NCT02018861|587615036|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
162700465|NCT02018861|587615037|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
162700466|NCT02018861|587615038|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700467|NCT02018861|587615039|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700468|NCT02018861|587615040|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700469|NCT02018861|587615041|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700470|NCT02018861|587615042|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162700471|NCT02018861|587615033|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700472|NCT02018861|587615034|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700473|NCT02018861|587615035|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700474|NCT02018861|587615036|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162950538|NCT04206332|588521725|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950539|NCT04206332|588521726|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950540|NCT04206332|588521727|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950541|NCT04206332|588521728|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950542|NCT04206332|588521729|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950543|NCT04206332|588521730|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950544|NCT04206332|588521731|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950545|NCT04206332|588521732|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950546|NCT04206332|588521733|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950547|NCT04206332|588521734|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
162950548|NCT04206332|588521718|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950549|NCT04206332|588521719|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950550|NCT04206332|588521720|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950551|NCT04206332|588521721|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950552|NCT04206332|588521722|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950553|NCT04206332|588521723|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950554|NCT04206332|588521724|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950555|NCT04206332|588521725|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
162950556|NCT04206332|588521726|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950557|NCT04206332|588521727|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950558|NCT04206332|588521728|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
162950559|NCT04206332|588521729|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950560|NCT04206332|588521730|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950561|NCT04206332|588521731|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950562|NCT04206332|588521732|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950563|NCT04206332|588521733|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950564|NCT04206332|588521734|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950565|NCT04206332|588521718|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950566|NCT04206332|588521719|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950567|NCT04206332|588521720|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950568|NCT04206332|588521721|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162842124|NCT03467958|588129069|FG008|Overall Study|Pregnancy|0|||
162842125|NCT03467958|588129061|FG000|Overall Study|Study terminated by sponsor|65|||
162842126|NCT03467958|588129062|FG001|Overall Study|Study terminated by sponsor|117|||
162842127|NCT03467958|588129063|FG002|Overall Study|Study terminated by sponsor|45|||
162842128|NCT03467958|588129064|FG003|Overall Study|Study terminated by sponsor|64|||
162842129|NCT03467958|588129065|FG004|Overall Study|Study terminated by sponsor|66|||
162842130|NCT03467958|588129066|FG005|Overall Study|Study terminated by sponsor|17|||
162842131|NCT03467958|588129067|FG006|Overall Study|Study terminated by sponsor|11|||
162842132|NCT03467958|588129068|FG007|Overall Study|Study terminated by sponsor|5|||
162842133|NCT03467958|588129069|FG008|Overall Study|Study terminated by sponsor|5|||
162842134|NCT03467958|588129061|FG000|Overall Study|Withdrawal by Subject|25|||
162842135|NCT03467958|588129062|FG001|Overall Study|Withdrawal by Subject|44|||
162842136|NCT03467958|588129063|FG002|Overall Study|Withdrawal by Subject|7|||
162842137|NCT03467958|588129064|FG003|Overall Study|Withdrawal by Subject|8|||
162842138|NCT03467958|588129065|FG004|Overall Study|Withdrawal by Subject|6|||
162842139|NCT03467958|588129066|FG005|Overall Study|Withdrawal by Subject|8|||
162842140|NCT03467958|588129067|FG006|Overall Study|Withdrawal by Subject|4|||
162842141|NCT03467958|588129068|FG007|Overall Study|Withdrawal by Subject|1|||
162842142|NCT03467958|588129069|FG008|Overall Study|Withdrawal by Subject|4|||
162842143|NCT02286947|588129070|FG000|Overall Study|Withdrawal by Subject|2|||
162842144|NCT00516737|588129075|FG000|Overall Study|Lost to Follow-up|2|||
162842145|NCT00516737|588129076|FG001|Overall Study|Lost to Follow-up|0|||
162842146|NCT00516737|588129075|FG000|Overall Study|Physician Decision|0|||
162842147|NCT00516737|588129076|FG001|Overall Study|Physician Decision|1|||
162842148|NCT00516737|588129075|FG000|Overall Study|Withdrawal by Subject|0|||
162842149|NCT00516737|588129076|FG001|Overall Study|Withdrawal by Subject|1|||
162842150|NCT00516737|588129075|FG000|Overall Study|Lack of Qualifying Event|9|||
162842151|NCT00516737|588129076|FG001|Overall Study|Lack of Qualifying Event|6|||
162842152|NCT02090855|588131106|FG000|Overall Study|no evaluable Standard of Truth results|2|||
162842153|NCT00619502|588131107|FG000|Overall Study|Lost to Follow-up|8|||
162842154|NCT00619502|588131108|FG001|Overall Study|Lost to Follow-up|10|||
162842155|NCT01354028|588131109|FG000|Overall Study|Physician Decision|0|||
162842156|NCT01354028|588131110|FG001|Overall Study|Physician Decision|2|||
162842157|NCT01354028|588131109|FG000|Overall Study|Discharged before study start|2|||
162842158|NCT01354028|588131110|FG001|Overall Study|Discharged before study start|2|||
162842159|NCT01354028|588131109|FG000|Overall Study|No quiet alert state|0|||
162842160|NCT01354028|588131110|FG001|Overall Study|No quiet alert state|1|||
162842161|NCT03968419|588131113|FG000|Treatment Period|Adverse Event|0|||
162842162|NCT03968419|588131114|FG001|Treatment Period|Adverse Event|0|||
162842163|NCT03968419|588131115|FG002|Treatment Period|Adverse Event|1|||
162842164|NCT03968419|588131113|FG000|Safety Follow-up Period|Death|3|||
162842165|NCT03968419|588131114|FG001|Safety Follow-up Period|Death|2|||
162842166|NCT03968419|588131115|FG002|Safety Follow-up Period|Death|1|||
162842167|NCT03968419|588131113|FG000|Safety Follow-up Period|Subject Decision|2|||
162842168|NCT03968419|588131114|FG001|Safety Follow-up Period|Subject Decision|1|||
162842169|NCT03968419|588131115|FG002|Safety Follow-up Period|Subject Decision|0|||
162842170|NCT01641939|588131118|FG000|Overall Study|Death|90|||
162842171|NCT01641939|588131119|FG001|Overall Study|Death|187|||
162842172|NCT01641939|588131120|FG002|Overall Study|Death|61|||
162842173|NCT01641939|588131118|FG000|Overall Study|Lost to Follow-up|3|||
162842174|NCT01641939|588131119|FG001|Overall Study|Lost to Follow-up|2|||
162700475|NCT02018861|587615037|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700476|NCT02018861|587615038|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700477|NCT02018861|587615039|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
162700478|NCT02018861|587615040|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
162700479|NCT02018861|587615041|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700480|NCT02018861|587615042|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162700481|NCT02018861|587615033|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700482|NCT02018861|587615034|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700483|NCT02018861|587615035|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162842175|NCT01641939|588131120|FG002|Overall Study|Lost to Follow-up|1|||
162842176|NCT01641939|588131118|FG000|Overall Study|Withdrawal by Subject|14|||
162842177|NCT01641939|588131119|FG001|Overall Study|Withdrawal by Subject|11|||
162842178|NCT01641939|588131120|FG002|Overall Study|Withdrawal by Subject|5|||
162842179|NCT01641939|588131118|FG000|Overall Study|Study Terminated by Sponsor|10|||
162842180|NCT01641939|588131119|FG001|Overall Study|Study Terminated by Sponsor|28|||
162842181|NCT01641939|588131120|FG002|Overall Study|Study Terminated by Sponsor|3|||
162842182|NCT02894840|588131121|FG000|Overall Study|Lost to Follow-up|1|||
162842183|NCT02894840|588131122|FG001|Overall Study|Lost to Follow-up|0|||
162842184|NCT02894840|588131123|FG002|Overall Study|Lost to Follow-up|3|||
162842185|NCT02894840|588131124|FG003|Overall Study|Lost to Follow-up|0|||
162842186|NCT05499559|588131125|FG000|Overall Study|Lost to Follow-up|467|||
162842187|NCT02971202|588131132|FG000|Overall Study|Pregnancy|1|||
162842188|NCT02971202|588131133|FG001|Overall Study|Pregnancy|0|||
162842189|NCT02971202|588131134|FG002|Overall Study|Pregnancy|0|||
162842190|NCT02971202|588131132|FG000|Overall Study|screen fail after consent|1|||
162700484|NCT02018861|587615036|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700485|NCT02018861|587615037|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700486|NCT02018861|587615038|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700487|NCT02018861|587615039|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
162700488|NCT02018861|587615040|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
162700489|NCT02018861|587615041|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700490|NCT02018861|587615042|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162700491|NCT02018861|587615033|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700492|NCT02018861|587615034|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700493|NCT02018861|587615035|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700494|NCT02018861|587615036|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700495|NCT02018861|587615037|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700496|NCT02018861|587615038|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700497|NCT02018861|587615039|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700498|NCT02018861|587615040|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700499|NCT02018861|587615041|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
162700500|NCT02018861|587615042|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162700501|NCT02018861|587615033|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700502|NCT02018861|587615034|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700503|NCT02018861|587615035|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700504|NCT02018861|587615036|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700505|NCT02018861|587615037|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700506|NCT02018861|587615038|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700507|NCT02018861|587615039|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700508|NCT02018861|587615040|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700509|NCT02018861|587615041|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
162700510|NCT02018861|587615042|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162700511|NCT02018861|587615033|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700512|NCT02018861|587615034|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700513|NCT02018861|587615035|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700514|NCT02018861|587615036|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700515|NCT02018861|587615037|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700516|NCT02018861|587615038|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700517|NCT02018861|587615039|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700518|NCT02018861|587615040|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700519|NCT02018861|587615041|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
162700520|NCT02018861|587615042|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162700521|NCT01642186|587615043|FG000|Overall Study|Death|0|||
162700522|NCT01642186|587615044|FG001|Overall Study|Death|2|||
162700523|NCT01642186|587615045|FG002|Overall Study|Death|2|||
162700524|NCT01642186|587615043|FG000|Overall Study|Lost to Follow-up|0|||
162700525|NCT01642186|587615044|FG001|Overall Study|Lost to Follow-up|0|||
162700526|NCT01642186|587615045|FG002|Overall Study|Lost to Follow-up|1|||
162700527|NCT00590980|587615048|FG000|Overall Study|Did not meet all inclusion criteria|10|||
162700528|NCT00504348|587615049|FG000|Overall Study|Adverse Event|3|||
162700529|NCT00504348|587615049|FG000|Overall Study|Lack of Efficacy|4|||
162700530|NCT00504348|587615049|FG000|Overall Study|Physician Decision|1|||
162700531|NCT01023308|587615051|FG000|Overall Study|Abnormal test proceedure results|3|||
162700532|NCT01023308|587615052|FG001|Overall Study|Abnormal test proceedure results|8|||
162700533|NCT01023308|587615051|FG000|Overall Study|Administrative problems|2|||
162700534|NCT01023308|587615052|FG001|Overall Study|Administrative problems|1|||
162700535|NCT01023308|587615051|FG000|Overall Study|Adverse Event|130|||
162700536|NCT01023308|587615052|FG001|Overall Study|Adverse Event|66|||
162700537|NCT01023308|587615051|FG000|Overall Study|Death|21|||
162700538|NCT01023308|587615052|FG001|Overall Study|Death|17|||
162700539|NCT01023308|587615051|FG000|Overall Study|Disease progression|82|||
162700540|NCT01023308|587615052|FG001|Overall Study|Disease progression|153|||
162700541|NCT01023308|587615051|FG000|Overall Study|New Cancer therapy|4|||
162842191|NCT02971202|588131133|FG001|Overall Study|screen fail after consent|0|||
162842192|NCT02971202|588131134|FG002|Overall Study|screen fail after consent|1|||
162842193|NCT04033367|588131135|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
162842194|NCT04033367|588131136|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
162842195|NCT04033367|588131135|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
162842196|NCT04033367|588131136|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
162842197|NCT04033367|588131135|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
162842198|NCT04033367|588131136|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
162842199|NCT04033367|588131135|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
162842200|NCT04033367|588131136|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
162842201|NCT02723201|588131137|FG000|Second Intervention Period|Protocol Violation|1|||
162842202|NCT02723201|588131138|FG001|Second Intervention Period|Protocol Violation|0|||
162842203|NCT02723201|588131139|FG002|Second Intervention Period|Protocol Violation|0|||
162842204|NCT02723201|588131137|FG000|Second Intervention Period|Adverse Event|1|||
162842205|NCT02723201|588131138|FG001|Second Intervention Period|Adverse Event|0|||
162842206|NCT02723201|588131139|FG002|Second Intervention Period|Adverse Event|0|||
162842207|NCT03472560|588131140|FG000|Overall Study|Subject transfer to continuation protocol|0|||
162842208|NCT03472560|588131141|FG001|Overall Study|Subject transfer to continuation protocol|1|||
162842209|NCT03472560|588131140|FG000|Overall Study|Withdrawal by Subject|4|||
162842210|NCT03472560|588131141|FG001|Overall Study|Withdrawal by Subject|0|||
162842211|NCT03472560|588131140|FG000|Overall Study|Progressive disease|24|||
162842212|NCT03472560|588131141|FG001|Overall Study|Progressive disease|8|||
162842213|NCT03472560|588131140|FG000|Overall Study|Physician Decision|1|||
162842214|NCT03472560|588131141|FG001|Overall Study|Physician Decision|0|||
162842215|NCT03472560|588131140|FG000|Overall Study|Death|7|||
162842216|NCT03472560|588131141|FG001|Overall Study|Death|4|||
162842217|NCT03472560|588131140|FG000|Overall Study|Adverse Event|5|||
162842218|NCT03472560|588131141|FG001|Overall Study|Adverse Event|3|||
162842219|NCT03472560|588131140|FG000|Overall Study|Global deterioration of health status|0|||
162842220|NCT03472560|588131141|FG001|Overall Study|Global deterioration of health status|4|||
162842221|NCT01946178|588131142|FG000|Overall Study|Pregnancy|1|||
162842222|NCT01946178|588131142|FG000|Overall Study|Lost to Follow-up|1|||
162842223|NCT05425563|588131147|FG000|Overall Study|Withdrawal by Subject|17|||
162842224|NCT01001702|588131148|FG000|Overall Study|Lost to Follow-up|7|||
162842225|NCT01001702|588131148|FG000|Overall Study|Adverse Event|7|||
162842226|NCT01001702|588131148|FG000|Overall Study|Sponsor Discontinued Study|4|||
162842227|NCT01001702|588131148|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
162842228|NCT01001702|588131148|FG000|Overall Study|Investigator withdrew Subject|10|||
162842229|NCT01001702|588131148|FG000|Overall Study|Withdrawal by Subject|19|||
162842230|NCT01001702|588131148|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
162842231|NCT00584233|588131151|FG000|Overall Study|Withdrawal by Subject|5|||
162842232|NCT00584233|588131151|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
162842233|NCT02494596|588131152|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162842234|NCT02494596|588131153|FG001|Overall Study|Insufficient Therapeutic Response|3|||
162842235|NCT02494596|588131154|FG002|Overall Study|Insufficient Therapeutic Response|1|||
162842236|NCT02494596|588131152|FG000|Overall Study|Adverse Event|0|||
162842237|NCT02494596|588131153|FG001|Overall Study|Adverse Event|1|||
162842238|NCT02494596|588131154|FG002|Overall Study|Adverse Event|0|||
162842239|NCT02494596|588131152|FG000|Overall Study|Refused Treatment|0|||
162842240|NCT02494596|588131153|FG001|Overall Study|Refused Treatment|1|||
162842241|NCT02494596|588131154|FG002|Overall Study|Refused Treatment|0|||
162842242|NCT02222714|588131155|FG000|Overall Study|Death|0|||
162842243|NCT02222714|588131156|FG001|Overall Study|Death|2|||
162842244|NCT02222714|588131157|FG002|Overall Study|Death|3|||
162842245|NCT02222714|588131158|FG003|Overall Study|Death|4|||
162842246|NCT02222714|588131159|FG004|Overall Study|Death|6|||
162700542|NCT01023308|587615052|FG001|Overall Study|New Cancer therapy|7|||
162700543|NCT01023308|587615051|FG000|Overall Study|Protocol Violation|3|||
162700544|NCT01023308|587615052|FG001|Overall Study|Protocol Violation|4|||
162700545|NCT01023308|587615051|FG000|Overall Study|Untreated|5|||
162700546|NCT01023308|587615052|FG001|Overall Study|Untreated|5|||
162950569|NCT04206332|588521722|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162700547|NCT01023308|587615051|FG000|Overall Study|Lost to Follow-up|1|||
162950570|NCT04206332|588521723|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162842247|NCT02222714|588131155|FG000|Overall Study|Withdrawal by Subject|0|||
162842248|NCT02222714|588131156|FG001|Overall Study|Withdrawal by Subject|0|||
162978984|NCT01660022|588623541|FG003|First Sequence (7 Days)|Adverse Event|0|||
162842249|NCT02222714|588131157|FG002|Overall Study|Withdrawal by Subject|1|||
162842250|NCT02222714|588131158|FG003|Overall Study|Withdrawal by Subject|0|||
162842251|NCT02222714|588131159|FG004|Overall Study|Withdrawal by Subject|1|||
162842252|NCT00159432|588131160|FG000|Overall Study|Adverse Event|1|||
162842253|NCT00159432|588131160|FG000|Overall Study|Death|1|||
162842254|NCT00159432|588131160|FG000|Overall Study|Lack of Efficacy|8|||
162700548|NCT01023308|587615052|FG001|Overall Study|Lost to Follow-up|0|||
162700549|NCT01023308|587615051|FG000|Overall Study|Withdrawal by Subject|34|||
162950571|NCT04206332|588521724|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950572|NCT04206332|588521725|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950573|NCT04206332|588521726|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950574|NCT04206332|588521727|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950575|NCT04206332|588521728|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950576|NCT04206332|588521729|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950577|NCT04206332|588521730|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950578|NCT04206332|588521731|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950579|NCT04206332|588521732|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950580|NCT04206332|588521733|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
162950581|NCT04206332|588521734|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
162950582|NCT04206332|588521718|FG000|Part C|Withdrawal by Subject|0|||
162950583|NCT04206332|588521719|FG001|Part C|Withdrawal by Subject|0|||
162950584|NCT04206332|588521720|FG002|Part C|Withdrawal by Subject|0|||
162950585|NCT04206332|588521721|FG003|Part C|Withdrawal by Subject|0|||
162700550|NCT01023308|587615052|FG001|Overall Study|Withdrawal by Subject|18|||
162700551|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
162700552|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
162950586|NCT04206332|588521722|FG004|Part C|Withdrawal by Subject|0|||
162950587|NCT04206332|588521723|FG005|Part C|Withdrawal by Subject|0|||
162950588|NCT04206332|588521724|FG006|Part C|Withdrawal by Subject|0|||
162950589|NCT04206332|588521725|FG007|Part C|Withdrawal by Subject|0|||
162950590|NCT04206332|588521726|FG008|Part C|Withdrawal by Subject|0|||
162950591|NCT04206332|588521727|FG009|Part C|Withdrawal by Subject|0|||
162950592|NCT04206332|588521728|FG010|Part C|Withdrawal by Subject|0|||
162950593|NCT04206332|588521729|FG011|Part C|Withdrawal by Subject|0|||
162950594|NCT04206332|588521730|FG012|Part C|Withdrawal by Subject|0|||
162950595|NCT04206332|588521731|FG013|Part C|Withdrawal by Subject|0|||
162950596|NCT04206332|588521732|FG014|Part C|Withdrawal by Subject|2|||
162950597|NCT04206332|588521733|FG015|Part C|Withdrawal by Subject|0|||
162950598|NCT04206332|588521734|FG016|Part C|Withdrawal by Subject|0|||
162950599|NCT05612724|588521736|FG000|Overall Study|Lost to Follow-up|4|||
162950600|NCT04000815|588521743|FG000|Overall Study|Lost to Follow-up|9|||
162950601|NCT04000815|588521744|FG001|Overall Study|Lost to Follow-up|2|||
162950602|NCT04000815|588521745|FG002|Overall Study|Lost to Follow-up|3|||
162950603|NCT04000815|588521743|FG000|Overall Study|Withdrawal by Subject|4|||
162950604|NCT04000815|588521744|FG001|Overall Study|Withdrawal by Subject|3|||
162950605|NCT04000815|588521745|FG002|Overall Study|Withdrawal by Subject|2|||
162950606|NCT04000815|588521743|FG000|Overall Study|Right ovarian cyst occured|1|||
162950607|NCT04000815|588521744|FG001|Overall Study|Right ovarian cyst occured|0|||
162950608|NCT04000815|588521745|FG002|Overall Study|Right ovarian cyst occured|0|||
162950609|NCT04000815|588521743|FG000|Overall Study|Hypertension occured on follow up|0|||
162950610|NCT04000815|588521744|FG001|Overall Study|Hypertension occured on follow up|0|||
162950611|NCT04000815|588521745|FG002|Overall Study|Hypertension occured on follow up|2|||
162950612|NCT00239577|588521746|FG000|Primary Phase|Adverse Event|0|||
162950613|NCT00239577|588521747|FG001|Primary Phase|Adverse Event|0|||
162950614|NCT00239577|588521748|FG002|Primary Phase|Adverse Event|1|||
162950615|NCT00239577|588521749|FG003|Primary Phase|Adverse Event|0|||
162950616|NCT00239577|588521746|FG000|Primary Phase|Other|5|||
162700553|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
162700554|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
162700555|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
162700556|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
162700557|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
162700558|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
162700559|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162700560|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162700561|NCT01646320|587615053|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
162700562|NCT01646320|587615054|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
162950617|NCT00239577|588521747|FG001|Primary Phase|Other|3|||
162950618|NCT00239577|588521748|FG002|Primary Phase|Other|2|||
162950619|NCT00239577|588521749|FG003|Primary Phase|Other|0|||
162950620|NCT01034358|588521752|FG000|Overall Study|Withdrawal by Subject|1|||
162950621|NCT01034358|588521752|FG000|Overall Study|Protocol Violation|1|||
162950622|NCT00377260|588521755|FG000|Overall Study|Lost to Follow-up|0|||
162950623|NCT00377260|588521756|FG001|Overall Study|Lost to Follow-up|1|||
162950624|NCT00377260|588521755|FG000|Overall Study|Withdrawal by Subject|2|||
162950625|NCT00377260|588521756|FG001|Overall Study|Withdrawal by Subject|4|||
162950626|NCT01617668|588521757|FG000|Overall Study|Adverse Event|7|||
162950627|NCT01617668|588521758|FG001|Overall Study|Adverse Event|0|||
162950628|NCT01617668|588521759|FG002|Overall Study|Adverse Event|12|||
162950629|NCT01617668|588521760|FG003|Overall Study|Adverse Event|5|||
162950630|NCT01617668|588521757|FG000|Overall Study|Physician Decision|1|||
162950631|NCT01617668|588521758|FG001|Overall Study|Physician Decision|2|||
162950632|NCT01617668|588521759|FG002|Overall Study|Physician Decision|3|||
162950633|NCT01617668|588521760|FG003|Overall Study|Physician Decision|0|||
162950634|NCT01617668|588521757|FG000|Overall Study|Progressive Disease|4|||
162950635|NCT01617668|588521758|FG001|Overall Study|Progressive Disease|4|||
162950636|NCT01617668|588521759|FG002|Overall Study|Progressive Disease|6|||
162950637|NCT01617668|588521760|FG003|Overall Study|Progressive Disease|9|||
162950638|NCT01617668|588521757|FG000|Overall Study|Subject/guardian decision|1|||
162950639|NCT01617668|588521758|FG001|Overall Study|Subject/guardian decision|3|||
162950640|NCT01617668|588521759|FG002|Overall Study|Subject/guardian decision|2|||
162950641|NCT01617668|588521760|FG003|Overall Study|Subject/guardian decision|1|||
162950642|NCT02017964|588521761|FG000|Overall Study|Patient deemed ineligible|1|||
162950643|NCT02300103|588521764|FG000|Overall Study|Lack of Efficacy|3|||
162950644|NCT02300103|588521764|FG000|Overall Study|Protocol Violation|1|||
162950645|NCT02300103|588521764|FG000|Overall Study|Withdrew Consent|2|||
162950646|NCT04091971|588521765|FG000|Overall Study|Withdrawal by Subject|1|||
162950647|NCT04091971|588521765|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
162950648|NCT04091971|588521765|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
162950649|NCT01391793|588521766|FG000|Overall Study|Ineligible|3|||
162950650|NCT01391793|588521767|FG001|Overall Study|Ineligible|0|||
162950651|NCT01391793|588521766|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
162950652|NCT01391793|588521767|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
162950653|NCT01391793|588521766|FG000|Overall Study|No DMSA|73|||
162950654|NCT01391793|588521767|FG001|Overall Study|No DMSA|57|||
162700563|NCT01646320|587615053|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
162950655|NCT01015625|588521768|FG000|Overall Study|Lost to Follow-up|3|||
162950656|NCT01015625|588521769|FG001|Overall Study|Lost to Follow-up|1|||
162950657|NCT01015625|588521768|FG000|Overall Study|Withdrawal by Subject|2|||
162950658|NCT01015625|588521769|FG001|Overall Study|Withdrawal by Subject|3|||
162950659|NCT01015625|588521768|FG000|Overall Study|Physician Decision|2|||
162950660|NCT01015625|588521769|FG001|Overall Study|Physician Decision|0|||
162950661|NCT01015625|588521768|FG000|Overall Study|Death|30|||
162950662|NCT01015625|588521769|FG001|Overall Study|Death|22|||
162950663|NCT00150462|588521772|FG000|Overall Study|Disease Progression or Relapse|3|||
162950664|NCT00150462|588521773|FG001|Overall Study|Disease Progression or Relapse|1|||
162950665|NCT00150462|588521774|FG002|Overall Study|Disease Progression or Relapse|2|||
162950666|NCT00150462|588521775|FG003|Overall Study|Disease Progression or Relapse|1|||
162950667|NCT00150462|588521776|FG004|Overall Study|Disease Progression or Relapse|2|||
162950668|NCT00150462|588521777|FG005|Overall Study|Disease Progression or Relapse|2|||
162950669|NCT00150462|588521778|FG006|Overall Study|Disease Progression or Relapse|3|||
162950670|NCT00150462|588521779|FG007|Overall Study|Disease Progression or Relapse|5|||
162950671|NCT00150462|588521780|FG008|Overall Study|Disease Progression or Relapse|5|||
162950672|NCT00150462|588521781|FG009|Overall Study|Disease Progression or Relapse|3|||
162950673|NCT00150462|588521782|FG010|Overall Study|Disease Progression or Relapse|2|||
162700564|NCT01646320|587615054|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
162700565|NCT01646320|587615053|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
162700566|NCT01646320|587615054|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
162700567|NCT01646320|587615053|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
162700568|NCT01646320|587615054|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
162700569|NCT01646320|587615053|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
162700570|NCT01646320|587615054|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
162700571|NCT01646320|587615053|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
162700572|NCT01646320|587615054|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
162700573|NCT02254421|587615055|FG000|Overall Study|Randomized but Not Treated|1|||
162700574|NCT02254421|587615056|FG001|Overall Study|Randomized but Not Treated|0|||
162700575|NCT02254421|587615055|FG000|Overall Study|Death|0|||
162700576|NCT02254421|587615056|FG001|Overall Study|Death|2|||
162842255|NCT04537208|588131161|FG000|Overall Study|Adverse Event|0|||
162842256|NCT04537208|588131162|FG001|Overall Study|Adverse Event|0|||
162842257|NCT04537208|588131163|FG002|Overall Study|Adverse Event|0|||
162842258|NCT04537208|588131164|FG003|Overall Study|Adverse Event|0|||
162842259|NCT04537208|588131165|FG004|Overall Study|Adverse Event|0|||
162842260|NCT04537208|588131166|FG005|Overall Study|Adverse Event|0|||
162842261|NCT04537208|588131167|FG006|Overall Study|Adverse Event|0|||
162842262|NCT04537208|588131168|FG007|Overall Study|Adverse Event|0|||
162842263|NCT04537208|588131169|FG008|Overall Study|Adverse Event|1|||
162842264|NCT04537208|588131170|FG009|Overall Study|Adverse Event|0|||
162842265|NCT04537208|588131171|FG010|Overall Study|Adverse Event|0|||
162842266|NCT04537208|588131161|FG000|Overall Study|Protocol deviation|0|||
162842267|NCT04537208|588131162|FG001|Overall Study|Protocol deviation|0|||
162842268|NCT04537208|588131163|FG002|Overall Study|Protocol deviation|2|||
162842269|NCT04537208|588131164|FG003|Overall Study|Protocol deviation|0|||
162842270|NCT04537208|588131165|FG004|Overall Study|Protocol deviation|0|||
162842271|NCT04537208|588131166|FG005|Overall Study|Protocol deviation|2|||
162842272|NCT04537208|588131167|FG006|Overall Study|Protocol deviation|4|||
162842273|NCT04537208|588131168|FG007|Overall Study|Protocol deviation|0|||
162842274|NCT04537208|588131169|FG008|Overall Study|Protocol deviation|1|||
162842275|NCT04537208|588131170|FG009|Overall Study|Protocol deviation|0|||
162842276|NCT04537208|588131171|FG010|Overall Study|Protocol deviation|2|||
162842277|NCT04537208|588131161|FG000|Overall Study|Withdrawal by Subject|4|||
162842278|NCT04537208|588131162|FG001|Overall Study|Withdrawal by Subject|2|||
162842279|NCT04537208|588131163|FG002|Overall Study|Withdrawal by Subject|1|||
162842280|NCT04537208|588131164|FG003|Overall Study|Withdrawal by Subject|3|||
162842281|NCT04537208|588131165|FG004|Overall Study|Withdrawal by Subject|5|||
162842282|NCT04537208|588131166|FG005|Overall Study|Withdrawal by Subject|1|||
162842283|NCT04537208|588131167|FG006|Overall Study|Withdrawal by Subject|6|||
162842284|NCT04537208|588131168|FG007|Overall Study|Withdrawal by Subject|1|||
162842285|NCT04537208|588131169|FG008|Overall Study|Withdrawal by Subject|7|||
162842286|NCT04537208|588131170|FG009|Overall Study|Withdrawal by Subject|2|||
162842287|NCT04537208|588131171|FG010|Overall Study|Withdrawal by Subject|4|||
162842288|NCT04537208|588131161|FG000|Overall Study|Lost to Follow-up|4|||
162842289|NCT04537208|588131162|FG001|Overall Study|Lost to Follow-up|1|||
162842290|NCT04537208|588131163|FG002|Overall Study|Lost to Follow-up|3|||
162842291|NCT04537208|588131164|FG003|Overall Study|Lost to Follow-up|4|||
162842292|NCT04537208|588131165|FG004|Overall Study|Lost to Follow-up|3|||
162842293|NCT04537208|588131166|FG005|Overall Study|Lost to Follow-up|2|||
162842294|NCT04537208|588131167|FG006|Overall Study|Lost to Follow-up|3|||
162842295|NCT04537208|588131168|FG007|Overall Study|Lost to Follow-up|2|||
162842296|NCT04537208|588131169|FG008|Overall Study|Lost to Follow-up|7|||
162842297|NCT04537208|588131170|FG009|Overall Study|Lost to Follow-up|2|||
162842298|NCT04537208|588131171|FG010|Overall Study|Lost to Follow-up|2|||
162842299|NCT03286842|588131172|FG000|Overall Study|Patients rolled over to another study|80|||
162842300|NCT03178487|588131176|FG000|Period 1|Adverse Event|1|||
162842301|NCT03178487|588131177|FG001|Period 1|Adverse Event|2|||
162842302|NCT03178487|588131176|FG000|Period 1|Withdrawal by Subject|2|||
162842303|NCT03178487|588131177|FG001|Period 1|Withdrawal by Subject|1|||
162842304|NCT03178487|588131176|FG000|Period 1|Lost to Follow-up|1|||
162842305|NCT03178487|588131177|FG001|Period 1|Lost to Follow-up|0|||
162842306|NCT03178487|588131176|FG000|Period 1|Other|0|||
162842307|NCT03178487|588131177|FG001|Period 1|Other|1|||
162842308|NCT03178487|588131176|FG000|Period 2|Adverse Event|4|||
162842309|NCT03178487|588131177|FG001|Period 2|Adverse Event|4|||
162842310|NCT03178487|588131176|FG000|Period 2|Withdrawal by Subject|6|||
162842311|NCT03178487|588131177|FG001|Period 2|Withdrawal by Subject|6|||
162842312|NCT03178487|588131176|FG000|Period 2|Lost to Follow-up|2|||
162842313|NCT03178487|588131177|FG001|Period 2|Lost to Follow-up|2|||
162842314|NCT03178487|588131176|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
162842315|NCT03178487|588131177|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
162842316|NCT03178487|588131176|FG000|Period 2|Other|8|||
162842317|NCT03178487|588131177|FG001|Period 2|Other|7|||
162842318|NCT00704964|588131183|FG000|Overall Study|Not completed on time|328|||
162842319|NCT02161562|588131184|FG000|Overall Study|Withdrawal by Subject|5|||
162842320|NCT02161562|588131185|FG001|Overall Study|Withdrawal by Subject|8|||
162842321|NCT02161562|588131184|FG000|Overall Study|Protocol Violation|9|||
162842322|NCT02161562|588131185|FG001|Overall Study|Protocol Violation|4|||
162842323|NCT02161562|588131184|FG000|Overall Study|Pregnancy|1|||
162842324|NCT02161562|588131185|FG001|Overall Study|Pregnancy|2|||
162842325|NCT02161562|588131184|FG000|Overall Study|Lost to Follow-up|3|||
162842326|NCT02161562|588131185|FG001|Overall Study|Lost to Follow-up|1|||
162842327|NCT02161562|588131184|FG000|Overall Study|Lack of Efficacy|4|||
162700577|NCT02254421|587615055|FG000|Overall Study|Withdrew Consent|1|||
162842328|NCT02161562|588131185|FG001|Overall Study|Lack of Efficacy|1|||
162842329|NCT02161562|588131184|FG000|Overall Study|Adverse Event|1|||
162842330|NCT02161562|588131185|FG001|Overall Study|Adverse Event|1|||
162842331|NCT02161562|588131184|FG000|Overall Study|Participant moved back to home country|1|||
162842332|NCT02161562|588131185|FG001|Overall Study|Participant moved back to home country|0|||
162842333|NCT02161562|588131184|FG000|Overall Study|Withdrew due to being out of the country|1|||
162950674|NCT00150462|588521772|FG000|Overall Study|Withdrawal by Subject|0|||
162950675|NCT00150462|588521773|FG001|Overall Study|Withdrawal by Subject|1|||
162950676|NCT00150462|588521774|FG002|Overall Study|Withdrawal by Subject|1|||
162950677|NCT00150462|588521775|FG003|Overall Study|Withdrawal by Subject|0|||
162950678|NCT00150462|588521776|FG004|Overall Study|Withdrawal by Subject|1|||
162950679|NCT00150462|588521777|FG005|Overall Study|Withdrawal by Subject|2|||
162950680|NCT00150462|588521778|FG006|Overall Study|Withdrawal by Subject|0|||
162950681|NCT00150462|588521779|FG007|Overall Study|Withdrawal by Subject|1|||
162950682|NCT00150462|588521780|FG008|Overall Study|Withdrawal by Subject|0|||
162950683|NCT00150462|588521781|FG009|Overall Study|Withdrawal by Subject|1|||
162950684|NCT00150462|588521782|FG010|Overall Study|Withdrawal by Subject|0|||
162950685|NCT00150462|588521772|FG000|Overall Study|Death|0|||
162950686|NCT00150462|588521773|FG001|Overall Study|Death|1|||
162950687|NCT00150462|588521774|FG002|Overall Study|Death|0|||
162950688|NCT00150462|588521775|FG003|Overall Study|Death|0|||
162950689|NCT00150462|588521776|FG004|Overall Study|Death|0|||
162950690|NCT00150462|588521777|FG005|Overall Study|Death|0|||
162950691|NCT00150462|588521778|FG006|Overall Study|Death|0|||
162950692|NCT00150462|588521779|FG007|Overall Study|Death|0|||
162950693|NCT00150462|588521780|FG008|Overall Study|Death|1|||
162950694|NCT00150462|588521781|FG009|Overall Study|Death|0|||
162950695|NCT00150462|588521782|FG010|Overall Study|Death|0|||
162950696|NCT00150462|588521772|FG000|Overall Study|Adverse Event|0|||
162950697|NCT00150462|588521773|FG001|Overall Study|Adverse Event|0|||
162950698|NCT00150462|588521774|FG002|Overall Study|Adverse Event|0|||
162950699|NCT00150462|588521775|FG003|Overall Study|Adverse Event|1|||
162950700|NCT00150462|588521776|FG004|Overall Study|Adverse Event|0|||
162950701|NCT00150462|588521777|FG005|Overall Study|Adverse Event|0|||
162950702|NCT00150462|588521778|FG006|Overall Study|Adverse Event|0|||
162950703|NCT00150462|588521779|FG007|Overall Study|Adverse Event|2|||
162950704|NCT00150462|588521780|FG008|Overall Study|Adverse Event|0|||
162950705|NCT00150462|588521781|FG009|Overall Study|Adverse Event|1|||
162950706|NCT00150462|588521782|FG010|Overall Study|Adverse Event|0|||
162950707|NCT00150462|588521772|FG000|Overall Study|Physician Decision|0|||
162950708|NCT00150462|588521773|FG001|Overall Study|Physician Decision|0|||
162950709|NCT00150462|588521774|FG002|Overall Study|Physician Decision|1|||
162950710|NCT00150462|588521775|FG003|Overall Study|Physician Decision|1|||
162950711|NCT00150462|588521776|FG004|Overall Study|Physician Decision|0|||
162950712|NCT00150462|588521777|FG005|Overall Study|Physician Decision|0|||
162950713|NCT00150462|588521778|FG006|Overall Study|Physician Decision|0|||
162950714|NCT00150462|588521779|FG007|Overall Study|Physician Decision|0|||
162950715|NCT00150462|588521780|FG008|Overall Study|Physician Decision|0|||
162950716|NCT00150462|588521781|FG009|Overall Study|Physician Decision|0|||
162950717|NCT00150462|588521782|FG010|Overall Study|Physician Decision|0|||
162950718|NCT00150462|588521772|FG000|Overall Study|Other|0|||
162950719|NCT00150462|588521773|FG001|Overall Study|Other|0|||
162950720|NCT00150462|588521774|FG002|Overall Study|Other|0|||
162950721|NCT00150462|588521775|FG003|Overall Study|Other|0|||
162950722|NCT00150462|588521776|FG004|Overall Study|Other|0|||
162950723|NCT00150462|588521777|FG005|Overall Study|Other|0|||
162950724|NCT00150462|588521778|FG006|Overall Study|Other|0|||
162950725|NCT00150462|588521779|FG007|Overall Study|Other|0|||
162950726|NCT00150462|588521780|FG008|Overall Study|Other|0|||
162950727|NCT00150462|588521781|FG009|Overall Study|Other|1|||
162950728|NCT00150462|588521782|FG010|Overall Study|Other|1|||
162950729|NCT03107091|588521785|FG000|Overall Study|Physician Decision|1|||
162950730|NCT00912288|588521788|FG000|Overall Study|Death|0|||
162700578|NCT02254421|587615056|FG001|Overall Study|Withdrew Consent|1|||
162700579|NCT01154036|587615059|FG000|Phase I|Physician Decision|0|||
162700580|NCT01154036|587615060|FG001|Phase I|Physician Decision|1|||
162700581|NCT01154036|587615061|FG002|Phase I|Physician Decision|0|||
162700582|NCT01154036|587615062|FG003|Phase I|Physician Decision|0|||
162700583|NCT01154036|587615063|FG004|Phase I|Physician Decision|0|||
162700584|NCT01154036|587615064|FG005|Phase I|Physician Decision|0|||
162700585|NCT01154036|587615065|FG006|Phase I|Physician Decision|0|||
162700586|NCT01154036|587615066|FG007|Phase I|Physician Decision|0|||
162700587|NCT01154036|587615059|FG000|Phase I|Lost to Follow-up|0|||
162700588|NCT01154036|587615060|FG001|Phase I|Lost to Follow-up|3|||
162950731|NCT00912288|588521789|FG001|Overall Study|Death|1|||
162950732|NCT00912288|588521788|FG000|Overall Study|Adverse Event|1|||
162950733|NCT00912288|588521789|FG001|Overall Study|Adverse Event|1|||
162950734|NCT00912288|588521788|FG000|Overall Study|Lost to Follow-up|1|||
162950735|NCT00912288|588521789|FG001|Overall Study|Lost to Follow-up|0|||
162950736|NCT00912288|588521788|FG000|Overall Study|Protocol Violation|1|||
162950737|NCT00912288|588521789|FG001|Overall Study|Protocol Violation|0|||
162950738|NCT00912288|588521788|FG000|Overall Study|Withdrawal by Subject|3|||
162700589|NCT01154036|587615061|FG002|Phase I|Lost to Follow-up|6|||
162700590|NCT01154036|587615062|FG003|Phase I|Lost to Follow-up|0|||
162700591|NCT01154036|587615063|FG004|Phase I|Lost to Follow-up|0|||
162950739|NCT00912288|588521789|FG001|Overall Study|Withdrawal by Subject|3|||
162950740|NCT00912288|588521788|FG000|Overall Study|Study terminated by sponsor|34|||
162950741|NCT00912288|588521789|FG001|Overall Study|Study terminated by sponsor|35|||
162842334|NCT02161562|588131185|FG001|Overall Study|Withdrew due to being out of the country|0|||
162842335|NCT02161562|588131184|FG000|Overall Study|Participant moved out of province|1|||
162842336|NCT02161562|588131185|FG001|Overall Study|Participant moved out of province|0|||
162842337|NCT00197054|588131192|FG000|Overall Study|Withdrawal by Subject|9|||
162842338|NCT00197054|588131193|FG001|Overall Study|Withdrawal by Subject|3|||
162842339|NCT00197054|588131194|FG002|Overall Study|Withdrawal by Subject|3|||
162842340|NCT00197054|588131192|FG000|Overall Study|Moved from area|7|||
162842341|NCT00197054|588131193|FG001|Overall Study|Moved from area|14|||
162950742|NCT00912288|588521788|FG000|Overall Study|Other|1|||
162950743|NCT00912288|588521789|FG001|Overall Study|Other|0|||
162950744|NCT01449630|588521790|FG000|Period 1|Physician Decision|1|||
162950745|NCT01449630|588521791|FG001|Period 1|Physician Decision|0|||
162950746|NCT01449630|588521792|FG002|Period 1|Physician Decision|0|||
162950747|NCT01449630|588521793|FG003|Period 1|Physician Decision|1|||
162950748|NCT01449630|588521794|FG004|Period 1|Physician Decision|0|||
162950749|NCT01449630|588521795|FG005|Period 1|Physician Decision|0|||
162950750|NCT01449630|588521796|FG006|Period 1|Physician Decision|0|||
162950751|NCT01449630|588521797|FG007|Period 1|Physician Decision|0|||
162950752|NCT01449630|588521798|FG008|Period 1|Physician Decision|0|||
162950753|NCT01449630|588521790|FG000|Period 1|Sponsor Decision|0|||
162950754|NCT01449630|588521791|FG001|Period 1|Sponsor Decision|0|||
162950755|NCT01449630|588521792|FG002|Period 1|Sponsor Decision|0|||
162950756|NCT01449630|588521793|FG003|Period 1|Sponsor Decision|0|||
162950757|NCT01449630|588521794|FG004|Period 1|Sponsor Decision|0|||
162950758|NCT01449630|588521795|FG005|Period 1|Sponsor Decision|1|||
162950759|NCT01449630|588521796|FG006|Period 1|Sponsor Decision|0|||
162950760|NCT01449630|588521797|FG007|Period 1|Sponsor Decision|0|||
162950761|NCT01449630|588521798|FG008|Period 1|Sponsor Decision|0|||
162950762|NCT01449630|588521790|FG000|Period 2|Sponsor Decision|0|||
162950763|NCT01449630|588521791|FG001|Period 2|Sponsor Decision|0|||
162950764|NCT01449630|588521792|FG002|Period 2|Sponsor Decision|0|||
162950765|NCT01449630|588521793|FG003|Period 2|Sponsor Decision|0|||
162950766|NCT01449630|588521794|FG004|Period 2|Sponsor Decision|0|||
162950767|NCT01449630|588521795|FG005|Period 2|Sponsor Decision|0|||
162950768|NCT01449630|588521796|FG006|Period 2|Sponsor Decision|1|||
162842342|NCT00197054|588131194|FG002|Overall Study|Moved from area|9|||
162842343|NCT00197054|588131192|FG000|Overall Study|Lost to Follow-up|1|||
162842344|NCT00197054|588131193|FG001|Overall Study|Lost to Follow-up|4|||
162842345|NCT00197054|588131194|FG002|Overall Study|Lost to Follow-up|0|||
162842346|NCT01163786|588131195|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
162842347|NCT01163786|588131195|FG000|Treatment With Bortezomib|Adverse Event|2|||
162842348|NCT01163786|588131195|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
162842349|NCT03021642|588131202|FG000|Washout Period (21 Days)|Adverse Event|1|||
162842350|NCT03021642|588131203|FG001|Washout Period (21 Days)|Adverse Event|1|||
162842351|NCT01192347|588131204|FG000|Overall Study|Death|3|||
162842352|NCT01192347|588131204|FG000|Overall Study|Lost to Follow-up|3|||
162842353|NCT01192347|588131204|FG000|Overall Study|Withdrawal by Subject|1|||
162842354|NCT01192347|588131204|FG000|Overall Study|Adverse Event|1|||
162950769|NCT01449630|588521797|FG007|Period 2|Sponsor Decision|0|||
162950770|NCT01449630|588521798|FG008|Period 2|Sponsor Decision|0|||
162842355|NCT01192347|588131204|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
162842356|NCT01192347|588131204|FG000|Overall Study|Patient seen in different hospital|1|||
162950771|NCT00105196|588521799|FG000|Overall Study|Lack of Efficacy|2|||
162950772|NCT00105196|588521800|FG001|Overall Study|Lack of Efficacy|3|||
162950773|NCT00105196|588521799|FG000|Overall Study|Adverse Event|11|||
162842357|NCT01192347|588131204|FG000|Overall Study|Patient not visiting hospital regularly|1|||
162842358|NCT01192347|588131204|FG000|Overall Study|Patient did not show up for visits|1|||
162842359|NCT00090545|588131205|FG000|Overall Study|Disease progression on study|21|||
162950774|NCT00105196|588521800|FG001|Overall Study|Adverse Event|3|||
162842360|NCT00090545|588131206|FG001|Overall Study|Disease progression on study|17|||
162842361|NCT00090545|588131205|FG000|Overall Study|Refused further treatment|1|||
162842362|NCT00090545|588131206|FG001|Overall Study|Refused further treatment|4|||
162842363|NCT00090545|588131205|FG000|Overall Study|Death|0|||
162842364|NCT00090545|588131206|FG001|Overall Study|Death|1|||
162842365|NCT00090545|588131205|FG000|Overall Study|Adverse Event|0|||
162842366|NCT00090545|588131206|FG001|Overall Study|Adverse Event|2|||
162842367|NCT02474082|588131207|FG000|Overall Study|Adverse Event|2|||
162842368|NCT02474082|588131208|FG001|Overall Study|Adverse Event|32|||
162842369|NCT02474082|588131207|FG000|Overall Study|Withdrawal of informed consent|1|||
162842370|NCT02474082|588131208|FG001|Overall Study|Withdrawal of informed consent|11|||
162842371|NCT02474082|588131207|FG000|Overall Study|Lost to Follow-up|2|||
162842372|NCT02474082|588131208|FG001|Overall Study|Lost to Follow-up|2|||
162842373|NCT02474082|588131207|FG000|Overall Study|Dose tapering not achieved|0|||
162842374|NCT02474082|588131208|FG001|Overall Study|Dose tapering not achieved|4|||
162842375|NCT02474082|588131207|FG000|Overall Study|Participant/guardian decision|1|||
162842376|NCT02474082|588131208|FG001|Overall Study|Participant/guardian decision|2|||
162842377|NCT02474082|588131207|FG000|Overall Study|Non-compliance with study treatment|0|||
162842378|NCT02474082|588131208|FG001|Overall Study|Non-compliance with study treatment|2|||
162842379|NCT02474082|588131207|FG000|Overall Study|Protocol deviation|0|||
162842380|NCT02474082|588131208|FG001|Overall Study|Protocol deviation|1|||
162842381|NCT04317274|588131211|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
162842382|NCT04317274|588131212|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
162842383|NCT04317274|588131213|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
162842384|NCT04317274|588131214|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
162842385|NCT00430508|588131215|FG000|Overall Study|Adverse Event|2|||
162842386|NCT00430508|588131216|FG001|Overall Study|Adverse Event|3|||
162842387|NCT00430508|588131217|FG002|Overall Study|Adverse Event|5|||
162842388|NCT00430508|588131218|FG003|Overall Study|Adverse Event|3|||
162842389|NCT00430508|588131215|FG000|Overall Study|Withdrawal by Subject|0|||
162842390|NCT00430508|588131216|FG001|Overall Study|Withdrawal by Subject|1|||
162842391|NCT00430508|588131217|FG002|Overall Study|Withdrawal by Subject|1|||
162842392|NCT00430508|588131218|FG003|Overall Study|Withdrawal by Subject|1|||
162842393|NCT00430508|588131215|FG000|Overall Study|responder at visit 4|0|||
162842394|NCT00430508|588131216|FG001|Overall Study|responder at visit 4|0|||
162842395|NCT00430508|588131217|FG002|Overall Study|responder at visit 4|2|||
162842396|NCT00430508|588131218|FG003|Overall Study|responder at visit 4|0|||
162842397|NCT00430508|588131215|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
162842398|NCT00430508|588131216|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
162842399|NCT00430508|588131217|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
162842400|NCT00430508|588131218|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
162842401|NCT00430508|588131215|FG000|Overall Study|Other|1|||
162842402|NCT00430508|588131216|FG001|Overall Study|Other|1|||
162842403|NCT00430508|588131217|FG002|Overall Study|Other|3|||
162842404|NCT00430508|588131218|FG003|Overall Study|Other|0|||
162842405|NCT00288080|588131225|FG000|Overall Study|Withdrawal by Subject|1|||
162950775|NCT00105196|588521799|FG000|Overall Study|Withdrawal by Subject|6|||
162950776|NCT00105196|588521800|FG001|Overall Study|Withdrawal by Subject|6|||
162842406|NCT00288080|588131226|FG001|Overall Study|Withdrawal by Subject|3|||
162842407|NCT00288080|588131225|FG000|Overall Study|Protocol Violation|25|||
162842408|NCT00288080|588131226|FG001|Overall Study|Protocol Violation|20|||
162842409|NCT00379795|588131227|FG000|Overall Study|Death|31|||
162842410|NCT00379795|588131228|FG001|Overall Study|Death|8|||
162842411|NCT00379795|588131229|FG002|Overall Study|Death|6|||
162842412|NCT00379795|588131230|FG003|Overall Study|Death|4|||
162842413|NCT00379795|588131231|FG004|Overall Study|Death|7|||
162842414|NCT00379795|588131227|FG000|Overall Study|Adverse Event|17|||
162842415|NCT00379795|588131228|FG001|Overall Study|Adverse Event|3|||
162842416|NCT00379795|588131229|FG002|Overall Study|Adverse Event|3|||
162842417|NCT00379795|588131230|FG003|Overall Study|Adverse Event|1|||
162842418|NCT00379795|588131231|FG004|Overall Study|Adverse Event|4|||
162842419|NCT00379795|588131227|FG000|Overall Study|Lost to Follow-up|8|||
162842420|NCT00379795|588131228|FG001|Overall Study|Lost to Follow-up|1|||
162842421|NCT00379795|588131229|FG002|Overall Study|Lost to Follow-up|2|||
162842422|NCT00379795|588131230|FG003|Overall Study|Lost to Follow-up|1|||
162842423|NCT00379795|588131231|FG004|Overall Study|Lost to Follow-up|4|||
162700592|NCT01154036|587615064|FG005|Phase I|Lost to Follow-up|0|||
162700593|NCT01154036|587615065|FG006|Phase I|Lost to Follow-up|0|||
162700594|NCT01154036|587615066|FG007|Phase I|Lost to Follow-up|0|||
162700595|NCT01154036|587615059|FG000|Phase I|Protocol Violation|0|||
162700596|NCT01154036|587615060|FG001|Phase I|Protocol Violation|3|||
162700597|NCT01154036|587615061|FG002|Phase I|Protocol Violation|9|||
162700598|NCT01154036|587615062|FG003|Phase I|Protocol Violation|0|||
162700599|NCT01154036|587615063|FG004|Phase I|Protocol Violation|0|||
162700600|NCT01154036|587615064|FG005|Phase I|Protocol Violation|0|||
162700601|NCT01154036|587615065|FG006|Phase I|Protocol Violation|0|||
162700602|NCT01154036|587615066|FG007|Phase I|Protocol Violation|0|||
162700603|NCT01154036|587615059|FG000|Phase I|Withdrawal by Subject|2|||
162700604|NCT01154036|587615060|FG001|Phase I|Withdrawal by Subject|10|||
162700605|NCT01154036|587615061|FG002|Phase I|Withdrawal by Subject|29|||
162700606|NCT01154036|587615062|FG003|Phase I|Withdrawal by Subject|0|||
162700607|NCT01154036|587615063|FG004|Phase I|Withdrawal by Subject|0|||
162700608|NCT01154036|587615064|FG005|Phase I|Withdrawal by Subject|0|||
162700609|NCT01154036|587615065|FG006|Phase I|Withdrawal by Subject|0|||
162700610|NCT01154036|587615066|FG007|Phase I|Withdrawal by Subject|0|||
162700611|NCT01154036|587615059|FG000|Phase I|Adverse Event|1|||
162700612|NCT01154036|587615060|FG001|Phase I|Adverse Event|11|||
162700613|NCT01154036|587615061|FG002|Phase I|Adverse Event|12|||
162700614|NCT01154036|587615062|FG003|Phase I|Adverse Event|0|||
162700615|NCT01154036|587615063|FG004|Phase I|Adverse Event|0|||
162700616|NCT01154036|587615064|FG005|Phase I|Adverse Event|0|||
162700617|NCT01154036|587615065|FG006|Phase I|Adverse Event|0|||
162700618|NCT01154036|587615066|FG007|Phase I|Adverse Event|0|||
162700619|NCT01154036|587615059|FG000|Phase II|Adverse Event|0|||
162700620|NCT01154036|587615060|FG001|Phase II|Adverse Event|0|||
162700621|NCT01154036|587615061|FG002|Phase II|Adverse Event|0|||
162700622|NCT01154036|587615062|FG003|Phase II|Adverse Event|0|||
162700623|NCT01154036|587615063|FG004|Phase II|Adverse Event|1|||
162842424|NCT00379795|588131227|FG000|Overall Study|Physician Decision|25|||
162842425|NCT00379795|588131228|FG001|Overall Study|Physician Decision|0|||
162700624|NCT01154036|587615064|FG005|Phase II|Adverse Event|1|||
162700625|NCT01154036|587615065|FG006|Phase II|Adverse Event|1|||
162700626|NCT01154036|587615066|FG007|Phase II|Adverse Event|1|||
162700627|NCT01154036|587615059|FG000|Phase II|Physician Decision|0|||
162700628|NCT01154036|587615060|FG001|Phase II|Physician Decision|0|||
162700629|NCT01154036|587615061|FG002|Phase II|Physician Decision|0|||
162700630|NCT01154036|587615062|FG003|Phase II|Physician Decision|0|||
162700631|NCT01154036|587615063|FG004|Phase II|Physician Decision|0|||
162842426|NCT00379795|588131229|FG002|Overall Study|Physician Decision|2|||
162842427|NCT00379795|588131230|FG003|Overall Study|Physician Decision|2|||
162842428|NCT00379795|588131231|FG004|Overall Study|Physician Decision|2|||
162842429|NCT00379795|588131227|FG000|Overall Study|Withdrawal by Subject|94|||
162842430|NCT00379795|588131228|FG001|Overall Study|Withdrawal by Subject|11|||
162842431|NCT00379795|588131229|FG002|Overall Study|Withdrawal by Subject|19|||
162842432|NCT00379795|588131230|FG003|Overall Study|Withdrawal by Subject|7|||
162842433|NCT00379795|588131231|FG004|Overall Study|Withdrawal by Subject|14|||
162842434|NCT00379795|588131227|FG000|Overall Study|Subject non-compliance|7|||
162700632|NCT01154036|587615064|FG005|Phase II|Physician Decision|0|||
162700633|NCT01154036|587615065|FG006|Phase II|Physician Decision|1|||
162700634|NCT01154036|587615066|FG007|Phase II|Physician Decision|0|||
162700635|NCT01154036|587615059|FG000|Phase II|Lost to Follow-up|0|||
162700636|NCT01154036|587615060|FG001|Phase II|Lost to Follow-up|0|||
162700637|NCT01154036|587615061|FG002|Phase II|Lost to Follow-up|0|||
162700638|NCT01154036|587615062|FG003|Phase II|Lost to Follow-up|1|||
162842435|NCT00379795|588131228|FG001|Overall Study|Subject non-compliance|2|||
162842436|NCT00379795|588131229|FG002|Overall Study|Subject non-compliance|0|||
162842437|NCT00379795|588131230|FG003|Overall Study|Subject non-compliance|0|||
162700639|NCT01154036|587615063|FG004|Phase II|Lost to Follow-up|2|||
162700640|NCT01154036|587615064|FG005|Phase II|Lost to Follow-up|0|||
162700641|NCT01154036|587615065|FG006|Phase II|Lost to Follow-up|2|||
162700642|NCT01154036|587615066|FG007|Phase II|Lost to Follow-up|1|||
162700643|NCT01154036|587615059|FG000|Phase II|Protocol Violation|0|||
162700644|NCT01154036|587615060|FG001|Phase II|Protocol Violation|0|||
162700645|NCT01154036|587615061|FG002|Phase II|Protocol Violation|0|||
162700646|NCT01154036|587615062|FG003|Phase II|Protocol Violation|0|||
162842438|NCT00379795|588131231|FG004|Overall Study|Subject non-compliance|1|||
162842439|NCT00379795|588131227|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
162842440|NCT00379795|588131228|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
162842441|NCT00379795|588131229|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
162842442|NCT00379795|588131230|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
162842443|NCT00379795|588131231|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
162842444|NCT00379795|588131227|FG000|Overall Study|Subjects condition mandated intervention|34|||
162842445|NCT00379795|588131228|FG001|Overall Study|Subjects condition mandated intervention|9|||
162842446|NCT00379795|588131229|FG002|Overall Study|Subjects condition mandated intervention|7|||
162842447|NCT00379795|588131230|FG003|Overall Study|Subjects condition mandated intervention|5|||
162842448|NCT00379795|588131231|FG004|Overall Study|Subjects condition mandated intervention|7|||
162842449|NCT00379795|588131227|FG000|Overall Study|Sponsor's decision|257|||
162842450|NCT00379795|588131228|FG001|Overall Study|Sponsor's decision|17|||
162842451|NCT00379795|588131229|FG002|Overall Study|Sponsor's decision|54|||
162842452|NCT00379795|588131230|FG003|Overall Study|Sponsor's decision|47|||
162842453|NCT00379795|588131231|FG004|Overall Study|Sponsor's decision|10|||
162842454|NCT00087646|588131232|FG000|Overall Study|Adverse Event|37|||
162842455|NCT00087646|588131233|FG001|Overall Study|Adverse Event|6|||
162842456|NCT00087646|588131234|FG002|Overall Study|Adverse Event|18|||
162842457|NCT00087646|588131235|FG003|Overall Study|Adverse Event|20|||
162842458|NCT00087646|588131232|FG000|Overall Study|Death|0|||
162842459|NCT00087646|588131233|FG001|Overall Study|Death|1|||
162842460|NCT00087646|588131234|FG002|Overall Study|Death|0|||
162842461|NCT00087646|588131235|FG003|Overall Study|Death|0|||
162842462|NCT00087646|588131232|FG000|Overall Study|Withdrawal by Subject|6|||
162842463|NCT00087646|588131233|FG001|Overall Study|Withdrawal by Subject|1|||
162842464|NCT00087646|588131234|FG002|Overall Study|Withdrawal by Subject|2|||
162842465|NCT00087646|588131235|FG003|Overall Study|Withdrawal by Subject|2|||
162842466|NCT00087646|588131232|FG000|Overall Study|Insufficient therapeutic response|64|||
162842467|NCT00087646|588131233|FG001|Overall Study|Insufficient therapeutic response|24|||
162842468|NCT00087646|588131234|FG002|Overall Study|Insufficient therapeutic response|38|||
162842469|NCT00087646|588131235|FG003|Overall Study|Insufficient therapeutic response|51|||
162842470|NCT00087646|588131232|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
162842471|NCT00087646|588131233|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
162842472|NCT00087646|588131234|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
162842473|NCT00087646|588131235|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
162842474|NCT00087646|588131232|FG000|Overall Study|Failure to Return|5|||
162842475|NCT00087646|588131233|FG001|Overall Study|Failure to Return|2|||
162842476|NCT00087646|588131234|FG002|Overall Study|Failure to Return|2|||
162842477|NCT00087646|588131235|FG003|Overall Study|Failure to Return|3|||
162842478|NCT00087646|588131232|FG000|Overall Study|Administrative/Other|6|||
162842479|NCT00087646|588131233|FG001|Overall Study|Administrative/Other|1|||
162842480|NCT00087646|588131234|FG002|Overall Study|Administrative/Other|1|||
162842481|NCT00087646|588131235|FG003|Overall Study|Administrative/Other|2|||
162842482|NCT00087646|588131232|FG000|Overall Study|Other Protocol Violation|3|||
162842483|NCT00087646|588131233|FG001|Overall Study|Other Protocol Violation|1|||
162842484|NCT00087646|588131234|FG002|Overall Study|Other Protocol Violation|0|||
162842485|NCT00087646|588131235|FG003|Overall Study|Other Protocol Violation|0|||
162842486|NCT00087646|588131232|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162842487|NCT00087646|588131233|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
162842488|NCT00087646|588131234|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
162842489|NCT00087646|588131235|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
162700647|NCT01154036|587615063|FG004|Phase II|Protocol Violation|1|||
162700648|NCT01154036|587615064|FG005|Phase II|Protocol Violation|2|||
162700649|NCT01154036|587615065|FG006|Phase II|Protocol Violation|0|||
162700650|NCT01154036|587615066|FG007|Phase II|Protocol Violation|0|||
162700651|NCT01154036|587615059|FG000|Phase II|Withdrawal by Subject|0|||
162700652|NCT01154036|587615060|FG001|Phase II|Withdrawal by Subject|0|||
162700653|NCT01154036|587615061|FG002|Phase II|Withdrawal by Subject|0|||
162700654|NCT01154036|587615062|FG003|Phase II|Withdrawal by Subject|0|||
162700655|NCT01154036|587615063|FG004|Phase II|Withdrawal by Subject|4|||
162700656|NCT01154036|587615064|FG005|Phase II|Withdrawal by Subject|2|||
162700657|NCT01154036|587615065|FG006|Phase II|Withdrawal by Subject|5|||
162700658|NCT01154036|587615066|FG007|Phase II|Withdrawal by Subject|4|||
162700659|NCT00390455|587615067|FG000|Overall Study|Adverse Event|17|||
162700660|NCT00390455|587615068|FG001|Overall Study|Adverse Event|3|||
162700661|NCT00390455|587615067|FG000|Overall Study|Withdrawal by Subject|8|||
162700662|NCT00390455|587615068|FG001|Overall Study|Withdrawal by Subject|8|||
162700663|NCT00390455|587615067|FG000|Overall Study|Alternate Treatment|0|||
162700664|NCT00390455|587615068|FG001|Overall Study|Alternate Treatment|1|||
162700665|NCT00390455|587615067|FG000|Overall Study|Other Medical Reasons|7|||
162842490|NCT01687712|588131242|FG000|Cycle 1|Not Biochemically Pregnant|386|||
162842491|NCT01687712|588131243|FG001|Cycle 1|Not Biochemically Pregnant|348|||
162842492|NCT01687712|588131242|FG000|Cycle 1|Early Pregnancy Loss|43|||
162842493|NCT01687712|588131243|FG001|Cycle 1|Early Pregnancy Loss|60|||
162842494|NCT01687712|588131242|FG000|Cycle 1|Ectopic Pregnancy|5|||
162700666|NCT00390455|587615068|FG001|Overall Study|Other Medical Reasons|11|||
162700667|NCT01591460|587615071|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
162700668|NCT01591460|587615071|FG000|Overall Study|Futility Rule (Week 12)|7|||
162700669|NCT01591460|587615071|FG000|Overall Study|Futility Rule (Week 24)|3|||
162700670|NCT01591460|587615071|FG000|Overall Study|Rebound or Breakthrough|3|||
162700671|NCT01591460|587615071|FG000|Overall Study|Treatment Discontinued by Error|1|||
162700672|NCT01591460|587615071|FG000|Overall Study|Lost to Follow-up|1|||
162700673|NCT01591460|587615071|FG000|Overall Study|Noncompliance|1|||
162700674|NCT01591460|587615071|FG000|Overall Study|Participant Refusal|3|||
162700675|NCT01591460|587615071|FG000|Overall Study|Withdrawal by Subject|1|||
162700676|NCT01591460|587615071|FG000|Overall Study|Protocol Violation|1|||
162842495|NCT01687712|588131243|FG001|Cycle 1|Ectopic Pregnancy|5|||
162842496|NCT01687712|588131242|FG000|Cycle 1|Heterotropic Pregnancy|1|||
162842497|NCT01687712|588131243|FG001|Cycle 1|Heterotropic Pregnancy|0|||
162842498|NCT01687712|588131242|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
162842499|NCT01687712|588131243|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
162842500|NCT01687712|588131242|FG000|Cycle 1|Abortion|3|||
162842501|NCT01687712|588131243|FG001|Cycle 1|Abortion|0|||
162842502|NCT01687712|588131242|FG000|Cycle 1|Intrauterine Fetal Death|0|||
162842503|NCT01687712|588131243|FG001|Cycle 1|Intrauterine Fetal Death|1|||
162950777|NCT00105196|588521799|FG000|Overall Study|Lost to Follow-up|3|||
162950778|NCT00105196|588521800|FG001|Overall Study|Lost to Follow-up|2|||
162950779|NCT00105196|588521799|FG000|Overall Study|Poor/noncompliance|3|||
162842504|NCT01687712|588131242|FG000|Cycle 1|Lost to Follow-up|1|||
162842505|NCT01687712|588131243|FG001|Cycle 1|Lost to Follow-up|1|||
162842506|NCT01687712|588131242|FG000|Cycle 2|Not Biochemically Pregnant|74|||
162842507|NCT01687712|588131243|FG001|Cycle 2|Not Biochemically Pregnant|77|||
162842508|NCT01687712|588131242|FG000|Cycle 2|Early Pregnancy Loss|18|||
162842509|NCT01687712|588131243|FG001|Cycle 2|Early Pregnancy Loss|16|||
162842510|NCT01687712|588131242|FG000|Cycle 2|Ectopic Pregnancy|0|||
162842511|NCT01687712|588131243|FG001|Cycle 2|Ectopic Pregnancy|1|||
162842512|NCT01687712|588131242|FG000|Cycle 2|Still Birth|1|||
162842513|NCT01687712|588131243|FG001|Cycle 2|Still Birth|0|||
162842514|NCT01687712|588131242|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
162842515|NCT01687712|588131243|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
162842516|NCT01687712|588131242|FG000|Cycle 3|Not Biochemically Pregnant|21|||
162842517|NCT01687712|588131243|FG001|Cycle 3|Not Biochemically Pregnant|22|||
162842518|NCT01687712|588131242|FG000|Cycle 3|Early Pregnancy Loss|1|||
162842519|NCT01687712|588131243|FG001|Cycle 3|Early Pregnancy Loss|2|||
162842520|NCT01687712|588131242|FG000|Cycle 3|Ectopic Pregnancy|1|||
162700677|NCT01686932|587615074|FG000|Period 1|Adverse Event|1|||
162700678|NCT01686932|587615075|FG001|Period 1|Adverse Event|1|||
162700679|NCT04827134|587615078|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162700680|NCT04827134|587615079|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162700681|NCT04827134|587615080|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
162950780|NCT00105196|588521800|FG001|Overall Study|Poor/noncompliance|4|||
162700682|NCT04827134|587615081|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162842521|NCT01687712|588131243|FG001|Cycle 3|Ectopic Pregnancy|0|||
162950781|NCT00105196|588521799|FG000|Overall Study|Protocol Violation|5|||
162950782|NCT00105196|588521800|FG001|Overall Study|Protocol Violation|2|||
162950783|NCT00105196|588521799|FG000|Overall Study|pending surgery|0|||
162950784|NCT00105196|588521800|FG001|Overall Study|pending surgery|1|||
162950785|NCT00105196|588521799|FG000|Overall Study|marijuana use|0|||
162950786|NCT00105196|588521800|FG001|Overall Study|marijuana use|1|||
162950787|NCT00105196|588521799|FG000|Overall Study|Subject became unblinded|0|||
162950788|NCT00105196|588521800|FG001|Overall Study|Subject became unblinded|1|||
162950789|NCT03340727|588521801|FG000|Overall Study|Death|1|||
162950790|NCT03340727|588521802|FG001|Overall Study|Death|0|||
162950791|NCT03340727|588521801|FG000|Overall Study|Lost to Follow-up|31|||
162950792|NCT03340727|588521802|FG001|Overall Study|Lost to Follow-up|35|||
162950793|NCT03340727|588521801|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
162950794|NCT03340727|588521802|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
162950795|NCT03340727|588521801|FG000|Overall Study|Transferred to another facility|10|||
162950796|NCT03340727|588521802|FG001|Overall Study|Transferred to another facility|7|||
162950797|NCT03340727|588521801|FG000|Overall Study|Withdrawal by Subject|28|||
162950798|NCT03340727|588521802|FG001|Overall Study|Withdrawal by Subject|17|||
162950799|NCT00874237|588521803|FG000|Overall Study|Physician Decision|0|||
162950800|NCT00874237|588521804|FG001|Overall Study|Physician Decision|1|||
162950801|NCT00874237|588521805|FG002|Overall Study|Physician Decision|0|||
162950802|NCT00874237|588521806|FG003|Overall Study|Physician Decision|0|||
162950803|NCT00874237|588521807|FG004|Overall Study|Physician Decision|0|||
162950804|NCT00874237|588521808|FG005|Overall Study|Physician Decision|0|||
162950805|NCT00874237|588521803|FG000|Overall Study|Withdrawal by Subject|0|||
162950806|NCT00874237|588521804|FG001|Overall Study|Withdrawal by Subject|0|||
162950807|NCT00874237|588521805|FG002|Overall Study|Withdrawal by Subject|1|||
162950808|NCT00874237|588521806|FG003|Overall Study|Withdrawal by Subject|0|||
162950809|NCT00874237|588521807|FG004|Overall Study|Withdrawal by Subject|0|||
162950810|NCT00874237|588521808|FG005|Overall Study|Withdrawal by Subject|0|||
162950811|NCT00522457|588521813|FG000|Overall Study|Due to disease progression|16|||
162950812|NCT00522457|588521813|FG000|Overall Study|Adverse Event|2|||
162950813|NCT03447262|588523563|FG000|Overall Study|Adverse Event|7|||
162950814|NCT03447262|588523563|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
162950815|NCT03447262|588523563|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
162950816|NCT03447262|588523563|FG000|Overall Study|Death|2|||
162950817|NCT03447262|588523563|FG000|Overall Study|Study Termination by Sponsor|455|||
162950818|NCT03447262|588523563|FG000|Overall Study|Other|4|||
162950819|NCT03478397|588523566|FG000|Overall Study|Refused to participate|31|||
162950820|NCT03478397|588523567|FG001|Overall Study|Refused to participate|7|||
162950821|NCT05327491|588523568|FG000|Periods 1 & 2|Miscellaneous|0|||
162950822|NCT05327491|588523569|FG001|Periods 1 & 2|Miscellaneous|1|||
162950823|NCT05327491|588523570|FG002|Periods 1 & 2|Miscellaneous|0|||
162950824|NCT05327491|588523571|FG003|Periods 1 & 2|Miscellaneous|0|||
162950825|NCT05327491|588523568|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
162950826|NCT05327491|588523569|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
162950827|NCT05327491|588523570|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
162950828|NCT05327491|588523571|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
162950829|NCT00096447|588523572|FG000|Overall Study|Never treated|1|||
162950830|NCT00569374|588523575|FG000|Overall Study|Withdrawal by Subject|4|||
162950831|NCT01126736|588523576|FG000|Overall Study|Death|2|||
162950832|NCT01126736|588523577|FG001|Overall Study|Death|2|||
162950833|NCT01126736|588523578|FG002|Overall Study|Death|1|||
162950834|NCT01126736|588523579|FG003|Overall Study|Death|19|||
162950835|NCT01126736|588523580|FG004|Overall Study|Death|19|||
162700683|NCT00924469|587615090|FG000|Overall Study|Adverse Event|2|||
162700684|NCT00924469|587615091|FG001|Overall Study|Adverse Event|0|||
162950836|NCT01126736|588523576|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
162950837|NCT01126736|588523577|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
162950838|NCT01126736|588523578|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
162950839|NCT01126736|588523579|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
162950840|NCT01126736|588523580|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
162950841|NCT01126736|588523576|FG000|Overall Study|Lost to Follow-up|0|||
162950842|NCT01126736|588523577|FG001|Overall Study|Lost to Follow-up|0|||
162950843|NCT01126736|588523578|FG002|Overall Study|Lost to Follow-up|0|||
162950844|NCT01126736|588523579|FG003|Overall Study|Lost to Follow-up|1|||
162950845|NCT01126736|588523580|FG004|Overall Study|Lost to Follow-up|1|||
162950846|NCT01126736|588523576|FG000|Overall Study|Administrative reasons|0|||
162950847|NCT01126736|588523577|FG001|Overall Study|Administrative reasons|0|||
162950848|NCT01126736|588523578|FG002|Overall Study|Administrative reasons|0|||
162950849|NCT01126736|588523579|FG003|Overall Study|Administrative reasons|0|||
162950850|NCT01126736|588523580|FG004|Overall Study|Administrative reasons|1|||
162950851|NCT01126736|588523576|FG000|Overall Study|Progressive disease|0|||
162950852|NCT01126736|588523577|FG001|Overall Study|Progressive disease|0|||
162950853|NCT01126736|588523578|FG002|Overall Study|Progressive disease|0|||
162950854|NCT01126736|588523579|FG003|Overall Study|Progressive disease|2|||
162950855|NCT01126736|588523580|FG004|Overall Study|Progressive disease|1|||
162700685|NCT00924469|587615090|FG000|Overall Study|Withdrawal by Subject|0|||
162700686|NCT00924469|587615091|FG001|Overall Study|Withdrawal by Subject|1|||
162700687|NCT00924469|587615090|FG000|Overall Study|Lost to Follow-up|0|||
162700688|NCT00924469|587615091|FG001|Overall Study|Lost to Follow-up|1|||
162700689|NCT01651936|587615093|FG000|Base Study|Adverse Event|3|||
162700690|NCT01651936|587615094|FG001|Base Study|Adverse Event|0|||
162700691|NCT01651936|587615095|FG002|Base Study|Adverse Event|0|||
162700692|NCT01651936|587615093|FG000|Base Study|Withdrawal by Subject|1|||
162700693|NCT01651936|587615094|FG001|Base Study|Withdrawal by Subject|1|||
162700694|NCT01651936|587615095|FG002|Base Study|Withdrawal by Subject|0|||
162700695|NCT01651936|587615093|FG000|Base Study|Early Escape|2|||
162700696|NCT01651936|587615094|FG001|Base Study|Early Escape|8|||
162700697|NCT01651936|587615095|FG002|Base Study|Early Escape|0|||
162700698|NCT01651936|587615093|FG000|Base Study|Study terminated by sponsor|21|||
162700699|NCT01651936|587615094|FG001|Base Study|Study terminated by sponsor|16|||
162700700|NCT01651936|587615095|FG002|Base Study|Study terminated by sponsor|0|||
162700701|NCT01651936|587615093|FG000|Extension Study|Lack of Efficacy|0|||
162700702|NCT01651936|587615094|FG001|Extension Study|Lack of Efficacy|0|||
162700703|NCT01651936|587615095|FG002|Extension Study|Lack of Efficacy|1|||
162700704|NCT01651936|587615093|FG000|Extension Study|Study terminated by sponsor|0|||
162700705|NCT01651936|587615094|FG001|Extension Study|Study terminated by sponsor|0|||
162700706|NCT01651936|587615095|FG002|Extension Study|Study terminated by sponsor|13|||
162700707|NCT03044353|587615096|FG000|Overall Study|Adverse Event|0|||
162700708|NCT03044353|587615097|FG001|Overall Study|Adverse Event|1|||
162700709|NCT03044353|587615098|FG002|Overall Study|Adverse Event|0|||
162700710|NCT03358329|587615099|FG000|Overall Study|Lost to Follow-up|2|||
162700711|NCT03358329|587615099|FG000|Overall Study|Withdrawal by Subject|2|||
162700712|NCT03875911|587615102|FG000|Overall Study|Lost to Follow-up|3|||
162700713|NCT03875911|587615103|FG001|Overall Study|Lost to Follow-up|6|||
162700714|NCT03875911|587615104|FG002|Overall Study|Lost to Follow-up|2|||
162700715|NCT03875911|587615102|FG000|Overall Study|Surgery cancelled|1|||
162700716|NCT03875911|587615103|FG001|Overall Study|Surgery cancelled|0|||
162700717|NCT03875911|587615104|FG002|Overall Study|Surgery cancelled|1|||
162700718|NCT03875911|587615102|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
162700719|NCT03875911|587615103|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
162700720|NCT03875911|587615104|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
162700721|NCT05284019|587615105|FG000|Overall Study|Study terminated|2|||
162700722|NCT05284019|587615106|FG001|Overall Study|Study terminated|2|||
162700723|NCT05284019|587615107|FG002|Overall Study|Study terminated|2|||
162700724|NCT05284019|587615108|FG003|Overall Study|Study terminated|5|||
162700725|NCT05284019|587615109|FG004|Overall Study|Study terminated|15|||
162700726|NCT05284019|587615105|FG000|Overall Study|Withdrawal by Subject|0|||
162700727|NCT05284019|587615106|FG001|Overall Study|Withdrawal by Subject|0|||
162700728|NCT05284019|587615107|FG002|Overall Study|Withdrawal by Subject|0|||
162700729|NCT05284019|587615108|FG003|Overall Study|Withdrawal by Subject|1|||
162700730|NCT05284019|587615109|FG004|Overall Study|Withdrawal by Subject|1|||
162700731|NCT05284019|587615105|FG000|Overall Study|Lost to Follow-up|1|||
162950856|NCT01126736|588523576|FG000|Overall Study|Withdrawal by Subject|0|||
162950857|NCT01126736|588523577|FG001|Overall Study|Withdrawal by Subject|0|||
162950858|NCT01126736|588523578|FG002|Overall Study|Withdrawal by Subject|0|||
162950859|NCT01126736|588523579|FG003|Overall Study|Withdrawal by Subject|1|||
162700732|NCT05284019|587615106|FG001|Overall Study|Lost to Follow-up|0|||
162700733|NCT05284019|587615107|FG002|Overall Study|Lost to Follow-up|0|||
162950860|NCT01126736|588523580|FG004|Overall Study|Withdrawal by Subject|1|||
162950861|NCT01126736|588523576|FG000|Overall Study|Other|2|||
162700734|NCT05284019|587615108|FG003|Overall Study|Lost to Follow-up|2|||
162700735|NCT05284019|587615109|FG004|Overall Study|Lost to Follow-up|1|||
162700736|NCT01990300|587615110|FG000|Overall Study|Case Report Forms Uncollected|89|||
162842522|NCT01687712|588131242|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
162950862|NCT01126736|588523577|FG001|Overall Study|Other|4|||
162950863|NCT01126736|588523578|FG002|Overall Study|Other|4|||
162950864|NCT01126736|588523579|FG003|Overall Study|Other|16|||
162950865|NCT01126736|588523580|FG004|Overall Study|Other|15|||
162950866|NCT02202850|588523582|FG000|Overall Study|Other|2|||
162950867|NCT02202850|588523583|FG001|Overall Study|Other|2|||
162950868|NCT02202850|588523582|FG000|Overall Study|Enbrel treatment discontinued|15|||
162950869|NCT02202850|588523583|FG001|Overall Study|Enbrel treatment discontinued|3|||
162950870|NCT02202850|588523582|FG000|Overall Study|Lost to Follow-up|7|||
162950871|NCT02202850|588523583|FG001|Overall Study|Lost to Follow-up|1|||
162950872|NCT01873586|588523584|FG000|Overall Study|Lost to Follow-up|3|||
162950873|NCT00615069|588523585|FG000|Overall Study|Death|10|||
162950874|NCT00615069|588523585|FG000|Overall Study|Physician Decision|2|||
162950875|NCT00615069|588523585|FG000|Overall Study|Withdrawal by Subject|4|||
162950876|NCT00669942|588523586|FG000|Parts 2 and 3|Adverse Event|0|||
162950877|NCT00669942|588523587|FG001|Parts 2 and 3|Adverse Event|0|||
162950878|NCT00669942|588523588|FG002|Parts 2 and 3|Adverse Event|0|||
162950879|NCT00669942|588523589|FG003|Parts 2 and 3|Adverse Event|0|||
162950880|NCT00669942|588523590|FG004|Parts 2 and 3|Adverse Event|0|||
162950881|NCT00669942|588523591|FG005|Parts 2 and 3|Adverse Event|0|||
162950882|NCT00669942|588523592|FG006|Parts 2 and 3|Adverse Event|0|||
162950883|NCT00669942|588523593|FG007|Parts 2 and 3|Adverse Event|2|||
162950884|NCT00669942|588523594|FG008|Parts 2 and 3|Adverse Event|1|||
162950885|NCT00669942|588523595|FG009|Parts 2 and 3|Adverse Event|0|||
162950886|NCT00669942|588523596|FG010|Parts 2 and 3|Adverse Event|0|||
162950887|NCT00669942|588523597|FG011|Parts 2 and 3|Adverse Event|0|||
162950888|NCT00669942|588523586|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
162950889|NCT00669942|588523587|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
162950890|NCT00669942|588523588|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
162950891|NCT00669942|588523589|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
162950892|NCT00669942|588523590|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
162950893|NCT00669942|588523591|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
162700737|NCT01990300|587615110|FG000|Overall Study|Protocol Deviation|53|||
162700738|NCT01231503|587615111|FG000|Overall Study|Adverse Event|0|||
162700739|NCT01231503|587615112|FG001|Overall Study|Adverse Event|0|||
162700740|NCT01231503|587615113|FG002|Overall Study|Adverse Event|0|||
162950894|NCT00669942|588523592|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
162950895|NCT00669942|588523593|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
162950896|NCT00669942|588523594|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
162950897|NCT00669942|588523595|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
162950898|NCT00669942|588523596|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
162950899|NCT00669942|588523597|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
162950900|NCT00669942|588523586|FG000|Parts 2 and 3|Protocol Violation|0|||
162950901|NCT00669942|588523587|FG001|Parts 2 and 3|Protocol Violation|0|||
162950902|NCT00669942|588523588|FG002|Parts 2 and 3|Protocol Violation|0|||
162950903|NCT00669942|588523589|FG003|Parts 2 and 3|Protocol Violation|0|||
162950904|NCT00669942|588523590|FG004|Parts 2 and 3|Protocol Violation|0|||
162950905|NCT00669942|588523591|FG005|Parts 2 and 3|Protocol Violation|1|||
162950906|NCT00669942|588523592|FG006|Parts 2 and 3|Protocol Violation|0|||
162950907|NCT00669942|588523593|FG007|Parts 2 and 3|Protocol Violation|0|||
162950908|NCT00669942|588523594|FG008|Parts 2 and 3|Protocol Violation|0|||
162950909|NCT00669942|588523595|FG009|Parts 2 and 3|Protocol Violation|0|||
162950910|NCT00669942|588523596|FG010|Parts 2 and 3|Protocol Violation|0|||
162950911|NCT00669942|588523597|FG011|Parts 2 and 3|Protocol Violation|0|||
162950912|NCT00282048|588523598|FG000|Overall Study|Lack of Efficacy|30|||
162700741|NCT01231503|587615114|FG003|Overall Study|Adverse Event|0|||
162700742|NCT01231503|587615115|FG004|Overall Study|Adverse Event|0|||
162950913|NCT00282048|588523598|FG000|Overall Study|Adverse Event|22|||
162950914|NCT00282048|588523598|FG000|Overall Study|Withdrawal by Subject|1|||
162950915|NCT00282048|588523598|FG000|Overall Study|Other|8|||
162950916|NCT00282048|588523598|FG000|Overall Study|Ongoing|1|||
162950917|NCT00259012|588523600|FG000|Overall Study|Adverse Event|0|||
162950918|NCT00259012|588523601|FG001|Overall Study|Adverse Event|1|||
162950919|NCT00259012|588523600|FG000|Overall Study|Withdrawal by Subject|1|||
162700743|NCT01231503|587615116|FG005|Overall Study|Adverse Event|1|||
162700744|NCT01231503|587615117|FG006|Overall Study|Adverse Event|0|||
162700745|NCT01231503|587615118|FG007|Overall Study|Adverse Event|0|||
162700746|NCT01231503|587615111|FG000|Overall Study|Adverse event, serious fatal|0|||
162700747|NCT01231503|587615112|FG001|Overall Study|Adverse event, serious fatal|0|||
162700748|NCT01231503|587615113|FG002|Overall Study|Adverse event, serious fatal|1|||
162700749|NCT01231503|587615114|FG003|Overall Study|Adverse event, serious fatal|1|||
162700750|NCT01231503|587615115|FG004|Overall Study|Adverse event, serious fatal|0|||
162700751|NCT01231503|587615116|FG005|Overall Study|Adverse event, serious fatal|1|||
162700752|NCT01231503|587615117|FG006|Overall Study|Adverse event, serious fatal|0|||
162700753|NCT01231503|587615118|FG007|Overall Study|Adverse event, serious fatal|0|||
162700754|NCT01231503|587615111|FG000|Overall Study|Withdrawal by Subject|6|||
162700755|NCT01231503|587615112|FG001|Overall Study|Withdrawal by Subject|3|||
162700756|NCT01231503|587615113|FG002|Overall Study|Withdrawal by Subject|3|||
162700757|NCT01231503|587615114|FG003|Overall Study|Withdrawal by Subject|1|||
162700758|NCT01231503|587615115|FG004|Overall Study|Withdrawal by Subject|3|||
162700759|NCT01231503|587615116|FG005|Overall Study|Withdrawal by Subject|5|||
162700760|NCT01231503|587615117|FG006|Overall Study|Withdrawal by Subject|1|||
162700761|NCT01231503|587615118|FG007|Overall Study|Withdrawal by Subject|2|||
162700762|NCT01231503|587615111|FG000|Overall Study|Lost to Follow-up|8|||
162700763|NCT01231503|587615112|FG001|Overall Study|Lost to Follow-up|10|||
162700764|NCT01231503|587615113|FG002|Overall Study|Lost to Follow-up|8|||
162700765|NCT01231503|587615114|FG003|Overall Study|Lost to Follow-up|5|||
162700766|NCT01231503|587615115|FG004|Overall Study|Lost to Follow-up|7|||
162700767|NCT01231503|587615116|FG005|Overall Study|Lost to Follow-up|9|||
162700768|NCT01231503|587615117|FG006|Overall Study|Lost to Follow-up|6|||
162700769|NCT01231503|587615118|FG007|Overall Study|Lost to Follow-up|6|||
162700770|NCT01231503|587615111|FG000|Overall Study|Protocol Violation|0|||
162700771|NCT01231503|587615112|FG001|Overall Study|Protocol Violation|0|||
162700772|NCT01231503|587615113|FG002|Overall Study|Protocol Violation|0|||
162700773|NCT01231503|587615114|FG003|Overall Study|Protocol Violation|1|||
162700774|NCT01231503|587615115|FG004|Overall Study|Protocol Violation|0|||
162700775|NCT01231503|587615116|FG005|Overall Study|Protocol Violation|0|||
162700776|NCT01231503|587615117|FG006|Overall Study|Protocol Violation|0|||
162700777|NCT01231503|587615118|FG007|Overall Study|Protocol Violation|0|||
162700778|NCT02293837|587615119|FG000|Overall Study|Lost to Follow-up|0|||
162700779|NCT02293837|587615120|FG001|Overall Study|Lost to Follow-up|2|||
162700780|NCT02293837|587615121|FG002|Overall Study|Lost to Follow-up|1|||
162700781|NCT02293837|587615122|FG003|Overall Study|Lost to Follow-up|0|||
162700782|NCT02293837|587615119|FG000|Overall Study|Withdrawal by Subject|2|||
162700783|NCT02293837|587615120|FG001|Overall Study|Withdrawal by Subject|1|||
162700784|NCT02293837|587615121|FG002|Overall Study|Withdrawal by Subject|2|||
162700785|NCT02293837|587615122|FG003|Overall Study|Withdrawal by Subject|1|||
162700786|NCT02293837|587615119|FG000|Overall Study|COVID-19 Related|1|||
162700787|NCT02293837|587615120|FG001|Overall Study|COVID-19 Related|1|||
162700788|NCT02293837|587615121|FG002|Overall Study|COVID-19 Related|0|||
162700789|NCT02293837|587615122|FG003|Overall Study|COVID-19 Related|0|||
162700790|NCT02293837|587615119|FG000|Overall Study|Participant ill and could not be infused|0|||
162700791|NCT02293837|587615120|FG001|Overall Study|Participant ill and could not be infused|0|||
162700792|NCT02293837|587615121|FG002|Overall Study|Participant ill and could not be infused|1|||
162700793|NCT02293837|587615122|FG003|Overall Study|Participant ill and could not be infused|0|||
162700794|NCT01076088|587615123|FG000|Overall Study|Adverse Event|1|||
162700795|NCT01076088|587615124|FG001|Overall Study|Adverse Event|6|||
162700796|NCT01076088|587615125|FG002|Overall Study|Adverse Event|3|||
162700797|NCT01076088|587615126|FG003|Overall Study|Adverse Event|2|||
162700798|NCT01076088|587615127|FG004|Overall Study|Adverse Event|3|||
162700799|NCT01076088|587615128|FG005|Overall Study|Adverse Event|3|||
162700800|NCT01076088|587615123|FG000|Overall Study|Lost to Follow-up|1|||
162700801|NCT01076088|587615124|FG001|Overall Study|Lost to Follow-up|1|||
162700802|NCT01076088|587615125|FG002|Overall Study|Lost to Follow-up|0|||
162700803|NCT01076088|587615126|FG003|Overall Study|Lost to Follow-up|1|||
162700804|NCT01076088|587615127|FG004|Overall Study|Lost to Follow-up|1|||
162700805|NCT01076088|587615128|FG005|Overall Study|Lost to Follow-up|2|||
162700806|NCT01076088|587615123|FG000|Overall Study|Non-compliance with study drug|0|||
162700807|NCT01076088|587615124|FG001|Overall Study|Non-compliance with study drug|0|||
162700808|NCT01076088|587615125|FG002|Overall Study|Non-compliance with study drug|0|||
162700809|NCT01076088|587615126|FG003|Overall Study|Non-compliance with study drug|1|||
162700810|NCT01076088|587615127|FG004|Overall Study|Non-compliance with study drug|0|||
162700811|NCT01076088|587615128|FG005|Overall Study|Non-compliance with study drug|0|||
162700812|NCT01076088|587615123|FG000|Overall Study|Physician Decision|1|||
162700813|NCT01076088|587615124|FG001|Overall Study|Physician Decision|3|||
162700814|NCT01076088|587615125|FG002|Overall Study|Physician Decision|0|||
162700815|NCT01076088|587615126|FG003|Overall Study|Physician Decision|1|||
162700816|NCT01076088|587615127|FG004|Overall Study|Physician Decision|1|||
162700817|NCT01076088|587615128|FG005|Overall Study|Physician Decision|0|||
162700818|NCT01076088|587615123|FG000|Overall Study|Withdrawal by Subject|8|||
162700819|NCT01076088|587615124|FG001|Overall Study|Withdrawal by Subject|8|||
162700820|NCT01076088|587615125|FG002|Overall Study|Withdrawal by Subject|14|||
162700821|NCT01076088|587615126|FG003|Overall Study|Withdrawal by Subject|10|||
162700822|NCT01076088|587615127|FG004|Overall Study|Withdrawal by Subject|11|||
162700823|NCT01076088|587615128|FG005|Overall Study|Withdrawal by Subject|17|||
162700824|NCT01076088|587615123|FG000|Overall Study|Other protocol specified criteria|0|||
162700825|NCT01076088|587615124|FG001|Overall Study|Other protocol specified criteria|0|||
162700826|NCT01076088|587615125|FG002|Overall Study|Other protocol specified criteria|0|||
162700827|NCT01076088|587615126|FG003|Overall Study|Other protocol specified criteria|0|||
162700828|NCT01076088|587615127|FG004|Overall Study|Other protocol specified criteria|0|||
162700829|NCT01076088|587615128|FG005|Overall Study|Other protocol specified criteria|1|||
162700830|NCT03285113|587615129|FG000|Overall Study|Unable to implant leads|2|||
162700831|NCT03053492|587615130|FG000|Overall Study|Adverse Event|1|||
162700832|NCT03053492|587615131|FG001|Overall Study|Adverse Event|1|||
162700833|NCT03053492|587615130|FG000|Overall Study|Withdrawal by Subject|7|||
162700834|NCT03053492|587615131|FG001|Overall Study|Withdrawal by Subject|5|||
162700835|NCT01448044|587615136|FG000|Treatment Period|Adverse Event|4|||
162700836|NCT01448044|587615137|FG001|Treatment Period|Adverse Event|3|||
162700837|NCT01448044|587615136|FG000|Treatment Period|Lack of Efficacy|5|||
162700838|NCT01448044|587615137|FG001|Treatment Period|Lack of Efficacy|12|||
162700839|NCT01448044|587615136|FG000|Treatment Period|Subject requested discontinue study drug|1|||
162700840|NCT01448044|587615137|FG001|Treatment Period|Subject requested discontinue study drug|0|||
162700841|NCT01448044|587615136|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
162700842|NCT01448044|587615137|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
162700843|NCT01448044|587615136|FG000|Treatment Period|Participant does not meet study criteria|1|||
162700844|NCT01448044|587615137|FG001|Treatment Period|Participant does not meet study criteria|0|||
162700845|NCT01448044|587615136|FG000|Treatment Period|Lost to Follow-up|2|||
162700846|NCT01448044|587615137|FG001|Treatment Period|Lost to Follow-up|1|||
162700847|NCT01448044|587615136|FG000|Treatment Period|Other reason|2|||
162700848|NCT01448044|587615137|FG001|Treatment Period|Other reason|0|||
162700849|NCT01448044|587615136|FG000|Follow Up Period|Withdrawal by Subject|1|||
162700850|NCT01448044|587615137|FG001|Follow Up Period|Withdrawal by Subject|1|||
162700851|NCT01448044|587615136|FG000|Follow Up Period|Lost to Follow-up|6|||
162700852|NCT01448044|587615137|FG001|Follow Up Period|Lost to Follow-up|2|||
162700853|NCT01448044|587615136|FG000|Follow Up Period|Other|5|||
162700854|NCT01448044|587615137|FG001|Follow Up Period|Other|11|||
162700855|NCT01010217|587615140|FG000|Overall Study|Lost to Follow-up|4|||
162700856|NCT01010217|587615141|FG001|Overall Study|Lost to Follow-up|5|||
162700857|NCT01010217|587615142|FG002|Overall Study|Lost to Follow-up|1|||
162700858|NCT01010217|587615143|FG003|Overall Study|Lost to Follow-up|0|||
162700859|NCT01010217|587615144|FG004|Overall Study|Lost to Follow-up|0|||
162700860|NCT01010217|587615140|FG000|Overall Study|Withdrawal by Subject|1|||
162700861|NCT01010217|587615141|FG001|Overall Study|Withdrawal by Subject|0|||
162700862|NCT01010217|587615142|FG002|Overall Study|Withdrawal by Subject|0|||
162700863|NCT01010217|587615143|FG003|Overall Study|Withdrawal by Subject|0|||
162700864|NCT01010217|587615144|FG004|Overall Study|Withdrawal by Subject|0|||
162700865|NCT01010217|587615140|FG000|Overall Study|Physician Decision|0|||
162700866|NCT01010217|587615141|FG001|Overall Study|Physician Decision|0|||
162700867|NCT01010217|587615142|FG002|Overall Study|Physician Decision|0|||
162700868|NCT01010217|587615143|FG003|Overall Study|Physician Decision|6|||
162700869|NCT01010217|587615144|FG004|Overall Study|Physician Decision|3|||
162700870|NCT02061761|587615145|FG000|Overall Study|Disease progression|2|||
162700871|NCT02061761|587615146|FG001|Overall Study|Disease progression|8|||
162700872|NCT02061761|587615147|FG002|Overall Study|Disease progression|4|||
162700873|NCT02061761|587615148|FG003|Overall Study|Disease progression|5|||
162700874|NCT02061761|587615149|FG004|Overall Study|Disease progression|9|||
162950920|NCT00259012|588523601|FG001|Overall Study|Withdrawal by Subject|0|||
162950921|NCT00259012|588523600|FG000|Overall Study|Physician Decision|0|||
162950922|NCT00259012|588523601|FG001|Overall Study|Physician Decision|1|||
162950923|NCT00259012|588523600|FG000|Overall Study|Lost to Follow-up|0|||
162950924|NCT00259012|588523601|FG001|Overall Study|Lost to Follow-up|1|||
162950925|NCT00259012|588523600|FG000|Overall Study|Protocol Violation|1|||
162950926|NCT00259012|588523601|FG001|Overall Study|Protocol Violation|1|||
162950927|NCT03522675|588523602|FG000|Overall Study|Screen fail|1|||
162950928|NCT03522675|588523602|FG000|Overall Study|Non-reactive to histamine|1|||
162950929|NCT00707161|588523603|FG000|Overall Study|Physician Decision|6|||
162950930|NCT02674477|588523604|FG000|Overall Study|Protocol Violation|8|||
162950931|NCT02674477|588523605|FG001|Overall Study|Protocol Violation|2|||
162950932|NCT02336165|588523610|FG000|Overall Study|Death|3|||
162950933|NCT02336165|588523611|FG001|Overall Study|Death|0|||
162950934|NCT02336165|588523612|FG002|Overall Study|Death|0|||
162950935|NCT02336165|588523613|FG003|Overall Study|Death|0|||
162950936|NCT02336165|588523614|FG004|Overall Study|Death|1|||
162950937|NCT02336165|588523610|FG000|Overall Study|Physician Decision|2|||
162950938|NCT02336165|588523611|FG001|Overall Study|Physician Decision|2|||
162950939|NCT02336165|588523612|FG002|Overall Study|Physician Decision|1|||
162950940|NCT02336165|588523613|FG003|Overall Study|Physician Decision|1|||
162950941|NCT02336165|588523614|FG004|Overall Study|Physician Decision|0|||
162950942|NCT02336165|588523610|FG000|Overall Study|Withdrawal by Subject|0|||
162950943|NCT02336165|588523611|FG001|Overall Study|Withdrawal by Subject|0|||
162950944|NCT02336165|588523612|FG002|Overall Study|Withdrawal by Subject|1|||
162950945|NCT02336165|588523613|FG003|Overall Study|Withdrawal by Subject|0|||
162950946|NCT02336165|588523614|FG004|Overall Study|Withdrawal by Subject|1|||
162950947|NCT02336165|588523610|FG000|Overall Study|Adverse Event|4|||
162950948|NCT02336165|588523611|FG001|Overall Study|Adverse Event|1|||
162950949|NCT02336165|588523612|FG002|Overall Study|Adverse Event|2|||
162950950|NCT02336165|588523613|FG003|Overall Study|Adverse Event|4|||
162950951|NCT02336165|588523614|FG004|Overall Study|Adverse Event|1|||
162950952|NCT02336165|588523610|FG000|Overall Study|Progressive disease|23|||
162950953|NCT02336165|588523611|FG001|Overall Study|Progressive disease|22|||
162950954|NCT02336165|588523612|FG002|Overall Study|Progressive disease|27|||
162950955|NCT02336165|588523613|FG003|Overall Study|Progressive disease|24|||
162950956|NCT02336165|588523614|FG004|Overall Study|Progressive disease|19|||
162950957|NCT02336165|588523610|FG000|Overall Study|Non-compliance|1|||
162950958|NCT02336165|588523611|FG001|Overall Study|Non-compliance|0|||
162950959|NCT02336165|588523612|FG002|Overall Study|Non-compliance|0|||
162950960|NCT02336165|588523613|FG003|Overall Study|Non-compliance|1|||
162950961|NCT02336165|588523614|FG004|Overall Study|Non-compliance|0|||
162950962|NCT02336165|588523610|FG000|Overall Study|Other|1|||
162950963|NCT02336165|588523611|FG001|Overall Study|Other|0|||
162950964|NCT02336165|588523612|FG002|Overall Study|Other|0|||
162950965|NCT02336165|588523613|FG003|Overall Study|Other|1|||
162950966|NCT02336165|588523614|FG004|Overall Study|Other|0|||
162950967|NCT00450190|588523615|FG000|Overall Study|Withdrawal by Subject|2|||
162950968|NCT03002077|588523618|FG000|Overall Study|Non-compliance with Study Drug|4|||
162950969|NCT03002077|588523618|FG000|Overall Study|Non-compliance w/Background ADT|1|||
162950970|NCT03002077|588523618|FG000|Overall Study|Study Terminated by Sponsor|257|||
162950971|NCT03002077|588523618|FG000|Overall Study|Site Terminated by Sponsor|5|||
162950972|NCT03002077|588523618|FG000|Overall Study|Miscellaneous Reasons|10|||
162950973|NCT03002077|588523618|FG000|Overall Study|Adverse Event|23|||
162950974|NCT03002077|588523618|FG000|Overall Study|Lack of Efficacy|20|||
162950975|NCT03002077|588523618|FG000|Overall Study|Withdrawal by Subject|72|||
162950976|NCT03002077|588523618|FG000|Overall Study|Lost to Follow-up|21|||
162950977|NCT03002077|588523618|FG000|Overall Study|Pregnancy|4|||
162950978|NCT03002077|588523618|FG000|Overall Study|Protocol Violation|21|||
162950979|NCT00834756|588523621|FG000|First Intervention|Adverse Event|1|||
162950980|NCT00834756|588523622|FG001|First Intervention|Adverse Event|0|||
162950981|NCT00834756|588523621|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
162950982|NCT00834756|588523622|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
162950983|NCT04625114|588523634|FG000|Overall Study|Adverse Event|3|||
162950984|NCT04625114|588523635|FG001|Overall Study|Adverse Event|1|||
162950985|NCT04625114|588523634|FG000|Overall Study|Withdrawal by Subject|2|||
162950986|NCT04625114|588523635|FG001|Overall Study|Withdrawal by Subject|0|||
162950987|NCT00986245|588523636|FG000|First Intervention|Poor compliance|8|||
162950988|NCT00986245|588523637|FG001|First Intervention|Poor compliance|4|||
162950989|NCT00986245|588523636|FG000|First Intervention|Lack of Efficacy|1|||
162950990|NCT00986245|588523637|FG001|First Intervention|Lack of Efficacy|2|||
162950991|NCT00986245|588523636|FG000|First Intervention|Withdrawal by Subject|0|||
162950992|NCT00986245|588523637|FG001|First Intervention|Withdrawal by Subject|1|||
162950993|NCT00986245|588523636|FG000|First Intervention|Protocol Violation|0|||
162950994|NCT00986245|588523637|FG001|First Intervention|Protocol Violation|1|||
162950995|NCT00986245|588523636|FG000|First Intervention|Out of indication|1|||
162950996|NCT00986245|588523637|FG001|First Intervention|Out of indication|0|||
162950997|NCT00986245|588523636|FG000|Second Intervention|Poor compliance|1|||
162950998|NCT00986245|588523637|FG001|Second Intervention|Poor compliance|0|||
162950999|NCT00986245|588523636|FG000|Second Intervention|Lost to Follow-up|1|||
162951000|NCT00986245|588523637|FG001|Second Intervention|Lost to Follow-up|0|||
162951001|NCT00986245|588523636|FG000|Second Intervention|Protocol Violation|0|||
162951002|NCT00986245|588523637|FG001|Second Intervention|Protocol Violation|1|||
162951003|NCT00854308|588523641|FG000|Overall Study|Disease progression|42|||
162951004|NCT00854308|588523642|FG001|Overall Study|Disease progression|50|||
162951005|NCT00854308|588523641|FG000|Overall Study|Adverse Event|8|||
162951006|NCT00854308|588523642|FG001|Overall Study|Adverse Event|3|||
162951007|NCT00854308|588523641|FG000|Overall Study|Death|2|||
162951008|NCT00854308|588523642|FG001|Overall Study|Death|5|||
162951009|NCT00854308|588523641|FG000|Overall Study|Physician Decision|6|||
162951010|NCT00854308|588523642|FG001|Overall Study|Physician Decision|6|||
162951011|NCT00854308|588523641|FG000|Overall Study|Withdrawal by Subject|4|||
162951012|NCT00854308|588523642|FG001|Overall Study|Withdrawal by Subject|2|||
162951013|NCT00854308|588523641|FG000|Overall Study|Sponsor's decision to terminate study|0|||
162951014|NCT00854308|588523642|FG001|Overall Study|Sponsor's decision to terminate study|1|||
162951015|NCT01390844|588523643|FG000|Treatment Phase|Adverse Event|12|||
162951016|NCT01390844|588523644|FG001|Treatment Phase|Adverse Event|2|||
162951017|NCT01390844|588523645|FG002|Treatment Phase|Adverse Event|3|||
162951018|NCT01390844|588523646|FG003|Treatment Phase|Adverse Event|2|||
162951019|NCT01390844|588523643|FG000|Treatment Phase|Treatment Failure|23|||
162951020|NCT01390844|588523644|FG001|Treatment Phase|Treatment Failure|25|||
162951021|NCT01390844|588523645|FG002|Treatment Phase|Treatment Failure|10|||
162951022|NCT01390844|588523646|FG003|Treatment Phase|Treatment Failure|13|||
162951023|NCT01390844|588523643|FG000|Treatment Phase|Non-Medical Reasons|5|||
162951024|NCT01390844|588523644|FG001|Treatment Phase|Non-Medical Reasons|1|||
162951025|NCT01390844|588523645|FG002|Treatment Phase|Non-Medical Reasons|8|||
162951026|NCT01390844|588523646|FG003|Treatment Phase|Non-Medical Reasons|1|||
162951027|NCT01390844|588523643|FG000|Treatment Phase|Non-GCP Compliant|0|||
162951028|NCT01390844|588523644|FG001|Treatment Phase|Non-GCP Compliant|0|||
162951029|NCT01390844|588523645|FG002|Treatment Phase|Non-GCP Compliant|10|||
162951030|NCT01390844|588523646|FG003|Treatment Phase|Non-GCP Compliant|3|||
162951031|NCT01390844|588523643|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
162951032|NCT01390844|588523644|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
162951033|NCT01390844|588523645|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
162951034|NCT01390844|588523646|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
162951035|NCT03048500|588523649|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
162951036|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
162951037|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Death|1|||
162951038|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
162951039|NCT03048500|588523649|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
162951040|NCT03048500|588523649|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
162951041|NCT03048500|588523649|FG000|Follow up for 3 Years|Death|12|||
162951042|NCT01479439|588523650|FG000|Overall Study|Adverse Event|1|||
162951043|NCT01479439|588523651|FG001|Overall Study|Adverse Event|0|||
162951044|NCT01479439|588523652|FG002|Overall Study|Adverse Event|0|||
162951045|NCT01479439|588523650|FG000|Overall Study|Lost to Follow-up|0|||
162951046|NCT01479439|588523651|FG001|Overall Study|Lost to Follow-up|1|||
162951047|NCT01479439|588523652|FG002|Overall Study|Lost to Follow-up|0|||
162951048|NCT01479439|588523650|FG000|Overall Study|Protocol Violation|0|||
162951049|NCT01479439|588523651|FG001|Overall Study|Protocol Violation|0|||
162951050|NCT01479439|588523652|FG002|Overall Study|Protocol Violation|2|||
162951051|NCT02079766|588523656|FG000|Overall Study|Physician Decision|1|||
162951052|NCT02079766|588523657|FG001|Overall Study|Physician Decision|0|||
162951053|NCT02079766|588523656|FG000|Overall Study|Withdrawal by Subject|1|||
162951054|NCT02079766|588523657|FG001|Overall Study|Withdrawal by Subject|0|||
162951055|NCT03018249|588523664|FG000|Overall Study|Withdrawal by Subject|2|||
162951056|NCT03018249|588523665|FG001|Overall Study|Withdrawal by Subject|2|||
162951057|NCT03929393|588523669|FG000|Overall Study|Death|1|||
162951058|NCT03929393|588523670|FG001|Overall Study|Death|0|||
162951059|NCT03929393|588523669|FG000|Overall Study|Time Commitment|2|||
162951060|NCT03929393|588523670|FG001|Overall Study|Time Commitment|5|||
162951061|NCT03929393|588523669|FG000|Overall Study|Motor Vehicle Accident|0|||
162951062|NCT03929393|588523670|FG001|Overall Study|Motor Vehicle Accident|1|||
162951063|NCT03929393|588523669|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
162951064|NCT03929393|588523670|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
162951065|NCT03929393|588523669|FG000|Overall Study|Other|1|||
162951066|NCT03929393|588523670|FG001|Overall Study|Other|3|||
162951067|NCT00694551|588523683|FG000|Overall Study|Disease Progression|1|||
162951068|NCT00694551|588523684|FG001|Overall Study|Disease Progression|0|||
162700875|NCT02061761|587615150|FG005|Overall Study|Disease progression|3|||
162951069|NCT00694551|588523685|FG002|Overall Study|Disease Progression|1|||
162951070|NCT01937390|588523689|FG000|Overall Study|Death|2|||
162951071|NCT01937390|588523689|FG000|Overall Study|Lost to Follow-up|7|||
162951072|NCT01937390|588523689|FG000|Overall Study|Withdrawal by Subject|5|||
162951073|NCT01937390|588523689|FG000|Overall Study|Fail to return|21|||
162951074|NCT02216071|588523690|FG000|Overall Study|Withdrawal by Subject|7|||
162951075|NCT02216071|588523691|FG001|Overall Study|Withdrawal by Subject|2|||
162951076|NCT02216071|588523690|FG000|Overall Study|Lost to Follow-up|3|||
162951077|NCT02216071|588523691|FG001|Overall Study|Lost to Follow-up|3|||
162951078|NCT02216071|588523690|FG000|Overall Study|Protocol Violation|3|||
162951079|NCT02216071|588523691|FG001|Overall Study|Protocol Violation|5|||
162951080|NCT02216071|588523690|FG000|Overall Study|Other|2|||
162951081|NCT02216071|588523691|FG001|Overall Study|Other|2|||
162951082|NCT03544138|588523692|FG000|Overall Study|Lost to Follow-up|29|||
162951083|NCT01706536|588523693|FG000|Overall Study|Withdrawal by Subject|1|||
162951084|NCT01706536|588523694|FG001|Overall Study|Withdrawal by Subject|0|||
162951085|NCT01706536|588523695|FG002|Overall Study|Withdrawal by Subject|1|||
162951086|NCT01706536|588523696|FG003|Overall Study|Withdrawal by Subject|0|||
162951087|NCT01706536|588523697|FG004|Overall Study|Withdrawal by Subject|0|||
162951088|NCT01706536|588523693|FG000|Overall Study|Adverse Event|2|||
162951089|NCT01706536|588523694|FG001|Overall Study|Adverse Event|3|||
162951090|NCT01706536|588523695|FG002|Overall Study|Adverse Event|4|||
162951091|NCT01706536|588523696|FG003|Overall Study|Adverse Event|3|||
162951092|NCT01706536|588523697|FG004|Overall Study|Adverse Event|2|||
162951093|NCT01706536|588523693|FG000|Overall Study|Lack of Efficacy|1|||
162951094|NCT01706536|588523694|FG001|Overall Study|Lack of Efficacy|0|||
162951095|NCT01706536|588523695|FG002|Overall Study|Lack of Efficacy|0|||
162951096|NCT01706536|588523696|FG003|Overall Study|Lack of Efficacy|1|||
162951097|NCT01706536|588523697|FG004|Overall Study|Lack of Efficacy|0|||
162951098|NCT01706536|588523693|FG000|Overall Study|non compliance|0|||
162951099|NCT01706536|588523694|FG001|Overall Study|non compliance|1|||
162951100|NCT01706536|588523695|FG002|Overall Study|non compliance|0|||
162951101|NCT01706536|588523696|FG003|Overall Study|non compliance|0|||
162951102|NCT01706536|588523697|FG004|Overall Study|non compliance|0|||
162951103|NCT04753437|588523700|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162951104|NCT04753437|588523701|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162951105|NCT04753437|588523700|FG000|Overall Study|Liver Function Test Abnormalities|2|||
162951106|NCT04753437|588523701|FG001|Overall Study|Liver Function Test Abnormalities|4|||
162951107|NCT00385684|588523704|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
162951108|NCT00385684|588523705|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
162951109|NCT00385684|588523704|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
162951110|NCT00385684|588523705|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
162951111|NCT00385684|588523704|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
162951112|NCT00385684|588523705|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
162951113|NCT00463606|588523706|FG000|Overall Study|Adverse Event|21|||
162951114|NCT00463606|588523707|FG001|Overall Study|Adverse Event|18|||
162951115|NCT00463606|588523708|FG002|Overall Study|Adverse Event|11|||
162842523|NCT01687712|588131243|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
162842524|NCT00512798|588131244|FG000|Overall Study|Death|0|||
162842525|NCT00512798|588131245|FG001|Overall Study|Death|3|||
162842526|NCT00512798|588131244|FG000|Overall Study|Adverse Event|2|||
162842527|NCT00512798|588131245|FG001|Overall Study|Adverse Event|4|||
162842528|NCT00512798|588131244|FG000|Overall Study|Progression of disease|14|||
162842529|NCT00512798|588131245|FG001|Overall Study|Progression of disease|20|||
162842530|NCT00512798|588131244|FG000|Overall Study|Withdrawal by Subject|3|||
162842531|NCT00512798|588131245|FG001|Overall Study|Withdrawal by Subject|0|||
162842532|NCT03551743|588131246|FG000|Overall Study|Adverse Event|1|||
162842533|NCT03551743|588131247|FG001|Overall Study|Adverse Event|0|||
162842534|NCT03551743|588131248|FG002|Overall Study|Adverse Event|0|||
162842535|NCT03551743|588131249|FG003|Overall Study|Adverse Event|0|||
162842536|NCT03551743|588131246|FG000|Overall Study|Withdrawal by Subject|1|||
162842537|NCT03551743|588131247|FG001|Overall Study|Withdrawal by Subject|0|||
162951116|NCT00463606|588523706|FG000|Overall Study|Withdrawal by Subject|11|||
162951117|NCT00463606|588523707|FG001|Overall Study|Withdrawal by Subject|11|||
162951118|NCT00463606|588523708|FG002|Overall Study|Withdrawal by Subject|5|||
162842538|NCT03551743|588131248|FG002|Overall Study|Withdrawal by Subject|0|||
162951119|NCT00463606|588523706|FG000|Overall Study|Lost to Follow-up|2|||
162951120|NCT00463606|588523707|FG001|Overall Study|Lost to Follow-up|2|||
162951121|NCT00463606|588523708|FG002|Overall Study|Lost to Follow-up|3|||
162951122|NCT00463606|588523706|FG000|Overall Study|Subject noncompliance|1|||
162951123|NCT00463606|588523707|FG001|Overall Study|Subject noncompliance|1|||
162842539|NCT03551743|588131249|FG003|Overall Study|Withdrawal by Subject|0|||
162700876|NCT02061761|587615151|FG006|Overall Study|Disease progression|1|||
162700877|NCT02061761|587615152|FG007|Overall Study|Disease progression|2|||
162700878|NCT02061761|587615153|FG008|Overall Study|Disease progression|28|||
162700879|NCT02061761|587615145|FG000|Overall Study|Study Drug toxicity|0|||
162700880|NCT02061761|587615146|FG001|Overall Study|Study Drug toxicity|0|||
162700881|NCT02061761|587615147|FG002|Overall Study|Study Drug toxicity|0|||
162700882|NCT02061761|587615148|FG003|Overall Study|Study Drug toxicity|0|||
162700883|NCT02061761|587615149|FG004|Overall Study|Study Drug toxicity|0|||
162700884|NCT02061761|587615150|FG005|Overall Study|Study Drug toxicity|1|||
162700885|NCT02061761|587615151|FG006|Overall Study|Study Drug toxicity|0|||
162700886|NCT02061761|587615152|FG007|Overall Study|Study Drug toxicity|2|||
162700887|NCT02061761|587615153|FG008|Overall Study|Study Drug toxicity|6|||
162700888|NCT02061761|587615145|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
162700889|NCT02061761|587615146|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
162700890|NCT02061761|587615147|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
162700891|NCT02061761|587615148|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
162700892|NCT02061761|587615149|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
162700893|NCT02061761|587615150|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
162700894|NCT02061761|587615151|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
162700895|NCT02061761|587615152|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
162700896|NCT02061761|587615153|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
162700897|NCT02061761|587615145|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162700898|NCT02061761|587615146|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162700899|NCT02061761|587615147|FG002|Overall Study|Participant request to discontinue study treatment|2|||
162700900|NCT02061761|587615148|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162700901|NCT02061761|587615149|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162700902|NCT02061761|587615150|FG005|Overall Study|Participant request to discontinue study treatment|1|||
162700903|NCT02061761|587615151|FG006|Overall Study|Participant request to discontinue study treatment|0|||
162700904|NCT02061761|587615152|FG007|Overall Study|Participant request to discontinue study treatment|0|||
162700905|NCT02061761|587615153|FG008|Overall Study|Participant request to discontinue study treatment|2|||
162700906|NCT02061761|587615145|FG000|Overall Study|Withdrawal by Subject|0|||
162700907|NCT02061761|587615146|FG001|Overall Study|Withdrawal by Subject|0|||
162700908|NCT02061761|587615147|FG002|Overall Study|Withdrawal by Subject|0|||
162700909|NCT02061761|587615148|FG003|Overall Study|Withdrawal by Subject|0|||
162700910|NCT02061761|587615149|FG004|Overall Study|Withdrawal by Subject|0|||
162842540|NCT02317562|588131250|FG000|Overall Study|Physician Decision|1|||
162842541|NCT02317562|588131250|FG000|Overall Study|early termination of the study|8|||
162842542|NCT02317562|588131250|FG000|Overall Study|Lack of Efficacy|4|||
162842543|NCT02317562|588131250|FG000|Overall Study|Withdrawal by Subject|1|||
162842544|NCT00911989|588131251|FG000|Overall Study|Adverse Event|1|||
162842545|NCT03434977|588131252|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
162842546|NCT03434977|588131253|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
162842547|NCT01145066|588131254|FG000|Overall Study|To resume NSAIDs|2|||
162842548|NCT01145066|588131255|FG001|Overall Study|To resume NSAIDs|2|||
162842549|NCT01145066|588131256|FG002|Overall Study|To resume NSAIDs|1|||
162842550|NCT01145066|588131254|FG000|Overall Study|Non-related surgery|0|||
162842551|NCT01145066|588131255|FG001|Overall Study|Non-related surgery|0|||
162842552|NCT01145066|588131256|FG002|Overall Study|Non-related surgery|1|||
162842553|NCT01145066|588131254|FG000|Overall Study|Withdrawal by Subject|0|||
162842554|NCT01145066|588131255|FG001|Overall Study|Withdrawal by Subject|0|||
162842555|NCT01145066|588131256|FG002|Overall Study|Withdrawal by Subject|2|||
162842556|NCT01145066|588131254|FG000|Overall Study|To start new med|1|||
162842557|NCT01145066|588131255|FG001|Overall Study|To start new med|0|||
162842558|NCT01145066|588131256|FG002|Overall Study|To start new med|0|||
162842559|NCT01145066|588131254|FG000|Overall Study|problems swallowing capsule|1|||
162842560|NCT01145066|588131255|FG001|Overall Study|problems swallowing capsule|0|||
162842561|NCT01145066|588131256|FG002|Overall Study|problems swallowing capsule|0|||
162842562|NCT01145066|588131254|FG000|Overall Study|Abdominal discomfort|0|||
162842563|NCT01145066|588131255|FG001|Overall Study|Abdominal discomfort|1|||
162842564|NCT01145066|588131256|FG002|Overall Study|Abdominal discomfort|0|||
162842565|NCT01145066|588131254|FG000|Overall Study|Low platelet count|0|||
162842566|NCT01145066|588131255|FG001|Overall Study|Low platelet count|1|||
162842567|NCT01145066|588131256|FG002|Overall Study|Low platelet count|0|||
162842568|NCT03920670|588131257|FG000|Overall Study|Protocol Violation|2|||
162842569|NCT03920670|588131258|FG001|Overall Study|Protocol Violation|2|||
162842570|NCT03920670|588131257|FG000|Overall Study|Adverse Event|1|||
162842571|NCT03920670|588131258|FG001|Overall Study|Adverse Event|0|||
162842572|NCT01250379|588131265|FG000|Overall Study|Death|141|||
162842573|NCT01250379|588131266|FG001|Overall Study|Death|148|||
162842574|NCT01250379|588131265|FG000|Overall Study|Withdrawal by Subject|32|||
162842575|NCT01250379|588131266|FG001|Overall Study|Withdrawal by Subject|20|||
162842576|NCT01250379|588131265|FG000|Overall Study|Physician Decision|11|||
162842577|NCT01250379|588131266|FG001|Overall Study|Physician Decision|3|||
162842578|NCT01250379|588131265|FG000|Overall Study|Protocol Violation|2|||
162842579|NCT01250379|588131266|FG001|Overall Study|Protocol Violation|8|||
162842580|NCT01250379|588131265|FG000|Overall Study|Lost to Follow-up|9|||
162842581|NCT01250379|588131266|FG001|Overall Study|Lost to Follow-up|6|||
162842582|NCT01250379|588131265|FG000|Overall Study|Adverse Event|5|||
162842583|NCT01250379|588131266|FG001|Overall Study|Adverse Event|4|||
162842584|NCT01250379|588131265|FG000|Overall Study|Other|0|||
162842585|NCT01250379|588131266|FG001|Overall Study|Other|4|||
162842586|NCT01250379|588131265|FG000|Overall Study|Participant noncompliance|2|||
162842587|NCT01250379|588131266|FG001|Overall Study|Participant noncompliance|0|||
162842588|NCT01984268|588131267|FG000|Overall Study|Study Terminated|15|||
162842589|NCT01314716|588131268|FG000|Double-Blind Phase|Randomized but not treated|1|||
162842590|NCT01314716|588131269|FG001|Double-Blind Phase|Randomized but not treated|1|||
162842591|NCT01314716|588131268|FG000|Double-Blind Phase|Adverse Event|10|||
162842592|NCT01314716|588131269|FG001|Double-Blind Phase|Adverse Event|4|||
162842593|NCT01314716|588131268|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
162951124|NCT00463606|588523708|FG002|Overall Study|Subject noncompliance|0|||
162951125|NCT00463606|588523706|FG000|Overall Study|Subject moved out of town|1|||
162951126|NCT00463606|588523707|FG001|Overall Study|Subject moved out of town|0|||
162951127|NCT00463606|588523708|FG002|Overall Study|Subject moved out of town|0|||
162951128|NCT00463606|588523706|FG000|Overall Study|Physician Decision|0|||
162951129|NCT00463606|588523707|FG001|Overall Study|Physician Decision|1|||
162951130|NCT00463606|588523708|FG002|Overall Study|Physician Decision|0|||
162951131|NCT00463606|588523706|FG000|Overall Study|Sponsor request|0|||
162951132|NCT00463606|588523707|FG001|Overall Study|Sponsor request|1|||
162951133|NCT00463606|588523708|FG002|Overall Study|Sponsor request|0|||
162951134|NCT00463606|588523706|FG000|Overall Study|Exclusion criteria violation|2|||
162951135|NCT00463606|588523707|FG001|Overall Study|Exclusion criteria violation|0|||
162951136|NCT00463606|588523708|FG002|Overall Study|Exclusion criteria violation|0|||
162951137|NCT00463606|588523706|FG000|Overall Study|Coordinator error|1|||
162951138|NCT00463606|588523707|FG001|Overall Study|Coordinator error|0|||
162951139|NCT00463606|588523708|FG002|Overall Study|Coordinator error|0|||
162951140|NCT00463606|588523706|FG000|Overall Study|Patient randomized in error|1|||
162951141|NCT00463606|588523707|FG001|Overall Study|Patient randomized in error|0|||
162951142|NCT00463606|588523708|FG002|Overall Study|Patient randomized in error|0|||
162951143|NCT00463606|588523706|FG000|Overall Study|Participation in another ABT-335 trial|1|||
162951144|NCT00463606|588523707|FG001|Overall Study|Participation in another ABT-335 trial|0|||
162951145|NCT00463606|588523708|FG002|Overall Study|Participation in another ABT-335 trial|0|||
162951146|NCT00463606|588523706|FG000|Overall Study|Protocol Violation|0|||
162951147|NCT00463606|588523707|FG001|Overall Study|Protocol Violation|0|||
162951148|NCT00463606|588523708|FG002|Overall Study|Protocol Violation|1|||
162951149|NCT02682602|588523710|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
162951150|NCT02682602|588523711|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
162951151|NCT02682602|588523710|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
162951152|NCT02682602|588523711|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
162951153|NCT03567174|588523712|FG000|Overall Study|Death|24|||
162951154|NCT03567174|588523713|FG001|Overall Study|Death|31|||
162951155|NCT03567174|588523712|FG000|Overall Study|Lost to Follow-up|165|||
162951156|NCT03567174|588523713|FG001|Overall Study|Lost to Follow-up|174|||
162951157|NCT02140060|588523714|FG000|Overall Study|Adverse Event|0|||
162951158|NCT02140060|588523715|FG001|Overall Study|Adverse Event|0|||
162951159|NCT02140060|588523716|FG002|Overall Study|Adverse Event|0|||
162951160|NCT02140060|588523717|FG003|Overall Study|Adverse Event|1|||
162951161|NCT02140060|588523718|FG004|Overall Study|Adverse Event|1|||
162951162|NCT02140060|588523719|FG005|Overall Study|Adverse Event|1|||
162951163|NCT02140060|588523714|FG000|Overall Study|Lack of Efficacy|0|||
162951164|NCT02140060|588523715|FG001|Overall Study|Lack of Efficacy|0|||
162951165|NCT02140060|588523716|FG002|Overall Study|Lack of Efficacy|0|||
162951166|NCT02140060|588523717|FG003|Overall Study|Lack of Efficacy|1|||
162951167|NCT02140060|588523718|FG004|Overall Study|Lack of Efficacy|0|||
162951168|NCT02140060|588523719|FG005|Overall Study|Lack of Efficacy|0|||
162951169|NCT02158936|588523720|FG000|Overall Study|Study closed/ terminated|57|||
162951170|NCT02158936|588523721|FG001|Overall Study|Study closed/ terminated|77|||
162951171|NCT02158936|588523720|FG000|Overall Study|Azacitidine tx discontinued|53|||
162951172|NCT02158936|588523721|FG001|Overall Study|Azacitidine tx discontinued|46|||
162951173|NCT02158936|588523720|FG000|Overall Study|Adverse Event|39|||
162951174|NCT02158936|588523721|FG001|Overall Study|Adverse Event|24|||
162951175|NCT02158936|588523720|FG000|Overall Study|Withdrawal by Subject|15|||
162951176|NCT02158936|588523721|FG001|Overall Study|Withdrawal by Subject|16|||
162951177|NCT02158936|588523720|FG000|Overall Study|Physician Decision|15|||
162951178|NCT02158936|588523721|FG001|Overall Study|Physician Decision|13|||
162951179|NCT02158936|588523720|FG000|Overall Study|Lost to Follow-up|0|||
162951180|NCT02158936|588523721|FG001|Overall Study|Lost to Follow-up|1|||
162951181|NCT01066143|588525331|FG000|Overall Study|ineligible for the study|8|||
162951182|NCT05376319|588525332|FG000|Overall Study|Funding termination|2|||
162700911|NCT02061761|587615150|FG005|Overall Study|Withdrawal by Subject|0|||
162700912|NCT02061761|587615151|FG006|Overall Study|Withdrawal by Subject|0|||
162700913|NCT02061761|587615152|FG007|Overall Study|Withdrawal by Subject|0|||
162700914|NCT02061761|587615153|FG008|Overall Study|Withdrawal by Subject|2|||
162700915|NCT02061761|587615145|FG000|Overall Study|Maximum clinical benefit|0|||
162700916|NCT02061761|587615146|FG001|Overall Study|Maximum clinical benefit|0|||
162700917|NCT02061761|587615147|FG002|Overall Study|Maximum clinical benefit|0|||
162700918|NCT02061761|587615148|FG003|Overall Study|Maximum clinical benefit|1|||
162951183|NCT05376319|588525333|FG001|Overall Study|Funding termination|4|||
162951184|NCT01340495|588525334|FG000|Overall Study|Withdrawal by Subject|1|||
162951185|NCT03497897|588525335|FG000|Overall Study|Adverse Event|1|||
162951186|NCT03497897|588525336|FG001|Overall Study|Adverse Event|1|||
162951187|NCT03497897|588525337|FG002|Overall Study|Adverse Event|1|||
162951188|NCT03497897|588525335|FG000|Overall Study|Lost to Follow-up|2|||
162951189|NCT03497897|588525336|FG001|Overall Study|Lost to Follow-up|0|||
162951190|NCT03497897|588525337|FG002|Overall Study|Lost to Follow-up|2|||
162951191|NCT03497897|588525335|FG000|Overall Study|Physician Decision|1|||
162700919|NCT02061761|587615149|FG004|Overall Study|Maximum clinical benefit|0|||
162951192|NCT03497897|588525336|FG001|Overall Study|Physician Decision|0|||
162951193|NCT03497897|588525337|FG002|Overall Study|Physician Decision|0|||
162951194|NCT03497897|588525335|FG000|Overall Study|Subject/Guardian Decision|2|||
162951195|NCT03497897|588525336|FG001|Overall Study|Subject/Guardian Decision|1|||
162951196|NCT03497897|588525337|FG002|Overall Study|Subject/Guardian Decision|3|||
162951197|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951198|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951199|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
162951200|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951201|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951202|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951203|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
162951204|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
162951205|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951206|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951207|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951208|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162700920|NCT02061761|587615150|FG005|Overall Study|Maximum clinical benefit|0|||
162700921|NCT02061761|587615151|FG006|Overall Study|Maximum clinical benefit|0|||
162951209|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951210|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
162951211|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951212|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951213|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
162951214|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951215|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951216|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951217|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
162951218|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951219|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951220|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
162951221|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951222|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951223|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951224|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
162951225|NCT00723528|588525338|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
162951226|NCT00723528|588525339|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951227|NCT00723528|588525340|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
162951228|NCT00723528|588525341|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951229|NCT00723528|588525342|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951230|NCT00723528|588525343|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951231|NCT00723528|588525344|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
162951232|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951233|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951234|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951235|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951236|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
162951237|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951238|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
162951239|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951240|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951241|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951242|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951243|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951244|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
162951245|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
162951246|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Other|0|||
162951247|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Other|0|||
162951248|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Other|0|||
162700922|NCT02061761|587615152|FG007|Overall Study|Maximum clinical benefit|0|||
162951249|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Other|0|||
162951250|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Other|1|||
162951251|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Other|4|||
162951252|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Other|0|||
162951253|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Adverse Event|0|||
162951254|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Adverse Event|0|||
162842594|NCT01314716|588131269|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
162842595|NCT01314716|588131268|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162951255|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Adverse Event|0|||
162951256|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Adverse Event|0|||
162951257|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Adverse Event|1|||
162951258|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Adverse Event|0|||
162951259|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Adverse Event|1|||
162951260|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951261|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951262|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951263|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951264|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951265|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
162951266|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
162700923|NCT02061761|587615153|FG008|Overall Study|Maximum clinical benefit|6|||
162700924|NCT02061761|587615145|FG000|Overall Study|Participant no longer meets study criteria|0|||
162700925|NCT02061761|587615146|FG001|Overall Study|Participant no longer meets study criteria|0|||
162700926|NCT02061761|587615147|FG002|Overall Study|Participant no longer meets study criteria|0|||
162700927|NCT02061761|587615148|FG003|Overall Study|Participant no longer meets study criteria|0|||
162700928|NCT02061761|587615149|FG004|Overall Study|Participant no longer meets study criteria|0|||
162842596|NCT01314716|588131269|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162842597|NCT01314716|588131268|FG000|Double-Blind Phase|Sponsor request|1|||
162842598|NCT01314716|588131269|FG001|Double-Blind Phase|Sponsor request|2|||
162842599|NCT01314716|588131268|FG000|Double-Blind Phase|Physician Decision|0|||
162842600|NCT01314716|588131269|FG001|Double-Blind Phase|Physician Decision|1|||
162842601|NCT01314716|588131268|FG000|Open-Label Phase|Adverse Event|4|||
162842602|NCT01314716|588131269|FG001|Open-Label Phase|Adverse Event|6|||
162842603|NCT01314716|588131268|FG000|Open-Label Phase|Withdrawal by Subject|1|||
162842604|NCT01314716|588131269|FG001|Open-Label Phase|Withdrawal by Subject|2|||
162842605|NCT01314716|588131268|FG000|Open-Label Phase|Physician Decision|5|||
162842606|NCT01314716|588131269|FG001|Open-Label Phase|Physician Decision|4|||
162842607|NCT01928381|588131273|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
162842608|NCT01928381|588131274|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842609|NCT01928381|588131275|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842610|NCT01928381|588131276|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842611|NCT01928381|588131277|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842612|NCT01928381|588131278|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842613|NCT01928381|588131279|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
162842614|NCT01928381|588131273|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
162842615|NCT01928381|588131274|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
162842616|NCT01928381|588131275|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
162842617|NCT01928381|588131276|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
162842618|NCT01928381|588131277|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
162842619|NCT01928381|588131278|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
162842620|NCT01928381|588131279|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
162842621|NCT01928381|588131273|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
162842622|NCT01928381|588131274|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842623|NCT01928381|588131275|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842624|NCT01928381|588131276|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842625|NCT01928381|588131277|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842626|NCT01928381|588131278|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842627|NCT01928381|588131279|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
162842628|NCT01928381|588131273|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
162842629|NCT01928381|588131274|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
162842630|NCT01928381|588131275|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
162842631|NCT01928381|588131276|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
162842632|NCT01928381|588131277|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
162842633|NCT01928381|588131278|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
162842634|NCT01928381|588131279|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
162842635|NCT01928381|588131273|FG000|Part 1 - Pain Training|Protocol Violation|1|||
162842636|NCT01928381|588131274|FG001|Part 1 - Pain Training|Protocol Violation|0|||
162842637|NCT01928381|588131275|FG002|Part 1 - Pain Training|Protocol Violation|0|||
162842638|NCT01928381|588131276|FG003|Part 1 - Pain Training|Protocol Violation|0|||
162842639|NCT01928381|588131277|FG004|Part 1 - Pain Training|Protocol Violation|0|||
162842640|NCT01928381|588131278|FG005|Part 1 - Pain Training|Protocol Violation|0|||
162842641|NCT01928381|588131279|FG006|Part 1 - Pain Training|Protocol Violation|0|||
162842642|NCT01928381|588131273|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
162842643|NCT01928381|588131274|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162700929|NCT02061761|587615150|FG005|Overall Study|Participant no longer meets study criteria|0|||
162700930|NCT02061761|587615151|FG006|Overall Study|Participant no longer meets study criteria|0|||
162700931|NCT02061761|587615152|FG007|Overall Study|Participant no longer meets study criteria|0|||
162700932|NCT02061761|587615153|FG008|Overall Study|Participant no longer meets study criteria|1|||
162700933|NCT02061761|587615145|FG000|Overall Study|Other reasons|0|||
162700934|NCT02061761|587615146|FG001|Overall Study|Other reasons|0|||
162700935|NCT02061761|587615147|FG002|Overall Study|Other reasons|0|||
162700936|NCT02061761|587615148|FG003|Overall Study|Other reasons|0|||
162700937|NCT02061761|587615149|FG004|Overall Study|Other reasons|2|||
162700938|NCT02061761|587615150|FG005|Overall Study|Other reasons|0|||
162700939|NCT02061761|587615151|FG006|Overall Study|Other reasons|0|||
162700940|NCT02061761|587615152|FG007|Overall Study|Other reasons|0|||
162700941|NCT02061761|587615153|FG008|Overall Study|Other reasons|6|||
162700942|NCT01024751|587615154|FG000|Enrolled Participants|Ineligible at baseline|3|||
162700943|NCT01024751|587615155|FG001|Enrolled Participants|Ineligible at baseline|4|||
162700944|NCT01024751|587615154|FG000|Eligible Participants|Withdrawal by Subject|0|||
162700945|NCT01024751|587615155|FG001|Eligible Participants|Withdrawal by Subject|1|||
162700946|NCT01024751|587615154|FG000|Eligible Participants|Lost to Follow-up|0|||
162700947|NCT01024751|587615155|FG001|Eligible Participants|Lost to Follow-up|1|||
162700948|NCT01024751|587615154|FG000|Eligible Participants|Ineligible|0|||
162700949|NCT01024751|587615155|FG001|Eligible Participants|Ineligible|1|||
162700950|NCT00577720|587615160|FG000|Overall Study|Adverse Event|2|||
162700951|NCT00577720|587615161|FG001|Overall Study|Adverse Event|1|||
162700952|NCT00577720|587615162|FG002|Overall Study|Adverse Event|0|||
162700953|NCT00577720|587615163|FG003|Overall Study|Adverse Event|4|||
162700954|NCT00577720|587615160|FG000|Overall Study|Lost to Follow-up|0|||
162700955|NCT00577720|587615161|FG001|Overall Study|Lost to Follow-up|0|||
162700956|NCT00577720|587615162|FG002|Overall Study|Lost to Follow-up|1|||
162700957|NCT00577720|587615163|FG003|Overall Study|Lost to Follow-up|0|||
162700958|NCT00577720|587615160|FG000|Overall Study|Protocol Violation|0|||
162700959|NCT00577720|587615161|FG001|Overall Study|Protocol Violation|0|||
162700960|NCT00577720|587615162|FG002|Overall Study|Protocol Violation|0|||
162700961|NCT00577720|587615163|FG003|Overall Study|Protocol Violation|1|||
162700962|NCT00577720|587615160|FG000|Overall Study|Withdrawal by Subject|2|||
162700963|NCT00577720|587615161|FG001|Overall Study|Withdrawal by Subject|0|||
162700964|NCT00577720|587615162|FG002|Overall Study|Withdrawal by Subject|0|||
162700965|NCT00577720|587615163|FG003|Overall Study|Withdrawal by Subject|2|||
162700966|NCT03246672|587615164|FG000|Overall Study|Lost to Follow-up|2|||
162700967|NCT03260504|587615165|FG000|Overall Study|Adverse Event|0|||
162700968|NCT03260504|587615166|FG001|Overall Study|Adverse Event|1|||
162700969|NCT00967018|587615167|FG000|Overall Study|Adverse Event|2|||
162700970|NCT00967018|587615167|FG000|Overall Study|Physician Decision|7|||
162700971|NCT00967018|587615167|FG000|Overall Study|Lost to Follow-up|2|||
162700972|NCT00967018|587615167|FG000|Overall Study|Withdrawal by Subject|1|||
162700973|NCT00967018|587615167|FG000|Overall Study|Miscellaneous Reasons|9|||
162700974|NCT01680458|587615177|FG000|Overall Study|Protocol Violation|3|||
162700975|NCT02138747|587615178|FG000|Treatment Period 1|Adverse Event|10|||
162842644|NCT01928381|588131275|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162842645|NCT01928381|588131276|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162842646|NCT01928381|588131277|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162700976|NCT02138747|587615179|FG001|Treatment Period 1|Adverse Event|14|||
162700977|NCT02138747|587615180|FG002|Treatment Period 1|Adverse Event|2|||
162700978|NCT02138747|587615181|FG003|Treatment Period 1|Adverse Event|1|||
162700979|NCT02138747|587615178|FG000|Treatment Period 1|Lost to Follow-up|0|||
162700980|NCT02138747|587615179|FG001|Treatment Period 1|Lost to Follow-up|1|||
162842647|NCT01928381|588131278|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162951267|NCT00723528|588525338|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951268|NCT00723528|588525339|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951269|NCT00723528|588525340|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951270|NCT00723528|588525341|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951271|NCT00723528|588525342|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951272|NCT00723528|588525343|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
162951273|NCT00723528|588525344|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
162951274|NCT00667862|588525346|FG000|Overall Study|Adverse Event|9|||
162951275|NCT00667862|588525346|FG000|Overall Study|Death|1|||
162842648|NCT01928381|588131279|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
162842649|NCT01928381|588131273|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
162842650|NCT01928381|588131274|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162842651|NCT01928381|588131275|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162842652|NCT01928381|588131276|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162842653|NCT01928381|588131277|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162842654|NCT01928381|588131278|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162842655|NCT01928381|588131279|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
162951276|NCT00667862|588525346|FG000|Overall Study|Disease Progression|22|||
162951277|NCT00667862|588525346|FG000|Overall Study|Withdrawal by Subject|3|||
162951278|NCT00667095|588525350|FG000|Overall Study|Withdrawal by Subject|0|||
162951279|NCT00667095|588525351|FG001|Overall Study|Withdrawal by Subject|1|||
162951280|NCT01520909|588525352|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
162951281|NCT01520909|588525353|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
162951282|NCT01520909|588525354|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
162951283|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
162951284|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
162951285|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
162951286|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
162951287|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
162951288|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
162951289|NCT01520909|588525352|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
162951290|NCT01520909|588525353|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
162951291|NCT01520909|588525354|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
162951292|NCT01435265|588525356|FG000|Overall Study|Lost to Follow-up|0|||
162951293|NCT01435265|588525357|FG001|Overall Study|Lost to Follow-up|1|||
162951294|NCT02128997|588525358|FG000|Overall Study|Lost to Follow-up|6|||
162951295|NCT02128997|588525359|FG001|Overall Study|Lost to Follow-up|11|||
162951296|NCT00856388|588525369|FG000|Overall Study|Other|1|||
162951297|NCT05038293|588525370|FG000|Overall Study|device was not operating properly for one subject.|1|||
162951298|NCT05038293|588525371|FG001|Overall Study|device was not operating properly for one subject.|0|||
162951299|NCT05038293|588525370|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
162951300|NCT05038293|588525371|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
162951301|NCT01171989|588525373|FG000|Overall Study|Lost to Follow-up|0|||
162951302|NCT01171989|588525374|FG001|Overall Study|Lost to Follow-up|0|||
162951303|NCT01171989|588525375|FG002|Overall Study|Lost to Follow-up|1|||
162951304|NCT00418184|588525376|FG000|Double-blind Phase|Withdrawal by Subject|22|||
162951305|NCT00418184|588525377|FG001|Double-blind Phase|Withdrawal by Subject|9|||
162951306|NCT00418184|588525376|FG000|Double-blind Phase|Adverse Event|2|||
162951307|NCT00418184|588525377|FG001|Double-blind Phase|Adverse Event|1|||
162951308|NCT00418184|588525376|FG000|Double-blind Phase|Poor compliance|3|||
162951309|NCT00418184|588525377|FG001|Double-blind Phase|Poor compliance|1|||
162951310|NCT00620074|588525379|FG000|Overall Study|Adverse Event|1|||
162951311|NCT04466111|588525384|FG000|Prior to Trial Phase|Physician Decision|1|||
162951312|NCT03553823|588525393|FG000|Overall Study|Physician Decision|0|||
162951313|NCT03553823|588525394|FG001|Overall Study|Physician Decision|1|||
162951314|NCT00893464|588525395|FG000|Overall Study|Did not complete therapy/experience PD|0|||
162951315|NCT00893464|588525396|FG001|Overall Study|Did not complete therapy/experience PD|0|||
162700981|NCT02138747|587615180|FG002|Treatment Period 1|Lost to Follow-up|1|||
162700982|NCT02138747|587615181|FG003|Treatment Period 1|Lost to Follow-up|0|||
162700983|NCT02138747|587615178|FG000|Treatment Period 1|Protocol Violation|0|||
162842656|NCT01928381|588131273|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
162842657|NCT01928381|588131274|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162842658|NCT01928381|588131275|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162951316|NCT00893464|588525397|FG002|Overall Study|Did not complete therapy/experience PD|0|||
162951317|NCT00893464|588525398|FG003|Overall Study|Did not complete therapy/experience PD|0|||
162951318|NCT00893464|588525399|FG004|Overall Study|Did not complete therapy/experience PD|0|||
162700984|NCT02138747|587615179|FG001|Treatment Period 1|Protocol Violation|2|||
162700985|NCT02138747|587615180|FG002|Treatment Period 1|Protocol Violation|0|||
162700986|NCT02138747|587615181|FG003|Treatment Period 1|Protocol Violation|0|||
162700987|NCT02138747|587615178|FG000|Treatment Period 1|Withdrawal by Subject|8|||
162700988|NCT02138747|587615179|FG001|Treatment Period 1|Withdrawal by Subject|4|||
162700989|NCT02138747|587615180|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162700990|NCT02138747|587615181|FG003|Treatment Period 1|Withdrawal by Subject|3|||
162700991|NCT02138747|587615178|FG000|Treatment Period 1|Other - Miscellaneous|2|||
162700992|NCT02138747|587615179|FG001|Treatment Period 1|Other - Miscellaneous|4|||
162700993|NCT02138747|587615180|FG002|Treatment Period 1|Other - Miscellaneous|0|||
162700994|NCT02138747|587615181|FG003|Treatment Period 1|Other - Miscellaneous|0|||
162700995|NCT02138747|587615178|FG000|Treatment Period 2|Adverse Event|6|||
162700996|NCT02138747|587615179|FG001|Treatment Period 2|Adverse Event|3|||
162700997|NCT02138747|587615180|FG002|Treatment Period 2|Adverse Event|1|||
162700998|NCT02138747|587615181|FG003|Treatment Period 2|Adverse Event|1|||
162700999|NCT02138747|587615178|FG000|Treatment Period 2|Lost to Follow-up|2|||
162701000|NCT02138747|587615179|FG001|Treatment Period 2|Lost to Follow-up|0|||
162701001|NCT02138747|587615180|FG002|Treatment Period 2|Lost to Follow-up|0|||
162701002|NCT02138747|587615181|FG003|Treatment Period 2|Lost to Follow-up|0|||
162701003|NCT02138747|587615178|FG000|Treatment Period 2|Protocol Violation|1|||
162701004|NCT02138747|587615179|FG001|Treatment Period 2|Protocol Violation|0|||
162701005|NCT02138747|587615180|FG002|Treatment Period 2|Protocol Violation|0|||
162701006|NCT02138747|587615181|FG003|Treatment Period 2|Protocol Violation|0|||
162701007|NCT02138747|587615178|FG000|Treatment Period 2|Withdrawal by Subject|5|||
162701008|NCT02138747|587615179|FG001|Treatment Period 2|Withdrawal by Subject|4|||
162701009|NCT02138747|587615180|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162701010|NCT02138747|587615181|FG003|Treatment Period 2|Withdrawal by Subject|2|||
162701011|NCT02138747|587615178|FG000|Treatment Period 2|Other - Miscellaneous|3|||
162701012|NCT02138747|587615179|FG001|Treatment Period 2|Other - Miscellaneous|0|||
162701013|NCT02138747|587615180|FG002|Treatment Period 2|Other - Miscellaneous|0|||
162701014|NCT02138747|587615181|FG003|Treatment Period 2|Other - Miscellaneous|0|||
162701015|NCT02302066|587615182|FG000|Overall Study|Adverse Event|1|||
162701016|NCT02302066|587615183|FG001|Overall Study|Adverse Event|1|||
162701017|NCT02302066|587615184|FG002|Overall Study|Adverse Event|3|||
162701018|NCT02302066|587615185|FG003|Overall Study|Adverse Event|0|||
162701019|NCT02302066|587615182|FG000|Overall Study|Lost to Follow-up|4|||
162701020|NCT02302066|587615183|FG001|Overall Study|Lost to Follow-up|5|||
162701021|NCT02302066|587615184|FG002|Overall Study|Lost to Follow-up|24|||
162701022|NCT02302066|587615185|FG003|Overall Study|Lost to Follow-up|7|||
162701023|NCT02302066|587615182|FG000|Overall Study|Withdrawal by Subject|25|||
162701024|NCT02302066|587615183|FG001|Overall Study|Withdrawal by Subject|58|||
162701025|NCT02302066|587615184|FG002|Overall Study|Withdrawal by Subject|124|||
162701026|NCT02302066|587615185|FG003|Overall Study|Withdrawal by Subject|33|||
162701027|NCT02302066|587615182|FG000|Overall Study|Pregnancy|2|||
162701028|NCT02302066|587615183|FG001|Overall Study|Pregnancy|10|||
162701029|NCT02302066|587615184|FG002|Overall Study|Pregnancy|12|||
162701030|NCT02302066|587615185|FG003|Overall Study|Pregnancy|0|||
162701031|NCT02302066|587615182|FG000|Overall Study|Reason Not Specified|1|||
162701032|NCT02302066|587615183|FG001|Overall Study|Reason Not Specified|1|||
162701033|NCT02302066|587615184|FG002|Overall Study|Reason Not Specified|9|||
162701034|NCT02302066|587615185|FG003|Overall Study|Reason Not Specified|1|||
162701035|NCT04793464|587615190|FG000|Overall Study|Lost to Follow-up|458|||
162701036|NCT04793464|587615191|FG001|Overall Study|Lost to Follow-up|168|||
162701037|NCT04793464|587615192|FG002|Overall Study|Lost to Follow-up|5|||
162701038|NCT04793464|587615190|FG000|Overall Study|Withdrawal by Subject|43|||
162701039|NCT04793464|587615191|FG001|Overall Study|Withdrawal by Subject|15|||
162701040|NCT04793464|587615192|FG002|Overall Study|Withdrawal by Subject|0|||
162701041|NCT02696902|587615196|FG000|Overall Study|Lost to Follow-up|0|||
162701042|NCT02696902|587615197|FG001|Overall Study|Lost to Follow-up|1|||
162701043|NCT02696902|587615198|FG002|Overall Study|Lost to Follow-up|1|||
162701044|NCT02696902|587615196|FG000|Overall Study|Withdrawal by Subject|0|||
162701045|NCT02696902|587615197|FG001|Overall Study|Withdrawal by Subject|0|||
162701046|NCT02696902|587615198|FG002|Overall Study|Withdrawal by Subject|1|||
162701047|NCT02696902|587615196|FG000|Overall Study|Death|19|||
162701048|NCT02696902|587615197|FG001|Overall Study|Death|3|||
162701049|NCT02696902|587615198|FG002|Overall Study|Death|24|||
162701050|NCT02696902|587615196|FG000|Overall Study|Participant not fit post-randomization|0|||
162701051|NCT02696902|587615197|FG001|Overall Study|Participant not fit post-randomization|0|||
162701052|NCT02696902|587615198|FG002|Overall Study|Participant not fit post-randomization|1|||
162701053|NCT02696902|587615196|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
162701054|NCT02696902|587615197|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
162701055|NCT02696902|587615198|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
162701056|NCT02696902|587615196|FG000|Overall Study|Principal investigator's decision|1|||
162701057|NCT02696902|587615197|FG001|Overall Study|Principal investigator's decision|0|||
162701058|NCT02696902|587615198|FG002|Overall Study|Principal investigator's decision|0|||
162701059|NCT02696902|587615196|FG000|Overall Study|Sponsor's decision|1|||
162701060|NCT02696902|587615197|FG001|Overall Study|Sponsor's decision|0|||
162701061|NCT02696902|587615198|FG002|Overall Study|Sponsor's decision|0|||
162701062|NCT02696902|587615196|FG000|Overall Study|Transferred to other hospital|1|||
162701063|NCT02696902|587615197|FG001|Overall Study|Transferred to other hospital|0|||
162701064|NCT02696902|587615198|FG002|Overall Study|Transferred to other hospital|0|||
162701065|NCT00845871|587615202|FG000|Assessment Period|Adverse Event|2|||
162701066|NCT00845871|587615202|FG000|Assessment Period|Abnormal laboratory values|1|||
162701067|NCT00845871|587615202|FG000|Assessment Period|Abnormal test procedure results|1|||
162701068|NCT00845871|587615202|FG000|Assessment Period|Patient withdrew consent|3|||
162701069|NCT01857622|587615203|FG000|Overall Study|Adverse Event|5|||
162701070|NCT01857622|587615204|FG001|Overall Study|Adverse Event|0|||
162701071|NCT01857622|587615205|FG002|Overall Study|Adverse Event|2|||
162701072|NCT01857622|587615203|FG000|Overall Study|Physician Decision|1|||
162701073|NCT01857622|587615204|FG001|Overall Study|Physician Decision|0|||
162701074|NCT01857622|587615205|FG002|Overall Study|Physician Decision|0|||
162701075|NCT01857622|587615203|FG000|Overall Study|Protocol Violation|4|||
162701076|NCT01857622|587615204|FG001|Overall Study|Protocol Violation|1|||
162701077|NCT01857622|587615205|FG002|Overall Study|Protocol Violation|0|||
162842659|NCT01928381|588131276|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162842660|NCT01928381|588131277|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162842661|NCT01928381|588131278|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162842662|NCT01928381|588131279|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
162842663|NCT01928381|588131273|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
162842664|NCT01928381|588131274|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842665|NCT01928381|588131275|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842666|NCT01928381|588131276|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842667|NCT01928381|588131277|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842668|NCT01928381|588131278|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842669|NCT01928381|588131279|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
162842670|NCT01928381|588131273|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842671|NCT01928381|588131274|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842672|NCT01928381|588131275|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
162842673|NCT01928381|588131276|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842674|NCT01928381|588131277|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842675|NCT01928381|588131278|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842676|NCT01928381|588131279|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
162842677|NCT01928381|588131273|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842678|NCT01928381|588131274|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842679|NCT01928381|588131275|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
162842680|NCT01928381|588131276|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842681|NCT01928381|588131277|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842682|NCT01928381|588131278|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842683|NCT01928381|588131279|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
162842684|NCT01928381|588131273|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
162842685|NCT01928381|588131274|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
162842686|NCT01928381|588131275|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
162842687|NCT01928381|588131276|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
162842688|NCT01928381|588131277|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
162842689|NCT01928381|588131278|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
162842690|NCT01928381|588131279|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
162842691|NCT01928381|588131273|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
162842692|NCT01928381|588131274|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
162842693|NCT01928381|588131275|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
162842694|NCT01928381|588131276|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
162842695|NCT01928381|588131277|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
162842696|NCT01928381|588131278|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
162701078|NCT01857622|587615203|FG000|Overall Study|Withdrawal by Subject|1|||
162701079|NCT01857622|587615204|FG001|Overall Study|Withdrawal by Subject|0|||
162701080|NCT01857622|587615205|FG002|Overall Study|Withdrawal by Subject|0|||
162701081|NCT01291225|587615208|FG000|Overall Study|Lost to Follow-up|85|||
162701082|NCT01291225|587615209|FG001|Overall Study|Lost to Follow-up|39|||
162701083|NCT01734434|587615210|FG000|Overall Study|Death Infant|3|||
162701084|NCT01734434|587615211|FG001|Overall Study|Death Infant|1|||
162701085|NCT01734434|587615212|FG002|Overall Study|Death Infant|17|||
162701086|NCT01734434|587615213|FG003|Overall Study|Death Infant|5|||
162701087|NCT01734434|587615210|FG000|Overall Study|Lost to Follow-up|2|||
162701088|NCT01734434|587615211|FG001|Overall Study|Lost to Follow-up|9|||
162701089|NCT01734434|587615212|FG002|Overall Study|Lost to Follow-up|67|||
162701090|NCT01734434|587615213|FG003|Overall Study|Lost to Follow-up|11|||
162701091|NCT01734434|587615210|FG000|Overall Study|No Live Birth|1|||
162701092|NCT01734434|587615211|FG001|Overall Study|No Live Birth|2|||
162701093|NCT01734434|587615212|FG002|Overall Study|No Live Birth|32|||
162701094|NCT01734434|587615213|FG003|Overall Study|No Live Birth|6|||
162701095|NCT01734434|587615210|FG000|Overall Study|Withdrawal by Subject|4|||
162701096|NCT01734434|587615211|FG001|Overall Study|Withdrawal by Subject|0|||
162701097|NCT01734434|587615212|FG002|Overall Study|Withdrawal by Subject|8|||
162701098|NCT01734434|587615213|FG003|Overall Study|Withdrawal by Subject|1|||
162701099|NCT01734434|587615210|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
162701100|NCT01734434|587615211|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
162701101|NCT01734434|587615212|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
162701102|NCT01734434|587615213|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
162701103|NCT01734434|587615210|FG000|Overall Study|Subject Not Reachable|0|||
162701104|NCT01734434|587615211|FG001|Overall Study|Subject Not Reachable|0|||
162701105|NCT01734434|587615212|FG002|Overall Study|Subject Not Reachable|1|||
162701106|NCT01734434|587615213|FG003|Overall Study|Subject Not Reachable|0|||
162701107|NCT01734434|587615210|FG000|Overall Study|Treatment Defaulter|0|||
162701108|NCT01734434|587615211|FG001|Overall Study|Treatment Defaulter|0|||
162701109|NCT01734434|587615212|FG002|Overall Study|Treatment Defaulter|1|||
162701110|NCT01734434|587615213|FG003|Overall Study|Treatment Defaulter|0|||
162701111|NCT01734434|587615210|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
162951319|NCT00893464|588525400|FG005|Overall Study|Did not complete therapy/experience PD|0|||
162951320|NCT00893464|588525401|FG006|Overall Study|Did not complete therapy/experience PD|2|||
162951321|NCT00893464|588525402|FG007|Overall Study|Did not complete therapy/experience PD|2|||
162951322|NCT03450070|588525403|FG000|Overall Study|Withdrawal by Subject|8|||
162951323|NCT02910037|588525406|FG000|Overall Study|Withdrawal by Subject|4|||
162951324|NCT02910037|588525406|FG000|Overall Study|Lost to Follow-up|6|||
162951325|NCT00813293|588525409|FG000|Overall Study|Intercurrent illness|1|||
162951326|NCT00813293|588525410|FG001|Overall Study|Intercurrent illness|0|||
162951327|NCT00813293|588525409|FG000|Overall Study|Adverse Event|0|||
162951328|NCT00813293|588525410|FG001|Overall Study|Adverse Event|1|||
162951329|NCT02794974|588525411|FG000|Overall Study|Physician Decision|0|||
162951330|NCT02794974|588525412|FG001|Overall Study|Physician Decision|1|||
162951331|NCT00533273|588525415|FG000|Double-blind|Withdrew consent|0|||
162951332|NCT00533273|588525416|FG001|Double-blind|Withdrew consent|2|||
162951333|NCT00533273|588525415|FG000|Open-label|Withdrawal by Subject|6|||
162951334|NCT00533273|588525416|FG001|Open-label|Withdrawal by Subject|0|||
162951335|NCT00454909|588525417|FG000|Overall Study|Withdrawal by Subject|1|||
162951336|NCT00454909|588525418|FG001|Overall Study|Withdrawal by Subject|0|||
162951337|NCT00454909|588525419|FG002|Overall Study|Withdrawal by Subject|0|||
162951338|NCT00454909|588525417|FG000|Overall Study|Migrated/moved from study area|0|||
162951339|NCT00454909|588525418|FG001|Overall Study|Migrated/moved from study area|0|||
162951340|NCT00454909|588525419|FG002|Overall Study|Migrated/moved from study area|1|||
162951341|NCT00454909|588525417|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
162951342|NCT00454909|588525418|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
162951343|NCT00454909|588525419|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
162951344|NCT00454909|588525417|FG000|Overall Study|Others|1|||
162951345|NCT00454909|588525418|FG001|Overall Study|Others|0|||
162951346|NCT00454909|588525419|FG002|Overall Study|Others|0|||
162951347|NCT03752528|588525420|FG000|Part A|Lost to Follow-up|1|||
162951348|NCT03752528|588525420|FG000|Part A|Protocol Violation|1|||
162951349|NCT03752528|588525420|FG000|Part B|Protocol Violation|1|||
162951350|NCT03752528|588525420|FG000|Part B|Study terminated by sponsor|3|||
162701112|NCT01734434|587615211|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
162701113|NCT01734434|587615212|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
162701114|NCT01734434|587615213|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
162701115|NCT01734434|587615210|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162701116|NCT01734434|587615211|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162951351|NCT01981720|588525421|FG000|Overall Study|Adverse Event|1|||
162951352|NCT01981720|588525421|FG000|Overall Study|Withdrawal by Subject|3|||
162951353|NCT01981720|588525421|FG000|Overall Study|Pregnancy|1|||
162951354|NCT02549092|588525423|FG000|Treatment Period|Adverse Event|2|||
162951355|NCT02549092|588525424|FG001|Treatment Period|Adverse Event|2|||
162951356|NCT02549092|588525423|FG000|Treatment Period|Withdrawal by Subject|1|||
162951357|NCT02549092|588525424|FG001|Treatment Period|Withdrawal by Subject|3|||
162951358|NCT02549092|588525423|FG000|Treatment Period|Lack of Efficacy|0|||
162951359|NCT02549092|588525424|FG001|Treatment Period|Lack of Efficacy|2|||
162842697|NCT01928381|588131279|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
162842698|NCT01928381|588131273|FG000|Washout First Intervention|Protocol Violation|0|||
162842699|NCT01928381|588131274|FG001|Washout First Intervention|Protocol Violation|0|||
162842700|NCT01928381|588131275|FG002|Washout First Intervention|Protocol Violation|0|||
162842701|NCT01928381|588131276|FG003|Washout First Intervention|Protocol Violation|0|||
162842702|NCT01928381|588131277|FG004|Washout First Intervention|Protocol Violation|1|||
162842703|NCT01928381|588131278|FG005|Washout First Intervention|Protocol Violation|0|||
162842704|NCT01928381|588131279|FG006|Washout First Intervention|Protocol Violation|0|||
162842705|NCT01928381|588131273|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
162842706|NCT01928381|588131274|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
162842707|NCT01928381|588131275|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
162842708|NCT01928381|588131276|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
162842709|NCT01928381|588131277|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
162842710|NCT01928381|588131278|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
162842711|NCT01928381|588131279|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
162842712|NCT01928381|588131273|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842713|NCT01928381|588131274|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842714|NCT01928381|588131275|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
162842715|NCT01928381|588131276|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842716|NCT01928381|588131277|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842717|NCT01928381|588131278|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842718|NCT01928381|588131279|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
162842719|NCT01227902|588133089|FG000|Overall Study|Adverse Event|12|||
162842720|NCT01227902|588133090|FG001|Overall Study|Adverse Event|8|||
162842721|NCT01227902|588133091|FG002|Overall Study|Adverse Event|11|||
162842722|NCT01227902|588133092|FG003|Overall Study|Adverse Event|4|||
162842723|NCT01227902|588133089|FG000|Overall Study|Lack of Efficacy|1|||
162842724|NCT01227902|588133090|FG001|Overall Study|Lack of Efficacy|2|||
162842725|NCT01227902|588133091|FG002|Overall Study|Lack of Efficacy|2|||
162842726|NCT01227902|588133092|FG003|Overall Study|Lack of Efficacy|1|||
162842727|NCT01227902|588133089|FG000|Overall Study|Protocol Violation|1|||
162842728|NCT01227902|588133090|FG001|Overall Study|Protocol Violation|0|||
162842729|NCT01227902|588133091|FG002|Overall Study|Protocol Violation|0|||
162842730|NCT01227902|588133092|FG003|Overall Study|Protocol Violation|0|||
162842731|NCT01227902|588133089|FG000|Overall Study|Lost to Follow-up|0|||
162842732|NCT01227902|588133090|FG001|Overall Study|Lost to Follow-up|0|||
162842733|NCT01227902|588133091|FG002|Overall Study|Lost to Follow-up|1|||
162842734|NCT01227902|588133092|FG003|Overall Study|Lost to Follow-up|2|||
162842735|NCT01227902|588133089|FG000|Overall Study|Physician Decision|0|||
162842736|NCT01227902|588133090|FG001|Overall Study|Physician Decision|1|||
162842737|NCT01227902|588133091|FG002|Overall Study|Physician Decision|1|||
162842738|NCT01227902|588133092|FG003|Overall Study|Physician Decision|0|||
162842739|NCT01227902|588133089|FG000|Overall Study|Withdrawal by Subject|4|||
162842740|NCT01227902|588133090|FG001|Overall Study|Withdrawal by Subject|2|||
162842741|NCT01227902|588133091|FG002|Overall Study|Withdrawal by Subject|4|||
162842742|NCT01227902|588133092|FG003|Overall Study|Withdrawal by Subject|3|||
162842743|NCT02363478|588133097|FG000|Overall Study|Lost to Follow-up|4|||
162842744|NCT02363478|588133097|FG000|Overall Study|Adverse Event|4|||
162842745|NCT00930059|588133098|FG000|Overall Study|Death|1|||
162842746|NCT00930059|588133099|FG001|Overall Study|Death|0|||
162842747|NCT00930059|588133098|FG000|Overall Study|Did not meet entrance criteria|1|||
162842748|NCT00930059|588133099|FG001|Overall Study|Did not meet entrance criteria|1|||
162842749|NCT00930059|588133098|FG000|Overall Study|Withdrawal by Subject|3|||
162842750|NCT00930059|588133099|FG001|Overall Study|Withdrawal by Subject|4|||
162842751|NCT00930059|588133098|FG000|Overall Study|Other|1|||
162842752|NCT00930059|588133099|FG001|Overall Study|Other|0|||
162842753|NCT00930059|588133098|FG000|Overall Study|1 site terminated by sponsor|1|||
162842754|NCT00930059|588133099|FG001|Overall Study|1 site terminated by sponsor|1|||
162842755|NCT00930059|588133098|FG000|Overall Study|Adverse Event|1|||
162842756|NCT00930059|588133099|FG001|Overall Study|Adverse Event|6|||
162842757|NCT01916980|588133103|FG000|Overall Study|Adverse Event|4|||
162842758|NCT01916980|588133104|FG001|Overall Study|Adverse Event|2|||
162842759|NCT01916980|588133103|FG000|Overall Study|Lack of Efficacy|2|||
162701117|NCT01734434|587615212|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
162701118|NCT01734434|587615213|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162701119|NCT02819479|587616905|FG000|Overall Study|Adverse Event|2|||
162701120|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
162701121|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
162701122|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
162701123|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
162701124|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
162701125|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
162701126|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
162701127|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
162701128|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
162701129|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
162842760|NCT01916980|588133104|FG001|Overall Study|Lack of Efficacy|2|||
162842761|NCT01916980|588133103|FG000|Overall Study|Withdrawal by Subject|1|||
162842762|NCT01916980|588133104|FG001|Overall Study|Withdrawal by Subject|0|||
162842763|NCT00546364|588133105|FG000|Overall Study|Disease progression|5|||
162842764|NCT00546364|588133106|FG001|Overall Study|Disease progression|11|||
162842765|NCT00546364|588133107|FG002|Overall Study|Disease progression|8|||
162842766|NCT00546364|588133105|FG000|Overall Study|Completed and off treatment|1|||
162842767|NCT00546364|588133106|FG001|Overall Study|Completed and off treatment|0|||
162842768|NCT00546364|588133107|FG002|Overall Study|Completed and off treatment|2|||
162842769|NCT00546364|588133105|FG000|Overall Study|Administrative reason by sponsor|1|||
162842770|NCT00546364|588133106|FG001|Overall Study|Administrative reason by sponsor|0|||
162842771|NCT00546364|588133107|FG002|Overall Study|Administrative reason by sponsor|0|||
162842772|NCT00546364|588133105|FG000|Overall Study|Poor compliance/noncompliance|0|||
162842773|NCT00546364|588133106|FG001|Overall Study|Poor compliance/noncompliance|0|||
162842774|NCT00546364|588133107|FG002|Overall Study|Poor compliance/noncompliance|1|||
162842775|NCT00546364|588133105|FG000|Overall Study|No longer meets study criteria|1|||
162842776|NCT00546364|588133106|FG001|Overall Study|No longer meets study criteria|1|||
162842777|NCT00546364|588133107|FG002|Overall Study|No longer meets study criteria|0|||
162842778|NCT00546364|588133105|FG000|Overall Study|Withdrawal by Subject|5|||
162842779|NCT00546364|588133106|FG001|Overall Study|Withdrawal by Subject|6|||
162842780|NCT00546364|588133107|FG002|Overall Study|Withdrawal by Subject|3|||
162842781|NCT00546364|588133105|FG000|Overall Study|Prior taxotere|1|||
162842782|NCT00546364|588133106|FG001|Overall Study|Prior taxotere|0|||
162842783|NCT00546364|588133107|FG002|Overall Study|Prior taxotere|0|||
162842784|NCT00546364|588133105|FG000|Overall Study|Mixed response|1|||
162842785|NCT00546364|588133106|FG001|Overall Study|Mixed response|0|||
162842786|NCT00546364|588133107|FG002|Overall Study|Mixed response|0|||
162842787|NCT00546364|588133105|FG000|Overall Study|Palliative treatment|1|||
162842788|NCT00546364|588133106|FG001|Overall Study|Palliative treatment|0|||
162842789|NCT00546364|588133107|FG002|Overall Study|Palliative treatment|1|||
162842790|NCT00546364|588133105|FG000|Overall Study|Target lesions resected|1|||
162842791|NCT00546364|588133106|FG001|Overall Study|Target lesions resected|0|||
162842792|NCT00546364|588133107|FG002|Overall Study|Target lesions resected|0|||
162842793|NCT00546364|588133105|FG000|Overall Study|Physician Decision|0|||
162842794|NCT00546364|588133106|FG001|Overall Study|Physician Decision|0|||
162842795|NCT00546364|588133107|FG002|Overall Study|Physician Decision|1|||
162842796|NCT00546364|588133105|FG000|Overall Study|Sponsor decision|0|||
162842797|NCT00546364|588133106|FG001|Overall Study|Sponsor decision|0|||
162842798|NCT00546364|588133107|FG002|Overall Study|Sponsor decision|1|||
162842799|NCT03064763|588133108|FG000|Overall Study|Lost to Follow-up|1|||
162842800|NCT03064763|588133108|FG000|Overall Study|Death|8|||
162951360|NCT02549092|588525423|FG000|Extension/Transition Period|Adverse Event|1|||
162701130|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
162842801|NCT00935883|588133111|FG000|Treatment Period|Physician Decision|1|||
162842802|NCT00935883|588133112|FG001|Treatment Period|Physician Decision|0|||
162842803|NCT00935883|588133111|FG000|Treatment Period|Withdrawal by Subject|0|||
162701131|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
162701132|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
162701133|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
162701134|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
162701135|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
162701136|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
162701137|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
162701138|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
162701139|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
162701140|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
162842804|NCT00935883|588133112|FG001|Treatment Period|Withdrawal by Subject|2|||
162842805|NCT02415712|588133117|FG000|Overall Study|Protocol Violation|16|||
162842806|NCT01537211|588133119|FG000|Overall Study|Lost to Follow-up|0|||
162701141|NCT02718417|587616907|FG000|Chemotherapy Phase (CP)|Other|2|||
162701142|NCT02718417|587616908|FG001|Chemotherapy Phase (CP)|Other|0|||
162701143|NCT02718417|587616909|FG002|Chemotherapy Phase (CP)|Other|1|||
162701144|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Adverse Event|21|||
162842807|NCT01537211|588133120|FG001|Overall Study|Lost to Follow-up|1|||
162842808|NCT02624492|588133138|FG000|Overall Study|Adverse Event|2|||
162701145|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Adverse Event|26|||
162701146|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Adverse Event|0|||
162701147|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
162701148|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
162701149|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
162701150|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
162701151|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
162701152|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
162701153|NCT02718417|587616907|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
162701154|NCT02718417|587616908|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
162701155|NCT02718417|587616909|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
162701156|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Physician's decision|6|||
162701157|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Physician's decision|7|||
162701158|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Physician's decision|0|||
162701159|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Progressive disease|100|||
162701160|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Progressive disease|88|||
162701161|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Progressive disease|0|||
162701162|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Other|2|||
162701163|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Other|1|||
162701164|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Other|0|||
162701165|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
162701166|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
162701167|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
162701168|NCT02718417|587616907|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
162701169|NCT02718417|587616908|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
162701170|NCT02718417|587616909|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
162701171|NCT02718417|587616907|FG000|Observation Phase (OP)|Adverse Event|0|||
162701172|NCT02718417|587616908|FG001|Observation Phase (OP)|Adverse Event|0|||
162701173|NCT02718417|587616909|FG002|Observation Phase (OP)|Adverse Event|1|||
162701174|NCT02718417|587616907|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
162701175|NCT02718417|587616908|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
162701176|NCT02718417|587616909|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
162701177|NCT02718417|587616907|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
162701178|NCT02718417|587616908|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
162701179|NCT02718417|587616909|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
162701180|NCT02718417|587616907|FG000|Observation Phase (OP)|Physician Decision|0|||
162701181|NCT02718417|587616908|FG001|Observation Phase (OP)|Physician Decision|0|||
162701182|NCT02718417|587616909|FG002|Observation Phase (OP)|Physician Decision|9|||
162701183|NCT02718417|587616907|FG000|Observation Phase (OP)|Progressive disease|0|||
162701184|NCT02718417|587616908|FG001|Observation Phase (OP)|Progressive disease|0|||
162701185|NCT02718417|587616909|FG002|Observation Phase (OP)|Progressive disease|92|||
162701186|NCT02718417|587616907|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
162701187|NCT02718417|587616908|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
162701188|NCT02718417|587616909|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
162701189|NCT02718417|587616907|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
162701190|NCT02718417|587616908|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
162701191|NCT02718417|587616909|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
162701192|NCT02718417|587616907|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
162701193|NCT02718417|587616908|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
162701194|NCT02718417|587616909|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
162701195|NCT02718417|587616907|FG000|Observation Phase (OP)|Other|0|||
162701196|NCT02718417|587616908|FG001|Observation Phase (OP)|Other|0|||
162842809|NCT02624492|588133139|FG001|Overall Study|Adverse Event|2|||
162842810|NCT02624492|588133140|FG002|Overall Study|Adverse Event|2|||
162842811|NCT02624492|588133138|FG000|Overall Study|Progressive disease|0|||
162842812|NCT02624492|588133139|FG001|Overall Study|Progressive disease|2|||
162951361|NCT02549092|588525424|FG001|Extension/Transition Period|Adverse Event|1|||
162951362|NCT02549092|588525423|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
162951363|NCT02549092|588525424|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
162951364|NCT02549092|588525423|FG000|Extension/Transition Period|Other, Not Specified|4|||
162951365|NCT02549092|588525424|FG001|Extension/Transition Period|Other, Not Specified|2|||
162951366|NCT00910663|588525425|FG000|Period 1|Withdrawal by Subject|0|||
162951367|NCT00910663|588525426|FG001|Period 1|Withdrawal by Subject|1|||
162951368|NCT01772537|588525427|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
162951369|NCT01772537|588525428|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
162951370|NCT01772537|588525429|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
162701197|NCT02718417|587616909|FG002|Observation Phase (OP)|Other|7|||
162701198|NCT02718417|587616907|FG000|Follow-up Phase|Adverse Event|3|||
162951371|NCT01376167|588525433|FG000|Overall Study|Lost to Follow-up|2|||
162951372|NCT01376167|588525434|FG001|Overall Study|Lost to Follow-up|4|||
162951373|NCT01376167|588525435|FG002|Overall Study|Lost to Follow-up|2|||
162951374|NCT01376167|588525433|FG000|Overall Study|Physician Decision|1|||
162951375|NCT01376167|588525434|FG001|Overall Study|Physician Decision|1|||
162951376|NCT01376167|588525435|FG002|Overall Study|Physician Decision|0|||
162951377|NCT01376167|588525433|FG000|Overall Study|Withdrawal by Subject|1|||
162951378|NCT01376167|588525434|FG001|Overall Study|Withdrawal by Subject|5|||
162951379|NCT01376167|588525435|FG002|Overall Study|Withdrawal by Subject|4|||
162951380|NCT02193165|588525438|FG000|4 Week Product Use|Lost to Follow-up|1|||
162951381|NCT02193165|588525439|FG001|4 Week Product Use|Lost to Follow-up|1|||
162951382|NCT02193165|588525440|FG002|4 Week Product Use|Lost to Follow-up|1|||
162951383|NCT02193165|588525438|FG000|6 Week Product Use|Lost to Follow-up|0|||
162951384|NCT02193165|588525439|FG001|6 Week Product Use|Lost to Follow-up|1|||
162951385|NCT02193165|588525440|FG002|6 Week Product Use|Lost to Follow-up|0|||
162951386|NCT01546545|588525442|FG000|Overall Study|Withdrawal by Subject|1|||
162951387|NCT01214850|588525443|FG000|Overall Study|Withdrawal by Subject|38|||
162951388|NCT01214850|588525444|FG001|Overall Study|Withdrawal by Subject|31|||
162951389|NCT01214850|588525445|FG002|Overall Study|Withdrawal by Subject|28|||
162951390|NCT01214850|588525443|FG000|Overall Study|Lost to Follow-up|124|||
162951391|NCT01214850|588525444|FG001|Overall Study|Lost to Follow-up|98|||
162701199|NCT02718417|587616908|FG001|Follow-up Phase|Adverse Event|1|||
162701200|NCT02718417|587616909|FG002|Follow-up Phase|Adverse Event|1|||
162701201|NCT02718417|587616907|FG000|Follow-up Phase|Other|4|||
162951392|NCT01214850|588525445|FG002|Overall Study|Lost to Follow-up|123|||
162951393|NCT01214850|588525443|FG000|Overall Study|Protocol Violation|5|||
162951394|NCT01214850|588525444|FG001|Overall Study|Protocol Violation|5|||
162951395|NCT01214850|588525445|FG002|Overall Study|Protocol Violation|6|||
162951396|NCT01214850|588525443|FG000|Overall Study|Adverse event or death|11|||
162951397|NCT01214850|588525444|FG001|Overall Study|Adverse event or death|8|||
162951398|NCT01214850|588525445|FG002|Overall Study|Adverse event or death|3|||
162951399|NCT01214850|588525443|FG000|Overall Study|Inappropriate enrollment|2|||
162951400|NCT01214850|588525444|FG001|Overall Study|Inappropriate enrollment|1|||
162951401|NCT01214850|588525445|FG002|Overall Study|Inappropriate enrollment|0|||
162951402|NCT01214850|588525443|FG000|Overall Study|Administrative reason|1|||
162951403|NCT01214850|588525444|FG001|Overall Study|Administrative reason|0|||
162701202|NCT02718417|587616908|FG001|Follow-up Phase|Other|6|||
162701203|NCT02718417|587616909|FG002|Follow-up Phase|Other|4|||
162951404|NCT01214850|588525445|FG002|Overall Study|Administrative reason|0|||
162951405|NCT01214850|588525443|FG000|Overall Study|Unable to classify|2|||
162951406|NCT01214850|588525444|FG001|Overall Study|Unable to classify|1|||
162951407|NCT01214850|588525445|FG002|Overall Study|Unable to classify|1|||
162951408|NCT00610363|588525450|FG000|Overall Study|Non-compliance with protocol|0|||
162951409|NCT00610363|588525451|FG001|Overall Study|Non-compliance with protocol|1|||
162951410|NCT00610363|588525450|FG000|Overall Study|Adverse Event|3|||
162951411|NCT00610363|588525451|FG001|Overall Study|Adverse Event|1|||
162951412|NCT00610363|588525450|FG000|Overall Study|Lack of Efficacy|2|||
162951413|NCT00610363|588525451|FG001|Overall Study|Lack of Efficacy|0|||
162951414|NCT00610363|588525450|FG000|Overall Study|Lost to Follow-up|4|||
162951415|NCT00610363|588525451|FG001|Overall Study|Lost to Follow-up|0|||
162951416|NCT00610363|588525450|FG000|Overall Study|Withdrawal by Subject|1|||
162951417|NCT00610363|588525451|FG001|Overall Study|Withdrawal by Subject|0|||
162951418|NCT00610363|588525450|FG000|Overall Study|Other than specified above|1|||
162951419|NCT00610363|588525451|FG001|Overall Study|Other than specified above|1|||
162951420|NCT03361228|588525461|FG000|Overall Study|Other|1|||
162951421|NCT03361228|588525462|FG001|Overall Study|Other|1|||
162951422|NCT03361228|588525461|FG000|Overall Study|Death|3|||
162951423|NCT03361228|588525462|FG001|Overall Study|Death|0|||
162951424|NCT01722877|588525466|FG000|Overall Study|Death|1|||
162951425|NCT01722877|588525466|FG000|Overall Study|Lost to Follow-up|1|||
162951426|NCT03693430|588525467|FG000|Overall Study|Lost to Follow-up|3|||
162951427|NCT03693430|588525468|FG001|Overall Study|Lost to Follow-up|14|||
162951428|NCT03693430|588525467|FG000|Overall Study|Death|1|||
162951429|NCT03693430|588525468|FG001|Overall Study|Death|0|||
162951430|NCT03693430|588525467|FG000|Overall Study|Withdrawal by Subject|0|||
162951431|NCT03693430|588525468|FG001|Overall Study|Withdrawal by Subject|4|||
162951432|NCT00585689|588525470|FG000|Overall Study|Received different ABI-007 schedule|3|||
162951433|NCT00585689|588525470|FG000|Overall Study|Adverse Event|1|||
162951434|NCT00585689|588525470|FG000|Overall Study|Patient Declined Surgery|1|||
162951435|NCT00585689|588525470|FG000|Overall Study|Patient had unresectable disease|1|||
162951436|NCT00585689|588525470|FG000|Overall Study|Death|1|||
162951437|NCT02930005|588525471|FG000|Overall Study|Lost to Follow-up|1|||
162951438|NCT02930005|588525472|FG001|Overall Study|Lost to Follow-up|5|||
162951439|NCT02373098|588525473|FG000|Overall Study|Lost to Follow-up|1|||
162951440|NCT02373098|588525474|FG001|Overall Study|Lost to Follow-up|0|||
162951441|NCT02373098|588525473|FG000|Overall Study|Protocol Violation|3|||
162951442|NCT02373098|588525474|FG001|Overall Study|Protocol Violation|0|||
162951443|NCT02373098|588525473|FG000|Overall Study|Withdrawal by Subject|5|||
162951444|NCT02373098|588525474|FG001|Overall Study|Withdrawal by Subject|0|||
162951445|NCT02373098|588525473|FG000|Overall Study|Adverse Event|3|||
162951446|NCT02373098|588525474|FG001|Overall Study|Adverse Event|0|||
162951447|NCT00870870|588525475|FG000|Overall Study|Withdrawal by Subject|0|||
162951448|NCT00870870|588525476|FG001|Overall Study|Withdrawal by Subject|1|||
162951449|NCT00870870|588525477|FG002|Overall Study|Withdrawal by Subject|1|||
162951450|NCT00870870|588525478|FG003|Overall Study|Withdrawal by Subject|3|||
162951451|NCT00870870|588525475|FG000|Overall Study|Adverse Event|0|||
162951452|NCT00870870|588525476|FG001|Overall Study|Adverse Event|0|||
162951453|NCT00870870|588525477|FG002|Overall Study|Adverse Event|2|||
162951454|NCT00870870|588525478|FG003|Overall Study|Adverse Event|2|||
162951455|NCT00855738|588525483|FG000|Overall Study|Lost to Follow-up|2|||
162951456|NCT00855738|588525483|FG000|Overall Study|Adverse Event|1|||
162951457|NCT00855738|588525483|FG000|Overall Study|Subject Defaulted|1|||
162951458|NCT00855738|588525483|FG000|Overall Study|Death|1|||
162951459|NCT00304083|588525486|FG000|Overall Study|Withdrawal by Subject|4|||
162951460|NCT00304083|588525487|FG001|Overall Study|Withdrawal by Subject|2|||
162951461|NCT00304083|588525486|FG000|Overall Study|Physician Decision|8|||
162701204|NCT02718417|587616907|FG000|Follow-up Phase|Withdrawal by Subject|19|||
162701205|NCT02718417|587616908|FG001|Follow-up Phase|Withdrawal by Subject|17|||
162701206|NCT02718417|587616909|FG002|Follow-up Phase|Withdrawal by Subject|5|||
162701207|NCT02718417|587616907|FG000|Follow-up Phase|Study terminated by sponsor|100|||
162701208|NCT02718417|587616908|FG001|Follow-up Phase|Study terminated by sponsor|138|||
162701209|NCT02718417|587616909|FG002|Follow-up Phase|Study terminated by sponsor|6|||
162701210|NCT02718417|587616907|FG000|Follow-up Phase|Lost to Follow-up|2|||
162701211|NCT02718417|587616908|FG001|Follow-up Phase|Lost to Follow-up|3|||
162701212|NCT02718417|587616909|FG002|Follow-up Phase|Lost to Follow-up|0|||
162701213|NCT02718417|587616907|FG000|Follow-up Phase|Death leading to discontinuation|7|||
162701214|NCT02718417|587616908|FG001|Follow-up Phase|Death leading to discontinuation|7|||
162701215|NCT02718417|587616909|FG002|Follow-up Phase|Death leading to discontinuation|3|||
162701216|NCT02718417|587616907|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
162701217|NCT02718417|587616908|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
162701218|NCT02718417|587616909|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
162842813|NCT02624492|588133140|FG002|Overall Study|Progressive disease|3|||
162842814|NCT00343512|588133141|FG000|Overall Study|Withdrawal by Subject|2|||
162842815|NCT00323557|588133142|FG000|Overall Study|Physician Decision|1|||
162842816|NCT00323557|588133143|FG001|Overall Study|Physician Decision|0|||
162842817|NCT00684515|588133144|FG000|Overall Study|Adverse Event|3|||
162701219|NCT02718417|587616907|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
162701220|NCT02718417|587616908|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
162701221|NCT02718417|587616909|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
162701222|NCT02718417|587616907|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
162701223|NCT02718417|587616908|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
162701224|NCT02718417|587616909|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
162701225|NCT02718417|587616907|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
162701226|NCT02718417|587616908|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
162701227|NCT02718417|587616909|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
162701228|NCT02718417|587616907|FG000|Long-term Follow-up Phase|Other|0|||
162701229|NCT02718417|587616908|FG001|Long-term Follow-up Phase|Other|2|||
162701230|NCT02718417|587616909|FG002|Long-term Follow-up Phase|Other|0|||
162842818|NCT00684515|588133145|FG001|Overall Study|Adverse Event|3|||
162842819|NCT00684515|588133146|FG002|Overall Study|Adverse Event|1|||
162842820|NCT00684515|588133144|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
162701231|NCT00506285|587616910|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
162842821|NCT00684515|588133145|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
162951462|NCT00304083|588525487|FG001|Overall Study|Physician Decision|3|||
162951463|NCT00304083|588525486|FG000|Overall Study|Disease Progression|5|||
162951464|NCT00304083|588525487|FG001|Overall Study|Disease Progression|1|||
162951465|NCT00304083|588525486|FG000|Overall Study|Other|5|||
162951466|NCT00304083|588525487|FG001|Overall Study|Other|2|||
162951467|NCT03966365|588525488|FG000|Overall Study|Protocol Violation|1|||
162951468|NCT03966365|588525489|FG001|Overall Study|Protocol Violation|0|||
162951469|NCT01378975|588525490|FG000|Overall Study|Death|77|||
162951470|NCT01378975|588525491|FG001|Overall Study|Death|46|||
162951471|NCT01378975|588525490|FG000|Overall Study|Investigator Request|1|||
162951472|NCT01378975|588525491|FG001|Overall Study|Investigator Request|0|||
162951473|NCT01378975|588525490|FG000|Overall Study|Lost to Follow-up|4|||
162951474|NCT01378975|588525491|FG001|Overall Study|Lost to Follow-up|1|||
162951475|NCT01378975|588525490|FG000|Overall Study|Withdrew Consent|4|||
162951476|NCT01378975|588525491|FG001|Overall Study|Withdrew Consent|3|||
162951477|NCT00319735|588525492|FG000|Overall Study|Death|2|||
162951478|NCT01149473|588527543|FG000|First Intervention|Adverse Event|1|||
162951479|NCT01149473|588527544|FG001|First Intervention|Adverse Event|1|||
162951480|NCT01149473|588527543|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162951481|NCT01149473|588527544|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162951482|NCT01247701|588527545|FG000|Overall Study|Death|2|||
162951483|NCT01247701|588527545|FG000|Overall Study|Relapsed|8|||
162951484|NCT04166630|588527546|FG000|Overall Study|Withdrawal by Subject|0|||
162951485|NCT04166630|588527547|FG001|Overall Study|Withdrawal by Subject|1|||
162951486|NCT01838941|588527548|FG000|Overall Study|Adverse Event|1|||
162951487|NCT01838941|588527548|FG000|Overall Study|Withdrawal by Subject|1|||
162951488|NCT02822235|588527549|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
162951489|NCT02822235|588527550|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
162951490|NCT02822235|588527549|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
162951491|NCT02822235|588527550|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
162951492|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
162951493|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
162951494|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
162951495|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
162951496|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
162951497|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
163042862|NCT00845676|588863980|FG000|Overall Study|Virologic breakthrough at week 20|1|||
162842822|NCT00684515|588133146|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
162842823|NCT02167945|588133147|FG000|Overall Study|Adverse Event|16|||
162842824|NCT02167945|588133147|FG000|Overall Study|Withdrew Consent|42|||
162842825|NCT02167945|588133147|FG000|Overall Study|Lost to Follow-up|122|||
162842826|NCT02167945|588133147|FG000|Overall Study|COVID-19 logistical restrictions|6|||
162842827|NCT02167945|588133147|FG000|Overall Study|Other, not specified|63|||
162842828|NCT00132730|588133148|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
162842829|NCT00132730|588133149|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
162842830|NCT00132730|588133150|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
162842831|NCT00132730|588133151|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
162842832|NCT00132730|588133152|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
162842833|NCT00132730|588133153|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
162842834|NCT00132730|588133148|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
162842835|NCT00132730|588133149|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
162842836|NCT00132730|588133150|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
162842837|NCT00132730|588133151|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
162842838|NCT00132730|588133152|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
162842839|NCT00132730|588133153|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
162842840|NCT00132730|588133148|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
162842841|NCT00132730|588133149|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
162842842|NCT00132730|588133150|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
162842843|NCT00132730|588133151|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
162842844|NCT00132730|588133152|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
162842845|NCT00132730|588133153|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
162842846|NCT00132730|588133148|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
162842847|NCT00132730|588133149|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
162842848|NCT00132730|588133150|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
162951498|NCT02822235|588527549|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
162951499|NCT02822235|588527550|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
162951500|NCT00829530|588527551|FG000|First Intervention|Adverse Event|0|||
162951501|NCT00829530|588527552|FG001|First Intervention|Adverse Event|1|||
162951502|NCT00829530|588527551|FG000|First Intervention|Intolerance to Venopuncture|0|||
162701232|NCT00506285|587616911|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
162701233|NCT00506285|587616910|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
162701234|NCT00506285|587616911|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
162701235|NCT00506285|587616910|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
162701236|NCT00506285|587616911|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
162701237|NCT00506285|587616910|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
162701238|NCT00506285|587616911|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
162701239|NCT00506285|587616910|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
162701240|NCT00506285|587616911|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
162701241|NCT00551213|587616914|FG000|Overall Study|Adverse Event|6|||
162701242|NCT00551213|587616915|FG001|Overall Study|Adverse Event|3|||
162701243|NCT00551213|587616914|FG000|Overall Study|Progressive Disease|41|||
162701244|NCT00551213|587616915|FG001|Overall Study|Progressive Disease|12|||
162701245|NCT00551213|587616914|FG000|Overall Study|Withdrawal by Subject|2|||
162701246|NCT00551213|587616915|FG001|Overall Study|Withdrawal by Subject|0|||
162701247|NCT00551213|587616914|FG000|Overall Study|Not Treated|1|||
162701248|NCT00551213|587616915|FG001|Overall Study|Not Treated|2|||
162701249|NCT01890967|587616916|FG000|Overall Study|Adverse Event|3|||
162701250|NCT01890967|587616917|FG001|Overall Study|Adverse Event|3|||
162701251|NCT01890967|587616918|FG002|Overall Study|Adverse Event|3|||
162701252|NCT01890967|587616919|FG003|Overall Study|Adverse Event|2|||
162701253|NCT01890967|587616920|FG004|Overall Study|Adverse Event|1|||
162701254|NCT01890967|587616921|FG005|Overall Study|Adverse Event|7|||
162701255|NCT01890967|587616916|FG000|Overall Study|Death|1|||
162701256|NCT01890967|587616917|FG001|Overall Study|Death|0|||
162701257|NCT01890967|587616918|FG002|Overall Study|Death|0|||
162701258|NCT01890967|587616919|FG003|Overall Study|Death|0|||
162701259|NCT01890967|587616920|FG004|Overall Study|Death|0|||
162701260|NCT01890967|587616921|FG005|Overall Study|Death|0|||
162701261|NCT01890967|587616916|FG000|Overall Study|Lost to Follow-up|1|||
162701262|NCT01890967|587616917|FG001|Overall Study|Lost to Follow-up|1|||
162701263|NCT01890967|587616918|FG002|Overall Study|Lost to Follow-up|1|||
162701264|NCT01890967|587616919|FG003|Overall Study|Lost to Follow-up|1|||
162701265|NCT01890967|587616920|FG004|Overall Study|Lost to Follow-up|0|||
162701266|NCT01890967|587616921|FG005|Overall Study|Lost to Follow-up|1|||
162701267|NCT01890967|587616916|FG000|Overall Study|Protocol Violation|0|||
162701268|NCT01890967|587616917|FG001|Overall Study|Protocol Violation|3|||
162701269|NCT01890967|587616918|FG002|Overall Study|Protocol Violation|3|||
162701270|NCT01890967|587616919|FG003|Overall Study|Protocol Violation|2|||
162701271|NCT01890967|587616920|FG004|Overall Study|Protocol Violation|4|||
162701272|NCT01890967|587616921|FG005|Overall Study|Protocol Violation|1|||
162701273|NCT01890967|587616916|FG000|Overall Study|Sponsor Decision|2|||
162701274|NCT01890967|587616917|FG001|Overall Study|Sponsor Decision|0|||
162701275|NCT01890967|587616918|FG002|Overall Study|Sponsor Decision|1|||
162701276|NCT01890967|587616919|FG003|Overall Study|Sponsor Decision|3|||
162701277|NCT01890967|587616920|FG004|Overall Study|Sponsor Decision|2|||
162701278|NCT01890967|587616921|FG005|Overall Study|Sponsor Decision|3|||
162701279|NCT01890967|587616916|FG000|Overall Study|Withdrawal by Subject|3|||
162951503|NCT00829530|588527552|FG001|First Intervention|Intolerance to Venopuncture|1|||
162951504|NCT00829530|588527551|FG000|Second Intervention|Intolerance to Venopuncture|1|||
162951505|NCT00829530|588527552|FG001|Second Intervention|Intolerance to Venopuncture|0|||
162951506|NCT01038856|588527555|FG000|Overall Study|Adverse Event|2|||
162951507|NCT04638153|588527556|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162951508|NCT04638153|588527557|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162951509|NCT04638153|588527558|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162951510|NCT04638153|588527556|FG000|Overall Study|Study terminated by sponsor|4|||
162701280|NCT01890967|587616917|FG001|Overall Study|Withdrawal by Subject|4|||
162701281|NCT01890967|587616918|FG002|Overall Study|Withdrawal by Subject|2|||
162701282|NCT01890967|587616919|FG003|Overall Study|Withdrawal by Subject|3|||
162701283|NCT01890967|587616920|FG004|Overall Study|Withdrawal by Subject|3|||
162701284|NCT01890967|587616921|FG005|Overall Study|Withdrawal by Subject|1|||
162951511|NCT04638153|588527557|FG001|Overall Study|Study terminated by sponsor|2|||
162842849|NCT00132730|588133151|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
162842850|NCT00132730|588133152|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
162842851|NCT00132730|588133153|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
162842852|NCT00132730|588133148|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
162842853|NCT00132730|588133149|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
162842854|NCT00132730|588133150|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
162842855|NCT00132730|588133151|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
162842856|NCT00132730|588133152|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
162842857|NCT00132730|588133153|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
162842858|NCT00132730|588133148|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
162842859|NCT00132730|588133149|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
162842860|NCT00132730|588133150|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
162842861|NCT00132730|588133151|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
162842862|NCT00132730|588133152|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
162842863|NCT00132730|588133153|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
162842864|NCT00132730|588133148|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
162842865|NCT00132730|588133149|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
162842866|NCT00132730|588133150|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
162842867|NCT00132730|588133151|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
162842868|NCT00132730|588133152|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
162842869|NCT00132730|588133153|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
162842870|NCT00132730|588133148|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
162842871|NCT00132730|588133149|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
162842872|NCT00132730|588133150|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
162842873|NCT00132730|588133151|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
162842874|NCT00132730|588133152|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
162842875|NCT00132730|588133153|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
162842876|NCT00132730|588133148|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
162842877|NCT00132730|588133149|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
162842878|NCT00132730|588133150|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
162842879|NCT00132730|588133151|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
162842880|NCT00132730|588133152|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
162842881|NCT00132730|588133153|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
162842882|NCT00132730|588133148|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
162842883|NCT00132730|588133149|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
162842884|NCT00132730|588133150|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
162842885|NCT00132730|588133151|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
162842886|NCT00132730|588133152|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
162842887|NCT00132730|588133153|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
162842888|NCT00132730|588133148|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
162842889|NCT00132730|588133149|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
162842890|NCT00132730|588133150|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
162842891|NCT00132730|588133151|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
162842892|NCT00132730|588133152|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
162842893|NCT00132730|588133153|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
162842894|NCT00132730|588133148|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
162842895|NCT00132730|588133149|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
162842896|NCT00132730|588133150|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
162842897|NCT00132730|588133151|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
162842898|NCT00132730|588133152|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
162842899|NCT00132730|588133153|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
162842900|NCT02623335|588133154|FG000|Overall Study|Death|8|||
162842901|NCT02623335|588133155|FG001|Overall Study|Death|7|||
162842902|NCT02623335|588133154|FG000|Overall Study|Lost to Follow-up|15|||
162842903|NCT02623335|588133155|FG001|Overall Study|Lost to Follow-up|23|||
162842904|NCT02623335|588133154|FG000|Overall Study|Withdrawal by Subject|2|||
162842905|NCT02623335|588133155|FG001|Overall Study|Withdrawal by Subject|5|||
162842906|NCT02623335|588133154|FG000|Overall Study|Protocol Violation|2|||
162842907|NCT02623335|588133155|FG001|Overall Study|Protocol Violation|1|||
162842908|NCT02971670|588133158|FG000|Overall Study|Withdrawal by Subject|4|||
162842909|NCT02971670|588133159|FG001|Overall Study|Withdrawal by Subject|1|||
162842910|NCT02971670|588133160|FG002|Overall Study|Withdrawal by Subject|1|||
162842911|NCT02971670|588133161|FG003|Overall Study|Withdrawal by Subject|2|||
162951512|NCT04638153|588527558|FG002|Overall Study|Study terminated by sponsor|14|||
162951513|NCT01440283|588527559|FG000|Overall Study|Death|3|||
162951514|NCT01440283|588527559|FG000|Overall Study|Withdrawal by Subject|4|||
162951515|NCT01440283|588527559|FG000|Overall Study|Physician Decision|3|||
162951516|NCT01196052|588527560|FG000|Overall Study|Adverse Event|9|||
162951517|NCT01196052|588527560|FG000|Overall Study|Lost to Follow-up|1|||
162951518|NCT01196052|588527560|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
162951519|NCT01196052|588527560|FG000|Overall Study|Reason not Specified|5|||
162951520|NCT01196052|588527560|FG000|Overall Study|Withdrawal by Subject|6|||
162951521|NCT01389102|588527561|FG000|Overall Study|Adverse Event|1|||
162951522|NCT01389102|588527562|FG001|Overall Study|Adverse Event|3|||
162951523|NCT01389102|588527563|FG002|Overall Study|Adverse Event|2|||
162951524|NCT01389102|588527564|FG003|Overall Study|Adverse Event|2|||
162951525|NCT01389102|588527565|FG004|Overall Study|Adverse Event|2|||
162951526|NCT01389102|588527566|FG005|Overall Study|Adverse Event|2|||
162951527|NCT01389102|588527561|FG000|Overall Study|Hurricane Katrina|4|||
162951528|NCT01389102|588527562|FG001|Overall Study|Hurricane Katrina|2|||
162951529|NCT01389102|588527563|FG002|Overall Study|Hurricane Katrina|3|||
162951530|NCT01389102|588527564|FG003|Overall Study|Hurricane Katrina|0|||
162951531|NCT01389102|588527565|FG004|Overall Study|Hurricane Katrina|3|||
162951532|NCT01389102|588527566|FG005|Overall Study|Hurricane Katrina|1|||
162951533|NCT01389102|588527561|FG000|Overall Study|Lost to Follow-up|4|||
162951534|NCT01389102|588527562|FG001|Overall Study|Lost to Follow-up|1|||
162951535|NCT01389102|588527563|FG002|Overall Study|Lost to Follow-up|1|||
162951536|NCT01389102|588527564|FG003|Overall Study|Lost to Follow-up|2|||
162951537|NCT01389102|588527565|FG004|Overall Study|Lost to Follow-up|4|||
162951538|NCT01389102|588527566|FG005|Overall Study|Lost to Follow-up|1|||
162951539|NCT01389102|588527561|FG000|Overall Study|Protocol Violation|0|||
162951540|NCT01389102|588527562|FG001|Overall Study|Protocol Violation|0|||
162951541|NCT01389102|588527563|FG002|Overall Study|Protocol Violation|3|||
162951542|NCT01389102|588527564|FG003|Overall Study|Protocol Violation|0|||
162701285|NCT02892409|587616922|FG000|Overall Study|Adverse Event|1|||
162701286|NCT02892409|587616923|FG001|Overall Study|Adverse Event|0|||
162951543|NCT01389102|588527565|FG004|Overall Study|Protocol Violation|1|||
162951544|NCT01389102|588527566|FG005|Overall Study|Protocol Violation|1|||
162951545|NCT01389102|588527561|FG000|Overall Study|Withdrawal by Subject|7|||
162951546|NCT01389102|588527562|FG001|Overall Study|Withdrawal by Subject|4|||
162951547|NCT01389102|588527563|FG002|Overall Study|Withdrawal by Subject|9|||
162842912|NCT01127165|588133162|FG000|Overall Study|Adverse Event|2|||
162842913|NCT01127165|588133163|FG001|Overall Study|Adverse Event|2|||
162842914|NCT01127165|588133162|FG000|Overall Study|Lack of Efficacy|10|||
162842915|NCT01127165|588133163|FG001|Overall Study|Lack of Efficacy|8|||
162842916|NCT01127165|588133162|FG000|Overall Study|Lost to Follow-up|3|||
162842917|NCT01127165|588133163|FG001|Overall Study|Lost to Follow-up|5|||
162842918|NCT01127165|588133162|FG000|Overall Study|Withdrawal by Subject|1|||
162842919|NCT01127165|588133163|FG001|Overall Study|Withdrawal by Subject|3|||
162842920|NCT01127165|588133162|FG000|Overall Study|Protocol Violation|0|||
162842921|NCT01127165|588133163|FG001|Overall Study|Protocol Violation|1|||
162842922|NCT00763321|588133164|FG000|Open-label Period|Adverse Event|24|||
162842923|NCT00763321|588133165|FG001|Open-label Period|Adverse Event|0|||
162842924|NCT00763321|588133166|FG002|Open-label Period|Adverse Event|0|||
162842925|NCT00763321|588133164|FG000|Open-label Period|Lost to Follow-up|14|||
162842926|NCT00763321|588133165|FG001|Open-label Period|Lost to Follow-up|0|||
162842927|NCT00763321|588133166|FG002|Open-label Period|Lost to Follow-up|0|||
162842928|NCT00763321|588133164|FG000|Open-label Period|Withdrawal by Subject|7|||
162842929|NCT00763321|588133165|FG001|Open-label Period|Withdrawal by Subject|0|||
162842930|NCT00763321|588133166|FG002|Open-label Period|Withdrawal by Subject|0|||
162842931|NCT00763321|588133164|FG000|Open-label Period|Subject noncompliant|7|||
162842932|NCT00763321|588133165|FG001|Open-label Period|Subject noncompliant|0|||
162842933|NCT00763321|588133166|FG002|Open-label Period|Subject noncompliant|0|||
162842934|NCT00763321|588133164|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
162842935|NCT00763321|588133165|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
162842936|NCT00763321|588133166|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
162842937|NCT00763321|588133164|FG000|Open-label Period|Lack of Efficacy|2|||
162842938|NCT00763321|588133165|FG001|Open-label Period|Lack of Efficacy|0|||
162842939|NCT00763321|588133166|FG002|Open-label Period|Lack of Efficacy|0|||
162842940|NCT00763321|588133164|FG000|Open-label Period|Other|4|||
162842941|NCT00763321|588133165|FG001|Open-label Period|Other|0|||
162842942|NCT00763321|588133166|FG002|Open-label Period|Other|0|||
162842943|NCT00763321|588133164|FG000|Double-blind Period|Lack of Efficacy|0|||
162842944|NCT00763321|588133165|FG001|Double-blind Period|Lack of Efficacy|9|||
162842945|NCT00763321|588133166|FG002|Double-blind Period|Lack of Efficacy|17|||
162842946|NCT00763321|588133164|FG000|Double-blind Period|Adverse Event|0|||
162842947|NCT00763321|588133165|FG001|Double-blind Period|Adverse Event|4|||
162951548|NCT01389102|588527564|FG003|Overall Study|Withdrawal by Subject|2|||
162951549|NCT01389102|588527565|FG004|Overall Study|Withdrawal by Subject|3|||
162951550|NCT01389102|588527566|FG005|Overall Study|Withdrawal by Subject|3|||
162951551|NCT01389102|588527561|FG000|Overall Study|Subject Traveling Out of Country|0|||
162951552|NCT01389102|588527562|FG001|Overall Study|Subject Traveling Out of Country|0|||
162951553|NCT01389102|588527563|FG002|Overall Study|Subject Traveling Out of Country|0|||
162842948|NCT00763321|588133166|FG002|Double-blind Period|Adverse Event|4|||
162842949|NCT00763321|588133164|FG000|Double-blind Period|Lost to Follow-up|0|||
162842950|NCT00763321|588133165|FG001|Double-blind Period|Lost to Follow-up|4|||
162842951|NCT00763321|588133166|FG002|Double-blind Period|Lost to Follow-up|2|||
162842952|NCT00763321|588133164|FG000|Double-blind Period|Withdrawal by Subject|0|||
162842953|NCT00763321|588133165|FG001|Double-blind Period|Withdrawal by Subject|2|||
162842954|NCT00763321|588133166|FG002|Double-blind Period|Withdrawal by Subject|3|||
162842955|NCT00763321|588133164|FG000|Double-blind Period|Other|0|||
162842956|NCT00763321|588133165|FG001|Double-blind Period|Other|2|||
162701287|NCT02892409|587616922|FG000|Overall Study|Withdrawal by Subject|2|||
162701288|NCT02892409|587616923|FG001|Overall Study|Withdrawal by Subject|1|||
162701289|NCT00867490|587616924|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
162701290|NCT00867490|587616924|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
162701291|NCT00867490|587616924|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
162701292|NCT00867490|587616924|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
162701293|NCT00867490|587616924|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
162701294|NCT02264574|587616931|FG000|Overall Study|Death|21|||
162701295|NCT02264574|587616932|FG001|Overall Study|Death|21|||
162701296|NCT02264574|587616931|FG000|Overall Study|Withdrawal by Subject|8|||
162701297|NCT02264574|587616932|FG001|Overall Study|Withdrawal by Subject|6|||
162701298|NCT02264574|587616931|FG000|Overall Study|Other, Not Specified|0|||
162701299|NCT02264574|587616932|FG001|Overall Study|Other, Not Specified|3|||
162701300|NCT02080520|587616933|FG000|Overall Study|Self-reported symptoms|5|||
162701301|NCT02080520|587616934|FG001|Overall Study|Self-reported symptoms|6|||
162701302|NCT02080520|587616933|FG000|Overall Study|Unable to contact|2|||
162701303|NCT02080520|587616934|FG001|Overall Study|Unable to contact|1|||
162701304|NCT02080520|587616933|FG000|Overall Study|Initiated aspirin|2|||
162701305|NCT02080520|587616934|FG001|Overall Study|Initiated aspirin|0|||
162701306|NCT02080520|587616933|FG000|Overall Study|Atrial fibrillation|1|||
162701307|NCT02080520|587616934|FG001|Overall Study|Atrial fibrillation|1|||
162701308|NCT02080520|587616933|FG000|Overall Study|Cancer|1|||
162701309|NCT02080520|587616934|FG001|Overall Study|Cancer|2|||
162701310|NCT02080520|587616933|FG000|Overall Study|Not interested in study|1|||
162701311|NCT02080520|587616934|FG001|Overall Study|Not interested in study|3|||
162701312|NCT02080520|587616933|FG000|Overall Study|Too busy|1|||
162701313|NCT02080520|587616934|FG001|Overall Study|Too busy|1|||
162701314|NCT02080520|587616933|FG000|Overall Study|Work-related injury|1|||
162701315|NCT02080520|587616934|FG001|Overall Study|Work-related injury|0|||
162701316|NCT02080520|587616933|FG000|Overall Study|Personal reasons|0|||
162701317|NCT02080520|587616934|FG001|Overall Study|Personal reasons|3|||
162701318|NCT02406261|587616935|FG000|Period 1|Lost to Follow-up|2|||
162701319|NCT02406261|587616936|FG001|Period 1|Lost to Follow-up|0|||
162701320|NCT02406261|587616935|FG000|Period 1|Adverse Event|1|||
162701321|NCT02406261|587616936|FG001|Period 1|Adverse Event|0|||
162701322|NCT02406261|587616935|FG000|Period 2|Physician Decision|0|||
162701323|NCT02406261|587616936|FG001|Period 2|Physician Decision|1|||
162701324|NCT02406261|587616935|FG000|Period 2|Protocol Violation|0|||
162701325|NCT02406261|587616936|FG001|Period 2|Protocol Violation|1|||
162701326|NCT02406261|587616935|FG000|Period 2|Withdrawal by Subject|0|||
162701327|NCT02406261|587616936|FG001|Period 2|Withdrawal by Subject|1|||
162701328|NCT04102540|587616944|FG000|Overall Study|Withdrawn by PI|2|||
162701329|NCT04102540|587616944|FG000|Overall Study|Lost to Follow-up|6|||
162701330|NCT01567163|587616945|FG000|Overall Study|Progressive Disease|2|||
162701331|NCT01567163|587616945|FG000|Overall Study|Lost to Follow-up|2|||
162701332|NCT01720797|587616946|FG000|Overall Study|Withdrawal by Subject|3|||
162701333|NCT01720797|587616947|FG001|Overall Study|Withdrawal by Subject|0|||
162951554|NCT01389102|588527564|FG003|Overall Study|Subject Traveling Out of Country|1|||
162951555|NCT01389102|588527565|FG004|Overall Study|Subject Traveling Out of Country|0|||
162951556|NCT01389102|588527566|FG005|Overall Study|Subject Traveling Out of Country|0|||
162951557|NCT01389102|588527561|FG000|Overall Study|Subject Moved|2|||
162951558|NCT01389102|588527562|FG001|Overall Study|Subject Moved|0|||
162951559|NCT01389102|588527563|FG002|Overall Study|Subject Moved|1|||
162951560|NCT01389102|588527564|FG003|Overall Study|Subject Moved|0|||
162951561|NCT01389102|588527565|FG004|Overall Study|Subject Moved|0|||
162951562|NCT01389102|588527566|FG005|Overall Study|Subject Moved|0|||
162951563|NCT01389102|588527561|FG000|Overall Study|Unavailable due to husband's illness|0|||
162951564|NCT01389102|588527562|FG001|Overall Study|Unavailable due to husband's illness|1|||
162951565|NCT01389102|588527563|FG002|Overall Study|Unavailable due to husband's illness|0|||
162951566|NCT01389102|588527564|FG003|Overall Study|Unavailable due to husband's illness|0|||
162951567|NCT01389102|588527565|FG004|Overall Study|Unavailable due to husband's illness|0|||
162951568|NCT01389102|588527566|FG005|Overall Study|Unavailable due to husband's illness|0|||
162951569|NCT01389102|588527561|FG000|Overall Study|Investigator Judgement|0|||
162951570|NCT01389102|588527562|FG001|Overall Study|Investigator Judgement|1|||
162951571|NCT01389102|588527563|FG002|Overall Study|Investigator Judgement|0|||
162951572|NCT01389102|588527564|FG003|Overall Study|Investigator Judgement|0|||
162951573|NCT01389102|588527565|FG004|Overall Study|Investigator Judgement|0|||
162951574|NCT01389102|588527566|FG005|Overall Study|Investigator Judgement|0|||
162951575|NCT00050778|588527567|FG000|Overall Study|Adverse Event|13|||
162951576|NCT00050778|588527568|FG001|Overall Study|Adverse Event|3|||
162951577|NCT00050778|588527569|FG002|Overall Study|Adverse Event|2|||
162701334|NCT00393094|587616951|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
162701335|NCT00393094|587616951|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
162701336|NCT02019602|587616952|FG000|Screening Period|Ineligibility|4|||
162701337|NCT02019602|587616953|FG001|Screening Period|Ineligibility|0|||
162701338|NCT02019602|587616952|FG000|Screening Period|Adverse Event|1|||
162701339|NCT02019602|587616953|FG001|Screening Period|Adverse Event|0|||
162842957|NCT00763321|588133166|FG002|Double-blind Period|Other|3|||
162842958|NCT03175549|588133167|FG000|Overall Study|Lost to Follow-up|2|||
162842959|NCT03175549|588133168|FG001|Overall Study|Lost to Follow-up|2|||
162842960|NCT03175549|588133167|FG000|Overall Study|Medication non-compliance|2|||
162842961|NCT03175549|588133168|FG001|Overall Study|Medication non-compliance|2|||
162842962|NCT02793232|588133169|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842963|NCT02793232|588133170|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842964|NCT02793232|588133171|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842965|NCT02793232|588133172|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842966|NCT02793232|588133173|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
162842967|NCT02793232|588133174|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842968|NCT02793232|588133175|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
162842969|NCT02793232|588133176|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842970|NCT02793232|588133177|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
162842971|NCT02387580|588133180|FG000|Overall Study|Withdrawal by Subject|0|||
162842972|NCT02387580|588133181|FG001|Overall Study|Withdrawal by Subject|0|||
162842973|NCT02387580|588133182|FG002|Overall Study|Withdrawal by Subject|0|||
162842974|NCT02387580|588133183|FG003|Overall Study|Withdrawal by Subject|1|||
162842975|NCT02387580|588133184|FG004|Overall Study|Withdrawal by Subject|0|||
162842976|NCT02387580|588133185|FG005|Overall Study|Withdrawal by Subject|0|||
162842977|NCT01064167|588133186|FG000|Overall Study|Protocol Violation|14|||
162842978|NCT01064167|588133187|FG001|Overall Study|Protocol Violation|15|||
162842979|NCT03984305|588133188|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
162842980|NCT03984305|588133189|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
162842981|NCT03984305|588133188|FG000|Overall Study|Withdrawal by Subject|3|||
162842982|NCT03984305|588133189|FG001|Overall Study|Withdrawal by Subject|3|||
162842983|NCT03984305|588133188|FG000|Overall Study|Lost to Follow-up|1|||
162842984|NCT03984305|588133189|FG001|Overall Study|Lost to Follow-up|0|||
162842985|NCT02883244|588133190|FG000|Overall Study|Lost to Follow-up|0|||
162842986|NCT02883244|588133191|FG001|Overall Study|Lost to Follow-up|1|||
162842987|NCT02301403|588133206|FG000|Overall Study|Withdrawal by Subject|28|||
162842988|NCT02301403|588133207|FG001|Overall Study|Withdrawal by Subject|41|||
162842989|NCT01060059|588133210|FG000|Overall Study|Adverse Event|1|||
162842990|NCT01060059|588133211|FG001|Overall Study|Adverse Event|1|||
162842991|NCT01060059|588133210|FG000|Overall Study|Death|2|||
162701340|NCT03207711|587616956|FG000|Overall Study|Withdrawal by Subject|1|||
162701341|NCT03207711|587616957|FG001|Overall Study|Withdrawal by Subject|2|||
162701342|NCT02372058|587616960|FG000|Overall Study|Withdrawal by Subject|3|||
162701343|NCT02788006|587616964|FG000|Overall Study|Patient not treated|1|||
162701344|NCT00318149|587616965|FG000|Overall Study|Adverse Event|0|||
162701345|NCT00318149|587616966|FG001|Overall Study|Adverse Event|0|||
162701346|NCT00318149|587616967|FG002|Overall Study|Adverse Event|0|||
162701347|NCT00318149|587616968|FG003|Overall Study|Adverse Event|0|||
162701348|NCT00318149|587616969|FG004|Overall Study|Adverse Event|0|||
162701349|NCT00318149|587616970|FG005|Overall Study|Adverse Event|2|||
162701350|NCT03541642|587616973|FG000|Overall Study|Withdrawal by Subject|1|||
162701351|NCT03541642|587616974|FG001|Overall Study|Withdrawal by Subject|2|||
162701352|NCT03541642|587616973|FG000|Overall Study|Lost to Follow-up|16|||
162701353|NCT03541642|587616974|FG001|Overall Study|Lost to Follow-up|12|||
162701354|NCT03541642|587616973|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
162701355|NCT03541642|587616974|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
162701356|NCT03050398|587616979|FG000|Overall Study|Study terminated by sponsor|8|||
162701357|NCT05108649|587616980|FG000|Overall Study|Lost to Follow-up|0|||
162842992|NCT01060059|588133211|FG001|Overall Study|Death|3|||
162842993|NCT01060059|588133210|FG000|Overall Study|Lost to Follow-up|18|||
162701358|NCT05108649|587616981|FG001|Overall Study|Lost to Follow-up|4|||
162701359|NCT05108649|587616982|FG002|Overall Study|Lost to Follow-up|3|||
162842994|NCT01060059|588133211|FG001|Overall Study|Lost to Follow-up|34|||
162842995|NCT01060059|588133210|FG000|Overall Study|entry criteria not met|4|||
162842996|NCT01060059|588133211|FG001|Overall Study|entry criteria not met|3|||
162842997|NCT01060059|588133210|FG000|Overall Study|Withdrawal by Subject|35|||
162842998|NCT01060059|588133211|FG001|Overall Study|Withdrawal by Subject|23|||
162842999|NCT01060059|588133210|FG000|Overall Study|lack of glycemic control|2|||
162843000|NCT01060059|588133211|FG001|Overall Study|lack of glycemic control|1|||
162843001|NCT01060059|588133210|FG000|Overall Study|lack of compliance|5|||
162843002|NCT01060059|588133211|FG001|Overall Study|lack of compliance|2|||
162843003|NCT02302963|588133212|FG000|Overall Study|Withdrawal by Subject|2|||
162843004|NCT02302963|588133213|FG001|Overall Study|Withdrawal by Subject|1|||
162843005|NCT02302963|588133212|FG000|Overall Study|Steroid injection|0|||
162843006|NCT02302963|588133213|FG001|Overall Study|Steroid injection|1|||
162843007|NCT02302963|588133212|FG000|Overall Study|Physician Decision|1|||
162843008|NCT02302963|588133213|FG001|Overall Study|Physician Decision|0|||
162843009|NCT01816243|588133214|FG000|Overall Study|Adverse Event|6|||
162843010|NCT01816243|588133214|FG000|Overall Study|Lost to Follow-up|1|||
162843011|NCT01816243|588133214|FG000|Overall Study|Lack of Efficacy|1|||
162843012|NCT01816243|588133214|FG000|Overall Study|Not eligible for the study|1|||
162843013|NCT01816243|588133214|FG000|Overall Study|Amputation|3|||
162843014|NCT01920711|588133215|FG000|Overall Study|Death|347|||
162843015|NCT01920711|588133216|FG001|Overall Study|Death|356|||
162843016|NCT01920711|588133215|FG000|Overall Study|Lost to Follow-up|13|||
162843017|NCT01920711|588133216|FG001|Overall Study|Lost to Follow-up|14|||
162843018|NCT01920711|588133215|FG000|Overall Study|Withdrawal by Subject|4|||
162843019|NCT01920711|588133216|FG001|Overall Study|Withdrawal by Subject|3|||
162843020|NCT03891901|588133217|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
162843021|NCT03891901|588133218|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843022|NCT03891901|588133219|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843023|NCT03891901|588133220|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843024|NCT03891901|588133221|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843025|NCT03891901|588133222|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843026|NCT03891901|588133223|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843027|NCT03891901|588133224|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843028|NCT03891901|588133225|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
162843029|NCT03891901|588133217|FG000|Overall Study|Adverse Event|2|||
162843030|NCT03891901|588133218|FG001|Overall Study|Adverse Event|2|||
162843031|NCT03891901|588133219|FG002|Overall Study|Adverse Event|0|||
162843032|NCT03891901|588133220|FG003|Overall Study|Adverse Event|0|||
162843033|NCT03891901|588133221|FG004|Overall Study|Adverse Event|0|||
162951578|NCT00050778|588527567|FG000|Overall Study|Death|0|||
162951579|NCT00050778|588527568|FG001|Overall Study|Death|1|||
162951580|NCT00050778|588527569|FG002|Overall Study|Death|1|||
162951581|NCT00050778|588527567|FG000|Overall Study|Lack of Efficacy|16|||
162951582|NCT00050778|588527568|FG001|Overall Study|Lack of Efficacy|2|||
162951583|NCT00050778|588527569|FG002|Overall Study|Lack of Efficacy|2|||
162951584|NCT00050778|588527567|FG000|Overall Study|Lost to Follow-up|0|||
162951585|NCT00050778|588527568|FG001|Overall Study|Lost to Follow-up|2|||
162951586|NCT00050778|588527569|FG002|Overall Study|Lost to Follow-up|4|||
162951587|NCT00050778|588527567|FG000|Overall Study|Physician Decision|3|||
162951588|NCT00050778|588527568|FG001|Overall Study|Physician Decision|0|||
162951589|NCT00050778|588527569|FG002|Overall Study|Physician Decision|2|||
162951590|NCT00050778|588527567|FG000|Overall Study|Protocol Violation|2|||
162951591|NCT00050778|588527568|FG001|Overall Study|Protocol Violation|0|||
162951592|NCT00050778|588527569|FG002|Overall Study|Protocol Violation|1|||
162951593|NCT00050778|588527567|FG000|Overall Study|Withdrawal by Subject|6|||
162951594|NCT00050778|588527568|FG001|Overall Study|Withdrawal by Subject|8|||
162951595|NCT00050778|588527569|FG002|Overall Study|Withdrawal by Subject|4|||
162951596|NCT00050778|588527567|FG000|Overall Study|Randomized but not treated|4|||
162951597|NCT00050778|588527568|FG001|Overall Study|Randomized but not treated|5|||
162951598|NCT00050778|588527569|FG002|Overall Study|Randomized but not treated|2|||
162951599|NCT00050778|588527567|FG000|Overall Study|Familial and personal reasons|1|||
162951600|NCT00050778|588527568|FG001|Overall Study|Familial and personal reasons|0|||
162951601|NCT00050778|588527569|FG002|Overall Study|Familial and personal reasons|0|||
162843034|NCT03891901|588133222|FG005|Overall Study|Adverse Event|0|||
162843035|NCT03891901|588133223|FG006|Overall Study|Adverse Event|0|||
162843036|NCT03891901|588133224|FG007|Overall Study|Adverse Event|0|||
162951602|NCT01035060|588527570|FG000|Overall Study|Lost to Follow-up|0|||
162951603|NCT01035060|588527571|FG001|Overall Study|Lost to Follow-up|7|||
162843037|NCT03891901|588133225|FG008|Overall Study|Adverse Event|0|||
162951604|NCT01035060|588527570|FG000|Overall Study|Did not quality after 2nd screening|14|||
162951605|NCT01035060|588527571|FG001|Overall Study|Did not quality after 2nd screening|1|||
162843038|NCT03891901|588133217|FG000|Overall Study|Poor venous access|1|||
162843039|NCT03891901|588133218|FG001|Overall Study|Poor venous access|0|||
162843040|NCT03891901|588133219|FG002|Overall Study|Poor venous access|0|||
162843041|NCT03891901|588133220|FG003|Overall Study|Poor venous access|0|||
162951606|NCT01035060|588527570|FG000|Overall Study|Withdrawal by Subject|8|||
162843042|NCT03891901|588133221|FG004|Overall Study|Poor venous access|0|||
162843043|NCT03891901|588133222|FG005|Overall Study|Poor venous access|0|||
162843044|NCT03891901|588133223|FG006|Overall Study|Poor venous access|0|||
162951607|NCT01035060|588527571|FG001|Overall Study|Withdrawal by Subject|6|||
162843045|NCT03891901|588133224|FG007|Overall Study|Poor venous access|0|||
162843046|NCT03891901|588133225|FG008|Overall Study|Poor venous access|0|||
162843047|NCT03891901|588133217|FG000|Overall Study|Withdrawal by Subject|0|||
162843048|NCT03891901|588133218|FG001|Overall Study|Withdrawal by Subject|2|||
162843049|NCT03891901|588133219|FG002|Overall Study|Withdrawal by Subject|0|||
162843050|NCT03891901|588133220|FG003|Overall Study|Withdrawal by Subject|0|||
162843051|NCT03891901|588133221|FG004|Overall Study|Withdrawal by Subject|0|||
162843052|NCT03891901|588133222|FG005|Overall Study|Withdrawal by Subject|0|||
162843053|NCT03891901|588133223|FG006|Overall Study|Withdrawal by Subject|0|||
162843054|NCT03891901|588133224|FG007|Overall Study|Withdrawal by Subject|0|||
162843055|NCT03891901|588133225|FG008|Overall Study|Withdrawal by Subject|0|||
162843056|NCT03064841|588133226|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
162843057|NCT03064841|588133226|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
162843058|NCT03064841|588133226|FG000|Overall Study|Screen failure|2|||
162843059|NCT00573794|588133227|FG000|Overall Study|Adverse Event|81|||
162843060|NCT00573794|588133227|FG000|Overall Study|Withdrew Consent|90|||
162843061|NCT00573794|588133227|FG000|Overall Study|Lost to Follow-up|13|||
162843062|NCT00573794|588133227|FG000|Overall Study|Protocol Violation|6|||
162843063|NCT00573794|588133227|FG000|Overall Study|Lack of Efficacy|94|||
162843064|NCT00573794|588133227|FG000|Overall Study|Other|46|||
162843065|NCT04556617|588133238|FG000|Overall Study|progressive disease|0|||
162843066|NCT04556617|588133239|FG001|Overall Study|progressive disease|2|||
162843067|NCT04556617|588133240|FG002|Overall Study|progressive disease|2|||
162843068|NCT04556617|588133241|FG003|Overall Study|progressive disease|1|||
162843069|NCT04556617|588133242|FG004|Overall Study|progressive disease|1|||
162843070|NCT04556617|588133238|FG000|Overall Study|Physician Decision|0|||
162843071|NCT04556617|588133239|FG001|Overall Study|Physician Decision|0|||
162843072|NCT04556617|588133240|FG002|Overall Study|Physician Decision|2|||
162843073|NCT04556617|588133241|FG003|Overall Study|Physician Decision|0|||
162843074|NCT04556617|588133242|FG004|Overall Study|Physician Decision|0|||
162843075|NCT04556617|588133238|FG000|Overall Study|Adverse Event|0|||
162843076|NCT04556617|588133239|FG001|Overall Study|Adverse Event|0|||
162843077|NCT04556617|588133240|FG002|Overall Study|Adverse Event|2|||
162843078|NCT04556617|588133241|FG003|Overall Study|Adverse Event|3|||
162843079|NCT04556617|588133242|FG004|Overall Study|Adverse Event|0|||
162843080|NCT04556617|588133238|FG000|Overall Study|Withdrawal by Subject|0|||
162843081|NCT04556617|588133239|FG001|Overall Study|Withdrawal by Subject|2|||
162843082|NCT04556617|588133240|FG002|Overall Study|Withdrawal by Subject|1|||
162843083|NCT04556617|588133241|FG003|Overall Study|Withdrawal by Subject|1|||
162843084|NCT04556617|588133242|FG004|Overall Study|Withdrawal by Subject|0|||
162843085|NCT04556617|588133238|FG000|Overall Study|PSA increase|0|||
162843086|NCT04556617|588133239|FG001|Overall Study|PSA increase|1|||
162843087|NCT04556617|588133240|FG002|Overall Study|PSA increase|0|||
162843088|NCT04556617|588133241|FG003|Overall Study|PSA increase|0|||
162843089|NCT04556617|588133242|FG004|Overall Study|PSA increase|0|||
162843090|NCT04556617|588133238|FG000|Overall Study|Sponsor study termination|1|||
162843091|NCT04556617|588133239|FG001|Overall Study|Sponsor study termination|0|||
162843092|NCT04556617|588133240|FG002|Overall Study|Sponsor study termination|0|||
162843093|NCT04556617|588133241|FG003|Overall Study|Sponsor study termination|0|||
162843094|NCT04556617|588133242|FG004|Overall Study|Sponsor study termination|0|||
162843095|NCT04949841|588133243|FG000|Overall Study|Adverse Event|7|||
162843096|NCT04949841|588133243|FG000|Overall Study|Death|1|||
162843097|NCT04949841|588133243|FG000|Overall Study|Withdrawal by Subject|52|||
162843098|NCT04949841|588133243|FG000|Overall Study|Pregnancy|4|||
162843099|NCT04949841|588133243|FG000|Overall Study|Lost to Follow-up|9|||
162843100|NCT04949841|588133243|FG000|Overall Study|Lack of Efficacy|55|||
162843101|NCT04949841|588133243|FG000|Overall Study|Various reasons|9|||
162843102|NCT04820309|588133244|FG000|Overall Study|Adverse Event|96|||
162843103|NCT04820309|588133244|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
162701360|NCT05108649|587616983|FG003|Overall Study|Lost to Follow-up|6|||
162843104|NCT04820309|588133244|FG000|Overall Study|Consent Withdrawn|93|||
162843105|NCT04820309|588133244|FG000|Overall Study|failure to adhere to protocol|32|||
162843106|NCT04820309|588133244|FG000|Overall Study|alcohol or drug use|6|||
162843107|NCT04820309|588133244|FG000|Overall Study|Lost to Follow-up|46|||
162843108|NCT04820309|588133244|FG000|Overall Study|Death|2|||
162843109|NCT04820309|588133244|FG000|Overall Study|Pregnancy|1|||
162843110|NCT04820309|588133244|FG000|Overall Study|Other reasons|12|||
162843111|NCT04202679|588133251|FG000|Overall Study|Adverse Event|2|||
162843112|NCT04202679|588133252|FG001|Overall Study|Adverse Event|0|||
162843113|NCT04202679|588133251|FG000|Overall Study|Poor compliance to protocol|1|||
162843114|NCT04202679|588133252|FG001|Overall Study|Poor compliance to protocol|0|||
162843115|NCT04202679|588133251|FG000|Overall Study|Withdrawal by Subject|23|||
162843116|NCT04202679|588133252|FG001|Overall Study|Withdrawal by Subject|6|||
162843117|NCT05902364|588133253|FG000|Overall Study|Adverse Event|1|||
162843118|NCT05902364|588133254|FG001|Overall Study|Adverse Event|0|||
162843119|NCT02270242|588133255|FG000|Overall Study|Withdrawal by Subject|18|||
162843120|NCT02270242|588133256|FG001|Overall Study|Withdrawal by Subject|25|||
162843121|NCT02270242|588133255|FG000|Overall Study|Lost to Follow-up|41|||
162843122|NCT02270242|588133256|FG001|Overall Study|Lost to Follow-up|27|||
162843123|NCT02270242|588133255|FG000|Overall Study|Physician Decision|0|||
162843124|NCT02270242|588133256|FG001|Overall Study|Physician Decision|1|||
162843125|NCT03864653|588133257|FG000|Overall Study|Withdrawal by Subject|1|||
162843126|NCT02531646|588133258|FG000|Overall Study|equip. image processing issue|5|||
162843127|NCT02531646|588133259|FG001|Overall Study|equip. image processing issue|1|||
162951608|NCT01035060|588527570|FG000|Overall Study|Physician Decision|2|||
162951609|NCT01035060|588527571|FG001|Overall Study|Physician Decision|0|||
162951610|NCT00625443|588527573|FG000|Overall Study|Adverse Event|1|||
162951611|NCT00625443|588527574|FG001|Overall Study|Adverse Event|4|||
162951612|NCT00625443|588527575|FG002|Overall Study|Adverse Event|0|||
162951613|NCT00625443|588527573|FG000|Overall Study|Non-compliance with protocol|0|||
162951614|NCT00625443|588527574|FG001|Overall Study|Non-compliance with protocol|1|||
162951615|NCT00625443|588527575|FG002|Overall Study|Non-compliance with protocol|0|||
162951616|NCT00625443|588527573|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
162951617|NCT00625443|588527574|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
162951618|NCT00625443|588527575|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
162951619|NCT00625443|588527573|FG000|Overall Study|Withdrawal by Subject|0|||
162951620|NCT00625443|588527574|FG001|Overall Study|Withdrawal by Subject|1|||
162951621|NCT00625443|588527575|FG002|Overall Study|Withdrawal by Subject|2|||
162951622|NCT00625443|588527573|FG000|Overall Study|Physician Decision|0|||
162951623|NCT00625443|588527574|FG001|Overall Study|Physician Decision|4|||
162951624|NCT00625443|588527575|FG002|Overall Study|Physician Decision|2|||
162951625|NCT00625443|588527573|FG000|Overall Study|Other|0|||
162951626|NCT00625443|588527574|FG001|Overall Study|Other|1|||
162951627|NCT00625443|588527575|FG002|Overall Study|Other|1|||
162951628|NCT02015390|588527576|FG000|Overall Study|Lost to Follow-up|1|||
162951629|NCT02015390|588527577|FG001|Overall Study|Lost to Follow-up|0|||
162951630|NCT02015390|588527576|FG000|Overall Study|Adverse Event|0|||
162951631|NCT02015390|588527577|FG001|Overall Study|Adverse Event|3|||
162951632|NCT02015390|588527576|FG000|Overall Study|Physician Decision|0|||
162951633|NCT02015390|588527577|FG001|Overall Study|Physician Decision|1|||
162951634|NCT03136380|588527578|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951635|NCT03136380|588527579|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
162951636|NCT03136380|588527580|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951637|NCT03136380|588527581|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951638|NCT03136380|588527582|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162951639|NCT01661686|588527583|FG000|Overall Study|Lost to Follow-up|2|||
162951640|NCT01661686|588527584|FG001|Overall Study|Lost to Follow-up|1|||
162951641|NCT01661686|588527583|FG000|Overall Study|did not receive allocated intervention|0|||
162951642|NCT01661686|588527584|FG001|Overall Study|did not receive allocated intervention|1|||
162951643|NCT01720264|588527589|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
162951644|NCT01720264|588527589|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
162951645|NCT01720264|588527589|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
162951646|NCT02728102|588527590|FG000|Overall Study|Death|3|||
162951647|NCT02728102|588527591|FG001|Overall Study|Death|0|||
162951648|NCT02728102|588527592|FG002|Overall Study|Death|1|||
162951649|NCT02728102|588527590|FG000|Overall Study|Withdrawal by Subject|0|||
162951650|NCT02728102|588527591|FG001|Overall Study|Withdrawal by Subject|2|||
162951651|NCT02728102|588527592|FG002|Overall Study|Withdrawal by Subject|3|||
162951652|NCT02728102|588527590|FG000|Overall Study|Physician Decision|1|||
162951653|NCT02728102|588527591|FG001|Overall Study|Physician Decision|1|||
162951654|NCT02728102|588527592|FG002|Overall Study|Physician Decision|0|||
162951655|NCT02728102|588527590|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
162951656|NCT02728102|588527591|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
162843128|NCT02531646|588133260|FG002|Overall Study|equip. image processing issue|0|||
162843129|NCT00429585|588133261|FG000|Overall Study|Death|1|||
162951657|NCT02728102|588527592|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
162843130|NCT00429585|588133262|FG001|Overall Study|Death|0|||
162843131|NCT00429585|588133261|FG000|Overall Study|Lost to Follow-up|27|||
162951658|NCT02728102|588527590|FG000|Overall Study|Covid|0|||
162843132|NCT00429585|588133262|FG001|Overall Study|Lost to Follow-up|20|||
162951659|NCT02728102|588527591|FG001|Overall Study|Covid|0|||
162951660|NCT02728102|588527592|FG002|Overall Study|Covid|1|||
162843133|NCT00429585|588133261|FG000|Overall Study|Physician Decision|2|||
162951661|NCT04869787|588527593|FG000|Screening|Physician Decision|1|||
162951662|NCT04869787|588527593|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
162843134|NCT00429585|588133262|FG001|Overall Study|Physician Decision|0|||
162843135|NCT01582308|588133263|FG000|Period 1|Withdrawal by Subject|0|||
162843136|NCT01582308|588133264|FG001|Period 1|Withdrawal by Subject|0|||
162843137|NCT01582308|588133265|FG002|Period 1|Withdrawal by Subject|0|||
162843138|NCT01582308|588133266|FG003|Period 1|Withdrawal by Subject|0|||
162843139|NCT01582308|588133267|FG004|Period 1|Withdrawal by Subject|0|||
162843140|NCT01582308|588133268|FG005|Period 1|Withdrawal by Subject|0|||
162843141|NCT01582308|588133269|FG006|Period 1|Withdrawal by Subject|1|||
162843142|NCT01582308|588133270|FG007|Period 1|Withdrawal by Subject|0|||
162843143|NCT01582308|588133271|FG008|Period 1|Withdrawal by Subject|0|||
162843144|NCT01582308|588133272|FG009|Period 1|Withdrawal by Subject|0|||
162843145|NCT01582308|588133263|FG000|10-day Washout Following Period 1|Physician Decision|0|||
162843146|NCT01582308|588133264|FG001|10-day Washout Following Period 1|Physician Decision|0|||
162843147|NCT01582308|588133265|FG002|10-day Washout Following Period 1|Physician Decision|0|||
162843148|NCT01582308|588133266|FG003|10-day Washout Following Period 1|Physician Decision|0|||
162843149|NCT01582308|588133267|FG004|10-day Washout Following Period 1|Physician Decision|1|||
162843150|NCT01582308|588133268|FG005|10-day Washout Following Period 1|Physician Decision|0|||
162843151|NCT01582308|588133269|FG006|10-day Washout Following Period 1|Physician Decision|0|||
162843152|NCT01582308|588133270|FG007|10-day Washout Following Period 1|Physician Decision|0|||
162843153|NCT01582308|588133271|FG008|10-day Washout Following Period 1|Physician Decision|0|||
162843154|NCT01582308|588133272|FG009|10-day Washout Following Period 1|Physician Decision|0|||
162843155|NCT01582308|588133263|FG000|Period 4|Physician Decision|1|||
162843156|NCT01582308|588133264|FG001|Period 4|Physician Decision|0|||
162843157|NCT01582308|588133265|FG002|Period 4|Physician Decision|0|||
162843158|NCT01582308|588133266|FG003|Period 4|Physician Decision|0|||
162843159|NCT01582308|588133267|FG004|Period 4|Physician Decision|0|||
162843160|NCT01582308|588133268|FG005|Period 4|Physician Decision|1|||
162843161|NCT01582308|588133269|FG006|Period 4|Physician Decision|0|||
162843162|NCT01582308|588133270|FG007|Period 4|Physician Decision|0|||
162843163|NCT01582308|588133271|FG008|Period 4|Physician Decision|0|||
162843164|NCT01582308|588133272|FG009|Period 4|Physician Decision|1|||
162843165|NCT00772668|588133275|FG000|Overall Study|Physician Decision|3|||
162843166|NCT01182428|588133276|FG000|Overall Study|Physician Decision|1|||
162701361|NCT05108649|587616980|FG000|Overall Study|Not Interested|1|||
162701362|NCT05108649|587616981|FG001|Overall Study|Not Interested|1|||
162701363|NCT05108649|587616982|FG002|Overall Study|Not Interested|0|||
162701364|NCT05108649|587616983|FG003|Overall Study|Not Interested|1|||
162701365|NCT05108649|587616980|FG000|Overall Study|Out of area|0|||
162701366|NCT05108649|587616981|FG001|Overall Study|Out of area|0|||
162701367|NCT05108649|587616982|FG002|Overall Study|Out of area|0|||
162701368|NCT05108649|587616983|FG003|Overall Study|Out of area|1|||
162701369|NCT05108649|587616980|FG000|Overall Study|PI decision|1|||
162701370|NCT05108649|587616981|FG001|Overall Study|PI decision|0|||
162701371|NCT05108649|587616982|FG002|Overall Study|PI decision|0|||
162701372|NCT05108649|587616983|FG003|Overall Study|PI decision|0|||
162701373|NCT05108649|587616980|FG000|Overall Study|Significant Non-Compliance|0|||
162701374|NCT05108649|587616981|FG001|Overall Study|Significant Non-Compliance|1|||
162701375|NCT05108649|587616982|FG002|Overall Study|Significant Non-Compliance|0|||
162701376|NCT05108649|587616983|FG003|Overall Study|Significant Non-Compliance|0|||
162701377|NCT05108649|587616980|FG000|Overall Study|Unable to adhere to study protocol|0|||
162701378|NCT05108649|587616981|FG001|Overall Study|Unable to adhere to study protocol|2|||
162701379|NCT05108649|587616982|FG002|Overall Study|Unable to adhere to study protocol|0|||
162701380|NCT05108649|587616983|FG003|Overall Study|Unable to adhere to study protocol|0|||
162701381|NCT03523871|587616984|FG000|Overall Study|Death|1|||
162701382|NCT01083160|587616985|FG000|Overall Study|Adverse Event|1|||
162701383|NCT01951092|587616986|FG000|Overall Study|Lost to Follow-up|10|||
162701384|NCT01951092|587616986|FG000|Overall Study|Incarceration|1|||
162701385|NCT01951092|587616986|FG000|Overall Study|Transfer of Care|1|||
162701386|NCT00918749|587616987|FG000|Overall Study|Adverse Event|1|||
162701387|NCT00918749|587616988|FG001|Overall Study|Adverse Event|0|||
162701388|NCT00918749|587616989|FG002|Overall Study|Adverse Event|1|||
162701389|NCT00918749|587616987|FG000|Overall Study|Lost to Follow-up|0|||
162701390|NCT00918749|587616988|FG001|Overall Study|Lost to Follow-up|0|||
162701391|NCT00918749|587616989|FG002|Overall Study|Lost to Follow-up|1|||
162701392|NCT00918749|587616987|FG000|Overall Study|Withdrawal by Subject|5|||
162701393|NCT00918749|587616988|FG001|Overall Study|Withdrawal by Subject|3|||
162701394|NCT00918749|587616989|FG002|Overall Study|Withdrawal by Subject|5|||
162701395|NCT00918749|587616987|FG000|Overall Study|No Study Medication Taken|1|||
162701396|NCT00918749|587616988|FG001|Overall Study|No Study Medication Taken|0|||
162843167|NCT01182428|588133277|FG001|Overall Study|Physician Decision|0|||
162843168|NCT01182428|588133276|FG000|Overall Study|Lost to Follow-up|9|||
162843169|NCT01182428|588133277|FG001|Overall Study|Lost to Follow-up|1|||
162843170|NCT01182428|588133276|FG000|Overall Study|Withdrawal by Subject|1|||
162843171|NCT01182428|588133277|FG001|Overall Study|Withdrawal by Subject|0|||
162843172|NCT03631706|588133279|FG000|Overall Study|Randomized, not treated|1|||
162843173|NCT03631706|588133280|FG001|Overall Study|Randomized, not treated|0|||
162843174|NCT02554929|588135351|FG000|Overall Study|Lost to Follow-up|4|||
162843175|NCT02554929|588135352|FG001|Overall Study|Lost to Follow-up|4|||
162843176|NCT02554929|588135351|FG000|Overall Study|Withdrawal by Subject|2|||
162843177|NCT02554929|588135352|FG001|Overall Study|Withdrawal by Subject|8|||
162843178|NCT00388947|588135354|FG000|Overall Study|Protocol Violation|47|||
162843179|NCT04187092|588135355|FG000|Overall Study|Lost to Follow-up|1|||
162843180|NCT04187092|588135356|FG001|Overall Study|Lost to Follow-up|1|||
162843181|NCT04187092|588135355|FG000|Overall Study|Withdrawal by Subject|1|||
162843182|NCT04187092|588135356|FG001|Overall Study|Withdrawal by Subject|1|||
162843183|NCT04187092|588135355|FG000|Overall Study|Adverse Event|0|||
162843184|NCT04187092|588135356|FG001|Overall Study|Adverse Event|1|||
162843185|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
162843186|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
162843187|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
162843188|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
162843189|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
162843190|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
162843191|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
162843192|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
162843193|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
162843194|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
162843195|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
162843196|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
162843197|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
162843198|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
162951663|NCT00553280|588527595|FG000|Overall Study|Adverse Event|19|||
162951664|NCT00553280|588527595|FG000|Overall Study|Lack of Efficacy|3|||
162951665|NCT00553280|588527595|FG000|Overall Study|Withdrawal by Subject|3|||
162843199|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
162843200|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
162843201|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
162843202|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
162843203|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
162843204|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
162843205|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
162951666|NCT00553280|588527595|FG000|Overall Study|Physician Decision|1|||
162951667|NCT01544127|588527596|FG000|Overall Study|Lost to Follow-up|4|||
162951668|NCT01544127|588527597|FG001|Overall Study|Lost to Follow-up|2|||
162951669|NCT01544127|588527598|FG002|Overall Study|Lost to Follow-up|9|||
162951670|NCT01544127|588527596|FG000|Overall Study|Withdrawal by Subject|2|||
162951671|NCT01544127|588527597|FG001|Overall Study|Withdrawal by Subject|2|||
162951672|NCT01544127|588527598|FG002|Overall Study|Withdrawal by Subject|1|||
162951673|NCT01544127|588527596|FG000|Overall Study|Discharged out of catchment area|1|||
162951674|NCT01544127|588527597|FG001|Overall Study|Discharged out of catchment area|1|||
162951675|NCT01544127|588527598|FG002|Overall Study|Discharged out of catchment area|1|||
162951676|NCT01544127|588527596|FG000|Overall Study|Death|1|||
162951677|NCT01544127|588527597|FG001|Overall Study|Death|0|||
162951678|NCT01544127|588527598|FG002|Overall Study|Death|0|||
162951679|NCT01544127|588527596|FG000|Overall Study|Jail or Prison|1|||
162951680|NCT01544127|588527597|FG001|Overall Study|Jail or Prison|1|||
162951681|NCT01544127|588527598|FG002|Overall Study|Jail or Prison|2|||
162951682|NCT01544127|588527596|FG000|Overall Study|Became Psychotic|1|||
162951683|NCT01544127|588527597|FG001|Overall Study|Became Psychotic|0|||
162951684|NCT01544127|588527598|FG002|Overall Study|Became Psychotic|0|||
162951685|NCT01544127|588527596|FG000|Overall Study|Researcher withdrew|1|||
162951686|NCT01544127|588527597|FG001|Overall Study|Researcher withdrew|0|||
162951687|NCT01544127|588527598|FG002|Overall Study|Researcher withdrew|0|||
162951688|NCT01544127|588527596|FG000|Overall Study|Went active duty|0|||
162951689|NCT01544127|588527597|FG001|Overall Study|Went active duty|0|||
162951690|NCT01544127|588527598|FG002|Overall Study|Went active duty|1|||
162843206|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
162843207|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
162843208|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
162843209|NCT04660643|588135357|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
162843210|NCT04660643|588135358|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
162843211|NCT04660643|588135359|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
162951691|NCT02914600|588527601|FG000|Overall Study|Adverse Event|298|||
162951692|NCT02914600|588527602|FG001|Overall Study|Adverse Event|35|||
162701397|NCT00918749|587616989|FG002|Overall Study|No Study Medication Taken|0|||
162701398|NCT01712789|587616990|FG000|Overall Study|Lack of Efficacy|2|||
162701399|NCT01712789|587616990|FG000|Overall Study|Lost to Follow-up|1|||
162701400|NCT01712789|587616990|FG000|Overall Study|Progressive Disease|504|||
162701401|NCT01712789|587616990|FG000|Overall Study|Death|57|||
162701402|NCT01712789|587616990|FG000|Overall Study|Adverse Event|52|||
162701403|NCT01712789|587616990|FG000|Overall Study|Miscellaneous|31|||
162701404|NCT01712789|587616990|FG000|Overall Study|Withdrawal by Subject|21|||
162701405|NCT01712789|587616990|FG000|Overall Study|Transition to Commercial Treatment|8|||
162701406|NCT01712789|587616990|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
162701407|NCT00219141|587616991|FG000|Overall Study|Adverse Event|4|||
162701408|NCT00219141|587616992|FG001|Overall Study|Adverse Event|10|||
162701409|NCT00219141|587616993|FG002|Overall Study|Adverse Event|5|||
162701410|NCT00219141|587616991|FG000|Overall Study|Lack of Efficacy|3|||
162701411|NCT00219141|587616992|FG001|Overall Study|Lack of Efficacy|2|||
162701412|NCT00219141|587616993|FG002|Overall Study|Lack of Efficacy|0|||
162701413|NCT00219141|587616991|FG000|Overall Study|Administrative problems|0|||
162701414|NCT00219141|587616992|FG001|Overall Study|Administrative problems|1|||
162701415|NCT00219141|587616993|FG002|Overall Study|Administrative problems|0|||
162701416|NCT00219141|587616991|FG000|Overall Study|Lost to Follow-up|2|||
162701417|NCT00219141|587616992|FG001|Overall Study|Lost to Follow-up|4|||
162701418|NCT00219141|587616993|FG002|Overall Study|Lost to Follow-up|1|||
162701419|NCT00219141|587616991|FG000|Overall Study|Protocol Violation|3|||
162701420|NCT00219141|587616992|FG001|Overall Study|Protocol Violation|1|||
162701421|NCT00219141|587616993|FG002|Overall Study|Protocol Violation|1|||
162701422|NCT00219141|587616991|FG000|Overall Study|Withdrawal by Subject|1|||
162701423|NCT00219141|587616992|FG001|Overall Study|Withdrawal by Subject|3|||
162701424|NCT00219141|587616993|FG002|Overall Study|Withdrawal by Subject|5|||
162701425|NCT00219141|587616991|FG000|Overall Study|Condition no longer requires study drug|1|||
162701426|NCT00219141|587616992|FG001|Overall Study|Condition no longer requires study drug|0|||
162701427|NCT00219141|587616993|FG002|Overall Study|Condition no longer requires study drug|0|||
162701428|NCT03018106|587616994|FG000|Overall Study|Lost to Follow-up|0|||
162701429|NCT03018106|587616995|FG001|Overall Study|Lost to Follow-up|1|||
162701430|NCT00972179|587616996|FG000|Overall Study|Noncompliance|1|||
162701431|NCT00972179|587616997|FG001|Overall Study|Noncompliance|0|||
162701432|NCT00972179|587616998|FG002|Overall Study|Noncompliance|0|||
162701433|NCT00972179|587616999|FG003|Overall Study|Noncompliance|0|||
162701434|NCT00972179|587617000|FG004|Overall Study|Noncompliance|1|||
162701435|NCT00972179|587617001|FG005|Overall Study|Noncompliance|0|||
162701436|NCT00972179|587617002|FG006|Overall Study|Noncompliance|1|||
162701437|NCT00972179|587616996|FG000|Overall Study|Withdrawal by Subject|0|||
162701438|NCT00972179|587616997|FG001|Overall Study|Withdrawal by Subject|3|||
162701439|NCT00972179|587616998|FG002|Overall Study|Withdrawal by Subject|0|||
162701440|NCT00972179|587616999|FG003|Overall Study|Withdrawal by Subject|1|||
162701441|NCT00972179|587617000|FG004|Overall Study|Withdrawal by Subject|0|||
162701442|NCT00972179|587617001|FG005|Overall Study|Withdrawal by Subject|0|||
162843212|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
162843213|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
162843214|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
162843215|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
162843216|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
162843217|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
162843218|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
162843219|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
162843220|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
162843221|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
162843222|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
162843223|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
162843224|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
162843225|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
162843226|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
162843227|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
162843228|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
162843229|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
162951693|NCT02914600|588527603|FG002|Overall Study|Adverse Event|25|||
162701443|NCT00972179|587617002|FG006|Overall Study|Withdrawal by Subject|2|||
162701444|NCT00972179|587616996|FG000|Overall Study|Administrative Decision|0|||
162701445|NCT00972179|587616997|FG001|Overall Study|Administrative Decision|0|||
162701446|NCT00972179|587616998|FG002|Overall Study|Administrative Decision|0|||
162701447|NCT00972179|587616999|FG003|Overall Study|Administrative Decision|0|||
162701448|NCT00972179|587617000|FG004|Overall Study|Administrative Decision|1|||
162701449|NCT00972179|587617001|FG005|Overall Study|Administrative Decision|0|||
162701450|NCT00972179|587617002|FG006|Overall Study|Administrative Decision|0|||
162843230|NCT04660643|588135357|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
162843231|NCT04660643|588135358|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
162843232|NCT04660643|588135359|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
162843233|NCT05162066|588135363|FG000|Overall Study|Adverse Event|1|||
162843234|NCT05162066|588135364|FG001|Overall Study|Adverse Event|0|||
162843235|NCT05162066|588135365|FG002|Overall Study|Adverse Event|0|||
162843236|NCT05162066|588135363|FG000|Overall Study|Perceived lack of efficacy|1|||
162843237|NCT05162066|588135364|FG001|Overall Study|Perceived lack of efficacy|0|||
162843238|NCT05162066|588135365|FG002|Overall Study|Perceived lack of efficacy|0|||
162843239|NCT01220414|588135366|FG000|Overall Study|Withdrawal by Subject|1|||
162843240|NCT01220414|588135367|FG001|Overall Study|Withdrawal by Subject|0|||
162843241|NCT01220414|588135368|FG002|Overall Study|Withdrawal by Subject|0|||
162843242|NCT01220414|588135369|FG003|Overall Study|Withdrawal by Subject|1|||
162843243|NCT00669617|588135372|FG000|Period 1|Withdrawal by Subject|0|||
162843244|NCT00669617|588135373|FG001|Period 1|Withdrawal by Subject|0|||
162843245|NCT00669617|588135374|FG002|Period 1|Withdrawal by Subject|1|||
162843246|NCT00669617|588135375|FG003|Period 1|Withdrawal by Subject|0|||
162843247|NCT00669617|588135376|FG004|Period 1|Withdrawal by Subject|0|||
162843248|NCT00669617|588135372|FG000|Period 1|Protocol Deviation|0|||
162843249|NCT00669617|588135373|FG001|Period 1|Protocol Deviation|0|||
162843250|NCT00669617|588135374|FG002|Period 1|Protocol Deviation|0|||
162701451|NCT00972179|587616996|FG000|Overall Study|Lost to Follow-up|0|||
162701452|NCT00972179|587616997|FG001|Overall Study|Lost to Follow-up|0|||
162701453|NCT00972179|587616998|FG002|Overall Study|Lost to Follow-up|1|||
162701454|NCT00972179|587616999|FG003|Overall Study|Lost to Follow-up|0|||
162701455|NCT00972179|587617000|FG004|Overall Study|Lost to Follow-up|0|||
162701456|NCT00972179|587617001|FG005|Overall Study|Lost to Follow-up|3|||
162701457|NCT00972179|587617002|FG006|Overall Study|Lost to Follow-up|1|||
162701458|NCT03055832|587617003|FG000|Week 2|Withdrawal by Subject|1|||
162701459|NCT03055832|587617004|FG001|Week 2|Withdrawal by Subject|0|||
162701460|NCT00136916|587617005|FG000|Overall Study|Never received study treatment|3|||
162701461|NCT00136916|587617006|FG001|Overall Study|Never received study treatment|5|||
162701462|NCT00136916|587617005|FG000|Overall Study|Death|1|||
162701463|NCT00136916|587617006|FG001|Overall Study|Death|3|||
162701464|NCT00136916|587617005|FG000|Overall Study|Adverse Event|27|||
162701465|NCT00136916|587617006|FG001|Overall Study|Adverse Event|8|||
162701466|NCT00136916|587617005|FG000|Overall Study|Laboratory abnormality|0|||
162701467|NCT00136916|587617006|FG001|Overall Study|Laboratory abnormality|1|||
162701468|NCT00136916|587617005|FG000|Overall Study|Lack of Efficacy|13|||
162701469|NCT00136916|587617006|FG001|Overall Study|Lack of Efficacy|3|||
162701470|NCT00136916|587617005|FG000|Overall Study|Lost to Follow-up|12|||
162701471|NCT00136916|587617006|FG001|Overall Study|Lost to Follow-up|14|||
162701472|NCT00136916|587617005|FG000|Overall Study|Withdrawal by Subject|44|||
162701473|NCT00136916|587617006|FG001|Overall Study|Withdrawal by Subject|46|||
162701474|NCT00136916|587617005|FG000|Overall Study|Other|22|||
162701475|NCT00136916|587617006|FG001|Overall Study|Other|24|||
162701476|NCT00136916|587617005|FG000|Overall Study|Discontinued in follow up period|3|||
162701477|NCT00136916|587617006|FG001|Overall Study|Discontinued in follow up period|0|||
162701478|NCT01994720|587617007|FG000|Overall Study|Withdrawal by Subject|46|||
162701479|NCT01994720|587617008|FG001|Overall Study|Withdrawal by Subject|56|||
162701480|NCT01991197|587617009|FG000|Overall Study|Lost to Follow-up|1|||
162701481|NCT01991197|587617010|FG001|Overall Study|Lost to Follow-up|1|||
162701482|NCT01991197|587617009|FG000|Overall Study|Physician Decision|0|||
162843251|NCT00669617|588135375|FG003|Period 1|Protocol Deviation|0|||
162843252|NCT00669617|588135376|FG004|Period 1|Protocol Deviation|1|||
162843253|NCT00669617|588135372|FG000|Period 3|Lost to Follow-up|1|||
162701483|NCT01991197|587617010|FG001|Overall Study|Physician Decision|2|||
162701484|NCT01991197|587617009|FG000|Overall Study|Withdrawal by Subject|2|||
162701485|NCT01991197|587617010|FG001|Overall Study|Withdrawal by Subject|0|||
162701486|NCT01012973|587617011|FG000|Overall Study|Adverse Event|5|||
162701487|NCT01012973|587617012|FG001|Overall Study|Adverse Event|5|||
162701488|NCT01012973|587617011|FG000|Overall Study|Lack of Efficacy|0|||
162701489|NCT01012973|587617012|FG001|Overall Study|Lack of Efficacy|5|||
162701490|NCT01012973|587617011|FG000|Overall Study|Lost to Follow-up|1|||
162701491|NCT01012973|587617012|FG001|Overall Study|Lost to Follow-up|0|||
162843254|NCT00669617|588135373|FG001|Period 3|Lost to Follow-up|0|||
162843255|NCT00669617|588135374|FG002|Period 3|Lost to Follow-up|0|||
162843256|NCT00669617|588135375|FG003|Period 3|Lost to Follow-up|0|||
162843257|NCT00669617|588135376|FG004|Period 3|Lost to Follow-up|0|||
162843258|NCT00623831|588135377|FG000|Overall Study|Withdrawal by Subject|1|||
162843259|NCT00623831|588135378|FG001|Overall Study|Withdrawal by Subject|0|||
162843260|NCT00623831|588135377|FG000|Overall Study|Progressive Disease|0|||
162843261|NCT00623831|588135378|FG001|Overall Study|Progressive Disease|1|||
162843262|NCT01276821|588135379|FG000|Overall Study|Protocol Violation|0|||
162843263|NCT01276821|588135380|FG001|Overall Study|Protocol Violation|1|||
162843264|NCT00066690|588135381|FG000|Overall Study|Adverse Event|145|||
162843265|NCT00066690|588135382|FG001|Overall Study|Adverse Event|58|||
162843266|NCT00066690|588135383|FG002|Overall Study|Adverse Event|126|||
162843267|NCT00066690|588135381|FG000|Overall Study|Death|3|||
162843268|NCT00066690|588135382|FG001|Overall Study|Death|0|||
162843269|NCT00066690|588135383|FG002|Overall Study|Death|2|||
162843270|NCT00066690|588135381|FG000|Overall Study|Lack of Efficacy|114|||
162843271|NCT00066690|588135382|FG001|Overall Study|Lack of Efficacy|110|||
162843272|NCT00066690|588135383|FG002|Overall Study|Lack of Efficacy|76|||
162843273|NCT00066690|588135381|FG000|Overall Study|Lost to Follow-up|40|||
162843274|NCT00066690|588135382|FG001|Overall Study|Lost to Follow-up|21|||
162843275|NCT00066690|588135383|FG002|Overall Study|Lost to Follow-up|29|||
162843276|NCT00066690|588135381|FG000|Overall Study|Withdrawal by Subject|50|||
162843277|NCT00066690|588135382|FG001|Overall Study|Withdrawal by Subject|55|||
162843278|NCT00066690|588135383|FG002|Overall Study|Withdrawal by Subject|49|||
162843279|NCT00066690|588135381|FG000|Overall Study|Treatment Ongoing|246|||
162843280|NCT00066690|588135382|FG001|Overall Study|Treatment Ongoing|278|||
162843281|NCT00066690|588135383|FG002|Overall Study|Treatment Ongoing|282|||
162843282|NCT00223496|588135384|FG000|Overall Study|screen failure|9|||
162843283|NCT00223496|588135384|FG000|Overall Study|Lost to Follow-up|4|||
162843284|NCT00223496|588135384|FG000|Overall Study|Lack of Efficacy|6|||
162843285|NCT00223496|588135384|FG000|Overall Study|Withdrawal by Subject|1|||
162843286|NCT00223496|588135384|FG000|Overall Study|Physician Decision|2|||
162843287|NCT02939131|588135387|FG000|Overall Study|Unable to get to clinic|6|||
162843288|NCT02939131|588135388|FG001|Overall Study|Unable to get to clinic|4|||
162843289|NCT02939131|588135387|FG000|Overall Study|Lost to Follow-up|2|||
162843290|NCT02939131|588135388|FG001|Overall Study|Lost to Follow-up|4|||
162843291|NCT02939131|588135387|FG000|Overall Study|severe debilitation|1|||
162843292|NCT02939131|588135388|FG001|Overall Study|severe debilitation|0|||
162843293|NCT02939131|588135387|FG000|Overall Study|Other|0|||
162843294|NCT02939131|588135388|FG001|Overall Study|Other|1|||
162843295|NCT02939131|588135387|FG000|Overall Study|not willing to adhere to protocol|2|||
162843296|NCT02939131|588135388|FG001|Overall Study|not willing to adhere to protocol|0|||
162843297|NCT03569202|588135389|FG000|Part 3|Physician Decision|1|||
162843298|NCT03569202|588135390|FG001|Part 3|Physician Decision|0|||
162843299|NCT03569202|588135389|FG000|Part 3|Other|1|||
162843300|NCT03569202|588135390|FG001|Part 3|Other|1|||
162843301|NCT02450578|588135391|FG000|Overall Study|ECG abnormality so not treated|1|||
162843302|NCT02450578|588135392|FG001|Overall Study|ECG abnormality so not treated|0|||
162843303|NCT02450578|588135393|FG002|Overall Study|ECG abnormality so not treated|0|||
162843304|NCT02450578|588135394|FG003|Overall Study|ECG abnormality so not treated|0|||
162843305|NCT04428411|588135397|FG000|Overall Study|Lost to Follow-up|114|||
162843306|NCT00634569|588135398|FG000|Overall Study|Withdrawal by Subject|0|||
162843307|NCT00634569|588135399|FG001|Overall Study|Withdrawal by Subject|4|||
162843308|NCT00634569|588135398|FG000|Overall Study|Physician Decision|0|||
162843309|NCT00634569|588135399|FG001|Overall Study|Physician Decision|1|||
162843310|NCT02918019|588135401|FG000|Overall Study|Death|0|||
162843311|NCT02918019|588135402|FG001|Overall Study|Death|0|||
162843312|NCT02918019|588135403|FG002|Overall Study|Death|1|||
162843313|NCT02918019|588135404|FG003|Overall Study|Death|0|||
162843314|NCT02918019|588135401|FG000|Overall Study|Lost to Follow-up|1|||
162843315|NCT02918019|588135402|FG001|Overall Study|Lost to Follow-up|1|||
162843316|NCT02918019|588135403|FG002|Overall Study|Lost to Follow-up|0|||
162843317|NCT02918019|588135404|FG003|Overall Study|Lost to Follow-up|1|||
162843318|NCT02918019|588135401|FG000|Overall Study|Principal investigator request|0|||
162843319|NCT02918019|588135402|FG001|Overall Study|Principal investigator request|0|||
162843320|NCT02918019|588135403|FG002|Overall Study|Principal investigator request|0|||
162843321|NCT02918019|588135404|FG003|Overall Study|Principal investigator request|1|||
162843322|NCT02918019|588135401|FG000|Overall Study|Physician Decision|1|||
162843323|NCT02918019|588135402|FG001|Overall Study|Physician Decision|3|||
162843324|NCT02918019|588135403|FG002|Overall Study|Physician Decision|2|||
162843325|NCT02918019|588135404|FG003|Overall Study|Physician Decision|0|||
162843326|NCT02918019|588135401|FG000|Overall Study|Protocol deviation|1|||
162843327|NCT02918019|588135402|FG001|Overall Study|Protocol deviation|1|||
162843328|NCT02918019|588135403|FG002|Overall Study|Protocol deviation|0|||
162843329|NCT02918019|588135404|FG003|Overall Study|Protocol deviation|2|||
162843330|NCT02918019|588135401|FG000|Overall Study|Withdrawal by Subject|3|||
162843331|NCT02918019|588135402|FG001|Overall Study|Withdrawal by Subject|4|||
162843332|NCT02918019|588135403|FG002|Overall Study|Withdrawal by Subject|6|||
162843333|NCT02918019|588135404|FG003|Overall Study|Withdrawal by Subject|4|||
162843334|NCT02918019|588135401|FG000|Overall Study|Adverse Event|0|||
162843335|NCT02918019|588135402|FG001|Overall Study|Adverse Event|1|||
162843336|NCT02918019|588135403|FG002|Overall Study|Adverse Event|0|||
162843337|NCT02918019|588135404|FG003|Overall Study|Adverse Event|1|||
162843338|NCT01212185|588135405|FG000|Overall Study|Protocol Violation|2|||
162843339|NCT01212185|588135406|FG001|Overall Study|Protocol Violation|1|||
162843340|NCT03370770|588135407|FG000|Overall Study|Patient was followed in another hospital center|1|||
162843341|NCT03370770|588135407|FG000|Overall Study|Progressive Disease|98|||
162843342|NCT03370770|588135407|FG000|Overall Study|Adverse Event|2|||
162843343|NCT03370770|588135407|FG000|Overall Study|Death|5|||
162843344|NCT01699087|588135408|FG000|Overall Study|Lost to Follow-up|7|||
162843345|NCT01699087|588135408|FG000|Overall Study|Screen failure (prior to treatment)|15|||
162843346|NCT01699087|588135408|FG000|Overall Study|Unable to make future visits|2|||
162843347|NCT00094757|588135409|FG000|Overall Study|Adverse Event|11|||
162843348|NCT00094757|588135410|FG001|Overall Study|Adverse Event|9|||
162843349|NCT00094757|588135411|FG002|Overall Study|Adverse Event|6|||
162843350|NCT00094757|588135409|FG000|Overall Study|Lack of Efficacy|11|||
162843351|NCT00094757|588135410|FG001|Overall Study|Lack of Efficacy|15|||
162843352|NCT00094757|588135411|FG002|Overall Study|Lack of Efficacy|8|||
162843353|NCT00094757|588135409|FG000|Overall Study|Lost to Follow-up|3|||
162843354|NCT00094757|588135410|FG001|Overall Study|Lost to Follow-up|5|||
162843355|NCT00094757|588135411|FG002|Overall Study|Lost to Follow-up|6|||
162843356|NCT00094757|588135409|FG000|Overall Study|Patient Moved|2|||
162843357|NCT00094757|588135410|FG001|Overall Study|Patient Moved|1|||
162843358|NCT00094757|588135411|FG002|Overall Study|Patient Moved|1|||
162843359|NCT00094757|588135409|FG000|Overall Study|Protocol Violation|8|||
162843360|NCT00094757|588135410|FG001|Overall Study|Protocol Violation|5|||
162843361|NCT00094757|588135411|FG002|Overall Study|Protocol Violation|3|||
162843362|NCT00094757|588135409|FG000|Overall Study|Withdrawal by Subject|14|||
162843363|NCT00094757|588135410|FG001|Overall Study|Withdrawal by Subject|21|||
163042863|NCT00845676|588863980|FG000|Overall Study|Adverse Event|1|||
162843364|NCT00094757|588135411|FG002|Overall Study|Withdrawal by Subject|5|||
162843365|NCT00094757|588135409|FG000|Overall Study|Other|3|||
162843366|NCT00094757|588135410|FG001|Overall Study|Other|3|||
162843367|NCT00094757|588135411|FG002|Overall Study|Other|1|||
162843368|NCT00094757|588135409|FG000|Overall Study|Protocol specified discontinuation|1|||
162843369|NCT00094757|588135410|FG001|Overall Study|Protocol specified discontinuation|3|||
162843370|NCT00094757|588135411|FG002|Overall Study|Protocol specified discontinuation|0|||
162843371|NCT01463098|588135412|FG000|Part A (11 Days)|Participant Choice|2|||
162843372|NCT01463098|588135413|FG001|Part A (11 Days)|Participant Choice|0|||
162843373|NCT01463098|588135414|FG002|Part A (11 Days)|Participant Choice|0|||
162843374|NCT01463098|588135415|FG003|Part A (11 Days)|Participant Choice|0|||
162843375|NCT01463098|588135416|FG004|Part A (11 Days)|Participant Choice|0|||
162843376|NCT01463098|588135417|FG005|Part A (11 Days)|Participant Choice|0|||
162843377|NCT01463098|588135418|FG006|Part A (11 Days)|Participant Choice|0|||
162843378|NCT01463098|588135419|FG007|Part A (11 Days)|Participant Choice|0|||
162843379|NCT01463098|588135420|FG008|Part A (11 Days)|Participant Choice|1|||
162843380|NCT01463098|588135421|FG009|Part A (11 Days)|Participant Choice|0|||
162843381|NCT01463098|588135422|FG010|Part A (11 Days)|Participant Choice|0|||
162843382|NCT01463098|588135423|FG011|Part A (11 Days)|Participant Choice|0|||
162843383|NCT01463098|588135424|FG012|Part A (11 Days)|Participant Choice|0|||
162843384|NCT01463098|588135425|FG013|Part A (11 Days)|Participant Choice|0|||
162843385|NCT01463098|588135412|FG000|Part A (11 Days)|Lost to Follow-up|0|||
162843386|NCT01463098|588135413|FG001|Part A (11 Days)|Lost to Follow-up|0|||
162701492|NCT01012973|587617011|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
162701493|NCT01012973|587617012|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
162843387|NCT01463098|588135414|FG002|Part A (11 Days)|Lost to Follow-up|0|||
162843388|NCT01463098|588135415|FG003|Part A (11 Days)|Lost to Follow-up|0|||
162843389|NCT01463098|588135416|FG004|Part A (11 Days)|Lost to Follow-up|1|||
162843390|NCT01463098|588135417|FG005|Part A (11 Days)|Lost to Follow-up|0|||
162843391|NCT01463098|588135418|FG006|Part A (11 Days)|Lost to Follow-up|0|||
162843392|NCT01463098|588135419|FG007|Part A (11 Days)|Lost to Follow-up|0|||
162843393|NCT01463098|588135420|FG008|Part A (11 Days)|Lost to Follow-up|0|||
162843394|NCT01463098|588135421|FG009|Part A (11 Days)|Lost to Follow-up|0|||
162843395|NCT01463098|588135422|FG010|Part A (11 Days)|Lost to Follow-up|0|||
162843396|NCT01463098|588135423|FG011|Part A (11 Days)|Lost to Follow-up|0|||
162843397|NCT01463098|588135424|FG012|Part A (11 Days)|Lost to Follow-up|0|||
162843398|NCT01463098|588135425|FG013|Part A (11 Days)|Lost to Follow-up|0|||
162843399|NCT01463098|588135412|FG000|Part B (11 Days)|Participant Choice|0|||
162843400|NCT01463098|588135413|FG001|Part B (11 Days)|Participant Choice|0|||
162843401|NCT01463098|588135414|FG002|Part B (11 Days)|Participant Choice|0|||
162843402|NCT01463098|588135415|FG003|Part B (11 Days)|Participant Choice|0|||
162843403|NCT01463098|588135416|FG004|Part B (11 Days)|Participant Choice|0|||
162843404|NCT01463098|588135417|FG005|Part B (11 Days)|Participant Choice|0|||
162843405|NCT01463098|588135418|FG006|Part B (11 Days)|Participant Choice|0|||
162843406|NCT01463098|588135419|FG007|Part B (11 Days)|Participant Choice|0|||
162843407|NCT01463098|588135420|FG008|Part B (11 Days)|Participant Choice|0|||
162843408|NCT01463098|588135421|FG009|Part B (11 Days)|Participant Choice|0|||
162843409|NCT01463098|588135422|FG010|Part B (11 Days)|Participant Choice|0|||
162843410|NCT01463098|588135423|FG011|Part B (11 Days)|Participant Choice|1|||
162843411|NCT01463098|588135424|FG012|Part B (11 Days)|Participant Choice|0|||
162843412|NCT01463098|588135425|FG013|Part B (11 Days)|Participant Choice|0|||
162843413|NCT00395967|588135426|FG000|Treatment Period|Failed Mobilization|1|||
162843414|NCT00395967|588135426|FG000|Follow-up Period|Death|1|||
162843415|NCT00395967|588135426|FG000|Follow-up Period|Lost to Follow-up|1|||
162843416|NCT01262976|588135427|FG000|Up to Month 2|Serious Adverse Event|0|||
162843417|NCT01262976|588135428|FG001|Up to Month 2|Serious Adverse Event|0|||
162843418|NCT01262976|588135429|FG002|Up to Month 2|Serious Adverse Event|1|||
162843419|NCT01262976|588135430|FG003|Up to Month 2|Serious Adverse Event|0|||
162843420|NCT01262976|588135431|FG004|Up to Month 2|Serious Adverse Event|0|||
162843421|NCT01262976|588135432|FG005|Up to Month 2|Serious Adverse Event|0|||
162843422|NCT01262976|588135427|FG000|Up to Month 2|Withdrawal by Subject|1|||
162951694|NCT02914600|588527601|FG000|Overall Study|Sponsors decision|287|||
162951695|NCT02914600|588527602|FG001|Overall Study|Sponsors decision|41|||
162951696|NCT02914600|588527603|FG002|Overall Study|Sponsors decision|12|||
162951697|NCT02914600|588527601|FG000|Overall Study|Withdrawal by Subject|158|||
162951698|NCT02914600|588527602|FG001|Overall Study|Withdrawal by Subject|20|||
162951699|NCT02914600|588527603|FG002|Overall Study|Withdrawal by Subject|18|||
162843423|NCT01262976|588135428|FG001|Up to Month 2|Withdrawal by Subject|0|||
162843424|NCT01262976|588135429|FG002|Up to Month 2|Withdrawal by Subject|0|||
162843425|NCT01262976|588135430|FG003|Up to Month 2|Withdrawal by Subject|0|||
162843426|NCT01262976|588135431|FG004|Up to Month 2|Withdrawal by Subject|0|||
162843427|NCT01262976|588135432|FG005|Up to Month 2|Withdrawal by Subject|0|||
162843428|NCT01262976|588135427|FG000|Up to Month 2|Migrated/moved from study area|0|||
162843429|NCT01262976|588135428|FG001|Up to Month 2|Migrated/moved from study area|1|||
162843430|NCT01262976|588135429|FG002|Up to Month 2|Migrated/moved from study area|0|||
162843431|NCT01262976|588135430|FG003|Up to Month 2|Migrated/moved from study area|0|||
162843432|NCT01262976|588135431|FG004|Up to Month 2|Migrated/moved from study area|1|||
162843433|NCT01262976|588135432|FG005|Up to Month 2|Migrated/moved from study area|1|||
162843434|NCT01262976|588135427|FG000|Up to Month 2|Lost to Follow-up|1|||
162843435|NCT01262976|588135428|FG001|Up to Month 2|Lost to Follow-up|0|||
162843436|NCT01262976|588135429|FG002|Up to Month 2|Lost to Follow-up|0|||
162843437|NCT01262976|588135430|FG003|Up to Month 2|Lost to Follow-up|1|||
162843438|NCT01262976|588135431|FG004|Up to Month 2|Lost to Follow-up|1|||
162843439|NCT01262976|588135432|FG005|Up to Month 2|Lost to Follow-up|1|||
162843440|NCT01262976|588135427|FG000|Up to Month 2|Other|1|||
162843441|NCT01262976|588135428|FG001|Up to Month 2|Other|0|||
162843442|NCT01262976|588135429|FG002|Up to Month 2|Other|0|||
162843443|NCT01262976|588135430|FG003|Up to Month 2|Other|1|||
162843444|NCT01262976|588135431|FG004|Up to Month 2|Other|0|||
162951700|NCT02914600|588527601|FG000|Overall Study|Investigators discretion|169|||
162843445|NCT01262976|588135432|FG005|Up to Month 2|Other|2|||
162843446|NCT01262976|588135427|FG000|Up to Month 7|Serious Adverse Event|0|||
162843447|NCT01262976|588135428|FG001|Up to Month 7|Serious Adverse Event|0|||
162843448|NCT01262976|588135429|FG002|Up to Month 7|Serious Adverse Event|2|||
162843449|NCT01262976|588135430|FG003|Up to Month 7|Serious Adverse Event|0|||
162951701|NCT02914600|588527602|FG001|Overall Study|Investigators discretion|14|||
162951702|NCT02914600|588527603|FG002|Overall Study|Investigators discretion|13|||
162843450|NCT01262976|588135431|FG004|Up to Month 7|Serious Adverse Event|0|||
162843451|NCT01262976|588135432|FG005|Up to Month 7|Serious Adverse Event|0|||
162843452|NCT01262976|588135427|FG000|Up to Month 7|Withdrawal by Subject|1|||
162843453|NCT01262976|588135428|FG001|Up to Month 7|Withdrawal by Subject|0|||
162843454|NCT01262976|588135429|FG002|Up to Month 7|Withdrawal by Subject|0|||
162843455|NCT01262976|588135430|FG003|Up to Month 7|Withdrawal by Subject|0|||
162843456|NCT01262976|588135431|FG004|Up to Month 7|Withdrawal by Subject|0|||
162843457|NCT01262976|588135432|FG005|Up to Month 7|Withdrawal by Subject|0|||
162843458|NCT01262976|588135427|FG000|Up to Month 7|Migrated/moved from study area|0|||
162843459|NCT01262976|588135428|FG001|Up to Month 7|Migrated/moved from study area|0|||
162843460|NCT01262976|588135429|FG002|Up to Month 7|Migrated/moved from study area|1|||
162843461|NCT01262976|588135430|FG003|Up to Month 7|Migrated/moved from study area|3|||
162843462|NCT01262976|588135431|FG004|Up to Month 7|Migrated/moved from study area|1|||
162843463|NCT01262976|588135432|FG005|Up to Month 7|Migrated/moved from study area|1|||
162843464|NCT01262976|588135427|FG000|Up to Month 7|Lost to Follow-up|1|||
162843465|NCT01262976|588135428|FG001|Up to Month 7|Lost to Follow-up|0|||
162843466|NCT01262976|588135429|FG002|Up to Month 7|Lost to Follow-up|1|||
162843467|NCT01262976|588135430|FG003|Up to Month 7|Lost to Follow-up|3|||
162843468|NCT01262976|588135431|FG004|Up to Month 7|Lost to Follow-up|1|||
162843469|NCT01262976|588135432|FG005|Up to Month 7|Lost to Follow-up|3|||
162843470|NCT01262976|588135427|FG000|Up to Month 7|Other|3|||
162843471|NCT01262976|588135428|FG001|Up to Month 7|Other|0|||
162843472|NCT01262976|588135429|FG002|Up to Month 7|Other|2|||
162843473|NCT01262976|588135430|FG003|Up to Month 7|Other|0|||
162843474|NCT01262976|588135431|FG004|Up to Month 7|Other|0|||
163042864|NCT00248833|588863983|FG000|Overall Study|Adverse Event|2|||
162843475|NCT01262976|588135432|FG005|Up to Month 7|Other|0|||
162843476|NCT01262976|588135427|FG000|Up to Year 1|Serious Adverse Event|0|||
162843477|NCT01262976|588135428|FG001|Up to Year 1|Serious Adverse Event|0|||
162843478|NCT01262976|588135429|FG002|Up to Year 1|Serious Adverse Event|2|||
162843479|NCT01262976|588135430|FG003|Up to Year 1|Serious Adverse Event|0|||
162843480|NCT01262976|588135431|FG004|Up to Year 1|Serious Adverse Event|0|||
162843481|NCT01262976|588135432|FG005|Up to Year 1|Serious Adverse Event|0|||
162843482|NCT01262976|588135427|FG000|Up to Year 1|Withdrawal by Subject|1|||
162843483|NCT01262976|588135428|FG001|Up to Year 1|Withdrawal by Subject|0|||
162843484|NCT01262976|588135429|FG002|Up to Year 1|Withdrawal by Subject|0|||
162843485|NCT01262976|588135430|FG003|Up to Year 1|Withdrawal by Subject|0|||
162843486|NCT01262976|588135431|FG004|Up to Year 1|Withdrawal by Subject|0|||
162843487|NCT01262976|588135432|FG005|Up to Year 1|Withdrawal by Subject|0|||
162843488|NCT01262976|588135427|FG000|Up to Year 1|Migrated/moved from study area|1|||
162843489|NCT01262976|588135428|FG001|Up to Year 1|Migrated/moved from study area|0|||
162843490|NCT01262976|588135429|FG002|Up to Year 1|Migrated/moved from study area|0|||
162843491|NCT01262976|588135430|FG003|Up to Year 1|Migrated/moved from study area|3|||
162843492|NCT01262976|588135431|FG004|Up to Year 1|Migrated/moved from study area|3|||
162843493|NCT01262976|588135432|FG005|Up to Year 1|Migrated/moved from study area|2|||
162843494|NCT01262976|588135427|FG000|Up to Year 1|Lost to Follow-up|4|||
162843495|NCT01262976|588135428|FG001|Up to Year 1|Lost to Follow-up|0|||
162843496|NCT01262976|588135429|FG002|Up to Year 1|Lost to Follow-up|0|||
162843497|NCT01262976|588135430|FG003|Up to Year 1|Lost to Follow-up|1|||
162843498|NCT01262976|588135431|FG004|Up to Year 1|Lost to Follow-up|6|||
162843499|NCT01262976|588135432|FG005|Up to Year 1|Lost to Follow-up|5|||
162843500|NCT01262976|588135427|FG000|Up to Year 1|Other|3|||
162843501|NCT01262976|588135428|FG001|Up to Year 1|Other|1|||
162843502|NCT01262976|588135429|FG002|Up to Year 1|Other|0|||
162843503|NCT01262976|588135430|FG003|Up to Year 1|Other|0|||
162843504|NCT01262976|588135431|FG004|Up to Year 1|Other|2|||
162843505|NCT01262976|588135432|FG005|Up to Year 1|Other|1|||
162843506|NCT01262976|588135427|FG000|Up to Year 1|Subjects with unknown completion status|0|||
162843507|NCT01262976|588135428|FG001|Up to Year 1|Subjects with unknown completion status|0|||
162843508|NCT01262976|588135429|FG002|Up to Year 1|Subjects with unknown completion status|1|||
162843509|NCT01262976|588135430|FG003|Up to Year 1|Subjects with unknown completion status|0|||
162843510|NCT01262976|588135431|FG004|Up to Year 1|Subjects with unknown completion status|0|||
162843511|NCT01262976|588135432|FG005|Up to Year 1|Subjects with unknown completion status|1|||
162843512|NCT01262976|588135427|FG000|Up to Year 2|Serious Adverse Event|0|||
162843513|NCT01262976|588135428|FG001|Up to Year 2|Serious Adverse Event|0|||
162843514|NCT01262976|588135429|FG002|Up to Year 2|Serious Adverse Event|2|||
162843515|NCT01262976|588135430|FG003|Up to Year 2|Serious Adverse Event|0|||
162843516|NCT01262976|588135431|FG004|Up to Year 2|Serious Adverse Event|0|||
162843517|NCT01262976|588135432|FG005|Up to Year 2|Serious Adverse Event|0|||
162843518|NCT01262976|588135427|FG000|Up to Year 2|Withdrawal by Subject|1|||
162843519|NCT01262976|588135428|FG001|Up to Year 2|Withdrawal by Subject|0|||
162843520|NCT01262976|588135429|FG002|Up to Year 2|Withdrawal by Subject|0|||
162843521|NCT01262976|588135430|FG003|Up to Year 2|Withdrawal by Subject|0|||
162843522|NCT01262976|588135431|FG004|Up to Year 2|Withdrawal by Subject|0|||
162843523|NCT01262976|588135432|FG005|Up to Year 2|Withdrawal by Subject|0|||
162843524|NCT01262976|588135427|FG000|Up to Year 2|Migrated/moved from study area|0|||
162843525|NCT01262976|588135428|FG001|Up to Year 2|Migrated/moved from study area|0|||
162843526|NCT01262976|588135429|FG002|Up to Year 2|Migrated/moved from study area|0|||
162843527|NCT01262976|588135430|FG003|Up to Year 2|Migrated/moved from study area|2|||
162843528|NCT01262976|588135431|FG004|Up to Year 2|Migrated/moved from study area|1|||
162843529|NCT01262976|588135432|FG005|Up to Year 2|Migrated/moved from study area|2|||
162843530|NCT01262976|588135427|FG000|Up to Year 2|Lost to Follow-up|1|||
162843531|NCT01262976|588135428|FG001|Up to Year 2|Lost to Follow-up|1|||
162843532|NCT01262976|588135429|FG002|Up to Year 2|Lost to Follow-up|2|||
162843533|NCT01262976|588135430|FG003|Up to Year 2|Lost to Follow-up|2|||
162843534|NCT01262976|588135431|FG004|Up to Year 2|Lost to Follow-up|3|||
162843535|NCT01262976|588135432|FG005|Up to Year 2|Lost to Follow-up|3|||
162843536|NCT01262976|588135427|FG000|Up to Year 2|Subjects with unknown completion status|0|||
162843537|NCT01262976|588135428|FG001|Up to Year 2|Subjects with unknown completion status|0|||
162951703|NCT02914600|588527601|FG000|Overall Study|Lost to Follow-up|10|||
162951704|NCT02914600|588527602|FG001|Overall Study|Lost to Follow-up|4|||
162951705|NCT02914600|588527603|FG002|Overall Study|Lost to Follow-up|0|||
162951706|NCT02914600|588527601|FG000|Overall Study|Pregnancy|8|||
162951707|NCT02914600|588527602|FG001|Overall Study|Pregnancy|0|||
162951708|NCT02914600|588527603|FG002|Overall Study|Pregnancy|0|||
162951709|NCT02914600|588527601|FG000|Overall Study|Protocol Violation|5|||
162951710|NCT02914600|588527602|FG001|Overall Study|Protocol Violation|3|||
162951711|NCT02914600|588527603|FG002|Overall Study|Protocol Violation|0|||
162951712|NCT02914600|588527601|FG000|Overall Study|Non-compliance with study drug|6|||
162951713|NCT02914600|588527602|FG001|Overall Study|Non-compliance with study drug|1|||
162951714|NCT02914600|588527603|FG002|Overall Study|Non-compliance with study drug|0|||
162951715|NCT02914600|588527601|FG000|Overall Study|Death|3|||
162951716|NCT02914600|588527602|FG001|Overall Study|Death|1|||
162951717|NCT02914600|588527603|FG002|Overall Study|Death|1|||
162951718|NCT02914600|588527601|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
162951719|NCT02914600|588527602|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
162951720|NCT02914600|588527603|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
162951721|NCT02914600|588527601|FG000|Overall Study|Enrolled but not treated|1|||
162951722|NCT02914600|588527602|FG001|Overall Study|Enrolled but not treated|0|||
162951723|NCT02914600|588527603|FG002|Overall Study|Enrolled but not treated|0|||
162951724|NCT02996682|588527605|FG000|Overall Study|Death|0|||
162951725|NCT02996682|588527606|FG001|Overall Study|Death|3|||
162951726|NCT02457520|588527607|FG000|Active Treatment Phase|Adverse Event|10|||
162951727|NCT02457520|588527607|FG000|Active Treatment Phase|Lost to Follow-up|8|||
162951728|NCT02457520|588527607|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
162951729|NCT02457520|588527607|FG000|Active Treatment Phase|other|4|||
162951730|NCT02457520|588527607|FG000|Active Treatment Phase|Physician Decision|1|||
162951731|NCT02457520|588527607|FG000|Active Treatment Phase|Protocol Violation|1|||
162701494|NCT01012973|587617011|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
162701495|NCT01012973|587617012|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
162951732|NCT02457520|588527607|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
162951733|NCT02457520|588527607|FG000|Post-treatment Period|Other: Retreatment Required|7|||
162951734|NCT02457520|588527607|FG000|Post-treatment Period|Lost to Follow-up|23|||
162951735|NCT02457520|588527607|FG000|Post-treatment Period|Other|3|||
162951736|NCT02457520|588527607|FG000|Post-treatment Period|Physician Decision|1|||
162951737|NCT02457520|588527607|FG000|Post-treatment Period|Withdrawal by Subject|14|||
162951738|NCT00696020|588527612|FG000|Overall Study|Adverse Event|3|||
162951739|NCT00696020|588527613|FG001|Overall Study|Adverse Event|1|||
162951740|NCT00696020|588527614|FG002|Overall Study|Adverse Event|2|||
162951741|NCT00696020|588527615|FG003|Overall Study|Adverse Event|1|||
162951742|NCT00696020|588527612|FG000|Overall Study|Lack of Efficacy|1|||
162951743|NCT00696020|588527613|FG001|Overall Study|Lack of Efficacy|0|||
162951744|NCT00696020|588527614|FG002|Overall Study|Lack of Efficacy|0|||
162951745|NCT00696020|588527615|FG003|Overall Study|Lack of Efficacy|0|||
162951746|NCT00696020|588527612|FG000|Overall Study|Protocol Violation|0|||
162951747|NCT00696020|588527613|FG001|Overall Study|Protocol Violation|0|||
162951748|NCT00696020|588527614|FG002|Overall Study|Protocol Violation|0|||
162951749|NCT00696020|588527615|FG003|Overall Study|Protocol Violation|1|||
162951750|NCT00696020|588527612|FG000|Overall Study|Withdrawal by Subject|0|||
162843538|NCT01262976|588135429|FG002|Up to Year 2|Subjects with unknown completion status|1|||
162843539|NCT01262976|588135430|FG003|Up to Year 2|Subjects with unknown completion status|0|||
162951751|NCT00696020|588527613|FG001|Overall Study|Withdrawal by Subject|1|||
162951752|NCT00696020|588527614|FG002|Overall Study|Withdrawal by Subject|0|||
162951753|NCT00696020|588527615|FG003|Overall Study|Withdrawal by Subject|1|||
162951754|NCT00696020|588527612|FG000|Overall Study|Other not stated above|0|||
162951755|NCT00696020|588527613|FG001|Overall Study|Other not stated above|0|||
162951756|NCT00696020|588527614|FG002|Overall Study|Other not stated above|1|||
162951757|NCT00696020|588527615|FG003|Overall Study|Other not stated above|1|||
162951758|NCT03687736|588527618|FG000|Overall Study|Lost to Follow-up|7|||
162951759|NCT03687736|588527618|FG000|Overall Study|Withdrawal by Subject|3|||
162951760|NCT02511782|588527619|FG000|Overall Study|Withdrawal by Subject|1|||
162843540|NCT01262976|588135431|FG004|Up to Year 2|Subjects with unknown completion status|0|||
162843541|NCT01262976|588135432|FG005|Up to Year 2|Subjects with unknown completion status|0|||
162843542|NCT01262976|588135427|FG000|Up to Year 2|Other|3|||
162843543|NCT01262976|588135428|FG001|Up to Year 2|Other|0|||
162843544|NCT01262976|588135429|FG002|Up to Year 2|Other|0|||
162843545|NCT01262976|588135430|FG003|Up to Year 2|Other|0|||
162843546|NCT01262976|588135431|FG004|Up to Year 2|Other|0|||
162843547|NCT01262976|588135432|FG005|Up to Year 2|Other|0|||
162843548|NCT01262976|588135427|FG000|Up to Year 3|Serious Adverse Event|0|||
162843549|NCT01262976|588135428|FG001|Up to Year 3|Serious Adverse Event|0|||
162843550|NCT01262976|588135429|FG002|Up to Year 3|Serious Adverse Event|2|||
162843551|NCT01262976|588135430|FG003|Up to Year 3|Serious Adverse Event|0|||
162843552|NCT01262976|588135431|FG004|Up to Year 3|Serious Adverse Event|0|||
162843553|NCT01262976|588135432|FG005|Up to Year 3|Serious Adverse Event|0|||
162843554|NCT01262976|588135427|FG000|Up to Year 3|Withdrawal by Subject|1|||
162843555|NCT01262976|588135428|FG001|Up to Year 3|Withdrawal by Subject|0|||
162843556|NCT01262976|588135429|FG002|Up to Year 3|Withdrawal by Subject|0|||
162843557|NCT01262976|588135430|FG003|Up to Year 3|Withdrawal by Subject|0|||
162843558|NCT01262976|588135431|FG004|Up to Year 3|Withdrawal by Subject|0|||
162843559|NCT01262976|588135432|FG005|Up to Year 3|Withdrawal by Subject|0|||
162843560|NCT01262976|588135427|FG000|Up to Year 3|Migrated/moved from study area|0|||
162843561|NCT01262976|588135428|FG001|Up to Year 3|Migrated/moved from study area|0|||
162843562|NCT01262976|588135429|FG002|Up to Year 3|Migrated/moved from study area|0|||
162843563|NCT01262976|588135430|FG003|Up to Year 3|Migrated/moved from study area|2|||
162843564|NCT01262976|588135431|FG004|Up to Year 3|Migrated/moved from study area|1|||
162843565|NCT01262976|588135432|FG005|Up to Year 3|Migrated/moved from study area|1|||
162843566|NCT01262976|588135427|FG000|Up to Year 3|Lost to Follow-up|2|||
162843567|NCT01262976|588135428|FG001|Up to Year 3|Lost to Follow-up|2|||
162843568|NCT01262976|588135429|FG002|Up to Year 3|Lost to Follow-up|4|||
162843569|NCT01262976|588135430|FG003|Up to Year 3|Lost to Follow-up|3|||
162843570|NCT01262976|588135431|FG004|Up to Year 3|Lost to Follow-up|1|||
162843571|NCT01262976|588135432|FG005|Up to Year 3|Lost to Follow-up|3|||
162843572|NCT01262976|588135427|FG000|Up to Year 3|Subjects with unknown completion status|0|||
162843573|NCT01262976|588135428|FG001|Up to Year 3|Subjects with unknown completion status|0|||
162843574|NCT01262976|588135429|FG002|Up to Year 3|Subjects with unknown completion status|1|||
162843575|NCT01262976|588135430|FG003|Up to Year 3|Subjects with unknown completion status|0|||
162843576|NCT01262976|588135431|FG004|Up to Year 3|Subjects with unknown completion status|0|||
162843577|NCT01262976|588135432|FG005|Up to Year 3|Subjects with unknown completion status|0|||
162843578|NCT01262976|588135427|FG000|Up to Year 3|Other|3|||
162843579|NCT01262976|588135428|FG001|Up to Year 3|Other|0|||
162843580|NCT01262976|588135429|FG002|Up to Year 3|Other|0|||
162701496|NCT01012973|587617011|FG000|Overall Study|Protocol Violation|5|||
162701497|NCT01012973|587617012|FG001|Overall Study|Protocol Violation|2|||
162701498|NCT01012973|587617011|FG000|Overall Study|Withdrawal by Subject|4|||
162701499|NCT01012973|587617012|FG001|Overall Study|Withdrawal by Subject|6|||
162951761|NCT02511782|588527620|FG001|Overall Study|Withdrawal by Subject|0|||
162951762|NCT02511782|588527621|FG002|Overall Study|Withdrawal by Subject|0|||
162951763|NCT01536574|588527622|FG000|Overall Study|Adverse Event|4|||
162951764|NCT01536574|588527623|FG001|Overall Study|Adverse Event|5|||
162701500|NCT02213055|587617013|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
162843581|NCT01262976|588135430|FG003|Up to Year 3|Other|0|||
162843582|NCT01262976|588135431|FG004|Up to Year 3|Other|0|||
162843583|NCT01262976|588135432|FG005|Up to Year 3|Other|0|||
162951765|NCT01536574|588527622|FG000|Overall Study|Withdrawal by Subject|1|||
162951766|NCT01536574|588527623|FG001|Overall Study|Withdrawal by Subject|2|||
162701501|NCT02213055|587617014|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
162701502|NCT02213055|587617013|FG000|Overall Study|Protocol was not Followed during Study|1|||
162701503|NCT02213055|587617014|FG001|Overall Study|Protocol was not Followed during Study|0|||
162701504|NCT02213055|587617013|FG000|Overall Study|Documentation Issue at Enrollment|1|||
162701505|NCT02213055|587617014|FG001|Overall Study|Documentation Issue at Enrollment|0|||
162701506|NCT02213055|587617013|FG000|Overall Study|Documentation Issue during Study|10|||
162701507|NCT02213055|587617014|FG001|Overall Study|Documentation Issue during Study|0|||
162701508|NCT02213055|587617013|FG000|Overall Study|Did not have Live Lice|8|||
162843584|NCT01528787|588135433|FG000|Overall Study|Withdrawal by Subject|0|||
162843585|NCT01528787|588135434|FG001|Overall Study|Withdrawal by Subject|0|||
162843586|NCT01528787|588135435|FG002|Overall Study|Withdrawal by Subject|0|||
162843587|NCT01528787|588135436|FG003|Overall Study|Withdrawal by Subject|1|||
162843588|NCT01528787|588135433|FG000|Overall Study|Family Emergency|0|||
162951767|NCT01536574|588527622|FG000|Overall Study|Lack of Efficacy|1|||
162951768|NCT01536574|588527623|FG001|Overall Study|Lack of Efficacy|0|||
162951769|NCT02514122|588527624|FG000|Overall Study|Withdrawal by Subject|2|||
162701509|NCT02213055|587617014|FG001|Overall Study|Did not have Live Lice|0|||
162701510|NCT02213055|587617013|FG000|Overall Study|Had another Treatment during the Study|3|||
162843589|NCT01528787|588135434|FG001|Overall Study|Family Emergency|0|||
162843590|NCT01528787|588135435|FG002|Overall Study|Family Emergency|1|||
163042865|NCT00248833|588863984|FG001|Overall Study|Adverse Event|0|||
163042866|NCT00248833|588863985|FG002|Overall Study|Adverse Event|0|||
163042867|NCT00248833|588863983|FG000|Overall Study|Withdrawal by Subject|0|||
163042868|NCT00248833|588863984|FG001|Overall Study|Withdrawal by Subject|1|||
163042869|NCT00248833|588863985|FG002|Overall Study|Withdrawal by Subject|1|||
163042870|NCT00248833|588863983|FG000|Overall Study|Lost to Follow-up|1|||
163042871|NCT00248833|588863984|FG001|Overall Study|Lost to Follow-up|1|||
163042872|NCT00248833|588863985|FG002|Overall Study|Lost to Follow-up|1|||
163042873|NCT00248833|588863983|FG000|Overall Study|Other|0|||
163042874|NCT00248833|588863984|FG001|Overall Study|Other|1|||
163042875|NCT00248833|588863985|FG002|Overall Study|Other|0|||
163042876|NCT01554163|588863986|FG000|Overall Study|Adverse Event|3|||
163042877|NCT01554163|588863987|FG001|Overall Study|Adverse Event|0|||
163042878|NCT01554163|588863986|FG000|Overall Study|Lack of Efficacy|1|||
162843591|NCT01528787|588135436|FG003|Overall Study|Family Emergency|0|||
162843592|NCT03433781|588135444|FG000|Overall Study|Progression of Disease|1|||
162843593|NCT03433781|588135445|FG001|Overall Study|Progression of Disease|0|||
162843594|NCT03433781|588135446|FG002|Overall Study|Progression of Disease|0|||
162843595|NCT03433781|588135444|FG000|Overall Study|Physician Decision|0|||
162843596|NCT03433781|588135445|FG001|Overall Study|Physician Decision|1|||
162843597|NCT03433781|588135446|FG002|Overall Study|Physician Decision|0|||
162843598|NCT02400255|588135447|FG000|Overall Study|Relapse|4|||
162843599|NCT02400255|588135448|FG001|Overall Study|Relapse|1|||
162843600|NCT02400255|588135449|FG002|Overall Study|Relapse|1|||
162843601|NCT02400255|588135450|FG003|Overall Study|Relapse|2|||
162843602|NCT02400255|588135447|FG000|Overall Study|Adverse Event|6|||
162843603|NCT02400255|588135448|FG001|Overall Study|Adverse Event|3|||
162843604|NCT02400255|588135449|FG002|Overall Study|Adverse Event|0|||
162843605|NCT02400255|588135450|FG003|Overall Study|Adverse Event|0|||
162843606|NCT02400255|588135447|FG000|Overall Study|Physician Decision|6|||
162843607|NCT02400255|588135448|FG001|Overall Study|Physician Decision|0|||
162843608|NCT02400255|588135449|FG002|Overall Study|Physician Decision|0|||
162843609|NCT02400255|588135450|FG003|Overall Study|Physician Decision|0|||
162843610|NCT02400255|588135447|FG000|Overall Study|Loss of insurance|1|||
162843611|NCT02400255|588135448|FG001|Overall Study|Loss of insurance|0|||
162843612|NCT02400255|588135449|FG002|Overall Study|Loss of insurance|0|||
162843613|NCT02400255|588135450|FG003|Overall Study|Loss of insurance|0|||
162843614|NCT02568046|588135451|FG000|Overall Study|Adverse Event|0|||
162843615|NCT02568046|588135452|FG001|Overall Study|Adverse Event|1|||
162843616|NCT02568046|588135451|FG000|Overall Study|Death|2|||
162843617|NCT02568046|588135452|FG001|Overall Study|Death|0|||
162843618|NCT02568046|588135451|FG000|Overall Study|Progressive Disease|1|||
162843619|NCT02568046|588135452|FG001|Overall Study|Progressive Disease|0|||
162843620|NCT02568046|588135451|FG000|Overall Study|Withdrawal by Subject|2|||
162843621|NCT02568046|588135452|FG001|Overall Study|Withdrawal by Subject|1|||
162843622|NCT02568046|588135451|FG000|Overall Study|Other Events|0|||
162843623|NCT02568046|588135452|FG001|Overall Study|Other Events|1|||
162843624|NCT02809833|588135453|FG000|Overall Study|Death|3|||
162843625|NCT02809833|588135453|FG000|Overall Study|Intolerance|54|||
162843626|NCT02809833|588135453|FG000|Overall Study|Lack of Efficacy|89|||
162843627|NCT02809833|588135453|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
162843628|NCT02809833|588135453|FG000|Overall Study|Noncompliance|1|||
162843629|NCT02809833|588135453|FG000|Overall Study|Withdrawal by Subject|34|||
162843630|NCT02809833|588135453|FG000|Overall Study|Lost to Follow-up|35|||
162843631|NCT02809833|588135453|FG000|Overall Study|Adverse Event (AE)|24|||
162843632|NCT02809833|588135453|FG000|Overall Study|Other|5|||
162843633|NCT02809833|588135453|FG000|Overall Study|Missing Information|52|||
162843634|NCT00523991|588135456|FG000|Overall Study|Adverse Event|6|||
162843635|NCT00523991|588135457|FG001|Overall Study|Adverse Event|5|||
162843636|NCT00523991|588135456|FG000|Overall Study|Protocol Violation|1|||
162843637|NCT00523991|588135457|FG001|Overall Study|Protocol Violation|4|||
162843638|NCT00523991|588135456|FG000|Overall Study|Lost to Follow-up|4|||
162843639|NCT00523991|588135457|FG001|Overall Study|Lost to Follow-up|1|||
162843640|NCT00523991|588135456|FG000|Overall Study|Withdrawal by Subject|7|||
162843641|NCT00523991|588135457|FG001|Overall Study|Withdrawal by Subject|17|||
162843642|NCT00523991|588135456|FG000|Overall Study|Other reason (not specified)|3|||
162843643|NCT00523991|588135457|FG001|Overall Study|Other reason (not specified)|0|||
162843644|NCT00193063|588135459|FG000|Overall Study|Lack of Efficacy|3|||
162843645|NCT00193063|588135459|FG000|Overall Study|Adverse Event|1|||
162843646|NCT03261531|588135460|FG000|Overall Study|Withdrawal by Subject|4|||
162843647|NCT00744874|588135462|FG000|Overall Study|Lost to Follow-up|1|||
162843648|NCT00744874|588135462|FG000|Overall Study|Withdrawal by Subject|1|||
162843649|NCT00744874|588135462|FG000|Overall Study|Study Device not available at procedure|1|||
162843650|NCT00744874|588135462|FG000|Overall Study|Unable to accomodate schedule|1|||
162843651|NCT02435849|588135463|FG000|Overall Study|Death|23|||
162951770|NCT02514122|588527625|FG001|Overall Study|Withdrawal by Subject|0|||
162951771|NCT01472341|588527629|FG000|Overall Study|Started insulin therapy|55|||
162951772|NCT01472341|588527629|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
162951773|NCT01472341|588527629|FG000|Overall Study|Withdrawal by Subject|39|||
162951774|NCT01472341|588527629|FG000|Overall Study|Lost to Follow-up|52|||
162951775|NCT01472341|588527629|FG000|Overall Study|Laboratory parameters unavailable|25|||
162951776|NCT01472341|588527629|FG000|Overall Study|Death|9|||
162951777|NCT00112463|588527632|FG000|Overall Study|Physician Decision|1|||
162951778|NCT00112463|588527632|FG000|Overall Study|Progression|30|||
162951779|NCT00112463|588527632|FG000|Overall Study|Second Primary|1|||
162951780|NCT00112463|588527632|FG000|Overall Study|Toxicity|3|||
162843652|NCT02435849|588135464|FG001|Overall Study|Death|0|||
162843653|NCT02435849|588135463|FG000|Overall Study|Lack of Efficacy|10|||
162843654|NCT02435849|588135464|FG001|Overall Study|Lack of Efficacy|0|||
162843655|NCT02435849|588135463|FG000|Overall Study|New therapy for study indication|8|||
162843656|NCT02435849|588135464|FG001|Overall Study|New therapy for study indication|0|||
162843657|NCT02435849|588135463|FG000|Overall Study|Subject/guardian decision|5|||
162843658|NCT02435849|588135464|FG001|Overall Study|Subject/guardian decision|1|||
163042879|NCT01554163|588863987|FG001|Overall Study|Lack of Efficacy|0|||
162843659|NCT02435849|588135463|FG000|Overall Study|Lost to Follow-up|1|||
162843660|NCT02435849|588135464|FG001|Overall Study|Lost to Follow-up|0|||
162843661|NCT02435849|588135463|FG000|Overall Study|Physician Decision|1|||
162843662|NCT02435849|588135464|FG001|Overall Study|Physician Decision|0|||
162843663|NCT02486757|588135465|FG000|Overall Study|Lost to Follow-up|1|||
162843664|NCT03979274|588135467|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162843665|NCT03979274|588135468|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162843666|NCT01614093|588135471|FG000|Overall Study|Withdrawal by Subject|1|||
162843667|NCT00603915|588135472|FG000|Overall Study|Physician Decision|1|||
162843668|NCT01724528|588135482|FG000|Overall Study|Death|3|||
162843669|NCT01724528|588135483|FG001|Overall Study|Death|0|||
162843670|NCT01724528|588135482|FG000|Overall Study|Withdrawal by Subject|0|||
162843671|NCT01724528|588135483|FG001|Overall Study|Withdrawal by Subject|2|||
162843672|NCT01724528|588135482|FG000|Overall Study|Protocol Violation|0|||
162843673|NCT01724528|588135483|FG001|Overall Study|Protocol Violation|1|||
162843674|NCT01724528|588135482|FG000|Overall Study|Patient refused to attend last visit|1|||
162843675|NCT01724528|588135483|FG001|Overall Study|Patient refused to attend last visit|0|||
162843676|NCT02183519|588135487|FG000|Overall Study|computer error|3|||
162843677|NCT02183519|588135488|FG001|Overall Study|computer error|0|||
162843678|NCT02183519|588135487|FG000|Overall Study|Did not respond to cough inducter|0|||
162843679|NCT02183519|588135488|FG001|Overall Study|Did not respond to cough inducter|3|||
162843680|NCT05574062|588135491|FG000|Pre Run-In|Screening failure|3|||
162843681|NCT05574062|588135492|FG001|Pre Run-In|Screening failure|0|||
162843682|NCT05574062|588135493|FG002|Pre Run-In|Screening failure|0|||
162843683|NCT05574062|588135494|FG003|Pre Run-In|Screening failure|0|||
162843684|NCT05574062|588135495|FG004|Pre Run-In|Screening failure|0|||
162843685|NCT05574062|588135491|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
162843686|NCT05574062|588135492|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
162843687|NCT05574062|588135493|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
162843688|NCT05574062|588135494|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
162843689|NCT05574062|588135495|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
162843690|NCT05574062|588135491|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
162843691|NCT05574062|588135492|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
162843692|NCT05574062|588135493|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
162843693|NCT05574062|588135494|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
162843694|NCT05574062|588135495|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
162843695|NCT05574062|588135491|FG000|Continuation Phase Period 1|Physician Decision|1|||
162843696|NCT05574062|588135492|FG001|Continuation Phase Period 1|Physician Decision|0|||
162843697|NCT05574062|588135493|FG002|Continuation Phase Period 1|Physician Decision|0|||
162843698|NCT05574062|588135494|FG003|Continuation Phase Period 1|Physician Decision|0|||
162843699|NCT05574062|588135495|FG004|Continuation Phase Period 1|Physician Decision|0|||
162843700|NCT05574062|588135491|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
162843701|NCT05574062|588135492|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
162843702|NCT05574062|588135493|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
162843703|NCT05574062|588135494|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
162843704|NCT05574062|588135495|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
162843705|NCT05574062|588135491|FG000|Continuation Phase Period 1|Adverse Event|1|||
162843706|NCT05574062|588135492|FG001|Continuation Phase Period 1|Adverse Event|0|||
162843707|NCT05574062|588135493|FG002|Continuation Phase Period 1|Adverse Event|0|||
162843708|NCT05574062|588135494|FG003|Continuation Phase Period 1|Adverse Event|0|||
162843709|NCT05574062|588135495|FG004|Continuation Phase Period 1|Adverse Event|0|||
162843710|NCT05574062|588135491|FG000|Continuation Phase Period 1|Death|1|||
162843711|NCT05574062|588135492|FG001|Continuation Phase Period 1|Death|0|||
163042880|NCT01554163|588863986|FG000|Overall Study|Lost to Follow-up|1|||
163042881|NCT01554163|588863987|FG001|Overall Study|Lost to Follow-up|0|||
163042882|NCT01554163|588863986|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163042883|NCT01554163|588863987|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163042884|NCT01554163|588863986|FG000|Overall Study|Protocol Violation|0|||
162843712|NCT05574062|588135493|FG002|Continuation Phase Period 1|Death|0|||
162843713|NCT05574062|588135494|FG003|Continuation Phase Period 1|Death|0|||
163042885|NCT01554163|588863987|FG001|Overall Study|Protocol Violation|4|||
163042886|NCT01554163|588863986|FG000|Overall Study|Withdrawal by Subject|1|||
162843714|NCT05574062|588135495|FG004|Continuation Phase Period 1|Death|0|||
162843715|NCT05574062|588135491|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
162843716|NCT05574062|588135492|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
162843717|NCT05574062|588135493|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
162843718|NCT05574062|588135494|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
162843719|NCT05574062|588135495|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
162843720|NCT05702736|588135496|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
162843721|NCT05702736|588135497|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
162843722|NCT05702736|588135496|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
162843723|NCT05702736|588135497|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
162843724|NCT00684957|588135512|FG000|Overall Study|Withdrawal by Subject|1|||
162843725|NCT00684957|588135513|FG001|Overall Study|Withdrawal by Subject|1|||
162843726|NCT00684957|588135512|FG000|Overall Study|Lost to Follow-up|1|||
162843727|NCT00684957|588135513|FG001|Overall Study|Lost to Follow-up|0|||
162843728|NCT04341948|588135514|FG000|Overall Study|Adverse Event|0|||
162843729|NCT04341948|588135515|FG001|Overall Study|Adverse Event|1|||
162843730|NCT04341948|588135514|FG000|Overall Study|Lost to Follow-up|6|||
162843731|NCT04341948|588135515|FG001|Overall Study|Lost to Follow-up|1|||
162843732|NCT04341948|588135514|FG000|Overall Study|Physician Decision|1|||
162843733|NCT04341948|588135515|FG001|Overall Study|Physician Decision|2|||
162843734|NCT04341948|588135514|FG000|Overall Study|Withdrawal by Participant|6|||
162843735|NCT04341948|588135515|FG001|Overall Study|Withdrawal by Participant|3|||
162843736|NCT04341948|588135514|FG000|Overall Study|Lack of compliance by Participant|1|||
162843737|NCT04341948|588135515|FG001|Overall Study|Lack of compliance by Participant|0|||
162843738|NCT03406897|588135516|FG000|Overall Study|Lost to Follow-up|1|||
162843739|NCT03406897|588135517|FG001|Overall Study|Lost to Follow-up|2|||
162843740|NCT03406897|588135516|FG000|Overall Study|Withdrawal by Subject|4|||
162843741|NCT03406897|588135517|FG001|Overall Study|Withdrawal by Subject|4|||
162843742|NCT03406897|588135516|FG000|Overall Study|Physician Decision|0|||
162843743|NCT03406897|588135517|FG001|Overall Study|Physician Decision|1|||
162843744|NCT01748071|588136969|FG000|Overall Study|Adverse Event|2|||
162843745|NCT01748071|588136970|FG001|Overall Study|Adverse Event|2|||
162843746|NCT01748071|588136971|FG002|Overall Study|Adverse Event|0|||
162843747|NCT03068325|588136972|FG000|Overall Study|Lost to Follow-up|5|||
162843748|NCT01445535|588136975|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
162843749|NCT01445535|588136976|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163042887|NCT01554163|588863987|FG001|Overall Study|Withdrawal by Subject|5|||
163042888|NCT01554163|588863986|FG000|Overall Study|Not Treated|1|||
163042889|NCT01554163|588863987|FG001|Overall Study|Not Treated|0|||
163042890|NCT01941537|588863988|FG000|Overall Study|Lack of Efficacy|1|||
163042891|NCT01941537|588863989|FG001|Overall Study|Lack of Efficacy|2|||
163042892|NCT01941537|588863988|FG000|Overall Study|Lost to Follow-up|1|||
163042893|NCT01941537|588863989|FG001|Overall Study|Lost to Follow-up|0|||
163042894|NCT01941537|588863988|FG000|Overall Study|Pregnancy|1|||
163042895|NCT01941537|588863989|FG001|Overall Study|Pregnancy|0|||
163042896|NCT01941537|588863988|FG000|Overall Study|Adverse Event|1|||
163042897|NCT01941537|588863989|FG001|Overall Study|Adverse Event|0|||
163042898|NCT01941537|588863988|FG000|Overall Study|Withdrawal by Subject|0|||
163042899|NCT01941537|588863989|FG001|Overall Study|Withdrawal by Subject|1|||
163042900|NCT02634983|588863990|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
163042901|NCT02634983|588863991|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
163042902|NCT00463801|588865665|FG000|Overall Study|Protocol Violation|1|||
163042903|NCT00463801|588865665|FG000|Overall Study|Lack of Efficacy|2|||
163042904|NCT00463801|588865665|FG000|Overall Study|Adverse Event|4|||
163042905|NCT00463801|588865665|FG000|Overall Study|Lost to Follow-up|5|||
163042906|NCT00463801|588865665|FG000|Overall Study|No longer require therapy|1|||
163042907|NCT00669318|588865666|FG000|Overall Study|Withdrawal by Subject|2|||
163042908|NCT04441788|588865669|FG000|Overall Study|Voluntary Withdrawl|0|||
163042909|NCT04441788|588865670|FG001|Overall Study|Voluntary Withdrawl|1|||
163042910|NCT04441788|588865671|FG002|Overall Study|Voluntary Withdrawl|0|||
163042911|NCT04441788|588865669|FG000|Overall Study|Ineligibility|1|||
162843750|NCT01445535|588136977|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
162843751|NCT01445535|588136978|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
163042912|NCT04441788|588865670|FG001|Overall Study|Ineligibility|0|||
163042913|NCT04441788|588865671|FG002|Overall Study|Ineligibility|0|||
163042914|NCT04441788|588865669|FG000|Overall Study|Adverse Event|0|||
163042915|NCT04441788|588865670|FG001|Overall Study|Adverse Event|0|||
163042916|NCT04441788|588865671|FG002|Overall Study|Adverse Event|4|||
162843752|NCT01445535|588136975|FG000|Overall Study|Disease progression|1|||
162843753|NCT01445535|588136976|FG001|Overall Study|Disease progression|0|||
162843754|NCT01445535|588136977|FG002|Overall Study|Disease progression|1|||
162843755|NCT01445535|588136978|FG003|Overall Study|Disease progression|0|||
162843756|NCT01445535|588136975|FG000|Overall Study|PI discretion|0|||
163042917|NCT04441788|588865669|FG000|Overall Study|Study Terminated by Sponsor|16|||
163042918|NCT04441788|588865670|FG001|Overall Study|Study Terminated by Sponsor|16|||
163042919|NCT04441788|588865671|FG002|Overall Study|Study Terminated by Sponsor|12|||
163042920|NCT02315664|588865674|FG000|Overall Study|Lost to Follow-up|1|||
163042921|NCT02315664|588865675|FG001|Overall Study|Lost to Follow-up|1|||
163042922|NCT02315664|588865674|FG000|Overall Study|Withdrawal by Subject|0|||
163042923|NCT02315664|588865675|FG001|Overall Study|Withdrawal by Subject|3|||
163042924|NCT01677182|588865676|FG000|Overall Study|Adverse Event|2|||
163042925|NCT01677182|588865677|FG001|Overall Study|Adverse Event|1|||
162843757|NCT01445535|588136976|FG001|Overall Study|PI discretion|0|||
162843758|NCT01445535|588136977|FG002|Overall Study|PI discretion|0|||
162843759|NCT01445535|588136978|FG003|Overall Study|PI discretion|1|||
162843760|NCT00420511|588136986|FG000|Overall Study|Adverse Event|1|||
162843761|NCT00420511|588136987|FG001|Overall Study|Adverse Event|1|||
162843762|NCT00420511|588136986|FG000|Overall Study|Lost to Follow-up|1|||
162843763|NCT00420511|588136987|FG001|Overall Study|Lost to Follow-up|0|||
162843764|NCT01668654|588136988|FG000|Overall Study|Study Closed/Terminated|3|||
162843765|NCT01668654|588136988|FG000|Overall Study|Withdrawal by Subject|1|||
162843766|NCT00454779|588136989|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
162843767|NCT00454779|588136990|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
162843768|NCT00454779|588136989|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
162843769|NCT00454779|588136990|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
162843770|NCT00454779|588136989|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
162843771|NCT00454779|588136990|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
162843772|NCT00454779|588136989|FG000|First-line Treatment Phase|Protocol Violation|0|||
162843773|NCT00454779|588136990|FG001|First-line Treatment Phase|Protocol Violation|1|||
162843774|NCT00454779|588136989|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
162843775|NCT00454779|588136990|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
162843776|NCT00454779|588136989|FG000|First-line Treatment Phase|Ongoing|1|||
162843777|NCT00454779|588136990|FG001|First-line Treatment Phase|Ongoing|0|||
162843778|NCT00454779|588136989|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
162843779|NCT00454779|588136990|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
162843780|NCT00454779|588136989|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
162843781|NCT00454779|588136990|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
162843782|NCT00454779|588136989|FG000|Second-line Treatment Phase|Ongoing|0|||
162843783|NCT00454779|588136990|FG001|Second-line Treatment Phase|Ongoing|1|||
162843784|NCT01337973|588136992|FG000|Overall Study|Lost to Follow-up|2|||
162843785|NCT01337973|588136993|FG001|Overall Study|Lost to Follow-up|4|||
162843786|NCT01337973|588136994|FG002|Overall Study|Lost to Follow-up|3|||
162843787|NCT01337973|588136992|FG000|Overall Study|Death|1|||
162843788|NCT01337973|588136993|FG001|Overall Study|Death|2|||
162843789|NCT01337973|588136994|FG002|Overall Study|Death|1|||
162843790|NCT01337973|588136992|FG000|Overall Study|Withdrawal by Subject|10|||
162843791|NCT01337973|588136993|FG001|Overall Study|Withdrawal by Subject|8|||
162843792|NCT01337973|588136994|FG002|Overall Study|Withdrawal by Subject|4|||
162843793|NCT01337973|588136992|FG000|Overall Study|missing data on primary outcome|3|||
162843794|NCT01337973|588136993|FG001|Overall Study|missing data on primary outcome|1|||
162843795|NCT01337973|588136994|FG002|Overall Study|missing data on primary outcome|3|||
162843796|NCT03634800|588136995|FG000|Overall Study|Adverse Event|1|||
162843797|NCT03634800|588136995|FG000|Overall Study|Disease Progression|4|||
162843798|NCT03634800|588136995|FG000|Overall Study|Withdrawal by Subject|1|||
162843799|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
162843800|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
162843801|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
162843802|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
162843803|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
162843804|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
162843805|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
162843806|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
162843807|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
162843808|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
162843809|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
162843810|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
162843811|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
162843812|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
162843813|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
162843814|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
162843815|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
162843816|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
162701511|NCT02213055|587617014|FG001|Overall Study|Had another Treatment during the Study|0|||
162701512|NCT02213055|587617013|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
162701513|NCT02213055|587617014|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
162701514|NCT02213055|587617013|FG000|Overall Study|Did not Return to School|5|||
162701515|NCT02213055|587617014|FG001|Overall Study|Did not Return to School|0|||
162701516|NCT01932996|587617015|FG000|Overall Study|Protocol Violation|2|||
162701517|NCT01932996|587617016|FG001|Overall Study|Protocol Violation|0|||
162701518|NCT00846742|587617019|FG000|Overall Study|Withdrawal by Subject|1|||
162843817|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
162843818|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
162843819|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
162843820|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
162843821|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
162843822|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
162701519|NCT05868954|587617025|FG000|Overall Study|Lost to Follow-up|0|||
162701520|NCT05868954|587617026|FG001|Overall Study|Lost to Follow-up|1|||
162701521|NCT05868954|587617025|FG000|Overall Study|Withdrawal by Subject|2|||
162701522|NCT05868954|587617026|FG001|Overall Study|Withdrawal by Subject|2|||
162701523|NCT05868954|587617025|FG000|Overall Study|Participant delivered|1|||
162701524|NCT05868954|587617026|FG001|Overall Study|Participant delivered|1|||
162701525|NCT05868954|587617025|FG000|Overall Study|Miscarriage|0|||
162951781|NCT00112463|588527632|FG000|Overall Study|Withdrawal by Subject|2|||
162951782|NCT00112463|588527632|FG000|Overall Study|Never started treatment|2|||
162951783|NCT00678639|588527633|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
162951784|NCT00678639|588527634|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
162951785|NCT00296647|588527636|FG000|Overall Study|Death|4|||
162951786|NCT00296647|588527637|FG001|Overall Study|Death|1|||
162951787|NCT00296647|588527638|FG002|Overall Study|Death|2|||
162951788|NCT00296647|588527639|FG003|Overall Study|Death|1|||
162951789|NCT00296647|588527640|FG004|Overall Study|Death|1|||
162951790|NCT00296647|588527636|FG000|Overall Study|Withdrawal by Subject|28|||
162951791|NCT00296647|588527637|FG001|Overall Study|Withdrawal by Subject|27|||
162951792|NCT00296647|588527638|FG002|Overall Study|Withdrawal by Subject|32|||
162951793|NCT00296647|588527639|FG003|Overall Study|Withdrawal by Subject|16|||
162951794|NCT00296647|588527640|FG004|Overall Study|Withdrawal by Subject|19|||
162951795|NCT05615935|588527641|FG000|Overall Study|Lost to Follow-up|1|||
162951796|NCT05615935|588527642|FG001|Overall Study|Lost to Follow-up|1|||
162951797|NCT00735904|588527643|FG000|Overall Study|Adverse Event|3|||
162951798|NCT00735904|588527643|FG000|Overall Study|Death|20|||
162951799|NCT00735904|588527643|FG000|Overall Study|Protocol Violation|1|||
162951800|NCT00735904|588527643|FG000|Overall Study|Withdrawal by Subject|1|||
162951801|NCT00735904|588527643|FG000|Overall Study|Study Terminated by Sponsor|5|||
162951802|NCT00735904|588527643|FG000|Overall Study|Other|8|||
162951803|NCT04510285|588527646|FG000|Overall Study|Death|1|||
162951804|NCT00048581|588527647|FG000|Double-Blind Period|Adverse Event|9|||
162951805|NCT00048581|588527648|FG001|Double-Blind Period|Adverse Event|5|||
162951806|NCT00048581|588527649|FG002|Double-Blind Period|Adverse Event|0|||
162951807|NCT00048581|588527647|FG000|Double-Blind Period|Lack of Efficacy|14|||
162951808|NCT00048581|588527648|FG001|Double-Blind Period|Lack of Efficacy|27|||
162951809|NCT00048581|588527649|FG002|Double-Blind Period|Lack of Efficacy|0|||
162951810|NCT00048581|588527647|FG000|Double-Blind Period|Lost to Follow-up|5|||
162951811|NCT00048581|588527648|FG001|Double-Blind Period|Lost to Follow-up|0|||
162951812|NCT00048581|588527649|FG002|Double-Blind Period|Lost to Follow-up|0|||
162951813|NCT00048581|588527647|FG000|Double-Blind Period|Withdrawal by Subject|5|||
162951814|NCT00048581|588527648|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162951815|NCT00048581|588527649|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162951816|NCT00048581|588527647|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
162951817|NCT00048581|588527648|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
162951818|NCT00048581|588527649|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
162951819|NCT00048581|588527647|FG000|Double-Blind Period|Investigator Decision|1|||
162951820|NCT00048581|588527648|FG001|Double-Blind Period|Investigator Decision|0|||
162951821|NCT00048581|588527649|FG002|Double-Blind Period|Investigator Decision|0|||
162951822|NCT00048581|588527647|FG000|Open-Label Period|Death|0|||
162951823|NCT00048581|588527648|FG001|Open-Label Period|Death|0|||
162951824|NCT00048581|588527649|FG002|Open-Label Period|Death|4|||
162951825|NCT00048581|588527647|FG000|Open-Label Period|Adverse Event|0|||
162951826|NCT00048581|588527648|FG001|Open-Label Period|Adverse Event|0|||
162951827|NCT00048581|588527649|FG002|Open-Label Period|Adverse Event|37|||
162951828|NCT00048581|588527647|FG000|Open-Label Period|Lack of Efficacy|0|||
162951829|NCT00048581|588527648|FG001|Open-Label Period|Lack of Efficacy|0|||
162951830|NCT00048581|588527649|FG002|Open-Label Period|Lack of Efficacy|69|||
162951831|NCT00048581|588527647|FG000|Open-Label Period|Lost to Follow-up|0|||
162951832|NCT00048581|588527648|FG001|Open-Label Period|Lost to Follow-up|0|||
162951833|NCT00048581|588527649|FG002|Open-Label Period|Lost to Follow-up|14|||
162951834|NCT00048581|588527647|FG000|Open-Label Period|Withdrawal by Subject|0|||
162951835|NCT00048581|588527648|FG001|Open-Label Period|Withdrawal by Subject|0|||
162951836|NCT00048581|588527649|FG002|Open-Label Period|Withdrawal by Subject|20|||
162951837|NCT00048581|588527647|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
162951838|NCT00048581|588527648|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
162951839|NCT00048581|588527649|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
162951840|NCT00048581|588527647|FG000|Open-Label Period|Poor/Non-compliance|0|||
162701526|NCT05868954|587617026|FG001|Overall Study|Miscarriage|1|||
162951841|NCT00048581|588527648|FG001|Open-Label Period|Poor/Non-compliance|0|||
162951842|NCT00048581|588527649|FG002|Open-Label Period|Poor/Non-compliance|5|||
162951843|NCT00048581|588527647|FG000|Open-Label Period|Pregnancy|0|||
162951844|NCT00048581|588527648|FG001|Open-Label Period|Pregnancy|0|||
162951845|NCT00048581|588527649|FG002|Open-Label Period|Pregnancy|7|||
162951846|NCT00048581|588527647|FG000|Open-Label Period|Study Site Closure|0|||
162951847|NCT00048581|588527648|FG001|Open-Label Period|Study Site Closure|0|||
162951848|NCT00048581|588527649|FG002|Open-Label Period|Study Site Closure|2|||
162951849|NCT00048581|588527647|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
162843823|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Death|2|||
162843824|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Death|1|||
162843825|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Death|2|||
162843826|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Graft loss|0|||
162843827|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Graft loss|2|||
162843828|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Graft loss|0|||
162843829|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
162843830|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
162843831|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
162843832|NCT01114529|588136996|FG000|Completed Study Medication at Month 24|Missing|2|||
162843833|NCT01114529|588136997|FG001|Completed Study Medication at Month 24|Missing|0|||
162843834|NCT01114529|588136998|FG002|Completed Study Medication at Month 24|Missing|0|||
162843835|NCT01114529|588136996|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
162843836|NCT01114529|588136997|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
162843837|NCT01114529|588136998|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
162843838|NCT01114529|588136996|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
162843839|NCT01114529|588136997|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
162843840|NCT01114529|588136998|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
162843841|NCT01114529|588136996|FG000|Completed Study Phase at Month 24|Death|8|||
162843842|NCT01114529|588136997|FG001|Completed Study Phase at Month 24|Death|5|||
162843843|NCT01114529|588136998|FG002|Completed Study Phase at Month 24|Death|4|||
162843844|NCT01114529|588136996|FG000|Completed Study Phase at Month 24|Other|2|||
162843845|NCT01114529|588136997|FG001|Completed Study Phase at Month 24|Other|0|||
162843846|NCT01114529|588136998|FG002|Completed Study Phase at Month 24|Other|0|||
162843847|NCT01114529|588136996|FG000|Completed Study Phase at Month 24|Missing|2|||
162843848|NCT01114529|588136997|FG001|Completed Study Phase at Month 24|Missing|0|||
162843849|NCT01114529|588136998|FG002|Completed Study Phase at Month 24|Missing|0|||
162843850|NCT03555266|588136999|FG000|Overall Study|Protocol Violation|6|||
162843851|NCT03555266|588137000|FG001|Overall Study|Protocol Violation|4|||
162843852|NCT00797823|588137005|FG000|First Period (Initial Randomization)|Physician Decision|1|||
162843853|NCT00797823|588137006|FG001|First Period (Initial Randomization)|Physician Decision|0|||
162843854|NCT00797823|588137007|FG002|First Period (Initial Randomization)|Physician Decision|0|||
162843855|NCT00408694|588137008|FG000|Overall Study|Ineligible|1|||
162843856|NCT00408694|588137008|FG000|Overall Study|No protocol treatment|1|||
162843857|NCT01700192|588137009|FG000|Overall Study|Adverse Event|73|||
162843858|NCT01700192|588137010|FG001|Overall Study|Adverse Event|18|||
162843859|NCT01700192|588137009|FG000|Overall Study|Lack of Efficacy|1|||
162843860|NCT01700192|588137010|FG001|Overall Study|Lack of Efficacy|0|||
162843861|NCT01700192|588137009|FG000|Overall Study|Lost to Follow-up|42|||
162843862|NCT01700192|588137010|FG001|Overall Study|Lost to Follow-up|29|||
162843863|NCT01700192|588137009|FG000|Overall Study|Noncompliance with study drug|0|||
162843864|NCT01700192|588137010|FG001|Overall Study|Noncompliance with study drug|5|||
162843865|NCT01700192|588137009|FG000|Overall Study|Physician Decision|2|||
162843866|NCT01700192|588137010|FG001|Overall Study|Physician Decision|3|||
162843867|NCT01700192|588137009|FG000|Overall Study|Pregnancy|1|||
162843868|NCT01700192|588137010|FG001|Overall Study|Pregnancy|4|||
162843869|NCT01700192|588137009|FG000|Overall Study|Progressive disease|1|||
162843870|NCT01700192|588137010|FG001|Overall Study|Progressive disease|0|||
162843871|NCT01700192|588137009|FG000|Overall Study|Protocol Violation|3|||
162843872|NCT01700192|588137010|FG001|Overall Study|Protocol Violation|4|||
162843873|NCT01700192|588137009|FG000|Overall Study|Technical problems|0|||
162843874|NCT01700192|588137010|FG001|Overall Study|Technical problems|1|||
162843875|NCT01700192|588137009|FG000|Overall Study|Withdrawal by Subject|56|||
162843876|NCT01700192|588137010|FG001|Overall Study|Withdrawal by Subject|64|||
162843877|NCT01700192|588137009|FG000|Overall Study|Never received study drug|1|||
162843878|NCT01700192|588137010|FG001|Overall Study|Never received study drug|0|||
162843879|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
163042926|NCT01677182|588865678|FG002|Overall Study|Adverse Event|8|||
162843880|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162843881|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162843882|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162843883|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162843884|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
162843885|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
162843886|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
162843887|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
162843888|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
162843889|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
162843890|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
162843891|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
162843892|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
162843893|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
162843894|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
162843895|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162843896|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162843897|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162843898|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162843899|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
162843900|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
162843901|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
162843902|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
162843903|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
162843904|NCT01017952|588137015|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
162843905|NCT01017952|588137016|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162843906|NCT01017952|588137017|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162843907|NCT01017952|588137018|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162843908|NCT01017952|588137019|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162843909|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
162843910|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
162843911|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
162843912|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
162843913|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
162843914|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162843915|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
162843916|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
162843917|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
162843918|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
162843919|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
162843920|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
162843921|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
162843922|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
162843923|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
162843924|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
162843925|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
162843926|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
162843927|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
162843928|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
162843929|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
162843930|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
162843931|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
162843932|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
162843933|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
162843934|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162843935|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
162843936|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
162843937|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162843938|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162843939|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162843940|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
162843941|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
163042927|NCT01677182|588865676|FG000|Overall Study|Protocol Violation|5|||
162843942|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
162843943|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
162843944|NCT01017952|588137015|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
162843945|NCT01017952|588137016|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
162843946|NCT01017952|588137017|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
163042928|NCT01677182|588865677|FG001|Overall Study|Protocol Violation|1|||
162843947|NCT01017952|588137018|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
163042929|NCT01677182|588865678|FG002|Overall Study|Protocol Violation|4|||
163042930|NCT01677182|588865676|FG000|Overall Study|Lost to Follow-up|4|||
163042931|NCT01677182|588865677|FG001|Overall Study|Lost to Follow-up|0|||
163042932|NCT01677182|588865678|FG002|Overall Study|Lost to Follow-up|3|||
163042933|NCT01677182|588865676|FG000|Overall Study|Withdrawal by Subject|7|||
163042934|NCT01677182|588865677|FG001|Overall Study|Withdrawal by Subject|12|||
163042935|NCT01677182|588865678|FG002|Overall Study|Withdrawal by Subject|10|||
163042936|NCT01677182|588865676|FG000|Overall Study|Study termination|12|||
163042937|NCT01677182|588865677|FG001|Overall Study|Study termination|9|||
163042938|NCT01677182|588865678|FG002|Overall Study|Study termination|11|||
163042939|NCT01677182|588865676|FG000|Overall Study|Lack of Efficacy|3|||
162843948|NCT01017952|588137019|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
162843949|NCT00352105|588137021|FG000|Overall Study|Death|5|||
162843950|NCT00352105|588137021|FG000|Overall Study|Withdrawal by Subject|5|||
162843951|NCT00352105|588137021|FG000|Overall Study|Lack of Efficacy|9|||
162843952|NCT00352105|588137021|FG000|Overall Study|Adverse Event|19|||
162843953|NCT00352105|588137021|FG000|Overall Study|Protocol Violation|2|||
162843954|NCT02979431|588137024|FG000|Overall Study|Parent/guardian withdrew consent|2|||
162843955|NCT02979431|588137025|FG001|Overall Study|Parent/guardian withdrew consent|1|||
162843956|NCT02979431|588137026|FG002|Overall Study|Parent/guardian withdrew consent|1|||
162843957|NCT02979431|588137027|FG003|Overall Study|Parent/guardian withdrew consent|1|||
162843958|NCT02979431|588137024|FG000|Overall Study|Randomized but received no study drug|1|||
162843959|NCT02979431|588137025|FG001|Overall Study|Randomized but received no study drug|1|||
162843960|NCT02979431|588137026|FG002|Overall Study|Randomized but received no study drug|0|||
162843961|NCT02979431|588137027|FG003|Overall Study|Randomized but received no study drug|0|||
162843962|NCT02979431|588137024|FG000|Overall Study|Adverse Event|0|||
162843963|NCT02979431|588137025|FG001|Overall Study|Adverse Event|0|||
162843964|NCT02979431|588137026|FG002|Overall Study|Adverse Event|1|||
162843965|NCT02979431|588137027|FG003|Overall Study|Adverse Event|0|||
162843966|NCT02979431|588137024|FG000|Overall Study|Subject left country after Day14|1|||
162843967|NCT02979431|588137025|FG001|Overall Study|Subject left country after Day14|0|||
162843968|NCT02979431|588137026|FG002|Overall Study|Subject left country after Day14|0|||
162843969|NCT02979431|588137027|FG003|Overall Study|Subject left country after Day14|0|||
162843970|NCT01656434|588137028|FG000|Overall Study|Adverse Event|199|||
162843971|NCT01656434|588137029|FG001|Overall Study|Adverse Event|63|||
162843972|NCT01656434|588137028|FG000|Overall Study|Enrollment terminated at trial site|2|||
162843973|NCT01656434|588137029|FG001|Overall Study|Enrollment terminated at trial site|0|||
162843974|NCT01656434|588137028|FG000|Overall Study|Lost to Follow-up|309|||
162843975|NCT01656434|588137029|FG001|Overall Study|Lost to Follow-up|76|||
162843976|NCT01656434|588137028|FG000|Overall Study|Site discontinued study participation|24|||
162843977|NCT01656434|588137029|FG001|Overall Study|Site discontinued study participation|9|||
162843978|NCT01656434|588137028|FG000|Overall Study|Screen failure|2|||
162843979|NCT01656434|588137029|FG001|Overall Study|Screen failure|0|||
162843980|NCT01656434|588137028|FG000|Overall Study|Protocol Violation|7|||
162843981|NCT01656434|588137029|FG001|Overall Study|Protocol Violation|0|||
162843982|NCT01656434|588137028|FG000|Overall Study|Pregnancy wish|18|||
162843983|NCT01656434|588137029|FG001|Overall Study|Pregnancy wish|6|||
162843984|NCT01656434|588137028|FG000|Overall Study|Pregnancy|45|||
162843985|NCT01656434|588137029|FG001|Overall Study|Pregnancy|10|||
162843986|NCT01656434|588137028|FG000|Overall Study|Physician Decision|7|||
162843987|NCT01656434|588137029|FG001|Overall Study|Physician Decision|2|||
162843988|NCT01656434|588137028|FG000|Overall Study|Non-compliance with study drug|48|||
162843989|NCT01656434|588137029|FG001|Overall Study|Non-compliance with study drug|9|||
162843990|NCT01656434|588137028|FG000|Overall Study|Study terminated by sponsor|1501|||
162843991|NCT01656434|588137029|FG001|Overall Study|Study terminated by sponsor|348|||
162843992|NCT01656434|588137028|FG000|Overall Study|Participant discontinued; drug related|13|||
162843993|NCT01656434|588137029|FG001|Overall Study|Participant discontinued; drug related|4|||
162843994|NCT01656434|588137028|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
162843995|NCT01656434|588137029|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
162843996|NCT01656434|588137028|FG000|Overall Study|Non-compliance with protocol|39|||
162843997|NCT01656434|588137029|FG001|Overall Study|Non-compliance with protocol|15|||
163042940|NCT01677182|588865677|FG001|Overall Study|Lack of Efficacy|0|||
163042941|NCT01677182|588865678|FG002|Overall Study|Lack of Efficacy|1|||
163042942|NCT01677182|588865676|FG000|Overall Study|Other reasons|1|||
163042943|NCT01677182|588865677|FG001|Overall Study|Other reasons|5|||
162843998|NCT01656434|588137028|FG000|Overall Study|Participant moved|40|||
162843999|NCT01656434|588137029|FG001|Overall Study|Participant moved|12|||
162844000|NCT01656434|588137028|FG000|Overall Study|Participant withdrew consent|28|||
162844001|NCT01656434|588137029|FG001|Overall Study|Participant withdrew consent|9|||
162844002|NCT01656434|588137028|FG000|Overall Study|Withdrawal by Subject|64|||
162844003|NCT01656434|588137029|FG001|Overall Study|Withdrawal by Subject|7|||
162844004|NCT02435914|588137030|FG000|Overall Study|Ocular Adverse Event|1|||
162844005|NCT02435914|588137031|FG001|Overall Study|Ocular Adverse Event|0|||
163042944|NCT01677182|588865678|FG002|Overall Study|Other reasons|2|||
163042945|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
162844006|NCT02435914|588137032|FG002|Overall Study|Ocular Adverse Event|0|||
162844007|NCT02435914|588137033|FG003|Overall Study|Ocular Adverse Event|0|||
162844008|NCT02435914|588137030|FG000|Overall Study|Withdrawal by Subject|0|||
162844009|NCT02435914|588137031|FG001|Overall Study|Withdrawal by Subject|1|||
162844010|NCT02435914|588137032|FG002|Overall Study|Withdrawal by Subject|0|||
162844011|NCT02435914|588137033|FG003|Overall Study|Withdrawal by Subject|0|||
162844012|NCT02435914|588137030|FG000|Overall Study|Other Miscellaneous Reason|0|||
162844013|NCT02435914|588137031|FG001|Overall Study|Other Miscellaneous Reason|0|||
162844014|NCT02435914|588137032|FG002|Overall Study|Other Miscellaneous Reason|1|||
162844015|NCT02435914|588137033|FG003|Overall Study|Other Miscellaneous Reason|0|||
162844016|NCT01405053|588137039|FG000|Overall Study|Adverse Event|3|||
162844017|NCT01405053|588137040|FG001|Overall Study|Adverse Event|0|||
162844018|NCT01405053|588137039|FG000|Overall Study|Lost to Follow-up|0|||
162844019|NCT01405053|588137040|FG001|Overall Study|Lost to Follow-up|1|||
162701527|NCT01435798|587617031|FG000|Overall Study|Withdrawal by Subject|1|||
162701528|NCT03257995|587617035|FG000|Overall Study|Adverse Event|0|||
162701529|NCT03257995|587617036|FG001|Overall Study|Adverse Event|1|||
162701530|NCT03257995|587617037|FG002|Overall Study|Adverse Event|0|||
162701531|NCT03257995|587617038|FG003|Overall Study|Adverse Event|0|||
162701532|NCT03257995|587617039|FG004|Overall Study|Adverse Event|0|||
162844020|NCT01405053|588137039|FG000|Overall Study|Participant choice|2|||
162844021|NCT01405053|588137040|FG001|Overall Study|Participant choice|1|||
162844022|NCT01405053|588137039|FG000|Overall Study|Inadequate therapeutic effect|2|||
162844023|NCT01405053|588137040|FG001|Overall Study|Inadequate therapeutic effect|1|||
162844024|NCT01405053|588137039|FG000|Overall Study|Withdrawal by Subject|3|||
162844025|NCT01405053|588137040|FG001|Overall Study|Withdrawal by Subject|4|||
162844026|NCT01405053|588137039|FG000|Overall Study|Other|0|||
162844027|NCT01405053|588137040|FG001|Overall Study|Other|1|||
162844028|NCT00130286|588137043|FG000|Overall Study|Withdrawal by Subject|0|||
162844029|NCT00130286|588137044|FG001|Overall Study|Withdrawal by Subject|1|||
162844030|NCT00130286|588137045|FG002|Overall Study|Withdrawal by Subject|2|||
162844031|NCT00130286|588137046|FG003|Overall Study|Withdrawal by Subject|2|||
162844032|NCT00130286|588137043|FG000|Overall Study|Adverse Event|0|||
162844033|NCT00130286|588137044|FG001|Overall Study|Adverse Event|0|||
162844034|NCT00130286|588137045|FG002|Overall Study|Adverse Event|2|||
162844035|NCT00130286|588137046|FG003|Overall Study|Adverse Event|0|||
162844036|NCT00130286|588137043|FG000|Overall Study|Missing lab specimens|0|||
162844037|NCT00130286|588137044|FG001|Overall Study|Missing lab specimens|2|||
162844038|NCT00130286|588137045|FG002|Overall Study|Missing lab specimens|0|||
162844039|NCT00130286|588137046|FG003|Overall Study|Missing lab specimens|0|||
162844040|NCT01818726|588137052|FG000|Overall Study|Administrative reasons|5|||
162844041|NCT01818726|588137053|FG001|Overall Study|Administrative reasons|1|||
162844042|NCT01818726|588137052|FG000|Overall Study|Withdrawal by Subject|0|||
162844043|NCT01818726|588137053|FG001|Overall Study|Withdrawal by Subject|1|||
162844044|NCT01818726|588137052|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
162844045|NCT01818726|588137053|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
162844046|NCT00357500|588137054|FG000|Overall Study|Adverse Event|3|||
162844047|NCT00357500|588137054|FG000|Overall Study|Withdrawal by Subject|5|||
162844048|NCT00357500|588137054|FG000|Overall Study|Progressive Disease|65|||
162844049|NCT00357500|588137054|FG000|Overall Study|Not Started Protocol Therapy|4|||
162844050|NCT00993928|588137055|FG000|Overall Study|Withdrawal by Subject|4|||
162844051|NCT00993928|588137056|FG001|Overall Study|Withdrawal by Subject|7|||
162844052|NCT00993928|588137055|FG000|Overall Study|ineligible|1|||
162844053|NCT00993928|588137056|FG001|Overall Study|ineligible|0|||
162844054|NCT02319044|588137061|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
162844055|NCT02319044|588137062|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
162844056|NCT02319044|588137063|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
162844057|NCT02319044|588137061|FG000|Overall Study|Withdrawal by Subject|3|||
162844058|NCT02319044|588137062|FG001|Overall Study|Withdrawal by Subject|3|||
162844059|NCT02319044|588137063|FG002|Overall Study|Withdrawal by Subject|6|||
162844060|NCT02319044|588137061|FG000|Overall Study|Condition under investigation worsened|100|||
162844061|NCT02319044|588137062|FG001|Overall Study|Condition under investigation worsened|50|||
162844062|NCT02319044|588137063|FG002|Overall Study|Condition under investigation worsened|46|||
162844063|NCT02319044|588137061|FG000|Overall Study|Adverse Event|17|||
162844064|NCT02319044|588137062|FG001|Overall Study|Adverse Event|2|||
162844065|NCT02319044|588137063|FG002|Overall Study|Adverse Event|8|||
162844066|NCT02319044|588137061|FG000|Overall Study|Study specific discontinuation criteria|2|||
162951850|NCT00048581|588527648|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
162951851|NCT00048581|588527649|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
162951852|NCT00048581|588527647|FG000|Open-Label Period|Problem With Transportation To Site|0|||
162951853|NCT00048581|588527648|FG001|Open-Label Period|Problem With Transportation To Site|0|||
162951854|NCT00048581|588527649|FG002|Open-Label Period|Problem With Transportation To Site|1|||
162951855|NCT00048581|588527647|FG000|Open-Label Period|Primary Investigator Retired|0|||
162951856|NCT00048581|588527648|FG001|Open-Label Period|Primary Investigator Retired|0|||
162951857|NCT00048581|588527649|FG002|Open-Label Period|Primary Investigator Retired|2|||
162951858|NCT00048581|588527647|FG000|Open-Label Period|Study Ended By Sponsor|0|||
162951859|NCT00048581|588527648|FG001|Open-Label Period|Study Ended By Sponsor|0|||
162951860|NCT00048581|588527649|FG002|Open-Label Period|Study Ended By Sponsor|1|||
162951861|NCT03639311|588527653|FG000|Maintenance Phase|Lost to Follow-up|1|||
162951862|NCT03639311|588527654|FG001|Maintenance Phase|Lost to Follow-up|0|||
162951863|NCT03639311|588527655|FG002|Maintenance Phase|Lost to Follow-up|0|||
162951864|NCT03639311|588527653|FG000|Maintenance Phase|Adverse Event|1|||
162951865|NCT03639311|588527654|FG001|Maintenance Phase|Adverse Event|0|||
162844067|NCT02319044|588137062|FG001|Overall Study|Study specific discontinuation criteria|2|||
162844068|NCT02319044|588137063|FG002|Overall Study|Study specific discontinuation criteria|1|||
162844069|NCT02319044|588137061|FG000|Overall Study|Not treated|0|||
162844070|NCT02319044|588137062|FG001|Overall Study|Not treated|2|||
162844071|NCT02319044|588137063|FG002|Overall Study|Not treated|2|||
162844072|NCT02154087|588137068|FG000|Overall Study|Study Termination|1|||
162844073|NCT03687502|588137069|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
162844074|NCT03687502|588137069|FG000|Overall Study|Lumason not available|1|||
162844075|NCT00486278|588137071|FG000|Overall Study|Adverse Event|5|||
162844076|NCT00486278|588137071|FG000|Overall Study|Withdrawal by Subject|2|||
162844077|NCT00486278|588137071|FG000|Overall Study|Physician Decision|2|||
162844078|NCT00695565|588137073|FG000|Overall Study|Lost to Follow-up|4|||
162844079|NCT00695565|588137074|FG001|Overall Study|Lost to Follow-up|4|||
162844080|NCT00695565|588137073|FG000|Overall Study|Adverse Event|3|||
162844081|NCT00695565|588137074|FG001|Overall Study|Adverse Event|1|||
162844082|NCT00695565|588137073|FG000|Overall Study|Protocol Violation|3|||
162844083|NCT00695565|588137074|FG001|Overall Study|Protocol Violation|1|||
162844084|NCT00695565|588137073|FG000|Overall Study|Withdrawal by Subject|1|||
162844085|NCT00695565|588137074|FG001|Overall Study|Withdrawal by Subject|1|||
162844086|NCT00695565|588137073|FG000|Overall Study|Lack of Efficacy|1|||
162844087|NCT00695565|588137074|FG001|Overall Study|Lack of Efficacy|1|||
162844088|NCT00695565|588137073|FG000|Overall Study|Subject did not follow instructions|1|||
162844089|NCT00695565|588137074|FG001|Overall Study|Subject did not follow instructions|1|||
162844090|NCT04811716|588137076|FG000|Overall Study|Withdrawal by Subject|2|||
162844091|NCT04811716|588137077|FG001|Overall Study|Withdrawal by Subject|0|||
162844092|NCT03110900|588137078|FG000|Overall Study|Sponsor withdrew|1|||
162844093|NCT03110900|588137079|FG001|Overall Study|Sponsor withdrew|1|||
162844094|NCT02321436|588137080|FG000|Overall Study|Withdrawal by Subject|1|||
162844095|NCT02321436|588137081|FG001|Overall Study|Withdrawal by Subject|0|||
162844096|NCT02321436|588137080|FG000|Overall Study|Lost to Follow-up|0|||
162844097|NCT02321436|588137081|FG001|Overall Study|Lost to Follow-up|1|||
162844098|NCT00644787|588137082|FG000|Period 1: Titration Phase|Adverse Event|11|||
162844099|NCT00644787|588137083|FG001|Period 1: Titration Phase|Adverse Event|0|||
162844100|NCT00644787|588137084|FG002|Period 1: Titration Phase|Adverse Event|0|||
162844101|NCT00644787|588137082|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
162844102|NCT00644787|588137083|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
162844103|NCT00644787|588137084|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
162844104|NCT00644787|588137082|FG000|Period 1: Titration Phase|Physician Decision|1|||
162844105|NCT00644787|588137083|FG001|Period 1: Titration Phase|Physician Decision|0|||
162844106|NCT00644787|588137084|FG002|Period 1: Titration Phase|Physician Decision|0|||
162844107|NCT00644787|588137082|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
162844108|NCT00644787|588137083|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
162844109|NCT00644787|588137084|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
162844110|NCT00644787|588137082|FG000|Period 1: Titration Phase|Worsening of complications|1|||
162844111|NCT00644787|588137083|FG001|Period 1: Titration Phase|Worsening of complications|0|||
162844112|NCT00644787|588137084|FG002|Period 1: Titration Phase|Worsening of complications|0|||
162844113|NCT00644787|588137082|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
162844114|NCT00644787|588137083|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
162844115|NCT00644787|588137084|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
162844116|NCT00644787|588137082|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
162844117|NCT00644787|588137083|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
162844118|NCT00644787|588137084|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
162844119|NCT00644787|588137082|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
162844120|NCT00644787|588137083|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
162844121|NCT00644787|588137084|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
162844122|NCT00644787|588137082|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
162844123|NCT00644787|588137083|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
162844124|NCT00644787|588137084|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
162844125|NCT00644787|588137082|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
162844126|NCT00644787|588137083|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
162951866|NCT03639311|588527655|FG002|Maintenance Phase|Adverse Event|0|||
162951867|NCT03639311|588527653|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
162951868|NCT03639311|588527654|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
162951869|NCT03639311|588527655|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
162951870|NCT03639311|588527653|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
162951871|NCT03639311|588527654|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
162951872|NCT03639311|588527655|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
162951873|NCT03639311|588527653|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
162951874|NCT03639311|588527654|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
162844127|NCT00644787|588137084|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
162844128|NCT00644787|588137082|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
162844129|NCT00644787|588137083|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
162844130|NCT00644787|588137084|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
162844131|NCT00644787|588137082|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
162844132|NCT00644787|588137083|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
162844133|NCT00644787|588137084|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
162844134|NCT03355300|588137085|FG000|Overall Study|Physician Decision|0|||
162844135|NCT03355300|588137086|FG001|Overall Study|Physician Decision|1|||
162844136|NCT03355300|588137085|FG000|Overall Study|Lack of Efficacy|2|||
162844137|NCT03355300|588137086|FG001|Overall Study|Lack of Efficacy|1|||
162844138|NCT03355300|588137085|FG000|Overall Study|Other reason|1|||
162844139|NCT03355300|588137086|FG001|Overall Study|Other reason|0|||
162844140|NCT00546052|588137087|FG000|Overall Study|Adverse Event|47|||
162844141|NCT00546052|588137087|FG000|Overall Study|Lost to Follow-up|144|||
162844142|NCT00546052|588137087|FG000|Overall Study|Protocol Violation|9|||
162844143|NCT00546052|588137087|FG000|Overall Study|Withdrawal by Subject|20|||
162844144|NCT00546052|588137087|FG000|Overall Study|Non Compliance|7|||
162844145|NCT03048422|588137090|FG000|Overall Study|Death|1|||
162844146|NCT03048422|588137091|FG001|Overall Study|Death|0|||
162844147|NCT03048422|588137092|FG002|Overall Study|Death|0|||
162844148|NCT03048422|588137090|FG000|Overall Study|Lost to Follow-up|5|||
162844149|NCT03048422|588137091|FG001|Overall Study|Lost to Follow-up|0|||
162844150|NCT03048422|588137092|FG002|Overall Study|Lost to Follow-up|1|||
162844151|NCT03048422|588137090|FG000|Overall Study|Withdrawal by Subject|5|||
162844152|NCT03048422|588137091|FG001|Overall Study|Withdrawal by Subject|7|||
162844153|NCT03048422|588137092|FG002|Overall Study|Withdrawal by Subject|4|||
162844154|NCT03048422|588137090|FG000|Overall Study|Moved|3|||
162844155|NCT03048422|588137091|FG001|Overall Study|Moved|2|||
162844156|NCT03048422|588137092|FG002|Overall Study|Moved|2|||
162844157|NCT03048422|588137090|FG000|Overall Study|Noncompliant with Study Requirements|2|||
162844158|NCT03048422|588137091|FG001|Overall Study|Noncompliant with Study Requirements|1|||
162844159|NCT03048422|588137092|FG002|Overall Study|Noncompliant with Study Requirements|2|||
162844160|NCT03048422|588137090|FG000|Overall Study|Not Able to Get to Clinic|1|||
162844161|NCT03048422|588137091|FG001|Overall Study|Not Able to Get to Clinic|0|||
162844162|NCT03048422|588137092|FG002|Overall Study|Not Able to Get to Clinic|0|||
162844163|NCT02482129|588137096|FG000|Overall Study|Adverse Event-prior to treatment|0|||
162844164|NCT02482129|588137097|FG001|Overall Study|Adverse Event-prior to treatment|1|||
162844165|NCT02482129|588137096|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
162844166|NCT02482129|588137097|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
162844167|NCT02482129|588137096|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
162844168|NCT02482129|588137097|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
162844169|NCT02482129|588137096|FG000|Overall Study|Criteria not met-prior to treatment|1|||
162844170|NCT02482129|588137097|FG001|Overall Study|Criteria not met-prior to treatment|0|||
162844171|NCT02482129|588137096|FG000|Overall Study|Adverse Event|1|||
162844172|NCT02482129|588137097|FG001|Overall Study|Adverse Event|0|||
162844173|NCT02482129|588137096|FG000|Overall Study|Withdrawal by Subject|2|||
162844174|NCT02482129|588137097|FG001|Overall Study|Withdrawal by Subject|0|||
162844175|NCT02482129|588137096|FG000|Overall Study|Criteria not met|1|||
162844176|NCT02482129|588137097|FG001|Overall Study|Criteria not met|0|||
162844177|NCT01031446|588137099|FG000|Overall Study|Disease Progression|38|||
162844178|NCT01031446|588137099|FG000|Overall Study|Adverse Event|9|||
162844179|NCT01031446|588137099|FG000|Overall Study|Physician Decision|4|||
162844180|NCT01031446|588137099|FG000|Overall Study|Withdrawal by Subject|3|||
162844181|NCT01031446|588137099|FG000|Overall Study|Still on treatment|1|||
162844182|NCT01877083|588137102|FG000|Treatment Phase|Disease Progression|10|||
162844183|NCT01877083|588137102|FG000|Treatment Phase|Clinical Progression|1|||
162844184|NCT01877083|588137102|FG000|Treatment Phase|Adverse Event|6|||
162844185|NCT01877083|588137102|FG000|Treatment Phase|Withdrawal by Subject|2|||
162844186|NCT01877083|588137102|FG000|Treatment Phase|Lost to Follow-up|1|||
162701533|NCT03257995|587617040|FG005|Overall Study|Adverse Event|0|||
162701534|NCT03257995|587617035|FG000|Overall Study|Protocol deviation|0|||
162701535|NCT03257995|587617036|FG001|Overall Study|Protocol deviation|0|||
162844187|NCT01877083|588137102|FG000|Extension Phase|Disease Progression|3|||
162844188|NCT01877083|588137102|FG000|Extension Phase|Adverse Event|2|||
162844189|NCT02320487|588137109|FG000|Overall Study|Reason not Specified|1|||
162701536|NCT03257995|587617037|FG002|Overall Study|Protocol deviation|0|||
162844190|NCT02320487|588137109|FG000|Overall Study|Physician Decision|5|||
162701537|NCT03257995|587617038|FG003|Overall Study|Protocol deviation|0|||
162844191|NCT02320487|588137109|FG000|Overall Study|Withdrawal by Subject|1|||
162844192|NCT02320487|588137109|FG000|Overall Study|Death|3|||
162844193|NCT02320487|588137109|FG000|Overall Study|Adverse Event|11|||
162844194|NCT03344003|588137110|FG000|Overall Study|Switched to alternative treatment|1|||
162844195|NCT03344003|588137111|FG001|Overall Study|Switched to alternative treatment|0|||
162844196|NCT03344003|588137110|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
162844197|NCT03344003|588137111|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
162844198|NCT05900115|588138067|FG000|Overall Study|Lost to Follow-up|129|||
162844199|NCT05900115|588138068|FG001|Overall Study|Lost to Follow-up|98|||
162844200|NCT01602341|588138069|FG000|Overall Study|Adverse Event|0|||
162844201|NCT01602341|588138070|FG001|Overall Study|Adverse Event|1|||
162844202|NCT02152345|588138071|FG000|Overall Study|Case Cancellations|2|||
162844203|NCT02152345|588138072|FG001|Overall Study|Case Cancellations|4|||
162844204|NCT02152345|588138071|FG000|Overall Study|Withdrawal by Subject|2|||
162844205|NCT02152345|588138072|FG001|Overall Study|Withdrawal by Subject|1|||
162844206|NCT02324270|588138074|FG000|Overall Study|Withdrawal by Subject|0|||
162844207|NCT02324270|588138075|FG001|Overall Study|Withdrawal by Subject|1|||
162844208|NCT02324270|588138076|FG002|Overall Study|Withdrawal by Subject|0|||
162844209|NCT02324270|588138074|FG000|Overall Study|Lost to Follow-up|4|||
162844210|NCT02324270|588138075|FG001|Overall Study|Lost to Follow-up|3|||
162844211|NCT02324270|588138076|FG002|Overall Study|Lost to Follow-up|4|||
162844212|NCT02324270|588138074|FG000|Overall Study|Protocol Violation|0|||
162844213|NCT02324270|588138075|FG001|Overall Study|Protocol Violation|1|||
162844214|NCT02324270|588138076|FG002|Overall Study|Protocol Violation|1|||
162844215|NCT02324270|588138074|FG000|Overall Study|Non Compliance with Study Drug|1|||
162844216|NCT02324270|588138075|FG001|Overall Study|Non Compliance with Study Drug|2|||
162844217|NCT02324270|588138076|FG002|Overall Study|Non Compliance with Study Drug|0|||
162844218|NCT03521791|588138077|FG000|Overall Study|Protocol Violation|7|||
162844219|NCT03521791|588138078|FG001|Overall Study|Protocol Violation|17|||
162844220|NCT00680836|588138079|FG000|Overall Study|Withdrawal by Subject|3|||
162844221|NCT00680836|588138080|FG001|Overall Study|Withdrawal by Subject|0|||
162844222|NCT00680836|588138079|FG000|Overall Study|Lost to Follow-up|3|||
162844223|NCT00680836|588138080|FG001|Overall Study|Lost to Follow-up|1|||
162844224|NCT00680836|588138079|FG000|Overall Study|Physician Decision|2|||
162844225|NCT00680836|588138080|FG001|Overall Study|Physician Decision|1|||
162844226|NCT03786432|588138081|FG000|Overall Study|Screen Failure after consent|1|||
162844227|NCT03786432|588138081|FG000|Overall Study|Lost to Follow-up|4|||
162844228|NCT03786432|588138081|FG000|Overall Study|did not complete 12 month CT scan|1|||
162844229|NCT03038308|588138082|FG000|Overall Study|Surgical resection|1|||
162844230|NCT03038308|588138082|FG000|Overall Study|Withdrawal by Subject|2|||
162844231|NCT03038308|588138082|FG000|Overall Study|Lost to Follow-up|1|||
162844232|NCT01475734|588138084|FG000|Overall Study|Withdrawal by Subject|1|||
162844233|NCT01475734|588138085|FG001|Overall Study|Withdrawal by Subject|0|||
162844234|NCT01475734|588138084|FG000|Overall Study|Protocol Violation|1|||
162844235|NCT01475734|588138085|FG001|Overall Study|Protocol Violation|0|||
162844236|NCT01475734|588138084|FG000|Overall Study|Physician Decision|0|||
162844237|NCT01475734|588138085|FG001|Overall Study|Physician Decision|1|||
162844238|NCT00771472|588138086|FG000|Overall Study|Physician Decision|2|||
162844239|NCT00771472|588138087|FG001|Overall Study|Physician Decision|3|||
162844240|NCT00771472|588138086|FG000|Overall Study|Progressive Disease|3|||
162844241|NCT00771472|588138087|FG001|Overall Study|Progressive Disease|1|||
162844242|NCT00771472|588138086|FG000|Overall Study|Protocol Violation|1|||
162844243|NCT00771472|588138087|FG001|Overall Study|Protocol Violation|0|||
162844244|NCT00667576|588138093|FG000|Overall Study|Withdrawal by Subject|1|||
162844245|NCT00667576|588138094|FG001|Overall Study|Withdrawal by Subject|0|||
162844246|NCT00667576|588138095|FG002|Overall Study|Withdrawal by Subject|1|||
162844247|NCT00667576|588138096|FG003|Overall Study|Withdrawal by Subject|1|||
162844248|NCT00667576|588138097|FG004|Overall Study|Withdrawal by Subject|1|||
162844249|NCT00667576|588138093|FG000|Overall Study|Adverse Event|1|||
162844250|NCT00667576|588138094|FG001|Overall Study|Adverse Event|1|||
162844251|NCT00667576|588138095|FG002|Overall Study|Adverse Event|0|||
162844252|NCT00667576|588138096|FG003|Overall Study|Adverse Event|0|||
162844253|NCT00667576|588138097|FG004|Overall Study|Adverse Event|0|||
162844254|NCT00667576|588138093|FG000|Overall Study|Lost to Follow-up|0|||
162844255|NCT00667576|588138094|FG001|Overall Study|Lost to Follow-up|0|||
162844256|NCT00667576|588138095|FG002|Overall Study|Lost to Follow-up|1|||
162844257|NCT00667576|588138096|FG003|Overall Study|Lost to Follow-up|0|||
162844258|NCT00667576|588138097|FG004|Overall Study|Lost to Follow-up|0|||
162844259|NCT00667576|588138093|FG000|Overall Study|Protocol Violation|0|||
162844260|NCT00667576|588138094|FG001|Overall Study|Protocol Violation|0|||
162844261|NCT00667576|588138095|FG002|Overall Study|Protocol Violation|0|||
162844262|NCT00667576|588138096|FG003|Overall Study|Protocol Violation|1|||
162844263|NCT00667576|588138097|FG004|Overall Study|Protocol Violation|0|||
162844264|NCT00667576|588138093|FG000|Overall Study|Physician Decision|0|||
162844265|NCT00667576|588138094|FG001|Overall Study|Physician Decision|0|||
162844266|NCT00667576|588138095|FG002|Overall Study|Physician Decision|0|||
162844267|NCT00667576|588138096|FG003|Overall Study|Physician Decision|1|||
162844268|NCT00667576|588138097|FG004|Overall Study|Physician Decision|0|||
162844269|NCT00667576|588138093|FG000|Overall Study|Missed Visit|0|||
162844270|NCT00667576|588138094|FG001|Overall Study|Missed Visit|0|||
162844271|NCT00667576|588138095|FG002|Overall Study|Missed Visit|0|||
162844272|NCT00667576|588138096|FG003|Overall Study|Missed Visit|1|||
162844273|NCT00667576|588138097|FG004|Overall Study|Missed Visit|0|||
162844274|NCT03609619|588138104|FG000|Overall Study|Adverse Event|1|||
162844275|NCT03609619|588138105|FG001|Overall Study|Adverse Event|0|||
162844276|NCT03609619|588138104|FG000|Overall Study|Lack of Efficacy|1|||
162844277|NCT03609619|588138105|FG001|Overall Study|Lack of Efficacy|2|||
162701538|NCT03257995|587617039|FG004|Overall Study|Protocol deviation|0|||
162701539|NCT03257995|587617040|FG005|Overall Study|Protocol deviation|2|||
162701540|NCT04170296|587617045|FG000|Overall Study|Adverse Event|1|||
162701541|NCT04170296|587617046|FG001|Overall Study|Adverse Event|0|||
162701542|NCT04170296|587617045|FG000|Overall Study|Withdrawal by Subject|3|||
162701543|NCT04170296|587617046|FG001|Overall Study|Withdrawal by Subject|2|||
162701544|NCT04170296|587617045|FG000|Overall Study|Lost to Follow-up|4|||
162701545|NCT04170296|587617046|FG001|Overall Study|Lost to Follow-up|2|||
162701546|NCT03567993|587617047|FG000|Overall Study|Lost to Follow-up|4|||
162701547|NCT03567993|587617048|FG001|Overall Study|Lost to Follow-up|2|||
162701548|NCT03567993|587617047|FG000|Overall Study|Death|1|||
162701549|NCT03567993|587617048|FG001|Overall Study|Death|1|||
162701550|NCT03567993|587617047|FG000|Overall Study|Withdrawal by Subject|1|||
162844278|NCT03609619|588138104|FG000|Overall Study|Protocol Violation|5|||
162844279|NCT03609619|588138105|FG001|Overall Study|Protocol Violation|0|||
162844280|NCT03609619|588138104|FG000|Overall Study|Withdrawal by Subject|2|||
162844281|NCT03609619|588138105|FG001|Overall Study|Withdrawal by Subject|3|||
162844282|NCT03609619|588138104|FG000|Overall Study|Lost to Follow-up|1|||
162844283|NCT03609619|588138105|FG001|Overall Study|Lost to Follow-up|1|||
162844284|NCT00568555|588138106|FG000|Overall Study|Withdrawal by Subject|1|||
162844285|NCT00568555|588138107|FG001|Overall Study|Withdrawal by Subject|1|||
162844286|NCT01231555|588138108|FG000|Overall Study|Study terminated|8|||
162844287|NCT01231555|588138109|FG001|Overall Study|Study terminated|5|||
162844288|NCT01231555|588138110|FG002|Overall Study|Study terminated|8|||
162844289|NCT01231555|588138108|FG000|Overall Study|Withdrawal by Subject|0|||
162844290|NCT01231555|588138109|FG001|Overall Study|Withdrawal by Subject|2|||
162844291|NCT01231555|588138110|FG002|Overall Study|Withdrawal by Subject|0|||
162844292|NCT00688909|588138111|FG000|Overall Study|Adverse Event|28|||
162844293|NCT00688909|588138111|FG000|Overall Study|Patient withdrew consent|2|||
162844294|NCT00688909|588138111|FG000|Overall Study|Administrative problems|1|||
162844295|NCT00688909|588138111|FG000|Overall Study|Protocol Violation|2|||
162844296|NCT00700180|588138115|FG000|Overall Study|Death|99|||
162844297|NCT00700180|588138116|FG001|Overall Study|Death|114|||
162978985|NCT01660022|588623542|FG004|First Sequence (7 Days)|Adverse Event|1|||
162701551|NCT03567993|587617048|FG001|Overall Study|Withdrawal by Subject|0|||
162701552|NCT00903786|587617052|FG000|Overall Study|Physician Decision|6|||
162701553|NCT00903786|587617052|FG000|Overall Study|Lack of Efficacy|5|||
162844298|NCT00700180|588138115|FG000|Overall Study|Alive on treatment|5|||
162844299|NCT00700180|588138116|FG001|Overall Study|Alive on treatment|3|||
162844300|NCT00700180|588138115|FG000|Overall Study|Alive in follow-up|46|||
162844301|NCT00700180|588138116|FG001|Overall Study|Alive in follow-up|27|||
162844302|NCT00700180|588138115|FG000|Overall Study|Lost to Follow-up|4|||
162844303|NCT00700180|588138116|FG001|Overall Study|Lost to Follow-up|5|||
162844304|NCT03588741|588138117|FG000|Overall Study|Withdrawal by Subject|1|||
162844305|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
162844306|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
162844307|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
162844308|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
162844309|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
162844310|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
162844311|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
162844312|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
162844313|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
162844314|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
162844315|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
162844316|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
162844317|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
162844318|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
162844319|NCT02288247|588138118|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
162844320|NCT02288247|588138119|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
162844321|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
162844322|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
162844323|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
162844324|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
162951875|NCT03639311|588527655|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
162951876|NCT03639311|588527653|FG000|Maintenance Phase|Lack of Efficacy|1|||
162951877|NCT03639311|588527654|FG001|Maintenance Phase|Lack of Efficacy|0|||
162951878|NCT03639311|588527655|FG002|Maintenance Phase|Lack of Efficacy|0|||
162951879|NCT00822926|588527658|FG000|Second Injection Visit|Lost to Follow-up|1|||
162951880|NCT00822926|588527659|FG001|Second Injection Visit|Lost to Follow-up|0|||
162951881|NCT00822926|588527658|FG000|Second Injection Visit|Withdrawal by Subject|0|||
162951882|NCT00822926|588527659|FG001|Second Injection Visit|Withdrawal by Subject|1|||
162951883|NCT04320849|588527670|FG000|Overall Study|Withdrawal by Subject|4|||
162951884|NCT04320849|588527670|FG000|Overall Study|Imaging data unavailable|2|||
162951885|NCT04320849|588527670|FG000|Overall Study|Incomplete imaging|2|||
162951886|NCT03135834|588527673|FG000|Stage 1|Adverse Event|1|||
162951887|NCT03135834|588527674|FG001|Stage 1|Adverse Event|2|||
162951888|NCT03135834|588527675|FG002|Stage 1|Adverse Event|2|||
162951889|NCT03135834|588527676|FG003|Stage 1|Adverse Event|1|||
162951890|NCT03135834|588527673|FG000|Stage 1|Death|1|||
162951891|NCT03135834|588527674|FG001|Stage 1|Death|0|||
162951892|NCT03135834|588527675|FG002|Stage 1|Death|0|||
162951893|NCT03135834|588527676|FG003|Stage 1|Death|0|||
162951894|NCT03135834|588527673|FG000|Stage 1|Lost to Follow-up|17|||
162951895|NCT03135834|588527674|FG001|Stage 1|Lost to Follow-up|24|||
162951896|NCT03135834|588527675|FG002|Stage 1|Lost to Follow-up|21|||
162951897|NCT03135834|588527676|FG003|Stage 1|Lost to Follow-up|38|||
162951898|NCT03135834|588527673|FG000|Stage 1|No longer met eligibility criteria|1|||
162951899|NCT03135834|588527674|FG001|Stage 1|No longer met eligibility criteria|6|||
162951900|NCT03135834|588527675|FG002|Stage 1|No longer met eligibility criteria|2|||
162951901|NCT03135834|588527676|FG003|Stage 1|No longer met eligibility criteria|5|||
162951902|NCT03135834|588527673|FG000|Stage 1|Other|0|||
162951903|NCT03135834|588527674|FG001|Stage 1|Other|2|||
162951904|NCT03135834|588527675|FG002|Stage 1|Other|1|||
162951905|NCT03135834|588527676|FG003|Stage 1|Other|0|||
162951906|NCT03135834|588527673|FG000|Stage 1|Physician Decision|0|||
162951907|NCT03135834|588527674|FG001|Stage 1|Physician Decision|1|||
162951908|NCT03135834|588527675|FG002|Stage 1|Physician Decision|0|||
162951909|NCT03135834|588527676|FG003|Stage 1|Physician Decision|0|||
162951910|NCT03135834|588527673|FG000|Stage 1|Pregnancy|0|||
162951911|NCT03135834|588527674|FG001|Stage 1|Pregnancy|4|||
162951912|NCT03135834|588527675|FG002|Stage 1|Pregnancy|2|||
162951913|NCT03135834|588527676|FG003|Stage 1|Pregnancy|4|||
162951914|NCT03135834|588527673|FG000|Stage 1|Protocol Violation|1|||
162951915|NCT03135834|588527674|FG001|Stage 1|Protocol Violation|1|||
162951916|NCT03135834|588527675|FG002|Stage 1|Protocol Violation|2|||
162951917|NCT03135834|588527676|FG003|Stage 1|Protocol Violation|1|||
162951918|NCT03135834|588527673|FG000|Stage 1|Withdrawal by parent/guardian|2|||
162951919|NCT03135834|588527674|FG001|Stage 1|Withdrawal by parent/guardian|10|||
162844325|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
162844326|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
162951920|NCT03135834|588527675|FG002|Stage 1|Withdrawal by parent/guardian|2|||
162951921|NCT03135834|588527676|FG003|Stage 1|Withdrawal by parent/guardian|1|||
162951922|NCT03135834|588527673|FG000|Stage 1|Withdrawal by Subject|16|||
162951923|NCT03135834|588527674|FG001|Stage 1|Withdrawal by Subject|22|||
162951924|NCT03135834|588527675|FG002|Stage 1|Withdrawal by Subject|7|||
162951925|NCT03135834|588527676|FG003|Stage 1|Withdrawal by Subject|10|||
162951926|NCT03135834|588527673|FG000|Stage 1|Randomized but not Vaccinated|0|||
162951927|NCT03135834|588527674|FG001|Stage 1|Randomized but not Vaccinated|3|||
162951928|NCT03135834|588527675|FG002|Stage 1|Randomized but not Vaccinated|1|||
163042946|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
163042947|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
163042948|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
163042949|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042950|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042951|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
163042952|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
163042953|NCT00667992|588865681|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042954|NCT00667992|588865682|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042955|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
163042956|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
163042957|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
163042958|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
163042959|NCT00667992|588865681|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
163042960|NCT00667992|588865682|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
163042961|NCT00667992|588865681|FG000|Wash-out|Not within one doubling dilution|4|||
163042962|NCT00667992|588865682|FG001|Wash-out|Not within one doubling dilution|3|||
163042963|NCT00667992|588865681|FG000|Wash-out|Failure to wash-out|2|||
163042964|NCT00667992|588865682|FG001|Wash-out|Failure to wash-out|2|||
163042965|NCT00667992|588865681|FG000|Wash-out|Withdrawal by Subject|1|||
163042966|NCT00667992|588865682|FG001|Wash-out|Withdrawal by Subject|0|||
163042967|NCT00667992|588865681|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
163042968|NCT00667992|588865682|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
163042969|NCT00667992|588865681|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
163042970|NCT00667992|588865682|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
163042971|NCT00762762|588865686|FG000|Overall Study|Did not return for appointments|6|||
163042972|NCT00762762|588865687|FG001|Overall Study|Did not return for appointments|8|||
163042973|NCT02489448|588865688|FG000|Overall Study|Death|3|||
163042974|NCT02489448|588865688|FG000|Overall Study|Withdrawal by Subject|2|||
163042975|NCT02748057|588865689|FG000|Overall Study|Adverse Event|1|||
163042976|NCT02748057|588865690|FG001|Overall Study|Adverse Event|0|||
163042977|NCT02748057|588865689|FG000|Overall Study|Physician Decision|0|||
163042978|NCT02748057|588865690|FG001|Overall Study|Physician Decision|1|||
163042979|NCT02748057|588865689|FG000|Overall Study|Protocol Violation|2|||
163042980|NCT02748057|588865690|FG001|Overall Study|Protocol Violation|1|||
163042981|NCT02748057|588865689|FG000|Overall Study|Participant Moved|1|||
163042982|NCT02748057|588865690|FG001|Overall Study|Participant Moved|0|||
163042983|NCT02748057|588865689|FG000|Overall Study|Withdrawal by Subject|1|||
163042984|NCT02748057|588865690|FG001|Overall Study|Withdrawal by Subject|0|||
163042985|NCT02793947|588865693|FG000|Overall Study|Death|1|||
163042986|NCT02793947|588865694|FG001|Overall Study|Death|0|||
163042987|NCT02793947|588865693|FG000|Overall Study|Physician Decision|1|||
163042988|NCT02793947|588865694|FG001|Overall Study|Physician Decision|5|||
163042989|NCT02542397|588865695|FG000|Overall Study|Death|2|||
163042990|NCT02542397|588865695|FG000|Overall Study|Physician Decision|6|||
163042991|NCT02542397|588865695|FG000|Overall Study|Withdrawal by Subject|6|||
163042992|NCT02542397|588865695|FG000|Overall Study|Lost to Follow-up|2|||
163042993|NCT02090283|588865696|FG000|Overall Study|Withdrawal by Subject|6|||
163042994|NCT02090283|588865697|FG001|Overall Study|Withdrawal by Subject|6|||
163042995|NCT02090283|588865698|FG002|Overall Study|Withdrawal by Subject|6|||
163042996|NCT02090283|588865696|FG000|Overall Study|Sponsor Terminated Study|6|||
163042997|NCT02090283|588865697|FG001|Overall Study|Sponsor Terminated Study|6|||
163042998|NCT02090283|588865698|FG002|Overall Study|Sponsor Terminated Study|1|||
163042999|NCT02090283|588865696|FG000|Overall Study|Lost to Follow-up|2|||
163043000|NCT02090283|588865697|FG001|Overall Study|Lost to Follow-up|2|||
163043001|NCT02090283|588865698|FG002|Overall Study|Lost to Follow-up|3|||
163043002|NCT02090283|588865696|FG000|Overall Study|Adverse Event|1|||
163043003|NCT02090283|588865697|FG001|Overall Study|Adverse Event|1|||
163043004|NCT02090283|588865698|FG002|Overall Study|Adverse Event|0|||
163043005|NCT02090283|588865696|FG000|Overall Study|Protocol Violation|2|||
163043006|NCT02090283|588865697|FG001|Overall Study|Protocol Violation|0|||
163043007|NCT02090283|588865698|FG002|Overall Study|Protocol Violation|0|||
163043008|NCT00281697|588865700|FG000|Overall Study|> 60 days since last dose of study drug|4|||
163043009|NCT00281697|588865701|FG001|Overall Study|> 60 days since last dose of study drug|4|||
163043010|NCT00281697|588865700|FG000|Overall Study|Adverse Event|54|||
163043011|NCT00281697|588865701|FG001|Overall Study|Adverse Event|15|||
163043012|NCT00281697|588865700|FG000|Overall Study|Death|8|||
163043013|NCT00281697|588865701|FG001|Overall Study|Death|3|||
163043014|NCT00281697|588865700|FG000|Overall Study|Disease progression|279|||
163043015|NCT00281697|588865701|FG001|Overall Study|Disease progression|149|||
163043016|NCT00281697|588865700|FG000|Overall Study|Other|5|||
163043017|NCT00281697|588865701|FG001|Overall Study|Other|6|||
163043018|NCT00281697|588865700|FG000|Overall Study|Physician's decision to withdraw|15|||
163043019|NCT00281697|588865701|FG001|Overall Study|Physician's decision to withdraw|12|||
163043020|NCT00281697|588865700|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
163043021|NCT00281697|588865701|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
163043022|NCT00281697|588865700|FG000|Overall Study|Did not receive study drug|3|||
163043023|NCT00281697|588865701|FG001|Overall Study|Did not receive study drug|2|||
163043024|NCT00632125|588865702|FG000|Overall Study|Death|82|||
163043025|NCT00632125|588865702|FG000|Overall Study|Withdrawal by Subject|44|||
163043026|NCT00632125|588865702|FG000|Overall Study|Adverse Event|36|||
163043027|NCT00632125|588865702|FG000|Overall Study|Renal transplantation|17|||
163043028|NCT00632125|588865702|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
162844327|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
162844328|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
163043029|NCT00632125|588865702|FG000|Overall Study|Non-compliance|8|||
163043030|NCT00632125|588865702|FG000|Overall Study|Development of uncontrolled hypertension|5|||
163043031|NCT00632125|588865702|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
163043032|NCT00577772|588865705|FG000|Overall Study|Lost to Follow-up|0|||
163043033|NCT00577772|588865706|FG001|Overall Study|Lost to Follow-up|1|||
162844329|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
162844330|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
162844331|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
162844332|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
162844333|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
162844334|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
162844335|NCT02288247|588138118|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
162844336|NCT02288247|588138119|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
162844337|NCT01235962|588138120|FG000|Overall Study|Withdrawal by Subject|20|||
162844338|NCT01235962|588138121|FG001|Overall Study|Withdrawal by Subject|19|||
162844339|NCT01235962|588138122|FG002|Overall Study|Withdrawal by Subject|62|||
162844340|NCT01235962|588138123|FG003|Overall Study|Withdrawal by Subject|49|||
162844341|NCT01235962|588138120|FG000|Overall Study|Lost to Follow-up|21|||
162844342|NCT01235962|588138121|FG001|Overall Study|Lost to Follow-up|16|||
162844343|NCT01235962|588138122|FG002|Overall Study|Lost to Follow-up|47|||
162844344|NCT01235962|588138123|FG003|Overall Study|Lost to Follow-up|32|||
162844345|NCT01235962|588138120|FG000|Overall Study|Physician Decision|5|||
162844346|NCT01235962|588138121|FG001|Overall Study|Physician Decision|0|||
162844347|NCT01235962|588138122|FG002|Overall Study|Physician Decision|9|||
162844348|NCT01235962|588138123|FG003|Overall Study|Physician Decision|5|||
162844349|NCT01580397|588138124|FG000|Overall Study|Lack of Efficacy|14|||
162844350|NCT01727258|588138125|FG000|Overall Study|Adverse Event|0|||
162844351|NCT01727258|588138126|FG001|Overall Study|Adverse Event|2|||
162844352|NCT01727258|588138127|FG002|Overall Study|Adverse Event|0|||
162844353|NCT01727258|588138125|FG000|Overall Study|Noncompliance with Study Drug|0|||
162844354|NCT01727258|588138126|FG001|Overall Study|Noncompliance with Study Drug|0|||
162844355|NCT01727258|588138127|FG002|Overall Study|Noncompliance with Study Drug|1|||
162844356|NCT01727258|588138125|FG000|Overall Study|Withdrawal by Subject|1|||
162844357|NCT01727258|588138126|FG001|Overall Study|Withdrawal by Subject|1|||
162844358|NCT01727258|588138127|FG002|Overall Study|Withdrawal by Subject|0|||
162844359|NCT01727258|588138125|FG000|Overall Study|Lost to Follow-up|1|||
162844360|NCT01727258|588138126|FG001|Overall Study|Lost to Follow-up|0|||
162844361|NCT01727258|588138127|FG002|Overall Study|Lost to Follow-up|0|||
162844362|NCT02817087|588138128|FG000|Overall Study|Withdrawal by Subject|2|||
163043034|NCT00540644|588865710|FG000|Overall Study|Adverse Event|3|||
163043035|NCT00540644|588865711|FG001|Overall Study|Adverse Event|1|||
163043036|NCT00540644|588865710|FG000|Overall Study|Disease Progression|3|||
163043037|NCT00540644|588865711|FG001|Overall Study|Disease Progression|1|||
162844363|NCT02817087|588138129|FG001|Overall Study|Withdrawal by Subject|0|||
162844364|NCT06098729|588138132|FG000|Overall Study|Withdrawal by Subject|1|||
162844365|NCT01890421|588138133|FG000|Overall Study|Adverse Event|1|||
162844366|NCT01890421|588138133|FG000|Overall Study|Other reason|10|||
162844367|NCT04871711|588138134|FG000|Overall Study|Withdrawal by Subject|11|||
162844368|NCT04871711|588138135|FG001|Overall Study|Withdrawal by Subject|5|||
162844369|NCT04871711|588138134|FG000|Overall Study|Lack of Efficacy|5|||
162844370|NCT04871711|588138135|FG001|Overall Study|Lack of Efficacy|7|||
162844371|NCT04871711|588138134|FG000|Overall Study|Adverse Event|2|||
162844372|NCT04871711|588138135|FG001|Overall Study|Adverse Event|6|||
162844373|NCT04871711|588138134|FG000|Overall Study|Various reasons|2|||
162844374|NCT04871711|588138135|FG001|Overall Study|Various reasons|1|||
162844375|NCT04871711|588138134|FG000|Overall Study|Lost to Follow-up|0|||
162844376|NCT04871711|588138135|FG001|Overall Study|Lost to Follow-up|2|||
162844377|NCT01665144|588138136|FG000|Core Part|Withdrawal by Subject|96|||
162844378|NCT01665144|588138137|FG001|Core Part|Withdrawal by Subject|77|||
162844379|NCT01665144|588138138|FG002|Core Part|Withdrawal by Subject|0|||
162844380|NCT01665144|588138136|FG000|Core Part|Adverse Event|45|||
162844381|NCT01665144|588138137|FG001|Core Part|Adverse Event|18|||
162844382|NCT01665144|588138138|FG002|Core Part|Adverse Event|0|||
162844383|NCT01665144|588138136|FG000|Core Part|Lack of Efficacy|16|||
162844384|NCT01665144|588138137|FG001|Core Part|Lack of Efficacy|11|||
162844385|NCT01665144|588138138|FG002|Core Part|Lack of Efficacy|0|||
162844386|NCT01665144|588138136|FG000|Core Part|Lost to Follow-up|9|||
162844387|NCT01665144|588138137|FG001|Core Part|Lost to Follow-up|8|||
162844388|NCT01665144|588138138|FG002|Core Part|Lost to Follow-up|0|||
162844389|NCT01665144|588138136|FG000|Core Part|Physician Decision|13|||
162844390|NCT01665144|588138137|FG001|Core Part|Physician Decision|1|||
162844391|NCT01665144|588138138|FG002|Core Part|Physician Decision|0|||
162844392|NCT01665144|588138136|FG000|Core Part|Progressive disease|8|||
162844393|NCT01665144|588138137|FG001|Core Part|Progressive disease|4|||
162844394|NCT01665144|588138138|FG002|Core Part|Progressive disease|0|||
162844395|NCT01665144|588138136|FG000|Core Part|Non-compliance with study treatment|5|||
162844396|NCT01665144|588138137|FG001|Core Part|Non-compliance with study treatment|0|||
162844397|NCT01665144|588138138|FG002|Core Part|Non-compliance with study treatment|0|||
162844398|NCT01665144|588138136|FG000|Core Part|Death|3|||
162844399|NCT01665144|588138137|FG001|Core Part|Death|1|||
162844400|NCT01665144|588138138|FG002|Core Part|Death|0|||
162844401|NCT01665144|588138136|FG000|Core Part|Protocol deviation|3|||
162844402|NCT01665144|588138137|FG001|Core Part|Protocol deviation|1|||
162844403|NCT01665144|588138138|FG002|Core Part|Protocol deviation|0|||
162844404|NCT01665144|588138136|FG000|Core Part|New therapy for study indication|2|||
162844405|NCT01665144|588138137|FG001|Core Part|New therapy for study indication|1|||
162844406|NCT01665144|588138138|FG002|Core Part|New therapy for study indication|0|||
162844407|NCT01665144|588138136|FG000|Core Part|Technical problems|2|||
162844408|NCT01665144|588138137|FG001|Core Part|Technical problems|0|||
162844409|NCT01665144|588138138|FG002|Core Part|Technical problems|0|||
162844410|NCT01665144|588138136|FG000|Extension Part|Patient/guardian decision|180|||
162844411|NCT01665144|588138137|FG001|Extension Part|Patient/guardian decision|0|||
162844412|NCT01665144|588138138|FG002|Extension Part|Patient/guardian decision|98|||
162844413|NCT01665144|588138136|FG000|Extension Part|Adverse Event|104|||
162844414|NCT01665144|588138137|FG001|Extension Part|Adverse Event|0|||
162844415|NCT01665144|588138138|FG002|Extension Part|Adverse Event|59|||
162844416|NCT01665144|588138136|FG000|Extension Part|Study closed early|42|||
162844417|NCT01665144|588138137|FG001|Extension Part|Study closed early|0|||
162844418|NCT01665144|588138138|FG002|Extension Part|Study closed early|19|||
162844419|NCT01665144|588138136|FG000|Extension Part|Progressive disease|36|||
162844420|NCT01665144|588138137|FG001|Extension Part|Progressive disease|0|||
162844421|NCT01665144|588138138|FG002|Extension Part|Progressive disease|14|||
162844422|NCT01665144|588138136|FG000|Extension Part|Lack of Efficacy|37|||
162844423|NCT01665144|588138137|FG001|Extension Part|Lack of Efficacy|0|||
162844424|NCT01665144|588138138|FG002|Extension Part|Lack of Efficacy|12|||
162844425|NCT01665144|588138136|FG000|Extension Part|Physician Decision|29|||
162844426|NCT01665144|588138137|FG001|Extension Part|Physician Decision|0|||
162844427|NCT01665144|588138138|FG002|Extension Part|Physician Decision|13|||
162844428|NCT01665144|588138136|FG000|Extension Part|Technical problems|20|||
162844429|NCT01665144|588138137|FG001|Extension Part|Technical problems|0|||
162844430|NCT01665144|588138138|FG002|Extension Part|Technical problems|8|||
162844431|NCT01665144|588138136|FG000|Extension Part|Death|20|||
162844432|NCT01665144|588138137|FG001|Extension Part|Death|0|||
162844433|NCT01665144|588138138|FG002|Extension Part|Death|4|||
162844434|NCT01665144|588138136|FG000|Extension Part|Missing|12|||
162844435|NCT01665144|588138137|FG001|Extension Part|Missing|0|||
162844436|NCT01665144|588138138|FG002|Extension Part|Missing|6|||
162844437|NCT01665144|588138136|FG000|Extension Part|Lost to Follow-up|9|||
162844438|NCT01665144|588138137|FG001|Extension Part|Lost to Follow-up|0|||
162844439|NCT01665144|588138138|FG002|Extension Part|Lost to Follow-up|5|||
162844440|NCT01665144|588138136|FG000|Extension Part|New therapy for study indication|3|||
162844441|NCT01665144|588138137|FG001|Extension Part|New therapy for study indication|0|||
162844442|NCT01665144|588138138|FG002|Extension Part|New therapy for study indication|2|||
162844443|NCT01665144|588138136|FG000|Extension Part|Protocol deviation|3|||
162844444|NCT01665144|588138137|FG001|Extension Part|Protocol deviation|0|||
162844445|NCT01665144|588138138|FG002|Extension Part|Protocol deviation|0|||
162844446|NCT01972074|588138143|FG000|Overall Study|Adverse Event|4|||
162844447|NCT01972074|588138144|FG001|Overall Study|Adverse Event|1|||
162844448|NCT01972074|588138145|FG002|Overall Study|Adverse Event|0|||
162844449|NCT01972074|588138143|FG000|Overall Study|Lack of Efficacy|1|||
162844450|NCT01972074|588138144|FG001|Overall Study|Lack of Efficacy|1|||
162844451|NCT01972074|588138145|FG002|Overall Study|Lack of Efficacy|0|||
162844452|NCT01972074|588138143|FG000|Overall Study|Lost to Follow-up|0|||
162844453|NCT01972074|588138144|FG001|Overall Study|Lost to Follow-up|1|||
162844454|NCT01972074|588138145|FG002|Overall Study|Lost to Follow-up|1|||
162844455|NCT01972074|588138143|FG000|Overall Study|Withdrawal by Subject|1|||
162844456|NCT01972074|588138144|FG001|Overall Study|Withdrawal by Subject|1|||
162844457|NCT01972074|588138145|FG002|Overall Study|Withdrawal by Subject|1|||
162844458|NCT01972074|588138143|FG000|Overall Study|Scanner Unavailable|0|||
162844459|NCT01972074|588138144|FG001|Overall Study|Scanner Unavailable|0|||
162844460|NCT01972074|588138145|FG002|Overall Study|Scanner Unavailable|1|||
162844461|NCT02026063|588138150|FG000|Overall Study|Physician Decision|0|||
162844462|NCT02026063|588138151|FG001|Overall Study|Physician Decision|10|||
162844463|NCT02026063|588138150|FG000|Overall Study|Noncompliance with Study Drug|1|||
162844464|NCT02026063|588138151|FG001|Overall Study|Noncompliance with Study Drug|1|||
162844465|NCT02026063|588138150|FG000|Overall Study|Withdrawal of Consent|1|||
162844466|NCT02026063|588138151|FG001|Overall Study|Withdrawal of Consent|6|||
162844467|NCT02026063|588138150|FG000|Overall Study|Adverse Event|5|||
162844468|NCT02026063|588138151|FG001|Overall Study|Adverse Event|20|||
162844469|NCT02026063|588138150|FG000|Overall Study|Lack of Efficacy|0|||
162844470|NCT02026063|588138151|FG001|Overall Study|Lack of Efficacy|4|||
162844471|NCT02026063|588138150|FG000|Overall Study|Lost to Follow-up|0|||
162844472|NCT02026063|588138151|FG001|Overall Study|Lost to Follow-up|1|||
162844473|NCT02026063|588138150|FG000|Overall Study|Reason not Specified|2|||
162844474|NCT02026063|588138151|FG001|Overall Study|Reason not Specified|7|||
162844475|NCT01777581|588138157|FG000|Overall Study|Lost to Follow-up|1|||
162844476|NCT01777581|588138158|FG001|Overall Study|Lost to Follow-up|1|||
162844477|NCT01777581|588138157|FG000|Overall Study|Adverse Event|2|||
162844478|NCT01777581|588138158|FG001|Overall Study|Adverse Event|0|||
162844479|NCT01777581|588138157|FG000|Overall Study|Lack of Efficacy|0|||
162844480|NCT01777581|588138158|FG001|Overall Study|Lack of Efficacy|1|||
162844481|NCT02887521|588138161|FG000|Overall Study|Withdrawal by Subject|0|||
162844482|NCT02887521|588138162|FG001|Overall Study|Withdrawal by Subject|3|||
162844483|NCT01462266|588138163|FG000|Overall Study|Adverse Event|7|||
162844484|NCT01462266|588138164|FG001|Overall Study|Adverse Event|6|||
162844485|NCT01462266|588138163|FG000|Overall Study|Death|2|||
162844486|NCT01462266|588138164|FG001|Overall Study|Death|1|||
162844487|NCT01462266|588138163|FG000|Overall Study|Lack of Efficacy|0|||
162844488|NCT01462266|588138164|FG001|Overall Study|Lack of Efficacy|2|||
162844489|NCT01462266|588138163|FG000|Overall Study|Lost to Follow-up|4|||
162844490|NCT01462266|588138164|FG001|Overall Study|Lost to Follow-up|3|||
162844491|NCT01462266|588138163|FG000|Overall Study|Non-compliance with study drug|3|||
162844492|NCT01462266|588138164|FG001|Overall Study|Non-compliance with study drug|0|||
162844493|NCT01462266|588138163|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
162844494|NCT01462266|588138164|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
162844495|NCT01462266|588138163|FG000|Overall Study|Physician Decision|2|||
162844496|NCT01462266|588138164|FG001|Overall Study|Physician Decision|5|||
162844497|NCT01462266|588138163|FG000|Overall Study|Protocol Violation|1|||
162844498|NCT01462266|588138164|FG001|Overall Study|Protocol Violation|3|||
162844499|NCT01462266|588138163|FG000|Overall Study|Withdrawal by Subject|7|||
162844500|NCT01462266|588138164|FG001|Overall Study|Withdrawal by Subject|2|||
162844501|NCT01462266|588138163|FG000|Overall Study|Screen failure|1|||
162844502|NCT01462266|588138164|FG001|Overall Study|Screen failure|1|||
162844503|NCT01106846|588138165|FG000|Overall Study|Change in surgical procedure|0|||
162844504|NCT01106846|588138166|FG001|Overall Study|Change in surgical procedure|1|||
162844505|NCT02949128|588139685|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
162844506|NCT02949128|588139685|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
162844507|NCT02949128|588139685|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
162844508|NCT02949128|588139685|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
162844509|NCT02949128|588139685|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
162844510|NCT02949128|588139685|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
162844511|NCT02949128|588139685|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
162844512|NCT02949128|588139685|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
162844513|NCT02949128|588139685|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
162844514|NCT02949128|588139685|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
162844515|NCT00880750|588139692|FG000|First Intervention|Adverse Event|1|||
162844516|NCT00880750|588139693|FG001|First Intervention|Adverse Event|0|||
162844517|NCT00880750|588139692|FG000|First Intervention|Unable to collect urine|4|||
162844518|NCT00880750|588139693|FG001|First Intervention|Unable to collect urine|0|||
162844519|NCT00880750|588139692|FG000|First Intervention|Non-compliance with meals|0|||
162844520|NCT00880750|588139693|FG001|First Intervention|Non-compliance with meals|1|||
162844521|NCT00880750|588139692|FG000|First Intervention|Withdrawal by Subject|2|||
162844522|NCT00880750|588139693|FG001|First Intervention|Withdrawal by Subject|0|||
162844523|NCT00880750|588139692|FG000|First Intervention|Lost to Follow-up|2|||
162844524|NCT00880750|588139693|FG001|First Intervention|Lost to Follow-up|0|||
162844525|NCT00880750|588139692|FG000|Second Intervention|Withdrawal by Subject|2|||
162844526|NCT00880750|588139693|FG001|Second Intervention|Withdrawal by Subject|2|||
162844527|NCT00880750|588139692|FG000|Second Intervention|Protocol Violation|1|||
162844528|NCT00880750|588139693|FG001|Second Intervention|Protocol Violation|0|||
162844529|NCT00880750|588139692|FG000|Second Intervention|Unable to collect urine|1|||
162844530|NCT00880750|588139693|FG001|Second Intervention|Unable to collect urine|0|||
162844531|NCT00483327|588139699|FG000|Overall Study|Adverse Event|1|||
162844532|NCT00483327|588139699|FG000|Overall Study|Withdrawal by Subject|3|||
162844533|NCT00483327|588139699|FG000|Overall Study|Lost to Follow-up|4|||
162844534|NCT00483327|588139699|FG000|Overall Study|Patient Non Compliance|2|||
162844535|NCT00670007|588139700|FG000|Overall Study|Drug abuse|1|||
162844536|NCT00670007|588139700|FG000|Overall Study|Lung transplant|1|||
162844537|NCT00670007|588139700|FG000|Overall Study|Travel/Vacation|1|||
162844538|NCT00670007|588139700|FG000|Overall Study|Adverse event, serious fatal|1|||
162844539|NCT00670007|588139700|FG000|Overall Study|Adverse Event|1|||
162844540|NCT00670007|588139700|FG000|Overall Study|Withdrawal by Subject|4|||
162844541|NCT00618722|588139701|FG000|Overall Study|Refusal of Treatment|0|||
162844542|NCT00618722|588139702|FG001|Overall Study|Refusal of Treatment|0|||
162844543|NCT00618722|588139703|FG002|Overall Study|Refusal of Treatment|1|||
162844544|NCT00618722|588139704|FG003|Overall Study|Refusal of Treatment|0|||
162844545|NCT00618722|588139701|FG000|Overall Study|Patient Request|1|||
162844546|NCT00618722|588139702|FG001|Overall Study|Patient Request|1|||
162844547|NCT00618722|588139703|FG002|Overall Study|Patient Request|1|||
162844548|NCT00618722|588139704|FG003|Overall Study|Patient Request|1|||
162844549|NCT00618722|588139701|FG000|Overall Study|Inability to Complete Study Procedure|0|||
162844550|NCT00618722|588139702|FG001|Overall Study|Inability to Complete Study Procedure|1|||
162844551|NCT00618722|588139703|FG002|Overall Study|Inability to Complete Study Procedure|0|||
162844552|NCT00618722|588139704|FG003|Overall Study|Inability to Complete Study Procedure|0|||
162844553|NCT00618722|588139701|FG000|Overall Study|Lost to Follow-up|2|||
162844554|NCT00618722|588139702|FG001|Overall Study|Lost to Follow-up|0|||
162844555|NCT00618722|588139703|FG002|Overall Study|Lost to Follow-up|0|||
162844556|NCT00618722|588139704|FG003|Overall Study|Lost to Follow-up|2|||
162844557|NCT00618722|588139701|FG000|Overall Study|Miscellaneous Reasons|0|||
162844558|NCT00618722|588139702|FG001|Overall Study|Miscellaneous Reasons|0|||
162844559|NCT00618722|588139703|FG002|Overall Study|Miscellaneous Reasons|1|||
162844560|NCT00618722|588139704|FG003|Overall Study|Miscellaneous Reasons|1|||
162844561|NCT00925600|588139705|FG000|Overall Study|Withdrawal by Subject|16|||
162844562|NCT00925600|588139706|FG001|Overall Study|Withdrawal by Subject|14|||
162844563|NCT00925600|588139705|FG000|Overall Study|Death|4|||
162844564|NCT00925600|588139706|FG001|Overall Study|Death|3|||
162844565|NCT00925600|588139705|FG000|Overall Study|Lost to Follow-up|2|||
162844566|NCT00925600|588139706|FG001|Overall Study|Lost to Follow-up|2|||
162844567|NCT00925600|588139705|FG000|Overall Study|Disease Progression|1|||
162844568|NCT00925600|588139706|FG001|Overall Study|Disease Progression|3|||
162844569|NCT00925600|588139705|FG000|Overall Study|Administrative Decision|1|||
162844570|NCT00925600|588139706|FG001|Overall Study|Administrative Decision|1|||
162844571|NCT00925600|588139705|FG000|Overall Study|Noncompliance|2|||
162844572|NCT00925600|588139706|FG001|Overall Study|Noncompliance|0|||
162844573|NCT00925600|588139705|FG000|Overall Study|Ineligibility Determined|2|||
162701554|NCT00903786|587617052|FG000|Overall Study|Reason other than lack of efficacy|4|||
162701555|NCT02285595|587617053|FG000|Overall Study|Lost to Follow-up|14|||
162701556|NCT02285595|587617053|FG000|Overall Study|Withdrawal by Subject|1|||
162701557|NCT01960790|587617054|FG000|Overall Study|Survey forms could not be recovered|3|||
162701558|NCT01960790|587617054|FG000|Overall Study|Treat with Humira outside survey period|3|||
162701559|NCT01960790|587617054|FG000|Overall Study|Transferred to another hospital|4|||
162701560|NCT01960790|587617054|FG000|Overall Study|Unevaluable for safety|1|||
162701561|NCT04318093|587617056|FG000|Overall Study|Adverse Event|2|||
162701562|NCT04318093|587617057|FG001|Overall Study|Adverse Event|2|||
162701563|NCT04318093|587617056|FG000|Overall Study|Participant withdrew consent|1|||
162701564|NCT04318093|587617057|FG001|Overall Study|Participant withdrew consent|0|||
162701565|NCT04318093|587617056|FG000|Overall Study|Other reasons|0|||
162701566|NCT04318093|587617057|FG001|Overall Study|Other reasons|1|||
162701567|NCT01370603|587617058|FG000|Period 1|Adverse Event|5|||
162701568|NCT01370603|587617059|FG001|Period 1|Adverse Event|3|||
162701569|NCT01370603|587617058|FG000|Period 1|Lost to Follow-up|2|||
162701570|NCT01370603|587617059|FG001|Period 1|Lost to Follow-up|0|||
162701571|NCT01370603|587617058|FG000|Period 1|Protocol Violation|2|||
162701572|NCT01370603|587617059|FG001|Period 1|Protocol Violation|2|||
162701573|NCT01370603|587617058|FG000|Period 1|Withdrawal by Subject|5|||
162701574|NCT01370603|587617059|FG001|Period 1|Withdrawal by Subject|5|||
162701575|NCT01370603|587617058|FG000|Crossover Washout|Adverse Event|2|||
162701576|NCT01370603|587617059|FG001|Crossover Washout|Adverse Event|1|||
162701577|NCT01370603|587617058|FG000|Crossover Washout|Lost to Follow-up|2|||
162701578|NCT01370603|587617059|FG001|Crossover Washout|Lost to Follow-up|0|||
162701579|NCT01370603|587617058|FG000|Crossover Washout|Protocol Violation|1|||
162701580|NCT01370603|587617059|FG001|Crossover Washout|Protocol Violation|0|||
162701581|NCT01370603|587617058|FG000|Crossover Washout|Withdrawal by Subject|4|||
162701582|NCT01370603|587617059|FG001|Crossover Washout|Withdrawal by Subject|1|||
162701583|NCT01370603|587617058|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
162701584|NCT01370603|587617059|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
162701585|NCT01370603|587617058|FG000|Period 2|Adverse Event|1|||
162701586|NCT01370603|587617059|FG001|Period 2|Adverse Event|4|||
162701587|NCT01370603|587617058|FG000|Period 2|Lost to Follow-up|1|||
162701588|NCT01370603|587617059|FG001|Period 2|Lost to Follow-up|0|||
162701589|NCT01370603|587617058|FG000|Period 2|Withdrawal by Subject|1|||
162701590|NCT01370603|587617059|FG001|Period 2|Withdrawal by Subject|0|||
162701591|NCT01268059|587618268|FG000|Overall Study|Lost to Follow-up|0|||
162844574|NCT00925600|588139706|FG001|Overall Study|Ineligibility Determined|0|||
162951929|NCT03135834|588527676|FG003|Stage 1|Randomized but not Vaccinated|6|||
162701592|NCT01268059|587618269|FG001|Overall Study|Lost to Follow-up|1|||
162701593|NCT01268059|587618270|FG002|Overall Study|Lost to Follow-up|0|||
162701594|NCT01268059|587618271|FG003|Overall Study|Lost to Follow-up|0|||
162701595|NCT01268059|587618268|FG000|Overall Study|Withdrawal by Subject|7|||
162701596|NCT01268059|587618269|FG001|Overall Study|Withdrawal by Subject|4|||
162701597|NCT01268059|587618270|FG002|Overall Study|Withdrawal by Subject|0|||
162701598|NCT01268059|587618271|FG003|Overall Study|Withdrawal by Subject|0|||
162701599|NCT01268059|587618268|FG000|Overall Study|Death|20|||
162701600|NCT01268059|587618269|FG001|Overall Study|Death|30|||
162701601|NCT01268059|587618270|FG002|Overall Study|Death|3|||
162701602|NCT01268059|587618271|FG003|Overall Study|Death|5|||
162701603|NCT01268059|587618268|FG000|Overall Study|Progression of disease|1|||
162701604|NCT01268059|587618269|FG001|Overall Study|Progression of disease|0|||
162701605|NCT01268059|587618270|FG002|Overall Study|Progression of disease|0|||
162701606|NCT01268059|587618271|FG003|Overall Study|Progression of disease|0|||
162701607|NCT03660943|587618272|FG000|Overall Study|Adverse Event|5|||
162701608|NCT03660943|587618273|FG001|Overall Study|Adverse Event|3|||
162701609|NCT03660943|587618272|FG000|Overall Study|Death|0|||
162701610|NCT03660943|587618273|FG001|Overall Study|Death|2|||
162701611|NCT03660943|587618272|FG000|Overall Study|Lost to Follow-up|7|||
162701612|NCT03660943|587618273|FG001|Overall Study|Lost to Follow-up|3|||
162701613|NCT03660943|587618272|FG000|Overall Study|Protocol Violation|3|||
162701614|NCT03660943|587618273|FG001|Overall Study|Protocol Violation|5|||
162701615|NCT03660943|587618272|FG000|Overall Study|Withdrawal by Subject|8|||
162951930|NCT03135834|588527673|FG000|Stage 2|Lost to Follow-up|0|||
162701616|NCT03660943|587618273|FG001|Overall Study|Withdrawal by Subject|15|||
162701617|NCT03660943|587618272|FG000|Overall Study|Lack of Efficacy|9|||
162844575|NCT00925600|588139705|FG000|Overall Study|Protocol Deviation|0|||
162844576|NCT00925600|588139706|FG001|Overall Study|Protocol Deviation|1|||
162844577|NCT00925600|588139705|FG000|Overall Study|Requirement for Alternative Therapy|0|||
162844578|NCT00925600|588139706|FG001|Overall Study|Requirement for Alternative Therapy|1|||
162844579|NCT00925600|588139705|FG000|Overall Study|Other|3|||
162844580|NCT00925600|588139706|FG001|Overall Study|Other|1|||
162844581|NCT00925600|588139705|FG000|Overall Study|Adverse Event|1|||
162844582|NCT00925600|588139706|FG001|Overall Study|Adverse Event|2|||
162844583|NCT00127127|588139711|FG000|Overall Study|Adverse Event|0|||
162844584|NCT00127127|588139712|FG001|Overall Study|Adverse Event|2|||
162844585|NCT00127127|588139713|FG002|Overall Study|Adverse Event|0|||
162844586|NCT00127127|588139714|FG003|Overall Study|Adverse Event|1|||
162844587|NCT00127127|588139711|FG000|Overall Study|Lack of Efficacy|1|||
162844588|NCT00127127|588139712|FG001|Overall Study|Lack of Efficacy|3|||
162844589|NCT00127127|588139713|FG002|Overall Study|Lack of Efficacy|0|||
162844590|NCT00127127|588139714|FG003|Overall Study|Lack of Efficacy|2|||
162844591|NCT00200057|588139715|FG000|Overall Study|Lack of Efficacy|3|||
162844592|NCT00200057|588139715|FG000|Overall Study|Exited due to terminal illness of PI|2|||
162844593|NCT00200057|588139715|FG000|Overall Study|Withdrawal by Subject|1|||
162844594|NCT00200057|588139715|FG000|Overall Study|Change in medical condition|1|||
162844595|NCT00200057|588139715|FG000|Overall Study|Infection|1|||
162844596|NCT00200057|588139715|FG000|Overall Study|Death|1|||
162844597|NCT01059448|588139717|FG000|Overall Study|Adverse Event|1|||
162844598|NCT01059448|588139718|FG001|Overall Study|Adverse Event|3|||
162844599|NCT01059448|588139719|FG002|Overall Study|Adverse Event|0|||
162844600|NCT01059448|588139720|FG003|Overall Study|Adverse Event|1|||
162844601|NCT01059448|588139717|FG000|Overall Study|Withdrawal by Subject|2|||
162844602|NCT01059448|588139718|FG001|Overall Study|Withdrawal by Subject|0|||
162844603|NCT01059448|588139719|FG002|Overall Study|Withdrawal by Subject|2|||
162844604|NCT01059448|588139720|FG003|Overall Study|Withdrawal by Subject|4|||
162844605|NCT01059448|588139717|FG000|Overall Study|Disease Progression|2|||
162844606|NCT01059448|588139718|FG001|Overall Study|Disease Progression|1|||
162844607|NCT01059448|588139719|FG002|Overall Study|Disease Progression|4|||
162844608|NCT01059448|588139720|FG003|Overall Study|Disease Progression|2|||
162844609|NCT01059448|588139717|FG000|Overall Study|Administrative Decision|43|||
162844610|NCT01059448|588139718|FG001|Overall Study|Administrative Decision|49|||
162844611|NCT01059448|588139719|FG002|Overall Study|Administrative Decision|45|||
162844612|NCT01059448|588139720|FG003|Overall Study|Administrative Decision|46|||
162844613|NCT01059448|588139717|FG000|Overall Study|Lost to Follow-up|0|||
162844614|NCT01059448|588139718|FG001|Overall Study|Lost to Follow-up|0|||
162844615|NCT01059448|588139719|FG002|Overall Study|Lost to Follow-up|2|||
162844616|NCT01059448|588139720|FG003|Overall Study|Lost to Follow-up|0|||
162844617|NCT01059448|588139717|FG000|Overall Study|Death|0|||
162844618|NCT01059448|588139718|FG001|Overall Study|Death|1|||
162844619|NCT01059448|588139719|FG002|Overall Study|Death|0|||
162844620|NCT01059448|588139720|FG003|Overall Study|Death|0|||
162844621|NCT01059448|588139717|FG000|Overall Study|Other|1|||
162844622|NCT01059448|588139718|FG001|Overall Study|Other|1|||
162844623|NCT01059448|588139719|FG002|Overall Study|Other|0|||
162844624|NCT01059448|588139720|FG003|Overall Study|Other|1|||
162844625|NCT01390389|588139721|FG000|Overall Study|Withdrawal by Subject|2|||
162844626|NCT01390389|588139722|FG001|Overall Study|Withdrawal by Subject|0|||
162844627|NCT01390389|588139721|FG000|Overall Study|Screen Fail|2|||
162844628|NCT01390389|588139722|FG001|Overall Study|Screen Fail|1|||
162844629|NCT00778830|588139723|FG000|Overall Study|Ongoing at data cut-off|0|||
162844630|NCT00778830|588139724|FG001|Overall Study|Ongoing at data cut-off|1|||
162844631|NCT05512949|588139725|FG000|Overall Study|Lost to Follow-up|4|||
162844632|NCT05512949|588139726|FG001|Overall Study|Lost to Follow-up|6|||
162844633|NCT05512949|588139727|FG002|Overall Study|Lost to Follow-up|2|||
162844634|NCT05512949|588139725|FG000|Overall Study|Protocol Violation|0|||
162844635|NCT05512949|588139726|FG001|Overall Study|Protocol Violation|0|||
162844636|NCT05512949|588139727|FG002|Overall Study|Protocol Violation|1|||
162844637|NCT05512949|588139725|FG000|Overall Study|Withdrawal by Subject|1|||
162844638|NCT05512949|588139726|FG001|Overall Study|Withdrawal by Subject|1|||
162844639|NCT05512949|588139727|FG002|Overall Study|Withdrawal by Subject|2|||
162844640|NCT05512949|588139725|FG000|Overall Study|Completion status unknown|1|||
162844641|NCT05512949|588139726|FG001|Overall Study|Completion status unknown|3|||
162844642|NCT05512949|588139727|FG002|Overall Study|Completion status unknown|0|||
162844643|NCT03593915|588139728|FG000|Overall Study|Adverse Event|0|||
162844644|NCT03593915|588139729|FG001|Overall Study|Adverse Event|0|||
162844645|NCT03593915|588139730|FG002|Overall Study|Adverse Event|0|||
162844646|NCT03593915|588139731|FG003|Overall Study|Adverse Event|1|||
162844647|NCT03593915|588139732|FG004|Overall Study|Adverse Event|0|||
162844648|NCT03593915|588139733|FG005|Overall Study|Adverse Event|0|||
162844649|NCT03593915|588139728|FG000|Overall Study|Physician Decision|0|||
162844650|NCT03593915|588139729|FG001|Overall Study|Physician Decision|0|||
162844651|NCT03593915|588139730|FG002|Overall Study|Physician Decision|0|||
162844652|NCT03593915|588139731|FG003|Overall Study|Physician Decision|0|||
162844653|NCT03593915|588139732|FG004|Overall Study|Physician Decision|0|||
162844654|NCT03593915|588139733|FG005|Overall Study|Physician Decision|1|||
162844655|NCT01583179|588139734|FG000|Overall Study|Screen failure|1|||
162844656|NCT01583179|588139735|FG001|Overall Study|Screen failure|2|||
162844657|NCT01246206|588139736|FG000|Overall Study|Patient did not receive study regiments.|1|||
162844658|NCT02002975|588139737|FG000|Overall Study|Case Report Forms Uncollected|135|||
162844659|NCT02002975|588139737|FG000|Overall Study|Protocol Deviation|437|||
162844660|NCT03988907|588139738|FG000|Overall Study|Unable to complete visit|0|||
162844661|NCT03988907|588139739|FG001|Overall Study|Unable to complete visit|1|||
162844662|NCT02810964|588139740|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
162844663|NCT02810964|588139741|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
162844664|NCT02810964|588139740|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
162844665|NCT02810964|588139741|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
162844666|NCT02810964|588139740|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
162844667|NCT02810964|588139741|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
162844668|NCT02810964|588139740|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
162844669|NCT02810964|588139741|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
162844670|NCT03523351|588139742|FG000|Overall Study|Death|13|||
162844671|NCT03523351|588139743|FG001|Overall Study|Death|11|||
162844672|NCT03523351|588139742|FG000|Overall Study|Lost to Follow-up|2|||
162844673|NCT03523351|588139743|FG001|Overall Study|Lost to Follow-up|3|||
162844674|NCT03523351|588139742|FG000|Overall Study|Withdrawal by Subject|4|||
162844675|NCT03523351|588139743|FG001|Overall Study|Withdrawal by Subject|0|||
162844676|NCT03523351|588139742|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
162844677|NCT03523351|588139743|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
162844678|NCT02472847|588139744|FG000|Overall Study|Withdrawal by Subject|1|||
162844679|NCT02472847|588139745|FG001|Overall Study|Withdrawal by Subject|5|||
162844680|NCT04656990|588139746|FG000|Baseline|pandemic|20|||
162844681|NCT04656990|588139747|FG001|Baseline|pandemic|24|||
162844682|NCT04656990|588139746|FG000|Follow Up Period|Lost to Follow-up|61|||
162844683|NCT04656990|588139747|FG001|Follow Up Period|Lost to Follow-up|73|||
162844684|NCT03244059|588139748|FG000|Specific Aim 1|Physician Decision|1|||
162844685|NCT03244059|588139749|FG001|Specific Aim 1|Physician Decision|0|||
162844686|NCT03244059|588139748|FG000|Specific Aim 2|Physician Decision|1|||
162844687|NCT03244059|588139749|FG001|Specific Aim 2|Physician Decision|0|||
162844688|NCT01613326|588139750|FG000|Overall Study|Adverse Event|7|||
162844689|NCT01613326|588139751|FG001|Overall Study|Adverse Event|5|||
162844690|NCT01613326|588139750|FG000|Overall Study|Withdrawal by Subject|3|||
162844691|NCT01613326|588139751|FG001|Overall Study|Withdrawal by Subject|4|||
162844692|NCT01613326|588139750|FG000|Overall Study|Abnormal test procedure result(s)|2|||
162844693|NCT01613326|588139751|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162844694|NCT01613326|588139750|FG000|Overall Study|inability to use device|1|||
162844695|NCT01613326|588139751|FG001|Overall Study|inability to use device|0|||
162844696|NCT01613326|588139750|FG000|Overall Study|Lack of Efficacy|0|||
162844697|NCT01613326|588139751|FG001|Overall Study|Lack of Efficacy|1|||
162844698|NCT01613326|588139750|FG000|Overall Study|Lost to Follow-up|0|||
162844699|NCT01613326|588139751|FG001|Overall Study|Lost to Follow-up|1|||
162844700|NCT01613326|588139750|FG000|Overall Study|Administrative|0|||
162844701|NCT01613326|588139751|FG001|Overall Study|Administrative|2|||
162844702|NCT01613326|588139750|FG000|Overall Study|Protocol Violation|0|||
162844703|NCT01613326|588139751|FG001|Overall Study|Protocol Violation|1|||
162844704|NCT01940484|588139752|FG000|Overall Study|Withdrawal by Subject|3|||
163043038|NCT00540644|588865710|FG000|Overall Study|Physician Decision|0|||
163043039|NCT00540644|588865711|FG001|Overall Study|Physician Decision|5|||
163043040|NCT00540644|588865710|FG000|Overall Study|Withdrawal by Subject|2|||
163043041|NCT00540644|588865711|FG001|Overall Study|Withdrawal by Subject|2|||
163043042|NCT00540644|588865710|FG000|Overall Study|Noncomplilance|1|||
163043043|NCT00540644|588865711|FG001|Overall Study|Noncomplilance|0|||
163043044|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
163043045|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
163043046|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
163043047|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
163043048|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
163043049|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
162844705|NCT01940484|588139752|FG000|Overall Study|Underwent transplantation|4|||
162844706|NCT01940484|588139752|FG000|Overall Study|Death|2|||
162844707|NCT01940484|588139752|FG000|Overall Study|Adverse Event|1|||
162844708|NCT01705691|588139754|FG000|Overall Study|Death|1|||
162844709|NCT01705691|588139755|FG001|Overall Study|Death|2|||
162844710|NCT01705691|588139754|FG000|Overall Study|Withdrawal by Subject|1|||
162844711|NCT01705691|588139755|FG001|Overall Study|Withdrawal by Subject|2|||
162844712|NCT01705691|588139754|FG000|Overall Study|Lost to Follow-up|1|||
162844713|NCT01705691|588139755|FG001|Overall Study|Lost to Follow-up|1|||
162844714|NCT01705691|588139754|FG000|Overall Study|Other|0|||
162844715|NCT01705691|588139755|FG001|Overall Study|Other|1|||
163043050|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
163043051|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
162844716|NCT02658448|588139756|FG000|Overall Study|Lost to Follow-up|1|||
162844717|NCT03106779|588139757|FG000|Overall Study|Lack of Efficacy|33|||
162844718|NCT03106779|588139758|FG001|Overall Study|Lack of Efficacy|24|||
162844719|NCT03106779|588139757|FG000|Overall Study|Adverse Event|8|||
162844720|NCT03106779|588139758|FG001|Overall Study|Adverse Event|16|||
162844721|NCT03106779|588139757|FG000|Overall Study|Physician Decision|10|||
162844722|NCT03106779|588139758|FG001|Overall Study|Physician Decision|6|||
162844723|NCT03106779|588139757|FG000|Overall Study|Patient/guardian decision|4|||
162844724|NCT03106779|588139758|FG001|Overall Study|Patient/guardian decision|3|||
162844725|NCT03106779|588139757|FG000|Overall Study|Progressive disease|1|||
162844726|NCT03106779|588139758|FG001|Overall Study|Progressive disease|3|||
162844727|NCT03106779|588139757|FG000|Overall Study|Lost to Follow-up|1|||
162844728|NCT03106779|588139758|FG001|Overall Study|Lost to Follow-up|2|||
162844729|NCT03106779|588139757|FG000|Overall Study|Death|1|||
162844730|NCT03106779|588139758|FG001|Overall Study|Death|0|||
162844731|NCT03106779|588139757|FG000|Overall Study|Protocol Violation|1|||
162844732|NCT03106779|588139758|FG001|Overall Study|Protocol Violation|0|||
162844733|NCT03106779|588139757|FG000|Overall Study|Not treated|1|||
162844734|NCT03106779|588139758|FG001|Overall Study|Not treated|0|||
162844735|NCT04233229|588139759|FG000|Overall Study|Withdrawal by Subject|0|||
162844736|NCT04233229|588139760|FG001|Overall Study|Withdrawal by Subject|1|||
162844737|NCT04233229|588139759|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
162844738|NCT04233229|588139760|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
162844739|NCT04233229|588139759|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
162844740|NCT04233229|588139760|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
162844741|NCT04652804|588139761|FG000|Overall Study|Ineligible post randomization|1|||
162844742|NCT04652804|588139762|FG001|Overall Study|Ineligible post randomization|0|||
162844743|NCT04652804|588139763|FG002|Overall Study|Ineligible post randomization|1|||
162844744|NCT04652804|588139764|FG003|Overall Study|Ineligible post randomization|0|||
162844745|NCT04652804|588139765|FG004|Overall Study|Ineligible post randomization|1|||
162844746|NCT04652804|588139766|FG005|Overall Study|Ineligible post randomization|1|||
162844747|NCT04652804|588139761|FG000|Overall Study|Missing SVR lab results|2|||
162844748|NCT04652804|588139762|FG001|Overall Study|Missing SVR lab results|0|||
162844749|NCT04652804|588139763|FG002|Overall Study|Missing SVR lab results|0|||
162844750|NCT04652804|588139764|FG003|Overall Study|Missing SVR lab results|0|||
162844751|NCT04652804|588139765|FG004|Overall Study|Missing SVR lab results|0|||
162844752|NCT04652804|588139766|FG005|Overall Study|Missing SVR lab results|0|||
162844753|NCT00584194|588139767|FG000|Overall Study|Other|135|||
162844754|NCT04093531|588139768|FG000|Overall Study|failed screening|4|||
162844755|NCT03665285|588139769|FG000|Overall Study|Started New Anticancer Treatment|1|||
162844756|NCT03665285|588139770|FG001|Overall Study|Started New Anticancer Treatment|1|||
162844757|NCT03665285|588139771|FG002|Overall Study|Started New Anticancer Treatment|2|||
162844758|NCT03665285|588139772|FG003|Overall Study|Started New Anticancer Treatment|4|||
162844759|NCT03665285|588139773|FG004|Overall Study|Started New Anticancer Treatment|1|||
162844760|NCT03665285|588139774|FG005|Overall Study|Started New Anticancer Treatment|1|||
162844761|NCT03665285|588139775|FG006|Overall Study|Started New Anticancer Treatment|2|||
162844762|NCT03665285|588139776|FG007|Overall Study|Started New Anticancer Treatment|15|||
162844763|NCT03665285|588139777|FG008|Overall Study|Started New Anticancer Treatment|1|||
162844764|NCT03665285|588139769|FG000|Overall Study|Disease Progression|0|||
162844765|NCT03665285|588139770|FG001|Overall Study|Disease Progression|0|||
162844766|NCT03665285|588139771|FG002|Overall Study|Disease Progression|3|||
162951931|NCT03135834|588527674|FG001|Stage 2|Lost to Follow-up|1|||
162951932|NCT03135834|588527675|FG002|Stage 2|Lost to Follow-up|0|||
162951933|NCT03135834|588527676|FG003|Stage 2|Lost to Follow-up|0|||
162951934|NCT03135834|588527673|FG000|Stage 2|Withdrawal by Subject|0|||
162951935|NCT03135834|588527674|FG001|Stage 2|Withdrawal by Subject|1|||
162951936|NCT03135834|588527675|FG002|Stage 2|Withdrawal by Subject|0|||
162951937|NCT03135834|588527676|FG003|Stage 2|Withdrawal by Subject|0|||
162951938|NCT03135834|588527673|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
162951939|NCT03135834|588527674|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
162951940|NCT03135834|588527675|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
162951941|NCT03135834|588527676|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
162951942|NCT03135834|588527673|FG000|Stage 2|Did not receive Booster Vaccination|1|||
162951943|NCT03135834|588527674|FG001|Stage 2|Did not receive Booster Vaccination|1|||
162951944|NCT03135834|588527675|FG002|Stage 2|Did not receive Booster Vaccination|0|||
162951945|NCT03135834|588527676|FG003|Stage 2|Did not receive Booster Vaccination|0|||
162951946|NCT00119379|588527679|FG000|Overall Study|Adverse Event|4|||
162951947|NCT00119379|588527680|FG001|Overall Study|Adverse Event|1|||
162951948|NCT02421952|588527687|FG000|Overall Study|Diary Not Returned|93|||
162951949|NCT02421952|588527687|FG000|Overall Study|Failed seriation task|13|||
162951950|NCT02421952|588527687|FG000|Overall Study|Subject uncooperative for baseline test|2|||
162951951|NCT02421952|588527687|FG000|Overall Study|Surgery cancelled|1|||
162951952|NCT03262012|588527698|FG000|Overall Study|Withdrawal by Subject|15|||
162951953|NCT03262012|588527699|FG001|Overall Study|Withdrawal by Subject|13|||
162951954|NCT03262012|588527700|FG002|Overall Study|Withdrawal by Subject|8|||
162951955|NCT03262012|588527701|FG003|Overall Study|Withdrawal by Subject|7|||
162951956|NCT03262012|588527698|FG000|Overall Study|Adverse Event|10|||
162951957|NCT03262012|588527699|FG001|Overall Study|Adverse Event|12|||
162951958|NCT03262012|588527700|FG002|Overall Study|Adverse Event|4|||
162951959|NCT03262012|588527701|FG003|Overall Study|Adverse Event|6|||
162951960|NCT03262012|588527698|FG000|Overall Study|Physician Decision|2|||
162951961|NCT03262012|588527699|FG001|Overall Study|Physician Decision|5|||
162951962|NCT03262012|588527700|FG002|Overall Study|Physician Decision|1|||
162844767|NCT03665285|588139772|FG003|Overall Study|Disease Progression|1|||
162951963|NCT03262012|588527701|FG003|Overall Study|Physician Decision|0|||
162951964|NCT03262012|588527698|FG000|Overall Study|Lack of Efficacy|0|||
162951965|NCT03262012|588527699|FG001|Overall Study|Lack of Efficacy|5|||
162951966|NCT03262012|588527700|FG002|Overall Study|Lack of Efficacy|1|||
162701618|NCT03660943|587618273|FG001|Overall Study|Lack of Efficacy|12|||
162951967|NCT03262012|588527701|FG003|Overall Study|Lack of Efficacy|2|||
162701619|NCT03660943|587618272|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
162701620|NCT03660943|587618273|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
162701621|NCT03699124|587618274|FG000|Overall Study|Adverse Event|6|||
162701622|NCT03699124|587618275|FG001|Overall Study|Adverse Event|5|||
162701623|NCT03699124|587618276|FG002|Overall Study|Adverse Event|2|||
162701624|NCT03699124|587618274|FG000|Overall Study|Death|0|||
162701625|NCT03699124|587618275|FG001|Overall Study|Death|2|||
162701626|NCT03699124|587618276|FG002|Overall Study|Death|0|||
162701627|NCT03699124|587618274|FG000|Overall Study|Lost to Follow-up|20|||
162701628|NCT03699124|587618275|FG001|Overall Study|Lost to Follow-up|16|||
162701629|NCT03699124|587618276|FG002|Overall Study|Lost to Follow-up|15|||
162701630|NCT03699124|587618274|FG000|Overall Study|Protocol Violation|1|||
162701631|NCT03699124|587618275|FG001|Overall Study|Protocol Violation|0|||
162701632|NCT03699124|587618276|FG002|Overall Study|Protocol Violation|0|||
162701633|NCT03699124|587618274|FG000|Overall Study|Withdrawal by Subject|13|||
162701634|NCT03699124|587618275|FG001|Overall Study|Withdrawal by Subject|14|||
162701635|NCT03699124|587618276|FG002|Overall Study|Withdrawal by Subject|13|||
162701636|NCT03699124|587618274|FG000|Overall Study|Other reasons|5|||
162701637|NCT03699124|587618275|FG001|Overall Study|Other reasons|3|||
162701638|NCT03699124|587618276|FG002|Overall Study|Other reasons|10|||
162701639|NCT00724061|587618282|FG000|Dose Escalation Phase|Adverse Event|2|||
162701640|NCT00724061|587618282|FG000|Dose Escalation Phase|Disease Progression|3|||
162701641|NCT01536145|587618285|FG000|Overall Study|Progressive disease|3|||
162701642|NCT01536145|587618286|FG001|Overall Study|Progressive disease|4|||
162701643|NCT01536145|587618287|FG002|Overall Study|Progressive disease|1|||
162701644|NCT01536145|587618288|FG003|Overall Study|Progressive disease|2|||
162701645|NCT01536145|587618289|FG004|Overall Study|Progressive disease|1|||
162701646|NCT01536145|587618290|FG005|Overall Study|Progressive disease|2|||
162701647|NCT01536145|587618291|FG006|Overall Study|Progressive disease|1|||
162701648|NCT01536145|587618292|FG007|Overall Study|Progressive disease|2|||
162701649|NCT01536145|587618293|FG008|Overall Study|Progressive disease|1|||
162701650|NCT01536145|587618294|FG009|Overall Study|Progressive disease|3|||
162701651|NCT01536145|587618295|FG010|Overall Study|Progressive disease|3|||
162701652|NCT01536145|587618285|FG000|Overall Study|Withdrawal by Subject|0|||
162701653|NCT01536145|587618286|FG001|Overall Study|Withdrawal by Subject|0|||
162701654|NCT01536145|587618287|FG002|Overall Study|Withdrawal by Subject|1|||
162701655|NCT01536145|587618288|FG003|Overall Study|Withdrawal by Subject|0|||
162701656|NCT01536145|587618289|FG004|Overall Study|Withdrawal by Subject|0|||
162701657|NCT01536145|587618290|FG005|Overall Study|Withdrawal by Subject|1|||
162701658|NCT01536145|587618291|FG006|Overall Study|Withdrawal by Subject|0|||
162701659|NCT01536145|587618292|FG007|Overall Study|Withdrawal by Subject|0|||
162701660|NCT01536145|587618293|FG008|Overall Study|Withdrawal by Subject|2|||
162701661|NCT01536145|587618294|FG009|Overall Study|Withdrawal by Subject|0|||
162701662|NCT01536145|587618295|FG010|Overall Study|Withdrawal by Subject|2|||
162701663|NCT01536145|587618285|FG000|Overall Study|Other|0|||
162701664|NCT01536145|587618286|FG001|Overall Study|Other|0|||
162701665|NCT01536145|587618287|FG002|Overall Study|Other|0|||
162701666|NCT01536145|587618288|FG003|Overall Study|Other|0|||
162701667|NCT01536145|587618289|FG004|Overall Study|Other|1|||
162701668|NCT01536145|587618290|FG005|Overall Study|Other|0|||
162701669|NCT01536145|587618291|FG006|Overall Study|Other|0|||
162844768|NCT03665285|588139773|FG004|Overall Study|Disease Progression|0|||
162844769|NCT03665285|588139774|FG005|Overall Study|Disease Progression|0|||
162844770|NCT03665285|588139775|FG006|Overall Study|Disease Progression|0|||
162844771|NCT03665285|588139776|FG007|Overall Study|Disease Progression|7|||
162844772|NCT03665285|588139777|FG008|Overall Study|Disease Progression|1|||
162844773|NCT03665285|588139769|FG000|Overall Study|Hospice|0|||
162844774|NCT03665285|588139770|FG001|Overall Study|Hospice|0|||
162844775|NCT03665285|588139771|FG002|Overall Study|Hospice|0|||
162844776|NCT03665285|588139772|FG003|Overall Study|Hospice|0|||
162844777|NCT03665285|588139773|FG004|Overall Study|Hospice|0|||
162844778|NCT03665285|588139774|FG005|Overall Study|Hospice|0|||
162844779|NCT03665285|588139775|FG006|Overall Study|Hospice|0|||
162844780|NCT03665285|588139776|FG007|Overall Study|Hospice|2|||
162844781|NCT03665285|588139777|FG008|Overall Study|Hospice|0|||
162844782|NCT03665285|588139769|FG000|Overall Study|Withdrawal by Subject|0|||
162844783|NCT03665285|588139770|FG001|Overall Study|Withdrawal by Subject|0|||
162844784|NCT03665285|588139771|FG002|Overall Study|Withdrawal by Subject|0|||
162844785|NCT03665285|588139772|FG003|Overall Study|Withdrawal by Subject|0|||
162844786|NCT03665285|588139773|FG004|Overall Study|Withdrawal by Subject|1|||
162844787|NCT03665285|588139774|FG005|Overall Study|Withdrawal by Subject|0|||
162844788|NCT03665285|588139775|FG006|Overall Study|Withdrawal by Subject|0|||
162844789|NCT03665285|588139776|FG007|Overall Study|Withdrawal by Subject|2|||
162844790|NCT03665285|588139777|FG008|Overall Study|Withdrawal by Subject|0|||
162844791|NCT03665285|588139769|FG000|Overall Study|Physician Decision|0|||
162844792|NCT03665285|588139770|FG001|Overall Study|Physician Decision|0|||
162844793|NCT03665285|588139771|FG002|Overall Study|Physician Decision|0|||
162844794|NCT03665285|588139772|FG003|Overall Study|Physician Decision|0|||
162844795|NCT03665285|588139773|FG004|Overall Study|Physician Decision|0|||
162844796|NCT03665285|588139774|FG005|Overall Study|Physician Decision|0|||
162844797|NCT03665285|588139775|FG006|Overall Study|Physician Decision|0|||
162844798|NCT03665285|588139776|FG007|Overall Study|Physician Decision|2|||
162844799|NCT03665285|588139777|FG008|Overall Study|Physician Decision|0|||
162844800|NCT03543410|588139778|FG000|Overall Study|Adverse Event|10|||
162844801|NCT03543410|588139779|FG001|Overall Study|Adverse Event|8|||
162844802|NCT03543410|588139780|FG002|Overall Study|Adverse Event|2|||
162844803|NCT03543410|588139778|FG000|Overall Study|Lack of Efficacy|0|||
162844804|NCT03543410|588139779|FG001|Overall Study|Lack of Efficacy|1|||
162844805|NCT03543410|588139780|FG002|Overall Study|Lack of Efficacy|0|||
162844806|NCT03543410|588139778|FG000|Overall Study|Lost to Follow-up|0|||
162844807|NCT03543410|588139779|FG001|Overall Study|Lost to Follow-up|1|||
162844808|NCT03543410|588139780|FG002|Overall Study|Lost to Follow-up|0|||
162844809|NCT03543410|588139778|FG000|Overall Study|Withdrawal by Subject|5|||
162844810|NCT03543410|588139779|FG001|Overall Study|Withdrawal by Subject|2|||
162844811|NCT03543410|588139780|FG002|Overall Study|Withdrawal by Subject|8|||
162844812|NCT03543410|588139778|FG000|Overall Study|Protocol Violation|0|||
162844813|NCT03543410|588139779|FG001|Overall Study|Protocol Violation|1|||
162844814|NCT03543410|588139780|FG002|Overall Study|Protocol Violation|0|||
162844815|NCT03543410|588139778|FG000|Overall Study|Due to COVID-19|4|||
162844816|NCT03543410|588139779|FG001|Overall Study|Due to COVID-19|0|||
162844817|NCT03543410|588139780|FG002|Overall Study|Due to COVID-19|2|||
162844818|NCT03543410|588139778|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
162844819|NCT03543410|588139779|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
162844820|NCT03543410|588139780|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
162844821|NCT03543410|588139778|FG000|Overall Study|Not Due to COVID-19|2|||
162844822|NCT03543410|588139779|FG001|Overall Study|Not Due to COVID-19|0|||
162844823|NCT03543410|588139780|FG002|Overall Study|Not Due to COVID-19|1|||
162844824|NCT01318122|588139781|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162844825|NCT01318122|588139782|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162844826|NCT01318122|588139783|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
162844827|NCT01318122|588139784|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
162844828|NCT01318122|588139781|FG000|Enrolled - Long-Term Extension Study|Other|1|||
162844829|NCT01318122|588139782|FG001|Enrolled - Long-Term Extension Study|Other|0|||
162844830|NCT01318122|588139783|FG002|Enrolled - Long-Term Extension Study|Other|0|||
162844831|NCT01318122|588139784|FG003|Enrolled - Long-Term Extension Study|Other|0|||
162844832|NCT01318122|588139781|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
162701670|NCT01536145|587618292|FG007|Overall Study|Other|0|||
162844833|NCT01318122|588139782|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
162844834|NCT01318122|588139783|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
162844835|NCT01318122|588139784|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
162844836|NCT01318122|588139781|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
162844837|NCT01318122|588139782|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162844838|NCT01318122|588139783|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162844839|NCT01318122|588139784|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162844840|NCT01318122|588139781|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162844841|NCT01318122|588139782|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
162844842|NCT01318122|588139783|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162844843|NCT01318122|588139784|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162844844|NCT01318122|588139781|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162844845|NCT01318122|588139782|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
162844846|NCT01318122|588139783|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
162844847|NCT01318122|588139784|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162844848|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
162844849|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
162844850|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
162844851|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Death|28|||
162844852|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Death|0|||
162844853|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Death|0|||
162844854|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
162844855|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
162844856|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
162844857|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
162844858|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
162844859|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
162844860|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
162844861|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
162844862|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
162844863|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
162844864|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
162844865|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
162844866|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
162844867|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
162844868|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
162844869|NCT00820755|588139785|FG000|Period 1: Combination Therapy Phase|Other|11|||
162844870|NCT00820755|588139786|FG001|Period 1: Combination Therapy Phase|Other|0|||
162844871|NCT00820755|588139787|FG002|Period 1: Combination Therapy Phase|Other|0|||
162844872|NCT00820755|588139785|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
162844873|NCT00820755|588139786|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
162844874|NCT00820755|588139787|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
162844875|NCT01486199|588139788|FG000|Two Year Period Between Study Days|Physician Decision|1|||
162844876|NCT01486199|588139789|FG001|Two Year Period Between Study Days|Physician Decision|0|||
162844877|NCT03604445|588139793|FG000|Overall Study|Death|0|||
162844878|NCT03604445|588139794|FG001|Overall Study|Death|0|||
162844879|NCT03604445|588139795|FG002|Overall Study|Death|0|||
162844880|NCT03604445|588139796|FG003|Overall Study|Death|0|||
162844881|NCT03604445|588139797|FG004|Overall Study|Death|0|||
162844882|NCT03604445|588139798|FG005|Overall Study|Death|0|||
162844883|NCT03604445|588139799|FG006|Overall Study|Death|0|||
162844884|NCT03604445|588139800|FG007|Overall Study|Death|0|||
162844885|NCT03604445|588139801|FG008|Overall Study|Death|1|||
162844886|NCT03604445|588139793|FG000|Overall Study|Withdrawal by Subject|0|||
162844887|NCT03604445|588139794|FG001|Overall Study|Withdrawal by Subject|0|||
162844888|NCT03604445|588139795|FG002|Overall Study|Withdrawal by Subject|0|||
162844889|NCT03604445|588139796|FG003|Overall Study|Withdrawal by Subject|0|||
162844890|NCT03604445|588139797|FG004|Overall Study|Withdrawal by Subject|0|||
162844891|NCT03604445|588139798|FG005|Overall Study|Withdrawal by Subject|0|||
162844892|NCT03604445|588139799|FG006|Overall Study|Withdrawal by Subject|1|||
162844893|NCT03604445|588139800|FG007|Overall Study|Withdrawal by Subject|0|||
162844894|NCT03604445|588139801|FG008|Overall Study|Withdrawal by Subject|0|||
162844895|NCT03604445|588139793|FG000|Overall Study|Missing visit|0|||
162844896|NCT03604445|588139794|FG001|Overall Study|Missing visit|0|||
162844897|NCT03604445|588139795|FG002|Overall Study|Missing visit|0|||
162844898|NCT03604445|588139796|FG003|Overall Study|Missing visit|0|||
162844899|NCT03604445|588139797|FG004|Overall Study|Missing visit|0|||
162701671|NCT01536145|587618293|FG008|Overall Study|Other|0|||
162844900|NCT03604445|588139798|FG005|Overall Study|Missing visit|1|||
162951968|NCT03262012|588527698|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
162951969|NCT03262012|588527699|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
162844901|NCT03604445|588139799|FG006|Overall Study|Missing visit|0|||
162844902|NCT03604445|588139800|FG007|Overall Study|Missing visit|1|||
162701672|NCT01536145|587618294|FG009|Overall Study|Other|3|||
162951970|NCT03262012|588527700|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
162951971|NCT03262012|588527701|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
162951972|NCT02801877|588527704|FG000|Overall Study|Lost to Follow-up|1|||
162951973|NCT02801877|588527705|FG001|Overall Study|Lost to Follow-up|1|||
162951974|NCT02801877|588527706|FG002|Overall Study|Lost to Follow-up|2|||
162951975|NCT02801877|588527707|FG003|Overall Study|Lost to Follow-up|0|||
162951976|NCT02801877|588527704|FG000|Overall Study|Never Started Treatment|2|||
162951977|NCT02801877|588527705|FG001|Overall Study|Never Started Treatment|0|||
162951978|NCT02801877|588527706|FG002|Overall Study|Never Started Treatment|4|||
162844903|NCT03604445|588139801|FG008|Overall Study|Missing visit|0|||
162844904|NCT03604445|588139793|FG000|Overall Study|Adverse Event|0|||
162844905|NCT03604445|588139794|FG001|Overall Study|Adverse Event|0|||
162844906|NCT03604445|588139795|FG002|Overall Study|Adverse Event|0|||
162844907|NCT03604445|588139796|FG003|Overall Study|Adverse Event|1|||
162844908|NCT03604445|588139797|FG004|Overall Study|Adverse Event|0|||
162844909|NCT03604445|588139798|FG005|Overall Study|Adverse Event|0|||
162844910|NCT03604445|588139799|FG006|Overall Study|Adverse Event|0|||
162844911|NCT03604445|588139800|FG007|Overall Study|Adverse Event|0|||
162844912|NCT03604445|588139801|FG008|Overall Study|Adverse Event|1|||
162844913|NCT02154425|588139802|FG000|Screening Period|Adverse Event|1|||
162844914|NCT00480857|588139805|FG000|Overall Study|Lack of Efficacy|2|||
162844915|NCT00611247|588139808|FG000|Overall Study|Death|1|||
162844916|NCT00611247|588139809|FG001|Overall Study|Death|5|||
162844917|NCT00611247|588139808|FG000|Overall Study|Lack of Efficacy|1|||
162844918|NCT00611247|588139809|FG001|Overall Study|Lack of Efficacy|16|||
162844919|NCT02551159|588139810|FG000|Overall Study|Death|352|||
162844920|NCT02551159|588139811|FG001|Overall Study|Death|174|||
162844921|NCT02551159|588139812|FG002|Overall Study|Death|161|||
162844922|NCT02551159|588139810|FG000|Overall Study|Withdrawal by Subject|8|||
162844923|NCT02551159|588139811|FG001|Overall Study|Withdrawal by Subject|5|||
162844924|NCT02551159|588139812|FG002|Overall Study|Withdrawal by Subject|16|||
162844925|NCT02551159|588139810|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
162844926|NCT02551159|588139811|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
162844927|NCT02551159|588139812|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
162844928|NCT00243659|588139813|FG000|Overall Study|Withdrawal by Subject|1|||
162844929|NCT00243659|588139814|FG001|Overall Study|Withdrawal by Subject|1|||
162844930|NCT00243659|588139813|FG000|Overall Study|Protocol Violation|1|||
162844931|NCT00243659|588139814|FG001|Overall Study|Protocol Violation|2|||
162844932|NCT01913483|588139821|FG000|Overall Study|Withdrawal by Subject|1|||
162844933|NCT01913483|588139822|FG001|Overall Study|Withdrawal by Subject|2|||
162844934|NCT01913483|588139821|FG000|Overall Study|Lost to Follow-up|6|||
162844935|NCT01913483|588139822|FG001|Overall Study|Lost to Follow-up|3|||
162844936|NCT01913483|588139821|FG000|Overall Study|Death|14|||
162844937|NCT01913483|588139822|FG001|Overall Study|Death|17|||
162844938|NCT00464178|588139827|FG000|Overall Study|Protocol Violation|1|||
162844939|NCT00464178|588139827|FG000|Overall Study|Withdrawal by Subject|1|||
162844940|NCT00769119|588139830|FG000|Overall Study|Voluntary discontinuation|0|||
162844941|NCT00769119|588139831|FG001|Overall Study|Voluntary discontinuation|2|||
162844942|NCT00769119|588139830|FG000|Overall Study|Adverse Event|1|||
162844943|NCT00769119|588139831|FG001|Overall Study|Adverse Event|1|||
162844944|NCT00769119|588139830|FG000|Overall Study|Disallowed medication|1|||
162844945|NCT00769119|588139831|FG001|Overall Study|Disallowed medication|0|||
162844946|NCT01116544|588139834|FG000|Overall Study|Protocol Violation|1|||
162844947|NCT01116544|588139835|FG001|Overall Study|Protocol Violation|0|||
162844948|NCT01116544|588139834|FG000|Overall Study|Withdrawal by Subject|1|||
162844949|NCT01116544|588139835|FG001|Overall Study|Withdrawal by Subject|1|||
162844950|NCT05168267|588139836|FG000|Overall Study|Withdrawal by Subject|2|||
162844951|NCT05168267|588139837|FG001|Overall Study|Withdrawal by Subject|1|||
162844952|NCT05168267|588139836|FG000|Overall Study|Withdrawn by Therapist|1|||
162844953|NCT05168267|588139837|FG001|Overall Study|Withdrawn by Therapist|1|||
162844954|NCT05168267|588139836|FG000|Overall Study|Left Facility|1|||
162844955|NCT05168267|588139837|FG001|Overall Study|Left Facility|0|||
162844956|NCT02937350|588139838|FG000|Overall Study|Withdrawal by Subject|0|||
162844957|NCT02937350|588139839|FG001|Overall Study|Withdrawal by Subject|1|||
162701673|NCT01536145|587618295|FG010|Overall Study|Other|2|||
162701674|NCT01536145|587618285|FG000|Overall Study|Death|0|||
162701675|NCT01536145|587618286|FG001|Overall Study|Death|0|||
162701676|NCT01536145|587618287|FG002|Overall Study|Death|0|||
162701677|NCT01536145|587618288|FG003|Overall Study|Death|0|||
162844958|NCT02937350|588139840|FG002|Overall Study|Withdrawal by Subject|0|||
162844959|NCT02419508|588139841|FG000|Overall Study|Adverse Event|9|||
162844960|NCT02419508|588139842|FG001|Overall Study|Adverse Event|3|||
162844961|NCT02419508|588139841|FG000|Overall Study|Withdrawal by Subject|1|||
162844962|NCT02419508|588139842|FG001|Overall Study|Withdrawal by Subject|0|||
162844963|NCT02419508|588139841|FG000|Overall Study|Other - Reason not specified|0|||
162844964|NCT02419508|588139842|FG001|Overall Study|Other - Reason not specified|1|||
162844965|NCT01738971|588139851|FG000|Overall Study|Lost to Follow-up|19|||
162844966|NCT01738971|588139852|FG001|Overall Study|Lost to Follow-up|30|||
162844967|NCT01738971|588139853|FG002|Overall Study|Lost to Follow-up|17|||
162844968|NCT04698629|588139856|FG000|Overall Study|Adverse Event|1|||
162844969|NCT01891643|588142252|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162844970|NCT01891643|588142253|FG001|Overall Study|Adverse event unrelated to study drug|5|||
162701678|NCT01536145|587618289|FG004|Overall Study|Death|0|||
162701679|NCT01536145|587618290|FG005|Overall Study|Death|0|||
162701680|NCT01536145|587618291|FG006|Overall Study|Death|1|||
162701681|NCT01536145|587618292|FG007|Overall Study|Death|0|||
162701682|NCT01536145|587618293|FG008|Overall Study|Death|0|||
162701683|NCT01536145|587618294|FG009|Overall Study|Death|0|||
162701684|NCT01536145|587618295|FG010|Overall Study|Death|0|||
162701685|NCT01536145|587618285|FG000|Overall Study|Adverse Event|0|||
162701686|NCT01536145|587618286|FG001|Overall Study|Adverse Event|0|||
162701687|NCT01536145|587618287|FG002|Overall Study|Adverse Event|0|||
162701688|NCT01536145|587618288|FG003|Overall Study|Adverse Event|0|||
162701689|NCT01536145|587618289|FG004|Overall Study|Adverse Event|0|||
162701690|NCT01536145|587618290|FG005|Overall Study|Adverse Event|0|||
162701691|NCT01536145|587618291|FG006|Overall Study|Adverse Event|0|||
162701692|NCT01536145|587618292|FG007|Overall Study|Adverse Event|2|||
162701693|NCT01536145|587618293|FG008|Overall Study|Adverse Event|0|||
162701694|NCT01536145|587618294|FG009|Overall Study|Adverse Event|0|||
162701695|NCT01536145|587618295|FG010|Overall Study|Adverse Event|3|||
162701696|NCT00688259|587618298|FG000|Overall Study|Lost to Follow-up|2|||
162701697|NCT00688259|587618299|FG001|Overall Study|Lost to Follow-up|4|||
162701698|NCT00688259|587618298|FG000|Overall Study|Physician Decision|1|||
162701699|NCT00688259|587618299|FG001|Overall Study|Physician Decision|0|||
162701700|NCT00688259|587618298|FG000|Overall Study|Withdrawal by Subject|2|||
162701701|NCT00688259|587618299|FG001|Overall Study|Withdrawal by Subject|0|||
162701702|NCT00688259|587618298|FG000|Overall Study|Declined Interview|2|||
162701703|NCT00688259|587618299|FG001|Overall Study|Declined Interview|3|||
162701704|NCT00688259|587618298|FG000|Overall Study|Hospitalized at Follow-up|0|||
162701705|NCT00688259|587618299|FG001|Overall Study|Hospitalized at Follow-up|1|||
162701706|NCT03824938|587618300|FG000|Overall Study|Withdrawal by Subject|2|||
162701707|NCT03824938|587618301|FG001|Overall Study|Withdrawal by Subject|1|||
162701708|NCT03824938|587618302|FG002|Overall Study|Withdrawal by Subject|0|||
162701709|NCT03824938|587618303|FG003|Overall Study|Withdrawal by Subject|2|||
162701710|NCT03824938|587618304|FG004|Overall Study|Withdrawal by Subject|0|||
162701711|NCT03824938|587618305|FG005|Overall Study|Withdrawal by Subject|1|||
162701712|NCT03824938|587618300|FG000|Overall Study|Lost to Follow-up|0|||
162701713|NCT03824938|587618301|FG001|Overall Study|Lost to Follow-up|1|||
162701714|NCT03824938|587618302|FG002|Overall Study|Lost to Follow-up|0|||
162701715|NCT03824938|587618303|FG003|Overall Study|Lost to Follow-up|0|||
162701716|NCT03824938|587618304|FG004|Overall Study|Lost to Follow-up|1|||
162701717|NCT03824938|587618305|FG005|Overall Study|Lost to Follow-up|0|||
162701718|NCT00287469|587618306|FG000|Overall Study|serious adverse event|1|||
162701719|NCT00287469|587618307|FG001|Overall Study|serious adverse event|6|||
162701720|NCT00287469|587618306|FG000|Overall Study|Adverse Event|1|||
162701721|NCT00287469|587618307|FG001|Overall Study|Adverse Event|1|||
162701722|NCT00287469|587618306|FG000|Overall Study|moved from area|144|||
162701723|NCT00287469|587618307|FG001|Overall Study|moved from area|138|||
162701724|NCT00287469|587618306|FG000|Overall Study|Lost to Follow-up|74|||
162701725|NCT00287469|587618307|FG001|Overall Study|Lost to Follow-up|69|||
162701726|NCT01058863|587618308|FG000|Overall Study|Lost to Follow-up|1|||
162701727|NCT01058863|587618308|FG000|Overall Study|Withdrawal by Subject|1|||
162701728|NCT01058863|587618308|FG000|Overall Study|Sponsor requested withdrawal|1|||
162701729|NCT01058863|587618308|FG000|Overall Study|Randomized in error|1|||
162701730|NCT03653416|587618309|FG000|Overall Study|Protocol Violation|6|||
162701731|NCT03653416|587618310|FG001|Overall Study|Protocol Violation|1|||
162701732|NCT00776100|587618313|FG000|Overall Study|Disease Progression|1|||
162701733|NCT00776100|587618314|FG001|Overall Study|Disease Progression|0|||
162701734|NCT04759885|587618319|FG000|Overall Study|Other|1|||
162701735|NCT04759885|587618320|FG001|Overall Study|Other|0|||
162701736|NCT04759885|587618321|FG002|Overall Study|Other|2|||
162701737|NCT04759885|587618322|FG003|Overall Study|Other|0|||
162701738|NCT04759885|587618323|FG004|Overall Study|Other|0|||
162701739|NCT04759885|587618319|FG000|Overall Study|Withdrawal by Subject|0|||
162701740|NCT04759885|587618320|FG001|Overall Study|Withdrawal by Subject|0|||
162701741|NCT04759885|587618321|FG002|Overall Study|Withdrawal by Subject|1|||
162701742|NCT04759885|587618322|FG003|Overall Study|Withdrawal by Subject|9|||
162701743|NCT04759885|587618323|FG004|Overall Study|Withdrawal by Subject|6|||
162701744|NCT04759885|587618319|FG000|Overall Study|Adverse Event|0|||
162701745|NCT04759885|587618320|FG001|Overall Study|Adverse Event|0|||
162701746|NCT04759885|587618321|FG002|Overall Study|Adverse Event|0|||
162701747|NCT04759885|587618322|FG003|Overall Study|Adverse Event|3|||
162701748|NCT04759885|587618323|FG004|Overall Study|Adverse Event|0|||
162701749|NCT04759885|587618319|FG000|Overall Study|Physician Decision|0|||
162701750|NCT04759885|587618320|FG001|Overall Study|Physician Decision|0|||
162701751|NCT04759885|587618321|FG002|Overall Study|Physician Decision|0|||
162701752|NCT04759885|587618322|FG003|Overall Study|Physician Decision|2|||
162701753|NCT04759885|587618323|FG004|Overall Study|Physician Decision|0|||
162701754|NCT00195715|587618324|FG000|Overall Study|Adverse Event|122|||
162701755|NCT00195715|587618324|FG000|Overall Study|Withdrawal by Subject|58|||
162701756|NCT00195715|587618324|FG000|Overall Study|Lost to Follow-up|27|||
162701757|NCT00195715|587618324|FG000|Overall Study|Protocol Violation|13|||
162701758|NCT00195715|587618324|FG000|Overall Study|Lack of Efficacy|93|||
162844971|NCT01891643|588142252|FG000|Overall Study|Disease Progression|4|||
162844972|NCT01891643|588142253|FG001|Overall Study|Disease Progression|3|||
162844973|NCT01891643|588142252|FG000|Overall Study|Study Drug Toxicity|3|||
162844974|NCT01891643|588142253|FG001|Overall Study|Study Drug Toxicity|0|||
162844975|NCT01891643|588142252|FG000|Overall Study|Maximum Clinical Benefit|0|||
162844976|NCT01891643|588142253|FG001|Overall Study|Maximum Clinical Benefit|1|||
162844977|NCT01891643|588142252|FG000|Overall Study|Poor/Non-compliance|0|||
162844978|NCT01891643|588142253|FG001|Overall Study|Poor/Non-compliance|1|||
162844979|NCT01891643|588142252|FG000|Overall Study|Participant request to discontinue|1|||
162844980|NCT01891643|588142253|FG001|Overall Study|Participant request to discontinue|0|||
162844981|NCT04047797|588142256|FG000|Overall Study|Progressive Disease|1|||
162844982|NCT01430442|588142257|FG000|Overall Study|Subject Withdrew Consent|3|||
162844983|NCT01430442|588142258|FG001|Overall Study|Subject Withdrew Consent|0|||
162844984|NCT01430442|588142259|FG002|Overall Study|Subject Withdrew Consent|1|||
162844985|NCT01430442|588142260|FG003|Overall Study|Subject Withdrew Consent|0|||
162844986|NCT01430442|588142261|FG004|Overall Study|Subject Withdrew Consent|2|||
162844987|NCT01430442|588142262|FG005|Overall Study|Subject Withdrew Consent|1|||
162844988|NCT01430442|588142263|FG006|Overall Study|Subject Withdrew Consent|5|||
162844989|NCT01430442|588142264|FG007|Overall Study|Subject Withdrew Consent|2|||
162844990|NCT01430442|588142257|FG000|Overall Study|Lost to Follow-up|2|||
162844991|NCT01430442|588142258|FG001|Overall Study|Lost to Follow-up|0|||
162844992|NCT01430442|588142259|FG002|Overall Study|Lost to Follow-up|1|||
162844993|NCT01430442|588142260|FG003|Overall Study|Lost to Follow-up|2|||
162844994|NCT01430442|588142261|FG004|Overall Study|Lost to Follow-up|2|||
162844995|NCT01430442|588142262|FG005|Overall Study|Lost to Follow-up|1|||
162844996|NCT01430442|588142263|FG006|Overall Study|Lost to Follow-up|5|||
162844997|NCT01430442|588142264|FG007|Overall Study|Lost to Follow-up|1|||
162844998|NCT01430442|588142257|FG000|Overall Study|Pregnancy|1|||
162844999|NCT01430442|588142258|FG001|Overall Study|Pregnancy|0|||
162845000|NCT01430442|588142259|FG002|Overall Study|Pregnancy|0|||
162845001|NCT01430442|588142260|FG003|Overall Study|Pregnancy|0|||
162845002|NCT01430442|588142261|FG004|Overall Study|Pregnancy|0|||
162845003|NCT01430442|588142262|FG005|Overall Study|Pregnancy|1|||
162845004|NCT01430442|588142263|FG006|Overall Study|Pregnancy|0|||
162845005|NCT01430442|588142264|FG007|Overall Study|Pregnancy|0|||
162845006|NCT01430442|588142257|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
162845007|NCT01430442|588142258|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
162845008|NCT01430442|588142259|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
162845009|NCT01430442|588142260|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
162845010|NCT01430442|588142261|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
162845011|NCT01430442|588142262|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
162845012|NCT01430442|588142263|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
162845013|NCT01430442|588142264|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
162845014|NCT00947531|588142267|FG000|Overall Study|Withdrawal by Subject|10|||
162845015|NCT00947531|588142268|FG001|Overall Study|Withdrawal by Subject|7|||
162845016|NCT00947531|588142267|FG000|Overall Study|Administrative Reason|0|||
162845017|NCT00947531|588142268|FG001|Overall Study|Administrative Reason|1|||
162845018|NCT00947531|588142267|FG000|Overall Study|Adverse Event|2|||
162845019|NCT00947531|588142268|FG001|Overall Study|Adverse Event|2|||
162845020|NCT00947531|588142267|FG000|Overall Study|Lack of Efficacy|1|||
162845021|NCT00947531|588142268|FG001|Overall Study|Lack of Efficacy|0|||
162845022|NCT00947531|588142267|FG000|Overall Study|Other|1|||
162845023|NCT00947531|588142268|FG001|Overall Study|Other|1|||
162845024|NCT01773421|588142269|FG000|Treatment Phase|Other|0|||
162845025|NCT01773421|588142270|FG001|Treatment Phase|Other|0|||
162845026|NCT01773421|588142271|FG002|Treatment Phase|Other|2|||
162845027|NCT01773421|588142272|FG003|Treatment Phase|Other|0|||
162845028|NCT01773421|588142273|FG004|Treatment Phase|Other|0|||
162845029|NCT01773421|588142274|FG005|Treatment Phase|Other|0|||
162845030|NCT01773421|588142275|FG006|Treatment Phase|Other|0|||
162845031|NCT01773421|588142269|FG000|Treatment Phase|Adverse Event|0|||
162845032|NCT01773421|588142270|FG001|Treatment Phase|Adverse Event|0|||
162845033|NCT01773421|588142271|FG002|Treatment Phase|Adverse Event|3|||
162845034|NCT01773421|588142272|FG003|Treatment Phase|Adverse Event|1|||
162845035|NCT01773421|588142273|FG004|Treatment Phase|Adverse Event|0|||
162845036|NCT01773421|588142274|FG005|Treatment Phase|Adverse Event|0|||
162845037|NCT01773421|588142275|FG006|Treatment Phase|Adverse Event|0|||
162845038|NCT01773421|588142269|FG000|Treatment Phase|Withdrawal by Subject|0|||
162845039|NCT01773421|588142270|FG001|Treatment Phase|Withdrawal by Subject|0|||
162845040|NCT01773421|588142271|FG002|Treatment Phase|Withdrawal by Subject|1|||
162845041|NCT01773421|588142272|FG003|Treatment Phase|Withdrawal by Subject|1|||
162845042|NCT01773421|588142273|FG004|Treatment Phase|Withdrawal by Subject|0|||
162845043|NCT01773421|588142274|FG005|Treatment Phase|Withdrawal by Subject|0|||
162845044|NCT01773421|588142275|FG006|Treatment Phase|Withdrawal by Subject|0|||
162845045|NCT01773421|588142269|FG000|Extension Phase|Other|0|||
162845046|NCT01773421|588142270|FG001|Extension Phase|Other|0|||
162845047|NCT01773421|588142271|FG002|Extension Phase|Other|0|||
162845048|NCT01773421|588142272|FG003|Extension Phase|Other|0|||
162845049|NCT01773421|588142273|FG004|Extension Phase|Other|1|||
162845050|NCT01773421|588142274|FG005|Extension Phase|Other|2|||
162845051|NCT01773421|588142275|FG006|Extension Phase|Other|0|||
162845052|NCT01773421|588142269|FG000|Extension Phase|Adverse Event|0|||
162845053|NCT01773421|588142270|FG001|Extension Phase|Adverse Event|0|||
162845054|NCT01773421|588142271|FG002|Extension Phase|Adverse Event|0|||
162845055|NCT01773421|588142272|FG003|Extension Phase|Adverse Event|0|||
162845056|NCT01773421|588142273|FG004|Extension Phase|Adverse Event|2|||
162845057|NCT01773421|588142274|FG005|Extension Phase|Adverse Event|0|||
162845058|NCT01773421|588142275|FG006|Extension Phase|Adverse Event|0|||
162845059|NCT02327260|588142276|FG000|Overall Study|Lost to Follow-up|2|||
162845060|NCT02327260|588142277|FG001|Overall Study|Lost to Follow-up|3|||
162845061|NCT02327260|588142278|FG002|Overall Study|Lost to Follow-up|2|||
162845062|NCT02327260|588142276|FG000|Overall Study|invalid phone number|1|||
162845063|NCT02327260|588142277|FG001|Overall Study|invalid phone number|1|||
162845064|NCT02327260|588142278|FG002|Overall Study|invalid phone number|0|||
162845065|NCT02327260|588142276|FG000|Overall Study|non-adherence to protocol|2|||
162845066|NCT02327260|588142277|FG001|Overall Study|non-adherence to protocol|0|||
162845067|NCT02327260|588142278|FG002|Overall Study|non-adherence to protocol|0|||
162845068|NCT02327260|588142276|FG000|Overall Study|cognitive concerns|1|||
162845069|NCT02327260|588142277|FG001|Overall Study|cognitive concerns|0|||
162845070|NCT02327260|588142278|FG002|Overall Study|cognitive concerns|0|||
162845071|NCT03502330|588142279|FG000|Overall Study|Adverse Event|2|||
162845072|NCT03502330|588142280|FG001|Overall Study|Adverse Event|1|||
162845073|NCT03502330|588142281|FG002|Overall Study|Adverse Event|0|||
162845074|NCT03502330|588142282|FG003|Overall Study|Adverse Event|0|||
162845075|NCT03502330|588142283|FG004|Overall Study|Adverse Event|1|||
162845076|NCT03502330|588142284|FG005|Overall Study|Adverse Event|0|||
162845077|NCT03502330|588142285|FG006|Overall Study|Adverse Event|1|||
162845078|NCT03502330|588142286|FG007|Overall Study|Adverse Event|1|||
162845079|NCT03502330|588142287|FG008|Overall Study|Adverse Event|0|||
162845080|NCT03502330|588142279|FG000|Overall Study|Lack of Efficacy|1|||
162845081|NCT03502330|588142280|FG001|Overall Study|Lack of Efficacy|5|||
162845082|NCT03502330|588142281|FG002|Overall Study|Lack of Efficacy|3|||
162845083|NCT03502330|588142282|FG003|Overall Study|Lack of Efficacy|5|||
162845084|NCT03502330|588142283|FG004|Overall Study|Lack of Efficacy|1|||
162845085|NCT03502330|588142284|FG005|Overall Study|Lack of Efficacy|5|||
162845086|NCT03502330|588142285|FG006|Overall Study|Lack of Efficacy|5|||
162845087|NCT03502330|588142286|FG007|Overall Study|Lack of Efficacy|6|||
162845088|NCT03502330|588142287|FG008|Overall Study|Lack of Efficacy|0|||
162845089|NCT03502330|588142279|FG000|Overall Study|Physician Decision|0|||
162845090|NCT03502330|588142280|FG001|Overall Study|Physician Decision|0|||
162845091|NCT03502330|588142281|FG002|Overall Study|Physician Decision|0|||
162845092|NCT03502330|588142282|FG003|Overall Study|Physician Decision|0|||
162845093|NCT03502330|588142283|FG004|Overall Study|Physician Decision|1|||
162845094|NCT03502330|588142284|FG005|Overall Study|Physician Decision|0|||
162845095|NCT03502330|588142285|FG006|Overall Study|Physician Decision|0|||
162845096|NCT03502330|588142286|FG007|Overall Study|Physician Decision|0|||
162845097|NCT03502330|588142287|FG008|Overall Study|Physician Decision|0|||
162845098|NCT03502330|588142279|FG000|Overall Study|Withdrawal by Subject|0|||
162951979|NCT02801877|588527707|FG003|Overall Study|Never Started Treatment|0|||
162845099|NCT03502330|588142280|FG001|Overall Study|Withdrawal by Subject|0|||
162845100|NCT03502330|588142281|FG002|Overall Study|Withdrawal by Subject|0|||
162845101|NCT03502330|588142282|FG003|Overall Study|Withdrawal by Subject|0|||
162845102|NCT03502330|588142283|FG004|Overall Study|Withdrawal by Subject|0|||
162845103|NCT03502330|588142284|FG005|Overall Study|Withdrawal by Subject|1|||
162701759|NCT00195715|587618324|FG000|Overall Study|Pregnancy|14|||
162701760|NCT00195715|587618324|FG000|Overall Study|Investigative site closure|8|||
162701761|NCT00195715|587618324|FG000|Overall Study|Subject moved/relocated|7|||
162701762|NCT00195715|587618324|FG000|Overall Study|Subject non-compliance|6|||
162701763|NCT00195715|587618324|FG000|Overall Study|Subject started commercial Humira|5|||
162701764|NCT00195715|587618324|FG000|Overall Study|Subject choice|3|||
162701765|NCT00195715|587618324|FG000|Overall Study|Loss of response/no improvement|3|||
162701766|NCT00195715|587618324|FG000|Overall Study|Sponsor stopped study|1|||
162701767|NCT00195715|587618324|FG000|Overall Study|Administrative reasons|2|||
162701768|NCT00195715|587618324|FG000|Overall Study|Investigator's decision|2|||
162701769|NCT00195715|587618324|FG000|Overall Study|Subject wants to get pregnant|4|||
162701770|NCT00195715|587618324|FG000|Overall Study|Use of prohibited medication|2|||
162701771|NCT00195715|587618324|FG000|Overall Study|Planned surgery|2|||
162701772|NCT00195715|587618324|FG000|Overall Study|Increased infection rate|1|||
162701773|NCT00195715|587618324|FG000|Overall Study|Ineligible|1|||
162701774|NCT00195715|587618324|FG000|Overall Study|Colonic stricture|1|||
162701775|NCT00195715|587618324|FG000|Overall Study|Sponsor discontinued trial|1|||
162701776|NCT00195715|587618324|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
162701777|NCT05822921|587618329|FG000|Overall Study|Lost to Follow-up|1|||
162701778|NCT05822921|587618330|FG001|Overall Study|Lost to Follow-up|1|||
162701779|NCT01267253|587618333|FG000|Overall Study|Ineligible - required test not done|1|||
162701780|NCT01267253|587618333|FG000|Overall Study|Inevaluable-never received study treatme|2|||
162701781|NCT00996580|587618334|FG000|Overall Study|Adverse Event|466|||
162701782|NCT00996580|587618334|FG000|Overall Study|Lost to Follow-up|480|||
162701783|NCT00996580|587618334|FG000|Overall Study|Noncompliance with the protocol|137|||
162701784|NCT00996580|587618334|FG000|Overall Study|Physician Decision|5|||
162701785|NCT00996580|587618334|FG000|Overall Study|Pregnancy|68|||
162701786|NCT00996580|587618334|FG000|Overall Study|Protocol Violation|16|||
162701787|NCT00996580|587618334|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
162701788|NCT00996580|587618334|FG000|Overall Study|Withdrawal by Subject|217|||
162701789|NCT00996580|587618334|FG000|Overall Study|Other|29|||
162701790|NCT00064025|587618335|FG000|Overall Study|Ineligible|4|||
162701791|NCT00064025|587618335|FG000|Overall Study|Inevaluable|3|||
162701792|NCT02468934|587618336|FG000|Overall Study|Withdrawal by Subject|4|||
162701793|NCT02468934|587618336|FG000|Overall Study|Screen Failure|3|||
162701794|NCT02036515|587618341|FG000|Overall Study|Adverse Event|1|||
162701795|NCT02036515|587618342|FG001|Overall Study|Adverse Event|1|||
162701796|NCT02036515|587618343|FG002|Overall Study|Adverse Event|2|||
162701797|NCT02036515|587618341|FG000|Overall Study|Lost to Follow-up|0|||
162701798|NCT02036515|587618342|FG001|Overall Study|Lost to Follow-up|2|||
162701799|NCT02036515|587618343|FG002|Overall Study|Lost to Follow-up|0|||
162701800|NCT02036515|587618341|FG000|Overall Study|Non-compliance with study drug|0|||
162701801|NCT02036515|587618342|FG001|Overall Study|Non-compliance with study drug|0|||
162701802|NCT02036515|587618343|FG002|Overall Study|Non-compliance with study drug|2|||
162701803|NCT02036515|587618341|FG000|Overall Study|Screen failure|0|||
162701804|NCT02036515|587618342|FG001|Overall Study|Screen failure|2|||
162701805|NCT02036515|587618343|FG002|Overall Study|Screen failure|0|||
162701806|NCT02036515|587618341|FG000|Overall Study|Withdrawal by Subject|4|||
162701807|NCT02036515|587618342|FG001|Overall Study|Withdrawal by Subject|7|||
162701808|NCT02036515|587618343|FG002|Overall Study|Withdrawal by Subject|9|||
162701809|NCT02036515|587618341|FG000|Overall Study|Hyperglycemia|0|||
162701810|NCT02036515|587618342|FG001|Overall Study|Hyperglycemia|0|||
162701811|NCT02036515|587618343|FG002|Overall Study|Hyperglycemia|1|||
162701812|NCT02218489|587618350|FG000|Overall Study|Withdrawal by Subject|4|||
162701813|NCT02218489|587618351|FG001|Overall Study|Withdrawal by Subject|3|||
162701814|NCT02218489|587618350|FG000|Overall Study|Lost to Follow-up|1|||
162701815|NCT02218489|587618351|FG001|Overall Study|Lost to Follow-up|0|||
162701816|NCT00547911|587618352|FG000|Overall Study|Adverse Event|0|||
162701817|NCT00547911|587618353|FG001|Overall Study|Adverse Event|0|||
162701818|NCT00547911|587618354|FG002|Overall Study|Adverse Event|0|||
162701819|NCT00547911|587618355|FG003|Overall Study|Adverse Event|1|||
162701820|NCT00547911|587618356|FG004|Overall Study|Adverse Event|0|||
162701821|NCT00547911|587618357|FG005|Overall Study|Adverse Event|0|||
162701822|NCT02133924|587618358|FG000|Overall Study|Death|38|||
162701823|NCT02133924|587618358|FG000|Overall Study|Physician Decision|1|||
162701824|NCT02133924|587618358|FG000|Overall Study|Withdrawal by Subject|3|||
162701825|NCT01644474|587618360|FG000|Overall Study|Poor compliance to protocol|1|||
162701826|NCT01644474|587618361|FG001|Overall Study|Poor compliance to protocol|0|||
162701827|NCT01644474|587618360|FG000|Overall Study|Consent withdrawn by participant|0|||
162701828|NCT01644474|587618361|FG001|Overall Study|Consent withdrawn by participant|1|||
162701829|NCT01644474|587618360|FG000|Overall Study|Participant moved|0|||
162701830|NCT01644474|587618361|FG001|Overall Study|Participant moved|1|||
162701831|NCT01644474|587618360|FG000|Overall Study|Adverse Event|4|||
162701832|NCT01644474|587618361|FG001|Overall Study|Adverse Event|5|||
162951980|NCT00154102|588527708|FG000|Overall Study|investigational study phase ongoing|7|||
162951981|NCT00154102|588527709|FG001|Overall Study|investigational study phase ongoing|2|||
162951982|NCT04934722|588529503|FG000|Overall Study|Death|4|||
162951983|NCT04934722|588529504|FG001|Overall Study|Death|3|||
162951984|NCT04934722|588529503|FG000|Overall Study|Participants Ongoing|88|||
162951985|NCT04934722|588529504|FG001|Overall Study|Participants Ongoing|91|||
162951986|NCT06358820|588529505|FG000|Overall Study|Adverse Event|11|||
162951987|NCT06358820|588529505|FG000|Overall Study|kidney transplantation|3|||
162951988|NCT06358820|588529505|FG000|Overall Study|patient voluntary withdrawal|6|||
162951989|NCT06358820|588529505|FG000|Overall Study|Physician Decision|1|||
162951990|NCT01294787|588529506|FG000|Period 1|Adverse Event|0|||
162951991|NCT01294787|588529507|FG001|Period 1|Adverse Event|0|||
162951992|NCT01294787|588529508|FG002|Period 1|Adverse Event|0|||
162951993|NCT01294787|588529509|FG003|Period 1|Adverse Event|0|||
162951994|NCT01294787|588529510|FG004|Period 1|Adverse Event|1|||
162951995|NCT01294787|588529511|FG005|Period 1|Adverse Event|0|||
162951996|NCT01294787|588529506|FG000|Period 1|Withdrawal by Subject|0|||
163043052|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
163043053|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
163043054|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
163043055|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
163043056|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
163043057|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
163043058|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Death|1|||
163043059|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Death|0|||
163043060|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
163043061|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
162701833|NCT01644474|587618360|FG000|Overall Study|Site scheduling error|1|||
162701834|NCT01644474|587618361|FG001|Overall Study|Site scheduling error|1|||
162701835|NCT01644474|587618360|FG000|Overall Study|Protocol Violation|1|||
162701836|NCT01644474|587618361|FG001|Overall Study|Protocol Violation|0|||
162701837|NCT04039503|587618367|FG000|Overall Study|Adverse Event|3|||
162701838|NCT04039503|587618368|FG001|Overall Study|Adverse Event|0|||
162701839|NCT04039503|587618369|FG002|Overall Study|Adverse Event|2|||
162701840|NCT04039503|587618370|FG003|Overall Study|Adverse Event|0|||
162701841|NCT04039503|587618367|FG000|Overall Study|Lost to Follow-up|0|||
162701842|NCT04039503|587618368|FG001|Overall Study|Lost to Follow-up|0|||
162701843|NCT04039503|587618369|FG002|Overall Study|Lost to Follow-up|1|||
162701844|NCT04039503|587618370|FG003|Overall Study|Lost to Follow-up|0|||
162701845|NCT04039503|587618367|FG000|Overall Study|Protocol Violation|0|||
162701846|NCT04039503|587618368|FG001|Overall Study|Protocol Violation|1|||
162701847|NCT04039503|587618369|FG002|Overall Study|Protocol Violation|2|||
162701848|NCT04039503|587618370|FG003|Overall Study|Protocol Violation|1|||
162951997|NCT01294787|588529507|FG001|Period 1|Withdrawal by Subject|0|||
162951998|NCT01294787|588529508|FG002|Period 1|Withdrawal by Subject|0|||
162951999|NCT01294787|588529509|FG003|Period 1|Withdrawal by Subject|1|||
162952000|NCT01294787|588529510|FG004|Period 1|Withdrawal by Subject|1|||
162952001|NCT01294787|588529511|FG005|Period 1|Withdrawal by Subject|1|||
162952002|NCT01294787|588529506|FG000|Period 1|Administrative problem|0|||
162952003|NCT01294787|588529507|FG001|Period 1|Administrative problem|0|||
162952004|NCT01294787|588529508|FG002|Period 1|Administrative problem|1|||
162952005|NCT01294787|588529509|FG003|Period 1|Administrative problem|0|||
162952006|NCT01294787|588529510|FG004|Period 1|Administrative problem|0|||
163043062|NCT00105989|588865712|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
163043063|NCT00105989|588865713|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
163043064|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
163043065|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
163043066|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
163043067|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
163043068|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
163043069|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
163043070|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
163043071|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
163043072|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
163043073|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
163043074|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
163043075|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
163043076|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
162701849|NCT04039503|587618367|FG000|Overall Study|Withdrawal by Subject|4|||
162701850|NCT04039503|587618368|FG001|Overall Study|Withdrawal by Subject|3|||
162701851|NCT04039503|587618369|FG002|Overall Study|Withdrawal by Subject|5|||
162952007|NCT01294787|588529511|FG005|Period 1|Administrative problem|1|||
162952008|NCT01294787|588529506|FG000|Period 2|Adverse Event|0|||
162952009|NCT01294787|588529507|FG001|Period 2|Adverse Event|3|||
163043077|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
162701852|NCT04039503|587618370|FG003|Overall Study|Withdrawal by Subject|2|||
162701853|NCT01163747|587618371|FG000|Overall Study|Adverse Event|0|||
162701854|NCT01163747|587618372|FG001|Overall Study|Adverse Event|5|||
162701855|NCT01163747|587618371|FG000|Overall Study|Insufficient Therapeutic Response|0|||
162845104|NCT03502330|588142285|FG006|Overall Study|Withdrawal by Subject|0|||
162845105|NCT03502330|588142286|FG007|Overall Study|Withdrawal by Subject|1|||
162845106|NCT03502330|588142287|FG008|Overall Study|Withdrawal by Subject|0|||
162845107|NCT03502330|588142279|FG000|Overall Study|Death|0|||
162845108|NCT03502330|588142280|FG001|Overall Study|Death|0|||
162845109|NCT03502330|588142281|FG002|Overall Study|Death|0|||
162845110|NCT03502330|588142282|FG003|Overall Study|Death|0|||
162845111|NCT03502330|588142283|FG004|Overall Study|Death|0|||
162845112|NCT03502330|588142284|FG005|Overall Study|Death|0|||
162845113|NCT03502330|588142285|FG006|Overall Study|Death|2|||
162845114|NCT03502330|588142286|FG007|Overall Study|Death|0|||
162845115|NCT03502330|588142287|FG008|Overall Study|Death|0|||
162845116|NCT02804763|588142291|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
162845117|NCT02804763|588142292|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
162845118|NCT02804763|588142293|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
162845119|NCT02804763|588142294|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
162845120|NCT02804763|588142291|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
162845121|NCT02804763|588142292|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
162845122|NCT02804763|588142293|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
162845123|NCT02804763|588142294|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
162845124|NCT02804763|588142291|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
162845125|NCT02804763|588142292|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
162845126|NCT02804763|588142293|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
162845127|NCT02804763|588142294|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
162845128|NCT02804763|588142291|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
162845129|NCT02804763|588142292|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
162845130|NCT02804763|588142293|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
162845131|NCT02804763|588142294|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
162845132|NCT02804763|588142291|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
162845133|NCT02804763|588142292|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
162845134|NCT02804763|588142293|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
162845135|NCT02804763|588142294|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
162845136|NCT02804763|588142291|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
162845137|NCT02804763|588142292|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
162845138|NCT02804763|588142293|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
162845139|NCT02804763|588142294|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
162845140|NCT01400932|588142299|FG000|Overall Study|Adverse Event|10|||
162845141|NCT01400932|588142300|FG001|Overall Study|Adverse Event|5|||
162845142|NCT01400932|588142299|FG000|Overall Study|Lack of Efficacy|0|||
162845143|NCT01400932|588142300|FG001|Overall Study|Lack of Efficacy|3|||
162845144|NCT01400932|588142299|FG000|Overall Study|Withdrawal by Subject|2|||
162845145|NCT01400932|588142300|FG001|Overall Study|Withdrawal by Subject|6|||
162845146|NCT01400932|588142299|FG000|Overall Study|Lost to Follow-up|1|||
162845147|NCT01400932|588142300|FG001|Overall Study|Lost to Follow-up|0|||
162845148|NCT01400932|588142299|FG000|Overall Study|Protocol Deviation|0|||
162845149|NCT01400932|588142300|FG001|Overall Study|Protocol Deviation|1|||
162845150|NCT01400932|588142299|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162845151|NCT01400932|588142300|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162845152|NCT00860158|588142301|FG000|Overall Study|Study Terminated|1|||
162845153|NCT05499520|588142304|FG000|Overall Study|Lost to Follow-up|0|||
162845154|NCT05499520|588142305|FG001|Overall Study|Lost to Follow-up|0|||
162845155|NCT05499520|588142306|FG002|Overall Study|Lost to Follow-up|38|||
162845156|NCT05499520|588142307|FG003|Overall Study|Lost to Follow-up|41|||
162845157|NCT05499520|588142308|FG004|Overall Study|Lost to Follow-up|46|||
162845158|NCT05499520|588142309|FG005|Overall Study|Lost to Follow-up|0|||
162845159|NCT05499520|588142310|FG006|Overall Study|Lost to Follow-up|31|||
162845160|NCT05499520|588142311|FG007|Overall Study|Lost to Follow-up|45|||
162845161|NCT05499520|588142312|FG008|Overall Study|Lost to Follow-up|42|||
162845162|NCT05499520|588142313|FG009|Overall Study|Lost to Follow-up|0|||
162845163|NCT05499520|588142314|FG010|Overall Study|Lost to Follow-up|0|||
162845164|NCT05499520|588142315|FG011|Overall Study|Lost to Follow-up|37|||
162845165|NCT05499520|588142316|FG012|Overall Study|Lost to Follow-up|53|||
162701856|NCT01163747|587618372|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162701857|NCT01163747|587618371|FG000|Overall Study|Protocol Violation|0|||
162845166|NCT05499520|588142317|FG013|Overall Study|Lost to Follow-up|49|||
162845167|NCT05499520|588142318|FG014|Overall Study|Lost to Follow-up|0|||
162845168|NCT05499520|588142319|FG015|Overall Study|Lost to Follow-up|36|||
162845169|NCT05499520|588142320|FG016|Overall Study|Lost to Follow-up|58|||
162845170|NCT05499520|588142321|FG017|Overall Study|Lost to Follow-up|53|||
162845171|NCT00605267|588142322|FG000|Overall Study|Adverse Event|0|||
162845172|NCT00605267|588142323|FG001|Overall Study|Adverse Event|1|||
162845173|NCT00605267|588142322|FG000|Overall Study|Lack of Efficacy|1|||
162845174|NCT00605267|588142323|FG001|Overall Study|Lack of Efficacy|5|||
162845175|NCT00605267|588142322|FG000|Overall Study|Withdrawal by Subject|2|||
163043078|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Death|0|||
163043079|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Death|0|||
163043080|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
163043081|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
163043082|NCT00105989|588865712|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
163043083|NCT00105989|588865713|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
163043084|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
163043085|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
163043086|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
163043087|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
163043088|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
163043089|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
163043090|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
162701858|NCT01163747|587618372|FG001|Overall Study|Protocol Violation|1|||
162701859|NCT01163747|587618371|FG000|Overall Study|Refused Treatment|6|||
162701860|NCT01163747|587618372|FG001|Overall Study|Refused Treatment|4|||
162701861|NCT02044458|587618379|FG000|Overall Study|Protocol Violation|3|||
162701862|NCT02044458|587618380|FG001|Overall Study|Protocol Violation|8|||
162701863|NCT02601937|587618382|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701864|NCT02601937|587618383|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701865|NCT02601937|587618384|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701866|NCT02601937|587618385|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701867|NCT02601937|587618386|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701868|NCT02601937|587618387|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
162701869|NCT02601937|587618388|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701870|NCT02601937|587618389|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701871|NCT02601937|587618390|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701872|NCT02601937|587618391|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701873|NCT02601937|587618392|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
162701874|NCT02601937|587618382|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
162701875|NCT02601937|587618383|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701876|NCT02601937|587618384|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701877|NCT02601937|587618385|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701878|NCT02601937|587618386|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701879|NCT02601937|587618387|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701880|NCT02601937|587618388|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
162701881|NCT02601937|587618389|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701882|NCT02601937|587618390|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701883|NCT02601937|587618391|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701884|NCT02601937|587618392|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162701885|NCT02601937|587618382|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701886|NCT02601937|587618383|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701887|NCT02601937|587618384|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
162701888|NCT02601937|587618385|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701889|NCT02601937|587618386|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701890|NCT02601937|587618387|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701891|NCT02601937|587618388|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701892|NCT02601937|587618389|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701893|NCT02601937|587618390|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701894|NCT02601937|587618391|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701895|NCT02601937|587618392|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162701896|NCT02601937|587618382|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
162701897|NCT02601937|587618383|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
162701898|NCT02601937|587618384|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
162701899|NCT02601937|587618385|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
162701900|NCT02601937|587618386|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
162701901|NCT02601937|587618387|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
162701902|NCT02601937|587618388|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
162701903|NCT02601937|587618389|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
162701904|NCT02601937|587618390|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
162701905|NCT02601937|587618391|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
162701906|NCT02601937|587618392|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
162701907|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701908|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701909|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162845176|NCT00605267|588142323|FG001|Overall Study|Withdrawal by Subject|3|||
162845177|NCT00793793|588142324|FG000|Overall Study|Adverse Event|0|||
162845178|NCT00793793|588142325|FG001|Overall Study|Adverse Event|0|||
162845179|NCT00793793|588142326|FG002|Overall Study|Adverse Event|1|||
162845180|NCT00793793|588142327|FG003|Overall Study|Adverse Event|1|||
162845181|NCT00793793|588142328|FG004|Overall Study|Adverse Event|0|||
162845182|NCT00793793|588142329|FG005|Overall Study|Adverse Event|1|||
162845183|NCT00793793|588142330|FG006|Overall Study|Adverse Event|2|||
162845184|NCT00793793|588142331|FG007|Overall Study|Adverse Event|0|||
162845185|NCT00793793|588142332|FG008|Overall Study|Adverse Event|0|||
162845186|NCT00793793|588142333|FG009|Overall Study|Adverse Event|0|||
162845187|NCT00793793|588142334|FG010|Overall Study|Adverse Event|0|||
162845188|NCT00793793|588142335|FG011|Overall Study|Adverse Event|2|||
162845189|NCT00793793|588142324|FG000|Overall Study|Protocol Violation|0|||
162845190|NCT00793793|588142325|FG001|Overall Study|Protocol Violation|0|||
162845191|NCT00793793|588142326|FG002|Overall Study|Protocol Violation|0|||
162845192|NCT00793793|588142327|FG003|Overall Study|Protocol Violation|1|||
162845193|NCT00793793|588142328|FG004|Overall Study|Protocol Violation|0|||
162845194|NCT00793793|588142329|FG005|Overall Study|Protocol Violation|0|||
162845195|NCT00793793|588142330|FG006|Overall Study|Protocol Violation|0|||
162845196|NCT00793793|588142331|FG007|Overall Study|Protocol Violation|0|||
162845197|NCT00793793|588142332|FG008|Overall Study|Protocol Violation|0|||
162845198|NCT00793793|588142333|FG009|Overall Study|Protocol Violation|0|||
162845199|NCT00793793|588142334|FG010|Overall Study|Protocol Violation|0|||
162845200|NCT00793793|588142335|FG011|Overall Study|Protocol Violation|0|||
162845201|NCT00793793|588142324|FG000|Overall Study|Lost to Follow-up|0|||
162845202|NCT00793793|588142325|FG001|Overall Study|Lost to Follow-up|0|||
162845203|NCT00793793|588142326|FG002|Overall Study|Lost to Follow-up|1|||
162845204|NCT00793793|588142327|FG003|Overall Study|Lost to Follow-up|0|||
162845205|NCT00793793|588142328|FG004|Overall Study|Lost to Follow-up|0|||
162845206|NCT00793793|588142329|FG005|Overall Study|Lost to Follow-up|0|||
162845207|NCT00793793|588142330|FG006|Overall Study|Lost to Follow-up|0|||
162845208|NCT00793793|588142331|FG007|Overall Study|Lost to Follow-up|0|||
162845209|NCT00793793|588142332|FG008|Overall Study|Lost to Follow-up|1|||
162845210|NCT00793793|588142333|FG009|Overall Study|Lost to Follow-up|3|||
162845211|NCT00793793|588142334|FG010|Overall Study|Lost to Follow-up|1|||
162845212|NCT00793793|588142335|FG011|Overall Study|Lost to Follow-up|0|||
162845213|NCT00793793|588142324|FG000|Overall Study|Withdrawal by Subject|0|||
162845214|NCT00793793|588142325|FG001|Overall Study|Withdrawal by Subject|0|||
162845215|NCT00793793|588142326|FG002|Overall Study|Withdrawal by Subject|0|||
162845216|NCT00793793|588142327|FG003|Overall Study|Withdrawal by Subject|0|||
162845217|NCT00793793|588142328|FG004|Overall Study|Withdrawal by Subject|1|||
162845218|NCT00793793|588142329|FG005|Overall Study|Withdrawal by Subject|0|||
162845219|NCT00793793|588142330|FG006|Overall Study|Withdrawal by Subject|0|||
162845220|NCT00793793|588142331|FG007|Overall Study|Withdrawal by Subject|0|||
162845221|NCT00793793|588142332|FG008|Overall Study|Withdrawal by Subject|1|||
162845222|NCT00793793|588142333|FG009|Overall Study|Withdrawal by Subject|0|||
162845223|NCT00793793|588142334|FG010|Overall Study|Withdrawal by Subject|0|||
162845224|NCT00793793|588142335|FG011|Overall Study|Withdrawal by Subject|0|||
162845225|NCT00793793|588142324|FG000|Overall Study|reason not specified|0|||
162845226|NCT00793793|588142325|FG001|Overall Study|reason not specified|1|||
163043091|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
163043092|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
163043093|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
162701910|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701911|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701912|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162845227|NCT00793793|588142326|FG002|Overall Study|reason not specified|0|||
162845228|NCT00793793|588142327|FG003|Overall Study|reason not specified|1|||
162701913|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162845229|NCT00793793|588142328|FG004|Overall Study|reason not specified|1|||
162845230|NCT00793793|588142329|FG005|Overall Study|reason not specified|1|||
162845231|NCT00793793|588142330|FG006|Overall Study|reason not specified|2|||
162845232|NCT00793793|588142331|FG007|Overall Study|reason not specified|0|||
162845233|NCT00793793|588142332|FG008|Overall Study|reason not specified|7|||
162845234|NCT00793793|588142333|FG009|Overall Study|reason not specified|6|||
162845235|NCT00793793|588142334|FG010|Overall Study|reason not specified|2|||
162845236|NCT00793793|588142335|FG011|Overall Study|reason not specified|4|||
162845237|NCT00840827|588142337|FG000|Overall Study|Adverse Event|1|||
162845238|NCT00840827|588142337|FG000|Overall Study|Lack of Efficacy|4|||
162845239|NCT00840827|588142337|FG000|Overall Study|Physician Decision|1|||
162845240|NCT01505894|588142338|FG000|Overall Study|Adverse Event|1|||
162845241|NCT01505894|588142339|FG001|Overall Study|Adverse Event|0|||
162845242|NCT01505894|588142340|FG002|Overall Study|Adverse Event|0|||
162845243|NCT01505894|588142341|FG003|Overall Study|Adverse Event|0|||
162845244|NCT01505894|588142342|FG004|Overall Study|Adverse Event|0|||
162845245|NCT01505894|588142343|FG005|Overall Study|Adverse Event|0|||
162845246|NCT01505894|588142344|FG006|Overall Study|Adverse Event|0|||
162845247|NCT01505894|588142345|FG007|Overall Study|Adverse Event|0|||
162845248|NCT01505894|588142346|FG008|Overall Study|Adverse Event|0|||
162845249|NCT01505894|588142338|FG000|Overall Study|Other than specified|0|||
162845250|NCT01505894|588142339|FG001|Overall Study|Other than specified|0|||
162845251|NCT01505894|588142340|FG002|Overall Study|Other than specified|0|||
162845252|NCT01505894|588142341|FG003|Overall Study|Other than specified|0|||
162845253|NCT01505894|588142342|FG004|Overall Study|Other than specified|1|||
162845254|NCT01505894|588142343|FG005|Overall Study|Other than specified|0|||
162845255|NCT01505894|588142344|FG006|Overall Study|Other than specified|0|||
162845256|NCT01505894|588142345|FG007|Overall Study|Other than specified|0|||
162845257|NCT01505894|588142346|FG008|Overall Study|Other than specified|0|||
162845258|NCT04088409|588142348|FG000|Part A|Withdrawal by Subject|2|||
162845259|NCT04088409|588142349|FG001|Part A|Withdrawal by Subject|1|||
162845260|NCT04088409|588142348|FG000|Part A|Did Not Meet Randomization Criteria|2|||
162845261|NCT04088409|588142349|FG001|Part A|Did Not Meet Randomization Criteria|0|||
162845262|NCT04088409|588142348|FG000|Part A|Lack of Efficacy|9|||
162845263|NCT04088409|588142349|FG001|Part A|Lack of Efficacy|0|||
163043094|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
163043095|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
163043096|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
163043097|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
163043098|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
163043099|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
162845264|NCT04088409|588142348|FG000|Part A|Lost to Follow-up|1|||
162845265|NCT04088409|588142349|FG001|Part A|Lost to Follow-up|0|||
162845266|NCT04088409|588142348|FG000|Part A|Adverse Event|1|||
162845267|NCT04088409|588142349|FG001|Part A|Adverse Event|0|||
162845268|NCT04088409|588142348|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
162845269|NCT04088409|588142349|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
162845270|NCT04088409|588142348|FG000|Part B|Ongoing Treatment|10|||
162845271|NCT04088409|588142349|FG001|Part B|Ongoing Treatment|0|||
162845272|NCT00648167|588142350|FG000|Overall Study|Adverse Event|6|||
162845273|NCT00648167|588142350|FG000|Overall Study|unable to swallow tablets|1|||
162845274|NCT00927368|588142351|FG000|Overall Study|enrollment in another study|1|||
162845275|NCT00927368|588142352|FG001|Overall Study|enrollment in another study|1|||
162845276|NCT00927368|588142353|FG002|Overall Study|enrollment in another study|2|||
162845277|NCT00927368|588142351|FG000|Overall Study|Lost to Follow-up|4|||
162845278|NCT00927368|588142352|FG001|Overall Study|Lost to Follow-up|0|||
162845279|NCT00927368|588142353|FG002|Overall Study|Lost to Follow-up|0|||
162845280|NCT00927368|588142351|FG000|Overall Study|equipment failure|1|||
162845281|NCT00927368|588142352|FG001|Overall Study|equipment failure|0|||
162845282|NCT00927368|588142353|FG002|Overall Study|equipment failure|0|||
162845283|NCT00927368|588142351|FG000|Overall Study|ineligible post randomization|0|||
162845284|NCT00927368|588142352|FG001|Overall Study|ineligible post randomization|3|||
162845285|NCT00927368|588142353|FG002|Overall Study|ineligible post randomization|1|||
162845286|NCT00927368|588142351|FG000|Overall Study|cancellation of surgery|0|||
162845287|NCT00927368|588142352|FG001|Overall Study|cancellation of surgery|1|||
163043100|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
163043101|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
163043102|NCT00105989|588865712|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
162845288|NCT00927368|588142353|FG002|Overall Study|cancellation of surgery|2|||
162845289|NCT00191451|588142354|FG000|Overall Study|Withdrawal by Subject|2|||
162845290|NCT00191451|588142355|FG001|Overall Study|Withdrawal by Subject|3|||
163043103|NCT00105989|588865713|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
162701914|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701915|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162701916|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
162701917|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162845291|NCT00191451|588142356|FG002|Overall Study|Withdrawal by Subject|5|||
162845292|NCT00191451|588142354|FG000|Overall Study|Physician Decision|2|||
162845293|NCT00191451|588142355|FG001|Overall Study|Physician Decision|9|||
162845294|NCT00191451|588142356|FG002|Overall Study|Physician Decision|6|||
162701918|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162845295|NCT00191451|588142354|FG000|Overall Study|Sponsor Decision|1|||
162845296|NCT00191451|588142355|FG001|Overall Study|Sponsor Decision|0|||
162845297|NCT00191451|588142356|FG002|Overall Study|Sponsor Decision|0|||
162845298|NCT00191451|588142354|FG000|Overall Study|Ineligible|0|||
163043104|NCT01716663|588865714|FG000|Overall Study|Withdrawn prior to procedure|4|||
163043105|NCT01716663|588865714|FG000|Overall Study|Treated with non-study catheter|2|||
163043106|NCT01059773|588865715|FG000|Overall Study|Adverse Event|2|||
163043107|NCT01059773|588865716|FG001|Overall Study|Adverse Event|2|||
163043108|NCT01059773|588865715|FG000|Overall Study|Withdrawal by Subject|1|||
163043109|NCT01059773|588865716|FG001|Overall Study|Withdrawal by Subject|5|||
162845299|NCT00191451|588142355|FG001|Overall Study|Ineligible|1|||
162701919|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701920|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701921|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701922|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701923|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701924|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701925|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
162701926|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701927|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701928|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162701929|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701930|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701931|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701932|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701933|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701934|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701935|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701936|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701937|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162701938|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
162701939|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
162701940|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701941|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701942|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701943|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701944|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701945|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701946|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162701947|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
162701948|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
162701949|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
162701950|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
162701951|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Other|0|||
162701952|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Other|0|||
162701953|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Other|0|||
162845300|NCT00191451|588142356|FG002|Overall Study|Ineligible|0|||
162845301|NCT00191451|588142354|FG000|Overall Study|Reason Not Specified|2|||
162845302|NCT00191451|588142355|FG001|Overall Study|Reason Not Specified|1|||
162701954|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Other|0|||
162845303|NCT00191451|588142356|FG002|Overall Study|Reason Not Specified|3|||
162845304|NCT00331409|588142364|FG000|Overall Study|Lack of Efficacy|4|||
162845305|NCT00272987|588142365|FG000|Overall Study|Adverse Event|1|||
162845306|NCT00272987|588142366|FG001|Overall Study|Adverse Event|0|||
162845307|NCT00272987|588142367|FG002|Overall Study|Adverse Event|0|||
162845308|NCT00272987|588142365|FG000|Overall Study|Lost to Follow-up|3|||
162845309|NCT00272987|588142366|FG001|Overall Study|Lost to Follow-up|1|||
162845310|NCT00272987|588142367|FG002|Overall Study|Lost to Follow-up|1|||
162845311|NCT00272987|588142365|FG000|Overall Study|Withdrawal by Subject|1|||
162845312|NCT00272987|588142366|FG001|Overall Study|Withdrawal by Subject|0|||
162845313|NCT00272987|588142367|FG002|Overall Study|Withdrawal by Subject|3|||
162845314|NCT00272987|588142365|FG000|Overall Study|Sponsor Terminated study|0|||
162845315|NCT00272987|588142366|FG001|Overall Study|Sponsor Terminated study|1|||
162845316|NCT00272987|588142367|FG002|Overall Study|Sponsor Terminated study|1|||
162845317|NCT00272987|588142365|FG000|Overall Study|Disease progression|1|||
162845318|NCT00272987|588142366|FG001|Overall Study|Disease progression|1|||
162845319|NCT00272987|588142367|FG002|Overall Study|Disease progression|2|||
162845320|NCT00272987|588142365|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
162845321|NCT00272987|588142366|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
162845322|NCT00272987|588142367|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
162845323|NCT00272987|588142365|FG000|Overall Study|Death|1|||
162845324|NCT00272987|588142366|FG001|Overall Study|Death|0|||
162845325|NCT00272987|588142367|FG002|Overall Study|Death|0|||
162845326|NCT01482910|588142368|FG000|Overall Study|Adverse Event|6|||
162845327|NCT01482910|588142369|FG001|Overall Study|Adverse Event|5|||
162845328|NCT01482910|588142368|FG000|Overall Study|Lost to Follow-up|0|||
162845329|NCT01482910|588142369|FG001|Overall Study|Lost to Follow-up|1|||
162845330|NCT01482910|588142368|FG000|Overall Study|Protocol Violation|1|||
162845331|NCT01482910|588142369|FG001|Overall Study|Protocol Violation|1|||
162845332|NCT01482910|588142368|FG000|Overall Study|Withdrawal by Subject|7|||
162845333|NCT01482910|588142369|FG001|Overall Study|Withdrawal by Subject|2|||
162845334|NCT01482910|588142368|FG000|Overall Study|Death|1|||
162845335|NCT01482910|588142369|FG001|Overall Study|Death|0|||
162845336|NCT03222349|588142373|FG000|Overall Study|Treatment B not done|5|||
162845337|NCT03222349|588142374|FG001|Overall Study|Treatment B not done|0|||
162845338|NCT03222349|588142373|FG000|Overall Study|Lost to Follow-up|1|||
162845339|NCT03222349|588142374|FG001|Overall Study|Lost to Follow-up|2|||
162845340|NCT03222349|588142373|FG000|Overall Study|Withdrawal by Subject|1|||
162845341|NCT03222349|588142374|FG001|Overall Study|Withdrawal by Subject|0|||
162845342|NCT03222349|588142373|FG000|Overall Study|Treatment A not done|0|||
162845343|NCT03222349|588142374|FG001|Overall Study|Treatment A not done|5|||
162845344|NCT03222349|588142373|FG000|Overall Study|Study terminated by sponsor|1|||
162845345|NCT03222349|588142374|FG001|Overall Study|Study terminated by sponsor|0|||
162845346|NCT02614079|588142375|FG000|Overall Study|Withdrawal by Subject|1|||
162845347|NCT03739528|588142378|FG000|Overall Study|Not treated|8|||
162845348|NCT03739528|588142379|FG001|Overall Study|Not treated|12|||
162845349|NCT03739528|588142378|FG000|Overall Study|Treatment and study discontinued|6|||
162845350|NCT03739528|588142379|FG001|Overall Study|Treatment and study discontinued|2|||
162845351|NCT03739528|588142378|FG000|Overall Study|Treatment discontinued + study completed|1|||
162845352|NCT03739528|588142379|FG001|Overall Study|Treatment discontinued + study completed|3|||
162845353|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Adverse Event|11|||
162845354|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Adverse Event|15|||
162845355|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
162845356|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
162845357|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
162845358|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
162845359|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
162845360|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
162845361|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162845362|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
162845363|NCT01058096|588142380|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
162952010|NCT01294787|588529508|FG002|Period 2|Adverse Event|0|||
162952011|NCT01294787|588529509|FG003|Period 2|Adverse Event|1|||
162952012|NCT01294787|588529510|FG004|Period 2|Adverse Event|0|||
162952013|NCT01294787|588529511|FG005|Period 2|Adverse Event|0|||
162845364|NCT01058096|588142381|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
162845365|NCT05655377|588142382|FG000|Overall Study|Withdrawal by Subject|2|||
162845366|NCT04451330|588142383|FG000|Overall Study|Adverse Event|1|||
162845367|NCT04451330|588142384|FG001|Overall Study|Adverse Event|2|||
162952014|NCT01294787|588529506|FG000|Period 2|No longer needs study drug|0|||
162845368|NCT04451330|588142383|FG000|Overall Study|Lost to Follow-up|5|||
162845369|NCT04451330|588142384|FG001|Overall Study|Lost to Follow-up|0|||
162845370|NCT04451330|588142383|FG000|Overall Study|Withdrawal by Subject|3|||
162845371|NCT04451330|588142384|FG001|Overall Study|Withdrawal by Subject|1|||
162845372|NCT04451330|588142383|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162845373|NCT04451330|588142384|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162952015|NCT01294787|588529507|FG001|Period 2|No longer needs study drug|0|||
162845374|NCT04451330|588142383|FG000|Overall Study|Other than specified|0|||
162845375|NCT04451330|588142384|FG001|Overall Study|Other than specified|1|||
162845376|NCT05099640|588142385|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
162845377|NCT05099640|588142386|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
162845378|NCT05099640|588142387|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
162845379|NCT05099640|588142385|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
162845380|NCT05099640|588142386|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
162845381|NCT05099640|588142387|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
162845382|NCT05099640|588142385|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
162845383|NCT05099640|588142386|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
162845384|NCT05099640|588142387|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
162845385|NCT05099640|588142385|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
162845386|NCT05099640|588142386|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
162845387|NCT05099640|588142387|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
162845388|NCT05099640|588142385|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
162845389|NCT05099640|588142386|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
162845390|NCT05099640|588142387|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
162845391|NCT05099640|588142385|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
162845392|NCT05099640|588142386|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
162845393|NCT05099640|588142387|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
162845394|NCT00179959|588142388|FG000|Overall Study|Lost to Follow-up|3|||
162845395|NCT00179959|588142389|FG001|Overall Study|Lost to Follow-up|1|||
162845396|NCT00179959|588142388|FG000|Overall Study|Withdrawal by Subject|3|||
162845397|NCT00179959|588142389|FG001|Overall Study|Withdrawal by Subject|2|||
162845398|NCT01552681|588142394|FG000|Overall Study|Withdrawal by Subject|4|||
162845399|NCT01552681|588142395|FG001|Overall Study|Withdrawal by Subject|0|||
162845400|NCT01552681|588142394|FG000|Overall Study|Physician Decision|1|||
162845401|NCT01552681|588142395|FG001|Overall Study|Physician Decision|0|||
162845402|NCT01552681|588142394|FG000|Overall Study|Subject moved away|0|||
162845403|NCT01552681|588142395|FG001|Overall Study|Subject moved away|1|||
162845404|NCT03075163|588142396|FG000|Overall Study|not eligible for treatment limb|138|||
162845405|NCT03075163|588142397|FG001|Overall Study|not eligible for treatment limb|138|||
162845406|NCT00236080|588142398|FG000|Overall Study|Adverse Event|0|||
162845407|NCT00236080|588142399|FG001|Overall Study|Adverse Event|0|||
162845408|NCT00236080|588142400|FG002|Overall Study|Adverse Event|3|||
162845409|NCT00236080|588142401|FG003|Overall Study|Adverse Event|1|||
162845410|NCT00236080|588142402|FG004|Overall Study|Adverse Event|0|||
162845411|NCT00236080|588142398|FG000|Overall Study|Lost to Follow-up|0|||
162845412|NCT00236080|588142399|FG001|Overall Study|Lost to Follow-up|1|||
162845413|NCT00236080|588142400|FG002|Overall Study|Lost to Follow-up|0|||
162845414|NCT00236080|588142401|FG003|Overall Study|Lost to Follow-up|0|||
162845415|NCT00236080|588142402|FG004|Overall Study|Lost to Follow-up|0|||
162845416|NCT00236080|588142398|FG000|Overall Study|Physician Decision|1|||
162845417|NCT00236080|588142399|FG001|Overall Study|Physician Decision|0|||
162845418|NCT00236080|588142400|FG002|Overall Study|Physician Decision|1|||
162845419|NCT00236080|588142401|FG003|Overall Study|Physician Decision|1|||
162845420|NCT00236080|588142402|FG004|Overall Study|Physician Decision|1|||
162845421|NCT00236080|588142398|FG000|Overall Study|Withdrawal by Subject|1|||
162845422|NCT00236080|588142399|FG001|Overall Study|Withdrawal by Subject|0|||
162845423|NCT00236080|588142400|FG002|Overall Study|Withdrawal by Subject|0|||
162845424|NCT00236080|588142401|FG003|Overall Study|Withdrawal by Subject|0|||
162845425|NCT00236080|588142402|FG004|Overall Study|Withdrawal by Subject|0|||
162845426|NCT00236080|588142398|FG000|Overall Study|Miscellaneous|0|||
162845427|NCT00236080|588142399|FG001|Overall Study|Miscellaneous|0|||
162845428|NCT00236080|588142400|FG002|Overall Study|Miscellaneous|1|||
162845429|NCT00236080|588142401|FG003|Overall Study|Miscellaneous|0|||
162845430|NCT00236080|588142402|FG004|Overall Study|Miscellaneous|0|||
162845431|NCT01214044|588142403|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
162845432|NCT01214044|588142403|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
162845433|NCT01214044|588142403|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
162845434|NCT01214044|588142403|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
162845435|NCT01214044|588142403|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
162845436|NCT01214044|588142403|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
162845437|NCT04698525|588142404|FG000|Overall Study|Lost to Follow-up|1|||
162845438|NCT04698525|588142405|FG001|Overall Study|Lost to Follow-up|2|||
162845439|NCT04698525|588142404|FG000|Overall Study|Three suffered of Covid-19|2|||
162845440|NCT04698525|588142405|FG001|Overall Study|Three suffered of Covid-19|1|||
162845441|NCT01961544|588142406|FG000|Overall Study|Protocol Violation|1|||
162845442|NCT01961544|588142406|FG000|Overall Study|Withdrawal by Subject|7|||
162845443|NCT01961544|588142406|FG000|Overall Study|Adverse Event|1|||
162845444|NCT01961544|588142406|FG000|Overall Study|Physician Decision|2|||
162845445|NCT01961544|588142406|FG000|Overall Study|Poor Tolerance|1|||
162845446|NCT01961544|588142406|FG000|Overall Study|Aggravation of Steral Pain|1|||
162845447|NCT03157531|588142409|FG000|Overall Study|Death|2|||
162845448|NCT03157531|588142409|FG000|Overall Study|Lost to Follow-up|4|||
162845449|NCT02211261|588142417|FG000|Overall Study|Withdrawal by Subject|0|||
162845450|NCT02211261|588142418|FG001|Overall Study|Withdrawal by Subject|0|||
162845451|NCT02211261|588142419|FG002|Overall Study|Withdrawal by Subject|1|||
162845452|NCT02211261|588142420|FG003|Overall Study|Withdrawal by Subject|0|||
162845453|NCT02211261|588142421|FG004|Overall Study|Withdrawal by Subject|2|||
162845454|NCT02211261|588142422|FG005|Overall Study|Withdrawal by Subject|0|||
162845455|NCT02211261|588142423|FG006|Overall Study|Withdrawal by Subject|0|||
162845456|NCT02211261|588142424|FG007|Overall Study|Withdrawal by Subject|0|||
162845457|NCT02211261|588142425|FG008|Overall Study|Withdrawal by Subject|0|||
162845458|NCT02211261|588142426|FG009|Overall Study|Withdrawal by Subject|0|||
162845459|NCT02211261|588142427|FG010|Overall Study|Withdrawal by Subject|0|||
162845460|NCT02211261|588142417|FG000|Overall Study|Other|0|||
162845461|NCT02211261|588142418|FG001|Overall Study|Other|0|||
162845462|NCT02211261|588142419|FG002|Overall Study|Other|0|||
162845463|NCT02211261|588142420|FG003|Overall Study|Other|0|||
162845464|NCT02211261|588142421|FG004|Overall Study|Other|0|||
162845465|NCT02211261|588142422|FG005|Overall Study|Other|1|||
162845466|NCT02211261|588142423|FG006|Overall Study|Other|0|||
162845467|NCT02211261|588142424|FG007|Overall Study|Other|0|||
162845468|NCT02211261|588142425|FG008|Overall Study|Other|0|||
162845469|NCT02211261|588142426|FG009|Overall Study|Other|2|||
162845470|NCT02211261|588142427|FG010|Overall Study|Other|0|||
162845471|NCT02211261|588142417|FG000|Overall Study|Lost to Follow-up|0|||
162845472|NCT02211261|588142418|FG001|Overall Study|Lost to Follow-up|0|||
162701955|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Other|0|||
162701956|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Other|0|||
162701957|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Other|0|||
162701958|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Other|0|||
162701959|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Other|2|||
162701960|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Other|2|||
162701961|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Other|0|||
162701962|NCT02601937|587618382|FG000|Period 2: Dose Expansion Cohort|Death|0|||
162701963|NCT02601937|587618383|FG001|Period 2: Dose Expansion Cohort|Death|0|||
162701964|NCT02601937|587618384|FG002|Period 2: Dose Expansion Cohort|Death|0|||
162701965|NCT02601937|587618385|FG003|Period 2: Dose Expansion Cohort|Death|0|||
162701966|NCT02601937|587618386|FG004|Period 2: Dose Expansion Cohort|Death|0|||
162701967|NCT02601937|587618387|FG005|Period 2: Dose Expansion Cohort|Death|0|||
162701968|NCT02601937|587618388|FG006|Period 2: Dose Expansion Cohort|Death|0|||
162701969|NCT02601937|587618389|FG007|Period 2: Dose Expansion Cohort|Death|0|||
162701970|NCT02601937|587618390|FG008|Period 2: Dose Expansion Cohort|Death|1|||
162701971|NCT02601937|587618391|FG009|Period 2: Dose Expansion Cohort|Death|0|||
162701972|NCT02601937|587618392|FG010|Period 2: Dose Expansion Cohort|Death|0|||
162701973|NCT02924389|587618394|FG000|Overall Study|Lost to Follow-up|1|||
162701974|NCT02924389|587618395|FG001|Overall Study|Lost to Follow-up|0|||
162701975|NCT02924389|587618394|FG000|Overall Study|Physician Decision|2|||
162701976|NCT02924389|587618395|FG001|Overall Study|Physician Decision|0|||
162701977|NCT02924389|587618394|FG000|Overall Study|Withdrawal by Subject|3|||
162701978|NCT02924389|587618395|FG001|Overall Study|Withdrawal by Subject|0|||
162701979|NCT02924389|587618394|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
162701980|NCT02924389|587618395|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
162701981|NCT03038672|587619776|FG000|Initial Treatment|Unacceptable chemistry|0|||
162701982|NCT03038672|587619777|FG001|Initial Treatment|Unacceptable chemistry|1|||
162701983|NCT03038672|587619776|FG000|Initial Treatment|Progression prior to treatment|1|||
162701984|NCT03038672|587619777|FG001|Initial Treatment|Progression prior to treatment|0|||
162701985|NCT03038672|587619776|FG000|Initial Treatment|No treatment per protocol|1|||
162701986|NCT03038672|587619777|FG001|Initial Treatment|No treatment per protocol|0|||
162701987|NCT05220501|587619778|FG000|Overall Study|Withdrawal by Subject|11|||
162701988|NCT05220501|587619779|FG001|Overall Study|Withdrawal by Subject|21|||
162701989|NCT05220501|587619780|FG002|Overall Study|Withdrawal by Subject|32|||
162701990|NCT05220501|587619778|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
162701991|NCT05220501|587619779|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
162701992|NCT05220501|587619780|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
162701993|NCT02692235|587619781|FG000|Overall Study|Withdrawal by Subject|2|||
162701994|NCT02692235|587619782|FG001|Overall Study|Withdrawal by Subject|1|||
162845473|NCT02211261|588142419|FG002|Overall Study|Lost to Follow-up|0|||
162845474|NCT02211261|588142420|FG003|Overall Study|Lost to Follow-up|0|||
162845475|NCT02211261|588142421|FG004|Overall Study|Lost to Follow-up|0|||
162845476|NCT02211261|588142422|FG005|Overall Study|Lost to Follow-up|0|||
162845477|NCT02211261|588142423|FG006|Overall Study|Lost to Follow-up|0|||
162845478|NCT02211261|588142424|FG007|Overall Study|Lost to Follow-up|1|||
162845479|NCT02211261|588142425|FG008|Overall Study|Lost to Follow-up|0|||
162701995|NCT02692235|587619781|FG000|Overall Study|Adverse Event|1|||
162701996|NCT02692235|587619782|FG001|Overall Study|Adverse Event|2|||
162701997|NCT00802841|587619783|FG000|Overall Study|Administrative problems|1|||
162701998|NCT00802841|587619784|FG001|Overall Study|Administrative problems|0|||
162701999|NCT00802841|587619783|FG000|Overall Study|Lost to Follow-up|2|||
162702000|NCT00802841|587619784|FG001|Overall Study|Lost to Follow-up|1|||
162702001|NCT00802841|587619783|FG000|Overall Study|Death|1|||
162702002|NCT00802841|587619784|FG001|Overall Study|Death|2|||
162702003|NCT00802841|587619783|FG000|Overall Study|Adverse Event|8|||
162702004|NCT00802841|587619784|FG001|Overall Study|Adverse Event|2|||
162702005|NCT00802841|587619783|FG000|Overall Study|Disease progression|7|||
162702006|NCT00802841|587619784|FG001|Overall Study|Disease progression|3|||
162702007|NCT00802841|587619783|FG000|Overall Study|Withdrawal by Subject|9|||
162702008|NCT00802841|587619784|FG001|Overall Study|Withdrawal by Subject|5|||
162702009|NCT00802841|587619783|FG000|Overall Study|Protocol deviation|2|||
162702010|NCT00802841|587619784|FG001|Overall Study|Protocol deviation|6|||
162702011|NCT00802841|587619783|FG000|Overall Study|Treatment duration completed|66|||
162702012|NCT00802841|587619784|FG001|Overall Study|Treatment duration completed|76|||
162702013|NCT01929993|587619786|FG000|Overall Study|Protocol Violation|4|||
162702014|NCT01929993|587619787|FG001|Overall Study|Protocol Violation|6|||
162702015|NCT01929993|587619786|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
162702016|NCT01929993|587619787|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
162702017|NCT03595683|587619788|FG000|Overall Study|Adverse Event|1|||
162702018|NCT03595683|587619789|FG001|Overall Study|Adverse Event|0|||
162702019|NCT03595683|587619788|FG000|Overall Study|Pursue alternative therapy|1|||
162702020|NCT03595683|587619789|FG001|Overall Study|Pursue alternative therapy|1|||
162702021|NCT03595683|587619788|FG000|Overall Study|Progressive disease|1|||
162702022|NCT03595683|587619789|FG001|Overall Study|Progressive disease|3|||
162702023|NCT01021878|587619790|FG000|Overall Study|Lost to Follow-up|4|||
162702024|NCT01021878|587619791|FG001|Overall Study|Lost to Follow-up|3|||
162702025|NCT01021878|587619790|FG000|Overall Study|Death|0|||
162702026|NCT01021878|587619791|FG001|Overall Study|Death|1|||
162702027|NCT01021878|587619790|FG000|Overall Study|Adverse Event|6|||
162702028|NCT01021878|587619791|FG001|Overall Study|Adverse Event|5|||
162702029|NCT01021878|587619790|FG000|Overall Study|Transplantation|6|||
162702030|NCT01021878|587619791|FG001|Overall Study|Transplantation|1|||
162702031|NCT03158948|587619793|FG000|Overall Study|Death|1|||
162702032|NCT03158948|587619794|FG001|Overall Study|Death|1|||
162702033|NCT03158948|587619795|FG002|Overall Study|Death|3|||
162702034|NCT03158948|587619796|FG003|Overall Study|Death|2|||
162702035|NCT03158948|587619793|FG000|Overall Study|Physician Decision|0|||
162702036|NCT03158948|587619794|FG001|Overall Study|Physician Decision|0|||
162702037|NCT03158948|587619795|FG002|Overall Study|Physician Decision|0|||
162702038|NCT03158948|587619796|FG003|Overall Study|Physician Decision|1|||
162702039|NCT00472186|587619797|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
162702040|NCT00472186|587619798|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
162702041|NCT05876351|587619799|FG000|Overall Study|Other than specified|2|||
162702042|NCT05876351|587619799|FG000|Overall Study|Study specific discontinuation criteria|1|||
162702043|NCT00997243|587619800|FG000|Overall Study|Early termination of study by sponsor|7|||
162702044|NCT03415022|587619803|FG000|Overall Study|Withdrawal by Subject|1|||
162702045|NCT03415022|587619804|FG001|Overall Study|Withdrawal by Subject|2|||
162702046|NCT03415022|587619803|FG000|Overall Study|COVID-19 Suspension|2|||
162702047|NCT03415022|587619804|FG001|Overall Study|COVID-19 Suspension|3|||
162702048|NCT03415022|587619803|FG000|Overall Study|Lost to Follow-up|2|||
162702049|NCT03415022|587619804|FG001|Overall Study|Lost to Follow-up|0|||
162702050|NCT02086552|587619807|FG000|Overall Study|Withdrawal by Subject|1|||
162845480|NCT02211261|588142426|FG009|Overall Study|Lost to Follow-up|0|||
162702051|NCT02206152|587619808|FG000|Pre-Randomization|Withdrawal by Subject|2|||
162702052|NCT00478608|587619809|FG000|Overall Study|Adverse Event|1|||
162702053|NCT00478608|587619809|FG000|Overall Study|Serious Adverse Event|14|||
162702054|NCT00478608|587619809|FG000|Overall Study|Withdrawal by Subject|2|||
162702055|NCT00478608|587619809|FG000|Overall Study|Protocol Violation|3|||
162702056|NCT01349907|587619810|FG000|Overall Study|Adverse Event|37|||
162702057|NCT01349907|587619811|FG001|Overall Study|Adverse Event|11|||
162702058|NCT01349907|587619810|FG000|Overall Study|Treatment failure|13|||
162702059|NCT01349907|587619811|FG001|Overall Study|Treatment failure|4|||
162702060|NCT01349907|587619810|FG000|Overall Study|Lost to Follow-up|25|||
162702061|NCT01349907|587619811|FG001|Overall Study|Lost to Follow-up|6|||
162702062|NCT01349907|587619810|FG000|Overall Study|Withdrawal by Subject|30|||
162845481|NCT02211261|588142427|FG010|Overall Study|Lost to Follow-up|0|||
162845482|NCT01573910|588142428|FG000|Overall Study|Adverse Event|4|||
162845483|NCT01573910|588142429|FG001|Overall Study|Adverse Event|4|||
162845484|NCT01573910|588142428|FG000|Overall Study|Lost to Follow-up|2|||
162845485|NCT01573910|588142429|FG001|Overall Study|Lost to Follow-up|1|||
162845486|NCT01573910|588142428|FG000|Overall Study|Withdrawal by Subject|0|||
162845487|NCT01573910|588142429|FG001|Overall Study|Withdrawal by Subject|1|||
162845488|NCT01573910|588142428|FG000|Overall Study|Protocol Violation|3|||
162845489|NCT01573910|588142429|FG001|Overall Study|Protocol Violation|0|||
162845490|NCT01573910|588142428|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
162845491|NCT01573910|588142429|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
162845492|NCT02251912|588142430|FG000|Overall Study|Withdrawal by Subject|2|||
162845493|NCT02251912|588142431|FG001|Overall Study|Withdrawal by Subject|3|||
162845494|NCT02251912|588142430|FG000|Overall Study|Adverse Event|0|||
162845495|NCT02251912|588142431|FG001|Overall Study|Adverse Event|2|||
162845496|NCT00268242|588142433|FG000|Overall Study|Death|1|||
162845497|NCT02175680|588142434|FG000|Overall Study|non-compliance|1|||
162845498|NCT02175680|588142434|FG000|Overall Study|other non-medical reason|1|||
162845499|NCT03969888|588142435|FG000|Overall Study|Never Received Study Drug|0|||
162845500|NCT03969888|588142436|FG001|Overall Study|Never Received Study Drug|0|||
162845501|NCT03969888|588142437|FG002|Overall Study|Never Received Study Drug|1|||
162845502|NCT03969888|588142438|FG003|Overall Study|Never Received Study Drug|0|||
162845503|NCT03969888|588142439|FG004|Overall Study|Never Received Study Drug|0|||
162845504|NCT03969888|588142440|FG005|Overall Study|Never Received Study Drug|0|||
162845505|NCT03969888|588142441|FG006|Overall Study|Never Received Study Drug|1|||
162845506|NCT03969888|588142442|FG007|Overall Study|Never Received Study Drug|0|||
162845507|NCT03969888|588142435|FG000|Overall Study|Reason Not Specified|0|||
162845508|NCT03969888|588142436|FG001|Overall Study|Reason Not Specified|0|||
162845509|NCT03969888|588142437|FG002|Overall Study|Reason Not Specified|0|||
162845510|NCT03969888|588142438|FG003|Overall Study|Reason Not Specified|0|||
162845511|NCT03969888|588142439|FG004|Overall Study|Reason Not Specified|0|||
162845512|NCT03969888|588142440|FG005|Overall Study|Reason Not Specified|0|||
162845513|NCT03969888|588142441|FG006|Overall Study|Reason Not Specified|0|||
162845514|NCT03969888|588142442|FG007|Overall Study|Reason Not Specified|1|||
162845515|NCT04062214|588142443|FG000|Week 12|Death|1|||
162845516|NCT04062214|588142444|FG001|Week 12|Death|1|||
162845517|NCT04062214|588142443|FG000|Week 12|Withdrawal by Subject|14|||
162845518|NCT04062214|588142444|FG001|Week 12|Withdrawal by Subject|13|||
162845519|NCT04062214|588142443|FG000|Week 12|Lost to Follow-up|55|||
162845520|NCT04062214|588142444|FG001|Week 12|Lost to Follow-up|68|||
162845521|NCT04062214|588142443|FG000|Week 12|Intermittent missing|31|||
162845522|NCT04062214|588142444|FG001|Week 12|Intermittent missing|29|||
162845523|NCT04062214|588142443|FG000|Week 36|Withdrawal by Subject|4|||
162845524|NCT04062214|588142444|FG001|Week 36|Withdrawal by Subject|5|||
162845525|NCT04062214|588142443|FG000|Week 36|Lost to Follow-up|50|||
162845526|NCT04062214|588142444|FG001|Week 36|Lost to Follow-up|46|||
162845527|NCT04062214|588142443|FG000|Week 36|Death|0|||
162845528|NCT04062214|588142444|FG001|Week 36|Death|1|||
162845529|NCT04506294|588142447|FG000|Overall Study|Lost to Follow-up|70|||
162845530|NCT04506294|588142448|FG001|Overall Study|Lost to Follow-up|20|||
162845531|NCT04506294|588142447|FG000|Overall Study|Withdrawal by Subject|16|||
162845532|NCT04506294|588142448|FG001|Overall Study|Withdrawal by Subject|2|||
162845533|NCT01469000|588142454|FG000|Overall Study|Withdrawal by Subject|16|||
162845534|NCT01469000|588142455|FG001|Overall Study|Withdrawal by Subject|3|||
162845535|NCT01469000|588142454|FG000|Overall Study|Sponsor Decision|4|||
162845536|NCT01469000|588142455|FG001|Overall Study|Sponsor Decision|1|||
162845537|NCT06228586|588142461|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
162845538|NCT06228586|588142462|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
162845539|NCT00865020|588142473|FG000|Overall Study|Withdrawal by Subject|22|||
162845540|NCT00865020|588142474|FG001|Overall Study|Withdrawal by Subject|16|||
162845541|NCT00865020|588142473|FG000|Overall Study|Adverse Event|9|||
162845542|NCT00865020|588142474|FG001|Overall Study|Adverse Event|14|||
163043110|NCT01059773|588865715|FG000|Overall Study|Lost to Follow-up|1|||
162845543|NCT00865020|588142473|FG000|Overall Study|Abnormal test procedure result(s)|6|||
162845544|NCT00865020|588142474|FG001|Overall Study|Abnormal test procedure result(s)|8|||
162845545|NCT00865020|588142473|FG000|Overall Study|Lost to Follow-up|6|||
162845546|NCT00865020|588142474|FG001|Overall Study|Lost to Follow-up|4|||
162845547|NCT00865020|588142473|FG000|Overall Study|Protocol deviation|4|||
162845548|NCT00865020|588142474|FG001|Overall Study|Protocol deviation|1|||
162845549|NCT00865020|588142473|FG000|Overall Study|Administrative problems|0|||
162845550|NCT00865020|588142474|FG001|Overall Study|Administrative problems|2|||
162845551|NCT00865020|588142473|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162845552|NCT00865020|588142474|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162845553|NCT00865020|588142473|FG000|Overall Study|Death|0|||
162845554|NCT00865020|588142474|FG001|Overall Study|Death|1|||
162845555|NCT00865020|588142473|FG000|Overall Study|Randomized but discontinued|2|||
162845556|NCT00865020|588142474|FG001|Overall Study|Randomized but discontinued|4|||
162845557|NCT00772629|588144215|FG000|Overall Study|Subject was not vaccinated|1|||
162845558|NCT00772629|588144216|FG001|Overall Study|Subject was not vaccinated|0|||
162845559|NCT00132041|588144222|FG000|Baseline|Ineligible|6|||
162845560|NCT00132041|588144222|FG000|3 Months Post Ablation|Transplant|1|||
162845561|NCT00132041|588144222|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
162845562|NCT00132041|588144222|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
162845563|NCT00132041|588144222|FG000|6 Months Post Ablation|Death|2|||
162845564|NCT00132041|588144222|FG000|6 Months Post Ablation|Transplant|6|||
162845565|NCT00132041|588144222|FG000|9 Months Post Ablation|Death|1|||
162845566|NCT00132041|588144222|FG000|9 Months Post Ablation|Transplant|1|||
162952016|NCT01294787|588529508|FG002|Period 2|No longer needs study drug|0|||
162952017|NCT01294787|588529509|FG003|Period 2|No longer needs study drug|1|||
162952018|NCT01294787|588529510|FG004|Period 2|No longer needs study drug|0|||
162952019|NCT01294787|588529511|FG005|Period 2|No longer needs study drug|0|||
162952020|NCT01294787|588529506|FG000|Period 3|Adverse Event|0|||
162952021|NCT01294787|588529507|FG001|Period 3|Adverse Event|0|||
162952022|NCT01294787|588529508|FG002|Period 3|Adverse Event|0|||
162952023|NCT01294787|588529509|FG003|Period 3|Adverse Event|0|||
162952024|NCT01294787|588529510|FG004|Period 3|Adverse Event|1|||
162952025|NCT01294787|588529511|FG005|Period 3|Adverse Event|0|||
162952026|NCT01124175|588529512|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162952027|NCT01124175|588529513|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
162952028|NCT00942968|588529514|FG000|Overall Study|Adverse Event|60|||
162952029|NCT00942968|588529514|FG000|Overall Study|Death|76|||
162952030|NCT00942968|588529514|FG000|Overall Study|Protocol Violation|9|||
162952031|NCT00942968|588529514|FG000|Overall Study|Lost to Follow-up|4|||
162952032|NCT00942968|588529514|FG000|Overall Study|Withdrawal by Subject|44|||
162952033|NCT00942968|588529514|FG000|Overall Study|Sponsor request|5|||
162952034|NCT00942968|588529514|FG000|Overall Study|Physician Decision|11|||
162952035|NCT00942968|588529514|FG000|Overall Study|Progression of disease|12|||
162952036|NCT00942968|588529514|FG000|Overall Study|Inferior vena cava filter placement|4|||
162952037|NCT00942968|588529514|FG000|Overall Study|Pulmonary embolism (PE)|1|||
162952038|NCT00942968|588529514|FG000|Overall Study|Participant required pancreatic biopsy|1|||
162952039|NCT00942968|588529514|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
162952040|NCT01948258|588529515|FG000|Overall Study|Pregnancy|41|||
162952041|NCT01948258|588529515|FG000|Overall Study|Did not complete by cut-off date|35|||
162952042|NCT01948258|588529515|FG000|Overall Study|Lost to Follow-up|27|||
162952043|NCT01948258|588529515|FG000|Overall Study|Withdrawal by SPD|8|||
162952044|NCT01948258|588529515|FG000|Overall Study|Withdrawal by Subject|6|||
162952045|NCT01948258|588529515|FG000|Overall Study|Health Care Professional|43|||
162952046|NCT01948258|588529515|FG000|Overall Study|Removed from statistical analysis|2|||
162845567|NCT00132041|588144222|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
162845568|NCT00132041|588144222|FG000|12 Months Post Ablation|Death|1|||
162845569|NCT00132041|588144222|FG000|12 Months Post Ablation|Transplant|1|||
162845570|NCT00132041|588144222|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
162845571|NCT00132041|588144222|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
162845572|NCT00132041|588144222|FG000|15 Months Post Ablation|Death|1|||
162845573|NCT00132041|588144222|FG000|15 Months Post Ablation|Transplant|5|||
162845574|NCT00132041|588144222|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
162845575|NCT00132041|588144222|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
162845576|NCT00132041|588144222|FG000|18 Months Post Ablation|Transplant|1|||
162845577|NCT00132041|588144222|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
162845578|NCT00132041|588144222|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
162952047|NCT00520130|588529522|FG000|Overall Study|Disease progression on study|4|||
162952048|NCT00520130|588529523|FG001|Overall Study|Disease progression on study|0|||
162952049|NCT00520130|588529522|FG000|Overall Study|Physician Decision|1|||
162952050|NCT00520130|588529523|FG001|Overall Study|Physician Decision|1|||
162952051|NCT01045096|588529526|FG000|Overall Study|Withdrawal by Subject|2|||
162952052|NCT01045096|588529527|FG001|Overall Study|Withdrawal by Subject|0|||
162952053|NCT01045096|588529528|FG002|Overall Study|Withdrawal by Subject|0|||
162952054|NCT01045096|588529526|FG000|Overall Study|Other|1|||
162952055|NCT01045096|588529527|FG001|Overall Study|Other|0|||
162952056|NCT01045096|588529528|FG002|Overall Study|Other|0|||
162952057|NCT01900691|588529529|FG000|Overall Study|Death|7|||
162952058|NCT01900691|588529529|FG000|Overall Study|Lost to Follow-up|4|||
162952059|NCT01900691|588529529|FG000|Overall Study|Study Device Not Placed|3|||
162952060|NCT01900691|588529529|FG000|Overall Study|Non study stent placed|2|||
162952061|NCT01900691|588529529|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
162952062|NCT01900691|588529529|FG000|Overall Study|Complete stent migration through digestive tract|1|||
162952063|NCT01954394|588529530|FG000|Overall Study|Enrolled but not treated|1|||
162952064|NCT01954394|588529531|FG001|Overall Study|Enrolled but not treated|0|||
162845579|NCT01171820|588144224|FG000|Overall Study|Death|3|||
162845580|NCT01171820|588144225|FG001|Overall Study|Death|3|||
162952065|NCT01954394|588529530|FG000|Overall Study|Adverse Event|10|||
162952066|NCT01954394|588529531|FG001|Overall Study|Adverse Event|23|||
162952067|NCT01954394|588529530|FG000|Overall Study|Poor compliance to protocol|7|||
162952068|NCT01954394|588529531|FG001|Overall Study|Poor compliance to protocol|7|||
162845581|NCT01171820|588144224|FG000|Overall Study|Lost to Follow-up|0|||
162845582|NCT01171820|588144225|FG001|Overall Study|Lost to Follow-up|1|||
162845583|NCT01171820|588144224|FG000|Overall Study|Withdrawal by Subject|2|||
162845584|NCT01171820|588144225|FG001|Overall Study|Withdrawal by Subject|0|||
162845585|NCT01171820|588144224|FG000|Overall Study|Physician Decision|0|||
162845586|NCT01171820|588144225|FG001|Overall Study|Physician Decision|1|||
162845587|NCT01171820|588144224|FG000|Overall Study|1-Year Missed Visit|1|||
162845588|NCT01171820|588144225|FG001|Overall Study|1-Year Missed Visit|1|||
162845589|NCT00167245|588144226|FG000|Overall Study|Lost to Follow-up|20|||
162845590|NCT00167245|588144227|FG001|Overall Study|Lost to Follow-up|31|||
162845591|NCT00167245|588144226|FG000|Overall Study|Withdrawal by Subject|5|||
162845592|NCT00167245|588144227|FG001|Overall Study|Withdrawal by Subject|8|||
162845593|NCT00167245|588144226|FG000|Overall Study|Incarcerated|3|||
162845594|NCT00167245|588144227|FG001|Overall Study|Incarcerated|2|||
162845595|NCT00167245|588144226|FG000|Overall Study|Drowsy|1|||
162845596|NCT00167245|588144227|FG001|Overall Study|Drowsy|0|||
162845597|NCT03969875|588144228|FG000|Overall Study|did not receive allocated intervention|3|||
162845598|NCT03969875|588144229|FG001|Overall Study|did not receive allocated intervention|3|||
162845599|NCT03969875|588144230|FG002|Overall Study|did not receive allocated intervention|4|||
162845600|NCT03969875|588144228|FG000|Overall Study|Protocol Violation|4|||
162845601|NCT03969875|588144229|FG001|Overall Study|Protocol Violation|2|||
162845602|NCT03969875|588144230|FG002|Overall Study|Protocol Violation|2|||
162845603|NCT01871090|588144231|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
162845604|NCT01871090|588144232|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
162845605|NCT01871090|588144231|FG000|Overall Study|Interrogation not completed correctly|1|||
162845606|NCT01871090|588144232|FG001|Overall Study|Interrogation not completed correctly|0|||
162845607|NCT01871090|588144231|FG000|Overall Study|Subject Non-Compliance|0|||
162845608|NCT01871090|588144232|FG001|Overall Study|Subject Non-Compliance|1|||
162845609|NCT02911688|588144236|FG000|Washout|Lost to Follow-up|1|||
162845610|NCT02911688|588144237|FG001|Washout|Lost to Follow-up|1|||
162845611|NCT02911688|588144236|FG000|Washout|Withdrawal by Subject|0|||
162845612|NCT02911688|588144237|FG001|Washout|Withdrawal by Subject|1|||
162845613|NCT01307033|588144240|FG000|8-week Double-blind Period|Adverse Event|2|||
162845614|NCT01307033|588144241|FG001|8-week Double-blind Period|Adverse Event|0|||
162845615|NCT01307033|588144242|FG002|8-week Double-blind Period|Adverse Event|0|||
162845616|NCT01307033|588144243|FG003|8-week Double-blind Period|Adverse Event|0|||
162845617|NCT01307033|588144240|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
162845618|NCT01307033|588144241|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
162845619|NCT01307033|588144242|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
162845620|NCT01307033|588144243|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
162845621|NCT01307033|588144240|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
162845622|NCT01307033|588144241|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
162845623|NCT01307033|588144242|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
162845624|NCT01307033|588144243|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
162845625|NCT01307033|588144240|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
162845626|NCT01307033|588144241|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
162845627|NCT01307033|588144242|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
162845628|NCT01307033|588144243|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
162845629|NCT01307033|588144240|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
162845630|NCT01307033|588144241|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
162845631|NCT01307033|588144242|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
162845632|NCT01307033|588144243|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
162845633|NCT01307033|588144240|FG000|44-week Open-label Extension|Adverse Event|0|||
162845634|NCT01307033|588144241|FG001|44-week Open-label Extension|Adverse Event|0|||
162845635|NCT01307033|588144242|FG002|44-week Open-label Extension|Adverse Event|2|||
162845636|NCT01307033|588144243|FG003|44-week Open-label Extension|Adverse Event|1|||
162845637|NCT01307033|588144240|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
162845638|NCT01307033|588144241|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
162845639|NCT01307033|588144242|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
162845640|NCT01307033|588144243|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
162845641|NCT01307033|588144240|FG000|44-week Open-label Extension|Physician Decision|0|||
162952069|NCT01954394|588529530|FG000|Overall Study|Participant Moved|0|||
162845642|NCT01307033|588144241|FG001|44-week Open-label Extension|Physician Decision|0|||
162845643|NCT01307033|588144242|FG002|44-week Open-label Extension|Physician Decision|1|||
162952070|NCT01954394|588529531|FG001|Overall Study|Participant Moved|4|||
162845644|NCT01307033|588144243|FG003|44-week Open-label Extension|Physician Decision|0|||
162845645|NCT01307033|588144240|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
162952071|NCT01954394|588529530|FG000|Overall Study|Related to Study Drug administration|2|||
162845646|NCT01307033|588144241|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
162845647|NCT01307033|588144242|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
162845648|NCT01307033|588144243|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
162845649|NCT01307033|588144240|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
162845650|NCT01307033|588144241|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
162845651|NCT01307033|588144242|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
162845652|NCT01307033|588144243|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
162845653|NCT01307033|588144240|FG000|44-week Open-label Extension|Death|0|||
162845654|NCT01307033|588144241|FG001|44-week Open-label Extension|Death|0|||
162845655|NCT01307033|588144242|FG002|44-week Open-label Extension|Death|0|||
162845656|NCT01307033|588144243|FG003|44-week Open-label Extension|Death|1|||
162845657|NCT00282243|588144247|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
162845658|NCT00282243|588144247|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
162845659|NCT00282243|588144247|FG000|Extension Treatment Period|Adverse Event|15|||
162845660|NCT00282243|588144247|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
162845661|NCT00282243|588144247|FG000|Extension Treatment Period|Non-compliance|2|||
162845662|NCT00282243|588144247|FG000|Extension Treatment Period|Physician Decision|1|||
162845663|NCT01070329|588144248|FG000|Overall Study|Adverse Event|13|||
162845664|NCT01070329|588144249|FG001|Overall Study|Adverse Event|10|||
162845665|NCT01070329|588144248|FG000|Overall Study|Lost to Follow-up|22|||
162845666|NCT01070329|588144249|FG001|Overall Study|Lost to Follow-up|12|||
162845667|NCT01070329|588144248|FG000|Overall Study|Withdrawal by Subject|9|||
162845668|NCT01070329|588144249|FG001|Overall Study|Withdrawal by Subject|11|||
162845669|NCT01070329|588144248|FG000|Overall Study|Protocol Violation|3|||
162845670|NCT01070329|588144249|FG001|Overall Study|Protocol Violation|8|||
163043111|NCT01059773|588865716|FG001|Overall Study|Lost to Follow-up|1|||
163043112|NCT01059773|588865715|FG000|Overall Study|Pregnancy|1|||
162845671|NCT01070329|588144248|FG000|Overall Study|Lack of Efficacy|2|||
162845672|NCT01070329|588144249|FG001|Overall Study|Lack of Efficacy|6|||
162845673|NCT01070329|588144248|FG000|Overall Study|Physician Decision|2|||
162845674|NCT01070329|588144249|FG001|Overall Study|Physician Decision|1|||
162845675|NCT01070329|588144248|FG000|Overall Study|Entry Criteria Not Met|1|||
162845676|NCT01070329|588144249|FG001|Overall Study|Entry Criteria Not Met|0|||
162845677|NCT01070329|588144248|FG000|Overall Study|Sponsor Decision|0|||
162845678|NCT01070329|588144249|FG001|Overall Study|Sponsor Decision|1|||
162845679|NCT02863848|588144250|FG000|Overall Study|Lost to Follow-up|1|||
162845680|NCT02863848|588144251|FG001|Overall Study|Lost to Follow-up|1|||
162845681|NCT02863848|588144250|FG000|Overall Study|Protocol Violation|1|||
162845682|NCT02863848|588144251|FG001|Overall Study|Protocol Violation|2|||
162845683|NCT03980938|588144255|FG000|Treatment Period 1|Study Terminated|1|||
162845684|NCT03980938|588144256|FG001|Treatment Period 1|Study Terminated|1|||
162845685|NCT03980938|588144255|FG000|Treatment Period 2|Study Terminated|2|||
162845686|NCT03980938|588144256|FG001|Treatment Period 2|Study Terminated|2|||
162845687|NCT03706365|588144258|FG000|Overall Study|Lost to Follow-up|7|||
162845688|NCT03706365|588144259|FG001|Overall Study|Lost to Follow-up|0|||
162845689|NCT03706365|588144258|FG000|Overall Study|Withdrawal by Subject|17|||
162845690|NCT03706365|588144259|FG001|Overall Study|Withdrawal by Subject|15|||
162845691|NCT03706365|588144258|FG000|Overall Study|On Study Treatment|51|||
162845692|NCT03706365|588144259|FG001|Overall Study|On Study Treatment|51|||
162845693|NCT04557384|588144260|FG000|Overall Study|Study Terminated by Sponsor|1|||
162845694|NCT04557384|588144260|FG000|Overall Study|Death|1|||
163043113|NCT01059773|588865716|FG001|Overall Study|Pregnancy|1|||
163043114|NCT01059773|588865715|FG000|Overall Study|Protocol Violation|6|||
163043115|NCT01059773|588865716|FG001|Overall Study|Protocol Violation|2|||
163043116|NCT01059773|588865715|FG000|Overall Study|Physician Decision|5|||
163043117|NCT01059773|588865716|FG001|Overall Study|Physician Decision|4|||
162845695|NCT00254566|588144264|FG000|Overall Study|Death|1|||
162845696|NCT00254566|588144265|FG001|Overall Study|Death|0|||
162845697|NCT00254566|588144264|FG000|Overall Study|Adverse Event|5|||
162845698|NCT00254566|588144265|FG001|Overall Study|Adverse Event|4|||
162845699|NCT00254566|588144264|FG000|Overall Study|Lack of Efficacy|12|||
162845700|NCT00254566|588144265|FG001|Overall Study|Lack of Efficacy|9|||
162845701|NCT00254566|588144264|FG000|Overall Study|Other|1|||
162845702|NCT00254566|588144265|FG001|Overall Study|Other|5|||
163043118|NCT01059773|588865715|FG000|Overall Study|Lack of Efficacy|3|||
163043119|NCT01059773|588865716|FG001|Overall Study|Lack of Efficacy|3|||
162845703|NCT00254566|588144264|FG000|Overall Study|Withdrawal by Subject|5|||
162845704|NCT00254566|588144265|FG001|Overall Study|Withdrawal by Subject|6|||
162845705|NCT00254566|588144264|FG000|Overall Study|Lost to Follow-up|7|||
162845706|NCT00254566|588144265|FG001|Overall Study|Lost to Follow-up|2|||
162845707|NCT00059202|588144268|FG000|Overall Study|Withdrawal by Subject|5|||
162845708|NCT00059202|588144269|FG001|Overall Study|Withdrawal by Subject|9|||
162845709|NCT00059202|588144268|FG000|Overall Study|Protocol Violation|1|||
163043120|NCT01059773|588865715|FG000|Overall Study|Death|0|||
162845710|NCT00059202|588144269|FG001|Overall Study|Protocol Violation|3|||
162845711|NCT00059202|588144268|FG000|Overall Study|drug toxicity|0|||
162845712|NCT00059202|588144269|FG001|Overall Study|drug toxicity|3|||
162845713|NCT00841763|588144272|FG000|Overall Study|Withdrawal by Subject|60|||
162845714|NCT00841763|588144273|FG001|Overall Study|Withdrawal by Subject|17|||
162845715|NCT00841763|588144274|FG002|Overall Study|Withdrawal by Subject|4|||
162845716|NCT00841763|588144275|FG003|Overall Study|Withdrawal by Subject|1|||
162845717|NCT00841763|588144272|FG000|Overall Study|Adverse Event|9|||
162845718|NCT00841763|588144273|FG001|Overall Study|Adverse Event|10|||
162845719|NCT00841763|588144274|FG002|Overall Study|Adverse Event|3|||
162845720|NCT00841763|588144275|FG003|Overall Study|Adverse Event|2|||
162845721|NCT00841763|588144272|FG000|Overall Study|Lost to Follow-up|63|||
162845722|NCT00841763|588144273|FG001|Overall Study|Lost to Follow-up|25|||
162845723|NCT00841763|588144274|FG002|Overall Study|Lost to Follow-up|0|||
162845724|NCT00841763|588144275|FG003|Overall Study|Lost to Follow-up|0|||
162845725|NCT00841763|588144272|FG000|Overall Study|Protocol Violation|20|||
162845726|NCT00841763|588144273|FG001|Overall Study|Protocol Violation|3|||
162845727|NCT00841763|588144274|FG002|Overall Study|Protocol Violation|1|||
162845728|NCT00841763|588144275|FG003|Overall Study|Protocol Violation|0|||
162845729|NCT00841763|588144272|FG000|Overall Study|Administrative Reasons|3|||
162845730|NCT00841763|588144273|FG001|Overall Study|Administrative Reasons|1|||
162845731|NCT00841763|588144274|FG002|Overall Study|Administrative Reasons|0|||
162845732|NCT00841763|588144275|FG003|Overall Study|Administrative Reasons|0|||
162845733|NCT00841763|588144272|FG000|Overall Study|Unable to Classify|7|||
162845734|NCT00841763|588144273|FG001|Overall Study|Unable to Classify|1|||
162845735|NCT00841763|588144274|FG002|Overall Study|Unable to Classify|0|||
162845736|NCT00841763|588144275|FG003|Overall Study|Unable to Classify|0|||
162845737|NCT00400400|588144276|FG000|Overall Study|Adverse Event|9|||
162845738|NCT00400400|588144277|FG001|Overall Study|Adverse Event|8|||
162845739|NCT00400400|588144276|FG000|Overall Study|Protocol Violation|2|||
162845740|NCT00400400|588144277|FG001|Overall Study|Protocol Violation|0|||
162845741|NCT00400400|588144276|FG000|Overall Study|Withdrawal by Subject|1|||
162845742|NCT00400400|588144277|FG001|Overall Study|Withdrawal by Subject|3|||
162845743|NCT00400400|588144276|FG000|Overall Study|Administrative Problem|1|||
162845744|NCT00400400|588144277|FG001|Overall Study|Administrative Problem|0|||
162845745|NCT00400400|588144276|FG000|Overall Study|Lost to Follow-up|0|||
162845746|NCT00400400|588144277|FG001|Overall Study|Lost to Follow-up|1|||
162845747|NCT00400400|588144276|FG000|Overall Study|Did not receive study drug|1|||
162845748|NCT00400400|588144277|FG001|Overall Study|Did not receive study drug|3|||
162845749|NCT01688050|588144278|FG000|Overall Study|Death|7|||
162845750|NCT01688050|588144278|FG000|Overall Study|Conversion to open repair|1|||
162845751|NCT01688050|588144278|FG000|Overall Study|Lost to Follow-up|13|||
162845752|NCT01688050|588144278|FG000|Overall Study|Withdrawal by Subject|10|||
162845753|NCT04303000|588144285|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
162845754|NCT04303000|588144286|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
162845755|NCT04303000|588144287|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
162845756|NCT03118947|588144290|FG000|Overall Study|Adverse Event|7|||
162845757|NCT03118947|588144290|FG000|Overall Study|Death|3|||
162845758|NCT03118947|588144290|FG000|Overall Study|Lack of Efficacy|4|||
162845759|NCT03118947|588144290|FG000|Overall Study|Non-compliance with study drug|1|||
162845760|NCT03118947|588144290|FG000|Overall Study|Protocol Violation|2|||
162845761|NCT03118947|588144290|FG000|Overall Study|Withdrawal by Subject|3|||
162845762|NCT03118947|588144290|FG000|Overall Study|Withdrawal by caregiver|3|||
162845763|NCT03118947|588144290|FG000|Overall Study|Change in patient's living situation|4|||
162845764|NCT03118947|588144290|FG000|Overall Study|Lost to Follow-up|2|||
162845765|NCT02769624|588144291|FG000|Overall Study|Lost to Follow-up|0|||
162845766|NCT02769624|588144292|FG001|Overall Study|Lost to Follow-up|1|||
162845767|NCT01987908|588144301|FG000|Placebo Lead-in Period|Adverse Event|2|||
162845768|NCT01987908|588144302|FG001|Placebo Lead-in Period|Adverse Event|0|||
162845769|NCT01987908|588144303|FG002|Placebo Lead-in Period|Adverse Event|0|||
162845770|NCT01987908|588144301|FG000|Placebo Lead-in Period|Physician Decision|2|||
162845771|NCT01987908|588144302|FG001|Placebo Lead-in Period|Physician Decision|0|||
162845772|NCT01987908|588144303|FG002|Placebo Lead-in Period|Physician Decision|0|||
162845773|NCT01987908|588144301|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
162845774|NCT01987908|588144302|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
162845775|NCT01987908|588144303|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
162845776|NCT01987908|588144301|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
162702063|NCT01349907|587619811|FG001|Overall Study|Withdrawal by Subject|8|||
162702064|NCT01349907|587619810|FG000|Overall Study|Protocol Violation|33|||
162702065|NCT01349907|587619811|FG001|Overall Study|Protocol Violation|13|||
162702066|NCT01349907|587619810|FG000|Overall Study|Administrative|1|||
162702067|NCT01349907|587619811|FG001|Overall Study|Administrative|1|||
162702068|NCT03583541|587619819|FG000|Overall Study|Lost to Follow-up|31|||
162702069|NCT03583541|587619820|FG001|Overall Study|Lost to Follow-up|65|||
162702070|NCT00884286|587619821|FG000|Overall Study|Progressive disease|21|||
162702071|NCT00884286|587619822|FG001|Overall Study|Progressive disease|28|||
162702072|NCT00884286|587619821|FG000|Overall Study|Toxicity|4|||
162702073|NCT00884286|587619822|FG001|Overall Study|Toxicity|1|||
162702074|NCT00884286|587619821|FG000|Overall Study|Death|2|||
162702075|NCT00884286|587619822|FG001|Overall Study|Death|2|||
162702076|NCT00884286|587619821|FG000|Overall Study|Physician Decision|1|||
162702077|NCT00884286|587619822|FG001|Overall Study|Physician Decision|0|||
162702078|NCT00884286|587619821|FG000|Overall Study|Septic shock|1|||
162702079|NCT00884286|587619822|FG001|Overall Study|Septic shock|0|||
162702080|NCT00884286|587619821|FG000|Overall Study|Thrombus in right auricle|1|||
162702081|NCT00884286|587619822|FG001|Overall Study|Thrombus in right auricle|0|||
162702082|NCT00884286|587619821|FG000|Overall Study|Not treated|2|||
162702083|NCT00884286|587619822|FG001|Overall Study|Not treated|1|||
162702084|NCT00884286|587619821|FG000|Overall Study|Comprised lung carcinoma|0|||
162702085|NCT00884286|587619822|FG001|Overall Study|Comprised lung carcinoma|1|||
162702086|NCT00594932|587619824|FG000|First 3 Months|Withdrawal by Subject|1|||
162702087|NCT00594932|587619825|FG001|First 3 Months|Withdrawal by Subject|3|||
162702088|NCT00594932|587619824|FG000|Final 3 Months|Withdrawal by Subject|4|||
162702089|NCT00594932|587619825|FG001|Final 3 Months|Withdrawal by Subject|3|||
162702090|NCT00088205|587619826|FG000|Overall Study|Adverse Event|4|||
162702091|NCT00088205|587619826|FG000|Overall Study|Progressive Disease|51|||
162702092|NCT00088205|587619826|FG000|Overall Study|Physician Decision|1|||
162702093|NCT00088205|587619826|FG000|Overall Study|Death Due to Study Disease|4|||
162702094|NCT05199233|587619827|FG000|Overall Study|Lack of Efficacy|1|||
162702095|NCT02491892|587619834|FG000|Overall Study|Adverse Event|1|||
162702096|NCT02491892|587619835|FG001|Overall Study|Adverse Event|1|||
162702097|NCT02491892|587619834|FG000|Overall Study|Death|1|||
162702098|NCT02491892|587619835|FG001|Overall Study|Death|1|||
162702099|NCT02491892|587619834|FG000|Overall Study|Lack of Efficacy|37|||
162702100|NCT02491892|587619835|FG001|Overall Study|Lack of Efficacy|36|||
162702101|NCT02491892|587619834|FG000|Overall Study|Refused Treatment|1|||
162702102|NCT02491892|587619835|FG001|Overall Study|Refused Treatment|0|||
162702103|NCT02491892|587619834|FG000|Overall Study|Lost to Follow-up|1|||
162702104|NCT02491892|587619835|FG001|Overall Study|Lost to Follow-up|0|||
162702105|NCT02982720|587619836|FG000|Overall Study|Adverse Event|3|||
162702106|NCT02982720|587619836|FG000|Overall Study|Death|1|||
162702107|NCT01734850|587619841|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
162702108|NCT01734850|587619842|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
162702109|NCT01734850|587619843|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
162702110|NCT01734850|587619841|FG000|Overall Study|Not infused due to manufacturing failure|0|||
162702111|NCT01734850|587619842|FG001|Overall Study|Not infused due to manufacturing failure|0|||
162702112|NCT01734850|587619843|FG002|Overall Study|Not infused due to manufacturing failure|1|||
162702113|NCT00681187|587619847|FG000|Overall Study|Withdrawal by Subject|1|||
162702114|NCT00681187|587619848|FG001|Overall Study|Withdrawal by Subject|0|||
162702115|NCT00681187|587619847|FG000|Overall Study|Death|0|||
162702116|NCT00681187|587619848|FG001|Overall Study|Death|1|||
162702117|NCT00681187|587619847|FG000|Overall Study|Adverse Event|0|||
162702118|NCT00681187|587619848|FG001|Overall Study|Adverse Event|1|||
162702119|NCT03619174|587619849|FG000|Overall Study|Lost to Follow-up|3|||
162702120|NCT03619174|587619850|FG001|Overall Study|Lost to Follow-up|0|||
162702121|NCT03619174|587619849|FG000|Overall Study|Withdrawal by Subject|4|||
162702122|NCT03619174|587619850|FG001|Overall Study|Withdrawal by Subject|3|||
162702123|NCT03619174|587619849|FG000|Overall Study|Pregnancy|1|||
162702124|NCT03619174|587619850|FG001|Overall Study|Pregnancy|1|||
162845777|NCT01987908|588144302|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
162702125|NCT03619174|587619849|FG000|Overall Study|Discomfort during treatment|1|||
162702126|NCT03619174|587619850|FG001|Overall Study|Discomfort during treatment|0|||
162702127|NCT02448719|587619857|FG000|Overall Study|Withdrawal by Subject|0|||
162702128|NCT02448719|587619858|FG001|Overall Study|Withdrawal by Subject|0|||
162702129|NCT02448719|587619859|FG002|Overall Study|Withdrawal by Subject|0|||
162702130|NCT02448719|587619860|FG003|Overall Study|Withdrawal by Subject|0|||
162702131|NCT02448719|587619861|FG004|Overall Study|Withdrawal by Subject|1|||
162702132|NCT02448719|587619862|FG005|Overall Study|Withdrawal by Subject|0|||
162702133|NCT02448719|587619863|FG006|Overall Study|Withdrawal by Subject|0|||
162702134|NCT02448719|587619864|FG007|Overall Study|Withdrawal by Subject|0|||
162702135|NCT02448719|587619865|FG008|Overall Study|Withdrawal by Subject|0|||
162702136|NCT02448719|587619866|FG009|Overall Study|Withdrawal by Subject|0|||
162702137|NCT02448719|587619867|FG010|Overall Study|Withdrawal by Subject|0|||
162702138|NCT04707391|587619870|FG000|Overall Study|Adverse Event|5|||
162702139|NCT04707391|587619871|FG001|Overall Study|Adverse Event|8|||
162845778|NCT01987908|588144303|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
162845779|NCT01987908|588144301|FG000|Treatment Period|Adverse Event|0|||
162845780|NCT01987908|588144302|FG001|Treatment Period|Adverse Event|1|||
162845781|NCT01987908|588144303|FG002|Treatment Period|Adverse Event|1|||
162845782|NCT01987908|588144301|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
162845783|NCT01987908|588144302|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
162845784|NCT01987908|588144303|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
162845785|NCT01987908|588144301|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
162845786|NCT01987908|588144302|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
162845787|NCT01987908|588144303|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
162845788|NCT01869348|588144304|FG000|Overall Study|Withdrawal by Subject|1|||
162845789|NCT01869348|588144305|FG001|Overall Study|Withdrawal by Subject|1|||
162845790|NCT01728779|588144307|FG000|Overall Study|Withdrawal by Subject|1|||
162845791|NCT02789657|588144308|FG000|Overall Study|Withdrawal by Subject|2|||
162845792|NCT02789657|588144309|FG001|Overall Study|Withdrawal by Subject|0|||
162845793|NCT02789657|588144310|FG002|Overall Study|Withdrawal by Subject|0|||
162845794|NCT02789657|588144311|FG003|Overall Study|Withdrawal by Subject|0|||
162845795|NCT00448708|588144312|FG000|Overall Study|Death|21|||
162845796|NCT00448708|588144313|FG001|Overall Study|Death|17|||
162845797|NCT00448708|588144312|FG000|Overall Study|Withdrawal by Subject|8|||
162845798|NCT00448708|588144313|FG001|Overall Study|Withdrawal by Subject|4|||
162845799|NCT00448708|588144312|FG000|Overall Study|Lost to Follow-up|6|||
162845800|NCT00448708|588144313|FG001|Overall Study|Lost to Follow-up|8|||
162845801|NCT00448708|588144312|FG000|Overall Study|not listed|0|||
162845802|NCT00448708|588144313|FG001|Overall Study|not listed|2|||
162845803|NCT01925209|588144314|FG000|Treatment Epoch|Physician Decision|1|||
162845804|NCT01925209|588144315|FG001|Treatment Epoch|Physician Decision|0|||
162845805|NCT01925209|588144316|FG002|Treatment Epoch|Physician Decision|0|||
162845806|NCT01925209|588144317|FG003|Treatment Epoch|Physician Decision|0|||
162845807|NCT01925209|588144314|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
162845808|NCT01925209|588144315|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
162845809|NCT01925209|588144316|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
162845810|NCT01925209|588144317|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
162845811|NCT01925209|588144314|FG000|Treatment Epoch|Death|1|||
162845812|NCT01925209|588144315|FG001|Treatment Epoch|Death|0|||
162845813|NCT01925209|588144316|FG002|Treatment Epoch|Death|0|||
162845814|NCT01925209|588144317|FG003|Treatment Epoch|Death|0|||
162845815|NCT01925209|588144314|FG000|Treatment Epoch|Protocol deviation|0|||
162845816|NCT01925209|588144315|FG001|Treatment Epoch|Protocol deviation|0|||
162845817|NCT01925209|588144316|FG002|Treatment Epoch|Protocol deviation|1|||
162845818|NCT01925209|588144317|FG003|Treatment Epoch|Protocol deviation|1|||
162845819|NCT01925209|588144314|FG000|Treatment Epoch|Withdrawal by Subject|4|||
162845820|NCT01925209|588144315|FG001|Treatment Epoch|Withdrawal by Subject|3|||
162845821|NCT01925209|588144316|FG002|Treatment Epoch|Withdrawal by Subject|3|||
162845822|NCT01925209|588144317|FG003|Treatment Epoch|Withdrawal by Subject|2|||
162845823|NCT01925209|588144314|FG000|Treatment Epoch|Adverse Event|3|||
162845824|NCT01925209|588144315|FG001|Treatment Epoch|Adverse Event|5|||
162845825|NCT01925209|588144316|FG002|Treatment Epoch|Adverse Event|3|||
162845826|NCT01925209|588144317|FG003|Treatment Epoch|Adverse Event|1|||
162845827|NCT01925209|588144314|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
162845828|NCT01925209|588144315|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
162845829|NCT01925209|588144316|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
162845830|NCT01925209|588144317|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
162702140|NCT04707391|587619870|FG000|Overall Study|Lost to Follow-up|44|||
162702141|NCT04707391|587619871|FG001|Overall Study|Lost to Follow-up|31|||
162702142|NCT04707391|587619870|FG000|Overall Study|Protocol Violation|1|||
162702143|NCT04707391|587619871|FG001|Overall Study|Protocol Violation|5|||
162845831|NCT01925209|588144314|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
162845832|NCT01925209|588144315|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
162845833|NCT01925209|588144316|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
162845834|NCT01925209|588144317|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
162845835|NCT01925209|588144314|FG000|Follow-up|Adverse Event|1|||
162845836|NCT01925209|588144315|FG001|Follow-up|Adverse Event|4|||
162845837|NCT01925209|588144316|FG002|Follow-up|Adverse Event|0|||
162845838|NCT01925209|588144317|FG003|Follow-up|Adverse Event|1|||
162845839|NCT01925209|588144314|FG000|Follow-up|Physician Decision|0|||
162845840|NCT01925209|588144315|FG001|Follow-up|Physician Decision|0|||
162845841|NCT01925209|588144316|FG002|Follow-up|Physician Decision|1|||
162845842|NCT01925209|588144317|FG003|Follow-up|Physician Decision|0|||
162845843|NCT01925209|588144314|FG000|Follow-up|Non-compliance with study treatment|0|||
162702144|NCT04707391|587619870|FG000|Overall Study|Withdrawal by Subject|27|||
162845844|NCT01925209|588144315|FG001|Follow-up|Non-compliance with study treatment|0|||
162845845|NCT01925209|588144316|FG002|Follow-up|Non-compliance with study treatment|0|||
162845846|NCT01925209|588144317|FG003|Follow-up|Non-compliance with study treatment|1|||
162845847|NCT01925209|588144314|FG000|Follow-up|Withdrawal by Subject|0|||
162845848|NCT01925209|588144315|FG001|Follow-up|Withdrawal by Subject|2|||
162845849|NCT01925209|588144316|FG002|Follow-up|Withdrawal by Subject|0|||
163043121|NCT01059773|588865716|FG001|Overall Study|Death|1|||
163043122|NCT01059773|588865715|FG000|Overall Study|Malignancy including squamous cell skin|0|||
163043123|NCT01059773|588865716|FG001|Overall Study|Malignancy including squamous cell skin|1|||
162845850|NCT01925209|588144317|FG003|Follow-up|Withdrawal by Subject|2|||
162845851|NCT01299727|588144318|FG000|Overall Study|Withdrawal by Subject|1|||
162845852|NCT01299727|588144319|FG001|Overall Study|Withdrawal by Subject|0|||
163043124|NCT01059773|588865715|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
163043125|NCT01059773|588865716|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
163043126|NCT01059773|588865715|FG000|Overall Study|Other|1|||
163043127|NCT01059773|588865716|FG001|Overall Study|Other|3|||
163043128|NCT01806168|588865719|FG000|Overall Study|Adverse Event|1|||
163043129|NCT01806168|588865720|FG001|Overall Study|Adverse Event|0|||
163043130|NCT01806168|588865721|FG002|Overall Study|Adverse Event|0|||
163043131|NCT01806168|588865719|FG000|Overall Study|Withdrawal by Subject|0|||
163043132|NCT01806168|588865720|FG001|Overall Study|Withdrawal by Subject|1|||
163043133|NCT01806168|588865721|FG002|Overall Study|Withdrawal by Subject|2|||
163043134|NCT01806168|588865719|FG000|Overall Study|Protocol Violation|0|||
163043135|NCT01806168|588865720|FG001|Overall Study|Protocol Violation|0|||
163043136|NCT01806168|588865721|FG002|Overall Study|Protocol Violation|1|||
163043137|NCT02620787|588865724|FG000|Overall Study|Adverse Event|1|||
163043138|NCT02620787|588865725|FG001|Overall Study|Adverse Event|0|||
163043139|NCT02620787|588865724|FG000|Overall Study|Eligibility Criteria Not Met|1|||
163043140|NCT02620787|588865725|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163043141|NCT01462630|588865728|FG000|Overall Study|Did not initiate therapy|3|||
163043142|NCT01462630|588865728|FG000|Overall Study|Death|1|||
163043143|NCT01462630|588865728|FG000|Overall Study|Protocol Violation|2|||
163043144|NCT01462630|588865728|FG000|Overall Study|Adverse Event|1|||
163043145|NCT03665077|588865729|FG000|Overall Study|Lost to Follow-up|2|||
163043146|NCT03665077|588865729|FG000|Overall Study|Physician Decision|2|||
163043147|NCT02364388|588865730|FG000|Overall Study|Protocol Violation|1|||
163043148|NCT02364388|588865730|FG000|Overall Study|Technical Failure|3|||
163043149|NCT02364388|588865730|FG000|Overall Study|No OA/US data|2|||
163043150|NCT02364388|588865730|FG000|Overall Study|No Biopsy|2|||
163043151|NCT00837967|588865731|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
163043152|NCT00837967|588865732|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
163043153|NCT02504320|588865736|FG000|Treatment Period 1|Positive Drug Screen|0|||
163043154|NCT02504320|588865737|FG001|Treatment Period 1|Positive Drug Screen|0|||
163043155|NCT02504320|588865738|FG002|Treatment Period 1|Positive Drug Screen|1|||
163043156|NCT02504320|588865739|FG003|Treatment Period 1|Positive Drug Screen|0|||
163043157|NCT02504320|588865736|FG000|Treatment Period 2|Positive Drug Screen|0|||
163043158|NCT02504320|588865737|FG001|Treatment Period 2|Positive Drug Screen|1|||
163043159|NCT02504320|588865738|FG002|Treatment Period 2|Positive Drug Screen|0|||
163043160|NCT02504320|588865739|FG003|Treatment Period 2|Positive Drug Screen|0|||
163043161|NCT02504320|588865736|FG000|Treatment Period 3|Positive Drug Screen|0|||
163043162|NCT02504320|588865737|FG001|Treatment Period 3|Positive Drug Screen|0|||
163043163|NCT02504320|588865738|FG002|Treatment Period 3|Positive Drug Screen|0|||
163043164|NCT02504320|588865739|FG003|Treatment Period 3|Positive Drug Screen|1|||
163043165|NCT02504320|588865736|FG000|Treatment Period 3|Adverse Event|0|||
163043166|NCT02504320|588865737|FG001|Treatment Period 3|Adverse Event|0|||
163043167|NCT02504320|588865738|FG002|Treatment Period 3|Adverse Event|1|||
163043168|NCT02504320|588865739|FG003|Treatment Period 3|Adverse Event|0|||
163043169|NCT02497404|588865742|FG000|Overall Study|Adverse Event|1|||
163043170|NCT01408901|588865743|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
163043171|NCT01408901|588865744|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
163043172|NCT01408901|588865745|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
163043173|NCT01408901|588865746|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
163043174|NCT01408901|588865743|FG000|6-Week Follow-Up|Death|1|||
163043175|NCT01408901|588865744|FG001|6-Week Follow-Up|Death|0|||
163043176|NCT01408901|588865745|FG002|6-Week Follow-Up|Death|0|||
163043177|NCT01408901|588865746|FG003|6-Week Follow-Up|Death|0|||
163043178|NCT01408901|588865743|FG000|6-Week Follow-Up|Cancelled visit|0|||
163043179|NCT01408901|588865744|FG001|6-Week Follow-Up|Cancelled visit|1|||
163043180|NCT01408901|588865745|FG002|6-Week Follow-Up|Cancelled visit|0|||
163043181|NCT01408901|588865746|FG003|6-Week Follow-Up|Cancelled visit|2|||
163043182|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043183|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043184|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
163043185|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
163043186|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
163043187|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043188|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043189|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
163043190|NCT01408901|588865743|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
163043191|NCT01408901|588865744|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
162845853|NCT01299727|588144320|FG002|Overall Study|Withdrawal by Subject|0|||
162845854|NCT01299727|588144318|FG000|Overall Study|Adverse Event|0|||
162845855|NCT01299727|588144319|FG001|Overall Study|Adverse Event|0|||
162845856|NCT01299727|588144320|FG002|Overall Study|Adverse Event|1|||
162845857|NCT01299727|588144318|FG000|Overall Study|Completed the Treatment Period|3|||
162845858|NCT01299727|588144319|FG001|Overall Study|Completed the Treatment Period|4|||
162845859|NCT01299727|588144320|FG002|Overall Study|Completed the Treatment Period|3|||
162845860|NCT03882424|588144321|FG000|Overall Study|Lost to Follow-up|3|||
162845861|NCT03882424|588144322|FG001|Overall Study|Lost to Follow-up|0|||
162845862|NCT03882424|588144323|FG002|Overall Study|Lost to Follow-up|0|||
162845863|NCT03882424|588144321|FG000|Overall Study|schedule conflict|1|||
162845864|NCT03882424|588144322|FG001|Overall Study|schedule conflict|0|||
162845865|NCT03882424|588144323|FG002|Overall Study|schedule conflict|0|||
162845866|NCT02772757|588144325|FG000|Overall Study|Withdrawal by Subject|1|||
162845867|NCT02772757|588144326|FG001|Overall Study|Withdrawal by Subject|0|||
162845868|NCT02772757|588144327|FG002|Overall Study|Withdrawal by Subject|1|||
162845869|NCT02772757|588144325|FG000|Overall Study|Protocol Violation|0|||
162845870|NCT02772757|588144326|FG001|Overall Study|Protocol Violation|0|||
162845871|NCT02772757|588144327|FG002|Overall Study|Protocol Violation|1|||
162845872|NCT02772757|588144325|FG000|Overall Study|Physician Decision|0|||
162845873|NCT02772757|588144326|FG001|Overall Study|Physician Decision|3|||
162845874|NCT02772757|588144327|FG002|Overall Study|Physician Decision|3|||
162845875|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Adverse Event|21|||
162845876|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Adverse Event|6|||
162845877|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
162845878|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
162845879|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
162845880|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
162845881|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
162845882|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
162845883|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Physician Decision|0|||
162845884|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Physician Decision|3|||
162845885|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
162845886|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
162845887|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
162845888|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
162845889|NCT00510276|588144334|FG000|Acute Double-Blind Phase|Subject Decision|26|||
162845890|NCT00510276|588144335|FG001|Acute Double-Blind Phase|Subject Decision|28|||
162845891|NCT00510276|588144334|FG000|Extension Open-Label Phase|Adverse Event|9|||
162845892|NCT00510276|588144335|FG001|Extension Open-Label Phase|Adverse Event|18|||
162845893|NCT00510276|588144334|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
162845894|NCT00510276|588144335|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
162845895|NCT00510276|588144334|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
162845896|NCT00510276|588144335|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
163043192|NCT01408901|588865745|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
163043193|NCT01408901|588865746|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
163043194|NCT01408901|588865743|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
163043195|NCT01408901|588865744|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
163043196|NCT01408901|588865745|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
163043197|NCT01408901|588865746|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
163043198|NCT01408901|588865743|FG000|26-Week Follow-Up|Death|0|||
163043199|NCT01408901|588865744|FG001|26-Week Follow-Up|Death|1|||
163043200|NCT01408901|588865745|FG002|26-Week Follow-Up|Death|0|||
163043201|NCT01408901|588865746|FG003|26-Week Follow-Up|Death|0|||
163043202|NCT02098395|588865749|FG000|Overall Study|Protocol Violation|2|||
163043203|NCT02098395|588865750|FG001|Overall Study|Protocol Violation|2|||
163043204|NCT02098395|588865751|FG002|Overall Study|Protocol Violation|0|||
163043205|NCT02098395|588865752|FG003|Overall Study|Protocol Violation|7|||
163043206|NCT02098395|588865749|FG000|Overall Study|Withdrawal by Subject|10|||
163043207|NCT02098395|588865750|FG001|Overall Study|Withdrawal by Subject|10|||
163043208|NCT02098395|588865751|FG002|Overall Study|Withdrawal by Subject|5|||
162845897|NCT00510276|588144334|FG000|Extension Open-Label Phase|Physician Decision|2|||
163043209|NCT02098395|588865752|FG003|Overall Study|Withdrawal by Subject|13|||
163043210|NCT02098395|588865749|FG000|Overall Study|Adverse Event|12|||
162845898|NCT00510276|588144335|FG001|Extension Open-Label Phase|Physician Decision|3|||
162845899|NCT00510276|588144334|FG000|Extension Open-Label Phase|Protocol Violation|0|||
163043211|NCT02098395|588865750|FG001|Overall Study|Adverse Event|19|||
162845900|NCT00510276|588144335|FG001|Extension Open-Label Phase|Protocol Violation|1|||
162845901|NCT00510276|588144334|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
162845902|NCT00510276|588144335|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
162845903|NCT00510276|588144334|FG000|Extension Open-Label Phase|Subject Decision|7|||
163043212|NCT02098395|588865751|FG002|Overall Study|Adverse Event|34|||
163043213|NCT02098395|588865752|FG003|Overall Study|Adverse Event|2|||
163043214|NCT02098395|588865749|FG000|Overall Study|Lost to Follow-up|2|||
163043215|NCT02098395|588865750|FG001|Overall Study|Lost to Follow-up|1|||
163043216|NCT02098395|588865751|FG002|Overall Study|Lost to Follow-up|0|||
163043217|NCT02098395|588865752|FG003|Overall Study|Lost to Follow-up|3|||
162702145|NCT04707391|587619871|FG001|Overall Study|Withdrawal by Subject|25|||
162702146|NCT04707391|587619870|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
162702147|NCT04707391|587619871|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
162702148|NCT04707391|587619870|FG000|Overall Study|Other|0|||
162702149|NCT04707391|587619871|FG001|Overall Study|Other|2|||
162702150|NCT01406717|587619874|FG000|Overall Study|Subject non-compliance|4|||
162702151|NCT01406717|587619875|FG001|Overall Study|Subject non-compliance|3|||
162702152|NCT01406717|587619874|FG000|Overall Study|Protocol Violation|5|||
162702153|NCT01406717|587619875|FG001|Overall Study|Protocol Violation|1|||
162702154|NCT01406717|587619874|FG000|Overall Study|Lost to Follow-up|14|||
162702155|NCT01406717|587619875|FG001|Overall Study|Lost to Follow-up|8|||
162702156|NCT01406717|587619874|FG000|Overall Study|Withdrawal by Subject|19|||
162702157|NCT01406717|587619875|FG001|Overall Study|Withdrawal by Subject|15|||
162702158|NCT01406717|587619874|FG000|Overall Study|Adverse Event|1|||
162702159|NCT01406717|587619875|FG001|Overall Study|Adverse Event|2|||
162702160|NCT01406717|587619874|FG000|Overall Study|Lack of Efficacy|0|||
162702161|NCT01406717|587619875|FG001|Overall Study|Lack of Efficacy|1|||
162702162|NCT01406717|587619874|FG000|Overall Study|Non-completion of visit activity|0|||
162702163|NCT01406717|587619875|FG001|Overall Study|Non-completion of visit activity|1|||
162702164|NCT02040090|587619876|FG000|Overall Study|Adverse Event|2|||
162702165|NCT02040090|587619877|FG001|Overall Study|Adverse Event|0|||
162702166|NCT02040090|587619876|FG000|Overall Study|Physician Decision|1|||
162702167|NCT02040090|587619877|FG001|Overall Study|Physician Decision|0|||
162702168|NCT02040090|587619876|FG000|Overall Study|Withdrawal by Subject|0|||
162702169|NCT02040090|587619877|FG001|Overall Study|Withdrawal by Subject|1|||
162702170|NCT02040090|587619876|FG000|Overall Study|Lost to Follow-up|0|||
162702171|NCT02040090|587619877|FG001|Overall Study|Lost to Follow-up|1|||
162702172|NCT02275533|587619880|FG000|Overall Study|Protocol Violation|2|||
162702173|NCT02275533|587619881|FG001|Overall Study|Protocol Violation|0|||
162702174|NCT02275533|587619880|FG000|Overall Study|Never received study treatment|1|||
162702175|NCT02275533|587619881|FG001|Overall Study|Never received study treatment|0|||
162702176|NCT01570868|587619882|FG000|Overall Study|Adverse Event|8|||
162702177|NCT01570868|587619883|FG001|Overall Study|Adverse Event|1|||
162702178|NCT01570868|587619882|FG000|Overall Study|FDA Recommendation|23|||
162702179|NCT01570868|587619883|FG001|Overall Study|FDA Recommendation|3|||
162702180|NCT01570868|587619882|FG000|Overall Study|Physician Decision|10|||
162702181|NCT01570868|587619883|FG001|Overall Study|Physician Decision|4|||
162702182|NCT01570868|587619882|FG000|Overall Study|Lost to Follow-up|1|||
162702183|NCT01570868|587619883|FG001|Overall Study|Lost to Follow-up|0|||
162702184|NCT01570868|587619882|FG000|Overall Study|Withdrawal by Subject|1|||
162702185|NCT01570868|587619883|FG001|Overall Study|Withdrawal by Subject|0|||
162702186|NCT03370276|587619884|FG000|Overall Study|Death|0|||
162702187|NCT03370276|587619885|FG001|Overall Study|Death|2|||
162702188|NCT03370276|587619886|FG002|Overall Study|Death|5|||
162702189|NCT01556763|587619892|FG000|Overall Study|Withdrawal by Subject|0|||
162702190|NCT01556763|587619893|FG001|Overall Study|Withdrawal by Subject|1|||
162702191|NCT01556763|587619894|FG002|Overall Study|Withdrawal by Subject|0|||
162702192|NCT02258464|587619895|FG000|Overall Study|Progressive disease (PD)|9|||
162702193|NCT02258464|587619896|FG001|Overall Study|Progressive disease (PD)|17|||
162702194|NCT02258464|587619895|FG000|Overall Study|Study drug never administered|1|||
162702195|NCT02258464|587619896|FG001|Overall Study|Study drug never administered|1|||
162702196|NCT02258464|587619895|FG000|Overall Study|AE not related to clinical PD|1|||
162702197|NCT02258464|587619896|FG001|Overall Study|AE not related to clinical PD|3|||
162702198|NCT02258464|587619895|FG000|Overall Study|Withdrawal by Subject|5|||
162702199|NCT02258464|587619896|FG001|Overall Study|Withdrawal by Subject|4|||
162702200|NCT02258464|587619895|FG000|Overall Study|AE related to clinical PD|1|||
162702201|NCT02258464|587619896|FG001|Overall Study|AE related to clinical PD|0|||
162702202|NCT00932646|587619897|FG000|Overall Study|Adverse Event|2|||
162702203|NCT00932646|587619898|FG001|Overall Study|Adverse Event|1|||
162702204|NCT00932646|587619899|FG002|Overall Study|Adverse Event|1|||
162702205|NCT00932646|587619900|FG003|Overall Study|Adverse Event|1|||
162702206|NCT00932646|587619897|FG000|Overall Study|Lost to Follow-up|2|||
162702207|NCT00932646|587619898|FG001|Overall Study|Lost to Follow-up|1|||
162702208|NCT00932646|587619899|FG002|Overall Study|Lost to Follow-up|0|||
162702209|NCT00932646|587619900|FG003|Overall Study|Lost to Follow-up|0|||
162952072|NCT01954394|588529531|FG001|Overall Study|Related to Study Drug administration|2|||
162845904|NCT00510276|588144335|FG001|Extension Open-Label Phase|Subject Decision|9|||
162845905|NCT00441792|588144338|FG000|Overall Study|Lost to Follow-up|0|||
162845906|NCT00441792|588144339|FG001|Overall Study|Lost to Follow-up|2|||
162845907|NCT01731678|588144340|FG000|Overall Study|Withdrawal by Subject|3|||
162845908|NCT01731678|588144340|FG000|Overall Study|Did not meet inclusion criteria|1|||
162845909|NCT01731678|588144340|FG000|Overall Study|RMT too high, making TMS difficult|3|||
162845910|NCT00888355|588144343|FG000|Overall Study|Adverse Event|10|||
162845911|NCT00888355|588144344|FG001|Overall Study|Adverse Event|0|||
162845912|NCT00888355|588144345|FG002|Overall Study|Adverse Event|3|||
162845913|NCT00888355|588144346|FG003|Overall Study|Adverse Event|3|||
162845914|NCT00888355|588144343|FG000|Overall Study|Lack of Efficacy|9|||
162845915|NCT00888355|588144344|FG001|Overall Study|Lack of Efficacy|2|||
162845916|NCT00888355|588144345|FG002|Overall Study|Lack of Efficacy|5|||
162845917|NCT00888355|588144346|FG003|Overall Study|Lack of Efficacy|2|||
162845918|NCT00888355|588144343|FG000|Overall Study|Lost to Follow-up|0|||
162845919|NCT00888355|588144344|FG001|Overall Study|Lost to Follow-up|2|||
162845920|NCT00888355|588144345|FG002|Overall Study|Lost to Follow-up|2|||
162845921|NCT00888355|588144346|FG003|Overall Study|Lost to Follow-up|0|||
162845922|NCT00888355|588144343|FG000|Overall Study|Protocol Violation|3|||
162845923|NCT00888355|588144344|FG001|Overall Study|Protocol Violation|2|||
162845924|NCT00888355|588144345|FG002|Overall Study|Protocol Violation|1|||
162845925|NCT00888355|588144346|FG003|Overall Study|Protocol Violation|2|||
162845926|NCT00888355|588144343|FG000|Overall Study|Withdrawal by Subject|0|||
162845927|NCT00888355|588144344|FG001|Overall Study|Withdrawal by Subject|3|||
162845928|NCT00888355|588144345|FG002|Overall Study|Withdrawal by Subject|1|||
162845929|NCT00888355|588144346|FG003|Overall Study|Withdrawal by Subject|3|||
162702210|NCT00932646|587619897|FG000|Overall Study|Withdrawal by Subject|1|||
162702211|NCT00932646|587619898|FG001|Overall Study|Withdrawal by Subject|1|||
162702212|NCT00932646|587619899|FG002|Overall Study|Withdrawal by Subject|3|||
162702213|NCT00932646|587619900|FG003|Overall Study|Withdrawal by Subject|0|||
162702214|NCT00653263|587619901|FG000|Overall Study|Withdrawal by Subject|1|||
162845930|NCT03434379|588144354|FG000|Global Period|Lost to Follow-up|3|||
162845931|NCT03434379|588144355|FG001|Global Period|Lost to Follow-up|6|||
162845932|NCT03434379|588144356|FG002|Global Period|Lost to Follow-up|0|||
162845933|NCT03434379|588144357|FG003|Global Period|Lost to Follow-up|0|||
162845934|NCT03434379|588144354|FG000|Global Period|Death|115|||
162845935|NCT03434379|588144355|FG001|Global Period|Death|228|||
162845936|NCT03434379|588144356|FG002|Global Period|Death|0|||
162845937|NCT03434379|588144357|FG003|Global Period|Death|0|||
162845938|NCT03434379|588144354|FG000|Global Period|Withdrawal by Subject|20|||
162845939|NCT03434379|588144355|FG001|Global Period|Withdrawal by Subject|21|||
162845940|NCT03434379|588144356|FG002|Global Period|Withdrawal by Subject|0|||
162845941|NCT03434379|588144357|FG003|Global Period|Withdrawal by Subject|0|||
162845942|NCT03434379|588144354|FG000|Global Period|Reason Unspecified|0|||
162845943|NCT03434379|588144355|FG001|Global Period|Reason Unspecified|1|||
162845944|NCT03434379|588144356|FG002|Global Period|Reason Unspecified|0|||
162845945|NCT03434379|588144357|FG003|Global Period|Reason Unspecified|0|||
162845946|NCT03434379|588144354|FG000|Global Period|Study Ended by Sponsor|26|||
162845947|NCT03434379|588144355|FG001|Global Period|Study Ended by Sponsor|80|||
162845948|NCT03434379|588144356|FG002|Global Period|Study Ended by Sponsor|0|||
162845949|NCT03434379|588144357|FG003|Global Period|Study Ended by Sponsor|0|||
162845950|NCT03434379|588144354|FG000|Global Period|Physician Decision|1|||
162845951|NCT03434379|588144355|FG001|Global Period|Physician Decision|0|||
162845952|NCT03434379|588144356|FG002|Global Period|Physician Decision|0|||
162845953|NCT03434379|588144357|FG003|Global Period|Physician Decision|0|||
163043218|NCT02098395|588865749|FG000|Overall Study|Unclassified|0|||
163043219|NCT02098395|588865750|FG001|Overall Study|Unclassified|0|||
162845954|NCT03434379|588144354|FG000|China Extension Period|Lost to Follow-up|0|||
162845955|NCT03434379|588144355|FG001|China Extension Period|Lost to Follow-up|0|||
162702215|NCT00653263|587619901|FG000|Overall Study|Physician Decision|1|||
162702216|NCT00895843|587619902|FG000|Overall Study|Protocol Violation|12|||
162702217|NCT00895843|587619903|FG001|Overall Study|Protocol Violation|12|||
162702218|NCT04963062|587619906|FG000|Overall Study|withdrew by the study team|4|||
162702219|NCT04963062|587619907|FG001|Overall Study|withdrew by the study team|2|||
162952073|NCT01954394|588529530|FG000|Overall Study|Other than specified above|10|||
162702220|NCT04145349|587621747|FG000|Overall Study|Withdrawal by Subject|3|||
162845956|NCT03434379|588144356|FG002|China Extension Period|Lost to Follow-up|2|||
162845957|NCT03434379|588144357|FG003|China Extension Period|Lost to Follow-up|3|||
162845958|NCT03434379|588144354|FG000|China Extension Period|Death|0|||
162845959|NCT03434379|588144355|FG001|China Extension Period|Death|0|||
162845960|NCT03434379|588144356|FG002|China Extension Period|Death|46|||
162845961|NCT03434379|588144357|FG003|China Extension Period|Death|88|||
162845962|NCT03434379|588144354|FG000|China Extension Period|Withdrawal by Subject|0|||
162845963|NCT03434379|588144355|FG001|China Extension Period|Withdrawal by Subject|0|||
162845964|NCT03434379|588144356|FG002|China Extension Period|Withdrawal by Subject|8|||
162845965|NCT03434379|588144357|FG003|China Extension Period|Withdrawal by Subject|6|||
162845966|NCT03434379|588144354|FG000|China Extension Period|Study Ended by Sponsor|0|||
162845967|NCT03434379|588144355|FG001|China Extension Period|Study Ended by Sponsor|0|||
162702221|NCT04145349|587621748|FG001|Overall Study|Withdrawal by Subject|0|||
162702222|NCT04145349|587621747|FG000|Overall Study|Lost to Follow-up|0|||
162702223|NCT04145349|587621748|FG001|Overall Study|Lost to Follow-up|1|||
162702224|NCT04145349|587621747|FG000|Overall Study|On study treatment (Ongoing)|0|||
162702225|NCT04145349|587621748|FG001|Overall Study|On study treatment (Ongoing)|1|||
162702226|NCT05567952|587621749|FG000|Overall Study|Lost to Follow-up|3|||
162606907|NCT04193410|587276746|FG000|Overall Study|Lost to Follow-up|7|||
162606908|NCT04193410|587276747|FG001|Overall Study|Lost to Follow-up|6|||
162702227|NCT05567952|587621750|FG001|Overall Study|Lost to Follow-up|2|||
162702228|NCT05567952|587621749|FG000|Overall Study|Withdrawal by Subject|6|||
163043220|NCT02098395|588865751|FG002|Overall Study|Unclassified|3|||
162702229|NCT05567952|587621750|FG001|Overall Study|Withdrawal by Subject|3|||
162702230|NCT05567952|587621749|FG000|Overall Study|Other|3|||
162702231|NCT05567952|587621750|FG001|Overall Study|Other|1|||
162845968|NCT03434379|588144356|FG002|China Extension Period|Study Ended by Sponsor|5|||
162845969|NCT03434379|588144357|FG003|China Extension Period|Study Ended by Sponsor|36|||
162845970|NCT00686647|588144358|FG000|Overall Study|Lost to Follow-up|1|||
162845971|NCT00686647|588144358|FG000|Overall Study|Death|1|||
162845972|NCT03179436|588144360|FG000|Overall Study|Withdrawal by Subject|1|||
162845973|NCT03179436|588144361|FG001|Overall Study|Withdrawal by Subject|0|||
162845974|NCT03179436|588144362|FG002|Overall Study|Withdrawal by Subject|0|||
162845975|NCT03179436|588144363|FG003|Overall Study|Withdrawal by Subject|4|||
162845976|NCT03179436|588144364|FG004|Overall Study|Withdrawal by Subject|2|||
162845977|NCT03179436|588144365|FG005|Overall Study|Withdrawal by Subject|2|||
162845978|NCT03179436|588144366|FG006|Overall Study|Withdrawal by Subject|5|||
162845979|NCT03179436|588144367|FG007|Overall Study|Withdrawal by Subject|0|||
162845980|NCT03179436|588144368|FG008|Overall Study|Withdrawal by Subject|3|||
162845981|NCT03179436|588144369|FG009|Overall Study|Withdrawal by Subject|0|||
162845982|NCT03179436|588144370|FG010|Overall Study|Withdrawal by Subject|0|||
162845983|NCT03179436|588144371|FG011|Overall Study|Withdrawal by Subject|0|||
162845984|NCT03179436|588144360|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162845985|NCT03179436|588144361|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162845986|NCT03179436|588144362|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162845987|NCT03179436|588144363|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162845988|NCT03179436|588144364|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162845989|NCT03179436|588144365|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162845990|NCT03179436|588144366|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
162845991|NCT03179436|588144367|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
162845992|NCT03179436|588144368|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
162845993|NCT03179436|588144369|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
162845994|NCT03179436|588144370|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
162845995|NCT03179436|588144371|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
162845996|NCT03179436|588144360|FG000|Overall Study|Sponsor Decision|0|||
162845997|NCT03179436|588144361|FG001|Overall Study|Sponsor Decision|0|||
162845998|NCT03179436|588144362|FG002|Overall Study|Sponsor Decision|1|||
162845999|NCT03179436|588144363|FG003|Overall Study|Sponsor Decision|3|||
162846000|NCT03179436|588144364|FG004|Overall Study|Sponsor Decision|9|||
162846001|NCT03179436|588144365|FG005|Overall Study|Sponsor Decision|7|||
162846002|NCT03179436|588144366|FG006|Overall Study|Sponsor Decision|2|||
162846003|NCT03179436|588144367|FG007|Overall Study|Sponsor Decision|4|||
162846004|NCT03179436|588144368|FG008|Overall Study|Sponsor Decision|23|||
162846005|NCT03179436|588144369|FG009|Overall Study|Sponsor Decision|6|||
162846006|NCT03179436|588144370|FG010|Overall Study|Sponsor Decision|7|||
162846007|NCT03179436|588144371|FG011|Overall Study|Sponsor Decision|5|||
162846008|NCT03179436|588144360|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846009|NCT03179436|588144361|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
162846010|NCT03179436|588144362|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846011|NCT03179436|588144363|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846012|NCT03179436|588144364|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846013|NCT03179436|588144365|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
162846014|NCT03179436|588144366|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846015|NCT03179436|588144367|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846016|NCT03179436|588144368|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846017|NCT03179436|588144369|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846018|NCT03179436|588144370|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846019|NCT03179436|588144371|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
162846020|NCT03179436|588144360|FG000|Overall Study|Lost to Follow-up|1|||
162846021|NCT03179436|588144361|FG001|Overall Study|Lost to Follow-up|0|||
162846022|NCT03179436|588144362|FG002|Overall Study|Lost to Follow-up|0|||
162846023|NCT03179436|588144363|FG003|Overall Study|Lost to Follow-up|1|||
162846024|NCT03179436|588144364|FG004|Overall Study|Lost to Follow-up|0|||
162846025|NCT03179436|588144365|FG005|Overall Study|Lost to Follow-up|1|||
162846026|NCT03179436|588144366|FG006|Overall Study|Lost to Follow-up|0|||
162846027|NCT03179436|588144367|FG007|Overall Study|Lost to Follow-up|0|||
162846028|NCT03179436|588144368|FG008|Overall Study|Lost to Follow-up|1|||
162846029|NCT03179436|588144369|FG009|Overall Study|Lost to Follow-up|1|||
162846030|NCT03179436|588144370|FG010|Overall Study|Lost to Follow-up|0|||
162846031|NCT03179436|588144371|FG011|Overall Study|Lost to Follow-up|0|||
162846032|NCT03179436|588144360|FG000|Overall Study|Death|12|||
162846033|NCT03179436|588144361|FG001|Overall Study|Death|17|||
162846034|NCT03179436|588144362|FG002|Overall Study|Death|7|||
162846035|NCT03179436|588144363|FG003|Overall Study|Death|32|||
162846036|NCT03179436|588144364|FG004|Overall Study|Death|29|||
162846037|NCT03179436|588144365|FG005|Overall Study|Death|30|||
162846038|NCT03179436|588144366|FG006|Overall Study|Death|33|||
162846039|NCT03179436|588144367|FG007|Overall Study|Death|9|||
162846040|NCT03179436|588144368|FG008|Overall Study|Death|84|||
162846041|NCT03179436|588144369|FG009|Overall Study|Death|33|||
162846042|NCT03179436|588144370|FG010|Overall Study|Death|22|||
162846043|NCT03179436|588144371|FG011|Overall Study|Death|15|||
162846044|NCT04025632|588146449|FG000|Overall Study|Adverse Event|1|||
162846045|NCT04025632|588146450|FG001|Overall Study|Adverse Event|1|||
162846046|NCT04025632|588146449|FG000|Overall Study|Withdrawal by Subject|1|||
162846047|NCT04025632|588146450|FG001|Overall Study|Withdrawal by Subject|1|||
162846048|NCT04025632|588146449|FG000|Overall Study|Study Terminated by Sponsor|10|||
162846049|NCT04025632|588146450|FG001|Overall Study|Study Terminated by Sponsor|9|||
162846050|NCT04025632|588146449|FG000|Overall Study|Physician Decision|3|||
162846051|NCT04025632|588146450|FG001|Overall Study|Physician Decision|1|||
162846052|NCT00376961|588146451|FG000|Initial Registration|Adverse Event|1|||
162846053|NCT00376961|588146452|FG001|Initial Registration|Adverse Event|0|||
162846054|NCT00376961|588146451|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
162846055|NCT00376961|588146452|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162846056|NCT00376961|588146451|FG000|Initial Registration|Progression/relapse|1|||
162846057|NCT00376961|588146452|FG001|Initial Registration|Progression/relapse|0|||
162846058|NCT00376961|588146451|FG000|Initial Registration|Ineligible|3|||
162846059|NCT00376961|588146452|FG001|Initial Registration|Ineligible|0|||
162846060|NCT00376961|588146451|FG000|Maintenance|Adverse Event|0|||
162846061|NCT00376961|588146452|FG001|Maintenance|Adverse Event|1|||
162846062|NCT00376961|588146451|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
162846063|NCT00376961|588146452|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
162846064|NCT00376961|588146451|FG000|Maintenance|Progression/relapse|0|||
162846065|NCT00376961|588146452|FG001|Maintenance|Progression/relapse|18|||
162846066|NCT00376961|588146451|FG000|Maintenance|Ineligible|0|||
162846067|NCT00376961|588146452|FG001|Maintenance|Ineligible|3|||
162846068|NCT02591615|588146459|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
162846069|NCT02591615|588146460|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
162846070|NCT02591615|588146461|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
162846071|NCT02591615|588146462|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
162846072|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
162846073|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
162846074|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
162846075|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
162846076|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
162846077|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
162846078|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
162846079|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
162846080|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
162846081|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
162846082|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
162846083|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
162846084|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
162846085|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
162846086|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
162846087|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
162846088|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
162846089|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
162846090|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
162846091|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
162846092|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
162846093|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
162846094|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
162952074|NCT01954394|588529531|FG001|Overall Study|Other than specified above|21|||
162952075|NCT00909610|588529532|FG000|Period: First Intervention|Adverse Event|0|||
162952076|NCT00909610|588529533|FG001|Period: First Intervention|Adverse Event|1|||
162702232|NCT03280563|587621752|FG000|Stage 1|Death|2|||
162702233|NCT03280563|587621753|FG001|Stage 1|Death|1|||
162702234|NCT03280563|587621754|FG002|Stage 1|Death|0|||
162702235|NCT03280563|587621755|FG003|Stage 1|Death|0|||
162702236|NCT03280563|587621756|FG004|Stage 1|Death|0|||
162702237|NCT03280563|587621757|FG005|Stage 1|Death|3|||
162702238|NCT03280563|587621758|FG006|Stage 1|Death|0|||
162846095|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
162846096|NCT02591615|588146459|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
162846097|NCT02591615|588146460|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
162846098|NCT02591615|588146461|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
162952077|NCT00909610|588529532|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
162702239|NCT03280563|587621759|FG007|Stage 1|Death|0|||
162846099|NCT02591615|588146462|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
162846100|NCT02591615|588146459|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
162846101|NCT02591615|588146460|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
162846102|NCT02591615|588146461|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
162846103|NCT02591615|588146462|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
162846104|NCT02591615|588146459|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
162846105|NCT02591615|588146460|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
162846106|NCT02591615|588146461|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
162846107|NCT02591615|588146462|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
162846108|NCT02591615|588146459|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
162846109|NCT02591615|588146460|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
162846110|NCT02591615|588146461|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
162846111|NCT02591615|588146462|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
162846112|NCT02591615|588146459|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
162846113|NCT02591615|588146460|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
162846114|NCT02591615|588146461|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
162846115|NCT02591615|588146462|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
162846116|NCT02591615|588146459|FG000|Maintenance MK-3475|Adverse Event|0|||
162846117|NCT02591615|588146460|FG001|Maintenance MK-3475|Adverse Event|3|||
162846118|NCT02591615|588146461|FG002|Maintenance MK-3475|Adverse Event|1|||
162846119|NCT02591615|588146462|FG003|Maintenance MK-3475|Adverse Event|2|||
162846120|NCT02591615|588146459|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
162846121|NCT02591615|588146460|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
162846122|NCT02591615|588146461|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
162846123|NCT02591615|588146462|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
162846124|NCT02591615|588146459|FG000|Maintenance MK-3475|Death|0|||
162846125|NCT02591615|588146460|FG001|Maintenance MK-3475|Death|1|||
162846126|NCT02591615|588146461|FG002|Maintenance MK-3475|Death|1|||
162846127|NCT02591615|588146462|FG003|Maintenance MK-3475|Death|0|||
162846128|NCT02591615|588146459|FG000|Maintenance MK-3475|Physician discretion|0|||
162846129|NCT02591615|588146460|FG001|Maintenance MK-3475|Physician discretion|0|||
162846130|NCT02591615|588146461|FG002|Maintenance MK-3475|Physician discretion|1|||
162846131|NCT02591615|588146462|FG003|Maintenance MK-3475|Physician discretion|0|||
162846132|NCT02591615|588146459|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
162846133|NCT02591615|588146460|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
162846134|NCT02591615|588146461|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
162846135|NCT02591615|588146462|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
162846136|NCT02591615|588146459|FG000|Maintenance MK-3475|In active treatment|2|||
162846137|NCT02591615|588146460|FG001|Maintenance MK-3475|In active treatment|0|||
162702240|NCT03280563|587621760|FG008|Stage 1|Death|0|||
162702241|NCT03280563|587621752|FG000|Stage 1|Study Ended by Sponsor|0|||
162702242|NCT03280563|587621753|FG001|Stage 1|Study Ended by Sponsor|0|||
162702243|NCT03280563|587621754|FG002|Stage 1|Study Ended by Sponsor|1|||
162702244|NCT03280563|587621755|FG003|Stage 1|Study Ended by Sponsor|0|||
162702245|NCT03280563|587621756|FG004|Stage 1|Study Ended by Sponsor|0|||
162702246|NCT03280563|587621757|FG005|Stage 1|Study Ended by Sponsor|1|||
162702247|NCT03280563|587621758|FG006|Stage 1|Study Ended by Sponsor|0|||
162846138|NCT02591615|588146461|FG002|Maintenance MK-3475|In active treatment|0|||
162846139|NCT02591615|588146462|FG003|Maintenance MK-3475|In active treatment|1|||
162846140|NCT01793792|588146463|FG000|Overall Study|Death|5|||
162846141|NCT01793792|588146463|FG000|Overall Study|Lost to Follow-up|5|||
162702248|NCT03280563|587621759|FG007|Stage 1|Study Ended by Sponsor|0|||
162702249|NCT03280563|587621760|FG008|Stage 1|Study Ended by Sponsor|0|||
162702250|NCT03280563|587621752|FG000|Stage 1|Withdrawal by Subject|5|||
162702251|NCT03280563|587621753|FG001|Stage 1|Withdrawal by Subject|1|||
162846142|NCT01793792|588146463|FG000|Overall Study|Withdrawal by Subject|1|||
162846143|NCT01793792|588146463|FG000|Overall Study|Device Not Implanted|1|||
162846144|NCT00851903|588146466|FG000|Overall Study|Withdrawal by Subject|2|||
162846145|NCT00270894|588146467|FG000|Overall Study|Adverse Event|1|||
162846146|NCT00270894|588146467|FG000|Overall Study|Withdrawal by Subject|1|||
162846147|NCT00686127|588146470|FG000|Overall Study|Withdrawal by Subject|14|||
162702252|NCT03280563|587621754|FG002|Stage 1|Withdrawal by Subject|2|||
162702253|NCT03280563|587621755|FG003|Stage 1|Withdrawal by Subject|0|||
162702254|NCT03280563|587621756|FG004|Stage 1|Withdrawal by Subject|0|||
162846148|NCT00686127|588146471|FG001|Overall Study|Withdrawal by Subject|6|||
162846149|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
162846150|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
162846151|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
162846152|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
162846153|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
162846154|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
162846155|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
162846156|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
162846157|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162846158|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162846159|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162846160|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
162846161|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
162846162|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162846163|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162846164|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
162846165|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
162846166|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
162846167|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
162846168|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
162846169|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
162846170|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
162846171|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
162846172|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
162846173|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
162846174|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
162846175|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
162846176|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
162846177|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
162846178|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
162846179|NCT05195528|588146477|FG000|Placebo-controlled Treatment Period|Other|0|||
162846180|NCT05195528|588146478|FG001|Placebo-controlled Treatment Period|Other|0|||
162846181|NCT05195528|588146479|FG002|Placebo-controlled Treatment Period|Other|1|||
162846182|NCT05195528|588146480|FG003|Placebo-controlled Treatment Period|Other|0|||
162846183|NCT05195528|588146481|FG004|Placebo-controlled Treatment Period|Other|0|||
162846184|NCT05195528|588146477|FG000|Extension Period|PTE or AE or SAE|0|||
162846185|NCT05195528|588146478|FG001|Extension Period|PTE or AE or SAE|4|||
162846186|NCT05195528|588146479|FG002|Extension Period|PTE or AE or SAE|5|||
162846187|NCT05195528|588146480|FG003|Extension Period|PTE or AE or SAE|4|||
162846188|NCT05195528|588146481|FG004|Extension Period|PTE or AE or SAE|4|||
162846189|NCT05195528|588146477|FG000|Extension Period|Protocol Violation|0|||
162846190|NCT05195528|588146478|FG001|Extension Period|Protocol Violation|2|||
162846191|NCT05195528|588146479|FG002|Extension Period|Protocol Violation|1|||
162846192|NCT05195528|588146480|FG003|Extension Period|Protocol Violation|0|||
162846193|NCT05195528|588146481|FG004|Extension Period|Protocol Violation|1|||
162846194|NCT05195528|588146477|FG000|Extension Period|Lost to Follow-up|0|||
162846195|NCT05195528|588146478|FG001|Extension Period|Lost to Follow-up|6|||
162846196|NCT05195528|588146479|FG002|Extension Period|Lost to Follow-up|13|||
162846197|NCT05195528|588146480|FG003|Extension Period|Lost to Follow-up|3|||
162846198|NCT05195528|588146481|FG004|Extension Period|Lost to Follow-up|7|||
162846199|NCT05195528|588146477|FG000|Extension Period|Withdrawal by Subject|0|||
162846200|NCT05195528|588146478|FG001|Extension Period|Withdrawal by Subject|12|||
162846201|NCT05195528|588146479|FG002|Extension Period|Withdrawal by Subject|9|||
162846202|NCT05195528|588146480|FG003|Extension Period|Withdrawal by Subject|6|||
162846203|NCT05195528|588146481|FG004|Extension Period|Withdrawal by Subject|5|||
162846204|NCT05195528|588146477|FG000|Extension Period|Lack of Efficacy|0|||
162846205|NCT05195528|588146478|FG001|Extension Period|Lack of Efficacy|3|||
162846206|NCT05195528|588146479|FG002|Extension Period|Lack of Efficacy|0|||
162846207|NCT05195528|588146480|FG003|Extension Period|Lack of Efficacy|0|||
162846208|NCT05195528|588146481|FG004|Extension Period|Lack of Efficacy|2|||
162846209|NCT05195528|588146477|FG000|Extension Period|Not Treated|0|||
162846210|NCT05195528|588146478|FG001|Extension Period|Not Treated|0|||
162846211|NCT05195528|588146479|FG002|Extension Period|Not Treated|2|||
162846212|NCT05195528|588146480|FG003|Extension Period|Not Treated|3|||
162846213|NCT05195528|588146481|FG004|Extension Period|Not Treated|0|||
162846214|NCT05195528|588146477|FG000|Extension Period|Other|0|||
162846215|NCT05195528|588146478|FG001|Extension Period|Other|1|||
162846216|NCT05195528|588146479|FG002|Extension Period|Other|1|||
162846217|NCT05195528|588146480|FG003|Extension Period|Other|0|||
162846218|NCT05195528|588146481|FG004|Extension Period|Other|0|||
162846219|NCT01552902|588146482|FG000|Overall Study|Adverse Event|1|||
162846220|NCT01552902|588146483|FG001|Overall Study|Adverse Event|15|||
162846221|NCT01552902|588146484|FG002|Overall Study|Adverse Event|14|||
162846222|NCT01552902|588146482|FG000|Overall Study|Protocol Violation|3|||
162846223|NCT01552902|588146483|FG001|Overall Study|Protocol Violation|3|||
162846224|NCT01552902|588146484|FG002|Overall Study|Protocol Violation|3|||
162846225|NCT01552902|588146482|FG000|Overall Study|Lack of Efficacy|4|||
162846226|NCT01552902|588146483|FG001|Overall Study|Lack of Efficacy|3|||
162846227|NCT01552902|588146484|FG002|Overall Study|Lack of Efficacy|1|||
162846228|NCT01552902|588146482|FG000|Overall Study|Withdrawal by Subject|1|||
162846229|NCT01552902|588146483|FG001|Overall Study|Withdrawal by Subject|9|||
162846230|NCT01552902|588146484|FG002|Overall Study|Withdrawal by Subject|6|||
162846231|NCT01552902|588146482|FG000|Overall Study|Lost to Follow-up|1|||
162846232|NCT01552902|588146483|FG001|Overall Study|Lost to Follow-up|3|||
162846233|NCT01552902|588146484|FG002|Overall Study|Lost to Follow-up|6|||
162846234|NCT01552902|588146482|FG000|Overall Study|Other|3|||
162846235|NCT01552902|588146483|FG001|Overall Study|Other|4|||
162846236|NCT01552902|588146484|FG002|Overall Study|Other|3|||
162846237|NCT02487108|588146485|FG000|Overall Study|Adverse Event|1|||
162846238|NCT02487108|588146486|FG001|Overall Study|Adverse Event|6|||
162846239|NCT02487108|588146487|FG002|Overall Study|Adverse Event|12|||
162846240|NCT02487108|588146488|FG003|Overall Study|Adverse Event|6|||
162846241|NCT02487108|588146485|FG000|Overall Study|Withdrawal by Subject|8|||
162846242|NCT02487108|588146486|FG001|Overall Study|Withdrawal by Subject|5|||
162846243|NCT02487108|588146487|FG002|Overall Study|Withdrawal by Subject|5|||
162846244|NCT02487108|588146488|FG003|Overall Study|Withdrawal by Subject|0|||
162846245|NCT02487108|588146485|FG000|Overall Study|Non-compliance to study medication|3|||
162846246|NCT02487108|588146486|FG001|Overall Study|Non-compliance to study medication|2|||
162846247|NCT02487108|588146487|FG002|Overall Study|Non-compliance to study medication|5|||
162846248|NCT02487108|588146488|FG003|Overall Study|Non-compliance to study medication|4|||
162846249|NCT02487108|588146485|FG000|Overall Study|Protocol Violation|1|||
162846250|NCT02487108|588146486|FG001|Overall Study|Protocol Violation|1|||
162846251|NCT02487108|588146487|FG002|Overall Study|Protocol Violation|2|||
162846252|NCT02487108|588146488|FG003|Overall Study|Protocol Violation|0|||
162846253|NCT02487108|588146485|FG000|Overall Study|Non-compliance to study procedures|0|||
162702255|NCT03280563|587621757|FG005|Stage 1|Withdrawal by Subject|2|||
162846254|NCT02487108|588146486|FG001|Overall Study|Non-compliance to study procedures|0|||
162846255|NCT02487108|588146487|FG002|Overall Study|Non-compliance to study procedures|0|||
162846256|NCT02487108|588146488|FG003|Overall Study|Non-compliance to study procedures|1|||
162846257|NCT02487108|588146485|FG000|Overall Study|Other than specified|3|||
162846258|NCT02487108|588146486|FG001|Overall Study|Other than specified|2|||
162846259|NCT02487108|588146487|FG002|Overall Study|Other than specified|2|||
162846260|NCT02487108|588146488|FG003|Overall Study|Other than specified|0|||
162846261|NCT00469612|588146489|FG000|Overall Study|Study terminated before data collected|2|||
162846262|NCT00469612|588146490|FG001|Overall Study|Study terminated before data collected|0|||
162846263|NCT02720757|588146491|FG000|Overall Study|Other reason|5|||
162846264|NCT02720757|588146491|FG000|Overall Study|Loss of contact|4|||
162846265|NCT02720757|588146491|FG000|Overall Study|Informed consent withdrawal|1|||
162846266|NCT02720757|588146491|FG000|Overall Study|Patients wish to withdraw|2|||
162846267|NCT02720757|588146491|FG000|Overall Study|Missing|3|||
162846268|NCT02720757|588146491|FG000|Overall Study|General exclusion|3|||
162846269|NCT00883493|588146492|FG000|Overall Study|Adverse Event|11|||
162846270|NCT00883493|588146493|FG001|Overall Study|Adverse Event|12|||
162846271|NCT00883493|588146492|FG000|Overall Study|Lack of Efficacy|4|||
162846272|NCT00883493|588146493|FG001|Overall Study|Lack of Efficacy|3|||
162846273|NCT00883493|588146492|FG000|Overall Study|Lost to Follow-up|7|||
162846274|NCT00883493|588146493|FG001|Overall Study|Lost to Follow-up|6|||
162846275|NCT00883493|588146492|FG000|Overall Study|Withdrawal by Subject|11|||
162846276|NCT00883493|588146493|FG001|Overall Study|Withdrawal by Subject|20|||
162846277|NCT00883493|588146492|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
162846278|NCT00883493|588146493|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
162846279|NCT00883493|588146492|FG000|Overall Study|Study specific disc. criteria|2|||
162846280|NCT00883493|588146493|FG001|Overall Study|Study specific disc. criteria|0|||
162846281|NCT00883493|588146492|FG000|Overall Study|Other|5|||
162846282|NCT00883493|588146493|FG001|Overall Study|Other|3|||
162846283|NCT00168831|588146495|FG000|Overall Study|Adverse Event|36|||
162846284|NCT00168831|588146496|FG001|Overall Study|Adverse Event|47|||
162846285|NCT00168831|588146497|FG002|Overall Study|Adverse Event|74|||
162846286|NCT00168831|588146495|FG000|Overall Study|Lost to Follow-up|5|||
162846287|NCT00168831|588146496|FG001|Overall Study|Lost to Follow-up|6|||
162846288|NCT00168831|588146497|FG002|Overall Study|Lost to Follow-up|4|||
162846289|NCT00168831|588146495|FG000|Overall Study|Withdrawal by Subject|7|||
162846290|NCT00168831|588146496|FG001|Overall Study|Withdrawal by Subject|14|||
162846291|NCT00168831|588146497|FG002|Overall Study|Withdrawal by Subject|19|||
162846292|NCT00168831|588146495|FG000|Overall Study|Protocol Violation|6|||
162846293|NCT00168831|588146496|FG001|Overall Study|Protocol Violation|11|||
162846294|NCT00168831|588146497|FG002|Overall Study|Protocol Violation|11|||
162846295|NCT00168831|588146495|FG000|Overall Study|Other|6|||
162846296|NCT00168831|588146496|FG001|Overall Study|Other|3|||
162846297|NCT00168831|588146497|FG002|Overall Study|Other|6|||
162846298|NCT01622569|588146498|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
162846299|NCT01622569|588146499|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
162846300|NCT01622569|588146500|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
162846301|NCT01622569|588146501|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
162846302|NCT01622569|588146498|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
162846303|NCT01622569|588146499|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
162846304|NCT01622569|588146500|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
162846305|NCT01622569|588146501|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
162846306|NCT01622569|588146498|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
162846307|NCT01622569|588146499|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
162846308|NCT01622569|588146500|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
162846309|NCT01622569|588146501|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
162846310|NCT01622569|588146498|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162846311|NCT01622569|588146499|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
162846312|NCT01622569|588146500|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
162846313|NCT01622569|588146501|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
162846314|NCT01622569|588146498|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
162846315|NCT01622569|588146499|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
162846316|NCT01622569|588146500|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
162846317|NCT01622569|588146501|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
162846318|NCT01622569|588146498|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
162846319|NCT01622569|588146499|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
162846320|NCT01622569|588146500|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
162846321|NCT01622569|588146501|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
162846322|NCT01622569|588146498|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
162846323|NCT01622569|588146499|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
162846324|NCT01622569|588146500|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
162846325|NCT01622569|588146501|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
162846326|NCT01622569|588146498|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162846327|NCT01622569|588146499|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162846328|NCT01622569|588146500|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
162846329|NCT01622569|588146501|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
162846330|NCT04173741|588146503|FG000|Overall Study|IVC measurement cannot be done|1|||
162846331|NCT04173741|588146504|FG001|Overall Study|IVC measurement cannot be done|1|||
162846332|NCT02522767|588146505|FG000|Double-blind|Withdrawal by Subject|8|||
162846333|NCT02522767|588146506|FG001|Double-blind|Withdrawal by Subject|11|||
162846334|NCT02522767|588146505|FG000|Double-blind|Lost to Follow-up|1|||
162846335|NCT02522767|588146506|FG001|Double-blind|Lost to Follow-up|0|||
162846336|NCT02522767|588146505|FG000|Double-blind|Adverse Event|1|||
162846337|NCT02522767|588146506|FG001|Double-blind|Adverse Event|10|||
162846338|NCT02522767|588146505|FG000|Double-blind|Protocol Violation|0|||
162846339|NCT02522767|588146506|FG001|Double-blind|Protocol Violation|1|||
162846340|NCT02522767|588146505|FG000|Double-blind|Lack of Efficacy|0|||
162702256|NCT03280563|587621758|FG006|Stage 1|Withdrawal by Subject|0|||
162702257|NCT03280563|587621759|FG007|Stage 1|Withdrawal by Subject|0|||
162702258|NCT03280563|587621760|FG008|Stage 1|Withdrawal by Subject|0|||
162702259|NCT03280563|587621752|FG000|Stage 1|Reason Not Specified|0|||
162702260|NCT03280563|587621753|FG001|Stage 1|Reason Not Specified|0|||
162702261|NCT03280563|587621754|FG002|Stage 1|Reason Not Specified|0|||
162702262|NCT03280563|587621755|FG003|Stage 1|Reason Not Specified|0|||
162702263|NCT03280563|587621756|FG004|Stage 1|Reason Not Specified|0|||
162702264|NCT03280563|587621757|FG005|Stage 1|Reason Not Specified|1|||
162702265|NCT03280563|587621758|FG006|Stage 1|Reason Not Specified|0|||
162702266|NCT03280563|587621759|FG007|Stage 1|Reason Not Specified|0|||
162702267|NCT03280563|587621760|FG008|Stage 1|Reason Not Specified|0|||
162702268|NCT03280563|587621752|FG000|Stage 1|Physician Decision|0|||
162702269|NCT03280563|587621753|FG001|Stage 1|Physician Decision|1|||
162702270|NCT03280563|587621754|FG002|Stage 1|Physician Decision|0|||
162702271|NCT03280563|587621755|FG003|Stage 1|Physician Decision|0|||
162702272|NCT03280563|587621756|FG004|Stage 1|Physician Decision|0|||
162702273|NCT03280563|587621757|FG005|Stage 1|Physician Decision|0|||
162702274|NCT03280563|587621758|FG006|Stage 1|Physician Decision|0|||
162702275|NCT03280563|587621759|FG007|Stage 1|Physician Decision|0|||
162702276|NCT03280563|587621760|FG008|Stage 1|Physician Decision|0|||
162702277|NCT03280563|587621752|FG000|Stage 2|Death|0|||
162702278|NCT03280563|587621753|FG001|Stage 2|Death|0|||
162702279|NCT03280563|587621754|FG002|Stage 2|Death|0|||
162702280|NCT03280563|587621755|FG003|Stage 2|Death|0|||
162846341|NCT02522767|588146506|FG001|Double-blind|Lack of Efficacy|2|||
162846342|NCT02522767|588146505|FG000|Double-blind|Protocol Deviation|1|||
162846343|NCT02522767|588146506|FG001|Double-blind|Protocol Deviation|0|||
162846344|NCT02522767|588146505|FG000|Open-label|Withdrawal by Subject|2|||
162846345|NCT02522767|588146506|FG001|Open-label|Withdrawal by Subject|3|||
162846346|NCT02522767|588146505|FG000|Open-label|Lost to Follow-up|0|||
162846347|NCT02522767|588146506|FG001|Open-label|Lost to Follow-up|1|||
162846348|NCT02522767|588146505|FG000|Open-label|Adverse Event|2|||
162846349|NCT02522767|588146506|FG001|Open-label|Adverse Event|1|||
162846350|NCT02522767|588146505|FG000|Open-label|Lack of Efficacy|1|||
162846351|NCT02522767|588146506|FG001|Open-label|Lack of Efficacy|1|||
162846352|NCT02522767|588146505|FG000|Open-label|Protocol Violation|0|||
162846353|NCT02522767|588146506|FG001|Open-label|Protocol Violation|1|||
162846354|NCT00548548|588146507|FG000|Overall Study|Death|345|||
162846355|NCT00548548|588146508|FG001|Overall Study|Death|348|||
162846356|NCT00548548|588146507|FG000|Overall Study|Lost to Follow-up|17|||
162846357|NCT00548548|588146508|FG001|Overall Study|Lost to Follow-up|18|||
162846358|NCT02357420|588146509|FG000|Overall Study|Adverse Event|3|||
162846359|NCT02357420|588146510|FG001|Overall Study|Adverse Event|3|||
162846360|NCT02357420|588146511|FG002|Overall Study|Adverse Event|8|||
162846361|NCT02357420|588146512|FG003|Overall Study|Adverse Event|9|||
162846362|NCT02357420|588146509|FG000|Overall Study|Investigator Decision|1|||
162846363|NCT02357420|588146510|FG001|Overall Study|Investigator Decision|0|||
162846364|NCT02357420|588146511|FG002|Overall Study|Investigator Decision|0|||
162846365|NCT02357420|588146512|FG003|Overall Study|Investigator Decision|0|||
162846366|NCT02357420|588146509|FG000|Overall Study|Prohibited Medication|1|||
162846367|NCT02357420|588146510|FG001|Overall Study|Prohibited Medication|1|||
162846368|NCT02357420|588146511|FG002|Overall Study|Prohibited Medication|0|||
162702281|NCT03280563|587621756|FG004|Stage 2|Death|0|||
162702282|NCT03280563|587621757|FG005|Stage 2|Death|0|||
162702283|NCT03280563|587621758|FG006|Stage 2|Death|0|||
162702284|NCT03280563|587621759|FG007|Stage 2|Death|1|||
162702285|NCT03280563|587621760|FG008|Stage 2|Death|0|||
162702286|NCT03280563|587621752|FG000|Stage 2|Progressive Disease|0|||
162702287|NCT03280563|587621753|FG001|Stage 2|Progressive Disease|0|||
162702288|NCT03280563|587621754|FG002|Stage 2|Progressive Disease|0|||
162702289|NCT03280563|587621755|FG003|Stage 2|Progressive Disease|0|||
162702290|NCT03280563|587621756|FG004|Stage 2|Progressive Disease|0|||
162702291|NCT03280563|587621757|FG005|Stage 2|Progressive Disease|0|||
162702292|NCT03280563|587621758|FG006|Stage 2|Progressive Disease|2|||
162702293|NCT03280563|587621759|FG007|Stage 2|Progressive Disease|0|||
162702294|NCT03280563|587621760|FG008|Stage 2|Progressive Disease|0|||
162702295|NCT03280563|587621752|FG000|Long-term Survival Follow-up|Death|10|||
162702296|NCT03280563|587621753|FG001|Long-term Survival Follow-up|Death|14|||
162702297|NCT03280563|587621754|FG002|Long-term Survival Follow-up|Death|15|||
162702298|NCT03280563|587621755|FG003|Long-term Survival Follow-up|Death|3|||
162702299|NCT03280563|587621756|FG004|Long-term Survival Follow-up|Death|6|||
162702300|NCT03280563|587621757|FG005|Long-term Survival Follow-up|Death|18|||
162702301|NCT03280563|587621758|FG006|Long-term Survival Follow-up|Death|11|||
162702302|NCT03280563|587621759|FG007|Long-term Survival Follow-up|Death|1|||
162702303|NCT03280563|587621760|FG008|Long-term Survival Follow-up|Death|3|||
162702304|NCT03280563|587621752|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
162702305|NCT03280563|587621753|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
162702306|NCT03280563|587621754|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
162702307|NCT03280563|587621755|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162702308|NCT03280563|587621756|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162702309|NCT03280563|587621757|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
162702310|NCT03280563|587621758|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162846369|NCT02357420|588146512|FG003|Overall Study|Prohibited Medication|0|||
162846370|NCT02357420|588146509|FG000|Overall Study|Protocol Non-compliance|0|||
162846371|NCT02357420|588146510|FG001|Overall Study|Protocol Non-compliance|0|||
162846372|NCT02357420|588146511|FG002|Overall Study|Protocol Non-compliance|0|||
162846373|NCT02357420|588146512|FG003|Overall Study|Protocol Non-compliance|1|||
162846374|NCT02357420|588146509|FG000|Overall Study|Withdrawn Consent|4|||
162846375|NCT02357420|588146510|FG001|Overall Study|Withdrawn Consent|8|||
162846376|NCT02357420|588146511|FG002|Overall Study|Withdrawn Consent|6|||
162846377|NCT02357420|588146512|FG003|Overall Study|Withdrawn Consent|6|||
162702311|NCT03280563|587621759|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
162702312|NCT03280563|587621760|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162702313|NCT03280563|587621752|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162702314|NCT03280563|587621753|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162702315|NCT03280563|587621754|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162702316|NCT03280563|587621755|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162846378|NCT02357420|588146509|FG000|Overall Study|Lost to Follow-up|3|||
162846379|NCT02357420|588146510|FG001|Overall Study|Lost to Follow-up|0|||
162846380|NCT02357420|588146511|FG002|Overall Study|Lost to Follow-up|2|||
162846381|NCT02357420|588146512|FG003|Overall Study|Lost to Follow-up|3|||
162846382|NCT00214461|588146513|FG000|Overall Study|Adverse Event|0|||
162846383|NCT00214461|588146514|FG001|Overall Study|Adverse Event|0|||
162846384|NCT00214461|588146515|FG002|Overall Study|Adverse Event|1|||
162846385|NCT00214461|588146516|FG003|Overall Study|Adverse Event|1|||
162846386|NCT00214461|588146513|FG000|Overall Study|Withdrawal by Subject|0|||
162846387|NCT00214461|588146514|FG001|Overall Study|Withdrawal by Subject|0|||
162846388|NCT00214461|588146515|FG002|Overall Study|Withdrawal by Subject|1|||
162846389|NCT00214461|588146516|FG003|Overall Study|Withdrawal by Subject|0|||
162846390|NCT01848145|588146517|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
162846391|NCT01848145|588146517|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
162846392|NCT01848145|588146517|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
162846393|NCT01848145|588146517|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
162846394|NCT01848145|588146517|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
162846395|NCT01848145|588146517|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
162846396|NCT01848145|588146517|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
162846397|NCT00364689|588146518|FG000|Overall Study|Lost to Follow-up|1|||
162846398|NCT00234039|588146521|FG000|Overall Study|Adverse Event|2|||
162846399|NCT00234039|588146521|FG000|Overall Study|Progression/relapse|34|||
162846400|NCT00234039|588146521|FG000|Overall Study|Other - Not Protocol Specified|3|||
162846401|NCT00234039|588146521|FG000|Overall Study|Ineligible|9|||
162846402|NCT00234039|588146521|FG000|Overall Study|No Protocol Treatment Received|2|||
162846403|NCT01808612|588146522|FG000|Treatment Period|Adverse Event|8|||
162846404|NCT01808612|588146523|FG001|Treatment Period|Adverse Event|4|||
162846405|NCT01808612|588146524|FG002|Treatment Period|Adverse Event|3|||
162846406|NCT01808612|588146522|FG000|Treatment Period|Lost to Follow-up|2|||
162846407|NCT01808612|588146523|FG001|Treatment Period|Lost to Follow-up|2|||
162846408|NCT01808612|588146524|FG002|Treatment Period|Lost to Follow-up|1|||
162846409|NCT01808612|588146522|FG000|Treatment Period|Protocol Violation|1|||
162846410|NCT01808612|588146523|FG001|Treatment Period|Protocol Violation|0|||
162846411|NCT01808612|588146524|FG002|Treatment Period|Protocol Violation|0|||
162846412|NCT01808612|588146522|FG000|Treatment Period|Withdrawal by Subject|1|||
162846413|NCT01808612|588146523|FG001|Treatment Period|Withdrawal by Subject|0|||
162846414|NCT01808612|588146524|FG002|Treatment Period|Withdrawal by Subject|4|||
162846415|NCT01808612|588146522|FG000|Treatment Period|Physician Decision|1|||
162846416|NCT01808612|588146523|FG001|Treatment Period|Physician Decision|0|||
162846417|NCT01808612|588146524|FG002|Treatment Period|Physician Decision|4|||
162846418|NCT01808612|588146522|FG000|Treatment Period|Sponsor Decision|1|||
162846419|NCT01808612|588146523|FG001|Treatment Period|Sponsor Decision|0|||
162846420|NCT01808612|588146524|FG002|Treatment Period|Sponsor Decision|0|||
162846421|NCT01808612|588146522|FG000|Treatment Period|Lack of Efficacy|1|||
162846422|NCT01808612|588146523|FG001|Treatment Period|Lack of Efficacy|1|||
162846423|NCT01808612|588146524|FG002|Treatment Period|Lack of Efficacy|2|||
162846424|NCT01808612|588146522|FG000|Discontinuation Period|Adverse Event|1|||
162846425|NCT01808612|588146523|FG001|Discontinuation Period|Adverse Event|0|||
162846426|NCT01808612|588146524|FG002|Discontinuation Period|Adverse Event|0|||
162846427|NCT01808612|588146522|FG000|Discontinuation Period|Physician Decision|1|||
162846428|NCT01808612|588146523|FG001|Discontinuation Period|Physician Decision|0|||
162846429|NCT01808612|588146524|FG002|Discontinuation Period|Physician Decision|0|||
162846430|NCT01808612|588146522|FG000|Discontinuation Period|Lost to Follow-up|0|||
162846431|NCT01808612|588146523|FG001|Discontinuation Period|Lost to Follow-up|1|||
162846432|NCT01808612|588146524|FG002|Discontinuation Period|Lost to Follow-up|0|||
162846433|NCT03683394|588146525|FG000|Overall Study|Withdrawal by Subject|4|||
162846434|NCT03683394|588146526|FG001|Overall Study|Withdrawal by Subject|8|||
162846435|NCT03683394|588146525|FG000|Overall Study|Lost to Follow-up|7|||
162846436|NCT03683394|588146526|FG001|Overall Study|Lost to Follow-up|0|||
162846437|NCT03683394|588146525|FG000|Overall Study|Death|3|||
162846438|NCT03683394|588146526|FG001|Overall Study|Death|1|||
162846439|NCT02239263|588146529|FG000|Overall Study|Protocol Violation|6|||
162846440|NCT04426695|588146530|FG000|Overall Study|Death|2|||
162846441|NCT04426695|588146531|FG001|Overall Study|Death|0|||
162846442|NCT04426695|588146532|FG002|Overall Study|Death|1|||
162846443|NCT04426695|588146533|FG003|Overall Study|Death|27|||
162846444|NCT04426695|588146534|FG004|Overall Study|Death|25|||
162846445|NCT04426695|588146535|FG005|Overall Study|Death|21|||
162846446|NCT04426695|588146536|FG006|Overall Study|Death|42|||
162846447|NCT04426695|588146537|FG007|Overall Study|Death|23|||
162846448|NCT04426695|588146538|FG008|Overall Study|Death|37|||
162846449|NCT04426695|588146539|FG009|Overall Study|Death|14|||
162846450|NCT04426695|588146540|FG010|Overall Study|Death|8|||
162846451|NCT04426695|588146541|FG011|Overall Study|Death|7|||
162846452|NCT04426695|588146542|FG012|Overall Study|Death|13|||
162846453|NCT04426695|588146543|FG013|Overall Study|Death|25|||
162846454|NCT04426695|588146544|FG014|Overall Study|Death|19|||
162846455|NCT04426695|588146545|FG015|Overall Study|Death|7|||
162846456|NCT04426695|588146546|FG016|Overall Study|Death|8|||
162846457|NCT04426695|588146547|FG017|Overall Study|Death|4|||
162846458|NCT04426695|588146530|FG000|Overall Study|Lost to Follow-up|2|||
162846459|NCT04426695|588146531|FG001|Overall Study|Lost to Follow-up|4|||
162846460|NCT04426695|588146532|FG002|Overall Study|Lost to Follow-up|1|||
162846461|NCT04426695|588146533|FG003|Overall Study|Lost to Follow-up|19|||
162846462|NCT04426695|588146534|FG004|Overall Study|Lost to Follow-up|10|||
162846463|NCT04426695|588146535|FG005|Overall Study|Lost to Follow-up|14|||
162846464|NCT04426695|588146536|FG006|Overall Study|Lost to Follow-up|5|||
162846465|NCT04426695|588146537|FG007|Overall Study|Lost to Follow-up|14|||
162846466|NCT04426695|588146538|FG008|Overall Study|Lost to Follow-up|10|||
162846467|NCT04426695|588146539|FG009|Overall Study|Lost to Follow-up|11|||
162846468|NCT04426695|588146540|FG010|Overall Study|Lost to Follow-up|12|||
162846469|NCT04426695|588146541|FG011|Overall Study|Lost to Follow-up|6|||
162846470|NCT04426695|588146542|FG012|Overall Study|Lost to Follow-up|2|||
162846471|NCT04426695|588146543|FG013|Overall Study|Lost to Follow-up|2|||
162846472|NCT04426695|588146544|FG014|Overall Study|Lost to Follow-up|2|||
162846473|NCT04426695|588146545|FG015|Overall Study|Lost to Follow-up|0|||
162846474|NCT04426695|588146546|FG016|Overall Study|Lost to Follow-up|0|||
162846475|NCT04426695|588146547|FG017|Overall Study|Lost to Follow-up|0|||
162846476|NCT04426695|588146530|FG000|Overall Study|Participant Decision|1|||
162846477|NCT04426695|588146531|FG001|Overall Study|Participant Decision|2|||
162846478|NCT04426695|588146532|FG002|Overall Study|Participant Decision|2|||
162846479|NCT04426695|588146533|FG003|Overall Study|Participant Decision|12|||
162846480|NCT04426695|588146534|FG004|Overall Study|Participant Decision|18|||
162846481|NCT04426695|588146535|FG005|Overall Study|Participant Decision|22|||
162846482|NCT04426695|588146536|FG006|Overall Study|Participant Decision|13|||
162846483|NCT04426695|588146537|FG007|Overall Study|Participant Decision|13|||
162846484|NCT04426695|588146538|FG008|Overall Study|Participant Decision|10|||
162846485|NCT04426695|588146539|FG009|Overall Study|Participant Decision|15|||
162846486|NCT04426695|588146540|FG010|Overall Study|Participant Decision|16|||
162846487|NCT04426695|588146541|FG011|Overall Study|Participant Decision|17|||
162846488|NCT04426695|588146542|FG012|Overall Study|Participant Decision|2|||
162846489|NCT04426695|588146543|FG013|Overall Study|Participant Decision|1|||
162846490|NCT04426695|588146544|FG014|Overall Study|Participant Decision|2|||
162846491|NCT04426695|588146545|FG015|Overall Study|Participant Decision|0|||
162846492|NCT04426695|588146546|FG016|Overall Study|Participant Decision|0|||
162846493|NCT04426695|588146547|FG017|Overall Study|Participant Decision|0|||
162846494|NCT04426695|588146530|FG000|Overall Study|Adverse Event|0|||
162846495|NCT04426695|588146531|FG001|Overall Study|Adverse Event|0|||
162846496|NCT04426695|588146532|FG002|Overall Study|Adverse Event|0|||
162846497|NCT04426695|588146533|FG003|Overall Study|Adverse Event|0|||
162846498|NCT04426695|588146534|FG004|Overall Study|Adverse Event|0|||
162846499|NCT04426695|588146535|FG005|Overall Study|Adverse Event|0|||
162846500|NCT04426695|588146536|FG006|Overall Study|Adverse Event|0|||
162846501|NCT04426695|588146537|FG007|Overall Study|Adverse Event|1|||
162846502|NCT04426695|588146538|FG008|Overall Study|Adverse Event|0|||
162846503|NCT04426695|588146539|FG009|Overall Study|Adverse Event|0|||
162846504|NCT04426695|588146540|FG010|Overall Study|Adverse Event|1|||
162846505|NCT04426695|588146541|FG011|Overall Study|Adverse Event|1|||
162846506|NCT04426695|588146542|FG012|Overall Study|Adverse Event|0|||
162846507|NCT04426695|588146543|FG013|Overall Study|Adverse Event|0|||
162846508|NCT04426695|588146544|FG014|Overall Study|Adverse Event|0|||
162846509|NCT04426695|588146545|FG015|Overall Study|Adverse Event|0|||
162846510|NCT04426695|588146546|FG016|Overall Study|Adverse Event|0|||
162846511|NCT04426695|588146547|FG017|Overall Study|Adverse Event|0|||
162846512|NCT04426695|588146530|FG000|Overall Study|Sponsor Request|0|||
162846513|NCT04426695|588146531|FG001|Overall Study|Sponsor Request|0|||
162846514|NCT04426695|588146532|FG002|Overall Study|Sponsor Request|0|||
162846515|NCT04426695|588146533|FG003|Overall Study|Sponsor Request|0|||
162846516|NCT04426695|588146534|FG004|Overall Study|Sponsor Request|0|||
162846517|NCT04426695|588146535|FG005|Overall Study|Sponsor Request|0|||
162846518|NCT04426695|588146536|FG006|Overall Study|Sponsor Request|1|||
162846519|NCT04426695|588146537|FG007|Overall Study|Sponsor Request|0|||
162846520|NCT04426695|588146538|FG008|Overall Study|Sponsor Request|0|||
162846521|NCT04426695|588146539|FG009|Overall Study|Sponsor Request|0|||
162846522|NCT04426695|588146540|FG010|Overall Study|Sponsor Request|0|||
162846523|NCT04426695|588146541|FG011|Overall Study|Sponsor Request|0|||
162846524|NCT04426695|588146542|FG012|Overall Study|Sponsor Request|0|||
162846525|NCT04426695|588146543|FG013|Overall Study|Sponsor Request|0|||
162846526|NCT04426695|588146544|FG014|Overall Study|Sponsor Request|0|||
162846527|NCT04426695|588146545|FG015|Overall Study|Sponsor Request|0|||
162846528|NCT04426695|588146546|FG016|Overall Study|Sponsor Request|0|||
162846529|NCT04426695|588146547|FG017|Overall Study|Sponsor Request|0|||
162846530|NCT04426695|588146530|FG000|Overall Study|Physician Decision|0|||
162846531|NCT04426695|588146531|FG001|Overall Study|Physician Decision|0|||
162846532|NCT04426695|588146532|FG002|Overall Study|Physician Decision|0|||
162846533|NCT04426695|588146533|FG003|Overall Study|Physician Decision|0|||
162846534|NCT04426695|588146534|FG004|Overall Study|Physician Decision|0|||
162846535|NCT04426695|588146535|FG005|Overall Study|Physician Decision|0|||
162846536|NCT04426695|588146536|FG006|Overall Study|Physician Decision|0|||
162846537|NCT04426695|588146537|FG007|Overall Study|Physician Decision|0|||
162846538|NCT04426695|588146538|FG008|Overall Study|Physician Decision|0|||
162846539|NCT04426695|588146539|FG009|Overall Study|Physician Decision|1|||
162846540|NCT04426695|588146540|FG010|Overall Study|Physician Decision|0|||
162846541|NCT04426695|588146541|FG011|Overall Study|Physician Decision|0|||
162846542|NCT04426695|588146542|FG012|Overall Study|Physician Decision|1|||
162846543|NCT04426695|588146543|FG013|Overall Study|Physician Decision|0|||
162846544|NCT04426695|588146544|FG014|Overall Study|Physician Decision|0|||
162846545|NCT04426695|588146545|FG015|Overall Study|Physician Decision|0|||
162846546|NCT04426695|588146546|FG016|Overall Study|Physician Decision|0|||
162846547|NCT04426695|588146547|FG017|Overall Study|Physician Decision|0|||
162846548|NCT04426695|588146530|FG000|Overall Study|Randomized but Never Treated|3|||
162846549|NCT04426695|588146531|FG001|Overall Study|Randomized but Never Treated|1|||
162846550|NCT04426695|588146532|FG002|Overall Study|Randomized but Never Treated|0|||
162846551|NCT04426695|588146533|FG003|Overall Study|Randomized but Never Treated|4|||
162846552|NCT04426695|588146534|FG004|Overall Study|Randomized but Never Treated|5|||
162846553|NCT04426695|588146535|FG005|Overall Study|Randomized but Never Treated|5|||
162846554|NCT04426695|588146536|FG006|Overall Study|Randomized but Never Treated|4|||
162846555|NCT04426695|588146537|FG007|Overall Study|Randomized but Never Treated|6|||
162846556|NCT04426695|588146538|FG008|Overall Study|Randomized but Never Treated|6|||
162846557|NCT04426695|588146539|FG009|Overall Study|Randomized but Never Treated|3|||
162846558|NCT04426695|588146540|FG010|Overall Study|Randomized but Never Treated|3|||
163043221|NCT02098395|588865752|FG003|Overall Study|Unclassified|2|||
162846559|NCT04426695|588146541|FG011|Overall Study|Randomized but Never Treated|6|||
162846560|NCT04426695|588146542|FG012|Overall Study|Randomized but Never Treated|1|||
162846561|NCT04426695|588146543|FG013|Overall Study|Randomized but Never Treated|2|||
162846562|NCT04426695|588146544|FG014|Overall Study|Randomized but Never Treated|0|||
162846563|NCT04426695|588146545|FG015|Overall Study|Randomized but Never Treated|0|||
162846564|NCT04426695|588146546|FG016|Overall Study|Randomized but Never Treated|0|||
162846565|NCT04426695|588146547|FG017|Overall Study|Randomized but Never Treated|0|||
162846566|NCT01109940|588146548|FG000|Overall Study|Administrative problems|2|||
162846567|NCT01109940|588146549|FG001|Overall Study|Administrative problems|0|||
162846568|NCT01109940|588146550|FG002|Overall Study|Administrative problems|0|||
162846569|NCT01109940|588146551|FG003|Overall Study|Administrative problems|0|||
162846570|NCT01109940|588146548|FG000|Overall Study|Serious Adverse Event|2|||
163043222|NCT00110357|588865758|FG000|Overall Study|Deterioration without progression|2|||
163043223|NCT00110357|588865759|FG001|Overall Study|Deterioration without progression|0|||
162702317|NCT03280563|587621756|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162702318|NCT03280563|587621757|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162702319|NCT03280563|587621758|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162702320|NCT03280563|587621759|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162702321|NCT03280563|587621760|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162702322|NCT03280563|587621752|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
162702323|NCT03280563|587621753|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
162702324|NCT03280563|587621754|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
162702325|NCT03280563|587621755|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
162846571|NCT01109940|588146549|FG001|Overall Study|Serious Adverse Event|1|||
162846572|NCT01109940|588146550|FG002|Overall Study|Serious Adverse Event|0|||
162846573|NCT01109940|588146551|FG003|Overall Study|Serious Adverse Event|0|||
162846574|NCT01109940|588146548|FG000|Overall Study|Lost to Follow-up|1|||
162846575|NCT01109940|588146549|FG001|Overall Study|Lost to Follow-up|0|||
162846576|NCT01109940|588146550|FG002|Overall Study|Lost to Follow-up|0|||
162846577|NCT01109940|588146551|FG003|Overall Study|Lost to Follow-up|0|||
162846578|NCT01109940|588146548|FG000|Overall Study|Patient withdrew consent|1|||
162846579|NCT01109940|588146549|FG001|Overall Study|Patient withdrew consent|1|||
162846580|NCT01109940|588146550|FG002|Overall Study|Patient withdrew consent|0|||
162846581|NCT01109940|588146551|FG003|Overall Study|Patient withdrew consent|0|||
162846582|NCT01109940|588146548|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162846583|NCT01109940|588146549|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162846584|NCT01109940|588146550|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
162846585|NCT01109940|588146551|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162846586|NCT00189462|588146553|FG000|Overall Study|Lack of Efficacy|5|||
162846587|NCT00189462|588146554|FG001|Overall Study|Lack of Efficacy|1|||
162846588|NCT00189462|588146553|FG000|Overall Study|Lost to Follow-up|18|||
162702326|NCT03280563|587621756|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
162702327|NCT03280563|587621757|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
162846589|NCT00189462|588146554|FG001|Overall Study|Lost to Follow-up|20|||
162846590|NCT00849667|588146555|FG000|Overall Study|Withdrawal by Subject|16|||
162846591|NCT00849667|588146556|FG001|Overall Study|Withdrawal by Subject|33|||
162846592|NCT00849667|588146557|FG002|Overall Study|Withdrawal by Subject|35|||
162846593|NCT00849667|588146555|FG000|Overall Study|Lost to Follow-up|8|||
162846594|NCT00849667|588146556|FG001|Overall Study|Lost to Follow-up|8|||
162846595|NCT00849667|588146557|FG002|Overall Study|Lost to Follow-up|8|||
162846596|NCT00849667|588146555|FG000|Overall Study|Adverse Event|1|||
162846597|NCT00849667|588146556|FG001|Overall Study|Adverse Event|2|||
162846598|NCT00849667|588146557|FG002|Overall Study|Adverse Event|0|||
162846599|NCT00849667|588146555|FG000|Overall Study|Other|18|||
162846600|NCT00849667|588146556|FG001|Overall Study|Other|19|||
162846601|NCT00849667|588146557|FG002|Overall Study|Other|18|||
162846602|NCT00849667|588146555|FG000|Overall Study|Progressive disease|119|||
162846603|NCT00849667|588146556|FG001|Overall Study|Progressive disease|100|||
162846604|NCT00849667|588146557|FG002|Overall Study|Progressive disease|112|||
162846605|NCT00849667|588146555|FG000|Overall Study|Sponsor decision|208|||
162846606|NCT00849667|588146556|FG001|Overall Study|Sponsor decision|204|||
162846607|NCT00849667|588146557|FG002|Overall Study|Sponsor decision|190|||
162846608|NCT00849667|588146555|FG000|Overall Study|Investigator discretion|0|||
162846609|NCT00849667|588146556|FG001|Overall Study|Investigator discretion|0|||
162846610|NCT00849667|588146557|FG002|Overall Study|Investigator discretion|1|||
162846611|NCT00553462|588146560|FG000|Overall Study|Adverse Event|4|||
162846612|NCT00553462|588146560|FG000|Overall Study|Progression|4|||
162846613|NCT00553462|588146560|FG000|Overall Study|Withdrawal by Subject|5|||
162846614|NCT00553462|588146560|FG000|Overall Study|Physician Decision|1|||
162846615|NCT01262625|588146561|FG000|Overall Study|Administrative Error|1|||
162846616|NCT01262625|588146562|FG001|Overall Study|Administrative Error|1|||
162846617|NCT01262625|588146561|FG000|Overall Study|Site Closed|1|||
162846618|NCT01262625|588146562|FG001|Overall Study|Site Closed|0|||
162846619|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
162846620|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
162846621|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|Death|1|||
162846622|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|Death|0|||
162846623|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
162846624|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
162846625|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
162846626|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
162846627|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
162846628|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
162846629|NCT00110994|588146563|FG000|Double-blind (DB) Treatment|other reasons|2|||
162846630|NCT00110994|588146564|FG001|Double-blind (DB) Treatment|other reasons|3|||
162846631|NCT00110994|588146563|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
162846632|NCT00110994|588146564|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
162846633|NCT00110994|588146563|FG000|Active Follow-up|Other reasons|0|||
162846634|NCT00110994|588146564|FG001|Active Follow-up|Other reasons|2|||
162846635|NCT00110994|588146563|FG000|Long Term Follow-up|Death|19|||
162846636|NCT00110994|588146564|FG001|Long Term Follow-up|Death|17|||
162702328|NCT03280563|587621758|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
162702329|NCT03280563|587621759|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
162702330|NCT03280563|587621760|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
162702331|NCT04423393|587621761|FG000|Overall Study|Withdrawal by Subject|0|||
162702332|NCT04423393|587621762|FG001|Overall Study|Withdrawal by Subject|0|||
162702333|NCT04423393|587621763|FG002|Overall Study|Withdrawal by Subject|0|||
162702334|NCT04423393|587621764|FG003|Overall Study|Withdrawal by Subject|0|||
162702335|NCT04423393|587621765|FG004|Overall Study|Withdrawal by Subject|0|||
162702336|NCT04423393|587621766|FG005|Overall Study|Withdrawal by Subject|1|||
162702337|NCT04423393|587621767|FG006|Overall Study|Withdrawal by Subject|0|||
162702338|NCT04423393|587621768|FG007|Overall Study|Withdrawal by Subject|0|||
162702339|NCT04423393|587621769|FG008|Overall Study|Withdrawal by Subject|0|||
162702340|NCT04423393|587621770|FG009|Overall Study|Withdrawal by Subject|0|||
162846637|NCT04398732|588146565|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
162846638|NCT00354601|588146575|FG000|Overall Study|Protocol Violation|1|||
162846639|NCT00354601|588146575|FG000|Overall Study|progression|1|||
162846640|NCT02471716|588146576|FG000|Overall Study|Withdrawal by Subject|0|||
162846641|NCT02471716|588146577|FG001|Overall Study|Withdrawal by Subject|1|||
162846642|NCT02471716|588146578|FG002|Overall Study|Withdrawal by Subject|0|||
162846643|NCT02471716|588146579|FG003|Overall Study|Withdrawal by Subject|2|||
162846644|NCT02471716|588146580|FG004|Overall Study|Withdrawal by Subject|5|||
162846645|NCT02471716|588146576|FG000|Overall Study|Study Terminiated by sponsor|0|||
162846646|NCT02471716|588146577|FG001|Overall Study|Study Terminiated by sponsor|0|||
162846647|NCT02471716|588146578|FG002|Overall Study|Study Terminiated by sponsor|0|||
162846648|NCT02471716|588146579|FG003|Overall Study|Study Terminiated by sponsor|1|||
162846649|NCT02471716|588146580|FG004|Overall Study|Study Terminiated by sponsor|0|||
162846650|NCT02471716|588146576|FG000|Overall Study|Lost to Follow-up|0|||
162846651|NCT02471716|588146577|FG001|Overall Study|Lost to Follow-up|0|||
162846652|NCT02471716|588146578|FG002|Overall Study|Lost to Follow-up|0|||
162846653|NCT02471716|588146579|FG003|Overall Study|Lost to Follow-up|3|||
162846654|NCT02471716|588146580|FG004|Overall Study|Lost to Follow-up|2|||
162846655|NCT02471716|588146576|FG000|Overall Study|Death|0|||
162846656|NCT02471716|588146577|FG001|Overall Study|Death|0|||
162846657|NCT02471716|588146578|FG002|Overall Study|Death|0|||
162846658|NCT02471716|588146579|FG003|Overall Study|Death|1|||
162846659|NCT02471716|588146580|FG004|Overall Study|Death|0|||
162846660|NCT02471716|588146576|FG000|Overall Study|Other|0|||
162846661|NCT02471716|588146577|FG001|Overall Study|Other|0|||
162846662|NCT02471716|588146578|FG002|Overall Study|Other|0|||
162846663|NCT02471716|588146579|FG003|Overall Study|Other|8|||
162846664|NCT02471716|588146580|FG004|Overall Study|Other|9|||
162846665|NCT01838044|588146590|FG000|Overall Study|Adverse Event|4|||
162846666|NCT01838044|588146591|FG001|Overall Study|Adverse Event|6|||
162846667|NCT01838044|588146590|FG000|Overall Study|Protocol Violation|3|||
162846668|NCT01838044|588146591|FG001|Overall Study|Protocol Violation|3|||
162846669|NCT01838044|588146590|FG000|Overall Study|Withdrawal by Subject|0|||
162846670|NCT01838044|588146591|FG001|Overall Study|Withdrawal by Subject|2|||
162846671|NCT01838044|588146590|FG000|Overall Study|Insufficient clinical response|1|||
162846672|NCT01838044|588146591|FG001|Overall Study|Insufficient clinical response|2|||
162846673|NCT01838044|588146590|FG000|Overall Study|Medication error without associated AE|0|||
162846674|NCT01838044|588146591|FG001|Overall Study|Medication error without associated AE|1|||
162846675|NCT01838044|588146590|FG000|Overall Study|Lost to Follow-up|0|||
162846676|NCT01838044|588146591|FG001|Overall Study|Lost to Follow-up|2|||
162846677|NCT00330187|588146592|FG000|Overall Study|Lost to Follow-up|12|||
162846678|NCT00330187|588146593|FG001|Overall Study|Lost to Follow-up|13|||
162846679|NCT00330187|588146594|FG002|Overall Study|Lost to Follow-up|14|||
162846680|NCT00330187|588146595|FG003|Overall Study|Lost to Follow-up|10|||
162846681|NCT00330187|588146592|FG000|Overall Study|Withdrawal by Subject|8|||
162846682|NCT00330187|588146593|FG001|Overall Study|Withdrawal by Subject|5|||
162846683|NCT00330187|588146594|FG002|Overall Study|Withdrawal by Subject|4|||
162846684|NCT00330187|588146595|FG003|Overall Study|Withdrawal by Subject|4|||
162846685|NCT01162421|588146603|FG000|Overall Study|Did not receive study drug|2|||
162846686|NCT01162421|588146604|FG001|Overall Study|Did not receive study drug|1|||
162846687|NCT01162421|588146603|FG000|Overall Study|Adverse Event|2|||
162846688|NCT01162421|588146604|FG001|Overall Study|Adverse Event|5|||
162846689|NCT01162421|588146603|FG000|Overall Study|Lost to Follow-up|0|||
162846690|NCT01162421|588146604|FG001|Overall Study|Lost to Follow-up|2|||
162846691|NCT01162421|588146603|FG000|Overall Study|Lack of Efficacy|2|||
162846692|NCT01162421|588146604|FG001|Overall Study|Lack of Efficacy|2|||
162846693|NCT01162421|588146603|FG000|Overall Study|Other|2|||
162846694|NCT01162421|588146604|FG001|Overall Study|Other|3|||
162846695|NCT01133171|588146610|FG000|Overall Study|Withdrawal by Subject|1|||
162846696|NCT01133171|588146611|FG001|Overall Study|Withdrawal by Subject|2|||
162846697|NCT01133171|588146612|FG002|Overall Study|Withdrawal by Subject|0|||
162846698|NCT02526550|588146613|FG000|Overall Study|Lost to Follow-up|1|||
162846699|NCT00091832|588146615|FG000|Overall Study|Physician Decision|1|||
162846700|NCT00091832|588146616|FG001|Overall Study|Physician Decision|0|||
162846701|NCT00091832|588146617|FG002|Overall Study|Physician Decision|0|||
162846702|NCT00091832|588146618|FG003|Overall Study|Physician Decision|0|||
162846703|NCT00091832|588146619|FG004|Overall Study|Physician Decision|0|||
162846704|NCT00091832|588146620|FG005|Overall Study|Physician Decision|0|||
162846705|NCT00091832|588146615|FG000|Overall Study|Adverse Event|0|||
162846706|NCT00091832|588146616|FG001|Overall Study|Adverse Event|0|||
162846707|NCT00091832|588146617|FG002|Overall Study|Adverse Event|0|||
162846708|NCT00091832|588146618|FG003|Overall Study|Adverse Event|1|||
162846709|NCT00091832|588146619|FG004|Overall Study|Adverse Event|3|||
162846710|NCT00091832|588146620|FG005|Overall Study|Adverse Event|0|||
162846711|NCT00091832|588146615|FG000|Overall Study|Withdrawal by Subject|4|||
162846712|NCT00091832|588146616|FG001|Overall Study|Withdrawal by Subject|5|||
162846713|NCT00091832|588146617|FG002|Overall Study|Withdrawal by Subject|0|||
162846714|NCT00091832|588146618|FG003|Overall Study|Withdrawal by Subject|1|||
162702341|NCT04423393|587621771|FG010|Overall Study|Withdrawal by Subject|0|||
162702342|NCT04423393|587621772|FG011|Overall Study|Withdrawal by Subject|0|||
162702343|NCT04423393|587621773|FG012|Overall Study|Withdrawal by Subject|0|||
162702344|NCT04423393|587621774|FG013|Overall Study|Withdrawal by Subject|1|||
162702345|NCT04423393|587621775|FG014|Overall Study|Withdrawal by Subject|0|||
162702346|NCT04423393|587621776|FG015|Overall Study|Withdrawal by Subject|0|||
162702347|NCT04423393|587621777|FG016|Overall Study|Withdrawal by Subject|0|||
162702348|NCT04423393|587621778|FG017|Overall Study|Withdrawal by Subject|0|||
162702349|NCT04423393|587621761|FG000|Overall Study|Sponsor Decision|0|||
162702350|NCT04423393|587621762|FG001|Overall Study|Sponsor Decision|0|||
162702351|NCT04423393|587621763|FG002|Overall Study|Sponsor Decision|0|||
162702352|NCT04423393|587621764|FG003|Overall Study|Sponsor Decision|0|||
162702353|NCT04423393|587621765|FG004|Overall Study|Sponsor Decision|0|||
162702354|NCT04423393|587621766|FG005|Overall Study|Sponsor Decision|0|||
162702355|NCT04423393|587621767|FG006|Overall Study|Sponsor Decision|0|||
162702356|NCT04423393|587621768|FG007|Overall Study|Sponsor Decision|0|||
162702357|NCT04423393|587621769|FG008|Overall Study|Sponsor Decision|0|||
162702358|NCT04423393|587621770|FG009|Overall Study|Sponsor Decision|0|||
162702359|NCT04423393|587621771|FG010|Overall Study|Sponsor Decision|0|||
162702360|NCT04423393|587621772|FG011|Overall Study|Sponsor Decision|0|||
162702361|NCT04423393|587621773|FG012|Overall Study|Sponsor Decision|0|||
162702362|NCT04423393|587621774|FG013|Overall Study|Sponsor Decision|1|||
162702363|NCT04423393|587621775|FG014|Overall Study|Sponsor Decision|0|||
162702364|NCT04423393|587621776|FG015|Overall Study|Sponsor Decision|0|||
162702365|NCT04423393|587621777|FG016|Overall Study|Sponsor Decision|0|||
162702366|NCT04423393|587621778|FG017|Overall Study|Sponsor Decision|0|||
162702367|NCT00432159|587621779|FG000|Overall Study|Death|0|||
162702368|NCT00432159|587621780|FG001|Overall Study|Death|1|||
162702369|NCT00432159|587621781|FG002|Overall Study|Death|0|||
162702370|NCT00432159|587621782|FG003|Overall Study|Death|0|||
162702371|NCT00432159|587621783|FG004|Overall Study|Death|0|||
162702372|NCT00432159|587621779|FG000|Overall Study|Failure|9|||
162702373|NCT00432159|587621780|FG001|Overall Study|Failure|5|||
162702374|NCT00432159|587621781|FG002|Overall Study|Failure|3|||
162702375|NCT00432159|587621782|FG003|Overall Study|Failure|2|||
162846715|NCT00091832|588146619|FG004|Overall Study|Withdrawal by Subject|3|||
162846716|NCT00091832|588146620|FG005|Overall Study|Withdrawal by Subject|1|||
162846717|NCT00091832|588146615|FG000|Overall Study|Death|6|||
162846718|NCT00091832|588146616|FG001|Overall Study|Death|4|||
162846719|NCT00091832|588146617|FG002|Overall Study|Death|5|||
162846720|NCT00091832|588146618|FG003|Overall Study|Death|8|||
162846721|NCT00091832|588146619|FG004|Overall Study|Death|5|||
162846722|NCT00091832|588146620|FG005|Overall Study|Death|6|||
162702376|NCT00432159|587621783|FG004|Overall Study|Failure|3|||
162702377|NCT00432159|587621779|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
162702378|NCT00432159|587621780|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
162702379|NCT00432159|587621781|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
162846723|NCT00091832|588146615|FG000|Overall Study|Disease Progression|2|||
162846724|NCT00091832|588146616|FG001|Overall Study|Disease Progression|0|||
162702380|NCT00432159|587621782|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
162702381|NCT00432159|587621783|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
162702382|NCT00107380|587621784|FG000|Overall Study|Adverse Event|7|||
162846725|NCT00091832|588146617|FG002|Overall Study|Disease Progression|0|||
162846726|NCT00091832|588146618|FG003|Overall Study|Disease Progression|1|||
162846727|NCT00091832|588146619|FG004|Overall Study|Disease Progression|1|||
162846728|NCT00091832|588146620|FG005|Overall Study|Disease Progression|2|||
162846729|NCT00091832|588146615|FG000|Overall Study|Ineligibility Determined|0|||
162846730|NCT00091832|588146616|FG001|Overall Study|Ineligibility Determined|0|||
162846731|NCT00091832|588146617|FG002|Overall Study|Ineligibility Determined|1|||
162846732|NCT00091832|588146618|FG003|Overall Study|Ineligibility Determined|0|||
162846733|NCT00091832|588146619|FG004|Overall Study|Ineligibility Determined|1|||
162846734|NCT00091832|588146620|FG005|Overall Study|Ineligibility Determined|0|||
162846735|NCT00091832|588146615|FG000|Overall Study|Lost to Follow-up|1|||
162846736|NCT00091832|588146616|FG001|Overall Study|Lost to Follow-up|0|||
162846737|NCT00091832|588146617|FG002|Overall Study|Lost to Follow-up|3|||
162846738|NCT00091832|588146618|FG003|Overall Study|Lost to Follow-up|3|||
162846739|NCT00091832|588146619|FG004|Overall Study|Lost to Follow-up|2|||
162846740|NCT00091832|588146620|FG005|Overall Study|Lost to Follow-up|1|||
162846741|NCT00091832|588146615|FG000|Overall Study|Noncompliance|0|||
162846742|NCT00091832|588146616|FG001|Overall Study|Noncompliance|1|||
162846743|NCT00091832|588146617|FG002|Overall Study|Noncompliance|0|||
162846744|NCT00091832|588146618|FG003|Overall Study|Noncompliance|0|||
162846745|NCT00091832|588146619|FG004|Overall Study|Noncompliance|0|||
162846746|NCT00091832|588146620|FG005|Overall Study|Noncompliance|0|||
162846747|NCT00091832|588146615|FG000|Overall Study|Other|0|||
162846748|NCT00091832|588146616|FG001|Overall Study|Other|1|||
162846749|NCT00091832|588146617|FG002|Overall Study|Other|2|||
162846750|NCT00091832|588146618|FG003|Overall Study|Other|0|||
162846751|NCT00091832|588146619|FG004|Overall Study|Other|0|||
162846752|NCT00091832|588146620|FG005|Overall Study|Other|0|||
162846753|NCT00091832|588146615|FG000|Overall Study|Protocol Violation|0|||
162846754|NCT00091832|588146616|FG001|Overall Study|Protocol Violation|0|||
162846755|NCT00091832|588146617|FG002|Overall Study|Protocol Violation|1|||
162846756|NCT00091832|588146618|FG003|Overall Study|Protocol Violation|0|||
162846757|NCT00091832|588146619|FG004|Overall Study|Protocol Violation|0|||
162846758|NCT00091832|588146620|FG005|Overall Study|Protocol Violation|1|||
162846759|NCT00578643|588146626|FG000|Overall Study|Death|1|||
162846760|NCT00578643|588146626|FG000|Overall Study|Lost to Follow-up|1|||
162846761|NCT01725750|588146627|FG000|Overall Study|Adverse Event|1|||
162846762|NCT01725750|588146628|FG001|Overall Study|Adverse Event|0|||
162846763|NCT01725750|588146627|FG000|Overall Study|Lost to Follow-up|1|||
162846764|NCT01725750|588146628|FG001|Overall Study|Lost to Follow-up|1|||
162846765|NCT01725750|588146627|FG000|Overall Study|Withdrawal by Subject|0|||
162846766|NCT01725750|588146628|FG001|Overall Study|Withdrawal by Subject|9|||
162846767|NCT01634555|588146629|FG000|Overall Study|Adverse Event|3|||
162846768|NCT01634555|588146629|FG000|Overall Study|Physician Decision|1|||
162846769|NCT01506882|588146630|FG000|Overall Study|Lack of Efficacy|4|||
162846770|NCT01506882|588146631|FG001|Overall Study|Lack of Efficacy|3|||
162846771|NCT01506882|588146630|FG000|Overall Study|Lost to Follow-up|1|||
162846772|NCT01506882|588146631|FG001|Overall Study|Lost to Follow-up|0|||
162846773|NCT01506882|588146630|FG000|Overall Study|Withdrawal by Subject|9|||
162846774|NCT01506882|588146631|FG001|Overall Study|Withdrawal by Subject|3|||
162846775|NCT01506882|588146630|FG000|Overall Study|SAE, non-fatal|2|||
162846776|NCT01506882|588146631|FG001|Overall Study|SAE, non-fatal|0|||
162846777|NCT01506882|588146630|FG000|Overall Study|AE, non-serious non-fatal|3|||
162846778|NCT01506882|588146631|FG001|Overall Study|AE, non-serious non-fatal|1|||
162846779|NCT01506882|588146630|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
162846780|NCT01506882|588146631|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162846781|NCT01506882|588146630|FG000|Overall Study|Other Reason|2|||
162846782|NCT01506882|588146631|FG001|Overall Study|Other Reason|0|||
162846783|NCT03617705|588148514|FG000|Overall Study|Withdrawal by Subject|2|||
162846784|NCT03617705|588148514|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
162846785|NCT03617705|588148514|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
162846786|NCT03502187|588148515|FG000|Overall Study|Withdrawal by Subject|4|||
162846787|NCT03502187|588148516|FG001|Overall Study|Withdrawal by Subject|3|||
162846788|NCT03502187|588148517|FG002|Overall Study|Withdrawal by Subject|3|||
162846789|NCT03502187|588148515|FG000|Overall Study|Lost to Follow-up|5|||
162846790|NCT03502187|588148516|FG001|Overall Study|Lost to Follow-up|4|||
162846791|NCT03502187|588148517|FG002|Overall Study|Lost to Follow-up|5|||
162846792|NCT06118385|588148518|FG000|Overall Study|Protocol Violation|0|||
162846793|NCT06118385|588148519|FG001|Overall Study|Protocol Violation|0|||
162846794|NCT06118385|588148520|FG002|Overall Study|Protocol Violation|0|||
162846795|NCT06118385|588148521|FG003|Overall Study|Protocol Violation|0|||
162846796|NCT06118385|588148522|FG004|Overall Study|Protocol Violation|0|||
162846797|NCT06118385|588148523|FG005|Overall Study|Protocol Violation|0|||
162846798|NCT06118385|588148524|FG006|Overall Study|Protocol Violation|0|||
162846799|NCT06118385|588148525|FG007|Overall Study|Protocol Violation|0|||
162846800|NCT06118385|588148526|FG008|Overall Study|Protocol Violation|1|||
162846801|NCT06118385|588148527|FG009|Overall Study|Protocol Violation|0|||
162846802|NCT06118385|588148528|FG010|Overall Study|Protocol Violation|0|||
162846803|NCT06118385|588148529|FG011|Overall Study|Protocol Violation|0|||
162846804|NCT06118385|588148518|FG000|Overall Study|Out-of-range blood tests|0|||
162846805|NCT06118385|588148519|FG001|Overall Study|Out-of-range blood tests|0|||
162846806|NCT06118385|588148520|FG002|Overall Study|Out-of-range blood tests|0|||
162846807|NCT06118385|588148521|FG003|Overall Study|Out-of-range blood tests|0|||
162846808|NCT06118385|588148522|FG004|Overall Study|Out-of-range blood tests|0|||
162846809|NCT06118385|588148523|FG005|Overall Study|Out-of-range blood tests|0|||
162846810|NCT06118385|588148524|FG006|Overall Study|Out-of-range blood tests|0|||
162846811|NCT06118385|588148525|FG007|Overall Study|Out-of-range blood tests|0|||
162846812|NCT06118385|588148526|FG008|Overall Study|Out-of-range blood tests|1|||
162846813|NCT06118385|588148527|FG009|Overall Study|Out-of-range blood tests|0|||
162846814|NCT06118385|588148528|FG010|Overall Study|Out-of-range blood tests|0|||
162846815|NCT06118385|588148529|FG011|Overall Study|Out-of-range blood tests|0|||
162846816|NCT01554579|588148530|FG000|Overall Study|Adverse Event|6|||
162846817|NCT01554579|588148531|FG001|Overall Study|Adverse Event|25|||
162846818|NCT01554579|588148530|FG000|Overall Study|Lack of Efficacy|2|||
162846819|NCT01554579|588148531|FG001|Overall Study|Lack of Efficacy|1|||
162846820|NCT01554579|588148530|FG000|Overall Study|Withdrawal by Subject|2|||
162846821|NCT01554579|588148531|FG001|Overall Study|Withdrawal by Subject|1|||
162846822|NCT03072160|588148532|FG000|Overall Study|Adverse Event|3|||
162846823|NCT03072160|588148533|FG001|Overall Study|Adverse Event|1|||
162846824|NCT03072160|588148532|FG000|Overall Study|Refused further treatment|6|||
162846825|NCT03072160|588148533|FG001|Overall Study|Refused further treatment|1|||
162846826|NCT03072160|588148532|FG000|Overall Study|Physician Decision|1|||
162846827|NCT03072160|588148533|FG001|Overall Study|Physician Decision|0|||
162846828|NCT03072160|588148532|FG000|Overall Study|Disease progression on study|1|||
162846829|NCT03072160|588148533|FG001|Overall Study|Disease progression on study|1|||
162846830|NCT03072160|588148532|FG000|Overall Study|No contact|0|||
162846831|NCT03072160|588148533|FG001|Overall Study|No contact|1|||
162846832|NCT01046695|588148534|FG000|Overall Study|Subject had a pacemaker|0|||
162846833|NCT01046695|588148535|FG001|Overall Study|Subject had a pacemaker|1|||
162846834|NCT01046695|588148534|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
162846835|NCT01046695|588148535|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
162846836|NCT00559273|588148536|FG000|Correction Period (20 Weeks)|Death|3|||
162846837|NCT00559273|588148537|FG001|Correction Period (20 Weeks)|Death|4|||
162846838|NCT00559273|588148536|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
162846839|NCT00559273|588148537|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
162846840|NCT00559273|588148536|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
162846841|NCT00559273|588148537|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
162846842|NCT00559273|588148536|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
162846843|NCT00559273|588148537|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
162846844|NCT00559273|588148536|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
162846845|NCT00559273|588148537|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
162846846|NCT00559273|588148536|FG000|Evaluation Period (8 Weeks)|Death|1|||
162846847|NCT00559273|588148537|FG001|Evaluation Period (8 Weeks)|Death|3|||
162846848|NCT00559273|588148536|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
162846849|NCT00559273|588148537|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
162846850|NCT00559273|588148536|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
162846851|NCT00559273|588148537|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
162846852|NCT00559273|588148536|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
162846853|NCT00559273|588148537|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
162846854|NCT03653390|588148541|FG000|Overall Study|Lost to Follow-up|12|||
162846855|NCT03653390|588148542|FG001|Overall Study|Lost to Follow-up|8|||
162846856|NCT03653390|588148543|FG002|Overall Study|Lost to Follow-up|7|||
162846857|NCT03653390|588148541|FG000|Overall Study|Withdrawal by Subject|6|||
162846858|NCT03653390|588148542|FG001|Overall Study|Withdrawal by Subject|1|||
162846859|NCT03653390|588148543|FG002|Overall Study|Withdrawal by Subject|1|||
162846860|NCT03653390|588148541|FG000|Overall Study|Death|1|||
162846861|NCT03653390|588148542|FG001|Overall Study|Death|0|||
162846862|NCT03653390|588148543|FG002|Overall Study|Death|0|||
162846863|NCT03653390|588148541|FG000|Overall Study|Paper Survey Lost|1|||
162846864|NCT03653390|588148542|FG001|Overall Study|Paper Survey Lost|0|||
162846865|NCT03653390|588148543|FG002|Overall Study|Paper Survey Lost|0|||
162846866|NCT01500057|588148546|FG000|Overall Study|Lost to Follow-up|6|||
162846867|NCT01500057|588148547|FG001|Overall Study|Lost to Follow-up|4|||
162846868|NCT02318784|588148550|FG000|Overall Study|Adverse Event|13|||
162846869|NCT02318784|588148550|FG000|Overall Study|Death|2|||
162846870|NCT02318784|588148550|FG000|Overall Study|Progressive Disease|37|||
162846871|NCT02318784|588148550|FG000|Overall Study|Withdrawal by Subject|10|||
162846872|NCT03603652|588148555|FG000|Overall Study|Death|2|||
162846873|NCT03213366|588148560|FG000|Overall Study|Lost to Follow-up|9|||
162846874|NCT03213366|588148561|FG001|Overall Study|Lost to Follow-up|4|||
162846875|NCT02532855|588148562|FG000|Overall Study|Lost to Follow-up|4|||
162846876|NCT02532855|588148563|FG001|Overall Study|Lost to Follow-up|3|||
162846877|NCT02532855|588148562|FG000|Overall Study|Withdrawal by Subject|4|||
162846878|NCT02532855|588148563|FG001|Overall Study|Withdrawal by Subject|8|||
162846879|NCT00666926|588148564|FG000|Overall Study|Adverse Event|0|||
162846880|NCT00666926|588148565|FG001|Overall Study|Adverse Event|0|||
162846881|NCT00666926|588148566|FG002|Overall Study|Adverse Event|0|||
162846882|NCT00666926|588148567|FG003|Overall Study|Adverse Event|0|||
162846883|NCT00666926|588148568|FG004|Overall Study|Adverse Event|0|||
162846884|NCT00666926|588148569|FG005|Overall Study|Adverse Event|0|||
162846885|NCT00666926|588148570|FG006|Overall Study|Adverse Event|0|||
162846886|NCT00666926|588148571|FG007|Overall Study|Adverse Event|0|||
162846887|NCT00666926|588148572|FG008|Overall Study|Adverse Event|0|||
162846888|NCT00666926|588148573|FG009|Overall Study|Adverse Event|2|||
162846889|NCT00666926|588148574|FG010|Overall Study|Adverse Event|2|||
162846890|NCT00666926|588148575|FG011|Overall Study|Adverse Event|2|||
162846891|NCT00666926|588148576|FG012|Overall Study|Adverse Event|0|||
162846892|NCT00666926|588148577|FG013|Overall Study|Adverse Event|1|||
162846893|NCT00666926|588148578|FG014|Overall Study|Adverse Event|0|||
162846894|NCT00666926|588148579|FG015|Overall Study|Adverse Event|0|||
162846895|NCT00666926|588148564|FG000|Overall Study|Laboratory abnormality|0|||
162846896|NCT00666926|588148565|FG001|Overall Study|Laboratory abnormality|0|||
162846897|NCT00666926|588148566|FG002|Overall Study|Laboratory abnormality|0|||
162846898|NCT00666926|588148567|FG003|Overall Study|Laboratory abnormality|0|||
162846899|NCT00666926|588148568|FG004|Overall Study|Laboratory abnormality|0|||
162846900|NCT00666926|588148569|FG005|Overall Study|Laboratory abnormality|0|||
162846901|NCT00666926|588148570|FG006|Overall Study|Laboratory abnormality|0|||
162846902|NCT00666926|588148571|FG007|Overall Study|Laboratory abnormality|0|||
162846903|NCT00666926|588148572|FG008|Overall Study|Laboratory abnormality|0|||
162846904|NCT00666926|588148573|FG009|Overall Study|Laboratory abnormality|0|||
162846905|NCT00666926|588148574|FG010|Overall Study|Laboratory abnormality|1|||
162846906|NCT00666926|588148575|FG011|Overall Study|Laboratory abnormality|0|||
162846907|NCT00666926|588148576|FG012|Overall Study|Laboratory abnormality|0|||
162846908|NCT00666926|588148577|FG013|Overall Study|Laboratory abnormality|0|||
162846909|NCT00666926|588148578|FG014|Overall Study|Laboratory abnormality|0|||
162846910|NCT00666926|588148579|FG015|Overall Study|Laboratory abnormality|1|||
162846911|NCT00666926|588148564|FG000|Overall Study|Lack of Efficacy|0|||
162846912|NCT00666926|588148565|FG001|Overall Study|Lack of Efficacy|0|||
162846913|NCT00666926|588148566|FG002|Overall Study|Lack of Efficacy|0|||
162846914|NCT00666926|588148567|FG003|Overall Study|Lack of Efficacy|0|||
162846915|NCT00666926|588148568|FG004|Overall Study|Lack of Efficacy|0|||
162846916|NCT00666926|588148569|FG005|Overall Study|Lack of Efficacy|1|||
162846917|NCT00666926|588148570|FG006|Overall Study|Lack of Efficacy|0|||
162846918|NCT00666926|588148571|FG007|Overall Study|Lack of Efficacy|0|||
162846919|NCT00666926|588148572|FG008|Overall Study|Lack of Efficacy|0|||
162846920|NCT00666926|588148573|FG009|Overall Study|Lack of Efficacy|0|||
162846921|NCT00666926|588148574|FG010|Overall Study|Lack of Efficacy|0|||
162846922|NCT00666926|588148575|FG011|Overall Study|Lack of Efficacy|1|||
162846923|NCT00666926|588148576|FG012|Overall Study|Lack of Efficacy|0|||
162846924|NCT00666926|588148577|FG013|Overall Study|Lack of Efficacy|0|||
162846925|NCT00666926|588148578|FG014|Overall Study|Lack of Efficacy|0|||
162846926|NCT00666926|588148579|FG015|Overall Study|Lack of Efficacy|0|||
162846927|NCT00666926|588148564|FG000|Overall Study|Lost to Follow-up|0|||
162846928|NCT00666926|588148565|FG001|Overall Study|Lost to Follow-up|0|||
162846929|NCT00666926|588148566|FG002|Overall Study|Lost to Follow-up|0|||
162846930|NCT00666926|588148567|FG003|Overall Study|Lost to Follow-up|1|||
162846931|NCT00666926|588148568|FG004|Overall Study|Lost to Follow-up|0|||
162846932|NCT00666926|588148569|FG005|Overall Study|Lost to Follow-up|0|||
162846933|NCT00666926|588148570|FG006|Overall Study|Lost to Follow-up|0|||
162846934|NCT00666926|588148571|FG007|Overall Study|Lost to Follow-up|0|||
162846935|NCT00666926|588148572|FG008|Overall Study|Lost to Follow-up|0|||
162846936|NCT00666926|588148573|FG009|Overall Study|Lost to Follow-up|0|||
162846937|NCT00666926|588148574|FG010|Overall Study|Lost to Follow-up|0|||
162846938|NCT00666926|588148575|FG011|Overall Study|Lost to Follow-up|0|||
162846939|NCT00666926|588148576|FG012|Overall Study|Lost to Follow-up|0|||
162846940|NCT00666926|588148577|FG013|Overall Study|Lost to Follow-up|0|||
162846941|NCT00666926|588148578|FG014|Overall Study|Lost to Follow-up|0|||
162846942|NCT00666926|588148579|FG015|Overall Study|Lost to Follow-up|0|||
162846943|NCT00666926|588148564|FG000|Overall Study|Other|2|||
162846944|NCT00666926|588148565|FG001|Overall Study|Other|4|||
162846945|NCT00666926|588148566|FG002|Overall Study|Other|3|||
162846946|NCT00666926|588148567|FG003|Overall Study|Other|3|||
162846947|NCT00666926|588148568|FG004|Overall Study|Other|3|||
162846948|NCT00666926|588148569|FG005|Overall Study|Other|3|||
162846949|NCT00666926|588148570|FG006|Overall Study|Other|4|||
162846950|NCT00666926|588148571|FG007|Overall Study|Other|0|||
162846951|NCT00666926|588148572|FG008|Overall Study|Other|3|||
162846952|NCT00666926|588148573|FG009|Overall Study|Other|5|||
162846953|NCT00666926|588148574|FG010|Overall Study|Other|3|||
162846954|NCT00666926|588148575|FG011|Overall Study|Other|26|||
162846955|NCT00666926|588148576|FG012|Overall Study|Other|3|||
162846956|NCT00666926|588148577|FG013|Overall Study|Other|2|||
162846957|NCT00666926|588148578|FG014|Overall Study|Other|4|||
162846958|NCT00666926|588148579|FG015|Overall Study|Other|4|||
162846959|NCT00666926|588148564|FG000|Overall Study|Withdrawal by Subject|0|||
162846960|NCT00666926|588148565|FG001|Overall Study|Withdrawal by Subject|0|||
162846961|NCT00666926|588148566|FG002|Overall Study|Withdrawal by Subject|0|||
162846962|NCT00666926|588148567|FG003|Overall Study|Withdrawal by Subject|0|||
162846963|NCT00666926|588148568|FG004|Overall Study|Withdrawal by Subject|0|||
162846964|NCT00666926|588148569|FG005|Overall Study|Withdrawal by Subject|0|||
162846965|NCT00666926|588148570|FG006|Overall Study|Withdrawal by Subject|0|||
162846966|NCT00666926|588148571|FG007|Overall Study|Withdrawal by Subject|1|||
162846967|NCT00666926|588148572|FG008|Overall Study|Withdrawal by Subject|0|||
162846968|NCT00666926|588148573|FG009|Overall Study|Withdrawal by Subject|3|||
162846969|NCT00666926|588148574|FG010|Overall Study|Withdrawal by Subject|0|||
162846970|NCT00666926|588148575|FG011|Overall Study|Withdrawal by Subject|3|||
162846971|NCT00666926|588148576|FG012|Overall Study|Withdrawal by Subject|0|||
162846972|NCT00666926|588148577|FG013|Overall Study|Withdrawal by Subject|1|||
162846973|NCT00666926|588148578|FG014|Overall Study|Withdrawal by Subject|3|||
162846974|NCT00666926|588148579|FG015|Overall Study|Withdrawal by Subject|3|||
162846975|NCT00666926|588148564|FG000|Overall Study|Death|0|||
162846976|NCT00666926|588148565|FG001|Overall Study|Death|0|||
162846977|NCT00666926|588148566|FG002|Overall Study|Death|0|||
162846978|NCT00666926|588148567|FG003|Overall Study|Death|0|||
162846979|NCT00666926|588148568|FG004|Overall Study|Death|0|||
162846980|NCT00666926|588148569|FG005|Overall Study|Death|0|||
162846981|NCT00666926|588148570|FG006|Overall Study|Death|0|||
162846982|NCT00666926|588148571|FG007|Overall Study|Death|0|||
162846983|NCT00666926|588148572|FG008|Overall Study|Death|0|||
162846984|NCT00666926|588148573|FG009|Overall Study|Death|0|||
162846985|NCT00666926|588148574|FG010|Overall Study|Death|0|||
162846986|NCT00666926|588148575|FG011|Overall Study|Death|1|||
162846987|NCT00666926|588148576|FG012|Overall Study|Death|0|||
162846988|NCT00666926|588148577|FG013|Overall Study|Death|0|||
162846989|NCT00666926|588148578|FG014|Overall Study|Death|0|||
162846990|NCT00666926|588148579|FG015|Overall Study|Death|0|||
162846991|NCT01960855|588148582|FG000|Overall Study|Subject noncompliant|1|||
162846992|NCT01960855|588148583|FG001|Overall Study|Subject noncompliant|0|||
162846993|NCT01960855|588148584|FG002|Overall Study|Subject noncompliant|0|||
162846994|NCT01960855|588148585|FG003|Overall Study|Subject noncompliant|0|||
162846995|NCT01960855|588148586|FG004|Overall Study|Subject noncompliant|0|||
162846996|NCT01960855|588148582|FG000|Overall Study|Adverse Event|2|||
162846997|NCT01960855|588148583|FG001|Overall Study|Adverse Event|0|||
162846998|NCT01960855|588148584|FG002|Overall Study|Adverse Event|6|||
162846999|NCT01960855|588148585|FG003|Overall Study|Adverse Event|2|||
162847000|NCT01960855|588148586|FG004|Overall Study|Adverse Event|2|||
162847001|NCT01960855|588148582|FG000|Overall Study|Lack of Efficacy|1|||
162847002|NCT01960855|588148583|FG001|Overall Study|Lack of Efficacy|1|||
162847003|NCT01960855|588148584|FG002|Overall Study|Lack of Efficacy|0|||
162847004|NCT01960855|588148585|FG003|Overall Study|Lack of Efficacy|0|||
162847005|NCT01960855|588148586|FG004|Overall Study|Lack of Efficacy|0|||
162847006|NCT01960855|588148582|FG000|Overall Study|Other|2|||
163043224|NCT00110357|588865758|FG000|Overall Study|Disease progression/relapse|20|||
163043225|NCT00110357|588865759|FG001|Overall Study|Disease progression/relapse|15|||
162847007|NCT01960855|588148583|FG001|Overall Study|Other|1|||
162847008|NCT01960855|588148584|FG002|Overall Study|Other|1|||
162847009|NCT01960855|588148585|FG003|Overall Study|Other|1|||
162847010|NCT01960855|588148586|FG004|Overall Study|Other|0|||
162847011|NCT01960855|588148582|FG000|Overall Study|Consent withdrawn by subject|3|||
162847012|NCT01960855|588148583|FG001|Overall Study|Consent withdrawn by subject|1|||
162847013|NCT01960855|588148584|FG002|Overall Study|Consent withdrawn by subject|2|||
162847014|NCT01960855|588148585|FG003|Overall Study|Consent withdrawn by subject|1|||
162847015|NCT01960855|588148586|FG004|Overall Study|Consent withdrawn by subject|1|||
162847016|NCT01960855|588148582|FG000|Overall Study|Lost to Follow-up|2|||
162847017|NCT01960855|588148583|FG001|Overall Study|Lost to Follow-up|1|||
162847018|NCT01960855|588148584|FG002|Overall Study|Lost to Follow-up|0|||
162847019|NCT01960855|588148585|FG003|Overall Study|Lost to Follow-up|0|||
162847020|NCT01960855|588148586|FG004|Overall Study|Lost to Follow-up|2|||
162847021|NCT01879410|588148587|FG000|Overall Study|Adverse Event|9|||
162847022|NCT01879410|588148588|FG001|Overall Study|Adverse Event|14|||
162847023|NCT01879410|588148587|FG000|Overall Study|Lack of Efficacy|4|||
162847024|NCT01879410|588148588|FG001|Overall Study|Lack of Efficacy|6|||
162847025|NCT01879410|588148587|FG000|Overall Study|Protocol Violation|1|||
162847026|NCT01879410|588148588|FG001|Overall Study|Protocol Violation|7|||
162847027|NCT01879410|588148587|FG000|Overall Study|Lost to Follow-up|2|||
162847028|NCT01879410|588148588|FG001|Overall Study|Lost to Follow-up|1|||
162847029|NCT01879410|588148587|FG000|Overall Study|Withdrawal by Subject|7|||
162847030|NCT01879410|588148588|FG001|Overall Study|Withdrawal by Subject|8|||
162847031|NCT01879410|588148587|FG000|Overall Study|Randomised in Error|1|||
162847032|NCT01879410|588148588|FG001|Overall Study|Randomised in Error|2|||
162847033|NCT02058147|588148589|FG000|Overall Study|Randomized but not treated|0|||
162847034|NCT02058147|588148590|FG001|Overall Study|Randomized but not treated|0|||
162847035|NCT02058147|588148591|FG002|Overall Study|Randomized but not treated|1|||
162847036|NCT02058147|588148589|FG000|Overall Study|Adverse Event|12|||
162847037|NCT02058147|588148590|FG001|Overall Study|Adverse Event|9|||
162847038|NCT02058147|588148591|FG002|Overall Study|Adverse Event|21|||
162847039|NCT02058147|588148589|FG000|Overall Study|Lack of Efficacy|1|||
162847040|NCT02058147|588148590|FG001|Overall Study|Lack of Efficacy|0|||
162847041|NCT02058147|588148591|FG002|Overall Study|Lack of Efficacy|3|||
162847042|NCT02058147|588148589|FG000|Overall Study|Poor compliance to protocol|8|||
162847043|NCT02058147|588148590|FG001|Overall Study|Poor compliance to protocol|9|||
162847044|NCT02058147|588148591|FG002|Overall Study|Poor compliance to protocol|4|||
162847045|NCT02058147|588148589|FG000|Overall Study|Other than specified|8|||
162847046|NCT02058147|588148590|FG001|Overall Study|Other than specified|9|||
162847047|NCT02058147|588148591|FG002|Overall Study|Other than specified|0|||
162847048|NCT04178772|588148593|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
162847049|NCT04178772|588148593|FG000|Overall Study|study terminated early due to COVID-19|7|||
162847050|NCT00773279|588148594|FG000|Period 1|Adverse Event|2|||
162847051|NCT00773279|588148595|FG001|Period 1|Adverse Event|1|||
162847052|NCT00773279|588148594|FG000|Period 1|Lack of Efficacy|0|||
162847053|NCT00773279|588148595|FG001|Period 1|Lack of Efficacy|2|||
162847054|NCT00773279|588148594|FG000|Period 1|Unclassified|5|||
162847055|NCT00773279|588148595|FG001|Period 1|Unclassified|1|||
162847056|NCT00773279|588148594|FG000|Period 2|Adverse Event|0|||
162847057|NCT00773279|588148595|FG001|Period 2|Adverse Event|1|||
162847058|NCT00773279|588148594|FG000|Period 2|Lack of Efficacy|1|||
162847059|NCT00773279|588148595|FG001|Period 2|Lack of Efficacy|0|||
162847060|NCT00773279|588148594|FG000|Period 2|Protocol Violation|0|||
162847061|NCT00773279|588148595|FG001|Period 2|Protocol Violation|3|||
162847062|NCT00773279|588148594|FG000|Period 2|Unclassified|2|||
162847063|NCT00773279|588148595|FG001|Period 2|Unclassified|2|||
162847064|NCT01737931|588148596|FG000|Overall Study|Withdrawal by Subject|0|||
162847065|NCT01737931|588148597|FG001|Overall Study|Withdrawal by Subject|1|||
162847066|NCT01737931|588148598|FG002|Overall Study|Withdrawal by Subject|1|||
162847067|NCT01737931|588148596|FG000|Overall Study|Physician Decision|0|||
162847068|NCT01737931|588148597|FG001|Overall Study|Physician Decision|1|||
162847069|NCT01737931|588148598|FG002|Overall Study|Physician Decision|0|||
162847070|NCT04897867|588148599|FG000|Overall Study|Withdrawal of Consent|1|||
162847071|NCT04897867|588148599|FG000|Overall Study|Pregnancy|1|||
162847072|NCT04897867|588148599|FG000|Overall Study|Lost to Follow-up|7|||
162847073|NCT04897867|588148599|FG000|Overall Study|Reason not Specified|2|||
162847074|NCT01481896|588148602|FG000|Overall Study|Lost to Follow-up|12|||
162847075|NCT00364182|588148604|FG000|First Intervention|Secondary prophylaxis|1|||
162847076|NCT00364182|588148605|FG001|First Intervention|Secondary prophylaxis|0|||
162847077|NCT00364182|588148606|FG002|First Intervention|Secondary prophylaxis|0|||
162847078|NCT00364182|588148604|FG000|First Intervention|Withdrawal by Subject|2|||
162847079|NCT00364182|588148605|FG001|First Intervention|Withdrawal by Subject|0|||
162847080|NCT00364182|588148606|FG002|First Intervention|Withdrawal by Subject|0|||
162847081|NCT00364182|588148604|FG000|Second Intervention|non-compliance|0|||
162847082|NCT00364182|588148605|FG001|Second Intervention|non-compliance|1|||
162847083|NCT00364182|588148606|FG002|Second Intervention|non-compliance|1|||
162847084|NCT00364182|588148604|FG000|Second Intervention|Protocol Violation|0|||
162847085|NCT00364182|588148605|FG001|Second Intervention|Protocol Violation|1|||
162847086|NCT00364182|588148606|FG002|Second Intervention|Protocol Violation|0|||
162847087|NCT00364182|588148604|FG000|Second Intervention|Adverse Event|0|||
162847088|NCT00364182|588148605|FG001|Second Intervention|Adverse Event|0|||
162847089|NCT00364182|588148606|FG002|Second Intervention|Adverse Event|1|||
162847090|NCT00364182|588148604|FG000|Third Intervention|non-compliance|0|||
162847091|NCT00364182|588148605|FG001|Third Intervention|non-compliance|1|||
162847092|NCT00364182|588148606|FG002|Third Intervention|non-compliance|0|||
162847093|NCT00364182|588148604|FG000|Third Intervention|Lost to Follow-up|0|||
162847094|NCT00364182|588148605|FG001|Third Intervention|Lost to Follow-up|0|||
162847095|NCT00364182|588148606|FG002|Third Intervention|Lost to Follow-up|1|||
162847096|NCT03336502|588148608|FG000|Overall Study|Physician Decision|0|||
162847097|NCT03336502|588148609|FG001|Overall Study|Physician Decision|1|||
162847098|NCT03336502|588148608|FG000|Overall Study|Prohibited Drugs|1|||
162847099|NCT03336502|588148609|FG001|Overall Study|Prohibited Drugs|1|||
162847100|NCT03336502|588148608|FG000|Overall Study|Death|1|||
162847101|NCT03336502|588148609|FG001|Overall Study|Death|2|||
162847102|NCT03336502|588148608|FG000|Overall Study|Adverse Event|2|||
162847103|NCT03336502|588148609|FG001|Overall Study|Adverse Event|5|||
162847104|NCT02601573|588148610|FG000|Overall Study|Lost to Follow-up|0|||
162847105|NCT02601573|588148611|FG001|Overall Study|Lost to Follow-up|3|||
162847106|NCT02601573|588148612|FG002|Overall Study|Lost to Follow-up|1|||
162847107|NCT02601573|588148613|FG003|Overall Study|Lost to Follow-up|0|||
162847108|NCT02601573|588148614|FG004|Overall Study|Lost to Follow-up|2|||
162847109|NCT02601573|588148610|FG000|Overall Study|Withdrawal by Subject|0|||
162847110|NCT02601573|588148611|FG001|Overall Study|Withdrawal by Subject|1|||
162847111|NCT02601573|588148612|FG002|Overall Study|Withdrawal by Subject|0|||
162847112|NCT02601573|588148613|FG003|Overall Study|Withdrawal by Subject|1|||
162847113|NCT02601573|588148614|FG004|Overall Study|Withdrawal by Subject|0|||
162847114|NCT01850615|588148615|FG000|Overall Study|Protocol Violation|4|||
162847115|NCT01850615|588148616|FG001|Overall Study|Protocol Violation|1|||
162847116|NCT01850615|588148615|FG000|Overall Study|Adverse Event|2|||
162847117|NCT01850615|588148616|FG001|Overall Study|Adverse Event|1|||
162847118|NCT01850615|588148615|FG000|Overall Study|Withdrawal by Subject|3|||
162847119|NCT01850615|588148616|FG001|Overall Study|Withdrawal by Subject|1|||
162847120|NCT01850615|588148615|FG000|Overall Study|Lost to Follow-up|0|||
162847121|NCT01850615|588148616|FG001|Overall Study|Lost to Follow-up|1|||
162847122|NCT01850615|588148615|FG000|Overall Study|Unclassified|0|||
162847123|NCT01850615|588148616|FG001|Overall Study|Unclassified|1|||
162847124|NCT00706628|588148617|FG000|Overall Study|Other Adverse Event|16|||
162847125|NCT00706628|588148618|FG001|Overall Study|Other Adverse Event|5|||
162847126|NCT00706628|588148619|FG002|Overall Study|Other Adverse Event|5|||
162847127|NCT00706628|588148620|FG003|Overall Study|Other Adverse Event|2|||
162847128|NCT00706628|588148617|FG000|Overall Study|Non compliant with protocol|0|||
162847129|NCT00706628|588148618|FG001|Overall Study|Non compliant with protocol|1|||
162847130|NCT00706628|588148619|FG002|Overall Study|Non compliant with protocol|0|||
162847131|NCT00706628|588148620|FG003|Overall Study|Non compliant with protocol|0|||
162847132|NCT00706628|588148617|FG000|Overall Study|Consent withdrawn|6|||
162847133|NCT00706628|588148618|FG001|Overall Study|Consent withdrawn|1|||
162847134|NCT00706628|588148619|FG002|Overall Study|Consent withdrawn|3|||
162847135|NCT00706628|588148620|FG003|Overall Study|Consent withdrawn|0|||
162847136|NCT00706628|588148617|FG000|Overall Study|Progressive disease|20|||
162847137|NCT00706628|588148618|FG001|Overall Study|Progressive disease|13|||
162847138|NCT00706628|588148619|FG002|Overall Study|Progressive disease|8|||
162847139|NCT00706628|588148620|FG003|Overall Study|Progressive disease|1|||
162847140|NCT00706628|588148617|FG000|Overall Study|Other than those stated above|4|||
162847141|NCT00706628|588148618|FG001|Overall Study|Other than those stated above|0|||
162847142|NCT00706628|588148619|FG002|Overall Study|Other than those stated above|0|||
162847143|NCT00706628|588148620|FG003|Overall Study|Other than those stated above|0|||
162847144|NCT00706628|588148617|FG000|Overall Study|Not treated|1|||
162847145|NCT00706628|588148618|FG001|Overall Study|Not treated|1|||
162847146|NCT00706628|588148619|FG002|Overall Study|Not treated|0|||
162847147|NCT00706628|588148620|FG003|Overall Study|Not treated|0|||
162847148|NCT02921425|588148621|FG000|Overall Study|Protocol Violation|9|||
162847149|NCT01227967|588148622|FG000|Overall Study|Protocol Violation|3|||
162847150|NCT01227967|588148623|FG001|Overall Study|Protocol Violation|1|||
162847151|NCT01227967|588148622|FG000|Overall Study|Death|0|||
162847152|NCT01227967|588148623|FG001|Overall Study|Death|1|||
162847153|NCT01227967|588148622|FG000|Overall Study|Lost to Follow-up|8|||
162847154|NCT01227967|588148623|FG001|Overall Study|Lost to Follow-up|3|||
162847155|NCT01227967|588148622|FG000|Overall Study|Withdrawal by Subject|4|||
162847156|NCT01227967|588148623|FG001|Overall Study|Withdrawal by Subject|3|||
162847157|NCT01227967|588148622|FG000|Overall Study|Physician Decision|0|||
162847158|NCT01227967|588148623|FG001|Overall Study|Physician Decision|1|||
162847159|NCT01227967|588148622|FG000|Overall Study|Never Started Treatment|0|||
162847160|NCT01227967|588148623|FG001|Overall Study|Never Started Treatment|4|||
162847161|NCT01227967|588148622|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
162847162|NCT01227967|588148623|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
162847163|NCT03403400|588148624|FG000|Overall Study|Lost to Follow-up|1|||
162847164|NCT03403400|588148625|FG001|Overall Study|Lost to Follow-up|0|||
162847165|NCT03403400|588148626|FG002|Overall Study|Lost to Follow-up|1|||
162847166|NCT03403400|588148624|FG000|Overall Study|Hospitalization|1|||
162847167|NCT03403400|588148625|FG001|Overall Study|Hospitalization|0|||
162847168|NCT03403400|588148626|FG002|Overall Study|Hospitalization|0|||
162847169|NCT03403400|588148624|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
162847170|NCT03403400|588148625|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
162847171|NCT03403400|588148626|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
162847172|NCT01107444|588148630|FG000|Overall Study|Withdrawal by Subject|8|||
162847173|NCT01107444|588148631|FG001|Overall Study|Withdrawal by Subject|12|||
162847174|NCT01107444|588148630|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
162847175|NCT01107444|588148631|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
162847176|NCT00737529|588148632|FG000|Overall Study|Disease Progression|95|||
162847177|NCT00737529|588148632|FG000|Overall Study|Adverse Event|24|||
162847178|NCT00737529|588148632|FG000|Overall Study|Withdrawal by Subject|5|||
162847179|NCT00737529|588148632|FG000|Overall Study|Death|4|||
162847180|NCT00737529|588148632|FG000|Overall Study|Protocol Violation|1|||
162847181|NCT00737529|588148632|FG000|Overall Study|Other|4|||
162847182|NCT01948830|588148633|FG000|Overall Study|Physician Decision|1|||
162847183|NCT01948830|588148634|FG001|Overall Study|Physician Decision|3|||
162847184|NCT01948830|588148633|FG000|Overall Study|Protocol deviation|1|||
162847185|NCT01948830|588148634|FG001|Overall Study|Protocol deviation|2|||
162847186|NCT01948830|588148633|FG000|Overall Study|Lost to Follow-up|5|||
162847187|NCT01948830|588148634|FG001|Overall Study|Lost to Follow-up|4|||
162847188|NCT01948830|588148633|FG000|Overall Study|Withdrawal by Subject|14|||
162847189|NCT01948830|588148634|FG001|Overall Study|Withdrawal by Subject|17|||
162847190|NCT01948830|588148633|FG000|Overall Study|Adverse Event|9|||
162847191|NCT01948830|588148634|FG001|Overall Study|Adverse Event|2|||
162847192|NCT01948830|588148633|FG000|Overall Study|Death|3|||
162847193|NCT01948830|588148634|FG001|Overall Study|Death|4|||
162847194|NCT01145560|588148635|FG000|Overall Study|Withdrawal by Subject|2|||
162847195|NCT01145560|588148636|FG001|Overall Study|Withdrawal by Subject|1|||
162847196|NCT01145560|588148637|FG002|Overall Study|Withdrawal by Subject|0|||
162847197|NCT01145560|588148635|FG000|Overall Study|Lost to Follow-up|1|||
162847198|NCT01145560|588148636|FG001|Overall Study|Lost to Follow-up|1|||
162847199|NCT01145560|588148637|FG002|Overall Study|Lost to Follow-up|1|||
162847200|NCT01145560|588148635|FG000|Overall Study|No study drug by 24h after organ failure|1|||
162847201|NCT01145560|588148636|FG001|Overall Study|No study drug by 24h after organ failure|0|||
162847202|NCT01145560|588148637|FG002|Overall Study|No study drug by 24h after organ failure|0|||
162847203|NCT01145560|588148635|FG000|Overall Study|Accidental unblinding of study treatment|0|||
162847204|NCT01145560|588148636|FG001|Overall Study|Accidental unblinding of study treatment|1|||
162847205|NCT01145560|588148637|FG002|Overall Study|Accidental unblinding of study treatment|0|||
162847206|NCT01145560|588148635|FG000|Overall Study|False insurance information|0|||
162847207|NCT01145560|588148636|FG001|Overall Study|False insurance information|1|||
162847208|NCT01145560|588148637|FG002|Overall Study|False insurance information|0|||
162847209|NCT01145560|588148635|FG000|Overall Study|Withdrawal of therapy|0|||
162847210|NCT01145560|588148636|FG001|Overall Study|Withdrawal of therapy|0|||
162847211|NCT01145560|588148637|FG002|Overall Study|Withdrawal of therapy|1|||
162847212|NCT00712348|588148638|FG000|Overall Study|Withdrawal by Subject|1|||
162847213|NCT03310970|588148640|FG000|Overall Study|Withdrawal by Subject|0|||
162847214|NCT03310970|588148641|FG001|Overall Study|Withdrawal by Subject|1|||
162847215|NCT01446419|588148646|FG000|Overall Study|Death|1|||
162847216|NCT01446419|588148647|FG001|Overall Study|Death|0|||
162847217|NCT01446419|588148646|FG000|Overall Study|Withdrawal by Subject|1|||
162847218|NCT01446419|588148647|FG001|Overall Study|Withdrawal by Subject|1|||
162847219|NCT01446419|588148646|FG000|Overall Study|Terminated per protocol|3|||
162847220|NCT01446419|588148647|FG001|Overall Study|Terminated per protocol|0|||
162847221|NCT01557166|588148648|FG000|Overall Study|Adverse Event|20|||
162847222|NCT01557166|588148649|FG001|Overall Study|Adverse Event|6|||
162847223|NCT01557166|588148648|FG000|Overall Study|Lack of Efficacy|2|||
162847224|NCT01557166|588148649|FG001|Overall Study|Lack of Efficacy|1|||
162847225|NCT01557166|588148648|FG000|Overall Study|Protocol Violation|8|||
162847226|NCT01557166|588148649|FG001|Overall Study|Protocol Violation|5|||
162847227|NCT01557166|588148648|FG000|Overall Study|Withdrawn consent|12|||
162702383|NCT00107380|587621784|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
162702384|NCT00107380|587621784|FG000|Overall Study|Progression/relapse|4|||
162702385|NCT00107380|587621784|FG000|Overall Study|Death|3|||
162702386|NCT00107380|587621784|FG000|Overall Study|Other - not protocol specified|7|||
162702387|NCT00107380|587621784|FG000|Overall Study|Ineligible|2|||
162702388|NCT03673098|587621785|FG000|Overall Study|Lost to Follow-up|2|||
162847228|NCT01557166|588148649|FG001|Overall Study|Withdrawn consent|20|||
162847229|NCT01557166|588148648|FG000|Overall Study|Target dose not tolerated|1|||
162847230|NCT01557166|588148649|FG001|Overall Study|Target dose not tolerated|0|||
162847231|NCT01557166|588148648|FG000|Overall Study|Psychiatric disorder|1|||
162847232|NCT01557166|588148649|FG001|Overall Study|Psychiatric disorder|0|||
162847233|NCT01557166|588148648|FG000|Overall Study|Unclassified|2|||
162847234|NCT01557166|588148649|FG001|Overall Study|Unclassified|5|||
162847235|NCT00946309|588148650|FG000|Overall Study|Protocol Violation|1|||
162847236|NCT00946309|588148651|FG001|Overall Study|Protocol Violation|0|||
162847237|NCT00946309|588148650|FG000|Overall Study|Lost to Follow-up|0|||
162847238|NCT00946309|588148651|FG001|Overall Study|Lost to Follow-up|1|||
162847239|NCT00946309|588148650|FG000|Overall Study|Procedure cancelled/discontinued|0|||
162847240|NCT00946309|588148651|FG001|Overall Study|Procedure cancelled/discontinued|3|||
162847241|NCT01465659|588148652|FG000|Completed 1 Cycle of Treatment|Death|0|||
162847242|NCT01465659|588148653|FG001|Completed 1 Cycle of Treatment|Death|1|||
162847243|NCT01465659|588148654|FG002|Completed 1 Cycle of Treatment|Death|0|||
162847244|NCT01465659|588148655|FG003|Completed 1 Cycle of Treatment|Death|0|||
162847245|NCT01465659|588148652|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
162847246|NCT01465659|588148653|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
162847247|NCT01465659|588148654|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
162847248|NCT01465659|588148655|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
162847249|NCT01465659|588148652|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
162847250|NCT01465659|588148653|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
162847251|NCT01465659|588148654|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
162847252|NCT01465659|588148655|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
162847253|NCT01465659|588148652|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
162847254|NCT01465659|588148653|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
162847255|NCT01465659|588148654|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
162847256|NCT01465659|588148655|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
162847257|NCT01465659|588148652|FG000|Completed Follow for 1 Year|Death|6|||
162847258|NCT01465659|588148653|FG001|Completed Follow for 1 Year|Death|3|||
162847259|NCT01465659|588148654|FG002|Completed Follow for 1 Year|Death|2|||
162847260|NCT01465659|588148655|FG003|Completed Follow for 1 Year|Death|4|||
162847261|NCT02411747|588148656|FG000|Overall Study|Withdrawal by Subject|1|||
162847262|NCT02411747|588148657|FG001|Overall Study|Withdrawal by Subject|0|||
162847263|NCT02411747|588148656|FG000|Overall Study|Protocol Violation|2|||
162847264|NCT02411747|588148657|FG001|Overall Study|Protocol Violation|4|||
162847265|NCT02149810|588148658|FG000|Overall Study|Physician Decision|1|||
162847266|NCT02149810|588148659|FG001|Overall Study|Physician Decision|2|||
162847267|NCT02149810|588148658|FG000|Overall Study|Lost to Follow-up|2|||
162847268|NCT02149810|588148659|FG001|Overall Study|Lost to Follow-up|1|||
162847269|NCT02149810|588148658|FG000|Overall Study|Withdrawal by Subject|5|||
162847270|NCT02149810|588148659|FG001|Overall Study|Withdrawal by Subject|1|||
162847271|NCT00428597|588148660|FG000|Overall Study|Randomized but not treated|3|||
162847272|NCT00428597|588148661|FG001|Overall Study|Randomized but not treated|3|||
162847273|NCT00428597|588148660|FG000|Overall Study|Objective Progression or Relapse|19|||
162847274|NCT00428597|588148661|FG001|Overall Study|Objective Progression or Relapse|47|||
162847275|NCT00428597|588148660|FG000|Overall Study|Study Terminated by Sponsor|41|||
162847276|NCT00428597|588148661|FG001|Overall Study|Study Terminated by Sponsor|16|||
162847277|NCT00428597|588148660|FG000|Overall Study|Adverse Event|15|||
162847278|NCT00428597|588148661|FG001|Overall Study|Adverse Event|7|||
162847279|NCT00428597|588148660|FG000|Overall Study|Global Deterioration of Health Status|1|||
162847280|NCT00428597|588148661|FG001|Overall Study|Global Deterioration of Health Status|5|||
162847281|NCT00428597|588148660|FG000|Overall Study|Protocol Violation|2|||
162847282|NCT00428597|588148661|FG001|Overall Study|Protocol Violation|1|||
162847283|NCT00428597|588148660|FG000|Overall Study|Withdrawal by Subject|2|||
162847284|NCT00428597|588148661|FG001|Overall Study|Withdrawal by Subject|1|||
162847285|NCT00428597|588148660|FG000|Overall Study|Other|1|||
162847286|NCT00428597|588148661|FG001|Overall Study|Other|1|||
162847287|NCT00428597|588148660|FG000|Overall Study|Lost to Follow-up|0|||
162847288|NCT00428597|588148661|FG001|Overall Study|Lost to Follow-up|1|||
162847289|NCT00428597|588148660|FG000|Overall Study|Pregnancy|1|||
162847290|NCT00428597|588148661|FG001|Overall Study|Pregnancy|0|||
162847291|NCT00428597|588148660|FG000|Overall Study|Death|1|||
162847292|NCT00428597|588148661|FG001|Overall Study|Death|3|||
162847293|NCT00675597|588148662|FG000|Overall Study|Withdrawal by Subject|3|||
162847294|NCT00560755|588148664|FG000|Overall Study|Protocol Violation|15|||
162847295|NCT00560755|588148664|FG000|Overall Study|Withdrawal by Subject|26|||
162847296|NCT00560755|588148664|FG000|Overall Study|Lost to Follow-up|9|||
162847297|NCT00560755|588148664|FG000|Overall Study|Adverse Event|8|||
162847298|NCT00560755|588148664|FG000|Overall Study|Physician Decision|2|||
162847299|NCT03828487|588148669|FG000|Overall Study|Physician Decision|1|||
162847300|NCT05032950|588148671|FG000|Overall Study|Adverse Event|0|||
162847301|NCT05032950|588148672|FG001|Overall Study|Adverse Event|0|||
162847302|NCT05032950|588148673|FG002|Overall Study|Adverse Event|1|||
162847303|NCT05032950|588148674|FG003|Overall Study|Adverse Event|1|||
162847304|NCT05032950|588148675|FG004|Overall Study|Adverse Event|0|||
162847305|NCT05032950|588148676|FG005|Overall Study|Adverse Event|0|||
162847306|NCT02474329|588148680|FG000|Overall Study|Withdraw or did not contribute data.|13|||
163043226|NCT00110357|588865758|FG000|Overall Study|Study Closure|1|||
162847307|NCT01356589|588148681|FG000|Overall Study|Enrolled, but not treated|3|||
162847308|NCT01356589|588148681|FG000|Overall Study|Dose data not recorded|2|||
162847309|NCT02447848|588148682|FG000|Overall Study|Patient discharged|3|||
162847310|NCT02447848|588148682|FG000|Overall Study|Lack of Efficacy|4|||
162847311|NCT02447848|588148682|FG000|Overall Study|Withdrawal by Subject|4|||
162847312|NCT02307370|588148683|FG000|Overall Study|Death|5|||
162847313|NCT02307370|588148683|FG000|Overall Study|Lost to Follow-up|1|||
162847314|NCT02307370|588148683|FG000|Overall Study|Withdrawal by Subject|1|||
162847315|NCT02307370|588148683|FG000|Overall Study|Declined Addendum ICF|6|||
162847316|NCT02307370|588148683|FG000|Overall Study|No response during telephone contact|5|||
162847317|NCT02307370|588148683|FG000|Overall Study|Protocol Violation|1|||
162847318|NCT03219164|588150525|FG000|Overall Study|Study Terminated by Sponsor|16|||
162847319|NCT03219164|588150526|FG001|Overall Study|Study Terminated by Sponsor|12|||
162847320|NCT03219164|588150525|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
162847321|NCT03219164|588150526|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
162847322|NCT03219164|588150525|FG000|Overall Study|Lost to Follow-up|1|||
162847323|NCT03219164|588150526|FG001|Overall Study|Lost to Follow-up|1|||
162847324|NCT03219164|588150525|FG000|Overall Study|Adverse Event|1|||
162847325|NCT03219164|588150526|FG001|Overall Study|Adverse Event|0|||
162847326|NCT03219164|588150525|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162847327|NCT03219164|588150526|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162847328|NCT03219164|588150525|FG000|Overall Study|Protocol Violation|0|||
162847329|NCT03219164|588150526|FG001|Overall Study|Protocol Violation|1|||
162847330|NCT03219164|588150525|FG000|Overall Study|Withdrew Assent|1|||
162847331|NCT03219164|588150526|FG001|Overall Study|Withdrew Assent|0|||
162847332|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
162847333|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
162847334|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
162847335|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162847336|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162847337|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162847338|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162847339|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162847340|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
162847341|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
162847342|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
162847343|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162847344|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162847345|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162847346|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162847347|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162847348|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
162847349|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
162847350|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
162847351|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162847352|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162847353|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162847354|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162847355|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162847356|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
162847357|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
162847358|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
162847359|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162847360|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162847361|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162847362|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162847363|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162847364|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
162847365|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
162847366|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
162702389|NCT03673098|587621786|FG001|Overall Study|Lost to Follow-up|3|||
162702390|NCT03673098|587621785|FG000|Overall Study|Withdrawal by Subject|6|||
162702391|NCT03673098|587621786|FG001|Overall Study|Withdrawal by Subject|1|||
162702392|NCT03673098|587621785|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
162702393|NCT03673098|587621786|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
162702394|NCT03850444|587621787|FG000|Overall Study|Adverse Event|16|||
162702395|NCT03850444|587621788|FG001|Overall Study|Adverse Event|10|||
162702396|NCT03850444|587621787|FG000|Overall Study|Death|87|||
162702397|NCT03850444|587621788|FG001|Overall Study|Death|107|||
162847367|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162847368|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162847369|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162847370|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162847371|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163043227|NCT00110357|588865759|FG001|Overall Study|Study Closure|0|||
162702398|NCT03850444|587621787|FG000|Overall Study|Lost to Follow-up|1|||
162702399|NCT03850444|587621788|FG001|Overall Study|Lost to Follow-up|1|||
162702400|NCT03850444|587621787|FG000|Overall Study|Withdrawal by Subject|1|||
162847372|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
162847373|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
162847374|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847375|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847376|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847377|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847378|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847379|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162847380|NCT01097629|588150537|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
162847381|NCT01097629|588150538|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
162847382|NCT01097629|588150539|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
162847383|NCT01097629|588150540|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162847384|NCT01097629|588150541|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162847385|NCT01097629|588150542|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162847386|NCT01097629|588150543|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162847387|NCT01097629|588150544|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162847388|NCT01097629|588150537|FG000|DB RO Phase|Withdrawal by Subject|0|||
162847389|NCT01097629|588150538|FG001|DB RO Phase|Withdrawal by Subject|0|||
162847390|NCT01097629|588150539|FG002|DB RO Phase|Withdrawal by Subject|0|||
162847391|NCT01097629|588150540|FG003|DB RO Phase|Withdrawal by Subject|0|||
162847392|NCT01097629|588150541|FG004|DB RO Phase|Withdrawal by Subject|0|||
162847393|NCT01097629|588150542|FG005|DB RO Phase|Withdrawal by Subject|0|||
162847394|NCT01097629|588150543|FG006|DB RO Phase|Withdrawal by Subject|0|||
162847395|NCT01097629|588150544|FG007|DB RO Phase|Withdrawal by Subject|1|||
162847396|NCT01097629|588150537|FG000|DB RO Phase|Protocol Violation|0|||
162847397|NCT01097629|588150538|FG001|DB RO Phase|Protocol Violation|0|||
162847398|NCT01097629|588150539|FG002|DB RO Phase|Protocol Violation|0|||
162847399|NCT01097629|588150540|FG003|DB RO Phase|Protocol Violation|1|||
162847400|NCT01097629|588150541|FG004|DB RO Phase|Protocol Violation|0|||
162847401|NCT01097629|588150542|FG005|DB RO Phase|Protocol Violation|1|||
162847402|NCT01097629|588150543|FG006|DB RO Phase|Protocol Violation|1|||
162847403|NCT01097629|588150544|FG007|DB RO Phase|Protocol Violation|0|||
162847404|NCT01097629|588150537|FG000|DB RO Phase|Lost to Follow-up|0|||
162631060|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
162847405|NCT01097629|588150538|FG001|DB RO Phase|Lost to Follow-up|0|||
162847406|NCT01097629|588150539|FG002|DB RO Phase|Lost to Follow-up|0|||
162847407|NCT01097629|588150540|FG003|DB RO Phase|Lost to Follow-up|0|||
162847408|NCT01097629|588150541|FG004|DB RO Phase|Lost to Follow-up|0|||
162847409|NCT01097629|588150542|FG005|DB RO Phase|Lost to Follow-up|0|||
162847410|NCT01097629|588150543|FG006|DB RO Phase|Lost to Follow-up|2|||
162847411|NCT01097629|588150544|FG007|DB RO Phase|Lost to Follow-up|0|||
162847412|NCT00956943|588150545|FG000|Overall Study|Lost to Follow-up|9|||
162847413|NCT00956943|588150546|FG001|Overall Study|Lost to Follow-up|10|||
162847414|NCT02613208|588150547|FG000|Overall Study|Withdrawal by Subject|1|||
162847415|NCT02613208|588150547|FG000|Overall Study|Change of address|2|||
162847416|NCT02613208|588150547|FG000|Overall Study|Physician Decision|2|||
162847417|NCT02613208|588150547|FG000|Overall Study|Lost to Follow-up|5|||
162847418|NCT02613208|588150547|FG000|Overall Study|Death|37|||
162847419|NCT02663895|588150548|FG000|Overall Study|Adverse Event|3|||
162847420|NCT02663895|588150548|FG000|Overall Study|Physician Decision|2|||
162847421|NCT02663895|588150548|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
162847422|NCT02663895|588150548|FG000|Overall Study|Withdrawal by Subject|1|||
162847423|NCT00809328|588150549|FG000|Overall Study|Lack of Efficacy|18|||
162847424|NCT00809328|588150549|FG000|Overall Study|Adverse Event|6|||
162847425|NCT00809328|588150549|FG000|Overall Study|Protocol Violation|3|||
162847426|NCT00809328|588150549|FG000|Overall Study|Withdrawal by Subject|2|||
162847427|NCT00008385|588150552|FG000|Overall Study|Off treatment reasons not reported|79|||
162847428|NCT00008385|588150553|FG001|Overall Study|Off treatment reasons not reported|70|||
162847429|NCT00008385|588150552|FG000|Overall Study|Progressive disease|52|||
162847430|NCT00008385|588150553|FG001|Overall Study|Progressive disease|117|||
162847431|NCT00008385|588150552|FG000|Overall Study|Adverse Event|8|||
162847432|NCT00008385|588150553|FG001|Overall Study|Adverse Event|20|||
162847433|NCT00008385|588150552|FG000|Overall Study|Death|12|||
162847434|NCT00008385|588150553|FG001|Overall Study|Death|18|||
162847435|NCT00008385|588150552|FG000|Overall Study|Withdrawal by Subject|67|||
162847436|NCT00008385|588150553|FG001|Overall Study|Withdrawal by Subject|157|||
162847437|NCT00008385|588150552|FG000|Overall Study|Start non-protocol therapy|3|||
162847438|NCT00008385|588150553|FG001|Overall Study|Start non-protocol therapy|1|||
162847439|NCT00008385|588150552|FG000|Overall Study|Other complicating disease|17|||
162847440|NCT00008385|588150553|FG001|Overall Study|Other complicating disease|30|||
162847441|NCT00008385|588150552|FG000|Overall Study|Maximum dose reached|0|||
162847442|NCT00008385|588150553|FG001|Overall Study|Maximum dose reached|2|||
162847443|NCT00008385|588150552|FG000|Overall Study|Other|105|||
162847444|NCT00008385|588150553|FG001|Overall Study|Other|212|||
162847445|NCT00008385|588150552|FG000|Overall Study|Not start protocol therapy|44|||
162847446|NCT00008385|588150553|FG001|Overall Study|Not start protocol therapy|175|||
162847447|NCT05148884|588150554|FG000|Overall Study|Withdrawal by Subject|3|||
162847448|NCT05148884|588150555|FG001|Overall Study|Withdrawal by Subject|0|||
162847449|NCT05148884|588150554|FG000|Overall Study|Deep brain stimulation operation|0|||
162847450|NCT05148884|588150555|FG001|Overall Study|Deep brain stimulation operation|1|||
163043228|NCT00110357|588865758|FG000|Overall Study|Study Drug Toxicity|1|||
162847451|NCT01341457|588150558|FG000|Overall Study|Adverse Event|2|||
162847452|NCT01341457|588150559|FG001|Overall Study|Adverse Event|0|||
162847453|NCT00365989|588150560|FG000|Overall Study|Withdrawal by Subject|1|||
162847454|NCT00365989|588150560|FG000|Overall Study|Non-compliance|1|||
162847455|NCT00317044|588150561|FG000|Overall Study|Protocol Violation|28|||
162847456|NCT00317044|588150562|FG001|Overall Study|Protocol Violation|22|||
162847457|NCT00317044|588150563|FG002|Overall Study|Protocol Violation|20|||
162847458|NCT00317044|588150561|FG000|Overall Study|Adverse Event|4|||
162847459|NCT00317044|588150562|FG001|Overall Study|Adverse Event|7|||
162847460|NCT00317044|588150563|FG002|Overall Study|Adverse Event|4|||
162847461|NCT00317044|588150561|FG000|Overall Study|Withdrawal by Subject|10|||
162847462|NCT00317044|588150562|FG001|Overall Study|Withdrawal by Subject|7|||
162847463|NCT00317044|588150563|FG002|Overall Study|Withdrawal by Subject|12|||
162847464|NCT00317044|588150561|FG000|Overall Study|Lost to Follow-up|0|||
162847465|NCT00317044|588150562|FG001|Overall Study|Lost to Follow-up|2|||
162847466|NCT00317044|588150563|FG002|Overall Study|Lost to Follow-up|3|||
162847467|NCT00317044|588150561|FG000|Overall Study|Multiple Reasons|6|||
162847468|NCT00317044|588150562|FG001|Overall Study|Multiple Reasons|2|||
162847469|NCT00317044|588150563|FG002|Overall Study|Multiple Reasons|6|||
162847470|NCT04317690|588150566|FG000|Overall Study|did not have complete information for primary outcome|0|||
162847471|NCT04317690|588150567|FG001|Overall Study|did not have complete information for primary outcome|4|||
162847472|NCT04317690|588150568|FG002|Overall Study|did not have complete information for primary outcome|0|||
162847473|NCT04317690|588150569|FG003|Overall Study|did not have complete information for primary outcome|2|||
162847474|NCT04317690|588150570|FG004|Overall Study|did not have complete information for primary outcome|0|||
162847475|NCT02318095|588150571|FG000|Overall Study|Adverse Event|1|||
162847476|NCT01717638|588150572|FG000|Overall Study|Lost to Follow-up|0|||
162847477|NCT01717638|588150573|FG001|Overall Study|Lost to Follow-up|0|||
162847478|NCT01717638|588150574|FG002|Overall Study|Lost to Follow-up|0|||
162847479|NCT01717638|588150575|FG003|Overall Study|Lost to Follow-up|0|||
162847480|NCT01717638|588150576|FG004|Overall Study|Lost to Follow-up|0|||
162847481|NCT01717638|588150577|FG005|Overall Study|Lost to Follow-up|1|||
162847482|NCT01717638|588150578|FG006|Overall Study|Lost to Follow-up|0|||
162847483|NCT01717638|588150579|FG007|Overall Study|Lost to Follow-up|0|||
162847484|NCT01717638|588150580|FG008|Overall Study|Lost to Follow-up|0|||
162847485|NCT01717638|588150581|FG009|Overall Study|Lost to Follow-up|0|||
162847486|NCT01717638|588150582|FG010|Overall Study|Lost to Follow-up|0|||
162847487|NCT01717638|588150583|FG011|Overall Study|Lost to Follow-up|0|||
162847488|NCT01717638|588150584|FG012|Overall Study|Lost to Follow-up|0|||
162847489|NCT01717638|588150572|FG000|Overall Study|Father in hospital|0|||
162847490|NCT01717638|588150573|FG001|Overall Study|Father in hospital|0|||
162847491|NCT01717638|588150574|FG002|Overall Study|Father in hospital|0|||
162847492|NCT01717638|588150575|FG003|Overall Study|Father in hospital|0|||
162847493|NCT01717638|588150576|FG004|Overall Study|Father in hospital|0|||
162847494|NCT01717638|588150577|FG005|Overall Study|Father in hospital|0|||
162847495|NCT01717638|588150578|FG006|Overall Study|Father in hospital|0|||
162847496|NCT01717638|588150579|FG007|Overall Study|Father in hospital|0|||
162847497|NCT01717638|588150580|FG008|Overall Study|Father in hospital|0|||
162847498|NCT01717638|588150581|FG009|Overall Study|Father in hospital|0|||
162847499|NCT01717638|588150582|FG010|Overall Study|Father in hospital|0|||
162847500|NCT01717638|588150583|FG011|Overall Study|Father in hospital|0|||
162847501|NCT01717638|588150584|FG012|Overall Study|Father in hospital|1|||
162847502|NCT01717638|588150572|FG000|Overall Study|Withdrawal by Subject|0|||
162847503|NCT01717638|588150573|FG001|Overall Study|Withdrawal by Subject|1|||
162847504|NCT01717638|588150574|FG002|Overall Study|Withdrawal by Subject|1|||
162847505|NCT01717638|588150575|FG003|Overall Study|Withdrawal by Subject|0|||
162847506|NCT01717638|588150576|FG004|Overall Study|Withdrawal by Subject|1|||
162847507|NCT01717638|588150577|FG005|Overall Study|Withdrawal by Subject|0|||
162847508|NCT01717638|588150578|FG006|Overall Study|Withdrawal by Subject|2|||
162847509|NCT01717638|588150579|FG007|Overall Study|Withdrawal by Subject|1|||
162847510|NCT01717638|588150580|FG008|Overall Study|Withdrawal by Subject|2|||
162847511|NCT01717638|588150581|FG009|Overall Study|Withdrawal by Subject|1|||
162847512|NCT01717638|588150582|FG010|Overall Study|Withdrawal by Subject|0|||
162847513|NCT01717638|588150583|FG011|Overall Study|Withdrawal by Subject|0|||
162847514|NCT01717638|588150584|FG012|Overall Study|Withdrawal by Subject|18|||
162631061|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
162847515|NCT01719757|588150585|FG000|Overall Study|Adverse Event|38|||
162847516|NCT01719757|588150585|FG000|Overall Study|Withdrawal by Subject|15|||
162847517|NCT01719757|588150585|FG000|Overall Study|Lost to Follow-up|20|||
162847518|NCT01719757|588150585|FG000|Overall Study|Protocol Violation|1|||
162847519|NCT01719757|588150585|FG000|Overall Study|well controlled pain|27|||
162847520|NCT02367521|588150588|FG000|Overall Study|severe headache after intervention|2|||
162847521|NCT02367521|588150589|FG001|Overall Study|severe headache after intervention|0|||
162847522|NCT02367521|588150588|FG000|Overall Study|unable to find transportation|2|||
162847523|NCT02367521|588150589|FG001|Overall Study|unable to find transportation|0|||
162847524|NCT00600171|588150590|FG000|Overall Study|Adverse Event|0|||
162847525|NCT00600171|588150591|FG001|Overall Study|Adverse Event|1|||
162847526|NCT00600171|588150592|FG002|Overall Study|Adverse Event|0|||
162847527|NCT00600171|588150593|FG003|Overall Study|Adverse Event|0|||
162847528|NCT00600171|588150594|FG004|Overall Study|Adverse Event|1|||
162847529|NCT00600171|588150595|FG005|Overall Study|Adverse Event|0|||
162847530|NCT00600171|588150590|FG000|Overall Study|Lack of Efficacy|9|||
162847531|NCT00600171|588150591|FG001|Overall Study|Lack of Efficacy|12|||
162847532|NCT00600171|588150592|FG002|Overall Study|Lack of Efficacy|3|||
162847533|NCT00600171|588150593|FG003|Overall Study|Lack of Efficacy|5|||
162847534|NCT00600171|588150594|FG004|Overall Study|Lack of Efficacy|4|||
162847535|NCT00600171|588150595|FG005|Overall Study|Lack of Efficacy|0|||
162847536|NCT00600171|588150590|FG000|Overall Study|Protocol Violation|1|||
162847537|NCT00600171|588150591|FG001|Overall Study|Protocol Violation|2|||
162847538|NCT00600171|588150592|FG002|Overall Study|Protocol Violation|0|||
162847539|NCT00600171|588150593|FG003|Overall Study|Protocol Violation|1|||
162847540|NCT00600171|588150594|FG004|Overall Study|Protocol Violation|0|||
162847541|NCT00600171|588150595|FG005|Overall Study|Protocol Violation|0|||
162847542|NCT00600171|588150590|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
162847543|NCT00600171|588150591|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162847544|NCT00600171|588150592|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
162847545|NCT00600171|588150593|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
162847546|NCT00600171|588150594|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
162847547|NCT00600171|588150595|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
162847548|NCT00600171|588150590|FG000|Overall Study|Withdrawal by Subject|3|||
162847549|NCT00600171|588150591|FG001|Overall Study|Withdrawal by Subject|0|||
162847550|NCT00600171|588150592|FG002|Overall Study|Withdrawal by Subject|0|||
162847551|NCT00600171|588150593|FG003|Overall Study|Withdrawal by Subject|1|||
162847552|NCT00600171|588150594|FG004|Overall Study|Withdrawal by Subject|1|||
162847553|NCT00600171|588150595|FG005|Overall Study|Withdrawal by Subject|1|||
162847554|NCT00600171|588150590|FG000|Overall Study|Physician Decision|0|||
162847555|NCT00600171|588150591|FG001|Overall Study|Physician Decision|1|||
162847556|NCT00600171|588150592|FG002|Overall Study|Physician Decision|0|||
162847557|NCT00600171|588150593|FG003|Overall Study|Physician Decision|1|||
162847558|NCT00600171|588150594|FG004|Overall Study|Physician Decision|0|||
162847559|NCT00600171|588150595|FG005|Overall Study|Physician Decision|2|||
162847560|NCT00600171|588150590|FG000|Overall Study|Lost to Follow-up|0|||
162847561|NCT00600171|588150591|FG001|Overall Study|Lost to Follow-up|0|||
162847562|NCT00600171|588150592|FG002|Overall Study|Lost to Follow-up|0|||
162847563|NCT00600171|588150593|FG003|Overall Study|Lost to Follow-up|1|||
163043229|NCT00110357|588865759|FG001|Overall Study|Study Drug Toxicity|3|||
162702401|NCT03850444|587621788|FG001|Overall Study|Withdrawal by Subject|5|||
162702402|NCT03850444|587621787|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
162702403|NCT03850444|587621788|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
162702404|NCT01518257|587621791|FG000|Overall Study|Lost to Follow-up|1|||
162702405|NCT01518257|587621792|FG001|Overall Study|Lost to Follow-up|0|||
162702406|NCT01518257|587621791|FG000|Overall Study|Other Miscellaneous Reason|1|||
162702407|NCT01518257|587621792|FG001|Overall Study|Other Miscellaneous Reason|0|||
162702408|NCT01155726|587621794|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
162702409|NCT01155726|587621795|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
162702410|NCT01155726|587621796|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
162702411|NCT01155726|587621797|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
162702412|NCT05257837|587621801|FG000|Overall Study|Excluded (did not find the guns)|4|||
162702413|NCT05257837|587621802|FG001|Overall Study|Excluded (did not find the guns)|2|||
162702414|NCT05257837|587621803|FG002|Overall Study|Excluded (did not find the guns)|4|||
162702415|NCT05257837|587621804|FG003|Overall Study|Excluded (did not find the guns)|0|||
162702416|NCT05675709|587621807|FG000|Overall Study|incomplete outcome data|2|||
162702417|NCT05675709|587621808|FG001|Overall Study|incomplete outcome data|8|||
162702418|NCT01254565|587621812|FG000|Overall Study|Non-compliance to Study Procedures|0|||
162702419|NCT01254565|587621813|FG001|Overall Study|Non-compliance to Study Procedures|0|||
162847564|NCT00600171|588150594|FG004|Overall Study|Lost to Follow-up|0|||
162847565|NCT00600171|588150595|FG005|Overall Study|Lost to Follow-up|0|||
162847566|NCT00542191|588150599|FG000|Overall Study|Death|3|||
162702420|NCT01254565|587621814|FG002|Overall Study|Non-compliance to Study Procedures|0|||
162847567|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847568|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
162847569|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847570|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847571|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847572|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
162847573|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
162847574|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
162847575|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
162847576|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
162847577|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
162847578|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
162847579|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847580|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
162847581|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
162847582|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
162847583|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
162847584|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
162847585|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
162847586|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
162847587|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847588|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847589|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847590|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
162847591|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847592|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
162847593|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
162847594|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
162847595|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
162847596|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
162847597|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
162847598|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
162847599|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
162847600|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
162847601|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
162847602|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
162847603|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
162847604|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
162847605|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
162847606|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
162847607|NCT00289913|588150600|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
162847608|NCT00289913|588150601|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847609|NCT00289913|588150602|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
162847610|NCT00289913|588150603|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847611|NCT00289913|588150604|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847612|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847613|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847614|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
162847615|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847616|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847617|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
162847618|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
162847619|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
162847620|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
162847621|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
162847622|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
162847623|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
162847624|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
162847625|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
162847626|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
162847627|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
162847628|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
162847629|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
162847630|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847631|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847632|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
162847633|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847634|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
162847635|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847636|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847637|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
162847638|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
162847639|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
162847640|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
162847641|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
162847642|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
162847643|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
162847644|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
162847645|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
162847646|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
162847647|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
162847648|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
162847649|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
162847650|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
162847651|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
162847652|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
162847653|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
162847654|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
162847655|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
162847656|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
162847657|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
162847658|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
162847659|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
162847660|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
162847661|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
162847662|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
162847663|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
162847664|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
162847665|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
162847666|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
162847667|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
162847668|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
162847669|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
162847670|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
162847671|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
162847672|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
162847673|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
162847674|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
162847675|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
162847676|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
162847677|NCT00289913|588150600|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
162847678|NCT00289913|588150601|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
162847679|NCT00289913|588150602|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
162847680|NCT00289913|588150603|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
162847681|NCT00289913|588150604|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
162847682|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847683|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
162847684|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847685|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847686|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
162847687|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
162847688|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
162847689|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
162847690|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
162847691|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
162847692|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847693|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847694|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847695|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
162847696|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
162847697|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847698|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847699|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847700|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
162847701|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
162847702|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
162847703|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
162847704|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
162847705|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
162847706|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
162847707|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
162847708|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
162847709|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
162847710|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
162847711|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
162847712|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
162847713|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
162847714|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
162847715|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
162847716|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
162847717|NCT00289913|588150600|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847718|NCT00289913|588150601|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
162847719|NCT00289913|588150602|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847720|NCT00289913|588150603|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847721|NCT00289913|588150604|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
162847722|NCT03822884|588150605|FG000|Overall Study|Withdrawal by Subject|0|||
162847723|NCT03822884|588150606|FG001|Overall Study|Withdrawal by Subject|0|||
162847724|NCT03822884|588150607|FG002|Overall Study|Withdrawal by Subject|0|||
162847725|NCT03822884|588150608|FG003|Overall Study|Withdrawal by Subject|0|||
162847726|NCT03822884|588150609|FG004|Overall Study|Withdrawal by Subject|1|||
162847727|NCT03822884|588150610|FG005|Overall Study|Withdrawal by Subject|0|||
162847728|NCT00434967|588150616|FG000|Overall Study|Adverse Event|2|||
162847729|NCT00434967|588150617|FG001|Overall Study|Adverse Event|4|||
162847730|NCT00434967|588150618|FG002|Overall Study|Adverse Event|3|||
162847731|NCT00434967|588150619|FG003|Overall Study|Adverse Event|3|||
162847732|NCT00434967|588150616|FG000|Overall Study|Lost to Follow-up|0|||
162847733|NCT00434967|588150617|FG001|Overall Study|Lost to Follow-up|0|||
162847734|NCT00434967|588150618|FG002|Overall Study|Lost to Follow-up|1|||
162847735|NCT00434967|588150619|FG003|Overall Study|Lost to Follow-up|0|||
162847736|NCT00434967|588150616|FG000|Overall Study|Withdrawal by Subject|2|||
162847737|NCT00434967|588150617|FG001|Overall Study|Withdrawal by Subject|2|||
162847738|NCT00434967|588150618|FG002|Overall Study|Withdrawal by Subject|4|||
162847739|NCT00434967|588150619|FG003|Overall Study|Withdrawal by Subject|6|||
162847740|NCT00434967|588150616|FG000|Overall Study|Randomized in error|0|||
162847741|NCT00434967|588150617|FG001|Overall Study|Randomized in error|0|||
162847742|NCT00434967|588150618|FG002|Overall Study|Randomized in error|0|||
162847743|NCT00434967|588150619|FG003|Overall Study|Randomized in error|1|||
162847744|NCT00434967|588150616|FG000|Overall Study|Protocol Violation|0|||
162847745|NCT00434967|588150617|FG001|Overall Study|Protocol Violation|1|||
162847746|NCT00434967|588150618|FG002|Overall Study|Protocol Violation|0|||
162847747|NCT00434967|588150619|FG003|Overall Study|Protocol Violation|1|||
162847748|NCT00434967|588150616|FG000|Overall Study|Physician Decision|1|||
162847749|NCT00434967|588150617|FG001|Overall Study|Physician Decision|1|||
162847750|NCT00434967|588150618|FG002|Overall Study|Physician Decision|1|||
162847751|NCT00434967|588150619|FG003|Overall Study|Physician Decision|0|||
162847752|NCT00434967|588150616|FG000|Overall Study|Patient Disposition Challenges|2|||
162847753|NCT00434967|588150617|FG001|Overall Study|Patient Disposition Challenges|0|||
162847754|NCT00434967|588150618|FG002|Overall Study|Patient Disposition Challenges|0|||
162847755|NCT00434967|588150619|FG003|Overall Study|Patient Disposition Challenges|3|||
162847756|NCT00110019|588150625|FG000|Overall Study|Lack of Efficacy|253|||
162847757|NCT00110019|588150626|FG001|Overall Study|Lack of Efficacy|285|||
162847758|NCT00110019|588150625|FG000|Overall Study|Adverse Event|61|||
162847759|NCT00110019|588150626|FG001|Overall Study|Adverse Event|40|||
162847760|NCT00110019|588150625|FG000|Overall Study|Death|13|||
162847761|NCT00110019|588150626|FG001|Overall Study|Death|15|||
162847762|NCT00110019|588150625|FG000|Overall Study|Withdrawal by Subject|21|||
162847763|NCT00110019|588150626|FG001|Overall Study|Withdrawal by Subject|9|||
162847764|NCT00110019|588150625|FG000|Overall Study|alternative therapy|5|||
162847765|NCT00110019|588150626|FG001|Overall Study|alternative therapy|1|||
162847766|NCT00110019|588150625|FG000|Overall Study|complicating disease|1|||
162847767|NCT00110019|588150626|FG001|Overall Study|complicating disease|1|||
162847768|NCT00110019|588150625|FG000|Overall Study|symptom deterioration|13|||
162847769|NCT00110019|588150626|FG001|Overall Study|symptom deterioration|16|||
162847770|NCT00110019|588150625|FG000|Overall Study|Not start protocol therapy|17|||
162847771|NCT00110019|588150626|FG001|Overall Study|Not start protocol therapy|16|||
162847772|NCT00110019|588150625|FG000|Overall Study|other reasons|22|||
162847773|NCT00110019|588150626|FG001|Overall Study|other reasons|30|||
162847774|NCT04276207|588150627|FG000|Period 1|Withdrawal by Subject|0|||
162847775|NCT04276207|588150628|FG001|Period 1|Withdrawal by Subject|1|||
162847776|NCT01256177|588150629|FG000|Overall Study|Withdrawal by Subject|23|||
162847777|NCT01256177|588150630|FG001|Overall Study|Withdrawal by Subject|22|||
162847778|NCT01256177|588150629|FG000|Overall Study|Lost to Follow-up|2|||
162847779|NCT01256177|588150630|FG001|Overall Study|Lost to Follow-up|2|||
162847780|NCT01256177|588150629|FG000|Overall Study|Adverse Event|8|||
162847781|NCT01256177|588150630|FG001|Overall Study|Adverse Event|9|||
162847782|NCT01256177|588150629|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
162847783|NCT01256177|588150630|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
162847784|NCT01256177|588150629|FG000|Overall Study|Condition under Investigation Worsened|1|||
162847785|NCT01256177|588150630|FG001|Overall Study|Condition under Investigation Worsened|0|||
162847786|NCT01256177|588150629|FG000|Overall Study|Lack of Efficacy|11|||
162847787|NCT01256177|588150630|FG001|Overall Study|Lack of Efficacy|2|||
162847788|NCT01256177|588150629|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
162847789|NCT01256177|588150630|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
162847790|NCT01596257|588150632|FG000|Overall Study|Inadequate Collection|23|||
162847791|NCT01596257|588150633|FG001|Overall Study|Inadequate Collection|19|||
162847792|NCT00531960|588150634|FG000|Overall Study|Adverse Event|5|||
162847793|NCT00531960|588150635|FG001|Overall Study|Adverse Event|4|||
162847794|NCT00531960|588150634|FG000|Overall Study|Death|3|||
162847795|NCT00531960|588150635|FG001|Overall Study|Death|2|||
162847796|NCT00531960|588150634|FG000|Overall Study|Lack of Efficacy|42|||
162847797|NCT00531960|588150635|FG001|Overall Study|Lack of Efficacy|41|||
162847798|NCT00531960|588150634|FG000|Overall Study|Violation of Selection Criteria|2|||
162847799|NCT00531960|588150635|FG001|Overall Study|Violation of Selection Criteria|0|||
162847800|NCT00531960|588150634|FG000|Overall Study|Refused Treatment|5|||
162847801|NCT00531960|588150635|FG001|Overall Study|Refused Treatment|6|||
162847802|NCT00531960|588150634|FG000|Overall Study|Other|4|||
162847803|NCT00531960|588150635|FG001|Overall Study|Other|10|||
162847804|NCT01014585|588150641|FG000|Overall Study|Adverse Event|0|||
162847805|NCT01014585|588150642|FG001|Overall Study|Adverse Event|2|||
162847806|NCT01014585|588150643|FG002|Overall Study|Adverse Event|0|||
162847807|NCT01014585|588150644|FG003|Overall Study|Adverse Event|3|||
162847808|NCT01014585|588150641|FG000|Overall Study|Withdrawal by Subject|2|||
162847809|NCT01014585|588150642|FG001|Overall Study|Withdrawal by Subject|0|||
162847810|NCT01014585|588150643|FG002|Overall Study|Withdrawal by Subject|1|||
162847811|NCT01014585|588150644|FG003|Overall Study|Withdrawal by Subject|3|||
162847812|NCT01014585|588150641|FG000|Overall Study|Lost to Follow-up|0|||
162847813|NCT01014585|588150642|FG001|Overall Study|Lost to Follow-up|0|||
162847814|NCT01014585|588150643|FG002|Overall Study|Lost to Follow-up|0|||
162847815|NCT01014585|588150644|FG003|Overall Study|Lost to Follow-up|2|||
162847816|NCT01014585|588150641|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
162847817|NCT01014585|588150642|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
162847818|NCT01014585|588150643|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
162847819|NCT01014585|588150644|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
162847820|NCT00508391|588150648|FG000|First Treatment|Withdrawal by Subject|6|||
162847821|NCT00508391|588150649|FG001|First Treatment|Withdrawal by Subject|3|||
162847822|NCT00508391|588150648|FG000|Second Treatment|Withdrawal by Subject|2|||
162847823|NCT00508391|588150649|FG001|Second Treatment|Withdrawal by Subject|0|||
162847824|NCT00880256|588150653|FG000|Overall Study|Lost to Follow-up|28|||
162847825|NCT02041962|588150654|FG000|Overall Study|Lost Aetna Coverage|43|||
162847826|NCT02041962|588150655|FG001|Overall Study|Lost Aetna Coverage|40|||
162847827|NCT02041962|588150654|FG000|Overall Study|Death|1|||
162847828|NCT02041962|588150655|FG001|Overall Study|Death|1|||
162847829|NCT02041962|588150654|FG000|Overall Study|Lost to Follow-up|37|||
162607071|NCT05217927|587276791|FG000|DBT Phase|Adverse Event|7|||
162607072|NCT05217927|587276792|FG001|DBT Phase|Adverse Event|2|||
162607073|NCT05217927|587276793|FG002|DBT Phase|Adverse Event|5|||
162607074|NCT05217927|587276791|FG000|DBT Phase|Lack of Efficacy|1|||
162607075|NCT05217927|587276792|FG001|DBT Phase|Lack of Efficacy|0|||
162607076|NCT05217927|587276793|FG002|DBT Phase|Lack of Efficacy|0|||
162607077|NCT05217927|587276791|FG000|DBT Phase|Lost to Follow-up|0|||
162607078|NCT05217927|587276792|FG001|DBT Phase|Lost to Follow-up|2|||
162607079|NCT05217927|587276793|FG002|DBT Phase|Lost to Follow-up|0|||
162607080|NCT05217927|587276791|FG000|DBT Phase|Non-compliance|1|||
162607081|NCT05217927|587276792|FG001|DBT Phase|Non-compliance|0|||
162607082|NCT05217927|587276793|FG002|DBT Phase|Non-compliance|0|||
162607083|NCT05217927|587276791|FG000|DBT Phase|Pregnancy|0|||
162607084|NCT05217927|587276792|FG001|DBT Phase|Pregnancy|0|||
162607085|NCT05217927|587276793|FG002|DBT Phase|Pregnancy|1|||
162607086|NCT05217927|587276791|FG000|DBT Phase|Protocol Violation|0|||
162607087|NCT05217927|587276792|FG001|DBT Phase|Protocol Violation|2|||
162607088|NCT05217927|587276793|FG002|DBT Phase|Protocol Violation|1|||
162607089|NCT05217927|587276791|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
162607090|NCT05217927|587276792|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
162607091|NCT05217927|587276793|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
162607092|NCT05217927|587276791|FG000|DBT Phase|Withdrawal of consent|8|||
162607093|NCT05217927|587276792|FG001|DBT Phase|Withdrawal of consent|5|||
162607094|NCT05217927|587276793|FG002|DBT Phase|Withdrawal of consent|7|||
162607095|NCT05217927|587276791|FG000|DBT Phase|Other|7|||
162607096|NCT05217927|587276792|FG001|DBT Phase|Other|3|||
162607097|NCT05217927|587276793|FG002|DBT Phase|Other|4|||
162607098|NCT05217927|587276791|FG000|DBT Phase|Randomized, not treated|2|||
162607099|NCT05217927|587276792|FG001|DBT Phase|Randomized, not treated|3|||
162607100|NCT05217927|587276793|FG002|DBT Phase|Randomized, not treated|2|||
162607101|NCT05217927|587276791|FG000|OLE Phase|Adverse Event|4|||
162607102|NCT05217927|587276792|FG001|OLE Phase|Adverse Event|1|||
162607103|NCT05217927|587276793|FG002|OLE Phase|Adverse Event|1|||
162607104|NCT05217927|587276791|FG000|OLE Phase|Extension phase eligibility failure|1|||
162607105|NCT05217927|587276792|FG001|OLE Phase|Extension phase eligibility failure|0|||
162607106|NCT05217927|587276793|FG002|OLE Phase|Extension phase eligibility failure|0|||
162607107|NCT05217927|587276791|FG000|OLE Phase|Lost to Follow-up|1|||
162607108|NCT05217927|587276792|FG001|OLE Phase|Lost to Follow-up|2|||
162607109|NCT05217927|587276793|FG002|OLE Phase|Lost to Follow-up|1|||
162607110|NCT05217927|587276791|FG000|OLE Phase|Non-compliance|0|||
162607111|NCT05217927|587276792|FG001|OLE Phase|Non-compliance|0|||
162607112|NCT05217927|587276793|FG002|OLE Phase|Non-compliance|1|||
162607113|NCT05217927|587276791|FG000|OLE Phase|Other|3|||
162607114|NCT05217927|587276792|FG001|OLE Phase|Other|5|||
162607115|NCT05217927|587276793|FG002|OLE Phase|Other|4|||
162607116|NCT05217927|587276791|FG000|OLE Phase|Withdrawal of consent|3|||
162607117|NCT05217927|587276792|FG001|OLE Phase|Withdrawal of consent|1|||
162607118|NCT05217927|587276793|FG002|OLE Phase|Withdrawal of consent|5|||
162607119|NCT00472459|587277646|FG000|Overall Study|Adverse Event|13|||
162607120|NCT00472459|587277647|FG001|Overall Study|Adverse Event|13|||
162607121|NCT00472459|587277646|FG000|Overall Study|Withdrawal by Subject|5|||
162607122|NCT00472459|587277647|FG001|Overall Study|Withdrawal by Subject|5|||
162607123|NCT00472459|587277646|FG000|Overall Study|Protocol Violation|3|||
162607124|NCT00472459|587277647|FG001|Overall Study|Protocol Violation|3|||
162607125|NCT00472459|587277646|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
162607126|NCT00472459|587277647|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
162607127|NCT00472459|587277646|FG000|Overall Study|Lost to Follow-up|1|||
162607128|NCT00472459|587277647|FG001|Overall Study|Lost to Follow-up|1|||
162607129|NCT00478881|587277650|FG000|Overall Study|Adverse Event|31|||
162607130|NCT00478881|587277651|FG001|Overall Study|Adverse Event|12|||
162607131|NCT00478881|587277650|FG000|Overall Study|Lack of Efficacy|0|||
162607132|NCT00478881|587277651|FG001|Overall Study|Lack of Efficacy|3|||
162607133|NCT00478881|587277650|FG000|Overall Study|Lost to Follow-up|0|||
162607134|NCT00478881|587277651|FG001|Overall Study|Lost to Follow-up|1|||
162607135|NCT00478881|587277650|FG000|Overall Study|Protocol Violation|2|||
162607136|NCT00478881|587277651|FG001|Overall Study|Protocol Violation|2|||
162607137|NCT00478881|587277650|FG000|Overall Study|Withdrawal by Subject|6|||
162607138|NCT00478881|587277651|FG001|Overall Study|Withdrawal by Subject|2|||
162607139|NCT00478881|587277650|FG000|Overall Study|Non-Compliance with Study Medication|0|||
162607140|NCT00478881|587277651|FG001|Overall Study|Non-Compliance with Study Medication|2|||
162607141|NCT04950608|587277655|FG000|Overall Study|Withdrawal by Subject|2|||
162607142|NCT04950608|587277655|FG000|Overall Study|Physician Decision|3|||
162607143|NCT04104438|587277656|FG000|Overall Study|Death|2|||
162607144|NCT04104438|587277657|FG001|Overall Study|Death|1|||
162607145|NCT04104438|587277658|FG002|Overall Study|Death|2|||
162847830|NCT02041962|588150655|FG001|Overall Study|Lost to Follow-up|32|||
162607146|NCT04104438|587277656|FG000|Overall Study|Adverse Event|0|||
162847831|NCT02041962|588150654|FG000|Overall Study|Withdrawal by Subject|0|||
162847832|NCT02041962|588150655|FG001|Overall Study|Withdrawal by Subject|11|||
162847833|NCT01686568|588150656|FG000|Main Study|Withdrawal by Subject|1|||
162847834|NCT01686568|588150657|FG001|Main Study|Withdrawal by Subject|3|||
162847835|NCT01686568|588150656|FG000|Main Study|Noncompliance with protocol|0|||
162847836|NCT01686568|588150657|FG001|Main Study|Noncompliance with protocol|1|||
162847837|NCT01686568|588150656|FG000|Main Study|Liver enzymes above range of exclusion|1|||
162847838|NCT01686568|588150657|FG001|Main Study|Liver enzymes above range of exclusion|0|||
162847839|NCT01686568|588150656|FG000|Sub-Study|Not consented for sub-study|2|||
162847840|NCT01686568|588150657|FG001|Sub-Study|Not consented for sub-study|2|||
162847841|NCT02928952|588150658|FG000|Overall Study|Lost to Follow-up|5|||
162847842|NCT02928952|588150659|FG001|Overall Study|Lost to Follow-up|5|||
162847843|NCT02928952|588150658|FG000|Overall Study|Withdrawal by Subject|5|||
162847844|NCT02928952|588150659|FG001|Overall Study|Withdrawal by Subject|1|||
162847845|NCT02928952|588150658|FG000|Overall Study|Physician Decision|0|||
162847846|NCT02928952|588150659|FG001|Overall Study|Physician Decision|1|||
162847847|NCT00974220|588150660|FG000|Treatment Period 1|Adverse Event|2|||
162847848|NCT00974220|588150661|FG001|Treatment Period 1|Adverse Event|1|||
162847849|NCT00974220|588150660|FG000|Treatment Period 1|noncompliant subjects|0|||
162847850|NCT00974220|588150661|FG001|Treatment Period 1|noncompliant subjects|1|||
162847851|NCT02266433|588150665|FG000|Overall Study|Lost to Follow-up|54|||
162847852|NCT02266433|588150666|FG001|Overall Study|Lost to Follow-up|46|||
162847853|NCT02266433|588150665|FG000|Overall Study|Withdrawal by Subject|5|||
162847854|NCT02266433|588150666|FG001|Overall Study|Withdrawal by Subject|7|||
162847855|NCT02959814|588150684|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
162847856|NCT02959814|588150684|FG000|Overall Study|Excluded based on anatomical criteria|2|||
162847857|NCT02959814|588150684|FG000|Overall Study|Protocol Violation|7|||
162847858|NCT02959814|588150684|FG000|Overall Study|FFR not measured|2|||
162847859|NCT02959814|588150684|FG000|Overall Study|In-procedure QFR not computed|6|||
162847860|NCT02959814|588150684|FG000|Overall Study|Excluded by FFR core-lab|24|||
162847861|NCT04343651|588150688|FG000|Overall Study|Physician Decision|2|||
162847862|NCT04343651|588150689|FG001|Overall Study|Physician Decision|1|||
162847863|NCT04343651|588150688|FG000|Overall Study|Lost to Follow-up|2|||
162847864|NCT04343651|588150689|FG001|Overall Study|Lost to Follow-up|1|||
162847865|NCT04343651|588150688|FG000|Overall Study|Protocol Violation|4|||
162847866|NCT04343651|588150689|FG001|Overall Study|Protocol Violation|6|||
162847867|NCT04343651|588150688|FG000|Overall Study|Missing|3|||
162847868|NCT04343651|588150689|FG001|Overall Study|Missing|9|||
162847869|NCT04343651|588150688|FG000|Overall Study|Withdrawal by Subject|0|||
162847870|NCT04343651|588150689|FG001|Overall Study|Withdrawal by Subject|4|||
162847871|NCT04343651|588150688|FG000|Overall Study|Death|0|||
162847872|NCT04343651|588150689|FG001|Overall Study|Death|1|||
162847873|NCT04343651|588150688|FG000|Overall Study|Did not start treatment|1|||
162847874|NCT04343651|588150689|FG001|Overall Study|Did not start treatment|1|||
162847875|NCT04343651|588150688|FG000|Overall Study|Patient did not complete visits 3-6|0|||
162847876|NCT04343651|588150689|FG001|Overall Study|Patient did not complete visits 3-6|1|||
162847877|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
162847878|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
162847879|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
162847880|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847881|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847882|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847883|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847884|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847885|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162847886|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
162847887|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
162847888|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
162847889|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162607147|NCT04104438|587277657|FG001|Overall Study|Adverse Event|3|||
162847890|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162847891|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162847892|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162847893|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162847894|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162847895|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
162847896|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
162847897|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847898|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847899|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847900|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847901|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847902|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847903|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162847904|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
162847905|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
162847906|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
162847907|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847908|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847909|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847910|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847911|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847912|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162847913|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
162847914|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
162847915|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847916|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847917|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847918|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847919|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847920|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847921|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
162847922|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847923|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847924|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
162847925|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847926|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847927|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847928|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847929|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847930|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162847931|NCT01583374|588150693|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847932|NCT01583374|588150694|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
162847933|NCT01583374|588150695|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847934|NCT01583374|588150696|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847935|NCT01583374|588150697|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847936|NCT01583374|588150698|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847937|NCT01583374|588150699|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847938|NCT01583374|588150700|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847939|NCT01583374|588150701|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
162847940|NCT01583374|588150693|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847941|NCT01583374|588150694|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847942|NCT01583374|588150695|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162952078|NCT00909610|588529533|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
162607148|NCT04104438|587277658|FG002|Overall Study|Adverse Event|0|||
162607149|NCT04104438|587277656|FG000|Overall Study|Withdrawal by Subject|0|||
162607150|NCT04104438|587277657|FG001|Overall Study|Withdrawal by Subject|1|||
162607151|NCT04104438|587277658|FG002|Overall Study|Withdrawal by Subject|0|||
162607152|NCT04104438|587277656|FG000|Overall Study|Disenrolled due to noncompliance|0|||
162607153|NCT04104438|587277657|FG001|Overall Study|Disenrolled due to noncompliance|1|||
162607154|NCT04104438|587277658|FG002|Overall Study|Disenrolled due to noncompliance|0|||
162607155|NCT04104438|587277656|FG000|Overall Study|stopped due to possible operation|0|||
162607156|NCT04104438|587277657|FG001|Overall Study|stopped due to possible operation|1|||
162607157|NCT04104438|587277658|FG002|Overall Study|stopped due to possible operation|0|||
162607158|NCT04104438|587277656|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
162702421|NCT01254565|587621815|FG003|Overall Study|Non-compliance to Study Procedures|0|||
162702422|NCT01254565|587621816|FG004|Overall Study|Non-compliance to Study Procedures|1|||
162702423|NCT01254565|587621817|FG005|Overall Study|Non-compliance to Study Procedures|0|||
162702424|NCT01254565|587621812|FG000|Overall Study|Did not Receive Treatment|1|||
162702425|NCT01254565|587621813|FG001|Overall Study|Did not Receive Treatment|1|||
162702426|NCT01254565|587621814|FG002|Overall Study|Did not Receive Treatment|0|||
162702427|NCT01254565|587621815|FG003|Overall Study|Did not Receive Treatment|0|||
162702428|NCT01254565|587621816|FG004|Overall Study|Did not Receive Treatment|3|||
162702429|NCT01254565|587621817|FG005|Overall Study|Did not Receive Treatment|4|||
162702430|NCT01254565|587621812|FG000|Overall Study|Other|0|||
162702431|NCT01254565|587621813|FG001|Overall Study|Other|0|||
162702432|NCT01254565|587621814|FG002|Overall Study|Other|0|||
162702433|NCT01254565|587621815|FG003|Overall Study|Other|1|||
162702434|NCT01254565|587621816|FG004|Overall Study|Other|0|||
162702435|NCT01254565|587621817|FG005|Overall Study|Other|0|||
162702436|NCT02726399|587621824|FG000|Overall Study|Participant Non-Compliance|1|||
162702437|NCT02726399|587621824|FG000|Overall Study|Adverse Event|2|||
162702438|NCT02726399|587621824|FG000|Overall Study|Progression of disease|4|||
162702439|NCT03468426|587621827|FG000|Overall Study|Progressive disease|3|||
162847943|NCT01583374|588150696|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847944|NCT01583374|588150697|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847945|NCT01583374|588150698|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847946|NCT01583374|588150699|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847947|NCT01583374|588150700|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
162847948|NCT01583374|588150701|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162847949|NCT01583374|588150693|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
162847950|NCT01583374|588150694|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162847951|NCT01583374|588150695|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
162847952|NCT01583374|588150696|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
162847953|NCT01583374|588150697|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162847954|NCT01583374|588150698|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162847955|NCT01583374|588150699|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
162847956|NCT01583374|588150700|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162847957|NCT01583374|588150701|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
162847958|NCT01583374|588150693|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
162847959|NCT01583374|588150694|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
162847960|NCT01583374|588150695|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
162847961|NCT01583374|588150696|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
162847962|NCT01583374|588150697|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
162847963|NCT01583374|588150698|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
162847964|NCT01583374|588150699|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
162847965|NCT01583374|588150700|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
162847966|NCT01583374|588150701|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
162847967|NCT01583374|588150693|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847968|NCT01583374|588150694|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
162847969|NCT01583374|588150695|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
162847970|NCT01583374|588150696|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847971|NCT01583374|588150697|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
162847972|NCT01583374|588150698|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847973|NCT01583374|588150699|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847974|NCT01583374|588150700|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847975|NCT01583374|588150701|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
162847976|NCT01583374|588150693|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162847977|NCT01583374|588150694|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162847978|NCT01583374|588150695|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
162847979|NCT01583374|588150696|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162847980|NCT01583374|588150697|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
162847981|NCT01583374|588150698|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
162847982|NCT01583374|588150699|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162847983|NCT01583374|588150700|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162847984|NCT01583374|588150701|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162702440|NCT03468426|587621828|FG001|Overall Study|Progressive disease|0|||
162702441|NCT03468426|587621829|FG002|Overall Study|Progressive disease|4|||
162702442|NCT03468426|587621830|FG003|Overall Study|Progressive disease|20|||
162702443|NCT03468426|587621831|FG004|Overall Study|Progressive disease|23|||
162702444|NCT03468426|587621832|FG005|Overall Study|Progressive disease|15|||
162702445|NCT03468426|587621833|FG006|Overall Study|Progressive disease|24|||
162702446|NCT03468426|587621834|FG007|Overall Study|Progressive disease|27|||
162702447|NCT03468426|587621835|FG008|Overall Study|Progressive disease|13|||
162702448|NCT03468426|587621836|FG009|Overall Study|Progressive disease|13|||
162702449|NCT03468426|587621837|FG010|Overall Study|Progressive disease|0|||
162702450|NCT03468426|587621827|FG000|Overall Study|Other adverse event or clinical progression|0|||
162702451|NCT03468426|587621828|FG001|Overall Study|Other adverse event or clinical progression|1|||
162702452|NCT03468426|587621829|FG002|Overall Study|Other adverse event or clinical progression|3|||
162702453|NCT03468426|587621830|FG003|Overall Study|Other adverse event or clinical progression|14|||
162702454|NCT03468426|587621831|FG004|Overall Study|Other adverse event or clinical progression|10|||
162702455|NCT03468426|587621832|FG005|Overall Study|Other adverse event or clinical progression|8|||
162702456|NCT03468426|587621833|FG006|Overall Study|Other adverse event or clinical progression|5|||
162702457|NCT03468426|587621834|FG007|Overall Study|Other adverse event or clinical progression|4|||
162702458|NCT03468426|587621835|FG008|Overall Study|Other adverse event or clinical progression|6|||
162702459|NCT03468426|587621836|FG009|Overall Study|Other adverse event or clinical progression|11|||
162702460|NCT03468426|587621837|FG010|Overall Study|Other adverse event or clinical progression|0|||
162702461|NCT03468426|587621827|FG000|Overall Study|Refused to continue taking trial medication|0|||
162702462|NCT03468426|587621828|FG001|Overall Study|Refused to continue taking trial medication|0|||
162702463|NCT03468426|587621829|FG002|Overall Study|Refused to continue taking trial medication|0|||
162702464|NCT03468426|587621830|FG003|Overall Study|Refused to continue taking trial medication|2|||
162702465|NCT03468426|587621831|FG004|Overall Study|Refused to continue taking trial medication|0|||
162847985|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
162847986|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
162847987|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
162847988|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
162847989|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
162847990|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
162847991|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
162847992|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
162847993|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
162847994|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
162847995|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
162847996|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
162847997|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
162847998|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
162847999|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
162848000|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
162848001|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
162848002|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
162848003|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848004|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848005|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848006|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848007|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
162848008|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848009|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
162848010|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
162848011|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
162848012|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
162848013|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
162848014|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
162848015|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
162848016|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
162848017|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
162848018|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
162848019|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
162848020|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
162848021|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848022|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848023|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848024|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848025|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
162848026|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848027|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
162848028|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848029|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
162848030|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
162848031|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
162848032|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
162848033|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
162848034|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
162848035|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
162848036|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
162848037|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
162848038|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
162848039|NCT01583374|588150693|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
162848040|NCT01583374|588150694|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
162848041|NCT01583374|588150695|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163043230|NCT00110357|588865758|FG000|Overall Study|Withdrawal by Subject|3|||
162848042|NCT01583374|588150696|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
162848043|NCT01583374|588150697|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
162848044|NCT01583374|588150698|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
162848045|NCT01583374|588150699|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
162848046|NCT01583374|588150700|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
162848047|NCT01583374|588150701|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
162848048|NCT01292057|588150704|FG000|Overall Study|Protocol Violation|1|||
162848049|NCT01292057|588150705|FG001|Overall Study|Protocol Violation|1|||
162848050|NCT01292057|588150704|FG000|Overall Study|Lost to Follow-up|1|||
162848051|NCT01292057|588150705|FG001|Overall Study|Lost to Follow-up|1|||
162848052|NCT03658889|588152705|FG000|Overall Study|Protocol Violation|2|||
162848053|NCT03658889|588152706|FG001|Overall Study|Protocol Violation|0|||
162848054|NCT04188197|588152707|FG000|Overall Study|Lost to Follow-up|4|||
162848055|NCT04188197|588152708|FG001|Overall Study|Lost to Follow-up|1|||
162848056|NCT04188197|588152707|FG000|Overall Study|Withdrawal by Subject|1|||
162848057|NCT04188197|588152708|FG001|Overall Study|Withdrawal by Subject|1|||
162848058|NCT04188197|588152707|FG000|Overall Study|Pregnancy|0|||
162848059|NCT04188197|588152708|FG001|Overall Study|Pregnancy|1|||
162848060|NCT01524991|588152711|FG000|Overall Study|Adverse Event|12|||
162848061|NCT01524991|588152711|FG000|Overall Study|Death|1|||
162848062|NCT01524991|588152711|FG000|Overall Study|Disease ProgressionDu|17|||
162848063|NCT01524991|588152711|FG000|Overall Study|Other complicating disease|1|||
162848064|NCT01524991|588152711|FG000|Overall Study|Withdrawal by Subject|2|||
162848065|NCT01524991|588152711|FG000|Overall Study|Symptomatic Deterioration|1|||
162848066|NCT04574999|588152712|FG000|Overall Study|Adverse Event|1|||
162848067|NCT04574999|588152713|FG001|Overall Study|Adverse Event|0|||
162848068|NCT04574999|588152712|FG000|Overall Study|Lack of Efficacy|2|||
162848069|NCT04574999|588152713|FG001|Overall Study|Lack of Efficacy|3|||
162848070|NCT04574999|588152712|FG000|Overall Study|Protocol Violation|1|||
162848071|NCT04574999|588152713|FG001|Overall Study|Protocol Violation|0|||
162848072|NCT04574999|588152712|FG000|Overall Study|Withdrawal by Subject|2|||
162848073|NCT04574999|588152713|FG001|Overall Study|Withdrawal by Subject|2|||
162848074|NCT04574999|588152712|FG000|Overall Study|Lost to Follow-up|1|||
162848075|NCT04574999|588152713|FG001|Overall Study|Lost to Follow-up|0|||
162848076|NCT04574999|588152712|FG000|Overall Study|Personal problems|1|||
162848077|NCT04574999|588152713|FG001|Overall Study|Personal problems|0|||
162848078|NCT04574999|588152712|FG000|Overall Study|Previous planned surgery|1|||
162848079|NCT04574999|588152713|FG001|Overall Study|Previous planned surgery|0|||
162848080|NCT00206726|588152715|FG000|Overall Study|Delayed recovery of blood counts|1|||
162848081|NCT00206726|588152715|FG000|Overall Study|Progressive disease or relapsed disease|18|||
162848082|NCT00206726|588152715|FG000|Overall Study|Placed on new protocol|1|||
162848083|NCT00206726|588152715|FG000|Overall Study|Bone marrow transplant|1|||
162848084|NCT00206726|588152715|FG000|Overall Study|Adverse Event|17|||
162848085|NCT00206726|588152715|FG000|Overall Study|Death|4|||
162848086|NCT00206726|588152715|FG000|Overall Study|Protocol Violation|1|||
162848087|NCT00206726|588152715|FG000|Overall Study|Withdrawal by Subject|8|||
162848088|NCT00832819|588152718|FG000|Overall Study|Adverse Event|0|||
162848089|NCT00832819|588152719|FG001|Overall Study|Adverse Event|1|||
162848090|NCT00832819|588152720|FG002|Overall Study|Adverse Event|0|||
162848091|NCT00832819|588152718|FG000|Overall Study|Protocol Violation|0|||
162848092|NCT00832819|588152719|FG001|Overall Study|Protocol Violation|0|||
162848093|NCT00832819|588152720|FG002|Overall Study|Protocol Violation|1|||
162848094|NCT02626338|588152721|FG000|Overall Study|Lack of Efficacy|3|||
162848095|NCT02626338|588152722|FG001|Overall Study|Lack of Efficacy|2|||
162848096|NCT02626338|588152723|FG002|Overall Study|Lack of Efficacy|0|||
162848097|NCT03312218|588152729|FG000|Overall Study|Never signed in to access the app|54|||
162848098|NCT03312218|588152730|FG001|Overall Study|Never signed in to access the app|58|||
162848099|NCT01901224|588152731|FG000|Overall Study|study was not funded and terminated|2|||
162848100|NCT06441877|588152732|FG000|Overall Study|Withdrawal by Subject|0|||
162848101|NCT06441877|588152733|FG001|Overall Study|Withdrawal by Subject|2|||
162848102|NCT06441877|588152734|FG002|Overall Study|Withdrawal by Subject|0|||
162848103|NCT06441877|588152735|FG003|Overall Study|Withdrawal by Subject|0|||
162848104|NCT05742984|588152736|FG000|Overall Study|Adverse Event|0|||
162848105|NCT05742984|588152737|FG001|Overall Study|Adverse Event|0|||
162848106|NCT05742984|588152738|FG002|Overall Study|Adverse Event|1|||
162848107|NCT05742984|588152739|FG003|Overall Study|Adverse Event|0|||
162848108|NCT05742984|588152740|FG004|Overall Study|Adverse Event|1|||
162848109|NCT05742984|588152741|FG005|Overall Study|Adverse Event|1|||
162848110|NCT05742984|588152736|FG000|Overall Study|Withdrawal by Subject|0|||
162848111|NCT05742984|588152737|FG001|Overall Study|Withdrawal by Subject|1|||
162848112|NCT05742984|588152738|FG002|Overall Study|Withdrawal by Subject|0|||
162848113|NCT05742984|588152739|FG003|Overall Study|Withdrawal by Subject|0|||
162848114|NCT05742984|588152740|FG004|Overall Study|Withdrawal by Subject|0|||
162848115|NCT05742984|588152741|FG005|Overall Study|Withdrawal by Subject|2|||
162848116|NCT02162862|588152742|FG000|Overall Study|Lost to Follow-up|0|||
162848117|NCT02162862|588152743|FG001|Overall Study|Lost to Follow-up|11|||
162848118|NCT02162862|588152744|FG002|Overall Study|Lost to Follow-up|0|||
162848119|NCT02162862|588152742|FG000|Overall Study|Subject did not feel the med was needed|0|||
162848120|NCT02162862|588152743|FG001|Overall Study|Subject did not feel the med was needed|0|||
162848121|NCT02162862|588152744|FG002|Overall Study|Subject did not feel the med was needed|4|||
162848122|NCT03116113|588152745|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848123|NCT03116113|588152746|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848124|NCT03116113|588152747|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848125|NCT03116113|588152748|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848126|NCT03116113|588152749|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848127|NCT03116113|588152750|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848128|NCT03116113|588152751|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
162848129|NCT03116113|588152752|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
162848130|NCT03116113|588152753|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
162848131|NCT02159807|588152754|FG000|Overall Study|Adverse Event|0|||
162848132|NCT02159807|588152755|FG001|Overall Study|Adverse Event|0|||
162848133|NCT02159807|588152756|FG002|Overall Study|Adverse Event|1|||
162848134|NCT02159807|588152754|FG000|Overall Study|No CSF|1|||
162848135|NCT02159807|588152755|FG001|Overall Study|No CSF|1|||
162848136|NCT02159807|588152756|FG002|Overall Study|No CSF|1|||
162848137|NCT02159807|588152754|FG000|Overall Study|elevated blood pressure|0|||
162848138|NCT02159807|588152755|FG001|Overall Study|elevated blood pressure|0|||
162848139|NCT02159807|588152756|FG002|Overall Study|elevated blood pressure|1|||
162848140|NCT00950170|588152757|FG000|Overall Study|Parent/Legal Guardian Request|1|||
162848141|NCT00950170|588152757|FG000|Overall Study|Adverse Event|2|||
162848142|NCT00950170|588152757|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
162848143|NCT01254669|588152760|FG000|Overall Study|Withdrawal by Subject|0|||
162848144|NCT01254669|588152761|FG001|Overall Study|Withdrawal by Subject|1|||
162848145|NCT01254669|588152760|FG000|Overall Study|time constraint|2|||
162848146|NCT01254669|588152761|FG001|Overall Study|time constraint|2|||
162848147|NCT01254669|588152760|FG000|Overall Study|called to clinic during intervention|1|||
162848148|NCT01254669|588152761|FG001|Overall Study|called to clinic during intervention|1|||
162848149|NCT00103012|588152762|FG000|Overall Study|Withdrawal by Subject|2|||
162848150|NCT00103012|588152763|FG001|Overall Study|Withdrawal by Subject|1|||
162848151|NCT00103012|588152764|FG002|Overall Study|Withdrawal by Subject|2|||
162848152|NCT00103012|588152762|FG000|Overall Study|Pregnancy|1|||
162848153|NCT00103012|588152763|FG001|Overall Study|Pregnancy|0|||
162848154|NCT00103012|588152764|FG002|Overall Study|Pregnancy|0|||
162848155|NCT00103012|588152762|FG000|Overall Study|Adverse Event|0|||
162848156|NCT00103012|588152763|FG001|Overall Study|Adverse Event|0|||
162848157|NCT00103012|588152764|FG002|Overall Study|Adverse Event|1|||
162848158|NCT00103012|588152762|FG000|Overall Study|Subject non-compliant with medications|0|||
162848159|NCT00103012|588152763|FG001|Overall Study|Subject non-compliant with medications|0|||
162952079|NCT00909610|588529532|FG000|Period: Second Intervention|Adverse Event|1|||
162607159|NCT04104438|587277657|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
162607160|NCT04104438|587277658|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
162607161|NCT01282203|587277661|FG000|Overall Study|Adverse Event|1|||
162607162|NCT03977454|587277662|FG000|Overall Study|immediate postoperative revision|2|||
162607163|NCT03977454|587277663|FG001|Overall Study|immediate postoperative revision|2|||
162607164|NCT00930982|587277664|FG000|Overall Study|Adverse Event|19|||
162607165|NCT00930982|587277665|FG001|Overall Study|Adverse Event|23|||
162607166|NCT00930982|587277664|FG000|Overall Study|Protocol Violation|1|||
162607167|NCT00930982|587277665|FG001|Overall Study|Protocol Violation|5|||
162607168|NCT00930982|587277664|FG000|Overall Study|Withdrawal by Subject|1|||
162607169|NCT00930982|587277665|FG001|Overall Study|Withdrawal by Subject|1|||
162607170|NCT00518973|587277666|FG000|Overall Study|Withdrawal by Subject|3|||
162848160|NCT00103012|588152764|FG002|Overall Study|Subject non-compliant with medications|1|||
162848161|NCT00393718|588152771|FG000|Overall Study|Adverse Event|20|||
162848162|NCT00393718|588152772|FG001|Overall Study|Adverse Event|8|||
162848163|NCT00393718|588152771|FG000|Overall Study|Protocol Violation|1|||
162848164|NCT00393718|588152772|FG001|Overall Study|Protocol Violation|2|||
162848165|NCT00393718|588152771|FG000|Overall Study|Lack of Efficacy|10|||
162848166|NCT00393718|588152772|FG001|Overall Study|Lack of Efficacy|9|||
162848167|NCT00393718|588152771|FG000|Overall Study|Hypoglycaemia|3|||
162848168|NCT00393718|588152772|FG001|Overall Study|Hypoglycaemia|2|||
162848169|NCT00393718|588152771|FG000|Overall Study|Subject decision|5|||
162848170|NCT00393718|588152772|FG001|Overall Study|Subject decision|0|||
162848171|NCT00393718|588152771|FG000|Overall Study|Withdrawal of consent|2|||
162848172|NCT00393718|588152772|FG001|Overall Study|Withdrawal of consent|1|||
162848173|NCT00393718|588152771|FG000|Overall Study|Missed measurement|1|||
162848174|NCT00393718|588152772|FG001|Overall Study|Missed measurement|0|||
162848175|NCT00393718|588152771|FG000|Overall Study|Move|1|||
162848176|NCT00393718|588152772|FG001|Overall Study|Move|0|||
162848177|NCT01084551|588152777|FG000|Overall Study|Adverse Event|2|||
162848178|NCT01084551|588152778|FG001|Overall Study|Adverse Event|9|||
162848179|NCT01084551|588152779|FG002|Overall Study|Adverse Event|4|||
162848180|NCT01084551|588152777|FG000|Overall Study|Lack of Efficacy|2|||
162848181|NCT01084551|588152778|FG001|Overall Study|Lack of Efficacy|0|||
162848182|NCT01084551|588152779|FG002|Overall Study|Lack of Efficacy|1|||
162848183|NCT01084551|588152777|FG000|Overall Study|Withdrawal by Subject|2|||
162848184|NCT01084551|588152778|FG001|Overall Study|Withdrawal by Subject|1|||
162848185|NCT01084551|588152779|FG002|Overall Study|Withdrawal by Subject|0|||
162848186|NCT01084551|588152777|FG000|Overall Study|Protocol Violation|2|||
162848187|NCT01084551|588152778|FG001|Overall Study|Protocol Violation|4|||
162848188|NCT01084551|588152779|FG002|Overall Study|Protocol Violation|0|||
162848189|NCT01084551|588152777|FG000|Overall Study|Lost to Follow-up|0|||
162848190|NCT01084551|588152778|FG001|Overall Study|Lost to Follow-up|0|||
162848191|NCT01084551|588152779|FG002|Overall Study|Lost to Follow-up|3|||
162848192|NCT01084551|588152777|FG000|Overall Study|Physician Decision|1|||
162848193|NCT01084551|588152778|FG001|Overall Study|Physician Decision|0|||
162848194|NCT01084551|588152779|FG002|Overall Study|Physician Decision|0|||
162848195|NCT03902080|588152780|FG000|Overall Study|Adverse Event|17|||
162848196|NCT03902080|588152781|FG001|Overall Study|Adverse Event|15|||
162848197|NCT03902080|588152780|FG000|Overall Study|Withdrawal by Subject|28|||
162848198|NCT03902080|588152781|FG001|Overall Study|Withdrawal by Subject|35|||
162848199|NCT03902080|588152780|FG000|Overall Study|Lost to Follow-up|6|||
162702466|NCT03468426|587621832|FG005|Overall Study|Refused to continue taking trial medication|3|||
162702467|NCT03468426|587621833|FG006|Overall Study|Refused to continue taking trial medication|0|||
162702468|NCT03468426|587621834|FG007|Overall Study|Refused to continue taking trial medication|0|||
162702469|NCT03468426|587621835|FG008|Overall Study|Refused to continue taking trial medication|1|||
162702470|NCT03468426|587621836|FG009|Overall Study|Refused to continue taking trial medication|0|||
162702471|NCT03468426|587621837|FG010|Overall Study|Refused to continue taking trial medication|0|||
162702472|NCT03468426|587621827|FG000|Overall Study|Other than listed|0|||
162848200|NCT03902080|588152781|FG001|Overall Study|Lost to Follow-up|7|||
162848201|NCT03902080|588152780|FG000|Overall Study|Other|3|||
162848202|NCT03902080|588152781|FG001|Overall Study|Other|5|||
162848203|NCT03902080|588152780|FG000|Overall Study|Non compliance|4|||
162848204|NCT03902080|588152781|FG001|Overall Study|Non compliance|3|||
162848205|NCT03902080|588152780|FG000|Overall Study|Physician Decision|5|||
162848206|NCT03902080|588152781|FG001|Overall Study|Physician Decision|1|||
162848207|NCT03902080|588152780|FG000|Overall Study|Protocol Violation|3|||
162848208|NCT03902080|588152781|FG001|Overall Study|Protocol Violation|3|||
162848209|NCT03902080|588152780|FG000|Overall Study|Lack of Efficacy|1|||
162848210|NCT03902080|588152781|FG001|Overall Study|Lack of Efficacy|3|||
162848211|NCT03902080|588152780|FG000|Overall Study|Withdrawn prior to dosing|0|||
162848212|NCT03902080|588152781|FG001|Overall Study|Withdrawn prior to dosing|1|||
162848213|NCT01703000|588152782|FG000|Overall Study|Death|1|||
162848214|NCT01279057|588152783|FG000|Overall Study|Adverse Event|1|||
162848215|NCT01279057|588152784|FG001|Overall Study|Adverse Event|0|||
162607171|NCT00518973|587277667|FG001|Overall Study|Withdrawal by Subject|2|||
162607172|NCT00582816|587277668|FG000|Overall Study|Engraftment Failure|3|||
162607173|NCT01001299|587277669|FG000|Overall Study|Insufficient Therapeutic Response|20|||
162607174|NCT01001299|587277669|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
162607175|NCT01001299|587277669|FG000|Overall Study|Death|1|||
162607176|NCT01001299|587277669|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
162607177|NCT01001299|587277669|FG000|Overall Study|Withdrew Consent|1|||
162607178|NCT01565499|587277670|FG000|Overall Study|Physician Decision|1|||
162607179|NCT01565499|587277670|FG000|Overall Study|Adverse Event|5|||
162607180|NCT01565499|587277670|FG000|Overall Study|Withdrawal by Subject|2|||
162607181|NCT01923168|587277671|FG000|Overall Study|Protocol Violation|1|||
162607182|NCT01923168|587277672|FG001|Overall Study|Protocol Violation|1|||
162607183|NCT01923168|587277673|FG002|Overall Study|Protocol Violation|0|||
162607184|NCT01923168|587277671|FG000|Overall Study|Subject/guardian decision|14|||
162607185|NCT01923168|587277672|FG001|Overall Study|Subject/guardian decision|14|||
162848216|NCT01279057|588152785|FG002|Overall Study|Adverse Event|1|||
162848217|NCT01279057|588152783|FG000|Overall Study|Insufficient therapeutic response|0|||
162848218|NCT01279057|588152784|FG001|Overall Study|Insufficient therapeutic response|0|||
162848219|NCT01279057|588152785|FG002|Overall Study|Insufficient therapeutic response|1|||
162848220|NCT01279057|588152783|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162848221|NCT01279057|588152784|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
162607186|NCT01923168|587277673|FG002|Overall Study|Subject/guardian decision|4|||
162607187|NCT01923168|587277671|FG000|Overall Study|Adverse Event|12|||
162607188|NCT01923168|587277672|FG001|Overall Study|Adverse Event|12|||
162607189|NCT01923168|587277673|FG002|Overall Study|Adverse Event|0|||
162607190|NCT01923168|587277671|FG000|Overall Study|Physician Decision|6|||
162607191|NCT01923168|587277672|FG001|Overall Study|Physician Decision|9|||
162607192|NCT01923168|587277673|FG002|Overall Study|Physician Decision|5|||
162607193|NCT01923168|587277671|FG000|Overall Study|Progressive disease|4|||
162607194|NCT01923168|587277672|FG001|Overall Study|Progressive disease|3|||
162848222|NCT01279057|588152785|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162848223|NCT01279057|588152783|FG000|Overall Study|Withdrew consent|2|||
162607195|NCT01923168|587277673|FG002|Overall Study|Progressive disease|7|||
162607196|NCT01923168|587277671|FG000|Overall Study|Death|0|||
162607197|NCT01923168|587277672|FG001|Overall Study|Death|0|||
162607198|NCT01923168|587277673|FG002|Overall Study|Death|1|||
162607199|NCT02241889|587277678|FG000|Overall Study|device issues|0|||
162607200|NCT02241889|587277679|FG001|Overall Study|device issues|0|||
162607201|NCT02241889|587277680|FG002|Overall Study|device issues|1|||
162607202|NCT02241889|587277681|FG003|Overall Study|device issues|0|||
162607203|NCT02241889|587277682|FG004|Overall Study|device issues|0|||
162607204|NCT02241889|587277683|FG005|Overall Study|device issues|0|||
162607205|NCT02241889|587277678|FG000|Overall Study|Withdrawal by Subject|0|||
162607206|NCT02241889|587277679|FG001|Overall Study|Withdrawal by Subject|0|||
162607207|NCT02241889|587277680|FG002|Overall Study|Withdrawal by Subject|0|||
162607208|NCT02241889|587277681|FG003|Overall Study|Withdrawal by Subject|0|||
162607209|NCT02241889|587277682|FG004|Overall Study|Withdrawal by Subject|0|||
162607210|NCT02241889|587277683|FG005|Overall Study|Withdrawal by Subject|1|||
162607211|NCT00773838|587277684|FG000|Overall Study|Adverse Event|29|||
162607212|NCT00773838|587277684|FG000|Overall Study|Lost to Follow-up|1|||
162607213|NCT00773838|587277684|FG000|Overall Study|Physician Decision|8|||
162607214|NCT00773838|587277684|FG000|Overall Study|Progressive Disease|82|||
162607215|NCT00773838|587277684|FG000|Overall Study|Protocol Violation|2|||
162607216|NCT00773838|587277684|FG000|Overall Study|Withdrawal by Subject|21|||
162607217|NCT00459056|587277687|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
162848224|NCT01279057|588152784|FG001|Overall Study|Withdrew consent|0|||
162848225|NCT01279057|588152785|FG002|Overall Study|Withdrew consent|1|||
162848226|NCT01279057|588152783|FG000|Overall Study|Pregnancy|0|||
162848227|NCT01279057|588152784|FG001|Overall Study|Pregnancy|1|||
162848228|NCT01279057|588152785|FG002|Overall Study|Pregnancy|0|||
162848229|NCT01279057|588152783|FG000|Overall Study|Other|3|||
162848230|NCT01279057|588152784|FG001|Overall Study|Other|3|||
162848231|NCT01279057|588152785|FG002|Overall Study|Other|0|||
162848232|NCT01427309|588152786|FG000|Overall Study|Lost to Follow-up|130|||
162848233|NCT01427309|588152787|FG001|Overall Study|Lost to Follow-up|145|||
162848234|NCT01427309|588152788|FG002|Overall Study|Lost to Follow-up|122|||
162607218|NCT00459056|587277688|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
162607219|NCT02522871|587277689|FG000|Overall Study|Protocol Violation|1|||
162848235|NCT01427309|588152789|FG003|Overall Study|Lost to Follow-up|135|||
162848236|NCT01427309|588152786|FG000|Overall Study|Protocol Violation|42|||
162607220|NCT02522871|587277690|FG001|Overall Study|Protocol Violation|4|||
162607221|NCT02522871|587277689|FG000|Overall Study|Treated without randomization|1|||
162607222|NCT02522871|587277690|FG001|Overall Study|Treated without randomization|0|||
162607223|NCT02522871|587277689|FG000|Overall Study|Death|9|||
162607224|NCT02522871|587277690|FG001|Overall Study|Death|9|||
162607225|NCT02522871|587277689|FG000|Overall Study|Died in operating room prior to transplant|0|||
162848237|NCT01427309|588152787|FG001|Overall Study|Protocol Violation|69|||
162848238|NCT01427309|588152788|FG002|Overall Study|Protocol Violation|125|||
162848239|NCT01427309|588152789|FG003|Overall Study|Protocol Violation|124|||
162848240|NCT01427309|588152786|FG000|Overall Study|Adverse Event|0|||
162848241|NCT01427309|588152787|FG001|Overall Study|Adverse Event|0|||
162848242|NCT01427309|588152788|FG002|Overall Study|Adverse Event|3|||
162848243|NCT01427309|588152789|FG003|Overall Study|Adverse Event|1|||
162848244|NCT01427309|588152786|FG000|Overall Study|Serious adverse event|52|||
162848245|NCT01427309|588152787|FG001|Overall Study|Serious adverse event|45|||
162848246|NCT01427309|588152788|FG002|Overall Study|Serious adverse event|50|||
162848247|NCT01427309|588152789|FG003|Overall Study|Serious adverse event|61|||
162848248|NCT01427309|588152786|FG000|Overall Study|Withdrawal by Subject|148|||
162848249|NCT01427309|588152787|FG001|Overall Study|Withdrawal by Subject|148|||
162848250|NCT01427309|588152788|FG002|Overall Study|Withdrawal by Subject|61|||
162848251|NCT01427309|588152789|FG003|Overall Study|Withdrawal by Subject|55|||
162848252|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
162848253|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
162848254|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
162848255|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
162848256|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
162848257|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
162848258|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
162848259|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
162848260|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
162848261|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
162848262|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
162848263|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
162848264|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
162848265|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
162848266|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
162848267|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
162848268|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
162848269|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
162848270|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
162848271|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
162848272|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
162848273|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
162702473|NCT03468426|587621828|FG001|Overall Study|Other than listed|1|||
162702474|NCT03468426|587621829|FG002|Overall Study|Other than listed|0|||
162702475|NCT03468426|587621830|FG003|Overall Study|Other than listed|0|||
162702476|NCT03468426|587621831|FG004|Overall Study|Other than listed|2|||
162702477|NCT03468426|587621832|FG005|Overall Study|Other than listed|2|||
162702478|NCT03468426|587621833|FG006|Overall Study|Other than listed|0|||
162702479|NCT03468426|587621834|FG007|Overall Study|Other than listed|0|||
162702480|NCT03468426|587621835|FG008|Overall Study|Other than listed|4|||
162702481|NCT03468426|587621836|FG009|Overall Study|Other than listed|4|||
162702482|NCT03468426|587621837|FG010|Overall Study|Other than listed|1|||
162702483|NCT03468426|587621827|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702484|NCT03468426|587621828|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702485|NCT03468426|587621829|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162702486|NCT03468426|587621830|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702487|NCT03468426|587621831|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702488|NCT03468426|587621832|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702489|NCT03468426|587621833|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702490|NCT03468426|587621834|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702491|NCT03468426|587621835|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702492|NCT03468426|587621836|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702493|NCT03468426|587621837|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162702494|NCT03468426|587621827|FG000|Overall Study|missing reason|0|||
162702495|NCT03468426|587621828|FG001|Overall Study|missing reason|0|||
162702496|NCT03468426|587621829|FG002|Overall Study|missing reason|0|||
162702497|NCT03468426|587621830|FG003|Overall Study|missing reason|0|||
162702498|NCT03468426|587621831|FG004|Overall Study|missing reason|0|||
162702499|NCT03468426|587621832|FG005|Overall Study|missing reason|0|||
162702500|NCT03468426|587621833|FG006|Overall Study|missing reason|0|||
162702501|NCT03468426|587621834|FG007|Overall Study|missing reason|0|||
162702502|NCT03468426|587621835|FG008|Overall Study|missing reason|0|||
162702503|NCT03468426|587621836|FG009|Overall Study|missing reason|1|||
162702504|NCT03468426|587621837|FG010|Overall Study|missing reason|0|||
162702505|NCT01440049|587621839|FG000|Overall Study|Adverse Event|5|||
162702506|NCT02268552|587621840|FG000|Part 1|Death|1|||
162848274|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
162848275|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
162848276|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
162848277|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
162702507|NCT02268552|587621841|FG001|Part 1|Death|1|||
162702508|NCT02268552|587621842|FG002|Part 1|Death|1|||
162702509|NCT02268552|587621843|FG003|Part 1|Death|2|||
162702510|NCT02268552|587621844|FG004|Part 1|Death|0|||
162702511|NCT02268552|587621845|FG005|Part 1|Death|0|||
162702512|NCT02268552|587621846|FG006|Part 1|Death|0|||
162702513|NCT02268552|587621840|FG000|Part 1|Subject/guardian decision|0|||
162702514|NCT02268552|587621841|FG001|Part 1|Subject/guardian decision|0|||
162702515|NCT02268552|587621842|FG002|Part 1|Subject/guardian decision|0|||
162702516|NCT02268552|587621843|FG003|Part 1|Subject/guardian decision|1|||
162702517|NCT02268552|587621844|FG004|Part 1|Subject/guardian decision|0|||
162607226|NCT02522871|587277690|FG001|Overall Study|Died in operating room prior to transplant|1|||
162607227|NCT02398227|587277691|FG000|Overall Study|Lost to Follow-up|21|||
162607228|NCT02398227|587277692|FG001|Overall Study|Lost to Follow-up|12|||
162607229|NCT02398227|587277691|FG000|Overall Study|Withdrawal by Subject|5|||
162607230|NCT02398227|587277692|FG001|Overall Study|Withdrawal by Subject|6|||
162607231|NCT02398227|587277691|FG000|Overall Study|Removed from treatment and dropped out|1|||
162607232|NCT02398227|587277692|FG001|Overall Study|Removed from treatment and dropped out|0|||
162607233|NCT01715129|587277693|FG000|Overall Study|Adverse Event, fatal|1|||
162607234|NCT01715129|587277693|FG000|Overall Study|Lack of Efficacy|3|||
162607235|NCT01715129|587277693|FG000|Overall Study|Protocol Violation|1|||
162607236|NCT01715129|587277693|FG000|Overall Study|Consent Withdrawn|2|||
162607237|NCT01715129|587277693|FG000|Overall Study|Lost to Follow-up|1|||
162607238|NCT01715129|587277693|FG000|Overall Study|Other|1|||
162607239|NCT02793622|587277694|FG000|Overall Study|Lost to Follow-up|31|||
162607240|NCT02793622|587277695|FG001|Overall Study|Lost to Follow-up|19|||
162607241|NCT02793622|587277694|FG000|Overall Study|Withdrawal by Subject|21|||
162607242|NCT02793622|587277695|FG001|Overall Study|Withdrawal by Subject|17|||
162607243|NCT02793622|587277694|FG000|Overall Study|Adverse Event|0|||
162607244|NCT02793622|587277695|FG001|Overall Study|Adverse Event|1|||
162607245|NCT02793622|587277694|FG000|Overall Study|Protocol Violation|1|||
162848278|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
162848279|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
162848280|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
162848281|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
162848282|NCT00849017|588152792|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
162848283|NCT00849017|588152793|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
162848284|NCT00849017|588152794|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
162848285|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
162848286|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
162848287|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
162607246|NCT02793622|587277695|FG001|Overall Study|Protocol Violation|5|||
162607247|NCT03149848|587277696|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
162607248|NCT03149848|587277696|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
162607249|NCT00378079|587277699|FG000|Overall Study|Lost to Follow-up|6|||
162607250|NCT00378079|587277700|FG001|Overall Study|Lost to Follow-up|1|||
162607251|NCT00378079|587277701|FG002|Overall Study|Lost to Follow-up|0|||
162607252|NCT02274038|587277702|FG000|Overall Study|Death|1|||
162607253|NCT00586664|587277707|FG000|Overall Study|Withdrawal by Subject|3|||
162607254|NCT00586664|587277708|FG001|Overall Study|Withdrawal by Subject|7|||
162607255|NCT00586664|587277709|FG002|Overall Study|Withdrawal by Subject|1|||
162607256|NCT00586664|587277707|FG000|Overall Study|Exclusion criteria met|2|||
162607257|NCT00586664|587277708|FG001|Overall Study|Exclusion criteria met|0|||
162607258|NCT00586664|587277709|FG002|Overall Study|Exclusion criteria met|0|||
162607259|NCT01602666|587277710|FG000|Induction Chemotherapy|Death|2|||
162607260|NCT01602666|587277711|FG001|Induction Chemotherapy|Death|1|||
162607261|NCT01602666|587277710|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
162607262|NCT01602666|587277711|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
162607263|NCT01602666|587277710|FG000|Induction Chemotherapy|Physician Decision|12|||
162607264|NCT01602666|587277711|FG001|Induction Chemotherapy|Physician Decision|5|||
162607265|NCT01602666|587277710|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
162607266|NCT01602666|587277711|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
162607267|NCT01602666|587277710|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
162607268|NCT01602666|587277711|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
162702518|NCT02268552|587621845|FG005|Part 1|Subject/guardian decision|0|||
162607269|NCT01602666|587277710|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
162607270|NCT01602666|587277711|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
162607271|NCT01602666|587277710|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
162607272|NCT01602666|587277711|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
162607273|NCT01602666|587277710|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
162607274|NCT01602666|587277711|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
162607275|NCT01602666|587277710|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
162607276|NCT01602666|587277711|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
162607277|NCT01602666|587277710|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
162607278|NCT01602666|587277711|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
162702519|NCT02268552|587621846|FG006|Part 1|Subject/guardian decision|0|||
162848288|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
162607279|NCT01602666|587277710|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
162607280|NCT01602666|587277711|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
162607281|NCT05458648|587277712|FG000|Overall Study|Physician Decision|1|||
162607282|NCT05458648|587277712|FG000|Overall Study|Patient presented in atrial flutter|1|||
162607283|NCT03610555|587277716|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
162702520|NCT02268552|587621840|FG000|Part 2|Death|0|||
162848289|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
162848290|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
162848291|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
162848292|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
162848293|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
162848294|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
162848295|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
162848296|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
162848297|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
162848298|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
162848299|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
162848300|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
162848301|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
162848302|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
162848303|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
162848304|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
162848305|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
162848306|NCT00849017|588152792|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
162848307|NCT00849017|588152793|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
162848308|NCT00849017|588152794|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
162848309|NCT02913313|588152795|FG000|Overall Study|DISEASE PROGRESSION|1|||
162848310|NCT02913313|588152796|FG001|Overall Study|DISEASE PROGRESSION|2|||
162848311|NCT02913313|588152797|FG002|Overall Study|DISEASE PROGRESSION|2|||
162848312|NCT02913313|588152798|FG003|Overall Study|DISEASE PROGRESSION|4|||
162607284|NCT03610555|587277717|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
162607285|NCT03610555|587277718|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
162607286|NCT03610555|587277719|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
162607287|NCT01892722|587277720|FG000|Overall Study|Protocol deviation|0|||
162607288|NCT01892722|587277721|FG001|Overall Study|Protocol deviation|1|||
162607289|NCT01892722|587277720|FG000|Overall Study|Administrative problems|0|||
162607290|NCT01892722|587277721|FG001|Overall Study|Administrative problems|1|||
162607291|NCT01892722|587277720|FG000|Overall Study|Patient/guardian decision|0|||
162607292|NCT01892722|587277721|FG001|Overall Study|Patient/guardian decision|2|||
162607293|NCT01892722|587277720|FG000|Overall Study|Physician Decision|1|||
162607294|NCT01892722|587277721|FG001|Overall Study|Physician Decision|2|||
162607295|NCT01892722|587277720|FG000|Overall Study|Adverse Event|3|||
162607296|NCT01892722|587277721|FG001|Overall Study|Adverse Event|2|||
162607297|NCT01892722|587277720|FG000|Overall Study|Lack of Efficacy|0|||
162607298|NCT01892722|587277721|FG001|Overall Study|Lack of Efficacy|7|||
162607299|NCT01892722|587277720|FG000|Overall Study|Withdrawal by Subject|3|||
162607300|NCT01892722|587277721|FG001|Overall Study|Withdrawal by Subject|5|||
162607301|NCT02275910|587277722|FG000|Overall Study|Subject Choice|0|||
162607302|NCT02275910|587277723|FG001|Overall Study|Subject Choice|0|||
162607303|NCT02275910|587277724|FG002|Overall Study|Subject Choice|0|||
162607304|NCT02275910|587277725|FG003|Overall Study|Subject Choice|0|||
162607305|NCT02275910|587277726|FG004|Overall Study|Subject Choice|0|||
162607306|NCT02275910|587277727|FG005|Overall Study|Subject Choice|0|||
162607307|NCT02275910|587277728|FG006|Overall Study|Subject Choice|0|||
162607308|NCT02275910|587277729|FG007|Overall Study|Subject Choice|0|||
162607309|NCT02275910|587277730|FG008|Overall Study|Subject Choice|1|||
162607310|NCT02275910|587277731|FG009|Overall Study|Subject Choice|0|||
162607311|NCT02275910|587277732|FG010|Overall Study|Subject Choice|0|||
162607312|NCT02275910|587277733|FG011|Overall Study|Subject Choice|0|||
162607313|NCT02275910|587277722|FG000|Overall Study|Radiological Disease Progression|0|||
162607314|NCT02275910|587277723|FG001|Overall Study|Radiological Disease Progression|0|||
162607315|NCT02275910|587277724|FG002|Overall Study|Radiological Disease Progression|0|||
162607316|NCT02275910|587277725|FG003|Overall Study|Radiological Disease Progression|0|||
162607317|NCT02275910|587277726|FG004|Overall Study|Radiological Disease Progression|0|||
162607318|NCT02275910|587277727|FG005|Overall Study|Radiological Disease Progression|0|||
162607319|NCT02275910|587277728|FG006|Overall Study|Radiological Disease Progression|1|||
162607320|NCT02275910|587277729|FG007|Overall Study|Radiological Disease Progression|1|||
162702521|NCT02268552|587621841|FG001|Part 2|Death|0|||
162607321|NCT02275910|587277730|FG008|Overall Study|Radiological Disease Progression|0|||
162607322|NCT02275910|587277731|FG009|Overall Study|Radiological Disease Progression|1|||
162848313|NCT02913313|588152799|FG004|Overall Study|DISEASE PROGRESSION|6|||
162848314|NCT02913313|588152800|FG005|Overall Study|DISEASE PROGRESSION|4|||
162848315|NCT02913313|588152801|FG006|Overall Study|DISEASE PROGRESSION|19|||
162848316|NCT02913313|588152802|FG007|Overall Study|DISEASE PROGRESSION|3|||
162848317|NCT02913313|588152803|FG008|Overall Study|DISEASE PROGRESSION|4|||
162848318|NCT02913313|588152804|FG009|Overall Study|DISEASE PROGRESSION|4|||
162848319|NCT02913313|588152805|FG010|Overall Study|DISEASE PROGRESSION|11|||
162848320|NCT02913313|588152806|FG011|Overall Study|DISEASE PROGRESSION|5|||
162848321|NCT02913313|588152807|FG012|Overall Study|DISEASE PROGRESSION|14|||
162607323|NCT02275910|587277732|FG010|Overall Study|Radiological Disease Progression|0|||
162607324|NCT02275910|587277733|FG011|Overall Study|Radiological Disease Progression|0|||
162607325|NCT00076024|587279007|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
162607326|NCT00076024|587279008|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
162607327|NCT00076024|587279009|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
162607328|NCT00076024|587279010|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
162607329|NCT00076024|587279007|FG000|Phase 1, Lead-in|Adverse Event|1|||
162607330|NCT00076024|587279008|FG001|Phase 1, Lead-in|Adverse Event|0|||
162607331|NCT00076024|587279009|FG002|Phase 1, Lead-in|Adverse Event|0|||
162607332|NCT00076024|587279010|FG003|Phase 1, Lead-in|Adverse Event|0|||
162607333|NCT00076024|587279007|FG000|Phase 1, Lead-in|Clinical progression|1|||
162607334|NCT00076024|587279008|FG001|Phase 1, Lead-in|Clinical progression|0|||
162607335|NCT00076024|587279009|FG002|Phase 1, Lead-in|Clinical progression|0|||
162607336|NCT00076024|587279010|FG003|Phase 1, Lead-in|Clinical progression|0|||
162607337|NCT00076024|587279007|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
162607338|NCT00076024|587279008|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
162607339|NCT00076024|587279009|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
162607340|NCT00076024|587279010|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
162607341|NCT00076024|587279007|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
162607342|NCT00076024|587279008|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
162607343|NCT00076024|587279009|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
162607344|NCT00076024|587279010|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
162607345|NCT00076024|587279007|FG000|Phase 2, Double-blind|Adverse Event|0|||
162607346|NCT00076024|587279008|FG001|Phase 2, Double-blind|Adverse Event|25|||
162607347|NCT00076024|587279009|FG002|Phase 2, Double-blind|Adverse Event|6|||
162607348|NCT00076024|587279010|FG003|Phase 2, Double-blind|Adverse Event|0|||
162607349|NCT00076024|587279007|FG000|Phase 2, Double-blind|Un-specified|0|||
162607350|NCT00076024|587279008|FG001|Phase 2, Double-blind|Un-specified|14|||
162607351|NCT00076024|587279009|FG002|Phase 2, Double-blind|Un-specified|6|||
162607352|NCT00076024|587279010|FG003|Phase 2, Double-blind|Un-specified|0|||
162607353|NCT00076024|587279007|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
162607354|NCT00076024|587279008|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
162607355|NCT00076024|587279009|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
162607356|NCT00076024|587279010|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
162607357|NCT00076024|587279007|FG000|Phase 2, Open-label|Adverse Event|0|||
162607358|NCT00076024|587279008|FG001|Phase 2, Open-label|Adverse Event|0|||
162607359|NCT00076024|587279009|FG002|Phase 2, Open-label|Adverse Event|0|||
162607360|NCT00076024|587279010|FG003|Phase 2, Open-label|Adverse Event|2|||
162607361|NCT00076024|587279007|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
162607362|NCT00076024|587279008|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
162607363|NCT00076024|587279009|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
162607364|NCT00076024|587279010|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
162607365|NCT00076024|587279007|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
162607366|NCT00076024|587279008|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
162607367|NCT00076024|587279009|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
162607368|NCT00076024|587279010|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
162607369|NCT00076024|587279007|FG000|Phase 2, Open-label|Other|0|||
162607370|NCT00076024|587279008|FG001|Phase 2, Open-label|Other|0|||
162848322|NCT02913313|588152808|FG013|Overall Study|DISEASE PROGRESSION|3|||
162607371|NCT00076024|587279009|FG002|Phase 2, Open-label|Other|0|||
162848323|NCT02913313|588152795|FG000|Overall Study|Not Reported|0|||
162848324|NCT02913313|588152796|FG001|Overall Study|Not Reported|0|||
162607372|NCT00076024|587279010|FG003|Phase 2, Open-label|Other|2|||
162607373|NCT01155219|587279017|FG000|Overall Study|Adverse Event|3|||
162607374|NCT01155219|587279018|FG001|Overall Study|Adverse Event|1|||
162607375|NCT01155219|587279017|FG000|Overall Study|non-medical reason|1|||
162607376|NCT01155219|587279018|FG001|Overall Study|non-medical reason|2|||
162607377|NCT03052764|587279019|FG000|Double-Blind Treatment Period|Adverse Event|2|||
162607378|NCT03052764|587279020|FG001|Double-Blind Treatment Period|Adverse Event|0|||
162607379|NCT03052764|587279019|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
162607380|NCT03052764|587279020|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
162607381|NCT03052764|587279019|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
162607382|NCT03052764|587279020|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
162607383|NCT03052764|587279019|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
162607384|NCT03052764|587279020|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162607385|NCT03052764|587279019|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
162607386|NCT03052764|587279020|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
162607387|NCT01314911|587279021|FG000|Overall Study|Lost to Follow-up|3|||
162607388|NCT01314911|587279022|FG001|Overall Study|Lost to Follow-up|2|||
162607389|NCT01314911|587279021|FG000|Overall Study|Withdrawal by Subject|1|||
162607390|NCT01314911|587279022|FG001|Overall Study|Withdrawal by Subject|3|||
162607391|NCT01314911|587279021|FG000|Overall Study|Received Non-randomized Study Drug|0|||
162607392|NCT01314911|587279022|FG001|Overall Study|Received Non-randomized Study Drug|1|||
162607393|NCT01314911|587279021|FG000|Overall Study|Never Started Treatment|1|||
162607394|NCT01314911|587279022|FG001|Overall Study|Never Started Treatment|0|||
162607395|NCT03150485|587279026|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162607396|NCT03150485|587279027|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162607397|NCT03150485|587279028|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
162607398|NCT03150485|587279029|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
162607399|NCT03150485|587279030|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
162607400|NCT03150485|587279031|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
162607401|NCT01695005|587279033|FG000|Overall Study|Lost to Follow-up|0|||
162607402|NCT01695005|587279034|FG001|Overall Study|Lost to Follow-up|1|||
162607403|NCT01695005|587279035|FG002|Overall Study|Lost to Follow-up|1|||
162607404|NCT01695005|587279036|FG003|Overall Study|Lost to Follow-up|0|||
162607405|NCT01695005|587279037|FG004|Overall Study|Lost to Follow-up|0|||
162607406|NCT01695005|587279038|FG005|Overall Study|Lost to Follow-up|1|||
162607407|NCT01695005|587279039|FG006|Overall Study|Lost to Follow-up|1|||
162607408|NCT01695005|587279040|FG007|Overall Study|Lost to Follow-up|1|||
162607409|NCT01695005|587279041|FG008|Overall Study|Lost to Follow-up|3|||
162607410|NCT01695005|587279042|FG009|Overall Study|Lost to Follow-up|3|||
162607411|NCT01695005|587279043|FG010|Overall Study|Lost to Follow-up|8|||
162607412|NCT01695005|587279044|FG011|Overall Study|Lost to Follow-up|5|||
162607413|NCT01695005|587279045|FG012|Overall Study|Lost to Follow-up|2|||
162607414|NCT01695005|587279046|FG013|Overall Study|Lost to Follow-up|5|||
162848325|NCT02913313|588152797|FG002|Overall Study|Not Reported|0|||
162848326|NCT02913313|588152798|FG003|Overall Study|Not Reported|0|||
162848327|NCT02913313|588152799|FG004|Overall Study|Not Reported|1|||
162848328|NCT02913313|588152800|FG005|Overall Study|Not Reported|0|||
162848329|NCT02913313|588152801|FG006|Overall Study|Not Reported|0|||
162848330|NCT02913313|588152802|FG007|Overall Study|Not Reported|0|||
162848331|NCT02913313|588152803|FG008|Overall Study|Not Reported|0|||
162848332|NCT02913313|588152804|FG009|Overall Study|Not Reported|0|||
162848333|NCT02913313|588152805|FG010|Overall Study|Not Reported|4|||
162848334|NCT02913313|588152806|FG011|Overall Study|Not Reported|0|||
162848335|NCT02913313|588152807|FG012|Overall Study|Not Reported|0|||
162848336|NCT02913313|588152808|FG013|Overall Study|Not Reported|0|||
162848337|NCT02913313|588152795|FG000|Overall Study|Other reasons|0|||
162848338|NCT02913313|588152796|FG001|Overall Study|Other reasons|0|||
162848339|NCT02913313|588152797|FG002|Overall Study|Other reasons|0|||
162848340|NCT02913313|588152798|FG003|Overall Study|Other reasons|0|||
162848341|NCT02913313|588152799|FG004|Overall Study|Other reasons|1|||
162848342|NCT02913313|588152800|FG005|Overall Study|Other reasons|0|||
162848343|NCT02913313|588152801|FG006|Overall Study|Other reasons|0|||
162848344|NCT02913313|588152802|FG007|Overall Study|Other reasons|0|||
162848345|NCT02913313|588152803|FG008|Overall Study|Other reasons|0|||
162848346|NCT02913313|588152804|FG009|Overall Study|Other reasons|0|||
162848347|NCT02913313|588152805|FG010|Overall Study|Other reasons|1|||
162848348|NCT02913313|588152806|FG011|Overall Study|Other reasons|0|||
162848349|NCT02913313|588152807|FG012|Overall Study|Other reasons|0|||
162702522|NCT02268552|587621842|FG002|Part 2|Death|0|||
162848350|NCT02913313|588152808|FG013|Overall Study|Other reasons|0|||
162848351|NCT02913313|588152795|FG000|Overall Study|Withdrawal by Subject|0|||
162848352|NCT02913313|588152796|FG001|Overall Study|Withdrawal by Subject|0|||
162848353|NCT02913313|588152797|FG002|Overall Study|Withdrawal by Subject|1|||
162607415|NCT01695005|587279047|FG014|Overall Study|Lost to Follow-up|0|||
162607416|NCT01695005|587279048|FG015|Overall Study|Lost to Follow-up|4|||
162607417|NCT01695005|587279049|FG016|Overall Study|Lost to Follow-up|0|||
162607418|NCT01695005|587279050|FG017|Overall Study|Lost to Follow-up|0|||
162607419|NCT01695005|587279051|FG018|Overall Study|Lost to Follow-up|0|||
162607420|NCT01695005|587279052|FG019|Overall Study|Lost to Follow-up|1|||
162607421|NCT01695005|587279053|FG020|Overall Study|Lost to Follow-up|1|||
162607422|NCT01695005|587279054|FG021|Overall Study|Lost to Follow-up|0|||
162607423|NCT01695005|587279055|FG022|Overall Study|Lost to Follow-up|2|||
162607424|NCT01695005|587279056|FG023|Overall Study|Lost to Follow-up|4|||
162607425|NCT01695005|587279057|FG024|Overall Study|Lost to Follow-up|2|||
162607426|NCT01695005|587279058|FG025|Overall Study|Lost to Follow-up|0|||
162607427|NCT01695005|587279059|FG026|Overall Study|Lost to Follow-up|0|||
162607428|NCT01695005|587279060|FG027|Overall Study|Lost to Follow-up|0|||
162607429|NCT01695005|587279061|FG028|Overall Study|Lost to Follow-up|1|||
162607430|NCT01695005|587279033|FG000|Overall Study|Withdrawal by Subject|0|||
162607431|NCT01695005|587279034|FG001|Overall Study|Withdrawal by Subject|0|||
162607432|NCT01695005|587279035|FG002|Overall Study|Withdrawal by Subject|0|||
162607433|NCT01695005|587279036|FG003|Overall Study|Withdrawal by Subject|2|||
162607434|NCT01695005|587279037|FG004|Overall Study|Withdrawal by Subject|0|||
162607435|NCT01695005|587279038|FG005|Overall Study|Withdrawal by Subject|1|||
162607436|NCT01695005|587279039|FG006|Overall Study|Withdrawal by Subject|0|||
162607437|NCT01695005|587279040|FG007|Overall Study|Withdrawal by Subject|1|||
162607438|NCT01695005|587279041|FG008|Overall Study|Withdrawal by Subject|0|||
162607439|NCT01695005|587279042|FG009|Overall Study|Withdrawal by Subject|1|||
162607440|NCT01695005|587279043|FG010|Overall Study|Withdrawal by Subject|2|||
162607441|NCT01695005|587279044|FG011|Overall Study|Withdrawal by Subject|1|||
162607442|NCT01695005|587279045|FG012|Overall Study|Withdrawal by Subject|1|||
162607443|NCT01695005|587279046|FG013|Overall Study|Withdrawal by Subject|0|||
162607444|NCT01695005|587279047|FG014|Overall Study|Withdrawal by Subject|0|||
162607445|NCT01695005|587279048|FG015|Overall Study|Withdrawal by Subject|0|||
162607446|NCT01695005|587279049|FG016|Overall Study|Withdrawal by Subject|0|||
162607447|NCT01695005|587279050|FG017|Overall Study|Withdrawal by Subject|0|||
162607448|NCT01695005|587279051|FG018|Overall Study|Withdrawal by Subject|2|||
162607449|NCT01695005|587279052|FG019|Overall Study|Withdrawal by Subject|0|||
162607450|NCT01695005|587279053|FG020|Overall Study|Withdrawal by Subject|1|||
162607451|NCT01695005|587279054|FG021|Overall Study|Withdrawal by Subject|0|||
162702523|NCT02268552|587621843|FG003|Part 2|Death|0|||
162702524|NCT02268552|587621844|FG004|Part 2|Death|0|||
162702525|NCT02268552|587621845|FG005|Part 2|Death|0|||
162702526|NCT02268552|587621846|FG006|Part 2|Death|2|||
162702527|NCT02268552|587621840|FG000|Part 2|Subject/guardian decision|0|||
162702528|NCT02268552|587621841|FG001|Part 2|Subject/guardian decision|0|||
162702529|NCT02268552|587621842|FG002|Part 2|Subject/guardian decision|0|||
162702530|NCT02268552|587621843|FG003|Part 2|Subject/guardian decision|0|||
162702531|NCT02268552|587621844|FG004|Part 2|Subject/guardian decision|0|||
162702532|NCT02268552|587621845|FG005|Part 2|Subject/guardian decision|0|||
162702533|NCT02268552|587621846|FG006|Part 2|Subject/guardian decision|1|||
162702534|NCT02268552|587621840|FG000|Part 3 Extension|Death|0|||
162702535|NCT02268552|587621841|FG001|Part 3 Extension|Death|1|||
162702536|NCT02268552|587621842|FG002|Part 3 Extension|Death|1|||
162702537|NCT02268552|587621843|FG003|Part 3 Extension|Death|1|||
162702538|NCT02268552|587621844|FG004|Part 3 Extension|Death|1|||
162702539|NCT02268552|587621845|FG005|Part 3 Extension|Death|1|||
162702540|NCT02268552|587621846|FG006|Part 3 Extension|Death|0|||
162702541|NCT02268552|587621840|FG000|Part 3 Extension|Early termination of trial|1|||
162702542|NCT02268552|587621841|FG001|Part 3 Extension|Early termination of trial|0|||
162702543|NCT02268552|587621842|FG002|Part 3 Extension|Early termination of trial|0|||
162702544|NCT02268552|587621843|FG003|Part 3 Extension|Early termination of trial|0|||
162702545|NCT02268552|587621844|FG004|Part 3 Extension|Early termination of trial|2|||
162702546|NCT02268552|587621845|FG005|Part 3 Extension|Early termination of trial|9|||
162702547|NCT02268552|587621846|FG006|Part 3 Extension|Early termination of trial|11|||
162702548|NCT02268552|587621840|FG000|Part 3 Extension|Subject/guardian decision|0|||
162702549|NCT02268552|587621841|FG001|Part 3 Extension|Subject/guardian decision|0|||
162702550|NCT02268552|587621842|FG002|Part 3 Extension|Subject/guardian decision|0|||
162702551|NCT02268552|587621843|FG003|Part 3 Extension|Subject/guardian decision|0|||
162607452|NCT01695005|587279055|FG022|Overall Study|Withdrawal by Subject|0|||
162607453|NCT01695005|587279056|FG023|Overall Study|Withdrawal by Subject|0|||
162607454|NCT01695005|587279057|FG024|Overall Study|Withdrawal by Subject|1|||
162607455|NCT01695005|587279058|FG025|Overall Study|Withdrawal by Subject|0|||
162607456|NCT01695005|587279059|FG026|Overall Study|Withdrawal by Subject|0|||
162607457|NCT01695005|587279060|FG027|Overall Study|Withdrawal by Subject|1|||
162607458|NCT01695005|587279061|FG028|Overall Study|Withdrawal by Subject|0|||
162607459|NCT04478123|587279062|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
162607460|NCT04478123|587279062|FG000|Overall Study|NE|1|||
162607461|NCT00588952|587279063|FG000|Overall Study|Adverse Event|0|||
162607462|NCT00588952|587279064|FG001|Overall Study|Adverse Event|2|||
162607463|NCT00588952|587279063|FG000|Overall Study|Withdrawal by Subject|3|||
162607464|NCT00588952|587279064|FG001|Overall Study|Withdrawal by Subject|5|||
162607465|NCT01362595|587279066|FG000|Overall Study|Screen failure|10|||
162607466|NCT01362595|587279066|FG000|Overall Study|Withdrawal by Subject|2|||
162607467|NCT02448680|587279067|FG000|Overall Study|Physician Decision|1|||
162702552|NCT02268552|587621844|FG004|Part 3 Extension|Subject/guardian decision|0|||
162702553|NCT02268552|587621845|FG005|Part 3 Extension|Subject/guardian decision|0|||
162848354|NCT02913313|588152798|FG003|Overall Study|Withdrawal by Subject|0|||
162848355|NCT02913313|588152799|FG004|Overall Study|Withdrawal by Subject|0|||
162848356|NCT02913313|588152800|FG005|Overall Study|Withdrawal by Subject|0|||
162848357|NCT02913313|588152801|FG006|Overall Study|Withdrawal by Subject|1|||
162848358|NCT02913313|588152802|FG007|Overall Study|Withdrawal by Subject|1|||
162848359|NCT02913313|588152803|FG008|Overall Study|Withdrawal by Subject|0|||
162848360|NCT02913313|588152804|FG009|Overall Study|Withdrawal by Subject|0|||
162848361|NCT02913313|588152805|FG010|Overall Study|Withdrawal by Subject|1|||
162848362|NCT02913313|588152806|FG011|Overall Study|Withdrawal by Subject|0|||
162848363|NCT02913313|588152807|FG012|Overall Study|Withdrawal by Subject|0|||
162848364|NCT02913313|588152808|FG013|Overall Study|Withdrawal by Subject|0|||
162607468|NCT02448680|587279068|FG001|Overall Study|Physician Decision|1|||
162607469|NCT02448680|587279067|FG000|Overall Study|Withdrawal by Subject|0|||
162607470|NCT02448680|587279068|FG001|Overall Study|Withdrawal by Subject|2|||
162607471|NCT01739400|587279069|FG000|Overall Study|Physician Decision|3|||
162607472|NCT01739400|587279070|FG001|Overall Study|Physician Decision|0|||
162607473|NCT01739400|587279069|FG000|Overall Study|Lost to Follow-up|2|||
162607474|NCT01739400|587279070|FG001|Overall Study|Lost to Follow-up|0|||
162607475|NCT01739400|587279069|FG000|Overall Study|Death|5|||
162607476|NCT01739400|587279070|FG001|Overall Study|Death|2|||
162607477|NCT01739400|587279069|FG000|Overall Study|Withdrawal by Subject|7|||
162607478|NCT01739400|587279070|FG001|Overall Study|Withdrawal by Subject|7|||
162607479|NCT01736657|587279071|FG000|Overall Study|insufficient vascular access|1|||
162607480|NCT03350984|587279072|FG000|Overall Study|Death|1|||
162607481|NCT03350984|587279073|FG001|Overall Study|Death|0|||
162607482|NCT03350984|587279072|FG000|Overall Study|Lost to Follow-up|5|||
162607483|NCT03350984|587279073|FG001|Overall Study|Lost to Follow-up|6|||
162607484|NCT03350984|587279072|FG000|Overall Study|Protocol Violation|1|||
162607485|NCT03350984|587279073|FG001|Overall Study|Protocol Violation|2|||
162607486|NCT03350984|587279072|FG000|Overall Study|Physician Decision|1|||
162607487|NCT03350984|587279073|FG001|Overall Study|Physician Decision|0|||
162607488|NCT00642473|587279082|FG000|Overall Study|Withdrawal by Subject|0|||
162607489|NCT00642473|587279083|FG001|Overall Study|Withdrawal by Subject|5|||
162607490|NCT00642473|587279082|FG000|Overall Study|Progression or death|2|||
162607491|NCT00642473|587279083|FG001|Overall Study|Progression or death|4|||
162607492|NCT00642473|587279082|FG000|Overall Study|Other|2|||
162607493|NCT00642473|587279083|FG001|Overall Study|Other|2|||
162607494|NCT04533880|587279084|FG000|Overall Study|Lost to Follow-up|0|||
162607495|NCT04533880|587279085|FG001|Overall Study|Lost to Follow-up|1|||
162607496|NCT04533880|587279086|FG002|Overall Study|Lost to Follow-up|1|||
162607497|NCT02284178|587279088|FG000|Overall Study|Met exclusion criteria|49|||
162607498|NCT02284178|587279089|FG001|Overall Study|Met exclusion criteria|54|||
162607499|NCT01741012|587279090|FG000|Overall Study|Lost to Follow-up|1|||
162607500|NCT01741012|587279090|FG000|Overall Study|Withdrawal by Subject|2|||
162607501|NCT04123665|587279091|FG000|Overall Study|Withdrawal by Subject|7|||
162607502|NCT04123665|587279092|FG001|Overall Study|Withdrawal by Subject|0|||
162607503|NCT04123665|587279091|FG000|Overall Study|Lost to Follow-up|1|||
162607504|NCT04123665|587279092|FG001|Overall Study|Lost to Follow-up|0|||
162607505|NCT01711879|587279095|FG000|Overall Study|Death|1|||
162607506|NCT01711879|587279096|FG001|Overall Study|Death|0|||
162607507|NCT00958789|587279100|FG000|Overall Study|Death|5|||
162607508|NCT00958789|587279100|FG000|Overall Study|Lost to Follow-up|14|||
162607509|NCT00958789|587279100|FG000|Overall Study|Withdrawal by Subject|17|||
162607510|NCT00958789|587279100|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
162607511|NCT00958789|587279100|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
162607512|NCT00958789|587279100|FG000|Overall Study|Subject terminated|2|||
162607513|NCT00958789|587279100|FG000|Overall Study|Revision|7|||
162607514|NCT01466179|587279103|FG000|Overall Study|Ongoing in core study|2|||
162607515|NCT01466179|587279103|FG000|Overall Study|Physician Decision|46|||
162607516|NCT01466179|587279103|FG000|Overall Study|Progressive disease|43|||
162702554|NCT02268552|587621846|FG006|Part 3 Extension|Subject/guardian decision|1|||
162702555|NCT04168385|587621848|FG000|Overall Study|Withdrawal by Subject|1|||
162702556|NCT04168385|587621849|FG001|Overall Study|Withdrawal by Subject|0|||
162702557|NCT04168385|587621848|FG000|Overall Study|Adverse Event|2|||
162702558|NCT04168385|587621849|FG001|Overall Study|Adverse Event|1|||
162702559|NCT04168385|587621848|FG000|Overall Study|Liver transplant|3|||
162702560|NCT04168385|587621849|FG001|Overall Study|Liver transplant|1|||
162702561|NCT04168385|587621848|FG000|Overall Study|Listed for liver transplant|1|||
162702562|NCT04168385|587621849|FG001|Overall Study|Listed for liver transplant|0|||
162702563|NCT02139982|587621850|FG000|Overall Study|Lack of Efficacy|0|||
162702564|NCT02139982|587621851|FG001|Overall Study|Lack of Efficacy|1|||
162607517|NCT01466179|587279103|FG000|Overall Study|Adverse Event|32|||
162607518|NCT01466179|587279103|FG000|Overall Study|Disease relapse|23|||
162607519|NCT01466179|587279103|FG000|Overall Study|Lack of Efficacy|14|||
162607520|NCT01466179|587279103|FG000|Overall Study|Death|7|||
162607521|NCT01466179|587279103|FG000|Overall Study|Withdrawal by Subject|7|||
162607522|NCT01466179|587279103|FG000|Overall Study|Protocol Violation|2|||
162607523|NCT01466179|587279103|FG000|Overall Study|Other|3|||
162607524|NCT03410823|587279104|FG000|Overall Study|Death|1|||
162607525|NCT03410823|587279104|FG000|Overall Study|Withdrawal by Subject|2|||
162607526|NCT03410823|587279104|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
162607527|NCT03707184|587279107|FG000|Overall Study|Withdrawal by Subject|2|||
162607528|NCT04704154|587279108|FG000|Overall Study|Adverse Event|3|||
162607529|NCT04704154|587279109|FG001|Overall Study|Adverse Event|2|||
162607530|NCT04704154|587279110|FG002|Overall Study|Adverse Event|4|||
162607531|NCT04704154|587279111|FG003|Overall Study|Adverse Event|2|||
162607532|NCT04704154|587279112|FG004|Overall Study|Adverse Event|3|||
162607533|NCT04704154|587279113|FG005|Overall Study|Adverse Event|0|||
162607534|NCT04704154|587279108|FG000|Overall Study|Death|3|||
162607535|NCT04704154|587279109|FG001|Overall Study|Death|0|||
162702565|NCT02139982|587621852|FG002|Overall Study|Lack of Efficacy|0|||
162702566|NCT02139982|587621853|FG003|Overall Study|Lack of Efficacy|1|||
162607536|NCT04704154|587279110|FG002|Overall Study|Death|0|||
162607537|NCT04704154|587279111|FG003|Overall Study|Death|0|||
162607538|NCT04704154|587279112|FG004|Overall Study|Death|3|||
162607539|NCT04704154|587279113|FG005|Overall Study|Death|0|||
162607540|NCT04704154|587279108|FG000|Overall Study|Physician Decision|1|||
162607541|NCT04704154|587279109|FG001|Overall Study|Physician Decision|0|||
162607542|NCT04704154|587279110|FG002|Overall Study|Physician Decision|1|||
162607543|NCT04704154|587279111|FG003|Overall Study|Physician Decision|0|||
162607544|NCT04704154|587279112|FG004|Overall Study|Physician Decision|2|||
162607545|NCT04704154|587279113|FG005|Overall Study|Physician Decision|0|||
162607546|NCT04704154|587279108|FG000|Overall Study|Participant Decision|1|||
162607547|NCT04704154|587279109|FG001|Overall Study|Participant Decision|1|||
162607548|NCT04704154|587279110|FG002|Overall Study|Participant Decision|0|||
162607549|NCT04704154|587279111|FG003|Overall Study|Participant Decision|0|||
162607550|NCT04704154|587279112|FG004|Overall Study|Participant Decision|0|||
162607551|NCT04704154|587279113|FG005|Overall Study|Participant Decision|0|||
162607552|NCT04704154|587279108|FG000|Overall Study|Progressive Disease|19|||
162607553|NCT04704154|587279109|FG001|Overall Study|Progressive Disease|17|||
162607554|NCT04704154|587279110|FG002|Overall Study|Progressive Disease|20|||
162607555|NCT04704154|587279111|FG003|Overall Study|Progressive Disease|18|||
162607556|NCT04704154|587279112|FG004|Overall Study|Progressive Disease|36|||
162607557|NCT04704154|587279113|FG005|Overall Study|Progressive Disease|30|||
162607558|NCT04704154|587279108|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
162607559|NCT04704154|587279109|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
162607560|NCT04704154|587279110|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
162607561|NCT04704154|587279111|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
162607562|NCT04704154|587279112|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
162607563|NCT04704154|587279113|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
162607564|NCT04704154|587279108|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
162607565|NCT04704154|587279109|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
162607566|NCT04704154|587279110|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
162607567|NCT04704154|587279111|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
162607568|NCT04704154|587279112|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
162607569|NCT04704154|587279113|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
162607570|NCT03220438|587279114|FG000|Overall Study|Lost to Follow-up|0|||
162607571|NCT03220438|587279115|FG001|Overall Study|Lost to Follow-up|0|||
162607572|NCT03220438|587279116|FG002|Overall Study|Lost to Follow-up|1|||
162607573|NCT03220438|587279117|FG003|Overall Study|Lost to Follow-up|0|||
162607574|NCT04062123|587279118|FG000|Overall Study|Withdrawal by Subject|0|||
162607575|NCT04062123|587279119|FG001|Overall Study|Withdrawal by Subject|1|||
162607576|NCT04062123|587279120|FG002|Overall Study|Withdrawal by Subject|0|||
162607577|NCT04190680|587279121|FG000|Overall Study|Not meeting criteria for data analysis|1|||
162607578|NCT04190680|587279122|FG001|Overall Study|Not meeting criteria for data analysis|15|||
162702567|NCT02139982|587621854|FG004|Overall Study|Lack of Efficacy|0|||
162702568|NCT02139982|587621855|FG005|Overall Study|Lack of Efficacy|0|||
162702569|NCT02139982|587621856|FG006|Overall Study|Lack of Efficacy|0|||
162702570|NCT02139982|587621857|FG007|Overall Study|Lack of Efficacy|0|||
162702571|NCT02139982|587621858|FG008|Overall Study|Lack of Efficacy|0|||
162702572|NCT02139982|587621859|FG009|Overall Study|Lack of Efficacy|0|||
162702573|NCT02748512|587621862|FG000|Overall Study|Lost to Follow-up|1|||
162702574|NCT02748512|587621863|FG001|Overall Study|Lost to Follow-up|1|||
162702575|NCT01196104|587621877|FG000|Overall Study|Lost to Follow-up|1|||
162702576|NCT01196104|587621878|FG001|Overall Study|Lost to Follow-up|0|||
162702577|NCT01196104|587621877|FG000|Overall Study|Physician Decision|0|||
162702578|NCT01196104|587621878|FG001|Overall Study|Physician Decision|1|||
162702579|NCT01196104|587621877|FG000|Overall Study|Withdrawal by Subject|3|||
162702580|NCT01196104|587621878|FG001|Overall Study|Withdrawal by Subject|3|||
162702581|NCT01196104|587621877|FG000|Overall Study|Various|0|||
162702582|NCT01196104|587621878|FG001|Overall Study|Various|1|||
162702583|NCT01094171|587621885|FG000|Overall Study|Lost to Follow-up|2|||
162607579|NCT04190680|587279121|FG000|Overall Study|Administrative error|0|||
162607580|NCT04190680|587279122|FG001|Overall Study|Administrative error|18|||
162607581|NCT03780400|587279123|FG000|Overall Study|Lost to Follow-up|5|||
162607582|NCT03780400|587279123|FG000|Overall Study|Withdrawal by Subject|2|||
162607583|NCT01850602|587279124|FG000|Overall Study|Adverse Event|7|||
162607584|NCT01850602|587279125|FG001|Overall Study|Adverse Event|10|||
162607585|NCT01850602|587279124|FG000|Overall Study|Physician Decision|2|||
162607586|NCT01850602|587279125|FG001|Overall Study|Physician Decision|1|||
162702584|NCT01094171|587621885|FG000|Overall Study|Informed consent withdrawal|4|||
162702585|NCT01094171|587621885|FG000|Overall Study|Migration from the study area|3|||
162702586|NCT01094171|587621885|FG000|Overall Study|Other|1|||
162702587|NCT01310868|587621886|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
162607587|NCT01850602|587279124|FG000|Overall Study|Withdrawal by Subject|2|||
162607588|NCT01850602|587279125|FG001|Overall Study|Withdrawal by Subject|4|||
162607589|NCT01850602|587279124|FG000|Overall Study|Decrease in serum calcium|2|||
162607590|NCT01850602|587279125|FG001|Overall Study|Decrease in serum calcium|3|||
162607591|NCT01850602|587279124|FG000|Overall Study|Increase in serum ferritin|1|||
162607592|NCT01850602|587279125|FG001|Overall Study|Increase in serum ferritin|0|||
162607593|NCT00740051|587279128|FG000|Overall Study|Lack of Efficacy|2|||
162607594|NCT00740051|587279129|FG001|Overall Study|Lack of Efficacy|5|||
162607595|NCT00740051|587279128|FG000|Overall Study|Adverse Event|1|||
162607596|NCT00740051|587279129|FG001|Overall Study|Adverse Event|4|||
162607597|NCT00740051|587279128|FG000|Overall Study|Protocol Violation|2|||
162607598|NCT00740051|587279129|FG001|Overall Study|Protocol Violation|6|||
162607599|NCT00740051|587279128|FG000|Overall Study|Lost to Follow-up|3|||
162607600|NCT00740051|587279129|FG001|Overall Study|Lost to Follow-up|8|||
162607601|NCT00740051|587279128|FG000|Overall Study|Withdrawal by Subject|6|||
162607602|NCT00740051|587279129|FG001|Overall Study|Withdrawal by Subject|8|||
162607603|NCT00740051|587279128|FG000|Overall Study|Other reason (not specified)|4|||
162607604|NCT00740051|587279129|FG001|Overall Study|Other reason (not specified)|1|||
162607605|NCT03452527|587279130|FG000|Overall Study|Withdrawal by Subject|1|||
162607606|NCT03452527|587279131|FG001|Overall Study|Withdrawal by Subject|1|||
162607607|NCT03452527|587279130|FG000|Overall Study|Study Terminated|2|||
162607608|NCT03452527|587279131|FG001|Overall Study|Study Terminated|3|||
162607609|NCT00476047|587279132|FG000|Overall Study|Lost to Follow-up|1|||
162607610|NCT01658813|587279134|FG000|Overall Study|Disease progression|3|||
162607611|NCT04738318|587279135|FG000|Overall Study|Protocol Violation|1|||
162607612|NCT04738318|587279136|FG001|Overall Study|Protocol Violation|0|||
162607613|NCT01585584|587279137|FG000|Overall Study|Lack of Efficacy|1|||
162607614|NCT01585584|587279137|FG000|Overall Study|Withdrawal by Subject|1|||
162607615|NCT01585584|587279137|FG000|Overall Study|Physician Decision|2|||
162607616|NCT04369053|587280193|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
162607617|NCT04369053|587280193|FG000|Overall Study|Withdrawal by Subject|773|||
162607618|NCT04369053|587280193|FG000|Overall Study|Lost to Follow-up|182|||
162607619|NCT04369053|587280193|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
162607620|NCT01394718|587280194|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
162607621|NCT01394718|587280195|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
162607622|NCT02395016|587280196|FG000|Overall Study|Adverse Event|4|||
162607623|NCT02395016|587280197|FG001|Overall Study|Adverse Event|3|||
162607624|NCT02395016|587280196|FG000|Overall Study|Withdrawal by Subject|9|||
162607625|NCT02395016|587280197|FG001|Overall Study|Withdrawal by Subject|6|||
162607626|NCT02395016|587280196|FG000|Overall Study|Protocol Violation|2|||
162607627|NCT02395016|587280197|FG001|Overall Study|Protocol Violation|3|||
162607628|NCT01547780|587280198|FG000|Baseline PET Scan|Physician Decision|1|||
162607629|NCT01547780|587280199|FG001|Baseline PET Scan|Physician Decision|0|||
162607630|NCT01547780|587280200|FG002|Baseline PET Scan|Physician Decision|1|||
162607631|NCT01547780|587280201|FG003|Baseline PET Scan|Physician Decision|0|||
162607632|NCT01547780|587280198|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
162607633|NCT01547780|587280199|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
162607634|NCT01547780|587280200|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
162607635|NCT01547780|587280201|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
162607636|NCT00814879|587280203|FG000|By Week 24|Cancer Diagnosis|1|||
162607637|NCT00814879|587280204|FG001|By Week 24|Cancer Diagnosis|0|||
162607638|NCT00814879|587280203|FG000|By Week 24|Incarceration|0|||
162607639|NCT00814879|587280204|FG001|By Week 24|Incarceration|1|||
162848365|NCT02913313|588152795|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848366|NCT02913313|588152796|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848367|NCT02913313|588152797|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848368|NCT02913313|588152798|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848369|NCT02913313|588152799|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848370|NCT02913313|588152800|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848371|NCT02913313|588152801|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848372|NCT02913313|588152802|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162952080|NCT00909610|588529533|FG001|Period: Second Intervention|Adverse Event|0|||
162607640|NCT00814879|587280203|FG000|By Week 48|Lost to Follow-up|2|||
162607641|NCT00814879|587280204|FG001|By Week 48|Lost to Follow-up|2|||
162607642|NCT00814879|587280203|FG000|By Week 48|Death|0|||
162607643|NCT00814879|587280204|FG001|By Week 48|Death|1|||
162607644|NCT01461057|587280205|FG000|Overall Study|Death|10|||
162607645|NCT01461057|587280206|FG001|Overall Study|Death|9|||
162607646|NCT01461057|587280205|FG000|Overall Study|Withdrawal by Subject|2|||
162607647|NCT01461057|587280206|FG001|Overall Study|Withdrawal by Subject|3|||
162607648|NCT01461057|587280205|FG000|Overall Study|Physician Decision|0|||
162607649|NCT01461057|587280206|FG001|Overall Study|Physician Decision|2|||
162607650|NCT01461057|587280205|FG000|Overall Study|Adverse Event|0|||
162607651|NCT01461057|587280206|FG001|Overall Study|Adverse Event|1|||
162607652|NCT01461057|587280205|FG000|Overall Study|Progression of Disease|1|||
162607653|NCT01461057|587280206|FG001|Overall Study|Progression of Disease|0|||
162848373|NCT02913313|588152803|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848374|NCT02913313|588152804|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848375|NCT02913313|588152805|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162848376|NCT02913313|588152806|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162848377|NCT02913313|588152807|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162848378|NCT02913313|588152808|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162848379|NCT02913313|588152795|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
162848380|NCT02913313|588152796|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
162848381|NCT02913313|588152797|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
162848382|NCT02913313|588152798|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
162848383|NCT02913313|588152799|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
162848384|NCT02913313|588152800|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
162848385|NCT02913313|588152801|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
162848386|NCT02913313|588152802|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
162848387|NCT02913313|588152803|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
162848388|NCT02913313|588152804|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
162848389|NCT02913313|588152805|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
162848390|NCT02913313|588152806|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
162848391|NCT02913313|588152807|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
162848392|NCT02913313|588152808|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
162848393|NCT01061008|588152809|FG000|Overall Study|Badiocephalic fistula failed|3|||
162848394|NCT01061008|588152810|FG001|Overall Study|Badiocephalic fistula failed|2|||
162848395|NCT01061008|588152809|FG000|Overall Study|Death|1|||
162848396|NCT01061008|588152810|FG001|Overall Study|Death|0|||
162848397|NCT01061008|588152809|FG000|Overall Study|Withdrawal by Subject|1|||
162848398|NCT01061008|588152810|FG001|Overall Study|Withdrawal by Subject|3|||
162848399|NCT01061008|588152809|FG000|Overall Study|Unable to exercise following surgery|1|||
162848400|NCT01061008|588152810|FG001|Overall Study|Unable to exercise following surgery|0|||
162848401|NCT01061008|588152809|FG000|Overall Study|Adverse Event|0|||
162848402|NCT01061008|588152810|FG001|Overall Study|Adverse Event|1|||
162848403|NCT02908100|588152813|FG000|Overall Study|Adverse Event|7|||
162848404|NCT02908100|588152814|FG001|Overall Study|Adverse Event|6|||
162848405|NCT02908100|588152815|FG002|Overall Study|Adverse Event|9|||
162848406|NCT02908100|588152813|FG000|Overall Study|Death|2|||
162848407|NCT02908100|588152814|FG001|Overall Study|Death|0|||
162848408|NCT02908100|588152815|FG002|Overall Study|Death|0|||
162848409|NCT02908100|588152813|FG000|Overall Study|Lack of Efficacy|2|||
162848410|NCT02908100|588152814|FG001|Overall Study|Lack of Efficacy|3|||
162848411|NCT02908100|588152815|FG002|Overall Study|Lack of Efficacy|3|||
162848412|NCT02908100|588152813|FG000|Overall Study|Lost to Follow-up|0|||
162848413|NCT02908100|588152814|FG001|Overall Study|Lost to Follow-up|1|||
162848414|NCT02908100|588152815|FG002|Overall Study|Lost to Follow-up|2|||
162848415|NCT02908100|588152813|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162848416|NCT02908100|588152814|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162848417|NCT02908100|588152815|FG002|Overall Study|Non-Compliance With Study Drug|2|||
162848418|NCT02908100|588152813|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
162848419|NCT02908100|588152814|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
162848420|NCT02908100|588152815|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
162848421|NCT02908100|588152813|FG000|Overall Study|Physician Decision|0|||
162848422|NCT02908100|588152814|FG001|Overall Study|Physician Decision|1|||
162848423|NCT02908100|588152815|FG002|Overall Study|Physician Decision|0|||
162848424|NCT02908100|588152813|FG000|Overall Study|Pregnancy|1|||
162848425|NCT02908100|588152814|FG001|Overall Study|Pregnancy|2|||
162848426|NCT02908100|588152815|FG002|Overall Study|Pregnancy|0|||
162848427|NCT02908100|588152813|FG000|Overall Study|Withdrawal by Subject|8|||
162848428|NCT02908100|588152814|FG001|Overall Study|Withdrawal by Subject|7|||
162848429|NCT02908100|588152815|FG002|Overall Study|Withdrawal by Subject|5|||
162848430|NCT02908100|588152813|FG000|Overall Study|Randomised in Error|1|||
162848431|NCT02908100|588152814|FG001|Overall Study|Randomised in Error|0|||
162848432|NCT02908100|588152815|FG002|Overall Study|Randomised in Error|0|||
162848433|NCT02024971|588152816|FG000|Overall Study|Data Not Available|30|||
162607654|NCT01461057|587280205|FG000|Overall Study|Study Terminated by Sponsor|2|||
162607655|NCT01461057|587280206|FG001|Overall Study|Study Terminated by Sponsor|0|||
162607656|NCT01288976|587280207|FG000|Overall Study|Withdrawal by Subject|58|||
162607657|NCT01288976|587280208|FG001|Overall Study|Withdrawal by Subject|12|||
162607658|NCT01288976|587280209|FG002|Overall Study|Withdrawal by Subject|9|||
162607659|NCT01288976|587280207|FG000|Overall Study|Death|98|||
162607660|NCT01288976|587280208|FG001|Overall Study|Death|6|||
162607661|NCT01288976|587280209|FG002|Overall Study|Death|4|||
162607662|NCT01288976|587280207|FG000|Overall Study|Data unavailable|22|||
162607663|NCT01288976|587280208|FG001|Overall Study|Data unavailable|9|||
162607664|NCT01288976|587280209|FG002|Overall Study|Data unavailable|7|||
162607665|NCT03560739|587280210|FG000|Overall Study|Adverse Event|0|||
162607666|NCT03560739|587280211|FG001|Overall Study|Adverse Event|1|||
162607667|NCT03560739|587280212|FG002|Overall Study|Adverse Event|0|||
162607668|NCT03560739|587280213|FG003|Overall Study|Adverse Event|0|||
162607669|NCT00959374|587280214|FG000|Overall Study|Withdrawal by Subject|2|||
162607670|NCT00959374|587280214|FG000|Overall Study|Lost to Follow-up|14|||
162607671|NCT00959374|587280214|FG000|Overall Study|Death|1|||
162607672|NCT00959374|587280214|FG000|Overall Study|Protocol Violation|1|||
162607673|NCT00959374|587280214|FG000|Overall Study|Implant Removed/Not Replaced|4|||
162607674|NCT00959374|587280214|FG000|Overall Study|Physician Decision|1|||
162607675|NCT03183778|587280215|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
162607676|NCT03228420|587280220|FG000|Overall Study|Lost to Follow-up|5|||
162607677|NCT03228420|587280221|FG001|Overall Study|Lost to Follow-up|3|||
162607678|NCT03228420|587280220|FG000|Overall Study|Withdrawal by Subject|10|||
162607679|NCT03228420|587280221|FG001|Overall Study|Withdrawal by Subject|0|||
162607680|NCT03228420|587280220|FG000|Overall Study|Adverse Event|5|||
162607681|NCT03228420|587280221|FG001|Overall Study|Adverse Event|2|||
162607682|NCT01083173|587280222|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
162607683|NCT01083173|587280223|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
162607684|NCT01083173|587280222|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
162607685|NCT01083173|587280223|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
162607686|NCT01083173|587280222|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
162607687|NCT01083173|587280223|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
162607688|NCT01083173|587280222|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
162607689|NCT01083173|587280223|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
162607690|NCT01083173|587280222|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
162607691|NCT01083173|587280223|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
162607692|NCT01083173|587280222|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
162607693|NCT01083173|587280223|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
162607694|NCT01083173|587280222|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
162607695|NCT01083173|587280223|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
162607696|NCT01083173|587280222|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
162607697|NCT01083173|587280223|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
162607698|NCT01083173|587280222|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
162607699|NCT01083173|587280223|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
162607700|NCT01083173|587280222|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
162607701|NCT01083173|587280223|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
162607702|NCT01083173|587280222|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
162607703|NCT01083173|587280223|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
162607704|NCT04626310|587280225|FG000|Overall Study|4-miss from treatment|6|||
162607705|NCT04626310|587280226|FG001|Overall Study|4-miss from treatment|5|||
162607706|NCT04626310|587280227|FG002|Overall Study|4-miss from treatment|5|||
162607707|NCT04626310|587280225|FG000|Overall Study|Withdrawal by Subject|1|||
162607708|NCT04626310|587280226|FG001|Overall Study|Withdrawal by Subject|0|||
162607709|NCT04626310|587280227|FG002|Overall Study|Withdrawal by Subject|3|||
162607710|NCT05101317|587280231|FG000|Week1-13|Adverse Event|0|||
162607711|NCT05101317|587280232|FG001|Week1-13|Adverse Event|1|||
162607712|NCT05101317|587280233|FG002|Week1-13|Adverse Event|0|||
162607713|NCT05101317|587280234|FG003|Week1-13|Adverse Event|0|||
162607714|NCT05101317|587280231|FG000|Week1-13|Withdrawal by Subject|0|||
162607715|NCT05101317|587280232|FG001|Week1-13|Withdrawal by Subject|2|||
162607716|NCT05101317|587280233|FG002|Week1-13|Withdrawal by Subject|0|||
162607717|NCT05101317|587280234|FG003|Week1-13|Withdrawal by Subject|0|||
162607718|NCT05101317|587280231|FG000|Week1-13|Early Withdrawl|0|||
162607719|NCT05101317|587280232|FG001|Week1-13|Early Withdrawl|0|||
162607720|NCT05101317|587280233|FG002|Week1-13|Early Withdrawl|0|||
162607721|NCT05101317|587280234|FG003|Week1-13|Early Withdrawl|1|||
162607722|NCT05101317|587280231|FG000|Week 13-25|Lost to Follow-up|0|||
162607723|NCT05101317|587280232|FG001|Week 13-25|Lost to Follow-up|0|||
162607724|NCT05101317|587280233|FG002|Week 13-25|Lost to Follow-up|1|||
162607725|NCT05101317|587280234|FG003|Week 13-25|Lost to Follow-up|0|||
162607726|NCT05101317|587280231|FG000|Week 13-25|Withdrawal by Subject|1|||
162607727|NCT05101317|587280232|FG001|Week 13-25|Withdrawal by Subject|1|||
162607728|NCT05101317|587280233|FG002|Week 13-25|Withdrawal by Subject|0|||
162607729|NCT05101317|587280234|FG003|Week 13-25|Withdrawal by Subject|0|||
162607730|NCT05101317|587280231|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
162607731|NCT05101317|587280232|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
162607732|NCT05101317|587280233|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
162607733|NCT05101317|587280234|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
162607734|NCT01853618|587280235|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
162607735|NCT01853618|587280236|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
162607736|NCT01853618|587280237|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
162607737|NCT01853618|587280238|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
162607738|NCT01853618|587280239|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
162607739|NCT01853618|587280235|FG000|Overall Study|Progressive disease|1|||
162607740|NCT01853618|587280236|FG001|Overall Study|Progressive disease|1|||
162607741|NCT01853618|587280237|FG002|Overall Study|Progressive disease|1|||
162607742|NCT01853618|587280238|FG003|Overall Study|Progressive disease|1|||
162607743|NCT01853618|587280239|FG004|Overall Study|Progressive disease|2|||
162607744|NCT01853618|587280235|FG000|Overall Study|Physician Decision|0|||
162607745|NCT01853618|587280236|FG001|Overall Study|Physician Decision|1|||
162607746|NCT01853618|587280237|FG002|Overall Study|Physician Decision|1|||
162607747|NCT01853618|587280238|FG003|Overall Study|Physician Decision|0|||
162607748|NCT01853618|587280239|FG004|Overall Study|Physician Decision|0|||
162607749|NCT01853618|587280235|FG000|Overall Study|Refused further treatment|0|||
162607750|NCT01853618|587280236|FG001|Overall Study|Refused further treatment|0|||
162607751|NCT01853618|587280237|FG002|Overall Study|Refused further treatment|0|||
162607752|NCT01853618|587280238|FG003|Overall Study|Refused further treatment|0|||
162607753|NCT01853618|587280239|FG004|Overall Study|Refused further treatment|1|||
162607754|NCT01092832|587280244|FG000|Overall Study|Other|1|||
162607755|NCT01092832|587280245|FG001|Overall Study|Other|0|||
162607756|NCT04777331|587280246|FG000|DBT Period|Death|2|||
162607757|NCT04777331|587280247|FG001|DBT Period|Death|1|||
162607758|NCT04777331|587280248|FG002|DBT Period|Death|0|||
162607759|NCT04777331|587280246|FG000|DBT Period|Reason not Specified|1|||
162607760|NCT04777331|587280247|FG001|DBT Period|Reason not Specified|1|||
162607761|NCT04777331|587280248|FG002|DBT Period|Reason not Specified|0|||
162607762|NCT04777331|587280246|FG000|DBT Period|Physician Decision|4|||
162607763|NCT04777331|587280247|FG001|DBT Period|Physician Decision|0|||
162607764|NCT04777331|587280248|FG002|DBT Period|Physician Decision|0|||
162607765|NCT04777331|587280246|FG000|DBT Period|Withdrawal by Subject|12|||
162607766|NCT04777331|587280247|FG001|DBT Period|Withdrawal by Subject|11|||
162607767|NCT04777331|587280248|FG002|DBT Period|Withdrawal by Subject|0|||
162607768|NCT04777331|587280246|FG000|DBT Period|Randomized but not Treated|1|||
162607769|NCT04777331|587280247|FG001|DBT Period|Randomized but not Treated|3|||
162607770|NCT04777331|587280248|FG002|DBT Period|Randomized but not Treated|0|||
162607771|NCT04777331|587280246|FG000|OLE Period|Ongoing in OLE|0|||
162607772|NCT04777331|587280247|FG001|OLE Period|Ongoing in OLE|0|||
162607773|NCT04777331|587280248|FG002|OLE Period|Ongoing in OLE|534|||
162607774|NCT01401959|587280249|FG000|Enrolled|Withdrawal by Subject|1|||
162607775|NCT01401959|587280250|FG001|Enrolled|Withdrawal by Subject|0|||
162607776|NCT01401959|587280251|FG002|Enrolled|Withdrawal by Subject|0|||
162607777|NCT01401959|587280249|FG000|Treated|Disease Progression|2|||
162607778|NCT01401959|587280250|FG001|Treated|Disease Progression|2|||
162607779|NCT01401959|587280251|FG002|Treated|Disease Progression|1|||
162607780|NCT01401959|587280249|FG000|Treated|Adverse Event|4|||
162607781|NCT01401959|587280250|FG001|Treated|Adverse Event|3|||
162607782|NCT01401959|587280251|FG002|Treated|Adverse Event|2|||
162607783|NCT01401959|587280249|FG000|Treated|Withdrawal by Subject|1|||
162607784|NCT01401959|587280250|FG001|Treated|Withdrawal by Subject|2|||
162607785|NCT01401959|587280251|FG002|Treated|Withdrawal by Subject|2|||
162607786|NCT01401959|587280249|FG000|Treated|Protocol Violation|0|||
162607787|NCT01401959|587280250|FG001|Treated|Protocol Violation|1|||
162607788|NCT01401959|587280251|FG002|Treated|Protocol Violation|0|||
162607789|NCT00400153|587280252|FG000|Overall Study|AE due to study disease worsening|14|||
162607790|NCT00400153|587280253|FG001|Overall Study|AE due to study disease worsening|19|||
162607791|NCT00400153|587280254|FG002|Overall Study|AE due to study disease worsening|20|||
162607792|NCT00400153|587280252|FG000|Overall Study|AE due to other disease worsening|2|||
162607793|NCT00400153|587280253|FG001|Overall Study|AE due to other disease worsening|1|||
162607794|NCT00400153|587280254|FG002|Overall Study|AE due to other disease worsening|0|||
162607795|NCT00400153|587280252|FG000|Overall Study|AE due to other condition|3|||
162607796|NCT00400153|587280253|FG001|Overall Study|AE due to other condition|14|||
162607797|NCT00400153|587280254|FG002|Overall Study|AE due to other condition|15|||
162607798|NCT00400153|587280252|FG000|Overall Study|Protocol Violation|7|||
162607799|NCT00400153|587280253|FG001|Overall Study|Protocol Violation|4|||
162607800|NCT00400153|587280254|FG002|Overall Study|Protocol Violation|9|||
162607801|NCT00400153|587280252|FG000|Overall Study|Lost to Follow-up|2|||
162607802|NCT00400153|587280253|FG001|Overall Study|Lost to Follow-up|1|||
162607803|NCT00400153|587280254|FG002|Overall Study|Lost to Follow-up|4|||
162607804|NCT00400153|587280252|FG000|Overall Study|Withdrawal by Subject|12|||
162607805|NCT00400153|587280253|FG001|Overall Study|Withdrawal by Subject|11|||
162607806|NCT00400153|587280254|FG002|Overall Study|Withdrawal by Subject|10|||
162607807|NCT00400153|587280252|FG000|Overall Study|Other reasons - not mentioned above|8|||
162607808|NCT00400153|587280253|FG001|Overall Study|Other reasons - not mentioned above|5|||
162607809|NCT00400153|587280254|FG002|Overall Study|Other reasons - not mentioned above|3|||
162607810|NCT01423604|587280255|FG000|Safety Run-In|Adverse Event|3|||
162607811|NCT01423604|587280256|FG001|Safety Run-In|Adverse Event|0|||
162607812|NCT01423604|587280255|FG000|Safety Run-In|Death|1|||
162607813|NCT01423604|587280256|FG001|Safety Run-In|Death|0|||
162607814|NCT01423604|587280255|FG000|Safety Run-In|Physician Decision|1|||
162607815|NCT01423604|587280256|FG001|Safety Run-In|Physician Decision|0|||
162607816|NCT01423604|587280255|FG000|Safety Run-In|Disease progression|3|||
162607817|NCT01423604|587280256|FG001|Safety Run-In|Disease progression|0|||
162607818|NCT01423604|587280255|FG000|Safety Run-In|Patient decision|1|||
162607819|NCT01423604|587280256|FG001|Safety Run-In|Patient decision|0|||
162607820|NCT01423604|587280255|FG000|Randomized|Adverse Event|4|||
162607821|NCT01423604|587280256|FG001|Randomized|Adverse Event|10|||
162607822|NCT01423604|587280255|FG000|Randomized|Death|1|||
162607823|NCT01423604|587280256|FG001|Randomized|Death|0|||
162607824|NCT01423604|587280255|FG000|Randomized|Physician Decision|16|||
162607825|NCT01423604|587280256|FG001|Randomized|Physician Decision|13|||
162607826|NCT01423604|587280255|FG000|Randomized|Other - unspecified|37|||
162607827|NCT01423604|587280256|FG001|Randomized|Other - unspecified|31|||
162607828|NCT01423604|587280255|FG000|Randomized|Patient decision|5|||
162607829|NCT01423604|587280256|FG001|Randomized|Patient decision|9|||
162607830|NCT06785857|587280272|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
162607831|NCT06785857|587280273|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
162607832|NCT05952401|587280281|FG000|Overall Study|Lost to Follow-up|4|||
162607833|NCT05952401|587280282|FG001|Overall Study|Lost to Follow-up|1|||
162607834|NCT00096954|587281409|FG000|Overall Study|Adverse Event|3|||
162607835|NCT00096954|587281410|FG001|Overall Study|Adverse Event|1|||
162607836|NCT00096954|587281409|FG000|Overall Study|Withdrawal by Subject|9|||
162607837|NCT00096954|587281410|FG001|Overall Study|Withdrawal by Subject|8|||
162607838|NCT00096954|587281409|FG000|Overall Study|Physician Decision|1|||
162607839|NCT00096954|587281410|FG001|Overall Study|Physician Decision|1|||
162607840|NCT00096954|587281409|FG000|Overall Study|Sponsors Decision|1|||
162607841|NCT00096954|587281410|FG001|Overall Study|Sponsors Decision|1|||
162848434|NCT02024971|588152816|FG000|Overall Study|Lost to Follow-up|6|||
162848435|NCT05254418|588152817|FG000|Overall Study|Adverse Event|2|||
162607842|NCT00096954|587281409|FG000|Overall Study|Pregnancy|1|||
162607843|NCT00096954|587281410|FG001|Overall Study|Pregnancy|1|||
162848436|NCT02631538|588152818|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
162848437|NCT02631538|588152819|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
162848438|NCT02631538|588152820|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
162607844|NCT00096954|587281409|FG000|Overall Study|Initiation of immunotherapy|1|||
162607845|NCT00096954|587281410|FG001|Overall Study|Initiation of immunotherapy|0|||
162607846|NCT00096954|587281409|FG000|Overall Study|Non-compliance|0|||
162607847|NCT00096954|587281410|FG001|Overall Study|Non-compliance|3|||
162607848|NCT00096954|587281409|FG000|Overall Study|Lost to Follow-up|8|||
162607849|NCT00096954|587281410|FG001|Overall Study|Lost to Follow-up|5|||
162607850|NCT01483690|587281411|FG000|Overall Study|Adverse Event|1|||
162607851|NCT01483690|587281412|FG001|Overall Study|Adverse Event|2|||
162607852|NCT01483690|587281411|FG000|Overall Study|clinical deterioration|1|||
162607853|NCT01483690|587281412|FG001|Overall Study|clinical deterioration|0|||
162607854|NCT01483690|587281411|FG000|Overall Study|Physician Decision|0|||
162607855|NCT01483690|587281412|FG001|Overall Study|Physician Decision|2|||
162607856|NCT01483690|587281411|FG000|Overall Study|exclusionary procedure|0|||
162607857|NCT01483690|587281412|FG001|Overall Study|exclusionary procedure|1|||
162607858|NCT02239224|587281413|FG000|Overall Study|Administrative|0|||
162607859|NCT02239224|587281414|FG001|Overall Study|Administrative|0|||
162607860|NCT02239224|587281415|FG002|Overall Study|Administrative|3|||
162607861|NCT02239224|587281416|FG003|Overall Study|Administrative|1|||
162607862|NCT04565236|587281423|FG000|Overall Study|Patient/Guardian Decision|0|||
162607863|NCT04565236|587281424|FG001|Overall Study|Patient/Guardian Decision|0|||
162607864|NCT04565236|587281425|FG002|Overall Study|Patient/Guardian Decision|1|||
162607865|NCT04565236|587281426|FG003|Overall Study|Patient/Guardian Decision|0|||
162607866|NCT00740246|587281429|FG000|Overall Study|Received Blood Transfusion|0|||
162607867|NCT00740246|587281430|FG001|Overall Study|Received Blood Transfusion|1|||
162607868|NCT00740246|587281429|FG000|Overall Study|Adverse Event|1|||
162607869|NCT00740246|587281430|FG001|Overall Study|Adverse Event|2|||
162607870|NCT00740246|587281429|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
162607871|NCT00740246|587281430|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
162607872|NCT00740246|587281429|FG000|Overall Study|Lost to Follow-up|2|||
162607873|NCT00740246|587281430|FG001|Overall Study|Lost to Follow-up|2|||
162607874|NCT00740246|587281429|FG000|Overall Study|Withdrawal by Subject|4|||
162607875|NCT00740246|587281430|FG001|Overall Study|Withdrawal by Subject|3|||
162607876|NCT00740246|587281429|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
162607877|NCT00740246|587281430|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
162607878|NCT00740246|587281429|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
162607879|NCT00740246|587281430|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
162607880|NCT00740246|587281429|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
162848439|NCT02631538|588152821|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
162848440|NCT02631538|588152818|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
162848441|NCT02631538|588152819|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
162848442|NCT02631538|588152820|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
162848443|NCT02631538|588152821|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
162848444|NCT02631538|588152818|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
162848445|NCT02631538|588152819|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
162848446|NCT02631538|588152820|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
162848447|NCT02631538|588152821|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
162848448|NCT02631538|588152818|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
162848449|NCT02631538|588152819|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
162848450|NCT02631538|588152820|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
162848451|NCT02631538|588152821|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
162607881|NCT00740246|587281430|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
162607882|NCT00740246|587281429|FG000|Overall Study|Unable To Comply With Study Visits|2|||
162607883|NCT00740246|587281430|FG001|Overall Study|Unable To Comply With Study Visits|0|||
162607884|NCT00740246|587281429|FG000|Overall Study|Unable to Access Vein|0|||
162702588|NCT00065468|587621887|FG000|Overall Study|Death|172|||
162607885|NCT00740246|587281430|FG001|Overall Study|Unable to Access Vein|2|||
162702589|NCT00065468|587621888|FG001|Overall Study|Death|169|||
162702590|NCT00065468|587621889|FG002|Overall Study|Death|171|||
162702591|NCT00065468|587621887|FG000|Overall Study|Withdrawal by Subject|3|||
162848452|NCT02631538|588152818|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
162848453|NCT02631538|588152819|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
162952081|NCT02422264|588529537|FG000|Overall Study|Serious Adverse Event|1|||
162607886|NCT00740246|587281429|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
162702592|NCT00065468|587621888|FG001|Overall Study|Withdrawal by Subject|4|||
162848454|NCT02631538|588152820|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
162848455|NCT02631538|588152821|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
162848456|NCT02631538|588152818|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
162848457|NCT02631538|588152819|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
162848458|NCT02631538|588152820|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
162848459|NCT02631538|588152821|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
162848460|NCT00440726|588152822|FG000|Phase 1|Dose-Limiting Toxicity|0|||
162848461|NCT00440726|588152823|FG001|Phase 1|Dose-Limiting Toxicity|1|||
162848462|NCT00440726|588152824|FG002|Phase 1|Dose-Limiting Toxicity|0|||
162848463|NCT00440726|588152822|FG000|Phase 1|Physician Decision|1|||
162848464|NCT00440726|588152823|FG001|Phase 1|Physician Decision|0|||
162848465|NCT00440726|588152824|FG002|Phase 1|Physician Decision|0|||
162848466|NCT00440726|588152822|FG000|Phase 2|Death|0|||
162848467|NCT00440726|588152823|FG001|Phase 2|Death|0|||
162848468|NCT00440726|588152824|FG002|Phase 2|Death|1|||
162848469|NCT00440726|588152822|FG000|Phase 2|Adverse Event|0|||
162848470|NCT00440726|588152823|FG001|Phase 2|Adverse Event|0|||
162848471|NCT00440726|588152824|FG002|Phase 2|Adverse Event|1|||
162848472|NCT04067518|588152825|FG000|Overall Study|Adverse Event|1|||
162848473|NCT04067518|588152826|FG001|Overall Study|Adverse Event|3|||
162848474|NCT04067518|588152825|FG000|Overall Study|Screen failures|0|||
162848475|NCT04067518|588152826|FG001|Overall Study|Screen failures|1|||
162848476|NCT04067518|588152825|FG000|Overall Study|Enrolled but not treated|0|||
162848477|NCT04067518|588152826|FG001|Overall Study|Enrolled but not treated|1|||
162848478|NCT03624946|588152830|FG000|Overall Study|Lost to Follow-up|0|||
162848479|NCT03624946|588152831|FG001|Overall Study|Lost to Follow-up|1|||
162848480|NCT00862251|588152835|FG000|Overall Study|Adverse Event|8|||
162607887|NCT00740246|587281430|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
162607888|NCT01041495|587281431|FG000|Overall Study|Withdrawal by Subject|2|||
162607889|NCT01041495|587281432|FG001|Overall Study|Withdrawal by Subject|5|||
162848481|NCT00862251|588152836|FG001|Overall Study|Adverse Event|3|||
162848482|NCT00862251|588152837|FG002|Overall Study|Adverse Event|1|||
162848483|NCT00862251|588152835|FG000|Overall Study|Lost to Follow-up|0|||
162848484|NCT00862251|588152836|FG001|Overall Study|Lost to Follow-up|0|||
162848485|NCT00862251|588152837|FG002|Overall Study|Lost to Follow-up|1|||
162848486|NCT00862251|588152835|FG000|Overall Study|Protocol Violation|2|||
162848487|NCT00862251|588152836|FG001|Overall Study|Protocol Violation|0|||
162848488|NCT00862251|588152837|FG002|Overall Study|Protocol Violation|1|||
162848489|NCT00862251|588152835|FG000|Overall Study|Withdrawal by Subject|9|||
162848490|NCT00862251|588152836|FG001|Overall Study|Withdrawal by Subject|2|||
162848491|NCT00862251|588152837|FG002|Overall Study|Withdrawal by Subject|6|||
162702593|NCT00065468|587621889|FG002|Overall Study|Withdrawal by Subject|5|||
162702594|NCT00065468|587621887|FG000|Overall Study|Lost to Follow-up|5|||
162702595|NCT00065468|587621888|FG001|Overall Study|Lost to Follow-up|3|||
162702596|NCT00065468|587621889|FG002|Overall Study|Lost to Follow-up|2|||
162702597|NCT00065468|587621887|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
162702598|NCT00065468|587621888|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
162702599|NCT00065468|587621889|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
162848492|NCT02796755|588152838|FG000|Overall Study|Adverse Event|2|||
162702600|NCT00065468|587621887|FG000|Overall Study|Disease progression|0|||
162702601|NCT00065468|587621888|FG001|Overall Study|Disease progression|0|||
162702602|NCT00065468|587621889|FG002|Overall Study|Disease progression|1|||
162702603|NCT00065468|587621887|FG000|Overall Study|Other|14|||
162702604|NCT00065468|587621888|FG001|Overall Study|Other|24|||
162702605|NCT00065468|587621889|FG002|Overall Study|Other|18|||
162702606|NCT04496167|587621890|FG000|Overall Study|Adverse Event|6|||
162702607|NCT04496167|587621891|FG001|Overall Study|Adverse Event|2|||
162702608|NCT04496167|587621890|FG000|Overall Study|Withdrawal by Subject|7|||
162702609|NCT04496167|587621891|FG001|Overall Study|Withdrawal by Subject|6|||
162702610|NCT04496167|587621890|FG000|Overall Study|Lost to Follow-up|3|||
162702611|NCT04496167|587621891|FG001|Overall Study|Lost to Follow-up|5|||
162702612|NCT04496167|587621890|FG000|Overall Study|Not Treated|1|||
162702613|NCT04496167|587621891|FG001|Overall Study|Not Treated|2|||
162702614|NCT04496167|587621890|FG000|Overall Study|Other Than Specified|1|||
162702615|NCT04496167|587621891|FG001|Overall Study|Other Than Specified|1|||
162702616|NCT00598481|587621892|FG000|Treatment|Physician Decision|1|||
162848493|NCT02796755|588152839|FG001|Overall Study|Adverse Event|0|||
162848494|NCT00675025|588152840|FG000|Overall Study|Study Terminated by Sponsor|38|||
162702617|NCT01708187|587621895|FG000|Overall Study|Lost to Follow-up|0|||
162702618|NCT01708187|587621896|FG001|Overall Study|Lost to Follow-up|1|||
162702619|NCT02117544|587621897|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
162702620|NCT02117544|587621898|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
162848495|NCT00675025|588152841|FG001|Overall Study|Study Terminated by Sponsor|42|||
162848496|NCT00675025|588152840|FG000|Overall Study|Adverse Event|6|||
162607890|NCT01041495|587281431|FG000|Overall Study|Adverse Event|2|||
162607891|NCT01041495|587281432|FG001|Overall Study|Adverse Event|1|||
162607892|NCT01041495|587281431|FG000|Overall Study|Lost to Follow-up|0|||
162607893|NCT01041495|587281432|FG001|Overall Study|Lost to Follow-up|1|||
162607894|NCT03584373|587281433|FG000|Overall Study|Lost to Follow-up|7|||
162607895|NCT03584373|587281434|FG001|Overall Study|Lost to Follow-up|8|||
162607896|NCT00662532|587281436|FG000|Overall Study|Adverse Event|0|||
162607897|NCT00662532|587281437|FG001|Overall Study|Adverse Event|1|||
162607898|NCT00662532|587281436|FG000|Overall Study|Lost to Follow-up|0|||
162607899|NCT00662532|587281437|FG001|Overall Study|Lost to Follow-up|1|||
162607900|NCT00366340|587281438|FG000|Infant Series|Protocol Violation|3|||
162607901|NCT00366340|587281439|FG001|Infant Series|Protocol Violation|4|||
162607902|NCT00366340|587281438|FG000|Infant Series|Withdrawal by Subject|3|||
162607903|NCT00366340|587281439|FG001|Infant Series|Withdrawal by Subject|3|||
162607904|NCT00366340|587281438|FG000|Infant Series|Adverse Event|0|||
162607905|NCT00366340|587281439|FG001|Infant Series|Adverse Event|2|||
162607906|NCT00366340|587281438|FG000|Infant Series|Lost to Follow-up|1|||
162607907|NCT00366340|587281439|FG001|Infant Series|Lost to Follow-up|1|||
162607908|NCT00366340|587281438|FG000|Infant Series|Failure to return|1|||
162607909|NCT00366340|587281439|FG001|Infant Series|Failure to return|0|||
162607910|NCT00366340|587281438|FG000|After the Infant Series|Parent/legal guardian request|1|||
162607911|NCT00366340|587281439|FG001|After the Infant Series|Parent/legal guardian request|1|||
162607912|NCT00366340|587281438|FG000|After the Infant Series|Failed to return|0|||
162607913|NCT00366340|587281439|FG001|After the Infant Series|Failed to return|1|||
162607914|NCT00366340|587281438|FG000|After the Infant Series|Protocol Violation|2|||
162607915|NCT00366340|587281439|FG001|After the Infant Series|Protocol Violation|2|||
162607916|NCT00366340|587281438|FG000|After the Infant Series|Adverse Event|0|||
162607917|NCT00366340|587281439|FG001|After the Infant Series|Adverse Event|1|||
162607918|NCT00366340|587281438|FG000|After the Infant Series|Lost to Follow-up|0|||
162607919|NCT00366340|587281439|FG001|After the Infant Series|Lost to Follow-up|1|||
162607920|NCT00366340|587281438|FG000|Toddler Dose|Failed to return|1|||
162607921|NCT00366340|587281439|FG001|Toddler Dose|Failed to return|0|||
162607922|NCT00366340|587281438|FG000|Toddler Dose|Parent/legal guardian request|0|||
162607923|NCT00366340|587281439|FG001|Toddler Dose|Parent/legal guardian request|1|||
162607924|NCT00367770|587281440|FG000|Overall Study|Adverse Event|1|||
162607925|NCT00367770|587281440|FG000|Overall Study|Withdrawal by Subject|1|||
162607926|NCT03282565|587281445|FG000|Overall Study|COVID-19 Research Shutdown|0|||
162607927|NCT03282565|587281446|FG001|Overall Study|COVID-19 Research Shutdown|2|||
162607928|NCT03282565|587281447|FG002|Overall Study|COVID-19 Research Shutdown|2|||
162607929|NCT02011893|587281449|FG000|Enrollment to Randomization|Adverse Event|2|||
162607930|NCT02011893|587281450|FG001|Enrollment to Randomization|Adverse Event|0|||
162607931|NCT02011893|587281451|FG002|Enrollment to Randomization|Adverse Event|0|||
162607932|NCT02011893|587281449|FG000|Enrollment to Randomization|Physician Decision|10|||
162607933|NCT02011893|587281450|FG001|Enrollment to Randomization|Physician Decision|0|||
162607934|NCT02011893|587281451|FG002|Enrollment to Randomization|Physician Decision|0|||
162607935|NCT02011893|587281449|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
162607936|NCT02011893|587281450|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
162607937|NCT02011893|587281451|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
162607938|NCT02011893|587281449|FG000|Enrollment to Randomization|Screening Failure|29|||
162607939|NCT02011893|587281450|FG001|Enrollment to Randomization|Screening Failure|0|||
162607940|NCT02011893|587281451|FG002|Enrollment to Randomization|Screening Failure|0|||
162607941|NCT02011893|587281449|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
162607942|NCT02011893|587281450|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
162607943|NCT02011893|587281451|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
162607944|NCT02011893|587281449|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
162607945|NCT02011893|587281450|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
162607946|NCT02011893|587281451|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
162607947|NCT02011893|587281449|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
162607948|NCT02011893|587281450|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
162607949|NCT02011893|587281451|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
162607950|NCT02011893|587281449|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
162607951|NCT02011893|587281450|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
162607952|NCT02011893|587281451|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
162607953|NCT02011893|587281449|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
162607954|NCT02011893|587281450|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
162607955|NCT02011893|587281451|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
162607956|NCT00991952|587281452|FG000|Overall Study|Adverse Event|0|||
162607957|NCT00991952|587281453|FG001|Overall Study|Adverse Event|1|||
162607958|NCT03116347|587281454|FG000|Overall Study|Withdrawal by Subject|1|||
162607959|NCT03116347|587281455|FG001|Overall Study|Withdrawal by Subject|2|||
162607960|NCT01255787|587281456|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
162607961|NCT01255787|587281457|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
162702621|NCT02408549|587621900|FG000|Overall Study|Adverse Event|15|||
162607962|NCT01255787|587281458|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
162607963|NCT01255787|587281459|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
162607964|NCT01255787|587281456|FG000|Overall Study|Major Protocol Deviation|1|||
162607965|NCT01255787|587281457|FG001|Overall Study|Major Protocol Deviation|1|||
162607966|NCT01255787|587281458|FG002|Overall Study|Major Protocol Deviation|0|||
162607967|NCT01255787|587281459|FG003|Overall Study|Major Protocol Deviation|4|||
162607968|NCT01255787|587281456|FG000|Overall Study|Lost to Follow-up|1|||
162607969|NCT01255787|587281457|FG001|Overall Study|Lost to Follow-up|2|||
162607970|NCT01255787|587281458|FG002|Overall Study|Lost to Follow-up|4|||
162607971|NCT01255787|587281459|FG003|Overall Study|Lost to Follow-up|2|||
162607972|NCT01255787|587281456|FG000|Overall Study|Withdrawal of Consent|3|||
162607973|NCT01255787|587281457|FG001|Overall Study|Withdrawal of Consent|9|||
162607974|NCT01255787|587281458|FG002|Overall Study|Withdrawal of Consent|3|||
162607975|NCT01255787|587281459|FG003|Overall Study|Withdrawal of Consent|4|||
162607976|NCT01255787|587281456|FG000|Overall Study|Pregnancy|0|||
162607977|NCT01255787|587281457|FG001|Overall Study|Pregnancy|0|||
162607978|NCT01255787|587281458|FG002|Overall Study|Pregnancy|0|||
162607979|NCT01255787|587281459|FG003|Overall Study|Pregnancy|1|||
162607980|NCT01255787|587281456|FG000|Overall Study|Lack of Efficacy|2|||
162607981|NCT01255787|587281457|FG001|Overall Study|Lack of Efficacy|2|||
162607982|NCT01255787|587281458|FG002|Overall Study|Lack of Efficacy|2|||
162607983|NCT01255787|587281459|FG003|Overall Study|Lack of Efficacy|2|||
162607984|NCT01255787|587281456|FG000|Overall Study|Noncompliance with Study Drug|3|||
162607985|NCT01255787|587281457|FG001|Overall Study|Noncompliance with Study Drug|1|||
162607986|NCT01255787|587281458|FG002|Overall Study|Noncompliance with Study Drug|0|||
162607987|NCT01255787|587281459|FG003|Overall Study|Noncompliance with Study Drug|0|||
162607988|NCT04966741|587281460|FG000|Overall Study|Lost to Follow-up|1|||
162607989|NCT04966741|587281461|FG001|Overall Study|Lost to Follow-up|0|||
162607990|NCT05764265|587281464|FG000|Overall Study|Adverse Event|1|||
162607991|NCT05764265|587281465|FG001|Overall Study|Adverse Event|0|||
162607992|NCT05764265|587281464|FG000|Overall Study|Physician Decision|1|||
162607993|NCT05764265|587281465|FG001|Overall Study|Physician Decision|8|||
162607994|NCT05764265|587281464|FG000|Overall Study|Study Terminated By Sponsor|20|||
162607995|NCT05764265|587281465|FG001|Overall Study|Study Terminated By Sponsor|0|||
162607996|NCT05764265|587281464|FG000|Overall Study|Participant Decision|1|||
162607997|NCT05764265|587281465|FG001|Overall Study|Participant Decision|0|||
162607998|NCT00509262|587281466|FG000|Overall Study|Adverse Event|16|||
162607999|NCT00509262|587281467|FG001|Overall Study|Adverse Event|18|||
162608000|NCT00509262|587281466|FG000|Overall Study|Other|2|||
162608001|NCT00509262|587281467|FG001|Overall Study|Other|2|||
162608002|NCT00509262|587281466|FG000|Overall Study|Lack of Efficacy|1|||
162608003|NCT00509262|587281467|FG001|Overall Study|Lack of Efficacy|0|||
162608004|NCT00509262|587281466|FG000|Overall Study|Lost to Follow-up|1|||
162608005|NCT00509262|587281467|FG001|Overall Study|Lost to Follow-up|6|||
162608006|NCT00509262|587281466|FG000|Overall Study|Physician Decision|1|||
162608007|NCT00509262|587281467|FG001|Overall Study|Physician Decision|3|||
162608008|NCT00509262|587281466|FG000|Overall Study|Protocol Violation|2|||
162608009|NCT00509262|587281467|FG001|Overall Study|Protocol Violation|2|||
162608010|NCT00509262|587281466|FG000|Overall Study|Withdrawal by Subject|24|||
162608011|NCT00509262|587281467|FG001|Overall Study|Withdrawal by Subject|11|||
162608012|NCT00725842|587281468|FG000|Overall Study|Lost to Follow-up|19|||
162608013|NCT00725842|587281468|FG000|Overall Study|Death|1|||
162608014|NCT00725842|587281468|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
162608015|NCT00725842|587281468|FG000|Overall Study|Consent date prior to study start date|5|||
162608016|NCT00725842|587281468|FG000|Overall Study|Inclusion criterion not met|1|||
162608017|NCT00725842|587281468|FG000|Overall Study|No Visit 1 data|1|||
162608018|NCT02009384|587281472|FG000|Overall Study|Death|2|||
162608019|NCT01075191|587281473|FG000|Overall Study|Death|1|||
162608020|NCT01075191|587281473|FG000|Overall Study|Intensification|3|||
162608021|NCT01075191|587281473|FG000|Overall Study|Co-morbidities|1|||
162608022|NCT01075191|587281473|FG000|Overall Study|Adverse Event|4|||
162702622|NCT02408549|587621900|FG000|Overall Study|Death|4|||
162608023|NCT01075191|587281473|FG000|Overall Study|Noncompliance|3|||
162608024|NCT01075191|587281473|FG000|Overall Study|Therapy Break|3|||
162608025|NCT01075191|587281473|FG000|Overall Study|Patient's Wish|2|||
162702623|NCT02408549|587621900|FG000|Overall Study|Lack of Efficacy|17|||
162608026|NCT01075191|587281473|FG000|Overall Study|Unknown Reasons|1|||
162608027|NCT01244490|587281478|FG000|Overall Study|Lack of Efficacy|14|||
162608028|NCT01244490|587281479|FG001|Overall Study|Lack of Efficacy|5|||
162608029|NCT01244490|587281480|FG002|Overall Study|Lack of Efficacy|5|||
162608030|NCT01244490|587281478|FG000|Overall Study|Withdrawal by Subject|4|||
162608031|NCT01244490|587281479|FG001|Overall Study|Withdrawal by Subject|4|||
162608032|NCT01244490|587281480|FG002|Overall Study|Withdrawal by Subject|9|||
162608033|NCT01244490|587281478|FG000|Overall Study|Adverse Event|1|||
162608034|NCT01244490|587281479|FG001|Overall Study|Adverse Event|9|||
162702624|NCT02408549|587621900|FG000|Overall Study|Protocol Violation|4|||
162608035|NCT01244490|587281480|FG002|Overall Study|Adverse Event|5|||
162608036|NCT01244490|587281478|FG000|Overall Study|Lost to Follow-up|0|||
162608037|NCT01244490|587281479|FG001|Overall Study|Lost to Follow-up|6|||
162608038|NCT01244490|587281480|FG002|Overall Study|Lost to Follow-up|3|||
162608039|NCT01244490|587281478|FG000|Overall Study|Other|0|||
162608040|NCT01244490|587281479|FG001|Overall Study|Other|0|||
162608041|NCT01244490|587281480|FG002|Overall Study|Other|1|||
162608042|NCT02414139|587281485|FG000|Treatment Period|Adverse Event|11|||
162608043|NCT02414139|587281486|FG001|Treatment Period|Adverse Event|6|||
162608044|NCT02414139|587281487|FG002|Treatment Period|Adverse Event|8|||
162608045|NCT02414139|587281488|FG003|Treatment Period|Adverse Event|5|||
162608046|NCT02414139|587281489|FG004|Treatment Period|Adverse Event|14|||
162608047|NCT02414139|587281490|FG005|Treatment Period|Adverse Event|3|||
162608048|NCT02414139|587281491|FG006|Treatment Period|Adverse Event|6|||
162608049|NCT02414139|587281492|FG007|Treatment Period|Adverse Event|1|||
162608050|NCT02414139|587281493|FG008|Treatment Period|Adverse Event|6|||
162608051|NCT02414139|587281494|FG009|Treatment Period|Adverse Event|8|||
162608052|NCT02414139|587281485|FG000|Treatment Period|Death|0|||
162608053|NCT02414139|587281486|FG001|Treatment Period|Death|0|||
162608054|NCT02414139|587281487|FG002|Treatment Period|Death|1|||
162608055|NCT02414139|587281488|FG003|Treatment Period|Death|1|||
162608056|NCT02414139|587281489|FG004|Treatment Period|Death|0|||
162608057|NCT02414139|587281490|FG005|Treatment Period|Death|0|||
162608058|NCT02414139|587281491|FG006|Treatment Period|Death|0|||
162608059|NCT02414139|587281492|FG007|Treatment Period|Death|0|||
162608060|NCT02414139|587281493|FG008|Treatment Period|Death|0|||
162608061|NCT02414139|587281494|FG009|Treatment Period|Death|1|||
162608062|NCT02414139|587281485|FG000|Treatment Period|Physician Decision|5|||
162608063|NCT02414139|587281486|FG001|Treatment Period|Physician Decision|4|||
162608064|NCT02414139|587281487|FG002|Treatment Period|Physician Decision|6|||
162608065|NCT02414139|587281488|FG003|Treatment Period|Physician Decision|1|||
162608066|NCT02414139|587281489|FG004|Treatment Period|Physician Decision|4|||
162608067|NCT02414139|587281490|FG005|Treatment Period|Physician Decision|0|||
162608068|NCT02414139|587281491|FG006|Treatment Period|Physician Decision|2|||
162608069|NCT02414139|587281492|FG007|Treatment Period|Physician Decision|0|||
162608070|NCT02414139|587281493|FG008|Treatment Period|Physician Decision|1|||
162608071|NCT02414139|587281494|FG009|Treatment Period|Physician Decision|4|||
162848497|NCT00675025|588152841|FG001|Overall Study|Adverse Event|11|||
162848498|NCT00675025|588152840|FG000|Overall Study|Lost to Follow-up|6|||
162848499|NCT00675025|588152841|FG001|Overall Study|Lost to Follow-up|4|||
162848500|NCT00675025|588152840|FG000|Overall Study|Withdrawal by Subject|4|||
162848501|NCT00675025|588152841|FG001|Overall Study|Withdrawal by Subject|6|||
162848502|NCT00944034|588152843|FG000|Overall Study|Inappropriate enrollment|0|||
162848503|NCT00944034|588152844|FG001|Overall Study|Inappropriate enrollment|1|||
162608072|NCT02414139|587281485|FG000|Treatment Period|Progressive disease|48|||
162608073|NCT02414139|587281486|FG001|Treatment Period|Progressive disease|31|||
162608074|NCT02414139|587281487|FG002|Treatment Period|Progressive disease|37|||
162848504|NCT00944034|588152845|FG002|Overall Study|Inappropriate enrollment|0|||
162608075|NCT02414139|587281488|FG003|Treatment Period|Progressive disease|21|||
162608076|NCT02414139|587281489|FG004|Treatment Period|Progressive disease|43|||
162608077|NCT02414139|587281490|FG005|Treatment Period|Progressive disease|12|||
162608078|NCT02414139|587281491|FG006|Treatment Period|Progressive disease|16|||
162608079|NCT02414139|587281492|FG007|Treatment Period|Progressive disease|2|||
162608080|NCT02414139|587281493|FG008|Treatment Period|Progressive disease|20|||
162608081|NCT02414139|587281494|FG009|Treatment Period|Progressive disease|14|||
162608082|NCT02414139|587281485|FG000|Treatment Period|Protocol deviation|0|||
162608083|NCT02414139|587281486|FG001|Treatment Period|Protocol deviation|0|||
162608084|NCT02414139|587281487|FG002|Treatment Period|Protocol deviation|1|||
162608085|NCT02414139|587281488|FG003|Treatment Period|Protocol deviation|0|||
162608086|NCT02414139|587281489|FG004|Treatment Period|Protocol deviation|0|||
162702625|NCT02408549|587621900|FG000|Overall Study|Lost to Follow-up|6|||
162702626|NCT02408549|587621900|FG000|Overall Study|Consent withdrawn|30|||
162608087|NCT02414139|587281490|FG005|Treatment Period|Protocol deviation|0|||
162608088|NCT02414139|587281491|FG006|Treatment Period|Protocol deviation|0|||
162608089|NCT02414139|587281492|FG007|Treatment Period|Protocol deviation|0|||
162608090|NCT02414139|587281493|FG008|Treatment Period|Protocol deviation|0|||
162608091|NCT02414139|587281494|FG009|Treatment Period|Protocol deviation|0|||
162608092|NCT02414139|587281485|FG000|Treatment Period|Subject/Guardian decision|5|||
162608093|NCT02414139|587281486|FG001|Treatment Period|Subject/Guardian decision|1|||
162608094|NCT02414139|587281487|FG002|Treatment Period|Subject/Guardian decision|1|||
162608095|NCT02414139|587281488|FG003|Treatment Period|Subject/Guardian decision|2|||
162608096|NCT02414139|587281489|FG004|Treatment Period|Subject/Guardian decision|5|||
162608097|NCT02414139|587281490|FG005|Treatment Period|Subject/Guardian decision|0|||
162608098|NCT02414139|587281491|FG006|Treatment Period|Subject/Guardian decision|2|||
162608099|NCT02414139|587281492|FG007|Treatment Period|Subject/Guardian decision|0|||
162608100|NCT02414139|587281493|FG008|Treatment Period|Subject/Guardian decision|1|||
162608101|NCT02414139|587281494|FG009|Treatment Period|Subject/Guardian decision|1|||
162608102|NCT02414139|587281485|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608103|NCT02414139|587281486|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608104|NCT02414139|587281487|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608105|NCT02414139|587281488|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608106|NCT02414139|587281489|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
162608107|NCT02414139|587281490|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608108|NCT02414139|587281491|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
162608109|NCT02414139|587281492|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162608110|NCT02414139|587281493|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
162702627|NCT02408549|587621900|FG000|Overall Study|Neurology research program closing at site|1|||
162702628|NCT02408549|587621900|FG000|Overall Study|Site closure|1|||
162702629|NCT02408549|587621900|FG000|Overall Study|Pregnancy|1|||
162702630|NCT02408549|587621900|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
162702631|NCT02408549|587621900|FG000|Overall Study|Subject moved to another place, far from site|1|||
162702632|NCT02408549|587621900|FG000|Overall Study|Study terminated at site|1|||
162702633|NCT00231894|587621901|FG000|Overall Study|Withdrawal by Subject|1|||
162702634|NCT00231894|587621902|FG001|Overall Study|Withdrawal by Subject|1|||
162702635|NCT02025205|587621903|FG000|Overall Study|Withdrawal by Subject|1|||
162702636|NCT02025205|587621904|FG001|Overall Study|Withdrawal by Subject|1|||
162702637|NCT02025205|587621903|FG000|Overall Study|Protocol Violation|2|||
162702638|NCT02025205|587621904|FG001|Overall Study|Protocol Violation|1|||
162702639|NCT02025205|587621903|FG000|Overall Study|Death|0|||
162608111|NCT02414139|587281494|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
162608112|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162608113|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162702640|NCT02025205|587621904|FG001|Overall Study|Death|1|||
162702641|NCT01232556|587621907|FG000|Overall Study|Withdrawal by Subject|21|||
162702642|NCT01232556|587621908|FG001|Overall Study|Withdrawal by Subject|17|||
162702643|NCT01232556|587621907|FG000|Overall Study|Death|97|||
162608114|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608115|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608116|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
162608117|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608118|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608119|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608120|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608121|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162608122|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Death|0|||
162608123|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Death|1|||
162608124|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Death|0|||
162608125|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Death|0|||
162608126|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Death|1|||
162608127|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Death|0|||
162608128|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Death|0|||
162608129|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Death|0|||
162608130|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Death|0|||
162608131|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Death|1|||
162608132|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
162608133|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608134|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608135|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608136|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608137|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608138|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608139|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608140|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608141|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162608142|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162608143|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162608144|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162608145|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162608146|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162608147|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162608148|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162608149|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162608150|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162608151|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162608152|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
162608153|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162608154|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
162608155|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162608156|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
162608157|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
162608158|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162608159|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
162608160|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
162608161|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
162608162|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608163|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
162608164|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608165|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608166|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608167|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608168|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608169|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608170|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162608171|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
162608172|NCT02414139|587281485|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
162608173|NCT02414139|587281486|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
162608174|NCT02414139|587281487|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
162608175|NCT02414139|587281488|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162608176|NCT02414139|587281489|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162608177|NCT02414139|587281490|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162608178|NCT02414139|587281491|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162608179|NCT02414139|587281492|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162608180|NCT02414139|587281493|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162608181|NCT02414139|587281494|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
162608182|NCT01226121|587281495|FG000|Overall Study|Lost to Follow-up|2|||
162608183|NCT01226121|587281496|FG001|Overall Study|Lost to Follow-up|0|||
162608184|NCT01226121|587281497|FG002|Overall Study|Lost to Follow-up|1|||
162608185|NCT03324581|587281498|FG000|Overall Study|Adverse Event|18|||
162608186|NCT03324581|587281499|FG001|Overall Study|Adverse Event|11|||
162608187|NCT03324581|587281500|FG002|Overall Study|Adverse Event|7|||
162608188|NCT03324581|587281498|FG000|Overall Study|Lack of Efficacy|0|||
162608189|NCT03324581|587281499|FG001|Overall Study|Lack of Efficacy|1|||
162608190|NCT03324581|587281500|FG002|Overall Study|Lack of Efficacy|0|||
162608191|NCT03324581|587281498|FG000|Overall Study|Lost to Follow-up|5|||
162608192|NCT03324581|587281499|FG001|Overall Study|Lost to Follow-up|3|||
162608193|NCT03324581|587281500|FG002|Overall Study|Lost to Follow-up|6|||
162608194|NCT03324581|587281498|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
162608195|NCT03324581|587281499|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
162608196|NCT03324581|587281500|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
162608197|NCT03324581|587281498|FG000|Overall Study|Physician Decision|0|||
162608198|NCT03324581|587281499|FG001|Overall Study|Physician Decision|1|||
162608199|NCT03324581|587281500|FG002|Overall Study|Physician Decision|2|||
162608200|NCT03324581|587281498|FG000|Overall Study|Protocol Deviation|8|||
162608201|NCT03324581|587281499|FG001|Overall Study|Protocol Deviation|9|||
162608202|NCT03324581|587281500|FG002|Overall Study|Protocol Deviation|4|||
162608203|NCT03324581|587281498|FG000|Overall Study|Withdrawal by Subject|6|||
162608204|NCT03324581|587281499|FG001|Overall Study|Withdrawal by Subject|8|||
162608205|NCT03324581|587281500|FG002|Overall Study|Withdrawal by Subject|6|||
162608206|NCT03324581|587281498|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
162608207|NCT03324581|587281499|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
162608208|NCT03324581|587281500|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
162608209|NCT04473482|587281501|FG000|Overall Study|Death|0|||
162608210|NCT04473482|587281502|FG001|Overall Study|Death|3|||
162608211|NCT04473482|587281501|FG000|Overall Study|Lost to Follow-up|9|||
162608212|NCT04473482|587281502|FG001|Overall Study|Lost to Follow-up|7|||
162608213|NCT04473482|587281501|FG000|Overall Study|Withdrawal by Subject|2|||
162608214|NCT04473482|587281502|FG001|Overall Study|Withdrawal by Subject|1|||
162608215|NCT00266864|587281504|FG000|Overall Study|Lost to Follow-up|4|||
162608216|NCT00266864|587281505|FG001|Overall Study|Lost to Follow-up|1|||
162608217|NCT00266864|587281504|FG000|Overall Study|Withdrawal by Subject|1|||
162608218|NCT00266864|587281505|FG001|Overall Study|Withdrawal by Subject|1|||
162848505|NCT00944034|588152846|FG003|Overall Study|Inappropriate enrollment|1|||
162608219|NCT00727532|587281506|FG000|Overall Study|Adverse Event|1|||
162608220|NCT00727532|587281506|FG000|Overall Study|Withdrawal by Subject|1|||
162608221|NCT00829933|587281507|FG000|Overall Study|Adverse Event|2|||
162608222|NCT00829933|587281508|FG001|Overall Study|Adverse Event|3|||
162608223|NCT00829933|587281509|FG002|Overall Study|Adverse Event|2|||
162608224|NCT00829933|587281510|FG003|Overall Study|Adverse Event|1|||
162608225|NCT00829933|587281507|FG000|Overall Study|Death|0|||
162608226|NCT00829933|587281508|FG001|Overall Study|Death|0|||
162608227|NCT00829933|587281509|FG002|Overall Study|Death|1|||
162608228|NCT00829933|587281510|FG003|Overall Study|Death|1|||
162608229|NCT00829933|587281507|FG000|Overall Study|Lack of Efficacy|0|||
162608230|NCT00829933|587281508|FG001|Overall Study|Lack of Efficacy|1|||
162608231|NCT00829933|587281509|FG002|Overall Study|Lack of Efficacy|0|||
162848506|NCT00944034|588152847|FG004|Overall Study|Inappropriate enrollment|2|||
162848507|NCT00944034|588152848|FG005|Overall Study|Inappropriate enrollment|1|||
162848508|NCT00944034|588152849|FG006|Overall Study|Inappropriate enrollment|0|||
162848509|NCT00944034|588152850|FG007|Overall Study|Inappropriate enrollment|0|||
162848510|NCT00944034|588152851|FG008|Overall Study|Inappropriate enrollment|1|||
162608232|NCT00829933|587281510|FG003|Overall Study|Lack of Efficacy|0|||
162608233|NCT00829933|587281507|FG000|Overall Study|Physician Decision|5|||
162848511|NCT00944034|588152852|FG009|Overall Study|Inappropriate enrollment|1|||
162848512|NCT00944034|588152853|FG010|Overall Study|Inappropriate enrollment|0|||
162848513|NCT00944034|588152854|FG011|Overall Study|Inappropriate enrollment|0|||
162608234|NCT00829933|587281508|FG001|Overall Study|Physician Decision|7|||
162608235|NCT00829933|587281509|FG002|Overall Study|Physician Decision|8|||
162608236|NCT00829933|587281510|FG003|Overall Study|Physician Decision|1|||
162608237|NCT00829933|587281507|FG000|Overall Study|Pregnancy|0|||
162608238|NCT00829933|587281508|FG001|Overall Study|Pregnancy|0|||
162608239|NCT00829933|587281509|FG002|Overall Study|Pregnancy|0|||
162608240|NCT00829933|587281510|FG003|Overall Study|Pregnancy|2|||
162608241|NCT00829933|587281507|FG000|Overall Study|Protocol Violation|2|||
162608242|NCT00829933|587281508|FG001|Overall Study|Protocol Violation|1|||
162608243|NCT00829933|587281509|FG002|Overall Study|Protocol Violation|0|||
162608244|NCT00829933|587281510|FG003|Overall Study|Protocol Violation|0|||
162848514|NCT00944034|588152843|FG000|Overall Study|Withdrawal by Subject|3|||
162848515|NCT00944034|588152844|FG001|Overall Study|Withdrawal by Subject|2|||
162608245|NCT00829933|587281507|FG000|Overall Study|withdrew before treatment started|5|||
162702644|NCT01232556|587621908|FG001|Overall Study|Death|97|||
162608246|NCT00829933|587281508|FG001|Overall Study|withdrew before treatment started|1|||
162608247|NCT00829933|587281509|FG002|Overall Study|withdrew before treatment started|2|||
162608248|NCT00829933|587281510|FG003|Overall Study|withdrew before treatment started|9|||
162608249|NCT03687970|587281514|FG000|Overall Study|visit scheduling conflicts|2|||
162608250|NCT03687970|587281515|FG001|Overall Study|visit scheduling conflicts|0|||
162608251|NCT00686998|587281516|FG000|Overall Study|Adverse Event|3|||
162608252|NCT00686998|587281517|FG001|Overall Study|Adverse Event|2|||
162608253|NCT00686998|587281518|FG002|Overall Study|Adverse Event|1|||
162608254|NCT00686998|587281516|FG000|Overall Study|Withdrawal by Subject|2|||
162608255|NCT00686998|587281517|FG001|Overall Study|Withdrawal by Subject|1|||
162608256|NCT00686998|587281518|FG002|Overall Study|Withdrawal by Subject|2|||
162608257|NCT00686998|587281516|FG000|Overall Study|Lack of Efficacy|7|||
162608258|NCT00686998|587281517|FG001|Overall Study|Lack of Efficacy|5|||
162608259|NCT00686998|587281518|FG002|Overall Study|Lack of Efficacy|0|||
162608260|NCT00686998|587281516|FG000|Overall Study|Other|0|||
162608261|NCT00686998|587281517|FG001|Overall Study|Other|0|||
162608262|NCT00686998|587281518|FG002|Overall Study|Other|1|||
162608263|NCT00686998|587281516|FG000|Overall Study|Safety Reasons|1|||
162608264|NCT00686998|587281517|FG001|Overall Study|Safety Reasons|0|||
162608265|NCT00686998|587281518|FG002|Overall Study|Safety Reasons|0|||
162608266|NCT06374394|587281522|FG000|Overall Study|Adverse Event|0|||
162608267|NCT06374394|587281523|FG001|Overall Study|Adverse Event|2|||
162608268|NCT06374394|587281522|FG000|Overall Study|Lost to Follow-up|6|||
162608269|NCT06374394|587281523|FG001|Overall Study|Lost to Follow-up|9|||
162608270|NCT06374394|587281522|FG000|Overall Study|Withdrawal by Subject|1|||
162608271|NCT06374394|587281523|FG001|Overall Study|Withdrawal by Subject|7|||
162608272|NCT06374394|587281522|FG000|Overall Study|Other|1|||
162608273|NCT06374394|587281523|FG001|Overall Study|Other|0|||
162608274|NCT00356122|587281524|FG000|TREATMENT|Lack of Efficacy|26|||
162608275|NCT00356122|587281524|FG000|TREATMENT|Adverse Event|10|||
162608276|NCT00356122|587281524|FG000|TREATMENT|Subject's request|4|||
162608277|NCT00356122|587281524|FG000|TREATMENT|Other|4|||
162608278|NCT00356122|587281524|FG000|TREATMENT|Did not receive study medication|1|||
162608279|NCT00356122|587281524|FG000|FOLLOW-UP|Death|37|||
162608280|NCT00356122|587281524|FG000|FOLLOW-UP|Lost to Follow-up|2|||
162608281|NCT00356122|587281524|FG000|FOLLOW-UP|Other|2|||
162608282|NCT00543855|587282621|FG000|Overall Study|Adverse Event|3|||
162608283|NCT00543855|587282622|FG001|Overall Study|Adverse Event|1|||
162608284|NCT00543855|587282623|FG002|Overall Study|Adverse Event|3|||
162608285|NCT00543855|587282624|FG003|Overall Study|Adverse Event|4|||
162608286|NCT00543855|587282621|FG000|Overall Study|Lost to Follow-up|0|||
162608287|NCT00543855|587282622|FG001|Overall Study|Lost to Follow-up|0|||
162608288|NCT00543855|587282623|FG002|Overall Study|Lost to Follow-up|1|||
162608289|NCT00543855|587282624|FG003|Overall Study|Lost to Follow-up|0|||
162608290|NCT00543855|587282621|FG000|Overall Study|Withdrawal by Subject|0|||
162608291|NCT00543855|587282622|FG001|Overall Study|Withdrawal by Subject|1|||
162608292|NCT00543855|587282623|FG002|Overall Study|Withdrawal by Subject|2|||
162608293|NCT00543855|587282624|FG003|Overall Study|Withdrawal by Subject|0|||
162608294|NCT00543855|587282621|FG000|Overall Study|Protocol Violation|1|||
162608295|NCT00543855|587282622|FG001|Overall Study|Protocol Violation|0|||
162608296|NCT00543855|587282623|FG002|Overall Study|Protocol Violation|0|||
162608297|NCT00543855|587282624|FG003|Overall Study|Protocol Violation|0|||
162608298|NCT01994590|587282628|FG000|Overall Study|Adverse Event|1|||
162608299|NCT01994590|587282628|FG000|Overall Study|Trial Terminated|1|||
162608300|NCT00719264|587282630|FG000|Overall Study|Adverse Event|41|||
162608301|NCT00719264|587282631|FG001|Overall Study|Adverse Event|49|||
162608302|NCT00719264|587282630|FG000|Overall Study|Death|13|||
162608303|NCT00719264|587282631|FG001|Overall Study|Death|10|||
162608304|NCT00719264|587282630|FG000|Overall Study|Administrative Problems|6|||
162608305|NCT00719264|587282631|FG001|Overall Study|Administrative Problems|4|||
162608306|NCT00719264|587282630|FG000|Overall Study|Lost to Follow-up|1|||
162608307|NCT00719264|587282631|FG001|Overall Study|Lost to Follow-up|1|||
162608308|NCT00719264|587282630|FG000|Overall Study|Withdrawal by Subject|12|||
162608309|NCT00719264|587282631|FG001|Overall Study|Withdrawal by Subject|7|||
162608310|NCT00719264|587282630|FG000|Overall Study|Protocol Deviation|1|||
162608311|NCT00719264|587282631|FG001|Overall Study|Protocol Deviation|3|||
162608312|NCT00719264|587282630|FG000|Overall Study|New Cancer Therapy|4|||
162608313|NCT00719264|587282631|FG001|Overall Study|New Cancer Therapy|2|||
162608314|NCT00719264|587282630|FG000|Overall Study|Disease Progression|104|||
162608315|NCT00719264|587282631|FG001|Overall Study|Disease Progression|107|||
162608316|NCT01277042|587282632|FG000|Overall Study|Adverse Event|4|||
162608317|NCT01277042|587282633|FG001|Overall Study|Adverse Event|3|||
162608318|NCT01277042|587282632|FG000|Overall Study|Lost to Follow-up|2|||
162608319|NCT01277042|587282633|FG001|Overall Study|Lost to Follow-up|2|||
162608320|NCT01277042|587282632|FG000|Overall Study|Withdrawal by Subject|2|||
162608321|NCT01277042|587282633|FG001|Overall Study|Withdrawal by Subject|0|||
162608322|NCT03581786|587282640|FG000|Overall Study|Death|67|||
162608323|NCT03581786|587282641|FG001|Overall Study|Death|47|||
162608324|NCT03581786|587282640|FG000|Overall Study|Withdrawal by Subject|2|||
162608325|NCT03581786|587282641|FG001|Overall Study|Withdrawal by Subject|5|||
162608326|NCT03581786|587282640|FG000|Overall Study|Lost to Follow-up|7|||
162608327|NCT03581786|587282641|FG001|Overall Study|Lost to Follow-up|4|||
162608328|NCT03581786|587282640|FG000|Overall Study|reason other than specified above|0|||
162608329|NCT03581786|587282641|FG001|Overall Study|reason other than specified above|1|||
162608330|NCT02469038|587282642|FG000|Overall Study|Physician Decision|4|||
162608331|NCT02469038|587282643|FG001|Overall Study|Physician Decision|5|||
162608332|NCT03435640|587282644|FG000|Overall Study|Withdrawal by Subject|0|||
162608333|NCT03435640|587282645|FG001|Overall Study|Withdrawal by Subject|1|||
162608334|NCT03435640|587282646|FG002|Overall Study|Withdrawal by Subject|0|||
162608335|NCT03435640|587282647|FG003|Overall Study|Withdrawal by Subject|2|||
162608336|NCT03435640|587282648|FG004|Overall Study|Withdrawal by Subject|0|||
162848516|NCT00944034|588152845|FG002|Overall Study|Withdrawal by Subject|6|||
162848517|NCT00944034|588152846|FG003|Overall Study|Withdrawal by Subject|2|||
162848518|NCT00944034|588152847|FG004|Overall Study|Withdrawal by Subject|5|||
162848519|NCT00944034|588152848|FG005|Overall Study|Withdrawal by Subject|8|||
162848520|NCT00944034|588152849|FG006|Overall Study|Withdrawal by Subject|2|||
162848521|NCT00944034|588152850|FG007|Overall Study|Withdrawal by Subject|2|||
162848522|NCT00944034|588152851|FG008|Overall Study|Withdrawal by Subject|3|||
162848523|NCT00944034|588152852|FG009|Overall Study|Withdrawal by Subject|4|||
162848524|NCT00944034|588152853|FG010|Overall Study|Withdrawal by Subject|0|||
162848525|NCT00944034|588152854|FG011|Overall Study|Withdrawal by Subject|4|||
162848526|NCT00944034|588152843|FG000|Overall Study|Lost to Follow-up|0|||
162848527|NCT00944034|588152844|FG001|Overall Study|Lost to Follow-up|4|||
162848528|NCT00944034|588152845|FG002|Overall Study|Lost to Follow-up|2|||
162848529|NCT00944034|588152846|FG003|Overall Study|Lost to Follow-up|0|||
162848530|NCT00944034|588152847|FG004|Overall Study|Lost to Follow-up|5|||
162848531|NCT00944034|588152848|FG005|Overall Study|Lost to Follow-up|7|||
162848532|NCT00944034|588152849|FG006|Overall Study|Lost to Follow-up|0|||
162848533|NCT00944034|588152850|FG007|Overall Study|Lost to Follow-up|1|||
162848534|NCT00944034|588152851|FG008|Overall Study|Lost to Follow-up|5|||
162848535|NCT00944034|588152852|FG009|Overall Study|Lost to Follow-up|1|||
162848536|NCT00944034|588152853|FG010|Overall Study|Lost to Follow-up|1|||
162848537|NCT00944034|588152854|FG011|Overall Study|Lost to Follow-up|0|||
162848538|NCT00944034|588152843|FG000|Overall Study|Death|0|||
162848539|NCT00944034|588152844|FG001|Overall Study|Death|0|||
162608337|NCT03435640|587282649|FG005|Overall Study|Withdrawal by Subject|0|||
162608338|NCT03435640|587282650|FG006|Overall Study|Withdrawal by Subject|3|||
162608339|NCT03435640|587282651|FG007|Overall Study|Withdrawal by Subject|0|||
162608340|NCT03435640|587282652|FG008|Overall Study|Withdrawal by Subject|0|||
162608341|NCT03435640|587282653|FG009|Overall Study|Withdrawal by Subject|2|||
162608342|NCT03435640|587282654|FG010|Overall Study|Withdrawal by Subject|3|||
162608343|NCT03435640|587282644|FG000|Overall Study|Lost to Follow-up|0|||
162608344|NCT03435640|587282645|FG001|Overall Study|Lost to Follow-up|0|||
162608345|NCT03435640|587282646|FG002|Overall Study|Lost to Follow-up|1|||
162608346|NCT03435640|587282647|FG003|Overall Study|Lost to Follow-up|0|||
162608347|NCT03435640|587282648|FG004|Overall Study|Lost to Follow-up|0|||
162608348|NCT03435640|587282649|FG005|Overall Study|Lost to Follow-up|0|||
162608349|NCT03435640|587282650|FG006|Overall Study|Lost to Follow-up|0|||
162608350|NCT03435640|587282651|FG007|Overall Study|Lost to Follow-up|0|||
162608351|NCT03435640|587282652|FG008|Overall Study|Lost to Follow-up|0|||
162608352|NCT03435640|587282653|FG009|Overall Study|Lost to Follow-up|0|||
162608353|NCT03435640|587282654|FG010|Overall Study|Lost to Follow-up|0|||
162608354|NCT01347307|587282655|FG000|Overall Study|Death|0|||
162608355|NCT01347307|587282656|FG001|Overall Study|Death|4|||
162608356|NCT01347307|587282655|FG000|Overall Study|Physician Decision|0|||
162608357|NCT01347307|587282656|FG001|Overall Study|Physician Decision|1|||
162608358|NCT03954041|587282662|FG000|Overall Study|Lost to Follow-up|3|||
162608359|NCT03954041|587282663|FG001|Overall Study|Lost to Follow-up|3|||
162848540|NCT00944034|588152845|FG002|Overall Study|Death|1|||
162848541|NCT00944034|588152846|FG003|Overall Study|Death|0|||
162848542|NCT00944034|588152847|FG004|Overall Study|Death|0|||
162608360|NCT03954041|587282664|FG002|Overall Study|Lost to Follow-up|6|||
162848543|NCT00944034|588152848|FG005|Overall Study|Death|0|||
162848544|NCT00944034|588152849|FG006|Overall Study|Death|0|||
162608361|NCT03954041|587282662|FG000|Overall Study|Death|4|||
162608362|NCT03954041|587282663|FG001|Overall Study|Death|0|||
162608363|NCT03954041|587282664|FG002|Overall Study|Death|1|||
162702645|NCT01232556|587621907|FG000|Overall Study|Lost to Follow-up|0|||
162848545|NCT00944034|588152850|FG007|Overall Study|Death|0|||
162848546|NCT00944034|588152851|FG008|Overall Study|Death|0|||
162848547|NCT00944034|588152852|FG009|Overall Study|Death|0|||
162848548|NCT00944034|588152853|FG010|Overall Study|Death|0|||
162608364|NCT03954041|587282662|FG000|Overall Study|Death by neurologic criteria|0|||
162608365|NCT03954041|587282663|FG001|Overall Study|Death by neurologic criteria|0|||
162608366|NCT03954041|587282664|FG002|Overall Study|Death by neurologic criteria|1|||
162608367|NCT03954041|587282662|FG000|Overall Study|Reason not specified|7|||
162608368|NCT03954041|587282663|FG001|Overall Study|Reason not specified|4|||
162848549|NCT00944034|588152854|FG011|Overall Study|Death|0|||
162848550|NCT00944034|588152843|FG000|Overall Study|Protocol Violation|2|||
162848551|NCT00944034|588152844|FG001|Overall Study|Protocol Violation|0|||
162848552|NCT00944034|588152845|FG002|Overall Study|Protocol Violation|0|||
162848553|NCT00944034|588152846|FG003|Overall Study|Protocol Violation|1|||
162848554|NCT00944034|588152847|FG004|Overall Study|Protocol Violation|2|||
162848555|NCT00944034|588152848|FG005|Overall Study|Protocol Violation|3|||
162848556|NCT00944034|588152849|FG006|Overall Study|Protocol Violation|0|||
162848557|NCT00944034|588152850|FG007|Overall Study|Protocol Violation|1|||
162848558|NCT00944034|588152851|FG008|Overall Study|Protocol Violation|1|||
162848559|NCT00944034|588152852|FG009|Overall Study|Protocol Violation|4|||
162848560|NCT00944034|588152853|FG010|Overall Study|Protocol Violation|0|||
162848561|NCT00944034|588152854|FG011|Overall Study|Protocol Violation|0|||
162848562|NCT00944034|588152843|FG000|Overall Study|Unable to classify|0|||
162848563|NCT00944034|588152844|FG001|Overall Study|Unable to classify|0|||
162848564|NCT00944034|588152845|FG002|Overall Study|Unable to classify|0|||
162848565|NCT00944034|588152846|FG003|Overall Study|Unable to classify|0|||
162848566|NCT00944034|588152847|FG004|Overall Study|Unable to classify|0|||
162848567|NCT00944034|588152848|FG005|Overall Study|Unable to classify|1|||
162848568|NCT00944034|588152849|FG006|Overall Study|Unable to classify|1|||
162848569|NCT00944034|588152850|FG007|Overall Study|Unable to classify|1|||
162848570|NCT00944034|588152851|FG008|Overall Study|Unable to classify|0|||
162848571|NCT00944034|588152852|FG009|Overall Study|Unable to classify|0|||
162848572|NCT00944034|588152853|FG010|Overall Study|Unable to classify|0|||
162848573|NCT00944034|588152854|FG011|Overall Study|Unable to classify|0|||
162848574|NCT00944034|588152843|FG000|Overall Study|Administrative reason|0|||
162848575|NCT00944034|588152844|FG001|Overall Study|Administrative reason|0|||
162848576|NCT00944034|588152845|FG002|Overall Study|Administrative reason|0|||
162848577|NCT00944034|588152846|FG003|Overall Study|Administrative reason|0|||
162848578|NCT00944034|588152847|FG004|Overall Study|Administrative reason|0|||
162848579|NCT00944034|588152848|FG005|Overall Study|Administrative reason|0|||
162848580|NCT00944034|588152849|FG006|Overall Study|Administrative reason|1|||
162848581|NCT00944034|588152850|FG007|Overall Study|Administrative reason|0|||
162848582|NCT00944034|588152851|FG008|Overall Study|Administrative reason|0|||
162848583|NCT00944034|588152852|FG009|Overall Study|Administrative reason|0|||
162848584|NCT00944034|588152853|FG010|Overall Study|Administrative reason|0|||
162848585|NCT00944034|588152854|FG011|Overall Study|Administrative reason|0|||
162848586|NCT04258579|588152855|FG000|Overall Study|Withdrawal by Subject|7|||
162848587|NCT04258579|588152855|FG000|Overall Study|Lost to Follow-up|3|||
162848588|NCT04258579|588152855|FG000|Overall Study|Protocol Violation|2|||
162848589|NCT04258579|588152855|FG000|Overall Study|Adverse Event|1|||
162848590|NCT04007159|588152856|FG000|Induction Phase|(missed study visits)|16|||
162848591|NCT04007159|588152856|FG000|Induction Phase|Withdrawal by Subject|4|||
162848592|NCT04007159|588152856|FG000|Induction Phase|Adverse Event|2|||
162608369|NCT03954041|587282664|FG002|Overall Study|Reason not specified|2|||
162608370|NCT03954041|587282662|FG000|Overall Study|Withdrew prior to dosing|4|||
162608371|NCT03954041|587282663|FG001|Overall Study|Withdrew prior to dosing|2|||
162608372|NCT03954041|587282664|FG002|Overall Study|Withdrew prior to dosing|0|||
162702646|NCT01232556|587621908|FG001|Overall Study|Lost to Follow-up|2|||
162702647|NCT01232556|587621907|FG000|Overall Study|Terminated by Sponsor|35|||
162702648|NCT01232556|587621908|FG001|Overall Study|Terminated by Sponsor|51|||
162702649|NCT01232556|587621907|FG000|Overall Study|Other|6|||
162702650|NCT01232556|587621908|FG001|Overall Study|Other|4|||
162702651|NCT04172987|587621909|FG000|Lead In Period|Adverse Event|1|||
162702652|NCT04172987|587621909|FG000|Lead In Period|Protocol Violation|1|||
162608373|NCT00442468|587282672|FG000|Overall Study|Adverse Event|4|||
162608374|NCT00442468|587282672|FG000|Overall Study|Withdrawal by Subject|91|||
162608375|NCT00442468|587282672|FG000|Overall Study|Did not complete all study procedures|88|||
162608376|NCT00589784|587282673|FG000|Overall Study|Withdrawal by Subject|0|||
162608377|NCT00589784|587282674|FG001|Overall Study|Withdrawal by Subject|6|||
162608378|NCT00589784|587282673|FG000|Overall Study|Patient inevaluable|1|||
162608379|NCT00589784|587282674|FG001|Overall Study|Patient inevaluable|0|||
162608380|NCT00589784|587282673|FG000|Overall Study|Adverse Event|0|||
162608381|NCT00589784|587282674|FG001|Overall Study|Adverse Event|4|||
162608382|NCT00287079|587282676|FG000|Overall Study|Qualifying relapse|12|||
162608383|NCT00287079|587282677|FG001|Overall Study|Qualifying relapse|1|||
162702653|NCT04172987|587621909|FG000|Period 1|Physician Decision|1|||
162702654|NCT04172987|587621909|FG000|Period 2|Adverse Event|5|||
162848593|NCT04007159|588152856|FG000|Challenge Phase|missed study visits|3|||
162848594|NCT00331006|588152858|FG000|Screening Phase|Withdrawal by Subject|1|||
162848595|NCT00331006|588152858|FG000|Screening Phase|enrollment halted|1|||
162848596|NCT00331006|588152858|FG000|Screening Phase|Lost to Follow-up|1|||
162848597|NCT00331006|588152858|FG000|Screening Phase|Ineligible for treatment phase|4|||
162848598|NCT00331006|588152858|FG000|Treatment Phase|Withdrawal by Subject|1|||
162848599|NCT00331006|588152858|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
162848600|NCT00331006|588152858|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
162848601|NCT03804684|588152859|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
162848602|NCT03804684|588152860|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
162608384|NCT00287079|587282676|FG000|Overall Study|Non-qualifying relapse|1|||
162608385|NCT00287079|587282677|FG001|Overall Study|Non-qualifying relapse|0|||
162848603|NCT00238264|588152861|FG000|Overall Study|Death|7|||
162848604|NCT00238264|588152861|FG000|Overall Study|Lost to Follow-up|18|||
162848605|NCT00238264|588152861|FG000|Overall Study|Withdrawal by Subject|4|||
162848606|NCT00238264|588152861|FG000|Overall Study|Ineligible|7|||
162848607|NCT03183128|588152862|FG000|Overall Study|Adverse Event|1|||
162848608|NCT03183128|588152863|FG001|Overall Study|Adverse Event|2|||
162848609|NCT03183128|588152862|FG000|Overall Study|Withdrawal by Subject|1|||
162848610|NCT03183128|588152863|FG001|Overall Study|Withdrawal by Subject|8|||
162848611|NCT03183128|588152862|FG000|Overall Study|Protocol Violation|2|||
162848612|NCT03183128|588152863|FG001|Overall Study|Protocol Violation|0|||
162848613|NCT03183128|588152862|FG000|Overall Study|Lack of Efficacy|4|||
162848614|NCT03183128|588152863|FG001|Overall Study|Lack of Efficacy|27|||
162848615|NCT03183128|588152862|FG000|Overall Study|Lost to Follow-up|1|||
162848616|NCT03183128|588152863|FG001|Overall Study|Lost to Follow-up|0|||
162848617|NCT03183128|588152862|FG000|Overall Study|Death|2|||
162848618|NCT03183128|588152863|FG001|Overall Study|Death|0|||
162848619|NCT03183128|588152862|FG000|Overall Study|Physician Decision|1|||
162848620|NCT03183128|588152863|FG001|Overall Study|Physician Decision|0|||
162848621|NCT01225562|588152864|FG000|Overall Study|Withdrawal by Subject|52|||
162848622|NCT01225562|588152865|FG001|Overall Study|Withdrawal by Subject|50|||
162848623|NCT01225562|588152866|FG002|Overall Study|Withdrawal by Subject|52|||
162848624|NCT01225562|588152864|FG000|Overall Study|Lost to Follow-up|3|||
162848625|NCT01225562|588152865|FG001|Overall Study|Lost to Follow-up|6|||
162848626|NCT01225562|588152866|FG002|Overall Study|Lost to Follow-up|1|||
162848627|NCT01375764|588152867|FG000|Overall Study|Lost to Follow-up|0|||
162848628|NCT01375764|588152868|FG001|Overall Study|Lost to Follow-up|1|||
162702655|NCT04172987|587621909|FG000|Period 2|Dosing Termination by Sponsor|4|||
162702656|NCT03785340|587621911|FG000|Overall Study|Lost to Follow-up|2|||
162702657|NCT03785340|587621912|FG001|Overall Study|Lost to Follow-up|0|||
162702658|NCT03785340|587621911|FG000|Overall Study|Adverse Event|1|||
162702659|NCT03785340|587621912|FG001|Overall Study|Adverse Event|0|||
162702660|NCT02500316|587621913|FG000|Overall Study|Adverse Event|3|||
162702661|NCT02500316|587621913|FG000|Overall Study|Lost to Follow-up|2|||
162702662|NCT02500316|587621913|FG000|Overall Study|Protocol Violation|1|||
162702663|NCT02500316|587621913|FG000|Overall Study|Withdrawal by Subject|15|||
162702664|NCT02500316|587621913|FG000|Overall Study|Final height achieved|5|||
162702665|NCT02500316|587621913|FG000|Overall Study|Due to war activity|1|||
162702666|NCT01848834|587621914|FG000|Overall Study|Adverse Event|3|||
162702667|NCT01848834|587621915|FG001|Overall Study|Adverse Event|11|||
162702668|NCT01848834|587621916|FG002|Overall Study|Adverse Event|3|||
162702669|NCT01848834|587621917|FG003|Overall Study|Adverse Event|5|||
162702670|NCT01848834|587621918|FG004|Overall Study|Adverse Event|9|||
162702671|NCT01848834|587621914|FG000|Overall Study|Death|2|||
162848629|NCT01375764|588152869|FG002|Overall Study|Lost to Follow-up|0|||
162702672|NCT01848834|587621915|FG001|Overall Study|Death|11|||
162702673|NCT01848834|587621916|FG002|Overall Study|Death|1|||
162848630|NCT01375764|588152870|FG003|Overall Study|Lost to Follow-up|0|||
162848631|NCT01375764|588152871|FG004|Overall Study|Lost to Follow-up|0|||
162848632|NCT01375764|588152867|FG000|Overall Study|Withdrawal by Subject|2|||
162848633|NCT01375764|588152868|FG001|Overall Study|Withdrawal by Subject|0|||
162848634|NCT01375764|588152869|FG002|Overall Study|Withdrawal by Subject|0|||
162848635|NCT01375764|588152870|FG003|Overall Study|Withdrawal by Subject|0|||
162848636|NCT01375764|588152871|FG004|Overall Study|Withdrawal by Subject|1|||
162848637|NCT01375764|588152867|FG000|Overall Study|Other|0|||
162848638|NCT01375764|588152868|FG001|Overall Study|Other|0|||
162848639|NCT01375764|588152869|FG002|Overall Study|Other|0|||
162848640|NCT01375764|588152870|FG003|Overall Study|Other|1|||
162848641|NCT01375764|588152871|FG004|Overall Study|Other|0|||
162848642|NCT02445586|588152875|FG000|Overall Study|Death|14|||
162848643|NCT02445586|588152875|FG000|Overall Study|Withdrawal by Subject|13|||
162848644|NCT02445586|588152875|FG000|Overall Study|Disease Progression|10|||
162848645|NCT02445586|588152875|FG000|Overall Study|Protocol Violation|1|||
162848646|NCT02445586|588152875|FG000|Overall Study|Medical Condition|1|||
162848647|NCT01194440|588152876|FG000|Baseline (First Dose)|Reason not specified|4|||
162848648|NCT01194440|588152876|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
162848649|NCT01194440|588152876|FG000|Baseline (First Dose)|Change in therapy|1|||
162848650|NCT01194440|588152876|FG000|Baseline (First Dose)|Adverse Event|1|||
162848651|NCT01194440|588152876|FG000|6-months (2nd Dose)|Change in therapy|4|||
162848652|NCT01990261|588152877|FG000|Overall Study|Death Before Treatment Start|2|||
162848653|NCT01990261|588152877|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
162848654|NCT01990261|588152877|FG000|Overall Study|Death From other Causes|1|||
162848655|NCT01990261|588152877|FG000|Overall Study|Disease Progression (PD)|8|||
162848656|NCT01990261|588152877|FG000|Overall Study|PD Before Treatment Start|1|||
162848657|NCT01990261|588152877|FG000|Overall Study|Dossier not Approved|1|||
162848658|NCT01990261|588152877|FG000|Overall Study|Lost to Follow-up|2|||
162848659|NCT01078805|588152880|FG000|Overall Study|Clinically significant abnormal lab|5|||
162848660|NCT01078805|588152880|FG000|Overall Study|Death|134|||
162848661|NCT01078805|588152880|FG000|Overall Study|Lost to Follow-up|676|||
162848662|NCT01078805|588152880|FG000|Overall Study|Physician Decision|169|||
162848663|NCT01078805|588152880|FG000|Overall Study|Serious adverse event|26|||
162848664|NCT01078805|588152880|FG000|Overall Study|Sponsor decision|46|||
162848665|NCT01078805|588152880|FG000|Overall Study|Withdrawal by Subject|739|||
162848666|NCT01078805|588152880|FG000|Overall Study|Other|173|||
162848667|NCT01078805|588152880|FG000|Overall Study|Didn't take study drug|82|||
162848668|NCT01609842|588152881|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
162848669|NCT01609842|588152882|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
162848670|NCT04722991|588152883|FG000|Overall Study|Adverse Event|12|||
162848671|NCT04722991|588152884|FG001|Overall Study|Adverse Event|4|||
162848672|NCT04722991|588152883|FG000|Overall Study|Death|2|||
162848673|NCT04722991|588152884|FG001|Overall Study|Death|0|||
162848674|NCT04722991|588152883|FG000|Overall Study|Lost to Follow-up|1|||
162848675|NCT04722991|588152884|FG001|Overall Study|Lost to Follow-up|1|||
162848676|NCT04722991|588152883|FG000|Overall Study|Withdrawal cirterion met|2|||
162848677|NCT04722991|588152884|FG001|Overall Study|Withdrawal cirterion met|2|||
162848678|NCT04722991|588152883|FG000|Overall Study|Other|1|||
162848679|NCT04722991|588152884|FG001|Overall Study|Other|0|||
162848680|NCT04722991|588152883|FG000|Overall Study|Non-compliance|0|||
162848681|NCT04722991|588152884|FG001|Overall Study|Non-compliance|1|||
162848682|NCT04722991|588152883|FG000|Overall Study|Withdrawal by Subject|0|||
162848683|NCT04722991|588152884|FG001|Overall Study|Withdrawal by Subject|1|||
162848684|NCT03186989|588152885|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848685|NCT03186989|588152886|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848686|NCT03186989|588152887|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
162848687|NCT03186989|588152888|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
162848688|NCT03186989|588152889|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
162848689|NCT03186989|588152890|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848690|NCT03186989|588152891|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848691|NCT03186989|588152892|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848692|NCT03186989|588152893|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848693|NCT03186989|588152894|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848694|NCT03186989|588152895|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
162848695|NCT03186989|588152885|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848696|NCT03186989|588152886|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848697|NCT03186989|588152887|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848698|NCT03186989|588152888|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848699|NCT03186989|588152889|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848700|NCT03186989|588152890|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
162848701|NCT03186989|588152891|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848702|NCT03186989|588152892|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848703|NCT03186989|588152893|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848704|NCT03186989|588152894|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848705|NCT03186989|588152895|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
162848706|NCT03186989|588152885|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848707|NCT03186989|588152886|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848708|NCT03186989|588152887|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848709|NCT03186989|588152888|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848710|NCT03186989|588152889|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848711|NCT03186989|588152890|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848712|NCT03186989|588152891|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
162848713|NCT03186989|588152892|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848714|NCT03186989|588152893|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848715|NCT03186989|588152894|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848716|NCT03186989|588152895|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
162848717|NCT03186989|588152885|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848718|NCT03186989|588152886|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848719|NCT03186989|588152887|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848720|NCT03186989|588152888|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848721|NCT03186989|588152889|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848722|NCT03186989|588152890|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
162848723|NCT03186989|588152891|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
162848724|NCT03186989|588152892|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848725|NCT03186989|588152893|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
162848726|NCT03186989|588152894|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848727|NCT03186989|588152895|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
162848728|NCT02246621|588152899|FG000|Overall Study|Withdrawal by Subject|28|||
162848729|NCT02246621|588152900|FG001|Overall Study|Withdrawal by Subject|16|||
162848730|NCT02246621|588152899|FG000|Overall Study|Lost to Follow-up|1|||
162848731|NCT02246621|588152900|FG001|Overall Study|Lost to Follow-up|0|||
162848732|NCT02246621|588152899|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
162848733|NCT02246621|588152900|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
162848734|NCT00821678|588152901|FG000|Overall Study|Withdrawal by Subject|8|||
162848735|NCT00821678|588152902|FG001|Overall Study|Withdrawal by Subject|0|||
162848736|NCT00821678|588152901|FG000|Overall Study|Lost to Follow-up|13|||
162848737|NCT00821678|588152902|FG001|Overall Study|Lost to Follow-up|12|||
162848738|NCT00821678|588152901|FG000|Overall Study|Death|0|||
162848739|NCT00821678|588152902|FG001|Overall Study|Death|2|||
162848740|NCT02732951|588154661|FG000|Overall Study|Other than listed|1|||
162848741|NCT02732951|588154662|FG001|Overall Study|Other than listed|0|||
162848742|NCT02732951|588154661|FG000|Overall Study|Lost to Follow-up|0|||
162848743|NCT02732951|588154662|FG001|Overall Study|Lost to Follow-up|1|||
162848744|NCT02732951|588154661|FG000|Overall Study|Adverse Event|4|||
162848745|NCT02732951|588154662|FG001|Overall Study|Adverse Event|4|||
162848746|NCT02732951|588154661|FG000|Overall Study|Protocol Violation|0|||
162848747|NCT02732951|588154662|FG001|Overall Study|Protocol Violation|1|||
162848748|NCT01974817|588154663|FG000|Overall Study|Death|4|||
162848749|NCT01974817|588154663|FG000|Overall Study|Lost to Follow-up|2|||
162848750|NCT01974817|588154663|FG000|Overall Study|Protocol Violation|2|||
162848751|NCT05047523|588154668|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
162848752|NCT05047523|588154669|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
162848753|NCT05047523|588154670|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
162848754|NCT05047523|588154671|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
162848755|NCT05047523|588154672|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
162848756|NCT05047523|588154673|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
162848757|NCT05047523|588154668|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162848758|NCT05047523|588154669|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
162848759|NCT05047523|588154670|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162608386|NCT00287079|587282676|FG000|Overall Study|Adverse Event|5|||
162608387|NCT00287079|587282677|FG001|Overall Study|Adverse Event|0|||
162608388|NCT00287079|587282676|FG000|Overall Study|Protocol Violation|1|||
162608389|NCT00287079|587282677|FG001|Overall Study|Protocol Violation|0|||
162608390|NCT00287079|587282676|FG000|Overall Study|Other|3|||
162608391|NCT00287079|587282677|FG001|Overall Study|Other|0|||
162608392|NCT02953509|587282682|FG000|Overall Study|Death|1|||
162608393|NCT02953509|587282683|FG001|Overall Study|Death|3|||
162608394|NCT02953509|587282684|FG002|Overall Study|Death|3|||
162608395|NCT02953509|587282685|FG003|Overall Study|Death|4|||
162608396|NCT02953509|587282686|FG004|Overall Study|Death|12|||
162702674|NCT01848834|587621917|FG003|Overall Study|Death|8|||
162702675|NCT01848834|587621918|FG004|Overall Study|Death|27|||
162608397|NCT02953509|587282687|FG005|Overall Study|Death|3|||
162608398|NCT02953509|587282688|FG006|Overall Study|Death|25|||
162702676|NCT01848834|587621914|FG000|Overall Study|Excluded Medication|5|||
162848760|NCT05047523|588154671|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162608399|NCT02953509|587282689|FG007|Overall Study|Death|10|||
162608400|NCT02953509|587282690|FG008|Overall Study|Death|21|||
162608401|NCT02953509|587282691|FG009|Overall Study|Death|20|||
162608402|NCT02953509|587282682|FG000|Overall Study|Reason Not Specified|0|||
162608403|NCT02953509|587282683|FG001|Overall Study|Reason Not Specified|2|||
162608404|NCT02953509|587282684|FG002|Overall Study|Reason Not Specified|8|||
162608405|NCT02953509|587282685|FG003|Overall Study|Reason Not Specified|2|||
162608406|NCT02953509|587282686|FG004|Overall Study|Reason Not Specified|11|||
162702677|NCT01848834|587621915|FG001|Overall Study|Excluded Medication|4|||
162702678|NCT01848834|587621916|FG002|Overall Study|Excluded Medication|3|||
162702679|NCT01848834|587621917|FG003|Overall Study|Excluded Medication|6|||
162702680|NCT01848834|587621918|FG004|Overall Study|Excluded Medication|6|||
162702681|NCT01848834|587621914|FG000|Overall Study|Lost to Follow-up|5|||
162702682|NCT01848834|587621915|FG001|Overall Study|Lost to Follow-up|5|||
162702683|NCT01848834|587621916|FG002|Overall Study|Lost to Follow-up|3|||
162702684|NCT01848834|587621917|FG003|Overall Study|Lost to Follow-up|0|||
162702685|NCT01848834|587621918|FG004|Overall Study|Lost to Follow-up|3|||
162702686|NCT01848834|587621914|FG000|Overall Study|Physician Decision|1|||
162702687|NCT01848834|587621915|FG001|Overall Study|Physician Decision|3|||
162702688|NCT01848834|587621916|FG002|Overall Study|Physician Decision|4|||
162702689|NCT01848834|587621917|FG003|Overall Study|Physician Decision|0|||
162702690|NCT01848834|587621918|FG004|Overall Study|Physician Decision|11|||
162702691|NCT01848834|587621914|FG000|Overall Study|Protocol Violation|0|||
162702692|NCT01848834|587621915|FG001|Overall Study|Protocol Violation|0|||
162702693|NCT01848834|587621916|FG002|Overall Study|Protocol Violation|0|||
162702694|NCT01848834|587621917|FG003|Overall Study|Protocol Violation|0|||
162608407|NCT02953509|587282687|FG005|Overall Study|Reason Not Specified|4|||
162608408|NCT02953509|587282688|FG006|Overall Study|Reason Not Specified|12|||
162608409|NCT02953509|587282689|FG007|Overall Study|Reason Not Specified|2|||
162608410|NCT02953509|587282690|FG008|Overall Study|Reason Not Specified|7|||
162608411|NCT02953509|587282691|FG009|Overall Study|Reason Not Specified|2|||
162608412|NCT02953509|587282682|FG000|Overall Study|Consent Withdrawn|1|||
162608413|NCT02953509|587282683|FG001|Overall Study|Consent Withdrawn|1|||
162608414|NCT02953509|587282684|FG002|Overall Study|Consent Withdrawn|2|||
162608415|NCT02953509|587282685|FG003|Overall Study|Consent Withdrawn|1|||
162608416|NCT02953509|587282686|FG004|Overall Study|Consent Withdrawn|3|||
162608417|NCT02953509|587282687|FG005|Overall Study|Consent Withdrawn|0|||
162608418|NCT02953509|587282688|FG006|Overall Study|Consent Withdrawn|4|||
162608419|NCT02953509|587282689|FG007|Overall Study|Consent Withdrawn|1|||
162608420|NCT02953509|587282690|FG008|Overall Study|Consent Withdrawn|1|||
162608421|NCT02953509|587282691|FG009|Overall Study|Consent Withdrawn|4|||
162608422|NCT02953509|587282682|FG000|Overall Study|Lost to Follow-up|0|||
162608423|NCT02953509|587282683|FG001|Overall Study|Lost to Follow-up|0|||
162608424|NCT02953509|587282684|FG002|Overall Study|Lost to Follow-up|0|||
162608425|NCT02953509|587282685|FG003|Overall Study|Lost to Follow-up|0|||
162608426|NCT02953509|587282686|FG004|Overall Study|Lost to Follow-up|0|||
162608427|NCT02953509|587282687|FG005|Overall Study|Lost to Follow-up|0|||
162608428|NCT02953509|587282688|FG006|Overall Study|Lost to Follow-up|1|||
162608429|NCT02953509|587282689|FG007|Overall Study|Lost to Follow-up|1|||
162608430|NCT02953509|587282690|FG008|Overall Study|Lost to Follow-up|1|||
162608431|NCT02953509|587282691|FG009|Overall Study|Lost to Follow-up|1|||
162608432|NCT02953509|587282682|FG000|Overall Study|Study terminated by sponsor|1|||
162608433|NCT02953509|587282683|FG001|Overall Study|Study terminated by sponsor|0|||
162608434|NCT02953509|587282684|FG002|Overall Study|Study terminated by sponsor|0|||
162608435|NCT02953509|587282685|FG003|Overall Study|Study terminated by sponsor|0|||
162608436|NCT02953509|587282686|FG004|Overall Study|Study terminated by sponsor|0|||
162608437|NCT02953509|587282687|FG005|Overall Study|Study terminated by sponsor|0|||
162608438|NCT02953509|587282688|FG006|Overall Study|Study terminated by sponsor|1|||
162608439|NCT02953509|587282689|FG007|Overall Study|Study terminated by sponsor|0|||
162608440|NCT02953509|587282690|FG008|Overall Study|Study terminated by sponsor|1|||
162608441|NCT02953509|587282691|FG009|Overall Study|Study terminated by sponsor|1|||
162608442|NCT02325791|587282694|FG000|Overall Study|Adverse Event|0|||
162608443|NCT02325791|587282695|FG001|Overall Study|Adverse Event|1|||
162608444|NCT02325791|587282696|FG002|Overall Study|Adverse Event|1|||
162608445|NCT02325791|587282697|FG003|Overall Study|Adverse Event|0|||
162608446|NCT02325791|587282694|FG000|Overall Study|Death|0|||
162608447|NCT02325791|587282695|FG001|Overall Study|Death|3|||
162608448|NCT02325791|587282696|FG002|Overall Study|Death|0|||
162608449|NCT02325791|587282697|FG003|Overall Study|Death|1|||
162608450|NCT02325791|587282694|FG000|Overall Study|Lost to Follow-up|0|||
162608451|NCT02325791|587282695|FG001|Overall Study|Lost to Follow-up|15|||
162608452|NCT02325791|587282696|FG002|Overall Study|Lost to Follow-up|14|||
162608453|NCT02325791|587282697|FG003|Overall Study|Lost to Follow-up|9|||
162608454|NCT02325791|587282694|FG000|Overall Study|Physician Decision|0|||
162608455|NCT02325791|587282695|FG001|Overall Study|Physician Decision|1|||
162608456|NCT02325791|587282696|FG002|Overall Study|Physician Decision|1|||
162608457|NCT02325791|587282697|FG003|Overall Study|Physician Decision|0|||
162608458|NCT02325791|587282694|FG000|Overall Study|Protocol Violation|0|||
162608459|NCT02325791|587282695|FG001|Overall Study|Protocol Violation|0|||
162608460|NCT02325791|587282696|FG002|Overall Study|Protocol Violation|1|||
162608461|NCT02325791|587282697|FG003|Overall Study|Protocol Violation|0|||
162608462|NCT02325791|587282694|FG000|Overall Study|Withdrawal by Subject|0|||
162608463|NCT02325791|587282695|FG001|Overall Study|Withdrawal by Subject|5|||
162608464|NCT02325791|587282696|FG002|Overall Study|Withdrawal by Subject|8|||
162608465|NCT02325791|587282697|FG003|Overall Study|Withdrawal by Subject|16|||
162608466|NCT00722371|587282698|FG000|Overall Study|Adverse Event|6|||
162608467|NCT00722371|587282699|FG001|Overall Study|Adverse Event|13|||
162608468|NCT00722371|587282700|FG002|Overall Study|Adverse Event|9|||
162608469|NCT00722371|587282701|FG003|Overall Study|Adverse Event|10|||
162608470|NCT00722371|587282702|FG004|Overall Study|Adverse Event|6|||
162608471|NCT00722371|587282703|FG005|Overall Study|Adverse Event|8|||
162608472|NCT00722371|587282704|FG006|Overall Study|Adverse Event|4|||
162608473|NCT00722371|587282698|FG000|Overall Study|Contraindication|0|||
162608474|NCT00722371|587282699|FG001|Overall Study|Contraindication|0|||
162608475|NCT00722371|587282700|FG002|Overall Study|Contraindication|1|||
162608476|NCT00722371|587282701|FG003|Overall Study|Contraindication|0|||
162608477|NCT00722371|587282702|FG004|Overall Study|Contraindication|0|||
162608478|NCT00722371|587282703|FG005|Overall Study|Contraindication|0|||
162608479|NCT00722371|587282704|FG006|Overall Study|Contraindication|0|||
162608480|NCT00722371|587282698|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
162608481|NCT00722371|587282699|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
162608482|NCT00722371|587282700|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
162608483|NCT00722371|587282701|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
162608484|NCT00722371|587282702|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
162608485|NCT00722371|587282703|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
162608486|NCT00722371|587282704|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
162608487|NCT00722371|587282698|FG000|Overall Study|Excluded medication|0|||
162608488|NCT00722371|587282699|FG001|Overall Study|Excluded medication|1|||
162608489|NCT00722371|587282700|FG002|Overall Study|Excluded medication|1|||
162608490|NCT00722371|587282701|FG003|Overall Study|Excluded medication|0|||
162608491|NCT00722371|587282702|FG004|Overall Study|Excluded medication|0|||
162608492|NCT00722371|587282703|FG005|Overall Study|Excluded medication|0|||
162702695|NCT01848834|587621918|FG004|Overall Study|Protocol Violation|1|||
162608493|NCT00722371|587282704|FG006|Overall Study|Excluded medication|1|||
162608494|NCT00722371|587282698|FG000|Overall Study|Hyperglycemia|2|||
162608495|NCT00722371|587282699|FG001|Overall Study|Hyperglycemia|6|||
162608496|NCT00722371|587282700|FG002|Overall Study|Hyperglycemia|4|||
162608497|NCT00722371|587282701|FG003|Overall Study|Hyperglycemia|2|||
162608498|NCT00722371|587282702|FG004|Overall Study|Hyperglycemia|5|||
162608499|NCT00722371|587282703|FG005|Overall Study|Hyperglycemia|1|||
162608500|NCT00722371|587282704|FG006|Overall Study|Hyperglycemia|1|||
162608501|NCT00722371|587282698|FG000|Overall Study|Hypoglycemia|1|||
162608502|NCT00722371|587282699|FG001|Overall Study|Hypoglycemia|0|||
162608503|NCT00722371|587282700|FG002|Overall Study|Hypoglycemia|0|||
162608504|NCT00722371|587282701|FG003|Overall Study|Hypoglycemia|0|||
162608505|NCT00722371|587282702|FG004|Overall Study|Hypoglycemia|0|||
162608506|NCT00722371|587282703|FG005|Overall Study|Hypoglycemia|0|||
162608507|NCT00722371|587282704|FG006|Overall Study|Hypoglycemia|0|||
162608508|NCT00722371|587282698|FG000|Overall Study|Lack of Efficacy|4|||
162608509|NCT00722371|587282699|FG001|Overall Study|Lack of Efficacy|6|||
162608510|NCT00722371|587282700|FG002|Overall Study|Lack of Efficacy|6|||
162608511|NCT00722371|587282701|FG003|Overall Study|Lack of Efficacy|6|||
162608512|NCT00722371|587282702|FG004|Overall Study|Lack of Efficacy|2|||
162608513|NCT00722371|587282703|FG005|Overall Study|Lack of Efficacy|3|||
162608514|NCT00722371|587282704|FG006|Overall Study|Lack of Efficacy|0|||
162608515|NCT00722371|587282698|FG000|Overall Study|Lost to Follow-up|11|||
162608516|NCT00722371|587282699|FG001|Overall Study|Lost to Follow-up|14|||
162608517|NCT00722371|587282700|FG002|Overall Study|Lost to Follow-up|21|||
162608518|NCT00722371|587282701|FG003|Overall Study|Lost to Follow-up|13|||
162608519|NCT00722371|587282702|FG004|Overall Study|Lost to Follow-up|8|||
162608520|NCT00722371|587282703|FG005|Overall Study|Lost to Follow-up|16|||
162608521|NCT00722371|587282704|FG006|Overall Study|Lost to Follow-up|13|||
162608522|NCT00722371|587282698|FG000|Overall Study|Physician Decision|5|||
162608523|NCT00722371|587282699|FG001|Overall Study|Physician Decision|2|||
162608524|NCT00722371|587282700|FG002|Overall Study|Physician Decision|2|||
162608525|NCT00722371|587282701|FG003|Overall Study|Physician Decision|5|||
162608526|NCT00722371|587282702|FG004|Overall Study|Physician Decision|2|||
162608527|NCT00722371|587282703|FG005|Overall Study|Physician Decision|3|||
162608528|NCT00722371|587282704|FG006|Overall Study|Physician Decision|4|||
162608529|NCT00722371|587282698|FG000|Overall Study|Pregnancy|1|||
162608530|NCT00722371|587282699|FG001|Overall Study|Pregnancy|1|||
162608531|NCT00722371|587282700|FG002|Overall Study|Pregnancy|0|||
162608532|NCT00722371|587282701|FG003|Overall Study|Pregnancy|0|||
162608533|NCT00722371|587282702|FG004|Overall Study|Pregnancy|0|||
162608534|NCT00722371|587282703|FG005|Overall Study|Pregnancy|1|||
162608535|NCT00722371|587282704|FG006|Overall Study|Pregnancy|0|||
162608536|NCT00722371|587282698|FG000|Overall Study|Protocol Violation|6|||
162608537|NCT00722371|587282699|FG001|Overall Study|Protocol Violation|1|||
162608538|NCT00722371|587282700|FG002|Overall Study|Protocol Violation|0|||
162608539|NCT00722371|587282701|FG003|Overall Study|Protocol Violation|1|||
162608540|NCT00722371|587282702|FG004|Overall Study|Protocol Violation|4|||
162608541|NCT00722371|587282703|FG005|Overall Study|Protocol Violation|2|||
162608542|NCT00722371|587282704|FG006|Overall Study|Protocol Violation|1|||
162608543|NCT00722371|587282698|FG000|Overall Study|Withdrawal by Subject|18|||
162608544|NCT00722371|587282699|FG001|Overall Study|Withdrawal by Subject|27|||
162608545|NCT00722371|587282700|FG002|Overall Study|Withdrawal by Subject|19|||
162702696|NCT01848834|587621914|FG000|Overall Study|Sponsor Decision|1|||
162702697|NCT01848834|587621915|FG001|Overall Study|Sponsor Decision|1|||
162702698|NCT01848834|587621916|FG002|Overall Study|Sponsor Decision|0|||
162702699|NCT01848834|587621917|FG003|Overall Study|Sponsor Decision|1|||
162702700|NCT01848834|587621918|FG004|Overall Study|Sponsor Decision|1|||
162702701|NCT01848834|587621914|FG000|Overall Study|Withdrawal by Subject|2|||
162702702|NCT01848834|587621915|FG001|Overall Study|Withdrawal by Subject|13|||
162702703|NCT01848834|587621916|FG002|Overall Study|Withdrawal by Subject|10|||
162702704|NCT01848834|587621917|FG003|Overall Study|Withdrawal by Subject|6|||
162702705|NCT01848834|587621918|FG004|Overall Study|Withdrawal by Subject|36|||
162702706|NCT02584855|587621919|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
162702707|NCT02584855|587621920|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162702708|NCT02584855|587621921|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
162702709|NCT02584855|587621922|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
162702710|NCT02584855|587621923|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
162702711|NCT02584855|587621924|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
162702712|NCT02584855|587621919|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
162702713|NCT02584855|587621920|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
162702714|NCT02584855|587621921|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
162702715|NCT02584855|587621922|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
162702716|NCT02584855|587621923|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
162702717|NCT02584855|587621924|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
162702718|NCT02584855|587621919|FG000|Open-Label Treatment Period|Adverse Event|14|||
162702719|NCT02584855|587621920|FG001|Open-Label Treatment Period|Adverse Event|0|||
162702720|NCT02584855|587621921|FG002|Open-Label Treatment Period|Adverse Event|0|||
162702721|NCT02584855|587621922|FG003|Open-Label Treatment Period|Adverse Event|0|||
162702722|NCT02584855|587621923|FG004|Open-Label Treatment Period|Adverse Event|0|||
162702723|NCT02584855|587621924|FG005|Open-Label Treatment Period|Adverse Event|0|||
162702724|NCT02584855|587621919|FG000|Open-Label Treatment Period|Death|2|||
162702725|NCT02584855|587621920|FG001|Open-Label Treatment Period|Death|0|||
162702726|NCT02584855|587621921|FG002|Open-Label Treatment Period|Death|0|||
162608546|NCT00722371|587282701|FG003|Overall Study|Withdrawal by Subject|23|||
162608547|NCT00722371|587282702|FG004|Overall Study|Withdrawal by Subject|19|||
162608548|NCT00722371|587282703|FG005|Overall Study|Withdrawal by Subject|18|||
162608549|NCT00722371|587282704|FG006|Overall Study|Withdrawal by Subject|26|||
162702727|NCT02584855|587621922|FG003|Open-Label Treatment Period|Death|0|||
162702728|NCT02584855|587621923|FG004|Open-Label Treatment Period|Death|0|||
162608550|NCT00718237|587282705|FG000|Overall Study|Adverse Event|1|||
162608551|NCT00718237|587282706|FG001|Overall Study|Adverse Event|3|||
162608552|NCT00718237|587282705|FG000|Overall Study|Lost to Follow-up|2|||
162608553|NCT00718237|587282706|FG001|Overall Study|Lost to Follow-up|2|||
162702729|NCT02584855|587621924|FG005|Open-Label Treatment Period|Death|0|||
162702730|NCT02584855|587621919|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
162608554|NCT00718237|587282705|FG000|Overall Study|Physician Decision|1|||
162608555|NCT00718237|587282706|FG001|Overall Study|Physician Decision|0|||
162608556|NCT00718237|587282705|FG000|Overall Study|Withdrawal by Subject|9|||
162608557|NCT00718237|587282706|FG001|Overall Study|Withdrawal by Subject|10|||
162608558|NCT02694718|587282708|FG000|Overall Study|Death|1|||
162608559|NCT02694718|587282708|FG000|Overall Study|Withdrawal by Subject|1|||
162702731|NCT02584855|587621920|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
162702732|NCT02584855|587621921|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
162702733|NCT02584855|587621922|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
162702734|NCT02584855|587621923|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
162702735|NCT02584855|587621924|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
162702736|NCT02584855|587621919|FG000|Open-Label Treatment Period|Protocol Violation|1|||
162702737|NCT02584855|587621920|FG001|Open-Label Treatment Period|Protocol Violation|0|||
162702738|NCT02584855|587621921|FG002|Open-Label Treatment Period|Protocol Violation|0|||
162702739|NCT02584855|587621922|FG003|Open-Label Treatment Period|Protocol Violation|0|||
162702740|NCT02584855|587621923|FG004|Open-Label Treatment Period|Protocol Violation|0|||
162702741|NCT02584855|587621924|FG005|Open-Label Treatment Period|Protocol Violation|0|||
162702742|NCT02584855|587621919|FG000|Open-Label Treatment Period|No PI Available|2|||
162702743|NCT02584855|587621920|FG001|Open-Label Treatment Period|No PI Available|0|||
162702744|NCT02584855|587621921|FG002|Open-Label Treatment Period|No PI Available|0|||
162702745|NCT02584855|587621922|FG003|Open-Label Treatment Period|No PI Available|0|||
162702746|NCT02584855|587621923|FG004|Open-Label Treatment Period|No PI Available|0|||
162702747|NCT02584855|587621924|FG005|Open-Label Treatment Period|No PI Available|0|||
162702748|NCT02584855|587621919|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
162702749|NCT02584855|587621920|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
162702750|NCT02584855|587621921|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
162702751|NCT02584855|587621922|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
162702752|NCT02584855|587621923|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
162702753|NCT02584855|587621924|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
162702754|NCT02584855|587621919|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162702755|NCT02584855|587621920|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162702756|NCT02584855|587621921|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
162702757|NCT02584855|587621922|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162702758|NCT02584855|587621923|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162702759|NCT02584855|587621924|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162702760|NCT02584855|587621919|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
162702761|NCT02584855|587621920|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
162702762|NCT02584855|587621921|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
162702763|NCT02584855|587621922|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
162702764|NCT02584855|587621923|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
162702765|NCT02584855|587621924|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
162702766|NCT02584855|587621919|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162608560|NCT00322153|587282710|FG000|Overall Study|Adverse Event|21|||
162608561|NCT00322153|587282711|FG001|Overall Study|Adverse Event|34|||
162608562|NCT00322153|587282710|FG000|Overall Study|Protocol Violation|6|||
162608563|NCT00322153|587282711|FG001|Overall Study|Protocol Violation|14|||
162608564|NCT00322153|587282710|FG000|Overall Study|Withdrawal by Subject|18|||
162608565|NCT00322153|587282711|FG001|Overall Study|Withdrawal by Subject|10|||
162608566|NCT00322153|587282710|FG000|Overall Study|Lack of Efficacy|8|||
162608567|NCT00322153|587282711|FG001|Overall Study|Lack of Efficacy|3|||
162608568|NCT00322153|587282710|FG000|Overall Study|Lost to Follow-up|5|||
162608569|NCT00322153|587282711|FG001|Overall Study|Lost to Follow-up|4|||
162608570|NCT00322153|587282710|FG000|Overall Study|Withdrawn for other reasons|5|||
162608571|NCT00322153|587282711|FG001|Overall Study|Withdrawn for other reasons|4|||
162702767|NCT02584855|587621920|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
162702768|NCT02584855|587621921|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162702769|NCT02584855|587621922|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162608572|NCT03523000|587282713|FG000|Overall Study|Withdrawal by Subject|3|||
162608573|NCT03523000|587282714|FG001|Overall Study|Withdrawal by Subject|0|||
162608574|NCT03523000|587282713|FG000|Overall Study|Unsuccessful trial|2|||
162608575|NCT03523000|587282714|FG001|Overall Study|Unsuccessful trial|0|||
162608576|NCT00772070|587282715|FG000|Overall Study|Lost to Follow-up|0|||
162608577|NCT00772070|587282716|FG001|Overall Study|Lost to Follow-up|8|||
162608578|NCT00772070|587282715|FG000|Overall Study|Withdrawal by Subject|0|||
162608579|NCT00772070|587282716|FG001|Overall Study|Withdrawal by Subject|2|||
162608580|NCT00772070|587282715|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
162608581|NCT00772070|587282716|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
162608582|NCT03993379|587282721|FG000|Overall Study|The study was terminated early due to business decision.|0|||
162608583|NCT03993379|587282722|FG001|Overall Study|The study was terminated early due to business decision.|2|||
162608584|NCT03993379|587282723|FG002|Overall Study|The study was terminated early due to business decision.|0|||
162608585|NCT03993379|587282724|FG003|Overall Study|The study was terminated early due to business decision.|0|||
162608586|NCT03993379|587282721|FG000|Overall Study|Withdrawal by Subject|0|||
162608587|NCT03993379|587282722|FG001|Overall Study|Withdrawal by Subject|1|||
162608588|NCT03993379|587282723|FG002|Overall Study|Withdrawal by Subject|0|||
162608589|NCT03993379|587282724|FG003|Overall Study|Withdrawal by Subject|0|||
162608590|NCT02380690|587282725|FG000|Overall Study|Lost to Follow-up|14|||
162608591|NCT02380690|587282726|FG001|Overall Study|Lost to Follow-up|4|||
162608592|NCT02380690|587282725|FG000|Overall Study|Withdrawal by Subject|20|||
162608593|NCT02380690|587282726|FG001|Overall Study|Withdrawal by Subject|8|||
162608594|NCT02361346|587282727|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608595|NCT02361346|587282728|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608596|NCT02361346|587282729|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608597|NCT02361346|587282730|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
162608598|NCT02361346|587282731|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608599|NCT02361346|587282732|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608600|NCT02361346|587282733|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608601|NCT02361346|587282734|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608602|NCT02361346|587282735|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
162608603|NCT02361346|587282727|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608604|NCT02361346|587282728|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608605|NCT02361346|587282729|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608606|NCT02361346|587282730|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608607|NCT02361346|587282731|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
162608608|NCT02361346|587282732|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608609|NCT02361346|587282733|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608610|NCT02361346|587282734|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608611|NCT02361346|587282735|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162608612|NCT02361346|587282727|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
162608613|NCT02361346|587282728|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
162608614|NCT02361346|587282729|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
162608615|NCT02361346|587282730|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
162608616|NCT02361346|587282731|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
162608617|NCT02361346|587282732|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
162608618|NCT02361346|587282733|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
162608619|NCT02361346|587282734|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
162608620|NCT02361346|587282735|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
162608621|NCT02361346|587282727|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608622|NCT02361346|587282728|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608623|NCT02361346|587282729|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608624|NCT02361346|587282730|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608625|NCT02361346|587282731|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608626|NCT02361346|587282732|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608627|NCT02361346|587282733|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162702770|NCT02584855|587621923|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162702771|NCT02584855|587621924|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162702772|NCT02584855|587621919|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162702773|NCT02584855|587621920|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
162702774|NCT02584855|587621921|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162702775|NCT02584855|587621922|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162608628|NCT02361346|587282734|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
162608629|NCT02361346|587282735|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162608630|NCT02361346|587282727|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608631|NCT02361346|587282728|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608632|NCT02361346|587282729|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608633|NCT02361346|587282730|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608634|NCT02361346|587282731|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608635|NCT02361346|587282732|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162702776|NCT02584855|587621923|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162702777|NCT02584855|587621924|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162702778|NCT02584855|587621919|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162702779|NCT02584855|587621920|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162702780|NCT02584855|587621921|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162702781|NCT02584855|587621922|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162702782|NCT02584855|587621923|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
162702783|NCT02584855|587621924|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162702784|NCT02584855|587621919|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
162702785|NCT02584855|587621920|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
162702786|NCT02584855|587621921|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
162702787|NCT02584855|587621922|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
162702788|NCT02584855|587621923|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
162702789|NCT02584855|587621924|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
162702790|NCT02337478|587621925|FG000|Overall Study|Lack of Efficacy|5|||
162702791|NCT01987830|587621926|FG000|Overall Study|Never received baseline scan|1|||
162702792|NCT00544544|587621927|FG000|Overall Study|Withdrawal by Subject|1|||
162702793|NCT00544544|587621927|FG000|Overall Study|Adverse Event|1|||
162702794|NCT00544544|587621927|FG000|Overall Study|Lost to Follow-up|1|||
162702795|NCT02424344|587623427|FG000|Overall Study|Lack of Efficacy|0|||
162702796|NCT02424344|587623428|FG001|Overall Study|Lack of Efficacy|1|||
162702797|NCT02424344|587623427|FG000|Overall Study|Withdrawal by Subject|2|||
162702798|NCT02424344|587623428|FG001|Overall Study|Withdrawal by Subject|1|||
162702799|NCT02424344|587623427|FG000|Overall Study|Lost to Follow-up|1|||
162702800|NCT02424344|587623428|FG001|Overall Study|Lost to Follow-up|0|||
162702801|NCT02424344|587623427|FG000|Overall Study|Adverse Event|4|||
162702802|NCT02424344|587623428|FG001|Overall Study|Adverse Event|8|||
162702803|NCT04730947|587623429|FG000|Overall Study|Withdrawal by Subject|0|||
162702804|NCT04730947|587623430|FG001|Overall Study|Withdrawal by Subject|1|||
162702805|NCT02123966|587623431|FG000|Overall Study|Intercurrent Illness|1|||
162702806|NCT02561455|587623432|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
162702807|NCT02561455|587623433|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
162702808|NCT02561455|587623434|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
162702809|NCT02561455|587623435|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
162702810|NCT02561455|587623432|FG000|Overall Study|Withdrawal by Subject|1|||
162702811|NCT02561455|587623433|FG001|Overall Study|Withdrawal by Subject|0|||
162702812|NCT02561455|587623434|FG002|Overall Study|Withdrawal by Subject|1|||
162702813|NCT02561455|587623435|FG003|Overall Study|Withdrawal by Subject|0|||
162702814|NCT02561455|587623432|FG000|Overall Study|Disease Progression|0|||
162702815|NCT02561455|587623433|FG001|Overall Study|Disease Progression|1|||
162702816|NCT02561455|587623434|FG002|Overall Study|Disease Progression|0|||
162702817|NCT02561455|587623435|FG003|Overall Study|Disease Progression|0|||
162702818|NCT03639675|587623436|FG000|Overall Study|Withdrawal by Subject|1|||
162702819|NCT01021332|587623437|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
162702820|NCT01021332|587623437|FG000|Overall Study|Adverse Event|43|||
162702821|NCT01021332|587623437|FG000|Overall Study|Lack of Efficacy|19|||
162702822|NCT01021332|587623437|FG000|Overall Study|Withdrawal of Consent|23|||
162702823|NCT01021332|587623437|FG000|Overall Study|Lost to Follow-up|4|||
162702824|NCT01021332|587623437|FG000|Overall Study|Protocol Violation|9|||
162702825|NCT01021332|587623437|FG000|Overall Study|Miscellaneous|3|||
162702826|NCT00826280|587623438|FG000|Overall Study|Randomized but drug not received|1|||
162702827|NCT00826280|587623439|FG001|Overall Study|Randomized but drug not received|0|||
162702828|NCT00826280|587623440|FG002|Overall Study|Randomized but drug not received|1|||
162702829|NCT00826280|587623438|FG000|Overall Study|Adverse Event|1|||
162702830|NCT00826280|587623439|FG001|Overall Study|Adverse Event|3|||
162702831|NCT00826280|587623440|FG002|Overall Study|Adverse Event|0|||
162702832|NCT00826280|587623438|FG000|Overall Study|Lost to Follow-up|0|||
162702833|NCT00826280|587623439|FG001|Overall Study|Lost to Follow-up|1|||
162702834|NCT00826280|587623440|FG002|Overall Study|Lost to Follow-up|0|||
162702835|NCT00826280|587623438|FG000|Overall Study|Sponsor discontinued subject or study|1|||
162702836|NCT00826280|587623439|FG001|Overall Study|Sponsor discontinued subject or study|0|||
162702837|NCT00826280|587623440|FG002|Overall Study|Sponsor discontinued subject or study|0|||
162702838|NCT00826280|587623438|FG000|Overall Study|Reversible ischemic defect not present|43|||
162702839|NCT00826280|587623439|FG001|Overall Study|Reversible ischemic defect not present|40|||
162702840|NCT00826280|587623440|FG002|Overall Study|Reversible ischemic defect not present|44|||
162702841|NCT00826280|587623438|FG000|Overall Study|Interpretation Failure|1|||
162702842|NCT00826280|587623439|FG001|Overall Study|Interpretation Failure|0|||
162702843|NCT00826280|587623440|FG002|Overall Study|Interpretation Failure|0|||
162702844|NCT00826280|587623438|FG000|Overall Study|Machine Failure|1|||
162702845|NCT00826280|587623439|FG001|Overall Study|Machine Failure|1|||
162702846|NCT00826280|587623440|FG002|Overall Study|Machine Failure|0|||
162702847|NCT00826280|587623438|FG000|Overall Study|One or more non-interpretable scan|0|||
162702848|NCT00826280|587623439|FG001|Overall Study|One or more non-interpretable scan|1|||
162608636|NCT02361346|587282733|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608637|NCT02361346|587282734|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
162608638|NCT02361346|587282735|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162608639|NCT02361346|587282727|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608640|NCT02361346|587282728|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608641|NCT02361346|587282729|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608642|NCT02361346|587282730|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608643|NCT02361346|587282731|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608644|NCT02361346|587282732|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608645|NCT02361346|587282733|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608646|NCT02361346|587282734|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
162608647|NCT02361346|587282735|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162608648|NCT02483429|587282739|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
162608649|NCT02483429|587282740|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
162608650|NCT03576274|587282741|FG000|Overall Study|Lost to Follow-up|3|||
162608651|NCT03576274|587282742|FG001|Overall Study|Lost to Follow-up|2|||
162608652|NCT03576274|587282743|FG002|Overall Study|Lost to Follow-up|3|||
162608653|NCT03576274|587282744|FG003|Overall Study|Lost to Follow-up|1|||
162608654|NCT03576274|587282745|FG004|Overall Study|Lost to Follow-up|3|||
162608655|NCT03576274|587282741|FG000|Overall Study|Withdrawal by Subject|5|||
162608656|NCT03576274|587282742|FG001|Overall Study|Withdrawal by Subject|3|||
162608657|NCT03576274|587282743|FG002|Overall Study|Withdrawal by Subject|2|||
162608658|NCT03576274|587282744|FG003|Overall Study|Withdrawal by Subject|8|||
162608659|NCT03576274|587282745|FG004|Overall Study|Withdrawal by Subject|6|||
162608660|NCT04854642|587284193|FG000|Overall Study|Adverse Event|1|||
162608661|NCT04854642|587284194|FG001|Overall Study|Adverse Event|2|||
162608662|NCT04854642|587284193|FG000|Overall Study|Withdrawal by Subject|0|||
162608663|NCT04854642|587284194|FG001|Overall Study|Withdrawal by Subject|1|||
162608664|NCT02294773|587284196|FG000|Overall Study|Withdrawal by Subject|0|||
162608665|NCT02294773|587284197|FG001|Overall Study|Withdrawal by Subject|2|||
162608666|NCT01865084|587284198|FG000|Double Blind Period (DB)|Adverse Event|2|||
162608667|NCT01865084|587284199|FG001|Double Blind Period (DB)|Adverse Event|2|||
162608668|NCT01865084|587284200|FG002|Double Blind Period (DB)|Adverse Event|1|||
162608669|NCT01865084|587284198|FG000|Double Blind Period (DB)|Protocol Violation|0|||
162608670|NCT01865084|587284199|FG001|Double Blind Period (DB)|Protocol Violation|0|||
162608671|NCT01865084|587284200|FG002|Double Blind Period (DB)|Protocol Violation|1|||
162608672|NCT01865084|587284198|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
162608673|NCT01865084|587284199|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
162608674|NCT01865084|587284200|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
162608675|NCT01865084|587284198|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
162608676|NCT01865084|587284199|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
162608677|NCT01865084|587284200|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
162608678|NCT01865084|587284198|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
162608679|NCT01865084|587284199|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
162702849|NCT00826280|587623440|FG002|Overall Study|One or more non-interpretable scan|1|||
162702850|NCT05343455|587623443|FG000|Overall Study|Withdrawal by Subject|4|||
162702851|NCT05343455|587623444|FG001|Overall Study|Withdrawal by Subject|9|||
162702852|NCT05343455|587623445|FG002|Overall Study|Withdrawal by Subject|7|||
162702853|NCT05343455|587623443|FG000|Overall Study|Adverse Event|2|||
162702854|NCT05343455|587623444|FG001|Overall Study|Adverse Event|1|||
162702855|NCT05343455|587623445|FG002|Overall Study|Adverse Event|2|||
162702856|NCT05343455|587623443|FG000|Overall Study|Lost to Follow-up|1|||
162702857|NCT05343455|587623444|FG001|Overall Study|Lost to Follow-up|1|||
162702858|NCT05343455|587623445|FG002|Overall Study|Lost to Follow-up|3|||
162702859|NCT05343455|587623443|FG000|Overall Study|Pregnancy|1|||
162702860|NCT05343455|587623444|FG001|Overall Study|Pregnancy|0|||
162702861|NCT05343455|587623445|FG002|Overall Study|Pregnancy|0|||
162702862|NCT05343455|587623443|FG000|Overall Study|Physician Decision|0|||
162702863|NCT05343455|587623444|FG001|Overall Study|Physician Decision|0|||
162702864|NCT05343455|587623445|FG002|Overall Study|Physician Decision|1|||
162702865|NCT05343455|587623443|FG000|Overall Study|Protocol Violation|0|||
162702866|NCT05343455|587623444|FG001|Overall Study|Protocol Violation|1|||
162702867|NCT05343455|587623445|FG002|Overall Study|Protocol Violation|1|||
162702868|NCT03354637|587623448|FG000|Double-blind Period|Protocol Violation|2|||
162702869|NCT03354637|587623449|FG001|Double-blind Period|Protocol Violation|0|||
162702870|NCT03354637|587623450|FG002|Double-blind Period|Protocol Violation|0|||
162702871|NCT03354637|587623448|FG000|Double-blind Period|Adverse Event|1|||
162608680|NCT01865084|587284200|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
162608681|NCT01865084|587284198|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
162608682|NCT01865084|587284199|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
162608683|NCT01865084|587284200|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
162608684|NCT01865084|587284198|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
162608685|NCT01865084|587284199|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
162608686|NCT01865084|587284200|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
162608687|NCT01865084|587284198|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
162608688|NCT01865084|587284199|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
162608689|NCT01865084|587284200|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
162608690|NCT01865084|587284198|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
162608691|NCT01865084|587284199|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
162608692|NCT01865084|587284200|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
162608693|NCT03442764|587284201|FG000|Overall Study|Adverse Event|1|||
162608694|NCT03442764|587284202|FG001|Overall Study|Adverse Event|0|||
162608695|NCT03442764|587284203|FG002|Overall Study|Adverse Event|0|||
162608696|NCT01801072|587284204|FG000|Overall Study|Lost to Follow-up|17|||
162608697|NCT01801072|587284205|FG001|Overall Study|Lost to Follow-up|14|||
162608698|NCT01801072|587284204|FG000|Overall Study|Physician Decision|2|||
162608699|NCT01801072|587284205|FG001|Overall Study|Physician Decision|3|||
162608700|NCT01801072|587284204|FG000|Overall Study|Withdrawal by Subject|1|||
162608701|NCT01801072|587284205|FG001|Overall Study|Withdrawal by Subject|0|||
162608702|NCT01801072|587284204|FG000|Overall Study|Protocol Violation|2|||
162608703|NCT01801072|587284205|FG001|Overall Study|Protocol Violation|0|||
162608704|NCT01801072|587284204|FG000|Overall Study|Death|7|||
162608705|NCT01801072|587284205|FG001|Overall Study|Death|8|||
162608706|NCT03693170|587284206|FG000|Overall Study|Disease Progression|48|||
162608707|NCT03693170|587284206|FG000|Overall Study|Adverse Event|16|||
162608708|NCT03693170|587284206|FG000|Overall Study|Physician Decision|6|||
162608709|NCT03693170|587284206|FG000|Overall Study|Protocol Violation|2|||
162608710|NCT03693170|587284206|FG000|Overall Study|Death|1|||
162608711|NCT03693170|587284206|FG000|Overall Study|Non compliance with study drug|1|||
162608712|NCT03693170|587284206|FG000|Overall Study|Withdrawal by Subject|1|||
162608713|NCT04444895|587284207|FG000|Overall Study|Adverse Event|2|||
162608714|NCT04444895|587284207|FG000|Overall Study|Lost to Follow-up|2|||
162608715|NCT04444895|587284207|FG000|Overall Study|Withdrawal by Subject|5|||
162608716|NCT03034200|587284208|FG000|Overall Study|Disease progression|8|||
162608717|NCT03034200|587284209|FG001|Overall Study|Disease progression|10|||
162608718|NCT03034200|587284210|FG002|Overall Study|Disease progression|4|||
162608719|NCT03034200|587284208|FG000|Overall Study|Physician Decision|2|||
162608720|NCT03034200|587284209|FG001|Overall Study|Physician Decision|0|||
162608721|NCT03034200|587284210|FG002|Overall Study|Physician Decision|3|||
162608722|NCT03034200|587284208|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
162608723|NCT03034200|587284209|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
162631062|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
162631063|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
162631064|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
162631065|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
162631066|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
162631067|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
162631068|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
162631069|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
162631070|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631071|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631072|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631073|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631074|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631075|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631076|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631077|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631078|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631079|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631080|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631081|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631082|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631083|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631084|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631085|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631086|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631087|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631088|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631089|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631090|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631091|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631092|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162608724|NCT03034200|587284210|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
162608725|NCT03034200|587284208|FG000|Overall Study|Adjuvant Therapy|0|||
162608726|NCT03034200|587284209|FG001|Overall Study|Adjuvant Therapy|0|||
162608727|NCT03034200|587284210|FG002|Overall Study|Adjuvant Therapy|1|||
162608728|NCT00510874|587284211|FG000|Overall Study|Withdrawal by Subject|1|||
162608729|NCT00510874|587284212|FG001|Overall Study|Withdrawal by Subject|1|||
162608730|NCT00510874|587284213|FG002|Overall Study|Withdrawal by Subject|0|||
162608731|NCT00510874|587284214|FG003|Overall Study|Withdrawal by Subject|0|||
162608732|NCT00510874|587284215|FG004|Overall Study|Withdrawal by Subject|3|||
162608733|NCT00510874|587284216|FG005|Overall Study|Withdrawal by Subject|0|||
162608734|NCT00510874|587284217|FG006|Overall Study|Withdrawal by Subject|0|||
162608735|NCT00510874|587284211|FG000|Overall Study|Lost to Follow-up|2|||
162608736|NCT00510874|587284212|FG001|Overall Study|Lost to Follow-up|3|||
162608737|NCT00510874|587284213|FG002|Overall Study|Lost to Follow-up|1|||
162608738|NCT00510874|587284214|FG003|Overall Study|Lost to Follow-up|3|||
162608739|NCT00510874|587284215|FG004|Overall Study|Lost to Follow-up|4|||
162608740|NCT00510874|587284216|FG005|Overall Study|Lost to Follow-up|0|||
162608741|NCT00510874|587284217|FG006|Overall Study|Lost to Follow-up|1|||
162608742|NCT00636987|587284218|FG000|Overall Study|Death|44|||
162608743|NCT00636987|587284218|FG000|Overall Study|Explanted|13|||
162608744|NCT00636987|587284218|FG000|Overall Study|Lost to Follow-up|63|||
162608745|NCT00636987|587284218|FG000|Overall Study|5 year visit window not complete|69|||
162608746|NCT01251146|587284219|FG000|Overall Study|Lost to Follow-up|3|||
162608747|NCT01251146|587284220|FG001|Overall Study|Lost to Follow-up|10|||
162608748|NCT00053365|587284221|FG000|Overall Study|Incorrect cell type|1|||
162608749|NCT00053365|587284221|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
162608750|NCT00053365|587284221|FG000|Overall Study|Never treated|4|||
162608751|NCT03347188|587284230|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
162608752|NCT03347188|587284231|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
162608753|NCT03347188|587284230|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
162702872|NCT03354637|587623449|FG001|Double-blind Period|Adverse Event|2|||
162702873|NCT03354637|587623450|FG002|Double-blind Period|Adverse Event|0|||
162702874|NCT03354637|587623448|FG000|Double-blind Period|Lost to Follow-up|3|||
162608754|NCT03347188|587284231|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
162702875|NCT03354637|587623449|FG001|Double-blind Period|Lost to Follow-up|4|||
162702876|NCT03354637|587623450|FG002|Double-blind Period|Lost to Follow-up|3|||
162702877|NCT03354637|587623448|FG000|Double-blind Period|Withdrawal by Subject|10|||
162702878|NCT03354637|587623449|FG001|Double-blind Period|Withdrawal by Subject|6|||
162702879|NCT03354637|587623450|FG002|Double-blind Period|Withdrawal by Subject|4|||
162702880|NCT03354637|587623448|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
162702881|NCT03354637|587623449|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
162608755|NCT03347188|587284230|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
162608756|NCT03347188|587284231|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
162608757|NCT03347188|587284230|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
162608758|NCT03347188|587284231|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
162608759|NCT03347188|587284230|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
162608760|NCT03347188|587284231|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
162608761|NCT03347188|587284230|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
162608762|NCT03347188|587284231|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
162608763|NCT03347188|587284230|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
162608764|NCT03347188|587284231|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
162608765|NCT03347188|587284230|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
162608766|NCT03347188|587284231|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
162608767|NCT04177355|587284233|FG000|Overall Study|Lost to Follow-up|0|||
162608768|NCT04177355|587284234|FG001|Overall Study|Lost to Follow-up|2|||
162608769|NCT04177355|587284235|FG002|Overall Study|Lost to Follow-up|0|||
162608770|NCT04177355|587284236|FG003|Overall Study|Lost to Follow-up|1|||
162608771|NCT04177355|587284237|FG004|Overall Study|Lost to Follow-up|2|||
162608772|NCT04177355|587284238|FG005|Overall Study|Lost to Follow-up|0|||
162608773|NCT04177355|587284239|FG006|Overall Study|Lost to Follow-up|1|||
162608774|NCT04177355|587284240|FG007|Overall Study|Lost to Follow-up|0|||
162608775|NCT04177355|587284241|FG008|Overall Study|Lost to Follow-up|0|||
162608776|NCT04177355|587284242|FG009|Overall Study|Lost to Follow-up|0|||
162608777|NCT04177355|587284243|FG010|Overall Study|Lost to Follow-up|0|||
162608778|NCT04177355|587284233|FG000|Overall Study|Withdrawal by Subject|0|||
162608779|NCT04177355|587284234|FG001|Overall Study|Withdrawal by Subject|0|||
162608780|NCT04177355|587284235|FG002|Overall Study|Withdrawal by Subject|0|||
162608781|NCT04177355|587284236|FG003|Overall Study|Withdrawal by Subject|1|||
162608782|NCT04177355|587284237|FG004|Overall Study|Withdrawal by Subject|1|||
162608783|NCT04177355|587284238|FG005|Overall Study|Withdrawal by Subject|0|||
162608784|NCT04177355|587284239|FG006|Overall Study|Withdrawal by Subject|0|||
162702882|NCT03354637|587623450|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
162702883|NCT03354637|587623448|FG000|Open Label Extension|Adverse Event|0|||
162608785|NCT04177355|587284240|FG007|Overall Study|Withdrawal by Subject|0|||
162608786|NCT04177355|587284241|FG008|Overall Study|Withdrawal by Subject|1|||
162608787|NCT04177355|587284242|FG009|Overall Study|Withdrawal by Subject|0|||
162608788|NCT04177355|587284243|FG010|Overall Study|Withdrawal by Subject|0|||
162608789|NCT03139604|587284244|FG000|Overall Study|Other|7|||
162608790|NCT03139604|587284245|FG001|Overall Study|Other|3|||
162608791|NCT03139604|587284244|FG000|Overall Study|Withdrawal by Subject|16|||
162608792|NCT03139604|587284245|FG001|Overall Study|Withdrawal by Subject|17|||
162608793|NCT03139604|587284244|FG000|Overall Study|Physician Decision|1|||
162608794|NCT03139604|587284245|FG001|Overall Study|Physician Decision|2|||
162608795|NCT03139604|587284244|FG000|Overall Study|Lost to Follow-up|3|||
162608796|NCT03139604|587284245|FG001|Overall Study|Lost to Follow-up|1|||
162608797|NCT03139604|587284244|FG000|Overall Study|Death|65|||
162608798|NCT03139604|587284245|FG001|Overall Study|Death|67|||
162608799|NCT03139604|587284244|FG000|Overall Study|Study Terminated by Sponsor|122|||
162608800|NCT03139604|587284245|FG001|Overall Study|Study Terminated by Sponsor|127|||
162608801|NCT03139604|587284244|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
162608802|NCT03139604|587284245|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
162608803|NCT04148911|587284246|FG000|Overall Study|Death|104|||
162608804|NCT04148911|587284246|FG000|Overall Study|Lost to Follow-up|5|||
162608805|NCT04148911|587284246|FG000|Overall Study|Withdrawal by Subject|17|||
162608806|NCT04148911|587284246|FG000|Overall Study|Study Ended by Sponsor|56|||
162608807|NCT00470184|587284249|FG000|Overall Study|Not Treated(became ineligible)|4|||
162608808|NCT00470184|587284249|FG000|Overall Study|Not treated (other)|1|||
162608809|NCT00470184|587284249|FG000|Overall Study|disease Progression|4|||
162608810|NCT00470184|587284249|FG000|Overall Study|Adverse Event|3|||
162608811|NCT00470184|587284249|FG000|Overall Study|Withdrawal by Subject|4|||
162608812|NCT00470184|587284249|FG000|Overall Study|other|5|||
162608813|NCT00470184|587284249|FG000|Overall Study|recurrence|1|||
162608814|NCT01606254|587284252|FG000|Overall Study|Withdrawal by Subject|1|||
162608815|NCT01606254|587284253|FG001|Overall Study|Withdrawal by Subject|3|||
162608816|NCT01606254|587284254|FG002|Overall Study|Withdrawal by Subject|0|||
162608817|NCT01606254|587284255|FG003|Overall Study|Withdrawal by Subject|2|||
162608818|NCT01606254|587284252|FG000|Overall Study|Adverse Event|1|||
162608819|NCT01606254|587284253|FG001|Overall Study|Adverse Event|1|||
162608820|NCT01606254|587284254|FG002|Overall Study|Adverse Event|0|||
162608821|NCT01606254|587284255|FG003|Overall Study|Adverse Event|1|||
162608822|NCT04543409|587284256|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162608823|NCT04543409|587284257|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162608824|NCT04543409|587284256|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
162608825|NCT04543409|587284257|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
162608826|NCT04543409|587284256|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
162608827|NCT04543409|587284257|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
162608828|NCT04543409|587284256|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
162608829|NCT04543409|587284257|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
162608830|NCT04543409|587284256|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
162608831|NCT04543409|587284257|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
162608832|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
162608833|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
162608834|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
162608835|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
162608836|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
162608837|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
162608838|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
162608839|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
162608840|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
162608841|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
162608842|NCT04543409|587284256|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
162608843|NCT04543409|587284257|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
162608844|NCT01052844|587284258|FG000|Overall Study|Adverse Event|0|||
162608845|NCT01052844|587284259|FG001|Overall Study|Adverse Event|1|||
162608846|NCT02093026|587284260|FG000|Overall Study|Adverse Event|26|||
162608847|NCT02093026|587284260|FG000|Overall Study|Death|10|||
162608848|NCT02093026|587284260|FG000|Overall Study|Other|157|||
162608849|NCT02195011|587284270|FG000|Overall Study|Adverse Event|4|||
162608850|NCT02195011|587284271|FG001|Overall Study|Adverse Event|0|||
162608851|NCT02195011|587284270|FG000|Overall Study|Progressive Disease|18|||
162608852|NCT02195011|587284271|FG001|Overall Study|Progressive Disease|1|||
162608853|NCT02195011|587284270|FG000|Overall Study|Withdrawal by Subject|3|||
162608854|NCT02195011|587284271|FG001|Overall Study|Withdrawal by Subject|0|||
162608855|NCT00174291|587284272|FG000|Overall Study|Lost to Follow-up|1|||
162608856|NCT00174291|587284273|FG001|Overall Study|Lost to Follow-up|1|||
162608857|NCT00174291|587284272|FG000|Overall Study|Protocol Violation|0|||
162608858|NCT00174291|587284273|FG001|Overall Study|Protocol Violation|2|||
162608859|NCT00174291|587284272|FG000|Overall Study|Study terminated by sponsor|1|||
162608860|NCT00174291|587284273|FG001|Overall Study|Study terminated by sponsor|0|||
162608861|NCT00174291|587284272|FG000|Overall Study|Withdrawal by Subject|3|||
162608862|NCT00174291|587284273|FG001|Overall Study|Withdrawal by Subject|3|||
162608863|NCT01466595|587284274|FG000|Overall Study|Withdrawal by Subject|0|||
162608864|NCT01466595|587284275|FG001|Overall Study|Withdrawal by Subject|1|||
162608865|NCT00450112|587284278|FG000|Overall Study|Other Treatment Required|5|||
162608866|NCT00450112|587284279|FG001|Overall Study|Other Treatment Required|1|||
162608867|NCT00450112|587284278|FG000|Overall Study|Withdrawal by Subject|4|||
162608868|NCT00450112|587284279|FG001|Overall Study|Withdrawal by Subject|1|||
162608869|NCT00450112|587284278|FG000|Overall Study|Lost to Follow-up|2|||
162608870|NCT00450112|587284279|FG001|Overall Study|Lost to Follow-up|1|||
162608871|NCT00450112|587284278|FG000|Overall Study|Others|2|||
162608872|NCT00450112|587284279|FG001|Overall Study|Others|3|||
162608873|NCT03418571|587284280|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
162608874|NCT03418571|587284281|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
162608875|NCT00559754|587284282|FG000|Overall Study|Disease progression|1|||
162608876|NCT00559754|587284282|FG000|Overall Study|Adverse Event|5|||
162608877|NCT00559754|587284282|FG000|Overall Study|Protocol Violation|1|||
162608878|NCT00559754|587284282|FG000|Overall Study|Investigator criteria|2|||
162608879|NCT00559754|587284282|FG000|Overall Study|Withdrawal by Subject|2|||
162608880|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
162608881|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
162608882|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
162608883|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
162608884|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
162608885|NCT00586326|587284283|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
162608886|NCT00586326|587284283|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
162608887|NCT00586326|587284283|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
162608888|NCT00586326|587284283|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
162608889|NCT00586326|587284283|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
162608890|NCT00586326|587284283|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
162608891|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
162608892|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
162608893|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
162608894|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
162608895|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
162608896|NCT00586326|587284283|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
162608897|NCT01439347|587284284|FG000|Overall Study|Death|10|||
162608898|NCT01439347|587284285|FG001|Overall Study|Death|9|||
162608899|NCT01439347|587284284|FG000|Overall Study|Withdrawal by Subject|0|||
162608900|NCT01439347|587284285|FG001|Overall Study|Withdrawal by Subject|1|||
162608901|NCT01439347|587284284|FG000|Overall Study|Physician Decision|1|||
162608902|NCT01439347|587284285|FG001|Overall Study|Physician Decision|0|||
162608903|NCT01439347|587284284|FG000|Overall Study|Sponsor Terminated Study|2|||
162608904|NCT01439347|587284285|FG001|Overall Study|Sponsor Terminated Study|3|||
162608905|NCT03595774|587284286|FG000|Overall Study|Adverse Event|1|||
162608906|NCT03595774|587284287|FG001|Overall Study|Adverse Event|0|||
162608907|NCT03595774|587284288|FG002|Overall Study|Adverse Event|1|||
162608908|NCT03595774|587284289|FG003|Overall Study|Adverse Event|0|||
162608909|NCT03595774|587284286|FG000|Overall Study|screen failure|0|||
162608910|NCT03595774|587284287|FG001|Overall Study|screen failure|1|||
162608911|NCT03595774|587284288|FG002|Overall Study|screen failure|0|||
162608912|NCT03595774|587284289|FG003|Overall Study|screen failure|1|||
162608913|NCT03882008|587284290|FG000|Overall Study|Withdrawal by Subject|1|||
162608914|NCT03882008|587284290|FG000|Overall Study|Lost to Follow-up|1|||
162608915|NCT03519386|587284295|FG000|Overall Study|Withdrawal by Subject|4|||
162608916|NCT03519386|587284296|FG001|Overall Study|Withdrawal by Subject|1|||
162608917|NCT03519386|587284297|FG002|Overall Study|Withdrawal by Subject|2|||
162608918|NCT03519386|587284295|FG000|Overall Study|Physician Decision|1|||
162608919|NCT03519386|587284296|FG001|Overall Study|Physician Decision|1|||
162608920|NCT03519386|587284297|FG002|Overall Study|Physician Decision|1|||
162608921|NCT03519386|587284295|FG000|Overall Study|Lost to Follow-up|0|||
162608922|NCT03519386|587284296|FG001|Overall Study|Lost to Follow-up|1|||
162608923|NCT03519386|587284297|FG002|Overall Study|Lost to Follow-up|1|||
162608924|NCT03519386|587284295|FG000|Overall Study|Death|1|||
162608925|NCT03519386|587284296|FG001|Overall Study|Death|0|||
162608926|NCT03519386|587284297|FG002|Overall Study|Death|4|||
162608927|NCT03519386|587284295|FG000|Overall Study|Adverse Event|2|||
162608928|NCT03519386|587284296|FG001|Overall Study|Adverse Event|1|||
162608929|NCT03519386|587284297|FG002|Overall Study|Adverse Event|2|||
162608930|NCT03519386|587284295|FG000|Overall Study|Explanted|2|||
162608931|NCT03519386|587284296|FG001|Overall Study|Explanted|1|||
162608932|NCT03519386|587284297|FG002|Overall Study|Explanted|0|||
162608933|NCT03519386|587284295|FG000|Overall Study|Ongoing in study|190|||
162608934|NCT03519386|587284296|FG001|Overall Study|Ongoing in study|192|||
162608935|NCT03519386|587284297|FG002|Overall Study|Ongoing in study|183|||
162608936|NCT01582854|587284303|FG000|Overall Study|Death|8|||
162608937|NCT01582854|587284304|FG001|Overall Study|Death|5|||
162608938|NCT01582854|587284303|FG000|Overall Study|Adverse Event|2|||
162608939|NCT01582854|587284304|FG001|Overall Study|Adverse Event|3|||
162608940|NCT01582854|587284303|FG000|Overall Study|Withdrawal by Participant|8|||
162608941|NCT01582854|587284304|FG001|Overall Study|Withdrawal by Participant|11|||
162608942|NCT01582854|587284303|FG000|Overall Study|Lost to Follow-up|1|||
162608943|NCT01582854|587284304|FG001|Overall Study|Lost to Follow-up|2|||
162608944|NCT01582854|587284303|FG000|Overall Study|Physician Decision|0|||
162608945|NCT01582854|587284304|FG001|Overall Study|Physician Decision|1|||
162608946|NCT01582854|587284303|FG000|Overall Study|Recurrent Stroke|13|||
162608947|NCT01582854|587284304|FG001|Overall Study|Recurrent Stroke|8|||
162608948|NCT01582854|587284303|FG000|Overall Study|Disallowed Concomitant Medication|3|||
162608949|NCT01582854|587284304|FG001|Overall Study|Disallowed Concomitant Medication|2|||
162608950|NCT01582854|587284303|FG000|Overall Study|Carotid or Neurosurgery|0|||
162608951|NCT01582854|587284304|FG001|Overall Study|Carotid or Neurosurgery|1|||
162608952|NCT01582854|587284303|FG000|Overall Study|General Anaesthesia|0|||
162608953|NCT01582854|587284304|FG001|Overall Study|General Anaesthesia|1|||
162608954|NCT01582854|587284303|FG000|Overall Study|Other Miscellaneous Reason|1|||
162608955|NCT01582854|587284304|FG001|Overall Study|Other Miscellaneous Reason|0|||
162608956|NCT03101267|587284305|FG000|Primary Study Period|Withdrawal by Subject|1|||
162608957|NCT03101267|587284306|FG001|Primary Study Period|Withdrawal by Subject|2|||
162608958|NCT03101267|587284307|FG002|Primary Study Period|Withdrawal by Subject|3|||
162608959|NCT03101267|587284305|FG000|Primary Study Period|Miscellaneous|2|||
162608960|NCT03101267|587284306|FG001|Primary Study Period|Miscellaneous|0|||
162608961|NCT03101267|587284307|FG002|Primary Study Period|Miscellaneous|0|||
162608962|NCT04068896|587284308|FG000|Overall Study|Adverse Event|2|||
162608963|NCT04068896|587284309|FG001|Overall Study|Adverse Event|0|||
162608964|NCT04068896|587284310|FG002|Overall Study|Adverse Event|1|||
162608965|NCT04068896|587284311|FG003|Overall Study|Adverse Event|0|||
162608966|NCT04068896|587284312|FG004|Overall Study|Adverse Event|0|||
162608967|NCT04068896|587284313|FG005|Overall Study|Adverse Event|0|||
162608968|NCT04068896|587284308|FG000|Overall Study|Death|3|||
162608969|NCT04068896|587284309|FG001|Overall Study|Death|1|||
162608970|NCT04068896|587284310|FG002|Overall Study|Death|3|||
162608971|NCT04068896|587284311|FG003|Overall Study|Death|19|||
162608972|NCT04068896|587284312|FG004|Overall Study|Death|17|||
162608973|NCT04068896|587284313|FG005|Overall Study|Death|0|||
162608974|NCT04068896|587284308|FG000|Overall Study|Physician Decision|0|||
162608975|NCT04068896|587284309|FG001|Overall Study|Physician Decision|0|||
162608976|NCT04068896|587284310|FG002|Overall Study|Physician Decision|0|||
162608977|NCT04068896|587284311|FG003|Overall Study|Physician Decision|1|||
162608978|NCT04068896|587284312|FG004|Overall Study|Physician Decision|0|||
162608979|NCT04068896|587284313|FG005|Overall Study|Physician Decision|0|||
162608980|NCT04068896|587284308|FG000|Overall Study|progressive disease|3|||
162608981|NCT04068896|587284309|FG001|Overall Study|progressive disease|5|||
162608982|NCT04068896|587284310|FG002|Overall Study|progressive disease|3|||
162608983|NCT04068896|587284311|FG003|Overall Study|progressive disease|2|||
162608984|NCT04068896|587284312|FG004|Overall Study|progressive disease|1|||
162608985|NCT04068896|587284313|FG005|Overall Study|progressive disease|2|||
162608986|NCT04068896|587284308|FG000|Overall Study|Study terminated by sponsor|0|||
162608987|NCT04068896|587284309|FG001|Overall Study|Study terminated by sponsor|0|||
162608988|NCT04068896|587284310|FG002|Overall Study|Study terminated by sponsor|1|||
162608989|NCT04068896|587284311|FG003|Overall Study|Study terminated by sponsor|2|||
162608990|NCT04068896|587284312|FG004|Overall Study|Study terminated by sponsor|1|||
162608991|NCT04068896|587284313|FG005|Overall Study|Study terminated by sponsor|4|||
162608992|NCT04068896|587284308|FG000|Overall Study|Protocol Violation|0|||
162608993|NCT04068896|587284309|FG001|Overall Study|Protocol Violation|0|||
162608994|NCT04068896|587284310|FG002|Overall Study|Protocol Violation|0|||
162702884|NCT03354637|587623449|FG001|Open Label Extension|Adverse Event|0|||
162702885|NCT03354637|587623450|FG002|Open Label Extension|Adverse Event|1|||
162702886|NCT03354637|587623448|FG000|Open Label Extension|Lost to Follow-up|0|||
162702887|NCT03354637|587623449|FG001|Open Label Extension|Lost to Follow-up|0|||
162702888|NCT03354637|587623450|FG002|Open Label Extension|Lost to Follow-up|2|||
162702889|NCT03354637|587623448|FG000|Open Label Extension|Withdrawal by Subject|0|||
162702890|NCT03354637|587623449|FG001|Open Label Extension|Withdrawal by Subject|0|||
162702891|NCT03354637|587623450|FG002|Open Label Extension|Withdrawal by Subject|5|||
162702892|NCT03354637|587623448|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
162702893|NCT03354637|587623449|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
162702894|NCT03354637|587623450|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
162702895|NCT03354637|587623448|FG000|Open Label Extension|Subject Noncompliance|0|||
162702896|NCT03354637|587623449|FG001|Open Label Extension|Subject Noncompliance|0|||
162702897|NCT03354637|587623450|FG002|Open Label Extension|Subject Noncompliance|1|||
162702898|NCT03354637|587623448|FG000|Open Label Extension|Lack of Efficacy|0|||
162702899|NCT03354637|587623449|FG001|Open Label Extension|Lack of Efficacy|0|||
162702900|NCT03354637|587623450|FG002|Open Label Extension|Lack of Efficacy|1|||
162702901|NCT03354637|587623448|FG000|Open Label Extension|Physician Decision|0|||
162702902|NCT03354637|587623449|FG001|Open Label Extension|Physician Decision|0|||
162702903|NCT03354637|587623450|FG002|Open Label Extension|Physician Decision|1|||
162702904|NCT04006366|587623451|FG000|Overall Study|Withdrawal by Subject|1|||
162702905|NCT01603121|587623454|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
162702906|NCT01603121|587623455|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
162702907|NCT00738530|587623456|FG000|Overall Study|Death|220|||
162702908|NCT00738530|587623457|FG001|Overall Study|Death|224|||
162702909|NCT00738530|587623456|FG000|Overall Study|Lost to Follow-up|8|||
162608995|NCT04068896|587284311|FG003|Overall Study|Protocol Violation|1|||
162608996|NCT04068896|587284312|FG004|Overall Study|Protocol Violation|0|||
162608997|NCT04068896|587284313|FG005|Overall Study|Protocol Violation|0|||
162608998|NCT04068896|587284308|FG000|Overall Study|Withdrawal by Subject|0|||
162608999|NCT04068896|587284309|FG001|Overall Study|Withdrawal by Subject|3|||
162609000|NCT04068896|587284310|FG002|Overall Study|Withdrawal by Subject|0|||
162609001|NCT04068896|587284311|FG003|Overall Study|Withdrawal by Subject|2|||
162609002|NCT04068896|587284312|FG004|Overall Study|Withdrawal by Subject|1|||
162702910|NCT00738530|587623457|FG001|Overall Study|Lost to Follow-up|6|||
162702911|NCT00738530|587623456|FG000|Overall Study|Withdrawal by Subject|6|||
162702912|NCT00738530|587623457|FG001|Overall Study|Withdrawal by Subject|8|||
162702913|NCT01656759|587623458|FG000|Overall Study|Protocol Violation|2|||
162702914|NCT01656759|587623459|FG001|Overall Study|Protocol Violation|3|||
162702915|NCT01628510|587623460|FG000|Overall Study|Withdrawal by Subject|0|||
162702916|NCT01628510|587623461|FG001|Overall Study|Withdrawal by Subject|4|||
162702917|NCT01628510|587623460|FG000|Overall Study|Death|3|||
162702918|NCT01628510|587623461|FG001|Overall Study|Death|1|||
162702919|NCT04179461|587623462|FG000|Overall Study|Lost to Follow-up|4|||
162702920|NCT03160079|587623470|FG000|Overall Study|Adverse Event|2|||
162702921|NCT03160079|587623471|FG001|Overall Study|Adverse Event|0|||
162702922|NCT03160079|587623470|FG000|Overall Study|Disease Progression|1|||
162702923|NCT03160079|587623471|FG001|Overall Study|Disease Progression|0|||
162702924|NCT03160079|587623470|FG000|Overall Study|Physician Decision|1|||
162702925|NCT03160079|587623471|FG001|Overall Study|Physician Decision|0|||
162702926|NCT03259373|587623483|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
162702927|NCT03259373|587623484|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
162702928|NCT03259373|587623483|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
162702929|NCT03259373|587623484|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
162702930|NCT03259373|587623483|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
162702931|NCT03259373|587623484|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
162702932|NCT03259373|587623483|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
162702933|NCT03259373|587623484|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
162702934|NCT03259373|587623483|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
162702935|NCT03259373|587623484|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
162702936|NCT03259373|587623483|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
162702937|NCT03259373|587623484|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
162702938|NCT02611830|587623485|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
162609003|NCT04068896|587284313|FG005|Overall Study|Withdrawal by Subject|0|||
162609004|NCT04068896|587284308|FG000|Overall Study|Symptomatic deterioration|2|||
162609005|NCT04068896|587284309|FG001|Overall Study|Symptomatic deterioration|0|||
162702939|NCT02611830|587623486|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162609006|NCT04068896|587284310|FG002|Overall Study|Symptomatic deterioration|0|||
162609007|NCT04068896|587284311|FG003|Overall Study|Symptomatic deterioration|0|||
162609008|NCT04068896|587284312|FG004|Overall Study|Symptomatic deterioration|0|||
162609009|NCT04068896|587284313|FG005|Overall Study|Symptomatic deterioration|0|||
162609010|NCT00484185|587284316|FG000|Overall Study|Lost to Follow-up|44|||
162609011|NCT00484185|587284316|FG000|Overall Study|Other|20|||
162609012|NCT00484185|587284316|FG000|Overall Study|Randomized but not treated|5|||
162609013|NCT00484185|587284316|FG000|Overall Study|Death|2|||
162609014|NCT01222403|587284317|FG000|Overall Study|Inappropriate enrollment|0|||
162609015|NCT01222403|587284318|FG001|Overall Study|Inappropriate enrollment|2|||
162609016|NCT02068768|587284320|FG000|Overall Study|Lost to Follow-up|5|||
162609017|NCT02068768|587284320|FG000|Overall Study|Early Termination by Sponsor|2|||
162609018|NCT00555425|587284321|FG000|Overall Study|Missed Medication > 1 wk|34|||
162609019|NCT00555425|587284322|FG001|Overall Study|Missed Medication > 1 wk|15|||
162609020|NCT00555425|587284321|FG000|Overall Study|Missed 3 physician management visits|1|||
162609021|NCT00555425|587284322|FG001|Overall Study|Missed 3 physician management visits|0|||
162609022|NCT00555425|587284321|FG000|Overall Study|Met criteria for protective transfer|16|||
162609023|NCT00555425|587284322|FG001|Overall Study|Met criteria for protective transfer|3|||
162609024|NCT00555425|587284321|FG000|Overall Study|Became pregnant and transferred care|0|||
162609025|NCT00555425|587284322|FG001|Overall Study|Became pregnant and transferred care|1|||
162609026|NCT01185834|587284323|FG000|Overall Study|Lost to Follow-up|2|||
162609027|NCT01185834|587284323|FG000|Overall Study|Discomfort|4|||
162609028|NCT01185834|587284323|FG000|Overall Study|Biomicroscopy|4|||
162609029|NCT01185834|587284323|FG000|Overall Study|Time/Job Conflict|2|||
162609030|NCT01185834|587284323|FG000|Overall Study|Early exit - Site error|2|||
162609031|NCT00913692|587284324|FG000|Screening (4 Months)|Physician Decision|3|||
162609032|NCT00913692|587284324|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
162609033|NCT00913692|587284324|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
162609034|NCT02290431|587284326|FG000|Overall Study|Adverse Event|20|||
162609035|NCT02290431|587284326|FG000|Overall Study|Progressive disease|4|||
162609036|NCT02290431|587284326|FG000|Overall Study|Study terminated by Sponsor|1|||
162609037|NCT02290431|587284326|FG000|Overall Study|Physician Decision|2|||
162609038|NCT00321893|587284327|FG000|Overall Study|Non-Compliance/Refusal|16|||
162609039|NCT00321893|587284328|FG001|Overall Study|Non-Compliance/Refusal|10|||
162609040|NCT00321893|587284327|FG000|Overall Study|Lost to Follow-up|2|||
162609041|NCT00321893|587284328|FG001|Overall Study|Lost to Follow-up|1|||
162609042|NCT00321893|587284327|FG000|Overall Study|Adverse Event|6|||
162609043|NCT00321893|587284328|FG001|Overall Study|Adverse Event|3|||
162609044|NCT03455764|587284329|FG000|Overall Study|Adverse Event|1|||
162609045|NCT03455764|587284330|FG001|Overall Study|Adverse Event|0|||
162609046|NCT03455764|587284331|FG002|Overall Study|Adverse Event|0|||
162609047|NCT03455764|587284332|FG003|Overall Study|Adverse Event|0|||
162609048|NCT03455764|587284333|FG004|Overall Study|Adverse Event|0|||
162609049|NCT03455764|587284329|FG000|Overall Study|Disease Progression|4|||
162609050|NCT03455764|587284330|FG001|Overall Study|Disease Progression|0|||
162609051|NCT03455764|587284331|FG002|Overall Study|Disease Progression|0|||
162609052|NCT03455764|587284332|FG003|Overall Study|Disease Progression|0|||
162609053|NCT03455764|587284333|FG004|Overall Study|Disease Progression|0|||
162609054|NCT03455764|587284329|FG000|Overall Study|On Treatment|1|||
162609055|NCT03455764|587284330|FG001|Overall Study|On Treatment|0|||
162609056|NCT03455764|587284331|FG002|Overall Study|On Treatment|0|||
162609057|NCT03455764|587284332|FG003|Overall Study|On Treatment|0|||
162609058|NCT03455764|587284333|FG004|Overall Study|On Treatment|0|||
162609059|NCT01683019|587286078|FG000|Overall Study|Withdrawal by Subject|2|||
162609060|NCT01683019|587286079|FG001|Overall Study|Withdrawal by Subject|1|||
162609061|NCT01683019|587286080|FG002|Overall Study|Withdrawal by Subject|4|||
162609062|NCT03437512|587286081|FG000|Randomized|Withdrawal by Subject|0|||
162609063|NCT03437512|587286082|FG001|Randomized|Withdrawal by Subject|2|||
162609064|NCT03437512|587286081|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
162609065|NCT03437512|587286082|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
162609066|NCT00301821|587286085|FG000|Overall Study|Ineligible|25|||
162609067|NCT00301821|587286085|FG000|Overall Study|Cancel|1|||
162609068|NCT03332771|587286086|FG000|Overall Study|Adverse Event|6|||
162609069|NCT03332771|587286087|FG001|Overall Study|Adverse Event|4|||
162609070|NCT03332771|587286088|FG002|Overall Study|Adverse Event|1|||
162609071|NCT03332771|587286089|FG003|Overall Study|Adverse Event|3|||
162609072|NCT03332771|587286086|FG000|Overall Study|Poor Compliance to Protocol|0|||
162609073|NCT03332771|587286087|FG001|Overall Study|Poor Compliance to Protocol|1|||
162609074|NCT03332771|587286088|FG002|Overall Study|Poor Compliance to Protocol|0|||
162609075|NCT03332771|587286089|FG003|Overall Study|Poor Compliance to Protocol|1|||
162609076|NCT03332771|587286086|FG000|Overall Study|Lost to Follow-up|2|||
162609077|NCT03332771|587286087|FG001|Overall Study|Lost to Follow-up|2|||
162609078|NCT03332771|587286088|FG002|Overall Study|Lost to Follow-up|1|||
162609079|NCT03332771|587286089|FG003|Overall Study|Lost to Follow-up|2|||
162609080|NCT03332771|587286086|FG000|Overall Study|At the Participant's own request|20|||
162609081|NCT03332771|587286087|FG001|Overall Study|At the Participant's own request|26|||
162609082|NCT03332771|587286088|FG002|Overall Study|At the Participant's own request|14|||
162609083|NCT03332771|587286089|FG003|Overall Study|At the Participant's own request|23|||
162609084|NCT03332771|587286086|FG000|Overall Study|Reason Not Specified|6|||
162609085|NCT03332771|587286087|FG001|Overall Study|Reason Not Specified|18|||
162609086|NCT03332771|587286088|FG002|Overall Study|Reason Not Specified|16|||
162609087|NCT03332771|587286089|FG003|Overall Study|Reason Not Specified|19|||
162609088|NCT00737464|587286094|FG000|Overall Study|Adverse Event|1|||
162609089|NCT00737464|587286094|FG000|Overall Study|Death|6|||
162609090|NCT00737464|587286094|FG000|Overall Study|Other - Failure to Return|1|||
162609091|NCT00737464|587286094|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
162609092|NCT00737464|587286094|FG000|Overall Study|Other reasons|4|||
162609093|NCT02423109|587286095|FG000|Lens 1|Adverse Event|1|||
162609094|NCT02423109|587286096|FG001|Lens 1|Adverse Event|0|||
162609095|NCT03868124|587286097|FG000|Overall Study|Withdrawal by Subject|4|||
162609096|NCT03868124|587286098|FG001|Overall Study|Withdrawal by Subject|0|||
162609097|NCT03868124|587286099|FG002|Overall Study|Withdrawal by Subject|1|||
162609098|NCT03868124|587286097|FG000|Overall Study|Physician Decision|1|||
162609099|NCT03868124|587286098|FG001|Overall Study|Physician Decision|0|||
162609100|NCT03868124|587286099|FG002|Overall Study|Physician Decision|1|||
162609101|NCT03868124|587286097|FG000|Overall Study|Lost to Follow-up|1|||
162609102|NCT03868124|587286098|FG001|Overall Study|Lost to Follow-up|1|||
162609103|NCT03868124|587286099|FG002|Overall Study|Lost to Follow-up|2|||
162609104|NCT03868124|587286097|FG000|Overall Study|Death|1|||
162609105|NCT03868124|587286098|FG001|Overall Study|Death|1|||
162609106|NCT03868124|587286099|FG002|Overall Study|Death|2|||
162609107|NCT03868124|587286097|FG000|Overall Study|Adverse Event|0|||
162609108|NCT03868124|587286098|FG001|Overall Study|Adverse Event|0|||
162609109|NCT03868124|587286099|FG002|Overall Study|Adverse Event|3|||
162609110|NCT03868124|587286097|FG000|Overall Study|Explanted|2|||
162609111|NCT03868124|587286098|FG001|Overall Study|Explanted|1|||
162609112|NCT03868124|587286099|FG002|Overall Study|Explanted|0|||
162609113|NCT03868124|587286097|FG000|Overall Study|Ongoing in study|176|||
162609114|NCT03868124|587286098|FG001|Overall Study|Ongoing in study|180|||
162609115|NCT03868124|587286099|FG002|Overall Study|Ongoing in study|183|||
162609116|NCT02742246|587286100|FG000|Overall Study|Never initiated treatment|5|||
162609117|NCT02742246|587286101|FG001|Overall Study|Never initiated treatment|3|||
162609118|NCT02742246|587286102|FG002|Overall Study|Never initiated treatment|1|||
162609119|NCT02742246|587286100|FG000|Overall Study|dropped out during treatment|7|||
162609120|NCT02742246|587286101|FG001|Overall Study|dropped out during treatment|13|||
162609121|NCT02742246|587286102|FG002|Overall Study|dropped out during treatment|10|||
162609122|NCT02742246|587286100|FG000|Overall Study|Death|1|||
162609123|NCT02742246|587286101|FG001|Overall Study|Death|0|||
162609124|NCT02742246|587286102|FG002|Overall Study|Death|0|||
162609125|NCT03489551|587286103|FG000|Overall Study|Withdrawal by Subject|2|||
162609126|NCT00054717|587286104|FG000|Overall Study|Randomized but not treated|2|||
162609127|NCT00054717|587286105|FG001|Overall Study|Randomized but not treated|8|||
162609128|NCT00054717|587286104|FG000|Overall Study|Adverse Event|70|||
162609129|NCT00054717|587286105|FG001|Overall Study|Adverse Event|22|||
162609130|NCT00054717|587286104|FG000|Overall Study|Protocol Violation|18|||
162609131|NCT00054717|587286105|FG001|Overall Study|Protocol Violation|19|||
162609132|NCT00054717|587286104|FG000|Overall Study|Lost to Follow-up|23|||
162609133|NCT00054717|587286105|FG001|Overall Study|Lost to Follow-up|13|||
162609134|NCT00054717|587286104|FG000|Overall Study|Withdrawal by Subject|32|||
162609135|NCT00054717|587286105|FG001|Overall Study|Withdrawal by Subject|20|||
162609136|NCT00054717|587286104|FG000|Overall Study|Other reason not defined above|117|||
162609137|NCT00054717|587286105|FG001|Overall Study|Other reason not defined above|217|||
162609138|NCT00521001|587286112|FG000|Overall Study|Ineligible|1|||
162609139|NCT01082640|587286116|FG000|Overall Study|Adverse Event|9|||
162609140|NCT01082640|587286117|FG001|Overall Study|Adverse Event|5|||
162609141|NCT01082640|587286118|FG002|Overall Study|Adverse Event|3|||
162609142|NCT01082640|587286116|FG000|Overall Study|Withdrawal by Subject|3|||
162609143|NCT01082640|587286117|FG001|Overall Study|Withdrawal by Subject|3|||
162609144|NCT01082640|587286118|FG002|Overall Study|Withdrawal by Subject|2|||
162609145|NCT01082640|587286116|FG000|Overall Study|Major protocol deviation|3|||
162702940|NCT02611830|587623487|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162702941|NCT02611830|587623488|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162702942|NCT02611830|587623485|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
162702943|NCT02611830|587623486|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
162609146|NCT01082640|587286117|FG001|Overall Study|Major protocol deviation|3|||
162609147|NCT01082640|587286118|FG002|Overall Study|Major protocol deviation|0|||
162609148|NCT01082640|587286116|FG000|Overall Study|Lost to Follow-up|0|||
162609149|NCT01082640|587286117|FG001|Overall Study|Lost to Follow-up|3|||
162609150|NCT01082640|587286118|FG002|Overall Study|Lost to Follow-up|0|||
162609151|NCT01082640|587286116|FG000|Overall Study|Other|2|||
162609152|NCT01082640|587286117|FG001|Overall Study|Other|1|||
162609153|NCT01082640|587286118|FG002|Overall Study|Other|3|||
162609154|NCT03823378|587286123|FG000|Overall Study|Adverse Event|2|||
162609155|NCT03823378|587286124|FG001|Overall Study|Adverse Event|2|||
162609156|NCT03823378|587286125|FG002|Overall Study|Adverse Event|0|||
162609157|NCT03823378|587286126|FG003|Overall Study|Adverse Event|0|||
162609158|NCT03823378|587286127|FG004|Overall Study|Adverse Event|0|||
162609159|NCT03823378|587286128|FG005|Overall Study|Adverse Event|0|||
162609160|NCT03823378|587286123|FG000|Overall Study|Lost to Follow-up|0|||
162609161|NCT03823378|587286124|FG001|Overall Study|Lost to Follow-up|1|||
162609162|NCT03823378|587286125|FG002|Overall Study|Lost to Follow-up|0|||
162609163|NCT03823378|587286126|FG003|Overall Study|Lost to Follow-up|0|||
162609164|NCT03823378|587286127|FG004|Overall Study|Lost to Follow-up|1|||
162609165|NCT03823378|587286128|FG005|Overall Study|Lost to Follow-up|0|||
162609166|NCT03823378|587286123|FG000|Overall Study|Withdrawal by Subject|0|||
162609167|NCT03823378|587286124|FG001|Overall Study|Withdrawal by Subject|1|||
162609168|NCT03823378|587286125|FG002|Overall Study|Withdrawal by Subject|4|||
162609169|NCT03823378|587286126|FG003|Overall Study|Withdrawal by Subject|2|||
162609170|NCT03823378|587286127|FG004|Overall Study|Withdrawal by Subject|0|||
162609171|NCT03823378|587286128|FG005|Overall Study|Withdrawal by Subject|1|||
162609172|NCT03823378|587286123|FG000|Overall Study|Other, not specified|19|||
162609173|NCT03823378|587286124|FG001|Overall Study|Other, not specified|12|||
162609174|NCT03823378|587286125|FG002|Overall Study|Other, not specified|6|||
162609175|NCT03823378|587286126|FG003|Overall Study|Other, not specified|8|||
162609176|NCT03823378|587286127|FG004|Overall Study|Other, not specified|17|||
162609177|NCT03823378|587286128|FG005|Overall Study|Other, not specified|7|||
162609178|NCT03190369|587286129|FG000|Overall Study|Poor compliance to protocol|0|||
162609179|NCT03190369|587286130|FG001|Overall Study|Poor compliance to protocol|1|||
162609180|NCT03190369|587286129|FG000|Overall Study|Withdraw before treatment|1|||
162609181|NCT03190369|587286130|FG001|Overall Study|Withdraw before treatment|5|||
162609182|NCT03190369|587286129|FG000|Overall Study|Randomized but not treated|0|||
162609183|NCT03190369|587286130|FG001|Overall Study|Randomized but not treated|2|||
162609184|NCT01289782|587286131|FG000|Overall Study|Lost to Follow-up|14|||
162609185|NCT01289782|587286132|FG001|Overall Study|Lost to Follow-up|7|||
162609186|NCT01289782|587286131|FG000|Overall Study|Protocol Violation|1|||
162609187|NCT01289782|587286132|FG001|Overall Study|Protocol Violation|1|||
162609188|NCT01289782|587286131|FG000|Overall Study|Withdrawal by Subject|8|||
162609189|NCT01289782|587286132|FG001|Overall Study|Withdrawal by Subject|2|||
162609190|NCT01289782|587286131|FG000|Overall Study|Sponsor's Decision|1|||
162609191|NCT01289782|587286132|FG001|Overall Study|Sponsor's Decision|0|||
162609192|NCT01289782|587286131|FG000|Overall Study|Reason not specified|1|||
162609193|NCT01289782|587286132|FG001|Overall Study|Reason not specified|2|||
162609194|NCT01264016|587286138|FG000|Overall Study|Withdrawal by Subject|1|||
162609195|NCT01264016|587286138|FG000|Overall Study|Felt faint at sight of blood|1|||
162609196|NCT01629706|587286139|FG000|Phase 1 PureVision|Screen Failure|4|||
162609197|NCT01629706|587286139|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
162609198|NCT01629706|587286139|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
162609199|NCT01629706|587286139|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
162609200|NCT01629706|587286139|FG000|Phase 2 Habitual|Screen Failure|6|||
162609201|NCT01629706|587286139|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
162609202|NCT01629706|587286139|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
162702944|NCT02611830|587623487|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
162702945|NCT02611830|587623488|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
162702946|NCT02611830|587623485|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
162702947|NCT02611830|587623486|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
162702948|NCT02611830|587623487|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
162702949|NCT02611830|587623488|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
162702950|NCT02611830|587623485|FG000|OL Induction Phase|Lack of Efficacy|9|||
162702951|NCT02611830|587623486|FG001|OL Induction Phase|Lack of Efficacy|0|||
162702952|NCT02611830|587623487|FG002|OL Induction Phase|Lack of Efficacy|0|||
162702953|NCT02611830|587623488|FG003|OL Induction Phase|Lack of Efficacy|0|||
162702954|NCT02611830|587623485|FG000|OL Induction Phase|Reason not specified|3|||
162702955|NCT02611830|587623486|FG001|OL Induction Phase|Reason not specified|0|||
162702956|NCT02611830|587623487|FG002|OL Induction Phase|Reason not specified|0|||
162702957|NCT02611830|587623488|FG003|OL Induction Phase|Reason not specified|0|||
162702958|NCT02611830|587623485|FG000|Maintenance Phase|Lack of Efficacy|0|||
162702959|NCT02611830|587623486|FG001|Maintenance Phase|Lack of Efficacy|29|||
162702960|NCT02611830|587623487|FG002|Maintenance Phase|Lack of Efficacy|18|||
162702961|NCT02611830|587623488|FG003|Maintenance Phase|Lack of Efficacy|6|||
162702962|NCT02611830|587623485|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
162702963|NCT02611830|587623486|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
162702964|NCT02611830|587623487|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
162702965|NCT02611830|587623488|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
162702966|NCT02611830|587623485|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
162702967|NCT02611830|587623486|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
162609203|NCT01629706|587286139|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
162609204|NCT01629706|587286139|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
162609205|NCT00048061|587286140|FG000|Overall Study|Adverse Event|41|||
162609206|NCT00048061|587286141|FG001|Overall Study|Adverse Event|32|||
162609207|NCT00048061|587286142|FG002|Overall Study|Adverse Event|44|||
162702968|NCT02611830|587623487|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
162702969|NCT02611830|587623488|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
162702970|NCT02611830|587623485|FG000|Maintenance Phase|Lost to Follow-up|0|||
162702971|NCT02611830|587623486|FG001|Maintenance Phase|Lost to Follow-up|0|||
162609208|NCT00048061|587286143|FG003|Overall Study|Adverse Event|37|||
162609209|NCT00048061|587286140|FG000|Overall Study|Lost to Follow-up|3|||
162609210|NCT00048061|587286141|FG001|Overall Study|Lost to Follow-up|2|||
162609211|NCT00048061|587286142|FG002|Overall Study|Lost to Follow-up|4|||
162609212|NCT00048061|587286143|FG003|Overall Study|Lost to Follow-up|5|||
162609213|NCT00048061|587286140|FG000|Overall Study|Withdrawal by Subject|20|||
162609214|NCT00048061|587286141|FG001|Overall Study|Withdrawal by Subject|29|||
162609215|NCT00048061|587286142|FG002|Overall Study|Withdrawal by Subject|29|||
162609216|NCT00048061|587286143|FG003|Overall Study|Withdrawal by Subject|32|||
162609217|NCT00048061|587286140|FG000|Overall Study|Did not follow-up|5|||
162609218|NCT00048061|587286141|FG001|Overall Study|Did not follow-up|5|||
162609219|NCT00048061|587286142|FG002|Overall Study|Did not follow-up|4|||
162609220|NCT00048061|587286143|FG003|Overall Study|Did not follow-up|5|||
162609221|NCT00048061|587286140|FG000|Overall Study|Early improvement|6|||
162609222|NCT00048061|587286141|FG001|Overall Study|Early improvement|5|||
162609223|NCT00048061|587286142|FG002|Overall Study|Early improvement|3|||
162609224|NCT00048061|587286143|FG003|Overall Study|Early improvement|0|||
162609225|NCT01262352|587286144|FG000|Period 1|Illness after randomization|1|||
162609226|NCT01262352|587286145|FG001|Period 1|Illness after randomization|0|||
162609227|NCT01262352|587286144|FG000|Washout|Adverse Event|1|||
162609228|NCT01262352|587286145|FG001|Washout|Adverse Event|1|||
162609229|NCT01262352|587286144|FG000|Washout|Extended Washout|0|||
162609230|NCT01262352|587286145|FG001|Washout|Extended Washout|1|||
162609231|NCT01298193|587286146|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
162609232|NCT01298193|587286146|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
162609233|NCT01298193|587286146|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
162609234|NCT01298193|587286146|FG000|Efficacy Phase (Second Cycle)|Death|1|||
162609235|NCT01975831|587286147|FG000|Overall Study|Adverse Event|1|||
162609236|NCT01975831|587286148|FG001|Overall Study|Adverse Event|2|||
162609237|NCT01975831|587286149|FG002|Overall Study|Adverse Event|2|||
162609238|NCT01975831|587286150|FG003|Overall Study|Adverse Event|0|||
162609239|NCT01975831|587286151|FG004|Overall Study|Adverse Event|1|||
162609240|NCT01975831|587286152|FG005|Overall Study|Adverse Event|1|||
162609241|NCT01975831|587286153|FG006|Overall Study|Adverse Event|3|||
162609242|NCT01975831|587286154|FG007|Overall Study|Adverse Event|4|||
162702972|NCT02611830|587623487|FG002|Maintenance Phase|Lost to Follow-up|0|||
162702973|NCT02611830|587623488|FG003|Maintenance Phase|Lost to Follow-up|1|||
162702974|NCT02611830|587623485|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
162609243|NCT01975831|587286155|FG008|Overall Study|Adverse Event|1|||
162609244|NCT01975831|587286147|FG000|Overall Study|Death|1|||
162609245|NCT01975831|587286148|FG001|Overall Study|Death|1|||
162609246|NCT01975831|587286149|FG002|Overall Study|Death|0|||
162952082|NCT02422264|588529538|FG001|Overall Study|Serious Adverse Event|0|||
162952083|NCT02422264|588529537|FG000|Overall Study|Withdrawal by Subject|1|||
162952084|NCT02422264|588529538|FG001|Overall Study|Withdrawal by Subject|2|||
162609247|NCT01975831|587286150|FG003|Overall Study|Death|0|||
162609248|NCT01975831|587286151|FG004|Overall Study|Death|1|||
162609249|NCT01975831|587286152|FG005|Overall Study|Death|0|||
162609250|NCT01975831|587286153|FG006|Overall Study|Death|1|||
162609251|NCT01975831|587286154|FG007|Overall Study|Death|0|||
162609252|NCT01975831|587286155|FG008|Overall Study|Death|0|||
162609253|NCT01975831|587286147|FG000|Overall Study|Progressive Disease|1|||
162609254|NCT01975831|587286148|FG001|Overall Study|Progressive Disease|3|||
162609255|NCT01975831|587286149|FG002|Overall Study|Progressive Disease|2|||
162609256|NCT01975831|587286150|FG003|Overall Study|Progressive Disease|4|||
162609257|NCT01975831|587286151|FG004|Overall Study|Progressive Disease|13|||
162609258|NCT01975831|587286152|FG005|Overall Study|Progressive Disease|9|||
162609259|NCT01975831|587286153|FG006|Overall Study|Progressive Disease|10|||
162609260|NCT01975831|587286154|FG007|Overall Study|Progressive Disease|8|||
162609261|NCT01975831|587286155|FG008|Overall Study|Progressive Disease|10|||
162609262|NCT01975831|587286147|FG000|Overall Study|Withdrawal by Subject|0|||
162609263|NCT01975831|587286148|FG001|Overall Study|Withdrawal by Subject|3|||
162609264|NCT01975831|587286149|FG002|Overall Study|Withdrawal by Subject|0|||
162609265|NCT01975831|587286150|FG003|Overall Study|Withdrawal by Subject|0|||
162609266|NCT01975831|587286151|FG004|Overall Study|Withdrawal by Subject|3|||
162609267|NCT01975831|587286152|FG005|Overall Study|Withdrawal by Subject|1|||
162609268|NCT01975831|587286153|FG006|Overall Study|Withdrawal by Subject|1|||
162609269|NCT01975831|587286154|FG007|Overall Study|Withdrawal by Subject|0|||
162609270|NCT01975831|587286155|FG008|Overall Study|Withdrawal by Subject|0|||
162609271|NCT01975831|587286147|FG000|Overall Study|Physician Decision|0|||
162609272|NCT01975831|587286148|FG001|Overall Study|Physician Decision|0|||
162609273|NCT01975831|587286149|FG002|Overall Study|Physician Decision|0|||
162609274|NCT01975831|587286150|FG003|Overall Study|Physician Decision|0|||
162609275|NCT01975831|587286151|FG004|Overall Study|Physician Decision|0|||
162609276|NCT01975831|587286152|FG005|Overall Study|Physician Decision|1|||
162609277|NCT01975831|587286153|FG006|Overall Study|Physician Decision|0|||
162609278|NCT01975831|587286154|FG007|Overall Study|Physician Decision|1|||
162609279|NCT01975831|587286155|FG008|Overall Study|Physician Decision|0|||
162609280|NCT01975831|587286147|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
162609281|NCT01975831|587286148|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
162609282|NCT01975831|587286149|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
162609283|NCT01975831|587286150|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
162609284|NCT01975831|587286151|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
162609285|NCT01975831|587286152|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
162609286|NCT01975831|587286153|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
162609287|NCT01975831|587286154|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
162609288|NCT01975831|587286155|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
162609289|NCT01975831|587286147|FG000|Overall Study|Entered Hospice|0|||
162609290|NCT01975831|587286148|FG001|Overall Study|Entered Hospice|0|||
162952085|NCT02422264|588529537|FG000|Overall Study|Migrated/moved from study area|3|||
162609291|NCT01975831|587286149|FG002|Overall Study|Entered Hospice|0|||
162609292|NCT01975831|587286150|FG003|Overall Study|Entered Hospice|0|||
162609293|NCT01975831|587286151|FG004|Overall Study|Entered Hospice|0|||
162609294|NCT01975831|587286152|FG005|Overall Study|Entered Hospice|1|||
162609295|NCT01975831|587286153|FG006|Overall Study|Entered Hospice|0|||
162609296|NCT01975831|587286154|FG007|Overall Study|Entered Hospice|0|||
162609297|NCT01975831|587286155|FG008|Overall Study|Entered Hospice|0|||
162609298|NCT01975831|587286147|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609299|NCT01975831|587286148|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609300|NCT01975831|587286149|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609301|NCT01975831|587286150|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609302|NCT01975831|587286151|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609303|NCT01975831|587286152|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609304|NCT01975831|587286153|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
162609305|NCT01975831|587286154|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
162609306|NCT01975831|587286155|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
162609307|NCT02925793|587286156|FG000|Overall Study|Adverse Event|3|||
162609308|NCT02925793|587286157|FG001|Overall Study|Adverse Event|3|||
162609309|NCT02925793|587286158|FG002|Overall Study|Adverse Event|6|||
162609310|NCT02925793|587286156|FG000|Overall Study|Withdrawal by Subject|16|||
162609311|NCT02925793|587286157|FG001|Overall Study|Withdrawal by Subject|15|||
162609312|NCT02925793|587286158|FG002|Overall Study|Withdrawal by Subject|13|||
162609313|NCT02925793|587286156|FG000|Overall Study|Investigator Discretion|0|||
162609314|NCT02925793|587286157|FG001|Overall Study|Investigator Discretion|1|||
162609315|NCT02925793|587286158|FG002|Overall Study|Investigator Discretion|1|||
162609316|NCT02925793|587286156|FG000|Overall Study|Lost to Follow-up|2|||
162609317|NCT02925793|587286157|FG001|Overall Study|Lost to Follow-up|3|||
162609318|NCT02925793|587286158|FG002|Overall Study|Lost to Follow-up|1|||
162609319|NCT02925793|587286156|FG000|Overall Study|Lack of Efficacy|2|||
162609320|NCT02925793|587286157|FG001|Overall Study|Lack of Efficacy|6|||
162609321|NCT02925793|587286158|FG002|Overall Study|Lack of Efficacy|4|||
162952086|NCT02422264|588529538|FG001|Overall Study|Migrated/moved from study area|1|||
162609322|NCT02925793|587286156|FG000|Overall Study|Other:|2|||
162609323|NCT02925793|587286157|FG001|Overall Study|Other:|1|||
162609324|NCT02925793|587286158|FG002|Overall Study|Other:|3|||
162609325|NCT00393042|587286161|FG000|First Intervention|Withdrawal by Subject|1|||
162609326|NCT00393042|587286162|FG001|First Intervention|Withdrawal by Subject|2|||
162609327|NCT00393042|587286161|FG000|First Intervention|Lost to Follow-up|3|||
162609328|NCT00393042|587286162|FG001|First Intervention|Lost to Follow-up|3|||
162609329|NCT00393042|587286161|FG000|First Intervention|Protocol Violation|1|||
162609330|NCT00393042|587286162|FG001|First Intervention|Protocol Violation|0|||
162609331|NCT00393042|587286161|FG000|First Intervention|Adverse Event|0|||
162609332|NCT00393042|587286162|FG001|First Intervention|Adverse Event|1|||
162609333|NCT00393042|587286161|FG000|Second Intervetion|Adverse Event|0|||
162609334|NCT00393042|587286162|FG001|Second Intervetion|Adverse Event|3|||
162609335|NCT00393042|587286161|FG000|Second Intervetion|Withdrawal by Subject|0|||
162609336|NCT00393042|587286162|FG001|Second Intervetion|Withdrawal by Subject|2|||
162609337|NCT00393042|587286161|FG000|Second Intervetion|Lack of Efficacy|1|||
162609338|NCT00393042|587286162|FG001|Second Intervetion|Lack of Efficacy|0|||
162609339|NCT00393042|587286161|FG000|Second Intervetion|Lost to Follow-up|0|||
162609340|NCT00393042|587286162|FG001|Second Intervetion|Lost to Follow-up|2|||
162609341|NCT00393042|587286161|FG000|Second Intervetion|Protocol Violation|1|||
162609342|NCT00393042|587286162|FG001|Second Intervetion|Protocol Violation|1|||
162609343|NCT03475875|587286163|FG000|Period 1|Lost to Follow-up|1|||
162609344|NCT03475875|587286164|FG001|Period 1|Lost to Follow-up|0|||
162609345|NCT03475875|587286163|FG000|Period 1|Adverse Event|2|||
162609346|NCT03475875|587286164|FG001|Period 1|Adverse Event|1|||
162609347|NCT03475875|587286163|FG000|Period 2|Adverse Event|3|||
162609348|NCT03475875|587286164|FG001|Period 2|Adverse Event|0|||
162609349|NCT03475875|587286163|FG000|Period 2|Protocol Violation|0|||
162609350|NCT03475875|587286164|FG001|Period 2|Protocol Violation|1|||
162609351|NCT01642407|587286168|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
162609352|NCT01642407|587286168|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
162609353|NCT01642407|587286168|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
162609354|NCT00256282|587286169|FG000|Overall Study|Disease progression, relapse during acti|12|||
162609355|NCT00256282|587286169|FG000|Overall Study|Adverse Event|3|||
162609356|NCT00256282|587286169|FG000|Overall Study|Physician Decision|1|||
162609357|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
162609358|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
162609359|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
162609360|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
162609361|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
162609362|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
162609363|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
162609364|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
162609365|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
162609366|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
162609367|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
162609368|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
162609369|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
162609370|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
162609371|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
162609372|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
162609373|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
162609374|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
162609375|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
162609376|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
162609377|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
162609378|NCT02431247|587286170|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
162609379|NCT02431247|587286171|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
162609380|NCT02431247|587286172|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
162609381|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162609382|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162609383|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
162609384|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162609385|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162609386|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
162609387|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162609388|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162609389|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
162609390|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162609391|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162609392|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
162609393|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162609394|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162609395|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
162609396|NCT02431247|587286170|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162609397|NCT02431247|587286171|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162609398|NCT02431247|587286172|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
162609399|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
162609400|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
162609401|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Other|2|||
162609402|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Other|2|||
162609403|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Personal reasons|2|||
162609404|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Personal reasons|2|||
162609405|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
162609406|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
162609407|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
162609408|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
162609409|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
162609410|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
162609411|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
162609412|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
162609413|NCT00667446|587286173|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
162609414|NCT00667446|587286174|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
162609415|NCT00667446|587286173|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
162609416|NCT00667446|587286174|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
162609417|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
162609418|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
162609419|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
162609420|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
162609421|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
162609422|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
162609423|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
162609424|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
162609425|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
162609426|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162609427|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162702975|NCT02611830|587623486|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
162702976|NCT02611830|587623487|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
162702977|NCT02611830|587623488|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
162702978|NCT02611830|587623485|FG000|Maintenance Phase|Pregnancy|0|||
162702979|NCT02611830|587623486|FG001|Maintenance Phase|Pregnancy|0|||
162702980|NCT02611830|587623487|FG002|Maintenance Phase|Pregnancy|1|||
162702981|NCT02611830|587623488|FG003|Maintenance Phase|Pregnancy|0|||
162702982|NCT02611830|587623485|FG000|Maintenance Phase|Reason not specified|0|||
162702983|NCT02611830|587623486|FG001|Maintenance Phase|Reason not specified|1|||
162702984|NCT02611830|587623487|FG002|Maintenance Phase|Reason not specified|4|||
162702985|NCT02611830|587623488|FG003|Maintenance Phase|Reason not specified|0|||
162702986|NCT01513967|587623502|FG000|Overall Study|Pregnancy|0|||
162609428|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162702987|NCT01513967|587623503|FG001|Overall Study|Pregnancy|0|||
162702988|NCT01513967|587623504|FG002|Overall Study|Pregnancy|0|||
162702989|NCT01513967|587623505|FG003|Overall Study|Pregnancy|0|||
162702990|NCT01513967|587623506|FG004|Overall Study|Pregnancy|0|||
162702991|NCT01513967|587623507|FG005|Overall Study|Pregnancy|0|||
162609429|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
162609430|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
162609431|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
162702992|NCT01513967|587623508|FG006|Overall Study|Pregnancy|1|||
162702993|NCT01513967|587623509|FG007|Overall Study|Pregnancy|0|||
162702994|NCT01513967|587623502|FG000|Overall Study|missed a study visit|0|||
162702995|NCT01513967|587623503|FG001|Overall Study|missed a study visit|0|||
162609432|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
162609433|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
162609434|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
162609435|NCT00591578|587286176|FG000|Double-Blind Treatment Phase|Other|4|||
162609436|NCT00591578|587286177|FG001|Double-Blind Treatment Phase|Other|9|||
162609437|NCT00591578|587286178|FG002|Double-Blind Treatment Phase|Other|4|||
162609438|NCT00591578|587286176|FG000|Open-Label Extension Phase|Adverse Event|3|||
162609439|NCT00591578|587286177|FG001|Open-Label Extension Phase|Adverse Event|5|||
162609440|NCT00591578|587286178|FG002|Open-Label Extension Phase|Adverse Event|0|||
162609441|NCT00591578|587286176|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
162609442|NCT00591578|587286177|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
162609443|NCT00591578|587286178|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162609444|NCT00591578|587286176|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
162609445|NCT00591578|587286177|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
162609446|NCT00591578|587286178|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162609447|NCT00591578|587286176|FG000|Open-Label Extension Phase|Other|1|||
162609448|NCT00591578|587286177|FG001|Open-Label Extension Phase|Other|0|||
162609449|NCT00591578|587286178|FG002|Open-Label Extension Phase|Other|0|||
162609450|NCT03631355|587286179|FG000|Overall Study|Lost to Follow-up|1|||
162609451|NCT03631355|587286180|FG001|Overall Study|Lost to Follow-up|2|||
162609452|NCT02810340|587286181|FG000|Overall Study|Withdrawal by Subject|1|||
162609453|NCT02810340|587286182|FG001|Overall Study|Withdrawal by Subject|0|||
162609454|NCT02810340|587286183|FG002|Overall Study|Withdrawal by Subject|0|||
162609455|NCT02810340|587286181|FG000|Overall Study|Incarceration|0|||
162609456|NCT02810340|587286182|FG001|Overall Study|Incarceration|1|||
162609457|NCT02810340|587286183|FG002|Overall Study|Incarceration|0|||
162609458|NCT02810340|587286181|FG000|Overall Study|Lost to Follow-up|0|||
162609459|NCT02810340|587286182|FG001|Overall Study|Lost to Follow-up|0|||
162609460|NCT02810340|587286183|FG002|Overall Study|Lost to Follow-up|1|||
162609461|NCT01307020|587286194|FG000|Overall Study|Lost to Follow-up|0|||
162609462|NCT01307020|587286195|FG001|Overall Study|Lost to Follow-up|0|||
162609463|NCT01307020|587286196|FG002|Overall Study|Lost to Follow-up|1|||
162609464|NCT01307020|587286197|FG003|Overall Study|Lost to Follow-up|1|||
162609465|NCT01307020|587286198|FG004|Overall Study|Lost to Follow-up|0|||
162609466|NCT01307020|587286199|FG005|Overall Study|Lost to Follow-up|0|||
162609467|NCT01307020|587286200|FG006|Overall Study|Lost to Follow-up|1|||
162609468|NCT01307020|587286201|FG007|Overall Study|Lost to Follow-up|0|||
162609469|NCT01307020|587286202|FG008|Overall Study|Lost to Follow-up|0|||
162609470|NCT01307020|587286203|FG009|Overall Study|Lost to Follow-up|0|||
162609471|NCT01307020|587286194|FG000|Overall Study|Electronic data capture failure|0|||
162609472|NCT01307020|587286195|FG001|Overall Study|Electronic data capture failure|1|||
162609473|NCT01307020|587286196|FG002|Overall Study|Electronic data capture failure|0|||
162609474|NCT01307020|587286197|FG003|Overall Study|Electronic data capture failure|0|||
162609475|NCT01307020|587286198|FG004|Overall Study|Electronic data capture failure|0|||
162609476|NCT01307020|587286199|FG005|Overall Study|Electronic data capture failure|0|||
162609477|NCT01307020|587286200|FG006|Overall Study|Electronic data capture failure|0|||
162609478|NCT01307020|587286201|FG007|Overall Study|Electronic data capture failure|0|||
162609479|NCT01307020|587286202|FG008|Overall Study|Electronic data capture failure|0|||
162609480|NCT01307020|587286203|FG009|Overall Study|Electronic data capture failure|0|||
162609481|NCT02125604|587286204|FG000|Overall Study|Other|4|||
162609482|NCT02125604|587286204|FG000|Overall Study|Investigator Decision|1|||
162609483|NCT02125604|587286204|FG000|Overall Study|Lost to Follow-up|2|||
162609484|NCT02125604|587286204|FG000|Overall Study|Consent Withdrawn|4|||
162609485|NCT02125604|587286204|FG000|Overall Study|Adverse Event|20|||
162609486|NCT00782795|587286207|FG000|Overall Study|Withdrawal by Subject|1|||
162609487|NCT00782795|587286208|FG001|Overall Study|Withdrawal by Subject|2|||
162609488|NCT04480424|587286209|FG000|Overall Study|Withdrawal by Subject|0|||
162609489|NCT04480424|587286210|FG001|Overall Study|Withdrawal by Subject|2|||
162609490|NCT04480424|587286209|FG000|Overall Study|Lost to Follow-up|3|||
162609491|NCT04480424|587286210|FG001|Overall Study|Lost to Follow-up|3|||
162609492|NCT04480424|587286209|FG000|Overall Study|Death|14|||
162609493|NCT04480424|587286210|FG001|Overall Study|Death|16|||
162609494|NCT04480424|587286209|FG000|Overall Study|Reason not Specified|5|||
162609495|NCT04480424|587286210|FG001|Overall Study|Reason not Specified|5|||
162609496|NCT01897714|587287872|FG000|Phase I (Dose Escalation)|Disease progression|3|||
162609497|NCT01897714|587287873|FG001|Phase I (Dose Escalation)|Disease progression|5|||
162609498|NCT01897714|587287874|FG002|Phase I (Dose Escalation)|Disease progression|1|||
162609499|NCT01897714|587287875|FG003|Phase I (Dose Escalation)|Disease progression|3|||
162609500|NCT01897714|587287876|FG004|Phase I (Dose Escalation)|Disease progression|0|||
162609501|NCT01897714|587287877|FG005|Phase I (Dose Escalation)|Disease progression|0|||
162609502|NCT01897714|587287872|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
162609503|NCT01897714|587287873|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
162609504|NCT01897714|587287874|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
162609505|NCT01897714|587287875|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
162609506|NCT01897714|587287876|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
162609507|NCT01897714|587287877|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
162609508|NCT01897714|587287872|FG000|Phase I (Dose Escalation)|Other|0|||
162609509|NCT01897714|587287873|FG001|Phase I (Dose Escalation)|Other|1|||
162609510|NCT01897714|587287874|FG002|Phase I (Dose Escalation)|Other|0|||
162609511|NCT01897714|587287875|FG003|Phase I (Dose Escalation)|Other|0|||
162609512|NCT01897714|587287876|FG004|Phase I (Dose Escalation)|Other|0|||
162609513|NCT01897714|587287877|FG005|Phase I (Dose Escalation)|Other|0|||
162609514|NCT01897714|587287872|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
162609515|NCT01897714|587287873|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
162609516|NCT01897714|587287874|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
162609517|NCT01897714|587287875|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
162609518|NCT01897714|587287876|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
162609519|NCT01897714|587287877|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
162609520|NCT01897714|587287872|FG000|Phase II (MTD)|Lost to Follow-up|0|||
162609521|NCT01897714|587287873|FG001|Phase II (MTD)|Lost to Follow-up|0|||
162609522|NCT01897714|587287874|FG002|Phase II (MTD)|Lost to Follow-up|0|||
162609523|NCT01897714|587287875|FG003|Phase II (MTD)|Lost to Follow-up|0|||
162609524|NCT01897714|587287876|FG004|Phase II (MTD)|Lost to Follow-up|1|||
162609525|NCT01897714|587287877|FG005|Phase II (MTD)|Lost to Follow-up|0|||
162609526|NCT01897714|587287872|FG000|Phase II (MTD)|Death|0|||
162609527|NCT01897714|587287873|FG001|Phase II (MTD)|Death|0|||
162609528|NCT01897714|587287874|FG002|Phase II (MTD)|Death|0|||
162609529|NCT01897714|587287875|FG003|Phase II (MTD)|Death|0|||
162609530|NCT01897714|587287876|FG004|Phase II (MTD)|Death|25|||
162609531|NCT01897714|587287877|FG005|Phase II (MTD)|Death|10|||
162609532|NCT01897714|587287872|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
162609533|NCT01897714|587287873|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
162609534|NCT01897714|587287874|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
162609535|NCT01897714|587287875|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
162609536|NCT01897714|587287876|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
162609537|NCT01897714|587287877|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
162609538|NCT01897714|587287872|FG000|Phase II (MTD)|Other|0|||
162609539|NCT01897714|587287873|FG001|Phase II (MTD)|Other|0|||
162609540|NCT01897714|587287874|FG002|Phase II (MTD)|Other|0|||
162609541|NCT01897714|587287875|FG003|Phase II (MTD)|Other|0|||
162609542|NCT01897714|587287876|FG004|Phase II (MTD)|Other|3|||
162609543|NCT01897714|587287877|FG005|Phase II (MTD)|Other|0|||
162609544|NCT05828095|587287884|FG000|Overall Study|Lost to Follow-up|1|||
162609545|NCT05828095|587287885|FG001|Overall Study|Lost to Follow-up|0|||
162609546|NCT05828095|587287884|FG000|Overall Study|Reactogenicity symptom|0|||
162609547|NCT05828095|587287885|FG001|Overall Study|Reactogenicity symptom|1|||
162609548|NCT03206073|587287886|FG000|Overall Study|Participant Noncompliance|0|||
162609549|NCT03206073|587287887|FG001|Overall Study|Participant Noncompliance|1|||
162609550|NCT03206073|587287888|FG002|Overall Study|Participant Noncompliance|0|||
162609551|NCT03206073|587287889|FG003|Overall Study|Participant Noncompliance|0|||
162609552|NCT03206073|587287886|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
162609553|NCT03206073|587287887|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162609554|NCT03206073|587287888|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162609555|NCT03206073|587287889|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162609556|NCT03206073|587287886|FG000|Overall Study|Death|0|||
162609557|NCT03206073|587287887|FG001|Overall Study|Death|0|||
162609558|NCT03206073|587287888|FG002|Overall Study|Death|1|||
162702996|NCT01513967|587623504|FG002|Overall Study|missed a study visit|0|||
162702997|NCT01513967|587623505|FG003|Overall Study|missed a study visit|0|||
162702998|NCT01513967|587623506|FG004|Overall Study|missed a study visit|0|||
162702999|NCT01513967|587623507|FG005|Overall Study|missed a study visit|0|||
162703000|NCT01513967|587623508|FG006|Overall Study|missed a study visit|1|||
162703001|NCT01513967|587623509|FG007|Overall Study|missed a study visit|0|||
162703002|NCT01513967|587623502|FG000|Overall Study|excluded due to positive drug screen|0|||
162703003|NCT01513967|587623503|FG001|Overall Study|excluded due to positive drug screen|0|||
162703004|NCT01513967|587623504|FG002|Overall Study|excluded due to positive drug screen|0|||
162703005|NCT01513967|587623505|FG003|Overall Study|excluded due to positive drug screen|0|||
162952087|NCT02422264|588529537|FG000|Overall Study|Subject vaccinated outside of the study|0|||
162609559|NCT03206073|587287889|FG003|Overall Study|Death|0|||
162609560|NCT03206073|587287886|FG000|Overall Study|Taken off active treatment|0|||
162609561|NCT03206073|587287887|FG001|Overall Study|Taken off active treatment|0|||
162703006|NCT01513967|587623506|FG004|Overall Study|excluded due to positive drug screen|0|||
162609562|NCT03206073|587287888|FG002|Overall Study|Taken off active treatment|3|||
162609563|NCT03206073|587287889|FG003|Overall Study|Taken off active treatment|0|||
162609564|NCT05523323|587287890|FG000|Overall Study|Death|26|||
162609565|NCT05523323|587287891|FG001|Overall Study|Death|21|||
162609566|NCT05523323|587287890|FG000|Overall Study|Ongoing participants|35|||
162609567|NCT05523323|587287891|FG001|Overall Study|Ongoing participants|30|||
162609568|NCT02428608|587287896|FG000|Overall Study|Pregnancy|2|||
162609569|NCT02428608|587287896|FG000|Overall Study|Lost to Follow-up|37|||
162609570|NCT02428608|587287896|FG000|Overall Study|Withdrawal by Subject|2|||
162609571|NCT02428608|587287896|FG000|Overall Study|scheduling conflicts|15|||
162609572|NCT02428608|587287896|FG000|Overall Study|moved away|10|||
162609573|NCT02428608|587287896|FG000|Overall Study|Death|1|||
162609574|NCT02428608|587287896|FG000|Overall Study|various|16|||
162609575|NCT00397943|587287897|FG000|Overall Study|Unspecified reasons|12|||
162609576|NCT00397943|587287898|FG001|Overall Study|Unspecified reasons|9|||
162609577|NCT00397943|587287899|FG002|Overall Study|Unspecified reasons|0|||
162609578|NCT00397943|587287900|FG003|Overall Study|Unspecified reasons|0|||
162609579|NCT00397943|587287901|FG004|Overall Study|Unspecified reasons|0|||
162609580|NCT05007717|587287902|FG000|Overall Study|Death|3|||
162609581|NCT05007717|587287903|FG001|Overall Study|Death|2|||
162609582|NCT01117051|587287904|FG000|Overall Study|Withdrawal by Subject|5|||
162609583|NCT01117051|587287905|FG001|Overall Study|Withdrawal by Subject|3|||
162609584|NCT01117051|587287904|FG000|Overall Study|Adverse Event|4|||
162609585|NCT01117051|587287905|FG001|Overall Study|Adverse Event|3|||
162609586|NCT01117051|587287904|FG000|Overall Study|Lost to Follow-up|0|||
162609587|NCT01117051|587287905|FG001|Overall Study|Lost to Follow-up|1|||
162609588|NCT01117051|587287904|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
162609589|NCT01117051|587287905|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
162609590|NCT01117051|587287904|FG000|Overall Study|Sponsor's decision|3|||
162609591|NCT01117051|587287905|FG001|Overall Study|Sponsor's decision|1|||
162609592|NCT01117051|587287904|FG000|Overall Study|Surgical procedure|0|||
162609593|NCT01117051|587287905|FG001|Overall Study|Surgical procedure|1|||
162609594|NCT01117051|587287904|FG000|Overall Study|Randomized by mistake|0|||
162609595|NCT01117051|587287905|FG001|Overall Study|Randomized by mistake|1|||
162609596|NCT01117051|587287904|FG000|Overall Study|Convenience issue|1|||
162609597|NCT01117051|587287905|FG001|Overall Study|Convenience issue|0|||
162609598|NCT00206076|587287906|FG000|Overall Study|Physician Decision|2|||
162609599|NCT00206076|587287907|FG001|Overall Study|Physician Decision|0|||
162609600|NCT00206076|587287906|FG000|Overall Study|Withdrawal by Subject|1|||
162609601|NCT00206076|587287907|FG001|Overall Study|Withdrawal by Subject|1|||
162609602|NCT00427960|587287908|FG000|Overall Study|Adverse Event|2|||
162609603|NCT00427960|587287909|FG001|Overall Study|Adverse Event|0|||
162609604|NCT00427960|587287908|FG000|Overall Study|Withdrawal by Subject|0|||
162609605|NCT00427960|587287909|FG001|Overall Study|Withdrawal by Subject|3|||
162609606|NCT00427960|587287908|FG000|Overall Study|Other|0|||
162609607|NCT00427960|587287909|FG001|Overall Study|Other|1|||
162609608|NCT01142128|587287910|FG000|Overall Study|Physician Decision|1|||
162609609|NCT01142128|587287910|FG000|Overall Study|Lost to Follow-up|1|||
162609610|NCT01142128|587287910|FG000|Overall Study|Withdrawal by Subject|2|||
162609611|NCT03355664|587287911|FG000|Overall Study|Adverse Event|1|||
162609612|NCT03355664|587287912|FG001|Overall Study|Adverse Event|2|||
162609613|NCT03355664|587287911|FG000|Overall Study|Lost to Follow-up|11|||
162609614|NCT03355664|587287912|FG001|Overall Study|Lost to Follow-up|7|||
162609615|NCT03355664|587287911|FG000|Overall Study|Protocol Violation|1|||
162609616|NCT03355664|587287912|FG001|Overall Study|Protocol Violation|2|||
162609617|NCT03355664|587287911|FG000|Overall Study|Withdrawal by Subject|2|||
162609618|NCT03355664|587287912|FG001|Overall Study|Withdrawal by Subject|1|||
162609619|NCT02821910|587287916|FG000|Overall Study|Withdrawal by Subject|0|||
162609620|NCT02821910|587287917|FG001|Overall Study|Withdrawal by Subject|0|||
162609621|NCT02821910|587287918|FG002|Overall Study|Withdrawal by Subject|1|||
162609622|NCT02821910|587287919|FG003|Overall Study|Withdrawal by Subject|0|||
162609623|NCT02821910|587287920|FG004|Overall Study|Withdrawal by Subject|0|||
162609624|NCT02821910|587287921|FG005|Overall Study|Withdrawal by Subject|1|||
162609625|NCT02821910|587287916|FG000|Overall Study|Other than specified|1|||
162609626|NCT02821910|587287917|FG001|Overall Study|Other than specified|0|||
162609627|NCT02821910|587287918|FG002|Overall Study|Other than specified|1|||
162609628|NCT02821910|587287919|FG003|Overall Study|Other than specified|0|||
162609629|NCT02821910|587287920|FG004|Overall Study|Other than specified|0|||
162609630|NCT02821910|587287921|FG005|Overall Study|Other than specified|0|||
162609631|NCT00423670|587287922|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
162609632|NCT00423670|587287923|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609633|NCT00423670|587287924|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609634|NCT00423670|587287925|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609635|NCT00423670|587287926|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609636|NCT00423670|587287927|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609637|NCT00423670|587287928|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609638|NCT00423670|587287929|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
162609639|NCT00423670|587287922|FG000|Treatment Period|Adverse Event|8|||
162609640|NCT00423670|587287923|FG001|Treatment Period|Adverse Event|12|||
162609641|NCT00423670|587287924|FG002|Treatment Period|Adverse Event|15|||
162609642|NCT00423670|587287925|FG003|Treatment Period|Adverse Event|20|||
162609643|NCT00423670|587287926|FG004|Treatment Period|Adverse Event|9|||
162609644|NCT00423670|587287927|FG005|Treatment Period|Adverse Event|4|||
162609645|NCT00423670|587287928|FG006|Treatment Period|Adverse Event|7|||
162609646|NCT00423670|587287929|FG007|Treatment Period|Adverse Event|2|||
162609647|NCT00423670|587287922|FG000|Treatment Period|Protocol-defined clinical event|0|||
162609648|NCT00423670|587287923|FG001|Treatment Period|Protocol-defined clinical event|7|||
162609649|NCT00423670|587287924|FG002|Treatment Period|Protocol-defined clinical event|4|||
162609650|NCT00423670|587287925|FG003|Treatment Period|Protocol-defined clinical event|12|||
162609651|NCT00423670|587287926|FG004|Treatment Period|Protocol-defined clinical event|5|||
162609652|NCT00423670|587287927|FG005|Treatment Period|Protocol-defined clinical event|4|||
162609653|NCT00423670|587287928|FG006|Treatment Period|Protocol-defined clinical event|16|||
162609654|NCT00423670|587287929|FG007|Treatment Period|Protocol-defined clinical event|15|||
162609655|NCT00423670|587287922|FG000|Treatment Period|Lost to Follow-up|2|||
162609656|NCT00423670|587287923|FG001|Treatment Period|Lost to Follow-up|1|||
162609657|NCT00423670|587287924|FG002|Treatment Period|Lost to Follow-up|3|||
162609658|NCT00423670|587287925|FG003|Treatment Period|Lost to Follow-up|1|||
162609659|NCT00423670|587287926|FG004|Treatment Period|Lost to Follow-up|6|||
162609660|NCT00423670|587287927|FG005|Treatment Period|Lost to Follow-up|0|||
162609661|NCT00423670|587287928|FG006|Treatment Period|Lost to Follow-up|3|||
162609662|NCT00423670|587287929|FG007|Treatment Period|Lost to Follow-up|1|||
162609663|NCT00423670|587287922|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
162609664|NCT00423670|587287923|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
162609665|NCT00423670|587287924|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
162609666|NCT00423670|587287925|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
162609667|NCT00423670|587287926|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
162609668|NCT00423670|587287927|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
162609669|NCT00423670|587287928|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
162609670|NCT00423670|587287929|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
162609671|NCT00423670|587287922|FG000|Treatment Period|Investigator decision|0|||
162609672|NCT00423670|587287923|FG001|Treatment Period|Investigator decision|0|||
162609673|NCT00423670|587287924|FG002|Treatment Period|Investigator decision|0|||
162609674|NCT00423670|587287925|FG003|Treatment Period|Investigator decision|0|||
162609675|NCT00423670|587287926|FG004|Treatment Period|Investigator decision|0|||
162609676|NCT00423670|587287927|FG005|Treatment Period|Investigator decision|0|||
162609677|NCT00423670|587287928|FG006|Treatment Period|Investigator decision|0|||
162609678|NCT00423670|587287929|FG007|Treatment Period|Investigator decision|1|||
162609679|NCT00423670|587287922|FG000|Treatment Period|Non-compliance with protocol|3|||
162609680|NCT00423670|587287923|FG001|Treatment Period|Non-compliance with protocol|1|||
162609681|NCT00423670|587287924|FG002|Treatment Period|Non-compliance with protocol|1|||
162609682|NCT00423670|587287925|FG003|Treatment Period|Non-compliance with protocol|3|||
162609683|NCT00423670|587287926|FG004|Treatment Period|Non-compliance with protocol|2|||
162609684|NCT00423670|587287927|FG005|Treatment Period|Non-compliance with protocol|0|||
162609685|NCT00423670|587287928|FG006|Treatment Period|Non-compliance with protocol|2|||
162609686|NCT00423670|587287929|FG007|Treatment Period|Non-compliance with protocol|2|||
162609687|NCT00423670|587287922|FG000|Follow-up Period|Lost to Follow-up|0|||
162609688|NCT00423670|587287923|FG001|Follow-up Period|Lost to Follow-up|12|||
162609689|NCT00423670|587287924|FG002|Follow-up Period|Lost to Follow-up|8|||
162609690|NCT00423670|587287925|FG003|Follow-up Period|Lost to Follow-up|3|||
162609691|NCT00423670|587287926|FG004|Follow-up Period|Lost to Follow-up|1|||
162609692|NCT00423670|587287927|FG005|Follow-up Period|Lost to Follow-up|0|||
162609693|NCT00423670|587287928|FG006|Follow-up Period|Lost to Follow-up|5|||
162609694|NCT00423670|587287929|FG007|Follow-up Period|Lost to Follow-up|0|||
162609695|NCT00423670|587287922|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
162609696|NCT00423670|587287923|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
162609697|NCT00423670|587287924|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
162609698|NCT00423670|587287925|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
162609699|NCT00423670|587287926|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
163043231|NCT00110357|588865759|FG001|Overall Study|Withdrawal by Subject|1|||
163043232|NCT05285787|588865760|FG000|Overall Study|Withdrawal by Subject|1|||
163043233|NCT04004260|588865764|FG000|Overall Study|Withdrawal by Subject|7|||
162609700|NCT00423670|587287927|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
162609701|NCT00423670|587287928|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
162609702|NCT00423670|587287929|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
162609703|NCT00423670|587287922|FG000|Follow-up Period|Non-compliance with protocol|2|||
162609704|NCT00423670|587287923|FG001|Follow-up Period|Non-compliance with protocol|0|||
162609705|NCT00423670|587287924|FG002|Follow-up Period|Non-compliance with protocol|1|||
162609706|NCT00423670|587287925|FG003|Follow-up Period|Non-compliance with protocol|1|||
162609707|NCT00423670|587287926|FG004|Follow-up Period|Non-compliance with protocol|0|||
162609708|NCT00423670|587287927|FG005|Follow-up Period|Non-compliance with protocol|0|||
162609709|NCT00423670|587287928|FG006|Follow-up Period|Non-compliance with protocol|3|||
162609710|NCT00423670|587287929|FG007|Follow-up Period|Non-compliance with protocol|2|||
162609711|NCT00900601|587287930|FG000|Overall Study|Physician Decision|1|||
162609712|NCT02131532|587287931|FG000|Overall Study|Withdrawal by Subject|1|||
162609713|NCT02131532|587287931|FG000|Overall Study|Physician Decision|1|||
162609714|NCT02131532|587287931|FG000|Overall Study|Other health conditions|2|||
162609715|NCT01056380|587287932|FG000|Overall Study|Lost to Follow-up|2|||
162609716|NCT01056380|587287933|FG001|Overall Study|Lost to Follow-up|3|||
162609717|NCT03583073|587287934|FG000|Overall Study|Lost to Follow-up|8|||
162609718|NCT03583073|587287935|FG001|Overall Study|Lost to Follow-up|12|||
162609719|NCT02045303|587287936|FG000|Overall Study|Protocol Violation|2|||
162609720|NCT02045303|587287937|FG001|Overall Study|Protocol Violation|1|||
162609721|NCT02045303|587287938|FG002|Overall Study|Protocol Violation|0|||
162609722|NCT02045303|587287936|FG000|Overall Study|Withdrawal by Subject|0|||
162609723|NCT02045303|587287937|FG001|Overall Study|Withdrawal by Subject|2|||
162609724|NCT02045303|587287938|FG002|Overall Study|Withdrawal by Subject|0|||
162609725|NCT01856023|587287939|FG000|Overall Study|Death|1|||
162609726|NCT01856023|587287940|FG001|Overall Study|Death|2|||
162609727|NCT01856023|587287939|FG000|Overall Study|Adverse Event|2|||
162609728|NCT01856023|587287940|FG001|Overall Study|Adverse Event|1|||
162609729|NCT01856023|587287939|FG000|Overall Study|Lack of Efficacy|5|||
162609730|NCT01856023|587287940|FG001|Overall Study|Lack of Efficacy|5|||
162609731|NCT01856023|587287939|FG000|Overall Study|non compliance, study closure|1|||
162609732|NCT01856023|587287940|FG001|Overall Study|non compliance, study closure|3|||
162609733|NCT01856023|587287939|FG000|Overall Study|Withdrawal by Subject|1|||
162609734|NCT01856023|587287940|FG001|Overall Study|Withdrawal by Subject|1|||
162609735|NCT00829283|587287941|FG000|Overall Study|Lost to Follow-up|7|||
162609736|NCT00829283|587287942|FG001|Overall Study|Lost to Follow-up|25|||
162609737|NCT00424255|587287943|FG000|Overall Study|Death|115|||
162609738|NCT00424255|587287944|FG001|Overall Study|Death|111|||
162609739|NCT00424255|587287943|FG000|Overall Study|Lost to Follow-up|26|||
162609740|NCT00424255|587287944|FG001|Overall Study|Lost to Follow-up|20|||
162609741|NCT00424255|587287943|FG000|Overall Study|Protocol Violation|0|||
162609742|NCT00424255|587287944|FG001|Overall Study|Protocol Violation|1|||
162609743|NCT00424255|587287943|FG000|Overall Study|Withdrawal by Subject|34|||
162609744|NCT00424255|587287944|FG001|Overall Study|Withdrawal by Subject|38|||
162609745|NCT00424255|587287943|FG000|Overall Study|Physician Decision|3|||
162609746|NCT00424255|587287944|FG001|Overall Study|Physician Decision|7|||
162609747|NCT00424255|587287943|FG000|Overall Study|Cognitive Disturbance|1|||
162609748|NCT00424255|587287944|FG001|Overall Study|Cognitive Disturbance|0|||
162609749|NCT00424255|587287943|FG000|Overall Study|Non-compliance by Participants|1|||
162609750|NCT00424255|587287944|FG001|Overall Study|Non-compliance by Participants|0|||
162609751|NCT00424255|587287943|FG000|Overall Study|Fatigue|1|||
162609752|NCT00424255|587287944|FG001|Overall Study|Fatigue|0|||
162609753|NCT00424255|587287943|FG000|Overall Study|Disease Progression|0|||
162609754|NCT00424255|587287944|FG001|Overall Study|Disease Progression|2|||
162609755|NCT00424255|587287943|FG000|Overall Study|Sponsor Terminated Study|161|||
162609756|NCT00424255|587287944|FG001|Overall Study|Sponsor Terminated Study|167|||
162609757|NCT03945175|587287945|FG000|Overall Study|Did not meet inclusion criteria|31|||
162609758|NCT03945175|587287945|FG000|Overall Study|Withdrew consent|2|||
162609759|NCT03945175|587287945|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
162609760|NCT03945175|587287945|FG000|Overall Study|Early termination during Mydayis treatment|1|||
162609761|NCT00870233|587287946|FG000|Overall Study|Withdrawal by Subject|18|||
162609762|NCT00870233|587287946|FG000|Overall Study|Did not undergo laparotomy|3|||
162609763|NCT00870233|587287946|FG000|Overall Study|Incompatible internet browser|2|||
162609764|NCT00870233|587287946|FG000|Overall Study|Death|1|||
162609765|NCT01369485|587287947|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
162609766|NCT01369485|587287948|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
162609767|NCT01369485|587287947|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
162609768|NCT01369485|587287948|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
162609769|NCT01369485|587287947|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
162609770|NCT01369485|587287948|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
162609771|NCT01369485|587287947|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
162609772|NCT01369485|587287948|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
162609773|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
162609774|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
162609775|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
162609776|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
162609777|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
162609778|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
162609779|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
162609780|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
162609781|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
162609782|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
162609783|NCT01369485|587287947|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
162609784|NCT01369485|587287948|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
162609785|NCT02942576|587287954|FG000|Overall Study|Adverse Event|28|||
162609786|NCT02942576|587287955|FG001|Overall Study|Adverse Event|6|||
162609787|NCT02942576|587287954|FG000|Overall Study|Withdrawal by Subject|7|||
162703007|NCT01513967|587623507|FG005|Overall Study|excluded due to positive drug screen|0|||
162703008|NCT01513967|587623508|FG006|Overall Study|excluded due to positive drug screen|0|||
162609788|NCT02942576|587287955|FG001|Overall Study|Withdrawal by Subject|5|||
162609789|NCT02942576|587287954|FG000|Overall Study|Physician Decision|1|||
162609790|NCT02942576|587287955|FG001|Overall Study|Physician Decision|4|||
162609791|NCT02942576|587287954|FG000|Overall Study|Other|10|||
162703009|NCT01513967|587623509|FG007|Overall Study|excluded due to positive drug screen|2|||
162703010|NCT01513967|587623502|FG000|Overall Study|Physician Decision|0|||
162703011|NCT01513967|587623503|FG001|Overall Study|Physician Decision|0|||
162703012|NCT01513967|587623504|FG002|Overall Study|Physician Decision|0|||
162703013|NCT01513967|587623505|FG003|Overall Study|Physician Decision|0|||
162703014|NCT01513967|587623506|FG004|Overall Study|Physician Decision|0|||
162703015|NCT01513967|587623507|FG005|Overall Study|Physician Decision|1|||
162703016|NCT01513967|587623508|FG006|Overall Study|Physician Decision|0|||
162703017|NCT01513967|587623509|FG007|Overall Study|Physician Decision|0|||
162703018|NCT05764239|587623512|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
162703019|NCT05764239|587623512|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
162703020|NCT05764239|587623512|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
162703021|NCT05764239|587623512|FG000|DEP (Part 1)|Adverse Event|1|||
162703022|NCT05764239|587623512|FG000|DEP (Part 1)|Lost to Follow-up|1|||
162703023|NCT05764239|587623512|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
162703024|NCT05764239|587623512|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
162703025|NCT05764239|587623512|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
162703026|NCT05764239|587623512|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
162703027|NCT00057811|587623516|FG000|Overall Study|Lack of Efficacy|1|||
162703028|NCT00057811|587623517|FG001|Overall Study|Lack of Efficacy|4|||
162703029|NCT00057811|587623516|FG000|Overall Study|Physician Decision|1|||
162703030|NCT00057811|587623517|FG001|Overall Study|Physician Decision|0|||
162703031|NCT00057811|587623516|FG000|Overall Study|Withdrawal by Subject|3|||
162703032|NCT00057811|587623517|FG001|Overall Study|Withdrawal by Subject|4|||
162703033|NCT00057811|587623516|FG000|Overall Study|Ineligible|4|||
162703034|NCT00057811|587623517|FG001|Overall Study|Ineligible|2|||
162703035|NCT00057811|587623516|FG000|Overall Study|Inevaluable|1|||
162703036|NCT00057811|587623517|FG001|Overall Study|Inevaluable|2|||
162703037|NCT00556374|587623518|FG000|Overall Study|Withdrawal by Subject|235|||
162703038|NCT00556374|587623519|FG001|Overall Study|Withdrawal by Subject|205|||
162703039|NCT00556374|587623518|FG000|Overall Study|Death|158|||
162703040|NCT00556374|587623519|FG001|Overall Study|Death|127|||
162703041|NCT00556374|587623518|FG000|Overall Study|Lost to Follow-up|24|||
162703042|NCT00556374|587623519|FG001|Overall Study|Lost to Follow-up|17|||
162703043|NCT00556374|587623518|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
162703044|NCT00556374|587623519|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
162703045|NCT04131907|587623520|FG000|Overall Study|Adverse Event|2|||
162703046|NCT04131907|587623521|FG001|Overall Study|Adverse Event|0|||
162703047|NCT04131907|587623522|FG002|Overall Study|Adverse Event|0|||
162703048|NCT04131907|587623520|FG000|Overall Study|Physician Decision|4|||
162703049|NCT04131907|587623521|FG001|Overall Study|Physician Decision|22|||
162703050|NCT04131907|587623522|FG002|Overall Study|Physician Decision|0|||
162703051|NCT04131907|587623520|FG000|Overall Study|Withdrawal by Subject|2|||
162703052|NCT04131907|587623521|FG001|Overall Study|Withdrawal by Subject|0|||
162703053|NCT04131907|587623522|FG002|Overall Study|Withdrawal by Subject|1|||
162703054|NCT04131907|587623520|FG000|Overall Study|Treatment failure|2|||
162609792|NCT02942576|587287955|FG001|Overall Study|Other|8|||
162609793|NCT00769483|587287956|FG000|Overall Study|Withdrawal by Subject|0|||
162609794|NCT00769483|587287957|FG001|Overall Study|Withdrawal by Subject|1|||
162703055|NCT04131907|587623521|FG001|Overall Study|Treatment failure|0|||
162703056|NCT04131907|587623522|FG002|Overall Study|Treatment failure|1|||
162703057|NCT05294419|587623523|FG000|Overall Study|Protocol Violation|4|||
162703058|NCT05294419|587623524|FG001|Overall Study|Protocol Violation|0|||
162703059|NCT05294419|587623525|FG002|Overall Study|Protocol Violation|0|||
162703060|NCT05294419|587623523|FG000|Overall Study|Lost to Follow-up|6|||
162703061|NCT05294419|587623524|FG001|Overall Study|Lost to Follow-up|0|||
162609795|NCT00769483|587287958|FG002|Overall Study|Withdrawal by Subject|0|||
162609796|NCT00769483|587287959|FG003|Overall Study|Withdrawal by Subject|0|||
162609797|NCT00769483|587287960|FG004|Overall Study|Withdrawal by Subject|1|||
162609798|NCT00769483|587287961|FG005|Overall Study|Withdrawal by Subject|0|||
162609799|NCT01306877|587287962|FG000|Overall Study|Lost to Follow-up|3|||
162609800|NCT01306877|587287963|FG001|Overall Study|Lost to Follow-up|3|||
162609801|NCT01306877|587287962|FG000|Overall Study|Physician Decision|0|||
162609802|NCT01306877|587287963|FG001|Overall Study|Physician Decision|1|||
162609803|NCT00006389|587287964|FG000|Overall Study|Adverse Event|1|||
162609804|NCT01285960|587287972|FG000|Overall Study|Withdrawal by Subject|2|||
162609805|NCT01285960|587287972|FG000|Overall Study|Lost to Follow-up|2|||
162609806|NCT01285960|587287972|FG000|Overall Study|2 subjects received less 10 sonications|2|||
162703062|NCT05294419|587623525|FG002|Overall Study|Lost to Follow-up|0|||
162703063|NCT05294419|587623523|FG000|Overall Study|Results voided after publishing|2|||
162609807|NCT01309308|587287973|FG000|Overall Study|Lost to Follow-up|6|||
162609808|NCT01309308|587287974|FG001|Overall Study|Lost to Follow-up|4|||
162609809|NCT00473746|587287975|FG000|Period 1 (Phase 1)|Adverse Event|1|||
162609810|NCT00473746|587287976|FG001|Period 1 (Phase 1)|Adverse Event|0|||
162609811|NCT00473746|587287977|FG002|Period 1 (Phase 1)|Adverse Event|0|||
162609812|NCT00473746|587287978|FG003|Period 1 (Phase 1)|Adverse Event|0|||
162609813|NCT00473746|587287979|FG004|Period 1 (Phase 1)|Adverse Event|0|||
162609814|NCT00473746|587287975|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162609815|NCT00473746|587287976|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
162609816|NCT00473746|587287977|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162609817|NCT00473746|587287978|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162609818|NCT00473746|587287979|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162609819|NCT00473746|587287975|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
162609820|NCT00473746|587287976|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
162609821|NCT00473746|587287977|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
162609822|NCT00473746|587287978|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
162609823|NCT00473746|587287979|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
162609824|NCT00473746|587287975|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162609825|NCT00473746|587287976|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
162609826|NCT00473746|587287977|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162609827|NCT00473746|587287978|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162609828|NCT00473746|587287979|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162609829|NCT00473746|587287975|FG000|Period 1 (Phase 1)|Reason not specified|0|||
162609830|NCT00473746|587287976|FG001|Period 1 (Phase 1)|Reason not specified|1|||
162609831|NCT00473746|587287977|FG002|Period 1 (Phase 1)|Reason not specified|0|||
162609832|NCT00473746|587287978|FG003|Period 1 (Phase 1)|Reason not specified|0|||
162609833|NCT00473746|587287979|FG004|Period 1 (Phase 1)|Reason not specified|0|||
162609834|NCT00473746|587287975|FG000|Period 2 (Phase 2)|Adverse Event|0|||
162609835|NCT00473746|587287976|FG001|Period 2 (Phase 2)|Adverse Event|0|||
162609836|NCT00473746|587287977|FG002|Period 2 (Phase 2)|Adverse Event|0|||
162609837|NCT00473746|587287978|FG003|Period 2 (Phase 2)|Adverse Event|0|||
162609838|NCT00473746|587287979|FG004|Period 2 (Phase 2)|Adverse Event|3|||
162609839|NCT00473746|587287975|FG000|Period 2 (Phase 2)|Death|0|||
162609840|NCT00473746|587287976|FG001|Period 2 (Phase 2)|Death|0|||
162609841|NCT00473746|587287977|FG002|Period 2 (Phase 2)|Death|0|||
162609842|NCT00473746|587287978|FG003|Period 2 (Phase 2)|Death|0|||
162609843|NCT00473746|587287979|FG004|Period 2 (Phase 2)|Death|1|||
162609844|NCT00473746|587287975|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
162609845|NCT00473746|587287976|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
162609846|NCT00473746|587287977|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
162609847|NCT00473746|587287978|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
162609848|NCT00473746|587287979|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
162609849|NCT00473746|587287975|FG000|Period 2 (Phase 2)|Reason not specified|0|||
162609850|NCT00473746|587287976|FG001|Period 2 (Phase 2)|Reason not specified|0|||
162609851|NCT00473746|587287977|FG002|Period 2 (Phase 2)|Reason not specified|0|||
162609852|NCT00473746|587287978|FG003|Period 2 (Phase 2)|Reason not specified|0|||
162609853|NCT00473746|587287979|FG004|Period 2 (Phase 2)|Reason not specified|3|||
162609854|NCT01017575|587287982|FG000|Overall Study|Lack of Efficacy|0|||
162609855|NCT01017575|587287983|FG001|Overall Study|Lack of Efficacy|1|||
162609856|NCT01017575|587287984|FG002|Overall Study|Lack of Efficacy|0|||
162703064|NCT05294419|587623524|FG001|Overall Study|Results voided after publishing|0|||
162703065|NCT05294419|587623525|FG002|Overall Study|Results voided after publishing|0|||
162703066|NCT00847301|587623526|FG000|Overall Study|Adverse Event|35|||
162609857|NCT01017575|587287985|FG003|Overall Study|Lack of Efficacy|1|||
162609858|NCT01017575|587287986|FG004|Overall Study|Lack of Efficacy|1|||
162609859|NCT01017575|587287982|FG000|Overall Study|Adverse Event|0|||
162609860|NCT01017575|587287983|FG001|Overall Study|Adverse Event|1|||
162609861|NCT01017575|587287984|FG002|Overall Study|Adverse Event|0|||
162609862|NCT01017575|587287985|FG003|Overall Study|Adverse Event|0|||
162609863|NCT01017575|587287986|FG004|Overall Study|Adverse Event|2|||
162609864|NCT01017575|587287982|FG000|Overall Study|Withdrawal by Subject|1|||
162609865|NCT01017575|587287983|FG001|Overall Study|Withdrawal by Subject|0|||
162609866|NCT01017575|587287984|FG002|Overall Study|Withdrawal by Subject|0|||
162703067|NCT00847301|587623526|FG000|Overall Study|Switch to other anticoagulants|16|||
162703068|NCT00847301|587623526|FG000|Overall Study|Lost to Follow-up|1|||
162703069|NCT00847301|587623526|FG000|Overall Study|No prescription after hospital discharge|1|||
162703070|NCT00847301|587623526|FG000|Overall Study|Other reason not defined above|1|||
162703071|NCT00442286|587623527|FG000|Overall Study|Death|2|||
162703072|NCT00442286|587623528|FG001|Overall Study|Death|2|||
162703073|NCT00442286|587623527|FG000|Overall Study|Lost to Follow-up|1|||
162703074|NCT00442286|587623528|FG001|Overall Study|Lost to Follow-up|0|||
162703075|NCT00442286|587623527|FG000|Overall Study|Withdrawal by Subject|2|||
162703076|NCT00442286|587623528|FG001|Overall Study|Withdrawal by Subject|0|||
162703077|NCT00442286|587623527|FG000|Overall Study|System explanted|1|||
162703078|NCT00442286|587623528|FG001|Overall Study|System explanted|0|||
162703079|NCT00442286|587623527|FG000|Overall Study|Patient Injury|1|||
162703080|NCT00442286|587623528|FG001|Overall Study|Patient Injury|0|||
162703081|NCT00641186|587623529|FG000|Overall Study|Adverse Event|3|||
162703082|NCT03428815|587623532|FG000|Overall Study|Lost to Follow-up|2|||
162703083|NCT03428815|587623533|FG001|Overall Study|Lost to Follow-up|2|||
162703084|NCT03428815|587623532|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
162703085|NCT03428815|587623533|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
162703086|NCT03428815|587623532|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
162703087|NCT03428815|587623533|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
162703088|NCT05221749|587623534|FG000|Overall Study|Lost to Follow-up|2|||
162703089|NCT05221749|587623535|FG001|Overall Study|Lost to Follow-up|3|||
162703090|NCT04140890|587623536|FG000|Overall Study|Withdrawal by Subject|0|||
162703091|NCT04140890|587623537|FG001|Overall Study|Withdrawal by Subject|1|||
162703092|NCT02404493|587623540|FG000|Overall Study|Adverse Event|1|||
162703093|NCT02404493|587623541|FG001|Overall Study|Adverse Event|1|||
162703094|NCT01700348|587623542|FG000|Overall Study|Withdrawal by Subject|22|||
162609867|NCT01017575|587287985|FG003|Overall Study|Withdrawal by Subject|0|||
162609868|NCT01017575|587287986|FG004|Overall Study|Withdrawal by Subject|0|||
162609869|NCT01962922|587287987|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
162609870|NCT01962922|587287988|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
162609871|NCT01962922|587287987|FG000|PK Portion Day 7|non-compliance|1|||
162609872|NCT01962922|587287988|FG001|PK Portion Day 7|non-compliance|0|||
162609873|NCT01962922|587287987|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
162609874|NCT01962922|587287988|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
162609875|NCT01962922|587287987|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
162609876|NCT01962922|587287988|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
162609877|NCT00976573|587287996|FG000|Overall Study|Ineligible|0|||
162609878|NCT00976573|587287997|FG001|Overall Study|Ineligible|1|||
162609879|NCT00976573|587287996|FG000|Overall Study|Cancel prior to receiving treatment|4|||
162609880|NCT00976573|587287997|FG001|Overall Study|Cancel prior to receiving treatment|2|||
162609881|NCT02730208|587287998|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162609882|NCT02730208|587287999|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
162609883|NCT00995865|587288004|FG000|Overall Study|Protocol Violation|2|||
162609884|NCT00995865|587288005|FG001|Overall Study|Protocol Violation|0|||
162609885|NCT00995865|587288006|FG002|Overall Study|Protocol Violation|0|||
162609886|NCT00995865|587288004|FG000|Overall Study|Lost to Follow-up|0|||
162609887|NCT00995865|587288005|FG001|Overall Study|Lost to Follow-up|0|||
162609888|NCT00995865|587288006|FG002|Overall Study|Lost to Follow-up|1|||
162609889|NCT02021656|587288011|FG000|Overall Study|Adverse Event|1|||
162609890|NCT02021656|587288011|FG000|Overall Study|Lack of Efficacy|2|||
162609891|NCT02021656|587288011|FG000|Overall Study|Lost to Follow-up|1|||
162609892|NCT02021656|587288011|FG000|Overall Study|Withdrew Consent|2|||
162609893|NCT00817479|587288014|FG000|Overall Study|Physician Decision|1|||
162609894|NCT00817479|587288015|FG001|Overall Study|Physician Decision|1|||
162609895|NCT05985980|587288018|FG000|Overall Study|Withdrawal by Subject|1|||
162609896|NCT05985980|587288018|FG000|Overall Study|Withdrawal by Subject|1|||
162609897|NCT05985980|587288018|FG000|Overall Study|Withdrawal by Subject|1|||
162609898|NCT05985980|587288018|FG000|Overall Study|Withdrawal by Subject|1|||
162609899|NCT02793128|587288019|FG000|Overall Study|Death|4|||
162703095|NCT01700348|587623542|FG000|Overall Study|Lost to Follow-up|1|||
162609900|NCT02793128|587288019|FG000|Overall Study|Withdrawal by Subject|2|||
162609901|NCT02793128|587288019|FG000|Overall Study|Physician Decision|1|||
162609902|NCT02793128|587288019|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
162703096|NCT02102464|587623543|FG000|Randomized Study|Withdrawal by Subject|0|||
162703097|NCT02102464|587623544|FG001|Randomized Study|Withdrawal by Subject|1|||
162703098|NCT02102464|587623545|FG002|Randomized Study|Withdrawal by Subject|0|||
162703099|NCT02388074|587623546|FG000|Overall Study|Lost in Transit|2|||
162848761|NCT05047523|588154672|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162609903|NCT02793128|587288019|FG000|Overall Study|Patient elected nephroureterectomy|1|||
162609904|NCT02359851|587288020|FG000|Overall Study|Death|1|||
162609905|NCT02359851|587288020|FG000|Overall Study|Disease progression|1|||
162609906|NCT00282347|587288021|FG000|Treatment Period|Death|2|||
162609907|NCT00282347|587288022|FG001|Treatment Period|Death|0|||
162609908|NCT00282347|587288021|FG000|Treatment Period|Lost to Follow-up|2|||
162848762|NCT05047523|588154673|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
162848763|NCT05047523|588154668|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
162848764|NCT05047523|588154669|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
162848765|NCT05047523|588154670|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
162848766|NCT05047523|588154671|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
162848767|NCT05047523|588154672|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
162848768|NCT05047523|588154673|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
162848769|NCT05047523|588154668|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
162848770|NCT05047523|588154669|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162848771|NCT05047523|588154670|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162848772|NCT05047523|588154671|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162703100|NCT02388074|587623546|FG000|Overall Study|Sample Not Returned|1|||
162703101|NCT01778062|587623549|FG000|Overall Study|Adverse Event|1|||
162703102|NCT01778062|587623550|FG001|Overall Study|Adverse Event|3|||
162609909|NCT00282347|587288022|FG001|Treatment Period|Lost to Follow-up|5|||
162609910|NCT00282347|587288021|FG000|Treatment Period|Withdrawal by Subject|1|||
162609911|NCT00282347|587288022|FG001|Treatment Period|Withdrawal by Subject|3|||
162609912|NCT00282347|587288021|FG000|Treatment Period|Physician Decision|0|||
162609913|NCT00282347|587288022|FG001|Treatment Period|Physician Decision|1|||
162609914|NCT00282347|587288021|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
162609915|NCT00282347|587288022|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
162609916|NCT00282347|587288021|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
162609917|NCT00282347|587288022|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
162609918|NCT00282347|587288021|FG000|Safety Follow-up Period|Physician Decision|1|||
162609919|NCT00282347|587288022|FG001|Safety Follow-up Period|Physician Decision|1|||
162609920|NCT00282347|587288021|FG000|Safety Follow-up Period|Protocol Deviation|0|||
162609921|NCT00282347|587288022|FG001|Safety Follow-up Period|Protocol Deviation|2|||
162848773|NCT05047523|588154672|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162848774|NCT05047523|588154673|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
162848775|NCT05047523|588154668|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
162848776|NCT05047523|588154669|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
162609922|NCT00282347|587288021|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
162609923|NCT00282347|587288022|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
162609924|NCT00282347|587288021|FG000|B Cell Follow-up Period|Physician Decision|1|||
162609925|NCT00282347|587288022|FG001|B Cell Follow-up Period|Physician Decision|0|||
162609926|NCT00282347|587288021|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
162609927|NCT00282347|587288022|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
162609928|NCT02101112|587288023|FG000|Overall Study|Adverse Event|0|||
162609929|NCT02101112|587288024|FG001|Overall Study|Adverse Event|0|||
162609930|NCT02101112|587288025|FG002|Overall Study|Adverse Event|1|||
162609931|NCT02101112|587288026|FG003|Overall Study|Adverse Event|0|||
162609932|NCT02101112|587288027|FG004|Overall Study|Adverse Event|0|||
162609933|NCT02101112|587288028|FG005|Overall Study|Adverse Event|0|||
162848777|NCT05047523|588154670|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
162848778|NCT05047523|588154671|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
162848779|NCT05047523|588154672|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
162848780|NCT05047523|588154673|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
162848781|NCT05047523|588154668|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
162848782|NCT05047523|588154669|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
162848783|NCT05047523|588154670|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
162848784|NCT05047523|588154671|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
162848785|NCT05047523|588154672|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
162848786|NCT05047523|588154673|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
162848787|NCT01805180|588154676|FG000|Lead-in Donor Phase|screen failure|1|||
162848788|NCT01805180|588154677|FG001|Lead-in Donor Phase|screen failure|0|||
162848789|NCT01805180|588154678|FG002|Lead-in Donor Phase|screen failure|0|||
162848790|NCT04684420|588154683|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162848791|NCT04684420|588154684|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162848792|NCT04684420|588154685|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
162848793|NCT04684420|588154686|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
162848794|NCT04684420|588154683|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
162848795|NCT04684420|588154684|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
162848796|NCT04684420|588154685|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
162848797|NCT04684420|588154686|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
162848798|NCT00463476|588154687|FG000|Overall Study|Withdrawal by Subject|1|||
162848799|NCT00463476|588154688|FG001|Overall Study|Withdrawal by Subject|2|||
162848800|NCT00463476|588154687|FG000|Overall Study|Lost to Follow-up|1|||
162848801|NCT00463476|588154688|FG001|Overall Study|Lost to Follow-up|1|||
162848802|NCT00928070|588154691|FG000|Overall Study|Lost to Follow-up|1|||
162848803|NCT00928070|588154692|FG001|Overall Study|Lost to Follow-up|2|||
162848804|NCT00928070|588154691|FG000|Overall Study|Withdrawal by Subject|10|||
162848805|NCT00928070|588154692|FG001|Overall Study|Withdrawal by Subject|3|||
162848806|NCT00928070|588154691|FG000|Overall Study|Adverse Event|14|||
162848807|NCT00928070|588154692|FG001|Overall Study|Adverse Event|26|||
162848808|NCT00928070|588154691|FG000|Overall Study|Lack of Efficacy|9|||
162848809|NCT00928070|588154692|FG001|Overall Study|Lack of Efficacy|5|||
162848810|NCT00928070|588154691|FG000|Overall Study|Did not meet entrance criteria|16|||
162848811|NCT00928070|588154692|FG001|Overall Study|Did not meet entrance criteria|9|||
162848812|NCT00928070|588154691|FG000|Overall Study|Protocol Violation|6|||
162848813|NCT00928070|588154692|FG001|Overall Study|Protocol Violation|5|||
162848814|NCT00928070|588154691|FG000|Overall Study|Randomized but not treated|2|||
162848815|NCT00928070|588154692|FG001|Overall Study|Randomized but not treated|2|||
162848816|NCT00928070|588154691|FG000|Overall Study|Other|5|||
162609934|NCT02101112|587288023|FG000|Overall Study|Withdrawal by Subject|0|||
162609935|NCT02101112|587288024|FG001|Overall Study|Withdrawal by Subject|0|||
162848817|NCT00928070|588154692|FG001|Overall Study|Other|5|||
162848818|NCT02690194|588154695|FG000|Overall Study|Withdrawal by Subject|1|||
162848819|NCT02690194|588154696|FG001|Overall Study|Withdrawal by Subject|4|||
162848820|NCT02690194|588154697|FG002|Overall Study|Withdrawal by Subject|0|||
162848821|NCT00624520|588154698|FG000|Overall Study|Withdrawal by Subject|12|||
162848822|NCT00624520|588154699|FG001|Overall Study|Withdrawal by Subject|7|||
162848823|NCT00624520|588154698|FG000|Overall Study|Death|0|||
162848824|NCT00624520|588154699|FG001|Overall Study|Death|1|||
162848825|NCT00556426|588154703|FG000|Overall Study|Withdrawal by Subject|3|||
162609936|NCT02101112|587288025|FG002|Overall Study|Withdrawal by Subject|0|||
162609937|NCT02101112|587288026|FG003|Overall Study|Withdrawal by Subject|0|||
162609938|NCT02101112|587288027|FG004|Overall Study|Withdrawal by Subject|1|||
162609939|NCT02101112|587288028|FG005|Overall Study|Withdrawal by Subject|0|||
162609940|NCT04340063|587288029|FG000|Overall Study|Withdrawal by Subject|1|||
162609941|NCT04340063|587288030|FG001|Overall Study|Withdrawal by Subject|2|||
162609942|NCT04340063|587288029|FG000|Overall Study|Lost to Follow-up|3|||
162609943|NCT04340063|587288030|FG001|Overall Study|Lost to Follow-up|1|||
162609944|NCT04340063|587288029|FG000|Overall Study|Protocol Violation|0|||
162609945|NCT04340063|587288030|FG001|Overall Study|Protocol Violation|1|||
162609946|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
162609947|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
162609948|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
162609949|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
162609950|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
162609951|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
162609952|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
162609953|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
162609954|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
162609955|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
162609956|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
162609957|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
162609958|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
162609959|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
162848826|NCT00556426|588154703|FG000|Overall Study|Death|6|||
162703103|NCT01778062|587623549|FG000|Overall Study|Consent Withdrawal|1|||
162703104|NCT01778062|587623550|FG001|Overall Study|Consent Withdrawal|5|||
162703105|NCT01778062|587623549|FG000|Overall Study|major protocol deviation|4|||
162703106|NCT01778062|587623550|FG001|Overall Study|major protocol deviation|3|||
162703107|NCT03958630|587623551|FG000|Overall Study|Withdrawal by Subject|0|||
162703108|NCT03958630|587623552|FG001|Overall Study|Withdrawal by Subject|0|||
162703109|NCT03958630|587623553|FG002|Overall Study|Withdrawal by Subject|1|||
162703110|NCT03958630|587623551|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
162703111|NCT03958630|587623552|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
162703112|NCT03958630|587623553|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
162703113|NCT03317379|587623563|FG000|Overall Study|Lost to Follow-up|0|||
162703114|NCT03317379|587623564|FG001|Overall Study|Lost to Follow-up|3|||
162703115|NCT03317379|587623565|FG002|Overall Study|Lost to Follow-up|2|||
162703116|NCT04445155|587623566|FG000|Overall Study|Lost to Follow-up|11|||
162703117|NCT04445155|587623567|FG001|Overall Study|Lost to Follow-up|2|||
162703118|NCT04445155|587623568|FG002|Overall Study|Lost to Follow-up|3|||
162703119|NCT04445155|587623569|FG003|Overall Study|Lost to Follow-up|0|||
162703120|NCT04445155|587623566|FG000|Overall Study|Withdrawal by Subject|8|||
162703121|NCT04445155|587623567|FG001|Overall Study|Withdrawal by Subject|0|||
162703122|NCT04445155|587623568|FG002|Overall Study|Withdrawal by Subject|0|||
162703123|NCT04445155|587623569|FG003|Overall Study|Withdrawal by Subject|0|||
162703124|NCT04445155|587623566|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
162703125|NCT04445155|587623567|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
162703126|NCT04445155|587623568|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
162703127|NCT04445155|587623569|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
162703128|NCT04445155|587623566|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
162703129|NCT04445155|587623567|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162703130|NCT04445155|587623568|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162703131|NCT04445155|587623569|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162703132|NCT04157686|587623570|FG000|Overall Study|Adverse Event|1|||
162703133|NCT04157686|587623571|FG001|Overall Study|Adverse Event|0|||
162703134|NCT04157686|587623572|FG002|Overall Study|Adverse Event|1|||
162703135|NCT04157686|587623573|FG003|Overall Study|Adverse Event|0|||
162703136|NCT04157686|587623574|FG004|Overall Study|Adverse Event|1|||
162703137|NCT04157686|587623575|FG005|Overall Study|Adverse Event|0|||
162703138|NCT04157686|587623576|FG006|Overall Study|Adverse Event|0|||
162703139|NCT04157686|587623577|FG007|Overall Study|Adverse Event|0|||
162703140|NCT04157686|587623570|FG000|Overall Study|Pregnancy|0|||
162703141|NCT04157686|587623571|FG001|Overall Study|Pregnancy|1|||
162703142|NCT04157686|587623572|FG002|Overall Study|Pregnancy|3|||
162703143|NCT04157686|587623573|FG003|Overall Study|Pregnancy|0|||
162703144|NCT04157686|587623574|FG004|Overall Study|Pregnancy|0|||
162703145|NCT04157686|587623575|FG005|Overall Study|Pregnancy|0|||
162703146|NCT04157686|587623576|FG006|Overall Study|Pregnancy|3|||
162703147|NCT04157686|587623577|FG007|Overall Study|Pregnancy|0|||
162703148|NCT04157686|587623570|FG000|Overall Study|Lost to Follow-up|1|||
162703149|NCT04157686|587623571|FG001|Overall Study|Lost to Follow-up|2|||
162703150|NCT04157686|587623572|FG002|Overall Study|Lost to Follow-up|8|||
162703151|NCT04157686|587623573|FG003|Overall Study|Lost to Follow-up|6|||
162703152|NCT04157686|587623574|FG004|Overall Study|Lost to Follow-up|6|||
162703153|NCT04157686|587623575|FG005|Overall Study|Lost to Follow-up|3|||
162703154|NCT04157686|587623576|FG006|Overall Study|Lost to Follow-up|7|||
162703155|NCT04157686|587623577|FG007|Overall Study|Lost to Follow-up|9|||
162703156|NCT04157686|587623570|FG000|Overall Study|Lack of Efficacy|0|||
162703157|NCT04157686|587623571|FG001|Overall Study|Lack of Efficacy|0|||
162703158|NCT04157686|587623572|FG002|Overall Study|Lack of Efficacy|0|||
162703159|NCT04157686|587623573|FG003|Overall Study|Lack of Efficacy|0|||
162703160|NCT04157686|587623574|FG004|Overall Study|Lack of Efficacy|0|||
162703161|NCT04157686|587623575|FG005|Overall Study|Lack of Efficacy|2|||
162703162|NCT04157686|587623576|FG006|Overall Study|Lack of Efficacy|0|||
162703163|NCT04157686|587623577|FG007|Overall Study|Lack of Efficacy|1|||
162703164|NCT04157686|587623570|FG000|Overall Study|Withdrawal by Subject|10|||
162703165|NCT04157686|587623571|FG001|Overall Study|Withdrawal by Subject|10|||
162703166|NCT04157686|587623572|FG002|Overall Study|Withdrawal by Subject|12|||
162703167|NCT04157686|587623573|FG003|Overall Study|Withdrawal by Subject|20|||
162703168|NCT04157686|587623574|FG004|Overall Study|Withdrawal by Subject|12|||
162703169|NCT04157686|587623575|FG005|Overall Study|Withdrawal by Subject|11|||
162703170|NCT04157686|587623576|FG006|Overall Study|Withdrawal by Subject|18|||
162703171|NCT04157686|587623577|FG007|Overall Study|Withdrawal by Subject|24|||
162703172|NCT04157686|587623570|FG000|Overall Study|Physician Decision|0|||
162703173|NCT04157686|587623571|FG001|Overall Study|Physician Decision|0|||
162703174|NCT04157686|587623572|FG002|Overall Study|Physician Decision|1|||
162703175|NCT04157686|587623573|FG003|Overall Study|Physician Decision|0|||
162703176|NCT04157686|587623574|FG004|Overall Study|Physician Decision|1|||
162703177|NCT04157686|587623575|FG005|Overall Study|Physician Decision|0|||
162703178|NCT04157686|587623576|FG006|Overall Study|Physician Decision|3|||
162848827|NCT01570244|588154707|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
162848828|NCT03486392|588154710|FG000|Overall Study|Lost to Follow-up|0|||
162848829|NCT03486392|588154711|FG001|Overall Study|Lost to Follow-up|0|||
162848830|NCT03486392|588154712|FG002|Overall Study|Lost to Follow-up|8|||
162703179|NCT04157686|587623577|FG007|Overall Study|Physician Decision|0|||
162703180|NCT04157686|587623570|FG000|Overall Study|Death|0|||
162703181|NCT04157686|587623571|FG001|Overall Study|Death|0|||
162703182|NCT04157686|587623572|FG002|Overall Study|Death|0|||
162703183|NCT04157686|587623573|FG003|Overall Study|Death|2|||
162703184|NCT04157686|587623574|FG004|Overall Study|Death|0|||
162703185|NCT04157686|587623575|FG005|Overall Study|Death|0|||
162703186|NCT04157686|587623576|FG006|Overall Study|Death|0|||
162703187|NCT04157686|587623577|FG007|Overall Study|Death|0|||
162703188|NCT04157686|587623570|FG000|Overall Study|Protocol Violation|0|||
162703189|NCT04157686|587623571|FG001|Overall Study|Protocol Violation|0|||
162703190|NCT04157686|587623572|FG002|Overall Study|Protocol Violation|0|||
162848831|NCT03486392|588154713|FG003|Overall Study|Lost to Follow-up|5|||
162848832|NCT03486392|588154714|FG004|Overall Study|Lost to Follow-up|2|||
162848833|NCT03486392|588154710|FG000|Overall Study|Withdrawal by Subject|3|||
162848834|NCT03486392|588154711|FG001|Overall Study|Withdrawal by Subject|0|||
162848835|NCT03486392|588154712|FG002|Overall Study|Withdrawal by Subject|6|||
162848836|NCT03486392|588154713|FG003|Overall Study|Withdrawal by Subject|4|||
162848837|NCT03486392|588154714|FG004|Overall Study|Withdrawal by Subject|1|||
162848838|NCT03486392|588154710|FG000|Overall Study|Death|0|||
162848839|NCT03486392|588154711|FG001|Overall Study|Death|0|||
162848840|NCT03486392|588154712|FG002|Overall Study|Death|0|||
162848841|NCT03486392|588154713|FG003|Overall Study|Death|0|||
162848842|NCT03486392|588154714|FG004|Overall Study|Death|1|||
162848843|NCT02347631|588154715|FG000|First Intervention (2 Months)|Adverse Event|1|||
162848844|NCT02347631|588154716|FG001|First Intervention (2 Months)|Adverse Event|1|||
162848845|NCT02347631|588154715|FG000|First Intervention (2 Months)|Pregnancy|1|||
162848846|NCT02347631|588154716|FG001|First Intervention (2 Months)|Pregnancy|0|||
162848847|NCT02347631|588154715|FG000|First Intervention (2 Months)|Moved out of area|0|||
162848848|NCT02347631|588154716|FG001|First Intervention (2 Months)|Moved out of area|2|||
162848849|NCT02347631|588154715|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
162848850|NCT02347631|588154716|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
162848851|NCT02347631|588154715|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
162848852|NCT02347631|588154716|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
162848853|NCT02347631|588154715|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
162848854|NCT02347631|588154716|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
162848855|NCT02347631|588154715|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
162848856|NCT02347631|588154716|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
162848857|NCT02347631|588154715|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
162848858|NCT02347631|588154716|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
162848859|NCT02304926|588154717|FG000|Overall Study|Lost to Follow-up|2|||
162848860|NCT02304926|588154718|FG001|Overall Study|Lost to Follow-up|1|||
162848861|NCT02076165|588154720|FG000|Overall Study|Lost to Follow-up|7|||
162848862|NCT02076165|588154721|FG001|Overall Study|Lost to Follow-up|5|||
162848863|NCT02076165|588154720|FG000|Overall Study|Refused follow-up assessment|1|||
162848864|NCT02076165|588154721|FG001|Overall Study|Refused follow-up assessment|1|||
162848865|NCT01950819|588154722|FG000|Overall Study|Graft Loss|35|||
162848866|NCT01950819|588154723|FG001|Overall Study|Graft Loss|30|||
162848867|NCT01950819|588154722|FG000|Overall Study|Death|29|||
162848868|NCT01950819|588154723|FG001|Overall Study|Death|34|||
162848869|NCT01950819|588154722|FG000|Overall Study|Subject / Gardian decision|54|||
162848870|NCT01950819|588154723|FG001|Overall Study|Subject / Gardian decision|51|||
162848871|NCT01950819|588154722|FG000|Overall Study|technical problems|2|||
162848872|NCT01950819|588154723|FG001|Overall Study|technical problems|0|||
162848873|NCT01950819|588154722|FG000|Overall Study|Pregnancy|0|||
162848874|NCT01950819|588154723|FG001|Overall Study|Pregnancy|2|||
162848875|NCT01950819|588154722|FG000|Overall Study|Lost to Follow-up|9|||
162848876|NCT01950819|588154723|FG001|Overall Study|Lost to Follow-up|17|||
162848877|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
162848878|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
162848879|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
162848880|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
162703191|NCT04157686|587623573|FG003|Overall Study|Protocol Violation|0|||
162703192|NCT04157686|587623574|FG004|Overall Study|Protocol Violation|1|||
162848881|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
162848882|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
162848883|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
162848884|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
162848885|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
162848886|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
162703193|NCT04157686|587623575|FG005|Overall Study|Protocol Violation|0|||
162703194|NCT04157686|587623576|FG006|Overall Study|Protocol Violation|0|||
162848887|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
162848888|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
162848889|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
162848890|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
162848891|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
162848892|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
162848893|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
162848894|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
162848895|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
162848896|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
162848897|NCT01360645|588154728|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
162703195|NCT04157686|587623577|FG007|Overall Study|Protocol Violation|0|||
162703196|NCT04157686|587623570|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
162703197|NCT04157686|587623571|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
162703198|NCT04157686|587623572|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
162609960|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
162609961|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
162609962|NCT00491556|587288031|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
162609963|NCT00491556|587288032|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
162609964|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
162609965|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
162848898|NCT01360645|588154729|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
162848899|NCT01360645|588154730|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
162848900|NCT01360645|588154731|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
162848901|NCT01360645|588154728|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
162848902|NCT01360645|588154729|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
162848903|NCT01360645|588154730|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
162848904|NCT01360645|588154731|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
162703199|NCT04157686|587623573|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
162703200|NCT04157686|587623574|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
162703201|NCT04157686|587623575|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
162703202|NCT04157686|587623576|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
162703203|NCT04157686|587623577|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
162703204|NCT01388543|587623579|FG000|Day 14|Adverse Event|1|||
162703205|NCT01388543|587623580|FG001|Day 14|Adverse Event|4|||
162703206|NCT03363659|587623581|FG000|Overall Study|Adverse Event|1|||
162703207|NCT03363659|587623581|FG000|Overall Study|Screen fail|1|||
162703208|NCT03363659|587623581|FG000|Overall Study|Withdrawal by Subject|1|||
162848905|NCT01360645|588154728|FG000|Phase B (6 Weeks)|Adverse Event|0|||
162848906|NCT01360645|588154729|FG001|Phase B (6 Weeks)|Adverse Event|6|||
162848907|NCT01360645|588154730|FG002|Phase B (6 Weeks)|Adverse Event|0|||
162848908|NCT01360645|588154731|FG003|Phase B (6 Weeks)|Adverse Event|0|||
162848909|NCT01360645|588154728|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162609966|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
162609967|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
162848910|NCT01360645|588154729|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
162848911|NCT01360645|588154730|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
162848912|NCT01360645|588154731|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
162848913|NCT01360645|588154728|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162848914|NCT01360645|588154729|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
162848915|NCT01360645|588154730|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
162848916|NCT01360645|588154731|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
162848917|NCT01360645|588154728|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
162848918|NCT01360645|588154729|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
162848919|NCT01360645|588154730|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
162848920|NCT01360645|588154731|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
162848921|NCT01360645|588154728|FG000|Phase A+|Lost to Follow-up|0|||
162848922|NCT01360645|588154729|FG001|Phase A+|Lost to Follow-up|0|||
162848923|NCT01360645|588154730|FG002|Phase A+|Lost to Follow-up|0|||
162848924|NCT01360645|588154731|FG003|Phase A+|Lost to Follow-up|7|||
162848925|NCT01360645|588154728|FG000|Phase A+|Adverse Event|0|||
162848926|NCT01360645|588154729|FG001|Phase A+|Adverse Event|0|||
162848927|NCT01360645|588154730|FG002|Phase A+|Adverse Event|0|||
162848928|NCT01360645|588154731|FG003|Phase A+|Adverse Event|2|||
162848929|NCT01360645|588154728|FG000|Phase A+|Met Withdrawal Criteria|0|||
162848930|NCT01360645|588154729|FG001|Phase A+|Met Withdrawal Criteria|0|||
162848931|NCT01360645|588154730|FG002|Phase A+|Met Withdrawal Criteria|0|||
162848932|NCT01360645|588154731|FG003|Phase A+|Met Withdrawal Criteria|4|||
162848933|NCT01360645|588154728|FG000|Phase A+|Physician Decision|0|||
162848934|NCT01360645|588154729|FG001|Phase A+|Physician Decision|0|||
162848935|NCT01360645|588154730|FG002|Phase A+|Physician Decision|0|||
162848936|NCT01360645|588154731|FG003|Phase A+|Physician Decision|2|||
162848937|NCT01360645|588154728|FG000|Phase A+|Withdrawal by Subject|0|||
162848938|NCT01360645|588154729|FG001|Phase A+|Withdrawal by Subject|0|||
162703209|NCT00904150|587623582|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
162703210|NCT00904150|587623583|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
162703211|NCT00904150|587623582|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
162848939|NCT01360645|588154730|FG002|Phase A+|Withdrawal by Subject|0|||
162848940|NCT01360645|588154731|FG003|Phase A+|Withdrawal by Subject|5|||
162848941|NCT01360645|588154728|FG000|Phase A+|Protocol Deviation|0|||
162848942|NCT01360645|588154729|FG001|Phase A+|Protocol Deviation|0|||
162703212|NCT00904150|587623583|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
162848943|NCT01360645|588154730|FG002|Phase A+|Protocol Deviation|0|||
162848944|NCT01360645|588154731|FG003|Phase A+|Protocol Deviation|4|||
162848945|NCT00713219|588154732|FG000|Overall Study|Death|1|||
162848946|NCT00713219|588154732|FG000|Overall Study|Protocol Violation|1|||
162848947|NCT02978222|588154733|FG000|Overall Study|Withdrawal by Subject|2|||
162848948|NCT02978222|588154734|FG001|Overall Study|Withdrawal by Subject|2|||
162848949|NCT02978222|588154733|FG000|Overall Study|Physician Decision|2|||
162848950|NCT02978222|588154734|FG001|Overall Study|Physician Decision|0|||
162848951|NCT02978222|588154733|FG000|Overall Study|Adverse Event|0|||
162848952|NCT02978222|588154734|FG001|Overall Study|Adverse Event|1|||
162848953|NCT02978222|588154733|FG000|Overall Study|Death|1|||
162848954|NCT02978222|588154734|FG001|Overall Study|Death|0|||
162848955|NCT02978222|588154733|FG000|Overall Study|Disease Progression|32|||
162848956|NCT02978222|588154734|FG001|Overall Study|Disease Progression|32|||
162848957|NCT02978222|588154733|FG000|Overall Study|Early Study Termination|24|||
162848958|NCT02978222|588154734|FG001|Overall Study|Early Study Termination|21|||
162848959|NCT03258814|588154735|FG000|Overall Study|Early Termination|4|||
162848960|NCT03258814|588154736|FG001|Overall Study|Early Termination|3|||
162848961|NCT03258814|588154737|FG002|Overall Study|Early Termination|10|||
162848962|NCT01413958|588154738|FG000|Overall Study|Lost to Follow-up|0|||
162848963|NCT01413958|588154739|FG001|Overall Study|Lost to Follow-up|1|||
162848964|NCT02908516|588154742|FG000|Overall Study|Study Terminated|3|||
162848965|NCT02908516|588154743|FG001|Overall Study|Study Terminated|3|||
162848966|NCT00348140|588154748|FG000|Overall Study|Adverse Event|46|||
162848967|NCT00348140|588154749|FG001|Overall Study|Adverse Event|49|||
162848968|NCT00348140|588154750|FG002|Overall Study|Adverse Event|78|||
162848969|NCT00348140|588154748|FG000|Overall Study|Lost to Follow-up|4|||
162848970|NCT00348140|588154749|FG001|Overall Study|Lost to Follow-up|4|||
162848971|NCT00348140|588154750|FG002|Overall Study|Lost to Follow-up|4|||
162848972|NCT00348140|588154748|FG000|Overall Study|Protocol Violation|12|||
162848973|NCT00348140|588154749|FG001|Overall Study|Protocol Violation|13|||
162848974|NCT00348140|588154750|FG002|Overall Study|Protocol Violation|14|||
162848975|NCT00348140|588154748|FG000|Overall Study|Withdrawal by Subject|32|||
162848976|NCT00348140|588154749|FG001|Overall Study|Withdrawal by Subject|40|||
162848977|NCT00348140|588154750|FG002|Overall Study|Withdrawal by Subject|40|||
162848978|NCT00348140|588154748|FG000|Overall Study|Non-compliance|8|||
162703213|NCT01671748|587623584|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
162703214|NCT01671748|587623585|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
162703215|NCT01671748|587623584|FG000|4 Week run-in Phase|Adverse Event|1|||
162703216|NCT01671748|587623585|FG001|4 Week run-in Phase|Adverse Event|0|||
162703217|NCT01671748|587623584|FG000|4 Week run-in Phase|Not eligible|9|||
162703218|NCT01671748|587623585|FG001|4 Week run-in Phase|Not eligible|0|||
162703219|NCT03872388|587623586|FG000|Overall Study|Disease Progression|0|||
162703220|NCT03872388|587623587|FG001|Overall Study|Disease Progression|0|||
162703221|NCT03872388|587623588|FG002|Overall Study|Disease Progression|0|||
162703222|NCT03872388|587623589|FG003|Overall Study|Disease Progression|0|||
162703223|NCT03872388|587623590|FG004|Overall Study|Disease Progression|0|||
162703224|NCT03872388|587623591|FG005|Overall Study|Disease Progression|0|||
162703225|NCT03872388|587623592|FG006|Overall Study|Disease Progression|1|||
162703226|NCT03872388|587623593|FG007|Overall Study|Disease Progression|1|||
162703227|NCT04191135|587623594|FG000|Induction Treatment|Not Treated|2|||
162703228|NCT04191135|587623595|FG001|Induction Treatment|Not Treated|0|||
162703229|NCT04191135|587623596|FG002|Induction Treatment|Not Treated|0|||
162703230|NCT04191135|587623594|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
162703231|NCT04191135|587623595|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
162703232|NCT04191135|587623596|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
162703233|NCT04191135|587623594|FG000|Induction Treatment|Adverse Event|25|||
162703234|NCT04191135|587623595|FG001|Induction Treatment|Adverse Event|0|||
162703235|NCT04191135|587623596|FG002|Induction Treatment|Adverse Event|0|||
162703236|NCT04191135|587623594|FG000|Induction Treatment|Clinical Progression|8|||
162703237|NCT04191135|587623595|FG001|Induction Treatment|Clinical Progression|0|||
162703238|NCT04191135|587623596|FG002|Induction Treatment|Clinical Progression|0|||
162703239|NCT04191135|587623594|FG000|Induction Treatment|Excluded Medication|1|||
162703240|NCT04191135|587623595|FG001|Induction Treatment|Excluded Medication|0|||
162703241|NCT04191135|587623596|FG002|Induction Treatment|Excluded Medication|0|||
162703242|NCT04191135|587623594|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
162848979|NCT00348140|588154749|FG001|Overall Study|Non-compliance|13|||
162703243|NCT04191135|587623595|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
162848980|NCT00348140|588154750|FG002|Overall Study|Non-compliance|5|||
162848981|NCT00348140|588154748|FG000|Overall Study|Participant at risk due to study drug|2|||
162848982|NCT00348140|588154749|FG001|Overall Study|Participant at risk due to study drug|0|||
162848983|NCT00348140|588154750|FG002|Overall Study|Participant at risk due to study drug|0|||
162848984|NCT00348140|588154748|FG000|Overall Study|Conditional medication increased dose|1|||
162848985|NCT00348140|588154749|FG001|Overall Study|Conditional medication increased dose|0|||
162848986|NCT00348140|588154750|FG002|Overall Study|Conditional medication increased dose|0|||
162703244|NCT04191135|587623596|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
162703245|NCT04191135|587623594|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
162703246|NCT04191135|587623595|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
162848987|NCT00348140|588154748|FG000|Overall Study|Caregiver related|4|||
162848988|NCT00348140|588154749|FG001|Overall Study|Caregiver related|7|||
162848989|NCT00348140|588154750|FG002|Overall Study|Caregiver related|3|||
162848990|NCT00348140|588154748|FG000|Overall Study|Participant hospitalised|3|||
162848991|NCT00348140|588154749|FG001|Overall Study|Participant hospitalised|0|||
162848992|NCT00348140|588154750|FG002|Overall Study|Participant hospitalised|0|||
162848993|NCT00348140|588154748|FG000|Overall Study|Efficacy related|1|||
162848994|NCT00348140|588154749|FG001|Overall Study|Efficacy related|1|||
162703247|NCT04191135|587623596|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
162703248|NCT04191135|587623594|FG000|Induction Treatment|Physician Decision|2|||
162703249|NCT04191135|587623595|FG001|Induction Treatment|Physician Decision|0|||
162703250|NCT04191135|587623596|FG002|Induction Treatment|Physician Decision|0|||
162609968|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
162609969|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
162609970|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
162609971|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
162609972|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
162609973|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
162609974|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
162609975|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
162609976|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
162609977|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
162609978|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
162609979|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
162609980|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
162609981|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
162609982|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
162609983|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
162609984|NCT00491556|587288031|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
162609985|NCT00491556|587288032|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
162609986|NCT00993044|587288033|FG000|Irinotecan 50 mg|Physician Decision|1|||
162848995|NCT00348140|588154750|FG002|Overall Study|Efficacy related|0|||
162848996|NCT00348140|588154748|FG000|Overall Study|Administration related|3|||
162609987|NCT00734747|587288034|FG000|SRS Procedure|No staples placed|3|||
162703251|NCT04191135|587623594|FG000|Induction Treatment|Progressive Disease|135|||
162703252|NCT04191135|587623595|FG001|Induction Treatment|Progressive Disease|0|||
162703253|NCT04191135|587623596|FG002|Induction Treatment|Progressive Disease|0|||
162703254|NCT04191135|587623594|FG000|Induction Treatment|Protocol Violation|10|||
162703255|NCT04191135|587623595|FG001|Induction Treatment|Protocol Violation|0|||
162703256|NCT04191135|587623596|FG002|Induction Treatment|Protocol Violation|0|||
162703257|NCT04191135|587623594|FG000|Induction Treatment|Withdrawal by Subject|4|||
162703258|NCT04191135|587623595|FG001|Induction Treatment|Withdrawal by Subject|0|||
162703259|NCT04191135|587623596|FG002|Induction Treatment|Withdrawal by Subject|0|||
162703260|NCT04191135|587623594|FG000|Randomized Treatment|Death|0|||
162703261|NCT04191135|587623595|FG001|Randomized Treatment|Death|50|||
162703262|NCT04191135|587623596|FG002|Randomized Treatment|Death|54|||
162703263|NCT04191135|587623594|FG000|Randomized Treatment|Lost to Follow-up|0|||
162703264|NCT04191135|587623595|FG001|Randomized Treatment|Lost to Follow-up|0|||
162703265|NCT04191135|587623596|FG002|Randomized Treatment|Lost to Follow-up|1|||
162703266|NCT04191135|587623594|FG000|Randomized Treatment|Withdrawal by Subject|0|||
162703267|NCT04191135|587623595|FG001|Randomized Treatment|Withdrawal by Subject|2|||
162703268|NCT04191135|587623596|FG002|Randomized Treatment|Withdrawal by Subject|0|||
162703269|NCT04191135|587623594|FG000|Randomized Treatment|Ongoing in Trial|0|||
162703270|NCT04191135|587623595|FG001|Randomized Treatment|Ongoing in Trial|83|||
162703271|NCT04191135|587623596|FG002|Randomized Treatment|Ongoing in Trial|81|||
162703272|NCT02107274|587625271|FG000|Treatment vs. Placebo|Adverse Event|3|||
162703273|NCT02107274|587625272|FG001|Treatment vs. Placebo|Adverse Event|0|||
162703274|NCT02107274|587625271|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
162703275|NCT02107274|587625272|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
162703276|NCT02107274|587625271|FG000|Control Phase|Lost to Follow-up|1|||
162609988|NCT00734747|587288034|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
162609989|NCT05063318|587288040|FG000|Overall Study|Progressive disease|2|||
162609990|NCT05063318|587288041|FG001|Overall Study|Progressive disease|0|||
162609991|NCT05063318|587288042|FG002|Overall Study|Progressive disease|3|||
162609992|NCT05063318|587288040|FG000|Overall Study|Compassionate use|1|||
162609993|NCT05063318|587288041|FG001|Overall Study|Compassionate use|3|||
162848997|NCT00348140|588154749|FG001|Overall Study|Administration related|1|||
162848998|NCT00348140|588154750|FG002|Overall Study|Administration related|1|||
162609994|NCT05063318|587288042|FG002|Overall Study|Compassionate use|3|||
162609995|NCT05063318|587288040|FG000|Overall Study|Adverse Event|0|||
162703277|NCT02107274|587625272|FG001|Control Phase|Lost to Follow-up|1|||
162703278|NCT02107274|587625271|FG000|Control Phase|Death|2|||
162703279|NCT02107274|587625272|FG001|Control Phase|Death|0|||
162703280|NCT02107274|587625271|FG000|Control Phase|Adverse Event|0|||
162703281|NCT02107274|587625272|FG001|Control Phase|Adverse Event|1|||
162848999|NCT00348140|588154748|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
162849000|NCT00348140|588154749|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
162849001|NCT00348140|588154750|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
162849002|NCT00348140|588154748|FG000|Overall Study|Participant unwell|1|||
162849003|NCT00348140|588154749|FG001|Overall Study|Participant unwell|0|||
162849004|NCT00348140|588154750|FG002|Overall Study|Participant unwell|0|||
162849005|NCT00348140|588154748|FG000|Overall Study|Screen failure|1|||
162849006|NCT00348140|588154749|FG001|Overall Study|Screen failure|0|||
162849007|NCT00348140|588154750|FG002|Overall Study|Screen failure|0|||
162849008|NCT00348140|588154748|FG000|Overall Study|Investigator decided to discontinue|4|||
162849009|NCT00348140|588154749|FG001|Overall Study|Investigator decided to discontinue|1|||
162849010|NCT00348140|588154750|FG002|Overall Study|Investigator decided to discontinue|4|||
162849011|NCT00348140|588154748|FG000|Overall Study|Decided to discontinue on their own|1|||
162849012|NCT00348140|588154749|FG001|Overall Study|Decided to discontinue on their own|4|||
162849013|NCT00348140|588154750|FG002|Overall Study|Decided to discontinue on their own|1|||
162849014|NCT00348140|588154748|FG000|Overall Study|Use of prohibited drug|1|||
162849015|NCT00348140|588154749|FG001|Overall Study|Use of prohibited drug|0|||
162849016|NCT00348140|588154750|FG002|Overall Study|Use of prohibited drug|2|||
162849017|NCT00348140|588154748|FG000|Overall Study|Disease progression|1|||
162849018|NCT00348140|588154749|FG001|Overall Study|Disease progression|2|||
162849019|NCT00348140|588154750|FG002|Overall Study|Disease progression|5|||
162849020|NCT00348140|588154748|FG000|Overall Study|Increased risk of cardiac infarction|0|||
162849021|NCT00348140|588154749|FG001|Overall Study|Increased risk of cardiac infarction|1|||
162849022|NCT00348140|588154750|FG002|Overall Study|Increased risk of cardiac infarction|0|||
162849023|NCT00348140|588154748|FG000|Overall Study|Serious adverse event|0|||
162849024|NCT00348140|588154749|FG001|Overall Study|Serious adverse event|1|||
162849025|NCT00348140|588154750|FG002|Overall Study|Serious adverse event|0|||
162849026|NCT00348140|588154748|FG000|Overall Study|Abnormal ECG|0|||
162849027|NCT00348140|588154749|FG001|Overall Study|Abnormal ECG|1|||
162849028|NCT00348140|588154750|FG002|Overall Study|Abnormal ECG|3|||
162849029|NCT00348140|588154748|FG000|Overall Study|Participant died|0|||
162609996|NCT05063318|587288041|FG001|Overall Study|Adverse Event|1|||
162609997|NCT05063318|587288042|FG002|Overall Study|Adverse Event|0|||
162609998|NCT05063318|587288040|FG000|Overall Study|Withdrawal by Subject|0|||
162609999|NCT05063318|587288041|FG001|Overall Study|Withdrawal by Subject|1|||
162610000|NCT05063318|587288042|FG002|Overall Study|Withdrawal by Subject|0|||
162610001|NCT03287635|587288043|FG000|Overall Study|Lost to Follow-up|5|||
162610002|NCT03287635|587288043|FG000|Overall Study|Withdrawal by Subject|1|||
162610003|NCT03287635|587288043|FG000|Overall Study|Physician Decision|1|||
162610004|NCT00920829|587289619|FG000|Allocation|No post randomization data|3|||
162610005|NCT00920829|587289620|FG001|Allocation|No post randomization data|1|||
162610006|NCT00920829|587289621|FG002|Allocation|No post randomization data|0|||
162610007|NCT00920829|587289622|FG003|Allocation|No post randomization data|2|||
162610008|NCT00920829|587289619|FG000|Available for Analysis|Withdrawal by Subject|6|||
162610009|NCT00920829|587289620|FG001|Available for Analysis|Withdrawal by Subject|6|||
162610010|NCT00920829|587289621|FG002|Available for Analysis|Withdrawal by Subject|6|||
162610011|NCT00920829|587289622|FG003|Available for Analysis|Withdrawal by Subject|10|||
162610012|NCT00920829|587289619|FG000|Available for Analysis|Required Medical Treatment|0|||
162610013|NCT00920829|587289620|FG001|Available for Analysis|Required Medical Treatment|1|||
162610014|NCT00920829|587289621|FG002|Available for Analysis|Required Medical Treatment|2|||
162610015|NCT00920829|587289622|FG003|Available for Analysis|Required Medical Treatment|0|||
162610016|NCT00920829|587289619|FG000|Available for Analysis|Adverse Event|1|||
162610017|NCT00920829|587289620|FG001|Available for Analysis|Adverse Event|2|||
162610018|NCT00920829|587289621|FG002|Available for Analysis|Adverse Event|1|||
162610019|NCT00920829|587289622|FG003|Available for Analysis|Adverse Event|0|||
162610020|NCT00920829|587289619|FG000|Available for Analysis|Death|1|||
162610021|NCT00920829|587289620|FG001|Available for Analysis|Death|0|||
162610022|NCT00920829|587289621|FG002|Available for Analysis|Death|0|||
162610023|NCT00920829|587289622|FG003|Available for Analysis|Death|0|||
162610024|NCT00920829|587289619|FG000|Available for Analysis|Protocol Violation|0|||
162610025|NCT00920829|587289620|FG001|Available for Analysis|Protocol Violation|0|||
162610026|NCT00920829|587289621|FG002|Available for Analysis|Protocol Violation|1|||
162610027|NCT00920829|587289622|FG003|Available for Analysis|Protocol Violation|0|||
162610028|NCT00920829|587289619|FG000|Available for Analysis|Required more treatment|0|||
162610029|NCT00920829|587289620|FG001|Available for Analysis|Required more treatment|2|||
162610030|NCT00920829|587289621|FG002|Available for Analysis|Required more treatment|0|||
162610031|NCT00920829|587289622|FG003|Available for Analysis|Required more treatment|1|||
162610032|NCT03875118|587289623|FG000|Overall Study|Withdrawal by Subject|4|||
162610033|NCT03875118|587289624|FG001|Overall Study|Withdrawal by Subject|4|||
162610034|NCT02237911|587289625|FG000|Overall Study|Withdrawal by Subject|4|||
162610035|NCT02237911|587289626|FG001|Overall Study|Withdrawal by Subject|7|||
162610036|NCT02237911|587289627|FG002|Overall Study|Withdrawal by Subject|2|||
162610037|NCT02237911|587289625|FG000|Overall Study|Lost to Follow-up|3|||
162610038|NCT02237911|587289626|FG001|Overall Study|Lost to Follow-up|1|||
162849030|NCT00348140|588154749|FG001|Overall Study|Participant died|1|||
162849031|NCT00348140|588154750|FG002|Overall Study|Participant died|0|||
162849032|NCT00348140|588154748|FG000|Overall Study|Exclusion criteria met|0|||
162849033|NCT00348140|588154749|FG001|Overall Study|Exclusion criteria met|0|||
162849034|NCT00348140|588154750|FG002|Overall Study|Exclusion criteria met|1|||
162849035|NCT00348140|588154748|FG000|Overall Study|Memory declined|0|||
162849036|NCT00348140|588154749|FG001|Overall Study|Memory declined|0|||
162849037|NCT00348140|588154750|FG002|Overall Study|Memory declined|1|||
162849038|NCT00868790|588154751|FG000|Period 1|Adverse Event|1|||
162849039|NCT00868790|588154752|FG001|Period 1|Adverse Event|0|||
162849040|NCT00868790|588154753|FG002|Period 1|Adverse Event|0|||
162849041|NCT00868790|588154754|FG003|Period 1|Adverse Event|0|||
162849042|NCT00868790|588154755|FG004|Period 1|Adverse Event|0|||
162849043|NCT00868790|588154756|FG005|Period 1|Adverse Event|0|||
162849044|NCT00868790|588154757|FG006|Period 1|Adverse Event|0|||
162849045|NCT00868790|588154758|FG007|Period 1|Adverse Event|3|||
162849046|NCT00868790|588154759|FG008|Period 1|Adverse Event|1|||
162849047|NCT00868790|588154760|FG009|Period 1|Adverse Event|0|||
162849048|NCT00868790|588154761|FG010|Period 1|Adverse Event|0|||
162849049|NCT00868790|588154762|FG011|Period 1|Adverse Event|0|||
162849050|NCT00868790|588154763|FG012|Period 1|Adverse Event|0|||
162849051|NCT00868790|588154764|FG013|Period 1|Adverse Event|1|||
162849052|NCT00868790|588154751|FG000|Period 1|Protocol Violation|1|||
162849053|NCT00868790|588154752|FG001|Period 1|Protocol Violation|0|||
162849054|NCT00868790|588154753|FG002|Period 1|Protocol Violation|0|||
162849055|NCT00868790|588154754|FG003|Period 1|Protocol Violation|0|||
162849056|NCT00868790|588154755|FG004|Period 1|Protocol Violation|0|||
162849057|NCT00868790|588154756|FG005|Period 1|Protocol Violation|0|||
162849058|NCT00868790|588154757|FG006|Period 1|Protocol Violation|0|||
162849059|NCT00868790|588154758|FG007|Period 1|Protocol Violation|0|||
162849060|NCT00868790|588154759|FG008|Period 1|Protocol Violation|0|||
162849061|NCT00868790|588154760|FG009|Period 1|Protocol Violation|0|||
162849062|NCT00868790|588154761|FG010|Period 1|Protocol Violation|0|||
162849063|NCT00868790|588154762|FG011|Period 1|Protocol Violation|0|||
162849064|NCT00868790|588154763|FG012|Period 1|Protocol Violation|0|||
162849065|NCT00868790|588154764|FG013|Period 1|Protocol Violation|0|||
162610039|NCT02237911|587289627|FG002|Overall Study|Lost to Follow-up|1|||
162610040|NCT00721123|587289628|FG000|Overall Study|Adverse Event|96|||
162610041|NCT00721123|587289628|FG000|Overall Study|Death|10|||
162610042|NCT00721123|587289628|FG000|Overall Study|Insufficient Therapeutic Response|21|||
162610043|NCT00721123|587289628|FG000|Overall Study|Protocol Violation|1|||
162610044|NCT00721123|587289628|FG000|Overall Study|Refused Treatment|41|||
162610045|NCT00721123|587289628|FG000|Overall Study|Failure to Return|9|||
162610046|NCT00721123|587289628|FG000|Overall Study|Withdrawal by Subject|5|||
162610047|NCT03468985|587289629|FG000|Overall Study|Adverse Event|0|||
162610048|NCT03468985|587289630|FG001|Overall Study|Adverse Event|2|||
162610049|NCT03468985|587289631|FG002|Overall Study|Adverse Event|0|||
162610050|NCT03468985|587289632|FG003|Overall Study|Adverse Event|0|||
162610051|NCT03468985|587289629|FG000|Overall Study|Withdrawal by Subject|0|||
162610052|NCT03468985|587289630|FG001|Overall Study|Withdrawal by Subject|0|||
162610053|NCT03468985|587289631|FG002|Overall Study|Withdrawal by Subject|0|||
162610054|NCT03468985|587289632|FG003|Overall Study|Withdrawal by Subject|1|||
162610055|NCT03981822|587289633|FG000|Overall Study|Lost to Follow-up|0|||
162610056|NCT03981822|587289634|FG001|Overall Study|Lost to Follow-up|1|||
162610057|NCT03981822|587289635|FG002|Overall Study|Lost to Follow-up|1|||
162610058|NCT03981822|587289636|FG003|Overall Study|Lost to Follow-up|0|||
162610059|NCT03981822|587289637|FG004|Overall Study|Lost to Follow-up|6|||
162610060|NCT03981822|587289638|FG005|Overall Study|Lost to Follow-up|4|||
162610061|NCT03981822|587289639|FG006|Overall Study|Lost to Follow-up|4|||
162610062|NCT03981822|587289640|FG007|Overall Study|Lost to Follow-up|2|||
162610063|NCT03981822|587289633|FG000|Overall Study|Withdrawal by Subject|0|||
162610064|NCT03981822|587289634|FG001|Overall Study|Withdrawal by Subject|1|||
162610065|NCT03981822|587289635|FG002|Overall Study|Withdrawal by Subject|0|||
162610066|NCT03981822|587289636|FG003|Overall Study|Withdrawal by Subject|0|||
162610067|NCT03981822|587289637|FG004|Overall Study|Withdrawal by Subject|0|||
162610068|NCT03981822|587289638|FG005|Overall Study|Withdrawal by Subject|1|||
162610069|NCT03981822|587289639|FG006|Overall Study|Withdrawal by Subject|0|||
162610070|NCT03981822|587289640|FG007|Overall Study|Withdrawal by Subject|2|||
162610071|NCT03981822|587289633|FG000|Overall Study|COVID-19 Related|0|||
162610072|NCT03981822|587289634|FG001|Overall Study|COVID-19 Related|0|||
162610073|NCT03981822|587289635|FG002|Overall Study|COVID-19 Related|0|||
162610074|NCT03981822|587289636|FG003|Overall Study|COVID-19 Related|0|||
162610075|NCT03981822|587289637|FG004|Overall Study|COVID-19 Related|2|||
162610076|NCT03981822|587289638|FG005|Overall Study|COVID-19 Related|1|||
162610077|NCT03981822|587289639|FG006|Overall Study|COVID-19 Related|2|||
162610078|NCT03981822|587289640|FG007|Overall Study|COVID-19 Related|1|||
162610079|NCT04521777|587289642|FG000|Overall Study|Death|2|||
162610080|NCT04521777|587289642|FG000|Overall Study|Withdrawal by Subject|2|||
162703282|NCT05305040|587625275|FG000|Overall Study|Not Dosed|37|||
162703283|NCT05305040|587625276|FG001|Overall Study|Not Dosed|37|||
162703284|NCT05305040|587625275|FG000|Overall Study|Study Closure|34|||
162703285|NCT05305040|587625276|FG001|Overall Study|Study Closure|46|||
162703286|NCT05305040|587625275|FG000|Overall Study|Death|14|||
162703287|NCT05305040|587625276|FG001|Overall Study|Death|13|||
162703288|NCT05305040|587625275|FG000|Overall Study|Withdrawal by Subject|15|||
162703289|NCT05305040|587625276|FG001|Overall Study|Withdrawal by Subject|10|||
162703290|NCT05305040|587625275|FG000|Overall Study|Other|13|||
162703291|NCT05305040|587625276|FG001|Overall Study|Other|10|||
162703292|NCT05305040|587625275|FG000|Overall Study|Primary Malignancy Relapse|3|||
162703293|NCT05305040|587625276|FG001|Overall Study|Primary Malignancy Relapse|4|||
162703294|NCT05305040|587625275|FG000|Overall Study|Adverse Event|3|||
162703295|NCT05305040|587625276|FG001|Overall Study|Adverse Event|3|||
162703296|NCT05305040|587625275|FG000|Overall Study|Lost to Follow-up|2|||
162703297|NCT05305040|587625276|FG001|Overall Study|Lost to Follow-up|1|||
162703298|NCT05305040|587625275|FG000|Overall Study|Graft versus host disease|2|||
162703299|NCT05305040|587625276|FG001|Overall Study|Graft versus host disease|0|||
162703300|NCT05305040|587625275|FG000|Overall Study|Investigator's Decision|1|||
162703301|NCT05305040|587625276|FG001|Overall Study|Investigator's Decision|1|||
162703302|NCT05305040|587625275|FG000|Overall Study|COVID-19 Reasons|1|||
162703303|NCT05305040|587625276|FG001|Overall Study|COVID-19 Reasons|0|||
162703304|NCT02206685|587625277|FG000|Overall Study|Surgery cancelled/changed|2|||
162703305|NCT02206685|587625278|FG001|Overall Study|Surgery cancelled/changed|3|||
162703306|NCT02206685|587625277|FG000|Overall Study|Withdrawal by Subject|1|||
162703307|NCT02206685|587625278|FG001|Overall Study|Withdrawal by Subject|2|||
162703308|NCT02206685|587625277|FG000|Overall Study|Protocol Violation|2|||
162703309|NCT02206685|587625278|FG001|Overall Study|Protocol Violation|2|||
162703310|NCT01195675|587625279|FG000|Overall Study|Adverse Event|1|||
162703311|NCT01195675|587625279|FG000|Overall Study|Withdrawal by Subject|2|||
162703312|NCT01174550|587625280|FG000|Overall Study|Death|75|||
162703313|NCT01174550|587625281|FG001|Overall Study|Death|74|||
162703314|NCT01174550|587625280|FG000|Overall Study|Lost to Follow-up|652|||
162703315|NCT01174550|587625281|FG001|Overall Study|Lost to Follow-up|510|||
162703316|NCT01174550|587625280|FG000|Overall Study|Withdrawal by Subject|543|||
162703317|NCT01174550|587625281|FG001|Overall Study|Withdrawal by Subject|289|||
162703318|NCT01536262|587625282|FG000|Overall Study|Adverse Event|6|||
162703319|NCT01536262|587625283|FG001|Overall Study|Adverse Event|1|||
162703320|NCT01536262|587625284|FG002|Overall Study|Adverse Event|2|||
162703321|NCT01536262|587625282|FG000|Overall Study|Withdrawal by Subject|1|||
162703322|NCT01536262|587625283|FG001|Overall Study|Withdrawal by Subject|1|||
162703323|NCT01536262|587625284|FG002|Overall Study|Withdrawal by Subject|0|||
162703324|NCT01536262|587625282|FG000|Overall Study|Other than stated above|1|||
162703325|NCT01536262|587625283|FG001|Overall Study|Other than stated above|0|||
162703326|NCT01536262|587625284|FG002|Overall Study|Other than stated above|0|||
162703327|NCT01460381|587625288|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
162703328|NCT01460381|587625289|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
162703329|NCT01097655|587625290|FG000|Overall Study|Withdrawal by Subject|1|||
162703330|NCT01097655|587625290|FG000|Overall Study|Subject Documented Twice|1|||
162703331|NCT01097655|587625290|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
162703332|NCT01781611|587625291|FG000|Overall Study|Adverse Event|4|||
162703333|NCT01781611|587625292|FG001|Overall Study|Adverse Event|0|||
162703334|NCT00354029|587625293|FG000|Overall Study|Protocol Violation|4|||
162703335|NCT00354029|587625294|FG001|Overall Study|Protocol Violation|2|||
162703336|NCT04466618|587625303|FG000|Overall Study|Withdrawal by Subject|0|||
162703337|NCT04466618|587625304|FG001|Overall Study|Withdrawal by Subject|1|||
162703338|NCT02800928|587625305|FG000|Overall Study|Withdrawal by Subject|1|||
162703339|NCT02800928|587625306|FG001|Overall Study|Withdrawal by Subject|1|||
162703340|NCT02800928|587625305|FG000|Overall Study|Protocol Violation|1|||
162703341|NCT02800928|587625306|FG001|Overall Study|Protocol Violation|1|||
162703342|NCT02886728|587625314|FG000|Overall Study|Withdrew Consent|31|||
162703343|NCT02886728|587625315|FG001|Overall Study|Withdrew Consent|13|||
162703344|NCT02886728|587625316|FG002|Overall Study|Withdrew Consent|11|||
162703345|NCT02886728|587625317|FG003|Overall Study|Withdrew Consent|47|||
162703346|NCT02886728|587625314|FG000|Overall Study|Lost to Follow-up|12|||
162703347|NCT02886728|587625315|FG001|Overall Study|Lost to Follow-up|6|||
162703348|NCT02886728|587625316|FG002|Overall Study|Lost to Follow-up|13|||
162703349|NCT02886728|587625317|FG003|Overall Study|Lost to Follow-up|12|||
162703350|NCT02886728|587625314|FG000|Overall Study|Adverse Event|13|||
162849066|NCT00868790|588154751|FG000|Period 1|Withdrawal by Subject|0|||
162703351|NCT02886728|587625315|FG001|Overall Study|Adverse Event|5|||
162849067|NCT00868790|588154752|FG001|Period 1|Withdrawal by Subject|1|||
162703352|NCT02886728|587625316|FG002|Overall Study|Adverse Event|5|||
162703353|NCT02886728|587625317|FG003|Overall Study|Adverse Event|11|||
162703354|NCT02886728|587625314|FG000|Overall Study|Investigator's Discretion|11|||
162703355|NCT02886728|587625315|FG001|Overall Study|Investigator's Discretion|7|||
162703356|NCT02886728|587625316|FG002|Overall Study|Investigator's Discretion|5|||
162703357|NCT02886728|587625317|FG003|Overall Study|Investigator's Discretion|11|||
162703358|NCT02886728|587625314|FG000|Overall Study|Death|3|||
162703359|NCT02886728|587625315|FG001|Overall Study|Death|1|||
162703360|NCT02886728|587625316|FG002|Overall Study|Death|0|||
162703361|NCT02886728|587625317|FG003|Overall Study|Death|0|||
162703362|NCT02886728|587625314|FG000|Overall Study|Protocol Violation|0|||
162703363|NCT02886728|587625315|FG001|Overall Study|Protocol Violation|0|||
162703364|NCT02886728|587625316|FG002|Overall Study|Protocol Violation|0|||
162703365|NCT02886728|587625317|FG003|Overall Study|Protocol Violation|4|||
162849068|NCT00868790|588154753|FG002|Period 1|Withdrawal by Subject|0|||
162849069|NCT00868790|588154754|FG003|Period 1|Withdrawal by Subject|0|||
162849070|NCT00868790|588154755|FG004|Period 1|Withdrawal by Subject|0|||
162849071|NCT00868790|588154756|FG005|Period 1|Withdrawal by Subject|0|||
162849072|NCT00868790|588154757|FG006|Period 1|Withdrawal by Subject|0|||
162849073|NCT00868790|588154758|FG007|Period 1|Withdrawal by Subject|0|||
162849074|NCT00868790|588154759|FG008|Period 1|Withdrawal by Subject|0|||
162849075|NCT00868790|588154760|FG009|Period 1|Withdrawal by Subject|0|||
162849076|NCT00868790|588154761|FG010|Period 1|Withdrawal by Subject|0|||
162849077|NCT00868790|588154762|FG011|Period 1|Withdrawal by Subject|0|||
162849078|NCT00868790|588154763|FG012|Period 1|Withdrawal by Subject|0|||
162849079|NCT00868790|588154764|FG013|Period 1|Withdrawal by Subject|1|||
162849080|NCT00868790|588154751|FG000|Period 1|Abnormal Triglycerides|0|||
162849081|NCT00868790|588154752|FG001|Period 1|Abnormal Triglycerides|0|||
162849082|NCT00868790|588154753|FG002|Period 1|Abnormal Triglycerides|0|||
162849083|NCT00868790|588154754|FG003|Period 1|Abnormal Triglycerides|0|||
162703366|NCT02886728|587625314|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162703367|NCT02886728|587625315|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162703368|NCT02886728|587625316|FG002|Overall Study|Non-Compliance with Study Drug|1|||
162703369|NCT02886728|587625317|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162703370|NCT02886728|587625314|FG000|Overall Study|Pregnancy|0|||
162703371|NCT02886728|587625315|FG001|Overall Study|Pregnancy|0|||
162703372|NCT02886728|587625316|FG002|Overall Study|Pregnancy|1|||
162703373|NCT02886728|587625317|FG003|Overall Study|Pregnancy|0|||
162703374|NCT02886728|587625314|FG000|Overall Study|Randomized but Not Dosed|1|||
162703375|NCT02886728|587625315|FG001|Overall Study|Randomized but Not Dosed|0|||
162703376|NCT02886728|587625316|FG002|Overall Study|Randomized but Not Dosed|0|||
162703377|NCT02886728|587625317|FG003|Overall Study|Randomized but Not Dosed|2|||
162703378|NCT00109928|587625318|FG000|Overall Study|Adverse Event|2|||
162703379|NCT00109928|587625318|FG000|Overall Study|Progression|6|||
162703380|NCT00109928|587625318|FG000|Overall Study|Death|2|||
162703381|NCT00109928|587625318|FG000|Overall Study|not protocol specified|2|||
162703382|NCT00109928|587625318|FG000|Overall Study|not eligible|1|||
162703383|NCT01364727|587625319|FG000|Overall Study|Not Eligible|2|||
162703384|NCT01676220|587625320|FG000|Overall Study|Randomized But Not Treated|4|||
162703385|NCT01676220|587625321|FG001|Overall Study|Randomized But Not Treated|1|||
162703386|NCT01676220|587625320|FG000|Overall Study|Adverse Event|10|||
162703387|NCT01676220|587625321|FG001|Overall Study|Adverse Event|8|||
162703388|NCT01676220|587625320|FG000|Overall Study|Lack of Efficacy|2|||
162703389|NCT01676220|587625321|FG001|Overall Study|Lack of Efficacy|5|||
162703390|NCT01676220|587625320|FG000|Overall Study|Protocol Violation|11|||
162703391|NCT01676220|587625321|FG001|Overall Study|Protocol Violation|12|||
162849084|NCT00868790|588154755|FG004|Period 1|Abnormal Triglycerides|1|||
162703392|NCT01676220|587625320|FG000|Overall Study|Received Rescue Therapy|14|||
162703393|NCT01676220|587625321|FG001|Overall Study|Received Rescue Therapy|22|||
162703394|NCT01676220|587625320|FG000|Overall Study|Personal Reason|34|||
162703395|NCT01676220|587625321|FG001|Overall Study|Personal Reason|45|||
162703396|NCT01676220|587625320|FG000|Overall Study|Lost to Follow-up|11|||
162703397|NCT01676220|587625321|FG001|Overall Study|Lost to Follow-up|18|||
162703398|NCT01676220|587625320|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
162849085|NCT00868790|588154756|FG005|Period 1|Abnormal Triglycerides|0|||
162849086|NCT00868790|588154757|FG006|Period 1|Abnormal Triglycerides|0|||
162703399|NCT01676220|587625321|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
162703400|NCT01676220|587625320|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
162703401|NCT01676220|587625321|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
162703402|NCT01676220|587625320|FG000|Overall Study|Perceived Lack of Efficacy|3|||
162703403|NCT01676220|587625321|FG001|Overall Study|Perceived Lack of Efficacy|1|||
162703404|NCT01676220|587625320|FG000|Overall Study|Non Serious Hypoglycemia|2|||
162703405|NCT01676220|587625321|FG001|Overall Study|Non Serious Hypoglycemia|0|||
162703406|NCT01676220|587625320|FG000|Overall Study|No More Need of Insulin|1|||
162703407|NCT01676220|587625321|FG001|Overall Study|No More Need of Insulin|0|||
162703408|NCT02411591|587625322|FG000|Overall Study|Adverse Event|0|||
162703409|NCT02411591|587625323|FG001|Overall Study|Adverse Event|4|||
162703410|NCT02411591|587625324|FG002|Overall Study|Adverse Event|2|||
162703411|NCT02411591|587625322|FG000|Overall Study|Withdrawal by Subject|0|||
162703412|NCT02411591|587625323|FG001|Overall Study|Withdrawal by Subject|3|||
162703413|NCT02411591|587625324|FG002|Overall Study|Withdrawal by Subject|0|||
162703414|NCT02411591|587625322|FG000|Overall Study|Physician Decision|0|||
162703415|NCT02411591|587625323|FG001|Overall Study|Physician Decision|3|||
162703416|NCT02411591|587625324|FG002|Overall Study|Physician Decision|1|||
162703417|NCT00750893|587625327|FG000|Overall Study|Adverse Event|5|||
162703418|NCT00750893|587625327|FG000|Overall Study|Withdrawal by Subject|10|||
162703419|NCT00750893|587625327|FG000|Overall Study|Lost to Follow-up|510|||
162703420|NCT00750893|587625327|FG000|Overall Study|Other|17|||
162703421|NCT00661258|587625335|FG000|Overall Study|Death|1|||
162703422|NCT00661258|587625336|FG001|Overall Study|Death|0|||
162703423|NCT00661258|587625335|FG000|Overall Study|caught by police and in detox center|2|||
162703424|NCT00661258|587625336|FG001|Overall Study|caught by police and in detox center|1|||
162703425|NCT01628874|587625337|FG000|Overall Study|Physician Decision|1|||
162703426|NCT01628874|587625338|FG001|Overall Study|Physician Decision|1|||
162703427|NCT01628874|587625337|FG000|Overall Study|Age >4 months|4|||
162703428|NCT01628874|587625338|FG001|Overall Study|Age >4 months|2|||
162703429|NCT00873093|587625339|FG000|Overall Study|Adverse Event|0|||
162703430|NCT00873093|587625340|FG001|Overall Study|Adverse Event|2|||
162703431|NCT00873093|587625341|FG002|Overall Study|Adverse Event|0|||
162703432|NCT00873093|587625342|FG003|Overall Study|Adverse Event|0|||
162703433|NCT00873093|587625343|FG004|Overall Study|Adverse Event|0|||
162703434|NCT00873093|587625339|FG000|Overall Study|Death|0|||
162703435|NCT00873093|587625340|FG001|Overall Study|Death|3|||
162703436|NCT00873093|587625341|FG002|Overall Study|Death|2|||
162703437|NCT00873093|587625342|FG003|Overall Study|Death|0|||
162703438|NCT00873093|587625343|FG004|Overall Study|Death|0|||
162703439|NCT00873093|587625339|FG000|Overall Study|Physician Decision|0|||
162703440|NCT00873093|587625340|FG001|Overall Study|Physician Decision|17|||
162703441|NCT00873093|587625341|FG002|Overall Study|Physician Decision|10|||
162703442|NCT00873093|587625342|FG003|Overall Study|Physician Decision|10|||
162703443|NCT00873093|587625343|FG004|Overall Study|Physician Decision|2|||
162703444|NCT00873093|587625339|FG000|Overall Study|Withdrawal by Subject|1|||
162703445|NCT00873093|587625340|FG001|Overall Study|Withdrawal by Subject|4|||
162703446|NCT00873093|587625341|FG002|Overall Study|Withdrawal by Subject|4|||
162703447|NCT00873093|587625342|FG003|Overall Study|Withdrawal by Subject|0|||
162703448|NCT00873093|587625343|FG004|Overall Study|Withdrawal by Subject|0|||
162703449|NCT00873093|587625339|FG000|Overall Study|Ineligible|0|||
162703450|NCT00873093|587625340|FG001|Overall Study|Ineligible|1|||
162703451|NCT00873093|587625341|FG002|Overall Study|Ineligible|0|||
162703452|NCT00873093|587625342|FG003|Overall Study|Ineligible|1|||
162703453|NCT00873093|587625343|FG004|Overall Study|Ineligible|0|||
162703454|NCT01152554|587625345|FG000|Overall Study|Withdrawal by Subject|73|||
162703455|NCT01152554|587625346|FG001|Overall Study|Withdrawal by Subject|28|||
162703456|NCT01152554|587625345|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
162703457|NCT01152554|587625346|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
162703458|NCT01152554|587625345|FG000|Overall Study|Adverse Event|67|||
162703459|NCT01152554|587625346|FG001|Overall Study|Adverse Event|14|||
162703460|NCT01152554|587625345|FG000|Overall Study|Severe non-compliance to protocol|36|||
162703461|NCT01152554|587625346|FG001|Overall Study|Severe non-compliance to protocol|14|||
162703462|NCT01152554|587625345|FG000|Overall Study|Condition under investigation worsened|5|||
162703463|NCT01152554|587625346|FG001|Overall Study|Condition under investigation worsened|2|||
162703464|NCT01152554|587625345|FG000|Overall Study|Lack of Efficacy|20|||
162703465|NCT01152554|587625346|FG001|Overall Study|Lack of Efficacy|3|||
162703466|NCT01152554|587625345|FG000|Overall Study|Study-specific withdrawal criteria|17|||
162703467|NCT01152554|587625346|FG001|Overall Study|Study-specific withdrawal criteria|8|||
162703468|NCT01152554|587625345|FG000|Overall Study|Lost to Follow-up|87|||
162703469|NCT01152554|587625346|FG001|Overall Study|Lost to Follow-up|32|||
162703470|NCT01152554|587625345|FG000|Overall Study|Other|28|||
162703471|NCT01152554|587625346|FG001|Overall Study|Other|8|||
162703472|NCT01152554|587625345|FG000|Overall Study|Death|1|||
162703473|NCT01152554|587625346|FG001|Overall Study|Death|1|||
162703474|NCT00146640|587625347|FG000|Overall Study|Adverse Event|12|||
162703475|NCT00146640|587625348|FG001|Overall Study|Adverse Event|10|||
162703476|NCT00146640|587625347|FG000|Overall Study|Medical Reasons|3|||
162849087|NCT00868790|588154758|FG007|Period 1|Abnormal Triglycerides|0|||
162703477|NCT00146640|587625348|FG001|Overall Study|Medical Reasons|0|||
162849088|NCT00868790|588154759|FG008|Period 1|Abnormal Triglycerides|0|||
162703478|NCT00146640|587625347|FG000|Overall Study|Non-Medical Reasons|8|||
162703479|NCT00146640|587625348|FG001|Overall Study|Non-Medical Reasons|4|||
162703480|NCT03486899|587625349|FG000|Overall Study|Lost to Follow-up|4|||
162703481|NCT03486899|587625350|FG001|Overall Study|Lost to Follow-up|1|||
162703482|NCT03486899|587625351|FG002|Overall Study|Lost to Follow-up|4|||
162703483|NCT03486899|587625352|FG003|Overall Study|Lost to Follow-up|3|||
162703484|NCT03486899|587625349|FG000|Overall Study|Death|1|||
162703485|NCT03486899|587625350|FG001|Overall Study|Death|0|||
162703486|NCT03486899|587625351|FG002|Overall Study|Death|0|||
162703487|NCT03486899|587625352|FG003|Overall Study|Death|1|||
162703488|NCT03486899|587625349|FG000|Overall Study|Adverse Event|0|||
162703489|NCT03486899|587625350|FG001|Overall Study|Adverse Event|2|||
162703490|NCT03486899|587625351|FG002|Overall Study|Adverse Event|0|||
162703491|NCT03486899|587625352|FG003|Overall Study|Adverse Event|2|||
162703492|NCT03486899|587625349|FG000|Overall Study|Withdrawal by Subject|3|||
162703493|NCT03486899|587625350|FG001|Overall Study|Withdrawal by Subject|7|||
162703494|NCT03486899|587625351|FG002|Overall Study|Withdrawal by Subject|4|||
162703495|NCT03486899|587625352|FG003|Overall Study|Withdrawal by Subject|3|||
162703496|NCT03486899|587625349|FG000|Overall Study|Other Reasons|0|||
162703497|NCT03486899|587625350|FG001|Overall Study|Other Reasons|1|||
162703498|NCT03486899|587625351|FG002|Overall Study|Other Reasons|0|||
162703499|NCT03486899|587625352|FG003|Overall Study|Other Reasons|1|||
162703500|NCT01439711|587625353|FG000|Overall Study|Ineligible|13|||
162703501|NCT01439711|587625353|FG000|Overall Study|Cancel|3|||
162703502|NCT01439711|587625353|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
162703503|NCT01439711|587625353|FG000|Overall Study|Adverse Event|5|||
162703504|NCT01439711|587625353|FG000|Overall Study|Withdrawal by Subject|3|||
162703505|NCT01439711|587625353|FG000|Overall Study|Progression During Active Tx|3|||
162703506|NCT01439711|587625353|FG000|Overall Study|Noncompliance|3|||
162703507|NCT01439711|587625353|FG000|Overall Study|No MRI|9|||
162703508|NCT04242875|587625354|FG000|Overall Study|Adverse Event|2|||
162703509|NCT02397460|587625355|FG000|Treatment Period 2|Adverse Event|0|||
162849089|NCT00868790|588154760|FG009|Period 1|Abnormal Triglycerides|0|||
162849090|NCT00868790|588154761|FG010|Period 1|Abnormal Triglycerides|0|||
162849091|NCT00868790|588154762|FG011|Period 1|Abnormal Triglycerides|0|||
162849092|NCT00868790|588154763|FG012|Period 1|Abnormal Triglycerides|0|||
162849093|NCT00868790|588154764|FG013|Period 1|Abnormal Triglycerides|0|||
162849094|NCT00868790|588154751|FG000|Period 1|Lost to Follow-up|0|||
162849095|NCT00868790|588154752|FG001|Period 1|Lost to Follow-up|0|||
162849096|NCT00868790|588154753|FG002|Period 1|Lost to Follow-up|0|||
162849097|NCT00868790|588154754|FG003|Period 1|Lost to Follow-up|0|||
162849098|NCT00868790|588154755|FG004|Period 1|Lost to Follow-up|0|||
162849099|NCT00868790|588154756|FG005|Period 1|Lost to Follow-up|1|||
162849100|NCT00868790|588154757|FG006|Period 1|Lost to Follow-up|0|||
162849101|NCT00868790|588154758|FG007|Period 1|Lost to Follow-up|0|||
162849102|NCT00868790|588154759|FG008|Period 1|Lost to Follow-up|0|||
162849103|NCT00868790|588154760|FG009|Period 1|Lost to Follow-up|0|||
162849104|NCT00868790|588154761|FG010|Period 1|Lost to Follow-up|0|||
162849105|NCT00868790|588154762|FG011|Period 1|Lost to Follow-up|0|||
162849106|NCT00868790|588154763|FG012|Period 1|Lost to Follow-up|0|||
162849107|NCT00868790|588154764|FG013|Period 1|Lost to Follow-up|0|||
162703510|NCT02397460|587625356|FG001|Treatment Period 2|Adverse Event|0|||
162703511|NCT02397460|587625357|FG002|Treatment Period 2|Adverse Event|0|||
162703512|NCT02397460|587625358|FG003|Treatment Period 2|Adverse Event|0|||
162703513|NCT02397460|587625359|FG004|Treatment Period 2|Adverse Event|0|||
162703514|NCT02397460|587625360|FG005|Treatment Period 2|Adverse Event|0|||
162703515|NCT02397460|587625361|FG006|Treatment Period 2|Adverse Event|0|||
162703516|NCT02397460|587625362|FG007|Treatment Period 2|Adverse Event|1|||
162849108|NCT00868790|588154751|FG000|Period 2|Adverse Event|0|||
162849109|NCT00868790|588154752|FG001|Period 2|Adverse Event|0|||
162703517|NCT02397460|587625355|FG000|Treatment Period 4|Adverse Event|0|||
162703518|NCT02397460|587625356|FG001|Treatment Period 4|Adverse Event|1|||
162703519|NCT02397460|587625357|FG002|Treatment Period 4|Adverse Event|0|||
162703520|NCT02397460|587625358|FG003|Treatment Period 4|Adverse Event|0|||
162703521|NCT02397460|587625359|FG004|Treatment Period 4|Adverse Event|0|||
162703522|NCT02397460|587625360|FG005|Treatment Period 4|Adverse Event|0|||
162703523|NCT02397460|587625361|FG006|Treatment Period 4|Adverse Event|0|||
162703524|NCT02397460|587625362|FG007|Treatment Period 4|Adverse Event|0|||
162703525|NCT02397460|587625355|FG000|Treatment Period 4|Physician Decision|0|||
162703526|NCT02397460|587625356|FG001|Treatment Period 4|Physician Decision|0|||
162703527|NCT02397460|587625357|FG002|Treatment Period 4|Physician Decision|0|||
162703528|NCT02397460|587625358|FG003|Treatment Period 4|Physician Decision|0|||
162703529|NCT02397460|587625359|FG004|Treatment Period 4|Physician Decision|1|||
162703530|NCT02397460|587625360|FG005|Treatment Period 4|Physician Decision|0|||
162703531|NCT02397460|587625361|FG006|Treatment Period 4|Physician Decision|0|||
162703532|NCT02397460|587625362|FG007|Treatment Period 4|Physician Decision|0|||
162703533|NCT01723826|587625366|FG000|Overall Study|Adverse Event|4|||
162703534|NCT01723826|587625367|FG001|Overall Study|Adverse Event|1|||
162703535|NCT01723826|587625368|FG002|Overall Study|Adverse Event|4|||
162703536|NCT01723826|587625369|FG003|Overall Study|Adverse Event|5|||
162703537|NCT01723826|587625366|FG000|Overall Study|Death according to AE eCRF|2|||
162703538|NCT01723826|587625367|FG001|Overall Study|Death according to AE eCRF|3|||
162703539|NCT01723826|587625368|FG002|Overall Study|Death according to AE eCRF|3|||
162703540|NCT01723826|587625369|FG003|Overall Study|Death according to AE eCRF|7|||
162703541|NCT01723826|587625366|FG000|Overall Study|Lost to Follow-up|1|||
162703542|NCT01723826|587625367|FG001|Overall Study|Lost to Follow-up|3|||
162703543|NCT01723826|587625368|FG002|Overall Study|Lost to Follow-up|1|||
162703544|NCT01723826|587625369|FG003|Overall Study|Lost to Follow-up|1|||
162703545|NCT01723826|587625366|FG000|Overall Study|Non-compliance|0|||
162703546|NCT01723826|587625367|FG001|Overall Study|Non-compliance|1|||
162703547|NCT01723826|587625368|FG002|Overall Study|Non-compliance|3|||
162703548|NCT01723826|587625369|FG003|Overall Study|Non-compliance|3|||
162703549|NCT01723826|587625366|FG000|Overall Study|Non-compliance With Study Drug|0|||
162703550|NCT01723826|587625367|FG001|Overall Study|Non-compliance With Study Drug|1|||
162703551|NCT01723826|587625368|FG002|Overall Study|Non-compliance With Study Drug|0|||
162703552|NCT01723826|587625369|FG003|Overall Study|Non-compliance With Study Drug|0|||
162703553|NCT01723826|587625366|FG000|Overall Study|Other Reason|8|||
162703554|NCT01723826|587625367|FG001|Overall Study|Other Reason|6|||
162703555|NCT01723826|587625368|FG002|Overall Study|Other Reason|12|||
162703556|NCT01723826|587625369|FG003|Overall Study|Other Reason|14|||
162703557|NCT01723826|587625366|FG000|Overall Study|Physician Decision|1|||
162703558|NCT01723826|587625367|FG001|Overall Study|Physician Decision|3|||
162703559|NCT01723826|587625368|FG002|Overall Study|Physician Decision|4|||
162703560|NCT01723826|587625369|FG003|Overall Study|Physician Decision|11|||
162703561|NCT01723826|587625366|FG000|Overall Study|Protocol Violation|1|||
162703562|NCT01723826|587625367|FG001|Overall Study|Protocol Violation|1|||
162703563|NCT01723826|587625368|FG002|Overall Study|Protocol Violation|3|||
162703564|NCT01723826|587625369|FG003|Overall Study|Protocol Violation|1|||
162703565|NCT01723826|587625366|FG000|Overall Study|Withdrawal by Subject|10|||
162703566|NCT01723826|587625367|FG001|Overall Study|Withdrawal by Subject|17|||
162703567|NCT01723826|587625368|FG002|Overall Study|Withdrawal by Subject|27|||
162703568|NCT01723826|587625369|FG003|Overall Study|Withdrawal by Subject|48|||
162703569|NCT01767129|587625370|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
162703570|NCT01767129|587625371|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
162703571|NCT01473420|587625375|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
162703572|NCT01473420|587625376|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
162703573|NCT01473420|587625375|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
162703574|NCT01473420|587625376|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
162703575|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
162703576|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
162703577|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
162703578|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
162703579|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
162703580|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
162703581|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
162703582|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
162703583|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
162703584|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
162703585|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
162703586|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
162703587|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
162849110|NCT00868790|588154753|FG002|Period 2|Adverse Event|0|||
162703588|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
162703589|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
162703590|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
162849111|NCT00868790|588154754|FG003|Period 2|Adverse Event|0|||
162703591|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
162703592|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
162703593|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
162703594|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
162703595|NCT01473420|587625375|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
162703596|NCT01473420|587625376|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
162703597|NCT02906202|587625383|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
162703598|NCT01824472|587625392|FG000|Overall Study|Lost to Follow-up|0|||
162703599|NCT01824472|587625393|FG001|Overall Study|Lost to Follow-up|0|||
162703600|NCT01824472|587625394|FG002|Overall Study|Lost to Follow-up|1|||
162703601|NCT01824472|587625392|FG000|Overall Study|Withdrawal by Subject|1|||
162703602|NCT01824472|587625393|FG001|Overall Study|Withdrawal by Subject|5|||
162703603|NCT01824472|587625394|FG002|Overall Study|Withdrawal by Subject|3|||
162703604|NCT01824472|587625392|FG000|Overall Study|Ineligible post randomization&screening|0|||
162703605|NCT01824472|587625393|FG001|Overall Study|Ineligible post randomization&screening|2|||
162703606|NCT01824472|587625394|FG002|Overall Study|Ineligible post randomization&screening|0|||
162703607|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
162703608|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
162703609|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
162703610|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
162703611|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
162703612|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
162703613|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
162703614|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
162703615|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
162703616|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
162703617|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
162703618|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
162703619|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
162703620|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
162703621|NCT01815736|587625395|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
162703622|NCT01815736|587625396|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
162703623|NCT01815736|587625395|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
162703624|NCT01815736|587625396|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
162703625|NCT01815736|587625395|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
162703626|NCT01815736|587625396|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
162703627|NCT01815736|587625395|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
162703628|NCT01815736|587625396|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
162703629|NCT01815736|587625395|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
162703630|NCT01815736|587625396|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
162703631|NCT01815736|587625395|FG000|Extension Treatment Phase- After Week 96|Death|1|||
162703632|NCT01815736|587625396|FG001|Extension Treatment Phase- After Week 96|Death|0|||
162703633|NCT03387514|587625399|FG000|Overall Study|Withdrawal by Subject|2|||
162703634|NCT03387514|587625399|FG000|Overall Study|Physician Decision|1|||
162703635|NCT03387514|587625399|FG000|Overall Study|Lost to Follow-up|2|||
162703636|NCT03040687|587625400|FG000|Overall Study|Withdrawal by Subject|1|||
162703637|NCT03040687|587625401|FG001|Overall Study|Withdrawal by Subject|0|||
162703638|NCT03040687|587625402|FG002|Overall Study|Withdrawal by Subject|0|||
162703639|NCT02846558|587625403|FG000|Overall Study|Adverse Event|1|||
162703640|NCT02846558|587625404|FG001|Overall Study|Adverse Event|0|||
162703641|NCT02846558|587625405|FG002|Overall Study|Adverse Event|0|||
162703642|NCT02846558|587625406|FG003|Overall Study|Adverse Event|0|||
162703643|NCT02846558|587625403|FG000|Overall Study|Withdrawal by Subject|5|||
162703644|NCT02846558|587625404|FG001|Overall Study|Withdrawal by Subject|4|||
162703645|NCT02846558|587625405|FG002|Overall Study|Withdrawal by Subject|2|||
162703646|NCT02846558|587625406|FG003|Overall Study|Withdrawal by Subject|2|||
162703647|NCT02846558|587625403|FG000|Overall Study|Lost to Follow-up|2|||
162703648|NCT02846558|587625404|FG001|Overall Study|Lost to Follow-up|0|||
162703649|NCT02846558|587625405|FG002|Overall Study|Lost to Follow-up|0|||
162703650|NCT02846558|587625406|FG003|Overall Study|Lost to Follow-up|0|||
162703651|NCT01556243|587625410|FG000|Overall Study|Ineligible|34|||
162703652|NCT01556243|587625410|FG000|Overall Study|Converted to mastectomy|14|||
162703653|NCT01556243|587625410|FG000|Overall Study|Unable to achieve negative margins|2|||
162703654|NCT01556243|587625410|FG000|Overall Study|Withdrawal by Subject|16|||
162703655|NCT04684914|587625411|FG000|Overall Study|Withdrawal by Subject|1|||
162703656|NCT04684914|587625412|FG001|Overall Study|Withdrawal by Subject|0|||
162703657|NCT04684914|587625411|FG000|Overall Study|Discontinued before receiving study treatment|1|||
162703658|NCT04684914|587625412|FG001|Overall Study|Discontinued before receiving study treatment|2|||
162703659|NCT02353832|587625413|FG000|Overall Study|Ineligible after enrollment|1|||
162703660|NCT02353832|587625413|FG000|Overall Study|Lost to Follow-up|1|||
162703661|NCT02401529|587626928|FG000|Overall Study|Lost to Follow-up|2|||
162703662|NCT02401529|587626929|FG001|Overall Study|Lost to Follow-up|1|||
162703663|NCT02401529|587626928|FG000|Overall Study|Physician Decision|2|||
162703664|NCT02401529|587626929|FG001|Overall Study|Physician Decision|6|||
162703665|NCT02401529|587626928|FG000|Overall Study|Protocol Violation|5|||
162703666|NCT02401529|587626929|FG001|Overall Study|Protocol Violation|0|||
162703667|NCT01939158|587626932|FG000|Overall Study|Adverse Event|1|||
162703668|NCT01939158|587626933|FG001|Overall Study|Adverse Event|0|||
162703669|NCT01939158|587626934|FG002|Overall Study|Adverse Event|0|||
162703670|NCT01939158|587626935|FG003|Overall Study|Adverse Event|0|||
162703671|NCT01939158|587626932|FG000|Overall Study|Withdrawal by Subject|22|||
162703672|NCT01939158|587626933|FG001|Overall Study|Withdrawal by Subject|25|||
162703673|NCT01939158|587626934|FG002|Overall Study|Withdrawal by Subject|15|||
162703674|NCT01939158|587626935|FG003|Overall Study|Withdrawal by Subject|17|||
162703675|NCT01939158|587626932|FG000|Overall Study|Migrated/moved from study area|5|||
162703676|NCT01939158|587626933|FG001|Overall Study|Migrated/moved from study area|7|||
162703677|NCT01939158|587626934|FG002|Overall Study|Migrated/moved from study area|3|||
162703678|NCT01939158|587626935|FG003|Overall Study|Migrated/moved from study area|6|||
162703679|NCT01939158|587626932|FG000|Overall Study|Lost to Follow-up|18|||
162703680|NCT01939158|587626933|FG001|Overall Study|Lost to Follow-up|17|||
162703681|NCT01939158|587626934|FG002|Overall Study|Lost to Follow-up|17|||
162703682|NCT01939158|587626935|FG003|Overall Study|Lost to Follow-up|17|||
162703683|NCT01939158|587626932|FG000|Overall Study|Death|0|||
162703684|NCT01939158|587626933|FG001|Overall Study|Death|0|||
162703685|NCT01939158|587626934|FG002|Overall Study|Death|1|||
162703686|NCT01939158|587626935|FG003|Overall Study|Death|1|||
162703687|NCT01939158|587626932|FG000|Overall Study|No longer meets eligibility criteria|0|||
162703688|NCT01939158|587626933|FG001|Overall Study|No longer meets eligibility criteria|0|||
162703689|NCT01939158|587626934|FG002|Overall Study|No longer meets eligibility criteria|1|||
162703690|NCT01939158|587626935|FG003|Overall Study|No longer meets eligibility criteria|0|||
162703691|NCT01939158|587626932|FG000|Overall Study|Other|1|||
162703692|NCT01939158|587626933|FG001|Overall Study|Other|3|||
162703693|NCT01939158|587626934|FG002|Overall Study|Other|4|||
162703694|NCT01939158|587626935|FG003|Overall Study|Other|3|||
162703695|NCT05310084|587626936|FG000|Overall Study|Withdrawal by Subject|2|||
162703696|NCT05310084|587626937|FG001|Overall Study|Withdrawal by Subject|3|||
162703697|NCT05310084|587626936|FG000|Overall Study|Participant availability|0|||
162703698|NCT05310084|587626937|FG001|Overall Study|Participant availability|4|||
162703699|NCT05310084|587626936|FG000|Overall Study|Lost to Follow-up|1|||
162703700|NCT05310084|587626937|FG001|Overall Study|Lost to Follow-up|1|||
162703701|NCT05310084|587626936|FG000|Overall Study|Adverse Event|1|||
162703702|NCT05310084|587626937|FG001|Overall Study|Adverse Event|1|||
162703703|NCT05310084|587626936|FG000|Overall Study|Randomized but not vaccinated|4|||
162703704|NCT05310084|587626937|FG001|Overall Study|Randomized but not vaccinated|2|||
162703705|NCT02065245|587626939|FG000|Infusion 1|Lost to Follow-up|0|||
162703706|NCT02065245|587626940|FG001|Infusion 1|Lost to Follow-up|0|||
162703707|NCT02065245|587626941|FG002|Infusion 1|Lost to Follow-up|0|||
162703708|NCT02065245|587626942|FG003|Infusion 1|Lost to Follow-up|0|||
162703709|NCT02065245|587626943|FG004|Infusion 1|Lost to Follow-up|0|||
162703710|NCT02065245|587626944|FG005|Infusion 1|Lost to Follow-up|0|||
162703711|NCT02065245|587626945|FG006|Infusion 1|Lost to Follow-up|1|||
162703712|NCT02065245|587626939|FG000|Infusion 1|Death|0|||
162703713|NCT02065245|587626940|FG001|Infusion 1|Death|0|||
162703714|NCT02065245|587626941|FG002|Infusion 1|Death|1|||
162703715|NCT02065245|587626942|FG003|Infusion 1|Death|0|||
162703716|NCT02065245|587626943|FG004|Infusion 1|Death|1|||
162703717|NCT02065245|587626944|FG005|Infusion 1|Death|0|||
162703718|NCT02065245|587626945|FG006|Infusion 1|Death|0|||
162703719|NCT02065245|587626939|FG000|Infusion 2|Death|0|||
162703720|NCT02065245|587626940|FG001|Infusion 2|Death|0|||
162703721|NCT02065245|587626941|FG002|Infusion 2|Death|0|||
162703722|NCT02065245|587626942|FG003|Infusion 2|Death|0|||
162703723|NCT02065245|587626943|FG004|Infusion 2|Death|0|||
162703724|NCT02065245|587626944|FG005|Infusion 2|Death|0|||
162703725|NCT02065245|587626945|FG006|Infusion 2|Death|1|||
162703726|NCT02065245|587626939|FG000|Infusion 3|Lost to Follow-up|1|||
162703727|NCT02065245|587626940|FG001|Infusion 3|Lost to Follow-up|1|||
162703728|NCT02065245|587626941|FG002|Infusion 3|Lost to Follow-up|0|||
162703729|NCT02065245|587626942|FG003|Infusion 3|Lost to Follow-up|0|||
162703730|NCT02065245|587626943|FG004|Infusion 3|Lost to Follow-up|0|||
162703731|NCT02065245|587626944|FG005|Infusion 3|Lost to Follow-up|0|||
162703732|NCT02065245|587626945|FG006|Infusion 3|Lost to Follow-up|0|||
162703733|NCT01598987|587626946|FG000|Baseline to Month 12|Administrative problems|2|||
162703734|NCT01598987|587626946|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
162703735|NCT01598987|587626946|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
162703736|NCT01598987|587626946|FG000|Baseline to 24 Month|Administrative problems|2|||
162703737|NCT01598987|587626946|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
162703738|NCT00924664|587626947|FG000|Overall Study|Adverse Event|23|||
162703739|NCT00924664|587626948|FG001|Overall Study|Adverse Event|39|||
162703740|NCT00924664|587626947|FG000|Overall Study|Lack of Efficacy|10|||
162703741|NCT00924664|587626948|FG001|Overall Study|Lack of Efficacy|15|||
162703742|NCT00924664|587626947|FG000|Overall Study|Lost to Follow-up|10|||
162703743|NCT00924664|587626948|FG001|Overall Study|Lost to Follow-up|12|||
162703744|NCT00924664|587626947|FG000|Overall Study|Withdrawal by Subject|47|||
162703745|NCT00924664|587626948|FG001|Overall Study|Withdrawal by Subject|71|||
162703746|NCT00924664|587626947|FG000|Overall Study|Protocol Violation|2|||
162703747|NCT00924664|587626948|FG001|Overall Study|Protocol Violation|5|||
162703748|NCT00924664|587626947|FG000|Overall Study|Pregnancy|1|||
162703749|NCT00924664|587626948|FG001|Overall Study|Pregnancy|1|||
162703750|NCT00924664|587626947|FG000|Overall Study|Death|0|||
162703751|NCT00924664|587626948|FG001|Overall Study|Death|2|||
162703752|NCT00924664|587626947|FG000|Overall Study|Study terminated by sponsor|199|||
162703753|NCT00924664|587626948|FG001|Overall Study|Study terminated by sponsor|330|||
162703754|NCT00924664|587626947|FG000|Overall Study|Other|29|||
162703755|NCT00924664|587626948|FG001|Overall Study|Other|52|||
162703756|NCT00924664|587626947|FG000|Overall Study|Randomized but not Treated|1|||
162703757|NCT00924664|587626948|FG001|Overall Study|Randomized but not Treated|0|||
162703758|NCT03531905|587626949|FG000|Overall Study|Withdrawal by Subject|3|||
162703759|NCT03531905|587626950|FG001|Overall Study|Withdrawal by Subject|3|||
162703760|NCT03531905|587626951|FG002|Overall Study|Withdrawal by Subject|2|||
162703761|NCT03531905|587626949|FG000|Overall Study|Lost to Follow-up|2|||
162703762|NCT03531905|587626950|FG001|Overall Study|Lost to Follow-up|2|||
162703763|NCT03531905|587626951|FG002|Overall Study|Lost to Follow-up|1|||
162703764|NCT03531905|587626949|FG000|Overall Study|Participant was out of town|1|||
162703765|NCT03531905|587626950|FG001|Overall Study|Participant was out of town|0|||
162703766|NCT03531905|587626951|FG002|Overall Study|Participant was out of town|0|||
162703767|NCT03531905|587626949|FG000|Overall Study|Could not speak with the participant|1|||
162703768|NCT03531905|587626950|FG001|Overall Study|Could not speak with the participant|0|||
162703769|NCT03531905|587626951|FG002|Overall Study|Could not speak with the participant|0|||
162703770|NCT01036087|587626952|FG000|Overall Study|Adverse Event|2|||
162703771|NCT01036087|587626952|FG000|Overall Study|Lack of Efficacy|1|||
162703772|NCT01616563|587626955|FG000|Overall Study|Lost to Follow-up|40|||
162703773|NCT01033643|587626958|FG000|Overall Study|Withdrew Consent|0|||
162703774|NCT01033643|587626959|FG001|Overall Study|Withdrew Consent|3|||
162703775|NCT01033643|587626960|FG002|Overall Study|Withdrew Consent|0|||
162703776|NCT01033643|587626961|FG003|Overall Study|Withdrew Consent|0|||
162703777|NCT01033643|587626962|FG004|Overall Study|Withdrew Consent|0|||
162703778|NCT01033643|587626963|FG005|Overall Study|Withdrew Consent|1|||
162703779|NCT03527277|587626964|FG000|Overall Study|Withdrawal by Subject|5|||
162703780|NCT03527277|587626965|FG001|Overall Study|Withdrawal by Subject|0|||
162703781|NCT03527277|587626964|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
162703782|NCT03527277|587626965|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
162703783|NCT03527277|587626964|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
162703784|NCT03527277|587626965|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
162703785|NCT01333943|587626969|FG000|Overall Study|Known neuropathy|1|||
162703786|NCT01333943|587626970|FG001|Overall Study|Known neuropathy|0|||
162703787|NCT02459587|587626977|FG000|3-Month Follow-up Assessment|Death|0|||
162703788|NCT02459587|587626978|FG001|3-Month Follow-up Assessment|Death|2|||
162703789|NCT02459587|587626977|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
162703790|NCT02459587|587626978|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
162703791|NCT02459587|587626977|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
162703792|NCT02459587|587626978|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
162703793|NCT02459587|587626977|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
162703794|NCT02459587|587626978|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
162703795|NCT02459587|587626977|FG000|6-month Follow-up Assessment|Death|2|||
162703796|NCT02459587|587626978|FG001|6-month Follow-up Assessment|Death|1|||
162703797|NCT02459587|587626977|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
162703798|NCT02459587|587626978|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
162703799|NCT02459587|587626977|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
162703800|NCT02459587|587626978|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
162703801|NCT02459587|587626977|FG000|12-month Follow-up Assessment|Death|2|||
162703802|NCT02459587|587626978|FG001|12-month Follow-up Assessment|Death|0|||
162703803|NCT02459587|587626977|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
162703804|NCT02459587|587626978|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
162703805|NCT02459587|587626977|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
162703806|NCT02459587|587626978|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
162703807|NCT02459587|587626977|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
162703808|NCT02459587|587626978|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
162703809|NCT02652130|587626981|FG000|Overall Study|Death|1|||
162849112|NCT00868790|588154755|FG004|Period 2|Adverse Event|0|||
162703810|NCT02028884|587626982|FG000|Double-blind Period|Adverse Event|5|||
162703811|NCT02028884|587626983|FG001|Double-blind Period|Adverse Event|3|||
162703812|NCT02028884|587626984|FG002|Double-blind Period|Adverse Event|0|||
162703813|NCT02028884|587626982|FG000|Double-blind Period|Eligibility Violation|1|||
162703814|NCT02028884|587626983|FG001|Double-blind Period|Eligibility Violation|0|||
162849113|NCT00868790|588154756|FG005|Period 2|Adverse Event|0|||
162703815|NCT02028884|587626984|FG002|Double-blind Period|Eligibility Violation|0|||
162703816|NCT02028884|587626982|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
162703817|NCT02028884|587626983|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
162703818|NCT02028884|587626984|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
162703819|NCT02028884|587626982|FG000|Double-blind Period|Withdrawal by Subject|2|||
162703820|NCT02028884|587626983|FG001|Double-blind Period|Withdrawal by Subject|0|||
162703821|NCT02028884|587626984|FG002|Double-blind Period|Withdrawal by Subject|0|||
162703822|NCT02028884|587626982|FG000|Open-label Extension Period|Adverse Event|3|||
162703823|NCT02028884|587626983|FG001|Open-label Extension Period|Adverse Event|1|||
162703824|NCT02028884|587626984|FG002|Open-label Extension Period|Adverse Event|0|||
162703825|NCT02028884|587626982|FG000|Open-label Extension Period|Lack of Efficacy|3|||
162703826|NCT02028884|587626983|FG001|Open-label Extension Period|Lack of Efficacy|0|||
162703827|NCT02028884|587626984|FG002|Open-label Extension Period|Lack of Efficacy|0|||
162703828|NCT02028884|587626982|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
162703829|NCT02028884|587626983|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
162703830|NCT02028884|587626984|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
162703831|NCT02028884|587626982|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162703832|NCT02028884|587626983|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
162703833|NCT02028884|587626984|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
162703834|NCT02028884|587626982|FG000|Open-label Extension Period|Switched to another treatment option|3|||
162703835|NCT02028884|587626983|FG001|Open-label Extension Period|Switched to another treatment option|0|||
162703836|NCT02028884|587626984|FG002|Open-label Extension Period|Switched to another treatment option|0|||
162703837|NCT00839917|587626988|FG000|Overall Study|Lost to Follow-up|1|||
162703838|NCT00839917|587626989|FG001|Overall Study|Lost to Follow-up|0|||
162703839|NCT00839917|587626988|FG000|Overall Study|Did not receive vaccine|0|||
162703840|NCT00839917|587626989|FG001|Overall Study|Did not receive vaccine|1|||
162703841|NCT02297503|587626990|FG000|Overall Study|Withdrawal by Subject|1|||
162703842|NCT02297503|587626991|FG001|Overall Study|Withdrawal by Subject|1|||
162703843|NCT02297503|587626990|FG000|Overall Study|Protocol Violation|1|||
162703844|NCT02297503|587626991|FG001|Overall Study|Protocol Violation|0|||
162703845|NCT02297503|587626990|FG000|Overall Study|Pregnancy|0|||
162703846|NCT02297503|587626991|FG001|Overall Study|Pregnancy|1|||
162703847|NCT02297503|587626990|FG000|Overall Study|Lost to Follow-up|0|||
162703848|NCT02297503|587626991|FG001|Overall Study|Lost to Follow-up|1|||
162703849|NCT02297503|587626990|FG000|Overall Study|Medical reason|0|||
162703850|NCT02297503|587626991|FG001|Overall Study|Medical reason|1|||
162703851|NCT00765362|587626992|FG000|Overall Study|Death|9|||
162703852|NCT00765362|587626992|FG000|Overall Study|Adverse Event|2|||
162703853|NCT00765362|587626992|FG000|Overall Study|Protocol Violation|18|||
162703854|NCT00765362|587626992|FG000|Overall Study|Withdrawal by Subject|13|||
162703855|NCT00765362|587626992|FG000|Overall Study|Lost to Follow-up|95|||
162703856|NCT00519779|587626995|FG000|Overall Study|Withdrawal by Subject|0|||
162703857|NCT00519779|587626996|FG001|Overall Study|Withdrawal by Subject|1|||
162703858|NCT01123161|587626999|FG000|Overall Study|Lost to Follow-up|1|||
162703859|NCT01123161|587627000|FG001|Overall Study|Lost to Follow-up|0|||
162703860|NCT01123161|587626999|FG000|Overall Study|Withdrawal by Subject|1|||
162703861|NCT01123161|587627000|FG001|Overall Study|Withdrawal by Subject|0|||
162703862|NCT03990363|587627005|FG000|Overall Study|Withdrawal by Subject|10|||
162703863|NCT03990363|587627006|FG001|Overall Study|Withdrawal by Subject|9|||
162703864|NCT03990363|587627007|FG002|Overall Study|Withdrawal by Subject|18|||
162703865|NCT03990363|587627008|FG003|Overall Study|Withdrawal by Subject|11|||
162703866|NCT03990363|587627009|FG004|Overall Study|Withdrawal by Subject|9|||
162703867|NCT03990363|587627005|FG000|Overall Study|Physician Decision|1|||
162703868|NCT03990363|587627006|FG001|Overall Study|Physician Decision|0|||
162703869|NCT03990363|587627007|FG002|Overall Study|Physician Decision|0|||
162703870|NCT03990363|587627008|FG003|Overall Study|Physician Decision|0|||
162703871|NCT03990363|587627009|FG004|Overall Study|Physician Decision|0|||
162703872|NCT03990363|587627005|FG000|Overall Study|Adverse Event|1|||
162703873|NCT03990363|587627006|FG001|Overall Study|Adverse Event|3|||
162703874|NCT03990363|587627007|FG002|Overall Study|Adverse Event|2|||
162703875|NCT03990363|587627008|FG003|Overall Study|Adverse Event|2|||
162703876|NCT03990363|587627009|FG004|Overall Study|Adverse Event|0|||
162703877|NCT03990363|587627005|FG000|Overall Study|Death|14|||
162703878|NCT03990363|587627006|FG001|Overall Study|Death|8|||
162703879|NCT03990363|587627007|FG002|Overall Study|Death|14|||
162703880|NCT03990363|587627008|FG003|Overall Study|Death|10|||
162703881|NCT03990363|587627009|FG004|Overall Study|Death|11|||
162703882|NCT03990363|587627005|FG000|Overall Study|Failure to meet randomization criteria|0|||
162703883|NCT03990363|587627006|FG001|Overall Study|Failure to meet randomization criteria|1|||
162703884|NCT03990363|587627007|FG002|Overall Study|Failure to meet randomization criteria|1|||
162703885|NCT03990363|587627008|FG003|Overall Study|Failure to meet randomization criteria|0|||
162703886|NCT03990363|587627009|FG004|Overall Study|Failure to meet randomization criteria|0|||
162703887|NCT03990363|587627005|FG000|Overall Study|Lost to Follow-up|0|||
162703888|NCT03990363|587627006|FG001|Overall Study|Lost to Follow-up|0|||
162703889|NCT03990363|587627007|FG002|Overall Study|Lost to Follow-up|0|||
162610081|NCT01143207|587289646|FG000|Overall Study|Lost to Follow-up|2|||
162610082|NCT03463031|587289649|FG000|Overall Study|Withdrawal by Subject|4|||
162610083|NCT03463031|587289650|FG001|Overall Study|Withdrawal by Subject|2|||
162610084|NCT03463031|587289649|FG000|Overall Study|Investigator/Sponsor Decision|0|||
162610085|NCT03463031|587289650|FG001|Overall Study|Investigator/Sponsor Decision|1|||
162610086|NCT03463031|587289649|FG000|Overall Study|Lost to Follow-up|1|||
162610087|NCT03463031|587289650|FG001|Overall Study|Lost to Follow-up|1|||
162610088|NCT03463031|587289649|FG000|Overall Study|Adverse Event|4|||
162610089|NCT03463031|587289650|FG001|Overall Study|Adverse Event|1|||
162610090|NCT03463031|587289649|FG000|Overall Study|Use of prohibited medication by subject|1|||
162610091|NCT03463031|587289650|FG001|Overall Study|Use of prohibited medication by subject|0|||
162610092|NCT01241240|587289651|FG000|Overall Study|Adverse Event|5|||
162610093|NCT01241240|587289652|FG001|Overall Study|Adverse Event|4|||
162610094|NCT01241240|587289651|FG000|Overall Study|Lost to Follow-up|2|||
162610095|NCT01241240|587289652|FG001|Overall Study|Lost to Follow-up|4|||
162610096|NCT01241240|587289651|FG000|Overall Study|Personal Reasons|1|||
162610097|NCT01241240|587289652|FG001|Overall Study|Personal Reasons|1|||
162610098|NCT02376829|587289659|FG000|Overall Study|Withdrawal by Subject|27|||
162610099|NCT02376829|587289660|FG001|Overall Study|Withdrawal by Subject|44|||
162610100|NCT00057954|587289661|FG000|Overall Study|Death|1|||
162610101|NCT00057954|587289661|FG000|Overall Study|Disease progression|1|||
162610102|NCT02147184|587289662|FG000|Overall Study|Lost to Follow-up|28|||
162610103|NCT02147184|587289663|FG001|Overall Study|Lost to Follow-up|15|||
162610104|NCT02147184|587289662|FG000|Overall Study|Study Burden|11|||
162610105|NCT02147184|587289663|FG001|Overall Study|Study Burden|7|||
162610106|NCT02147184|587289662|FG000|Overall Study|Pregnancy|6|||
162610107|NCT02147184|587289663|FG001|Overall Study|Pregnancy|0|||
162610108|NCT02147184|587289662|FG000|Overall Study|Moved out of state|3|||
162610109|NCT02147184|587289663|FG001|Overall Study|Moved out of state|3|||
162610110|NCT02147184|587289662|FG000|Overall Study|Physician Decision|0|||
162610111|NCT02147184|587289663|FG001|Overall Study|Physician Decision|2|||
162610112|NCT02147184|587289662|FG000|Overall Study|Other|1|||
162610113|NCT02147184|587289663|FG001|Overall Study|Other|0|||
162610114|NCT02117414|587289664|FG000|Overall Study|Death|5|||
162610115|NCT02117414|587289665|FG001|Overall Study|Death|2|||
162610116|NCT02117414|587289664|FG000|Overall Study|Withdrawal by Subject|10|||
162610117|NCT02117414|587289665|FG001|Overall Study|Withdrawal by Subject|4|||
162610118|NCT02663687|587289667|FG000|Overall Study|Adverse Event|1|||
162610119|NCT02663687|587289668|FG001|Overall Study|Adverse Event|0|||
162610120|NCT02663687|587289669|FG002|Overall Study|Adverse Event|0|||
162610121|NCT02663687|587289670|FG003|Overall Study|Adverse Event|0|||
162610122|NCT02663687|587289671|FG004|Overall Study|Adverse Event|0|||
162610123|NCT02663687|587289667|FG000|Overall Study|Other|1|||
162610124|NCT02663687|587289668|FG001|Overall Study|Other|0|||
162610125|NCT02663687|587289669|FG002|Overall Study|Other|1|||
162610126|NCT02663687|587289670|FG003|Overall Study|Other|0|||
162610127|NCT02663687|587289671|FG004|Overall Study|Other|0|||
162610128|NCT03189381|587289672|FG000|Overall Study|Death|1|||
162610129|NCT03189381|587289673|FG001|Overall Study|Death|0|||
162610130|NCT04025710|587289679|FG000|Overall Study|Death|3|||
162610131|NCT04025710|587289679|FG000|Overall Study|Lost to Follow-up|5|||
162610132|NCT04025710|587289679|FG000|Overall Study|Withdrawal by Subject|1|||
162610133|NCT04025710|587289679|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
162610134|NCT04025710|587289679|FG000|Overall Study|Drop-out according to protocol|34|||
162610135|NCT01343901|587289682|FG000|Overall Study|Death|85|||
162610136|NCT01343901|587289682|FG000|Overall Study|Physician Decision|4|||
162610137|NCT01343901|587289682|FG000|Overall Study|Lost to Follow-up|12|||
162610138|NCT01343901|587289682|FG000|Overall Study|Management by another medical team|11|||
162610139|NCT01343901|587289682|FG000|Overall Study|Participant decision|1|||
162610140|NCT05308290|587289685|FG000|Overall Study|Death|1|||
162610141|NCT05308290|587289686|FG001|Overall Study|Death|0|||
162610142|NCT05308290|587289685|FG000|Overall Study|Lost to Follow-up|2|||
162610143|NCT05308290|587289686|FG001|Overall Study|Lost to Follow-up|1|||
162610144|NCT05308290|587289685|FG000|Overall Study|still in study followup|0|||
162610145|NCT05308290|587289686|FG001|Overall Study|still in study followup|1|||
162610146|NCT02117427|587289687|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
162610147|NCT02117427|587289688|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
162610148|NCT02117427|587289689|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
162610149|NCT02117427|587289687|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
162610150|NCT02117427|587289688|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
162610151|NCT02117427|587289689|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
162610152|NCT02117427|587289687|FG000|Overall Study|Physician Decision|0|||
162610153|NCT02117427|587289688|FG001|Overall Study|Physician Decision|2|||
162610154|NCT02117427|587289689|FG002|Overall Study|Physician Decision|0|||
162610155|NCT02117427|587289687|FG000|Overall Study|No longer meets inclusion criteria|0|||
162610156|NCT02117427|587289688|FG001|Overall Study|No longer meets inclusion criteria|1|||
162610157|NCT02117427|587289689|FG002|Overall Study|No longer meets inclusion criteria|0|||
162610158|NCT02117427|587289687|FG000|Overall Study|Death|0|||
162610159|NCT02117427|587289688|FG001|Overall Study|Death|1|||
162703890|NCT03990363|587627008|FG003|Overall Study|Lost to Follow-up|1|||
162703891|NCT03990363|587627009|FG004|Overall Study|Lost to Follow-up|2|||
162703892|NCT03990363|587627005|FG000|Overall Study|Non-compliance with study drug|2|||
162703893|NCT03990363|587627006|FG001|Overall Study|Non-compliance with study drug|1|||
162703894|NCT03990363|587627007|FG002|Overall Study|Non-compliance with study drug|2|||
162703895|NCT03990363|587627008|FG003|Overall Study|Non-compliance with study drug|0|||
162703896|NCT03990363|587627009|FG004|Overall Study|Non-compliance with study drug|0|||
162703897|NCT03990363|587627005|FG000|Overall Study|Study terminated by sponsor|0|||
162703898|NCT03990363|587627006|FG001|Overall Study|Study terminated by sponsor|1|||
162703899|NCT03990363|587627007|FG002|Overall Study|Study terminated by sponsor|0|||
162703900|NCT03990363|587627008|FG003|Overall Study|Study terminated by sponsor|0|||
162703901|NCT03990363|587627009|FG004|Overall Study|Study terminated by sponsor|0|||
162703902|NCT03990363|587627005|FG000|Overall Study|Site terminated by sponsor|2|||
162703903|NCT03990363|587627006|FG001|Overall Study|Site terminated by sponsor|1|||
162703904|NCT03990363|587627007|FG002|Overall Study|Site terminated by sponsor|2|||
162703905|NCT03990363|587627008|FG003|Overall Study|Site terminated by sponsor|0|||
162703906|NCT03990363|587627009|FG004|Overall Study|Site terminated by sponsor|2|||
162703907|NCT03990363|587627005|FG000|Overall Study|Not categorized|5|||
162703908|NCT03990363|587627006|FG001|Overall Study|Not categorized|5|||
162703909|NCT03990363|587627007|FG002|Overall Study|Not categorized|3|||
162703910|NCT03990363|587627008|FG003|Overall Study|Not categorized|2|||
162703911|NCT03990363|587627009|FG004|Overall Study|Not categorized|2|||
162703912|NCT01349660|587627010|FG000|Overall Study|Still Receiving Study Treatment|0|||
162703913|NCT01349660|587627011|FG001|Overall Study|Still Receiving Study Treatment|0|||
162703914|NCT01349660|587627012|FG002|Overall Study|Still Receiving Study Treatment|1|||
162703915|NCT01349660|587627010|FG000|Overall Study|Disease Progression|2|||
162703916|NCT01349660|587627011|FG001|Overall Study|Disease Progression|4|||
162703917|NCT01349660|587627012|FG002|Overall Study|Disease Progression|50|||
162703918|NCT01349660|587627010|FG000|Overall Study|Adverse Event|1|||
162703919|NCT01349660|587627011|FG001|Overall Study|Adverse Event|1|||
162703920|NCT01349660|587627012|FG002|Overall Study|Adverse Event|12|||
162703921|NCT01349660|587627010|FG000|Overall Study|Withdrawal by Subject|2|||
162703922|NCT01349660|587627011|FG001|Overall Study|Withdrawal by Subject|0|||
162703923|NCT01349660|587627012|FG002|Overall Study|Withdrawal by Subject|9|||
162703924|NCT01349660|587627010|FG000|Overall Study|Death|1|||
162703925|NCT01349660|587627011|FG001|Overall Study|Death|1|||
162703926|NCT01349660|587627012|FG002|Overall Study|Death|0|||
162703927|NCT01349660|587627010|FG000|Overall Study|Non-Permitted Interventions|0|||
162703928|NCT01349660|587627011|FG001|Overall Study|Non-Permitted Interventions|0|||
162703929|NCT01349660|587627012|FG002|Overall Study|Non-Permitted Interventions|2|||
162703930|NCT01349660|587627010|FG000|Overall Study|Study Compliance|0|||
162703931|NCT01349660|587627011|FG001|Overall Study|Study Compliance|0|||
162703932|NCT01349660|587627012|FG002|Overall Study|Study Compliance|1|||
162703933|NCT01349660|587627010|FG000|Overall Study|Declining Performance Status|0|||
162703934|NCT01349660|587627011|FG001|Overall Study|Declining Performance Status|0|||
162703935|NCT01349660|587627012|FG002|Overall Study|Declining Performance Status|1|||
162703936|NCT01563978|587627013|FG000|Overall Study|Physician Decision|1|||
162952088|NCT02422264|588529538|FG001|Overall Study|Subject vaccinated outside of the study|1|||
162703937|NCT01563978|587627014|FG001|Overall Study|Physician Decision|0|||
162703938|NCT01563978|587627013|FG000|Overall Study|Lost to Follow-up|1|||
162703939|NCT01563978|587627014|FG001|Overall Study|Lost to Follow-up|0|||
162703940|NCT01563978|587627013|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
162703941|NCT01563978|587627014|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
162703942|NCT01563978|587627013|FG000|Overall Study|Adverse Event|1|||
162703943|NCT01563978|587627014|FG001|Overall Study|Adverse Event|2|||
162703944|NCT04630756|587627015|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
162703945|NCT04630756|587627016|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
162703946|NCT04630756|587627017|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
162703947|NCT05593211|587627019|FG000|Overall Study|Withdrawal by Subject|1|||
162703948|NCT03225846|587627020|FG000|Overall Study|Adverse Event|0|||
162703949|NCT03225846|587627021|FG001|Overall Study|Adverse Event|0|||
162703950|NCT03225846|587627022|FG002|Overall Study|Adverse Event|0|||
162703951|NCT03225846|587627023|FG003|Overall Study|Adverse Event|0|||
162703952|NCT03225846|587627024|FG004|Overall Study|Adverse Event|0|||
162703953|NCT03225846|587627025|FG005|Overall Study|Adverse Event|0|||
162703954|NCT03225846|587627026|FG006|Overall Study|Adverse Event|6|||
162703955|NCT03225846|587627020|FG000|Overall Study|Withdrawal by Subject|0|||
162703956|NCT03225846|587627021|FG001|Overall Study|Withdrawal by Subject|1|||
162703957|NCT03225846|587627022|FG002|Overall Study|Withdrawal by Subject|0|||
162703958|NCT03225846|587627023|FG003|Overall Study|Withdrawal by Subject|0|||
162703959|NCT03225846|587627024|FG004|Overall Study|Withdrawal by Subject|0|||
162703960|NCT03225846|587627025|FG005|Overall Study|Withdrawal by Subject|0|||
162703961|NCT03225846|587627026|FG006|Overall Study|Withdrawal by Subject|0|||
162703962|NCT03225846|587627020|FG000|Overall Study|Death|0|||
162703963|NCT03225846|587627021|FG001|Overall Study|Death|1|||
162703964|NCT03225846|587627022|FG002|Overall Study|Death|0|||
162703965|NCT03225846|587627023|FG003|Overall Study|Death|0|||
162703966|NCT03225846|587627024|FG004|Overall Study|Death|0|||
162703967|NCT03225846|587627025|FG005|Overall Study|Death|0|||
162703968|NCT03225846|587627026|FG006|Overall Study|Death|0|||
162703969|NCT03225846|587627020|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703970|NCT03225846|587627021|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703971|NCT03225846|587627022|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
162703972|NCT03225846|587627023|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703973|NCT03225846|587627024|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703974|NCT03225846|587627025|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703975|NCT03225846|587627026|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
162703976|NCT03225846|587627020|FG000|Overall Study|Patient decision|0|||
162703977|NCT03225846|587627021|FG001|Overall Study|Patient decision|0|||
162703978|NCT03225846|587627022|FG002|Overall Study|Patient decision|0|||
162703979|NCT03225846|587627023|FG003|Overall Study|Patient decision|0|||
162849114|NCT00868790|588154757|FG006|Period 2|Adverse Event|0|||
162849115|NCT00868790|588154758|FG007|Period 2|Adverse Event|0|||
162849116|NCT00868790|588154759|FG008|Period 2|Adverse Event|1|||
162849117|NCT00868790|588154760|FG009|Period 2|Adverse Event|0|||
162849118|NCT00868790|588154761|FG010|Period 2|Adverse Event|0|||
162849119|NCT00868790|588154762|FG011|Period 2|Adverse Event|0|||
162849120|NCT00868790|588154763|FG012|Period 2|Adverse Event|0|||
162849121|NCT00868790|588154764|FG013|Period 2|Adverse Event|0|||
162849122|NCT00868790|588154751|FG000|Period 2|Lost to Follow-up|0|||
162849123|NCT00868790|588154752|FG001|Period 2|Lost to Follow-up|1|||
162849124|NCT00868790|588154753|FG002|Period 2|Lost to Follow-up|0|||
162849125|NCT00868790|588154754|FG003|Period 2|Lost to Follow-up|0|||
162849126|NCT00868790|588154755|FG004|Period 2|Lost to Follow-up|0|||
162849127|NCT00868790|588154756|FG005|Period 2|Lost to Follow-up|1|||
162849128|NCT00868790|588154757|FG006|Period 2|Lost to Follow-up|0|||
162849129|NCT00868790|588154758|FG007|Period 2|Lost to Follow-up|0|||
162849130|NCT00868790|588154759|FG008|Period 2|Lost to Follow-up|0|||
162952089|NCT03021018|588529539|FG000|Overall Study|Adverse Event|1|||
162952090|NCT03021018|588529540|FG001|Overall Study|Adverse Event|0|||
162952091|NCT03021018|588529541|FG002|Overall Study|Adverse Event|0|||
162952092|NCT03021018|588529539|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
162952093|NCT03021018|588529540|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
162952094|NCT03021018|588529541|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
162952095|NCT00328926|588529544|FG000|Overall Study|Pregnancy|2|||
162952096|NCT00328926|588529545|FG001|Overall Study|Pregnancy|1|||
162610160|NCT02117427|587289689|FG002|Overall Study|Death|0|||
162610161|NCT00410202|587289690|FG000|On-Treatment|Continuing treatment|69|||
162610162|NCT00410202|587289691|FG001|On-Treatment|Continuing treatment|71|||
162610163|NCT00410202|587289692|FG002|On-Treatment|Continuing treatment|66|||
162610164|NCT00410202|587289690|FG000|On-Treatment|Adverse Event|1|||
162610165|NCT00410202|587289691|FG001|On-Treatment|Adverse Event|3|||
162610166|NCT00410202|587289692|FG002|On-Treatment|Adverse Event|2|||
162610167|NCT00410202|587289690|FG000|On-Treatment|Death|1|||
162610168|NCT00410202|587289691|FG001|On-Treatment|Death|0|||
162610169|NCT00410202|587289692|FG002|On-Treatment|Death|0|||
162610170|NCT00410202|587289690|FG000|On-Treatment|Lost to Follow-up|1|||
162610171|NCT00410202|587289691|FG001|On-Treatment|Lost to Follow-up|0|||
162610172|NCT00410202|587289692|FG002|On-Treatment|Lost to Follow-up|1|||
162610173|NCT00410202|587289690|FG000|On-Treatment|Lack of Efficacy|1|||
162610174|NCT00410202|587289691|FG001|On-Treatment|Lack of Efficacy|4|||
162610175|NCT00410202|587289692|FG002|On-Treatment|Lack of Efficacy|0|||
162610176|NCT00410202|587289690|FG000|On-Treatment|Withdrawal by Subject|2|||
162610177|NCT00410202|587289691|FG001|On-Treatment|Withdrawal by Subject|1|||
162610178|NCT00410202|587289692|FG002|On-Treatment|Withdrawal by Subject|1|||
162610179|NCT00410202|587289690|FG000|On-Treatment|Other Reason|0|||
162610180|NCT00410202|587289691|FG001|On-Treatment|Other Reason|0|||
162610181|NCT00410202|587289692|FG002|On-Treatment|Other Reason|1|||
162610182|NCT00410202|587289690|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
162610183|NCT00410202|587289691|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
162610184|NCT00410202|587289692|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
162849131|NCT00868790|588154760|FG009|Period 2|Lost to Follow-up|0|||
162849132|NCT00868790|588154761|FG010|Period 2|Lost to Follow-up|0|||
162849133|NCT00868790|588154762|FG011|Period 2|Lost to Follow-up|0|||
162849134|NCT00868790|588154763|FG012|Period 2|Lost to Follow-up|0|||
162849135|NCT00868790|588154764|FG013|Period 2|Lost to Follow-up|0|||
162849136|NCT00868790|588154751|FG000|Period 2|Withdrawal by Subject|0|||
162849137|NCT00868790|588154752|FG001|Period 2|Withdrawal by Subject|0|||
162849138|NCT00868790|588154753|FG002|Period 2|Withdrawal by Subject|0|||
162849139|NCT00868790|588154754|FG003|Period 2|Withdrawal by Subject|0|||
162849140|NCT00868790|588154755|FG004|Period 2|Withdrawal by Subject|0|||
162849141|NCT00868790|588154756|FG005|Period 2|Withdrawal by Subject|0|||
162849142|NCT00868790|588154757|FG006|Period 2|Withdrawal by Subject|0|||
162849143|NCT00868790|588154758|FG007|Period 2|Withdrawal by Subject|0|||
162849144|NCT00868790|588154759|FG008|Period 2|Withdrawal by Subject|1|||
162849145|NCT00868790|588154760|FG009|Period 2|Withdrawal by Subject|0|||
162849146|NCT00868790|588154761|FG010|Period 2|Withdrawal by Subject|0|||
162849147|NCT00868790|588154762|FG011|Period 2|Withdrawal by Subject|0|||
162849148|NCT00868790|588154763|FG012|Period 2|Withdrawal by Subject|0|||
162849149|NCT00868790|588154764|FG013|Period 2|Withdrawal by Subject|1|||
162849150|NCT00868790|588154751|FG000|Period 3|Adverse Event|0|||
162849151|NCT00868790|588154752|FG001|Period 3|Adverse Event|0|||
162849152|NCT00868790|588154753|FG002|Period 3|Adverse Event|0|||
162849153|NCT00868790|588154754|FG003|Period 3|Adverse Event|0|||
162849154|NCT00868790|588154755|FG004|Period 3|Adverse Event|0|||
162849155|NCT00868790|588154756|FG005|Period 3|Adverse Event|0|||
162849156|NCT00868790|588154757|FG006|Period 3|Adverse Event|0|||
162849157|NCT00868790|588154758|FG007|Period 3|Adverse Event|0|||
162849158|NCT00868790|588154759|FG008|Period 3|Adverse Event|0|||
162849159|NCT00868790|588154760|FG009|Period 3|Adverse Event|1|||
162849160|NCT00868790|588154761|FG010|Period 3|Adverse Event|0|||
162849161|NCT00868790|588154762|FG011|Period 3|Adverse Event|0|||
162849162|NCT00868790|588154763|FG012|Period 3|Adverse Event|0|||
162849163|NCT00868790|588154764|FG013|Period 3|Adverse Event|0|||
162849164|NCT00868790|588154751|FG000|Period 3|Protocol Violation|0|||
162849165|NCT00868790|588154752|FG001|Period 3|Protocol Violation|0|||
162849166|NCT00868790|588154753|FG002|Period 3|Protocol Violation|0|||
162849167|NCT00868790|588154754|FG003|Period 3|Protocol Violation|0|||
162849168|NCT00868790|588154755|FG004|Period 3|Protocol Violation|0|||
162849169|NCT00868790|588154756|FG005|Period 3|Protocol Violation|0|||
162849170|NCT00868790|588154757|FG006|Period 3|Protocol Violation|0|||
162849171|NCT00868790|588154758|FG007|Period 3|Protocol Violation|0|||
162849172|NCT00868790|588154759|FG008|Period 3|Protocol Violation|0|||
162849173|NCT00868790|588154760|FG009|Period 3|Protocol Violation|0|||
162849174|NCT00868790|588154761|FG010|Period 3|Protocol Violation|1|||
162849175|NCT00868790|588154762|FG011|Period 3|Protocol Violation|0|||
162849176|NCT00868790|588154763|FG012|Period 3|Protocol Violation|0|||
162849177|NCT00868790|588154764|FG013|Period 3|Protocol Violation|0|||
162610185|NCT00410202|587289690|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
162610186|NCT00410202|587289691|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
162610187|NCT00410202|587289692|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
162849178|NCT00868790|588154751|FG000|Period 3|Study Terminated by Sponsor|0|||
162849179|NCT00868790|588154752|FG001|Period 3|Study Terminated by Sponsor|0|||
162849180|NCT00868790|588154753|FG002|Period 3|Study Terminated by Sponsor|0|||
162849181|NCT00868790|588154754|FG003|Period 3|Study Terminated by Sponsor|1|||
162849182|NCT00868790|588154755|FG004|Period 3|Study Terminated by Sponsor|0|||
162952097|NCT00328926|588529546|FG002|Overall Study|Pregnancy|0|||
162952098|NCT00328926|588529544|FG000|Overall Study|Lost to Follow-up|0|||
162952099|NCT00328926|588529545|FG001|Overall Study|Lost to Follow-up|1|||
162952100|NCT00328926|588529546|FG002|Overall Study|Lost to Follow-up|0|||
162952101|NCT00328926|588529544|FG000|Overall Study|Death|0|||
162952102|NCT00328926|588529545|FG001|Overall Study|Death|0|||
162952103|NCT00328926|588529546|FG002|Overall Study|Death|1|||
162952104|NCT00328926|588529544|FG000|Overall Study|In vitro fertilization treatment|0|||
162952105|NCT00328926|588529545|FG001|Overall Study|In vitro fertilization treatment|0|||
162952106|NCT00328926|588529546|FG002|Overall Study|In vitro fertilization treatment|1|||
162952107|NCT00328926|588529544|FG000|Overall Study|Lack of ovarian response|0|||
162952108|NCT00328926|588529545|FG001|Overall Study|Lack of ovarian response|1|||
162952109|NCT00328926|588529546|FG002|Overall Study|Lack of ovarian response|0|||
162952110|NCT02269657|588529547|FG000|Overall Study|Protocol Violation|3|||
162952111|NCT00834249|588529554|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162952112|NCT00834249|588529555|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
162952113|NCT00834249|588529554|FG000|Second Intervention|Adverse Event|1|||
162952114|NCT00834249|588529555|FG001|Second Intervention|Adverse Event|0|||
162952115|NCT00834743|588529556|FG000|Second Intervention|Withdrawal by Subject|1|||
162952116|NCT00834743|588529557|FG001|Second Intervention|Withdrawal by Subject|0|||
162952117|NCT01534663|588529558|FG000|Overall Study|Lost to Follow-up|0|||
162952118|NCT01534663|588529559|FG001|Overall Study|Lost to Follow-up|2|||
162952119|NCT01534663|588529558|FG000|Overall Study|Adverse Event|2|||
162952120|NCT01534663|588529559|FG001|Overall Study|Adverse Event|1|||
162952121|NCT04112823|588529562|FG000|Overall Study|Lost to Follow-up|2|||
162952122|NCT04112823|588529563|FG001|Overall Study|Lost to Follow-up|3|||
162952123|NCT01693523|588529564|FG000|Overall Study|Adverse Event|2|||
162952124|NCT01693523|588529565|FG001|Overall Study|Adverse Event|1|||
162952125|NCT01693523|588529566|FG002|Overall Study|Adverse Event|0|||
162952126|NCT01693523|588529564|FG000|Overall Study|Death|0|||
162952127|NCT01693523|588529565|FG001|Overall Study|Death|1|||
162952128|NCT01693523|588529566|FG002|Overall Study|Death|1|||
162952129|NCT01693523|588529564|FG000|Overall Study|Lost to Follow-up|0|||
162952130|NCT01693523|588529565|FG001|Overall Study|Lost to Follow-up|0|||
162952131|NCT01693523|588529566|FG002|Overall Study|Lost to Follow-up|4|||
162952132|NCT01693523|588529564|FG000|Overall Study|Physician Decision|0|||
162952133|NCT01693523|588529565|FG001|Overall Study|Physician Decision|0|||
162952134|NCT01693523|588529566|FG002|Overall Study|Physician Decision|1|||
162952135|NCT01693523|588529564|FG000|Overall Study|Withdrawal by Subject|1|||
162952136|NCT01693523|588529565|FG001|Overall Study|Withdrawal by Subject|2|||
162952137|NCT01693523|588529566|FG002|Overall Study|Withdrawal by Subject|2|||
162952138|NCT01693523|588529564|FG000|Overall Study|Lack of compliance study medication|1|||
162952139|NCT01693523|588529565|FG001|Overall Study|Lack of compliance study medication|2|||
162952140|NCT01693523|588529566|FG002|Overall Study|Lack of compliance study medication|0|||
162952141|NCT01693523|588529564|FG000|Overall Study|Chemotherapy was held|1|||
162952142|NCT01693523|588529565|FG001|Overall Study|Chemotherapy was held|2|||
162952143|NCT01693523|588529566|FG002|Overall Study|Chemotherapy was held|0|||
162952144|NCT03603314|588529569|FG000|Overall Study|Lost to Follow-up|0|||
162952145|NCT03603314|588529570|FG001|Overall Study|Lost to Follow-up|3|||
162952146|NCT03603314|588529571|FG002|Overall Study|Lost to Follow-up|0|||
162952147|NCT03603314|588529569|FG000|Overall Study|Protocol Violation|0|||
162952148|NCT03603314|588529570|FG001|Overall Study|Protocol Violation|1|||
162952149|NCT03603314|588529571|FG002|Overall Study|Protocol Violation|0|||
162952150|NCT03603314|588529569|FG000|Overall Study|Adverse Event|2|||
162952151|NCT03603314|588529570|FG001|Overall Study|Adverse Event|0|||
162952152|NCT03603314|588529571|FG002|Overall Study|Adverse Event|0|||
162952153|NCT03603314|588529569|FG000|Overall Study|Physician Decision|1|||
162952154|NCT03603314|588529570|FG001|Overall Study|Physician Decision|1|||
162952155|NCT03603314|588529571|FG002|Overall Study|Physician Decision|0|||
162952156|NCT03603314|588529569|FG000|Overall Study|Withdrawal by Subject|4|||
162952157|NCT03603314|588529570|FG001|Overall Study|Withdrawal by Subject|5|||
162952158|NCT03603314|588529571|FG002|Overall Study|Withdrawal by Subject|3|||
162952159|NCT03603314|588529569|FG000|Overall Study|Other|0|||
162952160|NCT03603314|588529570|FG001|Overall Study|Other|1|||
162952161|NCT03603314|588529571|FG002|Overall Study|Other|0|||
162952162|NCT00436553|588529572|FG000|Overall Study|Adverse Event|4|||
162952163|NCT00436553|588529573|FG001|Overall Study|Adverse Event|3|||
162952164|NCT00436553|588529574|FG002|Overall Study|Adverse Event|4|||
162952165|NCT00436553|588529572|FG000|Overall Study|Death|3|||
162952166|NCT00436553|588529573|FG001|Overall Study|Death|1|||
162952167|NCT00436553|588529574|FG002|Overall Study|Death|3|||
162952168|NCT00436553|588529572|FG000|Overall Study|Lost to Follow-up|0|||
162952169|NCT00436553|588529573|FG001|Overall Study|Lost to Follow-up|2|||
162952170|NCT00436553|588529574|FG002|Overall Study|Lost to Follow-up|0|||
162952171|NCT00436553|588529572|FG000|Overall Study|Protocol Violation|1|||
162952172|NCT00436553|588529573|FG001|Overall Study|Protocol Violation|0|||
162952173|NCT00436553|588529574|FG002|Overall Study|Protocol Violation|0|||
162952174|NCT00436553|588529572|FG000|Overall Study|Withdrawal by Subject|5|||
162952175|NCT00436553|588529573|FG001|Overall Study|Withdrawal by Subject|6|||
162952176|NCT00436553|588529574|FG002|Overall Study|Withdrawal by Subject|3|||
162952177|NCT00064753|588529585|FG000|Overall Study|Death|251|||
162952178|NCT00064753|588529586|FG001|Overall Study|Death|242|||
162952179|NCT00064753|588529585|FG000|Overall Study|Withdrawal by Subject|198|||
162952180|NCT00064753|588529586|FG001|Overall Study|Withdrawal by Subject|171|||
162952181|NCT00064753|588529585|FG000|Overall Study|Lost to Follow-up|225|||
162952182|NCT00064753|588529586|FG001|Overall Study|Lost to Follow-up|235|||
162952183|NCT02193880|588529587|FG000|Overall Study|patients did not collect enough HPC|3|||
162952184|NCT02419937|588529594|FG000|Overall Study|Lost to Follow-up|1|||
162952185|NCT02419937|588529595|FG001|Overall Study|Lost to Follow-up|0|||
162952186|NCT01182415|588529596|FG000|Overall Study|Lost to Follow-up|1|||
162952187|NCT01256684|588529597|FG000|Overall Study|Adverse Event|1|||
162952188|NCT01256684|588529598|FG001|Overall Study|Adverse Event|4|||
162952189|NCT01256684|588529599|FG002|Overall Study|Adverse Event|2|||
162952190|NCT01256684|588529597|FG000|Overall Study|Withdrawal by Subject|4|||
162952191|NCT01256684|588529598|FG001|Overall Study|Withdrawal by Subject|0|||
162952192|NCT01256684|588529599|FG002|Overall Study|Withdrawal by Subject|2|||
162952193|NCT01256684|588529597|FG000|Overall Study|Physician Decision|0|||
162952194|NCT01256684|588529598|FG001|Overall Study|Physician Decision|1|||
162952195|NCT01256684|588529599|FG002|Overall Study|Physician Decision|0|||
162952196|NCT01256684|588529597|FG000|Overall Study|Lack of Efficacy|0|||
162952197|NCT01256684|588529598|FG001|Overall Study|Lack of Efficacy|1|||
162952198|NCT01256684|588529599|FG002|Overall Study|Lack of Efficacy|1|||
162952199|NCT01256684|588529597|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
162952200|NCT01256684|588529598|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
162952201|NCT01256684|588529599|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
162952202|NCT02587962|588529602|FG000|Overall Study|Adverse Event|0|||
162952203|NCT02587962|588529603|FG001|Overall Study|Adverse Event|0|||
162952204|NCT02587962|588529604|FG002|Overall Study|Adverse Event|1|||
162952205|NCT02587962|588529605|FG003|Overall Study|Adverse Event|0|||
162952206|NCT02587962|588529606|FG004|Overall Study|Adverse Event|0|||
162952207|NCT02587962|588529602|FG000|Overall Study|Withdrawal by Subject|0|||
162952208|NCT02587962|588529603|FG001|Overall Study|Withdrawal by Subject|0|||
162952209|NCT02587962|588529604|FG002|Overall Study|Withdrawal by Subject|1|||
162952210|NCT02587962|588529605|FG003|Overall Study|Withdrawal by Subject|1|||
162952211|NCT02587962|588529606|FG004|Overall Study|Withdrawal by Subject|4|||
162952212|NCT02587962|588529602|FG000|Overall Study|Radiological progression|2|||
162952213|NCT02587962|588529603|FG001|Overall Study|Radiological progression|2|||
162952214|NCT02587962|588529604|FG002|Overall Study|Radiological progression|2|||
162952215|NCT02587962|588529605|FG003|Overall Study|Radiological progression|5|||
162952216|NCT02587962|588529606|FG004|Overall Study|Radiological progression|10|||
162952217|NCT02587962|588529602|FG000|Overall Study|Clinical progression|0|||
162952218|NCT02587962|588529603|FG001|Overall Study|Clinical progression|1|||
162952219|NCT02587962|588529604|FG002|Overall Study|Clinical progression|2|||
162952220|NCT02587962|588529605|FG003|Overall Study|Clinical progression|0|||
162952221|NCT02587962|588529606|FG004|Overall Study|Clinical progression|1|||
162952222|NCT00184600|588529607|FG000|Overall Study|Adverse Event|9|||
162952223|NCT00184600|588529608|FG001|Overall Study|Adverse Event|0|||
162952224|NCT00184600|588529609|FG002|Overall Study|Adverse Event|5|||
162952225|NCT00184600|588529607|FG000|Overall Study|Death|3|||
162952226|NCT00184600|588529608|FG001|Overall Study|Death|9|||
162952227|NCT00184600|588529609|FG002|Overall Study|Death|7|||
162952228|NCT00184600|588529607|FG000|Overall Study|Lack of Efficacy|3|||
162952229|NCT00184600|588529608|FG001|Overall Study|Lack of Efficacy|1|||
162952230|NCT00184600|588529609|FG002|Overall Study|Lack of Efficacy|3|||
162952231|NCT00184600|588529607|FG000|Overall Study|Lost to Follow-up|4|||
162952232|NCT00184600|588529608|FG001|Overall Study|Lost to Follow-up|6|||
162952233|NCT00184600|588529609|FG002|Overall Study|Lost to Follow-up|1|||
162952234|NCT00184600|588529607|FG000|Overall Study|Protocol Violation|2|||
162952235|NCT00184600|588529608|FG001|Overall Study|Protocol Violation|2|||
162952236|NCT00184600|588529609|FG002|Overall Study|Protocol Violation|3|||
162952237|NCT00184600|588529607|FG000|Overall Study|Withdrawal by Subject|20|||
162952238|NCT00184600|588529608|FG001|Overall Study|Withdrawal by Subject|28|||
162952239|NCT00184600|588529609|FG002|Overall Study|Withdrawal by Subject|12|||
162952240|NCT00184600|588529607|FG000|Overall Study|Unclassified|4|||
162952241|NCT00184600|588529608|FG001|Overall Study|Unclassified|5|||
162952242|NCT00184600|588529609|FG002|Overall Study|Unclassified|3|||
162952243|NCT00624065|588529610|FG000|Overall Study|Adverse Event|5|||
162952244|NCT00624065|588529611|FG001|Overall Study|Adverse Event|6|||
162952245|NCT00624065|588529610|FG000|Overall Study|Lost to Follow-up|4|||
162952246|NCT00624065|588529611|FG001|Overall Study|Lost to Follow-up|1|||
162952247|NCT00624065|588529610|FG000|Overall Study|Consent withdrawn|6|||
162952248|NCT00624065|588529611|FG001|Overall Study|Consent withdrawn|5|||
162952249|NCT00624065|588529610|FG000|Overall Study|Lack of Efficacy|0|||
162952250|NCT00624065|588529611|FG001|Overall Study|Lack of Efficacy|3|||
162703980|NCT03225846|587627024|FG004|Overall Study|Patient decision|0|||
162849183|NCT00868790|588154756|FG005|Period 3|Study Terminated by Sponsor|0|||
162952251|NCT00624065|588529610|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
162952252|NCT00624065|588529611|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
162952253|NCT01387022|588529612|FG000|Overall Study|Death|1|||
162952254|NCT01387022|588529613|FG001|Overall Study|Death|1|||
162703981|NCT03225846|587627025|FG005|Overall Study|Patient decision|0|||
162703982|NCT03225846|587627026|FG006|Overall Study|Patient decision|1|||
162703983|NCT00810641|587627034|FG000|Overall Study|Withdrawal by Subject|0|||
162703984|NCT00810641|587627035|FG001|Overall Study|Withdrawal by Subject|1|||
162703985|NCT00810641|587627036|FG002|Overall Study|Withdrawal by Subject|2|||
162703986|NCT01213173|587627040|FG000|Overall Study|Protocol Violation|2|||
162703987|NCT01213173|587627041|FG001|Overall Study|Protocol Violation|0|||
162703988|NCT01213173|587627040|FG000|Overall Study|Adverse Event|4|||
162703989|NCT01213173|587627041|FG001|Overall Study|Adverse Event|8|||
162703990|NCT01213173|587627040|FG000|Overall Study|Withdrawal by Subject|5|||
162703991|NCT01213173|587627041|FG001|Overall Study|Withdrawal by Subject|5|||
162703992|NCT01213173|587627040|FG000|Overall Study|Incorrect Enrollment|1|||
162703993|NCT01213173|587627041|FG001|Overall Study|Incorrect Enrollment|3|||
162703994|NCT02253316|587627042|FG000|Consolidation|Progression|4|||
162703995|NCT02253316|587627043|FG001|Consolidation|Progression|0|||
162703996|NCT02253316|587627044|FG002|Consolidation|Progression|0|||
162703997|NCT02253316|587627042|FG000|Consolidation|Non-Compliance|1|||
162703998|NCT02253316|587627043|FG001|Consolidation|Non-Compliance|0|||
162703999|NCT02253316|587627044|FG002|Consolidation|Non-Compliance|0|||
162704000|NCT02253316|587627042|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
162704001|NCT02253316|587627043|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
162704002|NCT02253316|587627044|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
162704003|NCT02253316|587627042|FG000|Consolidation|Secondary Malignancy|2|||
162704004|NCT02253316|587627043|FG001|Consolidation|Secondary Malignancy|0|||
162704005|NCT02253316|587627044|FG002|Consolidation|Secondary Malignancy|0|||
162704006|NCT02253316|587627042|FG000|Consolidation|Adverse Event|7|||
162849184|NCT00868790|588154757|FG006|Period 3|Study Terminated by Sponsor|0|||
162849185|NCT00868790|588154758|FG007|Period 3|Study Terminated by Sponsor|0|||
162849186|NCT00868790|588154759|FG008|Period 3|Study Terminated by Sponsor|0|||
162849187|NCT00868790|588154760|FG009|Period 3|Study Terminated by Sponsor|0|||
162849188|NCT00868790|588154761|FG010|Period 3|Study Terminated by Sponsor|0|||
162849189|NCT00868790|588154762|FG011|Period 3|Study Terminated by Sponsor|0|||
162849190|NCT00868790|588154763|FG012|Period 3|Study Terminated by Sponsor|0|||
162849191|NCT00868790|588154764|FG013|Period 3|Study Terminated by Sponsor|0|||
162849192|NCT00868790|588154751|FG000|Period 4|Adverse Event|0|||
162849193|NCT00868790|588154752|FG001|Period 4|Adverse Event|0|||
162849194|NCT00868790|588154753|FG002|Period 4|Adverse Event|0|||
162849195|NCT00868790|588154754|FG003|Period 4|Adverse Event|0|||
162849196|NCT00868790|588154755|FG004|Period 4|Adverse Event|0|||
162849197|NCT00868790|588154756|FG005|Period 4|Adverse Event|0|||
162849198|NCT00868790|588154757|FG006|Period 4|Adverse Event|0|||
162849199|NCT00868790|588154758|FG007|Period 4|Adverse Event|1|||
162849200|NCT00868790|588154759|FG008|Period 4|Adverse Event|0|||
162849201|NCT00868790|588154760|FG009|Period 4|Adverse Event|0|||
162849202|NCT00868790|588154761|FG010|Period 4|Adverse Event|1|||
162849203|NCT00868790|588154762|FG011|Period 4|Adverse Event|0|||
162849204|NCT00868790|588154763|FG012|Period 4|Adverse Event|1|||
162849205|NCT00868790|588154764|FG013|Period 4|Adverse Event|0|||
162849206|NCT00868790|588154751|FG000|Period 4|Lost to Follow-up|0|||
162849207|NCT00868790|588154752|FG001|Period 4|Lost to Follow-up|0|||
162849208|NCT00868790|588154753|FG002|Period 4|Lost to Follow-up|0|||
162849209|NCT00868790|588154754|FG003|Period 4|Lost to Follow-up|0|||
162849210|NCT00868790|588154755|FG004|Period 4|Lost to Follow-up|0|||
162849211|NCT00868790|588154756|FG005|Period 4|Lost to Follow-up|0|||
162849212|NCT00868790|588154757|FG006|Period 4|Lost to Follow-up|0|||
162849213|NCT00868790|588154758|FG007|Period 4|Lost to Follow-up|1|||
162849214|NCT00868790|588154759|FG008|Period 4|Lost to Follow-up|0|||
162849215|NCT00868790|588154760|FG009|Period 4|Lost to Follow-up|0|||
162849216|NCT00868790|588154761|FG010|Period 4|Lost to Follow-up|0|||
162849217|NCT00868790|588154762|FG011|Period 4|Lost to Follow-up|0|||
162849218|NCT00868790|588154763|FG012|Period 4|Lost to Follow-up|0|||
162849219|NCT00868790|588154764|FG013|Period 4|Lost to Follow-up|0|||
162849220|NCT00868790|588154751|FG000|Period 4|Study Terminated by Sponsor|2|||
162849221|NCT00868790|588154752|FG001|Period 4|Study Terminated by Sponsor|0|||
162849222|NCT00868790|588154753|FG002|Period 4|Study Terminated by Sponsor|0|||
162952255|NCT01387022|588529612|FG000|Overall Study|Lost to Follow-up|0|||
162849223|NCT00868790|588154754|FG003|Period 4|Study Terminated by Sponsor|0|||
162849224|NCT00868790|588154755|FG004|Period 4|Study Terminated by Sponsor|0|||
162704007|NCT02253316|587627043|FG001|Consolidation|Adverse Event|0|||
162849225|NCT00868790|588154756|FG005|Period 4|Study Terminated by Sponsor|0|||
162849226|NCT00868790|588154757|FG006|Period 4|Study Terminated by Sponsor|0|||
162610188|NCT00410202|587289690|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
162610189|NCT00410202|587289691|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
162610190|NCT00410202|587289692|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
162610191|NCT01178073|587289695|FG000|Overall Study|Adverse Event|34|||
162610192|NCT01178073|587289696|FG001|Overall Study|Adverse Event|27|||
162610193|NCT01178073|587289697|FG002|Overall Study|Adverse Event|24|||
162610194|NCT01178073|587289695|FG000|Overall Study|Protocol Violation|1|||
162610195|NCT01178073|587289696|FG001|Overall Study|Protocol Violation|1|||
162610196|NCT01178073|587289697|FG002|Overall Study|Protocol Violation|1|||
162610197|NCT01178073|587289695|FG000|Overall Study|Lost to Follow-up|2|||
162610198|NCT01178073|587289696|FG001|Overall Study|Lost to Follow-up|0|||
162610199|NCT01178073|587289697|FG002|Overall Study|Lost to Follow-up|3|||
162610200|NCT01178073|587289695|FG000|Overall Study|Physician Decision|14|||
162610201|NCT01178073|587289696|FG001|Overall Study|Physician Decision|10|||
162610202|NCT01178073|587289697|FG002|Overall Study|Physician Decision|10|||
162610203|NCT01178073|587289695|FG000|Overall Study|Withdrawal by Subject|10|||
162610204|NCT01178073|587289696|FG001|Overall Study|Withdrawal by Subject|6|||
162610205|NCT01178073|587289697|FG002|Overall Study|Withdrawal by Subject|8|||
162610206|NCT01178073|587289695|FG000|Overall Study|Missing Completion Status|1|||
162610207|NCT01178073|587289696|FG001|Overall Study|Missing Completion Status|0|||
162610208|NCT01178073|587289697|FG002|Overall Study|Missing Completion Status|0|||
162610209|NCT01674634|587289698|FG000|Overall Study|Withdrawal by Subject|3|||
162610210|NCT01674634|587289698|FG000|Overall Study|Lost to Follow-up|3|||
162610211|NCT00937391|587289699|FG000|Stage 2|Withdrawal by Subject|1|||
162610212|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
162849227|NCT00868790|588154758|FG007|Period 4|Study Terminated by Sponsor|1|||
162849228|NCT00868790|588154759|FG008|Period 4|Study Terminated by Sponsor|2|||
162849229|NCT00868790|588154760|FG009|Period 4|Study Terminated by Sponsor|0|||
162849230|NCT00868790|588154761|FG010|Period 4|Study Terminated by Sponsor|2|||
162849231|NCT00868790|588154762|FG011|Period 4|Study Terminated by Sponsor|1|||
162849232|NCT00868790|588154763|FG012|Period 4|Study Terminated by Sponsor|0|||
162849233|NCT00868790|588154764|FG013|Period 4|Study Terminated by Sponsor|1|||
162849234|NCT00868790|588154751|FG000|Period 4|Abnormal ALT/AST|0|||
162849235|NCT00868790|588154752|FG001|Period 4|Abnormal ALT/AST|0|||
162849236|NCT00868790|588154753|FG002|Period 4|Abnormal ALT/AST|1|||
162849237|NCT00868790|588154754|FG003|Period 4|Abnormal ALT/AST|0|||
162849238|NCT00868790|588154755|FG004|Period 4|Abnormal ALT/AST|0|||
162849239|NCT00868790|588154756|FG005|Period 4|Abnormal ALT/AST|0|||
162849240|NCT00868790|588154757|FG006|Period 4|Abnormal ALT/AST|0|||
162849241|NCT00868790|588154758|FG007|Period 4|Abnormal ALT/AST|0|||
162849242|NCT00868790|588154759|FG008|Period 4|Abnormal ALT/AST|0|||
162849243|NCT00868790|588154760|FG009|Period 4|Abnormal ALT/AST|0|||
162849244|NCT00868790|588154761|FG010|Period 4|Abnormal ALT/AST|0|||
162849245|NCT00868790|588154762|FG011|Period 4|Abnormal ALT/AST|0|||
162849246|NCT00868790|588154763|FG012|Period 4|Abnormal ALT/AST|0|||
162849247|NCT00868790|588154764|FG013|Period 4|Abnormal ALT/AST|0|||
162849248|NCT00868790|588154751|FG000|Post-study|Withdrawal by Subject|0|||
162849249|NCT00868790|588154752|FG001|Post-study|Withdrawal by Subject|0|||
162849250|NCT00868790|588154753|FG002|Post-study|Withdrawal by Subject|0|||
162849251|NCT00868790|588154754|FG003|Post-study|Withdrawal by Subject|0|||
162849252|NCT00868790|588154755|FG004|Post-study|Withdrawal by Subject|1|||
162849253|NCT00868790|588154756|FG005|Post-study|Withdrawal by Subject|0|||
162849254|NCT00868790|588154757|FG006|Post-study|Withdrawal by Subject|0|||
162849255|NCT00868790|588154758|FG007|Post-study|Withdrawal by Subject|0|||
162849256|NCT00868790|588154759|FG008|Post-study|Withdrawal by Subject|0|||
162849257|NCT00868790|588154760|FG009|Post-study|Withdrawal by Subject|0|||
162849258|NCT00868790|588154761|FG010|Post-study|Withdrawal by Subject|0|||
162849259|NCT00868790|588154762|FG011|Post-study|Withdrawal by Subject|0|||
162849260|NCT00868790|588154763|FG012|Post-study|Withdrawal by Subject|0|||
162849261|NCT00868790|588154764|FG013|Post-study|Withdrawal by Subject|0|||
162849262|NCT00868790|588154751|FG000|Post-study|Excluded Medication|0|||
162849263|NCT00868790|588154752|FG001|Post-study|Excluded Medication|0|||
162849264|NCT00868790|588154753|FG002|Post-study|Excluded Medication|0|||
162849265|NCT00868790|588154754|FG003|Post-study|Excluded Medication|0|||
162849266|NCT00868790|588154755|FG004|Post-study|Excluded Medication|0|||
162849267|NCT00868790|588154756|FG005|Post-study|Excluded Medication|0|||
162849268|NCT00868790|588154757|FG006|Post-study|Excluded Medication|0|||
162849269|NCT00868790|588154758|FG007|Post-study|Excluded Medication|2|||
162849270|NCT00868790|588154759|FG008|Post-study|Excluded Medication|0|||
162849271|NCT00868790|588154760|FG009|Post-study|Excluded Medication|1|||
162849272|NCT00868790|588154761|FG010|Post-study|Excluded Medication|0|||
162849273|NCT00868790|588154762|FG011|Post-study|Excluded Medication|0|||
162610213|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
162610214|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
162610215|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
162610216|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162849274|NCT00868790|588154763|FG012|Post-study|Excluded Medication|0|||
162849275|NCT00868790|588154764|FG013|Post-study|Excluded Medication|0|||
162849276|NCT02909153|588154769|FG000|Overall Study|Withdrawal by Subject|0|||
162849277|NCT02909153|588154770|FG001|Overall Study|Withdrawal by Subject|1|||
162952256|NCT01387022|588529613|FG001|Overall Study|Lost to Follow-up|3|||
162952257|NCT02076022|588529614|FG000|Overall Study|Withdrawal by Subject|2|||
162952258|NCT02076022|588529615|FG001|Overall Study|Withdrawal by Subject|0|||
162952259|NCT01536405|588529618|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
162952260|NCT01536405|588529619|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
162952261|NCT01536405|588529618|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
162952262|NCT01536405|588529619|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
162952263|NCT01536405|588529618|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
162952264|NCT01536405|588529619|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
162952265|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
162952266|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
162952267|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
162952268|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
162952269|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
162952270|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
162952271|NCT01536405|588529618|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
162952272|NCT01536405|588529619|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
162952273|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
162952274|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
162952275|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
162952276|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
162952277|NCT01536405|588529618|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
162952278|NCT01536405|588529619|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
162952279|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
162952280|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
162952281|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
162952282|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
162952283|NCT01536405|588529618|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
162952284|NCT01536405|588529619|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
162952285|NCT01844375|588529623|FG000|Overall Study|Protocol Violation|1|||
162952286|NCT01844375|588529624|FG001|Overall Study|Protocol Violation|1|||
162952287|NCT03627091|588529625|FG000|Overall Study|Adverse Event|0|||
162952288|NCT03627091|588529626|FG001|Overall Study|Adverse Event|0|||
162952289|NCT03627091|588529627|FG002|Overall Study|Adverse Event|2|||
162952290|NCT03627091|588529625|FG000|Overall Study|Withdrawal by Subject|2|||
162952291|NCT03627091|588529626|FG001|Overall Study|Withdrawal by Subject|0|||
162952292|NCT03627091|588529627|FG002|Overall Study|Withdrawal by Subject|2|||
162952293|NCT03627091|588529625|FG000|Overall Study|Physician Decision|2|||
162952294|NCT03627091|588529626|FG001|Overall Study|Physician Decision|0|||
162952295|NCT03627091|588529627|FG002|Overall Study|Physician Decision|0|||
162952296|NCT03627091|588529625|FG000|Overall Study|Site terminated by sponsor|0|||
162952297|NCT03627091|588529626|FG001|Overall Study|Site terminated by sponsor|1|||
162952298|NCT03627091|588529627|FG002|Overall Study|Site terminated by sponsor|0|||
162952299|NCT03627091|588529625|FG000|Overall Study|Disease relapse|7|||
162952300|NCT03627091|588529626|FG001|Overall Study|Disease relapse|5|||
162952301|NCT03627091|588529627|FG002|Overall Study|Disease relapse|1|||
162952302|NCT03627091|588529625|FG000|Overall Study|Other|1|||
162952303|NCT03627091|588529626|FG001|Overall Study|Other|0|||
162952304|NCT03627091|588529627|FG002|Overall Study|Other|0|||
162849278|NCT02909153|588154771|FG002|Overall Study|Withdrawal by Subject|0|||
162849279|NCT02909153|588154772|FG003|Overall Study|Withdrawal by Subject|0|||
162849280|NCT02909153|588154773|FG004|Overall Study|Withdrawal by Subject|0|||
162849281|NCT01273064|588154774|FG000|Overall Study|Adverse Event|5|||
162849282|NCT01273064|588154775|FG001|Overall Study|Adverse Event|1|||
162849283|NCT01273064|588154776|FG002|Overall Study|Adverse Event|3|||
162849284|NCT01273064|588154777|FG003|Overall Study|Adverse Event|2|||
162952305|NCT00579670|588529628|FG000|Overall Study|Death|1|||
162952306|NCT00579670|588529629|FG001|Overall Study|Death|0|||
162952307|NCT00579670|588529630|FG002|Overall Study|Death|0|||
162952308|NCT00579670|588529631|FG003|Overall Study|Death|0|||
162952309|NCT00579670|588529632|FG004|Overall Study|Death|0|||
162952310|NCT00579670|588529628|FG000|Overall Study|Adverse Event|1|||
162952311|NCT00579670|588529629|FG001|Overall Study|Adverse Event|0|||
162952312|NCT00579670|588529630|FG002|Overall Study|Adverse Event|1|||
162952313|NCT00579670|588529631|FG003|Overall Study|Adverse Event|2|||
162952314|NCT00579670|588529632|FG004|Overall Study|Adverse Event|0|||
162952315|NCT00579670|588529628|FG000|Overall Study|Lack of Efficacy|0|||
162952316|NCT00579670|588529629|FG001|Overall Study|Lack of Efficacy|0|||
162952317|NCT00579670|588529630|FG002|Overall Study|Lack of Efficacy|1|||
162952318|NCT00579670|588529631|FG003|Overall Study|Lack of Efficacy|14|||
162952319|NCT00579670|588529632|FG004|Overall Study|Lack of Efficacy|0|||
162952320|NCT00579670|588529628|FG000|Overall Study|Lost to Follow-up|0|||
162952321|NCT00579670|588529629|FG001|Overall Study|Lost to Follow-up|1|||
162952322|NCT00579670|588529630|FG002|Overall Study|Lost to Follow-up|0|||
162952323|NCT00579670|588529631|FG003|Overall Study|Lost to Follow-up|4|||
162952324|NCT00579670|588529632|FG004|Overall Study|Lost to Follow-up|0|||
162952325|NCT00579670|588529628|FG000|Overall Study|Other|0|||
162952326|NCT00579670|588529629|FG001|Overall Study|Other|0|||
162952327|NCT00579670|588529630|FG002|Overall Study|Other|1|||
162952328|NCT00579670|588529631|FG003|Overall Study|Other|2|||
162952329|NCT00579670|588529632|FG004|Overall Study|Other|0|||
162952330|NCT00579670|588529628|FG000|Overall Study|Withdrawal by Subject|0|||
162952331|NCT00579670|588529629|FG001|Overall Study|Withdrawal by Subject|0|||
162952332|NCT00579670|588529630|FG002|Overall Study|Withdrawal by Subject|1|||
162952333|NCT00579670|588529631|FG003|Overall Study|Withdrawal by Subject|0|||
162952334|NCT00579670|588529632|FG004|Overall Study|Withdrawal by Subject|0|||
162952335|NCT01863745|588529635|FG000|Overall Study|Disease Progression|9|||
162952336|NCT01863745|588529635|FG000|Overall Study|Adverse Event|2|||
162952337|NCT01863745|588529635|FG000|Overall Study|Death|1|||
162952338|NCT01863745|588529635|FG000|Overall Study|Withdrawal by Subject|1|||
162952339|NCT01171963|588529638|FG000|Overall Study|Adverse Event|10|||
162952340|NCT01171963|588529639|FG001|Overall Study|Adverse Event|15|||
162952341|NCT01171963|588529638|FG000|Overall Study|Lost to Follow-up|23|||
162952342|NCT01171963|588529639|FG001|Overall Study|Lost to Follow-up|24|||
162952343|NCT01171963|588529638|FG000|Overall Study|Other - diarrhoea|1|||
162952344|NCT01171963|588529639|FG001|Overall Study|Other - diarrhoea|0|||
162952345|NCT01171963|588529638|FG000|Overall Study|Withdrawal by Subject|114|||
162952346|NCT01171963|588529639|FG001|Overall Study|Withdrawal by Subject|129|||
162952347|NCT05093205|588529640|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
162952348|NCT05093205|588529641|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
162952349|NCT05093205|588529642|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
162952350|NCT05093205|588529643|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
162952351|NCT05093205|588529644|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
162952352|NCT05093205|588529645|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
162952353|NCT05093205|588529646|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
162952354|NCT05093205|588529647|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
162849285|NCT01273064|588154778|FG004|Overall Study|Adverse Event|1|||
162849286|NCT01273064|588154774|FG000|Overall Study|Withdrawal by Subject|4|||
162952355|NCT05093205|588529648|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
162952356|NCT05093205|588529649|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
162952357|NCT05093205|588529650|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
162952358|NCT05093205|588529651|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
162952359|NCT05093205|588529652|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
162952360|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952361|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162849287|NCT01273064|588154775|FG001|Overall Study|Withdrawal by Subject|2|||
162952362|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
162610217|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
162610218|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162610219|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162610220|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
162610221|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162610222|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162952363|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952364|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952365|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952366|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952367|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952368|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952369|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952370|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952371|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952372|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
162952373|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
162952374|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
162952375|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
162952376|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
162952377|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
162952378|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
162952379|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
162952380|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
162952381|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
162952382|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
162952383|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
162952384|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
162952385|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
162952386|NCT05093205|588529640|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
162952387|NCT05093205|588529641|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
162952388|NCT05093205|588529642|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
162952389|NCT05093205|588529643|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
162952390|NCT05093205|588529644|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
162952391|NCT05093205|588529645|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
162952392|NCT05093205|588529646|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
162952393|NCT05093205|588529647|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
162952394|NCT05093205|588529648|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
162952395|NCT05093205|588529649|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
162952396|NCT05093205|588529650|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
162952397|NCT05093205|588529651|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
162952398|NCT05093205|588529652|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
162952399|NCT05093205|588529640|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
162952400|NCT05093205|588529641|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
162952401|NCT05093205|588529642|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
162952402|NCT05093205|588529643|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
162952403|NCT05093205|588529644|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
162952404|NCT05093205|588529645|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
162952405|NCT05093205|588529646|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
162952406|NCT05093205|588529647|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
162952407|NCT05093205|588529648|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
162952408|NCT05093205|588529649|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
162952409|NCT05093205|588529650|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
162952410|NCT05093205|588529651|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
162952411|NCT05093205|588529652|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
162952412|NCT05093205|588529640|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
162952413|NCT05093205|588529641|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
162952414|NCT05093205|588529642|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
162952415|NCT05093205|588529643|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
162952416|NCT05093205|588529644|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
162952417|NCT05093205|588529645|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
162952418|NCT05093205|588529646|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
162952419|NCT05093205|588529647|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
162952420|NCT05093205|588529648|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
162952421|NCT05093205|588529649|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
162952422|NCT05093205|588529650|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
162952423|NCT05093205|588529651|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
162952424|NCT05093205|588529652|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
162952425|NCT05093205|588529640|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
162952426|NCT05093205|588529641|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
162952427|NCT05093205|588529642|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
162610223|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162952428|NCT05093205|588529643|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
162952429|NCT05093205|588529644|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
162952430|NCT05093205|588529645|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
162952431|NCT05093205|588529646|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
162952432|NCT05093205|588529647|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
162952433|NCT05093205|588529648|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
162952434|NCT05093205|588529649|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
162952435|NCT05093205|588529650|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
162952436|NCT05093205|588529651|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
162952437|NCT05093205|588529652|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
162952438|NCT05093205|588529640|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
162952439|NCT05093205|588529641|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
162952440|NCT05093205|588529642|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
162952441|NCT05093205|588529643|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
162952442|NCT05093205|588529644|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
162952443|NCT05093205|588529645|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
162952444|NCT05093205|588529646|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
162952445|NCT05093205|588529647|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
162952446|NCT05093205|588529648|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
162952447|NCT05093205|588529649|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
162952448|NCT05093205|588529650|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
162952449|NCT05093205|588529651|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
162952450|NCT05093205|588529652|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
162952451|NCT05093205|588529640|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952452|NCT05093205|588529641|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952453|NCT05093205|588529642|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952454|NCT05093205|588529643|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952455|NCT05093205|588529644|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952456|NCT05093205|588529645|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952457|NCT05093205|588529646|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952458|NCT05093205|588529647|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952459|NCT05093205|588529648|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952460|NCT05093205|588529649|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
162952461|NCT05093205|588529650|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952462|NCT05093205|588529651|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952463|NCT05093205|588529652|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
162952464|NCT05093205|588529640|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
162952465|NCT05093205|588529641|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
162952466|NCT05093205|588529642|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
162952467|NCT05093205|588529643|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
162952468|NCT05093205|588529644|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
162952469|NCT05093205|588529645|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
162952470|NCT05093205|588529646|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
162952471|NCT05093205|588529647|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
162952472|NCT05093205|588529648|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
162952473|NCT05093205|588529649|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
162952474|NCT05093205|588529650|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
162952475|NCT05093205|588529651|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
162952476|NCT05093205|588529652|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
162952477|NCT05093205|588529640|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952478|NCT05093205|588529641|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952479|NCT05093205|588529642|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952480|NCT05093205|588529643|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952481|NCT05093205|588529644|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952482|NCT05093205|588529645|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952483|NCT05093205|588529646|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952484|NCT05093205|588529647|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952485|NCT05093205|588529648|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952486|NCT05093205|588529649|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952487|NCT05093205|588529650|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
162952488|NCT05093205|588529651|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952489|NCT05093205|588529652|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
162952490|NCT05093205|588529640|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952491|NCT05093205|588529641|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952492|NCT05093205|588529642|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952493|NCT05093205|588529643|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952494|NCT05093205|588529644|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952495|NCT05093205|588529645|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952496|NCT05093205|588529646|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952497|NCT05093205|588529647|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952498|NCT05093205|588529648|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952499|NCT05093205|588529649|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952500|NCT05093205|588529650|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952501|NCT05093205|588529651|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
162952502|NCT05093205|588529652|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
162952503|NCT05093205|588529640|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
162952504|NCT05093205|588529641|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
162952505|NCT05093205|588529642|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
162952506|NCT05093205|588529643|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
162952507|NCT05093205|588529644|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
162952508|NCT05093205|588529645|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
162952509|NCT05093205|588529646|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
162952510|NCT05093205|588529647|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
162952511|NCT05093205|588529648|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
162952512|NCT05093205|588529649|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
162952513|NCT05093205|588529650|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
162952514|NCT05093205|588529651|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
162952515|NCT05093205|588529652|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
162952516|NCT05093205|588529640|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952517|NCT05093205|588529641|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952518|NCT05093205|588529642|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952519|NCT05093205|588529643|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952520|NCT05093205|588529644|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952521|NCT05093205|588529645|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952522|NCT05093205|588529646|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952523|NCT05093205|588529647|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952524|NCT05093205|588529648|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952525|NCT05093205|588529649|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952526|NCT05093205|588529650|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952527|NCT05093205|588529651|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
162952528|NCT05093205|588529652|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
162952529|NCT00268905|588529660|FG000|Overall Study|Adverse Event|3|||
162952530|NCT00268905|588529661|FG001|Overall Study|Adverse Event|0|||
162952531|NCT00268905|588529662|FG002|Overall Study|Adverse Event|4|||
162952532|NCT00268905|588529660|FG000|Overall Study|Lost to Follow-up|0|||
162952533|NCT00268905|588529661|FG001|Overall Study|Lost to Follow-up|1|||
162952534|NCT00268905|588529662|FG002|Overall Study|Lost to Follow-up|0|||
162952535|NCT00268905|588529660|FG000|Overall Study|Withdrawal by Subject|0|||
162952536|NCT00268905|588529661|FG001|Overall Study|Withdrawal by Subject|0|||
162952537|NCT00268905|588529662|FG002|Overall Study|Withdrawal by Subject|3|||
162952538|NCT00268905|588529660|FG000|Overall Study|Progressive Disease|28|||
162952539|NCT00268905|588529661|FG001|Overall Study|Progressive Disease|4|||
162952540|NCT00268905|588529662|FG002|Overall Study|Progressive Disease|3|||
162952541|NCT00268905|588529660|FG000|Overall Study|Physician Decision|3|||
162952542|NCT00268905|588529661|FG001|Overall Study|Physician Decision|0|||
162952543|NCT00268905|588529662|FG002|Overall Study|Physician Decision|1|||
162952544|NCT00268905|588529660|FG000|Overall Study|Clinical Progression|9|||
162952545|NCT00268905|588529661|FG001|Overall Study|Clinical Progression|4|||
162952546|NCT00268905|588529662|FG002|Overall Study|Clinical Progression|1|||
162952547|NCT01406795|588529663|FG000|Overall Study|Withdrawal by Subject|1|||
162952548|NCT03897088|588529664|FG000|Overall Study|Withdrawal by Subject|12|||
162952549|NCT03897088|588529665|FG001|Overall Study|Withdrawal by Subject|12|||
162952550|NCT03897088|588529664|FG000|Overall Study|Lost to Follow-up|7|||
162952551|NCT03897088|588529665|FG001|Overall Study|Lost to Follow-up|15|||
162952552|NCT03897088|588529664|FG000|Overall Study|Sponsor Decision|1|||
162952553|NCT03897088|588529665|FG001|Overall Study|Sponsor Decision|2|||
162952554|NCT03897088|588529664|FG000|Overall Study|COVID-19|2|||
162952555|NCT03897088|588529665|FG001|Overall Study|COVID-19|0|||
162952556|NCT03897088|588529664|FG000|Overall Study|Other|3|||
162952557|NCT03897088|588529665|FG001|Overall Study|Other|0|||
162952558|NCT03897088|588529664|FG000|Overall Study|Non-compliance with Study Drug|1|||
162952559|NCT03897088|588529665|FG001|Overall Study|Non-compliance with Study Drug|1|||
162952560|NCT03897088|588529664|FG000|Overall Study|Pregnancy|0|||
162952561|NCT03897088|588529665|FG001|Overall Study|Pregnancy|1|||
162952562|NCT01469546|588529666|FG000|Received 5 mg Dose|Adverse Event|13|||
162952563|NCT01469546|588529666|FG000|Received 5 mg Dose|Death|2|||
162952564|NCT01469546|588529666|FG000|Received 5 mg Dose|Protocol Violation|2|||
162952565|NCT01469546|588529666|FG000|Received 5 mg Dose|Progressive Disease|3|||
162952566|NCT01469546|588529666|FG000|Received 5 mg Dose|Physician Decision|3|||
162952567|NCT02865122|588529667|FG000|Overall Study|Adverse Event|1|||
162952568|NCT02865122|588529668|FG001|Overall Study|Adverse Event|0|||
162952569|NCT02865122|588529669|FG002|Overall Study|Adverse Event|0|||
162952570|NCT01811953|588531592|FG000|Overall Study|Adverse Event|0|||
162849288|NCT01273064|588154776|FG002|Overall Study|Withdrawal by Subject|2|||
162849289|NCT01273064|588154777|FG003|Overall Study|Withdrawal by Subject|2|||
162849290|NCT01273064|588154778|FG004|Overall Study|Withdrawal by Subject|0|||
162849291|NCT01273064|588154774|FG000|Overall Study|Study Termination|13|||
162849292|NCT01273064|588154775|FG001|Overall Study|Study Termination|27|||
162952571|NCT01811953|588531593|FG001|Overall Study|Adverse Event|0|||
162952572|NCT01811953|588531594|FG002|Overall Study|Adverse Event|0|||
162952573|NCT01811953|588531595|FG003|Overall Study|Adverse Event|1|||
162952574|NCT01811953|588531596|FG004|Overall Study|Adverse Event|0|||
162952575|NCT01811953|588531597|FG005|Overall Study|Adverse Event|1|||
162952576|NCT01811953|588531592|FG000|Overall Study|Protocol Violation|0|||
162952577|NCT01811953|588531593|FG001|Overall Study|Protocol Violation|0|||
162952578|NCT01811953|588531594|FG002|Overall Study|Protocol Violation|0|||
162952579|NCT01811953|588531595|FG003|Overall Study|Protocol Violation|0|||
162952580|NCT01811953|588531596|FG004|Overall Study|Protocol Violation|1|||
162952581|NCT01811953|588531597|FG005|Overall Study|Protocol Violation|0|||
162952582|NCT04089735|588531606|FG000|Overall Study|Adverse Event|1|||
162952583|NCT04089735|588531607|FG001|Overall Study|Adverse Event|0|||
162952584|NCT04089735|588531608|FG002|Overall Study|Adverse Event|1|||
162952585|NCT04089735|588531609|FG003|Overall Study|Adverse Event|1|||
162952586|NCT04089735|588531610|FG004|Overall Study|Adverse Event|0|||
162952587|NCT04089735|588531611|FG005|Overall Study|Adverse Event|0|||
162952588|NCT04089735|588531606|FG000|Overall Study|Physician Decision|0|||
162952589|NCT04089735|588531607|FG001|Overall Study|Physician Decision|3|||
162952590|NCT04089735|588531608|FG002|Overall Study|Physician Decision|0|||
162952591|NCT04089735|588531609|FG003|Overall Study|Physician Decision|0|||
162952592|NCT04089735|588531610|FG004|Overall Study|Physician Decision|0|||
162952593|NCT04089735|588531611|FG005|Overall Study|Physician Decision|0|||
162952594|NCT04089735|588531606|FG000|Overall Study|Withdrawal by Subject|0|||
162952595|NCT04089735|588531607|FG001|Overall Study|Withdrawal by Subject|0|||
162952596|NCT04089735|588531608|FG002|Overall Study|Withdrawal by Subject|1|||
162952597|NCT04089735|588531609|FG003|Overall Study|Withdrawal by Subject|0|||
162952598|NCT04089735|588531610|FG004|Overall Study|Withdrawal by Subject|0|||
162952599|NCT04089735|588531611|FG005|Overall Study|Withdrawal by Subject|0|||
162952600|NCT04089735|588531606|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
162952601|NCT04089735|588531607|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
162952602|NCT04089735|588531608|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
162952603|NCT04089735|588531609|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
162952604|NCT04089735|588531610|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
162952605|NCT04089735|588531611|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
162952606|NCT04123548|588531614|FG000|Overall Study|Withdrawal by Subject|1|||
162952607|NCT04123548|588531614|FG000|Overall Study|Lost to Follow-up|8|||
162952608|NCT04123548|588531614|FG000|Overall Study|Death|4|||
162952609|NCT04123548|588531614|FG000|Overall Study|Reason Not Specified|1|||
162952610|NCT00851877|588531615|FG000|Phase I-1|Death|1|||
162849293|NCT01273064|588154776|FG002|Overall Study|Study Termination|26|||
162849294|NCT01273064|588154777|FG003|Overall Study|Study Termination|16|||
162849295|NCT01273064|588154778|FG004|Overall Study|Study Termination|8|||
162849296|NCT01273064|588154774|FG000|Overall Study|Lost to Follow-up|1|||
162849297|NCT01273064|588154775|FG001|Overall Study|Lost to Follow-up|0|||
162849298|NCT01273064|588154776|FG002|Overall Study|Lost to Follow-up|0|||
162849299|NCT01273064|588154777|FG003|Overall Study|Lost to Follow-up|0|||
162849300|NCT01273064|588154778|FG004|Overall Study|Lost to Follow-up|0|||
162849301|NCT01273064|588154774|FG000|Overall Study|Physician Decision|0|||
162849302|NCT01273064|588154775|FG001|Overall Study|Physician Decision|0|||
162849303|NCT01273064|588154776|FG002|Overall Study|Physician Decision|0|||
162849304|NCT01273064|588154777|FG003|Overall Study|Physician Decision|0|||
162849305|NCT01273064|588154778|FG004|Overall Study|Physician Decision|1|||
162849306|NCT04666038|588154779|FG000|Overall Study|Progressive Disease|2|||
162849307|NCT04666038|588154780|FG001|Overall Study|Progressive Disease|0|||
162952611|NCT00851877|588531616|FG001|Phase I-1|Death|0|||
162952612|NCT00851877|588531617|FG002|Phase I-1|Death|0|||
162952613|NCT00851877|588531615|FG000|Phase II|Withdrawal by Subject|0|||
162952614|NCT00851877|588531616|FG001|Phase II|Withdrawal by Subject|0|||
162952615|NCT00851877|588531617|FG002|Phase II|Withdrawal by Subject|3|||
162952616|NCT02440711|588531618|FG000|Second Intervention|Lost to Follow-up|1|||
162952617|NCT02440711|588531619|FG001|Second Intervention|Lost to Follow-up|0|||
162952618|NCT04129346|588531620|FG000|Overall Study|Death|1|||
162849308|NCT04666038|588154779|FG000|Overall Study|Death|38|||
162849309|NCT04666038|588154780|FG001|Overall Study|Death|32|||
162849310|NCT04666038|588154779|FG000|Overall Study|Withdrawal by Subject|10|||
162849311|NCT04666038|588154780|FG001|Overall Study|Withdrawal by Subject|19|||
162849312|NCT04666038|588154779|FG000|Overall Study|Lost to Follow-up|0|||
162849313|NCT04666038|588154780|FG001|Overall Study|Lost to Follow-up|2|||
162849314|NCT04666038|588154779|FG000|Overall Study|On Study Treatment|46|||
162849315|NCT04666038|588154780|FG001|Overall Study|On Study Treatment|5|||
162952619|NCT04129346|588531621|FG001|Overall Study|Death|0|||
162952620|NCT05755282|588531622|FG000|Overall Study|Protocol Violation|0|||
162952621|NCT05755282|588531623|FG001|Overall Study|Protocol Violation|1|||
162952622|NCT00573066|588531624|FG000|Overall Study|Exclusion criteria|18|||
162952623|NCT00573066|588531624|FG000|Overall Study|IV malfunction|1|||
162952624|NCT00573066|588531624|FG000|Overall Study|Postoperative bleeding|1|||
162952625|NCT00627016|588531625|FG000|Overall Study|Adverse Event|1|||
162952626|NCT00627016|588531626|FG001|Overall Study|Adverse Event|1|||
162952627|NCT00627016|588531625|FG000|Overall Study|Protocol Violation|0|||
162952628|NCT00627016|588531626|FG001|Overall Study|Protocol Violation|2|||
162952629|NCT00627016|588531625|FG000|Overall Study|Lost to Follow-up|0|||
162952630|NCT00627016|588531626|FG001|Overall Study|Lost to Follow-up|1|||
162952631|NCT00627016|588531625|FG000|Overall Study|Withdrawal by Subject|2|||
162952632|NCT00627016|588531626|FG001|Overall Study|Withdrawal by Subject|1|||
162952633|NCT00627016|588531625|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
162952634|NCT00627016|588531626|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
162952635|NCT00627016|588531625|FG000|Overall Study|Lack of Efficacy|1|||
162952636|NCT00627016|588531626|FG001|Overall Study|Lack of Efficacy|0|||
162952637|NCT00627016|588531625|FG000|Overall Study|Placed on Excluded Drugs|1|||
162952638|NCT00627016|588531626|FG001|Overall Study|Placed on Excluded Drugs|0|||
162952639|NCT00627016|588531625|FG000|Overall Study|Pregnancy|1|||
162952640|NCT00627016|588531626|FG001|Overall Study|Pregnancy|0|||
162952641|NCT03025880|588531627|FG000|Overall Study|Adverse Event|1|||
162952642|NCT03025880|588531628|FG001|Overall Study|Adverse Event|0|||
162952643|NCT03025880|588531627|FG000|Overall Study|Death|1|||
162952644|NCT03025880|588531628|FG001|Overall Study|Death|1|||
162952645|NCT03025880|588531627|FG000|Overall Study|Withdrawal by Subject|0|||
162952646|NCT03025880|588531628|FG001|Overall Study|Withdrawal by Subject|1|||
162952647|NCT03025880|588531627|FG000|Overall Study|Physician Decision|0|||
162952648|NCT03025880|588531628|FG001|Overall Study|Physician Decision|1|||
162952649|NCT03025880|588531627|FG000|Overall Study|Progressive Disease|12|||
162952650|NCT03025880|588531628|FG001|Overall Study|Progressive Disease|19|||
162952651|NCT01185548|588531630|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
162952652|NCT00086996|588531631|FG000|Overall Study|Adverse Event|29|||
162952653|NCT00086996|588531631|FG000|Overall Study|Death|4|||
162952654|NCT00086996|588531631|FG000|Overall Study|progression/relapse|7|||
162952655|NCT00086996|588531631|FG000|Overall Study|Withdrawal by Subject|13|||
162952656|NCT00086996|588531631|FG000|Overall Study|Other|6|||
162952657|NCT00086996|588531631|FG000|Overall Study|not eligible|5|||
162952658|NCT01422538|588531633|FG000|Overall Study|Lost to Follow-up|0|||
162952659|NCT01422538|588531634|FG001|Overall Study|Lost to Follow-up|1|||
162952660|NCT01422538|588531635|FG002|Overall Study|Lost to Follow-up|1|||
162952661|NCT01422538|588531633|FG000|Overall Study|Missed visit|0|||
162952662|NCT01422538|588531634|FG001|Overall Study|Missed visit|1|||
162952663|NCT01422538|588531635|FG002|Overall Study|Missed visit|1|||
162952664|NCT02770820|588531636|FG000|Overall Study|Death|1|||
162952665|NCT02770820|588531636|FG000|Overall Study|Physician Decision|2|||
162952666|NCT00312663|588531637|FG000|Immunization Phase|Adverse Event|0|||
162952667|NCT00312663|588531638|FG001|Immunization Phase|Adverse Event|1|||
162952668|NCT00312663|588531639|FG002|Immunization Phase|Adverse Event|0|||
162952669|NCT00286754|588531642|FG000|Overall Study|Adverse Event|2|||
162952670|NCT00286754|588531643|FG001|Overall Study|Adverse Event|2|||
162952671|NCT00286754|588531644|FG002|Overall Study|Adverse Event|3|||
162952672|NCT00286754|588531642|FG000|Overall Study|Withdrawal by Subject|6|||
162952673|NCT00286754|588531643|FG001|Overall Study|Withdrawal by Subject|2|||
162952674|NCT00286754|588531644|FG002|Overall Study|Withdrawal by Subject|0|||
162952675|NCT00286754|588531642|FG000|Overall Study|Lost to Follow-up|12|||
162952676|NCT00286754|588531643|FG001|Overall Study|Lost to Follow-up|14|||
162952677|NCT00286754|588531644|FG002|Overall Study|Lost to Follow-up|6|||
162952678|NCT00286754|588531642|FG000|Overall Study|Moved out of state|0|||
162952679|NCT00286754|588531643|FG001|Overall Study|Moved out of state|0|||
162952680|NCT00286754|588531644|FG002|Overall Study|Moved out of state|1|||
162952681|NCT02661295|588531645|FG000|Overall Study|Death|1|||
162952682|NCT02661295|588531645|FG000|Overall Study|Transferred Out|1|||
162952683|NCT02661295|588531645|FG000|Overall Study|Kidney Transplant|1|||
162952684|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to side effects|8|||
162952685|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to access type|1|||
162952686|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to allergies|1|||
162952687|NCT02661295|588531645|FG000|Overall Study|Withdrawn due to non-compliance|1|||
162952688|NCT02661295|588531645|FG000|Overall Study|Withdrawal by Subject|3|||
162952689|NCT02661295|588531645|FG000|Overall Study|Failed screening|2|||
162952690|NCT00301366|588531646|FG000|Overall Study|Adverse Event|1|||
162952691|NCT01313273|588531647|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
162952692|NCT01313273|588531648|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
162952693|NCT01313273|588531647|FG000|Overall Study|Withdrawal by Subject|1|||
162952694|NCT01313273|588531648|FG001|Overall Study|Withdrawal by Subject|0|||
162952695|NCT01313273|588531647|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
162952696|NCT01313273|588531648|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
162952697|NCT02726581|588531653|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
162952698|NCT02726581|588531654|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
162952699|NCT02726581|588531655|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
162952700|NCT02726581|588531653|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
162952701|NCT02726581|588531654|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
162952702|NCT02726581|588531655|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
162952703|NCT02726581|588531653|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162952704|NCT02726581|588531654|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162952705|NCT02726581|588531655|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162952706|NCT02726581|588531653|FG000|Treatment Period|Disease progression|47|||
162952707|NCT02726581|588531654|FG001|Treatment Period|Disease progression|50|||
162952708|NCT02726581|588531655|FG002|Treatment Period|Disease progression|16|||
162952709|NCT02726581|588531653|FG000|Treatment Period|Other reasons|9|||
162952710|NCT02726581|588531654|FG001|Treatment Period|Other reasons|8|||
162952711|NCT02726581|588531655|FG002|Treatment Period|Other reasons|2|||
162952712|NCT02726581|588531653|FG000|Treatment Period|Study drug toxicity|6|||
162952713|NCT02726581|588531654|FG001|Treatment Period|Study drug toxicity|3|||
162952714|NCT02726581|588531655|FG002|Treatment Period|Study drug toxicity|2|||
162952715|NCT02726581|588531653|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
162952716|NCT02726581|588531654|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
162952717|NCT02726581|588531655|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
162952718|NCT02726581|588531653|FG000|Treatment Period|Participant withdrew consent|3|||
162952719|NCT02726581|588531654|FG001|Treatment Period|Participant withdrew consent|1|||
162952720|NCT02726581|588531655|FG002|Treatment Period|Participant withdrew consent|1|||
162952721|NCT02726581|588531653|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
162952722|NCT02726581|588531654|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
162952723|NCT02726581|588531655|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
162952724|NCT02726581|588531653|FG000|Treatment Period|Maximum clinical benefit|0|||
162952725|NCT02726581|588531654|FG001|Treatment Period|Maximum clinical benefit|2|||
162952726|NCT02726581|588531655|FG002|Treatment Period|Maximum clinical benefit|0|||
162952727|NCT02726581|588531653|FG000|Treatment Period|Death|1|||
162952728|NCT02726581|588531654|FG001|Treatment Period|Death|0|||
162952729|NCT02726581|588531655|FG002|Treatment Period|Death|0|||
162952730|NCT02726581|588531653|FG000|Treatment Period|Poor/non-compliance|1|||
162952731|NCT02726581|588531654|FG001|Treatment Period|Poor/non-compliance|0|||
162952732|NCT02726581|588531655|FG002|Treatment Period|Poor/non-compliance|0|||
162952733|NCT02726581|588531653|FG000|Treatment Period|Participant no longer meets study criteria|0|||
162952734|NCT02726581|588531654|FG001|Treatment Period|Participant no longer meets study criteria|1|||
162952735|NCT02726581|588531655|FG002|Treatment Period|Participant no longer meets study criteria|0|||
162952736|NCT03195491|588531657|FG000|Overall Study|Study drug toxicity|25|||
162952737|NCT03195491|588531658|FG001|Overall Study|Study drug toxicity|3|||
162952738|NCT03195491|588531657|FG000|Overall Study|Maximum clinical benefit|5|||
162952739|NCT03195491|588531658|FG001|Overall Study|Maximum clinical benefit|0|||
162952740|NCT03195491|588531657|FG000|Overall Study|Lost to Follow-up|1|||
162952741|NCT03195491|588531658|FG001|Overall Study|Lost to Follow-up|0|||
162952742|NCT03195491|588531657|FG000|Overall Study|Death|3|||
162952743|NCT03195491|588531658|FG001|Overall Study|Death|0|||
162952744|NCT03195491|588531657|FG000|Overall Study|Adverse event unrelated to study drug|19|||
162952745|NCT03195491|588531658|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162952746|NCT03195491|588531657|FG000|Overall Study|Disease progression|266|||
162952747|NCT03195491|588531658|FG001|Overall Study|Disease progression|8|||
162952748|NCT03195491|588531657|FG000|Overall Study|Other reasons|10|||
162952749|NCT03195491|588531658|FG001|Overall Study|Other reasons|0|||
162952750|NCT03195491|588531657|FG000|Overall Study|Participant withdrew consent|8|||
162952751|NCT03195491|588531658|FG001|Overall Study|Participant withdrew consent|1|||
162952752|NCT03195491|588531657|FG000|Overall Study|Participant no longer meets study criteria|0|||
162952753|NCT03195491|588531658|FG001|Overall Study|Participant no longer meets study criteria|1|||
162952754|NCT03195491|588531657|FG000|Overall Study|Participant request to discontinue study treatment|10|||
162952755|NCT03195491|588531658|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162952756|NCT03496623|588531659|FG000|Run-In Period (2 Weeks)|Death|1|||
162952757|NCT03496623|588531660|FG001|Run-In Period (2 Weeks)|Death|0|||
162952758|NCT03496623|588531661|FG002|Run-In Period (2 Weeks)|Death|0|||
162952759|NCT03496623|588531662|FG003|Run-In Period (2 Weeks)|Death|0|||
162952760|NCT03496623|588531663|FG004|Run-In Period (2 Weeks)|Death|0|||
162952761|NCT03496623|588531659|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
162952762|NCT03496623|588531660|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952763|NCT03496623|588531661|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952764|NCT03496623|588531662|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952765|NCT03496623|588531663|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
162952766|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Death|0|||
162952767|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Death|3|||
162952768|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Death|0|||
162952769|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Death|0|||
162952770|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Death|0|||
162952771|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952772|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952773|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
162952774|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
162952775|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
162952776|NCT03496623|588531659|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952777|NCT03496623|588531660|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
162952778|NCT03496623|588531661|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
162952779|NCT03496623|588531662|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952780|NCT03496623|588531663|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162952781|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952782|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
162952783|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
162952784|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952785|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
162952786|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952787|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162849316|NCT04666038|588154779|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
162849317|NCT04666038|588154780|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
162849318|NCT02867761|588154786|FG000|Overall Study|Participant withdrawn by investigator|0|||
162849319|NCT02867761|588154787|FG001|Overall Study|Participant withdrawn by investigator|1|||
162849320|NCT02867761|588154786|FG000|Overall Study|Lost to Follow-up|25|||
162849321|NCT02867761|588154787|FG001|Overall Study|Lost to Follow-up|18|||
162849322|NCT02867761|588154786|FG000|Overall Study|Unable to complete protocol|3|||
162849323|NCT02867761|588154787|FG001|Overall Study|Unable to complete protocol|7|||
162849324|NCT03595280|588154788|FG000|Overall Study|Lost to Follow-up|6|||
162849325|NCT03595280|588154789|FG001|Overall Study|Lost to Follow-up|9|||
162849326|NCT03595280|588154790|FG002|Overall Study|Lost to Follow-up|15|||
162849327|NCT01931059|588154791|FG000|Day 1|Pregnancy|0|||
162849328|NCT01931059|588154792|FG001|Day 1|Pregnancy|1|||
162849329|NCT01931059|588154791|FG000|Day3|Lost to Follow-up|1|||
162849330|NCT01931059|588154792|FG001|Day3|Lost to Follow-up|0|||
162849331|NCT02292212|588154793|FG000|ViE Phase|Withdrawal by Subject|1|||
162849332|NCT02292212|588154793|FG000|ViE Phase|Protocol Violation|2|||
162849333|NCT02675075|588154794|FG000|Overall Study|Lost to Follow-up|3|||
162849334|NCT02675075|588154795|FG001|Overall Study|Lost to Follow-up|0|||
162849335|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849336|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849337|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849338|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
162849339|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849340|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
162849341|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849342|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849343|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849344|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849345|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849346|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849347|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849348|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849349|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162952788|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
162952789|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162849350|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849351|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849352|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849353|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849354|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849355|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849356|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162849357|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
162952790|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162952791|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952792|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162849358|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
162849359|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
162849360|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
162849361|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
162849362|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
162849363|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
162849364|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
162849365|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849366|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849367|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849368|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849369|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849370|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849371|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849372|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849373|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849374|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849375|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849376|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849377|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849378|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849379|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849380|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
162849381|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
162849382|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
162849383|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
162849384|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
162849385|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
162849386|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
162849387|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
162849388|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
162849389|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849390|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849391|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849392|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849393|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849394|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849395|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849396|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849397|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849398|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849399|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849400|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849401|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849402|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849403|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
162849404|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849405|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849406|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
162849407|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849408|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
162849409|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849410|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849411|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849412|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162952793|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
162952794|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952795|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
162952796|NCT03496623|588531659|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162610224|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
162610225|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
162610226|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
162849413|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849414|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849415|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849416|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849417|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849418|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849419|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849420|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849421|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849422|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849423|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849424|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849425|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849426|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
162849427|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
162849428|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849429|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849430|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
162849431|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849432|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849433|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849434|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849435|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849436|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849437|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849438|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849439|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849440|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849441|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849442|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849443|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849444|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849445|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849446|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849447|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849448|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849449|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
162849450|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849451|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849452|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
162849453|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849454|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849455|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849456|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849457|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849458|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849459|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849460|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849461|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849462|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849463|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849464|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849465|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849466|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849467|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849468|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162610227|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
162610228|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162610229|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
162610230|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162610231|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162610232|NCT01226043|587289709|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
162610233|NCT01226043|587289710|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
162610234|NCT01226043|587289711|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
162610235|NCT01226043|587289712|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
162610236|NCT01226043|587289709|FG000|6-week Re-randomization Phase|Adverse Event|0|||
162610237|NCT01226043|587289710|FG001|6-week Re-randomization Phase|Adverse Event|0|||
162610238|NCT01226043|587289711|FG002|6-week Re-randomization Phase|Adverse Event|1|||
162610239|NCT01226043|587289712|FG003|6-week Re-randomization Phase|Adverse Event|1|||
162610240|NCT01226043|587289709|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
162610241|NCT01226043|587289710|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
162610242|NCT01226043|587289711|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
162610243|NCT01226043|587289712|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
162610244|NCT01226043|587289709|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
162610245|NCT01226043|587289710|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
162610246|NCT01226043|587289711|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
162610247|NCT01226043|587289712|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
162610248|NCT01226043|587289709|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
162610249|NCT01226043|587289710|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
162610250|NCT01226043|587289711|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
162610251|NCT01226043|587289712|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
162610252|NCT01226043|587289709|FG000|6-week Re-randomization Phase|Physician Decision|0|||
162610253|NCT01226043|587289710|FG001|6-week Re-randomization Phase|Physician Decision|0|||
162610254|NCT01226043|587289711|FG002|6-week Re-randomization Phase|Physician Decision|3|||
162610255|NCT01226043|587289712|FG003|6-week Re-randomization Phase|Physician Decision|2|||
162610256|NCT01226043|587289709|FG000|6-week Re-randomization Phase|completed in error|0|||
162610257|NCT01226043|587289710|FG001|6-week Re-randomization Phase|completed in error|0|||
162610258|NCT01226043|587289711|FG002|6-week Re-randomization Phase|completed in error|0|||
162610259|NCT01226043|587289712|FG003|6-week Re-randomization Phase|completed in error|1|||
162610260|NCT01226043|587289709|FG000|30-week Observational Phase|Adverse Event|0|||
162610261|NCT01226043|587289710|FG001|30-week Observational Phase|Adverse Event|0|||
162610262|NCT01226043|587289711|FG002|30-week Observational Phase|Adverse Event|1|||
162610263|NCT01226043|587289712|FG003|30-week Observational Phase|Adverse Event|1|||
162610264|NCT01226043|587289709|FG000|30-week Observational Phase|Protocol Violation|0|||
162610265|NCT01226043|587289710|FG001|30-week Observational Phase|Protocol Violation|0|||
162610266|NCT01226043|587289711|FG002|30-week Observational Phase|Protocol Violation|0|||
162610267|NCT01226043|587289712|FG003|30-week Observational Phase|Protocol Violation|1|||
162610268|NCT01226043|587289709|FG000|30-week Observational Phase|Lost to Follow-up|0|||
162610269|NCT01226043|587289710|FG001|30-week Observational Phase|Lost to Follow-up|0|||
162610270|NCT01226043|587289711|FG002|30-week Observational Phase|Lost to Follow-up|2|||
162610271|NCT01226043|587289712|FG003|30-week Observational Phase|Lost to Follow-up|2|||
162610272|NCT01226043|587289709|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
162610273|NCT01226043|587289710|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
162610274|NCT01226043|587289711|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
162610275|NCT01226043|587289712|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
162610276|NCT01226043|587289709|FG000|30-week Observational Phase|Physician Decision|0|||
162610277|NCT01226043|587289710|FG001|30-week Observational Phase|Physician Decision|0|||
162610278|NCT01226043|587289711|FG002|30-week Observational Phase|Physician Decision|2|||
162610279|NCT01226043|587289712|FG003|30-week Observational Phase|Physician Decision|2|||
162610280|NCT00510952|587289721|FG000|Overall Study|Adverse Event|1|||
162610281|NCT00510952|587289722|FG001|Overall Study|Adverse Event|0|||
162610282|NCT00510952|587289721|FG000|Overall Study|Entry Criteria Not Met|3|||
162610283|NCT00510952|587289722|FG001|Overall Study|Entry Criteria Not Met|1|||
162610284|NCT00510952|587289721|FG000|Overall Study|Lost to Follow-up|5|||
162610285|NCT00510952|587289722|FG001|Overall Study|Lost to Follow-up|3|||
162610286|NCT00510952|587289721|FG000|Overall Study|Physician Decision|1|||
162610287|NCT00510952|587289722|FG001|Overall Study|Physician Decision|1|||
162610288|NCT00510952|587289721|FG000|Overall Study|Protocol Violation|7|||
162610289|NCT00510952|587289722|FG001|Overall Study|Protocol Violation|4|||
162610290|NCT00510952|587289721|FG000|Overall Study|Sponsor Decision|1|||
162610291|NCT00510952|587289722|FG001|Overall Study|Sponsor Decision|0|||
162610292|NCT00510952|587289721|FG000|Overall Study|Withdrawal by Subject|6|||
162610293|NCT00510952|587289722|FG001|Overall Study|Withdrawal by Subject|7|||
162610294|NCT00510952|587289721|FG000|Overall Study|Did Not Receive Study Drug|2|||
162610295|NCT00510952|587289722|FG001|Overall Study|Did Not Receive Study Drug|0|||
162610296|NCT00596362|587289730|FG000|Overall Study|Progressive Disease|1|||
162610297|NCT00523367|587289731|FG000|Overall Study|19 screen failures|19|||
162610298|NCT00523367|587289731|FG000|Overall Study|4 Withdrawn by PI|4|||
162849469|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849470|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849471|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849472|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
162849473|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849474|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849475|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
162849476|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849477|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849478|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849479|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849480|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849481|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849482|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849483|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849484|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849485|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162610299|NCT00055471|587289735|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
162610300|NCT00055471|587289736|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
162610301|NCT00055471|587289737|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
162610302|NCT00055471|587289735|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
162849486|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849487|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849488|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849489|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849490|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849491|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849492|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849493|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849494|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849495|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
162849496|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849497|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849498|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849499|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
162849500|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849501|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849502|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849503|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849504|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849505|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849506|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849507|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849508|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849509|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849510|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849511|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849512|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849513|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849514|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849515|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849516|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849517|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849518|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
162849519|NCT00896532|588154796|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849520|NCT00896532|588154797|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
162849521|NCT00896532|588154798|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849522|NCT00896532|588154799|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
162849523|NCT00896532|588154800|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
162849524|NCT00896532|588154801|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849525|NCT00896532|588154802|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162610303|NCT00055471|587289736|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
162849526|NCT00896532|588154803|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849527|NCT00896532|588154804|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849528|NCT00896532|588154805|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849529|NCT00896532|588154806|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849530|NCT00896532|588154807|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849531|NCT00896532|588154808|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162610304|NCT00055471|587289737|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
162610305|NCT00055471|587289735|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
162849532|NCT00896532|588154809|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849533|NCT00896532|588154810|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162610306|NCT00055471|587289736|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
162610307|NCT00055471|587289737|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
162610308|NCT01854944|587289738|FG000|Overall Study|Withdrawal by Subject|0|||
162610309|NCT01854944|587289739|FG001|Overall Study|Withdrawal by Subject|0|||
162610310|NCT01854944|587289740|FG002|Overall Study|Withdrawal by Subject|1|||
162610311|NCT02782923|587289743|FG000|Overall Study|Lost to Follow-up|15|||
162610312|NCT02418156|587289744|FG000|Overall Study|Lost to Follow-up|12|||
162610313|NCT02418156|587289744|FG000|Overall Study|Death|2|||
162610314|NCT02418156|587289744|FG000|Overall Study|Physician Decision|1|||
162610315|NCT02418156|587289744|FG000|Overall Study|Withdrawal by Subject|1|||
162610316|NCT02418156|587289744|FG000|Overall Study|Subject refused to return|1|||
162610317|NCT00323869|587289749|FG000|Overall Study|Death|1|||
162610318|NCT04090957|587289750|FG000|Overall Study|Lost to Follow-up|22|||
162610319|NCT04090957|587289751|FG001|Overall Study|Lost to Follow-up|25|||
162610320|NCT04090957|587289752|FG002|Overall Study|Lost to Follow-up|25|||
162610321|NCT04090957|587289753|FG003|Overall Study|Lost to Follow-up|36|||
162610322|NCT04090957|587289750|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
162610323|NCT04090957|587289751|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
162610324|NCT04090957|587289752|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
162610325|NCT04090957|587289753|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
162610326|NCT04090957|587289750|FG000|Overall Study|Adverse Event|19|||
162610327|NCT04090957|587289751|FG001|Overall Study|Adverse Event|25|||
162610328|NCT04090957|587289752|FG002|Overall Study|Adverse Event|8|||
162610329|NCT04090957|587289753|FG003|Overall Study|Adverse Event|104|||
162610330|NCT04090957|587289750|FG000|Overall Study|Other|10|||
162610331|NCT04090957|587289751|FG001|Overall Study|Other|6|||
162610332|NCT04090957|587289752|FG002|Overall Study|Other|5|||
162610333|NCT04090957|587289753|FG003|Overall Study|Other|12|||
162610334|NCT04090957|587289750|FG000|Overall Study|Serious Adverse Event|7|||
162610335|NCT04090957|587289751|FG001|Overall Study|Serious Adverse Event|11|||
162610336|NCT04090957|587289752|FG002|Overall Study|Serious Adverse Event|1|||
162610337|NCT04090957|587289753|FG003|Overall Study|Serious Adverse Event|32|||
162610338|NCT04090957|587289750|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
162610339|NCT04090957|587289751|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
162610340|NCT04090957|587289752|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
162610341|NCT04090957|587289753|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
162610342|NCT04090957|587289750|FG000|Overall Study|Lack of Efficacy|1|||
162610343|NCT04090957|587289751|FG001|Overall Study|Lack of Efficacy|1|||
162610344|NCT04090957|587289752|FG002|Overall Study|Lack of Efficacy|9|||
162610345|NCT04090957|587289753|FG003|Overall Study|Lack of Efficacy|0|||
162610346|NCT04090957|587289750|FG000|Overall Study|Protocol Violation|3|||
162610347|NCT04090957|587289751|FG001|Overall Study|Protocol Violation|5|||
162610348|NCT04090957|587289752|FG002|Overall Study|Protocol Violation|2|||
162610349|NCT04090957|587289753|FG003|Overall Study|Protocol Violation|1|||
162610350|NCT04090957|587289750|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
162849534|NCT00896532|588154811|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849535|NCT00896532|588154812|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849536|NCT00896532|588154813|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849537|NCT00896532|588154814|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849538|NCT00896532|588154815|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849539|NCT00896532|588154816|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162610351|NCT04090957|587289751|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
162610352|NCT04090957|587289752|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
162610353|NCT04090957|587289753|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
162610354|NCT04090957|587289750|FG000|Overall Study|COVID-19|2|||
162610355|NCT04090957|587289751|FG001|Overall Study|COVID-19|2|||
162610356|NCT04090957|587289752|FG002|Overall Study|COVID-19|3|||
162849540|NCT00896532|588154817|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162610357|NCT04090957|587289753|FG003|Overall Study|COVID-19|7|||
162610358|NCT04090957|587289750|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
162610359|NCT04090957|587289751|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
162610360|NCT04090957|587289752|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
162610361|NCT04090957|587289753|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
162849541|NCT00896532|588154818|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
162849542|NCT00896532|588154796|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849543|NCT00896532|588154797|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849544|NCT00896532|588154798|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849545|NCT00896532|588154799|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849546|NCT00896532|588154800|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849547|NCT00896532|588154801|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849548|NCT00896532|588154802|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849549|NCT00896532|588154803|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849550|NCT00896532|588154804|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
162849551|NCT00896532|588154805|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849552|NCT00896532|588154806|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849553|NCT00896532|588154807|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849554|NCT00896532|588154808|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849555|NCT00896532|588154809|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849556|NCT00896532|588154810|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849557|NCT00896532|588154811|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849558|NCT00896532|588154812|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849559|NCT00896532|588154813|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849560|NCT00896532|588154814|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849561|NCT00896532|588154815|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849562|NCT00896532|588154816|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849563|NCT00896532|588154817|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849564|NCT00896532|588154818|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
162849565|NCT00896532|588154796|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162610362|NCT04090957|587289750|FG000|Overall Study|Physician Decision|2|||
162610363|NCT04090957|587289751|FG001|Overall Study|Physician Decision|1|||
162610364|NCT04090957|587289752|FG002|Overall Study|Physician Decision|1|||
162610365|NCT04090957|587289753|FG003|Overall Study|Physician Decision|5|||
162610366|NCT04090957|587289750|FG000|Overall Study|Sponsor Decision|1|||
162610367|NCT04090957|587289751|FG001|Overall Study|Sponsor Decision|1|||
162610368|NCT04090957|587289752|FG002|Overall Study|Sponsor Decision|1|||
162610369|NCT04090957|587289753|FG003|Overall Study|Sponsor Decision|3|||
162610370|NCT04090957|587289750|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
162610371|NCT04090957|587289751|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
162610372|NCT04090957|587289752|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
162610373|NCT04090957|587289753|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
162610374|NCT04090957|587289750|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
162610375|NCT04090957|587289751|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
162610376|NCT04090957|587289752|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
162610377|NCT04090957|587289753|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
162610378|NCT04090957|587289750|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162610379|NCT04090957|587289751|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162610380|NCT04090957|587289752|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
162610381|NCT04090957|587289753|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162610382|NCT04090957|587289750|FG000|Overall Study|Death|1|||
162610383|NCT04090957|587289751|FG001|Overall Study|Death|0|||
162610384|NCT04090957|587289752|FG002|Overall Study|Death|0|||
162610385|NCT04090957|587289753|FG003|Overall Study|Death|0|||
162610386|NCT04090957|587289750|FG000|Overall Study|No Treatment Administered|2|||
162610387|NCT04090957|587289751|FG001|Overall Study|No Treatment Administered|1|||
162610388|NCT04090957|587289752|FG002|Overall Study|No Treatment Administered|2|||
162610389|NCT04090957|587289753|FG003|Overall Study|No Treatment Administered|1|||
162610390|NCT01909453|587289754|FG000|Overall Study|Ongoing|118|||
162610391|NCT01909453|587289755|FG001|Overall Study|Ongoing|103|||
162610392|NCT01909453|587289756|FG002|Overall Study|Ongoing|83|||
162610393|NCT01909453|587289757|FG003|Overall Study|Ongoing|164|||
162610394|NCT01909453|587289758|FG004|Overall Study|Ongoing|50|||
162610395|NCT01909453|587289754|FG000|Overall Study|Death|69|||
162610396|NCT01909453|587289755|FG001|Overall Study|Death|74|||
162610397|NCT01909453|587289756|FG002|Overall Study|Death|88|||
162610398|NCT01909453|587289757|FG003|Overall Study|Death|86|||
162610399|NCT01909453|587289758|FG004|Overall Study|Death|29|||
162610400|NCT01909453|587289754|FG000|Overall Study|Lost to Follow-up|3|||
162610401|NCT01909453|587289755|FG001|Overall Study|Lost to Follow-up|4|||
162610402|NCT01909453|587289756|FG002|Overall Study|Lost to Follow-up|4|||
162610403|NCT01909453|587289757|FG003|Overall Study|Lost to Follow-up|3|||
162610404|NCT01909453|587289758|FG004|Overall Study|Lost to Follow-up|3|||
162610405|NCT01909453|587289754|FG000|Overall Study|Withdrawal by Subject|2|||
162610406|NCT01909453|587289755|FG001|Overall Study|Withdrawal by Subject|13|||
162849566|NCT00896532|588154797|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849567|NCT00896532|588154798|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849568|NCT00896532|588154799|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849569|NCT00896532|588154800|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849570|NCT00896532|588154801|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849571|NCT00896532|588154802|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162704008|NCT02253316|587627044|FG002|Consolidation|Adverse Event|0|||
162704009|NCT02253316|587627042|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
162849572|NCT00896532|588154803|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162610407|NCT01909453|587289756|FG002|Overall Study|Withdrawal by Subject|16|||
162610408|NCT01909453|587289757|FG003|Overall Study|Withdrawal by Subject|5|||
162610409|NCT01909453|587289758|FG004|Overall Study|Withdrawal by Subject|4|||
162610410|NCT01751802|587291419|FG000|Overall Study|Adverse Event|4|||
162610411|NCT01751802|587291420|FG001|Overall Study|Adverse Event|2|||
162610412|NCT00608543|587291421|FG000|Overall Study|Adverse Event|4|||
162610413|NCT01869725|587291422|FG000|Overall Study|ineligible after registration|1|||
162610414|NCT01869725|587291422|FG000|Overall Study|Death|1|||
162610415|NCT01869725|587291422|FG000|Overall Study|Lost to Follow-up|2|||
162610416|NCT03416374|587291423|FG000|Between Treatment Period I and II|Other|0|||
162610417|NCT03416374|587291424|FG001|Between Treatment Period I and II|Other|9|||
162610418|NCT03416374|587291423|FG000|Treatment Period II|Lack of Efficacy|3|||
162704010|NCT02253316|587627043|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
162849573|NCT00896532|588154804|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162610419|NCT03416374|587291424|FG001|Treatment Period II|Lack of Efficacy|11|||
162610420|NCT03416374|587291423|FG000|Treatment Period II|Adverse Event|1|||
162610421|NCT03416374|587291424|FG001|Treatment Period II|Adverse Event|4|||
162610422|NCT03416374|587291423|FG000|Treatment Period II|Death|0|||
162610423|NCT03416374|587291424|FG001|Treatment Period II|Death|1|||
162610424|NCT03416374|587291423|FG000|Treatment Period II|Other|0|||
162849574|NCT00896532|588154805|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849575|NCT00896532|588154806|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849576|NCT00896532|588154807|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849577|NCT00896532|588154808|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
162849578|NCT00896532|588154809|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849579|NCT00896532|588154810|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849580|NCT00896532|588154811|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849581|NCT00896532|588154812|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849582|NCT00896532|588154813|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162704011|NCT02253316|587627044|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
162704012|NCT02253316|587627042|FG000|Maintenance|Physician Decision|0|||
162704013|NCT02253316|587627043|FG001|Maintenance|Physician Decision|7|||
162704014|NCT02253316|587627044|FG002|Maintenance|Physician Decision|16|||
162704015|NCT02253316|587627042|FG000|Maintenance|Non-Compliance|0|||
162704016|NCT02253316|587627043|FG001|Maintenance|Non-Compliance|1|||
162704017|NCT02253316|587627044|FG002|Maintenance|Non-Compliance|1|||
162704018|NCT02253316|587627042|FG000|Maintenance|Secondary Malignancy|0|||
162704019|NCT02253316|587627043|FG001|Maintenance|Secondary Malignancy|2|||
162704020|NCT02253316|587627044|FG002|Maintenance|Secondary Malignancy|6|||
162704021|NCT02253316|587627042|FG000|Maintenance|Adverse Event|0|||
162704022|NCT02253316|587627043|FG001|Maintenance|Adverse Event|8|||
162704023|NCT02253316|587627044|FG002|Maintenance|Adverse Event|12|||
162952797|NCT03496623|588531660|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
162704024|NCT02253316|587627042|FG000|Maintenance|Still receiving active treatment|0|||
162704025|NCT02253316|587627043|FG001|Maintenance|Still receiving active treatment|4|||
162610425|NCT03416374|587291424|FG001|Treatment Period II|Other|2|||
162610426|NCT01025154|587291427|FG000|Overall Study|Lost to Follow-up|1|||
162610427|NCT01025154|587291427|FG000|Overall Study|Withdrawal by Subject|1|||
162610428|NCT01251744|587291428|FG000|Overall Study|Lost to Follow-up|1|||
162610429|NCT01251744|587291429|FG001|Overall Study|Lost to Follow-up|0|||
162610430|NCT01068652|587291430|FG000|Overall Study|Adverse Event|4|||
162610431|NCT01068652|587291431|FG001|Overall Study|Adverse Event|0|||
162610432|NCT01068652|587291430|FG000|Overall Study|Lack of Efficacy|0|||
162610433|NCT01068652|587291431|FG001|Overall Study|Lack of Efficacy|2|||
162610434|NCT01068652|587291430|FG000|Overall Study|Lost to Follow-up|2|||
162610435|NCT01068652|587291431|FG001|Overall Study|Lost to Follow-up|1|||
162610436|NCT01068652|587291430|FG000|Overall Study|Protocol Violation|3|||
162610437|NCT01068652|587291431|FG001|Overall Study|Protocol Violation|6|||
162610438|NCT01068652|587291430|FG000|Overall Study|Withdrawal criteria|1|||
162610439|NCT01068652|587291431|FG001|Overall Study|Withdrawal criteria|2|||
162610440|NCT01068652|587291430|FG000|Overall Study|Patient was not eligible|1|||
162610441|NCT01068652|587291431|FG001|Overall Study|Patient was not eligible|0|||
162610442|NCT01068652|587291430|FG000|Overall Study|Unclassified|7|||
162610443|NCT01068652|587291431|FG001|Overall Study|Unclassified|4|||
162610444|NCT00147251|587291432|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
162610445|NCT00147251|587291433|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
162610446|NCT00417482|587291434|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
162610447|NCT00417482|587291435|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
162610448|NCT00417482|587291436|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
162610449|NCT00417482|587291434|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
162610450|NCT00417482|587291435|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
162610451|NCT00417482|587291436|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
162610452|NCT00417482|587291434|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
162610453|NCT00417482|587291435|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
162610454|NCT00417482|587291436|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
162610455|NCT00417482|587291434|FG000|Phase B 1st 16 Weeks|Death|1|||
162610456|NCT00417482|587291435|FG001|Phase B 1st 16 Weeks|Death|0|||
162952798|NCT03496623|588531661|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162952799|NCT03496623|588531662|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162952800|NCT03496623|588531663|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162952801|NCT02543203|588531664|FG000|Overall Study|Unpalatable Fragrance|2|||
162952802|NCT02543203|588531665|FG001|Overall Study|Unpalatable Fragrance|2|||
162952803|NCT02543203|588531664|FG000|Overall Study|Lost to Follow-up|1|||
162952804|NCT02543203|588531665|FG001|Overall Study|Lost to Follow-up|0|||
162952805|NCT02543203|588531664|FG000|Overall Study|Increased Irritability|1|||
162952806|NCT02543203|588531665|FG001|Overall Study|Increased Irritability|0|||
162952807|NCT02543203|588531664|FG000|Overall Study|Family|1|||
162952808|NCT02543203|588531665|FG001|Overall Study|Family|2|||
162610457|NCT00417482|587291436|FG002|Phase B 1st 16 Weeks|Death|0|||
162610458|NCT00417482|587291434|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
162610459|NCT00417482|587291435|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
162610460|NCT00417482|587291436|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
162610461|NCT00417482|587291434|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
162610462|NCT00417482|587291435|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
162610463|NCT00417482|587291436|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
162610464|NCT00417482|587291434|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
162610465|NCT00417482|587291435|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
162610466|NCT00417482|587291436|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
162610467|NCT00417482|587291434|FG000|Phase B 2nd 16 Weeks|Death|1|||
162610468|NCT00417482|587291435|FG001|Phase B 2nd 16 Weeks|Death|1|||
162610469|NCT00417482|587291436|FG002|Phase B 2nd 16 Weeks|Death|0|||
162610470|NCT01323946|587291439|FG000|Overall Study|Lost to Follow-up|0|||
162704026|NCT02253316|587627044|FG002|Maintenance|Still receiving active treatment|0|||
162704027|NCT02684903|587627045|FG000|Overall Study|COVID-19 shutdown of lab|4|||
162704028|NCT02684903|587627046|FG001|Overall Study|COVID-19 shutdown of lab|6|||
162704029|NCT02684903|587627045|FG000|Overall Study|Lost to Follow-up|31|||
162704030|NCT02684903|587627046|FG001|Overall Study|Lost to Follow-up|41|||
162704031|NCT06403605|587627051|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
162704032|NCT06403605|587627052|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
162704033|NCT06403605|587627051|FG000|Follow-up|Adverse Event|4|||
162952809|NCT02543203|588531664|FG000|Overall Study|Negative Behavior|1|||
162952810|NCT02543203|588531665|FG001|Overall Study|Negative Behavior|0|||
162952811|NCT02543203|588531664|FG000|Overall Study|Withdrawal by Subject|0|||
162952812|NCT02543203|588531665|FG001|Overall Study|Withdrawal by Subject|1|||
162952813|NCT04786184|588531666|FG000|Overall Study|Adverse Event|4|||
162610471|NCT01323946|587291440|FG001|Overall Study|Lost to Follow-up|1|||
162610472|NCT01323946|587291441|FG002|Overall Study|Lost to Follow-up|0|||
162610473|NCT01323946|587291439|FG000|Overall Study|Parents refused the last blood draw|1|||
162610474|NCT01323946|587291440|FG001|Overall Study|Parents refused the last blood draw|0|||
162610475|NCT01323946|587291441|FG002|Overall Study|Parents refused the last blood draw|0|||
162610476|NCT01323946|587291439|FG000|Overall Study|Withdrawal by Subject|2|||
162704034|NCT06403605|587627052|FG001|Follow-up|Adverse Event|2|||
162704035|NCT06403605|587627051|FG000|Follow-up|Withdrawal by Subject|2|||
162704036|NCT06403605|587627052|FG001|Follow-up|Withdrawal by Subject|3|||
162704037|NCT06403605|587627051|FG000|Follow-up|Lost to Follow-up|1|||
162952814|NCT04786184|588531667|FG001|Overall Study|Adverse Event|0|||
162704038|NCT06403605|587627052|FG001|Follow-up|Lost to Follow-up|0|||
162704039|NCT06403605|587627051|FG000|Follow-up|Death|1|||
162704040|NCT06403605|587627052|FG001|Follow-up|Death|0|||
162704041|NCT06403605|587627051|FG000|Follow-up|Other reasons|0|||
162704042|NCT06403605|587627052|FG001|Follow-up|Other reasons|4|||
162704043|NCT07083843|587627053|FG000|Intervention period.|Withdrawal by Subject|1|||
162704044|NCT07083843|587627054|FG001|Intervention period.|Withdrawal by Subject|0|||
162704045|NCT07083843|587627053|FG000|Intervention period.|Death|0|||
162704046|NCT07083843|587627054|FG001|Intervention period.|Death|1|||
162704047|NCT00394095|587628838|FG000|Screening|Withdrawal by Subject|1|||
162704048|NCT00394095|587628839|FG001|Screening|Withdrawal by Subject|0|||
162704049|NCT00394095|587628838|FG000|Randomized|Withdrawal by Subject|5|||
162704050|NCT00394095|587628839|FG001|Randomized|Withdrawal by Subject|1|||
162704051|NCT00394095|587628838|FG000|Randomized|Adverse Event|1|||
162704052|NCT00394095|587628839|FG001|Randomized|Adverse Event|1|||
162704053|NCT00394095|587628838|FG000|Randomized|Overdose|1|||
162704054|NCT00394095|587628839|FG001|Randomized|Overdose|0|||
162704055|NCT00394095|587628838|FG000|Randomized|Lost to Follow-up|1|||
162704056|NCT00394095|587628839|FG001|Randomized|Lost to Follow-up|2|||
162952815|NCT04786184|588531666|FG000|Overall Study|Withdrawal by Subject|3|||
162952816|NCT04786184|588531667|FG001|Overall Study|Withdrawal by Subject|1|||
162952817|NCT04786184|588531666|FG000|Overall Study|Lost to Follow-up|4|||
162704057|NCT04213846|587628840|FG000|Overall Study|Withdrawal by Subject|7|||
162704058|NCT04213846|587628841|FG001|Overall Study|Withdrawal by Subject|6|||
162704059|NCT04213846|587628840|FG000|Overall Study|Lost to Follow-up|15|||
162704060|NCT04213846|587628841|FG001|Overall Study|Lost to Follow-up|21|||
162704061|NCT04096365|587628854|FG000|Overall Study|Adverse Event|1|||
162704062|NCT00072475|587628857|FG000|Overall Study|Adverse Event|44|||
162610477|NCT01323946|587291440|FG001|Overall Study|Withdrawal by Subject|2|||
162610478|NCT01323946|587291441|FG002|Overall Study|Withdrawal by Subject|0|||
162610479|NCT00107952|587291443|FG000|Overall Study|Death|75|||
162610480|NCT00107952|587291444|FG001|Overall Study|Death|61|||
162610481|NCT00107952|587291443|FG000|Overall Study|Lost to Follow-up|0|||
162610482|NCT00107952|587291444|FG001|Overall Study|Lost to Follow-up|3|||
162610483|NCT00107952|587291443|FG000|Overall Study|Withdrawal by Subject|9|||
162610484|NCT00107952|587291444|FG001|Overall Study|Withdrawal by Subject|6|||
162610485|NCT00107952|587291443|FG000|Overall Study|Other|2|||
162610486|NCT00107952|587291444|FG001|Overall Study|Other|5|||
162610487|NCT00107952|587291443|FG000|Overall Study|Never received study treatment|9|||
162610488|NCT00107952|587291444|FG001|Overall Study|Never received study treatment|6|||
162610489|NCT00251004|587291445|FG000|Overall Study|Withdrawal by Subject|23|||
162610490|NCT00251004|587291446|FG001|Overall Study|Withdrawal by Subject|16|||
162610491|NCT00251004|587291447|FG002|Overall Study|Withdrawal by Subject|14|||
162610492|NCT00251004|587291445|FG000|Overall Study|Death|9|||
162610493|NCT00251004|587291446|FG001|Overall Study|Death|10|||
162610494|NCT00251004|587291447|FG002|Overall Study|Death|8|||
162610495|NCT00251004|587291445|FG000|Overall Study|Lost to Follow-up|1|||
162610496|NCT00251004|587291446|FG001|Overall Study|Lost to Follow-up|2|||
162610497|NCT00251004|587291447|FG002|Overall Study|Lost to Follow-up|1|||
162610498|NCT00251004|587291445|FG000|Overall Study|Graft Loss|12|||
162610499|NCT00251004|587291446|FG001|Overall Study|Graft Loss|13|||
162610500|NCT00251004|587291447|FG002|Overall Study|Graft Loss|8|||
162610501|NCT00887744|587291448|FG000|Overall Study|Adverse Event|3|||
162610502|NCT00887744|587291448|FG000|Overall Study|Death|1|||
162610503|NCT00887744|587291448|FG000|Overall Study|Lost to Follow-up|3|||
162610504|NCT00887744|587291448|FG000|Overall Study|Withdrawal by Subject|18|||
162610505|NCT00887744|587291448|FG000|Overall Study|Various reasons|9|||
162610506|NCT01569464|587291449|FG000|Overall Study|Adverse Event|4|||
162610507|NCT01569464|587291450|FG001|Overall Study|Adverse Event|0|||
162610508|NCT01569464|587291449|FG000|Overall Study|Lack of Efficacy|1|||
162610509|NCT01569464|587291450|FG001|Overall Study|Lack of Efficacy|0|||
162610510|NCT01569464|587291449|FG000|Overall Study|Protocol Violation|1|||
162610511|NCT01569464|587291450|FG001|Overall Study|Protocol Violation|0|||
162610512|NCT01569464|587291449|FG000|Overall Study|Lost to Follow-up|2|||
162610513|NCT01569464|587291450|FG001|Overall Study|Lost to Follow-up|3|||
162610514|NCT01569464|587291449|FG000|Overall Study|Withdrawal by Subject|1|||
162610515|NCT01569464|587291450|FG001|Overall Study|Withdrawal by Subject|1|||
162610516|NCT01569464|587291449|FG000|Overall Study|Other|1|||
162610517|NCT01569464|587291450|FG001|Overall Study|Other|1|||
162610518|NCT03533686|587291451|FG000|Overall Study|Withdrawal by Subject|1|||
162610519|NCT03533686|587291452|FG001|Overall Study|Withdrawal by Subject|0|||
162610520|NCT03533686|587291453|FG002|Overall Study|Withdrawal by Subject|0|||
162610521|NCT03533686|587291454|FG003|Overall Study|Withdrawal by Subject|3|||
162610522|NCT03533686|587291455|FG004|Overall Study|Withdrawal by Subject|5|||
162952818|NCT04786184|588531667|FG001|Overall Study|Lost to Follow-up|2|||
162610523|NCT03533686|587291456|FG005|Overall Study|Withdrawal by Subject|1|||
162610524|NCT03533686|587291451|FG000|Overall Study|Lost to Follow-up|0|||
162610525|NCT03533686|587291452|FG001|Overall Study|Lost to Follow-up|1|||
162610526|NCT03533686|587291453|FG002|Overall Study|Lost to Follow-up|0|||
162610527|NCT03533686|587291454|FG003|Overall Study|Lost to Follow-up|0|||
162610528|NCT03533686|587291455|FG004|Overall Study|Lost to Follow-up|2|||
162610529|NCT03533686|587291456|FG005|Overall Study|Lost to Follow-up|0|||
162610530|NCT03533686|587291451|FG000|Overall Study|Screen Failure|0|||
162610531|NCT03533686|587291452|FG001|Overall Study|Screen Failure|0|||
162610532|NCT03533686|587291453|FG002|Overall Study|Screen Failure|0|||
162610533|NCT03533686|587291454|FG003|Overall Study|Screen Failure|2|||
162610534|NCT03533686|587291455|FG004|Overall Study|Screen Failure|0|||
162610535|NCT03533686|587291456|FG005|Overall Study|Screen Failure|0|||
162610536|NCT02632838|587291457|FG000|Overall Study|Withdrawal by Subject|3|||
162610537|NCT02632838|587291458|FG001|Overall Study|Withdrawal by Subject|0|||
162610538|NCT02632838|587291457|FG000|Overall Study|Lost to Follow-up|0|||
162610539|NCT02632838|587291458|FG001|Overall Study|Lost to Follow-up|2|||
162610540|NCT01562873|587291462|FG000|Overall Study|Disease Progression per RECIST|10|||
162610541|NCT01562873|587291463|FG001|Overall Study|Disease Progression per RECIST|0|||
162952819|NCT02255097|588531668|FG000|Overall Study|Death|151|||
162952820|NCT02255097|588531668|FG000|Overall Study|Lost to Follow-up|5|||
162610542|NCT01562873|587291462|FG000|Overall Study|Adverse Event|1|||
162610543|NCT01562873|587291463|FG001|Overall Study|Adverse Event|0|||
162610544|NCT01562873|587291462|FG000|Overall Study|Clinical Disease Progression|9|||
162610545|NCT01562873|587291463|FG001|Overall Study|Clinical Disease Progression|0|||
162610546|NCT01562873|587291462|FG000|Overall Study|Clinical PD and adverse event|1|||
162610547|NCT01562873|587291463|FG001|Overall Study|Clinical PD and adverse event|0|||
162610548|NCT03370289|587291468|FG000|Overall Study|Screen Failure|1|||
162610549|NCT03370289|587291468|FG000|Overall Study|Sample Size Sufficient|4|||
162610550|NCT02140775|587291470|FG000|Overall Study|Withdrawal by Subject|30|||
162610551|NCT02140775|587291471|FG001|Overall Study|Withdrawal by Subject|7|||
162610552|NCT00938964|587291473|FG000|Overall Study|Death|3|||
162610553|NCT00938964|587291474|FG001|Overall Study|Death|3|||
162610554|NCT00938964|587291473|FG000|Overall Study|Lost to Follow-up|2|||
162610555|NCT00938964|587291474|FG001|Overall Study|Lost to Follow-up|3|||
162610556|NCT00938964|587291473|FG000|Overall Study|Withdrawal by Subject|22|||
162610557|NCT00938964|587291474|FG001|Overall Study|Withdrawal by Subject|18|||
162610558|NCT00938964|587291473|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
162610559|NCT00938964|587291474|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
162610560|NCT01858636|587291475|FG000|Overall Study|No Device Deployment Attempted|24|||
162610561|NCT01858636|587291475|FG000|Overall Study|Physician Decision|1|||
162610562|NCT01858636|587291475|FG000|Overall Study|Death|1|||
162610563|NCT01858636|587291475|FG000|Overall Study|Lost to Follow-up|1|||
162610564|NCT01858636|587291475|FG000|Overall Study|Withdrawal by Subject|1|||
162610565|NCT01227564|587291479|FG000|Overall Study|No Longer Willing to Participate|4|||
162610566|NCT01227564|587291480|FG001|Overall Study|No Longer Willing to Participate|2|||
162610567|NCT01227564|587291481|FG002|Overall Study|No Longer Willing to Participate|5|||
162610568|NCT01227564|587291479|FG000|Overall Study|Participant moved to another town|0|||
162610569|NCT01227564|587291480|FG001|Overall Study|Participant moved to another town|0|||
162610570|NCT01227564|587291481|FG002|Overall Study|Participant moved to another town|1|||
162610571|NCT00999921|587291497|FG000|Overall Study|Lost to Follow-up|10|||
162610572|NCT00999921|587291498|FG001|Overall Study|Lost to Follow-up|19|||
162610573|NCT04650854|587291499|FG000|Overall Study|Adverse Event|1|||
162610574|NCT04650854|587291500|FG001|Overall Study|Adverse Event|12|||
162610575|NCT04650854|587291501|FG002|Overall Study|Adverse Event|14|||
162849583|NCT00896532|588154814|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849584|NCT00896532|588154815|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849585|NCT00896532|588154816|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849586|NCT00896532|588154817|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849587|NCT00896532|588154818|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
162849588|NCT00896532|588154796|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849589|NCT00896532|588154797|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849590|NCT00896532|588154798|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849591|NCT00896532|588154799|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849592|NCT00896532|588154800|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849593|NCT00896532|588154801|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849594|NCT00896532|588154802|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849595|NCT00896532|588154803|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849596|NCT00896532|588154804|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162610576|NCT04650854|587291499|FG000|Overall Study|Lack of Efficacy|1|||
162610577|NCT04650854|587291500|FG001|Overall Study|Lack of Efficacy|3|||
162610578|NCT04650854|587291501|FG002|Overall Study|Lack of Efficacy|6|||
162610579|NCT04650854|587291499|FG000|Overall Study|Lost to Follow-up|1|||
162610580|NCT04650854|587291500|FG001|Overall Study|Lost to Follow-up|1|||
162610581|NCT04650854|587291501|FG002|Overall Study|Lost to Follow-up|0|||
162610582|NCT04650854|587291499|FG000|Overall Study|Withdrawal by Subject|2|||
162849597|NCT00896532|588154805|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849598|NCT00896532|588154806|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
162849599|NCT00896532|588154807|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849600|NCT00896532|588154808|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
162849601|NCT00896532|588154809|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849602|NCT00896532|588154810|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162610583|NCT04650854|587291500|FG001|Overall Study|Withdrawal by Subject|17|||
162610584|NCT04650854|587291501|FG002|Overall Study|Withdrawal by Subject|9|||
162610585|NCT04650854|587291499|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
162610586|NCT04650854|587291500|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
162610587|NCT04650854|587291501|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
162610588|NCT04650854|587291499|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
162849603|NCT00896532|588154811|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849604|NCT00896532|588154812|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849605|NCT00896532|588154813|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162610589|NCT04650854|587291500|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
162610590|NCT04650854|587291501|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
162610591|NCT04650854|587291499|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
162610592|NCT04650854|587291500|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
162610593|NCT04650854|587291501|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
162610594|NCT04650854|587291499|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
162849606|NCT00896532|588154814|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162610595|NCT04650854|587291500|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
162849607|NCT00896532|588154815|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162952821|NCT02255097|588531668|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
162610596|NCT04650854|587291501|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
162610597|NCT04650854|587291499|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
162610598|NCT04650854|587291500|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
162610599|NCT04650854|587291501|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
162610600|NCT04650854|587291499|FG000|Overall Study|Use of Rescue Medication|0|||
162610601|NCT04650854|587291500|FG001|Overall Study|Use of Rescue Medication|0|||
162610602|NCT04650854|587291501|FG002|Overall Study|Use of Rescue Medication|1|||
162610603|NCT04650854|587291499|FG000|Overall Study|Last Treatment Per Sponsor|0|||
162610604|NCT04650854|587291500|FG001|Overall Study|Last Treatment Per Sponsor|0|||
162610605|NCT04650854|587291501|FG002|Overall Study|Last Treatment Per Sponsor|2|||
162610606|NCT04650854|587291499|FG000|Overall Study|Rescue Medication|0|||
162610607|NCT04650854|587291500|FG001|Overall Study|Rescue Medication|0|||
162610608|NCT04650854|587291501|FG002|Overall Study|Rescue Medication|1|||
162610609|NCT04650854|587291499|FG000|Overall Study|Participant Want to Start a Family|0|||
162610610|NCT04650854|587291500|FG001|Overall Study|Participant Want to Start a Family|0|||
162610611|NCT04650854|587291501|FG002|Overall Study|Participant Want to Start a Family|1|||
162610612|NCT04650854|587291499|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
162610613|NCT04650854|587291500|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
162610614|NCT04650854|587291501|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
162610615|NCT04650854|587291499|FG000|Overall Study|Participant Screened For MG0020|0|||
162610616|NCT04650854|587291500|FG001|Overall Study|Participant Screened For MG0020|2|||
162610617|NCT04650854|587291501|FG002|Overall Study|Participant Screened For MG0020|3|||
162610618|NCT04650854|587291499|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
162610619|NCT04650854|587291500|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
162610620|NCT04650854|587291501|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
162610621|NCT04650854|587291499|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
162610622|NCT04650854|587291500|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
162610623|NCT04650854|587291501|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
162610624|NCT04650854|587291499|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
162610625|NCT04650854|587291500|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
162610626|NCT04650854|587291501|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
162610627|NCT04650854|587291499|FG000|Overall Study|End Of Study|0|||
162610628|NCT04650854|587291500|FG001|Overall Study|End Of Study|2|||
162610629|NCT04650854|587291501|FG002|Overall Study|End Of Study|1|||
162610630|NCT04650854|587291499|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
162610631|NCT04650854|587291500|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
162610632|NCT04650854|587291501|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
162610633|NCT04650854|587291499|FG000|Overall Study|Participant Received Rescue Medication|0|||
162610634|NCT04650854|587291500|FG001|Overall Study|Participant Received Rescue Medication|1|||
162610635|NCT04650854|587291501|FG002|Overall Study|Participant Received Rescue Medication|0|||
162610636|NCT04650854|587291499|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
162610637|NCT04650854|587291500|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
162610638|NCT04650854|587291501|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
162610639|NCT04650854|587291499|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
162610640|NCT04650854|587291500|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
162610641|NCT04650854|587291501|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
162610642|NCT04650854|587291499|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
162704063|NCT00072475|587628857|FG000|Overall Study|Death|3|||
162704064|NCT00072475|587628857|FG000|Overall Study|Withdrawal by Subject|46|||
162704065|NCT00072475|587628857|FG000|Overall Study|Patient/Investigator Decision|4|||
162704066|NCT03303105|587628858|FG000|Overall Study|Adverse Event|0|||
162704067|NCT03303105|587628859|FG001|Overall Study|Adverse Event|2|||
162704068|NCT03303105|587628858|FG000|Overall Study|Lack of Efficacy|1|||
162704069|NCT03303105|587628859|FG001|Overall Study|Lack of Efficacy|0|||
162704070|NCT03303105|587628858|FG000|Overall Study|Protocol Violation|1|||
162704071|NCT03303105|587628859|FG001|Overall Study|Protocol Violation|0|||
162704072|NCT03303105|587628858|FG000|Overall Study|Withdrawal by Subject|0|||
162704073|NCT03303105|587628859|FG001|Overall Study|Withdrawal by Subject|2|||
162704074|NCT02724020|587628875|FG000|Overall Study|Death|16|||
162704075|NCT02724020|587628876|FG001|Overall Study|Death|18|||
162704076|NCT02724020|587628877|FG002|Overall Study|Death|19|||
162704077|NCT02724020|587628875|FG000|Overall Study|Lost to Follow-up|0|||
162704078|NCT02724020|587628876|FG001|Overall Study|Lost to Follow-up|3|||
162704079|NCT02724020|587628877|FG002|Overall Study|Lost to Follow-up|0|||
162704080|NCT02724020|587628875|FG000|Overall Study|Site Terminated by Sponsor|15|||
162704081|NCT02724020|587628876|FG001|Overall Study|Site Terminated by Sponsor|8|||
162704082|NCT02724020|587628877|FG002|Overall Study|Site Terminated by Sponsor|8|||
162704083|NCT02724020|587628875|FG000|Overall Study|Withdrawal by Subject|1|||
162704084|NCT02724020|587628876|FG001|Overall Study|Withdrawal by Subject|3|||
162704085|NCT02724020|587628877|FG002|Overall Study|Withdrawal by Subject|5|||
162704086|NCT02179918|587628878|FG000|Overall Study|Death|0|||
162704087|NCT02179918|587628879|FG001|Overall Study|Death|0|||
162704088|NCT02179918|587628880|FG002|Overall Study|Death|0|||
162610643|NCT04650854|587291500|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
162610644|NCT04650854|587291501|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
162610645|NCT04650854|587291499|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
162610646|NCT04650854|587291500|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
162610647|NCT04650854|587291501|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
162610648|NCT04650854|587291499|FG000|Overall Study|Enrollment Cup|0|||
162610649|NCT04650854|587291500|FG001|Overall Study|Enrollment Cup|0|||
162610650|NCT04650854|587291501|FG002|Overall Study|Enrollment Cup|1|||
162610651|NCT00704808|587291518|FG000|Overall Study|Discontinued prior to starting treatment|14|||
162610652|NCT00704808|587291518|FG000|Overall Study|Death|7|||
162610653|NCT00704808|587291518|FG000|Overall Study|Tumor progression|80|||
162610654|NCT00704808|587291518|FG000|Overall Study|Patient's decision|11|||
162610655|NCT00704808|587291518|FG000|Overall Study|Early therapy discontinuation|16|||
162610656|NCT00704808|587291518|FG000|Overall Study|Adverse Event|1|||
162610657|NCT00704808|587291518|FG000|Overall Study|Lost to Follow-up|1|||
162849608|NCT00896532|588154816|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849609|NCT00896532|588154817|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162849610|NCT00896532|588154818|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
162610658|NCT00704808|587291518|FG000|Overall Study|Treatment change|1|||
162849611|NCT00896532|588154796|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162610659|NCT01982331|587291525|FG000|Received Vaccination 2|Adverse Event|1|||
162610660|NCT01982331|587291526|FG001|Received Vaccination 2|Adverse Event|2|||
162610661|NCT01982331|587291525|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
162610662|NCT01982331|587291526|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
162610663|NCT01982331|587291525|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
162610664|NCT01982331|587291526|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
162610665|NCT03500679|587291527|FG000|Overall Study|Lost to Follow-up|6|||
162610666|NCT03500679|587291528|FG001|Overall Study|Lost to Follow-up|3|||
162610667|NCT03500679|587291527|FG000|Overall Study|Withdrawal by Subject|3|||
162610668|NCT03500679|587291528|FG001|Overall Study|Withdrawal by Subject|0|||
162610669|NCT00744471|587291530|FG000|Overall Study|Randomized but not treated|1|||
162610670|NCT00744471|587291531|FG001|Overall Study|Randomized but not treated|1|||
162610671|NCT00744471|587291532|FG002|Overall Study|Randomized but not treated|4|||
162610672|NCT00744471|587291533|FG003|Overall Study|Randomized but not treated|0|||
162610673|NCT00744471|587291530|FG000|Overall Study|Death|0|||
162610674|NCT00744471|587291531|FG001|Overall Study|Death|0|||
162610675|NCT00744471|587291532|FG002|Overall Study|Death|0|||
162610676|NCT00744471|587291533|FG003|Overall Study|Death|1|||
162610677|NCT00744471|587291530|FG000|Overall Study|Adverse Event|6|||
162610678|NCT00744471|587291531|FG001|Overall Study|Adverse Event|7|||
162610679|NCT00744471|587291532|FG002|Overall Study|Adverse Event|5|||
162610680|NCT00744471|587291533|FG003|Overall Study|Adverse Event|9|||
162610681|NCT00744471|587291530|FG000|Overall Study|Withdrawal by Subject|9|||
162610682|NCT00744471|587291531|FG001|Overall Study|Withdrawal by Subject|9|||
162610683|NCT00744471|587291532|FG002|Overall Study|Withdrawal by Subject|15|||
162610684|NCT00744471|587291533|FG003|Overall Study|Withdrawal by Subject|12|||
162610685|NCT00744471|587291530|FG000|Overall Study|Protocol Violation|1|||
162610686|NCT00744471|587291531|FG001|Overall Study|Protocol Violation|4|||
162610687|NCT00744471|587291532|FG002|Overall Study|Protocol Violation|1|||
162610688|NCT00744471|587291533|FG003|Overall Study|Protocol Violation|2|||
162610689|NCT00744471|587291530|FG000|Overall Study|Entered extension study|41|||
162610690|NCT00744471|587291531|FG001|Overall Study|Entered extension study|84|||
162610691|NCT00744471|587291532|FG002|Overall Study|Entered extension study|100|||
162610692|NCT00744471|587291533|FG003|Overall Study|Entered extension study|91|||
162610693|NCT00744471|587291530|FG000|Overall Study|Other|2|||
162849612|NCT00896532|588154797|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849613|NCT00896532|588154798|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849614|NCT00896532|588154799|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849615|NCT00896532|588154800|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849616|NCT00896532|588154801|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849617|NCT00896532|588154802|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849618|NCT00896532|588154803|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849619|NCT00896532|588154804|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849620|NCT00896532|588154805|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849621|NCT00896532|588154806|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849622|NCT00896532|588154807|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162610694|NCT00744471|587291531|FG001|Overall Study|Other|3|||
162610695|NCT00744471|587291532|FG002|Overall Study|Other|6|||
162610696|NCT00744471|587291533|FG003|Overall Study|Other|2|||
162610697|NCT00744471|587291530|FG000|Overall Study|Lack of Efficacy|83|||
162610698|NCT00744471|587291531|FG001|Overall Study|Lack of Efficacy|37|||
162610699|NCT00744471|587291532|FG002|Overall Study|Lack of Efficacy|19|||
162610700|NCT00744471|587291533|FG003|Overall Study|Lack of Efficacy|31|||
162849623|NCT00896532|588154808|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
162849624|NCT00896532|588154809|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
162849625|NCT00896532|588154810|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849626|NCT00896532|588154811|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849627|NCT00896532|588154812|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849628|NCT00896532|588154813|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849629|NCT00896532|588154814|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162610701|NCT00744471|587291530|FG000|Overall Study|Lost to Follow-up|0|||
162610702|NCT00744471|587291531|FG001|Overall Study|Lost to Follow-up|0|||
162610703|NCT00744471|587291532|FG002|Overall Study|Lost to Follow-up|2|||
162610704|NCT00744471|587291533|FG003|Overall Study|Lost to Follow-up|0|||
162610705|NCT04706416|587291536|FG000|Overall Study|Lost to Follow-up|2|||
162610706|NCT04706416|587291537|FG001|Overall Study|Lost to Follow-up|0|||
162610707|NCT01280955|587291538|FG000|Overall Study|Death|2|||
162610708|NCT01280955|587291538|FG000|Overall Study|Withdrawal by Subject|1|||
162610709|NCT01484054|587291539|FG000|Period 1|Withdrawal by Subject|0|||
162610710|NCT01484054|587291540|FG001|Period 1|Withdrawal by Subject|1|||
162610711|NCT05281601|587291543|FG000|Overall Study|Physician Decision|2|||
162610712|NCT05281601|587291544|FG001|Overall Study|Physician Decision|0|||
162610713|NCT05281601|587291543|FG000|Overall Study|Lost to Follow-up|2|||
162610714|NCT05281601|587291544|FG001|Overall Study|Lost to Follow-up|0|||
162610715|NCT05281601|587291543|FG000|Overall Study|Death|1|||
162610716|NCT05281601|587291544|FG001|Overall Study|Death|0|||
162610717|NCT05281601|587291543|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162610718|NCT05281601|587291544|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162610719|NCT03119701|587291557|FG000|6-day Dosing|Death|4|||
162610720|NCT03119701|587291558|FG001|6-day Dosing|Death|1|||
162610721|NCT03119701|587291557|FG000|6-day Dosing|Adverse Event|3|||
162610722|NCT03119701|587291558|FG001|6-day Dosing|Adverse Event|0|||
162610723|NCT03119701|587291557|FG000|6-day Dosing|Physician Decision|0|||
162610724|NCT03119701|587291558|FG001|6-day Dosing|Physician Decision|1|||
162610725|NCT03119701|587291557|FG000|6-day Dosing|Withdrawal by Subject|0|||
162610726|NCT03119701|587291558|FG001|6-day Dosing|Withdrawal by Subject|1|||
162610727|NCT03119701|587291557|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
162610728|NCT03119701|587291558|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
162610729|NCT00406718|587291564|FG000|Overall Study|Withdrawal by Subject|2|||
162610730|NCT00406718|587291565|FG001|Overall Study|Withdrawal by Subject|9|||
162610731|NCT00406718|587291566|FG002|Overall Study|Withdrawal by Subject|4|||
162610732|NCT00406718|587291564|FG000|Overall Study|Lost to Follow-up|2|||
162610733|NCT00406718|587291565|FG001|Overall Study|Lost to Follow-up|5|||
162610734|NCT00406718|587291566|FG002|Overall Study|Lost to Follow-up|4|||
162610735|NCT01888003|587291569|FG000|Overall Study|Study Terminated|5|||
162610736|NCT01888003|587291570|FG001|Overall Study|Study Terminated|6|||
162610737|NCT01888003|587291571|FG002|Overall Study|Study Terminated|40|||
162610738|NCT03187756|587291572|FG000|Overall Study|Termination of study|4|||
162610739|NCT03172910|587293263|FG000|Overall Study|Adverse Event|0|||
162610740|NCT03172910|587293264|FG001|Overall Study|Adverse Event|0|||
162610741|NCT03172910|587293265|FG002|Overall Study|Adverse Event|0|||
162610742|NCT03172910|587293266|FG003|Overall Study|Adverse Event|0|||
162610743|NCT03172910|587293267|FG004|Overall Study|Adverse Event|1|||
162610744|NCT02247531|587293270|FG000|Overall Study|Adverse Event|3|||
162610745|NCT02247531|587293271|FG001|Overall Study|Adverse Event|4|||
162610746|NCT02247531|587293272|FG002|Overall Study|Adverse Event|9|||
162610747|NCT02247531|587293270|FG000|Overall Study|Death|8|||
162610748|NCT02247531|587293271|FG001|Overall Study|Death|9|||
162610749|NCT02247531|587293272|FG002|Overall Study|Death|5|||
162610750|NCT02247531|587293270|FG000|Overall Study|Lost to Follow-up|1|||
162610751|NCT02247531|587293271|FG001|Overall Study|Lost to Follow-up|8|||
162610752|NCT02247531|587293272|FG002|Overall Study|Lost to Follow-up|3|||
162610753|NCT02247531|587293270|FG000|Overall Study|Non-compliance|2|||
162610754|NCT02247531|587293271|FG001|Overall Study|Non-compliance|2|||
162610755|NCT02247531|587293272|FG002|Overall Study|Non-compliance|0|||
162610756|NCT02247531|587293270|FG000|Overall Study|Withdrawal by Subject|26|||
162610757|NCT02247531|587293271|FG001|Overall Study|Withdrawal by Subject|31|||
162610758|NCT02247531|587293272|FG002|Overall Study|Withdrawal by Subject|25|||
162610759|NCT02247531|587293270|FG000|Overall Study|Study Terminated by Sponsor|64|||
162610760|NCT02247531|587293271|FG001|Overall Study|Study Terminated by Sponsor|66|||
162610761|NCT02247531|587293272|FG002|Overall Study|Study Terminated by Sponsor|62|||
162610762|NCT02247531|587293270|FG000|Overall Study|Physician Decision|0|||
162610763|NCT02247531|587293271|FG001|Overall Study|Physician Decision|2|||
162610764|NCT02247531|587293272|FG002|Overall Study|Physician Decision|2|||
162610765|NCT02247531|587293270|FG000|Overall Study|Unspecified Reason|2|||
162610766|NCT02247531|587293271|FG001|Overall Study|Unspecified Reason|3|||
162610767|NCT02247531|587293272|FG002|Overall Study|Unspecified Reason|4|||
162610768|NCT04879225|587293275|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
162610769|NCT04879225|587293275|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
162610770|NCT03646643|587293276|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
162610771|NCT03646643|587293277|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
162610772|NCT03646643|587293276|FG000|Overall Study|Lost to Follow-up|0|||
162610773|NCT03646643|587293277|FG001|Overall Study|Lost to Follow-up|1|||
162610774|NCT01229397|587293283|FG000|Overall Study|Withdrawal by Subject|3|||
162610775|NCT01229397|587293284|FG001|Overall Study|Withdrawal by Subject|3|||
162610776|NCT01229397|587293283|FG000|Overall Study|Lost to Follow-up|7|||
162610777|NCT01229397|587293284|FG001|Overall Study|Lost to Follow-up|6|||
162610778|NCT01229397|587293283|FG000|Overall Study|Migrated/moved from study area|1|||
162610779|NCT01229397|587293284|FG001|Overall Study|Migrated/moved from study area|0|||
162610780|NCT01810432|587293287|FG000|Washout|Protocol Violation|0|||
162610781|NCT01810432|587293288|FG001|Washout|Protocol Violation|1|||
162610782|NCT01810432|587293287|FG000|Washout|Adverse Event|1|||
162610783|NCT01810432|587293288|FG001|Washout|Adverse Event|0|||
162610784|NCT01810432|587293287|FG000|Period 2|Withdrawal by Subject|2|||
162610785|NCT01810432|587293288|FG001|Period 2|Withdrawal by Subject|1|||
162610786|NCT01810432|587293287|FG000|Period 2|Physician Decision|1|||
162610787|NCT01810432|587293288|FG001|Period 2|Physician Decision|0|||
162610788|NCT01810432|587293287|FG000|Period 2|Lost to Follow-up|1|||
162610789|NCT01810432|587293288|FG001|Period 2|Lost to Follow-up|1|||
162610790|NCT00214500|587293289|FG000|Treatment Period|Adverse Event|1|||
162610791|NCT00214500|587293289|FG000|Extension Period|Withdrawal by Subject|2|||
162610792|NCT03170232|587293290|FG000|Overall Study|Adverse Event|0|||
162610793|NCT03170232|587293291|FG001|Overall Study|Adverse Event|1|||
162610794|NCT03170232|587293290|FG000|Overall Study|Protocol Violation|0|||
162610795|NCT03170232|587293291|FG001|Overall Study|Protocol Violation|1|||
162610796|NCT03170232|587293290|FG000|Overall Study|Lack of Efficacy|0|||
162610797|NCT03170232|587293291|FG001|Overall Study|Lack of Efficacy|1|||
162610798|NCT03170232|587293290|FG000|Overall Study|Study closed/terminated|26|||
162610799|NCT03170232|587293291|FG001|Overall Study|Study closed/terminated|23|||
162610800|NCT03170232|587293290|FG000|Overall Study|Lost to Follow-up|1|||
162610801|NCT03170232|587293291|FG001|Overall Study|Lost to Follow-up|0|||
162610802|NCT03170232|587293290|FG000|Overall Study|Withdrawal by Subject|0|||
162610803|NCT03170232|587293291|FG001|Overall Study|Withdrawal by Subject|1|||
162610804|NCT02537574|587293292|FG000|Overall Study|Adverse Event|1|||
162610805|NCT02537574|587293293|FG001|Overall Study|Adverse Event|3|||
162610806|NCT02537574|587293294|FG002|Overall Study|Adverse Event|2|||
162610807|NCT02537574|587293292|FG000|Overall Study|Lost to Follow-up|40|||
162610808|NCT02537574|587293293|FG001|Overall Study|Lost to Follow-up|51|||
162610809|NCT02537574|587293294|FG002|Overall Study|Lost to Follow-up|55|||
162610810|NCT02537574|587293292|FG000|Overall Study|Noncompliance with study drug|0|||
162610811|NCT02537574|587293293|FG001|Overall Study|Noncompliance with study drug|1|||
162610812|NCT02537574|587293294|FG002|Overall Study|Noncompliance with study drug|1|||
162610813|NCT02537574|587293292|FG000|Overall Study|Physician Decision|2|||
162610814|NCT02537574|587293293|FG001|Overall Study|Physician Decision|0|||
162610815|NCT02537574|587293294|FG002|Overall Study|Physician Decision|0|||
162610816|NCT02537574|587293292|FG000|Overall Study|Protocol Violation|4|||
162610817|NCT02537574|587293293|FG001|Overall Study|Protocol Violation|2|||
162610818|NCT02537574|587293294|FG002|Overall Study|Protocol Violation|3|||
162610819|NCT02537574|587293292|FG000|Overall Study|Withdrawal by Subject|37|||
162610820|NCT02537574|587293293|FG001|Overall Study|Withdrawal by Subject|27|||
162610821|NCT02537574|587293294|FG002|Overall Study|Withdrawal by Subject|29|||
162610822|NCT02537574|587293292|FG000|Overall Study|Lack of Efficacy|14|||
162610823|NCT02537574|587293293|FG001|Overall Study|Lack of Efficacy|16|||
162610824|NCT02537574|587293294|FG002|Overall Study|Lack of Efficacy|15|||
162610825|NCT02537574|587293292|FG000|Overall Study|Duplicate Patient|1|||
162610826|NCT02537574|587293293|FG001|Overall Study|Duplicate Patient|0|||
162610827|NCT02537574|587293294|FG002|Overall Study|Duplicate Patient|0|||
162610828|NCT02537574|587293292|FG000|Overall Study|Patient not Stable|0|||
162610829|NCT02537574|587293293|FG001|Overall Study|Patient not Stable|1|||
162610830|NCT02537574|587293294|FG002|Overall Study|Patient not Stable|0|||
162610831|NCT02537574|587293292|FG000|Overall Study|Incarceration|0|||
162610832|NCT02537574|587293293|FG001|Overall Study|Incarceration|1|||
162610833|NCT02537574|587293294|FG002|Overall Study|Incarceration|0|||
162610834|NCT02537574|587293292|FG000|Overall Study|Failed Naloxone Challenge|0|||
162610835|NCT02537574|587293293|FG001|Overall Study|Failed Naloxone Challenge|1|||
162610836|NCT02537574|587293294|FG002|Overall Study|Failed Naloxone Challenge|0|||
162610837|NCT02537574|587293292|FG000|Overall Study|Transportation Issues|0|||
162610838|NCT02537574|587293293|FG001|Overall Study|Transportation Issues|0|||
162610839|NCT02537574|587293294|FG002|Overall Study|Transportation Issues|1|||
162610840|NCT02537574|587293292|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
162610841|NCT02537574|587293293|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
162610842|NCT02537574|587293294|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
162610843|NCT02537574|587293292|FG000|Overall Study|Noncompliance with Protocol|0|||
162610844|NCT02537574|587293293|FG001|Overall Study|Noncompliance with Protocol|0|||
162610845|NCT02537574|587293294|FG002|Overall Study|Noncompliance with Protocol|1|||
162610846|NCT01151098|587293295|FG000|Overall Study|Adverse Event|82|||
162610847|NCT01151098|587293295|FG000|Overall Study|Lost to Follow-up|6|||
162610848|NCT01151098|587293295|FG000|Overall Study|Lack of Efficacy|15|||
162610849|NCT01151098|587293295|FG000|Overall Study|Protocol Violation|1|||
162610850|NCT01151098|587293295|FG000|Overall Study|Miscellaneous|13|||
162610851|NCT03343067|587293298|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
162610852|NCT03343067|587293299|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
162610853|NCT03343067|587293300|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
162610854|NCT00542451|587293301|FG000|Overall Study|Adverse Event|31|||
162610855|NCT00542451|587293301|FG000|Overall Study|Withdrawal by Subject|30|||
162610856|NCT00542451|587293301|FG000|Overall Study|Physician Decision|4|||
162610857|NCT00542451|587293301|FG000|Overall Study|Recurrent disease|1|||
162610858|NCT00542451|587293301|FG000|Overall Study|unknown reason|1|||
162610859|NCT00542451|587293301|FG000|Overall Study|Death|2|||
162610860|NCT00542451|587293301|FG000|Overall Study|Lost to Follow-up|10|||
162610861|NCT00116168|587293304|FG000|Overall Study|Lost to Follow-up|6|||
162610862|NCT00116168|587293305|FG001|Overall Study|Lost to Follow-up|5|||
162610863|NCT00116168|587293306|FG002|Overall Study|Lost to Follow-up|0|||
162610864|NCT00116168|587293307|FG003|Overall Study|Lost to Follow-up|0|||
162610865|NCT05153473|587293308|FG000|Overall Study|Death|46|||
162610866|NCT05153473|587293308|FG000|Overall Study|Lost to Follow-up|3|||
162952822|NCT02255097|588531668|FG000|Overall Study|Withdrawal by Subject|7|||
162952823|NCT02255097|588531668|FG000|Overall Study|Allocated but not treated|1|||
162952824|NCT03956862|588531669|FG000|Overall Study|Lost to Follow-up|1|||
162952825|NCT03956862|588531670|FG001|Overall Study|Lost to Follow-up|1|||
162952826|NCT03956862|588531669|FG000|Overall Study|Withdrawal by Subject|1|||
162952827|NCT03956862|588531670|FG001|Overall Study|Withdrawal by Subject|1|||
162952828|NCT01498120|588531671|FG000|Overall Study|Lost to Follow-up|1|||
162952829|NCT01498120|588531671|FG000|Overall Study|Withdrawal by Subject|5|||
162952830|NCT01498120|588531671|FG000|Overall Study|AE, non-serious non-fatal|3|||
162952831|NCT01498120|588531671|FG000|Overall Study|Other|4|||
162952832|NCT02294604|588531672|FG000|Overall Study|Did not provide samples for culture|0|||
162952833|NCT02294604|588531673|FG001|Overall Study|Did not provide samples for culture|1|||
162952834|NCT02294604|588531674|FG002|Overall Study|Did not provide samples for culture|0|||
162952835|NCT02294604|588531672|FG000|Overall Study|Culture contamination|1|||
162952836|NCT02294604|588531673|FG001|Overall Study|Culture contamination|2|||
162952837|NCT02294604|588531674|FG002|Overall Study|Culture contamination|0|||
162952838|NCT01118312|588531675|FG000|Overall Study|Lost to Follow-up|33|||
162952839|NCT01118312|588531676|FG001|Overall Study|Lost to Follow-up|32|||
162952840|NCT01118312|588531675|FG000|Overall Study|Withdrawal by Subject|1|||
162952841|NCT01118312|588531676|FG001|Overall Study|Withdrawal by Subject|3|||
162952842|NCT03965091|588531677|FG000|Overall Study|Adverse Event|0|||
162952843|NCT03965091|588531678|FG001|Overall Study|Adverse Event|2|||
162952844|NCT03965091|588531679|FG002|Overall Study|Adverse Event|3|||
162952845|NCT03965091|588531677|FG000|Overall Study|Withdrawal by Subject|11|||
162952846|NCT03965091|588531678|FG001|Overall Study|Withdrawal by Subject|3|||
162952847|NCT03965091|588531679|FG002|Overall Study|Withdrawal by Subject|5|||
162952848|NCT03965091|588531677|FG000|Overall Study|Non-compliance with study drug|0|||
162952849|NCT03965091|588531678|FG001|Overall Study|Non-compliance with study drug|0|||
162952850|NCT03965091|588531679|FG002|Overall Study|Non-compliance with study drug|1|||
162952851|NCT03965091|588531677|FG000|Overall Study|Lost to Follow-up|1|||
162952852|NCT03965091|588531678|FG001|Overall Study|Lost to Follow-up|1|||
162952853|NCT03965091|588531679|FG002|Overall Study|Lost to Follow-up|1|||
162952854|NCT03965091|588531677|FG000|Overall Study|Lack of Efficacy|2|||
162952855|NCT03965091|588531678|FG001|Overall Study|Lack of Efficacy|0|||
162952856|NCT03965091|588531679|FG002|Overall Study|Lack of Efficacy|0|||
162952857|NCT03965091|588531677|FG000|Overall Study|Other than specified|9|||
162952858|NCT03965091|588531678|FG001|Overall Study|Other than specified|11|||
162952859|NCT03965091|588531679|FG002|Overall Study|Other than specified|8|||
162610867|NCT00245583|587293312|FG000|Overall Study|Lost to Follow-up|1|||
162610868|NCT00245583|587293313|FG001|Overall Study|Lost to Follow-up|5|||
162610869|NCT00245583|587293312|FG000|Overall Study|Adverse Event|2|||
162610870|NCT00245583|587293313|FG001|Overall Study|Adverse Event|1|||
162610871|NCT00245583|587293312|FG000|Overall Study|Lack of Efficacy|1|||
162610872|NCT00245583|587293313|FG001|Overall Study|Lack of Efficacy|0|||
162610873|NCT00245583|587293312|FG000|Overall Study|Withdrawal by Subject|2|||
162610874|NCT00245583|587293313|FG001|Overall Study|Withdrawal by Subject|3|||
162610875|NCT01309893|587293314|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
162610876|NCT01309893|587293315|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
162610877|NCT01309893|587293314|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
162610878|NCT01309893|587293315|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
162610879|NCT02017171|587293316|FG000|Overall Study|Death|10|||
162610880|NCT02017171|587293317|FG001|Overall Study|Death|4|||
162610881|NCT02017171|587293316|FG000|Overall Study|Withdrawal by Subject|23|||
162610882|NCT02017171|587293317|FG001|Overall Study|Withdrawal by Subject|17|||
162610883|NCT02017171|587293316|FG000|Overall Study|Lost to Follow-up|21|||
162610884|NCT02017171|587293317|FG001|Overall Study|Lost to Follow-up|20|||
162610885|NCT02017171|587293316|FG000|Overall Study|ESKD|6|||
162610886|NCT02017171|587293317|FG001|Overall Study|ESKD|2|||
162952860|NCT00565448|588531680|FG000|Overall Study|Adverse Event|1|||
162610887|NCT02017171|587293316|FG000|Overall Study|Miscellaneous|2|||
162610888|NCT02017171|587293317|FG001|Overall Study|Miscellaneous|3|||
162610889|NCT01484938|587293318|FG000|Overall Study|Adverse Event|2|||
162610890|NCT01484938|587293318|FG000|Overall Study|Lost to Follow-up|1|||
162610891|NCT01484938|587293318|FG000|Overall Study|Noncompliance|1|||
162610892|NCT01172275|587293323|FG000|Overall Study|Lost to Follow-up|1|||
162610893|NCT01172275|587293324|FG001|Overall Study|Lost to Follow-up|0|||
162610894|NCT01172275|587293323|FG000|Overall Study|Protocol Violation|1|||
162610895|NCT01172275|587293324|FG001|Overall Study|Protocol Violation|0|||
162610896|NCT02862600|587293325|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
162610897|NCT02862600|587293325|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
162610898|NCT02862600|587293325|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
162610899|NCT02862600|587293325|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
162610900|NCT00194675|587293326|FG000|Overall Study|Lost to Follow-up|1|||
162610901|NCT00194675|587293327|FG001|Overall Study|Lost to Follow-up|1|||
162610902|NCT00194675|587293326|FG000|Overall Study|lack of interest|1|||
162610903|NCT00194675|587293327|FG001|Overall Study|lack of interest|1|||
162610904|NCT00194675|587293326|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
162610905|NCT00194675|587293327|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
162610906|NCT00194675|587293326|FG000|Overall Study|Protocol Violation|1|||
162610907|NCT00194675|587293327|FG001|Overall Study|Protocol Violation|0|||
162610908|NCT00194675|587293326|FG000|Overall Study|Death|1|||
162610909|NCT00194675|587293327|FG001|Overall Study|Death|0|||
162610910|NCT00667420|587293329|FG000|Overall Study|Adverse Event|2|||
162610911|NCT00667420|587293329|FG000|Overall Study|Lack of Efficacy|5|||
162610912|NCT00667420|587293329|FG000|Overall Study|Physician Decision|1|||
162610913|NCT00667420|587293329|FG000|Overall Study|Withdrawal by Subject|2|||
162610914|NCT04437368|587293333|FG000|Overall Study|Death|3|||
162610915|NCT04437368|587293334|FG001|Overall Study|Death|0|||
162610916|NCT04437368|587293335|FG002|Overall Study|Death|2|||
162610917|NCT04437368|587293333|FG000|Overall Study|Study terminated by sponsor|16|||
162610918|NCT04437368|587293334|FG001|Overall Study|Study terminated by sponsor|1|||
162610919|NCT04437368|587293335|FG002|Overall Study|Study terminated by sponsor|25|||
162610920|NCT04437368|587293333|FG000|Overall Study|Withdrawal by Subject|4|||
162610921|NCT04437368|587293334|FG001|Overall Study|Withdrawal by Subject|0|||
162610922|NCT04437368|587293335|FG002|Overall Study|Withdrawal by Subject|3|||
162610923|NCT04437368|587293333|FG000|Overall Study|Sponsor instructions|23|||
162610924|NCT04437368|587293334|FG001|Overall Study|Sponsor instructions|0|||
162610925|NCT04437368|587293335|FG002|Overall Study|Sponsor instructions|0|||
162610926|NCT00095628|587293336|FG000|Overall Study|Disease progression prior to treatment|1|||
162610927|NCT04271280|587293337|FG000|Overall Study|Lost to Follow-up|300|||
162610928|NCT04271280|587293337|FG000|Overall Study|Death|153|||
162610929|NCT04271280|587293337|FG000|Overall Study|Withdrawal of consent by patient|59|||
162610930|NCT04271280|587293337|FG000|Overall Study|Other|51|||
162610931|NCT04271280|587293337|FG000|Overall Study|No end of study information|42|||
162610932|NCT00495131|587293338|FG000|Overall Study|Adverse Event|6|||
162610933|NCT00495131|587293339|FG001|Overall Study|Adverse Event|2|||
162610934|NCT00495131|587293338|FG000|Overall Study|Lack of Efficacy|0|||
162610935|NCT00495131|587293339|FG001|Overall Study|Lack of Efficacy|2|||
162610936|NCT00495131|587293338|FG000|Overall Study|Lost to Follow-up|0|||
162610937|NCT00495131|587293339|FG001|Overall Study|Lost to Follow-up|2|||
162610938|NCT00495131|587293338|FG000|Overall Study|Withdrawal by Subject|1|||
162610939|NCT00495131|587293339|FG001|Overall Study|Withdrawal by Subject|0|||
162610940|NCT03224546|587293340|FG000|Overall Study|Lost to Follow-up|9|||
162610941|NCT03224546|587293341|FG001|Overall Study|Lost to Follow-up|8|||
162610942|NCT03224546|587293342|FG002|Overall Study|Lost to Follow-up|3|||
162610943|NCT03224546|587293340|FG000|Overall Study|Withdrawal by Subject|7|||
162610944|NCT03224546|587293341|FG001|Overall Study|Withdrawal by Subject|14|||
162610945|NCT03224546|587293342|FG002|Overall Study|Withdrawal by Subject|12|||
162610946|NCT01539317|587293345|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
162610947|NCT01539317|587293346|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
162610948|NCT04223232|587293347|FG000|Overall Study|Withdrawal by Subject|1|||
162610949|NCT00364130|587293348|FG000|Intervention Period|Lost to Follow-up|4|||
162610950|NCT00364130|587293349|FG001|Intervention Period|Lost to Follow-up|3|||
162610951|NCT00364130|587293348|FG000|Intervention Period|Pregnancy|1|||
162610952|NCT00364130|587293349|FG001|Intervention Period|Pregnancy|0|||
162610953|NCT00364130|587293348|FG000|Intervention Period|Withdrawal by Subject|4|||
162610954|NCT00364130|587293349|FG001|Intervention Period|Withdrawal by Subject|5|||
162610955|NCT00364130|587293348|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
162610956|NCT00364130|587293349|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
162610957|NCT00901927|587293359|FG000|Overall Study|Lack of Efficacy|1|||
162610958|NCT00901927|587293359|FG000|Overall Study|Protocol Violation|3|||
162610959|NCT00901927|587293359|FG000|Overall Study|Withdrawal by Subject|2|||
162610960|NCT00586846|587293360|FG000|Overall Study|Physician Decision|1|||
162610961|NCT00586846|587293360|FG000|Overall Study|Death|1|||
162610962|NCT00586846|587293360|FG000|Overall Study|Evaluable for Toxicity Only|4|||
162610963|NCT01702571|587293369|FG000|Overall Study|Death|1067|||
162610964|NCT01702571|587293370|FG001|Overall Study|Death|76|||
162610965|NCT01702571|587293369|FG000|Overall Study|Lost to Follow-up|144|||
162610966|NCT01702571|587293370|FG001|Overall Study|Lost to Follow-up|10|||
162610967|NCT01702571|587293369|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
162610968|NCT01702571|587293370|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
162610969|NCT01702571|587293369|FG000|Overall Study|Investigator Decision|5|||
162610970|NCT01702571|587293370|FG001|Overall Study|Investigator Decision|0|||
162610971|NCT01702571|587293369|FG000|Overall Study|Not Classifiable|1|||
162610972|NCT01702571|587293370|FG001|Overall Study|Not Classifiable|0|||
162610973|NCT01702571|587293369|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
162610974|NCT01702571|587293370|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
162610975|NCT01702571|587293369|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
162610976|NCT01702571|587293370|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
162610977|NCT01702571|587293369|FG000|Overall Study|Progressive Disease|3|||
162610978|NCT01702571|587293370|FG001|Overall Study|Progressive Disease|0|||
162610979|NCT01702571|587293369|FG000|Overall Study|Protocol Violation|2|||
162610980|NCT01702571|587293370|FG001|Overall Study|Protocol Violation|0|||
162610981|NCT01702571|587293369|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
162610982|NCT01702571|587293370|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
162610983|NCT01702571|587293369|FG000|Overall Study|Termination By Sponsor|4|||
162610984|NCT01702571|587293370|FG001|Overall Study|Termination By Sponsor|0|||
162610985|NCT01702571|587293369|FG000|Overall Study|Withdrawal by Subject|177|||
162610986|NCT01702571|587293370|FG001|Overall Study|Withdrawal by Subject|29|||
162610987|NCT03004443|587293371|FG000|Overall Study|Pregnancy|0|||
162610988|NCT03004443|587293372|FG001|Overall Study|Pregnancy|1|||
162610989|NCT00828854|587293373|FG000|Overall Study|Disease Progression|17|||
162610990|NCT00828854|587293373|FG000|Overall Study|Adverse Event|9|||
162610991|NCT00828854|587293373|FG000|Overall Study|Reason not Specified|1|||
162610992|NCT04221230|587293374|FG000|Overall Study|Lost to Follow-up|12|||
162610993|NCT04221230|587293375|FG001|Overall Study|Lost to Follow-up|12|||
162610994|NCT04221230|587293374|FG000|Overall Study|Protocol Violation|2|||
162610995|NCT04221230|587293375|FG001|Overall Study|Protocol Violation|2|||
162610996|NCT04221230|587293374|FG000|Overall Study|Adverse Event|0|||
162610997|NCT04221230|587293375|FG001|Overall Study|Adverse Event|8|||
162610998|NCT04221230|587293374|FG000|Overall Study|Physician Decision|1|||
162610999|NCT04221230|587293375|FG001|Overall Study|Physician Decision|0|||
162611000|NCT04221230|587293374|FG000|Overall Study|Withdrawal by Subject|13|||
162611001|NCT04221230|587293375|FG001|Overall Study|Withdrawal by Subject|11|||
162611002|NCT04221230|587293374|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162611003|NCT04221230|587293375|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162611004|NCT04221230|587293374|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162611005|NCT04221230|587293375|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
162611006|NCT04221230|587293374|FG000|Overall Study|Pregnancy|0|||
162611007|NCT04221230|587293375|FG001|Overall Study|Pregnancy|1|||
162611008|NCT04221230|587293374|FG000|Overall Study|Other|1|||
162849630|NCT00896532|588154815|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849631|NCT00896532|588154816|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162849632|NCT00896532|588154817|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162611009|NCT04221230|587293375|FG001|Overall Study|Other|2|||
162611010|NCT00915356|587293376|FG000|Overall Study|Withdrawal by Subject|1|||
162611011|NCT00915356|587293377|FG001|Overall Study|Withdrawal by Subject|0|||
162611012|NCT00915356|587293378|FG002|Overall Study|Withdrawal by Subject|0|||
162704089|NCT02179918|587628881|FG003|Overall Study|Death|1|||
162704090|NCT02179918|587628882|FG004|Overall Study|Death|0|||
162704091|NCT02179918|587628878|FG000|Overall Study|Lost to Follow-up|0|||
162704092|NCT02179918|587628879|FG001|Overall Study|Lost to Follow-up|0|||
162704093|NCT02179918|587628880|FG002|Overall Study|Lost to Follow-up|1|||
162704094|NCT02179918|587628881|FG003|Overall Study|Lost to Follow-up|0|||
162704095|NCT02179918|587628882|FG004|Overall Study|Lost to Follow-up|0|||
162704096|NCT02179918|587628878|FG000|Overall Study|Progressive Disease|4|||
162704097|NCT02179918|587628879|FG001|Overall Study|Progressive Disease|1|||
162704098|NCT02179918|587628880|FG002|Overall Study|Progressive Disease|1|||
162704099|NCT02179918|587628881|FG003|Overall Study|Progressive Disease|2|||
162704100|NCT02179918|587628882|FG004|Overall Study|Progressive Disease|6|||
162704101|NCT02179918|587628878|FG000|Overall Study|Other|0|||
162704102|NCT02179918|587628879|FG001|Overall Study|Other|1|||
162704103|NCT02179918|587628880|FG002|Overall Study|Other|0|||
162704104|NCT02179918|587628881|FG003|Overall Study|Other|0|||
162849633|NCT00896532|588154818|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
162611013|NCT00915356|587293379|FG003|Overall Study|Withdrawal by Subject|0|||
162611014|NCT00915356|587293380|FG004|Overall Study|Withdrawal by Subject|0|||
162611015|NCT00191646|587293382|FG000|Overall Study|Toxicity|26|||
162611016|NCT00191646|587293383|FG001|Overall Study|Toxicity|37|||
162704105|NCT02179918|587628882|FG004|Overall Study|Other|1|||
162704106|NCT02179918|587628878|FG000|Overall Study|Subject refused further follow-up|0|||
162704107|NCT02179918|587628879|FG001|Overall Study|Subject refused further follow-up|1|||
162704108|NCT02179918|587628880|FG002|Overall Study|Subject refused further follow-up|0|||
162952861|NCT00565448|588531681|FG001|Overall Study|Adverse Event|2|||
162952862|NCT00565448|588531680|FG000|Overall Study|Disease progression|1|||
162952863|NCT00565448|588531681|FG001|Overall Study|Disease progression|0|||
162952864|NCT00565448|588531680|FG000|Overall Study|Withdrawal by Subject|1|||
162952865|NCT00565448|588531681|FG001|Overall Study|Withdrawal by Subject|0|||
162952866|NCT00193609|588531682|FG000|Overall Study|Lack of Efficacy|2|||
162952867|NCT00193609|588531682|FG000|Overall Study|Adverse Event|2|||
162952868|NCT00302952|588531683|FG000|Overall Study|Physician Decision|1|||
162952869|NCT00302952|588531684|FG001|Overall Study|Physician Decision|1|||
162952870|NCT00302952|588531683|FG000|Overall Study|Withdrawal by Subject|2|||
162952871|NCT00302952|588531684|FG001|Overall Study|Withdrawal by Subject|3|||
162952872|NCT00302952|588531683|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
162952873|NCT00302952|588531684|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
162952874|NCT02979353|588531685|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
162952875|NCT02979353|588531686|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
162952876|NCT02979353|588531685|FG000|Overall Study|Withdrawal by Subject|16|||
162952877|NCT02979353|588531686|FG001|Overall Study|Withdrawal by Subject|12|||
162952878|NCT02979353|588531685|FG000|Overall Study|Death|10|||
162952879|NCT02979353|588531686|FG001|Overall Study|Death|11|||
162952880|NCT02979353|588531685|FG000|Overall Study|Transfer to Hospice Care|19|||
162952881|NCT02979353|588531686|FG001|Overall Study|Transfer to Hospice Care|14|||
162952882|NCT02979353|588531685|FG000|Overall Study|Lost to Follow-up|1|||
162952883|NCT02979353|588531686|FG001|Overall Study|Lost to Follow-up|5|||
162952884|NCT00857623|588531687|FG000|Overall Study|Adverse Event|5|||
162952885|NCT00857623|588531688|FG001|Overall Study|Adverse Event|2|||
162952886|NCT00857623|588531687|FG000|Overall Study|Study-specific discontinuation criteria|5|||
162952887|NCT00857623|588531688|FG001|Overall Study|Study-specific discontinuation criteria|3|||
162952888|NCT00857623|588531687|FG000|Overall Study|Withdrawal by Subject|2|||
162952889|NCT00857623|588531688|FG001|Overall Study|Withdrawal by Subject|1|||
162952890|NCT00857623|588531687|FG000|Overall Study|Lack of Efficacy|1|||
162952891|NCT00857623|588531688|FG001|Overall Study|Lack of Efficacy|1|||
162952892|NCT00857623|588531687|FG000|Overall Study|Severe non-compliance to protocol|1|||
162952893|NCT00857623|588531688|FG001|Overall Study|Severe non-compliance to protocol|1|||
162952894|NCT00857623|588531687|FG000|Overall Study|Intake of prohibited medication|0|||
162611017|NCT00191646|587293382|FG000|Overall Study|Disease Progression|5|||
162611018|NCT00191646|587293383|FG001|Overall Study|Disease Progression|6|||
162611019|NCT00191646|587293382|FG000|Overall Study|Physician Decision|20|||
162611020|NCT00191646|587293383|FG001|Overall Study|Physician Decision|11|||
162611021|NCT00191646|587293382|FG000|Overall Study|Withdrawal by Subject|58|||
162611022|NCT00191646|587293383|FG001|Overall Study|Withdrawal by Subject|39|||
162611023|NCT00191646|587293382|FG000|Overall Study|Protocol Violation|5|||
162611024|NCT00191646|587293383|FG001|Overall Study|Protocol Violation|7|||
162611025|NCT00191646|587293382|FG000|Overall Study|Death|6|||
162611026|NCT00191646|587293383|FG001|Overall Study|Death|8|||
162611027|NCT00191646|587293382|FG000|Overall Study|Other|33|||
162611028|NCT00191646|587293383|FG001|Overall Study|Other|34|||
162611029|NCT00191646|587293382|FG000|Overall Study|Missing Data|18|||
162611030|NCT00191646|587293383|FG001|Overall Study|Missing Data|11|||
162611031|NCT05211284|587293391|FG000|Overall Study|Study Terminated|3|||
162611032|NCT05211284|587293392|FG001|Overall Study|Study Terminated|1|||
162611033|NCT00395538|587293398|FG000|Overall Study|Did not re-consent to revised protocol|1|||
162611034|NCT00395538|587293399|FG001|Overall Study|Did not re-consent to revised protocol|10|||
162611035|NCT00395538|587293400|FG002|Overall Study|Did not re-consent to revised protocol|0|||
162611036|NCT00395538|587293398|FG000|Overall Study|FDA partial hold on PTH|0|||
162611037|NCT00395538|587293399|FG001|Overall Study|FDA partial hold on PTH|0|||
162611038|NCT00395538|587293400|FG002|Overall Study|FDA partial hold on PTH|11|||
162611039|NCT00395538|587293398|FG000|Overall Study|Failed screening|0|||
162611040|NCT00395538|587293399|FG001|Overall Study|Failed screening|0|||
162611041|NCT00395538|587293400|FG002|Overall Study|Failed screening|4|||
162611042|NCT00395538|587293398|FG000|Overall Study|Switch to Natpara|0|||
162611043|NCT00395538|587293399|FG001|Overall Study|Switch to Natpara|0|||
162611044|NCT00395538|587293400|FG002|Overall Study|Switch to Natpara|3|||
162611045|NCT00395538|587293398|FG000|Overall Study|Adverse Event|1|||
162611046|NCT00395538|587293399|FG001|Overall Study|Adverse Event|0|||
162611047|NCT00395538|587293400|FG002|Overall Study|Adverse Event|2|||
162611048|NCT00395538|587293398|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
162611049|NCT00395538|587293399|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
162611050|NCT00395538|587293400|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
162611051|NCT00395538|587293398|FG000|Overall Study|Non-compliance with study protocol|0|||
162611052|NCT00395538|587293399|FG001|Overall Study|Non-compliance with study protocol|1|||
162611053|NCT00395538|587293400|FG002|Overall Study|Non-compliance with study protocol|0|||
162611054|NCT00395538|587293398|FG000|Overall Study|PTH resistance|0|||
162611055|NCT00395538|587293399|FG001|Overall Study|PTH resistance|0|||
162611056|NCT00395538|587293400|FG002|Overall Study|PTH resistance|1|||
162611057|NCT00395538|587293398|FG000|Overall Study|Pregnancy|1|||
162611058|NCT00395538|587293399|FG001|Overall Study|Pregnancy|0|||
162611059|NCT00395538|587293400|FG002|Overall Study|Pregnancy|0|||
162611060|NCT00395538|587293398|FG000|Overall Study|Partial recovery of parathyroid function|0|||
162611061|NCT00395538|587293399|FG001|Overall Study|Partial recovery of parathyroid function|0|||
162611062|NCT00395538|587293400|FG002|Overall Study|Partial recovery of parathyroid function|1|||
162611063|NCT00395538|587293398|FG000|Overall Study|Participant elected to discontinue|0|||
162611064|NCT00395538|587293399|FG001|Overall Study|Participant elected to discontinue|0|||
162611065|NCT00395538|587293400|FG002|Overall Study|Participant elected to discontinue|1|||
162611066|NCT05140382|587293401|FG000|Overall Study|Death|3|||
162611067|NCT05140382|587293402|FG001|Overall Study|Death|0|||
162611068|NCT05140382|587293403|FG002|Overall Study|Death|0|||
162611069|NCT05140382|587293401|FG000|Overall Study|Investigator decision|1|||
162611070|NCT05140382|587293402|FG001|Overall Study|Investigator decision|0|||
162611071|NCT05140382|587293403|FG002|Overall Study|Investigator decision|0|||
162611072|NCT05140382|587293401|FG000|Overall Study|Other|4|||
162611073|NCT05140382|587293402|FG001|Overall Study|Other|0|||
162611074|NCT05140382|587293403|FG002|Overall Study|Other|1|||
162611075|NCT05140382|587293401|FG000|Overall Study|Progressive disease|20|||
162611076|NCT05140382|587293402|FG001|Overall Study|Progressive disease|1|||
162611077|NCT05140382|587293403|FG002|Overall Study|Progressive disease|12|||
162611078|NCT05140382|587293401|FG000|Overall Study|Subjective disease progression|2|||
162611079|NCT05140382|587293402|FG001|Overall Study|Subjective disease progression|1|||
162611080|NCT05140382|587293403|FG002|Overall Study|Subjective disease progression|0|||
162611081|NCT05140382|587293401|FG000|Overall Study|Unknown at data cut-off|0|||
162611082|NCT05140382|587293402|FG001|Overall Study|Unknown at data cut-off|0|||
162849634|NCT00896532|588154796|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
162849635|NCT00896532|588154797|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
162611083|NCT05140382|587293403|FG002|Overall Study|Unknown at data cut-off|1|||
162611084|NCT05140382|587293401|FG000|Overall Study|Withdrawal by Subject|1|||
162611085|NCT05140382|587293402|FG001|Overall Study|Withdrawal by Subject|0|||
162611086|NCT05140382|587293403|FG002|Overall Study|Withdrawal by Subject|4|||
162611087|NCT05140382|587293401|FG000|Overall Study|Withdrawal of consent|0|||
162611088|NCT05140382|587293402|FG001|Overall Study|Withdrawal of consent|0|||
162611089|NCT05140382|587293403|FG002|Overall Study|Withdrawal of consent|1|||
162631093|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162631094|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
162611090|NCT01659658|587294868|FG000|Overall Study|Withdrawal by Patient|18|||
162611091|NCT01659658|587294869|FG001|Overall Study|Withdrawal by Patient|4|||
162611092|NCT01659658|587294870|FG002|Overall Study|Withdrawal by Patient|2|||
162611093|NCT01659658|587294871|FG003|Overall Study|Withdrawal by Patient|0|||
162611094|NCT01659658|587294872|FG004|Overall Study|Withdrawal by Patient|11|||
162611095|NCT01659658|587294868|FG000|Overall Study|Study Terminated by Sponsor|9|||
162611096|NCT01659658|587294869|FG001|Overall Study|Study Terminated by Sponsor|7|||
162611097|NCT01659658|587294870|FG002|Overall Study|Study Terminated by Sponsor|0|||
162611098|NCT01659658|587294871|FG003|Overall Study|Study Terminated by Sponsor|1|||
162611099|NCT01659658|587294872|FG004|Overall Study|Study Terminated by Sponsor|4|||
162611100|NCT01659658|587294868|FG000|Overall Study|Reason not Specified|61|||
162611101|NCT01659658|587294869|FG001|Overall Study|Reason not Specified|15|||
162611102|NCT01659658|587294870|FG002|Overall Study|Reason not Specified|8|||
162611103|NCT01659658|587294871|FG003|Overall Study|Reason not Specified|1|||
162611104|NCT01659658|587294872|FG004|Overall Study|Reason not Specified|34|||
162611105|NCT01659658|587294868|FG000|Overall Study|Lost to Follow-up|2|||
162611106|NCT01659658|587294869|FG001|Overall Study|Lost to Follow-up|0|||
162611107|NCT01659658|587294870|FG002|Overall Study|Lost to Follow-up|0|||
162611108|NCT01659658|587294871|FG003|Overall Study|Lost to Follow-up|0|||
162611109|NCT01659658|587294872|FG004|Overall Study|Lost to Follow-up|0|||
162611110|NCT01397201|587294873|FG000|Overall Study|Not treated|0|||
162611111|NCT01397201|587294874|FG001|Overall Study|Not treated|0|||
162611112|NCT01397201|587294875|FG002|Overall Study|Not treated|1|||
162611113|NCT01397201|587294876|FG003|Overall Study|Not treated|0|||
162611114|NCT01397201|587294877|FG004|Overall Study|Not treated|0|||
162611115|NCT01397201|587294873|FG000|Overall Study|Not yet defined|3|||
162611116|NCT01397201|587294874|FG001|Overall Study|Not yet defined|6|||
162611117|NCT01397201|587294875|FG002|Overall Study|Not yet defined|5|||
162611118|NCT01397201|587294876|FG003|Overall Study|Not yet defined|5|||
162611119|NCT01397201|587294877|FG004|Overall Study|Not yet defined|4|||
162611120|NCT01397201|587294873|FG000|Overall Study|Adverse Event|2|||
162611121|NCT01397201|587294874|FG001|Overall Study|Adverse Event|0|||
162611122|NCT01397201|587294875|FG002|Overall Study|Adverse Event|0|||
162611123|NCT01397201|587294876|FG003|Overall Study|Adverse Event|0|||
162611124|NCT01397201|587294877|FG004|Overall Study|Adverse Event|0|||
162704109|NCT02179918|587628881|FG003|Overall Study|Subject refused further follow-up|0|||
162704110|NCT02179918|587628882|FG004|Overall Study|Subject refused further follow-up|1|||
162704111|NCT02954575|587628884|FG000|Overall Study|Withdrawal by Subject|2|||
162704112|NCT02954575|587628884|FG000|Overall Study|Adverse Event|1|||
162704113|NCT00570661|587628887|FG000|Overall Study|Disease worsening|5|||
162704114|NCT00570661|587628887|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
162704115|NCT00570661|587628887|FG000|Overall Study|Adverse Event|1|||
162704116|NCT01734382|587628891|FG000|Part 1|Adverse Event|2|||
162704117|NCT01734382|587628892|FG001|Part 1|Adverse Event|0|||
162704118|NCT01734382|587628893|FG002|Part 1|Adverse Event|0|||
162704119|NCT01734382|587628891|FG000|Part 2|Adverse Event|0|||
162704120|NCT01734382|587628892|FG001|Part 2|Adverse Event|0|||
162704121|NCT01734382|587628893|FG002|Part 2|Adverse Event|1|||
162952895|NCT00857623|588531688|FG001|Overall Study|Intake of prohibited medication|1|||
162952896|NCT00857623|588531687|FG000|Overall Study|Positive for HEP C|0|||
162952897|NCT00857623|588531688|FG001|Overall Study|Positive for HEP C|1|||
162704122|NCT01734382|587628891|FG000|Part 2|Lack of Efficacy|0|||
162704123|NCT01734382|587628892|FG001|Part 2|Lack of Efficacy|1|||
162704124|NCT01734382|587628893|FG002|Part 2|Lack of Efficacy|1|||
162704125|NCT01734382|587628891|FG000|Part 2|Other|0|||
162704126|NCT01734382|587628892|FG001|Part 2|Other|0|||
162704127|NCT01734382|587628893|FG002|Part 2|Other|1|||
162611125|NCT00122278|587294881|FG000|Overall Study|Lost to Follow-up|2|||
162611126|NCT00122278|587294882|FG001|Overall Study|Lost to Follow-up|0|||
162611127|NCT01002482|587294883|FG000|Overall Study|Withdrawal by Subject|14|||
162611128|NCT01002482|587294884|FG001|Overall Study|Withdrawal by Subject|21|||
162611129|NCT01002482|587294883|FG000|Overall Study|Included twice|1|||
162611130|NCT01002482|587294884|FG001|Overall Study|Included twice|0|||
162611131|NCT02598960|587294888|FG000|Treatment Period|Disease Progression|4|||
162611132|NCT02598960|587294889|FG001|Treatment Period|Disease Progression|4|||
162704128|NCT01734382|587628891|FG000|Part 2|Physician Decision|0|||
162704129|NCT01734382|587628892|FG001|Part 2|Physician Decision|0|||
162611133|NCT02598960|587294890|FG002|Treatment Period|Disease Progression|4|||
162611134|NCT02598960|587294891|FG003|Treatment Period|Disease Progression|6|||
162611135|NCT02598960|587294892|FG004|Treatment Period|Disease Progression|8|||
162611136|NCT02598960|587294893|FG005|Treatment Period|Disease Progression|2|||
162611137|NCT02598960|587294894|FG006|Treatment Period|Disease Progression|2|||
162611138|NCT02598960|587294895|FG007|Treatment Period|Disease Progression|3|||
162611139|NCT02598960|587294896|FG008|Treatment Period|Disease Progression|7|||
162611140|NCT02598960|587294897|FG009|Treatment Period|Disease Progression|9|||
162704130|NCT01734382|587628893|FG002|Part 2|Physician Decision|3|||
162704131|NCT01734382|587628891|FG000|Part 2|Protocol Violation|0|||
162704132|NCT01734382|587628892|FG001|Part 2|Protocol Violation|1|||
162704133|NCT01734382|587628893|FG002|Part 2|Protocol Violation|0|||
162704134|NCT01734382|587628891|FG000|Part 2|Withdrawal by Subject|0|||
162952898|NCT04185909|588531689|FG000|Overall Study|Lost to Follow-up|1|||
162952899|NCT02193178|588531690|FG000|Overall Study|Lost to Follow-up|1|||
162952900|NCT02193178|588531690|FG000|Overall Study|Dry eyes|1|||
162952901|NCT03435081|588531691|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
162952902|NCT03435081|588531692|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
162952903|NCT03435081|588531693|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
162952904|NCT03435081|588531691|FG000|Week 0 to Week 16|Adverse Event|2|||
162952905|NCT03435081|588531692|FG001|Week 0 to Week 16|Adverse Event|2|||
162952906|NCT03435081|588531693|FG002|Week 0 to Week 16|Adverse Event|2|||
162952907|NCT03435081|588531691|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
162952908|NCT03435081|588531692|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
162952909|NCT03435081|588531693|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
162952910|NCT03435081|588531691|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
162952911|NCT03435081|588531692|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
162952912|NCT03435081|588531693|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
162952913|NCT03435081|588531691|FG000|Week 0 to Week 16|Pregnancy|1|||
162952914|NCT03435081|588531692|FG001|Week 0 to Week 16|Pregnancy|0|||
162952915|NCT03435081|588531693|FG002|Week 0 to Week 16|Pregnancy|0|||
162952916|NCT03435081|588531691|FG000|Week 0 to Week 16|Non-compliance|1|||
162952917|NCT03435081|588531692|FG001|Week 0 to Week 16|Non-compliance|0|||
162952918|NCT03435081|588531693|FG002|Week 0 to Week 16|Non-compliance|2|||
162952919|NCT03435081|588531691|FG000|Week 0 to Week 16|Inadequate Response|0|||
162952920|NCT03435081|588531692|FG001|Week 0 to Week 16|Inadequate Response|1|||
162952921|NCT03435081|588531693|FG002|Week 0 to Week 16|Inadequate Response|0|||
162952922|NCT03435081|588531691|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
162952923|NCT03435081|588531692|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
162952924|NCT03435081|588531693|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
162952925|NCT03435081|588531691|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
162952926|NCT03435081|588531692|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
162952927|NCT03435081|588531693|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
162952928|NCT03435081|588531691|FG000|Week 16 to Week 104|Adverse Event|1|||
162952929|NCT03435081|588531692|FG001|Week 16 to Week 104|Adverse Event|0|||
162952930|NCT03435081|588531693|FG002|Week 16 to Week 104|Adverse Event|2|||
162952931|NCT03435081|588531691|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
162952932|NCT03435081|588531692|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
162952933|NCT03435081|588531693|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
162952934|NCT03435081|588531691|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
162952935|NCT03435081|588531692|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
162952936|NCT03435081|588531693|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
162952937|NCT03435081|588531691|FG000|Week 16 to Week 104|Non--Compliance|0|||
162952938|NCT03435081|588531692|FG001|Week 16 to Week 104|Non--Compliance|0|||
162952939|NCT03435081|588531693|FG002|Week 16 to Week 104|Non--Compliance|1|||
162952940|NCT02601560|588531694|FG000|Overall Study|Other|0|||
162952941|NCT02601560|588531695|FG001|Overall Study|Other|0|||
162952942|NCT02601560|588531696|FG002|Overall Study|Other|0|||
162952943|NCT02601560|588531697|FG003|Overall Study|Other|0|||
162952944|NCT02601560|588531698|FG004|Overall Study|Other|0|||
162952945|NCT02601560|588531699|FG005|Overall Study|Other|0|||
162952946|NCT02601560|588531700|FG006|Overall Study|Other|1|||
162952947|NCT02601560|588531701|FG007|Overall Study|Other|0|||
162952948|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
162952949|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
162952950|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
162952951|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
162952952|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
162952953|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
162952954|NCT00420238|588531704|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
162952955|NCT00420238|588531705|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
162952956|NCT00420238|588531704|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
162952957|NCT00420238|588531705|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
162952958|NCT00420238|588531704|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
162952959|NCT00420238|588531705|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
162952960|NCT00626548|588531706|FG000|Overall Study|Adverse Event|164|||
162952961|NCT00626548|588531707|FG001|Overall Study|Adverse Event|44|||
162952962|NCT00626548|588531706|FG000|Overall Study|Withdrawal by Subject|42|||
162952963|NCT00626548|588531707|FG001|Overall Study|Withdrawal by Subject|46|||
162952964|NCT00626548|588531706|FG000|Overall Study|Protocol Violation|4|||
162952965|NCT00626548|588531707|FG001|Overall Study|Protocol Violation|11|||
162952966|NCT00626548|588531706|FG000|Overall Study|Lost to Follow-up|2|||
162849636|NCT00896532|588154798|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
162849637|NCT00896532|588154799|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
162849638|NCT00896532|588154800|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
162849639|NCT00896532|588154801|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
162849640|NCT00896532|588154802|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
162849641|NCT00896532|588154803|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
162952967|NCT00626548|588531707|FG001|Overall Study|Lost to Follow-up|2|||
162952968|NCT00626548|588531706|FG000|Overall Study|Other termination reason|493|||
162952969|NCT00626548|588531707|FG001|Overall Study|Other termination reason|613|||
162952970|NCT04384978|588531708|FG000|Overall Study|Withdrawal by Subject|4|||
162952971|NCT04384978|588531709|FG001|Overall Study|Withdrawal by Subject|0|||
162952972|NCT00385593|588531710|FG000|Overall Study|Adverse Event|3|||
162952973|NCT00385593|588531711|FG001|Overall Study|Adverse Event|2|||
162952974|NCT00385593|588531710|FG000|Overall Study|Withdrawal by Subject|17|||
162952975|NCT00385593|588531711|FG001|Overall Study|Withdrawal by Subject|7|||
162952976|NCT00385593|588531710|FG000|Overall Study|Lost to Follow-up|12|||
162952977|NCT00385593|588531711|FG001|Overall Study|Lost to Follow-up|8|||
162952978|NCT00385593|588531710|FG000|Overall Study|Protocol Violation|7|||
162952979|NCT00385593|588531711|FG001|Overall Study|Protocol Violation|4|||
162952980|NCT00385593|588531710|FG000|Overall Study|Several reasons|17|||
162952981|NCT00385593|588531711|FG001|Overall Study|Several reasons|15|||
162952982|NCT00385593|588531710|FG000|Overall Study|Incorrect inclusion|2|||
162952983|NCT00385593|588531711|FG001|Overall Study|Incorrect inclusion|0|||
162952984|NCT00385593|588531710|FG000|Overall Study|Incorrect randomization|0|||
162952985|NCT00385593|588531711|FG001|Overall Study|Incorrect randomization|1|||
162952986|NCT03125200|588531714|FG000|Overall Study|Study Termination|0|||
162952987|NCT03125200|588531715|FG001|Overall Study|Study Termination|0|||
162611141|NCT02598960|587294898|FG010|Treatment Period|Disease Progression|7|||
162952988|NCT03125200|588531716|FG002|Overall Study|Study Termination|0|||
162952989|NCT03125200|588531717|FG003|Overall Study|Study Termination|1|||
162952990|NCT03125200|588531718|FG004|Overall Study|Study Termination|1|||
162952991|NCT03125200|588531719|FG005|Overall Study|Study Termination|2|||
162952992|NCT03125200|588531720|FG006|Overall Study|Study Termination|1|||
162952993|NCT03125200|588531714|FG000|Overall Study|Clinical Progression|0|||
162952994|NCT03125200|588531715|FG001|Overall Study|Clinical Progression|0|||
162952995|NCT03125200|588531716|FG002|Overall Study|Clinical Progression|0|||
162952996|NCT03125200|588531717|FG003|Overall Study|Clinical Progression|1|||
162952997|NCT03125200|588531718|FG004|Overall Study|Clinical Progression|0|||
162952998|NCT03125200|588531719|FG005|Overall Study|Clinical Progression|1|||
162952999|NCT03125200|588531720|FG006|Overall Study|Clinical Progression|0|||
162953000|NCT03125200|588531714|FG000|Overall Study|Progressive Disease|2|||
162953001|NCT03125200|588531715|FG001|Overall Study|Progressive Disease|1|||
162611142|NCT02598960|587294899|FG011|Treatment Period|Disease Progression|143|||
162611143|NCT02598960|587294900|FG012|Treatment Period|Disease Progression|23|||
162611144|NCT02598960|587294888|FG000|Treatment Period|Study drug toxicity|0|||
162611145|NCT02598960|587294889|FG001|Treatment Period|Study drug toxicity|0|||
162611146|NCT02598960|587294890|FG002|Treatment Period|Study drug toxicity|0|||
162849642|NCT00896532|588154804|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
162849643|NCT00896532|588154805|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
162849644|NCT00896532|588154806|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
162849645|NCT00896532|588154807|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
162849646|NCT00896532|588154808|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
162849647|NCT00896532|588154809|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
162849648|NCT00896532|588154810|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
162849649|NCT00896532|588154811|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
162849650|NCT00896532|588154812|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
162849651|NCT00896532|588154813|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
162849652|NCT00896532|588154814|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
162849653|NCT00896532|588154815|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
162611147|NCT02598960|587294891|FG003|Treatment Period|Study drug toxicity|0|||
162611148|NCT02598960|587294892|FG004|Treatment Period|Study drug toxicity|0|||
162849654|NCT00896532|588154816|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
162953002|NCT03125200|588531716|FG002|Overall Study|Progressive Disease|2|||
162953003|NCT03125200|588531717|FG003|Overall Study|Progressive Disease|1|||
162953004|NCT03125200|588531718|FG004|Overall Study|Progressive Disease|2|||
162611149|NCT02598960|587294893|FG005|Treatment Period|Study drug toxicity|0|||
162953005|NCT03125200|588531719|FG005|Overall Study|Progressive Disease|0|||
162953006|NCT03125200|588531720|FG006|Overall Study|Progressive Disease|1|||
162953007|NCT03125200|588531714|FG000|Overall Study|Lack of Efficacy|0|||
162953008|NCT03125200|588531715|FG001|Overall Study|Lack of Efficacy|0|||
162953009|NCT03125200|588531716|FG002|Overall Study|Lack of Efficacy|0|||
162953010|NCT03125200|588531717|FG003|Overall Study|Lack of Efficacy|1|||
162953011|NCT03125200|588531718|FG004|Overall Study|Lack of Efficacy|0|||
162953012|NCT03125200|588531719|FG005|Overall Study|Lack of Efficacy|0|||
162953013|NCT03125200|588531720|FG006|Overall Study|Lack of Efficacy|0|||
162953014|NCT03125200|588531714|FG000|Overall Study|Toxicity|0|||
162953015|NCT03125200|588531715|FG001|Overall Study|Toxicity|0|||
162953016|NCT03125200|588531716|FG002|Overall Study|Toxicity|0|||
162953017|NCT03125200|588531717|FG003|Overall Study|Toxicity|1|||
162953018|NCT03125200|588531718|FG004|Overall Study|Toxicity|0|||
162953019|NCT03125200|588531719|FG005|Overall Study|Toxicity|0|||
162953020|NCT03125200|588531720|FG006|Overall Study|Toxicity|0|||
162953021|NCT03125200|588531714|FG000|Overall Study|Consent Withdrawn by Subject|0|||
162953022|NCT03125200|588531715|FG001|Overall Study|Consent Withdrawn by Subject|1|||
162953023|NCT03125200|588531716|FG002|Overall Study|Consent Withdrawn by Subject|0|||
162953024|NCT03125200|588531717|FG003|Overall Study|Consent Withdrawn by Subject|0|||
162953025|NCT03125200|588531718|FG004|Overall Study|Consent Withdrawn by Subject|1|||
162953026|NCT03125200|588531719|FG005|Overall Study|Consent Withdrawn by Subject|0|||
162953027|NCT03125200|588531720|FG006|Overall Study|Consent Withdrawn by Subject|1|||
162953028|NCT03041025|588531724|FG000|Overall Study|Adverse Event|0|||
162953029|NCT03041025|588531725|FG001|Overall Study|Adverse Event|0|||
162953030|NCT03041025|588531726|FG002|Overall Study|Adverse Event|1|||
162953031|NCT03041025|588531724|FG000|Overall Study|Lost to Follow-up|1|||
162953032|NCT03041025|588531725|FG001|Overall Study|Lost to Follow-up|0|||
162953033|NCT03041025|588531726|FG002|Overall Study|Lost to Follow-up|0|||
162953034|NCT03041025|588531724|FG000|Overall Study|Withdrawal by Subject|0|||
162953035|NCT03041025|588531725|FG001|Overall Study|Withdrawal by Subject|0|||
162953036|NCT03041025|588531726|FG002|Overall Study|Withdrawal by Subject|1|||
162953037|NCT02963259|588531727|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
162953038|NCT02963259|588531727|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
162953039|NCT02963259|588531727|FG000|Overall Study|Death|1|||
162953040|NCT02963259|588531727|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
162953041|NCT02131129|588531728|FG000|Overall Study|Withdrawal by Subject|1|||
162953042|NCT02131129|588531729|FG001|Overall Study|Withdrawal by Subject|0|||
162953043|NCT00396279|588533314|FG000|Overall Study|Ongoing in study|26|||
162953044|NCT00396279|588533314|FG000|Overall Study|Disease progression|2|||
162953045|NCT00396279|588533314|FG000|Overall Study|Withdrawal by Subject|1|||
162953046|NCT00396279|588533314|FG000|Overall Study|Physician Decision|1|||
162953047|NCT01882257|588533315|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
162953048|NCT01882257|588533316|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
162953049|NCT01882257|588533317|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
162953050|NCT01882257|588533315|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
162953051|NCT01882257|588533316|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
162953052|NCT01882257|588533317|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
162953053|NCT00830206|588533318|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
162953054|NCT00830206|588533319|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
162953055|NCT00905346|588533320|FG000|Period 1|Withdrawal by Subject|1|||
162953056|NCT00905346|588533321|FG001|Period 1|Withdrawal by Subject|0|||
162953057|NCT02736721|588533328|FG000|Overall Study|Adverse Event|8|||
162953058|NCT02736721|588533328|FG000|Overall Study|Lost to Follow-up|3|||
162953059|NCT02736721|588533328|FG000|Overall Study|Other|5|||
162953060|NCT02956460|588533329|FG000|Lens 1|Lost to Follow-up|1|||
162849655|NCT00896532|588154817|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
162849656|NCT00896532|588154818|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
162849657|NCT00896532|588154796|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849658|NCT00896532|588154797|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849659|NCT00896532|588154798|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849660|NCT00896532|588154799|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849661|NCT00896532|588154800|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849662|NCT00896532|588154801|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849663|NCT00896532|588154802|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849664|NCT00896532|588154803|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849665|NCT00896532|588154804|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162953061|NCT02956460|588533330|FG001|Lens 1|Lost to Follow-up|0|||
162953062|NCT00829673|588533331|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162953063|NCT00829673|588533332|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162953064|NCT00272779|588533333|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
162953065|NCT00272779|588533334|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
162953066|NCT00272779|588533333|FG000|Baseline Through Week 48|Death before Week 48|4|||
162953067|NCT00272779|588533334|FG001|Baseline Through Week 48|Death before Week 48|4|||
162953068|NCT00272779|588533333|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
162953069|NCT00272779|588533334|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
162953070|NCT00272779|588533333|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
162953071|NCT00272779|588533334|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
162953072|NCT00272779|588533333|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
162953073|NCT00272779|588533334|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
162953074|NCT00272779|588533333|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
162953075|NCT00272779|588533334|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
162953076|NCT00272779|588533333|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
162953077|NCT00272779|588533334|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
162953078|NCT00272779|588533333|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
162953079|NCT00272779|588533334|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
162953080|NCT00272779|588533333|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
162953081|NCT00272779|588533334|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
162953082|NCT00272779|588533333|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
162953083|NCT00272779|588533334|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
162953084|NCT00272779|588533333|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
162953085|NCT00272779|588533334|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
162953086|NCT00272779|588533333|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
162953087|NCT00272779|588533334|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
162953088|NCT00272779|588533333|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
162953089|NCT00272779|588533334|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
162953090|NCT00272779|588533333|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
162953091|NCT00272779|588533334|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
162953092|NCT00272779|588533333|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
162953093|NCT00272779|588533334|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
162953094|NCT00272779|588533333|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
162953095|NCT00272779|588533334|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
162953096|NCT00272779|588533333|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
162953097|NCT00272779|588533334|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
162953098|NCT00272779|588533333|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
162953099|NCT00272779|588533334|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
162953100|NCT00272779|588533333|FG000|Baseline Through Week 48|Continuing treatment|385|||
162953101|NCT00272779|588533334|FG001|Baseline Through Week 48|Continuing treatment|368|||
162953102|NCT00272779|588533333|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
162953103|NCT00272779|588533334|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
162953104|NCT00272779|588533333|FG000|Baseline Through Week 48|Never treated|2|||
162953105|NCT00272779|588533334|FG001|Baseline Through Week 48|Never treated|3|||
162953106|NCT00272779|588533333|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
162953107|NCT00272779|588533334|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
162953108|NCT00272779|588533333|FG000|Baseline Through Week 96|Death before Week 96|6|||
162953109|NCT00272779|588533334|FG001|Baseline Through Week 96|Death before Week 96|5|||
162953110|NCT00272779|588533333|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
162953111|NCT00272779|588533334|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
162953112|NCT00272779|588533333|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
162953113|NCT00272779|588533334|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
162953114|NCT00272779|588533333|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
162953115|NCT00272779|588533334|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
162953116|NCT00272779|588533333|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
162953117|NCT00272779|588533334|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
162953118|NCT00272779|588533333|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
162953119|NCT00272779|588533334|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
162953120|NCT00272779|588533333|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
162953121|NCT00272779|588533334|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
162953122|NCT00272779|588533333|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
162953123|NCT00272779|588533334|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
162953124|NCT00272779|588533333|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
162953125|NCT00272779|588533334|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
162953126|NCT00272779|588533333|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
162953127|NCT00272779|588533334|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
162953128|NCT00272779|588533333|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
162953129|NCT00272779|588533334|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
162704135|NCT01734382|587628892|FG001|Part 2|Withdrawal by Subject|0|||
162704136|NCT01734382|587628893|FG002|Part 2|Withdrawal by Subject|1|||
162704137|NCT04537949|587628894|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
162704138|NCT04537949|587628895|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
162704139|NCT04537949|587628896|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
162704140|NCT04537949|587628897|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
162704141|NCT04537949|587628898|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
162704142|NCT04537949|587628899|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
162704143|NCT04537949|587628900|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
162704144|NCT04537949|587628901|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
162704145|NCT04537949|587628894|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
162704146|NCT04537949|587628895|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162704147|NCT04537949|587628896|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
162704148|NCT04537949|587628897|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
162704149|NCT04537949|587628898|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162704150|NCT04537949|587628899|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162704151|NCT04537949|587628900|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
162704152|NCT04537949|587628901|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
162704153|NCT04537949|587628894|FG000|Follow-up Phase|Lost to Follow-up|0|||
162704154|NCT04537949|587628895|FG001|Follow-up Phase|Lost to Follow-up|3|||
162704155|NCT04537949|587628896|FG002|Follow-up Phase|Lost to Follow-up|0|||
162704156|NCT04537949|587628897|FG003|Follow-up Phase|Lost to Follow-up|0|||
162849666|NCT00896532|588154805|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849667|NCT00896532|588154806|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849668|NCT00896532|588154807|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849669|NCT00896532|588154808|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849670|NCT00896532|588154809|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849671|NCT00896532|588154810|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849672|NCT00896532|588154811|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
162849673|NCT00896532|588154812|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
162849674|NCT00896532|588154813|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849675|NCT00896532|588154814|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849676|NCT00896532|588154815|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849677|NCT00896532|588154816|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849678|NCT00896532|588154817|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849679|NCT00896532|588154818|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
162849680|NCT00896532|588154796|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849681|NCT00896532|588154797|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849682|NCT00896532|588154798|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849683|NCT00896532|588154799|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849684|NCT00896532|588154800|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849685|NCT00896532|588154801|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849686|NCT00896532|588154802|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849687|NCT00896532|588154803|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162953130|NCT00272779|588533333|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
162953131|NCT00272779|588533334|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
162953132|NCT00272779|588533333|FG000|Baseline Through Week 96|Never treated|2|||
162953133|NCT00272779|588533334|FG001|Baseline Through Week 96|Never treated|3|||
162953134|NCT00272779|588533333|FG000|Baseline Through Week 96|Continuing on treatment|61|||
162953135|NCT00272779|588533334|FG001|Baseline Through Week 96|Continuing on treatment|38|||
162953136|NCT04088760|588533338|FG000|Overall Study|Physician Decision|1|||
162953137|NCT00376623|588533340|FG000|Overall Study|Progressive disease|35|||
162953138|NCT00376623|588533341|FG001|Overall Study|Progressive disease|22|||
162953139|NCT00376623|588533342|FG002|Overall Study|Progressive disease|17|||
162953140|NCT00376623|588533340|FG000|Overall Study|Lost to Follow-up|0|||
162953141|NCT00376623|588533341|FG001|Overall Study|Lost to Follow-up|1|||
162953142|NCT00376623|588533342|FG002|Overall Study|Lost to Follow-up|0|||
162953143|NCT00376623|588533340|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
162953144|NCT00376623|588533341|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
162953145|NCT00376623|588533342|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
162953146|NCT00376623|588533340|FG000|Overall Study|Not treated with BI 2536|1|||
162953147|NCT00376623|588533341|FG001|Overall Study|Not treated with BI 2536|0|||
162953148|NCT00376623|588533342|FG002|Overall Study|Not treated with BI 2536|0|||
162953149|NCT00376623|588533340|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
162953150|NCT00376623|588533341|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953151|NCT00376623|588533342|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953152|NCT00376623|588533340|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
162953153|NCT00376623|588533341|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
162953154|NCT00376623|588533342|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
162953155|NCT00376623|588533340|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
162611150|NCT02598960|587294894|FG006|Treatment Period|Study drug toxicity|0|||
162611151|NCT02598960|587294895|FG007|Treatment Period|Study drug toxicity|0|||
162611152|NCT02598960|587294896|FG008|Treatment Period|Study drug toxicity|0|||
162611153|NCT02598960|587294897|FG009|Treatment Period|Study drug toxicity|1|||
162953156|NCT00376623|588533341|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953157|NCT00376623|588533342|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953158|NCT00376623|588533340|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
162953159|NCT00376623|588533341|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
162953160|NCT00376623|588533342|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
162953161|NCT00376623|588533340|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953162|NCT00376623|588533341|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
162953163|NCT00376623|588533342|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
162953164|NCT00376623|588533340|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
162953165|NCT00376623|588533341|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
162953166|NCT00376623|588533342|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
162953167|NCT00376623|588533340|FG000|Overall Study|Increase of tumour markers|0|||
162953168|NCT00376623|588533341|FG001|Overall Study|Increase of tumour markers|1|||
162953169|NCT00376623|588533342|FG002|Overall Study|Increase of tumour markers|0|||
162953170|NCT00376623|588533340|FG000|Overall Study|Bone metastasis|1|||
162953171|NCT00376623|588533341|FG001|Overall Study|Bone metastasis|0|||
162611154|NCT02598960|587294898|FG010|Treatment Period|Study drug toxicity|0|||
162611155|NCT02598960|587294899|FG011|Treatment Period|Study drug toxicity|3|||
162611156|NCT02598960|587294900|FG012|Treatment Period|Study drug toxicity|0|||
162611157|NCT02598960|587294888|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
162953172|NCT00376623|588533342|FG002|Overall Study|Bone metastasis|0|||
162953173|NCT02331394|588533343|FG000|Overall Study|Disease progression|1|||
162953174|NCT02098876|588533347|FG000|Overall Study|Withdrawal by Subject|5|||
162953175|NCT02098876|588533348|FG001|Overall Study|Withdrawal by Subject|5|||
162953176|NCT01061866|588533351|FG000|Overall Study|Adverse Event|2|||
162953177|NCT01270503|588533352|FG000|Overall Study|Lost to Follow-up|1|||
162953178|NCT02459951|588533353|FG000|Overall Study|Unable to meet holding requirement|1|||
162953179|NCT04239872|588533355|FG000|Overall Study|Lost to Follow-up|0|||
162953180|NCT04239872|588533356|FG001|Overall Study|Lost to Follow-up|1|||
162953181|NCT01010542|588533359|FG000|Overall Study|Adverse Event|0|||
162953182|NCT01010542|588533360|FG001|Overall Study|Adverse Event|1|||
162953183|NCT01010542|588533361|FG002|Overall Study|Adverse Event|0|||
162953184|NCT01010542|588533359|FG000|Overall Study|Lost to Follow-up|0|||
162953185|NCT01010542|588533360|FG001|Overall Study|Lost to Follow-up|1|||
162953186|NCT01010542|588533361|FG002|Overall Study|Lost to Follow-up|0|||
162953187|NCT01010542|588533359|FG000|Overall Study|Withdrawal by Subject|0|||
162953188|NCT01010542|588533360|FG001|Overall Study|Withdrawal by Subject|3|||
162953189|NCT01010542|588533361|FG002|Overall Study|Withdrawal by Subject|2|||
162953190|NCT01975948|588533371|FG000|Overall Study|Withdrawal by Subject|17|||
162953191|NCT01975948|588533372|FG001|Overall Study|Withdrawal by Subject|21|||
162953192|NCT01975948|588533373|FG002|Overall Study|Withdrawal by Subject|7|||
162953193|NCT01975948|588533374|FG003|Overall Study|Withdrawal by Subject|6|||
162953194|NCT01675765|588533375|FG000|Overall Study|Progressive disease|4|||
162953195|NCT01675765|588533376|FG001|Overall Study|Progressive disease|4|||
162953196|NCT01675765|588533375|FG000|Overall Study|Adverse Event|1|||
162953197|NCT01675765|588533376|FG001|Overall Study|Adverse Event|2|||
162953198|NCT01675765|588533375|FG000|Overall Study|Withdrawal by Subject|2|||
162953199|NCT01675765|588533376|FG001|Overall Study|Withdrawal by Subject|0|||
162953200|NCT01675765|588533375|FG000|Overall Study|Death|1|||
162953201|NCT01675765|588533376|FG001|Overall Study|Death|0|||
162953202|NCT01675765|588533375|FG000|Overall Study|Clinical progression|3|||
162953203|NCT01675765|588533376|FG001|Overall Study|Clinical progression|2|||
162953204|NCT04060147|588533378|FG000|Overall Study|Withdrew consent|1|||
162953205|NCT01534520|588533379|FG000|Overall Study|Adverse Event|0|||
162953206|NCT01534520|588533380|FG001|Overall Study|Adverse Event|1|||
162953207|NCT03204539|588533383|FG000|Overall Study|Loss of funding|0|||
162953208|NCT03204539|588533384|FG001|Overall Study|Loss of funding|1|||
162953209|NCT00550537|588533387|FG000|Overall Study|Death|18|||
162953210|NCT00550537|588533387|FG000|Overall Study|Adverse Event|20|||
162953211|NCT00550537|588533387|FG000|Overall Study|Disease progression before|46|||
162953212|NCT00550537|588533387|FG000|Overall Study|Withdrawal by Subject|7|||
162953213|NCT00550537|588533387|FG000|Overall Study|Change in treatment plan|4|||
162953214|NCT00550537|588533387|FG000|Overall Study|Other complicating ilness|3|||
162953215|NCT00550537|588533387|FG000|Overall Study|Declining performance status|2|||
162953216|NCT00550537|588533387|FG000|Overall Study|Treated closer to home|4|||
162953217|NCT02008565|588533388|FG000|Overall Study|Protocol Violation|1|||
162953218|NCT02008565|588533389|FG001|Overall Study|Protocol Violation|1|||
162953219|NCT02008565|588533390|FG002|Overall Study|Protocol Violation|2|||
162953220|NCT02008565|588533391|FG003|Overall Study|Protocol Violation|0|||
162953221|NCT00617305|588533392|FG000|Overall Study|Adverse Event|4|||
162953222|NCT00617305|588533393|FG001|Overall Study|Adverse Event|0|||
162953223|NCT00617305|588533394|FG002|Overall Study|Adverse Event|0|||
162953224|NCT00617305|588533392|FG000|Overall Study|Death|1|||
162953225|NCT00617305|588533393|FG001|Overall Study|Death|0|||
162953226|NCT00617305|588533394|FG002|Overall Study|Death|0|||
162953227|NCT00617305|588533392|FG000|Overall Study|Physician Decision|1|||
162953228|NCT00617305|588533393|FG001|Overall Study|Physician Decision|0|||
162953229|NCT00617305|588533394|FG002|Overall Study|Physician Decision|0|||
162953230|NCT00617305|588533392|FG000|Overall Study|Protocol Violation|1|||
162953231|NCT00617305|588533393|FG001|Overall Study|Protocol Violation|0|||
162953232|NCT00617305|588533394|FG002|Overall Study|Protocol Violation|1|||
162953233|NCT00617305|588533392|FG000|Overall Study|Withdrawal by Subject|1|||
162953234|NCT00617305|588533393|FG001|Overall Study|Withdrawal by Subject|0|||
162953235|NCT00617305|588533394|FG002|Overall Study|Withdrawal by Subject|0|||
162953236|NCT00537979|588533396|FG000|Overall Study|Adverse Event|2|||
162953237|NCT00537979|588533397|FG001|Overall Study|Adverse Event|2|||
162953238|NCT00537979|588533396|FG000|Overall Study|Withdrawal by Subject|1|||
162953239|NCT00537979|588533397|FG001|Overall Study|Withdrawal by Subject|4|||
162953240|NCT00537979|588533396|FG000|Overall Study|Lost to Follow-up|1|||
162953241|NCT00537979|588533397|FG001|Overall Study|Lost to Follow-up|4|||
162953242|NCT00537979|588533396|FG000|Overall Study|Lack of Efficacy|0|||
162953243|NCT00537979|588533397|FG001|Overall Study|Lack of Efficacy|1|||
162953244|NCT00537979|588533396|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
162953245|NCT00537979|588533397|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
162704157|NCT04537949|587628898|FG004|Follow-up Phase|Lost to Follow-up|0|||
162953246|NCT00537979|588533396|FG000|Overall Study|Death|0|||
162953247|NCT00537979|588533397|FG001|Overall Study|Death|3|||
162953248|NCT00537979|588533396|FG000|Overall Study|Kidney transplant|0|||
162953249|NCT00537979|588533397|FG001|Overall Study|Kidney transplant|3|||
162953250|NCT00537979|588533396|FG000|Overall Study|Heart failure|0|||
162953251|NCT00537979|588533397|FG001|Overall Study|Heart failure|1|||
162953252|NCT01059903|588533399|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
162953253|NCT01059903|588533400|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
162611158|NCT02598960|587294889|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
162611159|NCT02598960|587294890|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
162611160|NCT02598960|587294891|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
162611161|NCT02598960|587294892|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
162611162|NCT02598960|587294893|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
162611163|NCT02598960|587294894|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
162611164|NCT02598960|587294895|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
162611165|NCT02598960|587294896|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
162611166|NCT02598960|587294897|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
162611167|NCT02598960|587294898|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
162611168|NCT02598960|587294899|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
162611169|NCT02598960|587294900|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
162611170|NCT02598960|587294888|FG000|Treatment Period|participant request to discontinue|0|||
162611171|NCT02598960|587294889|FG001|Treatment Period|participant request to discontinue|1|||
162611172|NCT02598960|587294890|FG002|Treatment Period|participant request to discontinue|0|||
162849688|NCT00896532|588154804|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849689|NCT00896532|588154805|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849690|NCT00896532|588154806|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849691|NCT00896532|588154807|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849692|NCT00896532|588154808|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849693|NCT00896532|588154809|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849694|NCT00896532|588154810|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849695|NCT00896532|588154811|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
162849696|NCT00896532|588154812|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
162849697|NCT00896532|588154813|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
162849698|NCT00896532|588154814|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849699|NCT00896532|588154815|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849700|NCT00896532|588154816|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849701|NCT00896532|588154817|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849702|NCT00896532|588154818|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
162849703|NCT00896532|588154796|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849704|NCT00896532|588154797|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849705|NCT00896532|588154798|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849706|NCT00896532|588154799|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849707|NCT00896532|588154800|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849708|NCT00896532|588154801|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849709|NCT00896532|588154802|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849710|NCT00896532|588154803|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849711|NCT00896532|588154804|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849712|NCT00896532|588154805|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849713|NCT00896532|588154806|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849714|NCT00896532|588154807|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849715|NCT00896532|588154808|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849716|NCT00896532|588154809|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849717|NCT00896532|588154810|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849718|NCT00896532|588154811|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849719|NCT00896532|588154812|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
162849720|NCT00896532|588154813|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849721|NCT00896532|588154814|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849722|NCT00896532|588154815|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849723|NCT00896532|588154816|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849724|NCT00896532|588154817|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849725|NCT00896532|588154818|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
162849726|NCT00896532|588154796|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
162849727|NCT00896532|588154797|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
162849728|NCT00896532|588154798|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
162849729|NCT00896532|588154799|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
162849730|NCT00896532|588154800|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
162849731|NCT00896532|588154801|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
162849732|NCT00896532|588154802|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
162849733|NCT00896532|588154803|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
162849734|NCT00896532|588154804|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
162849735|NCT00896532|588154805|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
162849736|NCT00896532|588154806|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
162953254|NCT03555305|588533401|FG000|Period 1|Physician Decision|0|||
162953255|NCT03555305|588533402|FG001|Period 1|Physician Decision|1|||
162849737|NCT00896532|588154807|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
162849738|NCT00896532|588154808|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
162849739|NCT00896532|588154809|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
162849740|NCT00896532|588154810|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
162849741|NCT00896532|588154811|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
162849742|NCT00896532|588154812|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
162849743|NCT00896532|588154813|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
162849744|NCT00896532|588154814|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
162849745|NCT00896532|588154815|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
162849746|NCT00896532|588154816|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
162953256|NCT03555305|588533401|FG000|Period 1|Adverse Event|0|||
162611173|NCT02598960|587294891|FG003|Treatment Period|participant request to discontinue|0|||
162611174|NCT02598960|587294892|FG004|Treatment Period|participant request to discontinue|1|||
162611175|NCT02598960|587294893|FG005|Treatment Period|participant request to discontinue|0|||
162611176|NCT02598960|587294894|FG006|Treatment Period|participant request to discontinue|0|||
162611177|NCT02598960|587294895|FG007|Treatment Period|participant request to discontinue|0|||
162953257|NCT03555305|588533402|FG001|Period 1|Adverse Event|1|||
162953258|NCT00858845|588533415|FG000|Overall Study|Patient underwent heart transplant.|0|||
162953259|NCT00858845|588533416|FG001|Overall Study|Patient underwent heart transplant.|1|||
162953260|NCT03031847|588533417|FG000|Overall Study|Death|1|||
162953261|NCT03031847|588533418|FG001|Overall Study|Death|1|||
162953262|NCT03031847|588533419|FG002|Overall Study|Death|2|||
162953263|NCT03031847|588533420|FG003|Overall Study|Death|3|||
162953264|NCT03031847|588533417|FG000|Overall Study|Lost to Follow-up|1|||
162953265|NCT03031847|588533418|FG001|Overall Study|Lost to Follow-up|1|||
162953266|NCT03031847|588533419|FG002|Overall Study|Lost to Follow-up|2|||
162953267|NCT03031847|588533420|FG003|Overall Study|Lost to Follow-up|3|||
162953268|NCT02100228|588533423|FG000|Overall Study|Other|19|||
162953269|NCT02100228|588533424|FG001|Overall Study|Other|19|||
162953270|NCT02100228|588533423|FG000|Overall Study|Administrative reason|0|||
162953271|NCT02100228|588533424|FG001|Overall Study|Administrative reason|1|||
162953272|NCT02100228|588533423|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
162953273|NCT02100228|588533424|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
162953274|NCT02100228|588533423|FG000|Overall Study|Non-compliance|0|||
162953275|NCT02100228|588533424|FG001|Overall Study|Non-compliance|3|||
162953276|NCT02100228|588533423|FG000|Overall Study|Lost to Follow-up|0|||
162953277|NCT02100228|588533424|FG001|Overall Study|Lost to Follow-up|1|||
162953278|NCT02100228|588533423|FG000|Overall Study|Withdrawal by Subject|27|||
162953279|NCT02100228|588533424|FG001|Overall Study|Withdrawal by Subject|37|||
162953280|NCT02100228|588533423|FG000|Overall Study|Adverse Event|16|||
162953281|NCT02100228|588533424|FG001|Overall Study|Adverse Event|12|||
162953282|NCT02100228|588533423|FG000|Overall Study|Death|1|||
162953283|NCT02100228|588533424|FG001|Overall Study|Death|1|||
162953284|NCT00214422|588533425|FG000|Overall Study|Physician Decision|2|||
162953285|NCT00214422|588533426|FG001|Overall Study|Physician Decision|0|||
162953286|NCT00214422|588533427|FG002|Overall Study|Physician Decision|0|||
162953287|NCT00214422|588533425|FG000|Overall Study|Developed esophageal ca|1|||
162953288|NCT00214422|588533426|FG001|Overall Study|Developed esophageal ca|0|||
162953289|NCT00214422|588533427|FG002|Overall Study|Developed esophageal ca|0|||
162953290|NCT00214422|588533425|FG000|Overall Study|Pt taken off study|1|||
162953291|NCT00214422|588533426|FG001|Overall Study|Pt taken off study|1|||
162953292|NCT00214422|588533427|FG002|Overall Study|Pt taken off study|0|||
162953293|NCT00214422|588533425|FG000|Overall Study|Disease progression on study|1|||
162953294|NCT00214422|588533426|FG001|Overall Study|Disease progression on study|0|||
162953295|NCT00214422|588533427|FG002|Overall Study|Disease progression on study|0|||
162953296|NCT00214422|588533425|FG000|Overall Study|Unable to make a radiation treatment|0|||
162953297|NCT00214422|588533426|FG001|Overall Study|Unable to make a radiation treatment|0|||
162953298|NCT00214422|588533427|FG002|Overall Study|Unable to make a radiation treatment|1|||
162953299|NCT00854100|588533436|FG000|Overall Study|Inability to complete the study visits|0|||
162953300|NCT00854100|588533437|FG001|Overall Study|Inability to complete the study visits|0|||
162611178|NCT02598960|587294896|FG008|Treatment Period|participant request to discontinue|0|||
162611179|NCT02598960|587294897|FG009|Treatment Period|participant request to discontinue|0|||
162611180|NCT02598960|587294898|FG010|Treatment Period|participant request to discontinue|1|||
162953301|NCT00854100|588533438|FG002|Overall Study|Inability to complete the study visits|1|||
162953302|NCT00854100|588533436|FG000|Overall Study|Lost to Follow-up|2|||
162953303|NCT00854100|588533437|FG001|Overall Study|Lost to Follow-up|0|||
162953304|NCT00854100|588533438|FG002|Overall Study|Lost to Follow-up|3|||
162953305|NCT00854100|588533436|FG000|Overall Study|Withdrawal by Subject|3|||
162611181|NCT02598960|587294899|FG011|Treatment Period|participant request to discontinue|4|||
162611182|NCT02598960|587294900|FG012|Treatment Period|participant request to discontinue|0|||
162611183|NCT02598960|587294888|FG000|Treatment Period|participant withdrew consent|0|||
162611184|NCT02598960|587294889|FG001|Treatment Period|participant withdrew consent|0|||
162611185|NCT02598960|587294890|FG002|Treatment Period|participant withdrew consent|0|||
162611186|NCT02598960|587294891|FG003|Treatment Period|participant withdrew consent|0|||
162611187|NCT02598960|587294892|FG004|Treatment Period|participant withdrew consent|0|||
162611188|NCT02598960|587294893|FG005|Treatment Period|participant withdrew consent|0|||
162611189|NCT02598960|587294894|FG006|Treatment Period|participant withdrew consent|0|||
162611190|NCT02598960|587294895|FG007|Treatment Period|participant withdrew consent|0|||
162611191|NCT02598960|587294896|FG008|Treatment Period|participant withdrew consent|0|||
162611192|NCT02598960|587294897|FG009|Treatment Period|participant withdrew consent|0|||
162953306|NCT00854100|588533437|FG001|Overall Study|Withdrawal by Subject|1|||
162953307|NCT00854100|588533438|FG002|Overall Study|Withdrawal by Subject|2|||
162953308|NCT00854100|588533436|FG000|Overall Study|Protocol Violation|2|||
162953309|NCT00854100|588533437|FG001|Overall Study|Protocol Violation|4|||
162953310|NCT00854100|588533438|FG002|Overall Study|Protocol Violation|3|||
162953311|NCT00854100|588533436|FG000|Overall Study|Adverse Event|2|||
162953312|NCT00854100|588533437|FG001|Overall Study|Adverse Event|1|||
162953313|NCT00854100|588533438|FG002|Overall Study|Adverse Event|2|||
162953314|NCT02242201|588533442|FG000|Overall Study|preoperative identified neuropathy|2|||
162953315|NCT02242201|588533443|FG001|Overall Study|preoperative identified neuropathy|0|||
162953316|NCT02242201|588533444|FG002|Overall Study|preoperative identified neuropathy|0|||
162953317|NCT02242201|588533442|FG000|Overall Study|planned post-op anticoagulation|1|||
162953318|NCT02242201|588533443|FG001|Overall Study|planned post-op anticoagulation|0|||
162953319|NCT02242201|588533444|FG002|Overall Study|planned post-op anticoagulation|0|||
162953320|NCT02242201|588533442|FG000|Overall Study|changed surgical procedure|1|||
162953321|NCT02242201|588533443|FG001|Overall Study|changed surgical procedure|0|||
162953322|NCT02242201|588533444|FG002|Overall Study|changed surgical procedure|0|||
162953323|NCT02242201|588533442|FG000|Overall Study|postponed surgery|0|||
162953324|NCT02242201|588533443|FG001|Overall Study|postponed surgery|0|||
162953325|NCT02242201|588533444|FG002|Overall Study|postponed surgery|1|||
162953326|NCT02242201|588533442|FG000|Overall Study|preoperative opioid consumption|0|||
162953327|NCT02242201|588533443|FG001|Overall Study|preoperative opioid consumption|1|||
162953328|NCT02242201|588533444|FG002|Overall Study|preoperative opioid consumption|0|||
162953329|NCT00389064|588533445|FG000|Overall Study|Adverse Event|11|||
162953330|NCT00389064|588533446|FG001|Overall Study|Adverse Event|3|||
162953331|NCT00389064|588533445|FG000|Overall Study|Lack of Efficacy|3|||
162953332|NCT00389064|588533446|FG001|Overall Study|Lack of Efficacy|14|||
162953333|NCT00389064|588533445|FG000|Overall Study|Withdrawal by Subject|17|||
162953334|NCT00389064|588533446|FG001|Overall Study|Withdrawal by Subject|27|||
162953335|NCT00389064|588533445|FG000|Overall Study|Physician Decision|2|||
162953336|NCT00389064|588533446|FG001|Overall Study|Physician Decision|2|||
162953337|NCT00389064|588533445|FG000|Overall Study|Lost to Follow-up|1|||
162953338|NCT00389064|588533446|FG001|Overall Study|Lost to Follow-up|2|||
162953339|NCT00389064|588533445|FG000|Overall Study|Protocol Violation|2|||
162953340|NCT00389064|588533446|FG001|Overall Study|Protocol Violation|0|||
162953341|NCT00389064|588533445|FG000|Overall Study|Multiple Reasons|9|||
162953342|NCT00389064|588533446|FG001|Overall Study|Multiple Reasons|11|||
162953343|NCT01223365|588533450|FG000|Open-label Titration Period|Enrolled but not treated|1|||
162953344|NCT01223365|588533450|FG000|Open-label Titration Period|Adverse Event|23|||
162953345|NCT01223365|588533450|FG000|Open-label Titration Period|Lack of Efficacy|3|||
162953346|NCT01223365|588533450|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
162953347|NCT01223365|588533450|FG000|Open-label Titration Period|Protocol Violation|1|||
162953348|NCT01223365|588533450|FG000|Open-label Titration Period|Lost to Follow-up|2|||
162953349|NCT01223365|588533450|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
162953350|NCT01223365|588533450|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
162953351|NCT01223365|588533450|FG000|Open-label Titration Period|Starting physical therapy|1|||
162953352|NCT01223365|588533450|FG000|Open-label Treatment Period|Adverse Event|39|||
162953353|NCT01223365|588533450|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
162953354|NCT01223365|588533450|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
162953355|NCT01223365|588533450|FG000|Open-label Treatment Period|Protocol Violation|15|||
162953356|NCT01223365|588533450|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
162953357|NCT01223365|588533450|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
162953358|NCT01223365|588533450|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
162953359|NCT01223365|588533450|FG000|Open-label Treatment Period|Moved out of area|2|||
162953360|NCT01223365|588533450|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
162953361|NCT01223365|588533450|FG000|Open-label Treatment Period|"Out of window"|1|||
162953362|NCT01223365|588533450|FG000|Open-label Treatment Period|Starting physical therapy|1|||
162953363|NCT01223365|588533450|FG000|Open-label Treatment Period|Physician Decision|2|||
162953364|NCT03880266|588533451|FG000|Overall Study|Withdrawal by Subject|0|||
163043234|NCT04004260|588865765|FG001|Overall Study|Withdrawal by Subject|3|||
163043235|NCT04004260|588865764|FG000|Overall Study|Lost to Follow-up|22|||
162611193|NCT02598960|587294898|FG010|Treatment Period|participant withdrew consent|0|||
162611194|NCT02598960|587294899|FG011|Treatment Period|participant withdrew consent|3|||
162611195|NCT02598960|587294900|FG012|Treatment Period|participant withdrew consent|0|||
162611196|NCT02598960|587294888|FG000|Treatment Period|No longer meets study criteria|0|||
162953365|NCT03880266|588533452|FG001|Overall Study|Withdrawal by Subject|1|||
162953366|NCT03880266|588533453|FG002|Overall Study|Withdrawal by Subject|1|||
162953367|NCT03880266|588533454|FG003|Overall Study|Withdrawal by Subject|0|||
162953368|NCT03880266|588533455|FG004|Overall Study|Withdrawal by Subject|0|||
162704158|NCT04537949|587628899|FG005|Follow-up Phase|Lost to Follow-up|0|||
162953369|NCT03880266|588533456|FG005|Overall Study|Withdrawal by Subject|0|||
162953370|NCT03880266|588533457|FG006|Overall Study|Withdrawal by Subject|0|||
162953371|NCT03880266|588533458|FG007|Overall Study|Withdrawal by Subject|0|||
162953372|NCT02186821|588533459|FG000|Overall Study|Adverse Event|9|||
162953373|NCT02186821|588533459|FG000|Overall Study|Death|2|||
162953374|NCT02186821|588533459|FG000|Overall Study|Disease progression|32|||
162953375|NCT02186821|588533459|FG000|Overall Study|Protocol Violation|1|||
162953376|NCT02186821|588533459|FG000|Overall Study|Physician Decision|1|||
162953377|NCT02186821|588533459|FG000|Overall Study|Study terminated by sponsor|2|||
162953378|NCT05472038|588534835|FG000|Overall Study|Adverse Event|0|||
162953379|NCT05472038|588534836|FG001|Overall Study|Adverse Event|0|||
162953380|NCT05472038|588534837|FG002|Overall Study|Adverse Event|1|||
162953381|NCT05472038|588534838|FG003|Overall Study|Adverse Event|0|||
162953382|NCT05472038|588534839|FG004|Overall Study|Adverse Event|0|||
162953383|NCT05472038|588534840|FG005|Overall Study|Adverse Event|0|||
162953384|NCT05472038|588534841|FG006|Overall Study|Adverse Event|0|||
162953385|NCT05472038|588534842|FG007|Overall Study|Adverse Event|0|||
162953386|NCT05472038|588534843|FG008|Overall Study|Adverse Event|0|||
162953387|NCT05472038|588534844|FG009|Overall Study|Adverse Event|0|||
162704159|NCT04537949|587628900|FG006|Follow-up Phase|Lost to Follow-up|0|||
162704160|NCT04537949|587628901|FG007|Follow-up Phase|Lost to Follow-up|0|||
162704161|NCT04537949|587628894|FG000|Follow-up Phase|personal reasons|0|||
162704162|NCT04537949|587628895|FG001|Follow-up Phase|personal reasons|0|||
162704163|NCT04537949|587628896|FG002|Follow-up Phase|personal reasons|0|||
162704164|NCT04537949|587628897|FG003|Follow-up Phase|personal reasons|1|||
162704165|NCT04537949|587628898|FG004|Follow-up Phase|personal reasons|1|||
162704166|NCT04537949|587628899|FG005|Follow-up Phase|personal reasons|0|||
162704167|NCT04537949|587628900|FG006|Follow-up Phase|personal reasons|0|||
162704168|NCT04537949|587628901|FG007|Follow-up Phase|personal reasons|0|||
162704169|NCT04537949|587628894|FG000|Follow-up Phase|Withdrawal by Subject|0|||
162704170|NCT04537949|587628895|FG001|Follow-up Phase|Withdrawal by Subject|0|||
162704171|NCT04537949|587628896|FG002|Follow-up Phase|Withdrawal by Subject|0|||
162704172|NCT04537949|587628897|FG003|Follow-up Phase|Withdrawal by Subject|0|||
162704173|NCT04537949|587628898|FG004|Follow-up Phase|Withdrawal by Subject|1|||
162704174|NCT04537949|587628899|FG005|Follow-up Phase|Withdrawal by Subject|0|||
162704175|NCT04537949|587628900|FG006|Follow-up Phase|Withdrawal by Subject|0|||
162704176|NCT04537949|587628901|FG007|Follow-up Phase|Withdrawal by Subject|0|||
162704177|NCT01347645|587628915|FG000|Overall Study|Death|1|||
162704178|NCT01347645|587628916|FG001|Overall Study|Death|5|||
162704179|NCT01347645|587628917|FG002|Overall Study|Death|2|||
162704180|NCT01347645|587628918|FG003|Overall Study|Death|7|||
162704181|NCT01347645|587628919|FG004|Overall Study|Death|7|||
162704182|NCT01347645|587628915|FG000|Overall Study|Lost to Follow-up|1|||
162704183|NCT01347645|587628916|FG001|Overall Study|Lost to Follow-up|1|||
162704184|NCT01347645|587628917|FG002|Overall Study|Lost to Follow-up|0|||
162704185|NCT01347645|587628918|FG003|Overall Study|Lost to Follow-up|1|||
162704186|NCT01347645|587628919|FG004|Overall Study|Lost to Follow-up|1|||
162704187|NCT01347645|587628915|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
162704188|NCT01347645|587628916|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
162704189|NCT01347645|587628917|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
162704190|NCT01347645|587628918|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
162704191|NCT01347645|587628919|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
162704192|NCT01347645|587628915|FG000|Overall Study|Other|1|||
162953388|NCT05472038|588534845|FG010|Overall Study|Adverse Event|0|||
162953389|NCT05472038|588534846|FG011|Overall Study|Adverse Event|0|||
162953390|NCT05472038|588534835|FG000|Overall Study|Death|0|||
162953391|NCT05472038|588534836|FG001|Overall Study|Death|0|||
162953392|NCT05472038|588534837|FG002|Overall Study|Death|0|||
162953393|NCT05472038|588534838|FG003|Overall Study|Death|0|||
162953394|NCT05472038|588534839|FG004|Overall Study|Death|0|||
162953395|NCT05472038|588534840|FG005|Overall Study|Death|1|||
162704193|NCT01347645|587628916|FG001|Overall Study|Other|0|||
162704194|NCT01347645|587628917|FG002|Overall Study|Other|0|||
162704195|NCT01347645|587628918|FG003|Overall Study|Other|0|||
162953396|NCT05472038|588534841|FG006|Overall Study|Death|0|||
162953397|NCT05472038|588534842|FG007|Overall Study|Death|0|||
162953398|NCT05472038|588534843|FG008|Overall Study|Death|0|||
162953399|NCT05472038|588534844|FG009|Overall Study|Death|0|||
162953400|NCT05472038|588534845|FG010|Overall Study|Death|0|||
162611197|NCT02598960|587294889|FG001|Treatment Period|No longer meets study criteria|0|||
162611198|NCT02598960|587294890|FG002|Treatment Period|No longer meets study criteria|0|||
162611199|NCT02598960|587294891|FG003|Treatment Period|No longer meets study criteria|0|||
162611200|NCT02598960|587294892|FG004|Treatment Period|No longer meets study criteria|0|||
162953401|NCT05472038|588534846|FG011|Overall Study|Death|0|||
162953402|NCT05472038|588534835|FG000|Overall Study|Lost to Follow-up|1|||
162953403|NCT05472038|588534836|FG001|Overall Study|Lost to Follow-up|3|||
162953404|NCT05472038|588534837|FG002|Overall Study|Lost to Follow-up|3|||
162953405|NCT05472038|588534838|FG003|Overall Study|Lost to Follow-up|9|||
162953406|NCT05472038|588534839|FG004|Overall Study|Lost to Follow-up|2|||
162953407|NCT05472038|588534840|FG005|Overall Study|Lost to Follow-up|2|||
162953408|NCT05472038|588534841|FG006|Overall Study|Lost to Follow-up|1|||
162953409|NCT05472038|588534842|FG007|Overall Study|Lost to Follow-up|0|||
162953410|NCT05472038|588534843|FG008|Overall Study|Lost to Follow-up|1|||
162953411|NCT05472038|588534844|FG009|Overall Study|Lost to Follow-up|0|||
162953412|NCT05472038|588534845|FG010|Overall Study|Lost to Follow-up|2|||
162953413|NCT05472038|588534846|FG011|Overall Study|Lost to Follow-up|1|||
162953414|NCT05472038|588534835|FG000|Overall Study|Physician Decision|0|||
162953415|NCT05472038|588534836|FG001|Overall Study|Physician Decision|0|||
162953416|NCT05472038|588534837|FG002|Overall Study|Physician Decision|0|||
162953417|NCT05472038|588534838|FG003|Overall Study|Physician Decision|0|||
162953418|NCT05472038|588534839|FG004|Overall Study|Physician Decision|1|||
162953419|NCT05472038|588534840|FG005|Overall Study|Physician Decision|0|||
162953420|NCT05472038|588534841|FG006|Overall Study|Physician Decision|0|||
162953421|NCT05472038|588534842|FG007|Overall Study|Physician Decision|0|||
162953422|NCT05472038|588534843|FG008|Overall Study|Physician Decision|0|||
162953423|NCT05472038|588534844|FG009|Overall Study|Physician Decision|0|||
162953424|NCT05472038|588534845|FG010|Overall Study|Physician Decision|0|||
162953425|NCT05472038|588534846|FG011|Overall Study|Physician Decision|0|||
162953426|NCT05472038|588534835|FG000|Overall Study|Withdrawal by Subject|1|||
162953427|NCT05472038|588534836|FG001|Overall Study|Withdrawal by Subject|3|||
162953428|NCT05472038|588534837|FG002|Overall Study|Withdrawal by Subject|1|||
162953429|NCT05472038|588534838|FG003|Overall Study|Withdrawal by Subject|6|||
162953430|NCT05472038|588534839|FG004|Overall Study|Withdrawal by Subject|1|||
162953431|NCT05472038|588534840|FG005|Overall Study|Withdrawal by Subject|3|||
162953432|NCT05472038|588534841|FG006|Overall Study|Withdrawal by Subject|0|||
162953433|NCT05472038|588534842|FG007|Overall Study|Withdrawal by Subject|2|||
162953434|NCT05472038|588534843|FG008|Overall Study|Withdrawal by Subject|3|||
162953435|NCT05472038|588534844|FG009|Overall Study|Withdrawal by Subject|1|||
162953436|NCT05472038|588534845|FG010|Overall Study|Withdrawal by Subject|2|||
162953437|NCT05472038|588534846|FG011|Overall Study|Withdrawal by Subject|2|||
162953438|NCT05472038|588534835|FG000|Overall Study|Protocol Violation|0|||
162953439|NCT05472038|588534836|FG001|Overall Study|Protocol Violation|0|||
162953440|NCT05472038|588534837|FG002|Overall Study|Protocol Violation|0|||
162953441|NCT05472038|588534838|FG003|Overall Study|Protocol Violation|0|||
162953442|NCT05472038|588534839|FG004|Overall Study|Protocol Violation|0|||
162953443|NCT05472038|588534840|FG005|Overall Study|Protocol Violation|0|||
162953444|NCT05472038|588534841|FG006|Overall Study|Protocol Violation|0|||
162953445|NCT05472038|588534842|FG007|Overall Study|Protocol Violation|1|||
162953446|NCT05472038|588534843|FG008|Overall Study|Protocol Violation|1|||
162953447|NCT05472038|588534844|FG009|Overall Study|Protocol Violation|1|||
162953448|NCT05472038|588534845|FG010|Overall Study|Protocol Violation|1|||
162953449|NCT05472038|588534846|FG011|Overall Study|Protocol Violation|1|||
162953450|NCT05472038|588534835|FG000|Overall Study|Not vaccinated|0|||
162953451|NCT05472038|588534836|FG001|Overall Study|Not vaccinated|0|||
162953452|NCT05472038|588534837|FG002|Overall Study|Not vaccinated|0|||
162953453|NCT05472038|588534838|FG003|Overall Study|Not vaccinated|1|||
162953454|NCT05472038|588534839|FG004|Overall Study|Not vaccinated|0|||
162953455|NCT05472038|588534840|FG005|Overall Study|Not vaccinated|0|||
162953456|NCT05472038|588534841|FG006|Overall Study|Not vaccinated|0|||
162953457|NCT05472038|588534842|FG007|Overall Study|Not vaccinated|0|||
162953458|NCT05472038|588534843|FG008|Overall Study|Not vaccinated|0|||
162953459|NCT05472038|588534844|FG009|Overall Study|Not vaccinated|0|||
162953460|NCT05472038|588534845|FG010|Overall Study|Not vaccinated|0|||
162953461|NCT05472038|588534846|FG011|Overall Study|Not vaccinated|0|||
162953462|NCT03785548|588534850|FG000|Overall Study|age > 80|1|||
162953463|NCT03785548|588534851|FG001|Overall Study|age > 80|0|||
162953464|NCT03785548|588534850|FG000|Overall Study|no Postop queries|1|||
162953465|NCT03785548|588534851|FG001|Overall Study|no Postop queries|0|||
162953466|NCT01993030|588534852|FG000|Overall Study|Adverse Event|0|||
162611201|NCT02598960|587294893|FG005|Treatment Period|No longer meets study criteria|0|||
162953467|NCT01993030|588534853|FG001|Overall Study|Adverse Event|4|||
162953468|NCT03351335|588534859|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
162953469|NCT03351335|588534860|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
162953470|NCT03351335|588534861|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
162953471|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
162953472|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
162953473|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Death|2|||
162611202|NCT02598960|587294894|FG006|Treatment Period|No longer meets study criteria|0|||
162611203|NCT02598960|587294895|FG007|Treatment Period|No longer meets study criteria|0|||
162611204|NCT02598960|587294896|FG008|Treatment Period|No longer meets study criteria|0|||
162611205|NCT02598960|587294897|FG009|Treatment Period|No longer meets study criteria|0|||
162611206|NCT02598960|587294898|FG010|Treatment Period|No longer meets study criteria|0|||
162611207|NCT02598960|587294899|FG011|Treatment Period|No longer meets study criteria|1|||
162611208|NCT02598960|587294900|FG012|Treatment Period|No longer meets study criteria|0|||
162611209|NCT02598960|587294888|FG000|Treatment Period|Other Reasons|0|||
162611210|NCT02598960|587294889|FG001|Treatment Period|Other Reasons|0|||
162611211|NCT02598960|587294890|FG002|Treatment Period|Other Reasons|0|||
162611212|NCT02598960|587294891|FG003|Treatment Period|Other Reasons|0|||
162611213|NCT02598960|587294892|FG004|Treatment Period|Other Reasons|0|||
162611214|NCT02598960|587294893|FG005|Treatment Period|Other Reasons|0|||
162611215|NCT02598960|587294894|FG006|Treatment Period|Other Reasons|0|||
162611216|NCT02598960|587294895|FG007|Treatment Period|Other Reasons|0|||
162611217|NCT02598960|587294896|FG008|Treatment Period|Other Reasons|0|||
162611218|NCT02598960|587294897|FG009|Treatment Period|Other Reasons|0|||
162611219|NCT02598960|587294898|FG010|Treatment Period|Other Reasons|0|||
162611220|NCT02598960|587294899|FG011|Treatment Period|Other Reasons|0|||
162611221|NCT02598960|587294900|FG012|Treatment Period|Other Reasons|1|||
162611222|NCT02598960|587294888|FG000|Participants Entering Follow Up Period|Death|1|||
162611223|NCT02598960|587294889|FG001|Participants Entering Follow Up Period|Death|0|||
162611224|NCT02598960|587294890|FG002|Participants Entering Follow Up Period|Death|0|||
162611225|NCT02598960|587294891|FG003|Participants Entering Follow Up Period|Death|0|||
162611226|NCT02598960|587294892|FG004|Participants Entering Follow Up Period|Death|0|||
162611227|NCT02598960|587294893|FG005|Participants Entering Follow Up Period|Death|0|||
162611228|NCT02598960|587294894|FG006|Participants Entering Follow Up Period|Death|0|||
162611229|NCT02598960|587294895|FG007|Participants Entering Follow Up Period|Death|0|||
162611230|NCT02598960|587294896|FG008|Participants Entering Follow Up Period|Death|0|||
162611231|NCT02598960|587294897|FG009|Participants Entering Follow Up Period|Death|1|||
162611232|NCT02598960|587294898|FG010|Participants Entering Follow Up Period|Death|0|||
162611233|NCT02598960|587294899|FG011|Participants Entering Follow Up Period|Death|11|||
162611234|NCT02598960|587294900|FG012|Participants Entering Follow Up Period|Death|2|||
162611235|NCT02598960|587294888|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611236|NCT02598960|587294889|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611237|NCT02598960|587294890|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611238|NCT02598960|587294891|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611239|NCT02598960|587294892|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611240|NCT02598960|587294893|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611241|NCT02598960|587294894|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611242|NCT02598960|587294895|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611243|NCT02598960|587294896|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611244|NCT02598960|587294897|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611245|NCT02598960|587294898|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611246|NCT02598960|587294899|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
162611247|NCT02598960|587294900|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
162611248|NCT02598960|587294888|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
162611249|NCT02598960|587294889|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
162611250|NCT02598960|587294890|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
162611251|NCT02598960|587294891|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
162611252|NCT02598960|587294892|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
162611253|NCT02598960|587294893|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
162611254|NCT02598960|587294894|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
162611255|NCT02598960|587294895|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
162611256|NCT02598960|587294896|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
162611257|NCT02598960|587294897|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
162611258|NCT02598960|587294898|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
162611259|NCT02598960|587294899|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
162611260|NCT02598960|587294900|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
162611261|NCT02598960|587294888|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611262|NCT02598960|587294889|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611263|NCT02598960|587294890|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611264|NCT02598960|587294891|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611265|NCT02598960|587294892|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611266|NCT02598960|587294893|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611267|NCT02598960|587294894|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611268|NCT02598960|587294895|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611269|NCT02598960|587294896|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611270|NCT02598960|587294897|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611271|NCT02598960|587294898|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611272|NCT02598960|587294899|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
162611273|NCT02598960|587294900|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162611274|NCT02598960|587294888|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
162611275|NCT02598960|587294889|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
162611276|NCT02598960|587294890|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
162611277|NCT02598960|587294891|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
162611278|NCT02598960|587294892|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
162611279|NCT02598960|587294893|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
162611280|NCT02598960|587294894|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
162611281|NCT02598960|587294895|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
162611282|NCT02598960|587294896|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
162611283|NCT02598960|587294897|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
162611284|NCT02598960|587294898|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
162704196|NCT01347645|587628919|FG004|Overall Study|Other|1|||
162704197|NCT01347645|587628915|FG000|Overall Study|Withdrawal by Subject|0|||
162704198|NCT01347645|587628916|FG001|Overall Study|Withdrawal by Subject|0|||
162704199|NCT01347645|587628917|FG002|Overall Study|Withdrawal by Subject|0|||
162704200|NCT01347645|587628918|FG003|Overall Study|Withdrawal by Subject|3|||
162704201|NCT01347645|587628919|FG004|Overall Study|Withdrawal by Subject|3|||
162704202|NCT01347645|587628915|FG000|Overall Study|Physician Decision|0|||
162704203|NCT01347645|587628916|FG001|Overall Study|Physician Decision|0|||
162704204|NCT01347645|587628917|FG002|Overall Study|Physician Decision|0|||
162611285|NCT02598960|587294899|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
162611286|NCT02598960|587294900|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
162611287|NCT00398411|587294901|FG000|Overall Study|Death|0|||
162611288|NCT00398411|587294902|FG001|Overall Study|Death|1|||
162611289|NCT00401531|587294903|FG000|Overall Study|Adverse Event|2|||
162611290|NCT00401531|587294904|FG001|Overall Study|Adverse Event|0|||
162611291|NCT00401531|587294903|FG000|Overall Study|Protocol Violation|3|||
162611292|NCT00401531|587294904|FG001|Overall Study|Protocol Violation|7|||
162611293|NCT00401531|587294903|FG000|Overall Study|Lost to Follow-up|1|||
162611294|NCT00401531|587294904|FG001|Overall Study|Lost to Follow-up|1|||
162611295|NCT00401531|587294903|FG000|Overall Study|Withdrawal by Subject|3|||
162611296|NCT00401531|587294904|FG001|Overall Study|Withdrawal by Subject|2|||
162611297|NCT01614600|587294909|FG000|Overall Study|Unacceptable fit|1|||
162611298|NCT01614600|587294909|FG000|Overall Study|Discomfort|1|||
162611299|NCT01614600|587294909|FG000|Overall Study|Unable to remove lens at the end of day|1|||
162611300|NCT01614600|587294909|FG000|Overall Study|Protocol deviation|1|||
162611301|NCT03403374|587294910|FG000|Overall Study|Lost to Follow-up|1|||
162611302|NCT00736957|587294916|FG000|Overall Study|Adverse Event|43|||
162611303|NCT00736957|587294916|FG000|Overall Study|Withdrawal by Subject|49|||
162611304|NCT00736957|587294916|FG000|Overall Study|violation of eligibility criteria|2|||
162611305|NCT00736957|587294916|FG000|Overall Study|did not attend hospital appointments|1|||
162611306|NCT00736957|587294916|FG000|Overall Study|not eligible for Treatment Period I|22|||
162611307|NCT00736957|587294916|FG000|Overall Study|Physician Decision|5|||
162611308|NCT02806973|587294917|FG000|Period 1|Withdrawal by Subject|0|||
162611309|NCT02806973|587294918|FG001|Period 1|Withdrawal by Subject|2|||
162611310|NCT02806973|587294919|FG002|Period 1|Withdrawal by Subject|1|||
162611311|NCT02806973|587294920|FG003|Period 1|Withdrawal by Subject|1|||
162611312|NCT02806973|587294917|FG000|Period 1|Adverse Event|0|||
162611313|NCT02806973|587294918|FG001|Period 1|Adverse Event|0|||
162611314|NCT02806973|587294919|FG002|Period 1|Adverse Event|0|||
162611315|NCT02806973|587294920|FG003|Period 1|Adverse Event|1|||
162704205|NCT01347645|587628918|FG003|Overall Study|Physician Decision|0|||
162611316|NCT02806973|587294917|FG000|Period 3|Withdrawal by Subject|0|||
162611317|NCT02806973|587294918|FG001|Period 3|Withdrawal by Subject|0|||
162611318|NCT02806973|587294919|FG002|Period 3|Withdrawal by Subject|0|||
162611319|NCT02806973|587294920|FG003|Period 3|Withdrawal by Subject|3|||
162611320|NCT02806973|587294917|FG000|Period 3|Adverse Event|0|||
162611321|NCT02806973|587294918|FG001|Period 3|Adverse Event|0|||
162611322|NCT02806973|587294919|FG002|Period 3|Adverse Event|1|||
162611323|NCT02806973|587294920|FG003|Period 3|Adverse Event|0|||
162611324|NCT04209426|587294923|FG000|Overall Study|Lost to Follow-up|3|||
162611325|NCT04209426|587294924|FG001|Overall Study|Lost to Follow-up|2|||
162611326|NCT04060862|587294925|FG000|Overall Study|Symptomatic Deterioration|1|||
162611327|NCT04060862|587294925|FG000|Overall Study|Un-specified|6|||
162611328|NCT04060862|587294925|FG000|Overall Study|Progressive disease|12|||
162611329|NCT04060862|587294925|FG000|Overall Study|Physician Decision|1|||
162704206|NCT01347645|587628919|FG004|Overall Study|Physician Decision|1|||
162704207|NCT01347645|587628915|FG000|Overall Study|Adverse Event|0|||
162704208|NCT01347645|587628916|FG001|Overall Study|Adverse Event|0|||
162953474|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Death|1|||
162953475|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
162953476|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
162953477|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
162953478|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
162953479|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Other|8|||
162953480|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Other|13|||
162953481|NCT01439880|588534865|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
162953482|NCT01439880|588534866|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
162953483|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
162953484|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
162953485|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
162953486|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
162953487|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Death|3|||
162953488|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Death|13|||
162953489|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
162953490|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
162953491|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Other|14|||
162953492|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Other|31|||
162953493|NCT01439880|588534865|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
162953494|NCT01439880|588534866|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
162953495|NCT02378935|588534869|FG000|Overall Study|Lack of Efficacy|10|||
162953496|NCT02378935|588534870|FG001|Overall Study|Lack of Efficacy|0|||
162953497|NCT02378935|588534871|FG002|Overall Study|Lack of Efficacy|2|||
162953498|NCT02378935|588534872|FG003|Overall Study|Lack of Efficacy|6|||
162953499|NCT02378935|588534873|FG004|Overall Study|Lack of Efficacy|0|||
162953500|NCT02378935|588534874|FG005|Overall Study|Lack of Efficacy|0|||
162953501|NCT02378935|588534875|FG006|Overall Study|Lack of Efficacy|0|||
162953502|NCT02378935|588534869|FG000|Overall Study|Death|0|||
162953503|NCT02378935|588534870|FG001|Overall Study|Death|0|||
162953504|NCT02378935|588534871|FG002|Overall Study|Death|1|||
162953505|NCT02378935|588534872|FG003|Overall Study|Death|0|||
162953506|NCT02378935|588534873|FG004|Overall Study|Death|0|||
162953507|NCT02378935|588534874|FG005|Overall Study|Death|0|||
162953508|NCT02378935|588534875|FG006|Overall Study|Death|0|||
162953509|NCT03450057|588534879|FG000|Overall Study|Death|17|||
162953510|NCT03450057|588534879|FG000|Overall Study|ICF withdrawal|4|||
162953511|NCT03450057|588534879|FG000|Overall Study|Lost to Follow-up|2|||
162953512|NCT03214952|588534882|FG000|Overall Study|Protocol Deviation|45|||
162953513|NCT03214952|588534882|FG000|Overall Study|Case Report Forms Uncollected|13|||
162953514|NCT00829790|588534883|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
162953515|NCT00829790|588534884|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
162953516|NCT03935880|588534885|FG000|Overall Study|Lost to Follow-up|0|||
162953517|NCT03935880|588534886|FG001|Overall Study|Lost to Follow-up|1|||
162953518|NCT00004562|588534887|FG000|Overall Study|Lost to Follow-up|102|||
162953519|NCT00004562|588534888|FG001|Overall Study|Lost to Follow-up|91|||
162953520|NCT04247282|588534889|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
162953521|NCT04247282|588534890|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
162953522|NCT04247282|588534891|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
162953523|NCT04247282|588534892|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
162953524|NCT04247282|588534889|FG000|Overall Study|Refused further treatment|0|||
162953525|NCT04247282|588534890|FG001|Overall Study|Refused further treatment|1|||
162953526|NCT04247282|588534891|FG002|Overall Study|Refused further treatment|0|||
162953527|NCT04247282|588534892|FG003|Overall Study|Refused further treatment|0|||
162953528|NCT02865850|588534893|FG000|Overall Study|Death|15|||
162953529|NCT02865850|588534894|FG001|Overall Study|Death|19|||
162953530|NCT02865850|588534893|FG000|Overall Study|Withdrawal by Subject|3|||
162953531|NCT02865850|588534894|FG001|Overall Study|Withdrawal by Subject|2|||
162953532|NCT02865850|588534893|FG000|Overall Study|Lost to Follow-up|3|||
162953533|NCT02865850|588534894|FG001|Overall Study|Lost to Follow-up|2|||
162953534|NCT00552669|588534895|FG000|Overall Study|Death|3|||
162953535|NCT00552669|588534896|FG001|Overall Study|Death|7|||
162953536|NCT01263704|588534898|FG000|Overall Study|Progressive disease|18|||
162953537|NCT01263704|588534898|FG000|Overall Study|Adverse Event|3|||
162611330|NCT01031381|587294930|FG000|Overall Study|Physician Decision|3|||
162611331|NCT01031381|587294930|FG000|Overall Study|Withdrawal by Subject|6|||
162611332|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
162611333|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
162611334|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
162611335|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
162611336|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162611337|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
162611338|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162611339|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
162611340|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
162611341|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
162611342|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
162611343|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
162611344|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162611345|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
162953538|NCT01263704|588534898|FG000|Overall Study|Death|2|||
162953539|NCT01263704|588534898|FG000|Overall Study|Patient withdrew consent|2|||
162953540|NCT01263704|588534898|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
162953541|NCT01263704|588534898|FG000|Overall Study|Lost to Follow-up|1|||
162953542|NCT01263704|588534898|FG000|Overall Study|Colon metastases|1|||
162953543|NCT01263704|588534898|FG000|Overall Study|Principal Investigator (PI) decision|1|||
162953544|NCT00252720|588534900|FG000|Overall Study|Withdrawal by Subject|95|||
162953545|NCT00252720|588534901|FG001|Overall Study|Withdrawal by Subject|97|||
162953546|NCT00252720|588534900|FG000|Overall Study|Death|7|||
162953547|NCT00252720|588534901|FG001|Overall Study|Death|8|||
162953548|NCT00252720|588534900|FG000|Overall Study|Moving|23|||
162953549|NCT00252720|588534901|FG001|Overall Study|Moving|42|||
162953550|NCT00252720|588534900|FG000|Overall Study|Mainly patients lost to follow-up|7|||
162953551|NCT00252720|588534901|FG001|Overall Study|Mainly patients lost to follow-up|18|||
162704209|NCT01347645|587628917|FG002|Overall Study|Adverse Event|0|||
162704210|NCT01347645|587628918|FG003|Overall Study|Adverse Event|1|||
162704211|NCT01347645|587628919|FG004|Overall Study|Adverse Event|1|||
162704212|NCT00388362|587628920|FG000|Enrolled|Ineligible|1|||
162704213|NCT00388362|587628920|FG000|Enrolled|Adverse Event|9|||
162704214|NCT00388362|587628920|FG000|Enrolled|Death|1|||
162704215|NCT00388362|587628920|FG000|Enrolled|Loss insurance|1|||
162704216|NCT00388362|587628920|FG000|Enrolled|Withdrawal by Subject|1|||
162953552|NCT00102440|588534904|FG000|Overall Study|Lost to Follow-up|25|||
162953553|NCT00102440|588534905|FG001|Overall Study|Lost to Follow-up|18|||
162953554|NCT00102440|588534906|FG002|Overall Study|Lost to Follow-up|21|||
162953555|NCT00102440|588534904|FG000|Overall Study|Adverse Event|16|||
162953556|NCT00102440|588534905|FG001|Overall Study|Adverse Event|23|||
162953557|NCT00102440|588534906|FG002|Overall Study|Adverse Event|8|||
162953558|NCT00102440|588534904|FG000|Overall Study|Gout Flare|10|||
162953559|NCT00102440|588534905|FG001|Overall Study|Gout Flare|28|||
162611346|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162611347|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162704217|NCT00388362|587628920|FG000|Remained on Study Median of 514 Days|Death|2|||
162953560|NCT00102440|588534906|FG002|Overall Study|Gout Flare|9|||
162953561|NCT00102440|588534904|FG000|Overall Study|Personal Reason(s)|19|||
162953562|NCT00102440|588534905|FG001|Overall Study|Personal Reason(s)|13|||
162704218|NCT01141660|587628921|FG000|Overall Study|Physician Decision|0|||
162953563|NCT00102440|588534906|FG002|Overall Study|Personal Reason(s)|13|||
162953564|NCT00102440|588534904|FG000|Overall Study|Other|11|||
162953565|NCT00102440|588534905|FG001|Overall Study|Other|14|||
162953566|NCT00102440|588534906|FG002|Overall Study|Other|14|||
162953567|NCT00102440|588534904|FG000|Overall Study|Protocol Violation|7|||
162953568|NCT00102440|588534905|FG001|Overall Study|Protocol Violation|2|||
162953569|NCT00102440|588534906|FG002|Overall Study|Protocol Violation|1|||
162953570|NCT04627038|588534907|FG000|Overall Study|Adverse Event|36|||
162953571|NCT04627038|588534908|FG001|Overall Study|Adverse Event|8|||
162953572|NCT04627038|588534907|FG000|Overall Study|Lost to Follow-up|1|||
162953573|NCT04627038|588534908|FG001|Overall Study|Lost to Follow-up|0|||
162953574|NCT04627038|588534907|FG000|Overall Study|Physician Decision|0|||
162953575|NCT04627038|588534908|FG001|Overall Study|Physician Decision|1|||
162953576|NCT04627038|588534907|FG000|Overall Study|Protocol Violation|3|||
162953577|NCT04627038|588534908|FG001|Overall Study|Protocol Violation|1|||
162953578|NCT04627038|588534907|FG000|Overall Study|Withdrawal by Subject|13|||
162953579|NCT04627038|588534908|FG001|Overall Study|Withdrawal by Subject|3|||
162953580|NCT04627038|588534907|FG000|Overall Study|Non-compliance with study drug|0|||
162849747|NCT00896532|588154817|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
162849748|NCT00896532|588154818|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
162953581|NCT04627038|588534908|FG001|Overall Study|Non-compliance with study drug|1|||
162953582|NCT04627038|588534907|FG000|Overall Study|Prohibited Concomitant Medication|1|||
162953583|NCT04627038|588534908|FG001|Overall Study|Prohibited Concomitant Medication|0|||
162953584|NCT01792635|588534913|FG000|Part B|Adverse Event|0|||
162849749|NCT00896532|588154796|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849750|NCT00896532|588154797|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849751|NCT00896532|588154798|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849752|NCT00896532|588154799|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162953585|NCT01792635|588534914|FG001|Part B|Adverse Event|0|||
162849753|NCT00896532|588154800|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849754|NCT00896532|588154801|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849755|NCT00896532|588154802|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849756|NCT00896532|588154803|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849757|NCT00896532|588154804|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849758|NCT00896532|588154805|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849759|NCT00896532|588154806|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849760|NCT00896532|588154807|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849761|NCT00896532|588154808|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849762|NCT00896532|588154809|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849763|NCT00896532|588154810|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849764|NCT00896532|588154811|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849765|NCT00896532|588154812|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
162849766|NCT00896532|588154813|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849767|NCT00896532|588154814|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849768|NCT00896532|588154815|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849769|NCT00896532|588154816|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849770|NCT00896532|588154817|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849771|NCT00896532|588154818|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
162849772|NCT00896532|588154796|FG000|Months 48-72: Follow-on Phase|Death|0|||
162849773|NCT00896532|588154797|FG001|Months 48-72: Follow-on Phase|Death|0|||
162849774|NCT00896532|588154798|FG002|Months 48-72: Follow-on Phase|Death|0|||
162849775|NCT00896532|588154799|FG003|Months 48-72: Follow-on Phase|Death|0|||
162849776|NCT00896532|588154800|FG004|Months 48-72: Follow-on Phase|Death|0|||
162849777|NCT00896532|588154801|FG005|Months 48-72: Follow-on Phase|Death|0|||
162849778|NCT00896532|588154802|FG006|Months 48-72: Follow-on Phase|Death|0|||
162849779|NCT00896532|588154803|FG007|Months 48-72: Follow-on Phase|Death|0|||
162849780|NCT00896532|588154804|FG008|Months 48-72: Follow-on Phase|Death|0|||
162849781|NCT00896532|588154805|FG009|Months 48-72: Follow-on Phase|Death|0|||
162849782|NCT00896532|588154806|FG010|Months 48-72: Follow-on Phase|Death|0|||
162611348|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Program Termination|3|||
162849783|NCT00896532|588154807|FG011|Months 48-72: Follow-on Phase|Death|0|||
162953586|NCT01792635|588534915|FG002|Part B|Adverse Event|1|||
162953587|NCT01792635|588534913|FG000|Part B|Study terminated|0|||
162953588|NCT01792635|588534914|FG001|Part B|Study terminated|4|||
162953589|NCT01792635|588534915|FG002|Part B|Study terminated|3|||
162849784|NCT00896532|588154808|FG012|Months 48-72: Follow-on Phase|Death|0|||
162849785|NCT00896532|588154809|FG013|Months 48-72: Follow-on Phase|Death|0|||
162849786|NCT00896532|588154810|FG014|Months 48-72: Follow-on Phase|Death|0|||
162849787|NCT00896532|588154811|FG015|Months 48-72: Follow-on Phase|Death|0|||
162849788|NCT00896532|588154812|FG016|Months 48-72: Follow-on Phase|Death|0|||
162849789|NCT00896532|588154813|FG017|Months 48-72: Follow-on Phase|Death|0|||
162849790|NCT00896532|588154814|FG018|Months 48-72: Follow-on Phase|Death|1|||
162849791|NCT00896532|588154815|FG019|Months 48-72: Follow-on Phase|Death|0|||
162849792|NCT00896532|588154816|FG020|Months 48-72: Follow-on Phase|Death|0|||
162849793|NCT00896532|588154817|FG021|Months 48-72: Follow-on Phase|Death|0|||
162849794|NCT00896532|588154818|FG022|Months 48-72: Follow-on Phase|Death|0|||
162953590|NCT01401647|588534920|FG000|Overall Study|Withdrawal by Subject|1|||
162953591|NCT01401647|588534921|FG001|Overall Study|Withdrawal by Subject|5|||
162953592|NCT01401647|588534922|FG002|Overall Study|Withdrawal by Subject|2|||
162953593|NCT01401647|588534920|FG000|Overall Study|Lost to Follow-up|3|||
162953594|NCT01401647|588534921|FG001|Overall Study|Lost to Follow-up|3|||
162953595|NCT01401647|588534922|FG002|Overall Study|Lost to Follow-up|1|||
162953596|NCT00473330|588534926|FG000|Core Study|Adverse Event|4|||
162953597|NCT00473330|588534927|FG001|Core Study|Adverse Event|4|||
162953598|NCT00473330|588534928|FG002|Core Study|Adverse Event|1|||
162953599|NCT00473330|588534926|FG000|Core Study|Death|6|||
162953600|NCT00473330|588534927|FG001|Core Study|Death|4|||
162953601|NCT00473330|588534928|FG002|Core Study|Death|4|||
162953602|NCT00473330|588534926|FG000|Core Study|Lost to Follow-up|5|||
162953603|NCT00473330|588534927|FG001|Core Study|Lost to Follow-up|5|||
162953604|NCT00473330|588534928|FG002|Core Study|Lost to Follow-up|10|||
162953605|NCT00473330|588534926|FG000|Core Study|Physician Decision|2|||
162953606|NCT00473330|588534927|FG001|Core Study|Physician Decision|1|||
162953607|NCT00473330|588534928|FG002|Core Study|Physician Decision|3|||
162953608|NCT00473330|588534926|FG000|Core Study|Subject Non-compliance|1|||
162953609|NCT00473330|588534927|FG001|Core Study|Subject Non-compliance|2|||
162953610|NCT00473330|588534928|FG002|Core Study|Subject Non-compliance|1|||
162953611|NCT00473330|588534926|FG000|Core Study|Subject Required Other Therapy|0|||
162953612|NCT00473330|588534927|FG001|Core Study|Subject Required Other Therapy|1|||
162953613|NCT00473330|588534928|FG002|Core Study|Subject Required Other Therapy|3|||
162953614|NCT00473330|588534926|FG000|Core Study|Subject's Decision|9|||
162953615|NCT00473330|588534927|FG001|Core Study|Subject's Decision|8|||
162953616|NCT00473330|588534928|FG002|Core Study|Subject's Decision|19|||
162953617|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
162953618|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
162953619|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
162953620|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Death|2|||
162953621|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Death|0|||
162849795|NCT00896532|588154796|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849796|NCT00896532|588154797|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849797|NCT00896532|588154798|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849798|NCT00896532|588154799|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849799|NCT00896532|588154800|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849800|NCT00896532|588154801|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849801|NCT00896532|588154802|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849802|NCT00896532|588154803|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849803|NCT00896532|588154804|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849804|NCT00896532|588154805|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849805|NCT00896532|588154806|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849806|NCT00896532|588154807|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849807|NCT00896532|588154808|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849808|NCT00896532|588154809|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849809|NCT00896532|588154810|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849810|NCT00896532|588154811|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849811|NCT00896532|588154812|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162953622|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Death|0|||
162953623|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
162953624|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
162953625|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
162953626|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
162953627|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
163043236|NCT04004260|588865765|FG001|Overall Study|Lost to Follow-up|12|||
162849812|NCT00896532|588154813|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849813|NCT00896532|588154814|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849814|NCT00896532|588154815|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849815|NCT00896532|588154816|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849816|NCT00896532|588154817|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
162849817|NCT00896532|588154818|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
162849818|NCT00896532|588154796|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849819|NCT00896532|588154797|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849820|NCT00896532|588154798|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849821|NCT00896532|588154799|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849822|NCT00896532|588154800|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849823|NCT00896532|588154801|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849824|NCT00896532|588154802|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849825|NCT00896532|588154803|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162704219|NCT01141660|587628922|FG001|Overall Study|Physician Decision|12|||
162704220|NCT00209027|587628924|FG000|Overall Study|study terminated|10|||
162704221|NCT00209027|587628925|FG001|Overall Study|study terminated|0|||
162704222|NCT02335268|587628926|FG000|Overall Study|Physician Decision|5|||
162704223|NCT02335268|587628927|FG001|Overall Study|Physician Decision|1|||
162704224|NCT02335268|587628926|FG000|Overall Study|Lack of Efficacy|2|||
162704225|NCT02335268|587628927|FG001|Overall Study|Lack of Efficacy|1|||
162704226|NCT02335268|587628926|FG000|Overall Study|Adverse Event|5|||
162704227|NCT02335268|587628927|FG001|Overall Study|Adverse Event|2|||
162704228|NCT02335268|587628926|FG000|Overall Study|increase blasts|2|||
162704229|NCT02335268|587628927|FG001|Overall Study|increase blasts|0|||
162704230|NCT02335268|587628926|FG000|Overall Study|Withdrawal by Subject|3|||
162704231|NCT02335268|587628927|FG001|Overall Study|Withdrawal by Subject|2|||
162849826|NCT00896532|588154804|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849827|NCT00896532|588154805|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162953628|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
162953629|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
162953630|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
162953631|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
162953632|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
162953633|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
162704232|NCT05893797|587628930|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
162849828|NCT00896532|588154806|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849829|NCT00896532|588154807|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162704233|NCT05893797|587628930|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
162849830|NCT00896532|588154808|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849831|NCT00896532|588154809|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849832|NCT00896532|588154810|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849833|NCT00896532|588154811|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162611349|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Program Termination|0|||
162611350|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Program Termination|1|||
162611351|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Program Termination|1|||
162611352|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
162611353|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162611354|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162611355|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162611356|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
162611357|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
162611358|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
162611359|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
162611360|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
162611361|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
162611362|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
162611363|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
162611364|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
162611365|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
162849834|NCT00896532|588154812|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849835|NCT00896532|588154813|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849836|NCT00896532|588154814|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849837|NCT00896532|588154815|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163043237|NCT04004260|588865764|FG000|Overall Study|Did not engage in intervention|13|||
163043238|NCT04004260|588865765|FG001|Overall Study|Did not engage in intervention|17|||
163043239|NCT02360280|588865769|FG000|Overall Study|Withdrawal by Subject|2|||
162849838|NCT00896532|588154816|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849839|NCT00896532|588154817|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
162849840|NCT00896532|588154818|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
162849841|NCT01176916|588154819|FG000|Overall Study|Adverse Event|61|||
162849842|NCT01176916|588154819|FG000|Overall Study|Death|1|||
162849843|NCT01176916|588154819|FG000|Overall Study|Lost to Follow-up|15|||
162849844|NCT01176916|588154819|FG000|Overall Study|Objective progression or relapse|17|||
162849845|NCT01176916|588154819|FG000|Overall Study|Protocol Violation|24|||
162849846|NCT01176916|588154819|FG000|Overall Study|Withdrawal by Subject|37|||
162849847|NCT01176916|588154819|FG000|Overall Study|Other|6|||
162849848|NCT01176916|588154819|FG000|Overall Study|Withdrawal prior to Treatment|6|||
162849849|NCT03158220|588154822|FG000|Overall Study|Screen Failure|0|||
162849850|NCT03158220|588154823|FG001|Overall Study|Screen Failure|1|||
162849851|NCT03158220|588154822|FG000|Overall Study|Withdrawal by Subject|8|||
162849852|NCT03158220|588154823|FG001|Overall Study|Withdrawal by Subject|9|||
162849853|NCT03158220|588154822|FG000|Overall Study|Status unknown|0|||
162849854|NCT03158220|588154823|FG001|Overall Study|Status unknown|1|||
162849855|NCT03158220|588154822|FG000|Overall Study|Lost to Follow-up|8|||
162849856|NCT03158220|588154823|FG001|Overall Study|Lost to Follow-up|5|||
162849857|NCT03158220|588154822|FG000|Overall Study|Physician Decision|1|||
162849858|NCT03158220|588154823|FG001|Overall Study|Physician Decision|0|||
162849859|NCT01961115|588154835|FG000|Overall Study|Disease Progression|1|||
162849860|NCT01961115|588154836|FG001|Overall Study|Disease Progression|0|||
162849861|NCT01961115|588154837|FG002|Overall Study|Disease Progression|3|||
162849862|NCT01961115|588154835|FG000|Overall Study|Adverse Event|1|||
162849863|NCT01961115|588154836|FG001|Overall Study|Adverse Event|0|||
162849864|NCT01961115|588154837|FG002|Overall Study|Adverse Event|1|||
162849865|NCT03887130|588154843|FG000|Overall Study|Progressive disease|23|||
162849866|NCT03887130|588154844|FG001|Overall Study|Progressive disease|14|||
162849867|NCT03887130|588154845|FG002|Overall Study|Progressive disease|7|||
162849868|NCT03887130|588154843|FG000|Overall Study|Protocol Violation|3|||
162849869|NCT03887130|588154844|FG001|Overall Study|Protocol Violation|1|||
162849870|NCT03887130|588154845|FG002|Overall Study|Protocol Violation|2|||
162849871|NCT03887130|588154843|FG000|Overall Study|Drug related toxicity|7|||
162849872|NCT03887130|588154844|FG001|Overall Study|Drug related toxicity|7|||
162849873|NCT03887130|588154845|FG002|Overall Study|Drug related toxicity|13|||
162849874|NCT03887130|588154843|FG000|Overall Study|Non drug related toxicity|3|||
162849875|NCT03887130|588154844|FG001|Overall Study|Non drug related toxicity|0|||
162849876|NCT03887130|588154845|FG002|Overall Study|Non drug related toxicity|0|||
162611366|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
162611367|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
162611368|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
162849877|NCT03887130|588154843|FG000|Overall Study|Death|2|||
162849878|NCT03887130|588154844|FG001|Overall Study|Death|2|||
162849879|NCT03887130|588154845|FG002|Overall Study|Death|1|||
162849880|NCT03887130|588154843|FG000|Overall Study|Withdrawal by Subject|7|||
162849881|NCT03887130|588154844|FG001|Overall Study|Withdrawal by Subject|6|||
162849882|NCT03887130|588154845|FG002|Overall Study|Withdrawal by Subject|11|||
162849883|NCT03887130|588154843|FG000|Overall Study|other reason|6|||
162849884|NCT03887130|588154844|FG001|Overall Study|other reason|20|||
162953634|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
162953635|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
162953636|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
162849885|NCT03887130|588154845|FG002|Overall Study|other reason|17|||
162849886|NCT01439945|588154846|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
162849887|NCT01439945|588154847|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
162849888|NCT01439945|588154848|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
162849889|NCT01439945|588154849|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
162849890|NCT01439945|588154846|FG000|Double-Blind Treatment Phase|Ineligible|1|||
162849891|NCT01439945|588154847|FG001|Double-Blind Treatment Phase|Ineligible|2|||
162849892|NCT01439945|588154848|FG002|Double-Blind Treatment Phase|Ineligible|0|||
162849893|NCT01439945|588154849|FG003|Double-Blind Treatment Phase|Ineligible|1|||
162849894|NCT04082663|588154850|FG000|Overall Study|Adverse Event|6|||
162849895|NCT04082663|588154850|FG000|Overall Study|Lost to Follow-up|1|||
162849896|NCT00927563|588154851|FG000|Overall Study|Lost to Follow-up|1|||
162849897|NCT00927563|588154851|FG000|Overall Study|Withdrawal by Subject|1|||
162849898|NCT00705263|588154854|FG000|Overall Study|Withdrawal by Subject|2|||
162849899|NCT02899156|588154855|FG000|Overall Study|Death|1|||
162849900|NCT02899156|588154856|FG001|Overall Study|Death|0|||
162849901|NCT02899156|588154855|FG000|Overall Study|Physician Decision|0|||
162849902|NCT02899156|588154856|FG001|Overall Study|Physician Decision|1|||
162849903|NCT00654498|588154857|FG000|Overall Study|Not Treated|1|||
162849904|NCT00654498|588154858|FG001|Overall Study|Not Treated|0|||
162849905|NCT00654498|588154857|FG000|Overall Study|Adverse Event|6|||
162849906|NCT00654498|588154858|FG001|Overall Study|Adverse Event|1|||
162849907|NCT00654498|588154857|FG000|Overall Study|Protocol Violation|1|||
162953637|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
162953638|NCT00473330|588534926|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
162953639|NCT00473330|588534927|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
162953640|NCT00473330|588534928|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
162953641|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
162953642|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
162953643|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
162953644|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Death|2|||
162953645|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Death|2|||
162953646|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Death|1|||
162953647|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
162953648|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
162953649|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
162953650|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
162953651|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
162953652|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
162953653|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
162953654|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
162953655|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
162953656|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
162953657|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
162953658|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
163043240|NCT02360280|588865770|FG001|Overall Study|Withdrawal by Subject|0|||
163043241|NCT02360280|588865769|FG000|Overall Study|Adverse Event|0|||
163043242|NCT02360280|588865770|FG001|Overall Study|Adverse Event|1|||
163043243|NCT02360280|588865769|FG000|Overall Study|Lost to Follow-up|1|||
163043244|NCT02360280|588865770|FG001|Overall Study|Lost to Follow-up|0|||
163043245|NCT00320788|588865771|FG000|Overall Study|Adverse Event|0|||
163043246|NCT00320788|588865772|FG001|Overall Study|Adverse Event|0|||
163043247|NCT00320788|588865773|FG002|Overall Study|Adverse Event|0|||
163043248|NCT00320788|588865774|FG003|Overall Study|Adverse Event|1|||
163043249|NCT00320788|588865775|FG004|Overall Study|Adverse Event|0|||
163043250|NCT00320788|588865771|FG000|Overall Study|Death|0|||
163043251|NCT00320788|588865772|FG001|Overall Study|Death|0|||
163043252|NCT00320788|588865773|FG002|Overall Study|Death|1|||
163043253|NCT00320788|588865774|FG003|Overall Study|Death|0|||
163043254|NCT00320788|588865775|FG004|Overall Study|Death|1|||
162704234|NCT05893797|587628930|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
162849908|NCT00654498|588154858|FG001|Overall Study|Protocol Violation|1|||
162849909|NCT00654498|588154857|FG000|Overall Study|Lost to Follow-up|1|||
163043255|NCT00320788|588865771|FG000|Overall Study|Lost to Follow-up|0|||
163043256|NCT00320788|588865772|FG001|Overall Study|Lost to Follow-up|2|||
162849910|NCT00654498|588154858|FG001|Overall Study|Lost to Follow-up|5|||
162849911|NCT00654498|588154857|FG000|Overall Study|Withdrawal by Subject|1|||
162849912|NCT00654498|588154858|FG001|Overall Study|Withdrawal by Subject|0|||
162849913|NCT00654498|588154857|FG000|Overall Study|Other reason not defined above|4|||
162849914|NCT00654498|588154858|FG001|Overall Study|Other reason not defined above|5|||
162849915|NCT00484315|588154860|FG000|12-Month Clinical Follow-up|Death|6|||
162849916|NCT00484315|588154861|FG001|12-Month Clinical Follow-up|Death|2|||
162849917|NCT00484315|588154860|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
162849918|NCT00484315|588154861|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
162849919|NCT00484315|588154860|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
162849920|NCT00484315|588154861|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
162849921|NCT00484315|588154860|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
162849922|NCT00484315|588154861|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
162849923|NCT00484315|588154860|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
162849924|NCT00484315|588154861|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
162849925|NCT00484315|588154860|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
162849926|NCT00484315|588154861|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
162849927|NCT00484315|588154860|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
162849928|NCT00484315|588154861|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
162849929|NCT00943683|588154862|FG000|Overall Study|Adverse Event|3|||
162849930|NCT00943683|588154863|FG001|Overall Study|Adverse Event|3|||
162611369|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
162849931|NCT00943683|588154862|FG000|Overall Study|Lost to Follow-up|1|||
162953659|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
162849932|NCT00943683|588154863|FG001|Overall Study|Lost to Follow-up|1|||
162849933|NCT00943683|588154862|FG000|Overall Study|Protocol Violation|1|||
162849934|NCT00943683|588154863|FG001|Overall Study|Protocol Violation|2|||
162849935|NCT00943683|588154862|FG000|Overall Study|Withdrawal by Subject|1|||
162849936|NCT00943683|588154863|FG001|Overall Study|Withdrawal by Subject|0|||
162849937|NCT00943683|588154862|FG000|Overall Study|Patient Moved|1|||
162953660|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
162953661|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
162953662|NCT00473330|588534926|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
162953663|NCT00473330|588534927|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
162953664|NCT00473330|588534928|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
162849938|NCT00943683|588154863|FG001|Overall Study|Patient Moved|0|||
162953665|NCT00336479|588534933|FG000|Overall Study|Adverse Event|8|||
162953666|NCT00336479|588534934|FG001|Overall Study|Adverse Event|11|||
162953667|NCT00336479|588534935|FG002|Overall Study|Adverse Event|18|||
162953668|NCT00336479|588534936|FG003|Overall Study|Adverse Event|4|||
162953669|NCT00336479|588534933|FG000|Overall Study|Noncompliant|1|||
162953670|NCT00336479|588534934|FG001|Overall Study|Noncompliant|7|||
162953671|NCT00336479|588534935|FG002|Overall Study|Noncompliant|3|||
162953672|NCT00336479|588534936|FG003|Overall Study|Noncompliant|0|||
162953673|NCT00336479|588534933|FG000|Overall Study|Physician Decision|2|||
162953674|NCT00336479|588534934|FG001|Overall Study|Physician Decision|3|||
162953675|NCT00336479|588534935|FG002|Overall Study|Physician Decision|1|||
162953676|NCT00336479|588534936|FG003|Overall Study|Physician Decision|0|||
162953677|NCT00336479|588534933|FG000|Overall Study|Lost to Follow-up|3|||
162953678|NCT00336479|588534934|FG001|Overall Study|Lost to Follow-up|2|||
162953679|NCT00336479|588534935|FG002|Overall Study|Lost to Follow-up|0|||
162953680|NCT00336479|588534936|FG003|Overall Study|Lost to Follow-up|0|||
162953681|NCT00336479|588534933|FG000|Overall Study|Withdrawal by Subject|3|||
162953682|NCT00336479|588534934|FG001|Overall Study|Withdrawal by Subject|2|||
162953683|NCT00336479|588534935|FG002|Overall Study|Withdrawal by Subject|3|||
162849939|NCT03641560|588154869|FG000|Overall Study|Withdrawal by Subject|6|||
162849940|NCT03641560|588154869|FG000|Overall Study|Progressive disease|40|||
162849941|NCT03641560|588154869|FG000|Overall Study|Death|6|||
162849942|NCT04439279|588156981|FG000|Overall Study|Adverse Event|7|||
162849943|NCT04439279|588156981|FG000|Overall Study|Death|4|||
162849944|NCT04439279|588156981|FG000|Overall Study|Disease progression|17|||
162849945|NCT04439279|588156981|FG000|Overall Study|Complicating disease|3|||
162849946|NCT04439279|588156981|FG000|Overall Study|Withdrawal by Subject|2|||
162849947|NCT04439279|588156981|FG000|Overall Study|Ineligible|1|||
162849948|NCT04439279|588156981|FG000|Overall Study|Treatment still ongoing|1|||
162849949|NCT02689492|588156982|FG000|Overall Study|Lost to Follow-up|61|||
162849950|NCT02689492|588156982|FG000|Overall Study|Withdrawal by Subject|11|||
162849951|NCT02689492|588156982|FG000|Overall Study|Death|9|||
162849952|NCT02689492|588156982|FG000|Overall Study|Physician Decision|2|||
162849953|NCT02689492|588156982|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
162849954|NCT02689492|588156982|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
162849955|NCT02689492|588156982|FG000|Overall Study|Other than listed|1|||
162849956|NCT01750918|588156983|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
162953684|NCT00336479|588534936|FG003|Overall Study|Withdrawal by Subject|0|||
162953685|NCT00336479|588534933|FG000|Overall Study|Other|0|||
162953686|NCT00336479|588534934|FG001|Overall Study|Other|0|||
162953687|NCT00336479|588534935|FG002|Overall Study|Other|1|||
162953688|NCT00336479|588534936|FG003|Overall Study|Other|0|||
162953689|NCT00336479|588534933|FG000|Overall Study|Virologic Stopping Rule|20|||
162953690|NCT00336479|588534934|FG001|Overall Study|Virologic Stopping Rule|0|||
162953691|NCT00336479|588534935|FG002|Overall Study|Virologic Stopping Rule|0|||
162953692|NCT00336479|588534936|FG003|Overall Study|Virologic Stopping Rule|0|||
162849957|NCT01750918|588156984|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
162849958|NCT01750918|588156985|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
162849959|NCT01750918|588156986|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
162849960|NCT01750918|588156987|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
162849961|NCT01750918|588156988|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
162849962|NCT01750918|588156989|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
162849963|NCT01750918|588156990|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
162849964|NCT01750918|588156983|FG000|Overall Study|Lost to Follow-up|0|||
162849965|NCT01750918|588156984|FG001|Overall Study|Lost to Follow-up|0|||
162849966|NCT01750918|588156985|FG002|Overall Study|Lost to Follow-up|2|||
162953693|NCT00846495|588534937|FG000|Overall Study|Lost to Follow-up|1|||
162953694|NCT00846495|588534938|FG001|Overall Study|Lost to Follow-up|0|||
162849967|NCT01750918|588156986|FG003|Overall Study|Lost to Follow-up|2|||
162849968|NCT01750918|588156987|FG004|Overall Study|Lost to Follow-up|0|||
162849969|NCT01750918|588156988|FG005|Overall Study|Lost to Follow-up|0|||
162953695|NCT00846495|588534937|FG000|Overall Study|Adverse Event|5|||
162953696|NCT00846495|588534938|FG001|Overall Study|Adverse Event|1|||
162953697|NCT00846495|588534937|FG000|Overall Study|Lack of Efficacy|1|||
162849970|NCT01750918|588156989|FG006|Overall Study|Lost to Follow-up|0|||
162849971|NCT01750918|588156990|FG007|Overall Study|Lost to Follow-up|1|||
162849972|NCT01750918|588156983|FG000|Overall Study|Withdrawal by Subject|0|||
162849973|NCT01750918|588156984|FG001|Overall Study|Withdrawal by Subject|0|||
162849974|NCT01750918|588156985|FG002|Overall Study|Withdrawal by Subject|1|||
162849975|NCT01750918|588156986|FG003|Overall Study|Withdrawal by Subject|2|||
162849976|NCT01750918|588156987|FG004|Overall Study|Withdrawal by Subject|1|||
162849977|NCT01750918|588156988|FG005|Overall Study|Withdrawal by Subject|1|||
162849978|NCT01750918|588156989|FG006|Overall Study|Withdrawal by Subject|2|||
162849979|NCT01750918|588156990|FG007|Overall Study|Withdrawal by Subject|2|||
162849980|NCT02031679|588156993|FG000|Overall Study|Protocol Violation|0|||
162849981|NCT02031679|588156994|FG001|Overall Study|Protocol Violation|1|||
162849982|NCT02031679|588156993|FG000|Overall Study|Lack of Efficacy|0|||
162849983|NCT02031679|588156994|FG001|Overall Study|Lack of Efficacy|1|||
162849984|NCT02338843|588156997|FG000|Overall Study|Adverse Event|2|||
162849985|NCT02338843|588156998|FG001|Overall Study|Adverse Event|1|||
162849986|NCT02338843|588156997|FG000|Overall Study|Death|40|||
162849987|NCT02338843|588156998|FG001|Overall Study|Death|53|||
162849988|NCT02338843|588156997|FG000|Overall Study|Physician Decision|1|||
162849989|NCT02338843|588156998|FG001|Overall Study|Physician Decision|0|||
162849990|NCT02338843|588156997|FG000|Overall Study|Withdrawal by Subject|0|||
162849991|NCT02338843|588156998|FG001|Overall Study|Withdrawal by Subject|2|||
162849992|NCT02338843|588156997|FG000|Overall Study|Subject Recovered|0|||
162849993|NCT02338843|588156998|FG001|Overall Study|Subject Recovered|2|||
162849994|NCT02338843|588156997|FG000|Overall Study|Discontinued prior to randomizat|1|||
162849995|NCT02338843|588156998|FG001|Overall Study|Discontinued prior to randomizat|0|||
162849996|NCT00110305|588156999|FG000|Overall Study|Adverse Event|46|||
162849997|NCT00110305|588157000|FG001|Overall Study|Adverse Event|13|||
162849998|NCT00110305|588156999|FG000|Overall Study|Sponsors Decision|1|||
162849999|NCT00110305|588157000|FG001|Overall Study|Sponsors Decision|0|||
162850000|NCT00110305|588156999|FG000|Overall Study|Subject Non-Compliant|9|||
162850001|NCT00110305|588157000|FG001|Overall Study|Subject Non-Compliant|2|||
162850002|NCT00110305|588156999|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
162850003|NCT00110305|588157000|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
162850004|NCT00110305|588156999|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
162850005|NCT00110305|588157000|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
162850006|NCT00110305|588156999|FG000|Overall Study|Protocol Violation|0|||
162850007|NCT00110305|588157000|FG001|Overall Study|Protocol Violation|1|||
162850008|NCT00110305|588156999|FG000|Overall Study|Withdrawal by Subject|7|||
162850009|NCT00110305|588157000|FG001|Overall Study|Withdrawal by Subject|7|||
162850010|NCT00110305|588156999|FG000|Overall Study|Lost to Follow-up|20|||
162850011|NCT00110305|588157000|FG001|Overall Study|Lost to Follow-up|3|||
162850012|NCT00110305|588156999|FG000|Overall Study|Other|8|||
162850013|NCT00110305|588157000|FG001|Overall Study|Other|2|||
162850014|NCT00224016|588157004|FG000|Titration Period|Withdrawal by Subject|0|||
162850015|NCT00224016|588157005|FG001|Titration Period|Withdrawal by Subject|1|||
162953698|NCT00846495|588534938|FG001|Overall Study|Lack of Efficacy|2|||
162953699|NCT00846495|588534937|FG000|Overall Study|Physician Decision|1|||
162953700|NCT00846495|588534938|FG001|Overall Study|Physician Decision|0|||
162953701|NCT01265056|588534939|FG000|Initial Study Period|Withdrawal by Subject|1|||
162953702|NCT01265056|588534940|FG001|Initial Study Period|Withdrawal by Subject|1|||
162953703|NCT01265056|588534939|FG000|Initial Study Period|Withdrawal by Subject|1|||
162953704|NCT01265056|588534940|FG001|Initial Study Period|Withdrawal by Subject|1|||
162850016|NCT00224016|588157004|FG000|Titration Period|Lost to Follow-up|1|||
162850017|NCT00224016|588157005|FG001|Titration Period|Lost to Follow-up|0|||
162850018|NCT00224016|588157004|FG000|Maintenance Period|Withdrawal by Subject|2|||
162850019|NCT00224016|588157005|FG001|Maintenance Period|Withdrawal by Subject|0|||
162850020|NCT00224016|588157004|FG000|Maintenance Period|Lost to Follow-up|0|||
162850021|NCT00224016|588157005|FG001|Maintenance Period|Lost to Follow-up|1|||
162850022|NCT01609933|588157006|FG000|Overall Study|Adverse Event|1|||
162850023|NCT01609933|588157006|FG000|Overall Study|Withdrawal by Subject|3|||
162850024|NCT01252966|588157007|FG000|Overall Study|Lost to Follow-up|16|||
162850025|NCT01252966|588157008|FG001|Overall Study|Lost to Follow-up|10|||
162850026|NCT01252966|588157007|FG000|Overall Study|Withdrawal by Subject|7|||
162850027|NCT01252966|588157008|FG001|Overall Study|Withdrawal by Subject|3|||
162850028|NCT00522392|588157032|FG000|Overall Study|Disease progression|0|||
162850029|NCT00522392|588157033|FG001|Overall Study|Disease progression|3|||
162850030|NCT00522392|588157032|FG000|Overall Study|Adverse Event|7|||
162850031|NCT00522392|588157033|FG001|Overall Study|Adverse Event|7|||
162953705|NCT01265056|588534939|FG000|Follow up|Lost to Follow-up|7|||
162953706|NCT01265056|588534940|FG001|Follow up|Lost to Follow-up|3|||
162850032|NCT00522392|588157032|FG000|Overall Study|Withdrawal by Subject|1|||
162850033|NCT00522392|588157033|FG001|Overall Study|Withdrawal by Subject|1|||
162953707|NCT02711852|588534945|FG000|Overall Study|Death|5|||
162953708|NCT02711852|588534945|FG000|Overall Study|Lost to Follow-up|1|||
162850034|NCT00522392|588157032|FG000|Overall Study|Physician Decision|0|||
162953709|NCT02711852|588534945|FG000|Overall Study|Completed follow-up|3|||
163043257|NCT00320788|588865773|FG002|Overall Study|Lost to Follow-up|1|||
162850035|NCT00522392|588157033|FG001|Overall Study|Physician Decision|1|||
162850036|NCT00522392|588157032|FG000|Overall Study|Non-compliance|0|||
162850037|NCT00522392|588157033|FG001|Overall Study|Non-compliance|1|||
162850038|NCT00430755|588157036|FG000|Overall Study|Withdrawal by Subject|53|||
162850039|NCT01154101|588157037|FG000|Overall Study|Adverse Event|0|||
162850040|NCT01154101|588157038|FG001|Overall Study|Adverse Event|2|||
162850041|NCT01154101|588157039|FG002|Overall Study|Adverse Event|1|||
162850042|NCT01154101|588157040|FG003|Overall Study|Adverse Event|1|||
162850043|NCT01154101|588157041|FG004|Overall Study|Adverse Event|0|||
162850044|NCT01154101|588157037|FG000|Overall Study|Lost to Follow-up|0|||
162850045|NCT01154101|588157038|FG001|Overall Study|Lost to Follow-up|1|||
162850046|NCT01154101|588157039|FG002|Overall Study|Lost to Follow-up|0|||
162850047|NCT01154101|588157040|FG003|Overall Study|Lost to Follow-up|1|||
162850048|NCT01154101|588157041|FG004|Overall Study|Lost to Follow-up|0|||
162850049|NCT01154101|588157037|FG000|Overall Study|Withdrawal by Subject|0|||
162850050|NCT01154101|588157038|FG001|Overall Study|Withdrawal by Subject|1|||
162850051|NCT01154101|588157039|FG002|Overall Study|Withdrawal by Subject|2|||
162850052|NCT01154101|588157040|FG003|Overall Study|Withdrawal by Subject|0|||
162850053|NCT01154101|588157041|FG004|Overall Study|Withdrawal by Subject|1|||
162850054|NCT05019131|588157042|FG000|Overall Study|Lost to Follow-up|0|||
162850055|NCT05019131|588157043|FG001|Overall Study|Lost to Follow-up|3|||
162850056|NCT03575104|588157044|FG000|Overall Study|Adverse Event|4|||
162850057|NCT03575104|588157045|FG001|Overall Study|Adverse Event|3|||
162850058|NCT03575104|588157046|FG002|Overall Study|Adverse Event|4|||
162850059|NCT03575104|588157044|FG000|Overall Study|Withdrawal by Subject|13|||
162850060|NCT03575104|588157045|FG001|Overall Study|Withdrawal by Subject|16|||
162850061|NCT03575104|588157046|FG002|Overall Study|Withdrawal by Subject|11|||
162850062|NCT03575104|588157044|FG000|Overall Study|Other reasons|6|||
162850063|NCT03575104|588157045|FG001|Overall Study|Other reasons|8|||
162850064|NCT03575104|588157046|FG002|Overall Study|Other reasons|6|||
162850065|NCT03575104|588157044|FG000|Overall Study|Lost to Follow-up|1|||
162850066|NCT03575104|588157045|FG001|Overall Study|Lost to Follow-up|2|||
162850067|NCT03575104|588157046|FG002|Overall Study|Lost to Follow-up|1|||
162850068|NCT02360098|588157049|FG000|Overall Study|Physician Decision|7|||
162850069|NCT01919307|588157054|FG000|Overall Study|Withdrawal by Subject|9|||
162850070|NCT02771522|588157058|FG000|Overall Study|Lost to Follow-up|3|||
162850071|NCT02771522|588157058|FG000|Overall Study|Withdrawal by Subject|2|||
162850072|NCT02771522|588157058|FG000|Overall Study|No white spot lesions|3|||
162850073|NCT03049449|588157061|FG000|Overall Study|Did not receive treatment.|0|||
162850074|NCT03049449|588157062|FG001|Overall Study|Did not receive treatment.|0|||
162850075|NCT03049449|588157063|FG002|Overall Study|Did not receive treatment.|0|||
162850076|NCT03049449|588157064|FG003|Overall Study|Did not receive treatment.|0|||
162850077|NCT03049449|588157065|FG004|Overall Study|Did not receive treatment.|0|||
162850078|NCT03049449|588157066|FG005|Overall Study|Did not receive treatment.|0|||
162850079|NCT03049449|588157067|FG006|Overall Study|Did not receive treatment.|0|||
162850080|NCT03049449|588157068|FG007|Overall Study|Did not receive treatment.|0|||
162850081|NCT03049449|588157069|FG008|Overall Study|Did not receive treatment.|1|||
162850082|NCT03049449|588157070|FG009|Overall Study|Did not receive treatment.|0|||
162850083|NCT03049449|588157061|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
162850084|NCT03049449|588157062|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
162850085|NCT03049449|588157063|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
162850086|NCT03049449|588157064|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
162850087|NCT03049449|588157065|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
162850088|NCT03049449|588157066|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
162850089|NCT03049449|588157067|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
162850090|NCT03049449|588157068|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
162850091|NCT03049449|588157069|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
162850092|NCT03049449|588157070|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
162850093|NCT03049449|588157061|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850094|NCT03049449|588157062|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850095|NCT03049449|588157063|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850096|NCT03049449|588157064|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850097|NCT03049449|588157065|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850098|NCT03049449|588157066|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850099|NCT03049449|588157067|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162924266|NCT02575807|588423847|FG001|Overall Study|Terminated due to physician decision|0|||
162924267|NCT02575807|588423848|FG002|Overall Study|Terminated due to physician decision|1|||
162704235|NCT05893797|587628930|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
162924268|NCT02575807|588423849|FG003|Overall Study|Terminated due to physician decision|0|||
162704236|NCT04770220|587628931|FG000|Overall Study|Adverse Event|2|||
162850100|NCT03049449|588157068|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
162850101|NCT03049449|588157069|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
162850102|NCT03049449|588157070|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
162850103|NCT02054702|588157074|FG000|Overall Study|Lost to Follow-up|3|||
162850104|NCT02054702|588157075|FG001|Overall Study|Lost to Follow-up|5|||
162850105|NCT02054702|588157074|FG000|Overall Study|Adverse Event|3|||
162850106|NCT02054702|588157075|FG001|Overall Study|Adverse Event|1|||
162850107|NCT02054702|588157074|FG000|Overall Study|Met Withdrawal Criteria|4|||
162850108|NCT02054702|588157075|FG001|Overall Study|Met Withdrawal Criteria|1|||
162850109|NCT02054702|588157074|FG000|Overall Study|Physician Decision|0|||
162850110|NCT02054702|588157075|FG001|Overall Study|Physician Decision|1|||
162850111|NCT02054702|588157074|FG000|Overall Study|Withdrawal by Subject|14|||
162850112|NCT02054702|588157075|FG001|Overall Study|Withdrawal by Subject|4|||
162850113|NCT02388295|588157086|FG000|Dose Escalation Week 1|Adverse Event|1|||
162850114|NCT02388295|588157087|FG001|Dose Escalation Week 1|Adverse Event|2|||
162850115|NCT02388295|588157088|FG002|Dose Escalation Week 1|Adverse Event|1|||
162850116|NCT02388295|588157086|FG000|Dose Escalation Week 1|Determined not eligible|1|||
162850117|NCT02388295|588157087|FG001|Dose Escalation Week 1|Determined not eligible|1|||
162850118|NCT02388295|588157088|FG002|Dose Escalation Week 1|Determined not eligible|1|||
162850119|NCT02388295|588157086|FG000|Dose Escalation Week 2|Protocol Violation|0|||
162850120|NCT02388295|588157087|FG001|Dose Escalation Week 2|Protocol Violation|1|||
162850121|NCT02388295|588157088|FG002|Dose Escalation Week 2|Protocol Violation|0|||
162850122|NCT02388295|588157086|FG000|Dose Escalation Week 2|Determined not eligible|1|||
162850123|NCT02388295|588157087|FG001|Dose Escalation Week 2|Determined not eligible|1|||
162850124|NCT02388295|588157088|FG002|Dose Escalation Week 2|Determined not eligible|1|||
162850125|NCT02388295|588157086|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
162850126|NCT02388295|588157087|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
162850127|NCT02388295|588157088|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
162850128|NCT01551693|588157090|FG000|Overall Study|Disease Progression|1|||
162850129|NCT01551693|588157091|FG001|Overall Study|Disease Progression|0|||
162850130|NCT01551693|588157090|FG000|Overall Study|Adverse Event|0|||
162850131|NCT01551693|588157091|FG001|Overall Study|Adverse Event|1|||
162850132|NCT01551693|588157090|FG000|Overall Study|Withdrawal by Subject|0|||
162953710|NCT02711852|588534945|FG000|Overall Study|Withdrawal by Subject|1|||
162953711|NCT01417078|588534949|FG000|Overall Study|Withdrawal by Subject|1|||
162953712|NCT02612337|588534952|FG000|Overall Study|Lack of Efficacy|1|||
162953713|NCT02612337|588534953|FG001|Overall Study|Lack of Efficacy|0|||
162953714|NCT02612337|588534952|FG000|Overall Study|Withdrawal by Subject|2|||
162850133|NCT01551693|588157091|FG001|Overall Study|Withdrawal by Subject|1|||
162953715|NCT02612337|588534953|FG001|Overall Study|Withdrawal by Subject|2|||
162953716|NCT02612337|588534952|FG000|Overall Study|Did not receive study drug|0|||
162953717|NCT02612337|588534953|FG001|Overall Study|Did not receive study drug|1|||
162953718|NCT01697696|588534954|FG000|Overall Study|Study terminated by sponsor|0|||
162953719|NCT01697696|588534955|FG001|Overall Study|Study terminated by sponsor|3|||
162953720|NCT01697696|588534954|FG000|Overall Study|Protocol deviation|1|||
162953721|NCT01697696|588534955|FG001|Overall Study|Protocol deviation|0|||
162953722|NCT01697696|588534954|FG000|Overall Study|Physician Decision|1|||
162953723|NCT01697696|588534955|FG001|Overall Study|Physician Decision|0|||
162953724|NCT01697696|588534954|FG000|Overall Study|Death|4|||
162953725|NCT01697696|588534955|FG001|Overall Study|Death|2|||
162953726|NCT01697696|588534954|FG000|Overall Study|Lost to Follow-up|10|||
162953727|NCT01697696|588534955|FG001|Overall Study|Lost to Follow-up|7|||
162953728|NCT01697696|588534954|FG000|Overall Study|Subject/guardian decision|31|||
162850134|NCT02429856|588157092|FG000|Overall Study|Death|12|||
162850135|NCT02429856|588157093|FG001|Overall Study|Death|13|||
162850136|NCT02429856|588157092|FG000|Overall Study|Lost to Follow-up|6|||
162850137|NCT02429856|588157093|FG001|Overall Study|Lost to Follow-up|5|||
162850138|NCT02429856|588157092|FG000|Overall Study|Withdrawal by Subject|1|||
162850139|NCT02429856|588157093|FG001|Overall Study|Withdrawal by Subject|1|||
162850140|NCT04134494|588157097|FG000|Overall Study|Lost to Follow-up|2|||
162850141|NCT00781365|588157098|FG000|Overall Study|Withdrawal by Subject|13|||
162850142|NCT00781365|588157099|FG001|Overall Study|Withdrawal by Subject|8|||
162850143|NCT00781365|588157098|FG000|Overall Study|Did Not Attend Visit|20|||
162953729|NCT01697696|588534955|FG001|Overall Study|Subject/guardian decision|35|||
162953730|NCT03616106|588534956|FG000|Overall Study|Removed by PI|6|||
162953731|NCT03616106|588534957|FG001|Overall Study|Removed by PI|0|||
162953732|NCT03616106|588534956|FG000|Overall Study|Withdrawal by Subject|1|||
162953733|NCT03616106|588534957|FG001|Overall Study|Withdrawal by Subject|1|||
162953734|NCT03616106|588534956|FG000|Overall Study|Lost to Follow-up|7|||
162953735|NCT03616106|588534957|FG001|Overall Study|Lost to Follow-up|0|||
162850144|NCT00781365|588157099|FG001|Overall Study|Did Not Attend Visit|28|||
162850145|NCT00781365|588157098|FG000|Overall Study|Language barrier|1|||
162850146|NCT00781365|588157099|FG001|Overall Study|Language barrier|0|||
162850147|NCT01900002|588157100|FG000|Overall Study|Withdrawal by Subject|2|||
162850148|NCT01900002|588157100|FG000|Overall Study|ineligible for Y-90|4|||
162850149|NCT03371355|588157104|FG000|Overall Study|Investigator judgment|0|||
162850150|NCT03371355|588157105|FG001|Overall Study|Investigator judgment|0|||
162850151|NCT03371355|588157106|FG002|Overall Study|Investigator judgment|1|||
162850152|NCT03371355|588157107|FG003|Overall Study|Investigator judgment|1|||
162850153|NCT03371355|588157104|FG000|Overall Study|Voluntary withdrawal|1|||
162850154|NCT03371355|588157105|FG001|Overall Study|Voluntary withdrawal|0|||
162850155|NCT03371355|588157106|FG002|Overall Study|Voluntary withdrawal|1|||
162850156|NCT03371355|588157107|FG003|Overall Study|Voluntary withdrawal|2|||
162850157|NCT03371355|588157104|FG000|Overall Study|Adverse Event|0|||
162850158|NCT03371355|588157105|FG001|Overall Study|Adverse Event|1|||
162850159|NCT03371355|588157106|FG002|Overall Study|Adverse Event|2|||
162850160|NCT03371355|588157107|FG003|Overall Study|Adverse Event|3|||
162850161|NCT03371355|588157104|FG000|Overall Study|Reason not Specified|0|||
162850162|NCT03371355|588157105|FG001|Overall Study|Reason not Specified|1|||
162850163|NCT03371355|588157106|FG002|Overall Study|Reason not Specified|0|||
162850164|NCT03371355|588157107|FG003|Overall Study|Reason not Specified|1|||
162850165|NCT01662648|588157108|FG000|Overall Study|Death|1|||
162850166|NCT01662648|588157109|FG001|Overall Study|Death|3|||
162850167|NCT01662648|588157108|FG000|Overall Study|Adverse Event|40|||
162850168|NCT01662648|588157109|FG001|Overall Study|Adverse Event|37|||
162850169|NCT01662648|588157108|FG000|Overall Study|Lack of Efficacy|17|||
162850170|NCT01662648|588157109|FG001|Overall Study|Lack of Efficacy|16|||
162850171|NCT01662648|588157108|FG000|Overall Study|Participant ineligible to continue trial|1|||
162850172|NCT01662648|588157109|FG001|Overall Study|Participant ineligible to continue trial|1|||
162850173|NCT01662648|588157108|FG000|Overall Study|Lost to Follow-up|24|||
162850174|NCT01662648|588157109|FG001|Overall Study|Lost to Follow-up|36|||
162850175|NCT01662648|588157108|FG000|Overall Study|Withdrawal by Subject|36|||
162850176|NCT01662648|588157109|FG001|Overall Study|Withdrawal by Subject|53|||
162850177|NCT01662648|588157108|FG000|Overall Study|Participant non-compliant|16|||
162850178|NCT01662648|588157109|FG001|Overall Study|Participant non-compliant|20|||
162850179|NCT01662648|588157108|FG000|Overall Study|Other|8|||
162850180|NCT01662648|588157109|FG001|Overall Study|Other|11|||
162850181|NCT01662648|588157108|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
162850182|NCT01662648|588157109|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
162850183|NCT01662648|588157108|FG000|Overall Study|LOE and other reason unspecified|1|||
162850184|NCT01662648|588157109|FG001|Overall Study|LOE and other reason unspecified|0|||
162850185|NCT01662648|588157108|FG000|Overall Study|LOE and Participant non-compliant|0|||
162850186|NCT01662648|588157109|FG001|Overall Study|LOE and Participant non-compliant|1|||
162953736|NCT01880593|588534958|FG000|Overall Study|Adverse Event|1|||
162850187|NCT02658812|588157111|FG000|Overall Study|Disease Progression|7|||
162611370|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
162611371|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
162611372|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162850188|NCT02658812|588157111|FG000|Overall Study|Unrelated to study treatment|1|||
162850189|NCT02658812|588157111|FG000|Overall Study|Adverse Event|1|||
162850190|NCT01512264|588157114|FG000|Overall Study|Lost to Follow-up|0|||
162850191|NCT01512264|588157115|FG001|Overall Study|Lost to Follow-up|0|||
162850192|NCT01512264|588157116|FG002|Overall Study|Lost to Follow-up|0|||
162850193|NCT01512264|588157117|FG003|Overall Study|Lost to Follow-up|1|||
162850194|NCT00854828|588157118|FG000|Overall Study|Death|1|||
162850195|NCT00854828|588157119|FG001|Overall Study|Death|0|||
162850196|NCT00854828|588157120|FG002|Overall Study|Death|0|||
162850197|NCT00854828|588157121|FG003|Overall Study|Death|0|||
162850198|NCT00854828|588157118|FG000|Overall Study|Withdrawal by Subject|1|||
162850199|NCT00854828|588157119|FG001|Overall Study|Withdrawal by Subject|1|||
162850200|NCT00854828|588157120|FG002|Overall Study|Withdrawal by Subject|0|||
162850201|NCT00854828|588157121|FG003|Overall Study|Withdrawal by Subject|9|||
162850202|NCT00854828|588157118|FG000|Overall Study|Missed 24mo visit|1|||
162850203|NCT00854828|588157119|FG001|Overall Study|Missed 24mo visit|1|||
162850204|NCT00854828|588157120|FG002|Overall Study|Missed 24mo visit|8|||
162850205|NCT00854828|588157121|FG003|Overall Study|Missed 24mo visit|8|||
162850206|NCT04957290|588157131|FG000|Overall Study|Progressive disease|3|||
162850207|NCT04957290|588157132|FG001|Overall Study|Progressive disease|3|||
162850208|NCT04957290|588157133|FG002|Overall Study|Progressive disease|2|||
162850209|NCT04957290|588157134|FG003|Overall Study|Progressive disease|0|||
162850210|NCT04957290|588157135|FG004|Overall Study|Progressive disease|0|||
162850211|NCT04957290|588157136|FG005|Overall Study|Progressive disease|0|||
162850212|NCT04957290|588157131|FG000|Overall Study|Withdrawal by Subject|1|||
162850213|NCT04957290|588157132|FG001|Overall Study|Withdrawal by Subject|0|||
162850214|NCT04957290|588157133|FG002|Overall Study|Withdrawal by Subject|1|||
162850215|NCT04957290|588157134|FG003|Overall Study|Withdrawal by Subject|0|||
162850216|NCT04957290|588157135|FG004|Overall Study|Withdrawal by Subject|0|||
162850217|NCT04957290|588157136|FG005|Overall Study|Withdrawal by Subject|0|||
162850218|NCT04957290|588157131|FG000|Overall Study|Death|0|||
162850219|NCT04957290|588157132|FG001|Overall Study|Death|2|||
162850220|NCT04957290|588157133|FG002|Overall Study|Death|1|||
162850221|NCT04957290|588157134|FG003|Overall Study|Death|0|||
162850222|NCT04957290|588157135|FG004|Overall Study|Death|0|||
162850223|NCT04957290|588157136|FG005|Overall Study|Death|0|||
162850224|NCT04957290|588157131|FG000|Overall Study|non compliance with study drug|0|||
162850225|NCT04957290|588157132|FG001|Overall Study|non compliance with study drug|1|||
162850226|NCT04957290|588157133|FG002|Overall Study|non compliance with study drug|0|||
162850227|NCT04957290|588157134|FG003|Overall Study|non compliance with study drug|0|||
162850228|NCT04957290|588157135|FG004|Overall Study|non compliance with study drug|0|||
162850229|NCT04957290|588157136|FG005|Overall Study|non compliance with study drug|0|||
162850230|NCT04957290|588157131|FG000|Overall Study|none specified.|0|||
162850231|NCT04957290|588157132|FG001|Overall Study|none specified.|1|||
162850232|NCT04957290|588157133|FG002|Overall Study|none specified.|2|||
162850233|NCT04957290|588157134|FG003|Overall Study|none specified.|0|||
162850234|NCT04957290|588157135|FG004|Overall Study|none specified.|0|||
162850235|NCT04957290|588157136|FG005|Overall Study|none specified.|0|||
162850236|NCT04957290|588157131|FG000|Overall Study|unacceptable toxicity|0|||
162850237|NCT04957290|588157132|FG001|Overall Study|unacceptable toxicity|0|||
162850238|NCT04957290|588157133|FG002|Overall Study|unacceptable toxicity|1|||
162850239|NCT04957290|588157134|FG003|Overall Study|unacceptable toxicity|0|||
162850240|NCT04957290|588157135|FG004|Overall Study|unacceptable toxicity|0|||
162850241|NCT04957290|588157136|FG005|Overall Study|unacceptable toxicity|0|||
162850242|NCT04957290|588157131|FG000|Overall Study|Adverse Event|0|||
162850243|NCT04957290|588157132|FG001|Overall Study|Adverse Event|0|||
162850244|NCT04957290|588157133|FG002|Overall Study|Adverse Event|1|||
162850245|NCT04957290|588157134|FG003|Overall Study|Adverse Event|0|||
162850246|NCT04957290|588157135|FG004|Overall Study|Adverse Event|0|||
162850247|NCT04957290|588157136|FG005|Overall Study|Adverse Event|0|||
162850248|NCT04957290|588157131|FG000|Overall Study|study terminated by sponsor|0|||
162850249|NCT04957290|588157132|FG001|Overall Study|study terminated by sponsor|0|||
162953737|NCT01880593|588534959|FG001|Overall Study|Adverse Event|0|||
162953738|NCT01880593|588534958|FG000|Overall Study|Lack of Efficacy|1|||
162953739|NCT01880593|588534959|FG001|Overall Study|Lack of Efficacy|5|||
162953740|NCT01880593|588534958|FG000|Overall Study|Withdrawal by Subject|6|||
162953741|NCT01880593|588534959|FG001|Overall Study|Withdrawal by Subject|1|||
162953742|NCT05275205|588534964|FG000|Overall Study|Adverse Event|1|||
162850250|NCT04957290|588157133|FG002|Overall Study|study terminated by sponsor|2|||
162850251|NCT04957290|588157134|FG003|Overall Study|study terminated by sponsor|0|||
162953743|NCT05275205|588534965|FG001|Overall Study|Adverse Event|2|||
163043258|NCT00320788|588865774|FG003|Overall Study|Lost to Follow-up|0|||
162850252|NCT04957290|588157135|FG004|Overall Study|study terminated by sponsor|0|||
162850253|NCT04957290|588157136|FG005|Overall Study|study terminated by sponsor|0|||
162850254|NCT01282229|588157137|FG000|Overall Study|Protocol Violation|2|||
162850255|NCT01671280|588157138|FG000|Overall Study|Withdrawal by Subject|2|||
162850256|NCT00996203|588157139|FG000|Overall Study|Adverse Event|3|||
162850257|NCT00996203|588157139|FG000|Overall Study|Lost to Follow-up|1|||
162850258|NCT00996203|588157139|FG000|Overall Study|Lack of Efficacy|1|||
162850259|NCT00996203|588157139|FG000|Overall Study|Protocol Violation|2|||
162953744|NCT05275205|588534964|FG000|Overall Study|Physician Decision|1|||
162850260|NCT01959165|588157140|FG000|Overall Study|Adverse Event|0|||
162850261|NCT01959165|588157141|FG001|Overall Study|Adverse Event|0|||
162850262|NCT01959165|588157142|FG002|Overall Study|Adverse Event|0|||
162850263|NCT01959165|588157143|FG003|Overall Study|Adverse Event|1|||
162850264|NCT01959165|588157140|FG000|Overall Study|Lack of Efficacy|1|||
162850265|NCT01959165|588157141|FG001|Overall Study|Lack of Efficacy|0|||
162850266|NCT01959165|588157142|FG002|Overall Study|Lack of Efficacy|0|||
162850267|NCT01959165|588157143|FG003|Overall Study|Lack of Efficacy|0|||
162850268|NCT01959165|588157140|FG000|Overall Study|overdose|0|||
162850269|NCT01959165|588157141|FG001|Overall Study|overdose|0|||
162850270|NCT01959165|588157142|FG002|Overall Study|overdose|0|||
162850271|NCT01959165|588157143|FG003|Overall Study|overdose|1|||
162850272|NCT01959165|588157140|FG000|Overall Study|Welfare recipient|0|||
162850273|NCT01959165|588157141|FG001|Overall Study|Welfare recipient|1|||
162850274|NCT01959165|588157142|FG002|Overall Study|Welfare recipient|0|||
162850275|NCT01959165|588157143|FG003|Overall Study|Welfare recipient|0|||
162850276|NCT03686969|588157144|FG000|Overall Study|Study terminated|1|||
162850277|NCT03686969|588157145|FG001|Overall Study|Study terminated|0|||
162850278|NCT00848120|588157147|FG000|Overall Study|Adverse Event|1|||
162850279|NCT01988090|588157151|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
162850280|NCT01988090|588157152|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
162850281|NCT01988090|588157151|FG000|Start Treament After Randomization|Protocol Violation|0|||
162850282|NCT01988090|588157152|FG001|Start Treament After Randomization|Protocol Violation|1|||
162850283|NCT01988090|588157151|FG000|Complete Study After Start|Withdrawal by Subject|2|||
162850284|NCT01988090|588157152|FG001|Complete Study After Start|Withdrawal by Subject|0|||
162850285|NCT01988090|588157151|FG000|Complete Study After Start|Protocol Violation|1|||
162850286|NCT01988090|588157152|FG001|Complete Study After Start|Protocol Violation|1|||
162850287|NCT02497001|588157155|FG000|Overall Study|Lost to Follow-up|10|||
162850288|NCT02497001|588157156|FG001|Overall Study|Lost to Follow-up|2|||
162850289|NCT02497001|588157157|FG002|Overall Study|Lost to Follow-up|0|||
162850290|NCT02497001|588157158|FG003|Overall Study|Lost to Follow-up|2|||
162850291|NCT02497001|588157155|FG000|Overall Study|Adverse Event|28|||
162953745|NCT05275205|588534965|FG001|Overall Study|Physician Decision|1|||
162953746|NCT05275205|588534964|FG000|Overall Study|Withdrawal by Subject|2|||
162704237|NCT04770220|587628932|FG001|Overall Study|Adverse Event|11|||
162704238|NCT04770220|587628931|FG000|Overall Study|Withdrawal by Subject|5|||
162953747|NCT05275205|588534965|FG001|Overall Study|Withdrawal by Subject|3|||
162704239|NCT04770220|587628932|FG001|Overall Study|Withdrawal by Subject|11|||
162704240|NCT04770220|587628931|FG000|Overall Study|Lost to Follow-up|4|||
162704241|NCT04770220|587628932|FG001|Overall Study|Lost to Follow-up|3|||
162704242|NCT04770220|587628931|FG000|Overall Study|not otherwise specified|2|||
162704243|NCT04770220|587628932|FG001|Overall Study|not otherwise specified|3|||
162704244|NCT04770220|587628931|FG000|Overall Study|Physician Decision|1|||
162704245|NCT04770220|587628932|FG001|Overall Study|Physician Decision|3|||
162704246|NCT04894903|587628934|FG000|Overall Study|Death|1|||
162704247|NCT04894903|587628935|FG001|Overall Study|Death|0|||
162704248|NCT04894903|587628934|FG000|Overall Study|Pregnancy|1|||
162850292|NCT02497001|588157156|FG001|Overall Study|Adverse Event|30|||
162850293|NCT02497001|588157157|FG002|Overall Study|Adverse Event|11|||
162850294|NCT02497001|588157158|FG003|Overall Study|Adverse Event|11|||
162850295|NCT02497001|588157155|FG000|Overall Study|Withdrawal by Subject|14|||
162850296|NCT02497001|588157156|FG001|Overall Study|Withdrawal by Subject|37|||
162850297|NCT02497001|588157157|FG002|Overall Study|Withdrawal by Subject|19|||
162850298|NCT02497001|588157158|FG003|Overall Study|Withdrawal by Subject|15|||
162850299|NCT02497001|588157155|FG000|Overall Study|Physician Decision|5|||
162850300|NCT02497001|588157156|FG001|Overall Study|Physician Decision|11|||
162850301|NCT02497001|588157157|FG002|Overall Study|Physician Decision|5|||
162850302|NCT02497001|588157158|FG003|Overall Study|Physician Decision|1|||
162850303|NCT02497001|588157155|FG000|Overall Study|subjects that were not treated|1|||
162850304|NCT02497001|588157156|FG001|Overall Study|subjects that were not treated|2|||
162850305|NCT02497001|588157157|FG002|Overall Study|subjects that were not treated|2|||
162850306|NCT02497001|588157158|FG003|Overall Study|subjects that were not treated|1|||
162704249|NCT04894903|587628935|FG001|Overall Study|Pregnancy|0|||
162850307|NCT02497001|588157155|FG000|Overall Study|Major Protocol Deviation|3|||
162850308|NCT02497001|588157156|FG001|Overall Study|Major Protocol Deviation|4|||
162953748|NCT05275205|588534964|FG000|Overall Study|Death|1|||
162850309|NCT02497001|588157157|FG002|Overall Study|Major Protocol Deviation|4|||
162850310|NCT02497001|588157158|FG003|Overall Study|Major Protocol Deviation|4|||
162850311|NCT02497001|588157155|FG000|Overall Study|Lack of Efficacy|10|||
162850312|NCT02497001|588157156|FG001|Overall Study|Lack of Efficacy|16|||
162850313|NCT02497001|588157157|FG002|Overall Study|Lack of Efficacy|6|||
162850314|NCT02497001|588157158|FG003|Overall Study|Lack of Efficacy|6|||
162850315|NCT02497001|588157155|FG000|Overall Study|Protocol Violation|3|||
162850316|NCT02497001|588157156|FG001|Overall Study|Protocol Violation|1|||
162850317|NCT02497001|588157157|FG002|Overall Study|Protocol Violation|3|||
162850318|NCT02497001|588157158|FG003|Overall Study|Protocol Violation|1|||
162704250|NCT04894903|587628934|FG000|Overall Study|Withdrawal by Subject|1|||
162850319|NCT05501119|588157159|FG000|Overall Study|Withdrawal by Subject|2|||
162850320|NCT05501119|588157159|FG000|Overall Study|Lost to Follow-up|5|||
162850321|NCT01752023|588157160|FG000|Overall Study|Physician Decision|2|||
162850322|NCT01752023|588157161|FG001|Overall Study|Physician Decision|1|||
162850323|NCT02542072|588157162|FG000|First Intervention (1 Month)|Adverse Event|1|||
162850324|NCT02542072|588157163|FG001|First Intervention (1 Month)|Adverse Event|1|||
162850325|NCT02542072|588157162|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
162850326|NCT02542072|588157163|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
162850327|NCT02542072|588157162|FG000|First Intervention (1 Month)|Lens discomfort|1|||
162850328|NCT02542072|588157163|FG001|First Intervention (1 Month)|Lens discomfort|2|||
162850329|NCT02542072|588157162|FG000|First Intervention (1 Month)|Protocol Violation|1|||
162850330|NCT02542072|588157163|FG001|First Intervention (1 Month)|Protocol Violation|0|||
162850331|NCT02542072|588157162|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
162850332|NCT02542072|588157163|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
162850333|NCT02542072|588157162|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
162850334|NCT02542072|588157163|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
162850335|NCT02440581|588157169|FG000|Overall Study|Death|0|||
162850336|NCT02440581|588157170|FG001|Overall Study|Death|0|||
162850337|NCT02440581|588157171|FG002|Overall Study|Death|7|||
162850338|NCT02440581|588157172|FG003|Overall Study|Death|5|||
162850339|NCT02440581|588157169|FG000|Overall Study|Transplanted|1|||
162850340|NCT02440581|588157170|FG001|Overall Study|Transplanted|0|||
162850341|NCT02440581|588157171|FG002|Overall Study|Transplanted|3|||
162850342|NCT02440581|588157172|FG003|Overall Study|Transplanted|2|||
162850343|NCT02440581|588157169|FG000|Overall Study|Withdrawal by Subject|4|||
162850344|NCT02440581|588157170|FG001|Overall Study|Withdrawal by Subject|11|||
162850345|NCT02440581|588157171|FG002|Overall Study|Withdrawal by Subject|3|||
162850346|NCT02440581|588157172|FG003|Overall Study|Withdrawal by Subject|7|||
162850347|NCT00787787|588157173|FG000|Overall Study|Lack of Efficacy|4|||
162850348|NCT00787787|588157173|FG000|Overall Study|Adverse Event|3|||
162704251|NCT04894903|587628935|FG001|Overall Study|Withdrawal by Subject|1|||
162704252|NCT04894903|587628934|FG000|Overall Study|moved or exited health system|1|||
162704253|NCT04894903|587628935|FG001|Overall Study|moved or exited health system|3|||
162704254|NCT01923428|587628936|FG000|Overall Study|Adverse Event|8|||
162704255|NCT01923428|587628937|FG001|Overall Study|Adverse Event|6|||
162704256|NCT01923428|587628938|FG002|Overall Study|Adverse Event|3|||
162704257|NCT01923428|587628939|FG003|Overall Study|Adverse Event|3|||
162704258|NCT01923428|587628936|FG000|Overall Study|Withdrawal by Subject|5|||
162704259|NCT01923428|587628937|FG001|Overall Study|Withdrawal by Subject|3|||
162850349|NCT01468987|588157174|FG000|Overall Study|Adverse Event|12|||
162850350|NCT01468987|588157175|FG001|Overall Study|Adverse Event|9|||
162850351|NCT01468987|588157174|FG000|Overall Study|Death|4|||
162850352|NCT01468987|588157175|FG001|Overall Study|Death|1|||
162850353|NCT01468987|588157174|FG000|Overall Study|Lost to Follow-up|10|||
162850354|NCT01468987|588157175|FG001|Overall Study|Lost to Follow-up|5|||
162850355|NCT01468987|588157174|FG000|Overall Study|Protocol Violation|8|||
162850356|NCT01468987|588157175|FG001|Overall Study|Protocol Violation|2|||
162850357|NCT01468987|588157174|FG000|Overall Study|Withdrawal by Subject|28|||
162850358|NCT01468987|588157175|FG001|Overall Study|Withdrawal by Subject|28|||
162850359|NCT01468987|588157174|FG000|Overall Study|Physician Decision|8|||
162850360|NCT01468987|588157175|FG001|Overall Study|Physician Decision|15|||
162850361|NCT01468987|588157174|FG000|Overall Study|Sponsor Decision|1|||
162850362|NCT01468987|588157175|FG001|Overall Study|Sponsor Decision|0|||
162850363|NCT01245673|588157176|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
162850364|NCT01445678|588157184|FG000|Overall Study|Adverse Event|12|||
162850365|NCT01445678|588157185|FG001|Overall Study|Adverse Event|8|||
162850366|NCT01445678|588157184|FG000|Overall Study|Lack of Efficacy|0|||
162850367|NCT01445678|588157185|FG001|Overall Study|Lack of Efficacy|2|||
162850368|NCT01445678|588157184|FG000|Overall Study|Lost to Follow-up|8|||
162850369|NCT01445678|588157185|FG001|Overall Study|Lost to Follow-up|5|||
162850370|NCT01445678|588157184|FG000|Overall Study|Protocol Violation|1|||
162704260|NCT01923428|587628938|FG002|Overall Study|Withdrawal by Subject|0|||
162850371|NCT01445678|588157185|FG001|Overall Study|Protocol Violation|1|||
162850372|NCT01445678|588157184|FG000|Overall Study|Withdrawal by Subject|9|||
162850373|NCT01445678|588157185|FG001|Overall Study|Withdrawal by Subject|5|||
162850374|NCT01459614|588157188|FG000|Overall Study|Adverse Event|1|||
162850375|NCT01459614|588157189|FG001|Overall Study|Adverse Event|0|||
162850376|NCT01565980|588157190|FG000|Overall Study|Death|1|||
162850377|NCT01565980|588157191|FG001|Overall Study|Death|0|||
162850378|NCT01565980|588157190|FG000|Overall Study|Lost to Follow-up|1|||
162850379|NCT01565980|588157191|FG001|Overall Study|Lost to Follow-up|0|||
162850380|NCT01565980|588157190|FG000|Overall Study|health complications|1|||
162850381|NCT01565980|588157191|FG001|Overall Study|health complications|1|||
162850382|NCT01565980|588157190|FG000|Overall Study|stopped medical treatment|1|||
162850383|NCT01565980|588157191|FG001|Overall Study|stopped medical treatment|0|||
162850384|NCT01565980|588157190|FG000|Overall Study|Withdrawal by Subject|0|||
162850385|NCT01565980|588157191|FG001|Overall Study|Withdrawal by Subject|3|||
162850386|NCT02078219|588157194|FG000|Overall Study|Other|2|||
162850387|NCT02078219|588157195|FG001|Overall Study|Other|2|||
162850388|NCT02078219|588157196|FG002|Overall Study|Other|3|||
162850389|NCT02078219|588157197|FG003|Overall Study|Other|0|||
162850390|NCT02078219|588157198|FG004|Overall Study|Other|1|||
162850391|NCT02078219|588157194|FG000|Overall Study|Withdrawal by Subject|0|||
162850392|NCT02078219|588157195|FG001|Overall Study|Withdrawal by Subject|1|||
162850393|NCT02078219|588157196|FG002|Overall Study|Withdrawal by Subject|0|||
162850394|NCT02078219|588157197|FG003|Overall Study|Withdrawal by Subject|1|||
162850395|NCT02078219|588157198|FG004|Overall Study|Withdrawal by Subject|1|||
162850396|NCT02078219|588157194|FG000|Overall Study|Protocol Violation|0|||
162850397|NCT02078219|588157195|FG001|Overall Study|Protocol Violation|0|||
162850398|NCT02078219|588157196|FG002|Overall Study|Protocol Violation|0|||
162850399|NCT02078219|588157197|FG003|Overall Study|Protocol Violation|1|||
162850400|NCT02078219|588157198|FG004|Overall Study|Protocol Violation|0|||
162850401|NCT02078219|588157194|FG000|Overall Study|Death|0|||
162850402|NCT02078219|588157195|FG001|Overall Study|Death|0|||
162850403|NCT02078219|588157196|FG002|Overall Study|Death|0|||
162850404|NCT02078219|588157197|FG003|Overall Study|Death|1|||
162850405|NCT02078219|588157198|FG004|Overall Study|Death|0|||
162850406|NCT02078219|588157194|FG000|Overall Study|Adverse Event|1|||
162850407|NCT02078219|588157195|FG001|Overall Study|Adverse Event|1|||
162850408|NCT02078219|588157196|FG002|Overall Study|Adverse Event|3|||
162850409|NCT02078219|588157197|FG003|Overall Study|Adverse Event|1|||
162850410|NCT02078219|588157198|FG004|Overall Study|Adverse Event|0|||
162850411|NCT03283085|588157199|FG000|Overall Study|Adverse Event|18|||
162850412|NCT03283085|588157200|FG001|Overall Study|Adverse Event|3|||
162850413|NCT03283085|588157201|FG002|Overall Study|Adverse Event|13|||
162850414|NCT03283085|588157202|FG003|Overall Study|Adverse Event|0|||
162850415|NCT03283085|588157203|FG004|Overall Study|Adverse Event|0|||
162850416|NCT03283085|588157204|FG005|Overall Study|Adverse Event|5|||
162850417|NCT03283085|588157199|FG000|Overall Study|Death|0|||
162850418|NCT03283085|588157200|FG001|Overall Study|Death|0|||
162850419|NCT03283085|588157201|FG002|Overall Study|Death|3|||
162850420|NCT03283085|588157202|FG003|Overall Study|Death|1|||
162850421|NCT03283085|588157203|FG004|Overall Study|Death|0|||
162850422|NCT03283085|588157204|FG005|Overall Study|Death|0|||
162850423|NCT03283085|588157199|FG000|Overall Study|Withdrawal by Subject|42|||
162850424|NCT03283085|588157200|FG001|Overall Study|Withdrawal by Subject|21|||
162850425|NCT03283085|588157201|FG002|Overall Study|Withdrawal by Subject|66|||
162850426|NCT03283085|588157202|FG003|Overall Study|Withdrawal by Subject|3|||
162850427|NCT03283085|588157203|FG004|Overall Study|Withdrawal by Subject|3|||
162850428|NCT03283085|588157204|FG005|Overall Study|Withdrawal by Subject|5|||
162850429|NCT03283085|588157199|FG000|Overall Study|Physician Decision|14|||
162850430|NCT03283085|588157200|FG001|Overall Study|Physician Decision|8|||
162850431|NCT03283085|588157201|FG002|Overall Study|Physician Decision|19|||
162850432|NCT03283085|588157202|FG003|Overall Study|Physician Decision|0|||
162850433|NCT03283085|588157203|FG004|Overall Study|Physician Decision|0|||
162850434|NCT03283085|588157204|FG005|Overall Study|Physician Decision|2|||
162850435|NCT03283085|588157199|FG000|Overall Study|Site Terminated by Sponsor|1|||
162850436|NCT03283085|588157200|FG001|Overall Study|Site Terminated by Sponsor|0|||
162953749|NCT05275205|588534965|FG001|Overall Study|Death|0|||
162953750|NCT05275205|588534964|FG000|Overall Study|Patient unable to attend visits|1|||
162850437|NCT03283085|588157201|FG002|Overall Study|Site Terminated by Sponsor|3|||
162850438|NCT03283085|588157202|FG003|Overall Study|Site Terminated by Sponsor|0|||
162850439|NCT03283085|588157203|FG004|Overall Study|Site Terminated by Sponsor|0|||
162850440|NCT03283085|588157204|FG005|Overall Study|Site Terminated by Sponsor|0|||
162850441|NCT03283085|588157199|FG000|Overall Study|Lost to Follow-up|2|||
162850442|NCT03283085|588157200|FG001|Overall Study|Lost to Follow-up|0|||
162850443|NCT03283085|588157201|FG002|Overall Study|Lost to Follow-up|2|||
162850444|NCT03283085|588157202|FG003|Overall Study|Lost to Follow-up|0|||
162850445|NCT03283085|588157203|FG004|Overall Study|Lost to Follow-up|0|||
162850446|NCT03283085|588157204|FG005|Overall Study|Lost to Follow-up|1|||
162850447|NCT03283085|588157199|FG000|Overall Study|Pregnancy|0|||
162850448|NCT03283085|588157200|FG001|Overall Study|Pregnancy|0|||
162850449|NCT03283085|588157201|FG002|Overall Study|Pregnancy|1|||
162850450|NCT03283085|588157202|FG003|Overall Study|Pregnancy|0|||
162850451|NCT03283085|588157203|FG004|Overall Study|Pregnancy|0|||
162850452|NCT03283085|588157204|FG005|Overall Study|Pregnancy|0|||
162850453|NCT03283085|588157199|FG000|Overall Study|Lack of Efficacy|12|||
162850454|NCT03283085|588157200|FG001|Overall Study|Lack of Efficacy|6|||
162850455|NCT03283085|588157201|FG002|Overall Study|Lack of Efficacy|24|||
162850456|NCT03283085|588157202|FG003|Overall Study|Lack of Efficacy|1|||
162850457|NCT03283085|588157203|FG004|Overall Study|Lack of Efficacy|1|||
162850458|NCT03283085|588157204|FG005|Overall Study|Lack of Efficacy|0|||
162850459|NCT03283085|588157199|FG000|Overall Study|Reason not Specified|0|||
162850460|NCT03283085|588157200|FG001|Overall Study|Reason not Specified|4|||
162850461|NCT03283085|588157201|FG002|Overall Study|Reason not Specified|8|||
162850462|NCT03283085|588157202|FG003|Overall Study|Reason not Specified|0|||
162850463|NCT03283085|588157203|FG004|Overall Study|Reason not Specified|0|||
162850464|NCT03283085|588157204|FG005|Overall Study|Reason not Specified|1|||
162850465|NCT00891202|588157205|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
162850466|NCT00891202|588157206|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
162850467|NCT00891202|588157207|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
162850468|NCT00891202|588157208|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
162850469|NCT00891202|588157205|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
162850470|NCT00891202|588157206|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
162850471|NCT00891202|588157207|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
162850472|NCT00891202|588157208|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
162850473|NCT00891202|588157205|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
162850474|NCT00891202|588157206|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
162850475|NCT00891202|588157207|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
162850476|NCT00891202|588157208|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
162850477|NCT00891202|588157205|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
162850478|NCT00891202|588157206|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
162850479|NCT00891202|588157207|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
162850480|NCT00891202|588157208|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
162850481|NCT00398112|588158849|FG000|Overall Study|Adverse Event|4|||
162850482|NCT00398112|588158849|FG000|Overall Study|Disease progression|9|||
162850483|NCT00398112|588158849|FG000|Overall Study|Alternative treatment|1|||
162850484|NCT00398112|588158849|FG000|Overall Study|Withdrawal by Subject|3|||
162850485|NCT00398112|588158849|FG000|Overall Study|Death|1|||
162850486|NCT00582556|588158850|FG000|Overall Study|Withdrawal by Subject|0|||
162850487|NCT00582556|588158851|FG001|Overall Study|Withdrawal by Subject|1|||
162850488|NCT00582556|588158852|FG002|Overall Study|Withdrawal by Subject|1|||
162850489|NCT00582556|588158850|FG000|Overall Study|Physician Decision|0|||
162953751|NCT05275205|588534965|FG001|Overall Study|Patient unable to attend visits|0|||
162953752|NCT03243630|588534967|FG000|Overall Study|Protocol Violation|1|||
162953753|NCT03243630|588534967|FG000|Overall Study|Physician Decision|1|||
162953754|NCT00939003|588534969|FG000|Double-blind Treatment Period|Adverse Event|1|||
162953755|NCT00939003|588534970|FG001|Double-blind Treatment Period|Adverse Event|1|||
162953756|NCT00939003|588534969|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
162953757|NCT00939003|588534970|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
162953758|NCT00939003|588534969|FG000|Double-blind Treatment Period|Pregnancy|0|||
162953759|NCT00939003|588534970|FG001|Double-blind Treatment Period|Pregnancy|1|||
162850490|NCT00582556|588158851|FG001|Overall Study|Physician Decision|0|||
162850491|NCT00582556|588158852|FG002|Overall Study|Physician Decision|1|||
162850492|NCT01993888|588158853|FG000|Overall Study|Death|1|||
162953760|NCT00939003|588534969|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
162953761|NCT00939003|588534970|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
162953762|NCT00939003|588534969|FG000|Open-label Treatment Period|Adverse Event|4|||
162953763|NCT00939003|588534970|FG001|Open-label Treatment Period|Adverse Event|8|||
162850493|NCT01993888|588158854|FG001|Overall Study|Death|1|||
162850494|NCT01993888|588158853|FG000|Overall Study|Lost to Follow-up|1|||
162850495|NCT01993888|588158854|FG001|Overall Study|Lost to Follow-up|1|||
162850496|NCT01993888|588158853|FG000|Overall Study|Withdrawal by Subject|0|||
162850497|NCT01993888|588158854|FG001|Overall Study|Withdrawal by Subject|1|||
162953764|NCT00939003|588534969|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
162953765|NCT00939003|588534970|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
162953766|NCT00939003|588534969|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
162953767|NCT00939003|588534970|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
162953768|NCT00939003|588534969|FG000|Open-label Treatment Period|Pregnancy|1|||
162953769|NCT00939003|588534970|FG001|Open-label Treatment Period|Pregnancy|1|||
162850498|NCT03124459|588158855|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
162953770|NCT00939003|588534969|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
162850499|NCT03124459|588158856|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
162850500|NCT03124459|588158857|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
162850501|NCT03124459|588158858|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
162953771|NCT00939003|588534970|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
162953772|NCT00939003|588534969|FG000|Open-label Treatment Period|Site Closure|3|||
162953773|NCT00939003|588534970|FG001|Open-label Treatment Period|Site Closure|4|||
162850502|NCT03124459|588158859|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
162850503|NCT03124459|588158860|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
162850504|NCT03124459|588158855|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
162850505|NCT03124459|588158856|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
162850506|NCT03124459|588158857|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
162850507|NCT03124459|588158858|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
162850508|NCT03124459|588158859|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
162850509|NCT03124459|588158860|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
162850510|NCT03124459|588158855|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
162850511|NCT03124459|588158856|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
162850512|NCT03124459|588158857|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
162850513|NCT03124459|588158858|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
162850514|NCT03124459|588158859|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
162850515|NCT03124459|588158860|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
162850516|NCT03124459|588158855|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
162850517|NCT03124459|588158856|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
162850518|NCT03124459|588158857|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
162850519|NCT03124459|588158858|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
162850520|NCT03124459|588158859|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
162850521|NCT03124459|588158860|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
162850522|NCT03124459|588158855|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
162850523|NCT03124459|588158856|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
162850524|NCT03124459|588158857|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
162850525|NCT03124459|588158858|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
162850526|NCT03124459|588158859|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
162850527|NCT03124459|588158860|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
162850528|NCT03124459|588158855|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
162850529|NCT03124459|588158856|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
162850530|NCT03124459|588158857|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
162850531|NCT03124459|588158858|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
162850532|NCT03124459|588158859|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
162850533|NCT03124459|588158860|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
162850534|NCT03932812|588158861|FG000|Overall Study|Lost to Follow-up|12|||
162850535|NCT03932812|588158862|FG001|Overall Study|Lost to Follow-up|14|||
162850536|NCT03932812|588158861|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
162850537|NCT03932812|588158862|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
162850538|NCT03293654|588158863|FG000|Overall Study|Lost to Follow-up|0|||
162850539|NCT03293654|588158864|FG001|Overall Study|Lost to Follow-up|1|||
162850540|NCT03293654|588158865|FG002|Overall Study|Lost to Follow-up|0|||
162850541|NCT05052723|588158866|FG000|Overall Study|Death|19|||
162850542|NCT01262898|588158869|FG000|Overall Study|Protocol Violation|1|||
162850543|NCT01262898|588158870|FG001|Overall Study|Protocol Violation|1|||
162850544|NCT01262898|588158871|FG002|Overall Study|Protocol Violation|0|||
162850545|NCT01262898|588158872|FG003|Overall Study|Protocol Violation|0|||
162850546|NCT01262898|588158869|FG000|Overall Study|Lost to Follow-up|1|||
162850547|NCT01262898|588158870|FG001|Overall Study|Lost to Follow-up|0|||
162850548|NCT01262898|588158871|FG002|Overall Study|Lost to Follow-up|0|||
162850549|NCT01262898|588158872|FG003|Overall Study|Lost to Follow-up|0|||
162850550|NCT01262898|588158869|FG000|Overall Study|Withdrawal by Subject|1|||
162850551|NCT01262898|588158870|FG001|Overall Study|Withdrawal by Subject|1|||
162850552|NCT01262898|588158871|FG002|Overall Study|Withdrawal by Subject|0|||
162850553|NCT01262898|588158872|FG003|Overall Study|Withdrawal by Subject|0|||
162850554|NCT01295125|588158874|FG000|Overall Study|Study stopped prematurely|9|||
162850555|NCT00891735|588158875|FG000|Overall Study|Adverse Event|2|||
162850556|NCT00891735|588158876|FG001|Overall Study|Adverse Event|0|||
162850557|NCT00891735|588158877|FG002|Overall Study|Adverse Event|2|||
162850558|NCT00891735|588158878|FG003|Overall Study|Adverse Event|0|||
162850559|NCT00891735|588158875|FG000|Overall Study|Death|8|||
162850560|NCT00891735|588158876|FG001|Overall Study|Death|5|||
162850561|NCT00891735|588158877|FG002|Overall Study|Death|4|||
162850562|NCT00891735|588158878|FG003|Overall Study|Death|5|||
162850563|NCT00891735|588158875|FG000|Overall Study|Lost to Follow-up|2|||
162850564|NCT00891735|588158876|FG001|Overall Study|Lost to Follow-up|2|||
162850565|NCT00891735|588158877|FG002|Overall Study|Lost to Follow-up|2|||
162850566|NCT00891735|588158878|FG003|Overall Study|Lost to Follow-up|2|||
162850567|NCT00891735|588158875|FG000|Overall Study|Physician's decision to withdraw patient|1|||
162850568|NCT00891735|588158876|FG001|Overall Study|Physician's decision to withdraw patient|0|||
162850569|NCT00891735|588158877|FG002|Overall Study|Physician's decision to withdraw patient|0|||
163043259|NCT00320788|588865775|FG004|Overall Study|Lost to Follow-up|0|||
162850570|NCT00891735|588158878|FG003|Overall Study|Physician's decision to withdraw patient|0|||
162850571|NCT00891735|588158875|FG000|Overall Study|Patient's decision to withdraw|4|||
162850572|NCT00891735|588158876|FG001|Overall Study|Patient's decision to withdraw|9|||
162850573|NCT00891735|588158877|FG002|Overall Study|Patient's decision to withdraw|4|||
162850574|NCT00891735|588158878|FG003|Overall Study|Patient's decision to withdraw|8|||
162850575|NCT01355289|588158879|FG000|Core Study|Adverse Event, Non-Fatal|1|||
162850576|NCT01355289|588158880|FG001|Core Study|Adverse Event, Non-Fatal|0|||
162850577|NCT01355289|588158881|FG002|Core Study|Adverse Event, Non-Fatal|0|||
162850578|NCT01355289|588158882|FG003|Core Study|Adverse Event, Non-Fatal|0|||
162850579|NCT01355289|588158883|FG004|Core Study|Adverse Event, Non-Fatal|0|||
162850580|NCT01355289|588158879|FG000|Core Study|Inadequate Therapeutic Effect|0|||
162850581|NCT01355289|588158880|FG001|Core Study|Inadequate Therapeutic Effect|0|||
162850582|NCT01355289|588158881|FG002|Core Study|Inadequate Therapeutic Effect|0|||
162850583|NCT01355289|588158882|FG003|Core Study|Inadequate Therapeutic Effect|1|||
162850584|NCT01355289|588158883|FG004|Core Study|Inadequate Therapeutic Effect|0|||
162850585|NCT01355289|588158879|FG000|Core Study|Other|0|||
162850586|NCT01355289|588158880|FG001|Core Study|Other|0|||
162850587|NCT01355289|588158881|FG002|Core Study|Other|0|||
162850588|NCT01355289|588158882|FG003|Core Study|Other|1|||
162850589|NCT01355289|588158883|FG004|Core Study|Other|0|||
162850590|NCT01355289|588158879|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
162850591|NCT01355289|588158880|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
162850592|NCT01355289|588158881|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
162850593|NCT01355289|588158882|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
162850594|NCT01355289|588158883|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
162850595|NCT01355289|588158879|FG000|Open Label Extension|Lost to Follow-up|0|||
162850596|NCT01355289|588158880|FG001|Open Label Extension|Lost to Follow-up|0|||
162850597|NCT01355289|588158881|FG002|Open Label Extension|Lost to Follow-up|0|||
162850598|NCT01355289|588158882|FG003|Open Label Extension|Lost to Follow-up|0|||
162850599|NCT01355289|588158883|FG004|Open Label Extension|Lost to Follow-up|1|||
162850600|NCT01355289|588158879|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
162850601|NCT01355289|588158880|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
162850602|NCT01355289|588158881|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
162850603|NCT01355289|588158882|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
162850604|NCT01355289|588158883|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
162953774|NCT03707912|588534972|FG000|Overall Study|Violation of inclusion criteria|1|||
162953775|NCT03707912|588534973|FG001|Overall Study|Violation of inclusion criteria|0|||
162953776|NCT01313780|588534982|FG000|Overall Study|Lack of Efficacy|4|||
162953777|NCT01313780|588534983|FG001|Overall Study|Lack of Efficacy|2|||
162953778|NCT01313780|588534982|FG000|Overall Study|Adverse Event|6|||
162953779|NCT01313780|588534983|FG001|Overall Study|Adverse Event|11|||
162953780|NCT01313780|588534982|FG000|Overall Study|Withdrawal by Subject|2|||
162953781|NCT01313780|588534983|FG001|Overall Study|Withdrawal by Subject|8|||
162953782|NCT01313780|588534982|FG000|Overall Study|Protocol Violation|10|||
162953783|NCT01313780|588534983|FG001|Overall Study|Protocol Violation|4|||
162953784|NCT01313780|588534982|FG000|Overall Study|missing data|3|||
162953785|NCT01313780|588534983|FG001|Overall Study|missing data|3|||
162953786|NCT03235739|588536159|FG000|Overall Study|Withdrawal by Subject|2|||
162953787|NCT03235739|588536160|FG001|Overall Study|Withdrawal by Subject|2|||
162953788|NCT03235739|588536159|FG000|Overall Study|Physician Decision|0|||
162953789|NCT03235739|588536160|FG001|Overall Study|Physician Decision|1|||
162850605|NCT01355289|588158879|FG000|Open Label Extension|Other|0|||
162850606|NCT01355289|588158880|FG001|Open Label Extension|Other|0|||
162850607|NCT01355289|588158881|FG002|Open Label Extension|Other|0|||
162850608|NCT01355289|588158882|FG003|Open Label Extension|Other|0|||
162850609|NCT01355289|588158883|FG004|Open Label Extension|Other|3|||
162850610|NCT00802360|588158886|FG000|Overall Study|Stimulation failure|4|||
162953790|NCT02847650|588536161|FG000|Overall Study|Adverse Event|2|||
162953791|NCT02847650|588536162|FG001|Overall Study|Adverse Event|4|||
162953792|NCT02847650|588536161|FG000|Overall Study|Lost to Follow-up|1|||
162953793|NCT02847650|588536162|FG001|Overall Study|Lost to Follow-up|0|||
162953794|NCT02847650|588536161|FG000|Overall Study|Protocol Violation|0|||
162850611|NCT00802360|588158887|FG001|Overall Study|Stimulation failure|0|||
162850612|NCT00802360|588158888|FG002|Overall Study|Stimulation failure|3|||
162850613|NCT00802360|588158889|FG003|Overall Study|Stimulation failure|3|||
162850614|NCT00802360|588158886|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
162850615|NCT00802360|588158887|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
162850616|NCT00802360|588158888|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
162850617|NCT00802360|588158889|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
162850618|NCT00802360|588158886|FG000|Overall Study|Cycle cancelled|0|||
162850619|NCT00802360|588158887|FG001|Overall Study|Cycle cancelled|1|||
162850620|NCT00802360|588158888|FG002|Overall Study|Cycle cancelled|1|||
162850621|NCT00802360|588158889|FG003|Overall Study|Cycle cancelled|1|||
162850622|NCT00802360|588158886|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
162850623|NCT00802360|588158887|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
162850624|NCT00802360|588158888|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
162850625|NCT00802360|588158889|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
162850626|NCT00802360|588158886|FG000|Overall Study|No positive serum pregnancy|17|||
162850627|NCT00802360|588158887|FG001|Overall Study|No positive serum pregnancy|20|||
162850628|NCT00802360|588158888|FG002|Overall Study|No positive serum pregnancy|14|||
162850629|NCT00802360|588158889|FG003|Overall Study|No positive serum pregnancy|10|||
162850630|NCT00802360|588158886|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
162850631|NCT00802360|588158887|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162850632|NCT00802360|588158888|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
162850633|NCT00802360|588158889|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162850634|NCT00802360|588158886|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
162850635|NCT00802360|588158887|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
162850636|NCT00802360|588158888|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
162850637|NCT00802360|588158889|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
162850638|NCT00802360|588158886|FG000|Overall Study|Other|2|||
162850639|NCT00802360|588158887|FG001|Overall Study|Other|3|||
162850640|NCT00802360|588158888|FG002|Overall Study|Other|6|||
162850641|NCT00802360|588158889|FG003|Overall Study|Other|3|||
162850642|NCT03838484|588158900|FG000|Overall Study|Lost to Follow-up|0|||
162850643|NCT03838484|588158901|FG001|Overall Study|Lost to Follow-up|1|||
162850644|NCT03838484|588158902|FG002|Overall Study|Lost to Follow-up|0|||
162850645|NCT03838484|588158903|FG003|Overall Study|Lost to Follow-up|0|||
162850646|NCT01614964|588158904|FG000|Overall Study|Withdrawal by Subject|2|||
162850647|NCT01614964|588158905|FG001|Overall Study|Withdrawal by Subject|0|||
162850648|NCT01614964|588158904|FG000|Overall Study|Lost to Follow-up|3|||
162850649|NCT01614964|588158905|FG001|Overall Study|Lost to Follow-up|0|||
162850650|NCT00860470|588158914|FG000|Overall Study|Death|6|||
162850651|NCT00860470|588158915|FG001|Overall Study|Death|10|||
162850652|NCT00860470|588158914|FG000|Overall Study|Moved away|8|||
162850653|NCT00860470|588158915|FG001|Overall Study|Moved away|10|||
162850654|NCT00860470|588158914|FG000|Overall Study|Lost to Follow-up|34|||
162850655|NCT00860470|588158915|FG001|Overall Study|Lost to Follow-up|39|||
162850656|NCT00888238|588158917|FG000|Washout Period After Period 2|Adverse Event|0|||
162850657|NCT00888238|588158918|FG001|Washout Period After Period 2|Adverse Event|0|||
162850658|NCT00888238|588158919|FG002|Washout Period After Period 2|Adverse Event|1|||
162850659|NCT01032629|588158920|FG000|Overall Study|Closed Site|21|||
162850660|NCT01032629|588158921|FG001|Overall Study|Closed Site|18|||
162850661|NCT01032629|588158922|FG002|Overall Study|Closed Site|16|||
162850662|NCT01032629|588158920|FG000|Overall Study|Withdrawal by Subject|50|||
162953795|NCT02847650|588536162|FG001|Overall Study|Protocol Violation|1|||
162953796|NCT02847650|588536161|FG000|Overall Study|Withdrawal by Subject|1|||
162953797|NCT02847650|588536162|FG001|Overall Study|Withdrawal by Subject|1|||
162953798|NCT00467896|588536163|FG000|Overall Study|Consent Withdrawal|18|||
162953799|NCT00467896|588536163|FG000|Overall Study|Adverse Event|7|||
162953800|NCT00467896|588536163|FG000|Overall Study|Serious Adverse Event|13|||
162953801|NCT00467896|588536163|FG000|Overall Study|Non-compliance|3|||
162953802|NCT00467896|588536163|FG000|Overall Study|Changed therapy|2|||
162850663|NCT01032629|588158921|FG001|Overall Study|Withdrawal by Subject|36|||
162850664|NCT01032629|588158922|FG002|Overall Study|Withdrawal by Subject|35|||
162850665|NCT01032629|588158920|FG000|Overall Study|Lost to Follow-up|74|||
162850666|NCT01032629|588158921|FG001|Overall Study|Lost to Follow-up|47|||
162850667|NCT01032629|588158922|FG002|Overall Study|Lost to Follow-up|37|||
162850668|NCT00619957|588158924|FG000|Month 24 Double-Blind|Adverse Event|9|||
162850669|NCT00619957|588158925|FG001|Month 24 Double-Blind|Adverse Event|7|||
162850670|NCT00619957|588158924|FG000|Month 24 Double-Blind|Protocol Violation|1|||
162850671|NCT00619957|588158925|FG001|Month 24 Double-Blind|Protocol Violation|0|||
162850672|NCT00619957|588158924|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
162953803|NCT00467896|588536163|FG000|Overall Study|Patient received transplant|2|||
162953804|NCT00467896|588536163|FG000|Overall Study|Patient had atrial septostomy|1|||
162850673|NCT00619957|588158925|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
162850674|NCT00619957|588158924|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
162850675|NCT00619957|588158925|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
162850676|NCT00619957|588158924|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
162850677|NCT00619957|588158925|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
162850678|NCT00619957|588158924|FG000|Month 48 Open-Label|Adverse Event|4|||
162850679|NCT00619957|588158925|FG001|Month 48 Open-Label|Adverse Event|4|||
162850680|NCT00619957|588158924|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
162850681|NCT00619957|588158925|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
162850682|NCT00619957|588158924|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
162850683|NCT00619957|588158925|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
162850684|NCT00723957|588158926|FG000|Overall Study|Adverse event unrelated to study drug|1|||
162850685|NCT00723957|588158927|FG001|Overall Study|Adverse event unrelated to study drug|4|||
162850686|NCT00723957|588158926|FG000|Overall Study|Death|3|||
162850687|NCT00723957|588158927|FG001|Overall Study|Death|4|||
162850688|NCT00723957|588158926|FG000|Overall Study|Disease progression|27|||
162850689|NCT00723957|588158927|FG001|Overall Study|Disease progression|25|||
162850690|NCT00723957|588158926|FG000|Overall Study|Maximum clinical benefit|4|||
162850691|NCT00723957|588158927|FG001|Overall Study|Maximum clinical benefit|5|||
162850692|NCT00723957|588158926|FG000|Overall Study|Investigator decision|1|||
162850693|NCT00723957|588158927|FG001|Overall Study|Investigator decision|1|||
162850694|NCT00723957|588158926|FG000|Overall Study|Study drug toxicity|4|||
162850695|NCT00723957|588158927|FG001|Overall Study|Study drug toxicity|6|||
162850696|NCT00723957|588158926|FG000|Overall Study|Withdrawal by Subject|7|||
162850697|NCT00723957|588158927|FG001|Overall Study|Withdrawal by Subject|5|||
162850698|NCT00723957|588158926|FG000|Overall Study|Reason not analyzed|1|||
162850699|NCT00723957|588158927|FG001|Overall Study|Reason not analyzed|0|||
162850700|NCT00723957|588158926|FG000|Overall Study|Never received treatment|3|||
162850701|NCT00723957|588158927|FG001|Overall Study|Never received treatment|3|||
162850702|NCT01763164|588158928|FG000|Treatment Phase|Participant/Guardian decision|26|||
162850703|NCT01763164|588158929|FG001|Treatment Phase|Participant/Guardian decision|14|||
162850704|NCT01763164|588158928|FG000|Treatment Phase|Protocol Violation|1|||
162850705|NCT01763164|588158929|FG001|Treatment Phase|Protocol Violation|1|||
162850706|NCT01763164|588158928|FG000|Treatment Phase|Progressive Disease|142|||
162850707|NCT01763164|588158929|FG001|Treatment Phase|Progressive Disease|76|||
162850708|NCT01763164|588158928|FG000|Treatment Phase|Physician Decision|24|||
162850709|NCT01763164|588158929|FG001|Treatment Phase|Physician Decision|13|||
162850710|NCT01763164|588158928|FG000|Treatment Phase|Death|10|||
162850711|NCT01763164|588158929|FG001|Treatment Phase|Death|1|||
162850712|NCT01763164|588158928|FG000|Treatment Phase|Adverse Event|66|||
162850713|NCT01763164|588158929|FG001|Treatment Phase|Adverse Event|8|||
162850714|NCT01763164|588158928|FG000|Treatment Phase|Randomized but not Treated|0|||
162850715|NCT01763164|588158929|FG001|Treatment Phase|Randomized but not Treated|19|||
162850716|NCT01763164|588158928|FG000|Treatment Phase|Other|0|||
162850717|NCT01763164|588158929|FG001|Treatment Phase|Other|1|||
162850718|NCT01763164|588158928|FG000|Follow up Phase|New therapy for study indication|12|||
162850719|NCT01763164|588158929|FG001|Follow up Phase|New therapy for study indication|3|||
162850720|NCT01763164|588158928|FG000|Follow up Phase|Death|21|||
162850721|NCT01763164|588158929|FG001|Follow up Phase|Death|4|||
162850722|NCT01763164|588158928|FG000|Follow up Phase|Subject/guardian decision|9|||
162850723|NCT01763164|588158929|FG001|Follow up Phase|Subject/guardian decision|2|||
162850724|NCT01763164|588158928|FG000|Follow up Phase|Progressive disease|127|||
162850725|NCT01763164|588158929|FG001|Follow up Phase|Progressive disease|62|||
162850726|NCT01763164|588158928|FG000|Follow up Phase|Physician Decision|10|||
162850727|NCT01763164|588158929|FG001|Follow up Phase|Physician Decision|3|||
162850728|NCT01763164|588158928|FG000|Follow up Phase|Lost to Follow-up|1|||
162850729|NCT01763164|588158929|FG001|Follow up Phase|Lost to Follow-up|0|||
162850730|NCT01763164|588158928|FG000|Follow up Phase|Adverse Event|17|||
162850731|NCT01763164|588158929|FG001|Follow up Phase|Adverse Event|1|||
162850732|NCT01264939|588158930|FG000|Overall Study|Adverse Event|1|||
162850733|NCT01264939|588158931|FG001|Overall Study|Adverse Event|3|||
162850734|NCT01264939|588158930|FG000|Overall Study|Lost to Follow-up|0|||
162850735|NCT01264939|588158931|FG001|Overall Study|Lost to Follow-up|3|||
162850736|NCT01264939|588158930|FG000|Overall Study|Physician Decision|1|||
162850737|NCT01264939|588158931|FG001|Overall Study|Physician Decision|1|||
162850738|NCT01264939|588158930|FG000|Overall Study|Patient/Guardian Decision|8|||
162850739|NCT01264939|588158931|FG001|Overall Study|Patient/Guardian Decision|10|||
162850740|NCT01264939|588158930|FG000|Overall Study|Disease Progression|8|||
162850741|NCT01264939|588158931|FG001|Overall Study|Disease Progression|11|||
162850742|NCT04964258|588158932|FG000|Overall Study|Lost to Follow-up|1|||
162850743|NCT04964258|588158933|FG001|Overall Study|Lost to Follow-up|0|||
162850744|NCT04964258|588158934|FG002|Overall Study|Lost to Follow-up|0|||
162850745|NCT04964258|588158935|FG003|Overall Study|Lost to Follow-up|0|||
162850746|NCT04964258|588158936|FG004|Overall Study|Lost to Follow-up|0|||
162850747|NCT04964258|588158937|FG005|Overall Study|Lost to Follow-up|1|||
162850748|NCT04964258|588158938|FG006|Overall Study|Lost to Follow-up|0|||
162850749|NCT04964258|588158939|FG007|Overall Study|Lost to Follow-up|0|||
162850750|NCT04964258|588158940|FG008|Overall Study|Lost to Follow-up|0|||
162850751|NCT04964258|588158941|FG009|Overall Study|Lost to Follow-up|0|||
162850752|NCT04964258|588158942|FG010|Overall Study|Lost to Follow-up|0|||
162850753|NCT02965378|588158943|FG000|Overall Study|Progression|16|||
162850754|NCT02965378|588158944|FG001|Overall Study|Progression|4|||
162850755|NCT02965378|588158943|FG000|Overall Study|Adverse Event|5|||
162850756|NCT02965378|588158944|FG001|Overall Study|Adverse Event|2|||
162850757|NCT02965378|588158943|FG000|Overall Study|Death|2|||
162850758|NCT02965378|588158944|FG001|Overall Study|Death|0|||
162850759|NCT02965378|588158943|FG000|Overall Study|Refusal|2|||
162850760|NCT02965378|588158944|FG001|Overall Study|Refusal|1|||
162850761|NCT02965378|588158943|FG000|Overall Study|Not protocol specified|0|||
162850762|NCT02965378|588158944|FG001|Overall Study|Not protocol specified|2|||
162850763|NCT01384292|588158947|FG000|Part B|Severe non-compliance to protocol|1|||
162850764|NCT01384292|588158948|FG001|Part B|Severe non-compliance to protocol|0|||
162850765|NCT01384292|588158949|FG002|Part B|Severe non-compliance to protocol|0|||
162850766|NCT01171612|588158951|FG000|Overall Study|Lost to Follow-up|51|||
162850767|NCT01285349|588158952|FG000|Overall Study|Lost to Follow-up|27|||
162850768|NCT01285349|588158953|FG001|Overall Study|Lost to Follow-up|20|||
162850769|NCT01285349|588158954|FG002|Overall Study|Lost to Follow-up|27|||
162850770|NCT00565617|588158955|FG000|Overall Study|Withdrawal by Subject|1|||
162850771|NCT03040024|588158956|FG000|Overall Study|Adverse Event|0|||
162850772|NCT03040024|588158957|FG001|Overall Study|Adverse Event|1|||
162850773|NCT03040024|588158958|FG002|Overall Study|Adverse Event|0|||
162850774|NCT03040024|588158956|FG000|Overall Study|Death|0|||
162850775|NCT03040024|588158957|FG001|Overall Study|Death|1|||
162850776|NCT03040024|588158958|FG002|Overall Study|Death|0|||
162850777|NCT03040024|588158956|FG000|Overall Study|Physician Decision|0|||
162850778|NCT03040024|588158957|FG001|Overall Study|Physician Decision|0|||
162850779|NCT03040024|588158958|FG002|Overall Study|Physician Decision|1|||
162850780|NCT01526148|588158960|FG000|Overall Study|Adverse Event|6|||
162850781|NCT01526148|588158961|FG001|Overall Study|Adverse Event|5|||
162850782|NCT01526148|588158960|FG000|Overall Study|Lost to Follow-up|3|||
162850783|NCT01526148|588158961|FG001|Overall Study|Lost to Follow-up|6|||
162850784|NCT01526148|588158960|FG000|Overall Study|Withdrawal by Subject|2|||
162850785|NCT01526148|588158961|FG001|Overall Study|Withdrawal by Subject|0|||
162850786|NCT01526148|588158960|FG000|Overall Study|Unstable Medical Condition|1|||
162850787|NCT01526148|588158961|FG001|Overall Study|Unstable Medical Condition|0|||
162850788|NCT01526148|588158960|FG000|Overall Study|Unable to discontinue concomitant med|1|||
162850789|NCT01526148|588158961|FG001|Overall Study|Unable to discontinue concomitant med|0|||
162850790|NCT01526148|588158960|FG000|Overall Study|Moved out of state|1|||
162850791|NCT01526148|588158961|FG001|Overall Study|Moved out of state|0|||
162850792|NCT01526148|588158960|FG000|Overall Study|Incarcerated|0|||
162850793|NCT01526148|588158961|FG001|Overall Study|Incarcerated|2|||
162850794|NCT01173653|588158962|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
162850795|NCT01173653|588158963|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
162850796|NCT03529409|588158974|FG000|Randomized|Lost to Follow-up|0|||
162850797|NCT03529409|588158975|FG001|Randomized|Lost to Follow-up|0|||
162850798|NCT03529409|588158976|FG002|Randomized|Lost to Follow-up|4|||
162850799|NCT03529409|588158974|FG000|Randomized|Excluded|0|||
162850800|NCT03529409|588158975|FG001|Randomized|Excluded|0|||
162850801|NCT03529409|588158976|FG002|Randomized|Excluded|1|||
162953805|NCT00467896|588536163|FG000|Overall Study|Patient weaned off iloprost|1|||
162953806|NCT00467896|588536163|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
162953807|NCT00467896|588536163|FG000|Overall Study|Started intravenous prostacyclin|1|||
162953808|NCT00467896|588536163|FG000|Overall Study|Started inhaled Remodulin|1|||
162850802|NCT03529409|588158974|FG000|Post-treatment Assessment|Death|1|||
162850803|NCT03529409|588158975|FG001|Post-treatment Assessment|Death|0|||
162953809|NCT00467896|588536163|FG000|Overall Study|Patient had no improvement|1|||
162953810|NCT03818581|588536166|FG000|Overall Study|Adverse Event|1|||
162850804|NCT03529409|588158976|FG002|Post-treatment Assessment|Death|0|||
162850805|NCT03529409|588158974|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
162850806|NCT03529409|588158975|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
162953811|NCT03818581|588536167|FG001|Overall Study|Adverse Event|0|||
162953812|NCT03818581|588536168|FG002|Overall Study|Adverse Event|0|||
162850807|NCT03529409|588158976|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
163043260|NCT00320788|588865771|FG000|Overall Study|Decision by the Sponsor|1|||
162850808|NCT03529409|588158974|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
162850809|NCT03529409|588158975|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
162850810|NCT03529409|588158976|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
162850811|NCT03529409|588158974|FG000|Follow-up Assessment|Death|1|||
162850812|NCT03529409|588158975|FG001|Follow-up Assessment|Death|0|||
162850813|NCT03529409|588158976|FG002|Follow-up Assessment|Death|0|||
162850814|NCT03529409|588158974|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
162850815|NCT03529409|588158975|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
162953813|NCT03818581|588536169|FG003|Overall Study|Adverse Event|0|||
162953814|NCT03818581|588536170|FG004|Overall Study|Adverse Event|0|||
162850816|NCT03529409|588158976|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
162850817|NCT01497262|588158977|FG000|Overall Study|Abnormal Lab Values|4|||
162850818|NCT01497262|588158977|FG000|Overall Study|Abnormal Test Procedure Result|1|||
162850819|NCT01497262|588158977|FG000|Overall Study|Physician Decision|1|||
162850820|NCT01497262|588158977|FG000|Overall Study|Withdrawal by Subject|2|||
162850821|NCT01497262|588158977|FG000|Overall Study|Adverse Event|2|||
162850822|NCT01497262|588158977|FG000|Overall Study|Protocol Violation|1|||
162850823|NCT03898063|588158978|FG000|Overall Study|Withdrawal by Subject|10|||
162850824|NCT03898063|588158979|FG001|Overall Study|Withdrawal by Subject|8|||
162850825|NCT03430986|588158980|FG000|24-week Control Period|Adverse Event|1|||
162850826|NCT03430986|588158981|FG001|24-week Control Period|Adverse Event|0|||
162850827|NCT03430986|588158980|FG000|24-week Control Period|Lost to Follow-up|2|||
162850828|NCT03430986|588158981|FG001|24-week Control Period|Lost to Follow-up|2|||
162850829|NCT03430986|588158980|FG000|24-week Control Period|Withdrawal by Participant|5|||
162850830|NCT03430986|588158981|FG001|24-week Control Period|Withdrawal by Participant|0|||
162850831|NCT03430986|588158980|FG000|24-week Control Period|Protocol Deviation|0|||
162850832|NCT03430986|588158981|FG001|24-week Control Period|Protocol Deviation|2|||
162850833|NCT03430986|588158980|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
162850834|NCT03430986|588158981|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
162850835|NCT03430986|588158980|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
162850836|NCT03430986|588158981|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
162850837|NCT01889602|588158985|FG000|First Intervention|Adverse Event|1|||
162850838|NCT01889602|588158986|FG001|First Intervention|Adverse Event|1|||
162850839|NCT01889602|588158987|FG002|First Intervention|Adverse Event|1|||
162850840|NCT01889602|588158985|FG000|First Intervention|Protocol Violation|0|||
162850841|NCT01889602|588158986|FG001|First Intervention|Protocol Violation|1|||
162850842|NCT01889602|588158987|FG002|First Intervention|Protocol Violation|1|||
162850843|NCT01889602|588158985|FG000|First Intervention|Study ending|0|||
162850844|NCT01889602|588158986|FG001|First Intervention|Study ending|1|||
162850845|NCT01889602|588158987|FG002|First Intervention|Study ending|0|||
162850846|NCT01889602|588158985|FG000|Second Intervention|Adverse Event|0|||
162850847|NCT01889602|588158986|FG001|Second Intervention|Adverse Event|0|||
162850848|NCT01889602|588158987|FG002|Second Intervention|Adverse Event|1|||
162850849|NCT01889602|588158985|FG000|Second Intervention|Study ending|1|||
162850850|NCT01889602|588158986|FG001|Second Intervention|Study ending|0|||
162850851|NCT01889602|588158987|FG002|Second Intervention|Study ending|0|||
162850852|NCT01889602|588158985|FG000|Second Intervention|Withdrawal by Subject|0|||
162850853|NCT01889602|588158986|FG001|Second Intervention|Withdrawal by Subject|0|||
162850854|NCT01889602|588158987|FG002|Second Intervention|Withdrawal by Subject|1|||
162850855|NCT01889602|588158985|FG000|Third Intervention|Protocol Violation|1|||
162850856|NCT01889602|588158986|FG001|Third Intervention|Protocol Violation|0|||
162850857|NCT01889602|588158987|FG002|Third Intervention|Protocol Violation|0|||
162850858|NCT01889602|588158985|FG000|Third Intervention|Withdrawal by Subject|2|||
162850859|NCT01889602|588158986|FG001|Third Intervention|Withdrawal by Subject|2|||
162850860|NCT01889602|588158987|FG002|Third Intervention|Withdrawal by Subject|0|||
162850861|NCT00961961|588158988|FG000|Phase I|Withdrawal by Subject|7|||
162850862|NCT00961961|588158989|FG001|Phase I|Withdrawal by Subject|0|||
162850863|NCT00961961|588158990|FG002|Phase I|Withdrawal by Subject|0|||
162850864|NCT00961961|588158991|FG003|Phase I|Withdrawal by Subject|0|||
162850865|NCT00961961|588158988|FG000|Phase I|Lost to Follow-up|10|||
162850866|NCT00961961|588158989|FG001|Phase I|Lost to Follow-up|0|||
162953815|NCT03818581|588536166|FG000|Overall Study|Covid-19|2|||
162953816|NCT03818581|588536167|FG001|Overall Study|Covid-19|0|||
162953817|NCT03818581|588536168|FG002|Overall Study|Covid-19|0|||
162953818|NCT03818581|588536169|FG003|Overall Study|Covid-19|0|||
162953819|NCT03818581|588536170|FG004|Overall Study|Covid-19|1|||
162953820|NCT03818581|588536166|FG000|Overall Study|Withdrawal by Subject|0|||
162953821|NCT03818581|588536167|FG001|Overall Study|Withdrawal by Subject|0|||
162953822|NCT03818581|588536168|FG002|Overall Study|Withdrawal by Subject|0|||
162953823|NCT03818581|588536169|FG003|Overall Study|Withdrawal by Subject|0|||
162953824|NCT03818581|588536170|FG004|Overall Study|Withdrawal by Subject|1|||
162953825|NCT03818581|588536166|FG000|Overall Study|No longer met study criteria|0|||
162953826|NCT03818581|588536167|FG001|Overall Study|No longer met study criteria|0|||
162953827|NCT03818581|588536168|FG002|Overall Study|No longer met study criteria|0|||
163043261|NCT00320788|588865772|FG001|Overall Study|Decision by the Sponsor|1|||
163043262|NCT00320788|588865773|FG002|Overall Study|Decision by the Sponsor|0|||
162850867|NCT00961961|588158990|FG002|Phase I|Lost to Follow-up|0|||
162850868|NCT00961961|588158991|FG003|Phase I|Lost to Follow-up|0|||
162850869|NCT00961961|588158988|FG000|Phase I|Lack of Efficacy|94|||
162850870|NCT00961961|588158989|FG001|Phase I|Lack of Efficacy|0|||
162850871|NCT00961961|588158990|FG002|Phase I|Lack of Efficacy|0|||
162850872|NCT00961961|588158991|FG003|Phase I|Lack of Efficacy|0|||
162850873|NCT00961961|588158988|FG000|Phase I|Adverse Event|7|||
162850874|NCT00961961|588158989|FG001|Phase I|Adverse Event|0|||
162953828|NCT03818581|588536169|FG003|Overall Study|No longer met study criteria|0|||
162953829|NCT03818581|588536170|FG004|Overall Study|No longer met study criteria|1|||
162953830|NCT01466166|588536176|FG000|Overall Study|Death|1|||
162850875|NCT00961961|588158990|FG002|Phase I|Adverse Event|0|||
162850876|NCT00961961|588158991|FG003|Phase I|Adverse Event|0|||
162850877|NCT00961961|588158988|FG000|Phase I|Physician Decision|8|||
162850878|NCT00961961|588158989|FG001|Phase I|Physician Decision|0|||
162850879|NCT00961961|588158990|FG002|Phase I|Physician Decision|0|||
162850880|NCT00961961|588158991|FG003|Phase I|Physician Decision|0|||
162850881|NCT00961961|588158988|FG000|Phase II|Lost to Follow-up|0|||
162850882|NCT00961961|588158989|FG001|Phase II|Lost to Follow-up|0|||
162850883|NCT00961961|588158990|FG002|Phase II|Lost to Follow-up|10|||
162850884|NCT00961961|588158991|FG003|Phase II|Lost to Follow-up|7|||
162850885|NCT00961961|588158988|FG000|Phase II|Adverse Event|0|||
162850886|NCT00961961|588158989|FG001|Phase II|Adverse Event|0|||
162850887|NCT00961961|588158990|FG002|Phase II|Adverse Event|0|||
162850888|NCT00961961|588158991|FG003|Phase II|Adverse Event|1|||
162850889|NCT00961961|588158988|FG000|Phase II|Physician Decision|0|||
162850890|NCT00961961|588158989|FG001|Phase II|Physician Decision|0|||
162850891|NCT00961961|588158990|FG002|Phase II|Physician Decision|1|||
162850892|NCT00961961|588158991|FG003|Phase II|Physician Decision|0|||
162850893|NCT00961961|588158988|FG000|Phase II|Withdrawal by Subject|0|||
162850894|NCT00961961|588158989|FG001|Phase II|Withdrawal by Subject|0|||
162850895|NCT00961961|588158990|FG002|Phase II|Withdrawal by Subject|1|||
162850896|NCT00961961|588158991|FG003|Phase II|Withdrawal by Subject|0|||
162850897|NCT01412957|588158992|FG000|Overall Study|Withdrawal by Subject|6|||
162850898|NCT01412957|588158993|FG001|Overall Study|Withdrawal by Subject|22|||
162850899|NCT01412957|588158992|FG000|Overall Study|Lost to Follow-up|7|||
162850900|NCT01412957|588158993|FG001|Overall Study|Lost to Follow-up|2|||
162850901|NCT01412957|588158992|FG000|Overall Study|Death|136|||
162850902|NCT01412957|588158993|FG001|Overall Study|Death|133|||
162850903|NCT01926626|588159013|FG000|Overall Study|Withdrawal by Subject|15|||
162850904|NCT01926626|588159013|FG000|Overall Study|Lost to Follow-up|7|||
162850905|NCT03636906|588159014|FG000|Overall Study|Adverse Event|0|||
162850906|NCT03636906|588159015|FG001|Overall Study|Adverse Event|0|||
162850907|NCT03636906|588159016|FG002|Overall Study|Adverse Event|1|||
162850908|NCT03636906|588159014|FG000|Overall Study|Lost to Follow-up|1|||
162850909|NCT03636906|588159015|FG001|Overall Study|Lost to Follow-up|0|||
162850910|NCT03636906|588159016|FG002|Overall Study|Lost to Follow-up|0|||
162850911|NCT03636906|588159014|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
162850912|NCT03636906|588159015|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
162850913|NCT03636906|588159016|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
162850914|NCT03636906|588159014|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
162850915|NCT03636906|588159015|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
162850916|NCT03636906|588159016|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
162850917|NCT03636906|588159014|FG000|Overall Study|Other|0|||
162850918|NCT03636906|588159015|FG001|Overall Study|Other|0|||
162850919|NCT03636906|588159016|FG002|Overall Study|Other|1|||
162850920|NCT02292771|588159022|FG000|Overall Study|Withdrawal by Subject|2|||
162850921|NCT02292771|588159023|FG001|Overall Study|Withdrawal by Subject|1|||
162850922|NCT02292771|588159022|FG000|Overall Study|Lost to Follow-up|2|||
162850923|NCT02292771|588159023|FG001|Overall Study|Lost to Follow-up|1|||
162850924|NCT04280081|588159025|FG000|Overall Study|Adverse Event|4|||
162850925|NCT04280081|588159025|FG000|Overall Study|Death|2|||
162850926|NCT04280081|588159025|FG000|Overall Study|Progressive Disease|6|||
162850927|NCT01468311|588159026|FG000|Overall Study|mobilization failure|1|||
162850928|NCT01468311|588159026|FG000|Overall Study|Withdrawal by Subject|1|||
162850929|NCT06001307|588160365|FG000|Overall Study|Lost to Follow-up|1|||
162850930|NCT06001307|588160366|FG001|Overall Study|Lost to Follow-up|2|||
162850931|NCT03532100|588160369|FG000|Overall Study|Intervention malfunction|1|||
162850932|NCT03896581|588160370|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
162850933|NCT03896581|588160371|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
162850934|NCT03896581|588160370|FG000|Overall Study|Withdrawal by Subject|4|||
162850935|NCT03896581|588160371|FG001|Overall Study|Withdrawal by Subject|1|||
162850936|NCT03896581|588160370|FG000|Overall Study|Lost to Follow-up|1|||
162850937|NCT03896581|588160371|FG001|Overall Study|Lost to Follow-up|0|||
162850938|NCT03896581|588160370|FG000|Overall Study|Lack of Efficacy|2|||
162850939|NCT03896581|588160371|FG001|Overall Study|Lack of Efficacy|1|||
162850940|NCT03896581|588160370|FG000|Overall Study|Adverse event, non-fatal|0|||
162850941|NCT03896581|588160371|FG001|Overall Study|Adverse event, non-fatal|2|||
162850942|NCT00162773|588160378|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
162850943|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
162850944|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
162850945|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
162850946|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
162850947|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
162850948|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
162850949|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
162850950|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
162850951|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
162850952|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
162850953|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
162850954|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
162850955|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
162850956|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
162850957|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
162850958|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
162850959|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
162850960|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
162850961|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
162850962|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
162850963|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
162850964|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
162850965|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
162850966|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
162850967|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
162850968|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
162850969|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
162850970|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
162850971|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
162850972|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
162850973|NCT02660580|588160383|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
162850974|NCT02660580|588160384|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
162850975|NCT02660580|588160385|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
162850976|NCT02660580|588160386|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
162850977|NCT02660580|588160387|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
162850978|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
162850979|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
162850980|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
162850981|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
162850982|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
162850983|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
162850984|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
162850985|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
162850986|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
162850987|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
162850988|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
162850989|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
162850990|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
162850991|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
162850992|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
162850993|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
162850994|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
162850995|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
162850996|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
162850997|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
162850998|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
162850999|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
162851000|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
162851001|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
162851002|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
162851003|NCT02660580|588160383|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
162851004|NCT02660580|588160384|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
162851005|NCT02660580|588160385|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
162851006|NCT02660580|588160386|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
162851007|NCT02660580|588160387|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
162851008|NCT05415449|588160388|FG000|Overall Study|Lost to Follow-up|2|||
162851009|NCT05415449|588160388|FG000|Overall Study|Withdrawal by Subject|4|||
162851010|NCT02185521|588160391|FG000|Overall Study|Withdrawal by Subject|1|||
162851011|NCT02185521|588160391|FG000|Overall Study|Protocol Violation|1|||
162851012|NCT01028352|588160395|FG000|Overall Study|Ineligible due to baseline average pain|5|||
162851013|NCT01028352|588160395|FG000|Overall Study|Withdrawal by Subject|1|||
162851014|NCT01903876|588160396|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
162851015|NCT01903876|588160397|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
162851016|NCT01903876|588160396|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
162851017|NCT01903876|588160397|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
162851018|NCT00826748|588160408|FG000|Overall Study|Withdrawal by Subject|0|||
162851019|NCT00826748|588160409|FG001|Overall Study|Withdrawal by Subject|0|||
162851020|NCT00826748|588160410|FG002|Overall Study|Withdrawal by Subject|2|||
162851021|NCT00826748|588160408|FG000|Overall Study|Physician Decision|0|||
162851022|NCT00826748|588160409|FG001|Overall Study|Physician Decision|0|||
162851023|NCT00826748|588160410|FG002|Overall Study|Physician Decision|1|||
162851024|NCT00826748|588160408|FG000|Overall Study|Samples Did Not pass QC|0|||
162851025|NCT00826748|588160409|FG001|Overall Study|Samples Did Not pass QC|0|||
162851026|NCT00826748|588160410|FG002|Overall Study|Samples Did Not pass QC|1|||
162851027|NCT02300129|588160412|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
162851028|NCT02300129|588160413|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
162851029|NCT02300129|588160414|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
162851030|NCT02300129|588160415|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
162851031|NCT02300129|588160412|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
162851032|NCT02300129|588160413|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
162851033|NCT02300129|588160414|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
162851034|NCT02300129|588160415|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
162851035|NCT02300129|588160412|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
162851036|NCT02300129|588160413|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
162851037|NCT02300129|588160414|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
162851038|NCT02300129|588160415|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
162851039|NCT01887912|588160416|FG000|Overall Study|Serious adverse event|400|||
162851040|NCT01887912|588160417|FG001|Overall Study|Serious adverse event|198|||
162851041|NCT01887912|588160416|FG000|Overall Study|Other Adverse Event|34|||
162851042|NCT01887912|588160417|FG001|Overall Study|Other Adverse Event|15|||
162851043|NCT01887912|588160416|FG000|Overall Study|Protocol Violation|67|||
162851044|NCT01887912|588160417|FG001|Overall Study|Protocol Violation|37|||
162851045|NCT01887912|588160416|FG000|Overall Study|Lost to Follow-up|163|||
162851046|NCT01887912|588160417|FG001|Overall Study|Lost to Follow-up|74|||
162851047|NCT01887912|588160416|FG000|Overall Study|Withdrawal by Subject|606|||
162851048|NCT01887912|588160417|FG001|Overall Study|Withdrawal by Subject|349|||
162851049|NCT01887912|588160416|FG000|Overall Study|Other|122|||
162851050|NCT01887912|588160417|FG001|Overall Study|Other|58|||
162851051|NCT04462536|588160418|FG000|Overall Study|Withdrawal by Subject|3|||
162851052|NCT04462536|588160419|FG001|Overall Study|Withdrawal by Subject|9|||
162851053|NCT04462536|588160418|FG000|Overall Study|Lost to Follow-up|2|||
162851054|NCT04462536|588160419|FG001|Overall Study|Lost to Follow-up|4|||
162851055|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
162851056|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
162851057|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
162851058|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
162851059|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
162851060|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
162851061|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
162851062|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
162851063|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
162851064|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
162851065|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
162851066|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
162851067|NCT02747927|588160420|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
162851068|NCT02747927|588160421|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
162851069|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
162851070|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
162851071|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
162851072|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
162851073|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
162851074|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
162851075|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
162851076|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
162851077|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
162851078|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
162953831|NCT01466166|588536176|FG000|Overall Study|Lost to Follow-up|7|||
162851079|NCT02747927|588160420|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
162851080|NCT02747927|588160421|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
162953832|NCT01466166|588536176|FG000|Overall Study|Infusion Reaction (IR)|27|||
162953833|NCT01466166|588536176|FG000|Overall Study|Adverse Event (Other than IR)|11|||
162851081|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
162851082|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
162851083|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
162851084|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
162851085|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
162851086|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
162851087|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
162851088|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
162851089|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
162851090|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
162851091|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
162851092|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
162851093|NCT02747927|588160420|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
162851094|NCT02747927|588160421|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
162851095|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
162851096|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
162851097|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
162851098|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
162851099|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
162851100|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
162851101|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
162851102|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
162851103|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
162851104|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
162851105|NCT02747927|588160420|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
162851106|NCT02747927|588160421|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
162851107|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
162851108|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
162851109|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
162851110|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
162851111|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
162851112|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
162851113|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
162851114|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
162851115|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
162851116|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
162851117|NCT02747927|588160420|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
162851118|NCT02747927|588160421|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
162851119|NCT00450580|588160424|FG000|Overall Study|Adverse Event|5|||
162851120|NCT00450580|588160425|FG001|Overall Study|Adverse Event|7|||
162851121|NCT00450580|588160424|FG000|Overall Study|Lost to Follow-up|4|||
162851122|NCT00450580|588160425|FG001|Overall Study|Lost to Follow-up|5|||
162851123|NCT00450580|588160424|FG000|Overall Study|Withdrawal by Subject|2|||
162851124|NCT00450580|588160425|FG001|Overall Study|Withdrawal by Subject|2|||
162851125|NCT00450580|588160424|FG000|Overall Study|Protocol Violation|1|||
162851126|NCT00450580|588160425|FG001|Overall Study|Protocol Violation|1|||
162851127|NCT00450580|588160424|FG000|Overall Study|Protocol-defined virologic failure|1|||
162851128|NCT00450580|588160425|FG001|Overall Study|Protocol-defined virologic failure|0|||
162851129|NCT00450580|588160424|FG000|Overall Study|Could not comply with scheduled visits|1|||
162851130|NCT00450580|588160425|FG001|Overall Study|Could not comply with scheduled visits|0|||
162851131|NCT00450580|588160424|FG000|Overall Study|Patient went to Brazil|1|||
162851132|NCT00450580|588160425|FG001|Overall Study|Patient went to Brazil|0|||
162851133|NCT00450580|588160424|FG000|Overall Study|Patient could not swallow Norvir|1|||
162851134|NCT00450580|588160425|FG001|Overall Study|Patient could not swallow Norvir|0|||
162851135|NCT00450580|588160424|FG000|Overall Study|Withdrawal due to pregnancy|0|||
162851136|NCT00450580|588160425|FG001|Overall Study|Withdrawal due to pregnancy|1|||
162851137|NCT00332709|588160434|FG000|Overall Study|Adverse Event|11|||
162851138|NCT00332709|588160435|FG001|Overall Study|Adverse Event|14|||
162851139|NCT00332709|588160434|FG000|Overall Study|Withdrawal by Subject|2|||
162851140|NCT00332709|588160435|FG001|Overall Study|Withdrawal by Subject|3|||
162851141|NCT00332709|588160434|FG000|Overall Study|Lost to Follow-up|2|||
162851142|NCT00332709|588160435|FG001|Overall Study|Lost to Follow-up|0|||
162953834|NCT01466166|588536176|FG000|Overall Study|Elevated Serum Uric Acid|78|||
162953835|NCT01466166|588536176|FG000|Overall Study|Withdrawal by Subject|13|||
162953836|NCT01466166|588536176|FG000|Overall Study|Sponsor Decision|4|||
162851143|NCT00332709|588160434|FG000|Overall Study|Administrative Problems|0|||
162851144|NCT00332709|588160435|FG001|Overall Study|Administrative Problems|3|||
162851145|NCT00332709|588160434|FG000|Overall Study|Abnormal test procedure result|1|||
162851146|NCT00332709|588160435|FG001|Overall Study|Abnormal test procedure result|0|||
162851147|NCT03480802|588160436|FG000|Overall Study|Lost to Follow-up|5|||
162851148|NCT03480802|588160437|FG001|Overall Study|Lost to Follow-up|1|||
162851149|NCT03480802|588160436|FG000|Overall Study|Withdrawal by Subject|2|||
162851150|NCT03480802|588160437|FG001|Overall Study|Withdrawal by Subject|1|||
162851151|NCT03480802|588160436|FG000|Overall Study|Relocated|0|||
162851152|NCT03480802|588160437|FG001|Overall Study|Relocated|1|||
162851153|NCT00988247|588160438|FG000|Overall Study|Adverse Event|17|||
162851154|NCT00988247|588160439|FG001|Overall Study|Adverse Event|3|||
162851155|NCT00988247|588160438|FG000|Overall Study|Withdrawal by Subject|44|||
162851156|NCT00988247|588160439|FG001|Overall Study|Withdrawal by Subject|13|||
162851157|NCT00988247|588160438|FG000|Overall Study|Pregnancy|1|||
162851158|NCT00988247|588160439|FG001|Overall Study|Pregnancy|2|||
162851159|NCT00988247|588160438|FG000|Overall Study|Lost to Follow-up|11|||
162851160|NCT00988247|588160439|FG001|Overall Study|Lost to Follow-up|2|||
162851161|NCT00988247|588160438|FG000|Overall Study|Protocol Violation|4|||
162851162|NCT00988247|588160439|FG001|Overall Study|Protocol Violation|5|||
162851163|NCT00988247|588160438|FG000|Overall Study|Sponsor requested withdrawal|3|||
162851164|NCT00988247|588160439|FG001|Overall Study|Sponsor requested withdrawal|1|||
162851165|NCT00988247|588160438|FG000|Overall Study|Other|3|||
162851166|NCT00988247|588160439|FG001|Overall Study|Other|0|||
162851167|NCT01409928|588160440|FG000|Overall Study|Physician Decision|12|||
162851168|NCT02661594|588160441|FG000|Overall Study|Protocol Violation|1|||
162851169|NCT02661594|588160442|FG001|Overall Study|Protocol Violation|0|||
162851170|NCT02661594|588160443|FG002|Overall Study|Protocol Violation|1|||
162851171|NCT02661594|588160444|FG003|Overall Study|Protocol Violation|0|||
162851172|NCT01169779|588160449|FG000|Overall Study|Adverse Event|3|||
162851173|NCT01169779|588160450|FG001|Overall Study|Adverse Event|11|||
162851174|NCT01169779|588160449|FG000|Overall Study|Lack of Efficacy|1|||
162851175|NCT01169779|588160450|FG001|Overall Study|Lack of Efficacy|0|||
162851176|NCT01169779|588160449|FG000|Overall Study|Protocol Violation|1|||
162851177|NCT01169779|588160450|FG001|Overall Study|Protocol Violation|1|||
162851178|NCT01169779|588160449|FG000|Overall Study|Withdrawal by Subject|3|||
162851179|NCT01169779|588160450|FG001|Overall Study|Withdrawal by Subject|2|||
162851180|NCT01169779|588160449|FG000|Overall Study|Familial and personal reasons|3|||
162851181|NCT01169779|588160450|FG001|Overall Study|Familial and personal reasons|3|||
162851182|NCT00432237|588160453|FG000|Overall Study|Adverse Event|0|||
162851183|NCT00432237|588160454|FG001|Overall Study|Adverse Event|0|||
162851184|NCT00432237|588160455|FG002|Overall Study|Adverse Event|0|||
162851185|NCT00432237|588160456|FG003|Overall Study|Adverse Event|1|||
162851186|NCT00432237|588160453|FG000|Overall Study|Lack of Efficacy|0|||
162851187|NCT00432237|588160454|FG001|Overall Study|Lack of Efficacy|0|||
162851188|NCT00432237|588160455|FG002|Overall Study|Lack of Efficacy|0|||
162851189|NCT00432237|588160456|FG003|Overall Study|Lack of Efficacy|1|||
162851190|NCT00432237|588160453|FG000|Overall Study|Lost to Follow-up|10|||
162851191|NCT00432237|588160454|FG001|Overall Study|Lost to Follow-up|10|||
162851192|NCT00432237|588160455|FG002|Overall Study|Lost to Follow-up|18|||
162851193|NCT00432237|588160456|FG003|Overall Study|Lost to Follow-up|18|||
162851194|NCT00432237|588160453|FG000|Overall Study|Physician Decision|1|||
162851195|NCT00432237|588160454|FG001|Overall Study|Physician Decision|3|||
162851196|NCT00432237|588160455|FG002|Overall Study|Physician Decision|2|||
162851197|NCT00432237|588160456|FG003|Overall Study|Physician Decision|1|||
162851198|NCT00432237|588160453|FG000|Overall Study|Pregnancy|0|||
162851199|NCT00432237|588160454|FG001|Overall Study|Pregnancy|1|||
162851200|NCT00432237|588160455|FG002|Overall Study|Pregnancy|0|||
162851201|NCT00432237|588160456|FG003|Overall Study|Pregnancy|0|||
162851202|NCT00432237|588160453|FG000|Overall Study|Protocol Violation|13|||
162851203|NCT00432237|588160454|FG001|Overall Study|Protocol Violation|10|||
162851204|NCT00432237|588160455|FG002|Overall Study|Protocol Violation|11|||
162851205|NCT00432237|588160456|FG003|Overall Study|Protocol Violation|8|||
162851206|NCT00432237|588160453|FG000|Overall Study|Withdrawal by Subject|5|||
162851207|NCT00432237|588160454|FG001|Overall Study|Withdrawal by Subject|6|||
162851208|NCT00432237|588160455|FG002|Overall Study|Withdrawal by Subject|9|||
162851209|NCT00432237|588160456|FG003|Overall Study|Withdrawal by Subject|11|||
162851210|NCT00432237|588160453|FG000|Overall Study|Lack of Qualifying Event|38|||
162851211|NCT00432237|588160454|FG001|Overall Study|Lack of Qualifying Event|71|||
162851212|NCT00432237|588160455|FG002|Overall Study|Lack of Qualifying Event|69|||
162851213|NCT00432237|588160456|FG003|Overall Study|Lack of Qualifying Event|84|||
162851214|NCT01354132|588160457|FG000|Randomization|Physician Decision|1|||
162851215|NCT01354132|588160458|FG001|Randomization|Physician Decision|0|||
162851216|NCT01354132|588160457|FG000|Randomization|Withdrawal by Subject|0|||
162851217|NCT01354132|588160458|FG001|Randomization|Withdrawal by Subject|1|||
162851218|NCT01354132|588160457|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
162851219|NCT01354132|588160458|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
162851220|NCT01354132|588160457|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
162851221|NCT01354132|588160458|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
162851222|NCT01354132|588160457|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
162851223|NCT01354132|588160458|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
162851224|NCT00191854|588160461|FG000|Overall Study|Death|26|||
162851225|NCT00191854|588160462|FG001|Overall Study|Death|23|||
162851226|NCT00191854|588160463|FG002|Overall Study|Death|29|||
162851227|NCT00191854|588160461|FG000|Overall Study|Lost to Follow-up|7|||
162851228|NCT00191854|588160462|FG001|Overall Study|Lost to Follow-up|5|||
162851229|NCT00191854|588160463|FG002|Overall Study|Lost to Follow-up|5|||
162851230|NCT00191854|588160461|FG000|Overall Study|Withdrawal by Subject|4|||
162851231|NCT00191854|588160462|FG001|Overall Study|Withdrawal by Subject|2|||
162851232|NCT00191854|588160463|FG002|Overall Study|Withdrawal by Subject|3|||
162851233|NCT00191854|588160461|FG000|Overall Study|Sponsor Decision|0|||
162851234|NCT00191854|588160462|FG001|Overall Study|Sponsor Decision|0|||
162851235|NCT00191854|588160463|FG002|Overall Study|Sponsor Decision|1|||
162851236|NCT00191854|588160461|FG000|Overall Study|Screen Failure|0|||
162851237|NCT00191854|588160462|FG001|Overall Study|Screen Failure|0|||
162851238|NCT00191854|588160463|FG002|Overall Study|Screen Failure|1|||
162851239|NCT01933932|588160466|FG000|Overall Study|Death|173|||
162851240|NCT01933932|588160467|FG001|Overall Study|Death|163|||
162851241|NCT01933932|588160466|FG000|Overall Study|Withdrawal by Subject|11|||
162851242|NCT01933932|588160467|FG001|Overall Study|Withdrawal by Subject|14|||
162851243|NCT01933932|588160466|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162851244|NCT01933932|588160467|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162851245|NCT00486603|588160471|FG000|Overall Study|Withdrawal by Subject|1|||
162851246|NCT00486603|588160472|FG001|Overall Study|Withdrawal by Subject|0|||
162851247|NCT00486603|588160473|FG002|Overall Study|Withdrawal by Subject|0|||
162851248|NCT00486603|588160474|FG003|Overall Study|Withdrawal by Subject|0|||
162851249|NCT00486603|588160475|FG004|Overall Study|Withdrawal by Subject|0|||
162851250|NCT00486603|588160471|FG000|Overall Study|Physician Decision|0|||
162851251|NCT00486603|588160472|FG001|Overall Study|Physician Decision|1|||
162851252|NCT00486603|588160473|FG002|Overall Study|Physician Decision|0|||
162851253|NCT00486603|588160474|FG003|Overall Study|Physician Decision|0|||
162851254|NCT00486603|588160475|FG004|Overall Study|Physician Decision|0|||
162851255|NCT00763009|588160478|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
162851256|NCT02013544|588160479|FG000|Overall Study|Adverse Event|5|||
162851257|NCT02013544|588160480|FG001|Overall Study|Adverse Event|5|||
162851258|NCT02013544|588160479|FG000|Overall Study|Lost to Follow-up|2|||
162851259|NCT02013544|588160480|FG001|Overall Study|Lost to Follow-up|3|||
162851260|NCT02013544|588160479|FG000|Overall Study|Withdrawal by Subject|2|||
162851261|NCT02013544|588160480|FG001|Overall Study|Withdrawal by Subject|8|||
162851262|NCT02013544|588160479|FG000|Overall Study|Physician Decision|0|||
162851263|NCT02013544|588160480|FG001|Overall Study|Physician Decision|1|||
162851264|NCT02013544|588160479|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
162851265|NCT02013544|588160480|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
162851266|NCT01360996|588160492|FG000|Overall Study|Withdrawal by Subject|4|||
162851267|NCT01360996|588160493|FG001|Overall Study|Withdrawal by Subject|3|||
162851268|NCT01360996|588160494|FG002|Overall Study|Withdrawal by Subject|2|||
162851269|NCT01360996|588160492|FG000|Overall Study|Noncompliant|2|||
162851270|NCT01360996|588160493|FG001|Overall Study|Noncompliant|0|||
162851271|NCT01360996|588160494|FG002|Overall Study|Noncompliant|0|||
162851272|NCT01454076|588160495|FG000|Overall Study|Other|2|||
162851273|NCT01454076|588160496|FG001|Overall Study|Other|0|||
162851274|NCT01454076|588160497|FG002|Overall Study|Other|0|||
162851275|NCT01454076|588160498|FG003|Overall Study|Other|1|||
162851276|NCT01454076|588160499|FG004|Overall Study|Other|2|||
162851277|NCT01454076|588160495|FG000|Overall Study|Withdrawal by Subject|3|||
162851278|NCT01454076|588160496|FG001|Overall Study|Withdrawal by Subject|4|||
162851279|NCT01454076|588160497|FG002|Overall Study|Withdrawal by Subject|2|||
162851280|NCT01454076|588160498|FG003|Overall Study|Withdrawal by Subject|1|||
162851281|NCT01454076|588160499|FG004|Overall Study|Withdrawal by Subject|2|||
162851282|NCT01454076|588160495|FG000|Overall Study|Adverse Event|8|||
162851283|NCT01454076|588160496|FG001|Overall Study|Adverse Event|2|||
162851284|NCT01454076|588160497|FG002|Overall Study|Adverse Event|7|||
162851285|NCT01454076|588160498|FG003|Overall Study|Adverse Event|0|||
162851286|NCT01454076|588160499|FG004|Overall Study|Adverse Event|2|||
162953837|NCT01466166|588536176|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
162851287|NCT04525703|588160500|FG000|Overall Study|Lost to Follow-up|6|||
162851288|NCT04525703|588160501|FG001|Overall Study|Lost to Follow-up|15|||
162851289|NCT04525703|588160502|FG002|Overall Study|Lost to Follow-up|8|||
162851290|NCT01870739|588160511|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
162851291|NCT01870739|588160512|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
162953838|NCT01466166|588536176|FG000|Overall Study|Other|20|||
162851292|NCT01870739|588160511|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
162851293|NCT01870739|588160512|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
162851294|NCT01870739|588160511|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
162851295|NCT01870739|588160512|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
162851296|NCT01870739|588160511|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
162953839|NCT02262377|588536177|FG000|Overall Study|Lost to Follow-up|5|||
162851297|NCT01870739|588160512|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
162851298|NCT01870739|588160511|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
162851299|NCT01870739|588160512|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
162851300|NCT01870739|588160511|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
162851301|NCT01870739|588160512|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
162851302|NCT01870739|588160511|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
162851303|NCT01870739|588160512|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
162851304|NCT02425098|588160513|FG000|Overall Study|Lost to Follow-up|7|||
162851305|NCT02425098|588160514|FG001|Overall Study|Lost to Follow-up|7|||
162851306|NCT02425098|588160513|FG000|Overall Study|Withdrawal by Subject|4|||
162851307|NCT02425098|588160514|FG001|Overall Study|Withdrawal by Subject|8|||
162851308|NCT02425098|588160513|FG000|Overall Study|Pregnancy|2|||
162851309|NCT02425098|588160514|FG001|Overall Study|Pregnancy|0|||
162851310|NCT02425098|588160513|FG000|Overall Study|Reason not Specified|0|||
162851311|NCT02425098|588160514|FG001|Overall Study|Reason not Specified|1|||
162851312|NCT04854499|588162559|FG000|Overall Study|Study Terminated by Sponsor|5|||
162851313|NCT04854499|588162560|FG001|Overall Study|Study Terminated by Sponsor|27|||
162851314|NCT04854499|588162561|FG002|Overall Study|Study Terminated by Sponsor|28|||
162851315|NCT04854499|588162562|FG003|Overall Study|Study Terminated by Sponsor|19|||
162851316|NCT04854499|588162563|FG004|Overall Study|Study Terminated by Sponsor|1|||
162851317|NCT04854499|588162564|FG005|Overall Study|Study Terminated by Sponsor|10|||
162851318|NCT04854499|588162559|FG000|Overall Study|Death|1|||
162851319|NCT04854499|588162560|FG001|Overall Study|Death|23|||
162851320|NCT04854499|588162561|FG002|Overall Study|Death|21|||
162851321|NCT04854499|588162562|FG003|Overall Study|Death|7|||
162851322|NCT04854499|588162563|FG004|Overall Study|Death|6|||
162851323|NCT04854499|588162564|FG005|Overall Study|Death|24|||
162851324|NCT04854499|588162559|FG000|Overall Study|Investigator's Discretion|0|||
162851325|NCT04854499|588162560|FG001|Overall Study|Investigator's Discretion|1|||
162851326|NCT04854499|588162561|FG002|Overall Study|Investigator's Discretion|3|||
162851327|NCT04854499|588162562|FG003|Overall Study|Investigator's Discretion|4|||
162851328|NCT04854499|588162563|FG004|Overall Study|Investigator's Discretion|1|||
162851329|NCT04854499|588162564|FG005|Overall Study|Investigator's Discretion|5|||
162851330|NCT04854499|588162559|FG000|Overall Study|Withdrew Consent|0|||
162851331|NCT04854499|588162560|FG001|Overall Study|Withdrew Consent|1|||
162851332|NCT04854499|588162561|FG002|Overall Study|Withdrew Consent|2|||
162851333|NCT04854499|588162562|FG003|Overall Study|Withdrew Consent|2|||
162851334|NCT04854499|588162563|FG004|Overall Study|Withdrew Consent|0|||
162851335|NCT04854499|588162564|FG005|Overall Study|Withdrew Consent|1|||
162851336|NCT04854499|588162559|FG000|Overall Study|Lost to Follow-up|0|||
162851337|NCT04854499|588162560|FG001|Overall Study|Lost to Follow-up|0|||
162851338|NCT04854499|588162561|FG002|Overall Study|Lost to Follow-up|0|||
162851339|NCT04854499|588162562|FG003|Overall Study|Lost to Follow-up|0|||
162851340|NCT04854499|588162563|FG004|Overall Study|Lost to Follow-up|0|||
162851341|NCT04854499|588162564|FG005|Overall Study|Lost to Follow-up|1|||
162851342|NCT02601950|588162571|FG000|Overall Study|Participant enrolled in rollover study|0|||
162851343|NCT02601950|588162572|FG001|Overall Study|Participant enrolled in rollover study|0|||
162851344|NCT02601950|588162573|FG002|Overall Study|Participant enrolled in rollover study|1|||
162851345|NCT02601950|588162574|FG003|Overall Study|Participant enrolled in rollover study|0|||
162851346|NCT02601950|588162575|FG004|Overall Study|Participant enrolled in rollover study|1|||
162851347|NCT02601950|588162576|FG005|Overall Study|Participant enrolled in rollover study|1|||
162851348|NCT02601950|588162577|FG006|Overall Study|Participant enrolled in rollover study|1|||
162851349|NCT02601950|588162578|FG007|Overall Study|Participant enrolled in rollover study|0|||
162851350|NCT02601950|588162571|FG000|Overall Study|Disease progression - radiological|21|||
162851351|NCT02601950|588162572|FG001|Overall Study|Disease progression - radiological|26|||
162851352|NCT02601950|588162573|FG002|Overall Study|Disease progression - radiological|22|||
162851353|NCT02601950|588162574|FG003|Overall Study|Disease progression - radiological|11|||
162851354|NCT02601950|588162575|FG004|Overall Study|Disease progression - radiological|46|||
162851355|NCT02601950|588162576|FG005|Overall Study|Disease progression - radiological|52|||
162851356|NCT02601950|588162577|FG006|Overall Study|Disease progression - radiological|7|||
162851357|NCT02601950|588162578|FG007|Overall Study|Disease progression - radiological|5|||
162851358|NCT02601950|588162571|FG000|Overall Study|Disease progression - clinical|3|||
162851359|NCT02601950|588162572|FG001|Overall Study|Disease progression - clinical|5|||
162851360|NCT02601950|588162573|FG002|Overall Study|Disease progression - clinical|4|||
162851361|NCT02601950|588162574|FG003|Overall Study|Disease progression - clinical|2|||
162851362|NCT02601950|588162575|FG004|Overall Study|Disease progression - clinical|6|||
162851363|NCT02601950|588162576|FG005|Overall Study|Disease progression - clinical|6|||
162851364|NCT02601950|588162577|FG006|Overall Study|Disease progression - clinical|5|||
162851365|NCT02601950|588162578|FG007|Overall Study|Disease progression - clinical|1|||
162851366|NCT02601950|588162571|FG000|Overall Study|Death|6|||
162851367|NCT02601950|588162572|FG001|Overall Study|Death|0|||
162851368|NCT02601950|588162573|FG002|Overall Study|Death|3|||
162851369|NCT02601950|588162574|FG003|Overall Study|Death|1|||
162851370|NCT02601950|588162575|FG004|Overall Study|Death|4|||
162851371|NCT02601950|588162576|FG005|Overall Study|Death|1|||
162851372|NCT02601950|588162577|FG006|Overall Study|Death|0|||
162851373|NCT02601950|588162578|FG007|Overall Study|Death|0|||
162851374|NCT02601950|588162571|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851375|NCT02601950|588162572|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851376|NCT02601950|588162573|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851377|NCT02601950|588162574|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851378|NCT02601950|588162575|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851379|NCT02601950|588162576|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
162851380|NCT02601950|588162577|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162851381|NCT02601950|588162578|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
162704261|NCT01923428|587628939|FG003|Overall Study|Withdrawal by Subject|4|||
162704262|NCT01923428|587628936|FG000|Overall Study|Lost to Follow-up|2|||
162704263|NCT01923428|587628937|FG001|Overall Study|Lost to Follow-up|1|||
162851382|NCT02601950|588162571|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
162851383|NCT02601950|588162572|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
162851384|NCT02601950|588162573|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
162851385|NCT02601950|588162574|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
162851386|NCT02601950|588162575|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
162851387|NCT02601950|588162576|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
162851388|NCT02601950|588162577|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
162851389|NCT02601950|588162578|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
162851390|NCT02601950|588162571|FG000|Overall Study|Non-compliance|0|||
162851391|NCT02601950|588162572|FG001|Overall Study|Non-compliance|1|||
162851392|NCT02601950|588162573|FG002|Overall Study|Non-compliance|0|||
162851393|NCT02601950|588162574|FG003|Overall Study|Non-compliance|0|||
162851394|NCT02601950|588162575|FG004|Overall Study|Non-compliance|0|||
162851395|NCT02601950|588162576|FG005|Overall Study|Non-compliance|1|||
162851396|NCT02601950|588162577|FG006|Overall Study|Non-compliance|1|||
162851397|NCT02601950|588162578|FG007|Overall Study|Non-compliance|0|||
162851398|NCT02601950|588162571|FG000|Overall Study|Participant refused further study treatment|0|||
162851399|NCT02601950|588162572|FG001|Overall Study|Participant refused further study treatment|1|||
162851400|NCT02601950|588162573|FG002|Overall Study|Participant refused further study treatment|1|||
162851401|NCT02601950|588162574|FG003|Overall Study|Participant refused further study treatment|0|||
162851402|NCT02601950|588162575|FG004|Overall Study|Participant refused further study treatment|2|||
162851403|NCT02601950|588162576|FG005|Overall Study|Participant refused further study treatment|2|||
162851404|NCT02601950|588162577|FG006|Overall Study|Participant refused further study treatment|2|||
162851405|NCT02601950|588162578|FG007|Overall Study|Participant refused further study treatment|1|||
162851406|NCT02601950|588162571|FG000|Overall Study|Investigator discretion|1|||
162851407|NCT02601950|588162572|FG001|Overall Study|Investigator discretion|0|||
162851408|NCT02601950|588162573|FG002|Overall Study|Investigator discretion|1|||
162851409|NCT02601950|588162574|FG003|Overall Study|Investigator discretion|0|||
162851410|NCT02601950|588162575|FG004|Overall Study|Investigator discretion|1|||
162851411|NCT02601950|588162576|FG005|Overall Study|Investigator discretion|1|||
162851412|NCT02601950|588162577|FG006|Overall Study|Investigator discretion|1|||
162851413|NCT02601950|588162578|FG007|Overall Study|Investigator discretion|0|||
162851414|NCT02601950|588162571|FG000|Overall Study|Other|0|||
162851415|NCT02601950|588162572|FG001|Overall Study|Other|0|||
162851416|NCT02601950|588162573|FG002|Overall Study|Other|0|||
162851417|NCT02601950|588162574|FG003|Overall Study|Other|0|||
162851418|NCT02601950|588162575|FG004|Overall Study|Other|2|||
162953840|NCT02262377|588536178|FG001|Overall Study|Lost to Follow-up|6|||
162953841|NCT02262377|588536177|FG000|Overall Study|Found ineligible after enrollment|3|||
162953842|NCT02262377|588536178|FG001|Overall Study|Found ineligible after enrollment|0|||
162953843|NCT02262377|588536177|FG000|Overall Study|Withdrawal by Subject|4|||
162953844|NCT02262377|588536178|FG001|Overall Study|Withdrawal by Subject|0|||
162953845|NCT00371839|588536179|FG000|Overall Study|Death|4|||
162953846|NCT00371839|588536180|FG001|Overall Study|Death|0|||
162953847|NCT00371839|588536181|FG002|Overall Study|Death|0|||
162953848|NCT00371839|588536179|FG000|Overall Study|Withdrawal by Subject|7|||
162953849|NCT00371839|588536180|FG001|Overall Study|Withdrawal by Subject|4|||
162953850|NCT00371839|588536181|FG002|Overall Study|Withdrawal by Subject|0|||
162851419|NCT02601950|588162576|FG005|Overall Study|Other|2|||
162851420|NCT02601950|588162577|FG006|Overall Study|Other|1|||
162851421|NCT02601950|588162578|FG007|Overall Study|Other|0|||
162851422|NCT02157883|588162579|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
162851423|NCT02157883|588162579|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
162953851|NCT00371839|588536179|FG000|Overall Study|Lost to Follow-up|6|||
162704264|NCT01923428|587628938|FG002|Overall Study|Lost to Follow-up|5|||
162704265|NCT01923428|587628939|FG003|Overall Study|Lost to Follow-up|0|||
162704266|NCT01923428|587628936|FG000|Overall Study|Protocol Violation|3|||
162851424|NCT02157883|588162579|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
162953852|NCT00371839|588536180|FG001|Overall Study|Lost to Follow-up|3|||
162953853|NCT00371839|588536181|FG002|Overall Study|Lost to Follow-up|2|||
162953854|NCT01511939|588536182|FG000|Overall Study|Withdrawal by Subject|2|||
162953855|NCT01511939|588536183|FG001|Overall Study|Withdrawal by Subject|1|||
162953856|NCT01511939|588536184|FG002|Overall Study|Withdrawal by Subject|0|||
162953857|NCT01591785|588536185|FG000|Overall Study|worsening condition|1|||
162953858|NCT01591785|588536186|FG001|Overall Study|worsening condition|2|||
162953859|NCT01591785|588536185|FG000|Overall Study|Protocol Violation|2|||
162704267|NCT01923428|587628937|FG001|Overall Study|Protocol Violation|0|||
162704268|NCT01923428|587628938|FG002|Overall Study|Protocol Violation|2|||
162704269|NCT01923428|587628939|FG003|Overall Study|Protocol Violation|1|||
162704270|NCT01923428|587628936|FG000|Overall Study|Non Compliance to treatment|1|||
162704271|NCT01923428|587628937|FG001|Overall Study|Non Compliance to treatment|2|||
162704272|NCT01923428|587628938|FG002|Overall Study|Non Compliance to treatment|0|||
162704273|NCT01923428|587628939|FG003|Overall Study|Non Compliance to treatment|1|||
162704274|NCT01923428|587628936|FG000|Overall Study|Lack of Efficacy|0|||
162704275|NCT01923428|587628937|FG001|Overall Study|Lack of Efficacy|0|||
162704276|NCT01923428|587628938|FG002|Overall Study|Lack of Efficacy|1|||
162704277|NCT01923428|587628939|FG003|Overall Study|Lack of Efficacy|1|||
162704278|NCT02550873|587628940|FG000|Randomized Double Blind|Adverse Event|3|||
162704279|NCT02550873|587628941|FG001|Randomized Double Blind|Adverse Event|1|||
162704280|NCT02550873|587628942|FG002|Randomized Double Blind|Adverse Event|0|||
162704281|NCT02550873|587628940|FG000|Randomized Double Blind|Disease progression|1|||
162704282|NCT02550873|587628941|FG001|Randomized Double Blind|Disease progression|1|||
162704283|NCT02550873|587628942|FG002|Randomized Double Blind|Disease progression|0|||
162704284|NCT02550873|587628940|FG000|Open Label Extension|Study ongoing|0|||
162704285|NCT02550873|587628941|FG001|Open Label Extension|Study ongoing|0|||
162704286|NCT02550873|587628942|FG002|Open Label Extension|Study ongoing|111|||
162704287|NCT01822353|587628943|FG000|Overall Study|Adverse Event|1|||
162704288|NCT01822353|587628944|FG001|Overall Study|Adverse Event|3|||
162704289|NCT01822353|587628945|FG002|Overall Study|Adverse Event|1|||
162704290|NCT01822353|587628943|FG000|Overall Study|Pregnancy|0|||
162704291|NCT01822353|587628944|FG001|Overall Study|Pregnancy|1|||
162704292|NCT01822353|587628945|FG002|Overall Study|Pregnancy|0|||
162704293|NCT01822353|587628943|FG000|Overall Study|Withdrawal by Subject|3|||
162704294|NCT01822353|587628944|FG001|Overall Study|Withdrawal by Subject|1|||
162704295|NCT01822353|587628945|FG002|Overall Study|Withdrawal by Subject|0|||
162704296|NCT04320615|587628946|FG000|Overall Study|Withdrawal by Subject|4|||
162704297|NCT04320615|587628947|FG001|Overall Study|Withdrawal by Subject|10|||
162704298|NCT04320615|587628946|FG000|Overall Study|Physician Decision|2|||
162704299|NCT04320615|587628947|FG001|Overall Study|Physician Decision|0|||
162704300|NCT04320615|587628946|FG000|Overall Study|Other|2|||
162704301|NCT04320615|587628947|FG001|Overall Study|Other|0|||
162704302|NCT04320615|587628946|FG000|Overall Study|Lost to Follow-up|5|||
162704303|NCT04320615|587628947|FG001|Overall Study|Lost to Follow-up|23|||
162704304|NCT04320615|587628946|FG000|Overall Study|Death|35|||
162704305|NCT04320615|587628947|FG001|Overall Study|Death|71|||
162704306|NCT03873246|587628949|FG000|Overall Study|Adverse Event|1|||
162704307|NCT03873246|587628950|FG001|Overall Study|Adverse Event|3|||
162704308|NCT03873246|587628951|FG002|Overall Study|Adverse Event|3|||
162704309|NCT03873246|587628949|FG000|Overall Study|Lost to Follow-up|4|||
162704310|NCT03873246|587628950|FG001|Overall Study|Lost to Follow-up|4|||
162704311|NCT03873246|587628951|FG002|Overall Study|Lost to Follow-up|5|||
162704312|NCT03873246|587628949|FG000|Overall Study|Protocol Violation|0|||
162704313|NCT03873246|587628950|FG001|Overall Study|Protocol Violation|1|||
162704314|NCT03873246|587628951|FG002|Overall Study|Protocol Violation|0|||
162704315|NCT03873246|587628949|FG000|Overall Study|Withdrawal by Subject|0|||
162704316|NCT03873246|587628950|FG001|Overall Study|Withdrawal by Subject|4|||
162704317|NCT03873246|587628951|FG002|Overall Study|Withdrawal by Subject|1|||
162704318|NCT00885495|587628952|FG000|Overall Study|Adverse Event|1|||
162704319|NCT00885495|587628953|FG001|Overall Study|Adverse Event|2|||
162704320|NCT00885495|587628952|FG000|Overall Study|Protocol Violation|0|||
162704321|NCT00885495|587628953|FG001|Overall Study|Protocol Violation|1|||
162704322|NCT00885495|587628952|FG000|Overall Study|Withdrawal by Subject|1|||
162704323|NCT00885495|587628953|FG001|Overall Study|Withdrawal by Subject|0|||
162704324|NCT02107443|587628954|FG000|Overall Study|Death|42|||
162704325|NCT02107443|587628955|FG001|Overall Study|Death|30|||
162704326|NCT02107443|587628954|FG000|Overall Study|Study Protocol Violation|3|||
162704327|NCT02107443|587628955|FG001|Overall Study|Study Protocol Violation|1|||
162704328|NCT02107443|587628954|FG000|Overall Study|Registered but Not Eligible|0|||
162704329|NCT02107443|587628955|FG001|Overall Study|Registered but Not Eligible|1|||
162704330|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
162953860|NCT01591785|588536186|FG001|Overall Study|Protocol Violation|0|||
162704331|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
162704332|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
162704333|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
162704334|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Changed Mind|2|||
162704335|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Changed Mind|0|||
162704336|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
162953861|NCT01591785|588536185|FG000|Overall Study|Lost to Follow-up|1|||
162953862|NCT01591785|588536186|FG001|Overall Study|Lost to Follow-up|0|||
162953863|NCT01049334|588536187|FG000|Overall Study|Withdrawal by Subject|5|||
162953864|NCT01049334|588536188|FG001|Overall Study|Withdrawal by Subject|3|||
162953865|NCT01049334|588536187|FG000|Overall Study|Adverse Event|2|||
162953866|NCT01049334|588536188|FG001|Overall Study|Adverse Event|3|||
162953867|NCT01049334|588536187|FG000|Overall Study|Physician Decision|2|||
162953868|NCT01049334|588536188|FG001|Overall Study|Physician Decision|0|||
162953869|NCT01049334|588536187|FG000|Overall Study|Protocol Violation|0|||
162953870|NCT01049334|588536188|FG001|Overall Study|Protocol Violation|1|||
162953871|NCT02476994|588536195|FG000|Overall Study|Based on feedback from FDA|1|||
162953872|NCT02476994|588536196|FG001|Overall Study|Based on feedback from FDA|0|||
162704337|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
162704338|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
162704339|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
162704340|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
162704341|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
162704342|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
162704343|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
162704344|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Other Medical|9|||
162704345|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Other Medical|5|||
162704346|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Disease Progression|4|||
162704347|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Disease Progression|2|||
162704348|NCT02107443|587628954|FG000|Overall Study|Withdrawal: Personal Issues|0|||
162704349|NCT02107443|587628955|FG001|Overall Study|Withdrawal: Personal Issues|3|||
162704350|NCT00946647|587628956|FG000|Phase 1 Part|Adverse Event|2|||
162704351|NCT00946647|587628957|FG001|Phase 1 Part|Adverse Event|5|||
162704352|NCT00946647|587628958|FG002|Phase 1 Part|Adverse Event|3|||
162704353|NCT00946647|587628959|FG003|Phase 1 Part|Adverse Event|0|||
162704354|NCT00946647|587628960|FG004|Phase 1 Part|Adverse Event|0|||
162704355|NCT00946647|587628956|FG000|Phase 1 Part|Disease progression|3|||
162704356|NCT00946647|587628957|FG001|Phase 1 Part|Disease progression|6|||
162704357|NCT00946647|587628958|FG002|Phase 1 Part|Disease progression|1|||
162704358|NCT00946647|587628959|FG003|Phase 1 Part|Disease progression|0|||
162953873|NCT02246166|588536197|FG000|Overall Study|Protocol Violation|1|||
162953874|NCT02246166|588536198|FG001|Overall Study|Protocol Violation|0|||
162953875|NCT02563561|588536199|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
162704359|NCT00946647|587628960|FG004|Phase 1 Part|Disease progression|0|||
162704360|NCT00946647|587628956|FG000|Phase 1 Part|Withdrawal by Subject|1|||
162704361|NCT00946647|587628957|FG001|Phase 1 Part|Withdrawal by Subject|4|||
162704362|NCT00946647|587628958|FG002|Phase 1 Part|Withdrawal by Subject|3|||
162704363|NCT00946647|587628959|FG003|Phase 1 Part|Withdrawal by Subject|0|||
162704364|NCT00946647|587628960|FG004|Phase 1 Part|Withdrawal by Subject|0|||
162704365|NCT00946647|587628956|FG000|Phase 1 Part|Abnormal values|0|||
162704366|NCT00946647|587628957|FG001|Phase 1 Part|Abnormal values|2|||
162704367|NCT00946647|587628958|FG002|Phase 1 Part|Abnormal values|0|||
162704368|NCT00946647|587628959|FG003|Phase 1 Part|Abnormal values|0|||
162704369|NCT00946647|587628960|FG004|Phase 1 Part|Abnormal values|0|||
162704370|NCT00946647|587628956|FG000|Phase 1 Part|Reason missing|0|||
162704371|NCT00946647|587628957|FG001|Phase 1 Part|Reason missing|1|||
162704372|NCT00946647|587628958|FG002|Phase 1 Part|Reason missing|0|||
162704373|NCT00946647|587628959|FG003|Phase 1 Part|Reason missing|0|||
162704374|NCT00946647|587628960|FG004|Phase 1 Part|Reason missing|0|||
162704375|NCT00946647|587628956|FG000|Phase ll Part|Untreated|0|||
162704376|NCT00946647|587628957|FG001|Phase ll Part|Untreated|0|||
162704377|NCT00946647|587628958|FG002|Phase ll Part|Untreated|0|||
162704378|NCT00946647|587628959|FG003|Phase ll Part|Untreated|0|||
162704379|NCT00946647|587628960|FG004|Phase ll Part|Untreated|2|||
162704380|NCT00946647|587628956|FG000|Phase ll Part|Adverse Event|0|||
162704381|NCT00946647|587628957|FG001|Phase ll Part|Adverse Event|0|||
162704382|NCT00946647|587628958|FG002|Phase ll Part|Adverse Event|0|||
162704383|NCT00946647|587628959|FG003|Phase ll Part|Adverse Event|10|||
162704384|NCT00946647|587628960|FG004|Phase ll Part|Adverse Event|6|||
162704385|NCT00946647|587628956|FG000|Phase ll Part|Withdrawal by Subject|0|||
162704386|NCT00946647|587628957|FG001|Phase ll Part|Withdrawal by Subject|0|||
162704387|NCT00946647|587628958|FG002|Phase ll Part|Withdrawal by Subject|0|||
162704388|NCT00946647|587628959|FG003|Phase ll Part|Withdrawal by Subject|8|||
162704389|NCT00946647|587628960|FG004|Phase ll Part|Withdrawal by Subject|6|||
162704390|NCT00946647|587628956|FG000|Phase ll Part|Administrative problems|0|||
162704391|NCT00946647|587628957|FG001|Phase ll Part|Administrative problems|0|||
162704392|NCT00946647|587628958|FG002|Phase ll Part|Administrative problems|0|||
162704393|NCT00946647|587628959|FG003|Phase ll Part|Administrative problems|3|||
162704394|NCT00946647|587628960|FG004|Phase ll Part|Administrative problems|8|||
162704395|NCT00946647|587628956|FG000|Phase ll Part|Death|0|||
162704396|NCT00946647|587628957|FG001|Phase ll Part|Death|0|||
162704397|NCT00946647|587628958|FG002|Phase ll Part|Death|0|||
162704398|NCT00946647|587628959|FG003|Phase ll Part|Death|7|||
162704399|NCT00946647|587628960|FG004|Phase ll Part|Death|4|||
162953876|NCT02563561|588536200|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
162851425|NCT02157883|588162579|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
162851426|NCT02157883|588162579|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
162851427|NCT01701258|588162580|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
162851428|NCT01701258|588162581|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
162851429|NCT01701258|588162582|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
162851430|NCT01701258|588162583|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
162704400|NCT00946647|587628956|FG000|Phase ll Part|Disease progression|0|||
162851431|NCT01701258|588162584|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
162851432|NCT01701258|588162585|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
162704401|NCT00946647|587628957|FG001|Phase ll Part|Disease progression|0|||
162704402|NCT00946647|587628958|FG002|Phase ll Part|Disease progression|0|||
162704403|NCT00946647|587628959|FG003|Phase ll Part|Disease progression|6|||
162704404|NCT00946647|587628960|FG004|Phase ll Part|Disease progression|14|||
162704405|NCT00946647|587628956|FG000|Phase ll Part|Protocol Violation|0|||
162704406|NCT00946647|587628957|FG001|Phase ll Part|Protocol Violation|0|||
162704407|NCT00946647|587628958|FG002|Phase ll Part|Protocol Violation|0|||
162704408|NCT00946647|587628959|FG003|Phase ll Part|Protocol Violation|4|||
162704409|NCT00946647|587628960|FG004|Phase ll Part|Protocol Violation|2|||
162704410|NCT00946647|587628956|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
162704411|NCT00946647|587628957|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
162704412|NCT00946647|587628958|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
162851433|NCT01701258|588162586|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
162851434|NCT01701258|588162587|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
162851435|NCT01701258|588162588|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
162953877|NCT02563561|588536201|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
162704413|NCT00946647|587628959|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
162704414|NCT00946647|587628960|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
162704415|NCT01368211|587628961|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
162704416|NCT01368211|587628962|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
162704417|NCT04248465|587628966|FG000|Randomized-Controlled Period|Death|12|||
162704418|NCT04248465|587628967|FG001|Randomized-Controlled Period|Death|5|||
162704419|NCT04248465|587628966|FG000|Randomized-Controlled Period|Adverse Event|2|||
162704420|NCT04248465|587628967|FG001|Randomized-Controlled Period|Adverse Event|0|||
162704421|NCT04248465|587628966|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
162704422|NCT04248465|587628967|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
162704423|NCT04248465|587628966|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
162704424|NCT04248465|587628967|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
162704425|NCT04248465|587628966|FG000|Randomized-Controlled Period|Physician Decision|1|||
162704426|NCT04248465|587628967|FG001|Randomized-Controlled Period|Physician Decision|1|||
162704427|NCT04248465|587628966|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
162704428|NCT04248465|587628967|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
162704429|NCT04248465|587628966|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
162704430|NCT04248465|587628967|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
162953878|NCT02563561|588536199|FG000|Overall Study|Withdrew of Consent|1|||
162953879|NCT02563561|588536200|FG001|Overall Study|Withdrew of Consent|1|||
162704431|NCT04248465|587628966|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162704432|NCT04248465|587628967|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
162704433|NCT05708846|587628968|FG000|Overall Study|Death|5|||
162851436|NCT01701258|588162589|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
162953880|NCT02563561|588536201|FG002|Overall Study|Withdrew of Consent|2|||
162953881|NCT02563561|588536199|FG000|Overall Study|Lost to Follow-up|1|||
162953882|NCT02563561|588536200|FG001|Overall Study|Lost to Follow-up|1|||
162953883|NCT02563561|588536201|FG002|Overall Study|Lost to Follow-up|0|||
162953884|NCT02563561|588536199|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
162953885|NCT02563561|588536200|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
162953886|NCT02563561|588536201|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
162953887|NCT02563561|588536199|FG000|Overall Study|Investigator Decision|3|||
162953888|NCT02563561|588536200|FG001|Overall Study|Investigator Decision|4|||
162953889|NCT02563561|588536201|FG002|Overall Study|Investigator Decision|2|||
162953890|NCT02563561|588536199|FG000|Overall Study|Sponsor Decision|5|||
162953891|NCT02563561|588536200|FG001|Overall Study|Sponsor Decision|2|||
162953892|NCT02563561|588536201|FG002|Overall Study|Sponsor Decision|4|||
162953893|NCT02563561|588536199|FG000|Overall Study|Other|1|||
162704434|NCT05708846|587628968|FG000|Overall Study|Withdrawal by Subject|20|||
162704435|NCT03621982|587628969|FG000|Overall Study|Withdrawal by Subject|1|||
162704436|NCT03621982|587628970|FG001|Overall Study|Withdrawal by Subject|0|||
162851437|NCT01701258|588162590|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
162851438|NCT01701258|588162591|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
162851439|NCT01701258|588162592|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
162953894|NCT02563561|588536200|FG001|Overall Study|Other|5|||
162953895|NCT02563561|588536201|FG002|Overall Study|Other|2|||
162953896|NCT03769896|588536202|FG000|Open-label Phase|Lack of Efficacy|5|||
162953897|NCT03769896|588536203|FG001|Open-label Phase|Lack of Efficacy|0|||
162851440|NCT01701258|588162580|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
162851441|NCT01701258|588162581|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
162851442|NCT01701258|588162582|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
162851443|NCT01701258|588162583|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
162851444|NCT01701258|588162584|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
162851445|NCT01701258|588162585|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
162851446|NCT01701258|588162586|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
162851447|NCT01701258|588162587|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
162851448|NCT01701258|588162588|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
162851449|NCT01701258|588162589|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
162851450|NCT01701258|588162590|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
162851451|NCT01701258|588162591|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
162704437|NCT03621982|587628971|FG002|Overall Study|Withdrawal by Subject|0|||
162704438|NCT03621982|587628972|FG003|Overall Study|Withdrawal by Subject|1|||
162704439|NCT03621982|587628973|FG004|Overall Study|Withdrawal by Subject|0|||
162704440|NCT03621982|587628974|FG005|Overall Study|Withdrawal by Subject|1|||
162704441|NCT03621982|587628975|FG006|Overall Study|Withdrawal by Subject|1|||
162704442|NCT03621982|587628976|FG007|Overall Study|Withdrawal by Subject|0|||
162704443|NCT03621982|587628977|FG008|Overall Study|Withdrawal by Subject|1|||
162851452|NCT01701258|588162592|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
162851453|NCT01701258|588162580|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
162851454|NCT01701258|588162581|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
162851455|NCT01701258|588162582|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
162851456|NCT01701258|588162583|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
162704444|NCT03621982|587628978|FG009|Overall Study|Withdrawal by Subject|0|||
162704445|NCT03621982|587628979|FG010|Overall Study|Withdrawal by Subject|2|||
162704446|NCT03621982|587628980|FG011|Overall Study|Withdrawal by Subject|1|||
162704447|NCT03621982|587628981|FG012|Overall Study|Withdrawal by Subject|2|||
162704448|NCT03621982|587628982|FG013|Overall Study|Withdrawal by Subject|2|||
162704449|NCT03621982|587628969|FG000|Overall Study|Investigator/Sponsor decision|0|||
162704450|NCT03621982|587628970|FG001|Overall Study|Investigator/Sponsor decision|0|||
162704451|NCT03621982|587628971|FG002|Overall Study|Investigator/Sponsor decision|0|||
162704452|NCT03621982|587628972|FG003|Overall Study|Investigator/Sponsor decision|0|||
162704453|NCT03621982|587628973|FG004|Overall Study|Investigator/Sponsor decision|0|||
162704454|NCT03621982|587628974|FG005|Overall Study|Investigator/Sponsor decision|0|||
162704455|NCT03621982|587628975|FG006|Overall Study|Investigator/Sponsor decision|0|||
162704456|NCT03621982|587628976|FG007|Overall Study|Investigator/Sponsor decision|0|||
162704457|NCT03621982|587628977|FG008|Overall Study|Investigator/Sponsor decision|0|||
162704458|NCT03621982|587628978|FG009|Overall Study|Investigator/Sponsor decision|0|||
162704459|NCT03621982|587628979|FG010|Overall Study|Investigator/Sponsor decision|0|||
162704460|NCT03621982|587628980|FG011|Overall Study|Investigator/Sponsor decision|4|||
162704461|NCT03621982|587628981|FG012|Overall Study|Investigator/Sponsor decision|0|||
162704462|NCT03621982|587628982|FG013|Overall Study|Investigator/Sponsor decision|2|||
162704463|NCT03621982|587628969|FG000|Overall Study|Death|2|||
162704464|NCT03621982|587628970|FG001|Overall Study|Death|4|||
162704465|NCT03621982|587628971|FG002|Overall Study|Death|4|||
162704466|NCT03621982|587628972|FG003|Overall Study|Death|3|||
162704467|NCT03621982|587628973|FG004|Overall Study|Death|8|||
162704468|NCT03621982|587628974|FG005|Overall Study|Death|4|||
162704469|NCT03621982|587628975|FG006|Overall Study|Death|6|||
162704470|NCT03621982|587628976|FG007|Overall Study|Death|3|||
162704471|NCT03621982|587628977|FG008|Overall Study|Death|0|||
162704472|NCT03621982|587628978|FG009|Overall Study|Death|3|||
162704473|NCT03621982|587628979|FG010|Overall Study|Death|8|||
162704474|NCT03621982|587628980|FG011|Overall Study|Death|4|||
162704475|NCT03621982|587628981|FG012|Overall Study|Death|2|||
162704476|NCT03621982|587628982|FG013|Overall Study|Death|2|||
162704477|NCT03621982|587628969|FG000|Overall Study|Lost to Follow-up|0|||
162704478|NCT03621982|587628970|FG001|Overall Study|Lost to Follow-up|0|||
162704479|NCT03621982|587628971|FG002|Overall Study|Lost to Follow-up|1|||
162704480|NCT03621982|587628972|FG003|Overall Study|Lost to Follow-up|0|||
162704481|NCT03621982|587628973|FG004|Overall Study|Lost to Follow-up|0|||
162704482|NCT03621982|587628974|FG005|Overall Study|Lost to Follow-up|0|||
162851457|NCT01701258|588162584|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
162953898|NCT03769896|588536202|FG000|Open-label Phase|Adverse Event|3|||
162704483|NCT03621982|587628975|FG006|Overall Study|Lost to Follow-up|1|||
162851458|NCT01701258|588162585|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
162851459|NCT01701258|588162586|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
162851460|NCT01701258|588162587|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
162704484|NCT03621982|587628976|FG007|Overall Study|Lost to Follow-up|0|||
162704485|NCT03621982|587628977|FG008|Overall Study|Lost to Follow-up|0|||
162704486|NCT03621982|587628978|FG009|Overall Study|Lost to Follow-up|1|||
162704487|NCT03621982|587628979|FG010|Overall Study|Lost to Follow-up|0|||
162704488|NCT03621982|587628980|FG011|Overall Study|Lost to Follow-up|0|||
162704489|NCT03621982|587628981|FG012|Overall Study|Lost to Follow-up|0|||
162704490|NCT03621982|587628982|FG013|Overall Study|Lost to Follow-up|0|||
162851461|NCT01701258|588162588|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
162851462|NCT01701258|588162589|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
162851463|NCT01701258|588162590|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
162851464|NCT01701258|588162591|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
162851465|NCT01701258|588162592|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
162851466|NCT01701258|588162580|FG000|Assessment and Scheduling|Investigator Terminated|2|||
162851467|NCT01701258|588162581|FG001|Assessment and Scheduling|Investigator Terminated|0|||
162851468|NCT01701258|588162582|FG002|Assessment and Scheduling|Investigator Terminated|0|||
162851469|NCT01701258|588162583|FG003|Assessment and Scheduling|Investigator Terminated|0|||
162851470|NCT01701258|588162584|FG004|Assessment and Scheduling|Investigator Terminated|0|||
162851471|NCT01701258|588162585|FG005|Assessment and Scheduling|Investigator Terminated|0|||
162851472|NCT01701258|588162586|FG006|Assessment and Scheduling|Investigator Terminated|0|||
162851473|NCT01701258|588162587|FG007|Assessment and Scheduling|Investigator Terminated|0|||
162851474|NCT01701258|588162588|FG008|Assessment and Scheduling|Investigator Terminated|0|||
162851475|NCT01701258|588162589|FG009|Assessment and Scheduling|Investigator Terminated|0|||
162851476|NCT01701258|588162590|FG010|Assessment and Scheduling|Investigator Terminated|0|||
162851477|NCT01701258|588162591|FG011|Assessment and Scheduling|Investigator Terminated|0|||
162851478|NCT01701258|588162592|FG012|Assessment and Scheduling|Investigator Terminated|0|||
162851479|NCT01323478|588162593|FG000|Overall Study|Adverse Event|7|||
162851480|NCT01323478|588162593|FG000|Overall Study|Lack of Efficacy|4|||
162851481|NCT01323478|588162593|FG000|Overall Study|Non-compliance With Study Product|3|||
162851482|NCT01323478|588162593|FG000|Overall Study|Protocol Violation|1|||
162851483|NCT01323478|588162593|FG000|Overall Study|Withdrawal of Consent|1|||
162851484|NCT01323478|588162593|FG000|Overall Study|Administrative or Other Reasons|8|||
162851485|NCT00934102|588162597|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
162851486|NCT00934102|588162598|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
162851487|NCT00934102|588162599|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
162851488|NCT00792298|588162600|FG000|Treatment Period 1|Adverse Event|0|||
162851489|NCT00792298|588162601|FG001|Treatment Period 1|Adverse Event|1|||
162851490|NCT00792298|588162602|FG002|Treatment Period 1|Adverse Event|0|||
162851491|NCT00792298|588162603|FG003|Treatment Period 1|Adverse Event|1|||
162851492|NCT00792298|588162604|FG004|Treatment Period 1|Adverse Event|0|||
162851493|NCT00792298|588162605|FG005|Treatment Period 1|Adverse Event|1|||
162851494|NCT00792298|588162606|FG006|Treatment Period 1|Adverse Event|1|||
162851495|NCT00792298|588162607|FG007|Treatment Period 1|Adverse Event|0|||
162851496|NCT00792298|588162600|FG000|Treatment Period 1|Lack of Efficacy|0|||
162851497|NCT00792298|588162601|FG001|Treatment Period 1|Lack of Efficacy|0|||
162851498|NCT00792298|588162602|FG002|Treatment Period 1|Lack of Efficacy|1|||
162851499|NCT00792298|588162603|FG003|Treatment Period 1|Lack of Efficacy|0|||
162851500|NCT00792298|588162604|FG004|Treatment Period 1|Lack of Efficacy|0|||
162851501|NCT00792298|588162605|FG005|Treatment Period 1|Lack of Efficacy|0|||
162851502|NCT00792298|588162606|FG006|Treatment Period 1|Lack of Efficacy|0|||
162851503|NCT00792298|588162607|FG007|Treatment Period 1|Lack of Efficacy|0|||
162851504|NCT00792298|588162600|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162851505|NCT00792298|588162601|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162851506|NCT00792298|588162602|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162851507|NCT00792298|588162603|FG003|Treatment Period 1|Withdrawal by Subject|2|||
162851508|NCT00792298|588162604|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162851509|NCT00792298|588162605|FG005|Treatment Period 1|Withdrawal by Subject|2|||
162704491|NCT00238420|587628983|FG000|Overall Study|Protocol Violation|1|||
162704492|NCT00238420|587628984|FG001|Overall Study|Protocol Violation|1|||
162704493|NCT01254890|587628985|FG000|Overall Study|Ineligible|0|||
162704494|NCT01254890|587628986|FG001|Overall Study|Ineligible|3|||
162704495|NCT01254890|587628985|FG000|Overall Study|Withdrawal by Subject|1|||
162851510|NCT00792298|588162606|FG006|Treatment Period 1|Withdrawal by Subject|1|||
162851511|NCT00792298|588162607|FG007|Treatment Period 1|Withdrawal by Subject|0|||
162851512|NCT00792298|588162600|FG000|Treatment Period 1|Lost to Follow-up|0|||
162851513|NCT00792298|588162601|FG001|Treatment Period 1|Lost to Follow-up|0|||
162851514|NCT00792298|588162602|FG002|Treatment Period 1|Lost to Follow-up|0|||
162851515|NCT00792298|588162603|FG003|Treatment Period 1|Lost to Follow-up|0|||
162851516|NCT00792298|588162604|FG004|Treatment Period 1|Lost to Follow-up|0|||
162851517|NCT00792298|588162605|FG005|Treatment Period 1|Lost to Follow-up|0|||
162851518|NCT00792298|588162606|FG006|Treatment Period 1|Lost to Follow-up|1|||
162851519|NCT00792298|588162607|FG007|Treatment Period 1|Lost to Follow-up|0|||
162851520|NCT00792298|588162600|FG000|Treatment Period 1|Physician Decision|0|||
162851521|NCT00792298|588162601|FG001|Treatment Period 1|Physician Decision|0|||
162851522|NCT00792298|588162602|FG002|Treatment Period 1|Physician Decision|0|||
162851523|NCT00792298|588162603|FG003|Treatment Period 1|Physician Decision|1|||
162851524|NCT00792298|588162604|FG004|Treatment Period 1|Physician Decision|0|||
162851525|NCT00792298|588162605|FG005|Treatment Period 1|Physician Decision|0|||
162851526|NCT00792298|588162606|FG006|Treatment Period 1|Physician Decision|1|||
162851527|NCT00792298|588162607|FG007|Treatment Period 1|Physician Decision|0|||
162851528|NCT00792298|588162600|FG000|Treatment Period 1|Protocol Violation|0|||
162851529|NCT00792298|588162601|FG001|Treatment Period 1|Protocol Violation|0|||
162851530|NCT00792298|588162602|FG002|Treatment Period 1|Protocol Violation|0|||
162851531|NCT00792298|588162603|FG003|Treatment Period 1|Protocol Violation|0|||
162851532|NCT00792298|588162604|FG004|Treatment Period 1|Protocol Violation|0|||
162851533|NCT00792298|588162605|FG005|Treatment Period 1|Protocol Violation|0|||
162851534|NCT00792298|588162606|FG006|Treatment Period 1|Protocol Violation|0|||
162851535|NCT00792298|588162607|FG007|Treatment Period 1|Protocol Violation|1|||
162851536|NCT00792298|588162600|FG000|Washout|Adverse Event|0|||
162851537|NCT00792298|588162601|FG001|Washout|Adverse Event|0|||
162851538|NCT00792298|588162602|FG002|Washout|Adverse Event|0|||
162851539|NCT00792298|588162603|FG003|Washout|Adverse Event|0|||
162851540|NCT00792298|588162604|FG004|Washout|Adverse Event|0|||
162851541|NCT00792298|588162605|FG005|Washout|Adverse Event|1|||
162851542|NCT00792298|588162606|FG006|Washout|Adverse Event|0|||
162851543|NCT00792298|588162607|FG007|Washout|Adverse Event|0|||
162851544|NCT00792298|588162600|FG000|Washout|Withdrawal by Subject|0|||
162851545|NCT00792298|588162601|FG001|Washout|Withdrawal by Subject|0|||
162851546|NCT00792298|588162602|FG002|Washout|Withdrawal by Subject|1|||
162851547|NCT00792298|588162603|FG003|Washout|Withdrawal by Subject|0|||
162704496|NCT01254890|587628986|FG001|Overall Study|Withdrawal by Subject|2|||
162704497|NCT01254890|587628985|FG000|Overall Study|Disease Progression|0|||
162704498|NCT01254890|587628986|FG001|Overall Study|Disease Progression|5|||
162704499|NCT02419755|587628994|FG000|Overall Study|Death|1|||
162704500|NCT02419755|587628995|FG001|Overall Study|Death|3|||
162704501|NCT02419755|587628994|FG000|Overall Study|Relapse|0|||
162704502|NCT02419755|587628995|FG001|Overall Study|Relapse|1|||
162704503|NCT02419755|587628994|FG000|Overall Study|Ineligible|1|||
162704504|NCT02419755|587628995|FG001|Overall Study|Ineligible|0|||
162704505|NCT02419755|587628994|FG000|Overall Study|Withdrawal by Subject|1|||
162704506|NCT02419755|587628995|FG001|Overall Study|Withdrawal by Subject|0|||
162704507|NCT02325713|587628996|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162851548|NCT00792298|588162604|FG004|Washout|Withdrawal by Subject|0|||
162851549|NCT00792298|588162605|FG005|Washout|Withdrawal by Subject|1|||
162851550|NCT00792298|588162606|FG006|Washout|Withdrawal by Subject|0|||
162851551|NCT00792298|588162607|FG007|Washout|Withdrawal by Subject|0|||
162851552|NCT00792298|588162600|FG000|Treatment Period 2|Lack of Efficacy|0|||
162851553|NCT00792298|588162601|FG001|Treatment Period 2|Lack of Efficacy|0|||
162851554|NCT00792298|588162602|FG002|Treatment Period 2|Lack of Efficacy|0|||
162851555|NCT00792298|588162603|FG003|Treatment Period 2|Lack of Efficacy|0|||
162851556|NCT00792298|588162604|FG004|Treatment Period 2|Lack of Efficacy|1|||
162851557|NCT00792298|588162605|FG005|Treatment Period 2|Lack of Efficacy|0|||
162851558|NCT00792298|588162606|FG006|Treatment Period 2|Lack of Efficacy|0|||
162851559|NCT00792298|588162607|FG007|Treatment Period 2|Lack of Efficacy|0|||
162851560|NCT00792298|588162600|FG000|Treatment Period 2|Physician Decision|0|||
162851561|NCT00792298|588162601|FG001|Treatment Period 2|Physician Decision|0|||
162851562|NCT00792298|588162602|FG002|Treatment Period 2|Physician Decision|0|||
162851563|NCT00792298|588162603|FG003|Treatment Period 2|Physician Decision|0|||
162851564|NCT00792298|588162604|FG004|Treatment Period 2|Physician Decision|0|||
162851565|NCT00792298|588162605|FG005|Treatment Period 2|Physician Decision|0|||
162851566|NCT00792298|588162606|FG006|Treatment Period 2|Physician Decision|1|||
162851567|NCT00792298|588162607|FG007|Treatment Period 2|Physician Decision|0|||
162851568|NCT00792298|588162600|FG000|Treatment Period 2|Pregnancy|0|||
162704508|NCT02325713|587628997|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704509|NCT02325713|587628998|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704510|NCT02325713|587628999|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704511|NCT02325713|587629000|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704512|NCT02325713|587629001|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162851569|NCT00792298|588162601|FG001|Treatment Period 2|Pregnancy|0|||
162851570|NCT00792298|588162602|FG002|Treatment Period 2|Pregnancy|1|||
162851571|NCT00792298|588162603|FG003|Treatment Period 2|Pregnancy|0|||
162851572|NCT00792298|588162604|FG004|Treatment Period 2|Pregnancy|0|||
162851573|NCT00792298|588162605|FG005|Treatment Period 2|Pregnancy|0|||
162851574|NCT00792298|588162606|FG006|Treatment Period 2|Pregnancy|0|||
162851575|NCT00792298|588162607|FG007|Treatment Period 2|Pregnancy|0|||
162851576|NCT00792298|588162600|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162851577|NCT00792298|588162601|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162851578|NCT00792298|588162602|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162851579|NCT00792298|588162603|FG003|Treatment Period 2|Withdrawal by Subject|2|||
162704513|NCT02325713|587629002|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704514|NCT02325713|587629003|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162953899|NCT03769896|588536203|FG001|Open-label Phase|Adverse Event|0|||
162704515|NCT02325713|587629004|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704516|NCT02325713|587629005|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704517|NCT02325713|587629006|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
162704518|NCT02325713|587629007|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704519|NCT02325713|587629008|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704520|NCT02325713|587629009|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704521|NCT02325713|587629010|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162851580|NCT00792298|588162604|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162851581|NCT00792298|588162605|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162851582|NCT00792298|588162606|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162851583|NCT00792298|588162607|FG007|Treatment Period 2|Withdrawal by Subject|2|||
162851584|NCT02649634|588162610|FG000|Overall Study|Withdrawal by Subject|3|||
162851585|NCT02649634|588162611|FG001|Overall Study|Withdrawal by Subject|5|||
162851586|NCT02649634|588162610|FG000|Overall Study|Lost to Follow-up|0|||
162851587|NCT02649634|588162611|FG001|Overall Study|Lost to Follow-up|1|||
162851588|NCT01670994|588162612|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
162851589|NCT01670994|588162613|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
162851590|NCT01670994|588162612|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
162851591|NCT01670994|588162613|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
162851592|NCT01670994|588162612|FG000|Overall Study|Patient experienced DLT|0|||
162851593|NCT01670994|588162613|FG001|Overall Study|Patient experienced DLT|1|||
162851594|NCT01111604|588162615|FG000|Overall Study|Lost to Follow-up|0|||
162851595|NCT01111604|588162616|FG001|Overall Study|Lost to Follow-up|0|||
162851596|NCT01111604|588162617|FG002|Overall Study|Lost to Follow-up|1|||
162851597|NCT01111604|588162615|FG000|Overall Study|Withdrew Consent|3|||
162851598|NCT01111604|588162616|FG001|Overall Study|Withdrew Consent|0|||
162851599|NCT01111604|588162617|FG002|Overall Study|Withdrew Consent|2|||
162851600|NCT01111604|588162615|FG000|Overall Study|Withdrawal by Subject|2|||
162851601|NCT01111604|588162616|FG001|Overall Study|Withdrawal by Subject|0|||
162851602|NCT01111604|588162617|FG002|Overall Study|Withdrawal by Subject|0|||
162851603|NCT01111604|588162615|FG000|Overall Study|Death|1|||
162851604|NCT01111604|588162616|FG001|Overall Study|Death|0|||
162851605|NCT01111604|588162617|FG002|Overall Study|Death|0|||
162851606|NCT01111604|588162615|FG000|Overall Study|Met Exclusion Criteria|2|||
162851607|NCT01111604|588162616|FG001|Overall Study|Met Exclusion Criteria|0|||
162851608|NCT01111604|588162617|FG002|Overall Study|Met Exclusion Criteria|0|||
162851609|NCT02706938|588162621|FG000|First Period, 6 Weeks|Adverse Event|8|||
162851610|NCT02706938|588162622|FG001|First Period, 6 Weeks|Adverse Event|0|||
162851611|NCT02706938|588162621|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
162851612|NCT02706938|588162622|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
162851613|NCT02706938|588162621|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
162851614|NCT02706938|588162622|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
162851615|NCT02706938|588162621|FG000|Second Period, 6 Weeks|Adverse Event|0|||
162851616|NCT02706938|588162622|FG001|Second Period, 6 Weeks|Adverse Event|7|||
162851617|NCT02706938|588162621|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
162851618|NCT02706938|588162622|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
162851619|NCT02868892|588162623|FG000|Overall Study|Investigator left site and no follow-up|6|||
162851620|NCT03377634|588162627|FG000|Study Period|Adverse Event|1|||
162851621|NCT03377634|588162628|FG001|Study Period|Adverse Event|0|||
162851622|NCT03377634|588162627|FG000|Study Period|Withdrawal by Subject|1|||
162851623|NCT03377634|588162628|FG001|Study Period|Withdrawal by Subject|0|||
162851624|NCT00291551|588162630|FG000|Overall Study|Death|7|||
162851625|NCT00291551|588162630|FG000|Overall Study|Withdrawal by Subject|6|||
162851626|NCT02452762|588162631|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
162851627|NCT02452762|588162632|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
162851628|NCT02452762|588162631|FG000|Overall Study|Withdrawal by Subject|1|||
162851629|NCT02452762|588162632|FG001|Overall Study|Withdrawal by Subject|0|||
162851630|NCT00584870|588162633|FG000|Overall Study|Adverse Event|4|||
162851631|NCT00584870|588162634|FG001|Overall Study|Adverse Event|3|||
162851632|NCT00584870|588162635|FG002|Overall Study|Adverse Event|2|||
162851633|NCT00584870|588162633|FG000|Overall Study|Lost to Follow-up|4|||
162851634|NCT00584870|588162634|FG001|Overall Study|Lost to Follow-up|1|||
162851635|NCT00584870|588162635|FG002|Overall Study|Lost to Follow-up|1|||
162851636|NCT00584870|588162633|FG000|Overall Study|Lack of Efficacy|7|||
162851637|NCT00584870|588162634|FG001|Overall Study|Lack of Efficacy|14|||
162851638|NCT00584870|588162635|FG002|Overall Study|Lack of Efficacy|8|||
162851639|NCT00584870|588162633|FG000|Overall Study|Withdrawal by Subject|10|||
162851640|NCT00584870|588162634|FG001|Overall Study|Withdrawal by Subject|5|||
162851641|NCT00584870|588162635|FG002|Overall Study|Withdrawal by Subject|3|||
162953900|NCT03769896|588536202|FG000|Open-label Phase|Withdrawal by Subject|1|||
162953901|NCT03769896|588536203|FG001|Open-label Phase|Withdrawal by Subject|0|||
162953902|NCT01015703|588536204|FG000|Overall Study|Withdrawal by Subject|0|||
162953903|NCT01015703|588536205|FG001|Overall Study|Withdrawal by Subject|1|||
162953904|NCT01015703|588536206|FG002|Overall Study|Withdrawal by Subject|0|||
162953905|NCT01015703|588536207|FG003|Overall Study|Withdrawal by Subject|0|||
162953906|NCT01015703|588536208|FG004|Overall Study|Withdrawal by Subject|0|||
162953907|NCT01015703|588536204|FG000|Overall Study|Adverse Event|1|||
162953908|NCT01015703|588536205|FG001|Overall Study|Adverse Event|0|||
162953909|NCT01015703|588536206|FG002|Overall Study|Adverse Event|0|||
162953910|NCT01015703|588536207|FG003|Overall Study|Adverse Event|0|||
162953911|NCT01015703|588536208|FG004|Overall Study|Adverse Event|0|||
162953912|NCT01015703|588536204|FG000|Overall Study|Protocol Violation|1|||
162953913|NCT01015703|588536205|FG001|Overall Study|Protocol Violation|0|||
162953914|NCT01015703|588536206|FG002|Overall Study|Protocol Violation|0|||
162953915|NCT01015703|588536207|FG003|Overall Study|Protocol Violation|0|||
162953916|NCT01015703|588536208|FG004|Overall Study|Protocol Violation|0|||
162953917|NCT03122535|588536209|FG000|Overall Study|Lost to Follow-up|68|||
162953918|NCT03122535|588536210|FG001|Overall Study|Lost to Follow-up|68|||
162953919|NCT03122535|588536209|FG000|Overall Study|Physician Decision|3|||
162953920|NCT03122535|588536210|FG001|Overall Study|Physician Decision|3|||
162953921|NCT03122535|588536209|FG000|Overall Study|Withdrawal by Subject|2|||
162953922|NCT03122535|588536210|FG001|Overall Study|Withdrawal by Subject|2|||
162953923|NCT02646124|588536211|FG000|Overall Study|Lost to Follow-up|0|||
162953924|NCT02646124|588536212|FG001|Overall Study|Lost to Follow-up|2|||
162953925|NCT00857454|588536215|FG000|Overall Study|Withdrawal by Subject|2|||
162953926|NCT00857454|588536215|FG000|Overall Study|Lost to Follow-up|1|||
162953927|NCT00857454|588536215|FG000|Overall Study|Adverse Event|2|||
162953928|NCT00857454|588536215|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
162704522|NCT02325713|587629011|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162704523|NCT02325713|587628996|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
162704524|NCT02325713|587628997|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704525|NCT02325713|587628998|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162953929|NCT00857454|588536215|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
162953930|NCT00857454|588536215|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
162953931|NCT03154047|588536216|FG000|Overall Study|Death|1|||
162953932|NCT03154047|588536216|FG000|Overall Study|Study terminated by sponsor|76|||
162953933|NCT03154047|588536216|FG000|Overall Study|Withdrawal by Subject|3|||
162953934|NCT00365365|588536217|FG000|Overall Study|Randomized but not treated|0|||
162953935|NCT00365365|588536218|FG001|Overall Study|Randomized but not treated|2|||
162953936|NCT00365365|588536219|FG002|Overall Study|Randomized but not treated|0|||
162611373|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
162611374|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162611375|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162611376|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
162611377|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
162611378|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
162611379|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
162611380|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162611381|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162611382|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
162611383|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162611384|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162611385|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162611386|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
162611387|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162611388|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162611389|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162611390|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162611391|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
162611392|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162611393|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162611394|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162611395|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
162611396|NCT03739840|587294931|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162611397|NCT03739840|587294932|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162611398|NCT03739840|587294933|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162611399|NCT03739840|587294934|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
162611400|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
162611401|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162611402|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162611403|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162611404|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162611405|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162611406|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162611407|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
162611408|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
162611409|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162611410|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162611411|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162611412|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162611413|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
162611414|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162611415|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162611416|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
162611417|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
162611418|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
162611419|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
162611420|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162611421|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162611422|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
162611423|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162611424|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162851642|NCT00584870|588162633|FG000|Overall Study|Protocol Violation|1|||
162851643|NCT00584870|588162634|FG001|Overall Study|Protocol Violation|1|||
162851644|NCT00584870|588162635|FG002|Overall Study|Protocol Violation|2|||
162851645|NCT00584870|588162633|FG000|Overall Study|Did not met entrance criteria|1|||
162851646|NCT00584870|588162634|FG001|Overall Study|Did not met entrance criteria|0|||
162851647|NCT00584870|588162635|FG002|Overall Study|Did not met entrance criteria|0|||
162851648|NCT00584870|588162633|FG000|Overall Study|Other|2|||
162611425|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162611426|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
162611427|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162611428|NCT03739840|587294931|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162851649|NCT00584870|588162634|FG001|Overall Study|Other|0|||
162851650|NCT00584870|588162635|FG002|Overall Study|Other|0|||
162851651|NCT00584870|588162633|FG000|Overall Study|Randomized but not treated|0|||
162851652|NCT00584870|588162634|FG001|Overall Study|Randomized but not treated|1|||
162851653|NCT00584870|588162635|FG002|Overall Study|Randomized but not treated|2|||
162851654|NCT00631137|588162636|FG000|Overall Study|Withdrawal by Subject|1|||
162851655|NCT00631137|588162637|FG001|Overall Study|Withdrawal by Subject|0|||
162851656|NCT03682120|588162638|FG000|Overall Study|Lost to Follow-up|11|||
162851657|NCT03682120|588162639|FG001|Overall Study|Lost to Follow-up|4|||
162851658|NCT03682120|588162640|FG002|Overall Study|Lost to Follow-up|5|||
162851659|NCT03682120|588162641|FG003|Overall Study|Lost to Follow-up|2|||
162851660|NCT03682120|588162638|FG000|Overall Study|Physician Decision|1|||
162851661|NCT03682120|588162639|FG001|Overall Study|Physician Decision|0|||
162851662|NCT03682120|588162640|FG002|Overall Study|Physician Decision|0|||
162851663|NCT03682120|588162641|FG003|Overall Study|Physician Decision|0|||
162851664|NCT03682120|588162638|FG000|Overall Study|Withdrawal by Subject|1|||
162851665|NCT03682120|588162639|FG001|Overall Study|Withdrawal by Subject|2|||
162851666|NCT03682120|588162640|FG002|Overall Study|Withdrawal by Subject|3|||
162851667|NCT03682120|588162641|FG003|Overall Study|Withdrawal by Subject|0|||
162851668|NCT03682120|588162638|FG000|Overall Study|Death|0|||
162851669|NCT03682120|588162639|FG001|Overall Study|Death|1|||
162851670|NCT03682120|588162640|FG002|Overall Study|Death|0|||
162851671|NCT03682120|588162641|FG003|Overall Study|Death|0|||
162851672|NCT03682120|588162638|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
162851673|NCT03682120|588162639|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
162851674|NCT03682120|588162640|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
162851675|NCT03682120|588162641|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
162851676|NCT01015833|588162642|FG000|Overall Study|Death|1|||
162851677|NCT01015833|588162643|FG001|Overall Study|Death|0|||
162953937|NCT00365365|588536217|FG000|Overall Study|Poor compliance to protocol|0|||
162953938|NCT00365365|588536218|FG001|Overall Study|Poor compliance to protocol|1|||
162953939|NCT00365365|588536219|FG002|Overall Study|Poor compliance to protocol|0|||
162953940|NCT00365365|588536217|FG000|Overall Study|Lost to Follow-up|3|||
162953941|NCT00365365|588536218|FG001|Overall Study|Lost to Follow-up|3|||
162851678|NCT01015833|588162642|FG000|Overall Study|Withdrawal by Subject|3|||
162851679|NCT01015833|588162643|FG001|Overall Study|Withdrawal by Subject|2|||
162851680|NCT01015833|588162642|FG000|Overall Study|Adverse Event|0|||
162851681|NCT01015833|588162643|FG001|Overall Study|Adverse Event|1|||
162851682|NCT01015833|588162642|FG000|Overall Study|Physician Decision|2|||
162851683|NCT01015833|588162643|FG001|Overall Study|Physician Decision|0|||
162953942|NCT00365365|588536219|FG002|Overall Study|Lost to Follow-up|3|||
162953943|NCT00365365|588536217|FG000|Overall Study|Death|1|||
162953944|NCT00365365|588536218|FG001|Overall Study|Death|3|||
162953945|NCT00365365|588536219|FG002|Overall Study|Death|0|||
162953946|NCT00365365|588536217|FG000|Overall Study|Subject's request|11|||
162953947|NCT00365365|588536218|FG001|Overall Study|Subject's request|13|||
162953948|NCT00365365|588536219|FG002|Overall Study|Subject's request|1|||
162953949|NCT00365365|588536217|FG000|Overall Study|Disease progression/relapse|9|||
162851684|NCT01015833|588162642|FG000|Overall Study|Symptomatic deterioration|0|||
162953950|NCT00365365|588536218|FG001|Overall Study|Disease progression/relapse|6|||
162953951|NCT00365365|588536219|FG002|Overall Study|Disease progression/relapse|7|||
162851685|NCT01015833|588162643|FG001|Overall Study|Symptomatic deterioration|1|||
162851686|NCT01015833|588162642|FG000|Overall Study|Other|5|||
162953952|NCT00365365|588536217|FG000|Overall Study|Adverse Event|6|||
162704526|NCT02325713|587628999|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162851687|NCT01015833|588162643|FG001|Overall Study|Other|1|||
162851688|NCT01015833|588162642|FG000|Overall Study|Motor Vehicle Accidents|1|||
162851689|NCT01015833|588162643|FG001|Overall Study|Motor Vehicle Accidents|0|||
162704527|NCT02325713|587629000|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704528|NCT02325713|587629001|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704529|NCT02325713|587629002|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704530|NCT02325713|587629003|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704531|NCT02325713|587629004|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704532|NCT02325713|587629005|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162851690|NCT01015833|588162642|FG000|Overall Study|Did not start treatment|1|||
162851691|NCT01015833|588162643|FG001|Overall Study|Did not start treatment|0|||
162851692|NCT02040142|588162644|FG000|Overall Study|Lost to Follow-up|5|||
162851693|NCT02040142|588162644|FG000|Overall Study|Death|17|||
162851694|NCT02040142|588162644|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
162851695|NCT04752384|588162645|FG000|Overall Study|Withdrawal by Subject|1|||
162851696|NCT04752384|588162645|FG000|Overall Study|Death|1|||
162851697|NCT04439331|588162652|FG000|Overall Study|Never Start Protocol Therapy|2|||
162851698|NCT04439331|588162652|FG000|Overall Study|Ineligible|2|||
162851699|NCT04439331|588162652|FG000|Overall Study|Mutation Status Not Confirmed|1|||
162851700|NCT04439331|588162652|FG000|Overall Study|Adverse Event|1|||
162851701|NCT04439331|588162652|FG000|Overall Study|Death|1|||
162851702|NCT04439331|588162652|FG000|Overall Study|Disease Progression|20|||
162953953|NCT00365365|588536218|FG001|Overall Study|Adverse Event|6|||
162704533|NCT02325713|587629006|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704534|NCT02325713|587629007|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704535|NCT02325713|587629008|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704536|NCT02325713|587629009|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704537|NCT02325713|587629010|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704538|NCT02325713|587629011|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162704539|NCT02325713|587628996|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704540|NCT02325713|587628997|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704541|NCT02325713|587628998|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704542|NCT02325713|587628999|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704543|NCT02325713|587629000|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704544|NCT02325713|587629001|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704545|NCT02325713|587629002|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704546|NCT02325713|587629003|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704547|NCT02325713|587629004|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704548|NCT02325713|587629005|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
162704549|NCT02325713|587629006|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704550|NCT02325713|587629007|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704551|NCT02325713|587629008|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162704552|NCT02325713|587629009|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162851703|NCT04439331|588162652|FG000|Overall Study|Withdrawal by Subject|6|||
162851704|NCT04439331|588162652|FG000|Overall Study|Physician Decision|1|||
162851705|NCT04439331|588162652|FG000|Overall Study|Other Complicating Disease|1|||
162851706|NCT04370509|588162654|FG000|Overall Study|Adverse Event|1|||
162953954|NCT00365365|588536219|FG002|Overall Study|Adverse Event|3|||
162953955|NCT00365365|588536217|FG000|Overall Study|Moved|2|||
162953956|NCT00365365|588536218|FG001|Overall Study|Moved|0|||
162611429|NCT03739840|587294932|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162611430|NCT03739840|587294933|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
162611431|NCT03739840|587294934|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162611432|NCT02788474|587294935|FG000|Double Blind Treatment Period|Not treated|1|||
162611433|NCT02788474|587294936|FG001|Double Blind Treatment Period|Not treated|0|||
162611434|NCT02788474|587294935|FG000|Double Blind Treatment Period|Patient's refusal|3|||
162611435|NCT02788474|587294936|FG001|Double Blind Treatment Period|Patient's refusal|0|||
162611436|NCT02788474|587294935|FG000|Double Blind Treatment Period|Adverse Event|6|||
162611437|NCT02788474|587294936|FG001|Double Blind Treatment Period|Adverse Event|4|||
162611438|NCT02788474|587294935|FG000|Open Label Treatment Period|Adverse Event|29|||
162611439|NCT02788474|587294936|FG001|Open Label Treatment Period|Adverse Event|9|||
162611440|NCT02788474|587294935|FG000|Open Label Treatment Period|Other than reason specified|1|||
162611441|NCT02788474|587294936|FG001|Open Label Treatment Period|Other than reason specified|0|||
162611442|NCT02788474|587294935|FG000|Open Label Treatment Period|Patient's refusal|1|||
162611443|NCT02788474|587294936|FG001|Open Label Treatment Period|Patient's refusal|3|||
162611444|NCT02788474|587294935|FG000|Open Label Treatment Period|Non-compliance|1|||
162611445|NCT02788474|587294936|FG001|Open Label Treatment Period|Non-compliance|0|||
162611446|NCT03555435|587294937|FG000|Overall Study|Lost to Follow-up|17|||
162611447|NCT03555435|587294938|FG001|Overall Study|Lost to Follow-up|19|||
162851707|NCT04370509|588162655|FG001|Overall Study|Adverse Event|0|||
162851708|NCT04370509|588162654|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
162851709|NCT04370509|588162655|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
162851710|NCT04743856|588162656|FG000|Overall Study|Lost to Follow-up|6|||
162851711|NCT04743856|588162657|FG001|Overall Study|Lost to Follow-up|7|||
162611448|NCT03555435|587294939|FG002|Overall Study|Lost to Follow-up|8|||
162611449|NCT02694523|587294942|FG000|Part A|Adverse Event|7|||
162611450|NCT02694523|587294943|FG001|Part A|Adverse Event|3|||
162611451|NCT02694523|587294944|FG002|Part A|Adverse Event|0|||
162611452|NCT02694523|587294945|FG003|Part A|Adverse Event|0|||
162611453|NCT02694523|587294946|FG004|Part A|Adverse Event|0|||
162611454|NCT02694523|587294947|FG005|Part A|Adverse Event|0|||
162611455|NCT02694523|587294948|FG006|Part A|Adverse Event|0|||
162611456|NCT02694523|587294942|FG000|Part A|Protocol Violation|1|||
162611457|NCT02694523|587294943|FG001|Part A|Protocol Violation|0|||
162611458|NCT02694523|587294944|FG002|Part A|Protocol Violation|0|||
162611459|NCT02694523|587294945|FG003|Part A|Protocol Violation|0|||
162611460|NCT02694523|587294946|FG004|Part A|Protocol Violation|0|||
162611461|NCT02694523|587294947|FG005|Part A|Protocol Violation|0|||
162611462|NCT02694523|587294948|FG006|Part A|Protocol Violation|0|||
162611463|NCT02694523|587294942|FG000|Part A|Lost to Follow-up|1|||
162611464|NCT02694523|587294943|FG001|Part A|Lost to Follow-up|2|||
162611465|NCT02694523|587294944|FG002|Part A|Lost to Follow-up|0|||
162611466|NCT02694523|587294945|FG003|Part A|Lost to Follow-up|0|||
162611467|NCT02694523|587294946|FG004|Part A|Lost to Follow-up|0|||
162611468|NCT02694523|587294947|FG005|Part A|Lost to Follow-up|0|||
162611469|NCT02694523|587294948|FG006|Part A|Lost to Follow-up|0|||
162611470|NCT02694523|587294942|FG000|Part A|Withdrawal by Subject|3|||
162611471|NCT02694523|587294943|FG001|Part A|Withdrawal by Subject|1|||
162611472|NCT02694523|587294944|FG002|Part A|Withdrawal by Subject|0|||
162611473|NCT02694523|587294945|FG003|Part A|Withdrawal by Subject|0|||
162611474|NCT02694523|587294946|FG004|Part A|Withdrawal by Subject|0|||
162611475|NCT02694523|587294947|FG005|Part A|Withdrawal by Subject|0|||
162611476|NCT02694523|587294948|FG006|Part A|Withdrawal by Subject|0|||
162611477|NCT02694523|587294942|FG000|Part A|Other|1|||
162611478|NCT02694523|587294943|FG001|Part A|Other|1|||
162611479|NCT02694523|587294944|FG002|Part A|Other|0|||
162611480|NCT02694523|587294945|FG003|Part A|Other|0|||
162851712|NCT04743856|588162656|FG000|Overall Study|Withdrawal by Subject|1|||
162851713|NCT04743856|588162657|FG001|Overall Study|Withdrawal by Subject|0|||
162851714|NCT04696861|588162658|FG000|Overall Study|Death|1|||
162851715|NCT04696861|588162659|FG001|Overall Study|Death|0|||
162611481|NCT02694523|587294946|FG004|Part A|Other|0|||
162611482|NCT02694523|587294947|FG005|Part A|Other|0|||
162611483|NCT02694523|587294948|FG006|Part A|Other|0|||
162611484|NCT02694523|587294942|FG000|Part B|Adverse Event|0|||
162611485|NCT02694523|587294943|FG001|Part B|Adverse Event|0|||
162611486|NCT02694523|587294944|FG002|Part B|Adverse Event|7|||
162851716|NCT04696861|588162658|FG000|Overall Study|Lost to Follow-up|3|||
162851717|NCT04696861|588162659|FG001|Overall Study|Lost to Follow-up|0|||
162851718|NCT04439188|588162660|FG000|Overall Study|Ineligible|3|||
162851719|NCT04439188|588162660|FG000|Overall Study|Adverse Event|4|||
162851720|NCT04439188|588162660|FG000|Overall Study|Death|1|||
162851721|NCT04439188|588162660|FG000|Overall Study|Disease Progression|25|||
162611487|NCT02694523|587294945|FG003|Part B|Adverse Event|1|||
162611488|NCT02694523|587294946|FG004|Part B|Adverse Event|1|||
162611489|NCT02694523|587294947|FG005|Part B|Adverse Event|2|||
162611490|NCT02694523|587294948|FG006|Part B|Adverse Event|0|||
162611491|NCT02694523|587294942|FG000|Part B|Protocol Violation|0|||
162611492|NCT02694523|587294943|FG001|Part B|Protocol Violation|0|||
162851722|NCT04439188|588162660|FG000|Overall Study|Withdrawal by Subject|2|||
162851723|NCT00413959|588162661|FG000|Overall Study|Pt had only one cycle.|1|||
162851724|NCT01813890|588162664|FG000|Overall Study|Adverse Event|0|||
162851725|NCT01813890|588162665|FG001|Overall Study|Adverse Event|3|||
162851726|NCT01813890|588162666|FG002|Overall Study|Adverse Event|4|||
162851727|NCT01813890|588162664|FG000|Overall Study|Lack of Efficacy|9|||
162851728|NCT01813890|588162665|FG001|Overall Study|Lack of Efficacy|1|||
162851729|NCT01813890|588162666|FG002|Overall Study|Lack of Efficacy|2|||
162851730|NCT04482647|588162667|FG000|Overall Study|Time constraints|2|||
162851731|NCT04482647|588162667|FG000|Overall Study|Health issues|1|||
162851732|NCT04482647|588162667|FG000|Overall Study|Death in the family|1|||
162851733|NCT04482647|588162667|FG000|Overall Study|Disliked the intervention|1|||
162851734|NCT04482647|588162667|FG000|Overall Study|No reasons specified|7|||
162851735|NCT03952559|588162668|FG000|Double Blind Treatment Period|Adverse Event|0|||
162851736|NCT03952559|588162669|FG001|Double Blind Treatment Period|Adverse Event|2|||
162851737|NCT03952559|588162670|FG002|Double Blind Treatment Period|Adverse Event|1|||
162851738|NCT03952559|588162671|FG003|Double Blind Treatment Period|Adverse Event|0|||
162851739|NCT03952559|588162672|FG004|Double Blind Treatment Period|Adverse Event|1|||
162851740|NCT03952559|588162668|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
162851741|NCT03952559|588162669|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
162851742|NCT03952559|588162670|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
162851743|NCT03952559|588162671|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
162851744|NCT03952559|588162672|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
162851745|NCT03952559|588162668|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
162851746|NCT03952559|588162669|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
162851747|NCT03952559|588162670|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
162851748|NCT03952559|588162671|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
162851749|NCT03952559|588162672|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
162851750|NCT03952559|588162668|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
162851751|NCT03952559|588162669|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
162851752|NCT03952559|588162670|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
162851753|NCT03952559|588162671|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
162851754|NCT03952559|588162672|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
162851755|NCT01986062|588162675|FG000|Overall Study|Lost to Follow-up|1|||
162851756|NCT01986062|588162676|FG001|Overall Study|Lost to Follow-up|0|||
162851757|NCT01986062|588162675|FG000|Overall Study|Withdrawal by Subject|0|||
162851758|NCT01986062|588162676|FG001|Overall Study|Withdrawal by Subject|1|||
162851759|NCT03538743|588162677|FG000|Overall Study|Adverse Event|0|||
162851760|NCT03538743|588162678|FG001|Overall Study|Adverse Event|0|||
162851761|NCT03538743|588162679|FG002|Overall Study|Adverse Event|1|||
162851762|NCT03538743|588162680|FG003|Overall Study|Adverse Event|1|||
162851763|NCT03538743|588162681|FG004|Overall Study|Adverse Event|0|||
162851764|NCT03538743|588162682|FG005|Overall Study|Adverse Event|0|||
162851765|NCT03538743|588162683|FG006|Overall Study|Adverse Event|0|||
162851766|NCT03538743|588162684|FG007|Overall Study|Adverse Event|0|||
162851767|NCT03538743|588162685|FG008|Overall Study|Adverse Event|0|||
162851768|NCT03538743|588162677|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
162851769|NCT03538743|588162678|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
162851770|NCT03538743|588162679|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
162851771|NCT03538743|588162680|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
162851772|NCT03538743|588162681|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
162851773|NCT03538743|588162682|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
162953957|NCT00365365|588536219|FG002|Overall Study|Moved|0|||
162953958|NCT00365365|588536217|FG000|Overall Study|New cancer|1|||
162953959|NCT00365365|588536218|FG001|Overall Study|New cancer|0|||
162953960|NCT00365365|588536219|FG002|Overall Study|New cancer|0|||
162953961|NCT00365365|588536217|FG000|Overall Study|Withdrew consent|1|||
162953962|NCT00365365|588536218|FG001|Overall Study|Withdrew consent|1|||
162953963|NCT00365365|588536219|FG002|Overall Study|Withdrew consent|0|||
162953964|NCT00365365|588536217|FG000|Overall Study|Second malignancy|0|||
162953965|NCT00365365|588536218|FG001|Overall Study|Second malignancy|1|||
162953966|NCT00365365|588536219|FG002|Overall Study|Second malignancy|0|||
162953967|NCT00365365|588536217|FG000|Overall Study|Patient/physician decision|0|||
162953968|NCT00365365|588536218|FG001|Overall Study|Patient/physician decision|0|||
162953969|NCT00365365|588536219|FG002|Overall Study|Patient/physician decision|1|||
162953970|NCT00984022|588536220|FG000|Overall Study|Lost to Follow-up|10|||
162953971|NCT00984022|588536221|FG001|Overall Study|Lost to Follow-up|14|||
162953972|NCT00573443|588536222|FG000|Double-Blind Phase|Lost to Follow-up|1|||
162953973|NCT00573443|588536223|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162953974|NCT00573443|588536224|FG002|Double-Blind Phase|Lost to Follow-up|2|||
162953975|NCT00573443|588536222|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
162953976|NCT00573443|588536223|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
162953977|NCT00573443|588536224|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
162953978|NCT00573443|588536222|FG000|Double-Blind Phase|Adverse Event|1|||
162953979|NCT00573443|588536223|FG001|Double-Blind Phase|Adverse Event|5|||
162953980|NCT00573443|588536224|FG002|Double-Blind Phase|Adverse Event|0|||
162953981|NCT00573443|588536222|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
162953982|NCT00573443|588536223|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
162953983|NCT00573443|588536224|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
162953984|NCT00573443|588536222|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
162953985|NCT00573443|588536223|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
162953986|NCT00573443|588536224|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
162953987|NCT00573443|588536222|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
162953988|NCT00573443|588536223|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
162953989|NCT00573443|588536224|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
162953990|NCT00573443|588536222|FG000|Double-Blind Phase|Protocol Violation|0|||
162953991|NCT00573443|588536223|FG001|Double-Blind Phase|Protocol Violation|2|||
162953992|NCT00573443|588536224|FG002|Double-Blind Phase|Protocol Violation|1|||
162953993|NCT00573443|588536222|FG000|Double-Blind Phase|Other|0|||
162953994|NCT00573443|588536223|FG001|Double-Blind Phase|Other|2|||
162953995|NCT00573443|588536224|FG002|Double-Blind Phase|Other|3|||
162953996|NCT00573443|588536222|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
162953997|NCT00573443|588536223|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162953998|NCT00573443|588536224|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162953999|NCT00573443|588536222|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
162954000|NCT00573443|588536223|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
162954001|NCT00573443|588536224|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
162954002|NCT00573443|588536222|FG000|Open-Label Extension Phase|Adverse Event|3|||
162611493|NCT02694523|587294944|FG002|Part B|Protocol Violation|1|||
162611494|NCT02694523|587294945|FG003|Part B|Protocol Violation|0|||
162611495|NCT02694523|587294946|FG004|Part B|Protocol Violation|0|||
162851774|NCT03538743|588162683|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
162851775|NCT03538743|588162684|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
162851776|NCT03538743|588162685|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
162851777|NCT03538743|588162677|FG000|Overall Study|Withdrawal by Subject|0|||
162851778|NCT03538743|588162678|FG001|Overall Study|Withdrawal by Subject|0|||
162851779|NCT03538743|588162679|FG002|Overall Study|Withdrawal by Subject|0|||
162851780|NCT03538743|588162680|FG003|Overall Study|Withdrawal by Subject|1|||
162851781|NCT03538743|588162681|FG004|Overall Study|Withdrawal by Subject|0|||
162851782|NCT03538743|588162682|FG005|Overall Study|Withdrawal by Subject|0|||
162851783|NCT03538743|588162683|FG006|Overall Study|Withdrawal by Subject|0|||
162851784|NCT03538743|588162684|FG007|Overall Study|Withdrawal by Subject|0|||
162851785|NCT03538743|588162685|FG008|Overall Study|Withdrawal by Subject|0|||
162851786|NCT01827384|588162689|FG000|Overall Study|Switched to alternative treatment|0|||
162851787|NCT01827384|588162690|FG001|Overall Study|Switched to alternative treatment|0|||
162851788|NCT01827384|588162691|FG002|Overall Study|Switched to alternative treatment|0|||
162851789|NCT01827384|588162692|FG003|Overall Study|Switched to alternative treatment|0|||
162851790|NCT01827384|588162693|FG004|Overall Study|Switched to alternative treatment|0|||
162851791|NCT01827384|588162694|FG005|Overall Study|Switched to alternative treatment|0|||
162851792|NCT01827384|588162695|FG006|Overall Study|Switched to alternative treatment|0|||
162851793|NCT01827384|588162696|FG007|Overall Study|Switched to alternative treatment|0|||
162851794|NCT01827384|588162697|FG008|Overall Study|Switched to alternative treatment|0|||
162851795|NCT01827384|588162698|FG009|Overall Study|Switched to alternative treatment|0|||
162851796|NCT01827384|588162699|FG010|Overall Study|Switched to alternative treatment|0|||
162954003|NCT00573443|588536223|FG001|Open-Label Extension Phase|Adverse Event|0|||
162954004|NCT00573443|588536224|FG002|Open-Label Extension Phase|Adverse Event|0|||
162954005|NCT00573443|588536222|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
162851797|NCT01827384|588162700|FG011|Overall Study|Switched to alternative treatment|0|||
162851798|NCT01827384|588162701|FG012|Overall Study|Switched to alternative treatment|0|||
162851799|NCT01827384|588162702|FG013|Overall Study|Switched to alternative treatment|2|||
162851800|NCT01827384|588162689|FG000|Overall Study|Disease progression before treatment|0|||
162851801|NCT01827384|588162690|FG001|Overall Study|Disease progression before treatment|0|||
162851802|NCT01827384|588162691|FG002|Overall Study|Disease progression before treatment|0|||
162851803|NCT01827384|588162692|FG003|Overall Study|Disease progression before treatment|0|||
162851804|NCT01827384|588162693|FG004|Overall Study|Disease progression before treatment|0|||
162851805|NCT01827384|588162694|FG005|Overall Study|Disease progression before treatment|0|||
162851806|NCT01827384|588162695|FG006|Overall Study|Disease progression before treatment|0|||
162851807|NCT01827384|588162696|FG007|Overall Study|Disease progression before treatment|0|||
162851808|NCT01827384|588162697|FG008|Overall Study|Disease progression before treatment|0|||
162851809|NCT01827384|588162698|FG009|Overall Study|Disease progression before treatment|0|||
162851810|NCT01827384|588162699|FG010|Overall Study|Disease progression before treatment|0|||
162851811|NCT01827384|588162700|FG011|Overall Study|Disease progression before treatment|0|||
162851812|NCT01827384|588162701|FG012|Overall Study|Disease progression before treatment|0|||
162851813|NCT01827384|588162702|FG013|Overall Study|Disease progression before treatment|4|||
162851814|NCT01827384|588162689|FG000|Overall Study|Ineligible|0|||
162851815|NCT01827384|588162690|FG001|Overall Study|Ineligible|0|||
162851816|NCT01827384|588162691|FG002|Overall Study|Ineligible|0|||
162851817|NCT01827384|588162692|FG003|Overall Study|Ineligible|0|||
162851818|NCT01827384|588162693|FG004|Overall Study|Ineligible|0|||
162851819|NCT01827384|588162694|FG005|Overall Study|Ineligible|0|||
162851820|NCT01827384|588162695|FG006|Overall Study|Ineligible|0|||
162851821|NCT01827384|588162696|FG007|Overall Study|Ineligible|0|||
162851822|NCT01827384|588162697|FG008|Overall Study|Ineligible|0|||
162851823|NCT01827384|588162698|FG009|Overall Study|Ineligible|0|||
162851824|NCT01827384|588162699|FG010|Overall Study|Ineligible|0|||
162704553|NCT02325713|587629010|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162851825|NCT01827384|588162700|FG011|Overall Study|Ineligible|0|||
162851826|NCT01827384|588162701|FG012|Overall Study|Ineligible|0|||
162851827|NCT01827384|588162702|FG013|Overall Study|Ineligible|19|||
162851828|NCT01827384|588162689|FG000|Overall Study|Participant died before treatment|0|||
162851829|NCT01827384|588162690|FG001|Overall Study|Participant died before treatment|0|||
162851830|NCT01827384|588162691|FG002|Overall Study|Participant died before treatment|0|||
162851831|NCT01827384|588162692|FG003|Overall Study|Participant died before treatment|0|||
162851832|NCT01827384|588162693|FG004|Overall Study|Participant died before treatment|0|||
162851833|NCT01827384|588162694|FG005|Overall Study|Participant died before treatment|0|||
162851834|NCT01827384|588162695|FG006|Overall Study|Participant died before treatment|0|||
162851835|NCT01827384|588162696|FG007|Overall Study|Participant died before treatment|0|||
162611496|NCT02694523|587294947|FG005|Part B|Protocol Violation|0|||
162611497|NCT02694523|587294948|FG006|Part B|Protocol Violation|0|||
162611498|NCT02694523|587294942|FG000|Part B|Lost to Follow-up|0|||
162611499|NCT02694523|587294943|FG001|Part B|Lost to Follow-up|0|||
162611500|NCT02694523|587294944|FG002|Part B|Lost to Follow-up|2|||
162851836|NCT01827384|588162697|FG008|Overall Study|Participant died before treatment|0|||
162851837|NCT01827384|588162698|FG009|Overall Study|Participant died before treatment|0|||
162851838|NCT01827384|588162699|FG010|Overall Study|Participant died before treatment|0|||
162851839|NCT01827384|588162700|FG011|Overall Study|Participant died before treatment|0|||
162851840|NCT01827384|588162701|FG012|Overall Study|Participant died before treatment|0|||
162851841|NCT01827384|588162702|FG013|Overall Study|Participant died before treatment|5|||
162851842|NCT01827384|588162689|FG000|Overall Study|Insufficient tumor cells|0|||
162851843|NCT01827384|588162690|FG001|Overall Study|Insufficient tumor cells|0|||
162851844|NCT01827384|588162691|FG002|Overall Study|Insufficient tumor cells|0|||
162851845|NCT01827384|588162692|FG003|Overall Study|Insufficient tumor cells|0|||
162851846|NCT01827384|588162693|FG004|Overall Study|Insufficient tumor cells|0|||
162851847|NCT01827384|588162694|FG005|Overall Study|Insufficient tumor cells|0|||
162611501|NCT02694523|587294945|FG003|Part B|Lost to Follow-up|3|||
162611502|NCT02694523|587294946|FG004|Part B|Lost to Follow-up|2|||
162611503|NCT02694523|587294947|FG005|Part B|Lost to Follow-up|0|||
162611504|NCT02694523|587294948|FG006|Part B|Lost to Follow-up|1|||
162611505|NCT02694523|587294942|FG000|Part B|Withdrawal by Subject|0|||
162851848|NCT01827384|588162695|FG006|Overall Study|Insufficient tumor cells|0|||
162851849|NCT01827384|588162696|FG007|Overall Study|Insufficient tumor cells|0|||
162851850|NCT01827384|588162697|FG008|Overall Study|Insufficient tumor cells|0|||
162611506|NCT02694523|587294943|FG001|Part B|Withdrawal by Subject|0|||
162611507|NCT02694523|587294944|FG002|Part B|Withdrawal by Subject|9|||
162611508|NCT02694523|587294945|FG003|Part B|Withdrawal by Subject|0|||
162611509|NCT02694523|587294946|FG004|Part B|Withdrawal by Subject|1|||
162851851|NCT01827384|588162698|FG009|Overall Study|Insufficient tumor cells|0|||
162851852|NCT01827384|588162699|FG010|Overall Study|Insufficient tumor cells|0|||
162851853|NCT01827384|588162700|FG011|Overall Study|Insufficient tumor cells|0|||
162851854|NCT01827384|588162701|FG012|Overall Study|Insufficient tumor cells|0|||
162851855|NCT01827384|588162702|FG013|Overall Study|Insufficient tumor cells|13|||
162851856|NCT01827384|588162689|FG000|Overall Study|No actionable mutation|0|||
162851857|NCT01827384|588162690|FG001|Overall Study|No actionable mutation|0|||
162851858|NCT01827384|588162691|FG002|Overall Study|No actionable mutation|0|||
162851859|NCT01827384|588162692|FG003|Overall Study|No actionable mutation|0|||
162851860|NCT01827384|588162693|FG004|Overall Study|No actionable mutation|0|||
162851861|NCT01827384|588162694|FG005|Overall Study|No actionable mutation|0|||
162851862|NCT01827384|588162695|FG006|Overall Study|No actionable mutation|0|||
162851863|NCT01827384|588162696|FG007|Overall Study|No actionable mutation|0|||
162851864|NCT01827384|588162697|FG008|Overall Study|No actionable mutation|0|||
162851865|NCT01827384|588162698|FG009|Overall Study|No actionable mutation|0|||
162851866|NCT01827384|588162699|FG010|Overall Study|No actionable mutation|0|||
162851867|NCT01827384|588162700|FG011|Overall Study|No actionable mutation|0|||
162851868|NCT01827384|588162701|FG012|Overall Study|No actionable mutation|0|||
162851869|NCT01827384|588162702|FG013|Overall Study|No actionable mutation|73|||
162851870|NCT01827384|588162689|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
162851871|NCT01827384|588162690|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
162851872|NCT01827384|588162691|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
162851873|NCT01827384|588162692|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
162851874|NCT01827384|588162693|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
162851875|NCT01827384|588162694|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
162851876|NCT01827384|588162695|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
162851877|NCT01827384|588162696|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
162851878|NCT01827384|588162697|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
162851879|NCT01827384|588162698|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
162851880|NCT01827384|588162699|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
162851881|NCT01827384|588162700|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
162851882|NCT01827384|588162701|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
162851883|NCT01827384|588162702|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
162851884|NCT00630331|588162703|FG000|Overall Study|Death|2|||
162851885|NCT00630331|588162704|FG001|Overall Study|Death|1|||
162851886|NCT00630331|588162705|FG002|Overall Study|Death|1|||
162851887|NCT00630331|588162703|FG000|Overall Study|Adverse Event|1|||
162851888|NCT00630331|588162704|FG001|Overall Study|Adverse Event|0|||
162851889|NCT00630331|588162705|FG002|Overall Study|Adverse Event|0|||
162851890|NCT00630331|588162703|FG000|Overall Study|Withdrawal by Subject|12|||
162851891|NCT00630331|588162704|FG001|Overall Study|Withdrawal by Subject|7|||
162851892|NCT00630331|588162705|FG002|Overall Study|Withdrawal by Subject|5|||
162851893|NCT00630331|588162703|FG000|Overall Study|Lost to Follow-up|175|||
162851894|NCT00630331|588162704|FG001|Overall Study|Lost to Follow-up|143|||
162851895|NCT00630331|588162705|FG002|Overall Study|Lost to Follow-up|170|||
162851896|NCT00630331|588162703|FG000|Overall Study|Inappropriate enrollment|3|||
162851897|NCT00630331|588162704|FG001|Overall Study|Inappropriate enrollment|6|||
162851898|NCT00630331|588162705|FG002|Overall Study|Inappropriate enrollment|3|||
162851899|NCT00630331|588162703|FG000|Overall Study|Unable to classify|9|||
162851900|NCT00630331|588162704|FG001|Overall Study|Unable to classify|4|||
162851901|NCT00630331|588162705|FG002|Overall Study|Unable to classify|3|||
162851902|NCT00630331|588162703|FG000|Overall Study|Protocol Violation|4|||
162851903|NCT00630331|588162704|FG001|Overall Study|Protocol Violation|5|||
162851904|NCT00630331|588162705|FG002|Overall Study|Protocol Violation|6|||
162851905|NCT01929135|588162713|FG000|Overall Study|Lost to Follow-up|1|||
162851906|NCT01929135|588162714|FG001|Overall Study|Lost to Follow-up|1|||
162851907|NCT01955707|588162717|FG000|Overall Study|Adverse Event|1|||
162851908|NCT01955707|588162718|FG001|Overall Study|Adverse Event|2|||
162851909|NCT01955707|588162717|FG000|Overall Study|Lost to Follow-up|2|||
162851910|NCT01955707|588162718|FG001|Overall Study|Lost to Follow-up|1|||
162851911|NCT01955707|588162717|FG000|Overall Study|Withdrawal by Subject|0|||
162851912|NCT01955707|588162718|FG001|Overall Study|Withdrawal by Subject|3|||
162851913|NCT01955707|588162717|FG000|Overall Study|Death|13|||
162851914|NCT01955707|588162718|FG001|Overall Study|Death|14|||
162851915|NCT01955707|588162717|FG000|Overall Study|Other|4|||
162851916|NCT01955707|588162718|FG001|Overall Study|Other|2|||
162851917|NCT01817790|588162723|FG000|Overall Study|Adverse Event|0|||
162851918|NCT01817790|588162724|FG001|Overall Study|Adverse Event|2|||
162851919|NCT01817790|588162723|FG000|Overall Study|Lost to Follow-up|0|||
162851920|NCT01817790|588162724|FG001|Overall Study|Lost to Follow-up|1|||
162851921|NCT01817790|588162723|FG000|Overall Study|Protocol Violation|2|||
162851922|NCT01817790|588162724|FG001|Overall Study|Protocol Violation|1|||
162851923|NCT01817790|588162723|FG000|Overall Study|Withdrawal by Subject|1|||
162851924|NCT01817790|588162724|FG001|Overall Study|Withdrawal by Subject|3|||
162851925|NCT01817790|588162723|FG000|Overall Study|Other: Could not attend appointment|1|||
162851926|NCT01817790|588162724|FG001|Overall Study|Other: Could not attend appointment|1|||
162851927|NCT01671345|588162725|FG000|Overall Study|Lost to Follow-up|10|||
162851928|NCT01671345|588162726|FG001|Overall Study|Lost to Follow-up|6|||
162851929|NCT01671345|588162725|FG000|Overall Study|visit with non-participating physician|3|||
162851930|NCT01671345|588162726|FG001|Overall Study|visit with non-participating physician|3|||
162851931|NCT02847598|588162729|FG000|Overall Study|Adverse Event|0|||
162851932|NCT02847598|588162730|FG001|Overall Study|Adverse Event|0|||
162851933|NCT02847598|588162731|FG002|Overall Study|Adverse Event|0|||
162851934|NCT02847598|588162732|FG003|Overall Study|Adverse Event|0|||
162851935|NCT02847598|588162733|FG004|Overall Study|Adverse Event|0|||
162851936|NCT02847598|588162734|FG005|Overall Study|Adverse Event|0|||
162851937|NCT02847598|588162735|FG006|Overall Study|Adverse Event|0|||
162851938|NCT02847598|588162736|FG007|Overall Study|Adverse Event|1|||
162851939|NCT02847598|588162729|FG000|Overall Study|Consent withdrawn|2|||
162851940|NCT02847598|588162730|FG001|Overall Study|Consent withdrawn|0|||
162851941|NCT02847598|588162731|FG002|Overall Study|Consent withdrawn|0|||
162851942|NCT02847598|588162732|FG003|Overall Study|Consent withdrawn|4|||
162851943|NCT02847598|588162733|FG004|Overall Study|Consent withdrawn|3|||
162851944|NCT02847598|588162734|FG005|Overall Study|Consent withdrawn|2|||
162851945|NCT02847598|588162735|FG006|Overall Study|Consent withdrawn|1|||
162851946|NCT02847598|588162736|FG007|Overall Study|Consent withdrawn|3|||
162851947|NCT02847598|588162729|FG000|Overall Study|Death|3|||
162851948|NCT02847598|588162730|FG001|Overall Study|Death|0|||
162851949|NCT02847598|588162731|FG002|Overall Study|Death|0|||
162851950|NCT02847598|588162732|FG003|Overall Study|Death|0|||
162851951|NCT02847598|588162733|FG004|Overall Study|Death|0|||
162851952|NCT02847598|588162734|FG005|Overall Study|Death|0|||
162851953|NCT02847598|588162735|FG006|Overall Study|Death|0|||
162851954|NCT02847598|588162736|FG007|Overall Study|Death|0|||
162851955|NCT02847598|588162729|FG000|Overall Study|Lost to Follow-up|0|||
162851956|NCT02847598|588162730|FG001|Overall Study|Lost to Follow-up|0|||
162851957|NCT02847598|588162731|FG002|Overall Study|Lost to Follow-up|0|||
162851958|NCT02847598|588162732|FG003|Overall Study|Lost to Follow-up|0|||
162851959|NCT02847598|588162733|FG004|Overall Study|Lost to Follow-up|0|||
162851960|NCT02847598|588162734|FG005|Overall Study|Lost to Follow-up|1|||
162851961|NCT02847598|588162735|FG006|Overall Study|Lost to Follow-up|1|||
162851962|NCT02847598|588162736|FG007|Overall Study|Lost to Follow-up|0|||
162851963|NCT03690869|588162737|FG000|Overall Study|Adverse Event|0|||
162851964|NCT03690869|588162738|FG001|Overall Study|Adverse Event|0|||
162851965|NCT03690869|588162739|FG002|Overall Study|Adverse Event|0|||
162851966|NCT03690869|588162740|FG003|Overall Study|Adverse Event|1|||
162851967|NCT03690869|588162741|FG004|Overall Study|Adverse Event|0|||
162851968|NCT03690869|588162742|FG005|Overall Study|Adverse Event|0|||
162851969|NCT03690869|588162743|FG006|Overall Study|Adverse Event|0|||
162851970|NCT03690869|588162744|FG007|Overall Study|Adverse Event|1|||
162611510|NCT02694523|587294947|FG005|Part B|Withdrawal by Subject|3|||
162851971|NCT03690869|588162745|FG008|Overall Study|Adverse Event|0|||
162851972|NCT03690869|588162746|FG009|Overall Study|Adverse Event|1|||
162851973|NCT03690869|588162737|FG000|Overall Study|Death|1|||
162611511|NCT02694523|587294948|FG006|Part B|Withdrawal by Subject|0|||
162611512|NCT02694523|587294942|FG000|Part B|Other|0|||
162611513|NCT02694523|587294943|FG001|Part B|Other|0|||
162611514|NCT02694523|587294944|FG002|Part B|Other|1|||
162611515|NCT02694523|587294945|FG003|Part B|Other|0|||
162611516|NCT02694523|587294946|FG004|Part B|Other|0|||
162611517|NCT02694523|587294947|FG005|Part B|Other|0|||
162611518|NCT02694523|587294948|FG006|Part B|Other|1|||
162611519|NCT01058265|587294950|FG000|Overall Study|Lost to Follow-up|11|||
162611520|NCT01058265|587294951|FG001|Overall Study|Lost to Follow-up|12|||
162611521|NCT01243671|587294952|FG000|Overall Study|Adverse Event|3|||
162851974|NCT03690869|588162738|FG001|Overall Study|Death|1|||
162851975|NCT03690869|588162739|FG002|Overall Study|Death|1|||
162851976|NCT03690869|588162740|FG003|Overall Study|Death|4|||
162851977|NCT03690869|588162741|FG004|Overall Study|Death|2|||
162851978|NCT03690869|588162742|FG005|Overall Study|Death|5|||
162851979|NCT03690869|588162743|FG006|Overall Study|Death|3|||
162851980|NCT03690869|588162744|FG007|Overall Study|Death|2|||
162851981|NCT03690869|588162745|FG008|Overall Study|Death|0|||
162611522|NCT01243671|587294952|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
162611523|NCT01243671|587294952|FG000|Overall Study|Other|1|||
162611524|NCT02962765|587294953|FG000|Overall Study|Protocol Violation|9|||
162851982|NCT03690869|588162746|FG009|Overall Study|Death|3|||
162851983|NCT03690869|588162737|FG000|Overall Study|Lost to Follow-up|0|||
162851984|NCT03690869|588162738|FG001|Overall Study|Lost to Follow-up|0|||
162611525|NCT02962765|587294953|FG000|Overall Study|Withdrawal by Subject|3|||
162851985|NCT03690869|588162739|FG002|Overall Study|Lost to Follow-up|1|||
162851986|NCT03690869|588162740|FG003|Overall Study|Lost to Follow-up|0|||
162851987|NCT03690869|588162741|FG004|Overall Study|Lost to Follow-up|0|||
162851988|NCT03690869|588162742|FG005|Overall Study|Lost to Follow-up|0|||
162851989|NCT03690869|588162743|FG006|Overall Study|Lost to Follow-up|0|||
162851990|NCT03690869|588162744|FG007|Overall Study|Lost to Follow-up|0|||
162851991|NCT03690869|588162745|FG008|Overall Study|Lost to Follow-up|0|||
162851992|NCT03690869|588162746|FG009|Overall Study|Lost to Follow-up|0|||
162851993|NCT03690869|588162737|FG000|Overall Study|Other Treatment|1|||
162851994|NCT03690869|588162738|FG001|Overall Study|Other Treatment|1|||
162851995|NCT03690869|588162739|FG002|Overall Study|Other Treatment|1|||
162851996|NCT03690869|588162740|FG003|Overall Study|Other Treatment|2|||
162851997|NCT03690869|588162741|FG004|Overall Study|Other Treatment|3|||
162851998|NCT03690869|588162742|FG005|Overall Study|Other Treatment|1|||
162851999|NCT03690869|588162743|FG006|Overall Study|Other Treatment|2|||
162954006|NCT00573443|588536223|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
162954007|NCT00573443|588536224|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
162954008|NCT00573443|588536222|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
162954009|NCT00573443|588536223|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
162954010|NCT00573443|588536224|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162954011|NCT00573443|588536222|FG000|Open-Label Extension Phase|Protocol Violation|2|||
162954012|NCT00573443|588536223|FG001|Open-Label Extension Phase|Protocol Violation|0|||
162954013|NCT00573443|588536224|FG002|Open-Label Extension Phase|Protocol Violation|0|||
162954014|NCT00573443|588536222|FG000|Open-Label Extension Phase|Other|2|||
162954015|NCT00573443|588536223|FG001|Open-Label Extension Phase|Other|0|||
162611526|NCT02962765|587294953|FG000|Overall Study|Lost to Follow-up|1|||
162611527|NCT02962765|587294953|FG000|Overall Study|Death|1|||
162611528|NCT02962765|587294953|FG000|Overall Study|Limited access to study medication|3|||
162611529|NCT02169284|587294954|FG000|Overall Study|Physician Decision|0|||
162611530|NCT02169284|587294955|FG001|Overall Study|Physician Decision|1|||
162611531|NCT01367119|587294956|FG000|Overall Study|Adverse Event|1|||
162611532|NCT01367119|587294957|FG001|Overall Study|Adverse Event|0|||
162611533|NCT01367119|587294956|FG000|Overall Study|Withdrawal by Subject|1|||
162611534|NCT01367119|587294957|FG001|Overall Study|Withdrawal by Subject|1|||
162611535|NCT02964507|587294960|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
162611536|NCT02964507|587294961|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
162611537|NCT02964507|587294962|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
162611538|NCT02964507|587294963|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
162611539|NCT02964507|587294964|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
162611540|NCT02964507|587294965|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
162611541|NCT02964507|587294966|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
162852000|NCT03690869|588162744|FG007|Overall Study|Other Treatment|7|||
162852001|NCT03690869|588162745|FG008|Overall Study|Other Treatment|0|||
162852002|NCT03690869|588162746|FG009|Overall Study|Other Treatment|3|||
162852003|NCT03690869|588162737|FG000|Overall Study|Physician Decision|0|||
162852004|NCT03690869|588162738|FG001|Overall Study|Physician Decision|1|||
162852005|NCT03690869|588162739|FG002|Overall Study|Physician Decision|0|||
162954016|NCT00573443|588536224|FG002|Open-Label Extension Phase|Other|0|||
162954017|NCT04567186|588536230|FG000|Period 1|COVID-19 related|1|||
162852006|NCT03690869|588162740|FG003|Overall Study|Physician Decision|0|||
162852007|NCT03690869|588162741|FG004|Overall Study|Physician Decision|0|||
162852008|NCT03690869|588162742|FG005|Overall Study|Physician Decision|0|||
162852009|NCT03690869|588162743|FG006|Overall Study|Physician Decision|0|||
162852010|NCT03690869|588162744|FG007|Overall Study|Physician Decision|0|||
162852011|NCT03690869|588162745|FG008|Overall Study|Physician Decision|0|||
162852012|NCT03690869|588162746|FG009|Overall Study|Physician Decision|0|||
162852013|NCT03690869|588162737|FG000|Overall Study|Progressive Disease|1|||
162852014|NCT03690869|588162738|FG001|Overall Study|Progressive Disease|2|||
162852015|NCT03690869|588162739|FG002|Overall Study|Progressive Disease|0|||
162852016|NCT03690869|588162740|FG003|Overall Study|Progressive Disease|1|||
162852017|NCT03690869|588162741|FG004|Overall Study|Progressive Disease|0|||
162852018|NCT03690869|588162742|FG005|Overall Study|Progressive Disease|0|||
162852019|NCT03690869|588162743|FG006|Overall Study|Progressive Disease|0|||
162852020|NCT03690869|588162744|FG007|Overall Study|Progressive Disease|0|||
162852021|NCT03690869|588162745|FG008|Overall Study|Progressive Disease|1|||
162852022|NCT03690869|588162746|FG009|Overall Study|Progressive Disease|1|||
162852023|NCT03690869|588162737|FG000|Overall Study|Subject Decision|0|||
162852024|NCT03690869|588162738|FG001|Overall Study|Subject Decision|0|||
162852025|NCT03690869|588162739|FG002|Overall Study|Subject Decision|0|||
162852026|NCT03690869|588162740|FG003|Overall Study|Subject Decision|1|||
162852027|NCT03690869|588162741|FG004|Overall Study|Subject Decision|0|||
162852028|NCT03690869|588162742|FG005|Overall Study|Subject Decision|0|||
162852029|NCT03690869|588162743|FG006|Overall Study|Subject Decision|0|||
162852030|NCT03690869|588162744|FG007|Overall Study|Subject Decision|1|||
162852031|NCT03690869|588162745|FG008|Overall Study|Subject Decision|0|||
162852032|NCT03690869|588162746|FG009|Overall Study|Subject Decision|0|||
162852033|NCT00960076|588164485|FG000|Overall Study|Adverse Event|1|||
162852034|NCT00960076|588164486|FG001|Overall Study|Adverse Event|7|||
162852035|NCT00960076|588164485|FG000|Overall Study|No longer met study criteria|1|||
162852036|NCT00960076|588164486|FG001|Overall Study|No longer met study criteria|5|||
162852037|NCT00960076|588164485|FG000|Overall Study|Withdrawal by Subject|1|||
162611542|NCT02964507|587294967|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
162611543|NCT02964507|587294960|FG000|Overall Study|Study terminated by Sponsor|9|||
162611544|NCT02964507|587294961|FG001|Overall Study|Study terminated by Sponsor|1|||
162611545|NCT02964507|587294962|FG002|Overall Study|Study terminated by Sponsor|9|||
162611546|NCT02964507|587294963|FG003|Overall Study|Study terminated by Sponsor|3|||
162611547|NCT02964507|587294964|FG004|Overall Study|Study terminated by Sponsor|3|||
162611548|NCT02964507|587294965|FG005|Overall Study|Study terminated by Sponsor|2|||
162611549|NCT02964507|587294966|FG006|Overall Study|Study terminated by Sponsor|0|||
162611550|NCT02964507|587294967|FG007|Overall Study|Study terminated by Sponsor|0|||
162611551|NCT02964507|587294960|FG000|Overall Study|Other|3|||
162611552|NCT02964507|587294961|FG001|Overall Study|Other|0|||
162611553|NCT02964507|587294962|FG002|Overall Study|Other|0|||
162611554|NCT02964507|587294963|FG003|Overall Study|Other|0|||
162611555|NCT02964507|587294964|FG004|Overall Study|Other|1|||
162611556|NCT02964507|587294965|FG005|Overall Study|Other|0|||
162611557|NCT02964507|587294966|FG006|Overall Study|Other|0|||
162611558|NCT02964507|587294967|FG007|Overall Study|Other|0|||
162611559|NCT02964507|587294960|FG000|Overall Study|Death|11|||
162611560|NCT02964507|587294961|FG001|Overall Study|Death|9|||
162611561|NCT02964507|587294962|FG002|Overall Study|Death|12|||
162611562|NCT02964507|587294963|FG003|Overall Study|Death|2|||
162611563|NCT02964507|587294964|FG004|Overall Study|Death|10|||
162852038|NCT00960076|588164486|FG001|Overall Study|Withdrawal by Subject|2|||
162852039|NCT00960076|588164485|FG000|Overall Study|Lost to Follow-up|3|||
162852040|NCT00960076|588164486|FG001|Overall Study|Lost to Follow-up|3|||
162852041|NCT00960076|588164485|FG000|Overall Study|Severe non-compliance to protocol|1|||
162852042|NCT00960076|588164486|FG001|Overall Study|Severe non-compliance to protocol|2|||
162852043|NCT00960076|588164485|FG000|Overall Study|Hyperglycemia|1|||
162611564|NCT02964507|587294965|FG005|Overall Study|Death|5|||
162611565|NCT02964507|587294966|FG006|Overall Study|Death|0|||
162611566|NCT02964507|587294967|FG007|Overall Study|Death|0|||
162611567|NCT02964507|587294960|FG000|Overall Study|Withdrawal by Subject|1|||
162611568|NCT02964507|587294961|FG001|Overall Study|Withdrawal by Subject|0|||
162611569|NCT02964507|587294962|FG002|Overall Study|Withdrawal by Subject|1|||
162852044|NCT00960076|588164486|FG001|Overall Study|Hyperglycemia|5|||
162954018|NCT04567186|588536231|FG001|Period 1|COVID-19 related|0|||
162954019|NCT04567186|588536230|FG000|Period 1|Protocol Violation|0|||
162954020|NCT04567186|588536231|FG001|Period 1|Protocol Violation|1|||
162954021|NCT04567186|588536230|FG000|Period 1|Adverse Event|0|||
162954022|NCT04567186|588536231|FG001|Period 1|Adverse Event|2|||
162954023|NCT04567186|588536230|FG000|Period 2|COVID-19 Related|0|||
162954024|NCT04567186|588536231|FG001|Period 2|COVID-19 Related|1|||
162954025|NCT04567186|588536230|FG000|Period 2|Protocol Violation|0|||
162954026|NCT04567186|588536231|FG001|Period 2|Protocol Violation|1|||
162954027|NCT04567186|588536230|FG000|Period 2|Lost to Follow-up|0|||
162954028|NCT04567186|588536231|FG001|Period 2|Lost to Follow-up|1|||
162954029|NCT04567186|588536230|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
162954030|NCT04567186|588536231|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
162954031|NCT02924883|588536232|FG000|Overall Study|Death|39|||
162954032|NCT02924883|588536233|FG001|Overall Study|Death|20|||
162954033|NCT02924883|588536232|FG000|Overall Study|Lost to Follow-up|1|||
162954034|NCT02924883|588536233|FG001|Overall Study|Lost to Follow-up|0|||
162954035|NCT02924883|588536232|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
162954036|NCT02924883|588536233|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
162954037|NCT02924883|588536232|FG000|Overall Study|Protocol Violation|1|||
162954038|NCT02924883|588536233|FG001|Overall Study|Protocol Violation|0|||
162954039|NCT02924883|588536232|FG000|Overall Study|Withdrawal by Subject|22|||
162852045|NCT00960076|588164485|FG000|Overall Study|Did not attend the termination visit|0|||
162852046|NCT00960076|588164486|FG001|Overall Study|Did not attend the termination visit|1|||
162852047|NCT02029976|588164487|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
162852048|NCT02029976|588164488|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
162852049|NCT02029976|588164487|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
162852050|NCT02029976|588164488|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
162852051|NCT02029976|588164487|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
162852052|NCT02029976|588164488|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
162852053|NCT02029976|588164487|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
162852054|NCT02029976|588164488|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
162852055|NCT03263806|588164489|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
162852056|NCT03263806|588164490|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
162852057|NCT03263806|588164489|FG000|Overall Study|Withdrawal by Subject|0|||
162852058|NCT03263806|588164490|FG001|Overall Study|Withdrawal by Subject|1|||
162852059|NCT03263806|588164489|FG000|Overall Study|Study Termination|5|||
162852060|NCT03263806|588164490|FG001|Overall Study|Study Termination|6|||
162852061|NCT04840667|588164491|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
162852062|NCT01445171|588164492|FG000|Overall Study|Lost to Follow-up|11|||
162852063|NCT01445171|588164492|FG000|Overall Study|Withdrawal by Subject|16|||
162852064|NCT01445171|588164492|FG000|Overall Study|Death|51|||
162852065|NCT01445171|588164492|FG000|Overall Study|Subjects declined to return for followup|9|||
162852066|NCT01445171|588164492|FG000|Overall Study|Consented but did not receive device|8|||
162852067|NCT00023322|588164493|FG000|Overall Study|Lost to Follow-up|1|||
162852068|NCT05194345|588164496|FG000|Overall Study|Withdrawal by Subject|6|||
162852069|NCT05194345|588164497|FG001|Overall Study|Withdrawal by Subject|4|||
162852070|NCT05194345|588164498|FG002|Overall Study|Withdrawal by Subject|0|||
162852071|NCT05194345|588164496|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
162852072|NCT05194345|588164497|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
162852073|NCT05194345|588164498|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
162852074|NCT02612909|588164499|FG000|Phase 2|Withdrawal by Subject|2|||
162852075|NCT02612909|588164500|FG001|Phase 2|Withdrawal by Subject|5|||
162852076|NCT02612909|588164501|FG002|Phase 2|Withdrawal by Subject|0|||
162852077|NCT02612909|588164502|FG003|Phase 2|Withdrawal by Subject|0|||
162852078|NCT02612909|588164503|FG004|Phase 2|Withdrawal by Subject|0|||
162852079|NCT02612909|588164499|FG000|Phase 2|Pregnancy|0|||
162852080|NCT02612909|588164500|FG001|Phase 2|Pregnancy|0|||
162852081|NCT02612909|588164501|FG002|Phase 2|Pregnancy|1|||
162852082|NCT02612909|588164502|FG003|Phase 2|Pregnancy|0|||
162852083|NCT02612909|588164503|FG004|Phase 2|Pregnancy|0|||
162852084|NCT02612909|588164499|FG000|Phase 3|Withdrawal by Subject|0|||
162852085|NCT02612909|588164500|FG001|Phase 3|Withdrawal by Subject|0|||
162852086|NCT02612909|588164501|FG002|Phase 3|Withdrawal by Subject|0|||
162852087|NCT02612909|588164502|FG003|Phase 3|Withdrawal by Subject|1|||
162852088|NCT02612909|588164503|FG004|Phase 3|Withdrawal by Subject|0|||
162852089|NCT05067127|588164508|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
162852090|NCT05067127|588164509|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
162852091|NCT05067127|588164510|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
162852092|NCT05067127|588164511|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
162852093|NCT05067127|588164508|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
162852094|NCT05067127|588164509|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
162852095|NCT05067127|588164510|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
162954040|NCT02924883|588536233|FG001|Overall Study|Withdrawal by Subject|16|||
162954041|NCT02924883|588536232|FG000|Overall Study|Progressive Disease|1|||
162954042|NCT02924883|588536233|FG001|Overall Study|Progressive Disease|0|||
162954043|NCT02924883|588536232|FG000|Overall Study|Study Terminated by Sponsor|69|||
162954044|NCT02924883|588536233|FG001|Overall Study|Study Terminated by Sponsor|32|||
162954045|NCT02481830|588536235|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
162852096|NCT05067127|588164511|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
162852097|NCT05067127|588164508|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
162954046|NCT02481830|588536236|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
162852098|NCT05067127|588164509|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
162852099|NCT05067127|588164510|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
162852100|NCT05067127|588164511|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
162852101|NCT05067127|588164508|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
162852102|NCT05067127|588164509|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
162852103|NCT05067127|588164510|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
162852104|NCT05067127|588164511|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
162852105|NCT05067127|588164508|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
162852106|NCT05067127|588164509|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
162852107|NCT05067127|588164510|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
162852108|NCT05067127|588164511|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
162852109|NCT05067127|588164508|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
162852110|NCT05067127|588164509|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
162852111|NCT05067127|588164510|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
162852112|NCT05067127|588164511|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
162852113|NCT05067127|588164508|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
162852114|NCT05067127|588164509|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
162852115|NCT05067127|588164510|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
162852116|NCT05067127|588164511|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
162852117|NCT03615222|588164513|FG000|Overall Study|Ineligible|26|||
162852118|NCT03615222|588164513|FG000|Overall Study|Withdrawal by Subject|7|||
162852119|NCT03615222|588164513|FG000|Overall Study|Death|1|||
162852120|NCT04572633|588164514|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
162852121|NCT03155997|588164517|FG000|Overall Study|Withdrawal by Subject|119|||
162852122|NCT03155997|588164518|FG001|Overall Study|Withdrawal by Subject|134|||
162852123|NCT03155997|588164517|FG000|Overall Study|Lost to Follow-up|12|||
162852124|NCT03155997|588164518|FG001|Overall Study|Lost to Follow-up|13|||
162852125|NCT03155997|588164517|FG000|Overall Study|Missing disposition data|0|||
162852126|NCT03155997|588164518|FG001|Overall Study|Missing disposition data|1|||
162852127|NCT03155997|588164517|FG000|Overall Study|On study treatment|2027|||
162852128|NCT03155997|588164518|FG001|Overall Study|On study treatment|2074|||
162852129|NCT03304522|588164521|FG000|Overall Study|Adverse Event|0|||
162852130|NCT03304522|588164522|FG001|Overall Study|Adverse Event|4|||
162852131|NCT03304522|588164521|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
162852132|NCT03304522|588164522|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
162852133|NCT03304522|588164521|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
162852134|NCT03304522|588164522|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
162852135|NCT03304522|588164521|FG000|Overall Study|Other|0|||
162852136|NCT03304522|588164522|FG001|Overall Study|Other|1|||
162852137|NCT03367871|588164523|FG000|Overall Study|Lost to Follow-up|1|||
162852138|NCT00885365|588164524|FG000|4 Weeks ON Treatment|Adverse Event|2|||
162852139|NCT00885365|588164525|FG001|4 Weeks ON Treatment|Adverse Event|4|||
162852140|NCT00885365|588164524|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
162852141|NCT00885365|588164525|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
162852142|NCT00885365|588164524|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
162852143|NCT00885365|588164525|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
162852144|NCT01824979|588164526|FG000|Overall Study|Withdrawal by Subject|5|||
162852145|NCT01824979|588164527|FG001|Overall Study|Withdrawal by Subject|0|||
162852146|NCT01824979|588164526|FG000|Overall Study|Physician Decision|2|||
162852147|NCT01824979|588164527|FG001|Overall Study|Physician Decision|0|||
162852148|NCT01824979|588164526|FG000|Overall Study|Protocol Violation|6|||
162852149|NCT01824979|588164527|FG001|Overall Study|Protocol Violation|13|||
162852150|NCT01756456|588164535|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
162852151|NCT01756456|588164536|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
162852152|NCT01756456|588164537|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
162852153|NCT01756456|588164538|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
162852154|NCT01756456|588164539|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
162852155|NCT01756456|588164540|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
162852156|NCT01756456|588164535|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
162852157|NCT01756456|588164536|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
162852158|NCT01756456|588164537|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
162852159|NCT01756456|588164538|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
162852160|NCT01756456|588164539|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
162852161|NCT01756456|588164540|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
162852162|NCT01756456|588164535|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
162852163|NCT01756456|588164536|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
162852164|NCT01756456|588164537|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
162852165|NCT01756456|588164538|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
162852166|NCT01756456|588164539|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
162852167|NCT01756456|588164540|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
162852168|NCT01756456|588164535|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
162852169|NCT01756456|588164536|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
162852170|NCT01756456|588164537|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
162852171|NCT01756456|588164538|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
162852172|NCT01756456|588164539|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
162852173|NCT01756456|588164540|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
162852174|NCT01756456|588164535|FG000|Treatment Period: Phase I/II|Other causes|0|||
162852175|NCT01756456|588164536|FG001|Treatment Period: Phase I/II|Other causes|0|||
162954047|NCT02481830|588536235|FG000|Pre-treatment|Withdrawal by Subject|0|||
162954048|NCT02481830|588536236|FG001|Pre-treatment|Withdrawal by Subject|10|||
162954049|NCT02481830|588536235|FG000|Pre-treatment|Disease Progression|1|||
162954050|NCT02481830|588536236|FG001|Pre-treatment|Disease Progression|1|||
162954051|NCT02481830|588536235|FG000|Pre-treatment|Other reasons|0|||
162954052|NCT02481830|588536236|FG001|Pre-treatment|Other reasons|1|||
162954053|NCT02481830|588536235|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
162954054|NCT02481830|588536236|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
162954055|NCT02481830|588536235|FG000|Treatment|Disease Progression|233|||
162954056|NCT02481830|588536236|FG001|Treatment|Disease Progression|171|||
162954057|NCT02481830|588536235|FG000|Treatment|Study drug toxicity|18|||
162852176|NCT01756456|588164537|FG002|Treatment Period: Phase I/II|Other causes|0|||
162852177|NCT01756456|588164538|FG003|Treatment Period: Phase I/II|Other causes|1|||
162852178|NCT01756456|588164539|FG004|Treatment Period: Phase I/II|Other causes|2|||
162852179|NCT01756456|588164540|FG005|Treatment Period: Phase I/II|Other causes|2|||
162852180|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
162852181|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
162852182|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
162954058|NCT02481830|588536236|FG001|Treatment|Study drug toxicity|38|||
162954059|NCT02481830|588536235|FG000|Treatment|Death|1|||
162954060|NCT02481830|588536236|FG001|Treatment|Death|1|||
162954061|NCT02481830|588536235|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
162954062|NCT02481830|588536236|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
162954063|NCT02481830|588536235|FG000|Treatment|Participants request to discontinue Study treatment|6|||
162954064|NCT02481830|588536236|FG001|Treatment|Participants request to discontinue Study treatment|34|||
162954065|NCT02481830|588536235|FG000|Treatment|Withdrawal by Subject|2|||
162954066|NCT02481830|588536236|FG001|Treatment|Withdrawal by Subject|3|||
162954067|NCT02481830|588536235|FG000|Treatment|Lost to Follow-up|1|||
162954068|NCT02481830|588536236|FG001|Treatment|Lost to Follow-up|0|||
162954069|NCT02481830|588536235|FG000|Treatment|Maximum Clinical Benefit|0|||
162954070|NCT02481830|588536236|FG001|Treatment|Maximum Clinical Benefit|5|||
163043263|NCT00320788|588865774|FG003|Overall Study|Decision by the Sponsor|0|||
163043264|NCT00320788|588865775|FG004|Overall Study|Decision by the Sponsor|1|||
163043265|NCT00320788|588865771|FG000|Overall Study|Other|1|||
163043266|NCT00320788|588865772|FG001|Overall Study|Other|2|||
163043267|NCT00320788|588865773|FG002|Overall Study|Other|1|||
163043268|NCT00320788|588865774|FG003|Overall Study|Other|1|||
163043269|NCT00320788|588865775|FG004|Overall Study|Other|1|||
163043270|NCT00320788|588865771|FG000|Overall Study|Physician Decision|1|||
163043271|NCT00320788|588865772|FG001|Overall Study|Physician Decision|1|||
163043272|NCT00320788|588865773|FG002|Overall Study|Physician Decision|0|||
163043273|NCT00320788|588865774|FG003|Overall Study|Physician Decision|0|||
163043274|NCT00320788|588865775|FG004|Overall Study|Physician Decision|0|||
163043275|NCT00320788|588865771|FG000|Overall Study|Protocol Violation|0|||
163043276|NCT00320788|588865772|FG001|Overall Study|Protocol Violation|0|||
163043277|NCT00320788|588865773|FG002|Overall Study|Protocol Violation|0|||
163043278|NCT00320788|588865774|FG003|Overall Study|Protocol Violation|0|||
163043279|NCT00320788|588865775|FG004|Overall Study|Protocol Violation|1|||
163043280|NCT00320788|588865771|FG000|Overall Study|Withdrawal by Subject|3|||
163043281|NCT00320788|588865772|FG001|Overall Study|Withdrawal by Subject|0|||
163043282|NCT00320788|588865773|FG002|Overall Study|Withdrawal by Subject|0|||
163043283|NCT00320788|588865774|FG003|Overall Study|Withdrawal by Subject|3|||
163043284|NCT00320788|588865775|FG004|Overall Study|Withdrawal by Subject|1|||
163043285|NCT04633226|588865777|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163043286|NCT04633226|588865777|FG000|Overall Study|Randomized by mistake without study treatment|1|||
163043287|NCT01765569|588865780|FG000|Period B|Withdrawal by Subject|1|||
163043288|NCT01765569|588865780|FG000|Period C|Death|1|||
163043289|NCT05415462|588865784|FG000|Overall Study|Death|18|||
163043290|NCT05415462|588865785|FG001|Overall Study|Death|10|||
162852183|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
162852184|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
162852185|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
162954071|NCT02481830|588536235|FG000|Treatment|Administrative reason by sponsor|1|||
162954072|NCT02481830|588536236|FG001|Treatment|Administrative reason by sponsor|1|||
162954073|NCT02481830|588536235|FG000|Treatment|Other reasons|6|||
162954074|NCT02481830|588536236|FG001|Treatment|Other reasons|1|||
162954075|NCT00772941|588536237|FG000|Overall Study|CRFs not available|195|||
163043291|NCT05415462|588865784|FG000|Overall Study|Lost to Follow-up|72|||
163043292|NCT05415462|588865785|FG001|Overall Study|Lost to Follow-up|64|||
163043293|NCT05415462|588865784|FG000|Overall Study|Physician Decision|5|||
163043294|NCT05415462|588865785|FG001|Overall Study|Physician Decision|5|||
163043295|NCT05415462|588865784|FG000|Overall Study|Protocol Deviation|1|||
163043296|NCT05415462|588865785|FG001|Overall Study|Protocol Deviation|0|||
163043297|NCT05415462|588865784|FG000|Overall Study|Withdrawal by Subject|129|||
163043298|NCT05415462|588865785|FG001|Overall Study|Withdrawal by Subject|101|||
162954076|NCT00772941|588536237|FG000|Overall Study|Study not completed|16|||
163043299|NCT05415462|588865784|FG000|Overall Study|Other Than Specified|8|||
162852186|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
162852187|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
162852188|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
162852189|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
162852190|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
162852191|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
162852192|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
162852193|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
162852194|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
162852195|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
162852196|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
162852197|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
162954077|NCT00772941|588536237|FG000|Overall Study|Missed Visits|374|||
162954078|NCT00772941|588536237|FG000|Overall Study|Poor Compliance|7|||
162954079|NCT00772941|588536237|FG000|Overall Study|GPSP Violation|90|||
162954080|NCT02714062|588536239|FG000|Overall Study|Adverse Event|0|||
162954081|NCT02714062|588536240|FG001|Overall Study|Adverse Event|0|||
162954082|NCT02714062|588536241|FG002|Overall Study|Adverse Event|2|||
162954083|NCT02714062|588536239|FG000|Overall Study|Withdrawal by Subject|1|||
162954084|NCT02714062|588536240|FG001|Overall Study|Withdrawal by Subject|0|||
162954085|NCT02714062|588536241|FG002|Overall Study|Withdrawal by Subject|1|||
162954086|NCT02714062|588536239|FG000|Overall Study|Protocol Violation|0|||
162954087|NCT02714062|588536240|FG001|Overall Study|Protocol Violation|1|||
162954088|NCT02714062|588536241|FG002|Overall Study|Protocol Violation|0|||
162954089|NCT02682784|588536242|FG000|Overall Study|Withdrawal by Subject|0|||
162954090|NCT02682784|588536243|FG001|Overall Study|Withdrawal by Subject|2|||
162954091|NCT02682784|588536244|FG002|Overall Study|Withdrawal by Subject|1|||
162954092|NCT02682784|588536245|FG003|Overall Study|Withdrawal by Subject|2|||
162954093|NCT02682784|588536242|FG000|Overall Study|Physician Decision|1|||
162954094|NCT02682784|588536243|FG001|Overall Study|Physician Decision|0|||
162954095|NCT02682784|588536244|FG002|Overall Study|Physician Decision|1|||
162954096|NCT02682784|588536245|FG003|Overall Study|Physician Decision|1|||
162954097|NCT01702987|588536246|FG000|Overall Study|Withdrawal by Subject|1|||
162954098|NCT01702987|588536247|FG001|Overall Study|Withdrawal by Subject|0|||
162954099|NCT00467363|588536248|FG000|Overall Study|Lost to Follow-up|80|||
162954100|NCT00467363|588536249|FG001|Overall Study|Lost to Follow-up|70|||
162954101|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
162954102|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
162954103|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
162954104|NCT03181594|588536250|FG000|Initial Study Protocol (12-month FU)|Death|1|||
162954105|NCT03181594|588536250|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
162954106|NCT03181594|588536250|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
162954107|NCT02017223|588536251|FG000|Overall Study|Algorithm problems|2|||
162954108|NCT00365846|588536253|FG000|Overall Study|Lost to Follow-up|1|||
162954109|NCT00904215|588536254|FG000|Overall Study|Adverse Event|25|||
162954110|NCT00904215|588536254|FG000|Overall Study|Protocol Violation|10|||
162954111|NCT00904215|588536254|FG000|Overall Study|Lost to Follow-up|63|||
162954112|NCT00904215|588536254|FG000|Overall Study|Withdrawal by Subject|9|||
162954113|NCT00904215|588536254|FG000|Overall Study|Other|28|||
162954114|NCT00838630|588536258|FG000|First Intervention|Adverse Event|1|||
162954115|NCT00838630|588536259|FG001|First Intervention|Adverse Event|0|||
162954116|NCT00838630|588536258|FG000|Washout: 7 Days|Protocol Violation|1|||
162954117|NCT00838630|588536259|FG001|Washout: 7 Days|Protocol Violation|0|||
162954118|NCT01185821|588536261|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162954119|NCT01185821|588536262|FG001|Overall Study|Abnormal laboratory value(s)|2|||
162954120|NCT01185821|588536263|FG002|Overall Study|Abnormal laboratory value(s)|1|||
162954121|NCT01185821|588536264|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162954122|NCT01185821|588536265|FG004|Overall Study|Abnormal laboratory value(s)|0|||
162954123|NCT01185821|588536261|FG000|Overall Study|Protocol Violation|0|||
162954124|NCT01185821|588536262|FG001|Overall Study|Protocol Violation|0|||
162954125|NCT01185821|588536263|FG002|Overall Study|Protocol Violation|0|||
162954126|NCT01185821|588536264|FG003|Overall Study|Protocol Violation|1|||
162954127|NCT01185821|588536265|FG004|Overall Study|Protocol Violation|1|||
162954128|NCT01185821|588536261|FG000|Overall Study|Abnormal test procedure result|0|||
162954129|NCT01185821|588536262|FG001|Overall Study|Abnormal test procedure result|0|||
162954130|NCT01185821|588536263|FG002|Overall Study|Abnormal test procedure result|0|||
162954131|NCT01185821|588536264|FG003|Overall Study|Abnormal test procedure result|0|||
162954132|NCT01185821|588536265|FG004|Overall Study|Abnormal test procedure result|1|||
162954133|NCT01185821|588536261|FG000|Overall Study|Death|0|||
162954134|NCT01185821|588536262|FG001|Overall Study|Death|1|||
162954135|NCT01185821|588536263|FG002|Overall Study|Death|0|||
162954136|NCT01185821|588536264|FG003|Overall Study|Death|0|||
162704554|NCT02325713|587629011|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162954137|NCT01185821|588536265|FG004|Overall Study|Death|0|||
162954138|NCT01185821|588536261|FG000|Overall Study|Condition no longer required study drug|0|||
162954139|NCT01185821|588536262|FG001|Overall Study|Condition no longer required study drug|0|||
162954140|NCT01185821|588536263|FG002|Overall Study|Condition no longer required study drug|0|||
162954141|NCT01185821|588536264|FG003|Overall Study|Condition no longer required study drug|0|||
162954142|NCT01185821|588536265|FG004|Overall Study|Condition no longer required study drug|1|||
162954143|NCT01185821|588536261|FG000|Overall Study|Adverse Event|2|||
162954144|NCT01185821|588536262|FG001|Overall Study|Adverse Event|3|||
162954145|NCT01185821|588536263|FG002|Overall Study|Adverse Event|1|||
162954146|NCT01185821|588536264|FG003|Overall Study|Adverse Event|2|||
162954147|NCT01185821|588536265|FG004|Overall Study|Adverse Event|5|||
162954148|NCT01185821|588536261|FG000|Overall Study|Lack of Efficacy|0|||
162954149|NCT01185821|588536262|FG001|Overall Study|Lack of Efficacy|0|||
162954150|NCT01185821|588536263|FG002|Overall Study|Lack of Efficacy|3|||
162954151|NCT01185821|588536264|FG003|Overall Study|Lack of Efficacy|0|||
162954152|NCT01185821|588536265|FG004|Overall Study|Lack of Efficacy|9|||
162954153|NCT01185821|588536261|FG000|Overall Study|Withdrawal by Subject|3|||
162954154|NCT01185821|588536262|FG001|Overall Study|Withdrawal by Subject|2|||
162954155|NCT01185821|588536263|FG002|Overall Study|Withdrawal by Subject|2|||
162954156|NCT01185821|588536264|FG003|Overall Study|Withdrawal by Subject|1|||
162954157|NCT01185821|588536265|FG004|Overall Study|Withdrawal by Subject|3|||
162954158|NCT01185821|588536261|FG000|Overall Study|Lost to Follow-up|1|||
162954159|NCT01185821|588536262|FG001|Overall Study|Lost to Follow-up|1|||
162954160|NCT01185821|588536263|FG002|Overall Study|Lost to Follow-up|2|||
162954161|NCT01185821|588536264|FG003|Overall Study|Lost to Follow-up|1|||
162954162|NCT01185821|588536265|FG004|Overall Study|Lost to Follow-up|2|||
162954163|NCT01185821|588536261|FG000|Overall Study|Administrative problems|0|||
162954164|NCT01185821|588536262|FG001|Overall Study|Administrative problems|0|||
162954165|NCT01185821|588536263|FG002|Overall Study|Administrative problems|1|||
162954166|NCT01185821|588536264|FG003|Overall Study|Administrative problems|1|||
162954167|NCT01185821|588536265|FG004|Overall Study|Administrative problems|2|||
162954168|NCT04263649|588536269|FG000|Overall Study|Adverse Event|53|||
162954169|NCT04263649|588536269|FG000|Overall Study|Lost to Follow-up|3|||
162954170|NCT04263649|588536269|FG000|Overall Study|Death|29|||
162954171|NCT04263649|588536269|FG000|Overall Study|Device deficiency|19|||
162954172|NCT04263649|588536269|FG000|Overall Study|other reasons|11|||
162954173|NCT02057458|588536270|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
162954174|NCT02057458|588536271|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
162954175|NCT02057458|588536272|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
162954176|NCT02057458|588536270|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
162954177|NCT02057458|588536271|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
162954178|NCT02057458|588536272|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
162954179|NCT02057458|588536270|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
162954180|NCT02057458|588536271|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
162954181|NCT02057458|588536272|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
162954182|NCT00723710|588536277|FG000|Overall Study|Disease progression|48|||
162954183|NCT00723710|588536277|FG000|Overall Study|Adverse Event|88|||
162954184|NCT00723710|588536277|FG000|Overall Study|Withdrawal by Subject|36|||
162954185|NCT00723710|588536277|FG000|Overall Study|Physician Decision|2|||
162954186|NCT01079988|588536278|FG000|Overall Study|Lost to Follow-up|0|||
162954187|NCT01079988|588536279|FG001|Overall Study|Lost to Follow-up|0|||
162954188|NCT01079988|588536280|FG002|Overall Study|Lost to Follow-up|0|||
162954189|NCT01079988|588536281|FG003|Overall Study|Lost to Follow-up|1|||
162954190|NCT01079988|588536282|FG004|Overall Study|Lost to Follow-up|0|||
162954191|NCT01079988|588536278|FG000|Overall Study|Lack of Efficacy|1|||
162954192|NCT01079988|588536279|FG001|Overall Study|Lack of Efficacy|0|||
162954193|NCT01079988|588536280|FG002|Overall Study|Lack of Efficacy|0|||
162954194|NCT01079988|588536281|FG003|Overall Study|Lack of Efficacy|0|||
162954195|NCT01079988|588536282|FG004|Overall Study|Lack of Efficacy|0|||
162954196|NCT01079988|588536278|FG000|Overall Study|Other|0|||
162954197|NCT01079988|588536279|FG001|Overall Study|Other|0|||
162954198|NCT01079988|588536280|FG002|Overall Study|Other|0|||
162954199|NCT01079988|588536281|FG003|Overall Study|Other|2|||
162954200|NCT01079988|588536282|FG004|Overall Study|Other|1|||
162954201|NCT00468286|588536283|FG000|Overall Study|Adverse Event|1|||
162954202|NCT00468286|588536284|FG001|Overall Study|Adverse Event|6|||
162954203|NCT00468286|588536283|FG000|Overall Study|Protocol Violation|2|||
162954204|NCT00468286|588536284|FG001|Overall Study|Protocol Violation|2|||
162954205|NCT00468286|588536283|FG000|Overall Study|Withdrawal by Subject|4|||
162954206|NCT00468286|588536284|FG001|Overall Study|Withdrawal by Subject|3|||
162954207|NCT00468286|588536283|FG000|Overall Study|Physician Decision|0|||
162954208|NCT00468286|588536284|FG001|Overall Study|Physician Decision|1|||
162954209|NCT02196675|588536286|FG000|Overall Study|Withdrawal by Subject|1|||
162954210|NCT02196675|588536287|FG001|Overall Study|Withdrawal by Subject|0|||
162954211|NCT02196675|588536288|FG002|Overall Study|Withdrawal by Subject|0|||
162852198|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
162852199|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
162852200|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
162852201|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
162852202|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
162852203|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
162852204|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
162852205|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
162852206|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
162852207|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
162852208|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
162852209|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
162852210|NCT01756456|588164535|FG000|Follow Up Period Phase I/II|Other causes|0|||
162852211|NCT01756456|588164536|FG001|Follow Up Period Phase I/II|Other causes|0|||
162852212|NCT01756456|588164537|FG002|Follow Up Period Phase I/II|Other causes|0|||
162852213|NCT01756456|588164538|FG003|Follow Up Period Phase I/II|Other causes|1|||
162852214|NCT01756456|588164539|FG004|Follow Up Period Phase I/II|Other causes|3|||
162852215|NCT01756456|588164540|FG005|Follow Up Period Phase I/II|Other causes|5|||
163043300|NCT05415462|588865785|FG001|Overall Study|Other Than Specified|8|||
163043301|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
163043302|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
163043303|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
162852216|NCT00813995|588164541|FG000|Overall Study|Clinical adverse event|9|||
162852217|NCT00813995|588164542|FG001|Overall Study|Clinical adverse event|3|||
162852218|NCT00813995|588164541|FG000|Overall Study|Laboratory adverse event|0|||
162852219|NCT00813995|588164542|FG001|Overall Study|Laboratory adverse event|2|||
162852220|NCT00813995|588164541|FG000|Overall Study|Lack of Efficacy|1|||
162852221|NCT00813995|588164542|FG001|Overall Study|Lack of Efficacy|0|||
162852222|NCT00813995|588164541|FG000|Overall Study|Lost to Follow-up|4|||
162852223|NCT00813995|588164542|FG001|Overall Study|Lost to Follow-up|2|||
162852224|NCT00813995|588164541|FG000|Overall Study|Other reason|2|||
162852225|NCT00813995|588164542|FG001|Overall Study|Other reason|2|||
162852226|NCT00813995|588164541|FG000|Overall Study|Protocol Violation|3|||
162852227|NCT00813995|588164542|FG001|Overall Study|Protocol Violation|2|||
162852228|NCT00813995|588164541|FG000|Overall Study|Subject moved|4|||
162852229|NCT00813995|588164542|FG001|Overall Study|Subject moved|0|||
162852230|NCT00813995|588164541|FG000|Overall Study|Withdrawal by Subject|0|||
162852231|NCT00813995|588164542|FG001|Overall Study|Withdrawal by Subject|5|||
162852232|NCT02507349|588164543|FG000|Overall Study|Death|12|||
162852233|NCT02507349|588164544|FG001|Overall Study|Death|16|||
162852234|NCT02507349|588164543|FG000|Overall Study|Withdrawal by Subject|1|||
162852235|NCT02507349|588164544|FG001|Overall Study|Withdrawal by Subject|1|||
162852236|NCT02507349|588164543|FG000|Overall Study|Lost to Follow-up|174|||
162852237|NCT02507349|588164544|FG001|Overall Study|Lost to Follow-up|144|||
162852238|NCT02700984|588164545|FG000|Overall Study|Death|2|||
162852239|NCT02700984|588164546|FG001|Overall Study|Death|1|||
162852240|NCT02700984|588164545|FG000|Overall Study|Lost to Follow-up|2|||
162852241|NCT02700984|588164546|FG001|Overall Study|Lost to Follow-up|1|||
162852242|NCT02700984|588164545|FG000|Overall Study|Physician Decision|0|||
162852243|NCT02700984|588164546|FG001|Overall Study|Physician Decision|1|||
162852244|NCT02700984|588164545|FG000|Overall Study|Withdrawal by Subject|8|||
162852245|NCT02700984|588164546|FG001|Overall Study|Withdrawal by Subject|9|||
162852246|NCT02700984|588164545|FG000|Overall Study|Reason not specified|3|||
162852247|NCT02700984|588164546|FG001|Overall Study|Reason not specified|2|||
162852248|NCT03094195|588164548|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
162852249|NCT03094195|588164549|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
162852250|NCT03094195|588164550|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
162852251|NCT03094195|588164551|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162852252|NCT03094195|588164552|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162852253|NCT03094195|588164553|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162852254|NCT03094195|588164554|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162852255|NCT03094195|588164555|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162852256|NCT03094195|588164548|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
162852257|NCT03094195|588164549|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
162852258|NCT03094195|588164550|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
162852259|NCT03094195|588164551|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162852260|NCT03094195|588164552|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162852261|NCT03094195|588164553|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162852262|NCT03094195|588164554|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162852263|NCT03094195|588164555|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162852264|NCT03094195|588164548|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852265|NCT03094195|588164549|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852266|NCT03094195|588164550|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
162852267|NCT03094195|588164551|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852268|NCT03094195|588164552|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852269|NCT03094195|588164553|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852270|NCT03094195|588164554|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852271|NCT03094195|588164555|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162852272|NCT03094195|588164548|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162852273|NCT03094195|588164549|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
162852274|NCT03094195|588164550|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
162852275|NCT03094195|588164551|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162852276|NCT03094195|588164552|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162852277|NCT03094195|588164553|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162852278|NCT03094195|588164554|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162954212|NCT02196675|588536286|FG000|Overall Study|Intra-operative surgical exclusion|1|||
162954213|NCT02196675|588536287|FG001|Overall Study|Intra-operative surgical exclusion|1|||
162954214|NCT02196675|588536288|FG002|Overall Study|Intra-operative surgical exclusion|0|||
162954215|NCT02196675|588536286|FG000|Overall Study|Protocol Violation|0|||
162954216|NCT02196675|588536287|FG001|Overall Study|Protocol Violation|1|||
162954217|NCT02196675|588536288|FG002|Overall Study|Protocol Violation|0|||
162954218|NCT02196675|588536286|FG000|Overall Study|Death|0|||
162954219|NCT02196675|588536287|FG001|Overall Study|Death|0|||
162954220|NCT02196675|588536288|FG002|Overall Study|Death|1|||
162954221|NCT03459807|588536289|FG000|Overall Study|Withdrawal due to transplant|0|||
162954222|NCT03459807|588536290|FG001|Overall Study|Withdrawal due to transplant|1|||
162704555|NCT04988477|587629014|FG000|Overall Study|Death|1|||
162954223|NCT02392000|588536295|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
162954224|NCT02392000|588536295|FG000|Overall Study|Withdrawal by Subject|1|||
162954225|NCT02392000|588536295|FG000|Overall Study|Lost to Follow-up|8|||
162954226|NCT00833937|588536296|FG000|Washout|Withdrawal by Subject|1|||
162954227|NCT00833937|588536297|FG001|Washout|Withdrawal by Subject|0|||
162704556|NCT04988477|587629015|FG001|Overall Study|Death|0|||
162704557|NCT04988477|587629016|FG002|Overall Study|Death|0|||
162704558|NCT04988477|587629014|FG000|Overall Study|Lost to Follow-up|5|||
162704559|NCT04988477|587629015|FG001|Overall Study|Lost to Follow-up|2|||
162704560|NCT04988477|587629016|FG002|Overall Study|Lost to Follow-up|0|||
162704561|NCT04988477|587629014|FG000|Overall Study|Withdrawal by Subject|2|||
162704562|NCT04988477|587629015|FG001|Overall Study|Withdrawal by Subject|0|||
162704563|NCT04988477|587629016|FG002|Overall Study|Withdrawal by Subject|0|||
162704564|NCT04034238|587630377|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
162704565|NCT04034238|587630378|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162704566|NCT04034238|587630379|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162704567|NCT04034238|587630380|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162704568|NCT04034238|587630377|FG000|Dose Escalation Phase|Screen failures|0|||
162704569|NCT04034238|587630378|FG001|Dose Escalation Phase|Screen failures|0|||
162704570|NCT04034238|587630379|FG002|Dose Escalation Phase|Screen failures|0|||
162704571|NCT04034238|587630380|FG003|Dose Escalation Phase|Screen failures|2|||
162704572|NCT04034238|587630377|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
162704573|NCT04034238|587630378|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
162704574|NCT04034238|587630379|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
162704575|NCT04034238|587630380|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
162704576|NCT04034238|587630377|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162704577|NCT04034238|587630378|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162704578|NCT04034238|587630379|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
162704579|NCT04034238|587630380|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162704580|NCT02153788|587630383|FG000|Overall Study|Physician Decision|2|||
162704581|NCT02153788|587630384|FG001|Overall Study|Physician Decision|1|||
162704582|NCT01106287|587630385|FG000|Overall Study|Adverse Event|1|||
162704583|NCT01106287|587630386|FG001|Overall Study|Adverse Event|0|||
162704584|NCT01106287|587630387|FG002|Overall Study|Adverse Event|0|||
162704585|NCT01106287|587630388|FG003|Overall Study|Adverse Event|0|||
162704586|NCT01450943|587630391|FG000|Overall Study|Screen failure, loss to follow-up|2|||
162704587|NCT01450943|587630392|FG001|Overall Study|Screen failure, loss to follow-up|7|||
162704588|NCT01450943|587630393|FG002|Overall Study|Screen failure, loss to follow-up|6|||
162852279|NCT03094195|588164555|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162978986|NCT01660022|588623543|FG005|First Sequence (7 Days)|Adverse Event|3|||
162978987|NCT01660022|588623538|FG000|First Sequence (7 Days)|Protocol Violation|0|||
162978988|NCT01660022|588623539|FG001|First Sequence (7 Days)|Protocol Violation|0|||
162978989|NCT01660022|588623540|FG002|First Sequence (7 Days)|Protocol Violation|0|||
162704589|NCT04822298|587630394|FG000|Overall Study|Death|3|||
162704590|NCT00465361|587630395|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
162704591|NCT01625338|587630396|FG000|Overall Study|Enrolled but not Treated|0|||
162704592|NCT01625338|587630397|FG001|Overall Study|Enrolled but not Treated|0|||
162704593|NCT01625338|587630398|FG002|Overall Study|Enrolled but not Treated|1|||
162852280|NCT01651780|588164556|FG000|Overall Study|Physician decision: No 30-day visit|2|||
162852281|NCT01651780|588164557|FG001|Overall Study|Physician decision: No 30-day visit|1|||
162852282|NCT01651780|588164556|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
162852283|NCT01651780|588164557|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
162852284|NCT01651780|588164556|FG000|Overall Study|Withdrawal by Subject|2|||
162852285|NCT01651780|588164557|FG001|Overall Study|Withdrawal by Subject|0|||
162852286|NCT01651780|588164556|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
162852287|NCT01651780|588164557|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162852288|NCT01651780|588164556|FG000|Overall Study|Lost to Follow-up|1|||
162852289|NCT01651780|588164557|FG001|Overall Study|Lost to Follow-up|2|||
162852290|NCT01651780|588164556|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
162852291|NCT01651780|588164557|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
162852292|NCT00054132|588164558|FG000|Overall Study|Not Treated|1|||
162852293|NCT02949830|588164559|FG000|Overall Study|Adverse Event|1|||
162852294|NCT02949830|588164559|FG000|Overall Study|Withdrawal by Subject|1|||
162852295|NCT01290887|588164560|FG000|Overall Study|Adverse Event|6|||
162852296|NCT01290887|588164561|FG001|Overall Study|Adverse Event|11|||
162852297|NCT01290887|588164560|FG000|Overall Study|Lack of Efficacy|4|||
162852298|NCT01290887|588164561|FG001|Overall Study|Lack of Efficacy|5|||
162852299|NCT01290887|588164560|FG000|Overall Study|Withdrawal by Subject|26|||
162852300|NCT01290887|588164561|FG001|Overall Study|Withdrawal by Subject|32|||
162852301|NCT01290887|588164560|FG000|Overall Study|Protocol Violation|2|||
162852302|NCT01290887|588164561|FG001|Overall Study|Protocol Violation|1|||
162852303|NCT01290887|588164560|FG000|Overall Study|Lost to Follow-up|4|||
162852304|NCT01290887|588164561|FG001|Overall Study|Lost to Follow-up|4|||
162852305|NCT01290887|588164560|FG000|Overall Study|Non-compliance to study procedures|0|||
162852306|NCT01290887|588164561|FG001|Overall Study|Non-compliance to study procedures|1|||
162852307|NCT01290887|588164560|FG000|Overall Study|Non-compliance to study medications|1|||
162852308|NCT01290887|588164561|FG001|Overall Study|Non-compliance to study medications|0|||
162852309|NCT01290887|588164560|FG000|Overall Study|Sponsor closure of study|420|||
162852310|NCT01290887|588164561|FG001|Overall Study|Sponsor closure of study|476|||
162852311|NCT01290887|588164560|FG000|Overall Study|Other|3|||
162852312|NCT01290887|588164561|FG001|Overall Study|Other|6|||
162852313|NCT03029832|588164562|FG000|Overall Study|Safety Follow-Up Completed|2|||
162852314|NCT03029832|588164563|FG001|Overall Study|Safety Follow-Up Completed|0|||
162852315|NCT03029832|588164562|FG000|Overall Study|Death due to Disease Progression|1|||
162852316|NCT03029832|588164563|FG001|Overall Study|Death due to Disease Progression|0|||
162852317|NCT03029832|588164562|FG000|Overall Study|Study Terminated By Sponsor|1|||
162852318|NCT03029832|588164563|FG001|Overall Study|Study Terminated By Sponsor|1|||
162852319|NCT01628926|588164564|FG000|Overall Study|Adverse Event|13|||
162852320|NCT01628926|588164565|FG001|Overall Study|Adverse Event|11|||
162852321|NCT01628926|588164566|FG002|Overall Study|Adverse Event|9|||
162852322|NCT01628926|588164564|FG000|Overall Study|Lack of Efficacy|2|||
162852323|NCT01628926|588164565|FG001|Overall Study|Lack of Efficacy|1|||
162852324|NCT01628926|588164566|FG002|Overall Study|Lack of Efficacy|5|||
162852325|NCT01628926|588164564|FG000|Overall Study|Withdrawal by Subject|6|||
162852326|NCT01628926|588164565|FG001|Overall Study|Withdrawal by Subject|4|||
162852327|NCT01628926|588164566|FG002|Overall Study|Withdrawal by Subject|2|||
162852328|NCT01628926|588164564|FG000|Overall Study|Protocol Violation|0|||
162852329|NCT01628926|588164565|FG001|Overall Study|Protocol Violation|1|||
162852330|NCT01628926|588164566|FG002|Overall Study|Protocol Violation|0|||
162852331|NCT01628926|588164564|FG000|Overall Study|Discontinuation criteria|3|||
162852332|NCT01628926|588164565|FG001|Overall Study|Discontinuation criteria|4|||
162852333|NCT01628926|588164566|FG002|Overall Study|Discontinuation criteria|0|||
162852334|NCT01628926|588164564|FG000|Overall Study|Physician Decision|2|||
162852335|NCT01628926|588164565|FG001|Overall Study|Physician Decision|2|||
162852336|NCT01628926|588164566|FG002|Overall Study|Physician Decision|1|||
162852337|NCT01412229|588164567|FG000|Overall Study|Physician Decision|1|||
163043304|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
163043305|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
163043306|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
162852338|NCT00454207|588164568|FG000|Overall Study|Adverse Event|3|||
163043307|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|Death|0|||
162852339|NCT00454207|588164569|FG001|Overall Study|Adverse Event|1|||
162852340|NCT00454207|588164568|FG000|Overall Study|Lack of Efficacy|1|||
162852341|NCT00454207|588164569|FG001|Overall Study|Lack of Efficacy|0|||
162852342|NCT00454207|588164568|FG000|Overall Study|Protocol Violation|0|||
162852343|NCT00454207|588164569|FG001|Overall Study|Protocol Violation|1|||
162852344|NCT01672957|588164570|FG000|Overall Study|Protocol Violation|48|||
162852345|NCT01672957|588164570|FG000|Overall Study|Death|2|||
162852346|NCT01672957|588164570|FG000|Overall Study|ICF Signed After Transplantation|5|||
162852347|NCT01795547|588164575|FG000|Overall Study|Adverse Event|16|||
162852348|NCT01795547|588164576|FG001|Overall Study|Adverse Event|27|||
162852349|NCT01795547|588164575|FG000|Overall Study|Lack of Efficacy|8|||
162852350|NCT01795547|588164576|FG001|Overall Study|Lack of Efficacy|3|||
162852351|NCT01795547|588164575|FG000|Overall Study|Protocol Violation|6|||
162852352|NCT01795547|588164576|FG001|Overall Study|Protocol Violation|4|||
162852353|NCT01795547|588164575|FG000|Overall Study|Lost to Follow-up|2|||
162852354|NCT01795547|588164576|FG001|Overall Study|Lost to Follow-up|5|||
162852355|NCT01795547|588164575|FG000|Overall Study|Withdrawal of consent|7|||
162852356|NCT01795547|588164576|FG001|Overall Study|Withdrawal of consent|12|||
162852357|NCT01795547|588164575|FG000|Overall Study|Not Treated|4|||
162852358|NCT01795547|588164576|FG001|Overall Study|Not Treated|10|||
162852359|NCT01795547|588164575|FG000|Overall Study|Non-compliance with IMP|1|||
162852360|NCT01795547|588164576|FG001|Overall Study|Non-compliance with IMP|1|||
162852361|NCT01795547|588164575|FG000|Overall Study|Others|4|||
162852362|NCT01795547|588164576|FG001|Overall Study|Others|1|||
162852363|NCT01795547|588164575|FG000|Overall Study|Not stated|0|||
162852364|NCT01795547|588164576|FG001|Overall Study|Not stated|1|||
162852365|NCT00642642|588164578|FG000|Treatment & Follow Up|Adverse Event|2|||
162852366|NCT00642642|588164578|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
162852367|NCT00642642|588164578|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
162852368|NCT02116621|588164579|FG000|Baseline|Withdrawal by Subject|0|||
162852369|NCT02116621|588164580|FG001|Baseline|Withdrawal by Subject|4|||
162852370|NCT02116621|588164579|FG000|Three Month Follow-up|Death|1|||
162852371|NCT02116621|588164580|FG001|Three Month Follow-up|Death|1|||
162852372|NCT02116621|588164579|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
162852373|NCT02116621|588164580|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
162852374|NCT02116621|588164579|FG000|Three Month Follow-up|Lost to Follow-up|0|||
162852375|NCT02116621|588164580|FG001|Three Month Follow-up|Lost to Follow-up|1|||
162852376|NCT02116621|588164579|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
162852377|NCT02116621|588164580|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
162852378|NCT02116621|588164579|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
162852379|NCT02116621|588164580|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
162852380|NCT02116621|588164579|FG000|Six Month Follow-up|Lost to Follow-up|2|||
162852381|NCT02116621|588164580|FG001|Six Month Follow-up|Lost to Follow-up|1|||
162852382|NCT02116621|588164579|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
162852383|NCT02116621|588164580|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
162852384|NCT02116621|588164579|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
162852385|NCT02116621|588164580|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
162852386|NCT02116621|588164579|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
162852387|NCT02116621|588164580|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
162852388|NCT02116621|588164579|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
162852389|NCT02116621|588164580|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
162852390|NCT02116621|588164579|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
162852391|NCT02116621|588164580|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
162852392|NCT00151892|588164581|FG000|Overall Study|Lack of Efficacy|50|||
162852393|NCT00151892|588164582|FG001|Overall Study|Lack of Efficacy|57|||
162852394|NCT00151892|588164581|FG000|Overall Study|Patient request|10|||
162852395|NCT00151892|588164582|FG001|Overall Study|Patient request|7|||
162852396|NCT00151892|588164581|FG000|Overall Study|Lost to Follow-up|5|||
162852397|NCT00151892|588164582|FG001|Overall Study|Lost to Follow-up|10|||
162852398|NCT00151892|588164581|FG000|Overall Study|Adverse Event|6|||
162852399|NCT00151892|588164582|FG001|Overall Study|Adverse Event|3|||
162852400|NCT00151892|588164581|FG000|Overall Study|Protocol Violation|3|||
162852401|NCT00151892|588164582|FG001|Overall Study|Protocol Violation|3|||
162852402|NCT00151892|588164581|FG000|Overall Study|Non-compliance|0|||
162852403|NCT00151892|588164582|FG001|Overall Study|Non-compliance|1|||
162852404|NCT00151892|588164581|FG000|Overall Study|Pregnancy|0|||
162852405|NCT00151892|588164582|FG001|Overall Study|Pregnancy|1|||
162852406|NCT00151892|588164581|FG000|Overall Study|Did not return for a visit|1|||
162852407|NCT00151892|588164582|FG001|Overall Study|Did not return for a visit|0|||
162852408|NCT00151892|588164581|FG000|Overall Study|Used prohibited corticosteroids|1|||
162852409|NCT00151892|588164582|FG001|Overall Study|Used prohibited corticosteroids|0|||
162852410|NCT00151892|588164581|FG000|Overall Study|Lack of study medication at center|0|||
162852411|NCT00151892|588164582|FG001|Overall Study|Lack of study medication at center|1|||
162852412|NCT03437447|588164583|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162852413|NCT03437447|588164584|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162852414|NCT03437447|588164585|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162852415|NCT04223609|588164586|FG000|Overall Study|Adverse Event|0|||
162852416|NCT04223609|588164587|FG001|Overall Study|Adverse Event|1|||
162852417|NCT04223609|588164586|FG000|Overall Study|Missed last visit|0|||
162852418|NCT04223609|588164587|FG001|Overall Study|Missed last visit|1|||
162852419|NCT03440944|588164590|FG000|Overall Study|Physician Decision|1|||
162852420|NCT03440944|588164591|FG001|Overall Study|Physician Decision|0|||
162852421|NCT03440944|588164590|FG000|Overall Study|No Acceptable Vasculature|0|||
162852422|NCT03440944|588164591|FG001|Overall Study|No Acceptable Vasculature|1|||
162852423|NCT00591734|588164592|FG000|Overall Study|Lack of Efficacy|35|||
162852424|NCT00591734|588164592|FG000|Overall Study|Adverse Event|5|||
162852425|NCT00591734|588164592|FG000|Overall Study|Physician Decision|5|||
162852426|NCT00591734|588164592|FG000|Overall Study|Intercurrent Illness|8|||
162852427|NCT04672083|588164593|FG000|Overall Study|Lost to Follow-up|1|||
162852428|NCT04672083|588164594|FG001|Overall Study|Lost to Follow-up|0|||
162852429|NCT04672083|588164595|FG002|Overall Study|Lost to Follow-up|0|||
163043308|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|Death|1|||
163043309|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|Death|0|||
163043310|NCT01030718|588865786|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
163043311|NCT01030718|588865787|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
163043312|NCT01030718|588865788|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
163043313|NCT01030718|588865786|FG000|Study CA180-036 Only|insufficient effect|1|||
163043314|NCT01030718|588865787|FG001|Study CA180-036 Only|insufficient effect|1|||
163043315|NCT01030718|588865788|FG002|Study CA180-036 Only|insufficient effect|5|||
163043316|NCT01030718|588865786|FG000|Study CA180-036 Only|Adverse Event|2|||
163043317|NCT01030718|588865787|FG001|Study CA180-036 Only|Adverse Event|3|||
163043318|NCT01030718|588865788|FG002|Study CA180-036 Only|Adverse Event|0|||
163043319|NCT01030718|588865786|FG000|Study CA180-036 Only|Death|0|||
163043320|NCT01030718|588865787|FG001|Study CA180-036 Only|Death|1|||
163043321|NCT01030718|588865788|FG002|Study CA180-036 Only|Death|0|||
162852430|NCT04672083|588164596|FG003|Overall Study|Lost to Follow-up|0|||
162852431|NCT04672083|588164597|FG004|Overall Study|Lost to Follow-up|0|||
162852432|NCT01551745|588164598|FG000|Overall Study|Withdrawal by Subject|1|||
162852433|NCT01551745|588164598|FG000|Overall Study|Disease Progression|2|||
162852434|NCT01661790|588164599|FG000|Overall Study|Lost to Follow-up|0|||
162852435|NCT01661790|588164600|FG001|Overall Study|Lost to Follow-up|2|||
162852436|NCT02764541|588164601|FG000|Overall Study|Withdrawal by Subject|0|||
162852437|NCT02764541|588164602|FG001|Overall Study|Withdrawal by Subject|0|||
162852438|NCT02764541|588164603|FG002|Overall Study|Withdrawal by Subject|0|||
162852439|NCT02764541|588164604|FG003|Overall Study|Withdrawal by Subject|0|||
162852440|NCT02764541|588164605|FG004|Overall Study|Withdrawal by Subject|1|||
162852441|NCT02764541|588164606|FG005|Overall Study|Withdrawal by Subject|1|||
162852442|NCT02764541|588164607|FG006|Overall Study|Withdrawal by Subject|0|||
162852443|NCT02764541|588164608|FG007|Overall Study|Withdrawal by Subject|1|||
162852444|NCT02764541|588164601|FG000|Overall Study|Adverse Event|1|||
162852445|NCT02764541|588164602|FG001|Overall Study|Adverse Event|0|||
162852446|NCT02764541|588164603|FG002|Overall Study|Adverse Event|0|||
162852447|NCT02764541|588164604|FG003|Overall Study|Adverse Event|0|||
162852448|NCT02764541|588164605|FG004|Overall Study|Adverse Event|0|||
162852449|NCT02764541|588164606|FG005|Overall Study|Adverse Event|0|||
162852450|NCT02764541|588164607|FG006|Overall Study|Adverse Event|1|||
162852451|NCT02764541|588164608|FG007|Overall Study|Adverse Event|0|||
162852452|NCT02764541|588164601|FG000|Overall Study|Metastasis|1|||
162852453|NCT02764541|588164602|FG001|Overall Study|Metastasis|0|||
162852454|NCT02764541|588164603|FG002|Overall Study|Metastasis|0|||
162852455|NCT02764541|588164604|FG003|Overall Study|Metastasis|0|||
162852456|NCT02764541|588164605|FG004|Overall Study|Metastasis|0|||
162852457|NCT02764541|588164606|FG005|Overall Study|Metastasis|0|||
162852458|NCT02764541|588164607|FG006|Overall Study|Metastasis|0|||
162852459|NCT02764541|588164608|FG007|Overall Study|Metastasis|0|||
162852460|NCT02764541|588164601|FG000|Overall Study|Disease progression|1|||
162852461|NCT02764541|588164602|FG001|Overall Study|Disease progression|1|||
162852462|NCT02764541|588164603|FG002|Overall Study|Disease progression|0|||
162852463|NCT02764541|588164604|FG003|Overall Study|Disease progression|0|||
162852464|NCT02764541|588164605|FG004|Overall Study|Disease progression|0|||
162852465|NCT02764541|588164606|FG005|Overall Study|Disease progression|0|||
162852466|NCT02764541|588164607|FG006|Overall Study|Disease progression|0|||
162852467|NCT02764541|588164608|FG007|Overall Study|Disease progression|1|||
162852468|NCT02764541|588164601|FG000|Overall Study|Protocol Violation|0|||
162852469|NCT02764541|588164602|FG001|Overall Study|Protocol Violation|0|||
162852470|NCT02764541|588164603|FG002|Overall Study|Protocol Violation|0|||
162852471|NCT02764541|588164604|FG003|Overall Study|Protocol Violation|1|||
162852472|NCT02764541|588164605|FG004|Overall Study|Protocol Violation|0|||
163043322|NCT01030718|588865786|FG000|Study CA180-036 Only|Other Reasons|0|||
163043323|NCT01030718|588865787|FG001|Study CA180-036 Only|Other Reasons|2|||
163043324|NCT01030718|588865788|FG002|Study CA180-036 Only|Other Reasons|0|||
163043325|NCT00423813|588865789|FG000|Overall Study|Adverse Event|11|||
163043326|NCT00423813|588865790|FG001|Overall Study|Adverse Event|30|||
163043327|NCT00423813|588865791|FG002|Overall Study|Adverse Event|40|||
162852473|NCT02764541|588164606|FG005|Overall Study|Protocol Violation|1|||
162852474|NCT02764541|588164607|FG006|Overall Study|Protocol Violation|0|||
162852475|NCT02764541|588164608|FG007|Overall Study|Protocol Violation|0|||
162852476|NCT02764541|588164601|FG000|Overall Study|Physician Decision|0|||
162852477|NCT02764541|588164602|FG001|Overall Study|Physician Decision|0|||
162852478|NCT02764541|588164603|FG002|Overall Study|Physician Decision|0|||
162852479|NCT02764541|588164604|FG003|Overall Study|Physician Decision|1|||
162852480|NCT02764541|588164605|FG004|Overall Study|Physician Decision|0|||
162852481|NCT02764541|588164606|FG005|Overall Study|Physician Decision|0|||
162852482|NCT02764541|588164607|FG006|Overall Study|Physician Decision|0|||
162852483|NCT02764541|588164608|FG007|Overall Study|Physician Decision|1|||
162852484|NCT02764541|588164601|FG000|Overall Study|Three Cycles completed before surgery|0|||
162852485|NCT02764541|588164602|FG001|Overall Study|Three Cycles completed before surgery|0|||
162852486|NCT02764541|588164603|FG002|Overall Study|Three Cycles completed before surgery|0|||
162852487|NCT02764541|588164604|FG003|Overall Study|Three Cycles completed before surgery|1|||
162852488|NCT02764541|588164605|FG004|Overall Study|Three Cycles completed before surgery|0|||
162852489|NCT02764541|588164606|FG005|Overall Study|Three Cycles completed before surgery|0|||
162852490|NCT02764541|588164607|FG006|Overall Study|Three Cycles completed before surgery|0|||
162852491|NCT02764541|588164608|FG007|Overall Study|Three Cycles completed before surgery|0|||
162852492|NCT02764541|588164601|FG000|Overall Study|Patient Compliance|0|||
162852493|NCT02764541|588164602|FG001|Overall Study|Patient Compliance|0|||
162852494|NCT02764541|588164603|FG002|Overall Study|Patient Compliance|1|||
162852495|NCT02764541|588164604|FG003|Overall Study|Patient Compliance|0|||
162852496|NCT02764541|588164605|FG004|Overall Study|Patient Compliance|0|||
162852497|NCT02764541|588164606|FG005|Overall Study|Patient Compliance|0|||
162852498|NCT02764541|588164607|FG006|Overall Study|Patient Compliance|0|||
162852499|NCT02764541|588164608|FG007|Overall Study|Patient Compliance|0|||
162852500|NCT02764541|588164601|FG000|Overall Study|Death|0|||
162852501|NCT02764541|588164602|FG001|Overall Study|Death|0|||
162852502|NCT02764541|588164603|FG002|Overall Study|Death|0|||
162852503|NCT02764541|588164604|FG003|Overall Study|Death|0|||
162852504|NCT02764541|588164605|FG004|Overall Study|Death|0|||
162852505|NCT02764541|588164606|FG005|Overall Study|Death|0|||
162852506|NCT02764541|588164607|FG006|Overall Study|Death|1|||
162852507|NCT02764541|588164608|FG007|Overall Study|Death|0|||
162852508|NCT02764541|588164601|FG000|Overall Study|Insurance reasons|0|||
162852509|NCT02764541|588164602|FG001|Overall Study|Insurance reasons|0|||
162852510|NCT02764541|588164603|FG002|Overall Study|Insurance reasons|0|||
162852511|NCT02764541|588164604|FG003|Overall Study|Insurance reasons|0|||
162852512|NCT02764541|588164605|FG004|Overall Study|Insurance reasons|0|||
162852513|NCT02764541|588164606|FG005|Overall Study|Insurance reasons|0|||
162852514|NCT02764541|588164607|FG006|Overall Study|Insurance reasons|1|||
162852515|NCT02764541|588164608|FG007|Overall Study|Insurance reasons|0|||
162852516|NCT02048904|588164613|FG000|Overall Study|Withdrawal by Subject|7|||
162852517|NCT02048904|588164613|FG000|Overall Study|Physician Decision|70|||
162852518|NCT00749190|588164614|FG000|Overall Study|Adverse Event|0|||
162852519|NCT00749190|588164615|FG001|Overall Study|Adverse Event|2|||
162852520|NCT00749190|588164616|FG002|Overall Study|Adverse Event|0|||
162852521|NCT00749190|588164617|FG003|Overall Study|Adverse Event|4|||
163043328|NCT00423813|588865789|FG000|Overall Study|Withdrawal by Subject|6|||
163043329|NCT00423813|588865790|FG001|Overall Study|Withdrawal by Subject|8|||
162611570|NCT02964507|587294963|FG003|Overall Study|Withdrawal by Subject|1|||
162611571|NCT02964507|587294964|FG004|Overall Study|Withdrawal by Subject|0|||
162852522|NCT00749190|588164618|FG004|Overall Study|Adverse Event|0|||
162852523|NCT00749190|588164619|FG005|Overall Study|Adverse Event|3|||
162852524|NCT00749190|588164620|FG006|Overall Study|Adverse Event|0|||
162852525|NCT00749190|588164614|FG000|Overall Study|Lack of Efficacy|3|||
162852526|NCT00749190|588164615|FG001|Overall Study|Lack of Efficacy|1|||
162852527|NCT00749190|588164616|FG002|Overall Study|Lack of Efficacy|1|||
162852528|NCT00749190|588164617|FG003|Overall Study|Lack of Efficacy|0|||
162852529|NCT00749190|588164618|FG004|Overall Study|Lack of Efficacy|0|||
162852530|NCT00749190|588164619|FG005|Overall Study|Lack of Efficacy|1|||
162852531|NCT00749190|588164620|FG006|Overall Study|Lack of Efficacy|0|||
162852532|NCT00749190|588164614|FG000|Overall Study|Withdrawal by Subject|2|||
162852533|NCT00749190|588164615|FG001|Overall Study|Withdrawal by Subject|1|||
162852534|NCT00749190|588164616|FG002|Overall Study|Withdrawal by Subject|0|||
162852535|NCT00749190|588164617|FG003|Overall Study|Withdrawal by Subject|0|||
162852536|NCT00749190|588164618|FG004|Overall Study|Withdrawal by Subject|0|||
162852537|NCT00749190|588164619|FG005|Overall Study|Withdrawal by Subject|1|||
162852538|NCT00749190|588164620|FG006|Overall Study|Withdrawal by Subject|0|||
162852539|NCT00749190|588164614|FG000|Overall Study|Protocol Violation|0|||
162852540|NCT00749190|588164615|FG001|Overall Study|Protocol Violation|1|||
162852541|NCT00749190|588164616|FG002|Overall Study|Protocol Violation|0|||
162852542|NCT00749190|588164617|FG003|Overall Study|Protocol Violation|0|||
162852543|NCT00749190|588164618|FG004|Overall Study|Protocol Violation|0|||
163043330|NCT00423813|588865791|FG002|Overall Study|Withdrawal by Subject|5|||
162611572|NCT02964507|587294965|FG005|Overall Study|Withdrawal by Subject|1|||
162611573|NCT02964507|587294966|FG006|Overall Study|Withdrawal by Subject|0|||
162852544|NCT00749190|588164619|FG005|Overall Study|Protocol Violation|0|||
162852545|NCT00749190|588164620|FG006|Overall Study|Protocol Violation|1|||
162852546|NCT00749190|588164614|FG000|Overall Study|Other reason not defined above|0|||
162852547|NCT00749190|588164615|FG001|Overall Study|Other reason not defined above|0|||
162852548|NCT00749190|588164616|FG002|Overall Study|Other reason not defined above|0|||
162852549|NCT00749190|588164617|FG003|Overall Study|Other reason not defined above|1|||
162852550|NCT00749190|588164618|FG004|Overall Study|Other reason not defined above|0|||
162852551|NCT00749190|588164619|FG005|Overall Study|Other reason not defined above|0|||
162852552|NCT00749190|588164620|FG006|Overall Study|Other reason not defined above|0|||
162852553|NCT03726268|588164623|FG000|Overall Study|Physician Decision|2|||
162852554|NCT03726268|588164624|FG001|Overall Study|Physician Decision|8|||
162852555|NCT03726268|588164625|FG002|Overall Study|Physician Decision|6|||
162852556|NCT03726268|588164626|FG003|Overall Study|Physician Decision|3|||
163043331|NCT00423813|588865789|FG000|Overall Study|Lost to Follow-up|5|||
163043332|NCT00423813|588865790|FG001|Overall Study|Lost to Follow-up|4|||
162611574|NCT02964507|587294967|FG007|Overall Study|Withdrawal by Subject|0|||
162611575|NCT02964507|587294960|FG000|Overall Study|Physician Decision|2|||
162611576|NCT02964507|587294961|FG001|Overall Study|Physician Decision|0|||
163043333|NCT00423813|588865791|FG002|Overall Study|Lost to Follow-up|4|||
163043334|NCT00423813|588865789|FG000|Overall Study|Lack of Efficacy|23|||
163043335|NCT00423813|588865790|FG001|Overall Study|Lack of Efficacy|18|||
163043336|NCT00423813|588865791|FG002|Overall Study|Lack of Efficacy|19|||
163043337|NCT00423813|588865789|FG000|Overall Study|Physician Decision|2|||
163043338|NCT00423813|588865790|FG001|Overall Study|Physician Decision|0|||
163043339|NCT00423813|588865791|FG002|Overall Study|Physician Decision|0|||
162611577|NCT02964507|587294962|FG002|Overall Study|Physician Decision|3|||
163043340|NCT00423813|588865789|FG000|Overall Study|Sponsor Decision|0|||
163043341|NCT00423813|588865790|FG001|Overall Study|Sponsor Decision|1|||
163043342|NCT00423813|588865791|FG002|Overall Study|Sponsor Decision|0|||
163043343|NCT00423813|588865789|FG000|Overall Study|Protocol Violation|9|||
163043344|NCT00423813|588865790|FG001|Overall Study|Protocol Violation|4|||
163043345|NCT00423813|588865791|FG002|Overall Study|Protocol Violation|4|||
163043346|NCT00423813|588865789|FG000|Overall Study|Pregnancy|0|||
163043347|NCT00423813|588865790|FG001|Overall Study|Pregnancy|0|||
163043348|NCT00423813|588865791|FG002|Overall Study|Pregnancy|1|||
163043349|NCT00423813|588865789|FG000|Overall Study|Subject started night shift work|1|||
163043350|NCT00423813|588865790|FG001|Overall Study|Subject started night shift work|0|||
163043351|NCT00423813|588865791|FG002|Overall Study|Subject started night shift work|0|||
163043352|NCT00423813|588865789|FG000|Overall Study|Will start exclusionary medications|0|||
163043353|NCT00423813|588865790|FG001|Overall Study|Will start exclusionary medications|1|||
163043354|NCT00423813|588865791|FG002|Overall Study|Will start exclusionary medications|0|||
163043355|NCT00423813|588865789|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
163043356|NCT00423813|588865790|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
163043357|NCT00423813|588865791|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
163043358|NCT01904032|588865794|FG000|Overall Study|Adverse Event|3|||
163043359|NCT01904032|588865795|FG001|Overall Study|Adverse Event|1|||
163043360|NCT01904032|588865794|FG000|Overall Study|Lost to Follow-up|4|||
163043361|NCT01904032|588865795|FG001|Overall Study|Lost to Follow-up|2|||
163043362|NCT02998996|588865802|FG000|Overall Study|Lost to Follow-up|0|||
163043363|NCT02998996|588865803|FG001|Overall Study|Lost to Follow-up|0|||
163043364|NCT02998996|588865804|FG002|Overall Study|Lost to Follow-up|1|||
163043365|NCT02998996|588865805|FG003|Overall Study|Lost to Follow-up|0|||
162611578|NCT02964507|587294963|FG003|Overall Study|Physician Decision|0|||
162611579|NCT02964507|587294964|FG004|Overall Study|Physician Decision|1|||
162611580|NCT02964507|587294965|FG005|Overall Study|Physician Decision|0|||
162611581|NCT02964507|587294966|FG006|Overall Study|Physician Decision|0|||
162611582|NCT02964507|587294967|FG007|Overall Study|Physician Decision|0|||
162611583|NCT04341662|587294968|FG000|Overall Study|Did not have source-verified blood loss data|423|||
163043366|NCT02998996|588865806|FG004|Overall Study|Lost to Follow-up|0|||
163043367|NCT02998996|588865807|FG005|Overall Study|Lost to Follow-up|0|||
163043368|NCT02998996|588865802|FG000|Overall Study|Pregnancy|0|||
163043369|NCT02998996|588865803|FG001|Overall Study|Pregnancy|1|||
163043370|NCT02998996|588865804|FG002|Overall Study|Pregnancy|0|||
163043371|NCT02998996|588865805|FG003|Overall Study|Pregnancy|0|||
163043372|NCT02998996|588865806|FG004|Overall Study|Pregnancy|0|||
163043373|NCT02998996|588865807|FG005|Overall Study|Pregnancy|0|||
162611584|NCT04341662|587294969|FG001|Overall Study|Did not have source-verified blood loss data|514|||
162704594|NCT01625338|587630396|FG000|Overall Study|Efficacy Failure|27|||
162704595|NCT01625338|587630397|FG001|Overall Study|Efficacy Failure|39|||
162704596|NCT01625338|587630398|FG002|Overall Study|Efficacy Failure|31|||
162704597|NCT01625338|587630396|FG000|Overall Study|Lost to Follow-up|3|||
162704598|NCT01625338|587630397|FG001|Overall Study|Lost to Follow-up|3|||
162704599|NCT01625338|587630398|FG002|Overall Study|Lost to Follow-up|2|||
162704600|NCT01625338|587630396|FG000|Overall Study|Investigator Decision|0|||
162704601|NCT01625338|587630397|FG001|Overall Study|Investigator Decision|2|||
162704602|NCT01625338|587630398|FG002|Overall Study|Investigator Decision|1|||
162704603|NCT01625338|587630396|FG000|Overall Study|Subject Withdrew Consent|1|||
162704604|NCT01625338|587630397|FG001|Overall Study|Subject Withdrew Consent|0|||
162852557|NCT03726268|588164623|FG000|Overall Study|Withdrawal by Subject|11|||
163043374|NCT02998996|588865802|FG000|Overall Study|Family reasons|0|||
163043375|NCT02998996|588865803|FG001|Overall Study|Family reasons|0|||
163043376|NCT02998996|588865804|FG002|Overall Study|Family reasons|0|||
163043377|NCT02998996|588865805|FG003|Overall Study|Family reasons|0|||
163043378|NCT02998996|588865806|FG004|Overall Study|Family reasons|1|||
163043379|NCT02998996|588865807|FG005|Overall Study|Family reasons|0|||
163043380|NCT01398358|588865812|FG000|Overall Study|Lost to Follow-up|11|||
162611585|NCT02675231|587294970|FG000|Overall Study|Withdrawal by Subject|2|||
162611586|NCT02675231|587294971|FG001|Overall Study|Withdrawal by Subject|4|||
162704605|NCT01625338|587630398|FG002|Overall Study|Subject Withdrew Consent|2|||
162704606|NCT01625338|587630396|FG000|Overall Study|Adverse Event|1|||
163043381|NCT01398358|588865813|FG001|Overall Study|Lost to Follow-up|21|||
163043382|NCT01398358|588865814|FG002|Overall Study|Lost to Follow-up|18|||
163043383|NCT01398358|588865812|FG000|Overall Study|Withdrawal by Subject|3|||
163043384|NCT01398358|588865813|FG001|Overall Study|Withdrawal by Subject|2|||
163043385|NCT01398358|588865814|FG002|Overall Study|Withdrawal by Subject|2|||
162852558|NCT03726268|588164624|FG001|Overall Study|Withdrawal by Subject|5|||
162852559|NCT03726268|588164625|FG002|Overall Study|Withdrawal by Subject|9|||
162852560|NCT03726268|588164626|FG003|Overall Study|Withdrawal by Subject|8|||
162852561|NCT00490542|588164627|FG000|Overall Study|Lost to Follow-up|3|||
162852562|NCT00490542|588164628|FG001|Overall Study|Lost to Follow-up|0|||
162852563|NCT00490542|588164627|FG000|Overall Study|Adverse Event|3|||
162852564|NCT00490542|588164628|FG001|Overall Study|Adverse Event|3|||
162852565|NCT00490542|588164627|FG000|Overall Study|Lack of Efficacy|1|||
162852566|NCT00490542|588164628|FG001|Overall Study|Lack of Efficacy|1|||
162852567|NCT02875223|588164629|FG000|Overall Study|Other reasons|0|||
162852568|NCT02875223|588164630|FG001|Overall Study|Other reasons|0|||
162852569|NCT02875223|588164631|FG002|Overall Study|Other reasons|1|||
162852570|NCT02875223|588164632|FG003|Overall Study|Other reasons|0|||
162852571|NCT02875223|588164633|FG004|Overall Study|Other reasons|1|||
162852572|NCT02875223|588164634|FG005|Overall Study|Other reasons|2|||
162852573|NCT02875223|588164635|FG006|Overall Study|Other reasons|0|||
162852574|NCT02875223|588164636|FG007|Overall Study|Other reasons|2|||
162852575|NCT02875223|588164637|FG008|Overall Study|Other reasons|0|||
162852576|NCT02875223|588164638|FG009|Overall Study|Other reasons|0|||
162852577|NCT02875223|588164639|FG010|Overall Study|Other reasons|0|||
162852578|NCT02875223|588164640|FG011|Overall Study|Other reasons|0|||
162852579|NCT02875223|588164641|FG012|Overall Study|Other reasons|0|||
162852580|NCT02875223|588164629|FG000|Overall Study|Withdrawal by Subject|0|||
162852581|NCT02875223|588164630|FG001|Overall Study|Withdrawal by Subject|0|||
162852582|NCT02875223|588164631|FG002|Overall Study|Withdrawal by Subject|0|||
162954228|NCT04115293|588537511|FG000|Overall Study|Adverse Event|0|||
162954229|NCT04115293|588537512|FG001|Overall Study|Adverse Event|2|||
162954230|NCT04115293|588537511|FG000|Overall Study|Withdrawal by Subject|2|||
162954231|NCT04115293|588537512|FG001|Overall Study|Withdrawal by Subject|1|||
162954232|NCT04115293|588537511|FG000|Overall Study|Physician Decision|1|||
163043386|NCT01398358|588865812|FG000|Overall Study|no longer eligible|1|||
162954233|NCT04115293|588537512|FG001|Overall Study|Physician Decision|0|||
162954234|NCT04115293|588537511|FG000|Overall Study|Death|1|||
162954235|NCT04115293|588537512|FG001|Overall Study|Death|1|||
162954236|NCT02674152|588537513|FG000|Overall Study|Personal Reasons|1|||
162954237|NCT02674152|588537514|FG001|Overall Study|Personal Reasons|0|||
162954238|NCT02674152|588537515|FG002|Overall Study|Personal Reasons|0|||
162954239|NCT02674152|588537516|FG003|Overall Study|Personal Reasons|1|||
162954240|NCT02674152|588537517|FG004|Overall Study|Personal Reasons|1|||
162954241|NCT02674152|588537513|FG000|Overall Study|Other adverse event or clinical progression|0|||
162954242|NCT02674152|588537514|FG001|Overall Study|Other adverse event or clinical progression|1|||
162954243|NCT02674152|588537515|FG002|Overall Study|Other adverse event or clinical progression|0|||
162954244|NCT02674152|588537516|FG003|Overall Study|Other adverse event or clinical progression|3|||
162954245|NCT02674152|588537517|FG004|Overall Study|Other adverse event or clinical progression|0|||
162954246|NCT02674152|588537513|FG000|Overall Study|Dose-limiting toxicity|0|||
162954247|NCT02674152|588537514|FG001|Overall Study|Dose-limiting toxicity|0|||
162954248|NCT02674152|588537515|FG002|Overall Study|Dose-limiting toxicity|0|||
162954249|NCT02674152|588537516|FG003|Overall Study|Dose-limiting toxicity|0|||
162954250|NCT02674152|588537517|FG004|Overall Study|Dose-limiting toxicity|1|||
162954251|NCT02674152|588537513|FG000|Overall Study|Progressive Disease|2|||
162954252|NCT02674152|588537514|FG001|Overall Study|Progressive Disease|1|||
162954253|NCT02674152|588537515|FG002|Overall Study|Progressive Disease|1|||
162954254|NCT02674152|588537516|FG003|Overall Study|Progressive Disease|13|||
163043387|NCT01398358|588865813|FG001|Overall Study|no longer eligible|0|||
163043388|NCT01398358|588865814|FG002|Overall Study|no longer eligible|1|||
163043389|NCT00003896|588865815|FG000|Overall Study|Adverse Event|16|||
162852583|NCT02875223|588164632|FG003|Overall Study|Withdrawal by Subject|0|||
162852584|NCT02875223|588164633|FG004|Overall Study|Withdrawal by Subject|1|||
162852585|NCT02875223|588164634|FG005|Overall Study|Withdrawal by Subject|1|||
162852586|NCT02875223|588164635|FG006|Overall Study|Withdrawal by Subject|0|||
162852587|NCT02875223|588164636|FG007|Overall Study|Withdrawal by Subject|0|||
162852588|NCT02875223|588164637|FG008|Overall Study|Withdrawal by Subject|1|||
162852589|NCT02875223|588164638|FG009|Overall Study|Withdrawal by Subject|0|||
162852590|NCT02875223|588164639|FG010|Overall Study|Withdrawal by Subject|0|||
162852591|NCT02875223|588164640|FG011|Overall Study|Withdrawal by Subject|0|||
162852592|NCT02875223|588164641|FG012|Overall Study|Withdrawal by Subject|0|||
162852593|NCT02875223|588164629|FG000|Overall Study|Progressive disease|0|||
162954255|NCT02674152|588537517|FG004|Overall Study|Progressive Disease|2|||
162954256|NCT02674152|588537513|FG000|Overall Study|Adverse Event|0|||
162954257|NCT02674152|588537514|FG001|Overall Study|Adverse Event|0|||
162954258|NCT02674152|588537515|FG002|Overall Study|Adverse Event|1|||
162954259|NCT02674152|588537516|FG003|Overall Study|Adverse Event|0|||
163043390|NCT00003896|588865815|FG000|Overall Study|Withdrawal by Subject|1|||
162852594|NCT02875223|588164630|FG001|Overall Study|Progressive disease|0|||
162852595|NCT02875223|588164631|FG002|Overall Study|Progressive disease|1|||
162852596|NCT02875223|588164632|FG003|Overall Study|Progressive disease|0|||
162852597|NCT02875223|588164633|FG004|Overall Study|Progressive disease|0|||
162852598|NCT02875223|588164634|FG005|Overall Study|Progressive disease|0|||
162852599|NCT02875223|588164635|FG006|Overall Study|Progressive disease|0|||
162852600|NCT02875223|588164636|FG007|Overall Study|Progressive disease|0|||
162852601|NCT02875223|588164637|FG008|Overall Study|Progressive disease|0|||
162852602|NCT02875223|588164638|FG009|Overall Study|Progressive disease|12|||
162852603|NCT02875223|588164639|FG010|Overall Study|Progressive disease|2|||
162852604|NCT02875223|588164640|FG011|Overall Study|Progressive disease|3|||
162852605|NCT02875223|588164641|FG012|Overall Study|Progressive disease|6|||
162852606|NCT02875223|588164629|FG000|Overall Study|Death|4|||
162852607|NCT02875223|588164630|FG001|Overall Study|Death|4|||
162852608|NCT02875223|588164631|FG002|Overall Study|Death|3|||
162852609|NCT02875223|588164632|FG003|Overall Study|Death|4|||
162852610|NCT02875223|588164633|FG004|Overall Study|Death|2|||
162852611|NCT02875223|588164634|FG005|Overall Study|Death|3|||
162852612|NCT02875223|588164635|FG006|Overall Study|Death|5|||
162852613|NCT02875223|588164636|FG007|Overall Study|Death|7|||
162852614|NCT02875223|588164637|FG008|Overall Study|Death|3|||
162852615|NCT02875223|588164638|FG009|Overall Study|Death|2|||
162852616|NCT02875223|588164639|FG010|Overall Study|Death|0|||
162852617|NCT02875223|588164640|FG011|Overall Study|Death|0|||
162852618|NCT02875223|588164641|FG012|Overall Study|Death|0|||
162852619|NCT02875223|588164629|FG000|Overall Study|Lost to Follow-up|0|||
162852620|NCT02875223|588164630|FG001|Overall Study|Lost to Follow-up|1|||
162852621|NCT02875223|588164631|FG002|Overall Study|Lost to Follow-up|1|||
162852622|NCT02875223|588164632|FG003|Overall Study|Lost to Follow-up|0|||
162852623|NCT02875223|588164633|FG004|Overall Study|Lost to Follow-up|1|||
162852624|NCT02875223|588164634|FG005|Overall Study|Lost to Follow-up|0|||
162852625|NCT02875223|588164635|FG006|Overall Study|Lost to Follow-up|1|||
162852626|NCT02875223|588164636|FG007|Overall Study|Lost to Follow-up|1|||
162852627|NCT02875223|588164637|FG008|Overall Study|Lost to Follow-up|0|||
162852628|NCT02875223|588164638|FG009|Overall Study|Lost to Follow-up|0|||
162852629|NCT02875223|588164639|FG010|Overall Study|Lost to Follow-up|0|||
162852630|NCT02875223|588164640|FG011|Overall Study|Lost to Follow-up|0|||
162852631|NCT02875223|588164641|FG012|Overall Study|Lost to Follow-up|0|||
162852632|NCT03136107|588164642|FG000|Overall Study|Other (Not specified)|1|||
162852633|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
162852634|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
162852635|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
162852636|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
162852637|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
162852638|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
162852639|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
162852640|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
162852641|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
162852642|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
162852643|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
162852644|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
162852645|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
162852646|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
162852647|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
162852648|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
162852649|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
162852650|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
162852651|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
162852652|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
162852653|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
162852654|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
162852655|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
162852656|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
162954260|NCT02674152|588537517|FG004|Overall Study|Adverse Event|1|||
162954261|NCT03772522|588537518|FG000|Pre-intervention|Withdrawal by Subject|3|||
162954262|NCT03772522|588537519|FG001|Pre-intervention|Withdrawal by Subject|4|||
162954263|NCT03772522|588537518|FG000|Intervention|Withdrawal by Subject|1|||
162954264|NCT03772522|588537519|FG001|Intervention|Withdrawal by Subject|0|||
162954265|NCT03772522|588537518|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
162852657|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
162852658|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
162852659|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
162852660|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
162852661|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
162954266|NCT03772522|588537519|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
163043391|NCT00003896|588865815|FG000|Overall Study|Lack of Efficacy|1|||
163043392|NCT00003896|588865815|FG000|Overall Study|Death|3|||
163043393|NCT00003896|588865815|FG000|Overall Study|not protocol specified|3|||
163043394|NCT00003896|588865815|FG000|Overall Study|ineligible|5|||
163043395|NCT02559570|588865819|FG000|Overall Study|Adverse Event|0|||
163043396|NCT02559570|588865820|FG001|Overall Study|Adverse Event|2|||
163043397|NCT02559570|588865821|FG002|Overall Study|Adverse Event|0|||
163043398|NCT02559570|588865822|FG003|Overall Study|Adverse Event|1|||
163043399|NCT02559570|588865823|FG004|Overall Study|Adverse Event|0|||
163043400|NCT02559570|588865819|FG000|Overall Study|Withdrawal of Consent|0|||
163043401|NCT02559570|588865820|FG001|Overall Study|Withdrawal of Consent|0|||
162611587|NCT02675231|587294972|FG002|Overall Study|Withdrawal by Subject|2|||
162611588|NCT02675231|587294970|FG000|Overall Study|Lost to Follow-up|3|||
162611589|NCT02675231|587294971|FG001|Overall Study|Lost to Follow-up|4|||
162611590|NCT02675231|587294972|FG002|Overall Study|Lost to Follow-up|3|||
162611591|NCT00064298|587294973|FG000|Overall Study|Withdrawal by Subject|2|||
162611592|NCT00064298|587294974|FG001|Overall Study|Withdrawal by Subject|1|||
162611593|NCT00064298|587294973|FG000|Overall Study|Lost to Follow-up|2|||
162611594|NCT00064298|587294974|FG001|Overall Study|Lost to Follow-up|2|||
162611595|NCT00064298|587294973|FG000|Overall Study|Death|0|||
162611596|NCT00064298|587294974|FG001|Overall Study|Death|1|||
162611597|NCT00064298|587294973|FG000|Overall Study|Disease Progression|2|||
162611598|NCT00064298|587294974|FG001|Overall Study|Disease Progression|1|||
162611599|NCT02220998|587294975|FG000|Overall Study|Randomized but Never Treated|1|||
162611600|NCT02220998|587294976|FG001|Overall Study|Randomized but Never Treated|2|||
162611601|NCT02220998|587294975|FG000|Overall Study|Death|2|||
162704607|NCT01625338|587630397|FG001|Overall Study|Adverse Event|0|||
163043402|NCT02559570|588865821|FG002|Overall Study|Withdrawal of Consent|1|||
163043403|NCT02559570|588865822|FG003|Overall Study|Withdrawal of Consent|2|||
163043404|NCT02559570|588865823|FG004|Overall Study|Withdrawal of Consent|1|||
163043405|NCT02559570|588865819|FG000|Overall Study|Lost to Follow-up|1|||
163043406|NCT02559570|588865820|FG001|Overall Study|Lost to Follow-up|0|||
163043407|NCT02559570|588865821|FG002|Overall Study|Lost to Follow-up|0|||
162704608|NCT01625338|587630398|FG002|Overall Study|Adverse Event|1|||
162704609|NCT01625338|587630396|FG000|Overall Study|Study Discontinued by Sponsor|0|||
162852662|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163043408|NCT02559570|588865822|FG003|Overall Study|Lost to Follow-up|0|||
162704610|NCT01625338|587630397|FG001|Overall Study|Study Discontinued by Sponsor|0|||
162704611|NCT01625338|587630398|FG002|Overall Study|Study Discontinued by Sponsor|1|||
162704612|NCT03201757|587630409|FG000|Overall Study|Withdrawal by Subject|133|||
162704613|NCT03201757|587630409|FG000|Overall Study|Adverse Event|44|||
162704614|NCT03201757|587630409|FG000|Overall Study|Lost to Follow-up|37|||
162704615|NCT03201757|587630409|FG000|Overall Study|Pregnancy|2|||
162704616|NCT03201757|587630409|FG000|Overall Study|Lack of Efficacy|1|||
162704617|NCT03201757|587630409|FG000|Overall Study|Protocol Violation|20|||
162704618|NCT03201757|587630409|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
162704619|NCT03201757|587630409|FG000|Overall Study|Not Yet Determined|5|||
162704620|NCT03201757|587630409|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
162704621|NCT03201757|587630409|FG000|Overall Study|Other|20|||
162704622|NCT03930186|587630413|FG000|Weeks 0 to 16|Adverse Event|6|||
162704623|NCT03930186|587630413|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
162704624|NCT03930186|587630413|FG000|Weeks 16 to 32|Adverse Event|1|||
162704625|NCT03930186|587630413|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
162704626|NCT00557505|587630416|FG000|Overall Study|Death|0|||
162704627|NCT00557505|587630417|FG001|Overall Study|Death|0|||
162704628|NCT00557505|587630418|FG002|Overall Study|Death|0|||
162704629|NCT00557505|587630419|FG003|Overall Study|Death|0|||
162704630|NCT00557505|587630420|FG004|Overall Study|Death|0|||
162704631|NCT00557505|587630421|FG005|Overall Study|Death|0|||
162704632|NCT00557505|587630422|FG006|Overall Study|Death|0|||
162704633|NCT00557505|587630423|FG007|Overall Study|Death|0|||
162704634|NCT00557505|587630424|FG008|Overall Study|Death|1|||
162704635|NCT00557505|587630416|FG000|Overall Study|Adverse Event|0|||
162704636|NCT00557505|587630417|FG001|Overall Study|Adverse Event|0|||
162704637|NCT00557505|587630418|FG002|Overall Study|Adverse Event|1|||
162852663|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
163043409|NCT02559570|588865823|FG004|Overall Study|Lost to Follow-up|0|||
163043410|NCT02559570|588865819|FG000|Overall Study|Protocol Violation|1|||
162611602|NCT02220998|587294976|FG001|Overall Study|Death|0|||
162611603|NCT02220998|587294975|FG000|Overall Study|Lack of Efficacy|0|||
162611604|NCT02220998|587294976|FG001|Overall Study|Lack of Efficacy|5|||
162611605|NCT02220998|587294975|FG000|Overall Study|Lost to Follow-up|4|||
162704638|NCT00557505|587630419|FG003|Overall Study|Adverse Event|0|||
162704639|NCT00557505|587630420|FG004|Overall Study|Adverse Event|0|||
162704640|NCT00557505|587630421|FG005|Overall Study|Adverse Event|0|||
162704641|NCT00557505|587630422|FG006|Overall Study|Adverse Event|1|||
162704642|NCT00557505|587630423|FG007|Overall Study|Adverse Event|0|||
162704643|NCT00557505|587630424|FG008|Overall Study|Adverse Event|0|||
162704644|NCT00557505|587630416|FG000|Overall Study|Global deterioration of health|1|||
162611606|NCT02220998|587294976|FG001|Overall Study|Lost to Follow-up|4|||
162611607|NCT03309046|587294977|FG000|Overall Study|Withdrawal by Subject|4|||
162611608|NCT03309046|587294978|FG001|Overall Study|Withdrawal by Subject|17|||
162611609|NCT00873860|587294979|FG000|Overall Study|Lost to Follow-up|1|||
162611610|NCT00873860|587294980|FG001|Overall Study|Lost to Follow-up|0|||
162611611|NCT00873860|587294981|FG002|Overall Study|Lost to Follow-up|0|||
162611612|NCT00873860|587294982|FG003|Overall Study|Lost to Follow-up|1|||
162611613|NCT00873860|587294979|FG000|Overall Study|Withdrawal by Subject|1|||
162611614|NCT00873860|587294980|FG001|Overall Study|Withdrawal by Subject|0|||
162611615|NCT00873860|587294981|FG002|Overall Study|Withdrawal by Subject|2|||
162611616|NCT00873860|587294982|FG003|Overall Study|Withdrawal by Subject|0|||
162611617|NCT00873860|587294979|FG000|Overall Study|Death|1|||
162611618|NCT00873860|587294980|FG001|Overall Study|Death|0|||
162611619|NCT00873860|587294981|FG002|Overall Study|Death|0|||
162611620|NCT00873860|587294982|FG003|Overall Study|Death|0|||
162611621|NCT00873860|587294979|FG000|Overall Study|Other|1|||
162611622|NCT00873860|587294980|FG001|Overall Study|Other|0|||
162611623|NCT00873860|587294981|FG002|Overall Study|Other|1|||
162611624|NCT00873860|587294982|FG003|Overall Study|Other|0|||
162611625|NCT02764190|587294983|FG000|Overall Study|Lost to Follow-up|17|||
162611626|NCT02764190|587294984|FG001|Overall Study|Lost to Follow-up|13|||
162611627|NCT00591266|587294985|FG000|Overall Study|Adverse Event|2|||
162611628|NCT00591266|587294986|FG001|Overall Study|Adverse Event|2|||
162611629|NCT00591266|587294987|FG002|Overall Study|Adverse Event|3|||
162611630|NCT00591266|587294985|FG000|Overall Study|Lost to Follow-up|0|||
162611631|NCT00591266|587294986|FG001|Overall Study|Lost to Follow-up|1|||
162611632|NCT00591266|587294987|FG002|Overall Study|Lost to Follow-up|0|||
162611633|NCT00591266|587294985|FG000|Overall Study|Protocol Violation|0|||
162611634|NCT00591266|587294986|FG001|Overall Study|Protocol Violation|0|||
162611635|NCT00591266|587294987|FG002|Overall Study|Protocol Violation|1|||
162611636|NCT00591266|587294985|FG000|Overall Study|Withdrawal by Subject|6|||
162611637|NCT00591266|587294986|FG001|Overall Study|Withdrawal by Subject|2|||
162704645|NCT00557505|587630417|FG001|Overall Study|Global deterioration of health|0|||
162704646|NCT00557505|587630418|FG002|Overall Study|Global deterioration of health|0|||
162704647|NCT00557505|587630419|FG003|Overall Study|Global deterioration of health|0|||
162704648|NCT00557505|587630420|FG004|Overall Study|Global deterioration of health|0|||
162704649|NCT00557505|587630421|FG005|Overall Study|Global deterioration of health|0|||
162704650|NCT00557505|587630422|FG006|Overall Study|Global deterioration of health|0|||
162704651|NCT00557505|587630423|FG007|Overall Study|Global deterioration of health|0|||
162704652|NCT00557505|587630424|FG008|Overall Study|Global deterioration of health|0|||
162704653|NCT00557505|587630416|FG000|Overall Study|Objective progression or relapse|2|||
162704654|NCT00557505|587630417|FG001|Overall Study|Objective progression or relapse|3|||
162704655|NCT00557505|587630418|FG002|Overall Study|Objective progression or relapse|3|||
162704656|NCT00557505|587630419|FG003|Overall Study|Objective progression or relapse|2|||
162704657|NCT00557505|587630420|FG004|Overall Study|Objective progression or relapse|2|||
162704658|NCT00557505|587630421|FG005|Overall Study|Objective progression or relapse|3|||
162954267|NCT00070291|588537523|FG000|Step 1|Withdrawal by Subject|1|||
162954268|NCT00070291|588537523|FG000|Step 1|Adverse Event|1|||
162954269|NCT00070291|588537523|FG000|Step 2|Adverse Event|1|||
162954270|NCT03255733|588537524|FG000|Overall Study|Lost to Follow-up|4|||
162954271|NCT02533258|588537526|FG000|Overall Study|Adverse Event|1|||
162954272|NCT02533258|588537526|FG000|Overall Study|Death|2|||
162704659|NCT00557505|587630422|FG006|Overall Study|Objective progression or relapse|2|||
162954273|NCT02533258|588537526|FG000|Overall Study|Other|1|||
162954274|NCT02533258|588537526|FG000|Overall Study|Economic factor|1|||
162954275|NCT02533258|588537526|FG000|Overall Study|Progression of pleural effusion|1|||
162954276|NCT02533258|588537526|FG000|Overall Study|Lack of Efficacy|2|||
162954277|NCT02096211|588537527|FG000|Overall Study|Death|2|||
162954278|NCT02096211|588537527|FG000|Overall Study|Withdrawal by Subject|8|||
162954279|NCT02096211|588537527|FG000|Overall Study|Revision of implant|7|||
162954280|NCT02096211|588537527|FG000|Overall Study|Lost to Follow-up|43|||
162954281|NCT02883452|588537531|FG000|Overall Study|Withdrawal by Subject|1|||
162954282|NCT02883452|588537532|FG001|Overall Study|Withdrawal by Subject|1|||
162954283|NCT02883452|588537533|FG002|Overall Study|Withdrawal by Subject|3|||
162954284|NCT02883452|588537534|FG003|Overall Study|Withdrawal by Subject|0|||
162954285|NCT02883452|588537535|FG004|Overall Study|Withdrawal by Subject|2|||
162954286|NCT02883452|588537536|FG005|Overall Study|Withdrawal by Subject|5|||
162954287|NCT02883452|588537531|FG000|Overall Study|Disease progression|1|||
162954288|NCT02883452|588537532|FG001|Overall Study|Disease progression|0|||
162954289|NCT02883452|588537533|FG002|Overall Study|Disease progression|0|||
162954290|NCT02883452|588537534|FG003|Overall Study|Disease progression|1|||
162611638|NCT00591266|587294987|FG002|Overall Study|Withdrawal by Subject|5|||
162611639|NCT00591266|587294985|FG000|Overall Study|Lack of Efficacy|0|||
162611640|NCT00591266|587294986|FG001|Overall Study|Lack of Efficacy|2|||
162611641|NCT00591266|587294987|FG002|Overall Study|Lack of Efficacy|0|||
162611642|NCT00591266|587294985|FG000|Overall Study|Other|1|||
162611643|NCT00591266|587294986|FG001|Overall Study|Other|4|||
162704660|NCT00557505|587630423|FG007|Overall Study|Objective progression or relapse|5|||
162852664|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
162852665|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
162852666|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
162852667|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
162852668|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
162852669|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
162852670|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
162852671|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
162852672|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
162852673|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
162852674|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
162852675|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
162852676|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
162852677|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
162852678|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
162852679|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
162852680|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
162852681|NCT01707992|588164644|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
162852682|NCT01707992|588164645|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
162852683|NCT01707992|588164646|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
162852684|NCT01707992|588164647|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
162852685|NCT01707992|588164648|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
162852686|NCT01707992|588164649|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
162852687|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
162852688|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
162852689|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
162852690|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
162852691|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
162852692|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
162852693|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
162852694|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
162852695|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
162852696|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
162852697|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
162852698|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
162852699|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
162954291|NCT02883452|588537535|FG004|Overall Study|Disease progression|4|||
162954292|NCT02883452|588537536|FG005|Overall Study|Disease progression|5|||
162954293|NCT02883452|588537531|FG000|Overall Study|Adverse Event|2|||
162852700|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
162852701|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
162852702|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
162852703|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
162852704|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
162852705|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
162852706|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
162852707|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
162852708|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
162852709|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
162852710|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
162852711|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
162852712|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
162852713|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
162852714|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
162852715|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
162852716|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
162852717|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Death|0|||
162852718|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Death|0|||
162852719|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Death|0|||
162852720|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Death|2|||
162852721|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Death|0|||
162852722|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Death|0|||
162852723|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
162852724|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
162852725|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
162852726|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
162852727|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
162852728|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
162852729|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
162852730|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
162852731|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
162852732|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
162852733|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
162852734|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
162852735|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
162852736|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
162852737|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
162852738|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
162852739|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
162852740|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
162852741|NCT01707992|588164644|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
162852742|NCT01707992|588164645|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
162852743|NCT01707992|588164646|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
162852744|NCT01707992|588164647|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
162852745|NCT01707992|588164648|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
162852746|NCT01707992|588164649|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
162852747|NCT04167345|588164650|FG000|Overall Study|Other|1|||
162852748|NCT04167345|588164651|FG001|Overall Study|Other|1|||
162852749|NCT04167345|588164652|FG002|Overall Study|Other|0|||
162852750|NCT04167345|588164653|FG003|Overall Study|Other|0|||
162852751|NCT04167345|588164654|FG004|Overall Study|Other|0|||
162852752|NCT04375761|588165942|FG000|Overall Study|Death|1|||
162852753|NCT04375761|588165943|FG001|Overall Study|Death|2|||
162852754|NCT04375761|588165942|FG000|Overall Study|Lost to Follow-up|203|||
162852755|NCT04375761|588165943|FG001|Overall Study|Lost to Follow-up|380|||
162852756|NCT04375761|588165942|FG000|Overall Study|Withdrawal by Subject|47|||
162852757|NCT04375761|588165943|FG001|Overall Study|Withdrawal by Subject|98|||
162852758|NCT04375761|588165942|FG000|Overall Study|Noncompliance with study procedure|121|||
162852759|NCT04375761|588165943|FG001|Overall Study|Noncompliance with study procedure|251|||
162852760|NCT04375761|588165942|FG000|Overall Study|Reimbursement not enough|1|||
162852761|NCT04375761|588165943|FG001|Overall Study|Reimbursement not enough|2|||
162852762|NCT04375761|588165942|FG000|Overall Study|Unforeseen family circumstances|1|||
162852763|NCT04375761|588165943|FG001|Overall Study|Unforeseen family circumstances|3|||
162852764|NCT04375761|588165942|FG000|Overall Study|Test too painful|1|||
162852765|NCT04375761|588165943|FG001|Overall Study|Test too painful|1|||
162852766|NCT04375761|588165942|FG000|Overall Study|Moved|0|||
162852767|NCT04375761|588165943|FG001|Overall Study|Moved|2|||
162852768|NCT04375761|588165942|FG000|Overall Study|Nonresponsive|0|||
162852769|NCT04375761|588165943|FG001|Overall Study|Nonresponsive|5|||
162611644|NCT00591266|587294987|FG002|Overall Study|Other|5|||
162611645|NCT03488927|587294988|FG000|Overall Study|Withdrawal by Subject|44|||
162611646|NCT03488927|587294989|FG001|Overall Study|Withdrawal by Subject|118|||
162611647|NCT03488927|587294990|FG002|Overall Study|Withdrawal by Subject|217|||
162611648|NCT03497676|587294991|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162611649|NCT03497676|587294992|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
162611650|NCT03497676|587294993|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162852770|NCT03797001|588165944|FG000|Overall Study|Withdrawn due to COVID19|4|||
162852771|NCT03797001|588165945|FG001|Overall Study|Withdrawn due to COVID19|0|||
162852772|NCT03797001|588165944|FG000|Overall Study|Withdrawal by Subject|7|||
162852773|NCT03797001|588165945|FG001|Overall Study|Withdrawal by Subject|6|||
162852774|NCT03797001|588165944|FG000|Overall Study|Adverse Event|0|||
162852775|NCT03797001|588165945|FG001|Overall Study|Adverse Event|1|||
162852776|NCT00500266|588165957|FG000|Overall Study|Death|3|||
162852777|NCT00500266|588165957|FG000|Overall Study|Lost to Follow-up|3|||
162852778|NCT00500266|588165957|FG000|Overall Study|Withdrawal by Subject|3|||
162852779|NCT00500266|588165957|FG000|Overall Study|Assigned, not treated|4|||
162852780|NCT02251743|588165958|FG000|Overall Study|Withdrawal by Subject|1|||
162852781|NCT02251743|588165959|FG001|Overall Study|Withdrawal by Subject|1|||
162852782|NCT00824564|588165960|FG000|Overall Study|Lost to Follow-up|5|||
162852783|NCT00824564|588165961|FG001|Overall Study|Lost to Follow-up|7|||
162852784|NCT00824564|588165960|FG000|Overall Study|Withdrawal by Subject|1|||
162852785|NCT00824564|588165961|FG001|Overall Study|Withdrawal by Subject|1|||
162852786|NCT00824564|588165960|FG000|Overall Study|Other|1|||
162852787|NCT00824564|588165961|FG001|Overall Study|Other|2|||
162852788|NCT00824564|588165960|FG000|Overall Study|Randomized, but not treated|1|||
162852789|NCT00824564|588165961|FG001|Overall Study|Randomized, but not treated|0|||
162852790|NCT01552057|588165967|FG000|Overall Study|Adverse Event|14|||
162852791|NCT01552057|588165968|FG001|Overall Study|Adverse Event|15|||
162852792|NCT01552057|588165967|FG000|Overall Study|Lack of Efficacy|8|||
162852793|NCT01552057|588165968|FG001|Overall Study|Lack of Efficacy|23|||
162852794|NCT01552057|588165967|FG000|Overall Study|Withdrawal by Subject|5|||
162852795|NCT01552057|588165968|FG001|Overall Study|Withdrawal by Subject|8|||
162852796|NCT01552057|588165967|FG000|Overall Study|Entry Criteria Not Met|2|||
162852797|NCT01552057|588165968|FG001|Overall Study|Entry Criteria Not Met|2|||
162852798|NCT01552057|588165967|FG000|Overall Study|Physician Decision|1|||
162852799|NCT01552057|588165968|FG001|Overall Study|Physician Decision|0|||
162852800|NCT00476086|588165969|FG000|Overall Study|Alternative therapy|1|||
162852801|NCT00476086|588165969|FG000|Overall Study|Progressive Disease|4|||
162852802|NCT02900092|588165970|FG000|Overall Study|Adverse Event|1|||
162852803|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
162852804|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
162852805|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
162852806|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
162852807|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
162852808|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
162852809|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
162852810|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
162852811|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
162852812|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
162852813|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
162852814|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
162852815|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
162852816|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
162852817|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
162852818|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
162852819|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
162852820|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
162852821|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
162852822|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
162852823|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
162852824|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
162852825|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
162611651|NCT03497676|587294994|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162611652|NCT03497676|587294991|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
162852826|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
162852827|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
162704661|NCT00557505|587630424|FG008|Overall Study|Objective progression or relapse|15|||
162852828|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
162852829|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
162852830|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
162852831|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
162852832|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
162852833|NCT03895203|588165971|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
162852834|NCT03895203|588165972|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
162852835|NCT03895203|588165973|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
162852836|NCT03895203|588165974|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
162852837|NCT03895203|588165975|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
162852838|NCT03895203|588165976|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
162852839|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
162852840|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
162852841|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
162852842|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
162852843|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
162852844|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
162852845|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
162852846|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
162852847|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
162852848|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
162852849|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
162852850|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
162852851|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
162852852|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
162852853|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
162852854|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
162852855|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
162852856|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
162852857|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
162852858|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
162852859|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
162852860|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
162852861|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
162852862|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
162852863|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
162852864|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
162852865|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
162852866|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
162852867|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
162852868|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
162852869|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
162852870|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
162852871|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
162852872|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
162852873|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
162852874|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
162852875|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
162852876|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
162852877|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
162852878|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
162852879|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
162852880|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
162852881|NCT03895203|588165971|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
162852882|NCT03895203|588165972|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
162954294|NCT02883452|588537532|FG001|Overall Study|Adverse Event|1|||
162954295|NCT02883452|588537533|FG002|Overall Study|Adverse Event|1|||
162954296|NCT02883452|588537534|FG003|Overall Study|Adverse Event|1|||
162954297|NCT02883452|588537535|FG004|Overall Study|Adverse Event|1|||
162954298|NCT02883452|588537536|FG005|Overall Study|Adverse Event|3|||
162954299|NCT02883452|588537531|FG000|Overall Study|Physician Decision|0|||
162954300|NCT02883452|588537532|FG001|Overall Study|Physician Decision|0|||
162954301|NCT02883452|588537533|FG002|Overall Study|Physician Decision|0|||
162954302|NCT02883452|588537534|FG003|Overall Study|Physician Decision|0|||
162954303|NCT02883452|588537535|FG004|Overall Study|Physician Decision|4|||
162954304|NCT02883452|588537536|FG005|Overall Study|Physician Decision|1|||
162954305|NCT02883452|588537531|FG000|Overall Study|Death|1|||
162954306|NCT02883452|588537532|FG001|Overall Study|Death|0|||
162954307|NCT02883452|588537533|FG002|Overall Study|Death|1|||
162852883|NCT03895203|588165973|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
162852884|NCT03895203|588165974|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
162852885|NCT03895203|588165975|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
162852886|NCT03895203|588165976|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
162852887|NCT01389245|588165977|FG000|Overall Study|Protocol Violation|10|||
162852888|NCT01389245|588165977|FG000|Overall Study|Lost to Follow-up|3|||
162852889|NCT01389245|588165977|FG000|Overall Study|Withdrawal by Subject|2|||
162852890|NCT05540652|588165978|FG000|Overall Study|Withdrawal by Subject|1|||
162852891|NCT04454489|588165979|FG000|Overall Study|Disease progression|12|||
162852892|NCT04454489|588165979|FG000|Overall Study|Death|4|||
163043411|NCT02559570|588865820|FG001|Overall Study|Protocol Violation|0|||
163043412|NCT02559570|588865821|FG002|Overall Study|Protocol Violation|0|||
163043413|NCT02559570|588865822|FG003|Overall Study|Protocol Violation|0|||
163043414|NCT02559570|588865823|FG004|Overall Study|Protocol Violation|1|||
163043415|NCT02559570|588865819|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163043416|NCT02559570|588865820|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163043417|NCT02559570|588865821|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163043418|NCT02559570|588865822|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163043419|NCT02559570|588865823|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163043420|NCT03373461|588865831|FG000|Part 2|Adverse Event|0|||
163043421|NCT03373461|588865832|FG001|Part 2|Adverse Event|1|||
163043422|NCT03373461|588865833|FG002|Part 2|Adverse Event|0|||
163043423|NCT03373461|588865834|FG003|Part 2|Adverse Event|0|||
163043424|NCT03373461|588865835|FG004|Part 2|Adverse Event|1|||
163043425|NCT01366638|588865836|FG000|Overall Study|Withdrawal by Subject|0|||
163043426|NCT01366638|588865837|FG001|Overall Study|Withdrawal by Subject|0|||
163043427|NCT01366638|588865838|FG002|Overall Study|Withdrawal by Subject|6|||
163043428|NCT01366638|588865836|FG000|Overall Study|Other|1|||
163043429|NCT01366638|588865837|FG001|Overall Study|Other|0|||
163043430|NCT01366638|588865838|FG002|Overall Study|Other|0|||
163043431|NCT00215644|588868035|FG000|Overall Study|Disease Progression|28|||
162852893|NCT04454489|588165979|FG000|Overall Study|Adverse Event|1|||
162852894|NCT04454489|588165979|FG000|Overall Study|Physician Decision|1|||
162852895|NCT01756274|588165983|FG000|Overall Study|Protocol Violation|2|||
162852896|NCT01756274|588165983|FG000|Overall Study|Laboratory error|1|||
162852897|NCT03514914|588165984|FG000|Overall Study|Death|3|||
162852898|NCT03514914|588165985|FG001|Overall Study|Death|3|||
162852899|NCT03514914|588165984|FG000|Overall Study|Lost to Follow-up|117|||
162852900|NCT03514914|588165985|FG001|Overall Study|Lost to Follow-up|89|||
162852901|NCT03926143|588165990|FG000|Overall Study|Physician Decision|3|||
162852902|NCT03926143|588165990|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
162852903|NCT03926143|588165990|FG000|Overall Study|Adverse Event|2|||
162852904|NCT03926143|588165990|FG000|Overall Study|Progressive disease|3|||
162852905|NCT01071070|588165995|FG000|Overall Study|Adverse Event|0|||
162852906|NCT01071070|588165996|FG001|Overall Study|Adverse Event|3|||
162852907|NCT01071070|588165995|FG000|Overall Study|Withdrawal by Subject|1|||
162852908|NCT01071070|588165996|FG001|Overall Study|Withdrawal by Subject|0|||
162852909|NCT01071070|588165995|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
162852910|NCT01071070|588165996|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
162852911|NCT01071070|588165995|FG000|Overall Study|Hypercalcemia|1|||
162852912|NCT01071070|588165996|FG001|Overall Study|Hypercalcemia|0|||
162852913|NCT00473876|588166005|FG000|Overall Study|Lost to Follow-up|3|||
162852914|NCT00473876|588166006|FG001|Overall Study|Lost to Follow-up|1|||
162852915|NCT00727402|588166007|FG000|Overall Study|Physician Decision|116|||
162852916|NCT03751111|588166008|FG000|Overall Study|Lack of Efficacy|9|||
162852917|NCT03751111|588166009|FG001|Overall Study|Lack of Efficacy|30|||
162852918|NCT03751111|588166008|FG000|Overall Study|Adverse Event|3|||
162852919|NCT03751111|588166009|FG001|Overall Study|Adverse Event|2|||
162852920|NCT00755079|588166010|FG000|Overall Study|Lost to Follow-up|1|||
162852921|NCT00755079|588166011|FG001|Overall Study|Lost to Follow-up|3|||
162852922|NCT00755079|588166010|FG000|Overall Study|Adverse Event|0|||
162852923|NCT00755079|588166011|FG001|Overall Study|Adverse Event|1|||
162852924|NCT00755079|588166010|FG000|Overall Study|Withdrawal by Subject|0|||
162852925|NCT00755079|588166011|FG001|Overall Study|Withdrawal by Subject|2|||
162852926|NCT03545282|588166012|FG000|Overall Study|Lost to Follow-up|15|||
162852927|NCT03545282|588166013|FG001|Overall Study|Lost to Follow-up|10|||
162852928|NCT03545282|588166012|FG000|Overall Study|Withdrawal by Subject|2|||
162852929|NCT03545282|588166013|FG001|Overall Study|Withdrawal by Subject|2|||
162852930|NCT02582671|588166014|FG000|Overall Study|Failure to return|1|||
162852931|NCT02582671|588166014|FG000|Overall Study|Other, not specified|1|||
163043432|NCT00215644|588868036|FG001|Overall Study|Disease Progression|10|||
162852932|NCT01287104|588166015|FG000|Overall Study|Patient developed progressive disease|1|||
162852933|NCT01287104|588166016|FG001|Overall Study|Patient developed progressive disease|1|||
162852934|NCT01287104|588166017|FG002|Overall Study|Patient developed progressive disease|3|||
162852935|NCT01287104|588166018|FG003|Overall Study|Patient developed progressive disease|2|||
162852936|NCT01287104|588166015|FG000|Overall Study|Donor anaphylaxis|0|||
162852937|NCT01287104|588166016|FG001|Overall Study|Donor anaphylaxis|1|||
162852938|NCT01287104|588166017|FG002|Overall Study|Donor anaphylaxis|0|||
162852939|NCT01287104|588166018|FG003|Overall Study|Donor anaphylaxis|1|||
162852940|NCT01287104|588166015|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
162852941|NCT01287104|588166016|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
162852942|NCT01287104|588166017|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
162852943|NCT01287104|588166018|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
162852944|NCT01287104|588166015|FG000|Overall Study|Low donor chimerism|0|||
162852945|NCT01287104|588166016|FG001|Overall Study|Low donor chimerism|1|||
162852946|NCT01287104|588166017|FG002|Overall Study|Low donor chimerism|0|||
162852947|NCT01287104|588166018|FG003|Overall Study|Low donor chimerism|0|||
162852948|NCT01287104|588166015|FG000|Overall Study|NK cells did not meet release criteria|0|||
162852949|NCT01287104|588166016|FG001|Overall Study|NK cells did not meet release criteria|1|||
162852950|NCT01287104|588166017|FG002|Overall Study|NK cells did not meet release criteria|0|||
162852951|NCT01287104|588166018|FG003|Overall Study|NK cells did not meet release criteria|0|||
162852952|NCT04373460|588166025|FG000|Overall Study|Did not receive tranfusion|18|||
162852953|NCT04373460|588166026|FG001|Overall Study|Did not receive tranfusion|26|||
162852954|NCT00998738|588166029|FG000|Overall Study|Uknown|1|||
162852955|NCT03498521|588166030|FG000|Overall Study|Death|227|||
162852956|NCT03498521|588166031|FG001|Overall Study|Death|79|||
162852957|NCT03498521|588166032|FG002|Overall Study|Death|84|||
162852958|NCT03498521|588166030|FG000|Overall Study|Exclusion criteria|1|||
162852959|NCT03498521|588166031|FG001|Overall Study|Exclusion criteria|0|||
162852960|NCT03498521|588166032|FG002|Overall Study|Exclusion criteria|0|||
162852961|NCT03498521|588166030|FG000|Overall Study|Lost to Follow-up|4|||
162852962|NCT03498521|588166031|FG001|Overall Study|Lost to Follow-up|3|||
162852963|NCT03498521|588166032|FG002|Overall Study|Lost to Follow-up|3|||
162852964|NCT03498521|588166030|FG000|Overall Study|No profile due to technical failure|1|||
162852965|NCT03498521|588166031|FG001|Overall Study|No profile due to technical failure|0|||
162852966|NCT03498521|588166032|FG002|Overall Study|No profile due to technical failure|0|||
162852967|NCT03498521|588166030|FG000|Overall Study|Physician Decision|3|||
162852968|NCT03498521|588166031|FG001|Overall Study|Physician Decision|1|||
162852969|NCT03498521|588166032|FG002|Overall Study|Physician Decision|0|||
162852970|NCT03498521|588166030|FG000|Overall Study|Withdrawal by Subject|11|||
162852971|NCT03498521|588166031|FG001|Overall Study|Withdrawal by Subject|6|||
162852972|NCT03498521|588166032|FG002|Overall Study|Withdrawal by Subject|2|||
162852973|NCT03498521|588166030|FG000|Overall Study|Study terminated by sponsor|79|||
162852974|NCT03498521|588166031|FG001|Overall Study|Study terminated by sponsor|21|||
162852975|NCT03498521|588166032|FG002|Overall Study|Study terminated by sponsor|4|||
162852976|NCT02848833|588166041|FG000|Overall Study|subject who are duplicated|1|||
162852977|NCT02848833|588166041|FG000|Overall Study|have not taken the study drug|11|||
162852978|NCT02848833|588166041|FG000|Overall Study|follow-up failure|6|||
162852979|NCT02848833|588166041|FG000|Overall Study|Protocol Violation|119|||
162852980|NCT04980391|588166042|FG000|Overall Study|Death|0|||
162852981|NCT04980391|588166043|FG001|Overall Study|Death|0|||
162852982|NCT04980391|588166044|FG002|Overall Study|Death|1|||
162852983|NCT04980391|588166045|FG003|Overall Study|Death|1|||
162852984|NCT04980391|588166042|FG000|Overall Study|Lost to Follow-up|3|||
162852985|NCT04980391|588166043|FG001|Overall Study|Lost to Follow-up|3|||
162852986|NCT04980391|588166044|FG002|Overall Study|Lost to Follow-up|2|||
162852987|NCT04980391|588166045|FG003|Overall Study|Lost to Follow-up|3|||
162852988|NCT04980391|588166042|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
162852989|NCT04980391|588166043|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
162852990|NCT04980391|588166044|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
162852991|NCT04980391|588166045|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
162852992|NCT04980391|588166042|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162852993|NCT04980391|588166043|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162852994|NCT04980391|588166044|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162852995|NCT04980391|588166045|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162852996|NCT04980391|588166042|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
162852997|NCT04980391|588166043|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
162852998|NCT04980391|588166044|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
162852999|NCT04980391|588166045|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
162853000|NCT00001337|588168786|FG000|Overall Study|Switched to alternate treatment|2|||
162853001|NCT00001337|588168787|FG001|Overall Study|Switched to alternate treatment|2|||
162853002|NCT00001337|588168788|FG002|Overall Study|Switched to alternate treatment|0|||
162853003|NCT00001337|588168786|FG000|Overall Study|Refused further treatment|2|||
162853004|NCT00001337|588168787|FG001|Overall Study|Refused further treatment|1|||
162853005|NCT00001337|588168788|FG002|Overall Study|Refused further treatment|0|||
162853006|NCT00001337|588168786|FG000|Overall Study|Began other Tx|1|||
162853007|NCT00001337|588168787|FG001|Overall Study|Began other Tx|0|||
162853008|NCT00001337|588168788|FG002|Overall Study|Began other Tx|0|||
162853009|NCT00001337|588168786|FG000|Overall Study|Physician Decision|3|||
162853010|NCT00001337|588168787|FG001|Overall Study|Physician Decision|1|||
162853011|NCT00001337|588168788|FG002|Overall Study|Physician Decision|0|||
162853012|NCT00001337|588168786|FG000|Overall Study|Doesn't have NHL|0|||
162853013|NCT00001337|588168787|FG001|Overall Study|Doesn't have NHL|1|||
162853014|NCT00001337|588168788|FG002|Overall Study|Doesn't have NHL|0|||
162853015|NCT00001337|588168786|FG000|Overall Study|Non protocol tx needed|3|||
162853016|NCT00001337|588168787|FG001|Overall Study|Non protocol tx needed|1|||
162853017|NCT00001337|588168788|FG002|Overall Study|Non protocol tx needed|0|||
162853018|NCT00001337|588168786|FG000|Overall Study|Protocol change|1|||
162853019|NCT00001337|588168787|FG001|Overall Study|Protocol change|0|||
162853020|NCT00001337|588168788|FG002|Overall Study|Protocol change|0|||
162853021|NCT00001337|588168786|FG000|Overall Study|2nd primary disease|0|||
162853022|NCT00001337|588168787|FG001|Overall Study|2nd primary disease|0|||
162853023|NCT00001337|588168788|FG002|Overall Study|2nd primary disease|1|||
162853024|NCT00001337|588168786|FG000|Overall Study|Death during follow up period|9|||
162853025|NCT00001337|588168787|FG001|Overall Study|Death during follow up period|4|||
162853026|NCT00001337|588168788|FG002|Overall Study|Death during follow up period|0|||
162954308|NCT02883452|588537534|FG003|Overall Study|Death|0|||
162954309|NCT02883452|588537535|FG004|Overall Study|Death|0|||
162954310|NCT02883452|588537536|FG005|Overall Study|Death|0|||
163043433|NCT00215644|588868035|FG000|Overall Study|Adverse Event|2|||
163043434|NCT00215644|588868036|FG001|Overall Study|Adverse Event|9|||
163043435|NCT00215644|588868035|FG000|Overall Study|Death|1|||
163043436|NCT00215644|588868036|FG001|Overall Study|Death|2|||
162954311|NCT02883452|588537531|FG000|Overall Study|Other|0|||
162954312|NCT02883452|588537532|FG001|Overall Study|Other|0|||
162954313|NCT02883452|588537533|FG002|Overall Study|Other|0|||
162954314|NCT02883452|588537534|FG003|Overall Study|Other|0|||
162954315|NCT02883452|588537535|FG004|Overall Study|Other|0|||
162954316|NCT02883452|588537536|FG005|Overall Study|Other|1|||
162954317|NCT00905840|588537542|FG000|Overall Study|Lost to Follow-up|11|||
162954318|NCT00905840|588537542|FG000|Overall Study|Death|3|||
162954319|NCT00905840|588537542|FG000|Overall Study|Withdrawal by Subject|1|||
162954320|NCT00905840|588537542|FG000|Overall Study|Adverse Event|1|||
162954321|NCT00448019|588537543|FG000|Overall Study|Withdrawal by Subject|3|||
162954322|NCT00448019|588537543|FG000|Overall Study|Disease progression|1|||
162954323|NCT00448019|588537543|FG000|Overall Study|Death|2|||
162954324|NCT00448019|588537543|FG000|Overall Study|Insurance Issues|1|||
162954325|NCT02699866|588537551|FG000|Overall Study|Withdrawal by Subject|3|||
162954326|NCT02699866|588537551|FG000|Overall Study|Physician Decision|2|||
162954327|NCT02699866|588537551|FG000|Overall Study|Adverse Event|3|||
162954328|NCT05169710|588537554|FG000|Overall Study|Adverse Event|1|||
162954329|NCT05169710|588537555|FG001|Overall Study|Adverse Event|2|||
162954330|NCT05169710|588537556|FG002|Overall Study|Adverse Event|2|||
162954331|NCT05169710|588537554|FG000|Overall Study|Lost to Follow-up|0|||
162954332|NCT05169710|588537555|FG001|Overall Study|Lost to Follow-up|0|||
162954333|NCT05169710|588537556|FG002|Overall Study|Lost to Follow-up|1|||
162954334|NCT05169710|588537554|FG000|Overall Study|Withdrawal by Subject|2|||
162954335|NCT05169710|588537555|FG001|Overall Study|Withdrawal by Subject|1|||
162954336|NCT05169710|588537556|FG002|Overall Study|Withdrawal by Subject|0|||
162954337|NCT05169710|588537554|FG000|Overall Study|Other Study Discontinuation Reason|0|||
162954338|NCT05169710|588537555|FG001|Overall Study|Other Study Discontinuation Reason|2|||
162954339|NCT05169710|588537556|FG002|Overall Study|Other Study Discontinuation Reason|0|||
162954340|NCT01208337|588537560|FG000|Overall Study|Death|3|||
162954341|NCT01864174|588537564|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
162954342|NCT01864174|588537565|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
162954343|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
162954344|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
162954345|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
162954346|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
162954347|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
163043437|NCT00215644|588868035|FG000|Overall Study|Withdrawal by Subject|1|||
163043438|NCT00215644|588868036|FG001|Overall Study|Withdrawal by Subject|0|||
163043439|NCT00215644|588868035|FG000|Overall Study|Other|3|||
162853027|NCT00001337|588168786|FG000|Overall Study|Death on study|19|||
162853028|NCT00001337|588168787|FG001|Overall Study|Death on study|9|||
162853029|NCT00001337|588168788|FG002|Overall Study|Death on study|0|||
162853030|NCT00001337|588168786|FG000|Overall Study|Disease progression during follow-up period|3|||
162954348|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
162954349|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Death|1|||
162954350|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Death|0|||
162954351|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
162954352|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
162853031|NCT00001337|588168787|FG001|Overall Study|Disease progression during follow-up period|1|||
162853032|NCT00001337|588168788|FG002|Overall Study|Disease progression during follow-up period|0|||
162853033|NCT00001337|588168786|FG000|Overall Study|Disease progression on study|33|||
162954353|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
163043440|NCT00215644|588868036|FG001|Overall Study|Other|15|||
162853034|NCT00001337|588168787|FG001|Overall Study|Disease progression on study|41|||
162853035|NCT00001337|588168788|FG002|Overall Study|Disease progression on study|0|||
162853036|NCT00001337|588168786|FG000|Overall Study|Lost to further follow-up|10|||
162853037|NCT00001337|588168787|FG001|Overall Study|Lost to further follow-up|6|||
162853038|NCT00001337|588168788|FG002|Overall Study|Lost to further follow-up|0|||
162853039|NCT00001337|588168786|FG000|Overall Study|2nd malignancy|1|||
162853040|NCT00001337|588168787|FG001|Overall Study|2nd malignancy|0|||
162853041|NCT00001337|588168788|FG002|Overall Study|2nd malignancy|0|||
162853042|NCT00001337|588168786|FG000|Overall Study|Treatment for second lymphoma|0|||
162853043|NCT00001337|588168787|FG001|Overall Study|Treatment for second lymphoma|1|||
162853044|NCT00001337|588168788|FG002|Overall Study|Treatment for second lymphoma|0|||
162853045|NCT00001337|588168786|FG000|Overall Study|Transfer to transplant|0|||
162853046|NCT00001337|588168787|FG001|Overall Study|Transfer to transplant|1|||
162853047|NCT00001337|588168788|FG002|Overall Study|Transfer to transplant|0|||
162853048|NCT04889209|588168793|FG000|All Cohorts Except 15E|Adverse Event|0|||
162853049|NCT04889209|588168794|FG001|All Cohorts Except 15E|Adverse Event|0|||
162853050|NCT04889209|588168795|FG002|All Cohorts Except 15E|Adverse Event|0|||
162853051|NCT04889209|588168796|FG003|All Cohorts Except 15E|Adverse Event|0|||
162853052|NCT04889209|588168797|FG004|All Cohorts Except 15E|Adverse Event|0|||
163043441|NCT00215644|588868035|FG000|Overall Study|Randomized but Not Treated|1|||
163043442|NCT00215644|588868036|FG001|Overall Study|Randomized but Not Treated|0|||
163043443|NCT02861664|588868039|FG000|Overall Study|Withdrawal of Consent|0|||
163043444|NCT02861664|588868040|FG001|Overall Study|Withdrawal of Consent|1|||
163043445|NCT03512353|588868041|FG000|Overall Study|Sponsor Decision|3|||
163043446|NCT03512353|588868041|FG000|Overall Study|Death|1|||
163043447|NCT01000974|588868042|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
163043448|NCT01000974|588868043|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
163043449|NCT01000974|588868044|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
163043450|NCT01000974|588868042|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
163043451|NCT01000974|588868043|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
163043452|NCT01000974|588868044|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
163043453|NCT01000974|588868042|FG000|Primary Vaccination Phase|Protocol Violation|40|||
163043454|NCT01000974|588868043|FG001|Primary Vaccination Phase|Protocol Violation|3|||
163043455|NCT01000974|588868044|FG002|Primary Vaccination Phase|Protocol Violation|2|||
163043456|NCT01000974|588868042|FG000|Primary Vaccination Phase|Adverse Event|14|||
163043457|NCT01000974|588868043|FG001|Primary Vaccination Phase|Adverse Event|2|||
163043458|NCT01000974|588868044|FG002|Primary Vaccination Phase|Adverse Event|2|||
163043459|NCT01000974|588868042|FG000|Primary Vaccination Phase|Other|4|||
163043460|NCT01000974|588868043|FG001|Primary Vaccination Phase|Other|9|||
163043461|NCT01000974|588868044|FG002|Primary Vaccination Phase|Other|12|||
163043462|NCT01000974|588868042|FG000|Booster Vaccination Phase|Protocol Violation|0|||
163043463|NCT01000974|588868043|FG001|Booster Vaccination Phase|Protocol Violation|0|||
162704662|NCT00557505|587630416|FG000|Overall Study|Withdrawal by Subject|0|||
162704663|NCT00557505|587630417|FG001|Overall Study|Withdrawal by Subject|0|||
162853053|NCT04889209|588168798|FG005|All Cohorts Except 15E|Adverse Event|0|||
162853054|NCT04889209|588168799|FG006|All Cohorts Except 15E|Adverse Event|1|||
162853055|NCT04889209|588168800|FG007|All Cohorts Except 15E|Adverse Event|0|||
162853056|NCT04889209|588168801|FG008|All Cohorts Except 15E|Adverse Event|0|||
162853057|NCT04889209|588168802|FG009|All Cohorts Except 15E|Adverse Event|0|||
162853058|NCT04889209|588168803|FG010|All Cohorts Except 15E|Adverse Event|0|||
162853059|NCT04889209|588168804|FG011|All Cohorts Except 15E|Adverse Event|0|||
162853060|NCT04889209|588168805|FG012|All Cohorts Except 15E|Adverse Event|0|||
162853061|NCT04889209|588168806|FG013|All Cohorts Except 15E|Adverse Event|0|||
162853062|NCT04889209|588168807|FG014|All Cohorts Except 15E|Adverse Event|0|||
162853063|NCT04889209|588168808|FG015|All Cohorts Except 15E|Adverse Event|0|||
162853064|NCT04889209|588168809|FG016|All Cohorts Except 15E|Adverse Event|0|||
162853065|NCT04889209|588168810|FG017|All Cohorts Except 15E|Adverse Event|0|||
162853066|NCT04889209|588168793|FG000|All Cohorts Except 15E|Death|0|||
162853067|NCT04889209|588168794|FG001|All Cohorts Except 15E|Death|1|||
162853068|NCT04889209|588168795|FG002|All Cohorts Except 15E|Death|0|||
162853069|NCT04889209|588168796|FG003|All Cohorts Except 15E|Death|0|||
162853070|NCT04889209|588168797|FG004|All Cohorts Except 15E|Death|0|||
162853071|NCT04889209|588168798|FG005|All Cohorts Except 15E|Death|0|||
162853072|NCT04889209|588168799|FG006|All Cohorts Except 15E|Death|0|||
162853073|NCT04889209|588168800|FG007|All Cohorts Except 15E|Death|0|||
162853074|NCT04889209|588168801|FG008|All Cohorts Except 15E|Death|0|||
162853075|NCT04889209|588168802|FG009|All Cohorts Except 15E|Death|0|||
162853076|NCT04889209|588168803|FG010|All Cohorts Except 15E|Death|0|||
162853077|NCT04889209|588168804|FG011|All Cohorts Except 15E|Death|0|||
162853078|NCT04889209|588168805|FG012|All Cohorts Except 15E|Death|0|||
162853079|NCT04889209|588168806|FG013|All Cohorts Except 15E|Death|0|||
162853080|NCT04889209|588168807|FG014|All Cohorts Except 15E|Death|0|||
162853081|NCT04889209|588168808|FG015|All Cohorts Except 15E|Death|0|||
163043464|NCT01000974|588868044|FG002|Booster Vaccination Phase|Protocol Violation|2|||
163043465|NCT01000974|588868042|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
162853082|NCT04889209|588168809|FG016|All Cohorts Except 15E|Death|0|||
162853083|NCT04889209|588168810|FG017|All Cohorts Except 15E|Death|0|||
162853084|NCT04889209|588168793|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
162853085|NCT04889209|588168794|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
162853086|NCT04889209|588168795|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
162853087|NCT04889209|588168796|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
162853088|NCT04889209|588168797|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
162853089|NCT04889209|588168798|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
162853090|NCT04889209|588168799|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
162853091|NCT04889209|588168800|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
162853092|NCT04889209|588168801|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
162853093|NCT04889209|588168802|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
162853094|NCT04889209|588168803|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
162954354|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
163043466|NCT01000974|588868043|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
163043467|NCT01000974|588868044|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
163043468|NCT01000974|588868042|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
162954355|NCT01864174|588537564|FG000|Double Blind - Compliant Randomized|Other|6|||
162954356|NCT01864174|588537565|FG001|Double Blind - Compliant Randomized|Other|10|||
162954357|NCT01864174|588537564|FG000|Off Treatment Follow-Up|Other|2|||
162954358|NCT01864174|588537565|FG001|Off Treatment Follow-Up|Other|0|||
162954359|NCT01864174|588537564|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
162954360|NCT01864174|588537565|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
162954361|NCT02158663|588537568|FG000|Overall Study|Withdrawal by Subject|5|||
162954362|NCT02158663|588537569|FG001|Overall Study|Withdrawal by Subject|4|||
162954363|NCT00576056|588537570|FG000|Overall Study|Adverse Event|1|||
162954364|NCT00576056|588537570|FG000|Overall Study|Death|1|||
162954365|NCT00576056|588537570|FG000|Overall Study|Lack of Efficacy|1|||
162954366|NCT00576056|588537570|FG000|Overall Study|Withdrawal by Subject|2|||
162954367|NCT00576056|588537570|FG000|Overall Study|did not meet eligibility criteria|8|||
162954368|NCT00576056|588537570|FG000|Overall Study|Physician Decision|1|||
162954369|NCT03197883|588537571|FG000|Overall Study|Adverse Event|1|||
162954370|NCT03197883|588537572|FG001|Overall Study|Adverse Event|1|||
162954371|NCT03197883|588537571|FG000|Overall Study|Lost to Follow-up|1|||
162954372|NCT03197883|588537572|FG001|Overall Study|Lost to Follow-up|0|||
162954373|NCT03197883|588537571|FG000|Overall Study|Protocol Violation|1|||
162954374|NCT03197883|588537572|FG001|Overall Study|Protocol Violation|0|||
162954375|NCT03197883|588537571|FG000|Overall Study|Other (Not Specified)|0|||
162954376|NCT03197883|588537572|FG001|Overall Study|Other (Not Specified)|5|||
162954377|NCT01353664|588537573|FG000|Overall Study|Other|3|||
162954378|NCT01353664|588537573|FG000|Overall Study|Disease Progression|16|||
162954379|NCT03273153|588537574|FG000|Overall Study|Adverse Event|1|||
162954380|NCT03273153|588537575|FG001|Overall Study|Adverse Event|2|||
162954381|NCT03273153|588537574|FG000|Overall Study|Missing|0|||
162954382|NCT03273153|588537575|FG001|Overall Study|Missing|2|||
162954383|NCT03273153|588537574|FG000|Overall Study|Other|3|||
162954384|NCT03273153|588537575|FG001|Overall Study|Other|2|||
162954385|NCT03273153|588537574|FG000|Overall Study|Symptomatic Deterioration|0|||
162954386|NCT03273153|588537575|FG001|Overall Study|Symptomatic Deterioration|1|||
162954387|NCT03273153|588537574|FG000|Overall Study|Progressive Disease|6|||
162954388|NCT03273153|588537575|FG001|Overall Study|Progressive Disease|5|||
162954389|NCT03273153|588537574|FG000|Overall Study|Physician Decision|1|||
162954390|NCT03273153|588537575|FG001|Overall Study|Physician Decision|3|||
162954391|NCT03273153|588537574|FG000|Overall Study|Study Terminated by Sponsor|112|||
162954392|NCT03273153|588537575|FG001|Overall Study|Study Terminated by Sponsor|102|||
162954393|NCT03273153|588537574|FG000|Overall Study|Withdrawal by Subject|26|||
162954394|NCT03273153|588537575|FG001|Overall Study|Withdrawal by Subject|25|||
163043469|NCT01000974|588868043|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
162853095|NCT04889209|588168804|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
162853096|NCT04889209|588168805|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
162853097|NCT04889209|588168806|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
162853098|NCT04889209|588168807|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
162853099|NCT04889209|588168808|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
162853100|NCT04889209|588168809|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
162853101|NCT04889209|588168810|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
162954395|NCT03273153|588537574|FG000|Overall Study|Protocol Deviation|3|||
163043470|NCT01000974|588868044|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
162853102|NCT04889209|588168793|FG000|All Cohorts Except 15E|Physician Decision|0|||
162954396|NCT03273153|588537575|FG001|Overall Study|Protocol Deviation|0|||
162954397|NCT03273153|588537574|FG000|Overall Study|Lost to Follow-up|6|||
162954398|NCT03273153|588537575|FG001|Overall Study|Lost to Follow-up|11|||
162954399|NCT03273153|588537574|FG000|Overall Study|Death|66|||
162954400|NCT03273153|588537575|FG001|Overall Study|Death|69|||
162954401|NCT02409355|588537576|FG000|Overall Study|Withdrawal by Subject|1|||
162954402|NCT02409355|588537577|FG001|Overall Study|Withdrawal by Subject|0|||
162954403|NCT02409355|588537576|FG000|Overall Study|Death|1|||
162954404|NCT02409355|588537577|FG001|Overall Study|Death|1|||
163043471|NCT01000974|588868042|FG000|Booster Vaccination Phase|Other|24|||
162954405|NCT02409355|588537576|FG000|Overall Study|Study terminated by Sponsor|2|||
162853103|NCT04889209|588168794|FG001|All Cohorts Except 15E|Physician Decision|0|||
162853104|NCT04889209|588168795|FG002|All Cohorts Except 15E|Physician Decision|0|||
162853105|NCT04889209|588168796|FG003|All Cohorts Except 15E|Physician Decision|0|||
162853106|NCT04889209|588168797|FG004|All Cohorts Except 15E|Physician Decision|1|||
162853107|NCT04889209|588168798|FG005|All Cohorts Except 15E|Physician Decision|0|||
162853108|NCT04889209|588168799|FG006|All Cohorts Except 15E|Physician Decision|0|||
162853109|NCT04889209|588168800|FG007|All Cohorts Except 15E|Physician Decision|1|||
162853110|NCT04889209|588168801|FG008|All Cohorts Except 15E|Physician Decision|0|||
162853111|NCT04889209|588168802|FG009|All Cohorts Except 15E|Physician Decision|1|||
162853112|NCT04889209|588168803|FG010|All Cohorts Except 15E|Physician Decision|0|||
162853113|NCT04889209|588168804|FG011|All Cohorts Except 15E|Physician Decision|1|||
162853114|NCT04889209|588168805|FG012|All Cohorts Except 15E|Physician Decision|1|||
162853115|NCT04889209|588168806|FG013|All Cohorts Except 15E|Physician Decision|0|||
162853116|NCT04889209|588168807|FG014|All Cohorts Except 15E|Physician Decision|0|||
162853117|NCT04889209|588168808|FG015|All Cohorts Except 15E|Physician Decision|0|||
162853118|NCT04889209|588168809|FG016|All Cohorts Except 15E|Physician Decision|0|||
162853119|NCT04889209|588168810|FG017|All Cohorts Except 15E|Physician Decision|0|||
162853120|NCT04889209|588168793|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
162853121|NCT04889209|588168794|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
162853122|NCT04889209|588168795|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
162853123|NCT04889209|588168796|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
162853124|NCT04889209|588168797|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
162853125|NCT04889209|588168798|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853126|NCT04889209|588168799|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853127|NCT04889209|588168800|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
162853128|NCT04889209|588168801|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853129|NCT04889209|588168802|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853130|NCT04889209|588168803|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853131|NCT04889209|588168804|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853132|NCT04889209|588168805|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853133|NCT04889209|588168806|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
162853134|NCT04889209|588168807|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
162853135|NCT04889209|588168808|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
162853136|NCT04889209|588168809|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
162853137|NCT04889209|588168810|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
162853138|NCT04889209|588168793|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
162853139|NCT04889209|588168794|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
162853140|NCT04889209|588168795|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853141|NCT04889209|588168796|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853142|NCT04889209|588168797|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853143|NCT04889209|588168798|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
162853144|NCT04889209|588168799|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853145|NCT04889209|588168800|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
162853146|NCT04889209|588168801|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853147|NCT04889209|588168802|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
162853148|NCT04889209|588168803|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853149|NCT04889209|588168804|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853150|NCT04889209|588168805|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853151|NCT04889209|588168806|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853152|NCT04889209|588168807|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853153|NCT04889209|588168808|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853154|NCT04889209|588168809|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
162853155|NCT04889209|588168810|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
162853156|NCT04889209|588168793|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162611653|NCT03497676|587294992|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
162853157|NCT04889209|588168794|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853158|NCT04889209|588168795|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
163043472|NCT01000974|588868043|FG001|Booster Vaccination Phase|Other|6|||
162853159|NCT04889209|588168796|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
162853160|NCT04889209|588168797|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853161|NCT04889209|588168798|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853162|NCT04889209|588168799|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853163|NCT04889209|588168800|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853164|NCT04889209|588168801|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853165|NCT04889209|588168802|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853166|NCT04889209|588168803|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853167|NCT04889209|588168804|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853168|NCT04889209|588168805|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853169|NCT04889209|588168806|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853170|NCT04889209|588168807|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853171|NCT04889209|588168808|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853172|NCT04889209|588168809|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853173|NCT04889209|588168810|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
162853174|NCT04889209|588168793|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853175|NCT04889209|588168794|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853176|NCT04889209|588168795|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853177|NCT04889209|588168796|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853178|NCT04889209|588168797|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853179|NCT04889209|588168798|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853180|NCT04889209|588168799|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853181|NCT04889209|588168800|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853182|NCT04889209|588168801|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853183|NCT04889209|588168802|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853184|NCT04889209|588168803|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853185|NCT04889209|588168804|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853186|NCT04889209|588168805|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853187|NCT04889209|588168806|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853188|NCT04889209|588168807|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853189|NCT04889209|588168808|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853190|NCT04889209|588168809|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
162853191|NCT04889209|588168810|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
162853192|NCT04889209|588168793|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853193|NCT04889209|588168794|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853194|NCT04889209|588168795|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853195|NCT04889209|588168796|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853196|NCT04889209|588168797|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853197|NCT04889209|588168798|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853198|NCT04889209|588168799|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853199|NCT04889209|588168800|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853200|NCT04889209|588168801|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853201|NCT04889209|588168802|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853202|NCT04889209|588168803|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853203|NCT04889209|588168804|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853204|NCT04889209|588168805|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853205|NCT04889209|588168806|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853206|NCT04889209|588168807|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853207|NCT04889209|588168808|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853208|NCT04889209|588168809|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
162853209|NCT04889209|588168810|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
162704664|NCT00557505|587630418|FG002|Overall Study|Withdrawal by Subject|0|||
162853210|NCT04889209|588168793|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853211|NCT04889209|588168794|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853212|NCT04889209|588168795|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853213|NCT04889209|588168796|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853214|NCT04889209|588168797|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853215|NCT04889209|588168798|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853216|NCT04889209|588168799|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853217|NCT04889209|588168800|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853218|NCT04889209|588168801|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853219|NCT04889209|588168802|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853220|NCT04889209|588168803|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853221|NCT04889209|588168804|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853222|NCT04889209|588168805|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853223|NCT04889209|588168806|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853224|NCT04889209|588168807|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853225|NCT04889209|588168808|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853226|NCT04889209|588168809|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
162853227|NCT04889209|588168810|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
162853228|NCT04889209|588168793|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853229|NCT04889209|588168794|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853230|NCT04889209|588168795|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853231|NCT04889209|588168796|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853232|NCT04889209|588168797|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853233|NCT04889209|588168798|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853234|NCT04889209|588168799|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853235|NCT04889209|588168800|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853236|NCT04889209|588168801|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853237|NCT04889209|588168802|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853238|NCT04889209|588168803|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853239|NCT04889209|588168804|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853240|NCT04889209|588168805|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853241|NCT04889209|588168806|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853242|NCT04889209|588168807|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
162853243|NCT04889209|588168808|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853244|NCT04889209|588168809|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853245|NCT04889209|588168810|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
162853246|NCT05424276|588168811|FG000|Overall Study|Adverse Event|1|||
162853247|NCT05424276|588168812|FG001|Overall Study|Adverse Event|0|||
162853248|NCT05424276|588168813|FG002|Overall Study|Adverse Event|0|||
162853249|NCT05424276|588168814|FG003|Overall Study|Adverse Event|2|||
162853250|NCT05424276|588168811|FG000|Overall Study|Withdrawal by Subject|0|||
162853251|NCT05424276|588168812|FG001|Overall Study|Withdrawal by Subject|0|||
162853252|NCT05424276|588168813|FG002|Overall Study|Withdrawal by Subject|2|||
162853253|NCT05424276|588168814|FG003|Overall Study|Withdrawal by Subject|0|||
162954406|NCT02409355|588537577|FG001|Overall Study|Study terminated by Sponsor|3|||
162954407|NCT01237054|588537578|FG000|Overall Study|imaging 10C0096|1|||
162954408|NCT00838539|588537579|FG000|Overall Study|Disease Progression|2|||
162954409|NCT00838539|588537580|FG001|Overall Study|Disease Progression|4|||
162954410|NCT00838539|588537581|FG002|Overall Study|Disease Progression|3|||
162954411|NCT00838539|588537582|FG003|Overall Study|Disease Progression|2|||
162954412|NCT00838539|588537583|FG004|Overall Study|Disease Progression|4|||
162954413|NCT00838539|588537584|FG005|Overall Study|Disease Progression|2|||
162954414|NCT00838539|588537585|FG006|Overall Study|Disease Progression|3|||
162853254|NCT05424276|588168811|FG000|Overall Study|Protocol Violation|0|||
162853255|NCT05424276|588168812|FG001|Overall Study|Protocol Violation|1|||
162853256|NCT05424276|588168813|FG002|Overall Study|Protocol Violation|0|||
162853257|NCT05424276|588168814|FG003|Overall Study|Protocol Violation|0|||
162853258|NCT05424276|588168811|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
162853259|NCT05424276|588168812|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
162853260|NCT05424276|588168813|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
162853261|NCT05424276|588168814|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
162853262|NCT01725165|588168815|FG000|Overall Study|Death|11|||
162853263|NCT01725165|588168816|FG001|Overall Study|Death|18|||
162853264|NCT05113940|588168819|FG000|Part A (18 Days)|Adverse Event|0|||
162853265|NCT05113940|588168820|FG001|Part A (18 Days)|Adverse Event|0|||
162853266|NCT05113940|588168821|FG002|Part A (18 Days)|Adverse Event|1|||
162954415|NCT00838539|588537586|FG007|Overall Study|Disease Progression|4|||
162954416|NCT00838539|588537587|FG008|Overall Study|Disease Progression|4|||
162954417|NCT00838539|588537588|FG009|Overall Study|Disease Progression|5|||
162704665|NCT00557505|587630419|FG003|Overall Study|Withdrawal by Subject|1|||
162853267|NCT05113940|588168822|FG003|Part A (18 Days)|Adverse Event|1|||
162853268|NCT05113940|588168823|FG004|Part A (18 Days)|Adverse Event|1|||
162853269|NCT05113940|588168824|FG005|Part A (18 Days)|Adverse Event|0|||
162853270|NCT05113940|588168825|FG006|Part A (18 Days)|Adverse Event|0|||
162853271|NCT05113940|588168826|FG007|Part A (18 Days)|Adverse Event|0|||
162853272|NCT05113940|588168827|FG008|Part A (18 Days)|Adverse Event|0|||
162853273|NCT05113940|588168828|FG009|Part A (18 Days)|Adverse Event|0|||
162853274|NCT05113940|588168829|FG010|Part A (18 Days)|Adverse Event|0|||
162853275|NCT05113940|588168830|FG011|Part A (18 Days)|Adverse Event|2|||
162853276|NCT05113940|588168831|FG012|Part A (18 Days)|Adverse Event|0|||
162853277|NCT05113940|588168832|FG013|Part A (18 Days)|Adverse Event|0|||
162853278|NCT05113940|588168833|FG014|Part A (18 Days)|Adverse Event|0|||
162853279|NCT05113940|588168819|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853280|NCT05113940|588168820|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853281|NCT05113940|588168821|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853282|NCT05113940|588168822|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853283|NCT05113940|588168823|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853284|NCT05113940|588168824|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853285|NCT05113940|588168825|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853286|NCT05113940|588168826|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853287|NCT05113940|588168827|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853288|NCT05113940|588168828|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853289|NCT05113940|588168829|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853290|NCT05113940|588168830|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853291|NCT05113940|588168831|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853292|NCT05113940|588168832|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
162853293|NCT05113940|588168833|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
162853294|NCT00442598|588168837|FG000|Overall Study|Adverse Event|1|||
162853295|NCT00442598|588168838|FG001|Overall Study|Adverse Event|0|||
162853296|NCT00442598|588168839|FG002|Overall Study|Adverse Event|0|||
162853297|NCT00442598|588168837|FG000|Overall Study|Tumor progression|3|||
162954418|NCT00838539|588537589|FG010|Overall Study|Disease Progression|1|||
162954419|NCT00838539|588537590|FG011|Overall Study|Disease Progression|4|||
162954420|NCT00838539|588537579|FG000|Overall Study|Adverse Event|1|||
162954421|NCT00838539|588537580|FG001|Overall Study|Adverse Event|1|||
162954422|NCT00838539|588537581|FG002|Overall Study|Adverse Event|1|||
162954423|NCT00838539|588537582|FG003|Overall Study|Adverse Event|1|||
162954424|NCT00838539|588537583|FG004|Overall Study|Adverse Event|2|||
162954425|NCT00838539|588537584|FG005|Overall Study|Adverse Event|1|||
162954426|NCT00838539|588537585|FG006|Overall Study|Adverse Event|0|||
162954427|NCT00838539|588537586|FG007|Overall Study|Adverse Event|2|||
162954428|NCT00838539|588537587|FG008|Overall Study|Adverse Event|0|||
162954429|NCT00838539|588537588|FG009|Overall Study|Adverse Event|1|||
162954430|NCT00838539|588537589|FG010|Overall Study|Adverse Event|2|||
162954431|NCT00838539|588537590|FG011|Overall Study|Adverse Event|0|||
162954432|NCT00838539|588537579|FG000|Overall Study|Withdrawal by Subject|0|||
162954433|NCT00838539|588537580|FG001|Overall Study|Withdrawal by Subject|1|||
162954434|NCT00838539|588537581|FG002|Overall Study|Withdrawal by Subject|0|||
162954435|NCT00838539|588537582|FG003|Overall Study|Withdrawal by Subject|0|||
162954436|NCT00838539|588537583|FG004|Overall Study|Withdrawal by Subject|0|||
162954437|NCT00838539|588537584|FG005|Overall Study|Withdrawal by Subject|0|||
162954438|NCT00838539|588537585|FG006|Overall Study|Withdrawal by Subject|0|||
162954439|NCT00838539|588537586|FG007|Overall Study|Withdrawal by Subject|0|||
162954440|NCT00838539|588537587|FG008|Overall Study|Withdrawal by Subject|0|||
162954441|NCT00838539|588537588|FG009|Overall Study|Withdrawal by Subject|1|||
162954442|NCT00838539|588537589|FG010|Overall Study|Withdrawal by Subject|2|||
162954443|NCT00838539|588537590|FG011|Overall Study|Withdrawal by Subject|0|||
162954444|NCT00838539|588537579|FG000|Overall Study|Death|0|||
162954445|NCT00838539|588537580|FG001|Overall Study|Death|0|||
162954446|NCT00838539|588537581|FG002|Overall Study|Death|0|||
162954447|NCT00838539|588537582|FG003|Overall Study|Death|0|||
162954448|NCT00838539|588537583|FG004|Overall Study|Death|0|||
162954449|NCT00838539|588537584|FG005|Overall Study|Death|0|||
162954450|NCT00838539|588537585|FG006|Overall Study|Death|1|||
162954451|NCT00838539|588537586|FG007|Overall Study|Death|0|||
162954452|NCT00838539|588537587|FG008|Overall Study|Death|0|||
162954453|NCT00838539|588537588|FG009|Overall Study|Death|0|||
162954454|NCT00838539|588537589|FG010|Overall Study|Death|0|||
162954455|NCT00838539|588537590|FG011|Overall Study|Death|0|||
162853298|NCT00442598|588168838|FG001|Overall Study|Tumor progression|4|||
162853299|NCT00442598|588168839|FG002|Overall Study|Tumor progression|0|||
162853300|NCT00442598|588168837|FG000|Overall Study|Clinical deterioration|1|||
162853301|NCT00442598|588168838|FG001|Overall Study|Clinical deterioration|2|||
162853302|NCT00442598|588168839|FG002|Overall Study|Clinical deterioration|0|||
162954456|NCT00838539|588537579|FG000|Overall Study|Physician Decision|0|||
162954457|NCT00838539|588537580|FG001|Overall Study|Physician Decision|0|||
162954458|NCT00838539|588537581|FG002|Overall Study|Physician Decision|0|||
162954459|NCT00838539|588537582|FG003|Overall Study|Physician Decision|0|||
162954460|NCT00838539|588537583|FG004|Overall Study|Physician Decision|0|||
162954461|NCT00838539|588537584|FG005|Overall Study|Physician Decision|0|||
163043473|NCT01000974|588868044|FG002|Booster Vaccination Phase|Other|4|||
163043474|NCT01639144|588868047|FG000|Overall Study|Withdrawal by Subject|4|||
163043475|NCT01639144|588868048|FG001|Overall Study|Withdrawal by Subject|2|||
163043476|NCT01639144|588868047|FG000|Overall Study|Physician Decision|2|||
163043477|NCT01639144|588868048|FG001|Overall Study|Physician Decision|0|||
163043478|NCT01639144|588868047|FG000|Overall Study|Met postoperative exclusion criteria|4|||
163043479|NCT01639144|588868048|FG001|Overall Study|Met postoperative exclusion criteria|3|||
163043480|NCT01307891|588868050|FG000|Overall Study|Progressive Disease|3|||
163043481|NCT01307891|588868051|FG001|Overall Study|Progressive Disease|1|||
163043482|NCT03365934|588868052|FG000|Overall Study|Adverse Event|1|||
163043483|NCT03365934|588868052|FG000|Overall Study|Withdrawal by Subject|1|||
163043484|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
163043485|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
163043486|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
163043487|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
163043488|NCT02937740|588868053|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
163043489|NCT02937740|588868054|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
163043490|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
163043491|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
163043492|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
163043493|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
163043494|NCT02937740|588868053|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
163043495|NCT02937740|588868054|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
163043496|NCT02964338|588868057|FG000|Overall Study|Sponsor terminated study for futility|12|||
163043497|NCT02964338|588868058|FG001|Overall Study|Sponsor terminated study for futility|15|||
163043498|NCT02964338|588868059|FG002|Overall Study|Sponsor terminated study for futility|14|||
163043499|NCT02964338|588868057|FG000|Overall Study|Lack of Efficacy|0|||
162954462|NCT00838539|588537585|FG006|Overall Study|Physician Decision|0|||
162954463|NCT00838539|588537586|FG007|Overall Study|Physician Decision|0|||
162954464|NCT00838539|588537587|FG008|Overall Study|Physician Decision|1|||
162954465|NCT00838539|588537588|FG009|Overall Study|Physician Decision|0|||
163043500|NCT02964338|588868058|FG001|Overall Study|Lack of Efficacy|3|||
162954466|NCT00838539|588537589|FG010|Overall Study|Physician Decision|0|||
162954467|NCT00838539|588537590|FG011|Overall Study|Physician Decision|0|||
162954468|NCT00838539|588537579|FG000|Overall Study|Clinical Progression|0|||
162954469|NCT00838539|588537580|FG001|Overall Study|Clinical Progression|0|||
162954470|NCT00838539|588537581|FG002|Overall Study|Clinical Progression|0|||
162954471|NCT00838539|588537582|FG003|Overall Study|Clinical Progression|0|||
162954472|NCT00838539|588537583|FG004|Overall Study|Clinical Progression|0|||
162954473|NCT00838539|588537584|FG005|Overall Study|Clinical Progression|0|||
162954474|NCT00838539|588537585|FG006|Overall Study|Clinical Progression|1|||
162954475|NCT00838539|588537586|FG007|Overall Study|Clinical Progression|0|||
163043501|NCT02964338|588868059|FG002|Overall Study|Lack of Efficacy|0|||
163043502|NCT02964338|588868057|FG000|Overall Study|Lost to Follow-up|1|||
163043503|NCT02964338|588868058|FG001|Overall Study|Lost to Follow-up|0|||
163043504|NCT02964338|588868059|FG002|Overall Study|Lost to Follow-up|3|||
163043505|NCT02964338|588868057|FG000|Overall Study|Protocol Violation|0|||
162853303|NCT00442598|588168837|FG000|Overall Study|CA125 progression|0|||
162853304|NCT00442598|588168838|FG001|Overall Study|CA125 progression|1|||
162853305|NCT00442598|588168839|FG002|Overall Study|CA125 progression|0|||
162853306|NCT00442598|588168837|FG000|Overall Study|Reduced creatinine clearance|1|||
162853307|NCT00442598|588168838|FG001|Overall Study|Reduced creatinine clearance|0|||
162853308|NCT00442598|588168839|FG002|Overall Study|Reduced creatinine clearance|0|||
162853309|NCT00442598|588168837|FG000|Overall Study|Death|0|||
162853310|NCT00442598|588168838|FG001|Overall Study|Death|1|||
162853311|NCT00442598|588168839|FG002|Overall Study|Death|0|||
162853312|NCT02886702|588168840|FG000|Overall Study|Other|4|||
162853313|NCT02886702|588168841|FG001|Overall Study|Other|3|||
162853314|NCT02886702|588168842|FG002|Overall Study|Other|9|||
162853315|NCT02886702|588168840|FG000|Overall Study|Withdrawal by Subject|24|||
162853316|NCT02886702|588168841|FG001|Overall Study|Withdrawal by Subject|18|||
162853317|NCT02886702|588168842|FG002|Overall Study|Withdrawal by Subject|22|||
162853318|NCT02886702|588168840|FG000|Overall Study|Significant Worsening of Condition|0|||
162853319|NCT02886702|588168841|FG001|Overall Study|Significant Worsening of Condition|1|||
162853320|NCT02886702|588168842|FG002|Overall Study|Significant Worsening of Condition|0|||
162853321|NCT02886702|588168840|FG000|Overall Study|Protocol Violation|2|||
162853322|NCT02886702|588168841|FG001|Overall Study|Protocol Violation|2|||
162853323|NCT02886702|588168842|FG002|Overall Study|Protocol Violation|1|||
162853324|NCT02886702|588168840|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162954476|NCT00838539|588537587|FG008|Overall Study|Clinical Progression|0|||
162853325|NCT02886702|588168841|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162853326|NCT02886702|588168842|FG002|Overall Study|Non-Compliance With Study Drug|4|||
162853327|NCT02886702|588168840|FG000|Overall Study|Lost to Follow-up|11|||
162853328|NCT02886702|588168841|FG001|Overall Study|Lost to Follow-up|13|||
162853329|NCT02886702|588168842|FG002|Overall Study|Lost to Follow-up|8|||
162853330|NCT02886702|588168840|FG000|Overall Study|Lack of Efficacy|3|||
162853331|NCT02886702|588168841|FG001|Overall Study|Lack of Efficacy|4|||
162853332|NCT02886702|588168842|FG002|Overall Study|Lack of Efficacy|5|||
162853333|NCT02886702|588168840|FG000|Overall Study|Adverse Event|4|||
162853334|NCT02886702|588168841|FG001|Overall Study|Adverse Event|9|||
162853335|NCT02886702|588168842|FG002|Overall Study|Adverse Event|3|||
162853336|NCT02886702|588168840|FG000|Overall Study|Administrative Reasons|0|||
162853337|NCT02886702|588168841|FG001|Overall Study|Administrative Reasons|0|||
162853338|NCT02886702|588168842|FG002|Overall Study|Administrative Reasons|1|||
162853339|NCT01147926|588168850|FG000|Overall Study|Subject Withdrew Consent|9|||
162853340|NCT01147926|588168851|FG001|Overall Study|Subject Withdrew Consent|10|||
162853341|NCT01147926|588168850|FG000|Overall Study|Adverse Event|7|||
162853342|NCT01147926|588168851|FG001|Overall Study|Adverse Event|6|||
162853343|NCT01147926|588168850|FG000|Overall Study|Subject Non-Compliant|5|||
162853344|NCT01147926|588168851|FG001|Overall Study|Subject Non-Compliant|4|||
162853345|NCT01147926|588168850|FG000|Overall Study|Principal investigator left hospital|1|||
162853346|NCT01147926|588168851|FG001|Overall Study|Principal investigator left hospital|3|||
162853347|NCT01147926|588168850|FG000|Overall Study|Selection criteria not met|3|||
162853348|NCT01147926|588168851|FG001|Overall Study|Selection criteria not met|1|||
162853349|NCT01147926|588168850|FG000|Overall Study|Lost to Follow-up|0|||
162853350|NCT01147926|588168851|FG001|Overall Study|Lost to Follow-up|2|||
162853351|NCT01147926|588168850|FG000|Overall Study|Sponsor's Decision|0|||
162853352|NCT01147926|588168851|FG001|Overall Study|Sponsor's Decision|1|||
162853353|NCT01147926|588168850|FG000|Overall Study|Lack of Efficacy|1|||
162853354|NCT01147926|588168851|FG001|Overall Study|Lack of Efficacy|0|||
162853355|NCT01147926|588168850|FG000|Overall Study|Too busy, no time for study|1|||
162853356|NCT01147926|588168851|FG001|Overall Study|Too busy, no time for study|0|||
162853357|NCT01147926|588168850|FG000|Overall Study|Went on holiday|0|||
162853358|NCT01147926|588168851|FG001|Overall Study|Went on holiday|1|||
162853359|NCT01147926|588168850|FG000|Overall Study|Colonoscopy result|0|||
162853360|NCT01147926|588168851|FG001|Overall Study|Colonoscopy result|1|||
162853361|NCT01085682|588168852|FG000|Overall Study|Withdrawal by Subject|25|||
162853362|NCT01085682|588168853|FG001|Overall Study|Withdrawal by Subject|25|||
162853363|NCT02561156|588168856|FG000|Part 2|Adverse Event|0|||
162853364|NCT02561156|588168857|FG001|Part 2|Adverse Event|0|||
162853365|NCT02561156|588168858|FG002|Part 2|Adverse Event|0|||
162853366|NCT02561156|588168859|FG003|Part 2|Adverse Event|0|||
162853367|NCT02561156|588168860|FG004|Part 2|Adverse Event|0|||
162853368|NCT02561156|588168861|FG005|Part 2|Adverse Event|0|||
162853369|NCT02561156|588168862|FG006|Part 2|Adverse Event|0|||
162853370|NCT02561156|588168863|FG007|Part 2|Adverse Event|0|||
162853371|NCT02561156|588168864|FG008|Part 2|Adverse Event|0|||
162853372|NCT02561156|588168865|FG009|Part 2|Adverse Event|0|||
162853373|NCT02561156|588168866|FG010|Part 2|Adverse Event|0|||
162853374|NCT02561156|588168867|FG011|Part 2|Adverse Event|1|||
162853375|NCT02561156|588168868|FG012|Part 2|Adverse Event|0|||
162853376|NCT02207907|588168869|FG000|Overall Study|Lost to Follow-up|3|||
162853377|NCT02207907|588168870|FG001|Overall Study|Lost to Follow-up|1|||
162853378|NCT02207907|588168869|FG000|Overall Study|Withdrawal by Subject|5|||
162611654|NCT03497676|587294993|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
162611655|NCT03497676|587294994|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
162611656|NCT03497676|587294991|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
162611657|NCT03497676|587294992|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
162611658|NCT03497676|587294993|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
162611659|NCT03497676|587294994|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
162611660|NCT03497676|587294991|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162611661|NCT03497676|587294992|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
162611662|NCT03497676|587294993|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162611663|NCT03497676|587294994|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162611664|NCT03497676|587294991|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162611665|NCT03497676|587294992|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162611666|NCT03497676|587294993|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
162611667|NCT03497676|587294994|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162611668|NCT03497676|587294991|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162853379|NCT02207907|588168870|FG001|Overall Study|Withdrawal by Subject|6|||
162853380|NCT02207907|588168869|FG000|Overall Study|Did not meet study criteria|3|||
162853381|NCT02207907|588168870|FG001|Overall Study|Did not meet study criteria|0|||
162853382|NCT02207907|588168869|FG000|Overall Study|Pregnancy|0|||
162853383|NCT02207907|588168870|FG001|Overall Study|Pregnancy|1|||
162853384|NCT00158184|588168871|FG000|Overall Study|personal issues|3|||
162853385|NCT00158184|588168872|FG001|Overall Study|personal issues|1|||
163043506|NCT02964338|588868058|FG001|Overall Study|Protocol Violation|1|||
163043507|NCT02964338|588868059|FG002|Overall Study|Protocol Violation|0|||
163043508|NCT02964338|588868057|FG000|Overall Study|Withdrawal by Subject|1|||
163043509|NCT02964338|588868058|FG001|Overall Study|Withdrawal by Subject|3|||
163043510|NCT02964338|588868059|FG002|Overall Study|Withdrawal by Subject|1|||
163043511|NCT02964338|588868057|FG000|Overall Study|Adverse Event|2|||
163043512|NCT02964338|588868058|FG001|Overall Study|Adverse Event|1|||
163043513|NCT02964338|588868059|FG002|Overall Study|Adverse Event|1|||
163043514|NCT02964338|588868057|FG000|Overall Study|Non-compliant with e-diary|0|||
163043515|NCT02964338|588868058|FG001|Overall Study|Non-compliant with e-diary|1|||
163043516|NCT02964338|588868059|FG002|Overall Study|Non-compliant with e-diary|0|||
163043517|NCT02964338|588868057|FG000|Overall Study|Did not meet criteria|1|||
163043518|NCT02964338|588868058|FG001|Overall Study|Did not meet criteria|0|||
163043519|NCT02964338|588868059|FG002|Overall Study|Did not meet criteria|0|||
163043520|NCT02291029|588868064|FG000|Overall Study|Withdrawal by Subject|0|||
163043521|NCT02291029|588868065|FG001|Overall Study|Withdrawal by Subject|0|||
163043522|NCT02291029|588868066|FG002|Overall Study|Withdrawal by Subject|1|||
163043523|NCT02291029|588868067|FG003|Overall Study|Withdrawal by Subject|0|||
162954477|NCT00838539|588537588|FG009|Overall Study|Clinical Progression|0|||
162954478|NCT00838539|588537589|FG010|Overall Study|Clinical Progression|0|||
162954479|NCT00838539|588537590|FG011|Overall Study|Clinical Progression|0|||
162954480|NCT00838539|588537579|FG000|Overall Study|Symptomatic Deterioration|0|||
162954481|NCT00838539|588537580|FG001|Overall Study|Symptomatic Deterioration|0|||
162954482|NCT00838539|588537581|FG002|Overall Study|Symptomatic Deterioration|1|||
162954483|NCT00838539|588537582|FG003|Overall Study|Symptomatic Deterioration|1|||
162954484|NCT00838539|588537583|FG004|Overall Study|Symptomatic Deterioration|0|||
162954485|NCT00838539|588537584|FG005|Overall Study|Symptomatic Deterioration|1|||
162954486|NCT00838539|588537585|FG006|Overall Study|Symptomatic Deterioration|0|||
162954487|NCT00838539|588537586|FG007|Overall Study|Symptomatic Deterioration|0|||
162954488|NCT00838539|588537587|FG008|Overall Study|Symptomatic Deterioration|0|||
162954489|NCT00838539|588537588|FG009|Overall Study|Symptomatic Deterioration|1|||
162954490|NCT00838539|588537589|FG010|Overall Study|Symptomatic Deterioration|0|||
162954491|NCT00838539|588537590|FG011|Overall Study|Symptomatic Deterioration|0|||
162954492|NCT01908205|588537591|FG000|Overall Study|Lost to Follow-up|2|||
162954493|NCT01908205|588537592|FG001|Overall Study|Lost to Follow-up|0|||
162954494|NCT01908205|588537591|FG000|Overall Study|Withdrawal by Subject|3|||
162954495|NCT01908205|588537592|FG001|Overall Study|Withdrawal by Subject|1|||
162954496|NCT05323396|588537593|FG000|Overall Study|Lost to Follow-up|1|||
162954497|NCT05323396|588537594|FG001|Overall Study|Lost to Follow-up|35|||
162954498|NCT05323396|588537593|FG000|Overall Study|Pregnancy|1|||
162954499|NCT05323396|588537594|FG001|Overall Study|Pregnancy|0|||
162954500|NCT03420300|588537601|FG000|Overall Study|Death|2|||
162954501|NCT03500692|588537609|FG000|Overall Study|Death|163|||
162954502|NCT03500692|588537609|FG000|Overall Study|Lost to Follow-up|75|||
162954503|NCT03500692|588537609|FG000|Overall Study|Termination Reasons|3|||
162954504|NCT02305758|588537610|FG000|Overall Study|Death|27|||
162954505|NCT02305758|588537611|FG001|Overall Study|Death|27|||
162954506|NCT02305758|588537610|FG000|Overall Study|Withdrew consent|9|||
162954507|NCT02305758|588537611|FG001|Overall Study|Withdrew consent|2|||
162954508|NCT02305758|588537610|FG000|Overall Study|Lost to Follow-up|6|||
162954509|NCT02305758|588537611|FG001|Overall Study|Lost to Follow-up|1|||
162954510|NCT02305758|588537610|FG000|Overall Study|Study Terminated by Sponsor|21|||
162954511|NCT02305758|588537611|FG001|Overall Study|Study Terminated by Sponsor|34|||
162954512|NCT02305758|588537610|FG000|Overall Study|Other, not specified|2|||
162954513|NCT02305758|588537611|FG001|Overall Study|Other, not specified|1|||
162954514|NCT02032888|588537613|FG000|Treatment Period|Poor compliance/noncompliance|1|||
162954515|NCT02032888|588537614|FG001|Treatment Period|Poor compliance/noncompliance|1|||
162954516|NCT02032888|588537615|FG002|Treatment Period|Poor compliance/noncompliance|0|||
162954517|NCT02032888|588537613|FG000|Treatment Period|Other|1|||
163043524|NCT02291029|588868068|FG004|Overall Study|Withdrawal by Subject|0|||
162954518|NCT02032888|588537614|FG001|Treatment Period|Other|1|||
162954519|NCT02032888|588537615|FG002|Treatment Period|Other|0|||
162954520|NCT02032888|588537613|FG000|Follow-up Period|Lost to Follow-up|1|||
163043525|NCT02291029|588868069|FG005|Overall Study|Withdrawal by Subject|0|||
162704666|NCT00557505|587630420|FG004|Overall Study|Withdrawal by Subject|0|||
162954521|NCT02032888|588537614|FG001|Follow-up Period|Lost to Follow-up|1|||
163043526|NCT02291029|588868064|FG000|Overall Study|Adverse Event|0|||
162704667|NCT00557505|587630421|FG005|Overall Study|Withdrawal by Subject|0|||
162954522|NCT02032888|588537615|FG002|Follow-up Period|Lost to Follow-up|0|||
162954523|NCT02032888|588537613|FG000|Follow-up Period|Death|1|||
162954524|NCT02032888|588537614|FG001|Follow-up Period|Death|1|||
162954525|NCT02032888|588537615|FG002|Follow-up Period|Death|0|||
162954526|NCT02032888|588537613|FG000|Follow-up Period|Other|1|||
162954527|NCT02032888|588537614|FG001|Follow-up Period|Other|0|||
163043527|NCT02291029|588868065|FG001|Overall Study|Adverse Event|1|||
163043528|NCT02291029|588868066|FG002|Overall Study|Adverse Event|0|||
163043529|NCT02291029|588868067|FG003|Overall Study|Adverse Event|0|||
163043530|NCT02291029|588868068|FG004|Overall Study|Adverse Event|0|||
163043531|NCT02291029|588868069|FG005|Overall Study|Adverse Event|0|||
162853386|NCT00158184|588168871|FG000|Overall Study|failed for follow unit/study rules|2|||
162853387|NCT00158184|588168872|FG001|Overall Study|failed for follow unit/study rules|0|||
162853388|NCT00158184|588168871|FG000|Overall Study|Adverse Event|1|||
162853389|NCT00158184|588168872|FG001|Overall Study|Adverse Event|1|||
162853390|NCT01025635|588168878|FG000|Overall Study|Withdrawal by Subject|6|||
162853391|NCT01025635|588168879|FG001|Overall Study|Withdrawal by Subject|7|||
162853392|NCT01025635|588168878|FG000|Overall Study|Protocol Violation|4|||
162853393|NCT01025635|588168879|FG001|Overall Study|Protocol Violation|2|||
162853394|NCT01025635|588168878|FG000|Overall Study|Lack of Efficacy|0|||
162853395|NCT01025635|588168879|FG001|Overall Study|Lack of Efficacy|1|||
162853396|NCT01025635|588168878|FG000|Overall Study|Lost to Follow-up|9|||
162853397|NCT01025635|588168879|FG001|Overall Study|Lost to Follow-up|13|||
162853398|NCT01025635|588168878|FG000|Overall Study|Reason not known|4|||
162853399|NCT01025635|588168879|FG001|Overall Study|Reason not known|2|||
162853400|NCT02393209|588168880|FG000|Overall Study|Study Terminated by Sponsor|1|||
162954528|NCT02032888|588537615|FG002|Follow-up Period|Other|0|||
162954529|NCT01424644|588537616|FG000|Overall Study|Adverse Event|2|||
162954530|NCT01424644|588537617|FG001|Overall Study|Adverse Event|0|||
162954531|NCT01424644|588537616|FG000|Overall Study|Withdrawal by Subject|9|||
162954532|NCT01424644|588537617|FG001|Overall Study|Withdrawal by Subject|12|||
162954533|NCT01424644|588537616|FG000|Overall Study|Lost to Follow-up|16|||
162954534|NCT01424644|588537617|FG001|Overall Study|Lost to Follow-up|12|||
162954535|NCT01424644|588537616|FG000|Overall Study|Protocol Violation|4|||
162954536|NCT01424644|588537617|FG001|Overall Study|Protocol Violation|3|||
162954537|NCT01424644|588537616|FG000|Overall Study|Administrative Reason|1|||
162954538|NCT01424644|588537617|FG001|Overall Study|Administrative Reason|0|||
162954539|NCT01424644|588537616|FG000|Overall Study|Unable to Classify|1|||
162954540|NCT01424644|588537617|FG001|Overall Study|Unable to Classify|0|||
162954541|NCT05593965|588537618|FG000|1st Intervention (1 Day)|Technical error|1|||
162954542|NCT05593965|588537619|FG001|1st Intervention (1 Day)|Technical error|0|||
162954543|NCT02272777|588537620|FG000|Overall Study|Adverse Event|0|||
162954544|NCT02272777|588537621|FG001|Overall Study|Adverse Event|1|||
162954545|NCT02272777|588537620|FG000|Overall Study|Withdrawal by Subject|0|||
162954546|NCT02272777|588537621|FG001|Overall Study|Withdrawal by Subject|3|||
162954547|NCT02272777|588537620|FG000|Overall Study|Lost to Follow-up|2|||
162954548|NCT02272777|588537621|FG001|Overall Study|Lost to Follow-up|0|||
162954549|NCT02272777|588537620|FG000|Overall Study|Other|2|||
162954550|NCT02272777|588537621|FG001|Overall Study|Other|0|||
162954551|NCT02066922|588537624|FG000|Overall Study|Adverse Event|1|||
162954552|NCT00440297|588537625|FG000|Overall Study|Adverse Event|8|||
162954553|NCT00440297|588537626|FG001|Overall Study|Adverse Event|5|||
162954554|NCT00440297|588537625|FG000|Overall Study|Lost to Follow-up|1|||
162954555|NCT00440297|588537626|FG001|Overall Study|Lost to Follow-up|0|||
162954556|NCT00440297|588537625|FG000|Overall Study|Physician Decision|1|||
162954557|NCT00440297|588537626|FG001|Overall Study|Physician Decision|0|||
162954558|NCT00440297|588537625|FG000|Overall Study|Protocol Violation|11|||
162954559|NCT00440297|588537626|FG001|Overall Study|Protocol Violation|7|||
162954560|NCT00440297|588537625|FG000|Overall Study|Withdrawal by Subject|1|||
162954561|NCT00440297|588537626|FG001|Overall Study|Withdrawal by Subject|6|||
162954562|NCT00440297|588537625|FG000|Overall Study|Randomized by mistake|1|||
162954563|NCT00440297|588537626|FG001|Overall Study|Randomized by mistake|0|||
162954564|NCT02445339|588537627|FG000|Overall Study|Physician Decision|1|||
162954565|NCT02445339|588537628|FG001|Overall Study|Physician Decision|0|||
162954566|NCT02445339|588537627|FG000|Overall Study|Lost to Follow-up|11|||
162954567|NCT02445339|588537628|FG001|Overall Study|Lost to Follow-up|15|||
162954568|NCT02024932|588537629|FG000|Overall Study|Adverse Event|2|||
162954569|NCT02024932|588537630|FG001|Overall Study|Adverse Event|3|||
162954570|NCT02024932|588537631|FG002|Overall Study|Adverse Event|0|||
162954571|NCT02024932|588537632|FG003|Overall Study|Adverse Event|0|||
162954572|NCT02024932|588537633|FG004|Overall Study|Adverse Event|2|||
163043532|NCT02171429|588868070|FG000|Overall Study|Other|0|||
163043533|NCT02171429|588868071|FG001|Overall Study|Other|1|||
162954573|NCT02024932|588537634|FG005|Overall Study|Adverse Event|0|||
162954574|NCT02024932|588537629|FG000|Overall Study|Abnormal laboratory value|0|||
162954575|NCT02024932|588537630|FG001|Overall Study|Abnormal laboratory value|0|||
162954576|NCT02024932|588537631|FG002|Overall Study|Abnormal laboratory value|0|||
162954577|NCT02024932|588537632|FG003|Overall Study|Abnormal laboratory value|2|||
162954578|NCT02024932|588537633|FG004|Overall Study|Abnormal laboratory value|0|||
162954579|NCT02024932|588537634|FG005|Overall Study|Abnormal laboratory value|0|||
162954580|NCT03206177|588537635|FG000|Overall Study|Withdrawal by Subject|1|||
162954581|NCT03020641|588537636|FG000|Overall Study|Lost to Follow-up|0|||
162853401|NCT02393209|588168881|FG001|Overall Study|Study Terminated by Sponsor|1|||
162853402|NCT02393209|588168882|FG002|Overall Study|Study Terminated by Sponsor|0|||
162853403|NCT02393209|588168883|FG003|Overall Study|Study Terminated by Sponsor|0|||
162954582|NCT03020641|588537637|FG001|Overall Study|Lost to Follow-up|1|||
162954583|NCT03020641|588537636|FG000|Overall Study|Converted to open surgery|2|||
162954584|NCT03020641|588537637|FG001|Overall Study|Converted to open surgery|1|||
162954585|NCT03020641|588537636|FG000|Overall Study|for surgery not performed|0|||
163043534|NCT02171429|588868072|FG002|Overall Study|Other|1|||
162853404|NCT02393209|588168880|FG000|Overall Study|Withdrawal by Patient|1|||
162853405|NCT02393209|588168881|FG001|Overall Study|Withdrawal by Patient|0|||
162853406|NCT02393209|588168882|FG002|Overall Study|Withdrawal by Patient|0|||
162853407|NCT02393209|588168883|FG003|Overall Study|Withdrawal by Patient|0|||
162853408|NCT02393209|588168880|FG000|Overall Study|Death|2|||
162853409|NCT02393209|588168881|FG001|Overall Study|Death|2|||
162853410|NCT02393209|588168882|FG002|Overall Study|Death|0|||
162853411|NCT02393209|588168883|FG003|Overall Study|Death|0|||
162853412|NCT02393209|588168880|FG000|Overall Study|Death due to Disease Progression|2|||
162853413|NCT02393209|588168881|FG001|Overall Study|Death due to Disease Progression|2|||
162853414|NCT02393209|588168882|FG002|Overall Study|Death due to Disease Progression|0|||
162853415|NCT02393209|588168883|FG003|Overall Study|Death due to Disease Progression|0|||
162853416|NCT02393209|588168880|FG000|Overall Study|Death from Legionella Infection|0|||
162853417|NCT02393209|588168881|FG001|Overall Study|Death from Legionella Infection|1|||
162853418|NCT02393209|588168882|FG002|Overall Study|Death from Legionella Infection|0|||
162853419|NCT02393209|588168883|FG003|Overall Study|Death from Legionella Infection|0|||
162853420|NCT02393209|588168880|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
162853421|NCT02393209|588168881|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
162853422|NCT02393209|588168882|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
162853423|NCT02393209|588168883|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
162853424|NCT02393209|588168880|FG000|Overall Study|Lost to Follow-up|0|||
162853425|NCT02393209|588168881|FG001|Overall Study|Lost to Follow-up|1|||
162853426|NCT02393209|588168882|FG002|Overall Study|Lost to Follow-up|0|||
162853427|NCT02393209|588168883|FG003|Overall Study|Lost to Follow-up|0|||
162853428|NCT00929240|588168884|FG000|Initial Treatment Phase|Adverse Event|31|||
162853429|NCT00929240|588168885|FG001|Initial Treatment Phase|Adverse Event|0|||
162853430|NCT00929240|588168886|FG002|Initial Treatment Phase|Adverse Event|0|||
162853431|NCT00929240|588168884|FG000|Initial Treatment Phase|Disease progression|41|||
162853432|NCT00929240|588168885|FG001|Initial Treatment Phase|Disease progression|0|||
162853433|NCT00929240|588168886|FG002|Initial Treatment Phase|Disease progression|0|||
162853434|NCT00929240|588168884|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
162853435|NCT00929240|588168885|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
162853436|NCT00929240|588168886|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
162853437|NCT00929240|588168884|FG000|Initial Treatment Phase|Protocol Violation|5|||
162853438|NCT00929240|588168885|FG001|Initial Treatment Phase|Protocol Violation|0|||
162853439|NCT00929240|588168886|FG002|Initial Treatment Phase|Protocol Violation|0|||
162853440|NCT00929240|588168884|FG000|Initial Treatment Phase|Death|2|||
162853441|NCT00929240|588168885|FG001|Initial Treatment Phase|Death|0|||
162853442|NCT00929240|588168886|FG002|Initial Treatment Phase|Death|0|||
162853443|NCT00929240|588168884|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
162853444|NCT00929240|588168885|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
162853445|NCT00929240|588168886|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
162853446|NCT00929240|588168884|FG000|Initial Treatment Phase|Physician Decision|4|||
162853447|NCT00929240|588168885|FG001|Initial Treatment Phase|Physician Decision|0|||
162853448|NCT00929240|588168886|FG002|Initial Treatment Phase|Physician Decision|0|||
162853449|NCT00929240|588168884|FG000|Maintenance Phase|Disease progression|0|||
162853450|NCT00929240|588168885|FG001|Maintenance Phase|Disease progression|73|||
162853451|NCT00929240|588168886|FG002|Maintenance Phase|Disease progression|60|||
162853452|NCT00929240|588168884|FG000|Maintenance Phase|Adverse Event|0|||
162853453|NCT00929240|588168885|FG001|Maintenance Phase|Adverse Event|9|||
162853454|NCT00929240|588168886|FG002|Maintenance Phase|Adverse Event|12|||
162853455|NCT00929240|588168884|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162853456|NCT00929240|588168885|FG001|Maintenance Phase|Withdrawal by Subject|2|||
162853457|NCT00929240|588168886|FG002|Maintenance Phase|Withdrawal by Subject|6|||
162853458|NCT00929240|588168884|FG000|Maintenance Phase|Protocol Violation|0|||
162853459|NCT00929240|588168885|FG001|Maintenance Phase|Protocol Violation|1|||
162853460|NCT00929240|588168886|FG002|Maintenance Phase|Protocol Violation|0|||
162853461|NCT00929240|588168884|FG000|Maintenance Phase|Health authority/Study termination|0|||
162954586|NCT03020641|588537637|FG001|Overall Study|for surgery not performed|1|||
162954587|NCT00727961|588537638|FG000|Overall Study|Lost to Follow-up|1|||
162954588|NCT00727961|588537638|FG000|Overall Study|Adverse Event|4|||
162954589|NCT00727961|588537638|FG000|Overall Study|Patient's refusal|2|||
162954590|NCT00727961|588537638|FG000|Overall Study|Progression|30|||
162954591|NCT03238781|588537639|FG000|Overall Study|Adverse Event|1|||
162954592|NCT03238781|588537640|FG001|Overall Study|Adverse Event|1|||
162954593|NCT03238781|588537641|FG002|Overall Study|Adverse Event|2|||
162954594|NCT03238781|588537639|FG000|Overall Study|Lost to Follow-up|2|||
162954595|NCT03238781|588537640|FG001|Overall Study|Lost to Follow-up|1|||
162853462|NCT00929240|588168885|FG001|Maintenance Phase|Health authority/Study termination|1|||
162853463|NCT00929240|588168886|FG002|Maintenance Phase|Health authority/Study termination|2|||
162853464|NCT00929240|588168884|FG000|Maintenance Phase|Physician Decision|0|||
162853465|NCT00929240|588168885|FG001|Maintenance Phase|Physician Decision|2|||
162853466|NCT00929240|588168886|FG002|Maintenance Phase|Physician Decision|1|||
162954596|NCT03238781|588537641|FG002|Overall Study|Lost to Follow-up|2|||
162853467|NCT00929240|588168884|FG000|Maintenance Phase|Change of treatment|0|||
162853468|NCT00929240|588168885|FG001|Maintenance Phase|Change of treatment|4|||
162853469|NCT00929240|588168886|FG002|Maintenance Phase|Change of treatment|0|||
163043535|NCT02171429|588868070|FG000|Overall Study|Non-Compliance|0|||
162853470|NCT00929240|588168884|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
162853471|NCT00929240|588168885|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
162853472|NCT00929240|588168886|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
162853473|NCT00929240|588168884|FG000|Maintenance Phase|Participant not treated|0|||
162853474|NCT00929240|588168885|FG001|Maintenance Phase|Participant not treated|2|||
162853475|NCT00929240|588168886|FG002|Maintenance Phase|Participant not treated|0|||
162853476|NCT01276288|588168891|FG000|Overall Study|Adverse Event|1|||
162853477|NCT01276288|588168892|FG001|Overall Study|Adverse Event|1|||
162853478|NCT01276288|588168893|FG002|Overall Study|Adverse Event|0|||
162853479|NCT01276288|588168894|FG003|Overall Study|Adverse Event|0|||
162853480|NCT01276288|588168891|FG000|Overall Study|not treated|1|||
162853481|NCT01276288|588168892|FG001|Overall Study|not treated|0|||
162853482|NCT01276288|588168893|FG002|Overall Study|not treated|0|||
162853483|NCT01276288|588168894|FG003|Overall Study|not treated|0|||
162853484|NCT00629083|588168899|FG000|Overall Study|Adverse Event|0|||
162853485|NCT00629083|588168900|FG001|Overall Study|Adverse Event|2|||
162853486|NCT00629083|588168899|FG000|Overall Study|Lack of Efficacy|3|||
162853487|NCT00629083|588168900|FG001|Overall Study|Lack of Efficacy|1|||
162853488|NCT00629083|588168899|FG000|Overall Study|Withdrawal by Subject|10|||
162853489|NCT00629083|588168900|FG001|Overall Study|Withdrawal by Subject|2|||
162853490|NCT00629083|588168899|FG000|Overall Study|Lost to Follow-up|12|||
162853491|NCT00629083|588168900|FG001|Overall Study|Lost to Follow-up|8|||
162853492|NCT00629083|588168899|FG000|Overall Study|Moved out of country/state|2|||
162853493|NCT00629083|588168900|FG001|Overall Study|Moved out of country/state|1|||
162853494|NCT00629083|588168899|FG000|Overall Study|Refused to return for 12 month visit|1|||
162853495|NCT00629083|588168900|FG001|Overall Study|Refused to return for 12 month visit|0|||
162853496|NCT01478958|588168901|FG000|Overall Study|Withdrawal by Subject|1|||
162853497|NCT01478958|588168902|FG001|Overall Study|Withdrawal by Subject|1|||
162853498|NCT01478958|588168903|FG002|Overall Study|Withdrawal by Subject|1|||
162853499|NCT01478958|588168901|FG000|Overall Study|Weight loss|1|||
162853500|NCT01478958|588168902|FG001|Overall Study|Weight loss|0|||
162853501|NCT01478958|588168903|FG002|Overall Study|Weight loss|0|||
162853502|NCT01478958|588168901|FG000|Overall Study|Re-located|0|||
162853503|NCT01478958|588168902|FG001|Overall Study|Re-located|1|||
162853504|NCT01478958|588168903|FG002|Overall Study|Re-located|0|||
162853505|NCT01478958|588168901|FG000|Overall Study|Unable to comply|0|||
162853506|NCT01478958|588168902|FG001|Overall Study|Unable to comply|0|||
162853507|NCT01478958|588168903|FG002|Overall Study|Unable to comply|2|||
162853508|NCT03401749|588168904|FG000|Overall Study|Lost to Follow-up|20|||
162853509|NCT03401749|588168905|FG001|Overall Study|Lost to Follow-up|16|||
162853510|NCT03401749|588168906|FG002|Overall Study|Lost to Follow-up|26|||
162853511|NCT01193686|588168907|FG000|Overall Study|Withdrawal by Subject|4|||
162853512|NCT01193686|588168908|FG001|Overall Study|Withdrawal by Subject|1|||
162853513|NCT01193686|588168907|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
162853514|NCT01193686|588168908|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
162853515|NCT01147809|588168911|FG000|Phase I (168 Days)|Adverse Event|0|||
162853516|NCT01147809|588168912|FG001|Phase I (168 Days)|Adverse Event|0|||
162853517|NCT01147809|588168913|FG002|Phase I (168 Days)|Adverse Event|0|||
162853518|NCT01147809|588168914|FG003|Phase I (168 Days)|Adverse Event|1|||
162853519|NCT01147809|588168915|FG004|Phase I (168 Days)|Adverse Event|0|||
162853520|NCT01147809|588168916|FG005|Phase I (168 Days)|Adverse Event|0|||
162853521|NCT01147809|588168911|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
162853522|NCT01147809|588168912|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
162853523|NCT01147809|588168913|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
162853524|NCT01147809|588168914|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
162853525|NCT01147809|588168915|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
163043536|NCT02171429|588868071|FG001|Overall Study|Non-Compliance|0|||
163043537|NCT02171429|588868072|FG002|Overall Study|Non-Compliance|1|||
162853526|NCT01147809|588168916|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
162853527|NCT01147809|588168911|FG000|Phase I (168 Days)|Physician Decision|0|||
162853528|NCT01147809|588168912|FG001|Phase I (168 Days)|Physician Decision|1|||
162853529|NCT01147809|588168913|FG002|Phase I (168 Days)|Physician Decision|2|||
162853530|NCT01147809|588168914|FG003|Phase I (168 Days)|Physician Decision|0|||
162853531|NCT01147809|588168915|FG004|Phase I (168 Days)|Physician Decision|0|||
162853532|NCT01147809|588168916|FG005|Phase I (168 Days)|Physician Decision|0|||
162853533|NCT01147809|588168911|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
162853534|NCT01147809|588168912|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
162853535|NCT01147809|588168913|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
162853536|NCT01147809|588168914|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
162853537|NCT01147809|588168915|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
162853538|NCT01147809|588168916|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
162853539|NCT01147809|588168911|FG000|Phase II (168 Days)|Adverse Event|0|||
162853540|NCT01147809|588168912|FG001|Phase II (168 Days)|Adverse Event|0|||
163043538|NCT02171429|588868070|FG000|Overall Study|Physician Decision|0|||
163043539|NCT02171429|588868071|FG001|Overall Study|Physician Decision|0|||
162853541|NCT01147809|588168913|FG002|Phase II (168 Days)|Adverse Event|0|||
162853542|NCT01147809|588168914|FG003|Phase II (168 Days)|Adverse Event|0|||
162853543|NCT01147809|588168915|FG004|Phase II (168 Days)|Adverse Event|3|||
162853544|NCT01147809|588168916|FG005|Phase II (168 Days)|Adverse Event|6|||
162853545|NCT01147809|588168911|FG000|Phase II (168 Days)|Protocol Violation|0|||
162853546|NCT01147809|588168912|FG001|Phase II (168 Days)|Protocol Violation|0|||
162853547|NCT01147809|588168913|FG002|Phase II (168 Days)|Protocol Violation|0|||
162853548|NCT01147809|588168914|FG003|Phase II (168 Days)|Protocol Violation|0|||
162853549|NCT01147809|588168915|FG004|Phase II (168 Days)|Protocol Violation|0|||
162853550|NCT01147809|588168916|FG005|Phase II (168 Days)|Protocol Violation|1|||
162853551|NCT01147809|588168911|FG000|Phase II (168 Days)|Physician Decision|0|||
162853552|NCT01147809|588168912|FG001|Phase II (168 Days)|Physician Decision|0|||
162853553|NCT01147809|588168913|FG002|Phase II (168 Days)|Physician Decision|0|||
162853554|NCT01147809|588168914|FG003|Phase II (168 Days)|Physician Decision|0|||
162853555|NCT01147809|588168915|FG004|Phase II (168 Days)|Physician Decision|5|||
162853556|NCT01147809|588168916|FG005|Phase II (168 Days)|Physician Decision|11|||
162853557|NCT01147809|588168911|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
162853558|NCT01147809|588168912|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
162853559|NCT01147809|588168913|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
162853560|NCT01147809|588168914|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
162853561|NCT01147809|588168915|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
162853562|NCT01147809|588168916|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
162853563|NCT01147809|588168911|FG000|Phase II (168 Days)|Ongoing|0|||
162853564|NCT01147809|588168912|FG001|Phase II (168 Days)|Ongoing|0|||
162853565|NCT01147809|588168913|FG002|Phase II (168 Days)|Ongoing|0|||
162853566|NCT01147809|588168914|FG003|Phase II (168 Days)|Ongoing|0|||
162853567|NCT01147809|588168915|FG004|Phase II (168 Days)|Ongoing|1|||
162853568|NCT01147809|588168916|FG005|Phase II (168 Days)|Ongoing|0|||
162853569|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
162853570|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
162853571|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
162853572|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853573|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853574|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853575|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853576|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853577|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162853578|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
162853579|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
162853580|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
162853581|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853582|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853583|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853584|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853585|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853586|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162853587|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
162853588|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
162853589|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
162853590|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853591|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853592|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853593|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853594|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853595|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162853596|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853597|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163043540|NCT02171429|588868072|FG002|Overall Study|Physician Decision|1|||
163043541|NCT02171429|588868070|FG000|Overall Study|Withdrawal by Subject|1|||
163043542|NCT02171429|588868071|FG001|Overall Study|Withdrawal by Subject|1|||
162611669|NCT03497676|587294992|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162611670|NCT03497676|587294993|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
162611671|NCT03497676|587294994|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162853598|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
162853599|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853600|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853601|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163043543|NCT02171429|588868072|FG002|Overall Study|Withdrawal by Subject|1|||
163043544|NCT02171429|588868070|FG000|Overall Study|Lost to Follow-up|0|||
163043545|NCT02171429|588868071|FG001|Overall Study|Lost to Follow-up|1|||
163043546|NCT02171429|588868072|FG002|Overall Study|Lost to Follow-up|0|||
163043547|NCT02171429|588868070|FG000|Overall Study|Death|0|||
163043548|NCT02171429|588868071|FG001|Overall Study|Death|0|||
163043549|NCT02171429|588868072|FG002|Overall Study|Death|1|||
163043550|NCT00493012|588868073|FG000|Overall Study|Lost to Follow-up|18|||
163043551|NCT00493012|588868074|FG001|Overall Study|Lost to Follow-up|17|||
163043552|NCT04147247|588868076|FG000|Overall Study|Progressive disease|3|||
163043553|NCT04147247|588868077|FG001|Overall Study|Progressive disease|3|||
163043554|NCT04147247|588868078|FG002|Overall Study|Progressive disease|4|||
163043555|NCT04147247|588868079|FG003|Overall Study|Progressive disease|4|||
163043556|NCT04147247|588868080|FG004|Overall Study|Progressive disease|3|||
163043557|NCT04147247|588868076|FG000|Overall Study|Physician Decision|0|||
162853602|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853603|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853604|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162853605|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
162853606|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162853607|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
162853608|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853609|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853610|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853611|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853612|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853613|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162853614|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162853615|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853616|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853617|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853618|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853619|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853620|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853621|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853622|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162853623|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
162853624|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
162853625|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853626|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853627|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853628|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853629|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853630|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853631|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162853632|NCT01307423|588168917|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853633|NCT01307423|588168918|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
162853634|NCT01307423|588168919|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
162853635|NCT01307423|588168920|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853636|NCT01307423|588168921|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853637|NCT01307423|588168922|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853638|NCT01307423|588168923|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853639|NCT01307423|588168924|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163043558|NCT04147247|588868077|FG001|Overall Study|Physician Decision|1|||
162853640|NCT01307423|588168925|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
162853641|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163043559|NCT04147247|588868078|FG002|Overall Study|Physician Decision|0|||
163043560|NCT04147247|588868079|FG003|Overall Study|Physician Decision|0|||
163043561|NCT04147247|588868080|FG004|Overall Study|Physician Decision|0|||
163043562|NCT04147247|588868076|FG000|Overall Study|Clinical Disease Progression|0|||
162853642|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
162853643|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
162853644|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
162853645|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
162853646|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
162853647|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
162853648|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
162853649|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
162853650|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
162853651|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
162853652|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
162853653|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
162853654|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
162853655|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
162853656|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
162853657|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
162853658|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
162853659|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853660|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853661|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853662|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853663|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853664|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
162853665|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853666|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853667|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
162853668|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
162853669|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
162853670|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
162853671|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
162853672|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
162853673|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
162853674|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
162853675|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
162853676|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
162853677|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853678|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853679|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853680|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
162853681|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853682|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853683|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853684|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162853685|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
162611672|NCT03497676|587294991|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162611673|NCT03497676|587294992|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162611674|NCT03497676|587294993|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
162611675|NCT03497676|587294994|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162853686|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
163043563|NCT04147247|588868077|FG001|Overall Study|Clinical Disease Progression|0|||
163043564|NCT04147247|588868078|FG002|Overall Study|Clinical Disease Progression|0|||
163043565|NCT04147247|588868079|FG003|Overall Study|Clinical Disease Progression|0|||
163043566|NCT04147247|588868080|FG004|Overall Study|Clinical Disease Progression|1|||
163043567|NCT04147247|588868076|FG000|Overall Study|Adverse Event|0|||
162853687|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
162853688|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
162853689|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
162853690|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
162853691|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
162853692|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
162853693|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
162853694|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
162853695|NCT01307423|588168917|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853696|NCT01307423|588168918|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163043568|NCT04147247|588868077|FG001|Overall Study|Adverse Event|0|||
162853697|NCT01307423|588168919|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853698|NCT01307423|588168920|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853699|NCT01307423|588168921|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853700|NCT01307423|588168922|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
162853701|NCT01307423|588168923|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853702|NCT01307423|588168924|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853703|NCT01307423|588168925|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
162853704|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162853705|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
162853706|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
162853707|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162853708|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162853709|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162853710|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162853711|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
162853712|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
162853713|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162853714|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
162853715|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
162853716|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162853717|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162853718|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162853719|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162853720|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
162853721|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
162853722|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853723|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853724|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
162853725|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853726|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853727|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853728|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853729|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853730|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
162853731|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162853732|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
162853733|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
162853734|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162853735|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162853736|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162853737|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162853738|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
162853739|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
162853740|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853741|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162853742|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853743|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853744|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853745|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853746|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162853747|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162853748|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162853749|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162853750|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
162853751|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162853752|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162853753|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162853754|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162853755|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162853756|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
162853757|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
162853758|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162853759|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162853760|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
162853761|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162853762|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162853763|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162853764|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162853765|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
162853766|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162853767|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853768|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
162853769|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
162853770|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853771|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853772|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853773|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853774|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853775|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
162853776|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162853777|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
162954597|NCT03238781|588537639|FG000|Overall Study|Withdrawal by Subject|23|||
162954598|NCT03238781|588537640|FG001|Overall Study|Withdrawal by Subject|14|||
162954599|NCT03238781|588537641|FG002|Overall Study|Withdrawal by Subject|16|||
162954600|NCT03238781|588537639|FG000|Overall Study|Decision by sponsor|0|||
162954601|NCT03238781|588537640|FG001|Overall Study|Decision by sponsor|1|||
162954602|NCT03238781|588537641|FG002|Overall Study|Decision by sponsor|0|||
162954603|NCT03161405|588537642|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
162954604|NCT01421277|588537643|FG000|Overall Study|Lack of qualifying event|0|||
162954605|NCT01421277|588537644|FG001|Overall Study|Lack of qualifying event|61|||
162954606|NCT01421277|588537643|FG000|Overall Study|Incomplete baseline data|0|||
162954607|NCT01421277|588537644|FG001|Overall Study|Incomplete baseline data|31|||
162954608|NCT02039908|588537645|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
162954609|NCT02039908|588537646|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
162954610|NCT02039908|588537647|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
162954611|NCT02039908|588537648|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
162954612|NCT02039908|588537645|FG000|Phase 1-Summer|Protocol Violation|6|||
162954613|NCT02039908|588537646|FG001|Phase 1-Summer|Protocol Violation|0|||
162954614|NCT02039908|588537647|FG002|Phase 1-Summer|Protocol Violation|0|||
162954615|NCT02039908|588537648|FG003|Phase 1-Summer|Protocol Violation|0|||
162954616|NCT02039908|588537645|FG000|Phase 2-School Year|Lost to Follow-up|0|||
162954617|NCT02039908|588537646|FG001|Phase 2-School Year|Lost to Follow-up|0|||
162954618|NCT02039908|588537647|FG002|Phase 2-School Year|Lost to Follow-up|1|||
162954619|NCT02039908|588537648|FG003|Phase 2-School Year|Lost to Follow-up|3|||
162954620|NCT02039908|588537645|FG000|Phase 2-School Year|Protocol Violation|0|||
162954621|NCT02039908|588537646|FG001|Phase 2-School Year|Protocol Violation|0|||
162954622|NCT02039908|588537647|FG002|Phase 2-School Year|Protocol Violation|3|||
162954623|NCT02039908|588537648|FG003|Phase 2-School Year|Protocol Violation|0|||
162954624|NCT02039908|588537645|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
162954625|NCT02039908|588537646|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
162954626|NCT02039908|588537647|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
162954627|NCT02039908|588537648|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
162954628|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
162954629|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
162954630|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
162954631|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
162954632|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954633|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954634|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954635|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954636|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954637|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954638|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954639|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954640|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954641|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954642|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954643|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954644|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954645|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954646|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954647|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954648|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
162954649|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
162954650|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
162954651|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
162954652|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
162954653|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162704668|NCT00557505|587630422|FG006|Overall Study|Withdrawal by Subject|0|||
162954654|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162853778|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
162853779|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162853780|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162853781|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162853782|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162853783|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
162853784|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
162853785|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162853786|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
162853787|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
162853788|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162853789|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162853790|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162853791|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162853792|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
162853793|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
162853794|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853795|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162853796|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853797|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853798|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853799|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853800|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853801|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162853802|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162853803|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853804|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
162853805|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163043569|NCT04147247|588868078|FG002|Overall Study|Adverse Event|1|||
163043570|NCT04147247|588868079|FG003|Overall Study|Adverse Event|0|||
163043571|NCT04147247|588868080|FG004|Overall Study|Adverse Event|1|||
163043572|NCT01724177|588868081|FG000|Overall Study|Adverse Event|8|||
163043573|NCT01724177|588868081|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
163043574|NCT01724177|588868081|FG000|Overall Study|Nervous participant|1|||
163043575|NCT01724177|588868081|FG000|Overall Study|Serious Adverse Event Related|1|||
163043576|NCT00327340|588868084|FG000|Overall Study|Withdrawal by Subject|1|||
163043577|NCT00327340|588868085|FG001|Overall Study|Withdrawal by Subject|5|||
163043578|NCT00327340|588868084|FG000|Overall Study|Physician Decision|1|||
163043579|NCT00327340|588868085|FG001|Overall Study|Physician Decision|1|||
163043580|NCT00327340|588868084|FG000|Overall Study|Disease Progression|10|||
163043581|NCT00327340|588868085|FG001|Overall Study|Disease Progression|19|||
163043582|NCT00327340|588868084|FG000|Overall Study|Symptomatic Disease|0|||
163043583|NCT00327340|588868085|FG001|Overall Study|Symptomatic Disease|2|||
163043584|NCT00327340|588868084|FG000|Overall Study|Adverse Event|3|||
163043585|NCT00327340|588868085|FG001|Overall Study|Adverse Event|3|||
163043586|NCT04085601|588868086|FG000|Overall Study|Lost to Follow-up|1|||
163043587|NCT04085601|588868087|FG001|Overall Study|Lost to Follow-up|0|||
163043588|NCT04085601|588868086|FG000|Overall Study|Death|1|||
163043589|NCT04085601|588868087|FG001|Overall Study|Death|1|||
163043590|NCT03492437|588868088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163043591|NCT03492437|588868089|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163043592|NCT01914393|588868090|FG000|Overall Study|Protocol Violation|11|||
163043593|NCT01914393|588868091|FG001|Overall Study|Protocol Violation|3|||
163043594|NCT01914393|588868092|FG002|Overall Study|Protocol Violation|19|||
163043595|NCT01914393|588868090|FG000|Overall Study|Lack of Efficacy|11|||
163043596|NCT01914393|588868091|FG001|Overall Study|Lack of Efficacy|16|||
163043597|NCT01914393|588868092|FG002|Overall Study|Lack of Efficacy|5|||
163043598|NCT01914393|588868090|FG000|Overall Study|no reason given|14|||
163043599|NCT01914393|588868091|FG001|Overall Study|no reason given|8|||
163043600|NCT01914393|588868092|FG002|Overall Study|no reason given|16|||
163043601|NCT01914393|588868090|FG000|Overall Study|Adverse Event|29|||
163043602|NCT01914393|588868091|FG001|Overall Study|Adverse Event|18|||
163043603|NCT01914393|588868092|FG002|Overall Study|Adverse Event|31|||
163043604|NCT01914393|588868090|FG000|Overall Study|Withdrawal by Subject|38|||
163043605|NCT01914393|588868091|FG001|Overall Study|Withdrawal by Subject|20|||
163043606|NCT01914393|588868092|FG002|Overall Study|Withdrawal by Subject|47|||
162853806|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853807|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853808|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853809|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853810|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853811|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162853812|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853813|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
162853814|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853815|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853816|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853817|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853818|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162853819|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162611676|NCT03497676|587294991|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162853820|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
162853821|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163043607|NCT01914393|588868090|FG000|Overall Study|Lost to Follow-up|12|||
163043608|NCT01914393|588868091|FG001|Overall Study|Lost to Follow-up|6|||
163043609|NCT01914393|588868092|FG002|Overall Study|Lost to Follow-up|19|||
163043610|NCT01914393|588868090|FG000|Overall Study|subject never dosed|0|||
163043611|NCT01914393|588868091|FG001|Overall Study|subject never dosed|0|||
163043612|NCT01914393|588868092|FG002|Overall Study|subject never dosed|1|||
163043613|NCT00572455|588868093|FG000|Stage I (14 Days)|Adverse Event|0|||
163043614|NCT00572455|588868094|FG001|Stage I (14 Days)|Adverse Event|0|||
163043615|NCT00572455|588868095|FG002|Stage I (14 Days)|Adverse Event|0|||
163043616|NCT00572455|588868096|FG003|Stage I (14 Days)|Adverse Event|0|||
163043617|NCT00572455|588868097|FG004|Stage I (14 Days)|Adverse Event|0|||
163043618|NCT00572455|588868098|FG005|Stage I (14 Days)|Adverse Event|3|||
163043619|NCT00572455|588868099|FG006|Stage I (14 Days)|Adverse Event|0|||
163043620|NCT00572455|588868100|FG007|Stage I (14 Days)|Adverse Event|0|||
163043621|NCT00572455|588868101|FG008|Stage I (14 Days)|Adverse Event|0|||
163043622|NCT00572455|588868102|FG009|Stage I (14 Days)|Adverse Event|0|||
163043623|NCT00572455|588868103|FG010|Stage I (14 Days)|Adverse Event|0|||
163043624|NCT00572455|588868104|FG011|Stage I (14 Days)|Adverse Event|0|||
163043625|NCT00572455|588868105|FG012|Stage I (14 Days)|Adverse Event|0|||
163043626|NCT00572455|588868106|FG013|Stage I (14 Days)|Adverse Event|0|||
163043627|NCT00572455|588868093|FG000|Stage I (14 Days)|Other|0|||
163043628|NCT00572455|588868094|FG001|Stage I (14 Days)|Other|0|||
163043629|NCT00572455|588868095|FG002|Stage I (14 Days)|Other|0|||
163043630|NCT00572455|588868096|FG003|Stage I (14 Days)|Other|0|||
163043631|NCT00572455|588868097|FG004|Stage I (14 Days)|Other|1|||
163043632|NCT00572455|588868098|FG005|Stage I (14 Days)|Other|0|||
163043633|NCT00572455|588868099|FG006|Stage I (14 Days)|Other|0|||
163043634|NCT00572455|588868100|FG007|Stage I (14 Days)|Other|0|||
163043635|NCT00572455|588868101|FG008|Stage I (14 Days)|Other|0|||
163043636|NCT00572455|588868102|FG009|Stage I (14 Days)|Other|0|||
163043637|NCT00572455|588868103|FG010|Stage I (14 Days)|Other|0|||
163043638|NCT00572455|588868104|FG011|Stage I (14 Days)|Other|0|||
163043639|NCT00572455|588868105|FG012|Stage I (14 Days)|Other|0|||
163043640|NCT00572455|588868106|FG013|Stage I (14 Days)|Other|0|||
163043641|NCT00572455|588868093|FG000|Stage II (28 Days)|Adverse Event|0|||
163043642|NCT00572455|588868094|FG001|Stage II (28 Days)|Adverse Event|0|||
162853822|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
162853823|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
162853824|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162853825|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163043643|NCT00572455|588868095|FG002|Stage II (28 Days)|Adverse Event|0|||
163043644|NCT00572455|588868096|FG003|Stage II (28 Days)|Adverse Event|0|||
163043645|NCT00572455|588868097|FG004|Stage II (28 Days)|Adverse Event|0|||
163043646|NCT00572455|588868098|FG005|Stage II (28 Days)|Adverse Event|0|||
163043647|NCT00572455|588868099|FG006|Stage II (28 Days)|Adverse Event|0|||
162853826|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162853827|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162853828|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
162853829|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
162853830|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853831|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853832|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
162853833|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853834|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853835|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853836|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853837|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853838|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162853839|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853840|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163043648|NCT00572455|588868100|FG007|Stage II (28 Days)|Adverse Event|0|||
163043649|NCT00572455|588868101|FG008|Stage II (28 Days)|Adverse Event|1|||
163043650|NCT00572455|588868102|FG009|Stage II (28 Days)|Adverse Event|3|||
163043651|NCT00572455|588868103|FG010|Stage II (28 Days)|Adverse Event|3|||
163043652|NCT00572455|588868104|FG011|Stage II (28 Days)|Adverse Event|4|||
163043653|NCT00572455|588868105|FG012|Stage II (28 Days)|Adverse Event|5|||
163043654|NCT00572455|588868106|FG013|Stage II (28 Days)|Adverse Event|1|||
163043655|NCT00572455|588868093|FG000|Stage II (28 Days)|Death|0|||
163043656|NCT00572455|588868094|FG001|Stage II (28 Days)|Death|0|||
163043657|NCT00572455|588868095|FG002|Stage II (28 Days)|Death|0|||
163043658|NCT00572455|588868096|FG003|Stage II (28 Days)|Death|0|||
163043659|NCT00572455|588868097|FG004|Stage II (28 Days)|Death|0|||
163043660|NCT00572455|588868098|FG005|Stage II (28 Days)|Death|0|||
163043661|NCT00572455|588868099|FG006|Stage II (28 Days)|Death|0|||
162853841|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853842|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853843|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853844|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853845|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853846|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
162853847|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162853848|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853849|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
162853850|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
162853851|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853852|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853853|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853854|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853855|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162853856|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
162853857|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853858|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
162853859|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
162853860|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853861|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853862|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853863|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853864|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853865|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162853866|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853867|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
162853868|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
162853869|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853870|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853871|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853872|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853873|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162853874|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162853875|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853876|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
162853877|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853878|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853879|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853880|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853881|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853882|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853883|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
162853884|NCT01307423|588168917|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853885|NCT01307423|588168918|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853886|NCT01307423|588168919|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
162853887|NCT01307423|588168920|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853888|NCT01307423|588168921|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853889|NCT01307423|588168922|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853890|NCT01307423|588168923|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162853891|NCT01307423|588168924|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
162853892|NCT01307423|588168925|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
162853893|NCT03406962|588168928|FG000|Overall Study|Death|2|||
162853894|NCT03406962|588168928|FG000|Overall Study|Adverse Event|1|||
162853895|NCT03853694|588168929|FG000|Overall Study|Protocol Violation|3|||
162853896|NCT03853694|588168930|FG001|Overall Study|Protocol Violation|5|||
162853897|NCT03853694|588168931|FG002|Overall Study|Protocol Violation|3|||
162853898|NCT03853694|588168929|FG000|Overall Study|Delivered early|0|||
162853899|NCT03853694|588168930|FG001|Overall Study|Delivered early|1|||
162954655|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954656|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162853900|NCT03853694|588168931|FG002|Overall Study|Delivered early|0|||
162704669|NCT00557505|587630423|FG007|Overall Study|Withdrawal by Subject|0|||
162853901|NCT03853694|588168929|FG000|Overall Study|not suitable to proceed|0|||
162853902|NCT03853694|588168930|FG001|Overall Study|not suitable to proceed|1|||
162853903|NCT03853694|588168931|FG002|Overall Study|not suitable to proceed|0|||
162853904|NCT03853694|588168929|FG000|Overall Study|difficult surgery|0|||
162704670|NCT00557505|587630424|FG008|Overall Study|Withdrawal by Subject|1|||
162853905|NCT03853694|588168930|FG001|Overall Study|difficult surgery|0|||
162853906|NCT03853694|588168931|FG002|Overall Study|difficult surgery|1|||
162853907|NCT03853694|588168929|FG000|Overall Study|Lost to Follow-up|0|||
162853908|NCT03853694|588168930|FG001|Overall Study|Lost to Follow-up|1|||
162853909|NCT03853694|588168931|FG002|Overall Study|Lost to Follow-up|0|||
162853910|NCT03853694|588168929|FG000|Overall Study|Withdrawal by Subject|0|||
162853911|NCT03853694|588168930|FG001|Overall Study|Withdrawal by Subject|1|||
162853912|NCT03853694|588168931|FG002|Overall Study|Withdrawal by Subject|0|||
162853913|NCT02209766|588168932|FG000|Overall Study|Withdrawal by Subject|0|||
162853914|NCT02209766|588168933|FG001|Overall Study|Withdrawal by Subject|0|||
162853915|NCT02209766|588168934|FG002|Overall Study|Withdrawal by Subject|0|||
162853916|NCT02209766|588168935|FG003|Overall Study|Withdrawal by Subject|1|||
162853917|NCT02209766|588168936|FG004|Overall Study|Withdrawal by Subject|0|||
162853918|NCT00805207|588168937|FG000|Overall Study|Protocol Violation|0|||
162853919|NCT00805207|588168938|FG001|Overall Study|Protocol Violation|0|||
162853920|NCT00805207|588168939|FG002|Overall Study|Protocol Violation|1|||
162853921|NCT00805207|588168940|FG003|Overall Study|Protocol Violation|0|||
162853922|NCT00805207|588168941|FG004|Overall Study|Protocol Violation|0|||
162853923|NCT00805207|588168942|FG005|Overall Study|Protocol Violation|0|||
162853924|NCT00805207|588168943|FG006|Overall Study|Protocol Violation|0|||
162853925|NCT00805207|588168944|FG007|Overall Study|Protocol Violation|0|||
162853926|NCT00805207|588168945|FG008|Overall Study|Protocol Violation|0|||
162853927|NCT00805207|588168937|FG000|Overall Study|Physician Decision|0|||
162853928|NCT00805207|588168938|FG001|Overall Study|Physician Decision|1|||
162853929|NCT00805207|588168939|FG002|Overall Study|Physician Decision|0|||
162853930|NCT00805207|588168940|FG003|Overall Study|Physician Decision|0|||
162853931|NCT00805207|588168941|FG004|Overall Study|Physician Decision|0|||
162853932|NCT00805207|588168942|FG005|Overall Study|Physician Decision|1|||
162853933|NCT00805207|588168943|FG006|Overall Study|Physician Decision|0|||
162853934|NCT00805207|588168944|FG007|Overall Study|Physician Decision|0|||
162853935|NCT00805207|588168945|FG008|Overall Study|Physician Decision|0|||
162853936|NCT00805207|588168937|FG000|Overall Study|Withdrawal by Subject|0|||
162853937|NCT00805207|588168938|FG001|Overall Study|Withdrawal by Subject|1|||
162853938|NCT00805207|588168939|FG002|Overall Study|Withdrawal by Subject|0|||
162853939|NCT00805207|588168940|FG003|Overall Study|Withdrawal by Subject|0|||
162853940|NCT00805207|588168941|FG004|Overall Study|Withdrawal by Subject|1|||
162853941|NCT00805207|588168942|FG005|Overall Study|Withdrawal by Subject|2|||
162853942|NCT00805207|588168943|FG006|Overall Study|Withdrawal by Subject|0|||
162853943|NCT00805207|588168944|FG007|Overall Study|Withdrawal by Subject|0|||
162853944|NCT00805207|588168945|FG008|Overall Study|Withdrawal by Subject|0|||
162853945|NCT00064701|588168946|FG000|One Year Post-transplant|Did not receive study drug|7|||
162853946|NCT00064701|588168947|FG001|One Year Post-transplant|Did not receive study drug|12|||
162853947|NCT00064701|588168948|FG002|One Year Post-transplant|Did not receive study drug|11|||
162853948|NCT00064701|588168946|FG000|One Year Post-transplant|Adverse Event|23|||
162853949|NCT00064701|588168947|FG001|One Year Post-transplant|Adverse Event|19|||
162853950|NCT00064701|588168948|FG002|One Year Post-transplant|Adverse Event|37|||
162853951|NCT00064701|588168946|FG000|One Year Post-transplant|Rejection|0|||
162853952|NCT00064701|588168947|FG001|One Year Post-transplant|Rejection|1|||
162853953|NCT00064701|588168948|FG002|One Year Post-transplant|Rejection|16|||
162853954|NCT00064701|588168946|FG000|One Year Post-transplant|Non-compliance|4|||
162853955|NCT00064701|588168947|FG001|One Year Post-transplant|Non-compliance|2|||
162853956|NCT00064701|588168948|FG002|One Year Post-transplant|Non-compliance|5|||
162853957|NCT00064701|588168946|FG000|One Year Post-transplant|Graft Failure|3|||
162853958|NCT00064701|588168947|FG001|One Year Post-transplant|Graft Failure|2|||
162853959|NCT00064701|588168948|FG002|One Year Post-transplant|Graft Failure|1|||
162853960|NCT00064701|588168946|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
162853961|NCT00064701|588168947|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
162853962|NCT00064701|588168948|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
162853963|NCT00064701|588168946|FG000|One Year Post-transplant|Lost to Follow-up|1|||
162954657|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954658|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954659|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162853964|NCT00064701|588168947|FG001|One Year Post-transplant|Lost to Follow-up|0|||
162853965|NCT00064701|588168948|FG002|One Year Post-transplant|Lost to Follow-up|0|||
162853966|NCT00064701|588168946|FG000|One Year Post-transplant|Converted to rapamycin|1|||
162853967|NCT00064701|588168947|FG001|One Year Post-transplant|Converted to rapamycin|0|||
162853968|NCT00064701|588168948|FG002|One Year Post-transplant|Converted to rapamycin|0|||
162853969|NCT00064701|588168946|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
162853970|NCT00064701|588168947|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
162853971|NCT00064701|588168948|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
162853972|NCT00064701|588168946|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
162853973|NCT00064701|588168947|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
162853974|NCT00064701|588168948|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
162954660|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
163043662|NCT00572455|588868100|FG007|Stage II (28 Days)|Death|0|||
163043663|NCT00572455|588868101|FG008|Stage II (28 Days)|Death|1|||
163043664|NCT00572455|588868102|FG009|Stage II (28 Days)|Death|0|||
163043665|NCT00572455|588868103|FG010|Stage II (28 Days)|Death|0|||
163043666|NCT00572455|588868104|FG011|Stage II (28 Days)|Death|0|||
162853975|NCT00064701|588168946|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
162853976|NCT00064701|588168947|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
162853977|NCT00064701|588168948|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
162853978|NCT00064701|588168946|FG000|One Year Post-transplant|Poor absorption|0|||
162853979|NCT00064701|588168947|FG001|One Year Post-transplant|Poor absorption|1|||
162853980|NCT00064701|588168948|FG002|One Year Post-transplant|Poor absorption|0|||
162853981|NCT00064701|588168946|FG000|One Year Post-transplant|Pancreas transplant|0|||
162853982|NCT00064701|588168947|FG001|One Year Post-transplant|Pancreas transplant|0|||
162853983|NCT00064701|588168948|FG002|One Year Post-transplant|Pancreas transplant|1|||
162853984|NCT00064701|588168946|FG000|Clinical Continuation Phase|Adverse Event|12|||
162853985|NCT00064701|588168947|FG001|Clinical Continuation Phase|Adverse Event|21|||
162853986|NCT00064701|588168948|FG002|Clinical Continuation Phase|Adverse Event|14|||
162853987|NCT00064701|588168946|FG000|Clinical Continuation Phase|Non-compliance|8|||
163043667|NCT00572455|588868105|FG012|Stage II (28 Days)|Death|0|||
163043668|NCT00572455|588868106|FG013|Stage II (28 Days)|Death|0|||
163043669|NCT00572455|588868093|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
163043670|NCT00572455|588868094|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
163043671|NCT00572455|588868095|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
163043672|NCT00572455|588868096|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
163043673|NCT00572455|588868097|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
163043674|NCT00572455|588868098|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
163043675|NCT00572455|588868099|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
163043676|NCT00572455|588868100|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
163043677|NCT00572455|588868101|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
163043678|NCT00572455|588868102|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
162853988|NCT00064701|588168947|FG001|Clinical Continuation Phase|Non-compliance|6|||
162853989|NCT00064701|588168948|FG002|Clinical Continuation Phase|Non-compliance|7|||
162853990|NCT00064701|588168946|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
162853991|NCT00064701|588168947|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
162853992|NCT00064701|588168948|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
162853993|NCT00064701|588168946|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
162853994|NCT00064701|588168947|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
162853995|NCT00064701|588168948|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
162853996|NCT00064701|588168946|FG000|Clinical Continuation Phase|Graft Failure|5|||
163043679|NCT00572455|588868103|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
163043680|NCT00572455|588868104|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
163043681|NCT00572455|588868105|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
163043682|NCT00572455|588868106|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
163043683|NCT00572455|588868093|FG000|Stage II (28 Days)|Other|0|||
163043684|NCT00572455|588868094|FG001|Stage II (28 Days)|Other|0|||
162853997|NCT00064701|588168947|FG001|Clinical Continuation Phase|Graft Failure|5|||
163043685|NCT00572455|588868095|FG002|Stage II (28 Days)|Other|0|||
163043686|NCT00572455|588868096|FG003|Stage II (28 Days)|Other|0|||
163043687|NCT00572455|588868097|FG004|Stage II (28 Days)|Other|0|||
163043688|NCT00572455|588868098|FG005|Stage II (28 Days)|Other|0|||
163043689|NCT00572455|588868099|FG006|Stage II (28 Days)|Other|0|||
163043690|NCT00572455|588868100|FG007|Stage II (28 Days)|Other|0|||
163043691|NCT00572455|588868101|FG008|Stage II (28 Days)|Other|1|||
162853998|NCT00064701|588168948|FG002|Clinical Continuation Phase|Graft Failure|2|||
162853999|NCT00064701|588168946|FG000|Clinical Continuation Phase|Rejection|1|||
162854000|NCT00064701|588168947|FG001|Clinical Continuation Phase|Rejection|2|||
162854001|NCT00064701|588168948|FG002|Clinical Continuation Phase|Rejection|2|||
162854002|NCT00064701|588168946|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
162854003|NCT00064701|588168947|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
162854004|NCT00064701|588168948|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
162854005|NCT00064701|588168946|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
162854006|NCT00064701|588168947|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
162854007|NCT00064701|588168948|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
163043692|NCT00572455|588868102|FG009|Stage II (28 Days)|Other|0|||
163043693|NCT00572455|588868103|FG010|Stage II (28 Days)|Other|0|||
162854008|NCT00064701|588168946|FG000|Clinical Continuation Phase|Physician Decision|1|||
162854009|NCT00064701|588168947|FG001|Clinical Continuation Phase|Physician Decision|3|||
162854010|NCT00064701|588168948|FG002|Clinical Continuation Phase|Physician Decision|0|||
162854011|NCT00064701|588168946|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
162854012|NCT00064701|588168947|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
163043694|NCT00572455|588868104|FG011|Stage II (28 Days)|Other|0|||
163043695|NCT00572455|588868105|FG012|Stage II (28 Days)|Other|0|||
163043696|NCT00572455|588868106|FG013|Stage II (28 Days)|Other|0|||
163043697|NCT00572455|588868093|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
163043698|NCT00572455|588868094|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
163043699|NCT00572455|588868095|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
163043700|NCT00572455|588868096|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
163043701|NCT00572455|588868097|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
163043702|NCT00572455|588868098|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
163043703|NCT00572455|588868099|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
163043704|NCT00572455|588868100|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
163043705|NCT00572455|588868101|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
163043706|NCT00572455|588868102|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
163043707|NCT00572455|588868103|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
163043708|NCT00572455|588868104|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
163043709|NCT00572455|588868105|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
163043710|NCT00572455|588868106|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
163043711|NCT02609386|588868107|FG000|Overall Study|Withdrawal by Subject|6|||
163043712|NCT02609386|588868108|FG001|Overall Study|Withdrawal by Subject|1|||
163043713|NCT02609386|588868107|FG000|Overall Study|Lost to Follow-up|3|||
163043714|NCT02609386|588868108|FG001|Overall Study|Lost to Follow-up|5|||
163043715|NCT02609386|588868107|FG000|Overall Study|Death|19|||
163043716|NCT02609386|588868108|FG001|Overall Study|Death|9|||
163043717|NCT02609386|588868107|FG000|Overall Study|Physician Decision|0|||
163043718|NCT02609386|588868108|FG001|Overall Study|Physician Decision|2|||
163043719|NCT03280056|588868109|FG000|Overall Study|Withdrawal by Subject|12|||
163043720|NCT03280056|588868110|FG001|Overall Study|Withdrawal by Subject|14|||
163043721|NCT03280056|588868109|FG000|Overall Study|Death|9|||
163043722|NCT03280056|588868110|FG001|Overall Study|Death|2|||
163043723|NCT03280056|588868109|FG000|Overall Study|Adverse Event|1|||
163043724|NCT03280056|588868110|FG001|Overall Study|Adverse Event|3|||
163043725|NCT03280056|588868109|FG000|Overall Study|Lost to Follow-up|1|||
163043726|NCT03280056|588868110|FG001|Overall Study|Lost to Follow-up|1|||
163043727|NCT03280056|588868109|FG000|Overall Study|Physician Decision|0|||
163043728|NCT03280056|588868110|FG001|Overall Study|Physician Decision|1|||
163043729|NCT03280056|588868109|FG000|Overall Study|Early Discontinuation|1|||
163043730|NCT03280056|588868110|FG001|Overall Study|Early Discontinuation|0|||
163043731|NCT00610168|588868111|FG000|Overall Study|Withdrawal by Subject|2|||
163043732|NCT00610168|588868112|FG001|Overall Study|Withdrawal by Subject|0|||
163043733|NCT01135524|588868118|FG000|Overall Study|Withdrawal by Subject|14|||
163043734|NCT01135524|588868118|FG000|Overall Study|Adverse Event|20|||
162854013|NCT00064701|588168948|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
162854014|NCT00064701|588168946|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
163043735|NCT01135524|588868118|FG000|Overall Study|Lost to Follow-up|3|||
162854015|NCT00064701|588168947|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
163043736|NCT01135524|588868118|FG000|Overall Study|Administrative|151|||
163043737|NCT01135524|588868118|FG000|Overall Study|Lack of Efficacy|8|||
163043738|NCT00613821|588868119|FG000|Overall Study|Withdrawal by Subject|1|||
163043739|NCT00613821|588868120|FG001|Overall Study|Withdrawal by Subject|0|||
163043740|NCT00613821|588868119|FG000|Overall Study|Physician Decision|1|||
163043741|NCT00613821|588868120|FG001|Overall Study|Physician Decision|1|||
163043742|NCT02907463|588868121|FG000|Overall Study|Lost to Follow-up|17|||
163043743|NCT02907463|588868121|FG000|Overall Study|Death|10|||
163043744|NCT02907463|588868121|FG000|Overall Study|Withdrawal by Subject|4|||
163043745|NCT02907463|588868121|FG000|Overall Study|MIS Approach was not used|2|||
163043746|NCT02907463|588868121|FG000|Overall Study|Not Implanted with Study Device|2|||
163043747|NCT02907463|588868121|FG000|Overall Study|Device Explanted|1|||
163043748|NCT02907463|588868121|FG000|Overall Study|Missing Exit Form|1|||
162854016|NCT00064701|588168948|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
162854017|NCT00064701|588168946|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
162854018|NCT00064701|588168947|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
162854019|NCT00064701|588168948|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
162854020|NCT00064701|588168946|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
162854021|NCT00064701|588168947|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
162854022|NCT00064701|588168948|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
162854023|NCT00064701|588168946|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
162854024|NCT00064701|588168947|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
162854025|NCT00064701|588168948|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
162854026|NCT00064701|588168946|FG000|Clinical Continuation Phase|Patient opted out|0|||
162854027|NCT00064701|588168947|FG001|Clinical Continuation Phase|Patient opted out|0|||
162854028|NCT00064701|588168948|FG002|Clinical Continuation Phase|Patient opted out|1|||
162854029|NCT01818297|588168949|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
162854030|NCT01818297|588168950|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
162854031|NCT01818297|588168949|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
162854032|NCT01818297|588168950|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
162854033|NCT01818297|588168949|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
162854034|NCT01818297|588168950|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
162854035|NCT03308188|588168951|FG000|Overall Study|Withdrawal by Subject|0|||
162854036|NCT03308188|588168952|FG001|Overall Study|Withdrawal by Subject|3|||
162854037|NCT03308188|588168951|FG000|Overall Study|Death|0|||
162854038|NCT03308188|588168952|FG001|Overall Study|Death|1|||
162854039|NCT01791855|588168953|FG000|Overall Study|Adverse Event|0|||
162854040|NCT01791855|588168954|FG001|Overall Study|Adverse Event|0|||
162854041|NCT01791855|588168955|FG002|Overall Study|Adverse Event|0|||
162854042|NCT01791855|588168956|FG003|Overall Study|Adverse Event|1|||
162854043|NCT01791855|588168953|FG000|Overall Study|Randomized, not treated|0|||
162854044|NCT01791855|588168954|FG001|Overall Study|Randomized, not treated|1|||
162854045|NCT01791855|588168955|FG002|Overall Study|Randomized, not treated|0|||
162854046|NCT01791855|588168956|FG003|Overall Study|Randomized, not treated|0|||
162854047|NCT00481065|588168957|FG000|Overall Study|Adverse event or death|1|||
162854048|NCT00481065|588168958|FG001|Overall Study|Adverse event or death|1|||
162854049|NCT00481065|588168959|FG002|Overall Study|Adverse event or death|3|||
162854050|NCT00481065|588168960|FG003|Overall Study|Adverse event or death|0|||
162854051|NCT00481065|588168961|FG004|Overall Study|Adverse event or death|2|||
162854052|NCT00481065|588168962|FG005|Overall Study|Adverse event or death|0|||
162854053|NCT00481065|588168963|FG006|Overall Study|Adverse event or death|1|||
162854054|NCT00481065|588168964|FG007|Overall Study|Adverse event or death|1|||
162854055|NCT00481065|588168957|FG000|Overall Study|Withdrawal by Subject|11|||
162854056|NCT00481065|588168958|FG001|Overall Study|Withdrawal by Subject|12|||
162854057|NCT00481065|588168959|FG002|Overall Study|Withdrawal by Subject|7|||
162854058|NCT00481065|588168960|FG003|Overall Study|Withdrawal by Subject|11|||
162854059|NCT00481065|588168961|FG004|Overall Study|Withdrawal by Subject|13|||
162954661|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954662|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954663|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954664|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954665|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954666|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954667|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954668|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954669|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
162954670|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
162954671|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
162954672|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
162954673|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
162954674|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954675|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954676|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954677|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162854060|NCT00481065|588168962|FG005|Overall Study|Withdrawal by Subject|12|||
162854061|NCT00481065|588168963|FG006|Overall Study|Withdrawal by Subject|9|||
162854062|NCT00481065|588168964|FG007|Overall Study|Withdrawal by Subject|10|||
162854063|NCT00481065|588168957|FG000|Overall Study|Lost to Follow-up|4|||
162854064|NCT00481065|588168958|FG001|Overall Study|Lost to Follow-up|2|||
162854065|NCT00481065|588168959|FG002|Overall Study|Lost to Follow-up|4|||
162854066|NCT00481065|588168960|FG003|Overall Study|Lost to Follow-up|3|||
162854067|NCT00481065|588168961|FG004|Overall Study|Lost to Follow-up|3|||
162854068|NCT00481065|588168962|FG005|Overall Study|Lost to Follow-up|3|||
162854069|NCT00481065|588168963|FG006|Overall Study|Lost to Follow-up|2|||
162854070|NCT00481065|588168964|FG007|Overall Study|Lost to Follow-up|5|||
162854071|NCT00481065|588168957|FG000|Overall Study|Inappropriate enrollment|4|||
162854072|NCT00481065|588168958|FG001|Overall Study|Inappropriate enrollment|0|||
162854073|NCT00481065|588168959|FG002|Overall Study|Inappropriate enrollment|2|||
162854074|NCT00481065|588168960|FG003|Overall Study|Inappropriate enrollment|0|||
162854075|NCT00481065|588168961|FG004|Overall Study|Inappropriate enrollment|2|||
162854076|NCT00481065|588168962|FG005|Overall Study|Inappropriate enrollment|1|||
162854077|NCT00481065|588168963|FG006|Overall Study|Inappropriate enrollment|0|||
162854078|NCT00481065|588168964|FG007|Overall Study|Inappropriate enrollment|1|||
162854079|NCT00481065|588168957|FG000|Overall Study|Administrative reason|0|||
162854080|NCT00481065|588168958|FG001|Overall Study|Administrative reason|0|||
162854081|NCT00481065|588168959|FG002|Overall Study|Administrative reason|0|||
162854082|NCT00481065|588168960|FG003|Overall Study|Administrative reason|0|||
162854083|NCT00481065|588168961|FG004|Overall Study|Administrative reason|0|||
162854084|NCT00481065|588168962|FG005|Overall Study|Administrative reason|2|||
162854085|NCT00481065|588168963|FG006|Overall Study|Administrative reason|1|||
162854086|NCT00481065|588168964|FG007|Overall Study|Administrative reason|0|||
162854087|NCT00481065|588168957|FG000|Overall Study|Protocol Violation|2|||
162854088|NCT00481065|588168958|FG001|Overall Study|Protocol Violation|1|||
162854089|NCT00481065|588168959|FG002|Overall Study|Protocol Violation|1|||
162854090|NCT00481065|588168960|FG003|Overall Study|Protocol Violation|1|||
162854091|NCT00481065|588168961|FG004|Overall Study|Protocol Violation|2|||
162854092|NCT00481065|588168962|FG005|Overall Study|Protocol Violation|6|||
162854093|NCT00481065|588168963|FG006|Overall Study|Protocol Violation|3|||
162611677|NCT03497676|587294992|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162611678|NCT03497676|587294993|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
162611679|NCT03497676|587294994|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162611680|NCT00880165|587294996|FG000|Overall Study|Withdrawal by Subject|27|||
162854094|NCT00481065|588168964|FG007|Overall Study|Protocol Violation|2|||
162854095|NCT00481065|588168957|FG000|Overall Study|Unable to classify|0|||
162854096|NCT00481065|588168958|FG001|Overall Study|Unable to classify|1|||
162854097|NCT00481065|588168959|FG002|Overall Study|Unable to classify|2|||
162854098|NCT00481065|588168960|FG003|Overall Study|Unable to classify|0|||
162854099|NCT00481065|588168961|FG004|Overall Study|Unable to classify|1|||
162854100|NCT00481065|588168962|FG005|Overall Study|Unable to classify|0|||
162854101|NCT00481065|588168963|FG006|Overall Study|Unable to classify|0|||
162854102|NCT00481065|588168964|FG007|Overall Study|Unable to classify|0|||
162854103|NCT01709331|588168965|FG000|Overall Study|Adverse Event|1|||
162854104|NCT00772447|588168966|FG000|Overall Study|Withdrawal by Subject|9|||
162854105|NCT00772447|588168967|FG001|Overall Study|Withdrawal by Subject|5|||
162854106|NCT00772447|588168966|FG000|Overall Study|Physician Decision|4|||
162854107|NCT00772447|588168967|FG001|Overall Study|Physician Decision|8|||
162854108|NCT00772447|588168966|FG000|Overall Study|Lost to Follow-up|2|||
162854109|NCT00772447|588168967|FG001|Overall Study|Lost to Follow-up|4|||
162854110|NCT00772447|588168966|FG000|Overall Study|incorrect enrolment|3|||
162854111|NCT00772447|588168967|FG001|Overall Study|incorrect enrolment|4|||
162854112|NCT00772447|588168966|FG000|Overall Study|Protocol Violation|0|||
162854113|NCT00772447|588168967|FG001|Overall Study|Protocol Violation|1|||
162854114|NCT00772447|588168966|FG000|Overall Study|all others|2|||
162854115|NCT00772447|588168967|FG001|Overall Study|all others|2|||
162854116|NCT04439344|588168968|FG000|Overall Study|Never started threapy|3|||
162854117|NCT04439344|588168968|FG000|Overall Study|Ineligible|3|||
162854118|NCT04439344|588168968|FG000|Overall Study|Adverse Event|13|||
162854119|NCT04439344|588168968|FG000|Overall Study|Death|2|||
162854120|NCT04439344|588168968|FG000|Overall Study|Disease progression|29|||
162854121|NCT04439344|588168968|FG000|Overall Study|Withdrawal by Subject|2|||
162854122|NCT04439344|588168968|FG000|Overall Study|Alternative therapy|1|||
162854123|NCT03770403|588168974|FG000|Overall Study|Adverse Event|8|||
162854124|NCT03770403|588168974|FG000|Overall Study|Death|5|||
162854125|NCT03770403|588168974|FG000|Overall Study|Physician Decision|1|||
162854126|NCT03770403|588168974|FG000|Overall Study|Sponsor decision|1|||
162854127|NCT03770403|588168974|FG000|Overall Study|Study terminated by Sponsor|1|||
162854128|NCT03770403|588168974|FG000|Overall Study|Withdrawal by Subject|13|||
162854129|NCT03770403|588168974|FG000|Overall Study|Other|88|||
162854130|NCT03896295|588168975|FG000|Overall Study|Adverse Event|0|||
162854131|NCT03896295|588168976|FG001|Overall Study|Adverse Event|1|||
162854132|NCT03896295|588168975|FG000|Overall Study|COVID-19|7|||
162854133|NCT03896295|588168976|FG001|Overall Study|COVID-19|29|||
162854134|NCT01957137|588168977|FG000|Randomized Portion|Adverse Event|1|||
162854135|NCT01957137|588168977|FG000|Randomized Portion|Withdrawal by Subject|1|||
162854136|NCT02901431|588168990|FG000|PK Part|Adverse Event|0|||
162854137|NCT02901431|588168991|FG001|PK Part|Adverse Event|1|||
163043749|NCT01266824|588868122|FG000|Overall Study|Study terminated prior to completion|2|||
163043750|NCT01266824|588868123|FG001|Overall Study|Study terminated prior to completion|3|||
163043751|NCT00397189|588868124|FG000|3 Weeks Period|Lost to Follow-up|5|||
163043752|NCT00397189|588868125|FG001|3 Weeks Period|Lost to Follow-up|4|||
163043753|NCT00397189|588868124|FG000|3 Weeks Period|Adverse Event|3|||
163043754|NCT00397189|588868125|FG001|3 Weeks Period|Adverse Event|2|||
163043755|NCT00397189|588868124|FG000|3 Weeks Period|Withdrawal by Subject|13|||
163043756|NCT00397189|588868125|FG001|3 Weeks Period|Withdrawal by Subject|9|||
163043757|NCT00397189|588868124|FG000|3 Weeks Period|Physician Decision|0|||
163043758|NCT00397189|588868125|FG001|3 Weeks Period|Physician Decision|2|||
163043759|NCT00397189|588868124|FG000|3 Weeks Period|Protocol Violation|0|||
163043760|NCT00397189|588868125|FG001|3 Weeks Period|Protocol Violation|3|||
163043761|NCT00397189|588868124|FG000|3 Weeks Period|Other|0|||
163043762|NCT00397189|588868125|FG001|3 Weeks Period|Other|2|||
163043763|NCT01447407|588868128|FG000|Overall Study|Withdrawal by Subject|2|||
163043764|NCT01447407|588868129|FG001|Overall Study|Withdrawal by Subject|0|||
163043765|NCT01447407|588868130|FG002|Overall Study|Withdrawal by Subject|0|||
163043766|NCT01447407|588868131|FG003|Overall Study|Withdrawal by Subject|1|||
163043767|NCT01447407|588868128|FG000|Overall Study|Physician Decision|0|||
163043768|NCT01447407|588868129|FG001|Overall Study|Physician Decision|0|||
163043769|NCT01447407|588868130|FG002|Overall Study|Physician Decision|1|||
163043770|NCT01447407|588868131|FG003|Overall Study|Physician Decision|1|||
163043771|NCT00141518|588868134|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
163043772|NCT00141518|588868135|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
163043773|NCT00141518|588868136|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
163043774|NCT00141518|588868134|FG000|Overall Study|Adverse Event|7|||
163043775|NCT00141518|588868135|FG001|Overall Study|Adverse Event|5|||
163043776|NCT00141518|588868136|FG002|Overall Study|Adverse Event|2|||
163043777|NCT00141518|588868134|FG000|Overall Study|Withdrawal by Subject|2|||
163043778|NCT00141518|588868135|FG001|Overall Study|Withdrawal by Subject|0|||
163043779|NCT00141518|588868136|FG002|Overall Study|Withdrawal by Subject|2|||
163043780|NCT00141518|588868134|FG000|Overall Study|Protocol Violation|1|||
163043781|NCT00141518|588868135|FG001|Overall Study|Protocol Violation|1|||
163043782|NCT00141518|588868136|FG002|Overall Study|Protocol Violation|2|||
163043783|NCT00141518|588868134|FG000|Overall Study|Lack of Efficacy|5|||
163043784|NCT00141518|588868135|FG001|Overall Study|Lack of Efficacy|0|||
163043785|NCT00141518|588868136|FG002|Overall Study|Lack of Efficacy|0|||
163043786|NCT01029262|588868140|FG000|Overall Study|Adverse Event|9|||
163043787|NCT01029262|588868141|FG001|Overall Study|Adverse Event|52|||
163043788|NCT01029262|588868140|FG000|Overall Study|Lack of therapeutic effect|57|||
163043789|NCT01029262|588868141|FG001|Overall Study|Lack of therapeutic effect|76|||
163043790|NCT01029262|588868140|FG000|Overall Study|Withdrawal by Subject|10|||
163043791|NCT01029262|588868141|FG001|Overall Study|Withdrawal by Subject|17|||
163043792|NCT01029262|588868140|FG000|Overall Study|Protocol Violation|2|||
163043793|NCT01029262|588868141|FG001|Overall Study|Protocol Violation|3|||
163043794|NCT01029262|588868140|FG000|Overall Study|Miscellaneous|1|||
163043795|NCT01029262|588868141|FG001|Overall Study|Miscellaneous|9|||
163043796|NCT01029262|588868140|FG000|Overall Study|Death|0|||
163043797|NCT01029262|588868141|FG001|Overall Study|Death|3|||
163043798|NCT01001910|588868142|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
163043799|NCT01468454|588868143|FG000|Overall Study|Did not have surgery after PET|9|||
163043800|NCT02896569|588868144|FG000|Overall Study|Lost to Follow-up|2|||
162704671|NCT01403987|587630429|FG000|Overall Study|Residents forgot their secret PIN|18|||
162704672|NCT01403987|587630430|FG001|Overall Study|Residents forgot their secret PIN|17|||
162704673|NCT01403987|587630431|FG002|Overall Study|Residents forgot their secret PIN|18|||
162704674|NCT03566680|587630434|FG000|Overall Study|Pregnancy|1|||
162704675|NCT03566680|587630434|FG000|Overall Study|Lost to Follow-up|13|||
162704676|NCT03566680|587630434|FG000|Overall Study|Withdrawal by Subject|3|||
162704677|NCT04227340|587630436|FG000|Overall Study|Withdrawal by Subject|3|||
162704678|NCT01066156|587630437|FG000|Overall Study|ineligible|2|||
162704679|NCT01066156|587630437|FG000|Overall Study|Lost to Follow-up|7|||
162704680|NCT01066156|587630437|FG000|Overall Study|Withdrawal by Subject|1|||
162704681|NCT04003974|587630438|FG000|Overall Study|Missing|1|||
162704682|NCT04003974|587630439|FG001|Overall Study|Missing|0|||
163043801|NCT02896569|588868145|FG001|Overall Study|Lost to Follow-up|1|||
163043802|NCT02896569|588868144|FG000|Overall Study|Physician Decision|1|||
163043803|NCT02896569|588868145|FG001|Overall Study|Physician Decision|3|||
163043804|NCT02896569|588868144|FG000|Overall Study|Adverse Event|0|||
163043805|NCT02896569|588868145|FG001|Overall Study|Adverse Event|1|||
163043806|NCT02896569|588868144|FG000|Overall Study|Withdrawal by Subject|1|||
162704683|NCT04003974|587630438|FG000|Overall Study|Withdrawal by Subject|0|||
163043807|NCT02896569|588868145|FG001|Overall Study|Withdrawal by Subject|0|||
163043808|NCT03060291|588868148|FG000|3-month Follow-up|Declined to respond|8|||
162704684|NCT04003974|587630439|FG001|Overall Study|Withdrawal by Subject|2|||
163043809|NCT03060291|588868149|FG001|3-month Follow-up|Declined to respond|10|||
163043810|NCT03060291|588868150|FG002|3-month Follow-up|Declined to respond|2|||
163043811|NCT03060291|588868148|FG000|6-month Follow-up|Declined to respond|7|||
163043812|NCT03060291|588868149|FG001|6-month Follow-up|Declined to respond|13|||
163043813|NCT03060291|588868150|FG002|6-month Follow-up|Declined to respond|4|||
163043814|NCT03060291|588868148|FG000|12-month Follow-up|Declined to respond|7|||
163043815|NCT03060291|588868149|FG001|12-month Follow-up|Declined to respond|16|||
163043816|NCT03060291|588868150|FG002|12-month Follow-up|Declined to respond|6|||
163043817|NCT01509664|588868153|FG000|Overall Study|Lost to Follow-up|15|||
163043818|NCT01509664|588868154|FG001|Overall Study|Lost to Follow-up|21|||
163043819|NCT02306850|588868159|FG000|Overall Study|Lack of Efficacy|2|||
163043820|NCT02420262|588868160|FG000|Overall Study|Adverse Event|1|||
163043821|NCT02420262|588868161|FG001|Overall Study|Adverse Event|0|||
163043822|NCT02420262|588868160|FG000|Overall Study|Withdrawal by Subject|1|||
163043823|NCT02420262|588868161|FG001|Overall Study|Withdrawal by Subject|4|||
163043824|NCT02420262|588868160|FG000|Overall Study|Unclassified|0|||
163043825|NCT02420262|588868161|FG001|Overall Study|Unclassified|1|||
163043826|NCT01210222|588868162|FG000|Overall Study|Ineligible|2|||
163043827|NCT01210222|588868162|FG000|Overall Study|Never treated|1|||
163043828|NCT00941304|588868163|FG000|Overall Study|Lost to Follow-up|1|||
163043829|NCT00941304|588868164|FG001|Overall Study|Lost to Follow-up|0|||
163043830|NCT00941304|588868165|FG002|Overall Study|Lost to Follow-up|0|||
163043831|NCT00941304|588868166|FG003|Overall Study|Lost to Follow-up|0|||
163043832|NCT00941304|588868167|FG004|Overall Study|Lost to Follow-up|0|||
163043833|NCT03293394|588868168|FG000|Follow-up (6 Months)|Adverse Event|4|||
163043834|NCT03293394|588868169|FG001|Follow-up (6 Months)|Adverse Event|2|||
163043835|NCT01903993|588868174|FG000|Overall Study|Death|118|||
163043836|NCT01903993|588868175|FG001|Overall Study|Death|121|||
163043837|NCT01903993|588868174|FG000|Overall Study|Withdrawal by Subject|15|||
163043838|NCT01903993|588868175|FG001|Overall Study|Withdrawal by Subject|4|||
162854138|NCT02901431|588168992|FG002|PK Part|Adverse Event|0|||
162854139|NCT02901431|588168993|FG003|PK Part|Adverse Event|0|||
162854140|NCT02901431|588168994|FG004|PK Part|Adverse Event|0|||
162854141|NCT02901431|588168995|FG005|PK Part|Adverse Event|0|||
162854142|NCT02901431|588168996|FG006|PK Part|Adverse Event|0|||
162854143|NCT02901431|588168997|FG007|PK Part|Adverse Event|0|||
163043839|NCT01903993|588868174|FG000|Overall Study|Lost to Follow-up|2|||
163043840|NCT01903993|588868175|FG001|Overall Study|Lost to Follow-up|3|||
163043841|NCT01903993|588868174|FG000|Overall Study|Study Terminated by Sponsor|8|||
162854144|NCT02901431|588168998|FG008|PK Part|Adverse Event|0|||
163043842|NCT01903993|588868175|FG001|Overall Study|Study Terminated by Sponsor|14|||
163043843|NCT01903993|588868174|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
163043844|NCT01903993|588868175|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
163043845|NCT00184093|588868178|FG000|Overall Study|Adverse Event|3|||
163043846|NCT00184093|588868178|FG000|Overall Study|Lost to Follow-up|3|||
163043847|NCT00184093|588868178|FG000|Overall Study|Physician Decision|1|||
163043848|NCT00184093|588868178|FG000|Overall Study|Withdrawal by Subject|2|||
162854145|NCT02901431|588168999|FG009|PK Part|Adverse Event|0|||
162854146|NCT02901431|588169000|FG010|PK Part|Adverse Event|0|||
162854147|NCT02901431|588169001|FG011|PK Part|Adverse Event|0|||
162854148|NCT02901431|588169002|FG012|PK Part|Adverse Event|0|||
162854149|NCT02901431|588168990|FG000|PK Part|Lost to Follow-up|0|||
162854150|NCT02901431|588168991|FG001|PK Part|Lost to Follow-up|0|||
162854151|NCT02901431|588168992|FG002|PK Part|Lost to Follow-up|1|||
162854152|NCT02901431|588168993|FG003|PK Part|Lost to Follow-up|0|||
162854153|NCT02901431|588168994|FG004|PK Part|Lost to Follow-up|0|||
162854154|NCT02901431|588168995|FG005|PK Part|Lost to Follow-up|0|||
162854155|NCT02901431|588168996|FG006|PK Part|Lost to Follow-up|0|||
162854156|NCT02901431|588168997|FG007|PK Part|Lost to Follow-up|0|||
162854157|NCT02901431|588168998|FG008|PK Part|Lost to Follow-up|0|||
162854158|NCT02901431|588168999|FG009|PK Part|Lost to Follow-up|0|||
162854159|NCT02901431|588169000|FG010|PK Part|Lost to Follow-up|0|||
162854160|NCT02901431|588169001|FG011|PK Part|Lost to Follow-up|0|||
162854161|NCT02901431|588169002|FG012|PK Part|Lost to Follow-up|0|||
162854162|NCT02901431|588168990|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
162854163|NCT02901431|588168991|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854164|NCT02901431|588168992|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854165|NCT02901431|588168993|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854166|NCT02901431|588168994|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854167|NCT02901431|588168995|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854168|NCT02901431|588168996|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854169|NCT02901431|588168997|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854170|NCT02901431|588168998|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854171|NCT02901431|588168999|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854172|NCT02901431|588169000|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854173|NCT02901431|588169001|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163043849|NCT03283930|588868183|FG000|Overall Study|Scheduling conflict|8|||
162854174|NCT02901431|588169002|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
162854175|NCT02901431|588168990|FG000|PK Part|Pending dose confirmation|0|||
163043850|NCT03283930|588868184|FG001|Overall Study|Scheduling conflict|10|||
162854176|NCT02901431|588168991|FG001|PK Part|Pending dose confirmation|1|||
162854177|NCT02901431|588168992|FG002|PK Part|Pending dose confirmation|0|||
162854178|NCT02901431|588168993|FG003|PK Part|Pending dose confirmation|0|||
162854179|NCT02901431|588168994|FG004|PK Part|Pending dose confirmation|0|||
162854180|NCT02901431|588168995|FG005|PK Part|Pending dose confirmation|0|||
162854181|NCT02901431|588168996|FG006|PK Part|Pending dose confirmation|0|||
162854182|NCT02901431|588168997|FG007|PK Part|Pending dose confirmation|0|||
162854183|NCT02901431|588168998|FG008|PK Part|Pending dose confirmation|0|||
162854184|NCT02901431|588168999|FG009|PK Part|Pending dose confirmation|0|||
162854185|NCT02901431|588169000|FG010|PK Part|Pending dose confirmation|0|||
162854186|NCT02901431|588169001|FG011|PK Part|Pending dose confirmation|0|||
162854187|NCT02901431|588169002|FG012|PK Part|Pending dose confirmation|0|||
162854188|NCT02901431|588168990|FG000|PK Part|8 weeks of treatment ran out|2|||
162854189|NCT02901431|588168991|FG001|PK Part|8 weeks of treatment ran out|0|||
162854190|NCT02901431|588168992|FG002|PK Part|8 weeks of treatment ran out|0|||
162854191|NCT02901431|588168993|FG003|PK Part|8 weeks of treatment ran out|0|||
162854192|NCT02901431|588168994|FG004|PK Part|8 weeks of treatment ran out|0|||
162854193|NCT02901431|588168995|FG005|PK Part|8 weeks of treatment ran out|0|||
162854194|NCT02901431|588168996|FG006|PK Part|8 weeks of treatment ran out|0|||
162854195|NCT02901431|588168997|FG007|PK Part|8 weeks of treatment ran out|0|||
162854196|NCT02901431|588168998|FG008|PK Part|8 weeks of treatment ran out|0|||
162854197|NCT02901431|588168999|FG009|PK Part|8 weeks of treatment ran out|0|||
162854198|NCT02901431|588169000|FG010|PK Part|8 weeks of treatment ran out|0|||
162854199|NCT02901431|588169001|FG011|PK Part|8 weeks of treatment ran out|0|||
162854200|NCT02901431|588169002|FG012|PK Part|8 weeks of treatment ran out|0|||
162854201|NCT02901431|588168990|FG000|PK Part|Stopped treatment after 8 weeks|1|||
162854202|NCT02901431|588168991|FG001|PK Part|Stopped treatment after 8 weeks|0|||
162854203|NCT02901431|588168992|FG002|PK Part|Stopped treatment after 8 weeks|1|||
162854204|NCT02901431|588168993|FG003|PK Part|Stopped treatment after 8 weeks|0|||
162854205|NCT02901431|588168994|FG004|PK Part|Stopped treatment after 8 weeks|0|||
162854206|NCT02901431|588168995|FG005|PK Part|Stopped treatment after 8 weeks|0|||
162854207|NCT02901431|588168996|FG006|PK Part|Stopped treatment after 8 weeks|0|||
162854208|NCT02901431|588168997|FG007|PK Part|Stopped treatment after 8 weeks|0|||
162854209|NCT02901431|588168998|FG008|PK Part|Stopped treatment after 8 weeks|0|||
162854210|NCT02901431|588168999|FG009|PK Part|Stopped treatment after 8 weeks|0|||
162854211|NCT02901431|588169000|FG010|PK Part|Stopped treatment after 8 weeks|0|||
162854212|NCT02901431|588169001|FG011|PK Part|Stopped treatment after 8 weeks|0|||
162854213|NCT02901431|588169002|FG012|PK Part|Stopped treatment after 8 weeks|0|||
162854214|NCT02901431|588168990|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
162854215|NCT02901431|588168991|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854216|NCT02901431|588168992|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
162854217|NCT02901431|588168993|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854218|NCT02901431|588168994|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854219|NCT02901431|588168995|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162954678|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954679|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954680|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954681|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954682|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954683|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954684|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954685|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954686|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954687|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954688|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954689|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954690|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
162954691|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
162954692|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
162954693|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
162954694|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954695|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954696|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954697|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954698|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162854220|NCT02901431|588168996|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854221|NCT02901431|588168997|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854222|NCT02901431|588168998|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854223|NCT02901431|588168999|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854224|NCT02901431|588169000|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854225|NCT02901431|588169001|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854226|NCT02901431|588169002|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
162854227|NCT02901431|588168990|FG000|PK Part|Discontinued per Sponsor|0|||
162954699|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954700|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954701|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954702|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954703|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954704|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954705|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954706|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954707|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954708|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954709|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954710|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954711|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162954712|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
162954713|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954714|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954715|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
162954716|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954717|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954718|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954719|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954720|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954721|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954722|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954723|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954724|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954725|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954726|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954727|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954728|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954729|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954730|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954731|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954732|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162954733|NCT01597245|588537649|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
162954734|NCT01597245|588537650|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
162954735|NCT01597245|588537651|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
162954736|NCT01597245|588537652|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954737|NCT01597245|588537653|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954738|NCT01597245|588537654|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954739|NCT01597245|588537655|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954740|NCT01597245|588537656|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954741|NCT01597245|588537657|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954742|NCT01597245|588537658|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954743|NCT01597245|588537659|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954744|NCT01597245|588537660|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954745|NCT01597245|588537661|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954746|NCT01597245|588537662|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954747|NCT01597245|588537663|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954748|NCT01597245|588537664|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954749|NCT01597245|588537665|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954750|NCT01597245|588537666|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954751|NCT01597245|588537667|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954752|NCT01597245|588537668|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954753|NCT01597245|588537669|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
162954754|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954755|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954756|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954757|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954758|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162704685|NCT02400307|587630440|FG000|Overall Study|Enrolled and Never Dosed|1|||
162954759|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
162954760|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
162954761|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954762|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954763|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954764|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954765|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954766|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954767|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954768|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954769|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954770|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954771|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954772|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954773|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954774|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
162954775|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954776|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954777|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954778|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954779|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
162954780|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
162954781|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
162954782|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
162954783|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954784|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
162954785|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954786|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954787|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954788|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954789|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954790|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954791|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954792|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954793|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954794|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954795|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162954796|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954797|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954798|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954799|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954800|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954801|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
162954802|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954803|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954804|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
162954805|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162704686|NCT02400307|587630441|FG001|Overall Study|Enrolled and Never Dosed|0|||
162954806|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
162954807|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
162954808|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
162954809|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954810|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954811|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162704687|NCT02015663|587630444|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
162854228|NCT02901431|588168991|FG001|PK Part|Discontinued per Sponsor|3|||
162854229|NCT02901431|588168992|FG002|PK Part|Discontinued per Sponsor|0|||
162854230|NCT02901431|588168993|FG003|PK Part|Discontinued per Sponsor|0|||
162854231|NCT02901431|588168994|FG004|PK Part|Discontinued per Sponsor|0|||
162854232|NCT02901431|588168995|FG005|PK Part|Discontinued per Sponsor|0|||
162854233|NCT02901431|588168996|FG006|PK Part|Discontinued per Sponsor|0|||
162854234|NCT02901431|588168997|FG007|PK Part|Discontinued per Sponsor|0|||
162854235|NCT02901431|588168998|FG008|PK Part|Discontinued per Sponsor|0|||
162854236|NCT02901431|588168999|FG009|PK Part|Discontinued per Sponsor|0|||
162854237|NCT02901431|588169000|FG010|PK Part|Discontinued per Sponsor|0|||
162854238|NCT02901431|588169001|FG011|PK Part|Discontinued per Sponsor|0|||
162854239|NCT02901431|588169002|FG012|PK Part|Discontinued per Sponsor|0|||
162854240|NCT02901431|588168990|FG000|PK Part|Withdrawal by Subject|1|||
162854241|NCT02901431|588168991|FG001|PK Part|Withdrawal by Subject|1|||
162854242|NCT02901431|588168992|FG002|PK Part|Withdrawal by Subject|3|||
162854243|NCT02901431|588168993|FG003|PK Part|Withdrawal by Subject|0|||
162854244|NCT02901431|588168994|FG004|PK Part|Withdrawal by Subject|0|||
163043851|NCT03283930|588868183|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
163043852|NCT03283930|588868184|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
162704688|NCT02015663|587630445|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
162854245|NCT02901431|588168995|FG005|PK Part|Withdrawal by Subject|0|||
162854246|NCT02901431|588168996|FG006|PK Part|Withdrawal by Subject|0|||
162854247|NCT02901431|588168997|FG007|PK Part|Withdrawal by Subject|0|||
162854248|NCT02901431|588168998|FG008|PK Part|Withdrawal by Subject|0|||
162854249|NCT02901431|588168999|FG009|PK Part|Withdrawal by Subject|0|||
162854250|NCT02901431|588169000|FG010|PK Part|Withdrawal by Subject|0|||
162854251|NCT02901431|588169001|FG011|PK Part|Withdrawal by Subject|0|||
162854252|NCT02901431|588169002|FG012|PK Part|Withdrawal by Subject|0|||
162854253|NCT02901431|588168990|FG000|Main Treatment Part|Adverse Event|0|||
162854254|NCT02901431|588168991|FG001|Main Treatment Part|Adverse Event|0|||
162854255|NCT02901431|588168992|FG002|Main Treatment Part|Adverse Event|0|||
162854256|NCT02901431|588168993|FG003|Main Treatment Part|Adverse Event|3|||
162854257|NCT02901431|588168994|FG004|Main Treatment Part|Adverse Event|3|||
162854258|NCT02901431|588168995|FG005|Main Treatment Part|Adverse Event|4|||
162854259|NCT02901431|588168996|FG006|Main Treatment Part|Adverse Event|1|||
162854260|NCT02901431|588168997|FG007|Main Treatment Part|Adverse Event|0|||
162854261|NCT02901431|588168998|FG008|Main Treatment Part|Adverse Event|0|||
162854262|NCT02901431|588168999|FG009|Main Treatment Part|Adverse Event|0|||
162854263|NCT02901431|588169000|FG010|Main Treatment Part|Adverse Event|0|||
162854264|NCT02901431|588169001|FG011|Main Treatment Part|Adverse Event|0|||
162854265|NCT02901431|588169002|FG012|Main Treatment Part|Adverse Event|0|||
162854266|NCT02901431|588168990|FG000|Main Treatment Part|Lack of Efficacy|0|||
162854267|NCT02901431|588168991|FG001|Main Treatment Part|Lack of Efficacy|0|||
162854268|NCT02901431|588168992|FG002|Main Treatment Part|Lack of Efficacy|0|||
162854269|NCT02901431|588168993|FG003|Main Treatment Part|Lack of Efficacy|1|||
162854270|NCT02901431|588168994|FG004|Main Treatment Part|Lack of Efficacy|0|||
162854271|NCT02901431|588168995|FG005|Main Treatment Part|Lack of Efficacy|0|||
162854272|NCT02901431|588168996|FG006|Main Treatment Part|Lack of Efficacy|0|||
162854273|NCT02901431|588168997|FG007|Main Treatment Part|Lack of Efficacy|0|||
162854274|NCT02901431|588168998|FG008|Main Treatment Part|Lack of Efficacy|0|||
162854275|NCT02901431|588168999|FG009|Main Treatment Part|Lack of Efficacy|0|||
162854276|NCT02901431|588169000|FG010|Main Treatment Part|Lack of Efficacy|0|||
162854277|NCT02901431|588169001|FG011|Main Treatment Part|Lack of Efficacy|0|||
162854278|NCT02901431|588169002|FG012|Main Treatment Part|Lack of Efficacy|0|||
162854279|NCT02901431|588168990|FG000|Main Treatment Part|Lost to Follow-up|0|||
162854280|NCT02901431|588168991|FG001|Main Treatment Part|Lost to Follow-up|0|||
162854281|NCT02901431|588168992|FG002|Main Treatment Part|Lost to Follow-up|0|||
162854282|NCT02901431|588168993|FG003|Main Treatment Part|Lost to Follow-up|3|||
162854283|NCT02901431|588168994|FG004|Main Treatment Part|Lost to Follow-up|1|||
162854284|NCT02901431|588168995|FG005|Main Treatment Part|Lost to Follow-up|2|||
162854285|NCT02901431|588168996|FG006|Main Treatment Part|Lost to Follow-up|3|||
162854286|NCT02901431|588168997|FG007|Main Treatment Part|Lost to Follow-up|0|||
162854287|NCT02901431|588168998|FG008|Main Treatment Part|Lost to Follow-up|0|||
162854288|NCT02901431|588168999|FG009|Main Treatment Part|Lost to Follow-up|0|||
162854289|NCT02901431|588169000|FG010|Main Treatment Part|Lost to Follow-up|0|||
162854290|NCT02901431|588169001|FG011|Main Treatment Part|Lost to Follow-up|0|||
162854291|NCT02901431|588169002|FG012|Main Treatment Part|Lost to Follow-up|0|||
162854292|NCT02901431|588168990|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
162854293|NCT02901431|588168991|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
162854294|NCT02901431|588168992|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
162854295|NCT02901431|588168993|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
162854296|NCT02901431|588168994|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
162854297|NCT02901431|588168995|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
162854298|NCT02901431|588168996|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
162854299|NCT02901431|588168997|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
162854300|NCT02901431|588168998|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
162854301|NCT02901431|588168999|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
162854302|NCT02901431|588169000|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
162854303|NCT02901431|588169001|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
162854304|NCT02901431|588169002|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
162854305|NCT02901431|588168990|FG000|Main Treatment Part|Physician Decision|0|||
162854306|NCT02901431|588168991|FG001|Main Treatment Part|Physician Decision|0|||
162854307|NCT02901431|588168992|FG002|Main Treatment Part|Physician Decision|0|||
162854308|NCT02901431|588168993|FG003|Main Treatment Part|Physician Decision|1|||
162854309|NCT02901431|588168994|FG004|Main Treatment Part|Physician Decision|0|||
162854310|NCT02901431|588168995|FG005|Main Treatment Part|Physician Decision|0|||
162854311|NCT02901431|588168996|FG006|Main Treatment Part|Physician Decision|1|||
162854312|NCT02901431|588168997|FG007|Main Treatment Part|Physician Decision|0|||
162854313|NCT02901431|588168998|FG008|Main Treatment Part|Physician Decision|0|||
162954812|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162854314|NCT02901431|588168999|FG009|Main Treatment Part|Physician Decision|0|||
162854315|NCT02901431|588169000|FG010|Main Treatment Part|Physician Decision|0|||
162854316|NCT02901431|588169001|FG011|Main Treatment Part|Physician Decision|0|||
162854317|NCT02901431|588169002|FG012|Main Treatment Part|Physician Decision|0|||
162854318|NCT02901431|588168990|FG000|Main Treatment Part|Withdrawal by Subject|0|||
162854319|NCT02901431|588168991|FG001|Main Treatment Part|Withdrawal by Subject|0|||
162854320|NCT02901431|588168992|FG002|Main Treatment Part|Withdrawal by Subject|0|||
162854321|NCT02901431|588168993|FG003|Main Treatment Part|Withdrawal by Subject|18|||
162854322|NCT02901431|588168994|FG004|Main Treatment Part|Withdrawal by Subject|3|||
162854323|NCT02901431|588168995|FG005|Main Treatment Part|Withdrawal by Subject|5|||
162854324|NCT02901431|588168996|FG006|Main Treatment Part|Withdrawal by Subject|6|||
162854325|NCT02901431|588168997|FG007|Main Treatment Part|Withdrawal by Subject|0|||
162854326|NCT02901431|588168998|FG008|Main Treatment Part|Withdrawal by Subject|0|||
162854327|NCT02901431|588168999|FG009|Main Treatment Part|Withdrawal by Subject|0|||
162854328|NCT02901431|588169000|FG010|Main Treatment Part|Withdrawal by Subject|0|||
162854329|NCT02901431|588169001|FG011|Main Treatment Part|Withdrawal by Subject|0|||
162854330|NCT02901431|588169002|FG012|Main Treatment Part|Withdrawal by Subject|0|||
162854331|NCT02901431|588168990|FG000|Open Label Part|Adverse Event|0|||
162854332|NCT02901431|588168991|FG001|Open Label Part|Adverse Event|0|||
162854333|NCT02901431|588168992|FG002|Open Label Part|Adverse Event|0|||
162854334|NCT02901431|588168993|FG003|Open Label Part|Adverse Event|0|||
162854335|NCT02901431|588168994|FG004|Open Label Part|Adverse Event|0|||
162854336|NCT02901431|588168995|FG005|Open Label Part|Adverse Event|0|||
162854337|NCT02901431|588168996|FG006|Open Label Part|Adverse Event|0|||
162854338|NCT02901431|588168997|FG007|Open Label Part|Adverse Event|0|||
162854339|NCT02901431|588168998|FG008|Open Label Part|Adverse Event|4|||
162854340|NCT02901431|588168999|FG009|Open Label Part|Adverse Event|4|||
162854341|NCT02901431|588169000|FG010|Open Label Part|Adverse Event|0|||
162854342|NCT02901431|588169001|FG011|Open Label Part|Adverse Event|4|||
162854343|NCT02901431|588169002|FG012|Open Label Part|Adverse Event|1|||
162854344|NCT02901431|588168990|FG000|Open Label Part|Lost to Follow-up|0|||
162854345|NCT02901431|588168991|FG001|Open Label Part|Lost to Follow-up|0|||
162854346|NCT02901431|588168992|FG002|Open Label Part|Lost to Follow-up|0|||
162854347|NCT02901431|588168993|FG003|Open Label Part|Lost to Follow-up|0|||
162854348|NCT02901431|588168994|FG004|Open Label Part|Lost to Follow-up|0|||
162854349|NCT02901431|588168995|FG005|Open Label Part|Lost to Follow-up|0|||
162854350|NCT02901431|588168996|FG006|Open Label Part|Lost to Follow-up|0|||
162854351|NCT02901431|588168997|FG007|Open Label Part|Lost to Follow-up|0|||
162854352|NCT02901431|588168998|FG008|Open Label Part|Lost to Follow-up|2|||
162854353|NCT02901431|588168999|FG009|Open Label Part|Lost to Follow-up|2|||
162854354|NCT02901431|588169000|FG010|Open Label Part|Lost to Follow-up|1|||
162854355|NCT02901431|588169001|FG011|Open Label Part|Lost to Follow-up|1|||
162854356|NCT02901431|588169002|FG012|Open Label Part|Lost to Follow-up|1|||
162854357|NCT02901431|588168990|FG000|Open Label Part|Physician Decision|0|||
162854358|NCT02901431|588168991|FG001|Open Label Part|Physician Decision|0|||
162854359|NCT02901431|588168992|FG002|Open Label Part|Physician Decision|0|||
162854360|NCT02901431|588168993|FG003|Open Label Part|Physician Decision|0|||
162854361|NCT02901431|588168994|FG004|Open Label Part|Physician Decision|0|||
162854362|NCT02901431|588168995|FG005|Open Label Part|Physician Decision|0|||
162854363|NCT02901431|588168996|FG006|Open Label Part|Physician Decision|0|||
162854364|NCT02901431|588168997|FG007|Open Label Part|Physician Decision|0|||
162854365|NCT02901431|588168998|FG008|Open Label Part|Physician Decision|1|||
162954813|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954814|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954815|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954816|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162954817|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954818|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954819|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954820|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954821|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
162954822|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
162954823|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
162954824|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
162954825|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
162954826|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
162954827|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
162954828|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
162954829|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
162954830|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954831|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954832|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162611681|NCT00880165|587294997|FG001|Overall Study|Withdrawal by Subject|23|||
162854366|NCT02901431|588168999|FG009|Open Label Part|Physician Decision|1|||
162854367|NCT02901431|588169000|FG010|Open Label Part|Physician Decision|0|||
162854368|NCT02901431|588169001|FG011|Open Label Part|Physician Decision|0|||
162954833|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954834|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162611682|NCT00880165|587294996|FG000|Overall Study|Not diagnosed with OSA|14|||
162611683|NCT00880165|587294997|FG001|Overall Study|Not diagnosed with OSA|8|||
162611684|NCT00880165|587294996|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
162854369|NCT02901431|588169002|FG012|Open Label Part|Physician Decision|0|||
162854370|NCT02901431|588168990|FG000|Open Label Part|Study Terminated By Sponsor|0|||
162854371|NCT02901431|588168991|FG001|Open Label Part|Study Terminated By Sponsor|0|||
162854372|NCT02901431|588168992|FG002|Open Label Part|Study Terminated By Sponsor|0|||
162854373|NCT02901431|588168993|FG003|Open Label Part|Study Terminated By Sponsor|0|||
162854374|NCT02901431|588168994|FG004|Open Label Part|Study Terminated By Sponsor|0|||
162854375|NCT02901431|588168995|FG005|Open Label Part|Study Terminated By Sponsor|0|||
162854376|NCT02901431|588168996|FG006|Open Label Part|Study Terminated By Sponsor|0|||
162854377|NCT02901431|588168997|FG007|Open Label Part|Study Terminated By Sponsor|0|||
162854378|NCT02901431|588168998|FG008|Open Label Part|Study Terminated By Sponsor|35|||
162854379|NCT02901431|588168999|FG009|Open Label Part|Study Terminated By Sponsor|12|||
162854380|NCT02901431|588169000|FG010|Open Label Part|Study Terminated By Sponsor|21|||
162854381|NCT02901431|588169001|FG011|Open Label Part|Study Terminated By Sponsor|31|||
162854382|NCT02901431|588169002|FG012|Open Label Part|Study Terminated By Sponsor|0|||
162854383|NCT02901431|588168990|FG000|Open Label Part|Withdrawal by Subject|0|||
162854384|NCT02901431|588168991|FG001|Open Label Part|Withdrawal by Subject|0|||
162854385|NCT02901431|588168992|FG002|Open Label Part|Withdrawal by Subject|0|||
162854386|NCT02901431|588168993|FG003|Open Label Part|Withdrawal by Subject|0|||
162954835|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954836|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954837|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
162954838|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954839|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954840|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954841|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954842|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
162954843|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
162954844|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
162954845|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954846|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
162954847|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
162954848|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
162954849|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
162954850|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
162954851|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954852|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954853|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954854|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954855|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954856|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954857|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954858|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162954859|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954860|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954861|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954862|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954863|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954864|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954865|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954866|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954867|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
162954868|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954869|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
162954870|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954871|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162954872|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954873|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954874|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954875|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954876|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954877|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954878|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954879|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162954880|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162854387|NCT02901431|588168994|FG004|Open Label Part|Withdrawal by Subject|0|||
162854388|NCT02901431|588168995|FG005|Open Label Part|Withdrawal by Subject|0|||
162854389|NCT02901431|588168996|FG006|Open Label Part|Withdrawal by Subject|0|||
162854390|NCT02901431|588168997|FG007|Open Label Part|Withdrawal by Subject|0|||
162854391|NCT02901431|588168998|FG008|Open Label Part|Withdrawal by Subject|6|||
162854392|NCT02901431|588168999|FG009|Open Label Part|Withdrawal by Subject|5|||
162854393|NCT02901431|588169000|FG010|Open Label Part|Withdrawal by Subject|7|||
162854394|NCT02901431|588169001|FG011|Open Label Part|Withdrawal by Subject|3|||
162854395|NCT02901431|588169002|FG012|Open Label Part|Withdrawal by Subject|1|||
162854396|NCT02500537|588169003|FG000|Overall Study|Death|2|||
162854397|NCT02500537|588169004|FG001|Overall Study|Death|0|||
162854398|NCT02500537|588169003|FG000|Overall Study|Lost to Follow-up|0|||
162854399|NCT02500537|588169004|FG001|Overall Study|Lost to Follow-up|1|||
162854400|NCT02500537|588169003|FG000|Overall Study|Withdrawal by Subject|1|||
162854401|NCT02500537|588169004|FG001|Overall Study|Withdrawal by Subject|0|||
162854402|NCT03832387|588169007|FG000|Overall Study|Protocol Violation|2|||
162854403|NCT03832387|588169008|FG001|Overall Study|Protocol Violation|6|||
162854404|NCT03832387|588169007|FG000|Overall Study|EXCLUSION CRITERIA|3|||
162854405|NCT03832387|588169008|FG001|Overall Study|EXCLUSION CRITERIA|1|||
162854406|NCT00355121|588169009|FG000|Overall Study|Did not receive study vaccine|1|||
162854407|NCT00355121|588169010|FG001|Overall Study|Did not receive study vaccine|0|||
162854408|NCT00355121|588169011|FG002|Overall Study|Did not receive study vaccine|1|||
162854409|NCT00355121|588169009|FG000|Overall Study|Adverse Event|0|||
162854410|NCT00355121|588169010|FG001|Overall Study|Adverse Event|1|||
162854411|NCT00355121|588169011|FG002|Overall Study|Adverse Event|0|||
162854412|NCT00355121|588169009|FG000|Overall Study|Protocol Violation|7|||
162854413|NCT00355121|588169010|FG001|Overall Study|Protocol Violation|9|||
162854414|NCT00355121|588169011|FG002|Overall Study|Protocol Violation|1|||
162854415|NCT00355121|588169009|FG000|Overall Study|Lost to Follow-up|4|||
162854416|NCT00355121|588169010|FG001|Overall Study|Lost to Follow-up|7|||
162954881|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162611685|NCT00880165|587294997|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
162854417|NCT00355121|588169011|FG002|Overall Study|Lost to Follow-up|1|||
162854418|NCT00355121|588169009|FG000|Overall Study|Withdrawal by Subject|9|||
162854419|NCT00355121|588169010|FG001|Overall Study|Withdrawal by Subject|10|||
162854420|NCT00355121|588169011|FG002|Overall Study|Withdrawal by Subject|2|||
162854421|NCT00355121|588169009|FG000|Overall Study|Serious adverse events|0|||
162854422|NCT00355121|588169010|FG001|Overall Study|Serious adverse events|2|||
162854423|NCT00355121|588169011|FG002|Overall Study|Serious adverse events|0|||
162954882|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954883|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954884|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
162954885|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
162954886|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954887|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954888|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954889|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954890|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954891|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
162954892|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
162954893|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954894|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954895|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954896|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954897|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954898|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954899|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954900|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
162954901|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954902|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954903|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954904|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954905|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954906|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954907|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954908|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954909|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954910|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954911|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954912|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
162954913|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954914|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954915|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954916|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954917|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954918|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954919|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954920|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954921|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162954922|NCT01597245|588537649|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954923|NCT01597245|588537650|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954924|NCT01597245|588537651|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954925|NCT01597245|588537652|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954926|NCT01597245|588537653|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954927|NCT01597245|588537654|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954928|NCT01597245|588537655|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954929|NCT01597245|588537656|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954930|NCT01597245|588537657|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954931|NCT01597245|588537658|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954932|NCT01597245|588537659|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
162611686|NCT00880165|587294996|FG000|Overall Study|Lost to follow|9|||
162611687|NCT00880165|587294997|FG001|Overall Study|Lost to follow|15|||
162954933|NCT01597245|588537660|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162854424|NCT00784758|588169012|FG000|Overall Study|Withdrawal by Subject|3|||
162854425|NCT00784758|588169013|FG001|Overall Study|Withdrawal by Subject|0|||
162854426|NCT00784758|588169012|FG000|Overall Study|Adverse Event|1|||
162854427|NCT00784758|588169013|FG001|Overall Study|Adverse Event|0|||
162854428|NCT02330419|588169015|FG000|Overall Study|Lost to Follow-up|3|||
162854429|NCT02330419|588169016|FG001|Overall Study|Lost to Follow-up|7|||
162854430|NCT01056107|588171388|FG000|Overall Study|Withdrawal by Subject|0|||
162854431|NCT01056107|588171389|FG001|Overall Study|Withdrawal by Subject|1|||
162854432|NCT01056107|588171390|FG002|Overall Study|Withdrawal by Subject|3|||
162854433|NCT01056107|588171391|FG003|Overall Study|Withdrawal by Subject|0|||
162854434|NCT00215150|588171394|FG000|Open Label Phase|Lost to Follow-up|7|||
162854435|NCT00215150|588171394|FG000|Open Label Phase|Withdrawal by Subject|1|||
162854436|NCT00215150|588171394|FG000|Open Label Phase|Did not complete a post base visit|13|||
162854437|NCT00215150|588171394|FG000|Open Label Phase|Did not meet randomization criteria|9|||
162854438|NCT00215150|588171394|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
162854439|NCT00215150|588171394|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
162854440|NCT00215150|588171394|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
162854441|NCT02091440|588171398|FG000|Overall Study|Death|2|||
162854442|NCT00278629|588171405|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
162854443|NCT01821963|588171406|FG000|Overall Study|Adverse Event|1|||
162854444|NCT00783289|588171407|FG000|Overall Study|Protocol Violation|0|||
162854445|NCT00783289|588171408|FG001|Overall Study|Protocol Violation|1|||
162854446|NCT00783289|588171409|FG002|Overall Study|Protocol Violation|0|||
162854447|NCT00783289|588171410|FG003|Overall Study|Protocol Violation|0|||
162854448|NCT00506389|588171411|FG000|In-treatment Period|Other|3|||
162854449|NCT00506389|588171412|FG001|In-treatment Period|Other|3|||
162854450|NCT00506389|588171413|FG002|In-treatment Period|Other|4|||
162854451|NCT00506389|588171411|FG000|In-treatment Period|Lost to Follow-up|0|||
162854452|NCT00506389|588171412|FG001|In-treatment Period|Lost to Follow-up|0|||
162854453|NCT00506389|588171413|FG002|In-treatment Period|Lost to Follow-up|1|||
162854454|NCT00506389|588171411|FG000|In-treatment Period|Lack of compliance|1|||
162854455|NCT00506389|588171412|FG001|In-treatment Period|Lack of compliance|0|||
162854456|NCT00506389|588171413|FG002|In-treatment Period|Lack of compliance|0|||
162854457|NCT00506389|588171411|FG000|In-treatment Period|Reasons not related to trial|4|||
162854458|NCT00506389|588171412|FG001|In-treatment Period|Reasons not related to trial|1|||
162854459|NCT00506389|588171413|FG002|In-treatment Period|Reasons not related to trial|0|||
162854460|NCT00506389|588171411|FG000|In-treatment Period|Withdrawal by Subject|3|||
162854461|NCT00506389|588171412|FG001|In-treatment Period|Withdrawal by Subject|3|||
162854462|NCT00506389|588171413|FG002|In-treatment Period|Withdrawal by Subject|4|||
162854463|NCT00506389|588171411|FG000|In-treatment Period|Lack of Efficacy|0|||
162854464|NCT00506389|588171412|FG001|In-treatment Period|Lack of Efficacy|2|||
162854465|NCT00506389|588171413|FG002|In-treatment Period|Lack of Efficacy|0|||
162854466|NCT00506389|588171411|FG000|In-treatment Period|Adverse Event|11|||
162854467|NCT00506389|588171412|FG001|In-treatment Period|Adverse Event|5|||
162854468|NCT00506389|588171413|FG002|In-treatment Period|Adverse Event|2|||
162854469|NCT00506389|588171411|FG000|In-treatment Period|Randomized but not treated|4|||
162854470|NCT00506389|588171412|FG001|In-treatment Period|Randomized but not treated|1|||
162854471|NCT00506389|588171413|FG002|In-treatment Period|Randomized but not treated|1|||
162854472|NCT05224258|588171415|FG000|Overall Study|Withdrawal by Subject|1|||
162854473|NCT05224258|588171416|FG001|Overall Study|Withdrawal by Subject|1|||
162854474|NCT05224258|588171415|FG000|Overall Study|Physician Decision|1|||
162854475|NCT05224258|588171416|FG001|Overall Study|Physician Decision|1|||
162854476|NCT05224258|588171415|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162854477|NCT05224258|588171416|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162854478|NCT05224258|588171415|FG000|Overall Study|Study Product No Longer in Use|1|||
162854479|NCT05224258|588171416|FG001|Overall Study|Study Product No Longer in Use|0|||
162854480|NCT05224258|588171415|FG000|Overall Study|Adverse Event|0|||
162854481|NCT05224258|588171416|FG001|Overall Study|Adverse Event|1|||
162854482|NCT05224258|588171415|FG000|Overall Study|Protocol Deviation|0|||
162854483|NCT05224258|588171416|FG001|Overall Study|Protocol Deviation|1|||
162854484|NCT03095703|588171418|FG000|Overall Study|Withdrawal by Subject|1|||
162854485|NCT03539432|588171419|FG000|Overall Study|Lost to Follow-up|0|||
162854486|NCT03539432|588171420|FG001|Overall Study|Lost to Follow-up|1|||
162854487|NCT01381094|588171421|FG000|Overall Study|Adverse Event|1|||
162854488|NCT01381094|588171422|FG001|Overall Study|Adverse Event|2|||
162854489|NCT01381094|588171423|FG002|Overall Study|Adverse Event|0|||
162854490|NCT01381094|588171424|FG003|Overall Study|Adverse Event|1|||
162854491|NCT01381094|588171425|FG004|Overall Study|Adverse Event|0|||
162854492|NCT01381094|588171421|FG000|Overall Study|Lost to Follow-up|0|||
162854493|NCT01381094|588171422|FG001|Overall Study|Lost to Follow-up|0|||
162854494|NCT01381094|588171423|FG002|Overall Study|Lost to Follow-up|0|||
162854495|NCT01381094|588171424|FG003|Overall Study|Lost to Follow-up|0|||
162854496|NCT01381094|588171425|FG004|Overall Study|Lost to Follow-up|1|||
162854497|NCT01381094|588171421|FG000|Overall Study|Withdrawal of informed consent|0|||
162854498|NCT01381094|588171422|FG001|Overall Study|Withdrawal of informed consent|1|||
162854499|NCT01381094|588171423|FG002|Overall Study|Withdrawal of informed consent|0|||
163043853|NCT03283930|588868183|FG000|Overall Study|Technical software issue|2|||
163043854|NCT03283930|588868184|FG001|Overall Study|Technical software issue|2|||
163043855|NCT00805129|588868185|FG000|Overall Study|Not treated|1|||
163043856|NCT00571662|588868186|FG000|Overall Study|Withdrawal by Subject|2|||
163043857|NCT00571662|588868186|FG000|Overall Study|psychiatric instability|1|||
163043858|NCT00571662|588868186|FG000|Overall Study|Adverse Event|5|||
163043859|NCT03681184|588868189|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
163043860|NCT03681184|588868190|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
163043861|NCT02787083|588868195|FG000|Overall Study|Adverse Event|1|||
163043862|NCT02787083|588868196|FG001|Overall Study|Adverse Event|0|||
163043863|NCT02787083|588868195|FG000|Overall Study|Withdrawal by Subject|2|||
163043864|NCT02787083|588868196|FG001|Overall Study|Withdrawal by Subject|2|||
163043865|NCT02710084|588868197|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
163043866|NCT02710084|588868198|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
163043867|NCT02453256|588868203|FG000|Double Blind Period|Death|1|||
163043868|NCT02453256|588868204|FG001|Double Blind Period|Death|1|||
163043869|NCT02453256|588868203|FG000|Double Blind Period|Adverse Event|3|||
163043870|NCT02453256|588868204|FG001|Double Blind Period|Adverse Event|2|||
163043871|NCT02453256|588868203|FG000|Double Blind Period|Withdrawal by Subject|9|||
163043872|NCT02453256|588868204|FG001|Double Blind Period|Withdrawal by Subject|5|||
163043873|NCT02453256|588868203|FG000|Double Blind Period|Other|0|||
163043874|NCT02453256|588868204|FG001|Double Blind Period|Other|1|||
163043875|NCT02453256|588868203|FG000|Open Label Period|Adverse Event|1|||
163043876|NCT02453256|588868204|FG001|Open Label Period|Adverse Event|3|||
163043877|NCT02453256|588868203|FG000|Open Label Period|Death|0|||
163043878|NCT02453256|588868204|FG001|Open Label Period|Death|1|||
163043879|NCT02453256|588868203|FG000|Open Label Period|Lost to Follow-up|1|||
163043880|NCT02453256|588868204|FG001|Open Label Period|Lost to Follow-up|0|||
162854500|NCT01381094|588171424|FG003|Overall Study|Withdrawal of informed consent|0|||
162854501|NCT01381094|588171425|FG004|Overall Study|Withdrawal of informed consent|0|||
162854502|NCT01381094|588171421|FG000|Overall Study|Participant given Aranesp injection|1|||
162854503|NCT01381094|588171422|FG001|Overall Study|Participant given Aranesp injection|0|||
162854504|NCT01381094|588171423|FG002|Overall Study|Participant given Aranesp injection|0|||
162854505|NCT01381094|588171424|FG003|Overall Study|Participant given Aranesp injection|0|||
162854506|NCT01381094|588171425|FG004|Overall Study|Participant given Aranesp injection|0|||
162854507|NCT02443402|588171428|FG000|Overall Study|Withdrawal by Subject|3|||
162854508|NCT02443402|588171429|FG001|Overall Study|Withdrawal by Subject|1|||
162854509|NCT02443402|588171428|FG000|Overall Study|Screen Failure|1|||
162854510|NCT02443402|588171429|FG001|Overall Study|Screen Failure|2|||
162854511|NCT01934504|588171431|FG000|Overall Study|Protocol Deviation|0|||
162854512|NCT01934504|588171432|FG001|Overall Study|Protocol Deviation|0|||
162854513|NCT01934504|588171433|FG002|Overall Study|Protocol Deviation|0|||
162854514|NCT01934504|588171434|FG003|Overall Study|Protocol Deviation|2|||
162854515|NCT01934504|588171431|FG000|Overall Study|Study Terminated by Sponsor|1|||
162854516|NCT01934504|588171432|FG001|Overall Study|Study Terminated by Sponsor|0|||
162854517|NCT01934504|588171433|FG002|Overall Study|Study Terminated by Sponsor|5|||
162854518|NCT01934504|588171434|FG003|Overall Study|Study Terminated by Sponsor|5|||
162854519|NCT02665689|588171435|FG000|Overall Study|Adverse Event|1|||
162854520|NCT02665689|588171436|FG001|Overall Study|Adverse Event|0|||
162854521|NCT02665689|588171435|FG000|Overall Study|Trial termination|1|||
162854522|NCT02665689|588171436|FG001|Overall Study|Trial termination|1|||
162854523|NCT02665689|588171435|FG000|Overall Study|Lost to Follow-up|0|||
162854524|NCT02665689|588171436|FG001|Overall Study|Lost to Follow-up|1|||
162854525|NCT00996840|588171443|FG000|Overall Study|Adverse Event|0|||
162854526|NCT00996840|588171444|FG001|Overall Study|Adverse Event|1|||
162854527|NCT00996840|588171445|FG002|Overall Study|Adverse Event|0|||
162854528|NCT00996840|588171446|FG003|Overall Study|Adverse Event|0|||
162854529|NCT00996840|588171447|FG004|Overall Study|Adverse Event|0|||
162854530|NCT00996840|588171443|FG000|Overall Study|Physician Decision|0|||
162854531|NCT00996840|588171444|FG001|Overall Study|Physician Decision|0|||
162854532|NCT00996840|588171445|FG002|Overall Study|Physician Decision|1|||
162854533|NCT00996840|588171446|FG003|Overall Study|Physician Decision|1|||
162854534|NCT00996840|588171447|FG004|Overall Study|Physician Decision|2|||
162854535|NCT00996840|588171443|FG000|Overall Study|Withdrawal by Subject|1|||
162854536|NCT00996840|588171444|FG001|Overall Study|Withdrawal by Subject|1|||
162854537|NCT00996840|588171445|FG002|Overall Study|Withdrawal by Subject|0|||
162854538|NCT00996840|588171446|FG003|Overall Study|Withdrawal by Subject|0|||
162854539|NCT00996840|588171447|FG004|Overall Study|Withdrawal by Subject|0|||
162854540|NCT02292849|588171448|FG000|Overall Study|Lost to Follow-up|0|||
162854541|NCT02292849|588171449|FG001|Overall Study|Lost to Follow-up|2|||
162854542|NCT02292849|588171450|FG002|Overall Study|Lost to Follow-up|2|||
162854543|NCT02292849|588171448|FG000|Overall Study|Physician Decision|4|||
163043881|NCT02453256|588868203|FG000|Open Label Period|Other|0|||
162854544|NCT02292849|588171449|FG001|Overall Study|Physician Decision|0|||
162854545|NCT02292849|588171450|FG002|Overall Study|Physician Decision|0|||
162854546|NCT01562028|588171452|FG000|Overall Study|Withdrawal by Subject|1|||
162854547|NCT01562028|588171453|FG001|Overall Study|Withdrawal by Subject|1|||
163043882|NCT02453256|588868204|FG001|Open Label Period|Other|2|||
162954934|NCT01597245|588537661|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954935|NCT01597245|588537662|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954936|NCT01597245|588537663|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954937|NCT01597245|588537664|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954938|NCT01597245|588537665|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954939|NCT01597245|588537666|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954940|NCT01597245|588537667|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954941|NCT01597245|588537668|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954942|NCT01597245|588537669|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
162954943|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954944|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954945|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954946|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954947|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954948|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954949|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954950|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954951|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954952|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954953|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954954|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954955|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954956|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
162954957|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
162954958|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
162954959|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954960|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954961|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954962|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954963|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162954964|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954965|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954966|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954967|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954968|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954969|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954970|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954971|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954972|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954973|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954974|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954975|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954976|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954977|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
162954978|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
162954979|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
162954980|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954981|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954982|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954983|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954984|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162954985|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954986|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954987|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954988|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954989|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954990|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954991|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954992|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954993|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954994|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954995|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954996|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
163043883|NCT02453256|588868203|FG000|Open Label Period|Withdrawal by Subject|5|||
162611688|NCT01074047|587294998|FG000|Treatment Phase|Adverse Event|89|||
162611689|NCT01074047|587294999|FG001|Treatment Phase|Adverse Event|66|||
162611690|NCT01074047|587294998|FG000|Treatment Phase|Disease Progression|16|||
162611691|NCT01074047|587294999|FG001|Treatment Phase|Disease Progression|21|||
162611692|NCT01074047|587294998|FG000|Treatment Phase|Withdrawal by Subject|27|||
162611693|NCT01074047|587294999|FG001|Treatment Phase|Withdrawal by Subject|48|||
162611694|NCT01074047|587294998|FG000|Treatment Phase|Death|53|||
162611695|NCT01074047|587294999|FG001|Treatment Phase|Death|58|||
162611696|NCT01074047|587294998|FG000|Treatment Phase|Lost to Follow-up|0|||
162611697|NCT01074047|587294999|FG001|Treatment Phase|Lost to Follow-up|1|||
162611698|NCT01074047|587294998|FG000|Treatment Phase|Protocol Violation|0|||
162611699|NCT01074047|587294999|FG001|Treatment Phase|Protocol Violation|1|||
162611700|NCT01074047|587294998|FG000|Treatment Phase|Miscellaneous|32|||
162611701|NCT01074047|587294999|FG001|Treatment Phase|Miscellaneous|39|||
162611702|NCT01074047|587294998|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
162704689|NCT02015663|587630444|FG000|Overall Study|Withdrawal by Subject|1|||
162954997|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954998|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162954999|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
162955000|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
162955001|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955002|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955003|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955004|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955005|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162955006|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955007|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955008|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955009|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955010|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955011|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955012|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955013|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955014|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955015|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955016|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955017|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955018|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955019|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955020|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
162955021|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
162955022|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955023|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955024|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955025|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955026|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
162955027|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955028|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955029|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955030|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955031|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955032|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955033|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955034|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955035|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955036|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955037|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955038|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955039|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955040|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
162955041|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
162955042|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
162955043|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955044|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162611703|NCT01074047|587294999|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
162854548|NCT01562028|588171452|FG000|Overall Study|Lost to Follow-up|2|||
162854549|NCT01562028|588171453|FG001|Overall Study|Lost to Follow-up|1|||
162854550|NCT04938648|588171454|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
162854551|NCT04938648|588171455|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
162854552|NCT04938648|588171454|FG000|Overall Study|Patient too ill|0|||
162854553|NCT04938648|588171455|FG001|Overall Study|Patient too ill|1|||
162854554|NCT04938648|588171454|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
162854555|NCT04938648|588171455|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
162854556|NCT04938648|588171454|FG000|Overall Study|Patient did not have memory problems|1|||
162854557|NCT04938648|588171455|FG001|Overall Study|Patient did not have memory problems|1|||
162854558|NCT04938648|588171454|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
162854559|NCT04938648|588171455|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
162854560|NCT04938648|588171454|FG000|Overall Study|Care partner could not be reached|0|||
162854561|NCT04938648|588171455|FG001|Overall Study|Care partner could not be reached|1|||
162854562|NCT04938648|588171454|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
162854563|NCT04938648|588171455|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
162854564|NCT04938648|588171454|FG000|Overall Study|Withdrawal by Subject|2|||
162854565|NCT04938648|588171455|FG001|Overall Study|Withdrawal by Subject|1|||
162854566|NCT00775021|588171456|FG000|First Intervention|Lost to Follow-up|1|||
162854567|NCT00775021|588171457|FG001|First Intervention|Lost to Follow-up|0|||
162854568|NCT00775021|588171456|FG000|Second Intervention|Adverse Event|0|||
162854569|NCT00775021|588171457|FG001|Second Intervention|Adverse Event|1|||
162854570|NCT01287754|588171458|FG000|Overall Study|Death|2|||
162854571|NCT01287754|588171459|FG001|Overall Study|Death|12|||
162854572|NCT01287754|588171458|FG000|Overall Study|Lost to Follow-up|1|||
162854573|NCT01287754|588171459|FG001|Overall Study|Lost to Follow-up|6|||
162854574|NCT01287754|588171458|FG000|Overall Study|Protocol Violation|0|||
162854575|NCT01287754|588171459|FG001|Overall Study|Protocol Violation|3|||
162854576|NCT04439266|588171460|FG000|Overall Study|Ineligible|1|||
162854577|NCT04439266|588171460|FG000|Overall Study|Adverse Event|1|||
162854578|NCT04439266|588171460|FG000|Overall Study|Death|1|||
162854579|NCT04439266|588171460|FG000|Overall Study|Disease progression|1|||
162854580|NCT04439266|588171460|FG000|Overall Study|Still on treatment|1|||
162854581|NCT05027802|588171462|FG000|Overall Study|Adverse Event|2|||
162854582|NCT05027802|588171462|FG000|Overall Study|Withdrawal by Subject|18|||
162854583|NCT05027802|588171462|FG000|Overall Study|Death|2|||
162854584|NCT05027802|588171462|FG000|Overall Study|Other|1|||
162854585|NCT06161012|588171463|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
162854586|NCT06161012|588171464|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
162854587|NCT00408005|588171465|FG000|Induction|Adverse Event|19|||
162854588|NCT00408005|588171466|FG001|Induction|Adverse Event|3|||
162854589|NCT00408005|588171467|FG002|Induction|Adverse Event|0|||
162854590|NCT00408005|588171468|FG003|Induction|Adverse Event|0|||
162854591|NCT00408005|588171469|FG004|Induction|Adverse Event|0|||
162854592|NCT00408005|588171470|FG005|Induction|Adverse Event|0|||
162854593|NCT00408005|588171471|FG006|Induction|Adverse Event|0|||
162854594|NCT00408005|588171472|FG007|Induction|Adverse Event|0|||
162854595|NCT00408005|588171465|FG000|Induction|Death|6|||
162854596|NCT00408005|588171466|FG001|Induction|Death|0|||
162854597|NCT00408005|588171467|FG002|Induction|Death|0|||
162854598|NCT00408005|588171468|FG003|Induction|Death|0|||
162854599|NCT00408005|588171469|FG004|Induction|Death|0|||
162854600|NCT00408005|588171470|FG005|Induction|Death|0|||
162854601|NCT00408005|588171471|FG006|Induction|Death|0|||
162854602|NCT00408005|588171472|FG007|Induction|Death|0|||
162854603|NCT00408005|588171465|FG000|Induction|Physician Decision|83|||
162854604|NCT00408005|588171466|FG001|Induction|Physician Decision|9|||
162854605|NCT00408005|588171467|FG002|Induction|Physician Decision|0|||
162854606|NCT00408005|588171468|FG003|Induction|Physician Decision|0|||
162854607|NCT00408005|588171469|FG004|Induction|Physician Decision|0|||
162854608|NCT00408005|588171470|FG005|Induction|Physician Decision|0|||
162854609|NCT00408005|588171471|FG006|Induction|Physician Decision|0|||
162854610|NCT00408005|588171472|FG007|Induction|Physician Decision|0|||
162854611|NCT00408005|588171465|FG000|Induction|Withdrawal by Subject|2|||
162854612|NCT00408005|588171466|FG001|Induction|Withdrawal by Subject|4|||
162854613|NCT00408005|588171467|FG002|Induction|Withdrawal by Subject|0|||
162854614|NCT00408005|588171468|FG003|Induction|Withdrawal by Subject|0|||
162854615|NCT00408005|588171469|FG004|Induction|Withdrawal by Subject|0|||
162854616|NCT00408005|588171470|FG005|Induction|Withdrawal by Subject|0|||
162854617|NCT00408005|588171471|FG006|Induction|Withdrawal by Subject|0|||
162854618|NCT00408005|588171472|FG007|Induction|Withdrawal by Subject|0|||
162854619|NCT00408005|588171465|FG000|Induction|Ineligible|33|||
162854620|NCT00408005|588171466|FG001|Induction|Ineligible|14|||
162854621|NCT00408005|588171467|FG002|Induction|Ineligible|0|||
162854622|NCT00408005|588171468|FG003|Induction|Ineligible|0|||
162854623|NCT00408005|588171469|FG004|Induction|Ineligible|0|||
162854624|NCT00408005|588171470|FG005|Induction|Ineligible|0|||
162854625|NCT00408005|588171471|FG006|Induction|Ineligible|0|||
162854626|NCT00408005|588171472|FG007|Induction|Ineligible|0|||
162854627|NCT00408005|588171465|FG000|Induction|Refusal of Further Protocol Therapy|225|||
162704690|NCT02015663|587630445|FG001|Overall Study|Withdrawal by Subject|0|||
162854628|NCT00408005|588171466|FG001|Induction|Refusal of Further Protocol Therapy|44|||
162854629|NCT00408005|588171467|FG002|Induction|Refusal of Further Protocol Therapy|0|||
163043884|NCT02453256|588868204|FG001|Open Label Period|Withdrawal by Subject|1|||
163043885|NCT01243177|588868206|FG000|Overall Study|Lack of Efficacy|47|||
163043886|NCT01243177|588868207|FG001|Overall Study|Lack of Efficacy|31|||
163043887|NCT01243177|588868206|FG000|Overall Study|Protocol Violation|11|||
163043888|NCT01243177|588868207|FG001|Overall Study|Protocol Violation|10|||
163043889|NCT01243177|588868206|FG000|Overall Study|Lost to Follow-up|15|||
163043890|NCT01243177|588868207|FG001|Overall Study|Lost to Follow-up|18|||
163043891|NCT01243177|588868206|FG000|Overall Study|Withdrawal by Subject|46|||
163043892|NCT01243177|588868207|FG001|Overall Study|Withdrawal by Subject|38|||
163043893|NCT01243177|588868206|FG000|Overall Study|AE, serious fatal|0|||
163043894|NCT01243177|588868207|FG001|Overall Study|AE, serious fatal|1|||
163043895|NCT01243177|588868206|FG000|Overall Study|SAE, non-fatal|7|||
163043896|NCT01243177|588868207|FG001|Overall Study|SAE, non-fatal|9|||
163043897|NCT01243177|588868206|FG000|Overall Study|AE, non-serious non-fatal|40|||
163043898|NCT01243177|588868207|FG001|Overall Study|AE, non-serious non-fatal|58|||
162854630|NCT00408005|588171468|FG003|Induction|Refusal of Further Protocol Therapy|0|||
162854631|NCT00408005|588171469|FG004|Induction|Refusal of Further Protocol Therapy|0|||
162854632|NCT00408005|588171470|FG005|Induction|Refusal of Further Protocol Therapy|0|||
162854633|NCT00408005|588171471|FG006|Induction|Refusal of Further Protocol Therapy|0|||
162854634|NCT00408005|588171472|FG007|Induction|Refusal of Further Protocol Therapy|0|||
162854635|NCT00408005|588171465|FG000|Induction|Entered another COG therapeutic protocol|4|||
162854636|NCT00408005|588171466|FG001|Induction|Entered another COG therapeutic protocol|0|||
162854637|NCT00408005|588171467|FG002|Induction|Entered another COG therapeutic protocol|0|||
162854638|NCT00408005|588171468|FG003|Induction|Entered another COG therapeutic protocol|0|||
162854639|NCT00408005|588171469|FG004|Induction|Entered another COG therapeutic protocol|0|||
162854640|NCT00408005|588171470|FG005|Induction|Entered another COG therapeutic protocol|0|||
162854641|NCT00408005|588171471|FG006|Induction|Entered another COG therapeutic protocol|0|||
162854642|NCT00408005|588171472|FG007|Induction|Entered another COG therapeutic protocol|0|||
162854643|NCT00408005|588171465|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
162854644|NCT00408005|588171466|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
162854645|NCT00408005|588171467|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
162854646|NCT00408005|588171468|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
162854647|NCT00408005|588171469|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
162854648|NCT00408005|588171470|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
162854649|NCT00408005|588171471|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
162854650|NCT00408005|588171472|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
162854651|NCT00408005|588171465|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
162854652|NCT00408005|588171466|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
162854653|NCT00408005|588171467|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
162854654|NCT00408005|588171468|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
162955045|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955046|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955047|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
162955048|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955049|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955050|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955051|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955052|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955053|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955054|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955055|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
163043899|NCT01243177|588868206|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
163043900|NCT01243177|588868207|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
163043901|NCT01243177|588868206|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163043902|NCT01243177|588868207|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
163043903|NCT01243177|588868206|FG000|Overall Study|Other Reason|11|||
162704691|NCT02015663|587630444|FG000|Overall Study|Protocol Violation|0|||
162704692|NCT02015663|587630445|FG001|Overall Study|Protocol Violation|1|||
162854655|NCT00408005|588171469|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
162854656|NCT00408005|588171470|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
162854657|NCT00408005|588171471|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
162854658|NCT00408005|588171472|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
162854659|NCT00408005|588171465|FG000|Induction|Progressive Disease|0|||
162854660|NCT00408005|588171466|FG001|Induction|Progressive Disease|1|||
162854661|NCT00408005|588171467|FG002|Induction|Progressive Disease|0|||
162854662|NCT00408005|588171468|FG003|Induction|Progressive Disease|0|||
162854663|NCT00408005|588171469|FG004|Induction|Progressive Disease|0|||
162854664|NCT00408005|588171470|FG005|Induction|Progressive Disease|0|||
162854665|NCT00408005|588171471|FG006|Induction|Progressive Disease|0|||
162854666|NCT00408005|588171472|FG007|Induction|Progressive Disease|0|||
162854667|NCT00408005|588171465|FG000|Induction|Inevaluable|18|||
162854668|NCT00408005|588171466|FG001|Induction|Inevaluable|14|||
162854669|NCT00408005|588171467|FG002|Induction|Inevaluable|0|||
162704693|NCT02015663|587630444|FG000|Overall Study|Adverse Event|3|||
162704694|NCT02015663|587630445|FG001|Overall Study|Adverse Event|0|||
162854670|NCT00408005|588171468|FG003|Induction|Inevaluable|0|||
162854671|NCT00408005|588171469|FG004|Induction|Inevaluable|0|||
162854672|NCT00408005|588171470|FG005|Induction|Inevaluable|0|||
162854673|NCT00408005|588171471|FG006|Induction|Inevaluable|0|||
162854674|NCT00408005|588171472|FG007|Induction|Inevaluable|0|||
162854675|NCT00408005|588171465|FG000|Induction|Failed to Complete Randomization|3|||
162854676|NCT00408005|588171466|FG001|Induction|Failed to Complete Randomization|2|||
162854677|NCT00408005|588171467|FG002|Induction|Failed to Complete Randomization|0|||
162854678|NCT00408005|588171468|FG003|Induction|Failed to Complete Randomization|0|||
162854679|NCT00408005|588171469|FG004|Induction|Failed to Complete Randomization|0|||
162854680|NCT00408005|588171470|FG005|Induction|Failed to Complete Randomization|0|||
162854681|NCT00408005|588171471|FG006|Induction|Failed to Complete Randomization|0|||
162854682|NCT00408005|588171472|FG007|Induction|Failed to Complete Randomization|0|||
162854683|NCT00408005|588171465|FG000|Induction|Protocol Deviation|3|||
162854684|NCT00408005|588171466|FG001|Induction|Protocol Deviation|1|||
162854685|NCT00408005|588171467|FG002|Induction|Protocol Deviation|0|||
162854686|NCT00408005|588171468|FG003|Induction|Protocol Deviation|0|||
162854687|NCT00408005|588171469|FG004|Induction|Protocol Deviation|0|||
162854688|NCT00408005|588171470|FG005|Induction|Protocol Deviation|0|||
162854689|NCT00408005|588171471|FG006|Induction|Protocol Deviation|0|||
162854690|NCT00408005|588171472|FG007|Induction|Protocol Deviation|0|||
162854691|NCT00408005|588171465|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
162854692|NCT00408005|588171466|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854693|NCT00408005|588171467|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854694|NCT00408005|588171468|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854695|NCT00408005|588171469|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854696|NCT00408005|588171470|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854697|NCT00408005|588171471|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854698|NCT00408005|588171472|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
162854699|NCT00408005|588171465|FG000|Induction|Recurrent leukemia|1|||
162854700|NCT00408005|588171466|FG001|Induction|Recurrent leukemia|0|||
162854701|NCT00408005|588171467|FG002|Induction|Recurrent leukemia|0|||
162955056|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955057|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955058|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955059|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955060|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955061|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955062|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
162955063|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
162955064|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955065|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955066|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955067|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955068|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
162955069|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162704695|NCT02015663|587630444|FG000|Overall Study|Administrative problems|10|||
162854702|NCT00408005|588171468|FG003|Induction|Recurrent leukemia|0|||
162854703|NCT00408005|588171469|FG004|Induction|Recurrent leukemia|0|||
162854704|NCT00408005|588171470|FG005|Induction|Recurrent leukemia|0|||
162854705|NCT00408005|588171471|FG006|Induction|Recurrent leukemia|0|||
162955070|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162854706|NCT00408005|588171472|FG007|Induction|Recurrent leukemia|0|||
162854707|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
162854708|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
162854709|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
162854710|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
163043904|NCT01243177|588868207|FG001|Overall Study|Other Reason|12|||
163043905|NCT05259163|588869363|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
162854711|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
162854712|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
162854713|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
162854714|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
162854715|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
162854716|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
162854717|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
162854718|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
162854719|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
162854720|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
163043906|NCT05259163|588869364|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
163043907|NCT05251233|588869365|FG000|Overall Study|Disease progression - did not start treatment|0|||
163043908|NCT05251233|588869366|FG001|Overall Study|Disease progression - did not start treatment|0|||
163043909|NCT05251233|588869367|FG002|Overall Study|Disease progression - did not start treatment|5|||
163043910|NCT05251233|588869365|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
163043911|NCT05251233|588869366|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
162611704|NCT01074047|587294998|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
162854721|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
162854722|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
162854723|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854724|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854725|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
162854726|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854727|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
162854728|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854729|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854730|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
162854731|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
162854732|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
162854733|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
162854734|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
162854735|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
162854736|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
162854737|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
162854738|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
162854739|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
162854740|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
162854741|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
162854742|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
162854743|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
162854744|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
162854745|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
162854746|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
162854747|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
162854748|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
162854749|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
162854750|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
162854751|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
162854752|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
162854753|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
162854754|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
162854755|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854756|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854757|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854758|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854759|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
162854760|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854761|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854762|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
162854763|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
162854764|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
162854765|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
162854766|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
162854767|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
162854768|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
162854769|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
162854770|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
162854771|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
162854772|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
162854773|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
162854774|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
162854775|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
162854776|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
162854777|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
162854778|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
162854779|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854780|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162704696|NCT02015663|587630445|FG001|Overall Study|Administrative problems|11|||
162854781|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854782|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854783|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854784|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
162854785|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854786|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
162854787|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
162854788|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
162854789|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
162854790|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
162854791|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
162854792|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
162854793|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
162854794|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
162854795|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854796|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854797|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854798|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854799|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
162854800|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
162854801|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854802|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
162854803|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
162854804|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
162854805|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
162854806|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
162854807|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
162854808|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
162854809|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
162854810|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
162854811|NCT00408005|588171465|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
162854812|NCT00408005|588171466|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
162854813|NCT00408005|588171467|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
162854814|NCT00408005|588171468|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
162854815|NCT00408005|588171469|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
162854816|NCT00408005|588171470|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
162854817|NCT00408005|588171471|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
162854818|NCT00408005|588171472|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
162955071|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955072|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955073|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955074|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955075|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955076|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955077|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955078|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955079|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955080|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955081|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955082|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955083|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
162955084|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
162955085|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955086|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955087|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955088|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955089|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
162955090|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955091|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955092|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955093|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955094|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955095|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955096|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955097|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955098|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955099|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955100|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955101|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955102|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955103|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955104|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
162955105|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
162955106|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955107|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955108|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955109|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955110|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
162955111|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955112|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955113|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955114|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955115|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955116|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955117|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955118|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955119|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955120|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955121|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955122|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955123|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955124|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955125|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
162955126|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
162955127|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955128|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955129|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955130|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162955131|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
162704697|NCT02059161|587630447|FG000|Overall Study|Pregnancy|0|||
162854819|NCT05817045|588171473|FG000|Overall Study|Protocol Violation|0|||
162854820|NCT05817045|588171474|FG001|Overall Study|Protocol Violation|3|||
162854821|NCT05817045|588171473|FG000|Overall Study|Withdrawal by Subject|10|||
162854822|NCT05817045|588171474|FG001|Overall Study|Withdrawal by Subject|7|||
162854823|NCT05817045|588171473|FG000|Overall Study|Physician Decision|3|||
162704698|NCT02059161|587630448|FG001|Overall Study|Pregnancy|2|||
162704699|NCT02059161|587630447|FG000|Overall Study|Adverse Event|2|||
162854824|NCT05817045|588171474|FG001|Overall Study|Physician Decision|0|||
162854825|NCT05817045|588171473|FG000|Overall Study|Lost to Follow-up|0|||
162854826|NCT05817045|588171474|FG001|Overall Study|Lost to Follow-up|1|||
162854827|NCT05817045|588171473|FG000|Overall Study|Device Deficiency|1|||
162854828|NCT05817045|588171474|FG001|Overall Study|Device Deficiency|0|||
162854829|NCT05817045|588171473|FG000|Overall Study|System Error|1|||
162854830|NCT05817045|588171474|FG001|Overall Study|System Error|0|||
162854831|NCT01506141|588171475|FG000|Overall Study|Adverse Event|0|||
162854832|NCT01506141|588171476|FG001|Overall Study|Adverse Event|2|||
162854833|NCT01506141|588171475|FG000|Overall Study|Participation Terminated by Investigator|1|||
162854834|NCT01506141|588171476|FG001|Overall Study|Participation Terminated by Investigator|1|||
162854835|NCT01506141|588171475|FG000|Overall Study|Site Terminated by Sponsor|2|||
162854836|NCT01506141|588171476|FG001|Overall Study|Site Terminated by Sponsor|0|||
162854837|NCT01506141|588171475|FG000|Overall Study|Reason Not Specified|4|||
162854838|NCT01506141|588171476|FG001|Overall Study|Reason Not Specified|2|||
162854839|NCT04607408|588171477|FG000|Overall Study|Lost to Follow-up|0|||
162854840|NCT04607408|588171478|FG001|Overall Study|Lost to Follow-up|0|||
162854841|NCT04607408|588171479|FG002|Overall Study|Lost to Follow-up|0|||
162854842|NCT04607408|588171480|FG003|Overall Study|Lost to Follow-up|1|||
162854843|NCT04607408|588171481|FG004|Overall Study|Lost to Follow-up|0|||
162854844|NCT04607408|588171477|FG000|Overall Study|Withdrawal by Subject|0|||
162854845|NCT04607408|588171478|FG001|Overall Study|Withdrawal by Subject|1|||
162854846|NCT04607408|588171479|FG002|Overall Study|Withdrawal by Subject|0|||
162854847|NCT04607408|588171480|FG003|Overall Study|Withdrawal by Subject|1|||
162854848|NCT04607408|588171481|FG004|Overall Study|Withdrawal by Subject|0|||
162854849|NCT03619213|588171488|FG000|Overall Study|Lost to Follow-up|2|||
162854850|NCT03619213|588171489|FG001|Overall Study|Lost to Follow-up|1|||
162854851|NCT03619213|588171488|FG000|Overall Study|Withdrawal by Subject|8|||
162854852|NCT03619213|588171489|FG001|Overall Study|Withdrawal by Subject|10|||
162854853|NCT00382967|588171490|FG000|Overall Study|Protocol Violation|1|||
162854854|NCT00382967|588171491|FG001|Overall Study|Protocol Violation|1|||
162854855|NCT00501228|588171493|FG000|Overall Study|Withdrawal by Subject|1|||
162854856|NCT00461175|588171494|FG000|Overall Study|Protocol Violation|522|||
162854857|NCT00461175|588171495|FG001|Overall Study|Protocol Violation|365|||
162854858|NCT00316264|588171497|FG000|Overall Study|Lost to Follow-up|0|||
162854859|NCT00316264|588171498|FG001|Overall Study|Lost to Follow-up|1|||
162854860|NCT00316264|588171499|FG002|Overall Study|Lost to Follow-up|0|||
162854861|NCT00316264|588171497|FG000|Overall Study|Withdrawal of Consent|3|||
162854862|NCT00316264|588171498|FG001|Overall Study|Withdrawal of Consent|5|||
162854863|NCT00316264|588171499|FG002|Overall Study|Withdrawal of Consent|6|||
162854864|NCT00316264|588171497|FG000|Overall Study|Death|2|||
162854865|NCT00316264|588171498|FG001|Overall Study|Death|0|||
162854866|NCT00316264|588171499|FG002|Overall Study|Death|0|||
162854867|NCT00316264|588171497|FG000|Overall Study|Other|1|||
162854868|NCT00316264|588171498|FG001|Overall Study|Other|1|||
162854869|NCT00316264|588171499|FG002|Overall Study|Other|0|||
162854870|NCT02209506|588171502|FG000|Overall Study|Withdrawal by Subject|0|||
162854871|NCT02209506|588171503|FG001|Overall Study|Withdrawal by Subject|0|||
162854872|NCT02209506|588171504|FG002|Overall Study|Withdrawal by Subject|0|||
162611705|NCT01074047|587294999|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
162611706|NCT01074047|587294998|FG000|Survival Follow-Up Phase|Death|116|||
162611707|NCT01074047|587294999|FG001|Survival Follow-Up Phase|Death|124|||
162611708|NCT01074047|587294998|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
162611709|NCT01074047|587294999|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
162611710|NCT01074047|587294998|FG000|Extension Phase|Physician Decision|1|||
162611711|NCT01074047|587294999|FG001|Extension Phase|Physician Decision|0|||
162611712|NCT01074047|587294998|FG000|Extension Phase|Adverse Event|5|||
162955132|NCT01597245|588537649|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955133|NCT01597245|588537650|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955134|NCT01597245|588537651|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955135|NCT01597245|588537652|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955136|NCT01597245|588537653|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955137|NCT01597245|588537654|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955138|NCT01597245|588537655|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955139|NCT01597245|588537656|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955140|NCT01597245|588537657|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955141|NCT01597245|588537658|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955142|NCT01597245|588537659|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955143|NCT01597245|588537660|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955144|NCT01597245|588537661|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955145|NCT01597245|588537662|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
162955146|NCT01597245|588537663|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955147|NCT01597245|588537664|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955148|NCT01597245|588537665|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955149|NCT01597245|588537666|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955150|NCT01597245|588537667|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955151|NCT01597245|588537668|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955152|NCT01597245|588537669|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
162955153|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955154|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955155|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955156|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955157|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955158|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955159|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955160|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955161|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955162|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955163|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955164|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955165|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955166|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955167|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955168|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162955169|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
162955170|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
162955171|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
162955172|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
162955173|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
162955174|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955175|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955176|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955177|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955178|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955179|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955180|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955181|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955182|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955183|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955184|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162704700|NCT02059161|587630448|FG001|Overall Study|Adverse Event|6|||
162611713|NCT01074047|587294999|FG001|Extension Phase|Adverse Event|0|||
162611714|NCT01074047|587294998|FG000|Extension Phase|Disease Progression|9|||
163043912|NCT05251233|588869367|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
163043913|NCT05251233|588869365|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
163043914|NCT05251233|588869366|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
163043915|NCT05251233|588869367|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
163043916|NCT05251233|588869365|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
163043917|NCT05251233|588869366|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
163043918|NCT05251233|588869367|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
163043919|NCT05251233|588869365|FG000|Overall Study|Death - did not start treatment|3|||
163043920|NCT05251233|588869366|FG001|Overall Study|Death - did not start treatment|0|||
163043921|NCT05251233|588869367|FG002|Overall Study|Death - did not start treatment|0|||
163043922|NCT05251233|588869365|FG000|Overall Study|Withdrawal by Subject|2|||
163043923|NCT05251233|588869366|FG001|Overall Study|Withdrawal by Subject|2|||
163043924|NCT05251233|588869367|FG002|Overall Study|Withdrawal by Subject|0|||
163043925|NCT05251233|588869365|FG000|Overall Study|Other complicating disease|2|||
163043926|NCT05251233|588869366|FG001|Overall Study|Other complicating disease|1|||
163043927|NCT05251233|588869367|FG002|Overall Study|Other complicating disease|0|||
162854873|NCT02209506|588171505|FG003|Overall Study|Withdrawal by Subject|0|||
162854874|NCT02209506|588171506|FG004|Overall Study|Withdrawal by Subject|1|||
162854875|NCT02203149|588171507|FG000|Part 1|Adverse Event|0|||
162854876|NCT02203149|588171508|FG001|Part 1|Adverse Event|1|||
162854877|NCT02203149|588171509|FG002|Part 1|Adverse Event|0|||
162854878|NCT02203149|588171510|FG003|Part 1|Adverse Event|0|||
162854879|NCT02203149|588171511|FG004|Part 1|Adverse Event|0|||
162854880|NCT02203149|588171507|FG000|Part 2|Death|0|||
162854881|NCT02203149|588171508|FG001|Part 2|Death|0|||
162854882|NCT02203149|588171509|FG002|Part 2|Death|1|||
162854883|NCT02203149|588171510|FG003|Part 2|Death|1|||
162854884|NCT02203149|588171511|FG004|Part 2|Death|0|||
162854885|NCT02203149|588171507|FG000|Part 2|Withdrawal by Subject|0|||
162854886|NCT02203149|588171508|FG001|Part 2|Withdrawal by Subject|0|||
162854887|NCT02203149|588171509|FG002|Part 2|Withdrawal by Subject|0|||
162854888|NCT02203149|588171510|FG003|Part 2|Withdrawal by Subject|1|||
162854889|NCT02203149|588171511|FG004|Part 2|Withdrawal by Subject|0|||
162854890|NCT02203149|588171507|FG000|Part 2|Adverse Event|0|||
162854891|NCT02203149|588171508|FG001|Part 2|Adverse Event|0|||
162854892|NCT02203149|588171509|FG002|Part 2|Adverse Event|0|||
162854893|NCT02203149|588171510|FG003|Part 2|Adverse Event|1|||
162854894|NCT02203149|588171511|FG004|Part 2|Adverse Event|1|||
162854895|NCT02537678|588171512|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
162854896|NCT02537678|588171513|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
162854897|NCT02537678|588171512|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
162854898|NCT02537678|588171513|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
162854899|NCT02537678|588171512|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
162854900|NCT02537678|588171513|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
162854901|NCT02537678|588171512|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
162854902|NCT02537678|588171513|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
162854903|NCT02537678|588171512|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
162854904|NCT02537678|588171513|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
162854905|NCT02537678|588171512|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
162854906|NCT02537678|588171513|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
162854907|NCT02537678|588171512|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
162854908|NCT02537678|588171513|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
162854909|NCT04348851|588171514|FG000|Post-Test 1|Withdrawal by Subject|0|||
162854910|NCT04348851|588171515|FG001|Post-Test 1|Withdrawal by Subject|1|||
162854911|NCT04348851|588171516|FG002|Post-Test 1|Withdrawal by Subject|0|||
162854912|NCT04348851|588171517|FG003|Post-Test 1|Withdrawal by Subject|0|||
162854913|NCT04348851|588171514|FG000|Post-Test 1|Lost to Follow-up|0|||
162854914|NCT04348851|588171515|FG001|Post-Test 1|Lost to Follow-up|1|||
162854915|NCT04348851|588171516|FG002|Post-Test 1|Lost to Follow-up|0|||
162854916|NCT04348851|588171517|FG003|Post-Test 1|Lost to Follow-up|0|||
162854917|NCT04348851|588171514|FG000|Post-Test 2|Stroke survivor death|0|||
162854918|NCT04348851|588171515|FG001|Post-Test 2|Stroke survivor death|1|||
162854919|NCT04348851|588171516|FG002|Post-Test 2|Stroke survivor death|0|||
162854920|NCT04348851|588171517|FG003|Post-Test 2|Stroke survivor death|1|||
162854921|NCT00195650|588171518|FG000|Overall Study|Adverse Event|194|||
162854922|NCT00195650|588171518|FG000|Overall Study|Lack of Efficacy|99|||
162854923|NCT00195650|588171518|FG000|Overall Study|Withdrawal by Subject|67|||
162854924|NCT00195650|588171518|FG000|Overall Study|Lost to Follow-up|44|||
162854925|NCT00195650|588171518|FG000|Overall Study|Death|23|||
162854926|NCT00195650|588171518|FG000|Overall Study|Protocol Violation|15|||
162854927|NCT00195650|588171518|FG000|Overall Study|Administrative reasons|83|||
162854928|NCT00432809|588171519|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
162955185|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955186|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955187|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955188|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955189|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955190|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
162955191|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
162955192|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
162955193|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
162955194|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
162955195|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955196|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955197|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955198|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955199|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955200|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955201|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955202|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955203|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955204|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955205|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955206|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955207|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955208|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955209|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955210|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955211|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
162955212|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955213|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
162955214|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
162955215|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
162955216|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955217|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955218|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955219|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955220|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955221|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955222|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955223|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955224|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955225|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955226|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955227|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955228|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955229|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955230|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955231|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955232|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955233|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
162955234|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
162955235|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
162955236|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
162955237|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955238|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955239|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955240|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955241|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955242|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955243|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955244|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955245|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955246|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162704701|NCT02059161|587630447|FG000|Overall Study|Lost to Follow-up|20|||
162854929|NCT00432809|588171520|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
162854930|NCT00432809|588171521|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
162854931|NCT00432809|588171519|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
162854932|NCT00432809|588171520|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
162854933|NCT00432809|588171521|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
162854934|NCT01499290|588171522|FG000|Overall Study|Withdrawal by Subject|22|||
162854935|NCT01499290|588171523|FG001|Overall Study|Withdrawal by Subject|15|||
162854936|NCT01499290|588171522|FG000|Overall Study|Not specified in study report|11|||
162854937|NCT01499290|588171523|FG001|Overall Study|Not specified in study report|5|||
162854938|NCT01499290|588171522|FG000|Overall Study|Condition improved/subject recovered|1|||
162854939|NCT01499290|588171523|FG001|Overall Study|Condition improved/subject recovered|0|||
162854940|NCT01499290|588171522|FG000|Overall Study|Lack of Efficacy|7|||
162854941|NCT01499290|588171523|FG001|Overall Study|Lack of Efficacy|8|||
162854942|NCT01499290|588171522|FG000|Overall Study|Adverse Event|14|||
162854943|NCT01499290|588171523|FG001|Overall Study|Adverse Event|7|||
162854944|NCT00552110|588171524|FG000|Overall Study|Serious or Life-Threatening AE|0|||
162854945|NCT00552110|588171525|FG001|Overall Study|Serious or Life-Threatening AE|0|||
162854946|NCT00552110|588171526|FG002|Overall Study|Serious or Life-Threatening AE|1|||
162854947|NCT00552110|588171527|FG003|Overall Study|Serious or Life-Threatening AE|0|||
162854948|NCT00552110|588171528|FG004|Overall Study|Serious or Life-Threatening AE|0|||
162854949|NCT00552110|588171524|FG000|Overall Study|Lack of Efficacy|1|||
162854950|NCT00552110|588171525|FG001|Overall Study|Lack of Efficacy|0|||
162854951|NCT00552110|588171526|FG002|Overall Study|Lack of Efficacy|0|||
162854952|NCT00552110|588171527|FG003|Overall Study|Lack of Efficacy|1|||
162854953|NCT00552110|588171528|FG004|Overall Study|Lack of Efficacy|4|||
162854954|NCT00552110|588171524|FG000|Overall Study|Withdrawal by Subject|0|||
162854955|NCT00552110|588171525|FG001|Overall Study|Withdrawal by Subject|2|||
162854956|NCT00552110|588171526|FG002|Overall Study|Withdrawal by Subject|0|||
162854957|NCT00552110|588171527|FG003|Overall Study|Withdrawal by Subject|3|||
162854958|NCT00552110|588171528|FG004|Overall Study|Withdrawal by Subject|2|||
162854959|NCT00552110|588171524|FG000|Overall Study|Lost to Follow-up|0|||
162854960|NCT00552110|588171525|FG001|Overall Study|Lost to Follow-up|0|||
162854961|NCT00552110|588171526|FG002|Overall Study|Lost to Follow-up|0|||
162854962|NCT00552110|588171527|FG003|Overall Study|Lost to Follow-up|1|||
162854963|NCT00552110|588171528|FG004|Overall Study|Lost to Follow-up|1|||
162854964|NCT00552110|588171524|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
162854965|NCT00552110|588171525|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
162854966|NCT00552110|588171526|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
162854967|NCT00552110|588171527|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
162854968|NCT00552110|588171528|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
162854969|NCT00552110|588171524|FG000|Overall Study|Withdrawn per Sponsor|0|||
162854970|NCT00552110|588171525|FG001|Overall Study|Withdrawn per Sponsor|1|||
162854971|NCT00552110|588171526|FG002|Overall Study|Withdrawn per Sponsor|0|||
162854972|NCT00552110|588171527|FG003|Overall Study|Withdrawn per Sponsor|0|||
162854973|NCT00552110|588171528|FG004|Overall Study|Withdrawn per Sponsor|1|||
162854974|NCT00552110|588171524|FG000|Overall Study|Use of Prohibited Medication|1|||
162854975|NCT00552110|588171525|FG001|Overall Study|Use of Prohibited Medication|1|||
162854976|NCT00552110|588171526|FG002|Overall Study|Use of Prohibited Medication|0|||
162704702|NCT02059161|587630448|FG001|Overall Study|Lost to Follow-up|12|||
162704703|NCT02059161|587630447|FG000|Overall Study|Physician Decision|4|||
162704704|NCT02059161|587630448|FG001|Overall Study|Physician Decision|4|||
162704705|NCT02059161|587630447|FG000|Overall Study|Protocol Violation|1|||
162704706|NCT02059161|587630448|FG001|Overall Study|Protocol Violation|1|||
162704707|NCT02059161|587630447|FG000|Overall Study|Withdrawal by Subject|16|||
162704708|NCT02059161|587630448|FG001|Overall Study|Withdrawal by Subject|13|||
162704709|NCT02059161|587630447|FG000|Overall Study|Randomized in error, no study drug|0|||
162704710|NCT02059161|587630448|FG001|Overall Study|Randomized in error, no study drug|1|||
162704711|NCT02059161|587630447|FG000|Overall Study|Non-compliance with study drug|6|||
162854977|NCT00552110|588171527|FG003|Overall Study|Use of Prohibited Medication|0|||
162854978|NCT00552110|588171528|FG004|Overall Study|Use of Prohibited Medication|0|||
162854979|NCT00552110|588171524|FG000|Overall Study|Delay of Study due to Relabeling|0|||
162854980|NCT00552110|588171525|FG001|Overall Study|Delay of Study due to Relabeling|0|||
162854981|NCT00552110|588171526|FG002|Overall Study|Delay of Study due to Relabeling|0|||
162854982|NCT00552110|588171527|FG003|Overall Study|Delay of Study due to Relabeling|1|||
162854983|NCT00552110|588171528|FG004|Overall Study|Delay of Study due to Relabeling|0|||
162854984|NCT00552110|588171524|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
162854985|NCT00552110|588171525|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
162854986|NCT00552110|588171526|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
162854987|NCT00552110|588171527|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
162854988|NCT00552110|588171528|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
162854989|NCT00552110|588171524|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
162854990|NCT00552110|588171525|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
162854991|NCT00552110|588171526|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
162854992|NCT00552110|588171527|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
162854993|NCT00552110|588171528|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
162854994|NCT00700804|588171529|FG000|Overall Study|Withdrawal by Subject|1|||
162854995|NCT00700804|588171530|FG001|Overall Study|Withdrawal by Subject|2|||
162854996|NCT00700804|588171529|FG000|Overall Study|Protocol Violation|1|||
162854997|NCT00700804|588171530|FG001|Overall Study|Protocol Violation|1|||
162854998|NCT00700804|588171529|FG000|Overall Study|Loose Stools|1|||
162854999|NCT00700804|588171530|FG001|Overall Study|Loose Stools|1|||
162855000|NCT05775289|588171531|FG000|Overall Study|Study Ongoing|20|||
162855001|NCT05775289|588171532|FG001|Overall Study|Study Ongoing|53|||
162855002|NCT05775289|588171533|FG002|Overall Study|Study Ongoing|15|||
162855003|NCT05775289|588171534|FG003|Overall Study|Study Ongoing|55|||
162855004|NCT05775289|588171531|FG000|Overall Study|Death|4|||
162855005|NCT05775289|588171532|FG001|Overall Study|Death|11|||
162855006|NCT05775289|588171533|FG002|Overall Study|Death|8|||
162855007|NCT05775289|588171534|FG003|Overall Study|Death|12|||
162855008|NCT05775289|588171531|FG000|Overall Study|Lost to Follow-up|0|||
162855009|NCT05775289|588171532|FG001|Overall Study|Lost to Follow-up|1|||
162855010|NCT05775289|588171533|FG002|Overall Study|Lost to Follow-up|0|||
162855011|NCT05775289|588171534|FG003|Overall Study|Lost to Follow-up|0|||
162855012|NCT05775289|588171531|FG000|Overall Study|Progressive Disease|0|||
162855013|NCT05775289|588171532|FG001|Overall Study|Progressive Disease|0|||
162855014|NCT05775289|588171533|FG002|Overall Study|Progressive Disease|1|||
162855015|NCT05775289|588171534|FG003|Overall Study|Progressive Disease|0|||
162855016|NCT05775289|588171531|FG000|Overall Study|Withdrawal by Subject|1|||
162855017|NCT05775289|588171532|FG001|Overall Study|Withdrawal by Subject|1|||
162855018|NCT05775289|588171533|FG002|Overall Study|Withdrawal by Subject|0|||
162855019|NCT05775289|588171534|FG003|Overall Study|Withdrawal by Subject|0|||
162855020|NCT01587989|588171539|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
162855021|NCT01587989|588171540|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
162855022|NCT01587989|588171541|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
162855023|NCT01587989|588171539|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
163043928|NCT05251233|588869365|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
162855024|NCT01587989|588171540|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
162855025|NCT01587989|588171541|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
162855026|NCT01587989|588171539|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
162855027|NCT01587989|588171540|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
162855028|NCT01587989|588171541|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
162855029|NCT01587989|588171539|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
162855030|NCT01587989|588171540|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
162855031|NCT01587989|588171541|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
163043929|NCT05251233|588869366|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
163043930|NCT05251233|588869367|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
163043931|NCT05251233|588869365|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
163043932|NCT05251233|588869366|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
163043933|NCT05251233|588869367|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
163043934|NCT00588146|588869381|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
163043935|NCT00588146|588869382|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
162855032|NCT01587989|588171539|FG000|Randomized Study Treatment|Screening failure|0|||
162855033|NCT01587989|588171540|FG001|Randomized Study Treatment|Screening failure|1|||
162855034|NCT01587989|588171541|FG002|Randomized Study Treatment|Screening failure|0|||
162855035|NCT01587989|588171539|FG000|Randomized Study Treatment|Physician Decision|0|||
162855036|NCT01587989|588171540|FG001|Randomized Study Treatment|Physician Decision|0|||
162855037|NCT01587989|588171541|FG002|Randomized Study Treatment|Physician Decision|1|||
162855038|NCT03313050|588171542|FG000|Stage 2: 12 Months|Adverse Event|0|||
162855039|NCT03313050|588171543|FG001|Stage 2: 12 Months|Adverse Event|0|||
162855040|NCT03313050|588171544|FG002|Stage 2: 12 Months|Adverse Event|0|||
162855041|NCT03313050|588171545|FG003|Stage 2: 12 Months|Adverse Event|1|||
162855042|NCT03313050|588171542|FG000|Stage 2: 12 Months|Death|0|||
162855043|NCT03313050|588171543|FG001|Stage 2: 12 Months|Death|0|||
162855044|NCT03313050|588171544|FG002|Stage 2: 12 Months|Death|3|||
162855045|NCT03313050|588171545|FG003|Stage 2: 12 Months|Death|0|||
162855046|NCT03313050|588171542|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
162855047|NCT03313050|588171543|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
162855048|NCT03313050|588171544|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
162855049|NCT03313050|588171545|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
163043936|NCT02100839|588869383|FG000|Multiple Ascending Dose|Adverse Event|2|||
162855050|NCT03313050|588171542|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
162855051|NCT03313050|588171543|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
162855052|NCT03313050|588171544|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
162855053|NCT03313050|588171545|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
163043937|NCT02100839|588869384|FG001|Multiple Ascending Dose|Adverse Event|0|||
163043938|NCT02100839|588869383|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
162855054|NCT03313050|588171542|FG000|Stage 2: 12 Months|Protocol deviation|0|||
162855055|NCT03313050|588171543|FG001|Stage 2: 12 Months|Protocol deviation|0|||
162855056|NCT03313050|588171544|FG002|Stage 2: 12 Months|Protocol deviation|7|||
162855057|NCT03313050|588171545|FG003|Stage 2: 12 Months|Protocol deviation|7|||
162855058|NCT03313050|588171542|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
162855059|NCT03313050|588171543|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
162855060|NCT03313050|588171544|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
162855061|NCT03313050|588171545|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
162855062|NCT03313050|588171542|FG000|Stage 2: 12 Months|Other|0|||
162855063|NCT03313050|588171543|FG001|Stage 2: 12 Months|Other|0|||
162855064|NCT03313050|588171544|FG002|Stage 2: 12 Months|Other|0|||
162855065|NCT03313050|588171545|FG003|Stage 2: 12 Months|Other|1|||
162855066|NCT04211337|588171546|FG000|Overall Study|On Treatment|175|||
162855067|NCT04211337|588171547|FG001|Overall Study|On Treatment|40|||
162855068|NCT04211337|588171546|FG000|Overall Study|Withdrawal by Subject|0|||
162855069|NCT04211337|588171547|FG001|Overall Study|Withdrawal by Subject|2|||
162855070|NCT01291017|588171548|FG000|Overall Study|Lost to Follow-up|2|||
162855071|NCT01291017|588171548|FG000|Overall Study|Withdrawal by Subject|3|||
162855072|NCT05630846|588173635|FG000|Overall Study|Death|1|||
162855073|NCT05630846|588173636|FG001|Overall Study|Death|0|||
162855074|NCT05630846|588173637|FG002|Overall Study|Death|0|||
162855075|NCT05630846|588173638|FG003|Overall Study|Death|0|||
162855076|NCT05630846|588173635|FG000|Overall Study|Withdrawal by Subject|3|||
162855077|NCT05630846|588173636|FG001|Overall Study|Withdrawal by Subject|3|||
162855078|NCT05630846|588173637|FG002|Overall Study|Withdrawal by Subject|4|||
162855079|NCT05630846|588173638|FG003|Overall Study|Withdrawal by Subject|1|||
162855080|NCT05630846|588173635|FG000|Overall Study|Lost to Follow-up|6|||
162855081|NCT05630846|588173636|FG001|Overall Study|Lost to Follow-up|5|||
162855082|NCT05630846|588173637|FG002|Overall Study|Lost to Follow-up|2|||
162855083|NCT05630846|588173638|FG003|Overall Study|Lost to Follow-up|5|||
162855084|NCT05630846|588173635|FG000|Overall Study|Other|1|||
162855085|NCT05630846|588173636|FG001|Overall Study|Other|0|||
162855086|NCT05630846|588173637|FG002|Overall Study|Other|0|||
162855087|NCT05630846|588173638|FG003|Overall Study|Other|0|||
162855088|NCT01431287|588173639|FG000|Overall Study|not treated|0|||
162855089|NCT01431287|588173640|FG001|Overall Study|not treated|0|||
162855090|NCT01431287|588173641|FG002|Overall Study|not treated|1|||
162855091|NCT01431287|588173642|FG003|Overall Study|not treated|0|||
162855092|NCT01431287|588173643|FG004|Overall Study|not treated|0|||
162855093|NCT01431287|588173639|FG000|Overall Study|Adverse Event|59|||
162855094|NCT01431287|588173640|FG001|Overall Study|Adverse Event|57|||
162855095|NCT01431287|588173641|FG002|Overall Study|Adverse Event|53|||
162855096|NCT01431287|588173642|FG003|Overall Study|Adverse Event|33|||
162855097|NCT01431287|588173643|FG004|Overall Study|Adverse Event|41|||
162855098|NCT01431287|588173639|FG000|Overall Study|Non compliant with protocol|6|||
162855099|NCT01431287|588173640|FG001|Overall Study|Non compliant with protocol|6|||
162855100|NCT01431287|588173641|FG002|Overall Study|Non compliant with protocol|5|||
162855101|NCT01431287|588173642|FG003|Overall Study|Non compliant with protocol|6|||
162855102|NCT01431287|588173643|FG004|Overall Study|Non compliant with protocol|5|||
162855103|NCT01431287|588173639|FG000|Overall Study|Lost to Follow-up|0|||
162855104|NCT01431287|588173640|FG001|Overall Study|Lost to Follow-up|3|||
162855105|NCT01431287|588173641|FG002|Overall Study|Lost to Follow-up|2|||
162704712|NCT02059161|587630448|FG001|Overall Study|Non-compliance with study drug|2|||
162855106|NCT01431287|588173642|FG003|Overall Study|Lost to Follow-up|3|||
162855107|NCT01431287|588173643|FG004|Overall Study|Lost to Follow-up|1|||
162855108|NCT01431287|588173639|FG000|Overall Study|Consent withdrawn not due to AE|29|||
162855109|NCT01431287|588173640|FG001|Overall Study|Consent withdrawn not due to AE|30|||
162855110|NCT01431287|588173641|FG002|Overall Study|Consent withdrawn not due to AE|34|||
162855111|NCT01431287|588173642|FG003|Overall Study|Consent withdrawn not due to AE|19|||
162855112|NCT01431287|588173643|FG004|Overall Study|Consent withdrawn not due to AE|29|||
162855113|NCT01431287|588173639|FG000|Overall Study|not stated above|4|||
162855114|NCT01431287|588173640|FG001|Overall Study|not stated above|2|||
162855115|NCT01431287|588173641|FG002|Overall Study|not stated above|2|||
162855116|NCT01431287|588173642|FG003|Overall Study|not stated above|2|||
162855117|NCT01431287|588173643|FG004|Overall Study|not stated above|1|||
162855118|NCT03019549|588173644|FG000|Washout|DId not meet genotype criteria|11|||
162855119|NCT03019549|588173644|FG000|Period 2|Adverse Event|2|||
162855120|NCT03019549|588173644|FG000|Period 2|Physician Decision|2|||
162855121|NCT03019549|588173644|FG000|Period 2|Withdrawal by Subject|1|||
162855122|NCT01412879|588173645|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
162855123|NCT01412879|588173646|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
162855124|NCT01412879|588173647|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
162855125|NCT01412879|588173645|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
162855126|NCT01412879|588173646|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
162855127|NCT01412879|588173647|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
162855128|NCT01412879|588173645|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
162855129|NCT01412879|588173646|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
162855130|NCT01412879|588173647|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
162855131|NCT01412879|588173645|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
162855132|NCT01412879|588173646|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
162855133|NCT01412879|588173647|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
162855134|NCT01412879|588173645|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
162855135|NCT01412879|588173646|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
162855136|NCT01412879|588173647|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
162855137|NCT04030195|588173648|FG000|Overall Study|Withdrawal by Subject|2|||
162855138|NCT04030195|588173649|FG001|Overall Study|Withdrawal by Subject|0|||
162855139|NCT04030195|588173650|FG002|Overall Study|Withdrawal by Subject|0|||
162855140|NCT03323749|588173659|FG000|Double-blind Period|Lost to Follow-up|4|||
162855141|NCT03323749|588173660|FG001|Double-blind Period|Lost to Follow-up|5|||
162855142|NCT03323749|588173659|FG000|Double-blind Period|Adverse Event|3|||
162855143|NCT03323749|588173660|FG001|Double-blind Period|Adverse Event|1|||
162855144|NCT03323749|588173659|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
162855145|NCT03323749|588173660|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
162855146|NCT03323749|588173659|FG000|Open-Label Period|Adverse Event|3|||
162855147|NCT03323749|588173660|FG001|Open-Label Period|Adverse Event|10|||
162855148|NCT03323749|588173659|FG000|Open-Label Period|Withdrawal by Subject|7|||
162855149|NCT03323749|588173660|FG001|Open-Label Period|Withdrawal by Subject|5|||
162855150|NCT00603239|588173663|FG000|Overall Study|Adverse Event|4|||
162855151|NCT00603239|588173664|FG001|Overall Study|Adverse Event|1|||
162855152|NCT00603239|588173663|FG000|Overall Study|Entry criteria not met|0|||
162855153|NCT00603239|588173664|FG001|Overall Study|Entry criteria not met|1|||
162855154|NCT00603239|588173663|FG000|Overall Study|Loss of glucose control|3|||
162855155|NCT00603239|588173664|FG001|Overall Study|Loss of glucose control|0|||
162855156|NCT00603239|588173663|FG000|Overall Study|Lost to Follow-up|2|||
162855157|NCT00603239|588173664|FG001|Overall Study|Lost to Follow-up|1|||
162855158|NCT00603239|588173663|FG000|Overall Study|Physician Decision|2|||
162855159|NCT00603239|588173664|FG001|Overall Study|Physician Decision|0|||
162855160|NCT00603239|588173663|FG000|Overall Study|Protocol Violation|2|||
162855161|NCT00603239|588173664|FG001|Overall Study|Protocol Violation|0|||
162855162|NCT00603239|588173663|FG000|Overall Study|Subject decision|2|||
162855163|NCT00603239|588173664|FG001|Overall Study|Subject decision|1|||
162855164|NCT02210780|588173665|FG000|Overall Study|Adverse Event|0|||
162855165|NCT02210780|588173666|FG001|Overall Study|Adverse Event|5|||
162855166|NCT02210780|588173665|FG000|Overall Study|Lost to Follow-up|2|||
162855167|NCT02210780|588173666|FG001|Overall Study|Lost to Follow-up|1|||
162855168|NCT02210780|588173665|FG000|Overall Study|Withdrawal by Subject|1|||
162855169|NCT02210780|588173666|FG001|Overall Study|Withdrawal by Subject|1|||
162855170|NCT02210780|588173665|FG000|Overall Study|Physician Decision|1|||
162855171|NCT02210780|588173666|FG001|Overall Study|Physician Decision|0|||
162855172|NCT02210780|588173665|FG000|Overall Study|Protocol Violation|1|||
162855173|NCT02210780|588173666|FG001|Overall Study|Protocol Violation|0|||
162855174|NCT02210780|588173665|FG000|Overall Study|Other than specified above|0|||
162855175|NCT02210780|588173666|FG001|Overall Study|Other than specified above|1|||
162855176|NCT00097539|588173667|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
162855177|NCT00097539|588173668|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
162855178|NCT00097539|588173669|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
162855179|NCT00097539|588173670|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
162855180|NCT00097539|588173671|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
162855181|NCT00097539|588173672|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
162855182|NCT00097539|588173673|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
162855183|NCT00097539|588173667|FG000|Overall Study|Withdrawal by Subject|925|||
162855184|NCT00097539|588173668|FG001|Overall Study|Withdrawal by Subject|323|||
162855185|NCT00097539|588173669|FG002|Overall Study|Withdrawal by Subject|346|||
162855186|NCT00097539|588173670|FG003|Overall Study|Withdrawal by Subject|217|||
162855187|NCT00097539|588173671|FG004|Overall Study|Withdrawal by Subject|68|||
162855188|NCT00097539|588173672|FG005|Overall Study|Withdrawal by Subject|229|||
162855189|NCT00097539|588173673|FG006|Overall Study|Withdrawal by Subject|3|||
162855190|NCT00097539|588173667|FG000|Overall Study|Participant Non-compliant|2140|||
162855191|NCT00097539|588173668|FG001|Overall Study|Participant Non-compliant|567|||
162855192|NCT00097539|588173669|FG002|Overall Study|Participant Non-compliant|1067|||
162855193|NCT00097539|588173670|FG003|Overall Study|Participant Non-compliant|353|||
162855194|NCT00097539|588173671|FG004|Overall Study|Participant Non-compliant|136|||
162855195|NCT00097539|588173672|FG005|Overall Study|Participant Non-compliant|543|||
162855196|NCT00097539|588173673|FG006|Overall Study|Participant Non-compliant|18|||
162955247|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955248|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955249|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955250|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162855197|NCT00097539|588173667|FG000|Overall Study|Lack of Efficacy|249|||
162855198|NCT00097539|588173668|FG001|Overall Study|Lack of Efficacy|122|||
162855199|NCT00097539|588173669|FG002|Overall Study|Lack of Efficacy|202|||
162855200|NCT00097539|588173670|FG003|Overall Study|Lack of Efficacy|105|||
162855201|NCT00097539|588173671|FG004|Overall Study|Lack of Efficacy|45|||
162855202|NCT00097539|588173672|FG005|Overall Study|Lack of Efficacy|228|||
162855203|NCT00097539|588173673|FG006|Overall Study|Lack of Efficacy|5|||
162855204|NCT00097539|588173667|FG000|Overall Study|Adverse Event|78|||
162855205|NCT00097539|588173668|FG001|Overall Study|Adverse Event|133|||
162855206|NCT00097539|588173669|FG002|Overall Study|Adverse Event|37|||
162855207|NCT00097539|588173670|FG003|Overall Study|Adverse Event|27|||
162855208|NCT00097539|588173671|FG004|Overall Study|Adverse Event|30|||
162855209|NCT00097539|588173672|FG005|Overall Study|Adverse Event|59|||
162855210|NCT00097539|588173673|FG006|Overall Study|Adverse Event|1|||
162855211|NCT00097539|588173667|FG000|Overall Study|Death|2|||
162855212|NCT00097539|588173668|FG001|Overall Study|Death|7|||
162855213|NCT00097539|588173669|FG002|Overall Study|Death|0|||
162855214|NCT00097539|588173670|FG003|Overall Study|Death|0|||
162855215|NCT00097539|588173671|FG004|Overall Study|Death|1|||
162855216|NCT00097539|588173672|FG005|Overall Study|Death|3|||
162855217|NCT00097539|588173673|FG006|Overall Study|Death|0|||
162855218|NCT00097539|588173667|FG000|Overall Study|Reasons Other Than Above|3602|||
162855219|NCT00097539|588173668|FG001|Overall Study|Reasons Other Than Above|1382|||
162855220|NCT00097539|588173669|FG002|Overall Study|Reasons Other Than Above|1757|||
162855221|NCT00097539|588173670|FG003|Overall Study|Reasons Other Than Above|692|||
162855222|NCT00097539|588173671|FG004|Overall Study|Reasons Other Than Above|361|||
162855223|NCT00097539|588173672|FG005|Overall Study|Reasons Other Than Above|1244|||
162855224|NCT00097539|588173673|FG006|Overall Study|Reasons Other Than Above|34|||
162855225|NCT00097539|588173667|FG000|Overall Study|Reason not Specified|111|||
162855226|NCT00097539|588173668|FG001|Overall Study|Reason not Specified|49|||
162855227|NCT00097539|588173669|FG002|Overall Study|Reason not Specified|53|||
162855228|NCT00097539|588173670|FG003|Overall Study|Reason not Specified|21|||
162855229|NCT00097539|588173671|FG004|Overall Study|Reason not Specified|11|||
162855230|NCT00097539|588173672|FG005|Overall Study|Reason not Specified|40|||
162855231|NCT00097539|588173673|FG006|Overall Study|Reason not Specified|2|||
162855232|NCT00364793|588173674|FG000|Overall Study|Adverse Event|2|||
162855233|NCT00364793|588173675|FG001|Overall Study|Adverse Event|0|||
162855234|NCT00364793|588173676|FG002|Overall Study|Adverse Event|0|||
162855235|NCT00364793|588173677|FG003|Overall Study|Adverse Event|0|||
162855236|NCT00364793|588173674|FG000|Overall Study|Death|1|||
162855237|NCT00364793|588173675|FG001|Overall Study|Death|0|||
162855238|NCT00364793|588173676|FG002|Overall Study|Death|1|||
162855239|NCT00364793|588173677|FG003|Overall Study|Death|0|||
162855240|NCT00364793|588173674|FG000|Overall Study|Lack of Efficacy|3|||
162855241|NCT00364793|588173675|FG001|Overall Study|Lack of Efficacy|3|||
162855242|NCT00364793|588173676|FG002|Overall Study|Lack of Efficacy|1|||
162855243|NCT00364793|588173677|FG003|Overall Study|Lack of Efficacy|1|||
162855244|NCT00364793|588173674|FG000|Overall Study|Lost to Follow-up|1|||
162855245|NCT00364793|588173675|FG001|Overall Study|Lost to Follow-up|0|||
162855246|NCT00364793|588173676|FG002|Overall Study|Lost to Follow-up|2|||
162855247|NCT00364793|588173677|FG003|Overall Study|Lost to Follow-up|0|||
162855248|NCT00364793|588173674|FG000|Overall Study|Poor or non-compliance|1|||
162855249|NCT00364793|588173675|FG001|Overall Study|Poor or non-compliance|1|||
162855250|NCT00364793|588173676|FG002|Overall Study|Poor or non-compliance|0|||
162855251|NCT00364793|588173677|FG003|Overall Study|Poor or non-compliance|1|||
162855252|NCT00364793|588173674|FG000|Overall Study|No longer meets criteria|0|||
162855253|NCT00364793|588173675|FG001|Overall Study|No longer meets criteria|0|||
162855254|NCT00364793|588173676|FG002|Overall Study|No longer meets criteria|0|||
162855255|NCT00364793|588173677|FG003|Overall Study|No longer meets criteria|1|||
162855256|NCT00364793|588173674|FG000|Overall Study|Withdrawal by Subject|0|||
162855257|NCT00364793|588173675|FG001|Overall Study|Withdrawal by Subject|1|||
162855258|NCT00364793|588173676|FG002|Overall Study|Withdrawal by Subject|0|||
162855259|NCT00364793|588173677|FG003|Overall Study|Withdrawal by Subject|0|||
162855260|NCT05127486|588173678|FG000|Overall Study|Adverse Event|2|||
162955251|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162855261|NCT05127486|588173679|FG001|Overall Study|Adverse Event|4|||
162855262|NCT05127486|588173678|FG000|Overall Study|Lack of Efficacy|1|||
162855263|NCT05127486|588173679|FG001|Overall Study|Lack of Efficacy|0|||
162855264|NCT05127486|588173678|FG000|Overall Study|Pregnancy|0|||
162855265|NCT05127486|588173679|FG001|Overall Study|Pregnancy|1|||
162855266|NCT05127486|588173678|FG000|Overall Study|Physician Decision|4|||
162855267|NCT05127486|588173679|FG001|Overall Study|Physician Decision|1|||
162855268|NCT05127486|588173678|FG000|Overall Study|Withdrawal by Subject|14|||
162855269|NCT05127486|588173679|FG001|Overall Study|Withdrawal by Subject|13|||
162855270|NCT05127486|588173678|FG000|Overall Study|Lost to Follow-up|5|||
162855271|NCT05127486|588173679|FG001|Overall Study|Lost to Follow-up|8|||
162855272|NCT00363415|588173683|FG000|Overall Study|Progressive Disease|196|||
162855273|NCT00363415|588173684|FG001|Overall Study|Progressive Disease|107|||
162855274|NCT00363415|588173683|FG000|Overall Study|Sponsor Decision|67|||
162855275|NCT00363415|588173684|FG001|Overall Study|Sponsor Decision|31|||
162855276|NCT00363415|588173683|FG000|Overall Study|Death|32|||
162855277|NCT00363415|588173684|FG001|Overall Study|Death|29|||
162855278|NCT00363415|588173683|FG000|Overall Study|Adverse Event|24|||
162855279|NCT00363415|588173684|FG001|Overall Study|Adverse Event|15|||
162855280|NCT00363415|588173683|FG000|Overall Study|Physician Decision|18|||
162855281|NCT00363415|588173684|FG001|Overall Study|Physician Decision|35|||
162855282|NCT00363415|588173683|FG000|Overall Study|Entry Criteria Not Met|11|||
162855283|NCT00363415|588173684|FG001|Overall Study|Entry Criteria Not Met|10|||
162855284|NCT00363415|588173683|FG000|Overall Study|Withdrawal by Subject|9|||
162855285|NCT00363415|588173684|FG001|Overall Study|Withdrawal by Subject|15|||
162855286|NCT00363415|588173683|FG000|Overall Study|Lost to Follow-up|3|||
162855287|NCT00363415|588173684|FG001|Overall Study|Lost to Follow-up|3|||
162855288|NCT00363415|588173683|FG000|Overall Study|Protocol Violation|1|||
162855289|NCT00363415|588173684|FG001|Overall Study|Protocol Violation|4|||
162855290|NCT02688647|588173703|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
162855291|NCT02688647|588173704|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
162855292|NCT02688647|588173703|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
162855293|NCT02688647|588173704|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
162855294|NCT02688647|588173703|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
162855295|NCT02688647|588173704|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
162855296|NCT02688647|588173703|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
162855297|NCT02688647|588173704|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
162855298|NCT02688647|588173703|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
162855299|NCT02688647|588173704|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
162855300|NCT02688647|588173703|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
162855301|NCT02688647|588173704|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
162855302|NCT02688647|588173703|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
162855303|NCT02688647|588173704|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
162855304|NCT02542267|588173705|FG000|Overall Study|Withdrawal by Subject|10|||
162855305|NCT02542267|588173705|FG000|Overall Study|Physician Decision|6|||
162855306|NCT02542267|588173705|FG000|Overall Study|Lost to Follow-up|4|||
162855307|NCT02542267|588173705|FG000|Overall Study|Death|13|||
162855308|NCT02542267|588173705|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
162855309|NCT02542267|588173705|FG000|Overall Study|Other|9|||
162855310|NCT03093402|588173706|FG000|Overall Study|Lost to Follow-up|1|||
162855311|NCT03093402|588173707|FG001|Overall Study|Lost to Follow-up|0|||
162855312|NCT03093402|588173708|FG002|Overall Study|Lost to Follow-up|0|||
162855313|NCT03093402|588173709|FG003|Overall Study|Lost to Follow-up|0|||
162855314|NCT03093402|588173706|FG000|Overall Study|Withdrawal by Subject|3|||
162855315|NCT03093402|588173707|FG001|Overall Study|Withdrawal by Subject|3|||
162855316|NCT03093402|588173708|FG002|Overall Study|Withdrawal by Subject|0|||
162855317|NCT03093402|588173709|FG003|Overall Study|Withdrawal by Subject|1|||
162855318|NCT03093402|588173706|FG000|Overall Study|Withdrew prior to dosing|2|||
162855319|NCT03093402|588173707|FG001|Overall Study|Withdrew prior to dosing|1|||
162855320|NCT03093402|588173708|FG002|Overall Study|Withdrew prior to dosing|2|||
162855321|NCT03093402|588173709|FG003|Overall Study|Withdrew prior to dosing|3|||
162855322|NCT03093402|588173706|FG000|Overall Study|Ineligible for study|1|||
162855323|NCT03093402|588173707|FG001|Overall Study|Ineligible for study|0|||
162855324|NCT03093402|588173708|FG002|Overall Study|Ineligible for study|0|||
162855325|NCT03093402|588173709|FG003|Overall Study|Ineligible for study|0|||
162855326|NCT03093402|588173706|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
162855327|NCT03093402|588173707|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
162855328|NCT03093402|588173708|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
162855329|NCT03093402|588173709|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
162855330|NCT01147497|588173714|FG000|Overall Study|failed insertion|2|||
162855331|NCT01147497|588173715|FG001|Overall Study|failed insertion|0|||
162855332|NCT02731742|588173716|FG000|Overall Study|Death|1|||
162855333|NCT02731742|588173717|FG001|Overall Study|Death|2|||
162855334|NCT02731742|588173718|FG002|Overall Study|Death|5|||
162855335|NCT02731742|588173719|FG003|Overall Study|Death|0|||
162855336|NCT02731742|588173716|FG000|Overall Study|Physician Decision|0|||
162855337|NCT02731742|588173717|FG001|Overall Study|Physician Decision|0|||
162855338|NCT02731742|588173718|FG002|Overall Study|Physician Decision|0|||
162855339|NCT02731742|588173719|FG003|Overall Study|Physician Decision|1|||
162855340|NCT02731742|588173716|FG000|Overall Study|Study Terminated by Sponsor|2|||
162855341|NCT02731742|588173717|FG001|Overall Study|Study Terminated by Sponsor|1|||
162855342|NCT02731742|588173718|FG002|Overall Study|Study Terminated by Sponsor|1|||
162855343|NCT02731742|588173719|FG003|Overall Study|Study Terminated by Sponsor|1|||
162955252|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955253|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
162855344|NCT04026568|588173720|FG000|Overall Study|study terminated|0|||
162855345|NCT04026568|588173721|FG001|Overall Study|study terminated|1|||
162855346|NCT01974323|588173722|FG000|Overall Study|Other Reasons|25|||
162855347|NCT01974323|588173723|FG001|Overall Study|Other Reasons|28|||
162855348|NCT01974323|588173722|FG000|Overall Study|Protocol Violation|2|||
162855349|NCT01974323|588173723|FG001|Overall Study|Protocol Violation|2|||
162855350|NCT01974323|588173722|FG000|Overall Study|Personal Reasons|15|||
162855351|NCT01974323|588173723|FG001|Overall Study|Personal Reasons|19|||
162855352|NCT01974323|588173722|FG000|Overall Study|Lost to Follow-up|45|||
162855353|NCT01974323|588173723|FG001|Overall Study|Lost to Follow-up|40|||
162855354|NCT01974323|588173722|FG000|Overall Study|Pregnancy|2|||
162855355|NCT01974323|588173723|FG001|Overall Study|Pregnancy|1|||
162855356|NCT01974323|588173722|FG000|Overall Study|Lack of Efficacy|1|||
162855357|NCT01974323|588173723|FG001|Overall Study|Lack of Efficacy|1|||
162855358|NCT01974323|588173722|FG000|Overall Study|Adverse Event|2|||
162855359|NCT01974323|588173723|FG001|Overall Study|Adverse Event|2|||
162855360|NCT00331760|588173724|FG000|Overall Study|Ineligible / no protocol treatment|15|||
162855361|NCT00331760|588173725|FG001|Overall Study|Ineligible / no protocol treatment|8|||
162855362|NCT00833092|588173728|FG000|Overall Study|Withdrawal by Subject|2|||
162855363|NCT00833092|588173729|FG001|Overall Study|Withdrawal by Subject|3|||
162855364|NCT00833092|588173728|FG000|Overall Study|Protocol Violation|2|||
162855365|NCT00833092|588173729|FG001|Overall Study|Protocol Violation|1|||
162855366|NCT00833092|588173728|FG000|Overall Study|Diarrhea|0|||
162855367|NCT00833092|588173729|FG001|Overall Study|Diarrhea|2|||
162855368|NCT00833092|588173728|FG000|Overall Study|constipation|0|||
162855369|NCT00833092|588173729|FG001|Overall Study|constipation|1|||
162855370|NCT00619229|588173730|FG000|Overall Study|Withdrawal by Subject|1|||
162855371|NCT00619229|588173731|FG001|Overall Study|Withdrawal by Subject|1|||
162855372|NCT00619229|588173730|FG000|Overall Study|Lost to Follow-up|1|||
162855373|NCT00619229|588173731|FG001|Overall Study|Lost to Follow-up|0|||
162855374|NCT00619229|588173730|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
162855375|NCT00619229|588173731|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
162611715|NCT01074047|587294999|FG001|Extension Phase|Disease Progression|0|||
162855376|NCT00619229|588173730|FG000|Overall Study|Investigator planned Cataract Operation|1|||
162855377|NCT00619229|588173731|FG001|Overall Study|Investigator planned Cataract Operation|0|||
162855378|NCT03417440|588173732|FG000|Overall Study|Lost to Follow-up|0|||
162855379|NCT03417440|588173733|FG001|Overall Study|Lost to Follow-up|1|||
162855380|NCT03417440|588173734|FG002|Overall Study|Lost to Follow-up|0|||
162855381|NCT03417440|588173735|FG003|Overall Study|Lost to Follow-up|0|||
162855382|NCT03417440|588173736|FG004|Overall Study|Lost to Follow-up|1|||
162955254|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955255|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
162955256|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
162955257|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
162955258|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955259|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955260|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955261|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162611716|NCT01074047|587294998|FG000|Extension Phase|Withdrawal by Subject|2|||
162611717|NCT01074047|587294999|FG001|Extension Phase|Withdrawal by Subject|0|||
162855383|NCT03417440|588173737|FG005|Overall Study|Lost to Follow-up|0|||
162855384|NCT03417440|588173738|FG006|Overall Study|Lost to Follow-up|0|||
162855385|NCT03417440|588173739|FG007|Overall Study|Lost to Follow-up|0|||
162611718|NCT01074047|587294998|FG000|Extension Phase|Death|5|||
162611719|NCT01074047|587294999|FG001|Extension Phase|Death|0|||
162611720|NCT02211638|587295000|FG000|Overall Study|Case Report Forms Uncollected|291|||
162855386|NCT03417440|588173732|FG000|Overall Study|Withdrawal by Subject|2|||
162855387|NCT03417440|588173733|FG001|Overall Study|Withdrawal by Subject|0|||
162855388|NCT03417440|588173734|FG002|Overall Study|Withdrawal by Subject|2|||
162955262|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162611721|NCT02211638|587295000|FG000|Overall Study|Protocol Violation|692|||
162611722|NCT03120624|587295002|FG000|Overall Study|Withdrawal by Subject|0|||
162611723|NCT03120624|587295003|FG001|Overall Study|Withdrawal by Subject|1|||
162611724|NCT03120624|587295004|FG002|Overall Study|Withdrawal by Subject|0|||
162611725|NCT03120624|587295005|FG003|Overall Study|Withdrawal by Subject|0|||
162704713|NCT03389893|587630449|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
162855389|NCT03417440|588173735|FG003|Overall Study|Withdrawal by Subject|1|||
162855390|NCT03417440|588173736|FG004|Overall Study|Withdrawal by Subject|1|||
162855391|NCT03417440|588173737|FG005|Overall Study|Withdrawal by Subject|0|||
162855392|NCT03417440|588173738|FG006|Overall Study|Withdrawal by Subject|0|||
162611726|NCT03120624|587295006|FG004|Overall Study|Withdrawal by Subject|0|||
162611727|NCT03120624|587295007|FG005|Overall Study|Withdrawal by Subject|0|||
162855393|NCT03417440|588173739|FG007|Overall Study|Withdrawal by Subject|1|||
162855394|NCT02786901|588173740|FG000|Overall Study|Adverse Event|1|||
162855395|NCT02786901|588173741|FG001|Overall Study|Adverse Event|1|||
162855396|NCT02786901|588173742|FG002|Overall Study|Adverse Event|2|||
162855397|NCT02786901|588173740|FG000|Overall Study|Physician Decision|1|||
162855398|NCT02786901|588173741|FG001|Overall Study|Physician Decision|0|||
162855399|NCT02786901|588173742|FG002|Overall Study|Physician Decision|0|||
162704714|NCT03389893|587630450|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
162704715|NCT03389893|587630451|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
162955263|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955264|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955265|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955266|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955267|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955268|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955269|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955270|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955271|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955272|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955273|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955274|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
162955275|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955276|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
162955277|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
162955278|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
162955279|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955280|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955281|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955282|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955283|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955284|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955285|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955286|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955287|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955288|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955289|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955290|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955291|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955292|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955293|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955294|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955295|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
162955296|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955297|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955298|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
162955299|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
162955300|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955301|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955302|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955303|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955304|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955305|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955306|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955307|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955308|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955309|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955310|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955311|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955312|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955313|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955314|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955315|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955316|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
162955317|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955318|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955319|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
162955320|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
162955321|NCT01597245|588537649|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955322|NCT01597245|588537650|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955323|NCT01597245|588537651|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162855400|NCT02786901|588173740|FG000|Overall Study|Rescue Therapy Use|71|||
162855401|NCT02786901|588173741|FG001|Overall Study|Rescue Therapy Use|49|||
162855402|NCT02786901|588173742|FG002|Overall Study|Rescue Therapy Use|33|||
162855403|NCT02786901|588173740|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
162855404|NCT02786901|588173741|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
162855405|NCT02786901|588173742|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
162855406|NCT02786901|588173740|FG000|Overall Study|Disallowed medication|1|||
162855407|NCT02786901|588173741|FG001|Overall Study|Disallowed medication|1|||
162855408|NCT02786901|588173742|FG002|Overall Study|Disallowed medication|0|||
162855409|NCT02786901|588173740|FG000|Overall Study|Randomized in error|2|||
162855410|NCT02786901|588173741|FG001|Overall Study|Randomized in error|0|||
162855411|NCT02786901|588173742|FG002|Overall Study|Randomized in error|1|||
162855412|NCT00466505|588173743|FG000|Overall Study|disease progression|13|||
162855413|NCT00466505|588173743|FG000|Overall Study|Adverse Event|4|||
162855414|NCT00355264|588173744|FG000|Extension (Variable Duration)|Adverse Event|1|||
162855415|NCT00355264|588173744|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
162855416|NCT00699192|588173745|FG000|Overall Study|Missing|1|||
162855417|NCT00699192|588173746|FG001|Overall Study|Missing|1|||
162855418|NCT00699192|588173747|FG002|Overall Study|Missing|1|||
162855419|NCT00699192|588173745|FG000|Overall Study|Adverse Event|9|||
162855420|NCT00699192|588173746|FG001|Overall Study|Adverse Event|4|||
162855421|NCT00699192|588173747|FG002|Overall Study|Adverse Event|3|||
162855422|NCT00699192|588173745|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162855423|NCT00699192|588173746|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162855424|NCT00699192|588173747|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162855425|NCT00699192|588173745|FG000|Overall Study|Lack of Efficacy|0|||
162855426|NCT00699192|588173746|FG001|Overall Study|Lack of Efficacy|0|||
162855427|NCT00699192|588173747|FG002|Overall Study|Lack of Efficacy|1|||
162855428|NCT00699192|588173745|FG000|Overall Study|Withdrawal by Subject|3|||
162855429|NCT00699192|588173746|FG001|Overall Study|Withdrawal by Subject|2|||
162855430|NCT00699192|588173747|FG002|Overall Study|Withdrawal by Subject|4|||
162855431|NCT00699192|588173745|FG000|Overall Study|Administrative problems|1|||
162855432|NCT00699192|588173746|FG001|Overall Study|Administrative problems|3|||
162855433|NCT00699192|588173747|FG002|Overall Study|Administrative problems|1|||
162855434|NCT00699192|588173745|FG000|Overall Study|Protocol Violation|2|||
162855435|NCT00699192|588173746|FG001|Overall Study|Protocol Violation|2|||
162855436|NCT00699192|588173747|FG002|Overall Study|Protocol Violation|0|||
162855437|NCT01773473|588173748|FG000|Overall Study|Adverse Event|3|||
162855438|NCT01773473|588173749|FG001|Overall Study|Adverse Event|2|||
162855439|NCT01773473|588173748|FG000|Overall Study|Protocol Violation|0|||
162855440|NCT01773473|588173749|FG001|Overall Study|Protocol Violation|4|||
162855441|NCT01773473|588173748|FG000|Overall Study|Physician Decision|3|||
162855442|NCT01773473|588173749|FG001|Overall Study|Physician Decision|5|||
162955324|NCT01597245|588537652|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955325|NCT01597245|588537653|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955326|NCT01597245|588537654|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955327|NCT01597245|588537655|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955328|NCT01597245|588537656|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955329|NCT01597245|588537657|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955330|NCT01597245|588537658|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955331|NCT01597245|588537659|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955332|NCT01597245|588537660|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955333|NCT01597245|588537661|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955334|NCT01597245|588537662|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955335|NCT01597245|588537663|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955336|NCT01597245|588537664|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955337|NCT01597245|588537665|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162704716|NCT03389893|587630452|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
162704717|NCT03389893|587630449|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
162855443|NCT01773473|588173748|FG000|Overall Study|Sponsor Decision|2|||
162855444|NCT01773473|588173749|FG001|Overall Study|Sponsor Decision|0|||
162855445|NCT01773473|588173748|FG000|Overall Study|Lack of Efficacy|0|||
162855446|NCT01773473|588173749|FG001|Overall Study|Lack of Efficacy|1|||
162855447|NCT01773473|588173748|FG000|Overall Study|Non-Compliance with study drug|1|||
162855448|NCT01773473|588173749|FG001|Overall Study|Non-Compliance with study drug|4|||
162855449|NCT01773473|588173748|FG000|Overall Study|Withdrawal by Subject|5|||
162855450|NCT01773473|588173749|FG001|Overall Study|Withdrawal by Subject|3|||
162855451|NCT01773473|588173748|FG000|Overall Study|Lost to Follow-up|2|||
162955338|NCT01597245|588537666|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955339|NCT01597245|588537667|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162855452|NCT01773473|588173749|FG001|Overall Study|Lost to Follow-up|0|||
162855453|NCT00826514|588173750|FG000|Overall Study|Adverse Event|1|||
162855454|NCT00826514|588173751|FG001|Overall Study|Adverse Event|1|||
162855455|NCT00826514|588173750|FG000|Overall Study|Lack of Efficacy|0|||
162855456|NCT00826514|588173751|FG001|Overall Study|Lack of Efficacy|1|||
162855457|NCT00826514|588173750|FG000|Overall Study|Withdrawal by Subject|2|||
162855458|NCT00826514|588173751|FG001|Overall Study|Withdrawal by Subject|3|||
162855459|NCT01451645|588173752|FG000|Overall Study|Protocol Violation|1|||
162855460|NCT01451645|588173753|FG001|Overall Study|Protocol Violation|0|||
162855461|NCT01451645|588173752|FG000|Overall Study|Adverse Event|0|||
162855462|NCT01451645|588173753|FG001|Overall Study|Adverse Event|3|||
162855463|NCT01451645|588173752|FG000|Overall Study|Withdrawal by Subject|4|||
162855464|NCT01451645|588173753|FG001|Overall Study|Withdrawal by Subject|2|||
162855465|NCT01451645|588173752|FG000|Overall Study|Lost to Follow-up|4|||
162855466|NCT01451645|588173753|FG001|Overall Study|Lost to Follow-up|3|||
162855467|NCT03663166|588173756|FG000|Overall Study|Withdrawal by Subject|1|||
162855468|NCT00098787|588173763|FG000|Overall Study|Never started treatment|3|||
162855469|NCT00098787|588173764|FG001|Overall Study|Never started treatment|2|||
162855470|NCT00098787|588173765|FG002|Overall Study|Never started treatment|1|||
162855471|NCT00098787|588173763|FG000|Overall Study|Ineligible|9|||
162855472|NCT00098787|588173764|FG001|Overall Study|Ineligible|7|||
162855473|NCT00098787|588173765|FG002|Overall Study|Ineligible|3|||
162855474|NCT00098787|588173763|FG000|Overall Study|Disease progression|28|||
162855475|NCT00098787|588173764|FG001|Overall Study|Disease progression|17|||
162855476|NCT00098787|588173765|FG002|Overall Study|Disease progression|23|||
162855477|NCT00098787|588173763|FG000|Overall Study|Adverse Event|8|||
162855478|NCT00098787|588173764|FG001|Overall Study|Adverse Event|17|||
162855479|NCT00098787|588173765|FG002|Overall Study|Adverse Event|8|||
162855480|NCT00098787|588173763|FG000|Overall Study|Death|6|||
162855481|NCT00098787|588173764|FG001|Overall Study|Death|1|||
162855482|NCT00098787|588173765|FG002|Overall Study|Death|0|||
162855483|NCT00098787|588173763|FG000|Overall Study|Withdrawal by Subject|4|||
162855484|NCT00098787|588173764|FG001|Overall Study|Withdrawal by Subject|12|||
162855485|NCT00098787|588173765|FG002|Overall Study|Withdrawal by Subject|6|||
162855486|NCT00098787|588173763|FG000|Overall Study|Alternative therapy|8|||
162855487|NCT00098787|588173764|FG001|Overall Study|Alternative therapy|13|||
162855488|NCT00098787|588173765|FG002|Overall Study|Alternative therapy|13|||
162855489|NCT00098787|588173763|FG000|Overall Study|Other|7|||
162855490|NCT00098787|588173764|FG001|Overall Study|Other|6|||
162955340|NCT01597245|588537668|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
162955341|NCT01597245|588537669|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
162955342|NCT00731783|588537670|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
162955343|NCT00731783|588537671|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
162955344|NCT00731783|588537670|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
162955345|NCT00731783|588537671|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
162955346|NCT00731783|588537670|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
162704718|NCT03389893|587630450|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
162704719|NCT03389893|587630451|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
162704720|NCT03389893|587630452|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
162704721|NCT03389893|587630449|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
162704722|NCT03389893|587630450|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
162704723|NCT03389893|587630451|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
162704724|NCT03389893|587630452|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
162704725|NCT03389893|587630449|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
162704726|NCT03389893|587630450|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
162704727|NCT03389893|587630451|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
162704728|NCT03389893|587630452|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
162704729|NCT01719861|587630456|FG000|Cycle 1|Death|4|||
162704730|NCT01719861|587630456|FG000|Cycle 2|Death|1|||
162704731|NCT00958009|587630457|FG000|Overall Study|Adverse Event|1|||
162704732|NCT00958009|587630457|FG000|Overall Study|Subject found device difficult to use|1|||
162704733|NCT00087490|587630461|FG000|Overall Study|Death|6|||
162704734|NCT00087490|587630462|FG001|Overall Study|Death|4|||
162704735|NCT00087490|587630461|FG000|Overall Study|Adverse Event|3|||
162704736|NCT00087490|587630462|FG001|Overall Study|Adverse Event|8|||
162704737|NCT00087490|587630461|FG000|Overall Study|Lack of Efficacy|0|||
162704738|NCT00087490|587630462|FG001|Overall Study|Lack of Efficacy|2|||
162704739|NCT00087490|587630461|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
162704740|NCT00087490|587630462|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
162704741|NCT00087490|587630461|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
162955347|NCT00731783|588537671|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
162955348|NCT00731783|588537670|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
162955349|NCT00731783|588537671|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
162955350|NCT02571907|588539234|FG000|Overall Study|Death|4|||
162704742|NCT00087490|587630462|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
162611728|NCT03120624|587295008|FG006|Overall Study|Withdrawal by Subject|0|||
162611729|NCT03120624|587295009|FG007|Overall Study|Withdrawal by Subject|0|||
162611730|NCT01927341|587296656|FG000|Phase 1b|Lost to Follow-up|1|||
162611731|NCT01927341|587296657|FG001|Phase 1b|Lost to Follow-up|0|||
162611732|NCT01927341|587296658|FG002|Phase 1b|Lost to Follow-up|0|||
162611733|NCT01927341|587296659|FG003|Phase 1b|Lost to Follow-up|0|||
162611734|NCT01927341|587296660|FG004|Phase 1b|Lost to Follow-up|0|||
162611735|NCT01927341|587296656|FG000|Phase 1b|Death|2|||
162611736|NCT01927341|587296657|FG001|Phase 1b|Death|0|||
162611737|NCT01927341|587296658|FG002|Phase 1b|Death|0|||
162611738|NCT01927341|587296659|FG003|Phase 1b|Death|0|||
162611739|NCT01927341|587296660|FG004|Phase 1b|Death|0|||
162611740|NCT01927341|587296656|FG000|Phase 1b|Follow-up completed|7|||
162611741|NCT01927341|587296657|FG001|Phase 1b|Follow-up completed|0|||
162611742|NCT01927341|587296658|FG002|Phase 1b|Follow-up completed|0|||
162611743|NCT01927341|587296659|FG003|Phase 1b|Follow-up completed|0|||
162611744|NCT01927341|587296660|FG004|Phase 1b|Follow-up completed|0|||
162611745|NCT01927341|587296656|FG000|Phase 2|Lost to Follow-up|0|||
162611746|NCT01927341|587296657|FG001|Phase 2|Lost to Follow-up|1|||
162611747|NCT01927341|587296658|FG002|Phase 2|Lost to Follow-up|0|||
162611748|NCT01927341|587296659|FG003|Phase 2|Lost to Follow-up|0|||
162611749|NCT01927341|587296660|FG004|Phase 2|Lost to Follow-up|0|||
162611750|NCT01927341|587296656|FG000|Phase 2|Participant withdrew consent|0|||
162611751|NCT01927341|587296657|FG001|Phase 2|Participant withdrew consent|2|||
162611752|NCT01927341|587296658|FG002|Phase 2|Participant withdrew consent|1|||
162611753|NCT01927341|587296659|FG003|Phase 2|Participant withdrew consent|2|||
162611754|NCT01927341|587296660|FG004|Phase 2|Participant withdrew consent|3|||
162611755|NCT01927341|587296656|FG000|Phase 2|Death|0|||
162611756|NCT01927341|587296657|FG001|Phase 2|Death|4|||
162611757|NCT01927341|587296658|FG002|Phase 2|Death|0|||
162611758|NCT01927341|587296659|FG003|Phase 2|Death|3|||
162611759|NCT01927341|587296660|FG004|Phase 2|Death|2|||
162611760|NCT01927341|587296656|FG000|Phase 2|New cancer therapy|0|||
162611761|NCT01927341|587296657|FG001|Phase 2|New cancer therapy|1|||
162611762|NCT01927341|587296658|FG002|Phase 2|New cancer therapy|0|||
162611763|NCT01927341|587296659|FG003|Phase 2|New cancer therapy|4|||
162611764|NCT01927341|587296660|FG004|Phase 2|New cancer therapy|1|||
162611765|NCT01927341|587296656|FG000|Phase 2|Disease progression|0|||
162611766|NCT01927341|587296657|FG001|Phase 2|Disease progression|1|||
162611767|NCT01927341|587296658|FG002|Phase 2|Disease progression|1|||
162611768|NCT01927341|587296659|FG003|Phase 2|Disease progression|1|||
162611769|NCT01927341|587296660|FG004|Phase 2|Disease progression|0|||
162611770|NCT01927341|587296656|FG000|Phase 2|Follow-up completed|0|||
162611771|NCT01927341|587296657|FG001|Phase 2|Follow-up completed|6|||
162611772|NCT01927341|587296658|FG002|Phase 2|Follow-up completed|3|||
162611773|NCT01927341|587296659|FG003|Phase 2|Follow-up completed|5|||
162611774|NCT01927341|587296660|FG004|Phase 2|Follow-up completed|2|||
162611775|NCT00674973|587296661|FG000|Overall Study|Insufficient Therapeutic Response|77|||
162611776|NCT00674973|587296662|FG001|Overall Study|Insufficient Therapeutic Response|72|||
162611777|NCT00674973|587296661|FG000|Overall Study|Refused Treatment|1|||
162955351|NCT02571907|588539234|FG000|Overall Study|Lost to Follow-up|3|||
162955352|NCT02571907|588539234|FG000|Overall Study|Withdrawal by Subject|3|||
162955353|NCT03071575|588539235|FG000|Overall Study|Death|0|||
162955354|NCT03071575|588539236|FG001|Overall Study|Death|1|||
162955355|NCT03071575|588539235|FG000|Overall Study|Lost to Follow-up|5|||
162955356|NCT03071575|588539236|FG001|Overall Study|Lost to Follow-up|11|||
162955357|NCT03071575|588539235|FG000|Overall Study|Withdrawal by Subject|4|||
162955358|NCT03071575|588539236|FG001|Overall Study|Withdrawal by Subject|2|||
162955359|NCT00218257|588539241|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
162955360|NCT00218257|588539242|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
162955361|NCT00579345|588539243|FG000|Overall Study|Withdrawal by Subject|2|||
162955362|NCT00579345|588539244|FG001|Overall Study|Withdrawal by Subject|0|||
162955363|NCT00579345|588539245|FG002|Overall Study|Withdrawal by Subject|0|||
162955364|NCT00579345|588539246|FG003|Overall Study|Withdrawal by Subject|0|||
162611778|NCT00674973|587296662|FG001|Overall Study|Refused Treatment|5|||
162611779|NCT00674973|587296661|FG000|Overall Study|Failure to Return|1|||
162611780|NCT00674973|587296662|FG001|Overall Study|Failure to Return|0|||
162611781|NCT00674973|587296661|FG000|Overall Study|Adverse Event|2|||
162611782|NCT00674973|587296662|FG001|Overall Study|Adverse Event|9|||
162611783|NCT00674973|587296661|FG000|Overall Study|Death|19|||
162611784|NCT00674973|587296662|FG001|Overall Study|Death|15|||
162611785|NCT00674973|587296661|FG000|Overall Study|Protocol Violation|0|||
162611786|NCT00674973|587296662|FG001|Overall Study|Protocol Violation|1|||
162611787|NCT00451451|587296663|FG000|Overall Study|Adverse Event|11|||
162611788|NCT00451451|587296664|FG001|Overall Study|Adverse Event|21|||
162611789|NCT00451451|587296665|FG002|Overall Study|Adverse Event|26|||
162611790|NCT00451451|587296666|FG003|Overall Study|Adverse Event|10|||
162611791|NCT00451451|587296663|FG000|Overall Study|Lost to Follow-up|11|||
162611792|NCT00451451|587296664|FG001|Overall Study|Lost to Follow-up|9|||
162611793|NCT00451451|587296665|FG002|Overall Study|Lost to Follow-up|8|||
162955365|NCT00579345|588539247|FG004|Overall Study|Withdrawal by Subject|0|||
162955366|NCT00579345|588539248|FG005|Overall Study|Withdrawal by Subject|0|||
163043939|NCT02100839|588869384|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
163043940|NCT03272347|588869386|FG000|Overall Study|Death|0|||
163043941|NCT03272347|588869387|FG001|Overall Study|Death|0|||
163043942|NCT03272347|588869388|FG002|Overall Study|Death|0|||
162704743|NCT00087490|587630461|FG000|Overall Study|Randomized but not treated|7|||
162704744|NCT00087490|587630462|FG001|Overall Study|Randomized but not treated|18|||
162704745|NCT01925170|587630465|FG000|Overall Study|Unverified cancer status|53|||
162704746|NCT01077024|587630466|FG000|Overall Study|Lost to Follow-up|20|||
162704747|NCT01077024|587630467|FG001|Overall Study|Lost to Follow-up|14|||
162704748|NCT01077024|587630466|FG000|Overall Study|Withdrawal by Subject|0|||
162704749|NCT01077024|587630467|FG001|Overall Study|Withdrawal by Subject|2|||
162704750|NCT01077024|587630466|FG000|Overall Study|Incarcerated|7|||
162704751|NCT01077024|587630467|FG001|Overall Study|Incarcerated|8|||
162704752|NCT01077024|587630466|FG000|Overall Study|Other|4|||
162704753|NCT01077024|587630467|FG001|Overall Study|Other|4|||
162704754|NCT02034435|587630468|FG000|Overall Study|Withdrawal by Subject|1|||
162704755|NCT02034435|587630469|FG001|Overall Study|Withdrawal by Subject|0|||
162704756|NCT02034435|587630470|FG002|Overall Study|Withdrawal by Subject|0|||
162704757|NCT02034435|587630471|FG003|Overall Study|Withdrawal by Subject|0|||
162704758|NCT02034435|587630468|FG000|Overall Study|Illness|0|||
162704759|NCT02034435|587630469|FG001|Overall Study|Illness|2|||
162704760|NCT02034435|587630470|FG002|Overall Study|Illness|0|||
162704761|NCT02034435|587630471|FG003|Overall Study|Illness|0|||
162704762|NCT02034435|587630468|FG000|Overall Study|Inadequate IV access|1|||
162704763|NCT02034435|587630469|FG001|Overall Study|Inadequate IV access|0|||
162704764|NCT02034435|587630470|FG002|Overall Study|Inadequate IV access|0|||
162704765|NCT02034435|587630471|FG003|Overall Study|Inadequate IV access|1|||
162704766|NCT02839681|587630477|FG000|Overall Study|Death|2|||
162704767|NCT02300311|587630478|FG000|Overall Study|Other than the reason specified|1|||
162704768|NCT02300311|587630479|FG001|Overall Study|Other than the reason specified|0|||
162704769|NCT02300311|587630478|FG000|Overall Study|Refused to continue taking medication|18|||
162704770|NCT02300311|587630479|FG001|Overall Study|Refused to continue taking medication|0|||
162704771|NCT00848211|587630480|FG000|Overall Study|Protocol Violation|0|||
162704772|NCT00848211|587630481|FG001|Overall Study|Protocol Violation|1|||
162704773|NCT00848211|587630482|FG002|Overall Study|Protocol Violation|1|||
162704774|NCT00848211|587630483|FG003|Overall Study|Protocol Violation|0|||
162704775|NCT00848211|587630480|FG000|Overall Study|Adverse Event|0|||
162704776|NCT00848211|587630481|FG001|Overall Study|Adverse Event|0|||
162704777|NCT00848211|587630482|FG002|Overall Study|Adverse Event|0|||
162704778|NCT00848211|587630483|FG003|Overall Study|Adverse Event|0|||
162704779|NCT00772928|587630484|FG000|Overall Study|Lost to Follow-up|9|||
162704780|NCT00772928|587630485|FG001|Overall Study|Lost to Follow-up|6|||
162704781|NCT00772928|587630484|FG000|Overall Study|Protocol Violation|10|||
162955367|NCT00579345|588539249|FG006|Overall Study|Withdrawal by Subject|0|||
162955368|NCT00579345|588539250|FG007|Overall Study|Withdrawal by Subject|1|||
162955369|NCT00579345|588539243|FG000|Overall Study|Lost to Follow-up|1|||
162955370|NCT00579345|588539244|FG001|Overall Study|Lost to Follow-up|0|||
162955371|NCT00579345|588539245|FG002|Overall Study|Lost to Follow-up|0|||
162955372|NCT00579345|588539246|FG003|Overall Study|Lost to Follow-up|0|||
162955373|NCT00579345|588539247|FG004|Overall Study|Lost to Follow-up|0|||
163043943|NCT03272347|588869389|FG003|Overall Study|Death|1|||
163043944|NCT03272347|588869386|FG000|Overall Study|Lost to Follow-up|1|||
163043945|NCT03272347|588869387|FG001|Overall Study|Lost to Follow-up|3|||
163043946|NCT03272347|588869388|FG002|Overall Study|Lost to Follow-up|5|||
162704782|NCT00772928|587630485|FG001|Overall Study|Protocol Violation|12|||
162704783|NCT00772928|587630484|FG000|Overall Study|Withdrawal by Subject|25|||
162704784|NCT00772928|587630485|FG001|Overall Study|Withdrawal by Subject|22|||
162704785|NCT00772928|587630484|FG000|Overall Study|Did not receive vaccine|0|||
162955374|NCT00579345|588539248|FG005|Overall Study|Lost to Follow-up|0|||
162955375|NCT00579345|588539249|FG006|Overall Study|Lost to Follow-up|0|||
162955376|NCT00579345|588539250|FG007|Overall Study|Lost to Follow-up|0|||
162955377|NCT00579345|588539243|FG000|Overall Study|Adverse Event|0|||
162955378|NCT00579345|588539244|FG001|Overall Study|Adverse Event|0|||
162955379|NCT00579345|588539245|FG002|Overall Study|Adverse Event|1|||
162955380|NCT00579345|588539246|FG003|Overall Study|Adverse Event|0|||
162955381|NCT00579345|588539247|FG004|Overall Study|Adverse Event|0|||
162955382|NCT00579345|588539248|FG005|Overall Study|Adverse Event|0|||
162955383|NCT00579345|588539249|FG006|Overall Study|Adverse Event|0|||
162955384|NCT00579345|588539250|FG007|Overall Study|Adverse Event|0|||
162955385|NCT00579345|588539243|FG000|Overall Study|Protocol Violation|1|||
162704786|NCT00772928|587630485|FG001|Overall Study|Did not receive vaccine|1|||
162704787|NCT03100838|587630487|FG000|Overall Study|Adverse Event|1|||
162955386|NCT00579345|588539244|FG001|Overall Study|Protocol Violation|0|||
162955387|NCT00579345|588539245|FG002|Overall Study|Protocol Violation|0|||
162955388|NCT00579345|588539246|FG003|Overall Study|Protocol Violation|0|||
162955389|NCT00579345|588539247|FG004|Overall Study|Protocol Violation|0|||
162955390|NCT00579345|588539248|FG005|Overall Study|Protocol Violation|0|||
162955391|NCT00579345|588539249|FG006|Overall Study|Protocol Violation|0|||
163043947|NCT03272347|588869389|FG003|Overall Study|Lost to Follow-up|1|||
163043948|NCT03272347|588869386|FG000|Overall Study|Physician Decision|4|||
162855491|NCT00098787|588173765|FG002|Overall Study|Other|9|||
162855492|NCT00684814|588173766|FG000|Washout Period of 7 Days|Adverse Event|1|||
162855493|NCT00684814|588173767|FG001|Washout Period of 7 Days|Adverse Event|2|||
162855494|NCT00684814|588173766|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
162855495|NCT00684814|588173767|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
162955392|NCT00579345|588539250|FG007|Overall Study|Protocol Violation|1|||
162955393|NCT00579345|588539243|FG000|Overall Study|Death|1|||
162955394|NCT00579345|588539244|FG001|Overall Study|Death|1|||
162955395|NCT00579345|588539245|FG002|Overall Study|Death|1|||
162955396|NCT00579345|588539246|FG003|Overall Study|Death|1|||
162955397|NCT00579345|588539247|FG004|Overall Study|Death|0|||
162955398|NCT00579345|588539248|FG005|Overall Study|Death|0|||
162955399|NCT00579345|588539249|FG006|Overall Study|Death|0|||
162955400|NCT00579345|588539250|FG007|Overall Study|Death|0|||
162955401|NCT02267187|588539256|FG000|Overall Study|Physician Decision|2|||
162955402|NCT02267187|588539256|FG000|Overall Study|Screen fail|3|||
162955403|NCT00712959|588539261|FG000|Overall Study|Protocol Violation|3|||
162955404|NCT00712959|588539262|FG001|Overall Study|Protocol Violation|1|||
162955405|NCT00712959|588539261|FG000|Overall Study|Lost to Follow-up|13|||
162955406|NCT00712959|588539262|FG001|Overall Study|Lost to Follow-up|2|||
162955407|NCT00712959|588539261|FG000|Overall Study|Withdrawal by Subject|3|||
162955408|NCT00712959|588539262|FG001|Overall Study|Withdrawal by Subject|0|||
162955409|NCT00834067|588539263|FG000|Washout of 21 Days|Protocol Violation|0|||
162955410|NCT00834067|588539264|FG001|Washout of 21 Days|Protocol Violation|1|||
162955411|NCT00418561|588539265|FG000|Overall Study|Participant's (guardian's) decision|0|||
162955412|NCT00418561|588539266|FG001|Overall Study|Participant's (guardian's) decision|1|||
162955413|NCT00418561|588539267|FG002|Overall Study|Participant's (guardian's) decision|0|||
162955414|NCT01796171|588539268|FG000|Enrolled|Death|0|||
162955415|NCT01796171|588539269|FG001|Enrolled|Death|0|||
162955416|NCT01796171|588539270|FG002|Enrolled|Death|0|||
162955417|NCT01796171|588539271|FG003|Enrolled|Death|0|||
162955418|NCT01796171|588539272|FG004|Enrolled|Death|0|||
162955419|NCT01796171|588539273|FG005|Enrolled|Death|0|||
162955420|NCT01796171|588539274|FG006|Enrolled|Death|0|||
162955421|NCT01796171|588539275|FG007|Enrolled|Death|0|||
162955422|NCT01796171|588539276|FG008|Enrolled|Death|0|||
162955423|NCT01796171|588539277|FG009|Enrolled|Death|0|||
162955424|NCT01796171|588539278|FG010|Enrolled|Death|0|||
162955425|NCT01796171|588539279|FG011|Enrolled|Death|0|||
162955426|NCT01796171|588539280|FG012|Enrolled|Death|0|||
162955427|NCT01796171|588539281|FG013|Enrolled|Death|0|||
162955428|NCT01796171|588539282|FG014|Enrolled|Death|1|||
162955429|NCT01796171|588539268|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
162955430|NCT01796171|588539269|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
162955431|NCT01796171|588539270|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
162955432|NCT01796171|588539271|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
163043949|NCT03272347|588869387|FG001|Overall Study|Physician Decision|2|||
162855496|NCT00684814|588173766|FG000|Second Intervention|Adverse Event|1|||
162855497|NCT00684814|588173767|FG001|Second Intervention|Adverse Event|0|||
162855498|NCT00144170|588173770|FG000|Overall Study|Adverse Event|84|||
162855499|NCT00144170|588173771|FG001|Overall Study|Adverse Event|41|||
162855500|NCT00144170|588173770|FG000|Overall Study|Protocol Violation|23|||
162855501|NCT00144170|588173771|FG001|Overall Study|Protocol Violation|16|||
162855502|NCT00144170|588173770|FG000|Overall Study|Lost to Follow-up|5|||
162855503|NCT00144170|588173771|FG001|Overall Study|Lost to Follow-up|10|||
162855504|NCT00144170|588173770|FG000|Overall Study|Withdrawal by Subject|29|||
162855505|NCT00144170|588173771|FG001|Overall Study|Withdrawal by Subject|13|||
162855506|NCT00144170|588173770|FG000|Overall Study|Other reason not defined above|211|||
162855507|NCT00144170|588173771|FG001|Overall Study|Other reason not defined above|316|||
162955433|NCT01796171|588539272|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
162855508|NCT00981526|588173772|FG000|Overall Study|Withdrawal by Subject|0|||
162955434|NCT01796171|588539273|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
162955435|NCT01796171|588539274|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
162855509|NCT00981526|588173773|FG001|Overall Study|Withdrawal by Subject|2|||
162855510|NCT00981526|588173772|FG000|Overall Study|Physician Decision|4|||
162855511|NCT00981526|588173773|FG001|Overall Study|Physician Decision|4|||
162955436|NCT01796171|588539275|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
162955437|NCT01796171|588539276|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
162955438|NCT01796171|588539277|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
162855512|NCT00655928|588173774|FG000|Overall Study|Withdrawal by Subject|2|||
162855513|NCT00655928|588173775|FG001|Overall Study|Withdrawal by Subject|1|||
162955439|NCT01796171|588539278|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
162955440|NCT01796171|588539279|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
162955441|NCT01796171|588539280|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
163043950|NCT03272347|588869388|FG002|Overall Study|Physician Decision|5|||
163043951|NCT03272347|588869389|FG003|Overall Study|Physician Decision|4|||
163043952|NCT03272347|588869386|FG000|Overall Study|Screen Failure|1|||
163043953|NCT03272347|588869387|FG001|Overall Study|Screen Failure|0|||
163043954|NCT03272347|588869388|FG002|Overall Study|Screen Failure|0|||
163043955|NCT03272347|588869389|FG003|Overall Study|Screen Failure|0|||
163043956|NCT03272347|588869386|FG000|Overall Study|Withdrawal by Subject|5|||
163043957|NCT03272347|588869387|FG001|Overall Study|Withdrawal by Subject|1|||
163043958|NCT03272347|588869388|FG002|Overall Study|Withdrawal by Subject|2|||
163043959|NCT03272347|588869389|FG003|Overall Study|Withdrawal by Subject|1|||
163043960|NCT01971567|588869390|FG000|Overall Study|Withdrawal by Subject|3|||
163043961|NCT01971567|588869391|FG001|Overall Study|Withdrawal by Subject|2|||
163043962|NCT01971567|588869390|FG000|Overall Study|Lost to Follow-up|1|||
163043963|NCT01971567|588869391|FG001|Overall Study|Lost to Follow-up|0|||
163043964|NCT04826484|588869392|FG000|Overall Study|Lost to Follow-up|2|||
163043965|NCT04826484|588869393|FG001|Overall Study|Lost to Follow-up|0|||
163043966|NCT02239640|588869396|FG000|Overall Study|Withdrawal by Subject|3|||
163043967|NCT02239640|588869396|FG000|Overall Study|Lost to Follow-up|72|||
163043968|NCT02239640|588869396|FG000|Overall Study|Death|142|||
163043969|NCT00206427|588869406|FG000|Overall Study|Adverse Event|2|||
163043970|NCT02915159|588869407|FG000|Overall Study|Participant no longer meets criteria|2|||
163043971|NCT02915159|588869408|FG001|Overall Study|Participant no longer meets criteria|0|||
163043972|NCT02915159|588869407|FG000|Overall Study|poor/non-compliance|1|||
163043973|NCT02915159|588869408|FG001|Overall Study|poor/non-compliance|0|||
163043974|NCT02915159|588869407|FG000|Overall Study|Participant withdrew consent|5|||
163043975|NCT02915159|588869408|FG001|Overall Study|Participant withdrew consent|1|||
163043976|NCT02915159|588869407|FG000|Overall Study|Request to discontinue treatment|1|||
163043977|NCT02915159|588869408|FG001|Overall Study|Request to discontinue treatment|2|||
163043978|NCT02915159|588869407|FG000|Overall Study|Adverse Event|2|||
163043979|NCT02915159|588869408|FG001|Overall Study|Adverse Event|2|||
163043980|NCT02915159|588869407|FG000|Overall Study|Lack of Efficacy|0|||
163043981|NCT02915159|588869408|FG001|Overall Study|Lack of Efficacy|3|||
163043982|NCT04534517|588869410|FG000|Overall Study|Adverse Event|1|||
163043983|NCT04534517|588869410|FG000|Overall Study|Withdrawal by Subject|1|||
163043984|NCT04534517|588869410|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163043985|NCT04534517|588869410|FG000|Overall Study|COVID-19 Related|1|||
163043986|NCT03872843|588869411|FG000|Overall Study|Lost to Follow-up|5|||
163043987|NCT03872843|588869412|FG001|Overall Study|Lost to Follow-up|7|||
163043988|NCT02121795|588869413|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
163043989|NCT02121795|588869414|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
163043990|NCT02121795|588869413|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
163043991|NCT02121795|588869414|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
163043992|NCT02121795|588869413|FG000|Double-Blind Phase|Lost to Follow-up|7|||
163043993|NCT02121795|588869414|FG001|Double-Blind Phase|Lost to Follow-up|4|||
163043994|NCT02121795|588869413|FG000|Double-Blind Phase|Physician Decision|2|||
163043995|NCT02121795|588869414|FG001|Double-Blind Phase|Physician Decision|5|||
163043996|NCT02121795|588869413|FG000|Double-Blind Phase|Adverse Event|5|||
163043997|NCT02121795|588869414|FG001|Double-Blind Phase|Adverse Event|0|||
163043998|NCT02121795|588869413|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
163043999|NCT02121795|588869414|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
163044000|NCT02121795|588869413|FG000|Double-Blind Phase|Protocol Violation|0|||
163044001|NCT02121795|588869414|FG001|Double-Blind Phase|Protocol Violation|3|||
163044002|NCT02121795|588869413|FG000|Double-Blind Phase|Death|1|||
163044003|NCT02121795|588869414|FG001|Double-Blind Phase|Death|1|||
163044004|NCT02121795|588869413|FG000|Open-Label Phase|Physician Decision|8|||
163044005|NCT02121795|588869414|FG001|Open-Label Phase|Physician Decision|8|||
163044006|NCT02121795|588869413|FG000|Open-Label Phase|Withdrawal by Subject|3|||
163044007|NCT02121795|588869414|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163044008|NCT02121795|588869413|FG000|Open-Label Phase|Lost to Follow-up|1|||
163044009|NCT02121795|588869414|FG001|Open-Label Phase|Lost to Follow-up|0|||
163044010|NCT00823264|588869415|FG000|Overall Study|Protocol Violation|2|||
163044011|NCT00823264|588869416|FG001|Overall Study|Protocol Violation|0|||
163044012|NCT00856999|588869417|FG000|Overall Study|Withdrawal by Subject|5|||
163044013|NCT02465437|588869418|FG000|Overall Study|Physician Decision|0|||
163044014|NCT02465437|588869419|FG001|Overall Study|Physician Decision|0|||
163044015|NCT02465437|588869420|FG002|Overall Study|Physician Decision|1|||
163044016|NCT02465437|588869421|FG003|Overall Study|Physician Decision|0|||
163044017|NCT02465437|588869418|FG000|Overall Study|Withdrawal by Subject|1|||
163044018|NCT02465437|588869419|FG001|Overall Study|Withdrawal by Subject|0|||
163044019|NCT02465437|588869420|FG002|Overall Study|Withdrawal by Subject|0|||
163044020|NCT02465437|588869421|FG003|Overall Study|Withdrawal by Subject|1|||
163044021|NCT02465437|588869418|FG000|Overall Study|Adverse Event|0|||
163044022|NCT02465437|588869419|FG001|Overall Study|Adverse Event|1|||
163044023|NCT02465437|588869420|FG002|Overall Study|Adverse Event|0|||
163044024|NCT02465437|588869421|FG003|Overall Study|Adverse Event|0|||
163044025|NCT00003483|588869422|FG000|Overall Study|Not evaluable|1|||
163044026|NCT01308463|588869423|FG000|Overall Study|Study Discontinued|23|||
163044027|NCT01308463|588869423|FG000|Overall Study|Death|4|||
163044028|NCT01308463|588869423|FG000|Overall Study|Revision|2|||
163044029|NCT00103662|588869426|FG000|Overall Study|Entered Rescue Procedure|0|||
163044030|NCT00103662|588869427|FG001|Overall Study|Entered Rescue Procedure|7|||
163044031|NCT00103662|588869426|FG000|Overall Study|Death|7|||
163044032|NCT00103662|588869427|FG001|Overall Study|Death|7|||
163044033|NCT00103662|588869426|FG000|Overall Study|Elective Withdrawal|5|||
163044034|NCT00103662|588869427|FG001|Overall Study|Elective Withdrawal|5|||
163044035|NCT00103662|588869426|FG000|Overall Study|Lost to Follow-up|0|||
163044036|NCT00103662|588869427|FG001|Overall Study|Lost to Follow-up|1|||
163044037|NCT00103662|588869426|FG000|Overall Study|Other|6|||
163044038|NCT00103662|588869427|FG001|Overall Study|Other|9|||
163044039|NCT00103662|588869426|FG000|Overall Study|Failed mobilization|0|||
163044040|NCT00103662|588869427|FG001|Overall Study|Failed mobilization|4|||
163044041|NCT00103662|588869426|FG000|Overall Study|Intercurrent illness|1|||
163044042|NCT00103662|588869427|FG001|Overall Study|Intercurrent illness|0|||
163044043|NCT03373760|588869430|FG000|Overall Study|Adverse Event|8|||
163044044|NCT03373760|588869430|FG000|Overall Study|Disease Progression|46|||
163044045|NCT03373760|588869430|FG000|Overall Study|Death|4|||
163044046|NCT02302846|588869435|FG000|Overall Study|Withdrawal by Subject|1|||
163044047|NCT00872521|588869438|FG000|Completed PAD Induction|Patient choice|0|||
163044048|NCT00872521|588869439|FG001|Completed PAD Induction|Patient choice|1|||
163044049|NCT00872521|588869440|FG002|Completed PAD Induction|Patient choice|0|||
163044050|NCT00872521|588869438|FG000|Completed PAD Induction|Disease progression|0|||
163044051|NCT00872521|588869439|FG001|Completed PAD Induction|Disease progression|2|||
163044052|NCT00872521|588869440|FG002|Completed PAD Induction|Disease progression|0|||
163044053|NCT00872521|588869438|FG000|Completed PAD Induction|Adverse Event|4|||
163044054|NCT00872521|588869439|FG001|Completed PAD Induction|Adverse Event|0|||
163044055|NCT00872521|588869440|FG002|Completed PAD Induction|Adverse Event|0|||
163044056|NCT00872521|588869438|FG000|Completed PAD Induction|Death|1|||
163044057|NCT00872521|588869439|FG001|Completed PAD Induction|Death|1|||
163044058|NCT00872521|588869440|FG002|Completed PAD Induction|Death|0|||
163044059|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Other|1|||
163044060|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Other|2|||
163044061|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Other|0|||
163044062|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Patient choice|0|||
163044063|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Patient choice|1|||
163044064|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Patient choice|0|||
163044065|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
163044066|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
163044067|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
163044068|NCT00872521|588869438|FG000|Primary Endpoint Analysis|Patient response missing|0|||
163044069|NCT00872521|588869439|FG001|Primary Endpoint Analysis|Patient response missing|0|||
163044070|NCT00872521|588869440|FG002|Primary Endpoint Analysis|Patient response missing|1|||
163044071|NCT00872521|588869438|FG000|Completed 3-month Follow up|Other|0|||
163044072|NCT00872521|588869439|FG001|Completed 3-month Follow up|Other|2|||
163044073|NCT00872521|588869440|FG002|Completed 3-month Follow up|Other|0|||
163044074|NCT00872521|588869438|FG000|Completed 3-month Follow up|Physician Decision|0|||
163044075|NCT00872521|588869439|FG001|Completed 3-month Follow up|Physician Decision|1|||
163044076|NCT00872521|588869440|FG002|Completed 3-month Follow up|Physician Decision|0|||
163044077|NCT00872521|588869438|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
163044078|NCT00872521|588869439|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
163044079|NCT00872521|588869440|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
163044080|NCT03200548|588869441|FG000|Overall Study|Withdrawal by Subject|5|||
163044081|NCT03200548|588869442|FG001|Overall Study|Withdrawal by Subject|11|||
163044082|NCT03200548|588869443|FG002|Overall Study|Withdrawal by Subject|7|||
163044083|NCT03200548|588869444|FG003|Overall Study|Withdrawal by Subject|6|||
163044084|NCT01048541|588869449|FG000|Overall Study|Withdrawal by Subject|1|||
163044085|NCT01048541|588869450|FG001|Overall Study|Withdrawal by Subject|0|||
163044086|NCT00922116|588869451|FG000|Overall Study|Adverse Event|4|||
163044087|NCT00922116|588869451|FG000|Overall Study|Death|1|||
163044088|NCT00922116|588869451|FG000|Overall Study|Lost to Follow-up|1|||
163044089|NCT00922116|588869451|FG000|Overall Study|Withdrawal by Subject|4|||
163044090|NCT00922116|588869451|FG000|Overall Study|Other|5|||
163044091|NCT02258659|588869453|FG000|Overall Study|Withdrawal by Subject|1|||
163044092|NCT01411852|588869454|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
163044093|NCT01411852|588869455|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
163044094|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
163044095|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
163044096|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Found to be under age|0|||
163044097|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Found to be under age|1|||
163044098|NCT01411852|588869454|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
163044099|NCT01411852|588869455|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
163044100|NCT01411852|588869454|FG000|Hospital Intervention Phase|Severe head injury|5|||
163044101|NCT01411852|588869455|FG001|Hospital Intervention Phase|Severe head injury|4|||
163044102|NCT01411852|588869454|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
163044103|NCT01411852|588869455|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
163044104|NCT01411852|588869454|FG000|Hospital Intervention Phase|Miscommunication error|1|||
163044105|NCT01411852|588869455|FG001|Hospital Intervention Phase|Miscommunication error|2|||
163044106|NCT01411852|588869454|FG000|Hospital Intervention Phase|CPR administered|3|||
163044107|NCT01411852|588869455|FG001|Hospital Intervention Phase|CPR administered|1|||
163044108|NCT01411852|588869454|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
163044109|NCT01411852|588869455|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
163044110|NCT01411852|588869454|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
163044111|NCT01411852|588869455|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
163044112|NCT01411852|588869454|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
163044113|NCT01411852|588869455|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
163044114|NCT01411852|588869454|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
163044115|NCT01411852|588869455|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
163044116|NCT01411852|588869454|FG000|Hospital Intervention Phase|Other ineligible|2|||
163044117|NCT01411852|588869455|FG001|Hospital Intervention Phase|Other ineligible|2|||
162955442|NCT01796171|588539281|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
162955443|NCT01796171|588539282|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
162955444|NCT01796171|588539268|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955445|NCT01796171|588539269|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955446|NCT01796171|588539270|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955447|NCT01796171|588539271|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955448|NCT01796171|588539272|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955449|NCT01796171|588539273|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955450|NCT01796171|588539274|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955451|NCT01796171|588539275|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955452|NCT01796171|588539276|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955453|NCT01796171|588539277|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955454|NCT01796171|588539278|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955455|NCT01796171|588539279|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955456|NCT01796171|588539280|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955457|NCT01796171|588539281|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
162955458|NCT01796171|588539282|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162955459|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Progressive disease|0|||
162955460|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Progressive disease|1|||
162955461|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Progressive disease|0|||
162955462|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Progressive disease|0|||
162955463|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Progressive disease|0|||
162955464|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Progressive disease|0|||
162955465|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Progressive disease|0|||
162955466|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Progressive disease|0|||
162955467|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Progressive disease|0|||
162955468|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Progressive disease|0|||
163044118|NCT01411852|588869454|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
163044119|NCT01411852|588869455|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
163044120|NCT01411852|588869454|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
163044121|NCT01411852|588869455|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
163044122|NCT01411852|588869454|FG000|Hospital Intervention Phase|Vascular access failed|1|||
163044123|NCT01411852|588869455|FG001|Hospital Intervention Phase|Vascular access failed|0|||
163044124|NCT00272844|588869456|FG000|Overall Study|Withdrawal by Subject|5|||
163044125|NCT03193047|588869457|FG000|Overall Study|Physician Decision|1|||
163044126|NCT03193047|588869458|FG001|Overall Study|Physician Decision|0|||
163044127|NCT03193047|588869457|FG000|Overall Study|Participant Left State|1|||
163044128|NCT03193047|588869458|FG001|Overall Study|Participant Left State|0|||
163044129|NCT03743025|588869462|FG000|Overall Study|Surgery was cancelled|2|||
163044130|NCT03743025|588869463|FG001|Overall Study|Surgery was cancelled|1|||
163044131|NCT00791700|588869464|FG000|Overall Study|Insufficient clinical response|1|||
163044132|NCT00791700|588869465|FG001|Overall Study|Insufficient clinical response|4|||
163044133|NCT00791700|588869466|FG002|Overall Study|Insufficient clinical response|1|||
163044134|NCT00791700|588869467|FG003|Overall Study|Insufficient clinical response|8|||
163044135|NCT00791700|588869464|FG000|Overall Study|No longer willing to participate|1|||
163044136|NCT00791700|588869465|FG001|Overall Study|No longer willing to participate|1|||
163044137|NCT00791700|588869466|FG002|Overall Study|No longer willing to participate|0|||
163044138|NCT00791700|588869467|FG003|Overall Study|No longer willing to participate|8|||
163044139|NCT00791700|588869464|FG000|Overall Study|Non-compliance with study treatment|0|||
163044140|NCT00791700|588869465|FG001|Overall Study|Non-compliance with study treatment|2|||
163044141|NCT00791700|588869466|FG002|Overall Study|Non-compliance with study treatment|0|||
163044142|NCT00791700|588869467|FG003|Overall Study|Non-compliance with study treatment|4|||
163044143|NCT00791700|588869464|FG000|Overall Study|Withdrawn due to pregnancy|0|||
163044144|NCT00791700|588869465|FG001|Overall Study|Withdrawn due to pregnancy|0|||
163044145|NCT00791700|588869466|FG002|Overall Study|Withdrawn due to pregnancy|0|||
163044146|NCT00791700|588869467|FG003|Overall Study|Withdrawn due to pregnancy|1|||
163044147|NCT00791700|588869464|FG000|Overall Study|Other|0|||
163044148|NCT00791700|588869465|FG001|Overall Study|Other|1|||
163044149|NCT00791700|588869466|FG002|Overall Study|Other|0|||
163044150|NCT00791700|588869467|FG003|Overall Study|Other|1|||
163044151|NCT00791700|588869464|FG000|Overall Study|Death|0|||
163044152|NCT00791700|588869465|FG001|Overall Study|Death|0|||
163044153|NCT00791700|588869466|FG002|Overall Study|Death|0|||
163044154|NCT00791700|588869467|FG003|Overall Study|Death|1|||
163044155|NCT00791700|588869464|FG000|Overall Study|Lost to Follow-up|4|||
163044156|NCT00791700|588869465|FG001|Overall Study|Lost to Follow-up|3|||
163044157|NCT00791700|588869466|FG002|Overall Study|Lost to Follow-up|4|||
163044158|NCT00791700|588869467|FG003|Overall Study|Lost to Follow-up|6|||
163044159|NCT00791700|588869464|FG000|Overall Study|Adverse Event|0|||
163044160|NCT00791700|588869465|FG001|Overall Study|Adverse Event|0|||
163044161|NCT00791700|588869466|FG002|Overall Study|Adverse Event|1|||
163044162|NCT00791700|588869467|FG003|Overall Study|Adverse Event|1|||
162611794|NCT00451451|587296666|FG003|Overall Study|Lost to Follow-up|11|||
162611795|NCT00451451|587296663|FG000|Overall Study|Consent Withdrawn|14|||
163044163|NCT00996034|588869468|FG000|Overall Study|Lost to Follow-up|2|||
163044164|NCT00996034|588869468|FG000|Overall Study|withdrawn by PI|1|||
162611796|NCT00451451|587296664|FG001|Overall Study|Consent Withdrawn|9|||
163044165|NCT05095311|588869469|FG000|Overall Study|Lost to Follow-up|7|||
163044166|NCT05095311|588869470|FG001|Overall Study|Lost to Follow-up|0|||
163044167|NCT05095311|588869471|FG002|Overall Study|Lost to Follow-up|0|||
163044168|NCT02588664|588869472|FG000|Overall Study|Death|56|||
163044169|NCT02588664|588869473|FG001|Overall Study|Death|55|||
163044170|NCT02588664|588869472|FG000|Overall Study|Lost to Follow-up|1305|||
163044171|NCT02588664|588869473|FG001|Overall Study|Lost to Follow-up|990|||
163044172|NCT02500719|588869474|FG000|Overall Study|Lost to Follow-up|2|||
163044173|NCT02500719|588869475|FG001|Overall Study|Lost to Follow-up|3|||
163044174|NCT02500719|588869474|FG000|Overall Study|Trauma history|1|||
162955469|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Progressive disease|0|||
162955470|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Progressive disease|0|||
162955471|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Progressive disease|0|||
162955472|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Progressive disease|0|||
162955473|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Progressive disease|0|||
162955474|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955475|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955476|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955477|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955478|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955479|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955480|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955481|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955482|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955483|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955484|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955485|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162955486|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955487|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955488|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162955489|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Physician Decision|0|||
162955490|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Physician Decision|0|||
162955491|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Physician Decision|0|||
162955492|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Physician Decision|0|||
162955493|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Physician Decision|0|||
162955494|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Physician Decision|0|||
162955495|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Physician Decision|0|||
162955496|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Physician Decision|0|||
162955497|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Physician Decision|0|||
162955498|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Physician Decision|0|||
162955499|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Physician Decision|5|||
162955500|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Physician Decision|1|||
162955501|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Physician Decision|1|||
162955502|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Physician Decision|0|||
162955503|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Physician Decision|0|||
162955504|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Death|0|||
163044175|NCT02500719|588869475|FG001|Overall Study|Trauma history|0|||
162855514|NCT00655928|588173774|FG000|Overall Study|Physician Decision|1|||
162855515|NCT00655928|588173775|FG001|Overall Study|Physician Decision|1|||
162855516|NCT00275561|588173781|FG000|Overall Study|Withdrawal by Subject|0|||
162855517|NCT00275561|588173782|FG001|Overall Study|Withdrawal by Subject|1|||
162855518|NCT00275561|588173781|FG000|Overall Study|Travel|1|||
162855519|NCT00275561|588173782|FG001|Overall Study|Travel|1|||
162855520|NCT00275561|588173781|FG000|Overall Study|Scheduling|1|||
162855521|NCT00275561|588173782|FG001|Overall Study|Scheduling|2|||
162855522|NCT00275561|588173781|FG000|Overall Study|Family Issues|0|||
162855523|NCT00275561|588173782|FG001|Overall Study|Family Issues|2|||
162855524|NCT01769105|588173783|FG000|First Intervention|Protocol Violation|2|||
162855525|NCT01769105|588173784|FG001|First Intervention|Protocol Violation|2|||
162855526|NCT01769105|588173783|FG000|Cross-over|Lost to Follow-up|5|||
162855527|NCT01769105|588173784|FG001|Cross-over|Lost to Follow-up|0|||
162611797|NCT00451451|587296665|FG002|Overall Study|Consent Withdrawn|17|||
162611798|NCT00451451|587296666|FG003|Overall Study|Consent Withdrawn|17|||
162855528|NCT01392183|588173789|FG000|First Drug Administration|Adverse Event|3|||
162855529|NCT01392183|588173790|FG001|First Drug Administration|Adverse Event|2|||
162955505|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Death|0|||
162955506|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Death|0|||
162955507|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Death|0|||
162955508|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Death|0|||
162955509|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Death|0|||
162955510|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Death|0|||
162955511|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Death|0|||
162955512|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Death|0|||
162955513|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Death|0|||
162955514|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Death|2|||
162955515|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Death|0|||
162955516|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Death|0|||
162955517|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Death|0|||
162955518|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Death|0|||
162955519|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
162955520|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
162955521|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
162955522|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
162955523|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
162955524|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
162955525|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
162955526|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
162955527|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
162955528|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
162955529|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
162955530|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
162955531|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
162955532|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
162955533|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
162955534|NCT01796171|588539268|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955535|NCT01796171|588539269|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955536|NCT01796171|588539270|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955537|NCT01796171|588539271|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955538|NCT01796171|588539272|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955539|NCT01796171|588539273|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955540|NCT01796171|588539274|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955541|NCT01796171|588539275|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955542|NCT01796171|588539276|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955543|NCT01796171|588539277|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955544|NCT01796171|588539278|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
162955545|NCT01796171|588539279|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
162955546|NCT01796171|588539280|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955547|NCT01796171|588539281|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955548|NCT01796171|588539282|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162955549|NCT01796171|588539268|FG000|Follow-up Period|Start of further anticancer therapy|4|||
162955550|NCT01796171|588539269|FG001|Follow-up Period|Start of further anticancer therapy|25|||
162955551|NCT01796171|588539270|FG002|Follow-up Period|Start of further anticancer therapy|2|||
162955552|NCT01796171|588539271|FG003|Follow-up Period|Start of further anticancer therapy|1|||
162955553|NCT01796171|588539272|FG004|Follow-up Period|Start of further anticancer therapy|2|||
162955554|NCT01796171|588539273|FG005|Follow-up Period|Start of further anticancer therapy|2|||
162955555|NCT01796171|588539274|FG006|Follow-up Period|Start of further anticancer therapy|1|||
162955556|NCT01796171|588539275|FG007|Follow-up Period|Start of further anticancer therapy|15|||
162955557|NCT01796171|588539276|FG008|Follow-up Period|Start of further anticancer therapy|2|||
162955558|NCT01796171|588539277|FG009|Follow-up Period|Start of further anticancer therapy|0|||
162955559|NCT01796171|588539278|FG010|Follow-up Period|Start of further anticancer therapy|0|||
162955560|NCT01796171|588539279|FG011|Follow-up Period|Start of further anticancer therapy|0|||
162955561|NCT01796171|588539280|FG012|Follow-up Period|Start of further anticancer therapy|0|||
162955562|NCT01796171|588539281|FG013|Follow-up Period|Start of further anticancer therapy|0|||
162955563|NCT01796171|588539282|FG014|Follow-up Period|Start of further anticancer therapy|0|||
162955564|NCT01796171|588539268|FG000|Follow-up Period|Progressive disease|0|||
162955565|NCT01796171|588539269|FG001|Follow-up Period|Progressive disease|1|||
162955566|NCT01796171|588539270|FG002|Follow-up Period|Progressive disease|0|||
162955567|NCT01796171|588539271|FG003|Follow-up Period|Progressive disease|0|||
162955568|NCT01796171|588539272|FG004|Follow-up Period|Progressive disease|0|||
163044176|NCT02500719|588869474|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
163044177|NCT02500719|588869475|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
162955569|NCT01796171|588539273|FG005|Follow-up Period|Progressive disease|0|||
162955570|NCT01796171|588539274|FG006|Follow-up Period|Progressive disease|0|||
162955571|NCT01796171|588539275|FG007|Follow-up Period|Progressive disease|3|||
162855530|NCT01392183|588173789|FG000|First Drug Administration|Death|1|||
162855531|NCT01392183|588173790|FG001|First Drug Administration|Death|0|||
163044178|NCT02500719|588869474|FG000|Overall Study|Did not meet criteria for PTSD|0|||
163044179|NCT02500719|588869475|FG001|Overall Study|Did not meet criteria for PTSD|1|||
163044180|NCT02500719|588869474|FG000|Overall Study|Claustrophobia|0|||
163044181|NCT02500719|588869475|FG001|Overall Study|Claustrophobia|1|||
163044182|NCT02500719|588869474|FG000|Overall Study|History of head trauma|0|||
163044183|NCT02500719|588869475|FG001|Overall Study|History of head trauma|1|||
163044184|NCT00154375|588869476|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
163044185|NCT00154375|588869477|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
163044186|NCT00154375|588869476|FG000|Overall Study|Adverse Event|18|||
163044187|NCT00154375|588869477|FG001|Overall Study|Adverse Event|20|||
163044188|NCT00154375|588869476|FG000|Overall Study|Withdrawal by Subject|14|||
163044189|NCT00154375|588869477|FG001|Overall Study|Withdrawal by Subject|10|||
163044190|NCT00154375|588869476|FG000|Overall Study|Death|5|||
163044191|NCT00154375|588869477|FG001|Overall Study|Death|13|||
163044192|NCT00154375|588869476|FG000|Overall Study|Study drug no longer required|5|||
163044193|NCT00154375|588869477|FG001|Overall Study|Study drug no longer required|3|||
163044194|NCT00154375|588869476|FG000|Overall Study|Lost to Follow-up|2|||
163044195|NCT00154375|588869477|FG001|Overall Study|Lost to Follow-up|1|||
163044196|NCT00154375|588869476|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163044197|NCT00154375|588869477|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163044198|NCT00154375|588869476|FG000|Overall Study|Protocol Violation|0|||
163044199|NCT00154375|588869477|FG001|Overall Study|Protocol Violation|1|||
163044200|NCT00154375|588869476|FG000|Overall Study|Suspected progression of disease|44|||
163044201|NCT00154375|588869477|FG001|Overall Study|Suspected progression of disease|30|||
163044202|NCT00792116|588869478|FG000|Overall Study|Lost to Follow-up|0|||
163044203|NCT00792116|588869479|FG001|Overall Study|Lost to Follow-up|1|||
163044204|NCT00792116|588869478|FG000|Overall Study|Discontnued intervention|1|||
163044205|NCT00792116|588869479|FG001|Overall Study|Discontnued intervention|0|||
163044206|NCT00103285|588871410|FG000|Induction|Adverse Event|14|||
163044207|NCT00103285|588871411|FG001|Induction|Adverse Event|0|||
163044208|NCT00103285|588871412|FG002|Induction|Adverse Event|0|||
163044209|NCT00103285|588871413|FG003|Induction|Adverse Event|0|||
163044210|NCT00103285|588871414|FG004|Induction|Adverse Event|0|||
163044211|NCT00103285|588871415|FG005|Induction|Adverse Event|0|||
163044212|NCT00103285|588871416|FG006|Induction|Adverse Event|0|||
163044213|NCT00103285|588871417|FG007|Induction|Adverse Event|0|||
163044214|NCT00103285|588871410|FG000|Induction|Death|24|||
163044215|NCT00103285|588871411|FG001|Induction|Death|0|||
163044216|NCT00103285|588871412|FG002|Induction|Death|0|||
163044217|NCT00103285|588871413|FG003|Induction|Death|0|||
163044218|NCT00103285|588871414|FG004|Induction|Death|0|||
163044219|NCT00103285|588871415|FG005|Induction|Death|0|||
163044220|NCT00103285|588871416|FG006|Induction|Death|0|||
163044221|NCT00103285|588871417|FG007|Induction|Death|0|||
163044222|NCT00103285|588871410|FG000|Induction|Physician Decision|103|||
163044223|NCT00103285|588871411|FG001|Induction|Physician Decision|0|||
163044224|NCT00103285|588871412|FG002|Induction|Physician Decision|0|||
163044225|NCT00103285|588871413|FG003|Induction|Physician Decision|0|||
163044226|NCT00103285|588871414|FG004|Induction|Physician Decision|0|||
163044227|NCT00103285|588871415|FG005|Induction|Physician Decision|0|||
162611799|NCT00451451|587296663|FG000|Overall Study|Investigator Decision|6|||
163044228|NCT00103285|588871416|FG006|Induction|Physician Decision|0|||
163044229|NCT00103285|588871417|FG007|Induction|Physician Decision|0|||
163044230|NCT00103285|588871410|FG000|Induction|Withdrawal by Subject|1|||
163044231|NCT00103285|588871411|FG001|Induction|Withdrawal by Subject|0|||
163044232|NCT00103285|588871412|FG002|Induction|Withdrawal by Subject|0|||
163044233|NCT00103285|588871413|FG003|Induction|Withdrawal by Subject|0|||
163044234|NCT00103285|588871414|FG004|Induction|Withdrawal by Subject|0|||
163044235|NCT00103285|588871415|FG005|Induction|Withdrawal by Subject|0|||
163044236|NCT00103285|588871416|FG006|Induction|Withdrawal by Subject|0|||
163044237|NCT00103285|588871417|FG007|Induction|Withdrawal by Subject|0|||
162611800|NCT00451451|587296664|FG001|Overall Study|Investigator Decision|2|||
162611801|NCT00451451|587296665|FG002|Overall Study|Investigator Decision|1|||
162611802|NCT00451451|587296666|FG003|Overall Study|Investigator Decision|2|||
162611803|NCT00451451|587296663|FG000|Overall Study|Subject Non-Compliance|8|||
162611804|NCT00451451|587296664|FG001|Overall Study|Subject Non-Compliance|4|||
162611805|NCT00451451|587296665|FG002|Overall Study|Subject Non-Compliance|3|||
162611806|NCT00451451|587296666|FG003|Overall Study|Subject Non-Compliance|3|||
162611807|NCT00451451|587296663|FG000|Overall Study|Death|1|||
162855532|NCT01392183|588173789|FG000|First Drug Administration|Withdrawal by Subject|10|||
162855533|NCT01392183|588173790|FG001|First Drug Administration|Withdrawal by Subject|17|||
162855534|NCT00963807|588173793|FG000|Overall Study|Physician Decision|2|||
162855535|NCT00963807|588173793|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
162855536|NCT00963807|588173793|FG000|Overall Study|Disease progression|15|||
162855537|NCT00075881|588175338|FG000|Overall Study|Lack of Efficacy|18|||
162855538|NCT00075881|588175338|FG000|Overall Study|Adverse Event|7|||
162855539|NCT00075881|588175338|FG000|Overall Study|Death|1|||
162855540|NCT00075881|588175338|FG000|Overall Study|Withdrawal by Subject|2|||
162855541|NCT00075881|588175338|FG000|Overall Study|Protocol Violation|4|||
162855542|NCT00075881|588175338|FG000|Overall Study|other complicating disease|3|||
162855543|NCT00075881|588175338|FG000|Overall Study|other|4|||
162855544|NCT00075881|588175338|FG000|Overall Study|missing data|2|||
162855545|NCT00075881|588175338|FG000|Overall Study|Ineligible|1|||
162855546|NCT00075881|588175338|FG000|Overall Study|never start protocol therapy|1|||
162855547|NCT02224664|588175339|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
162855548|NCT02224664|588175340|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
162855549|NCT02224664|588175341|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
162855550|NCT02224664|588175342|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
162855551|NCT02224664|588175343|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
162855552|NCT02224664|588175339|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
162855553|NCT02224664|588175340|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
162855554|NCT02224664|588175341|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
162855555|NCT02224664|588175342|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
162855556|NCT02224664|588175343|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
162855557|NCT02224664|588175339|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
162855558|NCT02224664|588175340|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
162855559|NCT02224664|588175341|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
162855560|NCT02224664|588175342|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
162955572|NCT01796171|588539276|FG008|Follow-up Period|Progressive disease|0|||
162955573|NCT01796171|588539277|FG009|Follow-up Period|Progressive disease|0|||
162955574|NCT01796171|588539278|FG010|Follow-up Period|Progressive disease|0|||
162955575|NCT01796171|588539279|FG011|Follow-up Period|Progressive disease|0|||
162955576|NCT01796171|588539280|FG012|Follow-up Period|Progressive disease|0|||
162955577|NCT01796171|588539281|FG013|Follow-up Period|Progressive disease|0|||
162955578|NCT01796171|588539282|FG014|Follow-up Period|Progressive disease|0|||
162955579|NCT01796171|588539268|FG000|Follow-up Period|Physician Decision|0|||
162955580|NCT01796171|588539269|FG001|Follow-up Period|Physician Decision|2|||
162955581|NCT01796171|588539270|FG002|Follow-up Period|Physician Decision|0|||
162955582|NCT01796171|588539271|FG003|Follow-up Period|Physician Decision|0|||
162955583|NCT01796171|588539272|FG004|Follow-up Period|Physician Decision|0|||
162955584|NCT01796171|588539273|FG005|Follow-up Period|Physician Decision|0|||
162955585|NCT01796171|588539274|FG006|Follow-up Period|Physician Decision|0|||
162955586|NCT01796171|588539275|FG007|Follow-up Period|Physician Decision|0|||
162955587|NCT01796171|588539276|FG008|Follow-up Period|Physician Decision|0|||
162955588|NCT01796171|588539277|FG009|Follow-up Period|Physician Decision|0|||
162955589|NCT01796171|588539278|FG010|Follow-up Period|Physician Decision|5|||
162955590|NCT01796171|588539279|FG011|Follow-up Period|Physician Decision|0|||
162955591|NCT01796171|588539280|FG012|Follow-up Period|Physician Decision|0|||
162955592|NCT01796171|588539281|FG013|Follow-up Period|Physician Decision|0|||
162955593|NCT01796171|588539282|FG014|Follow-up Period|Physician Decision|0|||
162955594|NCT01796171|588539268|FG000|Follow-up Period|Withdrawal by Subject|0|||
162955595|NCT01796171|588539269|FG001|Follow-up Period|Withdrawal by Subject|1|||
162955596|NCT01796171|588539270|FG002|Follow-up Period|Withdrawal by Subject|0|||
162955597|NCT01796171|588539271|FG003|Follow-up Period|Withdrawal by Subject|0|||
162955598|NCT01796171|588539272|FG004|Follow-up Period|Withdrawal by Subject|0|||
162955599|NCT01796171|588539273|FG005|Follow-up Period|Withdrawal by Subject|1|||
162955600|NCT01796171|588539274|FG006|Follow-up Period|Withdrawal by Subject|0|||
162955601|NCT01796171|588539275|FG007|Follow-up Period|Withdrawal by Subject|0|||
162955602|NCT01796171|588539276|FG008|Follow-up Period|Withdrawal by Subject|0|||
162955603|NCT01796171|588539277|FG009|Follow-up Period|Withdrawal by Subject|0|||
162955604|NCT01796171|588539278|FG010|Follow-up Period|Withdrawal by Subject|3|||
162955605|NCT01796171|588539279|FG011|Follow-up Period|Withdrawal by Subject|1|||
162611808|NCT00451451|587296664|FG001|Overall Study|Death|0|||
162611809|NCT00451451|587296665|FG002|Overall Study|Death|0|||
162611810|NCT00451451|587296666|FG003|Overall Study|Death|1|||
163044238|NCT00103285|588871410|FG000|Induction|Ineligible|43|||
163044239|NCT00103285|588871411|FG001|Induction|Ineligible|0|||
163044240|NCT00103285|588871412|FG002|Induction|Ineligible|0|||
163044241|NCT00103285|588871413|FG003|Induction|Ineligible|0|||
163044242|NCT00103285|588871414|FG004|Induction|Ineligible|0|||
163044243|NCT00103285|588871415|FG005|Induction|Ineligible|0|||
163044244|NCT00103285|588871416|FG006|Induction|Ineligible|0|||
163044245|NCT00103285|588871417|FG007|Induction|Ineligible|0|||
163044246|NCT00103285|588871410|FG000|Induction|Refusal|906|||
163044247|NCT00103285|588871411|FG001|Induction|Refusal|0|||
163044248|NCT00103285|588871412|FG002|Induction|Refusal|0|||
163044249|NCT00103285|588871413|FG003|Induction|Refusal|0|||
163044250|NCT00103285|588871414|FG004|Induction|Refusal|0|||
163044251|NCT00103285|588871415|FG005|Induction|Refusal|0|||
163044252|NCT00103285|588871416|FG006|Induction|Refusal|0|||
162611811|NCT00451451|587296663|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
162704788|NCT03100838|587630488|FG001|Overall Study|Adverse Event|0|||
163044253|NCT00103285|588871417|FG007|Induction|Refusal|0|||
163044254|NCT00103285|588871410|FG000|Induction|Other|258|||
162955606|NCT01796171|588539280|FG012|Follow-up Period|Withdrawal by Subject|0|||
162955607|NCT01796171|588539281|FG013|Follow-up Period|Withdrawal by Subject|0|||
162955608|NCT01796171|588539282|FG014|Follow-up Period|Withdrawal by Subject|0|||
162955609|NCT01796171|588539268|FG000|Follow-up Period|Death|0|||
162955610|NCT01796171|588539269|FG001|Follow-up Period|Death|0|||
162955611|NCT01796171|588539270|FG002|Follow-up Period|Death|0|||
162955612|NCT01796171|588539271|FG003|Follow-up Period|Death|0|||
162955613|NCT01796171|588539272|FG004|Follow-up Period|Death|0|||
162955614|NCT01796171|588539273|FG005|Follow-up Period|Death|0|||
162955615|NCT01796171|588539274|FG006|Follow-up Period|Death|1|||
162955616|NCT01796171|588539275|FG007|Follow-up Period|Death|0|||
162955617|NCT01796171|588539276|FG008|Follow-up Period|Death|0|||
162955618|NCT01796171|588539277|FG009|Follow-up Period|Death|0|||
163044255|NCT00103285|588871411|FG001|Induction|Other|0|||
163044256|NCT00103285|588871412|FG002|Induction|Other|0|||
163044257|NCT00103285|588871413|FG003|Induction|Other|0|||
163044258|NCT00103285|588871414|FG004|Induction|Other|0|||
163044259|NCT00103285|588871415|FG005|Induction|Other|0|||
163044260|NCT00103285|588871416|FG006|Induction|Other|0|||
163044261|NCT00103285|588871417|FG007|Induction|Other|0|||
163044262|NCT00103285|588871410|FG000|Response Assignment|Adverse Event|0|||
163044263|NCT00103285|588871411|FG001|Response Assignment|Adverse Event|8|||
163044264|NCT00103285|588871412|FG002|Response Assignment|Adverse Event|3|||
163044265|NCT00103285|588871413|FG003|Response Assignment|Adverse Event|2|||
163044266|NCT00103285|588871414|FG004|Response Assignment|Adverse Event|3|||
163044267|NCT00103285|588871415|FG005|Response Assignment|Adverse Event|1|||
163044268|NCT00103285|588871416|FG006|Response Assignment|Adverse Event|1|||
163044269|NCT00103285|588871417|FG007|Response Assignment|Adverse Event|2|||
163044270|NCT00103285|588871410|FG000|Response Assignment|Death|0|||
162704789|NCT03100838|587630489|FG002|Overall Study|Adverse Event|0|||
162955619|NCT01796171|588539278|FG010|Follow-up Period|Death|17|||
162955620|NCT01796171|588539279|FG011|Follow-up Period|Death|9|||
162955621|NCT01796171|588539280|FG012|Follow-up Period|Death|1|||
162955622|NCT01796171|588539281|FG013|Follow-up Period|Death|0|||
162955623|NCT01796171|588539282|FG014|Follow-up Period|Death|0|||
163044271|NCT00103285|588871411|FG001|Response Assignment|Death|5|||
163044272|NCT00103285|588871412|FG002|Response Assignment|Death|2|||
162955624|NCT01796171|588539268|FG000|Follow-up Period|Patient transferred to other hospital|0|||
162955625|NCT01796171|588539269|FG001|Follow-up Period|Patient transferred to other hospital|1|||
163044273|NCT00103285|588871413|FG003|Response Assignment|Death|2|||
163044274|NCT00103285|588871414|FG004|Response Assignment|Death|3|||
162704790|NCT03100838|587630490|FG003|Overall Study|Adverse Event|0|||
162855561|NCT02224664|588175343|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
162855562|NCT02109029|588175346|FG000|Part B|Adverse Event|0|||
162855563|NCT02109029|588175347|FG001|Part B|Adverse Event|0|||
162855564|NCT02109029|588175348|FG002|Part B|Adverse Event|0|||
162855565|NCT02109029|588175349|FG003|Part B|Adverse Event|0|||
162855566|NCT02109029|588175350|FG004|Part B|Adverse Event|1|||
162855567|NCT02109029|588175351|FG005|Part B|Adverse Event|1|||
162855568|NCT03195894|588175352|FG000|Overall Study|"An example is Started other treatment."|4|||
162855569|NCT03195894|588175353|FG001|Overall Study|"An example is Started other treatment."|5|||
162855570|NCT03195894|588175352|FG000|Overall Study|Withdrawal by Subject|15|||
162855571|NCT03195894|588175353|FG001|Overall Study|Withdrawal by Subject|4|||
162855572|NCT03195894|588175352|FG000|Overall Study|Lost to Follow-up|14|||
162855573|NCT03195894|588175353|FG001|Overall Study|Lost to Follow-up|19|||
162855574|NCT00377962|588175361|FG000|Core Study: 0-12 Months|Adverse Event|18|||
162855575|NCT00377962|588175362|FG001|Core Study: 0-12 Months|Adverse Event|2|||
162855576|NCT00377962|588175361|FG000|Core Study: 0-12 Months|Death|3|||
162855577|NCT00377962|588175362|FG001|Core Study: 0-12 Months|Death|0|||
162855578|NCT00377962|588175361|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
162855579|NCT00377962|588175362|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
162855580|NCT00377962|588175361|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
162855581|NCT00377962|588175362|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
162855582|NCT00377962|588175361|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
162855583|NCT00377962|588175362|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
162855584|NCT00377962|588175361|FG000|Extension Study: 12-24 Months|Death|1|||
162855585|NCT00377962|588175362|FG001|Extension Study: 12-24 Months|Death|1|||
162855586|NCT00377962|588175361|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
162704791|NCT03100838|587630487|FG000|Overall Study|Physician Decision|1|||
162704792|NCT03100838|587630488|FG001|Overall Study|Physician Decision|1|||
162704793|NCT03100838|587630489|FG002|Overall Study|Physician Decision|1|||
162704794|NCT03100838|587630490|FG003|Overall Study|Physician Decision|1|||
162855587|NCT00377962|588175362|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
162855588|NCT00377962|588175361|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
162855589|NCT00377962|588175362|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
162855590|NCT00377962|588175361|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
162855591|NCT00377962|588175362|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
162855592|NCT00496366|588175363|FG000|Overall Study|Death|1|||
162855593|NCT00260208|588175365|FG000|Overall Study|Subject withdrew consent|11|||
162855594|NCT00260208|588175366|FG001|Overall Study|Subject withdrew consent|7|||
162855595|NCT00260208|588175365|FG000|Overall Study|Lost to Follow-up|6|||
162855596|NCT00260208|588175366|FG001|Overall Study|Lost to Follow-up|1|||
162855597|NCT00260208|588175365|FG000|Overall Study|Death|12|||
162855598|NCT00260208|588175366|FG001|Overall Study|Death|10|||
162855599|NCT00260208|588175365|FG000|Overall Study|Missing|18|||
162855600|NCT00260208|588175366|FG001|Overall Study|Missing|16|||
162855601|NCT03263091|588175368|FG000|OL Component|Withdrawal by Subject|1|||
162855602|NCT03263091|588175369|FG001|OL Component|Withdrawal by Subject|1|||
162855603|NCT03263091|588175370|FG002|OL Component|Withdrawal by Subject|0|||
162855604|NCT03263091|588175371|FG003|OL Component|Withdrawal by Subject|0|||
162855605|NCT03263091|588175372|FG004|OL Component|Withdrawal by Subject|0|||
162855606|NCT03263091|588175373|FG005|OL Component|Withdrawal by Subject|0|||
162855607|NCT03263091|588175368|FG000|OL Component|Physician Decision|0|||
162855608|NCT03263091|588175369|FG001|OL Component|Physician Decision|1|||
162855609|NCT03263091|588175370|FG002|OL Component|Physician Decision|2|||
162855610|NCT03263091|588175371|FG003|OL Component|Physician Decision|0|||
162855611|NCT03263091|588175372|FG004|OL Component|Physician Decision|0|||
162855612|NCT03263091|588175373|FG005|OL Component|Physician Decision|0|||
162855613|NCT03263091|588175368|FG000|OL Component|Death|1|||
162855614|NCT03263091|588175369|FG001|OL Component|Death|0|||
162855615|NCT03263091|588175370|FG002|OL Component|Death|0|||
162855616|NCT03263091|588175371|FG003|OL Component|Death|0|||
162855617|NCT03263091|588175372|FG004|OL Component|Death|0|||
162855618|NCT03263091|588175373|FG005|OL Component|Death|0|||
162855619|NCT03263091|588175368|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
162855620|NCT03263091|588175369|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
162855621|NCT03263091|588175370|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
162855622|NCT03263091|588175371|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
162855623|NCT03263091|588175372|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
162855624|NCT03263091|588175373|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
162855625|NCT03263091|588175368|FG000|OL High-EPO Component|Physician Decision|0|||
162855626|NCT03263091|588175369|FG001|OL High-EPO Component|Physician Decision|0|||
162704795|NCT03100838|587630487|FG000|Overall Study|Pregnancy|0|||
162704796|NCT03100838|587630488|FG001|Overall Study|Pregnancy|1|||
162704797|NCT03100838|587630489|FG002|Overall Study|Pregnancy|0|||
162855627|NCT03263091|588175370|FG002|OL High-EPO Component|Physician Decision|0|||
162855628|NCT03263091|588175371|FG003|OL High-EPO Component|Physician Decision|1|||
162855629|NCT03263091|588175372|FG004|OL High-EPO Component|Physician Decision|0|||
162855630|NCT03263091|588175373|FG005|OL High-EPO Component|Physician Decision|0|||
162855631|NCT03263091|588175368|FG000|OL High-EPO Component|Death|0|||
162855632|NCT03263091|588175369|FG001|OL High-EPO Component|Death|0|||
162855633|NCT03263091|588175370|FG002|OL High-EPO Component|Death|0|||
162855634|NCT03263091|588175371|FG003|OL High-EPO Component|Death|3|||
162855635|NCT03263091|588175372|FG004|OL High-EPO Component|Death|0|||
162855636|NCT03263091|588175373|FG005|OL High-EPO Component|Death|0|||
162855637|NCT03263091|588175368|FG000|DB Component|Withdrawal by Subject|0|||
162704798|NCT03100838|587630490|FG003|Overall Study|Pregnancy|0|||
162855638|NCT03263091|588175369|FG001|DB Component|Withdrawal by Subject|0|||
162855639|NCT03263091|588175370|FG002|DB Component|Withdrawal by Subject|0|||
162855640|NCT03263091|588175371|FG003|DB Component|Withdrawal by Subject|0|||
162855641|NCT03263091|588175372|FG004|DB Component|Withdrawal by Subject|22|||
162855642|NCT03263091|588175373|FG005|DB Component|Withdrawal by Subject|8|||
162855643|NCT03263091|588175368|FG000|DB Component|Physician Decision|0|||
162855644|NCT03263091|588175369|FG001|DB Component|Physician Decision|0|||
162855645|NCT03263091|588175370|FG002|DB Component|Physician Decision|0|||
162955626|NCT01796171|588539270|FG002|Follow-up Period|Patient transferred to other hospital|0|||
162955627|NCT01796171|588539271|FG003|Follow-up Period|Patient transferred to other hospital|0|||
162955628|NCT01796171|588539272|FG004|Follow-up Period|Patient transferred to other hospital|0|||
162955629|NCT01796171|588539273|FG005|Follow-up Period|Patient transferred to other hospital|0|||
162955630|NCT01796171|588539274|FG006|Follow-up Period|Patient transferred to other hospital|0|||
162955631|NCT01796171|588539275|FG007|Follow-up Period|Patient transferred to other hospital|0|||
162955632|NCT01796171|588539276|FG008|Follow-up Period|Patient transferred to other hospital|0|||
162955633|NCT01796171|588539277|FG009|Follow-up Period|Patient transferred to other hospital|0|||
162955634|NCT01796171|588539278|FG010|Follow-up Period|Patient transferred to other hospital|0|||
162955635|NCT01796171|588539279|FG011|Follow-up Period|Patient transferred to other hospital|0|||
162955636|NCT01796171|588539280|FG012|Follow-up Period|Patient transferred to other hospital|0|||
162955637|NCT01796171|588539281|FG013|Follow-up Period|Patient transferred to other hospital|0|||
162955638|NCT01796171|588539282|FG014|Follow-up Period|Patient transferred to other hospital|0|||
162955639|NCT01796171|588539268|FG000|Follow-up Period|Sponsor Decision|0|||
162955640|NCT01796171|588539269|FG001|Follow-up Period|Sponsor Decision|0|||
162955641|NCT01796171|588539270|FG002|Follow-up Period|Sponsor Decision|0|||
162955642|NCT01796171|588539271|FG003|Follow-up Period|Sponsor Decision|0|||
162955643|NCT01796171|588539272|FG004|Follow-up Period|Sponsor Decision|0|||
162955644|NCT01796171|588539273|FG005|Follow-up Period|Sponsor Decision|0|||
162955645|NCT01796171|588539274|FG006|Follow-up Period|Sponsor Decision|0|||
162955646|NCT01796171|588539275|FG007|Follow-up Period|Sponsor Decision|0|||
162955647|NCT01796171|588539276|FG008|Follow-up Period|Sponsor Decision|0|||
162955648|NCT01796171|588539277|FG009|Follow-up Period|Sponsor Decision|0|||
162955649|NCT01796171|588539278|FG010|Follow-up Period|Sponsor Decision|40|||
162955650|NCT01796171|588539279|FG011|Follow-up Period|Sponsor Decision|15|||
162955651|NCT01796171|588539280|FG012|Follow-up Period|Sponsor Decision|7|||
162955652|NCT01796171|588539281|FG013|Follow-up Period|Sponsor Decision|0|||
162955653|NCT01796171|588539282|FG014|Follow-up Period|Sponsor Decision|0|||
162955654|NCT00829309|588539283|FG000|Washout: 7 Days|Protocol Violation|1|||
162955655|NCT00829309|588539284|FG001|Washout: 7 Days|Protocol Violation|0|||
162955656|NCT01083693|588539285|FG000|Overall Study|Adverse Event|1|||
162955657|NCT01083693|588539286|FG001|Overall Study|Adverse Event|1|||
162955658|NCT01083693|588539287|FG002|Overall Study|Adverse Event|0|||
162955659|NCT01083693|588539285|FG000|Overall Study|Lost to Follow-up|2|||
162955660|NCT01083693|588539286|FG001|Overall Study|Lost to Follow-up|0|||
162855646|NCT03263091|588175371|FG003|DB Component|Physician Decision|0|||
162955661|NCT01083693|588539287|FG002|Overall Study|Lost to Follow-up|2|||
162955662|NCT01083693|588539285|FG000|Overall Study|Lack of effectiveness|13|||
162955663|NCT01083693|588539286|FG001|Overall Study|Lack of effectiveness|2|||
162955664|NCT01083693|588539287|FG002|Overall Study|Lack of effectiveness|2|||
162955665|NCT01083693|588539285|FG000|Overall Study|Patient Moved|0|||
163044275|NCT00103285|588871415|FG005|Response Assignment|Death|1|||
163044276|NCT00103285|588871416|FG006|Response Assignment|Death|0|||
162855647|NCT03263091|588175372|FG004|DB Component|Physician Decision|3|||
163044277|NCT00103285|588871417|FG007|Response Assignment|Death|8|||
163044278|NCT00103285|588871410|FG000|Response Assignment|Lost to Follow-up|0|||
163044279|NCT00103285|588871411|FG001|Response Assignment|Lost to Follow-up|9|||
162855648|NCT03263091|588175373|FG005|DB Component|Physician Decision|1|||
162855649|NCT03263091|588175368|FG000|DB Component|Adverse Event|0|||
162855650|NCT03263091|588175369|FG001|DB Component|Adverse Event|0|||
162855651|NCT03263091|588175370|FG002|DB Component|Adverse Event|0|||
162855652|NCT03263091|588175371|FG003|DB Component|Adverse Event|0|||
162855653|NCT03263091|588175372|FG004|DB Component|Adverse Event|2|||
162855654|NCT03263091|588175373|FG005|DB Component|Adverse Event|1|||
162855655|NCT03263091|588175368|FG000|DB Component|Lost to Follow-up|0|||
162855656|NCT03263091|588175369|FG001|DB Component|Lost to Follow-up|0|||
162955666|NCT01083693|588539286|FG001|Overall Study|Patient Moved|1|||
162955667|NCT01083693|588539287|FG002|Overall Study|Patient Moved|0|||
162955668|NCT01083693|588539285|FG000|Overall Study|Complete remission|0|||
163044280|NCT00103285|588871412|FG002|Response Assignment|Lost to Follow-up|5|||
162855657|NCT03263091|588175370|FG002|DB Component|Lost to Follow-up|0|||
162855658|NCT03263091|588175371|FG003|DB Component|Lost to Follow-up|0|||
162855659|NCT03263091|588175372|FG004|DB Component|Lost to Follow-up|2|||
162855660|NCT03263091|588175373|FG005|DB Component|Lost to Follow-up|1|||
162855661|NCT03263091|588175368|FG000|DB Component|Death|0|||
162855662|NCT03263091|588175369|FG001|DB Component|Death|0|||
162855663|NCT03263091|588175370|FG002|DB Component|Death|0|||
162855664|NCT03263091|588175371|FG003|DB Component|Death|0|||
162855665|NCT03263091|588175372|FG004|DB Component|Death|7|||
162855666|NCT03263091|588175373|FG005|DB Component|Death|4|||
162855667|NCT03263091|588175368|FG000|DB Component|Other than specified|0|||
162855668|NCT03263091|588175369|FG001|DB Component|Other than specified|0|||
162855669|NCT03263091|588175370|FG002|DB Component|Other than specified|0|||
162855670|NCT03263091|588175371|FG003|DB Component|Other than specified|0|||
162855671|NCT03263091|588175372|FG004|DB Component|Other than specified|8|||
162855672|NCT03263091|588175373|FG005|DB Component|Other than specified|6|||
162855673|NCT00265941|588175383|FG000|Overall Study|Protocol Violation|22|||
162855674|NCT00265941|588175384|FG001|Overall Study|Protocol Violation|25|||
162855675|NCT00265941|588175383|FG000|Overall Study|Lost to Follow-up|1|||
162855676|NCT00265941|588175384|FG001|Overall Study|Lost to Follow-up|1|||
162855677|NCT01217606|588175396|FG000|Initial Treatment Phase|Other Reasons|0|||
162855678|NCT01217606|588175397|FG001|Initial Treatment Phase|Other Reasons|2|||
162855679|NCT01217606|588175396|FG000|Initial Treatment Phase|Protocol Violation|3|||
162855680|NCT01217606|588175397|FG001|Initial Treatment Phase|Protocol Violation|2|||
162855681|NCT01217606|588175396|FG000|Initial Treatment Phase|Personal Reasons|0|||
162855682|NCT01217606|588175397|FG001|Initial Treatment Phase|Personal Reasons|2|||
162855683|NCT01217606|588175396|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
162855684|NCT01217606|588175397|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
162855685|NCT01217606|588175396|FG000|Initial Treatment Phase|Adverse Event|10|||
162855686|NCT01217606|588175397|FG001|Initial Treatment Phase|Adverse Event|6|||
162855687|NCT01217606|588175396|FG000|9-Month Masked Extension|Adverse Event|3|||
162855688|NCT01217606|588175397|FG001|9-Month Masked Extension|Adverse Event|6|||
162855689|NCT01217606|588175396|FG000|9-Month Masked Extension|Other Reasons|4|||
162855690|NCT01217606|588175397|FG001|9-Month Masked Extension|Other Reasons|4|||
162855691|NCT01217606|588175396|FG000|9-Month Masked Extension|Personal Reasons|2|||
162855692|NCT01217606|588175397|FG001|9-Month Masked Extension|Personal Reasons|1|||
162855693|NCT01217606|588175396|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
162855694|NCT01217606|588175397|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
162855695|NCT01217606|588175396|FG000|9-Month Masked Extension|Pregnancy|1|||
162855696|NCT01217606|588175397|FG001|9-Month Masked Extension|Pregnancy|0|||
162855697|NCT01217606|588175396|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
162855698|NCT01217606|588175397|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
162855699|NCT02432807|588175404|FG000|Overall Study|Adverse Event|0|||
162855700|NCT02432807|588175405|FG001|Overall Study|Adverse Event|2|||
162855701|NCT02432807|588175404|FG000|Overall Study|Lost to Follow-up|1|||
162855702|NCT02432807|588175405|FG001|Overall Study|Lost to Follow-up|0|||
162855703|NCT02432807|588175404|FG000|Overall Study|Withdrawal by Subject|1|||
162855704|NCT02432807|588175405|FG001|Overall Study|Withdrawal by Subject|1|||
162855705|NCT02432807|588175404|FG000|Overall Study|Other|1|||
162855706|NCT02432807|588175405|FG001|Overall Study|Other|1|||
162855707|NCT03976401|588175406|FG000|Overall Study|Adverse Event|2|||
162855708|NCT03976401|588175407|FG001|Overall Study|Adverse Event|0|||
162855709|NCT03976401|588175408|FG002|Overall Study|Adverse Event|4|||
162855710|NCT03976401|588175409|FG003|Overall Study|Adverse Event|1|||
162855711|NCT03976401|588175410|FG004|Overall Study|Adverse Event|1|||
162855712|NCT03976401|588175411|FG005|Overall Study|Adverse Event|0|||
162855713|NCT03976401|588175406|FG000|Overall Study|Withdrawal by Subject|0|||
162855714|NCT03976401|588175407|FG001|Overall Study|Withdrawal by Subject|1|||
162855715|NCT03976401|588175408|FG002|Overall Study|Withdrawal by Subject|0|||
162855716|NCT03976401|588175409|FG003|Overall Study|Withdrawal by Subject|0|||
162955669|NCT01083693|588539286|FG001|Overall Study|Complete remission|1|||
162955670|NCT01083693|588539287|FG002|Overall Study|Complete remission|0|||
162955671|NCT01083693|588539285|FG000|Overall Study|Other medical condition/surgery|1|||
162955672|NCT01083693|588539286|FG001|Overall Study|Other medical condition/surgery|1|||
162955673|NCT01083693|588539287|FG002|Overall Study|Other medical condition/surgery|0|||
162955674|NCT01083693|588539285|FG000|Overall Study|Withdrawal by Subject|3|||
162855717|NCT03976401|588175410|FG004|Overall Study|Withdrawal by Subject|0|||
162855718|NCT03976401|588175411|FG005|Overall Study|Withdrawal by Subject|1|||
162855719|NCT03976401|588175406|FG000|Overall Study|Physician Decision|0|||
162855720|NCT03976401|588175407|FG001|Overall Study|Physician Decision|0|||
162855721|NCT03976401|588175408|FG002|Overall Study|Physician Decision|1|||
162855722|NCT03976401|588175409|FG003|Overall Study|Physician Decision|0|||
162855723|NCT03976401|588175410|FG004|Overall Study|Physician Decision|0|||
162855724|NCT03976401|588175411|FG005|Overall Study|Physician Decision|0|||
162855725|NCT03976401|588175406|FG000|Overall Study|Lost to Follow-up|1|||
163044281|NCT00103285|588871413|FG003|Response Assignment|Lost to Follow-up|5|||
163044282|NCT00103285|588871414|FG004|Response Assignment|Lost to Follow-up|1|||
163044283|NCT00103285|588871415|FG005|Response Assignment|Lost to Follow-up|2|||
163044284|NCT00103285|588871416|FG006|Response Assignment|Lost to Follow-up|2|||
163044285|NCT00103285|588871417|FG007|Response Assignment|Lost to Follow-up|5|||
163044286|NCT00103285|588871410|FG000|Response Assignment|Physician Decision|0|||
163044287|NCT00103285|588871411|FG001|Response Assignment|Physician Decision|13|||
163044288|NCT00103285|588871412|FG002|Response Assignment|Physician Decision|14|||
163044289|NCT00103285|588871413|FG003|Response Assignment|Physician Decision|9|||
163044290|NCT00103285|588871414|FG004|Response Assignment|Physician Decision|13|||
163044291|NCT00103285|588871415|FG005|Response Assignment|Physician Decision|7|||
163044292|NCT00103285|588871416|FG006|Response Assignment|Physician Decision|4|||
163044293|NCT00103285|588871417|FG007|Response Assignment|Physician Decision|35|||
162955675|NCT01083693|588539286|FG001|Overall Study|Withdrawal by Subject|0|||
162955676|NCT01083693|588539287|FG002|Overall Study|Withdrawal by Subject|2|||
163044294|NCT00103285|588871410|FG000|Response Assignment|Protocol Violation|0|||
163044295|NCT00103285|588871411|FG001|Response Assignment|Protocol Violation|2|||
163044296|NCT00103285|588871412|FG002|Response Assignment|Protocol Violation|0|||
162955677|NCT01083693|588539285|FG000|Overall Study|Reason unknown|0|||
162955678|NCT01083693|588539286|FG001|Overall Study|Reason unknown|0|||
162955679|NCT01083693|588539287|FG002|Overall Study|Reason unknown|1|||
162955680|NCT03699020|588539291|FG000|Overall Study|Withdrawal by Subject|3|||
163044297|NCT00103285|588871413|FG003|Response Assignment|Protocol Violation|0|||
163044298|NCT00103285|588871414|FG004|Response Assignment|Protocol Violation|0|||
163044299|NCT00103285|588871415|FG005|Response Assignment|Protocol Violation|0|||
163044300|NCT00103285|588871416|FG006|Response Assignment|Protocol Violation|0|||
163044301|NCT00103285|588871417|FG007|Response Assignment|Protocol Violation|0|||
163044302|NCT00103285|588871410|FG000|Response Assignment|Withdrawal by Subject|0|||
163044303|NCT00103285|588871411|FG001|Response Assignment|Withdrawal by Subject|4|||
163044304|NCT00103285|588871412|FG002|Response Assignment|Withdrawal by Subject|1|||
162955681|NCT03699020|588539292|FG001|Overall Study|Withdrawal by Subject|2|||
162955682|NCT03020615|588539296|FG000|Overall Study|Physician Decision|3|||
162955683|NCT03020615|588539297|FG001|Overall Study|Physician Decision|1|||
162955684|NCT03020615|588539298|FG002|Overall Study|Physician Decision|2|||
162955685|NCT03020615|588539296|FG000|Overall Study|Parent/guardian/patient choice|3|||
162955686|NCT03020615|588539297|FG001|Overall Study|Parent/guardian/patient choice|0|||
162955687|NCT03020615|588539298|FG002|Overall Study|Parent/guardian/patient choice|4|||
162955688|NCT03020615|588539296|FG000|Overall Study|Screen failure|0|||
162955689|NCT03020615|588539297|FG001|Overall Study|Screen failure|0|||
162955690|NCT03020615|588539298|FG002|Overall Study|Screen failure|1|||
162955691|NCT03020615|588539296|FG000|Overall Study|Death|1|||
162955692|NCT03020615|588539297|FG001|Overall Study|Death|0|||
162955693|NCT03020615|588539298|FG002|Overall Study|Death|0|||
162955694|NCT03020615|588539296|FG000|Overall Study|Lost to Follow-up|0|||
162955695|NCT03020615|588539297|FG001|Overall Study|Lost to Follow-up|1|||
162955696|NCT03020615|588539298|FG002|Overall Study|Lost to Follow-up|0|||
162955697|NCT00089661|588539299|FG000|Overall Study|Adverse Event|0|||
162955698|NCT00089661|588539300|FG001|Overall Study|Adverse Event|2|||
162955699|NCT00089661|588539299|FG000|Overall Study|Death|1|||
162955700|NCT00089661|588539300|FG001|Overall Study|Death|0|||
162955701|NCT00089661|588539299|FG000|Overall Study|Lost to Follow-up|0|||
162955702|NCT00089661|588539300|FG001|Overall Study|Lost to Follow-up|3|||
162955703|NCT00089661|588539299|FG000|Overall Study|Withdrawal by Subject|11|||
162955704|NCT00089661|588539300|FG001|Overall Study|Withdrawal by Subject|9|||
162955705|NCT00089661|588539299|FG000|Overall Study|Disease progression|1|||
162955706|NCT00089661|588539300|FG001|Overall Study|Disease progression|3|||
163044305|NCT00103285|588871413|FG003|Response Assignment|Withdrawal by Subject|1|||
163044306|NCT00103285|588871414|FG004|Response Assignment|Withdrawal by Subject|2|||
163044307|NCT00103285|588871415|FG005|Response Assignment|Withdrawal by Subject|2|||
163044308|NCT00103285|588871416|FG006|Response Assignment|Withdrawal by Subject|0|||
163044309|NCT00103285|588871417|FG007|Response Assignment|Withdrawal by Subject|2|||
163044310|NCT00103285|588871410|FG000|Response Assignment|Ineligible|0|||
163044311|NCT00103285|588871411|FG001|Response Assignment|Ineligible|8|||
163044312|NCT00103285|588871412|FG002|Response Assignment|Ineligible|6|||
163044313|NCT00103285|588871413|FG003|Response Assignment|Ineligible|2|||
163044314|NCT00103285|588871414|FG004|Response Assignment|Ineligible|0|||
163044315|NCT00103285|588871415|FG005|Response Assignment|Ineligible|3|||
162955707|NCT00089661|588539299|FG000|Overall Study|Ineligibility determined|4|||
162955708|NCT00089661|588539300|FG001|Overall Study|Ineligibility determined|4|||
162955709|NCT00089661|588539299|FG000|Overall Study|Noncompliance|2|||
163044316|NCT00103285|588871416|FG006|Response Assignment|Ineligible|1|||
163044317|NCT00103285|588871417|FG007|Response Assignment|Ineligible|5|||
162955710|NCT00089661|588539300|FG001|Overall Study|Noncompliance|4|||
162855726|NCT03976401|588175407|FG001|Overall Study|Lost to Follow-up|2|||
162855727|NCT03976401|588175408|FG002|Overall Study|Lost to Follow-up|0|||
162855728|NCT03976401|588175409|FG003|Overall Study|Lost to Follow-up|0|||
162855729|NCT03976401|588175410|FG004|Overall Study|Lost to Follow-up|0|||
162855730|NCT03976401|588175411|FG005|Overall Study|Lost to Follow-up|0|||
162855731|NCT03976401|588175406|FG000|Overall Study|Protocol Violation|0|||
162855732|NCT03976401|588175407|FG001|Overall Study|Protocol Violation|1|||
162855733|NCT03976401|588175408|FG002|Overall Study|Protocol Violation|0|||
162855734|NCT03976401|588175409|FG003|Overall Study|Protocol Violation|0|||
162855735|NCT03976401|588175410|FG004|Overall Study|Protocol Violation|0|||
162855736|NCT03976401|588175411|FG005|Overall Study|Protocol Violation|0|||
162855737|NCT03976401|588175406|FG000|Overall Study|Withdrew Consent|0|||
162855738|NCT03976401|588175407|FG001|Overall Study|Withdrew Consent|0|||
162855739|NCT03976401|588175408|FG002|Overall Study|Withdrew Consent|0|||
162855740|NCT03976401|588175409|FG003|Overall Study|Withdrew Consent|1|||
162855741|NCT03976401|588175410|FG004|Overall Study|Withdrew Consent|0|||
162855742|NCT03976401|588175411|FG005|Overall Study|Withdrew Consent|0|||
162855743|NCT04125680|588175414|FG000|Overall Study|Lost to Follow-up|15|||
162855744|NCT02966314|588175415|FG000|Overall Study|Lost to Follow-up|1|||
162855745|NCT02966314|588175416|FG001|Overall Study|Lost to Follow-up|0|||
162855746|NCT00391976|588175417|FG000|Overall Study|Adverse Event|0|||
162855747|NCT00391976|588175418|FG001|Overall Study|Adverse Event|0|||
162855748|NCT00391976|588175419|FG002|Overall Study|Adverse Event|1|||
162855749|NCT00391976|588175417|FG000|Overall Study|Withdrawal of consent|0|||
162855750|NCT00391976|588175418|FG001|Overall Study|Withdrawal of consent|1|||
162855751|NCT00391976|588175419|FG002|Overall Study|Withdrawal of consent|1|||
162855752|NCT00391976|588175417|FG000|Overall Study|Lost to Follow-up|1|||
162855753|NCT00391976|588175418|FG001|Overall Study|Lost to Follow-up|2|||
162855754|NCT00391976|588175419|FG002|Overall Study|Lost to Follow-up|0|||
162855755|NCT00391976|588175417|FG000|Overall Study|Inappropriate enrollment|1|||
162855756|NCT00391976|588175418|FG001|Overall Study|Inappropriate enrollment|1|||
162855757|NCT00391976|588175419|FG002|Overall Study|Inappropriate enrollment|0|||
162855758|NCT00391976|588175417|FG000|Overall Study|Protocol deviation/violation|4|||
162855759|NCT00391976|588175418|FG001|Overall Study|Protocol deviation/violation|2|||
162855760|NCT00391976|588175419|FG002|Overall Study|Protocol deviation/violation|1|||
162855761|NCT00391976|588175417|FG000|Overall Study|Recurrence/no eradication of infection|21|||
162855762|NCT00391976|588175418|FG001|Overall Study|Recurrence/no eradication of infection|19|||
162855763|NCT00391976|588175419|FG002|Overall Study|Recurrence/no eradication of infection|0|||
162855764|NCT00391976|588175417|FG000|Overall Study|Unable to classify|0|||
162855765|NCT00391976|588175418|FG001|Overall Study|Unable to classify|0|||
162855766|NCT00391976|588175419|FG002|Overall Study|Unable to classify|1|||
162855767|NCT00391976|588175417|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
162855768|NCT00391976|588175418|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
162855769|NCT00391976|588175419|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
162855770|NCT00049127|588175420|FG000|Overall Study|Withdrawal by Subject|0|||
162855771|NCT00049127|588175421|FG001|Overall Study|Withdrawal by Subject|0|||
162855772|NCT00049127|588175422|FG002|Overall Study|Withdrawal by Subject|1|||
162855773|NCT00049127|588175423|FG003|Overall Study|Withdrawal by Subject|0|||
162855774|NCT00049127|588175424|FG004|Overall Study|Withdrawal by Subject|0|||
162855775|NCT02582515|588175425|FG000|Overall Study|Withdrawal by Subject|0|||
162855776|NCT02582515|588175426|FG001|Overall Study|Withdrawal by Subject|1|||
162855777|NCT02725788|588175431|FG000|Overall Study|Lost to Follow-up|1|||
162855778|NCT02725788|588175432|FG001|Overall Study|Lost to Follow-up|1|||
162855779|NCT02725788|588175431|FG000|Overall Study|Protocol Violation|0|||
162855780|NCT02725788|588175432|FG001|Overall Study|Protocol Violation|1|||
162855781|NCT00828464|588175433|FG000|Overall Study|Withdrawal by Subject|1|||
162855782|NCT00474240|588175434|FG000|Overall Study|Withdrawal by Subject|1|||
162855783|NCT00474240|588175435|FG001|Overall Study|Withdrawal by Subject|1|||
162855784|NCT00474240|588175436|FG002|Overall Study|Withdrawal by Subject|0|||
162855785|NCT00474240|588175437|FG003|Overall Study|Withdrawal by Subject|2|||
162855786|NCT00474240|588175438|FG004|Overall Study|Withdrawal by Subject|3|||
162855787|NCT00474240|588175439|FG005|Overall Study|Withdrawal by Subject|1|||
162855788|NCT00474240|588175434|FG000|Overall Study|Adverse Event|0|||
162855789|NCT00474240|588175435|FG001|Overall Study|Adverse Event|0|||
162855790|NCT00474240|588175436|FG002|Overall Study|Adverse Event|9|||
162855791|NCT00474240|588175437|FG003|Overall Study|Adverse Event|14|||
162955711|NCT00089661|588539299|FG000|Overall Study|Other|2|||
162855792|NCT00474240|588175438|FG004|Overall Study|Adverse Event|5|||
162855793|NCT00474240|588175439|FG005|Overall Study|Adverse Event|16|||
162855794|NCT00474240|588175434|FG000|Overall Study|Removed due to lab value|0|||
162855795|NCT00474240|588175435|FG001|Overall Study|Removed due to lab value|0|||
162855796|NCT00474240|588175436|FG002|Overall Study|Removed due to lab value|0|||
162855797|NCT00474240|588175437|FG003|Overall Study|Removed due to lab value|0|||
162855798|NCT00474240|588175438|FG004|Overall Study|Removed due to lab value|0|||
162855799|NCT00474240|588175439|FG005|Overall Study|Removed due to lab value|1|||
162855800|NCT00502840|588175440|FG000|Overall Study|Adverse Event|5|||
162855801|NCT00502840|588175440|FG000|Overall Study|Additional or changed therapy|48|||
163044318|NCT00103285|588871410|FG000|Response Assignment|Refusal|0|||
163044319|NCT00103285|588871411|FG001|Response Assignment|Refusal|53|||
163044320|NCT00103285|588871412|FG002|Response Assignment|Refusal|5|||
163044321|NCT00103285|588871413|FG003|Response Assignment|Refusal|3|||
163044322|NCT00103285|588871414|FG004|Response Assignment|Refusal|25|||
163044323|NCT00103285|588871415|FG005|Response Assignment|Refusal|15|||
163044324|NCT00103285|588871416|FG006|Response Assignment|Refusal|30|||
163044325|NCT00103285|588871417|FG007|Response Assignment|Refusal|10|||
163044326|NCT00103285|588871410|FG000|Response Assignment|Other|0|||
163044327|NCT00103285|588871411|FG001|Response Assignment|Other|30|||
163044328|NCT00103285|588871412|FG002|Response Assignment|Other|48|||
163044329|NCT00103285|588871413|FG003|Response Assignment|Other|38|||
163044330|NCT00103285|588871414|FG004|Response Assignment|Other|37|||
163044331|NCT00103285|588871415|FG005|Response Assignment|Other|17|||
163044332|NCT00103285|588871416|FG006|Response Assignment|Other|11|||
163044333|NCT00103285|588871417|FG007|Response Assignment|Other|53|||
163044334|NCT00452439|588871418|FG000|Overall Study|Lost to Follow-up|1|||
163044335|NCT00452439|588871419|FG001|Overall Study|Lost to Follow-up|1|||
163044336|NCT00452439|588871418|FG000|Overall Study|Refused Treatment|4|||
163044337|NCT00452439|588871419|FG001|Overall Study|Refused Treatment|3|||
163044338|NCT00452439|588871418|FG000|Overall Study|Death|3|||
163044339|NCT00452439|588871419|FG001|Overall Study|Death|1|||
163044340|NCT00452439|588871418|FG000|Overall Study|Bone Marrow Transplant|0|||
163044341|NCT00452439|588871419|FG001|Overall Study|Bone Marrow Transplant|1|||
163044342|NCT00452439|588871418|FG000|Overall Study|Too Ill to Continue|0|||
163044343|NCT00452439|588871419|FG001|Overall Study|Too Ill to Continue|1|||
163044344|NCT00452439|588871418|FG000|Overall Study|Failed to achieve complete response|2|||
163044345|NCT00452439|588871419|FG001|Overall Study|Failed to achieve complete response|0|||
163044346|NCT00452439|588871418|FG000|Overall Study|Relapse|3|||
163044347|NCT00452439|588871419|FG001|Overall Study|Relapse|0|||
163044348|NCT00452439|588871418|FG000|Overall Study|Fracture|1|||
163044349|NCT00452439|588871419|FG001|Overall Study|Fracture|0|||
163044350|NCT01381926|588871422|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
163044351|NCT01381926|588871423|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
163044352|NCT01381926|588871422|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
163044353|NCT01381926|588871423|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
163044354|NCT02624947|588871428|FG000|Maternal Participants|Adverse Event|5|||
163044355|NCT02624947|588871429|FG001|Maternal Participants|Adverse Event|0|||
163044356|NCT02624947|588871428|FG000|Maternal Participants|Investigator Decision|5|||
163044357|NCT02624947|588871429|FG001|Maternal Participants|Investigator Decision|3|||
163044358|NCT02624947|588871428|FG000|Maternal Participants|Lost to Follow-up|54|||
163044359|NCT02624947|588871429|FG001|Maternal Participants|Lost to Follow-up|24|||
163044360|NCT02624947|588871428|FG000|Maternal Participants|Non Compliance|8|||
163044361|NCT02624947|588871429|FG001|Maternal Participants|Non Compliance|5|||
163044362|NCT02624947|588871428|FG000|Maternal Participants|Sponsor Request|1|||
163044363|NCT02624947|588871429|FG001|Maternal Participants|Sponsor Request|1|||
163044364|NCT02624947|588871428|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
163044365|NCT02624947|588871429|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
163044366|NCT02624947|588871428|FG000|Maternal Participants|Miscellaneous|23|||
163044367|NCT02624947|588871429|FG001|Maternal Participants|Miscellaneous|15|||
163044368|NCT02624947|588871428|FG000|Infant Participants|Adverse Event|18|||
163044369|NCT02624947|588871429|FG001|Infant Participants|Adverse Event|11|||
163044370|NCT02624947|588871428|FG000|Infant Participants|Investigator Decision|5|||
163044371|NCT02624947|588871429|FG001|Infant Participants|Investigator Decision|4|||
163044372|NCT02624947|588871428|FG000|Infant Participants|Lost to Follow-up|93|||
163044373|NCT02624947|588871429|FG001|Infant Participants|Lost to Follow-up|58|||
163044374|NCT02624947|588871428|FG000|Infant Participants|Non Compliance|17|||
163044375|NCT02624947|588871429|FG001|Infant Participants|Non Compliance|7|||
163044376|NCT02624947|588871428|FG000|Infant Participants|Sponsor Request|0|||
163044377|NCT02624947|588871429|FG001|Infant Participants|Sponsor Request|1|||
163044378|NCT02624947|588871428|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
162704799|NCT03100838|587630487|FG000|Overall Study|Lost to Follow-up|0|||
163044379|NCT02624947|588871429|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
163044380|NCT02624947|588871428|FG000|Infant Participants|Miscellaneous|50|||
163044381|NCT02624947|588871429|FG001|Infant Participants|Miscellaneous|26|||
163044382|NCT03654729|588871438|FG000|Overall Study|Death|9|||
163044383|NCT03654729|588871439|FG001|Overall Study|Death|9|||
163044384|NCT03654729|588871440|FG002|Overall Study|Death|16|||
163044385|NCT03654729|588871438|FG000|Overall Study|Withdrawal by Subject|8|||
163044386|NCT03654729|588871439|FG001|Overall Study|Withdrawal by Subject|6|||
163044387|NCT03654729|588871440|FG002|Overall Study|Withdrawal by Subject|4|||
163044388|NCT03654729|588871438|FG000|Overall Study|Study terminated by Sponsor|3|||
163044389|NCT03654729|588871439|FG001|Overall Study|Study terminated by Sponsor|5|||
163044390|NCT03654729|588871440|FG002|Overall Study|Study terminated by Sponsor|4|||
163044391|NCT03654729|588871438|FG000|Overall Study|Not reported|2|||
163044392|NCT03654729|588871439|FG001|Overall Study|Not reported|4|||
163044393|NCT03654729|588871440|FG002|Overall Study|Not reported|5|||
163044394|NCT03654729|588871438|FG000|Overall Study|Progressive disease|3|||
163044395|NCT03654729|588871439|FG001|Overall Study|Progressive disease|0|||
162855802|NCT00502840|588175440|FG000|Overall Study|Lack of Efficacy|11|||
162855803|NCT00502840|588175440|FG000|Overall Study|Protocol Violation|4|||
162855804|NCT00502840|588175440|FG000|Overall Study|Withdrawal by Subject|5|||
162855805|NCT00502840|588175440|FG000|Overall Study|Lost to Follow-up|6|||
162855806|NCT00502840|588175440|FG000|Overall Study|Administrative problems|1|||
162855807|NCT00502840|588175440|FG000|Overall Study|Other|20|||
162855808|NCT02197377|588175441|FG000|Overall Study|Insertion Failure|0|||
162855809|NCT02197377|588175442|FG001|Overall Study|Insertion Failure|3|||
162855810|NCT00607048|588175443|FG000|Overall Study|Adverse Event|0|||
162855811|NCT00607048|588175444|FG001|Overall Study|Adverse Event|1|||
162855812|NCT00607048|588175445|FG002|Overall Study|Adverse Event|0|||
162855813|NCT00607048|588175446|FG003|Overall Study|Adverse Event|0|||
162855814|NCT00607048|588175447|FG004|Overall Study|Adverse Event|4|||
162855815|NCT00607048|588175448|FG005|Overall Study|Adverse Event|0|||
162855816|NCT00607048|588175443|FG000|Overall Study|Global deterioration of health|1|||
162855817|NCT00607048|588175444|FG001|Overall Study|Global deterioration of health|0|||
162855818|NCT00607048|588175445|FG002|Overall Study|Global deterioration of health|0|||
162855819|NCT00607048|588175446|FG003|Overall Study|Global deterioration of health|0|||
162855820|NCT00607048|588175447|FG004|Overall Study|Global deterioration of health|0|||
162855821|NCT00607048|588175448|FG005|Overall Study|Global deterioration of health|0|||
162855822|NCT00607048|588175443|FG000|Overall Study|Objective disease progression - relapse|1|||
162855823|NCT00607048|588175444|FG001|Overall Study|Objective disease progression - relapse|2|||
162855824|NCT00607048|588175445|FG002|Overall Study|Objective disease progression - relapse|4|||
162855825|NCT00607048|588175446|FG003|Overall Study|Objective disease progression - relapse|2|||
162855826|NCT00607048|588175447|FG004|Overall Study|Objective disease progression - relapse|2|||
162855827|NCT00607048|588175448|FG005|Overall Study|Objective disease progression - relapse|2|||
162855828|NCT00607048|588175443|FG000|Overall Study|Withdrawal by Subject|0|||
162855829|NCT00607048|588175444|FG001|Overall Study|Withdrawal by Subject|0|||
162855830|NCT00607048|588175445|FG002|Overall Study|Withdrawal by Subject|0|||
162855831|NCT00607048|588175446|FG003|Overall Study|Withdrawal by Subject|1|||
162855832|NCT00607048|588175447|FG004|Overall Study|Withdrawal by Subject|0|||
162855833|NCT00607048|588175448|FG005|Overall Study|Withdrawal by Subject|2|||
162855834|NCT00607048|588175443|FG000|Overall Study|Other|1|||
162855835|NCT00607048|588175444|FG001|Overall Study|Other|1|||
162855836|NCT00607048|588175445|FG002|Overall Study|Other|0|||
162855837|NCT00607048|588175446|FG003|Overall Study|Other|0|||
162855838|NCT00607048|588175447|FG004|Overall Study|Other|0|||
162855839|NCT00607048|588175448|FG005|Overall Study|Other|1|||
162855840|NCT04927312|588175449|FG000|Overall Study|Adverse Event|1|||
162855841|NCT04927312|588175449|FG000|Overall Study|Death|1|||
162855842|NCT04927312|588175449|FG000|Overall Study|Withdrawal by Subject|1|||
162855843|NCT04927312|588175449|FG000|Overall Study|Other|1|||
162855844|NCT04919564|588175455|FG000|Overall Study|Lost to Follow-up|1|||
162855845|NCT04919564|588175456|FG001|Overall Study|Lost to Follow-up|0|||
162855846|NCT04919564|588175455|FG000|Overall Study|Physician Decision|1|||
162955712|NCT00089661|588539300|FG001|Overall Study|Other|1|||
162955713|NCT02760368|588539301|FG000|Overall Study|Withdrawal by Subject|8|||
162955714|NCT02760368|588539302|FG001|Overall Study|Withdrawal by Subject|12|||
162955715|NCT02760368|588539303|FG002|Overall Study|Withdrawal by Subject|9|||
162955716|NCT02760368|588539301|FG000|Overall Study|Screen Failure|0|||
162955717|NCT02760368|588539302|FG001|Overall Study|Screen Failure|0|||
162855847|NCT04919564|588175456|FG001|Overall Study|Physician Decision|1|||
162855848|NCT02620020|588175457|FG000|Overall Study|Adverse Event|8|||
162855849|NCT02620020|588175458|FG001|Overall Study|Adverse Event|4|||
162855850|NCT02620020|588175459|FG002|Overall Study|Adverse Event|3|||
162955718|NCT02760368|588539303|FG002|Overall Study|Screen Failure|1|||
162955719|NCT02760368|588539301|FG000|Overall Study|Death|0|||
162855851|NCT02620020|588175460|FG003|Overall Study|Adverse Event|5|||
162855852|NCT02620020|588175457|FG000|Overall Study|Lost to Follow-up|4|||
162955720|NCT02760368|588539302|FG001|Overall Study|Death|1|||
162855853|NCT02620020|588175458|FG001|Overall Study|Lost to Follow-up|8|||
162855854|NCT02620020|588175459|FG002|Overall Study|Lost to Follow-up|1|||
162855855|NCT02620020|588175460|FG003|Overall Study|Lost to Follow-up|4|||
162855856|NCT02620020|588175457|FG000|Overall Study|Physician Decision|7|||
162855857|NCT02620020|588175458|FG001|Overall Study|Physician Decision|4|||
162855858|NCT02620020|588175459|FG002|Overall Study|Physician Decision|3|||
162855859|NCT02620020|588175460|FG003|Overall Study|Physician Decision|4|||
162855860|NCT02620020|588175457|FG000|Overall Study|Protocol Violation|5|||
162855861|NCT02620020|588175458|FG001|Overall Study|Protocol Violation|2|||
162855862|NCT02620020|588175459|FG002|Overall Study|Protocol Violation|1|||
162855863|NCT02620020|588175460|FG003|Overall Study|Protocol Violation|1|||
162855864|NCT02620020|588175457|FG000|Overall Study|Withdrawal by Subject|20|||
162855865|NCT02620020|588175458|FG001|Overall Study|Withdrawal by Subject|16|||
162855866|NCT02620020|588175459|FG002|Overall Study|Withdrawal by Subject|17|||
162855867|NCT02620020|588175460|FG003|Overall Study|Withdrawal by Subject|12|||
162855868|NCT02620020|588175457|FG000|Overall Study|Death|0|||
162855869|NCT02620020|588175458|FG001|Overall Study|Death|1|||
162855870|NCT02620020|588175459|FG002|Overall Study|Death|0|||
162855871|NCT02620020|588175460|FG003|Overall Study|Death|0|||
162855872|NCT05292755|588175461|FG000|Overall Study|Lost to Follow-up|5|||
162855873|NCT05292755|588175462|FG001|Overall Study|Lost to Follow-up|9|||
162855874|NCT04052139|588175463|FG000|Overall Study|Lost to Follow-up|2|||
162855875|NCT04052139|588175464|FG001|Overall Study|Lost to Follow-up|0|||
162855876|NCT04052139|588175465|FG002|Overall Study|Lost to Follow-up|0|||
162855877|NCT04052139|588175463|FG000|Overall Study|Withdrawal by Subject|1|||
162855878|NCT04052139|588175464|FG001|Overall Study|Withdrawal by Subject|0|||
162855879|NCT04052139|588175465|FG002|Overall Study|Withdrawal by Subject|0|||
162855880|NCT00707577|588175466|FG000|Overall Study|Withdrawal by Subject|3|||
162855881|NCT00707577|588175467|FG001|Overall Study|Withdrawal by Subject|2|||
162855882|NCT00707577|588175466|FG000|Overall Study|Lost to Follow-up|34|||
162855883|NCT00707577|588175467|FG001|Overall Study|Lost to Follow-up|25|||
162855884|NCT00707577|588175466|FG000|Overall Study|Left employment|13|||
162855885|NCT00707577|588175467|FG001|Overall Study|Left employment|10|||
162855886|NCT00707577|588175466|FG000|Overall Study|Pregnancy|4|||
162855887|NCT00707577|588175467|FG001|Overall Study|Pregnancy|1|||
162855888|NCT00190775|588175468|FG000|Overall Study|Adverse Event|57|||
162855889|NCT00190775|588175469|FG001|Overall Study|Adverse Event|22|||
162855890|NCT00190775|588175468|FG000|Overall Study|Satisfactory Response|1|||
162855891|NCT00190775|588175469|FG001|Overall Study|Satisfactory Response|0|||
162855892|NCT00190775|588175468|FG000|Overall Study|Lack of Efficacy|28|||
162855893|NCT00190775|588175469|FG001|Overall Study|Lack of Efficacy|32|||
162855894|NCT00190775|588175468|FG000|Overall Study|Lost to Follow-up|31|||
162855895|NCT00190775|588175469|FG001|Overall Study|Lost to Follow-up|23|||
162855896|NCT00190775|588175468|FG000|Overall Study|Participant Moved|0|||
162855897|NCT00190775|588175469|FG001|Overall Study|Participant Moved|1|||
162855898|NCT00190775|588175468|FG000|Overall Study|Withdrawal by Subject|24|||
162855899|NCT00190775|588175469|FG001|Overall Study|Withdrawal by Subject|13|||
162855900|NCT00190775|588175468|FG000|Overall Study|Sponsor Decision|1|||
162855901|NCT00190775|588175469|FG001|Overall Study|Sponsor Decision|0|||
162855902|NCT00190775|588175468|FG000|Overall Study|Physician Decision|3|||
162855903|NCT00190775|588175469|FG001|Overall Study|Physician Decision|0|||
162855904|NCT00190775|588175468|FG000|Overall Study|Noncompliance|3|||
162855905|NCT00190775|588175469|FG001|Overall Study|Noncompliance|5|||
162855906|NCT00190775|588175468|FG000|Overall Study|Protocol Violation|0|||
162855907|NCT00190775|588175469|FG001|Overall Study|Protocol Violation|1|||
162855908|NCT00190775|588175468|FG000|Overall Study|Exclusion Criteria Met|1|||
162855909|NCT00190775|588175469|FG001|Overall Study|Exclusion Criteria Met|3|||
162855910|NCT01794780|588175470|FG000|Overall Study|Adverse Event|0|||
162855911|NCT01794780|588175471|FG001|Overall Study|Adverse Event|1|||
162855912|NCT01794780|588175472|FG002|Overall Study|Adverse Event|2|||
162855913|NCT01794780|588175473|FG003|Overall Study|Adverse Event|0|||
162855914|NCT01794780|588175474|FG004|Overall Study|Adverse Event|0|||
162855915|NCT01794780|588175475|FG005|Overall Study|Adverse Event|0|||
162855916|NCT01794780|588175476|FG006|Overall Study|Adverse Event|0|||
162855917|NCT01794780|588175477|FG007|Overall Study|Adverse Event|0|||
162855918|NCT01794780|588175470|FG000|Overall Study|Death|0|||
162855919|NCT01794780|588175471|FG001|Overall Study|Death|2|||
162855920|NCT01794780|588175472|FG002|Overall Study|Death|14|||
162855921|NCT01794780|588175473|FG003|Overall Study|Death|1|||
162855922|NCT01794780|588175474|FG004|Overall Study|Death|0|||
162855923|NCT01794780|588175475|FG005|Overall Study|Death|9|||
162855924|NCT01794780|588175476|FG006|Overall Study|Death|4|||
162855925|NCT01794780|588175477|FG007|Overall Study|Death|0|||
162855926|NCT01794780|588175470|FG000|Overall Study|Lost to Follow-up|10|||
162855927|NCT01794780|588175471|FG001|Overall Study|Lost to Follow-up|64|||
162855928|NCT01794780|588175472|FG002|Overall Study|Lost to Follow-up|165|||
162855929|NCT01794780|588175473|FG003|Overall Study|Lost to Follow-up|53|||
162855930|NCT01794780|588175474|FG004|Overall Study|Lost to Follow-up|2|||
162855931|NCT01794780|588175475|FG005|Overall Study|Lost to Follow-up|99|||
162855932|NCT01794780|588175476|FG006|Overall Study|Lost to Follow-up|30|||
162855933|NCT01794780|588175477|FG007|Overall Study|Lost to Follow-up|5|||
162955721|NCT02760368|588539303|FG002|Overall Study|Death|0|||
162955722|NCT02760368|588539301|FG000|Overall Study|Withdrawal by Sponsor|0|||
162955723|NCT02760368|588539302|FG001|Overall Study|Withdrawal by Sponsor|0|||
162955724|NCT02760368|588539303|FG002|Overall Study|Withdrawal by Sponsor|1|||
162955725|NCT00794963|588539304|FG000|Overall Study|Withdrawal by Subject|1|||
162955726|NCT00794963|588539305|FG001|Overall Study|Withdrawal by Subject|4|||
162955727|NCT01037114|588539306|FG000|Year 20|Others|1|||
162955728|NCT01602419|588539307|FG000|Overall Study|Not treated with Wilate|9|||
162955729|NCT01602419|588539307|FG000|Overall Study|Adverse Drug Reaction|4|||
162955730|NCT01602419|588539307|FG000|Overall Study|Insurance issues|3|||
162955731|NCT01602419|588539307|FG000|Overall Study|Changed treatment centre|1|||
162955732|NCT01602419|588539307|FG000|Overall Study|Treatment centre closed|1|||
162955733|NCT01602419|588539307|FG000|Overall Study|Withdrawal by Subject|5|||
162955734|NCT01602419|588539307|FG000|Overall Study|Lost to Follow-up|6|||
162955735|NCT03620747|588539313|FG000|Overall Study|Participant decision|7|||
162955736|NCT03620747|588539313|FG000|Overall Study|Adverse Event|6|||
162955737|NCT03620747|588539313|FG000|Overall Study|Lack of Efficacy|1|||
162955738|NCT03620747|588539313|FG000|Overall Study|Poor compliance to protocol|2|||
162955739|NCT03620747|588539313|FG000|Overall Study|Other-unspecified|3|||
162955740|NCT00850174|588539316|FG000|Washout: One Week|Withdrawal by Subject|0|||
162955741|NCT00850174|588539317|FG001|Washout: One Week|Withdrawal by Subject|2|||
162855934|NCT01794780|588175470|FG000|Overall Study|Withdrew informed consent|7|||
162855935|NCT01794780|588175471|FG001|Overall Study|Withdrew informed consent|17|||
162855936|NCT01794780|588175472|FG002|Overall Study|Withdrew informed consent|36|||
162855937|NCT01794780|588175473|FG003|Overall Study|Withdrew informed consent|9|||
162855938|NCT01794780|588175474|FG004|Overall Study|Withdrew informed consent|0|||
162855939|NCT01794780|588175475|FG005|Overall Study|Withdrew informed consent|48|||
162855940|NCT01794780|588175476|FG006|Overall Study|Withdrew informed consent|4|||
162855941|NCT01794780|588175477|FG007|Overall Study|Withdrew informed consent|3|||
162855942|NCT01794780|588175470|FG000|Overall Study|Other|0|||
162855943|NCT01794780|588175471|FG001|Overall Study|Other|12|||
162855944|NCT01794780|588175472|FG002|Overall Study|Other|25|||
162855945|NCT01794780|588175473|FG003|Overall Study|Other|20|||
162855946|NCT01794780|588175474|FG004|Overall Study|Other|1|||
162855947|NCT01794780|588175475|FG005|Overall Study|Other|24|||
162855948|NCT01794780|588175476|FG006|Overall Study|Other|4|||
162855949|NCT01794780|588175477|FG007|Overall Study|Other|1|||
162855950|NCT00519077|588175478|FG000|Overall Study|Death|6|||
162855951|NCT00519077|588175478|FG000|Overall Study|Other|2|||
162855952|NCT01967225|588175480|FG000|Overall Study|Adverse Event|3|||
162855953|NCT01967225|588175481|FG001|Overall Study|Adverse Event|1|||
162855954|NCT01967225|588175480|FG000|Overall Study|Withdrawal by Subject|2|||
162855955|NCT01967225|588175481|FG001|Overall Study|Withdrawal by Subject|1|||
162855956|NCT01967225|588175480|FG000|Overall Study|Lack of Efficacy|1|||
162855957|NCT01967225|588175481|FG001|Overall Study|Lack of Efficacy|1|||
162855958|NCT01967225|588175480|FG000|Overall Study|Switching to other therapy|2|||
162855959|NCT01967225|588175481|FG001|Overall Study|Switching to other therapy|0|||
162855960|NCT01967225|588175480|FG000|Overall Study|Protocol driven decision point|1|||
162855961|NCT01967225|588175481|FG001|Overall Study|Protocol driven decision point|0|||
162855962|NCT01967225|588175480|FG000|Overall Study|Logistical difficulties|1|||
162855963|NCT01967225|588175481|FG001|Overall Study|Logistical difficulties|0|||
162855964|NCT01967225|588175480|FG000|Overall Study|Protocol Violation|2|||
162855965|NCT01967225|588175481|FG001|Overall Study|Protocol Violation|0|||
162855966|NCT02286102|588175482|FG000|Overall Study|Screen Failure|1|||
162855967|NCT02286102|588175483|FG001|Overall Study|Screen Failure|1|||
162855968|NCT00327444|588175484|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
162855969|NCT00327444|588175485|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
162855970|NCT00327444|588175484|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
162855971|NCT00327444|588175485|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
162855972|NCT00327444|588175484|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
162955742|NCT00850174|588539316|FG000|Second Intervention|Withdrawal by Subject|1|||
162855973|NCT00327444|588175485|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
162855974|NCT00327444|588175484|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
162855975|NCT00327444|588175485|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
162855976|NCT00327444|588175484|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
162855977|NCT00327444|588175485|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
162955743|NCT00850174|588539317|FG001|Second Intervention|Withdrawal by Subject|0|||
162955744|NCT00635492|588539318|FG000|Overall Study|Death|12|||
162955745|NCT00635492|588539319|FG001|Overall Study|Death|40|||
162955746|NCT00635492|588539318|FG000|Overall Study|Lost to Follow-up|151|||
162955747|NCT00635492|588539319|FG001|Overall Study|Lost to Follow-up|172|||
162955748|NCT00635492|588539318|FG000|Overall Study|Physician Decision|32|||
162955749|NCT00635492|588539319|FG001|Overall Study|Physician Decision|22|||
162955750|NCT00635492|588539318|FG000|Overall Study|Sponsor decision|2|||
162955751|NCT00635492|588539319|FG001|Overall Study|Sponsor decision|3|||
162855978|NCT00327444|588175484|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
162855979|NCT00327444|588175485|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
162855980|NCT00327444|588175484|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
162855981|NCT00327444|588175485|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
162855982|NCT00327444|588175484|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
162855983|NCT00327444|588175485|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
162855984|NCT01658514|588175486|FG000|Overall Study|Protocol Violation|1|||
162855985|NCT01658514|588175487|FG001|Overall Study|Protocol Violation|0|||
162855986|NCT01658514|588175488|FG002|Overall Study|Protocol Violation|2|||
162855987|NCT00332202|588175489|FG000|Overall Study|Adverse Event|72|||
162855988|NCT00332202|588175490|FG001|Overall Study|Adverse Event|28|||
162855989|NCT00332202|588175489|FG000|Overall Study|Lost to Follow-up|2|||
162855990|NCT00332202|588175490|FG001|Overall Study|Lost to Follow-up|1|||
162855991|NCT00332202|588175489|FG000|Overall Study|Physician Decision|6|||
162855992|NCT00332202|588175490|FG001|Overall Study|Physician Decision|8|||
162855993|NCT00332202|588175489|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
162855994|NCT00332202|588175490|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
162855995|NCT00332202|588175489|FG000|Overall Study|Protocol Violation|7|||
162855996|NCT00332202|588175490|FG001|Overall Study|Protocol Violation|2|||
162855997|NCT00332202|588175489|FG000|Overall Study|Sponsor Decision|1|||
162855998|NCT00332202|588175490|FG001|Overall Study|Sponsor Decision|2|||
162855999|NCT00332202|588175489|FG000|Overall Study|Withdrawal by Subject|36|||
162856000|NCT00332202|588175490|FG001|Overall Study|Withdrawal by Subject|17|||
162856001|NCT00332202|588175489|FG000|Overall Study|Progressive Disease|106|||
162856002|NCT00332202|588175490|FG001|Overall Study|Progressive Disease|60|||
162856003|NCT00332202|588175489|FG000|Overall Study|Death|5|||
162856004|NCT00332202|588175490|FG001|Overall Study|Death|2|||
162856005|NCT02370121|588175491|FG000|Overall Study|Lost to Follow-up|1|||
162856006|NCT02370121|588175492|FG001|Overall Study|Lost to Follow-up|1|||
162856007|NCT02654002|588175497|FG000|Overall Study|Adverse Event|0|||
162856008|NCT02654002|588175498|FG001|Overall Study|Adverse Event|0|||
162856009|NCT02654002|588175499|FG002|Overall Study|Adverse Event|0|||
162856010|NCT02654002|588175500|FG003|Overall Study|Adverse Event|0|||
162856011|NCT02654002|588175501|FG004|Overall Study|Adverse Event|0|||
162856012|NCT02654002|588175502|FG005|Overall Study|Adverse Event|0|||
162856013|NCT02654002|588175503|FG006|Overall Study|Adverse Event|1|||
162856014|NCT02654002|588175504|FG007|Overall Study|Adverse Event|0|||
162856015|NCT02654002|588175505|FG008|Overall Study|Adverse Event|0|||
162856016|NCT02654002|588175497|FG000|Overall Study|Withdrew Consent|0|||
162856017|NCT02654002|588175498|FG001|Overall Study|Withdrew Consent|0|||
162856018|NCT02654002|588175499|FG002|Overall Study|Withdrew Consent|0|||
162856019|NCT02654002|588175500|FG003|Overall Study|Withdrew Consent|0|||
162856020|NCT02654002|588175501|FG004|Overall Study|Withdrew Consent|0|||
162856021|NCT02654002|588175502|FG005|Overall Study|Withdrew Consent|1|||
162856022|NCT02654002|588175503|FG006|Overall Study|Withdrew Consent|0|||
162856023|NCT02654002|588175504|FG007|Overall Study|Withdrew Consent|1|||
162856024|NCT02654002|588175505|FG008|Overall Study|Withdrew Consent|0|||
162856025|NCT05262764|588175506|FG000|Overall Study|Case report form not collected|9|||
162856026|NCT05262764|588175506|FG000|Overall Study|No patient visits after entry|23|||
162856027|NCT05262764|588175506|FG000|Overall Study|Registration rule not followed|2|||
162856028|NCT05262764|588175506|FG000|Overall Study|Patient of non-chronic heart failure|1|||
162856029|NCT00684177|588175508|FG000|Overall Study|Adverse Event|4|||
162856030|NCT00684177|588175509|FG001|Overall Study|Adverse Event|3|||
162856031|NCT00684177|588175508|FG000|Overall Study|Lack of Efficacy|10|||
162856032|NCT00684177|588175509|FG001|Overall Study|Lack of Efficacy|15|||
162856033|NCT00684177|588175508|FG000|Overall Study|Protocol Violation|1|||
162856034|NCT00684177|588175509|FG001|Overall Study|Protocol Violation|0|||
162856035|NCT00684177|588175508|FG000|Overall Study|Lost to Follow-up|2|||
162856036|NCT00684177|588175509|FG001|Overall Study|Lost to Follow-up|1|||
162856037|NCT00684177|588175508|FG000|Overall Study|Physician Decision|2|||
162856038|NCT00684177|588175509|FG001|Overall Study|Physician Decision|0|||
162856039|NCT00684177|588175508|FG000|Overall Study|Withdrawal by Subject|1|||
162856040|NCT00684177|588175509|FG001|Overall Study|Withdrawal by Subject|2|||
162856041|NCT00684177|588175508|FG000|Overall Study|Other|1|||
162856042|NCT00684177|588175509|FG001|Overall Study|Other|2|||
162856043|NCT00768222|588177129|FG000|Overall Study|Lost to Follow-up|1|||
162856044|NCT00768222|588177130|FG001|Overall Study|Lost to Follow-up|1|||
162856045|NCT00768222|588177129|FG000|Overall Study|Withdrawal by Subject|3|||
162856046|NCT00768222|588177130|FG001|Overall Study|Withdrawal by Subject|1|||
162856047|NCT00768222|588177129|FG000|Overall Study|Protocol Violation|0|||
162856048|NCT00768222|588177130|FG001|Overall Study|Protocol Violation|2|||
162856049|NCT00809133|588177133|FG000|Overall Study|Progressive disease|2|||
162856050|NCT00809133|588177134|FG001|Overall Study|Progressive disease|5|||
162856051|NCT00809133|588177135|FG002|Overall Study|Progressive disease|5|||
162856052|NCT00809133|588177136|FG003|Overall Study|Progressive disease|3|||
162856053|NCT00809133|588177137|FG004|Overall Study|Progressive disease|4|||
162856054|NCT00809133|588177138|FG005|Overall Study|Progressive disease|1|||
162856055|NCT00809133|588177139|FG006|Overall Study|Progressive disease|3|||
162856056|NCT00809133|588177140|FG007|Overall Study|Progressive disease|3|||
162856057|NCT00809133|588177141|FG008|Overall Study|Progressive disease|3|||
162856058|NCT00809133|588177142|FG009|Overall Study|Progressive disease|9|||
162856059|NCT00809133|588177143|FG010|Overall Study|Progressive disease|5|||
162856060|NCT00809133|588177144|FG011|Overall Study|Progressive disease|7|||
162856061|NCT00809133|588177145|FG012|Overall Study|Progressive disease|5|||
162856062|NCT00809133|588177146|FG013|Overall Study|Progressive disease|4|||
162856063|NCT00809133|588177133|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856064|NCT00809133|588177134|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856065|NCT00809133|588177135|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856066|NCT00809133|588177136|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856067|NCT00809133|588177137|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856068|NCT00809133|588177138|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162856069|NCT00809133|588177139|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162856070|NCT00809133|588177140|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162856071|NCT00809133|588177141|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856072|NCT00809133|588177142|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856073|NCT00809133|588177143|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856074|NCT00809133|588177144|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856075|NCT00809133|588177145|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162856076|NCT00809133|588177146|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162856077|NCT00809133|588177133|FG000|Overall Study|Other adverse event|1|||
162856078|NCT00809133|588177134|FG001|Overall Study|Other adverse event|1|||
162856079|NCT00809133|588177135|FG002|Overall Study|Other adverse event|1|||
162856080|NCT00809133|588177136|FG003|Overall Study|Other adverse event|0|||
162856081|NCT00809133|588177137|FG004|Overall Study|Other adverse event|0|||
162856082|NCT00809133|588177138|FG005|Overall Study|Other adverse event|3|||
162856083|NCT00809133|588177139|FG006|Overall Study|Other adverse event|2|||
162856084|NCT00809133|588177140|FG007|Overall Study|Other adverse event|4|||
162856085|NCT00809133|588177141|FG008|Overall Study|Other adverse event|0|||
162856086|NCT00809133|588177142|FG009|Overall Study|Other adverse event|0|||
162856087|NCT00809133|588177143|FG010|Overall Study|Other adverse event|1|||
162856088|NCT00809133|588177144|FG011|Overall Study|Other adverse event|1|||
162856089|NCT00809133|588177145|FG012|Overall Study|Other adverse event|0|||
162856090|NCT00809133|588177146|FG013|Overall Study|Other adverse event|1|||
162856091|NCT00809133|588177133|FG000|Overall Study|Lost to Follow-up|0|||
162856092|NCT00809133|588177134|FG001|Overall Study|Lost to Follow-up|0|||
162856093|NCT00809133|588177135|FG002|Overall Study|Lost to Follow-up|0|||
162856094|NCT00809133|588177136|FG003|Overall Study|Lost to Follow-up|0|||
162856095|NCT00809133|588177137|FG004|Overall Study|Lost to Follow-up|0|||
162856096|NCT00809133|588177138|FG005|Overall Study|Lost to Follow-up|1|||
162856097|NCT00809133|588177139|FG006|Overall Study|Lost to Follow-up|0|||
162856098|NCT00809133|588177140|FG007|Overall Study|Lost to Follow-up|0|||
162856099|NCT00809133|588177141|FG008|Overall Study|Lost to Follow-up|0|||
162856100|NCT00809133|588177142|FG009|Overall Study|Lost to Follow-up|0|||
162856101|NCT00809133|588177143|FG010|Overall Study|Lost to Follow-up|0|||
162856102|NCT00809133|588177144|FG011|Overall Study|Lost to Follow-up|0|||
162856103|NCT00809133|588177145|FG012|Overall Study|Lost to Follow-up|0|||
162856104|NCT00809133|588177146|FG013|Overall Study|Lost to Follow-up|0|||
162856105|NCT00809133|588177133|FG000|Overall Study|Consent withdrawn|0|||
162856106|NCT00809133|588177134|FG001|Overall Study|Consent withdrawn|0|||
162856107|NCT00809133|588177135|FG002|Overall Study|Consent withdrawn|0|||
162856108|NCT00809133|588177136|FG003|Overall Study|Consent withdrawn|0|||
162856109|NCT00809133|588177137|FG004|Overall Study|Consent withdrawn|1|||
162856110|NCT00809133|588177138|FG005|Overall Study|Consent withdrawn|0|||
162856111|NCT00809133|588177139|FG006|Overall Study|Consent withdrawn|0|||
162856112|NCT00809133|588177140|FG007|Overall Study|Consent withdrawn|0|||
162856113|NCT00809133|588177141|FG008|Overall Study|Consent withdrawn|0|||
162856114|NCT00809133|588177142|FG009|Overall Study|Consent withdrawn|0|||
162856115|NCT00809133|588177143|FG010|Overall Study|Consent withdrawn|0|||
162856116|NCT00809133|588177144|FG011|Overall Study|Consent withdrawn|0|||
162856117|NCT00809133|588177145|FG012|Overall Study|Consent withdrawn|0|||
162856118|NCT00809133|588177146|FG013|Overall Study|Consent withdrawn|0|||
162856119|NCT00809133|588177133|FG000|Overall Study|Other not mentioned above|0|||
162856120|NCT00809133|588177134|FG001|Overall Study|Other not mentioned above|1|||
162856121|NCT00809133|588177135|FG002|Overall Study|Other not mentioned above|0|||
162856122|NCT00809133|588177136|FG003|Overall Study|Other not mentioned above|0|||
162856123|NCT00809133|588177137|FG004|Overall Study|Other not mentioned above|0|||
162856124|NCT00809133|588177138|FG005|Overall Study|Other not mentioned above|1|||
162856125|NCT00809133|588177139|FG006|Overall Study|Other not mentioned above|0|||
162856126|NCT00809133|588177140|FG007|Overall Study|Other not mentioned above|0|||
162856127|NCT00809133|588177141|FG008|Overall Study|Other not mentioned above|0|||
162856128|NCT00809133|588177142|FG009|Overall Study|Other not mentioned above|0|||
162856129|NCT00809133|588177143|FG010|Overall Study|Other not mentioned above|0|||
162856130|NCT00809133|588177144|FG011|Overall Study|Other not mentioned above|0|||
162856131|NCT00809133|588177145|FG012|Overall Study|Other not mentioned above|0|||
162856132|NCT00809133|588177146|FG013|Overall Study|Other not mentioned above|0|||
162856133|NCT03093155|588177148|FG000|Overall Study|Not Eligible|1|||
162856134|NCT03093155|588177149|FG001|Overall Study|Not Eligible|0|||
162856135|NCT03093155|588177148|FG000|Overall Study|Withdrawal by Subject|0|||
162856136|NCT03093155|588177149|FG001|Overall Study|Withdrawal by Subject|1|||
162856137|NCT01700829|588177150|FG000|Overall Study|Withdrawal by Subject|1|||
162856138|NCT01700829|588177151|FG001|Overall Study|Withdrawal by Subject|1|||
162856139|NCT01075178|588177152|FG000|Subject Matching|eligible but not matched|130|||
162856140|NCT01075178|588177153|FG001|Subject Matching|eligible but not matched|403|||
162856141|NCT01075178|588177152|FG000|Subject Chart Review|died before chart review period|0|||
162856142|NCT01075178|588177153|FG001|Subject Chart Review|died before chart review period|2|||
162856143|NCT01075178|588177152|FG000|Subject Chart Review|no data collected due to site closure|3|||
162856144|NCT01075178|588177153|FG001|Subject Chart Review|no data collected due to site closure|4|||
162856145|NCT01075178|588177152|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
162856146|NCT01075178|588177153|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
162856147|NCT02983604|588177154|FG000|Overall Study|Enrolled but not Treated|0|||
162856148|NCT02983604|588177155|FG001|Overall Study|Enrolled but not Treated|0|||
162856149|NCT02983604|588177156|FG002|Overall Study|Enrolled but not Treated|1|||
162856150|NCT02983604|588177157|FG003|Overall Study|Enrolled but not Treated|0|||
162856151|NCT04336163|588177159|FG000|Overall Study|Lost to Follow-up|55|||
162856152|NCT04336163|588177160|FG001|Overall Study|Lost to Follow-up|0|||
162856153|NCT01241786|588177161|FG000|Overall Study|Lack of Efficacy|5|||
162856154|NCT03182738|588177184|FG000|Overall Study|Lost to Follow-up|9|||
162856155|NCT03182738|588177185|FG001|Overall Study|Lost to Follow-up|3|||
162856156|NCT03182738|588177184|FG000|Overall Study|Pregnancy|0|||
162955752|NCT00635492|588539318|FG000|Overall Study|Withdrawal by Subject|82|||
162955753|NCT00635492|588539319|FG001|Overall Study|Withdrawal by Subject|45|||
162955754|NCT04533594|588539320|FG000|Overall Study|Death|26|||
162955755|NCT03500341|588539325|FG000|Overall Study|Withdrawn prior to Completion|2|||
162955756|NCT02937870|588539326|FG000|Overall Study|Adverse Event|1|||
162955757|NCT02937870|588539326|FG000|Overall Study|Protocol Deviation|2|||
162955758|NCT01294917|588539327|FG000|Overall Study|Relocation|5|||
162955759|NCT01294917|588539327|FG000|Overall Study|Inconvenience|1|||
162955760|NCT03017885|588539328|FG000|Overall Study|Adverse Event|2|||
162955761|NCT03017885|588539329|FG001|Overall Study|Adverse Event|0|||
162955762|NCT03017885|588539330|FG002|Overall Study|Adverse Event|0|||
162955763|NCT03017885|588539331|FG003|Overall Study|Adverse Event|0|||
162955764|NCT03017885|588539332|FG004|Overall Study|Adverse Event|0|||
162955765|NCT03017885|588539333|FG005|Overall Study|Adverse Event|0|||
162955766|NCT03017885|588539328|FG000|Overall Study|Progression of disease|4|||
162955767|NCT03017885|588539329|FG001|Overall Study|Progression of disease|3|||
162955768|NCT03017885|588539330|FG002|Overall Study|Progression of disease|4|||
162955769|NCT03017885|588539331|FG003|Overall Study|Progression of disease|0|||
162955770|NCT03017885|588539332|FG004|Overall Study|Progression of disease|0|||
162955771|NCT03017885|588539333|FG005|Overall Study|Progression of disease|0|||
162955772|NCT03017885|588539328|FG000|Overall Study|Other than listed|1|||
162955773|NCT03017885|588539329|FG001|Overall Study|Other than listed|2|||
162955774|NCT03017885|588539330|FG002|Overall Study|Other than listed|1|||
162955775|NCT03017885|588539331|FG003|Overall Study|Other than listed|0|||
162955776|NCT03017885|588539332|FG004|Overall Study|Other than listed|0|||
162955777|NCT03017885|588539333|FG005|Overall Study|Other than listed|0|||
162955778|NCT03017885|588539328|FG000|Overall Study|Lost to Follow-up|2|||
163044396|NCT03654729|588871440|FG002|Overall Study|Progressive disease|0|||
163044397|NCT03654729|588871438|FG000|Overall Study|Lost to Follow-up|2|||
163044398|NCT03654729|588871439|FG001|Overall Study|Lost to Follow-up|0|||
163044399|NCT03654729|588871440|FG002|Overall Study|Lost to Follow-up|0|||
162856157|NCT03182738|588177185|FG001|Overall Study|Pregnancy|1|||
162856158|NCT03182738|588177184|FG000|Overall Study|Withdrawal by Subject|0|||
162856159|NCT03182738|588177185|FG001|Overall Study|Withdrawal by Subject|1|||
162856160|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
162856161|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
162856162|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
162856163|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
162856164|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
162856165|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
162856166|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
162856167|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
162856168|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
162955779|NCT03017885|588539329|FG001|Overall Study|Lost to Follow-up|0|||
162955780|NCT03017885|588539330|FG002|Overall Study|Lost to Follow-up|3|||
162955781|NCT03017885|588539331|FG003|Overall Study|Lost to Follow-up|0|||
162955782|NCT03017885|588539332|FG004|Overall Study|Lost to Follow-up|0|||
162955783|NCT03017885|588539333|FG005|Overall Study|Lost to Follow-up|0|||
162955784|NCT03017885|588539328|FG000|Overall Study|Change to other anti-cancer therapy|0|||
162955785|NCT03017885|588539329|FG001|Overall Study|Change to other anti-cancer therapy|0|||
162955786|NCT03017885|588539330|FG002|Overall Study|Change to other anti-cancer therapy|1|||
163044400|NCT03654729|588871438|FG000|Overall Study|Physician Decision|2|||
162856169|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
162856170|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
162856171|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
162856172|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
162856173|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
162856174|NCT00446030|588177186|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
162856175|NCT00446030|588177187|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
162856176|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
162856177|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
162856178|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
162856179|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
162856180|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
162856181|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
162856182|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
162856183|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
162856184|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
162856185|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
162856186|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
162856187|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
162856188|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
162856189|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
162856190|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
162856191|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
162856192|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
162856193|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
162856194|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
162856195|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
162856196|NCT00446030|588177186|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
162856197|NCT00446030|588177187|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
162856198|NCT02886715|588177191|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162856199|NCT02886715|588177192|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162856200|NCT02886715|588177193|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162856201|NCT02886715|588177191|FG000|Overall Study|Adverse Event|4|||
162856202|NCT02886715|588177192|FG001|Overall Study|Adverse Event|2|||
162856203|NCT02886715|588177193|FG002|Overall Study|Adverse Event|0|||
162856204|NCT02886715|588177191|FG000|Overall Study|Lack of Efficacy|0|||
162856205|NCT02886715|588177192|FG001|Overall Study|Lack of Efficacy|2|||
162856206|NCT02886715|588177193|FG002|Overall Study|Lack of Efficacy|1|||
162856207|NCT02886715|588177191|FG000|Overall Study|Lost to Follow-up|29|||
162856208|NCT02886715|588177192|FG001|Overall Study|Lost to Follow-up|26|||
162856209|NCT02886715|588177193|FG002|Overall Study|Lost to Follow-up|10|||
162856210|NCT02886715|588177191|FG000|Overall Study|Pregnancy|1|||
162856211|NCT02886715|588177192|FG001|Overall Study|Pregnancy|1|||
162856212|NCT02886715|588177193|FG002|Overall Study|Pregnancy|1|||
162856213|NCT02886715|588177191|FG000|Overall Study|Protocol Violation|3|||
162856214|NCT02886715|588177192|FG001|Overall Study|Protocol Violation|2|||
162856215|NCT02886715|588177193|FG002|Overall Study|Protocol Violation|1|||
162856216|NCT02886715|588177191|FG000|Overall Study|Withdrawal by Subject|20|||
162856217|NCT02886715|588177192|FG001|Overall Study|Withdrawal by Subject|18|||
162955787|NCT03017885|588539331|FG003|Overall Study|Change to other anti-cancer therapy|0|||
162955788|NCT03017885|588539332|FG004|Overall Study|Change to other anti-cancer therapy|0|||
162856218|NCT02886715|588177193|FG002|Overall Study|Withdrawal by Subject|5|||
162955789|NCT03017885|588539333|FG005|Overall Study|Change to other anti-cancer therapy|0|||
162704800|NCT03100838|587630488|FG001|Overall Study|Lost to Follow-up|0|||
162856219|NCT02886715|588177191|FG000|Overall Study|missing|7|||
162856220|NCT02886715|588177192|FG001|Overall Study|missing|2|||
162856221|NCT02886715|588177193|FG002|Overall Study|missing|2|||
162856222|NCT00503399|588177194|FG000|Overall Study|Death|2|||
162856223|NCT00503399|588177195|FG001|Overall Study|Death|1|||
162856224|NCT00503399|588177194|FG000|Overall Study|Protocol Violation|1|||
162856225|NCT00503399|588177195|FG001|Overall Study|Protocol Violation|0|||
162955790|NCT00836056|588539343|FG000|First Intervention|Adverse Event|1|||
162856226|NCT00503399|588177194|FG000|Overall Study|Withdrawal by Subject|4|||
162856227|NCT00503399|588177195|FG001|Overall Study|Withdrawal by Subject|2|||
162955791|NCT00836056|588539344|FG001|First Intervention|Adverse Event|0|||
162955792|NCT01001208|588539348|FG000|Overall Study|Adverse Event|10|||
162856228|NCT00503399|588177194|FG000|Overall Study|Adverse Event|0|||
162856229|NCT00503399|588177195|FG001|Overall Study|Adverse Event|3|||
162856230|NCT00503399|588177194|FG000|Overall Study|Lost to Follow-up|0|||
162856231|NCT00503399|588177195|FG001|Overall Study|Lost to Follow-up|2|||
162856232|NCT01676961|588177196|FG000|Overall Study|Death|3|||
162856233|NCT01676961|588177196|FG000|Overall Study|Lost to Follow-up|1|||
162856234|NCT01676961|588177196|FG000|Overall Study|Withdrawal by Subject|1|||
162856235|NCT01128387|588177199|FG000|Overall Study|Physician Decision|0|||
162856236|NCT01128387|588177200|FG001|Overall Study|Physician Decision|1|||
162856237|NCT01535235|588177201|FG000|Overall Study|Adverse Event|1|||
162856238|NCT01535235|588177202|FG001|Overall Study|Adverse Event|0|||
162856239|NCT02499952|588177206|FG000|Overall Study|Lost to Follow-up|1|||
162856240|NCT02499952|588177206|FG000|Overall Study|Death|9|||
162856241|NCT02120417|588177207|FG000|Overall Study|Death|5|||
162856242|NCT02120417|588177208|FG001|Overall Study|Death|1|||
162856243|NCT02120417|588177207|FG000|Overall Study|Adverse Event|3|||
162856244|NCT02120417|588177208|FG001|Overall Study|Adverse Event|9|||
162856245|NCT02120417|588177207|FG000|Overall Study|Participant decision|4|||
162856246|NCT02120417|588177208|FG001|Overall Study|Participant decision|4|||
162856247|NCT02120417|588177207|FG000|Overall Study|Disease progression|41|||
162856248|NCT02120417|588177208|FG001|Overall Study|Disease progression|45|||
162856249|NCT02120417|588177207|FG000|Overall Study|Noncompliance with study treatment|0|||
162856250|NCT02120417|588177208|FG001|Overall Study|Noncompliance with study treatment|2|||
162856251|NCT02120417|588177207|FG000|Overall Study|Physician Decision|2|||
162856252|NCT02120417|588177208|FG001|Overall Study|Physician Decision|3|||
162856253|NCT02120417|588177207|FG000|Overall Study|Other unspecified|5|||
162856254|NCT02120417|588177208|FG001|Overall Study|Other unspecified|4|||
162856255|NCT00927485|588177209|FG000|Overall Study|Adverse Event|4|||
162856256|NCT00927485|588177210|FG001|Overall Study|Adverse Event|2|||
162856257|NCT00927485|588177209|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
162856258|NCT00927485|588177210|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
162856259|NCT01440101|588177211|FG000|Overall Study|Adverse Event|2|||
162856260|NCT01440101|588177212|FG001|Overall Study|Adverse Event|0|||
162856261|NCT01440101|588177213|FG002|Overall Study|Adverse Event|0|||
162856262|NCT01440101|588177211|FG000|Overall Study|Withdrawal by Subject|0|||
162856263|NCT01440101|588177212|FG001|Overall Study|Withdrawal by Subject|3|||
162856264|NCT01440101|588177213|FG002|Overall Study|Withdrawal by Subject|1|||
162856265|NCT01440101|588177211|FG000|Overall Study|Other|0|||
162856266|NCT01440101|588177212|FG001|Overall Study|Other|1|||
162856267|NCT01440101|588177213|FG002|Overall Study|Other|0|||
162856268|NCT02305563|588177218|FG000|Treatment Period|Disease progression|0|||
162856269|NCT02305563|588177219|FG001|Treatment Period|Disease progression|0|||
162856270|NCT02305563|588177220|FG002|Treatment Period|Disease progression|15|||
162856271|NCT02305563|588177221|FG003|Treatment Period|Disease progression|6|||
162856272|NCT02305563|588177222|FG004|Treatment Period|Disease progression|6|||
162856273|NCT02305563|588177218|FG000|Treatment Period|Study drug toxicity|0|||
162856274|NCT02305563|588177219|FG001|Treatment Period|Study drug toxicity|0|||
162856275|NCT02305563|588177220|FG002|Treatment Period|Study drug toxicity|0|||
162856276|NCT02305563|588177221|FG003|Treatment Period|Study drug toxicity|1|||
162856277|NCT02305563|588177222|FG004|Treatment Period|Study drug toxicity|2|||
162856278|NCT02305563|588177218|FG000|Treatment Period|Death|0|||
162856279|NCT02305563|588177219|FG001|Treatment Period|Death|0|||
162856280|NCT02305563|588177220|FG002|Treatment Period|Death|1|||
162856281|NCT02305563|588177221|FG003|Treatment Period|Death|2|||
162856282|NCT02305563|588177222|FG004|Treatment Period|Death|1|||
162704801|NCT03100838|587630489|FG002|Overall Study|Lost to Follow-up|1|||
162856283|NCT02305563|588177218|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
162856284|NCT02305563|588177219|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
162856285|NCT02305563|588177220|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
162856286|NCT02305563|588177221|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
162856287|NCT02305563|588177222|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
162856288|NCT02305563|588177218|FG000|Treatment Period|Participant request to stop therapy|0|||
162856289|NCT02305563|588177219|FG001|Treatment Period|Participant request to stop therapy|2|||
162856290|NCT02305563|588177220|FG002|Treatment Period|Participant request to stop therapy|0|||
162856291|NCT02305563|588177221|FG003|Treatment Period|Participant request to stop therapy|1|||
162856292|NCT02305563|588177222|FG004|Treatment Period|Participant request to stop therapy|0|||
162856293|NCT02305563|588177218|FG000|Treatment Period|Participant withdrew consent|0|||
162856294|NCT02305563|588177219|FG001|Treatment Period|Participant withdrew consent|0|||
162955793|NCT01001208|588539349|FG001|Overall Study|Adverse Event|5|||
162955794|NCT01001208|588539348|FG000|Overall Study|Lost to Follow-up|5|||
162955795|NCT01001208|588539349|FG001|Overall Study|Lost to Follow-up|9|||
162955796|NCT01001208|588539348|FG000|Overall Study|Physician Decision|1|||
162955797|NCT01001208|588539349|FG001|Overall Study|Physician Decision|0|||
162955798|NCT01001208|588539348|FG000|Overall Study|Withdrawal by Subject|4|||
162955799|NCT01001208|588539349|FG001|Overall Study|Withdrawal by Subject|5|||
162955800|NCT01001208|588539348|FG000|Overall Study|Ineligibility Determined|4|||
163044401|NCT03654729|588871439|FG001|Overall Study|Physician Decision|0|||
163044402|NCT03654729|588871440|FG002|Overall Study|Physician Decision|0|||
163044403|NCT03654729|588871438|FG000|Overall Study|Protocol Violation|1|||
163044404|NCT03654729|588871439|FG001|Overall Study|Protocol Violation|1|||
163044405|NCT03654729|588871440|FG002|Overall Study|Protocol Violation|0|||
162704802|NCT03100838|587630490|FG003|Overall Study|Lost to Follow-up|0|||
162704803|NCT00801242|587630491|FG000|Overall Study|Adverse Event|10|||
162704804|NCT00801242|587630491|FG000|Overall Study|Withdrawal by Subject|13|||
162704805|NCT00801242|587630491|FG000|Overall Study|Protocol Violation|5|||
162704806|NCT00801242|587630491|FG000|Overall Study|Physician Decision|3|||
162704807|NCT00801242|587630491|FG000|Overall Study|Lost to Follow-up|1|||
162704808|NCT00801242|587630491|FG000|Overall Study|Miscellaneous reasons|20|||
162704809|NCT00184028|587630492|FG000|Overall Study|Death|1|||
162704810|NCT00184028|587630492|FG000|Overall Study|Lack of Efficacy|4|||
162704811|NCT00184028|587630492|FG000|Overall Study|Adverse Event|2|||
162704812|NCT00184028|587630492|FG000|Overall Study|Withdrawal by Subject|1|||
162704813|NCT00184028|587630492|FG000|Overall Study|Non-compliance|2|||
162704814|NCT00994279|587630493|FG000|Overall Study|Withdrawal by Subject|2|||
162704815|NCT00994279|587630494|FG001|Overall Study|Withdrawal by Subject|2|||
162704816|NCT00994279|587630493|FG000|Overall Study|Toxicity|1|||
162704817|NCT00994279|587630494|FG001|Overall Study|Toxicity|0|||
162704818|NCT00994279|587630493|FG000|Overall Study|Multiple reasons|1|||
162704819|NCT00994279|587630494|FG001|Overall Study|Multiple reasons|3|||
162704820|NCT01606189|587630495|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
162704821|NCT01606189|587630496|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
162704822|NCT01606189|587630497|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
162704823|NCT01606189|587630498|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
162704824|NCT01606189|587630499|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
162704825|NCT01606189|587630500|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
162704826|NCT01606189|587630495|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162704827|NCT01606189|587630496|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162955801|NCT01001208|588539349|FG001|Overall Study|Ineligibility Determined|2|||
163044406|NCT03654729|588871438|FG000|Overall Study|Non-compliance with study drug|0|||
163044407|NCT03654729|588871439|FG001|Overall Study|Non-compliance with study drug|1|||
163044408|NCT03654729|588871440|FG002|Overall Study|Non-compliance with study drug|0|||
163044409|NCT03654729|588871438|FG000|Overall Study|Site terminated by Sponsor|1|||
163044410|NCT03654729|588871439|FG001|Overall Study|Site terminated by Sponsor|0|||
163044411|NCT03654729|588871440|FG002|Overall Study|Site terminated by Sponsor|0|||
163044412|NCT00391872|588871441|FG000|Overall Study|Protocol Violation|7|||
163044413|NCT00391872|588871442|FG001|Overall Study|Protocol Violation|2|||
163044414|NCT00391872|588871441|FG000|Overall Study|Withdrawal by Subject|296|||
163044415|NCT00391872|588871442|FG001|Overall Study|Withdrawal by Subject|249|||
163044416|NCT00391872|588871441|FG000|Overall Study|Reason unknown|2|||
163044417|NCT00391872|588871442|FG001|Overall Study|Reason unknown|4|||
163044418|NCT00391872|588871441|FG000|Overall Study|Lost to Follow-up|2|||
163044419|NCT00391872|588871442|FG001|Overall Study|Lost to Follow-up|0|||
163044420|NCT01239394|588871443|FG000|Overall Study|Adverse Event|1|||
162611812|NCT00451451|587296664|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
162611813|NCT00451451|587296665|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
162611814|NCT00451451|587296666|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
162611815|NCT00084838|587296669|FG000|Overall Study|Death|1|||
162611816|NCT00084838|587296669|FG000|Overall Study|Adverse Event|2|||
162611817|NCT00084838|587296669|FG000|Overall Study|Withdrawal by Subject|1|||
162611818|NCT00084838|587296669|FG000|Overall Study|Progressive Disease|4|||
162704828|NCT01606189|587630497|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162955802|NCT01001208|588539348|FG000|Overall Study|Noncompliance|4|||
162955803|NCT01001208|588539349|FG001|Overall Study|Noncompliance|7|||
162955804|NCT01001208|588539348|FG000|Overall Study|Disease Progression|0|||
162955805|NCT01001208|588539349|FG001|Overall Study|Disease Progression|3|||
163044421|NCT00905632|588871445|FG000|Overall Study|Adverse Event|0|||
163044422|NCT00905632|588871446|FG001|Overall Study|Adverse Event|0|||
163044423|NCT00905632|588871447|FG002|Overall Study|Adverse Event|0|||
163044424|NCT00905632|588871448|FG003|Overall Study|Adverse Event|0|||
163044425|NCT00905632|588871449|FG004|Overall Study|Adverse Event|0|||
162611819|NCT00084838|587296669|FG000|Overall Study|Pt Non-Compliance|1|||
162611820|NCT00084838|587296669|FG000|Overall Study|Ineligible|4|||
162704829|NCT01606189|587630498|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162704830|NCT01606189|587630499|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162704831|NCT01606189|587630500|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
162856295|NCT02305563|588177220|FG002|Treatment Period|Participant withdrew consent|1|||
162856296|NCT02305563|588177221|FG003|Treatment Period|Participant withdrew consent|1|||
162856297|NCT02305563|588177222|FG004|Treatment Period|Participant withdrew consent|1|||
162856298|NCT02305563|588177218|FG000|Treatment Period|Maximum clinical benefit|0|||
163044426|NCT00905632|588871450|FG005|Overall Study|Adverse Event|1|||
163044427|NCT00905632|588871451|FG006|Overall Study|Adverse Event|4|||
163044428|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
163044429|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
163044430|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
163044431|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
163044432|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
163044433|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
163044434|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
163044435|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
163044436|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
163044437|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
163044438|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
163044439|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
163044440|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
163044441|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
163044442|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
163044443|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
163044444|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
163044445|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
163044446|NCT03569098|588871452|FG000|Double-Blind Treatment Cycle 1|Other|1|||
163044447|NCT03569098|588871453|FG001|Double-Blind Treatment Cycle 1|Other|0|||
163044448|NCT03569098|588871454|FG002|Double-Blind Treatment Cycle 1|Other|1|||
163044449|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
163044450|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
162856299|NCT02305563|588177219|FG001|Treatment Period|Maximum clinical benefit|0|||
162856300|NCT02305563|588177220|FG002|Treatment Period|Maximum clinical benefit|0|||
162856301|NCT02305563|588177221|FG003|Treatment Period|Maximum clinical benefit|0|||
162856302|NCT02305563|588177222|FG004|Treatment Period|Maximum clinical benefit|1|||
162856303|NCT02305563|588177218|FG000|Treatment Period|Poor/non-compliance|0|||
162856304|NCT02305563|588177219|FG001|Treatment Period|Poor/non-compliance|0|||
162856305|NCT02305563|588177220|FG002|Treatment Period|Poor/non-compliance|0|||
162856306|NCT02305563|588177221|FG003|Treatment Period|Poor/non-compliance|0|||
162856307|NCT02305563|588177222|FG004|Treatment Period|Poor/non-compliance|1|||
162856308|NCT02305563|588177218|FG000|Treatment Period|Administrative reason by Sponsor|0|||
163044451|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
163044452|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
163044453|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
163044454|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
163044455|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
163044456|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
163044457|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
162856309|NCT02305563|588177219|FG001|Treatment Period|Administrative reason by Sponsor|0|||
162856310|NCT02305563|588177220|FG002|Treatment Period|Administrative reason by Sponsor|0|||
162856311|NCT02305563|588177221|FG003|Treatment Period|Administrative reason by Sponsor|0|||
162856312|NCT02305563|588177222|FG004|Treatment Period|Administrative reason by Sponsor|1|||
162856313|NCT02305563|588177218|FG000|Treatment Period|other reason|2|||
162856314|NCT02305563|588177219|FG001|Treatment Period|other reason|0|||
162856315|NCT02305563|588177220|FG002|Treatment Period|other reason|2|||
162856316|NCT02305563|588177221|FG003|Treatment Period|other reason|2|||
162856317|NCT02305563|588177222|FG004|Treatment Period|other reason|1|||
162856318|NCT02305563|588177218|FG000|Treatment Period|Randomized but not treated|0|||
162856319|NCT02305563|588177219|FG001|Treatment Period|Randomized but not treated|0|||
162856320|NCT02305563|588177220|FG002|Treatment Period|Randomized but not treated|0|||
162856321|NCT02305563|588177221|FG003|Treatment Period|Randomized but not treated|0|||
162856322|NCT02305563|588177222|FG004|Treatment Period|Randomized but not treated|2|||
162856323|NCT02305563|588177218|FG000|Treatment Period|added ULO, then disease progression|0|||
162856324|NCT02305563|588177219|FG001|Treatment Period|added ULO, then disease progression|0|||
162856325|NCT02305563|588177220|FG002|Treatment Period|added ULO, then disease progression|0|||
163044458|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
163044459|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
162856326|NCT02305563|588177221|FG003|Treatment Period|added ULO, then disease progression|0|||
162856327|NCT02305563|588177222|FG004|Treatment Period|added ULO, then disease progression|4|||
162856328|NCT02305563|588177218|FG000|Treatment Period|added ULO; then other reason|0|||
162856329|NCT02305563|588177219|FG001|Treatment Period|added ULO; then other reason|0|||
162856330|NCT02305563|588177220|FG002|Treatment Period|added ULO; then other reason|0|||
162856331|NCT02305563|588177221|FG003|Treatment Period|added ULO; then other reason|0|||
162856332|NCT02305563|588177222|FG004|Treatment Period|added ULO; then other reason|1|||
162856333|NCT02305563|588177218|FG000|Treatment Period|added ULO, then request to stop|0|||
162856334|NCT02305563|588177219|FG001|Treatment Period|added ULO, then request to stop|0|||
162856335|NCT02305563|588177220|FG002|Treatment Period|added ULO, then request to stop|0|||
162856336|NCT02305563|588177221|FG003|Treatment Period|added ULO, then request to stop|0|||
162856337|NCT02305563|588177222|FG004|Treatment Period|added ULO, then request to stop|1|||
162856338|NCT02305563|588177218|FG000|Follow-up Period|Death|0|||
162856339|NCT02305563|588177219|FG001|Follow-up Period|Death|0|||
162856340|NCT02305563|588177220|FG002|Follow-up Period|Death|5|||
162856341|NCT02305563|588177221|FG003|Follow-up Period|Death|4|||
162856342|NCT02305563|588177222|FG004|Follow-up Period|Death|7|||
162856343|NCT02305563|588177218|FG000|Follow-up Period|Participant withdrew consent|0|||
162856344|NCT02305563|588177219|FG001|Follow-up Period|Participant withdrew consent|0|||
162856345|NCT02305563|588177220|FG002|Follow-up Period|Participant withdrew consent|2|||
162856346|NCT02305563|588177221|FG003|Follow-up Period|Participant withdrew consent|1|||
162856347|NCT02305563|588177222|FG004|Follow-up Period|Participant withdrew consent|0|||
162856348|NCT02305563|588177218|FG000|Follow-up Period|other reason|0|||
162856349|NCT02305563|588177219|FG001|Follow-up Period|other reason|0|||
162856350|NCT02305563|588177220|FG002|Follow-up Period|other reason|0|||
162856351|NCT02305563|588177221|FG003|Follow-up Period|other reason|0|||
162856352|NCT02305563|588177222|FG004|Follow-up Period|other reason|1|||
162856353|NCT02305563|588177218|FG000|Follow-up Period|Followup no longer required per protocol|3|||
162856354|NCT02305563|588177219|FG001|Follow-up Period|Followup no longer required per protocol|3|||
162856355|NCT02305563|588177220|FG002|Follow-up Period|Followup no longer required per protocol|4|||
162856356|NCT02305563|588177221|FG003|Follow-up Period|Followup no longer required per protocol|1|||
162856357|NCT02305563|588177222|FG004|Follow-up Period|Followup no longer required per protocol|4|||
162856358|NCT01275222|588177228|FG000|Phase l by Treatment|Adverse Event|1|||
162856359|NCT01275222|588177229|FG001|Phase l by Treatment|Adverse Event|4|||
162856360|NCT01275222|588177230|FG002|Phase l by Treatment|Adverse Event|2|||
162856361|NCT01275222|588177231|FG003|Phase l by Treatment|Adverse Event|3|||
162856362|NCT01275222|588177232|FG004|Phase l by Treatment|Adverse Event|0|||
162856363|NCT01275222|588177233|FG005|Phase l by Treatment|Adverse Event|0|||
162856364|NCT01275222|588177228|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
162856365|NCT01275222|588177229|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
162856366|NCT01275222|588177230|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
162856367|NCT01275222|588177231|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
162955806|NCT01001208|588539348|FG000|Overall Study|Other|0|||
162955807|NCT01001208|588539349|FG001|Overall Study|Other|2|||
162955808|NCT02648347|588539350|FG000|Overall Study|Death|174|||
162955809|NCT02648347|588539351|FG001|Overall Study|Death|167|||
162955810|NCT02648347|588539350|FG000|Overall Study|Withdrawal by Subject|16|||
162955811|NCT02648347|588539351|FG001|Overall Study|Withdrawal by Subject|9|||
162955812|NCT02648347|588539350|FG000|Overall Study|Lost to Follow-up|18|||
162955813|NCT02648347|588539351|FG001|Overall Study|Lost to Follow-up|21|||
162955814|NCT02648347|588539350|FG000|Overall Study|Missing|1|||
162955815|NCT02648347|588539351|FG001|Overall Study|Missing|0|||
162955816|NCT03546842|588539353|FG000|Overall Study|Protocol Violation|1|||
162856368|NCT01275222|588177232|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
162856369|NCT01275222|588177233|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
162856370|NCT01275222|588177228|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162856371|NCT01275222|588177229|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162856372|NCT01275222|588177230|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162856373|NCT01275222|588177231|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
162856374|NCT01275222|588177232|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162856375|NCT01275222|588177233|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162856376|NCT01275222|588177228|FG000|Phase l by Treatment|Disease progression|12|||
162856377|NCT01275222|588177229|FG001|Phase l by Treatment|Disease progression|8|||
162856378|NCT01275222|588177230|FG002|Phase l by Treatment|Disease progression|2|||
162856379|NCT01275222|588177231|FG003|Phase l by Treatment|Disease progression|5|||
162955817|NCT03546842|588539353|FG000|Overall Study|Withdrawal by Subject|2|||
162955818|NCT01723397|588539354|FG000|Study Period 1|Protocol Violation|0|||
162955819|NCT01723397|588539355|FG001|Study Period 1|Protocol Violation|1|||
162856380|NCT01275222|588177232|FG004|Phase l by Treatment|Disease progression|0|||
162856381|NCT01275222|588177233|FG005|Phase l by Treatment|Disease progression|0|||
162856382|NCT01275222|588177228|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
162856383|NCT01275222|588177229|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
162856384|NCT01275222|588177230|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
162856385|NCT01275222|588177231|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
162856386|NCT01275222|588177232|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
162856387|NCT01275222|588177233|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
162856388|NCT01275222|588177228|FG000|Phase l by Treatment|Death|0|||
162856389|NCT01275222|588177229|FG001|Phase l by Treatment|Death|1|||
162856390|NCT01275222|588177230|FG002|Phase l by Treatment|Death|0|||
162856391|NCT01275222|588177231|FG003|Phase l by Treatment|Death|1|||
162856392|NCT01275222|588177232|FG004|Phase l by Treatment|Death|0|||
162856393|NCT01275222|588177233|FG005|Phase l by Treatment|Death|0|||
162856394|NCT01275222|588177228|FG000|Phase ll by Stratum|Adverse Event|0|||
162856395|NCT01275222|588177229|FG001|Phase ll by Stratum|Adverse Event|0|||
162856396|NCT01275222|588177230|FG002|Phase ll by Stratum|Adverse Event|0|||
162856397|NCT01275222|588177231|FG003|Phase ll by Stratum|Adverse Event|0|||
162856398|NCT01275222|588177232|FG004|Phase ll by Stratum|Adverse Event|2|||
162856399|NCT01275222|588177233|FG005|Phase ll by Stratum|Adverse Event|10|||
162856400|NCT01275222|588177228|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
162856401|NCT01275222|588177229|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
162856402|NCT01275222|588177230|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
162856403|NCT01275222|588177231|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
162856404|NCT01275222|588177232|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
162856405|NCT01275222|588177233|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
162856406|NCT01275222|588177228|FG000|Phase ll by Stratum|Disease progression|0|||
162856407|NCT01275222|588177229|FG001|Phase ll by Stratum|Disease progression|0|||
162856408|NCT01275222|588177230|FG002|Phase ll by Stratum|Disease progression|0|||
162856409|NCT01275222|588177231|FG003|Phase ll by Stratum|Disease progression|0|||
162856410|NCT01275222|588177232|FG004|Phase ll by Stratum|Disease progression|23|||
162856411|NCT01275222|588177233|FG005|Phase ll by Stratum|Disease progression|31|||
162856412|NCT01275222|588177228|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
162856413|NCT01275222|588177229|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
162856414|NCT01275222|588177230|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
162856415|NCT01275222|588177231|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
162856416|NCT01275222|588177232|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
162856417|NCT01275222|588177233|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
162856418|NCT01275222|588177228|FG000|Phase ll by Stratum|Death|0|||
162856419|NCT01275222|588177229|FG001|Phase ll by Stratum|Death|0|||
162856420|NCT01275222|588177230|FG002|Phase ll by Stratum|Death|0|||
162856421|NCT01275222|588177231|FG003|Phase ll by Stratum|Death|0|||
162856422|NCT01275222|588177232|FG004|Phase ll by Stratum|Death|1|||
162856423|NCT01275222|588177233|FG005|Phase ll by Stratum|Death|1|||
162856424|NCT00957853|588177234|FG000|Overall Study|Withdrawal by Subject|1|||
162856425|NCT00957853|588177235|FG001|Overall Study|Withdrawal by Subject|0|||
162856426|NCT00957853|588177236|FG002|Overall Study|Withdrawal by Subject|0|||
162856427|NCT05202808|588177237|FG000|Overall Study|Lost to Follow-up|3|||
162856428|NCT05202808|588177238|FG001|Overall Study|Lost to Follow-up|1|||
162856429|NCT02793544|588177239|FG000|Overall Study|Death|10|||
162856430|NCT02793544|588177240|FG001|Overall Study|Death|8|||
162856431|NCT02793544|588177239|FG000|Overall Study|Lost to Follow-up|2|||
162856432|NCT02793544|588177240|FG001|Overall Study|Lost to Follow-up|0|||
162856433|NCT02793544|588177239|FG000|Overall Study|Withdrawal by Subject|1|||
162856434|NCT02793544|588177240|FG001|Overall Study|Withdrawal by Subject|0|||
162856435|NCT02495948|588177243|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
162856436|NCT02495948|588177244|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
162856437|NCT02495948|588177243|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
162856438|NCT02495948|588177244|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
162856439|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
162856440|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
162856441|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
162856442|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
162856443|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
162856444|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
162856445|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
162856446|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
162856447|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
162856448|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
162856449|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
162856450|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
162856451|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
163044460|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
162856452|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
162611821|NCT00518687|587296670|FG000|Overall Study|Adverse Event|201|||
162611822|NCT00518687|587296671|FG001|Overall Study|Adverse Event|177|||
162611823|NCT00518687|587296670|FG000|Overall Study|Lost to Follow-up|144|||
162611824|NCT00518687|587296671|FG001|Overall Study|Lost to Follow-up|155|||
162611825|NCT00518687|587296670|FG000|Overall Study|Physician Decision|42|||
162611826|NCT00518687|587296671|FG001|Overall Study|Physician Decision|48|||
162611827|NCT00518687|587296670|FG000|Overall Study|Progressive disease|2|||
162611828|NCT00518687|587296671|FG001|Overall Study|Progressive disease|2|||
162611829|NCT00518687|587296670|FG000|Overall Study|Protocol Violation|8|||
162611830|NCT00518687|587296671|FG001|Overall Study|Protocol Violation|10|||
162611831|NCT00518687|587296670|FG000|Overall Study|Study terminated by sponsor|930|||
162955820|NCT01723397|588539354|FG000|Study Period 2|Protocol Violation|0|||
162955821|NCT01723397|588539355|FG001|Study Period 2|Protocol Violation|1|||
162955822|NCT02739997|588539356|FG000|Overall Study|Death|1|||
162955823|NCT02739997|588539356|FG000|Overall Study|Withdrawal by Subject|1|||
162955824|NCT04419311|588539360|FG000|Overall Study|Lost to Follow-up|1|||
162955825|NCT04419311|588539361|FG001|Overall Study|Lost to Follow-up|0|||
162955826|NCT01921062|588539362|FG000|Overall Study|Withdrawal by Subject|0|||
162955827|NCT01921062|588539363|FG001|Overall Study|Withdrawal by Subject|7|||
162955828|NCT01921062|588539362|FG000|Overall Study|Adverse Event|5|||
162955829|NCT01921062|588539363|FG001|Overall Study|Adverse Event|6|||
162955830|NCT01921062|588539362|FG000|Overall Study|Protocol Violation|0|||
162955831|NCT01921062|588539363|FG001|Overall Study|Protocol Violation|1|||
162955832|NCT01921062|588539362|FG000|Overall Study|VMIQ score > 72|4|||
162611832|NCT00518687|587296671|FG001|Overall Study|Study terminated by sponsor|918|||
162611833|NCT00518687|587296670|FG000|Overall Study|Withdrawal by Subject|110|||
162611834|NCT00518687|587296671|FG001|Overall Study|Withdrawal by Subject|110|||
162611835|NCT01442038|587296674|FG000|Overall Study|Death|35|||
162955833|NCT01921062|588539363|FG001|Overall Study|VMIQ score > 72|1|||
162856453|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
162856454|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
162856455|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
162856456|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
162856457|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
162856458|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
162955834|NCT01921062|588539362|FG000|Overall Study|Logistic error|0|||
162955835|NCT01921062|588539363|FG001|Overall Study|Logistic error|1|||
162955836|NCT00965185|588539364|FG000|Overall Study|Lost to Follow-up|2|||
162955837|NCT00965185|588539365|FG001|Overall Study|Lost to Follow-up|0|||
162955838|NCT00965185|588539364|FG000|Overall Study|Withdrawal by Subject|0|||
162955839|NCT00965185|588539365|FG001|Overall Study|Withdrawal by Subject|1|||
162955840|NCT03686033|588539366|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955841|NCT03686033|588539367|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955842|NCT03686033|588539368|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955843|NCT03686033|588539369|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955844|NCT03686033|588539370|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
162955845|NCT03686033|588539371|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
162955846|NCT01302548|588539373|FG000|Overall Study|Lost to Follow-up|2|||
162955847|NCT01302548|588539374|FG001|Overall Study|Lost to Follow-up|1|||
162955848|NCT02089997|588539385|FG000|Overall Study|Case report forms uncollected|99|||
162955849|NCT02089997|588539385|FG000|Overall Study|Protocol Violation|147|||
162955850|NCT00095212|588539386|FG000|Overall Study|Withdrawal by Subject|1|||
162955851|NCT00095212|588539387|FG001|Overall Study|Withdrawal by Subject|3|||
162955852|NCT02374853|588539390|FG000|Overall Study|Surgery Cancelled|5|||
162955853|NCT02374853|588539391|FG001|Overall Study|Surgery Cancelled|11|||
162955854|NCT03681470|588539393|FG000|Overall Study|Lack of Efficacy|3|||
162955855|NCT03681470|588539393|FG000|Overall Study|Lost to Follow-up|1|||
162955856|NCT03681470|588539393|FG000|Overall Study|Protocol Violation|3|||
162955857|NCT03681470|588539393|FG000|Overall Study|Withdrawal by Subject|1|||
162955858|NCT02335658|588539398|FG000|Overall Study|Adverse Event|18|||
162955859|NCT02335658|588539399|FG001|Overall Study|Adverse Event|12|||
162955860|NCT02335658|588539398|FG000|Overall Study|Lack of Efficacy|4|||
162955861|NCT02335658|588539399|FG001|Overall Study|Lack of Efficacy|5|||
162955862|NCT02335658|588539398|FG000|Overall Study|Pregnancy|1|||
162955863|NCT02335658|588539399|FG001|Overall Study|Pregnancy|0|||
162955864|NCT02335658|588539398|FG000|Overall Study|Withdrawal by Subject|13|||
162955865|NCT02335658|588539399|FG001|Overall Study|Withdrawal by Subject|21|||
162955866|NCT02335658|588539398|FG000|Overall Study|non-compliance|2|||
162955867|NCT02335658|588539399|FG001|Overall Study|non-compliance|3|||
162955868|NCT02335658|588539398|FG000|Overall Study|other reason|2|||
162955869|NCT02335658|588539399|FG001|Overall Study|other reason|3|||
162955870|NCT04149964|588539404|FG000|Overall Study|Lost to Follow-up|19|||
162955871|NCT04149964|588539405|FG001|Overall Study|Lost to Follow-up|18|||
162955872|NCT00837486|588539407|FG000|Blinded-treatment Phase|Physician Decision|1|||
162955873|NCT00837486|588539408|FG001|Blinded-treatment Phase|Physician Decision|0|||
162955874|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
162955875|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
162955876|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
162955877|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
162955878|NCT00837486|588539407|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
162955879|NCT00837486|588539408|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
162955880|NCT01577381|588539409|FG000|Overall Study|Discontinued|2|||
162955881|NCT01577381|588539410|FG001|Overall Study|Discontinued|1|||
162955882|NCT01577381|588539411|FG002|Overall Study|Discontinued|2|||
162955883|NCT01577381|588539412|FG003|Overall Study|Discontinued|2|||
162955884|NCT01577381|588539409|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
162955885|NCT01577381|588539410|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
162955886|NCT01577381|588539411|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
162856459|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
162856460|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
162856461|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
162856462|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
162856463|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
162955887|NCT01577381|588539412|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
162955888|NCT01754597|588539413|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
162955889|NCT01754597|588539414|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
162955890|NCT03447353|588541305|FG000|Overall Study|Failure at Screening Visit|2|||
162955891|NCT03447353|588541305|FG000|Overall Study|Lost to Follow-up|4|||
162955892|NCT03447353|588541305|FG000|Overall Study|Scheduling Conflicts|3|||
162955893|NCT03447353|588541305|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
162955894|NCT02175095|588541306|FG000|Overall Study|Withdrawal by Subject|3|||
162704832|NCT01857323|587630501|FG000|Overall Study|Adverse Event|1|||
162704833|NCT01857323|587630501|FG000|Overall Study|Withdrawal by Subject|3|||
162704834|NCT01857323|587630501|FG000|Overall Study|Non-compliance|1|||
162704835|NCT01857323|587630501|FG000|Overall Study|Protocol Violation|6|||
162704836|NCT01857323|587630501|FG000|Overall Study|Lost to Follow-up|1|||
162704837|NCT01857323|587630501|FG000|Overall Study|Other|4|||
162704838|NCT01857323|587630501|FG000|Overall Study|Did not complete 180 doses|48|||
162704839|NCT01400893|587630502|FG000|Overall Study|Death|27|||
162704840|NCT01400893|587630503|FG001|Overall Study|Death|21|||
162704841|NCT01400893|587630502|FG000|Overall Study|Lost to Follow-up|0|||
162704842|NCT01400893|587630503|FG001|Overall Study|Lost to Follow-up|6|||
162856464|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
162856465|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
162856466|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
162856467|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
162856468|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
162856469|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
162856470|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
162856471|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
162856472|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
162856473|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
162856474|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
162856475|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
162856476|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
162856477|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
162856478|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
162856479|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
162856480|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
162856481|NCT00100048|588177245|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
162856482|NCT00100048|588177246|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
162856483|NCT00100048|588177247|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
162856484|NCT00100048|588177248|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
162856485|NCT00100048|588177249|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
162856486|NCT00100048|588177250|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
162856487|NCT02747004|588177253|FG000|Overall Study|Withdrawal by Subject|8|||
162856488|NCT02747004|588177254|FG001|Overall Study|Withdrawal by Subject|5|||
162856489|NCT02747004|588177255|FG002|Overall Study|Withdrawal by Subject|4|||
162856490|NCT02747004|588177253|FG000|Overall Study|Lost to Follow-up|1|||
162856491|NCT02747004|588177254|FG001|Overall Study|Lost to Follow-up|2|||
162856492|NCT02747004|588177255|FG002|Overall Study|Lost to Follow-up|2|||
162856493|NCT02747004|588177253|FG000|Overall Study|on study treatment/follow-up|48|||
162856494|NCT02747004|588177254|FG001|Overall Study|on study treatment/follow-up|42|||
162856495|NCT02747004|588177255|FG002|Overall Study|on study treatment/follow-up|41|||
162856496|NCT02722044|588177256|FG000|Overall Study|Adverse Event|2|||
162856497|NCT02722044|588177256|FG000|Overall Study|Physician Decision|1|||
162856498|NCT02722044|588177256|FG000|Overall Study|Withdrawal by Subject|1|||
162856499|NCT02722044|588177256|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
162856500|NCT04885257|588177260|FG000|Overall Study|Withdrawal by Subject|1|||
162856501|NCT04885257|588177261|FG001|Overall Study|Withdrawal by Subject|0|||
162856502|NCT00818259|588177262|FG000|Part I|Withdrawal by Subject|1|||
162856503|NCT00818259|588177263|FG001|Part I|Withdrawal by Subject|0|||
162856504|NCT00818259|588177264|FG002|Part I|Withdrawal by Subject|0|||
162856505|NCT00818259|588177265|FG003|Part I|Withdrawal by Subject|0|||
162856506|NCT00818259|588177266|FG004|Part I|Withdrawal by Subject|0|||
162856507|NCT00818259|588177267|FG005|Part I|Withdrawal by Subject|0|||
162856508|NCT00818259|588177268|FG006|Part I|Withdrawal by Subject|0|||
162856509|NCT00818259|588177269|FG007|Part I|Withdrawal by Subject|0|||
162856510|NCT00818259|588177270|FG008|Part I|Withdrawal by Subject|0|||
162856511|NCT00818259|588177262|FG000|Part II|Physician Decision|0|||
162856512|NCT00818259|588177263|FG001|Part II|Physician Decision|0|||
162856513|NCT00818259|588177264|FG002|Part II|Physician Decision|1|||
162856514|NCT00818259|588177265|FG003|Part II|Physician Decision|0|||
162856515|NCT00818259|588177266|FG004|Part II|Physician Decision|0|||
162856516|NCT00818259|588177267|FG005|Part II|Physician Decision|0|||
162856517|NCT00818259|588177268|FG006|Part II|Physician Decision|0|||
162856518|NCT00818259|588177269|FG007|Part II|Physician Decision|0|||
162856519|NCT00818259|588177270|FG008|Part II|Physician Decision|0|||
162856520|NCT00818259|588177262|FG000|Part II|Lack of Efficacy|0|||
162704843|NCT00519636|587630504|FG000|Treatment Period 1|Adverse Event|1|||
162856521|NCT00818259|588177263|FG001|Part II|Lack of Efficacy|0|||
162704844|NCT00519636|587630505|FG001|Treatment Period 1|Adverse Event|0|||
162704845|NCT00519636|587630506|FG002|Treatment Period 1|Adverse Event|1|||
162856522|NCT00818259|588177264|FG002|Part II|Lack of Efficacy|0|||
162856523|NCT00818259|588177265|FG003|Part II|Lack of Efficacy|1|||
162856524|NCT00818259|588177266|FG004|Part II|Lack of Efficacy|0|||
162856525|NCT00818259|588177267|FG005|Part II|Lack of Efficacy|0|||
162856526|NCT00818259|588177268|FG006|Part II|Lack of Efficacy|0|||
162856527|NCT00818259|588177269|FG007|Part II|Lack of Efficacy|0|||
162856528|NCT00818259|588177270|FG008|Part II|Lack of Efficacy|0|||
162856529|NCT00818259|588177262|FG000|Part II|Not Treated|0|||
162856530|NCT00818259|588177263|FG001|Part II|Not Treated|0|||
162856531|NCT00818259|588177264|FG002|Part II|Not Treated|0|||
162856532|NCT00818259|588177265|FG003|Part II|Not Treated|1|||
162856533|NCT00818259|588177266|FG004|Part II|Not Treated|0|||
162856534|NCT00818259|588177267|FG005|Part II|Not Treated|0|||
162856535|NCT00818259|588177268|FG006|Part II|Not Treated|0|||
162856536|NCT00818259|588177269|FG007|Part II|Not Treated|0|||
162856537|NCT00818259|588177270|FG008|Part II|Not Treated|0|||
162856538|NCT00818259|588177262|FG000|Part IV|Physician Decision|0|||
162856539|NCT00818259|588177263|FG001|Part IV|Physician Decision|0|||
162856540|NCT00818259|588177264|FG002|Part IV|Physician Decision|0|||
162856541|NCT00818259|588177265|FG003|Part IV|Physician Decision|0|||
162856542|NCT00818259|588177266|FG004|Part IV|Physician Decision|0|||
162856543|NCT00818259|588177267|FG005|Part IV|Physician Decision|1|||
162856544|NCT00818259|588177268|FG006|Part IV|Physician Decision|0|||
162856545|NCT00818259|588177269|FG007|Part IV|Physician Decision|0|||
162856546|NCT00818259|588177270|FG008|Part IV|Physician Decision|0|||
162856547|NCT00818259|588177262|FG000|Part V|Adverse Event|0|||
162856548|NCT00818259|588177263|FG001|Part V|Adverse Event|0|||
162856549|NCT00818259|588177264|FG002|Part V|Adverse Event|0|||
162856550|NCT00818259|588177265|FG003|Part V|Adverse Event|0|||
162856551|NCT00818259|588177266|FG004|Part V|Adverse Event|0|||
162856552|NCT00818259|588177267|FG005|Part V|Adverse Event|0|||
162856553|NCT00818259|588177268|FG006|Part V|Adverse Event|0|||
162856554|NCT00818259|588177269|FG007|Part V|Adverse Event|1|||
162856555|NCT00818259|588177270|FG008|Part V|Adverse Event|0|||
162856556|NCT04640766|588177271|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
162856557|NCT00609622|588177272|FG000|Overall Study|Adverse Event|14|||
162856558|NCT00609622|588177273|FG001|Overall Study|Adverse Event|10|||
162856559|NCT00609622|588177272|FG000|Overall Study|Withdrawal by Subject|4|||
162856560|NCT00609622|588177273|FG001|Overall Study|Withdrawal by Subject|20|||
162856561|NCT00609622|588177272|FG000|Overall Study|Death|1|||
162856562|NCT00609622|588177273|FG001|Overall Study|Death|4|||
162856563|NCT00609622|588177272|FG000|Overall Study|Protocol Violation|1|||
162856564|NCT00609622|588177273|FG001|Overall Study|Protocol Violation|1|||
162856565|NCT00609622|588177272|FG000|Overall Study|Objective progression or relapse|47|||
162856566|NCT00609622|588177273|FG001|Overall Study|Objective progression or relapse|41|||
162856567|NCT00609622|588177272|FG000|Overall Study|Study terminated by sponsor|16|||
162856568|NCT00609622|588177273|FG001|Overall Study|Study terminated by sponsor|3|||
162856569|NCT00609622|588177272|FG000|Overall Study|Other|7|||
162856570|NCT00609622|588177273|FG001|Overall Study|Other|14|||
162856571|NCT00609622|588177272|FG000|Overall Study|Global deterioration of health status|6|||
162856572|NCT00609622|588177273|FG001|Overall Study|Global deterioration of health status|2|||
162856573|NCT01237951|588177276|FG000|Overall Study|Death|1|||
162856574|NCT01708057|588177277|FG000|Overall Study|Withdrawal due to study termination.|1|||
162856575|NCT01708057|588177278|FG001|Overall Study|Withdrawal due to study termination.|1|||
162955895|NCT02635750|588541307|FG000|Part 1, Period 2|Adverse Event|1|||
162955896|NCT02635750|588541308|FG001|Part 1, Period 2|Adverse Event|0|||
162611836|NCT01442038|587296675|FG001|Overall Study|Death|29|||
162611837|NCT01442038|587296674|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
162611838|NCT01442038|587296675|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
162611839|NCT01442038|587296674|FG000|Overall Study|Participant Withdrew Consent|137|||
162955897|NCT02635750|588541309|FG002|Part 1, Period 2|Adverse Event|0|||
162611840|NCT01442038|587296675|FG001|Overall Study|Participant Withdrew Consent|102|||
162611841|NCT01442038|587296674|FG000|Overall Study|Lost to Follow-up|37|||
162856576|NCT01708057|588177279|FG002|Overall Study|Withdrawal due to study termination.|1|||
162856577|NCT02970929|588177284|FG000|Overall Study|Adverse Event|18|||
162856578|NCT02970929|588177284|FG000|Overall Study|Lack of Efficacy|8|||
162856579|NCT02970929|588177284|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
162856580|NCT02970929|588177284|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
162856581|NCT02970929|588177284|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
162856582|NCT02970929|588177284|FG000|Overall Study|LOST TO FOLLOWUP|6|||
162856583|NCT02970929|588177284|FG000|Overall Study|MOVED OUT OF STATE|1|||
162856584|NCT02970929|588177284|FG000|Overall Study|Withdrawal by Subject|16|||
162856585|NCT00666562|588177287|FG000|Overall Study|Withdrawal by Subject|0|||
162856586|NCT00666562|588177288|FG001|Overall Study|Withdrawal by Subject|1|||
162955898|NCT00462345|588541312|FG000|Overall Study|Withdrawal by Subject|2|||
162611842|NCT01442038|587296675|FG001|Overall Study|Lost to Follow-up|51|||
162856587|NCT00666562|588177289|FG002|Overall Study|Withdrawal by Subject|0|||
162856588|NCT00666562|588177287|FG000|Overall Study|Concomitant Medication|0|||
162856589|NCT00666562|588177288|FG001|Overall Study|Concomitant Medication|1|||
162856590|NCT00666562|588177289|FG002|Overall Study|Concomitant Medication|0|||
162856591|NCT03874234|588178706|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856592|NCT03874234|588178707|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856593|NCT03874234|588178708|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856594|NCT03874234|588178709|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
162856595|NCT03874234|588178710|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856596|NCT03874234|588178711|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856597|NCT03874234|588178712|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856598|NCT03874234|588178713|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856599|NCT03874234|588178714|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856600|NCT03874234|588178715|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856601|NCT03874234|588178716|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856602|NCT03874234|588178717|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856603|NCT03874234|588178718|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
162856604|NCT03874234|588178706|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
162856605|NCT03874234|588178707|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856606|NCT03874234|588178708|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856607|NCT03874234|588178709|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856608|NCT03874234|588178710|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856609|NCT03874234|588178711|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856610|NCT03874234|588178712|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856611|NCT03874234|588178713|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856612|NCT03874234|588178714|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856613|NCT03874234|588178715|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856614|NCT03874234|588178716|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856615|NCT03874234|588178717|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856616|NCT03874234|588178718|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
162856617|NCT03874234|588178706|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856618|NCT03874234|588178707|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856619|NCT03874234|588178708|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856620|NCT03874234|588178709|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
162856621|NCT03874234|588178710|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856622|NCT03874234|588178711|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856623|NCT03874234|588178712|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856624|NCT03874234|588178713|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856625|NCT03874234|588178714|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856626|NCT03874234|588178715|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856627|NCT03874234|588178716|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856628|NCT03874234|588178717|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856629|NCT03874234|588178718|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
162856630|NCT03874234|588178706|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856631|NCT03874234|588178707|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856632|NCT03874234|588178708|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856633|NCT03874234|588178709|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856634|NCT03874234|588178710|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
162856635|NCT03874234|588178711|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856636|NCT03874234|588178712|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856637|NCT03874234|588178713|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856638|NCT03874234|588178714|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856639|NCT03874234|588178715|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856640|NCT03874234|588178716|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856641|NCT03874234|588178717|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856642|NCT03874234|588178718|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
162856643|NCT03874234|588178706|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856644|NCT03874234|588178707|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856645|NCT03874234|588178708|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856646|NCT03874234|588178709|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856647|NCT03874234|588178710|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856648|NCT03874234|588178711|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856649|NCT03874234|588178712|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856650|NCT03874234|588178713|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
162856651|NCT03874234|588178714|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856652|NCT03874234|588178715|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856653|NCT03874234|588178716|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856654|NCT03874234|588178717|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856655|NCT03874234|588178718|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
162856656|NCT03874234|588178706|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856657|NCT03874234|588178707|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856658|NCT03874234|588178708|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856659|NCT03874234|588178709|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856660|NCT03874234|588178710|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
162856661|NCT03874234|588178711|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
162856662|NCT03874234|588178712|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856663|NCT03874234|588178713|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856664|NCT03874234|588178714|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856665|NCT03874234|588178715|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856666|NCT03874234|588178716|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856667|NCT03874234|588178717|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856668|NCT03874234|588178718|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
162856669|NCT03874234|588178706|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856670|NCT03874234|588178707|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856671|NCT03874234|588178708|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856672|NCT03874234|588178709|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856673|NCT03874234|588178710|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856674|NCT03874234|588178711|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856675|NCT03874234|588178712|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
162856676|NCT03874234|588178713|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856677|NCT03874234|588178714|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856678|NCT03874234|588178715|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856679|NCT03874234|588178716|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856680|NCT03874234|588178717|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856681|NCT03874234|588178718|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
162856682|NCT03874234|588178706|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856683|NCT03874234|588178707|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856684|NCT03874234|588178708|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856685|NCT03874234|588178709|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856686|NCT03874234|588178710|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
162856687|NCT03874234|588178711|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856688|NCT03874234|588178712|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856689|NCT03874234|588178713|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856690|NCT03874234|588178714|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856691|NCT03874234|588178715|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856692|NCT03874234|588178716|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856693|NCT03874234|588178717|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856694|NCT03874234|588178718|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
162856695|NCT01896232|588178723|FG000|Overall Study|Death|6|||
162856696|NCT01896232|588178724|FG001|Overall Study|Death|10|||
162856697|NCT01896232|588178723|FG000|Overall Study|Withdrawal by Subject|32|||
162856698|NCT01896232|588178724|FG001|Overall Study|Withdrawal by Subject|31|||
162856699|NCT01896232|588178723|FG000|Overall Study|Sponsor Decision|2|||
162856700|NCT01896232|588178724|FG001|Overall Study|Sponsor Decision|0|||
162856701|NCT01896232|588178723|FG000|Overall Study|Lost to Follow-up|9|||
162856702|NCT01896232|588178724|FG001|Overall Study|Lost to Follow-up|12|||
162955899|NCT00462345|588541312|FG000|Overall Study|Did not complete second course|1|||
162955900|NCT02642653|588541314|FG000|Overall Study|Adverse Event|2|||
162955901|NCT02642653|588541315|FG001|Overall Study|Adverse Event|0|||
162955902|NCT02875392|588541319|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
162955903|NCT02875392|588541320|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
162955904|NCT00508651|588541324|FG000|Overall Study|Lost to Follow-up|3|||
162856703|NCT00686205|588178725|FG000|Overall Study|Protocol Violation|127|||
162955905|NCT00508651|588541325|FG001|Overall Study|Lost to Follow-up|1|||
163044461|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
163044462|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
162856704|NCT00686205|588178726|FG001|Overall Study|Protocol Violation|0|||
162856705|NCT00686205|588178725|FG000|Overall Study|Withdrawal by Subject|2|||
162856706|NCT00686205|588178726|FG001|Overall Study|Withdrawal by Subject|0|||
162856707|NCT00686205|588178725|FG000|Overall Study|Specimen handling procedure altered|5878|||
162856708|NCT00686205|588178726|FG001|Overall Study|Specimen handling procedure altered|0|||
162856709|NCT00686205|588178725|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
162856710|NCT00686205|588178726|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
162856711|NCT03168867|588178727|FG000|Overall Study|Withdrawal by Subject|1|||
162856712|NCT03168867|588178728|FG001|Overall Study|Withdrawal by Subject|5|||
162856713|NCT03812510|588178729|FG000|Overall Study|Lost to Follow-up|39|||
162856714|NCT03812510|588178729|FG000|Overall Study|Withdrawal by Subject|42|||
162856715|NCT03812510|588178729|FG000|Overall Study|Physician Decision|2|||
162856716|NCT03812510|588178729|FG000|Overall Study|Study Terminated by Sponsor|9|||
162856717|NCT03812510|588178729|FG000|Overall Study|Did Not Start Study Medication|55|||
162856718|NCT03812510|588178729|FG000|Overall Study|Adverse Event|5|||
162856719|NCT00858832|588178730|FG000|Overall Study|became ineligible: delivered vaginally|1|||
162856720|NCT00858832|588178731|FG001|Overall Study|became ineligible: delivered vaginally|0|||
162856721|NCT00858832|588178730|FG000|Overall Study|Adverse Event|0|||
162856722|NCT00858832|588178731|FG001|Overall Study|Adverse Event|1|||
162856723|NCT03075839|588178736|FG000|Overall Study|Lost to Follow-up|4|||
162856724|NCT05421754|588178741|FG000|Overall Study|Technical issue with sensor|1|||
162856725|NCT04433117|588178742|FG000|Overall Study|Withdrawal by Subject|1|||
162856726|NCT04433117|588178743|FG001|Overall Study|Withdrawal by Subject|0|||
162856727|NCT01051739|588178744|FG000|Overall Study|Death|3|||
162856728|NCT01051739|588178745|FG001|Overall Study|Death|3|||
162856729|NCT01051739|588178744|FG000|Overall Study|Withdrawal by Subject|25|||
162856730|NCT01051739|588178745|FG001|Overall Study|Withdrawal by Subject|10|||
162856731|NCT00824421|588178746|FG000|Overall Study|Adverse Event|6|||
162856732|NCT00824421|588178747|FG001|Overall Study|Adverse Event|6|||
162856733|NCT00824421|588178748|FG002|Overall Study|Adverse Event|6|||
162856734|NCT00824421|588178746|FG000|Overall Study|Death|0|||
162856735|NCT00824421|588178747|FG001|Overall Study|Death|1|||
162856736|NCT00824421|588178748|FG002|Overall Study|Death|0|||
162856737|NCT00824421|588178746|FG000|Overall Study|Lack of Efficacy|5|||
162856738|NCT00824421|588178747|FG001|Overall Study|Lack of Efficacy|7|||
162955906|NCT00508651|588541324|FG000|Overall Study|Withdrawal by Subject|1|||
162955907|NCT00508651|588541325|FG001|Overall Study|Withdrawal by Subject|1|||
162955908|NCT03874715|588541328|FG000|Overall Study|Adverse Event|2|||
162955909|NCT03874715|588541329|FG001|Overall Study|Adverse Event|0|||
162955910|NCT03874715|588541328|FG000|Overall Study|Poor compliance to protocol|5|||
162955911|NCT03874715|588541329|FG001|Overall Study|Poor compliance to protocol|1|||
162955912|NCT03874715|588541328|FG000|Overall Study|Withdrawal by Subject|1|||
162955913|NCT03874715|588541329|FG001|Overall Study|Withdrawal by Subject|0|||
162955914|NCT03874715|588541328|FG000|Overall Study|Other-unspecified|1|||
162955915|NCT03874715|588541329|FG001|Overall Study|Other-unspecified|0|||
162955916|NCT00461786|588541332|FG000|Overall Study|Entry Criteria Not Met|2|||
162955917|NCT00461786|588541332|FG000|Overall Study|Inevaluable (Never Treated)|1|||
162955918|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
162955919|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955920|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955921|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
162955922|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955923|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
162955924|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
162955925|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
162955926|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
162955927|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
162611843|NCT01442038|587296674|FG000|Overall Study|Adverse Event|26|||
162611844|NCT01442038|587296675|FG001|Overall Study|Adverse Event|15|||
162955928|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
162955929|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
162856739|NCT00824421|588178748|FG002|Overall Study|Lack of Efficacy|4|||
162856740|NCT00824421|588178746|FG000|Overall Study|Lost to Follow-up|2|||
162955930|NCT00934050|588541333|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955931|NCT00934050|588541334|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955932|NCT00934050|588541335|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
162955933|NCT00934050|588541336|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955934|NCT00934050|588541337|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162856741|NCT00824421|588178747|FG001|Overall Study|Lost to Follow-up|3|||
162856742|NCT00824421|588178748|FG002|Overall Study|Lost to Follow-up|0|||
162856743|NCT00824421|588178746|FG000|Overall Study|Pregnancy|1|||
162856744|NCT00824421|588178747|FG001|Overall Study|Pregnancy|0|||
162856745|NCT00824421|588178748|FG002|Overall Study|Pregnancy|1|||
162955935|NCT00934050|588541338|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
162955936|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
163044463|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
163044464|NCT03569098|588871452|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
163044465|NCT03569098|588871453|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
163044466|NCT03569098|588871454|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
163044467|NCT02581488|588871459|FG000|Overall Study|Adverse Event|6|||
163044468|NCT02581488|588871460|FG001|Overall Study|Adverse Event|7|||
163044469|NCT02581488|588871459|FG000|Overall Study|Lost to Follow-up|1|||
163044470|NCT02581488|588871460|FG001|Overall Study|Lost to Follow-up|0|||
163044471|NCT02581488|588871459|FG000|Overall Study|Withdrawal by Subject|1|||
163044472|NCT02581488|588871460|FG001|Overall Study|Withdrawal by Subject|0|||
163044473|NCT02581488|588871459|FG000|Overall Study|Non-Compliance|1|||
163044474|NCT02581488|588871460|FG001|Overall Study|Non-Compliance|0|||
163044475|NCT02581488|588871459|FG000|Overall Study|Protocol Violation|0|||
163044476|NCT02581488|588871460|FG001|Overall Study|Protocol Violation|4|||
163044477|NCT04194489|588871461|FG000|Overall Study|Withdrawal by Subject|5|||
163044478|NCT04194489|588871461|FG000|Overall Study|Lost to Follow-up|48|||
163044479|NCT02485483|588871462|FG000|Overall Study|Depression at baseline|15|||
163044480|NCT02485483|588871463|FG001|Overall Study|Depression at baseline|0|||
163044481|NCT02485483|588871462|FG000|Overall Study|Discontinued after baseline|39|||
163044482|NCT02485483|588871463|FG001|Overall Study|Discontinued after baseline|0|||
163044483|NCT00377637|588871464|FG000|Induction Phase|Adverse Event|12|||
163044484|NCT00377637|588871465|FG001|Induction Phase|Adverse Event|21|||
163044485|NCT00377637|588871466|FG002|Induction Phase|Adverse Event|0|||
163044486|NCT00377637|588871467|FG003|Induction Phase|Adverse Event|0|||
163044487|NCT00377637|588871464|FG000|Induction Phase|Deterioration/serum creatinine|2|||
163044488|NCT00377637|588871465|FG001|Induction Phase|Deterioration/serum creatinine|0|||
163044489|NCT00377637|588871466|FG002|Induction Phase|Deterioration/serum creatinine|0|||
163044490|NCT00377637|588871467|FG003|Induction Phase|Deterioration/serum creatinine|0|||
163044491|NCT00377637|588871464|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044492|NCT00377637|588871465|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
163044493|NCT00377637|588871466|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044494|NCT00377637|588871467|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
163044495|NCT00377637|588871464|FG000|Induction Phase|Lost to Follow-up|2|||
163044496|NCT00377637|588871465|FG001|Induction Phase|Lost to Follow-up|1|||
163044497|NCT00377637|588871466|FG002|Induction Phase|Lost to Follow-up|0|||
163044498|NCT00377637|588871467|FG003|Induction Phase|Lost to Follow-up|0|||
163044499|NCT00377637|588871464|FG000|Induction Phase|Death|1|||
163044500|NCT00377637|588871465|FG001|Induction Phase|Death|3|||
163044501|NCT00377637|588871466|FG002|Induction Phase|Death|0|||
163044502|NCT00377637|588871467|FG003|Induction Phase|Death|0|||
163044503|NCT00377637|588871464|FG000|Induction Phase|Withdrawal by Subject|5|||
163044504|NCT00377637|588871465|FG001|Induction Phase|Withdrawal by Subject|6|||
163044505|NCT00377637|588871466|FG002|Induction Phase|Withdrawal by Subject|0|||
163044506|NCT00377637|588871467|FG003|Induction Phase|Withdrawal by Subject|0|||
163044507|NCT00377637|588871464|FG000|Induction Phase|Physician Decision|3|||
163044508|NCT00377637|588871465|FG001|Induction Phase|Physician Decision|1|||
163044509|NCT00377637|588871466|FG002|Induction Phase|Physician Decision|0|||
163044510|NCT00377637|588871467|FG003|Induction Phase|Physician Decision|0|||
163044511|NCT00377637|588871464|FG000|Induction Phase|Sponsor decision|1|||
163044512|NCT00377637|588871465|FG001|Induction Phase|Sponsor decision|2|||
163044513|NCT00377637|588871466|FG002|Induction Phase|Sponsor decision|0|||
163044514|NCT00377637|588871467|FG003|Induction Phase|Sponsor decision|0|||
163044515|NCT00377637|588871464|FG000|Induction Phase|Non-Compliance|1|||
163044516|NCT00377637|588871465|FG001|Induction Phase|Non-Compliance|0|||
163044517|NCT00377637|588871466|FG002|Induction Phase|Non-Compliance|0|||
163044518|NCT00377637|588871467|FG003|Induction Phase|Non-Compliance|0|||
163044519|NCT00377637|588871464|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
163044520|NCT00377637|588871465|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
163044521|NCT00377637|588871466|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
163044522|NCT00377637|588871467|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
163044523|NCT00377637|588871464|FG000|Maintenance Phase|Adverse Event|0|||
163044524|NCT00377637|588871465|FG001|Maintenance Phase|Adverse Event|0|||
163044525|NCT00377637|588871466|FG002|Maintenance Phase|Adverse Event|29|||
163044526|NCT00377637|588871467|FG003|Maintenance Phase|Adverse Event|43|||
163044527|NCT00377637|588871464|FG000|Maintenance Phase|Physician Decision|0|||
163044528|NCT00377637|588871465|FG001|Maintenance Phase|Physician Decision|0|||
163044529|NCT00377637|588871466|FG002|Maintenance Phase|Physician Decision|5|||
163044530|NCT00377637|588871467|FG003|Maintenance Phase|Physician Decision|4|||
163044531|NCT00377637|588871464|FG000|Maintenance Phase|Lost to Follow-up|0|||
163044532|NCT00377637|588871465|FG001|Maintenance Phase|Lost to Follow-up|0|||
163044533|NCT00377637|588871466|FG002|Maintenance Phase|Lost to Follow-up|3|||
163044534|NCT00377637|588871467|FG003|Maintenance Phase|Lost to Follow-up|1|||
163044535|NCT00377637|588871464|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163044536|NCT00377637|588871465|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163044537|NCT00377637|588871466|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163044538|NCT00377637|588871467|FG003|Maintenance Phase|Withdrawal by Subject|3|||
162856746|NCT00824421|588178746|FG000|Overall Study|Withdrawal by Subject|2|||
162856747|NCT00824421|588178747|FG001|Overall Study|Withdrawal by Subject|3|||
162856748|NCT00824421|588178748|FG002|Overall Study|Withdrawal by Subject|3|||
162856749|NCT00824421|588178746|FG000|Overall Study|Randomized but not Treated|1|||
162856750|NCT00824421|588178747|FG001|Overall Study|Randomized but not Treated|1|||
162856751|NCT00824421|588178748|FG002|Overall Study|Randomized but not Treated|0|||
162856752|NCT00824421|588178746|FG000|Overall Study|Other|0|||
162856753|NCT00824421|588178747|FG001|Overall Study|Other|1|||
162856754|NCT00824421|588178748|FG002|Overall Study|Other|0|||
162856755|NCT05089708|588178750|FG000|Overall Study|Lost to Follow-up|9|||
162856756|NCT05089708|588178751|FG001|Overall Study|Lost to Follow-up|7|||
162856757|NCT05089708|588178750|FG000|Overall Study|Withdrawal by Subject|3|||
162856758|NCT05089708|588178751|FG001|Overall Study|Withdrawal by Subject|1|||
162955937|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955938|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955939|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955940|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
162955941|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
162955942|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Death|0|||
162955943|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Death|0|||
162955944|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Death|0|||
162955945|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Death|0|||
162955946|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Death|0|||
162955947|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Death|1|||
162955948|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955949|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955950|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955951|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955952|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162955953|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
162955954|NCT00934050|588541333|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955955|NCT00934050|588541334|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955956|NCT00934050|588541335|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955957|NCT00934050|588541336|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162955958|NCT00934050|588541337|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
162955959|NCT00934050|588541338|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
162955960|NCT03616535|588541342|FG000|Overall Study|Death|2|||
162955961|NCT03616535|588541343|FG001|Overall Study|Death|0|||
162955962|NCT03616535|588541344|FG002|Overall Study|Death|0|||
162955963|NCT03616535|588541345|FG003|Overall Study|Death|1|||
162955964|NCT03616535|588541342|FG000|Overall Study|Lost to Follow-up|2|||
162955965|NCT03616535|588541343|FG001|Overall Study|Lost to Follow-up|1|||
162955966|NCT03616535|588541344|FG002|Overall Study|Lost to Follow-up|0|||
162955967|NCT03616535|588541345|FG003|Overall Study|Lost to Follow-up|2|||
162955968|NCT03616535|588541342|FG000|Overall Study|Withdrawal by Subject|1|||
162955969|NCT03616535|588541343|FG001|Overall Study|Withdrawal by Subject|2|||
162955970|NCT03616535|588541344|FG002|Overall Study|Withdrawal by Subject|5|||
162955971|NCT03616535|588541345|FG003|Overall Study|Withdrawal by Subject|1|||
162955972|NCT03616535|588541342|FG000|Overall Study|Not specified or change in eligibility|2|||
162955973|NCT03616535|588541343|FG001|Overall Study|Not specified or change in eligibility|3|||
162955974|NCT03616535|588541344|FG002|Overall Study|Not specified or change in eligibility|3|||
162955975|NCT03616535|588541345|FG003|Overall Study|Not specified or change in eligibility|1|||
162611845|NCT01442038|587296674|FG000|Overall Study|Protocol Deviation|9|||
162856759|NCT05089708|588178750|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
162856760|NCT05089708|588178751|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
162856761|NCT05089708|588178750|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
162856762|NCT05089708|588178751|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
162856763|NCT00659438|588178752|FG000|Overall Study|Withdrawal by Subject|2|||
162856764|NCT00659438|588178753|FG001|Overall Study|Withdrawal by Subject|2|||
162856765|NCT00659438|588178752|FG000|Overall Study|Death|11|||
162856766|NCT00659438|588178753|FG001|Overall Study|Death|6|||
162856767|NCT00659438|588178752|FG000|Overall Study|Lost to Follow-up|1|||
162856768|NCT00659438|588178753|FG001|Overall Study|Lost to Follow-up|0|||
162856769|NCT00201851|588178754|FG000|Overall Study|Lost to Follow-up|2|||
162856770|NCT00201851|588178755|FG001|Overall Study|Lost to Follow-up|1|||
162856771|NCT00201851|588178756|FG002|Overall Study|Lost to Follow-up|0|||
162856772|NCT00201851|588178754|FG000|Overall Study|Ineligible post enrollment|6|||
162856773|NCT00201851|588178755|FG001|Overall Study|Ineligible post enrollment|1|||
162856774|NCT00201851|588178756|FG002|Overall Study|Ineligible post enrollment|1|||
162856775|NCT02469246|588178757|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
162856776|NCT02469246|588178758|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
162856777|NCT02469246|588178757|FG000|Double-Blind Phase|Adverse Event|12|||
162856778|NCT02469246|588178758|FG001|Double-Blind Phase|Adverse Event|9|||
162856779|NCT02469246|588178757|FG000|Double-Blind Phase|Death|2|||
162856780|NCT02469246|588178758|FG001|Double-Blind Phase|Death|0|||
162856781|NCT02469246|588178757|FG000|Double-Blind Phase|Lack of Efficacy|2|||
162856782|NCT02469246|588178758|FG001|Double-Blind Phase|Lack of Efficacy|1|||
162856783|NCT02469246|588178757|FG000|Double-Blind Phase|Investigator's Discretion|8|||
162856784|NCT02469246|588178758|FG001|Double-Blind Phase|Investigator's Discretion|8|||
162856785|NCT02469246|588178757|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
162856786|NCT02469246|588178758|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
162856787|NCT02469246|588178757|FG000|Double-Blind Phase|Protocol Violation|1|||
162856788|NCT02469246|588178758|FG001|Double-Blind Phase|Protocol Violation|1|||
162856789|NCT02469246|588178757|FG000|Double-Blind Phase|Withdrew Consent|25|||
162856790|NCT02469246|588178758|FG001|Double-Blind Phase|Withdrew Consent|25|||
162856791|NCT02469246|588178757|FG000|Double-Blind Phase|Lost to Follow-up|9|||
162856792|NCT02469246|588178758|FG001|Double-Blind Phase|Lost to Follow-up|5|||
162856793|NCT02690701|588178764|FG000|Treatment Period 1|Adverse Event|2|||
162856794|NCT02690701|588178765|FG001|Treatment Period 1|Adverse Event|2|||
162856795|NCT02690701|588178764|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162856796|NCT02690701|588178765|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162856797|NCT02690701|588178764|FG000|Treatment Period 2|Adverse Event|2|||
162856798|NCT02690701|588178765|FG001|Treatment Period 2|Adverse Event|0|||
162856799|NCT02690701|588178764|FG000|Treatment Period 2|Lack of Efficacy|1|||
162856800|NCT02690701|588178765|FG001|Treatment Period 2|Lack of Efficacy|0|||
162856801|NCT02690701|588178764|FG000|Treatment Period 2|Lost to Follow-up|0|||
162856802|NCT02690701|588178765|FG001|Treatment Period 2|Lost to Follow-up|2|||
162856803|NCT02690701|588178764|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162611846|NCT01442038|587296675|FG001|Overall Study|Protocol Deviation|20|||
162611847|NCT01442038|587296674|FG000|Overall Study|Investigator's Discretion|13|||
162611848|NCT01442038|587296675|FG001|Overall Study|Investigator's Discretion|16|||
162611849|NCT01442038|587296674|FG000|Overall Study|Study Terminated By Sponsor|2|||
162611850|NCT01442038|587296675|FG001|Overall Study|Study Terminated By Sponsor|3|||
162611851|NCT00089284|587296676|FG000|Overall Study|Adverse event before starting treatment|0|||
162611852|NCT00089284|587296677|FG001|Overall Study|Adverse event before starting treatment|0|||
162856804|NCT02690701|588178765|FG001|Treatment Period 2|Withdrawal by Subject|2|||
162856805|NCT02690701|588178764|FG000|Treatment Period 2|Protocol Violation|0|||
162856806|NCT02690701|588178765|FG001|Treatment Period 2|Protocol Violation|1|||
162856807|NCT02700451|588178766|FG000|Overall Study|Protocol Violation|2|||
162856808|NCT02700451|588178767|FG001|Overall Study|Protocol Violation|2|||
162611853|NCT00089284|587296678|FG002|Overall Study|Adverse event before starting treatment|0|||
162611854|NCT00089284|587296679|FG003|Overall Study|Adverse event before starting treatment|0|||
162611855|NCT00089284|587296680|FG004|Overall Study|Adverse event before starting treatment|0|||
162611856|NCT00089284|587296681|FG005|Overall Study|Adverse event before starting treatment|0|||
162611857|NCT00089284|587296682|FG006|Overall Study|Adverse event before starting treatment|1|||
162611858|NCT02395666|587296683|FG000|Overall Study|Physician Decision|3|||
162611859|NCT02395666|587296684|FG001|Overall Study|Physician Decision|0|||
162611860|NCT02395666|587296683|FG000|Overall Study|Lost to Follow-up|1|||
162611861|NCT02395666|587296684|FG001|Overall Study|Lost to Follow-up|0|||
162611862|NCT02395666|587296683|FG000|Overall Study|Withdrawal by Subject|2|||
162611863|NCT02395666|587296684|FG001|Overall Study|Withdrawal by Subject|1|||
162856809|NCT02700451|588178768|FG002|Overall Study|Protocol Violation|3|||
162856810|NCT02700451|588178766|FG000|Overall Study|Discontinued intervention|14|||
162856811|NCT02700451|588178767|FG001|Overall Study|Discontinued intervention|15|||
162611864|NCT02611960|587296685|FG000|Overall Study|Adverse Event|7|||
162611865|NCT02611960|587296686|FG001|Overall Study|Adverse Event|8|||
162611866|NCT02611960|587296685|FG000|Overall Study|Death|98|||
162704846|NCT00519636|587630507|FG003|Treatment Period 1|Adverse Event|0|||
162856812|NCT02700451|588178768|FG002|Overall Study|Discontinued intervention|14|||
162856813|NCT00404092|588178772|FG000|Overall Study|Death|1|||
162856814|NCT00404092|588178773|FG001|Overall Study|Death|0|||
162856815|NCT00404092|588178774|FG002|Overall Study|Death|0|||
162856816|NCT00404092|588178775|FG003|Overall Study|Death|0|||
162856817|NCT00404092|588178772|FG000|Overall Study|Adverse Event|0|||
162856818|NCT00404092|588178773|FG001|Overall Study|Adverse Event|0|||
162856819|NCT00404092|588178774|FG002|Overall Study|Adverse Event|1|||
162856820|NCT00404092|588178775|FG003|Overall Study|Adverse Event|0|||
162856821|NCT02344576|588178779|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
162856822|NCT02344576|588178780|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
162856823|NCT02344576|588178781|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
162856824|NCT02344576|588178782|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
162856825|NCT02344576|588178779|FG000|1-Month Follow-Up|Death|13|||
162856826|NCT02344576|588178780|FG001|1-Month Follow-Up|Death|8|||
162856827|NCT02344576|588178781|FG002|1-Month Follow-Up|Death|0|||
162856828|NCT02344576|588178782|FG003|1-Month Follow-Up|Death|0|||
162856829|NCT02344576|588178779|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
162856830|NCT02344576|588178780|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
162856831|NCT02344576|588178781|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
162856832|NCT02344576|588178782|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
162856833|NCT02344576|588178779|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
162856834|NCT02344576|588178780|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
162856835|NCT02344576|588178781|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
162856836|NCT02344576|588178782|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
162856837|NCT02344576|588178779|FG000|6-Month Follow-Up|Death|14|||
162856838|NCT02344576|588178780|FG001|6-Month Follow-Up|Death|14|||
162856839|NCT02344576|588178781|FG002|6-Month Follow-Up|Death|0|||
162856840|NCT02344576|588178782|FG003|6-Month Follow-Up|Death|0|||
162856841|NCT02344576|588178779|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
162856842|NCT02344576|588178780|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
162856843|NCT02344576|588178781|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
162856844|NCT02344576|588178782|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
162856845|NCT02344576|588178779|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
162856846|NCT02344576|588178780|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
162856847|NCT02344576|588178781|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
162856848|NCT02344576|588178782|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
162856849|NCT04325503|588178784|FG000|Overall Study|Withdrawal by Subject|1|||
162856850|NCT04325503|588178784|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
162856851|NCT02337387|588178785|FG000|Overall Study|Adverse Event|0|||
162856852|NCT02337387|588178786|FG001|Overall Study|Adverse Event|1|||
162856853|NCT02337387|588178787|FG002|Overall Study|Adverse Event|0|||
162856854|NCT02337387|588178788|FG003|Overall Study|Adverse Event|0|||
162856855|NCT02337387|588178785|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
162856856|NCT02337387|588178786|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
162856857|NCT02337387|588178787|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
162856858|NCT02337387|588178788|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
162856859|NCT01642212|588178789|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
162856860|NCT01642212|588178790|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
162856861|NCT01642212|588178791|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
162856862|NCT01642212|588178792|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
162856863|NCT01642212|588178793|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
162856864|NCT01642212|588178789|FG000|Double-blind Treatment|Other|0|||
162856865|NCT01642212|588178790|FG001|Double-blind Treatment|Other|2|||
162856866|NCT01642212|588178791|FG002|Double-blind Treatment|Other|1|||
162955976|NCT00834418|588541348|FG000|Overall Study|Adverse Event|0|||
162955977|NCT00834418|588541349|FG001|Overall Study|Adverse Event|2|||
162955978|NCT01705574|588541350|FG000|Double-Blind Phase|Lost to Follow-up|12|||
162955979|NCT01705574|588541351|FG001|Double-Blind Phase|Lost to Follow-up|16|||
162955980|NCT01705574|588541352|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162955981|NCT01705574|588541353|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162955982|NCT01705574|588541350|FG000|Double-Blind Phase|Adverse Event|3|||
162955983|NCT01705574|588541351|FG001|Double-Blind Phase|Adverse Event|10|||
162955984|NCT01705574|588541352|FG002|Double-Blind Phase|Adverse Event|0|||
162955985|NCT01705574|588541353|FG003|Double-Blind Phase|Adverse Event|0|||
162856867|NCT01642212|588178792|FG003|Double-blind Treatment|Other|0|||
162856868|NCT01642212|588178793|FG004|Double-blind Treatment|Other|0|||
162856869|NCT01642212|588178789|FG000|Double-blind Treatment|Non-compliance|0|||
162856870|NCT01642212|588178790|FG001|Double-blind Treatment|Non-compliance|1|||
162856871|NCT01642212|588178791|FG002|Double-blind Treatment|Non-compliance|0|||
162856872|NCT01642212|588178792|FG003|Double-blind Treatment|Non-compliance|0|||
162856873|NCT01642212|588178793|FG004|Double-blind Treatment|Non-compliance|0|||
162856874|NCT01642212|588178789|FG000|Double-blind Treatment|Adverse Event|0|||
162955986|NCT01705574|588541350|FG000|Double-Blind Phase|Withdrew Consent|8|||
162955987|NCT01705574|588541351|FG001|Double-Blind Phase|Withdrew Consent|5|||
162856875|NCT01642212|588178790|FG001|Double-blind Treatment|Adverse Event|0|||
162856876|NCT01642212|588178791|FG002|Double-blind Treatment|Adverse Event|1|||
162611867|NCT02611960|587296686|FG001|Overall Study|Death|92|||
162611868|NCT02611960|587296685|FG000|Overall Study|Withdrawal by Subject|1|||
162611869|NCT02611960|587296686|FG001|Overall Study|Withdrawal by Subject|5|||
162611870|NCT02611960|587296685|FG000|Overall Study|Sponsor Decision|11|||
162611871|NCT02611960|587296686|FG001|Overall Study|Sponsor Decision|11|||
162611872|NCT00137631|587296687|FG000|Overall Study|Lost to Follow-up|37|||
162611873|NCT00137631|587296688|FG001|Overall Study|Lost to Follow-up|41|||
162611874|NCT01092507|587296689|FG000|Overall Study|Withdrawal by Subject|2|||
162611875|NCT01092507|587296690|FG001|Overall Study|Withdrawal by Subject|0|||
162611876|NCT00085709|587296702|FG000|Overall Study|Adverse Event|8|||
162611877|NCT00085709|587296703|FG001|Overall Study|Adverse Event|0|||
162611878|NCT00085709|587296702|FG000|Overall Study|Death|8|||
162611879|NCT00085709|587296703|FG001|Overall Study|Death|2|||
162611880|NCT00085709|587296702|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162611881|NCT00085709|587296703|FG001|Overall Study|Refusal unrelated to adverse events|2|||
162611882|NCT00085709|587296702|FG000|Overall Study|Progression|3|||
162611883|NCT00085709|587296703|FG001|Overall Study|Progression|4|||
162611884|NCT00085709|587296702|FG000|Overall Study|Not protocol specified|12|||
162611885|NCT00085709|587296703|FG001|Overall Study|Not protocol specified|22|||
162611886|NCT00085709|587296702|FG000|Overall Study|Not eligible|19|||
162611887|NCT00085709|587296703|FG001|Overall Study|Not eligible|19|||
162611888|NCT00085709|587296702|FG000|Overall Study|Withdrawal by Subject|2|||
162611889|NCT00085709|587296703|FG001|Overall Study|Withdrawal by Subject|1|||
162611890|NCT04131556|587296704|FG000|Overall Study|Adverse Event|1|||
162611891|NCT04131556|587296704|FG000|Overall Study|Withdrawal by Subject|1|||
162611892|NCT01229371|587296705|FG000|Overall Study|Withdrawal by Subject|0|||
162611893|NCT01229371|587296706|FG001|Overall Study|Withdrawal by Subject|1|||
162611894|NCT01229371|587296707|FG002|Overall Study|Withdrawal by Subject|0|||
162611895|NCT01229371|587296708|FG003|Overall Study|Withdrawal by Subject|0|||
162611896|NCT05314478|587296709|FG000|Overall Study|Physician Decision|1|||
162611897|NCT00145600|587296710|FG000|Overall Study|Death|1|||
162611898|NCT00145600|587296711|FG001|Overall Study|Death|2|||
162611899|NCT00145600|587296712|FG002|Overall Study|Death|2|||
162611900|NCT00145600|587296713|FG003|Overall Study|Death|6|||
162611901|NCT00145600|587296710|FG000|Overall Study|Ineligible|3|||
162611902|NCT00145600|587296711|FG001|Overall Study|Ineligible|0|||
162611903|NCT00145600|587296712|FG002|Overall Study|Ineligible|1|||
162611904|NCT00145600|587296713|FG003|Overall Study|Ineligible|5|||
162611905|NCT00145600|587296710|FG000|Overall Study|Lost to Follow-up|2|||
162611906|NCT00145600|587296711|FG001|Overall Study|Lost to Follow-up|6|||
162611907|NCT00145600|587296712|FG002|Overall Study|Lost to Follow-up|2|||
162611908|NCT00145600|587296713|FG003|Overall Study|Lost to Follow-up|4|||
162611909|NCT00145600|587296710|FG000|Overall Study|Noncompliance|1|||
162611910|NCT00145600|587296711|FG001|Overall Study|Noncompliance|0|||
162611911|NCT00145600|587296712|FG002|Overall Study|Noncompliance|0|||
162611912|NCT00145600|587296713|FG003|Overall Study|Noncompliance|0|||
162611913|NCT00145600|587296710|FG000|Overall Study|Withdrawal by Subject|1|||
162955988|NCT01705574|588541352|FG002|Double-Blind Phase|Withdrew Consent|0|||
162955989|NCT01705574|588541353|FG003|Double-Blind Phase|Withdrew Consent|0|||
162955990|NCT01705574|588541350|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
162955991|NCT01705574|588541351|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
162955992|NCT01705574|588541352|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
162611914|NCT00145600|587296711|FG001|Overall Study|Withdrawal by Subject|2|||
162611915|NCT00145600|587296712|FG002|Overall Study|Withdrawal by Subject|0|||
162611916|NCT00145600|587296713|FG003|Overall Study|Withdrawal by Subject|1|||
162611917|NCT00736879|587296717|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
162611918|NCT00736879|587296718|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
162955993|NCT01705574|588541353|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
162955994|NCT01705574|588541350|FG000|Double-Blind Phase|Pregnancy|1|||
162955995|NCT01705574|588541351|FG001|Double-Blind Phase|Pregnancy|1|||
162955996|NCT01705574|588541352|FG002|Double-Blind Phase|Pregnancy|0|||
162955997|NCT01705574|588541353|FG003|Double-Blind Phase|Pregnancy|0|||
162955998|NCT01705574|588541350|FG000|Double-Blind Phase|Protocol Violation|1|||
162955999|NCT01705574|588541351|FG001|Double-Blind Phase|Protocol Violation|0|||
162956000|NCT01705574|588541352|FG002|Double-Blind Phase|Protocol Violation|0|||
162956001|NCT01705574|588541353|FG003|Double-Blind Phase|Protocol Violation|0|||
162611919|NCT00736879|587296719|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
162611920|NCT00736879|587296720|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
162611921|NCT00736879|587296717|FG000|Double Blind Treatment Period|Adverse Event|0|||
162611922|NCT00736879|587296718|FG001|Double Blind Treatment Period|Adverse Event|1|||
162611923|NCT00736879|587296719|FG002|Double Blind Treatment Period|Adverse Event|1|||
162611924|NCT00736879|587296720|FG003|Double Blind Treatment Period|Adverse Event|0|||
162611925|NCT00736879|587296717|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
162611926|NCT00736879|587296718|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
162611927|NCT00736879|587296719|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
162611928|NCT00736879|587296720|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
162611929|NCT00736879|587296717|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162956002|NCT01705574|588541350|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
162956003|NCT01705574|588541351|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
162956004|NCT01705574|588541352|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
162956005|NCT01705574|588541353|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
162956006|NCT01705574|588541350|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
162956007|NCT01705574|588541351|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162956008|NCT01705574|588541352|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
162956009|NCT01705574|588541353|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
162956010|NCT01705574|588541350|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
162956011|NCT01705574|588541351|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
162956012|NCT01705574|588541352|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
162956013|NCT01705574|588541353|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
162956014|NCT01705574|588541350|FG000|Open-Label Extension Phase|Adverse Event|3|||
162956015|NCT01705574|588541351|FG001|Open-Label Extension Phase|Adverse Event|0|||
162956016|NCT01705574|588541352|FG002|Open-Label Extension Phase|Adverse Event|0|||
162956017|NCT01705574|588541353|FG003|Open-Label Extension Phase|Adverse Event|1|||
162956018|NCT01705574|588541350|FG000|Open-Label Extension Phase|Death|2|||
162956019|NCT01705574|588541351|FG001|Open-Label Extension Phase|Death|0|||
162956020|NCT01705574|588541352|FG002|Open-Label Extension Phase|Death|1|||
162956021|NCT01705574|588541353|FG003|Open-Label Extension Phase|Death|0|||
162956022|NCT01705574|588541350|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956023|NCT01705574|588541351|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956024|NCT01705574|588541352|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
162956025|NCT01705574|588541353|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
162956026|NCT01705574|588541350|FG000|Open-Label Extension Phase|Physician Decision|0|||
162611930|NCT00736879|587296718|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
162956027|NCT01705574|588541351|FG001|Open-Label Extension Phase|Physician Decision|0|||
162611931|NCT00736879|587296719|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
162611932|NCT00736879|587296720|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
162611933|NCT00736879|587296717|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
162611934|NCT00736879|587296718|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
162611935|NCT00736879|587296719|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
162611936|NCT00736879|587296720|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
162611937|NCT00736879|587296717|FG000|Double Blind Treatment Period|No longer met criteria|0|||
162611938|NCT00736879|587296718|FG001|Double Blind Treatment Period|No longer met criteria|1|||
162611939|NCT00736879|587296719|FG002|Double Blind Treatment Period|No longer met criteria|0|||
162611940|NCT00736879|587296720|FG003|Double Blind Treatment Period|No longer met criteria|0|||
162611941|NCT00736879|587296717|FG000|Double Blind Treatment Period|non-specified|0|||
162611942|NCT00736879|587296718|FG001|Double Blind Treatment Period|non-specified|1|||
162611943|NCT00736879|587296719|FG002|Double Blind Treatment Period|non-specified|0|||
162611944|NCT00736879|587296720|FG003|Double Blind Treatment Period|non-specified|0|||
162611945|NCT00736879|587296717|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162611946|NCT00736879|587296718|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
162611947|NCT00736879|587296719|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162611948|NCT00736879|587296720|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162611949|NCT00736879|587296717|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
162611950|NCT00736879|587296718|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
162611951|NCT00736879|587296719|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
162611952|NCT00736879|587296720|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
162611953|NCT03583164|587296727|FG000|Overall Study|Death in Main Phase|35|||
162611954|NCT03583164|587296727|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
162611955|NCT03583164|587296727|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
162611956|NCT03583164|587296727|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
162611957|NCT03583164|587296727|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
162611958|NCT03583164|587296727|FG000|Overall Study|Physician decision in Main Phase|1|||
162611959|NCT03583164|587296727|FG000|Overall Study|Physician decision in Extended Phase|2|||
162611960|NCT03583164|587296727|FG000|Overall Study|Death in Extended Phase|13|||
162611961|NCT03583164|587296727|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
162611962|NCT03583164|587296727|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
162611963|NCT03583164|587296727|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
162611964|NCT03583164|587296727|FG000|Overall Study|Treatment failure in Main Phase|2|||
162611965|NCT03583164|587296727|FG000|Overall Study|Treatment failure in Extended Phase|4|||
162611966|NCT03583164|587296727|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
162611967|NCT03583164|587296727|FG000|Overall Study|Other not specified reason in Main Phase|2|||
162956028|NCT01705574|588541352|FG002|Open-Label Extension Phase|Physician Decision|2|||
162956029|NCT01705574|588541353|FG003|Open-Label Extension Phase|Physician Decision|0|||
162956030|NCT01705574|588541350|FG000|Open-Label Extension Phase|Pregnancy|0|||
162611968|NCT02869438|587296735|FG000|Overall Study|Lost to Follow-up|1|||
162611969|NCT02869438|587296736|FG001|Overall Study|Lost to Follow-up|0|||
162856877|NCT01642212|588178792|FG003|Double-blind Treatment|Adverse Event|0|||
162856878|NCT01642212|588178793|FG004|Double-blind Treatment|Adverse Event|0|||
162856879|NCT01642212|588178789|FG000|Open-label Extension|Adverse Event|0|||
162856880|NCT01642212|588178790|FG001|Open-label Extension|Adverse Event|0|||
162856881|NCT01642212|588178791|FG002|Open-label Extension|Adverse Event|0|||
162856882|NCT01642212|588178792|FG003|Open-label Extension|Adverse Event|3|||
162856883|NCT01642212|588178793|FG004|Open-label Extension|Adverse Event|0|||
162856884|NCT01642212|588178789|FG000|Open-label Extension|Sponsor Decision|0|||
162856885|NCT01642212|588178790|FG001|Open-label Extension|Sponsor Decision|0|||
162856886|NCT01642212|588178791|FG002|Open-label Extension|Sponsor Decision|0|||
162856887|NCT01642212|588178792|FG003|Open-label Extension|Sponsor Decision|7|||
162856888|NCT01642212|588178793|FG004|Open-label Extension|Sponsor Decision|4|||
162856889|NCT01642212|588178789|FG000|Open-label Extension|Consent Withdrawn|0|||
162856890|NCT01642212|588178790|FG001|Open-label Extension|Consent Withdrawn|0|||
162856891|NCT01642212|588178791|FG002|Open-label Extension|Consent Withdrawn|0|||
162856892|NCT01642212|588178792|FG003|Open-label Extension|Consent Withdrawn|0|||
162856893|NCT01642212|588178793|FG004|Open-label Extension|Consent Withdrawn|2|||
162856894|NCT01642212|588178789|FG000|Open-label Extension|Lost to Follow-up|0|||
162856895|NCT01642212|588178790|FG001|Open-label Extension|Lost to Follow-up|0|||
162856896|NCT01642212|588178791|FG002|Open-label Extension|Lost to Follow-up|0|||
162856897|NCT01642212|588178792|FG003|Open-label Extension|Lost to Follow-up|0|||
162856898|NCT01642212|588178793|FG004|Open-label Extension|Lost to Follow-up|1|||
162856899|NCT01642212|588178789|FG000|Open-label Extension|Other|0|||
162856900|NCT01642212|588178790|FG001|Open-label Extension|Other|0|||
162856901|NCT01642212|588178791|FG002|Open-label Extension|Other|0|||
162856902|NCT01642212|588178792|FG003|Open-label Extension|Other|0|||
162856903|NCT01642212|588178793|FG004|Open-label Extension|Other|1|||
162856904|NCT01243268|588178795|FG000|Overall Study|Lost to Follow-up|4|||
162856905|NCT01243268|588178795|FG000|Overall Study|Protocol Violation|51|||
162856906|NCT01243268|588178795|FG000|Overall Study|Deviation with contract date|7|||
162856907|NCT01243268|588178795|FG000|Overall Study|Duplicate subject|2|||
162856908|NCT00702143|588178796|FG000|Overall Study|Lost to Follow-up|0|||
162856909|NCT00702143|588178797|FG001|Overall Study|Lost to Follow-up|0|||
162856910|NCT00702143|588178798|FG002|Overall Study|Lost to Follow-up|1|||
162856911|NCT03871491|588178801|FG000|Overall Study|Withdrawal by Subject|14|||
162856912|NCT03871491|588178802|FG001|Overall Study|Withdrawal by Subject|14|||
162856913|NCT03871491|588178803|FG002|Overall Study|Withdrawal by Subject|14|||
162856914|NCT03871491|588178804|FG003|Overall Study|Withdrawal by Subject|14|||
162856915|NCT03871491|588178801|FG000|Overall Study|Physician Decision|0|||
162856916|NCT03871491|588178802|FG001|Overall Study|Physician Decision|0|||
162856917|NCT03871491|588178803|FG002|Overall Study|Physician Decision|1|||
162856918|NCT03871491|588178804|FG003|Overall Study|Physician Decision|1|||
162856919|NCT03871491|588178801|FG000|Overall Study|Lost to Follow-up|50|||
162856920|NCT03871491|588178802|FG001|Overall Study|Lost to Follow-up|15|||
162856921|NCT03871491|588178803|FG002|Overall Study|Lost to Follow-up|36|||
162856922|NCT03871491|588178804|FG003|Overall Study|Lost to Follow-up|11|||
162856923|NCT04996797|588178805|FG000|Overall Study|Adverse Event|0|||
162856924|NCT04996797|588178806|FG001|Overall Study|Adverse Event|2|||
162856925|NCT04996797|588178807|FG002|Overall Study|Adverse Event|0|||
162856926|NCT04996797|588178808|FG003|Overall Study|Adverse Event|1|||
162611970|NCT02869438|587296735|FG000|Overall Study|Adverse Event|1|||
162611971|NCT02869438|587296736|FG001|Overall Study|Adverse Event|0|||
162611972|NCT02869438|587296735|FG000|Overall Study|Withdrawal by Subject|1|||
162611973|NCT02869438|587296736|FG001|Overall Study|Withdrawal by Subject|2|||
162611974|NCT05323656|587296739|FG000|Overall Study|Still On-Treatment|6|||
162704847|NCT00519636|587630504|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
162704848|NCT00519636|587630505|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
162704849|NCT00519636|587630506|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
162704850|NCT00519636|587630507|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
162704851|NCT00519636|587630504|FG000|Washout Period|Adverse Event|2|||
162704852|NCT00519636|587630505|FG001|Washout Period|Adverse Event|1|||
162704853|NCT00519636|587630506|FG002|Washout Period|Adverse Event|1|||
162704854|NCT00519636|587630507|FG003|Washout Period|Adverse Event|0|||
162704855|NCT00519636|587630504|FG000|Washout Period|Lost to Follow-up|1|||
162704856|NCT00519636|587630505|FG001|Washout Period|Lost to Follow-up|0|||
162704857|NCT00519636|587630506|FG002|Washout Period|Lost to Follow-up|0|||
162611975|NCT05323656|587296740|FG001|Overall Study|Still On-Treatment|6|||
162611976|NCT05323656|587296739|FG000|Overall Study|Progressive Disease|15|||
162611977|NCT05323656|587296740|FG001|Overall Study|Progressive Disease|14|||
162611978|NCT05323656|587296739|FG000|Overall Study|Adverse Event|2|||
162704858|NCT00519636|587630507|FG003|Washout Period|Lost to Follow-up|0|||
162611979|NCT05323656|587296740|FG001|Overall Study|Adverse Event|3|||
162704859|NCT00519636|587630504|FG000|Washout Period|Protocol Violation|0|||
162704860|NCT00519636|587630505|FG001|Washout Period|Protocol Violation|0|||
162704861|NCT00519636|587630506|FG002|Washout Period|Protocol Violation|1|||
162704862|NCT00519636|587630507|FG003|Washout Period|Protocol Violation|2|||
162704863|NCT00519636|587630504|FG000|Washout Period|Withdrawal by Subject|1|||
162704864|NCT00519636|587630505|FG001|Washout Period|Withdrawal by Subject|0|||
162704865|NCT00519636|587630506|FG002|Washout Period|Withdrawal by Subject|1|||
162704866|NCT00519636|587630507|FG003|Washout Period|Withdrawal by Subject|0|||
162704867|NCT00519636|587630504|FG000|Washout Period|Failed to meet continuation criteria|14|||
162704868|NCT00519636|587630505|FG001|Washout Period|Failed to meet continuation criteria|11|||
162704869|NCT00519636|587630506|FG002|Washout Period|Failed to meet continuation criteria|9|||
162704870|NCT00519636|587630507|FG003|Washout Period|Failed to meet continuation criteria|3|||
162704871|NCT00519636|587630504|FG000|Washout Period|Out of pollen area > 48 hours|1|||
162704872|NCT00519636|587630505|FG001|Washout Period|Out of pollen area > 48 hours|0|||
162704873|NCT00519636|587630506|FG002|Washout Period|Out of pollen area > 48 hours|0|||
162704874|NCT00519636|587630507|FG003|Washout Period|Out of pollen area > 48 hours|0|||
162704875|NCT00519636|587630504|FG000|Washout Period|Participating in study at another site|1|||
162704876|NCT00519636|587630505|FG001|Washout Period|Participating in study at another site|0|||
162704877|NCT00519636|587630506|FG002|Washout Period|Participating in study at another site|0|||
162704878|NCT00519636|587630507|FG003|Washout Period|Participating in study at another site|0|||
162704879|NCT00519636|587630504|FG000|Washout Period|Non-compliant|0|||
162704880|NCT00519636|587630505|FG001|Washout Period|Non-compliant|1|||
162704881|NCT00519636|587630506|FG002|Washout Period|Non-compliant|0|||
162704882|NCT00519636|587630507|FG003|Washout Period|Non-compliant|0|||
162704883|NCT00519636|587630504|FG000|Washout Period|Per doctors request|0|||
162704884|NCT00519636|587630505|FG001|Washout Period|Per doctors request|1|||
162704885|NCT00519636|587630506|FG002|Washout Period|Per doctors request|0|||
162704886|NCT00519636|587630507|FG003|Washout Period|Per doctors request|0|||
162704887|NCT00519636|587630504|FG000|Washout Period|Subject randomized in error|0|||
162704888|NCT00519636|587630505|FG001|Washout Period|Subject randomized in error|0|||
162704889|NCT00519636|587630506|FG002|Washout Period|Subject randomized in error|1|||
162704890|NCT00519636|587630507|FG003|Washout Period|Subject randomized in error|0|||
162704891|NCT00519636|587630504|FG000|Washout Period|Prohibited medications|0|||
162704892|NCT00519636|587630505|FG001|Washout Period|Prohibited medications|0|||
162704893|NCT00519636|587630506|FG002|Washout Period|Prohibited medications|1|||
162704894|NCT00519636|587630507|FG003|Washout Period|Prohibited medications|0|||
162704895|NCT00519636|587630504|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162704896|NCT00519636|587630505|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162704897|NCT00519636|587630506|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162704898|NCT00519636|587630507|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
162704899|NCT00519636|587630504|FG000|Treatment Period 2|Subject randomized in error|0|||
162704900|NCT00519636|587630505|FG001|Treatment Period 2|Subject randomized in error|1|||
162704901|NCT00519636|587630506|FG002|Treatment Period 2|Subject randomized in error|0|||
162704902|NCT00519636|587630507|FG003|Treatment Period 2|Subject randomized in error|0|||
162704903|NCT00519636|587630504|FG000|Treatment Period 2|Per doctors request|0|||
162704904|NCT00519636|587630505|FG001|Treatment Period 2|Per doctors request|0|||
162704905|NCT00519636|587630506|FG002|Treatment Period 2|Per doctors request|1|||
162704906|NCT00519636|587630507|FG003|Treatment Period 2|Per doctors request|0|||
162704907|NCT00519636|587630504|FG000|Treatment Period 2|Subject misrandomized|0|||
162611980|NCT05323656|587296739|FG000|Overall Study|Death|1|||
162611981|NCT05323656|587296740|FG001|Overall Study|Death|2|||
162611982|NCT05323656|587296739|FG000|Overall Study|Withdrawal by Subject|1|||
162611983|NCT05323656|587296740|FG001|Overall Study|Withdrawal by Subject|0|||
162611984|NCT05323656|587296739|FG000|Overall Study|Clinical disease progression|0|||
162611985|NCT05323656|587296740|FG001|Overall Study|Clinical disease progression|1|||
162611986|NCT05323656|587296739|FG000|Overall Study|Patient and Investigator decision|1|||
162611987|NCT05323656|587296740|FG001|Overall Study|Patient and Investigator decision|0|||
163044539|NCT00377637|588871464|FG000|Maintenance Phase|Sponsor decision|0|||
163044540|NCT00377637|588871465|FG001|Maintenance Phase|Sponsor decision|0|||
163044541|NCT00377637|588871466|FG002|Maintenance Phase|Sponsor decision|2|||
163044542|NCT00377637|588871467|FG003|Maintenance Phase|Sponsor decision|3|||
163044543|NCT00377637|588871464|FG000|Maintenance Phase|Non-compliance|0|||
163044544|NCT00377637|588871465|FG001|Maintenance Phase|Non-compliance|0|||
163044545|NCT00377637|588871466|FG002|Maintenance Phase|Non-compliance|1|||
163044546|NCT00377637|588871467|FG003|Maintenance Phase|Non-compliance|1|||
163044547|NCT00377637|588871464|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
163044548|NCT00377637|588871465|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
163044549|NCT00377637|588871466|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
163044550|NCT00377637|588871467|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
163044551|NCT00377637|588871464|FG000|Maintenance Phase|Death|0|||
163044552|NCT00377637|588871465|FG001|Maintenance Phase|Death|0|||
163044553|NCT00377637|588871466|FG002|Maintenance Phase|Death|0|||
163044554|NCT00377637|588871467|FG003|Maintenance Phase|Death|1|||
163044555|NCT00522548|588871468|FG000|Overall Study|Adverse Event|2|||
163044556|NCT00522548|588871469|FG001|Overall Study|Adverse Event|2|||
163044557|NCT00522548|588871468|FG000|Overall Study|Withdrawal by Subject|0|||
163044558|NCT00522548|588871469|FG001|Overall Study|Withdrawal by Subject|2|||
162611988|NCT05323656|587296739|FG000|Overall Study|Physician Decision|0|||
162611989|NCT05323656|587296740|FG001|Overall Study|Physician Decision|1|||
162611990|NCT03880461|587296741|FG000|Overall Study|Determined ineligible after enrollment|45|||
163044559|NCT05225558|588871476|FG000|Overall Study|Withdrawal by Subject|4|||
163044560|NCT05225558|588871477|FG001|Overall Study|Withdrawal by Subject|3|||
163044561|NCT05225558|588871476|FG000|Overall Study|Adverse Event|1|||
163044562|NCT05225558|588871477|FG001|Overall Study|Adverse Event|0|||
163044563|NCT05225558|588871476|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
163044564|NCT05225558|588871477|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
163044565|NCT05225558|588871476|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
163044566|NCT05225558|588871477|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
163044567|NCT00313846|588871478|FG000|Overall Study|Withdrawal by Subject|2|||
163044568|NCT00313846|588871479|FG001|Overall Study|Withdrawal by Subject|0|||
163044569|NCT00313846|588871478|FG000|Overall Study|Adverse Event|1|||
163044570|NCT00313846|588871479|FG001|Overall Study|Adverse Event|8|||
163044571|NCT00313846|588871478|FG000|Overall Study|Administrative|2|||
163044572|NCT00313846|588871479|FG001|Overall Study|Administrative|3|||
163044573|NCT01896193|588871480|FG000|Overall Study|Lack of Efficacy|20|||
163044574|NCT01896193|588871481|FG001|Overall Study|Lack of Efficacy|11|||
163044575|NCT01896193|588871480|FG000|Overall Study|Protocol Violation|0|||
163044576|NCT01896193|588871481|FG001|Overall Study|Protocol Violation|1|||
163044577|NCT01896193|588871480|FG000|Overall Study|Withdrew Consent|1|||
163044578|NCT01896193|588871481|FG001|Overall Study|Withdrew Consent|0|||
163044579|NCT02592447|588871484|FG000|Overall Study|Lost to Follow-up|1|||
163044580|NCT02592447|588871485|FG001|Overall Study|Lost to Follow-up|0|||
163044581|NCT02592447|588871484|FG000|Overall Study|Ineligible after randomization|1|||
163044582|NCT02592447|588871485|FG001|Overall Study|Ineligible after randomization|0|||
163044583|NCT02592447|588871484|FG000|Overall Study|Withdrawal by Subject|0|||
163044584|NCT02592447|588871485|FG001|Overall Study|Withdrawal by Subject|1|||
163044585|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
163044586|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
162611991|NCT03880461|587296742|FG001|Overall Study|Determined ineligible after enrollment|44|||
162611992|NCT03880461|587296741|FG000|Overall Study|No weight measurement after enrollment|24|||
162611993|NCT03880461|587296742|FG001|Overall Study|No weight measurement after enrollment|17|||
162611994|NCT03953183|587296744|FG000|Overall Study|Physician Decision|0|||
162611995|NCT03953183|587296745|FG001|Overall Study|Physician Decision|1|||
162856927|NCT04996797|588178805|FG000|Overall Study|Lack of Efficacy|0|||
162856928|NCT04996797|588178806|FG001|Overall Study|Lack of Efficacy|2|||
162856929|NCT04996797|588178807|FG002|Overall Study|Lack of Efficacy|0|||
163044587|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
163044588|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
163044589|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044590|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044591|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044592|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
162611996|NCT03953183|587296744|FG000|Overall Study|Withdrawal by Subject|0|||
162611997|NCT03953183|587296745|FG001|Overall Study|Withdrawal by Subject|1|||
163044593|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044594|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044595|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044596|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044597|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044598|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044599|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044600|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044601|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044602|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044603|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
163044604|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
163044605|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
163044606|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
163044607|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
163044608|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044609|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044610|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044611|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044612|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044613|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044614|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044615|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044616|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044617|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044618|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044619|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044620|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044621|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044622|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
163044623|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044624|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
163044625|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
163044626|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044627|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044628|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044629|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044630|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044631|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044632|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044633|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044634|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044635|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044636|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044637|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044638|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044639|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044640|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044641|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
163044642|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
163044643|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044644|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044645|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044646|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044647|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044648|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162611998|NCT01115803|587296759|FG000|Overall Study|Withdrawal by Subject|0|||
162611999|NCT01115803|587296760|FG001|Overall Study|Withdrawal by Subject|0|||
162612000|NCT01115803|587296761|FG002|Overall Study|Withdrawal by Subject|0|||
162612001|NCT01115803|587296762|FG003|Overall Study|Withdrawal by Subject|0|||
162612002|NCT01115803|587296763|FG004|Overall Study|Withdrawal by Subject|0|||
162612003|NCT01115803|587296764|FG005|Overall Study|Withdrawal by Subject|0|||
162612004|NCT01115803|587296765|FG006|Overall Study|Withdrawal by Subject|1|||
162612005|NCT01115803|587296759|FG000|Overall Study|Lost to Follow-up|0|||
162612006|NCT01115803|587296760|FG001|Overall Study|Lost to Follow-up|0|||
162856930|NCT04996797|588178808|FG003|Overall Study|Lack of Efficacy|0|||
162856931|NCT04996797|588178805|FG000|Overall Study|Prohibited Medication|0|||
162856932|NCT04996797|588178806|FG001|Overall Study|Prohibited Medication|1|||
162856933|NCT04996797|588178807|FG002|Overall Study|Prohibited Medication|0|||
162856934|NCT04996797|588178808|FG003|Overall Study|Prohibited Medication|0|||
162856935|NCT04996797|588178805|FG000|Overall Study|Ongoing|68|||
162856936|NCT04996797|588178806|FG001|Overall Study|Ongoing|60|||
162856937|NCT04996797|588178807|FG002|Overall Study|Ongoing|22|||
162856938|NCT04996797|588178808|FG003|Overall Study|Ongoing|20|||
162856939|NCT04996797|588178805|FG000|Overall Study|Withdrawal by Subject|0|||
162856940|NCT04996797|588178806|FG001|Overall Study|Withdrawal by Subject|2|||
162856941|NCT04996797|588178807|FG002|Overall Study|Withdrawal by Subject|0|||
162856942|NCT04996797|588178808|FG003|Overall Study|Withdrawal by Subject|0|||
162856943|NCT04091217|588178811|FG000|Overall Study|Lost to Follow-up|2|||
162856944|NCT01822561|588178812|FG000|Overall Study|Withdrawal by Subject|2|||
162856945|NCT01624142|588178813|FG000|Overall Study|Withdrawal by Subject|14|||
162856946|NCT01624142|588178814|FG001|Overall Study|Withdrawal by Subject|4|||
162856947|NCT01624142|588178813|FG000|Overall Study|Death|3|||
162856948|NCT01624142|588178814|FG001|Overall Study|Death|6|||
162856949|NCT01624142|588178813|FG000|Overall Study|Study Closure|12|||
162856950|NCT01624142|588178814|FG001|Overall Study|Study Closure|6|||
162856951|NCT01624142|588178813|FG000|Overall Study|Lost to Follow-up|2|||
162856952|NCT01624142|588178814|FG001|Overall Study|Lost to Follow-up|0|||
162856953|NCT01624142|588178813|FG000|Overall Study|Other|1|||
162856954|NCT01624142|588178814|FG001|Overall Study|Other|0|||
162856955|NCT00667277|588178815|FG000|Overall Study|Withdrawal by Subject|2|||
162856956|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
162856957|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
162856958|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
162856959|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
162856960|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
162856961|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
162856962|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
162856963|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
162856964|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
162856965|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
162856966|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
162856967|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
162856968|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
162856969|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
162856970|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
162856971|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
162856972|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
162856973|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
162856974|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
162856975|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
162856976|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Death|0|||
162856977|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Death|1|||
162856978|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Death|0|||
162856979|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Death|0|||
162856980|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Death|0|||
162856981|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
162856982|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
162856983|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
162856984|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
162856985|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
162856986|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
162856987|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
162856988|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
162856989|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
162856990|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
162956031|NCT01705574|588541351|FG001|Open-Label Extension Phase|Pregnancy|0|||
162956032|NCT01705574|588541352|FG002|Open-Label Extension Phase|Pregnancy|1|||
162956033|NCT01705574|588541353|FG003|Open-Label Extension Phase|Pregnancy|1|||
162956034|NCT00777023|588541354|FG000|Overall Study|Adverse Event|15|||
162856991|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
162856992|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
162856993|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
162856994|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
162956035|NCT00777023|588541355|FG001|Overall Study|Adverse Event|21|||
162856995|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
162856996|NCT05087030|588178816|FG000|Main Period (Week 0 to Week 52)|Other|1|||
162856997|NCT05087030|588178817|FG001|Main Period (Week 0 to Week 52)|Other|2|||
162856998|NCT05087030|588178818|FG002|Main Period (Week 0 to Week 52)|Other|0|||
162856999|NCT05087030|588178819|FG003|Main Period (Week 0 to Week 52)|Other|0|||
162956036|NCT00777023|588541356|FG002|Overall Study|Adverse Event|8|||
162956037|NCT00777023|588541354|FG000|Overall Study|Lack of Efficacy|1|||
162956038|NCT00777023|588541355|FG001|Overall Study|Lack of Efficacy|0|||
162956039|NCT00777023|588541356|FG002|Overall Study|Lack of Efficacy|14|||
162956040|NCT00777023|588541354|FG000|Overall Study|Protocol Violation|2|||
162956041|NCT00777023|588541355|FG001|Overall Study|Protocol Violation|1|||
162956042|NCT00777023|588541356|FG002|Overall Study|Protocol Violation|1|||
162956043|NCT00777023|588541354|FG000|Overall Study|Lost to Follow-up|2|||
162956044|NCT00777023|588541355|FG001|Overall Study|Lost to Follow-up|3|||
162956045|NCT00777023|588541356|FG002|Overall Study|Lost to Follow-up|3|||
162956046|NCT00777023|588541354|FG000|Overall Study|Death|0|||
162956047|NCT00777023|588541355|FG001|Overall Study|Death|1|||
162956048|NCT00777023|588541356|FG002|Overall Study|Death|0|||
162956049|NCT00777023|588541354|FG000|Overall Study|Withdrawal by Subject|7|||
162956050|NCT00777023|588541355|FG001|Overall Study|Withdrawal by Subject|7|||
162956051|NCT00777023|588541356|FG002|Overall Study|Withdrawal by Subject|8|||
162956052|NCT00777023|588541354|FG000|Overall Study|Missing data|1|||
162956053|NCT00777023|588541355|FG001|Overall Study|Missing data|1|||
162956054|NCT00777023|588541356|FG002|Overall Study|Missing data|0|||
162956055|NCT00777023|588541354|FG000|Overall Study|Reasons not specified|4|||
163044649|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044650|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044651|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162857000|NCT05087030|588178820|FG004|Main Period (Week 0 to Week 52)|Other|0|||
162857001|NCT05087030|588178816|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162857002|NCT05087030|588178817|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162857003|NCT05087030|588178818|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162857004|NCT05087030|588178819|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162857005|NCT05087030|588178820|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
162857006|NCT04826900|588178821|FG000|Overall Study|Family factor|1|||
162857007|NCT04826900|588178822|FG001|Overall Study|Family factor|1|||
162857008|NCT01024244|588180134|FG000|Overall Study|Adverse Event|1|||
162857009|NCT01024244|588180135|FG001|Overall Study|Adverse Event|2|||
162857010|NCT01024244|588180136|FG002|Overall Study|Adverse Event|0|||
162857011|NCT01024244|588180137|FG003|Overall Study|Adverse Event|1|||
162857012|NCT01024244|588180138|FG004|Overall Study|Adverse Event|2|||
162857013|NCT01024244|588180134|FG000|Overall Study|Entry Criteria Not Met|0|||
162857014|NCT01024244|588180135|FG001|Overall Study|Entry Criteria Not Met|1|||
162857015|NCT01024244|588180136|FG002|Overall Study|Entry Criteria Not Met|0|||
162857016|NCT01024244|588180137|FG003|Overall Study|Entry Criteria Not Met|0|||
162857017|NCT01024244|588180138|FG004|Overall Study|Entry Criteria Not Met|0|||
162857018|NCT01024244|588180134|FG000|Overall Study|Lack of Efficacy|1|||
162857019|NCT01024244|588180135|FG001|Overall Study|Lack of Efficacy|0|||
162857020|NCT01024244|588180136|FG002|Overall Study|Lack of Efficacy|0|||
162857021|NCT01024244|588180137|FG003|Overall Study|Lack of Efficacy|0|||
162857022|NCT01024244|588180138|FG004|Overall Study|Lack of Efficacy|0|||
162857023|NCT01024244|588180134|FG000|Overall Study|Protocol Violation|1|||
162857024|NCT01024244|588180135|FG001|Overall Study|Protocol Violation|0|||
162857025|NCT01024244|588180136|FG002|Overall Study|Protocol Violation|0|||
162857026|NCT01024244|588180137|FG003|Overall Study|Protocol Violation|0|||
162857027|NCT01024244|588180138|FG004|Overall Study|Protocol Violation|2|||
162857028|NCT01024244|588180134|FG000|Overall Study|Sponsor Decision|14|||
162857029|NCT01024244|588180135|FG001|Overall Study|Sponsor Decision|7|||
162857030|NCT01024244|588180136|FG002|Overall Study|Sponsor Decision|14|||
162857031|NCT01024244|588180137|FG003|Overall Study|Sponsor Decision|12|||
162857032|NCT01024244|588180138|FG004|Overall Study|Sponsor Decision|10|||
162857033|NCT01024244|588180134|FG000|Overall Study|Withdrawal by Subject|0|||
162857034|NCT01024244|588180135|FG001|Overall Study|Withdrawal by Subject|1|||
162857035|NCT01024244|588180136|FG002|Overall Study|Withdrawal by Subject|0|||
162857036|NCT01024244|588180137|FG003|Overall Study|Withdrawal by Subject|0|||
162956056|NCT00777023|588541355|FG001|Overall Study|Reasons not specified|4|||
163044652|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162857037|NCT01024244|588180138|FG004|Overall Study|Withdrawal by Subject|0|||
162857038|NCT00942409|588180140|FG000|Overall Study|Lack of Efficacy|1|||
162956057|NCT00777023|588541356|FG002|Overall Study|Reasons not specified|2|||
162612007|NCT01115803|587296761|FG002|Overall Study|Lost to Follow-up|1|||
162857039|NCT00942409|588180140|FG000|Overall Study|study drug unavailable|2|||
162857040|NCT01697215|588180141|FG000|Overall Study|Physician Decision|5|||
162857041|NCT01697215|588180141|FG000|Overall Study|Malfunction|9|||
162857042|NCT01697215|588180141|FG000|Overall Study|CXR not available|9|||
162857043|NCT01929083|588180142|FG000|Intervention 1|Lost to Follow-up|2|||
162956058|NCT00777023|588541354|FG000|Overall Study|Last dose date unknown|3|||
162956059|NCT00777023|588541355|FG001|Overall Study|Last dose date unknown|3|||
162857044|NCT01929083|588180143|FG001|Intervention 1|Lost to Follow-up|0|||
162857045|NCT01929083|588180142|FG000|Intervention 1|Nonadherent to study medications|1|||
162612008|NCT01115803|587296762|FG003|Overall Study|Lost to Follow-up|0|||
162612009|NCT01115803|587296763|FG004|Overall Study|Lost to Follow-up|0|||
162612010|NCT01115803|587296764|FG005|Overall Study|Lost to Follow-up|0|||
162612011|NCT01115803|587296765|FG006|Overall Study|Lost to Follow-up|0|||
162612012|NCT01115803|587296759|FG000|Overall Study|Progressive Disease during Cycle1|0|||
162857046|NCT01929083|588180143|FG001|Intervention 1|Nonadherent to study medications|0|||
162857047|NCT01929083|588180142|FG000|Intervention 2|Adverse Event|0|||
162857048|NCT01929083|588180143|FG001|Intervention 2|Adverse Event|1|||
162857049|NCT02599402|588180144|FG000|Overall Study|Disease progression|153|||
162857050|NCT02599402|588180144|FG000|Overall Study|Study drug toxicity|201|||
162857051|NCT02599402|588180144|FG000|Overall Study|Death|26|||
162857052|NCT02599402|588180144|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
162857053|NCT02599402|588180144|FG000|Overall Study|Participant request to discontinue study treatment|13|||
162857054|NCT02599402|588180144|FG000|Overall Study|Participant withdrew consent|5|||
162857055|NCT02599402|588180144|FG000|Overall Study|Lost to Follow-up|1|||
162857056|NCT02599402|588180144|FG000|Overall Study|Maximum Clinical Benefit|7|||
162857057|NCT02599402|588180144|FG000|Overall Study|Poor/non-compliance|1|||
162857058|NCT02599402|588180144|FG000|Overall Study|Pregnancy|1|||
162857059|NCT02599402|588180144|FG000|Overall Study|Participant no longer met study criteria|7|||
162857060|NCT02599402|588180144|FG000|Overall Study|Other Reasons|95|||
162857061|NCT02945657|588180145|FG000|Overall Study|Adverse Event|1|||
162857062|NCT02945657|588180145|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
162857063|NCT00087438|588180150|FG000|Overall Study|Ineligible / No protocol treatment|4|||
162857064|NCT00283387|588180151|FG000|First Intervention|Subject non-compliant|1|||
162857065|NCT00283387|588180152|FG001|First Intervention|Subject non-compliant|1|||
162857066|NCT00283387|588180151|FG000|First Intervention|Withdrawal by Subject|0|||
162857067|NCT00283387|588180152|FG001|First Intervention|Withdrawal by Subject|1|||
162857068|NCT05340504|588180153|FG000|Overall Study|Withdrawal by Subject|1|||
162857069|NCT05340504|588180154|FG001|Overall Study|Withdrawal by Subject|0|||
162857070|NCT03068715|588180158|FG000|Overall Study|No longer met inclusion criteria|1|||
162857071|NCT03068715|588180159|FG001|Overall Study|No longer met inclusion criteria|0|||
162857072|NCT00728416|588180160|FG000|Overall Study|Adverse Event|1|||
162857073|NCT00728416|588180161|FG001|Overall Study|Adverse Event|1|||
162857074|NCT00728416|588180160|FG000|Overall Study|Treatment Failure|0|||
162857075|NCT00728416|588180161|FG001|Overall Study|Treatment Failure|1|||
162857076|NCT00728416|588180160|FG000|Overall Study|Withdrawal by Subject|1|||
162857077|NCT00728416|588180161|FG001|Overall Study|Withdrawal by Subject|0|||
162857078|NCT00117312|588180162|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
162857079|NCT00117312|588180163|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
162857080|NCT00117312|588180164|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
162857081|NCT00117312|588180165|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
162857082|NCT00117312|588180162|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
162857083|NCT00117312|588180163|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
162857084|NCT00117312|588180164|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
162857085|NCT00117312|588180165|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
162857086|NCT00117312|588180162|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
162857087|NCT00117312|588180163|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
162857088|NCT00117312|588180164|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
162857089|NCT00117312|588180165|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
162857090|NCT00117312|588180162|FG000|Overall Study|Other|0|||
162857091|NCT00117312|588180163|FG001|Overall Study|Other|1|||
162857092|NCT00117312|588180164|FG002|Overall Study|Other|3|||
162857093|NCT00117312|588180165|FG003|Overall Study|Other|1|||
162857094|NCT00117312|588180162|FG000|Overall Study|Patient choice|0|||
162857095|NCT00117312|588180163|FG001|Overall Study|Patient choice|0|||
162857096|NCT00117312|588180164|FG002|Overall Study|Patient choice|2|||
162857097|NCT00117312|588180165|FG003|Overall Study|Patient choice|1|||
162857098|NCT00117312|588180162|FG000|Overall Study|Adverse Event|0|||
162857099|NCT00117312|588180163|FG001|Overall Study|Adverse Event|2|||
162857100|NCT00117312|588180164|FG002|Overall Study|Adverse Event|0|||
162857101|NCT00117312|588180165|FG003|Overall Study|Adverse Event|0|||
162857102|NCT00117312|588180162|FG000|Overall Study|Protocol Violation|0|||
162857103|NCT00117312|588180163|FG001|Overall Study|Protocol Violation|1|||
162857104|NCT00117312|588180164|FG002|Overall Study|Protocol Violation|3|||
162857105|NCT00117312|588180165|FG003|Overall Study|Protocol Violation|0|||
162857106|NCT00117312|588180162|FG000|Overall Study|PSA decrease <=50%|0|||
162857107|NCT00117312|588180163|FG001|Overall Study|PSA decrease <=50%|2|||
162857108|NCT00117312|588180164|FG002|Overall Study|PSA decrease <=50%|2|||
162612013|NCT01115803|587296760|FG001|Overall Study|Progressive Disease during Cycle1|0|||
162857109|NCT00117312|588180165|FG003|Overall Study|PSA decrease <=50%|4|||
162857110|NCT00117312|588180162|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
162857111|NCT00117312|588180163|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
162612014|NCT01115803|587296761|FG002|Overall Study|Progressive Disease during Cycle1|0|||
162612015|NCT01115803|587296762|FG003|Overall Study|Progressive Disease during Cycle1|0|||
163044653|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044654|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044655|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044656|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044657|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044658|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044659|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044660|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163044661|NCT03428100|588871486|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044662|NCT03428100|588871487|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
163044663|NCT03428100|588871488|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044664|NCT03428100|588871489|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044665|NCT03428100|588871490|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044666|NCT03428100|588871491|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044667|NCT03428100|588871492|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044668|NCT03428100|588871493|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044669|NCT03428100|588871494|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044670|NCT03428100|588871495|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044671|NCT03428100|588871496|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044672|NCT03428100|588871497|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044673|NCT03428100|588871498|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044674|NCT03428100|588871499|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044675|NCT03428100|588871500|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044676|NCT03428100|588871501|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044677|NCT03428100|588871502|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044678|NCT03428100|588871503|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044679|NCT03428100|588871504|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
163044680|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044681|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044682|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044683|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044684|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044685|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
163044686|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044687|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
163044688|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044689|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044690|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044691|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044692|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
163044693|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044694|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044695|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
163044696|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
163044697|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044698|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
163044699|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
163044700|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
163044701|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
163044702|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
163044703|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
163044704|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
163044705|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
163044706|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
163044707|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
163044708|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
163044709|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
163044710|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
163044711|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
163044712|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
163044713|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
163044714|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
163044715|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
162704908|NCT00519636|587630505|FG001|Treatment Period 2|Subject misrandomized|0|||
162857112|NCT00117312|588180164|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
162857113|NCT00117312|588180165|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
162857114|NCT00117312|588180162|FG000|Overall Study|Hepatic abnormality|0|||
162857115|NCT00117312|588180163|FG001|Overall Study|Hepatic abnormality|1|||
162857116|NCT00117312|588180164|FG002|Overall Study|Hepatic abnormality|0|||
162857117|NCT00117312|588180165|FG003|Overall Study|Hepatic abnormality|1|||
162857118|NCT00117312|588180162|FG000|Overall Study|Withdrawal by Subject|0|||
162857119|NCT00117312|588180163|FG001|Overall Study|Withdrawal by Subject|2|||
162857120|NCT00117312|588180164|FG002|Overall Study|Withdrawal by Subject|0|||
162857121|NCT00117312|588180165|FG003|Overall Study|Withdrawal by Subject|0|||
162857122|NCT01120626|588180166|FG000|Overall Study|Withdrawal by Subject|1|||
162857123|NCT01120626|588180167|FG001|Overall Study|Withdrawal by Subject|0|||
162857124|NCT00509106|588180169|FG000|Overall Study|Adverse Event|3|||
162857125|NCT00509106|588180170|FG001|Overall Study|Adverse Event|2|||
162857126|NCT00509106|588180169|FG000|Overall Study|Noncompliance|0|||
162857127|NCT00509106|588180170|FG001|Overall Study|Noncompliance|1|||
162857128|NCT00509106|588180169|FG000|Overall Study|At the request of sponsor/investigator|1|||
162857129|NCT00509106|588180170|FG001|Overall Study|At the request of sponsor/investigator|2|||
162857130|NCT00509106|588180169|FG000|Overall Study|Withdrew consent|4|||
162857131|NCT00509106|588180170|FG001|Overall Study|Withdrew consent|8|||
162857132|NCT00509106|588180169|FG000|Overall Study|Lost to Follow-up|16|||
162857133|NCT00509106|588180170|FG001|Overall Study|Lost to Follow-up|10|||
162857134|NCT00509106|588180169|FG000|Overall Study|Other|1|||
162857135|NCT00509106|588180170|FG001|Overall Study|Other|0|||
162857136|NCT00509106|588180169|FG000|Overall Study|Death|6|||
162857137|NCT00509106|588180170|FG001|Overall Study|Death|6|||
162857138|NCT03527043|588180173|FG000|Overall Study|Withdrawal by Subject|1|||
162857139|NCT03527043|588180174|FG001|Overall Study|Withdrawal by Subject|0|||
162857140|NCT02500550|588180176|FG000|Overall Study|Death|7|||
162857141|NCT03293680|588180177|FG000|Overall Study|Death|1|||
162857142|NCT03293680|588180177|FG000|Overall Study|Did not meet inclusion criteria|8|||
162857143|NCT01491945|588180178|FG000|Overall Study|Death|30|||
162857144|NCT01491945|588180178|FG000|Overall Study|Withdrwan/LTF|16|||
162857145|NCT01491945|588180178|FG000|Overall Study|Conversion|4|||
162857146|NCT01491945|588180178|FG000|Overall Study|Missed Visit|1|||
162857147|NCT02201940|588180179|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
162857148|NCT02201940|588180180|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
162857149|NCT02201940|588180179|FG000|Overall Study|Lack of Efficacy|2|||
162857150|NCT02201940|588180180|FG001|Overall Study|Lack of Efficacy|113|||
162857151|NCT02201940|588180179|FG000|Overall Study|Lost to Follow-up|5|||
162857152|NCT02201940|588180180|FG001|Overall Study|Lost to Follow-up|0|||
162857153|NCT02201940|588180179|FG000|Overall Study|Withdrew Consent|2|||
162857154|NCT02201940|588180180|FG001|Overall Study|Withdrew Consent|1|||
162857155|NCT02201940|588180179|FG000|Overall Study|Investigator's Discretion|1|||
162857156|NCT02201940|588180180|FG001|Overall Study|Investigator's Discretion|1|||
162857157|NCT02201940|588180179|FG000|Overall Study|Death|1|||
162857158|NCT02201940|588180180|FG001|Overall Study|Death|0|||
162857159|NCT02201940|588180179|FG000|Overall Study|Adverse Event|0|||
162857160|NCT02201940|588180180|FG001|Overall Study|Adverse Event|1|||
162857161|NCT00636818|588180181|FG000|Overall Study|Adverse Event|1|||
162857162|NCT00636818|588180181|FG000|Overall Study|Lost to Follow-up|2|||
162857163|NCT00636818|588180181|FG000|Overall Study|Entry Criteria Exclusion|3|||
162857164|NCT00636818|588180181|FG000|Overall Study|Protocol Violation|1|||
162857165|NCT00636818|588180181|FG000|Overall Study|Withdrawal by Subject|4|||
162857166|NCT00074958|588180183|FG000|Overall Study|Adverse Event|1|||
162857167|NCT02604264|588180185|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
162857168|NCT02604264|588180186|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
162857169|NCT03192904|588180188|FG000|Overall Study|Physician Decision|3|||
162857170|NCT03192904|588180189|FG001|Overall Study|Physician Decision|1|||
162857171|NCT03192904|588180188|FG000|Overall Study|Lost to Follow-up|0|||
162857172|NCT03192904|588180189|FG001|Overall Study|Lost to Follow-up|1|||
162857173|NCT01511445|588180196|FG000|Overall Study|Lost to Follow-up|3|||
162857174|NCT01511445|588180197|FG001|Overall Study|Lost to Follow-up|1|||
162857175|NCT01511445|588180196|FG000|Overall Study|Protocol Violation|1|||
162857176|NCT01511445|588180197|FG001|Overall Study|Protocol Violation|3|||
162857177|NCT01511445|588180196|FG000|Overall Study|Protocol Violation|1|||
162857178|NCT01511445|588180197|FG001|Overall Study|Protocol Violation|0|||
162857179|NCT00709202|588180198|FG000|Overall Study|Withdrawal by Subject|6|||
162857180|NCT00709202|588180199|FG001|Overall Study|Withdrawal by Subject|6|||
162857181|NCT01444300|588180202|FG000|Overall Study|Adverse Event|4|||
162857182|NCT01444300|588180203|FG001|Overall Study|Adverse Event|0|||
162857183|NCT02597062|588180205|FG000|Overall Study|Ineligible|1|||
162857184|NCT01731002|588180217|FG000|Overall Study|Adverse Event|0|||
162857185|NCT01731002|588180218|FG001|Overall Study|Adverse Event|2|||
162857186|NCT01731002|588180219|FG002|Overall Study|Adverse Event|2|||
162857187|NCT01731002|588180217|FG000|Overall Study|Non-Compliant|0|||
162857188|NCT01731002|588180218|FG001|Overall Study|Non-Compliant|1|||
162857189|NCT01731002|588180219|FG002|Overall Study|Non-Compliant|0|||
162857190|NCT01731002|588180217|FG000|Overall Study|Lost to Follow-up|1|||
162857191|NCT01731002|588180218|FG001|Overall Study|Lost to Follow-up|0|||
162857192|NCT01731002|588180219|FG002|Overall Study|Lost to Follow-up|0|||
162857193|NCT01731002|588180217|FG000|Overall Study|Test Agent Discontinuation|0|||
162857194|NCT01731002|588180218|FG001|Overall Study|Test Agent Discontinuation|1|||
162857195|NCT01731002|588180219|FG002|Overall Study|Test Agent Discontinuation|0|||
162857196|NCT01731002|588180217|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
162857197|NCT01731002|588180218|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
162857198|NCT01731002|588180219|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
162857199|NCT01731002|588180217|FG000|Overall Study|Elevated IOP|1|||
162857200|NCT01731002|588180218|FG001|Overall Study|Elevated IOP|0|||
162857201|NCT01731002|588180219|FG002|Overall Study|Elevated IOP|0|||
162857202|NCT01731002|588180217|FG000|Overall Study|Inappropriate use of study medications|0|||
162857203|NCT01731002|588180218|FG001|Overall Study|Inappropriate use of study medications|0|||
162857204|NCT01731002|588180219|FG002|Overall Study|Inappropriate use of study medications|1|||
162857205|NCT00686543|588180220|FG000|Overall Study|Adverse Event|9|||
162857206|NCT00686543|588180221|FG001|Overall Study|Adverse Event|1|||
162857207|NCT00686543|588180222|FG002|Overall Study|Adverse Event|3|||
162857208|NCT00686543|588180223|FG003|Overall Study|Adverse Event|2|||
162857209|NCT00686543|588180220|FG000|Overall Study|Withdrawal by Subject|2|||
162857210|NCT00686543|588180221|FG001|Overall Study|Withdrawal by Subject|0|||
162857211|NCT00686543|588180222|FG002|Overall Study|Withdrawal by Subject|0|||
162857212|NCT00686543|588180223|FG003|Overall Study|Withdrawal by Subject|0|||
162857213|NCT00686543|588180220|FG000|Overall Study|Protocol Violation|3|||
162857214|NCT00686543|588180221|FG001|Overall Study|Protocol Violation|0|||
162857215|NCT00686543|588180222|FG002|Overall Study|Protocol Violation|2|||
162857216|NCT00686543|588180223|FG003|Overall Study|Protocol Violation|1|||
162857217|NCT01053429|588180224|FG000|Overall Study|Adverse Event|64|||
162857218|NCT01053429|588180224|FG000|Overall Study|Other|309|||
162857219|NCT00752986|588180225|FG000|Overall Study|Withdrawal by Subject|2|||
162857220|NCT00752986|588180226|FG001|Overall Study|Withdrawal by Subject|1|||
162857221|NCT00752986|588180227|FG002|Overall Study|Withdrawal by Subject|2|||
162857222|NCT00752986|588180225|FG000|Overall Study|Protocol Violation|3|||
162857223|NCT00752986|588180226|FG001|Overall Study|Protocol Violation|0|||
162857224|NCT00752986|588180227|FG002|Overall Study|Protocol Violation|0|||
162857225|NCT01697345|588180228|FG000|Overall Study|Withdrawal by Subject|1|||
162857226|NCT00924703|588180229|FG000|Overall Study|Withdrawal by Subject|11|||
162857227|NCT00924703|588180229|FG000|Overall Study|Physician Decision|5|||
162857228|NCT00924703|588180229|FG000|Overall Study|Lost to Follow-up|3|||
162857229|NCT00924703|588180229|FG000|Overall Study|Adverse Event|2|||
162857230|NCT00924703|588180229|FG000|Overall Study|Withdrawal by Sponsor|1|||
162857231|NCT04906707|588180230|FG000|Overall Study|Withdrawal by Subject|2|||
162857232|NCT04906707|588180231|FG001|Overall Study|Withdrawal by Subject|0|||
162857233|NCT04906707|588180230|FG000|Overall Study|Withdrawal due to PI decision|1|||
162857234|NCT04906707|588180231|FG001|Overall Study|Withdrawal due to PI decision|0|||
162857235|NCT04906707|588180230|FG000|Overall Study|Lost to Follow-up|0|||
162857236|NCT04906707|588180231|FG001|Overall Study|Lost to Follow-up|1|||
162857237|NCT01976806|588180232|FG000|Overall Study|Lost to Follow-up|1|||
162857238|NCT01976806|588180233|FG001|Overall Study|Lost to Follow-up|4|||
162857239|NCT01976806|588180232|FG000|Overall Study|Adverse Event|1|||
162857240|NCT01976806|588180233|FG001|Overall Study|Adverse Event|1|||
162857241|NCT01976806|588180232|FG000|Overall Study|Withdrawal by Subject|1|||
162857242|NCT01976806|588180233|FG001|Overall Study|Withdrawal by Subject|1|||
162857243|NCT03929250|588180237|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
162857244|NCT03929250|588180238|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
162857245|NCT01523873|588180241|FG000|Overall Study|Protocol Violation|422|||
162857246|NCT04429022|588180242|FG000|Overall Study|Protocol Violation|18|||
162857247|NCT04429022|588180243|FG001|Overall Study|Protocol Violation|1|||
162857248|NCT00045032|588180248|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
162857249|NCT00045032|588180249|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
162857250|NCT00045032|588180250|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
162857251|NCT00045032|588180248|FG000|Overall Study|Death|22|||
162857252|NCT00045032|588180249|FG001|Overall Study|Death|24|||
162857253|NCT00045032|588180250|FG002|Overall Study|Death|17|||
162857254|NCT00045032|588180248|FG000|Overall Study|Insufficient Therapeutic Response|542|||
162857255|NCT00045032|588180249|FG001|Overall Study|Insufficient Therapeutic Response|437|||
162857256|NCT00045032|588180250|FG002|Overall Study|Insufficient Therapeutic Response|445|||
162857257|NCT00045032|588180248|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
162857258|NCT00045032|588180249|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
162857259|NCT00045032|588180250|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
162857260|NCT00045032|588180248|FG000|Overall Study|Other Protocol Violation|2|||
162857261|NCT00045032|588180249|FG001|Overall Study|Other Protocol Violation|0|||
162857262|NCT00045032|588180250|FG002|Overall Study|Other Protocol Violation|1|||
162857263|NCT00045032|588180248|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
162857264|NCT00045032|588180249|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
162857265|NCT00045032|588180250|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
162857266|NCT00045032|588180248|FG000|Overall Study|Failure to Return|57|||
162857267|NCT00045032|588180249|FG001|Overall Study|Failure to Return|62|||
162857268|NCT00045032|588180250|FG002|Overall Study|Failure to Return|61|||
162857269|NCT00045032|588180248|FG000|Overall Study|Other|93|||
162857270|NCT00045032|588180249|FG001|Overall Study|Other|84|||
162857271|NCT00045032|588180250|FG002|Overall Study|Other|105|||
162857272|NCT02582658|588180251|FG000|Overall Study|Failure to Return|10|||
162857273|NCT02582658|588180251|FG000|Overall Study|Insufficient Virological Response|2|||
162857274|NCT02582658|588180251|FG000|Overall Study|Withdrawn Consent|1|||
162857275|NCT02582658|588180251|FG000|Overall Study|Death|1|||
162857276|NCT02582658|588180251|FG000|Overall Study|Not further specified|11|||
162857277|NCT02581995|588180252|FG000|Overall Study|Unspecified other|3|||
162857278|NCT02581995|588180252|FG000|Overall Study|Adverse Event|6|||
162857279|NCT02581995|588180252|FG000|Overall Study|Lost to Follow-up|5|||
162857280|NCT02581995|588180252|FG000|Overall Study|Withdrawal by participant|12|||
162857281|NCT02581995|588180252|FG000|Overall Study|Physician Decision|1|||
162857282|NCT02581995|588180252|FG000|Overall Study|Death|4|||
162857283|NCT06119191|588180254|FG000|Overall Study|Adverse Event|0|||
162857284|NCT06119191|588180255|FG001|Overall Study|Adverse Event|1|||
162857285|NCT06119191|588180254|FG000|Overall Study|Protocol Violation|1|||
162857286|NCT06119191|588180255|FG001|Overall Study|Protocol Violation|0|||
162857287|NCT04909463|588182540|FG000|Overall Study|Withdrawal by Subject|0|||
162704909|NCT00519636|587630506|FG002|Treatment Period 2|Subject misrandomized|0|||
162857288|NCT04909463|588182541|FG001|Overall Study|Withdrawal by Subject|1|||
162857289|NCT04909463|588182542|FG002|Overall Study|Withdrawal by Subject|0|||
162857290|NCT04909463|588182543|FG003|Overall Study|Withdrawal by Subject|0|||
162857291|NCT04909463|588182540|FG000|Overall Study|Lost to Follow-up|2|||
162857292|NCT04909463|588182541|FG001|Overall Study|Lost to Follow-up|1|||
162857293|NCT04909463|588182542|FG002|Overall Study|Lost to Follow-up|1|||
162857294|NCT04909463|588182543|FG003|Overall Study|Lost to Follow-up|0|||
162857295|NCT04364854|588182544|FG000|Overall Study|Withdrawal by Subject|1|||
162857296|NCT04364854|588182545|FG001|Overall Study|Withdrawal by Subject|0|||
162857297|NCT04364854|588182546|FG002|Overall Study|Withdrawal by Subject|1|||
162857298|NCT04364854|588182547|FG003|Overall Study|Withdrawal by Subject|3|||
162857299|NCT04364854|588182544|FG000|Overall Study|Death|1|||
162857300|NCT04364854|588182545|FG001|Overall Study|Death|0|||
162857301|NCT04364854|588182546|FG002|Overall Study|Death|0|||
162857302|NCT04364854|588182547|FG003|Overall Study|Death|0|||
162857303|NCT04364854|588182544|FG000|Overall Study|Lost to Follow-up|0|||
162857304|NCT04364854|588182545|FG001|Overall Study|Lost to Follow-up|0|||
162857305|NCT04364854|588182546|FG002|Overall Study|Lost to Follow-up|0|||
162857306|NCT04364854|588182547|FG003|Overall Study|Lost to Follow-up|1|||
162857307|NCT03528681|588182552|FG000|Open-Label Phase|Physician Decision|2|||
162857308|NCT03528681|588182553|FG001|Open-Label Phase|Physician Decision|0|||
162857309|NCT03528681|588182554|FG002|Open-Label Phase|Physician Decision|0|||
162857310|NCT03528681|588182555|FG003|Open-Label Phase|Physician Decision|0|||
162857311|NCT03528681|588182552|FG000|Open-Label Phase|Withdrawal by Subject|8|||
162857312|NCT03528681|588182553|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162857313|NCT03528681|588182554|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162857314|NCT03528681|588182555|FG003|Open-Label Phase|Withdrawal by Subject|0|||
162857315|NCT03528681|588182552|FG000|Open-Label Phase|(Not collected)|4|||
162704910|NCT00519636|587630507|FG003|Treatment Period 2|Subject misrandomized|1|||
162857316|NCT03528681|588182553|FG001|Open-Label Phase|(Not collected)|0|||
162857317|NCT03528681|588182554|FG002|Open-Label Phase|(Not collected)|0|||
162857318|NCT03528681|588182555|FG003|Open-Label Phase|(Not collected)|0|||
162857319|NCT03528681|588182552|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
162857320|NCT03528681|588182553|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
162857321|NCT03528681|588182554|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
162956060|NCT00777023|588541356|FG002|Overall Study|Last dose date unknown|1|||
162956061|NCT02472366|588541357|FG000|Overall Study|Lost to Follow-up|1|||
162956062|NCT02472366|588541358|FG001|Overall Study|Lost to Follow-up|0|||
162956063|NCT02678286|588541359|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
162956064|NCT02678286|588541360|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
162857322|NCT03528681|588182555|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
162857323|NCT03528681|588182552|FG000|Randomized Treatment Phase|Physician Decision|0|||
162857324|NCT03528681|588182553|FG001|Randomized Treatment Phase|Physician Decision|5|||
162704911|NCT00519636|587630504|FG000|Post Study Period|Subject randomized in error|0|||
162857325|NCT03528681|588182554|FG002|Randomized Treatment Phase|Physician Decision|1|||
162857326|NCT03528681|588182555|FG003|Randomized Treatment Phase|Physician Decision|2|||
162857327|NCT03528681|588182552|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
162857328|NCT03528681|588182553|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
162956065|NCT02678286|588541359|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
162857329|NCT03528681|588182554|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
162857330|NCT03528681|588182555|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
162857331|NCT03528681|588182552|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
162857332|NCT03528681|588182553|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
162857333|NCT03528681|588182554|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
162857334|NCT03528681|588182555|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
162857335|NCT03528681|588182552|FG000|Randomized Treatment Phase|(Not collected)|0|||
162857336|NCT03528681|588182553|FG001|Randomized Treatment Phase|(Not collected)|4|||
162857337|NCT03528681|588182554|FG002|Randomized Treatment Phase|(Not collected)|6|||
162857338|NCT03528681|588182555|FG003|Randomized Treatment Phase|(Not collected)|5|||
162857339|NCT01614457|588182561|FG000|Overall Study|Non-Compliance|1|||
162857340|NCT01614457|588182562|FG001|Overall Study|Non-Compliance|0|||
162857341|NCT01614457|588182561|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
162857342|NCT01614457|588182562|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
162857343|NCT03518840|588182565|FG000|Overall Study|Lost to Follow-up|6|||
162857344|NCT00374556|588182570|FG000|Overall Study|Lost to Follow-up|1|||
162857345|NCT00374556|588182571|FG001|Overall Study|Lost to Follow-up|0|||
162857346|NCT00374556|588182570|FG000|Overall Study|Removed at baseline due to medical cond|0|||
162704912|NCT00519636|587630505|FG001|Post Study Period|Subject randomized in error|0|||
162857347|NCT00374556|588182571|FG001|Overall Study|Removed at baseline due to medical cond|1|||
162956066|NCT02678286|588541360|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
162857348|NCT00473694|588182572|FG000|Overall Study|Adverse Event|0|||
162857349|NCT00473694|588182573|FG001|Overall Study|Adverse Event|1|||
162857350|NCT00473694|588182574|FG002|Overall Study|Adverse Event|0|||
162857351|NCT00473694|588182575|FG003|Overall Study|Adverse Event|0|||
162857352|NCT00473694|588182572|FG000|Overall Study|Participants did not receive treatment|11|||
162857353|NCT00473694|588182573|FG001|Overall Study|Participants did not receive treatment|3|||
162857354|NCT00473694|588182574|FG002|Overall Study|Participants did not receive treatment|5|||
162857355|NCT00473694|588182575|FG003|Overall Study|Participants did not receive treatment|6|||
162857356|NCT00473694|588182572|FG000|Overall Study|Lost to Follow-up|0|||
162857357|NCT00473694|588182573|FG001|Overall Study|Lost to Follow-up|0|||
162857358|NCT00473694|588182574|FG002|Overall Study|Lost to Follow-up|0|||
162956067|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
162956068|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
162956069|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
162956070|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
162956071|NCT02678286|588541359|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
162956072|NCT02678286|588541360|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
162956073|NCT04274686|588541361|FG000|Overall Study|Physician Decision|1|||
162956074|NCT04274686|588541362|FG001|Overall Study|Physician Decision|0|||
162956075|NCT01273805|588541365|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
162704913|NCT00519636|587630506|FG002|Post Study Period|Subject randomized in error|0|||
162704914|NCT00519636|587630507|FG003|Post Study Period|Subject randomized in error|1|||
162704915|NCT04504916|587630508|FG000|Overall Study|Study terminated|7|||
162704916|NCT04504916|587630509|FG001|Overall Study|Study terminated|8|||
162704917|NCT04504916|587630508|FG000|Overall Study|Death|54|||
162704918|NCT04504916|587630509|FG001|Overall Study|Death|18|||
162704919|NCT04504916|587630508|FG000|Overall Study|Lost to Follow-up|1|||
162704920|NCT04504916|587630509|FG001|Overall Study|Lost to Follow-up|1|||
162704921|NCT04504916|587630508|FG000|Overall Study|Withdrawal by Subject|8|||
162704922|NCT04504916|587630509|FG001|Overall Study|Withdrawal by Subject|4|||
162704923|NCT04504916|587630508|FG000|Overall Study|Did not agree to follow-up|0|||
162704924|NCT04504916|587630509|FG001|Overall Study|Did not agree to follow-up|1|||
162704925|NCT03057834|587630510|FG000|Overall Study|Withdrawal by Subject|25|||
162704926|NCT03057834|587630511|FG001|Overall Study|Withdrawal by Subject|29|||
162704927|NCT00003509|587630513|FG000|Overall Study|Not evaluable|5|||
162704928|NCT03803774|587630514|FG000|Dose Escalation|Withdrawal by Subject|0|||
162704929|NCT03803774|587630515|FG001|Dose Escalation|Withdrawal by Subject|0|||
162704930|NCT03803774|587630516|FG002|Dose Escalation|Withdrawal by Subject|0|||
162704931|NCT03803774|587630517|FG003|Dose Escalation|Withdrawal by Subject|1|||
162704932|NCT03803774|587630518|FG004|Dose Escalation|Withdrawal by Subject|0|||
162704933|NCT03077620|587630523|FG000|Overall Study|Unable to place lumbar catheter|1|||
162704934|NCT03077620|587630524|FG001|Overall Study|Unable to place lumbar catheter|0|||
162704935|NCT03077620|587630525|FG002|Overall Study|Unable to place lumbar catheter|1|||
162704936|NCT03077620|587630526|FG003|Overall Study|Unable to place lumbar catheter|0|||
162704937|NCT03077620|587630523|FG000|Overall Study|Withdrawal by Subject|0|||
162704938|NCT03077620|587630524|FG001|Overall Study|Withdrawal by Subject|1|||
162704939|NCT03077620|587630525|FG002|Overall Study|Withdrawal by Subject|0|||
162704940|NCT03077620|587630526|FG003|Overall Study|Withdrawal by Subject|0|||
162704941|NCT03077620|587630523|FG000|Overall Study|Physician Decision|0|||
162704942|NCT03077620|587630524|FG001|Overall Study|Physician Decision|0|||
162704943|NCT03077620|587630525|FG002|Overall Study|Physician Decision|1|||
162704944|NCT03077620|587630526|FG003|Overall Study|Physician Decision|0|||
162704945|NCT00245011|587630528|FG000|Overall Study|Lack of Efficacy|1|||
162704946|NCT00550173|587630529|FG000|Overall Study|Death|45|||
162704947|NCT00550173|587630530|FG001|Overall Study|Death|38|||
162704948|NCT00550173|587630531|FG002|Overall Study|Death|50|||
162704949|NCT00550173|587630529|FG000|Overall Study|Physician Decision|1|||
162704950|NCT00550173|587630530|FG001|Overall Study|Physician Decision|2|||
162704951|NCT00550173|587630531|FG002|Overall Study|Physician Decision|2|||
162704952|NCT00550173|587630529|FG000|Overall Study|Withdrawal by Subject|9|||
162704953|NCT00550173|587630530|FG001|Overall Study|Withdrawal by Subject|12|||
162704954|NCT00550173|587630531|FG002|Overall Study|Withdrawal by Subject|17|||
162704955|NCT00550173|587630529|FG000|Overall Study|Sponsor Decision|13|||
162704956|NCT00550173|587630530|FG001|Overall Study|Sponsor Decision|7|||
162704957|NCT00550173|587630531|FG002|Overall Study|Sponsor Decision|1|||
162704958|NCT00550173|587630529|FG000|Overall Study|Lost to Follow-up|4|||
162704959|NCT00550173|587630530|FG001|Overall Study|Lost to Follow-up|4|||
162857359|NCT00473694|588182575|FG003|Overall Study|Lost to Follow-up|1|||
162704960|NCT00550173|587630531|FG002|Overall Study|Lost to Follow-up|3|||
162704961|NCT01345292|587632070|FG000|Overall Study|Withdrawal by Subject|2|||
162857360|NCT02468193|588182576|FG000|Overall Study|Adverse Event|4|||
162857361|NCT02468193|588182576|FG000|Overall Study|Subject/ Guardian decision|2|||
162857362|NCT00742781|588182577|FG000|Overall Study|Withdrawal by Subject|3|||
162704962|NCT01345292|587632071|FG001|Overall Study|Withdrawal by Subject|0|||
162704963|NCT01345292|587632072|FG002|Overall Study|Withdrawal by Subject|1|||
162704964|NCT05406791|587632078|FG000|Overall Study|Lost to Follow-up|13|||
162704965|NCT05406791|587632079|FG001|Overall Study|Lost to Follow-up|10|||
162704966|NCT01789203|587632080|FG000|Overall Study|Adverse Event|2|||
162704967|NCT01789203|587632081|FG001|Overall Study|Adverse Event|2|||
162704968|NCT01789203|587632080|FG000|Overall Study|Withdrawal by Subject|1|||
162704969|NCT01789203|587632081|FG001|Overall Study|Withdrawal by Subject|0|||
162704970|NCT01789203|587632080|FG000|Overall Study|Death|1|||
162704971|NCT01789203|587632081|FG001|Overall Study|Death|0|||
162704972|NCT01789203|587632080|FG000|Overall Study|Protocol Violation|2|||
162704973|NCT01789203|587632081|FG001|Overall Study|Protocol Violation|1|||
162704974|NCT01789203|587632080|FG000|Overall Study|Other|1|||
162704975|NCT01789203|587632081|FG001|Overall Study|Other|1|||
162704976|NCT01789203|587632080|FG000|Overall Study|patient non-adherent|2|||
162704977|NCT01789203|587632081|FG001|Overall Study|patient non-adherent|0|||
162704978|NCT00515086|587632082|FG000|Overall Study|Adverse Event|1|||
162704979|NCT00515086|587632083|FG001|Overall Study|Adverse Event|1|||
162704980|NCT00515086|587632084|FG002|Overall Study|Adverse Event|2|||
162704981|NCT00515086|587632085|FG003|Overall Study|Adverse Event|3|||
162704982|NCT00515086|587632082|FG000|Overall Study|Administrative|1|||
162704983|NCT00515086|587632083|FG001|Overall Study|Administrative|1|||
162704984|NCT00515086|587632084|FG002|Overall Study|Administrative|0|||
162704985|NCT00515086|587632085|FG003|Overall Study|Administrative|0|||
162704986|NCT00515086|587632082|FG000|Overall Study|Withdrawal by Subject|1|||
162704987|NCT00515086|587632083|FG001|Overall Study|Withdrawal by Subject|0|||
162704988|NCT00515086|587632084|FG002|Overall Study|Withdrawal by Subject|0|||
162704989|NCT00515086|587632085|FG003|Overall Study|Withdrawal by Subject|1|||
162704990|NCT00515086|587632082|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
162704991|NCT00515086|587632083|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162704992|NCT00515086|587632084|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
162704993|NCT00515086|587632085|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162704994|NCT00515086|587632082|FG000|Overall Study|Lost to Follow-up|1|||
162704995|NCT00515086|587632083|FG001|Overall Study|Lost to Follow-up|0|||
162704996|NCT00515086|587632084|FG002|Overall Study|Lost to Follow-up|0|||
162704997|NCT00515086|587632085|FG003|Overall Study|Lost to Follow-up|0|||
162704998|NCT00515086|587632082|FG000|Overall Study|Study drug no longer required|0|||
162704999|NCT00515086|587632083|FG001|Overall Study|Study drug no longer required|1|||
162705000|NCT00515086|587632084|FG002|Overall Study|Study drug no longer required|0|||
162705001|NCT00515086|587632085|FG003|Overall Study|Study drug no longer required|0|||
162705002|NCT00515086|587632082|FG000|Overall Study|Death|2|||
162705003|NCT00515086|587632083|FG001|Overall Study|Death|0|||
162705004|NCT00515086|587632084|FG002|Overall Study|Death|0|||
162705005|NCT00515086|587632085|FG003|Overall Study|Death|0|||
162705006|NCT02403674|587632086|FG000|Base Study|Death|1|||
162705007|NCT02403674|587632087|FG001|Base Study|Death|4|||
162705008|NCT02403674|587632086|FG000|Base Study|Adverse Event|11|||
162705009|NCT02403674|587632087|FG001|Base Study|Adverse Event|26|||
162705010|NCT02403674|587632086|FG000|Base Study|Lack of Efficacy|31|||
162705011|NCT02403674|587632087|FG001|Base Study|Lack of Efficacy|23|||
162705012|NCT02403674|587632086|FG000|Base Study|Lost to Follow-up|6|||
162705013|NCT02403674|587632087|FG001|Base Study|Lost to Follow-up|8|||
162705014|NCT02403674|587632086|FG000|Base Study|Withdrawal by Subject|10|||
162705015|NCT02403674|587632087|FG001|Base Study|Withdrawal by Subject|17|||
162705016|NCT02403674|587632086|FG000|Base Study|Physician Decision|2|||
162705017|NCT02403674|587632087|FG001|Base Study|Physician Decision|2|||
162705018|NCT02403674|587632086|FG000|Base Study|Pregnancy|2|||
162705019|NCT02403674|587632087|FG001|Base Study|Pregnancy|2|||
162705020|NCT02403674|587632086|FG000|Base Study|Protocol Violation|8|||
162705021|NCT02403674|587632087|FG001|Base Study|Protocol Violation|4|||
162705022|NCT02403674|587632086|FG000|Base Study|Non-Compliance with study drug|1|||
162705023|NCT02403674|587632087|FG001|Base Study|Non-Compliance with study drug|4|||
162705024|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
162705025|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
162705026|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
162857363|NCT01416181|588182578|FG000|Part 1|Other|10|||
162705027|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
162857364|NCT01416181|588182579|FG001|Part 1|Other|24|||
162705028|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
162705029|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
162705030|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
162705031|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
162705032|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
162705033|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
162705034|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
162705035|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
162705036|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Death|1|||
162705037|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Death|0|||
162705038|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
162705039|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
162705040|NCT02403674|587632086|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
162857365|NCT01416181|588182578|FG000|Part 1|Death|0|||
162857366|NCT01416181|588182579|FG001|Part 1|Death|1|||
162857367|NCT01416181|588182578|FG000|Part 1|Investigator Decision|7|||
162857368|NCT01416181|588182579|FG001|Part 1|Investigator Decision|6|||
162857369|NCT01416181|588182578|FG000|Part 1|Withdrawal by Subject|74|||
162857370|NCT01416181|588182579|FG001|Part 1|Withdrawal by Subject|48|||
162857371|NCT01416181|588182578|FG000|Part 1|Lack of Efficacy|16|||
162857372|NCT01416181|588182579|FG001|Part 1|Lack of Efficacy|8|||
162857373|NCT01416181|588182578|FG000|Part 1|Lost to Follow-up|1|||
162857374|NCT01416181|588182579|FG001|Part 1|Lost to Follow-up|1|||
162857375|NCT01416181|588182578|FG000|Part 1|Adverse Event|15|||
162857376|NCT01416181|588182579|FG001|Part 1|Adverse Event|18|||
162857377|NCT01416181|588182578|FG000|Part 1|Ongoing in Follow-Up|14|||
162857378|NCT01416181|588182579|FG001|Part 1|Ongoing in Follow-Up|8|||
162857379|NCT01416181|588182578|FG000|Part 2|Adverse Event|11|||
162857380|NCT01416181|588182579|FG001|Part 2|Adverse Event|4|||
162857381|NCT01416181|588182578|FG000|Part 2|Other|234|||
162857382|NCT01416181|588182579|FG001|Part 2|Other|267|||
162857383|NCT01416181|588182578|FG000|Part 2|Investigator Decision|6|||
162857384|NCT01416181|588182579|FG001|Part 2|Investigator Decision|7|||
162857385|NCT01416181|588182578|FG000|Part 2|Withdrawal by Subject|14|||
162857386|NCT01416181|588182579|FG001|Part 2|Withdrawal by Subject|5|||
162857387|NCT01416181|588182578|FG000|Part 2|Lack of Efficacy|4|||
162857388|NCT01416181|588182579|FG001|Part 2|Lack of Efficacy|1|||
162857389|NCT01416181|588182578|FG000|Part 2|Lost to Follow-up|2|||
162857390|NCT01416181|588182579|FG001|Part 2|Lost to Follow-up|2|||
162857391|NCT03816995|588182582|FG000|Overall Study|Withdrawal by Subject|3|||
162857392|NCT03816995|588182583|FG001|Overall Study|Withdrawal by Subject|1|||
162857393|NCT03816995|588182582|FG000|Overall Study|Cancelled Surgery|8|||
162857394|NCT03816995|588182583|FG001|Overall Study|Cancelled Surgery|12|||
162857395|NCT03816995|588182582|FG000|Overall Study|No wound protector used|11|||
162857396|NCT03816995|588182583|FG001|Overall Study|No wound protector used|17|||
162857397|NCT03816995|588182582|FG000|Overall Study|Protocol Violation|2|||
162857398|NCT03816995|588182583|FG001|Overall Study|Protocol Violation|3|||
162857399|NCT00486902|588182584|FG000|Overall Study|Withdrawal by Subject|1|||
162857400|NCT00486902|588182585|FG001|Overall Study|Withdrawal by Subject|2|||
162857401|NCT00486902|588182584|FG000|Overall Study|decision for postpartum tubal ligation|3|||
162857402|NCT00486902|588182585|FG001|Overall Study|decision for postpartum tubal ligation|1|||
162857403|NCT00486902|588182584|FG000|Overall Study|spinal anesthetic protocal violation|1|||
162857404|NCT00486902|588182585|FG001|Overall Study|spinal anesthetic protocal violation|1|||
162857405|NCT00486902|588182584|FG000|Overall Study|Did not meet inclusion criteria|1|||
162857406|NCT00486902|588182585|FG001|Overall Study|Did not meet inclusion criteria|0|||
162857407|NCT00486902|588182584|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
162857408|NCT00486902|588182585|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
162857409|NCT00541307|588182586|FG000|Overall Study|Death|5|||
162857410|NCT00541307|588182586|FG000|Overall Study|Physician Decision|3|||
162857411|NCT00541307|588182586|FG000|Overall Study|Withdrawal by Subject|6|||
162857412|NCT00541307|588182586|FG000|Overall Study|Lost to Follow-up|4|||
162857413|NCT00541307|588182586|FG000|Overall Study|Subject returned early (outside window)|1|||
162857414|NCT00541307|588182586|FG000|Overall Study|Surgical Bypass|5|||
162857415|NCT04178590|588182587|FG000|Overall Study|Pregnancy|1|||
162857416|NCT04178590|588182587|FG000|Overall Study|Lost to Follow-up|1|||
162857417|NCT04723537|588182588|FG000|Overall Study|Withdrawal by Subject|3|||
162857418|NCT04723537|588182589|FG001|Overall Study|Withdrawal by Subject|0|||
162857419|NCT04723537|588182590|FG002|Overall Study|Withdrawal by Subject|0|||
162857420|NCT04723537|588182588|FG000|Overall Study|Physician Decision|0|||
162857421|NCT04723537|588182589|FG001|Overall Study|Physician Decision|0|||
162857422|NCT04723537|588182590|FG002|Overall Study|Physician Decision|1|||
162857423|NCT04723537|588182588|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
162857424|NCT04723537|588182589|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
162857425|NCT04723537|588182590|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
162857426|NCT01845025|588182591|FG000|Overall Study|Adverse Event|6|||
162857427|NCT01845025|588182592|FG001|Overall Study|Adverse Event|3|||
162857428|NCT01845025|588182591|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162857429|NCT01845025|588182592|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162857430|NCT01845025|588182591|FG000|Overall Study|Withdrawal by Subject|48|||
162857431|NCT01845025|588182592|FG001|Overall Study|Withdrawal by Subject|44|||
162857432|NCT01845025|588182591|FG000|Overall Study|Lost to Follow-up|13|||
162857433|NCT01845025|588182592|FG001|Overall Study|Lost to Follow-up|13|||
162857434|NCT01845025|588182591|FG000|Overall Study|Administrative problems|8|||
162857435|NCT01845025|588182592|FG001|Overall Study|Administrative problems|8|||
162857436|NCT01845025|588182591|FG000|Overall Study|Death|2|||
162956076|NCT01273805|588541366|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
162956077|NCT02647944|588541367|FG000|Overall Study|Withdrawal by Subject|0|||
162857437|NCT01845025|588182592|FG001|Overall Study|Death|0|||
162857438|NCT01845025|588182591|FG000|Overall Study|Protocol deviation|3|||
162956078|NCT02647944|588541368|FG001|Overall Study|Withdrawal by Subject|3|||
162857439|NCT01845025|588182592|FG001|Overall Study|Protocol deviation|6|||
162857440|NCT01845025|588182591|FG000|Overall Study|Missing|1|||
162857441|NCT01845025|588182592|FG001|Overall Study|Missing|1|||
162857442|NCT01485614|588182599|FG000|Randomization|Not Treated|1|||
162857443|NCT01485614|588182600|FG001|Randomization|Not Treated|0|||
162857444|NCT01485614|588182601|FG002|Randomization|Not Treated|0|||
162857445|NCT01485614|588182602|FG003|Randomization|Not Treated|0|||
162857446|NCT01485614|588182599|FG000|Weeks 0-20|Lost to Follow-up|2|||
162857447|NCT01485614|588182600|FG001|Weeks 0-20|Lost to Follow-up|0|||
162857448|NCT01485614|588182601|FG002|Weeks 0-20|Lost to Follow-up|0|||
162857449|NCT01485614|588182602|FG003|Weeks 0-20|Lost to Follow-up|0|||
162857450|NCT01485614|588182599|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
162857451|NCT01485614|588182600|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
162857452|NCT01485614|588182601|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
162857453|NCT01485614|588182602|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
162857454|NCT01485614|588182599|FG000|Weeks 0-20|Withdrawal by Subject|3|||
162857455|NCT01485614|588182600|FG001|Weeks 0-20|Withdrawal by Subject|2|||
162857456|NCT01485614|588182601|FG002|Weeks 0-20|Withdrawal by Subject|1|||
162857457|NCT01485614|588182602|FG003|Weeks 0-20|Withdrawal by Subject|0|||
162857458|NCT01485614|588182599|FG000|Weeks 20-54|Lost to Follow-up|4|||
162857459|NCT01485614|588182600|FG001|Weeks 20-54|Lost to Follow-up|3|||
162857460|NCT01485614|588182601|FG002|Weeks 20-54|Lost to Follow-up|1|||
162857461|NCT01485614|588182602|FG003|Weeks 20-54|Lost to Follow-up|0|||
162857462|NCT01485614|588182599|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
162857463|NCT01485614|588182600|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
162857464|NCT01485614|588182601|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
162857465|NCT01485614|588182602|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
162857466|NCT01485614|588182599|FG000|Weeks 20-54|Withdrawal by Subject|5|||
162857467|NCT01485614|588182600|FG001|Weeks 20-54|Withdrawal by Subject|3|||
162857468|NCT01485614|588182601|FG002|Weeks 20-54|Withdrawal by Subject|0|||
162857469|NCT01485614|588182602|FG003|Weeks 20-54|Withdrawal by Subject|0|||
162857470|NCT00733902|588182603|FG000|Overall Study|Death|0|||
162857471|NCT00733902|588182604|FG001|Overall Study|Death|0|||
162857472|NCT00733902|588182605|FG002|Overall Study|Death|0|||
162857473|NCT00733902|588182606|FG003|Overall Study|Death|1|||
162857474|NCT00733902|588182603|FG000|Overall Study|Adverse Event|3|||
162857475|NCT00733902|588182604|FG001|Overall Study|Adverse Event|4|||
162857476|NCT00733902|588182605|FG002|Overall Study|Adverse Event|7|||
162857477|NCT00733902|588182606|FG003|Overall Study|Adverse Event|11|||
162857478|NCT00733902|588182603|FG000|Overall Study|Lack of Efficacy|56|||
162857479|NCT00733902|588182604|FG001|Overall Study|Lack of Efficacy|21|||
162857480|NCT00733902|588182605|FG002|Overall Study|Lack of Efficacy|34|||
162857481|NCT00733902|588182606|FG003|Overall Study|Lack of Efficacy|23|||
162857482|NCT00733902|588182603|FG000|Overall Study|Protocol Violation|4|||
162857483|NCT00733902|588182604|FG001|Overall Study|Protocol Violation|6|||
162857484|NCT00733902|588182605|FG002|Overall Study|Protocol Violation|3|||
162857485|NCT00733902|588182606|FG003|Overall Study|Protocol Violation|3|||
162857486|NCT00733902|588182603|FG000|Overall Study|Withdrawal by Subject|10|||
162857487|NCT00733902|588182604|FG001|Overall Study|Withdrawal by Subject|5|||
162857488|NCT00733902|588182605|FG002|Overall Study|Withdrawal by Subject|4|||
162857489|NCT00733902|588182606|FG003|Overall Study|Withdrawal by Subject|16|||
162857490|NCT00733902|588182603|FG000|Overall Study|Entered extension study|89|||
162857491|NCT00733902|588182604|FG001|Overall Study|Entered extension study|124|||
162857492|NCT00733902|588182605|FG002|Overall Study|Entered extension study|111|||
162857493|NCT00733902|588182606|FG003|Overall Study|Entered extension study|109|||
162857494|NCT00733902|588182603|FG000|Overall Study|Randomized but not treated|2|||
162857495|NCT00733902|588182604|FG001|Overall Study|Randomized but not treated|2|||
162857496|NCT00733902|588182605|FG002|Overall Study|Randomized but not treated|2|||
162857497|NCT00733902|588182606|FG003|Overall Study|Randomized but not treated|1|||
162857498|NCT01503021|588182611|FG000|Overall Study|Adverse Event|7|||
162857499|NCT01503021|588182612|FG001|Overall Study|Adverse Event|6|||
162857500|NCT01503021|588182611|FG000|Overall Study|Death|0|||
162857501|NCT01503021|588182612|FG001|Overall Study|Death|2|||
162857502|NCT01503021|588182611|FG000|Overall Study|Lost to Follow-up|2|||
162857503|NCT01503021|588182612|FG001|Overall Study|Lost to Follow-up|0|||
162956079|NCT02647944|588541367|FG000|Overall Study|Adverse Event|2|||
162956080|NCT02647944|588541368|FG001|Overall Study|Adverse Event|0|||
162956081|NCT02077465|588541370|FG000|Overall Study|Withdrew Consent|0|||
162956082|NCT02077465|588541371|FG001|Overall Study|Withdrew Consent|1|||
162956083|NCT02077465|588541370|FG000|Overall Study|Lost to Follow-up|1|||
162956084|NCT02077465|588541371|FG001|Overall Study|Lost to Follow-up|0|||
162956085|NCT01827163|588541373|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
162956086|NCT01827163|588541373|FG000|Overall Study|Adverse Event|9|||
162857504|NCT01503021|588182611|FG000|Overall Study|Physician Decision|3|||
162857505|NCT01503021|588182612|FG001|Overall Study|Physician Decision|0|||
162857506|NCT01503021|588182611|FG000|Overall Study|Protocol Violation|1|||
162857507|NCT01503021|588182612|FG001|Overall Study|Protocol Violation|3|||
162857508|NCT01503021|588182611|FG000|Overall Study|Withdrawal by Subject|9|||
162857509|NCT01503021|588182612|FG001|Overall Study|Withdrawal by Subject|8|||
162857510|NCT01503021|588182611|FG000|Overall Study|Moved, received transplant, etc.|5|||
162857511|NCT01503021|588182612|FG001|Overall Study|Moved, received transplant, etc.|7|||
162857512|NCT03941548|588182613|FG000|Overall Study|Adverse Event|0|||
162956087|NCT03375463|588541374|FG000|Period 1|Lost to Follow-up|0|||
162857513|NCT03941548|588182614|FG001|Overall Study|Adverse Event|1|||
162857514|NCT03941548|588182613|FG000|Overall Study|Lost to Follow-up|0|||
162857515|NCT03941548|588182614|FG001|Overall Study|Lost to Follow-up|1|||
162857516|NCT03941548|588182613|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
162857517|NCT03941548|588182614|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
162857518|NCT01242111|588182616|FG000|Overall Study|Adverse Event|1|||
162857519|NCT01242111|588182616|FG000|Overall Study|Withdrawal by Subject|1|||
162857520|NCT01242111|588182616|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
162857521|NCT00870688|588182617|FG000|Overall Study|Lost to Follow-up|2|||
162857522|NCT00870688|588182617|FG000|Overall Study|Death, Unrelated|1|||
162857523|NCT00870688|588182617|FG000|Overall Study|Granules in the Stools|1|||
162857524|NCT02015819|588182618|FG000|Overall Study|Rickham catheter was misaligned|0|||
162857525|NCT02015819|588182619|FG001|Overall Study|Rickham catheter was misaligned|0|||
162857526|NCT02015819|588182620|FG002|Overall Study|Rickham catheter was misaligned|0|||
162857527|NCT02015819|588182621|FG003|Overall Study|Rickham catheter was misaligned|1|||
162857528|NCT01486264|588182628|FG000|Overall Study|Death|1|||
162857529|NCT01486264|588182629|FG001|Overall Study|Death|1|||
162857530|NCT01486264|588182628|FG000|Overall Study|Adverse Event|3|||
162857531|NCT01486264|588182629|FG001|Overall Study|Adverse Event|3|||
162857532|NCT01486264|588182628|FG000|Overall Study|Lack of Efficacy|6|||
162857533|NCT01486264|588182629|FG001|Overall Study|Lack of Efficacy|10|||
162857534|NCT01486264|588182628|FG000|Overall Study|Withdrawal by Subject|7|||
162857535|NCT01486264|588182629|FG001|Overall Study|Withdrawal by Subject|18|||
162857536|NCT01486264|588182628|FG000|Overall Study|Physician Decision|1|||
162857537|NCT01486264|588182629|FG001|Overall Study|Physician Decision|1|||
162857538|NCT01486264|588182628|FG000|Overall Study|Protocol Violation|3|||
162857539|NCT01486264|588182629|FG001|Overall Study|Protocol Violation|0|||
162857540|NCT01486264|588182628|FG000|Overall Study|Lost to Follow-up|3|||
162857541|NCT01486264|588182629|FG001|Overall Study|Lost to Follow-up|2|||
162857542|NCT01486264|588182628|FG000|Overall Study|Other|5|||
162857543|NCT01486264|588182629|FG001|Overall Study|Other|11|||
162857544|NCT01486264|588182628|FG000|Overall Study|Not treated|0|||
162857545|NCT01486264|588182629|FG001|Overall Study|Not treated|1|||
162857546|NCT03584009|588182631|FG000|Overall Study|Death|25|||
162857547|NCT03584009|588182632|FG001|Overall Study|Death|18|||
162857548|NCT03584009|588182631|FG000|Overall Study|Lost to Follow-up|0|||
162857549|NCT03584009|588182632|FG001|Overall Study|Lost to Follow-up|1|||
162857550|NCT03584009|588182631|FG000|Overall Study|Physician Decision|1|||
162857551|NCT03584009|588182632|FG001|Overall Study|Physician Decision|1|||
162857552|NCT03584009|588182631|FG000|Overall Study|Study Terminated by Sponsor|22|||
162857553|NCT03584009|588182632|FG001|Overall Study|Study Terminated by Sponsor|30|||
162857554|NCT03584009|588182631|FG000|Overall Study|Withdrawal by Subject|3|||
162857555|NCT03584009|588182632|FG001|Overall Study|Withdrawal by Subject|2|||
162857556|NCT04112914|588182633|FG000|Overall Study|Lost to Follow-up|13|||
162857557|NCT04112914|588182634|FG001|Overall Study|Lost to Follow-up|9|||
162857558|NCT04112914|588182633|FG000|Overall Study|Withdrawal by Subject|1|||
162857559|NCT04112914|588182634|FG001|Overall Study|Withdrawal by Subject|0|||
162857560|NCT00768560|588182635|FG000|Intervention Set 1|Adverse Event|0|||
162857561|NCT00768560|588182636|FG001|Intervention Set 1|Adverse Event|1|||
162857562|NCT00768560|588182637|FG002|Intervention Set 1|Adverse Event|0|||
162857563|NCT00768560|588182638|FG003|Intervention Set 1|Adverse Event|0|||
162857564|NCT00768560|588182639|FG004|Intervention Set 1|Adverse Event|0|||
162857565|NCT00768560|588182640|FG005|Intervention Set 1|Adverse Event|0|||
162857566|NCT02635204|588182641|FG000|Overall Study|Adverse Event|1|||
162857567|NCT02635204|588182642|FG001|Overall Study|Adverse Event|0|||
162857568|NCT02635204|588182641|FG000|Overall Study|Lost to Follow-up|1|||
162857569|NCT02635204|588182642|FG001|Overall Study|Lost to Follow-up|1|||
162857570|NCT00389207|588182643|FG000|Overall Study|Adverse Event|26|||
162857571|NCT00389207|588182644|FG001|Overall Study|Adverse Event|32|||
162857572|NCT00389207|588182645|FG002|Overall Study|Adverse Event|10|||
162857573|NCT00389207|588182643|FG000|Overall Study|Protocol Violation|3|||
162857574|NCT00389207|588182644|FG001|Overall Study|Protocol Violation|1|||
162857575|NCT00389207|588182645|FG002|Overall Study|Protocol Violation|4|||
162857576|NCT00389207|588182643|FG000|Overall Study|Lost to Follow-up|12|||
162956088|NCT03375463|588541375|FG001|Period 1|Lost to Follow-up|0|||
162857577|NCT00389207|588182644|FG001|Overall Study|Lost to Follow-up|9|||
162857578|NCT00389207|588182645|FG002|Overall Study|Lost to Follow-up|7|||
162857579|NCT00389207|588182643|FG000|Overall Study|Withdrawal by Subject|5|||
162857580|NCT00389207|588182644|FG001|Overall Study|Withdrawal by Subject|7|||
162857581|NCT00389207|588182645|FG002|Overall Study|Withdrawal by Subject|11|||
162956089|NCT03375463|588541376|FG002|Period 1|Lost to Follow-up|1|||
162857582|NCT00389207|588182643|FG000|Overall Study|Other|17|||
162857583|NCT00389207|588182644|FG001|Overall Study|Other|23|||
162857584|NCT00389207|588182645|FG002|Overall Study|Other|9|||
162857585|NCT01772134|588182651|FG000|Overall Study|Adverse Event|6|||
162857586|NCT01772134|588182652|FG001|Overall Study|Adverse Event|5|||
162956090|NCT03375463|588541377|FG003|Period 1|Lost to Follow-up|0|||
162857587|NCT01772134|588182653|FG002|Overall Study|Adverse Event|10|||
162857588|NCT01772134|588182651|FG000|Overall Study|Withdrew Consent|3|||
162705041|NCT02403674|587632087|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
162705042|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
162705043|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
162705044|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
162705045|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
162705046|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
162705047|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
162705048|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
162705049|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
162705050|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
162705051|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
162705052|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Death|2|||
162705053|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Death|2|||
162705054|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
162705055|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
162705056|NCT02403674|587632086|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
162705057|NCT02403674|587632087|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
162705058|NCT02403674|587632086|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
162705059|NCT02403674|587632087|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
162705060|NCT02403674|587632086|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
162705061|NCT02403674|587632087|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
162705062|NCT02403674|587632086|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
162705063|NCT02403674|587632087|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
162705064|NCT02403674|587632086|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
162705065|NCT02403674|587632087|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
162705066|NCT02403674|587632086|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
162705067|NCT02403674|587632087|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
162705068|NCT03487666|587632088|FG000|Overall Study|Disease progression|4|||
162705069|NCT03487666|587632089|FG001|Overall Study|Disease progression|2|||
162705070|NCT03487666|587632090|FG002|Overall Study|Disease progression|0|||
162705071|NCT03487666|587632088|FG000|Overall Study|Adverse Event|0|||
162705072|NCT03487666|587632089|FG001|Overall Study|Adverse Event|0|||
162705073|NCT03487666|587632090|FG002|Overall Study|Adverse Event|1|||
162705074|NCT01254305|587632091|FG000|Overall Study|Adverse Event|6|||
162705075|NCT01254305|587632092|FG001|Overall Study|Adverse Event|3|||
162705076|NCT01254305|587632093|FG002|Overall Study|Adverse Event|2|||
162705077|NCT01254305|587632091|FG000|Overall Study|Lack of Efficacy|1|||
162705078|NCT01254305|587632092|FG001|Overall Study|Lack of Efficacy|0|||
162705079|NCT01254305|587632093|FG002|Overall Study|Lack of Efficacy|1|||
162705080|NCT01254305|587632091|FG000|Overall Study|Protocol Violation|1|||
162705081|NCT01254305|587632092|FG001|Overall Study|Protocol Violation|7|||
162705082|NCT01254305|587632093|FG002|Overall Study|Protocol Violation|3|||
162705083|NCT01254305|587632091|FG000|Overall Study|Withdrawal by Subject|4|||
162705084|NCT01254305|587632092|FG001|Overall Study|Withdrawal by Subject|2|||
162705085|NCT01254305|587632093|FG002|Overall Study|Withdrawal by Subject|4|||
162705086|NCT01254305|587632091|FG000|Overall Study|Lost to Follow-up|10|||
162705087|NCT01254305|587632092|FG001|Overall Study|Lost to Follow-up|6|||
162705088|NCT01254305|587632093|FG002|Overall Study|Lost to Follow-up|5|||
162705089|NCT01254305|587632091|FG000|Overall Study|Other Reasons|0|||
162705090|NCT01254305|587632092|FG001|Overall Study|Other Reasons|0|||
162705091|NCT01254305|587632093|FG002|Overall Study|Other Reasons|2|||
162705092|NCT03019458|587632094|FG000|Overall Study|Death|0|||
162705093|NCT03019458|587632095|FG001|Overall Study|Death|1|||
162705094|NCT00031447|587632096|FG000|Overall Study|Lost to Follow-up|0|||
162956091|NCT03375463|588541378|FG004|Period 1|Lost to Follow-up|0|||
162956092|NCT03375463|588541379|FG005|Period 1|Lost to Follow-up|0|||
162956093|NCT03375463|588541374|FG000|Period 1|Adverse Event|0|||
162956094|NCT03375463|588541375|FG001|Period 1|Adverse Event|0|||
162956095|NCT03375463|588541376|FG002|Period 1|Adverse Event|0|||
162956096|NCT03375463|588541377|FG003|Period 1|Adverse Event|0|||
162956097|NCT03375463|588541378|FG004|Period 1|Adverse Event|1|||
162705095|NCT00031447|587632097|FG001|Overall Study|Lost to Follow-up|1|||
162705096|NCT00031447|587632096|FG000|Overall Study|Non-compliant|1|||
162705097|NCT00031447|587632097|FG001|Overall Study|Non-compliant|1|||
162705098|NCT00031447|587632096|FG000|Overall Study|Re-activation of Disease|2|||
162705099|NCT00031447|587632097|FG001|Overall Study|Re-activation of Disease|1|||
162705100|NCT00031447|587632096|FG000|Overall Study|Disruption of blinded study drug supply|7|||
162705101|NCT00031447|587632097|FG001|Overall Study|Disruption of blinded study drug supply|4|||
162705102|NCT01636362|587632101|FG000|Overall Study|Physician Decision|6|||
162705103|NCT01636362|587632101|FG000|Overall Study|Subject healed, not returning|1|||
162956098|NCT03375463|588541379|FG005|Period 1|Adverse Event|0|||
162956099|NCT03375463|588541374|FG000|Period 2|Lost to Follow-up|1|||
162956100|NCT03375463|588541375|FG001|Period 2|Lost to Follow-up|1|||
162612016|NCT01115803|587296763|FG004|Overall Study|Progressive Disease during Cycle1|0|||
162612017|NCT01115803|587296764|FG005|Overall Study|Progressive Disease during Cycle1|0|||
162612018|NCT01115803|587296765|FG006|Overall Study|Progressive Disease during Cycle1|1|||
162612019|NCT03063203|587296766|FG000|Overall Study|Chose alternative therapy|3|||
162857589|NCT01772134|588182652|FG001|Overall Study|Withdrew Consent|1|||
162612020|NCT03063203|587296766|FG000|Overall Study|Death|2|||
162612021|NCT03063203|587296766|FG000|Overall Study|Disease progression|4|||
162612022|NCT03063203|587296766|FG000|Overall Study|Physician Decision|5|||
162612023|NCT02273739|587296767|FG000|Overall Study|Progression of Disease|3|||
162612024|NCT02273739|587296768|FG001|Overall Study|Progression of Disease|4|||
162612025|NCT02273739|587296769|FG002|Overall Study|Progression of Disease|5|||
162612026|NCT02273739|587296770|FG003|Overall Study|Progression of Disease|2|||
162612027|NCT02273739|587296767|FG000|Overall Study|Death|0|||
162612028|NCT02273739|587296768|FG001|Overall Study|Death|0|||
162612029|NCT02273739|587296769|FG002|Overall Study|Death|0|||
162612030|NCT02273739|587296770|FG003|Overall Study|Death|2|||
162612031|NCT02273739|587296767|FG000|Overall Study|Adverse Event|0|||
162612032|NCT02273739|587296768|FG001|Overall Study|Adverse Event|0|||
162612033|NCT02273739|587296769|FG002|Overall Study|Adverse Event|0|||
162612034|NCT02273739|587296770|FG003|Overall Study|Adverse Event|1|||
162612035|NCT02273739|587296767|FG000|Overall Study|Withdrawal by Subject|0|||
162612036|NCT02273739|587296768|FG001|Overall Study|Withdrawal by Subject|0|||
162612037|NCT02273739|587296769|FG002|Overall Study|Withdrawal by Subject|2|||
162612038|NCT02273739|587296770|FG003|Overall Study|Withdrawal by Subject|1|||
162612039|NCT02273739|587296767|FG000|Overall Study|Physician Decision|0|||
162612040|NCT02273739|587296768|FG001|Overall Study|Physician Decision|0|||
162612041|NCT02273739|587296769|FG002|Overall Study|Physician Decision|0|||
162612042|NCT02273739|587296770|FG003|Overall Study|Physician Decision|1|||
162612043|NCT04718103|587296771|FG000|Overall Study|Adverse Event|1|||
162612044|NCT04718103|587296772|FG001|Overall Study|Adverse Event|1|||
162612045|NCT04718103|587296771|FG000|Overall Study|Lack of Efficacy|4|||
162612046|NCT04718103|587296772|FG001|Overall Study|Lack of Efficacy|1|||
162612047|NCT04718103|587296771|FG000|Overall Study|Lost to Follow-up|2|||
162612048|NCT04718103|587296772|FG001|Overall Study|Lost to Follow-up|2|||
162612049|NCT04718103|587296771|FG000|Overall Study|Physician Decision|2|||
162612050|NCT04718103|587296772|FG001|Overall Study|Physician Decision|0|||
162612051|NCT04718103|587296771|FG000|Overall Study|Pregnancy|0|||
162612052|NCT04718103|587296772|FG001|Overall Study|Pregnancy|1|||
162612053|NCT04718103|587296771|FG000|Overall Study|Withdrawal by Subject|10|||
162612054|NCT04718103|587296772|FG001|Overall Study|Withdrawal by Subject|6|||
162612055|NCT04718103|587296771|FG000|Overall Study|Randomized, not treated|4|||
162612056|NCT04718103|587296772|FG001|Overall Study|Randomized, not treated|1|||
162612057|NCT04718103|587296771|FG000|Overall Study|GCP violations|7|||
162612058|NCT04718103|587296772|FG001|Overall Study|GCP violations|5|||
162612059|NCT02280473|587296774|FG000|Overall Study|Adverse Event|1|||
162612060|NCT02280473|587296775|FG001|Overall Study|Adverse Event|1|||
162612061|NCT02280473|587296774|FG000|Overall Study|Lack of Efficacy|0|||
162612062|NCT02280473|587296775|FG001|Overall Study|Lack of Efficacy|1|||
162612063|NCT02280473|587296774|FG000|Overall Study|Lost to Follow-up|0|||
162612064|NCT02280473|587296775|FG001|Overall Study|Lost to Follow-up|1|||
162612065|NCT02393690|587296776|FG000|Overall Study|Ineligible|0|||
162612066|NCT02393690|587296777|FG001|Overall Study|Ineligible|1|||
162612067|NCT05298306|587296778|FG000|Overall Study|Physician Decision|0|||
162612068|NCT05298306|587296779|FG001|Overall Study|Physician Decision|0|||
162612069|NCT05298306|587296780|FG002|Overall Study|Physician Decision|0|||
162612070|NCT05298306|587296781|FG003|Overall Study|Physician Decision|1|||
162612071|NCT05298306|587296782|FG004|Overall Study|Physician Decision|0|||
162612072|NCT05298306|587296783|FG005|Overall Study|Physician Decision|0|||
162612073|NCT00144027|587296785|FG000|Overall Study|Lost to Follow-up|1|||
162612074|NCT00144027|587296786|FG001|Overall Study|Lost to Follow-up|3|||
162612075|NCT00144027|587296785|FG000|Overall Study|Withdrawal by Subject|2|||
162612076|NCT00144027|587296786|FG001|Overall Study|Withdrawal by Subject|2|||
162612077|NCT00144027|587296785|FG000|Overall Study|did not complete baseline assessment|0|||
162857590|NCT01772134|588182653|FG002|Overall Study|Withdrew Consent|5|||
162612078|NCT00144027|587296786|FG001|Overall Study|did not complete baseline assessment|6|||
162612079|NCT05080660|587296787|FG000|Overall Study|Adverse Event|4|||
162612080|NCT05080660|587296788|FG001|Overall Study|Adverse Event|0|||
162612081|NCT05080660|587296787|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
162612082|NCT05080660|587296788|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
162612083|NCT05080660|587296787|FG000|Overall Study|Physician Decision|1|||
162612084|NCT05080660|587296788|FG001|Overall Study|Physician Decision|0|||
162612085|NCT05080660|587296787|FG000|Overall Study|Protocol Deviation|2|||
162612086|NCT05080660|587296788|FG001|Overall Study|Protocol Deviation|0|||
162612087|NCT05080660|587296787|FG000|Overall Study|Withdrawal by Subject|5|||
162612088|NCT05080660|587296788|FG001|Overall Study|Withdrawal by Subject|2|||
162612089|NCT00237185|587296789|FG000|Core|Adverse Event|3|||
162612090|NCT00237185|587296790|FG001|Core|Adverse Event|4|||
162612091|NCT00237185|587296789|FG000|Core|Abnormal laboratory value|0|||
162612092|NCT00237185|587296790|FG001|Core|Abnormal laboratory value|4|||
162857591|NCT01772134|588182651|FG000|Overall Study|Lost to Follow-up|2|||
162857592|NCT01772134|588182652|FG001|Overall Study|Lost to Follow-up|0|||
162857593|NCT01772134|588182653|FG002|Overall Study|Lost to Follow-up|0|||
162857594|NCT01772134|588182651|FG000|Overall Study|Protocol Deviation|4|||
162857595|NCT01772134|588182652|FG001|Overall Study|Protocol Deviation|3|||
162857596|NCT01772134|588182653|FG002|Overall Study|Protocol Deviation|3|||
162857597|NCT01772134|588182651|FG000|Overall Study|Lack of Efficacy|11|||
162857598|NCT01772134|588182652|FG001|Overall Study|Lack of Efficacy|5|||
162857599|NCT01772134|588182653|FG002|Overall Study|Lack of Efficacy|3|||
162857600|NCT01772134|588182651|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
162857601|NCT01772134|588182652|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
162857602|NCT01772134|588182653|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
162857603|NCT01772134|588182651|FG000|Overall Study|Randomized Study Medication Not Received|2|||
162857604|NCT01772134|588182652|FG001|Overall Study|Randomized Study Medication Not Received|0|||
162857605|NCT01772134|588182653|FG002|Overall Study|Randomized Study Medication Not Received|1|||
162857606|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
162857607|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
162857608|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
162857609|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
162857610|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
162857611|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
162857612|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Personal issues|2|||
162857613|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Personal issues|0|||
162857614|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Personal issues|0|||
162857615|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Too busy|7|||
162857616|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Too busy|1|||
162857617|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Too busy|0|||
162857618|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Pain|2|||
162857619|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Pain|0|||
162857620|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Pain|0|||
162857621|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Moved|1|||
162857622|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Moved|0|||
162857623|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Moved|0|||
162857624|NCT00594399|588182658|FG000|Initial 3 Month Counseling|Family illness|1|||
162857625|NCT00594399|588182659|FG001|Initial 3 Month Counseling|Family illness|0|||
162857626|NCT00594399|588182660|FG002|Initial 3 Month Counseling|Family illness|0|||
162857627|NCT00594399|588182658|FG000|Rerandomization Arm 1 Only|Death|2|||
162857628|NCT00594399|588182659|FG001|Rerandomization Arm 1 Only|Death|1|||
162857629|NCT00594399|588182660|FG002|Rerandomization Arm 1 Only|Death|0|||
162956101|NCT03375463|588541376|FG002|Period 2|Lost to Follow-up|0|||
162956102|NCT03375463|588541377|FG003|Period 2|Lost to Follow-up|0|||
162956103|NCT03375463|588541378|FG004|Period 2|Lost to Follow-up|0|||
162956104|NCT03375463|588541379|FG005|Period 2|Lost to Follow-up|0|||
162956105|NCT01745120|588541383|FG000|Overall Study|Investigator decision|1|||
162956106|NCT01745120|588541384|FG001|Overall Study|Investigator decision|0|||
162956107|NCT02909907|588541392|FG000|Overall Study|Withdrawal by Subject|0|||
162956108|NCT02909907|588541393|FG001|Overall Study|Withdrawal by Subject|1|||
162956109|NCT01513174|588541394|FG000|Overall Study|Inclusion Error|1|||
162956110|NCT01513174|588541395|FG001|Overall Study|Inclusion Error|7|||
162956111|NCT01513174|588541394|FG000|Overall Study|Not receive study treatment|3|||
162956112|NCT01513174|588541395|FG001|Overall Study|Not receive study treatment|1|||
162956113|NCT01900626|588541398|FG000|Overall Study|study was closed due to low enrollment|1|||
162956114|NCT01900626|588541399|FG001|Overall Study|study was closed due to low enrollment|1|||
162956115|NCT01200810|588541405|FG000|Overall Study|Physician Decision|1|||
162956116|NCT01200810|588541406|FG001|Overall Study|Physician Decision|0|||
162956117|NCT01200810|588541405|FG000|Overall Study|Withdrawal by Subject|1|||
162956118|NCT01200810|588541406|FG001|Overall Study|Withdrawal by Subject|2|||
162956119|NCT01200810|588541405|FG000|Overall Study|Sponsor stopped making study drug|3|||
162956120|NCT01200810|588541406|FG001|Overall Study|Sponsor stopped making study drug|3|||
162956121|NCT02576938|588541411|FG000|Overall Study|Adverse Event|5|||
162956122|NCT02576938|588541412|FG001|Overall Study|Adverse Event|3|||
162956123|NCT02576938|588541413|FG002|Overall Study|Adverse Event|6|||
162956124|NCT02576938|588541411|FG000|Overall Study|Protocol Violation|1|||
163044716|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
163044717|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
162612093|NCT00237185|587296789|FG000|Core|Abnormal test procedure results|1|||
162956125|NCT02576938|588541412|FG001|Overall Study|Protocol Violation|1|||
162956126|NCT02576938|588541413|FG002|Overall Study|Protocol Violation|1|||
162612094|NCT00237185|587296790|FG001|Core|Abnormal test procedure results|0|||
162857630|NCT00594399|588182658|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
162857631|NCT00594399|588182659|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
162857632|NCT00594399|588182660|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
162857633|NCT03830281|588182661|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
162857634|NCT03830281|588182662|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
162956127|NCT02576938|588541411|FG000|Overall Study|Withdrawal by Subject|3|||
162956128|NCT02576938|588541412|FG001|Overall Study|Withdrawal by Subject|2|||
162956129|NCT02576938|588541413|FG002|Overall Study|Withdrawal by Subject|4|||
162956130|NCT02576938|588541411|FG000|Overall Study|Lack of Efficacy|9|||
162956131|NCT02576938|588541412|FG001|Overall Study|Lack of Efficacy|4|||
162956132|NCT02576938|588541413|FG002|Overall Study|Lack of Efficacy|0|||
162956133|NCT02576938|588541411|FG000|Overall Study|Lost to Follow-up|2|||
162956134|NCT02576938|588541412|FG001|Overall Study|Lost to Follow-up|0|||
162956135|NCT02576938|588541413|FG002|Overall Study|Lost to Follow-up|1|||
162956136|NCT02576938|588541411|FG000|Overall Study|Physician Decision|0|||
162956137|NCT02576938|588541412|FG001|Overall Study|Physician Decision|1|||
162956138|NCT02576938|588541413|FG002|Overall Study|Physician Decision|0|||
162956139|NCT02576938|588541411|FG000|Overall Study|Met Exclusion Criteria|0|||
162956140|NCT02576938|588541412|FG001|Overall Study|Met Exclusion Criteria|1|||
162956141|NCT02576938|588541413|FG002|Overall Study|Met Exclusion Criteria|0|||
162956142|NCT00448591|588541414|FG000|Overall Study|Withdrawal by Subject|178|||
162956143|NCT00448591|588541414|FG000|Overall Study|Progressive Disease|1382|||
162956144|NCT00448591|588541414|FG000|Overall Study|Adverse Event|382|||
162956145|NCT00448591|588541414|FG000|Overall Study|Protocol Violation|41|||
162956146|NCT00448591|588541414|FG000|Overall Study|Lost to Follow-up|19|||
162956147|NCT00448591|588541414|FG000|Overall Study|Treatment Regimen Completed|70|||
162956148|NCT00448591|588541414|FG000|Overall Study|Other|154|||
162956149|NCT00448591|588541414|FG000|Overall Study|Termination of Study|70|||
162956150|NCT00640562|588541415|FG000|Overall Study|Adverse Event|8|||
162956151|NCT00640562|588541416|FG001|Overall Study|Adverse Event|5|||
162956152|NCT00640562|588541415|FG000|Overall Study|Lack of Efficacy|1|||
162956153|NCT00640562|588541416|FG001|Overall Study|Lack of Efficacy|4|||
162956154|NCT00640562|588541415|FG000|Overall Study|Protocol Violation|2|||
162956155|NCT00640562|588541416|FG001|Overall Study|Protocol Violation|4|||
162956156|NCT00640562|588541415|FG000|Overall Study|Withdrawal by Subject|6|||
162956157|NCT00640562|588541416|FG001|Overall Study|Withdrawal by Subject|10|||
162956158|NCT00640562|588541415|FG000|Overall Study|Known risperidone intolerance|0|||
162956159|NCT00640562|588541416|FG001|Overall Study|Known risperidone intolerance|1|||
162956160|NCT00640562|588541415|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
162956161|NCT00640562|588541416|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
162956162|NCT00640562|588541415|FG000|Overall Study|Low study drug dose|0|||
162956163|NCT00640562|588541416|FG001|Overall Study|Low study drug dose|1|||
162956164|NCT00640562|588541415|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
162956165|NCT00640562|588541416|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
162956166|NCT03098394|588541420|FG000|Overall Study|Pregnancy|0|||
162612095|NCT00237185|587296789|FG000|Core|Lack of Efficacy|30|||
162612096|NCT00237185|587296790|FG001|Core|Lack of Efficacy|23|||
162612097|NCT00237185|587296789|FG000|Core|Protocol Violation|1|||
162612098|NCT00237185|587296790|FG001|Core|Protocol Violation|1|||
162612099|NCT00237185|587296789|FG000|Core|Withdrawal by Subject|4|||
162612100|NCT00237185|587296790|FG001|Core|Withdrawal by Subject|4|||
162612101|NCT00237185|587296789|FG000|Core|Administrative problems|0|||
162612102|NCT00237185|587296790|FG001|Core|Administrative problems|1|||
162612103|NCT00237185|587296789|FG000|Core|Death|4|||
162612104|NCT00237185|587296790|FG001|Core|Death|0|||
162612105|NCT00237185|587296789|FG000|Core|Determined ineligible post randomization|1|||
162612106|NCT00237185|587296790|FG001|Core|Determined ineligible post randomization|0|||
162612107|NCT00237185|587296789|FG000|Extension|Adverse Event|1|||
162612108|NCT00237185|587296790|FG001|Extension|Adverse Event|0|||
162612109|NCT00237185|587296789|FG000|Extension|Abnormal laboratory value|0|||
162612110|NCT00237185|587296790|FG001|Extension|Abnormal laboratory value|1|||
162612111|NCT00237185|587296789|FG000|Extension|Lack of Efficacy|9|||
162612112|NCT00237185|587296790|FG001|Extension|Lack of Efficacy|14|||
162612113|NCT00237185|587296789|FG000|Extension|Condition no longer required study drug|0|||
162612114|NCT00237185|587296790|FG001|Extension|Condition no longer required study drug|1|||
162612115|NCT00237185|587296789|FG000|Extension|Withdrawal by Subject|3|||
162612116|NCT00237185|587296790|FG001|Extension|Withdrawal by Subject|2|||
162956167|NCT03098394|588541421|FG001|Overall Study|Pregnancy|1|||
162956168|NCT04408794|588541422|FG000|Overall Study|Adverse Event|43|||
162612117|NCT00237185|587296789|FG000|Extension|Lost to Follow-up|1|||
162612118|NCT00237185|587296790|FG001|Extension|Lost to Follow-up|0|||
162612119|NCT00237185|587296789|FG000|Extension|Administrative problems|1|||
162612120|NCT00237185|587296790|FG001|Extension|Administrative problems|0|||
162612121|NCT00237185|587296789|FG000|Extension|Death|1|||
162612122|NCT00237185|587296790|FG001|Extension|Death|1|||
162857635|NCT03830281|588182661|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
162857636|NCT03830281|588182662|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
162857637|NCT03830281|588182661|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
162857638|NCT03830281|588182662|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
162857639|NCT03830281|588182661|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
162857640|NCT03830281|588182662|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
162857641|NCT03830281|588182661|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
162857642|NCT03830281|588182662|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
162857643|NCT03830281|588182661|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
162956169|NCT04408794|588541422|FG000|Overall Study|Infrequent study drug usage|43|||
162956170|NCT04408794|588541422|FG000|Overall Study|Lack of Efficacy|61|||
162956171|NCT04408794|588541422|FG000|Overall Study|Lost to Follow-up|33|||
162956172|NCT04408794|588541422|FG000|Overall Study|Non-compliance|6|||
162956173|NCT04408794|588541422|FG000|Overall Study|Physician Decision|1|||
162956174|NCT04408794|588541422|FG000|Overall Study|Pregnancy|6|||
162956175|NCT04408794|588541422|FG000|Overall Study|Protocol Deviation|9|||
162956176|NCT04408794|588541422|FG000|Overall Study|Sheehan-STS Result|1|||
162612123|NCT02204007|587296791|FG000|Overall Study|Surgery Canceled|1|||
162612124|NCT02204007|587296792|FG001|Overall Study|Surgery Canceled|1|||
162612125|NCT01977937|587296793|FG000|Overall Study|Withdrawal by Subject|2|||
162612126|NCT01977937|587296794|FG001|Overall Study|Withdrawal by Subject|1|||
162612127|NCT01977937|587296793|FG000|Overall Study|Adverse Event|1|||
162612128|NCT01977937|587296794|FG001|Overall Study|Adverse Event|0|||
162612129|NCT01977937|587296793|FG000|Overall Study|Physician Decision|0|||
162612130|NCT01977937|587296794|FG001|Overall Study|Physician Decision|1|||
162612131|NCT03194490|587296797|FG000|Overall Study|Lost to Follow-up|1|||
162612132|NCT03194490|587296798|FG001|Overall Study|Lost to Follow-up|3|||
162612133|NCT03194490|587296797|FG000|Overall Study|participant developed specific neck pain|1|||
162612134|NCT03194490|587296798|FG001|Overall Study|participant developed specific neck pain|0|||
162612135|NCT03911843|587296799|FG000|Overall Study|Adverse Event|2|||
162612136|NCT03911843|587296800|FG001|Overall Study|Adverse Event|0|||
162612137|NCT03911843|587296799|FG000|Overall Study|Protocol Violation|2|||
162612138|NCT03911843|587296800|FG001|Overall Study|Protocol Violation|0|||
162612139|NCT03911843|587296799|FG000|Overall Study|Lost to Follow-up|0|||
162612140|NCT03911843|587296800|FG001|Overall Study|Lost to Follow-up|1|||
162612141|NCT02819518|587296801|FG000|Overall Study|Death|9|||
162612142|NCT02819518|587296802|FG001|Overall Study|Death|12|||
162612143|NCT02819518|587296803|FG002|Overall Study|Death|9|||
162612144|NCT02819518|587296804|FG003|Overall Study|Death|475|||
162612145|NCT02819518|587296805|FG004|Overall Study|Death|244|||
162612146|NCT02819518|587296801|FG000|Overall Study|Withdrawal by Subject|0|||
162612147|NCT02819518|587296802|FG001|Overall Study|Withdrawal by Subject|0|||
162612148|NCT02819518|587296803|FG002|Overall Study|Withdrawal by Subject|0|||
162612149|NCT02819518|587296804|FG003|Overall Study|Withdrawal by Subject|25|||
162612150|NCT02819518|587296805|FG004|Overall Study|Withdrawal by Subject|8|||
162612151|NCT02819518|587296801|FG000|Overall Study|Lost to Follow-up|0|||
162612152|NCT02819518|587296802|FG001|Overall Study|Lost to Follow-up|0|||
162612153|NCT02819518|587296803|FG002|Overall Study|Lost to Follow-up|0|||
162612154|NCT02819518|587296804|FG003|Overall Study|Lost to Follow-up|0|||
162612155|NCT02819518|587296805|FG004|Overall Study|Lost to Follow-up|1|||
162612156|NCT02819518|587296801|FG000|Overall Study|Sponsor Decision|1|||
162612157|NCT02819518|587296802|FG001|Overall Study|Sponsor Decision|1|||
162612158|NCT02819518|587296803|FG002|Overall Study|Sponsor Decision|0|||
162612159|NCT02819518|587296804|FG003|Overall Study|Sponsor Decision|34|||
162612160|NCT02819518|587296805|FG004|Overall Study|Sponsor Decision|17|||
162612161|NCT02819518|587296801|FG000|Overall Study|Transferred to extension study|1|||
162612162|NCT02819518|587296802|FG001|Overall Study|Transferred to extension study|1|||
162612163|NCT02819518|587296803|FG002|Overall Study|Transferred to extension study|1|||
162612164|NCT02819518|587296804|FG003|Overall Study|Transferred to extension study|32|||
162612165|NCT02819518|587296805|FG004|Overall Study|Transferred to extension study|11|||
162705104|NCT01636362|587632101|FG000|Overall Study|Withdrawal by Subject|1|||
162857644|NCT03830281|588182662|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
162857645|NCT03830281|588182661|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
162612166|NCT01505647|587296806|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
162612167|NCT01505647|587296807|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
162612168|NCT01505647|587296806|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
162612169|NCT01505647|587296807|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
162612170|NCT01505647|587296806|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
162612171|NCT01505647|587296807|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
162612172|NCT01505647|587296806|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
162612173|NCT01505647|587296807|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
162612174|NCT01505647|587296806|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
162612175|NCT01505647|587296807|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
162857646|NCT03830281|588182662|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
162956177|NCT04408794|588541422|FG000|Overall Study|Withdrawal by Subject|57|||
162978990|NCT01660022|588623541|FG003|First Sequence (7 Days)|Protocol Violation|0|||
162857647|NCT03830281|588182661|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
162857648|NCT03830281|588182662|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
162857649|NCT03830281|588182661|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
162857650|NCT03830281|588182662|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
162857651|NCT00922935|588182663|FG000|Overall Study|Protocol Violation|0|||
162857652|NCT00922935|588182664|FG001|Overall Study|Protocol Violation|3|||
162857653|NCT00922935|588182665|FG002|Overall Study|Protocol Violation|0|||
162857654|NCT00922935|588182663|FG000|Overall Study|Physician Decision|1|||
162857655|NCT00922935|588182664|FG001|Overall Study|Physician Decision|1|||
162857656|NCT00922935|588182665|FG002|Overall Study|Physician Decision|0|||
162857657|NCT00922935|588182663|FG000|Overall Study|Lost to Follow-up|0|||
162857658|NCT00922935|588182664|FG001|Overall Study|Lost to Follow-up|1|||
162857659|NCT00922935|588182665|FG002|Overall Study|Lost to Follow-up|0|||
162612176|NCT02750943|587296811|FG000|Overall Study|Lost to Follow-up|1|||
162857660|NCT03133767|588182666|FG000|Overall Study|Lost to Follow-up|38|||
162857661|NCT03133767|588182667|FG001|Overall Study|Lost to Follow-up|24|||
162857662|NCT03133767|588182666|FG000|Overall Study|Protocol Violation|0|||
162857663|NCT03133767|588182667|FG001|Overall Study|Protocol Violation|1|||
162857664|NCT03301857|588182668|FG000|Overall Study|Death|0|||
162857665|NCT03301857|588182669|FG001|Overall Study|Death|2|||
162857666|NCT03301857|588182668|FG000|Overall Study|Lost to Follow-up|4|||
162857667|NCT03301857|588182669|FG001|Overall Study|Lost to Follow-up|2|||
162857668|NCT03301857|588182668|FG000|Overall Study|Decision by Sponsor|6|||
162857669|NCT03301857|588182669|FG001|Overall Study|Decision by Sponsor|0|||
162857670|NCT03301857|588182668|FG000|Overall Study|Withdrawal by Subject|12|||
162857671|NCT03301857|588182669|FG001|Overall Study|Withdrawal by Subject|4|||
162857672|NCT01856114|588182683|FG000|Overall Study|Withdrawal by Subject|1|||
162857673|NCT01856114|588182684|FG001|Overall Study|Withdrawal by Subject|0|||
162857674|NCT01856114|588182683|FG000|Overall Study|Adverse Event|1|||
162857675|NCT01856114|588182684|FG001|Overall Study|Adverse Event|0|||
162857676|NCT02853760|588182685|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
162857677|NCT02853760|588182686|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
162857678|NCT02853760|588182687|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
162857679|NCT02853760|588182688|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
162857680|NCT02853760|588182689|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
162857681|NCT02853760|588182690|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
162857682|NCT00488631|588182691|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
162857683|NCT00488631|588182692|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
162857684|NCT00488631|588182693|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
162857685|NCT00488631|588182694|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
162857686|NCT00488631|588182695|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
162857687|NCT00488631|588182696|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
162857688|NCT00488631|588182697|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
162857689|NCT00488631|588182698|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
162857690|NCT00488631|588182699|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
162857691|NCT00488631|588182700|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
162857692|NCT00488631|588182691|FG000|Double Blind Period (Week 0-54)|Death|0|||
162857693|NCT00488631|588182692|FG001|Double Blind Period (Week 0-54)|Death|0|||
162857694|NCT00488631|588182693|FG002|Double Blind Period (Week 0-54)|Death|0|||
162857695|NCT00488631|588182694|FG003|Double Blind Period (Week 0-54)|Death|0|||
162857696|NCT00488631|588182695|FG004|Double Blind Period (Week 0-54)|Death|0|||
162857697|NCT00488631|588182696|FG005|Double Blind Period (Week 0-54)|Death|1|||
162857698|NCT00488631|588182697|FG006|Double Blind Period (Week 0-54)|Death|0|||
162857699|NCT00488631|588182698|FG007|Double Blind Period (Week 0-54)|Death|0|||
162857700|NCT00488631|588182699|FG008|Double Blind Period (Week 0-54)|Death|0|||
162612177|NCT02750943|587296812|FG001|Overall Study|Lost to Follow-up|2|||
162857701|NCT00488631|588182700|FG009|Double Blind Period (Week 0-54)|Death|0|||
162857702|NCT00488631|588182691|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
162857703|NCT00488631|588182692|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
162857704|NCT00488631|588182693|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
162857705|NCT00488631|588182694|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
162857706|NCT00488631|588182695|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
162857707|NCT00488631|588182696|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
162857708|NCT00488631|588182697|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
162857709|NCT00488631|588182698|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
162857710|NCT00488631|588182699|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
162612178|NCT02750943|587296811|FG000|Overall Study|Withdrawal by Subject|5|||
162956178|NCT04408794|588541422|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
162956179|NCT04408794|588541422|FG000|Overall Study|Never Treated Migraine|5|||
162956180|NCT00244764|588541423|FG000|Overall Study|Adverse Event|37|||
162956181|NCT00244764|588541423|FG000|Overall Study|Lost to Follow-up|23|||
162612179|NCT02750943|587296812|FG001|Overall Study|Withdrawal by Subject|7|||
162857711|NCT00488631|588182700|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
162857712|NCT00488631|588182691|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
162857713|NCT00488631|588182692|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
162857714|NCT00488631|588182693|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
162857715|NCT00488631|588182694|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
162857716|NCT00488631|588182695|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
162857717|NCT00488631|588182696|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
162857718|NCT00488631|588182697|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
162857719|NCT00488631|588182698|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
162857720|NCT00488631|588182699|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
162857721|NCT00488631|588182700|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
162857722|NCT00488631|588182691|FG000|Double Blind Period (Week 0-54)|Other|6|||
162857723|NCT00488631|588182692|FG001|Double Blind Period (Week 0-54)|Other|12|||
162857724|NCT00488631|588182693|FG002|Double Blind Period (Week 0-54)|Other|10|||
162857725|NCT00488631|588182694|FG003|Double Blind Period (Week 0-54)|Other|11|||
162857726|NCT00488631|588182695|FG004|Double Blind Period (Week 0-54)|Other|14|||
162857727|NCT00488631|588182696|FG005|Double Blind Period (Week 0-54)|Other|34|||
162857728|NCT00488631|588182697|FG006|Double Blind Period (Week 0-54)|Other|0|||
162857729|NCT00488631|588182698|FG007|Double Blind Period (Week 0-54)|Other|0|||
162857730|NCT00488631|588182699|FG008|Double Blind Period (Week 0-54)|Other|0|||
162857731|NCT00488631|588182700|FG009|Double Blind Period (Week 0-54)|Other|0|||
162857732|NCT00488631|588182691|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857733|NCT00488631|588182692|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857734|NCT00488631|588182693|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857735|NCT00488631|588182694|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857736|NCT00488631|588182695|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857737|NCT00488631|588182696|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857738|NCT00488631|588182697|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
162857739|NCT00488631|588182698|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
162857740|NCT00488631|588182699|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
162857741|NCT00488631|588182700|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
162857742|NCT00488631|588182691|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
162857743|NCT00488631|588182692|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
162857744|NCT00488631|588182693|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
162857745|NCT00488631|588182694|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
162857746|NCT00488631|588182695|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
162857747|NCT00488631|588182696|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
162857748|NCT00488631|588182697|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
162857749|NCT00488631|588182698|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
162857750|NCT00488631|588182699|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
162857751|NCT00488631|588182700|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
162857752|NCT00488631|588182691|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857753|NCT00488631|588182692|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857754|NCT00488631|588182693|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857755|NCT00488631|588182694|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857756|NCT00488631|588182695|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857757|NCT00488631|588182696|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
162857758|NCT00488631|588182697|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
162857759|NCT00488631|588182698|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
162857760|NCT00488631|588182699|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
162857761|NCT00488631|588182700|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
162857762|NCT00488631|588182691|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857763|NCT00488631|588182692|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857764|NCT00488631|588182693|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857765|NCT00488631|588182694|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857766|NCT00488631|588182695|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857767|NCT00488631|588182696|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857768|NCT00488631|588182697|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
162857769|NCT00488631|588182698|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857770|NCT00488631|588182699|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
162857771|NCT00488631|588182700|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
162857772|NCT00488631|588182691|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857773|NCT00488631|588182692|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857774|NCT00488631|588182693|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857775|NCT00488631|588182694|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857776|NCT00488631|588182695|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857777|NCT00488631|588182696|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857778|NCT00488631|588182697|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
162857779|NCT00488631|588182698|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
162857780|NCT00488631|588182699|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
162857781|NCT00488631|588182700|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
162857782|NCT05300087|588182701|FG000|Overall Study|Withdrawal by Subject|0|||
162857783|NCT05300087|588182702|FG001|Overall Study|Withdrawal by Subject|1|||
162857784|NCT03248128|588182703|FG000|Overall Study|Lost to Follow-up|1|||
162857785|NCT03248128|588182704|FG001|Overall Study|Lost to Follow-up|0|||
162857786|NCT03248128|588182703|FG000|Overall Study|Withdrawal by Subject|16|||
162857787|NCT03248128|588182704|FG001|Overall Study|Withdrawal by Subject|14|||
162857788|NCT03248128|588182703|FG000|Overall Study|Site Closed|4|||
162857789|NCT03248128|588182704|FG001|Overall Study|Site Closed|3|||
162857790|NCT03248128|588182703|FG000|Overall Study|Randomized, but did not receive treatment|1|||
162857791|NCT03248128|588182704|FG001|Overall Study|Randomized, but did not receive treatment|3|||
162857792|NCT03372941|588182707|FG000|Overall Study|Lost to Follow-up|2|||
162857793|NCT03372941|588182708|FG001|Overall Study|Lost to Follow-up|4|||
162857794|NCT00741819|588182709|FG000|Overall Study|Adverse Event|3|||
162857795|NCT00741819|588182709|FG000|Overall Study|Withdrawal by Subject|3|||
162857796|NCT00741819|588182709|FG000|Overall Study|Death|1|||
162857797|NCT00741819|588182709|FG000|Overall Study|Disease progression|1|||
162857798|NCT01126580|588182710|FG000|Overall Study|Adverse Event|14|||
162857799|NCT01126580|588182711|FG001|Overall Study|Adverse Event|8|||
162857800|NCT01126580|588182712|FG002|Overall Study|Adverse Event|12|||
162857801|NCT01126580|588182710|FG000|Overall Study|Withdrawal by Subject|11|||
162857802|NCT01126580|588182711|FG001|Overall Study|Withdrawal by Subject|19|||
162857803|NCT01126580|588182712|FG002|Overall Study|Withdrawal by Subject|14|||
162857804|NCT01126580|588182710|FG000|Overall Study|Sponsor Decision|5|||
162857805|NCT01126580|588182711|FG001|Overall Study|Sponsor Decision|4|||
162857806|NCT01126580|588182712|FG002|Overall Study|Sponsor Decision|7|||
162857807|NCT01126580|588182710|FG000|Overall Study|Physician Decision|1|||
162857808|NCT01126580|588182711|FG001|Overall Study|Physician Decision|1|||
162857809|NCT01126580|588182712|FG002|Overall Study|Physician Decision|2|||
162857810|NCT01126580|588182710|FG000|Overall Study|Entry Criteria Not Met|1|||
162857811|NCT01126580|588182711|FG001|Overall Study|Entry Criteria Not Met|1|||
162857812|NCT01126580|588182712|FG002|Overall Study|Entry Criteria Not Met|2|||
162857813|NCT01126580|588182710|FG000|Overall Study|Lack of Efficacy|2|||
162857814|NCT01126580|588182711|FG001|Overall Study|Lack of Efficacy|3|||
162857815|NCT01126580|588182712|FG002|Overall Study|Lack of Efficacy|4|||
162857816|NCT01126580|588182710|FG000|Overall Study|Protocol Violation|0|||
162857817|NCT01126580|588182711|FG001|Overall Study|Protocol Violation|1|||
162857818|NCT01126580|588182712|FG002|Overall Study|Protocol Violation|2|||
162857819|NCT01126580|588182710|FG000|Overall Study|Lost to Follow-up|15|||
162857820|NCT01126580|588182711|FG001|Overall Study|Lost to Follow-up|13|||
162857821|NCT01126580|588182712|FG002|Overall Study|Lost to Follow-up|9|||
162857822|NCT01126580|588182710|FG000|Overall Study|Treatment Non-compliance|0|||
162857823|NCT01126580|588182711|FG001|Overall Study|Treatment Non-compliance|2|||
162857824|NCT01126580|588182712|FG002|Overall Study|Treatment Non-compliance|3|||
162857825|NCT02382133|588182715|FG000|Overall Study|Death|22|||
162857826|NCT02382133|588182715|FG000|Overall Study|transfer out of ICU|4|||
162857827|NCT02382133|588182715|FG000|Overall Study|Physician Decision|2|||
163044718|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044719|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044720|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
162857828|NCT02382133|588182715|FG000|Overall Study|arterial catheter loss|4|||
162857829|NCT02382133|588182715|FG000|Overall Study|pressure injury both sites|1|||
162857830|NCT04321343|588182717|FG000|Overall Study|Adverse Event|0|||
162857831|NCT04321343|588182718|FG001|Overall Study|Adverse Event|0|||
162857832|NCT04321343|588182719|FG002|Overall Study|Adverse Event|1|||
162857833|NCT04321343|588182720|FG003|Overall Study|Adverse Event|0|||
162857834|NCT04321343|588182717|FG000|Overall Study|Death|0|||
162857835|NCT04321343|588182718|FG001|Overall Study|Death|0|||
162857836|NCT04321343|588182719|FG002|Overall Study|Death|0|||
162857837|NCT04321343|588182720|FG003|Overall Study|Death|1|||
162857838|NCT04321343|588182717|FG000|Overall Study|Pregnancy|1|||
162857839|NCT04321343|588182718|FG001|Overall Study|Pregnancy|0|||
162857840|NCT04321343|588182719|FG002|Overall Study|Pregnancy|0|||
162857841|NCT04321343|588182720|FG003|Overall Study|Pregnancy|0|||
162857842|NCT04321343|588182717|FG000|Overall Study|Protocol Violation|1|||
162857843|NCT04321343|588182718|FG001|Overall Study|Protocol Violation|1|||
162857844|NCT04321343|588182719|FG002|Overall Study|Protocol Violation|1|||
162857845|NCT04321343|588182720|FG003|Overall Study|Protocol Violation|1|||
162857846|NCT04321343|588182717|FG000|Overall Study|Withdrawal by Subject|0|||
162857847|NCT04321343|588182718|FG001|Overall Study|Withdrawal by Subject|6|||
162857848|NCT04321343|588182719|FG002|Overall Study|Withdrawal by Subject|0|||
162857849|NCT04321343|588182720|FG003|Overall Study|Withdrawal by Subject|2|||
162857850|NCT04321343|588182717|FG000|Overall Study|Lost to Follow-up|2|||
162857851|NCT04321343|588182718|FG001|Overall Study|Lost to Follow-up|2|||
162857852|NCT04321343|588182719|FG002|Overall Study|Lost to Follow-up|1|||
162857853|NCT04321343|588182720|FG003|Overall Study|Lost to Follow-up|3|||
162857854|NCT03430310|588182721|FG000|Overall Study|Protocol Violation|2|||
162857855|NCT03430310|588182722|FG001|Overall Study|Protocol Violation|0|||
162857856|NCT03430310|588182721|FG000|Overall Study|Withdrawal by Subject|3|||
162857857|NCT03430310|588182722|FG001|Overall Study|Withdrawal by Subject|2|||
162857858|NCT03430310|588182721|FG000|Overall Study|COVID shutdown March 2020|0|||
162857859|NCT03430310|588182722|FG001|Overall Study|COVID shutdown March 2020|1|||
162857860|NCT03972488|588182723|FG000|Overall Study|Progressive disease|42|||
162956182|NCT00244764|588541423|FG000|Overall Study|Withdrawal by Subject|12|||
162956183|NCT00244764|588541423|FG000|Overall Study|Disease Progression|13|||
162956184|NCT00244764|588541423|FG000|Overall Study|Protocol Violation|2|||
162956185|NCT00244764|588541423|FG000|Overall Study|Death|1|||
162956186|NCT00244764|588541423|FG000|Overall Study|Off Study Medication for >21 Days|1|||
162956187|NCT00244764|588541423|FG000|Overall Study|Declining Performance Status|1|||
162956188|NCT00244764|588541423|FG000|Overall Study|Participant was Hospitalized until Death|1|||
162956189|NCT00244764|588541423|FG000|Overall Study|Primary Investigator Discretion|2|||
162956190|NCT00244764|588541423|FG000|Overall Study|Sponsor Terminated Study|2|||
162956191|NCT00244764|588541423|FG000|Overall Study|Developed Secondary Malignancy|1|||
162956192|NCT01518972|588541424|FG000|Overall Study|Lost to Follow-up|2|||
162956193|NCT01518972|588541425|FG001|Overall Study|Lost to Follow-up|1|||
162956194|NCT01518972|588541424|FG000|Overall Study|Withdrawal by Subject|1|||
162956195|NCT01518972|588541425|FG001|Overall Study|Withdrawal by Subject|0|||
162956196|NCT01518972|588541424|FG000|Overall Study|Moved from area|1|||
162956197|NCT01518972|588541425|FG001|Overall Study|Moved from area|0|||
162956198|NCT01518972|588541424|FG000|Overall Study|Transportation problems|1|||
162956199|NCT01518972|588541425|FG001|Overall Study|Transportation problems|0|||
162956200|NCT01518972|588541424|FG000|Overall Study|Exclusionary medical condition|1|||
162956201|NCT01518972|588541425|FG001|Overall Study|Exclusionary medical condition|0|||
162956202|NCT01518972|588541424|FG000|Overall Study|Missed safety visits|0|||
162956203|NCT01518972|588541425|FG001|Overall Study|Missed safety visits|1|||
162956204|NCT01518972|588541424|FG000|Overall Study|Exclusionary medication|0|||
162956205|NCT01518972|588541425|FG001|Overall Study|Exclusionary medication|1|||
162956206|NCT01518972|588541424|FG000|Overall Study|Declined medication starting on day 12|0|||
162956207|NCT01518972|588541425|FG001|Overall Study|Declined medication starting on day 12|1|||
162956208|NCT04022954|588541427|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
162956209|NCT04022954|588541427|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
162956210|NCT04022954|588541427|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
162956211|NCT03637764|588541428|FG000|Overall Study|Adverse Event|2|||
162956212|NCT03637764|588541429|FG001|Overall Study|Adverse Event|0|||
162956213|NCT03637764|588541430|FG002|Overall Study|Adverse Event|0|||
162956214|NCT03637764|588541431|FG003|Overall Study|Adverse Event|1|||
162956215|NCT03637764|588541428|FG000|Overall Study|Progressive Disease|23|||
162956216|NCT03637764|588541429|FG001|Overall Study|Progressive Disease|23|||
162956217|NCT03637764|588541430|FG002|Overall Study|Progressive Disease|18|||
162956218|NCT03637764|588541431|FG003|Overall Study|Progressive Disease|31|||
162956219|NCT03637764|588541428|FG000|Overall Study|Withdrawal by Subject|1|||
162956220|NCT03637764|588541429|FG001|Overall Study|Withdrawal by Subject|3|||
162956221|NCT03637764|588541430|FG002|Overall Study|Withdrawal by Subject|0|||
162956222|NCT03637764|588541431|FG003|Overall Study|Withdrawal by Subject|1|||
162857861|NCT03972488|588182724|FG001|Overall Study|Progressive disease|44|||
162857862|NCT03972488|588182723|FG000|Overall Study|Physician Decision|13|||
162857863|NCT03972488|588182724|FG001|Overall Study|Physician Decision|7|||
162857864|NCT03972488|588182723|FG000|Overall Study|Adverse Event|8|||
162857865|NCT03972488|588182724|FG001|Overall Study|Adverse Event|1|||
162857866|NCT03972488|588182723|FG000|Overall Study|Death|4|||
162857867|NCT03972488|588182724|FG001|Overall Study|Death|4|||
162956223|NCT02648438|588541432|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162956224|NCT02648438|588541433|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
162956225|NCT02648438|588541434|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
162956226|NCT02648438|588541432|FG000|Overall Study|Protocol Violation|2|||
162956227|NCT02648438|588541433|FG001|Overall Study|Protocol Violation|0|||
162956228|NCT02648438|588541434|FG002|Overall Study|Protocol Violation|0|||
162956229|NCT02648438|588541432|FG000|Overall Study|Withdrawal by Subject|1|||
162857868|NCT03972488|588182723|FG000|Overall Study|Withdrawal by Subject|3|||
162857869|NCT03972488|588182724|FG001|Overall Study|Withdrawal by Subject|4|||
162857870|NCT03972488|588182723|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
162857871|NCT03972488|588182724|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
162857872|NCT02770807|588182725|FG000|Overall Study|Adverse Event|3|||
162857873|NCT02770807|588182726|FG001|Overall Study|Adverse Event|3|||
162857874|NCT02770807|588182727|FG002|Overall Study|Adverse Event|1|||
162857875|NCT02770807|588182725|FG000|Overall Study|Withdrawal by Subject|7|||
162857876|NCT02770807|588182726|FG001|Overall Study|Withdrawal by Subject|3|||
162857877|NCT02770807|588182727|FG002|Overall Study|Withdrawal by Subject|4|||
162857878|NCT02770807|588182725|FG000|Overall Study|Other|0|||
162857879|NCT02770807|588182726|FG001|Overall Study|Other|1|||
162857880|NCT02770807|588182727|FG002|Overall Study|Other|0|||
162857881|NCT02770807|588182725|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
162857882|NCT02770807|588182726|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
162857883|NCT02770807|588182727|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
162857884|NCT02770807|588182725|FG000|Overall Study|Physician Decision|0|||
162857885|NCT02770807|588182726|FG001|Overall Study|Physician Decision|0|||
162857886|NCT02770807|588182727|FG002|Overall Study|Physician Decision|1|||
162857887|NCT03277196|588182728|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
162857888|NCT03277196|588182728|FG000|Overall Study|Lost to Follow-up|3|||
162857889|NCT03277196|588182728|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
162857890|NCT03277196|588182728|FG000|Overall Study|Other|2|||
162857891|NCT01084252|588184976|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857892|NCT01084252|588184977|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857893|NCT01084252|588184978|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857894|NCT01084252|588184979|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857895|NCT01084252|588184980|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857896|NCT01084252|588184981|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857897|NCT01084252|588184982|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857898|NCT01084252|588184983|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857899|NCT01084252|588184984|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857900|NCT01084252|588184985|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857901|NCT01084252|588184986|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857902|NCT01084252|588184987|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857903|NCT01084252|588184988|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
162857904|NCT01084252|588184989|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
162857905|NCT00853632|588184990|FG000|Overall Study|Death|88|||
162857906|NCT00853632|588184990|FG000|Overall Study|Withdrawal by Subject|45|||
162857907|NCT00853632|588184990|FG000|Overall Study|Lost to Follow-up|30|||
162857908|NCT00853632|588184990|FG000|Overall Study|Reoperation/Explant|17|||
162857909|NCT00853632|588184990|FG000|Overall Study|Exit with other reason|22|||
162857910|NCT04493619|588184991|FG000|Overall Study|Death|4|||
162857911|NCT04493619|588184992|FG001|Overall Study|Death|3|||
162857912|NCT04493619|588184993|FG002|Overall Study|Death|3|||
162857913|NCT04493619|588184994|FG003|Overall Study|Death|4|||
162857914|NCT04493619|588184991|FG000|Overall Study|Study discontinued early|10|||
163044721|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044722|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
163044723|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
163044724|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
163044725|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044726|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044727|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044728|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044729|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163044730|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
163044731|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
163044732|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
163044733|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
163044734|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163044735|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
162705105|NCT01244763|587632102|FG000|Overall Study|Adverse Event|1|||
162857915|NCT04493619|588184992|FG001|Overall Study|Study discontinued early|0|||
162705106|NCT01244763|587632103|FG001|Overall Study|Adverse Event|0|||
162857916|NCT04493619|588184993|FG002|Overall Study|Study discontinued early|4|||
162857917|NCT04493619|588184994|FG003|Overall Study|Study discontinued early|8|||
162857918|NCT04493619|588184991|FG000|Overall Study|Lost to Follow-up|0|||
162857919|NCT04493619|588184992|FG001|Overall Study|Lost to Follow-up|0|||
162857920|NCT04493619|588184993|FG002|Overall Study|Lost to Follow-up|0|||
162857921|NCT04493619|588184994|FG003|Overall Study|Lost to Follow-up|1|||
162857922|NCT02342171|588185001|FG000|Overall Study|Death|4|||
162857923|NCT02342171|588185002|FG001|Overall Study|Death|87|||
162857924|NCT02342171|588185001|FG000|Overall Study|Received favipiravir|10|||
162857925|NCT02342171|588185002|FG001|Overall Study|Received favipiravir|0|||
162857926|NCT02342171|588185001|FG000|Overall Study|Missing cycle treshold value|1|||
162857927|NCT02342171|588185002|FG001|Overall Study|Missing cycle treshold value|0|||
162857928|NCT02342171|588185001|FG000|Overall Study|Unknown outcome|0|||
162857929|NCT02342171|588185002|FG001|Overall Study|Unknown outcome|1|||
162857930|NCT02342171|588185001|FG000|Overall Study|Missing age data|0|||
162857931|NCT02342171|588185002|FG001|Overall Study|Missing age data|1|||
162857932|NCT00875420|588185003|FG000|Overall Study|Adverse Event|0|||
162857933|NCT00875420|588185004|FG001|Overall Study|Adverse Event|1|||
162857934|NCT00875420|588185005|FG002|Overall Study|Adverse Event|1|||
162857935|NCT00875420|588185006|FG003|Overall Study|Adverse Event|0|||
162857936|NCT00875420|588185007|FG004|Overall Study|Adverse Event|0|||
162857937|NCT00875420|588185003|FG000|Overall Study|Inability to complete study procedures|1|||
162857938|NCT00875420|588185004|FG001|Overall Study|Inability to complete study procedures|0|||
162857939|NCT00875420|588185005|FG002|Overall Study|Inability to complete study procedures|1|||
162857940|NCT00875420|588185006|FG003|Overall Study|Inability to complete study procedures|1|||
162857941|NCT00875420|588185007|FG004|Overall Study|Inability to complete study procedures|1|||
162857942|NCT00875420|588185003|FG000|Overall Study|Lost to Follow-up|1|||
162857943|NCT00875420|588185004|FG001|Overall Study|Lost to Follow-up|0|||
162857944|NCT00875420|588185005|FG002|Overall Study|Lost to Follow-up|0|||
162857945|NCT00875420|588185006|FG003|Overall Study|Lost to Follow-up|0|||
162857946|NCT00875420|588185007|FG004|Overall Study|Lost to Follow-up|0|||
162857947|NCT00875420|588185003|FG000|Overall Study|Personal reason|0|||
162857948|NCT00875420|588185004|FG001|Overall Study|Personal reason|0|||
162857949|NCT00875420|588185005|FG002|Overall Study|Personal reason|0|||
162857950|NCT00875420|588185006|FG003|Overall Study|Personal reason|0|||
162857951|NCT00875420|588185007|FG004|Overall Study|Personal reason|1|||
162857952|NCT00875420|588185003|FG000|Overall Study|Prohibited medication|0|||
162857953|NCT00875420|588185004|FG001|Overall Study|Prohibited medication|0|||
162857954|NCT00875420|588185005|FG002|Overall Study|Prohibited medication|0|||
162857955|NCT00875420|588185006|FG003|Overall Study|Prohibited medication|1|||
162857956|NCT00875420|588185007|FG004|Overall Study|Prohibited medication|0|||
162857957|NCT00875420|588185003|FG000|Overall Study|Sponsor decision|0|||
162857958|NCT00875420|588185004|FG001|Overall Study|Sponsor decision|1|||
162857959|NCT00875420|588185005|FG002|Overall Study|Sponsor decision|0|||
162857960|NCT00875420|588185006|FG003|Overall Study|Sponsor decision|0|||
162857961|NCT00875420|588185007|FG004|Overall Study|Sponsor decision|0|||
162857962|NCT00875420|588185003|FG000|Overall Study|Withdrawal by Subject|0|||
162857963|NCT00875420|588185004|FG001|Overall Study|Withdrawal by Subject|0|||
162857964|NCT00875420|588185005|FG002|Overall Study|Withdrawal by Subject|1|||
162857965|NCT00875420|588185006|FG003|Overall Study|Withdrawal by Subject|0|||
162857966|NCT00875420|588185007|FG004|Overall Study|Withdrawal by Subject|0|||
162857967|NCT00914628|588185008|FG000|Overall Study|Death|35|||
162857968|NCT00914628|588185009|FG001|Overall Study|Death|17|||
162857969|NCT00914628|588185008|FG000|Overall Study|Medical decision|4|||
162857970|NCT00914628|588185009|FG001|Overall Study|Medical decision|0|||
162857971|NCT00914628|588185008|FG000|Overall Study|Protocol Violation|1|||
162857972|NCT00914628|588185009|FG001|Overall Study|Protocol Violation|0|||
162857973|NCT00914628|588185008|FG000|Overall Study|Lack of Efficacy|1|||
162857974|NCT00914628|588185009|FG001|Overall Study|Lack of Efficacy|0|||
162857975|NCT00914628|588185008|FG000|Overall Study|non-randomized|1|||
162857976|NCT00914628|588185009|FG001|Overall Study|non-randomized|0|||
162857977|NCT00914628|588185008|FG000|Overall Study|Relapse|1|||
162857978|NCT00914628|588185009|FG001|Overall Study|Relapse|2|||
162857979|NCT00914628|588185008|FG000|Overall Study|Study terminated by Sponsor|14|||
162857980|NCT00914628|588185009|FG001|Overall Study|Study terminated by Sponsor|8|||
162857981|NCT00914628|588185008|FG000|Overall Study|Patients who did not receive a single dose|7|||
163044736|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
162705107|NCT01244763|587632104|FG002|Overall Study|Adverse Event|0|||
162857982|NCT00914628|588185009|FG001|Overall Study|Patients who did not receive a single dose|1|||
162857983|NCT01756157|588185010|FG000|First Intervention Period|Withdrawal by Subject|1|||
162857984|NCT01756157|588185011|FG001|First Intervention Period|Withdrawal by Subject|0|||
162857985|NCT01756157|588185010|FG000|First Intervention Period|Lost to Follow-up|0|||
162857986|NCT01756157|588185011|FG001|First Intervention Period|Lost to Follow-up|2|||
162857987|NCT02799381|588185014|FG000|Overall Study|Withdrew consent|3|||
162857988|NCT02799381|588185015|FG001|Overall Study|Withdrew consent|2|||
162857989|NCT02799381|588185014|FG000|Overall Study|Adverse Event|0|||
162857990|NCT02799381|588185015|FG001|Overall Study|Adverse Event|1|||
162857991|NCT02799381|588185014|FG000|Overall Study|Participant did not take any study drug|1|||
162857992|NCT02799381|588185015|FG001|Overall Study|Participant did not take any study drug|0|||
162857993|NCT02698410|588185018|FG000|Overall Study|Adverse Event|2|||
162857994|NCT02698410|588185018|FG000|Overall Study|Withdrawal by Subject|1|||
162857995|NCT02698410|588185018|FG000|Overall Study|Other|1|||
162857996|NCT03952130|588185019|FG000|Overall Study|Adverse Event|0|||
162857997|NCT03952130|588185020|FG001|Overall Study|Adverse Event|1|||
162857998|NCT03952130|588185019|FG000|Overall Study|Lost to Follow-up|1|||
162857999|NCT03952130|588185020|FG001|Overall Study|Lost to Follow-up|0|||
162858000|NCT03952130|588185019|FG000|Overall Study|Withdrawal by Subject|1|||
162858001|NCT03952130|588185020|FG001|Overall Study|Withdrawal by Subject|5|||
162858002|NCT01713348|588185021|FG000|Overall Study|Withdrawal by Subject|3|||
162858003|NCT01713348|588185022|FG001|Overall Study|Withdrawal by Subject|2|||
162858004|NCT01713348|588185023|FG002|Overall Study|Withdrawal by Subject|2|||
162858005|NCT01713348|588185024|FG003|Overall Study|Withdrawal by Subject|0|||
162858006|NCT01713348|588185021|FG000|Overall Study|Lost to Follow-up|1|||
162858007|NCT01713348|588185022|FG001|Overall Study|Lost to Follow-up|0|||
162858008|NCT01713348|588185023|FG002|Overall Study|Lost to Follow-up|0|||
162858009|NCT01713348|588185024|FG003|Overall Study|Lost to Follow-up|0|||
162858010|NCT02638012|588185025|FG000|Overall Study|Lost to Follow-up|1|||
162858011|NCT00621023|588185026|FG000|Overall Study|Death|5|||
162858012|NCT00621023|588185026|FG000|Overall Study|Follow up discontinued|1|||
162858013|NCT03199911|588185033|FG000|Overall Study|Lost to Follow-up|5|||
162858014|NCT03199911|588185034|FG001|Overall Study|Lost to Follow-up|5|||
162858015|NCT03199911|588185033|FG000|Overall Study|Did not proceed with surgery|2|||
162858016|NCT03199911|588185034|FG001|Overall Study|Did not proceed with surgery|1|||
162858017|NCT04331899|588185035|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
162858018|NCT04331899|588185036|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
162858019|NCT01062399|588185039|FG000|Overall Study|Protocol Violation|0|||
162858020|NCT01062399|588185040|FG001|Overall Study|Protocol Violation|1|||
162858021|NCT01062399|588185041|FG002|Overall Study|Protocol Violation|0|||
162858022|NCT01062399|588185042|FG003|Overall Study|Protocol Violation|6|||
162858023|NCT01062399|588185043|FG004|Overall Study|Protocol Violation|4|||
162858024|NCT02424539|588185044|FG000|Overall Study|Adverse Event|0|||
162858025|NCT02424539|588185045|FG001|Overall Study|Adverse Event|0|||
162858026|NCT02424539|588185046|FG002|Overall Study|Adverse Event|1|||
162858027|NCT02424539|588185044|FG000|Overall Study|Physician Decision|0|||
162858028|NCT02424539|588185045|FG001|Overall Study|Physician Decision|0|||
162858029|NCT02424539|588185046|FG002|Overall Study|Physician Decision|1|||
162858030|NCT02424539|588185044|FG000|Overall Study|Withdrawal by Subject|3|||
162858031|NCT02424539|588185045|FG001|Overall Study|Withdrawal by Subject|1|||
162858032|NCT02424539|588185046|FG002|Overall Study|Withdrawal by Subject|0|||
162858033|NCT02424539|588185044|FG000|Overall Study|Other: Reached stopping criteria|11|||
162858034|NCT02424539|588185045|FG001|Overall Study|Other: Reached stopping criteria|7|||
162858035|NCT02424539|588185046|FG002|Overall Study|Other: Reached stopping criteria|6|||
162858036|NCT00813748|588185047|FG000|Skin Test Substudy|Physician Decision|0|||
162858037|NCT00813748|588185048|FG001|Skin Test Substudy|Physician Decision|1|||
162858038|NCT01829048|588185049|FG000|Overall Study|Withdrawal by Subject|0|||
162858039|NCT01829048|588185050|FG001|Overall Study|Withdrawal by Subject|0|||
162858040|NCT01829048|588185051|FG002|Overall Study|Withdrawal by Subject|0|||
162858041|NCT01829048|588185052|FG003|Overall Study|Withdrawal by Subject|2|||
162858042|NCT01829048|588185053|FG004|Overall Study|Withdrawal by Subject|0|||
162858043|NCT00504257|588185054|FG000|Overall Study|Withdrawal by Subject|2|||
162858044|NCT00504257|588185054|FG000|Overall Study|ineligible histology|2|||
162858045|NCT00500071|588185064|FG000|Screening and Washout Phase|Protocol Violation|1|||
162858046|NCT00500071|588185064|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
162858047|NCT00500071|588185064|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
162858048|NCT00500071|588185064|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
162858049|NCT00500071|588185064|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
162858050|NCT00500071|588185064|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
162858051|NCT00500071|588185064|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
162858052|NCT00424398|588185068|FG000|Overall Study|Withdrawal by Subject|2|||
162858053|NCT00424398|588185069|FG001|Overall Study|Withdrawal by Subject|1|||
162858054|NCT00424398|588185070|FG002|Overall Study|Withdrawal by Subject|0|||
162858055|NCT00424398|588185068|FG000|Overall Study|Subject met exclusion criteria|1|||
162858056|NCT00424398|588185069|FG001|Overall Study|Subject met exclusion criteria|0|||
162858057|NCT00424398|588185070|FG002|Overall Study|Subject met exclusion criteria|0|||
162858058|NCT01023789|588185071|FG000|3 - Year Visit|Death|29|||
162858059|NCT01023789|588185071|FG000|3 - Year Visit|Withdrawal of consent|1|||
162858060|NCT01023789|588185071|FG000|3 - Year Visit|Lost to Follow-up|13|||
162858061|NCT02115308|588185082|FG000|Overall Study|Safety Screening|2|||
162858062|NCT02115308|588185083|FG001|Overall Study|Safety Screening|2|||
162858063|NCT01309737|588185084|FG000|Week 0 to 16|Death|1|||
162858064|NCT01309737|588185085|FG001|Week 0 to 16|Death|0|||
162858065|NCT01309737|588185086|FG002|Week 0 to 16|Death|1|||
162858066|NCT01309737|588185087|FG003|Week 0 to 16|Death|0|||
162858067|NCT01309737|588185088|FG004|Week 0 to 16|Death|0|||
162858068|NCT01309737|588185084|FG000|Week 0 to 16|Adverse Event|11|||
162858069|NCT01309737|588185085|FG001|Week 0 to 16|Adverse Event|10|||
162858070|NCT01309737|588185086|FG002|Week 0 to 16|Adverse Event|5|||
162858071|NCT01309737|588185087|FG003|Week 0 to 16|Adverse Event|0|||
162858072|NCT01309737|588185088|FG004|Week 0 to 16|Adverse Event|0|||
162858073|NCT01309737|588185084|FG000|Week 0 to 16|Lack of Efficacy|15|||
162858074|NCT01309737|588185085|FG001|Week 0 to 16|Lack of Efficacy|2|||
162858075|NCT01309737|588185086|FG002|Week 0 to 16|Lack of Efficacy|24|||
162858076|NCT01309737|588185087|FG003|Week 0 to 16|Lack of Efficacy|0|||
162858077|NCT01309737|588185088|FG004|Week 0 to 16|Lack of Efficacy|0|||
162858078|NCT01309737|588185084|FG000|Week 0 to 16|Lost to Follow-up|7|||
162858079|NCT01309737|588185085|FG001|Week 0 to 16|Lost to Follow-up|8|||
162858080|NCT01309737|588185086|FG002|Week 0 to 16|Lost to Follow-up|3|||
162858081|NCT01309737|588185087|FG003|Week 0 to 16|Lost to Follow-up|0|||
162858082|NCT01309737|588185088|FG004|Week 0 to 16|Lost to Follow-up|0|||
162858083|NCT01309737|588185084|FG000|Week 0 to 16|Withdrawal by Subject|7|||
162858084|NCT01309737|588185085|FG001|Week 0 to 16|Withdrawal by Subject|6|||
162858085|NCT01309737|588185086|FG002|Week 0 to 16|Withdrawal by Subject|7|||
162858086|NCT01309737|588185087|FG003|Week 0 to 16|Withdrawal by Subject|0|||
162858087|NCT01309737|588185088|FG004|Week 0 to 16|Withdrawal by Subject|0|||
162858088|NCT01309737|588185084|FG000|Week 0 to 16|Other|10|||
162858089|NCT01309737|588185085|FG001|Week 0 to 16|Other|14|||
162858090|NCT01309737|588185086|FG002|Week 0 to 16|Other|4|||
162858091|NCT01309737|588185087|FG003|Week 0 to 16|Other|0|||
162858092|NCT01309737|588185088|FG004|Week 0 to 16|Other|0|||
162858093|NCT01309737|588185084|FG000|Week 0 to 16|Randomized, but not treated|1|||
162858094|NCT01309737|588185085|FG001|Week 0 to 16|Randomized, but not treated|0|||
162858095|NCT01309737|588185086|FG002|Week 0 to 16|Randomized, but not treated|0|||
162858096|NCT01309737|588185087|FG003|Week 0 to 16|Randomized, but not treated|0|||
162858097|NCT01309737|588185088|FG004|Week 0 to 16|Randomized, but not treated|0|||
162858098|NCT01309737|588185084|FG000|Week 16 to 52|Death|0|||
162858099|NCT01309737|588185085|FG001|Week 16 to 52|Death|0|||
162858100|NCT01309737|588185086|FG002|Week 16 to 52|Death|0|||
162858101|NCT01309737|588185087|FG003|Week 16 to 52|Death|0|||
162858102|NCT01309737|588185088|FG004|Week 16 to 52|Death|1|||
162858103|NCT01309737|588185084|FG000|Week 16 to 52|Adverse Event|7|||
162858104|NCT01309737|588185085|FG001|Week 16 to 52|Adverse Event|7|||
162858105|NCT01309737|588185086|FG002|Week 16 to 52|Adverse Event|0|||
162858106|NCT01309737|588185087|FG003|Week 16 to 52|Adverse Event|6|||
162858107|NCT01309737|588185088|FG004|Week 16 to 52|Adverse Event|5|||
162858108|NCT01309737|588185084|FG000|Week 16 to 52|Lack of Efficacy|107|||
162858109|NCT01309737|588185085|FG001|Week 16 to 52|Lack of Efficacy|76|||
162858110|NCT01309737|588185086|FG002|Week 16 to 52|Lack of Efficacy|0|||
162858111|NCT01309737|588185087|FG003|Week 16 to 52|Lack of Efficacy|25|||
162858112|NCT01309737|588185088|FG004|Week 16 to 52|Lack of Efficacy|21|||
162858113|NCT01309737|588185084|FG000|Week 16 to 52|Lost to Follow-up|4|||
162705108|NCT01244763|587632105|FG003|Overall Study|Adverse Event|0|||
162705109|NCT01244763|587632106|FG004|Overall Study|Adverse Event|0|||
162705110|NCT01244763|587632107|FG005|Overall Study|Adverse Event|1|||
162705111|NCT01244763|587632102|FG000|Overall Study|Death|1|||
162705112|NCT01244763|587632103|FG001|Overall Study|Death|0|||
162705113|NCT01244763|587632104|FG002|Overall Study|Death|1|||
162705114|NCT01244763|587632105|FG003|Overall Study|Death|0|||
162705115|NCT01244763|587632106|FG004|Overall Study|Death|2|||
162705116|NCT01244763|587632107|FG005|Overall Study|Death|0|||
162858114|NCT01309737|588185085|FG001|Week 16 to 52|Lost to Follow-up|2|||
162705117|NCT01244763|587632102|FG000|Overall Study|Physician Decision|0|||
162858115|NCT01309737|588185086|FG002|Week 16 to 52|Lost to Follow-up|0|||
162858116|NCT01309737|588185087|FG003|Week 16 to 52|Lost to Follow-up|1|||
162858117|NCT01309737|588185088|FG004|Week 16 to 52|Lost to Follow-up|4|||
162858118|NCT01309737|588185084|FG000|Week 16 to 52|Withdrawal by Subject|5|||
162858119|NCT01309737|588185085|FG001|Week 16 to 52|Withdrawal by Subject|6|||
162858120|NCT01309737|588185086|FG002|Week 16 to 52|Withdrawal by Subject|0|||
162858121|NCT01309737|588185087|FG003|Week 16 to 52|Withdrawal by Subject|0|||
162858122|NCT01309737|588185088|FG004|Week 16 to 52|Withdrawal by Subject|2|||
162705118|NCT01244763|587632103|FG001|Overall Study|Physician Decision|0|||
162705119|NCT01244763|587632104|FG002|Overall Study|Physician Decision|1|||
162705120|NCT01244763|587632105|FG003|Overall Study|Physician Decision|0|||
162858123|NCT01309737|588185084|FG000|Week 16 to 52|Other|10|||
162858124|NCT01309737|588185085|FG001|Week 16 to 52|Other|12|||
162858125|NCT01309737|588185086|FG002|Week 16 to 52|Other|0|||
162858126|NCT01309737|588185087|FG003|Week 16 to 52|Other|2|||
162858127|NCT01309737|588185088|FG004|Week 16 to 52|Other|0|||
162858128|NCT01442181|588185090|FG000|Overall Study|patient refused surgery|1|||
162858129|NCT01442181|588185091|FG001|Overall Study|patient refused surgery|0|||
162858130|NCT01442181|588185090|FG000|Overall Study|no insurance for surgery|1|||
162858131|NCT01442181|588185091|FG001|Overall Study|no insurance for surgery|0|||
162858132|NCT01442181|588185090|FG000|Overall Study|low ejection factor|0|||
162858133|NCT01442181|588185091|FG001|Overall Study|low ejection factor|1|||
162858134|NCT01442181|588185090|FG000|Overall Study|Lost to Follow-up|1|||
162858135|NCT01442181|588185091|FG001|Overall Study|Lost to Follow-up|1|||
162858136|NCT01442181|588185090|FG000|Overall Study|patient in an additional study|1|||
162858137|NCT01442181|588185091|FG001|Overall Study|patient in an additional study|0|||
162858138|NCT01442181|588185090|FG000|Overall Study|atrial fibrillation not noted|0|||
162858139|NCT01442181|588185091|FG001|Overall Study|atrial fibrillation not noted|1|||
162858140|NCT00749203|588185092|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
162858141|NCT00749203|588185093|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
162858142|NCT00749203|588185092|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
162858143|NCT00749203|588185093|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
162858144|NCT00749203|588185092|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
162858145|NCT00749203|588185093|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
162858146|NCT00749203|588185092|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
162858147|NCT00749203|588185093|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
162858148|NCT00749203|588185092|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
162858149|NCT00749203|588185093|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
162858150|NCT00749203|588185092|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
162858151|NCT00749203|588185093|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
162858152|NCT02034123|588185094|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858153|NCT02034123|588185095|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858154|NCT02034123|588185096|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858155|NCT02034123|588185097|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858156|NCT02034123|588185098|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
162858157|NCT02034123|588185099|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858158|NCT02034123|588185100|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858159|NCT02034123|588185101|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
162858160|NCT02034123|588185102|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
162858161|NCT02034123|588185103|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858162|NCT02034123|588185104|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858163|NCT02034123|588185105|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858164|NCT02034123|588185106|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858165|NCT02034123|588185107|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858166|NCT02034123|588185108|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858167|NCT02034123|588185109|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858168|NCT02034123|588185110|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858169|NCT02034123|588185111|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
162858170|NCT02034123|588185094|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858171|NCT02034123|588185095|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858172|NCT02034123|588185096|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858173|NCT02034123|588185097|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
162858174|NCT02034123|588185098|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858175|NCT02034123|588185099|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858176|NCT02034123|588185100|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858177|NCT02034123|588185101|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858178|NCT02034123|588185102|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858179|NCT02034123|588185103|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858180|NCT02034123|588185104|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858181|NCT02034123|588185105|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858182|NCT02034123|588185106|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858183|NCT02034123|588185107|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858184|NCT02034123|588185108|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858185|NCT02034123|588185109|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858186|NCT02034123|588185110|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858187|NCT02034123|588185111|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
162858188|NCT02034123|588185094|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858189|NCT02034123|588185095|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858190|NCT02034123|588185096|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858191|NCT02034123|588185097|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858192|NCT02034123|588185098|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858193|NCT02034123|588185099|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858194|NCT02034123|588185100|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858195|NCT02034123|588185101|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858196|NCT02034123|588185102|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
162858197|NCT02034123|588185103|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858198|NCT02034123|588185104|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858199|NCT02034123|588185105|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858200|NCT02034123|588185106|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858201|NCT02034123|588185107|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858202|NCT02034123|588185108|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858203|NCT02034123|588185109|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858204|NCT02034123|588185110|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858205|NCT02034123|588185111|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
162858206|NCT02034123|588185094|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858207|NCT02034123|588185095|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858208|NCT02034123|588185096|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858209|NCT02034123|588185097|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
162858210|NCT02034123|588185098|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
162858211|NCT02034123|588185099|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858212|NCT02034123|588185100|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858213|NCT02034123|588185101|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858214|NCT02034123|588185102|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858215|NCT02034123|588185103|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858216|NCT02034123|588185104|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858217|NCT02034123|588185105|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858218|NCT02034123|588185106|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858219|NCT02034123|588185107|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858220|NCT02034123|588185108|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858221|NCT02034123|588185109|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858222|NCT02034123|588185110|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858223|NCT02034123|588185111|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
162858224|NCT04233424|588185112|FG000|Overall Study|Death|15|||
162858225|NCT04233424|588185113|FG001|Overall Study|Death|16|||
162858226|NCT04233424|588185112|FG000|Overall Study|Withdrawal by Subject|2|||
162858227|NCT04233424|588185113|FG001|Overall Study|Withdrawal by Subject|8|||
162858228|NCT04233424|588185112|FG000|Overall Study|Physician Decision|1|||
162858229|NCT04233424|588185113|FG001|Overall Study|Physician Decision|3|||
162858230|NCT04233424|588185112|FG000|Overall Study|Protocol Violation|3|||
162858231|NCT04233424|588185113|FG001|Overall Study|Protocol Violation|1|||
162858232|NCT04233424|588185112|FG000|Overall Study|Lost to Follow-up|1|||
162858233|NCT04233424|588185113|FG001|Overall Study|Lost to Follow-up|3|||
162858234|NCT04233424|588185112|FG000|Overall Study|subject refuse to visit site|2|||
162858235|NCT04233424|588185113|FG001|Overall Study|subject refuse to visit site|0|||
162956230|NCT02648438|588541433|FG001|Overall Study|Withdrawal by Subject|1|||
162858236|NCT02698189|588185114|FG000|Overall Study|Physician Decision|3|||
162858237|NCT02698189|588185115|FG001|Overall Study|Physician Decision|0|||
162858238|NCT02698189|588185114|FG000|Overall Study|Progressive disease|0|||
162858239|NCT02698189|588185115|FG001|Overall Study|Progressive disease|5|||
162858240|NCT02698189|588185114|FG000|Overall Study|Study terminated by sponsor|0|||
162858241|NCT02698189|588185115|FG001|Overall Study|Study terminated by sponsor|1|||
162858242|NCT02240706|588185116|FG000|Overall Study|Lack of Efficacy|2|||
162858243|NCT02240706|588185117|FG001|Overall Study|Lack of Efficacy|2|||
162858244|NCT02240706|588185118|FG002|Overall Study|Lack of Efficacy|2|||
162858245|NCT02240706|588185119|FG003|Overall Study|Lack of Efficacy|2|||
162858246|NCT02240706|588185120|FG004|Overall Study|Lack of Efficacy|5|||
162858247|NCT02240706|588185121|FG005|Overall Study|Lack of Efficacy|0|||
162858248|NCT02240706|588185122|FG006|Overall Study|Lack of Efficacy|0|||
162858249|NCT02240706|588185116|FG000|Overall Study|Adverse Event|1|||
162858250|NCT02240706|588185117|FG001|Overall Study|Adverse Event|0|||
162858251|NCT02240706|588185118|FG002|Overall Study|Adverse Event|1|||
162858252|NCT02240706|588185119|FG003|Overall Study|Adverse Event|0|||
162858253|NCT02240706|588185120|FG004|Overall Study|Adverse Event|2|||
162858254|NCT02240706|588185121|FG005|Overall Study|Adverse Event|0|||
162858255|NCT02240706|588185122|FG006|Overall Study|Adverse Event|0|||
162858256|NCT02240706|588185116|FG000|Overall Study|Progressive disease|0|||
162858257|NCT02240706|588185117|FG001|Overall Study|Progressive disease|0|||
162858258|NCT02240706|588185118|FG002|Overall Study|Progressive disease|0|||
162858259|NCT02240706|588185119|FG003|Overall Study|Progressive disease|0|||
162858260|NCT02240706|588185120|FG004|Overall Study|Progressive disease|1|||
162858261|NCT02240706|588185121|FG005|Overall Study|Progressive disease|0|||
162858262|NCT02240706|588185122|FG006|Overall Study|Progressive disease|0|||
162858263|NCT02240706|588185116|FG000|Overall Study|Dose limiting toxicity|0|||
162858264|NCT02240706|588185117|FG001|Overall Study|Dose limiting toxicity|0|||
162858265|NCT02240706|588185118|FG002|Overall Study|Dose limiting toxicity|0|||
162858266|NCT02240706|588185119|FG003|Overall Study|Dose limiting toxicity|0|||
162858267|NCT02240706|588185120|FG004|Overall Study|Dose limiting toxicity|1|||
162858268|NCT02240706|588185121|FG005|Overall Study|Dose limiting toxicity|0|||
162858269|NCT02240706|588185122|FG006|Overall Study|Dose limiting toxicity|0|||
162858270|NCT02240706|588185116|FG000|Overall Study|Refused to continue taking medication|0|||
162858271|NCT02240706|588185117|FG001|Overall Study|Refused to continue taking medication|1|||
162858272|NCT02240706|588185118|FG002|Overall Study|Refused to continue taking medication|3|||
162858273|NCT02240706|588185119|FG003|Overall Study|Refused to continue taking medication|1|||
162858274|NCT02240706|588185120|FG004|Overall Study|Refused to continue taking medication|2|||
162858275|NCT02240706|588185121|FG005|Overall Study|Refused to continue taking medication|0|||
162858276|NCT02240706|588185122|FG006|Overall Study|Refused to continue taking medication|0|||
162705121|NCT01244763|587632106|FG004|Overall Study|Physician Decision|0|||
162705122|NCT01244763|587632107|FG005|Overall Study|Physician Decision|0|||
162705123|NCT01244763|587632102|FG000|Overall Study|Withdrawal by Subject|1|||
162705124|NCT01244763|587632103|FG001|Overall Study|Withdrawal by Subject|2|||
162705125|NCT01244763|587632104|FG002|Overall Study|Withdrawal by Subject|0|||
162705126|NCT01244763|587632105|FG003|Overall Study|Withdrawal by Subject|1|||
162858277|NCT02240706|588185116|FG000|Overall Study|Insurance billing concerns|0|||
162858278|NCT02240706|588185117|FG001|Overall Study|Insurance billing concerns|0|||
162858279|NCT02240706|588185118|FG002|Overall Study|Insurance billing concerns|0|||
162858280|NCT02240706|588185119|FG003|Overall Study|Insurance billing concerns|1|||
162858281|NCT02240706|588185120|FG004|Overall Study|Insurance billing concerns|0|||
162858282|NCT02240706|588185121|FG005|Overall Study|Insurance billing concerns|0|||
162858283|NCT02240706|588185122|FG006|Overall Study|Insurance billing concerns|0|||
162858284|NCT00855439|588185127|FG000|Overall Study|Withdrawal by Subject|2|||
162858285|NCT00855439|588185128|FG001|Overall Study|Withdrawal by Subject|0|||
162858286|NCT00855439|588185127|FG000|Overall Study|Pregnancy|1|||
162858287|NCT00855439|588185128|FG001|Overall Study|Pregnancy|0|||
162705127|NCT01244763|587632106|FG004|Overall Study|Withdrawal by Subject|1|||
162858288|NCT05502289|588185129|FG000|Period 1|Out Of Window|1|||
162858289|NCT05502289|588185130|FG001|Period 1|Out Of Window|0|||
162858290|NCT02333227|588185136|FG000|Overall Study|Lost to Follow-up|137|||
162858291|NCT02333227|588185137|FG001|Overall Study|Lost to Follow-up|106|||
162705128|NCT01244763|587632107|FG005|Overall Study|Withdrawal by Subject|2|||
162705129|NCT01244763|587632102|FG000|Overall Study|Lost to Follow-up|0|||
162858292|NCT02333227|588185136|FG000|Overall Study|Pregnancy Interrupted|42|||
162858293|NCT02333227|588185137|FG001|Overall Study|Pregnancy Interrupted|89|||
162858294|NCT02333227|588185136|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
162858295|NCT02333227|588185137|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
162858296|NCT03459040|588185138|FG000|Overall Study|Death|8|||
162858297|NCT03459040|588185138|FG000|Overall Study|Withdrawal by Subject|1|||
162858298|NCT01073943|588185143|FG000|Overall Study|Withdrawal by Subject|8|||
162858299|NCT01073943|588185144|FG001|Overall Study|Withdrawal by Subject|2|||
162858300|NCT01073943|588185143|FG000|Overall Study|Protocol Violation|2|||
162858301|NCT01073943|588185144|FG001|Overall Study|Protocol Violation|1|||
162858302|NCT01073943|588185143|FG000|Overall Study|Adverse Event|1|||
162858303|NCT01073943|588185144|FG001|Overall Study|Adverse Event|1|||
162858304|NCT01073943|588185143|FG000|Overall Study|Lost to Follow-up|0|||
162858305|NCT01073943|588185144|FG001|Overall Study|Lost to Follow-up|2|||
162858306|NCT01073943|588185143|FG000|Overall Study|Power outage; colonoscopy not done|1|||
162858307|NCT01073943|588185144|FG001|Overall Study|Power outage; colonoscopy not done|0|||
162858308|NCT01073943|588185143|FG000|Overall Study|Subject forgot|0|||
162858309|NCT01073943|588185144|FG001|Overall Study|Subject forgot|1|||
162858310|NCT01073943|588185143|FG000|Overall Study|Unable to return for follow-up|0|||
162858311|NCT01073943|588185144|FG001|Overall Study|Unable to return for follow-up|1|||
162858312|NCT01073943|588185143|FG000|Overall Study|Could not tolerate prep|1|||
162858313|NCT01073943|588185144|FG001|Overall Study|Could not tolerate prep|0|||
162858314|NCT00761215|588185145|FG000|Overall Study|Randomized but didn't receive drug|1|||
162858315|NCT00761215|588185146|FG001|Overall Study|Randomized but didn't receive drug|1|||
162858316|NCT00761215|588185147|FG002|Overall Study|Randomized but didn't receive drug|2|||
162858317|NCT00761215|588185145|FG000|Overall Study|Lost to Follow-up|6|||
162858318|NCT00761215|588185146|FG001|Overall Study|Lost to Follow-up|3|||
162858319|NCT00761215|588185147|FG002|Overall Study|Lost to Follow-up|6|||
162858320|NCT00761215|588185145|FG000|Overall Study|Withdrawal by Subject|1|||
162858321|NCT00761215|588185146|FG001|Overall Study|Withdrawal by Subject|0|||
162858322|NCT00761215|588185147|FG002|Overall Study|Withdrawal by Subject|0|||
162858323|NCT00761215|588185145|FG000|Overall Study|Bacteremia|1|||
162858324|NCT00761215|588185146|FG001|Overall Study|Bacteremia|0|||
162858325|NCT00761215|588185147|FG002|Overall Study|Bacteremia|0|||
162858326|NCT05662332|588185148|FG000|Overall Study|Death|3|||
162858327|NCT05662332|588185149|FG001|Overall Study|Death|3|||
162612180|NCT04597918|587296813|FG000|Overall Study|Withdrawal by Subject|6|||
162858328|NCT05662332|588185148|FG000|Overall Study|Lost to Follow-up|3|||
162858329|NCT05662332|588185149|FG001|Overall Study|Lost to Follow-up|8|||
162612181|NCT04597918|587296813|FG000|Overall Study|Lost to Follow-up|3|||
162612182|NCT04597918|587296813|FG000|Overall Study|Death|1|||
162858330|NCT05662332|588185148|FG000|Overall Study|Physician Decision|1|||
162858331|NCT05662332|588185149|FG001|Overall Study|Physician Decision|2|||
162858332|NCT05662332|588185148|FG000|Overall Study|Protocol Deviation|2|||
162858333|NCT05662332|588185149|FG001|Overall Study|Protocol Deviation|1|||
162858334|NCT05662332|588185148|FG000|Overall Study|Withdrawal by Subject|14|||
162612183|NCT04041700|587296820|FG000|Overall Study|Pregnancy|1|||
162612184|NCT04041700|587296820|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
162612185|NCT05419908|587296821|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
162612186|NCT05419908|587296822|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
162612187|NCT05419908|587296821|FG000|Overall Study|Serious Adverse Event|0|||
162858335|NCT05662332|588185149|FG001|Overall Study|Withdrawal by Subject|14|||
162858336|NCT05662332|588185148|FG000|Overall Study|Assigned Treatment by Mistake|5|||
162858337|NCT05662332|588185149|FG001|Overall Study|Assigned Treatment by Mistake|7|||
162858338|NCT05662332|588185148|FG000|Overall Study|Non-compliance with study drug|4|||
162858339|NCT05662332|588185149|FG001|Overall Study|Non-compliance with study drug|1|||
162858340|NCT05662332|588185148|FG000|Overall Study|Due to Bariatric surgery|1|||
162858341|NCT05662332|588185149|FG001|Overall Study|Due to Bariatric surgery|0|||
162858342|NCT05662332|588185148|FG000|Overall Study|Subject Moving out of State|0|||
162612188|NCT05419908|587296822|FG001|Overall Study|Serious Adverse Event|2|||
162858343|NCT05662332|588185149|FG001|Overall Study|Subject Moving out of State|1|||
162858344|NCT05662332|588185148|FG000|Overall Study|Subject Missed the Schedule|1|||
162858345|NCT05662332|588185149|FG001|Overall Study|Subject Missed the Schedule|0|||
162858346|NCT05662332|588185148|FG000|Overall Study|The Patient Moved to Another City|1|||
162858347|NCT05662332|588185149|FG001|Overall Study|The Patient Moved to Another City|0|||
162858348|NCT01914679|588185150|FG000|Overall Study|Lack of Efficacy|1|||
162858349|NCT01914679|588185150|FG000|Overall Study|Sponsor terminated study|4|||
162858350|NCT00256295|588185151|FG000|Overall Study|Withdrawal by Subject|3|||
162858351|NCT00256295|588185151|FG000|Overall Study|Death|1|||
162858352|NCT00947349|588185152|FG000|Triple Treatment Combination Period|Adverse Event|0|||
162858353|NCT00947349|588185153|FG001|Triple Treatment Combination Period|Adverse Event|1|||
162612189|NCT05419908|587296821|FG000|Overall Study|Withdrawal by Subject|2|||
162612190|NCT05419908|587296822|FG001|Overall Study|Withdrawal by Subject|0|||
162858354|NCT00947349|588185154|FG002|Triple Treatment Combination Period|Adverse Event|0|||
162858355|NCT00947349|588185155|FG003|Triple Treatment Combination Period|Adverse Event|0|||
162858356|NCT00947349|588185152|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
162858357|NCT00947349|588185153|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
162858358|NCT00947349|588185154|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
162858359|NCT00947349|588185155|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
162858360|NCT00947349|588185152|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
162858361|NCT00947349|588185153|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
162858362|NCT00947349|588185154|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
162858363|NCT00947349|588185155|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
162858364|NCT00947349|588185152|FG000|Overall Study Standard of Care|Other|0|||
162858365|NCT00947349|588185153|FG001|Overall Study Standard of Care|Other|0|||
162858366|NCT00947349|588185154|FG002|Overall Study Standard of Care|Other|0|||
162858367|NCT00947349|588185155|FG003|Overall Study Standard of Care|Other|1|||
162858368|NCT00538681|588185156|FG000|Overall Study|Progressive Disease|7|||
162858369|NCT00538681|588185157|FG001|Overall Study|Progressive Disease|0|||
162858370|NCT00538681|588185158|FG002|Overall Study|Progressive Disease|1|||
162858371|NCT00538681|588185159|FG003|Overall Study|Progressive Disease|0|||
162858372|NCT00538681|588185156|FG000|Overall Study|Sponsor Decision|1|||
162858373|NCT00538681|588185157|FG001|Overall Study|Sponsor Decision|3|||
162858374|NCT00538681|588185158|FG002|Overall Study|Sponsor Decision|8|||
162858375|NCT00538681|588185159|FG003|Overall Study|Sponsor Decision|9|||
163044737|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
162858376|NCT00538681|588185156|FG000|Overall Study|Adverse Event|1|||
162858377|NCT00538681|588185157|FG001|Overall Study|Adverse Event|1|||
162858378|NCT00538681|588185158|FG002|Overall Study|Adverse Event|1|||
162858379|NCT00538681|588185159|FG003|Overall Study|Adverse Event|0|||
163044738|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044739|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044740|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044741|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044742|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044743|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044744|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
163044745|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
162612191|NCT05419908|587296821|FG000|Overall Study|Miscellaneous|1|||
162858380|NCT00538681|588185156|FG000|Overall Study|Death|0|||
162858381|NCT00538681|588185157|FG001|Overall Study|Death|0|||
162858382|NCT00538681|588185158|FG002|Overall Study|Death|1|||
162858383|NCT00538681|588185159|FG003|Overall Study|Death|1|||
162858384|NCT00538681|588185156|FG000|Overall Study|Investigator Decision|0|||
162858385|NCT00538681|588185157|FG001|Overall Study|Investigator Decision|0|||
162858386|NCT00538681|588185158|FG002|Overall Study|Investigator Decision|0|||
162858387|NCT00538681|588185159|FG003|Overall Study|Investigator Decision|1|||
162858388|NCT05369806|588185160|FG000|Overall Study|Lost to Follow-up|1|||
162858389|NCT00628355|588185161|FG000|Overall Study|Withdrawal by Subject|1|||
162858390|NCT00628355|588185162|FG001|Overall Study|Withdrawal by Subject|1|||
162858391|NCT01446809|588185164|FG000|Overall Study|Adverse Event|0|||
162858392|NCT01446809|588185165|FG001|Overall Study|Adverse Event|0|||
162858393|NCT01446809|588185166|FG002|Overall Study|Adverse Event|1|||
162858394|NCT01446809|588185164|FG000|Overall Study|Failure to complete study procedures|0|||
162858395|NCT01446809|588185165|FG001|Overall Study|Failure to complete study procedures|0|||
162858396|NCT01446809|588185166|FG002|Overall Study|Failure to complete study procedures|1|||
162858397|NCT01331161|588185167|FG000|Overall Study|Physician Decision|1|||
162858398|NCT01331161|588185168|FG001|Overall Study|Physician Decision|0|||
162858399|NCT01331161|588185167|FG000|Overall Study|Lost to Follow-up|0|||
162858400|NCT01331161|588185168|FG001|Overall Study|Lost to Follow-up|1|||
162858401|NCT01331161|588185167|FG000|Overall Study|Pregnancy|0|||
162858402|NCT01331161|588185168|FG001|Overall Study|Pregnancy|1|||
163044746|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044747|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044748|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
162612192|NCT05419908|587296822|FG001|Overall Study|Miscellaneous|1|||
162612193|NCT00423722|587298254|FG000|Overall Study|Death|4|||
162612194|NCT00423722|587298255|FG001|Overall Study|Death|4|||
162612195|NCT00423722|587298254|FG000|Overall Study|Declined to participate|2|||
162612196|NCT00423722|587298255|FG001|Overall Study|Declined to participate|3|||
162612197|NCT00423722|587298254|FG000|Overall Study|Unable to complete questionnaires|4|||
162858403|NCT05738486|588187467|FG000|Overall Study|Continuing Study|194|||
163044749|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
162612198|NCT00423722|587298255|FG001|Overall Study|Unable to complete questionnaires|4|||
162858404|NCT05738486|588187468|FG001|Overall Study|Continuing Study|196|||
162858405|NCT05738486|588187469|FG002|Overall Study|Continuing Study|193|||
162858406|NCT05738486|588187470|FG003|Overall Study|Continuing Study|191|||
162858407|NCT05738486|588187467|FG000|Overall Study|Withdrawal by Subject|8|||
162858408|NCT05738486|588187468|FG001|Overall Study|Withdrawal by Subject|5|||
162612199|NCT00423722|587298254|FG000|Overall Study|Withdrawal by Subject|4|||
162858409|NCT05738486|588187469|FG002|Overall Study|Withdrawal by Subject|7|||
162858410|NCT05738486|588187470|FG003|Overall Study|Withdrawal by Subject|13|||
162858411|NCT05738486|588187467|FG000|Overall Study|Adverse Event|4|||
162858412|NCT05738486|588187468|FG001|Overall Study|Adverse Event|6|||
162858413|NCT05738486|588187469|FG002|Overall Study|Adverse Event|4|||
162858414|NCT05738486|588187470|FG003|Overall Study|Adverse Event|5|||
162858415|NCT05738486|588187467|FG000|Overall Study|Physician Decision|0|||
162858416|NCT05738486|588187468|FG001|Overall Study|Physician Decision|2|||
162858417|NCT05738486|588187469|FG002|Overall Study|Physician Decision|4|||
162858418|NCT05738486|588187470|FG003|Overall Study|Physician Decision|1|||
162858419|NCT05738486|588187467|FG000|Overall Study|Lost to Follow-up|1|||
162858420|NCT05738486|588187468|FG001|Overall Study|Lost to Follow-up|1|||
162858421|NCT05738486|588187469|FG002|Overall Study|Lost to Follow-up|2|||
162858422|NCT05738486|588187470|FG003|Overall Study|Lost to Follow-up|1|||
162858423|NCT05738486|588187467|FG000|Overall Study|Participant was Non-ambulatory|0|||
162858424|NCT05738486|588187468|FG001|Overall Study|Participant was Non-ambulatory|0|||
162858425|NCT05738486|588187469|FG002|Overall Study|Participant was Non-ambulatory|1|||
162858426|NCT05738486|588187470|FG003|Overall Study|Participant was Non-ambulatory|0|||
162858427|NCT05738486|588187467|FG000|Overall Study|Participant had Poor Venous Access|0|||
162858428|NCT05738486|588187468|FG001|Overall Study|Participant had Poor Venous Access|0|||
162858429|NCT05738486|588187469|FG002|Overall Study|Participant had Poor Venous Access|0|||
162858430|NCT05738486|588187470|FG003|Overall Study|Participant had Poor Venous Access|1|||
162858431|NCT05738486|588187467|FG000|Overall Study|Assigned Treatment by Mistake|0|||
162858432|NCT05738486|588187468|FG001|Overall Study|Assigned Treatment by Mistake|0|||
162858433|NCT05738486|588187469|FG002|Overall Study|Assigned Treatment by Mistake|0|||
162858434|NCT05738486|588187470|FG003|Overall Study|Assigned Treatment by Mistake|1|||
162858435|NCT05738486|588187467|FG000|Overall Study|Death|0|||
162858436|NCT05738486|588187468|FG001|Overall Study|Death|0|||
162858437|NCT05738486|588187469|FG002|Overall Study|Death|1|||
162858438|NCT05738486|588187470|FG003|Overall Study|Death|0|||
162858439|NCT05738486|588187467|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
162858440|NCT05738486|588187468|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
162858441|NCT05738486|588187469|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
162858442|NCT05738486|588187470|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
162858443|NCT02017444|588187474|FG000|Overall Study|Physician Decision|1|||
162858444|NCT02017444|588187475|FG001|Overall Study|Physician Decision|0|||
162858445|NCT02017444|588187474|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
162858446|NCT02017444|588187475|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
162858447|NCT00886821|588187476|FG000|Stage 2|Adverse Event|0|||
162858448|NCT00886821|588187477|FG001|Stage 2|Adverse Event|0|||
162858449|NCT00886821|588187478|FG002|Stage 2|Adverse Event|0|||
162858450|NCT00886821|588187479|FG003|Stage 2|Adverse Event|0|||
162858451|NCT00886821|588187480|FG004|Stage 2|Adverse Event|0|||
162858452|NCT00886821|588187481|FG005|Stage 2|Adverse Event|0|||
162858453|NCT00886821|588187482|FG006|Stage 2|Adverse Event|0|||
162858454|NCT00886821|588187483|FG007|Stage 2|Adverse Event|0|||
162858455|NCT00886821|588187484|FG008|Stage 2|Adverse Event|0|||
162858456|NCT00886821|588187485|FG009|Stage 2|Adverse Event|0|||
162858457|NCT00886821|588187486|FG010|Stage 2|Adverse Event|0|||
162858458|NCT00886821|588187487|FG011|Stage 2|Adverse Event|1|||
162858459|NCT00886821|588187488|FG012|Stage 2|Adverse Event|3|||
162858460|NCT00886821|588187489|FG013|Stage 2|Adverse Event|0|||
162858461|NCT00886821|588187476|FG000|Stage 2|Lost to Follow-up|0|||
162858462|NCT00886821|588187477|FG001|Stage 2|Lost to Follow-up|0|||
162858463|NCT00886821|588187478|FG002|Stage 2|Lost to Follow-up|0|||
162858464|NCT00886821|588187479|FG003|Stage 2|Lost to Follow-up|0|||
162858465|NCT00886821|588187480|FG004|Stage 2|Lost to Follow-up|0|||
162858466|NCT00886821|588187481|FG005|Stage 2|Lost to Follow-up|0|||
162858467|NCT00886821|588187482|FG006|Stage 2|Lost to Follow-up|0|||
162858468|NCT00886821|588187483|FG007|Stage 2|Lost to Follow-up|0|||
162858469|NCT00886821|588187484|FG008|Stage 2|Lost to Follow-up|0|||
162858470|NCT00886821|588187485|FG009|Stage 2|Lost to Follow-up|0|||
162858471|NCT00886821|588187486|FG010|Stage 2|Lost to Follow-up|0|||
162858472|NCT00886821|588187487|FG011|Stage 2|Lost to Follow-up|0|||
162858473|NCT00886821|588187488|FG012|Stage 2|Lost to Follow-up|2|||
162858474|NCT00886821|588187489|FG013|Stage 2|Lost to Follow-up|1|||
162858475|NCT03716726|588187490|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
162858476|NCT03716726|588187491|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
162858477|NCT03716726|588187490|FG000|12 Months Followup|Lost to Follow-up|10|||
162858478|NCT03716726|588187491|FG001|12 Months Followup|Lost to Follow-up|17|||
162858479|NCT02579603|588187492|FG000|Overall Study|Not treated|1|||
162858480|NCT02579603|588187493|FG001|Overall Study|Not treated|0|||
162858481|NCT02579603|588187492|FG000|Overall Study|Adverse Event|2|||
162858482|NCT02579603|588187493|FG001|Overall Study|Adverse Event|2|||
162858483|NCT02579603|588187492|FG000|Overall Study|Other than stated|1|||
162858484|NCT02579603|588187493|FG001|Overall Study|Other than stated|0|||
162858485|NCT00469079|588187494|FG000|Overall Study|Lack of Efficacy|3|||
162858486|NCT00469079|588187495|FG001|Overall Study|Lack of Efficacy|8|||
162858487|NCT00469079|588187496|FG002|Overall Study|Lack of Efficacy|5|||
162858488|NCT00469079|588187494|FG000|Overall Study|Adverse Event|1|||
162858489|NCT00469079|588187495|FG001|Overall Study|Adverse Event|3|||
162858490|NCT00469079|588187496|FG002|Overall Study|Adverse Event|2|||
162858491|NCT00469079|588187494|FG000|Overall Study|Lost to Follow-up|4|||
162858492|NCT00469079|588187495|FG001|Overall Study|Lost to Follow-up|8|||
162858493|NCT00469079|588187496|FG002|Overall Study|Lost to Follow-up|10|||
162858494|NCT00469079|588187494|FG000|Overall Study|Withdrawal by Subject|1|||
162858495|NCT00469079|588187495|FG001|Overall Study|Withdrawal by Subject|2|||
162858496|NCT00469079|588187496|FG002|Overall Study|Withdrawal by Subject|2|||
162858497|NCT00469079|588187494|FG000|Overall Study|Ineligible|0|||
162858498|NCT00469079|588187495|FG001|Overall Study|Ineligible|1|||
162858499|NCT00469079|588187496|FG002|Overall Study|Ineligible|0|||
162858500|NCT00942162|588187497|FG000|Overall Study|Death|45|||
162858501|NCT00942162|588187498|FG001|Overall Study|Death|35|||
162858502|NCT00942162|588187499|FG002|Overall Study|Death|0|||
162858503|NCT00942162|588187497|FG000|Overall Study|Withdrawal by Subject|7|||
162858504|NCT00942162|588187498|FG001|Overall Study|Withdrawal by Subject|2|||
162858505|NCT00942162|588187499|FG002|Overall Study|Withdrawal by Subject|0|||
162858506|NCT00942162|588187497|FG000|Overall Study|Lost to Follow-up|4|||
162858507|NCT00942162|588187498|FG001|Overall Study|Lost to Follow-up|0|||
162858508|NCT00942162|588187499|FG002|Overall Study|Lost to Follow-up|0|||
162858509|NCT00942162|588187497|FG000|Overall Study|Other|14|||
162858510|NCT00942162|588187498|FG001|Overall Study|Other|13|||
162858511|NCT00942162|588187499|FG002|Overall Study|Other|2|||
162858512|NCT04419506|588187502|FG000|Overall Study|Adverse Event|0|||
162858513|NCT04419506|588187503|FG001|Overall Study|Adverse Event|10|||
162858514|NCT04419506|588187504|FG002|Overall Study|Adverse Event|0|||
162858515|NCT04419506|588187505|FG003|Overall Study|Adverse Event|3|||
162858516|NCT04419506|588187502|FG000|Overall Study|Withdrawal by Subject|0|||
162858517|NCT04419506|588187503|FG001|Overall Study|Withdrawal by Subject|0|||
162858518|NCT04419506|588187504|FG002|Overall Study|Withdrawal by Subject|0|||
162858519|NCT04419506|588187505|FG003|Overall Study|Withdrawal by Subject|1|||
162858520|NCT04419506|588187502|FG000|Overall Study|poor-compliance|0|||
162858521|NCT04419506|588187503|FG001|Overall Study|poor-compliance|0|||
162858522|NCT04419506|588187504|FG002|Overall Study|poor-compliance|0|||
162858523|NCT04419506|588187505|FG003|Overall Study|poor-compliance|1|||
162858524|NCT04329949|588187506|FG000|Overall Study|Death|36|||
162858525|NCT04329949|588187506|FG000|Overall Study|Withdrawal by Subject|4|||
162858526|NCT04329949|588187506|FG000|Overall Study|Termination of study by sponsor|3|||
162858527|NCT04645797|588187507|FG000|Overall Study|Disease Progression|3|||
162858528|NCT04645797|588187508|FG001|Overall Study|Disease Progression|3|||
162858529|NCT04645797|588187509|FG002|Overall Study|Disease Progression|1|||
162858530|NCT04645797|588187510|FG003|Overall Study|Disease Progression|0|||
162858531|NCT04645797|588187511|FG004|Overall Study|Disease Progression|0|||
162858532|NCT04645797|588187512|FG005|Overall Study|Disease Progression|0|||
162858533|NCT04645797|588187513|FG006|Overall Study|Disease Progression|0|||
162858534|NCT04645797|588187507|FG000|Overall Study|Death|3|||
162858535|NCT04645797|588187508|FG001|Overall Study|Death|1|||
162858536|NCT04645797|588187509|FG002|Overall Study|Death|0|||
162858537|NCT04645797|588187510|FG003|Overall Study|Death|0|||
162858538|NCT04645797|588187511|FG004|Overall Study|Death|0|||
162705130|NCT01244763|587632103|FG001|Overall Study|Lost to Follow-up|1|||
162705131|NCT01244763|587632104|FG002|Overall Study|Lost to Follow-up|0|||
162705132|NCT01244763|587632105|FG003|Overall Study|Lost to Follow-up|0|||
162705133|NCT01244763|587632106|FG004|Overall Study|Lost to Follow-up|0|||
162705134|NCT01244763|587632107|FG005|Overall Study|Lost to Follow-up|0|||
162705135|NCT01244763|587632102|FG000|Overall Study|Enrolled into the Extension Study|0|||
162858539|NCT04645797|588187512|FG005|Overall Study|Death|0|||
162858540|NCT04645797|588187513|FG006|Overall Study|Death|0|||
162858541|NCT00345605|588187516|FG000|Arm 1|Adverse Event|0|||
162858542|NCT00345605|588187517|FG001|Arm 1|Adverse Event|1|||
162858543|NCT00345605|588187516|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
162858544|NCT00345605|588187517|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
162858545|NCT00817414|588187518|FG000|Overall Study|Adverse Event|1|||
162858546|NCT00817414|588187519|FG001|Overall Study|Adverse Event|1|||
162858547|NCT00817414|588187520|FG002|Overall Study|Adverse Event|1|||
162858548|NCT00817414|588187521|FG003|Overall Study|Adverse Event|0|||
162858549|NCT00817414|588187522|FG004|Overall Study|Adverse Event|0|||
162858550|NCT00817414|588187518|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
162858551|NCT00817414|588187519|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
162858552|NCT00817414|588187520|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
162858553|NCT00817414|588187521|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
162705136|NCT01244763|587632103|FG001|Overall Study|Enrolled into the Extension Study|0|||
162858554|NCT00817414|588187522|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
162858555|NCT00817414|588187518|FG000|Overall Study|Withdrawal by Subject|1|||
162858556|NCT00817414|588187519|FG001|Overall Study|Withdrawal by Subject|1|||
162858557|NCT00817414|588187520|FG002|Overall Study|Withdrawal by Subject|0|||
162858558|NCT00817414|588187521|FG003|Overall Study|Withdrawal by Subject|0|||
162858559|NCT00817414|588187522|FG004|Overall Study|Withdrawal by Subject|0|||
162858560|NCT00817414|588187518|FG000|Overall Study|Lost to Follow-up|0|||
162858561|NCT00817414|588187519|FG001|Overall Study|Lost to Follow-up|0|||
162858562|NCT00817414|588187520|FG002|Overall Study|Lost to Follow-up|1|||
162858563|NCT00817414|588187521|FG003|Overall Study|Lost to Follow-up|1|||
162858564|NCT00817414|588187522|FG004|Overall Study|Lost to Follow-up|1|||
162858565|NCT00817414|588187518|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
162858566|NCT00817414|588187519|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
162858567|NCT00817414|588187520|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
162858568|NCT00817414|588187521|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
162858569|NCT00817414|588187522|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
162858570|NCT00817414|588187518|FG000|Overall Study|Protocol Violation|0|||
162858571|NCT00817414|588187519|FG001|Overall Study|Protocol Violation|0|||
162858572|NCT00817414|588187520|FG002|Overall Study|Protocol Violation|0|||
162858573|NCT00817414|588187521|FG003|Overall Study|Protocol Violation|0|||
162858574|NCT00817414|588187522|FG004|Overall Study|Protocol Violation|1|||
162858575|NCT03717922|588187525|FG000|Overall Study|Lost to Follow-up|2|||
162858576|NCT03717922|588187526|FG001|Overall Study|Lost to Follow-up|2|||
162858577|NCT03126227|588187527|FG000|Overall Study|Adverse Event|43|||
162858578|NCT03126227|588187528|FG001|Overall Study|Adverse Event|4|||
162858579|NCT03126227|588187527|FG000|Overall Study|Death|0|||
162858580|NCT03126227|588187528|FG001|Overall Study|Death|1|||
162858581|NCT03126227|588187527|FG000|Overall Study|Lost to Follow-up|0|||
162858582|NCT03126227|588187528|FG001|Overall Study|Lost to Follow-up|1|||
162858583|NCT03126227|588187527|FG000|Overall Study|Physician Decision|2|||
162858584|NCT03126227|588187528|FG001|Overall Study|Physician Decision|0|||
162858585|NCT03126227|588187527|FG000|Overall Study|Protocol Violation|1|||
162858586|NCT03126227|588187528|FG001|Overall Study|Protocol Violation|0|||
162858587|NCT03126227|588187527|FG000|Overall Study|Withdrawal by Subject|19|||
162612200|NCT00423722|587298255|FG001|Overall Study|Withdrawal by Subject|2|||
162612201|NCT00215683|587298256|FG000|Overall Study|Adverse Event|15|||
162612202|NCT00215683|587298257|FG001|Overall Study|Adverse Event|16|||
162612203|NCT00215683|587298258|FG002|Overall Study|Adverse Event|15|||
162612204|NCT00215683|587298256|FG000|Overall Study|Lack of Efficacy|5|||
162612205|NCT00215683|587298257|FG001|Overall Study|Lack of Efficacy|1|||
162612206|NCT00215683|587298258|FG002|Overall Study|Lack of Efficacy|2|||
162612207|NCT00215683|587298256|FG000|Overall Study|Lost to Follow-up|0|||
162612208|NCT00215683|587298257|FG001|Overall Study|Lost to Follow-up|2|||
162858588|NCT03126227|588187528|FG001|Overall Study|Withdrawal by Subject|3|||
162858589|NCT03126227|588187527|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
162858590|NCT03126227|588187528|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
162858591|NCT03126227|588187527|FG000|Overall Study|Lack of dosing compliance|2|||
162858592|NCT03126227|588187528|FG001|Overall Study|Lack of dosing compliance|0|||
162858593|NCT03126227|588187527|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
162858594|NCT03126227|588187528|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
162858595|NCT03126227|588187527|FG000|Overall Study|Scheduling conflict|1|||
162858596|NCT03126227|588187528|FG001|Overall Study|Scheduling conflict|0|||
162858597|NCT01126619|588187529|FG000|Overall Study|Not eligible for the study|2|||
162858598|NCT01126619|588187529|FG000|Overall Study|Investigator decision|4|||
162858599|NCT01126619|588187529|FG000|Overall Study|Serious adverse event|1|||
162858600|NCT01126619|588187529|FG000|Overall Study|Withdrawal by Subject|9|||
162858601|NCT01126619|588187529|FG000|Overall Study|Non-compliance|1|||
162858602|NCT04876391|588187530|FG000|Overall Study|Withdrawal by Subject|1|||
162858603|NCT04876391|588187531|FG001|Overall Study|Withdrawal by Subject|10|||
162858604|NCT04876391|588187530|FG000|Overall Study|Lost to Follow-up|2|||
162858605|NCT04876391|588187531|FG001|Overall Study|Lost to Follow-up|4|||
162858606|NCT04876391|588187530|FG000|Overall Study|Lack of Efficacy|0|||
162858607|NCT04876391|588187531|FG001|Overall Study|Lack of Efficacy|2|||
162705137|NCT01244763|587632104|FG002|Overall Study|Enrolled into the Extension Study|0|||
162705138|NCT01244763|587632105|FG003|Overall Study|Enrolled into the Extension Study|0|||
162705139|NCT01244763|587632106|FG004|Overall Study|Enrolled into the Extension Study|0|||
162858608|NCT04876391|588187530|FG000|Overall Study|Adverse Event|3|||
162858609|NCT04876391|588187531|FG001|Overall Study|Adverse Event|1|||
162858610|NCT04876391|588187530|FG000|Overall Study|Patient non-compliance|0|||
162858611|NCT04876391|588187531|FG001|Overall Study|Patient non-compliance|1|||
162858612|NCT04876391|588187530|FG000|Overall Study|Personal reasons|0|||
162858613|NCT04876391|588187531|FG001|Overall Study|Personal reasons|1|||
162858614|NCT04876391|588187530|FG000|Overall Study|Withdrawn as per protocol|2|||
162858615|NCT04876391|588187531|FG001|Overall Study|Withdrawn as per protocol|2|||
162612209|NCT00215683|587298258|FG002|Overall Study|Lost to Follow-up|1|||
162612210|NCT00215683|587298256|FG000|Overall Study|Withdrawal by Subject|9|||
162612211|NCT00215683|587298257|FG001|Overall Study|Withdrawal by Subject|4|||
162705140|NCT01244763|587632107|FG005|Overall Study|Enrolled into the Extension Study|1|||
162858616|NCT01859403|588187536|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
162858617|NCT01859403|588187537|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
162858618|NCT01859403|588187536|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
162858619|NCT01859403|588187537|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
162858620|NCT01859403|588187536|FG000|Primary Endpoint Measure|Physician Decision|0|||
162858621|NCT01859403|588187537|FG001|Primary Endpoint Measure|Physician Decision|1|||
162858622|NCT01859403|588187536|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
162858623|NCT01859403|588187537|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
162858624|NCT00811252|588187538|FG000|Overall Study|Adverse Event|6|||
162858625|NCT00811252|588187539|FG001|Overall Study|Adverse Event|10|||
162858626|NCT00811252|588187540|FG002|Overall Study|Adverse Event|15|||
162858627|NCT00811252|588187538|FG000|Overall Study|Lack of Efficacy|7|||
162858628|NCT00811252|588187539|FG001|Overall Study|Lack of Efficacy|2|||
162858629|NCT00811252|588187540|FG002|Overall Study|Lack of Efficacy|0|||
162858630|NCT00811252|588187538|FG000|Overall Study|Protocol Violation|3|||
162858631|NCT00811252|588187539|FG001|Overall Study|Protocol Violation|3|||
162858632|NCT00811252|588187540|FG002|Overall Study|Protocol Violation|2|||
162858633|NCT00811252|588187538|FG000|Overall Study|Withdrawal of Consent|1|||
162858634|NCT00811252|588187539|FG001|Overall Study|Withdrawal of Consent|2|||
162858635|NCT00811252|588187540|FG002|Overall Study|Withdrawal of Consent|2|||
162858636|NCT00811252|588187538|FG000|Overall Study|Lost to Follow-up|0|||
162858637|NCT00811252|588187539|FG001|Overall Study|Lost to Follow-up|0|||
162858638|NCT00811252|588187540|FG002|Overall Study|Lost to Follow-up|2|||
162858639|NCT00811252|588187538|FG000|Overall Study|Administrative or Other Reasons|0|||
162858640|NCT00811252|588187539|FG001|Overall Study|Administrative or Other Reasons|3|||
162858641|NCT00811252|588187540|FG002|Overall Study|Administrative or Other Reasons|2|||
162858642|NCT01157117|588187541|FG000|Overall Study|Dosing Symptoms|0|||
162858643|NCT01157117|588187542|FG001|Overall Study|Dosing Symptoms|4|||
162858644|NCT01157117|588187543|FG002|Overall Study|Dosing Symptoms|0|||
162858645|NCT01157117|588187541|FG000|Overall Study|Withdrawal by Subject|4|||
162858646|NCT01157117|588187542|FG001|Overall Study|Withdrawal by Subject|1|||
162858647|NCT01157117|588187543|FG002|Overall Study|Withdrawal by Subject|1|||
162956231|NCT02648438|588541434|FG002|Overall Study|Withdrawal by Subject|0|||
162956232|NCT03138967|588541437|FG000|Overall Study|Death|0|||
162858648|NCT01157117|588187541|FG000|Overall Study|Lack of Efficacy|1|||
162858649|NCT01157117|588187542|FG001|Overall Study|Lack of Efficacy|1|||
162858650|NCT01157117|588187543|FG002|Overall Study|Lack of Efficacy|0|||
162858651|NCT01157117|588187541|FG000|Overall Study|Lost to Follow-up|0|||
162956233|NCT03138967|588541438|FG001|Overall Study|Death|1|||
162858652|NCT01157117|588187542|FG001|Overall Study|Lost to Follow-up|0|||
162858653|NCT01157117|588187543|FG002|Overall Study|Lost to Follow-up|1|||
162858654|NCT01157117|588187541|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
162858655|NCT01157117|588187542|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
162858656|NCT01157117|588187543|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
162858657|NCT01931865|588187547|FG000|Overall Study|Lost to Follow-up|2|||
162858658|NCT01931865|588187547|FG000|Overall Study|Withdrawal by Subject|2|||
162858659|NCT01121406|588187548|FG000|Overall Study|Progressive disease RECIST|44|||
162858660|NCT01121406|588187549|FG001|Overall Study|Progressive disease RECIST|28|||
162858661|NCT01121406|588187548|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
162858662|NCT01121406|588187549|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
162858663|NCT01121406|588187548|FG000|Overall Study|Other AE|3|||
162858664|NCT01121406|588187549|FG001|Overall Study|Other AE|10|||
162858665|NCT01121406|588187548|FG000|Overall Study|Non-compliant with protocol|0|||
162858666|NCT01121406|588187549|FG001|Overall Study|Non-compliant with protocol|2|||
162858667|NCT01121406|588187548|FG000|Overall Study|Lost to Follow-up|0|||
162858668|NCT01121406|588187549|FG001|Overall Study|Lost to Follow-up|1|||
162858669|NCT01121406|588187548|FG000|Overall Study|Refused continuation of study med.|1|||
162858670|NCT01121406|588187549|FG001|Overall Study|Refused continuation of study med.|2|||
162858671|NCT01121406|588187548|FG000|Overall Study|Reason other than specified above|2|||
162858672|NCT01121406|588187549|FG001|Overall Study|Reason other than specified above|6|||
162858673|NCT01121406|588187548|FG000|Overall Study|Not treated|1|||
162858674|NCT01121406|588187549|FG001|Overall Study|Not treated|0|||
162858675|NCT00892437|588187550|FG000|Randomized Phase|Randomized but not treated|6|||
162858676|NCT00892437|588187551|FG001|Randomized Phase|Randomized but not treated|0|||
162858677|NCT00892437|588187550|FG000|Randomized Phase|Adverse Event|2|||
162858678|NCT00892437|588187551|FG001|Randomized Phase|Adverse Event|2|||
162858679|NCT00892437|588187550|FG000|Randomized Phase|Lost to Follow-up|1|||
162858680|NCT00892437|588187551|FG001|Randomized Phase|Lost to Follow-up|3|||
162858681|NCT00892437|588187550|FG000|Randomized Phase|Investigator's Discretion|1|||
162858682|NCT00892437|588187551|FG001|Randomized Phase|Investigator's Discretion|0|||
162858683|NCT00892437|588187550|FG000|Randomized Phase|Withdrew Consent|1|||
162858684|NCT00892437|588187551|FG001|Randomized Phase|Withdrew Consent|0|||
162858685|NCT00892437|588187550|FG000|Open-Label Extension Phase|Adverse Event|4|||
162858686|NCT00892437|588187551|FG001|Open-Label Extension Phase|Adverse Event|2|||
162858687|NCT00892437|588187550|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
162858688|NCT00892437|588187551|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
162858689|NCT00892437|588187550|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
162858690|NCT00892437|588187551|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
162858691|NCT00892437|588187550|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
162858692|NCT00892437|588187551|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
162858693|NCT00892437|588187550|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
162858694|NCT00892437|588187551|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
162858695|NCT03185130|588187552|FG000|Overall Study|Withdrawal by Subject|0|||
162858696|NCT03185130|588187553|FG001|Overall Study|Withdrawal by Subject|2|||
162858697|NCT02286960|588187554|FG000|Overall Study|Lost to Follow-up|3|||
162956234|NCT03138967|588541437|FG000|Overall Study|Physician Decision|1|||
162956235|NCT03138967|588541438|FG001|Overall Study|Physician Decision|3|||
162956236|NCT04604275|588541439|FG000|Washout-1 Week|Withdrawal by Subject|1|||
162705141|NCT02271594|587632108|FG000|Overall Study|Study closed; recruiting failure|19|||
162858698|NCT02286960|588187555|FG001|Overall Study|Lost to Follow-up|3|||
162858699|NCT03596164|588187560|FG000|Overall Study|Adverse Event|0|||
162612212|NCT00215683|587298258|FG002|Overall Study|Withdrawal by Subject|13|||
162612213|NCT00215683|587298256|FG000|Overall Study|Physician Decision|0|||
162956237|NCT04604275|588541440|FG001|Washout-1 Week|Withdrawal by Subject|0|||
162956238|NCT04405570|588541441|FG000|Overall Study|Adverse Event|0|||
162956239|NCT04405570|588541442|FG001|Overall Study|Adverse Event|1|||
162956240|NCT04405570|588541443|FG002|Overall Study|Adverse Event|1|||
162956241|NCT04405570|588541444|FG003|Overall Study|Adverse Event|1|||
162956242|NCT04405570|588541441|FG000|Overall Study|Lost to Follow-up|0|||
162956243|NCT04405570|588541442|FG001|Overall Study|Lost to Follow-up|1|||
162956244|NCT04405570|588541443|FG002|Overall Study|Lost to Follow-up|0|||
162956245|NCT04405570|588541444|FG003|Overall Study|Lost to Follow-up|0|||
162956246|NCT04405570|588541441|FG000|Overall Study|Physician Decision|0|||
162956247|NCT04405570|588541442|FG001|Overall Study|Physician Decision|0|||
162956248|NCT04405570|588541443|FG002|Overall Study|Physician Decision|1|||
162956249|NCT04405570|588541444|FG003|Overall Study|Physician Decision|0|||
162956250|NCT04405570|588541441|FG000|Overall Study|Withdrawal by Subject|0|||
162956251|NCT04405570|588541442|FG001|Overall Study|Withdrawal by Subject|1|||
162956252|NCT04405570|588541443|FG002|Overall Study|Withdrawal by Subject|1|||
162956253|NCT04405570|588541444|FG003|Overall Study|Withdrawal by Subject|0|||
162956254|NCT04405570|588541441|FG000|Overall Study|Randomized not dosed|0|||
162956255|NCT04405570|588541442|FG001|Overall Study|Randomized not dosed|2|||
162956256|NCT04405570|588541443|FG002|Overall Study|Randomized not dosed|0|||
162956257|NCT04405570|588541444|FG003|Overall Study|Randomized not dosed|0|||
162956258|NCT04499963|588541445|FG000|Overall Study|Adverse Event|3|||
162956259|NCT04499963|588541446|FG001|Overall Study|Adverse Event|0|||
162956260|NCT04499963|588541445|FG000|Overall Study|Death|3|||
162956261|NCT04499963|588541446|FG001|Overall Study|Death|0|||
162956262|NCT04499963|588541445|FG000|Overall Study|Lack of Efficacy|7|||
162956263|NCT04499963|588541446|FG001|Overall Study|Lack of Efficacy|0|||
162956264|NCT04499963|588541445|FG000|Overall Study|Lost to Follow-up|2|||
162956265|NCT04499963|588541446|FG001|Overall Study|Lost to Follow-up|0|||
162956266|NCT02601625|588541450|FG000|Overall Study|Lost to Follow-up|0|||
162956267|NCT02601625|588541451|FG001|Overall Study|Lost to Follow-up|0|||
162956268|NCT02601625|588541452|FG002|Overall Study|Lost to Follow-up|1|||
162956269|NCT02601625|588541453|FG003|Overall Study|Lost to Follow-up|1|||
162956270|NCT00838279|588541454|FG000|Washout|Protocol Violation|1|||
162956271|NCT00838279|588541455|FG001|Washout|Protocol Violation|0|||
162956272|NCT00838279|588541454|FG000|Washout|Withdrawal by Subject|0|||
162956273|NCT00838279|588541455|FG001|Washout|Withdrawal by Subject|1|||
162956274|NCT04608188|588541456|FG000|Overall Study|Withdrawal by Subject|4|||
162956275|NCT04608188|588541457|FG001|Overall Study|Withdrawal by Subject|8|||
162956276|NCT03586726|588541460|FG000|Overall Study|Withdrawal by Subject|1|||
162956277|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
162956278|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
162956279|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
162956280|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
162956281|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
162956282|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
162956283|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
162956284|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
162956285|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
162956286|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
162612214|NCT00215683|587298257|FG001|Overall Study|Physician Decision|0|||
162612215|NCT00215683|587298258|FG002|Overall Study|Physician Decision|1|||
162612216|NCT00215683|587298256|FG000|Overall Study|Difficult to attend visits|0|||
162612217|NCT00215683|587298257|FG001|Overall Study|Difficult to attend visits|1|||
162612218|NCT00215683|587298258|FG002|Overall Study|Difficult to attend visits|0|||
162612219|NCT00215683|587298256|FG000|Overall Study|No study drug available|0|||
162612220|NCT00215683|587298257|FG001|Overall Study|No study drug available|1|||
162612221|NCT00215683|587298258|FG002|Overall Study|No study drug available|0|||
162612222|NCT00215683|587298256|FG000|Overall Study|Intermittent therapy required|0|||
162612223|NCT00215683|587298257|FG001|Overall Study|Intermittent therapy required|1|||
162612224|NCT00215683|587298258|FG002|Overall Study|Intermittent therapy required|0|||
162612225|NCT02437513|587298260|FG000|Overall Study|Withdrawal by Subject|2|||
162612226|NCT00595465|587298261|FG000|Overall Study|Adverse Event|4|||
162612227|NCT00595465|587298262|FG001|Overall Study|Adverse Event|3|||
162705142|NCT02271594|587632109|FG001|Overall Study|Study closed; recruiting failure|12|||
162956287|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
162956288|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
162956289|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
162612228|NCT00595465|587298263|FG002|Overall Study|Adverse Event|3|||
162612229|NCT00595465|587298261|FG000|Overall Study|Pregnancy|0|||
162612230|NCT00595465|587298262|FG001|Overall Study|Pregnancy|0|||
162612231|NCT00595465|587298263|FG002|Overall Study|Pregnancy|1|||
162956290|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
162956291|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
162956292|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
162956293|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
162956294|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
162956295|NCT01045161|588541461|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
162956296|NCT01045161|588541462|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
162956297|NCT01045161|588541463|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
162956298|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
162956299|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
162956300|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
162956301|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
162956302|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
162956303|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
162956304|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
162956305|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
162956306|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
162858700|NCT03596164|588187561|FG001|Overall Study|Adverse Event|1|||
162858701|NCT03596164|588187560|FG000|Overall Study|Death|1|||
162858702|NCT03596164|588187561|FG001|Overall Study|Death|0|||
162858703|NCT03427073|588187562|FG000|Overall Study|Disease Progression|1|||
162858704|NCT03427073|588187563|FG001|Overall Study|Disease Progression|1|||
162858705|NCT03427073|588187564|FG002|Overall Study|Disease Progression|1|||
162858706|NCT03427073|588187565|FG003|Overall Study|Disease Progression|3|||
162858707|NCT03427073|588187566|FG004|Overall Study|Disease Progression|3|||
162858708|NCT03427073|588187567|FG005|Overall Study|Disease Progression|4|||
162858709|NCT03427073|588187568|FG006|Overall Study|Disease Progression|2|||
162858710|NCT03427073|588187569|FG007|Overall Study|Disease Progression|3|||
162858711|NCT03427073|588187562|FG000|Overall Study|Physician Decision|0|||
162858712|NCT03427073|588187563|FG001|Overall Study|Physician Decision|0|||
162858713|NCT03427073|588187564|FG002|Overall Study|Physician Decision|0|||
162858714|NCT03427073|588187565|FG003|Overall Study|Physician Decision|0|||
162858715|NCT03427073|588187566|FG004|Overall Study|Physician Decision|0|||
162858716|NCT03427073|588187567|FG005|Overall Study|Physician Decision|0|||
162858717|NCT03427073|588187568|FG006|Overall Study|Physician Decision|1|||
162858718|NCT03427073|588187569|FG007|Overall Study|Physician Decision|1|||
162858719|NCT02835495|588187572|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
162858720|NCT02835495|588187573|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
162858721|NCT02835495|588187572|FG000|Overall Study|Declined in-person follow-up visit|4|||
162858722|NCT02835495|588187573|FG001|Overall Study|Declined in-person follow-up visit|2|||
162858723|NCT02580058|588187575|FG000|Overall Study|Adverse Event|16|||
162858724|NCT02580058|588187576|FG001|Overall Study|Adverse Event|30|||
162858725|NCT02580058|588187577|FG002|Overall Study|Adverse Event|20|||
162858726|NCT02580058|588187575|FG000|Overall Study|Death|4|||
162858727|NCT02580058|588187576|FG001|Overall Study|Death|4|||
162858728|NCT02580058|588187577|FG002|Overall Study|Death|5|||
162858729|NCT02580058|588187575|FG000|Overall Study|Physician Decision|1|||
162858730|NCT02580058|588187576|FG001|Overall Study|Physician Decision|3|||
162858731|NCT02580058|588187577|FG002|Overall Study|Physician Decision|11|||
162858732|NCT02580058|588187575|FG000|Overall Study|Other|5|||
162858733|NCT02580058|588187576|FG001|Overall Study|Other|1|||
162858734|NCT02580058|588187577|FG002|Overall Study|Other|3|||
162858735|NCT02580058|588187575|FG000|Overall Study|Withdrawal by Subject|4|||
162858736|NCT02580058|588187576|FG001|Overall Study|Withdrawal by Subject|7|||
162858737|NCT02580058|588187577|FG002|Overall Study|Withdrawal by Subject|31|||
162858738|NCT02580058|588187575|FG000|Overall Study|Global Deterioration of Health Status|19|||
162858739|NCT02580058|588187576|FG001|Overall Study|Global Deterioration of Health Status|18|||
162858740|NCT02580058|588187577|FG002|Overall Study|Global Deterioration of Health Status|24|||
162858741|NCT02580058|588187575|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
162858742|NCT02580058|588187576|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162858743|NCT02580058|588187577|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
162858744|NCT02580058|588187575|FG000|Overall Study|Progressive Disease|137|||
163044750|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
162612232|NCT00595465|587298261|FG000|Overall Study|Protocol Violation|2|||
162612233|NCT00595465|587298262|FG001|Overall Study|Protocol Violation|1|||
162612234|NCT00595465|587298263|FG002|Overall Study|Protocol Violation|0|||
162612235|NCT00595465|587298261|FG000|Overall Study|Lost to Follow-up|0|||
162612236|NCT00595465|587298262|FG001|Overall Study|Lost to Follow-up|0|||
162612237|NCT00595465|587298263|FG002|Overall Study|Lost to Follow-up|2|||
162612238|NCT00595465|587298261|FG000|Overall Study|administrative reason|0|||
162612239|NCT00595465|587298262|FG001|Overall Study|administrative reason|0|||
162858745|NCT02580058|588187576|FG001|Overall Study|Progressive Disease|125|||
162858746|NCT02580058|588187577|FG002|Overall Study|Progressive Disease|94|||
162858747|NCT02580058|588187575|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162858748|NCT02580058|588187576|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162956307|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
162956308|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
162956309|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
162956310|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
162956311|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
162956312|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
162956313|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
162956314|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
162956315|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
162956316|NCT01045161|588541461|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
162956317|NCT01045161|588541462|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
162956318|NCT01045161|588541463|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
162956319|NCT01854047|588541464|FG000|Overall Study|Lack of Efficacy|1|||
162956320|NCT01854047|588541465|FG001|Overall Study|Lack of Efficacy|0|||
162956321|NCT01854047|588541466|FG002|Overall Study|Lack of Efficacy|0|||
162956322|NCT01854047|588541467|FG003|Overall Study|Lack of Efficacy|0|||
162956323|NCT01854047|588541468|FG004|Overall Study|Lack of Efficacy|0|||
162956324|NCT01854047|588541464|FG000|Overall Study|Poor compliance to protocol|3|||
162956325|NCT01854047|588541465|FG001|Overall Study|Poor compliance to protocol|0|||
162956326|NCT01854047|588541466|FG002|Overall Study|Poor compliance to protocol|2|||
162956327|NCT01854047|588541467|FG003|Overall Study|Poor compliance to protocol|0|||
162956328|NCT01854047|588541468|FG004|Overall Study|Poor compliance to protocol|0|||
162956329|NCT01854047|588541464|FG000|Overall Study|Adverse Event|5|||
162956330|NCT01854047|588541465|FG001|Overall Study|Adverse Event|4|||
162956331|NCT01854047|588541466|FG002|Overall Study|Adverse Event|6|||
162956332|NCT01854047|588541467|FG003|Overall Study|Adverse Event|10|||
162956333|NCT01854047|588541468|FG004|Overall Study|Adverse Event|7|||
162612240|NCT00595465|587298263|FG002|Overall Study|administrative reason|1|||
162612241|NCT00107783|587298264|FG000|Overall Study|Adverse Event|0|||
162612242|NCT00107783|587298265|FG001|Overall Study|Adverse Event|2|||
162612243|NCT00107783|587298264|FG000|Overall Study|Death|0|||
162612244|NCT00107783|587298265|FG001|Overall Study|Death|1|||
162612245|NCT00107783|587298264|FG000|Overall Study|Withdrawal by Subject|2|||
162612246|NCT00107783|587298265|FG001|Overall Study|Withdrawal by Subject|0|||
162612247|NCT00107783|587298264|FG000|Overall Study|Second hip replacement|1|||
162612248|NCT00107783|587298265|FG001|Overall Study|Second hip replacement|1|||
162612249|NCT01298531|587298266|FG000|Overall Study|Lack of Efficacy|0|||
162612250|NCT01298531|587298267|FG001|Overall Study|Lack of Efficacy|1|||
162612251|NCT01298531|587298266|FG000|Overall Study|Lost to Follow-up|2|||
162612252|NCT01298531|587298267|FG001|Overall Study|Lost to Follow-up|0|||
162612253|NCT01298531|587298266|FG000|Overall Study|Protocol Violation|1|||
162612254|NCT01298531|587298267|FG001|Overall Study|Protocol Violation|1|||
162612255|NCT01298531|587298266|FG000|Overall Study|Adverse Event|4|||
162612256|NCT01298531|587298267|FG001|Overall Study|Adverse Event|3|||
162612257|NCT01298531|587298266|FG000|Overall Study|Does not meet entrance criteria|0|||
162612258|NCT01298531|587298267|FG001|Overall Study|Does not meet entrance criteria|1|||
162612259|NCT01298531|587298266|FG000|Overall Study|Other|2|||
162612260|NCT01298531|587298267|FG001|Overall Study|Other|1|||
162612261|NCT00422097|587298268|FG000|Dose Level 2|Still on treatment|0|||
162612262|NCT00422097|587298269|FG001|Dose Level 2|Still on treatment|1|||
162612263|NCT00422097|587298270|FG002|Dose Level 2|Still on treatment|0|||
162612264|NCT00422097|587298271|FG003|Dose Level 2|Still on treatment|0|||
162612265|NCT00422097|587298272|FG004|Dose Level 2|Still on treatment|0|||
162612266|NCT00422097|587298273|FG005|Dose Level 2|Still on treatment|0|||
162612267|NCT00422097|587298274|FG006|Dose Level 2|Still on treatment|0|||
162612268|NCT00422097|587298275|FG007|Dose Level 2|Still on treatment|0|||
162612269|NCT02360995|587298276|FG000|Overall Study|Lost to Follow-up|2|||
162612270|NCT02360995|587298277|FG001|Overall Study|Lost to Follow-up|0|||
162612271|NCT02360995|587298278|FG002|Overall Study|Lost to Follow-up|2|||
162612272|NCT02360995|587298276|FG000|Overall Study|Withdrawal by Subject|0|||
162612273|NCT02360995|587298277|FG001|Overall Study|Withdrawal by Subject|1|||
162612274|NCT02360995|587298278|FG002|Overall Study|Withdrawal by Subject|0|||
162612275|NCT02231918|587298279|FG000|Overall Study|Withdrawal by Subject|0|||
162612276|NCT02231918|587298280|FG001|Overall Study|Withdrawal by Subject|1|||
162612277|NCT02231918|587298281|FG002|Overall Study|Withdrawal by Subject|0|||
162612278|NCT02231918|587298279|FG000|Overall Study|Adverse Event|0|||
162612279|NCT02231918|587298280|FG001|Overall Study|Adverse Event|0|||
162612280|NCT02231918|587298281|FG002|Overall Study|Adverse Event|1|||
162612281|NCT04622735|587298284|FG000|Overall Study|Lost to Follow-up|1|||
162612282|NCT04622735|587298285|FG001|Overall Study|Lost to Follow-up|2|||
162612283|NCT04622735|587298286|FG002|Overall Study|Lost to Follow-up|1|||
162612284|NCT04622735|587298284|FG000|Overall Study|Adverse Event|0|||
162612285|NCT04622735|587298285|FG001|Overall Study|Adverse Event|0|||
162612286|NCT04622735|587298286|FG002|Overall Study|Adverse Event|1|||
162612287|NCT04622735|587298284|FG000|Overall Study|Protocol Violation|1|||
162612288|NCT04622735|587298285|FG001|Overall Study|Protocol Violation|0|||
162612289|NCT04622735|587298286|FG002|Overall Study|Protocol Violation|0|||
162612290|NCT02476422|587298291|FG000|Overall Study|Subject/guardian decision|0|||
162612291|NCT02476422|587298292|FG001|Overall Study|Subject/guardian decision|1|||
162612292|NCT03960554|587298298|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
162612293|NCT03960554|587298299|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
162612294|NCT02545075|587298300|FG000|Randomization|Lost to Follow-up|0|||
162612295|NCT02545075|587298301|FG001|Randomization|Lost to Follow-up|1|||
162612296|NCT02545075|587298300|FG000|Randomization|Withdrawal by Subject|0|||
162612297|NCT02545075|587298301|FG001|Randomization|Withdrawal by Subject|6|||
162612298|NCT02545075|587298300|FG000|Treatment|Disease progression|71|||
162612299|NCT02545075|587298301|FG001|Treatment|Disease progression|32|||
162612300|NCT02545075|587298300|FG000|Treatment|Participant dicontinued study treatment|7|||
162612301|NCT02545075|587298301|FG001|Treatment|Participant dicontinued study treatment|9|||
162612302|NCT02545075|587298300|FG000|Treatment|Withdrawal by Subject|1|||
162612303|NCT02545075|587298301|FG001|Treatment|Withdrawal by Subject|0|||
162612304|NCT02545075|587298300|FG000|Treatment|Adverse event not related to study drug|1|||
162612305|NCT02545075|587298301|FG001|Treatment|Adverse event not related to study drug|0|||
162612306|NCT02545075|587298300|FG000|Treatment|Death|1|||
162612307|NCT02545075|587298301|FG001|Treatment|Death|0|||
162612308|NCT02545075|587298300|FG000|Treatment|Participant drug toxicity|1|||
162612309|NCT02545075|587298301|FG001|Treatment|Participant drug toxicity|0|||
162612310|NCT02545075|587298300|FG000|Treatment|Completed treatment|40|||
162612311|NCT02545075|587298301|FG001|Treatment|Completed treatment|12|||
162612312|NCT00735254|587298306|FG000|Overall Study|Protocol Violation|1|||
162612313|NCT00735254|587298307|FG001|Overall Study|Protocol Violation|1|||
162612314|NCT00735254|587298308|FG002|Overall Study|Protocol Violation|1|||
162612315|NCT00735254|587298309|FG003|Overall Study|Protocol Violation|0|||
162612316|NCT06400979|587298310|FG000|Overall Study|Lost to Follow-up|29|||
162612317|NCT06400979|587298310|FG000|Overall Study|Withdrawal by Subject|1|||
162612318|NCT00750880|587298317|FG000|Overall Study|Adverse Event|76|||
162612319|NCT00750880|587298317|FG000|Overall Study|Death|4|||
162612320|NCT00750880|587298317|FG000|Overall Study|Lack of Efficacy|46|||
162612321|NCT00750880|587298317|FG000|Overall Study|Lost to Follow-up|10|||
162612322|NCT00750880|587298317|FG000|Overall Study|Protocol Violation|15|||
162612323|NCT00750880|587298317|FG000|Overall Study|Withdrawal by Subject|33|||
162612324|NCT00750880|587298317|FG000|Overall Study|Physician Decision|20|||
162612325|NCT00750880|587298317|FG000|Overall Study|Administrative|11|||
162612326|NCT00925990|587298321|FG000|Overall Study|Adverse Event|1|||
162612327|NCT00925990|587298322|FG001|Overall Study|Adverse Event|3|||
162612328|NCT00925990|587298321|FG000|Overall Study|Withdrawal by Subject|2|||
162612329|NCT00925990|587298322|FG001|Overall Study|Withdrawal by Subject|2|||
162612330|NCT00925990|587298321|FG000|Overall Study|Lost to Follow-up|1|||
162612331|NCT00925990|587298322|FG001|Overall Study|Lost to Follow-up|3|||
162612332|NCT00925990|587298321|FG000|Overall Study|Physician Decision|1|||
162612333|NCT00925990|587298322|FG001|Overall Study|Physician Decision|1|||
162612334|NCT00925990|587298321|FG000|Overall Study|moved out of state, missed medication|0|||
162612335|NCT00925990|587298322|FG001|Overall Study|moved out of state, missed medication|2|||
162612336|NCT00573248|587298328|FG000|Overall Study|scheduling conflicts|15|||
162612337|NCT00573248|587298329|FG001|Overall Study|scheduling conflicts|11|||
162612338|NCT02536833|587298332|FG000|Overall Study|Discontinued Before Treatment|0|||
162858749|NCT02580058|588187577|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162858750|NCT04283461|588187578|FG000|Overall Study|Enrolled in separate trial|0|||
162858751|NCT04283461|588187579|FG001|Overall Study|Enrolled in separate trial|0|||
162858752|NCT04283461|588187580|FG002|Overall Study|Enrolled in separate trial|8|||
162858753|NCT04283461|588187581|FG003|Overall Study|Enrolled in separate trial|13|||
162858754|NCT04283461|588187582|FG004|Overall Study|Enrolled in separate trial|12|||
162858755|NCT04283461|588187583|FG005|Overall Study|Enrolled in separate trial|0|||
162858756|NCT04283461|588187584|FG006|Overall Study|Enrolled in separate trial|0|||
162858757|NCT04283461|588187585|FG007|Overall Study|Enrolled in separate trial|8|||
162858758|NCT04283461|588187586|FG008|Overall Study|Enrolled in separate trial|0|||
162858759|NCT04283461|588187587|FG009|Overall Study|Enrolled in separate trial|0|||
162858760|NCT04283461|588187588|FG010|Overall Study|Enrolled in separate trial|0|||
162858761|NCT04283461|588187589|FG011|Overall Study|Enrolled in separate trial|7|||
162858762|NCT04283461|588187590|FG012|Overall Study|Enrolled in separate trial|0|||
162858763|NCT05490771|588187591|FG000|Overall Study|Disease progression|18|||
162858764|NCT05490771|588187591|FG000|Overall Study|Adverse Event|3|||
162858765|NCT05490771|588187591|FG000|Overall Study|Other complicating disease|1|||
162858766|NCT05490771|588187591|FG000|Overall Study|Withdrawal by Subject|3|||
162858767|NCT05490771|588187591|FG000|Overall Study|Physician Decision|1|||
162858768|NCT05490771|588187591|FG000|Overall Study|Still on treatment|2|||
162858769|NCT05490771|588187591|FG000|Overall Study|Never start protocol therapy|5|||
162612339|NCT02536833|587298333|FG001|Overall Study|Discontinued Before Treatment|0|||
162612340|NCT02536833|587298334|FG002|Overall Study|Discontinued Before Treatment|1|||
162612341|NCT02536833|587298335|FG003|Overall Study|Discontinued Before Treatment|2|||
162612342|NCT02536833|587298332|FG000|Overall Study|Adverse Event|1|||
162858770|NCT05490771|588187591|FG000|Overall Study|Ineligible|2|||
162858771|NCT00246259|588187595|FG000|Overall Study|Other|3|||
162858772|NCT00246259|588187596|FG001|Overall Study|Other|3|||
162858773|NCT00246259|588187595|FG000|Overall Study|Not stable by Week 18|2|||
162858774|NCT00246259|588187596|FG001|Overall Study|Not stable by Week 18|1|||
162858775|NCT00246259|588187595|FG000|Overall Study|Participant non-compliant|4|||
162858776|NCT00246259|588187596|FG001|Overall Study|Participant non-compliant|9|||
162612343|NCT02536833|587298333|FG001|Overall Study|Adverse Event|3|||
162858777|NCT00246259|588187595|FG000|Overall Study|Lack of Efficacy|2|||
162858778|NCT00246259|588187596|FG001|Overall Study|Lack of Efficacy|2|||
162858779|NCT00246259|588187595|FG000|Overall Study|Investigator withdrew participant|2|||
162858780|NCT00246259|588187596|FG001|Overall Study|Investigator withdrew participant|0|||
162858781|NCT00246259|588187595|FG000|Overall Study|Adverse Event|5|||
162858782|NCT00246259|588187596|FG001|Overall Study|Adverse Event|0|||
162858783|NCT00246259|588187595|FG000|Overall Study|Lost to Follow-up|3|||
162858784|NCT00246259|588187596|FG001|Overall Study|Lost to Follow-up|4|||
162858785|NCT00246259|588187595|FG000|Overall Study|Withdrawal by Subject|5|||
162858786|NCT00246259|588187596|FG001|Overall Study|Withdrawal by Subject|1|||
162858787|NCT00246259|588187595|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
162612344|NCT02536833|587298334|FG002|Overall Study|Adverse Event|4|||
162858788|NCT00246259|588187596|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
162858789|NCT01564784|588187601|FG000|Overall Study|Other|1|||
162956334|NCT01854047|588541464|FG000|Overall Study|Randomized but not treated|0|||
162612345|NCT02536833|587298335|FG003|Overall Study|Adverse Event|1|||
162612346|NCT02536833|587298332|FG000|Overall Study|Lost to Follow-up|2|||
162612347|NCT02536833|587298333|FG001|Overall Study|Lost to Follow-up|1|||
162612348|NCT02536833|587298334|FG002|Overall Study|Lost to Follow-up|2|||
162612349|NCT02536833|587298335|FG003|Overall Study|Lost to Follow-up|2|||
162612350|NCT02536833|587298332|FG000|Overall Study|Physician Decision|0|||
162705143|NCT01561079|587632112|FG000|Overall Study|Physician Decision|17|||
162612351|NCT02536833|587298333|FG001|Overall Study|Physician Decision|0|||
162612352|NCT02536833|587298334|FG002|Overall Study|Physician Decision|0|||
162612353|NCT02536833|587298335|FG003|Overall Study|Physician Decision|1|||
162858790|NCT01564784|588187602|FG001|Overall Study|Other|0|||
162858791|NCT01564784|588187601|FG000|Overall Study|Subject refused further follow-up|1|||
162858792|NCT01564784|588187602|FG001|Overall Study|Subject refused further follow-up|6|||
162858793|NCT01564784|588187601|FG000|Overall Study|Lost to Follow-up|1|||
162858794|NCT01564784|588187602|FG001|Overall Study|Lost to Follow-up|1|||
162858795|NCT01564784|588187601|FG000|Overall Study|Death|131|||
162858796|NCT01564784|588187602|FG001|Overall Study|Death|126|||
162858797|NCT02272790|588187603|FG000|Overall Study|Physician Decision|0|||
162858798|NCT02272790|588187604|FG001|Overall Study|Physician Decision|1|||
162858799|NCT02272790|588187605|FG002|Overall Study|Physician Decision|0|||
162858800|NCT02272790|588187606|FG003|Overall Study|Physician Decision|0|||
162858801|NCT02272790|588187607|FG004|Overall Study|Physician Decision|0|||
162858802|NCT02272790|588187608|FG005|Overall Study|Physician Decision|0|||
162858803|NCT03022461|588187609|FG000|Overall Study|Death|3|||
162858804|NCT01982630|588187610|FG000|Overall Study|Adverse Event|2|||
162858805|NCT01982630|588187611|FG001|Overall Study|Adverse Event|0|||
162858806|NCT01982630|588187612|FG002|Overall Study|Adverse Event|1|||
162858807|NCT01982630|588187613|FG003|Overall Study|Adverse Event|0|||
162858808|NCT01982630|588187614|FG004|Overall Study|Adverse Event|1|||
162858809|NCT01982630|588187615|FG005|Overall Study|Adverse Event|2|||
162858810|NCT01982630|588187616|FG006|Overall Study|Adverse Event|1|||
162858811|NCT01982630|588187617|FG007|Overall Study|Adverse Event|0|||
162858812|NCT01982630|588187610|FG000|Overall Study|Physician Decision|1|||
162858813|NCT01982630|588187611|FG001|Overall Study|Physician Decision|0|||
162956335|NCT01854047|588541465|FG001|Overall Study|Randomized but not treated|1|||
162956336|NCT01854047|588541466|FG002|Overall Study|Randomized but not treated|2|||
162956337|NCT01854047|588541467|FG003|Overall Study|Randomized but not treated|0|||
162956338|NCT01854047|588541468|FG004|Overall Study|Randomized but not treated|4|||
162956339|NCT01854047|588541464|FG000|Overall Study|Other than specified above|3|||
162612354|NCT02536833|587298332|FG000|Overall Study|Site Terminated by Sponsor|2|||
162612355|NCT02536833|587298333|FG001|Overall Study|Site Terminated by Sponsor|2|||
162612356|NCT02536833|587298334|FG002|Overall Study|Site Terminated by Sponsor|2|||
162612357|NCT02536833|587298335|FG003|Overall Study|Site Terminated by Sponsor|2|||
162612358|NCT02536833|587298332|FG000|Overall Study|Subject Non-Compliance|0|||
162612359|NCT02536833|587298333|FG001|Overall Study|Subject Non-Compliance|1|||
162612360|NCT02536833|587298334|FG002|Overall Study|Subject Non-Compliance|1|||
162612361|NCT02536833|587298335|FG003|Overall Study|Subject Non-Compliance|0|||
162612362|NCT02536833|587298332|FG000|Overall Study|Withdrawal by Subject|4|||
162612363|NCT02536833|587298333|FG001|Overall Study|Withdrawal by Subject|3|||
162612364|NCT02536833|587298334|FG002|Overall Study|Withdrawal by Subject|5|||
162612365|NCT02536833|587298335|FG003|Overall Study|Withdrawal by Subject|11|||
162612366|NCT00586066|587298338|FG000|Overall Study|Lost to Follow-up|6|||
162612367|NCT00586066|587298339|FG001|Overall Study|Lost to Follow-up|3|||
162612368|NCT00586066|587298338|FG000|Overall Study|Lack of Efficacy|5|||
162612369|NCT00586066|587298339|FG001|Overall Study|Lack of Efficacy|3|||
162612370|NCT00586066|587298338|FG000|Overall Study|Adverse Event|2|||
162612371|NCT00586066|587298339|FG001|Overall Study|Adverse Event|2|||
162612372|NCT00586066|587298338|FG000|Overall Study|Physician Decision|1|||
162612373|NCT00586066|587298339|FG001|Overall Study|Physician Decision|0|||
162612374|NCT00586066|587298338|FG000|Overall Study|Withdrawal of consent|4|||
162612375|NCT00586066|587298339|FG001|Overall Study|Withdrawal of consent|2|||
162612376|NCT00910988|587298340|FG000|Overall Study|Lost to Follow-up|2|||
162612377|NCT00910988|587298341|FG001|Overall Study|Lost to Follow-up|4|||
162612378|NCT00910988|587298342|FG002|Overall Study|Lost to Follow-up|3|||
162612379|NCT00910988|587298343|FG003|Overall Study|Lost to Follow-up|0|||
162612380|NCT02766465|587298344|FG000|Overall Study|Withdrawal by Subject|0|||
162612381|NCT02766465|587298345|FG001|Overall Study|Withdrawal by Subject|10|||
162612382|NCT01907100|587298346|FG000|Overall Study|PD based on modified RECIST criteria|31|||
162612383|NCT01907100|587298347|FG001|Overall Study|PD based on modified RECIST criteria|32|||
162612384|NCT01907100|587298348|FG002|Overall Study|PD based on modified RECIST criteria|95|||
162612385|NCT01907100|587298349|FG003|Overall Study|PD based on modified RECIST criteria|92|||
162612386|NCT01907100|587298346|FG000|Overall Study|Withdrawal by Subject|2|||
162612387|NCT01907100|587298347|FG001|Overall Study|Withdrawal by Subject|5|||
162612388|NCT01907100|587298348|FG002|Overall Study|Withdrawal by Subject|10|||
162612389|NCT01907100|587298349|FG003|Overall Study|Withdrawal by Subject|13|||
162612390|NCT01907100|587298346|FG000|Overall Study|Protocol Violation|0|||
162612391|NCT01907100|587298347|FG001|Overall Study|Protocol Violation|0|||
162612392|NCT01907100|587298348|FG002|Overall Study|Protocol Violation|1|||
162612393|NCT01907100|587298349|FG003|Overall Study|Protocol Violation|1|||
162956340|NCT01854047|588541465|FG001|Overall Study|Other than specified above|3|||
162956341|NCT01854047|588541466|FG002|Overall Study|Other than specified above|3|||
162612394|NCT01907100|587298346|FG000|Overall Study|Lost to Follow-up|0|||
162612395|NCT01907100|587298347|FG001|Overall Study|Lost to Follow-up|0|||
162612396|NCT01907100|587298348|FG002|Overall Study|Lost to Follow-up|0|||
162612397|NCT01907100|587298349|FG003|Overall Study|Lost to Follow-up|1|||
162612398|NCT01907100|587298346|FG000|Overall Study|Not treated|2|||
162612399|NCT01907100|587298347|FG001|Overall Study|Not treated|0|||
162612400|NCT01907100|587298348|FG002|Overall Study|Not treated|1|||
162612401|NCT01907100|587298349|FG003|Overall Study|Not treated|2|||
162858814|NCT01982630|588187612|FG002|Overall Study|Physician Decision|2|||
162858815|NCT01982630|588187613|FG003|Overall Study|Physician Decision|1|||
162858816|NCT01982630|588187614|FG004|Overall Study|Physician Decision|2|||
162858817|NCT01982630|588187615|FG005|Overall Study|Physician Decision|0|||
162858818|NCT01982630|588187616|FG006|Overall Study|Physician Decision|0|||
162858819|NCT01982630|588187617|FG007|Overall Study|Physician Decision|0|||
162858820|NCT01982630|588187610|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858821|NCT01982630|588187611|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858822|NCT01982630|588187612|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
162858823|NCT01982630|588187613|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858824|NCT01982630|588187614|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858825|NCT01982630|588187615|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163044751|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
163044752|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044753|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044754|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
163044755|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
163044756|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
163044757|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
163044758|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
163044759|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
163044760|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
163044761|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
163044762|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
163044763|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
163044764|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
163044765|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
163044766|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
163044767|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
163044768|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
163044769|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
163044770|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
163044771|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
163044772|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
163044773|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
163044774|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
163044775|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044776|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044777|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044778|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162705144|NCT01561079|587632112|FG000|Overall Study|Withdrawal by Subject|59|||
162705145|NCT01561079|587632112|FG000|Overall Study|Protocol Violation|2|||
162705146|NCT03330119|587632113|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
162705147|NCT03330119|587632114|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
162705148|NCT00550732|587632121|FG000|Overall Study|Death|4|||
162705149|NCT00550732|587632121|FG000|Overall Study|Withdrawal by Subject|2|||
162705150|NCT00550732|587632121|FG000|Overall Study|Physician Decision|2|||
163044779|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044780|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044781|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
163044782|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044783|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044784|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044785|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044786|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044787|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044788|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044789|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044790|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163044791|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162705151|NCT00550732|587632121|FG000|Overall Study|Lost to Follow-up|1|||
162705152|NCT00550732|587632121|FG000|Overall Study|Palliative care|1|||
162705153|NCT00550732|587632121|FG000|Overall Study|Adverse Event|1|||
162858826|NCT01982630|588187616|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858827|NCT01982630|588187617|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
162858828|NCT01982630|588187610|FG000|Overall Study|Withdrawal by Subject|0|||
162858829|NCT01982630|588187611|FG001|Overall Study|Withdrawal by Subject|0|||
162858830|NCT01982630|588187612|FG002|Overall Study|Withdrawal by Subject|0|||
162705154|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
162705155|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162858831|NCT01982630|588187613|FG003|Overall Study|Withdrawal by Subject|0|||
162956342|NCT01854047|588541467|FG003|Overall Study|Other than specified above|5|||
162956343|NCT01854047|588541468|FG004|Overall Study|Other than specified above|8|||
162956344|NCT02281084|588541472|FG000|Overall Study|Death|21|||
162956345|NCT02281084|588541473|FG001|Overall Study|Death|18|||
162956346|NCT02281084|588541474|FG002|Overall Study|Death|3|||
162956347|NCT02281084|588541475|FG003|Overall Study|Death|5|||
162956348|NCT02281084|588541472|FG000|Overall Study|Adverse Event|1|||
162956349|NCT02281084|588541473|FG001|Overall Study|Adverse Event|0|||
162956350|NCT02281084|588541474|FG002|Overall Study|Adverse Event|0|||
162956351|NCT02281084|588541475|FG003|Overall Study|Adverse Event|0|||
162956352|NCT02281084|588541472|FG000|Overall Study|Withdrawal by Subject|2|||
162956353|NCT02281084|588541473|FG001|Overall Study|Withdrawal by Subject|2|||
162956354|NCT02281084|588541474|FG002|Overall Study|Withdrawal by Subject|0|||
162956355|NCT02281084|588541475|FG003|Overall Study|Withdrawal by Subject|0|||
162956356|NCT02281084|588541472|FG000|Overall Study|Site Closure by Sponsor|5|||
162956357|NCT02281084|588541473|FG001|Overall Study|Site Closure by Sponsor|1|||
162956358|NCT02281084|588541474|FG002|Overall Study|Site Closure by Sponsor|2|||
162956359|NCT02281084|588541475|FG003|Overall Study|Site Closure by Sponsor|0|||
162956360|NCT02957942|588541476|FG000|Overall Study|Withdrawal by Subject|0|||
162956361|NCT02957942|588541477|FG001|Overall Study|Withdrawal by Subject|1|||
162956362|NCT02957942|588541476|FG000|Overall Study|Practicing experiment protocol|0|||
162956363|NCT02957942|588541477|FG001|Overall Study|Practicing experiment protocol|6|||
162956364|NCT02655679|588541480|FG000|Overall Study|Adverse Event|0|||
162956365|NCT02655679|588541481|FG001|Overall Study|Adverse Event|1|||
162612402|NCT01907100|587298346|FG000|Overall Study|Other than reasons specified|1|||
162612403|NCT01907100|587298347|FG001|Overall Study|Other than reasons specified|0|||
162612404|NCT01907100|587298348|FG002|Overall Study|Other than reasons specified|10|||
162612405|NCT01907100|587298349|FG003|Overall Study|Other than reasons specified|6|||
162612406|NCT01907100|587298346|FG000|Overall Study|Adverse event (AE)|6|||
162612407|NCT01907100|587298347|FG001|Overall Study|Adverse event (AE)|3|||
162612408|NCT01907100|587298348|FG002|Overall Study|Adverse event (AE)|22|||
162612409|NCT01907100|587298349|FG003|Overall Study|Adverse event (AE)|23|||
162612410|NCT01907100|587298346|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
162612411|NCT01907100|587298347|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
162612412|NCT01907100|587298348|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
162612413|NCT01907100|587298349|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
162612414|NCT01758289|587298350|FG000|Overall Study|Premature Study Termination|44|||
162612415|NCT01758289|587298350|FG000|Overall Study|Adverse Event|9|||
162612416|NCT01574079|587298351|FG000|Overall Study|Physician Decision|0|||
162612417|NCT01574079|587298352|FG001|Overall Study|Physician Decision|2|||
162612418|NCT01574079|587298351|FG000|Overall Study|Lost to Follow-up|1|||
162612419|NCT01574079|587298352|FG001|Overall Study|Lost to Follow-up|0|||
162612420|NCT02059005|587298355|FG000|Overall Study|Death|1|||
162612421|NCT02059005|587298356|FG001|Overall Study|Death|3|||
162612422|NCT02059005|587298355|FG000|Overall Study|Lost to Follow-up|19|||
162612423|NCT02059005|587298356|FG001|Overall Study|Lost to Follow-up|19|||
162612424|NCT02059005|587298355|FG000|Overall Study|Incarceration|0|||
162612425|NCT02059005|587298356|FG001|Overall Study|Incarceration|1|||
162612426|NCT02059005|587298355|FG000|Overall Study|Inpatient|0|||
162612427|NCT02059005|587298356|FG001|Overall Study|Inpatient|1|||
162612428|NCT00908011|587298357|FG000|Overall Study|Withdrawal by Subject|2|||
162612429|NCT00908011|587298358|FG001|Overall Study|Withdrawal by Subject|2|||
162612430|NCT00843726|587298359|FG000|Overall Study|Death|1|||
162612431|NCT00843726|587298360|FG001|Overall Study|Death|0|||
162612432|NCT00843726|587298359|FG000|Overall Study|Withdrawal by Subject|0|||
162612433|NCT00843726|587298360|FG001|Overall Study|Withdrawal by Subject|1|||
162612434|NCT00667602|587298361|FG000|Overall Study|Withdrawal by Subject|4|||
162612435|NCT00667602|587298362|FG001|Overall Study|Withdrawal by Subject|9|||
162612436|NCT00667602|587298363|FG002|Overall Study|Withdrawal by Subject|10|||
162612437|NCT00667602|587298361|FG000|Overall Study|Lost to Follow-up|4|||
162612438|NCT00667602|587298362|FG001|Overall Study|Lost to Follow-up|5|||
162612439|NCT00667602|587298363|FG002|Overall Study|Lost to Follow-up|6|||
162612440|NCT00667602|587298361|FG000|Overall Study|Administrative reason|0|||
162612441|NCT00667602|587298362|FG001|Overall Study|Administrative reason|0|||
162612442|NCT00667602|587298363|FG002|Overall Study|Administrative reason|2|||
162612443|NCT00667602|587298361|FG000|Overall Study|Protocol Violation|0|||
162612444|NCT00667602|587298362|FG001|Overall Study|Protocol Violation|1|||
162612445|NCT00667602|587298363|FG002|Overall Study|Protocol Violation|0|||
162612446|NCT03640559|587298366|FG000|Overall Study|Physician Decision|1|||
162612447|NCT03640559|587298367|FG001|Overall Study|Physician Decision|1|||
162956366|NCT02655679|588541482|FG002|Overall Study|Adverse Event|0|||
162956367|NCT02655679|588541483|FG003|Overall Study|Adverse Event|0|||
162956368|NCT02655679|588541484|FG004|Overall Study|Adverse Event|0|||
162956369|NCT02655679|588541480|FG000|Overall Study|Withdrawal by Subject|1|||
162956370|NCT02655679|588541481|FG001|Overall Study|Withdrawal by Subject|1|||
162956371|NCT02655679|588541482|FG002|Overall Study|Withdrawal by Subject|0|||
162612448|NCT03640559|587298366|FG000|Overall Study|Withdrawal by Subject|1|||
162612449|NCT03640559|587298367|FG001|Overall Study|Withdrawal by Subject|0|||
162858832|NCT01982630|588187614|FG004|Overall Study|Withdrawal by Subject|0|||
162858833|NCT01982630|588187615|FG005|Overall Study|Withdrawal by Subject|1|||
162956372|NCT02655679|588541483|FG003|Overall Study|Withdrawal by Subject|3|||
162956373|NCT02655679|588541484|FG004|Overall Study|Withdrawal by Subject|1|||
162956374|NCT02655679|588541480|FG000|Overall Study|Inability to Comply with the Protocol|1|||
162956375|NCT02655679|588541481|FG001|Overall Study|Inability to Comply with the Protocol|0|||
162956376|NCT02655679|588541482|FG002|Overall Study|Inability to Comply with the Protocol|0|||
162956377|NCT02655679|588541483|FG003|Overall Study|Inability to Comply with the Protocol|0|||
162956378|NCT02655679|588541484|FG004|Overall Study|Inability to Comply with the Protocol|0|||
162956379|NCT02655679|588541480|FG000|Overall Study|Lost to Follow-up|0|||
162956380|NCT02655679|588541481|FG001|Overall Study|Lost to Follow-up|1|||
162956381|NCT02655679|588541482|FG002|Overall Study|Lost to Follow-up|1|||
162956382|NCT02655679|588541483|FG003|Overall Study|Lost to Follow-up|1|||
162858834|NCT01982630|588187616|FG006|Overall Study|Withdrawal by Subject|0|||
162858835|NCT01982630|588187617|FG007|Overall Study|Withdrawal by Subject|0|||
162858836|NCT01076179|588187618|FG000|Overall Study|Withdrawal by Subject|1|||
162858837|NCT00986349|588187619|FG000|Overall Study|Unsuccessful implant procedure|3|||
162858838|NCT00986349|588187619|FG000|Overall Study|Adverse Event|2|||
162858839|NCT00986349|588187619|FG000|Overall Study|Physician Decision|1|||
162858840|NCT00986349|588187619|FG000|Overall Study|device migration|1|||
162858841|NCT02299934|588187620|FG000|Overall Study|Termination of study|13|||
162956383|NCT02655679|588541484|FG004|Overall Study|Lost to Follow-up|0|||
162956384|NCT02655679|588541480|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162956385|NCT02655679|588541481|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162956386|NCT02655679|588541482|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162956387|NCT02655679|588541483|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162956388|NCT02655679|588541484|FG004|Overall Study|Other Miscellaneous Reasons|0|||
162612450|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
162858842|NCT00561353|588187621|FG000|Overall Study|Subject reached a virologic endpoint|2|||
162858843|NCT00561353|588187622|FG001|Overall Study|Subject reached a virologic endpoint|1|||
162858844|NCT00561353|588187623|FG002|Overall Study|Subject reached a virologic endpoint|1|||
162858845|NCT00561353|588187624|FG003|Overall Study|Subject reached a virologic endpoint|4|||
162858846|NCT00561353|588187625|FG004|Overall Study|Subject reached a virologic endpoint|1|||
162858847|NCT00561353|588187626|FG005|Overall Study|Subject reached a virologic endpoint|3|||
162858848|NCT00561353|588187627|FG006|Overall Study|Subject reached a virologic endpoint|4|||
162858849|NCT00561353|588187628|FG007|Overall Study|Subject reached a virologic endpoint|4|||
162858850|NCT00561353|588187629|FG008|Overall Study|Subject reached a virologic endpoint|5|||
162858851|NCT00561353|588187630|FG009|Overall Study|Subject reached a virologic endpoint|0|||
162858852|NCT00561353|588187621|FG000|Overall Study|Subject ineligible to continue the trial|0|||
162858853|NCT00561353|588187622|FG001|Overall Study|Subject ineligible to continue the trial|0|||
162858854|NCT00561353|588187623|FG002|Overall Study|Subject ineligible to continue the trial|0|||
162858855|NCT00561353|588187624|FG003|Overall Study|Subject ineligible to continue the trial|0|||
162858856|NCT00561353|588187625|FG004|Overall Study|Subject ineligible to continue the trial|0|||
162858857|NCT00561353|588187626|FG005|Overall Study|Subject ineligible to continue the trial|1|||
162858858|NCT00561353|588187627|FG006|Overall Study|Subject ineligible to continue the trial|1|||
162858859|NCT00561353|588187628|FG007|Overall Study|Subject ineligible to continue the trial|0|||
162858860|NCT00561353|588187629|FG008|Overall Study|Subject ineligible to continue the trial|2|||
162858861|NCT00561353|588187630|FG009|Overall Study|Subject ineligible to continue the trial|1|||
162858862|NCT00561353|588187621|FG000|Overall Study|Other|1|||
162858863|NCT00561353|588187622|FG001|Overall Study|Other|0|||
162858864|NCT00561353|588187623|FG002|Overall Study|Other|1|||
162858865|NCT00561353|588187624|FG003|Overall Study|Other|0|||
162858866|NCT00561353|588187625|FG004|Overall Study|Other|0|||
162858867|NCT00561353|588187626|FG005|Overall Study|Other|2|||
162858868|NCT00561353|588187627|FG006|Overall Study|Other|0|||
162858869|NCT00561353|588187628|FG007|Overall Study|Other|0|||
162858870|NCT00561353|588187629|FG008|Overall Study|Other|0|||
162858871|NCT00561353|588187630|FG009|Overall Study|Other|0|||
162858872|NCT00561353|588187621|FG000|Overall Study|Adverse Event|0|||
162956389|NCT03801707|588541485|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
163044792|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162612451|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
162612452|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
162612453|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
162612454|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
162612455|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
162612456|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
162956390|NCT00819741|588541486|FG000|Overall Study|Adverse Event|5|||
162956391|NCT00819741|588541487|FG001|Overall Study|Adverse Event|2|||
162858873|NCT00561353|588187622|FG001|Overall Study|Adverse Event|0|||
162858874|NCT00561353|588187623|FG002|Overall Study|Adverse Event|0|||
162858875|NCT00561353|588187624|FG003|Overall Study|Adverse Event|2|||
162858876|NCT00561353|588187625|FG004|Overall Study|Adverse Event|0|||
162705156|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162705157|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162705158|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162705159|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
162705160|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
162705161|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
162705162|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
162705163|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
162705164|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
162705165|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
162705166|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162705167|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
162705168|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162705169|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162705170|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162705171|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162705172|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162705173|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162705174|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162705175|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162705176|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
162705177|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162705178|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162705179|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162705180|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162705181|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162705182|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162705183|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162705184|NCT01323660|587632122|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
162705185|NCT01323660|587632123|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162705186|NCT01323660|587632124|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162705187|NCT01323660|587632125|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162705188|NCT01323660|587632126|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
162705189|NCT01323660|587632127|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162705190|NCT01323660|587632122|FG000|Washout Period (14 Days)|Adverse Event|0|||
162705191|NCT01323660|587632123|FG001|Washout Period (14 Days)|Adverse Event|0|||
162705192|NCT01323660|587632124|FG002|Washout Period (14 Days)|Adverse Event|0|||
162705193|NCT01323660|587632125|FG003|Washout Period (14 Days)|Adverse Event|0|||
162705194|NCT01323660|587632126|FG004|Washout Period (14 Days)|Adverse Event|1|||
162705195|NCT01323660|587632127|FG005|Washout Period (14 Days)|Adverse Event|0|||
162705196|NCT01323660|587632122|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
162705197|NCT01323660|587632123|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
162705198|NCT01323660|587632124|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
162705199|NCT01323660|587632125|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
162705200|NCT01323660|587632126|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
162705201|NCT01323660|587632127|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
162705202|NCT01323660|587632122|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162705203|NCT01323660|587632123|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162705204|NCT01323660|587632124|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162705205|NCT01323660|587632125|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162705206|NCT01323660|587632126|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162705207|NCT01323660|587632127|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
162705208|NCT01323660|587632122|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
162705209|NCT01323660|587632123|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
162705210|NCT01323660|587632124|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162705211|NCT01323660|587632125|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162705212|NCT01323660|587632126|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162705213|NCT01323660|587632127|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
162705214|NCT01323660|587632122|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162705215|NCT01323660|587632123|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162705216|NCT01323660|587632124|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162705217|NCT01323660|587632125|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162858877|NCT00561353|588187626|FG005|Overall Study|Adverse Event|0|||
162858878|NCT00561353|588187627|FG006|Overall Study|Adverse Event|1|||
162858879|NCT00561353|588187628|FG007|Overall Study|Adverse Event|0|||
162858880|NCT00561353|588187629|FG008|Overall Study|Adverse Event|0|||
162858881|NCT00561353|588187630|FG009|Overall Study|Adverse Event|1|||
162858882|NCT00561353|588187621|FG000|Overall Study|Lost to Follow-up|2|||
162858883|NCT00561353|588187622|FG001|Overall Study|Lost to Follow-up|0|||
162858884|NCT00561353|588187623|FG002|Overall Study|Lost to Follow-up|1|||
162705218|NCT01323660|587632126|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162705219|NCT01323660|587632127|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
162705220|NCT01323660|587632122|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162705221|NCT01323660|587632123|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162705222|NCT01323660|587632124|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162705223|NCT01323660|587632125|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162705224|NCT01323660|587632126|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162705225|NCT01323660|587632127|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162705226|NCT01323660|587632122|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162705227|NCT01323660|587632123|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162705228|NCT01323660|587632124|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162705229|NCT01323660|587632125|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162705230|NCT01323660|587632126|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
162705231|NCT01323660|587632127|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162705232|NCT00926393|587632131|FG000|Overall Study|Withdrawal by Subject|1|||
162705233|NCT00926393|587632132|FG001|Overall Study|Withdrawal by Subject|2|||
162705234|NCT00926393|587632131|FG000|Overall Study|Adverse Event|1|||
162705235|NCT00926393|587632132|FG001|Overall Study|Adverse Event|1|||
162705236|NCT00751790|587632138|FG000|Overall Study|Lost to Follow-up|1|||
162705237|NCT00751790|587632138|FG000|Overall Study|Death|3|||
162705238|NCT00751790|587632138|FG000|Overall Study|Withdrawal by Subject|1|||
162705239|NCT00180674|587632140|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
162705240|NCT00180674|587632140|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
162705241|NCT03302910|587632141|FG000|Overall Study|Protocol Violation|1|||
162705242|NCT03302910|587632142|FG001|Overall Study|Protocol Violation|0|||
162705243|NCT01106976|587632145|FG000|Overall Study|Lost to Follow-up|8|||
162705244|NCT01477749|587632148|FG000|Overall Study|Physician Decision|4|||
162705245|NCT01094743|587632155|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
162705246|NCT04004208|587632158|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162705247|NCT04004208|587632159|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162705248|NCT04004208|587632158|FG000|Overall Study|Death|3|||
162705249|NCT04004208|587632159|FG001|Overall Study|Death|0|||
162705250|NCT04004208|587632158|FG000|Overall Study|COVID-19 pandemic|1|||
162705251|NCT04004208|587632159|FG001|Overall Study|COVID-19 pandemic|0|||
162705252|NCT04004208|587632158|FG000|Overall Study|Physician Decision|1|||
162705253|NCT04004208|587632159|FG001|Overall Study|Physician Decision|0|||
162705254|NCT04004208|587632158|FG000|Overall Study|Adverse Event|1|||
162705255|NCT04004208|587632159|FG001|Overall Study|Adverse Event|1|||
162705256|NCT02118714|587632171|FG000|Overall Study|Lost to Follow-up|2|||
162705257|NCT02118714|587632171|FG000|Overall Study|Protocol Violation|1|||
162705258|NCT03023332|587632175|FG000|Overall Study|Withdrawal by Subject|10|||
162705259|NCT03023332|587632176|FG001|Overall Study|Withdrawal by Subject|5|||
162705260|NCT03023332|587632177|FG002|Overall Study|Withdrawal by Subject|4|||
162705261|NCT03023332|587632178|FG003|Overall Study|Withdrawal by Subject|7|||
162705262|NCT03023332|587632175|FG000|Overall Study|Lost to Follow-up|13|||
162858885|NCT00561353|588187624|FG003|Overall Study|Lost to Follow-up|0|||
162858886|NCT00561353|588187625|FG004|Overall Study|Lost to Follow-up|0|||
162858887|NCT00561353|588187626|FG005|Overall Study|Lost to Follow-up|0|||
162858888|NCT00561353|588187627|FG006|Overall Study|Lost to Follow-up|0|||
162858889|NCT00561353|588187628|FG007|Overall Study|Lost to Follow-up|0|||
162858890|NCT00561353|588187629|FG008|Overall Study|Lost to Follow-up|0|||
162858891|NCT00561353|588187630|FG009|Overall Study|Lost to Follow-up|0|||
162858892|NCT00561353|588187621|FG000|Overall Study|Withdrawal by Subject|0|||
162858893|NCT00561353|588187622|FG001|Overall Study|Withdrawal by Subject|2|||
162858894|NCT00561353|588187623|FG002|Overall Study|Withdrawal by Subject|0|||
162858895|NCT00561353|588187624|FG003|Overall Study|Withdrawal by Subject|0|||
162858896|NCT00561353|588187625|FG004|Overall Study|Withdrawal by Subject|0|||
162858897|NCT00561353|588187626|FG005|Overall Study|Withdrawal by Subject|0|||
162858898|NCT00561353|588187627|FG006|Overall Study|Withdrawal by Subject|0|||
162858899|NCT00561353|588187628|FG007|Overall Study|Withdrawal by Subject|0|||
162858900|NCT00561353|588187629|FG008|Overall Study|Withdrawal by Subject|0|||
162858901|NCT00561353|588187630|FG009|Overall Study|Withdrawal by Subject|0|||
162705263|NCT03023332|587632176|FG001|Overall Study|Lost to Follow-up|16|||
162705264|NCT03023332|587632177|FG002|Overall Study|Lost to Follow-up|8|||
162705265|NCT03023332|587632178|FG003|Overall Study|Lost to Follow-up|13|||
162705266|NCT03023332|587632175|FG000|Overall Study|Death|1|||
162705267|NCT03023332|587632176|FG001|Overall Study|Death|0|||
162705268|NCT03023332|587632177|FG002|Overall Study|Death|0|||
162705269|NCT03023332|587632178|FG003|Overall Study|Death|0|||
162705270|NCT02412761|587632179|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162705271|NCT02412761|587632180|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162858902|NCT01273818|588187631|FG000|Overall Study|Physician Decision|13|||
162858903|NCT01273818|588187632|FG001|Overall Study|Physician Decision|2|||
162705272|NCT02412761|587632181|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162858904|NCT01273818|588187633|FG002|Overall Study|Physician Decision|9|||
162858905|NCT03934684|588187634|FG000|Overall Study|Participants continuing in study|11|||
162612457|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
162612458|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
162612459|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
162612460|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
162612461|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
162612462|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
162612463|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
162612464|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
162612465|NCT01436162|587298368|FG000|Single-blind Lead-in Phase|Other|107|||
162612466|NCT01436162|587298369|FG001|Single-blind Lead-in Phase|Other|0|||
162612467|NCT01436162|587298370|FG002|Single-blind Lead-in Phase|Other|0|||
162612468|NCT01436162|587298368|FG000|Randomized Phase|Adverse Event|1|||
162612469|NCT01436162|587298369|FG001|Randomized Phase|Adverse Event|5|||
162612470|NCT01436162|587298370|FG002|Randomized Phase|Adverse Event|6|||
162612471|NCT01436162|587298368|FG000|Randomized Phase|Protocol Violation|4|||
162612472|NCT01436162|587298369|FG001|Randomized Phase|Protocol Violation|4|||
162612473|NCT01436162|587298370|FG002|Randomized Phase|Protocol Violation|2|||
162612474|NCT01436162|587298368|FG000|Randomized Phase|Withdrawal by Subject|16|||
162612475|NCT01436162|587298369|FG001|Randomized Phase|Withdrawal by Subject|9|||
162612476|NCT01436162|587298370|FG002|Randomized Phase|Withdrawal by Subject|8|||
162612477|NCT01436162|587298368|FG000|Randomized Phase|Lost to Follow-up|17|||
162612478|NCT01436162|587298369|FG001|Randomized Phase|Lost to Follow-up|5|||
162612479|NCT01436162|587298370|FG002|Randomized Phase|Lost to Follow-up|4|||
162612480|NCT01436162|587298368|FG000|Randomized Phase|Lack of Efficacy|0|||
162612481|NCT01436162|587298369|FG001|Randomized Phase|Lack of Efficacy|1|||
162612482|NCT01436162|587298370|FG002|Randomized Phase|Lack of Efficacy|1|||
162612483|NCT01436162|587298368|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
162612484|NCT01436162|587298369|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
162612485|NCT01436162|587298370|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
162612486|NCT01436162|587298368|FG000|Randomized Phase|Other|2|||
162612487|NCT01436162|587298369|FG001|Randomized Phase|Other|5|||
162612488|NCT01436162|587298370|FG002|Randomized Phase|Other|4|||
162612489|NCT02567552|587298371|FG000|Overall Study|Adverse Event|0|||
162612490|NCT02567552|587298372|FG001|Overall Study|Adverse Event|1|||
162612491|NCT00171054|587298377|FG000|Overall Study|Protocol Violation|1|||
162612492|NCT00171054|587298378|FG001|Overall Study|Protocol Violation|2|||
162612493|NCT00171054|587298377|FG000|Overall Study|Patient withdrew consent|1|||
162612494|NCT00171054|587298378|FG001|Overall Study|Patient withdrew consent|0|||
162612495|NCT00171054|587298377|FG000|Overall Study|Lost to Follow-up|0|||
162612496|NCT00171054|587298378|FG001|Overall Study|Lost to Follow-up|1|||
162612497|NCT00171054|587298377|FG000|Overall Study|Adverse Event|8|||
162956392|NCT00819741|588541486|FG000|Overall Study|Lack of Efficacy|0|||
162956393|NCT00819741|588541487|FG001|Overall Study|Lack of Efficacy|2|||
162956394|NCT00819741|588541486|FG000|Overall Study|Lost to Follow-up|3|||
162956395|NCT00819741|588541487|FG001|Overall Study|Lost to Follow-up|1|||
162956396|NCT00819741|588541486|FG000|Overall Study|Protocol Violation|3|||
162956397|NCT00819741|588541487|FG001|Overall Study|Protocol Violation|4|||
162956398|NCT00819741|588541486|FG000|Overall Study|Withdrawal by Subject|2|||
162956399|NCT00819741|588541487|FG001|Overall Study|Withdrawal by Subject|2|||
162612498|NCT00171054|587298378|FG001|Overall Study|Adverse Event|8|||
162612499|NCT00171054|587298377|FG000|Overall Study|Condition no longer required study drug|0|||
162612500|NCT00171054|587298378|FG001|Overall Study|Condition no longer required study drug|1|||
162612501|NCT04669535|587298379|FG000|Overall Study|Death|1|||
162612502|NCT04669535|587298380|FG001|Overall Study|Death|1|||
162612503|NCT04669535|587298381|FG002|Overall Study|Death|0|||
162612504|NCT04669535|587298382|FG003|Overall Study|Death|0|||
162612505|NCT01876810|587298383|FG000|Overall Study|Physician Decision|0|||
162612506|NCT01876810|587298384|FG001|Overall Study|Physician Decision|1|||
162612507|NCT04382755|587298388|FG000|Overall Study|Withdrawal by Subject|1|||
162612508|NCT04382755|587298389|FG001|Overall Study|Withdrawal by Subject|0|||
162612509|NCT04382755|587298388|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
162612510|NCT04382755|587298389|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
162612511|NCT04382755|587298388|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
162612512|NCT04382755|587298389|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
162612513|NCT00458536|587298397|FG000|Overall Study|Disease progression prior to treatment|7|||
162612514|NCT00458536|587298397|FG000|Overall Study|Unable to make vaccine|3|||
162612515|NCT00458536|587298397|FG000|Overall Study|No measurable disease after surgery|2|||
162612516|NCT00458536|587298397|FG000|Overall Study|Did not have renal cell carcinoma|2|||
162612517|NCT00458536|587298397|FG000|Overall Study|Patient did not have surgery|1|||
162612518|NCT00458536|587298397|FG000|Overall Study|Ineligible due to toxicity|1|||
162612519|NCT00458536|587298397|FG000|Overall Study|Withdrawal by Subject|1|||
162612520|NCT00458536|587298397|FG000|Overall Study|Progressive disease during treatment|2|||
162956400|NCT00819741|588541486|FG000|Overall Study|Unclassified|6|||
162956401|NCT00819741|588541487|FG001|Overall Study|Unclassified|0|||
162956402|NCT00819741|588541486|FG000|Overall Study|Reasons unknown|3|||
162956403|NCT00819741|588541487|FG001|Overall Study|Reasons unknown|3|||
162956404|NCT02222818|588543507|FG000|Period 1|Eligibility criteria not met|0|||
162956405|NCT02222818|588543508|FG001|Period 1|Eligibility criteria not met|3|||
162956406|NCT00834717|588543509|FG000|First Intervention|Adverse Event|1|||
162956407|NCT00834717|588543510|FG001|First Intervention|Adverse Event|0|||
162956408|NCT00834717|588543509|FG000|First Intervention|Withdrawal by Subject|0|||
162956409|NCT00834717|588543510|FG001|First Intervention|Withdrawal by Subject|1|||
162956410|NCT01660243|588543511|FG000|Overall Study|Adverse Event|1|||
162956411|NCT01660243|588543512|FG001|Overall Study|Adverse Event|0|||
162956412|NCT01660243|588543513|FG002|Overall Study|Adverse Event|1|||
162956413|NCT01660243|588543514|FG003|Overall Study|Adverse Event|0|||
162956414|NCT01660243|588543511|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
162956415|NCT01660243|588543512|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956416|NCT01660243|588543513|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956417|NCT01660243|588543514|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
162956418|NCT01660243|588543511|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956419|NCT01660243|588543512|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956420|NCT01660243|588543513|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
162956421|NCT01660243|588543514|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
162956422|NCT01660243|588543511|FG000|Overall Study|Randomization error|0|||
162956423|NCT01660243|588543512|FG001|Overall Study|Randomization error|0|||
162956424|NCT01660243|588543513|FG002|Overall Study|Randomization error|0|||
162956425|NCT01660243|588543514|FG003|Overall Study|Randomization error|1|||
162956426|NCT04299087|588543515|FG000|Overall Study|Lost to Follow-up|2|||
162956427|NCT04299087|588543516|FG001|Overall Study|Lost to Follow-up|1|||
162956428|NCT03025087|588543517|FG000|Overall Study|Physician Decision|3|||
162956429|NCT03025087|588543518|FG001|Overall Study|Physician Decision|3|||
162956430|NCT03025087|588543519|FG002|Overall Study|Physician Decision|0|||
162956431|NCT03025087|588543520|FG003|Overall Study|Physician Decision|0|||
162956432|NCT03025087|588543521|FG004|Overall Study|Physician Decision|0|||
162956433|NCT03025087|588543517|FG000|Overall Study|Withdrawal by Subject|1|||
162956434|NCT03025087|588543518|FG001|Overall Study|Withdrawal by Subject|1|||
162956435|NCT03025087|588543519|FG002|Overall Study|Withdrawal by Subject|0|||
162956436|NCT03025087|588543520|FG003|Overall Study|Withdrawal by Subject|0|||
162956437|NCT03025087|588543521|FG004|Overall Study|Withdrawal by Subject|0|||
162956438|NCT03025087|588543517|FG000|Overall Study|Unable to complete MRI|2|||
162956439|NCT03025087|588543518|FG001|Overall Study|Unable to complete MRI|2|||
162956440|NCT03025087|588543519|FG002|Overall Study|Unable to complete MRI|0|||
162956441|NCT03025087|588543520|FG003|Overall Study|Unable to complete MRI|0|||
162956442|NCT03025087|588543521|FG004|Overall Study|Unable to complete MRI|0|||
162956443|NCT00594035|588543522|FG000|Overall Study|Lost to Follow-up|1|||
162956444|NCT00594035|588543523|FG001|Overall Study|Lost to Follow-up|1|||
162956445|NCT00594035|588543522|FG000|Overall Study|Withdrawal by Subject|1|||
162956446|NCT00594035|588543523|FG001|Overall Study|Withdrawal by Subject|0|||
162956447|NCT00594035|588543522|FG000|Overall Study|Subject transferred to nursing home|0|||
162956448|NCT00594035|588543523|FG001|Overall Study|Subject transferred to nursing home|1|||
162956449|NCT00594035|588543522|FG000|Overall Study|Subject couldn't return due to job|0|||
162956450|NCT00594035|588543523|FG001|Overall Study|Subject couldn't return due to job|1|||
162956451|NCT00795821|588543524|FG000|Acute Treatment Phase|Adverse Event|23|||
162956452|NCT00795821|588543525|FG001|Acute Treatment Phase|Adverse Event|4|||
162956453|NCT00795821|588543524|FG000|Acute Treatment Phase|Death|1|||
162956454|NCT00795821|588543525|FG001|Acute Treatment Phase|Death|0|||
162956455|NCT00795821|588543524|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
162956456|NCT00795821|588543525|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
162956457|NCT00795821|588543524|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
162956458|NCT00795821|588543525|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
162956459|NCT00795821|588543524|FG000|Acute Treatment Phase|Physician Decision|1|||
162956460|NCT00795821|588543525|FG001|Acute Treatment Phase|Physician Decision|1|||
162956461|NCT00795821|588543524|FG000|Acute Treatment Phase|Protocol Violation|1|||
163044793|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
163044794|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
162858906|NCT03934684|588187635|FG001|Overall Study|Participants continuing in study|4|||
162858907|NCT03934684|588187634|FG000|Overall Study|Discontinuation of carfilzomib|20|||
162858908|NCT03934684|588187635|FG001|Overall Study|Discontinuation of carfilzomib|30|||
162858909|NCT03934684|588187634|FG000|Overall Study|Death|2|||
162858910|NCT03934684|588187635|FG001|Overall Study|Death|2|||
162858911|NCT03934684|588187634|FG000|Overall Study|Lost to Follow-up|2|||
162858912|NCT03934684|588187635|FG001|Overall Study|Lost to Follow-up|5|||
162858913|NCT03934684|588187634|FG000|Overall Study|Withdrawal by Subject|7|||
162858914|NCT03934684|588187635|FG001|Overall Study|Withdrawal by Subject|8|||
162858915|NCT01097044|588187645|FG000|Overall Study|Withdrawal by Subject|4|||
162858916|NCT01097044|588187646|FG001|Overall Study|Withdrawal by Subject|4|||
162858917|NCT01097044|588187645|FG000|Overall Study|Lost to Follow-up|1|||
162858918|NCT01097044|588187646|FG001|Overall Study|Lost to Follow-up|0|||
162858919|NCT01097044|588187645|FG000|Overall Study|Withdrawal by Sponsor|0|||
162858920|NCT01097044|588187646|FG001|Overall Study|Withdrawal by Sponsor|1|||
162858921|NCT02452359|588187648|FG000|Overall Study|Adverse Event|1|||
162858922|NCT02452359|588187648|FG000|Overall Study|Lost to Follow-up|15|||
162858923|NCT02452359|588187648|FG000|Overall Study|Pregnancy|1|||
162858924|NCT02452359|588187648|FG000|Overall Study|Withdrawal by Subject|4|||
162858925|NCT03414359|588187649|FG000|Overall Study|Lack of Efficacy|1|||
162858926|NCT03414359|588187650|FG001|Overall Study|Lack of Efficacy|1|||
162858927|NCT03414359|588187649|FG000|Overall Study|Protocol Violation|0|||
162858928|NCT03414359|588187650|FG001|Overall Study|Protocol Violation|1|||
162858929|NCT04865731|588187651|FG000|Overall Study|Physician Decision|2|||
162858930|NCT04865731|588187652|FG001|Overall Study|Physician Decision|1|||
162858931|NCT04865731|588187651|FG000|Overall Study|Adverse Event|1|||
162858932|NCT04865731|588187652|FG001|Overall Study|Adverse Event|0|||
162858933|NCT04865731|588187651|FG000|Overall Study|Withdrawal by Subject|0|||
162858934|NCT04865731|588187652|FG001|Overall Study|Withdrawal by Subject|1|||
162858935|NCT00222105|588187655|FG000|Overall Study|Removed due to wrong diagnosis|1|||
162858936|NCT00222105|588187655|FG000|Overall Study|Withdrawal by Subject|1|||
162858937|NCT00222105|588187655|FG000|Overall Study|Adverse Event|8|||
162858938|NCT00222105|588187655|FG000|Overall Study|Treatment delays|2|||
162858939|NCT00222105|588187655|FG000|Overall Study|Death|2|||
162858940|NCT03395210|588189095|FG000|Overall Study|Other|0|||
162858941|NCT03395210|588189096|FG001|Overall Study|Other|0|||
162858942|NCT03395210|588189097|FG002|Overall Study|Other|0|||
162858943|NCT03395210|588189098|FG003|Overall Study|Other|0|||
162858944|NCT03395210|588189099|FG004|Overall Study|Other|1|||
162858945|NCT03395210|588189095|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
162858946|NCT03395210|588189096|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
162858947|NCT03395210|588189097|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
162858948|NCT03395210|588189098|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
162858949|NCT03395210|588189099|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
162858950|NCT03395210|588189095|FG000|Overall Study|Adverse Event|1|||
162858951|NCT03395210|588189096|FG001|Overall Study|Adverse Event|0|||
162858952|NCT03395210|588189097|FG002|Overall Study|Adverse Event|2|||
162858953|NCT03395210|588189098|FG003|Overall Study|Adverse Event|4|||
162858954|NCT03395210|588189099|FG004|Overall Study|Adverse Event|3|||
162858955|NCT03395210|588189095|FG000|Overall Study|Need of Rescue Medication|1|||
162858956|NCT03395210|588189096|FG001|Overall Study|Need of Rescue Medication|0|||
162858957|NCT03395210|588189097|FG002|Overall Study|Need of Rescue Medication|1|||
162858958|NCT03395210|588189098|FG003|Overall Study|Need of Rescue Medication|4|||
162858959|NCT03395210|588189099|FG004|Overall Study|Need of Rescue Medication|0|||
162858960|NCT03395210|588189095|FG000|Overall Study|Lack of Response|0|||
162858961|NCT03395210|588189096|FG001|Overall Study|Lack of Response|0|||
162858962|NCT03395210|588189097|FG002|Overall Study|Lack of Response|0|||
162858963|NCT03395210|588189098|FG003|Overall Study|Lack of Response|5|||
162858964|NCT03395210|588189099|FG004|Overall Study|Lack of Response|5|||
162858965|NCT03395210|588189095|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
162858966|NCT03395210|588189096|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
162858967|NCT03395210|588189097|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
162858968|NCT03395210|588189098|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
162858969|NCT03395210|588189099|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
162858970|NCT03395210|588189095|FG000|Overall Study|Participant Decision|1|||
162858971|NCT03395210|588189096|FG001|Overall Study|Participant Decision|1|||
162858972|NCT03395210|588189097|FG002|Overall Study|Participant Decision|0|||
162858973|NCT03395210|588189098|FG003|Overall Study|Participant Decision|4|||
162858974|NCT03395210|588189099|FG004|Overall Study|Participant Decision|0|||
162858975|NCT03395210|588189095|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
162858976|NCT03395210|588189096|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
162858977|NCT03395210|588189097|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
162956462|NCT00795821|588543525|FG001|Acute Treatment Phase|Protocol Violation|2|||
162956463|NCT00795821|588543524|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
162956464|NCT00795821|588543525|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
162956465|NCT00795821|588543524|FG000|Long-term Extension Phase|Adverse Event|25|||
162956466|NCT00795821|588543525|FG001|Long-term Extension Phase|Adverse Event|32|||
162956467|NCT00795821|588543524|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
162956468|NCT00795821|588543525|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
162956469|NCT00795821|588543524|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
162956470|NCT00795821|588543525|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
162956471|NCT00795821|588543524|FG000|Long-term Extension Phase|Physician Decision|1|||
162956472|NCT00795821|588543525|FG001|Long-term Extension Phase|Physician Decision|2|||
162956473|NCT00795821|588543524|FG000|Long-term Extension Phase|Protocol Violation|3|||
162956474|NCT00795821|588543525|FG001|Long-term Extension Phase|Protocol Violation|5|||
162956475|NCT00795821|588543524|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
162956476|NCT00795821|588543525|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
162956477|NCT00795821|588543524|FG000|Taper Phase|Adverse Event|2|||
162956478|NCT00795821|588543525|FG001|Taper Phase|Adverse Event|0|||
162956479|NCT00795821|588543524|FG000|Taper Phase|Lost to Follow-up|1|||
162956480|NCT00795821|588543525|FG001|Taper Phase|Lost to Follow-up|0|||
162956481|NCT00795821|588543524|FG000|Taper Phase|Physician Decision|2|||
162956482|NCT00795821|588543525|FG001|Taper Phase|Physician Decision|0|||
162956483|NCT00795821|588543524|FG000|Taper Phase|Withdrawal by Subject|4|||
162956484|NCT00795821|588543525|FG001|Taper Phase|Withdrawal by Subject|0|||
162956485|NCT00440518|588543531|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
162956486|NCT00440518|588543532|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
162956487|NCT00440518|588543533|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
162956488|NCT00440518|588543531|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
162956489|NCT00440518|588543532|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
162956490|NCT00440518|588543533|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
162956491|NCT00440518|588543531|FG000|Randomized /Titration Period|Protocol Deviation|1|||
162956492|NCT00440518|588543532|FG001|Randomized /Titration Period|Protocol Deviation|0|||
162956493|NCT00440518|588543533|FG002|Randomized /Titration Period|Protocol Deviation|0|||
162956494|NCT00440518|588543531|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
162956495|NCT00440518|588543532|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
162956496|NCT00440518|588543533|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
162956497|NCT00440518|588543531|FG000|Randomized /Titration Period|Other|1|||
162956498|NCT00440518|588543532|FG001|Randomized /Titration Period|Other|0|||
162956499|NCT00440518|588543533|FG002|Randomized /Titration Period|Other|0|||
162956500|NCT00440518|588543531|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
162956501|NCT00440518|588543532|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
162956502|NCT00440518|588543533|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
162956503|NCT00440518|588543531|FG000|Randomized /Titration Period|Adverse Event|2|||
162956504|NCT00440518|588543532|FG001|Randomized /Titration Period|Adverse Event|3|||
162956505|NCT00440518|588543533|FG002|Randomized /Titration Period|Adverse Event|0|||
162956506|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
162956507|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
162956508|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
162956509|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
162956510|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
162956511|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
162956512|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
162956513|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
162956514|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
162956515|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
162956516|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
162612521|NCT00285207|587298398|FG000|Overall Study|Lost to Follow-up|3|||
162612522|NCT00285207|587298399|FG001|Overall Study|Lost to Follow-up|2|||
162612523|NCT00285207|587298398|FG000|Overall Study|Withdrawal by Subject|5|||
162612524|NCT00285207|587298399|FG001|Overall Study|Withdrawal by Subject|2|||
162612525|NCT00285207|587298398|FG000|Overall Study|Pregnancy|1|||
162612526|NCT00285207|587298399|FG001|Overall Study|Pregnancy|1|||
162612527|NCT00285207|587298398|FG000|Overall Study|non-compliance|0|||
162612528|NCT00285207|587298399|FG001|Overall Study|non-compliance|1|||
162612529|NCT03670836|587298400|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
162612530|NCT03670836|587298401|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
162612531|NCT03670836|587298400|FG000|Per Protocol Population (PP)|Physician Decision|9|||
162612532|NCT03670836|587298401|FG001|Per Protocol Population (PP)|Physician Decision|10|||
162612533|NCT03670836|587298400|FG000|Per Protocol Population (PP)|Physician Decision|4|||
162612534|NCT03670836|587298401|FG001|Per Protocol Population (PP)|Physician Decision|6|||
162956517|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
162956518|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
162956519|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
162612535|NCT03670836|587298400|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
162612536|NCT03670836|587298401|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
162612537|NCT02160782|587299769|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
162612538|NCT02160782|587299770|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
162612539|NCT02160782|587299771|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
162612540|NCT02160782|587299772|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
162612541|NCT02160782|587299773|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
162612542|NCT02160782|587299769|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162612543|NCT02160782|587299770|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162612544|NCT02160782|587299771|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162612545|NCT02160782|587299772|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
162612546|NCT02160782|587299773|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162612547|NCT02160782|587299769|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162612548|NCT02160782|587299770|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162612549|NCT02160782|587299771|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162612550|NCT02160782|587299772|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
162858978|NCT03395210|588189098|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
162858979|NCT03395210|588189099|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
162858980|NCT01006356|588189103|FG000|Overall Study|Adverse Event|6|||
162858981|NCT01006356|588189103|FG000|Overall Study|Physician Decision|1|||
162858982|NCT01006356|588189103|FG000|Overall Study|Paticipants did not cooperate|6|||
162858983|NCT01006356|588189103|FG000|Overall Study|Withdrawal by Subject|1|||
162858984|NCT01006356|588189103|FG000|Overall Study|Choice by participants|2|||
162858985|NCT01006356|588189103|FG000|Overall Study|Protocol Violation|3|||
162858986|NCT01006356|588189103|FG000|Overall Study|Other|23|||
162858987|NCT03368859|588189107|FG000|Overall Study|Withdrew Consent|5|||
162858988|NCT03368859|588189108|FG001|Overall Study|Withdrew Consent|4|||
162858989|NCT03368859|588189107|FG000|Overall Study|Death|12|||
162858990|NCT03368859|588189108|FG001|Overall Study|Death|6|||
162858991|NCT03368859|588189107|FG000|Overall Study|Study terminated by Sponsor|18|||
162858992|NCT03368859|588189108|FG001|Overall Study|Study terminated by Sponsor|23|||
162858993|NCT03368859|588189107|FG000|Overall Study|Other|1|||
162858994|NCT03368859|588189108|FG001|Overall Study|Other|1|||
162858995|NCT02559505|588189114|FG000|Overall Study|Lost to Follow-up|23|||
162858996|NCT02559505|588189115|FG001|Overall Study|Lost to Follow-up|20|||
162858997|NCT02559505|588189114|FG000|Overall Study|Withdrawal by Subject|4|||
162858998|NCT02559505|588189115|FG001|Overall Study|Withdrawal by Subject|2|||
162858999|NCT03523585|588189116|FG000|Overall Study|Progressive Disease|174|||
162859000|NCT03523585|588189117|FG001|Overall Study|Progressive Disease|64|||
162859001|NCT03523585|588189118|FG002|Overall Study|Progressive Disease|77|||
162859002|NCT03523585|588189116|FG000|Overall Study|Adverse Event|74|||
162859003|NCT03523585|588189117|FG001|Overall Study|Adverse Event|5|||
162859004|NCT03523585|588189118|FG002|Overall Study|Adverse Event|9|||
162859005|NCT03523585|588189116|FG000|Overall Study|Withdrawal by Subject|30|||
162859006|NCT03523585|588189117|FG001|Overall Study|Withdrawal by Subject|11|||
162859007|NCT03523585|588189118|FG002|Overall Study|Withdrawal by Subject|6|||
162859008|NCT03523585|588189116|FG000|Overall Study|Clinical Progression|23|||
162859009|NCT03523585|588189117|FG001|Overall Study|Clinical Progression|5|||
162859010|NCT03523585|588189118|FG002|Overall Study|Clinical Progression|10|||
162859011|NCT03523585|588189116|FG000|Overall Study|Death|4|||
162859012|NCT03523585|588189117|FG001|Overall Study|Death|0|||
162859013|NCT03523585|588189118|FG002|Overall Study|Death|1|||
162859014|NCT03523585|588189116|FG000|Overall Study|Physician Decision|2|||
162859015|NCT03523585|588189117|FG001|Overall Study|Physician Decision|1|||
162859016|NCT03523585|588189118|FG002|Overall Study|Physician Decision|0|||
162859017|NCT03523585|588189116|FG000|Overall Study|Lost to Follow-up|1|||
162859018|NCT03523585|588189117|FG001|Overall Study|Lost to Follow-up|0|||
162859019|NCT03523585|588189118|FG002|Overall Study|Lost to Follow-up|0|||
162859020|NCT03523585|588189116|FG000|Overall Study|Miscellaneous|1|||
162859021|NCT03523585|588189117|FG001|Overall Study|Miscellaneous|0|||
162859022|NCT03523585|588189118|FG002|Overall Study|Miscellaneous|0|||
162859023|NCT03523585|588189116|FG000|Overall Study|Protocol Deviation|1|||
162859024|NCT03523585|588189117|FG001|Overall Study|Protocol Deviation|0|||
162859025|NCT03523585|588189118|FG002|Overall Study|Protocol Deviation|1|||
162859026|NCT03523585|588189116|FG000|Overall Study|Randomized But Not Treated|2|||
162859027|NCT03523585|588189117|FG001|Overall Study|Randomized But Not Treated|4|||
162859028|NCT03523585|588189118|FG002|Overall Study|Randomized But Not Treated|3|||
162859029|NCT02874794|588189121|FG000|Overall Study|Physician Decision|3|||
162859030|NCT02874794|588189122|FG001|Overall Study|Physician Decision|2|||
162859031|NCT02874794|588189121|FG000|Overall Study|Withdrawal by Subject|2|||
162956520|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
162956521|NCT00440518|588543531|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
162859032|NCT02874794|588189122|FG001|Overall Study|Withdrawal by Subject|8|||
163044795|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044796|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044797|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
163044798|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
163044799|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
163044800|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044801|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044802|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
163044803|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
163044804|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
163044805|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
163044806|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
163044807|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
163044808|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
163044809|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
163044810|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
163044811|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
163044812|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
163044813|NCT03428100|588871486|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044814|NCT03428100|588871487|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044815|NCT03428100|588871488|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044816|NCT03428100|588871489|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044817|NCT03428100|588871490|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044818|NCT03428100|588871491|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044819|NCT03428100|588871492|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044820|NCT03428100|588871493|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044821|NCT03428100|588871494|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044822|NCT03428100|588871495|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
163044823|NCT03428100|588871496|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
163044824|NCT03428100|588871497|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044825|NCT03428100|588871498|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044826|NCT03428100|588871499|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
163044827|NCT03428100|588871500|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
163044828|NCT03428100|588871501|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044829|NCT03428100|588871502|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
163044830|NCT03428100|588871503|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
163044831|NCT03428100|588871504|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
163044832|NCT01300247|588871505|FG000|Overall Study|Death|1|||
163044833|NCT01300247|588871506|FG001|Overall Study|Death|1|||
163044834|NCT01300247|588871505|FG000|Overall Study|Lost to Follow-up|2|||
163044835|NCT01300247|588871506|FG001|Overall Study|Lost to Follow-up|0|||
163044836|NCT01300247|588871505|FG000|Overall Study|Withdrawal by Subject|1|||
163044837|NCT01300247|588871506|FG001|Overall Study|Withdrawal by Subject|0|||
163044838|NCT01300247|588871505|FG000|Overall Study|Non-Compliance|0|||
163044839|NCT01300247|588871506|FG001|Overall Study|Non-Compliance|1|||
163044840|NCT03990051|588871507|FG000|Masked Period|Lost to Follow-up|1|||
163044841|NCT03990051|588871508|FG001|Masked Period|Lost to Follow-up|0|||
163044842|NCT03990051|588871507|FG000|Long Term Period|Death|1|||
163044843|NCT03990051|588871508|FG001|Long Term Period|Death|1|||
163044844|NCT03990051|588871507|FG000|Long Term Period|Lost to Follow-up|7|||
163044845|NCT03990051|588871508|FG001|Long Term Period|Lost to Follow-up|2|||
163044846|NCT01720524|588871509|FG000|Part A|Insufficient Clinical Response|2|||
163044847|NCT01720524|588871510|FG001|Part A|Insufficient Clinical Response|4|||
163044848|NCT01720524|588871509|FG000|Part A|Adverse Event|2|||
163044849|NCT01720524|588871510|FG001|Part A|Adverse Event|2|||
163044850|NCT01720524|588871509|FG000|Part A|Death|2|||
163044851|NCT01720524|588871510|FG001|Part A|Death|1|||
163044852|NCT01720524|588871509|FG000|Part A|Lost to Follow-up|0|||
163044853|NCT01720524|588871510|FG001|Part A|Lost to Follow-up|1|||
162612551|NCT02160782|587299773|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162612552|NCT02160782|587299769|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162612553|NCT02160782|587299770|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162612554|NCT02160782|587299771|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162612555|NCT02160782|587299772|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162612556|NCT02160782|587299773|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
162859033|NCT02874794|588189121|FG000|Overall Study|Death|2|||
162859034|NCT02874794|588189122|FG001|Overall Study|Death|1|||
162859035|NCT01473004|588189123|FG000|Overall Study|Incomplete Lobar Treatment|1|||
162859036|NCT01473004|588189124|FG001|Overall Study|Incomplete Lobar Treatment|0|||
162859037|NCT00698516|588189125|FG000|Overall Study|Study Termination|2|||
162859038|NCT00698516|588189125|FG000|Overall Study|Withdrawal by Subject|3|||
162859039|NCT05882890|588189126|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
162859040|NCT00613314|588189129|FG000|Overall Study|Adverse Event|5|||
162859041|NCT00613314|588189129|FG000|Overall Study|Protocol Violation|14|||
162859042|NCT00613314|588189129|FG000|Overall Study|Lost to Follow-up|46|||
162859043|NCT00613314|588189129|FG000|Overall Study|Other reason not defined above|90|||
162859044|NCT03090191|588189130|FG000|Overall Study|Adverse Event|90|||
162859045|NCT03090191|588189131|FG001|Overall Study|Adverse Event|72|||
162859046|NCT03090191|588189130|FG000|Overall Study|Death|365|||
162859047|NCT03090191|588189131|FG001|Overall Study|Death|358|||
162859048|NCT03090191|588189130|FG000|Overall Study|Lost to Follow-up|382|||
162859049|NCT03090191|588189131|FG001|Overall Study|Lost to Follow-up|394|||
162859050|NCT03090191|588189130|FG000|Overall Study|Physician Decision|77|||
162859051|NCT03090191|588189131|FG001|Overall Study|Physician Decision|66|||
162859052|NCT03090191|588189130|FG000|Overall Study|Protocol Violation|43|||
162859053|NCT03090191|588189131|FG001|Overall Study|Protocol Violation|52|||
162859054|NCT03090191|588189130|FG000|Overall Study|Withdrawal by Subject|2160|||
162859055|NCT03090191|588189131|FG001|Overall Study|Withdrawal by Subject|2133|||
162859056|NCT03090191|588189130|FG000|Overall Study|Site terminated|7|||
162859057|NCT03090191|588189131|FG001|Overall Study|Site terminated|8|||
162859058|NCT03090191|588189130|FG000|Overall Study|Other|66|||
162859059|NCT03090191|588189131|FG001|Overall Study|Other|60|||
162859060|NCT03090191|588189130|FG000|Overall Study|Withdrawn before any study vaccination|43|||
162859061|NCT03090191|588189131|FG001|Overall Study|Withdrawn before any study vaccination|52|||
162859062|NCT01324830|588189134|FG000|Overall Study|Progressive Disease|3|||
162859063|NCT01324830|588189135|FG001|Overall Study|Progressive Disease|2|||
162859064|NCT01324830|588189136|FG002|Overall Study|Progressive Disease|3|||
162859065|NCT01324830|588189137|FG003|Overall Study|Progressive Disease|3|||
162859066|NCT01324830|588189138|FG004|Overall Study|Progressive Disease|6|||
162859067|NCT01324830|588189139|FG005|Overall Study|Progressive Disease|6|||
162859068|NCT01324830|588189140|FG006|Overall Study|Progressive Disease|3|||
162859069|NCT01324830|588189141|FG007|Overall Study|Progressive Disease|3|||
162859070|NCT01324830|588189142|FG008|Overall Study|Progressive Disease|3|||
162859071|NCT01324830|588189143|FG009|Overall Study|Progressive Disease|6|||
162859072|NCT01324830|588189144|FG010|Overall Study|Progressive Disease|2|||
162859073|NCT01324830|588189145|FG011|Overall Study|Progressive Disease|1|||
162859074|NCT01324830|588189146|FG012|Overall Study|Progressive Disease|1|||
162859075|NCT01324830|588189147|FG013|Overall Study|Progressive Disease|1|||
162859076|NCT01324830|588189148|FG014|Overall Study|Progressive Disease|1|||
162859077|NCT01324830|588189149|FG015|Overall Study|Progressive Disease|3|||
162859078|NCT01324830|588189150|FG016|Overall Study|Progressive Disease|2|||
162859079|NCT01324830|588189151|FG017|Overall Study|Progressive Disease|3|||
162859080|NCT01324830|588189152|FG018|Overall Study|Progressive Disease|4|||
162859081|NCT01324830|588189134|FG000|Overall Study|Dose limiting toxicity|0|||
162859082|NCT01324830|588189135|FG001|Overall Study|Dose limiting toxicity|0|||
162859083|NCT01324830|588189136|FG002|Overall Study|Dose limiting toxicity|0|||
162859084|NCT01324830|588189137|FG003|Overall Study|Dose limiting toxicity|0|||
162859085|NCT01324830|588189138|FG004|Overall Study|Dose limiting toxicity|1|||
162859086|NCT01324830|588189139|FG005|Overall Study|Dose limiting toxicity|0|||
162859087|NCT01324830|588189140|FG006|Overall Study|Dose limiting toxicity|0|||
162859088|NCT01324830|588189141|FG007|Overall Study|Dose limiting toxicity|0|||
162859089|NCT01324830|588189142|FG008|Overall Study|Dose limiting toxicity|0|||
162859090|NCT01324830|588189143|FG009|Overall Study|Dose limiting toxicity|0|||
162859091|NCT01324830|588189144|FG010|Overall Study|Dose limiting toxicity|0|||
162859092|NCT01324830|588189145|FG011|Overall Study|Dose limiting toxicity|0|||
162859093|NCT01324830|588189146|FG012|Overall Study|Dose limiting toxicity|0|||
162859094|NCT01324830|588189147|FG013|Overall Study|Dose limiting toxicity|0|||
162859095|NCT01324830|588189148|FG014|Overall Study|Dose limiting toxicity|0|||
162859096|NCT01324830|588189149|FG015|Overall Study|Dose limiting toxicity|0|||
162859097|NCT01324830|588189150|FG016|Overall Study|Dose limiting toxicity|1|||
162859098|NCT01324830|588189151|FG017|Overall Study|Dose limiting toxicity|1|||
162859099|NCT01324830|588189152|FG018|Overall Study|Dose limiting toxicity|1|||
162859100|NCT01324830|588189134|FG000|Overall Study|Reason not mentioned above|0|||
162859101|NCT01324830|588189135|FG001|Overall Study|Reason not mentioned above|0|||
162859102|NCT01324830|588189136|FG002|Overall Study|Reason not mentioned above|0|||
162859103|NCT01324830|588189137|FG003|Overall Study|Reason not mentioned above|0|||
162859104|NCT01324830|588189138|FG004|Overall Study|Reason not mentioned above|0|||
162859105|NCT01324830|588189139|FG005|Overall Study|Reason not mentioned above|0|||
162859106|NCT01324830|588189140|FG006|Overall Study|Reason not mentioned above|0|||
162859107|NCT01324830|588189141|FG007|Overall Study|Reason not mentioned above|0|||
162859108|NCT01324830|588189142|FG008|Overall Study|Reason not mentioned above|0|||
162859109|NCT01324830|588189143|FG009|Overall Study|Reason not mentioned above|0|||
162859110|NCT01324830|588189144|FG010|Overall Study|Reason not mentioned above|0|||
162705273|NCT02412761|587632182|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162705274|NCT02412761|587632183|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162705275|NCT02412761|587632184|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162705276|NCT02013687|587632185|FG000|Overall Study|Lost to Follow-up|0|||
162705277|NCT02013687|587632186|FG001|Overall Study|Lost to Follow-up|0|||
162705278|NCT02013687|587632187|FG002|Overall Study|Lost to Follow-up|1|||
162705279|NCT02013687|587632188|FG003|Overall Study|Lost to Follow-up|0|||
162859111|NCT01324830|588189145|FG011|Overall Study|Reason not mentioned above|0|||
162859112|NCT01324830|588189146|FG012|Overall Study|Reason not mentioned above|0|||
162859113|NCT01324830|588189147|FG013|Overall Study|Reason not mentioned above|0|||
162859114|NCT01324830|588189148|FG014|Overall Study|Reason not mentioned above|0|||
162859115|NCT01324830|588189149|FG015|Overall Study|Reason not mentioned above|0|||
162859116|NCT01324830|588189150|FG016|Overall Study|Reason not mentioned above|0|||
162859117|NCT01324830|588189151|FG017|Overall Study|Reason not mentioned above|1|||
162859118|NCT01324830|588189152|FG018|Overall Study|Reason not mentioned above|0|||
162859119|NCT01324830|588189134|FG000|Overall Study|Adverse Event, serious fatal|0|||
162859120|NCT01324830|588189135|FG001|Overall Study|Adverse Event, serious fatal|1|||
162859121|NCT01324830|588189136|FG002|Overall Study|Adverse Event, serious fatal|0|||
162859122|NCT01324830|588189137|FG003|Overall Study|Adverse Event, serious fatal|0|||
162859123|NCT01324830|588189138|FG004|Overall Study|Adverse Event, serious fatal|0|||
162859124|NCT01324830|588189139|FG005|Overall Study|Adverse Event, serious fatal|0|||
162859125|NCT01324830|588189140|FG006|Overall Study|Adverse Event, serious fatal|0|||
162859126|NCT01324830|588189141|FG007|Overall Study|Adverse Event, serious fatal|0|||
162859127|NCT01324830|588189142|FG008|Overall Study|Adverse Event, serious fatal|0|||
162859128|NCT01324830|588189143|FG009|Overall Study|Adverse Event, serious fatal|0|||
162859129|NCT01324830|588189144|FG010|Overall Study|Adverse Event, serious fatal|0|||
162859130|NCT01324830|588189145|FG011|Overall Study|Adverse Event, serious fatal|0|||
162859131|NCT01324830|588189146|FG012|Overall Study|Adverse Event, serious fatal|0|||
162859132|NCT01324830|588189147|FG013|Overall Study|Adverse Event, serious fatal|0|||
162859133|NCT01324830|588189148|FG014|Overall Study|Adverse Event, serious fatal|0|||
162859134|NCT01324830|588189149|FG015|Overall Study|Adverse Event, serious fatal|0|||
162859135|NCT01324830|588189150|FG016|Overall Study|Adverse Event, serious fatal|0|||
162859136|NCT01324830|588189151|FG017|Overall Study|Adverse Event, serious fatal|0|||
162859137|NCT01324830|588189152|FG018|Overall Study|Adverse Event, serious fatal|0|||
162859138|NCT01324830|588189134|FG000|Overall Study|Adverse Event, non-fatal|0|||
162859139|NCT01324830|588189135|FG001|Overall Study|Adverse Event, non-fatal|0|||
162859140|NCT01324830|588189136|FG002|Overall Study|Adverse Event, non-fatal|0|||
162859141|NCT01324830|588189137|FG003|Overall Study|Adverse Event, non-fatal|0|||
162859142|NCT01324830|588189138|FG004|Overall Study|Adverse Event, non-fatal|0|||
162859143|NCT01324830|588189139|FG005|Overall Study|Adverse Event, non-fatal|0|||
162859144|NCT01324830|588189140|FG006|Overall Study|Adverse Event, non-fatal|0|||
162859145|NCT01324830|588189141|FG007|Overall Study|Adverse Event, non-fatal|0|||
162859146|NCT01324830|588189142|FG008|Overall Study|Adverse Event, non-fatal|2|||
162859147|NCT01324830|588189143|FG009|Overall Study|Adverse Event, non-fatal|0|||
162859148|NCT01324830|588189144|FG010|Overall Study|Adverse Event, non-fatal|1|||
162859149|NCT01324830|588189145|FG011|Overall Study|Adverse Event, non-fatal|0|||
162859150|NCT01324830|588189146|FG012|Overall Study|Adverse Event, non-fatal|0|||
162859151|NCT01324830|588189147|FG013|Overall Study|Adverse Event, non-fatal|0|||
162859152|NCT01324830|588189148|FG014|Overall Study|Adverse Event, non-fatal|0|||
162859153|NCT01324830|588189149|FG015|Overall Study|Adverse Event, non-fatal|0|||
162859154|NCT01324830|588189150|FG016|Overall Study|Adverse Event, non-fatal|0|||
162859155|NCT01324830|588189151|FG017|Overall Study|Adverse Event, non-fatal|1|||
162859156|NCT01324830|588189152|FG018|Overall Study|Adverse Event, non-fatal|0|||
162859157|NCT01324830|588189134|FG000|Overall Study|Withdrawal by Subject|0|||
162859158|NCT01324830|588189135|FG001|Overall Study|Withdrawal by Subject|0|||
162859159|NCT01324830|588189136|FG002|Overall Study|Withdrawal by Subject|0|||
162859160|NCT01324830|588189137|FG003|Overall Study|Withdrawal by Subject|0|||
162859161|NCT01324830|588189138|FG004|Overall Study|Withdrawal by Subject|0|||
162859162|NCT01324830|588189139|FG005|Overall Study|Withdrawal by Subject|1|||
162859163|NCT01324830|588189140|FG006|Overall Study|Withdrawal by Subject|0|||
162859164|NCT01324830|588189141|FG007|Overall Study|Withdrawal by Subject|0|||
162859165|NCT01324830|588189142|FG008|Overall Study|Withdrawal by Subject|0|||
162859166|NCT01324830|588189143|FG009|Overall Study|Withdrawal by Subject|0|||
162705280|NCT02013687|587632185|FG000|Overall Study|Protocol Violation|0|||
162859167|NCT01324830|588189144|FG010|Overall Study|Withdrawal by Subject|1|||
162859168|NCT01324830|588189145|FG011|Overall Study|Withdrawal by Subject|0|||
162859169|NCT01324830|588189146|FG012|Overall Study|Withdrawal by Subject|0|||
162859170|NCT01324830|588189147|FG013|Overall Study|Withdrawal by Subject|0|||
162859171|NCT01324830|588189148|FG014|Overall Study|Withdrawal by Subject|0|||
162859172|NCT01324830|588189149|FG015|Overall Study|Withdrawal by Subject|0|||
162859173|NCT01324830|588189150|FG016|Overall Study|Withdrawal by Subject|0|||
162859174|NCT01324830|588189151|FG017|Overall Study|Withdrawal by Subject|0|||
162859175|NCT01324830|588189152|FG018|Overall Study|Withdrawal by Subject|1|||
162956522|NCT00440518|588543532|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
162956523|NCT00440518|588543533|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
162705281|NCT02013687|587632186|FG001|Overall Study|Protocol Violation|0|||
162705282|NCT02013687|587632187|FG002|Overall Study|Protocol Violation|0|||
162705283|NCT02013687|587632188|FG003|Overall Study|Protocol Violation|1|||
162705284|NCT02013687|587632185|FG000|Overall Study|Withdrawal by Subject|0|||
162705285|NCT02013687|587632186|FG001|Overall Study|Withdrawal by Subject|0|||
162705286|NCT02013687|587632187|FG002|Overall Study|Withdrawal by Subject|0|||
162705287|NCT02013687|587632188|FG003|Overall Study|Withdrawal by Subject|1|||
162705288|NCT02013687|587632185|FG000|Overall Study|Missed visits due to patient travel|0|||
162705289|NCT02013687|587632186|FG001|Overall Study|Missed visits due to patient travel|0|||
162705290|NCT02013687|587632187|FG002|Overall Study|Missed visits due to patient travel|1|||
162705291|NCT02013687|587632188|FG003|Overall Study|Missed visits due to patient travel|0|||
162705292|NCT01782326|587632189|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
162705293|NCT01782326|587632190|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
162705294|NCT01782326|587632189|FG000|Planned Treatment Epoch|Death|29|||
162705295|NCT01782326|587632190|FG001|Planned Treatment Epoch|Death|30|||
162705296|NCT01782326|587632189|FG000|Planned Treatment Epoch|Physician Decision|18|||
162705297|NCT01782326|587632190|FG001|Planned Treatment Epoch|Physician Decision|16|||
162705298|NCT01782326|587632189|FG000|Planned Treatment Epoch|Protocol deviation|2|||
162705299|NCT01782326|587632190|FG001|Planned Treatment Epoch|Protocol deviation|3|||
162705300|NCT01782326|587632189|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
162705301|NCT01782326|587632190|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
162705302|NCT01782326|587632189|FG000|Planned Treatment Epoch|Technical problems|0|||
162705303|NCT01782326|587632190|FG001|Planned Treatment Epoch|Technical problems|4|||
162705304|NCT01782326|587632189|FG000|Double-blind Treatment|Adverse Event|129|||
162705305|NCT01782326|587632190|FG001|Double-blind Treatment|Adverse Event|145|||
162705306|NCT01782326|587632189|FG000|Double-blind Treatment|Subject/guardian decision|111|||
162705307|NCT01782326|587632190|FG001|Double-blind Treatment|Subject/guardian decision|125|||
162705308|NCT01782326|587632189|FG000|Double-blind Treatment|Lack of Efficacy|17|||
162705309|NCT01782326|587632190|FG001|Double-blind Treatment|Lack of Efficacy|22|||
162705310|NCT01782326|587632189|FG000|Double-blind Treatment|Physician Decision|13|||
162705311|NCT01782326|587632190|FG001|Double-blind Treatment|Physician Decision|16|||
162705312|NCT01782326|587632189|FG000|Double-blind Treatment|Protocol deviation|8|||
162705313|NCT01782326|587632190|FG001|Double-blind Treatment|Protocol deviation|7|||
162705314|NCT01782326|587632189|FG000|Double-blind Treatment|Technical problems|0|||
162705315|NCT01782326|587632190|FG001|Double-blind Treatment|Technical problems|5|||
162705316|NCT05968482|587632191|FG000|First Crossover Period|Withdrawal by Subject|0|||
162705317|NCT05968482|587632192|FG001|First Crossover Period|Withdrawal by Subject|0|||
162705318|NCT05968482|587632193|FG002|First Crossover Period|Withdrawal by Subject|1|||
162705319|NCT05968482|587632194|FG003|First Crossover Period|Withdrawal by Subject|0|||
162705320|NCT05968482|587632195|FG004|First Crossover Period|Withdrawal by Subject|0|||
162705321|NCT05968482|587632196|FG005|First Crossover Period|Withdrawal by Subject|0|||
162705322|NCT05968482|587632191|FG000|First Crossover Period|Adverse Event|0|||
162705323|NCT05968482|587632192|FG001|First Crossover Period|Adverse Event|0|||
162705324|NCT05968482|587632193|FG002|First Crossover Period|Adverse Event|0|||
162705325|NCT05968482|587632194|FG003|First Crossover Period|Adverse Event|0|||
162705326|NCT05968482|587632195|FG004|First Crossover Period|Adverse Event|0|||
162705327|NCT05968482|587632196|FG005|First Crossover Period|Adverse Event|1|||
162705328|NCT05968482|587632191|FG000|Second Crossover Period|Withdrawal by Subject|0|||
162705329|NCT05968482|587632192|FG001|Second Crossover Period|Withdrawal by Subject|0|||
162956524|NCT03570749|588543534|FG000|Overall Study|Ongoing|26|||
162956525|NCT03570749|588543535|FG001|Overall Study|Ongoing|25|||
162956526|NCT03570749|588543536|FG002|Overall Study|Ongoing|25|||
162956527|NCT03570749|588543537|FG003|Overall Study|Ongoing|26|||
162705330|NCT05968482|587632193|FG002|Second Crossover Period|Withdrawal by Subject|0|||
162705331|NCT05968482|587632194|FG003|Second Crossover Period|Withdrawal by Subject|0|||
162705332|NCT05968482|587632195|FG004|Second Crossover Period|Withdrawal by Subject|1|||
162705333|NCT05968482|587632196|FG005|Second Crossover Period|Withdrawal by Subject|0|||
162705334|NCT05968482|587632191|FG000|Third Crossover Period|Adverse Event|0|||
162705335|NCT05968482|587632192|FG001|Third Crossover Period|Adverse Event|0|||
162705336|NCT05968482|587632193|FG002|Third Crossover Period|Adverse Event|0|||
162705337|NCT05968482|587632194|FG003|Third Crossover Period|Adverse Event|0|||
162705338|NCT05968482|587632195|FG004|Third Crossover Period|Adverse Event|1|||
162705339|NCT05968482|587632196|FG005|Third Crossover Period|Adverse Event|0|||
162705340|NCT05968482|587632191|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
162956528|NCT03570749|588543538|FG004|Overall Study|Ongoing|140|||
162956529|NCT03570749|588543539|FG005|Overall Study|Ongoing|142|||
162705341|NCT05968482|587632192|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
162705342|NCT05968482|587632193|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
162705343|NCT05968482|587632194|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
162705344|NCT05968482|587632195|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
162705345|NCT05968482|587632196|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
162705346|NCT02559817|587632197|FG000|Treatment Period|Adverse Event|1|||
162705347|NCT02559817|587632198|FG001|Treatment Period|Adverse Event|0|||
162705348|NCT02559817|587632199|FG002|Treatment Period|Adverse Event|1|||
162956530|NCT03570749|588543540|FG006|Overall Study|Ongoing|220|||
162956531|NCT03570749|588543534|FG000|Overall Study|Adverse Event|0|||
162956532|NCT03570749|588543535|FG001|Overall Study|Adverse Event|0|||
162956533|NCT03570749|588543536|FG002|Overall Study|Adverse Event|0|||
162956534|NCT03570749|588543537|FG003|Overall Study|Adverse Event|0|||
162956535|NCT03570749|588543538|FG004|Overall Study|Adverse Event|2|||
162956536|NCT03570749|588543539|FG005|Overall Study|Adverse Event|3|||
162956537|NCT03570749|588543540|FG006|Overall Study|Adverse Event|6|||
162956538|NCT03570749|588543534|FG000|Overall Study|Lack of Efficacy|0|||
162956539|NCT03570749|588543535|FG001|Overall Study|Lack of Efficacy|0|||
162956540|NCT03570749|588543536|FG002|Overall Study|Lack of Efficacy|0|||
162956541|NCT03570749|588543537|FG003|Overall Study|Lack of Efficacy|0|||
162956542|NCT03570749|588543538|FG004|Overall Study|Lack of Efficacy|8|||
162956543|NCT03570749|588543539|FG005|Overall Study|Lack of Efficacy|2|||
162956544|NCT03570749|588543540|FG006|Overall Study|Lack of Efficacy|7|||
162956545|NCT03570749|588543534|FG000|Overall Study|Lost to Follow-up|0|||
162956546|NCT03570749|588543535|FG001|Overall Study|Lost to Follow-up|0|||
162956547|NCT03570749|588543536|FG002|Overall Study|Lost to Follow-up|0|||
162956548|NCT03570749|588543537|FG003|Overall Study|Lost to Follow-up|0|||
162956549|NCT03570749|588543538|FG004|Overall Study|Lost to Follow-up|5|||
162956550|NCT03570749|588543539|FG005|Overall Study|Lost to Follow-up|10|||
162956551|NCT03570749|588543540|FG006|Overall Study|Lost to Follow-up|10|||
162956552|NCT03570749|588543534|FG000|Overall Study|Pregnancy|0|||
162956553|NCT03570749|588543535|FG001|Overall Study|Pregnancy|0|||
162956554|NCT03570749|588543536|FG002|Overall Study|Pregnancy|0|||
162956555|NCT03570749|588543537|FG003|Overall Study|Pregnancy|0|||
162956556|NCT03570749|588543538|FG004|Overall Study|Pregnancy|0|||
162612557|NCT02160782|587299769|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162612558|NCT02160782|587299770|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162612559|NCT02160782|587299771|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162612560|NCT02160782|587299772|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162612561|NCT02160782|587299773|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
162612562|NCT02160782|587299769|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162612563|NCT02160782|587299770|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162612564|NCT02160782|587299771|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162612565|NCT02160782|587299772|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162612566|NCT02160782|587299773|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
162612567|NCT02160782|587299769|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162612568|NCT02160782|587299770|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162612569|NCT02160782|587299771|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162612570|NCT02160782|587299772|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162612571|NCT02160782|587299773|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
162612572|NCT01104701|587299777|FG000|Overall Study|Withdrawal by Subject|0|||
162612573|NCT01104701|587299778|FG001|Overall Study|Withdrawal by Subject|1|||
162612574|NCT01104701|587299779|FG002|Overall Study|Withdrawal by Subject|2|||
162612575|NCT01104701|587299780|FG003|Overall Study|Withdrawal by Subject|1|||
162612576|NCT01104701|587299777|FG000|Overall Study|Adverse Event|0|||
162612577|NCT01104701|587299778|FG001|Overall Study|Adverse Event|0|||
162612578|NCT01104701|587299779|FG002|Overall Study|Adverse Event|0|||
162612579|NCT01104701|587299780|FG003|Overall Study|Adverse Event|1|||
162612580|NCT01104701|587299777|FG000|Overall Study|Physician Decision|0|||
162612581|NCT01104701|587299778|FG001|Overall Study|Physician Decision|2|||
162956557|NCT03570749|588543539|FG005|Overall Study|Pregnancy|1|||
162956558|NCT03570749|588543540|FG006|Overall Study|Pregnancy|1|||
162612582|NCT01104701|587299779|FG002|Overall Study|Physician Decision|0|||
162612583|NCT01104701|587299780|FG003|Overall Study|Physician Decision|0|||
162612584|NCT00891462|587299781|FG000|Overall Study|Withdrawal by Subject|9|||
162612585|NCT00891462|587299782|FG001|Overall Study|Withdrawal by Subject|6|||
162612586|NCT00891462|587299783|FG002|Overall Study|Withdrawal by Subject|7|||
162612587|NCT00891462|587299781|FG000|Overall Study|Adverse Event|7|||
162612588|NCT00891462|587299782|FG001|Overall Study|Adverse Event|8|||
162612589|NCT00891462|587299783|FG002|Overall Study|Adverse Event|7|||
162956559|NCT03570749|588543534|FG000|Overall Study|Screen Fail|0|||
162956560|NCT03570749|588543535|FG001|Overall Study|Screen Fail|0|||
162956561|NCT03570749|588543536|FG002|Overall Study|Screen Fail|0|||
162956562|NCT03570749|588543537|FG003|Overall Study|Screen Fail|0|||
162956563|NCT03570749|588543538|FG004|Overall Study|Screen Fail|0|||
162956564|NCT03570749|588543539|FG005|Overall Study|Screen Fail|0|||
162956565|NCT03570749|588543540|FG006|Overall Study|Screen Fail|1|||
162956566|NCT03570749|588543534|FG000|Overall Study|Withdrawal by Subject|2|||
162956567|NCT03570749|588543535|FG001|Overall Study|Withdrawal by Subject|3|||
162956568|NCT03570749|588543536|FG002|Overall Study|Withdrawal by Subject|2|||
162956569|NCT03570749|588543537|FG003|Overall Study|Withdrawal by Subject|1|||
162956570|NCT03570749|588543538|FG004|Overall Study|Withdrawal by Subject|17|||
162956571|NCT03570749|588543539|FG005|Overall Study|Withdrawal by Subject|12|||
162956572|NCT03570749|588543540|FG006|Overall Study|Withdrawal by Subject|15|||
162956573|NCT03570749|588543534|FG000|Overall Study|Other|0|||
162956574|NCT03570749|588543535|FG001|Overall Study|Other|0|||
162956575|NCT03570749|588543536|FG002|Overall Study|Other|0|||
162956576|NCT03570749|588543537|FG003|Overall Study|Other|0|||
162956577|NCT03570749|588543538|FG004|Overall Study|Other|17|||
162956578|NCT03570749|588543539|FG005|Overall Study|Other|14|||
162956579|NCT03570749|588543540|FG006|Overall Study|Other|21|||
162956580|NCT00561015|588543541|FG000|Overall Study|Adverse Event|0|||
162956581|NCT00561015|588543542|FG001|Overall Study|Adverse Event|0|||
162956582|NCT00561015|588543543|FG002|Overall Study|Adverse Event|0|||
162956583|NCT00561015|588543544|FG003|Overall Study|Adverse Event|0|||
162956584|NCT00561015|588543545|FG004|Overall Study|Adverse Event|1|||
162956585|NCT00561015|588543546|FG005|Overall Study|Adverse Event|0|||
162956586|NCT00561015|588543541|FG000|Overall Study|Lost to Follow-up|2|||
162956587|NCT00561015|588543542|FG001|Overall Study|Lost to Follow-up|0|||
162956588|NCT00561015|588543543|FG002|Overall Study|Lost to Follow-up|0|||
162956589|NCT00561015|588543544|FG003|Overall Study|Lost to Follow-up|1|||
162956590|NCT00561015|588543545|FG004|Overall Study|Lost to Follow-up|0|||
162956591|NCT00561015|588543546|FG005|Overall Study|Lost to Follow-up|3|||
162612590|NCT00891462|587299781|FG000|Overall Study|Lack of Efficacy|10|||
162612591|NCT00891462|587299782|FG001|Overall Study|Lack of Efficacy|5|||
162612592|NCT00891462|587299783|FG002|Overall Study|Lack of Efficacy|1|||
162612593|NCT00891462|587299781|FG000|Overall Study|COPD exacerbation|7|||
162612594|NCT00891462|587299782|FG001|Overall Study|COPD exacerbation|4|||
162612595|NCT00891462|587299783|FG002|Overall Study|COPD exacerbation|1|||
162612596|NCT00891462|587299781|FG000|Overall Study|Other Reason|2|||
162612597|NCT00891462|587299782|FG001|Overall Study|Other Reason|5|||
162612598|NCT00891462|587299783|FG002|Overall Study|Other Reason|3|||
162612599|NCT00891462|587299781|FG000|Overall Study|Protocol Violation|2|||
162612600|NCT00891462|587299782|FG001|Overall Study|Protocol Violation|1|||
162612601|NCT00891462|587299783|FG002|Overall Study|Protocol Violation|3|||
162612602|NCT00891462|587299781|FG000|Overall Study|Inclusion/exclusion criteria|0|||
162612603|NCT00891462|587299782|FG001|Overall Study|Inclusion/exclusion criteria|2|||
162612604|NCT00891462|587299783|FG002|Overall Study|Inclusion/exclusion criteria|2|||
162612605|NCT00891462|587299781|FG000|Overall Study|Lost to Follow-up|0|||
162612606|NCT00891462|587299782|FG001|Overall Study|Lost to Follow-up|2|||
162612607|NCT00891462|587299783|FG002|Overall Study|Lost to Follow-up|0|||
162612608|NCT01083485|587299786|FG000|Overall Study|Adverse Event|0|||
162612609|NCT01083485|587299787|FG001|Overall Study|Adverse Event|1|||
162612610|NCT01083485|587299786|FG000|Overall Study|Protocol Violation|1|||
162612611|NCT01083485|587299787|FG001|Overall Study|Protocol Violation|0|||
162612612|NCT01083485|587299786|FG000|Overall Study|Withdrawal by Subject|5|||
162612613|NCT01083485|587299787|FG001|Overall Study|Withdrawal by Subject|2|||
162612614|NCT01083485|587299786|FG000|Overall Study|Other|1|||
162612615|NCT01083485|587299787|FG001|Overall Study|Other|0|||
162612616|NCT02171065|587299788|FG000|Overall Study|Withdrawal by Subject|1|||
162612617|NCT02171065|587299789|FG001|Overall Study|Withdrawal by Subject|0|||
162612618|NCT02171065|587299790|FG002|Overall Study|Withdrawal by Subject|0|||
162612619|NCT02171065|587299788|FG000|Overall Study|Lost to Follow-up|0|||
162612620|NCT02171065|587299789|FG001|Overall Study|Lost to Follow-up|0|||
162705349|NCT02559817|587632200|FG003|Treatment Period|Adverse Event|0|||
162956592|NCT00561015|588543541|FG000|Overall Study|Participant non-compliance|2|||
162956593|NCT00561015|588543542|FG001|Overall Study|Participant non-compliance|0|||
162956594|NCT00561015|588543543|FG002|Overall Study|Participant non-compliance|0|||
162612621|NCT02171065|587299790|FG002|Overall Study|Lost to Follow-up|1|||
162612622|NCT00851630|587299792|FG000|Overall Study|Death|2|||
162612623|NCT00851630|587299793|FG001|Overall Study|Death|1|||
162956595|NCT00561015|588543544|FG003|Overall Study|Participant non-compliance|0|||
162956596|NCT00561015|588543545|FG004|Overall Study|Participant non-compliance|0|||
162956597|NCT00561015|588543546|FG005|Overall Study|Participant non-compliance|0|||
162956598|NCT02146105|588543547|FG000|Overall Study|Adverse Event|1|||
162956599|NCT02146105|588543547|FG000|Overall Study|Withdrawal by Subject|5|||
162956600|NCT03086460|588543548|FG000|Study Participants|Lost to Follow-up|2|||
162956601|NCT03086460|588543548|FG000|Study Participants|Protocol Violation|1|||
162956602|NCT03086460|588543548|FG000|Study Participants|Withdrawal by Subject|6|||
162956603|NCT03086460|588543548|FG000|Treatment A|Lost to Follow-up|1|||
162956604|NCT03086460|588543548|FG000|Treatment A|Protocol Violation|1|||
162956605|NCT03086460|588543548|FG000|Treatment A|Withdrawal by Subject|2|||
162956606|NCT03086460|588543548|FG000|Treatment C|Withdrawal by Subject|2|||
162956607|NCT03086460|588543548|FG000|Treatment E|Lost to Follow-up|1|||
162956608|NCT03086460|588543548|FG000|Treatment E|Withdrawal by Subject|3|||
162956609|NCT02545283|588543549|FG000|Overall Study|Lost to Follow-up|2|||
162956610|NCT02545283|588543550|FG001|Overall Study|Lost to Follow-up|4|||
162956611|NCT02545283|588543549|FG000|Overall Study|Withdrawal by Subject|5|||
162956612|NCT02545283|588543550|FG001|Overall Study|Withdrawal by Subject|9|||
162956613|NCT02545283|588543549|FG000|Overall Study|Death|109|||
162956614|NCT02545283|588543550|FG001|Overall Study|Death|211|||
162956615|NCT02545283|588543549|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
162956616|NCT02545283|588543550|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
162956617|NCT02545283|588543549|FG000|Overall Study|Study Terminated By Sponsor|33|||
162956618|NCT02545283|588543550|FG001|Overall Study|Study Terminated By Sponsor|71|||
162956619|NCT02436005|588543551|FG000|Second Intervention|Adverse Event|0|||
162956620|NCT02436005|588543552|FG001|Second Intervention|Adverse Event|1|||
162956621|NCT00583453|588543553|FG000|Overall Study|discontinued intervention|0|||
162956622|NCT00583453|588543554|FG001|Overall Study|discontinued intervention|2|||
162956623|NCT00905606|588543555|FG000|Period 1|Adverse Event|0|||
162956624|NCT00905606|588543556|FG001|Period 1|Adverse Event|1|||
162956625|NCT00905606|588543555|FG000|Washout|Withdrawal by Subject|1|||
162956626|NCT00905606|588543556|FG001|Washout|Withdrawal by Subject|0|||
162956627|NCT00455312|588543557|FG000|Overall Study|Death|0|||
162956628|NCT00455312|588543558|FG001|Overall Study|Death|1|||
162956629|NCT02659150|588543559|FG000|Subject Enrollment|Physician Decision|3|||
162956630|NCT02659150|588543559|FG000|Subject Enrollment|Withdrawal by Subject|2|||
162956631|NCT02659150|588543559|FG000|Baseline Imaging|Withdrawal by Subject|1|||
162956632|NCT02659150|588543559|FG000|Baseline Imaging|Physician Decision|1|||
162956633|NCT02659150|588543559|FG000|Study Drug Dosing|Adverse Event|1|||
162956634|NCT02902211|588543562|FG000|First Three Months|Withdrawal by Subject|7|||
162956635|NCT02902211|588543563|FG001|First Three Months|Withdrawal by Subject|3|||
162956636|NCT01363765|588543564|FG000|Overall Study|non-diagnostic|2621|||
162956637|NCT01363765|588543565|FG001|Overall Study|non-diagnostic|1124|||
162956638|NCT01363765|588543564|FG000|Overall Study|duplicate records|736|||
163044854|NCT01720524|588871509|FG000|Part A|Missed 28 day follow-up visit|1|||
163044855|NCT01720524|588871510|FG001|Part A|Missed 28 day follow-up visit|1|||
162956639|NCT01363765|588543565|FG001|Overall Study|duplicate records|3177|||
162956640|NCT01363765|588543564|FG000|Overall Study|non-resident|156|||
162956641|NCT01363765|588543565|FG001|Overall Study|non-resident|76|||
162956642|NCT01363765|588543564|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
162956643|NCT01363765|588543565|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
162956644|NCT01363765|588543564|FG000|Overall Study|smear during intervention|2170|||
162956645|NCT01363765|588543565|FG001|Overall Study|smear during intervention|0|||
162956646|NCT00609674|588543566|FG000|Overall Study|Adverse Event|1|||
162956647|NCT00609674|588543567|FG001|Overall Study|Adverse Event|1|||
162956648|NCT00609674|588543566|FG000|Overall Study|Protocol Violation|3|||
162956649|NCT00609674|588543567|FG001|Overall Study|Protocol Violation|5|||
162956650|NCT00609674|588543566|FG000|Overall Study|Lost to Follow-up|1|||
162956651|NCT00609674|588543567|FG001|Overall Study|Lost to Follow-up|0|||
162956652|NCT00609674|588543566|FG000|Overall Study|Withdrew consent|2|||
162956653|NCT00609674|588543567|FG001|Overall Study|Withdrew consent|1|||
162956654|NCT00571064|588543570|FG000|Overall Study|Adverse Event|13|||
162956655|NCT00571064|588543570|FG000|Overall Study|Protocol Violation|4|||
162956656|NCT00571064|588543570|FG000|Overall Study|Withdrawal by Subject|2|||
162956657|NCT00571064|588543570|FG000|Overall Study|Other|2|||
162956658|NCT02159950|588543580|FG000|Overall Study|Adverse Event|0|||
162956659|NCT02159950|588543581|FG001|Overall Study|Adverse Event|1|||
162956660|NCT02159950|588543580|FG000|Overall Study|Progression|0|||
162956661|NCT02159950|588543581|FG001|Overall Study|Progression|1|||
162956662|NCT00003659|588543582|FG000|Overall Study|Withdrawal by Subject|3|||
162956663|NCT03872128|588543585|FG000|Overall Study|Dropped out before treatment|1|||
162956664|NCT03872128|588543586|FG001|Overall Study|Dropped out before treatment|0|||
162956665|NCT03872128|588543587|FG002|Overall Study|Dropped out before treatment|4|||
162956666|NCT03872128|588543585|FG000|Overall Study|Lost to Follow-up|2|||
162956667|NCT03872128|588543586|FG001|Overall Study|Lost to Follow-up|5|||
162705350|NCT02559817|587632201|FG004|Treatment Period|Adverse Event|0|||
162705351|NCT02559817|587632197|FG000|Treatment Period|Lack of Efficacy|0|||
162705352|NCT02559817|587632198|FG001|Treatment Period|Lack of Efficacy|1|||
162859176|NCT01973283|588189153|FG000|Overall Study|Lost to Follow-up|4|||
162859177|NCT02586805|588189161|FG000|Overall Study|Withdrawal by Subject|3|||
162859178|NCT02586805|588189162|FG001|Overall Study|Withdrawal by Subject|1|||
162859179|NCT02586805|588189163|FG002|Overall Study|Withdrawal by Subject|1|||
162859180|NCT02586805|588189164|FG003|Overall Study|Withdrawal by Subject|2|||
162859181|NCT02586805|588189161|FG000|Overall Study|Adverse Event|2|||
162859182|NCT02586805|588189162|FG001|Overall Study|Adverse Event|0|||
162859183|NCT02586805|588189163|FG002|Overall Study|Adverse Event|1|||
162859184|NCT02586805|588189164|FG003|Overall Study|Adverse Event|0|||
162859185|NCT02586805|588189161|FG000|Overall Study|Lost to Follow-up|0|||
162859186|NCT02586805|588189162|FG001|Overall Study|Lost to Follow-up|0|||
162859187|NCT02586805|588189163|FG002|Overall Study|Lost to Follow-up|1|||
162859188|NCT02586805|588189164|FG003|Overall Study|Lost to Follow-up|0|||
162859189|NCT02586805|588189161|FG000|Overall Study|Physician Decision|1|||
162859190|NCT02586805|588189162|FG001|Overall Study|Physician Decision|0|||
162859191|NCT02586805|588189163|FG002|Overall Study|Physician Decision|0|||
162859192|NCT02586805|588189164|FG003|Overall Study|Physician Decision|0|||
162859193|NCT02750410|588189167|FG000|Double-Blind Treatment Period|Adverse Event|2|||
162859194|NCT02750410|588189168|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162859195|NCT02750410|588189167|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162859196|NCT02750410|588189168|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162859197|NCT02750410|588189167|FG000|Open-Label Extension Period|Adverse Event|5|||
162859198|NCT02750410|588189168|FG001|Open-Label Extension Period|Adverse Event|3|||
162859199|NCT02750410|588189167|FG000|Open-Label Extension Period|Protocol Violation|0|||
162859200|NCT02750410|588189168|FG001|Open-Label Extension Period|Protocol Violation|1|||
162859201|NCT02750410|588189167|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
162859202|NCT02750410|588189168|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
162859203|NCT02504541|588189169|FG000|Overall Study|Adverse Event|4|||
162859204|NCT02504541|588189169|FG000|Overall Study|Withdrawal by Subject|4|||
162859205|NCT02504541|588189169|FG000|Overall Study|Lost to Follow-up|1|||
162859206|NCT02504541|588189169|FG000|Overall Study|Met Stopping Criteria|1|||
162859207|NCT02504541|588189169|FG000|Overall Study|Protocol Violation|2|||
162859208|NCT02504541|588189169|FG000|Overall Study|Termination by Sponsor|1|||
162859209|NCT02504541|588189169|FG000|Overall Study|Other|2|||
162859210|NCT02504541|588189169|FG000|Overall Study|Multiple|5|||
162859211|NCT01531725|588189174|FG000|Overall Study|Protocol Violation|5|||
162859212|NCT03215277|588189175|FG000|Overall Study|Adverse Event|2|||
162859213|NCT03215277|588189176|FG001|Overall Study|Adverse Event|3|||
162859214|NCT03215277|588189175|FG000|Overall Study|Death|1|||
162859215|NCT03215277|588189176|FG001|Overall Study|Death|0|||
162859216|NCT03215277|588189175|FG000|Overall Study|Lost to Follow-up|0|||
162859217|NCT03215277|588189176|FG001|Overall Study|Lost to Follow-up|1|||
162956668|NCT03872128|588543587|FG002|Overall Study|Lost to Follow-up|8|||
162956669|NCT03285594|588543592|FG000|Overall Study|At the Participant's Own Request|10|||
162956670|NCT03285594|588543593|FG001|Overall Study|At the Participant's Own Request|5|||
162956671|NCT03285594|588543594|FG002|Overall Study|At the Participant's Own Request|21|||
162956672|NCT03285594|588543592|FG000|Overall Study|Adverse Event|2|||
162956673|NCT03285594|588543593|FG001|Overall Study|Adverse Event|2|||
162956674|NCT03285594|588543594|FG002|Overall Study|Adverse Event|6|||
162956675|NCT03285594|588543592|FG000|Overall Study|Poor Compliance to Protocol|0|||
162956676|NCT03285594|588543593|FG001|Overall Study|Poor Compliance to Protocol|0|||
162956677|NCT03285594|588543594|FG002|Overall Study|Poor Compliance to Protocol|1|||
162859218|NCT03215277|588189175|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
162859219|NCT03215277|588189176|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
162956678|NCT03285594|588543592|FG000|Overall Study|Lost to Follow-up|0|||
162956679|NCT03285594|588543593|FG001|Overall Study|Lost to Follow-up|0|||
162956680|NCT03285594|588543594|FG002|Overall Study|Lost to Follow-up|1|||
162956681|NCT03285594|588543592|FG000|Overall Study|Reason Not Specified|3|||
162705353|NCT02559817|587632199|FG002|Treatment Period|Lack of Efficacy|0|||
162705354|NCT02559817|587632200|FG003|Treatment Period|Lack of Efficacy|0|||
162859220|NCT02317510|588189177|FG000|Overall Study|Adverse Event|0|||
162859221|NCT02317510|588189178|FG001|Overall Study|Adverse Event|1|||
162859222|NCT00472303|588189179|FG000|Titration Phase|Adverse Event|22|||
162859223|NCT00472303|588189180|FG001|Titration Phase|Adverse Event|12|||
162859224|NCT00472303|588189181|FG002|Titration Phase|Adverse Event|0|||
162859225|NCT00472303|588189179|FG000|Titration Phase|Death|4|||
162859226|NCT00472303|588189180|FG001|Titration Phase|Death|2|||
162859227|NCT00472303|588189181|FG002|Titration Phase|Death|0|||
162859228|NCT00472303|588189179|FG000|Titration Phase|Lack of Efficacy|10|||
162956682|NCT03285594|588543593|FG001|Overall Study|Reason Not Specified|4|||
162956683|NCT03285594|588543594|FG002|Overall Study|Reason Not Specified|8|||
162859229|NCT00472303|588189180|FG001|Titration Phase|Lack of Efficacy|0|||
162859230|NCT00472303|588189181|FG002|Titration Phase|Lack of Efficacy|0|||
162859231|NCT00472303|588189179|FG000|Titration Phase|Withdrawal by Subject|16|||
162956684|NCT00834431|588543595|FG000|First Intervention|Adverse Event|0|||
162859232|NCT00472303|588189180|FG001|Titration Phase|Withdrawal by Subject|13|||
162859233|NCT00472303|588189181|FG002|Titration Phase|Withdrawal by Subject|0|||
162859234|NCT00472303|588189179|FG000|Titration Phase|Trial Medication non-compliant|4|||
162859235|NCT00472303|588189180|FG001|Titration Phase|Trial Medication non-compliant|1|||
162859236|NCT00472303|588189181|FG002|Titration Phase|Trial Medication non-compliant|0|||
162859237|NCT00472303|588189179|FG000|Titration Phase|Other|3|||
162859238|NCT00472303|588189180|FG001|Titration Phase|Other|1|||
162859239|NCT00472303|588189181|FG002|Titration Phase|Other|0|||
162859240|NCT00472303|588189179|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
162859241|NCT00472303|588189180|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
162859242|NCT00472303|588189181|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
162859243|NCT00472303|588189179|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
162859244|NCT00472303|588189180|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
162859245|NCT00472303|588189181|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
162859246|NCT00472303|588189179|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
162859247|NCT00472303|588189180|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
162859248|NCT00472303|588189181|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
162859249|NCT00472303|588189179|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
162859250|NCT00472303|588189180|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
162859251|NCT00472303|588189181|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
162859252|NCT00472303|588189179|FG000|Discontinuations After Titration Phase|Other|5|||
162859253|NCT00472303|588189180|FG001|Discontinuations After Titration Phase|Other|0|||
162859254|NCT00472303|588189181|FG002|Discontinuations After Titration Phase|Other|0|||
162859255|NCT00472303|588189179|FG000|Maintenance Phase|Adverse Event|5|||
162859256|NCT00472303|588189180|FG001|Maintenance Phase|Adverse Event|6|||
162859257|NCT00472303|588189181|FG002|Maintenance Phase|Adverse Event|6|||
162859258|NCT00472303|588189179|FG000|Maintenance Phase|Death|3|||
162859259|NCT00472303|588189180|FG001|Maintenance Phase|Death|0|||
162859260|NCT00472303|588189181|FG002|Maintenance Phase|Death|2|||
162859261|NCT00472303|588189179|FG000|Maintenance Phase|Lack of Efficacy|2|||
162859262|NCT00472303|588189180|FG001|Maintenance Phase|Lack of Efficacy|2|||
162859263|NCT00472303|588189181|FG002|Maintenance Phase|Lack of Efficacy|4|||
162859264|NCT00472303|588189179|FG000|Maintenance Phase|Withdrawal by Subject|6|||
162859265|NCT00472303|588189180|FG001|Maintenance Phase|Withdrawal by Subject|7|||
162859266|NCT00472303|588189181|FG002|Maintenance Phase|Withdrawal by Subject|3|||
162859267|NCT00472303|588189179|FG000|Maintenance Phase|Trial medication non-compliant|0|||
162859268|NCT00472303|588189180|FG001|Maintenance Phase|Trial medication non-compliant|0|||
162859269|NCT00472303|588189181|FG002|Maintenance Phase|Trial medication non-compliant|1|||
162612624|NCT00851630|587299792|FG000|Overall Study|Clinical failure|0|||
162859270|NCT00472303|588189179|FG000|Maintenance Phase|Resolution of pain|0|||
162859271|NCT00472303|588189180|FG001|Maintenance Phase|Resolution of pain|0|||
162859272|NCT00472303|588189181|FG002|Maintenance Phase|Resolution of pain|1|||
162859273|NCT00472303|588189179|FG000|Maintenance Phase|Other|1|||
162859274|NCT00472303|588189180|FG001|Maintenance Phase|Other|1|||
162859275|NCT00472303|588189181|FG002|Maintenance Phase|Other|0|||
162859276|NCT01122927|588189182|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
162859277|NCT01122927|588189183|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
162859278|NCT01122927|588189182|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
162859279|NCT01122927|588189183|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
162859280|NCT01122927|588189182|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
162859281|NCT01122927|588189183|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
162859282|NCT01122927|588189182|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
162859283|NCT01122927|588189183|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
162859284|NCT01122927|588189182|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
162859285|NCT01122927|588189183|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
162859286|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
162859287|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
162956685|NCT00834431|588543596|FG001|First Intervention|Adverse Event|1|||
162956686|NCT00834431|588543595|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162612625|NCT00851630|587299793|FG001|Overall Study|Clinical failure|1|||
162612626|NCT03061097|587299800|FG000|Overall Study|Withdrawal by Subject|0|||
162612627|NCT03061097|587299801|FG001|Overall Study|Withdrawal by Subject|3|||
162859288|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
162859289|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
162859290|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
162859291|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
162859292|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
162859293|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
162859294|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
162956687|NCT00834431|588543596|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162705355|NCT02559817|587632201|FG004|Treatment Period|Lack of Efficacy|0|||
162859295|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
162859296|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
162859297|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
162859298|NCT01122927|588189182|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
162859299|NCT01122927|588189183|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
162859300|NCT03486314|588189199|FG000|Part A|Adverse Event|1|||
162859301|NCT03486314|588189200|FG001|Part A|Adverse Event|0|||
162859302|NCT03486314|588189201|FG002|Part A|Adverse Event|0|||
162859303|NCT03486314|588189199|FG000|Part A|Symptomatic Deterioration|2|||
162859304|NCT03486314|588189200|FG001|Part A|Symptomatic Deterioration|0|||
162859305|NCT03486314|588189201|FG002|Part A|Symptomatic Deterioration|0|||
162859306|NCT01364467|588189204|FG000|Overall Study|Lost to Follow-up|1|||
162859307|NCT01364467|588189205|FG001|Overall Study|Lost to Follow-up|2|||
162859308|NCT02502864|588189206|FG000|Overall Study|Withdrawal by Subject|1|||
162859309|NCT04375878|588189207|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
162859310|NCT04375878|588189208|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
162859311|NCT04375878|588189209|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
162612628|NCT03956056|587299802|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
162859312|NCT04375878|588189210|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
162859313|NCT04375878|588189211|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
162859314|NCT04375878|588189212|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
162859315|NCT04375878|588189207|FG000|Crossover First and Second Interventions|Adverse Event|0|||
162859316|NCT04375878|588189208|FG001|Crossover First and Second Interventions|Adverse Event|0|||
162859317|NCT04375878|588189209|FG002|Crossover First and Second Interventions|Adverse Event|1|||
162859318|NCT04375878|588189210|FG003|Crossover First and Second Interventions|Adverse Event|0|||
162859319|NCT04375878|588189211|FG004|Crossover First and Second Interventions|Adverse Event|0|||
162859320|NCT04375878|588189212|FG005|Crossover First and Second Interventions|Adverse Event|0|||
162859321|NCT04375878|588189207|FG000|Extension Phase|Withdrawal by Subject|0|||
162859322|NCT04375878|588189208|FG001|Extension Phase|Withdrawal by Subject|0|||
162859323|NCT04375878|588189209|FG002|Extension Phase|Withdrawal by Subject|0|||
162859324|NCT04375878|588189210|FG003|Extension Phase|Withdrawal by Subject|0|||
162859325|NCT04375878|588189211|FG004|Extension Phase|Withdrawal by Subject|1|||
162859326|NCT04375878|588189212|FG005|Extension Phase|Withdrawal by Subject|0|||
162859327|NCT03815175|588189213|FG000|Overall Study|Subject Lost to Follow-up|6|||
162859328|NCT03815175|588189213|FG000|Overall Study|Subject Withdrew Consent|48|||
162859329|NCT03815175|588189213|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
162859330|NCT03815175|588189213|FG000|Overall Study|Death|86|||
162859331|NCT03815175|588189213|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
162859332|NCT03815175|588189213|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
162859333|NCT03815175|588189213|FG000|Overall Study|Other Status Change Reason|1|||
162859334|NCT03815175|588189213|FG000|Overall Study|Missed Visit|12|||
162859335|NCT03577990|588189214|FG000|Overall Study|Lost to Follow-up|4|||
162859336|NCT03577990|588189215|FG001|Overall Study|Lost to Follow-up|6|||
162859337|NCT03577990|588189214|FG000|Overall Study|Withdrawal by Subject|4|||
162859338|NCT03577990|588189215|FG001|Overall Study|Withdrawal by Subject|7|||
162859339|NCT00140855|588189225|FG000|Overall Study|Progressive disease|2|||
162859340|NCT01682044|588189232|FG000|Overall Study|Death|1|||
162859341|NCT01682044|588189232|FG000|Overall Study|Progression|3|||
162859342|NCT01672892|588190813|FG000|Overall Study|Protocol Violation|7|||
162859343|NCT01672892|588190814|FG001|Overall Study|Protocol Violation|3|||
162859344|NCT02981472|588190825|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
162859345|NCT02981472|588190826|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
162859346|NCT02981472|588190825|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162859347|NCT02981472|588190826|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162859348|NCT02981472|588190825|FG000|Treatment Period|Adverse Event|6|||
162859349|NCT02981472|588190826|FG001|Treatment Period|Adverse Event|1|||
162859350|NCT02981472|588190825|FG000|Treatment Period|Participant withdrew consent|1|||
162859351|NCT02981472|588190826|FG001|Treatment Period|Participant withdrew consent|0|||
162859352|NCT02981472|588190825|FG000|Treatment Period|Lost to Follow-up|0|||
162859353|NCT02981472|588190826|FG001|Treatment Period|Lost to Follow-up|1|||
162859354|NCT01584024|588190833|FG000|Overall Study|Lost to Follow-up|10|||
162859355|NCT01584024|588190833|FG000|Overall Study|Withdrawal by Subject|3|||
162612629|NCT03956056|587299802|FG000|Overall Study|Lack of Efficacy|1|||
162612630|NCT04629508|587299809|FG000|Overall Study|Adverse Event|1|||
162859356|NCT00719810|588190839|FG000|Overall Study|Adverse Event|0|||
162859357|NCT00719810|588190840|FG001|Overall Study|Adverse Event|2|||
162859358|NCT00719810|588190841|FG002|Overall Study|Adverse Event|3|||
162859359|NCT00719810|588190839|FG000|Overall Study|Lost to Follow-up|2|||
162859360|NCT00719810|588190840|FG001|Overall Study|Lost to Follow-up|0|||
162859361|NCT00719810|588190841|FG002|Overall Study|Lost to Follow-up|3|||
162859362|NCT00719810|588190839|FG000|Overall Study|Physician Decision|0|||
162859363|NCT00719810|588190840|FG001|Overall Study|Physician Decision|1|||
162859364|NCT00719810|588190841|FG002|Overall Study|Physician Decision|0|||
162859365|NCT00719810|588190839|FG000|Overall Study|Withdrawal by Subject|1|||
163044856|NCT01720524|588871509|FG000|Part A|Withdrawal by Subject|0|||
163044857|NCT01720524|588871510|FG001|Part A|Withdrawal by Subject|1|||
163044858|NCT01720524|588871509|FG000|Part A|Other|0|||
163044859|NCT01720524|588871510|FG001|Part A|Other|1|||
163044860|NCT01720524|588871509|FG000|Part A|Lost to Follow-up|0|||
163044861|NCT01720524|588871510|FG001|Part A|Lost to Follow-up|1|||
163044862|NCT01720524|588871509|FG000|Part B|No longer willing to participate in study|1|||
163044863|NCT01720524|588871510|FG001|Part B|No longer willing to participate in study|4|||
163044864|NCT01720524|588871509|FG000|Part B|Other|2|||
163044865|NCT01720524|588871510|FG001|Part B|Other|0|||
163044866|NCT01720524|588871509|FG000|Part B|Lost to Follow-up|2|||
163044867|NCT01720524|588871510|FG001|Part B|Lost to Follow-up|3|||
163044868|NCT01720524|588871509|FG000|Part B|Death|0|||
163044869|NCT01720524|588871510|FG001|Part B|Death|2|||
163044870|NCT00158262|588871514|FG000|Overall Study|Lost to Follow-up|1|||
163044871|NCT00158262|588871515|FG001|Overall Study|Lost to Follow-up|1|||
163044872|NCT00527826|588871516|FG000|Overall Study|Adverse Event|10|||
163044873|NCT00527826|588871517|FG001|Overall Study|Adverse Event|10|||
163044874|NCT00527826|588871516|FG000|Overall Study|Lost to Follow-up|3|||
163044875|NCT00527826|588871517|FG001|Overall Study|Lost to Follow-up|2|||
163044876|NCT00527826|588871516|FG000|Overall Study|Withdrawal by Subject|5|||
163044877|NCT00527826|588871517|FG001|Overall Study|Withdrawal by Subject|8|||
163044878|NCT00527826|588871516|FG000|Overall Study|Inclusion Criteria Not Met|3|||
163044879|NCT00527826|588871517|FG001|Overall Study|Inclusion Criteria Not Met|3|||
163044880|NCT00527826|588871516|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
163044881|NCT00527826|588871517|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
163044882|NCT00527826|588871516|FG000|Overall Study|Additional Intake of Viani forte|0|||
163044883|NCT00527826|588871517|FG001|Overall Study|Additional Intake of Viani forte|1|||
163044884|NCT00527826|588871516|FG000|Overall Study|Participant moved away|0|||
163044885|NCT00527826|588871517|FG001|Overall Study|Participant moved away|1|||
163044886|NCT04501952|588871525|FG000|Overall Study|Adverse Event|0|||
163044887|NCT04501952|588871526|FG001|Overall Study|Adverse Event|3|||
163044888|NCT04501952|588871525|FG000|Overall Study|Investigator's Discretion|0|||
163044889|NCT04501952|588871526|FG001|Overall Study|Investigator's Discretion|1|||
163044890|NCT04501952|588871525|FG000|Overall Study|Protocol Violation|1|||
163044891|NCT04501952|588871526|FG001|Overall Study|Protocol Violation|1|||
163044892|NCT04501952|588871525|FG000|Overall Study|Withdrew Consent|5|||
163044893|NCT04501952|588871526|FG001|Overall Study|Withdrew Consent|4|||
163044894|NCT04501952|588871525|FG000|Overall Study|Lost to Follow-up|7|||
162859366|NCT00719810|588190840|FG001|Overall Study|Withdrawal by Subject|1|||
162859367|NCT00719810|588190841|FG002|Overall Study|Withdrawal by Subject|2|||
162859368|NCT04893265|588190864|FG000|Overall Study|Withdrawal by Subject|2|||
162859369|NCT04893265|588190865|FG001|Overall Study|Withdrawal by Subject|5|||
162859370|NCT04893265|588190864|FG000|Overall Study|Lost to Follow-up|0|||
162956688|NCT00556322|588543601|FG000|Overall Study|Insufficient therapeutic response|158|||
162956689|NCT00556322|588543602|FG001|Overall Study|Insufficient therapeutic response|168|||
162956690|NCT00556322|588543601|FG000|Overall Study|Adverse Event|7|||
163044895|NCT04501952|588871526|FG001|Overall Study|Lost to Follow-up|2|||
163044896|NCT04501952|588871525|FG000|Overall Study|Randomized and Never Treated|13|||
163044897|NCT04501952|588871526|FG001|Overall Study|Randomized and Never Treated|9|||
162859371|NCT04893265|588190865|FG001|Overall Study|Lost to Follow-up|4|||
162859372|NCT02465034|588190867|FG000|Overall Study|Withdrawal by Subject|1|||
162859373|NCT02465034|588190868|FG001|Overall Study|Withdrawal by Subject|1|||
162956691|NCT00556322|588543602|FG001|Overall Study|Adverse Event|4|||
162956692|NCT00556322|588543601|FG000|Overall Study|Other|4|||
162956693|NCT00556322|588543602|FG001|Overall Study|Other|1|||
162956694|NCT00556322|588543601|FG000|Overall Study|Lost to Follow-up|5|||
162956695|NCT00556322|588543602|FG001|Overall Study|Lost to Follow-up|3|||
163044898|NCT03382418|588871533|FG000|Overall Study|Withdrawal by Subject|1|||
163044899|NCT03382418|588871534|FG001|Overall Study|Withdrawal by Subject|0|||
162956696|NCT00556322|588543601|FG000|Overall Study|Withdrawal by Subject|19|||
163044900|NCT03382418|588871535|FG002|Overall Study|Withdrawal by Subject|0|||
163044901|NCT03382418|588871533|FG000|Overall Study|Lost to Follow-up|2|||
163044902|NCT03382418|588871534|FG001|Overall Study|Lost to Follow-up|3|||
162956697|NCT00556322|588543602|FG001|Overall Study|Withdrawal by Subject|7|||
162956698|NCT00556322|588543601|FG000|Overall Study|Protocol Violation|5|||
162956699|NCT00556322|588543602|FG001|Overall Study|Protocol Violation|1|||
162956700|NCT00556322|588543601|FG000|Overall Study|Ongoing at data cutoff|3|||
163044903|NCT03382418|588871535|FG002|Overall Study|Lost to Follow-up|0|||
163044904|NCT01189461|588871544|FG000|Overall Study|Lack of Efficacy|13|||
163044905|NCT01189461|588871544|FG000|Overall Study|Lost to Follow-up|1|||
163044906|NCT01189461|588871544|FG000|Overall Study|Withdrawal by Subject|6|||
163044907|NCT01189461|588871544|FG000|Overall Study|Protocol Violation|1|||
162859374|NCT02465034|588190867|FG000|Overall Study|Screen fail|2|||
162859375|NCT02465034|588190868|FG001|Overall Study|Screen fail|0|||
162956701|NCT00556322|588543602|FG001|Overall Study|Ongoing at data cutoff|5|||
162956702|NCT00556322|588543601|FG000|Overall Study|Death|20|||
162956703|NCT00556322|588543602|FG001|Overall Study|Death|14|||
163044908|NCT01189461|588871544|FG000|Overall Study|Adverse Event|2|||
162859376|NCT02465034|588190867|FG000|Overall Study|Could not be scheduled for study visit|0|||
162859377|NCT02465034|588190868|FG001|Overall Study|Could not be scheduled for study visit|5|||
162859378|NCT00573131|588190869|FG000|Overall Study|Withdrawal by Subject|10|||
162859379|NCT00573131|588190870|FG001|Overall Study|Withdrawal by Subject|8|||
162859380|NCT02401256|588190876|FG000|Overall Study|Adverse Event|5|||
162859381|NCT02401256|588190876|FG000|Overall Study|Withdrawal by Subject|12|||
162859382|NCT00893789|588190878|FG000|Overall Study|Withdrawal by Subject|3|||
162859383|NCT00893789|588190879|FG001|Overall Study|Withdrawal by Subject|1|||
162859384|NCT00893789|588190880|FG002|Overall Study|Withdrawal by Subject|3|||
162859385|NCT00893789|588190881|FG003|Overall Study|Withdrawal by Subject|1|||
162859386|NCT00893789|588190878|FG000|Overall Study|Noncompliance With Study Drug|1|||
162859387|NCT00893789|588190879|FG001|Overall Study|Noncompliance With Study Drug|0|||
162859388|NCT00893789|588190880|FG002|Overall Study|Noncompliance With Study Drug|1|||
162859389|NCT00893789|588190881|FG003|Overall Study|Noncompliance With Study Drug|2|||
162859390|NCT00893789|588190878|FG000|Overall Study|Noncompliance With Study Procedures|1|||
162859391|NCT00893789|588190879|FG001|Overall Study|Noncompliance With Study Procedures|0|||
162859392|NCT00893789|588190880|FG002|Overall Study|Noncompliance With Study Procedures|0|||
162859393|NCT00893789|588190881|FG003|Overall Study|Noncompliance With Study Procedures|0|||
162859394|NCT00893789|588190878|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
162859395|NCT00893789|588190879|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
162859396|NCT00893789|588190880|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
162859397|NCT00893789|588190881|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
162859398|NCT00893789|588190878|FG000|Overall Study|Adverse Event|0|||
162859399|NCT00893789|588190879|FG001|Overall Study|Adverse Event|2|||
162859400|NCT00893789|588190880|FG002|Overall Study|Adverse Event|1|||
162859401|NCT00893789|588190881|FG003|Overall Study|Adverse Event|5|||
162859402|NCT00893789|588190878|FG000|Overall Study|Protocol Violation|0|||
162859403|NCT00893789|588190879|FG001|Overall Study|Protocol Violation|1|||
162859404|NCT00893789|588190880|FG002|Overall Study|Protocol Violation|1|||
162859405|NCT00893789|588190881|FG003|Overall Study|Protocol Violation|4|||
162859406|NCT00893789|588190878|FG000|Overall Study|Lost to Follow-up|0|||
162859407|NCT00893789|588190879|FG001|Overall Study|Lost to Follow-up|0|||
162859408|NCT00893789|588190880|FG002|Overall Study|Lost to Follow-up|0|||
162859409|NCT00893789|588190881|FG003|Overall Study|Lost to Follow-up|1|||
162859410|NCT02024464|588190882|FG000|Overall Study|Discontinued|5|||
162859411|NCT02024464|588190883|FG001|Overall Study|Discontinued|4|||
162859412|NCT02024464|588190882|FG000|Overall Study|Missed Visits|1|||
162859413|NCT02024464|588190883|FG001|Overall Study|Missed Visits|0|||
162859414|NCT02024464|588190882|FG000|Overall Study|Lost to Follow-up|4|||
162859415|NCT02024464|588190883|FG001|Overall Study|Lost to Follow-up|7|||
162859416|NCT01575548|588190888|FG000|Overall Study|Adverse Event|15|||
162859417|NCT01575548|588190889|FG001|Overall Study|Adverse Event|2|||
162859418|NCT01575548|588190888|FG000|Overall Study|Disease progression|12|||
162859419|NCT01575548|588190889|FG001|Overall Study|Disease progression|25|||
162859420|NCT01575548|588190888|FG000|Overall Study|Death|1|||
162859421|NCT01575548|588190889|FG001|Overall Study|Death|0|||
162859422|NCT01575548|588190888|FG000|Overall Study|Other complicating disease|1|||
162859423|NCT01575548|588190889|FG001|Overall Study|Other complicating disease|0|||
162859424|NCT01575548|588190888|FG000|Overall Study|Withdrawal by Subject|7|||
162859425|NCT01575548|588190889|FG001|Overall Study|Withdrawal by Subject|3|||
162612631|NCT04629508|587299809|FG000|Overall Study|Death|2|||
162612632|NCT04629508|587299809|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
162859426|NCT01575548|588190888|FG000|Overall Study|Noncompliance|1|||
162859427|NCT01575548|588190889|FG001|Overall Study|Noncompliance|0|||
162859428|NCT01575548|588190888|FG000|Overall Study|Anticipated surgery|0|||
162859429|NCT01575548|588190889|FG001|Overall Study|Anticipated surgery|1|||
162859430|NCT01575548|588190888|FG000|Overall Study|Never started protocol therapy|3|||
162859431|NCT01575548|588190889|FG001|Overall Study|Never started protocol therapy|2|||
162859432|NCT03872180|588190892|FG000|Overall Study|Adverse Event|4|||
162859433|NCT03872180|588190892|FG000|Overall Study|Lack of Efficacy|2|||
162859434|NCT01244737|588190894|FG000|Overall Study|Physician Decision|2|||
162859435|NCT01244737|588190895|FG001|Overall Study|Physician Decision|18|||
162859436|NCT01244737|588190896|FG002|Overall Study|Physician Decision|5|||
162612633|NCT04073368|587299810|FG000|Overall Study|Adverse Event|2|||
162859437|NCT01244737|588190894|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
162859438|NCT01244737|588190895|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
162859439|NCT01244737|588190896|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
162859440|NCT01244737|588190894|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
162859441|NCT01244737|588190895|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
162859442|NCT01244737|588190896|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
162859443|NCT01244737|588190894|FG000|Overall Study|MIB immunopathology results not available|3|||
162859444|NCT01244737|588190895|FG001|Overall Study|MIB immunopathology results not available|2|||
162859445|NCT01244737|588190896|FG002|Overall Study|MIB immunopathology results not available|0|||
162612634|NCT04073368|587299811|FG001|Overall Study|Adverse Event|0|||
162612635|NCT04073368|587299812|FG002|Overall Study|Adverse Event|1|||
162612636|NCT04073368|587299813|FG003|Overall Study|Adverse Event|1|||
162612637|NCT04073368|587299810|FG000|Overall Study|Withdrawal by Subject|2|||
162612638|NCT04073368|587299811|FG001|Overall Study|Withdrawal by Subject|2|||
162612639|NCT04073368|587299812|FG002|Overall Study|Withdrawal by Subject|1|||
162612640|NCT04073368|587299813|FG003|Overall Study|Withdrawal by Subject|1|||
162612641|NCT04073368|587299810|FG000|Overall Study|Lost to Follow-up|1|||
162612642|NCT04073368|587299811|FG001|Overall Study|Lost to Follow-up|1|||
162612643|NCT04073368|587299812|FG002|Overall Study|Lost to Follow-up|1|||
162612644|NCT04073368|587299813|FG003|Overall Study|Lost to Follow-up|0|||
162859446|NCT01244737|588190894|FG000|Overall Study|PET data failure|0|||
162859447|NCT01244737|588190895|FG001|Overall Study|PET data failure|1|||
162859448|NCT01244737|588190896|FG002|Overall Study|PET data failure|0|||
162859449|NCT01244737|588190894|FG000|Overall Study|Withdrawal by Subject|0|||
162859450|NCT01244737|588190895|FG001|Overall Study|Withdrawal by Subject|0|||
162859451|NCT01244737|588190896|FG002|Overall Study|Withdrawal by Subject|1|||
162859452|NCT00356915|588190901|FG000|Overall Study|Non compliance|1|||
162859453|NCT00356915|588190902|FG001|Overall Study|Non compliance|2|||
162859454|NCT00356915|588190903|FG002|Overall Study|Non compliance|1|||
162859455|NCT00356915|588190901|FG000|Overall Study|Protocol Violation|2|||
162859456|NCT00356915|588190902|FG001|Overall Study|Protocol Violation|3|||
162859457|NCT00356915|588190903|FG002|Overall Study|Protocol Violation|2|||
162859458|NCT00356915|588190901|FG000|Overall Study|Withdrawal by Subject|14|||
162859459|NCT00356915|588190902|FG001|Overall Study|Withdrawal by Subject|14|||
162859460|NCT00356915|588190903|FG002|Overall Study|Withdrawal by Subject|10|||
162859461|NCT00356915|588190901|FG000|Overall Study|Lack of Efficacy|0|||
162859462|NCT00356915|588190902|FG001|Overall Study|Lack of Efficacy|0|||
162859463|NCT00356915|588190903|FG002|Overall Study|Lack of Efficacy|3|||
162859464|NCT00356915|588190901|FG000|Overall Study|Lost to Follow-up|27|||
162859465|NCT00356915|588190902|FG001|Overall Study|Lost to Follow-up|34|||
162859466|NCT00356915|588190903|FG002|Overall Study|Lost to Follow-up|14|||
162859467|NCT00356915|588190901|FG000|Overall Study|Administrative Decision|0|||
162859468|NCT00356915|588190902|FG001|Overall Study|Administrative Decision|0|||
162859469|NCT00356915|588190903|FG002|Overall Study|Administrative Decision|1|||
162859470|NCT00356915|588190901|FG000|Overall Study|Physician Decision|0|||
162859471|NCT00356915|588190902|FG001|Overall Study|Physician Decision|2|||
162859472|NCT00356915|588190903|FG002|Overall Study|Physician Decision|0|||
162859473|NCT00356915|588190901|FG000|Overall Study|Adverse Event|21|||
162859474|NCT00356915|588190902|FG001|Overall Study|Adverse Event|31|||
162859475|NCT00356915|588190903|FG002|Overall Study|Adverse Event|8|||
162859476|NCT00356915|588190901|FG000|Overall Study|Miscellaneous reasons|11|||
162859477|NCT00356915|588190902|FG001|Overall Study|Miscellaneous reasons|8|||
162859478|NCT00356915|588190903|FG002|Overall Study|Miscellaneous reasons|3|||
162859479|NCT02371629|588190904|FG000|Overall Study|Patient decision|14|||
162859480|NCT02371629|588190905|FG001|Overall Study|Patient decision|10|||
162859481|NCT02371629|588190904|FG000|Overall Study|Adverse Event|8|||
162859482|NCT02371629|588190905|FG001|Overall Study|Adverse Event|8|||
162859483|NCT02371629|588190904|FG000|Overall Study|Physician Decision|2|||
162859484|NCT02371629|588190905|FG001|Overall Study|Physician Decision|3|||
162859485|NCT02371629|588190904|FG000|Overall Study|Death|1|||
162859486|NCT02371629|588190905|FG001|Overall Study|Death|1|||
162859487|NCT02371629|588190904|FG000|Overall Study|Noncompliance with study treatment|1|||
162859488|NCT02371629|588190905|FG001|Overall Study|Noncompliance with study treatment|0|||
162859489|NCT02371629|588190904|FG000|Overall Study|Lack of Efficacy|0|||
162859490|NCT02371629|588190905|FG001|Overall Study|Lack of Efficacy|2|||
162859491|NCT02371629|588190904|FG000|Overall Study|Protocol deviation|0|||
162859492|NCT02371629|588190905|FG001|Overall Study|Protocol deviation|1|||
162859493|NCT01193335|588190906|FG000|After Infant Series|Lost to Follow-up|1|||
162859494|NCT01193335|588190907|FG001|After Infant Series|Lost to Follow-up|2|||
162859495|NCT01193335|588190906|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
162859496|NCT01193335|588190907|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
162859497|NCT01193335|588190906|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
162859498|NCT01193335|588190907|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
162859499|NCT01193335|588190906|FG000|1-Year Follow-up|Lost to Follow-up|4|||
162859500|NCT01193335|588190907|FG001|1-Year Follow-up|Lost to Follow-up|0|||
162859501|NCT01193335|588190906|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
162612645|NCT04073368|587299810|FG000|Overall Study|Protocol Violation|0|||
162612646|NCT04073368|587299811|FG001|Overall Study|Protocol Violation|1|||
162859502|NCT01193335|588190907|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
162859503|NCT01193335|588190906|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
162859504|NCT01193335|588190907|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
162859505|NCT01985321|588190909|FG000|Overall Study|Protocol Violation|4|||
162859506|NCT01985321|588190910|FG001|Overall Study|Protocol Violation|3|||
162612647|NCT04073368|587299812|FG002|Overall Study|Protocol Violation|0|||
162859507|NCT01985321|588190909|FG000|Overall Study|Withdrawal by Subject|1|||
162859508|NCT01985321|588190910|FG001|Overall Study|Withdrawal by Subject|0|||
162859509|NCT01985321|588190909|FG000|Overall Study|Lost to Follow-up|5|||
162859510|NCT01985321|588190910|FG001|Overall Study|Lost to Follow-up|2|||
162859511|NCT01985321|588190909|FG000|Overall Study|Subject treated wrong type of sore|1|||
162859512|NCT01985321|588190910|FG001|Overall Study|Subject treated wrong type of sore|0|||
162859513|NCT03228186|588190911|FG000|Overall Study|Patient never started treatment|1|||
162859514|NCT03953118|588190912|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
162859515|NCT03953118|588190913|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
162859516|NCT00816036|588190917|FG000|Overall Study|Death|47|||
162859517|NCT00816036|588190918|FG001|Overall Study|Death|28|||
162859518|NCT00816036|588190917|FG000|Overall Study|Lost to Follow-up|75|||
162859519|NCT00816036|588190918|FG001|Overall Study|Lost to Follow-up|57|||
162859520|NCT00816036|588190917|FG000|Overall Study|Withdrawal by Subject|54|||
162859521|NCT00816036|588190918|FG001|Overall Study|Withdrawal by Subject|23|||
162859522|NCT01624194|588190919|FG000|Overall Study|Lost to Follow-up|1|||
162859523|NCT01624194|588190920|FG001|Overall Study|Lost to Follow-up|0|||
162859524|NCT01624194|588190919|FG000|Overall Study|Withdrawal by Subject|1|||
162859525|NCT01624194|588190920|FG001|Overall Study|Withdrawal by Subject|0|||
162859526|NCT03212261|588190924|FG000|Overall Study|Became ineligible d/t tech|2|||
162859527|NCT03212261|588190924|FG000|Overall Study|Tech Trouble- No first study visit|1|||
162859528|NCT03212261|588190924|FG000|Overall Study|Lost to Follow-up|7|||
162859529|NCT03212261|588190924|FG000|Overall Study|Family Emergency|1|||
162859530|NCT03212261|588190924|FG000|Overall Study|Too busy/ No time|5|||
162859531|NCT02296840|588190930|FG000|Overall Study|Adverse Event|1|||
162859532|NCT02296840|588190931|FG001|Overall Study|Adverse Event|1|||
162859533|NCT02296840|588190930|FG000|Overall Study|Protocol Violation|2|||
162859534|NCT02296840|588190931|FG001|Overall Study|Protocol Violation|1|||
162859535|NCT02296840|588190930|FG000|Overall Study|Lost to Follow-up|6|||
162956704|NCT03733444|588543603|FG000|Overall Study|Adverse Event|8|||
162956705|NCT03733444|588543604|FG001|Overall Study|Adverse Event|10|||
162956706|NCT03733444|588543605|FG002|Overall Study|Adverse Event|5|||
162956707|NCT03733444|588543603|FG000|Overall Study|Death|20|||
162956708|NCT03733444|588543604|FG001|Overall Study|Death|19|||
162859536|NCT02296840|588190931|FG001|Overall Study|Lost to Follow-up|17|||
162859537|NCT02485717|588190932|FG000|Overall Study|Lost to Follow-up|6|||
162859538|NCT02485717|588190933|FG001|Overall Study|Lost to Follow-up|0|||
162859539|NCT02485717|588190934|FG002|Overall Study|Lost to Follow-up|0|||
162859540|NCT02485717|588190932|FG000|Overall Study|Withdrawal by Subject|0|||
162859541|NCT02485717|588190933|FG001|Overall Study|Withdrawal by Subject|0|||
162859542|NCT02485717|588190934|FG002|Overall Study|Withdrawal by Subject|1|||
162859543|NCT02485717|588190932|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
162859544|NCT02485717|588190933|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
162859545|NCT02485717|588190934|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
162859546|NCT02485717|588190932|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
162859547|NCT02485717|588190933|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
162859548|NCT02485717|588190934|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
162859549|NCT02827877|588190935|FG000|Overall Study|Withdrawal by Subject|1|||
162859550|NCT00519532|588190936|FG000|Overall Study|Adverse Event|11|||
162859551|NCT00519532|588190936|FG000|Overall Study|Withdrawal by Subject|5|||
162859552|NCT00519532|588190936|FG000|Overall Study|Lost to Follow-up|2|||
162859553|NCT03914300|588190937|FG000|Overall Study|Adverse Event|1|||
162859554|NCT00814710|588190938|FG000|Overall Study|Adverse Event|1|||
162859555|NCT00814710|588190939|FG001|Overall Study|Adverse Event|0|||
162859556|NCT00814710|588190938|FG000|Overall Study|Lost to Follow-up|7|||
162859557|NCT00814710|588190939|FG001|Overall Study|Lost to Follow-up|3|||
162859558|NCT01450540|588190945|FG000|Overall Study|Withdrawal by Subject|19|||
162859559|NCT01450540|588190946|FG001|Overall Study|Withdrawal by Subject|13|||
162859560|NCT01450540|588190945|FG000|Overall Study|protocol deviation|3|||
162859561|NCT01450540|588190946|FG001|Overall Study|protocol deviation|23|||
162859562|NCT03542682|588190947|FG000|Overall Study|COVID-19 Protocol|0|||
162859563|NCT03542682|588190948|FG001|Overall Study|COVID-19 Protocol|1|||
162859564|NCT04090164|588190952|FG000|Overall Study|incomplete data on file|245|||
162859565|NCT04090164|588190953|FG001|Overall Study|incomplete data on file|0|||
162859566|NCT01887210|588190958|FG000|Overall Study|Withdrawal by Subject|1|||
162859567|NCT01887210|588190959|FG001|Overall Study|Withdrawal by Subject|3|||
162859568|NCT01887210|588190958|FG000|Overall Study|Lost to Follow-up|0|||
162956709|NCT03733444|588543605|FG002|Overall Study|Death|11|||
162956710|NCT03733444|588543603|FG000|Overall Study|Lost to Follow-up|3|||
162956711|NCT03733444|588543604|FG001|Overall Study|Lost to Follow-up|0|||
163044909|NCT01189461|588871544|FG000|Overall Study|Did not meet entrance criteria|3|||
162859569|NCT01887210|588190959|FG001|Overall Study|Lost to Follow-up|1|||
162859570|NCT00840463|588190963|FG000|Overall Study|Adverse Event|1|||
162859571|NCT00840463|588190964|FG001|Overall Study|Adverse Event|0|||
162859572|NCT02515669|588190971|FG000|228 Week Open-Label Phase|Other|0|||
162859573|NCT02515669|588190972|FG001|228 Week Open-Label Phase|Other|0|||
162859574|NCT02515669|588190973|FG002|228 Week Open-Label Phase|Other|1|||
162956712|NCT03733444|588543605|FG002|Overall Study|Lost to Follow-up|1|||
162956713|NCT03733444|588543603|FG000|Overall Study|Lack of Efficacy|0|||
162859575|NCT02515669|588190974|FG003|228 Week Open-Label Phase|Other|4|||
162859576|NCT02515669|588190971|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
162859577|NCT02515669|588190972|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
162859578|NCT02515669|588190973|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
162859579|NCT02515669|588190974|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
162859580|NCT02515669|588190971|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
162859581|NCT02515669|588190972|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
162859582|NCT02515669|588190973|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
162859583|NCT02515669|588190974|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
162859584|NCT02515669|588190971|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
162859585|NCT02515669|588190972|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
162859586|NCT02515669|588190973|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
162859587|NCT02515669|588190974|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
162859588|NCT02515669|588190971|FG000|228 Week Open-Label Phase|Missing|0|||
162859589|NCT02515669|588190972|FG001|228 Week Open-Label Phase|Missing|2|||
162859590|NCT02515669|588190973|FG002|228 Week Open-Label Phase|Missing|2|||
162859591|NCT02515669|588190974|FG003|228 Week Open-Label Phase|Missing|2|||
162859592|NCT00957372|588190975|FG000|PART I|Lost to Follow-up|0|||
162859593|NCT00957372|588190976|FG001|PART I|Lost to Follow-up|0|||
162859594|NCT00957372|588190977|FG002|PART I|Lost to Follow-up|1|||
162859595|NCT00957372|588190978|FG003|PART I|Lost to Follow-up|0|||
162859596|NCT00957372|588190975|FG000|PART II|Withdrawal by Subject|0|||
162859597|NCT00957372|588190976|FG001|PART II|Withdrawal by Subject|0|||
162859598|NCT00957372|588190977|FG002|PART II|Withdrawal by Subject|0|||
162859599|NCT00957372|588190978|FG003|PART II|Withdrawal by Subject|8|||
162859600|NCT00957372|588190975|FG000|PART II|Physician Decision|0|||
162859601|NCT00957372|588190976|FG001|PART II|Physician Decision|0|||
162859602|NCT00957372|588190977|FG002|PART II|Physician Decision|0|||
162859603|NCT00957372|588190978|FG003|PART II|Physician Decision|1|||
162859604|NCT00957372|588190975|FG000|PART II|Pregnancy|0|||
162859605|NCT00957372|588190976|FG001|PART II|Pregnancy|0|||
162859606|NCT00957372|588190977|FG002|PART II|Pregnancy|0|||
162859607|NCT00957372|588190978|FG003|PART II|Pregnancy|1|||
162859608|NCT00957372|588190975|FG000|PART II|Not Know|0|||
162859609|NCT00957372|588190976|FG001|PART II|Not Know|0|||
162859610|NCT00957372|588190977|FG002|PART II|Not Know|0|||
162859611|NCT00957372|588190978|FG003|PART II|Not Know|20|||
162859612|NCT00957372|588190975|FG000|PART II|Adverse Event|0|||
162859613|NCT00957372|588190976|FG001|PART II|Adverse Event|0|||
162859614|NCT00957372|588190977|FG002|PART II|Adverse Event|0|||
162859615|NCT00957372|588190978|FG003|PART II|Adverse Event|10|||
162859616|NCT00957372|588190975|FG000|PART II|Patient non-compliance|0|||
162859617|NCT00957372|588190976|FG001|PART II|Patient non-compliance|0|||
162859618|NCT00957372|588190977|FG002|PART II|Patient non-compliance|0|||
162859619|NCT00957372|588190978|FG003|PART II|Patient non-compliance|4|||
162859620|NCT01444391|588190979|FG000|Overall Study|Death|1|||
162859621|NCT05847881|588190983|FG000|Overall Study|Principal Investigator Decision|8|||
162859622|NCT05847881|588190983|FG000|Overall Study|Withdrawal by Subject|2|||
162859623|NCT03439345|588192590|FG000|Overall Study|Lost to Follow-up|0|||
162859624|NCT03439345|588192591|FG001|Overall Study|Lost to Follow-up|1|||
162859625|NCT03439345|588192590|FG000|Overall Study|Consent withdrawn|0|||
162859626|NCT03439345|588192591|FG001|Overall Study|Consent withdrawn|1|||
162859627|NCT05405166|588192592|FG000|Overall Study|Death|49|||
162859628|NCT05405166|588192593|FG001|Overall Study|Death|50|||
162859629|NCT05405166|588192592|FG000|Overall Study|Withdrawal by Subject|10|||
162859630|NCT05405166|588192593|FG001|Overall Study|Withdrawal by Subject|3|||
162859631|NCT05405166|588192592|FG000|Overall Study|Ongoing at the time of PCD|209|||
162859632|NCT05405166|588192593|FG001|Overall Study|Ongoing at the time of PCD|210|||
162859633|NCT03746080|588192594|FG000|Overall Study|In follow up|2|||
162612648|NCT04073368|587299813|FG003|Overall Study|Protocol Violation|0|||
162612649|NCT04073368|587299810|FG000|Overall Study|Subject noncompliance|7|||
162612650|NCT04073368|587299811|FG001|Overall Study|Subject noncompliance|4|||
162612651|NCT04073368|587299812|FG002|Overall Study|Subject noncompliance|0|||
162612652|NCT04073368|587299813|FG003|Overall Study|Subject noncompliance|0|||
162859634|NCT03746080|588192594|FG000|Overall Study|Death|15|||
162859635|NCT01843374|588192595|FG000|Overall Study|Death|155|||
162859636|NCT01843374|588192596|FG001|Overall Study|Death|313|||
162859637|NCT01843374|588192595|FG000|Overall Study|Withdrawal by Subject|14|||
162859638|NCT01843374|588192596|FG001|Overall Study|Withdrawal by Subject|20|||
162859639|NCT01843374|588192595|FG000|Overall Study|Withdrawing due to Other reason|20|||
162612653|NCT03026088|587299814|FG000|Overall Study|Study termination|20|||
162859640|NCT01843374|588192596|FG001|Overall Study|Withdrawing due to Other reason|46|||
162859641|NCT01826214|588192600|FG000|Overall Study|Adverse Event|7|||
162859642|NCT01826214|588192601|FG001|Overall Study|Adverse Event|6|||
162859643|NCT01826214|588192600|FG000|Overall Study|Death|3|||
162859644|NCT01826214|588192601|FG001|Overall Study|Death|1|||
162859645|NCT01826214|588192600|FG000|Overall Study|Lost to Follow-up|1|||
162612654|NCT00761579|587299815|FG000|Overall Study|Adverse Event|10|||
162859646|NCT01826214|588192601|FG001|Overall Study|Lost to Follow-up|0|||
162859647|NCT01826214|588192600|FG000|Overall Study|Physician Decision|0|||
162859648|NCT01826214|588192601|FG001|Overall Study|Physician Decision|2|||
162859649|NCT01826214|588192600|FG000|Overall Study|Progressive disease|22|||
162859650|NCT01826214|588192601|FG001|Overall Study|Progressive disease|21|||
162859651|NCT01826214|588192600|FG000|Overall Study|Study terminated by Sponsor|0|||
162859652|NCT01826214|588192601|FG001|Overall Study|Study terminated by Sponsor|1|||
162859653|NCT01826214|588192600|FG000|Overall Study|Subject/guardian decision|2|||
162859654|NCT01826214|588192601|FG001|Overall Study|Subject/guardian decision|3|||
162859655|NCT00955110|588192602|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
162859656|NCT00955110|588192602|FG000|Treatment Phase|Adverse Event|2|||
162859657|NCT00955110|588192602|FG000|Treatment Phase|Administrative reasons|2|||
162859658|NCT00955110|588192602|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
162859659|NCT00955110|588192602|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
162859660|NCT02128490|588192603|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162859661|NCT02128490|588192604|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162859662|NCT02128490|588192605|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
162859663|NCT02128490|588192606|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162859664|NCT02128490|588192607|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162859665|NCT02128490|588192603|FG000|Overall Study|Major Protocol Deviation|1|||
162859666|NCT02128490|588192604|FG001|Overall Study|Major Protocol Deviation|2|||
162859667|NCT02128490|588192605|FG002|Overall Study|Major Protocol Deviation|0|||
162859668|NCT02128490|588192606|FG003|Overall Study|Major Protocol Deviation|2|||
162859669|NCT02128490|588192607|FG004|Overall Study|Major Protocol Deviation|2|||
162859670|NCT02128490|588192603|FG000|Overall Study|Lost to Follow-up|0|||
162859671|NCT02128490|588192604|FG001|Overall Study|Lost to Follow-up|0|||
162859672|NCT02128490|588192605|FG002|Overall Study|Lost to Follow-up|1|||
162859673|NCT02128490|588192606|FG003|Overall Study|Lost to Follow-up|1|||
162859674|NCT02128490|588192607|FG004|Overall Study|Lost to Follow-up|1|||
162859675|NCT02128490|588192603|FG000|Overall Study|Voluntary Withdrawal|3|||
162859676|NCT02128490|588192604|FG001|Overall Study|Voluntary Withdrawal|3|||
162859677|NCT02128490|588192605|FG002|Overall Study|Voluntary Withdrawal|1|||
162859678|NCT02128490|588192606|FG003|Overall Study|Voluntary Withdrawal|1|||
162859679|NCT02128490|588192607|FG004|Overall Study|Voluntary Withdrawal|2|||
162859680|NCT02128490|588192603|FG000|Overall Study|Lack of Efficacy|0|||
162859681|NCT02128490|588192604|FG001|Overall Study|Lack of Efficacy|1|||
162859682|NCT02128490|588192605|FG002|Overall Study|Lack of Efficacy|0|||
162859683|NCT02128490|588192606|FG003|Overall Study|Lack of Efficacy|0|||
162859684|NCT02128490|588192607|FG004|Overall Study|Lack of Efficacy|0|||
162859685|NCT02128490|588192603|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
162859686|NCT02128490|588192604|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
162859687|NCT02128490|588192605|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
162859688|NCT02128490|588192606|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
162859689|NCT02128490|588192607|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
162859690|NCT02128490|588192603|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162859691|NCT02128490|588192604|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162859692|NCT02128490|588192605|FG002|Overall Study|Other Miscellaneous Reasons|2|||
162859693|NCT02128490|588192606|FG003|Overall Study|Other Miscellaneous Reasons|1|||
162859694|NCT02128490|588192607|FG004|Overall Study|Other Miscellaneous Reasons|1|||
162859695|NCT02243176|588192608|FG000|Overall Study|Other reason|1|||
162859696|NCT02243176|588192609|FG001|Overall Study|Other reason|2|||
162859697|NCT02243176|588192608|FG000|Overall Study|protocol specified withdrawal critera|1|||
162859698|NCT02243176|588192609|FG001|Overall Study|protocol specified withdrawal critera|3|||
162859699|NCT02243176|588192608|FG000|Overall Study|Protocol Violation|2|||
162859700|NCT02243176|588192609|FG001|Overall Study|Protocol Violation|1|||
162859701|NCT02243176|588192608|FG000|Overall Study|Withdrawal by Subject|8|||
162859702|NCT02243176|588192609|FG001|Overall Study|Withdrawal by Subject|7|||
162859703|NCT02243176|588192608|FG000|Overall Study|Adverse Event|2|||
162859704|NCT02243176|588192609|FG001|Overall Study|Adverse Event|2|||
162859705|NCT03704051|588192615|FG000|Overall Study|Withdrawal by Subject|4|||
162859706|NCT03704051|588192616|FG001|Overall Study|Withdrawal by Subject|0|||
162859707|NCT03311126|588192619|FG000|Induction|Death|1|||
162859708|NCT03311126|588192619|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
162859709|NCT03113500|588192620|FG000|Overall Study|Withdrawal by Subject|1|||
162859710|NCT01348919|588192623|FG000|Overall Study|Adverse Event|3|||
162859711|NCT01348919|588192624|FG001|Overall Study|Adverse Event|1|||
162859712|NCT01348919|588192625|FG002|Overall Study|Adverse Event|0|||
163044910|NCT01189461|588871544|FG000|Overall Study|Other|8|||
162859713|NCT01348919|588192623|FG000|Overall Study|Withdrawal by Subject|0|||
162859714|NCT01348919|588192624|FG001|Overall Study|Withdrawal by Subject|1|||
162859715|NCT01348919|588192625|FG002|Overall Study|Withdrawal by Subject|0|||
162859716|NCT01348919|588192623|FG000|Overall Study|Disease progression|0|||
162859717|NCT01348919|588192624|FG001|Overall Study|Disease progression|1|||
162859718|NCT01348919|588192625|FG002|Overall Study|Disease progression|1|||
162859719|NCT02517515|588192626|FG000|Overall Study|Adverse Event|0|||
162859720|NCT02517515|588192627|FG001|Overall Study|Adverse Event|1|||
162859721|NCT02517515|588192626|FG000|Overall Study|Withdrew Consent|0|||
162859722|NCT02517515|588192627|FG001|Overall Study|Withdrew Consent|1|||
162859723|NCT02517515|588192626|FG000|Overall Study|Lost to Follow-up|1|||
162859724|NCT02517515|588192627|FG001|Overall Study|Lost to Follow-up|0|||
162859725|NCT02517515|588192626|FG000|Overall Study|Other|1|||
162859726|NCT02517515|588192627|FG001|Overall Study|Other|0|||
162859727|NCT03839524|588192629|FG000|Overall Study|Adverse Event|1|||
162859728|NCT02037919|588192635|FG000|Overall Study|Lost to Follow-up|30|||
162859729|NCT02037919|588192636|FG001|Overall Study|Lost to Follow-up|45|||
162859730|NCT00886938|588192637|FG000|Overall Study|Adverse Event|1|||
162859731|NCT00886938|588192637|FG000|Overall Study|Withdrawal by Subject|1|||
162859732|NCT00917384|588192638|FG000|Overall Study|Lost to Follow-up|4|||
162859733|NCT00917384|588192639|FG001|Overall Study|Lost to Follow-up|2|||
162859734|NCT00917384|588192638|FG000|Overall Study|Withdrawal by Subject|10|||
162859735|NCT00917384|588192639|FG001|Overall Study|Withdrawal by Subject|2|||
162859736|NCT01458340|588192642|FG000|Overall Study|Adverse Event|5|||
162859737|NCT01458340|588192643|FG001|Overall Study|Adverse Event|4|||
162859738|NCT01458340|588192644|FG002|Overall Study|Adverse Event|2|||
162859739|NCT01458340|588192642|FG000|Overall Study|Lost to Follow-up|3|||
162859740|NCT01458340|588192643|FG001|Overall Study|Lost to Follow-up|3|||
162859741|NCT01458340|588192644|FG002|Overall Study|Lost to Follow-up|10|||
162612655|NCT00761579|587299815|FG000|Overall Study|Death|2|||
162612656|NCT00761579|587299815|FG000|Overall Study|Lack of Efficacy|21|||
162612657|NCT00761579|587299815|FG000|Overall Study|Lost to Follow-up|16|||
162612658|NCT00761579|587299815|FG000|Overall Study|Pregnancy|1|||
162612659|NCT00761579|587299815|FG000|Overall Study|Withdrawal by Subject|34|||
162612660|NCT00761579|587299815|FG000|Overall Study|Lack of compliance|2|||
162612661|NCT00761579|587299815|FG000|Overall Study|Protocol deviation|1|||
162612662|NCT00761579|587299815|FG000|Overall Study|Drug overdose|1|||
162612663|NCT00761579|587299815|FG000|Overall Study|Aggravation of depression|1|||
162612664|NCT00761579|587299815|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
162612665|NCT00761579|587299815|FG000|Overall Study|Lost survey form|1|||
162612666|NCT00761579|587299815|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
162612667|NCT00950911|587299816|FG000|Overall Study|Adverse Event|0|||
162612668|NCT00950911|587299817|FG001|Overall Study|Adverse Event|2|||
162612669|NCT00950911|587299816|FG000|Overall Study|Death|4|||
162612670|NCT00950911|587299817|FG001|Overall Study|Death|6|||
162859742|NCT01458340|588192642|FG000|Overall Study|Miscellaneous|0|||
162859743|NCT01458340|588192643|FG001|Overall Study|Miscellaneous|1|||
162859744|NCT01458340|588192644|FG002|Overall Study|Miscellaneous|0|||
162859745|NCT01458340|588192642|FG000|Overall Study|Physician Decision|1|||
162859746|NCT01458340|588192643|FG001|Overall Study|Physician Decision|1|||
162859747|NCT01458340|588192644|FG002|Overall Study|Physician Decision|2|||
162859748|NCT01458340|588192642|FG000|Overall Study|Protocol Violation|6|||
162859749|NCT01458340|588192643|FG001|Overall Study|Protocol Violation|6|||
162859750|NCT01458340|588192644|FG002|Overall Study|Protocol Violation|5|||
162859751|NCT01458340|588192642|FG000|Overall Study|Withdrawal by Subject|12|||
162859752|NCT01458340|588192643|FG001|Overall Study|Withdrawal by Subject|6|||
162859753|NCT01458340|588192644|FG002|Overall Study|Withdrawal by Subject|4|||
162956714|NCT03733444|588543604|FG001|Overall Study|Lack of Efficacy|1|||
162956715|NCT03733444|588543605|FG002|Overall Study|Lack of Efficacy|1|||
162956716|NCT03733444|588543603|FG000|Overall Study|Physician Decision|2|||
162956717|NCT03733444|588543604|FG001|Overall Study|Physician Decision|1|||
162956718|NCT03733444|588543605|FG002|Overall Study|Physician Decision|0|||
162956719|NCT03733444|588543603|FG000|Overall Study|Protocol Violation|2|||
162956720|NCT03733444|588543604|FG001|Overall Study|Protocol Violation|1|||
162956721|NCT03733444|588543605|FG002|Overall Study|Protocol Violation|0|||
162956722|NCT03733444|588543603|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162956723|NCT03733444|588543604|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162956724|NCT03733444|588543605|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
162956725|NCT03733444|588543603|FG000|Overall Study|Study Terminated by Sponsor|203|||
162956726|NCT03733444|588543604|FG001|Overall Study|Study Terminated by Sponsor|209|||
162956727|NCT03733444|588543605|FG002|Overall Study|Study Terminated by Sponsor|221|||
162956728|NCT03733444|588543603|FG000|Overall Study|Withdrawal by Subject|19|||
162956729|NCT03733444|588543604|FG001|Overall Study|Withdrawal by Subject|18|||
162956730|NCT03733444|588543605|FG002|Overall Study|Withdrawal by Subject|16|||
162612671|NCT00950911|587299816|FG000|Overall Study|Disease progression|2|||
162612672|NCT00950911|587299817|FG001|Overall Study|Disease progression|2|||
162612673|NCT00950911|587299816|FG000|Overall Study|Consent withdrawn|1|||
162956731|NCT03733444|588543603|FG000|Overall Study|Miscellaneous|1|||
162956732|NCT03733444|588543604|FG001|Overall Study|Miscellaneous|0|||
162956733|NCT03733444|588543605|FG002|Overall Study|Miscellaneous|1|||
162612674|NCT00950911|587299817|FG001|Overall Study|Consent withdrawn|3|||
162612675|NCT00950911|587299816|FG000|Overall Study|Administrative decision|3|||
162612676|NCT00950911|587299817|FG001|Overall Study|Administrative decision|1|||
162859754|NCT01021007|588192647|FG000|Overall Study|Lost to Follow-up|1|||
162859755|NCT01021007|588192648|FG001|Overall Study|Lost to Follow-up|1|||
162859756|NCT01021007|588192647|FG000|Overall Study|Adverse Event|1|||
162859757|NCT01021007|588192648|FG001|Overall Study|Adverse Event|3|||
162956734|NCT03733444|588543603|FG000|Overall Study|Not Treated|1|||
162612677|NCT00950911|587299816|FG000|Overall Study|Ineligibility determined|1|||
162612678|NCT00950911|587299817|FG001|Overall Study|Ineligibility determined|0|||
162612679|NCT00950911|587299816|FG000|Overall Study|Noncompliance|1|||
162612680|NCT00950911|587299817|FG001|Overall Study|Noncompliance|0|||
162612681|NCT00950911|587299816|FG000|Overall Study|Poor performance status|0|||
162612682|NCT00950911|587299817|FG001|Overall Study|Poor performance status|1|||
162612683|NCT02600351|587299818|FG000|Overall Study|Lack of Efficacy|3|||
162612684|NCT02600351|587299819|FG001|Overall Study|Lack of Efficacy|0|||
162612685|NCT02600351|587299820|FG002|Overall Study|Lack of Efficacy|5|||
162612686|NCT02600351|587299821|FG003|Overall Study|Lack of Efficacy|2|||
162612687|NCT02600351|587299818|FG000|Overall Study|Lost to Follow-up|1|||
162612688|NCT02600351|587299819|FG001|Overall Study|Lost to Follow-up|0|||
162612689|NCT02600351|587299820|FG002|Overall Study|Lost to Follow-up|0|||
162612690|NCT02600351|587299821|FG003|Overall Study|Lost to Follow-up|0|||
162612691|NCT02600351|587299818|FG000|Overall Study|Randomized but Not Treated|1|||
162612692|NCT02600351|587299819|FG001|Overall Study|Randomized but Not Treated|0|||
162612693|NCT02600351|587299820|FG002|Overall Study|Randomized but Not Treated|1|||
162612694|NCT02600351|587299821|FG003|Overall Study|Randomized but Not Treated|3|||
162612695|NCT02063880|587299822|FG000|Overall Study|Death|21|||
162612696|NCT02063880|587299823|FG001|Overall Study|Death|18|||
162612697|NCT02063880|587299822|FG000|Overall Study|Lost to Follow-up|7|||
162612698|NCT02063880|587299823|FG001|Overall Study|Lost to Follow-up|7|||
162612699|NCT02063880|587299822|FG000|Overall Study|Ineligible|0|||
162612700|NCT02063880|587299823|FG001|Overall Study|Ineligible|2|||
162612701|NCT00567593|587299824|FG000|Overall Study|Adverse Event|1|||
162612702|NCT00567593|587299824|FG000|Overall Study|Physician Decision|1|||
162612703|NCT02106910|587299825|FG000|Overall Study|Lost to Follow-up|1|||
162612704|NCT02106910|587299826|FG001|Overall Study|Lost to Follow-up|1|||
162612705|NCT04087213|587299829|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
162705356|NCT02559817|587632197|FG000|Treatment Period|Lost to Follow-up|0|||
162705357|NCT02559817|587632198|FG001|Treatment Period|Lost to Follow-up|1|||
162705358|NCT02559817|587632199|FG002|Treatment Period|Lost to Follow-up|0|||
162956735|NCT03733444|588543604|FG001|Overall Study|Not Treated|2|||
162956736|NCT03733444|588543605|FG002|Overall Study|Not Treated|1|||
162956737|NCT01913405|588543606|FG000|Overall Study|Withdrawal by Subject|1|||
162956738|NCT01913405|588543606|FG000|Overall Study|Adverse Event|1|||
162956739|NCT04400890|588543607|FG000|Overall Study|Withdrawal by Subject|3|||
162956740|NCT04400890|588543608|FG001|Overall Study|Withdrawal by Subject|2|||
162956741|NCT03925532|588543609|FG000|Overall Study|Lost to Follow-up|1|||
162956742|NCT02258074|588543610|FG000|Overall Study|Withdrawal by Subject|1|||
162956743|NCT02258074|588543611|FG001|Overall Study|Withdrawal by Subject|0|||
162956744|NCT02258074|588543612|FG002|Overall Study|Withdrawal by Subject|0|||
162956745|NCT02258074|588543613|FG003|Overall Study|Withdrawal by Subject|0|||
162956746|NCT05446870|588543614|FG000|Overall Study|Death|6|||
162956747|NCT05446870|588543615|FG001|Overall Study|Death|5|||
162956748|NCT05446870|588543614|FG000|Overall Study|Lost to Follow-up|0|||
162956749|NCT05446870|588543615|FG001|Overall Study|Lost to Follow-up|1|||
162956750|NCT05446870|588543614|FG000|Overall Study|Physician Decision|52|||
162956751|NCT05446870|588543615|FG001|Overall Study|Physician Decision|53|||
162956752|NCT05446870|588543614|FG000|Overall Study|Withdrawal by Subject|3|||
162956753|NCT05446870|588543615|FG001|Overall Study|Withdrawal by Subject|3|||
162956754|NCT01615198|588543618|FG000|Overall Study|Withdrawal by Subject|5|||
162956755|NCT01615198|588543619|FG001|Overall Study|Withdrawal by Subject|5|||
162956756|NCT01615198|588543618|FG000|Overall Study|Protocol deviation|1|||
162956757|NCT01615198|588543619|FG001|Overall Study|Protocol deviation|1|||
162956758|NCT01615198|588543618|FG000|Overall Study|Physician Decision|5|||
162956759|NCT01615198|588543619|FG001|Overall Study|Physician Decision|1|||
162956760|NCT01615198|588543618|FG000|Overall Study|Lost to Follow-up|1|||
162956761|NCT01615198|588543619|FG001|Overall Study|Lost to Follow-up|1|||
162956762|NCT01615198|588543618|FG000|Overall Study|Lack of Efficacy|1|||
162956763|NCT01615198|588543619|FG001|Overall Study|Lack of Efficacy|6|||
162956764|NCT01615198|588543618|FG000|Overall Study|Adverse Event|11|||
162956765|NCT01615198|588543619|FG001|Overall Study|Adverse Event|5|||
162956766|NCT01686438|588543620|FG000|Overall Study|Lost to Follow-up|8|||
162612706|NCT04087213|587299829|FG000|In-Facility Introduction|Adverse Event|1|||
162612707|NCT04087213|587299829|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
162956767|NCT01686438|588543621|FG001|Overall Study|Lost to Follow-up|9|||
162956768|NCT01686438|588543622|FG002|Overall Study|Lost to Follow-up|10|||
162956769|NCT01686438|588543620|FG000|Overall Study|Adverse Event|0|||
162956770|NCT01686438|588543621|FG001|Overall Study|Adverse Event|0|||
162956771|NCT01686438|588543622|FG002|Overall Study|Adverse Event|1|||
162956772|NCT01686438|588543620|FG000|Overall Study|Protocol Violation|0|||
162612708|NCT04087213|587299829|FG000|Assisted Evaluable Period|Personal reasons|3|||
162612709|NCT04087213|587299829|FG000|Transition Period B|Renal Transplantation|1|||
162612710|NCT01272661|587299832|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
162612711|NCT01272661|587299833|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
162956773|NCT01686438|588543621|FG001|Overall Study|Protocol Violation|0|||
162956774|NCT01686438|588543622|FG002|Overall Study|Protocol Violation|1|||
162956775|NCT01686438|588543620|FG000|Overall Study|Withdrawal by Subject|0|||
162612712|NCT01272661|587299834|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
162612713|NCT01086423|587299835|FG000|Overall Study|Protocol Violation|0|||
162612714|NCT01086423|587299836|FG001|Overall Study|Protocol Violation|0|||
162612715|NCT01086423|587299837|FG002|Overall Study|Protocol Violation|1|||
162612716|NCT01086423|587299835|FG000|Overall Study|Migrated/moved from study area|2|||
162612717|NCT01086423|587299836|FG001|Overall Study|Migrated/moved from study area|0|||
162612718|NCT01086423|587299837|FG002|Overall Study|Migrated/moved from study area|4|||
162612719|NCT01086423|587299835|FG000|Overall Study|Adverse event, fatal|1|||
162612720|NCT01086423|587299836|FG001|Overall Study|Adverse event, fatal|1|||
162612721|NCT01086423|587299837|FG002|Overall Study|Adverse event, fatal|0|||
162612722|NCT01086423|587299835|FG000|Overall Study|Adverse event, non-fatal|2|||
162612723|NCT01086423|587299836|FG001|Overall Study|Adverse event, non-fatal|1|||
162612724|NCT01086423|587299837|FG002|Overall Study|Adverse event, non-fatal|0|||
162612725|NCT01086423|587299835|FG000|Overall Study|Withdrawal by Subject|5|||
162612726|NCT01086423|587299836|FG001|Overall Study|Withdrawal by Subject|1|||
162612727|NCT01086423|587299837|FG002|Overall Study|Withdrawal by Subject|3|||
162612728|NCT01086423|587299835|FG000|Overall Study|Lost to Follow-up|0|||
162612729|NCT01086423|587299836|FG001|Overall Study|Lost to Follow-up|0|||
162612730|NCT01086423|587299837|FG002|Overall Study|Lost to Follow-up|1|||
162612731|NCT02057393|587299838|FG000|Overall Study|Withdrawal by Subject|1|||
162612732|NCT02057393|587299838|FG000|Overall Study|Patient did not meet criteria|1|||
162612733|NCT02652767|587299839|FG000|Overall Study|Death|2|||
162612734|NCT02652767|587299839|FG000|Overall Study|Lost to Follow-up|1|||
162612735|NCT02652767|587299839|FG000|Overall Study|Withdrawal by Subject|1|||
162612736|NCT01130103|587299840|FG000|Randomized Treatment|Adverse Event|1|||
162612737|NCT01130103|587299841|FG001|Randomized Treatment|Adverse Event|1|||
162612738|NCT01130103|587299840|FG000|Randomized Treatment|Lost to Follow-up|1|||
162612739|NCT01130103|587299841|FG001|Randomized Treatment|Lost to Follow-up|0|||
162612740|NCT01130103|587299840|FG000|Randomized Treatment|Protocol Violation|3|||
162859758|NCT00947154|588192651|FG000|Overall Study|Lost to Follow-up|1|||
162859759|NCT03293030|588192654|FG000|Overall Study|Withdrawal by Subject|3|||
162859760|NCT04899271|588192655|FG000|Overall Study|Lost to Follow-up|1|||
162859761|NCT04899271|588192656|FG001|Overall Study|Lost to Follow-up|0|||
162859762|NCT04899271|588192655|FG000|Overall Study|Subject request/consent withdrawal|2|||
162859763|NCT04899271|588192656|FG001|Overall Study|Subject request/consent withdrawal|0|||
162859764|NCT00900796|588192657|FG000|Phase 1|Lacked sufficient information|4|||
162859765|NCT00900796|588192657|FG000|Phase 1|Missing information at Week 16|7|||
162859766|NCT00900796|588192657|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
162859767|NCT00900796|588192657|FG000|Phase 2|Lost to Follow-up|5|||
162859768|NCT02318602|588192661|FG000|Overall Study|Adverse Event|0|||
162859769|NCT02318602|588192662|FG001|Overall Study|Adverse Event|1|||
162859770|NCT02318602|588192663|FG002|Overall Study|Adverse Event|1|||
162859771|NCT02318602|588192661|FG000|Overall Study|Withdrawal by Subject|0|||
162859772|NCT02318602|588192662|FG001|Overall Study|Withdrawal by Subject|3|||
162859773|NCT02318602|588192663|FG002|Overall Study|Withdrawal by Subject|0|||
162859774|NCT02318602|588192661|FG000|Overall Study|Death|1|||
162859775|NCT02318602|588192662|FG001|Overall Study|Death|0|||
162859776|NCT02318602|588192663|FG002|Overall Study|Death|0|||
162859777|NCT02318602|588192661|FG000|Overall Study|Guardian decision to withdraw|0|||
162956776|NCT01686438|588543621|FG001|Overall Study|Withdrawal by Subject|0|||
162956777|NCT01686438|588543622|FG002|Overall Study|Withdrawal by Subject|1|||
162956778|NCT00984126|588543623|FG000|Overall Study|Protocol Violation|0|||
162956779|NCT00984126|588543624|FG001|Overall Study|Protocol Violation|0|||
162956780|NCT00984126|588543625|FG002|Overall Study|Protocol Violation|1|||
162612741|NCT01130103|587299841|FG001|Randomized Treatment|Protocol Violation|2|||
162612742|NCT01130103|587299840|FG000|Randomized Treatment|Withdrawal by Subject|1|||
162612743|NCT01130103|587299841|FG001|Randomized Treatment|Withdrawal by Subject|2|||
162612744|NCT01130103|587299840|FG000|Maintenance Treatment|Lack of Efficacy|0|||
162956781|NCT00984126|588543626|FG003|Overall Study|Protocol Violation|2|||
162612745|NCT01130103|587299841|FG001|Maintenance Treatment|Lack of Efficacy|1|||
162612746|NCT01130103|587299840|FG000|Maintenance Treatment|Lost to Follow-up|1|||
162612747|NCT01130103|587299841|FG001|Maintenance Treatment|Lost to Follow-up|1|||
162612748|NCT01130103|587299840|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
162612749|NCT01130103|587299841|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
162612750|NCT01028378|587299842|FG000|Overall Study|Lost to Follow-up|12|||
162612751|NCT01028378|587299842|FG000|Overall Study|Withdrawal by Subject|1|||
162612752|NCT01028378|587299842|FG000|Overall Study|Adminstrative Reasons|4|||
162612753|NCT00450385|587299843|FG000|Overall Study|Death|3|||
162612754|NCT00450385|587299843|FG000|Overall Study|Protocol Violation|1|||
162612755|NCT00450385|587299843|FG000|Overall Study|Withdrawal by Subject|2|||
162612756|NCT00450385|587299843|FG000|Overall Study|Lack of Efficacy|2|||
162612757|NCT00450385|587299843|FG000|Overall Study|Adverse Event|1|||
162612758|NCT00450385|587299843|FG000|Overall Study|Physician Decision|1|||
162612759|NCT00450385|587299843|FG000|Overall Study|Other|3|||
162612760|NCT00249288|587299844|FG000|Overall Study|Lost to Follow-up|3|||
162612761|NCT00249288|587299845|FG001|Overall Study|Lost to Follow-up|3|||
162612762|NCT00249288|587299844|FG000|Overall Study|Withdrawal by Subject|2|||
162612763|NCT00249288|587299845|FG001|Overall Study|Withdrawal by Subject|2|||
162612764|NCT03091777|587299846|FG000|Overall Study|Pregnancy|2|||
162705359|NCT02559817|587632200|FG003|Treatment Period|Lost to Follow-up|1|||
162705360|NCT02559817|587632201|FG004|Treatment Period|Lost to Follow-up|0|||
162705361|NCT02559817|587632197|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
162705362|NCT02559817|587632198|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
162705363|NCT02559817|587632199|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
162705364|NCT02559817|587632200|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
162705365|NCT02559817|587632201|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
162705366|NCT02559817|587632197|FG000|Treatment Period|Protocol Violation|0|||
162705367|NCT02559817|587632198|FG001|Treatment Period|Protocol Violation|0|||
162705368|NCT02559817|587632199|FG002|Treatment Period|Protocol Violation|0|||
162705369|NCT02559817|587632200|FG003|Treatment Period|Protocol Violation|1|||
162705370|NCT02559817|587632201|FG004|Treatment Period|Protocol Violation|0|||
162705371|NCT00419003|587632202|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
162705372|NCT00419003|587632203|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
162705373|NCT00419003|587632202|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
162705374|NCT00419003|587632203|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
162705375|NCT02687919|587632204|FG000|Overall Study|Withdrawal by Subject|6|||
162705376|NCT02687919|587632205|FG001|Overall Study|Withdrawal by Subject|6|||
162705377|NCT02687919|587632204|FG000|Overall Study|Protocol Violation|2|||
162705378|NCT02687919|587632205|FG001|Overall Study|Protocol Violation|0|||
162705379|NCT01653847|587632206|FG000|Overall Study|Withdrawal by Subject|1|||
162705380|NCT01653847|587632207|FG001|Overall Study|Withdrawal by Subject|0|||
162705381|NCT02554513|587632208|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
162705382|NCT02554513|587632209|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
162705383|NCT02303574|587632210|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705384|NCT02303574|587632211|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705385|NCT02303574|587632212|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
162705386|NCT02303574|587632213|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705387|NCT02303574|587632214|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705388|NCT02303574|587632215|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705389|NCT02303574|587632216|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705390|NCT02303574|587632217|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705391|NCT02303574|587632218|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705392|NCT02303574|587632219|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162705393|NCT02303574|587632210|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162859778|NCT02318602|588192662|FG001|Overall Study|Guardian decision to withdraw|0|||
162859779|NCT02318602|588192663|FG002|Overall Study|Guardian decision to withdraw|1|||
162859780|NCT00693706|588192664|FG000|Overall Study|Protocol Violation|0|||
162859781|NCT00693706|588192665|FG001|Overall Study|Protocol Violation|1|||
162859782|NCT01733329|588192667|FG000|Overall Study|Protocol Violation|1|||
162859783|NCT01733329|588192668|FG001|Overall Study|Protocol Violation|1|||
162859784|NCT01733329|588192667|FG000|Overall Study|Uterine artery injury|1|||
162859785|NCT01733329|588192668|FG001|Overall Study|Uterine artery injury|0|||
162859786|NCT00730236|588192669|FG000|Overall Study|Adverse Event|4|||
162859787|NCT00730236|588192669|FG000|Overall Study|Withdrawal by Subject|1|||
162859788|NCT00730236|588192669|FG000|Overall Study|Non-compliance|1|||
162859789|NCT00498173|588192672|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
162859790|NCT00498173|588192673|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
162956782|NCT00984126|588543623|FG000|Overall Study|Adverse Event|0|||
162612765|NCT03091777|587299847|FG001|Overall Study|Pregnancy|1|||
162612766|NCT03091777|587299848|FG002|Overall Study|Pregnancy|0|||
162612767|NCT03091777|587299846|FG000|Overall Study|Adverse Event|2|||
162612768|NCT03091777|587299847|FG001|Overall Study|Adverse Event|1|||
162612769|NCT03091777|587299848|FG002|Overall Study|Adverse Event|4|||
162956783|NCT00984126|588543624|FG001|Overall Study|Adverse Event|0|||
162956784|NCT00984126|588543625|FG002|Overall Study|Adverse Event|0|||
162956785|NCT00984126|588543626|FG003|Overall Study|Adverse Event|2|||
162956786|NCT00984126|588543623|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
162956787|NCT00984126|588543624|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
162956788|NCT00984126|588543625|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
162956789|NCT00984126|588543626|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
162956790|NCT00984126|588543623|FG000|Overall Study|Withdrawal criteria|0|||
162956791|NCT00984126|588543624|FG001|Overall Study|Withdrawal criteria|1|||
162956792|NCT00984126|588543625|FG002|Overall Study|Withdrawal criteria|3|||
162956793|NCT00984126|588543626|FG003|Overall Study|Withdrawal criteria|9|||
162956794|NCT01029340|588543629|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
162612770|NCT03091777|587299846|FG000|Overall Study|Withdrawal by Subject|4|||
162956795|NCT01029340|588543630|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
162612771|NCT03091777|587299847|FG001|Overall Study|Withdrawal by Subject|2|||
162612772|NCT03091777|587299848|FG002|Overall Study|Withdrawal by Subject|6|||
162612773|NCT03091777|587299846|FG000|Overall Study|Protocol Violation|2|||
162612774|NCT03091777|587299847|FG001|Overall Study|Protocol Violation|1|||
162612775|NCT03091777|587299848|FG002|Overall Study|Protocol Violation|1|||
162612776|NCT03091777|587299846|FG000|Overall Study|Lost to Follow-up|12|||
162612777|NCT03091777|587299847|FG001|Overall Study|Lost to Follow-up|14|||
162612778|NCT03091777|587299848|FG002|Overall Study|Lost to Follow-up|7|||
162612779|NCT03091777|587299846|FG000|Overall Study|Lack of Efficacy|0|||
162612780|NCT03091777|587299847|FG001|Overall Study|Lack of Efficacy|0|||
162859791|NCT00498173|588192674|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
162859792|NCT00542828|588192677|FG000|Overall Study|Physician Decision|1|||
162859793|NCT00542828|588192677|FG000|Overall Study|Need for Prohibited Treatment|3|||
162859794|NCT00542828|588192677|FG000|Overall Study|Study Prematurely Discontinued|7|||
162956796|NCT01029340|588543631|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
162956797|NCT01029340|588543632|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
162956798|NCT01029340|588543633|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
162956799|NCT01029340|588543634|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
162956800|NCT01029340|588543629|FG000|Part B Treatment Period|Protocol Violation|0|||
162956801|NCT01029340|588543630|FG001|Part B Treatment Period|Protocol Violation|0|||
162956802|NCT01029340|588543631|FG002|Part B Treatment Period|Protocol Violation|1|||
162956803|NCT01029340|588543632|FG003|Part B Treatment Period|Protocol Violation|0|||
162956804|NCT01029340|588543633|FG004|Part B Treatment Period|Protocol Violation|0|||
162956805|NCT01029340|588543634|FG005|Part B Treatment Period|Protocol Violation|0|||
162956806|NCT01029340|588543629|FG000|Extension Period|Adverse Event|0|||
162956807|NCT01029340|588543630|FG001|Extension Period|Adverse Event|0|||
162956808|NCT01029340|588543631|FG002|Extension Period|Adverse Event|0|||
162956809|NCT01029340|588543632|FG003|Extension Period|Adverse Event|0|||
162956810|NCT01029340|588543633|FG004|Extension Period|Adverse Event|0|||
162956811|NCT01029340|588543634|FG005|Extension Period|Adverse Event|1|||
162956812|NCT01029340|588543629|FG000|Extension Period|starting another study|0|||
162956813|NCT01029340|588543630|FG001|Extension Period|starting another study|0|||
162956814|NCT01029340|588543631|FG002|Extension Period|starting another study|0|||
162956815|NCT01029340|588543632|FG003|Extension Period|starting another study|0|||
162956816|NCT01029340|588543633|FG004|Extension Period|starting another study|0|||
162956817|NCT01029340|588543634|FG005|Extension Period|starting another study|8|||
162956818|NCT01029340|588543629|FG000|Extension Period|non-compliance|0|||
162956819|NCT01029340|588543630|FG001|Extension Period|non-compliance|0|||
162956820|NCT01029340|588543631|FG002|Extension Period|non-compliance|0|||
162956821|NCT01029340|588543632|FG003|Extension Period|non-compliance|0|||
162956822|NCT01029340|588543633|FG004|Extension Period|non-compliance|0|||
162956823|NCT01029340|588543634|FG005|Extension Period|non-compliance|1|||
162859795|NCT00542828|588192677|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
162859796|NCT00095303|588192678|FG000|Main Study|Lost to Follow-up|91|||
162859797|NCT00095303|588192679|FG001|Main Study|Lost to Follow-up|87|||
162859798|NCT00095303|588192678|FG000|Follow Up Study|Lost to Follow-up|59|||
162859799|NCT00095303|588192679|FG001|Follow Up Study|Lost to Follow-up|58|||
162859800|NCT01634243|588192682|FG000|Overall Study|Adverse Event|5|||
162859801|NCT01634243|588192683|FG001|Overall Study|Adverse Event|5|||
162859802|NCT01634243|588192682|FG000|Overall Study|Lack of Efficacy|1|||
162859803|NCT01634243|588192683|FG001|Overall Study|Lack of Efficacy|0|||
162859804|NCT00258154|588192684|FG000|Overall Study|Adverse Event|1|||
162859805|NCT00258154|588192685|FG001|Overall Study|Adverse Event|0|||
162859806|NCT00258154|588192684|FG000|Overall Study|Lost to Follow-up|0|||
162859807|NCT00258154|588192685|FG001|Overall Study|Lost to Follow-up|1|||
162859808|NCT00258154|588192684|FG000|Overall Study|Protocol Violation|2|||
162859809|NCT00258154|588192685|FG001|Overall Study|Protocol Violation|1|||
162859810|NCT00258154|588192684|FG000|Overall Study|Withdrawal by Subject|3|||
162859811|NCT00258154|588192685|FG001|Overall Study|Withdrawal by Subject|4|||
162859812|NCT00258154|588192684|FG000|Overall Study|Patient Moved|3|||
162859813|NCT00258154|588192685|FG001|Overall Study|Patient Moved|1|||
162859814|NCT05139030|588192688|FG000|Overall Study|Withdrawal by Subject|1|||
162956824|NCT01029340|588543629|FG000|Extension Period|Withdrawal by Subject|0|||
162859815|NCT05139030|588192689|FG001|Overall Study|Withdrawal by Subject|3|||
162859816|NCT05139030|588192688|FG000|Overall Study|Adverse Event|0|||
162859817|NCT05139030|588192689|FG001|Overall Study|Adverse Event|1|||
162859818|NCT05139030|588192688|FG000|Overall Study|Failure to meet continuation criteria|0|||
162956825|NCT01029340|588543630|FG001|Extension Period|Withdrawal by Subject|0|||
162956826|NCT01029340|588543631|FG002|Extension Period|Withdrawal by Subject|0|||
162956827|NCT01029340|588543632|FG003|Extension Period|Withdrawal by Subject|0|||
162956828|NCT01029340|588543633|FG004|Extension Period|Withdrawal by Subject|0|||
162612781|NCT03091777|587299848|FG002|Overall Study|Lack of Efficacy|5|||
162612782|NCT03091777|587299846|FG000|Overall Study|Noncompliance with study drug|2|||
162859819|NCT05139030|588192689|FG001|Overall Study|Failure to meet continuation criteria|1|||
162956829|NCT01029340|588543634|FG005|Extension Period|Withdrawal by Subject|1|||
162956830|NCT01029340|588543629|FG000|Extension Period|Physician Decision|0|||
162612783|NCT03091777|587299847|FG001|Overall Study|Noncompliance with study drug|3|||
162612784|NCT03091777|587299848|FG002|Overall Study|Noncompliance with study drug|1|||
162612785|NCT03091777|587299846|FG000|Overall Study|Physician Decision|1|||
162612786|NCT03091777|587299847|FG001|Overall Study|Physician Decision|0|||
162612787|NCT03091777|587299848|FG002|Overall Study|Physician Decision|1|||
162612788|NCT03091777|587299846|FG000|Overall Study|Abnormal Laboratory Value|7|||
162612789|NCT03091777|587299847|FG001|Overall Study|Abnormal Laboratory Value|11|||
162612790|NCT03091777|587299848|FG002|Overall Study|Abnormal Laboratory Value|12|||
162612791|NCT00089674|587299849|FG000|Overall Study|Physician Decision|4|||
162612792|NCT00089674|587299850|FG001|Overall Study|Physician Decision|2|||
162612793|NCT00089674|587299849|FG000|Overall Study|Adverse Event|23|||
162612794|NCT00089674|587299850|FG001|Overall Study|Adverse Event|29|||
162612795|NCT00089674|587299849|FG000|Overall Study|Withdrawal by Subject|143|||
162612796|NCT00089674|587299850|FG001|Overall Study|Withdrawal by Subject|127|||
162612797|NCT00089674|587299849|FG000|Overall Study|Death|43|||
162612798|NCT00089674|587299850|FG001|Overall Study|Death|43|||
162612799|NCT00089674|587299849|FG000|Overall Study|Disease progression|21|||
162612800|NCT00089674|587299850|FG001|Overall Study|Disease progression|23|||
162612801|NCT00089674|587299849|FG000|Overall Study|Ineligibility determined|8|||
162612802|NCT00089674|587299850|FG001|Overall Study|Ineligibility determined|10|||
162612803|NCT00089674|587299849|FG000|Overall Study|Lost to Follow-up|21|||
162612804|NCT00089674|587299850|FG001|Overall Study|Lost to Follow-up|17|||
162612805|NCT00089674|587299849|FG000|Overall Study|Noncompliance|7|||
162612806|NCT00089674|587299850|FG001|Overall Study|Noncompliance|3|||
162612807|NCT00089674|587299849|FG000|Overall Study|Other|5|||
162612808|NCT00089674|587299850|FG001|Overall Study|Other|9|||
162612809|NCT00089674|587299849|FG000|Overall Study|Requirement for alternative therapy|14|||
162612810|NCT00089674|587299850|FG001|Overall Study|Requirement for alternative therapy|4|||
162612811|NCT01437878|587299851|FG000|Overall Study|Withdrawal by Subject|1|||
162612812|NCT01437878|587299852|FG001|Overall Study|Withdrawal by Subject|0|||
162612813|NCT01476644|587299859|FG000|Overall Study|Death|5|||
162612814|NCT01476644|587299859|FG000|Overall Study|moved to another state|2|||
162612815|NCT01476644|587299859|FG000|Overall Study|Lost to Follow-up|19|||
162612816|NCT01476644|587299859|FG000|Overall Study|Withdrawal by Subject|13|||
162612817|NCT01462227|587299861|FG000|Second Assignment|Lost to Follow-up|1|||
162612818|NCT01462227|587299862|FG001|Second Assignment|Lost to Follow-up|0|||
162612819|NCT01462227|587299863|FG002|Second Assignment|Lost to Follow-up|0|||
162612820|NCT01462227|587299864|FG003|Second Assignment|Lost to Follow-up|0|||
162612821|NCT01462227|587299861|FG000|Second Assignment|Protocol Violation|0|||
162612822|NCT01462227|587299862|FG001|Second Assignment|Protocol Violation|1|||
162612823|NCT01462227|587299863|FG002|Second Assignment|Protocol Violation|1|||
162612824|NCT01462227|587299864|FG003|Second Assignment|Protocol Violation|0|||
162612825|NCT00471146|587299865|FG000|Overall Study|Adverse Event|32|||
162612826|NCT00471146|587299866|FG001|Overall Study|Adverse Event|33|||
162612827|NCT00471146|587299865|FG000|Overall Study|Withdrawal by Subject|14|||
162612828|NCT00471146|587299866|FG001|Overall Study|Withdrawal by Subject|11|||
162705394|NCT02303574|587632211|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162859820|NCT00613626|588192694|FG000|Overall Study|Ineligible|0|||
162859821|NCT00613626|588192695|FG001|Overall Study|Ineligible|1|||
162859822|NCT00613626|588192696|FG002|Overall Study|Ineligible|0|||
162859823|NCT01299025|588192697|FG000|Overall Study|Withdrawal by Subject|2|||
162859824|NCT01299025|588192698|FG001|Overall Study|Withdrawal by Subject|1|||
162859825|NCT01299025|588192697|FG000|Overall Study|Lost to Follow-up|1|||
162859826|NCT01299025|588192698|FG001|Overall Study|Lost to Follow-up|0|||
162859827|NCT00004980|588192699|FG000|Overall Study|Withdrawal by Subject|1|||
162859828|NCT00004980|588192700|FG001|Overall Study|Withdrawal by Subject|0|||
162859829|NCT00004980|588192699|FG000|Overall Study|memory difficulties|1|||
162859830|NCT00004980|588192700|FG001|Overall Study|memory difficulties|1|||
162859831|NCT00004980|588192699|FG000|Overall Study|Physician Decision|0|||
162859832|NCT00004980|588192700|FG001|Overall Study|Physician Decision|1|||
162859833|NCT05480514|588192701|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
162859834|NCT05480514|588192702|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
162859835|NCT05480514|588192701|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
162859836|NCT05480514|588192702|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
162859837|NCT05480514|588192701|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162859838|NCT05480514|588192702|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
162859839|NCT05480514|588192701|FG000|Period 1|Covid-19 Related|1|||
162859840|NCT05480514|588192702|FG001|Period 1|Covid-19 Related|0|||
162859841|NCT05480514|588192701|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
162612829|NCT00471146|587299865|FG000|Overall Study|Death|11|||
162612830|NCT00471146|587299866|FG001|Overall Study|Death|12|||
162612831|NCT00471146|587299865|FG000|Overall Study|Lost to Follow-up|4|||
162612832|NCT00471146|587299866|FG001|Overall Study|Lost to Follow-up|2|||
162859842|NCT05480514|588192702|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
162859843|NCT00820040|588192706|FG000|Overall Study|Death|1|||
162859844|NCT00820040|588192706|FG000|Overall Study|Sponsor terminated study|1|||
162612833|NCT00471146|587299865|FG000|Overall Study|Protocol Violation|2|||
162612834|NCT00471146|587299866|FG001|Overall Study|Protocol Violation|2|||
162612835|NCT00471146|587299865|FG000|Overall Study|Objective progression or relapse|84|||
162612836|NCT00471146|587299866|FG001|Overall Study|Objective progression or relapse|87|||
162859845|NCT00820040|588192706|FG000|Overall Study|Screen failure|1|||
162859846|NCT01259466|588192709|FG000|Overall Study|Withdrawal by Subject|1|||
163044911|NCT00420628|588871546|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
163044912|NCT00420628|588871547|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
163044913|NCT00420628|588871546|FG000|Overall Study|Lost to Follow-up|3|||
163044914|NCT00420628|588871547|FG001|Overall Study|Lost to Follow-up|2|||
163044915|NCT00420628|588871546|FG000|Overall Study|Adverse Event|1|||
163044916|NCT00420628|588871547|FG001|Overall Study|Adverse Event|0|||
163044917|NCT02716584|588871548|FG000|Overall Study|Lost to Follow-up|8|||
163044918|NCT02716584|588871549|FG001|Overall Study|Lost to Follow-up|5|||
163044919|NCT03301831|588871555|FG000|Overall Study|Lost to Follow-up|5|||
163044920|NCT03301831|588871556|FG001|Overall Study|Lost to Follow-up|3|||
163044921|NCT03301831|588871555|FG000|Overall Study|Protocol Violation|4|||
162859847|NCT01259466|588192710|FG001|Overall Study|Withdrawal by Subject|9|||
162859848|NCT00184054|588192712|FG000|Overall Study|Adverse Event|1|||
162859849|NCT00457639|588192713|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
163044922|NCT03301831|588871556|FG001|Overall Study|Protocol Violation|0|||
163044923|NCT03301831|588871555|FG000|Overall Study|Withdrawal by Subject|11|||
162612837|NCT00471146|587299865|FG000|Overall Study|Global deterioration of health status|12|||
162612838|NCT00471146|587299866|FG001|Overall Study|Global deterioration of health status|14|||
162612839|NCT00471146|587299865|FG000|Overall Study|Randomized but not treated|9|||
162612840|NCT00471146|587299866|FG001|Overall Study|Randomized but not treated|8|||
162612841|NCT00471146|587299865|FG000|Overall Study|Other|4|||
162612842|NCT00471146|587299866|FG001|Overall Study|Other|5|||
162612843|NCT00467610|587299869|FG000|Overall Study|Withdrawal by Subject|1|||
162612844|NCT02676466|587299870|FG000|Overall Study|Death|0|||
162612845|NCT02676466|587299871|FG001|Overall Study|Death|2|||
162612846|NCT02676466|587299872|FG002|Overall Study|Death|1|||
162612847|NCT02676466|587299873|FG003|Overall Study|Death|0|||
162612848|NCT02676466|587299874|FG004|Overall Study|Death|0|||
162612849|NCT02676466|587299875|FG005|Overall Study|Death|0|||
162612850|NCT02676466|587299876|FG006|Overall Study|Death|0|||
162612851|NCT02676466|587299877|FG007|Overall Study|Death|0|||
162612852|NCT02676466|587299870|FG000|Overall Study|Withdrawal by Subject|4|||
162612853|NCT02676466|587299871|FG001|Overall Study|Withdrawal by Subject|3|||
162612854|NCT02676466|587299872|FG002|Overall Study|Withdrawal by Subject|1|||
162612855|NCT02676466|587299873|FG003|Overall Study|Withdrawal by Subject|0|||
162612856|NCT02676466|587299874|FG004|Overall Study|Withdrawal by Subject|3|||
162612857|NCT02676466|587299875|FG005|Overall Study|Withdrawal by Subject|1|||
162612858|NCT02676466|587299876|FG006|Overall Study|Withdrawal by Subject|1|||
162612859|NCT02676466|587299877|FG007|Overall Study|Withdrawal by Subject|1|||
162612860|NCT02001181|587299879|FG000|Overall Study|Adverse Event|0|||
162612861|NCT02001181|587299880|FG001|Overall Study|Adverse Event|2|||
162612862|NCT02001181|587299879|FG000|Overall Study|Lost to Follow-up|1|||
162612863|NCT02001181|587299880|FG001|Overall Study|Lost to Follow-up|0|||
162612864|NCT02001181|587299879|FG000|Overall Study|Withdrawal by Subject|0|||
162612865|NCT02001181|587299880|FG001|Overall Study|Withdrawal by Subject|1|||
162612866|NCT02520661|587299882|FG000|Overall Study|Lost to Follow-up|7|||
162612867|NCT02520661|587299883|FG001|Overall Study|Lost to Follow-up|3|||
162612868|NCT02520661|587299882|FG000|Overall Study|Admitted from ED|49|||
162612869|NCT02520661|587299883|FG001|Overall Study|Admitted from ED|48|||
162612870|NCT02520661|587299882|FG000|Overall Study|ED greater than 24 hours|29|||
162612871|NCT02520661|587299883|FG001|Overall Study|ED greater than 24 hours|38|||
162612872|NCT02520661|587299882|FG000|Overall Study|other ineligibility|14|||
162612873|NCT02520661|587299883|FG001|Overall Study|other ineligibility|22|||
162612874|NCT02520661|587299882|FG000|Overall Study|Withdrawal by Subject|7|||
162612875|NCT02520661|587299883|FG001|Overall Study|Withdrawal by Subject|16|||
162612876|NCT01414608|587299887|FG000|Overall Study|Ineligible|5|||
162612877|NCT01414608|587299888|FG001|Overall Study|Ineligible|2|||
162612878|NCT00760084|587299890|FG000|Overall Study|Physician Decision|5|||
162612879|NCT00760084|587299890|FG000|Overall Study|Withdrawal by Subject|2|||
162612880|NCT00760084|587299890|FG000|Overall Study|Progressive Disease|3|||
162612881|NCT02301988|587299891|FG000|Overall Study|Withdrawal by Subject|2|||
162612882|NCT02301988|587299892|FG001|Overall Study|Withdrawal by Subject|1|||
162612883|NCT02301988|587299891|FG000|Overall Study|Physician Decision|2|||
162612884|NCT02301988|587299892|FG001|Overall Study|Physician Decision|2|||
162612885|NCT02301988|587299891|FG000|Overall Study|Unknown Reason|1|||
162612886|NCT02301988|587299892|FG001|Overall Study|Unknown Reason|3|||
162612887|NCT02301988|587299891|FG000|Overall Study|Lack of Efficacy|3|||
162612888|NCT02301988|587299892|FG001|Overall Study|Lack of Efficacy|2|||
162612889|NCT02301988|587299891|FG000|Overall Study|Death|1|||
162612890|NCT02301988|587299892|FG001|Overall Study|Death|0|||
162612891|NCT02301988|587299891|FG000|Overall Study|Adverse Event|1|||
162612892|NCT02301988|587299892|FG001|Overall Study|Adverse Event|1|||
162705395|NCT02303574|587632212|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163044924|NCT03301831|588871556|FG001|Overall Study|Withdrawal by Subject|0|||
162612893|NCT02891161|587299893|FG000|Study Treatment|Disease Progression|2|||
162612894|NCT02891161|587299894|FG001|Study Treatment|Disease Progression|4|||
162612895|NCT02891161|587299893|FG000|Study Treatment|AE/Side Effects/Complications|1|||
162612896|NCT02891161|587299894|FG001|Study Treatment|AE/Side Effects/Complications|5|||
162612897|NCT02891161|587299893|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
162612898|NCT02891161|587299894|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
162612899|NCT02891161|587299893|FG000|Follow up|Death|4|||
162612900|NCT02891161|587299894|FG001|Follow up|Death|8|||
162612901|NCT02891161|587299893|FG000|Follow up|Refused to Follow up|0|||
162612902|NCT02891161|587299894|FG001|Follow up|Refused to Follow up|2|||
162612903|NCT02891161|587299893|FG000|Follow up|Symptomatic deterioration|0|||
162612904|NCT02891161|587299894|FG001|Follow up|Symptomatic deterioration|1|||
162612905|NCT02891161|587299893|FG000|Follow up|Study terminated|0|||
162612906|NCT02891161|587299894|FG001|Follow up|Study terminated|6|||
162612907|NCT01931202|587299897|FG000|Overall Study|Withdrawal by Subject|0|||
162612908|NCT01931202|587299898|FG001|Overall Study|Withdrawal by Subject|0|||
162612909|NCT01931202|587299899|FG002|Overall Study|Withdrawal by Subject|2|||
162612910|NCT01931202|587299897|FG000|Overall Study|Lost to Follow-up|0|||
162612911|NCT01931202|587299898|FG001|Overall Study|Lost to Follow-up|5|||
162612912|NCT01931202|587299899|FG002|Overall Study|Lost to Follow-up|2|||
162612913|NCT01857583|587299900|FG000|Overall Study|Adverse Event|0|||
162612914|NCT01857583|587299901|FG001|Overall Study|Adverse Event|0|||
162612915|NCT01857583|587299902|FG002|Overall Study|Adverse Event|1|||
162612916|NCT01857583|587299903|FG003|Overall Study|Adverse Event|1|||
162612917|NCT01857583|587299900|FG000|Overall Study|Death|0|||
162612918|NCT01857583|587299901|FG001|Overall Study|Death|1|||
162612919|NCT01857583|587299902|FG002|Overall Study|Death|1|||
162705396|NCT02303574|587632213|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705397|NCT02303574|587632214|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705398|NCT02303574|587632215|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705399|NCT02303574|587632216|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705400|NCT02303574|587632217|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
162705401|NCT02303574|587632218|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705402|NCT02303574|587632219|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162705403|NCT00859014|587632224|FG000|Overall Study|Death|4|||
162705404|NCT00859014|587632224|FG000|Overall Study|Lost to Follow-up|1|||
162705405|NCT04796935|587632225|FG000|Overall Study|Withdrawal by Subject|0|||
162705406|NCT04796935|587632226|FG001|Overall Study|Withdrawal by Subject|1|||
162705407|NCT04796935|587632225|FG000|Overall Study|Physician Decision|0|||
162705408|NCT04796935|587632226|FG001|Overall Study|Physician Decision|1|||
162705409|NCT04796935|587632225|FG000|Overall Study|Device not available|1|||
162705410|NCT04796935|587632226|FG001|Overall Study|Device not available|0|||
162705411|NCT04796935|587632225|FG000|Overall Study|Trained provider not available|1|||
162705412|NCT04796935|587632226|FG001|Overall Study|Trained provider not available|0|||
162705413|NCT00052962|587632227|FG000|Overall Study|Not evaluable|0|||
162705414|NCT00052962|587632228|FG001|Overall Study|Not evaluable|2|||
162705415|NCT00052962|587632227|FG000|Overall Study|Not randomized/not evaluable|1|||
162705416|NCT00052962|587632228|FG001|Overall Study|Not randomized/not evaluable|0|||
162705417|NCT03782727|587632229|FG000|Overall Study|Lost to Follow-up|32|||
162705418|NCT00495469|587633708|FG000|Overall Study|Adverse Event|0|||
162705419|NCT00495469|587633709|FG001|Overall Study|Adverse Event|1|||
162705420|NCT00495469|587633710|FG002|Overall Study|Adverse Event|3|||
162705421|NCT00495469|587633711|FG003|Overall Study|Adverse Event|0|||
162705422|NCT00495469|587633712|FG004|Overall Study|Adverse Event|1|||
162705423|NCT00495469|587633713|FG005|Overall Study|Adverse Event|1|||
162705424|NCT00495469|587633714|FG006|Overall Study|Adverse Event|1|||
162705425|NCT00495469|587633708|FG000|Overall Study|Lost to Follow-up|1|||
162705426|NCT00495469|587633709|FG001|Overall Study|Lost to Follow-up|1|||
162705427|NCT00495469|587633710|FG002|Overall Study|Lost to Follow-up|3|||
162705428|NCT00495469|587633711|FG003|Overall Study|Lost to Follow-up|1|||
162705429|NCT00495469|587633712|FG004|Overall Study|Lost to Follow-up|0|||
162705430|NCT00495469|587633713|FG005|Overall Study|Lost to Follow-up|0|||
162705431|NCT00495469|587633714|FG006|Overall Study|Lost to Follow-up|0|||
162705432|NCT00495469|587633708|FG000|Overall Study|Protocol Violation|0|||
162705433|NCT00495469|587633709|FG001|Overall Study|Protocol Violation|0|||
162705434|NCT00495469|587633710|FG002|Overall Study|Protocol Violation|0|||
162705435|NCT00495469|587633711|FG003|Overall Study|Protocol Violation|0|||
162705436|NCT00495469|587633712|FG004|Overall Study|Protocol Violation|1|||
162705437|NCT00495469|587633713|FG005|Overall Study|Protocol Violation|2|||
162705438|NCT00495469|587633714|FG006|Overall Study|Protocol Violation|0|||
162705439|NCT00495469|587633708|FG000|Overall Study|Withdrawal by Subject|5|||
162705440|NCT00495469|587633709|FG001|Overall Study|Withdrawal by Subject|3|||
162705441|NCT00495469|587633710|FG002|Overall Study|Withdrawal by Subject|1|||
162612920|NCT01857583|587299903|FG003|Overall Study|Death|0|||
162705442|NCT00495469|587633711|FG003|Overall Study|Withdrawal by Subject|3|||
162705443|NCT00495469|587633712|FG004|Overall Study|Withdrawal by Subject|3|||
162612921|NCT01857583|587299900|FG000|Overall Study|Physician Decision|0|||
162859850|NCT00457639|588192714|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
162859851|NCT00457639|588192713|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
162859852|NCT00457639|588192714|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
162859853|NCT00457639|588192713|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
162859854|NCT00457639|588192714|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
162612922|NCT01857583|587299901|FG001|Overall Study|Physician Decision|0|||
162612923|NCT01857583|587299902|FG002|Overall Study|Physician Decision|0|||
162612924|NCT01857583|587299903|FG003|Overall Study|Physician Decision|1|||
162612925|NCT01857583|587299900|FG000|Overall Study|Withdrawal by Subject|1|||
162612926|NCT01857583|587299901|FG001|Overall Study|Withdrawal by Subject|0|||
162612927|NCT01857583|587299902|FG002|Overall Study|Withdrawal by Subject|1|||
162612928|NCT01857583|587299903|FG003|Overall Study|Withdrawal by Subject|2|||
162612929|NCT02775903|587299908|FG000|Overall Study|Death|7|||
162612930|NCT02775903|587299909|FG001|Overall Study|Death|11|||
162612931|NCT02775903|587299910|FG002|Overall Study|Death|12|||
162612932|NCT02775903|587299911|FG003|Overall Study|Death|11|||
162612933|NCT02775903|587299908|FG000|Overall Study|Adverse Event|0|||
162612934|NCT02775903|587299909|FG001|Overall Study|Adverse Event|1|||
162612935|NCT02775903|587299910|FG002|Overall Study|Adverse Event|12|||
162612936|NCT02775903|587299911|FG003|Overall Study|Adverse Event|3|||
162612937|NCT02775903|587299908|FG000|Overall Study|Progressive disease|15|||
162612938|NCT02775903|587299909|FG001|Overall Study|Progressive disease|14|||
162612939|NCT02775903|587299910|FG002|Overall Study|Progressive disease|30|||
162612940|NCT02775903|587299911|FG003|Overall Study|Progressive disease|20|||
162612941|NCT02775903|587299908|FG000|Overall Study|Lack of Efficacy|2|||
162612942|NCT02775903|587299909|FG001|Overall Study|Lack of Efficacy|2|||
162612943|NCT02775903|587299910|FG002|Overall Study|Lack of Efficacy|2|||
162612944|NCT02775903|587299911|FG003|Overall Study|Lack of Efficacy|6|||
162612945|NCT02775903|587299908|FG000|Overall Study|Withdrawal by Subject|7|||
162612946|NCT02775903|587299909|FG001|Overall Study|Withdrawal by Subject|5|||
162612947|NCT02775903|587299910|FG002|Overall Study|Withdrawal by Subject|5|||
162612948|NCT02775903|587299911|FG003|Overall Study|Withdrawal by Subject|8|||
162612949|NCT02775903|587299908|FG000|Overall Study|Other reasons|7|||
162612950|NCT02775903|587299909|FG001|Overall Study|Other reasons|8|||
162612951|NCT02775903|587299910|FG002|Overall Study|Other reasons|2|||
162612952|NCT02775903|587299911|FG003|Overall Study|Other reasons|12|||
162612953|NCT03552965|587299915|FG000|Overall Study|Death|1|||
162612954|NCT03552965|587299916|FG001|Overall Study|Death|1|||
162612955|NCT03552965|587299915|FG000|Overall Study|Lost to Follow-up|1|||
162612956|NCT03552965|587299916|FG001|Overall Study|Lost to Follow-up|1|||
162612957|NCT03552965|587299915|FG000|Overall Study|Physician Decision|1|||
162612958|NCT03552965|587299916|FG001|Overall Study|Physician Decision|1|||
162612959|NCT03552965|587299915|FG000|Overall Study|Withdrawal by Subject|0|||
162612960|NCT03552965|587299916|FG001|Overall Study|Withdrawal by Subject|2|||
162612961|NCT03552965|587299915|FG000|Overall Study|Continuation not in patient best interest|1|||
162612962|NCT03552965|587299916|FG001|Overall Study|Continuation not in patient best interest|0|||
162612963|NCT03552965|587299915|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
162612964|NCT03552965|587299916|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
162612965|NCT05108922|587301056|FG000|Overall Study|Adverse Event|2|||
162612966|NCT05108922|587301057|FG001|Overall Study|Adverse Event|3|||
162612967|NCT05108922|587301056|FG000|Overall Study|Lost to Follow-up|2|||
162612968|NCT05108922|587301057|FG001|Overall Study|Lost to Follow-up|1|||
162612969|NCT05108922|587301056|FG000|Overall Study|Inadvertent enrollment|0|||
162612970|NCT05108922|587301057|FG001|Overall Study|Inadvertent enrollment|1|||
162612971|NCT05108922|587301056|FG000|Overall Study|Physician Decision|2|||
162612972|NCT05108922|587301057|FG001|Overall Study|Physician Decision|3|||
162612973|NCT05108922|587301056|FG000|Overall Study|Protocol deviation|1|||
162612974|NCT05108922|587301057|FG001|Overall Study|Protocol deviation|0|||
162612975|NCT05108922|587301056|FG000|Overall Study|Screen failure|1|||
162612976|NCT05108922|587301057|FG001|Overall Study|Screen failure|0|||
162612977|NCT05108922|587301056|FG000|Overall Study|Withdrawal by Subject|11|||
162612978|NCT05108922|587301057|FG001|Overall Study|Withdrawal by Subject|8|||
162612979|NCT05036369|587301058|FG000|Overall Study|Run In non compliance|1|||
162612980|NCT05036369|587301059|FG001|Overall Study|Run In non compliance|2|||
162612981|NCT05036369|587301058|FG000|Overall Study|Change in eligibility criteria|0|||
162612982|NCT05036369|587301059|FG001|Overall Study|Change in eligibility criteria|1|||
162612983|NCT01846104|587301060|FG000|Overall Study|Withdrawal by Subject|1|||
162612984|NCT01854658|587301065|FG000|Overall Study|Protocol Violation|6|||
162612985|NCT01854658|587301066|FG001|Overall Study|Protocol Violation|2|||
162612986|NCT01854658|587301067|FG002|Overall Study|Protocol Violation|2|||
162859855|NCT03885284|588192715|FG000|Overall Study|Disease Progression|1|||
162612987|NCT01854658|587301068|FG003|Overall Study|Protocol Violation|1|||
162859856|NCT03885284|588192716|FG001|Overall Study|Disease Progression|3|||
162612988|NCT01854658|587301065|FG000|Overall Study|Physician Decision|7|||
162612989|NCT01854658|587301066|FG001|Overall Study|Physician Decision|5|||
162612990|NCT01854658|587301067|FG002|Overall Study|Physician Decision|2|||
162612991|NCT01854658|587301068|FG003|Overall Study|Physician Decision|4|||
162612992|NCT01854658|587301065|FG000|Overall Study|Lost to Follow-up|8|||
162612993|NCT01854658|587301066|FG001|Overall Study|Lost to Follow-up|9|||
162612994|NCT01854658|587301067|FG002|Overall Study|Lost to Follow-up|8|||
162612995|NCT01854658|587301068|FG003|Overall Study|Lost to Follow-up|4|||
162612996|NCT01854658|587301065|FG000|Overall Study|Withdrawal by Subject|28|||
162612997|NCT01854658|587301066|FG001|Overall Study|Withdrawal by Subject|21|||
162612998|NCT01854658|587301067|FG002|Overall Study|Withdrawal by Subject|29|||
162612999|NCT01854658|587301068|FG003|Overall Study|Withdrawal by Subject|15|||
162859857|NCT03885284|588192715|FG000|Overall Study|Physician Decision|0|||
162859858|NCT03885284|588192716|FG001|Overall Study|Physician Decision|1|||
162859859|NCT02932267|588192721|FG000|Overall Study|Withdrawal by Subject|3|||
162859860|NCT02932267|588192721|FG000|Overall Study|Lost to Follow-up|4|||
162859861|NCT02932267|588192721|FG000|Overall Study|Pregnancy|1|||
162859862|NCT03750838|588192724|FG000|Overall Study|Lost to Follow-up|10|||
162859863|NCT03750838|588192725|FG001|Overall Study|Lost to Follow-up|6|||
162859864|NCT00630032|588192728|FG000|Overall Study|Death|55|||
162613000|NCT01854658|587301065|FG000|Overall Study|Protocol-specified criteria|15|||
162613001|NCT01854658|587301066|FG001|Overall Study|Protocol-specified criteria|15|||
162613002|NCT01854658|587301067|FG002|Overall Study|Protocol-specified criteria|10|||
162613003|NCT01854658|587301068|FG003|Overall Study|Protocol-specified criteria|7|||
162613004|NCT01854658|587301065|FG000|Overall Study|Lack of Efficacy|3|||
162613005|NCT01854658|587301066|FG001|Overall Study|Lack of Efficacy|8|||
162613006|NCT01854658|587301067|FG002|Overall Study|Lack of Efficacy|4|||
162613007|NCT01854658|587301068|FG003|Overall Study|Lack of Efficacy|7|||
162613008|NCT01854658|587301065|FG000|Overall Study|Adverse Event|21|||
162613009|NCT01854658|587301066|FG001|Overall Study|Adverse Event|14|||
162613010|NCT01854658|587301067|FG002|Overall Study|Adverse Event|23|||
162613011|NCT01854658|587301068|FG003|Overall Study|Adverse Event|19|||
162613012|NCT01854658|587301065|FG000|Overall Study|Administrative reasons|5|||
162613013|NCT01854658|587301066|FG001|Overall Study|Administrative reasons|1|||
162613014|NCT01854658|587301067|FG002|Overall Study|Administrative reasons|2|||
162613015|NCT01854658|587301068|FG003|Overall Study|Administrative reasons|2|||
162859865|NCT00630032|588192729|FG001|Overall Study|Death|49|||
162859866|NCT00630032|588192728|FG000|Overall Study|Withdrawal by Subject|3|||
162859867|NCT00630032|588192729|FG001|Overall Study|Withdrawal by Subject|2|||
162859868|NCT00630032|588192728|FG000|Overall Study|Lost to Follow-up|18|||
162859869|NCT00630032|588192729|FG001|Overall Study|Lost to Follow-up|31|||
162859870|NCT00630032|588192728|FG000|Overall Study|Protocol Violation|1|||
162859871|NCT00630032|588192729|FG001|Overall Study|Protocol Violation|0|||
162859872|NCT00630032|588192728|FG000|Overall Study|Patient has moved|1|||
162859873|NCT00630032|588192729|FG001|Overall Study|Patient has moved|1|||
162859874|NCT00630032|588192728|FG000|Overall Study|Disease progression|1|||
162859875|NCT00630032|588192729|FG001|Overall Study|Disease progression|1|||
162859876|NCT00630032|588192728|FG000|Overall Study|End of monitoring in US centers|11|||
162859877|NCT00630032|588192729|FG001|Overall Study|End of monitoring in US centers|11|||
162859878|NCT02332915|588192730|FG000|Overall Study|Moved out of region|3|||
162859879|NCT02332915|588192731|FG001|Overall Study|Moved out of region|0|||
162859880|NCT02332915|588192730|FG000|Overall Study|Unrelated illness|1|||
162859881|NCT02332915|588192731|FG001|Overall Study|Unrelated illness|1|||
162859882|NCT02332915|588192730|FG000|Overall Study|Travel distance prohibitive|0|||
162859883|NCT02332915|588192731|FG001|Overall Study|Travel distance prohibitive|1|||
162859884|NCT02332915|588192730|FG000|Overall Study|did not meet inclusion criteria|2|||
162956831|NCT01029340|588543630|FG001|Extension Period|Physician Decision|0|||
162956832|NCT01029340|588543631|FG002|Extension Period|Physician Decision|0|||
162956833|NCT01029340|588543632|FG003|Extension Period|Physician Decision|0|||
162613016|NCT03906461|587301069|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
162613017|NCT03906461|587301069|FG000|Completed 12-month Follow-up|Missed Visit|6|||
162956834|NCT01029340|588543633|FG004|Extension Period|Physician Decision|0|||
162956835|NCT01029340|588543634|FG005|Extension Period|Physician Decision|1|||
162956836|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
162956837|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
162956838|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
162859885|NCT02332915|588192731|FG001|Overall Study|did not meet inclusion criteria|4|||
162956839|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
162956840|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
162956841|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
162613018|NCT01795638|587301072|FG000|Overall Study|Death|0|||
162859886|NCT03232073|588192732|FG000|Overall Study|Death|1|||
162859887|NCT03232073|588192733|FG001|Overall Study|Death|0|||
162859888|NCT03232073|588192732|FG000|Overall Study|Adverse Event|7|||
162859889|NCT03232073|588192733|FG001|Overall Study|Adverse Event|12|||
162613019|NCT01795638|587301073|FG001|Overall Study|Death|3|||
162613020|NCT01795638|587301072|FG000|Overall Study|transferred to quaternary hospital|2|||
162613021|NCT01795638|587301073|FG001|Overall Study|transferred to quaternary hospital|3|||
162613022|NCT01795638|587301072|FG000|Overall Study|Protocol Violation|3|||
162613023|NCT01795638|587301073|FG001|Overall Study|Protocol Violation|0|||
162613024|NCT01795638|587301072|FG000|Overall Study|discharged from hospital|7|||
162859890|NCT03232073|588192732|FG000|Overall Study|Lost to Follow-up|6|||
162859891|NCT03232073|588192733|FG001|Overall Study|Lost to Follow-up|6|||
162859892|NCT03232073|588192732|FG000|Overall Study|Lack of Efficacy|10|||
162613025|NCT01795638|587301073|FG001|Overall Study|discharged from hospital|5|||
162613026|NCT01795638|587301072|FG000|Overall Study|Withdrawal by Subject|1|||
162613027|NCT01795638|587301073|FG001|Overall Study|Withdrawal by Subject|0|||
162613028|NCT00331864|587301082|FG000|Overall Study|Adverse Event|30|||
162613029|NCT00331864|587301083|FG001|Overall Study|Adverse Event|1|||
162613030|NCT00331864|587301082|FG000|Overall Study|Lack of Efficacy|4|||
162613031|NCT00331864|587301083|FG001|Overall Study|Lack of Efficacy|0|||
162613032|NCT00331864|587301082|FG000|Overall Study|Protocol Violation|3|||
162613033|NCT00331864|587301083|FG001|Overall Study|Protocol Violation|0|||
162613034|NCT00331864|587301082|FG000|Overall Study|Withdrawal by Subject|10|||
162859893|NCT03232073|588192733|FG001|Overall Study|Lack of Efficacy|8|||
162613035|NCT00331864|587301083|FG001|Overall Study|Withdrawal by Subject|0|||
162613036|NCT00331864|587301082|FG000|Overall Study|Lost to Follow-up|4|||
162859894|NCT03232073|588192732|FG000|Overall Study|Physician Decision|9|||
162859895|NCT03232073|588192733|FG001|Overall Study|Physician Decision|2|||
162859896|NCT03232073|588192732|FG000|Overall Study|Withdrawal by Subject|54|||
162859897|NCT03232073|588192733|FG001|Overall Study|Withdrawal by Subject|39|||
162859898|NCT02032875|588192734|FG000|Treatment Period|Adverse Event|1|||
162859899|NCT02032875|588192735|FG001|Treatment Period|Adverse Event|0|||
162859900|NCT02032875|588192734|FG000|Treatment Period|Liver transplant, No extension needed|0|||
162613037|NCT00331864|587301083|FG001|Overall Study|Lost to Follow-up|3|||
162613038|NCT00331864|587301082|FG000|Overall Study|Administrative Problems|1|||
162613039|NCT00331864|587301083|FG001|Overall Study|Administrative Problems|0|||
162613040|NCT00331864|587301082|FG000|Overall Study|Death|6|||
162613041|NCT00331864|587301083|FG001|Overall Study|Death|0|||
162613042|NCT01409434|587301085|FG000|Overall Study|Protocol Violation|4|||
162705444|NCT00495469|587633713|FG005|Overall Study|Withdrawal by Subject|2|||
162705445|NCT00495469|587633714|FG006|Overall Study|Withdrawal by Subject|3|||
162705446|NCT00495469|587633708|FG000|Overall Study|Lack of Efficacy|0|||
162705447|NCT00495469|587633709|FG001|Overall Study|Lack of Efficacy|0|||
162705448|NCT00495469|587633710|FG002|Overall Study|Lack of Efficacy|0|||
162705449|NCT00495469|587633711|FG003|Overall Study|Lack of Efficacy|0|||
162705450|NCT00495469|587633712|FG004|Overall Study|Lack of Efficacy|0|||
162705451|NCT00495469|587633713|FG005|Overall Study|Lack of Efficacy|0|||
162705452|NCT00495469|587633714|FG006|Overall Study|Lack of Efficacy|1|||
162705453|NCT00495469|587633708|FG000|Overall Study|Liver function test abnormality|0|||
162705454|NCT00495469|587633709|FG001|Overall Study|Liver function test abnormality|1|||
162705455|NCT00495469|587633710|FG002|Overall Study|Liver function test abnormality|0|||
162705456|NCT00495469|587633711|FG003|Overall Study|Liver function test abnormality|0|||
162705457|NCT00495469|587633712|FG004|Overall Study|Liver function test abnormality|0|||
162705458|NCT00495469|587633713|FG005|Overall Study|Liver function test abnormality|0|||
162859901|NCT02032875|588192735|FG001|Treatment Period|Liver transplant, No extension needed|1|||
162956842|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
162956843|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
162956844|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
162956845|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
162956846|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
162956847|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
162956848|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
162956849|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
162956850|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
162956851|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
162956852|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
162956853|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
162613043|NCT00293215|587301086|FG000|Overall Study|Progressive disease|3|||
162613044|NCT00293215|587301087|FG001|Overall Study|Progressive disease|1|||
162613045|NCT00293215|587301086|FG000|Overall Study|Adverse Event|2|||
162705459|NCT00495469|587633714|FG006|Overall Study|Liver function test abnormality|0|||
162956854|NCT02009163|588543642|FG000|Open-label Period (Non-randomized)|Other|13|||
162956855|NCT02009163|588543643|FG001|Open-label Period (Non-randomized)|Other|0|||
162613046|NCT00293215|587301087|FG001|Overall Study|Adverse Event|2|||
162613047|NCT02213042|587301088|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
162613048|NCT02213042|587301089|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
162956856|NCT02009163|588543644|FG002|Open-label Period (Non-randomized)|Other|0|||
162705460|NCT00495469|587633708|FG000|Overall Study|ST depression at randomisation in ECG|0|||
162705461|NCT00495469|587633709|FG001|Overall Study|ST depression at randomisation in ECG|1|||
162705462|NCT00495469|587633710|FG002|Overall Study|ST depression at randomisation in ECG|0|||
162859902|NCT02032875|588192734|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
162859903|NCT02032875|588192735|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
162956857|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
163044925|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
162859904|NCT02032875|588192734|FG000|Follow-up Period|Death|0|||
162859905|NCT02032875|588192735|FG001|Follow-up Period|Death|1|||
162859906|NCT02032875|588192734|FG000|Follow-up Period|Virologic Relapse|3|||
162859907|NCT02032875|588192735|FG001|Follow-up Period|Virologic Relapse|10|||
162859908|NCT03191786|588192740|FG000|Overall Study|Death|236|||
162859909|NCT03191786|588192741|FG001|Overall Study|Death|127|||
162859910|NCT03191786|588192740|FG000|Overall Study|Lost to Follow-up|9|||
162859911|NCT03191786|588192741|FG001|Overall Study|Lost to Follow-up|3|||
162859912|NCT03191786|588192740|FG000|Overall Study|Physician Decision|1|||
162859913|NCT03191786|588192741|FG001|Overall Study|Physician Decision|0|||
162859914|NCT03191786|588192740|FG000|Overall Study|Moved to Post Trial Access Program|30|||
162613049|NCT02213042|587301090|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
162613050|NCT02213042|587301088|FG000|Overall Study|Adverse Event|2|||
162613051|NCT02213042|587301089|FG001|Overall Study|Adverse Event|1|||
162613052|NCT02213042|587301090|FG002|Overall Study|Adverse Event|0|||
162613053|NCT02213042|587301088|FG000|Overall Study|Withdrawal by Subject|0|||
162613054|NCT02213042|587301089|FG001|Overall Study|Withdrawal by Subject|1|||
162613055|NCT02213042|587301090|FG002|Overall Study|Withdrawal by Subject|1|||
162613056|NCT02213042|587301088|FG000|Overall Study|Protocol Violation|1|||
162613057|NCT02213042|587301089|FG001|Overall Study|Protocol Violation|0|||
162613058|NCT02213042|587301090|FG002|Overall Study|Protocol Violation|0|||
162613059|NCT02213042|587301088|FG000|Overall Study|Investigator discretion|0|||
162613060|NCT02213042|587301089|FG001|Overall Study|Investigator discretion|0|||
162613061|NCT02213042|587301090|FG002|Overall Study|Investigator discretion|1|||
162613062|NCT02007512|587301091|FG000|Double Blind Treatment Period|Adverse Event|4|||
162613063|NCT02007512|587301092|FG001|Double Blind Treatment Period|Adverse Event|6|||
162613064|NCT02007512|587301093|FG002|Double Blind Treatment Period|Adverse Event|2|||
162613065|NCT02007512|587301094|FG003|Double Blind Treatment Period|Adverse Event|2|||
162613066|NCT02007512|587301091|FG000|Double Blind Treatment Period|Death|1|||
162613067|NCT02007512|587301092|FG001|Double Blind Treatment Period|Death|0|||
162613068|NCT02007512|587301093|FG002|Double Blind Treatment Period|Death|0|||
162613069|NCT02007512|587301094|FG003|Double Blind Treatment Period|Death|0|||
162613070|NCT02007512|587301091|FG000|Double Blind Treatment Period|Disease progression|51|||
162705463|NCT00495469|587633711|FG003|Overall Study|ST depression at randomisation in ECG|0|||
162613071|NCT02007512|587301092|FG001|Double Blind Treatment Period|Disease progression|50|||
162613072|NCT02007512|587301093|FG002|Double Blind Treatment Period|Disease progression|57|||
162859915|NCT03191786|588192741|FG001|Overall Study|Moved to Post Trial Access Program|5|||
162859916|NCT03191786|588192740|FG000|Overall Study|Withdrawal by Subject|26|||
162859917|NCT03191786|588192741|FG001|Overall Study|Withdrawal by Subject|16|||
162859918|NCT05781542|588193981|FG000|Overall Study|Lost to Follow-up|1|||
162859919|NCT05781542|588193982|FG001|Overall Study|Lost to Follow-up|0|||
162859920|NCT05781542|588193983|FG002|Overall Study|Lost to Follow-up|1|||
162859921|NCT01386385|588193988|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
162859922|NCT01386385|588193989|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859923|NCT01386385|588193990|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859924|NCT01386385|588193991|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859925|NCT01386385|588193992|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859926|NCT01386385|588193993|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859927|NCT01386385|588193994|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859928|NCT01386385|588193995|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
162859929|NCT01386385|588193988|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
162859930|NCT01386385|588193989|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859931|NCT01386385|588193990|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859932|NCT01386385|588193991|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859933|NCT01386385|588193992|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859934|NCT01386385|588193993|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859935|NCT01386385|588193994|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859936|NCT01386385|588193995|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
162859937|NCT01386385|588193988|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859938|NCT01386385|588193989|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859939|NCT01386385|588193990|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
162859940|NCT01386385|588193991|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859941|NCT01386385|588193992|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859942|NCT01386385|588193993|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859943|NCT01386385|588193994|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859944|NCT01386385|588193995|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
162859945|NCT01386385|588193988|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859946|NCT01386385|588193989|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859947|NCT01386385|588193990|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859948|NCT01386385|588193991|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162705464|NCT00495469|587633712|FG004|Overall Study|ST depression at randomisation in ECG|0|||
162705465|NCT00495469|587633713|FG005|Overall Study|ST depression at randomisation in ECG|0|||
162705466|NCT00495469|587633714|FG006|Overall Study|ST depression at randomisation in ECG|0|||
162705467|NCT02851511|587633715|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
162705468|NCT02851511|587633716|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
162705469|NCT02851511|587633717|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
162705470|NCT02851511|587633718|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
162705471|NCT02851511|587633715|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
162705472|NCT02851511|587633716|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
162705473|NCT02851511|587633717|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
162705474|NCT02851511|587633718|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
162705475|NCT02851511|587633715|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
162705476|NCT02851511|587633716|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
162705477|NCT02851511|587633717|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
162705478|NCT02851511|587633718|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
162705479|NCT02851511|587633715|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162705480|NCT02851511|587633716|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
162705481|NCT02851511|587633717|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162705482|NCT02851511|587633718|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162705483|NCT02851511|587633715|FG000|Phase I|Physician Decision|0|||
162705484|NCT02851511|587633716|FG001|Phase I|Physician Decision|0|||
162705485|NCT02851511|587633717|FG002|Phase I|Physician Decision|0|||
162705486|NCT02851511|587633718|FG003|Phase I|Physician Decision|1|||
162705487|NCT02851511|587633715|FG000|Phase I|Withdrawal by Subject|2|||
162705488|NCT02851511|587633716|FG001|Phase I|Withdrawal by Subject|1|||
162705489|NCT02851511|587633717|FG002|Phase I|Withdrawal by Subject|0|||
162705490|NCT02851511|587633718|FG003|Phase I|Withdrawal by Subject|3|||
162705491|NCT02851511|587633715|FG000|Phase II|Physician Decision|18|||
162705492|NCT02851511|587633716|FG001|Phase II|Physician Decision|16|||
162705493|NCT02851511|587633717|FG002|Phase II|Physician Decision|0|||
162705494|NCT02851511|587633718|FG003|Phase II|Physician Decision|0|||
162705495|NCT02851511|587633715|FG000|Phase II|Withdrawal by Subject|18|||
162705496|NCT02851511|587633716|FG001|Phase II|Withdrawal by Subject|16|||
162705497|NCT02851511|587633717|FG002|Phase II|Withdrawal by Subject|0|||
162705498|NCT02851511|587633718|FG003|Phase II|Withdrawal by Subject|0|||
162705499|NCT02851511|587633715|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
162705500|NCT02851511|587633716|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
162705501|NCT02851511|587633717|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
163044926|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
163044927|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
162613073|NCT02007512|587301094|FG003|Double Blind Treatment Period|Disease progression|52|||
162613074|NCT02007512|587301091|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
162613075|NCT02007512|587301092|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
162613076|NCT02007512|587301093|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
162613077|NCT02007512|587301094|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
162613078|NCT02007512|587301091|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162613079|NCT02007512|587301092|FG001|Double Blind Treatment Period|Protocol Violation|0|||
162613080|NCT02007512|587301093|FG002|Double Blind Treatment Period|Protocol Violation|0|||
162613081|NCT02007512|587301094|FG003|Double Blind Treatment Period|Protocol Violation|1|||
162613082|NCT02007512|587301091|FG000|Double Blind Treatment Period|Other|2|||
162613083|NCT02007512|587301092|FG001|Double Blind Treatment Period|Other|1|||
162613084|NCT02007512|587301093|FG002|Double Blind Treatment Period|Other|1|||
162613085|NCT02007512|587301094|FG003|Double Blind Treatment Period|Other|2|||
162613086|NCT02007512|587301091|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
162613087|NCT02007512|587301092|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
162613088|NCT02007512|587301093|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
162613089|NCT02007512|587301094|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
162613090|NCT02007512|587301091|FG000|Open Label Treatment Period|Adverse Event|1|||
162613091|NCT02007512|587301092|FG001|Open Label Treatment Period|Adverse Event|0|||
162613092|NCT02007512|587301093|FG002|Open Label Treatment Period|Adverse Event|0|||
162705502|NCT02851511|587633718|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
162705503|NCT02851511|587633715|FG000|Phase II|Lost to Follow-up|0|||
162705504|NCT02851511|587633716|FG001|Phase II|Lost to Follow-up|1|||
162705505|NCT02851511|587633717|FG002|Phase II|Lost to Follow-up|0|||
162705506|NCT02851511|587633718|FG003|Phase II|Lost to Follow-up|0|||
162705507|NCT00051311|587633719|FG000|Overall Study|Starting new study|0|||
162705508|NCT00051311|587633720|FG001|Overall Study|Starting new study|1|||
162705509|NCT00051311|587633719|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
163044928|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
162613093|NCT02007512|587301094|FG003|Open Label Treatment Period|Adverse Event|0|||
162613094|NCT02007512|587301091|FG000|Open Label Treatment Period|Other|1|||
162613095|NCT02007512|587301092|FG001|Open Label Treatment Period|Other|1|||
162613096|NCT02007512|587301093|FG002|Open Label Treatment Period|Other|0|||
162613097|NCT02007512|587301094|FG003|Open Label Treatment Period|Other|0|||
162613098|NCT02007512|587301091|FG000|Open Label Treatment Period|Disease progression|23|||
162613099|NCT02007512|587301092|FG001|Open Label Treatment Period|Disease progression|11|||
162613100|NCT02007512|587301093|FG002|Open Label Treatment Period|Disease progression|0|||
162613101|NCT02007512|587301094|FG003|Open Label Treatment Period|Disease progression|0|||
162613102|NCT01225887|587301100|FG000|Overall Study|Ineligible:required test not done|2|||
162705510|NCT00051311|587633720|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
162705511|NCT00051311|587633719|FG000|Overall Study|Death of recipient|8|||
162859949|NCT01386385|588193992|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
162859950|NCT01386385|588193993|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859951|NCT01386385|588193994|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859952|NCT01386385|588193995|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
162859953|NCT01386385|588193988|FG000|Phase II Concurrent CRT|Adverse Event|0|||
162859954|NCT01386385|588193989|FG001|Phase II Concurrent CRT|Adverse Event|0|||
162859955|NCT01386385|588193990|FG002|Phase II Concurrent CRT|Adverse Event|0|||
162859956|NCT01386385|588193991|FG003|Phase II Concurrent CRT|Adverse Event|0|||
162859957|NCT01386385|588193992|FG004|Phase II Concurrent CRT|Adverse Event|0|||
162859958|NCT01386385|588193993|FG005|Phase II Concurrent CRT|Adverse Event|0|||
162859959|NCT01386385|588193994|FG006|Phase II Concurrent CRT|Adverse Event|3|||
162859960|NCT01386385|588193995|FG007|Phase II Concurrent CRT|Adverse Event|3|||
162859961|NCT01386385|588193988|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859962|NCT01386385|588193989|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859963|NCT01386385|588193990|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859964|NCT01386385|588193991|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859965|NCT01386385|588193992|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859966|NCT01386385|588193993|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859967|NCT01386385|588193994|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
162859968|NCT01386385|588193995|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
162859969|NCT01386385|588193988|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
162859970|NCT01386385|588193989|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
162859971|NCT01386385|588193990|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
162859972|NCT01386385|588193991|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
162859973|NCT01386385|588193992|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
162859974|NCT01386385|588193993|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
162859975|NCT01386385|588193994|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
162859976|NCT01386385|588193995|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
162859977|NCT01386385|588193988|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859978|NCT01386385|588193989|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859979|NCT01386385|588193990|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859980|NCT01386385|588193991|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859981|NCT01386385|588193992|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859982|NCT01386385|588193993|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859983|NCT01386385|588193994|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
162859984|NCT01386385|588193995|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
162859985|NCT01386385|588193988|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859986|NCT01386385|588193989|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859987|NCT01386385|588193990|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859988|NCT01386385|588193991|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859989|NCT01386385|588193992|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859990|NCT01386385|588193993|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
162859991|NCT01386385|588193994|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
162859992|NCT01386385|588193995|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
162859993|NCT03167619|588194005|FG000|Overall Study|Death|11|||
162859994|NCT03167619|588194006|FG001|Overall Study|Death|8|||
162859995|NCT03167619|588194005|FG000|Overall Study|Withdrawal by Subject|1|||
162859996|NCT03167619|588194006|FG001|Overall Study|Withdrawal by Subject|2|||
162859997|NCT03167619|588194005|FG000|Overall Study|Physician Decision|0|||
162859998|NCT03167619|588194006|FG001|Overall Study|Physician Decision|1|||
162859999|NCT06400238|588194008|FG000|Overall Study|Started Protocol Therapy|2|||
162860000|NCT06400238|588194008|FG000|Overall Study|Adverse Event|1|||
162860001|NCT06400238|588194008|FG000|Overall Study|Death|1|||
162860002|NCT06400238|588194008|FG000|Overall Study|Disease Progression|27|||
162860003|NCT06400238|588194008|FG000|Overall Study|Withdrawal by Subject|2|||
162613103|NCT01225887|587301100|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
162705512|NCT00051311|587633720|FG001|Overall Study|Death of recipient|8|||
162860004|NCT06400238|588194008|FG000|Overall Study|Physician Decision|2|||
162860005|NCT01009463|588194011|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
162860006|NCT01009463|588194012|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162860007|NCT01009463|588194013|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162705513|NCT00051311|587633719|FG000|Overall Study|Recipient taken off study|4|||
162705514|NCT00051311|587633720|FG001|Overall Study|Recipient taken off study|4|||
162705515|NCT04170023|587633721|FG000|LTE Period|Withdrawal by Subject|1|||
162705516|NCT04170023|587633722|FG001|LTE Period|Withdrawal by Subject|0|||
162705517|NCT04170023|587633723|FG002|LTE Period|Withdrawal by Subject|0|||
162705518|NCT04170023|587633721|FG000|LTE Period|Study Termination|11|||
162705519|NCT04170023|587633722|FG001|LTE Period|Study Termination|11|||
162705520|NCT04170023|587633723|FG002|LTE Period|Study Termination|5|||
162705521|NCT04990440|587633724|FG000|Overall Study|Sponsor's Decision|0|||
162705522|NCT04990440|587633725|FG001|Overall Study|Sponsor's Decision|0|||
162860008|NCT01009463|588194014|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162705523|NCT04990440|587633726|FG002|Overall Study|Sponsor's Decision|1|||
162860009|NCT01009463|588194015|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
162860010|NCT01009463|588194011|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
162860011|NCT01009463|588194012|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
162860012|NCT01009463|588194013|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
162860013|NCT01009463|588194014|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
162860014|NCT01009463|588194015|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
162860015|NCT01009463|588194011|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
162860016|NCT01009463|588194012|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162860017|NCT01009463|588194013|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162860018|NCT01009463|588194014|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162860019|NCT01009463|588194015|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
162860020|NCT01009463|588194011|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
162860021|NCT01009463|588194012|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
162860022|NCT01009463|588194013|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
162860023|NCT01009463|588194014|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
162860024|NCT01009463|588194015|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
162860025|NCT01009463|588194011|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
162860026|NCT01009463|588194012|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162860027|NCT01009463|588194013|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162860028|NCT01009463|588194014|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162860029|NCT01009463|588194015|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
162860030|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
162860031|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
162860032|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
162860033|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
162860034|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
162860035|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162860036|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
162860037|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
162860038|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
162860039|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
162860040|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
162860041|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
162860042|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
162860043|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
162860044|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
162860045|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
162860046|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
162860047|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
162860048|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
162860049|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
162860050|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
162860051|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
162860052|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
162860053|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
162860054|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
162860055|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162860056|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
162860057|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162705524|NCT03712098|587633727|FG000|Overall Study|Lost to Follow-up|3|||
162705525|NCT03712098|587633728|FG001|Overall Study|Lost to Follow-up|7|||
162705526|NCT03712098|587633727|FG000|Overall Study|Withdrawal by Subject|9|||
162705527|NCT03712098|587633728|FG001|Overall Study|Withdrawal by Subject|4|||
162705528|NCT03712098|587633727|FG000|Overall Study|Protocol Violation|2|||
162860058|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
162860059|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
162860060|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162860061|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
162860062|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
162860063|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
162860064|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
162860065|NCT01009463|588194011|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
162860066|NCT01009463|588194012|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
162860067|NCT01009463|588194013|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
162860068|NCT01009463|588194014|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
162860069|NCT01009463|588194015|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
162860070|NCT04430348|588194016|FG000|Overall Study|Death|3|||
162860071|NCT04430348|588194017|FG001|Overall Study|Death|2|||
162860072|NCT04430348|588194018|FG002|Overall Study|Death|2|||
162860073|NCT04430348|588194019|FG003|Overall Study|Death|2|||
162860074|NCT04430348|588194020|FG004|Overall Study|Death|2|||
162860075|NCT04430348|588194021|FG005|Overall Study|Death|3|||
162860076|NCT04430348|588194016|FG000|Overall Study|Lost to Follow-up|0|||
162860077|NCT04430348|588194017|FG001|Overall Study|Lost to Follow-up|0|||
162860078|NCT04430348|588194018|FG002|Overall Study|Lost to Follow-up|0|||
162860079|NCT04430348|588194019|FG003|Overall Study|Lost to Follow-up|1|||
162860080|NCT04430348|588194020|FG004|Overall Study|Lost to Follow-up|0|||
162860081|NCT04430348|588194021|FG005|Overall Study|Lost to Follow-up|0|||
162860082|NCT04430348|588194016|FG000|Overall Study|Adverse Event|0|||
162860083|NCT04430348|588194017|FG001|Overall Study|Adverse Event|0|||
162860084|NCT04430348|588194018|FG002|Overall Study|Adverse Event|0|||
162860085|NCT04430348|588194019|FG003|Overall Study|Adverse Event|0|||
162860086|NCT04430348|588194020|FG004|Overall Study|Adverse Event|0|||
162860087|NCT04430348|588194021|FG005|Overall Study|Adverse Event|1|||
162860088|NCT04430348|588194016|FG000|Overall Study|Withdrawal by Subject|0|||
162860089|NCT04430348|588194017|FG001|Overall Study|Withdrawal by Subject|1|||
162860090|NCT04430348|588194018|FG002|Overall Study|Withdrawal by Subject|0|||
162860091|NCT04430348|588194019|FG003|Overall Study|Withdrawal by Subject|0|||
162860092|NCT04430348|588194020|FG004|Overall Study|Withdrawal by Subject|0|||
162860093|NCT04430348|588194021|FG005|Overall Study|Withdrawal by Subject|1|||
162956858|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
162956859|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
162956860|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
162956861|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
162956862|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
162956863|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Adverse Event|0|||
162613104|NCT01225887|587301100|FG000|Overall Study|Ineligible:inadequate pathology|2|||
162860094|NCT04430348|588194016|FG000|Overall Study|Study Terminated by Sponsor|0|||
162956864|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Adverse Event|0|||
162956865|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Adverse Event|6|||
162956866|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
162613105|NCT04505540|587301103|FG000|Baseline|Protocol Violation|10|||
162860095|NCT04430348|588194017|FG001|Overall Study|Study Terminated by Sponsor|0|||
162860096|NCT04430348|588194018|FG002|Overall Study|Study Terminated by Sponsor|2|||
162860097|NCT04430348|588194019|FG003|Overall Study|Study Terminated by Sponsor|0|||
162860098|NCT04430348|588194020|FG004|Overall Study|Study Terminated by Sponsor|1|||
162860099|NCT04430348|588194021|FG005|Overall Study|Study Terminated by Sponsor|1|||
162860100|NCT05408858|588194026|FG000|Overall Study|no longer met eligibility criteria|1|||
162860101|NCT00384956|588194027|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
162860102|NCT00881205|588194029|FG000|Overall Study|Adverse Event|8|||
162860103|NCT00881205|588194030|FG001|Overall Study|Adverse Event|3|||
162860104|NCT00881205|588194029|FG000|Overall Study|Withdrawal by Subject|1|||
162860105|NCT00881205|588194030|FG001|Overall Study|Withdrawal by Subject|2|||
162860106|NCT00881205|588194029|FG000|Overall Study|Lost to Follow-up|0|||
162860107|NCT00881205|588194030|FG001|Overall Study|Lost to Follow-up|1|||
162860108|NCT00881205|588194029|FG000|Overall Study|Administrative problems|1|||
162860109|NCT00881205|588194030|FG001|Overall Study|Administrative problems|1|||
162860110|NCT00881205|588194029|FG000|Overall Study|Condition no longer requires drug|1|||
162860111|NCT00881205|588194030|FG001|Overall Study|Condition no longer requires drug|0|||
162860112|NCT01824602|588194038|FG000|Overall Study|Withdrawal by Subject|0|||
162860113|NCT01824602|588194039|FG001|Overall Study|Withdrawal by Subject|0|||
162860114|NCT01824602|588194040|FG002|Overall Study|Withdrawal by Subject|1|||
162860115|NCT01824602|588194041|FG003|Overall Study|Withdrawal by Subject|2|||
162860116|NCT01824602|588194038|FG000|Overall Study|Patient non-compliance|0|||
162860117|NCT01824602|588194039|FG001|Overall Study|Patient non-compliance|0|||
162860118|NCT01824602|588194040|FG002|Overall Study|Patient non-compliance|1|||
162860119|NCT01824602|588194041|FG003|Overall Study|Patient non-compliance|0|||
162860120|NCT01824602|588194038|FG000|Overall Study|Adverse Event|1|||
162860121|NCT01824602|588194039|FG001|Overall Study|Adverse Event|0|||
162860122|NCT01824602|588194040|FG002|Overall Study|Adverse Event|2|||
162860123|NCT01824602|588194041|FG003|Overall Study|Adverse Event|2|||
162860124|NCT01824602|588194038|FG000|Overall Study|Treatment failure|0|||
162860125|NCT01824602|588194039|FG001|Overall Study|Treatment failure|0|||
162860126|NCT01824602|588194040|FG002|Overall Study|Treatment failure|0|||
162860127|NCT01824602|588194041|FG003|Overall Study|Treatment failure|1|||
162860128|NCT02192359|588194044|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
162860129|NCT02192359|588194045|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
162860130|NCT02192359|588194046|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
162860131|NCT02192359|588194047|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
162860132|NCT02192359|588194044|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
162860133|NCT02192359|588194045|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
162860134|NCT02192359|588194046|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
162860135|NCT02192359|588194047|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
162860136|NCT02192359|588194044|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
162860137|NCT02192359|588194045|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
162860138|NCT02192359|588194046|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
162860139|NCT02192359|588194047|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
162860140|NCT02117687|588194053|FG000|Overall Study|Lost to Follow-up|0|||
162860141|NCT02117687|588194054|FG001|Overall Study|Lost to Follow-up|1|||
162860142|NCT02117687|588194053|FG000|Overall Study|Adverse Event|0|||
162860143|NCT02117687|588194054|FG001|Overall Study|Adverse Event|2|||
162860144|NCT02117687|588194053|FG000|Overall Study|Other Reasons|1|||
162860145|NCT02117687|588194054|FG001|Overall Study|Other Reasons|1|||
162860146|NCT00002850|588194055|FG000|Overall Study|Death|4|||
162860147|NCT00002850|588194056|FG001|Overall Study|Death|1|||
162860148|NCT00002850|588194057|FG002|Overall Study|Death|3|||
162860149|NCT00002850|588194055|FG000|Overall Study|Protocol Violation|1|||
162860150|NCT00002850|588194056|FG001|Overall Study|Protocol Violation|0|||
162860151|NCT00002850|588194057|FG002|Overall Study|Protocol Violation|1|||
162860152|NCT00002850|588194055|FG000|Overall Study|Withdrawal by Subject|0|||
162860153|NCT00002850|588194056|FG001|Overall Study|Withdrawal by Subject|1|||
162860154|NCT00002850|588194057|FG002|Overall Study|Withdrawal by Subject|0|||
162860155|NCT01687673|588194064|FG000|Overall Study|Physician Decision|1|||
162860156|NCT02234622|588194065|FG000|Overall Study|Withdrawal by Subject|16|||
162860157|NCT02234622|588194066|FG001|Overall Study|Withdrawal by Subject|22|||
162860158|NCT02234622|588194065|FG000|Overall Study|Lost to Follow-up|27|||
162860159|NCT02234622|588194066|FG001|Overall Study|Lost to Follow-up|14|||
162860160|NCT03476239|588194067|FG000|Overall Study|Withdrawal by Subject|10|||
162613106|NCT04505540|587301103|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
162705529|NCT03712098|587633728|FG001|Overall Study|Protocol Violation|1|||
162860161|NCT03476239|588194067|FG000|Overall Study|Death|80|||
162860162|NCT03476239|588194067|FG000|Overall Study|Lost to Follow-up|8|||
162860163|NCT00618956|588194068|FG000|Overall Study|Adverse Event|10|||
162860164|NCT00618956|588194069|FG001|Overall Study|Adverse Event|34|||
162860165|NCT00618956|588194068|FG000|Overall Study|Lack of Efficacy|2|||
162860166|NCT00618956|588194069|FG001|Overall Study|Lack of Efficacy|1|||
162860167|NCT00618956|588194068|FG000|Overall Study|Withdrawal by Subject|5|||
162860168|NCT00618956|588194069|FG001|Overall Study|Withdrawal by Subject|7|||
162860169|NCT00618956|588194068|FG000|Overall Study|Lost to Follow-up|4|||
162860170|NCT00618956|588194069|FG001|Overall Study|Lost to Follow-up|5|||
162860171|NCT00618956|588194068|FG000|Overall Study|Protocol Violation|2|||
162860172|NCT00618956|588194069|FG001|Overall Study|Protocol Violation|2|||
162860173|NCT00618956|588194068|FG000|Overall Study|did not meet criteria, non-compliance|2|||
162860174|NCT00618956|588194069|FG001|Overall Study|did not meet criteria, non-compliance|1|||
162860175|NCT03598777|588194070|FG000|Overall Study|Study Terminated by Sponsor|3|||
162860176|NCT03598777|588194071|FG001|Overall Study|Study Terminated by Sponsor|0|||
162860177|NCT03598777|588194072|FG002|Overall Study|Study Terminated by Sponsor|0|||
162860178|NCT03598777|588194073|FG003|Overall Study|Study Terminated by Sponsor|0|||
162860179|NCT03598777|588194074|FG004|Overall Study|Study Terminated by Sponsor|15|||
162860180|NCT03598777|588194070|FG000|Overall Study|Withdrawal by Subject|1|||
162860181|NCT03598777|588194071|FG001|Overall Study|Withdrawal by Subject|1|||
162860182|NCT03598777|588194072|FG002|Overall Study|Withdrawal by Subject|0|||
162860183|NCT03598777|588194073|FG003|Overall Study|Withdrawal by Subject|0|||
162860184|NCT03598777|588194074|FG004|Overall Study|Withdrawal by Subject|0|||
162860185|NCT03598777|588194070|FG000|Overall Study|Adverse Event|1|||
162860186|NCT03598777|588194071|FG001|Overall Study|Adverse Event|0|||
162860187|NCT03598777|588194072|FG002|Overall Study|Adverse Event|0|||
162860188|NCT03598777|588194073|FG003|Overall Study|Adverse Event|0|||
162860189|NCT03598777|588194074|FG004|Overall Study|Adverse Event|0|||
162860190|NCT03598777|588194070|FG000|Overall Study|Lost to Follow-up|1|||
162860191|NCT03598777|588194071|FG001|Overall Study|Lost to Follow-up|0|||
162860192|NCT03598777|588194072|FG002|Overall Study|Lost to Follow-up|0|||
162860193|NCT03598777|588194073|FG003|Overall Study|Lost to Follow-up|0|||
162860194|NCT03598777|588194074|FG004|Overall Study|Lost to Follow-up|0|||
162860195|NCT02006576|588194075|FG000|Overall Study|Withdrawal by Subject|4|||
162860196|NCT02006576|588194076|FG001|Overall Study|Withdrawal by Subject|6|||
162860197|NCT02006576|588194077|FG002|Overall Study|Withdrawal by Subject|2|||
162860198|NCT02006576|588194075|FG000|Overall Study|Death|0|||
162956867|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
162956868|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
162956869|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
162956870|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
162956871|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
162956872|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Pregnancy|0|||
162956873|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Pregnancy|0|||
162956874|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Pregnancy|2|||
162956875|NCT02009163|588543642|FG000|Randomized-withdrawal Period|Other|0|||
162956876|NCT02009163|588543643|FG001|Randomized-withdrawal Period|Other|9|||
162956877|NCT02009163|588543644|FG002|Randomized-withdrawal Period|Other|5|||
162956878|NCT02453386|588543645|FG000|Overall Study|Adverse Event|22|||
162956879|NCT02453386|588543646|FG001|Overall Study|Adverse Event|30|||
162956880|NCT02453386|588543647|FG002|Overall Study|Adverse Event|15|||
162956881|NCT02453386|588543645|FG000|Overall Study|Protocol Violation|1|||
162956882|NCT02453386|588543646|FG001|Overall Study|Protocol Violation|0|||
162956883|NCT02453386|588543647|FG002|Overall Study|Protocol Violation|1|||
162956884|NCT02453386|588543645|FG000|Overall Study|Withdrawal by Subject|10|||
162956885|NCT02453386|588543646|FG001|Overall Study|Withdrawal by Subject|9|||
162956886|NCT02453386|588543647|FG002|Overall Study|Withdrawal by Subject|9|||
162956887|NCT02453386|588543645|FG000|Overall Study|Sponsor Terminated Study|14|||
162956888|NCT02453386|588543646|FG001|Overall Study|Sponsor Terminated Study|8|||
162956889|NCT02453386|588543647|FG002|Overall Study|Sponsor Terminated Study|11|||
162956890|NCT02453386|588543645|FG000|Overall Study|Subject Terminated by Sponsor|1|||
162956891|NCT02453386|588543646|FG001|Overall Study|Subject Terminated by Sponsor|1|||
162956892|NCT02453386|588543647|FG002|Overall Study|Subject Terminated by Sponsor|1|||
162956893|NCT02453386|588543645|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
162956894|NCT02453386|588543646|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
162613107|NCT04505540|587301103|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
162613108|NCT04505540|587301103|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
162613109|NCT04505540|587301103|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
162860199|NCT02006576|588194076|FG001|Overall Study|Death|0|||
162860200|NCT02006576|588194077|FG002|Overall Study|Death|1|||
162956895|NCT02453386|588543647|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
162956896|NCT02453386|588543645|FG000|Overall Study|Lost to Follow-up|0|||
162956897|NCT02453386|588543646|FG001|Overall Study|Lost to Follow-up|0|||
162956898|NCT02453386|588543647|FG002|Overall Study|Lost to Follow-up|1|||
162613110|NCT04505540|587301103|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
162860201|NCT02006576|588194075|FG000|Overall Study|Lost to Follow-up|1|||
162860202|NCT02006576|588194076|FG001|Overall Study|Lost to Follow-up|0|||
162860203|NCT02006576|588194077|FG002|Overall Study|Lost to Follow-up|1|||
162860204|NCT02006576|588194075|FG000|Overall Study|Screen Failure, too sick, other|13|||
162860205|NCT02006576|588194076|FG001|Overall Study|Screen Failure, too sick, other|1|||
162860206|NCT02006576|588194077|FG002|Overall Study|Screen Failure, too sick, other|13|||
162860207|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
162860208|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
162860209|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
162860210|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
162860211|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
162860212|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162860213|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162860214|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162860215|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162860216|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
162860217|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
162860218|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
162613111|NCT04505540|587301103|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
162613112|NCT04505540|587301103|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
162613113|NCT04505540|587301103|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
162613114|NCT04505540|587301103|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
162613115|NCT04505540|587301103|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
162613116|NCT04505540|587301103|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
162613117|NCT04505540|587301103|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
162613118|NCT05342532|587301106|FG000|Overall Study|Adverse Event|5|||
162613119|NCT05342532|587301107|FG001|Overall Study|Adverse Event|20|||
162613120|NCT05342532|587301106|FG000|Overall Study|Lost to Follow-up|10|||
162613121|NCT05342532|587301107|FG001|Overall Study|Lost to Follow-up|15|||
162613122|NCT01123850|587301112|FG000|Overall Study|Slow enrollment|45|||
162613123|NCT03180684|587301113|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
162613124|NCT03180684|587301114|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
162613125|NCT03180684|587301113|FG000|Overall Study|Physician Decision|1|||
162613126|NCT03180684|587301114|FG001|Overall Study|Physician Decision|0|||
162860219|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
162860220|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
162860221|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
162860222|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
162860223|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
162613127|NCT03180684|587301113|FG000|Overall Study|Lost to Follow-up|1|||
162613128|NCT03180684|587301114|FG001|Overall Study|Lost to Follow-up|0|||
162613129|NCT03180684|587301113|FG000|Overall Study|Progressive Disease|1|||
162613130|NCT03180684|587301114|FG001|Overall Study|Progressive Disease|0|||
162613131|NCT02495233|587301118|FG000|Overall Study|Miscellaneous|0|||
162613132|NCT02495233|587301119|FG001|Overall Study|Miscellaneous|1|||
162613133|NCT01369615|587301123|FG000|Overall Study|Withdrawal by Subject|0|||
162613134|NCT01369615|587301124|FG001|Overall Study|Withdrawal by Subject|1|||
162613135|NCT01369615|587301123|FG000|Overall Study|Lost to Follow-up|0|||
162613136|NCT01369615|587301124|FG001|Overall Study|Lost to Follow-up|1|||
162613137|NCT04263454|587301125|FG000|Overall Study|Adverse Event|0|||
162613138|NCT04263454|587301126|FG001|Overall Study|Adverse Event|2|||
162613139|NCT04263454|587301125|FG000|Overall Study|Physician Decision|3|||
162613140|NCT04263454|587301126|FG001|Overall Study|Physician Decision|5|||
162613141|NCT04263454|587301125|FG000|Overall Study|Poor Data Quality|0|||
162613142|NCT04263454|587301126|FG001|Overall Study|Poor Data Quality|1|||
162613143|NCT01231347|587301127|FG000|Overall Study|Full Consent withdrawn|19|||
162613144|NCT01231347|587301128|FG001|Overall Study|Full Consent withdrawn|19|||
162613145|NCT01231347|587301129|FG002|Overall Study|Full Consent withdrawn|11|||
162613146|NCT01231347|587301127|FG000|Overall Study|Lost to Follow-up|4|||
162613147|NCT01231347|587301128|FG001|Overall Study|Lost to Follow-up|2|||
162860224|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
162860225|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
162956899|NCT02453386|588543645|FG000|Overall Study|Other|1|||
162956900|NCT02453386|588543646|FG001|Overall Study|Other|0|||
162956901|NCT02453386|588543647|FG002|Overall Study|Other|1|||
162956902|NCT00359281|588543648|FG000|Overall Study|Adverse Event|1|||
162956903|NCT00359281|588543649|FG001|Overall Study|Adverse Event|0|||
162956904|NCT00359281|588543650|FG002|Overall Study|Adverse Event|0|||
162956905|NCT00359281|588543651|FG003|Overall Study|Adverse Event|0|||
162956906|NCT00359281|588543652|FG004|Overall Study|Adverse Event|0|||
162956907|NCT00359281|588543653|FG005|Overall Study|Adverse Event|0|||
162613148|NCT01231347|587301129|FG002|Overall Study|Lost to Follow-up|2|||
162613149|NCT01231347|587301127|FG000|Overall Study|Death|202|||
162613150|NCT01231347|587301128|FG001|Overall Study|Death|210|||
162613151|NCT01231347|587301129|FG002|Overall Study|Death|101|||
162613152|NCT01231347|587301127|FG000|Overall Study|other event|7|||
162613153|NCT01231347|587301128|FG001|Overall Study|other event|9|||
162613154|NCT01231347|587301129|FG002|Overall Study|other event|3|||
162613155|NCT01460368|587301130|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162860226|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
162860227|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
162956908|NCT00359281|588543654|FG006|Overall Study|Adverse Event|1|||
162956909|NCT00359281|588543655|FG007|Overall Study|Adverse Event|0|||
162860228|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
162860229|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
162860230|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
162860231|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
162860232|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
162860233|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
162860234|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
162860235|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
162860236|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
162860237|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
162860238|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
162860239|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
162860240|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
162860241|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
162860242|NCT00785577|588194078|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
162860243|NCT00785577|588194079|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
162860244|NCT00785577|588194080|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
162860245|NCT00785577|588194081|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
162860246|NCT00785577|588194082|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
162860247|NCT00785577|588194078|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
162860248|NCT00785577|588194079|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
162956910|NCT00359281|588543656|FG008|Overall Study|Adverse Event|0|||
162956911|NCT00359281|588543648|FG000|Overall Study|Withdrawal by Subject|0|||
162956912|NCT00359281|588543649|FG001|Overall Study|Withdrawal by Subject|0|||
162956913|NCT00359281|588543650|FG002|Overall Study|Withdrawal by Subject|0|||
162956914|NCT00359281|588543651|FG003|Overall Study|Withdrawal by Subject|0|||
162956915|NCT00359281|588543652|FG004|Overall Study|Withdrawal by Subject|0|||
162860249|NCT00785577|588194080|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
162860250|NCT00785577|588194081|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
162613156|NCT01460368|587301131|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162613157|NCT01460368|587301132|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162613158|NCT01460368|587301133|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162613159|NCT01460368|587301134|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
162613160|NCT01460368|587301135|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162613161|NCT01460368|587301136|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162613162|NCT01460368|587301130|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162613163|NCT01460368|587301131|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
162613164|NCT01460368|587301132|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162613165|NCT01460368|587301133|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162613166|NCT01460368|587301134|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162613167|NCT01460368|587301135|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162613168|NCT01460368|587301136|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
162613169|NCT01460368|587301130|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613170|NCT01460368|587301131|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
162613171|NCT01460368|587301132|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613172|NCT01460368|587301133|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613173|NCT01460368|587301134|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613174|NCT01460368|587301135|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613175|NCT01460368|587301136|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162613176|NCT01460368|587301130|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613177|NCT01460368|587301131|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613178|NCT01460368|587301132|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
162613179|NCT01460368|587301133|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613180|NCT01460368|587301134|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613181|NCT01460368|587301135|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613182|NCT01460368|587301136|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162613183|NCT01460368|587301130|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162613184|NCT01460368|587301131|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162613185|NCT01460368|587301132|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162613186|NCT01460368|587301133|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162613187|NCT01460368|587301134|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162613188|NCT01460368|587301135|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162613189|NCT01460368|587301136|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162613190|NCT02047227|587301137|FG000|Overall Study|Adverse Event|2|||
162613191|NCT02047227|587301138|FG001|Overall Study|Adverse Event|4|||
162613192|NCT02047227|587301137|FG000|Overall Study|Lost to Follow-up|0|||
162613193|NCT02047227|587301138|FG001|Overall Study|Lost to Follow-up|3|||
162613194|NCT02047227|587301137|FG000|Overall Study|Protocol Violation|1|||
162613195|NCT02047227|587301138|FG001|Overall Study|Protocol Violation|0|||
162860251|NCT00785577|588194082|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
162860252|NCT00785577|588194078|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
162860253|NCT00785577|588194079|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
162860254|NCT00785577|588194080|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
162860255|NCT00785577|588194081|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
162860256|NCT00785577|588194082|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
162860257|NCT01919411|588194083|FG000|Overall Study|Lost to Follow-up|2|||
162860258|NCT01919411|588194084|FG001|Overall Study|Lost to Follow-up|4|||
162860259|NCT01919411|588194083|FG000|Overall Study|Physician Decision|1|||
162860260|NCT01919411|588194084|FG001|Overall Study|Physician Decision|0|||
162860261|NCT01919411|588194083|FG000|Overall Study|Protocol Violation|2|||
162860262|NCT01919411|588194084|FG001|Overall Study|Protocol Violation|1|||
162860263|NCT01650805|588194089|FG000|Overall Study|Withdrawal by Subject|1|||
162860264|NCT01650805|588194090|FG001|Overall Study|Withdrawal by Subject|0|||
162860265|NCT02403206|588194092|FG000|Overall Study|Lost to Follow-up|4|||
162860266|NCT02403206|588194093|FG001|Overall Study|Lost to Follow-up|3|||
162860267|NCT02403206|588194092|FG000|Overall Study|Physician Decision|2|||
162860268|NCT02403206|588194093|FG001|Overall Study|Physician Decision|0|||
162860269|NCT02403206|588194092|FG000|Overall Study|Withdrawal by Subject|3|||
162956916|NCT00359281|588543653|FG005|Overall Study|Withdrawal by Subject|0|||
162613196|NCT02047227|587301137|FG000|Overall Study|Spontaneous pregnancy|1|||
162613197|NCT02047227|587301138|FG001|Overall Study|Spontaneous pregnancy|0|||
162860270|NCT02403206|588194093|FG001|Overall Study|Withdrawal by Subject|3|||
162860271|NCT02403206|588194092|FG000|Overall Study|Reason not given|2|||
162860272|NCT02403206|588194093|FG001|Overall Study|Reason not given|4|||
162956917|NCT00359281|588543654|FG006|Overall Study|Withdrawal by Subject|1|||
162860273|NCT01901328|588194099|FG000|Overall Study|Lost to Follow-up|1|||
162860274|NCT01901328|588194100|FG001|Overall Study|Lost to Follow-up|0|||
162956918|NCT00359281|588543655|FG007|Overall Study|Withdrawal by Subject|0|||
162860275|NCT01901328|588194099|FG000|Overall Study|Physician Decision|0|||
162705530|NCT02256969|587633729|FG000|Overall Study|Screenfailed or withdrew|2|||
162705531|NCT02256969|587633730|FG001|Overall Study|Screenfailed or withdrew|1|||
162705532|NCT02256969|587633731|FG002|Overall Study|Screenfailed or withdrew|1|||
162705533|NCT00372567|587633734|FG000|Phase 3 Study|Adverse Event|5|||
162705534|NCT00372567|587633735|FG001|Phase 3 Study|Adverse Event|1|||
162705535|NCT00372567|587633736|FG002|Phase 3 Study|Adverse Event|1|||
162705536|NCT00372567|587633734|FG000|Phase 3 Study|Death|1|||
162705537|NCT00372567|587633735|FG001|Phase 3 Study|Death|1|||
162705538|NCT00372567|587633736|FG002|Phase 3 Study|Death|0|||
162705539|NCT00372567|587633734|FG000|Phase 3 Study|Protocol Violation|0|||
162705540|NCT00372567|587633735|FG001|Phase 3 Study|Protocol Violation|0|||
162705541|NCT00372567|587633736|FG002|Phase 3 Study|Protocol Violation|1|||
162705542|NCT00372567|587633734|FG000|Phase 3 Study|Objective progression or relapse|10|||
162705543|NCT00372567|587633735|FG001|Phase 3 Study|Objective progression or relapse|13|||
162956919|NCT00359281|588543656|FG008|Overall Study|Withdrawal by Subject|0|||
162956920|NCT01415986|588543659|FG000|Overall Study|Lost to Follow-up|1|||
162956921|NCT01474551|588543662|FG000|Overall Study|Death|1|||
162956922|NCT03122457|588543671|FG000|Overall Study|Withdrawal by Subject|6|||
162956923|NCT03769025|588543675|FG000|Overall Study|Withdrawal by Subject|1|||
162956924|NCT03769025|588543676|FG001|Overall Study|Withdrawal by Subject|1|||
162956925|NCT03769025|588543675|FG000|Overall Study|Lost to Follow-up|4|||
162956926|NCT03769025|588543676|FG001|Overall Study|Lost to Follow-up|3|||
162956927|NCT02911701|588543679|FG000|Overall Study|Withdrawal by Subject|2|||
162956928|NCT02911701|588543680|FG001|Overall Study|Withdrawal by Subject|4|||
162956929|NCT02911701|588543679|FG000|Overall Study|Adverse Event|1|||
162956930|NCT02911701|588543680|FG001|Overall Study|Adverse Event|0|||
162956931|NCT04659603|588543683|FG000|Overall Study|Study terminated by sponsor|0|||
162956932|NCT04659603|588543684|FG001|Overall Study|Study terminated by sponsor|0|||
162705544|NCT00372567|587633736|FG002|Phase 3 Study|Objective progression or relapse|4|||
162705545|NCT00372567|587633734|FG000|Phase 3 Study|Global deterioration of health status|0|||
162705546|NCT00372567|587633735|FG001|Phase 3 Study|Global deterioration of health status|1|||
162956933|NCT04659603|588543685|FG002|Overall Study|Study terminated by sponsor|2|||
162956934|NCT04659603|588543683|FG000|Overall Study|Withdrawal by Subject|0|||
162956935|NCT04659603|588543684|FG001|Overall Study|Withdrawal by Subject|5|||
162613198|NCT02047227|587301137|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
162613199|NCT02047227|587301138|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
162613200|NCT02047227|587301137|FG000|Overall Study|No oocytes retrieved|21|||
162613201|NCT02047227|587301138|FG001|Overall Study|No oocytes retrieved|20|||
162860276|NCT01901328|588194100|FG001|Overall Study|Physician Decision|1|||
162860277|NCT01901328|588194099|FG000|Overall Study|Protocol Violation|1|||
162860278|NCT01901328|588194100|FG001|Overall Study|Protocol Violation|1|||
162860279|NCT01901328|588194099|FG000|Overall Study|Study Terminated by Sponsor|19|||
162860280|NCT01901328|588194100|FG001|Overall Study|Study Terminated by Sponsor|16|||
162860281|NCT01901328|588194099|FG000|Overall Study|Withdrawal by Subject|1|||
162860282|NCT01901328|588194100|FG001|Overall Study|Withdrawal by Subject|2|||
162860283|NCT01901328|588194099|FG000|Overall Study|Lack of Efficacy|0|||
162860284|NCT01901328|588194100|FG001|Overall Study|Lack of Efficacy|1|||
162860285|NCT02462889|588194101|FG000|Overall Study|Withdrawal by Subject|2|||
162860286|NCT02462889|588194102|FG001|Overall Study|Withdrawal by Subject|6|||
162860287|NCT02462889|588194101|FG000|Overall Study|Death|1|||
162956936|NCT04659603|588543685|FG002|Overall Study|Withdrawal by Subject|0|||
162956937|NCT04659603|588543683|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
162956938|NCT04659603|588543684|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
162956939|NCT04659603|588543685|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
162956940|NCT01110005|588543686|FG000|Overall Study|ineligible|1|||
163044929|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
163044930|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044931|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044932|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
163044933|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
163044934|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044935|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044936|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
163044937|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
163044938|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044939|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044940|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
163044941|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
162956941|NCT01110005|588543687|FG001|Overall Study|ineligible|2|||
162956942|NCT01110005|588543686|FG000|Overall Study|missing consent|3|||
162956943|NCT01110005|588543687|FG001|Overall Study|missing consent|2|||
162956944|NCT01110005|588543686|FG000|Overall Study|Withdrawal by Subject|0|||
162956945|NCT01110005|588543687|FG001|Overall Study|Withdrawal by Subject|1|||
162956946|NCT04646213|588543688|FG000|Overall Study|Physician Decision|3|||
162956947|NCT04646213|588543688|FG000|Overall Study|Withdrawal by Subject|2|||
162956948|NCT02441309|588543689|FG000|Overall Study|Disease progression|2|||
162956949|NCT02441309|588543690|FG001|Overall Study|Disease progression|1|||
162956950|NCT02441309|588543691|FG002|Overall Study|Disease progression|2|||
162956951|NCT02441309|588543689|FG000|Overall Study|Adverse Event|0|||
162956952|NCT02441309|588543690|FG001|Overall Study|Adverse Event|1|||
162956953|NCT02441309|588543691|FG002|Overall Study|Adverse Event|0|||
162956954|NCT02441309|588543689|FG000|Overall Study|Withdrawal by Subject|1|||
162956955|NCT02441309|588543690|FG001|Overall Study|Withdrawal by Subject|0|||
162613202|NCT02047227|587301137|FG000|Overall Study|No fertilization|61|||
162956956|NCT02441309|588543691|FG002|Overall Study|Withdrawal by Subject|1|||
162956957|NCT02658084|588543692|FG000|Overall Study|Withdrawal by Subject|1|||
162956958|NCT02658084|588543693|FG001|Overall Study|Withdrawal by Subject|0|||
162860288|NCT02462889|588194102|FG001|Overall Study|Death|5|||
162860289|NCT04358458|588194105|FG000|Overall Study|Death|1|||
162860290|NCT04358458|588194106|FG001|Overall Study|Death|1|||
162860291|NCT04358458|588194107|FG002|Overall Study|Death|3|||
162860292|NCT04358458|588194108|FG003|Overall Study|Death|8|||
162860293|NCT04358458|588194109|FG004|Overall Study|Death|1|||
162860294|NCT04358458|588194110|FG005|Overall Study|Death|6|||
162860295|NCT04358458|588194111|FG006|Overall Study|Death|2|||
162860296|NCT04358458|588194112|FG007|Overall Study|Death|3|||
162860297|NCT04358458|588194105|FG000|Overall Study|Lost to Follow-up|0|||
162860298|NCT04358458|588194106|FG001|Overall Study|Lost to Follow-up|0|||
162956959|NCT02658084|588543692|FG000|Overall Study|Study Termination|1|||
162956960|NCT02658084|588543693|FG001|Overall Study|Study Termination|0|||
162956961|NCT03290781|588543694|FG000|Overall Study|Adverse Event|5|||
162956962|NCT03290781|588543695|FG001|Overall Study|Adverse Event|7|||
162956963|NCT03290781|588543696|FG002|Overall Study|Adverse Event|4|||
162956964|NCT03290781|588543697|FG003|Overall Study|Adverse Event|1|||
162956965|NCT03290781|588543698|FG004|Overall Study|Adverse Event|0|||
162956966|NCT03290781|588543699|FG005|Overall Study|Adverse Event|0|||
162956967|NCT03290781|588543700|FG006|Overall Study|Adverse Event|0|||
162956968|NCT03290781|588543694|FG000|Overall Study|Death|0|||
162956969|NCT03290781|588543695|FG001|Overall Study|Death|0|||
162956970|NCT03290781|588543696|FG002|Overall Study|Death|1|||
162956971|NCT03290781|588543697|FG003|Overall Study|Death|0|||
162956972|NCT03290781|588543698|FG004|Overall Study|Death|1|||
162956973|NCT03290781|588543699|FG005|Overall Study|Death|0|||
162956974|NCT03290781|588543700|FG006|Overall Study|Death|0|||
162956975|NCT03290781|588543694|FG000|Overall Study|Withdrawal by Subject|6|||
162956976|NCT03290781|588543695|FG001|Overall Study|Withdrawal by Subject|5|||
162956977|NCT03290781|588543696|FG002|Overall Study|Withdrawal by Subject|9|||
162956978|NCT03290781|588543697|FG003|Overall Study|Withdrawal by Subject|10|||
162956979|NCT03290781|588543698|FG004|Overall Study|Withdrawal by Subject|1|||
162956980|NCT03290781|588543699|FG005|Overall Study|Withdrawal by Subject|2|||
162956981|NCT03290781|588543700|FG006|Overall Study|Withdrawal by Subject|0|||
162956982|NCT03290781|588543694|FG000|Overall Study|Physician Decision|0|||
162956983|NCT03290781|588543695|FG001|Overall Study|Physician Decision|1|||
162956984|NCT03290781|588543696|FG002|Overall Study|Physician Decision|0|||
162956985|NCT03290781|588543697|FG003|Overall Study|Physician Decision|0|||
162956986|NCT03290781|588543698|FG004|Overall Study|Physician Decision|0|||
162956987|NCT03290781|588543699|FG005|Overall Study|Physician Decision|0|||
162956988|NCT03290781|588543700|FG006|Overall Study|Physician Decision|0|||
162956989|NCT03290781|588543694|FG000|Overall Study|Site Terminated by Sponsor|1|||
162956990|NCT03290781|588543695|FG001|Overall Study|Site Terminated by Sponsor|0|||
162956991|NCT03290781|588543696|FG002|Overall Study|Site Terminated by Sponsor|2|||
162956992|NCT03290781|588543697|FG003|Overall Study|Site Terminated by Sponsor|1|||
162956993|NCT03290781|588543698|FG004|Overall Study|Site Terminated by Sponsor|0|||
162956994|NCT03290781|588543699|FG005|Overall Study|Site Terminated by Sponsor|0|||
162956995|NCT03290781|588543700|FG006|Overall Study|Site Terminated by Sponsor|0|||
162956996|NCT03290781|588543694|FG000|Overall Study|Lost to Follow-up|0|||
162956997|NCT03290781|588543695|FG001|Overall Study|Lost to Follow-up|0|||
162956998|NCT03290781|588543696|FG002|Overall Study|Lost to Follow-up|0|||
162956999|NCT03290781|588543697|FG003|Overall Study|Lost to Follow-up|1|||
162957000|NCT03290781|588543698|FG004|Overall Study|Lost to Follow-up|0|||
162957001|NCT03290781|588543699|FG005|Overall Study|Lost to Follow-up|0|||
162957002|NCT03290781|588543700|FG006|Overall Study|Lost to Follow-up|0|||
162957003|NCT03290781|588543694|FG000|Overall Study|Protocol Deviation|2|||
162957004|NCT03290781|588543695|FG001|Overall Study|Protocol Deviation|0|||
162957005|NCT03290781|588543696|FG002|Overall Study|Protocol Deviation|0|||
162957006|NCT03290781|588543697|FG003|Overall Study|Protocol Deviation|1|||
162957007|NCT03290781|588543698|FG004|Overall Study|Protocol Deviation|0|||
162957008|NCT03290781|588543699|FG005|Overall Study|Protocol Deviation|0|||
162957009|NCT03290781|588543700|FG006|Overall Study|Protocol Deviation|0|||
162957010|NCT03290781|588543694|FG000|Overall Study|Disease Relapse|32|||
162957011|NCT03290781|588543695|FG001|Overall Study|Disease Relapse|5|||
162957012|NCT03290781|588543696|FG002|Overall Study|Disease Relapse|38|||
162957013|NCT03290781|588543697|FG003|Overall Study|Disease Relapse|7|||
162957014|NCT03290781|588543698|FG004|Overall Study|Disease Relapse|3|||
162957015|NCT03290781|588543699|FG005|Overall Study|Disease Relapse|1|||
162957016|NCT03290781|588543700|FG006|Overall Study|Disease Relapse|4|||
162860299|NCT04358458|588194107|FG002|Overall Study|Lost to Follow-up|0|||
162860300|NCT04358458|588194108|FG003|Overall Study|Lost to Follow-up|0|||
162860301|NCT04358458|588194109|FG004|Overall Study|Lost to Follow-up|0|||
162957017|NCT03290781|588543694|FG000|Overall Study|Other|3|||
162957018|NCT03290781|588543695|FG001|Overall Study|Other|0|||
162860302|NCT04358458|588194110|FG005|Overall Study|Lost to Follow-up|0|||
162860303|NCT04358458|588194111|FG006|Overall Study|Lost to Follow-up|0|||
162957019|NCT03290781|588543696|FG002|Overall Study|Other|2|||
162957020|NCT03290781|588543697|FG003|Overall Study|Other|2|||
162957021|NCT03290781|588543698|FG004|Overall Study|Other|0|||
162957022|NCT03290781|588543699|FG005|Overall Study|Other|0|||
162957023|NCT03290781|588543700|FG006|Overall Study|Other|0|||
162957024|NCT02820350|588543717|FG000|Overall Study|Withdrawal by Subject|3|||
163044942|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
163044943|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
162860304|NCT04358458|588194112|FG007|Overall Study|Lost to Follow-up|1|||
162860305|NCT04358458|588194105|FG000|Overall Study|Site is closing study participation|0|||
162860306|NCT04358458|588194106|FG001|Overall Study|Site is closing study participation|0|||
162860307|NCT04358458|588194107|FG002|Overall Study|Site is closing study participation|0|||
162860308|NCT04358458|588194108|FG003|Overall Study|Site is closing study participation|1|||
162860309|NCT04358458|588194109|FG004|Overall Study|Site is closing study participation|0|||
162860310|NCT04358458|588194110|FG005|Overall Study|Site is closing study participation|0|||
162860311|NCT04358458|588194111|FG006|Overall Study|Site is closing study participation|0|||
162860312|NCT04358458|588194112|FG007|Overall Study|Site is closing study participation|0|||
162860313|NCT04358458|588194105|FG000|Overall Study|Sponsor request|2|||
162860314|NCT04358458|588194106|FG001|Overall Study|Sponsor request|3|||
162860315|NCT04358458|588194107|FG002|Overall Study|Sponsor request|3|||
162860316|NCT04358458|588194108|FG003|Overall Study|Sponsor request|0|||
162860317|NCT04358458|588194109|FG004|Overall Study|Sponsor request|2|||
162860318|NCT04358458|588194110|FG005|Overall Study|Sponsor request|3|||
162860319|NCT04358458|588194111|FG006|Overall Study|Sponsor request|1|||
162860320|NCT04358458|588194112|FG007|Overall Study|Sponsor request|1|||
162860321|NCT04358458|588194105|FG000|Overall Study|Withdrawal by Subject|0|||
162860322|NCT04358458|588194106|FG001|Overall Study|Withdrawal by Subject|0|||
162860323|NCT04358458|588194107|FG002|Overall Study|Withdrawal by Subject|1|||
162860324|NCT04358458|588194108|FG003|Overall Study|Withdrawal by Subject|1|||
162860325|NCT04358458|588194109|FG004|Overall Study|Withdrawal by Subject|0|||
162860326|NCT04358458|588194110|FG005|Overall Study|Withdrawal by Subject|1|||
162860327|NCT04358458|588194111|FG006|Overall Study|Withdrawal by Subject|0|||
163044944|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
163044945|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
163044946|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044947|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044948|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
163044949|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
163044950|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044951|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044952|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163044953|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
163044954|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044955|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044956|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
163044957|NCT03538691|588871557|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
163044958|NCT03538691|588871558|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
163044959|NCT03538691|588871559|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
163044960|NCT03538691|588871560|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
162860328|NCT04358458|588194112|FG007|Overall Study|Withdrawal by Subject|1|||
162860329|NCT04636177|588194113|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
162860330|NCT04636177|588194114|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
162860331|NCT04636177|588194113|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
162860332|NCT04636177|588194114|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
162860333|NCT04636177|588194113|FG000|Single-arm portion|Withdrawal by Subject|1|||
162860334|NCT04636177|588194114|FG001|Single-arm portion|Withdrawal by Subject|0|||
162860335|NCT04636177|588194113|FG000|Single-arm portion|Adverse Event|1|||
162860336|NCT04636177|588194114|FG001|Single-arm portion|Adverse Event|0|||
162860337|NCT01981187|588195708|FG000|Overall Study|Participant/guardian decision|2|||
162860338|NCT01981187|588195708|FG000|Overall Study|Physician Decision|1|||
162860339|NCT01981187|588195708|FG000|Overall Study|Disease progression|2|||
162860340|NCT01981187|588195708|FG000|Overall Study|Adverse Event|7|||
162860341|NCT02082184|588195713|FG000|Overall Study|Adverse Event|1|||
162860342|NCT02082184|588195714|FG001|Overall Study|Adverse Event|0|||
162860343|NCT02082184|588195713|FG000|Overall Study|Medical diagnosis|1|||
162860344|NCT02082184|588195714|FG001|Overall Study|Medical diagnosis|2|||
162860345|NCT02082184|588195713|FG000|Overall Study|Device associated symptoms|5|||
162860346|NCT02082184|588195714|FG001|Overall Study|Device associated symptoms|0|||
162860347|NCT02082184|588195713|FG000|Overall Study|Withdrawal by Subject|3|||
162957025|NCT02820350|588543717|FG000|Overall Study|Death|4|||
162957026|NCT02057835|588544879|FG000|Overall Study|Withdrawal by Subject|0|||
162957027|NCT02057835|588544880|FG001|Overall Study|Withdrawal by Subject|2|||
162957028|NCT02057835|588544881|FG002|Overall Study|Withdrawal by Subject|0|||
162957029|NCT02057835|588544882|FG003|Overall Study|Withdrawal by Subject|0|||
162957030|NCT02057835|588544883|FG004|Overall Study|Withdrawal by Subject|0|||
162957031|NCT02057835|588544884|FG005|Overall Study|Withdrawal by Subject|0|||
162957032|NCT02057835|588544885|FG006|Overall Study|Withdrawal by Subject|0|||
162957033|NCT02057835|588544886|FG007|Overall Study|Withdrawal by Subject|0|||
162957034|NCT02057835|588544887|FG008|Overall Study|Withdrawal by Subject|0|||
162957035|NCT02057835|588544888|FG009|Overall Study|Withdrawal by Subject|0|||
162957036|NCT01376037|588544889|FG000|Overall Study|Lost to Follow-up|0|||
162957037|NCT01376037|588544890|FG001|Overall Study|Lost to Follow-up|2|||
162957038|NCT02328040|588544891|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
162957039|NCT02328040|588544892|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
162957040|NCT03697109|588544893|FG000|Open-label (OL) Phase|Adverse Event|24|||
162957041|NCT03697109|588544894|FG001|Open-label (OL) Phase|Adverse Event|0|||
162957042|NCT03697109|588544895|FG002|Open-label (OL) Phase|Adverse Event|0|||
162957043|NCT03697109|588544893|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
162957044|NCT03697109|588544894|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
162957045|NCT03697109|588544895|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
162957046|NCT03697109|588544893|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
162957047|NCT03697109|588544894|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
162957048|NCT03697109|588544895|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
162957049|NCT03697109|588544893|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
162957050|NCT03697109|588544894|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
162957051|NCT03697109|588544895|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
162957052|NCT03697109|588544893|FG000|Open-label (OL) Phase|Physician Decision|2|||
162957053|NCT03697109|588544894|FG001|Open-label (OL) Phase|Physician Decision|0|||
162957054|NCT03697109|588544895|FG002|Open-label (OL) Phase|Physician Decision|0|||
162957055|NCT03697109|588544893|FG000|Open-label (OL) Phase|Death|2|||
162957056|NCT03697109|588544894|FG001|Open-label (OL) Phase|Death|0|||
162957057|NCT03697109|588544895|FG002|Open-label (OL) Phase|Death|0|||
162957058|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
162957059|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
162957060|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
162957061|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
162957062|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
162957063|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
162957064|NCT03697109|588544893|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
162957065|NCT03697109|588544894|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
162957066|NCT03697109|588544895|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
162957067|NCT02301975|588544899|FG000|Overall Study|Adverse Event|8|||
162957068|NCT02301975|588544900|FG001|Overall Study|Adverse Event|3|||
162957069|NCT02301975|588544901|FG002|Overall Study|Adverse Event|2|||
162957070|NCT02301975|588544899|FG000|Overall Study|Lack of Efficacy|1|||
162957071|NCT02301975|588544900|FG001|Overall Study|Lack of Efficacy|1|||
162957072|NCT02301975|588544901|FG002|Overall Study|Lack of Efficacy|1|||
162957073|NCT02301975|588544899|FG000|Overall Study|Protocol Violation|3|||
162957074|NCT02301975|588544900|FG001|Overall Study|Protocol Violation|5|||
162957075|NCT02301975|588544901|FG002|Overall Study|Protocol Violation|3|||
162957076|NCT02301975|588544899|FG000|Overall Study|Lost to Follow-up|0|||
162957077|NCT02301975|588544900|FG001|Overall Study|Lost to Follow-up|2|||
162957078|NCT02301975|588544901|FG002|Overall Study|Lost to Follow-up|2|||
162957079|NCT02301975|588544899|FG000|Overall Study|Physician Decision|4|||
162957080|NCT02301975|588544900|FG001|Overall Study|Physician Decision|2|||
162957081|NCT02301975|588544901|FG002|Overall Study|Physician Decision|3|||
162957082|NCT02301975|588544899|FG000|Overall Study|Withdrawal by Subject|15|||
162957083|NCT02301975|588544900|FG001|Overall Study|Withdrawal by Subject|12|||
162957084|NCT02301975|588544901|FG002|Overall Study|Withdrawal by Subject|11|||
162957085|NCT00835991|588544902|FG000|First Intervention|Adverse Event|0|||
162957086|NCT00835991|588544903|FG001|First Intervention|Adverse Event|1|||
162957087|NCT00835991|588544902|FG000|Washout|Protocol Violation|0|||
162957088|NCT00835991|588544903|FG001|Washout|Protocol Violation|2|||
162957089|NCT00835991|588544902|FG000|Washout|Withdrawal by Subject|3|||
162957090|NCT00835991|588544903|FG001|Washout|Withdrawal by Subject|1|||
162957091|NCT02149420|588544904|FG000|Core Study|Administrative problems|0|||
162957092|NCT02149420|588544905|FG001|Core Study|Administrative problems|1|||
162957093|NCT02149420|588544906|FG002|Core Study|Administrative problems|2|||
162957094|NCT02149420|588544904|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
162957095|NCT02149420|588544905|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
162957096|NCT02149420|588544906|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
162957097|NCT04278560|588544907|FG000|Overall Study|Adverse Event|1|||
162957098|NCT04278560|588544908|FG001|Overall Study|Adverse Event|2|||
162957099|NCT04278560|588544907|FG000|Overall Study|Withdrawal by Subject|0|||
162860348|NCT02082184|588195714|FG001|Overall Study|Withdrawal by Subject|2|||
162860349|NCT02082184|588195713|FG000|Overall Study|Protocol Violation|0|||
162860350|NCT02082184|588195714|FG001|Overall Study|Protocol Violation|6|||
162860351|NCT02082184|588195713|FG000|Overall Study|Lost to Follow-up|0|||
163044961|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044962|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
163044963|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044964|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
163044965|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044966|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
163044967|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044968|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
163044969|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044970|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
163044971|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044972|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
163044973|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044974|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
163044975|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044976|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
163044977|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044978|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
163044979|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044980|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
163044981|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044982|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
163044983|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044984|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163044985|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044986|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
163044987|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044988|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
163044989|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044990|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
163044991|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044992|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
163044993|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044994|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
163044995|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044996|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
163044997|NCT03538691|588871557|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163044998|NCT03538691|588871558|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
163044999|NCT03538691|588871559|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045000|NCT03538691|588871560|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045001|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
163045002|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
163045003|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
163045004|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
163045005|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
163045006|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
163045007|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
162860352|NCT02082184|588195714|FG001|Overall Study|Lost to Follow-up|2|||
162860353|NCT02082184|588195713|FG000|Overall Study|Subject non-compliance|0|||
162860354|NCT02082184|588195714|FG001|Overall Study|Subject non-compliance|1|||
162860355|NCT01943539|588195717|FG000|Overall Study|Non-compliance with at-home intervention|4|||
162860356|NCT01943539|588195718|FG001|Overall Study|Non-compliance with at-home intervention|0|||
162860357|NCT01362322|588195719|FG000|Overall Study|Withdrawal by Subject|3|||
162860358|NCT01362322|588195720|FG001|Overall Study|Withdrawal by Subject|1|||
162860359|NCT01362322|588195719|FG000|Overall Study|Lost to Follow-up|2|||
162860360|NCT01362322|588195720|FG001|Overall Study|Lost to Follow-up|6|||
162860361|NCT02413398|588195723|FG000|Overall Study|Lost to Follow-up|2|||
162860362|NCT02413398|588195724|FG001|Overall Study|Lost to Follow-up|4|||
162860363|NCT02413398|588195723|FG000|Overall Study|Withdrawal by Subject|1|||
162860364|NCT02413398|588195724|FG001|Overall Study|Withdrawal by Subject|1|||
162957100|NCT04278560|588544908|FG001|Overall Study|Withdrawal by Subject|1|||
162957101|NCT00163657|588544909|FG000|Overall Study|Death|12|||
162957102|NCT00163657|588544910|FG001|Overall Study|Death|14|||
162957103|NCT00163657|588544911|FG002|Overall Study|Death|19|||
162957104|NCT00163657|588544909|FG000|Overall Study|graft loss|4|||
162957105|NCT00163657|588544910|FG001|Overall Study|graft loss|1|||
162957106|NCT00163657|588544911|FG002|Overall Study|graft loss|2|||
162957107|NCT00163657|588544909|FG000|Overall Study|Withdrawal by Subject|2|||
162957108|NCT00163657|588544910|FG001|Overall Study|Withdrawal by Subject|3|||
162957109|NCT00163657|588544911|FG002|Overall Study|Withdrawal by Subject|2|||
162957110|NCT00163657|588544909|FG000|Overall Study|Physician Decision|0|||
162957111|NCT00163657|588544910|FG001|Overall Study|Physician Decision|1|||
162957112|NCT00163657|588544911|FG002|Overall Study|Physician Decision|1|||
162957113|NCT00163657|588544909|FG000|Overall Study|Non Compliance|1|||
162957114|NCT00163657|588544910|FG001|Overall Study|Non Compliance|0|||
162957115|NCT00163657|588544911|FG002|Overall Study|Non Compliance|0|||
162957116|NCT00163657|588544909|FG000|Overall Study|Lost to Follow-up|1|||
162957117|NCT00163657|588544910|FG001|Overall Study|Lost to Follow-up|3|||
162957118|NCT00163657|588544911|FG002|Overall Study|Lost to Follow-up|10|||
162957119|NCT00163657|588544909|FG000|Overall Study|Other reason|0|||
162957120|NCT00163657|588544910|FG001|Overall Study|Other reason|1|||
162613203|NCT02047227|587301138|FG001|Overall Study|No fertilization|51|||
162705547|NCT00372567|587633736|FG002|Phase 3 Study|Global deterioration of health status|0|||
162705548|NCT00372567|587633734|FG000|Phase 3 Study|Other|2|||
162705549|NCT00372567|587633735|FG001|Phase 3 Study|Other|2|||
162705550|NCT00372567|587633736|FG002|Phase 3 Study|Other|1|||
162705551|NCT00372567|587633734|FG000|Phase 3 Study|study terminated by sponsor|13|||
162705552|NCT00372567|587633735|FG001|Phase 3 Study|study terminated by sponsor|8|||
162705553|NCT00372567|587633736|FG002|Phase 3 Study|study terminated by sponsor|5|||
162705554|NCT00953160|587633737|FG000|Overall Study|Lost to Follow-up|23|||
162705555|NCT00953160|587633737|FG000|Overall Study|Withdrawal by Subject|4|||
162705556|NCT03836664|587633740|FG000|Overall Study|Didn't complete forms and lost drug|3|||
162705557|NCT03836664|587633741|FG001|Overall Study|Didn't complete forms and lost drug|3|||
162705558|NCT01427907|587633742|FG000|Overall Study|Withdrawal by Subject|3|||
162705559|NCT01427907|587633743|FG001|Overall Study|Withdrawal by Subject|4|||
162705560|NCT00425503|587633746|FG000|Overall Study|Adverse Event|2|||
162705561|NCT00425503|587633746|FG000|Overall Study|Protocol Violation|1|||
162705562|NCT03278028|587633748|FG000|Overall Study|Lost to Follow-up|1|||
162705563|NCT03278028|587633749|FG001|Overall Study|Lost to Follow-up|0|||
162705564|NCT03278028|587633748|FG000|Overall Study|Withdrawal by Subject|3|||
162705565|NCT03278028|587633749|FG001|Overall Study|Withdrawal by Subject|1|||
162705566|NCT03278028|587633748|FG000|Overall Study|Pregnancy|0|||
162705567|NCT03278028|587633749|FG001|Overall Study|Pregnancy|1|||
162705568|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
162705569|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
162705570|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
162705571|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
162705572|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
162705573|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
162705574|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
162705575|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
162705576|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
162705577|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
162705578|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
162705579|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
162957121|NCT00163657|588544911|FG002|Overall Study|Other reason|3|||
162957122|NCT01319383|588544912|FG000|Overall Study|No ex vivo or in vivo response|4|||
162957123|NCT01319383|588544913|FG001|Overall Study|No ex vivo or in vivo response|0|||
162957124|NCT01319383|588544912|FG000|Overall Study|Physician Decision|3|||
162957125|NCT01319383|588544913|FG001|Overall Study|Physician Decision|0|||
162613204|NCT02047227|587301137|FG000|Overall Study|Intention to freeze all embryos|1|||
162613205|NCT02047227|587301138|FG001|Overall Study|Intention to freeze all embryos|0|||
162613206|NCT02047227|587301137|FG000|Overall Study|All embryos discarded|12|||
162613207|NCT02047227|587301138|FG001|Overall Study|All embryos discarded|11|||
162613208|NCT02047227|587301137|FG000|Overall Study|Other|10|||
162613209|NCT02047227|587301138|FG001|Overall Study|Other|9|||
162613210|NCT01385371|587301151|FG000|Overall Study|Adverse Event|54|||
162613211|NCT01385371|587301152|FG001|Overall Study|Adverse Event|19|||
162613212|NCT01385371|587301151|FG000|Overall Study|Lost to Follow-up|16|||
162613213|NCT01385371|587301152|FG001|Overall Study|Lost to Follow-up|16|||
162613214|NCT01385371|587301151|FG000|Overall Study|Withdrawal by Subject|52|||
162613215|NCT01385371|587301152|FG001|Overall Study|Withdrawal by Subject|39|||
162613216|NCT01385371|587301151|FG000|Overall Study|Protocol Violation|25|||
162613217|NCT01385371|587301152|FG001|Overall Study|Protocol Violation|21|||
162613218|NCT01385371|587301151|FG000|Overall Study|Administrative|2|||
162613219|NCT01385371|587301152|FG001|Overall Study|Administrative|2|||
162860365|NCT02413398|588195723|FG000|Overall Study|Other Eligibility criteria|1|||
162860366|NCT02413398|588195724|FG001|Overall Study|Other Eligibility criteria|2|||
162860367|NCT02158533|588195725|FG000|Stage 1|Adverse Event|6|||
162860368|NCT02158533|588195726|FG001|Stage 1|Adverse Event|4|||
162860369|NCT02158533|588195727|FG002|Stage 1|Adverse Event|7|||
162860370|NCT02158533|588195728|FG003|Stage 1|Adverse Event|0|||
162860371|NCT02158533|588195729|FG004|Stage 1|Adverse Event|0|||
162860372|NCT02158533|588195730|FG005|Stage 1|Adverse Event|0|||
162860373|NCT02158533|588195725|FG000|Stage 1|Withdrawal by Subject|3|||
162860374|NCT02158533|588195726|FG001|Stage 1|Withdrawal by Subject|2|||
162860375|NCT02158533|588195727|FG002|Stage 1|Withdrawal by Subject|1|||
162860376|NCT02158533|588195728|FG003|Stage 1|Withdrawal by Subject|0|||
162860377|NCT02158533|588195729|FG004|Stage 1|Withdrawal by Subject|0|||
162860378|NCT02158533|588195730|FG005|Stage 1|Withdrawal by Subject|0|||
162860379|NCT02158533|588195725|FG000|Stage 1|Lack of Efficacy|1|||
162860380|NCT02158533|588195726|FG001|Stage 1|Lack of Efficacy|0|||
162860381|NCT02158533|588195727|FG002|Stage 1|Lack of Efficacy|0|||
162860382|NCT02158533|588195728|FG003|Stage 1|Lack of Efficacy|0|||
162860383|NCT02158533|588195729|FG004|Stage 1|Lack of Efficacy|0|||
162860384|NCT02158533|588195730|FG005|Stage 1|Lack of Efficacy|0|||
162860385|NCT02158533|588195725|FG000|Stage 1|Lost to Follow-up|3|||
162860386|NCT02158533|588195726|FG001|Stage 1|Lost to Follow-up|1|||
162860387|NCT02158533|588195727|FG002|Stage 1|Lost to Follow-up|0|||
162860388|NCT02158533|588195728|FG003|Stage 1|Lost to Follow-up|0|||
162860389|NCT02158533|588195729|FG004|Stage 1|Lost to Follow-up|0|||
162860390|NCT02158533|588195730|FG005|Stage 1|Lost to Follow-up|0|||
162860391|NCT02158533|588195725|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
162860392|NCT02158533|588195726|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
162860393|NCT02158533|588195727|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
162860394|NCT02158533|588195728|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
162860395|NCT02158533|588195729|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
162860396|NCT02158533|588195730|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
162860397|NCT02158533|588195725|FG000|Stage 1|Non-compliance with study visits|1|||
162860398|NCT02158533|588195726|FG001|Stage 1|Non-compliance with study visits|0|||
162860399|NCT02158533|588195727|FG002|Stage 1|Non-compliance with study visits|0|||
162860400|NCT02158533|588195728|FG003|Stage 1|Non-compliance with study visits|0|||
162860401|NCT02158533|588195729|FG004|Stage 1|Non-compliance with study visits|0|||
162860402|NCT02158533|588195730|FG005|Stage 1|Non-compliance with study visits|0|||
162860403|NCT02158533|588195725|FG000|Stage 2|Adverse Event|0|||
162860404|NCT02158533|588195726|FG001|Stage 2|Adverse Event|0|||
162860405|NCT02158533|588195727|FG002|Stage 2|Adverse Event|0|||
162860406|NCT02158533|588195728|FG003|Stage 2|Adverse Event|0|||
162860407|NCT02158533|588195729|FG004|Stage 2|Adverse Event|0|||
162860408|NCT02158533|588195730|FG005|Stage 2|Adverse Event|1|||
162860409|NCT02158533|588195725|FG000|Stage 2|Lack of Efficacy|0|||
162860410|NCT02158533|588195726|FG001|Stage 2|Lack of Efficacy|0|||
162860411|NCT02158533|588195727|FG002|Stage 2|Lack of Efficacy|0|||
162860412|NCT02158533|588195728|FG003|Stage 2|Lack of Efficacy|0|||
162860413|NCT02158533|588195729|FG004|Stage 2|Lack of Efficacy|1|||
162860414|NCT02158533|588195730|FG005|Stage 2|Lack of Efficacy|0|||
162860415|NCT02158533|588195725|FG000|Stage 2|Lost to Follow-up|0|||
162860416|NCT02158533|588195726|FG001|Stage 2|Lost to Follow-up|0|||
162860417|NCT02158533|588195727|FG002|Stage 2|Lost to Follow-up|0|||
162860418|NCT02158533|588195728|FG003|Stage 2|Lost to Follow-up|1|||
162860419|NCT02158533|588195729|FG004|Stage 2|Lost to Follow-up|1|||
162860420|NCT02158533|588195730|FG005|Stage 2|Lost to Follow-up|2|||
162860421|NCT02158533|588195725|FG000|Stage 2|Withdrawal by Subject|0|||
162860422|NCT02158533|588195726|FG001|Stage 2|Withdrawal by Subject|0|||
162860423|NCT02158533|588195727|FG002|Stage 2|Withdrawal by Subject|0|||
162860424|NCT02158533|588195728|FG003|Stage 2|Withdrawal by Subject|0|||
162860425|NCT02158533|588195729|FG004|Stage 2|Withdrawal by Subject|1|||
162860426|NCT02158533|588195730|FG005|Stage 2|Withdrawal by Subject|2|||
162860427|NCT02158533|588195725|FG000|Stage 2|Physician Decision|0|||
162860428|NCT02158533|588195726|FG001|Stage 2|Physician Decision|0|||
162860429|NCT02158533|588195727|FG002|Stage 2|Physician Decision|0|||
162860430|NCT02158533|588195728|FG003|Stage 2|Physician Decision|0|||
162860431|NCT02158533|588195729|FG004|Stage 2|Physician Decision|1|||
162860432|NCT02158533|588195730|FG005|Stage 2|Physician Decision|0|||
162860433|NCT02158533|588195725|FG000|Stage 2|Pregnancy|0|||
162860434|NCT02158533|588195726|FG001|Stage 2|Pregnancy|0|||
162860435|NCT02158533|588195727|FG002|Stage 2|Pregnancy|0|||
162860436|NCT02158533|588195728|FG003|Stage 2|Pregnancy|1|||
162860437|NCT02158533|588195729|FG004|Stage 2|Pregnancy|0|||
162860438|NCT02158533|588195730|FG005|Stage 2|Pregnancy|0|||
162860439|NCT02158533|588195725|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
162860440|NCT02158533|588195726|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
162860441|NCT02158533|588195727|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
162860442|NCT02158533|588195728|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
162860443|NCT02158533|588195729|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
163045008|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
163045009|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
163045010|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
163045011|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
163045012|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
163045013|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
163045014|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
163045015|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
163045016|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
163045017|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
163045018|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
163045019|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
163045020|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
163045021|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
163045022|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
163045023|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
163045024|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
162860444|NCT02158533|588195730|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
163045025|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
163045026|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
162860445|NCT02158533|588195725|FG000|Stage 2|Non-adherence with study visits|0|||
162860446|NCT02158533|588195726|FG001|Stage 2|Non-adherence with study visits|0|||
162860447|NCT02158533|588195727|FG002|Stage 2|Non-adherence with study visits|0|||
162860448|NCT02158533|588195728|FG003|Stage 2|Non-adherence with study visits|0|||
162860449|NCT02158533|588195729|FG004|Stage 2|Non-adherence with study visits|0|||
162860450|NCT02158533|588195730|FG005|Stage 2|Non-adherence with study visits|1|||
162860451|NCT01925703|588195743|FG000|Overall Study|Physician Decision|1|||
162860452|NCT01925703|588195743|FG000|Overall Study|Lost to Follow-up|2|||
162860453|NCT01925703|588195743|FG000|Overall Study|Discharge prior to full iron repletion|1|||
162860454|NCT01938625|588195744|FG000|Overall Study|Withdrawal by Subject|0|||
162860455|NCT01938625|588195745|FG001|Overall Study|Withdrawal by Subject|1|||
162860456|NCT01938625|588195744|FG000|Overall Study|Adverse Event|0|||
162860457|NCT01938625|588195745|FG001|Overall Study|Adverse Event|1|||
162860458|NCT00091793|588195746|FG000|Overall Study|Adverse Event|1|||
162860459|NCT00091793|588195747|FG001|Overall Study|Adverse Event|2|||
162860460|NCT00091793|588195746|FG000|Overall Study|Withdrawal by Subject|10|||
162860461|NCT00091793|588195747|FG001|Overall Study|Withdrawal by Subject|15|||
162860462|NCT00091793|588195746|FG000|Overall Study|Ineligibility determined|2|||
162860463|NCT00091793|588195747|FG001|Overall Study|Ineligibility determined|0|||
162860464|NCT00091793|588195746|FG000|Overall Study|Lost to Follow-up|7|||
162860465|NCT00091793|588195747|FG001|Overall Study|Lost to Follow-up|5|||
162860466|NCT00091793|588195746|FG000|Overall Study|Noncompliance|2|||
162860467|NCT00091793|588195747|FG001|Overall Study|Noncompliance|0|||
162860468|NCT00091793|588195746|FG000|Overall Study|Other|2|||
162860469|NCT00091793|588195747|FG001|Overall Study|Other|0|||
162860470|NCT00308620|588195748|FG000|Overall Study|Death|1|||
162860471|NCT00308620|588195749|FG001|Overall Study|Death|1|||
162860472|NCT00308620|588195750|FG002|Overall Study|Death|0|||
162860473|NCT00308620|588195748|FG000|Overall Study|Lost to Follow-up|0|||
162860474|NCT00308620|588195749|FG001|Overall Study|Lost to Follow-up|0|||
162860475|NCT00308620|588195750|FG002|Overall Study|Lost to Follow-up|1|||
162860476|NCT02424149|588195754|FG000|Overall Study|surgery cancelled|2|||
162860477|NCT02424149|588195755|FG001|Overall Study|surgery cancelled|0|||
162860478|NCT02424149|588195754|FG000|Overall Study|Withdrawal by Subject|0|||
162860479|NCT02424149|588195755|FG001|Overall Study|Withdrawal by Subject|1|||
162860480|NCT01238120|588195756|FG000|Overall Study|Withdrawal by Subject|4|||
162860481|NCT01238120|588195757|FG001|Overall Study|Withdrawal by Subject|1|||
162860482|NCT01238120|588195758|FG002|Overall Study|Withdrawal by Subject|2|||
162860483|NCT01238120|588195759|FG003|Overall Study|Withdrawal by Subject|5|||
162860484|NCT01238120|588195756|FG000|Overall Study|Lost to Follow-up|2|||
162860485|NCT01238120|588195757|FG001|Overall Study|Lost to Follow-up|0|||
162860486|NCT01238120|588195758|FG002|Overall Study|Lost to Follow-up|1|||
162860487|NCT01238120|588195759|FG003|Overall Study|Lost to Follow-up|1|||
162860488|NCT01238120|588195756|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
162860489|NCT01238120|588195757|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
162860490|NCT01238120|588195758|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
162860491|NCT01238120|588195759|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
162860492|NCT02498652|588195763|FG000|Overall Study|Protocol Violation|0|||
162860493|NCT02498652|588195764|FG001|Overall Study|Protocol Violation|1|||
162860494|NCT01184989|588195769|FG000|Overall Study|Adverse Event|11|||
162860495|NCT01184989|588195769|FG000|Overall Study|Withdrawal by Subject|1|||
162860496|NCT00465569|588195770|FG000|Overall Study|persistent eczema during dose escalation|1|||
163045027|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
163045028|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
163045029|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045030|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045031|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
163045032|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
163045033|NCT03538691|588871557|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045034|NCT03538691|588871558|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
163045035|NCT03538691|588871559|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
163045036|NCT03538691|588871560|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
163045037|NCT00481767|588871562|FG000|Overall Study|Withdrawal by Subject|16|||
163045038|NCT00481767|588871563|FG001|Overall Study|Withdrawal by Subject|11|||
163045039|NCT00481767|588871562|FG000|Overall Study|Lost to Follow-up|16|||
163045040|NCT00481767|588871563|FG001|Overall Study|Lost to Follow-up|10|||
163045041|NCT00636636|588871564|FG000|Overall Study|Other reason|4|||
163045042|NCT00636636|588871565|FG001|Overall Study|Other reason|6|||
163045043|NCT00636636|588871564|FG000|Overall Study|Adverse Event|19|||
163045044|NCT00636636|588871565|FG001|Overall Study|Adverse Event|8|||
163045045|NCT00636636|588871564|FG000|Overall Study|Lack of Efficacy|7|||
163045046|NCT00636636|588871565|FG001|Overall Study|Lack of Efficacy|12|||
163045047|NCT00636636|588871564|FG000|Overall Study|Protocol Violation|2|||
163045048|NCT00636636|588871565|FG001|Overall Study|Protocol Violation|2|||
163045049|NCT00636636|588871564|FG000|Overall Study|Lost to Follow-up|0|||
163045050|NCT00636636|588871565|FG001|Overall Study|Lost to Follow-up|1|||
163045051|NCT00636636|588871564|FG000|Overall Study|Death|0|||
163045052|NCT00636636|588871565|FG001|Overall Study|Death|1|||
163045053|NCT00636636|588871564|FG000|Overall Study|Withdrawal by Subject|4|||
163045054|NCT00636636|588871565|FG001|Overall Study|Withdrawal by Subject|9|||
163045055|NCT00524173|588871566|FG000|Overall Study|Lost to Follow-up|0|||
163045056|NCT00524173|588871567|FG001|Overall Study|Lost to Follow-up|1|||
163045057|NCT00524173|588871566|FG000|Overall Study|Death|1|||
163045058|NCT00524173|588871567|FG001|Overall Study|Death|0|||
163045059|NCT00524173|588871566|FG000|Overall Study|Had not reached endpoint at study close|4|||
163045060|NCT00524173|588871567|FG001|Overall Study|Had not reached endpoint at study close|1|||
163045061|NCT03300180|588871568|FG000|Baseline|Withdrawal by Subject|4|||
163045062|NCT03300180|588871569|FG001|Baseline|Withdrawal by Subject|6|||
163045063|NCT03300180|588871570|FG002|Baseline|Withdrawal by Subject|4|||
163045064|NCT03300180|588871568|FG000|6 Month Outcome|Withdrawal by Subject|12|||
163045065|NCT03300180|588871569|FG001|6 Month Outcome|Withdrawal by Subject|12|||
163045066|NCT03300180|588871570|FG002|6 Month Outcome|Withdrawal by Subject|19|||
163045067|NCT03300180|588871568|FG000|6 Month Outcome|Death|2|||
163045068|NCT03300180|588871569|FG001|6 Month Outcome|Death|4|||
163045069|NCT03300180|588871570|FG002|6 Month Outcome|Death|3|||
163045070|NCT03300180|588871568|FG000|6 Month Outcome|Missed Assessment|43|||
163045071|NCT03300180|588871569|FG001|6 Month Outcome|Missed Assessment|52|||
163045072|NCT03300180|588871570|FG002|6 Month Outcome|Missed Assessment|46|||
163045073|NCT03300180|588871568|FG000|12 Month Outcome|Withdrawal by Subject|3|||
163045074|NCT03300180|588871569|FG001|12 Month Outcome|Withdrawal by Subject|6|||
163045075|NCT03300180|588871570|FG002|12 Month Outcome|Withdrawal by Subject|6|||
163045076|NCT03300180|588871568|FG000|12 Month Outcome|Death|9|||
163045077|NCT03300180|588871569|FG001|12 Month Outcome|Death|6|||
163045078|NCT03300180|588871570|FG002|12 Month Outcome|Death|6|||
163045079|NCT03300180|588871568|FG000|12 Month Outcome|Missed Assessment|62|||
163045080|NCT03300180|588871569|FG001|12 Month Outcome|Missed Assessment|59|||
163045081|NCT03300180|588871570|FG002|12 Month Outcome|Missed Assessment|58|||
163045082|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
163045083|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
163045084|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
163045085|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Death|8|||
163045086|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Death|5|||
163045087|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Death|5|||
163045088|NCT03300180|588871568|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
163045089|NCT03300180|588871569|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
163045090|NCT03300180|588871570|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
163045091|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
163045092|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
163045093|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
163045094|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Death|13|||
163045095|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Death|13|||
163045096|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Death|3|||
163045097|NCT03300180|588871568|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
163045098|NCT03300180|588871569|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
163045099|NCT03300180|588871570|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
163045100|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
163045101|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
163045102|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
163045103|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
163045104|NCT01972464|588871573|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
163045105|NCT01972464|588871574|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
163045106|NCT01972464|588871573|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
163045107|NCT01972464|588871574|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
163045108|NCT01409915|588873092|FG000|Overall Study|Adverse Event|0|||
163045109|NCT01409915|588873093|FG001|Overall Study|Adverse Event|2|||
163045110|NCT01409915|588873092|FG000|Overall Study|Withdrawal by Subject|0|||
163045111|NCT01409915|588873093|FG001|Overall Study|Withdrawal by Subject|1|||
163045112|NCT01409915|588873092|FG000|Overall Study|Protocol Violation|1|||
163045113|NCT01409915|588873093|FG001|Overall Study|Protocol Violation|0|||
163045114|NCT02922153|588873097|FG000|Overall Study|Death|8|||
163045115|NCT02922153|588873098|FG001|Overall Study|Death|1|||
163045116|NCT02922153|588873097|FG000|Overall Study|Lost to Follow-up|1|||
163045117|NCT02922153|588873098|FG001|Overall Study|Lost to Follow-up|0|||
163045118|NCT02922153|588873097|FG000|Overall Study|Physician Decision|1|||
163045119|NCT02922153|588873098|FG001|Overall Study|Physician Decision|1|||
163045120|NCT03506438|588873099|FG000|Overall Study|Lost to Follow-up|8|||
163045121|NCT03506438|588873100|FG001|Overall Study|Lost to Follow-up|7|||
163045122|NCT03506438|588873101|FG002|Overall Study|Lost to Follow-up|8|||
163045123|NCT03506438|588873102|FG003|Overall Study|Lost to Follow-up|7|||
163045124|NCT03506438|588873103|FG004|Overall Study|Lost to Follow-up|0|||
163045125|NCT03506438|588873104|FG005|Overall Study|Lost to Follow-up|0|||
163045126|NCT01128296|588873105|FG000|Overall Study|Physician Decision|0|||
163045127|NCT01128296|588873106|FG001|Overall Study|Physician Decision|0|||
163045128|NCT01128296|588873107|FG002|Overall Study|Physician Decision|0|||
163045129|NCT01128296|588873108|FG003|Overall Study|Physician Decision|0|||
163045130|NCT01128296|588873109|FG004|Overall Study|Physician Decision|0|||
163045131|NCT01128296|588873110|FG005|Overall Study|Physician Decision|3|||
163045132|NCT01128296|588873105|FG000|Overall Study|Withdrawal by Subject|0|||
163045133|NCT01128296|588873106|FG001|Overall Study|Withdrawal by Subject|0|||
163045134|NCT01128296|588873107|FG002|Overall Study|Withdrawal by Subject|0|||
163045135|NCT01128296|588873108|FG003|Overall Study|Withdrawal by Subject|0|||
162860497|NCT00465569|588195771|FG001|Overall Study|persistent eczema during dose escalation|0|||
162860498|NCT00482001|588195773|FG000|Overall Study|Protocol Violation|1|||
162860499|NCT00482001|588195774|FG001|Overall Study|Protocol Violation|1|||
162860500|NCT04786210|588195775|FG000|Overall Study|Lost to Follow-up|2|||
162860501|NCT04786210|588195775|FG000|Overall Study|Withdrawal by Subject|4|||
162860502|NCT03826914|588195776|FG000|Overall Study|Withdrawal by Subject|1|||
162860503|NCT03826914|588195777|FG001|Overall Study|Withdrawal by Subject|1|||
162860504|NCT04334148|588195779|FG000|Overall Study|positive nasal swab at baseline|0|||
162860505|NCT04334148|588195780|FG001|Overall Study|positive nasal swab at baseline|1|||
162860506|NCT05370157|588195781|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
162860507|NCT05370157|588195782|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
162860508|NCT05370157|588195781|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
162860509|NCT05370157|588195782|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
162860510|NCT01508676|588195783|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
162860511|NCT01508676|588195784|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
162860512|NCT01508676|588195783|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
162860513|NCT01508676|588195784|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
162860514|NCT01508676|588195783|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
162860515|NCT01508676|588195784|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
162860516|NCT01508676|588195783|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
162860517|NCT01508676|588195784|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
162860518|NCT01508676|588195783|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
162860519|NCT01508676|588195784|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
162860520|NCT06129487|588195785|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
162860521|NCT06129487|588195786|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
162860522|NCT03772327|588195787|FG000|Overall Study|Lost to Follow-up|3|||
162860523|NCT03772327|588195788|FG001|Overall Study|Lost to Follow-up|4|||
162860524|NCT03772327|588195787|FG000|Overall Study|Withdrawal by Subject|2|||
162860525|NCT03772327|588195788|FG001|Overall Study|Withdrawal by Subject|3|||
163045136|NCT01128296|588873109|FG004|Overall Study|Withdrawal by Subject|0|||
163045137|NCT01128296|588873110|FG005|Overall Study|Withdrawal by Subject|2|||
163045138|NCT01714544|588873111|FG000|Overall Study|Lost to Follow-up|1|||
163045139|NCT01714544|588873111|FG000|Overall Study|Physician Decision|1|||
163045140|NCT01714544|588873111|FG000|Overall Study|Withdrawal by Subject|1|||
163045141|NCT01053741|588873112|FG000|2nd Study Intervention|Physician Decision|0|||
163045142|NCT01053741|588873113|FG001|2nd Study Intervention|Physician Decision|1|||
163045143|NCT00666211|588873114|FG000|Overall Study|Withdrawal by Subject|10|||
163045144|NCT00666211|588873115|FG001|Overall Study|Withdrawal by Subject|13|||
163045145|NCT00666211|588873114|FG000|Overall Study|went off medication, no more pain|1|||
163045146|NCT00666211|588873115|FG001|Overall Study|went off medication, no more pain|0|||
163045147|NCT00666211|588873114|FG000|Overall Study|patient non-compliant|6|||
163045148|NCT00666211|588873115|FG001|Overall Study|patient non-compliant|6|||
163045149|NCT00666211|588873114|FG000|Overall Study|disease progression|1|||
163045150|NCT00666211|588873115|FG001|Overall Study|disease progression|8|||
163045151|NCT00666211|588873114|FG000|Overall Study|Lost to Follow-up|2|||
163045152|NCT00666211|588873115|FG001|Overall Study|Lost to Follow-up|0|||
163045153|NCT00666211|588873114|FG000|Overall Study|toxicity|0|||
163045154|NCT00666211|588873115|FG001|Overall Study|toxicity|2|||
163045155|NCT00666211|588873114|FG000|Overall Study|hospital admission|0|||
163045156|NCT00666211|588873115|FG001|Overall Study|hospital admission|5|||
163045157|NCT00666211|588873114|FG000|Overall Study|Death|0|||
163045158|NCT00666211|588873115|FG001|Overall Study|Death|2|||
163045159|NCT00666211|588873114|FG000|Overall Study|off tx for other complicating disease|0|||
163045160|NCT00666211|588873115|FG001|Overall Study|off tx for other complicating disease|1|||
163045161|NCT00666211|588873114|FG000|Overall Study|Physician Decision|0|||
163045162|NCT00666211|588873115|FG001|Overall Study|Physician Decision|1|||
163045163|NCT00003537|588873124|FG000|Overall Study|Not evalauable|1|||
163045164|NCT01001520|588873125|FG000|Medication Period 1|Withdrawal by Subject|2|||
163045165|NCT01001520|588873126|FG001|Medication Period 1|Withdrawal by Subject|2|||
163045166|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
163045167|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
163045168|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
163045169|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
163045170|NCT01001520|588873125|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
163045171|NCT01001520|588873126|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
163045172|NCT01001520|588873125|FG000|Washout Period|Withdrawal by Subject|2|||
163045173|NCT01001520|588873126|FG001|Washout Period|Withdrawal by Subject|1|||
163045174|NCT01001520|588873125|FG000|Medication Period 2|Withdrawal by Subject|0|||
163045175|NCT01001520|588873126|FG001|Medication Period 2|Withdrawal by Subject|3|||
163045176|NCT04668209|588873127|FG000|Overall Study|Withdrawal by Subject|2|||
163045177|NCT04668209|588873128|FG001|Overall Study|Withdrawal by Subject|2|||
163045178|NCT04668209|588873127|FG000|Overall Study|Lost to Follow-up|3|||
163045179|NCT04668209|588873128|FG001|Overall Study|Lost to Follow-up|4|||
163045180|NCT04668209|588873127|FG000|Overall Study|Subject Expired|2|||
163045181|NCT04668209|588873128|FG001|Overall Study|Subject Expired|0|||
163045182|NCT04668209|588873127|FG000|Overall Study|Withdrawn from study|0|||
163045183|NCT04668209|588873128|FG001|Overall Study|Withdrawn from study|1|||
163045184|NCT04668209|588873127|FG000|Overall Study|Adverse Event|0|||
163045185|NCT04668209|588873128|FG001|Overall Study|Adverse Event|1|||
163045186|NCT01089127|588873130|FG000|Overall Study|Adverse Event|5|||
163045187|NCT01089127|588873131|FG001|Overall Study|Adverse Event|1|||
163045188|NCT01089127|588873132|FG002|Overall Study|Adverse Event|1|||
163045189|NCT01089127|588873133|FG003|Overall Study|Adverse Event|0|||
163045190|NCT01089127|588873134|FG004|Overall Study|Adverse Event|0|||
163045191|NCT01089127|588873135|FG005|Overall Study|Adverse Event|1|||
163045192|NCT01089127|588873130|FG000|Overall Study|Subject withdrew consent|0|||
163045193|NCT01089127|588873131|FG001|Overall Study|Subject withdrew consent|1|||
163045194|NCT01089127|588873132|FG002|Overall Study|Subject withdrew consent|1|||
163045195|NCT01089127|588873133|FG003|Overall Study|Subject withdrew consent|1|||
163045196|NCT01089127|588873134|FG004|Overall Study|Subject withdrew consent|0|||
163045197|NCT01089127|588873135|FG005|Overall Study|Subject withdrew consent|2|||
163045198|NCT01089127|588873130|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163045199|NCT01089127|588873131|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163045200|NCT01089127|588873132|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163045201|NCT01089127|588873133|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163045202|NCT01089127|588873134|FG004|Overall Study|Abnormal test procedure result(s)|0|||
163045203|NCT01089127|588873135|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163045204|NCT01089127|588873130|FG000|Overall Study|Lost to Follow-up|1|||
163045205|NCT01089127|588873131|FG001|Overall Study|Lost to Follow-up|1|||
163045206|NCT01089127|588873132|FG002|Overall Study|Lost to Follow-up|0|||
163045207|NCT01089127|588873133|FG003|Overall Study|Lost to Follow-up|0|||
163045208|NCT01089127|588873134|FG004|Overall Study|Lost to Follow-up|1|||
163045209|NCT01089127|588873135|FG005|Overall Study|Lost to Follow-up|0|||
163045210|NCT01089127|588873130|FG000|Overall Study|Protocol deviation|0|||
163045211|NCT01089127|588873131|FG001|Overall Study|Protocol deviation|1|||
163045212|NCT01089127|588873132|FG002|Overall Study|Protocol deviation|0|||
163045213|NCT01089127|588873133|FG003|Overall Study|Protocol deviation|0|||
163045214|NCT01089127|588873134|FG004|Overall Study|Protocol deviation|1|||
162860526|NCT04689828|588195789|FG000|Overall Study|Subject decision|5|||
162860527|NCT04689828|588195790|FG001|Overall Study|Subject decision|5|||
162860528|NCT04689828|588195789|FG000|Overall Study|Adverse Event|12|||
162860529|NCT04689828|588195790|FG001|Overall Study|Adverse Event|12|||
162860530|NCT04689828|588195789|FG000|Overall Study|Physician Decision|24|||
162860531|NCT04689828|588195790|FG001|Overall Study|Physician Decision|32|||
162860532|NCT04689828|588195789|FG000|Overall Study|Progressive disease|54|||
162860533|NCT04689828|588195790|FG001|Overall Study|Progressive disease|173|||
162860534|NCT04689828|588195789|FG000|Overall Study|Death|0|||
162860535|NCT04689828|588195790|FG001|Overall Study|Death|1|||
162860536|NCT04689828|588195789|FG000|Overall Study|Lost to Follow-up|1|||
162860537|NCT04689828|588195790|FG001|Overall Study|Lost to Follow-up|0|||
162860538|NCT04689828|588195789|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
162860539|NCT04689828|588195790|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
162860540|NCT04689828|588195789|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
162860541|NCT04689828|588195790|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
162860542|NCT04689828|588195789|FG000|Overall Study|Participants not treated|7|||
162860543|NCT04689828|588195790|FG001|Overall Study|Participants not treated|2|||
163045215|NCT01089127|588873135|FG005|Overall Study|Protocol deviation|0|||
162860544|NCT00195351|588195795|FG000|Overall Study|Lost to Follow-up|9|||
162860545|NCT00195351|588195796|FG001|Overall Study|Lost to Follow-up|9|||
162860546|NCT00195351|588195795|FG000|Overall Study|Withdrawal by Subject|6|||
162860547|NCT00195351|588195796|FG001|Overall Study|Withdrawal by Subject|3|||
162860548|NCT00195351|588195795|FG000|Overall Study|Protocol Deviation|3|||
162860549|NCT00195351|588195796|FG001|Overall Study|Protocol Deviation|2|||
162860550|NCT00195351|588195795|FG000|Overall Study|Death|3|||
162860551|NCT00195351|588195796|FG001|Overall Study|Death|1|||
162860552|NCT00195351|588195795|FG000|Overall Study|Lack of Efficacy|0|||
162860553|NCT00195351|588195796|FG001|Overall Study|Lack of Efficacy|1|||
162860554|NCT04332419|588195799|FG000|Overall Study|Withdrawal by Subject|1|||
162860555|NCT02493751|588195800|FG000|Overall Study|Withdrawal by Subject|2|||
162860556|NCT02493751|588195801|FG001|Overall Study|Withdrawal by Subject|8|||
162860557|NCT02493751|588195800|FG000|Overall Study|Death|6|||
162860558|NCT02493751|588195801|FG001|Overall Study|Death|13|||
162860559|NCT02493751|588195800|FG000|Overall Study|Lost to Follow-up|2|||
162860560|NCT02493751|588195801|FG001|Overall Study|Lost to Follow-up|3|||
162860561|NCT02493751|588195800|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
162860562|NCT02493751|588195801|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
162860563|NCT01480180|588195802|FG000|Main Phase|Withdrawal criteria|12|||
162860564|NCT01480180|588195803|FG001|Main Phase|Withdrawal criteria|1|||
162860565|NCT01480180|588195804|FG002|Main Phase|Withdrawal criteria|0|||
162860566|NCT01480180|588195805|FG003|Main Phase|Withdrawal criteria|0|||
162860567|NCT01480180|588195806|FG004|Main Phase|Withdrawal criteria|0|||
162860568|NCT01480180|588195807|FG005|Main Phase|Withdrawal criteria|0|||
162860569|NCT01480180|588195802|FG000|Main Phase|Lack of Efficacy|1|||
162860570|NCT01480180|588195803|FG001|Main Phase|Lack of Efficacy|0|||
162860571|NCT01480180|588195804|FG002|Main Phase|Lack of Efficacy|0|||
162860572|NCT01480180|588195805|FG003|Main Phase|Lack of Efficacy|0|||
162860573|NCT01480180|588195806|FG004|Main Phase|Lack of Efficacy|0|||
162860574|NCT01480180|588195807|FG005|Main Phase|Lack of Efficacy|0|||
162860575|NCT01480180|588195802|FG000|Main Phase|Non-compliance|3|||
162860576|NCT01480180|588195803|FG001|Main Phase|Non-compliance|0|||
162860577|NCT01480180|588195804|FG002|Main Phase|Non-compliance|0|||
162860578|NCT01480180|588195805|FG003|Main Phase|Non-compliance|0|||
162860579|NCT01480180|588195806|FG004|Main Phase|Non-compliance|0|||
162860580|NCT01480180|588195807|FG005|Main Phase|Non-compliance|0|||
162860581|NCT01480180|588195802|FG000|Main Phase|Unclassified|3|||
162860582|NCT01480180|588195803|FG001|Main Phase|Unclassified|0|||
162860583|NCT01480180|588195804|FG002|Main Phase|Unclassified|0|||
162860584|NCT01480180|588195805|FG003|Main Phase|Unclassified|0|||
162860585|NCT01480180|588195806|FG004|Main Phase|Unclassified|0|||
162860586|NCT01480180|588195807|FG005|Main Phase|Unclassified|0|||
162860587|NCT01480180|588195802|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
162860588|NCT01480180|588195803|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
162860589|NCT01480180|588195804|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
162860590|NCT01480180|588195805|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
162860591|NCT01480180|588195806|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
162860592|NCT01480180|588195807|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
162860593|NCT01480180|588195802|FG000|Extension Phase, Part 1|Unclassified|0|||
162860594|NCT01480180|588195803|FG001|Extension Phase, Part 1|Unclassified|0|||
162860595|NCT01480180|588195804|FG002|Extension Phase, Part 1|Unclassified|1|||
162860596|NCT01480180|588195805|FG003|Extension Phase, Part 1|Unclassified|0|||
163045216|NCT00875563|588873137|FG000|Overall Study|Death|4|||
162860597|NCT01480180|588195806|FG004|Extension Phase, Part 1|Unclassified|0|||
162860598|NCT01480180|588195807|FG005|Extension Phase, Part 1|Unclassified|0|||
162860599|NCT01480180|588195802|FG000|Extension Phase, Part 1|Adverse Event|0|||
162860600|NCT01480180|588195803|FG001|Extension Phase, Part 1|Adverse Event|0|||
163045217|NCT00875563|588873137|FG000|Overall Study|Withdrawal by Subject|7|||
163045218|NCT00875563|588873137|FG000|Overall Study|No long-term (3-5 year) consent|6|||
163045219|NCT00875563|588873137|FG000|Overall Study|Still be eligible for follow-up|7|||
163045220|NCT00511810|588873140|FG000|Overall Study|Lost to Follow-up|1|||
163045221|NCT00511810|588873141|FG001|Overall Study|Lost to Follow-up|2|||
163045222|NCT00511810|588873140|FG000|Overall Study|Lack of Efficacy|0|||
163045223|NCT00511810|588873141|FG001|Overall Study|Lack of Efficacy|2|||
163045224|NCT00511810|588873140|FG000|Overall Study|Refused second scn|0|||
163045225|NCT00511810|588873141|FG001|Overall Study|Refused second scn|1|||
163045226|NCT00618826|588873143|FG000|Overall Study|Adverse Event|1|||
163045227|NCT01421641|588873146|FG000|Overall Study|Protocol Violation|2|||
163045228|NCT01421641|588873147|FG001|Overall Study|Protocol Violation|2|||
163045229|NCT03231306|588873148|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
163045230|NCT03231306|588873148|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
163045231|NCT03231306|588873148|FG000|Overall Study|Treatment delay > 21 days|2|||
163045232|NCT03231306|588873148|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
163045233|NCT03231306|588873148|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
163045234|NCT03231306|588873148|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
163045235|NCT03231306|588873148|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
163045236|NCT03231306|588873148|FG000|Overall Study|More than 1 Reason|2|||
163045237|NCT01502033|588873149|FG000|Overall Study|1 participant had scalp discomfort|1|||
163045238|NCT01502033|588873149|FG000|Overall Study|1 participant had worsening depression|1|||
163045239|NCT01502033|588873149|FG000|Overall Study|1 participant went back to school|1|||
163045240|NCT02983045|588873150|FG000|Overall Study|Withdrawal by Subject|0|||
163045241|NCT02983045|588873151|FG001|Overall Study|Withdrawal by Subject|1|||
163045242|NCT02983045|588873152|FG002|Overall Study|Withdrawal by Subject|0|||
163045243|NCT02983045|588873153|FG003|Overall Study|Withdrawal by Subject|5|||
163045244|NCT02983045|588873154|FG004|Overall Study|Withdrawal by Subject|0|||
163045245|NCT02983045|588873155|FG005|Overall Study|Withdrawal by Subject|72|||
163045246|NCT02983045|588873156|FG006|Overall Study|Withdrawal by Subject|0|||
163045247|NCT02983045|588873157|FG007|Overall Study|Withdrawal by Subject|0|||
163045248|NCT02983045|588873158|FG008|Overall Study|Withdrawal by Subject|0|||
163045249|NCT02983045|588873159|FG009|Overall Study|Withdrawal by Subject|2|||
163045250|NCT02983045|588873150|FG000|Overall Study|Lost to Follow-up|0|||
163045251|NCT02983045|588873151|FG001|Overall Study|Lost to Follow-up|0|||
163045252|NCT02983045|588873152|FG002|Overall Study|Lost to Follow-up|0|||
163045253|NCT02983045|588873153|FG003|Overall Study|Lost to Follow-up|0|||
163045254|NCT02983045|588873154|FG004|Overall Study|Lost to Follow-up|0|||
163045255|NCT02983045|588873155|FG005|Overall Study|Lost to Follow-up|10|||
162705580|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
162705581|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
162705582|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
162705583|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
162705584|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
162705585|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
162705586|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
162705587|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
162705588|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
162705589|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
162705590|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
162705591|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
162705592|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
162705593|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
162705594|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
162705595|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
162705596|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
162705597|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
162705598|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163045256|NCT02983045|588873156|FG006|Overall Study|Lost to Follow-up|0|||
163045257|NCT02983045|588873157|FG007|Overall Study|Lost to Follow-up|0|||
163045258|NCT02983045|588873158|FG008|Overall Study|Lost to Follow-up|0|||
163045259|NCT02983045|588873159|FG009|Overall Study|Lost to Follow-up|0|||
162705599|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
162705600|NCT03890120|587633751|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
162705601|NCT03890120|587633752|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
162705602|NCT03890120|587633753|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163045260|NCT01808261|588873160|FG000|Overall Study|Physician Decision|0|||
163045261|NCT01808261|588873161|FG001|Overall Study|Physician Decision|2|||
162705603|NCT03890120|587633754|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
162957126|NCT01319383|588544912|FG000|Overall Study|Lack of Efficacy|5|||
162957127|NCT01319383|588544913|FG001|Overall Study|Lack of Efficacy|9|||
162957128|NCT01319383|588544912|FG000|Overall Study|No in vivo response to interval doses|0|||
162957129|NCT01319383|588544913|FG001|Overall Study|No in vivo response to interval doses|1|||
162957130|NCT01531894|588544916|FG000|Overall Study|Physician Decision|8|||
162957131|NCT01531894|588544916|FG000|Overall Study|Death|1|||
162957132|NCT03635320|588544922|FG000|Overall Study|not implanted the device|1|||
162957133|NCT03635320|588544923|FG001|Overall Study|not implanted the device|2|||
162957134|NCT03635320|588544922|FG000|Overall Study|Withdrawal by Subject|11|||
162957135|NCT03635320|588544923|FG001|Overall Study|Withdrawal by Subject|6|||
162957136|NCT01558635|588544924|FG000|Overall Study|Death|1|||
162957137|NCT01558635|588544924|FG000|Overall Study|Withdrawal by Subject|2|||
162957138|NCT01558635|588544924|FG000|Overall Study|Physician Decision|1|||
162957139|NCT01558635|588544924|FG000|Overall Study|Subject received other treatment|1|||
162957140|NCT01558635|588544924|FG000|Overall Study|Reveal XT was explanted|1|||
162957141|NCT03868891|588544927|FG000|Overall Study|Adverse Event|1|||
162957142|NCT03868891|588544928|FG001|Overall Study|Adverse Event|0|||
162957143|NCT03868891|588544927|FG000|Overall Study|Lost to Follow-up|2|||
162957144|NCT03868891|588544928|FG001|Overall Study|Lost to Follow-up|1|||
162957145|NCT03868891|588544927|FG000|Overall Study|COVID-19 Restrictions|1|||
162957146|NCT03868891|588544928|FG001|Overall Study|COVID-19 Restrictions|2|||
162957147|NCT01158118|588544929|FG000|Overall Study|Screen failure|1|||
162957148|NCT01158118|588544930|FG001|Overall Study|Screen failure|0|||
162957149|NCT01158118|588544929|FG000|Overall Study|Donor match was a screen failure|0|||
162957150|NCT01158118|588544930|FG001|Overall Study|Donor match was a screen failure|1|||
162957151|NCT01158118|588544929|FG000|Overall Study|Suffered stroke prior to transplant|0|||
162957152|NCT01158118|588544930|FG001|Overall Study|Suffered stroke prior to transplant|1|||
162957153|NCT01158118|588544929|FG000|Overall Study|Death|0|||
162957154|NCT01158118|588544930|FG001|Overall Study|Death|1|||
162957155|NCT04994535|588544931|FG000|Overall Study|Lost to Follow-up|7|||
162957156|NCT04994535|588544932|FG001|Overall Study|Lost to Follow-up|7|||
162957157|NCT04994535|588544931|FG000|Overall Study|Withdrawal by Subject|10|||
162957158|NCT04994535|588544932|FG001|Overall Study|Withdrawal by Subject|7|||
162957159|NCT04994535|588544931|FG000|Overall Study|Other|1|||
162957160|NCT04994535|588544932|FG001|Overall Study|Other|1|||
162957161|NCT00604162|588544933|FG000|Overall Study|Physician Decision|3|||
162957162|NCT00604162|588544933|FG000|Overall Study|Withdrawal by Subject|1|||
162957163|NCT02246920|588544935|FG000|Overall Study|Adverse Event|3|||
162957164|NCT02246920|588544936|FG001|Overall Study|Adverse Event|1|||
162957165|NCT02246920|588544937|FG002|Overall Study|Adverse Event|1|||
162957166|NCT02246920|588544935|FG000|Overall Study|Lost to Follow-up|2|||
162957167|NCT02246920|588544936|FG001|Overall Study|Lost to Follow-up|1|||
162957168|NCT02246920|588544937|FG002|Overall Study|Lost to Follow-up|0|||
162957169|NCT02246920|588544935|FG000|Overall Study|Protocol Violation|2|||
162957170|NCT02246920|588544936|FG001|Overall Study|Protocol Violation|5|||
162957171|NCT02246920|588544937|FG002|Overall Study|Protocol Violation|1|||
162957172|NCT02246920|588544935|FG000|Overall Study|Withdrawal by Subject|0|||
162957173|NCT02246920|588544936|FG001|Overall Study|Withdrawal by Subject|0|||
162957174|NCT02246920|588544937|FG002|Overall Study|Withdrawal by Subject|1|||
162957175|NCT00960297|588544941|FG000|Overall Study|Physician Decision|1|||
162957176|NCT00960297|588544941|FG000|Overall Study|Venous port infection|1|||
162957177|NCT00960297|588544941|FG000|Overall Study|Disease progression|1|||
162957178|NCT03247972|588544942|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
162957179|NCT03247972|588544942|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
162957180|NCT00968812|588544943|FG000|Overall Study|Adverse Event|30|||
162957181|NCT00968812|588544944|FG001|Overall Study|Adverse Event|46|||
162957182|NCT00968812|588544945|FG002|Overall Study|Adverse Event|33|||
162957183|NCT00968812|588544943|FG000|Overall Study|Death|2|||
162957184|NCT00968812|588544944|FG001|Overall Study|Death|2|||
162957185|NCT00968812|588544945|FG002|Overall Study|Death|1|||
162957186|NCT00968812|588544943|FG000|Overall Study|Lack of Efficacy|9|||
162957187|NCT00968812|588544944|FG001|Overall Study|Lack of Efficacy|7|||
162957188|NCT00968812|588544945|FG002|Overall Study|Lack of Efficacy|16|||
162957189|NCT00968812|588544943|FG000|Overall Study|Lost to Follow-up|17|||
162957190|NCT00968812|588544944|FG001|Overall Study|Lost to Follow-up|12|||
162957191|NCT00968812|588544945|FG002|Overall Study|Lost to Follow-up|11|||
162957192|NCT00968812|588544943|FG000|Overall Study|Physician Decision|8|||
162957193|NCT00968812|588544944|FG001|Overall Study|Physician Decision|5|||
162957194|NCT00968812|588544945|FG002|Overall Study|Physician Decision|9|||
162957195|NCT00968812|588544943|FG000|Overall Study|Protocol Violation|7|||
162957196|NCT00968812|588544944|FG001|Overall Study|Protocol Violation|4|||
162957197|NCT00968812|588544945|FG002|Overall Study|Protocol Violation|3|||
162957198|NCT00968812|588544943|FG000|Overall Study|Withdrawal by Subject|17|||
162957199|NCT00968812|588544944|FG001|Overall Study|Withdrawal by Subject|23|||
163045262|NCT01808261|588873160|FG000|Overall Study|Study Closed/Terminated|25|||
163045263|NCT01808261|588873161|FG001|Overall Study|Study Closed/Terminated|23|||
163045264|NCT01808261|588873160|FG000|Overall Study|Adverse event, non-fatal|2|||
163045265|NCT01808261|588873161|FG001|Overall Study|Adverse event, non-fatal|0|||
163045266|NCT01808261|588873160|FG000|Overall Study|Consent withdrawn by subject|6|||
163045267|NCT01808261|588873161|FG001|Overall Study|Consent withdrawn by subject|7|||
163045268|NCT01808261|588873160|FG000|Overall Study|Lost to Follow-up|3|||
163045269|NCT01808261|588873161|FG001|Overall Study|Lost to Follow-up|1|||
163045270|NCT02585713|588873162|FG000|Overall Study|Withdrew prior to treatment|2|||
163045271|NCT02585713|588873163|FG001|Overall Study|Withdrew prior to treatment|7|||
163045272|NCT02585713|588873162|FG000|Overall Study|Other|3|||
163045273|NCT02585713|588873163|FG001|Overall Study|Other|1|||
163045274|NCT02609984|588873166|FG000|Overall Study|Death|29|||
163045275|NCT02609984|588873167|FG001|Overall Study|Death|26|||
163045276|NCT02609984|588873166|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
163045277|NCT02609984|588873167|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
163045278|NCT02609984|588873166|FG000|Overall Study|Lost to Follow-up|1|||
163045279|NCT02609984|588873167|FG001|Overall Study|Lost to Follow-up|2|||
163045280|NCT02609984|588873166|FG000|Overall Study|Withdrawal by Subject|0|||
163045281|NCT02609984|588873167|FG001|Overall Study|Withdrawal by Subject|1|||
163045282|NCT02609984|588873166|FG000|Overall Study|Disease Progression|2|||
163045283|NCT02609984|588873167|FG001|Overall Study|Disease Progression|0|||
163045284|NCT02080364|588873168|FG000|Baseline Period|Protocol Violation|2|||
163045285|NCT02080364|588873169|FG001|Baseline Period|Protocol Violation|1|||
163045286|NCT02080364|588873170|FG002|Baseline Period|Protocol Violation|0|||
163045287|NCT02080364|588873171|FG003|Baseline Period|Protocol Violation|0|||
163045288|NCT02080364|588873168|FG000|Baseline Period|Other|0|||
163045289|NCT02080364|588873169|FG001|Baseline Period|Other|1|||
163045290|NCT02080364|588873170|FG002|Baseline Period|Other|1|||
163045291|NCT02080364|588873171|FG003|Baseline Period|Other|0|||
163045292|NCT02080364|588873168|FG000|Treatment Period|Adverse Event|10|||
162860601|NCT01480180|588195804|FG002|Extension Phase, Part 1|Adverse Event|4|||
162860602|NCT01480180|588195805|FG003|Extension Phase, Part 1|Adverse Event|1|||
162860603|NCT01480180|588195806|FG004|Extension Phase, Part 1|Adverse Event|0|||
162860604|NCT01480180|588195807|FG005|Extension Phase, Part 1|Adverse Event|0|||
162860605|NCT01480180|588195802|FG000|Extension Phase, Part 1|Change of treatment|0|||
162860606|NCT01480180|588195803|FG001|Extension Phase, Part 1|Change of treatment|0|||
162860607|NCT01480180|588195804|FG002|Extension Phase, Part 1|Change of treatment|0|||
162860608|NCT01480180|588195805|FG003|Extension Phase, Part 1|Change of treatment|9|||
162860609|NCT01480180|588195806|FG004|Extension Phase, Part 1|Change of treatment|0|||
162860610|NCT01480180|588195807|FG005|Extension Phase, Part 1|Change of treatment|0|||
162860611|NCT01480180|588195802|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
162860612|NCT01480180|588195803|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
162860613|NCT01480180|588195804|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
162860614|NCT01480180|588195805|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
162860615|NCT01480180|588195806|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
162860616|NCT01480180|588195807|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
162860617|NCT01480180|588195802|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
162860618|NCT01480180|588195803|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
162860619|NCT01480180|588195804|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
162860620|NCT01480180|588195805|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
162860621|NCT01480180|588195806|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
162860622|NCT01480180|588195807|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
162860623|NCT01480180|588195802|FG000|Extension Phase, Part 2|Unclassified|0|||
162860624|NCT01480180|588195803|FG001|Extension Phase, Part 2|Unclassified|0|||
162860625|NCT01480180|588195804|FG002|Extension Phase, Part 2|Unclassified|3|||
162860626|NCT01480180|588195805|FG003|Extension Phase, Part 2|Unclassified|1|||
162860627|NCT01480180|588195806|FG004|Extension Phase, Part 2|Unclassified|1|||
162860628|NCT01480180|588195807|FG005|Extension Phase, Part 2|Unclassified|0|||
162860629|NCT00519623|588195808|FG000|Overall Study|Adverse Event|1|||
162860630|NCT04222725|588195811|FG000|Overall Study|Adverse Event|0|||
162860631|NCT04222725|588195812|FG001|Overall Study|Adverse Event|1|||
162860632|NCT04222725|588195813|FG002|Overall Study|Adverse Event|0|||
162860633|NCT04222725|588195814|FG003|Overall Study|Adverse Event|0|||
163045293|NCT02080364|588873169|FG001|Treatment Period|Adverse Event|15|||
163045294|NCT02080364|588873170|FG002|Treatment Period|Adverse Event|11|||
163045295|NCT02080364|588873171|FG003|Treatment Period|Adverse Event|14|||
163045296|NCT02080364|588873168|FG000|Treatment Period|Lost to Follow-up|2|||
163045297|NCT02080364|588873169|FG001|Treatment Period|Lost to Follow-up|3|||
162613220|NCT01090973|587301157|FG000|Overall Study|Disease progression|1|||
162613221|NCT00445978|587301160|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
162860634|NCT03819140|588195815|FG000|Overall Study|Lost to Follow-up|1|||
162860635|NCT03819140|588195816|FG001|Overall Study|Lost to Follow-up|2|||
163045298|NCT02080364|588873170|FG002|Treatment Period|Lost to Follow-up|5|||
163045299|NCT02080364|588873171|FG003|Treatment Period|Lost to Follow-up|0|||
163045300|NCT02080364|588873168|FG000|Treatment Period|Protocol Violation|5|||
162860636|NCT03819140|588195815|FG000|Overall Study|Withdrawal by Subject|3|||
162860637|NCT03819140|588195816|FG001|Overall Study|Withdrawal by Subject|2|||
162860638|NCT03819140|588195815|FG000|Overall Study|Adverse Event|0|||
162860639|NCT03819140|588195816|FG001|Overall Study|Adverse Event|1|||
162860640|NCT03819140|588195815|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
162860641|NCT03819140|588195816|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
162860642|NCT03819140|588195815|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
162860643|NCT03819140|588195816|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
162860644|NCT00104871|588195817|FG000|Overall Study|Not evaluable|1|||
162860645|NCT00658333|588195818|FG000|Overall Study|Adverse Event|2|||
162860646|NCT00658333|588195819|FG001|Overall Study|Adverse Event|1|||
162860647|NCT00828451|588195822|FG000|Overall Study|Death|2|||
162860648|NCT00828451|588195822|FG000|Overall Study|Lack of intravenous line|7|||
162860649|NCT00828451|588195822|FG000|Overall Study|Withdrawal by Subject|1|||
162860650|NCT00828451|588195822|FG000|Overall Study|Deterioration in clinical status|1|||
162860651|NCT03256539|588195823|FG000|Overall Study|Withdrawal by Subject|0|||
162860652|NCT03256539|588195824|FG001|Overall Study|Withdrawal by Subject|3|||
162860653|NCT03256539|588195823|FG000|Overall Study|Unexpected closure of study components|8|||
162860654|NCT03256539|588195824|FG001|Overall Study|Unexpected closure of study components|4|||
162860655|NCT05755438|588195827|FG000|12-week DBVC Period|Adverse Event|4|||
162860656|NCT05755438|588195828|FG001|12-week DBVC Period|Adverse Event|1|||
162860657|NCT05755438|588195827|FG000|12-week DBVC Period|Physician Decision|1|||
162860658|NCT05755438|588195828|FG001|12-week DBVC Period|Physician Decision|1|||
162860659|NCT05755438|588195827|FG000|12-week DBVC Period|Protocol Violation|4|||
162860660|NCT05755438|588195828|FG001|12-week DBVC Period|Protocol Violation|2|||
162860661|NCT05755438|588195827|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
162860662|NCT05755438|588195828|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
162860663|NCT05755438|588195827|FG000|12-week DBVC Period|Sponsor Decision|1|||
162860664|NCT05755438|588195828|FG001|12-week DBVC Period|Sponsor Decision|0|||
162860665|NCT05755438|588195827|FG000|40-week OLE Period|Adverse Event|0|||
162860666|NCT05755438|588195828|FG001|40-week OLE Period|Adverse Event|2|||
162860667|NCT05755438|588195827|FG000|40-week OLE Period|Lack of Efficacy|1|||
162860668|NCT05755438|588195828|FG001|40-week OLE Period|Lack of Efficacy|1|||
162860669|NCT05755438|588195827|FG000|40-week OLE Period|Lost to Follow-up|1|||
162860670|NCT05755438|588195828|FG001|40-week OLE Period|Lost to Follow-up|0|||
162860671|NCT05755438|588195827|FG000|40-week OLE Period|Physician Decision|1|||
162860672|NCT05755438|588195828|FG001|40-week OLE Period|Physician Decision|1|||
162860673|NCT05755438|588195827|FG000|40-week OLE Period|Protocol Violation|1|||
162860674|NCT05755438|588195828|FG001|40-week OLE Period|Protocol Violation|1|||
162860675|NCT05755438|588195827|FG000|40-week OLE Period|Withdrawal by Subject|6|||
162860676|NCT05755438|588195828|FG001|40-week OLE Period|Withdrawal by Subject|6|||
162860677|NCT05755438|588195827|FG000|40-week OLE Period|Sponsor Decision|3|||
162860678|NCT05755438|588195828|FG001|40-week OLE Period|Sponsor Decision|0|||
162860679|NCT05755438|588195827|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
162860680|NCT05755438|588195828|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
162860681|NCT05755438|588195827|FG000|40-week OLE Period|Ongoing|46|||
162860682|NCT05755438|588195828|FG001|40-week OLE Period|Ongoing|58|||
162860683|NCT01548638|588195833|FG000|Overall Study|Protocol Violation|3|||
162860684|NCT01548638|588195833|FG000|Overall Study|Withdrawal by Subject|1|||
162860685|NCT01476787|588195835|FG000|Treatment|Progression|64|||
162860686|NCT01476787|588195836|FG001|Treatment|Progression|71|||
162860687|NCT01476787|588195835|FG000|Treatment|Toxicity|44|||
162860688|NCT01476787|588195836|FG001|Treatment|Toxicity|16|||
162860689|NCT01476787|588195835|FG000|Treatment|Death|0|||
162860690|NCT01476787|588195836|FG001|Treatment|Death|1|||
162860691|NCT01476787|588195835|FG000|Treatment|Withdrawal by Subject|3|||
162860692|NCT01476787|588195836|FG001|Treatment|Withdrawal by Subject|14|||
162860693|NCT01476787|588195835|FG000|Treatment|Major protocol violation|1|||
162860694|NCT01476787|588195836|FG001|Treatment|Major protocol violation|6|||
162860695|NCT01476787|588195835|FG000|Treatment|Other reasons|10|||
162860696|NCT01476787|588195836|FG001|Treatment|Other reasons|22|||
162860697|NCT01476787|588195835|FG000|Treatment|Concurrent illness|12|||
162860698|NCT01476787|588195836|FG001|Treatment|Concurrent illness|9|||
162860699|NCT01476787|588195835|FG000|Treatment|Insufficient response|15|||
162860700|NCT01476787|588195836|FG001|Treatment|Insufficient response|3|||
162860701|NCT01476787|588195835|FG000|Treatment|Voluntary treatment discontinuation|8|||
162860702|NCT01476787|588195836|FG001|Treatment|Voluntary treatment discontinuation|4|||
162860703|NCT04070378|588195845|FG000|Overall Study|Withdrawal by Subject|2|||
162860704|NCT04070378|588195845|FG000|Overall Study|Screen Failure|6|||
162860705|NCT04070378|588195845|FG000|Overall Study|Physician Decision|1|||
162860706|NCT04070378|588195845|FG000|Overall Study|Adverse Event|1|||
162860707|NCT00443560|588197458|FG000|Overall Study|No intrathecal dose|58|||
162860708|NCT00443560|588197459|FG001|Overall Study|No intrathecal dose|26|||
162860709|NCT00443560|588197458|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
162860710|NCT00443560|588197459|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
162860711|NCT01494038|588197464|FG000|Overall Study|Protocol Violation|1|||
162860712|NCT01494038|588197465|FG001|Overall Study|Protocol Violation|1|||
162860713|NCT01494038|588197464|FG000|Overall Study|Lost to Follow-up|18|||
162860714|NCT01494038|588197465|FG001|Overall Study|Lost to Follow-up|20|||
163045301|NCT02080364|588873169|FG001|Treatment Period|Protocol Violation|3|||
163045302|NCT02080364|588873170|FG002|Treatment Period|Protocol Violation|5|||
163045303|NCT02080364|588873171|FG003|Treatment Period|Protocol Violation|1|||
163045304|NCT02080364|588873168|FG000|Treatment Period|Withdrawal by Subject|16|||
163045305|NCT02080364|588873169|FG001|Treatment Period|Withdrawal by Subject|16|||
163045306|NCT02080364|588873170|FG002|Treatment Period|Withdrawal by Subject|15|||
163045307|NCT02080364|588873171|FG003|Treatment Period|Withdrawal by Subject|10|||
163045308|NCT02080364|588873168|FG000|Treatment Period|Study Terminated by Sponsor|0|||
163045309|NCT02080364|588873169|FG001|Treatment Period|Study Terminated by Sponsor|0|||
163045310|NCT02080364|588873170|FG002|Treatment Period|Study Terminated by Sponsor|180|||
163045311|NCT02080364|588873171|FG003|Treatment Period|Study Terminated by Sponsor|183|||
163045312|NCT02080364|588873168|FG000|Treatment Period|Other|14|||
163045313|NCT02080364|588873169|FG001|Treatment Period|Other|12|||
163045314|NCT02080364|588873170|FG002|Treatment Period|Other|21|||
163045315|NCT02080364|588873171|FG003|Treatment Period|Other|16|||
163045316|NCT00991289|588873172|FG000|Overall Study|Adverse Event|1|||
163045317|NCT00991289|588873172|FG000|Overall Study|Physician Decision|2|||
163045318|NCT00991289|588873172|FG000|Overall Study|Withdrawal by Subject|3|||
163045319|NCT00991289|588873172|FG000|Overall Study|Lost to Follow-up|4|||
163045320|NCT00991289|588873172|FG000|Overall Study|Protocol Violation|2|||
163045321|NCT02256839|588873174|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
163045322|NCT02256839|588873175|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
162860715|NCT01494038|588197464|FG000|Overall Study|Withdrawal by Subject|44|||
162860716|NCT01494038|588197465|FG001|Overall Study|Withdrawal by Subject|34|||
162860717|NCT01494038|588197464|FG000|Overall Study|Not able to get to clinic|21|||
162860718|NCT01494038|588197465|FG001|Overall Study|Not able to get to clinic|15|||
162860719|NCT01494038|588197464|FG000|Overall Study|Not willing to adhere to reqs|2|||
162860720|NCT01494038|588197465|FG001|Overall Study|Not willing to adhere to reqs|9|||
162860721|NCT01494038|588197464|FG000|Overall Study|Death|2|||
162860722|NCT01494038|588197465|FG001|Overall Study|Death|4|||
162860723|NCT00537940|588197466|FG000|Overall Study|Adverse Event|20|||
162860724|NCT00537940|588197467|FG001|Overall Study|Adverse Event|19|||
162860725|NCT00537940|588197466|FG000|Overall Study|Lack of Efficacy|8|||
162860726|NCT00537940|588197467|FG001|Overall Study|Lack of Efficacy|16|||
162860727|NCT00537940|588197466|FG000|Overall Study|Lost to Follow-up|23|||
162860728|NCT00537940|588197467|FG001|Overall Study|Lost to Follow-up|29|||
162860729|NCT00537940|588197466|FG000|Overall Study|Withdrawal by Subject|113|||
162860730|NCT00537940|588197467|FG001|Overall Study|Withdrawal by Subject|95|||
162860731|NCT00537940|588197466|FG000|Overall Study|Protocol Violation|6|||
162860732|NCT00537940|588197467|FG001|Overall Study|Protocol Violation|4|||
162860733|NCT00537940|588197466|FG000|Overall Study|Pregnancy|1|||
162860734|NCT00537940|588197467|FG001|Overall Study|Pregnancy|1|||
162860735|NCT00537940|588197466|FG000|Overall Study|Study terminated by sponsor|2|||
162860736|NCT00537940|588197467|FG001|Overall Study|Study terminated by sponsor|3|||
162860737|NCT00537940|588197466|FG000|Overall Study|Other|10|||
162860738|NCT00537940|588197467|FG001|Overall Study|Other|12|||
162860739|NCT03715465|588197471|FG000|Overall Study|Withdrawal by Subject|1|||
162860740|NCT03715465|588197472|FG001|Overall Study|Withdrawal by Subject|2|||
162860741|NCT02138110|588197474|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
162860742|NCT02138110|588197474|FG000|Overall Scaffold Implantation|Death|3|||
162860743|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
162860744|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
162860745|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
162860746|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
162860747|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
162860748|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
162860749|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
162860750|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
162860751|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
162860752|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
162860753|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
162860754|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
162860755|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
163045323|NCT01843803|588873176|FG000|Overall Study|not a Veteran, did not see provider|1|||
162860756|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
163045324|NCT01843803|588873177|FG001|Overall Study|not a Veteran, did not see provider|3|||
163045325|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Adverse Event|2|||
162860757|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
163045326|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Adverse Event|0|||
163045327|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Adverse Event|0|||
163045328|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Adverse Event|0|||
162705604|NCT03890120|587633751|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
162705605|NCT03890120|587633752|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
162705606|NCT03890120|587633753|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
162705607|NCT03890120|587633754|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
162705608|NCT03890120|587633751|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
162705609|NCT03890120|587633752|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
162705610|NCT03890120|587633753|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
162705611|NCT03890120|587633754|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
162705612|NCT03890120|587633751|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162705613|NCT03890120|587633752|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162705614|NCT03890120|587633753|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162705615|NCT03890120|587633754|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
162705616|NCT03890120|587633751|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162705617|NCT03890120|587633752|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162705618|NCT03890120|587633753|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
162705619|NCT03890120|587633754|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162705620|NCT01052662|587633755|FG000|Overall Study|Lost to Follow-up|15|||
162705621|NCT01052662|587633756|FG001|Overall Study|Lost to Follow-up|13|||
162705622|NCT01052662|587633757|FG002|Overall Study|Lost to Follow-up|18|||
162705623|NCT01052662|587633755|FG000|Overall Study|Withdrawal by Subject|3|||
162705624|NCT01052662|587633756|FG001|Overall Study|Withdrawal by Subject|2|||
162705625|NCT01052662|587633757|FG002|Overall Study|Withdrawal by Subject|1|||
162705626|NCT01052662|587633755|FG000|Overall Study|Pharmacy issue|1|||
162705627|NCT01052662|587633756|FG001|Overall Study|Pharmacy issue|3|||
162705628|NCT01052662|587633757|FG002|Overall Study|Pharmacy issue|3|||
162705629|NCT01052662|587633755|FG000|Overall Study|Adverse Event|1|||
162705630|NCT01052662|587633756|FG001|Overall Study|Adverse Event|1|||
162705631|NCT01052662|587633757|FG002|Overall Study|Adverse Event|0|||
162705632|NCT01052662|587633755|FG000|Overall Study|Legal Problem|2|||
162705633|NCT01052662|587633756|FG001|Overall Study|Legal Problem|0|||
162705634|NCT01052662|587633757|FG002|Overall Study|Legal Problem|0|||
162705635|NCT01052662|587633755|FG000|Overall Study|Administrative|0|||
162705636|NCT01052662|587633756|FG001|Overall Study|Administrative|3|||
162705637|NCT01052662|587633757|FG002|Overall Study|Administrative|0|||
162705638|NCT00479674|587633758|FG000|Overall Study|Adverse Event|18|||
162705639|NCT00479674|587633758|FG000|Overall Study|Withdrawal by Subject|6|||
162705640|NCT00479674|587633758|FG000|Overall Study|Physician Decision|14|||
162705641|NCT00479674|587633758|FG000|Overall Study|none provided|3|||
162705642|NCT02478359|587633760|FG000|Overall Study|Disenrolled from health plan|106|||
162705643|NCT02478359|587633761|FG001|Overall Study|Disenrolled from health plan|65|||
162705644|NCT03293485|587633763|FG000|Overall Study|Death|1|||
162705645|NCT03293485|587633763|FG000|Overall Study|Screen Failure|2|||
162705646|NCT03293485|587633763|FG000|Overall Study|Withdrawal by Subject|2|||
162705647|NCT01818700|587633764|FG000|Overall Study|Adverse Event|67|||
162705648|NCT01818700|587633764|FG000|Overall Study|Lack of Efficacy|2|||
162705649|NCT01818700|587633764|FG000|Overall Study|Lost to Follow-up|5|||
162705650|NCT01818700|587633764|FG000|Overall Study|Withdrawal by Subject|27|||
162705651|NCT01818700|587633764|FG000|Overall Study|Protocol Violation|2|||
162705652|NCT01818700|587633764|FG000|Overall Study|Other|1|||
162705653|NCT01627340|587633767|FG000|Overall Study|Adverse Event|1|||
162705654|NCT01627340|587633768|FG001|Overall Study|Adverse Event|0|||
162705655|NCT01627340|587633767|FG000|Overall Study|Lost to Follow-up|8|||
162705656|NCT01627340|587633768|FG001|Overall Study|Lost to Follow-up|4|||
162705657|NCT01627340|587633767|FG000|Overall Study|Pregnancy|1|||
162705658|NCT01627340|587633768|FG001|Overall Study|Pregnancy|0|||
162705659|NCT01627340|587633767|FG000|Overall Study|Withdrawal by Subject|2|||
162705660|NCT01627340|587633768|FG001|Overall Study|Withdrawal by Subject|0|||
162705661|NCT01272011|587633769|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
162705662|NCT01272011|587633770|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
162705663|NCT01272011|587633771|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
162705664|NCT02240680|587633774|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
162705665|NCT02240680|587633775|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
162705666|NCT02240680|587633776|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
162705667|NCT02240680|587633777|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
162705668|NCT02240680|587633774|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
162705669|NCT02240680|587633775|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
162705670|NCT02240680|587633776|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
162705671|NCT02240680|587633777|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
162705672|NCT02240680|587633774|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
162705673|NCT02240680|587633775|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162705674|NCT02240680|587633776|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162957200|NCT00968812|588544945|FG002|Overall Study|Withdrawal by Subject|25|||
162957201|NCT00968812|588544943|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
163045329|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Adverse Event|0|||
163045330|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Adverse Event|0|||
163045331|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
163045332|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
163045333|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
163045334|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
163045335|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
163045336|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
163045337|NCT00436826|588873181|FG000|Double Blind Period (DBP)|Other|10|||
163045338|NCT00436826|588873182|FG001|Double Blind Period (DBP)|Other|11|||
163045339|NCT00436826|588873183|FG002|Double Blind Period (DBP)|Other|0|||
163045340|NCT00436826|588873184|FG003|Double Blind Period (DBP)|Other|0|||
163045341|NCT00436826|588873185|FG004|Double Blind Period (DBP)|Other|0|||
163045342|NCT00436826|588873186|FG005|Double Blind Period (DBP)|Other|0|||
163045343|NCT00436826|588873181|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045344|NCT00436826|588873182|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045345|NCT00436826|588873183|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045346|NCT00436826|588873184|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
163045347|NCT00436826|588873185|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045348|NCT00436826|588873186|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
163045349|NCT00436826|588873181|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045350|NCT00436826|588873182|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045351|NCT00436826|588873183|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
163045352|NCT00436826|588873184|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
163045353|NCT00436826|588873185|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045354|NCT00436826|588873186|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
163045355|NCT00436826|588873181|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045356|NCT00436826|588873182|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045357|NCT00436826|588873183|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045358|NCT00436826|588873184|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
163045359|NCT00436826|588873185|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
163045360|NCT00436826|588873186|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
163045361|NCT00784719|588873201|FG000|Overall Study|Adverse Event|0|||
163045362|NCT00784719|588873202|FG001|Overall Study|Adverse Event|2|||
163045363|NCT00784719|588873203|FG002|Overall Study|Adverse Event|0|||
163045364|NCT00784719|588873204|FG003|Overall Study|Adverse Event|0|||
163045365|NCT00784719|588873205|FG004|Overall Study|Adverse Event|1|||
163045366|NCT00784719|588873206|FG005|Overall Study|Adverse Event|1|||
163045367|NCT00784719|588873207|FG006|Overall Study|Adverse Event|1|||
163045368|NCT00784719|588873201|FG000|Overall Study|Lost to Follow-up|0|||
163045369|NCT00784719|588873202|FG001|Overall Study|Lost to Follow-up|0|||
163045370|NCT00784719|588873203|FG002|Overall Study|Lost to Follow-up|0|||
163045371|NCT00784719|588873204|FG003|Overall Study|Lost to Follow-up|0|||
163045372|NCT00784719|588873205|FG004|Overall Study|Lost to Follow-up|1|||
163045373|NCT00784719|588873206|FG005|Overall Study|Lost to Follow-up|1|||
162957202|NCT00968812|588544944|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
162957203|NCT00968812|588544945|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
162957204|NCT00968812|588544943|FG000|Overall Study|Noncompliance with study drug|4|||
162957205|NCT00968812|588544944|FG001|Overall Study|Noncompliance with study drug|1|||
162957206|NCT00968812|588544945|FG002|Overall Study|Noncompliance with study drug|6|||
162957207|NCT00968812|588544943|FG000|Overall Study|Unable to take rescue therapy|12|||
162957208|NCT00968812|588544944|FG001|Overall Study|Unable to take rescue therapy|12|||
162957209|NCT00968812|588544945|FG002|Overall Study|Unable to take rescue therapy|17|||
162957210|NCT00968812|588544943|FG000|Overall Study|Other|25|||
162957211|NCT00968812|588544944|FG001|Overall Study|Other|37|||
162957212|NCT00968812|588544945|FG002|Overall Study|Other|40|||
162957213|NCT00834340|588544946|FG000|Washout|Adverse Event|1|||
162957214|NCT00834340|588544947|FG001|Washout|Adverse Event|0|||
162957215|NCT00834340|588544946|FG000|Washout|Withdrawal by Subject|1|||
162957216|NCT00834340|588544947|FG001|Washout|Withdrawal by Subject|0|||
162957217|NCT00395694|588544948|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
163045374|NCT00784719|588873207|FG006|Overall Study|Lost to Follow-up|0|||
163045375|NCT00784719|588873201|FG000|Overall Study|Other|2|||
163045376|NCT00784719|588873202|FG001|Overall Study|Other|1|||
163045377|NCT00784719|588873203|FG002|Overall Study|Other|1|||
163045378|NCT00784719|588873204|FG003|Overall Study|Other|0|||
162957218|NCT00395694|588544949|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
162957219|NCT00395694|588544948|FG000|Continuation Phase|Adverse Event|1|||
162957220|NCT00395694|588544949|FG001|Continuation Phase|Adverse Event|0|||
162957221|NCT00395694|588544948|FG000|Continuation Phase|Lack of Efficacy|12|||
162957222|NCT00395694|588544949|FG001|Continuation Phase|Lack of Efficacy|11|||
162957223|NCT00395694|588544948|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
162957224|NCT00395694|588544949|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
162957225|NCT00395694|588544948|FG000|Continuation Phase|Poor Compliance|1|||
162957226|NCT00395694|588544949|FG001|Continuation Phase|Poor Compliance|0|||
162957227|NCT00395694|588544948|FG000|Continuation Phase|Withdrawal by Subject|0|||
162957228|NCT00395694|588544949|FG001|Continuation Phase|Withdrawal by Subject|2|||
162957229|NCT02689505|588544952|FG000|Overall Study|Progressive disease|2|||
162957230|NCT02689505|588544953|FG001|Overall Study|Progressive disease|2|||
162957231|NCT02689505|588544954|FG002|Overall Study|Progressive disease|3|||
162957232|NCT02689505|588544955|FG003|Overall Study|Progressive disease|9|||
162957233|NCT02689505|588544956|FG004|Overall Study|Progressive disease|1|||
162957234|NCT02689505|588544952|FG000|Overall Study|Dose Limiting Toxicity|0|||
162957235|NCT02689505|588544953|FG001|Overall Study|Dose Limiting Toxicity|1|||
162957236|NCT02689505|588544954|FG002|Overall Study|Dose Limiting Toxicity|0|||
162957237|NCT02689505|588544955|FG003|Overall Study|Dose Limiting Toxicity|0|||
162957238|NCT02689505|588544956|FG004|Overall Study|Dose Limiting Toxicity|2|||
162957239|NCT02689505|588544952|FG000|Overall Study|Other AE or clinical progression|0|||
162957240|NCT02689505|588544953|FG001|Overall Study|Other AE or clinical progression|2|||
162957241|NCT02689505|588544954|FG002|Overall Study|Other AE or clinical progression|0|||
162957242|NCT02689505|588544955|FG003|Overall Study|Other AE or clinical progression|2|||
162957243|NCT02689505|588544956|FG004|Overall Study|Other AE or clinical progression|0|||
162957244|NCT04108858|588544957|FG000|Overall Study|Adverse Event|1|||
162957245|NCT03663179|588544958|FG000|Overall Study|Withdrawal by Subject|2|||
162957246|NCT03663179|588544959|FG001|Overall Study|Withdrawal by Subject|0|||
162957247|NCT03663179|588544958|FG000|Overall Study|Lost to Follow-up|1|||
162957248|NCT03663179|588544959|FG001|Overall Study|Lost to Follow-up|1|||
162957249|NCT03663179|588544958|FG000|Overall Study|Revealed exclusionary condition|1|||
162957250|NCT03663179|588544959|FG001|Overall Study|Revealed exclusionary condition|0|||
162957251|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
162957252|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
162957253|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
162957254|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
162957255|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
162957256|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
162957257|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162957258|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
162957259|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
162957260|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
162957261|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
162957262|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
162957263|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
162957264|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
162957265|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162957266|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
162957267|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
162957268|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
162957269|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
162957270|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
162957271|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Death|0|||
162957272|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Death|1|||
162957273|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Death|0|||
162957274|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Death|0|||
162957275|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
162957276|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
162957277|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
162957278|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
162957279|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
162957280|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957281|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957282|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
162957283|NCT01940341|588544960|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163045379|NCT00784719|588873205|FG004|Overall Study|Other|2|||
162957284|NCT01940341|588544961|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
162957285|NCT01940341|588544962|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162957286|NCT01940341|588544963|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
162957287|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162957288|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
162957289|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
162957290|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
162957291|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162957292|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
162957293|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
162957294|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
162957295|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957296|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957297|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
162957298|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
162957299|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
162957300|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
162957301|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
162957302|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
162957303|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957304|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957305|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
162957306|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
162957307|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957308|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957309|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
162957310|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
162957311|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957312|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957313|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
162957314|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
162957315|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957316|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957317|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
162957318|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
162957319|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957320|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957321|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
162957322|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
162957323|NCT01940341|588544960|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957324|NCT01940341|588544961|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957325|NCT01940341|588544962|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
162957326|NCT01940341|588544963|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
162957327|NCT01289262|588544966|FG000|Overall Study|Lost to Follow-up|29|||
162957328|NCT01289262|588544967|FG001|Overall Study|Lost to Follow-up|16|||
162957329|NCT01289262|588544966|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
162957330|NCT01289262|588544967|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
162957331|NCT03792477|588544970|FG000|Overall Study|Adverse Event|0|||
162957332|NCT03792477|588544971|FG001|Overall Study|Adverse Event|0|||
162957333|NCT03792477|588544972|FG002|Overall Study|Adverse Event|0|||
162957334|NCT03792477|588544973|FG003|Overall Study|Adverse Event|1|||
162957335|NCT03792477|588544974|FG004|Overall Study|Adverse Event|0|||
162957336|NCT03792477|588544970|FG000|Overall Study|Lost to Follow-up|0|||
162957337|NCT03792477|588544971|FG001|Overall Study|Lost to Follow-up|0|||
162957338|NCT03792477|588544972|FG002|Overall Study|Lost to Follow-up|2|||
162957339|NCT03792477|588544973|FG003|Overall Study|Lost to Follow-up|0|||
162957340|NCT03792477|588544974|FG004|Overall Study|Lost to Follow-up|0|||
162957341|NCT03792477|588544970|FG000|Overall Study|Other|0|||
162957342|NCT03792477|588544971|FG001|Overall Study|Other|0|||
162957343|NCT03792477|588544972|FG002|Overall Study|Other|0|||
162957344|NCT03792477|588544973|FG003|Overall Study|Other|0|||
162957345|NCT03792477|588544974|FG004|Overall Study|Other|1|||
162957346|NCT00446563|588544977|FG000|Overall Study|Adverse Event|4|||
162957347|NCT00446563|588544978|FG001|Overall Study|Adverse Event|3|||
162957348|NCT00446563|588544977|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162957349|NCT00446563|588544978|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162957350|NCT00446563|588544977|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162957351|NCT00446563|588544978|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162957352|NCT00446563|588544977|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162957353|NCT00446563|588544978|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162957354|NCT00446563|588544977|FG000|Overall Study|Withdrawal by Subject|2|||
162957355|NCT00446563|588544978|FG001|Overall Study|Withdrawal by Subject|1|||
162957356|NCT00446563|588544977|FG000|Overall Study|Administrative problems|0|||
162957357|NCT00446563|588544978|FG001|Overall Study|Administrative problems|1|||
162957358|NCT01169558|588544979|FG000|Overall Study|Disease progression|98|||
162957359|NCT01169558|588544979|FG000|Overall Study|Adverse Event|25|||
162957360|NCT01169558|588544979|FG000|Overall Study|Withdrawal of Consent|8|||
162957361|NCT01169558|588544979|FG000|Overall Study|Medical Decision|7|||
163045380|NCT00784719|588873206|FG005|Overall Study|Other|1|||
163045381|NCT00784719|588873207|FG006|Overall Study|Other|3|||
163045382|NCT00784719|588873201|FG000|Overall Study|Withdrawal by Subject|1|||
163045383|NCT00784719|588873202|FG001|Overall Study|Withdrawal by Subject|0|||
163045384|NCT00784719|588873203|FG002|Overall Study|Withdrawal by Subject|0|||
163045385|NCT00784719|588873204|FG003|Overall Study|Withdrawal by Subject|0|||
163045386|NCT00784719|588873205|FG004|Overall Study|Withdrawal by Subject|2|||
163045387|NCT00784719|588873206|FG005|Overall Study|Withdrawal by Subject|0|||
163045388|NCT00784719|588873207|FG006|Overall Study|Withdrawal by Subject|1|||
163045389|NCT04533438|588873208|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
163045390|NCT04533438|588873209|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
163045391|NCT05568797|588873212|FG000|Overall Study|Adverse Event|0|||
163045392|NCT05568797|588873213|FG001|Overall Study|Adverse Event|8|||
163045393|NCT05568797|588873212|FG000|Overall Study|Lost to Follow-up|2|||
163045394|NCT05568797|588873213|FG001|Overall Study|Lost to Follow-up|3|||
163045395|NCT05568797|588873212|FG000|Overall Study|Withdrawal by Subject|1|||
163045396|NCT05568797|588873213|FG001|Overall Study|Withdrawal by Subject|10|||
163045397|NCT05568797|588873212|FG000|Overall Study|Other|2|||
163045398|NCT05568797|588873213|FG001|Overall Study|Other|2|||
163045399|NCT02401035|588873215|FG000|Overall Study|Withdrawal by Subject|1|||
163045400|NCT02401035|588873216|FG001|Overall Study|Withdrawal by Subject|0|||
163045401|NCT00869128|588873217|FG000|Overall Study|lack of Compliance|6|||
163045402|NCT00869128|588873218|FG001|Overall Study|lack of Compliance|6|||
163045403|NCT00985686|588873224|FG000|Overall Study|Lost to Follow-up|1|||
163045404|NCT00985686|588873225|FG001|Overall Study|Lost to Follow-up|1|||
163045405|NCT00985686|588873226|FG002|Overall Study|Lost to Follow-up|0|||
163045406|NCT00985686|588873227|FG003|Overall Study|Lost to Follow-up|2|||
163045407|NCT03046953|588873228|FG000|Overall Study|Relapse/progressive disease|21|||
163045408|NCT03046953|588873228|FG000|Overall Study|Death|2|||
163045409|NCT03046953|588873228|FG000|Overall Study|Withdrawal by Subject|3|||
163045410|NCT04039204|588873230|FG000|Overall Study|Withdrawal by Subject|0|||
163045411|NCT04039204|588873231|FG001|Overall Study|Withdrawal by Subject|2|||
163045412|NCT00396383|588873238|FG000|Overall Study|Death|2|||
163045413|NCT00396383|588873238|FG000|Overall Study|Lost to Follow-up|1|||
163045414|NCT02385110|588873241|FG000|Overall Study|Early Death|1|||
163045415|NCT02385110|588873242|FG001|Overall Study|Early Death|0|||
163045416|NCT00534638|588873243|FG000|Overall Study|Withdrawal by Subject|3|||
163045417|NCT00534638|588873244|FG001|Overall Study|Withdrawal by Subject|4|||
163045418|NCT00534638|588873243|FG000|Overall Study|Migrated/moved from study area|13|||
163045419|NCT00534638|588873244|FG001|Overall Study|Migrated/moved from study area|11|||
163045420|NCT00534638|588873243|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
163045421|NCT00534638|588873244|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
163045422|NCT00534638|588873243|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
163045423|NCT00534638|588873244|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
163045424|NCT00534638|588873243|FG000|Overall Study|Other|1685|||
163045425|NCT00534638|588873244|FG001|Overall Study|Other|902|||
163045426|NCT00282152|588873247|FG000|Overall Study|Withdrawal by Subject|1|||
163045427|NCT00282152|588873248|FG001|Overall Study|Withdrawal by Subject|0|||
163045428|NCT00585325|588873249|FG000|Overall Study|Withdrawal by Subject|1|||
163045429|NCT00585325|588873250|FG001|Overall Study|Withdrawal by Subject|1|||
163045430|NCT01124292|588873251|FG000|Overall Study|Lost to Follow-up|2|||
163045431|NCT01124292|588873252|FG001|Overall Study|Lost to Follow-up|4|||
163045432|NCT01124292|588873253|FG002|Overall Study|Lost to Follow-up|3|||
163045433|NCT01124292|588873251|FG000|Overall Study|Physician Decision|0|||
163045434|NCT01124292|588873252|FG001|Overall Study|Physician Decision|3|||
163045435|NCT01124292|588873253|FG002|Overall Study|Physician Decision|2|||
163045436|NCT01124292|588873251|FG000|Overall Study|Withdrawal by Subject|0|||
163045437|NCT01124292|588873252|FG001|Overall Study|Withdrawal by Subject|6|||
163045438|NCT01124292|588873253|FG002|Overall Study|Withdrawal by Subject|2|||
163045439|NCT01124292|588873251|FG000|Overall Study|medical issue unrelated to the study|0|||
163045440|NCT01124292|588873252|FG001|Overall Study|medical issue unrelated to the study|0|||
163045441|NCT01124292|588873253|FG002|Overall Study|medical issue unrelated to the study|2|||
163045442|NCT01124292|588873251|FG000|Overall Study|piercing track closed|0|||
163045443|NCT01124292|588873252|FG001|Overall Study|piercing track closed|2|||
163045444|NCT01124292|588873253|FG002|Overall Study|piercing track closed|1|||
163045445|NCT01237327|588873254|FG000|Overall Study|Protocol Violation: Core Study|1|||
163045446|NCT01237327|588873255|FG001|Overall Study|Protocol Violation: Core Study|0|||
163045447|NCT01237327|588873254|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
163045448|NCT01237327|588873255|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
163045449|NCT01237327|588873254|FG000|Overall Study|Progression of Disease: Core Study|18|||
163045450|NCT01237327|588873255|FG001|Overall Study|Progression of Disease: Core Study|22|||
163045451|NCT01237327|588873254|FG000|Overall Study|Progression of Disease: Extension Study|15|||
163045452|NCT01237327|588873255|FG001|Overall Study|Progression of Disease: Extension Study|13|||
163045453|NCT01237327|588873254|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
163045454|NCT01237327|588873255|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
162957362|NCT01169558|588544979|FG000|Overall Study|Stable Disease|4|||
162957363|NCT01169558|588544979|FG000|Overall Study|Lost to Follow-up|4|||
162957364|NCT01169558|588544979|FG000|Overall Study|Need for Surgery|4|||
162957365|NCT01169558|588544979|FG000|Overall Study|Non-compliance|2|||
162957366|NCT01169558|588544979|FG000|Overall Study|Protocol Violation|2|||
162957367|NCT01169558|588544979|FG000|Overall Study|Partial response|2|||
162957368|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
162957369|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
162957370|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957371|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957372|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
162957373|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957374|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957375|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
162957376|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
162957377|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
162957378|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957379|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
162957380|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957381|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957382|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
162957383|NCT03134222|588544982|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957384|NCT03134222|588544983|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
162957385|NCT03134222|588544984|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
162957386|NCT03134222|588544985|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957387|NCT03134222|588544986|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
162957388|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957389|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
162957390|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957391|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
162957392|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
162957393|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
162957394|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957395|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957396|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957397|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
162957398|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957399|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957400|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957401|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
162957402|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
162957403|NCT03134222|588544982|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957404|NCT03134222|588544983|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
162957405|NCT03134222|588544984|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957406|NCT03134222|588544985|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957407|NCT03134222|588544986|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
162957408|NCT02605928|588544987|FG000|Overall Study|Model tuning phase|28|||
162957409|NCT02605928|588544987|FG000|Overall Study|Lack of Efficacy|5|||
162957410|NCT03482882|588544990|FG000|Overall Study|Adverse Event|3|||
162957411|NCT03482882|588544990|FG000|Overall Study|Lost to Follow-up|1|||
162957412|NCT03482882|588544990|FG000|Overall Study|Protocol Violation|2|||
162957413|NCT03482882|588544990|FG000|Overall Study|Not further specified|1|||
162957414|NCT05341622|588544997|FG000|Overall Study|Death|0|||
162957415|NCT05341622|588544998|FG001|Overall Study|Death|0|||
162957416|NCT05341622|588544999|FG002|Overall Study|Death|0|||
162957417|NCT05341622|588545000|FG003|Overall Study|Death|0|||
162957418|NCT05341622|588545001|FG004|Overall Study|Death|1|||
162957419|NCT05341622|588545002|FG005|Overall Study|Death|0|||
162957420|NCT05341622|588545003|FG006|Overall Study|Death|0|||
162957421|NCT05341622|588545004|FG007|Overall Study|Death|1|||
162957422|NCT05341622|588544997|FG000|Overall Study|Invalid Address|0|||
162957423|NCT05341622|588544998|FG001|Overall Study|Invalid Address|1|||
162957424|NCT05341622|588544999|FG002|Overall Study|Invalid Address|0|||
162957425|NCT05341622|588545000|FG003|Overall Study|Invalid Address|0|||
162957426|NCT05341622|588545001|FG004|Overall Study|Invalid Address|0|||
162957427|NCT05341622|588545002|FG005|Overall Study|Invalid Address|0|||
162957428|NCT05341622|588545003|FG006|Overall Study|Invalid Address|0|||
162957429|NCT05341622|588545004|FG007|Overall Study|Invalid Address|0|||
162957430|NCT05341622|588544997|FG000|Overall Study|Ineligible|26|||
162957431|NCT05341622|588544998|FG001|Overall Study|Ineligible|21|||
162957432|NCT05341622|588544999|FG002|Overall Study|Ineligible|28|||
162957433|NCT05341622|588545000|FG003|Overall Study|Ineligible|24|||
162957434|NCT05341622|588545001|FG004|Overall Study|Ineligible|29|||
162860758|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
162860759|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
162860760|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
162860761|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Death|0|||
162860762|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Death|1|||
162860763|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Death|0|||
162860764|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
162860765|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
162860766|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
162860767|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
162860768|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
162860769|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
162860770|NCT00430781|588197476|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
162860771|NCT00430781|588197477|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
162860772|NCT00430781|588197478|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
162860773|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
162860774|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
162860775|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
162860776|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
162860777|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
162860778|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
162860779|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
162860780|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
162860781|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
162860782|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
162860783|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
162860784|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
162860785|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Other|0|||
162957435|NCT05341622|588545002|FG005|Overall Study|Ineligible|31|||
162957436|NCT05341622|588545003|FG006|Overall Study|Ineligible|28|||
162957437|NCT05341622|588545004|FG007|Overall Study|Ineligible|26|||
162957438|NCT04611789|588545005|FG000|Overall Study|Lost to Follow-up|1|||
162957439|NCT04611789|588545006|FG001|Overall Study|Lost to Follow-up|0|||
162957440|NCT04611789|588545007|FG002|Overall Study|Lost to Follow-up|0|||
162957441|NCT05152576|588545008|FG000|Overall Study|Lost to Follow-up|3|||
162957442|NCT05152576|588545009|FG001|Overall Study|Lost to Follow-up|0|||
162957443|NCT05152576|588545010|FG002|Overall Study|Lost to Follow-up|0|||
162957444|NCT05152576|588545011|FG003|Overall Study|Lost to Follow-up|1|||
162957445|NCT05152576|588545008|FG000|Overall Study|Withdrawal by Subject|0|||
162957446|NCT05152576|588545009|FG001|Overall Study|Withdrawal by Subject|1|||
162957447|NCT05152576|588545010|FG002|Overall Study|Withdrawal by Subject|0|||
162957448|NCT05152576|588545011|FG003|Overall Study|Withdrawal by Subject|1|||
162957449|NCT05152576|588545008|FG000|Overall Study|Other|2|||
162957450|NCT05152576|588545009|FG001|Overall Study|Other|0|||
162957451|NCT05152576|588545010|FG002|Overall Study|Other|0|||
162957452|NCT05152576|588545011|FG003|Overall Study|Other|0|||
162957453|NCT00859430|588545012|FG000|First Intervention|Withdrawal by Subject|0|||
162957454|NCT00859430|588545013|FG001|First Intervention|Withdrawal by Subject|1|||
162957455|NCT02286739|588546447|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
162957456|NCT02286739|588546448|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
162957457|NCT02286739|588546447|FG000|Overall Study|No Verasense type documented|0|||
162957458|NCT02286739|588546448|FG001|Overall Study|No Verasense type documented|23|||
162957459|NCT02286739|588546447|FG000|Overall Study|Adverse Event|1|||
162957460|NCT02286739|588546448|FG001|Overall Study|Adverse Event|2|||
162957461|NCT02286739|588546447|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
162957462|NCT02286739|588546448|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
162957463|NCT00834795|588546449|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
162957464|NCT00834795|588546450|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
162957465|NCT00834795|588546449|FG000|Second Intervention|Adverse Event|1|||
162957466|NCT00834795|588546450|FG001|Second Intervention|Adverse Event|0|||
162957467|NCT02718326|588546458|FG000|Overall Study|Adverse Event|4|||
162957468|NCT02718326|588546459|FG001|Overall Study|Adverse Event|9|||
162957469|NCT02718326|588546460|FG002|Overall Study|Adverse Event|0|||
162957470|NCT02718326|588546458|FG000|Overall Study|Death|8|||
162957471|NCT02718326|588546459|FG001|Overall Study|Death|1|||
162957472|NCT02718326|588546460|FG002|Overall Study|Death|2|||
162957473|NCT02718326|588546458|FG000|Overall Study|Withdrawal by Subject|4|||
162957474|NCT02718326|588546459|FG001|Overall Study|Withdrawal by Subject|9|||
162957475|NCT02718326|588546460|FG002|Overall Study|Withdrawal by Subject|6|||
162957476|NCT02718326|588546458|FG000|Overall Study|Lost to Follow-up|18|||
162957477|NCT02718326|588546459|FG001|Overall Study|Lost to Follow-up|5|||
162957478|NCT02718326|588546460|FG002|Overall Study|Lost to Follow-up|14|||
162957479|NCT02718326|588546458|FG000|Overall Study|Protocol Deviation|1|||
163045455|NCT01237327|588873254|FG000|Overall Study|Withdrawal by Subject|1|||
163045456|NCT01237327|588873255|FG001|Overall Study|Withdrawal by Subject|3|||
163045457|NCT01237327|588873254|FG000|Overall Study|Lost to Follow-up|3|||
163045458|NCT01237327|588873255|FG001|Overall Study|Lost to Follow-up|0|||
163045459|NCT02557516|588873256|FG000|Overall Study|Adverse Event|1|||
163045460|NCT02557516|588873257|FG001|Overall Study|Adverse Event|0|||
163045461|NCT02557516|588873258|FG002|Overall Study|Adverse Event|2|||
163045462|NCT02557516|588873259|FG003|Overall Study|Adverse Event|1|||
163045463|NCT02557516|588873256|FG000|Overall Study|Disease progression|0|||
163045464|NCT02557516|588873257|FG001|Overall Study|Disease progression|2|||
163045465|NCT02557516|588873258|FG002|Overall Study|Disease progression|0|||
163045466|NCT02557516|588873259|FG003|Overall Study|Disease progression|0|||
163045467|NCT02557516|588873256|FG000|Overall Study|Physician Decision|0|||
163045468|NCT02557516|588873257|FG001|Overall Study|Physician Decision|2|||
163045469|NCT02557516|588873258|FG002|Overall Study|Physician Decision|0|||
163045470|NCT02557516|588873259|FG003|Overall Study|Physician Decision|0|||
163045471|NCT02557516|588873256|FG000|Overall Study|Sponsor decision|0|||
163045472|NCT02557516|588873257|FG001|Overall Study|Sponsor decision|1|||
163045473|NCT02557516|588873258|FG002|Overall Study|Sponsor decision|2|||
163045474|NCT02557516|588873259|FG003|Overall Study|Sponsor decision|8|||
163045475|NCT01919164|588874994|FG000|Overall Study|Adverse Event|6|||
163045476|NCT01919164|588874995|FG001|Overall Study|Adverse Event|4|||
163045477|NCT01919164|588874996|FG002|Overall Study|Adverse Event|9|||
163045478|NCT01919164|588874997|FG003|Overall Study|Adverse Event|3|||
163045479|NCT01919164|588874998|FG004|Overall Study|Adverse Event|2|||
163045480|NCT01919164|588874994|FG000|Overall Study|Lost to Follow-up|2|||
163045481|NCT01919164|588874995|FG001|Overall Study|Lost to Follow-up|2|||
163045482|NCT01919164|588874996|FG002|Overall Study|Lost to Follow-up|2|||
163045483|NCT01919164|588874997|FG003|Overall Study|Lost to Follow-up|0|||
163045484|NCT01919164|588874998|FG004|Overall Study|Lost to Follow-up|4|||
163045485|NCT01919164|588874994|FG000|Overall Study|Death|1|||
162957480|NCT02718326|588546459|FG001|Overall Study|Protocol Deviation|0|||
162957481|NCT02718326|588546460|FG002|Overall Study|Protocol Deviation|0|||
162957482|NCT02718326|588546458|FG000|Overall Study|Pregnancy|1|||
162957483|NCT02718326|588546459|FG001|Overall Study|Pregnancy|0|||
162957484|NCT02718326|588546460|FG002|Overall Study|Pregnancy|0|||
162957485|NCT06195579|588546461|FG000|Overall Study|Withdrawal by Subject|1|||
162957486|NCT03049748|588546464|FG000|Overall Study|Lost to Follow-up|1|||
162957487|NCT03049748|588546465|FG001|Overall Study|Lost to Follow-up|0|||
162957488|NCT03049748|588546464|FG000|Overall Study|Death|3|||
162957489|NCT03049748|588546465|FG001|Overall Study|Death|0|||
162957490|NCT03049748|588546464|FG000|Overall Study|Withdrawal by Subject|0|||
162957491|NCT03049748|588546465|FG001|Overall Study|Withdrawal by Subject|3|||
162957492|NCT03049748|588546464|FG000|Overall Study|Protocol Violation|0|||
162957493|NCT03049748|588546465|FG001|Overall Study|Protocol Violation|2|||
162957494|NCT03049748|588546464|FG000|Overall Study|Moved out of state (relocation)|0|||
162957495|NCT03049748|588546465|FG001|Overall Study|Moved out of state (relocation)|1|||
163045486|NCT01919164|588874995|FG001|Overall Study|Death|0|||
163045487|NCT01919164|588874996|FG002|Overall Study|Death|0|||
163045488|NCT01919164|588874997|FG003|Overall Study|Death|0|||
163045489|NCT01919164|588874998|FG004|Overall Study|Death|0|||
163045490|NCT01919164|588874994|FG000|Overall Study|Protocol Violation|6|||
163045491|NCT01919164|588874995|FG001|Overall Study|Protocol Violation|0|||
163045492|NCT01919164|588874996|FG002|Overall Study|Protocol Violation|3|||
163045493|NCT01919164|588874997|FG003|Overall Study|Protocol Violation|2|||
163045494|NCT01919164|588874998|FG004|Overall Study|Protocol Violation|2|||
163045495|NCT01919164|588874994|FG000|Overall Study|Disease progression|2|||
163045496|NCT01919164|588874995|FG001|Overall Study|Disease progression|2|||
163045497|NCT01919164|588874996|FG002|Overall Study|Disease progression|1|||
163045498|NCT01919164|588874997|FG003|Overall Study|Disease progression|2|||
163045499|NCT01919164|588874998|FG004|Overall Study|Disease progression|1|||
163045500|NCT01919164|588874994|FG000|Overall Study|Withdrew consent|13|||
163045501|NCT01919164|588874995|FG001|Overall Study|Withdrew consent|13|||
163045502|NCT01919164|588874996|FG002|Overall Study|Withdrew consent|14|||
163045503|NCT01919164|588874997|FG003|Overall Study|Withdrew consent|14|||
163045504|NCT01919164|588874998|FG004|Overall Study|Withdrew consent|9|||
163045505|NCT01919164|588874994|FG000|Overall Study|Other Un-specified|13|||
163045506|NCT01919164|588874995|FG001|Overall Study|Other Un-specified|9|||
163045507|NCT01919164|588874996|FG002|Overall Study|Other Un-specified|8|||
163045508|NCT01919164|588874997|FG003|Overall Study|Other Un-specified|7|||
163045509|NCT01919164|588874998|FG004|Overall Study|Other Un-specified|15|||
163045510|NCT01845597|588875002|FG000|Overall Study|Death|8|||
163045511|NCT01845597|588875002|FG000|Overall Study|Lost to Follow-up|22|||
163045512|NCT01957579|588875008|FG000|Overall Study|Withdrawal of concent|0|||
163045513|NCT01957579|588875009|FG001|Overall Study|Withdrawal of concent|1|||
163045514|NCT01957579|588875010|FG002|Overall Study|Withdrawal of concent|0|||
163045515|NCT01957579|588875011|FG003|Overall Study|Withdrawal of concent|0|||
163045516|NCT01957579|588875008|FG000|Overall Study|Death|0|||
163045517|NCT01957579|588875009|FG001|Overall Study|Death|0|||
163045518|NCT01957579|588875010|FG002|Overall Study|Death|2|||
163045519|NCT01957579|588875011|FG003|Overall Study|Death|0|||
163045520|NCT02019550|588875012|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163045521|NCT02019550|588875013|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163045522|NCT02750332|588875014|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163045523|NCT02750332|588875015|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162860786|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Other|1|||
162860787|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Other|0|||
162860788|NCT00430781|588197476|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
162860789|NCT00430781|588197477|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
162860790|NCT00430781|588197478|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
162860791|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
162860792|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
162860793|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
162860794|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
162860795|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
162860796|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
162860797|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
162860798|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
162860799|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
162860800|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
162860801|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
162860802|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
162860803|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
162860804|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
162860805|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
162860806|NCT00430781|588197476|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
162860807|NCT00430781|588197477|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
162860808|NCT00430781|588197478|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
162860809|NCT01389128|588197481|FG000|Overall Study|Fetal distress|1|||
162860810|NCT01389128|588197482|FG001|Overall Study|Fetal distress|0|||
163045524|NCT00956839|588875019|FG000|Overall Study|Lost to Follow-up|3|||
163045525|NCT00956839|588875020|FG001|Overall Study|Lost to Follow-up|0|||
163045526|NCT00956839|588875021|FG002|Overall Study|Lost to Follow-up|3|||
163045527|NCT04155463|588875022|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
163045528|NCT04155463|588875023|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
162860811|NCT01389128|588197481|FG000|Overall Study|Cervix dilation stop|1|||
162860812|NCT01389128|588197482|FG001|Overall Study|Cervix dilation stop|2|||
162860813|NCT01389128|588197481|FG000|Overall Study|Rapid labor evolution|3|||
163045529|NCT00113295|588875026|FG000|Overall Study|Adverse Event|4|||
163045530|NCT00113295|588875027|FG001|Overall Study|Adverse Event|1|||
163045531|NCT00113295|588875026|FG000|Overall Study|Unrelated Medical Illness|1|||
163045532|NCT00113295|588875027|FG001|Overall Study|Unrelated Medical Illness|0|||
163045533|NCT02806713|588875028|FG000|Overall Study|Urethral injury during procedure|1|||
163045534|NCT02806713|588875029|FG001|Overall Study|Urethral injury during procedure|0|||
163045535|NCT02806713|588875028|FG000|Overall Study|cancelled surgery|1|||
163045536|NCT02806713|588875029|FG001|Overall Study|cancelled surgery|2|||
162957496|NCT01735994|588546466|FG000|Overall Study|Withdrawal by Subject|6|||
162957497|NCT01735994|588546467|FG001|Overall Study|Withdrawal by Subject|4|||
162957498|NCT01735994|588546466|FG000|Overall Study|Injury|2|||
162957499|NCT01735994|588546467|FG001|Overall Study|Injury|0|||
162957500|NCT01735994|588546466|FG000|Overall Study|Kicked off team|5|||
162957501|NCT01735994|588546467|FG001|Overall Study|Kicked off team|0|||
162957502|NCT01735994|588546466|FG000|Overall Study|Lost to Follow-up|50|||
162957503|NCT01735994|588546467|FG001|Overall Study|Lost to Follow-up|62|||
162957504|NCT03437265|588546484|FG000|Overall Study|Protocol Violation|6|||
162957505|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
162957506|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
162957507|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
162957508|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
162957509|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
162957510|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
162957511|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
162957512|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
162957513|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
162957514|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
162957515|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
162957516|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
162957517|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
162957518|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
162957519|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
162957520|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
162957521|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
162957522|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
162957523|NCT01667679|588546494|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
162957524|NCT01667679|588546495|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
162957525|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
162957526|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
162957527|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
162957528|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
162957529|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
162957530|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
162957531|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
162957532|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
162957533|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
162957534|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
162957535|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
162957536|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
162957537|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
162957538|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
162957539|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
162957540|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
162957541|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
162957542|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
162957543|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
162957544|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
162957545|NCT01667679|588546494|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
162957546|NCT01667679|588546495|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
162957547|NCT01175018|588546498|FG000|Overall Study|Adverse Event|3|||
162957548|NCT01175018|588546499|FG001|Overall Study|Adverse Event|1|||
162957549|NCT02911792|588546500|FG000|Overall Study|Lost to Follow-up|3|||
162957550|NCT02911792|588546501|FG001|Overall Study|Lost to Follow-up|3|||
162957551|NCT02911792|588546502|FG002|Overall Study|Lost to Follow-up|3|||
162957552|NCT02911792|588546503|FG003|Overall Study|Lost to Follow-up|3|||
162957553|NCT00840073|588546510|FG000|Second Intervention|Missed 72 hour blood draw|1|||
162957554|NCT00840073|588546511|FG001|Second Intervention|Missed 72 hour blood draw|1|||
162957555|NCT01788423|588546513|FG000|Overall Study|See Comments in Completed (above)|0|||
162957556|NCT01788423|588546514|FG001|Overall Study|See Comments in Completed (above)|4|||
162957557|NCT01788423|588546515|FG002|Overall Study|See Comments in Completed (above)|5|||
162957558|NCT00835263|588546516|FG000|Second Intervention|Adverse Event|1|||
162957559|NCT00835263|588546517|FG001|Second Intervention|Adverse Event|0|||
162957560|NCT03249454|588546518|FG000|Overall Study|Withdrawal by Subject|0|||
162957561|NCT03249454|588546519|FG001|Overall Study|Withdrawal by Subject|0|||
162957562|NCT03249454|588546520|FG002|Overall Study|Withdrawal by Subject|0|||
162957563|NCT03249454|588546521|FG003|Overall Study|Withdrawal by Subject|0|||
162957564|NCT03249454|588546522|FG004|Overall Study|Withdrawal by Subject|0|||
162860814|NCT01389128|588197482|FG001|Overall Study|Rapid labor evolution|2|||
162860815|NCT01389128|588197481|FG000|Overall Study|Intolerance to procedure|0|||
162860816|NCT01389128|588197482|FG001|Overall Study|Intolerance to procedure|2|||
162860817|NCT01451515|588197483|FG000|Overall Study|Death|0|||
162860818|NCT01451515|588197484|FG001|Overall Study|Death|1|||
162860819|NCT01451515|588197485|FG002|Overall Study|Death|0|||
162860820|NCT01451515|588197483|FG000|Overall Study|Withdrawal by Subject|0|||
162860821|NCT01451515|588197484|FG001|Overall Study|Withdrawal by Subject|1|||
162860822|NCT01451515|588197485|FG002|Overall Study|Withdrawal by Subject|0|||
162860823|NCT01451515|588197483|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
162860824|NCT01451515|588197484|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
162860825|NCT01451515|588197485|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
162860826|NCT01451515|588197483|FG000|Overall Study|Relapse (except CNS)|1|||
162860827|NCT01451515|588197484|FG001|Overall Study|Relapse (except CNS)|1|||
162860828|NCT01451515|588197485|FG002|Overall Study|Relapse (except CNS)|0|||
162860829|NCT00174941|588197489|FG000|Overall Study|Adverse Event|1|||
162860830|NCT00174941|588197490|FG001|Overall Study|Adverse Event|10|||
162860831|NCT00174941|588197491|FG002|Overall Study|Adverse Event|2|||
162860832|NCT00174941|588197492|FG003|Overall Study|Adverse Event|13|||
162860833|NCT00174941|588197489|FG000|Overall Study|Protocol Violation|0|||
162860834|NCT00174941|588197490|FG001|Overall Study|Protocol Violation|1|||
162860835|NCT00174941|588197491|FG002|Overall Study|Protocol Violation|0|||
162860836|NCT00174941|588197492|FG003|Overall Study|Protocol Violation|1|||
162860837|NCT00174941|588197489|FG000|Overall Study|Lost to Follow-up|0|||
162860838|NCT00174941|588197490|FG001|Overall Study|Lost to Follow-up|3|||
162860839|NCT00174941|588197491|FG002|Overall Study|Lost to Follow-up|2|||
162860840|NCT00174941|588197492|FG003|Overall Study|Lost to Follow-up|5|||
162860841|NCT00174941|588197489|FG000|Overall Study|Personal Reason(s)|0|||
162860842|NCT00174941|588197490|FG001|Overall Study|Personal Reason(s)|14|||
162860843|NCT00174941|588197491|FG002|Overall Study|Personal Reason(s)|8|||
162957565|NCT03249454|588546523|FG005|Overall Study|Withdrawal by Subject|0|||
162957566|NCT03249454|588546524|FG006|Overall Study|Withdrawal by Subject|0|||
162957567|NCT03249454|588546525|FG007|Overall Study|Withdrawal by Subject|0|||
162957568|NCT03249454|588546526|FG008|Overall Study|Withdrawal by Subject|0|||
162957569|NCT03249454|588546527|FG009|Overall Study|Withdrawal by Subject|1|||
162957570|NCT03249454|588546528|FG010|Overall Study|Withdrawal by Subject|1|||
162957571|NCT03987191|588546531|FG000|Overall Study|COVID-19 related research disruption|0|||
162957572|NCT03987191|588546532|FG001|Overall Study|COVID-19 related research disruption|2|||
162957573|NCT01020474|588546533|FG000|Overall Study|Adverse Event|4|||
162957574|NCT01020474|588546534|FG001|Overall Study|Adverse Event|4|||
162957575|NCT01020474|588546533|FG000|Overall Study|Protocol Violation|0|||
162957576|NCT01020474|588546534|FG001|Overall Study|Protocol Violation|2|||
162957577|NCT01020474|588546533|FG000|Overall Study|Withdrawal by Subject|5|||
162957578|NCT01020474|588546534|FG001|Overall Study|Withdrawal by Subject|7|||
162957579|NCT01020474|588546533|FG000|Overall Study|Other Reasons|1|||
162957580|NCT01020474|588546534|FG001|Overall Study|Other Reasons|1|||
162957581|NCT01020474|588546533|FG000|Overall Study|Insufficient Clinical Response|0|||
162957582|NCT01020474|588546534|FG001|Overall Study|Insufficient Clinical Response|3|||
162957583|NCT00107991|588546535|FG000|Eligibility Assessment|Disease not severe enough|7|||
162957584|NCT00107991|588546535|FG000|Eligibility Assessment|Unwilling to participate|7|||
162957585|NCT00107991|588546535|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
162957586|NCT00107991|588546535|FG000|Eligibility Assessment|Abnormal labs|2|||
162957587|NCT00107991|588546535|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
162957588|NCT00107991|588546535|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
162957589|NCT00107991|588546535|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
162957590|NCT00107991|588546535|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
162957591|NCT00107991|588546535|FG000|12 Week Treatment Period|Adverse Event|1|||
162957592|NCT00107991|588546535|FG000|12 Week Treatment Period|Protocol Violation|1|||
162957593|NCT00107991|588546535|FG000|12 Week Treatment Period|Incarcerated|1|||
162957594|NCT00107991|588546535|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
162957595|NCT03669861|588546536|FG000|Overall Study|Disease Flare|5|||
162957596|NCT03669861|588546536|FG000|Overall Study|Lack of Efficacy|2|||
162957597|NCT02760927|588546537|FG000|Overall Study|Tube Slippage from Device|1|||
162957598|NCT03256695|588546539|FG000|Overall Study|Adverse Event|8|||
162957599|NCT03256695|588546539|FG000|Overall Study|Death|2|||
162957600|NCT03256695|588546539|FG000|Overall Study|Withdrawal by Subject|14|||
162957601|NCT03256695|588546539|FG000|Overall Study|Non-compliance with study drug|1|||
162957602|NCT03256695|588546539|FG000|Overall Study|Lost to Follow-up|3|||
162957603|NCT03256695|588546539|FG000|Overall Study|Lack of Efficacy|3|||
162957604|NCT03256695|588546539|FG000|Overall Study|Protocol Violation|5|||
162860844|NCT00174941|588197492|FG003|Overall Study|Personal Reason(s)|22|||
162957605|NCT03256695|588546539|FG000|Overall Study|Other than specified|3|||
163045537|NCT02824224|588875030|FG000|Overall Study|Discontinued, IUS expulsion|0|||
163045538|NCT02824224|588875031|FG001|Overall Study|Discontinued, IUS expulsion|1|||
163045539|NCT02824224|588875030|FG000|Overall Study|Did not show up for allocation visit|2|||
163045540|NCT02824224|588875031|FG001|Overall Study|Did not show up for allocation visit|0|||
163045541|NCT04878055|588875038|FG000|Overall Study|Patient transferred in another department|0|||
163045542|NCT04878055|588875039|FG001|Overall Study|Patient transferred in another department|2|||
163045543|NCT04878055|588875038|FG000|Overall Study|Physician Decision|1|||
163045544|NCT04878055|588875039|FG001|Overall Study|Physician Decision|1|||
163045545|NCT04878055|588875038|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
163045546|NCT04878055|588875039|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
163045547|NCT04878055|588875038|FG000|Overall Study|Adverse Event|12|||
163045548|NCT04878055|588875039|FG001|Overall Study|Adverse Event|7|||
163045549|NCT04878055|588875038|FG000|Overall Study|Other|5|||
163045550|NCT04878055|588875039|FG001|Overall Study|Other|0|||
163045551|NCT04878055|588875038|FG000|Overall Study|Withdrawal by Subject|7|||
163045552|NCT04878055|588875039|FG001|Overall Study|Withdrawal by Subject|3|||
163045553|NCT04878055|588875038|FG000|Overall Study|Lost to Follow-up|10|||
163045554|NCT04878055|588875039|FG001|Overall Study|Lost to Follow-up|1|||
163045555|NCT01968811|588875040|FG000|Overall Study|Protocol Violation|4|||
163045556|NCT01968811|588875040|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
163045557|NCT01178125|588875042|FG000|Overall Study|Lost to Follow-up|397|||
163045558|NCT01178125|588875042|FG000|Overall Study|Adverse Event|244|||
163045559|NCT01178125|588875042|FG000|Overall Study|Withdrawal by Subject|209|||
163045560|NCT01178125|588875042|FG000|Overall Study|Noncompliance|184|||
163045561|NCT01178125|588875042|FG000|Overall Study|Pregnancy|55|||
163045562|NCT01178125|588875042|FG000|Overall Study|Other Reason|39|||
163045563|NCT01178125|588875042|FG000|Overall Study|Sponsor Decision|28|||
163045564|NCT01178125|588875042|FG000|Overall Study|Protocol Violation|17|||
163045565|NCT01178125|588875042|FG000|Overall Study|Investigator Decision|5|||
163045566|NCT01004978|588875043|FG000|Overall Study|Disease progression|31|||
163045567|NCT01004978|588875044|FG001|Overall Study|Disease progression|48|||
163045568|NCT01004978|588875043|FG000|Overall Study|Adverse Event|42|||
163045569|NCT01004978|588875044|FG001|Overall Study|Adverse Event|22|||
163045570|NCT01004978|588875043|FG000|Overall Study|Death|3|||
163045571|NCT01004978|588875044|FG001|Overall Study|Death|2|||
163045572|NCT01004978|588875043|FG000|Overall Study|Withdrawal by Subject|16|||
163045573|NCT01004978|588875044|FG001|Overall Study|Withdrawal by Subject|16|||
163045574|NCT01004978|588875043|FG000|Overall Study|Alternative therapy|4|||
163045575|NCT01004978|588875044|FG001|Overall Study|Alternative therapy|8|||
163045576|NCT01004978|588875043|FG000|Overall Study|Physician Decision|6|||
163045577|NCT01004978|588875044|FG001|Overall Study|Physician Decision|3|||
163045578|NCT01004978|588875043|FG000|Overall Study|Other complicating disease|2|||
163045579|NCT01004978|588875044|FG001|Overall Study|Other complicating disease|2|||
163045580|NCT01004978|588875043|FG000|Overall Study|Protocol Violation|2|||
163045581|NCT01004978|588875044|FG001|Overall Study|Protocol Violation|3|||
163045582|NCT01004978|588875043|FG000|Overall Study|Non-compliance|3|||
163045583|NCT01004978|588875044|FG001|Overall Study|Non-compliance|2|||
163045584|NCT01004978|588875043|FG000|Overall Study|Ineligible|1|||
163045585|NCT01004978|588875044|FG001|Overall Study|Ineligible|0|||
163045586|NCT01004978|588875043|FG000|Overall Study|Unblinded|0|||
163045587|NCT01004978|588875044|FG001|Overall Study|Unblinded|1|||
163045588|NCT01004978|588875043|FG000|Overall Study|Performance status worsening|0|||
163045589|NCT01004978|588875044|FG001|Overall Study|Performance status worsening|1|||
163045590|NCT01004978|588875043|FG000|Overall Study|Never started treatment|8|||
163045591|NCT01004978|588875044|FG001|Overall Study|Never started treatment|9|||
163045592|NCT00369915|588875045|FG000|Overall Study|expected side effects|2|||
163045593|NCT00369915|588875046|FG001|Overall Study|expected side effects|1|||
163045594|NCT00369915|588875045|FG000|Overall Study|Withdrawal by Subject|4|||
163045595|NCT00369915|588875046|FG001|Overall Study|Withdrawal by Subject|1|||
163045596|NCT00369915|588875045|FG000|Overall Study|W/drawl by investigators|0|||
163045597|NCT00369915|588875046|FG001|Overall Study|W/drawl by investigators|1|||
163045598|NCT00268983|588875056|FG000|Overall Study|Death|3|||
163045599|NCT00268983|588875057|FG001|Overall Study|Death|0|||
163045600|NCT01719380|588875058|FG000|Overall Study|Adverse Event|0|||
163045601|NCT01719380|588875059|FG001|Overall Study|Adverse Event|0|||
163045602|NCT01719380|588875060|FG002|Overall Study|Adverse Event|1|||
163045603|NCT01719380|588875061|FG003|Overall Study|Adverse Event|2|||
163045604|NCT01719380|588875062|FG004|Overall Study|Adverse Event|0|||
163045605|NCT01719380|588875063|FG005|Overall Study|Adverse Event|1|||
163045606|NCT01719380|588875064|FG006|Overall Study|Adverse Event|0|||
163045607|NCT01719380|588875065|FG007|Overall Study|Adverse Event|1|||
163045608|NCT01719380|588875066|FG008|Overall Study|Adverse Event|4|||
163045609|NCT01719380|588875067|FG009|Overall Study|Adverse Event|3|||
163045610|NCT01719380|588875058|FG000|Overall Study|Death|0|||
163045611|NCT01719380|588875059|FG001|Overall Study|Death|1|||
163045612|NCT01719380|588875060|FG002|Overall Study|Death|0|||
163045613|NCT01719380|588875061|FG003|Overall Study|Death|0|||
162957606|NCT02964039|588546545|FG000|Overall Study|Medical reason unrelated to study participation|1|||
162957607|NCT02964039|588546546|FG001|Overall Study|Medical reason unrelated to study participation|0|||
162957608|NCT02964039|588546547|FG002|Overall Study|Medical reason unrelated to study participation|3|||
162957609|NCT02964039|588546545|FG000|Overall Study|Research shutdown due to pandemic|2|||
162957610|NCT02964039|588546546|FG001|Overall Study|Research shutdown due to pandemic|0|||
162957611|NCT02964039|588546547|FG002|Overall Study|Research shutdown due to pandemic|1|||
162957612|NCT02964039|588546545|FG000|Overall Study|Withdrawal by Subject|0|||
162957613|NCT02964039|588546546|FG001|Overall Study|Withdrawal by Subject|1|||
162957614|NCT02964039|588546547|FG002|Overall Study|Withdrawal by Subject|0|||
162957615|NCT02964039|588546545|FG000|Overall Study|Lost to Follow-up|1|||
162957616|NCT02964039|588546546|FG001|Overall Study|Lost to Follow-up|0|||
162957617|NCT02964039|588546547|FG002|Overall Study|Lost to Follow-up|1|||
162957618|NCT01103713|588546548|FG000|Overall Study|Lost to Follow-up|2|||
162957619|NCT01103713|588546548|FG000|Overall Study|Withdrawal by Subject|8|||
162957620|NCT01103713|588546548|FG000|Overall Study|Study terminated by sponsor|2|||
162957621|NCT01103713|588546548|FG000|Overall Study|Other|1|||
162957622|NCT02089685|588546549|FG000|Overall Study|Adverse Event|1|||
162957623|NCT02089685|588546550|FG001|Overall Study|Adverse Event|0|||
162957624|NCT02089685|588546551|FG002|Overall Study|Adverse Event|0|||
162957625|NCT02089685|588546552|FG003|Overall Study|Adverse Event|0|||
162957626|NCT02089685|588546553|FG004|Overall Study|Adverse Event|1|||
162957627|NCT02089685|588546554|FG005|Overall Study|Adverse Event|0|||
162957628|NCT02089685|588546549|FG000|Overall Study|Clinical Progression|4|||
162957629|NCT02089685|588546550|FG001|Overall Study|Clinical Progression|0|||
162957630|NCT02089685|588546551|FG002|Overall Study|Clinical Progression|0|||
162957631|NCT02089685|588546552|FG003|Overall Study|Clinical Progression|5|||
162957632|NCT02089685|588546553|FG004|Overall Study|Clinical Progression|1|||
162957633|NCT02089685|588546554|FG005|Overall Study|Clinical Progression|2|||
162957634|NCT02089685|588546549|FG000|Overall Study|Excluded Medication|1|||
162957635|NCT02089685|588546550|FG001|Overall Study|Excluded Medication|0|||
162957636|NCT02089685|588546551|FG002|Overall Study|Excluded Medication|0|||
162957637|NCT02089685|588546552|FG003|Overall Study|Excluded Medication|11|||
162957638|NCT02089685|588546553|FG004|Overall Study|Excluded Medication|2|||
162957639|NCT02089685|588546554|FG005|Overall Study|Excluded Medication|1|||
162957640|NCT02089685|588546549|FG000|Overall Study|Progressive disease|13|||
162957641|NCT02089685|588546550|FG001|Overall Study|Progressive disease|10|||
162957642|NCT02089685|588546551|FG002|Overall Study|Progressive disease|3|||
162957643|NCT02089685|588546552|FG003|Overall Study|Progressive disease|51|||
162957644|NCT02089685|588546553|FG004|Overall Study|Progressive disease|17|||
162957645|NCT02089685|588546554|FG005|Overall Study|Progressive disease|12|||
162957646|NCT02089685|588546549|FG000|Overall Study|Follow up ended by sponsor|2|||
162957647|NCT02089685|588546550|FG001|Overall Study|Follow up ended by sponsor|2|||
162957648|NCT02089685|588546551|FG002|Overall Study|Follow up ended by sponsor|0|||
162957649|NCT02089685|588546552|FG003|Overall Study|Follow up ended by sponsor|70|||
162957650|NCT02089685|588546553|FG004|Overall Study|Follow up ended by sponsor|26|||
162957651|NCT02089685|588546554|FG005|Overall Study|Follow up ended by sponsor|26|||
162957652|NCT02089685|588546549|FG000|Overall Study|Withdrawal by Subject|0|||
162957653|NCT02089685|588546550|FG001|Overall Study|Withdrawal by Subject|2|||
162957654|NCT02089685|588546551|FG002|Overall Study|Withdrawal by Subject|0|||
162957655|NCT02089685|588546552|FG003|Overall Study|Withdrawal by Subject|8|||
162957656|NCT02089685|588546553|FG004|Overall Study|Withdrawal by Subject|1|||
162957657|NCT02089685|588546554|FG005|Overall Study|Withdrawal by Subject|1|||
162957658|NCT02089685|588546549|FG000|Overall Study|Status not recorded|1|||
162957659|NCT02089685|588546550|FG001|Overall Study|Status not recorded|0|||
162957660|NCT02089685|588546551|FG002|Overall Study|Status not recorded|0|||
162957661|NCT02089685|588546552|FG003|Overall Study|Status not recorded|0|||
162957662|NCT02089685|588546553|FG004|Overall Study|Status not recorded|1|||
162957663|NCT02089685|588546554|FG005|Overall Study|Status not recorded|0|||
162957664|NCT02089685|588546549|FG000|Overall Study|Death|0|||
162957665|NCT02089685|588546550|FG001|Overall Study|Death|0|||
162957666|NCT02089685|588546551|FG002|Overall Study|Death|0|||
162957667|NCT02089685|588546552|FG003|Overall Study|Death|7|||
162957668|NCT02089685|588546553|FG004|Overall Study|Death|2|||
162957669|NCT02089685|588546554|FG005|Overall Study|Death|5|||
162957670|NCT02089685|588546549|FG000|Overall Study|Lost to Follow-up|0|||
162957671|NCT02089685|588546550|FG001|Overall Study|Lost to Follow-up|0|||
162957672|NCT02089685|588546551|FG002|Overall Study|Lost to Follow-up|0|||
162957673|NCT02089685|588546552|FG003|Overall Study|Lost to Follow-up|1|||
162957674|NCT02089685|588546553|FG004|Overall Study|Lost to Follow-up|0|||
162957675|NCT02089685|588546554|FG005|Overall Study|Lost to Follow-up|0|||
162957676|NCT02089685|588546549|FG000|Overall Study|Physician Decision|0|||
162957677|NCT02089685|588546550|FG001|Overall Study|Physician Decision|0|||
163045614|NCT01719380|588875062|FG004|Overall Study|Death|0|||
162957678|NCT02089685|588546551|FG002|Overall Study|Physician Decision|0|||
162957679|NCT02089685|588546552|FG003|Overall Study|Physician Decision|0|||
162957680|NCT02089685|588546553|FG004|Overall Study|Physician Decision|0|||
162957681|NCT02089685|588546554|FG005|Overall Study|Physician Decision|4|||
162957682|NCT02089685|588546549|FG000|Overall Study|Screen failure|1|||
162957683|NCT02089685|588546550|FG001|Overall Study|Screen failure|0|||
162957684|NCT02089685|588546551|FG002|Overall Study|Screen failure|0|||
162957685|NCT02089685|588546552|FG003|Overall Study|Screen failure|0|||
162957686|NCT02089685|588546553|FG004|Overall Study|Screen failure|0|||
162957687|NCT02089685|588546554|FG005|Overall Study|Screen failure|0|||
162957688|NCT04887415|588546557|FG000|Overall Study|Lost to Follow-up|2|||
162957689|NCT00840411|588546558|FG000|First Intervention|Adverse Event|1|||
162957690|NCT00840411|588546559|FG001|First Intervention|Adverse Event|0|||
162957691|NCT00840411|588546558|FG000|Washout|Withdrawal by Subject|1|||
162957692|NCT00840411|588546559|FG001|Washout|Withdrawal by Subject|0|||
162957693|NCT01576042|588546561|FG000|Overall Study|Physician Decision|2|||
162957694|NCT01576042|588546562|FG001|Overall Study|Physician Decision|0|||
162957695|NCT03233724|588546563|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957696|NCT03233724|588546564|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957697|NCT03233724|588546565|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957698|NCT03233724|588546566|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162957699|NCT03233724|588546567|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
162957700|NCT03233724|588546563|FG000|Phase I Dose Escalation|Best interest of participant|1|||
162957701|NCT03233724|588546564|FG001|Phase I Dose Escalation|Best interest of participant|1|||
162957702|NCT03233724|588546565|FG002|Phase I Dose Escalation|Best interest of participant|1|||
162957703|NCT03233724|588546566|FG003|Phase I Dose Escalation|Best interest of participant|0|||
162957704|NCT03233724|588546567|FG004|Phase I Dose Escalation|Best interest of participant|0|||
162957705|NCT03233724|588546563|FG000|Phase I Dose Escalation|Physician Decision|0|||
162957706|NCT03233724|588546564|FG001|Phase I Dose Escalation|Physician Decision|0|||
162957707|NCT03233724|588546565|FG002|Phase I Dose Escalation|Physician Decision|1|||
162957708|NCT03233724|588546566|FG003|Phase I Dose Escalation|Physician Decision|0|||
162957709|NCT03233724|588546567|FG004|Phase I Dose Escalation|Physician Decision|0|||
162957710|NCT03233724|588546563|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957711|NCT03233724|588546564|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957712|NCT03233724|588546565|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
162957713|NCT03233724|588546566|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957714|NCT03233724|588546567|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
162957715|NCT00651820|588546570|FG000|Overall Study|Lost to Follow-up|2|||
162957716|NCT01911676|588546571|FG000|Period 1 of Study|Withdrawal by Subject|4|||
162957717|NCT01911676|588546572|FG001|Period 1 of Study|Withdrawal by Subject|2|||
162957718|NCT01911676|588546573|FG002|Period 1 of Study|Withdrawal by Subject|1|||
162957719|NCT01911676|588546574|FG003|Period 1 of Study|Withdrawal by Subject|2|||
162957720|NCT01911676|588546571|FG000|Period 1 of Study|Physician Decision|2|||
162957721|NCT01911676|588546572|FG001|Period 1 of Study|Physician Decision|0|||
162957722|NCT01911676|588546573|FG002|Period 1 of Study|Physician Decision|0|||
162957723|NCT01911676|588546574|FG003|Period 1 of Study|Physician Decision|1|||
162957724|NCT01911676|588546571|FG000|Period 2 of Study|Physician Decision|2|||
162957725|NCT01911676|588546572|FG001|Period 2 of Study|Physician Decision|0|||
162957726|NCT01911676|588546573|FG002|Period 2 of Study|Physician Decision|0|||
162957727|NCT01911676|588546574|FG003|Period 2 of Study|Physician Decision|1|||
162957728|NCT01911676|588546571|FG000|Period 2 of Study|Lost to Follow-up|0|||
162957729|NCT01911676|588546572|FG001|Period 2 of Study|Lost to Follow-up|0|||
162957730|NCT01911676|588546573|FG002|Period 2 of Study|Lost to Follow-up|0|||
162957731|NCT01911676|588546574|FG003|Period 2 of Study|Lost to Follow-up|1|||
162957732|NCT00773253|588546577|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
162957733|NCT00773253|588546578|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
162957734|NCT00657553|588546580|FG000|Overall Study|low accrual, no analysis run|5|||
162957735|NCT00657553|588546581|FG001|Overall Study|low accrual, no analysis run|5|||
162957736|NCT03173547|588546582|FG000|Overall Study|Adverse Event|2|||
162957737|NCT03173547|588546583|FG001|Overall Study|Adverse Event|0|||
162957738|NCT03173547|588546582|FG000|Overall Study|Withdrawal by Subject|2|||
162957739|NCT03173547|588546583|FG001|Overall Study|Withdrawal by Subject|2|||
162957740|NCT01566721|588546584|FG000|Treatment Period|Withdrawal by Subject|35|||
163045615|NCT01719380|588875063|FG005|Overall Study|Death|0|||
162957741|NCT01566721|588546585|FG001|Treatment Period|Withdrawal by Subject|9|||
162957742|NCT01566721|588546584|FG000|Treatment Period|Disease Progression/Recurrence|37|||
162957743|NCT01566721|588546585|FG001|Treatment Period|Disease Progression/Recurrence|13|||
162957744|NCT01566721|588546584|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
162957745|NCT01566721|588546585|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
162957746|NCT01566721|588546584|FG000|Treatment Period|Other|13|||
162957747|NCT01566721|588546585|FG001|Treatment Period|Other|2|||
162957748|NCT01566721|588546584|FG000|Treatment Period|Lack of Compliance|5|||
162860845|NCT00174941|588197489|FG000|Overall Study|Gout Flare|0|||
162860846|NCT00174941|588197490|FG001|Overall Study|Gout Flare|4|||
162860847|NCT00174941|588197491|FG002|Overall Study|Gout Flare|4|||
162860848|NCT00174941|588197492|FG003|Overall Study|Gout Flare|8|||
162860849|NCT00174941|588197489|FG000|Overall Study|Reason Not Specified|1|||
162860850|NCT00174941|588197490|FG001|Overall Study|Reason Not Specified|6|||
162860851|NCT00174941|588197491|FG002|Overall Study|Reason Not Specified|2|||
162860852|NCT00174941|588197492|FG003|Overall Study|Reason Not Specified|9|||
162860853|NCT03230097|588197495|FG000|Overall Study|Adverse Event|2|||
162860854|NCT03230097|588197496|FG001|Overall Study|Adverse Event|1|||
162860855|NCT03230097|588197495|FG000|Overall Study|non-compliance|0|||
162860856|NCT03230097|588197496|FG001|Overall Study|non-compliance|1|||
162860857|NCT03230097|588197495|FG000|Overall Study|Lost to Follow-up|2|||
162860858|NCT03230097|588197496|FG001|Overall Study|Lost to Follow-up|4|||
162860859|NCT03230097|588197495|FG000|Overall Study|Withdrawal by Subject|7|||
162860860|NCT03230097|588197496|FG001|Overall Study|Withdrawal by Subject|3|||
162860861|NCT03230097|588197495|FG000|Overall Study|Trial termination|4|||
162860862|NCT03230097|588197496|FG001|Overall Study|Trial termination|5|||
162860863|NCT03230097|588197495|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
162860864|NCT03230097|588197496|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
162860865|NCT03230097|588197495|FG000|Overall Study|outcome event|0|||
162860866|NCT03230097|588197496|FG001|Overall Study|outcome event|1|||
162860867|NCT01588197|588197513|FG000|Overall Study|Lack of Efficacy|0|||
162860868|NCT01588197|588197514|FG001|Overall Study|Lack of Efficacy|1|||
162860869|NCT01588197|588197513|FG000|Overall Study|No MRI|1|||
162860870|NCT01588197|588197514|FG001|Overall Study|No MRI|0|||
162860871|NCT01844076|588197521|FG000|Overall Study|Adverse Event|1|||
162860872|NCT01844076|588197522|FG001|Overall Study|Adverse Event|0|||
162860873|NCT01844076|588197523|FG002|Overall Study|Adverse Event|0|||
162860874|NCT01844076|588197524|FG003|Overall Study|Adverse Event|0|||
162860875|NCT01844076|588197521|FG000|Overall Study|Withdrawal by Subject|1|||
162860876|NCT01844076|588197522|FG001|Overall Study|Withdrawal by Subject|0|||
162860877|NCT01844076|588197523|FG002|Overall Study|Withdrawal by Subject|0|||
162860878|NCT01844076|588197524|FG003|Overall Study|Withdrawal by Subject|0|||
162860879|NCT00635102|588197531|FG000|Overall Study|Withdrawal by Subject|7|||
162860880|NCT00635102|588197532|FG001|Overall Study|Withdrawal by Subject|8|||
162860881|NCT00440401|588197535|FG000|Overall Study|Adverse Event|2|||
162860882|NCT00440401|588197536|FG001|Overall Study|Adverse Event|1|||
162860883|NCT00440401|588197535|FG000|Overall Study|Other|2|||
162860884|NCT00440401|588197536|FG001|Overall Study|Other|5|||
162860885|NCT02088034|588197537|FG000|Overall Study|Lost to Follow-up|1|||
162860886|NCT02088034|588197538|FG001|Overall Study|Lost to Follow-up|1|||
162860887|NCT02088034|588197539|FG002|Overall Study|Lost to Follow-up|0|||
162860888|NCT02088034|588197537|FG000|Overall Study|Pregnancy|2|||
162860889|NCT02088034|588197538|FG001|Overall Study|Pregnancy|1|||
162860890|NCT02088034|588197539|FG002|Overall Study|Pregnancy|2|||
162860891|NCT01937312|588197540|FG000|Overall Study|Adverse Event|10|||
162860892|NCT01937312|588197541|FG001|Overall Study|Adverse Event|1|||
162860893|NCT01937312|588197540|FG000|Overall Study|Lack of Efficacy|0|||
162860894|NCT01937312|588197541|FG001|Overall Study|Lack of Efficacy|1|||
162860895|NCT01937312|588197540|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
162860896|NCT01937312|588197541|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
162860897|NCT05309083|588197543|FG000|Overall Study|Withdrawal by Subject|2|||
162860898|NCT02388776|588197544|FG000|Overall Study|Death|1|||
162860899|NCT02388776|588197544|FG000|Overall Study|Lost to Follow-up|1|||
162860900|NCT04246047|588197551|FG000|Overall Study|Death|50|||
162860901|NCT04246047|588197552|FG001|Overall Study|Death|77|||
162860902|NCT04246047|588197551|FG000|Overall Study|Lost to Follow-up|1|||
162860903|NCT04246047|588197552|FG001|Overall Study|Lost to Follow-up|3|||
162860904|NCT04246047|588197551|FG000|Overall Study|Physician Decision|4|||
162860905|NCT04246047|588197552|FG001|Overall Study|Physician Decision|10|||
162860906|NCT04246047|588197551|FG000|Overall Study|Withdrawal by Subject|19|||
162860907|NCT04246047|588197552|FG001|Overall Study|Withdrawal by Subject|26|||
162860908|NCT04246047|588197551|FG000|Overall Study|Ongoing|169|||
162860909|NCT04246047|588197552|FG001|Overall Study|Ongoing|135|||
162860910|NCT00845429|588197562|FG000|Overall Study|Protocol Violation|5|||
162860911|NCT00845429|588197563|FG001|Overall Study|Protocol Violation|4|||
162860912|NCT00845429|588197564|FG002|Overall Study|Protocol Violation|7|||
162957749|NCT01566721|588546585|FG001|Treatment Period|Lack of Compliance|1|||
162957750|NCT01566721|588546584|FG000|Treatment Period|Adverse Event|100|||
162860913|NCT00845429|588197562|FG000|Overall Study|Lost to Follow-up|7|||
162860914|NCT00845429|588197563|FG001|Overall Study|Lost to Follow-up|9|||
162860915|NCT00845429|588197564|FG002|Overall Study|Lost to Follow-up|10|||
162860916|NCT00845429|588197562|FG000|Overall Study|Withdrawal by Subject|2|||
162860917|NCT00845429|588197563|FG001|Overall Study|Withdrawal by Subject|2|||
162860918|NCT00845429|588197564|FG002|Overall Study|Withdrawal by Subject|2|||
162860919|NCT00845429|588197562|FG000|Overall Study|Serious adverse event|0|||
162860920|NCT00845429|588197563|FG001|Overall Study|Serious adverse event|0|||
162860921|NCT00845429|588197564|FG002|Overall Study|Serious adverse event|1|||
162860922|NCT00587223|588197567|FG000|Overall Study|Adverse Event|1|||
163045616|NCT01719380|588875064|FG006|Overall Study|Death|0|||
163045617|NCT01719380|588875065|FG007|Overall Study|Death|0|||
163045618|NCT01719380|588875066|FG008|Overall Study|Death|3|||
163045619|NCT01719380|588875067|FG009|Overall Study|Death|3|||
163045620|NCT01719380|588875058|FG000|Overall Study|Participant/Guardian Decision|0|||
163045621|NCT01719380|588875059|FG001|Overall Study|Participant/Guardian Decision|0|||
163045622|NCT01719380|588875060|FG002|Overall Study|Participant/Guardian Decision|1|||
163045623|NCT01719380|588875061|FG003|Overall Study|Participant/Guardian Decision|0|||
163045624|NCT01719380|588875062|FG004|Overall Study|Participant/Guardian Decision|0|||
163045625|NCT01719380|588875063|FG005|Overall Study|Participant/Guardian Decision|0|||
163045626|NCT01719380|588875064|FG006|Overall Study|Participant/Guardian Decision|0|||
163045627|NCT01719380|588875065|FG007|Overall Study|Participant/Guardian Decision|0|||
163045628|NCT01719380|588875066|FG008|Overall Study|Participant/Guardian Decision|2|||
163045629|NCT01719380|588875067|FG009|Overall Study|Participant/Guardian Decision|2|||
162613222|NCT00445978|587301160|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
162613223|NCT00445978|587301160|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
162613224|NCT00445978|587301160|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
162613225|NCT00445978|587301160|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
162613226|NCT00445978|587301160|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
162613227|NCT00445978|587301160|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
162613228|NCT00445978|587301160|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
162613229|NCT00445978|587301160|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
162613230|NCT03112590|587301161|FG000|Overall Study|Adverse Event|0|||
162613231|NCT03112590|587301162|FG001|Overall Study|Adverse Event|1|||
162613232|NCT03112590|587301163|FG002|Overall Study|Adverse Event|0|||
162613233|NCT02436681|587301164|FG000|Overall Study|Lost to Follow-up|10|||
162613234|NCT02436681|587301164|FG000|Overall Study|Withdrawal by Subject|2|||
162613235|NCT02436681|587301164|FG000|Overall Study|Death|2|||
162613236|NCT00739596|587301165|FG000|Overall Study|Adverse Event|12|||
162613237|NCT00739596|587301166|FG001|Overall Study|Adverse Event|6|||
162613238|NCT00739596|587301165|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162613239|NCT00739596|587301166|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162613240|NCT00739596|587301165|FG000|Overall Study|Patient Withdrew Consent|8|||
162613241|NCT00739596|587301166|FG001|Overall Study|Patient Withdrew Consent|8|||
162613242|NCT00739596|587301165|FG000|Overall Study|Lost to Follow-up|0|||
162613243|NCT00739596|587301166|FG001|Overall Study|Lost to Follow-up|2|||
162613244|NCT00739596|587301165|FG000|Overall Study|Protocol Deviation|1|||
162613245|NCT00739596|587301166|FG001|Overall Study|Protocol Deviation|1|||
162613246|NCT03635788|587301176|FG000|Step 1|Death|1|||
162613247|NCT03635788|587301177|FG001|Step 1|Death|0|||
162613248|NCT03635788|587301178|FG002|Step 1|Death|0|||
162613249|NCT03635788|587301176|FG000|Step 1|Lost to Follow-up|31|||
162613250|NCT03635788|587301177|FG001|Step 1|Lost to Follow-up|0|||
162613251|NCT03635788|587301178|FG002|Step 1|Lost to Follow-up|0|||
162613252|NCT03635788|587301176|FG000|Step 1|Pregnancy|1|||
162613253|NCT03635788|587301177|FG001|Step 1|Pregnancy|0|||
162613254|NCT03635788|587301178|FG002|Step 1|Pregnancy|0|||
162613255|NCT03635788|587301176|FG000|Step 1|Protocol Violation|8|||
162613256|NCT03635788|587301177|FG001|Step 1|Protocol Violation|0|||
162613257|NCT03635788|587301178|FG002|Step 1|Protocol Violation|0|||
162613258|NCT03635788|587301176|FG000|Step 1|Withdrawal by Subject|13|||
162613259|NCT03635788|587301177|FG001|Step 1|Withdrawal by Subject|0|||
162613260|NCT03635788|587301178|FG002|Step 1|Withdrawal by Subject|0|||
162613261|NCT03635788|587301176|FG000|Step 1|Other reasons|12|||
162613262|NCT03635788|587301177|FG001|Step 1|Other reasons|0|||
162613263|NCT03635788|587301178|FG002|Step 1|Other reasons|0|||
162613264|NCT03635788|587301176|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
162613265|NCT03635788|587301177|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
162613266|NCT03635788|587301178|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
162613267|NCT03635788|587301176|FG000|Step 2|Lost to Follow-up|0|||
162613268|NCT03635788|587301177|FG001|Step 2|Lost to Follow-up|8|||
162613269|NCT03635788|587301178|FG002|Step 2|Lost to Follow-up|15|||
162613270|NCT03635788|587301176|FG000|Step 2|Withdrawal by Subject|0|||
162613271|NCT03635788|587301177|FG001|Step 2|Withdrawal by Subject|6|||
162613272|NCT03635788|587301178|FG002|Step 2|Withdrawal by Subject|6|||
162613273|NCT03635788|587301176|FG000|Step 2|Death|0|||
162613274|NCT03635788|587301177|FG001|Step 2|Death|2|||
162613275|NCT03635788|587301178|FG002|Step 2|Death|0|||
162613276|NCT03635788|587301176|FG000|Step 2|Incarceration|0|||
162613277|NCT03635788|587301177|FG001|Step 2|Incarceration|2|||
162613278|NCT03635788|587301178|FG002|Step 2|Incarceration|0|||
162613279|NCT03635788|587301176|FG000|Step 2|Non-Compliance With Study Requirements|0|||
162613280|NCT03635788|587301177|FG001|Step 2|Non-Compliance With Study Requirements|1|||
162613281|NCT03635788|587301178|FG002|Step 2|Non-Compliance With Study Requirements|1|||
162613282|NCT03635788|587301176|FG000|Step 2|Confounding Medical Condition|0|||
162613283|NCT03635788|587301177|FG001|Step 2|Confounding Medical Condition|0|||
162613284|NCT03635788|587301178|FG002|Step 2|Confounding Medical Condition|1|||
162613285|NCT03635788|587301176|FG000|Step 2|Out Of State With No Plan To Return|0|||
162613286|NCT03635788|587301177|FG001|Step 2|Out Of State With No Plan To Return|1|||
162860923|NCT03519178|588197568|FG000|PF-06873600 Treatment|Adverse Event|0|||
162860924|NCT03519178|588197569|FG001|PF-06873600 Treatment|Adverse Event|0|||
162860925|NCT03519178|588197570|FG002|PF-06873600 Treatment|Adverse Event|0|||
162860926|NCT03519178|588197571|FG003|PF-06873600 Treatment|Adverse Event|0|||
162860927|NCT03519178|588197572|FG004|PF-06873600 Treatment|Adverse Event|0|||
162860928|NCT03519178|588197573|FG005|PF-06873600 Treatment|Adverse Event|0|||
162860929|NCT03519178|588197574|FG006|PF-06873600 Treatment|Adverse Event|0|||
162860930|NCT03519178|588197575|FG007|PF-06873600 Treatment|Adverse Event|2|||
162860931|NCT03519178|588197576|FG008|PF-06873600 Treatment|Adverse Event|1|||
162860932|NCT03519178|588197577|FG009|PF-06873600 Treatment|Adverse Event|0|||
162860933|NCT03519178|588197578|FG010|PF-06873600 Treatment|Adverse Event|0|||
162860934|NCT03519178|588197579|FG011|PF-06873600 Treatment|Adverse Event|0|||
162860935|NCT03519178|588197580|FG012|PF-06873600 Treatment|Adverse Event|1|||
162860936|NCT03519178|588197581|FG013|PF-06873600 Treatment|Adverse Event|3|||
162860937|NCT03519178|588197582|FG014|PF-06873600 Treatment|Adverse Event|2|||
162860938|NCT03519178|588197568|FG000|PF-06873600 Treatment|Death|0|||
162860939|NCT03519178|588197569|FG001|PF-06873600 Treatment|Death|0|||
162860940|NCT03519178|588197570|FG002|PF-06873600 Treatment|Death|0|||
162860941|NCT03519178|588197571|FG003|PF-06873600 Treatment|Death|0|||
162860942|NCT03519178|588197572|FG004|PF-06873600 Treatment|Death|0|||
162860943|NCT03519178|588197573|FG005|PF-06873600 Treatment|Death|0|||
162860944|NCT03519178|588197574|FG006|PF-06873600 Treatment|Death|0|||
162860945|NCT03519178|588197575|FG007|PF-06873600 Treatment|Death|0|||
162860946|NCT03519178|588197576|FG008|PF-06873600 Treatment|Death|1|||
162860947|NCT03519178|588197577|FG009|PF-06873600 Treatment|Death|1|||
162860948|NCT03519178|588197578|FG010|PF-06873600 Treatment|Death|0|||
162860949|NCT03519178|588197579|FG011|PF-06873600 Treatment|Death|0|||
162860950|NCT03519178|588197580|FG012|PF-06873600 Treatment|Death|0|||
162860951|NCT03519178|588197581|FG013|PF-06873600 Treatment|Death|0|||
162860952|NCT03519178|588197582|FG014|PF-06873600 Treatment|Death|1|||
162860953|NCT03519178|588197568|FG000|PF-06873600 Treatment|Physician Decision|0|||
162860954|NCT03519178|588197569|FG001|PF-06873600 Treatment|Physician Decision|0|||
162860955|NCT03519178|588197570|FG002|PF-06873600 Treatment|Physician Decision|0|||
162860956|NCT03519178|588197571|FG003|PF-06873600 Treatment|Physician Decision|0|||
162860957|NCT03519178|588197572|FG004|PF-06873600 Treatment|Physician Decision|0|||
162860958|NCT03519178|588197573|FG005|PF-06873600 Treatment|Physician Decision|0|||
162860959|NCT03519178|588197574|FG006|PF-06873600 Treatment|Physician Decision|0|||
162860960|NCT03519178|588197575|FG007|PF-06873600 Treatment|Physician Decision|1|||
162860961|NCT03519178|588197576|FG008|PF-06873600 Treatment|Physician Decision|0|||
162860962|NCT03519178|588197577|FG009|PF-06873600 Treatment|Physician Decision|0|||
162860963|NCT03519178|588197578|FG010|PF-06873600 Treatment|Physician Decision|1|||
162860964|NCT03519178|588197579|FG011|PF-06873600 Treatment|Physician Decision|0|||
162860965|NCT03519178|588197580|FG012|PF-06873600 Treatment|Physician Decision|0|||
162860966|NCT03519178|588197581|FG013|PF-06873600 Treatment|Physician Decision|4|||
162860967|NCT03519178|588197582|FG014|PF-06873600 Treatment|Physician Decision|1|||
162860968|NCT03519178|588197568|FG000|PF-06873600 Treatment|Progressive disease|1|||
162860969|NCT03519178|588197569|FG001|PF-06873600 Treatment|Progressive disease|1|||
162860970|NCT03519178|588197570|FG002|PF-06873600 Treatment|Progressive disease|1|||
162860971|NCT03519178|588197571|FG003|PF-06873600 Treatment|Progressive disease|1|||
162860972|NCT03519178|588197572|FG004|PF-06873600 Treatment|Progressive disease|6|||
162860973|NCT03519178|588197573|FG005|PF-06873600 Treatment|Progressive disease|7|||
162860974|NCT03519178|588197574|FG006|PF-06873600 Treatment|Progressive disease|3|||
162860975|NCT03519178|588197575|FG007|PF-06873600 Treatment|Progressive disease|7|||
162860976|NCT03519178|588197576|FG008|PF-06873600 Treatment|Progressive disease|3|||
162860977|NCT03519178|588197577|FG009|PF-06873600 Treatment|Progressive disease|5|||
162860978|NCT03519178|588197578|FG010|PF-06873600 Treatment|Progressive disease|4|||
162860979|NCT03519178|588197579|FG011|PF-06873600 Treatment|Progressive disease|3|||
162860980|NCT03519178|588197580|FG012|PF-06873600 Treatment|Progressive disease|4|||
162860981|NCT03519178|588197581|FG013|PF-06873600 Treatment|Progressive disease|28|||
162860982|NCT03519178|588197582|FG014|PF-06873600 Treatment|Progressive disease|8|||
162860983|NCT03519178|588197568|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
162860984|NCT03519178|588197569|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
162860985|NCT03519178|588197570|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
162860986|NCT03519178|588197571|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
162957751|NCT01566721|588546585|FG001|Treatment Period|Adverse Event|30|||
162957752|NCT01566721|588546584|FG000|Treatment Period|Pregnancy|1|||
162957753|NCT01566721|588546585|FG001|Treatment Period|Pregnancy|0|||
162957754|NCT01566721|588546584|FG000|Safety Follow-up|Physician Decision|6|||
162957755|NCT01566721|588546585|FG001|Safety Follow-up|Physician Decision|4|||
162957756|NCT01566721|588546584|FG000|Safety Follow-up|Lost to Follow-up|101|||
162860987|NCT03519178|588197572|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
162860988|NCT03519178|588197573|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
162860989|NCT03519178|588197574|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
162860990|NCT03519178|588197575|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
162860991|NCT03519178|588197576|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
162860992|NCT03519178|588197577|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
162860993|NCT03519178|588197578|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
162860994|NCT03519178|588197579|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
162860995|NCT03519178|588197580|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
162860996|NCT03519178|588197581|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
162860997|NCT03519178|588197582|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
162860998|NCT03519178|588197568|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
162860999|NCT03519178|588197569|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
162861000|NCT03519178|588197570|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
162861001|NCT03519178|588197571|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
162861002|NCT03519178|588197572|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
162861003|NCT03519178|588197573|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
162861004|NCT03519178|588197574|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
162861005|NCT03519178|588197575|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
162861006|NCT03519178|588197576|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
162861007|NCT03519178|588197577|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
162861008|NCT03519178|588197578|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
162861009|NCT03519178|588197579|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
162861010|NCT03519178|588197580|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
162861011|NCT03519178|588197581|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
162861012|NCT03519178|588197582|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
162861013|NCT03519178|588197568|FG000|PF-06873600 Treatment|Refused further treatment|0|||
162861014|NCT03519178|588197569|FG001|PF-06873600 Treatment|Refused further treatment|1|||
162861015|NCT03519178|588197570|FG002|PF-06873600 Treatment|Refused further treatment|0|||
162861016|NCT03519178|588197571|FG003|PF-06873600 Treatment|Refused further treatment|0|||
162861017|NCT03519178|588197572|FG004|PF-06873600 Treatment|Refused further treatment|1|||
162861018|NCT03519178|588197573|FG005|PF-06873600 Treatment|Refused further treatment|0|||
162861019|NCT03519178|588197574|FG006|PF-06873600 Treatment|Refused further treatment|0|||
162861020|NCT03519178|588197575|FG007|PF-06873600 Treatment|Refused further treatment|0|||
162861021|NCT03519178|588197576|FG008|PF-06873600 Treatment|Refused further treatment|0|||
162861022|NCT03519178|588197577|FG009|PF-06873600 Treatment|Refused further treatment|0|||
162861023|NCT03519178|588197578|FG010|PF-06873600 Treatment|Refused further treatment|0|||
162861024|NCT03519178|588197579|FG011|PF-06873600 Treatment|Refused further treatment|0|||
162861025|NCT03519178|588197580|FG012|PF-06873600 Treatment|Refused further treatment|0|||
162861026|NCT03519178|588197581|FG013|PF-06873600 Treatment|Refused further treatment|0|||
162861027|NCT03519178|588197582|FG014|PF-06873600 Treatment|Refused further treatment|1|||
162861028|NCT03519178|588197568|FG000|PF-06873600 Treatment|Other|0|||
162861029|NCT03519178|588197569|FG001|PF-06873600 Treatment|Other|0|||
162861030|NCT03519178|588197570|FG002|PF-06873600 Treatment|Other|0|||
162861031|NCT03519178|588197571|FG003|PF-06873600 Treatment|Other|0|||
162957757|NCT01566721|588546585|FG001|Safety Follow-up|Lost to Follow-up|48|||
162957758|NCT01566721|588546584|FG000|Safety Follow-up|Withdrawal by Subject|155|||
162957759|NCT01566721|588546585|FG001|Safety Follow-up|Withdrawal by Subject|49|||
162957760|NCT01566721|588546584|FG000|Safety Follow-up|Death|28|||
162957761|NCT01566721|588546585|FG001|Safety Follow-up|Death|4|||
162957762|NCT01566721|588546584|FG000|Safety Follow-up|Non-compliance|7|||
162957763|NCT01566721|588546585|FG001|Safety Follow-up|Non-compliance|3|||
162957764|NCT01566721|588546584|FG000|Safety Follow-up|Protocol Violation|7|||
162957765|NCT01566721|588546585|FG001|Safety Follow-up|Protocol Violation|0|||
162957766|NCT01566721|588546584|FG000|Safety Follow-up|Site closure|2|||
162957767|NCT01566721|588546585|FG001|Safety Follow-up|Site closure|3|||
162957768|NCT01566721|588546584|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
162957769|NCT01566721|588546585|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
162957770|NCT01566721|588546584|FG000|Safety Follow-up|Missing|7|||
162957771|NCT01566721|588546585|FG001|Safety Follow-up|Missing|2|||
162957772|NCT01566721|588546584|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
162957773|NCT01566721|588546585|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
162957774|NCT01566721|588546584|FG000|Safety Follow-up|Sponsor decision|1|||
162957775|NCT01566721|588546585|FG001|Safety Follow-up|Sponsor decision|0|||
162957776|NCT01566721|588546584|FG000|Safety Follow-up|Adverse Event|8|||
162957777|NCT01566721|588546585|FG001|Safety Follow-up|Adverse Event|4|||
162957778|NCT00811655|588546591|FG000|Overall Study|Physician Decision|1|||
162957779|NCT00119015|588546593|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
162861032|NCT03519178|588197572|FG004|PF-06873600 Treatment|Other|0|||
162861033|NCT03519178|588197573|FG005|PF-06873600 Treatment|Other|0|||
162957780|NCT00119015|588546594|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
162957781|NCT00119015|588546595|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
162957782|NCT00787254|588546598|FG000|Overall Study|Adverse Event|24|||
162957783|NCT00787254|588546599|FG001|Overall Study|Adverse Event|23|||
162957784|NCT00787254|588546598|FG000|Overall Study|Protocol Violation|26|||
162957785|NCT00787254|588546599|FG001|Overall Study|Protocol Violation|23|||
162957786|NCT00787254|588546598|FG000|Overall Study|Withdrawal by Subject|16|||
163045630|NCT01719380|588875058|FG000|Overall Study|Physician Decision|0|||
163045631|NCT01719380|588875059|FG001|Overall Study|Physician Decision|0|||
163045632|NCT01719380|588875060|FG002|Overall Study|Physician Decision|2|||
163045633|NCT01719380|588875061|FG003|Overall Study|Physician Decision|0|||
163045634|NCT01719380|588875062|FG004|Overall Study|Physician Decision|0|||
163045635|NCT01719380|588875063|FG005|Overall Study|Physician Decision|0|||
163045636|NCT01719380|588875064|FG006|Overall Study|Physician Decision|0|||
163045637|NCT01719380|588875065|FG007|Overall Study|Physician Decision|0|||
163045638|NCT01719380|588875066|FG008|Overall Study|Physician Decision|1|||
163045639|NCT01719380|588875067|FG009|Overall Study|Physician Decision|1|||
163045640|NCT01719380|588875058|FG000|Overall Study|Lack of Efficacy|2|||
163045641|NCT01719380|588875059|FG001|Overall Study|Lack of Efficacy|6|||
163045642|NCT01719380|588875060|FG002|Overall Study|Lack of Efficacy|5|||
163045643|NCT01719380|588875061|FG003|Overall Study|Lack of Efficacy|6|||
163045644|NCT01719380|588875062|FG004|Overall Study|Lack of Efficacy|3|||
163045645|NCT01719380|588875063|FG005|Overall Study|Lack of Efficacy|7|||
163045646|NCT01719380|588875064|FG006|Overall Study|Lack of Efficacy|10|||
163045647|NCT01719380|588875065|FG007|Overall Study|Lack of Efficacy|6|||
163045648|NCT01719380|588875066|FG008|Overall Study|Lack of Efficacy|39|||
163045649|NCT01719380|588875067|FG009|Overall Study|Lack of Efficacy|42|||
163045650|NCT01719380|588875058|FG000|Overall Study|Progressive Disease|0|||
163045651|NCT01719380|588875059|FG001|Overall Study|Progressive Disease|0|||
163045652|NCT01719380|588875060|FG002|Overall Study|Progressive Disease|0|||
163045653|NCT01719380|588875061|FG003|Overall Study|Progressive Disease|0|||
163045654|NCT01719380|588875062|FG004|Overall Study|Progressive Disease|0|||
163045655|NCT01719380|588875063|FG005|Overall Study|Progressive Disease|0|||
163045656|NCT01719380|588875064|FG006|Overall Study|Progressive Disease|0|||
163045657|NCT01719380|588875065|FG007|Overall Study|Progressive Disease|0|||
163045658|NCT01719380|588875066|FG008|Overall Study|Progressive Disease|1|||
163045659|NCT01719380|588875067|FG009|Overall Study|Progressive Disease|0|||
163045660|NCT00249873|588875070|FG000|Overall Study|Not treated|7|||
163045661|NCT00249873|588875071|FG001|Overall Study|Not treated|8|||
163045662|NCT00249873|588875070|FG000|Overall Study|Significant thrombocytopenia|9|||
163045663|NCT00249873|588875071|FG001|Overall Study|Significant thrombocytopenia|8|||
163045664|NCT00249873|588875070|FG000|Overall Study|Severe allergic reaction|8|||
163045665|NCT00249873|588875071|FG001|Overall Study|Severe allergic reaction|1|||
163045666|NCT00249873|588875070|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
163045667|NCT00249873|588875071|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
163045668|NCT00249873|588875070|FG000|Overall Study|Other Serious Adverse Event|86|||
163045669|NCT00249873|588875071|FG001|Overall Study|Other Serious Adverse Event|97|||
163045670|NCT00249873|588875070|FG000|Overall Study|Qualifying condition not present|20|||
163045671|NCT00249873|588875071|FG001|Overall Study|Qualifying condition not present|23|||
163045672|NCT00249873|588875070|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
163045673|NCT00249873|588875071|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
163045674|NCT00249873|588875070|FG000|Overall Study|Withdrawal by Subject|504|||
163045675|NCT00249873|588875071|FG001|Overall Study|Withdrawal by Subject|466|||
163045676|NCT00249873|588875070|FG000|Overall Study|Lost to Follow-up|4|||
163045677|NCT00249873|588875071|FG001|Overall Study|Lost to Follow-up|7|||
163045678|NCT00249873|588875070|FG000|Overall Study|Minor bleeding|99|||
163045679|NCT00249873|588875071|FG001|Overall Study|Minor bleeding|37|||
163045680|NCT00249873|588875070|FG000|Overall Study|Non-compliance|41|||
163045681|NCT00249873|588875071|FG001|Overall Study|Non-compliance|46|||
163045682|NCT00249873|588875070|FG000|Overall Study|Other non serious Adverse Event|112|||
163045683|NCT00249873|588875071|FG001|Overall Study|Other non serious Adverse Event|108|||
163045684|NCT00249873|588875070|FG000|Overall Study|Other contraindicated medication|1|||
163045685|NCT00249873|588875071|FG001|Overall Study|Other contraindicated medication|0|||
163045686|NCT00249873|588875070|FG000|Overall Study|Patient not wish to continue after May08|3|||
163045687|NCT00249873|588875071|FG001|Overall Study|Patient not wish to continue after May08|4|||
163045688|NCT00249873|588875070|FG000|Overall Study|Physician withdrew consent|59|||
163045689|NCT00249873|588875071|FG001|Overall Study|Physician withdrew consent|60|||
163045690|NCT00249873|588875070|FG000|Overall Study|Open label clopidogrel required|31|||
163045691|NCT00249873|588875071|FG001|Overall Study|Open label clopidogrel required|42|||
163045692|NCT00249873|588875070|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
163045693|NCT00249873|588875071|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
163045694|NCT00249873|588875070|FG000|Overall Study|Oral anticoagulant required|159|||
163045695|NCT00249873|588875071|FG001|Overall Study|Oral anticoagulant required|157|||
163045696|NCT00249873|588875070|FG000|Overall Study|Study drug intolerance|5|||
163045697|NCT00249873|588875071|FG001|Overall Study|Study drug intolerance|0|||
163045698|NCT00249873|588875070|FG000|Overall Study|Surgery/ procedure|9|||
163045699|NCT00249873|588875071|FG001|Overall Study|Surgery/ procedure|9|||
163045700|NCT00249873|588875070|FG000|Overall Study|Event related to cardiac condition|12|||
163045701|NCT00249873|588875071|FG001|Overall Study|Event related to cardiac condition|21|||
163045702|NCT00249873|588875070|FG000|Overall Study|Thromboembolic/outcome event|82|||
163045703|NCT00249873|588875071|FG001|Overall Study|Thromboembolic/outcome event|122|||
163045704|NCT02532374|588875072|FG000|Overall Study|Withdrawal by Subject|1|||
163045705|NCT02532374|588875072|FG000|Overall Study|Physician Decision|1|||
162861034|NCT03519178|588197574|FG006|PF-06873600 Treatment|Other|0|||
162861035|NCT03519178|588197575|FG007|PF-06873600 Treatment|Other|0|||
162861036|NCT03519178|588197576|FG008|PF-06873600 Treatment|Other|1|||
162861037|NCT03519178|588197577|FG009|PF-06873600 Treatment|Other|0|||
162861038|NCT03519178|588197578|FG010|PF-06873600 Treatment|Other|0|||
162861039|NCT03519178|588197579|FG011|PF-06873600 Treatment|Other|0|||
162861040|NCT03519178|588197580|FG012|PF-06873600 Treatment|Other|0|||
162861041|NCT03519178|588197581|FG013|PF-06873600 Treatment|Other|1|||
162861042|NCT03519178|588197582|FG014|PF-06873600 Treatment|Other|3|||
162861043|NCT03519178|588197568|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
162861044|NCT03519178|588197569|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
162861045|NCT03519178|588197570|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
162861046|NCT03519178|588197571|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
162861047|NCT03519178|588197572|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
162861048|NCT03519178|588197573|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
162861049|NCT03519178|588197574|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
162861050|NCT03519178|588197575|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
162861051|NCT03519178|588197576|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
162861052|NCT03519178|588197577|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
162861053|NCT03519178|588197578|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
162861054|NCT03519178|588197579|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
162861055|NCT03519178|588197580|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
162861056|NCT03519178|588197581|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
162861057|NCT03519178|588197582|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
162861058|NCT03519178|588197568|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861059|NCT03519178|588197569|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861060|NCT03519178|588197570|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861061|NCT03519178|588197571|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861062|NCT03519178|588197572|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861063|NCT03519178|588197573|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861064|NCT03519178|588197574|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861065|NCT03519178|588197575|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861066|NCT03519178|588197576|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861067|NCT03519178|588197577|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861068|NCT03519178|588197578|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861069|NCT03519178|588197579|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861070|NCT03519178|588197580|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
162861071|NCT03519178|588197581|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
162861072|NCT03519178|588197582|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
162861073|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Adverse Event|0|||
162861074|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Adverse Event|0|||
162861075|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Adverse Event|0|||
162861076|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Adverse Event|0|||
162861077|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Adverse Event|0|||
162861078|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Adverse Event|0|||
162861079|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Adverse Event|0|||
162861080|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Adverse Event|0|||
162861081|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Adverse Event|0|||
162861082|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Adverse Event|0|||
162861083|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Adverse Event|0|||
162861084|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Adverse Event|0|||
162861085|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Adverse Event|0|||
162861086|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Adverse Event|1|||
162861087|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Adverse Event|0|||
162861088|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Death|0|||
162861089|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Death|0|||
162861090|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Death|0|||
162861091|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Death|0|||
162861092|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Death|0|||
162861093|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Death|0|||
162861094|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Death|0|||
162861095|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Death|0|||
162861096|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Death|0|||
162861097|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Death|1|||
162861098|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Death|0|||
162861099|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Death|0|||
162957787|NCT00787254|588546599|FG001|Overall Study|Withdrawal by Subject|11|||
162613287|NCT03635788|587301178|FG002|Step 2|Out Of State With No Plan To Return|0|||
162861100|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Death|0|||
162861101|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Death|0|||
162861102|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Death|1|||
162957788|NCT00787254|588546598|FG000|Overall Study|Lack of Efficacy|4|||
162613288|NCT03635788|587301176|FG000|Step 2|Switched To Injectables|0|||
162861103|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861104|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861105|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861106|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861107|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861108|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861109|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861110|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861111|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861112|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861113|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861114|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861115|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861116|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
162861117|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
162861118|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Physician Decision|0|||
162861119|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Physician Decision|0|||
162861120|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Physician Decision|0|||
162861121|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Physician Decision|0|||
162861122|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Physician Decision|0|||
162861123|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Physician Decision|0|||
162861124|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Physician Decision|0|||
162861125|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Physician Decision|0|||
162861126|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Physician Decision|0|||
162861127|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Physician Decision|0|||
162861128|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Physician Decision|0|||
162861129|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Physician Decision|0|||
162861130|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Physician Decision|0|||
162861131|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Physician Decision|4|||
162861132|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Physician Decision|2|||
162861133|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Progressive disease|0|||
162861134|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Progressive disease|0|||
162861135|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Progressive disease|0|||
162861136|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Progressive disease|0|||
162861137|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Progressive disease|0|||
162861138|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Progressive disease|0|||
162861139|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Progressive disease|0|||
162861140|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Progressive disease|0|||
162861141|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Progressive disease|0|||
162861142|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Progressive disease|5|||
162861143|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Progressive disease|0|||
162861144|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Progressive disease|0|||
162861145|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Progressive disease|0|||
162861146|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Progressive disease|30|||
162861147|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Progressive disease|8|||
162861148|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861149|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861150|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861151|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861152|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861153|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861154|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861155|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861156|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861157|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861158|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861159|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861160|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
162861161|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
162861162|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
162861163|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861164|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861165|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861166|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861167|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861168|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861169|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861170|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861171|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861172|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
162861173|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861174|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861175|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
162861176|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
162957789|NCT00787254|588546599|FG001|Overall Study|Lack of Efficacy|15|||
162957790|NCT00787254|588546598|FG000|Overall Study|NSAIDs discontinuation|1|||
162957791|NCT00787254|588546599|FG001|Overall Study|NSAIDs discontinuation|2|||
162957792|NCT00787254|588546598|FG000|Overall Study|Institution closed|1|||
162705675|NCT02240680|587633777|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162705676|NCT02240680|587633774|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
162705677|NCT02240680|587633775|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
162705678|NCT02240680|587633776|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
162957793|NCT00787254|588546599|FG001|Overall Study|Institution closed|0|||
162613289|NCT03635788|587301177|FG001|Step 2|Switched To Injectables|0|||
162705679|NCT02240680|587633777|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
162705680|NCT02240680|587633774|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
162705681|NCT02240680|587633775|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162705682|NCT02240680|587633776|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162705683|NCT02240680|587633777|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162705684|NCT02240680|587633774|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
162705685|NCT02240680|587633775|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
162705686|NCT02240680|587633776|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
162705687|NCT02240680|587633777|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
162705688|NCT02240680|587633774|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162705689|NCT02240680|587633775|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162705690|NCT02240680|587633776|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
162705691|NCT02240680|587633777|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162705692|NCT02240680|587633774|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162705693|NCT02240680|587633775|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162705694|NCT02240680|587633776|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
162705695|NCT02240680|587633777|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162705696|NCT01657032|587633778|FG000|Overall Study|Lost to Follow-up|0|||
162705697|NCT01657032|587633779|FG001|Overall Study|Lost to Follow-up|7|||
162705698|NCT03633903|587633780|FG000|Overall Study|Withdrawal by Subject|1|||
162705699|NCT03633903|587633781|FG001|Overall Study|Withdrawal by Subject|2|||
162705700|NCT03633903|587633780|FG000|Overall Study|Lost to Follow-up|5|||
162613290|NCT03635788|587301178|FG002|Step 2|Switched To Injectables|1|||
162613291|NCT03635788|587301176|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
162613292|NCT03635788|587301177|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
162613293|NCT03635788|587301178|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
162613294|NCT04571515|587301182|FG000|Overall Study|Physician Decision|0|||
162613295|NCT04571515|587301183|FG001|Overall Study|Physician Decision|0|||
162613296|NCT04571515|587301184|FG002|Overall Study|Physician Decision|0|||
162613297|NCT04571515|587301185|FG003|Overall Study|Physician Decision|0|||
162613298|NCT04571515|587301186|FG004|Overall Study|Physician Decision|1|||
162613299|NCT04571515|587301182|FG000|Overall Study|Withdrawal by Subject|0|||
162613300|NCT04571515|587301183|FG001|Overall Study|Withdrawal by Subject|0|||
162613301|NCT04571515|587301184|FG002|Overall Study|Withdrawal by Subject|0|||
162613302|NCT04571515|587301185|FG003|Overall Study|Withdrawal by Subject|0|||
162613303|NCT04571515|587301186|FG004|Overall Study|Withdrawal by Subject|1|||
162613304|NCT04571515|587301182|FG000|Overall Study|insufficient pain|1|||
162613305|NCT04571515|587301183|FG001|Overall Study|insufficient pain|0|||
162613306|NCT04571515|587301184|FG002|Overall Study|insufficient pain|0|||
162613307|NCT04571515|587301185|FG003|Overall Study|insufficient pain|0|||
162613308|NCT04571515|587301186|FG004|Overall Study|insufficient pain|1|||
162613309|NCT05098938|587301195|FG000|Overall Study|Adverse Event|4|||
162613310|NCT05098938|587301196|FG001|Overall Study|Adverse Event|3|||
162613311|NCT05098938|587301195|FG000|Overall Study|inclusion/exclusion criteria change|11|||
162613312|NCT05098938|587301196|FG001|Overall Study|inclusion/exclusion criteria change|5|||
162613313|NCT05098938|587301195|FG000|Overall Study|lack of compliance|26|||
162613314|NCT05098938|587301196|FG001|Overall Study|lack of compliance|19|||
162613315|NCT05098938|587301195|FG000|Overall Study|Lost to Follow-up|37|||
162613316|NCT05098938|587301196|FG001|Overall Study|Lost to Follow-up|40|||
162613317|NCT05098938|587301195|FG000|Overall Study|Lost in treatment period|17|||
162613318|NCT05098938|587301196|FG001|Overall Study|Lost in treatment period|13|||
162613319|NCT05098938|587301195|FG000|Overall Study|Met an exclusion criterion|0|||
162613320|NCT05098938|587301196|FG001|Overall Study|Met an exclusion criterion|3|||
162613321|NCT05098938|587301195|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
162613322|NCT05098938|587301196|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
162613323|NCT05098938|587301195|FG000|Overall Study|Physician Decision|25|||
162613324|NCT05098938|587301196|FG001|Overall Study|Physician Decision|32|||
162613325|NCT05098938|587301195|FG000|Overall Study|Run in failure in treatment phase|1|||
162613326|NCT05098938|587301196|FG001|Overall Study|Run in failure in treatment phase|1|||
162705701|NCT03633903|587633781|FG001|Overall Study|Lost to Follow-up|5|||
162705702|NCT03379233|587633788|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
162957794|NCT00787254|588546598|FG000|Overall Study|Physician Decision|4|||
162957795|NCT00787254|588546599|FG001|Overall Study|Physician Decision|8|||
162957796|NCT01952691|588548466|FG000|Overall Study|Lost to Follow-up|2|||
162861177|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
162861178|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861179|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861180|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861181|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861182|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861183|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861184|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861185|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861186|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861187|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
162861188|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
162957797|NCT05265624|588548467|FG000|Overall Study|Lost to Follow-up|3|||
162957798|NCT05265624|588548468|FG001|Overall Study|Lost to Follow-up|0|||
162957799|NCT05265624|588548467|FG000|Overall Study|Withdrawal by Subject|1|||
162957800|NCT05265624|588548468|FG001|Overall Study|Withdrawal by Subject|0|||
162957801|NCT00001703|588548469|FG000|Overall Study|progressed disease|2|||
162957802|NCT00001703|588548469|FG000|Overall Study|No evidence of disease|1|||
162957803|NCT00001703|588548469|FG000|Overall Study|recurrent disease|2|||
162957804|NCT00665925|588548471|FG000|Overall Study|Lack of Efficacy|10|||
162861189|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861190|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861191|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
162861192|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
162861193|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
162861194|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
162861195|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
162861196|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
162861197|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
162861198|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
162861199|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
162861200|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
162861201|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
162861202|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
162861203|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
162861204|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
162861205|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
162861206|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
162861207|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
162861208|NCT03519178|588197568|FG000|Fulvestrant. Treatment|Other|0|||
162861209|NCT03519178|588197569|FG001|Fulvestrant. Treatment|Other|0|||
162861210|NCT03519178|588197570|FG002|Fulvestrant. Treatment|Other|0|||
162861211|NCT03519178|588197571|FG003|Fulvestrant. Treatment|Other|0|||
162861212|NCT03519178|588197572|FG004|Fulvestrant. Treatment|Other|0|||
162861213|NCT03519178|588197573|FG005|Fulvestrant. Treatment|Other|0|||
162957805|NCT00665925|588548472|FG001|Overall Study|Lack of Efficacy|8|||
162957806|NCT00665925|588548473|FG002|Overall Study|Lack of Efficacy|9|||
162957807|NCT00665925|588548474|FG003|Overall Study|Lack of Efficacy|8|||
162957808|NCT00665925|588548471|FG000|Overall Study|Lost to Follow-up|1|||
162957809|NCT00665925|588548472|FG001|Overall Study|Lost to Follow-up|2|||
162957810|NCT00665925|588548473|FG002|Overall Study|Lost to Follow-up|2|||
162957811|NCT00665925|588548474|FG003|Overall Study|Lost to Follow-up|2|||
162957812|NCT00665925|588548471|FG000|Overall Study|Withdrawal by Subject|2|||
162957813|NCT00665925|588548472|FG001|Overall Study|Withdrawal by Subject|2|||
162957814|NCT00665925|588548473|FG002|Overall Study|Withdrawal by Subject|3|||
162957815|NCT00665925|588548474|FG003|Overall Study|Withdrawal by Subject|2|||
162957816|NCT00665925|588548471|FG000|Overall Study|Physician Decision|0|||
162957817|NCT00665925|588548472|FG001|Overall Study|Physician Decision|0|||
162861214|NCT03519178|588197574|FG006|Fulvestrant. Treatment|Other|0|||
162957818|NCT00665925|588548473|FG002|Overall Study|Physician Decision|1|||
162957819|NCT00665925|588548474|FG003|Overall Study|Physician Decision|2|||
162957820|NCT00665925|588548471|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
162957821|NCT00665925|588548472|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
162957822|NCT00665925|588548473|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
162957823|NCT00665925|588548474|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
162957824|NCT00665925|588548471|FG000|Overall Study|Adverse Event|1|||
162957825|NCT00665925|588548472|FG001|Overall Study|Adverse Event|5|||
162957826|NCT00665925|588548473|FG002|Overall Study|Adverse Event|10|||
162957827|NCT00665925|588548474|FG003|Overall Study|Adverse Event|5|||
162957828|NCT00665925|588548471|FG000|Overall Study|Enrolled by mistake|0|||
162957829|NCT00665925|588548472|FG001|Overall Study|Enrolled by mistake|0|||
162957830|NCT00665925|588548473|FG002|Overall Study|Enrolled by mistake|0|||
162957831|NCT00665925|588548474|FG003|Overall Study|Enrolled by mistake|1|||
162957832|NCT00665925|588548471|FG000|Overall Study|Due to exclusion criteria|1|||
162957833|NCT00665925|588548472|FG001|Overall Study|Due to exclusion criteria|0|||
162957834|NCT00665925|588548473|FG002|Overall Study|Due to exclusion criteria|0|||
162957835|NCT00665925|588548474|FG003|Overall Study|Due to exclusion criteria|0|||
162957836|NCT04035187|588548477|FG000|Overall Study|Withdrawal by Subject|2|||
162957837|NCT04035187|588548478|FG001|Overall Study|Withdrawal by Subject|1|||
162705703|NCT03379233|587633789|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
162705704|NCT00965484|587633790|FG000|Overall Study|Protocol Violation|1|||
162705705|NCT00965484|587633790|FG000|Overall Study|Withdrawal by Subject|1|||
162705706|NCT02531438|587633791|FG000|Overall Study|Adverse Event|7|||
162705707|NCT02531438|587633792|FG001|Overall Study|Adverse Event|9|||
162705708|NCT02531438|587633791|FG000|Overall Study|Lost to Follow-up|0|||
162705709|NCT02531438|587633792|FG001|Overall Study|Lost to Follow-up|3|||
162705710|NCT02531438|587633791|FG000|Overall Study|Withdrawal by Subject|7|||
162705711|NCT02531438|587633792|FG001|Overall Study|Withdrawal by Subject|8|||
162705712|NCT02531438|587633791|FG000|Overall Study|Physician Decision|0|||
162705713|NCT02531438|587633792|FG001|Overall Study|Physician Decision|1|||
162705714|NCT02531438|587633791|FG000|Overall Study|Death|6|||
162705715|NCT02531438|587633792|FG001|Overall Study|Death|3|||
162705716|NCT02531438|587633791|FG000|Overall Study|Randomized, but Not Treated|4|||
162705717|NCT02531438|587633792|FG001|Overall Study|Randomized, but Not Treated|0|||
162705718|NCT02531438|587633791|FG000|Overall Study|Missed EOT/PTE Visit|5|||
162705719|NCT02531438|587633792|FG001|Overall Study|Missed EOT/PTE Visit|2|||
162705720|NCT02531438|587633791|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
162705721|NCT02531438|587633792|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
162705722|NCT01813422|587633793|FG000|Overall Study|Withdrawal by Subject|14|||
162705723|NCT01813422|587633794|FG001|Overall Study|Withdrawal by Subject|8|||
162705724|NCT01813422|587633793|FG000|Overall Study|Death|2|||
162705725|NCT01813422|587633794|FG001|Overall Study|Death|3|||
162705726|NCT01813422|587633793|FG000|Overall Study|Sponsor Decision|2|||
162705727|NCT01813422|587633794|FG001|Overall Study|Sponsor Decision|1|||
162705728|NCT01813422|587633793|FG000|Overall Study|Lost to Follow-up|2|||
162705729|NCT01813422|587633794|FG001|Overall Study|Lost to Follow-up|4|||
162705730|NCT01653743|587633797|FG000|Overall Study|Withdrawal by Subject|1|||
162705731|NCT01653743|587633798|FG001|Overall Study|Withdrawal by Subject|0|||
162705732|NCT01653743|587633797|FG000|Overall Study|Investigator discretion|3|||
162705733|NCT01653743|587633798|FG001|Overall Study|Investigator discretion|0|||
162705734|NCT02015195|587633800|FG000|Overall Study|Adverse Event|0|||
162705735|NCT02015195|587633801|FG001|Overall Study|Adverse Event|0|||
162705736|NCT02015195|587633802|FG002|Overall Study|Adverse Event|0|||
162705737|NCT02015195|587633803|FG003|Overall Study|Adverse Event|1|||
162705738|NCT02015195|587633804|FG004|Overall Study|Adverse Event|0|||
162705739|NCT02015195|587633805|FG005|Overall Study|Adverse Event|0|||
162705740|NCT02015195|587633806|FG006|Overall Study|Adverse Event|0|||
162705741|NCT00783718|587633813|FG000|Induction Phase|Adverse Event|4|||
162705742|NCT00783718|587633814|FG001|Induction Phase|Adverse Event|0|||
162705743|NCT00783718|587633815|FG002|Induction Phase|Adverse Event|7|||
162705744|NCT00783718|587633816|FG003|Induction Phase|Adverse Event|0|||
162705745|NCT00783718|587633817|FG004|Induction Phase|Adverse Event|0|||
162705746|NCT00783718|587633818|FG005|Induction Phase|Adverse Event|0|||
162705747|NCT00783718|587633819|FG006|Induction Phase|Adverse Event|0|||
162705748|NCT00783718|587633813|FG000|Induction Phase|Protocol Violation|1|||
162705749|NCT00783718|587633814|FG001|Induction Phase|Protocol Violation|1|||
162705750|NCT00783718|587633815|FG002|Induction Phase|Protocol Violation|6|||
162705751|NCT00783718|587633816|FG003|Induction Phase|Protocol Violation|0|||
162705752|NCT00783718|587633817|FG004|Induction Phase|Protocol Violation|0|||
162705753|NCT00783718|587633818|FG005|Induction Phase|Protocol Violation|0|||
162705754|NCT00783718|587633819|FG006|Induction Phase|Protocol Violation|0|||
162705755|NCT00783718|587633813|FG000|Induction Phase|Lack of Efficacy|5|||
162705756|NCT00783718|587633814|FG001|Induction Phase|Lack of Efficacy|2|||
162705757|NCT00783718|587633815|FG002|Induction Phase|Lack of Efficacy|14|||
162705758|NCT00783718|587633816|FG003|Induction Phase|Lack of Efficacy|0|||
162957838|NCT04035187|588548479|FG002|Overall Study|Withdrawal by Subject|0|||
162957839|NCT04035187|588548480|FG003|Overall Study|Withdrawal by Subject|0|||
162978991|NCT01660022|588623542|FG004|First Sequence (7 Days)|Protocol Violation|0|||
162705759|NCT00783718|587633817|FG004|Induction Phase|Lack of Efficacy|0|||
162705760|NCT00783718|587633818|FG005|Induction Phase|Lack of Efficacy|0|||
162705761|NCT00783718|587633819|FG006|Induction Phase|Lack of Efficacy|0|||
162705762|NCT00783718|587633813|FG000|Induction Phase|Withdrawal by Subject|3|||
162705763|NCT00783718|587633814|FG001|Induction Phase|Withdrawal by Subject|4|||
162705764|NCT00783718|587633815|FG002|Induction Phase|Withdrawal by Subject|8|||
162705765|NCT00783718|587633816|FG003|Induction Phase|Withdrawal by Subject|0|||
162705766|NCT00783718|587633817|FG004|Induction Phase|Withdrawal by Subject|0|||
162705767|NCT00783718|587633818|FG005|Induction Phase|Withdrawal by Subject|0|||
162705768|NCT00783718|587633819|FG006|Induction Phase|Withdrawal by Subject|0|||
162705769|NCT00783718|587633813|FG000|Induction Phase|Lost to Follow-up|1|||
162705770|NCT00783718|587633814|FG001|Induction Phase|Lost to Follow-up|0|||
162705771|NCT00783718|587633815|FG002|Induction Phase|Lost to Follow-up|1|||
163045706|NCT02762084|588875073|FG000|Overall Study|Withdrawal by Subject|1|||
163045707|NCT02762084|588875074|FG001|Overall Study|Withdrawal by Subject|0|||
163045708|NCT02762084|588875075|FG002|Overall Study|Withdrawal by Subject|0|||
163045709|NCT02762084|588875073|FG000|Overall Study|Adverse Event|0|||
163045710|NCT02762084|588875074|FG001|Overall Study|Adverse Event|0|||
163045711|NCT02762084|588875075|FG002|Overall Study|Adverse Event|1|||
163045712|NCT02659943|588875076|FG000|Overall Study|Switched to alternative treatment|1|||
163045713|NCT02659943|588875077|FG001|Overall Study|Switched to alternative treatment|1|||
163045714|NCT02659943|588875078|FG002|Overall Study|Switched to alternative treatment|0|||
163045715|NCT02659943|588875079|FG003|Overall Study|Switched to alternative treatment|2|||
163045716|NCT02659943|588875080|FG004|Overall Study|Switched to alternative treatment|1|||
162957840|NCT04035187|588548477|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
162957841|NCT04035187|588548478|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
162957842|NCT04035187|588548479|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
162957843|NCT04035187|588548480|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
162957844|NCT02255149|588548493|FG000|Overall Study|Lost to Follow-up|2|||
162957845|NCT02255149|588548493|FG000|Overall Study|Withdrawal by Subject|1|||
162957846|NCT02255149|588548493|FG000|Overall Study|Withdrawal by PI|1|||
162957847|NCT02255149|588548493|FG000|Overall Study|Implant Failure|1|||
162957848|NCT00373256|588548494|FG000|Overall Study|Adverse Event (AE)|1|||
162957849|NCT00373256|588548495|FG001|Overall Study|Adverse Event (AE)|5|||
162957850|NCT00373256|588548494|FG000|Overall Study|Lost to Follow-up|2|||
162957851|NCT00373256|588548495|FG001|Overall Study|Lost to Follow-up|1|||
162957852|NCT00373256|588548494|FG000|Overall Study|Death|9|||
162957853|NCT00373256|588548495|FG001|Overall Study|Death|8|||
162957854|NCT00373256|588548494|FG000|Overall Study|Objective Progression or Relapse|111|||
162957855|NCT00373256|588548495|FG001|Overall Study|Objective Progression or Relapse|104|||
162957856|NCT00373256|588548494|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
162957857|NCT00373256|588548495|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
162957858|NCT00373256|588548494|FG000|Overall Study|Other|73|||
162957859|NCT00373256|588548495|FG001|Overall Study|Other|107|||
162957860|NCT00373256|588548494|FG000|Overall Study|Protocol Violation|0|||
162957861|NCT00373256|588548495|FG001|Overall Study|Protocol Violation|2|||
162957862|NCT00373256|588548494|FG000|Overall Study|Study Terminated by Sponsor|41|||
162957863|NCT00373256|588548495|FG001|Overall Study|Study Terminated by Sponsor|13|||
162957864|NCT03032172|588548498|FG000|Treatment Period|Adverse Event|0|||
162957865|NCT03032172|588548499|FG001|Treatment Period|Adverse Event|1|||
162957866|NCT03032172|588548500|FG002|Treatment Period|Adverse Event|0|||
162957867|NCT03032172|588548501|FG003|Treatment Period|Adverse Event|0|||
162957868|NCT03032172|588548502|FG004|Treatment Period|Adverse Event|0|||
162957869|NCT03032172|588548503|FG005|Treatment Period|Adverse Event|0|||
162957870|NCT03032172|588548504|FG006|Treatment Period|Adverse Event|0|||
162957871|NCT03032172|588548505|FG007|Treatment Period|Adverse Event|0|||
162957872|NCT03032172|588548498|FG000|Treatment Period|Lack of Efficacy|0|||
162957873|NCT03032172|588548499|FG001|Treatment Period|Lack of Efficacy|1|||
162957874|NCT03032172|588548500|FG002|Treatment Period|Lack of Efficacy|0|||
162957875|NCT03032172|588548501|FG003|Treatment Period|Lack of Efficacy|0|||
162957876|NCT03032172|588548502|FG004|Treatment Period|Lack of Efficacy|0|||
162957877|NCT03032172|588548503|FG005|Treatment Period|Lack of Efficacy|0|||
162957878|NCT03032172|588548504|FG006|Treatment Period|Lack of Efficacy|0|||
162957879|NCT03032172|588548505|FG007|Treatment Period|Lack of Efficacy|0|||
162957880|NCT03032172|588548498|FG000|Treatment Period|Non-compliance With Study Drug|0|||
162957881|NCT03032172|588548499|FG001|Treatment Period|Non-compliance With Study Drug|1|||
162957882|NCT03032172|588548500|FG002|Treatment Period|Non-compliance With Study Drug|0|||
162957883|NCT03032172|588548501|FG003|Treatment Period|Non-compliance With Study Drug|0|||
162957884|NCT03032172|588548502|FG004|Treatment Period|Non-compliance With Study Drug|0|||
162957885|NCT03032172|588548503|FG005|Treatment Period|Non-compliance With Study Drug|0|||
162957886|NCT03032172|588548504|FG006|Treatment Period|Non-compliance With Study Drug|0|||
162957887|NCT03032172|588548505|FG007|Treatment Period|Non-compliance With Study Drug|0|||
162957888|NCT03032172|588548498|FG000|Treatment Period|Reason Not Specified|0|||
162957889|NCT03032172|588548499|FG001|Treatment Period|Reason Not Specified|4|||
162957890|NCT03032172|588548500|FG002|Treatment Period|Reason Not Specified|1|||
162957891|NCT03032172|588548501|FG003|Treatment Period|Reason Not Specified|0|||
162957892|NCT03032172|588548502|FG004|Treatment Period|Reason Not Specified|0|||
162957893|NCT03032172|588548503|FG005|Treatment Period|Reason Not Specified|0|||
162957894|NCT03032172|588548504|FG006|Treatment Period|Reason Not Specified|0|||
162957895|NCT03032172|588548505|FG007|Treatment Period|Reason Not Specified|0|||
162957896|NCT03032172|588548498|FG000|Treatment Period|Physician Decision|0|||
162957897|NCT03032172|588548499|FG001|Treatment Period|Physician Decision|2|||
163045717|NCT02659943|588875081|FG005|Overall Study|Switched to alternative treatment|0|||
163045718|NCT02659943|588875082|FG006|Overall Study|Switched to alternative treatment|1|||
162613327|NCT05098938|587301195|FG000|Overall Study|Withdrawal by Subject|0|||
162613328|NCT05098938|587301196|FG001|Overall Study|Withdrawal by Subject|3|||
162613329|NCT05098938|587301195|FG000|Overall Study|Run-in Failure in early study|505|||
162861215|NCT03519178|588197575|FG007|Fulvestrant. Treatment|Other|0|||
162861216|NCT03519178|588197576|FG008|Fulvestrant. Treatment|Other|0|||
162861217|NCT03519178|588197577|FG009|Fulvestrant. Treatment|Other|0|||
162861218|NCT03519178|588197578|FG010|Fulvestrant. Treatment|Other|0|||
162861219|NCT03519178|588197579|FG011|Fulvestrant. Treatment|Other|0|||
162861220|NCT03519178|588197580|FG012|Fulvestrant. Treatment|Other|0|||
162861221|NCT03519178|588197581|FG013|Fulvestrant. Treatment|Other|1|||
162861222|NCT03519178|588197582|FG014|Fulvestrant. Treatment|Other|3|||
162861223|NCT03519178|588197568|FG000|Letrozole Treatment|Physician Decision|0|||
162861224|NCT03519178|588197569|FG001|Letrozole Treatment|Physician Decision|0|||
162861225|NCT03519178|588197570|FG002|Letrozole Treatment|Physician Decision|0|||
162861226|NCT03519178|588197571|FG003|Letrozole Treatment|Physician Decision|0|||
162861227|NCT03519178|588197572|FG004|Letrozole Treatment|Physician Decision|0|||
162861228|NCT03519178|588197573|FG005|Letrozole Treatment|Physician Decision|0|||
162861229|NCT03519178|588197574|FG006|Letrozole Treatment|Physician Decision|0|||
162861230|NCT03519178|588197575|FG007|Letrozole Treatment|Physician Decision|0|||
162861231|NCT03519178|588197576|FG008|Letrozole Treatment|Physician Decision|0|||
162861232|NCT03519178|588197577|FG009|Letrozole Treatment|Physician Decision|0|||
162861233|NCT03519178|588197578|FG010|Letrozole Treatment|Physician Decision|1|||
162861234|NCT03519178|588197579|FG011|Letrozole Treatment|Physician Decision|0|||
162861235|NCT03519178|588197580|FG012|Letrozole Treatment|Physician Decision|0|||
162861236|NCT03519178|588197581|FG013|Letrozole Treatment|Physician Decision|0|||
162861237|NCT03519178|588197582|FG014|Letrozole Treatment|Physician Decision|0|||
162861238|NCT03519178|588197568|FG000|Letrozole Treatment|Progressive disease|0|||
162861239|NCT03519178|588197569|FG001|Letrozole Treatment|Progressive disease|0|||
162861240|NCT03519178|588197570|FG002|Letrozole Treatment|Progressive disease|0|||
162861241|NCT03519178|588197571|FG003|Letrozole Treatment|Progressive disease|0|||
162861242|NCT03519178|588197572|FG004|Letrozole Treatment|Progressive disease|0|||
162861243|NCT03519178|588197573|FG005|Letrozole Treatment|Progressive disease|0|||
162861244|NCT03519178|588197574|FG006|Letrozole Treatment|Progressive disease|0|||
162861245|NCT03519178|588197575|FG007|Letrozole Treatment|Progressive disease|0|||
162861246|NCT03519178|588197576|FG008|Letrozole Treatment|Progressive disease|0|||
162861247|NCT03519178|588197577|FG009|Letrozole Treatment|Progressive disease|0|||
162861248|NCT03519178|588197578|FG010|Letrozole Treatment|Progressive disease|4|||
162861249|NCT03519178|588197579|FG011|Letrozole Treatment|Progressive disease|0|||
162861250|NCT03519178|588197580|FG012|Letrozole Treatment|Progressive disease|0|||
162861251|NCT03519178|588197581|FG013|Letrozole Treatment|Progressive disease|0|||
162861252|NCT03519178|588197582|FG014|Letrozole Treatment|Progressive disease|0|||
162957898|NCT03032172|588548500|FG002|Treatment Period|Physician Decision|1|||
162957899|NCT03032172|588548501|FG003|Treatment Period|Physician Decision|0|||
162957900|NCT03032172|588548502|FG004|Treatment Period|Physician Decision|0|||
162957901|NCT03032172|588548503|FG005|Treatment Period|Physician Decision|0|||
162957902|NCT03032172|588548504|FG006|Treatment Period|Physician Decision|0|||
162957903|NCT03032172|588548505|FG007|Treatment Period|Physician Decision|0|||
162957904|NCT03032172|588548498|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957905|NCT03032172|588548499|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
162957906|NCT03032172|588548500|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
162957907|NCT03032172|588548501|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
162957908|NCT03032172|588548502|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957909|NCT03032172|588548503|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957910|NCT03032172|588548504|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957911|NCT03032172|588548505|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162957912|NCT03032172|588548498|FG000|Treatment Period|Withdrawal by Subject|2|||
162957913|NCT03032172|588548499|FG001|Treatment Period|Withdrawal by Subject|0|||
162957914|NCT03032172|588548500|FG002|Treatment Period|Withdrawal by Subject|3|||
162957915|NCT03032172|588548501|FG003|Treatment Period|Withdrawal by Subject|0|||
162957916|NCT03032172|588548502|FG004|Treatment Period|Withdrawal by Subject|0|||
162957917|NCT03032172|588548503|FG005|Treatment Period|Withdrawal by Subject|0|||
162957918|NCT03032172|588548504|FG006|Treatment Period|Withdrawal by Subject|0|||
162957919|NCT03032172|588548505|FG007|Treatment Period|Withdrawal by Subject|0|||
162957920|NCT03032172|588548498|FG000|Open-label Extension Period|Death|0|||
162957921|NCT03032172|588548499|FG001|Open-label Extension Period|Death|0|||
162957922|NCT03032172|588548500|FG002|Open-label Extension Period|Death|0|||
162957923|NCT03032172|588548501|FG003|Open-label Extension Period|Death|0|||
162957924|NCT03032172|588548502|FG004|Open-label Extension Period|Death|0|||
162861253|NCT03519178|588197568|FG000|Letrozole Treatment|Global deterioration of health status|0|||
162957925|NCT03032172|588548503|FG005|Open-label Extension Period|Death|0|||
162957926|NCT03032172|588548504|FG006|Open-label Extension Period|Death|0|||
162861254|NCT03519178|588197569|FG001|Letrozole Treatment|Global deterioration of health status|0|||
162861255|NCT03519178|588197570|FG002|Letrozole Treatment|Global deterioration of health status|0|||
162861256|NCT03519178|588197571|FG003|Letrozole Treatment|Global deterioration of health status|0|||
162861257|NCT03519178|588197572|FG004|Letrozole Treatment|Global deterioration of health status|0|||
162861258|NCT03519178|588197573|FG005|Letrozole Treatment|Global deterioration of health status|0|||
162861259|NCT03519178|588197574|FG006|Letrozole Treatment|Global deterioration of health status|0|||
162861260|NCT03519178|588197575|FG007|Letrozole Treatment|Global deterioration of health status|0|||
162861261|NCT03519178|588197576|FG008|Letrozole Treatment|Global deterioration of health status|0|||
162861262|NCT03519178|588197577|FG009|Letrozole Treatment|Global deterioration of health status|0|||
162861263|NCT03519178|588197578|FG010|Letrozole Treatment|Global deterioration of health status|2|||
162861264|NCT03519178|588197579|FG011|Letrozole Treatment|Global deterioration of health status|0|||
162861265|NCT03519178|588197580|FG012|Letrozole Treatment|Global deterioration of health status|0|||
162861266|NCT03519178|588197581|FG013|Letrozole Treatment|Global deterioration of health status|0|||
162861267|NCT03519178|588197582|FG014|Letrozole Treatment|Global deterioration of health status|0|||
162861268|NCT03519178|588197568|FG000|Follow-Up|Death|0|||
162861269|NCT03519178|588197569|FG001|Follow-Up|Death|0|||
162861270|NCT03519178|588197570|FG002|Follow-Up|Death|0|||
162861271|NCT03519178|588197571|FG003|Follow-Up|Death|0|||
162861272|NCT03519178|588197572|FG004|Follow-Up|Death|0|||
162861273|NCT03519178|588197573|FG005|Follow-Up|Death|0|||
162861274|NCT03519178|588197574|FG006|Follow-Up|Death|0|||
162861275|NCT03519178|588197575|FG007|Follow-Up|Death|0|||
162861276|NCT03519178|588197576|FG008|Follow-Up|Death|3|||
162861277|NCT03519178|588197577|FG009|Follow-Up|Death|1|||
162861278|NCT03519178|588197578|FG010|Follow-Up|Death|0|||
162861279|NCT03519178|588197579|FG011|Follow-Up|Death|0|||
162861280|NCT03519178|588197580|FG012|Follow-Up|Death|2|||
162861281|NCT03519178|588197581|FG013|Follow-Up|Death|0|||
162861282|NCT03519178|588197582|FG014|Follow-Up|Death|0|||
162861283|NCT03519178|588197568|FG000|Follow-Up|Lost to Follow-up|0|||
162861284|NCT03519178|588197569|FG001|Follow-Up|Lost to Follow-up|0|||
162861285|NCT03519178|588197570|FG002|Follow-Up|Lost to Follow-up|0|||
162861286|NCT03519178|588197571|FG003|Follow-Up|Lost to Follow-up|0|||
162861287|NCT03519178|588197572|FG004|Follow-Up|Lost to Follow-up|0|||
162861288|NCT03519178|588197573|FG005|Follow-Up|Lost to Follow-up|3|||
162861289|NCT03519178|588197574|FG006|Follow-Up|Lost to Follow-up|1|||
162957927|NCT03032172|588548505|FG007|Open-label Extension Period|Death|2|||
162957928|NCT03032172|588548498|FG000|Open-label Extension Period|Reason Not Specified|0|||
162957929|NCT03032172|588548499|FG001|Open-label Extension Period|Reason Not Specified|0|||
162957930|NCT03032172|588548500|FG002|Open-label Extension Period|Reason Not Specified|0|||
162957931|NCT03032172|588548501|FG003|Open-label Extension Period|Reason Not Specified|0|||
162957932|NCT03032172|588548502|FG004|Open-label Extension Period|Reason Not Specified|0|||
162957933|NCT03032172|588548503|FG005|Open-label Extension Period|Reason Not Specified|5|||
162861290|NCT03519178|588197575|FG007|Follow-Up|Lost to Follow-up|4|||
162861291|NCT03519178|588197576|FG008|Follow-Up|Lost to Follow-up|1|||
162861292|NCT03519178|588197577|FG009|Follow-Up|Lost to Follow-up|0|||
162861293|NCT03519178|588197578|FG010|Follow-Up|Lost to Follow-up|0|||
162861294|NCT03519178|588197579|FG011|Follow-Up|Lost to Follow-up|0|||
162861295|NCT03519178|588197580|FG012|Follow-Up|Lost to Follow-up|0|||
162861296|NCT03519178|588197581|FG013|Follow-Up|Lost to Follow-up|0|||
162861297|NCT03519178|588197582|FG014|Follow-Up|Lost to Follow-up|0|||
162861298|NCT03519178|588197568|FG000|Follow-Up|Withdrawal by Subject|1|||
162861299|NCT03519178|588197569|FG001|Follow-Up|Withdrawal by Subject|2|||
162861300|NCT03519178|588197570|FG002|Follow-Up|Withdrawal by Subject|2|||
162861301|NCT03519178|588197571|FG003|Follow-Up|Withdrawal by Subject|3|||
162861302|NCT03519178|588197572|FG004|Follow-Up|Withdrawal by Subject|5|||
162861303|NCT03519178|588197573|FG005|Follow-Up|Withdrawal by Subject|1|||
162957934|NCT03032172|588548504|FG006|Open-label Extension Period|Reason Not Specified|3|||
162957935|NCT03032172|588548505|FG007|Open-label Extension Period|Reason Not Specified|0|||
162957936|NCT03032172|588548498|FG000|Open-label Extension Period|Pregnancy|0|||
162957937|NCT03032172|588548499|FG001|Open-label Extension Period|Pregnancy|0|||
162957938|NCT03032172|588548500|FG002|Open-label Extension Period|Pregnancy|0|||
162957939|NCT03032172|588548501|FG003|Open-label Extension Period|Pregnancy|0|||
162957940|NCT03032172|588548502|FG004|Open-label Extension Period|Pregnancy|0|||
162957941|NCT03032172|588548503|FG005|Open-label Extension Period|Pregnancy|0|||
162957942|NCT03032172|588548504|FG006|Open-label Extension Period|Pregnancy|1|||
162957943|NCT03032172|588548505|FG007|Open-label Extension Period|Pregnancy|0|||
162957944|NCT03032172|588548498|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162957945|NCT03032172|588548499|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
162957946|NCT03032172|588548500|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
162957947|NCT03032172|588548501|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
162957948|NCT03032172|588548502|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
162957949|NCT03032172|588548503|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
162957950|NCT03032172|588548504|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
162957951|NCT03032172|588548505|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
162957952|NCT06144424|588548510|FG000|Overall Study|Withdrawal by Subject|2|||
162957953|NCT06144424|588548511|FG001|Overall Study|Withdrawal by Subject|0|||
162957954|NCT06144424|588548510|FG000|Overall Study|Incarceration|1|||
162957955|NCT06144424|588548511|FG001|Overall Study|Incarceration|0|||
162861304|NCT03519178|588197574|FG006|Follow-Up|Withdrawal by Subject|2|||
162861305|NCT03519178|588197575|FG007|Follow-Up|Withdrawal by Subject|6|||
162861306|NCT03519178|588197576|FG008|Follow-Up|Withdrawal by Subject|5|||
162861307|NCT03519178|588197577|FG009|Follow-Up|Withdrawal by Subject|2|||
162861308|NCT03519178|588197578|FG010|Follow-Up|Withdrawal by Subject|3|||
162861309|NCT03519178|588197579|FG011|Follow-Up|Withdrawal by Subject|5|||
162861310|NCT03519178|588197580|FG012|Follow-Up|Withdrawal by Subject|2|||
162861311|NCT03519178|588197581|FG013|Follow-Up|Withdrawal by Subject|0|||
162861312|NCT03519178|588197582|FG014|Follow-Up|Withdrawal by Subject|0|||
162861313|NCT03519178|588197568|FG000|Follow-Up|Other|0|||
162957956|NCT00834522|588548512|FG000|Washout|Adverse Event|1|||
162957957|NCT00834522|588548513|FG001|Washout|Adverse Event|0|||
162957958|NCT00834522|588548512|FG000|Washout|Withdrawal by Subject|2|||
162957959|NCT00834522|588548513|FG001|Washout|Withdrawal by Subject|1|||
162957960|NCT03165994|588548514|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
162957961|NCT03165994|588548514|FG000|Overall Study|Death|2|||
162957962|NCT03165994|588548514|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
162957963|NCT03165994|588548514|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
162957964|NCT03165994|588548514|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
162957965|NCT03165994|588548514|FG000|Overall Study|Miscellaneous|1|||
162957966|NCT01111461|588548515|FG000|Overall Study|Adverse Event|32|||
162957967|NCT01111461|588548515|FG000|Overall Study|Participant choice|11|||
162957968|NCT01111461|588548515|FG000|Overall Study|Lost to Follow-up|1|||
162957969|NCT01111461|588548515|FG000|Overall Study|Withdrawal by Subject|1|||
162957970|NCT01111461|588548515|FG000|Overall Study|Other|6|||
162957971|NCT03600805|588548528|FG000|Overall Study|Adverse Event|2|||
162957972|NCT03600805|588548529|FG001|Overall Study|Adverse Event|1|||
162957973|NCT03600805|588548530|FG002|Overall Study|Adverse Event|1|||
162957974|NCT03600805|588548531|FG003|Overall Study|Adverse Event|7|||
162957975|NCT03600805|588548528|FG000|Overall Study|Lack of Efficacy|2|||
162957976|NCT03600805|588548529|FG001|Overall Study|Lack of Efficacy|1|||
162957977|NCT03600805|588548530|FG002|Overall Study|Lack of Efficacy|0|||
162957978|NCT03600805|588548531|FG003|Overall Study|Lack of Efficacy|0|||
162957979|NCT03600805|588548528|FG000|Overall Study|Withdrawal by Subject|1|||
162957980|NCT03600805|588548529|FG001|Overall Study|Withdrawal by Subject|0|||
162957981|NCT03600805|588548530|FG002|Overall Study|Withdrawal by Subject|0|||
162957982|NCT03600805|588548531|FG003|Overall Study|Withdrawal by Subject|1|||
162957983|NCT03600805|588548528|FG000|Overall Study|Other unspecified|14|||
162957984|NCT03600805|588548529|FG001|Overall Study|Other unspecified|6|||
162957985|NCT03600805|588548530|FG002|Overall Study|Other unspecified|7|||
162957986|NCT03600805|588548531|FG003|Overall Study|Other unspecified|11|||
162957987|NCT00804856|588548536|FG000|Overall Study|Progressive Disease|3|||
162957988|NCT00804856|588548537|FG001|Overall Study|Progressive Disease|2|||
162957989|NCT00804856|588548538|FG002|Overall Study|Progressive Disease|4|||
162957990|NCT00804856|588548539|FG003|Overall Study|Progressive Disease|6|||
162957991|NCT00804856|588548540|FG004|Overall Study|Progressive Disease|4|||
162957992|NCT00804856|588548541|FG005|Overall Study|Progressive Disease|1|||
162957993|NCT00804856|588548542|FG006|Overall Study|Progressive Disease|8|||
162957994|NCT00804856|588548543|FG007|Overall Study|Progressive Disease|2|||
162957995|NCT00804856|588548544|FG008|Overall Study|Progressive Disease|4|||
162957996|NCT00804856|588548545|FG009|Overall Study|Progressive Disease|5|||
162957997|NCT00804856|588548546|FG010|Overall Study|Progressive Disease|12|||
162957998|NCT00804856|588548547|FG011|Overall Study|Progressive Disease|2|||
162957999|NCT00804856|588548548|FG012|Overall Study|Progressive Disease|2|||
162958000|NCT00804856|588548549|FG013|Overall Study|Progressive Disease|26|||
162958001|NCT00804856|588548550|FG014|Overall Study|Progressive Disease|20|||
162958002|NCT00804856|588548536|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958003|NCT00804856|588548537|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958004|NCT00804856|588548538|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958005|NCT00804856|588548539|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958006|NCT00804856|588548540|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162958007|NCT00804856|588548541|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958008|NCT00804856|588548542|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958009|NCT00804856|588548543|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958010|NCT00804856|588548544|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958011|NCT00804856|588548545|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162861314|NCT03519178|588197569|FG001|Follow-Up|Other|0|||
162861315|NCT03519178|588197570|FG002|Follow-Up|Other|0|||
162958012|NCT00804856|588548546|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958013|NCT00804856|588548547|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162861316|NCT03519178|588197571|FG003|Follow-Up|Other|0|||
162958014|NCT00804856|588548548|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958015|NCT00804856|588548549|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162958016|NCT00804856|588548550|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162958017|NCT00804856|588548536|FG000|Overall Study|Other Adverse Event|1|||
162958018|NCT00804856|588548537|FG001|Overall Study|Other Adverse Event|1|||
162958019|NCT00804856|588548538|FG002|Overall Study|Other Adverse Event|1|||
162958020|NCT00804856|588548539|FG003|Overall Study|Other Adverse Event|2|||
162861317|NCT03519178|588197572|FG004|Follow-Up|Other|0|||
162861318|NCT03519178|588197573|FG005|Follow-Up|Other|0|||
162861319|NCT03519178|588197574|FG006|Follow-Up|Other|0|||
162861320|NCT03519178|588197575|FG007|Follow-Up|Other|1|||
162861321|NCT03519178|588197576|FG008|Follow-Up|Other|0|||
162861322|NCT03519178|588197577|FG009|Follow-Up|Other|0|||
162861323|NCT03519178|588197578|FG010|Follow-Up|Other|0|||
162861324|NCT03519178|588197579|FG011|Follow-Up|Other|0|||
162861325|NCT03519178|588197580|FG012|Follow-Up|Other|0|||
162861326|NCT03519178|588197581|FG013|Follow-Up|Other|0|||
162861327|NCT03519178|588197582|FG014|Follow-Up|Other|0|||
162861328|NCT03519178|588197568|FG000|Long-term Follow-up|Death|0|||
162861329|NCT03519178|588197569|FG001|Long-term Follow-up|Death|0|||
162861330|NCT03519178|588197570|FG002|Long-term Follow-up|Death|0|||
162861331|NCT03519178|588197571|FG003|Long-term Follow-up|Death|0|||
162861332|NCT03519178|588197572|FG004|Long-term Follow-up|Death|0|||
162861333|NCT03519178|588197573|FG005|Long-term Follow-up|Death|0|||
162861334|NCT03519178|588197574|FG006|Long-term Follow-up|Death|0|||
162861335|NCT03519178|588197575|FG007|Long-term Follow-up|Death|0|||
162861336|NCT03519178|588197576|FG008|Long-term Follow-up|Death|0|||
162861337|NCT03519178|588197577|FG009|Long-term Follow-up|Death|0|||
162861338|NCT03519178|588197578|FG010|Long-term Follow-up|Death|0|||
162861339|NCT03519178|588197579|FG011|Long-term Follow-up|Death|0|||
162861340|NCT03519178|588197580|FG012|Long-term Follow-up|Death|0|||
162861341|NCT03519178|588197581|FG013|Long-term Follow-up|Death|4|||
162861342|NCT03519178|588197582|FG014|Long-term Follow-up|Death|4|||
162861343|NCT03519178|588197568|FG000|Long-term Follow-up|Lost to Follow-up|0|||
162861344|NCT03519178|588197569|FG001|Long-term Follow-up|Lost to Follow-up|0|||
162861345|NCT03519178|588197570|FG002|Long-term Follow-up|Lost to Follow-up|0|||
162861346|NCT03519178|588197571|FG003|Long-term Follow-up|Lost to Follow-up|0|||
162861347|NCT03519178|588197572|FG004|Long-term Follow-up|Lost to Follow-up|0|||
162861348|NCT03519178|588197573|FG005|Long-term Follow-up|Lost to Follow-up|0|||
162861349|NCT03519178|588197574|FG006|Long-term Follow-up|Lost to Follow-up|0|||
162861350|NCT03519178|588197575|FG007|Long-term Follow-up|Lost to Follow-up|0|||
162861351|NCT03519178|588197576|FG008|Long-term Follow-up|Lost to Follow-up|0|||
162861352|NCT03519178|588197577|FG009|Long-term Follow-up|Lost to Follow-up|0|||
162861353|NCT03519178|588197578|FG010|Long-term Follow-up|Lost to Follow-up|0|||
162861354|NCT03519178|588197579|FG011|Long-term Follow-up|Lost to Follow-up|0|||
162861355|NCT03519178|588197580|FG012|Long-term Follow-up|Lost to Follow-up|0|||
162861356|NCT03519178|588197581|FG013|Long-term Follow-up|Lost to Follow-up|1|||
162861357|NCT03519178|588197582|FG014|Long-term Follow-up|Lost to Follow-up|1|||
162861358|NCT03519178|588197568|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
162861359|NCT03519178|588197569|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
162861360|NCT03519178|588197570|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
162861361|NCT03519178|588197571|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
162958021|NCT00804856|588548540|FG004|Overall Study|Other Adverse Event|2|||
162958022|NCT00804856|588548541|FG005|Overall Study|Other Adverse Event|1|||
162958023|NCT00804856|588548542|FG006|Overall Study|Other Adverse Event|3|||
162958024|NCT00804856|588548543|FG007|Overall Study|Other Adverse Event|0|||
162958025|NCT00804856|588548544|FG008|Overall Study|Other Adverse Event|0|||
162958026|NCT00804856|588548545|FG009|Overall Study|Other Adverse Event|1|||
162958027|NCT00804856|588548546|FG010|Overall Study|Other Adverse Event|5|||
162958028|NCT00804856|588548547|FG011|Overall Study|Other Adverse Event|2|||
162958029|NCT00804856|588548548|FG012|Overall Study|Other Adverse Event|0|||
162958030|NCT00804856|588548549|FG013|Overall Study|Other Adverse Event|6|||
162958031|NCT00804856|588548550|FG014|Overall Study|Other Adverse Event|13|||
162958032|NCT00804856|588548536|FG000|Overall Study|Non compliance with protocol|0|||
162958033|NCT00804856|588548537|FG001|Overall Study|Non compliance with protocol|0|||
162958034|NCT00804856|588548538|FG002|Overall Study|Non compliance with protocol|0|||
162958035|NCT00804856|588548539|FG003|Overall Study|Non compliance with protocol|0|||
162958036|NCT00804856|588548540|FG004|Overall Study|Non compliance with protocol|0|||
162958037|NCT00804856|588548541|FG005|Overall Study|Non compliance with protocol|0|||
162958038|NCT00804856|588548542|FG006|Overall Study|Non compliance with protocol|0|||
162958039|NCT00804856|588548543|FG007|Overall Study|Non compliance with protocol|0|||
162958040|NCT00804856|588548544|FG008|Overall Study|Non compliance with protocol|0|||
162958041|NCT00804856|588548545|FG009|Overall Study|Non compliance with protocol|0|||
162958042|NCT00804856|588548546|FG010|Overall Study|Non compliance with protocol|0|||
162958043|NCT00804856|588548547|FG011|Overall Study|Non compliance with protocol|0|||
162958044|NCT00804856|588548548|FG012|Overall Study|Non compliance with protocol|0|||
162958045|NCT00804856|588548549|FG013|Overall Study|Non compliance with protocol|2|||
162958046|NCT00804856|588548550|FG014|Overall Study|Non compliance with protocol|0|||
162958047|NCT00804856|588548536|FG000|Overall Study|Refused to continue medication|0|||
162958048|NCT00804856|588548537|FG001|Overall Study|Refused to continue medication|0|||
162958049|NCT00804856|588548538|FG002|Overall Study|Refused to continue medication|0|||
162958050|NCT00804856|588548539|FG003|Overall Study|Refused to continue medication|1|||
162958051|NCT00804856|588548540|FG004|Overall Study|Refused to continue medication|1|||
162861362|NCT03519178|588197572|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
162861363|NCT03519178|588197573|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
162861364|NCT03519178|588197574|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
162861365|NCT03519178|588197575|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
162861366|NCT03519178|588197576|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
162861367|NCT03519178|588197577|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
162861368|NCT03519178|588197578|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
162861369|NCT03519178|588197579|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
162861370|NCT03519178|588197580|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
162861371|NCT03519178|588197581|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
162861372|NCT03519178|588197582|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
162861373|NCT03519178|588197568|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
162861374|NCT03519178|588197569|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
162861375|NCT03519178|588197570|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
162861376|NCT03519178|588197571|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
162861377|NCT03519178|588197572|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
162861378|NCT03519178|588197573|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
162861379|NCT03519178|588197574|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
162861380|NCT03519178|588197575|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
162861381|NCT03519178|588197576|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
162861382|NCT03519178|588197577|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
162861383|NCT03519178|588197578|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
162861384|NCT03519178|588197579|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
162861385|NCT03519178|588197580|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
162861386|NCT03519178|588197581|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
162861387|NCT03519178|588197582|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
162861388|NCT03519178|588197568|FG000|Long-term Follow-up|Other|0|||
162861389|NCT03519178|588197569|FG001|Long-term Follow-up|Other|0|||
162861390|NCT03519178|588197570|FG002|Long-term Follow-up|Other|0|||
162861391|NCT03519178|588197571|FG003|Long-term Follow-up|Other|0|||
162861392|NCT03519178|588197572|FG004|Long-term Follow-up|Other|0|||
162861393|NCT03519178|588197573|FG005|Long-term Follow-up|Other|0|||
162861394|NCT03519178|588197574|FG006|Long-term Follow-up|Other|0|||
162861395|NCT03519178|588197575|FG007|Long-term Follow-up|Other|0|||
162861396|NCT03519178|588197576|FG008|Long-term Follow-up|Other|0|||
162861397|NCT03519178|588197577|FG009|Long-term Follow-up|Other|0|||
162861398|NCT03519178|588197578|FG010|Long-term Follow-up|Other|0|||
162861399|NCT03519178|588197579|FG011|Long-term Follow-up|Other|0|||
162861400|NCT03519178|588197580|FG012|Long-term Follow-up|Other|0|||
162861401|NCT03519178|588197581|FG013|Long-term Follow-up|Other|0|||
162861402|NCT03519178|588197582|FG014|Long-term Follow-up|Other|1|||
162861403|NCT03519178|588197568|FG000|Long-term Follow-up|Global deterioration of health status|0|||
162861404|NCT03519178|588197569|FG001|Long-term Follow-up|Global deterioration of health status|0|||
162861405|NCT03519178|588197570|FG002|Long-term Follow-up|Global deterioration of health status|0|||
162861406|NCT03519178|588197571|FG003|Long-term Follow-up|Global deterioration of health status|0|||
162861407|NCT03519178|588197572|FG004|Long-term Follow-up|Global deterioration of health status|0|||
162861408|NCT03519178|588197573|FG005|Long-term Follow-up|Global deterioration of health status|0|||
162861409|NCT03519178|588197574|FG006|Long-term Follow-up|Global deterioration of health status|0|||
162861410|NCT03519178|588197575|FG007|Long-term Follow-up|Global deterioration of health status|0|||
162861411|NCT03519178|588197576|FG008|Long-term Follow-up|Global deterioration of health status|0|||
162861412|NCT03519178|588197577|FG009|Long-term Follow-up|Global deterioration of health status|0|||
162861413|NCT03519178|588197578|FG010|Long-term Follow-up|Global deterioration of health status|0|||
162861414|NCT03519178|588197579|FG011|Long-term Follow-up|Global deterioration of health status|0|||
162861415|NCT03519178|588197580|FG012|Long-term Follow-up|Global deterioration of health status|0|||
162958052|NCT00804856|588548541|FG005|Overall Study|Refused to continue medication|0|||
162958053|NCT00804856|588548542|FG006|Overall Study|Refused to continue medication|0|||
162958054|NCT00804856|588548543|FG007|Overall Study|Refused to continue medication|0|||
162958055|NCT00804856|588548544|FG008|Overall Study|Refused to continue medication|0|||
162958056|NCT00804856|588548545|FG009|Overall Study|Refused to continue medication|0|||
162958057|NCT00804856|588548546|FG010|Overall Study|Refused to continue medication|3|||
162958058|NCT00804856|588548547|FG011|Overall Study|Refused to continue medication|0|||
162958059|NCT00804856|588548548|FG012|Overall Study|Refused to continue medication|1|||
163045719|NCT02659943|588875076|FG000|Overall Study|Disease progression on study|0|||
162705772|NCT00783718|587633816|FG003|Induction Phase|Lost to Follow-up|0|||
162861416|NCT03519178|588197581|FG013|Long-term Follow-up|Global deterioration of health status|1|||
162861417|NCT03519178|588197582|FG014|Long-term Follow-up|Global deterioration of health status|0|||
162861418|NCT00624338|588197583|FG000|Overall Study|Adverse Event|14|||
162861419|NCT00624338|588197584|FG001|Overall Study|Adverse Event|14|||
162861420|NCT00624338|588197585|FG002|Overall Study|Adverse Event|18|||
162861421|NCT00624338|588197583|FG000|Overall Study|Lost to Follow-up|1|||
162861422|NCT00624338|588197584|FG001|Overall Study|Lost to Follow-up|0|||
162861423|NCT00624338|588197585|FG002|Overall Study|Lost to Follow-up|0|||
162861424|NCT00624338|588197583|FG000|Overall Study|Lack of Efficacy|11|||
162861425|NCT00624338|588197584|FG001|Overall Study|Lack of Efficacy|3|||
162861426|NCT00624338|588197585|FG002|Overall Study|Lack of Efficacy|14|||
162861427|NCT00624338|588197583|FG000|Overall Study|Protocol Violation|3|||
162861428|NCT00624338|588197584|FG001|Overall Study|Protocol Violation|3|||
162861429|NCT00624338|588197585|FG002|Overall Study|Protocol Violation|2|||
162861430|NCT00624338|588197583|FG000|Overall Study|Death|0|||
162861431|NCT00624338|588197584|FG001|Overall Study|Death|2|||
162861432|NCT00624338|588197585|FG002|Overall Study|Death|0|||
162861433|NCT00624338|588197583|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
162861434|NCT00624338|588197584|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
162861435|NCT00624338|588197585|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
162861436|NCT00624338|588197583|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
162861437|NCT00624338|588197584|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
162705773|NCT00783718|587633817|FG004|Induction Phase|Lost to Follow-up|0|||
162861438|NCT00624338|588197585|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
162958060|NCT00804856|588548549|FG013|Overall Study|Refused to continue medication|1|||
162958061|NCT00804856|588548550|FG014|Overall Study|Refused to continue medication|5|||
162958062|NCT00804856|588548536|FG000|Overall Study|Other reason than listed above|0|||
162958063|NCT00804856|588548537|FG001|Overall Study|Other reason than listed above|0|||
162958064|NCT00804856|588548538|FG002|Overall Study|Other reason than listed above|0|||
162958065|NCT00804856|588548539|FG003|Overall Study|Other reason than listed above|0|||
162958066|NCT00804856|588548540|FG004|Overall Study|Other reason than listed above|0|||
162958067|NCT00804856|588548541|FG005|Overall Study|Other reason than listed above|1|||
162958068|NCT00804856|588548542|FG006|Overall Study|Other reason than listed above|0|||
162958069|NCT00804856|588548543|FG007|Overall Study|Other reason than listed above|0|||
162958070|NCT00804856|588548544|FG008|Overall Study|Other reason than listed above|1|||
162958071|NCT00804856|588548545|FG009|Overall Study|Other reason than listed above|0|||
162958072|NCT00804856|588548546|FG010|Overall Study|Other reason than listed above|3|||
162958073|NCT00804856|588548547|FG011|Overall Study|Other reason than listed above|1|||
162958074|NCT00804856|588548548|FG012|Overall Study|Other reason than listed above|1|||
162958075|NCT00804856|588548549|FG013|Overall Study|Other reason than listed above|10|||
162958076|NCT00804856|588548550|FG014|Overall Study|Other reason than listed above|3|||
162958077|NCT03343535|588548553|FG000|Overall Study|Lost to Follow-up|1|||
162958078|NCT03343535|588548553|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
162958079|NCT03343535|588548553|FG000|Overall Study|Death|12|||
162958080|NCT03415308|588548556|FG000|Overall Study|Lost to Follow-up|0|||
162958081|NCT03415308|588548557|FG001|Overall Study|Lost to Follow-up|0|||
162958082|NCT03415308|588548558|FG002|Overall Study|Lost to Follow-up|1|||
162958083|NCT03415308|588548556|FG000|Overall Study|Scheduling Conflicts|0|||
162958084|NCT03415308|588548557|FG001|Overall Study|Scheduling Conflicts|0|||
162958085|NCT03415308|588548558|FG002|Overall Study|Scheduling Conflicts|7|||
162958086|NCT01471353|588548561|FG000|Overall Study|remain on study|3|||
162958087|NCT03123094|588548563|FG000|Overall Study|Withdrawal by Subject|0|||
162958088|NCT03123094|588548564|FG001|Overall Study|Withdrawal by Subject|2|||
162958089|NCT03123094|588548565|FG002|Overall Study|Withdrawal by Subject|1|||
162958090|NCT03123094|588548566|FG003|Overall Study|Withdrawal by Subject|0|||
162958091|NCT03123094|588548567|FG004|Overall Study|Withdrawal by Subject|1|||
162958092|NCT04238754|588548572|FG000|Washout - 1 Week|Lost to Follow-up|1|||
162958093|NCT04238754|588548573|FG001|Washout - 1 Week|Lost to Follow-up|0|||
162958094|NCT01444378|588548578|FG000|Overall Study|Lost to Follow-up|1|||
162958095|NCT01444378|588548578|FG000|Overall Study|Withdrawal by Subject|1|||
162958096|NCT01444378|588548578|FG000|Overall Study|Death|3|||
162958097|NCT01444378|588548578|FG000|Overall Study|Administrative Closure Of The Study|2|||
162958098|NCT01444378|588548578|FG000|Overall Study|Missed Visits|10|||
162958099|NCT00705666|588548579|FG000|Overall Study|No post-treatment questionnaire|279|||
162958100|NCT00705666|588548579|FG000|Overall Study|Withdrawal by Subject|21|||
162958101|NCT00705666|588548579|FG000|Overall Study|Physician Decision|7|||
162958102|NCT00705666|588548579|FG000|Overall Study|Lost to Follow-up|5|||
162958103|NCT00705666|588548579|FG000|Overall Study|Death|1|||
162958104|NCT00705666|588548579|FG000|Overall Study|Adverse Event|4|||
162958105|NCT00705666|588548579|FG000|Overall Study|Other|12|||
162958106|NCT00705666|588548579|FG000|Overall Study|Other|2|||
162958107|NCT00705666|588548579|FG000|Overall Study|Lack of data|3|||
162958108|NCT00705666|588548579|FG000|Overall Study|Untreated|5|||
162958109|NCT02645409|588548581|FG000|Overall Study|Withdrawal by Subject|3|||
162958110|NCT02645409|588548582|FG001|Overall Study|Withdrawal by Subject|0|||
162958111|NCT02645409|588548581|FG000|Overall Study|Physician Decision|1|||
162958112|NCT02645409|588548582|FG001|Overall Study|Physician Decision|0|||
162958113|NCT03552393|588548585|FG000|Core Period|Kidney Transplant|1|||
162958114|NCT03552393|588548585|FG000|Core Period|Prohibited Medication|1|||
162861439|NCT00624338|588197583|FG000|Overall Study|Other|15|||
162861440|NCT00624338|588197584|FG001|Overall Study|Other|5|||
162861441|NCT00624338|588197585|FG002|Overall Study|Other|9|||
162861442|NCT00624338|588197583|FG000|Overall Study|Randomized but not treated|2|||
162861443|NCT00624338|588197584|FG001|Overall Study|Randomized but not treated|1|||
162861444|NCT00624338|588197585|FG002|Overall Study|Randomized but not treated|3|||
162861445|NCT00144300|588197595|FG000|Overall Study|Adverse Event|18|||
163045720|NCT02659943|588875077|FG001|Overall Study|Disease progression on study|1|||
163045721|NCT02659943|588875078|FG002|Overall Study|Disease progression on study|1|||
163045722|NCT02659943|588875079|FG003|Overall Study|Disease progression on study|1|||
163045723|NCT02659943|588875080|FG004|Overall Study|Disease progression on study|1|||
163045724|NCT02659943|588875081|FG005|Overall Study|Disease progression on study|4|||
163045725|NCT02659943|588875082|FG006|Overall Study|Disease progression on study|0|||
163045726|NCT02659943|588875076|FG000|Overall Study|Patient's condition per principal investigator|0|||
163045727|NCT02659943|588875077|FG001|Overall Study|Patient's condition per principal investigator|0|||
163045728|NCT02659943|588875078|FG002|Overall Study|Patient's condition per principal investigator|0|||
163045729|NCT02659943|588875079|FG003|Overall Study|Patient's condition per principal investigator|0|||
163045730|NCT02659943|588875080|FG004|Overall Study|Patient's condition per principal investigator|0|||
163045731|NCT02659943|588875081|FG005|Overall Study|Patient's condition per principal investigator|1|||
163045732|NCT02659943|588875082|FG006|Overall Study|Patient's condition per principal investigator|0|||
163045733|NCT02659943|588875076|FG000|Overall Study|Ineligible|0|||
163045734|NCT02659943|588875077|FG001|Overall Study|Ineligible|0|||
163045735|NCT02659943|588875078|FG002|Overall Study|Ineligible|0|||
163045736|NCT02659943|588875079|FG003|Overall Study|Ineligible|0|||
163045737|NCT02659943|588875080|FG004|Overall Study|Ineligible|0|||
163045738|NCT02659943|588875081|FG005|Overall Study|Ineligible|0|||
163045739|NCT02659943|588875082|FG006|Overall Study|Ineligible|1|||
163045740|NCT02659943|588875076|FG000|Overall Study|No longer meets eligibility|0|||
163045741|NCT02659943|588875077|FG001|Overall Study|No longer meets eligibility|0|||
163045742|NCT02659943|588875078|FG002|Overall Study|No longer meets eligibility|0|||
163045743|NCT02659943|588875079|FG003|Overall Study|No longer meets eligibility|0|||
163045744|NCT02659943|588875080|FG004|Overall Study|No longer meets eligibility|0|||
163045745|NCT02659943|588875081|FG005|Overall Study|No longer meets eligibility|0|||
163045746|NCT02659943|588875082|FG006|Overall Study|No longer meets eligibility|1|||
163045747|NCT02659943|588875076|FG000|Overall Study|No treatment, per protocol|0|||
163045748|NCT02659943|588875077|FG001|Overall Study|No treatment, per protocol|0|||
163045749|NCT02659943|588875078|FG002|Overall Study|No treatment, per protocol|0|||
163045750|NCT02659943|588875079|FG003|Overall Study|No treatment, per protocol|0|||
163045751|NCT02659943|588875080|FG004|Overall Study|No treatment, per protocol|0|||
163045752|NCT02659943|588875081|FG005|Overall Study|No treatment, per protocol|0|||
163045753|NCT02659943|588875082|FG006|Overall Study|No treatment, per protocol|3|||
163045754|NCT03478371|588875083|FG000|Overall Study|non-compliance|1|||
163045755|NCT03478371|588875083|FG000|Overall Study|Lost to Follow-up|4|||
163045756|NCT01096160|588875087|FG000|Overall Study|Adverse Event|0|||
163045757|NCT01096160|588875088|FG001|Overall Study|Adverse Event|0|||
163045758|NCT01096160|588875089|FG002|Overall Study|Adverse Event|1|||
163045759|NCT01096160|588875090|FG003|Overall Study|Adverse Event|0|||
163045760|NCT01096160|588875091|FG004|Overall Study|Adverse Event|0|||
163045761|NCT01096160|588875092|FG005|Overall Study|Adverse Event|0|||
163045762|NCT01096160|588875093|FG006|Overall Study|Adverse Event|0|||
163045763|NCT01096160|588875094|FG007|Overall Study|Adverse Event|0|||
163045764|NCT01096160|588875095|FG008|Overall Study|Adverse Event|0|||
163045765|NCT01096160|588875096|FG009|Overall Study|Adverse Event|1|||
163045766|NCT01096160|588875087|FG000|Overall Study|Met stopping criteria per protocol|0|||
163045767|NCT01096160|588875088|FG001|Overall Study|Met stopping criteria per protocol|0|||
163045768|NCT01096160|588875089|FG002|Overall Study|Met stopping criteria per protocol|0|||
163045769|NCT01096160|588875090|FG003|Overall Study|Met stopping criteria per protocol|0|||
163045770|NCT01096160|588875091|FG004|Overall Study|Met stopping criteria per protocol|1|||
163045771|NCT01096160|588875092|FG005|Overall Study|Met stopping criteria per protocol|0|||
163045772|NCT01096160|588875093|FG006|Overall Study|Met stopping criteria per protocol|2|||
163045773|NCT01096160|588875094|FG007|Overall Study|Met stopping criteria per protocol|0|||
163045774|NCT01096160|588875095|FG008|Overall Study|Met stopping criteria per protocol|2|||
163045775|NCT01096160|588875096|FG009|Overall Study|Met stopping criteria per protocol|0|||
163045776|NCT00627497|588875097|FG000|Overall Study|Lost to Follow-up|1|||
162861446|NCT00144300|588197596|FG001|Overall Study|Adverse Event|16|||
162861447|NCT00144300|588197595|FG000|Overall Study|Protocol Violation|1|||
162861448|NCT00144300|588197596|FG001|Overall Study|Protocol Violation|3|||
162861449|NCT00144300|588197595|FG000|Overall Study|Lost to Follow-up|3|||
162861450|NCT00144300|588197596|FG001|Overall Study|Lost to Follow-up|0|||
162861451|NCT00144300|588197595|FG000|Overall Study|Withdrawal by Subject|6|||
162861452|NCT00144300|588197596|FG001|Overall Study|Withdrawal by Subject|6|||
163045777|NCT00627497|588875098|FG001|Overall Study|Lost to Follow-up|1|||
163045778|NCT00627497|588875099|FG002|Overall Study|Lost to Follow-up|0|||
162705774|NCT00783718|587633818|FG005|Induction Phase|Lost to Follow-up|0|||
163045779|NCT00627497|588875100|FG003|Overall Study|Lost to Follow-up|0|||
163045780|NCT02028507|588875103|FG000|Overall Study|Progressive Disease|122|||
163045781|NCT02028507|588875104|FG001|Overall Study|Progressive Disease|90|||
163045782|NCT02028507|588875105|FG002|Overall Study|Progressive Disease|102|||
163045783|NCT02028507|588875106|FG003|Overall Study|Progressive Disease|89|||
162861453|NCT00144300|588197595|FG000|Overall Study|Other reason (not specified)|1|||
162861454|NCT00144300|588197596|FG001|Overall Study|Other reason (not specified)|3|||
162861455|NCT03567187|588197600|FG000|Overall Study|Lost to Follow-up|18|||
162861456|NCT03497689|588197601|FG000|Overall Study|Adverse Event|2|||
162861457|NCT03497689|588197601|FG000|Overall Study|Death|1|||
162861458|NCT03497689|588197601|FG000|Overall Study|Physician Decision|1|||
162861459|NCT03497689|588197601|FG000|Overall Study|Withdrawal by Subject|1|||
162861460|NCT03497689|588197601|FG000|Overall Study|Protocol Violation|2|||
162861461|NCT05165394|588199212|FG000|Overall Study|Withdrawal by Subject|5|||
162861462|NCT05165394|588199213|FG001|Overall Study|Withdrawal by Subject|1|||
162861463|NCT05165394|588199212|FG000|Overall Study|Lost to Follow-up|1|||
162861464|NCT05165394|588199213|FG001|Overall Study|Lost to Follow-up|2|||
162861465|NCT05165394|588199212|FG000|Overall Study|Other Than Specified|0|||
162958115|NCT03552393|588548585|FG000|Safety Extension Period|Kidney Transplant|4|||
162958116|NCT05646251|588548588|FG000|Overall Study|Physician Decision|1|||
162958117|NCT05646251|588548589|FG001|Overall Study|Physician Decision|0|||
162958118|NCT05646251|588548590|FG002|Overall Study|Physician Decision|2|||
162958119|NCT00465270|588548591|FG000|Overall Study|Death|7|||
162958120|NCT00465270|588548592|FG001|Overall Study|Death|11|||
162958121|NCT00465270|588548591|FG000|Overall Study|Withdrawal by Subject|34|||
162958122|NCT00465270|588548592|FG001|Overall Study|Withdrawal by Subject|78|||
162958123|NCT00465270|588548591|FG000|Overall Study|Lost to Follow-up|60|||
162958124|NCT00465270|588548592|FG001|Overall Study|Lost to Follow-up|67|||
162958125|NCT00465270|588548591|FG000|Overall Study|Investigator request|3|||
162958126|NCT00465270|588548592|FG001|Overall Study|Investigator request|4|||
162958127|NCT02388191|588548593|FG000|Overall Study|Patient did not receive IUD|1|||
162958128|NCT02388191|588548594|FG001|Overall Study|Patient did not receive IUD|0|||
162958129|NCT02530905|588548595|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
162958130|NCT02530905|588548596|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
162958131|NCT02530905|588548597|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
162958132|NCT01231906|588548598|FG000|Overall Study|Lack of Efficacy|75|||
162958133|NCT01231906|588548599|FG001|Overall Study|Lack of Efficacy|68|||
162958134|NCT01231906|588548598|FG000|Overall Study|Lost to Follow-up|1|||
162958135|NCT01231906|588548599|FG001|Overall Study|Lost to Follow-up|0|||
162958136|NCT01231906|588548598|FG000|Overall Study|Physician Decision|34|||
162958137|NCT01231906|588548599|FG001|Overall Study|Physician Decision|24|||
162958138|NCT01231906|588548598|FG000|Overall Study|Withdrawal by Subject|0|||
162958139|NCT01231906|588548599|FG001|Overall Study|Withdrawal by Subject|4|||
162958140|NCT01231906|588548598|FG000|Overall Study|Ineligible|10|||
162958141|NCT01231906|588548599|FG001|Overall Study|Ineligible|3|||
162958142|NCT01231906|588548598|FG000|Overall Study|No treatment|1|||
162958143|NCT01231906|588548599|FG001|Overall Study|No treatment|2|||
162958144|NCT01136174|588548600|FG000|Overall Study|Adverse Event|0|||
162958145|NCT01136174|588548601|FG001|Overall Study|Adverse Event|0|||
162958146|NCT01136174|588548602|FG002|Overall Study|Adverse Event|0|||
162958147|NCT01136174|588548603|FG003|Overall Study|Adverse Event|4|||
162958148|NCT01249651|588548606|FG000|Overall Study|Withdrawal by Subject|4|||
162958149|NCT01249651|588548606|FG000|Overall Study|Adverse Event|1|||
162958150|NCT01249651|588548606|FG000|Overall Study|Protocol Violation|1|||
162958151|NCT01249651|588548606|FG000|Overall Study|Sponsor Decision|1|||
162958152|NCT03873272|588548613|FG000|Overall Study|Withdrawal by Subject|2|||
162958153|NCT03873272|588548614|FG001|Overall Study|Withdrawal by Subject|0|||
162958154|NCT03873272|588548615|FG002|Overall Study|Withdrawal by Subject|1|||
162958155|NCT03873272|588548613|FG000|Overall Study|Death|0|||
162958156|NCT03873272|588548614|FG001|Overall Study|Death|2|||
162958157|NCT03873272|588548615|FG002|Overall Study|Death|1|||
162958158|NCT03761173|588548616|FG000|Overall Study|Lost to Follow-up|93|||
162958159|NCT03761173|588548616|FG000|Overall Study|Withdrawal by Subject|74|||
162958160|NCT03761173|588548616|FG000|Overall Study|Death|45|||
162958161|NCT03761173|588548616|FG000|Overall Study|Withdrawal for Other Reasons|29|||
162958162|NCT03761173|588548616|FG000|Overall Study|Protocol Violation|1|||
162958163|NCT00316186|588548618|FG000|Overall Study|Adverse Event|6|||
162958164|NCT00316186|588548618|FG000|Overall Study|Disease Progression|4|||
162958165|NCT00316186|588548618|FG000|Overall Study|Lost to Follow-up|1|||
162958166|NCT00316186|588548618|FG000|Overall Study|Other|1|||
162958167|NCT01802320|588548620|FG000|Overall Study|Death|1|||
162861466|NCT05165394|588199213|FG001|Overall Study|Other Than Specified|1|||
162958168|NCT01802320|588548620|FG000|Overall Study|Withdrawal by Subject|1|||
162958169|NCT00199901|588549586|FG000|Overall Study|Protocol Violation|2|||
162958170|NCT00199901|588549587|FG001|Overall Study|Protocol Violation|0|||
162958171|NCT00199901|588549586|FG000|Overall Study|Withdrawal by Subject|1|||
162958172|NCT00199901|588549587|FG001|Overall Study|Withdrawal by Subject|0|||
163045784|NCT02028507|588875103|FG000|Overall Study|Adverse Event|8|||
162958173|NCT00199901|588549586|FG000|Overall Study|Progressive Disease|24|||
163045785|NCT02028507|588875104|FG001|Overall Study|Adverse Event|25|||
162705775|NCT00783718|587633819|FG006|Induction Phase|Lost to Follow-up|0|||
162861467|NCT03705494|588199214|FG000|Overall Study|Lost to Follow-up|2|||
162861468|NCT03705494|588199215|FG001|Overall Study|Lost to Follow-up|1|||
162958174|NCT00199901|588549587|FG001|Overall Study|Progressive Disease|24|||
162958175|NCT05776901|588549590|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
162958176|NCT01958294|588549599|FG000|Overall Study|Clinical Circumstances|2|||
163045786|NCT02028507|588875105|FG002|Overall Study|Adverse Event|3|||
162861469|NCT03705494|588199214|FG000|Overall Study|Withdrawal by Subject|5|||
162861470|NCT03705494|588199215|FG001|Overall Study|Withdrawal by Subject|2|||
162861471|NCT02495077|588199216|FG000|Overall Study|Adverse Event|0|||
162861472|NCT02495077|588199217|FG001|Overall Study|Adverse Event|1|||
162861473|NCT02495077|588199218|FG002|Overall Study|Adverse Event|1|||
162861474|NCT02495077|588199219|FG003|Overall Study|Adverse Event|0|||
162861475|NCT02495077|588199216|FG000|Overall Study|Death|3|||
162861476|NCT02495077|588199217|FG001|Overall Study|Death|5|||
162861477|NCT02495077|588199218|FG002|Overall Study|Death|0|||
162861478|NCT02495077|588199219|FG003|Overall Study|Death|0|||
162861479|NCT02495077|588199216|FG000|Overall Study|Lost to Follow-up|6|||
162861480|NCT02495077|588199217|FG001|Overall Study|Lost to Follow-up|4|||
162861481|NCT02495077|588199218|FG002|Overall Study|Lost to Follow-up|0|||
162861482|NCT02495077|588199219|FG003|Overall Study|Lost to Follow-up|0|||
162861483|NCT02495077|588199216|FG000|Overall Study|Physician Decision|2|||
162861484|NCT02495077|588199217|FG001|Overall Study|Physician Decision|1|||
162861485|NCT02495077|588199218|FG002|Overall Study|Physician Decision|4|||
162861486|NCT02495077|588199219|FG003|Overall Study|Physician Decision|0|||
162861487|NCT02495077|588199216|FG000|Overall Study|Protocol Violation|0|||
162861488|NCT02495077|588199217|FG001|Overall Study|Protocol Violation|1|||
162861489|NCT02495077|588199218|FG002|Overall Study|Protocol Violation|0|||
162861490|NCT02495077|588199219|FG003|Overall Study|Protocol Violation|0|||
162861491|NCT02495077|588199216|FG000|Overall Study|Screen Failure|0|||
162861492|NCT02495077|588199217|FG001|Overall Study|Screen Failure|0|||
162861493|NCT02495077|588199218|FG002|Overall Study|Screen Failure|0|||
162861494|NCT02495077|588199219|FG003|Overall Study|Screen Failure|48|||
162861495|NCT02495077|588199216|FG000|Overall Study|Withdrawal by Subject|7|||
162861496|NCT02495077|588199217|FG001|Overall Study|Withdrawal by Subject|7|||
162861497|NCT02495077|588199218|FG002|Overall Study|Withdrawal by Subject|7|||
162958177|NCT06137781|588549603|FG000|Baseline measurements|Lost to Follow-up|2|||
162958178|NCT06137781|588549603|FG000|Baseline measurements|Withdrawal by Subject|1|||
162958179|NCT06137781|588549603|FG000|Baseline measurements|Expedited surgery|1|||
162958180|NCT06137781|588549603|FG000|Intervention period|Lost to Follow-up|2|||
162958181|NCT06137781|588549603|FG000|Intervention period|Withdrawal by Subject|3|||
162958182|NCT06137781|588549603|FG000|Intervention period|Expedited surgery|1|||
162958183|NCT06137781|588549603|FG000|Intervention period|Adverse Event|1|||
162958184|NCT06284525|588549609|FG000|Overall Study|Withdrawal by Subject|1|||
162958185|NCT00519194|588549610|FG000|Overall Study|Withdrawal by Subject|9|||
162958186|NCT00519194|588549610|FG000|Overall Study|Death|9|||
162958187|NCT00519194|588549610|FG000|Overall Study|Lost to Follow-up|3|||
162958188|NCT05014828|588549618|FG000|Overall Study|Study Completed by Sponsor|16|||
162958189|NCT05014828|588549619|FG001|Overall Study|Study Completed by Sponsor|16|||
162958190|NCT05014828|588549620|FG002|Overall Study|Study Completed by Sponsor|3|||
162958191|NCT05014828|588549621|FG003|Overall Study|Study Completed by Sponsor|3|||
162958192|NCT05014828|588549618|FG000|Overall Study|Death|11|||
162958193|NCT05014828|588549619|FG001|Overall Study|Death|6|||
162958194|NCT05014828|588549620|FG002|Overall Study|Death|0|||
162958195|NCT05014828|588549621|FG003|Overall Study|Death|0|||
162958196|NCT05014828|588549618|FG000|Overall Study|Lost to Follow-up|0|||
162958197|NCT05014828|588549619|FG001|Overall Study|Lost to Follow-up|0|||
162958198|NCT05014828|588549620|FG002|Overall Study|Lost to Follow-up|2|||
162958199|NCT05014828|588549621|FG003|Overall Study|Lost to Follow-up|0|||
162958200|NCT05014828|588549618|FG000|Overall Study|Miscellaneous.|0|||
162958201|NCT05014828|588549619|FG001|Overall Study|Miscellaneous.|1|||
162958202|NCT05014828|588549620|FG002|Overall Study|Miscellaneous.|0|||
162958203|NCT05014828|588549621|FG003|Overall Study|Miscellaneous.|0|||
162861498|NCT02495077|588199219|FG003|Overall Study|Withdrawal by Subject|0|||
162861499|NCT02495077|588199216|FG000|Overall Study|Covid-19 research restrictions|1|||
162861500|NCT02495077|588199217|FG001|Overall Study|Covid-19 research restrictions|0|||
162958204|NCT02682238|588549624|FG000|Overall Study|Lost to Follow-up|0|||
162958205|NCT02682238|588549625|FG001|Overall Study|Lost to Follow-up|2|||
162861501|NCT02495077|588199218|FG002|Overall Study|Covid-19 research restrictions|0|||
162958206|NCT02682238|588549624|FG000|Overall Study|Withdrawal by Subject|1|||
162958207|NCT02682238|588549625|FG001|Overall Study|Withdrawal by Subject|0|||
162958208|NCT02682238|588549624|FG000|Overall Study|Adverse Event|1|||
162958209|NCT02682238|588549625|FG001|Overall Study|Adverse Event|0|||
162958210|NCT02682238|588549624|FG000|Overall Study|Non-compliance with Study Drug|1|||
162861502|NCT02495077|588199219|FG003|Overall Study|Covid-19 research restrictions|0|||
162861503|NCT02495077|588199216|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
162861504|NCT02495077|588199217|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
162861505|NCT02495077|588199218|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
162861506|NCT02495077|588199219|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
162861507|NCT02495077|588199216|FG000|Overall Study|Incarcerated|0|||
162958211|NCT02682238|588549625|FG001|Overall Study|Non-compliance with Study Drug|0|||
162861508|NCT02495077|588199217|FG001|Overall Study|Incarcerated|1|||
162861509|NCT02495077|588199218|FG002|Overall Study|Incarcerated|0|||
162861510|NCT02495077|588199219|FG003|Overall Study|Incarcerated|0|||
162861511|NCT02495077|588199216|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
162861512|NCT02495077|588199217|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
162861513|NCT02495077|588199218|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
162861514|NCT02495077|588199219|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
162861515|NCT02495077|588199216|FG000|Overall Study|Timing of transplant and randomization|0|||
162861516|NCT02495077|588199217|FG001|Overall Study|Timing of transplant and randomization|0|||
162861517|NCT02495077|588199218|FG002|Overall Study|Timing of transplant and randomization|5|||
162861518|NCT02495077|588199219|FG003|Overall Study|Timing of transplant and randomization|0|||
162861519|NCT02742649|588199220|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
162861520|NCT02742649|588199221|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
162861521|NCT02742649|588199222|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
162861522|NCT02742649|588199223|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
162861523|NCT02742649|588199224|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
162861524|NCT02742649|588199220|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162861525|NCT02742649|588199221|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162861526|NCT02742649|588199222|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162861527|NCT02742649|588199223|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162861528|NCT02742649|588199224|FG004|Double-Blind Treatment Period|Adverse Event|0|||
162861529|NCT02742649|588199220|FG000|Open-Label Period|Lost to Follow-up|0|||
162861530|NCT02742649|588199221|FG001|Open-Label Period|Lost to Follow-up|0|||
162861531|NCT02742649|588199222|FG002|Open-Label Period|Lost to Follow-up|0|||
162861532|NCT02742649|588199223|FG003|Open-Label Period|Lost to Follow-up|0|||
162861533|NCT02742649|588199224|FG004|Open-Label Period|Lost to Follow-up|1|||
162861534|NCT03937986|588199225|FG000|Overall Study|COVID-19 Pandemic|1|||
162861535|NCT02839746|588199226|FG000|Overall Study|Not met selection criteria|12|||
162861536|NCT02089737|588199227|FG000|Overall Study|Survey form not completed|5|||
162861537|NCT02089737|588199227|FG000|Overall Study|Not treated|1|||
162861538|NCT00744055|588199228|FG000|Overall Study|Withdrawal by Subject|6|||
162861539|NCT00744055|588199229|FG001|Overall Study|Withdrawal by Subject|9|||
162861540|NCT00744055|588199228|FG000|Overall Study|Lack of Efficacy|0|||
162861541|NCT00744055|588199229|FG001|Overall Study|Lack of Efficacy|1|||
162861542|NCT00744055|588199228|FG000|Overall Study|Physician Decision|0|||
162861543|NCT00744055|588199229|FG001|Overall Study|Physician Decision|2|||
162861544|NCT00744055|588199228|FG000|Overall Study|Protocol Violation|1|||
162861545|NCT00744055|588199229|FG001|Overall Study|Protocol Violation|1|||
162861546|NCT00744055|588199228|FG000|Overall Study|Lost to Follow-up|0|||
162861547|NCT00744055|588199229|FG001|Overall Study|Lost to Follow-up|1|||
162861548|NCT01123889|588199230|FG000|Overall Study|Lost to Follow-up|3|||
162861549|NCT01123889|588199231|FG001|Overall Study|Lost to Follow-up|1|||
162861550|NCT02333331|588199232|FG000|Overall Study|Adverse Event|1|||
162861551|NCT02333331|588199233|FG001|Overall Study|Adverse Event|0|||
162861552|NCT02333331|588199234|FG002|Overall Study|Adverse Event|4|||
162861553|NCT02333331|588199235|FG003|Overall Study|Adverse Event|1|||
162861554|NCT02333331|588199232|FG000|Overall Study|Death|0|||
162861555|NCT02333331|588199233|FG001|Overall Study|Death|0|||
162861556|NCT02333331|588199234|FG002|Overall Study|Death|2|||
162861557|NCT02333331|588199235|FG003|Overall Study|Death|0|||
162861558|NCT02333331|588199232|FG000|Overall Study|Lost to Follow-up|0|||
162861559|NCT02333331|588199233|FG001|Overall Study|Lost to Follow-up|0|||
162861560|NCT02333331|588199234|FG002|Overall Study|Lost to Follow-up|1|||
162861561|NCT02333331|588199235|FG003|Overall Study|Lost to Follow-up|0|||
162861562|NCT02333331|588199232|FG000|Overall Study|Physician Decision|0|||
162861563|NCT02333331|588199233|FG001|Overall Study|Physician Decision|1|||
162861564|NCT02333331|588199234|FG002|Overall Study|Physician Decision|0|||
162861565|NCT02333331|588199235|FG003|Overall Study|Physician Decision|0|||
162861566|NCT02333331|588199232|FG000|Overall Study|Protocol Deviation|0|||
162861567|NCT02333331|588199233|FG001|Overall Study|Protocol Deviation|3|||
162861568|NCT02333331|588199234|FG002|Overall Study|Protocol Deviation|2|||
162861569|NCT02333331|588199235|FG003|Overall Study|Protocol Deviation|1|||
162958212|NCT02682238|588549624|FG000|Overall Study|Non-compliance with Protocol|0|||
162958213|NCT02682238|588549625|FG001|Overall Study|Non-compliance with Protocol|2|||
162958214|NCT00075478|588549626|FG000|Overall Study|not eligible|1|||
162958215|NCT00075478|588549627|FG001|Overall Study|not eligible|0|||
162958216|NCT00075478|588549626|FG000|Overall Study|Physician Decision|0|||
162958217|NCT00075478|588549627|FG001|Overall Study|Physician Decision|1|||
162958218|NCT00824291|588549632|FG000|Overall Study|Adverse Event|15|||
162958219|NCT00824291|588549633|FG001|Overall Study|Adverse Event|6|||
162861570|NCT02333331|588199232|FG000|Overall Study|Patient/Guardian Decision|1|||
162861571|NCT02333331|588199233|FG001|Overall Study|Patient/Guardian Decision|2|||
162861572|NCT02333331|588199234|FG002|Overall Study|Patient/Guardian Decision|9|||
162861573|NCT02333331|588199235|FG003|Overall Study|Patient/Guardian Decision|1|||
162861574|NCT00685178|588199241|FG000|Overall Study|Adverse Event|1|||
162958220|NCT00824291|588549632|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
162861575|NCT00685178|588199242|FG001|Overall Study|Adverse Event|5|||
162861576|NCT00685178|588199243|FG002|Overall Study|Adverse Event|2|||
162861577|NCT00685178|588199244|FG003|Overall Study|Adverse Event|4|||
162861578|NCT00685178|588199241|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
162861579|NCT00685178|588199242|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
162861580|NCT00685178|588199243|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
163045787|NCT02028507|588875106|FG003|Overall Study|Adverse Event|16|||
163045788|NCT02028507|588875103|FG000|Overall Study|Withdrawal by Subject|6|||
163045789|NCT02028507|588875104|FG001|Overall Study|Withdrawal by Subject|8|||
163045790|NCT02028507|588875105|FG002|Overall Study|Withdrawal by Subject|5|||
163045791|NCT02028507|588875106|FG003|Overall Study|Withdrawal by Subject|9|||
163045792|NCT02028507|588875103|FG000|Overall Study|Protocol Violation|2|||
162861581|NCT00685178|588199244|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
162861582|NCT00685178|588199241|FG000|Overall Study|voluntary study discharge|4|||
162861583|NCT00685178|588199242|FG001|Overall Study|voluntary study discharge|5|||
162861584|NCT00685178|588199243|FG002|Overall Study|voluntary study discharge|1|||
162861585|NCT00685178|588199244|FG003|Overall Study|voluntary study discharge|1|||
162861586|NCT00685178|588199241|FG000|Overall Study|incarcerated|1|||
162861587|NCT00685178|588199242|FG001|Overall Study|incarcerated|3|||
162861588|NCT00685178|588199243|FG002|Overall Study|incarcerated|7|||
162861589|NCT00685178|588199244|FG003|Overall Study|incarcerated|0|||
162861590|NCT00685178|588199241|FG000|Overall Study|administrative (disciplinary) discharge|0|||
162861591|NCT00685178|588199242|FG001|Overall Study|administrative (disciplinary) discharge|1|||
162861592|NCT00685178|588199243|FG002|Overall Study|administrative (disciplinary) discharge|0|||
162861593|NCT00685178|588199244|FG003|Overall Study|administrative (disciplinary) discharge|2|||
162861594|NCT00685178|588199241|FG000|Overall Study|Pregnancy|0|||
162958221|NCT00824291|588549633|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
162958222|NCT00824291|588549632|FG000|Overall Study|Lost to Follow-up|11|||
162958223|NCT00824291|588549633|FG001|Overall Study|Lost to Follow-up|9|||
162958224|NCT00824291|588549632|FG000|Overall Study|Non-compliance|1|||
162958225|NCT00824291|588549633|FG001|Overall Study|Non-compliance|1|||
162958226|NCT00824291|588549632|FG000|Overall Study|Protocol Violation|4|||
162958227|NCT00824291|588549633|FG001|Overall Study|Protocol Violation|1|||
162958228|NCT00824291|588549632|FG000|Overall Study|Withdrawal by Subject|14|||
162958229|NCT00824291|588549633|FG001|Overall Study|Withdrawal by Subject|8|||
162958230|NCT00824291|588549632|FG000|Overall Study|Lack of Efficacy|7|||
162958231|NCT00824291|588549633|FG001|Overall Study|Lack of Efficacy|8|||
162958232|NCT00824291|588549632|FG000|Overall Study|Participant on prohibited medication|1|||
162958233|NCT00824291|588549633|FG001|Overall Study|Participant on prohibited medication|0|||
162958234|NCT00123734|588549638|FG000|Overall Study|Death|3|||
162958235|NCT00123734|588549638|FG000|Overall Study|Lost to Follow-up|3|||
162958236|NCT00123734|588549638|FG000|Overall Study|Dropout|1|||
162958237|NCT00123734|588549638|FG000|Overall Study|Withdrawal by Subject|1|||
162958238|NCT00113386|588549639|FG000|Overall Study|Withdrawal by Subject|1|||
162958239|NCT00113386|588549640|FG001|Overall Study|Withdrawal by Subject|0|||
162958240|NCT00113386|588549639|FG000|Overall Study|Physician Decision|0|||
162958241|NCT00113386|588549640|FG001|Overall Study|Physician Decision|1|||
162958242|NCT00113386|588549639|FG000|Overall Study|Toxicity|3|||
162958243|NCT00113386|588549640|FG001|Overall Study|Toxicity|0|||
162958244|NCT00113386|588549639|FG000|Overall Study|Ineligible|1|||
162958245|NCT00113386|588549640|FG001|Overall Study|Ineligible|2|||
162958246|NCT00113386|588549639|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
162958247|NCT00113386|588549640|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
162958248|NCT02849457|588549641|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958249|NCT02849457|588549642|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958250|NCT02849457|588549643|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
162958251|NCT02849457|588549644|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
162958252|NCT01778010|588549648|FG000|Overall Study|Withdrawal by Subject|2|||
162958253|NCT01778010|588549648|FG000|Overall Study|abnormal ECG before meds|1|||
162958254|NCT01778010|588549648|FG000|Overall Study|Arrested|1|||
162958255|NCT01778010|588549648|FG000|Overall Study|rash while on placebo|1|||
162958256|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
162958257|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
162705776|NCT00783718|587633813|FG000|Maintenance Phase|Adverse Event|12|||
162958258|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
162958259|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
163045793|NCT02028507|588875104|FG001|Overall Study|Protocol Violation|4|||
163045794|NCT02028507|588875105|FG002|Overall Study|Protocol Violation|1|||
162861595|NCT00685178|588199242|FG001|Overall Study|Pregnancy|0|||
162861596|NCT00685178|588199243|FG002|Overall Study|Pregnancy|0|||
162861597|NCT00685178|588199244|FG003|Overall Study|Pregnancy|1|||
162861598|NCT01059812|588199260|FG000|Overall Study|Adverse Event|9|||
162861599|NCT01059812|588199261|FG001|Overall Study|Adverse Event|5|||
162861600|NCT01059812|588199260|FG000|Overall Study|Lack of Efficacy|2|||
162861601|NCT01059812|588199261|FG001|Overall Study|Lack of Efficacy|2|||
162861602|NCT01059812|588199260|FG000|Overall Study|Protocol Violation|3|||
162861603|NCT01059812|588199261|FG001|Overall Study|Protocol Violation|1|||
162861604|NCT01059812|588199260|FG000|Overall Study|Withdrawal Criteria|9|||
162861605|NCT01059812|588199261|FG001|Overall Study|Withdrawal Criteria|4|||
162861606|NCT01059812|588199260|FG000|Overall Study|Unclassified|14|||
162861607|NCT01059812|588199261|FG001|Overall Study|Unclassified|4|||
162861608|NCT05299892|588199262|FG000|Overall Study|Withdrawal by Subject|2|||
162861609|NCT00149214|588199263|FG000|Overall Study|Adverse Event|12|||
162861610|NCT00149214|588199264|FG001|Overall Study|Adverse Event|9|||
162861611|NCT00149214|588199263|FG000|Overall Study|Withdrawal by Subject|4|||
162861612|NCT00149214|588199264|FG001|Overall Study|Withdrawal by Subject|1|||
162861613|NCT00149214|588199263|FG000|Overall Study|Physician Decision|3|||
162861614|NCT00149214|588199264|FG001|Overall Study|Physician Decision|3|||
162861615|NCT00149214|588199263|FG000|Overall Study|Sponsor Decision|0|||
162861616|NCT00149214|588199264|FG001|Overall Study|Sponsor Decision|1|||
162861617|NCT00149214|588199263|FG000|Overall Study|Progressive Disease|7|||
162861618|NCT00149214|588199264|FG001|Overall Study|Progressive Disease|3|||
162861619|NCT00756002|588199268|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
162861620|NCT00756002|588199269|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
162861621|NCT00756002|588199268|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162861622|NCT00756002|588199269|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162861623|NCT00756002|588199268|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
162861624|NCT00756002|588199269|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
162861625|NCT00756002|588199268|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
162861626|NCT00756002|588199269|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
162861627|NCT00756002|588199268|FG000|Double-Blind Treatment Period|Other|2|||
162861628|NCT00756002|588199269|FG001|Double-Blind Treatment Period|Other|2|||
162861629|NCT04329923|588199273|FG000|Overall Study|Withdrawal by Subject|1|||
162861630|NCT04329923|588199274|FG001|Overall Study|Withdrawal by Subject|4|||
162861631|NCT04329923|588199275|FG002|Overall Study|Withdrawal by Subject|1|||
162861632|NCT04329923|588199276|FG003|Overall Study|Withdrawal by Subject|1|||
162861633|NCT04329923|588199277|FG004|Overall Study|Withdrawal by Subject|1|||
162861634|NCT04329923|588199278|FG005|Overall Study|Withdrawal by Subject|1|||
162861635|NCT04329923|588199273|FG000|Overall Study|early termination of study|0|||
162861636|NCT04329923|588199274|FG001|Overall Study|early termination of study|0|||
162861637|NCT04329923|588199275|FG002|Overall Study|early termination of study|0|||
162861638|NCT04329923|588199276|FG003|Overall Study|early termination of study|0|||
162861639|NCT04329923|588199277|FG004|Overall Study|early termination of study|1|||
162861640|NCT04329923|588199278|FG005|Overall Study|early termination of study|2|||
162861641|NCT04329923|588199273|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
162861642|NCT04329923|588199274|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
162861643|NCT04329923|588199275|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
162861644|NCT04329923|588199276|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
162861645|NCT04329923|588199277|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
162861646|NCT04329923|588199278|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
162861647|NCT01272180|588199279|FG000|Overall Study|Adverse Event|0|||
162861648|NCT01272180|588199280|FG001|Overall Study|Adverse Event|0|||
162861649|NCT01272180|588199281|FG002|Overall Study|Adverse Event|1|||
162861650|NCT01272180|588199282|FG003|Overall Study|Adverse Event|0|||
162861651|NCT01272180|588199279|FG000|Overall Study|Withdrawal by Subject|2|||
162861652|NCT01272180|588199280|FG001|Overall Study|Withdrawal by Subject|6|||
162861653|NCT01272180|588199281|FG002|Overall Study|Withdrawal by Subject|3|||
162861654|NCT01272180|588199282|FG003|Overall Study|Withdrawal by Subject|2|||
162861655|NCT01272180|588199279|FG000|Overall Study|Lost to Follow-up|15|||
162861656|NCT01272180|588199280|FG001|Overall Study|Lost to Follow-up|14|||
162861657|NCT01272180|588199281|FG002|Overall Study|Lost to Follow-up|8|||
162861658|NCT01272180|588199282|FG003|Overall Study|Lost to Follow-up|10|||
162861659|NCT01272180|588199279|FG000|Overall Study|Inappropriate enrollment|0|||
162861660|NCT01272180|588199280|FG001|Overall Study|Inappropriate enrollment|0|||
162861661|NCT01272180|588199281|FG002|Overall Study|Inappropriate enrollment|1|||
162861662|NCT01272180|588199282|FG003|Overall Study|Inappropriate enrollment|1|||
162861663|NCT01272180|588199279|FG000|Overall Study|Protocol Violation|0|||
162861664|NCT01272180|588199280|FG001|Overall Study|Protocol Violation|1|||
162861665|NCT01272180|588199281|FG002|Overall Study|Protocol Violation|0|||
162861666|NCT01272180|588199282|FG003|Overall Study|Protocol Violation|1|||
162861667|NCT03334214|588199283|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
162861668|NCT03334214|588199284|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
162861669|NCT03334214|588199283|FG000|Overall Study|Withdrawal by Subject|0|||
162861670|NCT03334214|588199284|FG001|Overall Study|Withdrawal by Subject|1|||
162861671|NCT03334214|588199283|FG000|Overall Study|Other|1|||
162861672|NCT03334214|588199284|FG001|Overall Study|Other|0|||
162861673|NCT01702805|588199291|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
162861674|NCT01702805|588199292|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
162861675|NCT01702805|588199291|FG000|Overall Study|Incomplete Follow-up|18|||
162861676|NCT01702805|588199292|FG001|Overall Study|Incomplete Follow-up|15|||
162861677|NCT01702805|588199291|FG000|Overall Study|Vital Status Assessment Only|40|||
162861678|NCT01702805|588199292|FG001|Overall Study|Vital Status Assessment Only|39|||
162861679|NCT01702805|588199291|FG000|Overall Study|Lost to Follow-up|5|||
162958260|NCT02159183|588549651|FG000|Analysis After the 36 Months Follow-up|Death|0|||
162958261|NCT02159183|588549652|FG001|Analysis After the 36 Months Follow-up|Death|1|||
162958262|NCT02159183|588549651|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
162861680|NCT01702805|588199292|FG001|Overall Study|Lost to Follow-up|5|||
162861681|NCT03056287|588199293|FG000|Overall Study|Withdrawal by Subject|0|||
162861682|NCT03056287|588199294|FG001|Overall Study|Withdrawal by Subject|1|||
162861683|NCT03056287|588199295|FG002|Overall Study|Withdrawal by Subject|0|||
162861684|NCT03056287|588199296|FG003|Overall Study|Withdrawal by Subject|0|||
162861685|NCT03056287|588199293|FG000|Overall Study|move out of area|0|||
162861686|NCT03056287|588199294|FG001|Overall Study|move out of area|0|||
162861687|NCT03056287|588199295|FG002|Overall Study|move out of area|1|||
162861688|NCT03056287|588199296|FG003|Overall Study|move out of area|1|||
162861689|NCT01025336|588199297|FG000|Overall Study|Protocol Violation|0|||
162861690|NCT01025336|588199298|FG001|Overall Study|Protocol Violation|0|||
162861691|NCT01025336|588199299|FG002|Overall Study|Protocol Violation|0|||
162861692|NCT01025336|588199300|FG003|Overall Study|Protocol Violation|2|||
162861693|NCT01025336|588199301|FG004|Overall Study|Protocol Violation|0|||
162861694|NCT03794986|588199302|FG000|Overall Study|0 Sessions Attended|34|||
162861695|NCT03794986|588199303|FG001|Overall Study|0 Sessions Attended|37|||
162861696|NCT03794986|588199302|FG000|Overall Study|Withdrawal by Subject|4|||
162861697|NCT03794986|588199303|FG001|Overall Study|Withdrawal by Subject|6|||
162861698|NCT03794986|588199302|FG000|Overall Study|Protocol Violation|1|||
162861699|NCT03794986|588199303|FG001|Overall Study|Protocol Violation|0|||
162861700|NCT00550238|588199309|FG000|Overall Study|Adverse Event|88|||
162861701|NCT00550238|588199309|FG000|Overall Study|Death|34|||
162861702|NCT00550238|588199309|FG000|Overall Study|Disease progression|46|||
162861703|NCT00550238|588199309|FG000|Overall Study|Withdrawal by Subject|167|||
162861704|NCT00550238|588199309|FG000|Overall Study|Physician Decision|31|||
162861705|NCT00550238|588199309|FG000|Overall Study|Patient noncompliance|25|||
162861706|NCT00550238|588199309|FG000|Overall Study|Lost to Follow-up|13|||
162861707|NCT00550238|588199309|FG000|Overall Study|Sponsor decision|55|||
162861708|NCT01486238|588199315|FG000|Overall Study|Death|0|||
162861709|NCT01486238|588199316|FG001|Overall Study|Death|2|||
162861710|NCT01486238|588199315|FG000|Overall Study|Withdrawal by Subject|2|||
162861711|NCT01486238|588199316|FG001|Overall Study|Withdrawal by Subject|1|||
162861712|NCT01486238|588199315|FG000|Overall Study|Lost to Follow-up|0|||
162861713|NCT01486238|588199316|FG001|Overall Study|Lost to Follow-up|3|||
162861714|NCT03043365|588199317|FG000|Weeks 0 to Week 8|Adverse Event|1|||
162861715|NCT03043365|588199318|FG001|Weeks 0 to Week 8|Adverse Event|3|||
162861716|NCT03043365|588199317|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
162861717|NCT03043365|588199318|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
162861718|NCT03043365|588199317|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
162861719|NCT03043365|588199318|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
162861720|NCT02723630|588199319|FG000|Intervention Period 1|Adverse Event|1|||
162861721|NCT02723630|588199320|FG001|Intervention Period 1|Adverse Event|0|||
162861722|NCT02723630|588199321|FG002|Intervention Period 1|Adverse Event|0|||
162861723|NCT02723630|588199322|FG003|Intervention Period 1|Adverse Event|0|||
162861724|NCT02723630|588199323|FG004|Intervention Period 1|Adverse Event|0|||
162861725|NCT02723630|588199324|FG005|Intervention Period 1|Adverse Event|0|||
162861726|NCT02723630|588199319|FG000|Intervention Period 3|consumption of restricted item|0|||
162861727|NCT02723630|588199320|FG001|Intervention Period 3|consumption of restricted item|1|||
162861728|NCT02723630|588199321|FG002|Intervention Period 3|consumption of restricted item|0|||
162861729|NCT02723630|588199322|FG003|Intervention Period 3|consumption of restricted item|0|||
162861730|NCT02723630|588199323|FG004|Intervention Period 3|consumption of restricted item|0|||
162861731|NCT02723630|588199324|FG005|Intervention Period 3|consumption of restricted item|0|||
162861732|NCT00923091|588199330|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
162861733|NCT00923091|588199331|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
162861734|NCT00923091|588199332|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
162861735|NCT00923091|588199333|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
162861736|NCT00923091|588199334|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
162861737|NCT00923091|588199335|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
162861738|NCT00923091|588199336|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
162861739|NCT00923091|588199337|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
162861740|NCT00923091|588199338|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
162861741|NCT00923091|588199339|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
162861742|NCT00923091|588199340|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
162861743|NCT00923091|588199341|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
162861744|NCT00923091|588199342|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
162958263|NCT02159183|588549652|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
162958264|NCT02159183|588549651|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
162958265|NCT02159183|588549652|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
162958266|NCT02558491|588549654|FG000|First Invention|Withdrawal by Subject|3|||
162958267|NCT02558491|588549655|FG001|First Invention|Withdrawal by Subject|1|||
162958268|NCT02558491|588549654|FG000|First Invention|Data collection issues|1|||
162958269|NCT02558491|588549655|FG001|First Invention|Data collection issues|0|||
162958270|NCT02558491|588549654|FG000|First Invention|Stopping criteria|0|||
162958271|NCT02558491|588549655|FG001|First Invention|Stopping criteria|1|||
162958272|NCT02558491|588549654|FG000|First Invention|Changed parameters during trial|1|||
162958273|NCT02558491|588549655|FG001|First Invention|Changed parameters during trial|0|||
162958274|NCT02558491|588549654|FG000|Second Intervention|Withdrawal by Subject|1|||
162958275|NCT02558491|588549655|FG001|Second Intervention|Withdrawal by Subject|0|||
162958276|NCT02558491|588549654|FG000|Second Intervention|Stopping Criteria|1|||
162958277|NCT02558491|588549655|FG001|Second Intervention|Stopping Criteria|0|||
162958278|NCT05630885|588549664|FG000|Study Completion|Took prohibited medications|2|||
162958279|NCT05630885|588549665|FG001|Study Completion|Took prohibited medications|0|||
162958280|NCT05630885|588549664|FG000|Study Completion|Non-compliance with study drug|1|||
162958281|NCT05630885|588549665|FG001|Study Completion|Non-compliance with study drug|0|||
162958282|NCT05630885|588549664|FG000|Study Completion|Adverse Event|1|||
162958283|NCT05630885|588549665|FG001|Study Completion|Adverse Event|0|||
162958284|NCT05630885|588549664|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
162958285|NCT05630885|588549665|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
162958286|NCT05630885|588549664|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
162958287|NCT05630885|588549665|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
162958288|NCT03419403|588549666|FG000|Overall Study|Withdrawal by Subject|5|||
162958289|NCT03419403|588549667|FG001|Overall Study|Withdrawal by Subject|2|||
162958290|NCT03419403|588549668|FG002|Overall Study|Withdrawal by Subject|5|||
162958291|NCT03419403|588549669|FG003|Overall Study|Withdrawal by Subject|1|||
162958292|NCT03419403|588549666|FG000|Overall Study|Progressive disease (per protocol)|0|||
162958293|NCT03419403|588549667|FG001|Overall Study|Progressive disease (per protocol)|2|||
162958294|NCT03419403|588549668|FG002|Overall Study|Progressive disease (per protocol)|2|||
162958295|NCT03419403|588549669|FG003|Overall Study|Progressive disease (per protocol)|0|||
162958296|NCT03419403|588549666|FG000|Overall Study|Other, not specified|6|||
162958297|NCT03419403|588549667|FG001|Overall Study|Other, not specified|4|||
162958298|NCT03419403|588549668|FG002|Overall Study|Other, not specified|5|||
162958299|NCT03419403|588549669|FG003|Overall Study|Other, not specified|1|||
162958300|NCT03419403|588549666|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
162958301|NCT03419403|588549667|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
162958302|NCT03419403|588549668|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
162958303|NCT03419403|588549669|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
162958304|NCT03084471|588549674|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
162958305|NCT03084471|588549674|FG000|Overall Study|Condition under investigation worsened|84|||
162958306|NCT03084471|588549674|FG000|Overall Study|Lack of therapeutic response|2|||
162958307|NCT03084471|588549674|FG000|Overall Study|Protocol Violation|1|||
162958308|NCT03084471|588549674|FG000|Overall Study|Adverse Event|73|||
162958309|NCT03084471|588549674|FG000|Overall Study|Withdrawal by Subject|12|||
162958310|NCT03084471|588549674|FG000|Overall Study|Disease relapse|181|||
162958311|NCT03084471|588549674|FG000|Overall Study|Subjective disease progression|359|||
162958312|NCT03084471|588549674|FG000|Overall Study|Other (as recorded)|33|||
162958313|NCT03084471|588549674|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
162958314|NCT00429416|588549677|FG000|Overall Study|Death|1|||
162958315|NCT00730691|588549679|FG000|Overall Study|Adverse Event|4|||
162958316|NCT00730691|588549680|FG001|Overall Study|Adverse Event|8|||
162958317|NCT00730691|588549681|FG002|Overall Study|Adverse Event|11|||
162958318|NCT00730691|588549682|FG003|Overall Study|Adverse Event|11|||
162958319|NCT00730691|588549683|FG004|Overall Study|Adverse Event|23|||
162958320|NCT00730691|588549679|FG000|Overall Study|Lack of Efficacy|4|||
162958321|NCT00730691|588549680|FG001|Overall Study|Lack of Efficacy|4|||
162958322|NCT00730691|588549681|FG002|Overall Study|Lack of Efficacy|2|||
162958323|NCT00730691|588549682|FG003|Overall Study|Lack of Efficacy|1|||
162958324|NCT00730691|588549683|FG004|Overall Study|Lack of Efficacy|1|||
162958325|NCT00730691|588549679|FG000|Overall Study|Non-compliance with Study Drug|6|||
162958326|NCT00730691|588549680|FG001|Overall Study|Non-compliance with Study Drug|1|||
162958327|NCT00730691|588549681|FG002|Overall Study|Non-compliance with Study Drug|6|||
162958328|NCT00730691|588549682|FG003|Overall Study|Non-compliance with Study Drug|3|||
162958329|NCT00730691|588549683|FG004|Overall Study|Non-compliance with Study Drug|3|||
162958330|NCT00730691|588549679|FG000|Overall Study|Protocol Deviations|3|||
162958331|NCT00730691|588549680|FG001|Overall Study|Protocol Deviations|5|||
162705777|NCT00783718|587633814|FG001|Maintenance Phase|Adverse Event|0|||
162958332|NCT00730691|588549681|FG002|Overall Study|Protocol Deviations|3|||
162958333|NCT00730691|588549682|FG003|Overall Study|Protocol Deviations|7|||
162958334|NCT00730691|588549683|FG004|Overall Study|Protocol Deviations|5|||
162958335|NCT00730691|588549679|FG000|Overall Study|Withdrawal of Consent|7|||
163045795|NCT02028507|588875106|FG003|Overall Study|Protocol Violation|3|||
163045796|NCT02028507|588875103|FG000|Overall Study|Physician Decision|0|||
163045797|NCT02028507|588875104|FG001|Overall Study|Physician Decision|4|||
163045798|NCT02028507|588875105|FG002|Overall Study|Physician Decision|0|||
163045799|NCT02028507|588875106|FG003|Overall Study|Physician Decision|0|||
163045800|NCT02028507|588875103|FG000|Overall Study|Death|1|||
163045801|NCT02028507|588875104|FG001|Overall Study|Death|0|||
163045802|NCT02028507|588875105|FG002|Overall Study|Death|1|||
163045803|NCT02028507|588875106|FG003|Overall Study|Death|3|||
163045804|NCT02028507|588875103|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
163045805|NCT02028507|588875104|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
163045806|NCT02028507|588875105|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
163045807|NCT02028507|588875106|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
163045808|NCT02028507|588875103|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
163045809|NCT02028507|588875104|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
163045810|NCT02028507|588875105|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
163045811|NCT02028507|588875106|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
163045812|NCT02028507|588875103|FG000|Overall Study|Randomized But Not Treated|3|||
163045813|NCT02028507|588875104|FG001|Overall Study|Randomized But Not Treated|6|||
163045814|NCT02028507|588875105|FG002|Overall Study|Randomized But Not Treated|0|||
163045815|NCT02028507|588875106|FG003|Overall Study|Randomized But Not Treated|4|||
163045816|NCT02028507|588875103|FG000|Overall Study|Enzyme defect|0|||
163045817|NCT02028507|588875104|FG001|Overall Study|Enzyme defect|0|||
163045818|NCT02028507|588875105|FG002|Overall Study|Enzyme defect|0|||
163045819|NCT02028507|588875106|FG003|Overall Study|Enzyme defect|1|||
163045820|NCT02028507|588875103|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045821|NCT02028507|588875104|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045822|NCT02028507|588875105|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
163045823|NCT02028507|588875106|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
163045824|NCT02028507|588875103|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
163045825|NCT02028507|588875104|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
163045826|NCT02028507|588875105|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
163045827|NCT02028507|588875106|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
163045828|NCT03361306|588875107|FG000|Overall Study|Death|6|||
163045829|NCT01556932|588875108|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
163045830|NCT01556932|588875109|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
163045831|NCT02105285|588875114|FG000|Overall Study|Adverse Event|1|||
163045832|NCT02105285|588875115|FG001|Overall Study|Adverse Event|1|||
163045833|NCT02105285|588875116|FG002|Overall Study|Adverse Event|0|||
163045834|NCT02105285|588875114|FG000|Overall Study|Protocol Violation|0|||
163045835|NCT02105285|588875115|FG001|Overall Study|Protocol Violation|1|||
163045836|NCT02105285|588875116|FG002|Overall Study|Protocol Violation|0|||
163045837|NCT02105285|588875114|FG000|Overall Study|Withdrawal by Subject|1|||
163045838|NCT02105285|588875115|FG001|Overall Study|Withdrawal by Subject|0|||
163045839|NCT02105285|588875116|FG002|Overall Study|Withdrawal by Subject|0|||
163045840|NCT02420119|588875117|FG000|Overall Study|insufficient laboratory data|5|||
163045841|NCT04767373|588875118|FG000|Overall Study|Death|6|||
163045842|NCT04767373|588875119|FG001|Overall Study|Death|3|||
163045843|NCT04767373|588875118|FG000|Overall Study|Lost to Follow-up|67|||
163045844|NCT04767373|588875119|FG001|Overall Study|Lost to Follow-up|35|||
163045845|NCT04767373|588875118|FG000|Overall Study|Physician Decision|15|||
163045846|NCT04767373|588875119|FG001|Overall Study|Physician Decision|4|||
163045847|NCT04767373|588875118|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163045848|NCT04767373|588875119|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163045849|NCT04767373|588875118|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
163045850|NCT04767373|588875119|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
163045851|NCT04767373|588875118|FG000|Overall Study|Other|1|||
163045852|NCT04767373|588875119|FG001|Overall Study|Other|2|||
163045853|NCT02472886|588875121|FG000|Overall Study|Lack of Efficacy|0|||
163045854|NCT02472886|588875122|FG001|Overall Study|Lack of Efficacy|2|||
163045855|NCT02472886|588875123|FG002|Overall Study|Lack of Efficacy|1|||
163045856|NCT04346199|588875125|FG000|Overall Study|Death|8|||
163045857|NCT04346199|588875126|FG001|Overall Study|Death|9|||
163045858|NCT04346199|588875125|FG000|Overall Study|Lost to Follow-up|0|||
163045859|NCT04346199|588875126|FG001|Overall Study|Lost to Follow-up|1|||
162705778|NCT00783718|587633815|FG002|Maintenance Phase|Adverse Event|0|||
162705779|NCT00783718|587633816|FG003|Maintenance Phase|Adverse Event|15|||
163045860|NCT04346199|588875125|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
163045861|NCT04346199|588875126|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
163045862|NCT04346199|588875125|FG000|Overall Study|Withdrawal by Subject|5|||
163045863|NCT04346199|588875126|FG001|Overall Study|Withdrawal by Subject|1|||
162861745|NCT00923091|588199330|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
162861746|NCT00923091|588199331|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
162861747|NCT00923091|588199332|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
162861748|NCT00923091|588199333|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
162861749|NCT00923091|588199334|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
162861750|NCT00923091|588199335|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
162861751|NCT00923091|588199336|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
162861752|NCT00923091|588199337|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
162861753|NCT00923091|588199338|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
162861754|NCT00923091|588199339|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
162861755|NCT00923091|588199340|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
162861756|NCT00923091|588199341|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
162861757|NCT00923091|588199342|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
162861758|NCT00923091|588199330|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
162861759|NCT00923091|588199331|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
162861760|NCT00923091|588199332|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
162861761|NCT00923091|588199333|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
162861762|NCT00923091|588199334|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
162861763|NCT00923091|588199335|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
162861764|NCT00923091|588199336|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
162861765|NCT00923091|588199337|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
162861766|NCT00923091|588199338|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
162861767|NCT00923091|588199339|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
162861768|NCT00923091|588199340|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
162861769|NCT00923091|588199341|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
162861770|NCT00923091|588199342|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
162861771|NCT00923091|588199330|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861772|NCT00923091|588199331|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861773|NCT00923091|588199332|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861774|NCT00923091|588199333|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861775|NCT00923091|588199334|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861776|NCT00923091|588199335|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
162861777|NCT00923091|588199336|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861778|NCT00923091|588199337|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861779|NCT00923091|588199338|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861780|NCT00923091|588199339|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861781|NCT00923091|588199340|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861782|NCT00923091|588199341|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861783|NCT00923091|588199342|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
162861784|NCT00923091|588199330|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861785|NCT00923091|588199331|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
162861786|NCT00923091|588199332|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861787|NCT00923091|588199333|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
162861788|NCT00923091|588199334|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861789|NCT00923091|588199335|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
162861790|NCT00923091|588199336|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861791|NCT00923091|588199337|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861792|NCT00923091|588199338|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861793|NCT00923091|588199339|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861794|NCT00923091|588199340|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861795|NCT00923091|588199341|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861796|NCT00923091|588199342|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
162861797|NCT00923091|588199330|FG000|Period III (Single-Blind)|Adverse Event|5|||
162861798|NCT00923091|588199331|FG001|Period III (Single-Blind)|Adverse Event|0|||
162861799|NCT00923091|588199332|FG002|Period III (Single-Blind)|Adverse Event|0|||
162861800|NCT00923091|588199333|FG003|Period III (Single-Blind)|Adverse Event|0|||
162861801|NCT00923091|588199334|FG004|Period III (Single-Blind)|Adverse Event|0|||
162861802|NCT00923091|588199335|FG005|Period III (Single-Blind)|Adverse Event|0|||
162861803|NCT00923091|588199336|FG006|Period III (Single-Blind)|Adverse Event|0|||
162861804|NCT00923091|588199337|FG007|Period III (Single-Blind)|Adverse Event|0|||
162861805|NCT00923091|588199338|FG008|Period III (Single-Blind)|Adverse Event|0|||
162861806|NCT00923091|588199339|FG009|Period III (Single-Blind)|Adverse Event|0|||
162861807|NCT00923091|588199340|FG010|Period III (Single-Blind)|Adverse Event|0|||
162861808|NCT00923091|588199341|FG011|Period III (Single-Blind)|Adverse Event|0|||
162861809|NCT00923091|588199342|FG012|Period III (Single-Blind)|Adverse Event|0|||
163045864|NCT00099632|588875130|FG000|Overall Study|Lost to Follow-up|1|||
163045865|NCT00099632|588875131|FG001|Overall Study|Lost to Follow-up|0|||
163045866|NCT00099632|588875132|FG002|Overall Study|Lost to Follow-up|3|||
163045867|NCT00099632|588875133|FG003|Overall Study|Lost to Follow-up|1|||
163045868|NCT00099632|588875134|FG004|Overall Study|Lost to Follow-up|1|||
162861810|NCT00923091|588199330|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
162861811|NCT00923091|588199331|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861812|NCT00923091|588199332|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861813|NCT00923091|588199333|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861814|NCT00923091|588199334|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861815|NCT00923091|588199335|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
163045869|NCT00099632|588875135|FG005|Overall Study|Lost to Follow-up|0|||
163045870|NCT00099632|588875130|FG000|Overall Study|Withdrawal by Subject|0|||
162861816|NCT00923091|588199336|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861817|NCT00923091|588199337|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861818|NCT00923091|588199338|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861819|NCT00923091|588199339|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861820|NCT00923091|588199340|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861821|NCT00923091|588199341|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
162861822|NCT00923091|588199342|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
163045871|NCT00099632|588875131|FG001|Overall Study|Withdrawal by Subject|1|||
163045872|NCT00099632|588875132|FG002|Overall Study|Withdrawal by Subject|0|||
163045873|NCT00099632|588875133|FG003|Overall Study|Withdrawal by Subject|0|||
163045874|NCT00099632|588875134|FG004|Overall Study|Withdrawal by Subject|0|||
163045875|NCT00099632|588875135|FG005|Overall Study|Withdrawal by Subject|1|||
163045876|NCT00099632|588875130|FG000|Overall Study|Protocol Violation|0|||
163045877|NCT00099632|588875131|FG001|Overall Study|Protocol Violation|0|||
163045878|NCT00099632|588875132|FG002|Overall Study|Protocol Violation|0|||
163045879|NCT00099632|588875133|FG003|Overall Study|Protocol Violation|0|||
163045880|NCT00099632|588875134|FG004|Overall Study|Protocol Violation|0|||
163045881|NCT00099632|588875135|FG005|Overall Study|Protocol Violation|1|||
163045882|NCT03131687|588875136|FG000|Overall Study|Adverse Event|0|||
163045883|NCT03131687|588875137|FG001|Overall Study|Adverse Event|1|||
162861823|NCT00923091|588199330|FG000|Period III (Single-Blind)|Protocol Violation|3|||
162861824|NCT00923091|588199331|FG001|Period III (Single-Blind)|Protocol Violation|0|||
162861825|NCT00923091|588199332|FG002|Period III (Single-Blind)|Protocol Violation|0|||
162861826|NCT00923091|588199333|FG003|Period III (Single-Blind)|Protocol Violation|0|||
162861827|NCT00923091|588199334|FG004|Period III (Single-Blind)|Protocol Violation|0|||
162861828|NCT00923091|588199335|FG005|Period III (Single-Blind)|Protocol Violation|0|||
162958336|NCT00730691|588549680|FG001|Overall Study|Withdrawal of Consent|9|||
162958337|NCT00730691|588549681|FG002|Overall Study|Withdrawal of Consent|3|||
162958338|NCT00730691|588549682|FG003|Overall Study|Withdrawal of Consent|6|||
162958339|NCT00730691|588549683|FG004|Overall Study|Withdrawal of Consent|3|||
162958340|NCT00730691|588549679|FG000|Overall Study|Lost to Follow-up|11|||
162958341|NCT00730691|588549680|FG001|Overall Study|Lost to Follow-up|8|||
162958342|NCT00730691|588549681|FG002|Overall Study|Lost to Follow-up|13|||
162958343|NCT00730691|588549682|FG003|Overall Study|Lost to Follow-up|15|||
162958344|NCT00730691|588549683|FG004|Overall Study|Lost to Follow-up|13|||
162958345|NCT00730691|588549679|FG000|Overall Study|Other|1|||
162958346|NCT00730691|588549680|FG001|Overall Study|Other|1|||
162958347|NCT00730691|588549681|FG002|Overall Study|Other|1|||
162958348|NCT00730691|588549682|FG003|Overall Study|Other|2|||
162958349|NCT00730691|588549683|FG004|Overall Study|Other|2|||
162958350|NCT00813592|588549684|FG000|Overall Study|Disease assessment was not completed per|2|||
162958351|NCT02566850|588551552|FG000|Overall Study|Protocol Violation|1|||
162958352|NCT00682461|588551553|FG000|Overall Study|Adverse Event|5|||
162958353|NCT00682461|588551554|FG001|Overall Study|Adverse Event|7|||
162958354|NCT00682461|588551553|FG000|Overall Study|Lost to Follow-up|8|||
162958355|NCT00682461|588551554|FG001|Overall Study|Lost to Follow-up|5|||
162958356|NCT00682461|588551553|FG000|Overall Study|Withdrawal by Subject|12|||
162958357|NCT00682461|588551554|FG001|Overall Study|Withdrawal by Subject|19|||
162958358|NCT06298396|588551565|FG000|Default MAP|Protocol Violation|1|||
162958359|NCT01528696|588551568|FG000|Overall Study|See detailed description|18|||
162958360|NCT01528696|588551569|FG001|Overall Study|See detailed description|19|||
162958361|NCT01547286|588551572|FG000|Overall Study|Did not meet all eligibility criteria|1|||
162958362|NCT01547286|588551572|FG000|Overall Study|Physician Decision|1|||
162958363|NCT00836472|588551573|FG000|Washout|Adverse Event|1|||
162958364|NCT00836472|588551574|FG001|Washout|Adverse Event|2|||
162958365|NCT00836472|588551573|FG000|Washout|Withdrawal by Subject|1|||
162958366|NCT00836472|588551574|FG001|Washout|Withdrawal by Subject|1|||
162958367|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
163045884|NCT03131687|588875138|FG002|Overall Study|Adverse Event|0|||
163045885|NCT03131687|588875139|FG003|Overall Study|Adverse Event|1|||
163045886|NCT03131687|588875140|FG004|Overall Study|Adverse Event|2|||
163045887|NCT03131687|588875141|FG005|Overall Study|Adverse Event|2|||
162861829|NCT00923091|588199336|FG006|Period III (Single-Blind)|Protocol Violation|0|||
162861830|NCT00923091|588199337|FG007|Period III (Single-Blind)|Protocol Violation|0|||
162861831|NCT00923091|588199338|FG008|Period III (Single-Blind)|Protocol Violation|0|||
162861832|NCT00923091|588199339|FG009|Period III (Single-Blind)|Protocol Violation|0|||
162861833|NCT00923091|588199340|FG010|Period III (Single-Blind)|Protocol Violation|0|||
162861834|NCT00923091|588199341|FG011|Period III (Single-Blind)|Protocol Violation|0|||
162861835|NCT00923091|588199342|FG012|Period III (Single-Blind)|Protocol Violation|0|||
162861836|NCT00923091|588199330|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
162861837|NCT00923091|588199331|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
162861838|NCT00923091|588199332|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
162861839|NCT00923091|588199333|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
162861840|NCT00923091|588199334|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
162861841|NCT00923091|588199335|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
162861842|NCT00923091|588199336|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
162861843|NCT00923091|588199337|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
162861844|NCT00923091|588199338|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
162861845|NCT00923091|588199339|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
162861846|NCT00923091|588199340|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
162861847|NCT00923091|588199341|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
162861848|NCT00923091|588199342|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
162861849|NCT00923091|588199330|FG000|Period IV (Double-Blind)|Adverse Event|2|||
162861850|NCT00923091|588199331|FG001|Period IV (Double-Blind)|Adverse Event|0|||
162861851|NCT00923091|588199332|FG002|Period IV (Double-Blind)|Adverse Event|0|||
162861852|NCT00923091|588199333|FG003|Period IV (Double-Blind)|Adverse Event|0|||
162861853|NCT00923091|588199334|FG004|Period IV (Double-Blind)|Adverse Event|0|||
162861854|NCT00923091|588199335|FG005|Period IV (Double-Blind)|Adverse Event|0|||
162861855|NCT00923091|588199336|FG006|Period IV (Double-Blind)|Adverse Event|0|||
162861856|NCT00923091|588199337|FG007|Period IV (Double-Blind)|Adverse Event|0|||
162861857|NCT00923091|588199338|FG008|Period IV (Double-Blind)|Adverse Event|0|||
162861858|NCT00923091|588199339|FG009|Period IV (Double-Blind)|Adverse Event|0|||
162861859|NCT00923091|588199340|FG010|Period IV (Double-Blind)|Adverse Event|0|||
162861860|NCT00923091|588199341|FG011|Period IV (Double-Blind)|Adverse Event|0|||
162861861|NCT00923091|588199342|FG012|Period IV (Double-Blind)|Adverse Event|0|||
162861862|NCT00923091|588199330|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861863|NCT00923091|588199331|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
162861864|NCT00923091|588199332|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861865|NCT00923091|588199333|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861866|NCT00923091|588199334|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861867|NCT00923091|588199335|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861868|NCT00923091|588199336|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861869|NCT00923091|588199337|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163045888|NCT03131687|588875136|FG000|Overall Study|Death|1|||
163045889|NCT03131687|588875137|FG001|Overall Study|Death|0|||
162861870|NCT00923091|588199338|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861871|NCT00923091|588199339|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861872|NCT00923091|588199340|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861873|NCT00923091|588199341|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861874|NCT00923091|588199342|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
162861875|NCT00923091|588199330|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
162861876|NCT00923091|588199331|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
162861877|NCT00923091|588199332|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
162861878|NCT00923091|588199333|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
162861879|NCT00923091|588199334|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
162861880|NCT00923091|588199335|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
162861881|NCT00923091|588199336|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
162861882|NCT00923091|588199337|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
162861883|NCT00923091|588199338|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
162861884|NCT00923091|588199339|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
162861885|NCT00923091|588199340|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
162861886|NCT00923091|588199341|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
162861887|NCT00923091|588199342|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
162861888|NCT00923091|588199330|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861889|NCT00923091|588199331|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861890|NCT00923091|588199332|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861891|NCT00923091|588199333|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
163045890|NCT03131687|588875138|FG002|Overall Study|Death|0|||
162861892|NCT00923091|588199334|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861893|NCT00923091|588199335|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861894|NCT00923091|588199336|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861895|NCT00923091|588199337|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
163045891|NCT03131687|588875139|FG003|Overall Study|Death|0|||
163045892|NCT03131687|588875140|FG004|Overall Study|Death|0|||
163045893|NCT03131687|588875141|FG005|Overall Study|Death|0|||
163045894|NCT03131687|588875136|FG000|Overall Study|Withdrawal by Subject|3|||
163045895|NCT03131687|588875137|FG001|Overall Study|Withdrawal by Subject|3|||
163045896|NCT03131687|588875138|FG002|Overall Study|Withdrawal by Subject|3|||
163045897|NCT03131687|588875139|FG003|Overall Study|Withdrawal by Subject|1|||
163045898|NCT03131687|588875140|FG004|Overall Study|Withdrawal by Subject|2|||
163045899|NCT03131687|588875141|FG005|Overall Study|Withdrawal by Subject|1|||
163045900|NCT03131687|588875136|FG000|Overall Study|Lost to Follow-up|1|||
163045901|NCT03131687|588875137|FG001|Overall Study|Lost to Follow-up|4|||
163045902|NCT03131687|588875138|FG002|Overall Study|Lost to Follow-up|0|||
163045903|NCT03131687|588875139|FG003|Overall Study|Lost to Follow-up|1|||
163045904|NCT03131687|588875140|FG004|Overall Study|Lost to Follow-up|4|||
163045905|NCT03131687|588875141|FG005|Overall Study|Lost to Follow-up|2|||
163045906|NCT03131687|588875136|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
163045907|NCT03131687|588875137|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
162861896|NCT00923091|588199338|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
162861897|NCT00923091|588199339|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861898|NCT00923091|588199340|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861899|NCT00923091|588199341|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
162861900|NCT00923091|588199342|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
162861901|NCT00923091|588199330|FG000|Period V (Double -Blind)|Protocol Violation|0|||
162861902|NCT00923091|588199331|FG001|Period V (Double -Blind)|Protocol Violation|0|||
162861903|NCT00923091|588199332|FG002|Period V (Double -Blind)|Protocol Violation|0|||
162861904|NCT00923091|588199333|FG003|Period V (Double -Blind)|Protocol Violation|0|||
162861905|NCT00923091|588199334|FG004|Period V (Double -Blind)|Protocol Violation|0|||
162861906|NCT00923091|588199335|FG005|Period V (Double -Blind)|Protocol Violation|0|||
162861907|NCT00923091|588199336|FG006|Period V (Double -Blind)|Protocol Violation|0|||
162861908|NCT00923091|588199337|FG007|Period V (Double -Blind)|Protocol Violation|0|||
162861909|NCT00923091|588199338|FG008|Period V (Double -Blind)|Protocol Violation|0|||
162861910|NCT00923091|588199339|FG009|Period V (Double -Blind)|Protocol Violation|0|||
162861911|NCT00923091|588199340|FG010|Period V (Double -Blind)|Protocol Violation|0|||
162861912|NCT00923091|588199341|FG011|Period V (Double -Blind)|Protocol Violation|0|||
162861913|NCT00923091|588199342|FG012|Period V (Double -Blind)|Protocol Violation|1|||
162861914|NCT00923091|588199330|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
162861915|NCT00923091|588199331|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
162861916|NCT00923091|588199332|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
162861917|NCT00923091|588199333|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
162861918|NCT00923091|588199334|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
162861919|NCT00923091|588199335|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
162861920|NCT00923091|588199336|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
162861921|NCT00923091|588199337|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
162861922|NCT00923091|588199338|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
162861923|NCT00923091|588199339|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
162861924|NCT00923091|588199340|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
162861925|NCT00923091|588199341|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
162861926|NCT00923091|588199342|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
162861927|NCT00923091|588199330|FG000|Period VI (Open-Label)|Adverse Event|17|||
163045908|NCT03131687|588875138|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
163045909|NCT03131687|588875139|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
163045910|NCT03131687|588875140|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
163045911|NCT03131687|588875141|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
162861928|NCT00923091|588199331|FG001|Period VI (Open-Label)|Adverse Event|0|||
162861929|NCT00923091|588199332|FG002|Period VI (Open-Label)|Adverse Event|4|||
162861930|NCT00923091|588199333|FG003|Period VI (Open-Label)|Adverse Event|1|||
162861931|NCT00923091|588199334|FG004|Period VI (Open-Label)|Adverse Event|1|||
162861932|NCT00923091|588199335|FG005|Period VI (Open-Label)|Adverse Event|0|||
162861933|NCT00923091|588199336|FG006|Period VI (Open-Label)|Adverse Event|0|||
162861934|NCT00923091|588199337|FG007|Period VI (Open-Label)|Adverse Event|0|||
162861935|NCT00923091|588199338|FG008|Period VI (Open-Label)|Adverse Event|0|||
162861936|NCT00923091|588199339|FG009|Period VI (Open-Label)|Adverse Event|0|||
162861937|NCT00923091|588199340|FG010|Period VI (Open-Label)|Adverse Event|0|||
163045912|NCT03131687|588875136|FG000|Overall Study|Principle Investigator Decision|0|||
163045913|NCT03131687|588875137|FG001|Overall Study|Principle Investigator Decision|1|||
163045914|NCT03131687|588875138|FG002|Overall Study|Principle Investigator Decision|0|||
162861938|NCT00923091|588199341|FG011|Period VI (Open-Label)|Adverse Event|0|||
162861939|NCT00923091|588199342|FG012|Period VI (Open-Label)|Adverse Event|0|||
162861940|NCT00923091|588199330|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
162861941|NCT00923091|588199331|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
162861942|NCT00923091|588199332|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
163045915|NCT03131687|588875139|FG003|Overall Study|Principle Investigator Decision|0|||
163045916|NCT03131687|588875140|FG004|Overall Study|Principle Investigator Decision|0|||
162861943|NCT00923091|588199333|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861944|NCT00923091|588199334|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
162861945|NCT00923091|588199335|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861946|NCT00923091|588199336|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861947|NCT00923091|588199337|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861948|NCT00923091|588199338|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861949|NCT00923091|588199339|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861950|NCT00923091|588199340|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861951|NCT00923091|588199341|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861952|NCT00923091|588199342|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
162861953|NCT00923091|588199330|FG000|Period VI (Open-Label)|Protocol Violation|6|||
162861954|NCT00923091|588199331|FG001|Period VI (Open-Label)|Protocol Violation|1|||
162861955|NCT00923091|588199332|FG002|Period VI (Open-Label)|Protocol Violation|3|||
162861956|NCT00923091|588199333|FG003|Period VI (Open-Label)|Protocol Violation|1|||
162861957|NCT00923091|588199334|FG004|Period VI (Open-Label)|Protocol Violation|4|||
162861958|NCT00923091|588199335|FG005|Period VI (Open-Label)|Protocol Violation|0|||
162861959|NCT00923091|588199336|FG006|Period VI (Open-Label)|Protocol Violation|0|||
162861960|NCT00923091|588199337|FG007|Period VI (Open-Label)|Protocol Violation|0|||
162861961|NCT00923091|588199338|FG008|Period VI (Open-Label)|Protocol Violation|0|||
162861962|NCT00923091|588199339|FG009|Period VI (Open-Label)|Protocol Violation|0|||
162861963|NCT00923091|588199340|FG010|Period VI (Open-Label)|Protocol Violation|0|||
162861964|NCT00923091|588199341|FG011|Period VI (Open-Label)|Protocol Violation|0|||
162861965|NCT00923091|588199342|FG012|Period VI (Open-Label)|Protocol Violation|0|||
162861966|NCT00923091|588199330|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
162861967|NCT00923091|588199331|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
162861968|NCT00923091|588199332|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
162861969|NCT00923091|588199333|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
162861970|NCT00923091|588199334|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
162861971|NCT00923091|588199335|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
162861972|NCT00923091|588199336|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
162861973|NCT00923091|588199337|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
162861974|NCT00923091|588199338|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
162861975|NCT00923091|588199339|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
162861976|NCT00923091|588199340|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
162861977|NCT00923091|588199341|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
162861978|NCT00923091|588199342|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
162861979|NCT00923091|588199330|FG000|Period VI (Open-Label)|Other Reason|0|||
162861980|NCT00923091|588199331|FG001|Period VI (Open-Label)|Other Reason|0|||
162861981|NCT00923091|588199332|FG002|Period VI (Open-Label)|Other Reason|0|||
162861982|NCT00923091|588199333|FG003|Period VI (Open-Label)|Other Reason|1|||
162861983|NCT00923091|588199334|FG004|Period VI (Open-Label)|Other Reason|1|||
162861984|NCT00923091|588199335|FG005|Period VI (Open-Label)|Other Reason|0|||
162861985|NCT00923091|588199336|FG006|Period VI (Open-Label)|Other Reason|0|||
162861986|NCT00923091|588199337|FG007|Period VI (Open-Label)|Other Reason|0|||
162861987|NCT00923091|588199338|FG008|Period VI (Open-Label)|Other Reason|0|||
162861988|NCT00923091|588199339|FG009|Period VI (Open-Label)|Other Reason|0|||
162861989|NCT00923091|588199340|FG010|Period VI (Open-Label)|Other Reason|0|||
162861990|NCT00923091|588199341|FG011|Period VI (Open-Label)|Other Reason|0|||
162861991|NCT00923091|588199342|FG012|Period VI (Open-Label)|Other Reason|0|||
162861992|NCT00754390|588199346|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
162861993|NCT00754390|588199346|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
162861994|NCT00754390|588199346|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
162861995|NCT00754390|588199346|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
162861996|NCT00847613|588199347|FG000|Overall Study|Ongoing at cut-off date|250|||
162861997|NCT00847613|588199348|FG001|Overall Study|Ongoing at cut-off date|265|||
162861998|NCT00847613|588199349|FG002|Overall Study|Ongoing at cut-off date|64|||
162861999|NCT00847613|588199350|FG003|Overall Study|Ongoing at cut-off date|64|||
162862000|NCT00847613|588199347|FG000|Overall Study|Death|1|||
162862001|NCT00847613|588199348|FG001|Overall Study|Death|1|||
162862002|NCT00847613|588199349|FG002|Overall Study|Death|0|||
162862003|NCT00847613|588199350|FG003|Overall Study|Death|0|||
162862004|NCT00847613|588199347|FG000|Overall Study|Adverse Event|36|||
162862005|NCT00847613|588199348|FG001|Overall Study|Adverse Event|26|||
162862006|NCT00847613|588199349|FG002|Overall Study|Adverse Event|5|||
162862007|NCT00847613|588199350|FG003|Overall Study|Adverse Event|6|||
162862008|NCT00847613|588199347|FG000|Overall Study|Lack of Efficacy|7|||
162862009|NCT00847613|588199348|FG001|Overall Study|Lack of Efficacy|3|||
162862010|NCT00847613|588199349|FG002|Overall Study|Lack of Efficacy|3|||
162958368|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
162958369|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
162958370|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
162705780|NCT00783718|587633817|FG004|Maintenance Phase|Adverse Event|7|||
162862011|NCT00847613|588199350|FG003|Overall Study|Lack of Efficacy|1|||
162862012|NCT00847613|588199347|FG000|Overall Study|Study terminated by Sponsor|1|||
162862013|NCT00847613|588199348|FG001|Overall Study|Study terminated by Sponsor|0|||
162862014|NCT00847613|588199349|FG002|Overall Study|Study terminated by Sponsor|2|||
162862015|NCT00847613|588199350|FG003|Overall Study|Study terminated by Sponsor|1|||
162862016|NCT00847613|588199347|FG000|Overall Study|Lost to Follow-up|5|||
162862017|NCT00847613|588199348|FG001|Overall Study|Lost to Follow-up|0|||
162862018|NCT00847613|588199349|FG002|Overall Study|Lost to Follow-up|0|||
162862019|NCT00847613|588199350|FG003|Overall Study|Lost to Follow-up|3|||
162862020|NCT00847613|588199347|FG000|Overall Study|Protocol Violation|6|||
162862021|NCT00847613|588199348|FG001|Overall Study|Protocol Violation|6|||
162862022|NCT00847613|588199349|FG002|Overall Study|Protocol Violation|3|||
162862023|NCT00847613|588199350|FG003|Overall Study|Protocol Violation|1|||
162862024|NCT00847613|588199347|FG000|Overall Study|Pregnancy|1|||
162862025|NCT00847613|588199348|FG001|Overall Study|Pregnancy|1|||
162862026|NCT00847613|588199349|FG002|Overall Study|Pregnancy|0|||
162862027|NCT00847613|588199350|FG003|Overall Study|Pregnancy|0|||
162862028|NCT00847613|588199347|FG000|Overall Study|Site closure|1|||
162862029|NCT00847613|588199348|FG001|Overall Study|Site closure|0|||
162862030|NCT00847613|588199349|FG002|Overall Study|Site closure|0|||
162862031|NCT00847613|588199350|FG003|Overall Study|Site closure|1|||
162862032|NCT00847613|588199347|FG000|Overall Study|Withdrawal by Subject|8|||
162862033|NCT00847613|588199348|FG001|Overall Study|Withdrawal by Subject|11|||
162862034|NCT00847613|588199349|FG002|Overall Study|Withdrawal by Subject|2|||
162862035|NCT00847613|588199350|FG003|Overall Study|Withdrawal by Subject|2|||
162862036|NCT00847613|588199347|FG000|Overall Study|Participant moved|4|||
162862037|NCT00847613|588199348|FG001|Overall Study|Participant moved|1|||
162862038|NCT00847613|588199349|FG002|Overall Study|Participant moved|0|||
162862039|NCT00847613|588199350|FG003|Overall Study|Participant moved|0|||
162862040|NCT00847613|588199347|FG000|Overall Study|Sponsor request|0|||
162862041|NCT00847613|588199348|FG001|Overall Study|Sponsor request|1|||
162862042|NCT00847613|588199349|FG002|Overall Study|Sponsor request|0|||
162862043|NCT00847613|588199350|FG003|Overall Study|Sponsor request|0|||
162862044|NCT00847613|588199347|FG000|Overall Study|Randomized, but not treated|0|||
163045917|NCT03131687|588875141|FG005|Overall Study|Principle Investigator Decision|0|||
162862045|NCT00847613|588199348|FG001|Overall Study|Randomized, but not treated|3|||
162862046|NCT00847613|588199349|FG002|Overall Study|Randomized, but not treated|0|||
162862047|NCT00847613|588199350|FG003|Overall Study|Randomized, but not treated|0|||
162862048|NCT00847613|588199347|FG000|Overall Study|Other|1|||
162862049|NCT00847613|588199348|FG001|Overall Study|Other|1|||
162862050|NCT00847613|588199349|FG002|Overall Study|Other|2|||
162862051|NCT00847613|588199350|FG003|Overall Study|Other|0|||
162862052|NCT02111369|588199351|FG000|Overall Study|Lost to Follow-up|2|||
162862053|NCT02111369|588199351|FG000|Overall Study|Withdrawal by Subject|1|||
162862054|NCT00072189|588199356|FG000|Overall Study|Withdrawal by Subject|1|||
162862055|NCT01933672|588199358|FG000|Metformin Run-in Period|Adverse Event|1|||
162862056|NCT01933672|588199359|FG001|Metformin Run-in Period|Adverse Event|0|||
162862057|NCT01933672|588199360|FG002|Metformin Run-in Period|Adverse Event|0|||
162862058|NCT01933672|588199361|FG003|Metformin Run-in Period|Adverse Event|0|||
162862059|NCT01933672|588199362|FG004|Metformin Run-in Period|Adverse Event|0|||
162862060|NCT01933672|588199363|FG005|Metformin Run-in Period|Adverse Event|0|||
162862061|NCT01933672|588199364|FG006|Metformin Run-in Period|Adverse Event|0|||
162862062|NCT01933672|588199358|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
162862063|NCT01933672|588199359|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862064|NCT01933672|588199360|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862065|NCT01933672|588199361|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862066|NCT01933672|588199362|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862067|NCT01933672|588199363|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862068|NCT01933672|588199364|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
162862069|NCT01933672|588199358|FG000|Metformin Run-in Period|Other|5|||
162862070|NCT01933672|588199359|FG001|Metformin Run-in Period|Other|0|||
162862071|NCT01933672|588199360|FG002|Metformin Run-in Period|Other|0|||
162862072|NCT01933672|588199361|FG003|Metformin Run-in Period|Other|0|||
162862073|NCT01933672|588199362|FG004|Metformin Run-in Period|Other|0|||
162862074|NCT01933672|588199363|FG005|Metformin Run-in Period|Other|0|||
162862075|NCT01933672|588199364|FG006|Metformin Run-in Period|Other|0|||
162862076|NCT01933672|588199358|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862077|NCT01933672|588199359|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862078|NCT01933672|588199360|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862079|NCT01933672|588199361|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
163045918|NCT03131687|588875136|FG000|Overall Study|Inadvertent Enrollment|0|||
162862080|NCT01933672|588199362|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
162862081|NCT01933672|588199363|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862082|NCT01933672|588199364|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862083|NCT01933672|588199358|FG000|First Intervention Period (12-16 Days)|Other|0|||
162862084|NCT01933672|588199359|FG001|First Intervention Period (12-16 Days)|Other|0|||
162862085|NCT01933672|588199360|FG002|First Intervention Period (12-16 Days)|Other|1|||
163045919|NCT03131687|588875137|FG001|Overall Study|Inadvertent Enrollment|0|||
162862086|NCT01933672|588199361|FG003|First Intervention Period (12-16 Days)|Other|0|||
162862087|NCT01933672|588199362|FG004|First Intervention Period (12-16 Days)|Other|0|||
162862088|NCT01933672|588199363|FG005|First Intervention Period (12-16 Days)|Other|1|||
162862089|NCT01933672|588199364|FG006|First Intervention Period (12-16 Days)|Other|0|||
162862090|NCT01933672|588199358|FG000|Second Intervention Period (12-16 Days)|Other|0|||
162862091|NCT01933672|588199359|FG001|Second Intervention Period (12-16 Days)|Other|1|||
162862092|NCT01933672|588199360|FG002|Second Intervention Period (12-16 Days)|Other|1|||
162862093|NCT01933672|588199361|FG003|Second Intervention Period (12-16 Days)|Other|0|||
162862094|NCT01933672|588199362|FG004|Second Intervention Period (12-16 Days)|Other|0|||
162862095|NCT01933672|588199363|FG005|Second Intervention Period (12-16 Days)|Other|0|||
162862096|NCT01933672|588199364|FG006|Second Intervention Period (12-16 Days)|Other|0|||
162862097|NCT01933672|588199358|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862098|NCT01933672|588199359|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862099|NCT01933672|588199360|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862100|NCT01933672|588199361|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
162862101|NCT01933672|588199362|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862102|NCT01933672|588199363|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862103|NCT01933672|588199364|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
162862104|NCT01933672|588199358|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862105|NCT01933672|588199359|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
162862106|NCT01933672|588199360|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862107|NCT01933672|588199361|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862108|NCT01933672|588199362|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862109|NCT01933672|588199363|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862110|NCT01933672|588199364|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
162862111|NCT00524303|588199365|FG000|Overall Study|Lost to Follow-up|6|||
162862112|NCT00524303|588199366|FG001|Overall Study|Lost to Follow-up|0|||
162862113|NCT00524303|588199367|FG002|Overall Study|Lost to Follow-up|3|||
162862114|NCT00524303|588199365|FG000|Overall Study|Protocol Violation|0|||
162862115|NCT00524303|588199366|FG001|Overall Study|Protocol Violation|1|||
162862116|NCT00524303|588199367|FG002|Overall Study|Protocol Violation|1|||
162862117|NCT00524303|588199365|FG000|Overall Study|Withdrawal by Subject|3|||
162862118|NCT00524303|588199366|FG001|Overall Study|Withdrawal by Subject|0|||
162862119|NCT00524303|588199367|FG002|Overall Study|Withdrawal by Subject|4|||
162862120|NCT00524303|588199365|FG000|Overall Study|Death|0|||
162862121|NCT00524303|588199366|FG001|Overall Study|Death|2|||
162862122|NCT00524303|588199367|FG002|Overall Study|Death|3|||
162862123|NCT00524303|588199365|FG000|Overall Study|Adverse Event|1|||
162862124|NCT00524303|588199366|FG001|Overall Study|Adverse Event|2|||
162862125|NCT00524303|588199367|FG002|Overall Study|Adverse Event|3|||
162862126|NCT00524303|588199365|FG000|Overall Study|Did not Complete Study Dosing|1|||
162862127|NCT00524303|588199366|FG001|Overall Study|Did not Complete Study Dosing|0|||
162862128|NCT00524303|588199367|FG002|Overall Study|Did not Complete Study Dosing|0|||
162862129|NCT00524303|588199365|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
162862130|NCT00524303|588199366|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
162862131|NCT00524303|588199367|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
162862132|NCT00524303|588199365|FG000|Overall Study|Disease Progression|0|||
162862133|NCT00524303|588199366|FG001|Overall Study|Disease Progression|4|||
162862134|NCT00524303|588199367|FG002|Overall Study|Disease Progression|1|||
162862135|NCT00524303|588199365|FG000|Overall Study|Disease Recurrence|0|||
162862136|NCT00524303|588199366|FG001|Overall Study|Disease Recurrence|1|||
162862137|NCT00524303|588199367|FG002|Overall Study|Disease Recurrence|0|||
162862138|NCT00524303|588199365|FG000|Overall Study|Sponsor Request|0|||
162862139|NCT00524303|588199366|FG001|Overall Study|Sponsor Request|0|||
162862140|NCT00524303|588199367|FG002|Overall Study|Sponsor Request|1|||
162862141|NCT00524303|588199365|FG000|Overall Study|Physician Decision|0|||
162862142|NCT00524303|588199366|FG001|Overall Study|Physician Decision|0|||
162862143|NCT00524303|588199367|FG002|Overall Study|Physician Decision|1|||
162862144|NCT00524303|588199365|FG000|Overall Study|Completed 5 years|0|||
162862145|NCT00524303|588199366|FG001|Overall Study|Completed 5 years|0|||
162862146|NCT00524303|588199367|FG002|Overall Study|Completed 5 years|1|||
162862147|NCT00970294|588199371|FG000|Overall Study|Physician Decision|4|||
162862148|NCT00970294|588199371|FG000|Overall Study|Withdrawal by Subject|1|||
162862149|NCT01877655|588199374|FG000|Overall Study|Death|57|||
162862150|NCT01877655|588199375|FG001|Overall Study|Death|52|||
162862151|NCT01877655|588199374|FG000|Overall Study|Withdrawal by Subject|18|||
162862152|NCT01877655|588199375|FG001|Overall Study|Withdrawal by Subject|26|||
162862153|NCT01877655|588199374|FG000|Overall Study|Physician Decision|11|||
162862154|NCT01877655|588199375|FG001|Overall Study|Physician Decision|10|||
162862155|NCT01877655|588199374|FG000|Overall Study|Miscellaneous|4|||
162862156|NCT01877655|588199375|FG001|Overall Study|Miscellaneous|4|||
162862157|NCT01877655|588199374|FG000|Overall Study|Randomized but Never Received Drug|8|||
162862158|NCT01877655|588199375|FG001|Overall Study|Randomized but Never Received Drug|5|||
162862159|NCT00095121|588199376|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
162705781|NCT00783718|587633818|FG005|Maintenance Phase|Adverse Event|6|||
162705782|NCT00783718|587633819|FG006|Maintenance Phase|Adverse Event|16|||
162705783|NCT00783718|587633813|FG000|Maintenance Phase|Protocol Violation|1|||
162705784|NCT00783718|587633814|FG001|Maintenance Phase|Protocol Violation|0|||
162705785|NCT00783718|587633815|FG002|Maintenance Phase|Protocol Violation|0|||
162705786|NCT00783718|587633816|FG003|Maintenance Phase|Protocol Violation|0|||
162705787|NCT00783718|587633817|FG004|Maintenance Phase|Protocol Violation|0|||
162705788|NCT00783718|587633818|FG005|Maintenance Phase|Protocol Violation|0|||
162705789|NCT00783718|587633819|FG006|Maintenance Phase|Protocol Violation|2|||
162705790|NCT00783718|587633813|FG000|Maintenance Phase|Lack of Efficacy|83|||
162705791|NCT00783718|587633814|FG001|Maintenance Phase|Lack of Efficacy|0|||
162705792|NCT00783718|587633815|FG002|Maintenance Phase|Lack of Efficacy|0|||
162705793|NCT00783718|587633816|FG003|Maintenance Phase|Lack of Efficacy|61|||
162705794|NCT00783718|587633817|FG004|Maintenance Phase|Lack of Efficacy|31|||
162705795|NCT00783718|587633818|FG005|Maintenance Phase|Lack of Efficacy|33|||
162705796|NCT00783718|587633819|FG006|Maintenance Phase|Lack of Efficacy|155|||
162705797|NCT00783718|587633813|FG000|Maintenance Phase|Withdrawal by Subject|6|||
162705798|NCT00783718|587633814|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162705799|NCT00783718|587633815|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162705800|NCT00783718|587633816|FG003|Maintenance Phase|Withdrawal by Subject|2|||
162705801|NCT00783718|587633817|FG004|Maintenance Phase|Withdrawal by Subject|5|||
162705802|NCT00783718|587633818|FG005|Maintenance Phase|Withdrawal by Subject|2|||
162705803|NCT00783718|587633819|FG006|Maintenance Phase|Withdrawal by Subject|20|||
162705804|NCT00783718|587633813|FG000|Maintenance Phase|Lost to Follow-up|3|||
162705805|NCT00783718|587633814|FG001|Maintenance Phase|Lost to Follow-up|0|||
162705806|NCT00783718|587633815|FG002|Maintenance Phase|Lost to Follow-up|0|||
162705807|NCT00783718|587633816|FG003|Maintenance Phase|Lost to Follow-up|0|||
162705808|NCT00783718|587633817|FG004|Maintenance Phase|Lost to Follow-up|2|||
162705809|NCT00783718|587633818|FG005|Maintenance Phase|Lost to Follow-up|0|||
162705810|NCT00783718|587633819|FG006|Maintenance Phase|Lost to Follow-up|2|||
162705811|NCT01027871|587633822|FG000|Overall Study|Physician Decision|1|||
162705812|NCT01027871|587633823|FG001|Overall Study|Physician Decision|5|||
162705813|NCT01027871|587633824|FG002|Overall Study|Physician Decision|0|||
162705814|NCT01027871|587633822|FG000|Overall Study|Protocol Violation|0|||
162705815|NCT01027871|587633823|FG001|Overall Study|Protocol Violation|2|||
162705816|NCT01027871|587633824|FG002|Overall Study|Protocol Violation|2|||
162705817|NCT01027871|587633822|FG000|Overall Study|Withdrawal by Subject|1|||
162705818|NCT01027871|587633823|FG001|Overall Study|Withdrawal by Subject|2|||
162705819|NCT01027871|587633824|FG002|Overall Study|Withdrawal by Subject|2|||
162705820|NCT01027871|587633822|FG000|Overall Study|Adverse Event|0|||
162705821|NCT01027871|587633823|FG001|Overall Study|Adverse Event|2|||
162705822|NCT01027871|587633824|FG002|Overall Study|Adverse Event|2|||
162705823|NCT01027871|587633822|FG000|Overall Study|Sponsor Decision|0|||
162705824|NCT01027871|587633823|FG001|Overall Study|Sponsor Decision|2|||
162705825|NCT01027871|587633824|FG002|Overall Study|Sponsor Decision|0|||
162705826|NCT01027871|587633822|FG000|Overall Study|Discontinued Prior to Treatment|0|||
162705827|NCT01027871|587633823|FG001|Overall Study|Discontinued Prior to Treatment|0|||
162705828|NCT01027871|587633824|FG002|Overall Study|Discontinued Prior to Treatment|1|||
162705829|NCT01414166|587633825|FG000|Overall Study|Adverse Event|10|||
162705830|NCT01414166|587633826|FG001|Overall Study|Adverse Event|2|||
162705831|NCT01414166|587633825|FG000|Overall Study|Lost to Follow-up|4|||
162705832|NCT01414166|587633826|FG001|Overall Study|Lost to Follow-up|1|||
162705833|NCT01414166|587633825|FG000|Overall Study|Non-compliance with study drug|2|||
162705834|NCT01414166|587633826|FG001|Overall Study|Non-compliance with study drug|0|||
162705835|NCT01414166|587633825|FG000|Overall Study|Physician Decision|2|||
162705836|NCT01414166|587633826|FG001|Overall Study|Physician Decision|0|||
162705837|NCT01414166|587633825|FG000|Overall Study|Protocol Violation|2|||
162705838|NCT01414166|587633826|FG001|Overall Study|Protocol Violation|0|||
162705839|NCT01414166|587633825|FG000|Overall Study|Study terminated by Sponsor|68|||
162705840|NCT01414166|587633826|FG001|Overall Study|Study terminated by Sponsor|75|||
162705841|NCT01414166|587633825|FG000|Overall Study|Withdrawal by Subject|3|||
162705842|NCT01414166|587633826|FG001|Overall Study|Withdrawal by Subject|5|||
162705843|NCT05489224|587633827|FG000|Treatment Period I|Withdrawal by Subject|6|||
162862160|NCT00095121|588199377|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
162862161|NCT00095121|588199376|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
162862162|NCT00095121|588199377|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
162705844|NCT05489224|587633828|FG001|Treatment Period I|Withdrawal by Subject|5|||
162705845|NCT05489224|587633829|FG002|Treatment Period I|Withdrawal by Subject|0|||
162705846|NCT05489224|587633827|FG000|Treatment Period I|Adverse Event|3|||
162705847|NCT05489224|587633828|FG001|Treatment Period I|Adverse Event|11|||
162705848|NCT05489224|587633829|FG002|Treatment Period I|Adverse Event|0|||
162705849|NCT05489224|587633827|FG000|Treatment Period I|Lost to Follow-up|0|||
162705850|NCT05489224|587633828|FG001|Treatment Period I|Lost to Follow-up|1|||
162705851|NCT05489224|587633829|FG002|Treatment Period I|Lost to Follow-up|0|||
162705852|NCT05489224|587633827|FG000|Treatment Period I|Physician Decision|0|||
162705853|NCT05489224|587633828|FG001|Treatment Period I|Physician Decision|1|||
162705854|NCT05489224|587633829|FG002|Treatment Period I|Physician Decision|0|||
162705855|NCT05489224|587633827|FG000|Treatment Period II up to Week 32|Ongoing|222|||
162958371|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958372|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958373|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958374|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958375|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958376|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958377|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958378|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958379|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958380|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162958381|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958382|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958383|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
162958384|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
162958385|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958386|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958387|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958388|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958389|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958390|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958391|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958392|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958393|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958394|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162958395|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
162958396|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958397|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
162958398|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958399|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958400|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958401|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958402|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958403|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958404|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958405|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958406|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958407|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958408|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162958409|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
162705856|NCT05489224|587633828|FG001|Treatment Period II up to Week 32|Ongoing|107|||
162705857|NCT05489224|587633829|FG002|Treatment Period II up to Week 32|Ongoing|107|||
162705858|NCT05489224|587633827|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
162705859|NCT05489224|587633828|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
162705860|NCT05489224|587633829|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
162705861|NCT05489224|587633827|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
162705862|NCT05489224|587633828|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
162705863|NCT05489224|587633829|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
162705864|NCT04887285|587633830|FG000|Overall Study|Lost to Follow-up|0|||
162705865|NCT04887285|587633831|FG001|Overall Study|Lost to Follow-up|2|||
162705866|NCT04887285|587633832|FG002|Overall Study|Lost to Follow-up|3|||
162705867|NCT04640571|587633833|FG000|Overall Study|Withdrawal by Subject|0|||
162705868|NCT04640571|587633834|FG001|Overall Study|Withdrawal by Subject|0|||
162705869|NCT04640571|587633835|FG002|Overall Study|Withdrawal by Subject|0|||
162705870|NCT04640571|587633836|FG003|Overall Study|Withdrawal by Subject|0|||
162705871|NCT04640571|587633837|FG004|Overall Study|Withdrawal by Subject|0|||
162705872|NCT04640571|587633838|FG005|Overall Study|Withdrawal by Subject|2|||
162705873|NCT00832780|587633843|FG000|Overall Study|Death|16|||
162705874|NCT00832780|587633843|FG000|Overall Study|Lost to Follow-up|4|||
162705875|NCT00832780|587633843|FG000|Overall Study|no reason given|2|||
162705876|NCT00832780|587633843|FG000|Overall Study|other complicating condition|2|||
162705877|NCT00832780|587633843|FG000|Overall Study|Physician Decision|1|||
162705878|NCT05705167|587633844|FG000|Overall Study|Randomised but not Treated|0|||
162958410|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162958411|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162705879|NCT05705167|587633845|FG001|Overall Study|Randomised but not Treated|2|||
162705880|NCT05705167|587633846|FG002|Overall Study|Randomised but not Treated|0|||
162705881|NCT05705167|587633847|FG003|Overall Study|Randomised but not Treated|7|||
162705882|NCT05705167|587633848|FG004|Overall Study|Randomised but not Treated|0|||
162862173|NCT05176847|588200640|FG000|Overall Study|Lost to Follow-up|23|||
162862174|NCT05176847|588200641|FG001|Overall Study|Lost to Follow-up|36|||
162862175|NCT05176847|588200640|FG000|Overall Study|Withdrawal by Subject|7|||
162862176|NCT05176847|588200641|FG001|Overall Study|Withdrawal by Subject|12|||
162862177|NCT05176847|588200640|FG000|Overall Study|Removed from analysis|1|||
162862178|NCT05176847|588200641|FG001|Overall Study|Removed from analysis|0|||
162862179|NCT02562235|588200642|FG000|Overall Study|Adverse Event|3|||
162862181|NCT05369208|588200644|FG000|Core Phase|Prohibited Medication Required|2|||
162862182|NCT05369208|588200644|FG000|Core Phase|Adverse Event|1|||
162862183|NCT05369208|588200644|FG000|Core Phase|Lack of Efficacy|1|||
162862184|NCT05441670|588200648|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
162862185|NCT05441670|588200649|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
162958412|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958413|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958414|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958415|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958416|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958417|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958418|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958419|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958420|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958421|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958422|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162958423|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
162958424|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958425|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
162958426|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958427|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958428|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958429|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958430|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162613330|NCT05098938|587301196|FG001|Overall Study|Run-in Failure in early study|514|||
162862208|NCT05248945|588200655|FG000|Overall Study|Adverse Event|1|||
162958431|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958432|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958433|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162613331|NCT05098938|587301195|FG000|Overall Study|IMP delivery missed|1|||
162862209|NCT05248945|588200655|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
162862210|NCT05525975|588200656|FG000|Overall Study|Surgery cancellation|4|||
162862211|NCT05525975|588200657|FG001|Overall Study|Surgery cancellation|5|||
162862212|NCT05525975|588200656|FG000|Overall Study|didn't fill prescription|1|||
162862213|NCT05525975|588200657|FG001|Overall Study|didn't fill prescription|0|||
162862214|NCT05525975|588200656|FG000|Overall Study|Withdrawal by Subject|0|||
162862215|NCT05525975|588200657|FG001|Overall Study|Withdrawal by Subject|3|||
162862218|NCT05090423|588200659|FG000|Overall Study|Because of the covid-19|3|||
162862219|NCT05090423|588200660|FG001|Overall Study|Because of the covid-19|2|||
162862220|NCT05090423|588200659|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
162862221|NCT05090423|588200660|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
162862226|NCT05733286|588200667|FG000|Overall Study|Never received study drug|2|||
162862227|NCT05733286|588200668|FG001|Overall Study|Never received study drug|3|||
162862230|NCT05098015|588200675|FG000|Overall Study|Death|1|||
162862231|NCT05098015|588200676|FG001|Overall Study|Death|1|||
162862232|NCT05098015|588200677|FG002|Overall Study|Death|3|||
162862233|NCT05098015|588200678|FG003|Overall Study|Death|0|||
162862234|NCT05098015|588200675|FG000|Overall Study|Lost to Follow-up|1|||
162862235|NCT05098015|588200676|FG001|Overall Study|Lost to Follow-up|1|||
162862236|NCT05098015|588200677|FG002|Overall Study|Lost to Follow-up|3|||
162862237|NCT05098015|588200678|FG003|Overall Study|Lost to Follow-up|3|||
162862238|NCT05098015|588200675|FG000|Overall Study|Withdrawal by Subject|0|||
162862239|NCT05098015|588200676|FG001|Overall Study|Withdrawal by Subject|1|||
162862240|NCT05098015|588200677|FG002|Overall Study|Withdrawal by Subject|0|||
162862241|NCT05098015|588200678|FG003|Overall Study|Withdrawal by Subject|2|||
162862243|NCT05655832|588200682|FG000|Overall Study|Not mentioned|0|||
162862244|NCT05655832|588200683|FG001|Overall Study|Not mentioned|1|||
162862245|NCT05655832|588200682|FG000|Overall Study|Withdrawal by Subject|0|||
162862246|NCT05655832|588200683|FG001|Overall Study|Withdrawal by Subject|1|||
162862247|NCT05655832|588200682|FG000|Overall Study|Protocol non-compliance|0|||
162862248|NCT05655832|588200683|FG001|Overall Study|Protocol non-compliance|1|||
162862249|NCT04516967|588200684|FG000|Core Phase|Adverse Event|2|||
162862250|NCT04516967|588200685|FG001|Core Phase|Adverse Event|1|||
162862251|NCT04516967|588200686|FG002|Core Phase|Adverse Event|0|||
162862252|NCT04516967|588200684|FG000|Core Phase|Physician Decision|1|||
162862253|NCT04516967|588200685|FG001|Core Phase|Physician Decision|1|||
162862254|NCT04516967|588200686|FG002|Core Phase|Physician Decision|0|||
162862255|NCT04516967|588200684|FG000|Core Phase|Lack of Efficacy|7|||
162862256|NCT04516967|588200685|FG001|Core Phase|Lack of Efficacy|18|||
162862257|NCT04516967|588200686|FG002|Core Phase|Lack of Efficacy|0|||
162862270|NCT05916170|588200691|FG000|No Warning Control|Lost to Follow-up|12|||
162862271|NCT05916170|588200691|FG000|No Warning Control|Withdrawal by Subject|15|||
162862272|NCT05916170|588200691|FG000|No Warning Control|Noncompliance with protocol|1|||
162862273|NCT05916170|588200691|FG000|Health Warning Intervention|Lost to Follow-up|15|||
162862274|NCT05916170|588200691|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
162862275|NCT05916170|588200691|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
162862276|NCT04576949|588200692|FG000|Overall Study|Adverse Event|1|||
162862277|NCT04576949|588200693|FG001|Overall Study|Adverse Event|3|||
162862278|NCT04576949|588200694|FG002|Overall Study|Adverse Event|2|||
162862279|NCT04576949|588200692|FG000|Overall Study|Withdrawal by Subject|41|||
162958434|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162862280|NCT04576949|588200693|FG001|Overall Study|Withdrawal by Subject|26|||
162862281|NCT04576949|588200694|FG002|Overall Study|Withdrawal by Subject|18|||
162862282|NCT04576949|588200692|FG000|Overall Study|Physician Decision|3|||
162862283|NCT04576949|588200693|FG001|Overall Study|Physician Decision|0|||
162862284|NCT04576949|588200694|FG002|Overall Study|Physician Decision|0|||
162862285|NCT04576949|588200692|FG000|Overall Study|Death|0|||
162862286|NCT04576949|588200693|FG001|Overall Study|Death|1|||
162862287|NCT04576949|588200694|FG002|Overall Study|Death|0|||
162862288|NCT04576949|588200692|FG000|Overall Study|Lost to Follow-up|29|||
162862289|NCT04576949|588200693|FG001|Overall Study|Lost to Follow-up|37|||
162862290|NCT04576949|588200694|FG002|Overall Study|Lost to Follow-up|24|||
162862291|NCT04576949|588200692|FG000|Overall Study|Other, Not Specified|2|||
162862292|NCT04576949|588200693|FG001|Overall Study|Other, Not Specified|3|||
162862293|NCT04576949|588200694|FG002|Overall Study|Other, Not Specified|1|||
162862294|NCT04576949|588200692|FG000|Overall Study|Other|1|||
162862295|NCT04576949|588200693|FG001|Overall Study|Other|0|||
162862296|NCT04576949|588200694|FG002|Overall Study|Other|0|||
162862297|NCT03556904|588200697|FG000|Overall Study|Disease Progression after treatment started|3|||
162862298|NCT03556904|588200698|FG001|Overall Study|Disease Progression after treatment started|3|||
162862299|NCT03556904|588200697|FG000|Overall Study|Sponsor Termination|2|||
162862300|NCT03556904|588200698|FG001|Overall Study|Sponsor Termination|2|||
162862301|NCT03556904|588200697|FG000|Overall Study|Physician Decision|2|||
162862302|NCT03556904|588200698|FG001|Overall Study|Physician Decision|0|||
162862303|NCT03556904|588200697|FG000|Overall Study|Withdrawal by Subject|1|||
162862304|NCT03556904|588200698|FG001|Overall Study|Withdrawal by Subject|0|||
162862325|NCT05243680|588200703|FG000|Overall Study|Adverse Event|1|||
162862326|NCT05243680|588200704|FG001|Overall Study|Adverse Event|1|||
162862327|NCT05243680|588200703|FG000|Overall Study|Lack of Efficacy|1|||
162862328|NCT05243680|588200704|FG001|Overall Study|Lack of Efficacy|1|||
162862329|NCT05243680|588200703|FG000|Overall Study|Lost to Follow-up|5|||
162862330|NCT05243680|588200704|FG001|Overall Study|Lost to Follow-up|4|||
162862331|NCT05243680|588200703|FG000|Overall Study|Physician Decision|1|||
162862332|NCT05243680|588200704|FG001|Overall Study|Physician Decision|0|||
162862333|NCT05243680|588200703|FG000|Overall Study|Withdrawal by Subject|3|||
162862334|NCT05243680|588200704|FG001|Overall Study|Withdrawal by Subject|10|||
162862335|NCT05243680|588200703|FG000|Overall Study|Data integrity and GCP violations|4|||
162862336|NCT05243680|588200704|FG001|Overall Study|Data integrity and GCP violations|8|||
162862349|NCT05642442|588200708|FG000|Overall Study|Adverse Event|0|||
162862350|NCT05642442|588200709|FG001|Overall Study|Adverse Event|1|||
162862351|NCT05642442|588200708|FG000|Overall Study|Lack of Efficacy|0|||
162862352|NCT05642442|588200709|FG001|Overall Study|Lack of Efficacy|1|||
162862353|NCT05642442|588200708|FG000|Overall Study|Withdrawal by Subject|13|||
162862354|NCT05642442|588200709|FG001|Overall Study|Withdrawal by Subject|9|||
162862355|NCT05642442|588200708|FG000|Overall Study|Other|5|||
162862356|NCT05642442|588200709|FG001|Overall Study|Other|2|||
162862357|NCT05642442|588200708|FG000|Overall Study|Lost to Follow-up|0|||
162862358|NCT05642442|588200709|FG001|Overall Study|Lost to Follow-up|1|||
162705883|NCT05705167|587633849|FG005|Overall Study|Randomised but not Treated|0|||
162705884|NCT05705167|587633850|FG006|Overall Study|Randomised but not Treated|0|||
162705885|NCT05705167|587633844|FG000|Overall Study|Death|0|||
162705886|NCT05705167|587633845|FG001|Overall Study|Death|0|||
162705887|NCT05705167|587633846|FG002|Overall Study|Death|3|||
162705888|NCT05705167|587633847|FG003|Overall Study|Death|0|||
162705889|NCT05705167|587633848|FG004|Overall Study|Death|1|||
162705890|NCT05705167|587633849|FG005|Overall Study|Death|1|||
162705891|NCT05705167|587633850|FG006|Overall Study|Death|1|||
162705892|NCT05705167|587633844|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162705893|NCT05705167|587633845|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162705894|NCT05705167|587633846|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
162705895|NCT05705167|587633847|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
162705896|NCT05705167|587633848|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162705897|NCT05705167|587633849|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162705898|NCT05705167|587633850|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
162705899|NCT03658811|587633853|FG000|Overall Study|Lost to Follow-up|3|||
162705900|NCT04209790|587633854|FG000|Overall Study|Physician Decision|1|||
162705901|NCT04060680|587633855|FG000|Overall Study|Unsuccessful implant|17|||
162705902|NCT04060680|587633856|FG001|Overall Study|Unsuccessful implant|2|||
163045920|NCT03131687|588875138|FG002|Overall Study|Inadvertent Enrollment|0|||
163045921|NCT03131687|588875139|FG003|Overall Study|Inadvertent Enrollment|1|||
163045922|NCT03131687|588875140|FG004|Overall Study|Inadvertent Enrollment|0|||
163045923|NCT03131687|588875141|FG005|Overall Study|Inadvertent Enrollment|0|||
163045924|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
163045925|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
163045926|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
163045927|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
163045928|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
163045929|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
163045930|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
163045931|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045932|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045933|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
163045934|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
163045935|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
163045936|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
163045937|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
163045938|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
163045939|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
163045940|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
163045941|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045942|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045943|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
163045944|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
163045945|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045946|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045947|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045948|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
163045949|NCT02137226|588875142|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
163045950|NCT02137226|588875143|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
163045951|NCT02137226|588875144|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
163045952|NCT02137226|588875145|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
163045953|NCT02137226|588875146|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
163045954|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
163045955|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
163045956|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
163045957|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
163045958|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
162958435|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958436|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
162958437|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162958438|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958439|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162958440|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958441|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958442|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958443|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958444|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958445|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958446|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958447|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958448|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958449|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958450|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162958451|NCT01695239|588551575|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
162958452|NCT01695239|588551576|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958453|NCT01695239|588551577|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958454|NCT01695239|588551578|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958455|NCT01695239|588551579|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958456|NCT01695239|588551580|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958457|NCT01695239|588551581|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958458|NCT01695239|588551582|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958459|NCT01695239|588551583|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958460|NCT01695239|588551584|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958461|NCT01695239|588551585|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958462|NCT01695239|588551586|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958463|NCT01695239|588551587|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958464|NCT01695239|588551588|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
162958465|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958466|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958467|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958468|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958469|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958470|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958471|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958472|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
162958473|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958474|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958475|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958476|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958477|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958478|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162958479|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958480|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958481|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958482|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958483|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958484|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958485|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958486|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
162958487|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958488|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958489|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958490|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958491|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958492|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162958493|NCT01695239|588551575|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958494|NCT01695239|588551576|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958495|NCT01695239|588551577|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
163045959|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
163045960|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
163045961|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
163045962|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
163045963|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
163045964|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
163045965|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
163045966|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
163045967|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
163045968|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
163045969|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045970|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045971|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
163045972|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
162862616|NCT05270265|588200733|FG000|Overall Study|Lost to Follow-up|0|||
162862617|NCT05270265|588200734|FG001|Overall Study|Lost to Follow-up|1|||
162862618|NCT05270265|588200735|FG002|Overall Study|Lost to Follow-up|0|||
162862632|NCT02296684|588200742|FG000|Overall Study|Withdrawal by Subject|0|||
162862633|NCT02296684|588200743|FG001|Overall Study|Withdrawal by Subject|1|||
162862634|NCT02296684|588200744|FG002|Overall Study|Withdrawal by Subject|1|||
162862635|NCT02296684|588200742|FG000|Overall Study|Death|2|||
162862636|NCT02296684|588200743|FG001|Overall Study|Death|0|||
162862637|NCT02296684|588200744|FG002|Overall Study|Death|0|||
163045973|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
163045974|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045975|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045976|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
162862668|NCT03734666|588201139|FG000|Overall Study|Other|7|||
162862669|NCT03734666|588201140|FG001|Overall Study|Other|4|||
162862670|NCT03734666|588201139|FG000|Overall Study|Lost to Follow-up|12|||
162862671|NCT03734666|588201140|FG001|Overall Study|Lost to Follow-up|12|||
162862672|NCT05866185|588201141|FG000|Overall Study|Lost to Follow-up|2|||
162862673|NCT05866185|588201142|FG001|Overall Study|Lost to Follow-up|4|||
162958496|NCT01695239|588551578|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958497|NCT01695239|588551579|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958498|NCT01695239|588551580|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958499|NCT01695239|588551581|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958500|NCT01695239|588551582|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
162958501|NCT01695239|588551583|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958502|NCT01695239|588551584|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958503|NCT01695239|588551585|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958504|NCT01695239|588551586|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958505|NCT01695239|588551587|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958506|NCT01695239|588551588|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162958507|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958508|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958509|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958510|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958511|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958512|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958513|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958514|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958515|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
162958516|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
162958517|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958518|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958519|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958520|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
162958521|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
162958522|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
162958523|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
162958524|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
162958525|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
162958526|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
162958527|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
162958528|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
162958529|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
162958530|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
162958531|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
162958532|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
162958533|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
162958534|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
162958535|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958536|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958537|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958538|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958539|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958540|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958541|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958542|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958543|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
162958544|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
162958545|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958546|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958547|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958548|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
162958549|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
162958550|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
162958551|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
162958552|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
162958553|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
163045977|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045978|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
163045979|NCT02137226|588875142|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
162958554|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
162958555|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
163045980|NCT02137226|588875143|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
162862674|NCT05866185|588201143|FG002|Overall Study|Lost to Follow-up|4|||
162862675|NCT05866185|588201144|FG003|Overall Study|Lost to Follow-up|6|||
162862703|NCT03246529|588201148|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
162862704|NCT03246529|588201149|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
162862705|NCT03246529|588201150|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
162862706|NCT03246529|588201148|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
162862707|NCT03246529|588201149|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
162862708|NCT03246529|588201150|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
162862709|NCT03246529|588201148|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
162862710|NCT03246529|588201149|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
162862711|NCT03246529|588201150|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
162862712|NCT03246529|588201148|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
162862713|NCT03246529|588201149|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
162862714|NCT03246529|588201150|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
162862715|NCT03246529|588201148|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
162862716|NCT03246529|588201149|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
162862717|NCT03246529|588201150|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
162862718|NCT03246529|588201148|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
162862719|NCT03246529|588201149|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
162862720|NCT03246529|588201150|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
162862721|NCT03246529|588201148|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
162862722|NCT03246529|588201149|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
162958556|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
162958557|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
162958558|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
162958559|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
162958560|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
162958561|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
162958562|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
162958563|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958564|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958565|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958566|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958567|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958568|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958569|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958570|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958571|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
162862723|NCT03246529|588201150|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
162862724|NCT03246529|588201148|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
162862725|NCT03246529|588201149|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
162862726|NCT03246529|588201150|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
162862727|NCT03246529|588201148|FG000|Follow-up period at 1 year FU Completion|Death|0|||
162862728|NCT03246529|588201149|FG001|Follow-up period at 1 year FU Completion|Death|0|||
162862729|NCT03246529|588201150|FG002|Follow-up period at 1 year FU Completion|Death|1|||
162862730|NCT05561673|588201467|FG000|Overall Study|Lost to Follow-up|0|||
162862731|NCT05561673|588201468|FG001|Overall Study|Lost to Follow-up|1|||
162862732|NCT05561673|588201469|FG002|Overall Study|Lost to Follow-up|0|||
162862733|NCT05561673|588201470|FG003|Overall Study|Lost to Follow-up|1|||
162862734|NCT05561673|588201471|FG004|Overall Study|Lost to Follow-up|0|||
162862735|NCT05561673|588201467|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162862736|NCT05561673|588201468|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
162862737|NCT05561673|588201469|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162862738|NCT05561673|588201470|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162862739|NCT05561673|588201471|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162862740|NCT05561673|588201467|FG000|Overall Study|Other|1|||
162862741|NCT05561673|588201468|FG001|Overall Study|Other|0|||
162862742|NCT05561673|588201469|FG002|Overall Study|Other|1|||
162862743|NCT05561673|588201470|FG003|Overall Study|Other|0|||
162862744|NCT05561673|588201471|FG004|Overall Study|Other|0|||
162924269|NCT02575807|588423850|FG004|Overall Study|Terminated due to physician decision|0|||
162924270|NCT02575807|588423846|FG000|Overall Study|Subject ineligible - medical implant|0|||
162924271|NCT02575807|588423847|FG001|Overall Study|Subject ineligible - medical implant|0|||
162924272|NCT02575807|588423848|FG002|Overall Study|Subject ineligible - medical implant|0|||
162924273|NCT02575807|588423849|FG003|Overall Study|Subject ineligible - medical implant|1|||
162924274|NCT02575807|588423850|FG004|Overall Study|Subject ineligible - medical implant|0|||
163045981|NCT02137226|588875144|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
162924275|NCT02575807|588423846|FG000|Overall Study|Withdrawal by Subject|0|||
162924276|NCT02575807|588423847|FG001|Overall Study|Withdrawal by Subject|0|||
162924277|NCT02575807|588423848|FG002|Overall Study|Withdrawal by Subject|1|||
162924278|NCT02575807|588423849|FG003|Overall Study|Withdrawal by Subject|1|||
162924279|NCT02575807|588423850|FG004|Overall Study|Withdrawal by Subject|2|||
162924280|NCT03319368|588423851|FG000|Overall Study|Discharge swabs not collected from resident|57|||
162924281|NCT03319368|588423852|FG001|Overall Study|Discharge swabs not collected from resident|46|||
162924282|NCT02180659|588423853|FG000|Overall Study|Adverse Event|1|||
162862786|NCT00001259|588203701|FG000|Study 2|Adverse Event|0|||
162862787|NCT00001259|588203702|FG001|Study 2|Adverse Event|0|||
162862788|NCT00001259|588203703|FG002|Study 2|Adverse Event|0|||
162862789|NCT00001259|588203704|FG003|Study 2|Adverse Event|0|||
162862790|NCT00001259|588203705|FG004|Study 2|Adverse Event|2|||
162862791|NCT00001259|588203706|FG005|Study 2|Adverse Event|0|||
162862792|NCT00001259|588203707|FG006|Study 2|Adverse Event|0|||
162862793|NCT01582282|588203708|FG000|Overall Study|Adverse Event|1|||
162862794|NCT01582282|588203709|FG001|Overall Study|Adverse Event|1|||
162862795|NCT01582282|588203710|FG002|Overall Study|Adverse Event|0|||
162862796|NCT01582282|588203708|FG000|Overall Study|Lost to Follow-up|1|||
162862797|NCT01582282|588203709|FG001|Overall Study|Lost to Follow-up|0|||
162862798|NCT01582282|588203710|FG002|Overall Study|Lost to Follow-up|0|||
162862799|NCT01582282|588203708|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
162862800|NCT01582282|588203709|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
162862801|NCT01582282|588203710|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
162862802|NCT04426630|588203712|FG000|Overall Study|Death|4|||
162862803|NCT04426630|588203712|FG000|Overall Study|Lost to Follow-up|2|||
162862804|NCT02786537|588203713|FG000|As Randomized|Adverse Event|0|||
162862805|NCT02786537|588203714|FG001|As Randomized|Adverse Event|11|||
162862806|NCT02786537|588203715|FG002|As Randomized|Adverse Event|0|||
162862807|NCT02786537|588203716|FG003|As Randomized|Adverse Event|4|||
162862808|NCT02786537|588203717|FG004|As Randomized|Adverse Event|6|||
162862809|NCT02786537|588203718|FG005|As Randomized|Adverse Event|2|||
162862810|NCT02786537|588203713|FG000|As Randomized|Lack of Efficacy|0|||
162862811|NCT02786537|588203714|FG001|As Randomized|Lack of Efficacy|0|||
162862812|NCT02786537|588203715|FG002|As Randomized|Lack of Efficacy|0|||
162862813|NCT02786537|588203716|FG003|As Randomized|Lack of Efficacy|1|||
162862814|NCT02786537|588203717|FG004|As Randomized|Lack of Efficacy|0|||
162862815|NCT02786537|588203718|FG005|As Randomized|Lack of Efficacy|0|||
162862816|NCT02786537|588203713|FG000|As Randomized|Withdrawal by Subject|1|||
162862817|NCT02786537|588203714|FG001|As Randomized|Withdrawal by Subject|2|||
162862818|NCT02786537|588203715|FG002|As Randomized|Withdrawal by Subject|0|||
162862819|NCT02786537|588203716|FG003|As Randomized|Withdrawal by Subject|1|||
162862820|NCT02786537|588203717|FG004|As Randomized|Withdrawal by Subject|1|||
162862821|NCT02786537|588203718|FG005|As Randomized|Withdrawal by Subject|0|||
162862822|NCT02786537|588203713|FG000|As Randomized|Death|0|||
162862823|NCT02786537|588203714|FG001|As Randomized|Death|2|||
162862824|NCT02786537|588203715|FG002|As Randomized|Death|0|||
162862825|NCT02786537|588203716|FG003|As Randomized|Death|3|||
162862826|NCT02786537|588203717|FG004|As Randomized|Death|1|||
162862827|NCT02786537|588203718|FG005|As Randomized|Death|0|||
162862828|NCT02786537|588203713|FG000|As Randomized|Non-compliance with study drug|1|||
162862829|NCT02786537|588203714|FG001|As Randomized|Non-compliance with study drug|11|||
162862830|NCT02786537|588203715|FG002|As Randomized|Non-compliance with study drug|0|||
162862831|NCT02786537|588203716|FG003|As Randomized|Non-compliance with study drug|1|||
162862832|NCT02786537|588203717|FG004|As Randomized|Non-compliance with study drug|0|||
162862833|NCT02786537|588203718|FG005|As Randomized|Non-compliance with study drug|1|||
162862834|NCT02786537|588203713|FG000|As Randomized|Lost to treatment follow-up|4|||
162862835|NCT02786537|588203714|FG001|As Randomized|Lost to treatment follow-up|32|||
162862836|NCT02786537|588203715|FG002|As Randomized|Lost to treatment follow-up|0|||
162862837|NCT02786537|588203716|FG003|As Randomized|Lost to treatment follow-up|24|||
162862838|NCT02786537|588203717|FG004|As Randomized|Lost to treatment follow-up|4|||
162862839|NCT02786537|588203718|FG005|As Randomized|Lost to treatment follow-up|4|||
162862840|NCT02786537|588203713|FG000|As Randomized|Incarceration|0|||
162862841|NCT02786537|588203714|FG001|As Randomized|Incarceration|1|||
162862842|NCT02786537|588203715|FG002|As Randomized|Incarceration|0|||
162862843|NCT02786537|588203716|FG003|As Randomized|Incarceration|0|||
162862844|NCT02786537|588203717|FG004|As Randomized|Incarceration|0|||
162862845|NCT02786537|588203718|FG005|As Randomized|Incarceration|0|||
162862846|NCT02786537|588203713|FG000|As Randomized|Opiate Dependency Relapse|0|||
162862847|NCT02786537|588203714|FG001|As Randomized|Opiate Dependency Relapse|1|||
162862848|NCT02786537|588203715|FG002|As Randomized|Opiate Dependency Relapse|0|||
162862849|NCT02786537|588203716|FG003|As Randomized|Opiate Dependency Relapse|0|||
162862850|NCT02786537|588203717|FG004|As Randomized|Opiate Dependency Relapse|0|||
162862851|NCT02786537|588203718|FG005|As Randomized|Opiate Dependency Relapse|0|||
162862852|NCT02786537|588203713|FG000|As Randomized|HCV drugs stolen from pt|0|||
162862853|NCT02786537|588203714|FG001|As Randomized|HCV drugs stolen from pt|1|||
162862854|NCT02786537|588203715|FG002|As Randomized|HCV drugs stolen from pt|0|||
162862855|NCT02786537|588203716|FG003|As Randomized|HCV drugs stolen from pt|0|||
162862856|NCT02786537|588203717|FG004|As Randomized|HCV drugs stolen from pt|0|||
162862857|NCT02786537|588203718|FG005|As Randomized|HCV drugs stolen from pt|0|||
162862858|NCT02786537|588203713|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
162862859|NCT02786537|588203714|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
162862860|NCT02786537|588203715|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
162862861|NCT02786537|588203716|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
162862862|NCT02786537|588203717|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
162924283|NCT02180659|588423854|FG001|Overall Study|Adverse Event|0|||
162862863|NCT02786537|588203718|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
162862864|NCT02786537|588203713|FG000|As Randomized|Subject lost insurance|0|||
162862865|NCT02786537|588203714|FG001|As Randomized|Subject lost insurance|0|||
162862866|NCT02786537|588203715|FG002|As Randomized|Subject lost insurance|0|||
162862867|NCT02786537|588203716|FG003|As Randomized|Subject lost insurance|1|||
162862868|NCT02786537|588203717|FG004|As Randomized|Subject lost insurance|0|||
162862869|NCT02786537|588203718|FG005|As Randomized|Subject lost insurance|0|||
162862870|NCT02786537|588203713|FG000|As Treated|Adverse Event|0|||
162862871|NCT02786537|588203714|FG001|As Treated|Adverse Event|11|||
162862872|NCT02786537|588203715|FG002|As Treated|Adverse Event|0|||
162862873|NCT02786537|588203716|FG003|As Treated|Adverse Event|4|||
162862874|NCT02786537|588203717|FG004|As Treated|Adverse Event|6|||
162862875|NCT02786537|588203718|FG005|As Treated|Adverse Event|2|||
162862876|NCT02786537|588203713|FG000|As Treated|Death|0|||
162862877|NCT02786537|588203714|FG001|As Treated|Death|2|||
162862878|NCT02786537|588203715|FG002|As Treated|Death|0|||
162862879|NCT02786537|588203716|FG003|As Treated|Death|3|||
162862880|NCT02786537|588203717|FG004|As Treated|Death|1|||
162862881|NCT02786537|588203718|FG005|As Treated|Death|0|||
162862882|NCT02786537|588203713|FG000|As Treated|Lack of Efficacy|0|||
162862883|NCT02786537|588203714|FG001|As Treated|Lack of Efficacy|0|||
162862884|NCT02786537|588203715|FG002|As Treated|Lack of Efficacy|0|||
162862885|NCT02786537|588203716|FG003|As Treated|Lack of Efficacy|1|||
162862886|NCT02786537|588203717|FG004|As Treated|Lack of Efficacy|0|||
162862887|NCT02786537|588203718|FG005|As Treated|Lack of Efficacy|0|||
162862888|NCT02786537|588203713|FG000|As Treated|Lost to Follow-up|4|||
162862889|NCT02786537|588203714|FG001|As Treated|Lost to Follow-up|32|||
162862890|NCT02786537|588203715|FG002|As Treated|Lost to Follow-up|0|||
162862891|NCT02786537|588203716|FG003|As Treated|Lost to Follow-up|25|||
162862892|NCT02786537|588203717|FG004|As Treated|Lost to Follow-up|4|||
162862893|NCT02786537|588203718|FG005|As Treated|Lost to Follow-up|4|||
162862894|NCT02786537|588203713|FG000|As Treated|Non-compliance with study drug|1|||
162862895|NCT02786537|588203714|FG001|As Treated|Non-compliance with study drug|11|||
162862896|NCT02786537|588203715|FG002|As Treated|Non-compliance with study drug|0|||
162862897|NCT02786537|588203716|FG003|As Treated|Non-compliance with study drug|1|||
162862898|NCT02786537|588203717|FG004|As Treated|Non-compliance with study drug|0|||
162862899|NCT02786537|588203718|FG005|As Treated|Non-compliance with study drug|1|||
162862900|NCT02786537|588203713|FG000|As Treated|Lost insurance|0|||
162862901|NCT02786537|588203714|FG001|As Treated|Lost insurance|0|||
162862902|NCT02786537|588203715|FG002|As Treated|Lost insurance|0|||
162862903|NCT02786537|588203716|FG003|As Treated|Lost insurance|1|||
162862904|NCT02786537|588203717|FG004|As Treated|Lost insurance|0|||
162862905|NCT02786537|588203718|FG005|As Treated|Lost insurance|0|||
162862906|NCT02786537|588203713|FG000|As Treated|Withdrawal by Subject|1|||
162862907|NCT02786537|588203714|FG001|As Treated|Withdrawal by Subject|2|||
162862908|NCT02786537|588203715|FG002|As Treated|Withdrawal by Subject|0|||
162862909|NCT02786537|588203716|FG003|As Treated|Withdrawal by Subject|0|||
162862910|NCT02786537|588203717|FG004|As Treated|Withdrawal by Subject|1|||
162862911|NCT02786537|588203718|FG005|As Treated|Withdrawal by Subject|0|||
162862912|NCT02786537|588203713|FG000|As Treated|Incarceration|0|||
162862913|NCT02786537|588203714|FG001|As Treated|Incarceration|1|||
162862914|NCT02786537|588203715|FG002|As Treated|Incarceration|0|||
162862915|NCT02786537|588203716|FG003|As Treated|Incarceration|0|||
162862916|NCT02786537|588203717|FG004|As Treated|Incarceration|0|||
162862917|NCT02786537|588203718|FG005|As Treated|Incarceration|0|||
162862918|NCT02786537|588203713|FG000|As Treated|Opiate dependency relapse|0|||
162862919|NCT02786537|588203714|FG001|As Treated|Opiate dependency relapse|1|||
162862920|NCT02786537|588203715|FG002|As Treated|Opiate dependency relapse|0|||
162862921|NCT02786537|588203716|FG003|As Treated|Opiate dependency relapse|0|||
162862922|NCT02786537|588203717|FG004|As Treated|Opiate dependency relapse|0|||
163045982|NCT02137226|588875145|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
163045983|NCT02137226|588875146|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
162862923|NCT02786537|588203718|FG005|As Treated|Opiate dependency relapse|0|||
162862924|NCT02786537|588203713|FG000|As Treated|Drugs stolen from patient|0|||
162862925|NCT02786537|588203714|FG001|As Treated|Drugs stolen from patient|1|||
162862926|NCT02786537|588203715|FG002|As Treated|Drugs stolen from patient|0|||
162862927|NCT02786537|588203716|FG003|As Treated|Drugs stolen from patient|0|||
162862928|NCT02786537|588203717|FG004|As Treated|Drugs stolen from patient|0|||
162862929|NCT02786537|588203718|FG005|As Treated|Drugs stolen from patient|0|||
162862930|NCT02786537|588203713|FG000|As Treated|Advised to stop tx after loss of meds|0|||
162862931|NCT02786537|588203714|FG001|As Treated|Advised to stop tx after loss of meds|1|||
162862932|NCT02786537|588203715|FG002|As Treated|Advised to stop tx after loss of meds|0|||
162862933|NCT02786537|588203716|FG003|As Treated|Advised to stop tx after loss of meds|0|||
162862934|NCT02786537|588203717|FG004|As Treated|Advised to stop tx after loss of meds|0|||
162862935|NCT02786537|588203718|FG005|As Treated|Advised to stop tx after loss of meds|0|||
162862936|NCT02413255|588203721|FG000|Overall Study|Voluntary Withdrawal|0|||
162862937|NCT02413255|588203722|FG001|Overall Study|Voluntary Withdrawal|0|||
162862938|NCT02413255|588203723|FG002|Overall Study|Voluntary Withdrawal|0|||
163045984|NCT03134911|588875147|FG000|Overall Study|Screen failure|31|||
162862939|NCT02413255|588203724|FG003|Overall Study|Voluntary Withdrawal|0|||
163045985|NCT03134911|588875147|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
163045986|NCT01118663|588875148|FG000|Overall Study|Adverse Event|2|||
163045987|NCT01118663|588875149|FG001|Overall Study|Adverse Event|1|||
163045988|NCT01118663|588875148|FG000|Overall Study|Withdrawal by Subject|0|||
163045989|NCT01118663|588875149|FG001|Overall Study|Withdrawal by Subject|1|||
163045990|NCT00672633|588875156|FG000|Overall Study|Withdrawal by Subject|0|||
163045991|NCT00672633|588875157|FG001|Overall Study|Withdrawal by Subject|1|||
163045992|NCT02824627|588875158|FG000|Overall Study|Adverse Event|1|||
163045993|NCT02824627|588875159|FG001|Overall Study|Adverse Event|2|||
163045994|NCT02824627|588875158|FG000|Overall Study|Lost to Follow-up|2|||
163045995|NCT02824627|588875159|FG001|Overall Study|Lost to Follow-up|1|||
163045996|NCT01868165|588875160|FG000|Overall Study|Withdrawal by Subject|36|||
163045997|NCT01868165|588875160|FG000|Overall Study|Physician Decision|2|||
163045998|NCT01868165|588875160|FG000|Overall Study|Lost to Follow-up|3|||
163045999|NCT01868165|588875160|FG000|Overall Study|Death|4|||
163046000|NCT03472521|588875161|FG000|Overall Study|Lost to Follow-up|3|||
163046001|NCT03472521|588875162|FG001|Overall Study|Lost to Follow-up|2|||
163046002|NCT03472521|588875161|FG000|Overall Study|Discontinued intervention|3|||
163046003|NCT03472521|588875162|FG001|Overall Study|Discontinued intervention|1|||
163046004|NCT01603407|588875163|FG000|Overall Study|Adverse Event|1|||
163046005|NCT01603407|588875164|FG001|Overall Study|Adverse Event|1|||
163046006|NCT01603407|588875165|FG002|Overall Study|Adverse Event|1|||
162705903|NCT04060680|587633855|FG000|Overall Study|Adverse Event|3|||
162705904|NCT04060680|587633856|FG001|Overall Study|Adverse Event|0|||
162705905|NCT04060680|587633855|FG000|Overall Study|Death|2|||
162705906|NCT04060680|587633856|FG001|Overall Study|Death|0|||
162705907|NCT04060680|587633855|FG000|Overall Study|Study product no longer in use|1|||
162705908|NCT04060680|587633856|FG001|Overall Study|Study product no longer in use|0|||
162705909|NCT04060680|587633855|FG000|Overall Study|Withdrawal by Subject|1|||
162705910|NCT04060680|587633856|FG001|Overall Study|Withdrawal by Subject|0|||
162705911|NCT04482855|587633857|FG000|Overall Study|Lost to Follow-up|1|||
162705912|NCT04482855|587633858|FG001|Overall Study|Lost to Follow-up|0|||
162705913|NCT04482855|587633857|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
162705914|NCT04482855|587633858|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
162705915|NCT04482855|587633857|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
162705916|NCT04482855|587633858|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
162705917|NCT02320721|587633862|FG000|Overall Study|Adverse Event|6|||
162705918|NCT02320721|587633863|FG001|Overall Study|Adverse Event|6|||
162705919|NCT02320721|587633862|FG000|Overall Study|Lack of Efficacy|2|||
162705920|NCT02320721|587633863|FG001|Overall Study|Lack of Efficacy|0|||
162705921|NCT02320721|587633862|FG000|Overall Study|Poor compliance to protocol|3|||
162705922|NCT02320721|587633863|FG001|Overall Study|Poor compliance to protocol|7|||
162705923|NCT02320721|587633862|FG000|Overall Study|Randomized but not treated|0|||
162705924|NCT02320721|587633863|FG001|Overall Study|Randomized but not treated|1|||
162705925|NCT02320721|587633862|FG000|Overall Study|Hypoglycemia|1|||
162705926|NCT02320721|587633863|FG001|Overall Study|Hypoglycemia|0|||
162705927|NCT02320721|587633862|FG000|Overall Study|Other than specified above|15|||
162705928|NCT02320721|587633863|FG001|Overall Study|Other than specified above|20|||
162705929|NCT03173248|587633864|FG000|Overall Study|Death|28|||
162705930|NCT03173248|587633865|FG001|Overall Study|Death|46|||
162705931|NCT03173248|587633864|FG000|Overall Study|Lost to Follow-up|0|||
162705932|NCT03173248|587633865|FG001|Overall Study|Lost to Follow-up|1|||
162705933|NCT03173248|587633864|FG000|Overall Study|Withdrawal by Subject|6|||
162705934|NCT03173248|587633865|FG001|Overall Study|Withdrawal by Subject|4|||
162705935|NCT03173248|587633864|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
162705936|NCT03173248|587633865|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
162705937|NCT01544582|587633866|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
162705938|NCT01544582|587633867|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162705939|NCT01544582|587633868|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162705940|NCT01544582|587633869|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162705941|NCT01544582|587633866|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
162705942|NCT01544582|587633867|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162705943|NCT01544582|587633868|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162705944|NCT01544582|587633869|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162705945|NCT01544582|587633866|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
162705946|NCT01544582|587633867|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
162705947|NCT01544582|587633868|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
162705948|NCT01544582|587633869|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
162705949|NCT01544582|587633866|FG000|Analysis Population|Physician Decision|0|||
162705950|NCT01544582|587633867|FG001|Analysis Population|Physician Decision|13|||
163046007|NCT01603407|588875163|FG000|Overall Study|Protocol Violation|2|||
163046008|NCT01603407|588875164|FG001|Overall Study|Protocol Violation|2|||
163046009|NCT01603407|588875165|FG002|Overall Study|Protocol Violation|0|||
162862940|NCT02413255|588203725|FG004|Overall Study|Voluntary Withdrawal|0|||
162862941|NCT02413255|588203726|FG005|Overall Study|Voluntary Withdrawal|0|||
162862942|NCT02413255|588203727|FG006|Overall Study|Voluntary Withdrawal|0|||
162862943|NCT02413255|588203728|FG007|Overall Study|Voluntary Withdrawal|0|||
162862944|NCT02413255|588203729|FG008|Overall Study|Voluntary Withdrawal|0|||
162862945|NCT02413255|588203730|FG009|Overall Study|Voluntary Withdrawal|0|||
162862946|NCT02413255|588203731|FG010|Overall Study|Voluntary Withdrawal|0|||
162862947|NCT02413255|588203732|FG011|Overall Study|Voluntary Withdrawal|0|||
162862948|NCT02413255|588203733|FG012|Overall Study|Voluntary Withdrawal|0|||
162862949|NCT02413255|588203734|FG013|Overall Study|Voluntary Withdrawal|0|||
162862950|NCT02413255|588203735|FG014|Overall Study|Voluntary Withdrawal|1|||
162862951|NCT02413255|588203736|FG015|Overall Study|Voluntary Withdrawal|0|||
162862952|NCT02413255|588203737|FG016|Overall Study|Voluntary Withdrawal|0|||
162862953|NCT00077623|588203738|FG000|Overall Study|Adverse Event|1|||
162862954|NCT00077623|588203739|FG001|Overall Study|Adverse Event|0|||
162862955|NCT00077623|588203740|FG002|Overall Study|Adverse Event|1|||
162862956|NCT00077623|588203738|FG000|Overall Study|Withdrawal by Subject|2|||
162862957|NCT00077623|588203739|FG001|Overall Study|Withdrawal by Subject|10|||
162862958|NCT00077623|588203740|FG002|Overall Study|Withdrawal by Subject|1|||
162862959|NCT00077623|588203738|FG000|Overall Study|Other-Non safety reason|18|||
162862960|NCT00077623|588203739|FG001|Overall Study|Other-Non safety reason|15|||
162862961|NCT00077623|588203740|FG002|Overall Study|Other-Non safety reason|19|||
162862962|NCT00077623|588203738|FG000|Overall Study|Insufficient therapeutic response|2|||
162862963|NCT00077623|588203739|FG001|Overall Study|Insufficient therapeutic response|0|||
162862964|NCT00077623|588203740|FG002|Overall Study|Insufficient therapeutic response|0|||
162862965|NCT00077623|588203738|FG000|Overall Study|Death|12|||
162862966|NCT00077623|588203739|FG001|Overall Study|Death|18|||
162862967|NCT00077623|588203740|FG002|Overall Study|Death|11|||
162862968|NCT00077623|588203738|FG000|Overall Study|Failure to return|1|||
162862969|NCT00077623|588203739|FG001|Overall Study|Failure to return|0|||
162862970|NCT00077623|588203740|FG002|Overall Study|Failure to return|0|||
162862971|NCT01334125|588203741|FG000|Overall Study|Lost to Follow-up|3|||
162862972|NCT01334125|588203742|FG001|Overall Study|Lost to Follow-up|3|||
162862973|NCT00882713|588203745|FG000|Overall Study|Adverse Event|2|||
162862974|NCT00882713|588203745|FG000|Overall Study|Death|3|||
162862975|NCT00882713|588203745|FG000|Overall Study|Administrative reasons|4|||
162862976|NCT00882713|588203745|FG000|Overall Study|refused treatment/withdrew consent|4|||
162862977|NCT00882713|588203745|FG000|Overall Study|Blood transfusion|2|||
162862978|NCT00882713|588203745|FG000|Overall Study|Insufficient therapeutic response|3|||
162862979|NCT00882713|588203745|FG000|Overall Study|Failure to return|2|||
162862980|NCT00882713|588203745|FG000|Overall Study|Other - Reasons|2|||
162862981|NCT00401973|588203748|FG000|Overall Study|Adverse Event|2|||
162862982|NCT00401973|588203749|FG001|Overall Study|Adverse Event|8|||
162862983|NCT00401973|588203750|FG002|Overall Study|Adverse Event|4|||
162862984|NCT00401973|588203748|FG000|Overall Study|Clinical Relapse|0|||
162862985|NCT00401973|588203749|FG001|Overall Study|Clinical Relapse|1|||
162862986|NCT00401973|588203750|FG002|Overall Study|Clinical Relapse|1|||
162862987|NCT00401973|588203748|FG000|Overall Study|Lack of Efficacy|0|||
162862988|NCT00401973|588203749|FG001|Overall Study|Lack of Efficacy|0|||
162862989|NCT00401973|588203750|FG002|Overall Study|Lack of Efficacy|3|||
162958572|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
162958573|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958574|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958575|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162958576|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
162862990|NCT00401973|588203748|FG000|Overall Study|Lost to Follow-up|2|||
162862991|NCT00401973|588203749|FG001|Overall Study|Lost to Follow-up|2|||
162862992|NCT00401973|588203750|FG002|Overall Study|Lost to Follow-up|2|||
162862993|NCT00401973|588203748|FG000|Overall Study|Physician Decision|2|||
162958577|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958578|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
163046010|NCT01603407|588875163|FG000|Overall Study|Withdrawal by Subject|8|||
162862994|NCT00401973|588203749|FG001|Overall Study|Physician Decision|0|||
162862995|NCT00401973|588203750|FG002|Overall Study|Physician Decision|1|||
162862996|NCT00401973|588203748|FG000|Overall Study|Protocol Violation|1|||
162862997|NCT00401973|588203749|FG001|Overall Study|Protocol Violation|2|||
162862998|NCT00401973|588203750|FG002|Overall Study|Protocol Violation|3|||
162862999|NCT00401973|588203748|FG000|Overall Study|Sponsor Decision|0|||
162863000|NCT00401973|588203749|FG001|Overall Study|Sponsor Decision|1|||
162863001|NCT00401973|588203750|FG002|Overall Study|Sponsor Decision|0|||
162863002|NCT00401973|588203748|FG000|Overall Study|Withdrawal by Subject|4|||
162863003|NCT00401973|588203749|FG001|Overall Study|Withdrawal by Subject|12|||
162863004|NCT00401973|588203750|FG002|Overall Study|Withdrawal by Subject|9|||
162863005|NCT02584634|588203751|FG000|Overall Study|Adverse Event|3|||
162863006|NCT02584634|588203752|FG001|Overall Study|Adverse Event|5|||
162863007|NCT02584634|588203751|FG000|Overall Study|Death|0|||
162863008|NCT02584634|588203752|FG001|Overall Study|Death|1|||
162863009|NCT02584634|588203751|FG000|Overall Study|Lost to Follow-up|0|||
162863010|NCT02584634|588203752|FG001|Overall Study|Lost to Follow-up|1|||
163046011|NCT01603407|588875164|FG001|Overall Study|Withdrawal by Subject|5|||
163046012|NCT01603407|588875165|FG002|Overall Study|Withdrawal by Subject|7|||
162863011|NCT02584634|588203751|FG000|Overall Study|Physician Decision|1|||
162863012|NCT02584634|588203752|FG001|Overall Study|Physician Decision|2|||
162863013|NCT02584634|588203751|FG000|Overall Study|Progressive disease|7|||
163046013|NCT01603407|588875163|FG000|Overall Study|Lost to Follow-up|0|||
163046014|NCT01603407|588875164|FG001|Overall Study|Lost to Follow-up|3|||
163046015|NCT01603407|588875165|FG002|Overall Study|Lost to Follow-up|2|||
163046016|NCT02358031|588877269|FG000|Overall Study|Death|253|||
163046017|NCT02358031|588877270|FG001|Overall Study|Death|237|||
163046018|NCT02358031|588877271|FG002|Overall Study|Death|266|||
163046019|NCT02358031|588877269|FG000|Overall Study|Lost to Follow-up|1|||
163046020|NCT02358031|588877270|FG001|Overall Study|Lost to Follow-up|1|||
163046021|NCT02358031|588877271|FG002|Overall Study|Lost to Follow-up|0|||
163046022|NCT02358031|588877269|FG000|Overall Study|Withdrawal by Subject|19|||
163046023|NCT02358031|588877270|FG001|Overall Study|Withdrawal by Subject|14|||
163046024|NCT02358031|588877271|FG002|Overall Study|Withdrawal by Subject|18|||
162863014|NCT02584634|588203752|FG001|Overall Study|Progressive disease|15|||
162863015|NCT02584634|588203751|FG000|Overall Study|Withdrawal by Subject|1|||
162863016|NCT02584634|588203752|FG001|Overall Study|Withdrawal by Subject|1|||
162863017|NCT02584634|588203751|FG000|Overall Study|Other|0|||
162863018|NCT02584634|588203752|FG001|Overall Study|Other|6|||
162863019|NCT04075604|588203754|FG000|Overall Study|Adverse Event|0|||
162863020|NCT04075604|588203755|FG001|Overall Study|Adverse Event|0|||
162863021|NCT04075604|588203756|FG002|Overall Study|Adverse Event|3|||
162863022|NCT04075604|588203754|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162863023|NCT04075604|588203755|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162863024|NCT04075604|588203756|FG002|Overall Study|Participant request to discontinue study treatment|1|||
162863025|NCT04075604|588203754|FG000|Overall Study|Participant withdrew consent|0|||
162863026|NCT04075604|588203755|FG001|Overall Study|Participant withdrew consent|0|||
162863027|NCT04075604|588203756|FG002|Overall Study|Participant withdrew consent|1|||
162863028|NCT04075604|588203754|FG000|Overall Study|Other reasons|1|||
163046025|NCT02358031|588877269|FG000|Overall Study|Sponsor Decision|26|||
163046026|NCT02358031|588877270|FG001|Overall Study|Sponsor Decision|28|||
163046027|NCT02358031|588877271|FG002|Overall Study|Sponsor Decision|16|||
163046028|NCT04980014|588877274|FG000|Overall Study|Participants who are Duplicated|1|||
163046029|NCT04980014|588877274|FG000|Overall Study|Follow-up Failure|13|||
163046030|NCT04980014|588877274|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
163046031|NCT04980014|588877274|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
163046032|NCT04980014|588877274|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
163046033|NCT00940888|588877275|FG000|Overall Study|Unsuccessful Implant|4|||
163046034|NCT00940888|588877275|FG000|Overall Study|Death|461|||
162863029|NCT04075604|588203755|FG001|Overall Study|Other reasons|0|||
162863030|NCT04075604|588203756|FG002|Overall Study|Other reasons|0|||
162863031|NCT04075604|588203754|FG000|Overall Study|Disease progression|0|||
162863032|NCT04075604|588203755|FG001|Overall Study|Disease progression|1|||
162863033|NCT04075604|588203756|FG002|Overall Study|Disease progression|0|||
162863034|NCT04075604|588203754|FG000|Overall Study|Study drug toxicity|0|||
162863035|NCT04075604|588203755|FG001|Overall Study|Study drug toxicity|5|||
162863036|NCT04075604|588203756|FG002|Overall Study|Study drug toxicity|1|||
162863037|NCT01050062|588203760|FG000|Overall Study|Adverse Event|75|||
162863038|NCT01050062|588203761|FG001|Overall Study|Adverse Event|22|||
162863039|NCT01050062|588203760|FG000|Overall Study|Lost to Follow-up|83|||
162863040|NCT01050062|588203761|FG001|Overall Study|Lost to Follow-up|35|||
162863041|NCT01050062|588203760|FG000|Overall Study|Lack of Efficacy|22|||
162863042|NCT01050062|588203761|FG001|Overall Study|Lack of Efficacy|35|||
162863043|NCT01050062|588203760|FG000|Overall Study|Physician Decision|74|||
162863044|NCT01050062|588203761|FG001|Overall Study|Physician Decision|9|||
162863045|NCT01050062|588203760|FG000|Overall Study|Others|17|||
163046035|NCT00940888|588877275|FG000|Overall Study|Withdrawn - Non-Death|364|||
163046036|NCT00940888|588877275|FG000|Overall Study|Lost to Follow-up|6|||
163046037|NCT02250300|588877279|FG000|Expansion Phase|Death|6|||
163046038|NCT02250300|588877280|FG001|Expansion Phase|Death|7|||
163046039|NCT02250300|588877281|FG002|Expansion Phase|Death|0|||
162863046|NCT01050062|588203761|FG001|Overall Study|Others|11|||
162863047|NCT03894540|588203762|FG000|Overall Study|Adverse Event|0|||
162863048|NCT03894540|588203763|FG001|Overall Study|Adverse Event|0|||
163046040|NCT02250300|588877282|FG003|Expansion Phase|Death|0|||
163046041|NCT00715559|588877284|FG000|Overall Study|medication not tolerated - nausea|1|||
162863049|NCT03894540|588203764|FG002|Overall Study|Adverse Event|0|||
162863050|NCT03894540|588203765|FG003|Overall Study|Adverse Event|0|||
162863051|NCT03894540|588203766|FG004|Overall Study|Adverse Event|1|||
162863052|NCT03894540|588203767|FG005|Overall Study|Adverse Event|0|||
163046042|NCT00758498|588877285|FG000|Overall Study|Adverse Event|2|||
162705951|NCT01544582|587633868|FG002|Analysis Population|Physician Decision|10|||
162705952|NCT01544582|587633869|FG003|Analysis Population|Physician Decision|9|||
162705953|NCT01544582|587633866|FG000|Analysis Population|Safety Reason|0|||
162705954|NCT01544582|587633867|FG001|Analysis Population|Safety Reason|33|||
162705955|NCT01544582|587633868|FG002|Analysis Population|Safety Reason|31|||
162705956|NCT01544582|587633869|FG003|Analysis Population|Safety Reason|8|||
162705957|NCT01544582|587633866|FG000|Analysis Population|Effectiveness Reason|0|||
162705958|NCT01544582|587633867|FG001|Analysis Population|Effectiveness Reason|48|||
162705959|NCT01544582|587633868|FG002|Analysis Population|Effectiveness Reason|29|||
162705960|NCT01544582|587633869|FG003|Analysis Population|Effectiveness Reason|12|||
162705961|NCT01544582|587633866|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162705962|NCT01544582|587633867|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162705963|NCT01544582|587633868|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162705964|NCT01544582|587633869|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
162705965|NCT01544582|587633866|FG000|Analysis Population|Lost to Follow-up|0|||
162705966|NCT01544582|587633867|FG001|Analysis Population|Lost to Follow-up|6|||
162705967|NCT01544582|587633868|FG002|Analysis Population|Lost to Follow-up|6|||
162705968|NCT01544582|587633869|FG003|Analysis Population|Lost to Follow-up|5|||
162705969|NCT01544582|587633866|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
162705970|NCT01544582|587633867|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
162705971|NCT01544582|587633868|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
162705972|NCT01544582|587633869|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
162705973|NCT01544582|587633866|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162705974|NCT01544582|587633867|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162705975|NCT01544582|587633868|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
162705976|NCT01544582|587633869|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162705977|NCT01544582|587633866|FG000|Analysis Population|Intolerance|0|||
162705978|NCT01544582|587633867|FG001|Analysis Population|Intolerance|1|||
162705979|NCT01544582|587633868|FG002|Analysis Population|Intolerance|0|||
162705980|NCT01544582|587633869|FG003|Analysis Population|Intolerance|0|||
162705981|NCT01544582|587633866|FG000|Analysis Population|Liver Transplantation|0|||
162705982|NCT01544582|587633867|FG001|Analysis Population|Liver Transplantation|0|||
162705983|NCT01544582|587633868|FG002|Analysis Population|Liver Transplantation|1|||
162705984|NCT01544582|587633869|FG003|Analysis Population|Liver Transplantation|0|||
162705985|NCT01544582|587633866|FG000|Analysis Population|No Social Insurance|0|||
162705986|NCT01544582|587633867|FG001|Analysis Population|No Social Insurance|0|||
162705987|NCT01544582|587633868|FG002|Analysis Population|No Social Insurance|1|||
162705988|NCT01544582|587633869|FG003|Analysis Population|No Social Insurance|0|||
162705989|NCT01544582|587633866|FG000|Analysis Population|Poor Adherence|0|||
162705990|NCT01544582|587633867|FG001|Analysis Population|Poor Adherence|0|||
162705991|NCT01544582|587633868|FG002|Analysis Population|Poor Adherence|1|||
162705992|NCT01544582|587633869|FG003|Analysis Population|Poor Adherence|0|||
162705993|NCT01544582|587633866|FG000|Analysis Population|Poor Participant Compliance|0|||
162705994|NCT01544582|587633867|FG001|Analysis Population|Poor Participant Compliance|1|||
162705995|NCT01544582|587633868|FG002|Analysis Population|Poor Participant Compliance|0|||
162705996|NCT01544582|587633869|FG003|Analysis Population|Poor Participant Compliance|0|||
162705997|NCT01544582|587633866|FG000|Analysis Population|Programmed Surgery|0|||
162705998|NCT01544582|587633867|FG001|Analysis Population|Programmed Surgery|1|||
162705999|NCT01544582|587633868|FG002|Analysis Population|Programmed Surgery|0|||
162706000|NCT01544582|587633869|FG003|Analysis Population|Programmed Surgery|0|||
162706001|NCT01544582|587633866|FG000|Analysis Population|Participant in Jail|0|||
162706002|NCT01544582|587633867|FG001|Analysis Population|Participant in Jail|0|||
162706003|NCT01544582|587633868|FG002|Analysis Population|Participant in Jail|1|||
162706004|NCT01544582|587633869|FG003|Analysis Population|Participant in Jail|0|||
162706005|NCT03015740|587633872|FG000|Overall Study|Adverse Event|1|||
162706006|NCT03015740|587633873|FG001|Overall Study|Adverse Event|0|||
162706007|NCT03015740|587633874|FG002|Overall Study|Adverse Event|0|||
162706008|NCT03015740|587633872|FG000|Overall Study|Death|3|||
162706009|NCT03015740|587633873|FG001|Overall Study|Death|5|||
162706010|NCT03015740|587633874|FG002|Overall Study|Death|0|||
162706011|NCT03015740|587633872|FG000|Overall Study|Withdrawal by Subject|2|||
162706012|NCT03015740|587633873|FG001|Overall Study|Withdrawal by Subject|0|||
162706013|NCT03015740|587633874|FG002|Overall Study|Withdrawal by Subject|0|||
162706014|NCT05194735|587636504|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
162706015|NCT05194735|587636505|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
162706016|NCT05194735|587636506|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
162706017|NCT05194735|587636504|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
162706018|NCT05194735|587636505|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
162706019|NCT05194735|587636506|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
162706020|NCT05194735|587636504|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
162810737|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
162863053|NCT03894540|588203762|FG000|Overall Study|Withdrawal by Subject|0|||
162863054|NCT03894540|588203763|FG001|Overall Study|Withdrawal by Subject|0|||
162863055|NCT03894540|588203764|FG002|Overall Study|Withdrawal by Subject|0|||
162863056|NCT03894540|588203765|FG003|Overall Study|Withdrawal by Subject|0|||
162863057|NCT03894540|588203766|FG004|Overall Study|Withdrawal by Subject|1|||
162863058|NCT03894540|588203767|FG005|Overall Study|Withdrawal by Subject|0|||
162863059|NCT03894540|588203762|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
162863060|NCT03894540|588203763|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
162863061|NCT03894540|588203764|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
162863062|NCT03894540|588203765|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
162863063|NCT03894540|588203766|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
162863064|NCT03894540|588203767|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
162863065|NCT03894540|588203762|FG000|Overall Study|Progressive Disease Clinical|1|||
162863066|NCT03894540|588203763|FG001|Overall Study|Progressive Disease Clinical|1|||
162863067|NCT03894540|588203764|FG002|Overall Study|Progressive Disease Clinical|0|||
162863068|NCT03894540|588203765|FG003|Overall Study|Progressive Disease Clinical|1|||
162863069|NCT03894540|588203766|FG004|Overall Study|Progressive Disease Clinical|5|||
162863070|NCT03894540|588203767|FG005|Overall Study|Progressive Disease Clinical|1|||
162863071|NCT03894540|588203762|FG000|Overall Study|Study termination by sponsor|0|||
162863072|NCT03894540|588203763|FG001|Overall Study|Study termination by sponsor|0|||
162863073|NCT03894540|588203764|FG002|Overall Study|Study termination by sponsor|0|||
162863074|NCT03894540|588203765|FG003|Overall Study|Study termination by sponsor|0|||
163046043|NCT00758498|588877286|FG001|Overall Study|Adverse Event|2|||
163046044|NCT00758498|588877287|FG002|Overall Study|Adverse Event|3|||
163046045|NCT00758498|588877285|FG000|Overall Study|Subject legally detained out of state|1|||
163046046|NCT00758498|588877286|FG001|Overall Study|Subject legally detained out of state|0|||
163046047|NCT00758498|588877287|FG002|Overall Study|Subject legally detained out of state|0|||
162863075|NCT03894540|588203766|FG004|Overall Study|Study termination by sponsor|2|||
162863076|NCT03894540|588203767|FG005|Overall Study|Study termination by sponsor|0|||
162863077|NCT03000452|588203768|FG000|Treatment Period|Death|1|||
162863078|NCT03000452|588203768|FG000|Treatment Period|Progressive Disease (PD)|14|||
162863079|NCT03000452|588203768|FG000|Treatment Period|Physician Decision|1|||
162863080|NCT03000452|588203768|FG000|Treatment Period|Miscellaneous|2|||
162863081|NCT03000452|588203768|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
162863082|NCT03000452|588203768|FG000|Follow-Up Period|Death|3|||
162863083|NCT03000452|588203768|FG000|Follow-Up Period|Withdrawal by Subject|3|||
162863084|NCT00593112|588203769|FG000|Overall Study|Scan Anxiety|3|||
162863085|NCT00593112|588203770|FG001|Overall Study|Scan Anxiety|0|||
162863086|NCT00593112|588203769|FG000|Overall Study|Abnormal Scan|1|||
162863087|NCT00593112|588203770|FG001|Overall Study|Abnormal Scan|0|||
162863088|NCT00593112|588203769|FG000|Overall Study|Unreadable Scan|1|||
162863089|NCT00593112|588203770|FG001|Overall Study|Unreadable Scan|0|||
162863090|NCT00593112|588203769|FG000|Overall Study|Withdrawal by Subject|5|||
162863091|NCT00593112|588203770|FG001|Overall Study|Withdrawal by Subject|0|||
162863092|NCT00852930|588203771|FG000|Overall Study|Withdrawal by Subject|1|||
162863093|NCT00852930|588203772|FG001|Overall Study|Withdrawal by Subject|1|||
162863094|NCT00852930|588203773|FG002|Overall Study|Withdrawal by Subject|1|||
162863095|NCT00852930|588203771|FG000|Overall Study|Physician Decision|0|||
162863096|NCT00852930|588203772|FG001|Overall Study|Physician Decision|0|||
162863097|NCT00852930|588203773|FG002|Overall Study|Physician Decision|1|||
162863098|NCT00537745|588203774|FG000|Overall Study|Did not meet eligibility criteria|2|||
162924284|NCT02180659|588423853|FG000|Overall Study|Lost to Follow-up|4|||
162924285|NCT02180659|588423854|FG001|Overall Study|Lost to Follow-up|2|||
162924286|NCT02180659|588423853|FG000|Overall Study|Subject incarcerated during conduct|1|||
162924287|NCT02180659|588423854|FG001|Overall Study|Subject incarcerated during conduct|0|||
162924288|NCT02180659|588423853|FG000|Overall Study|Withdrawal by Subject|0|||
162924289|NCT02180659|588423854|FG001|Overall Study|Withdrawal by Subject|2|||
162924290|NCT02180659|588423853|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
162924291|NCT02180659|588423854|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
162924292|NCT00824993|588423855|FG000|Overall Study|Withdrawal by Subject|1|||
162924293|NCT00824993|588423856|FG001|Overall Study|Withdrawal by Subject|1|||
162924294|NCT00824993|588423855|FG000|Overall Study|Malignancy Relapse|9|||
162924295|NCT00824993|588423856|FG001|Overall Study|Malignancy Relapse|10|||
162924296|NCT00824993|588423855|FG000|Overall Study|Rapid Bone Loss|0|||
162924297|NCT00824993|588423856|FG001|Overall Study|Rapid Bone Loss|1|||
162924298|NCT00824993|588423855|FG000|Overall Study|Non-Compliant|2|||
162924299|NCT00824993|588423856|FG001|Overall Study|Non-Compliant|1|||
162924300|NCT00824993|588423855|FG000|Overall Study|Insurance Issue|2|||
162924301|NCT00824993|588423856|FG001|Overall Study|Insurance Issue|1|||
162924302|NCT00824993|588423855|FG000|Overall Study|Death|0|||
162924303|NCT00824993|588423856|FG001|Overall Study|Death|3|||
162924304|NCT00518011|588423857|FG000|Overall Study|Death|1|||
162863099|NCT00537745|588203774|FG000|Overall Study|Withdrawal by Subject|2|||
162863100|NCT00537745|588203774|FG000|Overall Study|Subject unable to provide Interlock info|1|||
162863101|NCT03700892|588203776|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
162863102|NCT03700892|588203777|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
162863103|NCT03700892|588203778|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
162863104|NCT02532543|588203779|FG000|Overall Study|Lost to Follow-up|0|||
162863105|NCT02532543|588203780|FG001|Overall Study|Lost to Follow-up|0|||
162863106|NCT02532543|588203781|FG002|Overall Study|Lost to Follow-up|1|||
162863107|NCT02532543|588203782|FG003|Overall Study|Lost to Follow-up|0|||
162863108|NCT00650585|588203783|FG000|Overall Study|Lost to Follow-up|505|||
162863109|NCT00650585|588203784|FG001|Overall Study|Lost to Follow-up|482|||
162863110|NCT00650585|588203783|FG000|Overall Study|No parental consent|935|||
162863111|NCT00650585|588203784|FG001|Overall Study|No parental consent|866|||
162863112|NCT00650585|588203783|FG000|Overall Study|Excluded/ruled ineligible|357|||
162863113|NCT00650585|588203784|FG001|Overall Study|Excluded/ruled ineligible|129|||
162863114|NCT00849212|588203785|FG000|Overall Study|Lack of Efficacy|1|||
162863115|NCT00849212|588203785|FG000|Overall Study|Withdrawal by Subject|3|||
162863116|NCT00849212|588203785|FG000|Overall Study|Adverse Event|2|||
162863117|NCT00849212|588203785|FG000|Overall Study|Miscellaneous|1|||
162863118|NCT02640612|588203786|FG000|Overall Study|Adverse Event|6|||
162863119|NCT02640612|588203787|FG001|Overall Study|Adverse Event|7|||
162863120|NCT02640612|588203788|FG002|Overall Study|Adverse Event|2|||
162863121|NCT02640612|588203786|FG000|Overall Study|Death|1|||
162863122|NCT02640612|588203787|FG001|Overall Study|Death|0|||
162863123|NCT02640612|588203788|FG002|Overall Study|Death|0|||
162863124|NCT02640612|588203786|FG000|Overall Study|Withdrawal by Subject|10|||
162863125|NCT02640612|588203787|FG001|Overall Study|Withdrawal by Subject|3|||
162863126|NCT02640612|588203788|FG002|Overall Study|Withdrawal by Subject|3|||
162863127|NCT02640612|588203786|FG000|Overall Study|Lost to Follow-up|4|||
162863128|NCT02640612|588203787|FG001|Overall Study|Lost to Follow-up|1|||
162863129|NCT02640612|588203788|FG002|Overall Study|Lost to Follow-up|1|||
162863130|NCT02640612|588203786|FG000|Overall Study|Protocol Violation|0|||
162863131|NCT02640612|588203787|FG001|Overall Study|Protocol Violation|2|||
162863132|NCT02640612|588203788|FG002|Overall Study|Protocol Violation|0|||
162863133|NCT02640612|588203786|FG000|Overall Study|Lack of Efficacy|1|||
162863134|NCT02640612|588203787|FG001|Overall Study|Lack of Efficacy|1|||
162863135|NCT02640612|588203788|FG002|Overall Study|Lack of Efficacy|0|||
162863136|NCT03472534|588203797|FG000|Overall Study|Withdrawal by Subject|9|||
162863137|NCT03472534|588203797|FG000|Overall Study|Adverse Event|2|||
162863138|NCT02614794|588203798|FG000|Overall Study|Death|258|||
162863139|NCT02614794|588203799|FG001|Overall Study|Death|151|||
162863140|NCT02614794|588203798|FG000|Overall Study|Study closure by Sponsor|119|||
162863141|NCT02614794|588203799|FG001|Overall Study|Study closure by Sponsor|45|||
162863142|NCT02614794|588203798|FG000|Overall Study|Withdrawal by Subject|24|||
162863143|NCT02614794|588203799|FG001|Overall Study|Withdrawal by Subject|5|||
162863144|NCT02614794|588203798|FG000|Overall Study|Lost to Follow-up|7|||
162863145|NCT02614794|588203799|FG001|Overall Study|Lost to Follow-up|0|||
162863146|NCT02614794|588203798|FG000|Overall Study|Physician Decision|1|||
162863147|NCT02614794|588203799|FG001|Overall Study|Physician Decision|1|||
162863148|NCT02614794|588203798|FG000|Overall Study|Hospital closure|1|||
162863149|NCT02614794|588203799|FG001|Overall Study|Hospital closure|0|||
162863150|NCT03237845|588203804|FG000|Overall Study|Adverse Event|0|||
162863151|NCT03237845|588203805|FG001|Overall Study|Adverse Event|1|||
162863152|NCT03237845|588203804|FG000|Overall Study|Lost to Follow-up|13|||
162863153|NCT03237845|588203805|FG001|Overall Study|Lost to Follow-up|10|||
162863154|NCT03237845|588203804|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
162863155|NCT03237845|588203805|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
162863156|NCT03237845|588203804|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
162863157|NCT03237845|588203805|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
162958579|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958580|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958581|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958582|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958583|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162863158|NCT03237845|588203804|FG000|Overall Study|Physician Decision|1|||
162863159|NCT03237845|588203805|FG001|Overall Study|Physician Decision|2|||
162958584|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958585|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
162958586|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
162863160|NCT03237845|588203804|FG000|Overall Study|Pregnancy|1|||
162706021|NCT05194735|587636505|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
162863161|NCT03237845|588203805|FG001|Overall Study|Pregnancy|0|||
162863162|NCT03237845|588203804|FG000|Overall Study|Protocol Deviation|0|||
162863163|NCT03237845|588203805|FG001|Overall Study|Protocol Deviation|1|||
162863164|NCT03237845|588203804|FG000|Overall Study|Technical Problems|8|||
162863165|NCT03237845|588203805|FG001|Overall Study|Technical Problems|1|||
162863166|NCT03237845|588203804|FG000|Overall Study|Withdrawal by Subject|3|||
162863167|NCT03237845|588203805|FG001|Overall Study|Withdrawal by Subject|3|||
162863168|NCT03237845|588203804|FG000|Overall Study|Other Reasons|4|||
162863169|NCT03237845|588203805|FG001|Overall Study|Other Reasons|0|||
162863170|NCT02117050|588203806|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
162863171|NCT01856673|588203807|FG000|Overall Study|Withdrawal by Subject|44|||
162863172|NCT01856673|588203808|FG001|Overall Study|Withdrawal by Subject|50|||
162863173|NCT01856673|588203809|FG002|Overall Study|Withdrawal by Subject|33|||
162863174|NCT01856673|588203807|FG000|Overall Study|Lost to Follow-up|31|||
162863175|NCT01856673|588203808|FG001|Overall Study|Lost to Follow-up|34|||
162863176|NCT01856673|588203809|FG002|Overall Study|Lost to Follow-up|0|||
162863177|NCT01856673|588203807|FG000|Overall Study|Unknown reasons|9|||
162863178|NCT01856673|588203808|FG001|Overall Study|Unknown reasons|0|||
162863179|NCT01856673|588203809|FG002|Overall Study|Unknown reasons|0|||
162863180|NCT01856673|588203807|FG000|Overall Study|Psychologist decision|1|||
162863181|NCT01856673|588203808|FG001|Overall Study|Psychologist decision|0|||
162863182|NCT01856673|588203809|FG002|Overall Study|Psychologist decision|0|||
162863183|NCT01856673|588203807|FG000|Overall Study|Paperwork errors|8|||
162863184|NCT01856673|588203808|FG001|Overall Study|Paperwork errors|0|||
162863185|NCT01856673|588203809|FG002|Overall Study|Paperwork errors|0|||
162863186|NCT01856673|588203807|FG000|Overall Study|Death|1|||
162863187|NCT01856673|588203808|FG001|Overall Study|Death|1|||
162863188|NCT01856673|588203809|FG002|Overall Study|Death|0|||
162863189|NCT01856673|588203807|FG000|Overall Study|Protocol Violation|1|||
162863190|NCT01856673|588203808|FG001|Overall Study|Protocol Violation|0|||
162863191|NCT01856673|588203809|FG002|Overall Study|Protocol Violation|1|||
162863192|NCT00491530|588203810|FG000|Overall Study|Adverse Event|6|||
162863193|NCT00491530|588203811|FG001|Overall Study|Adverse Event|1|||
162863194|NCT00491530|588203812|FG002|Overall Study|Adverse Event|2|||
162863195|NCT00491530|588203810|FG000|Overall Study|Withdrawal by Subject|3|||
162863196|NCT00491530|588203811|FG001|Overall Study|Withdrawal by Subject|0|||
162863197|NCT00491530|588203812|FG002|Overall Study|Withdrawal by Subject|0|||
162863198|NCT00491530|588203810|FG000|Overall Study|Lost to Follow-up|3|||
162863199|NCT00491530|588203811|FG001|Overall Study|Lost to Follow-up|2|||
162863200|NCT00491530|588203812|FG002|Overall Study|Lost to Follow-up|2|||
162863201|NCT00491530|588203810|FG000|Overall Study|Lack of Efficacy|0|||
162863202|NCT00491530|588203811|FG001|Overall Study|Lack of Efficacy|1|||
162863203|NCT00491530|588203812|FG002|Overall Study|Lack of Efficacy|0|||
162863204|NCT00491530|588203810|FG000|Overall Study|Investigator Discretion|0|||
162863205|NCT00491530|588203811|FG001|Overall Study|Investigator Discretion|1|||
162863206|NCT00491530|588203812|FG002|Overall Study|Investigator Discretion|0|||
162863207|NCT00491530|588203810|FG000|Overall Study|Patient Request|0|||
162863208|NCT00491530|588203811|FG001|Overall Study|Patient Request|1|||
162863209|NCT00491530|588203812|FG002|Overall Study|Patient Request|0|||
162863210|NCT00491530|588203810|FG000|Overall Study|Use of Prohibited Medication|0|||
162863211|NCT00491530|588203811|FG001|Overall Study|Use of Prohibited Medication|0|||
162863212|NCT00491530|588203812|FG002|Overall Study|Use of Prohibited Medication|1|||
162863213|NCT01591330|588203813|FG000|Period 1|Adverse Event|1|||
162863214|NCT01591330|588203814|FG001|Period 1|Adverse Event|0|||
162863215|NCT01591330|588203815|FG002|Period 1|Adverse Event|0|||
162863216|NCT01591330|588203816|FG003|Period 1|Adverse Event|0|||
162863217|NCT01591330|588203813|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
162863218|NCT01591330|588203814|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
162863219|NCT01591330|588203815|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
162863220|NCT01591330|588203816|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
162863221|NCT01591330|588203813|FG000|Period 2|Adverse Event|1|||
162863222|NCT01591330|588203814|FG001|Period 2|Adverse Event|0|||
162863223|NCT01591330|588203815|FG002|Period 2|Adverse Event|0|||
162863224|NCT01591330|588203816|FG003|Period 2|Adverse Event|0|||
162863225|NCT01662999|588203827|FG000|Period 3|Withdrawal by Subject|0|||
162863226|NCT01662999|588203828|FG001|Period 3|Withdrawal by Subject|1|||
162863227|NCT01662999|588203829|FG002|Period 3|Withdrawal by Subject|0|||
162863228|NCT01662999|588203830|FG003|Period 3|Withdrawal by Subject|0|||
162863229|NCT01662999|588203831|FG004|Period 3|Withdrawal by Subject|0|||
162863230|NCT01662999|588203832|FG005|Period 3|Withdrawal by Subject|0|||
162863231|NCT00196937|588203833|FG000|Overall Study|Serious Adverse Event|1|||
162863232|NCT00196937|588203834|FG001|Overall Study|Serious Adverse Event|0|||
162863233|NCT00196937|588203835|FG002|Overall Study|Serious Adverse Event|0|||
162863234|NCT00196937|588203833|FG000|Overall Study|Non-serious adverse event|1|||
162863235|NCT00196937|588203834|FG001|Overall Study|Non-serious adverse event|1|||
162863236|NCT00196937|588203835|FG002|Overall Study|Non-serious adverse event|1|||
162863237|NCT00196937|588203833|FG000|Overall Study|Withdrawal by Subject|0|||
162958587|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958588|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958589|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958590|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
162958591|NCT01695239|588551575|FG000|Extension Long-Term Extension Periods|Death|0|||
162863238|NCT00196937|588203834|FG001|Overall Study|Withdrawal by Subject|0|||
162863239|NCT00196937|588203835|FG002|Overall Study|Withdrawal by Subject|2|||
162863240|NCT00196937|588203833|FG000|Overall Study|Lost to Follow-up|4|||
162863241|NCT00196937|588203834|FG001|Overall Study|Lost to Follow-up|3|||
162863242|NCT00196937|588203835|FG002|Overall Study|Lost to Follow-up|3|||
162863243|NCT00196937|588203833|FG000|Overall Study|Other|3|||
162863244|NCT00196937|588203834|FG001|Overall Study|Other|1|||
162863245|NCT00196937|588203835|FG002|Overall Study|Other|1|||
162863246|NCT03368404|588203842|FG000|Overall Study|Adverse Event|2|||
162863247|NCT03368404|588203843|FG001|Overall Study|Adverse Event|1|||
162863248|NCT03368404|588203842|FG000|Overall Study|Withdrawal by Subject|1|||
162863249|NCT03368404|588203843|FG001|Overall Study|Withdrawal by Subject|1|||
162863250|NCT04725682|588203844|FG000|Overall Study|Withdrawal by Subject|7|||
162863251|NCT04725682|588203845|FG001|Overall Study|Withdrawal by Subject|5|||
162863252|NCT04725682|588203844|FG000|Overall Study|Failed to comply with the requirements|2|||
162863253|NCT04725682|588203845|FG001|Overall Study|Failed to comply with the requirements|1|||
162863254|NCT04725682|588203844|FG000|Overall Study|Adverse Event|1|||
162863255|NCT04725682|588203845|FG001|Overall Study|Adverse Event|1|||
162863256|NCT04725682|588203844|FG000|Overall Study|Death|0|||
162863257|NCT04725682|588203845|FG001|Overall Study|Death|1|||
162863258|NCT00964795|588203846|FG000|Overall Study|Withdrawal by Subject|79|||
162863259|NCT00964795|588203846|FG000|Overall Study|Adverse Event|12|||
162863260|NCT00964795|588203846|FG000|Overall Study|Death|14|||
162863261|NCT00964795|588203846|FG000|Overall Study|Lost to Follow-up|7|||
162863262|NCT00964795|588203846|FG000|Overall Study|Termination of Study by Sponsor|169|||
162863263|NCT00964795|588203846|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
162863264|NCT00964795|588203846|FG000|Overall Study|Other|23|||
162863265|NCT02453841|588203854|FG000|Overall Study|Protocol Violation|1|||
162863266|NCT02453841|588203854|FG000|Overall Study|Unable to obtain blood samples|2|||
162863267|NCT00586690|588203855|FG000|Overall Study|Death|2|||
162863268|NCT00586690|588203856|FG001|Overall Study|Death|0|||
162863269|NCT00586690|588203855|FG000|Overall Study|Disease Progression|10|||
162863270|NCT00586690|588203856|FG001|Overall Study|Disease Progression|0|||
162863271|NCT00586690|588203855|FG000|Overall Study|Adverse Event|1|||
162863272|NCT00586690|588203856|FG001|Overall Study|Adverse Event|0|||
162863273|NCT00586690|588203855|FG000|Overall Study|Lack of Efficacy|2|||
162863274|NCT00586690|588203856|FG001|Overall Study|Lack of Efficacy|0|||
162863275|NCT00586690|588203855|FG000|Overall Study|Lab can't accommodate|1|||
162863276|NCT00586690|588203856|FG001|Overall Study|Lab can't accommodate|0|||
162863277|NCT01751646|588203857|FG000|Overall Study|Lost to Follow-up|5|||
162863278|NCT01751646|588203858|FG001|Overall Study|Lost to Follow-up|1|||
162863279|NCT01751646|588203857|FG000|Overall Study|Withdrawal by Subject|0|||
162863280|NCT01751646|588203858|FG001|Overall Study|Withdrawal by Subject|4|||
162863281|NCT01751646|588203857|FG000|Overall Study|Starting hormone therapy|1|||
162863282|NCT01751646|588203858|FG001|Overall Study|Starting hormone therapy|0|||
162863283|NCT01751646|588203857|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
162863284|NCT01751646|588203858|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
162863285|NCT01751646|588203857|FG000|Overall Study|Inadvertent enrollment|1|||
162863286|NCT01751646|588203858|FG001|Overall Study|Inadvertent enrollment|1|||
162863287|NCT01751646|588203857|FG000|Overall Study|Moved out of the area|1|||
162863288|NCT01751646|588203858|FG001|Overall Study|Moved out of the area|5|||
162863289|NCT01751646|588203857|FG000|Overall Study|Inability to attend required visits|0|||
162863290|NCT01751646|588203858|FG001|Overall Study|Inability to attend required visits|1|||
162863291|NCT01751646|588203857|FG000|Overall Study|Off study due to multiple obligations|0|||
162863292|NCT01751646|588203858|FG001|Overall Study|Off study due to multiple obligations|1|||
162863293|NCT01751646|588203857|FG000|Overall Study|Fails to comply with study requirements|0|||
162863294|NCT01751646|588203858|FG001|Overall Study|Fails to comply with study requirements|1|||
162958592|NCT01695239|588551576|FG001|Extension Long-Term Extension Periods|Death|0|||
162958593|NCT01695239|588551577|FG002|Extension Long-Term Extension Periods|Death|0|||
162958594|NCT01695239|588551578|FG003|Extension Long-Term Extension Periods|Death|0|||
162958595|NCT01695239|588551579|FG004|Extension Long-Term Extension Periods|Death|0|||
162958596|NCT01695239|588551580|FG005|Extension Long-Term Extension Periods|Death|0|||
162958597|NCT01695239|588551581|FG006|Extension Long-Term Extension Periods|Death|0|||
162958598|NCT01695239|588551582|FG007|Extension Long-Term Extension Periods|Death|0|||
162613332|NCT05098938|587301196|FG001|Overall Study|IMP delivery missed|5|||
162863295|NCT01751646|588203857|FG000|Overall Study|Childcare issues|1|||
162863296|NCT01751646|588203858|FG001|Overall Study|Childcare issues|1|||
162863297|NCT02190591|588203859|FG000|Overall Study|Withdrawal by Subject|1|||
162863298|NCT02190591|588203860|FG001|Overall Study|Withdrawal by Subject|8|||
162863299|NCT02190591|588203859|FG000|Overall Study|Protocol Violation|1|||
162863300|NCT02190591|588203860|FG001|Overall Study|Protocol Violation|0|||
162863301|NCT02190591|588203859|FG000|Overall Study|did not use peanut ball as instructed|0|||
162863302|NCT02190591|588203860|FG001|Overall Study|did not use peanut ball as instructed|2|||
162863303|NCT02190591|588203859|FG000|Overall Study|face presentation so she was ineligible|0|||
162863304|NCT02190591|588203860|FG001|Overall Study|face presentation so she was ineligible|1|||
162863305|NCT01151137|588203863|FG000|Overall Study|Death|15|||
162863306|NCT01151137|588203864|FG001|Overall Study|Death|27|||
162863307|NCT01151137|588203863|FG000|Overall Study|Lost to Follow-up|1|||
162863308|NCT01151137|588203864|FG001|Overall Study|Lost to Follow-up|1|||
162863309|NCT02973815|588203865|FG000|Post Intervention|Death|1|||
162863310|NCT02973815|588203866|FG001|Post Intervention|Death|0|||
162863311|NCT02973815|588203865|FG000|Post Intervention|Lost to Follow-up|7|||
162863312|NCT02973815|588203866|FG001|Post Intervention|Lost to Follow-up|24|||
162863313|NCT02973815|588203865|FG000|Follow-up|Lost to Follow-up|2|||
162863314|NCT02973815|588203866|FG001|Follow-up|Lost to Follow-up|0|||
162863315|NCT03478683|588203869|FG000|Overall Study|Adverse Event|5|||
162863316|NCT03478683|588203870|FG001|Overall Study|Adverse Event|3|||
162863317|NCT03478683|588203869|FG000|Overall Study|Lost to Follow-up|0|||
162863318|NCT03478683|588203870|FG001|Overall Study|Lost to Follow-up|5|||
162863319|NCT03478683|588203869|FG000|Overall Study|Physician Decision|1|||
162863320|NCT03478683|588203870|FG001|Overall Study|Physician Decision|3|||
162863321|NCT03478683|588203869|FG000|Overall Study|Withdrawal by Subject|7|||
162863322|NCT03478683|588203870|FG001|Overall Study|Withdrawal by Subject|7|||
162863323|NCT01607892|588203879|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
162863324|NCT01607892|588203880|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
162863325|NCT01607892|588203881|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
162863326|NCT01607892|588203882|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
162863327|NCT01607892|588203883|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
162863328|NCT01607892|588203879|FG000|Overall Study|Death|4|||
162863329|NCT01607892|588203880|FG001|Overall Study|Death|2|||
162863330|NCT01607892|588203881|FG002|Overall Study|Death|8|||
162863331|NCT01607892|588203882|FG003|Overall Study|Death|10|||
162863332|NCT01607892|588203883|FG004|Overall Study|Death|3|||
162863333|NCT01607892|588203879|FG000|Overall Study|Investigator discretion|2|||
162863334|NCT01607892|588203880|FG001|Overall Study|Investigator discretion|4|||
162863335|NCT01607892|588203881|FG002|Overall Study|Investigator discretion|4|||
162863336|NCT01607892|588203882|FG003|Overall Study|Investigator discretion|8|||
162863337|NCT01607892|588203883|FG004|Overall Study|Investigator discretion|0|||
162863338|NCT01607892|588203879|FG000|Overall Study|Other treatments became available|1|||
162863339|NCT01607892|588203880|FG001|Overall Study|Other treatments became available|1|||
162863340|NCT01607892|588203881|FG002|Overall Study|Other treatments became available|0|||
162863341|NCT01607892|588203882|FG003|Overall Study|Other treatments became available|0|||
162863342|NCT01607892|588203883|FG004|Overall Study|Other treatments became available|2|||
162863343|NCT01607892|588203879|FG000|Overall Study|Intercurrent illness|1|||
162863344|NCT01607892|588203880|FG001|Overall Study|Intercurrent illness|0|||
162863345|NCT01607892|588203881|FG002|Overall Study|Intercurrent illness|0|||
162863346|NCT01607892|588203882|FG003|Overall Study|Intercurrent illness|3|||
162863347|NCT01607892|588203883|FG004|Overall Study|Intercurrent illness|0|||
162863348|NCT01607892|588203879|FG000|Overall Study|Non-Compliance with study procedures|0|||
162863349|NCT01607892|588203880|FG001|Overall Study|Non-Compliance with study procedures|0|||
162863350|NCT01607892|588203881|FG002|Overall Study|Non-Compliance with study procedures|1|||
162863351|NCT01607892|588203882|FG003|Overall Study|Non-Compliance with study procedures|0|||
162863352|NCT01607892|588203883|FG004|Overall Study|Non-Compliance with study procedures|0|||
162863353|NCT01607892|588203879|FG000|Overall Study|Consent withdrawn by participant|9|||
162863354|NCT01607892|588203880|FG001|Overall Study|Consent withdrawn by participant|4|||
162863355|NCT01607892|588203881|FG002|Overall Study|Consent withdrawn by participant|24|||
162863356|NCT01607892|588203882|FG003|Overall Study|Consent withdrawn by participant|14|||
162863357|NCT01607892|588203883|FG004|Overall Study|Consent withdrawn by participant|4|||
162863358|NCT01607892|588203879|FG000|Overall Study|Disease progression|38|||
162863359|NCT01607892|588203880|FG001|Overall Study|Disease progression|13|||
162863360|NCT01607892|588203881|FG002|Overall Study|Disease progression|37|||
162863361|NCT01607892|588203882|FG003|Overall Study|Disease progression|57|||
162863362|NCT01607892|588203883|FG004|Overall Study|Disease progression|9|||
162863363|NCT01607892|588203879|FG000|Overall Study|Incidence or severity of Adverse events|3|||
162863364|NCT01607892|588203880|FG001|Overall Study|Incidence or severity of Adverse events|3|||
162863365|NCT01607892|588203881|FG002|Overall Study|Incidence or severity of Adverse events|7|||
162863366|NCT01607892|588203882|FG003|Overall Study|Incidence or severity of Adverse events|2|||
162863367|NCT01607892|588203883|FG004|Overall Study|Incidence or severity of Adverse events|6|||
162863368|NCT02273973|588203886|FG000|Overall Study|Adverse Event|4|||
162863369|NCT02273973|588203887|FG001|Overall Study|Adverse Event|0|||
162863370|NCT02273973|588203886|FG000|Overall Study|Withdrawal by Subject|2|||
162863371|NCT02273973|588203887|FG001|Overall Study|Withdrawal by Subject|3|||
162863372|NCT02273973|588203886|FG000|Overall Study|Death|1|||
162863373|NCT02273973|588203887|FG001|Overall Study|Death|0|||
162863374|NCT02273973|588203886|FG000|Overall Study|Non-compliance|1|||
162863375|NCT02273973|588203887|FG001|Overall Study|Non-compliance|0|||
162863376|NCT02273973|588203886|FG000|Overall Study|Protocol Violation|1|||
162863377|NCT02273973|588203887|FG001|Overall Study|Protocol Violation|0|||
162924305|NCT00518011|588423858|FG001|Overall Study|Death|1|||
162863378|NCT02273973|588203886|FG000|Overall Study|Progression of disease|0|||
162863379|NCT02273973|588203887|FG001|Overall Study|Progression of disease|2|||
162863380|NCT02273973|588203886|FG000|Overall Study|Lost to Follow-up|0|||
162863381|NCT02273973|588203887|FG001|Overall Study|Lost to Follow-up|1|||
162863382|NCT02273973|588203886|FG000|Overall Study|Physician Decision|0|||
162863383|NCT02273973|588203887|FG001|Overall Study|Physician Decision|1|||
162863384|NCT02273973|588203886|FG000|Overall Study|Reason not specified|0|||
162863385|NCT02273973|588203887|FG001|Overall Study|Reason not specified|1|||
162863386|NCT03022422|588203888|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
162863387|NCT03022422|588203889|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
162863388|NCT03022422|588203890|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
162863389|NCT03022422|588203891|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
162863390|NCT03022422|588203892|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
162863391|NCT03022422|588203893|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
162863392|NCT02104180|588203894|FG000|Overall Study|Protocol Violation|1|||
162863393|NCT02104180|588203895|FG001|Overall Study|Protocol Violation|0|||
162863394|NCT01676116|588203896|FG000|Overall Study|Withdrawal criteria|2|||
162863395|NCT01676116|588203897|FG001|Overall Study|Withdrawal criteria|14|||
162863396|NCT01676116|588203896|FG000|Overall Study|Adverse Event|1|||
162863397|NCT01676116|588203897|FG001|Overall Study|Adverse Event|2|||
162863398|NCT01676116|588203896|FG000|Overall Study|Unclassified|4|||
162863399|NCT01676116|588203897|FG001|Overall Study|Unclassified|10|||
162863400|NCT01676116|588203896|FG000|Overall Study|Protocol Violation|9|||
162863401|NCT01676116|588203897|FG001|Overall Study|Protocol Violation|3|||
162863402|NCT00793585|588203898|FG000|Overall Study|Adverse Event|1|||
162863403|NCT00793585|588203899|FG001|Overall Study|Adverse Event|1|||
162863404|NCT00793585|588203898|FG000|Overall Study|Protocol Violation|1|||
162863405|NCT00793585|588203899|FG001|Overall Study|Protocol Violation|2|||
162863406|NCT01769404|588203900|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
162863407|NCT01769404|588203901|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
162863408|NCT01769404|588203900|FG000|Treatment Period 1|Withdrawal by Subject|3|||
162863409|NCT01769404|588203901|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162863410|NCT01769404|588203900|FG000|Treatment Period 1|Sponsor decision|1|||
162863411|NCT01769404|588203901|FG001|Treatment Period 1|Sponsor decision|0|||
162863412|NCT01769404|588203900|FG000|Treatment Period 2|Sponsor decision|7|||
162863413|NCT01769404|588203901|FG001|Treatment Period 2|Sponsor decision|0|||
162863414|NCT01821677|588203902|FG000|Overall Study|Adverse Event|4|||
162863415|NCT01821677|588203903|FG001|Overall Study|Adverse Event|6|||
162863416|NCT01821677|588203904|FG002|Overall Study|Adverse Event|5|||
162863417|NCT01821677|588203902|FG000|Overall Study|Physician Decision|1|||
162863418|NCT01821677|588203903|FG001|Overall Study|Physician Decision|4|||
162863419|NCT01821677|588203904|FG002|Overall Study|Physician Decision|1|||
162863420|NCT01821677|588203902|FG000|Overall Study|Non-compliance|0|||
162863421|NCT01821677|588203903|FG001|Overall Study|Non-compliance|1|||
162863422|NCT01821677|588203904|FG002|Overall Study|Non-compliance|2|||
162863423|NCT01821677|588203902|FG000|Overall Study|Lost to Follow-up|2|||
162863424|NCT01821677|588203903|FG001|Overall Study|Lost to Follow-up|1|||
162863425|NCT01821677|588203904|FG002|Overall Study|Lost to Follow-up|3|||
162863426|NCT01821677|588203902|FG000|Overall Study|Protocol Violation|0|||
162863427|NCT01821677|588203903|FG001|Overall Study|Protocol Violation|0|||
162863428|NCT01821677|588203904|FG002|Overall Study|Protocol Violation|2|||
162863429|NCT01821677|588203902|FG000|Overall Study|Withdrawal by Subject|7|||
162863430|NCT01821677|588203903|FG001|Overall Study|Withdrawal by Subject|3|||
162863431|NCT01821677|588203904|FG002|Overall Study|Withdrawal by Subject|2|||
162863432|NCT01821677|588203902|FG000|Overall Study|Other|9|||
162863433|NCT01821677|588203903|FG001|Overall Study|Other|0|||
162863434|NCT01821677|588203904|FG002|Overall Study|Other|0|||
162863435|NCT00538733|588203905|FG000|Overall Study|Adverse Event|8|||
162863436|NCT00538733|588203905|FG000|Overall Study|Death|1|||
162863437|NCT00538733|588203905|FG000|Overall Study|declined to participate|2|||
162863438|NCT00538733|588203905|FG000|Overall Study|still on therapy|1|||
162863439|NCT04513158|588203919|FG000|Overall Study|Screen Failure|1|||
162863440|NCT05278104|588203920|FG000|Overall Study|Not treated|1|||
162863441|NCT05278104|588203921|FG001|Overall Study|Not treated|0|||
162863442|NCT05278104|588203920|FG000|Overall Study|Adverse Event|2|||
162613333|NCT05098938|587301195|FG000|Overall Study|6 months visit was missed|2|||
162863443|NCT05278104|588203921|FG001|Overall Study|Adverse Event|1|||
162863444|NCT05278104|588203920|FG000|Overall Study|Exclusion criteria not met|1|||
162863445|NCT05278104|588203921|FG001|Overall Study|Exclusion criteria not met|0|||
162863446|NCT02629393|588205826|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
162863447|NCT02629393|588205826|FG000|Overall Study|Physician Decision|1|||
162863448|NCT01269125|588205827|FG000|Overall Study|Adverse Event|3|||
162863449|NCT01269125|588205828|FG001|Overall Study|Adverse Event|5|||
162863450|NCT01269125|588205829|FG002|Overall Study|Adverse Event|0|||
162863451|NCT01269125|588205827|FG000|Overall Study|Lost to Follow-up|4|||
162863452|NCT01269125|588205828|FG001|Overall Study|Lost to Follow-up|0|||
162863453|NCT01269125|588205829|FG002|Overall Study|Lost to Follow-up|0|||
162863454|NCT01040832|588205830|FG000|Overall Study|Adverse Event|4|||
163046048|NCT00758498|588877285|FG000|Overall Study|Withdrawal by Subject|0|||
163046049|NCT00758498|588877286|FG001|Overall Study|Withdrawal by Subject|0|||
163046050|NCT00758498|588877287|FG002|Overall Study|Withdrawal by Subject|1|||
163046051|NCT00758498|588877285|FG000|Overall Study|Noncompliance to study procedures|0|||
163046052|NCT00758498|588877286|FG001|Overall Study|Noncompliance to study procedures|0|||
163046053|NCT00758498|588877287|FG002|Overall Study|Noncompliance to study procedures|1|||
163046054|NCT01516736|588877288|FG000|Overall Study|Withdrawal by Subject|10|||
163046055|NCT01516736|588877289|FG001|Overall Study|Withdrawal by Subject|4|||
163046056|NCT01516736|588877288|FG000|Overall Study|Adverse Event|4|||
163046057|NCT01516736|588877289|FG001|Overall Study|Adverse Event|5|||
163046058|NCT01516736|588877288|FG000|Overall Study|Death|3|||
163046059|NCT01516736|588877289|FG001|Overall Study|Death|1|||
163046060|NCT01516736|588877288|FG000|Overall Study|Physician Decision|2|||
163046061|NCT01516736|588877289|FG001|Overall Study|Physician Decision|1|||
163046062|NCT01516736|588877288|FG000|Overall Study|Lack of Efficacy|1|||
163046063|NCT01516736|588877289|FG001|Overall Study|Lack of Efficacy|0|||
163046064|NCT01516736|588877288|FG000|Overall Study|Protocol Violation|0|||
163046065|NCT01516736|588877289|FG001|Overall Study|Protocol Violation|1|||
163046066|NCT01516736|588877288|FG000|Overall Study|Other (not specified)|0|||
163046067|NCT01516736|588877289|FG001|Overall Study|Other (not specified)|1|||
163046068|NCT00524771|588877290|FG000|Overall Study|Protocol Violation|220|||
163046069|NCT00524771|588877291|FG001|Overall Study|Protocol Violation|585|||
163046070|NCT02781818|588877292|FG000|Overall Study|Lost to Follow-up|4|||
163046071|NCT02781818|588877293|FG001|Overall Study|Lost to Follow-up|2|||
163046072|NCT02781818|588877294|FG002|Overall Study|Lost to Follow-up|1|||
163046073|NCT01877668|588877295|FG000|Overall Study|Death|0|||
163046074|NCT01877668|588877296|FG001|Overall Study|Death|0|||
163046075|NCT01877668|588877297|FG002|Overall Study|Death|0|||
163046076|NCT01877668|588877298|FG003|Overall Study|Death|1|||
163046077|NCT01877668|588877299|FG004|Overall Study|Death|0|||
163046078|NCT01877668|588877295|FG000|Overall Study|No longer met study criteria|1|||
163046079|NCT01877668|588877296|FG001|Overall Study|No longer met study criteria|0|||
163046080|NCT01877668|588877297|FG002|Overall Study|No longer met study criteria|1|||
163046081|NCT01877668|588877298|FG003|Overall Study|No longer met study criteria|0|||
163046082|NCT01877668|588877299|FG004|Overall Study|No longer met study criteria|0|||
163046083|NCT01877668|588877295|FG000|Overall Study|Insufficient clinical response|0|||
163046084|NCT01877668|588877296|FG001|Overall Study|Insufficient clinical response|1|||
163046085|NCT01877668|588877297|FG002|Overall Study|Insufficient clinical response|2|||
163046086|NCT01877668|588877298|FG003|Overall Study|Insufficient clinical response|2|||
163046087|NCT01877668|588877299|FG004|Overall Study|Insufficient clinical response|0|||
163046088|NCT01877668|588877295|FG000|Overall Study|Lost to Follow-up|0|||
163046089|NCT01877668|588877296|FG001|Overall Study|Lost to Follow-up|2|||
163046090|NCT01877668|588877297|FG002|Overall Study|Lost to Follow-up|1|||
163046091|NCT01877668|588877298|FG003|Overall Study|Lost to Follow-up|0|||
163046092|NCT01877668|588877299|FG004|Overall Study|Lost to Follow-up|0|||
163046093|NCT01877668|588877295|FG000|Overall Study|Withdrawal by Subject|2|||
163046094|NCT01877668|588877296|FG001|Overall Study|Withdrawal by Subject|0|||
163046095|NCT01877668|588877297|FG002|Overall Study|Withdrawal by Subject|3|||
163046096|NCT01877668|588877298|FG003|Overall Study|Withdrawal by Subject|2|||
163046097|NCT01877668|588877299|FG004|Overall Study|Withdrawal by Subject|2|||
163046098|NCT01877668|588877295|FG000|Overall Study|Other|1|||
163046099|NCT01877668|588877296|FG001|Overall Study|Other|1|||
163046100|NCT01877668|588877297|FG002|Overall Study|Other|1|||
163046101|NCT01877668|588877298|FG003|Overall Study|Other|1|||
163046102|NCT01877668|588877299|FG004|Overall Study|Other|3|||
163046103|NCT01877668|588877295|FG000|Overall Study|Protocol Violation|1|||
163046104|NCT01877668|588877296|FG001|Overall Study|Protocol Violation|1|||
163046105|NCT01877668|588877297|FG002|Overall Study|Protocol Violation|0|||
163046106|NCT01877668|588877298|FG003|Overall Study|Protocol Violation|0|||
163046107|NCT01877668|588877299|FG004|Overall Study|Protocol Violation|3|||
163046108|NCT01877668|588877295|FG000|Overall Study|Adverse event related to study drug|2|||
163046109|NCT01877668|588877296|FG001|Overall Study|Adverse event related to study drug|2|||
163046110|NCT01877668|588877297|FG002|Overall Study|Adverse event related to study drug|2|||
163046111|NCT01877668|588877298|FG003|Overall Study|Adverse event related to study drug|2|||
163046112|NCT01877668|588877299|FG004|Overall Study|Adverse event related to study drug|1|||
163046113|NCT01877668|588877295|FG000|Overall Study|Adverse event unrelated to study drug|4|||
163046114|NCT01877668|588877296|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162706022|NCT05194735|587636506|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
162810738|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
163046115|NCT01877668|588877297|FG002|Overall Study|Adverse event unrelated to study drug|2|||
163046116|NCT01877668|588877298|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163046117|NCT01877668|588877299|FG004|Overall Study|Adverse event unrelated to study drug|1|||
163046118|NCT02317991|588877300|FG000|Overall Study|Adverse Event|12|||
163046119|NCT02317991|588877300|FG000|Overall Study|Death|4|||
163046120|NCT02317991|588877300|FG000|Overall Study|Withdrawal by Subject|8|||
163046121|NCT02317991|588877300|FG000|Overall Study|Progressive Disease|41|||
162863455|NCT01040832|588205831|FG001|Overall Study|Adverse Event|5|||
162863456|NCT01040832|588205830|FG000|Overall Study|Death|4|||
162863457|NCT01040832|588205831|FG001|Overall Study|Death|6|||
162863458|NCT01040832|588205830|FG000|Overall Study|Withdrawal by Subject|2|||
162863459|NCT01040832|588205831|FG001|Overall Study|Withdrawal by Subject|3|||
162863460|NCT01040832|588205830|FG000|Overall Study|Progressive disease|32|||
162863461|NCT01040832|588205831|FG001|Overall Study|Progressive disease|17|||
162863462|NCT01040832|588205830|FG000|Overall Study|Symptomatic deterioration|2|||
162863463|NCT01040832|588205831|FG001|Overall Study|Symptomatic deterioration|5|||
162863464|NCT01040832|588205830|FG000|Overall Study|Other|2|||
162863465|NCT01040832|588205831|FG001|Overall Study|Other|1|||
162863466|NCT00151411|588205832|FG000|Overall Study|Lost to Follow-up|15|||
162863467|NCT00151411|588205833|FG001|Overall Study|Lost to Follow-up|19|||
162863468|NCT00151411|588205832|FG000|Overall Study|Withdrawal by Subject|12|||
162863469|NCT00151411|588205833|FG001|Overall Study|Withdrawal by Subject|20|||
162863470|NCT00151411|588205832|FG000|Overall Study|Adverse Event|6|||
162863471|NCT00151411|588205833|FG001|Overall Study|Adverse Event|0|||
162863472|NCT00151411|588205832|FG000|Overall Study|Pregnancy|0|||
162863473|NCT00151411|588205833|FG001|Overall Study|Pregnancy|4|||
162863474|NCT00417612|588205834|FG000|Overall Study|Errant diagnosis|0|||
162863475|NCT00417612|588205835|FG001|Overall Study|Errant diagnosis|1|||
162863476|NCT00417612|588205834|FG000|Overall Study|Adverse Event|2|||
162863477|NCT00417612|588205835|FG001|Overall Study|Adverse Event|0|||
162863478|NCT00417612|588205834|FG000|Overall Study|Protocol Violation|0|||
162863479|NCT00417612|588205835|FG001|Overall Study|Protocol Violation|2|||
162863480|NCT00417612|588205834|FG000|Overall Study|Lost to Follow-up|1|||
162863481|NCT00417612|588205835|FG001|Overall Study|Lost to Follow-up|0|||
162863482|NCT01283581|588205836|FG000|Overall Study|Lost to Follow-up|8|||
162863483|NCT01283581|588205837|FG001|Overall Study|Lost to Follow-up|6|||
162863484|NCT01283581|588205838|FG002|Overall Study|Lost to Follow-up|8|||
162863485|NCT01283581|588205836|FG000|Overall Study|Withdrawal by Subject|2|||
162863486|NCT01283581|588205837|FG001|Overall Study|Withdrawal by Subject|5|||
162863487|NCT01283581|588205838|FG002|Overall Study|Withdrawal by Subject|2|||
162863488|NCT01283581|588205836|FG000|Overall Study|Adverse Event|1|||
162863489|NCT01283581|588205837|FG001|Overall Study|Adverse Event|1|||
162863490|NCT01283581|588205838|FG002|Overall Study|Adverse Event|4|||
162863491|NCT01283581|588205836|FG000|Overall Study|Physician Decision|0|||
162863492|NCT01283581|588205837|FG001|Overall Study|Physician Decision|1|||
162863493|NCT01283581|588205838|FG002|Overall Study|Physician Decision|2|||
162863494|NCT01283581|588205836|FG000|Overall Study|Protocol Violation|0|||
162863495|NCT01283581|588205837|FG001|Overall Study|Protocol Violation|1|||
162863496|NCT01283581|588205838|FG002|Overall Study|Protocol Violation|2|||
162863497|NCT01283581|588205836|FG000|Overall Study|Noncompliance|1|||
162863498|NCT01283581|588205837|FG001|Overall Study|Noncompliance|0|||
162863499|NCT01283581|588205838|FG002|Overall Study|Noncompliance|0|||
162863500|NCT01283581|588205836|FG000|Overall Study|Investigator unblinded|0|||
162863501|NCT01283581|588205837|FG001|Overall Study|Investigator unblinded|0|||
162863502|NCT01283581|588205838|FG002|Overall Study|Investigator unblinded|1|||
162863503|NCT01283581|588205836|FG000|Overall Study|"Early termination"|0|||
162863504|NCT01283581|588205837|FG001|Overall Study|"Early termination"|0|||
162863505|NCT01283581|588205838|FG002|Overall Study|"Early termination"|1|||
162863506|NCT05523362|588205839|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
162958599|NCT01695239|588551583|FG008|Extension Long-Term Extension Periods|Death|1|||
162958600|NCT01695239|588551584|FG009|Extension Long-Term Extension Periods|Death|0|||
162958601|NCT01695239|588551585|FG010|Extension Long-Term Extension Periods|Death|0|||
162958602|NCT01695239|588551586|FG011|Extension Long-Term Extension Periods|Death|0|||
162958603|NCT01695239|588551587|FG012|Extension Long-Term Extension Periods|Death|0|||
162958604|NCT01695239|588551588|FG013|Extension Long-Term Extension Periods|Death|0|||
162958605|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162863507|NCT05523362|588205839|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
162958606|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958607|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958608|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958609|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958610|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958611|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958612|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958613|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958614|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162863508|NCT05523362|588205839|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
162863509|NCT05523362|588205839|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
162863510|NCT02760602|588205840|FG000|Overall Study|Withdrawal by Subject|1|||
162863511|NCT02760602|588205841|FG001|Overall Study|Withdrawal by Subject|0|||
162863512|NCT02760602|588205840|FG000|Overall Study|Terminated by sponsor|12|||
162863513|NCT02760602|588205841|FG001|Overall Study|Terminated by sponsor|13|||
162863514|NCT01260181|588205845|FG000|Overall Study|Decision of Investigator|1|||
162863515|NCT03351244|588205846|FG000|Overall Study|Adverse Event|7|||
162863516|NCT03351244|588205847|FG001|Overall Study|Adverse Event|11|||
162863517|NCT03351244|588205848|FG002|Overall Study|Adverse Event|12|||
162863518|NCT03351244|588205846|FG000|Overall Study|Investigator's decision|0|||
162863519|NCT03351244|588205847|FG001|Overall Study|Investigator's decision|0|||
162863520|NCT03351244|588205848|FG002|Overall Study|Investigator's decision|2|||
162863521|NCT03351244|588205846|FG000|Overall Study|System error|0|||
162863522|NCT03351244|588205847|FG001|Overall Study|System error|0|||
162863523|NCT03351244|588205848|FG002|Overall Study|System error|2|||
162863524|NCT03351244|588205846|FG000|Overall Study|COVID-19 restrictions|3|||
162863525|NCT03351244|588205847|FG001|Overall Study|COVID-19 restrictions|0|||
162863526|NCT03351244|588205848|FG002|Overall Study|COVID-19 restrictions|1|||
162863527|NCT03351244|588205846|FG000|Overall Study|Non-compliance|2|||
162863528|NCT03351244|588205847|FG001|Overall Study|Non-compliance|5|||
162863529|NCT03351244|588205848|FG002|Overall Study|Non-compliance|0|||
162863530|NCT03351244|588205846|FG000|Overall Study|Withdrawal by Subject|11|||
162863531|NCT03351244|588205847|FG001|Overall Study|Withdrawal by Subject|16|||
162863532|NCT03351244|588205848|FG002|Overall Study|Withdrawal by Subject|13|||
162863533|NCT03351244|588205846|FG000|Overall Study|Lost to Follow-up|2|||
162863534|NCT03351244|588205847|FG001|Overall Study|Lost to Follow-up|6|||
162863535|NCT03351244|588205848|FG002|Overall Study|Lost to Follow-up|4|||
162863536|NCT03351244|588205846|FG000|Overall Study|Protocol Violation|2|||
162863537|NCT03351244|588205847|FG001|Overall Study|Protocol Violation|2|||
162863538|NCT03351244|588205848|FG002|Overall Study|Protocol Violation|0|||
162863539|NCT00474253|588205851|FG000|Overall Study|Withdrew consent|2|||
162863540|NCT00474253|588205852|FG001|Overall Study|Withdrew consent|0|||
162863541|NCT00474253|588205851|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
162863542|NCT00474253|588205852|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
162863543|NCT00474253|588205851|FG000|Overall Study|Lost to Follow-up|1|||
162863544|NCT00474253|588205852|FG001|Overall Study|Lost to Follow-up|0|||
162863545|NCT00474253|588205851|FG000|Overall Study|Discharged prior to study completion|0|||
162863546|NCT00474253|588205852|FG001|Overall Study|Discharged prior to study completion|1|||
162863547|NCT01165229|588205853|FG000|Overall Study|Serious Adverse Event|456|||
162863548|NCT01165229|588205854|FG001|Overall Study|Serious Adverse Event|487|||
162863549|NCT01165229|588205853|FG000|Overall Study|Non-Serious Adverse Event|47|||
162863550|NCT01165229|588205854|FG001|Overall Study|Non-Serious Adverse Event|15|||
162863551|NCT01165229|588205853|FG000|Overall Study|Protocol Violation|6|||
162863552|NCT01165229|588205854|FG001|Overall Study|Protocol Violation|8|||
162863553|NCT01165229|588205853|FG000|Overall Study|Withdrawal by Subject|387|||
162863554|NCT01165229|588205854|FG001|Overall Study|Withdrawal by Subject|396|||
162863555|NCT01165229|588205853|FG000|Overall Study|Migrated/moved from study area|51|||
162863556|NCT01165229|588205854|FG001|Overall Study|Migrated/moved from study area|46|||
162863557|NCT01165229|588205853|FG000|Overall Study|Lost to Follow-up|123|||
162863558|NCT01165229|588205854|FG001|Overall Study|Lost to Follow-up|133|||
162863559|NCT01165229|588205853|FG000|Overall Study|Suspected HZ Episode|2|||
162863560|NCT01165229|588205854|FG001|Overall Study|Suspected HZ Episode|2|||
162863561|NCT01165229|588205853|FG000|Overall Study|No reason from the subject|108|||
162863562|NCT01165229|588205854|FG001|Overall Study|No reason from the subject|102|||
162863563|NCT01165229|588205853|FG000|Overall Study|Unknown completion status|0|||
162863564|NCT01165229|588205854|FG001|Overall Study|Unknown completion status|1|||
162863565|NCT01357239|588205855|FG000|Stratum: All Patients|Adverse Event|0|||
163046122|NCT01223404|588877301|FG000|First Intervention (1 Day)|Adverse Event|0|||
163046123|NCT01223404|588877302|FG001|First Intervention (1 Day)|Adverse Event|0|||
162863566|NCT01357239|588205856|FG001|Stratum: All Patients|Adverse Event|0|||
162863567|NCT01357239|588205857|FG002|Stratum: All Patients|Adverse Event|1|||
162863568|NCT01357239|588205858|FG003|Stratum: All Patients|Adverse Event|1|||
162863569|NCT01357239|588205855|FG000|Stratum: All Patients|Subject withdrew consent|0|||
162863570|NCT01357239|588205856|FG001|Stratum: All Patients|Subject withdrew consent|0|||
162863571|NCT01357239|588205857|FG002|Stratum: All Patients|Subject withdrew consent|1|||
162863572|NCT01357239|588205858|FG003|Stratum: All Patients|Subject withdrew consent|1|||
162863573|NCT01357239|588205855|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
162863574|NCT01357239|588205856|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
162863575|NCT01357239|588205857|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
162863576|NCT01357239|588205858|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
162863577|NCT01357239|588205855|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
162863578|NCT01357239|588205856|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
162863579|NCT01357239|588205857|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
162863580|NCT01357239|588205858|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
162863581|NCT01357239|588205855|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
162863582|NCT01357239|588205856|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
162863583|NCT01357239|588205857|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
162863584|NCT01357239|588205858|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
162863585|NCT03133481|588205861|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
162863586|NCT03133481|588205862|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
162863587|NCT00637728|588205866|FG000|Double-blind Phase|Adverse Event|1|||
162863588|NCT00637728|588205867|FG001|Double-blind Phase|Adverse Event|0|||
162863589|NCT00637728|588205868|FG002|Double-blind Phase|Adverse Event|0|||
162863590|NCT00637728|588205866|FG000|Double-blind Phase|Non-compliance|2|||
162863591|NCT00637728|588205867|FG001|Double-blind Phase|Non-compliance|0|||
162863592|NCT00637728|588205868|FG002|Double-blind Phase|Non-compliance|0|||
162863593|NCT00637728|588205866|FG000|Double-blind Phase|Study Discontinued|1|||
162863594|NCT00637728|588205867|FG001|Double-blind Phase|Study Discontinued|1|||
162863595|NCT00637728|588205868|FG002|Double-blind Phase|Study Discontinued|0|||
162863596|NCT01873950|588205871|FG000|Period 5|Withdrawal by Subject|0|||
162863597|NCT01873950|588205872|FG001|Period 5|Withdrawal by Subject|0|||
162863598|NCT01873950|588205873|FG002|Period 5|Withdrawal by Subject|0|||
162863599|NCT01873950|588205874|FG003|Period 5|Withdrawal by Subject|1|||
162863600|NCT01873950|588205875|FG004|Period 5|Withdrawal by Subject|0|||
162863601|NCT05372315|588205877|FG000|Overall Study|Withdrawal by Subject|1|||
162863602|NCT05372315|588205878|FG001|Overall Study|Withdrawal by Subject|0|||
162958615|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162958616|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
162958617|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
162958618|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
162958619|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958620|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958621|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958622|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958623|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958624|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958625|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958626|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958627|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958628|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958629|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958630|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162958631|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162958632|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162958633|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958634|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958635|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958636|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958637|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958638|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958639|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958640|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958641|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958642|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958643|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958644|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958645|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
162958646|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
162958647|NCT01695239|588551575|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958648|NCT01695239|588551576|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958649|NCT01695239|588551577|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958650|NCT01695239|588551578|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958651|NCT01695239|588551579|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958652|NCT01695239|588551580|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958653|NCT01695239|588551581|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958654|NCT01695239|588551582|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958655|NCT01695239|588551583|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958656|NCT01695239|588551584|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958657|NCT01695239|588551585|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958658|NCT01695239|588551586|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958659|NCT01695239|588551587|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162958660|NCT01695239|588551588|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
162863603|NCT01512368|588205880|FG000|Overall Study|Protocol Violation|3|||
162863604|NCT00328198|588205881|FG000|Treatment|Adverse Event|21|||
162863605|NCT00328198|588205881|FG000|Treatment|Death|1|||
162863606|NCT00328198|588205881|FG000|Treatment|Physician Decision|5|||
162863607|NCT00328198|588205881|FG000|Treatment|Withdrawal by Subject|5|||
162863608|NCT00328198|588205881|FG000|Treatment|Evidence of disease progression|2|||
162863609|NCT00328198|588205881|FG000|Treatment|Non-compliance|1|||
162863610|NCT00328198|588205881|FG000|Treatment|Confirmed complete response, MRD -|3|||
162863611|NCT00328198|588205881|FG000|Follow-up|Lost to Follow-up|4|||
162863612|NCT00328198|588205881|FG000|Follow-up|Death|31|||
162613334|NCT05098938|587301196|FG001|Overall Study|6 months visit was missed|0|||
162863613|NCT01570491|588205884|FG000|Overall Study|Lost to Follow-up|3|||
162863614|NCT01570491|588205885|FG001|Overall Study|Lost to Follow-up|1|||
162863615|NCT01570491|588205884|FG000|Overall Study|treatment: not given or discontinued|2|||
162863616|NCT01570491|588205885|FG001|Overall Study|treatment: not given or discontinued|0|||
162863617|NCT01720667|588205889|FG000|Overall Study|Adverse Event|1|||
162863618|NCT01720667|588205890|FG001|Overall Study|Adverse Event|1|||
162863619|NCT01720667|588205889|FG000|Overall Study|Withdrawal by Subject|3|||
162863620|NCT01720667|588205890|FG001|Overall Study|Withdrawal by Subject|0|||
162863621|NCT04407507|588205891|FG000|Overall Study|Withdrawal by Subject|0|||
162863622|NCT04407507|588205892|FG001|Overall Study|Withdrawal by Subject|1|||
162863623|NCT01499576|588205893|FG000|Overall Study|Physician Decision|12|||
162863624|NCT01499576|588205893|FG000|Overall Study|Withdrawal by Subject|9|||
162863625|NCT03396471|588205901|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
162863626|NCT03396471|588205901|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
162863627|NCT03396471|588205901|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
162863628|NCT03396471|588205901|FG000|Study Treatment - Up to 22 Months|Death|2|||
162863629|NCT03396471|588205901|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
162863630|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|Death|9|||
162863631|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
162863632|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
162863633|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|study terminated|1|||
162863634|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
162863635|NCT03396471|588205901|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
162863636|NCT01319929|588205902|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
162863637|NCT01319929|588205903|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
162863638|NCT01319929|588205902|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
162863639|NCT01319929|588205903|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
162863640|NCT01319929|588205902|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
162863641|NCT01319929|588205903|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
162863642|NCT01319929|588205902|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
162863643|NCT01319929|588205903|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
162863644|NCT01319929|588205902|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
162863645|NCT01319929|588205903|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
162863646|NCT01221233|588205904|FG000|Overall Study|Withdrawal by Subject|3|||
162863647|NCT01221233|588205905|FG001|Overall Study|Withdrawal by Subject|1|||
162863648|NCT03865407|588205907|FG000|Overall Study|Adverse Event|1|||
162863649|NCT03865407|588205908|FG001|Overall Study|Adverse Event|0|||
162863650|NCT03865407|588205907|FG000|Overall Study|Withdrawal by Subject|1|||
162863651|NCT03865407|588205908|FG001|Overall Study|Withdrawal by Subject|0|||
162863652|NCT03865407|588205907|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
162863653|NCT03865407|588205908|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
162863654|NCT01645280|588205909|FG000|Overall Study|Death|0|||
162863655|NCT01645280|588205910|FG001|Overall Study|Death|1|||
162863656|NCT01645280|588205911|FG002|Overall Study|Death|0|||
162863657|NCT01645280|588205912|FG003|Overall Study|Death|0|||
162863658|NCT01645280|588205913|FG004|Overall Study|Death|0|||
162863659|NCT01645280|588205909|FG000|Overall Study|Withdrawal by Subject|4|||
162863660|NCT01645280|588205910|FG001|Overall Study|Withdrawal by Subject|0|||
162863661|NCT01645280|588205911|FG002|Overall Study|Withdrawal by Subject|2|||
162863662|NCT01645280|588205912|FG003|Overall Study|Withdrawal by Subject|4|||
162958661|NCT05239195|588551590|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
162958662|NCT05239195|588551591|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
162958663|NCT00081653|588551592|FG000|Overall Study|Adverse Event|23|||
162958664|NCT00081653|588551593|FG001|Overall Study|Adverse Event|17|||
162958665|NCT00081653|588551592|FG000|Overall Study|Lost to Follow-up|2|||
162958666|NCT00081653|588551593|FG001|Overall Study|Lost to Follow-up|4|||
162958667|NCT00081653|588551592|FG000|Overall Study|Refused Treatment|18|||
162958668|NCT00081653|588551593|FG001|Overall Study|Refused Treatment|14|||
162613335|NCT05098938|587301195|FG000|Overall Study|fit for use was not completed within window|3|||
162613336|NCT05098938|587301196|FG001|Overall Study|fit for use was not completed within window|0|||
162863663|NCT01645280|588205913|FG004|Overall Study|Withdrawal by Subject|5|||
162863664|NCT01645280|588205909|FG000|Overall Study|Lost to Follow-up|0|||
162863665|NCT01645280|588205910|FG001|Overall Study|Lost to Follow-up|0|||
162863666|NCT01645280|588205911|FG002|Overall Study|Lost to Follow-up|0|||
162958669|NCT00081653|588551592|FG000|Overall Study|Low bone mineral density|1|||
162863667|NCT01645280|588205912|FG003|Overall Study|Lost to Follow-up|2|||
162863668|NCT01645280|588205913|FG004|Overall Study|Lost to Follow-up|1|||
162863669|NCT01645280|588205909|FG000|Overall Study|Other|1|||
162863670|NCT01645280|588205910|FG001|Overall Study|Other|1|||
162863671|NCT01645280|588205911|FG002|Overall Study|Other|2|||
162863672|NCT01645280|588205912|FG003|Overall Study|Other|0|||
162863673|NCT01645280|588205913|FG004|Overall Study|Other|0|||
162863674|NCT01645280|588205909|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
162863675|NCT01645280|588205910|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
162863676|NCT01645280|588205911|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
162863677|NCT01645280|588205912|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
162863678|NCT01645280|588205913|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
162863679|NCT00234104|588205918|FG000|Overall Study|Adverse Event|4|||
162863680|NCT00234104|588205919|FG001|Overall Study|Adverse Event|0|||
162863681|NCT00234104|588205920|FG002|Overall Study|Adverse Event|3|||
162863682|NCT00234104|588205921|FG003|Overall Study|Adverse Event|5|||
162863683|NCT00234104|588205918|FG000|Overall Study|Protocol Violation|0|||
162863684|NCT00234104|588205919|FG001|Overall Study|Protocol Violation|0|||
162863685|NCT00234104|588205920|FG002|Overall Study|Protocol Violation|0|||
162863686|NCT00234104|588205921|FG003|Overall Study|Protocol Violation|1|||
162863687|NCT00234104|588205918|FG000|Overall Study|Physician Decision|0|||
162863688|NCT00234104|588205919|FG001|Overall Study|Physician Decision|1|||
162863689|NCT00234104|588205920|FG002|Overall Study|Physician Decision|2|||
162863690|NCT00234104|588205921|FG003|Overall Study|Physician Decision|2|||
162863691|NCT00546819|588205922|FG000|Overall Study|Adverse Event|2|||
162863692|NCT00546819|588205923|FG001|Overall Study|Adverse Event|3|||
162863693|NCT00546819|588205922|FG000|Overall Study|Lost to Follow-up|2|||
162863694|NCT00546819|588205923|FG001|Overall Study|Lost to Follow-up|1|||
162863695|NCT00546819|588205922|FG000|Overall Study|Withdrawal by Subject|4|||
162863696|NCT00546819|588205923|FG001|Overall Study|Withdrawal by Subject|2|||
162863697|NCT02052960|588205925|FG000|Overall Study|Adverse Event|19|||
162863698|NCT02052960|588205926|FG001|Overall Study|Adverse Event|17|||
162863699|NCT02052960|588205925|FG000|Overall Study|Protocol Violation|4|||
162863700|NCT02052960|588205926|FG001|Overall Study|Protocol Violation|3|||
162863701|NCT02052960|588205925|FG000|Overall Study|Withdrawal by Subject|6|||
162863702|NCT02052960|588205926|FG001|Overall Study|Withdrawal by Subject|11|||
162863703|NCT02052960|588205925|FG000|Overall Study|Other|25|||
162863704|NCT02052960|588205926|FG001|Overall Study|Other|15|||
162863705|NCT02460822|588205927|FG000|Overall Study|Withdrawal by Subject|1|||
162863706|NCT03849560|588205928|FG000|Overall Study|Withdrawal by Subject|1|||
162863707|NCT03849560|588205929|FG001|Overall Study|Withdrawal by Subject|0|||
162863708|NCT03849560|588205930|FG002|Overall Study|Withdrawal by Subject|0|||
162863709|NCT04045613|588205931|FG000|Overall Study|Adverse Event|2|||
162863710|NCT04045613|588205932|FG001|Overall Study|Adverse Event|2|||
162863711|NCT04045613|588205933|FG002|Overall Study|Adverse Event|1|||
162863712|NCT04045613|588205934|FG003|Overall Study|Adverse Event|1|||
162863713|NCT04045613|588205935|FG004|Overall Study|Adverse Event|0|||
162863714|NCT04045613|588205936|FG005|Overall Study|Adverse Event|0|||
162863715|NCT04045613|588205937|FG006|Overall Study|Adverse Event|1|||
162863716|NCT04045613|588205931|FG000|Overall Study|Withdrawal by Subject|0|||
162863717|NCT04045613|588205932|FG001|Overall Study|Withdrawal by Subject|5|||
162863718|NCT04045613|588205933|FG002|Overall Study|Withdrawal by Subject|0|||
162863719|NCT04045613|588205934|FG003|Overall Study|Withdrawal by Subject|0|||
162863720|NCT04045613|588205935|FG004|Overall Study|Withdrawal by Subject|0|||
162863721|NCT04045613|588205936|FG005|Overall Study|Withdrawal by Subject|1|||
162863722|NCT04045613|588205937|FG006|Overall Study|Withdrawal by Subject|0|||
162863723|NCT04045613|588205931|FG000|Overall Study|Physician Decision|2|||
162863724|NCT04045613|588205932|FG001|Overall Study|Physician Decision|0|||
162863725|NCT04045613|588205933|FG002|Overall Study|Physician Decision|0|||
162863726|NCT04045613|588205934|FG003|Overall Study|Physician Decision|0|||
162863727|NCT04045613|588205935|FG004|Overall Study|Physician Decision|1|||
162863728|NCT04045613|588205936|FG005|Overall Study|Physician Decision|0|||
162863729|NCT04045613|588205937|FG006|Overall Study|Physician Decision|0|||
162863730|NCT04045613|588205931|FG000|Overall Study|Death|3|||
162863731|NCT04045613|588205932|FG001|Overall Study|Death|0|||
162863732|NCT04045613|588205933|FG002|Overall Study|Death|0|||
162863733|NCT04045613|588205934|FG003|Overall Study|Death|0|||
162863734|NCT04045613|588205935|FG004|Overall Study|Death|0|||
162863735|NCT04045613|588205936|FG005|Overall Study|Death|0|||
162863736|NCT04045613|588205937|FG006|Overall Study|Death|1|||
162863737|NCT04045613|588205931|FG000|Overall Study|Other reasons|0|||
162863738|NCT04045613|588205932|FG001|Overall Study|Other reasons|1|||
162863739|NCT04045613|588205933|FG002|Overall Study|Other reasons|0|||
162863740|NCT04045613|588205934|FG003|Overall Study|Other reasons|0|||
162863741|NCT04045613|588205935|FG004|Overall Study|Other reasons|0|||
162863742|NCT04045613|588205936|FG005|Overall Study|Other reasons|0|||
162863743|NCT04045613|588205937|FG006|Overall Study|Other reasons|1|||
162863744|NCT04045613|588205931|FG000|Overall Study|Progressive disease: Clinical progression|1|||
162863745|NCT04045613|588205932|FG001|Overall Study|Progressive disease: Clinical progression|0|||
162863746|NCT04045613|588205933|FG002|Overall Study|Progressive disease: Clinical progression|3|||
162863747|NCT04045613|588205934|FG003|Overall Study|Progressive disease: Clinical progression|1|||
162863748|NCT04045613|588205935|FG004|Overall Study|Progressive disease: Clinical progression|1|||
162863749|NCT04045613|588205936|FG005|Overall Study|Progressive disease: Clinical progression|3|||
162863750|NCT04045613|588205937|FG006|Overall Study|Progressive disease: Clinical progression|3|||
162863751|NCT04045613|588205931|FG000|Overall Study|Progressive disease: Radiological progression|24|||
162863752|NCT04045613|588205932|FG001|Overall Study|Progressive disease: Radiological progression|6|||
162863753|NCT04045613|588205933|FG002|Overall Study|Progressive disease: Radiological progression|8|||
162863754|NCT04045613|588205934|FG003|Overall Study|Progressive disease: Radiological progression|0|||
162863755|NCT04045613|588205935|FG004|Overall Study|Progressive disease: Radiological progression|6|||
162863756|NCT04045613|588205936|FG005|Overall Study|Progressive disease: Radiological progression|6|||
162863757|NCT04045613|588205937|FG006|Overall Study|Progressive disease: Radiological progression|11|||
162863758|NCT01254344|588205947|FG000|Overall Study|Adverse Event|2|||
162863759|NCT01254344|588205948|FG001|Overall Study|Adverse Event|5|||
162863760|NCT01254344|588205947|FG000|Overall Study|Physician Decision|7|||
162863761|NCT01254344|588205948|FG001|Overall Study|Physician Decision|4|||
162863762|NCT01254344|588205947|FG000|Overall Study|Protocol Violation|1|||
162863763|NCT01254344|588205948|FG001|Overall Study|Protocol Violation|4|||
162863764|NCT01254344|588205947|FG000|Overall Study|Withdrawal by Subject|3|||
162863765|NCT01254344|588205948|FG001|Overall Study|Withdrawal by Subject|6|||
162863766|NCT00467649|588205949|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
162863767|NCT00467649|588205950|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
162863768|NCT00467649|588205951|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
162863769|NCT00467649|588205952|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
162863770|NCT00467649|588205953|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
162863771|NCT00467649|588205954|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
162863772|NCT00467649|588205949|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
162863773|NCT00467649|588205950|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
162863774|NCT00467649|588205951|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
162863775|NCT00467649|588205952|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
162863776|NCT00467649|588205953|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
162863777|NCT00467649|588205954|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
162863778|NCT00467649|588205949|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
162863779|NCT00467649|588205950|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
162863780|NCT00467649|588205951|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
162863781|NCT00467649|588205952|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
162863782|NCT00467649|588205953|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
162863783|NCT00467649|588205954|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
162863784|NCT00467649|588205949|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
162863785|NCT00467649|588205950|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
162863786|NCT00467649|588205951|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
162863787|NCT00467649|588205952|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
162863788|NCT00467649|588205953|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
162863789|NCT00467649|588205954|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
162863790|NCT00467649|588205949|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
162863791|NCT00467649|588205950|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
162863792|NCT00467649|588205951|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
162863793|NCT00467649|588205952|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
162863794|NCT00467649|588205953|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
162863795|NCT00467649|588205954|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
162863796|NCT00467649|588205949|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
162863797|NCT00467649|588205950|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
162863798|NCT00467649|588205951|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
162863799|NCT00467649|588205952|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
162863800|NCT00467649|588205953|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
162863801|NCT00467649|588205954|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
162863802|NCT00467649|588205949|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
162863803|NCT00467649|588205950|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
162863804|NCT00467649|588205951|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
162863805|NCT00467649|588205952|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
162863806|NCT00467649|588205953|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
162863807|NCT00467649|588205954|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
162863808|NCT01633060|588205955|FG000|Randomization Phase|Protocol deviation|1|||
162863809|NCT01633060|588205956|FG001|Randomization Phase|Protocol deviation|2|||
162863810|NCT01633060|588205955|FG000|Randomization Phase|Technical problem|0|||
162863811|NCT01633060|588205956|FG001|Randomization Phase|Technical problem|1|||
162863812|NCT01633060|588205955|FG000|Treatment Phase|Adverse Event|24|||
162863813|NCT01633060|588205956|FG001|Treatment Phase|Adverse Event|3|||
162613337|NCT05098938|587301195|FG000|Overall Study|V2 visit was not completed within window|0|||
162613338|NCT05098938|587301196|FG001|Overall Study|V2 visit was not completed within window|1|||
162613339|NCT05098938|587301195|FG000|Overall Study|exclusionary medication use|1|||
162706023|NCT05194735|587636504|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
162706024|NCT05194735|587636505|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
162613340|NCT05098938|587301196|FG001|Overall Study|exclusionary medication use|2|||
162613341|NCT05098938|587301195|FG000|Overall Study|change in medication|1|||
162613342|NCT05098938|587301196|FG001|Overall Study|change in medication|0|||
162613343|NCT05098938|587301195|FG000|Overall Study|treatment failure|2|||
162613344|NCT05098938|587301196|FG001|Overall Study|treatment failure|1|||
162613345|NCT02570074|587303161|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
162613346|NCT02570074|587303162|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
162613347|NCT01859143|587303164|FG000|Overall Study|Lost to Follow-up|2|||
162613348|NCT01859143|587303165|FG001|Overall Study|Lost to Follow-up|0|||
162613349|NCT00760214|587303166|FG000|Overall Study|Adverse Event|8|||
162613350|NCT00760214|587303167|FG001|Overall Study|Adverse Event|9|||
162613351|NCT00760214|587303168|FG002|Overall Study|Adverse Event|12|||
162613352|NCT00760214|587303166|FG000|Overall Study|Protocol Violation|3|||
162613353|NCT00760214|587303167|FG001|Overall Study|Protocol Violation|0|||
162613354|NCT00760214|587303168|FG002|Overall Study|Protocol Violation|3|||
162613355|NCT00760214|587303166|FG000|Overall Study|Lost to Follow-up|0|||
162613356|NCT00760214|587303167|FG001|Overall Study|Lost to Follow-up|0|||
162613357|NCT00760214|587303168|FG002|Overall Study|Lost to Follow-up|1|||
162613358|NCT00760214|587303166|FG000|Overall Study|Withdrawal by Subject|12|||
162613359|NCT00760214|587303167|FG001|Overall Study|Withdrawal by Subject|14|||
162613360|NCT00760214|587303168|FG002|Overall Study|Withdrawal by Subject|13|||
162613361|NCT00760214|587303166|FG000|Overall Study|Lack of Efficacy|3|||
162613362|NCT00760214|587303167|FG001|Overall Study|Lack of Efficacy|2|||
162613363|NCT00760214|587303168|FG002|Overall Study|Lack of Efficacy|4|||
162706025|NCT05194735|587636506|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
162706026|NCT00731042|587636507|FG000|Second Intervention|Did not meet inclusion criteria|0|||
162706027|NCT00731042|587636508|FG001|Second Intervention|Did not meet inclusion criteria|2|||
162706028|NCT01256476|587636509|FG000|Overall Study|Adverse Event|2|||
162706029|NCT01256476|587636510|FG001|Overall Study|Adverse Event|1|||
162706030|NCT01256476|587636509|FG000|Overall Study|Withdrawal by Subject|2|||
162706031|NCT01256476|587636510|FG001|Overall Study|Withdrawal by Subject|1|||
162706032|NCT01256476|587636509|FG000|Overall Study|Lost to Follow-up|1|||
162706033|NCT01256476|587636510|FG001|Overall Study|Lost to Follow-up|2|||
162706034|NCT01256476|587636509|FG000|Overall Study|Persistent ALT or AST elevation|1|||
162706035|NCT01256476|587636510|FG001|Overall Study|Persistent ALT or AST elevation|0|||
162706036|NCT01256476|587636509|FG000|Overall Study|Physician Decision|0|||
162706037|NCT01256476|587636510|FG001|Overall Study|Physician Decision|1|||
162706038|NCT01256476|587636509|FG000|Overall Study|Subject non-compliance|0|||
162706039|NCT01256476|587636510|FG001|Overall Study|Subject non-compliance|1|||
162706040|NCT01256476|587636509|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
162706041|NCT01256476|587636510|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
162706042|NCT00231179|587636513|FG000|Overall Study|Lost to Follow-up|21|||
162706043|NCT00231179|587636514|FG001|Overall Study|Lost to Follow-up|21|||
162706044|NCT00231179|587636513|FG000|Overall Study|Withdrawal by Subject|3|||
162706045|NCT00231179|587636514|FG001|Overall Study|Withdrawal by Subject|3|||
162706046|NCT02491411|587636515|FG000|Overall Study|Physician Decision|4|||
162706047|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
162706048|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
162706049|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
162706050|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
162706051|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
162706052|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
162706053|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
162706054|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
162706055|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
162706056|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
162706057|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
162706058|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
162706059|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
162706060|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
162706061|NCT04672460|587636517|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
162706062|NCT04672460|587636518|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
162613364|NCT00760214|587303166|FG000|Overall Study|Pregnancy|0|||
162613365|NCT00760214|587303167|FG001|Overall Study|Pregnancy|0|||
162613366|NCT00760214|587303168|FG002|Overall Study|Pregnancy|1|||
162613367|NCT00760214|587303166|FG000|Overall Study|Physician Decision|1|||
162613368|NCT00760214|587303167|FG001|Overall Study|Physician Decision|1|||
162863814|NCT01633060|588205955|FG000|Treatment Phase|Lost to Follow-up|1|||
162863815|NCT01633060|588205956|FG001|Treatment Phase|Lost to Follow-up|0|||
162863816|NCT01633060|588205955|FG000|Treatment Phase|Physician Decision|16|||
162863817|NCT01633060|588205956|FG001|Treatment Phase|Physician Decision|7|||
162863818|NCT01633060|588205955|FG000|Treatment Phase|Progressive Disease|210|||
162863819|NCT01633060|588205956|FG001|Treatment Phase|Progressive Disease|120|||
162863820|NCT01633060|588205955|FG000|Treatment Phase|Protocol Deviation|1|||
162863821|NCT01633060|588205956|FG001|Treatment Phase|Protocol Deviation|0|||
162863822|NCT01633060|588205955|FG000|Treatment Phase|Study Terminated by sponsor|7|||
162863823|NCT01633060|588205956|FG001|Treatment Phase|Study Terminated by sponsor|3|||
162863824|NCT01633060|588205955|FG000|Treatment Phase|Subject/guardian decision|25|||
162863825|NCT01633060|588205956|FG001|Treatment Phase|Subject/guardian decision|4|||
162863826|NCT01633060|588205955|FG000|Treatment Phase|Death|4|||
162863827|NCT01633060|588205956|FG001|Treatment Phase|Death|3|||
162863828|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
162863829|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
162863830|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
162863831|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
162863832|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
162863833|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
162863834|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
162863835|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
162863836|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
162863837|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
162863838|NCT01633060|588205955|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
162863839|NCT01633060|588205956|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
162863840|NCT03233048|588205959|FG000|Overall Study|Withdrawal by Subject|1|||
162863841|NCT00883753|588205960|FG000|Overall Study|Adverse Event|37|||
162863842|NCT00883753|588205960|FG000|Overall Study|Death|2|||
162863843|NCT00883753|588205960|FG000|Overall Study|Insufficient therapeutic response|16|||
162863844|NCT00883753|588205960|FG000|Overall Study|Lost to Follow-up|4|||
162863845|NCT00883753|588205960|FG000|Overall Study|Violation of selection criteria at entry|7|||
162863846|NCT00883753|588205960|FG000|Overall Study|Protocol Violation|2|||
162863847|NCT00883753|588205960|FG000|Overall Study|Refused treatment|4|||
162863848|NCT00883753|588205960|FG000|Overall Study|Withdrew consent|10|||
162863849|NCT00883753|588205960|FG000|Overall Study|Investigator's decision|17|||
162863850|NCT00883753|588205960|FG000|Overall Study|Administrative/Other|8|||
162863851|NCT02859415|588205961|FG000|Overall Study|Physician Decision|1|||
162863852|NCT02859415|588205962|FG001|Overall Study|Physician Decision|0|||
162863853|NCT02859415|588205961|FG000|Overall Study|Off treatment due to cardiac event|0|||
162863854|NCT02859415|588205962|FG001|Overall Study|Off treatment due to cardiac event|1|||
162863855|NCT01396525|588205965|FG000|Overall Study|Withdrawal by Subject|8|||
162863856|NCT01396525|588205965|FG000|Overall Study|Death|14|||
162863857|NCT01396525|588205965|FG000|Overall Study|Lost to Follow-up|4|||
162863858|NCT03114969|588205966|FG000|Overall Study|Lost to Follow-up|0|||
162863859|NCT03114969|588205967|FG001|Overall Study|Lost to Follow-up|0|||
162863860|NCT03114969|588205968|FG002|Overall Study|Lost to Follow-up|3|||
162863861|NCT03114969|588205969|FG003|Overall Study|Lost to Follow-up|2|||
162863862|NCT03114969|588205970|FG004|Overall Study|Lost to Follow-up|0|||
162863863|NCT03114969|588205971|FG005|Overall Study|Lost to Follow-up|0|||
162863864|NCT03114969|588205972|FG006|Overall Study|Lost to Follow-up|0|||
162863865|NCT03114969|588205973|FG007|Overall Study|Lost to Follow-up|0|||
162863866|NCT03114969|588205974|FG008|Overall Study|Lost to Follow-up|0|||
162863867|NCT03114969|588205966|FG000|Overall Study|Adverse Event|0|||
162863868|NCT03114969|588205967|FG001|Overall Study|Adverse Event|0|||
162863869|NCT03114969|588205968|FG002|Overall Study|Adverse Event|1|||
162863870|NCT03114969|588205969|FG003|Overall Study|Adverse Event|0|||
162958670|NCT00081653|588551593|FG001|Overall Study|Low bone mineral density|0|||
162958671|NCT00081653|588551592|FG000|Overall Study|Bone loss|2|||
162958672|NCT00081653|588551593|FG001|Overall Study|Bone loss|0|||
162958673|NCT00081653|588551592|FG000|Overall Study|Participant leaving country|1|||
162958674|NCT00081653|588551593|FG001|Overall Study|Participant leaving country|0|||
162958675|NCT00081653|588551592|FG000|Overall Study|Loss of bone mass|0|||
162958676|NCT00081653|588551593|FG001|Overall Study|Loss of bone mass|2|||
162958677|NCT00736190|588551594|FG000|Overall Study|Pregnancy|1|||
162863871|NCT03114969|588205970|FG004|Overall Study|Adverse Event|0|||
162863872|NCT03114969|588205971|FG005|Overall Study|Adverse Event|1|||
162863873|NCT03114969|588205972|FG006|Overall Study|Adverse Event|1|||
162863874|NCT03114969|588205973|FG007|Overall Study|Adverse Event|0|||
162958678|NCT00736190|588551594|FG000|Overall Study|Withdrawal by Subject|1|||
162863875|NCT03114969|588205974|FG008|Overall Study|Adverse Event|2|||
162863876|NCT00971321|588205975|FG000|Up to Month 7|Withdrawal by Subject|1|||
162863877|NCT00971321|588205976|FG001|Up to Month 7|Withdrawal by Subject|0|||
162863878|NCT00971321|588205975|FG000|Up to Month 7|Migrated/moved from study area|3|||
162863879|NCT00971321|588205976|FG001|Up to Month 7|Migrated/moved from study area|2|||
162863880|NCT00971321|588205975|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
162863881|NCT00971321|588205976|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
162863882|NCT00971321|588205975|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
162863883|NCT00971321|588205976|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
162863884|NCT00971321|588205975|FG000|Up to Month 11-12|Lost to Follow-up|1|||
162863885|NCT00971321|588205976|FG001|Up to Month 11-12|Lost to Follow-up|0|||
162863886|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Adverse Event|12|||
162863887|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Adverse Event|3|||
162863888|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Adverse Event|4|||
162863889|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Adverse Event|2|||
162863890|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
162863891|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
162863892|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
162863893|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
162863894|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
162863895|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
162863896|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
162863897|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
162863898|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
162863899|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
162863900|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
162863901|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
162863902|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
162863903|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
162863904|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
162863905|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
162863906|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
162863907|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
162863908|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
162863909|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
162863910|NCT02436239|588205980|FG000|Open-Lable Treatment Period|Other Reason|1|||
162863911|NCT02436239|588205981|FG001|Open-Lable Treatment Period|Other Reason|1|||
162863912|NCT02436239|588205982|FG002|Open-Lable Treatment Period|Other Reason|0|||
162863913|NCT02436239|588205983|FG003|Open-Lable Treatment Period|Other Reason|0|||
162863914|NCT02436239|588205980|FG000|Down-Taper Period|Withdrawal by Subject|4|||
162863915|NCT02436239|588205981|FG001|Down-Taper Period|Withdrawal by Subject|4|||
162863916|NCT02436239|588205982|FG002|Down-Taper Period|Withdrawal by Subject|1|||
162863917|NCT02436239|588205983|FG003|Down-Taper Period|Withdrawal by Subject|2|||
162863918|NCT02168946|588205984|FG000|Overall Study|Adverse Event|8|||
162863919|NCT02168946|588205985|FG001|Overall Study|Adverse Event|5|||
162863920|NCT02168946|588205984|FG000|Overall Study|Lost to Follow-up|3|||
162863921|NCT02168946|588205985|FG001|Overall Study|Lost to Follow-up|0|||
162863922|NCT02168946|588205984|FG000|Overall Study|Subject unable to come back for visits|1|||
162863923|NCT02168946|588205985|FG001|Overall Study|Subject unable to come back for visits|0|||
162863924|NCT01743027|588205993|FG000|Overall Study|Adverse Event|2|||
162863925|NCT01743027|588205994|FG001|Overall Study|Adverse Event|0|||
162863926|NCT01743027|588205995|FG002|Overall Study|Adverse Event|0|||
162863927|NCT01743027|588205996|FG003|Overall Study|Adverse Event|0|||
162863928|NCT01743027|588205993|FG000|Overall Study|Lost to Follow-up|0|||
162863929|NCT01743027|588205994|FG001|Overall Study|Lost to Follow-up|0|||
162863930|NCT01743027|588205995|FG002|Overall Study|Lost to Follow-up|2|||
162863931|NCT01743027|588205996|FG003|Overall Study|Lost to Follow-up|0|||
162863932|NCT01743027|588205993|FG000|Overall Study|Progressive Disease|1|||
162863933|NCT01743027|588205994|FG001|Overall Study|Progressive Disease|4|||
162863934|NCT01743027|588205995|FG002|Overall Study|Progressive Disease|3|||
162863935|NCT01743027|588205996|FG003|Overall Study|Progressive Disease|0|||
162863936|NCT01743027|588205993|FG000|Overall Study|Protocol Violation|1|||
162863937|NCT01743027|588205994|FG001|Overall Study|Protocol Violation|1|||
162863938|NCT01743027|588205995|FG002|Overall Study|Protocol Violation|1|||
162863939|NCT01743027|588205996|FG003|Overall Study|Protocol Violation|0|||
162863940|NCT01743027|588205993|FG000|Overall Study|Withdrawal by Subject|1|||
162863941|NCT01743027|588205994|FG001|Overall Study|Withdrawal by Subject|0|||
162863942|NCT01743027|588205995|FG002|Overall Study|Withdrawal by Subject|3|||
163046124|NCT01223404|588877303|FG002|First Intervention (1 Day)|Adverse Event|0|||
162863943|NCT01743027|588205996|FG003|Overall Study|Withdrawal by Subject|1|||
162863944|NCT00450866|588205997|FG000|Overall Study|Adverse Event|0|||
162863945|NCT00450866|588205998|FG001|Overall Study|Adverse Event|1|||
162863946|NCT00450866|588205997|FG000|Overall Study|Withdrawal by Subject|5|||
162863947|NCT00450866|588205998|FG001|Overall Study|Withdrawal by Subject|2|||
162863948|NCT00450866|588205997|FG000|Overall Study|Death|1|||
162863949|NCT00450866|588205998|FG001|Overall Study|Death|0|||
163046125|NCT01223404|588877304|FG003|First Intervention (1 Day)|Adverse Event|1|||
162863950|NCT00450866|588205997|FG000|Overall Study|Physician Decision|1|||
162863951|NCT00450866|588205998|FG001|Overall Study|Physician Decision|0|||
162863952|NCT02675517|588205999|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
162613369|NCT00760214|587303168|FG002|Overall Study|Physician Decision|1|||
162613370|NCT00760214|587303166|FG000|Overall Study|Other|3|||
162613371|NCT00760214|587303167|FG001|Overall Study|Other|4|||
162613372|NCT00760214|587303168|FG002|Overall Study|Other|6|||
162613373|NCT00700570|587303169|FG000|Overall Study|Adverse Event|2|||
162613374|NCT00700570|587303170|FG001|Overall Study|Adverse Event|6|||
162613375|NCT00700570|587303169|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
162613376|NCT00700570|587303170|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
162613377|NCT00700570|587303169|FG000|Overall Study|Disease Progression|8|||
162613378|NCT00700570|587303170|FG001|Overall Study|Disease Progression|11|||
162613379|NCT00700570|587303169|FG000|Overall Study|Withdrawal by Subject|1|||
162613380|NCT00700570|587303170|FG001|Overall Study|Withdrawal by Subject|6|||
162613381|NCT01134315|587303171|FG000|Overall Study|Adverse Event|1|||
162613382|NCT01134315|587303172|FG001|Overall Study|Adverse Event|2|||
162613383|NCT01134315|587303171|FG000|Overall Study|Other Reason|8|||
162613384|NCT01134315|587303172|FG001|Overall Study|Other Reason|17|||
162613385|NCT04587271|587303175|FG000|Overall Study|Lost to Follow-up|2|||
162613386|NCT04587271|587303176|FG001|Overall Study|Lost to Follow-up|2|||
162613387|NCT04587271|587303177|FG002|Overall Study|Lost to Follow-up|0|||
162613388|NCT04587271|587303178|FG003|Overall Study|Lost to Follow-up|2|||
162613389|NCT04587271|587303179|FG004|Overall Study|Lost to Follow-up|2|||
162613390|NCT04587271|587303180|FG005|Overall Study|Lost to Follow-up|0|||
162613391|NCT04587271|587303175|FG000|Overall Study|Caregiver brought child to visits|0|||
162706063|NCT04672460|587636517|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
162706064|NCT04672460|587636518|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
162706065|NCT04672460|587636517|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
162706066|NCT04672460|587636518|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
162706067|NCT04672460|587636517|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
162706068|NCT04672460|587636518|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
162706069|NCT04672460|587636517|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
162706070|NCT04672460|587636518|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
162706071|NCT04672460|587636517|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
162706072|NCT04672460|587636518|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
162706073|NCT04672460|587636517|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
162706074|NCT04672460|587636518|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
162706075|NCT04672460|587636517|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
162706076|NCT04672460|587636518|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
162706077|NCT04672460|587636517|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
162706078|NCT04672460|587636518|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
162706079|NCT04672460|587636517|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
162706080|NCT04672460|587636518|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
162706081|NCT00940017|587636521|FG000|Overall Study|did not meet entrance criteria|3|||
162706082|NCT00940017|587636521|FG000|Overall Study|Adverse Event|1|||
162706083|NCT00569946|587636522|FG000|Overall Study|Adverse Event|16|||
162706084|NCT00569946|587636522|FG000|Overall Study|Objective Progression or Relapse|42|||
162706085|NCT00569946|587636522|FG000|Overall Study|Global Deterioration of Health Status|1|||
162706086|NCT02949271|587636525|FG000|Overall Study|Lack of Efficacy|5|||
162706087|NCT02949271|587636526|FG001|Overall Study|Lack of Efficacy|4|||
162706088|NCT02949271|587636525|FG000|Overall Study|Lost to Follow-up|3|||
162706089|NCT02949271|587636526|FG001|Overall Study|Lost to Follow-up|6|||
162706090|NCT02949271|587636525|FG000|Overall Study|Physician Decision|5|||
162706091|NCT02949271|587636526|FG001|Overall Study|Physician Decision|5|||
162706092|NCT02949271|587636525|FG000|Overall Study|Protocol Violation|6|||
162706093|NCT02949271|587636526|FG001|Overall Study|Protocol Violation|3|||
162706094|NCT02949271|587636525|FG000|Overall Study|Withdrawal by Subject|1|||
162706095|NCT02949271|587636526|FG001|Overall Study|Withdrawal by Subject|0|||
162706096|NCT02949271|587636525|FG000|Overall Study|Delivered prior to intervention|7|||
162706097|NCT02949271|587636526|FG001|Overall Study|Delivered prior to intervention|9|||
162706098|NCT02949271|587636525|FG000|Overall Study|Outside the window for cervical dilation|2|||
162706099|NCT02949271|587636526|FG001|Overall Study|Outside the window for cervical dilation|3|||
162706100|NCT05458102|587636527|FG000|Overall Study|Withdrew consent|2|||
162706101|NCT05458102|587636528|FG001|Overall Study|Withdrew consent|0|||
162706102|NCT05458102|587636527|FG000|Overall Study|Adverse Event|1|||
162706103|NCT05458102|587636528|FG001|Overall Study|Adverse Event|0|||
162706104|NCT05458102|587636527|FG000|Overall Study|Enrolled but never treated|1|||
162706105|NCT05458102|587636528|FG001|Overall Study|Enrolled but never treated|0|||
162706106|NCT05458102|587636527|FG000|Overall Study|Protocol Violation|1|||
162706107|NCT05458102|587636528|FG001|Overall Study|Protocol Violation|0|||
162706108|NCT01511536|587636534|FG000|Phase 1|Other|0|||
162706109|NCT01511536|587636535|FG001|Phase 1|Other|1|||
162706110|NCT01511536|587636536|FG002|Phase 1|Other|0|||
162706111|NCT01511536|587636534|FG000|Phase 2|Other|0|||
162706112|NCT01511536|587636535|FG001|Phase 2|Other|0|||
162958679|NCT00736190|588551594|FG000|Overall Study|Adverse Event|1|||
162613392|NCT04587271|587303176|FG001|Overall Study|Caregiver brought child to visits|0|||
163046126|NCT01223404|588877305|FG004|First Intervention (1 Day)|Adverse Event|0|||
162863953|NCT02675517|588205999|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
162863954|NCT03443024|588206002|FG000|Overall Study|Adverse Event|2|||
162863955|NCT03443024|588206003|FG001|Overall Study|Adverse Event|4|||
162863956|NCT03443024|588206004|FG002|Overall Study|Adverse Event|3|||
162863957|NCT03443024|588206005|FG003|Overall Study|Adverse Event|1|||
162863958|NCT03443024|588206002|FG000|Overall Study|Lost to Follow-up|9|||
162863959|NCT03443024|588206003|FG001|Overall Study|Lost to Follow-up|9|||
162863960|NCT03443024|588206004|FG002|Overall Study|Lost to Follow-up|7|||
162863961|NCT03443024|588206005|FG003|Overall Study|Lost to Follow-up|5|||
162863962|NCT03443024|588206002|FG000|Overall Study|Withdrawal by Subject|8|||
162863963|NCT03443024|588206003|FG001|Overall Study|Withdrawal by Subject|15|||
162863964|NCT03443024|588206004|FG002|Overall Study|Withdrawal by Subject|9|||
162863965|NCT03443024|588206005|FG003|Overall Study|Withdrawal by Subject|23|||
162863966|NCT03443024|588206002|FG000|Overall Study|Physician Decision|1|||
162863967|NCT03443024|588206003|FG001|Overall Study|Physician Decision|2|||
162863968|NCT03443024|588206004|FG002|Overall Study|Physician Decision|0|||
162863969|NCT03443024|588206005|FG003|Overall Study|Physician Decision|1|||
162863970|NCT03443024|588206002|FG000|Overall Study|Sponsor Decision|1|||
162863971|NCT03443024|588206003|FG001|Overall Study|Sponsor Decision|1|||
162863972|NCT03443024|588206004|FG002|Overall Study|Sponsor Decision|0|||
162863973|NCT03443024|588206005|FG003|Overall Study|Sponsor Decision|0|||
162863974|NCT03443024|588206002|FG000|Overall Study|Protocol Deviation|0|||
162863975|NCT03443024|588206003|FG001|Overall Study|Protocol Deviation|0|||
162863976|NCT03443024|588206004|FG002|Overall Study|Protocol Deviation|0|||
162863977|NCT03443024|588206005|FG003|Overall Study|Protocol Deviation|2|||
162863978|NCT02782715|588206006|FG000|Overall Study|Withdrawal by Subject|1|||
162863979|NCT02277444|588206007|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
162863980|NCT02277444|588206007|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
162863981|NCT02277444|588206007|FG000|Treatment Period (Week 0-52)|Other|1|||
162863982|NCT02277444|588206007|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
162863983|NCT02277444|588206007|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
162863984|NCT02277444|588206007|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
162863985|NCT02277444|588206007|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
162863986|NCT02277444|588206007|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
162863987|NCT02277444|588206007|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
162863988|NCT05635838|588207280|FG000|16-Week DBVC Period|Adverse Event|2|||
162863989|NCT05635838|588207281|FG001|16-Week DBVC Period|Adverse Event|0|||
162863990|NCT05635838|588207282|FG002|16-Week DBVC Period|Adverse Event|0|||
162863991|NCT05635838|588207283|FG003|16-Week DBVC Period|Adverse Event|0|||
162863992|NCT05635838|588207280|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
162863993|NCT05635838|588207281|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
162863994|NCT05635838|588207282|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
162863995|NCT05635838|588207283|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
162863996|NCT05635838|588207280|FG000|16-Week DBVC Period|Physician Decision|0|||
162863997|NCT05635838|588207281|FG001|16-Week DBVC Period|Physician Decision|1|||
162863998|NCT05635838|588207282|FG002|16-Week DBVC Period|Physician Decision|0|||
162863999|NCT05635838|588207283|FG003|16-Week DBVC Period|Physician Decision|0|||
162864000|NCT05635838|588207280|FG000|16-Week DBVC Period|Protocol Violation|1|||
162864001|NCT05635838|588207281|FG001|16-Week DBVC Period|Protocol Violation|0|||
162864002|NCT05635838|588207282|FG002|16-Week DBVC Period|Protocol Violation|0|||
162864003|NCT05635838|588207283|FG003|16-Week DBVC Period|Protocol Violation|0|||
162864004|NCT05635838|588207280|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
162864005|NCT05635838|588207281|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
162864006|NCT05635838|588207282|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
162864007|NCT05635838|588207283|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
162864008|NCT05635838|588207280|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
162864009|NCT05635838|588207281|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
162864010|NCT05635838|588207282|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
162864011|NCT05635838|588207283|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
162864012|NCT05635838|588207280|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
162864013|NCT05635838|588207281|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
162864014|NCT05635838|588207282|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
162864015|NCT05635838|588207283|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
162864016|NCT05635838|588207280|FG000|16-Week OLE Period|Adverse Event|0|||
162864017|NCT05635838|588207281|FG001|16-Week OLE Period|Adverse Event|0|||
162864018|NCT05635838|588207282|FG002|16-Week OLE Period|Adverse Event|0|||
162864019|NCT05635838|588207283|FG003|16-Week OLE Period|Adverse Event|2|||
162864020|NCT05635838|588207280|FG000|16-Week OLE Period|Lost to Follow-up|0|||
162864021|NCT05635838|588207281|FG001|16-Week OLE Period|Lost to Follow-up|0|||
162864022|NCT05635838|588207282|FG002|16-Week OLE Period|Lost to Follow-up|1|||
162864023|NCT05635838|588207283|FG003|16-Week OLE Period|Lost to Follow-up|3|||
162864024|NCT05635838|588207280|FG000|16-Week OLE Period|Physician Decision|0|||
162864025|NCT05635838|588207281|FG001|16-Week OLE Period|Physician Decision|0|||
162864026|NCT05635838|588207282|FG002|16-Week OLE Period|Physician Decision|0|||
162864027|NCT05635838|588207283|FG003|16-Week OLE Period|Physician Decision|1|||
162864028|NCT05635838|588207280|FG000|16-Week OLE Period|Protocol Violation|0|||
162864029|NCT05635838|588207281|FG001|16-Week OLE Period|Protocol Violation|0|||
162864030|NCT05635838|588207282|FG002|16-Week OLE Period|Protocol Violation|1|||
162864031|NCT05635838|588207283|FG003|16-Week OLE Period|Protocol Violation|1|||
162864032|NCT05635838|588207280|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
162864033|NCT05635838|588207281|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
162864034|NCT05635838|588207282|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
162864035|NCT05635838|588207283|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
162864036|NCT05635838|588207280|FG000|16-Week OLE Period|Pregnancy|0|||
162864037|NCT05635838|588207281|FG001|16-Week OLE Period|Pregnancy|0|||
162864038|NCT05635838|588207282|FG002|16-Week OLE Period|Pregnancy|1|||
162864039|NCT05635838|588207283|FG003|16-Week OLE Period|Pregnancy|0|||
162864040|NCT02699515|588207290|FG000|Overall Study|Death|3|||
162864041|NCT02699515|588207291|FG001|Overall Study|Death|3|||
162864042|NCT02699515|588207292|FG002|Overall Study|Death|3|||
162864043|NCT02699515|588207293|FG003|Overall Study|Death|23|||
162864044|NCT02699515|588207294|FG004|Overall Study|Death|22|||
162864045|NCT02699515|588207295|FG005|Overall Study|Death|23|||
162864046|NCT02699515|588207296|FG006|Overall Study|Death|3|||
162864047|NCT02699515|588207297|FG007|Overall Study|Death|5|||
162864048|NCT02699515|588207290|FG000|Overall Study|Withdrawal by Subject|0|||
162864049|NCT02699515|588207291|FG001|Overall Study|Withdrawal by Subject|0|||
162864050|NCT02699515|588207292|FG002|Overall Study|Withdrawal by Subject|3|||
162864051|NCT02699515|588207293|FG003|Overall Study|Withdrawal by Subject|1|||
162864052|NCT02699515|588207294|FG004|Overall Study|Withdrawal by Subject|5|||
162864053|NCT02699515|588207295|FG005|Overall Study|Withdrawal by Subject|3|||
162864054|NCT02699515|588207296|FG006|Overall Study|Withdrawal by Subject|0|||
162864055|NCT02699515|588207297|FG007|Overall Study|Withdrawal by Subject|1|||
162864056|NCT02699515|588207290|FG000|Overall Study|Other|1|||
162864057|NCT02699515|588207291|FG001|Overall Study|Other|0|||
162864058|NCT02699515|588207292|FG002|Overall Study|Other|1|||
162864059|NCT02699515|588207293|FG003|Overall Study|Other|6|||
162864060|NCT02699515|588207294|FG004|Overall Study|Other|4|||
162864061|NCT02699515|588207295|FG005|Overall Study|Other|3|||
162864062|NCT02699515|588207296|FG006|Overall Study|Other|0|||
162864063|NCT02699515|588207297|FG007|Overall Study|Other|0|||
162864064|NCT05243550|588207298|FG000|Overall Study|Ongoing in the Study|171|||
162958680|NCT03246503|588551595|FG000|Overall Study|Lost to Follow-up|23|||
162958681|NCT03246503|588551595|FG000|Overall Study|Withdrawal by Subject|20|||
162958682|NCT03246503|588551595|FG000|Overall Study|Physician Decision|5|||
162958683|NCT03246503|588551595|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
162958684|NCT01370317|588551596|FG000|Overall Study|Participant withdrew consent|1|||
162958685|NCT01370317|588551597|FG001|Overall Study|Participant withdrew consent|0|||
162958686|NCT01370317|588551596|FG000|Overall Study|Protocol deviation|0|||
162958687|NCT01370317|588551597|FG001|Overall Study|Protocol deviation|1|||
162958688|NCT00392665|588551599|FG000|Overall Study|Death|16|||
162958689|NCT00392665|588551600|FG001|Overall Study|Death|14|||
162958690|NCT00392665|588551599|FG000|Overall Study|Lost to Follow-up|1|||
162613393|NCT04587271|587303177|FG002|Overall Study|Caregiver brought child to visits|0|||
162613394|NCT04587271|587303178|FG003|Overall Study|Caregiver brought child to visits|1|||
162613395|NCT04587271|587303179|FG004|Overall Study|Caregiver brought child to visits|0|||
162613396|NCT04587271|587303180|FG005|Overall Study|Caregiver brought child to visits|0|||
162613397|NCT02360111|587303181|FG000|Overall Study|Death|2|||
162613398|NCT00611533|587303182|FG000|First Intervention (6 Weeks)|Never started study|0|||
162613399|NCT00611533|587303183|FG001|First Intervention (6 Weeks)|Never started study|1|||
162613400|NCT00611533|587303182|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
162613401|NCT00611533|587303183|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162613402|NCT00611533|587303182|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162613403|NCT00611533|587303183|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
162613404|NCT02180165|587303184|FG000|Overall Study|Not Treated|0|||
162613405|NCT02180165|587303185|FG001|Overall Study|Not Treated|0|||
162613406|NCT02180165|587303186|FG002|Overall Study|Not Treated|1|||
162613407|NCT02180165|587303187|FG003|Overall Study|Not Treated|0|||
162613408|NCT02180165|587303184|FG000|Overall Study|Adverse Event|7|||
162613409|NCT02180165|587303185|FG001|Overall Study|Adverse Event|0|||
162613410|NCT02180165|587303186|FG002|Overall Study|Adverse Event|18|||
162613411|NCT02180165|587303187|FG003|Overall Study|Adverse Event|3|||
162613412|NCT02180165|587303184|FG000|Overall Study|Lack of Efficacy|0|||
162613413|NCT02180165|587303185|FG001|Overall Study|Lack of Efficacy|1|||
162613414|NCT02180165|587303186|FG002|Overall Study|Lack of Efficacy|3|||
162613415|NCT02180165|587303187|FG003|Overall Study|Lack of Efficacy|2|||
162613416|NCT02180165|587303184|FG000|Overall Study|Physician Decision|1|||
162613417|NCT02180165|587303185|FG001|Overall Study|Physician Decision|0|||
162613418|NCT02180165|587303186|FG002|Overall Study|Physician Decision|5|||
162864065|NCT05243550|588207298|FG000|Overall Study|Withdrawal by Subject|10|||
162864066|NCT05243550|588207298|FG000|Overall Study|Lost to Follow-up|7|||
162864067|NCT05243550|588207298|FG000|Overall Study|Adverse Event|3|||
162864068|NCT05243550|588207298|FG000|Overall Study|Noncompliance|1|||
162864069|NCT05243550|588207298|FG000|Overall Study|Physician Decision|1|||
162864070|NCT05243550|588207298|FG000|Overall Study|Other Reason|4|||
162864071|NCT02031146|588207301|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
162864072|NCT02031146|588207302|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
162864073|NCT02031146|588207303|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
162864074|NCT02031146|588207304|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
162864075|NCT02031146|588207305|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
162864076|NCT02031146|588207306|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
162864077|NCT02031146|588207307|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
162864078|NCT01486316|588207308|FG000|Overall Study|Device explanted with/without re-implant|3|||
162864079|NCT01486316|588207309|FG001|Overall Study|Device explanted with/without re-implant|2|||
162864080|NCT01486316|588207310|FG002|Overall Study|Device explanted with/without re-implant|0|||
162864081|NCT01486316|588207311|FG003|Overall Study|Device explanted with/without re-implant|2|||
162864082|NCT01486316|588207308|FG000|Overall Study|Not meeting eligibility criteria|0|||
162864083|NCT01486316|588207309|FG001|Overall Study|Not meeting eligibility criteria|0|||
162864084|NCT01486316|588207310|FG002|Overall Study|Not meeting eligibility criteria|1|||
162864085|NCT01486316|588207311|FG003|Overall Study|Not meeting eligibility criteria|0|||
162864086|NCT01486316|588207308|FG000|Overall Study|Withdrawal by Subject|1|||
162864087|NCT01486316|588207309|FG001|Overall Study|Withdrawal by Subject|0|||
162864088|NCT01486316|588207310|FG002|Overall Study|Withdrawal by Subject|3|||
162864089|NCT01486316|588207311|FG003|Overall Study|Withdrawal by Subject|0|||
162864090|NCT01486316|588207308|FG000|Overall Study|Physician Decision|0|||
162864091|NCT01486316|588207309|FG001|Overall Study|Physician Decision|0|||
162864092|NCT01486316|588207310|FG002|Overall Study|Physician Decision|1|||
162864093|NCT01486316|588207311|FG003|Overall Study|Physician Decision|0|||
162864094|NCT01486316|588207308|FG000|Overall Study|Death|0|||
162864095|NCT01486316|588207309|FG001|Overall Study|Death|1|||
162864096|NCT01486316|588207310|FG002|Overall Study|Death|0|||
162864097|NCT01486316|588207311|FG003|Overall Study|Death|0|||
162864098|NCT02452970|588207319|FG000|Overall Study|Adverse Event|1|||
162864099|NCT02100657|588207320|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
162864100|NCT02100657|588207321|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
162864101|NCT02100657|588207322|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
162864102|NCT02100657|588207320|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
162864103|NCT02100657|588207321|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
162864104|NCT02100657|588207322|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
162864105|NCT02100657|588207320|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
162864106|NCT02100657|588207321|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
162864107|NCT02100657|588207322|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
162864108|NCT02100657|588207320|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
162864109|NCT02100657|588207321|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
162864110|NCT02100657|588207322|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
162864111|NCT02100657|588207320|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
162864112|NCT02100657|588207321|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
162864113|NCT02100657|588207322|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
162864114|NCT02100657|588207320|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
162864115|NCT02100657|588207321|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
162864116|NCT02100657|588207322|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
162864117|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
162864118|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
162864119|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
162864120|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Death|0|||
162864121|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Death|0|||
162864122|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Death|1|||
162864123|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
162864124|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
162864125|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
162864126|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
162864127|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
162864128|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
162864129|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
162864130|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
162864131|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
162864132|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
162864133|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
162864134|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
162864135|NCT02100657|588207320|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
162864136|NCT02100657|588207321|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
162864137|NCT02100657|588207322|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
162864138|NCT02531035|588207323|FG000|Overall Study|Death|0|||
162864139|NCT02531035|588207324|FG001|Overall Study|Death|1|||
162864140|NCT02531035|588207323|FG000|Overall Study|Protocol Violation|1|||
162864141|NCT02531035|588207324|FG001|Overall Study|Protocol Violation|1|||
162864142|NCT02531035|588207323|FG000|Overall Study|Noncompliance with study drug|8|||
162864143|NCT02531035|588207324|FG001|Overall Study|Noncompliance with study drug|3|||
162864144|NCT02531035|588207323|FG000|Overall Study|Physician Decision|1|||
162864145|NCT02531035|588207324|FG001|Overall Study|Physician Decision|0|||
162864146|NCT02531035|588207323|FG000|Overall Study|Adverse Event|16|||
162864147|NCT02531035|588207324|FG001|Overall Study|Adverse Event|45|||
162864148|NCT02531035|588207323|FG000|Overall Study|Other|3|||
162864149|NCT02531035|588207324|FG001|Overall Study|Other|2|||
162864150|NCT02531035|588207323|FG000|Overall Study|Withdrawal by Subject|42|||
162864151|NCT02531035|588207324|FG001|Overall Study|Withdrawal by Subject|32|||
162864152|NCT02531035|588207323|FG000|Overall Study|Lost to Follow-up|8|||
162864153|NCT02531035|588207324|FG001|Overall Study|Lost to Follow-up|10|||
162864154|NCT02531035|588207323|FG000|Overall Study|Randomized, not treated|2|||
162864155|NCT02531035|588207324|FG001|Overall Study|Randomized, not treated|1|||
162864156|NCT01266148|588207325|FG000|Overall Study|Adverse Event|2|||
162864157|NCT01266148|588207326|FG001|Overall Study|Adverse Event|0|||
162864158|NCT01266148|588207325|FG000|Overall Study|Ongoing rejection|1|||
162864159|NCT01266148|588207326|FG001|Overall Study|Ongoing rejection|0|||
162864160|NCT01266148|588207325|FG000|Overall Study|2 2R rejections|1|||
162864161|NCT01266148|588207326|FG001|Overall Study|2 2R rejections|0|||
162864162|NCT01266148|588207325|FG000|Overall Study|Death|2|||
162864163|NCT01266148|588207326|FG001|Overall Study|Death|3|||
162864164|NCT01266148|588207325|FG000|Overall Study|missing mGFR value + AE|1|||
162864165|NCT01266148|588207326|FG001|Overall Study|missing mGFR value + AE|0|||
162864166|NCT01543490|588207327|FG000|Overall Study|Adverse Event|4|||
162864167|NCT01543490|588207328|FG001|Overall Study|Adverse Event|0|||
162864168|NCT01543490|588207327|FG000|Overall Study|Physician Decision|1|||
162864169|NCT01543490|588207328|FG001|Overall Study|Physician Decision|0|||
162864170|NCT01543490|588207327|FG000|Overall Study|Lack of Efficacy|3|||
162864171|NCT01543490|588207328|FG001|Overall Study|Lack of Efficacy|3|||
162864172|NCT01543490|588207327|FG000|Overall Study|Lost to Follow-up|5|||
162864173|NCT01543490|588207328|FG001|Overall Study|Lost to Follow-up|0|||
162864174|NCT01543490|588207327|FG000|Overall Study|Withdrawal by Subject|2|||
162864175|NCT01543490|588207328|FG001|Overall Study|Withdrawal by Subject|0|||
162864176|NCT01543490|588207327|FG000|Overall Study|Other-Various Administrative Reasons|1|||
162864177|NCT01543490|588207328|FG001|Overall Study|Other-Various Administrative Reasons|2|||
162864178|NCT01712438|588207337|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
162864179|NCT01712438|588207337|FG000|Overall Study|Ongoing ITI treatment|6|||
162864180|NCT01712438|588207337|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
162864181|NCT01712438|588207337|FG000|Overall Study|Prematurely Discontinued|25|||
162864182|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
162864183|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
162864184|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
163046127|NCT01223404|588877306|FG005|First Intervention (1 Day)|Adverse Event|0|||
163046128|NCT01223404|588877301|FG000|Second Intervention (1 Day)|Adverse Event|1|||
163046129|NCT01223404|588877302|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163046130|NCT01223404|588877303|FG002|Second Intervention (1 Day)|Adverse Event|0|||
162864185|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
162864186|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
162864187|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
162864188|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
162864189|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
162864190|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
162864191|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
162864192|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
163046131|NCT01223404|588877304|FG003|Second Intervention (1 Day)|Adverse Event|0|||
163046132|NCT01223404|588877305|FG004|Second Intervention (1 Day)|Adverse Event|0|||
163046133|NCT01223404|588877306|FG005|Second Intervention (1 Day)|Adverse Event|0|||
163046134|NCT01223404|588877301|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163046135|NCT01223404|588877302|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
162864193|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
162864194|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
162864195|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
162864196|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
162864197|NCT01330381|588207338|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
162864198|NCT01330381|588207339|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
162864199|NCT01330381|588207340|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
162864200|NCT01330381|588207338|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
162864201|NCT01330381|588207339|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
163046136|NCT01223404|588877303|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
162864202|NCT01330381|588207340|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
162864203|NCT01330381|588207338|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
162864204|NCT01330381|588207339|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
162864205|NCT01330381|588207340|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
162864206|NCT01330381|588207338|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
162864207|NCT01330381|588207339|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
162864208|NCT01330381|588207340|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
162864209|NCT01330381|588207338|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
162864210|NCT01330381|588207339|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
162864211|NCT01330381|588207340|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
162864212|NCT01335971|588207343|FG000|Overall Study|Withdrawal by Subject|1|||
162864213|NCT01335971|588207344|FG001|Overall Study|Withdrawal by Subject|0|||
162864214|NCT01335971|588207345|FG002|Overall Study|Withdrawal by Subject|0|||
162864215|NCT01335971|588207343|FG000|Overall Study|Did not complete bronchoscopy|1|||
162864216|NCT01335971|588207344|FG001|Overall Study|Did not complete bronchoscopy|1|||
162864217|NCT01335971|588207345|FG002|Overall Study|Did not complete bronchoscopy|1|||
162864218|NCT01183858|588207346|FG000|Overall Study|Death not related to Progressive Disease|5|||
162864219|NCT01183858|588207347|FG001|Overall Study|Death not related to Progressive Disease|6|||
162864220|NCT01183858|588207346|FG000|Overall Study|Adverse Event|14|||
162864221|NCT01183858|588207347|FG001|Overall Study|Adverse Event|11|||
162864222|NCT01183858|588207346|FG000|Overall Study|Investigator's Decision|0|||
162864223|NCT01183858|588207347|FG001|Overall Study|Investigator's Decision|3|||
162864224|NCT01183858|588207346|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162864225|NCT01183858|588207347|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162864226|NCT01183858|588207346|FG000|Overall Study|Refused Treatment|1|||
162864227|NCT01183858|588207347|FG001|Overall Study|Refused Treatment|4|||
162864228|NCT01183858|588207346|FG000|Overall Study|Withdrew Consent|4|||
162864229|NCT01183858|588207347|FG001|Overall Study|Withdrew Consent|4|||
162864230|NCT01183858|588207346|FG000|Overall Study|Discontinued Smoking|3|||
162864231|NCT01183858|588207347|FG001|Overall Study|Discontinued Smoking|1|||
162864232|NCT01183858|588207346|FG000|Overall Study|Protocol Violation|1|||
162864233|NCT01183858|588207347|FG001|Overall Study|Protocol Violation|0|||
162864234|NCT01183858|588207346|FG000|Overall Study|Administrative/Other|6|||
162864235|NCT01183858|588207347|FG001|Overall Study|Administrative/Other|6|||
162864236|NCT01183858|588207346|FG000|Overall Study|Progressive Disease|112|||
162864237|NCT01183858|588207347|FG001|Overall Study|Progressive Disease|115|||
162864238|NCT01183858|588207346|FG000|Overall Study|Death related to Progressive Disease|4|||
162864239|NCT01183858|588207347|FG001|Overall Study|Death related to Progressive Disease|5|||
162864240|NCT01183858|588207346|FG000|Overall Study|Lost to Follow-up|1|||
162864241|NCT01183858|588207347|FG001|Overall Study|Lost to Follow-up|1|||
162864242|NCT00414440|588207348|FG000|Core Period|Withdrawal by Subject|70|||
162864243|NCT00414440|588207349|FG001|Core Period|Withdrawal by Subject|32|||
162864244|NCT00414440|588207348|FG000|Extension Period|Lost to Follow-up|44|||
162864245|NCT00414440|588207349|FG001|Extension Period|Lost to Follow-up|52|||
162864246|NCT00414440|588207348|FG000|Extension Period|Did not consent to continue follow up|61|||
162864247|NCT00414440|588207349|FG001|Extension Period|Did not consent to continue follow up|54|||
162864248|NCT00414440|588207348|FG000|Extension Period|Other|1|||
162864249|NCT00414440|588207349|FG001|Extension Period|Other|1|||
162864250|NCT00414440|588207348|FG000|Extension Period|Administrative|16|||
162864251|NCT00414440|588207349|FG001|Extension Period|Administrative|16|||
162864252|NCT00414440|588207348|FG000|Extension Period|Death|1|||
162864253|NCT00414440|588207349|FG001|Extension Period|Death|2|||
162864254|NCT00414440|588207348|FG000|Extension Period|Withdrawal by Subject|9|||
162864255|NCT00414440|588207349|FG001|Extension Period|Withdrawal by Subject|7|||
162864256|NCT00414440|588207348|FG000|Extension Period|Not included in follow up period|18|||
162864257|NCT00414440|588207349|FG001|Extension Period|Not included in follow up period|8|||
162864258|NCT00138151|588207350|FG000|Overall Study|Withdrawal by Subject|3|||
162864259|NCT00138151|588207350|FG000|Overall Study|Physician Decision|1|||
162864260|NCT04925570|588207353|FG000|Overall Study|Protocol Violation|24|||
162864261|NCT04925570|588207354|FG001|Overall Study|Protocol Violation|30|||
162864262|NCT04925570|588207353|FG000|Overall Study|Withdrawal by Subject|0|||
162864263|NCT04925570|588207354|FG001|Overall Study|Withdrawal by Subject|2|||
162864264|NCT01088412|588207355|FG000|Overall Study|Adverse Event|38|||
162864265|NCT01088412|588207356|FG001|Overall Study|Adverse Event|0|||
162864266|NCT01088412|588207357|FG002|Overall Study|Adverse Event|0|||
162864267|NCT01088412|588207355|FG000|Overall Study|Death|42|||
162864268|NCT01088412|588207356|FG001|Overall Study|Death|6|||
162864269|NCT01088412|588207357|FG002|Overall Study|Death|0|||
162864270|NCT01088412|588207355|FG000|Overall Study|Other Reason per Case Report Form|2089|||
162864271|NCT01088412|588207356|FG001|Overall Study|Other Reason per Case Report Form|103|||
162864272|NCT01088412|588207357|FG002|Overall Study|Other Reason per Case Report Form|9|||
162864273|NCT01088412|588207355|FG000|Overall Study|Withdrawal by Subject|1761|||
162864274|NCT01088412|588207356|FG001|Overall Study|Withdrawal by Subject|25|||
162864275|NCT01088412|588207357|FG002|Overall Study|Withdrawal by Subject|1|||
162864276|NCT01088412|588207355|FG000|Overall Study|Received Another GH Product|79|||
162864277|NCT01088412|588207356|FG001|Overall Study|Received Another GH Product|0|||
162864278|NCT01088412|588207357|FG002|Overall Study|Received Another GH Product|0|||
162864279|NCT01088412|588207355|FG000|Overall Study|Participant Moved|601|||
162864280|NCT01088412|588207356|FG001|Overall Study|Participant Moved|21|||
162864281|NCT01088412|588207357|FG002|Overall Study|Participant Moved|2|||
162864282|NCT01088412|588207355|FG000|Overall Study|Physician Decision|1041|||
162864283|NCT01088412|588207356|FG001|Overall Study|Physician Decision|8|||
162864284|NCT01088412|588207357|FG002|Overall Study|Physician Decision|4|||
162864285|NCT01088412|588207355|FG000|Overall Study|Sponsor Decision|4467|||
162864286|NCT01088412|588207356|FG001|Overall Study|Sponsor Decision|79|||
162864287|NCT01088412|588207357|FG002|Overall Study|Sponsor Decision|23|||
162864288|NCT01088412|588207355|FG000|Overall Study|Third Party Required to Change Brand|487|||
162864289|NCT01088412|588207356|FG001|Overall Study|Third Party Required to Change Brand|0|||
162864290|NCT01088412|588207357|FG002|Overall Study|Third Party Required to Change Brand|0|||
162864291|NCT01088412|588207355|FG000|Overall Study|Lost to Follow-up|3052|||
162864292|NCT01088412|588207356|FG001|Overall Study|Lost to Follow-up|130|||
162706113|NCT01511536|587636536|FG002|Phase 2|Other|9|||
162706114|NCT01764386|587636540|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
162864293|NCT01088412|588207357|FG002|Overall Study|Lost to Follow-up|11|||
162864294|NCT01088412|588207355|FG000|Overall Study|Study Summary Not Completed|4360|||
162864295|NCT01088412|588207356|FG001|Overall Study|Study Summary Not Completed|64|||
162864296|NCT01088412|588207357|FG002|Overall Study|Study Summary Not Completed|22|||
162864297|NCT00793104|588207358|FG000|Overall Study|Lost to Follow-up|1|||
162864298|NCT03494725|588207361|FG000|Overall Study|Withdrawal by Subject|0|||
162864299|NCT03494725|588207362|FG001|Overall Study|Withdrawal by Subject|2|||
162864300|NCT03494725|588207361|FG000|Overall Study|Antibiotic use|1|||
162864301|NCT03494725|588207362|FG001|Overall Study|Antibiotic use|0|||
162864302|NCT02619253|588207363|FG000|Overall Study|Adverse Event|0|||
162864303|NCT02619253|588207364|FG001|Overall Study|Adverse Event|0|||
162864304|NCT02619253|588207365|FG002|Overall Study|Adverse Event|1|||
162864305|NCT02619253|588207366|FG003|Overall Study|Adverse Event|1|||
162864306|NCT02619253|588207367|FG004|Overall Study|Adverse Event|3|||
162864307|NCT02619253|588207363|FG000|Overall Study|Alternative Therapy|0|||
162864308|NCT02619253|588207364|FG001|Overall Study|Alternative Therapy|0|||
162864309|NCT02619253|588207365|FG002|Overall Study|Alternative Therapy|1|||
162864310|NCT02619253|588207366|FG003|Overall Study|Alternative Therapy|0|||
162864311|NCT02619253|588207367|FG004|Overall Study|Alternative Therapy|0|||
162864312|NCT02619253|588207363|FG000|Overall Study|Death|0|||
162864313|NCT02619253|588207364|FG001|Overall Study|Death|0|||
162864314|NCT02619253|588207365|FG002|Overall Study|Death|0|||
162864315|NCT02619253|588207366|FG003|Overall Study|Death|1|||
162864316|NCT02619253|588207367|FG004|Overall Study|Death|0|||
162864317|NCT02619253|588207363|FG000|Overall Study|Disease Progression|4|||
162864318|NCT02619253|588207364|FG001|Overall Study|Disease Progression|2|||
162864319|NCT02619253|588207365|FG002|Overall Study|Disease Progression|8|||
162864320|NCT02619253|588207366|FG003|Overall Study|Disease Progression|9|||
162864321|NCT02619253|588207367|FG004|Overall Study|Disease Progression|10|||
162864322|NCT02619253|588207363|FG000|Overall Study|Needed a disqualifying therapy|0|||
162864323|NCT02619253|588207364|FG001|Overall Study|Needed a disqualifying therapy|0|||
162864324|NCT02619253|588207365|FG002|Overall Study|Needed a disqualifying therapy|1|||
162864325|NCT02619253|588207366|FG003|Overall Study|Needed a disqualifying therapy|0|||
162864326|NCT02619253|588207367|FG004|Overall Study|Needed a disqualifying therapy|0|||
162864327|NCT02619253|588207363|FG000|Overall Study|Transferred to hospice|0|||
162864328|NCT02619253|588207364|FG001|Overall Study|Transferred to hospice|0|||
162864329|NCT02619253|588207365|FG002|Overall Study|Transferred to hospice|1|||
162864330|NCT02619253|588207366|FG003|Overall Study|Transferred to hospice|0|||
162864331|NCT02619253|588207367|FG004|Overall Study|Transferred to hospice|0|||
162864332|NCT02619253|588207363|FG000|Overall Study|Physician Decision|0|||
162864333|NCT02619253|588207364|FG001|Overall Study|Physician Decision|1|||
162864334|NCT02619253|588207365|FG002|Overall Study|Physician Decision|2|||
162864335|NCT02619253|588207366|FG003|Overall Study|Physician Decision|3|||
162864336|NCT02619253|588207367|FG004|Overall Study|Physician Decision|0|||
162864337|NCT02619253|588207363|FG000|Overall Study|Withdrawal by Subject|0|||
162864338|NCT02619253|588207364|FG001|Overall Study|Withdrawal by Subject|1|||
163046137|NCT01223404|588877304|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
163046138|NCT01223404|588877305|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
162706115|NCT01764386|587636541|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
162864339|NCT02619253|588207365|FG002|Overall Study|Withdrawal by Subject|0|||
162864340|NCT02619253|588207366|FG003|Overall Study|Withdrawal by Subject|0|||
162864341|NCT02619253|588207367|FG004|Overall Study|Withdrawal by Subject|2|||
162864342|NCT02111811|588207368|FG000|Treatment Phase|Lost to Follow-up|22|||
162864343|NCT02111811|588207369|FG001|Treatment Phase|Lost to Follow-up|18|||
162864344|NCT02111811|588207368|FG000|Treatment Phase|Death|2|||
162864345|NCT02111811|588207369|FG001|Treatment Phase|Death|0|||
162864346|NCT02111811|588207368|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
162864347|NCT02111811|588207369|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
162864348|NCT02111811|588207368|FG000|Follow up Period (Aim 2)|Death|2|||
162864349|NCT02111811|588207369|FG001|Follow up Period (Aim 2)|Death|0|||
162864350|NCT01359982|588207370|FG000|Overall Study|Adverse Event|2|||
162864351|NCT01359982|588207371|FG001|Overall Study|Adverse Event|0|||
162864352|NCT01359982|588207372|FG002|Overall Study|Adverse Event|0|||
162864353|NCT01359982|588207373|FG003|Overall Study|Adverse Event|1|||
162864354|NCT01359982|588207374|FG004|Overall Study|Adverse Event|0|||
162864355|NCT01359982|588207375|FG005|Overall Study|Adverse Event|0|||
162864356|NCT01359982|588207370|FG000|Overall Study|Death|1|||
162864357|NCT01359982|588207371|FG001|Overall Study|Death|0|||
162864358|NCT01359982|588207372|FG002|Overall Study|Death|0|||
162864359|NCT01359982|588207373|FG003|Overall Study|Death|0|||
162864360|NCT01359982|588207374|FG004|Overall Study|Death|0|||
162864361|NCT01359982|588207375|FG005|Overall Study|Death|0|||
162864362|NCT05593432|588207376|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
162864363|NCT05593432|588207377|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
162864364|NCT05593432|588207378|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
162864365|NCT05593432|588207379|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
162864366|NCT05593432|588207376|FG000|16-Week OLE Period|Lack of Efficacy|0|||
162864367|NCT05593432|588207377|FG001|16-Week OLE Period|Lack of Efficacy|0|||
162864368|NCT05593432|588207378|FG002|16-Week OLE Period|Lack of Efficacy|0|||
162864369|NCT05593432|588207379|FG003|16-Week OLE Period|Lack of Efficacy|1|||
162864370|NCT05593432|588207376|FG000|16-Week OLE Period|Lost to Follow-up|0|||
162864371|NCT05593432|588207377|FG001|16-Week OLE Period|Lost to Follow-up|0|||
162864372|NCT05593432|588207378|FG002|16-Week OLE Period|Lost to Follow-up|1|||
162864373|NCT05593432|588207379|FG003|16-Week OLE Period|Lost to Follow-up|2|||
162864374|NCT05593432|588207376|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
162864375|NCT05593432|588207377|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
162864376|NCT05593432|588207378|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
162864377|NCT05593432|588207379|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
162864378|NCT01450137|588207381|FG000|Up to Week 12|Adverse Event|2|||
162864379|NCT01450137|588207382|FG001|Up to Week 12|Adverse Event|1|||
162864380|NCT01450137|588207381|FG000|Up to Week 12|Withdrawal by Subject|0|||
162864381|NCT01450137|588207382|FG001|Up to Week 12|Withdrawal by Subject|2|||
162864382|NCT01450137|588207381|FG000|Week 12 to Study End|Death|0|||
162864383|NCT01450137|588207382|FG001|Week 12 to Study End|Death|1|||
162864384|NCT01450137|588207381|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
162864385|NCT01450137|588207382|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
162864386|NCT01926886|588207383|FG000|Overall Study|Administrative/other|1|||
162864387|NCT01926886|588207384|FG001|Overall Study|Administrative/other|0|||
162864388|NCT01926886|588207383|FG000|Overall Study|Adverse event/intercurrent illness|4|||
162864389|NCT01926886|588207384|FG001|Overall Study|Adverse event/intercurrent illness|0|||
162864390|NCT01926886|588207383|FG000|Overall Study|Disease progression/recurrence|4|||
162864391|NCT01926886|588207384|FG001|Overall Study|Disease progression/recurrence|0|||
162864392|NCT01926886|588207383|FG000|Overall Study|Withdrawal by Subject|15|||
162864393|NCT01926886|588207384|FG001|Overall Study|Withdrawal by Subject|0|||
162864394|NCT01926886|588207383|FG000|Overall Study|Failure to return|3|||
162958691|NCT00392665|588551600|FG001|Overall Study|Lost to Follow-up|1|||
162958692|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
162958693|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958694|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958695|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958696|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162958697|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
162864395|NCT01926886|588207384|FG001|Overall Study|Failure to return|0|||
162864396|NCT01926886|588207383|FG000|Overall Study|Recurrence of disease|1|||
162864397|NCT01926886|588207384|FG001|Overall Study|Recurrence of disease|0|||
162864398|NCT01926886|588207383|FG000|Overall Study|Progression of disease|2|||
162864399|NCT01926886|588207384|FG001|Overall Study|Progression of disease|0|||
162864400|NCT01926886|588207383|FG000|Overall Study|Death|1|||
162864401|NCT01926886|588207384|FG001|Overall Study|Death|0|||
162958698|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958699|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958700|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
162958701|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958702|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
162864402|NCT01926886|588207383|FG000|Overall Study|Did not cooperate|1|||
162864403|NCT01926886|588207384|FG001|Overall Study|Did not cooperate|0|||
163046139|NCT01223404|588877306|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
163046140|NCT00707057|588877307|FG000|Overall Study|Withdrawal by Subject|8|||
163046141|NCT00707057|588877308|FG001|Overall Study|Withdrawal by Subject|3|||
163046142|NCT00707057|588877307|FG000|Overall Study|Dosed incorrectly|0|||
163046143|NCT00707057|588877308|FG001|Overall Study|Dosed incorrectly|1|||
163046144|NCT02492165|588877309|FG000|Overall Study|Withdrawal by Subject|0|||
163046145|NCT02492165|588877310|FG001|Overall Study|Withdrawal by Subject|1|||
163046146|NCT02492165|588877311|FG002|Overall Study|Withdrawal by Subject|0|||
163046147|NCT02492165|588877312|FG003|Overall Study|Withdrawal by Subject|0|||
163046148|NCT01697800|588877313|FG000|Overall Study|Death|0|||
163046149|NCT01697800|588877314|FG001|Overall Study|Death|1|||
163046150|NCT00954122|588877315|FG000|Overall Study|Withdrawal by Subject|5|||
163046151|NCT00954122|588877315|FG000|Overall Study|Adverse Event|1|||
163046152|NCT00954122|588877315|FG000|Overall Study|Safety Reason|1|||
163046153|NCT00823134|588877324|FG000|Overall Study|Invalid measurement|1|||
163046154|NCT03316586|588877333|FG000|Overall Study|Adverse Event|2|||
163046155|NCT03316586|588877333|FG000|Overall Study|Physician Decision|3|||
163046156|NCT03316586|588877333|FG000|Overall Study|Lack of Efficacy|10|||
163046157|NCT03316586|588877333|FG000|Overall Study|still on treatment|1|||
163046158|NCT03316586|588877333|FG000|Overall Study|Patient needed radiation therapy|1|||
163046159|NCT03316586|588877333|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
163046160|NCT00994110|588877334|FG000|Overall Study|Withdrawal by Subject|9|||
163046161|NCT00994110|588877335|FG001|Overall Study|Withdrawal by Subject|9|||
163046162|NCT00994110|588877334|FG000|Overall Study|Not Treated|4|||
163046163|NCT00994110|588877335|FG001|Overall Study|Not Treated|8|||
163046164|NCT00994110|588877334|FG000|Overall Study|Adverse Event|1|||
163046165|NCT00994110|588877335|FG001|Overall Study|Adverse Event|0|||
163046166|NCT00994110|588877334|FG000|Overall Study|Patient not resected|41|||
163046167|NCT00994110|588877335|FG001|Overall Study|Patient not resected|52|||
163046168|NCT00994110|588877334|FG000|Overall Study|Pt not eligible|10|||
163046169|NCT00994110|588877335|FG001|Overall Study|Pt not eligible|5|||
163046170|NCT00619827|588877336|FG000|Overall Study|Adverse Event|1|||
163046171|NCT00619827|588877337|FG001|Overall Study|Adverse Event|2|||
163046172|NCT00619827|588877336|FG000|Overall Study|Withdrawal by Subject|2|||
163046173|NCT00619827|588877337|FG001|Overall Study|Withdrawal by Subject|2|||
163046174|NCT02163395|588877338|FG000|Overall Study|Withdrawal by Subject|1|||
163046175|NCT02163395|588877338|FG000|Overall Study|Lost to Follow-up|3|||
163046176|NCT02163395|588877338|FG000|Overall Study|Adverse Event|1|||
163046177|NCT02999789|588877339|FG000|Overall Study|Withdrawal by Subject|0|||
163046178|NCT02999789|588877340|FG001|Overall Study|Withdrawal by Subject|1|||
163046179|NCT02999789|588877339|FG000|Overall Study|Became ineligible|1|||
163046180|NCT02999789|588877340|FG001|Overall Study|Became ineligible|2|||
163046181|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
163046182|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046183|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046184|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046185|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
163046186|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
163046187|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046188|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046189|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046190|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
163046191|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
163046192|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046193|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046194|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046195|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
163046196|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
163046197|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046198|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046199|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046200|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
163046201|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
163046202|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046203|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046204|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046205|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
163046206|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
163046207|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
163046208|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
163046209|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
162864404|NCT00069121|588207385|FG000|Overall Study|Death|286|||
162864405|NCT00069121|588207386|FG001|Overall Study|Death|242|||
162864406|NCT00069121|588207385|FG000|Overall Study|Withdrawal by Subject|18|||
162864407|NCT00069121|588207386|FG001|Overall Study|Withdrawal by Subject|20|||
162864408|NCT00069121|588207385|FG000|Overall Study|Lost to Follow-up|63|||
162864409|NCT00069121|588207386|FG001|Overall Study|Lost to Follow-up|63|||
162864410|NCT02986373|588207387|FG000|Overall Study|Adverse Event|4|||
162864411|NCT02986373|588207387|FG000|Overall Study|Lost to Follow-up|1|||
162864412|NCT02986373|588207387|FG000|Overall Study|Withdrawal by Subject|10|||
162864413|NCT02986373|588207387|FG000|Overall Study|Other|24|||
162864414|NCT04800315|588207388|FG000|Randomization|Did not receive study treatment|1|||
162864415|NCT04800315|588207389|FG001|Randomization|Did not receive study treatment|0|||
162864416|NCT04800315|588207390|FG002|Randomization|Did not receive study treatment|0|||
162864417|NCT04800315|588207391|FG003|Randomization|Did not receive study treatment|0|||
162864418|NCT04800315|588207388|FG000|Treatment Period|Adverse Event|4|||
162864419|NCT04800315|588207389|FG001|Treatment Period|Adverse Event|2|||
162864420|NCT04800315|588207390|FG002|Treatment Period|Adverse Event|1|||
162864421|NCT04800315|588207391|FG003|Treatment Period|Adverse Event|2|||
162864422|NCT04800315|588207388|FG000|Treatment Period|Lack of Efficacy|1|||
162864423|NCT04800315|588207389|FG001|Treatment Period|Lack of Efficacy|0|||
162864424|NCT04800315|588207390|FG002|Treatment Period|Lack of Efficacy|0|||
162864425|NCT04800315|588207391|FG003|Treatment Period|Lack of Efficacy|3|||
162864426|NCT04800315|588207388|FG000|Treatment Period|Lost to Follow-up|0|||
162864427|NCT04800315|588207389|FG001|Treatment Period|Lost to Follow-up|1|||
162864428|NCT04800315|588207390|FG002|Treatment Period|Lost to Follow-up|2|||
162864429|NCT04800315|588207391|FG003|Treatment Period|Lost to Follow-up|2|||
162864430|NCT04800315|588207388|FG000|Treatment Period|Withdrawal by participant|0|||
162924306|NCT00518011|588423857|FG000|Overall Study|Adverse Event|2|||
162924307|NCT00518011|588423858|FG001|Overall Study|Adverse Event|3|||
162924308|NCT00518011|588423857|FG000|Overall Study|Disease Progression|2|||
162924309|NCT00518011|588423858|FG001|Overall Study|Disease Progression|2|||
162924310|NCT00518011|588423857|FG000|Overall Study|Other Reasons|3|||
162924311|NCT00518011|588423858|FG001|Overall Study|Other Reasons|2|||
162924312|NCT00518011|588423857|FG000|Overall Study|Withdrawal by Subject|1|||
162924313|NCT00518011|588423858|FG001|Overall Study|Withdrawal by Subject|0|||
162924314|NCT02998645|588423859|FG000|Treatment Period 1|Adverse Event|6|||
162924315|NCT02998645|588423859|FG000|Treatment Period 1|Death|5|||
162924316|NCT02998645|588423859|FG000|Treatment Period 1|Technical Problems|4|||
162924317|NCT02998645|588423859|FG000|Treatment Period 1|Lack of Efficacy|2|||
162924318|NCT02998645|588423859|FG000|Treatment Period 1|Progressive disease|1|||
162924319|NCT02998645|588423859|FG000|Treatment Period 1|Subject/guardian decision|1|||
162924320|NCT02998645|588423859|FG000|Treatment Period 2|Lack of Efficacy|5|||
162924321|NCT02998645|588423859|FG000|Treatment Period 2|Adverse Event|2|||
162924322|NCT02998645|588423859|FG000|Treatment Period 2|Progressive disease|2|||
162924323|NCT02998645|588423859|FG000|Treatment Period 2|Physician Decision|1|||
162924324|NCT00090259|588423860|FG000|Overall Study|Lost to Follow-up|30|||
162924325|NCT00090259|588423861|FG001|Overall Study|Lost to Follow-up|26|||
162924326|NCT00090259|588423860|FG000|Overall Study|Withdrawal by Subject|21|||
162924327|NCT00090259|588423861|FG001|Overall Study|Withdrawal by Subject|15|||
162924328|NCT00090259|588423860|FG000|Overall Study|Investigator site closed|11|||
162924329|NCT00090259|588423861|FG001|Overall Study|Investigator site closed|7|||
162924330|NCT03701516|588423862|FG000|Period 1|Lost to Follow-up|0|||
162924331|NCT03701516|588423863|FG001|Period 1|Lost to Follow-up|1|||
162924332|NCT03701516|588423862|FG000|Period 1|Adverse Event|0|||
162924333|NCT03701516|588423863|FG001|Period 1|Adverse Event|2|||
162924334|NCT03701516|588423862|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
162924335|NCT03701516|588423863|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
162924336|NCT03701516|588423862|FG000|Period 1|Non Compliance to Protocol|2|||
162924337|NCT03701516|588423863|FG001|Period 1|Non Compliance to Protocol|1|||
162924338|NCT03701516|588423862|FG000|Period 1|Withdrawal by Subject|0|||
162924339|NCT03701516|588423863|FG001|Period 1|Withdrawal by Subject|1|||
162924340|NCT03701516|588423862|FG000|Period 2|failed to meet all eligibility creiteria|1|||
162924341|NCT03701516|588423863|FG001|Period 2|failed to meet all eligibility creiteria|0|||
162924342|NCT03701516|588423862|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
162924343|NCT03701516|588423863|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
162924344|NCT03644927|588423869|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
162924345|NCT03644927|588423870|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
162924346|NCT00956813|588423871|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
162924347|NCT00956813|588423872|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
162924348|NCT00956813|588423871|FG000|Flaxseed and Placebo|Ineligible|3|||
162924349|NCT00956813|588423872|FG001|Flaxseed and Placebo|Ineligible|1|||
162924350|NCT04797637|588423873|FG000|Overall Study|Lost to Follow-up|23|||
162924351|NCT04797637|588423874|FG001|Overall Study|Lost to Follow-up|32|||
162924352|NCT04797637|588423873|FG000|Overall Study|Withdrawal by Subject|0|||
162864431|NCT04800315|588207389|FG001|Treatment Period|Withdrawal by participant|0|||
162864432|NCT04800315|588207390|FG002|Treatment Period|Withdrawal by participant|0|||
162864433|NCT04800315|588207391|FG003|Treatment Period|Withdrawal by participant|4|||
162864434|NCT04800315|588207388|FG000|Treatment Period|Other Reasons|0|||
162864435|NCT04800315|588207389|FG001|Treatment Period|Other Reasons|2|||
162864436|NCT04800315|588207390|FG002|Treatment Period|Other Reasons|0|||
162864437|NCT04800315|588207391|FG003|Treatment Period|Other Reasons|1|||
162864438|NCT00753922|588207392|FG000|Overall Study|Lost to Follow-up|155|||
162864439|NCT00753922|588207393|FG001|Overall Study|Lost to Follow-up|24|||
162864440|NCT00753922|588207394|FG002|Overall Study|Lost to Follow-up|28|||
162864441|NCT00753922|588207395|FG003|Overall Study|Lost to Follow-up|5|||
162864442|NCT00753922|588207392|FG000|Overall Study|Withdrawal by Subject|9|||
162864443|NCT00753922|588207393|FG001|Overall Study|Withdrawal by Subject|11|||
162864444|NCT00753922|588207394|FG002|Overall Study|Withdrawal by Subject|4|||
162864445|NCT00753922|588207395|FG003|Overall Study|Withdrawal by Subject|2|||
162864446|NCT00753922|588207392|FG000|Overall Study|Patient Non-compliance|55|||
162864447|NCT00753922|588207393|FG001|Overall Study|Patient Non-compliance|22|||
162864448|NCT00753922|588207394|FG002|Overall Study|Patient Non-compliance|14|||
162864449|NCT00753922|588207395|FG003|Overall Study|Patient Non-compliance|11|||
162864450|NCT00753922|588207392|FG000|Overall Study|Patients Not Completing Visit|11|||
162864451|NCT00753922|588207393|FG001|Overall Study|Patients Not Completing Visit|0|||
162864452|NCT00753922|588207394|FG002|Overall Study|Patients Not Completing Visit|1|||
162864453|NCT00753922|588207395|FG003|Overall Study|Patients Not Completing Visit|0|||
162864454|NCT00753922|588207392|FG000|Overall Study|Death|2|||
162864455|NCT00753922|588207393|FG001|Overall Study|Death|23|||
162864456|NCT00753922|588207394|FG002|Overall Study|Death|2|||
162864457|NCT00753922|588207395|FG003|Overall Study|Death|1|||
162864458|NCT00753922|588207392|FG000|Overall Study|Discontinuation Due to Explantation|14|||
162864459|NCT00753922|588207393|FG001|Overall Study|Discontinuation Due to Explantation|14|||
162864460|NCT00753922|588207394|FG002|Overall Study|Discontinuation Due to Explantation|14|||
162864461|NCT00753922|588207395|FG003|Overall Study|Discontinuation Due to Explantation|4|||
162864462|NCT02983292|588207400|FG000|Overall Study|Participant unwell & cannot travel|2|||
162864463|NCT02983292|588207400|FG000|Overall Study|Lost to Follow-up|3|||
162864464|NCT02983292|588207400|FG000|Overall Study|Participant withdrew consent|2|||
162864465|NCT02983292|588207400|FG000|Overall Study|Revision|7|||
162864466|NCT02983292|588207400|FG000|Overall Study|Death|1|||
162864467|NCT02983292|588207400|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
162864468|NCT02983292|588207400|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
162864469|NCT02983292|588207400|FG000|Overall Study|Participant relocation|1|||
162864470|NCT00857246|588207401|FG000|Induction Regimen|Adverse Event|1|||
162864471|NCT00857246|588207401|FG000|Induction Regimen|disease-related complications|1|||
162864472|NCT00857246|588207401|FG000|Induction Regimen|Withdrawal by Subject|1|||
162864473|NCT00857246|588207401|FG000|Surgery (Curative)|disease progression|6|||
162864474|NCT00857246|588207401|FG000|ChemoRT|Withdrawal by Subject|1|||
162864475|NCT00857246|588207401|FG000|ChemoRT|Adverse Event|2|||
162864476|NCT03851510|588207402|FG000|Overall Study|Screen Fail|1|||
162864477|NCT03851510|588207402|FG000|Overall Study|Adverse Event|1|||
162864478|NCT03851510|588207402|FG000|Overall Study|Withdrawal by Subject|1|||
162864479|NCT02426086|588207403|FG000|Overall Study|Death|33|||
162864480|NCT02426086|588207404|FG001|Overall Study|Death|36|||
162864481|NCT02426086|588207403|FG000|Overall Study|Lost to Follow-up|2|||
162864482|NCT02426086|588207404|FG001|Overall Study|Lost to Follow-up|0|||
162864483|NCT02426086|588207403|FG000|Overall Study|Study Terminated by Sponsor|5|||
162864484|NCT02426086|588207404|FG001|Overall Study|Study Terminated by Sponsor|14|||
162864485|NCT02426086|588207403|FG000|Overall Study|Withdrawal by Subject|8|||
162864486|NCT02426086|588207404|FG001|Overall Study|Withdrawal by Subject|9|||
162864487|NCT04542291|588207405|FG000|Overall Study|Adverse Event|1|||
162864488|NCT04542291|588207405|FG000|Overall Study|Physician Decision|2|||
162864489|NCT01287117|588207406|FG000|Overall Study|Adverse Event|2|||
162864490|NCT01287117|588207407|FG001|Overall Study|Adverse Event|1|||
162864491|NCT01287117|588207408|FG002|Overall Study|Adverse Event|1|||
162864492|NCT01287117|588207409|FG003|Overall Study|Adverse Event|1|||
162864493|NCT01287117|588207406|FG000|Overall Study|Lost to Follow-up|1|||
163046210|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
162864494|NCT01287117|588207407|FG001|Overall Study|Lost to Follow-up|1|||
162864495|NCT01287117|588207408|FG002|Overall Study|Lost to Follow-up|0|||
162864496|NCT01287117|588207409|FG003|Overall Study|Lost to Follow-up|0|||
162864497|NCT01287117|588207406|FG000|Overall Study|Physician Decision|0|||
162864498|NCT01287117|588207407|FG001|Overall Study|Physician Decision|1|||
162864499|NCT01287117|588207408|FG002|Overall Study|Physician Decision|1|||
162864500|NCT01287117|588207409|FG003|Overall Study|Physician Decision|1|||
162864501|NCT01287117|588207406|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
162864502|NCT01287117|588207407|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
162864503|NCT01287117|588207408|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
162864504|NCT01287117|588207409|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
162864505|NCT01287117|588207406|FG000|Overall Study|Disease Progression|10|||
162864506|NCT01287117|588207407|FG001|Overall Study|Disease Progression|5|||
162864507|NCT01287117|588207408|FG002|Overall Study|Disease Progression|6|||
162864508|NCT01287117|588207409|FG003|Overall Study|Disease Progression|5|||
162864509|NCT00035815|588207417|FG000|Overall Study|Withdrawal by Subject|17|||
162864510|NCT00035815|588207418|FG001|Overall Study|Withdrawal by Subject|11|||
162864511|NCT02606877|588207424|FG000|Overall Study|Adverse Event|3|||
162864512|NCT02606877|588207425|FG001|Overall Study|Adverse Event|0|||
162864513|NCT02606877|588207424|FG000|Overall Study|Non-compliance with protocol|0|||
162864514|NCT02606877|588207425|FG001|Overall Study|Non-compliance with protocol|1|||
162864515|NCT02606877|588207424|FG000|Overall Study|Other than listed above|1|||
162864516|NCT02606877|588207425|FG001|Overall Study|Other than listed above|0|||
162864517|NCT04952389|588207428|FG000|Overall Study|Withdrawal by Subject|8|||
162864518|NCT04952389|588207429|FG001|Overall Study|Withdrawal by Subject|4|||
162864519|NCT05094154|588209104|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
162864520|NCT05094154|588209105|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
162864521|NCT05094154|588209104|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
162864522|NCT05094154|588209105|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
162864523|NCT02400346|588209112|FG000|Overall Study|Adverse Event|24|||
162864524|NCT02400346|588209112|FG000|Overall Study|Lack of Efficacy|9|||
162864525|NCT02400346|588209112|FG000|Overall Study|Non-compliance with IMP|1|||
162864526|NCT02400346|588209112|FG000|Overall Study|Withdrawal by Subject|7|||
162864527|NCT02400346|588209112|FG000|Overall Study|Administrative or other reason(s)|2|||
162864528|NCT02400346|588209112|FG000|Overall Study|Lost to Follow-up|1|||
162864529|NCT02767570|588209115|FG000|Overall Study|Lost to Follow-up|3|||
162864530|NCT02767570|588209116|FG001|Overall Study|Lost to Follow-up|0|||
162864531|NCT02767570|588209115|FG000|Overall Study|COVID shutdown|2|||
162864532|NCT02767570|588209116|FG001|Overall Study|COVID shutdown|5|||
162864533|NCT02767570|588209115|FG000|Overall Study|Increased pain|2|||
162864534|NCT02767570|588209116|FG001|Overall Study|Increased pain|0|||
162864535|NCT02767570|588209115|FG000|Overall Study|Withdrawal by Subject|1|||
162864536|NCT02767570|588209116|FG001|Overall Study|Withdrawal by Subject|3|||
162864537|NCT02767570|588209115|FG000|Overall Study|Unrelated medical issue|1|||
162864538|NCT02767570|588209116|FG001|Overall Study|Unrelated medical issue|1|||
162864539|NCT02767570|588209115|FG000|Overall Study|Received intra-articular injection|0|||
162864540|NCT02767570|588209116|FG001|Overall Study|Received intra-articular injection|1|||
162864541|NCT01981122|588209118|FG000|Overall Study|Withdrawal by Subject|0|||
162864542|NCT01981122|588209119|FG001|Overall Study|Withdrawal by Subject|2|||
162864543|NCT01981122|588209118|FG000|Overall Study|Protocol Violation|0|||
162864544|NCT01981122|588209119|FG001|Overall Study|Protocol Violation|1|||
162864545|NCT01981122|588209118|FG000|Overall Study|Lost to Follow-up|0|||
162864546|NCT01981122|588209119|FG001|Overall Study|Lost to Follow-up|1|||
162864547|NCT01981122|588209118|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
162864548|NCT01981122|588209119|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
162864549|NCT01981122|588209118|FG000|Overall Study|Death|14|||
162864550|NCT01981122|588209119|FG001|Overall Study|Death|15|||
162864551|NCT00089843|588209120|FG000|Overall Study|Withdrawal by Subject|1|||
162864552|NCT00089843|588209121|FG001|Overall Study|Withdrawal by Subject|4|||
162864553|NCT00089843|588209122|FG002|Overall Study|Withdrawal by Subject|5|||
162864554|NCT00089843|588209123|FG003|Overall Study|Withdrawal by Subject|6|||
162864555|NCT00089843|588209120|FG000|Overall Study|Physician Decision|1|||
162864556|NCT00089843|588209121|FG001|Overall Study|Physician Decision|0|||
162864557|NCT00089843|588209122|FG002|Overall Study|Physician Decision|0|||
162864558|NCT00089843|588209123|FG003|Overall Study|Physician Decision|1|||
162864559|NCT03846947|588209124|FG000|Overall Study|technical issues with imaging sequence|2|||
162864560|NCT03060577|588209125|FG000|Overall Study|Withdrawal by Subject|25|||
162864561|NCT03060577|588209126|FG001|Overall Study|Withdrawal by Subject|5|||
162864562|NCT03060577|588209125|FG000|Overall Study|Physician Decision|4|||
162864563|NCT03060577|588209126|FG001|Overall Study|Physician Decision|3|||
162864564|NCT03060577|588209125|FG000|Overall Study|Lost to Follow-up|3|||
162864565|NCT03060577|588209126|FG001|Overall Study|Lost to Follow-up|0|||
162864566|NCT03060577|588209125|FG000|Overall Study|Death|7|||
162864567|NCT03060577|588209126|FG001|Overall Study|Death|1|||
162864568|NCT03060577|588209125|FG000|Overall Study|Adverse Event|9|||
162864569|NCT03060577|588209126|FG001|Overall Study|Adverse Event|1|||
162864570|NCT03060577|588209125|FG000|Overall Study|Inclusion/Exclusion|1|||
162864571|NCT03060577|588209126|FG001|Overall Study|Inclusion/Exclusion|0|||
162864572|NCT03060577|588209125|FG000|Overall Study|Other|8|||
162864573|NCT03060577|588209126|FG001|Overall Study|Other|2|||
162864574|NCT03216265|588209127|FG000|Overall Study|Adverse Event|2|||
162864575|NCT03216265|588209128|FG001|Overall Study|Adverse Event|0|||
162864576|NCT03216265|588209129|FG002|Overall Study|Adverse Event|2|||
162864577|NCT03216265|588209127|FG000|Overall Study|Lost to Follow-up|0|||
162864578|NCT03216265|588209128|FG001|Overall Study|Lost to Follow-up|1|||
162864579|NCT03216265|588209129|FG002|Overall Study|Lost to Follow-up|0|||
162864580|NCT03216265|588209127|FG000|Overall Study|Withdrawal by Subject|0|||
162864581|NCT03216265|588209128|FG001|Overall Study|Withdrawal by Subject|0|||
162864582|NCT03216265|588209129|FG002|Overall Study|Withdrawal by Subject|1|||
162864583|NCT01306058|588209130|FG000|Overall Study|Death|1|||
162958703|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
162958704|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958705|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958706|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958707|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958708|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
162958709|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
162958710|NCT03673670|588551601|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958711|NCT03673670|588551602|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958712|NCT03673670|588551603|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958713|NCT03673670|588551604|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958714|NCT03673670|588551605|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
162958715|NCT03673670|588551606|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
162958716|NCT03673670|588551601|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958717|NCT03673670|588551602|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958718|NCT03673670|588551603|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
162958719|NCT03673670|588551604|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958720|NCT03673670|588551605|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
162958721|NCT03673670|588551606|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
162958722|NCT03673670|588551601|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958723|NCT03673670|588551602|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958724|NCT03673670|588551603|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958725|NCT03673670|588551604|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958726|NCT03673670|588551605|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
162958727|NCT03673670|588551606|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162958728|NCT03673670|588551601|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958729|NCT03673670|588551602|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958730|NCT03673670|588551603|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958731|NCT03673670|588551604|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958732|NCT03673670|588551605|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
162958733|NCT03673670|588551606|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
162958734|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Adverse Event|8|||
162958735|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Adverse Event|15|||
162958736|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Adverse Event|25|||
162958737|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
162958738|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
162958739|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
162958740|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
162958741|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
162958742|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
162958743|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
162958744|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
162958745|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
162958746|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162958747|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
162958748|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
162958749|NCT01058668|588551607|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
162958750|NCT01058668|588551608|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
162958751|NCT01058668|588551609|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
162958752|NCT02294786|588551612|FG000|Overall Study|Withdrawal by Subject|0|||
162958753|NCT02294786|588551613|FG001|Overall Study|Withdrawal by Subject|1|||
162958754|NCT02294786|588551612|FG000|Overall Study|Physician Decision|6|||
162958755|NCT02294786|588551613|FG001|Overall Study|Physician Decision|7|||
162958756|NCT02294786|588551612|FG000|Overall Study|Lost to Follow-up|1|||
162958757|NCT02294786|588551613|FG001|Overall Study|Lost to Follow-up|2|||
162958758|NCT02294786|588551612|FG000|Overall Study|Protocol Violation|1|||
162958759|NCT02294786|588551613|FG001|Overall Study|Protocol Violation|0|||
162958760|NCT02294786|588551612|FG000|Overall Study|Adverse Event|1|||
162958761|NCT02294786|588551613|FG001|Overall Study|Adverse Event|1|||
162958762|NCT02294786|588551612|FG000|Overall Study|Death|2|||
162958763|NCT02294786|588551613|FG001|Overall Study|Death|3|||
162958764|NCT01663233|588551616|FG000|Overall Study|Withdrawal by Subject|3|||
162958765|NCT01663233|588551617|FG001|Overall Study|Withdrawal by Subject|2|||
162958766|NCT01663233|588551616|FG000|Overall Study|Protocol Deviation|1|||
163058597|NCT00042289|588924237|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
162958767|NCT01663233|588551617|FG001|Overall Study|Protocol Deviation|4|||
162958768|NCT01663233|588551616|FG000|Overall Study|Lost to Follow-up|0|||
162958769|NCT01663233|588551617|FG001|Overall Study|Lost to Follow-up|1|||
162958770|NCT00796328|588551618|FG000|Overall Study|experienced hypotension requiring tx|6|||
162958771|NCT03406156|588551619|FG000|Overall Study|Death|9|||
162958772|NCT03406156|588551620|FG001|Overall Study|Death|3|||
162613419|NCT02180165|587303187|FG003|Overall Study|Physician Decision|0|||
162864584|NCT01306058|588209130|FG000|Overall Study|Enrolled but did not get treatment|1|||
162864585|NCT01539837|588209131|FG000|Overall Study|reduce neutrophil level|0|||
162864586|NCT01539837|588209132|FG001|Overall Study|reduce neutrophil level|1|||
163046211|NCT01111565|588877341|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
163046212|NCT01111565|588877342|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
162864587|NCT01539837|588209133|FG002|Overall Study|reduce neutrophil level|1|||
163046213|NCT01111565|588877343|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
162864588|NCT01539837|588209131|FG000|Overall Study|bad compliance|0|||
162864589|NCT01539837|588209132|FG001|Overall Study|bad compliance|0|||
162864590|NCT01539837|588209133|FG002|Overall Study|bad compliance|1|||
162864591|NCT00849693|588209134|FG000|Acute Treatment Phase|Adverse Event|12|||
162864592|NCT00849693|588209135|FG001|Acute Treatment Phase|Adverse Event|7|||
162864593|NCT00849693|588209136|FG002|Acute Treatment Phase|Adverse Event|6|||
162958773|NCT03406156|588551619|FG000|Overall Study|Withdrawal by Subject|1|||
162958774|NCT03406156|588551620|FG001|Overall Study|Withdrawal by Subject|2|||
162958775|NCT03406156|588551619|FG000|Overall Study|COVID-19 infection|1|||
162958776|NCT03406156|588551620|FG001|Overall Study|COVID-19 infection|0|||
162958777|NCT03406156|588551619|FG000|Overall Study|Non-compliance with study procedures|1|||
162958778|NCT03406156|588551620|FG001|Overall Study|Non-compliance with study procedures|1|||
162958779|NCT03406156|588551619|FG000|Overall Study|Lost to Follow-up|0|||
162958780|NCT03406156|588551620|FG001|Overall Study|Lost to Follow-up|2|||
162958781|NCT03406156|588551619|FG000|Overall Study|Other, not specified|72|||
162958782|NCT03406156|588551620|FG001|Overall Study|Other, not specified|28|||
162958783|NCT05479058|588551621|FG000|Overall Study|Withdrawal by Subject|1|||
162958784|NCT05479058|588551622|FG001|Overall Study|Withdrawal by Subject|1|||
162958785|NCT05479058|588551621|FG000|Overall Study|Study terminated by sponsor|10|||
162958786|NCT05479058|588551622|FG001|Overall Study|Study terminated by sponsor|10|||
162958787|NCT02414152|588551627|FG000|Overall Study|Withdrawal by Subject|1|||
162958788|NCT02414152|588551627|FG000|Overall Study|Lack of Efficacy|1|||
162958789|NCT01757392|588551628|FG000|Overall Study|Withdrawal by Subject|1|||
162958790|NCT01757392|588551628|FG000|Overall Study|Screen Fail|3|||
162958791|NCT00841698|588551635|FG000|First Intervention|Withdrawal by Subject|1|||
162958792|NCT00841698|588551636|FG001|First Intervention|Withdrawal by Subject|0|||
162958793|NCT04078022|588551643|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
162958794|NCT04078022|588551644|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
162958795|NCT01250912|588551645|FG000|Overall Study|Lost to Follow-up|1|||
162958796|NCT00191815|588551646|FG000|Overall Study|Adverse Event|2|||
162958797|NCT00191815|588551646|FG000|Overall Study|Disease progression or relapse|24|||
162958798|NCT00191815|588551646|FG000|Overall Study|Death|2|||
162958799|NCT00191815|588551646|FG000|Overall Study|Protocol Violation|3|||
162958800|NCT00191815|588551646|FG000|Overall Study|Physician Decision|2|||
162958801|NCT00191815|588551646|FG000|Overall Study|Withdrawal by Subject|7|||
162958802|NCT01929863|588551647|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
162958803|NCT01929863|588551648|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
162958804|NCT01929863|588551647|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
162958805|NCT01929863|588551648|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
162958806|NCT01929863|588551647|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
162958807|NCT01929863|588551648|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
162958808|NCT00251979|588551649|FG000|Overall Study|Protocol Violation|3|||
162958809|NCT00251979|588551650|FG001|Overall Study|Protocol Violation|5|||
163046214|NCT01111565|588877344|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
163046215|NCT01111565|588877345|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
162958810|NCT00251979|588551649|FG000|Overall Study|Adverse Event|11|||
162958811|NCT00251979|588551650|FG001|Overall Study|Adverse Event|17|||
162958812|NCT00251979|588551649|FG000|Overall Study|Withdrawal by Subject|13|||
162958813|NCT00251979|588551650|FG001|Overall Study|Withdrawal by Subject|7|||
162958814|NCT00251979|588551649|FG000|Overall Study|Lost to Follow-up|8|||
162958815|NCT00251979|588551650|FG001|Overall Study|Lost to Follow-up|6|||
162958816|NCT00251979|588551649|FG000|Overall Study|Death|3|||
162958817|NCT00251979|588551650|FG001|Overall Study|Death|5|||
162958818|NCT01348789|588551660|FG000|Overall Study|Protocol Violation|2|||
163046216|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162864594|NCT00849693|588209137|FG003|Acute Treatment Phase|Adverse Event|4|||
162958819|NCT01348789|588551660|FG000|Overall Study|Withdrawal by Subject|2|||
162958820|NCT01878292|588551661|FG000|Randomized|Protocol Violation|1|||
162958821|NCT01878292|588551662|FG001|Randomized|Protocol Violation|0|||
162958822|NCT01878292|588551663|FG002|Randomized|Protocol Violation|0|||
162958823|NCT01878292|588551661|FG000|Randomized|Lost to Follow-up|1|||
162958824|NCT01878292|588551662|FG001|Randomized|Lost to Follow-up|0|||
162958825|NCT01878292|588551663|FG002|Randomized|Lost to Follow-up|0|||
162958826|NCT01878292|588551661|FG000|Randomized|Adverse Event|1|||
162958827|NCT01878292|588551662|FG001|Randomized|Adverse Event|0|||
162958828|NCT01878292|588551663|FG002|Randomized|Adverse Event|0|||
162958829|NCT01878292|588551661|FG000|Double-blind Treatment Period|Other Reasons|2|||
162958830|NCT01878292|588551662|FG001|Double-blind Treatment Period|Other Reasons|0|||
162864595|NCT00849693|588209134|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
162864596|NCT00849693|588209135|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
162864597|NCT00849693|588209136|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
162864598|NCT00849693|588209137|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
162864599|NCT00849693|588209134|FG000|Acute Treatment Phase|Protocol Violation|1|||
162864600|NCT00849693|588209135|FG001|Acute Treatment Phase|Protocol Violation|5|||
162864601|NCT00849693|588209136|FG002|Acute Treatment Phase|Protocol Violation|2|||
162864602|NCT00849693|588209137|FG003|Acute Treatment Phase|Protocol Violation|6|||
162864603|NCT00849693|588209134|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
162864604|NCT00849693|588209135|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
162864605|NCT00849693|588209136|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
162864606|NCT00849693|588209137|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
162864607|NCT00849693|588209134|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
162864608|NCT00849693|588209135|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
162864609|NCT00849693|588209136|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
162864610|NCT00849693|588209137|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
162864611|NCT00849693|588209134|FG000|Acute Treatment Phase|Physician Decision|2|||
162864612|NCT00849693|588209135|FG001|Acute Treatment Phase|Physician Decision|1|||
162864613|NCT00849693|588209136|FG002|Acute Treatment Phase|Physician Decision|2|||
162864614|NCT00849693|588209137|FG003|Acute Treatment Phase|Physician Decision|1|||
162864615|NCT00849693|588209134|FG000|Acute Treatment Phase|Sponsor decision|0|||
162864616|NCT00849693|588209135|FG001|Acute Treatment Phase|Sponsor decision|0|||
162864617|NCT00849693|588209136|FG002|Acute Treatment Phase|Sponsor decision|1|||
162864618|NCT00849693|588209137|FG003|Acute Treatment Phase|Sponsor decision|0|||
162864619|NCT00849693|588209134|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
162864620|NCT00849693|588209135|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
162864621|NCT00849693|588209136|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
162864622|NCT00849693|588209137|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
162864623|NCT00849693|588209134|FG000|Extension Phase|Adverse Event|4|||
162864624|NCT00849693|588209135|FG001|Extension Phase|Adverse Event|6|||
162864625|NCT00849693|588209136|FG002|Extension Phase|Adverse Event|3|||
162864626|NCT00849693|588209137|FG003|Extension Phase|Adverse Event|7|||
162864627|NCT00849693|588209134|FG000|Extension Phase|Lost to Follow-up|7|||
162864628|NCT00849693|588209135|FG001|Extension Phase|Lost to Follow-up|5|||
162864629|NCT00849693|588209136|FG002|Extension Phase|Lost to Follow-up|6|||
162864630|NCT00849693|588209137|FG003|Extension Phase|Lost to Follow-up|6|||
162864631|NCT00849693|588209134|FG000|Extension Phase|Protocol Violation|0|||
162864632|NCT00849693|588209135|FG001|Extension Phase|Protocol Violation|3|||
162864633|NCT00849693|588209136|FG002|Extension Phase|Protocol Violation|2|||
162864634|NCT00849693|588209137|FG003|Extension Phase|Protocol Violation|3|||
162864635|NCT00849693|588209134|FG000|Extension Phase|Withdrawal by Subject|6|||
162864636|NCT00849693|588209135|FG001|Extension Phase|Withdrawal by Subject|9|||
162864637|NCT00849693|588209136|FG002|Extension Phase|Withdrawal by Subject|10|||
162864638|NCT00849693|588209137|FG003|Extension Phase|Withdrawal by Subject|15|||
162864639|NCT00849693|588209134|FG000|Extension Phase|Parent or caregiver decision|9|||
162864640|NCT00849693|588209135|FG001|Extension Phase|Parent or caregiver decision|4|||
162864641|NCT00849693|588209136|FG002|Extension Phase|Parent or caregiver decision|10|||
162864642|NCT00849693|588209137|FG003|Extension Phase|Parent or caregiver decision|5|||
162864643|NCT00849693|588209134|FG000|Extension Phase|Physician Decision|1|||
162864644|NCT00849693|588209135|FG001|Extension Phase|Physician Decision|1|||
162864645|NCT00849693|588209136|FG002|Extension Phase|Physician Decision|2|||
162864646|NCT00849693|588209137|FG003|Extension Phase|Physician Decision|0|||
162864647|NCT00849693|588209134|FG000|Extension Phase|Sponsor decision|1|||
162864648|NCT00849693|588209135|FG001|Extension Phase|Sponsor decision|0|||
162864649|NCT00849693|588209136|FG002|Extension Phase|Sponsor decision|0|||
162864650|NCT00849693|588209137|FG003|Extension Phase|Sponsor decision|1|||
162864651|NCT00849693|588209134|FG000|Extension Phase|Lack of Efficacy|2|||
162864652|NCT00849693|588209135|FG001|Extension Phase|Lack of Efficacy|2|||
162864653|NCT00849693|588209136|FG002|Extension Phase|Lack of Efficacy|2|||
162864654|NCT00849693|588209137|FG003|Extension Phase|Lack of Efficacy|1|||
162864655|NCT01978912|588209140|FG000|Overall Study|Adverse Event|0|||
162864656|NCT01978912|588209141|FG001|Overall Study|Adverse Event|1|||
162864657|NCT01978912|588209142|FG002|Overall Study|Adverse Event|0|||
162864658|NCT01978912|588209143|FG003|Overall Study|Adverse Event|0|||
162864659|NCT01978912|588209140|FG000|Overall Study|Lost to Follow-up|1|||
162864660|NCT01978912|588209141|FG001|Overall Study|Lost to Follow-up|1|||
162864661|NCT01978912|588209142|FG002|Overall Study|Lost to Follow-up|0|||
162864662|NCT01978912|588209143|FG003|Overall Study|Lost to Follow-up|1|||
162864663|NCT01978912|588209140|FG000|Overall Study|Withdrawal by Subject|1|||
162864664|NCT01978912|588209141|FG001|Overall Study|Withdrawal by Subject|0|||
162864665|NCT01978912|588209142|FG002|Overall Study|Withdrawal by Subject|2|||
162864666|NCT01978912|588209143|FG003|Overall Study|Withdrawal by Subject|2|||
162864667|NCT01978912|588209140|FG000|Overall Study|Lumbar Surgery|1|||
162864668|NCT01978912|588209141|FG001|Overall Study|Lumbar Surgery|0|||
162864669|NCT01978912|588209142|FG002|Overall Study|Lumbar Surgery|1|||
162864670|NCT01978912|588209143|FG003|Overall Study|Lumbar Surgery|0|||
163046217|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162864671|NCT01978912|588209140|FG000|Overall Study|Intradiscal Steroid Injection|0|||
162864672|NCT01978912|588209141|FG001|Overall Study|Intradiscal Steroid Injection|1|||
162864673|NCT01978912|588209142|FG002|Overall Study|Intradiscal Steroid Injection|0|||
162864674|NCT01978912|588209143|FG003|Overall Study|Intradiscal Steroid Injection|0|||
162864675|NCT00224107|588209144|FG000|Overall Study|Adverse Event|20|||
162864676|NCT00224107|588209145|FG001|Overall Study|Adverse Event|6|||
162864677|NCT00224107|588209144|FG000|Overall Study|Protocol Violation|2|||
162864678|NCT00224107|588209145|FG001|Overall Study|Protocol Violation|3|||
162864679|NCT00224107|588209144|FG000|Overall Study|Withdrawal by Subject|1|||
163046218|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162864680|NCT00224107|588209145|FG001|Overall Study|Withdrawal by Subject|4|||
162864681|NCT00224107|588209144|FG000|Overall Study|Lack of Efficacy|2|||
162864682|NCT00224107|588209145|FG001|Overall Study|Lack of Efficacy|0|||
162864683|NCT00224107|588209144|FG000|Overall Study|Lost to Follow-up|4|||
162864684|NCT00224107|588209145|FG001|Overall Study|Lost to Follow-up|0|||
162864685|NCT00224107|588209144|FG000|Overall Study|Physician Decision|1|||
162864686|NCT00224107|588209145|FG001|Overall Study|Physician Decision|0|||
162864687|NCT00224107|588209144|FG000|Overall Study|Other|1|||
162864688|NCT00224107|588209145|FG001|Overall Study|Other|1|||
162864689|NCT01408537|588209148|FG000|Overall Study|Withdrawal by Subject|2|||
162864690|NCT01408537|588209148|FG000|Overall Study|Protocol Violation|3|||
162864691|NCT01408537|588209148|FG000|Overall Study|Lost to Follow-up|3|||
162864692|NCT00098345|588209151|FG000|Overall Study|Adverse Event|7|||
162864693|NCT00098345|588209151|FG000|Overall Study|Withdrawal by Subject|2|||
162864694|NCT00098345|588209151|FG000|Overall Study|progression|4|||
162864695|NCT01295905|588209154|FG000|Overall Study|Did not meet inclusion criteria|1|||
162864696|NCT01295905|588209155|FG001|Overall Study|Did not meet inclusion criteria|0|||
162864697|NCT01295905|588209154|FG000|Overall Study|Met exclusion criteria|1|||
162864698|NCT01295905|588209155|FG001|Overall Study|Met exclusion criteria|0|||
162864699|NCT03707977|588209156|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
162864700|NCT03707977|588209157|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
162864701|NCT03707977|588209158|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
162864702|NCT03707977|588209156|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
162864703|NCT03707977|588209157|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
162864704|NCT03707977|588209158|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
162864705|NCT03069690|588209159|FG000|Pregnancy Intervention|Pregnancy loss|9|||
162864706|NCT03069690|588209160|FG001|Pregnancy Intervention|Pregnancy loss|4|||
162864707|NCT03069690|588209161|FG002|Pregnancy Intervention|Pregnancy loss|0|||
162864708|NCT03069690|588209162|FG003|Pregnancy Intervention|Pregnancy loss|0|||
162864709|NCT03069690|588209163|FG004|Pregnancy Intervention|Pregnancy loss|0|||
162864710|NCT03069690|588209164|FG005|Pregnancy Intervention|Pregnancy loss|0|||
162864711|NCT03069690|588209159|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
162864712|NCT03069690|588209160|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
162864713|NCT03069690|588209161|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
162864714|NCT03069690|588209162|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
162864715|NCT03069690|588209163|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
162864716|NCT03069690|588209164|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
162864717|NCT03069690|588209159|FG000|Postpartum Intervention|Lost to Follow-up|0|||
162864718|NCT03069690|588209160|FG001|Postpartum Intervention|Lost to Follow-up|0|||
162864719|NCT03069690|588209161|FG002|Postpartum Intervention|Lost to Follow-up|5|||
162864720|NCT03069690|588209162|FG003|Postpartum Intervention|Lost to Follow-up|5|||
162864721|NCT03069690|588209163|FG004|Postpartum Intervention|Lost to Follow-up|2|||
162958831|NCT01878292|588551663|FG002|Double-blind Treatment Period|Other Reasons|0|||
162958832|NCT01878292|588551661|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
162958833|NCT01878292|588551662|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
162958834|NCT01878292|588551663|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
162958835|NCT01878292|588551661|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
162958836|NCT01878292|588551662|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
162958837|NCT01878292|588551663|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
162958838|NCT01878292|588551661|FG000|Double-blind Treatment Period|Protocol Violation|3|||
162958839|NCT01878292|588551662|FG001|Double-blind Treatment Period|Protocol Violation|4|||
162958840|NCT01878292|588551663|FG002|Double-blind Treatment Period|Protocol Violation|2|||
162958841|NCT01878292|588551661|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
162864722|NCT03069690|588209164|FG005|Postpartum Intervention|Lost to Follow-up|4|||
162864723|NCT02564120|588209165|FG000|Overall Study|Did not return release forms|160|||
162864724|NCT02564120|588209165|FG000|Overall Study|Death|58|||
162864725|NCT02564120|588209165|FG000|Overall Study|Withdrawal by Subject|204|||
162864726|NCT02564120|588209165|FG000|Overall Study|Other medical condition|24|||
162864727|NCT03842709|588209166|FG000|Overall Study|Withdrawal by Subject|3|||
162864728|NCT03842709|588209167|FG001|Overall Study|Withdrawal by Subject|3|||
162864729|NCT03842709|588209166|FG000|Overall Study|Lost to Follow-up|1|||
162864730|NCT03842709|588209167|FG001|Overall Study|Lost to Follow-up|0|||
162864731|NCT00641147|588209168|FG000|Completed 4 Months.|Physician Decision|1|||
162864732|NCT00641147|588209169|FG001|Completed 4 Months.|Physician Decision|0|||
162864733|NCT00641147|588209168|FG000|Completed 4 Months.|Adverse Event|1|||
162864734|NCT00641147|588209169|FG001|Completed 4 Months.|Adverse Event|0|||
162864735|NCT00641147|588209168|FG000|Completed 8 Months.|Physician Decision|2|||
162864736|NCT00641147|588209169|FG001|Completed 8 Months.|Physician Decision|1|||
162864737|NCT00641147|588209168|FG000|Completed 8 Months.|non compliance|1|||
162864738|NCT00641147|588209169|FG001|Completed 8 Months.|non compliance|0|||
162864739|NCT00641147|588209168|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
162864740|NCT00641147|588209169|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
162864741|NCT00641147|588209168|FG000|Completed 12 Months.|Physician Decision|1|||
162864742|NCT00641147|588209169|FG001|Completed 12 Months.|Physician Decision|1|||
162864743|NCT00641147|588209168|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
162864744|NCT00641147|588209169|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
162864745|NCT00641147|588209168|FG000|Completed 16 Months.|Physician Decision|1|||
162864746|NCT00641147|588209169|FG001|Completed 16 Months.|Physician Decision|0|||
162864747|NCT00641147|588209168|FG000|Completed 16 Months.|Lost to Follow-up|1|||
162864748|NCT00641147|588209169|FG001|Completed 16 Months.|Lost to Follow-up|0|||
162864749|NCT00791128|588209170|FG000|Overall Study|Adverse Event|4|||
162864750|NCT00791128|588209170|FG000|Overall Study|Device migration|2|||
162864751|NCT00791128|588209170|FG000|Overall Study|non-compliance by subject|2|||
162864752|NCT00791128|588209170|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
162864753|NCT01629667|588209171|FG000|Overall Study|Lost to Follow-up|0|||
162864754|NCT01629667|588209172|FG001|Overall Study|Lost to Follow-up|1|||
162864755|NCT01629667|588209173|FG002|Overall Study|Lost to Follow-up|1|||
162864756|NCT01629667|588209171|FG000|Overall Study|Withdrawal by Subject|31|||
162864757|NCT01629667|588209172|FG001|Overall Study|Withdrawal by Subject|20|||
162864758|NCT01629667|588209173|FG002|Overall Study|Withdrawal by Subject|28|||
162864759|NCT01629667|588209171|FG000|Overall Study|Death|1|||
162864760|NCT01629667|588209172|FG001|Overall Study|Death|5|||
162864761|NCT01629667|588209173|FG002|Overall Study|Death|3|||
162864762|NCT01629667|588209171|FG000|Overall Study|Randomized, not treated|2|||
162864763|NCT01629667|588209172|FG001|Overall Study|Randomized, not treated|1|||
162864764|NCT01629667|588209173|FG002|Overall Study|Randomized, not treated|0|||
162864765|NCT01629667|588209171|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
162864766|NCT01629667|588209172|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
162864767|NCT01629667|588209173|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
162864768|NCT01629667|588209171|FG000|Overall Study|Requiring lung transplant|2|||
162864769|NCT01629667|588209172|FG001|Overall Study|Requiring lung transplant|1|||
162864770|NCT01629667|588209173|FG002|Overall Study|Requiring lung transplant|3|||
162864771|NCT01629667|588209171|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
162864772|NCT01629667|588209172|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
162864773|NCT01629667|588209173|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
162864774|NCT01629667|588209171|FG000|Overall Study|Started other medicine|1|||
162864775|NCT01629667|588209172|FG001|Overall Study|Started other medicine|0|||
162864776|NCT01629667|588209173|FG002|Overall Study|Started other medicine|1|||
162864777|NCT01629667|588209171|FG000|Overall Study|Site error in safety follow-up|0|||
162864778|NCT01629667|588209172|FG001|Overall Study|Site error in safety follow-up|0|||
162864779|NCT01629667|588209173|FG002|Overall Study|Site error in safety follow-up|1|||
162864780|NCT01629667|588209171|FG000|Overall Study|Enrolled in another clinical study|0|||
162864781|NCT01629667|588209172|FG001|Overall Study|Enrolled in another clinical study|1|||
162864782|NCT01629667|588209173|FG002|Overall Study|Enrolled in another clinical study|0|||
162864783|NCT01629667|588209171|FG000|Overall Study|Code break|1|||
162864784|NCT01629667|588209172|FG001|Overall Study|Code break|0|||
162864785|NCT01629667|588209173|FG002|Overall Study|Code break|0|||
162864786|NCT00553059|588209174|FG000|Overall Study|Deemed ineligible|1|||
162864787|NCT00553059|588209175|FG001|Overall Study|Deemed ineligible|1|||
162864788|NCT00553059|588209174|FG000|Overall Study|Drug supply not available|0|||
162864789|NCT00553059|588209175|FG001|Overall Study|Drug supply not available|1|||
162864790|NCT00984659|588209176|FG000|2-week Run-in Period|Adverse Event|8|||
162864791|NCT00984659|588209177|FG001|2-week Run-in Period|Adverse Event|0|||
162864792|NCT00984659|588209178|FG002|2-week Run-in Period|Adverse Event|0|||
162864793|NCT00984659|588209179|FG003|2-week Run-in Period|Adverse Event|0|||
162864794|NCT00984659|588209176|FG000|2-week Run-in Period|Protocol Violation|5|||
162864795|NCT00984659|588209177|FG001|2-week Run-in Period|Protocol Violation|0|||
162864796|NCT00984659|588209178|FG002|2-week Run-in Period|Protocol Violation|0|||
162864797|NCT00984659|588209179|FG003|2-week Run-in Period|Protocol Violation|0|||
162864798|NCT00984659|588209176|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
162864799|NCT00984659|588209177|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
162864800|NCT00984659|588209178|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
162864801|NCT00984659|588209179|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
162864802|NCT00984659|588209176|FG000|2-week Run-in Period|Lost to Follow-up|3|||
162864803|NCT00984659|588209177|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162864804|NCT00984659|588209178|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162864805|NCT00984659|588209179|FG003|2-week Run-in Period|Lost to Follow-up|0|||
162864806|NCT00984659|588209176|FG000|2-week Run-in Period|Physician Decision|10|||
162864807|NCT00984659|588209177|FG001|2-week Run-in Period|Physician Decision|0|||
162864808|NCT00984659|588209178|FG002|2-week Run-in Period|Physician Decision|0|||
162864809|NCT00984659|588209179|FG003|2-week Run-in Period|Physician Decision|0|||
162864810|NCT00984659|588209176|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
162864811|NCT00984659|588209177|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162864812|NCT00984659|588209178|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162864813|NCT00984659|588209179|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
162864814|NCT00984659|588209176|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
162958842|NCT01878292|588551662|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
163046219|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
163046220|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162958843|NCT01878292|588551663|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162958844|NCT01878292|588551661|FG000|Double-blind Treatment Period|Adverse Event|4|||
162958845|NCT01878292|588551662|FG001|Double-blind Treatment Period|Adverse Event|9|||
162958846|NCT01878292|588551663|FG002|Double-blind Treatment Period|Adverse Event|8|||
162613420|NCT02180165|587303184|FG000|Overall Study|Withdrawal by Subject|3|||
162613421|NCT02180165|587303185|FG001|Overall Study|Withdrawal by Subject|0|||
162958847|NCT01878292|588551661|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
162958848|NCT01878292|588551662|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
162958849|NCT01878292|588551663|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
162958850|NCT00323882|588551664|FG000|Overall Study|Adverse Event|2|||
162958851|NCT00323882|588551665|FG001|Overall Study|Adverse Event|1|||
162958852|NCT00323882|588551666|FG002|Overall Study|Adverse Event|1|||
162958853|NCT00323882|588551667|FG003|Overall Study|Adverse Event|1|||
162958854|NCT00323882|588551668|FG004|Overall Study|Adverse Event|3|||
162958855|NCT00323882|588551664|FG000|Overall Study|Disease Progression|6|||
162958856|NCT00323882|588551665|FG001|Overall Study|Disease Progression|4|||
162958857|NCT00323882|588551666|FG002|Overall Study|Disease Progression|10|||
162958858|NCT00323882|588551667|FG003|Overall Study|Disease Progression|5|||
162958859|NCT00323882|588551668|FG004|Overall Study|Disease Progression|22|||
162958860|NCT00323882|588551664|FG000|Overall Study|Death|0|||
162958861|NCT00323882|588551665|FG001|Overall Study|Death|1|||
162958862|NCT00323882|588551666|FG002|Overall Study|Death|1|||
162958863|NCT00323882|588551667|FG003|Overall Study|Death|0|||
162958864|NCT00323882|588551668|FG004|Overall Study|Death|5|||
162958865|NCT00323882|588551664|FG000|Overall Study|Lost to Follow-up|0|||
162958866|NCT00323882|588551665|FG001|Overall Study|Lost to Follow-up|0|||
162958867|NCT00323882|588551666|FG002|Overall Study|Lost to Follow-up|1|||
162958868|NCT00323882|588551667|FG003|Overall Study|Lost to Follow-up|0|||
162958869|NCT00323882|588551668|FG004|Overall Study|Lost to Follow-up|1|||
162958870|NCT00323882|588551664|FG000|Overall Study|Other|0|||
162958871|NCT00323882|588551665|FG001|Overall Study|Other|0|||
162958872|NCT00323882|588551666|FG002|Overall Study|Other|0|||
162958873|NCT00323882|588551667|FG003|Overall Study|Other|1|||
162958874|NCT00323882|588551668|FG004|Overall Study|Other|1|||
162958875|NCT00415363|588551678|FG000|Overall Study|Withdrawal by Subject|4|||
162958876|NCT00415363|588551679|FG001|Overall Study|Withdrawal by Subject|4|||
162958877|NCT00415363|588551678|FG000|Overall Study|Adverse Event|4|||
162958878|NCT00415363|588551679|FG001|Overall Study|Adverse Event|4|||
162958879|NCT00415363|588551678|FG000|Overall Study|Lost to Follow-up|2|||
162958880|NCT00415363|588551679|FG001|Overall Study|Lost to Follow-up|1|||
162958881|NCT00415363|588551678|FG000|Overall Study|Physician Decision|3|||
162958882|NCT00415363|588551679|FG001|Overall Study|Physician Decision|1|||
162958883|NCT00415363|588551678|FG000|Overall Study|Death|16|||
162958884|NCT00415363|588551679|FG001|Overall Study|Death|12|||
162958885|NCT00415363|588551678|FG000|Overall Study|Progressive disease|26|||
162958886|NCT00415363|588551679|FG001|Overall Study|Progressive disease|32|||
162958887|NCT02152163|588551680|FG000|Overall Study|Physician Decision|12|||
162958888|NCT02152163|588551681|FG001|Overall Study|Physician Decision|13|||
162958889|NCT03123471|588551682|FG000|Placebo-controlled Phase|Adverse Event|3|||
162958890|NCT03123471|588551683|FG001|Placebo-controlled Phase|Adverse Event|8|||
162958891|NCT03123471|588551682|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
162958892|NCT03123471|588551683|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
162958893|NCT03123471|588551682|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
162958894|NCT03123471|588551683|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
162958895|NCT03123471|588551682|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
162613422|NCT02180165|587303186|FG002|Overall Study|Withdrawal by Subject|2|||
162613423|NCT02180165|587303187|FG003|Overall Study|Withdrawal by Subject|1|||
162613424|NCT01933217|587303188|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
162958896|NCT03123471|588551683|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
162958897|NCT03123471|588551682|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
162958898|NCT03123471|588551683|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
162958899|NCT03123471|588551682|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
162864815|NCT00984659|588209177|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162613425|NCT01933217|587303189|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
162613426|NCT01933217|587303188|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
162613427|NCT01933217|587303189|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
162613428|NCT03923738|587303193|FG000|Period 1|Adverse Event|1|||
162613429|NCT03923738|587303193|FG000|Period 1|Withdrawal by Subject|1|||
162613430|NCT05246397|587303194|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
162613431|NCT03875768|587303196|FG000|Overall Study|Lost to Follow-up|16|||
162613432|NCT03875768|587303197|FG001|Overall Study|Lost to Follow-up|13|||
162613433|NCT03875768|587303196|FG000|Overall Study|Withdrawal by Subject|10|||
162613434|NCT03875768|587303197|FG001|Overall Study|Withdrawal by Subject|21|||
162613435|NCT03875768|587303196|FG000|Overall Study|Did not complete assessment|21|||
162613436|NCT03875768|587303197|FG001|Overall Study|Did not complete assessment|12|||
162613437|NCT03875768|587303196|FG000|Overall Study|Became ineligible|1|||
162613438|NCT03875768|587303197|FG001|Overall Study|Became ineligible|0|||
162613439|NCT01925274|587303198|FG000|Overall Study|Death|1|||
162613440|NCT01925274|587303199|FG001|Overall Study|Death|0|||
162613441|NCT01925274|587303200|FG002|Overall Study|Death|0|||
162613442|NCT01925274|587303198|FG000|Overall Study|Lost to Follow-up|0|||
162613443|NCT01925274|587303199|FG001|Overall Study|Lost to Follow-up|1|||
162613444|NCT01925274|587303200|FG002|Overall Study|Lost to Follow-up|0|||
162613445|NCT01925274|587303198|FG000|Overall Study|Withdrawal by Subject|1|||
162613446|NCT01925274|587303199|FG001|Overall Study|Withdrawal by Subject|2|||
162613447|NCT01925274|587303200|FG002|Overall Study|Withdrawal by Subject|0|||
162613448|NCT01925274|587303198|FG000|Overall Study|Study terminated by sponsor|4|||
162613449|NCT01925274|587303199|FG001|Overall Study|Study terminated by sponsor|0|||
162613450|NCT01925274|587303200|FG002|Overall Study|Study terminated by sponsor|0|||
162613451|NCT01925274|587303198|FG000|Overall Study|Protocol amendment|1|||
162613452|NCT01925274|587303199|FG001|Overall Study|Protocol amendment|3|||
162613453|NCT01925274|587303200|FG002|Overall Study|Protocol amendment|6|||
162613454|NCT04327674|587303205|FG000|Overall Study|Protocol Violation|19|||
162613455|NCT00723398|587303206|FG000|Overall Study|Withdrawal by Subject|2|||
162613456|NCT00723398|587303207|FG001|Overall Study|Withdrawal by Subject|6|||
162613457|NCT00723398|587303208|FG002|Overall Study|Withdrawal by Subject|4|||
162613458|NCT00723398|587303209|FG003|Overall Study|Withdrawal by Subject|4|||
162613459|NCT00723398|587303210|FG004|Overall Study|Withdrawal by Subject|4|||
162613460|NCT00723398|587303206|FG000|Overall Study|Protocol Violation|2|||
162613461|NCT00723398|587303207|FG001|Overall Study|Protocol Violation|1|||
162613462|NCT00723398|587303208|FG002|Overall Study|Protocol Violation|5|||
162613463|NCT00723398|587303209|FG003|Overall Study|Protocol Violation|0|||
162613464|NCT00723398|587303210|FG004|Overall Study|Protocol Violation|0|||
162613465|NCT00723398|587303206|FG000|Overall Study|Physician Decision|2|||
162613466|NCT00723398|587303207|FG001|Overall Study|Physician Decision|2|||
162613467|NCT00723398|587303208|FG002|Overall Study|Physician Decision|5|||
162613468|NCT00723398|587303209|FG003|Overall Study|Physician Decision|0|||
162613469|NCT00723398|587303210|FG004|Overall Study|Physician Decision|1|||
162613470|NCT00723398|587303206|FG000|Overall Study|Adverse Event|0|||
162613471|NCT00723398|587303207|FG001|Overall Study|Adverse Event|5|||
162613472|NCT00723398|587303208|FG002|Overall Study|Adverse Event|3|||
162613473|NCT00723398|587303209|FG003|Overall Study|Adverse Event|1|||
162613474|NCT00723398|587303210|FG004|Overall Study|Adverse Event|4|||
162613475|NCT00723398|587303206|FG000|Overall Study|Lost to Follow-up|0|||
162613476|NCT00723398|587303207|FG001|Overall Study|Lost to Follow-up|1|||
162613477|NCT00723398|587303208|FG002|Overall Study|Lost to Follow-up|0|||
162613478|NCT00723398|587303209|FG003|Overall Study|Lost to Follow-up|0|||
162613479|NCT00723398|587303210|FG004|Overall Study|Lost to Follow-up|0|||
162613480|NCT00267189|587303211|FG000|Overall Study|Patient withdrew consent|1|||
162613481|NCT00267189|587303212|FG001|Overall Study|Patient withdrew consent|1|||
162613482|NCT00267189|587303211|FG000|Overall Study|Death|1|||
162613483|NCT00267189|587303212|FG001|Overall Study|Death|0|||
162613484|NCT00267189|587303211|FG000|Overall Study|Missing|3|||
162613485|NCT00267189|587303212|FG001|Overall Study|Missing|0|||
162613486|NCT00751621|587303213|FG000|Overall Study|Adverse Event|1|||
162613487|NCT00751621|587303213|FG000|Overall Study|Withdrawal by Subject|1|||
162613488|NCT00751621|587303213|FG000|Overall Study|Subject moved to another country|1|||
162613489|NCT00751621|587303213|FG000|Overall Study|Poor adherence to asthma treatment|1|||
162613490|NCT03719586|587303214|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
162613491|NCT03719586|587303215|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
162613492|NCT03719586|587303216|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
162613493|NCT03719586|587303217|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
162613494|NCT02791594|587303218|FG000|Overall Study|Physician Decision|2|||
162613495|NCT02310321|587303219|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
162613496|NCT02310321|587303220|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162613497|NCT02310321|587303221|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162613498|NCT02310321|587303219|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
163046221|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046222|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046223|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
162864816|NCT00984659|588209178|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162864817|NCT00984659|588209179|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162864818|NCT00984659|588209176|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
162864819|NCT00984659|588209177|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
162864820|NCT00984659|588209178|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
162864821|NCT00984659|588209179|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
162864822|NCT00984659|588209176|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
162864823|NCT00984659|588209177|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
162864824|NCT00984659|588209178|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
162864825|NCT00984659|588209179|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
162864826|NCT00984659|588209176|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
162864827|NCT00984659|588209177|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
162864828|NCT00984659|588209178|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
162864829|NCT00984659|588209179|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
162864830|NCT00984659|588209176|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
162864831|NCT00984659|588209177|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
162864832|NCT00984659|588209178|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
162864833|NCT00984659|588209179|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
162864834|NCT00984659|588209176|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
162864835|NCT00984659|588209177|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
162864836|NCT00984659|588209178|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
162864837|NCT00984659|588209179|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
162864838|NCT01966731|588209180|FG000|Overall Study|Death|2|||
162864839|NCT01966731|588209180|FG000|Overall Study|Lost to Follow-up|1|||
162958900|NCT03123471|588551683|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
162958901|NCT03123471|588551682|FG000|Placebo-controlled Phase|Miscellaneous|0|||
162958902|NCT03123471|588551683|FG001|Placebo-controlled Phase|Miscellaneous|1|||
162958903|NCT03123471|588551682|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
162958904|NCT03123471|588551683|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
163046224|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046225|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163046226|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
163046227|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
163046228|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163046229|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
163046230|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163046231|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046232|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046233|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046234|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
163046235|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
163046236|NCT01111565|588877341|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046237|NCT01111565|588877342|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046238|NCT01111565|588877343|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046239|NCT01111565|588877344|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
163046240|NCT01111565|588877345|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
163046241|NCT03150082|588877346|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
162613499|NCT02310321|587303220|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162864840|NCT01966731|588209180|FG000|Overall Study|Physician Decision|2|||
162864841|NCT01966731|588209180|FG000|Overall Study|Follow up is not complete|600|||
162864842|NCT01966731|588209180|FG000|Overall Study|Screening Failure|29|||
162958905|NCT03123471|588551682|FG000|Apremilast Extension Phase|Adverse Event|1|||
162958906|NCT03123471|588551683|FG001|Apremilast Extension Phase|Adverse Event|5|||
162958907|NCT03123471|588551682|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
162958908|NCT03123471|588551683|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
162958909|NCT03123471|588551682|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
162958910|NCT03123471|588551683|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
162958911|NCT02358538|588551686|FG000|Through Week 26|Adverse Event|0|||
162958912|NCT02358538|588551687|FG001|Through Week 26|Adverse Event|1|||
162958913|NCT02358538|588551688|FG002|Through Week 26|Adverse Event|1|||
162958914|NCT02358538|588551689|FG003|Through Week 26|Adverse Event|2|||
162958915|NCT02358538|588551686|FG000|Through Week 26|Lack of Efficacy|1|||
162958916|NCT02358538|588551687|FG001|Through Week 26|Lack of Efficacy|1|||
162958917|NCT02358538|588551688|FG002|Through Week 26|Lack of Efficacy|3|||
162864843|NCT01966731|588209180|FG000|Overall Study|Found to be ineligible|1|||
162864844|NCT00592683|588209183|FG000|Overall Study|Found ineligible|0|||
162864845|NCT00592683|588209184|FG001|Overall Study|Found ineligible|1|||
162864846|NCT00592683|588209183|FG000|Overall Study|Withdrawal by Subject|1|||
162864847|NCT00592683|588209184|FG001|Overall Study|Withdrawal by Subject|0|||
162864848|NCT00592683|588209183|FG000|Overall Study|Adverse Event|0|||
162864849|NCT00592683|588209184|FG001|Overall Study|Adverse Event|2|||
162864850|NCT00592683|588209183|FG000|Overall Study|Protocol Violation|1|||
162864851|NCT00592683|588209184|FG001|Overall Study|Protocol Violation|0|||
162864852|NCT00592683|588209183|FG000|Overall Study|Study drug expired|1|||
162864853|NCT00592683|588209184|FG001|Overall Study|Study drug expired|0|||
162864854|NCT00592683|588209183|FG000|Overall Study|Other|1|||
162864855|NCT00592683|588209184|FG001|Overall Study|Other|0|||
162864856|NCT00592683|588209183|FG000|Overall Study|Lost to Follow-up|0|||
162864857|NCT00592683|588209184|FG001|Overall Study|Lost to Follow-up|1|||
162864858|NCT00201201|588209185|FG000|Overall Study|Death|0|||
162864859|NCT00201201|588209186|FG001|Overall Study|Death|2|||
162864860|NCT00201201|588209185|FG000|Overall Study|Withdrawal by Subject|5|||
162864861|NCT00201201|588209186|FG001|Overall Study|Withdrawal by Subject|5|||
162864862|NCT00891657|588209190|FG000|Overall Study|Withdrawal by Subject|1|||
162864863|NCT00891657|588209191|FG001|Overall Study|Withdrawal by Subject|1|||
162864864|NCT00537823|588209199|FG000|Overall Study|Adverse Event|2|||
162864865|NCT00537823|588209200|FG001|Overall Study|Adverse Event|0|||
162864866|NCT03455543|588209201|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
162864867|NCT03455543|588209202|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
162864868|NCT03455543|588209203|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
162864869|NCT03455543|588209201|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
162864870|NCT03455543|588209202|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
162864871|NCT03455543|588209203|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
162864872|NCT03455543|588209201|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
162864873|NCT03455543|588209202|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
162864874|NCT03455543|588209203|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
162864875|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
162864876|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
162864877|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
162864878|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
162864879|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
162864880|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
162864881|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
162864882|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
162864883|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
162864884|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
162864885|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
162864886|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
162864887|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
162864888|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
162864889|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
162864890|NCT03455543|588209201|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
162864891|NCT03455543|588209202|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
162864892|NCT03455543|588209203|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
162864893|NCT00779038|588209204|FG000|Overall Study|Study Prematurely Terminated|13|||
162864894|NCT02717546|588209208|FG000|Overall Study|Lost to Follow-up|12|||
162864895|NCT00909090|588209209|FG000|Overall Study|Lost to Follow-up|17|||
162864896|NCT00909090|588209210|FG001|Overall Study|Lost to Follow-up|17|||
162864897|NCT02926573|588209212|FG000|Overall Study|Nausea|1|||
162864898|NCT02926573|588209213|FG001|Overall Study|Nausea|0|||
162864899|NCT02926573|588209212|FG000|Overall Study|Remain intubated|2|||
162864900|NCT02926573|588209213|FG001|Overall Study|Remain intubated|2|||
162864901|NCT02926573|588209212|FG000|Overall Study|Change in surgery plan|3|||
162864902|NCT02926573|588209213|FG001|Overall Study|Change in surgery plan|1|||
162864903|NCT02926573|588209212|FG000|Overall Study|Change to outpatient status|5|||
162864904|NCT02926573|588209213|FG001|Overall Study|Change to outpatient status|1|||
162864905|NCT02926573|588209212|FG000|Overall Study|Withdrawal by Subject|0|||
162864906|NCT02926573|588209213|FG001|Overall Study|Withdrawal by Subject|2|||
162864907|NCT02926573|588209212|FG000|Overall Study|Return to operating room|0|||
162864908|NCT02926573|588209213|FG001|Overall Study|Return to operating room|2|||
162864909|NCT02926573|588209212|FG000|Overall Study|Delirium|0|||
162864910|NCT02926573|588209213|FG001|Overall Study|Delirium|1|||
162864911|NCT03633331|588209223|FG000|Overall Study|Withdrawal by Subject|1|||
162864912|NCT01009294|588209224|FG000|Overall Study|Study discontinued by Sponsor|6|||
162864913|NCT03240081|588209225|FG000|Overall Study|Withdrawal by Subject|0|||
162864914|NCT03240081|588209226|FG001|Overall Study|Withdrawal by Subject|2|||
162864915|NCT03240081|588209225|FG000|Overall Study|Lost to Follow-up|0|||
162864916|NCT03240081|588209226|FG001|Overall Study|Lost to Follow-up|1|||
162864917|NCT00949650|588209227|FG000|Overall Study|Progressive disease|188|||
162864918|NCT00949650|588209228|FG001|Overall Study|Progressive disease|19|||
162864919|NCT00949650|588209227|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
162864920|NCT00949650|588209228|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
162864921|NCT00949650|588209227|FG000|Overall Study|Other Adverse Event (AE)|28|||
162958918|NCT02358538|588551689|FG003|Through Week 26|Lack of Efficacy|3|||
162958919|NCT02358538|588551686|FG000|Through Week 26|Withdrawal by Subject|1|||
162958920|NCT02358538|588551687|FG001|Through Week 26|Withdrawal by Subject|0|||
162958921|NCT02358538|588551688|FG002|Through Week 26|Withdrawal by Subject|0|||
162958922|NCT02358538|588551689|FG003|Through Week 26|Withdrawal by Subject|0|||
162958923|NCT02358538|588551686|FG000|Through Week 26|Non-Compliance|0|||
162958924|NCT02358538|588551687|FG001|Through Week 26|Non-Compliance|0|||
162958925|NCT02358538|588551688|FG002|Through Week 26|Non-Compliance|1|||
162958926|NCT02358538|588551689|FG003|Through Week 26|Non-Compliance|0|||
162958927|NCT02358538|588551686|FG000|Through Week 26|Family did not see benefit from IP|1|||
162958928|NCT02358538|588551687|FG001|Through Week 26|Family did not see benefit from IP|0|||
162958929|NCT02358538|588551688|FG002|Through Week 26|Family did not see benefit from IP|0|||
162958930|NCT02358538|588551689|FG003|Through Week 26|Family did not see benefit from IP|0|||
162958931|NCT02358538|588551686|FG000|52 Week Extension Period|Lack of Efficacy|0|||
162958932|NCT02358538|588551687|FG001|52 Week Extension Period|Lack of Efficacy|0|||
162958933|NCT02358538|588551688|FG002|52 Week Extension Period|Lack of Efficacy|2|||
162958934|NCT02358538|588551689|FG003|52 Week Extension Period|Lack of Efficacy|4|||
162958935|NCT01686477|588551690|FG000|Feeding Intervention|Death|1|||
162958936|NCT01686477|588551691|FG001|Feeding Intervention|Death|0|||
162958937|NCT01686477|588551692|FG002|Feeding Intervention|Death|1|||
162958938|NCT01686477|588551690|FG000|Feeding Intervention|Withdrawal by Subject|0|||
162958939|NCT01686477|588551691|FG001|Feeding Intervention|Withdrawal by Subject|6|||
162958940|NCT01686477|588551692|FG002|Feeding Intervention|Withdrawal by Subject|0|||
162958941|NCT01686477|588551690|FG000|Feeding Intervention|Physician Decision|1|||
162958942|NCT01686477|588551691|FG001|Feeding Intervention|Physician Decision|2|||
162958943|NCT01686477|588551692|FG002|Feeding Intervention|Physician Decision|0|||
162958944|NCT01686477|588551690|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
162958945|NCT01686477|588551691|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
162958946|NCT01686477|588551692|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
162958947|NCT01686477|588551690|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
162958948|NCT01686477|588551691|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
162958949|NCT01686477|588551692|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
162958950|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
162958951|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
162958952|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
162958953|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
162613500|NCT02310321|587303221|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162613501|NCT02310321|587303219|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
162613502|NCT02310321|587303220|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162613503|NCT02310321|587303221|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162613504|NCT02310321|587303219|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
162613505|NCT02310321|587303220|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
162958954|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
162613506|NCT02310321|587303221|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
162613507|NCT02310321|587303219|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162613508|NCT02310321|587303220|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
162958955|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
162958956|NCT01686477|588551690|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
162613509|NCT02310321|587303221|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162864922|NCT00949650|588209228|FG001|Overall Study|Other Adverse Event (AE)|17|||
162864923|NCT00949650|588209227|FG000|Overall Study|Protocol Violation|1|||
162864924|NCT00949650|588209228|FG001|Overall Study|Protocol Violation|4|||
162864925|NCT00949650|588209227|FG000|Overall Study|Refusal to continue medication|7|||
162864926|NCT00949650|588209228|FG001|Overall Study|Refusal to continue medication|11|||
162864927|NCT00949650|588209227|FG000|Overall Study|Not treated|1|||
162864928|NCT00949650|588209228|FG001|Overall Study|Not treated|4|||
162958957|NCT01686477|588551691|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
162864929|NCT00949650|588209227|FG000|Overall Study|Other not specified above|5|||
162864930|NCT00949650|588209228|FG001|Overall Study|Other not specified above|0|||
162958958|NCT01686477|588551692|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
162958959|NCT01686477|588551690|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
162958960|NCT01686477|588551691|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
162958961|NCT01686477|588551692|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
162958962|NCT01686477|588551690|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
162864931|NCT04601272|588209229|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
162864932|NCT04601272|588209230|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
162864933|NCT04601272|588209231|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
162864934|NCT00940342|588209236|FG000|Overall Study|Adverse Event|0|||
162864935|NCT00940342|588209237|FG001|Overall Study|Adverse Event|2|||
162864936|NCT00940342|588209238|FG002|Overall Study|Adverse Event|1|||
162864937|NCT03249350|588209241|FG000|Overall Study|Participant did not initiate treatment|5|||
162864938|NCT03249350|588209242|FG001|Overall Study|Participant did not initiate treatment|8|||
162864939|NCT01716169|588209244|FG000|Overall Study|Adverse Event|1|||
162864940|NCT01716169|588209244|FG000|Overall Study|Lost to Follow-up|1|||
162864941|NCT01716169|588209244|FG000|Overall Study|Withdrawal by Subject|1|||
162864942|NCT01716169|588209244|FG000|Overall Study|inconsistent dressing application|1|||
162864943|NCT00553787|588209245|FG000|Overall Study|Adverse Event|34|||
162864944|NCT00553787|588209246|FG001|Overall Study|Adverse Event|21|||
162864945|NCT00553787|588209247|FG002|Overall Study|Adverse Event|67|||
162864946|NCT00553787|588209245|FG000|Overall Study|Lost to Follow-up|132|||
162864947|NCT00553787|588209246|FG001|Overall Study|Lost to Follow-up|44|||
162864948|NCT00553787|588209247|FG002|Overall Study|Lost to Follow-up|78|||
162864949|NCT00553787|588209245|FG000|Overall Study|Withdrawal by Subject|151|||
162864950|NCT00553787|588209246|FG001|Overall Study|Withdrawal by Subject|40|||
162864951|NCT00553787|588209247|FG002|Overall Study|Withdrawal by Subject|83|||
162864952|NCT00553787|588209245|FG000|Overall Study|Lack of Efficacy|31|||
162864953|NCT00553787|588209246|FG001|Overall Study|Lack of Efficacy|1|||
162864954|NCT00553787|588209247|FG002|Overall Study|Lack of Efficacy|3|||
162864955|NCT00553787|588209245|FG000|Overall Study|Pregnancy|0|||
162864956|NCT00553787|588209246|FG001|Overall Study|Pregnancy|1|||
162864957|NCT00553787|588209247|FG002|Overall Study|Pregnancy|2|||
162864958|NCT00553787|588209245|FG000|Overall Study|non compliance|4|||
162864959|NCT00553787|588209246|FG001|Overall Study|non compliance|0|||
162864960|NCT00553787|588209247|FG002|Overall Study|non compliance|11|||
162864961|NCT00553787|588209245|FG000|Overall Study|Requirement for restricted medication|8|||
162864962|NCT00553787|588209246|FG001|Overall Study|Requirement for restricted medication|7|||
162864963|NCT00553787|588209247|FG002|Overall Study|Requirement for restricted medication|5|||
162864964|NCT00553787|588209245|FG000|Overall Study|Other|18|||
162864965|NCT00553787|588209246|FG001|Overall Study|Other|10|||
162864966|NCT00553787|588209247|FG002|Overall Study|Other|13|||
162864967|NCT00301067|588209248|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
162864968|NCT00301067|588209249|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
162864969|NCT00301067|588209250|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
162864970|NCT00301067|588209251|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
162864971|NCT00301067|588209248|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
162864972|NCT00301067|588209249|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
162864973|NCT00301067|588209250|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
162864974|NCT00301067|588209251|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
162864975|NCT00301067|588209248|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
162864976|NCT00301067|588209249|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
162864977|NCT00301067|588209250|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
162864978|NCT00301067|588209251|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
162864979|NCT00301067|588209248|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
162864980|NCT00301067|588209249|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
162864981|NCT00301067|588209250|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
162864982|NCT00301067|588209251|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
162864983|NCT00301067|588209248|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
162864984|NCT00301067|588209249|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
162864985|NCT00301067|588209250|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
162864986|NCT00301067|588209251|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
162864987|NCT00301067|588209248|FG000|Follow up Until Death|Alive at last data cut point|1|||
162864988|NCT00301067|588209249|FG001|Follow up Until Death|Alive at last data cut point|0|||
162864989|NCT00301067|588209250|FG002|Follow up Until Death|Alive at last data cut point|0|||
162864990|NCT00301067|588209251|FG003|Follow up Until Death|Alive at last data cut point|1|||
162864991|NCT00149825|588209252|FG000|Overall Study|Intolerance to medication side effects|1|||
162864992|NCT00149825|588209253|FG001|Overall Study|Intolerance to medication side effects|2|||
162864993|NCT00149825|588209252|FG000|Overall Study|Time commitments|2|||
162864994|NCT00149825|588209253|FG001|Overall Study|Time commitments|1|||
162864995|NCT00149825|588209252|FG000|Overall Study|Not liking insomnia therapy|1|||
162864996|NCT00149825|588209253|FG001|Overall Study|Not liking insomnia therapy|0|||
162864997|NCT00149825|588209252|FG000|Overall Study|Other|1|||
163046242|NCT03150082|588877347|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
162864998|NCT00149825|588209253|FG001|Overall Study|Other|0|||
162864999|NCT04285723|588209256|FG000|Overall Study|Subject decision|1|||
162865000|NCT04285723|588209257|FG001|Overall Study|Subject decision|2|||
162865001|NCT04285723|588209256|FG000|Overall Study|Physician Decision|1|||
162865002|NCT04285723|588209257|FG001|Overall Study|Physician Decision|0|||
162865003|NCT04285723|588209256|FG000|Overall Study|No efficiency|1|||
162865004|NCT04285723|588209257|FG001|Overall Study|No efficiency|0|||
162865005|NCT00778999|588209258|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
162865006|NCT00778999|588209259|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
162865007|NCT00778999|588209258|FG000|Overall Study|Did not receive recFSH|14|||
162865008|NCT00778999|588209259|FG001|Overall Study|Did not receive recFSH|20|||
162865009|NCT02032524|588209260|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
162865010|NCT02032524|588209261|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
162865011|NCT02032524|588209262|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
162865012|NCT02032524|588209263|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
162865013|NCT02032524|588209264|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
162865014|NCT02032524|588209265|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
162865015|NCT02032524|588209260|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
162865016|NCT02032524|588209261|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
162865017|NCT02032524|588209262|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
162865018|NCT02032524|588209263|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
162865019|NCT02032524|588209264|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
162865020|NCT02032524|588209265|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
162865021|NCT02032524|588209260|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
162865022|NCT02032524|588209261|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
162865023|NCT02032524|588209262|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
162865024|NCT02032524|588209263|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
162865025|NCT02032524|588209264|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
162865026|NCT02032524|588209265|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
162865027|NCT02032524|588209260|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
162865028|NCT02032524|588209261|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
162865029|NCT02032524|588209262|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
162865030|NCT02032524|588209263|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
162865031|NCT02032524|588209264|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
162865032|NCT02032524|588209265|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
162865033|NCT02032524|588209260|FG000|Period 2: LTS13769 Study|Other|0|||
162865034|NCT02032524|588209261|FG001|Period 2: LTS13769 Study|Other|0|||
162865035|NCT02032524|588209262|FG002|Period 2: LTS13769 Study|Other|0|||
162865036|NCT02032524|588209263|FG003|Period 2: LTS13769 Study|Other|0|||
162865037|NCT02032524|588209264|FG004|Period 2: LTS13769 Study|Other|0|||
162865038|NCT02032524|588209265|FG005|Period 2: LTS13769 Study|Other|1|||
162865039|NCT01089725|588209269|FG000|Overall Study|Adverse Event|1|||
162865040|NCT01089725|588209270|FG001|Overall Study|Adverse Event|1|||
162865041|NCT01089725|588209271|FG002|Overall Study|Adverse Event|0|||
162865042|NCT01089725|588209272|FG003|Overall Study|Adverse Event|0|||
162865043|NCT01089725|588209273|FG004|Overall Study|Adverse Event|2|||
162865044|NCT01089725|588209269|FG000|Overall Study|Lack of Efficacy|4|||
162865045|NCT01089725|588209270|FG001|Overall Study|Lack of Efficacy|3|||
162865046|NCT01089725|588209271|FG002|Overall Study|Lack of Efficacy|1|||
162865047|NCT01089725|588209272|FG003|Overall Study|Lack of Efficacy|0|||
162865048|NCT01089725|588209273|FG004|Overall Study|Lack of Efficacy|4|||
162865049|NCT01089725|588209269|FG000|Overall Study|Lost to Follow-up|2|||
162865050|NCT01089725|588209270|FG001|Overall Study|Lost to Follow-up|2|||
162865051|NCT01089725|588209271|FG002|Overall Study|Lost to Follow-up|0|||
162865052|NCT01089725|588209272|FG003|Overall Study|Lost to Follow-up|3|||
162865053|NCT01089725|588209273|FG004|Overall Study|Lost to Follow-up|0|||
162865054|NCT01089725|588209269|FG000|Overall Study|Protocol Violation|0|||
162865055|NCT01089725|588209270|FG001|Overall Study|Protocol Violation|0|||
162865056|NCT01089725|588209271|FG002|Overall Study|Protocol Violation|1|||
163046243|NCT04131712|588877350|FG000|Overall Study|COVID related|0|||
162865057|NCT01089725|588209272|FG003|Overall Study|Protocol Violation|1|||
162865058|NCT01089725|588209273|FG004|Overall Study|Protocol Violation|0|||
162865059|NCT01089725|588209269|FG000|Overall Study|Withdrawal by Subject|5|||
162865060|NCT01089725|588209270|FG001|Overall Study|Withdrawal by Subject|5|||
162865061|NCT01089725|588209271|FG002|Overall Study|Withdrawal by Subject|4|||
162865062|NCT01089725|588209272|FG003|Overall Study|Withdrawal by Subject|5|||
162865063|NCT01089725|588209273|FG004|Overall Study|Withdrawal by Subject|4|||
162865064|NCT01089725|588209269|FG000|Overall Study|Study Terminated by Sponsor|51|||
162865065|NCT01089725|588209270|FG001|Overall Study|Study Terminated by Sponsor|56|||
162865066|NCT01089725|588209271|FG002|Overall Study|Study Terminated by Sponsor|53|||
162865067|NCT01089725|588209272|FG003|Overall Study|Study Terminated by Sponsor|68|||
162865068|NCT01089725|588209273|FG004|Overall Study|Study Terminated by Sponsor|68|||
162865069|NCT01089725|588209269|FG000|Overall Study|Randomized, but not treated|0|||
162865070|NCT01089725|588209270|FG001|Overall Study|Randomized, but not treated|1|||
162865071|NCT01089725|588209271|FG002|Overall Study|Randomized, but not treated|2|||
162865072|NCT01089725|588209272|FG003|Overall Study|Randomized, but not treated|1|||
162865073|NCT01089725|588209273|FG004|Overall Study|Randomized, but not treated|2|||
162865074|NCT01089725|588209269|FG000|Overall Study|Other|3|||
162865075|NCT01089725|588209270|FG001|Overall Study|Other|0|||
162865076|NCT01089725|588209271|FG002|Overall Study|Other|0|||
162865077|NCT01089725|588209272|FG003|Overall Study|Other|1|||
162865078|NCT01089725|588209273|FG004|Overall Study|Other|0|||
162865079|NCT04168645|588210460|FG000|Overall Study|Lost to Follow-up|23|||
162865080|NCT04168645|588210461|FG001|Overall Study|Lost to Follow-up|28|||
162865081|NCT04168645|588210462|FG002|Overall Study|Lost to Follow-up|15|||
162865082|NCT04168645|588210463|FG003|Overall Study|Lost to Follow-up|12|||
162865083|NCT04168645|588210460|FG000|Overall Study|Death|1|||
162865084|NCT04168645|588210461|FG001|Overall Study|Death|1|||
162865085|NCT04168645|588210462|FG002|Overall Study|Death|0|||
162865086|NCT04168645|588210463|FG003|Overall Study|Death|0|||
162865087|NCT04168645|588210460|FG000|Overall Study|Withdrawal by Subject|5|||
162865088|NCT04168645|588210461|FG001|Overall Study|Withdrawal by Subject|2|||
162865089|NCT04168645|588210462|FG002|Overall Study|Withdrawal by Subject|2|||
162865090|NCT04168645|588210463|FG003|Overall Study|Withdrawal by Subject|2|||
162865091|NCT04168645|588210460|FG000|Overall Study|Administrative Withdrawal|3|||
162865092|NCT04168645|588210461|FG001|Overall Study|Administrative Withdrawal|1|||
162865093|NCT04168645|588210462|FG002|Overall Study|Administrative Withdrawal|1|||
162865094|NCT04168645|588210463|FG003|Overall Study|Administrative Withdrawal|3|||
162865095|NCT01853228|588210464|FG000|Phase 1|Lack of Efficacy|8|||
162865096|NCT01853228|588210465|FG001|Phase 1|Lack of Efficacy|0|||
162865097|NCT01853228|588210464|FG000|Phase 1|Other|1|||
162865098|NCT01853228|588210465|FG001|Phase 1|Other|0|||
162865099|NCT01853228|588210464|FG000|Phase 2|Physician Decision|0|||
162865100|NCT01853228|588210465|FG001|Phase 2|Physician Decision|1|||
162865101|NCT01853228|588210464|FG000|Phase 2|Proceed To Transplant|0|||
162865102|NCT01853228|588210465|FG001|Phase 2|Proceed To Transplant|3|||
162865103|NCT01853228|588210464|FG000|Phase 2|Lack of Efficacy|0|||
162865104|NCT01853228|588210465|FG001|Phase 2|Lack of Efficacy|4|||
162865105|NCT02114203|588210471|FG000|Overall Study|Adverse Event|0|||
162865106|NCT02114203|588210472|FG001|Overall Study|Adverse Event|1|||
162865107|NCT02114203|588210473|FG002|Overall Study|Adverse Event|0|||
162865108|NCT02114203|588210471|FG000|Overall Study|Withdrawal by Subject|0|||
162865109|NCT02114203|588210472|FG001|Overall Study|Withdrawal by Subject|1|||
162865110|NCT02114203|588210473|FG002|Overall Study|Withdrawal by Subject|0|||
162865111|NCT01518699|588210474|FG000|Period 2|Protocol Violation|1|||
162865112|NCT01518699|588210475|FG001|Period 2|Protocol Violation|1|||
162865113|NCT01518699|588210476|FG002|Period 2|Protocol Violation|0|||
162865114|NCT01518699|588210477|FG003|Period 2|Protocol Violation|0|||
162865115|NCT01518699|588210478|FG004|Period 2|Protocol Violation|0|||
162865116|NCT01518699|588210479|FG005|Period 2|Protocol Violation|0|||
162865117|NCT01518699|588210474|FG000|Period 2|Lost to Follow-up|0|||
162865118|NCT01518699|588210475|FG001|Period 2|Lost to Follow-up|1|||
162865119|NCT01518699|588210476|FG002|Period 2|Lost to Follow-up|0|||
162865120|NCT01518699|588210477|FG003|Period 2|Lost to Follow-up|0|||
162865121|NCT01518699|588210478|FG004|Period 2|Lost to Follow-up|0|||
162865122|NCT01518699|588210479|FG005|Period 2|Lost to Follow-up|0|||
162865123|NCT01518699|588210474|FG000|Period 2|Adverse Event|1|||
162865124|NCT01518699|588210475|FG001|Period 2|Adverse Event|0|||
162865125|NCT01518699|588210476|FG002|Period 2|Adverse Event|0|||
162958963|NCT01686477|588551691|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
162865126|NCT01518699|588210477|FG003|Period 2|Adverse Event|0|||
162865127|NCT01518699|588210478|FG004|Period 2|Adverse Event|0|||
162958964|NCT01686477|588551692|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
162958965|NCT06999265|588551694|FG000|Overall Study|Lost to Follow-up|1|||
162958966|NCT06999265|588551695|FG001|Overall Study|Lost to Follow-up|1|||
162958967|NCT02178787|588551696|FG000|Overall Study|Lost to Follow-up|1|||
162958968|NCT02178787|588551697|FG001|Overall Study|Lost to Follow-up|0|||
162958969|NCT02178787|588551696|FG000|Overall Study|Withdrawal by Subject|0|||
162958970|NCT02178787|588551697|FG001|Overall Study|Withdrawal by Subject|2|||
162958971|NCT02178787|588551696|FG000|Overall Study|No TCD window|3|||
162958972|NCT02178787|588551697|FG001|Overall Study|No TCD window|7|||
162958973|NCT02178787|588551696|FG000|Overall Study|Physician Decision|1|||
162958974|NCT02178787|588551697|FG001|Overall Study|Physician Decision|0|||
162958975|NCT01588236|588551702|FG000|Overall Study|Adverse Event|5|||
162958976|NCT01588236|588551703|FG001|Overall Study|Adverse Event|4|||
162613510|NCT02310321|587303219|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
162865128|NCT01518699|588210479|FG005|Period 2|Adverse Event|0|||
162865129|NCT01300286|588210481|FG000|Overall Study|did not get dosed|1|||
162865130|NCT03635190|588210482|FG000|Overall Study|Lost to Follow-up|4|||
162865131|NCT03635190|588210482|FG000|Overall Study|Death|3|||
162865132|NCT03635190|588210482|FG000|Overall Study|Withdrawal by Subject|1|||
162865133|NCT03635190|588210482|FG000|Overall Study|Patient moved and did not return for follow up|1|||
162865134|NCT03692910|588210483|FG000|Overall Study|Lost to Follow-up|4|||
162958977|NCT01588236|588551704|FG002|Overall Study|Adverse Event|1|||
162958978|NCT01588236|588551702|FG000|Overall Study|Lost to Follow-up|8|||
162958979|NCT01588236|588551703|FG001|Overall Study|Lost to Follow-up|13|||
162958980|NCT01588236|588551704|FG002|Overall Study|Lost to Follow-up|6|||
162865135|NCT03692910|588210484|FG001|Overall Study|Lost to Follow-up|0|||
162865136|NCT03692910|588210485|FG002|Overall Study|Lost to Follow-up|0|||
162865137|NCT03692910|588210483|FG000|Overall Study|Withdrawal by Subject|2|||
162958981|NCT01588236|588551702|FG000|Overall Study|Physician Decision|1|||
162865138|NCT03692910|588210484|FG001|Overall Study|Withdrawal by Subject|0|||
162865139|NCT03692910|588210485|FG002|Overall Study|Withdrawal by Subject|0|||
162865140|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
162865141|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
162865142|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
162865143|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
162865144|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
162865145|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
162865146|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
162865147|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
162865148|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
162865149|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
162865150|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
162865151|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
162865152|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
162865153|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
162865154|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
162865155|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
162865156|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
162865157|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
162865158|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
162865159|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
162865160|NCT01259492|588210491|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
162865161|NCT01259492|588210492|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
162865162|NCT01259492|588210493|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
162865163|NCT01259492|588210494|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
162865164|NCT01259492|588210491|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
162865165|NCT01259492|588210492|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
162865166|NCT01259492|588210493|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
162865167|NCT01259492|588210494|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
162865168|NCT01259492|588210491|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
162865169|NCT01259492|588210492|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
162865170|NCT01259492|588210493|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
162865171|NCT01259492|588210494|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
162865172|NCT01259492|588210491|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
162865173|NCT01259492|588210492|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
162865174|NCT01259492|588210493|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
162865175|NCT01259492|588210494|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
162865176|NCT01259492|588210491|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
162865177|NCT01259492|588210492|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
162865178|NCT01259492|588210493|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
162865179|NCT01259492|588210494|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
162865180|NCT01259492|588210491|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
162865181|NCT01259492|588210492|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
162865182|NCT01259492|588210493|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
162865183|NCT01259492|588210494|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
162865184|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
162865185|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
162865186|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
162865187|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
162865188|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
162865189|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
162958982|NCT01588236|588551703|FG001|Overall Study|Physician Decision|2|||
162958983|NCT01588236|588551704|FG002|Overall Study|Physician Decision|0|||
162958984|NCT01588236|588551702|FG000|Overall Study|Protocol Violation|0|||
162958985|NCT01588236|588551703|FG001|Overall Study|Protocol Violation|1|||
162958986|NCT01588236|588551704|FG002|Overall Study|Protocol Violation|1|||
162958987|NCT01588236|588551702|FG000|Overall Study|Withdrawal by Subject|14|||
162958988|NCT01588236|588551703|FG001|Overall Study|Withdrawal by Subject|16|||
162958989|NCT01588236|588551704|FG002|Overall Study|Withdrawal by Subject|18|||
162958990|NCT01588236|588551702|FG000|Overall Study|Exclusion Criteria met during study|2|||
162958991|NCT01588236|588551703|FG001|Overall Study|Exclusion Criteria met during study|1|||
163046244|NCT04131712|588877351|FG001|Overall Study|COVID related|0|||
163046245|NCT04131712|588877352|FG002|Overall Study|COVID related|2|||
163046246|NCT04131712|588877353|FG003|Overall Study|COVID related|0|||
162865190|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
162865191|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
162865192|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
162865193|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
162865194|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
162958992|NCT01588236|588551704|FG002|Overall Study|Exclusion Criteria met during study|0|||
162865195|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
162865196|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
162865197|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
162865198|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
162865199|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
162865200|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
162865201|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
162865202|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
162865203|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
162865204|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
162865205|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
162865206|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
162865207|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
162865208|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
162865209|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
162865210|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
162865211|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
162865212|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
162865213|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
162865214|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
162865215|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
162865216|NCT01259492|588210491|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
162865217|NCT01259492|588210492|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
162865218|NCT01259492|588210493|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
162865219|NCT01259492|588210494|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
162865220|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
162865221|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
162865222|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162865223|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
162865224|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162865225|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162865226|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
162865227|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
162865228|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162865229|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162865230|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162865231|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162865232|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
162865233|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
162865234|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
162865235|NCT00611455|588210512|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
162865236|NCT00611455|588210513|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
162865237|NCT00611455|588210514|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
162865238|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162865239|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
162865240|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162865241|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162865242|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
162865243|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162865244|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162865245|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
162865246|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162865247|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162865248|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
162865249|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162865250|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
162865251|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
162865252|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
162865253|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
162865254|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
162865255|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
162865256|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162865257|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
162865258|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162865259|NCT00611455|588210512|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162865260|NCT00611455|588210513|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
162865261|NCT00611455|588210514|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162865262|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
162865263|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
162865264|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
162865265|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
162865266|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
162865267|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
162865268|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
162865269|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
162865270|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
162865271|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
162865272|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
162865273|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
162865274|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
162865275|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
162865276|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
162865277|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
162865278|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
162865279|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
162865280|NCT00611455|588210512|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
162865281|NCT00611455|588210513|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
162865282|NCT00611455|588210514|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
162865283|NCT03671369|588210515|FG000|Overall Study|Other|1|||
162865284|NCT03671369|588210515|FG000|Overall Study|Withdrawal by Subject|289|||
162865285|NCT03671369|588210515|FG000|Overall Study|Not willing to be vaccinated|1|||
162865286|NCT04382651|588210516|FG000|Overall Study|Death|26|||
162865287|NCT04382651|588210517|FG001|Overall Study|Death|23|||
162865288|NCT04382651|588210516|FG000|Overall Study|Lost to Follow-up|3|||
162865289|NCT04382651|588210517|FG001|Overall Study|Lost to Follow-up|4|||
162865290|NCT04382651|588210516|FG000|Overall Study|Withdrawal by Subject|2|||
162865291|NCT04382651|588210517|FG001|Overall Study|Withdrawal by Subject|0|||
162865292|NCT04382651|588210516|FG000|Overall Study|Physician Decision|0|||
162865293|NCT04382651|588210517|FG001|Overall Study|Physician Decision|1|||
162865294|NCT02732912|588210518|FG000|Overall Study|Discharged before night|2|||
162865295|NCT02732912|588210519|FG001|Overall Study|Discharged before night|6|||
162865296|NCT02732912|588210518|FG000|Overall Study|Incomplete completion of questionnaire|2|||
162865297|NCT02732912|588210519|FG001|Overall Study|Incomplete completion of questionnaire|3|||
162865298|NCT02732912|588210518|FG000|Overall Study|No outcome; discharged or refused|6|||
162865299|NCT02732912|588210519|FG001|Overall Study|No outcome; discharged or refused|9|||
162865300|NCT01507545|588210525|FG000|Overall Study|Withdrawal by Subject|6|||
162865301|NCT01507545|588210526|FG001|Overall Study|Withdrawal by Subject|2|||
162865302|NCT01507545|588210525|FG000|Overall Study|Lost to Follow-up|1|||
162865303|NCT01507545|588210526|FG001|Overall Study|Lost to Follow-up|0|||
162865304|NCT01507545|588210525|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
162865305|NCT01507545|588210526|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
162865306|NCT01507545|588210525|FG000|Overall Study|Progressive disease|60|||
162865307|NCT01507545|588210526|FG001|Overall Study|Progressive disease|27|||
162865308|NCT01507545|588210525|FG000|Overall Study|Other|6|||
162865309|NCT01507545|588210526|FG001|Overall Study|Other|4|||
162865310|NCT00790296|588210528|FG000|Overall Study|Did not meet study eligibility criteria|1|||
162865311|NCT00790296|588210529|FG001|Overall Study|Did not meet study eligibility criteria|1|||
162865312|NCT00790296|588210528|FG000|Overall Study|Adverse Event|0|||
162865313|NCT00790296|588210529|FG001|Overall Study|Adverse Event|1|||
162865314|NCT02612077|588210530|FG000|Overall Study|Adverse Event|3|||
162865315|NCT02612077|588210530|FG000|Overall Study|Withdrawal by Subject|9|||
162865316|NCT02612077|588210530|FG000|Overall Study|Protocol Violation|28|||
162865317|NCT02612077|588210530|FG000|Overall Study|Lost to Follow-up|20|||
162865318|NCT02612077|588210530|FG000|Overall Study|Death|377|||
162865319|NCT02612077|588210530|FG000|Overall Study|Moved or Changed Medical Team|23|||
162865320|NCT02612077|588210530|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
162865321|NCT02612077|588210530|FG000|Overall Study|Disease Progression|3|||
162865322|NCT02612077|588210530|FG000|Overall Study|Unknown reason|2|||
162865323|NCT01753518|588210531|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
162865324|NCT01753518|588210532|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
162865325|NCT01753518|588210531|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
162865326|NCT01753518|588210532|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
162865327|NCT01753518|588210531|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
162865328|NCT01753518|588210532|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
162865329|NCT01753518|588210531|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
162865330|NCT01753518|588210532|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
162865331|NCT01971476|588210533|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
162865332|NCT01971476|588210534|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
162865333|NCT01971476|588210535|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
162865334|NCT01971476|588210533|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
162865335|NCT01971476|588210534|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
162865336|NCT01971476|588210535|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
162865337|NCT01971476|588210533|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
162865338|NCT01971476|588210534|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
162865339|NCT01971476|588210535|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
162865340|NCT05121103|588210538|FG000|Overall Study|Progressive disease|2|||
162865341|NCT05121103|588210539|FG001|Overall Study|Progressive disease|1|||
162865342|NCT05121103|588210540|FG002|Overall Study|Progressive disease|6|||
162865343|NCT05121103|588210538|FG000|Overall Study|Physician Decision|2|||
162865344|NCT05121103|588210539|FG001|Overall Study|Physician Decision|1|||
162865345|NCT05121103|588210540|FG002|Overall Study|Physician Decision|0|||
162865346|NCT05121103|588210538|FG000|Overall Study|Withdrawal by Subject|0|||
162865347|NCT05121103|588210539|FG001|Overall Study|Withdrawal by Subject|1|||
162865348|NCT05121103|588210540|FG002|Overall Study|Withdrawal by Subject|0|||
162865349|NCT00514449|588210541|FG000|Overall Study|Withdrawal by Subject|1|||
162865350|NCT00514449|588210542|FG001|Overall Study|Withdrawal by Subject|2|||
162865351|NCT00514449|588210541|FG000|Overall Study|Protocol Violation|1|||
162865352|NCT00514449|588210542|FG001|Overall Study|Protocol Violation|2|||
162865353|NCT00514449|588210541|FG000|Overall Study|Lost to Follow-up|1|||
162865354|NCT00514449|588210542|FG001|Overall Study|Lost to Follow-up|0|||
162865355|NCT05897853|588210552|FG000|Overall Study|Lost to Follow-up|2|||
162865356|NCT05897853|588210553|FG001|Overall Study|Lost to Follow-up|0|||
162865357|NCT05897853|588210552|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
162865358|NCT05897853|588210553|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
162865359|NCT04458857|588210557|FG000|Overall Study|Adverse Event|0|||
162865360|NCT04458857|588210558|FG001|Overall Study|Adverse Event|1|||
162865361|NCT04458857|588210559|FG002|Overall Study|Adverse Event|0|||
162865362|NCT04458857|588210557|FG000|Overall Study|Withdrawal by Subject|2|||
162865363|NCT04458857|588210558|FG001|Overall Study|Withdrawal by Subject|0|||
162865364|NCT04458857|588210559|FG002|Overall Study|Withdrawal by Subject|0|||
162865365|NCT04458857|588210557|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162865366|NCT04458857|588210558|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162865367|NCT04458857|588210559|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162865368|NCT04458857|588210557|FG000|Overall Study|Non-compliance with study drug|0|||
162865369|NCT04458857|588210558|FG001|Overall Study|Non-compliance with study drug|1|||
162865370|NCT04458857|588210559|FG002|Overall Study|Non-compliance with study drug|0|||
162865371|NCT04458857|588210557|FG000|Overall Study|Lost to Follow-up|4|||
162865372|NCT04458857|588210558|FG001|Overall Study|Lost to Follow-up|1|||
162865373|NCT04458857|588210559|FG002|Overall Study|Lost to Follow-up|0|||
162865374|NCT02609399|588210563|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
162865375|NCT02609399|588210564|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
162865376|NCT02609399|588210563|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
162865377|NCT02609399|588210564|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
162958993|NCT01588236|588551702|FG000|Overall Study|sponsor decision|1|||
162958994|NCT01588236|588551703|FG001|Overall Study|sponsor decision|6|||
162865378|NCT02609399|588210563|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
162865379|NCT02609399|588210564|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
162865380|NCT00306891|588210565|FG000|Part A|Withdrawal by Subject|1|||
162958995|NCT01588236|588551704|FG002|Overall Study|sponsor decision|2|||
162958996|NCT02430480|588551705|FG000|Overall Study|Death|1|||
162958997|NCT02430480|588551705|FG000|Overall Study|Anesthesia concerns|1|||
162958998|NCT02430480|588551705|FG000|Overall Study|Progressed on treatment|1|||
162958999|NCT01030133|588551706|FG000|Overall Study|failed to experience pain at level 7/10|2|||
162959000|NCT01030133|588551707|FG001|Overall Study|failed to experience pain at level 7/10|2|||
162959001|NCT01097577|588551708|FG000|Overall Study|Adverse Event|0|||
163046247|NCT04131712|588877350|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
162865381|NCT00306891|588210566|FG001|Part A|Withdrawal by Subject|1|||
162865382|NCT00306891|588210567|FG002|Part A|Withdrawal by Subject|0|||
162865383|NCT00306891|588210568|FG003|Part A|Withdrawal by Subject|0|||
162959002|NCT01097577|588551709|FG001|Overall Study|Adverse Event|1|||
162959003|NCT04493684|588551717|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
163046248|NCT04131712|588877351|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
163046249|NCT04131712|588877352|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
163046250|NCT04131712|588877353|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
163046251|NCT02299388|588877354|FG000|Overall Study|Withdrawal by Subject|0|||
163046252|NCT02299388|588877355|FG001|Overall Study|Withdrawal by Subject|1|||
163046253|NCT03334188|588877356|FG000|Overall Study|Withdrawal by Subject|0|||
163046254|NCT03334188|588877357|FG001|Overall Study|Withdrawal by Subject|1|||
163046255|NCT03334188|588877356|FG000|Overall Study|Death|1|||
163046256|NCT03334188|588877357|FG001|Overall Study|Death|0|||
163046257|NCT03334188|588877356|FG000|Overall Study|Never had qualifying clinic visit|7|||
162613511|NCT02310321|587303220|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
162613512|NCT02310321|587303221|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
162613513|NCT02310321|587303219|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
162613514|NCT02310321|587303220|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
162613515|NCT02310321|587303221|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
162613516|NCT02310321|587303219|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
162613517|NCT02310321|587303220|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
162613518|NCT02310321|587303221|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
162613519|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
162613520|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
162613521|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
162613522|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
162613523|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
162613524|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
162613525|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
162613526|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
162613527|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
162613528|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
162613529|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
162613530|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
162613531|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
162613532|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
162613533|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
162613534|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
162613535|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
162613536|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
162613537|NCT02310321|587303219|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
162613538|NCT02310321|587303220|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
162613539|NCT02310321|587303221|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
162613540|NCT02310321|587303219|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
162613541|NCT02310321|587303220|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
162613542|NCT02310321|587303221|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
162613543|NCT02310321|587303219|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
162613544|NCT02310321|587303220|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
162613545|NCT02310321|587303221|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
162613546|NCT02310321|587303219|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
162613547|NCT02310321|587303220|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
162613548|NCT02310321|587303221|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
162613549|NCT02310321|587303219|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
162613550|NCT02310321|587303220|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
162613551|NCT02310321|587303221|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
162613552|NCT02310321|587303219|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
162613553|NCT02310321|587303220|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
162613554|NCT02310321|587303221|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
162613555|NCT02310321|587303219|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
162613556|NCT02310321|587303220|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
162613557|NCT02310321|587303221|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
162613558|NCT02310321|587303219|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
162613559|NCT02310321|587303220|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
162613560|NCT02310321|587303221|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
162613561|NCT02310321|587303219|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
162613562|NCT02310321|587303220|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
162613563|NCT02310321|587303221|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
162613564|NCT04950166|587303222|FG000|Overall Study|Withdrawal by Subject|1|||
162613565|NCT01698905|587303223|FG000|Overall Study|Adverse Event|4|||
162613566|NCT01698905|587303223|FG000|Overall Study|Physician Decision|2|||
162865384|NCT00306891|588210565|FG000|Part A|Condition under investigation worsened|2|||
162865385|NCT00306891|588210566|FG001|Part A|Condition under investigation worsened|2|||
162865386|NCT00306891|588210567|FG002|Part A|Condition under investigation worsened|0|||
162865387|NCT00306891|588210568|FG003|Part A|Condition under investigation worsened|0|||
162865388|NCT00306891|588210565|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
162865389|NCT00306891|588210566|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
162865390|NCT00306891|588210567|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
162865391|NCT00306891|588210568|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
162865392|NCT00306891|588210565|FG000|Part A|Partial bowel obstruction|1|||
162865393|NCT00306891|588210566|FG001|Part A|Partial bowel obstruction|0|||
162865394|NCT00306891|588210567|FG002|Part A|Partial bowel obstruction|0|||
162865395|NCT00306891|588210568|FG003|Part A|Partial bowel obstruction|0|||
162865396|NCT00306891|588210565|FG000|Part A|Reaccumul. of ascites following drainage|0|||
162865397|NCT00306891|588210566|FG001|Part A|Reaccumul. of ascites following drainage|1|||
162613567|NCT01698905|587303223|FG000|Overall Study|Pregnancy|1|||
162613568|NCT01698905|587303223|FG000|Overall Study|Protocol Violation|1|||
162613569|NCT01698905|587303223|FG000|Overall Study|Subject/guardian decision|2|||
162613570|NCT01698905|587303223|FG000|Overall Study|Death|1|||
162613571|NCT05896748|587303224|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
162613572|NCT05896748|587303224|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
162613573|NCT05896748|587303224|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
162613574|NCT05896748|587303224|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
162613575|NCT05896748|587303224|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
162613576|NCT00857415|587303232|FG000|Overall Study|Image acquisition failure|2|||
162613577|NCT00857415|587303233|FG001|Overall Study|Image acquisition failure|0|||
162865398|NCT00306891|588210567|FG002|Part A|Reaccumul. of ascites following drainage|0|||
162865399|NCT00306891|588210568|FG003|Part A|Reaccumul. of ascites following drainage|0|||
162865400|NCT00306891|588210565|FG000|Part A|Suspicion of second malignancy|0|||
162959004|NCT04493684|588551718|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959005|NCT04493684|588551719|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
162959006|NCT04493684|588551720|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959007|NCT04493684|588551721|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959008|NCT04493684|588551722|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
162959009|NCT04493684|588551723|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959010|NCT04493684|588551724|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959011|NCT04493684|588551725|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959012|NCT04493684|588551726|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959013|NCT04493684|588551727|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959014|NCT04493684|588551728|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959015|NCT04493684|588551729|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959016|NCT04493684|588551730|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959017|NCT04493684|588551731|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959018|NCT04493684|588551732|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959019|NCT04493684|588551733|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162959020|NCT04493684|588551717|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
162959021|NCT04493684|588551718|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959022|NCT04493684|588551719|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959023|NCT04493684|588551720|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959024|NCT04493684|588551721|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959025|NCT04493684|588551722|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959026|NCT04493684|588551723|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959027|NCT04493684|588551724|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959028|NCT04493684|588551725|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959029|NCT04493684|588551726|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959030|NCT04493684|588551727|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959031|NCT04493684|588551728|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959032|NCT04493684|588551729|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959033|NCT04493684|588551730|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959034|NCT04493684|588551731|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959035|NCT04493684|588551732|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162613578|NCT00857415|587303232|FG000|Overall Study|Invalid image or not imaged|3|||
162613579|NCT00857415|587303233|FG001|Overall Study|Invalid image or not imaged|0|||
162865401|NCT00306891|588210566|FG001|Part A|Suspicion of second malignancy|1|||
162613580|NCT00857415|587303232|FG000|Overall Study|Subject still living at end of study|110|||
162865402|NCT00306891|588210567|FG002|Part A|Suspicion of second malignancy|0|||
162865403|NCT00306891|588210568|FG003|Part A|Suspicion of second malignancy|0|||
162865404|NCT00306891|588210565|FG000|Part A|QTC interval outwith elig. criteria|1|||
162865405|NCT00306891|588210566|FG001|Part A|QTC interval outwith elig. criteria|0|||
162865406|NCT00306891|588210567|FG002|Part A|QTC interval outwith elig. criteria|0|||
162865407|NCT00306891|588210568|FG003|Part A|QTC interval outwith elig. criteria|0|||
162865408|NCT00306891|588210565|FG000|Part B|Death|0|||
162865409|NCT00306891|588210566|FG001|Part B|Death|0|||
162865410|NCT00306891|588210567|FG002|Part B|Death|1|||
162865411|NCT00306891|588210568|FG003|Part B|Death|2|||
162865412|NCT00306891|588210565|FG000|Part B|Adverse Event|0|||
162865413|NCT00306891|588210566|FG001|Part B|Adverse Event|0|||
162865414|NCT00306891|588210567|FG002|Part B|Adverse Event|5|||
162865415|NCT00306891|588210568|FG003|Part B|Adverse Event|5|||
162865416|NCT00306891|588210565|FG000|Part B|Withdrawal by Subject|0|||
162865417|NCT00306891|588210566|FG001|Part B|Withdrawal by Subject|0|||
162865418|NCT00306891|588210567|FG002|Part B|Withdrawal by Subject|3|||
162865419|NCT00306891|588210568|FG003|Part B|Withdrawal by Subject|1|||
162865420|NCT00306891|588210565|FG000|Part B|Condition under investigation worsened|0|||
162865421|NCT00306891|588210566|FG001|Part B|Condition under investigation worsened|0|||
162865422|NCT00306891|588210567|FG002|Part B|Condition under investigation worsened|2|||
162865423|NCT00306891|588210568|FG003|Part B|Condition under investigation worsened|8|||
162865424|NCT00306891|588210565|FG000|Part B|Development of study specific disc crit.|0|||
162865425|NCT00306891|588210566|FG001|Part B|Development of study specific disc crit.|0|||
162865426|NCT00306891|588210567|FG002|Part B|Development of study specific disc crit.|0|||
162865427|NCT00306891|588210568|FG003|Part B|Development of study specific disc crit.|1|||
162865428|NCT00853905|588210572|FG000|Overall Study|Lost to Follow-up|1|||
162865429|NCT00853905|588210573|FG001|Overall Study|Lost to Follow-up|3|||
162865430|NCT00853905|588210572|FG000|Overall Study|Withdrawal by Subject|0|||
162865431|NCT00853905|588210573|FG001|Overall Study|Withdrawal by Subject|1|||
162865432|NCT00853905|588210572|FG000|Overall Study|never had surgery|1|||
162865433|NCT00853905|588210573|FG001|Overall Study|never had surgery|0|||
162865434|NCT00847561|588210576|FG000|Overall Study|Withdrawal by Subject|4|||
162865435|NCT00847561|588210577|FG001|Overall Study|Withdrawal by Subject|3|||
162865436|NCT00847561|588210576|FG000|Overall Study|Unable to schedule|9|||
162865437|NCT00847561|588210577|FG001|Overall Study|Unable to schedule|1|||
162865438|NCT01333189|588210578|FG000|Overall Study|Time constraints|1|||
162865439|NCT01333189|588210579|FG001|Overall Study|Time constraints|0|||
162865440|NCT01333189|588210578|FG000|Overall Study|Adverse Event|1|||
162865441|NCT01333189|588210579|FG001|Overall Study|Adverse Event|0|||
162865442|NCT01333189|588210578|FG000|Overall Study|Transportation difficulties|0|||
162865443|NCT01333189|588210579|FG001|Overall Study|Transportation difficulties|1|||
162865444|NCT01333189|588210578|FG000|Overall Study|Moved from region|0|||
162865445|NCT01333189|588210579|FG001|Overall Study|Moved from region|1|||
162865446|NCT01739595|588210581|FG000|Overall Study|Adverse Event|3|||
162865447|NCT01739595|588210582|FG001|Overall Study|Adverse Event|0|||
162865448|NCT01739595|588210583|FG002|Overall Study|Adverse Event|0|||
162865449|NCT01739595|588210581|FG000|Overall Study|Lost to Follow-up|2|||
163046258|NCT03334188|588877357|FG001|Overall Study|Never had qualifying clinic visit|7|||
163046259|NCT01093586|588877358|FG000|Overall Study|Failed to engraft|3|||
163046260|NCT00357877|588877359|FG000|Overall Study|Death|2|||
163046261|NCT00357877|588877360|FG001|Overall Study|Death|1|||
163046262|NCT00357877|588877359|FG000|Overall Study|Lost to Follow-up|20|||
163046263|NCT00357877|588877360|FG001|Overall Study|Lost to Follow-up|23|||
163046264|NCT00357877|588877359|FG000|Overall Study|Withdrawal by Subject|3|||
163046265|NCT00357877|588877360|FG001|Overall Study|Withdrawal by Subject|3|||
163046266|NCT00357877|588877359|FG000|Overall Study|Administrative withdrawal|1|||
163046267|NCT00357877|588877360|FG001|Overall Study|Administrative withdrawal|1|||
163046268|NCT00357877|588877359|FG000|Overall Study|Other|0|||
163046269|NCT00357877|588877360|FG001|Overall Study|Other|2|||
163046270|NCT00613366|588877370|FG000|Overall Study|Withdrawal by Subject|3|||
163046271|NCT00613366|588877371|FG001|Overall Study|Withdrawal by Subject|2|||
162865450|NCT01739595|588210582|FG001|Overall Study|Lost to Follow-up|0|||
162865451|NCT01739595|588210583|FG002|Overall Study|Lost to Follow-up|0|||
162865452|NCT01739595|588210581|FG000|Overall Study|Withdrawal by Subject|2|||
162865453|NCT01739595|588210582|FG001|Overall Study|Withdrawal by Subject|1|||
163046272|NCT00943397|588877372|FG000|Overall Study|Adverse Event|0|||
163046273|NCT00943397|588877373|FG001|Overall Study|Adverse Event|6|||
163046274|NCT00943397|588877372|FG000|Overall Study|Lost to Follow-up|0|||
163046275|NCT00943397|588877373|FG001|Overall Study|Lost to Follow-up|4|||
163046276|NCT00943397|588877372|FG000|Overall Study|Protocol Violation|2|||
162865454|NCT01739595|588210583|FG002|Overall Study|Withdrawal by Subject|2|||
162865455|NCT01739595|588210581|FG000|Overall Study|Eligibility issue|3|||
162865456|NCT01739595|588210582|FG001|Overall Study|Eligibility issue|0|||
162865457|NCT01739595|588210583|FG002|Overall Study|Eligibility issue|0|||
162865458|NCT01739595|588210581|FG000|Overall Study|Protocol Violation|1|||
162865459|NCT01739595|588210582|FG001|Overall Study|Protocol Violation|0|||
162865460|NCT01739595|588210583|FG002|Overall Study|Protocol Violation|0|||
162865461|NCT01739595|588210581|FG000|Overall Study|Lab assessment|1|||
162865462|NCT01739595|588210582|FG001|Overall Study|Lab assessment|0|||
162865463|NCT01739595|588210583|FG002|Overall Study|Lab assessment|0|||
162865464|NCT01739595|588210581|FG000|Overall Study|Drug discrepancy|1|||
162865465|NCT01739595|588210582|FG001|Overall Study|Drug discrepancy|0|||
162865466|NCT01739595|588210583|FG002|Overall Study|Drug discrepancy|0|||
162865467|NCT02725177|588210586|FG000|Overall Study|Physician Decision|4|||
162865468|NCT02725177|588210586|FG000|Overall Study|Adverse Event|1|||
162865469|NCT02903511|588210588|FG000|Overall Study|Withdrawal by Subject|1|||
162865470|NCT02903511|588210589|FG001|Overall Study|Withdrawal by Subject|0|||
162865471|NCT02903511|588210588|FG000|Overall Study|Lost to Follow-up|3|||
162865472|NCT02903511|588210589|FG001|Overall Study|Lost to Follow-up|2|||
162865473|NCT00969618|588210590|FG000|Overall Study|Adverse Event|29|||
162865474|NCT00969618|588210590|FG000|Overall Study|Entry Criteria Not Met|3|||
162865475|NCT00969618|588210590|FG000|Overall Study|Lack of Efficacy|2|||
162865476|NCT00969618|588210590|FG000|Overall Study|Lost to Follow-up|7|||
162865477|NCT00969618|588210590|FG000|Overall Study|Physician Decision|1|||
162865478|NCT00969618|588210590|FG000|Overall Study|Protocol Violation|9|||
162865479|NCT00969618|588210590|FG000|Overall Study|Withdrawal by Subject|27|||
162865480|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
162865481|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
162865482|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
162865483|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
162865484|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
162865485|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162865486|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162865487|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162865488|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
162865489|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
162865490|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
162865491|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
162865492|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
162865493|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
162865494|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
162865495|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
162865496|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
162865497|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162865498|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162865499|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
162865500|NCT01894516|588212013|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162865501|NCT01894516|588212014|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
162865502|NCT01894516|588212015|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
162865503|NCT01894516|588212016|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162865504|NCT01894516|588212013|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
162865505|NCT01894516|588212014|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
162865506|NCT01894516|588212015|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
162865507|NCT01894516|588212016|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
162865508|NCT01894516|588212013|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162865509|NCT01894516|588212014|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162865510|NCT01894516|588212015|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
162865511|NCT01894516|588212016|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162865512|NCT00375934|588212025|FG000|Overall Study|Adverse Event|1|||
162865513|NCT00375934|588212026|FG001|Overall Study|Adverse Event|1|||
162865514|NCT00375934|588212025|FG000|Overall Study|Withdrawal by Subject|2|||
162865515|NCT00375934|588212026|FG001|Overall Study|Withdrawal by Subject|2|||
162865516|NCT00375934|588212025|FG000|Overall Study|Lack of Efficacy|0|||
162865517|NCT00375934|588212026|FG001|Overall Study|Lack of Efficacy|2|||
162865518|NCT00375934|588212025|FG000|Overall Study|Physician Decision|0|||
162865519|NCT00375934|588212026|FG001|Overall Study|Physician Decision|1|||
162865520|NCT03191396|588212027|FG000|Overall Study|Lost to Follow-up|0|||
162865521|NCT03191396|588212028|FG001|Overall Study|Lost to Follow-up|3|||
162865522|NCT03191396|588212027|FG000|Overall Study|Withdrawal by Subject|3|||
162865523|NCT03191396|588212028|FG001|Overall Study|Withdrawal by Subject|2|||
162959036|NCT04493684|588551733|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162959037|NCT04493684|588551717|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959038|NCT04493684|588551718|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959039|NCT04493684|588551719|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959040|NCT04493684|588551720|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959041|NCT04493684|588551721|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959042|NCT04493684|588551722|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162865524|NCT00893113|588212029|FG000|Overall Study|Lost to Follow-up|4|||
162865525|NCT00893113|588212030|FG001|Overall Study|Lost to Follow-up|8|||
162865526|NCT00893113|588212029|FG000|Overall Study|Early Termination|1|||
163046277|NCT00943397|588877373|FG001|Overall Study|Protocol Violation|5|||
163046278|NCT00943397|588877372|FG000|Overall Study|Withdrawal by Subject|1|||
163046279|NCT00943397|588877373|FG001|Overall Study|Withdrawal by Subject|1|||
163046280|NCT00943397|588877372|FG000|Overall Study|Site terminated and other|12|||
163046281|NCT00943397|588877373|FG001|Overall Study|Site terminated and other|56|||
163046282|NCT01765296|588877374|FG000|Overall Study|Protocol Violation|0|||
163046283|NCT01765296|588877375|FG001|Overall Study|Protocol Violation|5|||
162865527|NCT00893113|588212030|FG001|Overall Study|Early Termination|1|||
162865528|NCT00893113|588212029|FG000|Overall Study|Withdrew Consent|8|||
162865529|NCT00893113|588212030|FG001|Overall Study|Withdrew Consent|7|||
162865530|NCT01240811|588212033|FG000|Overall Study|Physician Decision|0|||
162865531|NCT01240811|588212034|FG001|Overall Study|Physician Decision|1|||
162865532|NCT01240811|588212035|FG002|Overall Study|Physician Decision|0|||
162865533|NCT01240811|588212033|FG000|Overall Study|Withdrawal by Subject|0|||
162865534|NCT01240811|588212034|FG001|Overall Study|Withdrawal by Subject|0|||
162865535|NCT01240811|588212035|FG002|Overall Study|Withdrawal by Subject|1|||
162865536|NCT00486226|588212054|FG000|Overall Study|Death|3|||
162865537|NCT00486226|588212054|FG000|Overall Study|Adverse Event|1|||
162865538|NCT00486226|588212054|FG000|Overall Study|Withdrawal by Subject|1|||
162865539|NCT00486226|588212054|FG000|Overall Study|Lost to Follow-up|8|||
162865540|NCT00500149|588212055|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
162865541|NCT00500149|588212056|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
162865542|NCT00500149|588212055|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
162865543|NCT00500149|588212056|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
162865544|NCT00500149|588212055|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
162865545|NCT00500149|588212056|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
162865546|NCT00500149|588212055|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
162865547|NCT00500149|588212056|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
162865548|NCT00500149|588212055|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
162865549|NCT00500149|588212056|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
162865550|NCT00500149|588212055|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
162865551|NCT00500149|588212056|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
162865552|NCT00500149|588212055|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
162865553|NCT00500149|588212056|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
162865554|NCT01157169|588212057|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
162865555|NCT01157169|588212058|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
162865556|NCT01157169|588212057|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
162865557|NCT01157169|588212058|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
163046284|NCT01765296|588877376|FG002|Overall Study|Protocol Violation|4|||
163046285|NCT01765296|588877374|FG000|Overall Study|Withdrawal by Subject|4|||
163046286|NCT01765296|588877375|FG001|Overall Study|Withdrawal by Subject|2|||
163046287|NCT01765296|588877376|FG002|Overall Study|Withdrawal by Subject|2|||
163046288|NCT01765296|588877374|FG000|Overall Study|Adverse Event|1|||
163046289|NCT01765296|588877375|FG001|Overall Study|Adverse Event|13|||
163046290|NCT01765296|588877376|FG002|Overall Study|Adverse Event|5|||
163046291|NCT01765296|588877374|FG000|Overall Study|Lack of Efficacy|0|||
163046292|NCT01765296|588877375|FG001|Overall Study|Lack of Efficacy|0|||
163046293|NCT01765296|588877376|FG002|Overall Study|Lack of Efficacy|2|||
163046294|NCT03257436|588877377|FG000|Overall Study|Withdrawal by Subject|76|||
163046295|NCT03257436|588877377|FG000|Overall Study|Death|19|||
163046296|NCT01619852|588877378|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
163046297|NCT01619852|588877379|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
163046298|NCT01619852|588877378|FG000|3 Month Follow up|Lost to Follow-up|31|||
163046299|NCT01619852|588877379|FG001|3 Month Follow up|Lost to Follow-up|34|||
163046300|NCT00970489|588877380|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
163046301|NCT00970489|588877381|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
163046302|NCT03489343|588877385|FG000|Overall Study|Documented progressive disease|1|||
163046303|NCT03489343|588877386|FG001|Overall Study|Documented progressive disease|0|||
163046304|NCT03489343|588877387|FG002|Overall Study|Documented progressive disease|3|||
163046305|NCT03489343|588877388|FG003|Overall Study|Documented progressive disease|1|||
163046306|NCT03489343|588877389|FG004|Overall Study|Documented progressive disease|3|||
162865558|NCT02940886|588212059|FG000|Overall Study|Adverse Event|7|||
162865559|NCT02940886|588212060|FG001|Overall Study|Adverse Event|3|||
162865560|NCT02940886|588212059|FG000|Overall Study|Protocol Violation|0|||
163046307|NCT03489343|588877390|FG005|Overall Study|Documented progressive disease|5|||
162865561|NCT02940886|588212060|FG001|Overall Study|Protocol Violation|2|||
162865562|NCT02940886|588212059|FG000|Overall Study|Withdrawal by Subject|28|||
162865563|NCT02940886|588212060|FG001|Overall Study|Withdrawal by Subject|20|||
163046308|NCT03489343|588877391|FG006|Overall Study|Documented progressive disease|4|||
163046309|NCT03489343|588877385|FG000|Overall Study|Adverse Event|0|||
163046310|NCT03489343|588877386|FG001|Overall Study|Adverse Event|1|||
163046311|NCT03489343|588877387|FG002|Overall Study|Adverse Event|0|||
163046312|NCT03489343|588877388|FG003|Overall Study|Adverse Event|0|||
162865564|NCT02940886|588212059|FG000|Overall Study|Death|1|||
162865565|NCT02940886|588212060|FG001|Overall Study|Death|0|||
162865566|NCT02940886|588212059|FG000|Overall Study|Lack of Efficacy|1|||
162865567|NCT02940886|588212060|FG001|Overall Study|Lack of Efficacy|0|||
162865568|NCT02940886|588212059|FG000|Overall Study|Lost to Follow-up|49|||
162865569|NCT02940886|588212060|FG001|Overall Study|Lost to Follow-up|21|||
162865570|NCT02940886|588212059|FG000|Overall Study|Physician Decision|9|||
162865571|NCT02940886|588212060|FG001|Overall Study|Physician Decision|4|||
162865572|NCT02940886|588212059|FG000|Overall Study|Sponsor decision|0|||
162865573|NCT02940886|588212060|FG001|Overall Study|Sponsor decision|1|||
162865574|NCT02940886|588212059|FG000|Overall Study|No treatment|7|||
162865575|NCT02940886|588212060|FG001|Overall Study|No treatment|2|||
162865576|NCT02940886|588212059|FG000|Overall Study|Enrolment error|0|||
162865577|NCT02940886|588212060|FG001|Overall Study|Enrolment error|1|||
162865578|NCT03042611|588212061|FG000|Core Phase|Withdrawal by Subject|13|||
162865579|NCT03042611|588212062|FG001|Core Phase|Withdrawal by Subject|4|||
162865580|NCT03042611|588212063|FG002|Core Phase|Withdrawal by Subject|0|||
162865581|NCT03042611|588212064|FG003|Core Phase|Withdrawal by Subject|0|||
162865582|NCT03042611|588212061|FG000|Core Phase|Death|232|||
162865583|NCT03042611|588212062|FG001|Core Phase|Death|110|||
162613581|NCT00857415|587303233|FG001|Overall Study|Subject still living at end of study|0|||
162613582|NCT00857415|587303232|FG000|Overall Study|Deceased with no autopsy|2|||
162865584|NCT03042611|588212063|FG002|Core Phase|Death|0|||
162613583|NCT00857415|587303233|FG001|Overall Study|Deceased with no autopsy|0|||
162613584|NCT04508140|587303234|FG000|Overall Study|Adverse Event|2|||
162613585|NCT04508140|587303235|FG001|Overall Study|Adverse Event|2|||
162613586|NCT04508140|587303234|FG000|Overall Study|Withdrawal by Subject|0|||
162613587|NCT04508140|587303235|FG001|Overall Study|Withdrawal by Subject|2|||
162613588|NCT04508140|587303234|FG000|Overall Study|progressive disease|9|||
162613589|NCT04508140|587303235|FG001|Overall Study|progressive disease|3|||
162613590|NCT01822678|587303236|FG000|Overall Study|Withdrawal by Subject|5|||
162613591|NCT01822678|587303237|FG001|Overall Study|Withdrawal by Subject|4|||
162613592|NCT01822678|587303238|FG002|Overall Study|Withdrawal by Subject|4|||
162613593|NCT01822678|587303236|FG000|Overall Study|Adverse Event|4|||
162613594|NCT01822678|587303237|FG001|Overall Study|Adverse Event|3|||
162613595|NCT01822678|587303238|FG002|Overall Study|Adverse Event|1|||
162613596|NCT01822678|587303236|FG000|Overall Study|Lack of Efficacy|3|||
162613597|NCT01822678|587303237|FG001|Overall Study|Lack of Efficacy|6|||
162613598|NCT01822678|587303238|FG002|Overall Study|Lack of Efficacy|5|||
162613599|NCT01822678|587303236|FG000|Overall Study|Lost to Follow-up|0|||
162613600|NCT01822678|587303237|FG001|Overall Study|Lost to Follow-up|2|||
162613601|NCT01822678|587303238|FG002|Overall Study|Lost to Follow-up|1|||
162865585|NCT03042611|588212064|FG003|Core Phase|Death|0|||
162865586|NCT03042611|588212061|FG000|Core Phase|Lost to Follow-up|4|||
162613602|NCT00764504|587303239|FG000|Overall Study|Death|12|||
162613603|NCT00764504|587303240|FG001|Overall Study|Death|6|||
162613604|NCT00764504|587303241|FG002|Overall Study|Death|13|||
162865587|NCT03042611|588212062|FG001|Core Phase|Lost to Follow-up|7|||
162865588|NCT03042611|588212063|FG002|Core Phase|Lost to Follow-up|0|||
162865589|NCT03042611|588212064|FG003|Core Phase|Lost to Follow-up|0|||
162865590|NCT03042611|588212061|FG000|Core Phase|Physician Decision|7|||
162613605|NCT00764504|587303239|FG000|Overall Study|Revision of Device|12|||
162613606|NCT00764504|587303240|FG001|Overall Study|Revision of Device|23|||
162613607|NCT00764504|587303241|FG002|Overall Study|Revision of Device|14|||
162613608|NCT00764504|587303239|FG000|Overall Study|Physician Decision|1|||
162865591|NCT03042611|588212062|FG001|Core Phase|Physician Decision|2|||
162865592|NCT03042611|588212063|FG002|Core Phase|Physician Decision|0|||
162865593|NCT03042611|588212064|FG003|Core Phase|Physician Decision|0|||
162865594|NCT03042611|588212061|FG000|Core Phase|Study Closed|0|||
162865595|NCT03042611|588212062|FG001|Core Phase|Study Closed|1|||
162865596|NCT03042611|588212063|FG002|Core Phase|Study Closed|0|||
162865597|NCT03042611|588212064|FG003|Core Phase|Study Closed|0|||
162865598|NCT03042611|588212061|FG000|Extension Phase|Death|0|||
162865599|NCT03042611|588212062|FG001|Extension Phase|Death|0|||
162865600|NCT03042611|588212063|FG002|Extension Phase|Death|34|||
162865601|NCT03042611|588212064|FG003|Extension Phase|Death|16|||
162865602|NCT03042611|588212061|FG000|Extension Phase|Lost to Follow-up|0|||
162865603|NCT03042611|588212062|FG001|Extension Phase|Lost to Follow-up|0|||
162865604|NCT03042611|588212063|FG002|Extension Phase|Lost to Follow-up|1|||
162865605|NCT03042611|588212064|FG003|Extension Phase|Lost to Follow-up|1|||
162865606|NCT03042611|588212061|FG000|Extension Phase|Study Closed|0|||
162865607|NCT03042611|588212062|FG001|Extension Phase|Study Closed|0|||
162865608|NCT03042611|588212063|FG002|Extension Phase|Study Closed|17|||
162865609|NCT03042611|588212064|FG003|Extension Phase|Study Closed|11|||
162865610|NCT00474630|588212065|FG000|Overall Study|Adverse Event|98|||
162865611|NCT00474630|588212066|FG001|Overall Study|Adverse Event|26|||
162865612|NCT00474630|588212065|FG000|Overall Study|Lost to Follow-up|22|||
162865613|NCT00474630|588212066|FG001|Overall Study|Lost to Follow-up|15|||
162865614|NCT00474630|588212065|FG000|Overall Study|Withdrawal by Subject|21|||
162865615|NCT00474630|588212066|FG001|Overall Study|Withdrawal by Subject|15|||
162865616|NCT00474630|588212065|FG000|Overall Study|Protocol Violation|3|||
162865617|NCT00474630|588212066|FG001|Overall Study|Protocol Violation|4|||
162865618|NCT00474630|588212065|FG000|Overall Study|Lack of Efficacy|5|||
162865619|NCT00474630|588212066|FG001|Overall Study|Lack of Efficacy|6|||
162865620|NCT00474630|588212065|FG000|Overall Study|Drug noncompliance, other|11|||
162865621|NCT00474630|588212066|FG001|Overall Study|Drug noncompliance, other|4|||
162865622|NCT02397655|588212072|FG000|Overall Study|data not completed|1301|||
162865623|NCT00545818|588212086|FG000|Overall Study|Protocol Violation|1|||
162865624|NCT00545818|588212087|FG001|Overall Study|Protocol Violation|0|||
162865625|NCT00545818|588212086|FG000|Overall Study|Adverse Event|1|||
162865626|NCT00545818|588212087|FG001|Overall Study|Adverse Event|1|||
162865627|NCT00545818|588212086|FG000|Overall Study|Lost to Follow-up|1|||
162865628|NCT00545818|588212087|FG001|Overall Study|Lost to Follow-up|6|||
162865629|NCT02623361|588212088|FG000|Overall Study|Protocol Violation|0|||
162865630|NCT02623361|588212089|FG001|Overall Study|Protocol Violation|1|||
162865631|NCT02623361|588212088|FG000|Overall Study|Withdrawal by Subject|0|||
162865632|NCT02623361|588212089|FG001|Overall Study|Withdrawal by Subject|1|||
162865633|NCT01873742|588212090|FG000|Overall Study|Lost to Follow-up|68|||
162865634|NCT01873742|588212091|FG001|Overall Study|Lost to Follow-up|76|||
162865635|NCT02498821|588212092|FG000|Overall Study|Screen failure|3|||
162865636|NCT02498821|588212093|FG001|Overall Study|Screen failure|5|||
162865637|NCT00942708|588212095|FG000|Overall Study|Withdrawal by Subject|1|||
162865638|NCT01457339|588212096|FG000|Period 3 (100 mg)|Adverse Event|0|||
162865639|NCT01457339|588212097|FG001|Period 3 (100 mg)|Adverse Event|1|||
162865640|NCT01457339|588212096|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
162865641|NCT01457339|588212097|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
162865642|NCT01457339|588212096|FG000|Period 6 (250 mg)|Family Emergency|1|||
162865643|NCT01457339|588212097|FG001|Period 6 (250 mg)|Family Emergency|0|||
162865644|NCT01457339|588212096|FG000|Period 6 (250 mg)|Personal appointment|0|||
162865645|NCT01457339|588212097|FG001|Period 6 (250 mg)|Personal appointment|1|||
162865646|NCT00995371|588212098|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
162865647|NCT00995371|588212099|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
162865648|NCT00673673|588212100|FG000|Overall Study|Progressive disease|27|||
162865649|NCT00673673|588212100|FG000|Overall Study|Adverse Event|4|||
162865650|NCT00673673|588212100|FG000|Overall Study|Withdrawal by Subject|3|||
162865651|NCT00673673|588212100|FG000|Overall Study|Investigators' discretion|2|||
162865652|NCT00206518|588212106|FG000|Overall Study|Lack of Efficacy|6|||
162865653|NCT00206518|588212107|FG001|Overall Study|Lack of Efficacy|4|||
162865654|NCT00206518|588212106|FG000|Overall Study|Adverse Event|2|||
162865655|NCT00206518|588212107|FG001|Overall Study|Adverse Event|1|||
162865656|NCT00206518|588212106|FG000|Overall Study|Physician Decision|1|||
162865657|NCT00206518|588212107|FG001|Overall Study|Physician Decision|0|||
162865658|NCT00206518|588212106|FG000|Overall Study|Protocol Violation|1|||
162865659|NCT00206518|588212107|FG001|Overall Study|Protocol Violation|1|||
162865660|NCT02335450|588212108|FG000|Overall Study|Pregnancy|1|||
162865661|NCT02613572|588212109|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
162865662|NCT02613572|588212110|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
162865663|NCT02613572|588212111|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
162865664|NCT02613572|588212109|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
162865665|NCT02613572|588212110|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
162865666|NCT02613572|588212111|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
162865667|NCT04538950|588212114|FG000|Overall Study|Pulmonary Issues|2|||
162865668|NCT04538950|588212114|FG000|Overall Study|illness|2|||
162865669|NCT05258058|588212115|FG000|Overall Study|Withdrawal by Subject|2|||
162865670|NCT04579393|588212118|FG000|Overall Study|Withdrawal by Subject|2|||
162706116|NCT01764386|587636540|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
162706117|NCT01764386|587636541|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
162706118|NCT01764386|587636540|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
162706119|NCT01764386|587636541|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
162706120|NCT01764386|587636540|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
162865671|NCT04579393|588212119|FG001|Overall Study|Withdrawal by Subject|2|||
162865672|NCT04579393|588212118|FG000|Overall Study|Death|1|||
162865673|NCT04579393|588212119|FG001|Overall Study|Death|3|||
162865674|NCT00393458|588212122|FG000|Overall Study|Adverse Event|35|||
162865675|NCT00393458|588212123|FG001|Overall Study|Adverse Event|24|||
162865676|NCT00393458|588212124|FG002|Overall Study|Adverse Event|40|||
162865677|NCT00393458|588212125|FG003|Overall Study|Adverse Event|35|||
162865678|NCT00393458|588212122|FG000|Overall Study|Subject withdrew consent|27|||
162865679|NCT00393458|588212123|FG001|Overall Study|Subject withdrew consent|40|||
162865680|NCT00393458|588212124|FG002|Overall Study|Subject withdrew consent|33|||
162865681|NCT00393458|588212125|FG003|Overall Study|Subject withdrew consent|50|||
162865682|NCT00393458|588212122|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
162865683|NCT00393458|588212123|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
162865684|NCT00393458|588212124|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
162865685|NCT00393458|588212125|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
162865686|NCT00393458|588212122|FG000|Overall Study|Protocol deviation|11|||
162865687|NCT00393458|588212123|FG001|Overall Study|Protocol deviation|11|||
162865688|NCT00393458|588212124|FG002|Overall Study|Protocol deviation|11|||
162865689|NCT00393458|588212125|FG003|Overall Study|Protocol deviation|10|||
162865690|NCT00393458|588212122|FG000|Overall Study|Administrative problems|7|||
162865691|NCT00393458|588212123|FG001|Overall Study|Administrative problems|8|||
162865692|NCT00393458|588212124|FG002|Overall Study|Administrative problems|5|||
162865693|NCT00393458|588212125|FG003|Overall Study|Administrative problems|2|||
162865694|NCT00393458|588212122|FG000|Overall Study|Lost to Follow-up|5|||
162865695|NCT00393458|588212123|FG001|Overall Study|Lost to Follow-up|6|||
162865696|NCT00393458|588212124|FG002|Overall Study|Lost to Follow-up|5|||
162865697|NCT00393458|588212125|FG003|Overall Study|Lost to Follow-up|3|||
162865698|NCT00393458|588212122|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162865699|NCT00393458|588212123|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162959043|NCT04493684|588551723|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
162959044|NCT04493684|588551724|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959045|NCT04493684|588551725|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959046|NCT04493684|588551726|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959047|NCT04493684|588551727|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959048|NCT04493684|588551728|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959049|NCT04493684|588551729|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959050|NCT04493684|588551730|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959051|NCT04493684|588551731|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959052|NCT04493684|588551732|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959053|NCT04493684|588551733|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
162959054|NCT04493684|588551717|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
162959055|NCT04493684|588551718|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959056|NCT04493684|588551719|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959057|NCT04493684|588551720|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959058|NCT04493684|588551721|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959059|NCT04493684|588551722|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959060|NCT04493684|588551723|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959061|NCT04493684|588551724|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959062|NCT04493684|588551725|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959063|NCT04493684|588551726|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959064|NCT04493684|588551727|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959065|NCT04493684|588551728|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959066|NCT04493684|588551729|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959067|NCT04493684|588551730|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959068|NCT04493684|588551731|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959069|NCT04493684|588551732|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959070|NCT04493684|588551733|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
162959071|NCT04493684|588551717|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959072|NCT04493684|588551718|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
163046313|NCT03489343|588877389|FG004|Overall Study|Adverse Event|0|||
162865700|NCT00393458|588212124|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162865701|NCT00393458|588212125|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162865702|NCT00393458|588212122|FG000|Overall Study|Death|1|||
162865703|NCT00393458|588212123|FG001|Overall Study|Death|1|||
162865704|NCT00393458|588212124|FG002|Overall Study|Death|5|||
162865705|NCT00393458|588212125|FG003|Overall Study|Death|5|||
162865706|NCT00393458|588212122|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162865707|NCT00393458|588212123|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162865708|NCT00393458|588212124|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162865709|NCT00393458|588212125|FG003|Overall Study|Abnormal test procedure result(s)|2|||
162865710|NCT00393458|588212122|FG000|Overall Study|Subject no longer requires study drug|0|||
162865711|NCT00393458|588212123|FG001|Overall Study|Subject no longer requires study drug|1|||
162865712|NCT00393458|588212124|FG002|Overall Study|Subject no longer requires study drug|0|||
162865713|NCT00393458|588212125|FG003|Overall Study|Subject no longer requires study drug|0|||
162865714|NCT01282814|588212132|FG000|First Intervention|Emesis During Dosing Interval|0|||
162865715|NCT01282814|588212133|FG001|First Intervention|Emesis During Dosing Interval|3|||
162865716|NCT01282814|588212132|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
162865717|NCT01282814|588212133|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162865718|NCT01524289|588212134|FG000|Overall Study|Lost to Follow-up|0|||
162865719|NCT01524289|588212135|FG001|Overall Study|Lost to Follow-up|1|||
162865720|NCT01524289|588212134|FG000|Overall Study|Physician Decision|1|||
162865721|NCT01524289|588212135|FG001|Overall Study|Physician Decision|0|||
162865722|NCT01524289|588212134|FG000|Overall Study|Protocol Violation|5|||
162959073|NCT04493684|588551719|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959074|NCT04493684|588551720|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959075|NCT04493684|588551721|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162865723|NCT01524289|588212135|FG001|Overall Study|Protocol Violation|1|||
162865724|NCT01524289|588212134|FG000|Overall Study|Withdrawal by Subject|11|||
162865725|NCT01524289|588212135|FG001|Overall Study|Withdrawal by Subject|7|||
162865726|NCT01524289|588212134|FG000|Overall Study|Adverse Event|12|||
162865727|NCT01524289|588212135|FG001|Overall Study|Adverse Event|5|||
162865728|NCT01524289|588212134|FG000|Overall Study|Did not take study medication|1|||
162865729|NCT01524289|588212135|FG001|Overall Study|Did not take study medication|0|||
162865730|NCT02704429|588212138|FG000|Part A: 24 Weeks|Adverse Event|3|||
162865731|NCT02704429|588212139|FG001|Part A: 24 Weeks|Adverse Event|0|||
162865732|NCT02704429|588212138|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
162865733|NCT02704429|588212139|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
162865734|NCT02519231|588212140|FG000|Overall Study|Lost to Follow-up|2|||
162865735|NCT02519231|588212141|FG001|Overall Study|Lost to Follow-up|5|||
162865736|NCT02519231|588212140|FG000|Overall Study|Withdrawal by Subject|0|||
162865737|NCT02519231|588212141|FG001|Overall Study|Withdrawal by Subject|1|||
162865738|NCT00104104|588212142|FG000|Overall Study|Adverse Event|8|||
162865739|NCT00104104|588212143|FG001|Overall Study|Adverse Event|8|||
162865740|NCT00104104|588212142|FG000|Overall Study|Abnormal laboratory value(s)|20|||
162865741|NCT00104104|588212143|FG001|Overall Study|Abnormal laboratory value(s)|14|||
162865742|NCT00104104|588212142|FG000|Overall Study|Lack of Efficacy|0|||
162865743|NCT00104104|588212143|FG001|Overall Study|Lack of Efficacy|3|||
162865744|NCT00104104|588212142|FG000|Overall Study|Condition no longer requires study drug|7|||
162865745|NCT00104104|588212143|FG001|Overall Study|Condition no longer requires study drug|4|||
162865746|NCT00104104|588212142|FG000|Overall Study|Protocol Violation|5|||
162865747|NCT00104104|588212143|FG001|Overall Study|Protocol Violation|2|||
162865748|NCT00104104|588212142|FG000|Overall Study|Withdrawal by Subject|11|||
162865749|NCT00104104|588212143|FG001|Overall Study|Withdrawal by Subject|15|||
162865750|NCT00104104|588212142|FG000|Overall Study|Lost to Follow-up|3|||
162865751|NCT00104104|588212143|FG001|Overall Study|Lost to Follow-up|7|||
162865752|NCT00104104|588212142|FG000|Overall Study|Administrative problems|12|||
162865753|NCT00104104|588212143|FG001|Overall Study|Administrative problems|13|||
162865754|NCT00104104|588212142|FG000|Overall Study|Death|9|||
162865755|NCT00104104|588212143|FG001|Overall Study|Death|6|||
162865756|NCT00447421|588212145|FG000|Overall Study|Lack of Efficacy|1|||
162865757|NCT00447421|588212145|FG000|Overall Study|Adverse Event|3|||
162865758|NCT00447421|588212145|FG000|Overall Study|Sponsor Decision|2|||
162865759|NCT01707147|588212146|FG000|Overall Study|Administered Trajenta prior to contract|5|||
162865760|NCT01707147|588212146|FG000|Overall Study|Patients who have not taken Trajenta|1|||
162865761|NCT01707147|588212146|FG000|Overall Study|Follow-up failure|17|||
162865762|NCT01707147|588212146|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
162865763|NCT01326962|588212150|FG000|Overall Study|Adverse Event|1|||
162865764|NCT01326962|588212150|FG000|Overall Study|Withdrawal by Subject|1|||
162865765|NCT01326962|588212150|FG000|Overall Study|Lost to Follow-up|3|||
162865766|NCT01326962|588212150|FG000|Overall Study|Other|2|||
162865767|NCT02053246|588212151|FG000|Overall Study|Withdrawal by Subject|3|||
162865768|NCT02053246|588212151|FG000|Overall Study|Physician Decision|1|||
162959076|NCT04493684|588551722|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
162865769|NCT02707757|588212152|FG000|Overall Study|Protocol Violation|3|||
162865770|NCT02707757|588212153|FG001|Overall Study|Protocol Violation|2|||
162865771|NCT02707757|588212152|FG000|Overall Study|Withdrawal by Subject|2|||
162865772|NCT02707757|588212153|FG001|Overall Study|Withdrawal by Subject|0|||
162865773|NCT02707757|588212152|FG000|Overall Study|Death|0|||
162865774|NCT02707757|588212153|FG001|Overall Study|Death|1|||
162865775|NCT02707757|588212152|FG000|Overall Study|Adverse Event|6|||
162865776|NCT02707757|588212153|FG001|Overall Study|Adverse Event|4|||
162865777|NCT02707757|588212152|FG000|Overall Study|Renal transplant/elective operation|1|||
162865778|NCT02707757|588212153|FG001|Overall Study|Renal transplant/elective operation|5|||
162865779|NCT01318902|588212154|FG000|Overall Study|Symptomatic Deterioration|0|||
162865780|NCT01318902|588212155|FG001|Overall Study|Symptomatic Deterioration|1|||
162865781|NCT01318902|588212156|FG002|Overall Study|Symptomatic Deterioration|1|||
162865782|NCT01318902|588212157|FG003|Overall Study|Symptomatic Deterioration|2|||
162959077|NCT04493684|588551723|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162613609|NCT00764504|587303240|FG001|Overall Study|Physician Decision|0|||
162613610|NCT00764504|587303241|FG002|Overall Study|Physician Decision|0|||
162613611|NCT00764504|587303239|FG000|Overall Study|Withdrawal by Subject|1|||
162613612|NCT00764504|587303240|FG001|Overall Study|Withdrawal by Subject|7|||
162613613|NCT00764504|587303241|FG002|Overall Study|Withdrawal by Subject|4|||
162865783|NCT01318902|588212154|FG000|Overall Study|Withdrawal by Patient|0|||
162865784|NCT01318902|588212155|FG001|Overall Study|Withdrawal by Patient|1|||
162865785|NCT01318902|588212156|FG002|Overall Study|Withdrawal by Patient|0|||
162865786|NCT01318902|588212157|FG003|Overall Study|Withdrawal by Patient|3|||
162865787|NCT01318902|588212154|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
162865788|NCT01318902|588212155|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162865789|NCT01318902|588212156|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162865790|NCT01318902|588212157|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
162865791|NCT01318902|588212154|FG000|Overall Study|Adverse Event|0|||
162865792|NCT01318902|588212155|FG001|Overall Study|Adverse Event|1|||
162865793|NCT01318902|588212156|FG002|Overall Study|Adverse Event|0|||
162865794|NCT01318902|588212157|FG003|Overall Study|Adverse Event|0|||
162865795|NCT01318902|588212154|FG000|Overall Study|Terminated by Sponsor|0|||
162865796|NCT01318902|588212155|FG001|Overall Study|Terminated by Sponsor|0|||
162865797|NCT01318902|588212156|FG002|Overall Study|Terminated by Sponsor|1|||
162865798|NCT01318902|588212157|FG003|Overall Study|Terminated by Sponsor|0|||
162865799|NCT00663858|588214109|FG000|Overall Study|Adverse Event|9|||
162865800|NCT00663858|588214110|FG001|Overall Study|Adverse Event|1|||
162865801|NCT00663858|588214111|FG002|Overall Study|Adverse Event|6|||
162865802|NCT00663858|588214109|FG000|Overall Study|Lack of Efficacy|5|||
162865803|NCT00663858|588214110|FG001|Overall Study|Lack of Efficacy|1|||
162865804|NCT00663858|588214111|FG002|Overall Study|Lack of Efficacy|3|||
162865805|NCT00663858|588214109|FG000|Overall Study|Withdrawal by Subject|7|||
162865806|NCT00663858|588214110|FG001|Overall Study|Withdrawal by Subject|3|||
162865807|NCT00663858|588214111|FG002|Overall Study|Withdrawal by Subject|3|||
162865808|NCT00663858|588214109|FG000|Overall Study|Protocol Violation|5|||
162865809|NCT00663858|588214110|FG001|Overall Study|Protocol Violation|3|||
162865810|NCT00663858|588214111|FG002|Overall Study|Protocol Violation|4|||
162865811|NCT00663858|588214109|FG000|Overall Study|Other|8|||
162865812|NCT00663858|588214110|FG001|Overall Study|Other|2|||
162865813|NCT00663858|588214111|FG002|Overall Study|Other|4|||
162865814|NCT01666444|588214114|FG000|Overall Study|Did not initiate treatment|2|||
162865815|NCT01666444|588214115|FG001|Overall Study|Did not initiate treatment|1|||
162865816|NCT00950690|588214116|FG000|Overall Study|Death|4|||
162865817|NCT00950690|588214116|FG000|Overall Study|Adverse Event|15|||
162865818|NCT00950690|588214116|FG000|Overall Study|Lack of Efficacy|22|||
162865819|NCT00950690|588214116|FG000|Overall Study|Lost to Follow-up|40|||
162865820|NCT00950690|588214116|FG000|Overall Study|Other|163|||
162865821|NCT01713036|588214117|FG000|Overall Study|Death|1|||
162865822|NCT00592358|588214118|FG000|Overall Study|Withdrawal by Subject|2|||
162865823|NCT00592358|588214118|FG000|Overall Study|Adverse Event|1|||
162865824|NCT00592358|588214118|FG000|Overall Study|Lack of Efficacy|2|||
162865825|NCT00592358|588214118|FG000|Overall Study|Inability to swallow pills|1|||
162865826|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
162865827|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
162865828|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
162865829|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
162865830|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
162865831|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
162865832|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
162865833|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
162865834|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
162865835|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
162865836|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
162865837|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
162865838|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
162865839|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
162865840|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
162865841|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
162865842|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
162613614|NCT00764504|587303239|FG000|Overall Study|Lost to Follow-up|40|||
162865843|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
162865844|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
162865845|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
162865846|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
162865847|NCT00092547|588214119|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
162865848|NCT00092547|588214120|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
162865849|NCT00092547|588214121|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
162865850|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
162865851|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
162865852|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
162865853|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
162865854|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
162865855|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
162865856|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
162865857|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
162865858|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
162865859|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
162865860|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
162865861|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
162865862|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
162865863|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
162865864|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
162865865|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
162865866|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
162865867|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
162865868|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
162865869|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
162865870|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
162865871|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
162865872|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
162865873|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
162865874|NCT00092547|588214119|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
162865875|NCT00092547|588214120|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
162865876|NCT00092547|588214121|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
162865877|NCT00092547|588214119|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
162865878|NCT00092547|588214120|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
162865879|NCT00092547|588214121|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
162865880|NCT00092547|588214119|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
162865881|NCT00092547|588214120|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
162865882|NCT00092547|588214121|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
162865883|NCT00092547|588214119|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
162865884|NCT00092547|588214120|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
162865885|NCT00092547|588214121|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
162865886|NCT00092547|588214119|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
162865887|NCT00092547|588214120|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
162865888|NCT00092547|588214121|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
162865889|NCT00084682|588214122|FG000|Overall Study|Withdrawal by Subject|1|||
162865890|NCT01166659|588214123|FG000|Overall Study|Subject Decision|8|||
162865891|NCT01166659|588214123|FG000|Overall Study|Investigator Decision|2|||
162865892|NCT01166659|588214123|FG000|Overall Study|Death|1|||
162865893|NCT01166659|588214123|FG000|Overall Study|Lost to Follow-up|1|||
162865894|NCT01166659|588214123|FG000|Overall Study|Study Closed at Site|1|||
162865895|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
162865896|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
162865897|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
162865898|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
162865899|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
162865900|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
162865901|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
162865902|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
162865903|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
162865904|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
162865905|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
162865906|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
162959078|NCT04493684|588551724|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
163046314|NCT03489343|588877390|FG005|Overall Study|Adverse Event|1|||
162706121|NCT01764386|587636541|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
162865907|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
162706122|NCT01764386|587636540|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
162706123|NCT01764386|587636541|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
163046315|NCT03489343|588877391|FG006|Overall Study|Adverse Event|0|||
162865908|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
162865909|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
162865910|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
162865911|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
162865912|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
162865913|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
162865914|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
162865915|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
162865916|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
163046316|NCT03489343|588877385|FG000|Overall Study|Withdrawal by Subject|0|||
163046317|NCT03489343|588877386|FG001|Overall Study|Withdrawal by Subject|0|||
163046318|NCT03489343|588877387|FG002|Overall Study|Withdrawal by Subject|0|||
163046319|NCT03489343|588877388|FG003|Overall Study|Withdrawal by Subject|1|||
163046320|NCT03489343|588877389|FG004|Overall Study|Withdrawal by Subject|0|||
163046321|NCT03489343|588877390|FG005|Overall Study|Withdrawal by Subject|1|||
163046322|NCT03489343|588877391|FG006|Overall Study|Withdrawal by Subject|1|||
163046323|NCT03489343|588877385|FG000|Overall Study|Clinical progression|0|||
162865917|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
162865918|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
162865919|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
162865920|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
162865921|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
162865922|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
162865923|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
162865924|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
162865925|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
162865926|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
162865927|NCT00958568|588214133|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
162865928|NCT00958568|588214134|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
162865929|NCT00958568|588214135|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
163046324|NCT03489343|588877386|FG001|Overall Study|Clinical progression|0|||
163046325|NCT03489343|588877387|FG002|Overall Study|Clinical progression|0|||
163046326|NCT03489343|588877388|FG003|Overall Study|Clinical progression|1|||
163046327|NCT03489343|588877389|FG004|Overall Study|Clinical progression|0|||
163046328|NCT03489343|588877390|FG005|Overall Study|Clinical progression|0|||
162613615|NCT00764504|587303240|FG001|Overall Study|Lost to Follow-up|34|||
162865930|NCT00958568|588214136|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
162865931|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
162865932|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
162865933|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
162865934|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
162865935|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
162865936|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
162865937|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
162865938|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
162865939|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
162865940|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
162865941|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
162959079|NCT04493684|588551725|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959080|NCT04493684|588551726|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959081|NCT04493684|588551727|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959082|NCT04493684|588551728|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959083|NCT04493684|588551729|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959084|NCT04493684|588551730|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959085|NCT04493684|588551731|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959086|NCT04493684|588551732|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959087|NCT04493684|588551733|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
162959088|NCT04493684|588551717|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959089|NCT04493684|588551718|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959090|NCT04493684|588551719|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959091|NCT04493684|588551720|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959092|NCT04493684|588551721|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959093|NCT04493684|588551722|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959094|NCT04493684|588551723|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959095|NCT04493684|588551724|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959096|NCT04493684|588551725|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959097|NCT04493684|588551726|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959098|NCT04493684|588551727|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959099|NCT04493684|588551728|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
162959100|NCT04493684|588551729|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959101|NCT04493684|588551730|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959102|NCT04493684|588551731|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959103|NCT04493684|588551732|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959104|NCT04493684|588551733|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
162959105|NCT04493684|588551717|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959106|NCT04493684|588551718|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959107|NCT04493684|588551719|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959108|NCT04493684|588551720|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959109|NCT04493684|588551721|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959110|NCT04493684|588551722|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959111|NCT04493684|588551723|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959112|NCT04493684|588551724|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959113|NCT04493684|588551725|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959114|NCT04493684|588551726|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959115|NCT04493684|588551727|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959116|NCT04493684|588551728|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959117|NCT04493684|588551729|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959118|NCT04493684|588551730|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959119|NCT04493684|588551731|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959120|NCT04493684|588551732|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
162959121|NCT04493684|588551733|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
162959122|NCT04493684|588551717|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162865942|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
162865943|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
162865944|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
162865945|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
162865946|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
162865947|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
162865948|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
162865949|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
162865950|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
162865951|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
162865952|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
162865953|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
162865954|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
162865955|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
162865956|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
162865957|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
162865958|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
162865959|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
162865960|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
162865961|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
162706124|NCT01764386|587636540|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
162865962|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
162865963|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
162865964|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
162865965|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
162865966|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
162865967|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
162865968|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
162865969|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
162865970|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
162865971|NCT00958568|588214133|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
162865972|NCT00958568|588214134|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
162865973|NCT00958568|588214135|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
162865974|NCT00958568|588214136|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
162865975|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
162865976|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
162865977|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
162865978|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
162865979|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
162865980|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
162865981|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
162865982|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
162865983|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
162865984|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
162865985|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
162865986|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
162865987|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
162865988|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
162865989|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
162865990|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
162865991|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
162865992|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
162865993|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
162865994|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
162865995|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
162959123|NCT04493684|588551718|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959124|NCT04493684|588551719|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959125|NCT04493684|588551720|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959126|NCT04493684|588551721|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959127|NCT04493684|588551722|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959128|NCT04493684|588551723|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959129|NCT04493684|588551724|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162865996|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
162865997|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
162865998|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
162865999|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
162866000|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
162866001|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
162866002|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
162866003|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
162866004|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
162866005|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
162866006|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
162866007|NCT00958568|588214133|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
162866008|NCT00958568|588214134|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
162866009|NCT00958568|588214135|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
162866010|NCT00958568|588214136|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
162866011|NCT00915005|588214137|FG000|Overall Study|Withdrawal by Subject|4|||
162866012|NCT00915005|588214138|FG001|Overall Study|Withdrawal by Subject|4|||
162866013|NCT00915005|588214137|FG000|Overall Study|Patient preferred protons therapy|6|||
162866014|NCT00915005|588214138|FG001|Overall Study|Patient preferred protons therapy|0|||
162866015|NCT00915005|588214137|FG000|Overall Study|Insurance denial|3|||
162866016|NCT00915005|588214138|FG001|Overall Study|Insurance denial|15|||
162866017|NCT00589472|588214141|FG000|Overall Study|Adverse Event|1|||
162866018|NCT00117338|588214142|FG000|Overall Study|Adverse Event|0|||
162866019|NCT00117338|588214143|FG001|Overall Study|Adverse Event|1|||
162866020|NCT00117338|588214142|FG000|Overall Study|Protocol Violation|3|||
162866021|NCT00117338|588214143|FG001|Overall Study|Protocol Violation|2|||
162866022|NCT00117338|588214142|FG000|Overall Study|Withdrawal by Subject|1|||
162866023|NCT00117338|588214143|FG001|Overall Study|Withdrawal by Subject|0|||
162866024|NCT00117338|588214142|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
162866025|NCT00117338|588214143|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
162866026|NCT00117338|588214142|FG000|Overall Study|Lack of Efficacy|0|||
162866027|NCT00117338|588214143|FG001|Overall Study|Lack of Efficacy|1|||
162866028|NCT01380093|588214144|FG000|Naloxone Challenge Phase|Screen failures|21|||
162866029|NCT01380093|588214145|FG001|Naloxone Challenge Phase|Screen failures|0|||
162866030|NCT01380093|588214146|FG002|Naloxone Challenge Phase|Screen failures|0|||
162866031|NCT01380093|588214147|FG003|Naloxone Challenge Phase|Screen failures|0|||
162866032|NCT01380093|588214148|FG004|Naloxone Challenge Phase|Screen failures|0|||
162866033|NCT01380093|588214149|FG005|Naloxone Challenge Phase|Screen failures|0|||
162866034|NCT01380093|588214150|FG006|Naloxone Challenge Phase|Screen failures|0|||
162866035|NCT01380093|588214151|FG007|Naloxone Challenge Phase|Screen failures|0|||
162866036|NCT01380093|588214152|FG008|Naloxone Challenge Phase|Screen failures|0|||
162866037|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866038|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
162866039|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866040|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866041|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162959130|NCT04493684|588551725|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959131|NCT04493684|588551726|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959132|NCT04493684|588551727|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959133|NCT04493684|588551728|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959134|NCT04493684|588551729|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959135|NCT04493684|588551730|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959136|NCT04493684|588551731|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959137|NCT04493684|588551732|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
162959138|NCT04493684|588551733|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162959139|NCT04825275|588553464|FG000|Overall Study|Withdrawal by Subject|1|||
162959140|NCT04825275|588553465|FG001|Overall Study|Withdrawal by Subject|0|||
162959141|NCT05710718|588553471|FG000|Overall Study|Withdrawal by Subject|5|||
162959142|NCT05710718|588553472|FG001|Overall Study|Withdrawal by Subject|1|||
162959143|NCT05710718|588553471|FG000|Overall Study|Lost to Follow-up|0|||
162959144|NCT05710718|588553472|FG001|Overall Study|Lost to Follow-up|1|||
162959145|NCT05710718|588553471|FG000|Overall Study|Death|0|||
162959146|NCT05710718|588553472|FG001|Overall Study|Death|1|||
162959147|NCT04372238|588553473|FG000|Overall Study|Duplicate|3|||
162613616|NCT00764504|587303241|FG002|Overall Study|Lost to Follow-up|72|||
162866042|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866043|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866044|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162866045|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
162959148|NCT04372238|588553474|FG001|Overall Study|Duplicate|3|||
162959149|NCT04372238|588553473|FG000|Overall Study|Did not consent for data linkage|6|||
162866046|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866047|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
162866048|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
162866049|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866050|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866051|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866052|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866053|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162866054|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
162613617|NCT02456103|587303245|FG000|Overall Study|Study Closure|207|||
162613618|NCT02456103|587303245|FG000|Overall Study|Physician Decision|1|||
162613619|NCT02456103|587303245|FG000|Overall Study|Required prohibited medications|5|||
162866055|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162866056|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
162866057|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162866058|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162866059|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162866060|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162959150|NCT04372238|588553474|FG001|Overall Study|Did not consent for data linkage|10|||
162959151|NCT02591420|588553475|FG000|Overall Study|Lost to Follow-up|0|||
162866061|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162959152|NCT02591420|588553476|FG001|Overall Study|Lost to Follow-up|1|||
162959153|NCT02591420|588553477|FG002|Overall Study|Lost to Follow-up|2|||
162959154|NCT04241458|588553478|FG000|Overall Study|Withdrawal by Subject|0|||
162959155|NCT04241458|588553479|FG001|Overall Study|Withdrawal by Subject|0|||
162959156|NCT04241458|588553480|FG002|Overall Study|Withdrawal by Subject|0|||
162959157|NCT04241458|588553481|FG003|Overall Study|Withdrawal by Subject|0|||
162959158|NCT04241458|588553482|FG004|Overall Study|Withdrawal by Subject|1|||
162959159|NCT05005442|588553483|FG000|Overall Study|Death|14|||
162959160|NCT05005442|588553484|FG001|Overall Study|Death|10|||
162959161|NCT05005442|588553485|FG002|Overall Study|Death|8|||
162959162|NCT05005442|588553486|FG003|Overall Study|Death|22|||
162959163|NCT05005442|588553487|FG004|Overall Study|Death|13|||
162959164|NCT05005442|588553488|FG005|Overall Study|Death|15|||
162959165|NCT05005442|588553483|FG000|Overall Study|Lost to Follow-up|0|||
162959166|NCT05005442|588553484|FG001|Overall Study|Lost to Follow-up|2|||
162959167|NCT05005442|588553485|FG002|Overall Study|Lost to Follow-up|0|||
162959168|NCT05005442|588553486|FG003|Overall Study|Lost to Follow-up|0|||
162959169|NCT05005442|588553487|FG004|Overall Study|Lost to Follow-up|1|||
162959170|NCT05005442|588553488|FG005|Overall Study|Lost to Follow-up|0|||
162959171|NCT05005442|588553483|FG000|Overall Study|Physician Decision|0|||
162959172|NCT05005442|588553484|FG001|Overall Study|Physician Decision|0|||
162959173|NCT05005442|588553485|FG002|Overall Study|Physician Decision|1|||
162959174|NCT05005442|588553486|FG003|Overall Study|Physician Decision|0|||
162959175|NCT05005442|588553487|FG004|Overall Study|Physician Decision|2|||
162959176|NCT05005442|588553488|FG005|Overall Study|Physician Decision|0|||
162959177|NCT05005442|588553483|FG000|Overall Study|Sponsor decision|26|||
162959178|NCT05005442|588553484|FG001|Overall Study|Sponsor decision|26|||
162959179|NCT05005442|588553485|FG002|Overall Study|Sponsor decision|10|||
162959180|NCT05005442|588553486|FG003|Overall Study|Sponsor decision|5|||
162959181|NCT05005442|588553487|FG004|Overall Study|Sponsor decision|9|||
162959182|NCT05005442|588553488|FG005|Overall Study|Sponsor decision|12|||
162959183|NCT05005442|588553483|FG000|Overall Study|Withdrawal by Subject|2|||
162959184|NCT05005442|588553484|FG001|Overall Study|Withdrawal by Subject|2|||
162959185|NCT05005442|588553485|FG002|Overall Study|Withdrawal by Subject|1|||
162959186|NCT05005442|588553486|FG003|Overall Study|Withdrawal by Subject|3|||
162959187|NCT05005442|588553487|FG004|Overall Study|Withdrawal by Subject|0|||
162959188|NCT05005442|588553488|FG005|Overall Study|Withdrawal by Subject|5|||
162959189|NCT05005442|588553483|FG000|Overall Study|Site terminated by sponsor|0|||
162866062|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162866063|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
162959190|NCT05005442|588553484|FG001|Overall Study|Site terminated by sponsor|2|||
162959191|NCT05005442|588553485|FG002|Overall Study|Site terminated by sponsor|0|||
162959192|NCT05005442|588553486|FG003|Overall Study|Site terminated by sponsor|0|||
162959193|NCT05005442|588553487|FG004|Overall Study|Site terminated by sponsor|0|||
162959194|NCT05005442|588553488|FG005|Overall Study|Site terminated by sponsor|1|||
162959195|NCT03696160|588553489|FG000|Overall Study|Withdrew before IMP dosing|2|||
162959196|NCT03696160|588553490|FG001|Overall Study|Withdrew before IMP dosing|3|||
162959197|NCT00334815|588553491|FG000|Overall Study|Adverse Event|3|||
162959198|NCT00334815|588553492|FG001|Overall Study|Adverse Event|2|||
162959199|NCT00334815|588553491|FG000|Overall Study|Death|0|||
162959200|NCT00334815|588553492|FG001|Overall Study|Death|2|||
162959201|NCT00334815|588553491|FG000|Overall Study|Progression|1|||
162959202|NCT00334815|588553492|FG001|Overall Study|Progression|0|||
162959203|NCT00334815|588553491|FG000|Overall Study|ineligible|1|||
162613620|NCT02456103|587303245|FG000|Overall Study|Protocol Violation|1|||
162866064|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866065|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
162866066|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
162866067|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866068|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866069|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866070|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866071|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866072|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
162866073|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866074|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
162866075|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
162866076|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866077|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866078|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866079|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866080|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866081|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
162866082|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866083|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866084|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
162866085|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866086|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866087|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866088|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866089|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866090|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
162866091|NCT01380093|588214144|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866092|NCT01380093|588214145|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866093|NCT01380093|588214146|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
162866094|NCT01380093|588214147|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866095|NCT01380093|588214148|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866096|NCT01380093|588214149|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866097|NCT01380093|588214150|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866098|NCT01380093|588214151|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866099|NCT01380093|588214152|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
162866100|NCT01380093|588214144|FG000|Treatment Phase: Second Intervention|Other|0|||
162866101|NCT01380093|588214145|FG001|Treatment Phase: Second Intervention|Other|0|||
162866102|NCT01380093|588214146|FG002|Treatment Phase: Second Intervention|Other|0|||
162866103|NCT01380093|588214147|FG003|Treatment Phase: Second Intervention|Other|1|||
162866104|NCT01380093|588214148|FG004|Treatment Phase: Second Intervention|Other|0|||
162866105|NCT01380093|588214149|FG005|Treatment Phase: Second Intervention|Other|0|||
162866106|NCT01380093|588214150|FG006|Treatment Phase: Second Intervention|Other|0|||
162866107|NCT01380093|588214151|FG007|Treatment Phase: Second Intervention|Other|0|||
162866108|NCT01380093|588214152|FG008|Treatment Phase: Second Intervention|Other|0|||
162866109|NCT01380093|588214144|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
162866110|NCT01380093|588214145|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
162866111|NCT01380093|588214146|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
162866112|NCT01380093|588214147|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
162866113|NCT01380093|588214148|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
162866114|NCT01380093|588214149|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
162866115|NCT01380093|588214150|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
162866116|NCT01380093|588214151|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
162866117|NCT01380093|588214152|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
162866118|NCT01380093|588214144|FG000|Treatment Phase: Third Intervention|Other|0|||
162866119|NCT01380093|588214145|FG001|Treatment Phase: Third Intervention|Other|0|||
162866120|NCT01380093|588214146|FG002|Treatment Phase: Third Intervention|Other|0|||
162866121|NCT01380093|588214147|FG003|Treatment Phase: Third Intervention|Other|0|||
162866122|NCT01380093|588214148|FG004|Treatment Phase: Third Intervention|Other|0|||
162866123|NCT01380093|588214149|FG005|Treatment Phase: Third Intervention|Other|0|||
162866124|NCT01380093|588214150|FG006|Treatment Phase: Third Intervention|Other|0|||
162866125|NCT01380093|588214151|FG007|Treatment Phase: Third Intervention|Other|0|||
162866126|NCT01380093|588214152|FG008|Treatment Phase: Third Intervention|Other|1|||
162866127|NCT03952650|588214153|FG000|Overall Study|TRAVEL|0|||
162866128|NCT03952650|588214154|FG001|Overall Study|TRAVEL|4|||
162866129|NCT03952650|588214155|FG002|Overall Study|TRAVEL|0|||
162866130|NCT03952650|588214156|FG003|Overall Study|TRAVEL|4|||
162959204|NCT00334815|588553492|FG001|Overall Study|ineligible|1|||
162959205|NCT00334815|588553491|FG000|Overall Study|patient refused treatment|0|||
162866131|NCT03952650|588214157|FG004|Overall Study|TRAVEL|0|||
162866132|NCT03952650|588214158|FG005|Overall Study|TRAVEL|3|||
162866133|NCT03952650|588214159|FG006|Overall Study|TRAVEL|2|||
162866134|NCT03952650|588214153|FG000|Overall Study|Withdrawal by Subject|0|||
162866135|NCT03952650|588214154|FG001|Overall Study|Withdrawal by Subject|2|||
162866136|NCT03952650|588214155|FG002|Overall Study|Withdrawal by Subject|0|||
162866137|NCT03952650|588214156|FG003|Overall Study|Withdrawal by Subject|3|||
162866138|NCT03952650|588214157|FG004|Overall Study|Withdrawal by Subject|0|||
162866139|NCT03952650|588214158|FG005|Overall Study|Withdrawal by Subject|1|||
162866140|NCT03952650|588214159|FG006|Overall Study|Withdrawal by Subject|1|||
162866141|NCT03952650|588214153|FG000|Overall Study|Lost to Follow-up|0|||
162866142|NCT03952650|588214154|FG001|Overall Study|Lost to Follow-up|1|||
162866143|NCT03952650|588214155|FG002|Overall Study|Lost to Follow-up|0|||
162866144|NCT03952650|588214156|FG003|Overall Study|Lost to Follow-up|0|||
162866145|NCT03952650|588214157|FG004|Overall Study|Lost to Follow-up|0|||
162866146|NCT03952650|588214158|FG005|Overall Study|Lost to Follow-up|1|||
162866147|NCT03952650|588214159|FG006|Overall Study|Lost to Follow-up|1|||
162866148|NCT03952650|588214153|FG000|Overall Study|Received wrong vaccine and travelled|0|||
162866149|NCT03952650|588214154|FG001|Overall Study|Received wrong vaccine and travelled|0|||
162866150|NCT03952650|588214155|FG002|Overall Study|Received wrong vaccine and travelled|0|||
162866151|NCT03952650|588214156|FG003|Overall Study|Received wrong vaccine and travelled|0|||
162866152|NCT03952650|588214157|FG004|Overall Study|Received wrong vaccine and travelled|0|||
162866153|NCT03952650|588214158|FG005|Overall Study|Received wrong vaccine and travelled|1|||
162866154|NCT03952650|588214159|FG006|Overall Study|Received wrong vaccine and travelled|0|||
162866155|NCT03952650|588214153|FG000|Overall Study|Unable to make study visit|0|||
162866156|NCT03952650|588214154|FG001|Overall Study|Unable to make study visit|0|||
162866157|NCT03952650|588214155|FG002|Overall Study|Unable to make study visit|0|||
162866158|NCT03952650|588214156|FG003|Overall Study|Unable to make study visit|0|||
162866159|NCT03952650|588214157|FG004|Overall Study|Unable to make study visit|0|||
162866160|NCT03952650|588214158|FG005|Overall Study|Unable to make study visit|1|||
162866161|NCT03952650|588214159|FG006|Overall Study|Unable to make study visit|0|||
162866162|NCT01342640|588214160|FG000|Overall Study|Adverse Event|3|||
162866163|NCT01342640|588214160|FG000|Overall Study|Protocol Violation|16|||
162866164|NCT01342640|588214160|FG000|Overall Study|Lost to Follow-up|21|||
162866165|NCT01342640|588214160|FG000|Overall Study|Other|1|||
162866166|NCT00670111|588214163|FG000|Enrollment to One Month|Testing Failure|0|||
162866167|NCT00670111|588214164|FG001|Enrollment to One Month|Testing Failure|0|||
162866168|NCT00670111|588214165|FG002|Enrollment to One Month|Testing Failure|13|||
162866169|NCT00670111|588214163|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
162866170|NCT00670111|588214164|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
162866171|NCT00670111|588214165|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
162866172|NCT00670111|588214163|FG000|Enrollment to One Month|Physician Decision|1|||
162866173|NCT00670111|588214164|FG001|Enrollment to One Month|Physician Decision|0|||
162866174|NCT00670111|588214165|FG002|Enrollment to One Month|Physician Decision|0|||
162866175|NCT02441803|588214166|FG000|Overall Study|Physician Decision|0|||
162866176|NCT02441803|588214167|FG001|Overall Study|Physician Decision|2|||
162866177|NCT02441803|588214168|FG002|Overall Study|Physician Decision|2|||
162866178|NCT02873221|588214169|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
162866179|NCT02873221|588214170|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
162866180|NCT02873221|588214171|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
162866181|NCT02873221|588214169|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
162866182|NCT02873221|588214170|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
162866183|NCT02873221|588214171|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
162866184|NCT02873221|588214169|FG000|Treatment Period|Protocol Violation|2|||
162866185|NCT02873221|588214170|FG001|Treatment Period|Protocol Violation|5|||
162866186|NCT02873221|588214171|FG002|Treatment Period|Protocol Violation|8|||
162866187|NCT02873221|588214169|FG000|Treatment Period|Pregnancy|4|||
162866188|NCT02873221|588214170|FG001|Treatment Period|Pregnancy|6|||
162866189|NCT02873221|588214171|FG002|Treatment Period|Pregnancy|3|||
162866190|NCT02873221|588214169|FG000|Treatment Period|Lack of Qualifying Event|0|||
162866191|NCT02873221|588214170|FG001|Treatment Period|Lack of Qualifying Event|3|||
162866192|NCT02873221|588214171|FG002|Treatment Period|Lack of Qualifying Event|1|||
162866193|NCT02873221|588214169|FG000|Treatment Period|Withdrawal of Consent|52|||
162866194|NCT02873221|588214170|FG001|Treatment Period|Withdrawal of Consent|51|||
162866195|NCT02873221|588214171|FG002|Treatment Period|Withdrawal of Consent|41|||
162866196|NCT02873221|588214169|FG000|Treatment Period|Lack of Efficacy|0|||
162866197|NCT02873221|588214170|FG001|Treatment Period|Lack of Efficacy|17|||
162866198|NCT02873221|588214171|FG002|Treatment Period|Lack of Efficacy|12|||
162866199|NCT02873221|588214169|FG000|Treatment Period|Adverse Event|4|||
162866200|NCT02873221|588214170|FG001|Treatment Period|Adverse Event|9|||
162866201|NCT02873221|588214171|FG002|Treatment Period|Adverse Event|11|||
162866202|NCT02873221|588214169|FG000|Treatment Period|Lost to Follow-up|26|||
163046329|NCT03489343|588877391|FG006|Overall Study|Clinical progression|1|||
162866203|NCT02873221|588214170|FG001|Treatment Period|Lost to Follow-up|30|||
162866204|NCT02873221|588214171|FG002|Treatment Period|Lost to Follow-up|26|||
162866205|NCT02873221|588214169|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
162866206|NCT02873221|588214170|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
162866207|NCT02873221|588214171|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
162866208|NCT02873221|588214169|FG000|Safety Follow-up Period|Protocol Violation|0|||
162866209|NCT02873221|588214170|FG001|Safety Follow-up Period|Protocol Violation|0|||
162866210|NCT02873221|588214171|FG002|Safety Follow-up Period|Protocol Violation|1|||
162866211|NCT02873221|588214169|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
162866212|NCT02873221|588214170|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
162866213|NCT02873221|588214171|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
162866214|NCT02873221|588214169|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
162866215|NCT02873221|588214170|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
162866216|NCT02873221|588214171|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
162866217|NCT01749735|588214172|FG000|Overall Study|Withdrawal by Subject|1|||
162866218|NCT01749735|588214173|FG001|Overall Study|Withdrawal by Subject|0|||
162866219|NCT02234583|588214178|FG000|Overall Study|Adverse Event|172|||
162866220|NCT02234583|588214179|FG001|Overall Study|Adverse Event|156|||
162866221|NCT02234583|588214178|FG000|Overall Study|Withdrawal by Subject|109|||
162866222|NCT02234583|588214179|FG001|Overall Study|Withdrawal by Subject|157|||
162866223|NCT02234583|588214178|FG000|Overall Study|Lost to Follow-up|0|||
162866224|NCT02234583|588214179|FG001|Overall Study|Lost to Follow-up|1|||
162866225|NCT02234583|588214178|FG000|Overall Study|Lack of Efficacy|58|||
162866226|NCT02234583|588214179|FG001|Overall Study|Lack of Efficacy|103|||
162866227|NCT02234583|588214178|FG000|Overall Study|Protocol Violation|35|||
162866228|NCT02234583|588214179|FG001|Overall Study|Protocol Violation|42|||
162866229|NCT02234583|588214178|FG000|Overall Study|Other|39|||
162866230|NCT02234583|588214179|FG001|Overall Study|Other|97|||
162866231|NCT01849250|588214180|FG000|Overall Study|Withdrawal by Subject|1|||
162866232|NCT01849250|588214181|FG001|Overall Study|Withdrawal by Subject|0|||
162866233|NCT01849250|588214180|FG000|Overall Study|Not Evaluable|5|||
162866234|NCT01849250|588214181|FG001|Overall Study|Not Evaluable|3|||
162866235|NCT01849250|588214180|FG000|Overall Study|Screen Failure|1|||
162866236|NCT01849250|588214181|FG001|Overall Study|Screen Failure|0|||
162866237|NCT00771030|588214184|FG000|Overall Study|Adverse Event|0|||
162866238|NCT00771030|588214185|FG001|Overall Study|Adverse Event|1|||
162866239|NCT00771030|588214186|FG002|Overall Study|Adverse Event|0|||
162866240|NCT00771030|588214187|FG003|Overall Study|Adverse Event|0|||
162866241|NCT00771030|588214188|FG004|Overall Study|Adverse Event|0|||
162866242|NCT00771030|588214189|FG005|Overall Study|Adverse Event|0|||
162866243|NCT00771030|588214190|FG006|Overall Study|Adverse Event|0|||
162866244|NCT01022853|588214197|FG000|Overall Study|Progressive disease|2|||
162866245|NCT01022853|588214198|FG001|Overall Study|Progressive disease|3|||
162866246|NCT01022853|588214199|FG002|Overall Study|Progressive disease|11|||
162866247|NCT01022853|588214200|FG003|Overall Study|Progressive disease|7|||
162866248|NCT01022853|588214201|FG004|Overall Study|Progressive disease|1|||
162866249|NCT01022853|588214197|FG000|Overall Study|Dose-limiting toxicity|0|||
162866250|NCT01022853|588214198|FG001|Overall Study|Dose-limiting toxicity|0|||
162866251|NCT01022853|588214199|FG002|Overall Study|Dose-limiting toxicity|0|||
162866252|NCT01022853|588214200|FG003|Overall Study|Dose-limiting toxicity|0|||
162866253|NCT01022853|588214201|FG004|Overall Study|Dose-limiting toxicity|1|||
162866254|NCT01022853|588214197|FG000|Overall Study|Withdrawal by Subject|0|||
162866255|NCT01022853|588214198|FG001|Overall Study|Withdrawal by Subject|1|||
162959206|NCT00334815|588553492|FG001|Overall Study|patient refused treatment|1|||
162959207|NCT00334815|588553491|FG000|Overall Study|Physician Decision|2|||
162959208|NCT00334815|588553492|FG001|Overall Study|Physician Decision|4|||
162959209|NCT05604170|588553493|FG000|Overall Study|Lack of Efficacy|5|||
162959210|NCT05604170|588553493|FG000|Overall Study|Adverse Event|6|||
162959211|NCT05604170|588553493|FG000|Overall Study|Physician Decision|6|||
162959212|NCT05604170|588553493|FG000|Overall Study|Lost to Follow-up|6|||
162959213|NCT05604170|588553493|FG000|Overall Study|Withdrawal by Subject|11|||
162959214|NCT05604170|588553493|FG000|Overall Study|Early study termination by sponsor|77|||
162866256|NCT01022853|588214199|FG002|Overall Study|Withdrawal by Subject|1|||
162866257|NCT01022853|588214200|FG003|Overall Study|Withdrawal by Subject|1|||
162866258|NCT01022853|588214201|FG004|Overall Study|Withdrawal by Subject|0|||
162866259|NCT01022853|588214197|FG000|Overall Study|Other not stated above|1|||
162866260|NCT01022853|588214198|FG001|Overall Study|Other not stated above|0|||
162866261|NCT01022853|588214199|FG002|Overall Study|Other not stated above|1|||
162866262|NCT01022853|588214200|FG003|Overall Study|Other not stated above|0|||
162959215|NCT05604170|588553493|FG000|Overall Study|Other|6|||
162959216|NCT04742491|588553496|FG000|Overall Study|Death|2|||
162866263|NCT01022853|588214201|FG004|Overall Study|Other not stated above|0|||
162866264|NCT01651052|588214202|FG000|Overall Study|Death|21|||
162866265|NCT01651052|588214202|FG000|Overall Study|Explant|1|||
162866266|NCT01651052|588214202|FG000|Overall Study|Withdrawal by Subject|1|||
162866267|NCT01651052|588214202|FG000|Overall Study|Lost to Follow-up|3|||
162866268|NCT03503773|588214203|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
162866269|NCT03503773|588214204|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
162866270|NCT03503773|588214203|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
162866271|NCT03503773|588214204|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
162866272|NCT03503773|588214203|FG000|Overall Study|Not completing the primary ABPM|3|||
162866273|NCT03503773|588214204|FG001|Overall Study|Not completing the primary ABPM|1|||
162866274|NCT03503773|588214203|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
162866275|NCT03503773|588214204|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162866276|NCT04156646|588214211|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
162866277|NCT04156646|588214212|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
162866278|NCT01208181|588214215|FG000|Part 1|Withdrawal by Subject|11|||
162866279|NCT01208181|588214216|FG001|Part 1|Withdrawal by Subject|10|||
162866280|NCT01208181|588214217|FG002|Part 1|Withdrawal by Subject|0|||
162866281|NCT01208181|588214218|FG003|Part 1|Withdrawal by Subject|0|||
162866282|NCT01208181|588214219|FG004|Part 1|Withdrawal by Subject|0|||
162866283|NCT01208181|588214215|FG000|Part 1|Technical problem|5|||
162866284|NCT01208181|588214216|FG001|Part 1|Technical problem|0|||
162866285|NCT01208181|588214217|FG002|Part 1|Technical problem|0|||
162866286|NCT01208181|588214218|FG003|Part 1|Technical problem|0|||
162866287|NCT01208181|588214219|FG004|Part 1|Technical problem|0|||
162866288|NCT01208181|588214215|FG000|Part 1|Protocol Violation|10|||
162866289|NCT01208181|588214216|FG001|Part 1|Protocol Violation|5|||
162866290|NCT01208181|588214217|FG002|Part 1|Protocol Violation|0|||
162866291|NCT01208181|588214218|FG003|Part 1|Protocol Violation|0|||
162866292|NCT01208181|588214219|FG004|Part 1|Protocol Violation|0|||
162866293|NCT01208181|588214215|FG000|Part 1|Physician Decision|4|||
162866294|NCT01208181|588214216|FG001|Part 1|Physician Decision|0|||
162866295|NCT01208181|588214217|FG002|Part 1|Physician Decision|0|||
162866296|NCT01208181|588214218|FG003|Part 1|Physician Decision|0|||
162706125|NCT01764386|587636541|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
162706126|NCT01764386|587636540|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
162706127|NCT01764386|587636541|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
162866297|NCT01208181|588214219|FG004|Part 1|Physician Decision|0|||
162866298|NCT01208181|588214215|FG000|Part 1|Non-compliance with study drug|1|||
162866299|NCT01208181|588214216|FG001|Part 1|Non-compliance with study drug|1|||
162866300|NCT01208181|588214217|FG002|Part 1|Non-compliance with study drug|0|||
162866301|NCT01208181|588214218|FG003|Part 1|Non-compliance with study drug|0|||
162866302|NCT01208181|588214219|FG004|Part 1|Non-compliance with study drug|0|||
162866303|NCT01208181|588214215|FG000|Part 1|Lost to Follow-up|5|||
162866304|NCT01208181|588214216|FG001|Part 1|Lost to Follow-up|3|||
162866305|NCT01208181|588214217|FG002|Part 1|Lost to Follow-up|0|||
162866306|NCT01208181|588214218|FG003|Part 1|Lost to Follow-up|0|||
162866307|NCT01208181|588214219|FG004|Part 1|Lost to Follow-up|1|||
162866308|NCT01208181|588214215|FG000|Part 1|Lack of Efficacy|37|||
162866309|NCT01208181|588214216|FG001|Part 1|Lack of Efficacy|12|||
162866310|NCT01208181|588214217|FG002|Part 1|Lack of Efficacy|0|||
162866311|NCT01208181|588214218|FG003|Part 1|Lack of Efficacy|0|||
162866312|NCT01208181|588214219|FG004|Part 1|Lack of Efficacy|17|||
162866313|NCT01208181|588214215|FG000|Part 1|Adverse Event|26|||
162866314|NCT01208181|588214216|FG001|Part 1|Adverse Event|24|||
162866315|NCT01208181|588214217|FG002|Part 1|Adverse Event|0|||
162866316|NCT01208181|588214218|FG003|Part 1|Adverse Event|0|||
162866317|NCT01208181|588214219|FG004|Part 1|Adverse Event|4|||
162866318|NCT01208181|588214215|FG000|Part 2|Adverse Event|0|||
162866319|NCT01208181|588214216|FG001|Part 2|Adverse Event|0|||
162959217|NCT04742491|588553497|FG001|Overall Study|Death|0|||
162959218|NCT04742491|588553496|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
162959219|NCT04742491|588553497|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
162959220|NCT04742491|588553496|FG000|Overall Study|Lost to Follow-up|6|||
162959221|NCT04742491|588553497|FG001|Overall Study|Lost to Follow-up|8|||
162959222|NCT04742491|588553496|FG000|Overall Study|Withdrawal by Subject|4|||
162959223|NCT04742491|588553497|FG001|Overall Study|Withdrawal by Subject|2|||
162959224|NCT04742491|588553496|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
162959225|NCT04742491|588553497|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
162959226|NCT04742491|588553496|FG000|Overall Study|Participant refused further participation|2|||
162959227|NCT04742491|588553497|FG001|Overall Study|Participant refused further participation|7|||
162959228|NCT04742491|588553496|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
162959229|NCT04742491|588553497|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
162959230|NCT04742491|588553496|FG000|Overall Study|Other reasons|3|||
162959231|NCT04742491|588553497|FG001|Overall Study|Other reasons|4|||
162866320|NCT01208181|588214217|FG002|Part 2|Adverse Event|6|||
162866321|NCT01208181|588214218|FG003|Part 2|Adverse Event|7|||
162866322|NCT01208181|588214219|FG004|Part 2|Adverse Event|0|||
162866323|NCT01208181|588214215|FG000|Part 2|Withdrawal by Subject|0|||
162866324|NCT01208181|588214216|FG001|Part 2|Withdrawal by Subject|0|||
162866325|NCT01208181|588214217|FG002|Part 2|Withdrawal by Subject|1|||
162866326|NCT01208181|588214218|FG003|Part 2|Withdrawal by Subject|1|||
163046330|NCT00327717|588877392|FG000|Overall Study|Adverse Event|6|||
163046331|NCT00327717|588877393|FG001|Overall Study|Adverse Event|6|||
163046332|NCT00327717|588877392|FG000|Overall Study|Lack of Efficacy|0|||
163046333|NCT00327717|588877393|FG001|Overall Study|Lack of Efficacy|1|||
162866327|NCT01208181|588214219|FG004|Part 2|Withdrawal by Subject|0|||
162866328|NCT01208181|588214215|FG000|Part 2|Protocol Violation|0|||
162866329|NCT01208181|588214216|FG001|Part 2|Protocol Violation|0|||
162866330|NCT01208181|588214217|FG002|Part 2|Protocol Violation|1|||
162866331|NCT01208181|588214218|FG003|Part 2|Protocol Violation|0|||
162866332|NCT01208181|588214219|FG004|Part 2|Protocol Violation|0|||
162866333|NCT01208181|588214215|FG000|Part 2|Physician Decision|0|||
162866334|NCT01208181|588214216|FG001|Part 2|Physician Decision|0|||
162866335|NCT01208181|588214217|FG002|Part 2|Physician Decision|1|||
162866336|NCT01208181|588214218|FG003|Part 2|Physician Decision|2|||
162866337|NCT01208181|588214219|FG004|Part 2|Physician Decision|0|||
162866338|NCT01208181|588214215|FG000|Part 2|Non-compliance with study drug|0|||
162866339|NCT01208181|588214216|FG001|Part 2|Non-compliance with study drug|0|||
162866340|NCT01208181|588214217|FG002|Part 2|Non-compliance with study drug|1|||
162866341|NCT01208181|588214218|FG003|Part 2|Non-compliance with study drug|1|||
162866342|NCT01208181|588214219|FG004|Part 2|Non-compliance with study drug|0|||
162866343|NCT01208181|588214215|FG000|Part 2|Lost to Follow-up|0|||
162866344|NCT01208181|588214216|FG001|Part 2|Lost to Follow-up|0|||
162866345|NCT01208181|588214217|FG002|Part 2|Lost to Follow-up|1|||
162866346|NCT01208181|588214218|FG003|Part 2|Lost to Follow-up|2|||
162866347|NCT01208181|588214219|FG004|Part 2|Lost to Follow-up|0|||
162866348|NCT01208181|588214215|FG000|Part 2|Lack of Efficacy|0|||
162866349|NCT01208181|588214216|FG001|Part 2|Lack of Efficacy|0|||
162866350|NCT01208181|588214217|FG002|Part 2|Lack of Efficacy|5|||
162866351|NCT01208181|588214218|FG003|Part 2|Lack of Efficacy|7|||
162866352|NCT01208181|588214219|FG004|Part 2|Lack of Efficacy|0|||
162866353|NCT01478347|588214225|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
162866354|NCT01478347|588214225|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
162866355|NCT01478347|588214225|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
162866356|NCT01645930|588214226|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
162866357|NCT01645930|588214226|FG000|Overall Study|Progressive Disease|12|||
162866358|NCT01645930|588214226|FG000|Overall Study|Adverse Event|4|||
162866359|NCT01645930|588214226|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
162866360|NCT01645930|588214226|FG000|Overall Study|Withdrawal by Participant|2|||
162866361|NCT01645930|588214226|FG000|Overall Study|Reason not Defined|1|||
162866362|NCT03245814|588214227|FG000|Overall Study|Lost to Follow-up|5|||
162866363|NCT03245814|588214228|FG001|Overall Study|Lost to Follow-up|8|||
162866364|NCT03245814|588214227|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
162866365|NCT03245814|588214228|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
162866366|NCT01096667|588214232|FG000|Overall Study|Lost to Follow-up|1|||
162866367|NCT01096667|588214233|FG001|Overall Study|Lost to Follow-up|1|||
162866368|NCT01096667|588214234|FG002|Overall Study|Lost to Follow-up|1|||
162866369|NCT01096667|588214235|FG003|Overall Study|Lost to Follow-up|0|||
162866370|NCT01096667|588214236|FG004|Overall Study|Lost to Follow-up|0|||
162866371|NCT01096667|588214232|FG000|Overall Study|Withdrawal by Subject|1|||
162866372|NCT01096667|588214233|FG001|Overall Study|Withdrawal by Subject|0|||
162866373|NCT01096667|588214234|FG002|Overall Study|Withdrawal by Subject|0|||
162866374|NCT01096667|588214235|FG003|Overall Study|Withdrawal by Subject|1|||
162866375|NCT01096667|588214236|FG004|Overall Study|Withdrawal by Subject|0|||
162866376|NCT01096667|588214232|FG000|Overall Study|Reason not available|0|||
162866377|NCT01096667|588214233|FG001|Overall Study|Reason not available|1|||
162866378|NCT01096667|588214234|FG002|Overall Study|Reason not available|1|||
162866379|NCT01096667|588214235|FG003|Overall Study|Reason not available|1|||
162866380|NCT01096667|588214236|FG004|Overall Study|Reason not available|0|||
162866381|NCT01096667|588214232|FG000|Overall Study|Protocol Violation|0|||
162866382|NCT01096667|588214233|FG001|Overall Study|Protocol Violation|0|||
162959232|NCT03317899|588553498|FG000|Overall Study|Death|6|||
162959233|NCT03317899|588553499|FG001|Overall Study|Death|9|||
162959234|NCT00446966|588553500|FG000|Overall Study|Lost to Follow-up|10|||
162959235|NCT00446966|588553501|FG001|Overall Study|Lost to Follow-up|7|||
162959236|NCT01440803|588553502|FG000|Overall Study|Met study stopping rule|2|||
162959237|NCT01440803|588553503|FG001|Overall Study|Met study stopping rule|1|||
162959238|NCT01440803|588553502|FG000|Overall Study|Lost to Follow-up|0|||
162959239|NCT01440803|588553503|FG001|Overall Study|Lost to Follow-up|2|||
162866383|NCT01096667|588214234|FG002|Overall Study|Protocol Violation|0|||
162866384|NCT01096667|588214235|FG003|Overall Study|Protocol Violation|1|||
162866385|NCT01096667|588214236|FG004|Overall Study|Protocol Violation|0|||
162866386|NCT01096667|588214232|FG000|Overall Study|Not treated|1|||
162959240|NCT01440803|588553502|FG000|Overall Study|Withdrawal by Subject|0|||
162866387|NCT01096667|588214233|FG001|Overall Study|Not treated|0|||
162866388|NCT01096667|588214234|FG002|Overall Study|Not treated|0|||
162866389|NCT01096667|588214235|FG003|Overall Study|Not treated|0|||
162866390|NCT01096667|588214236|FG004|Overall Study|Not treated|0|||
162866391|NCT02263365|588214237|FG000|Overall Study|Physician Decision|22|||
162866392|NCT02263365|588214238|FG001|Overall Study|Physician Decision|18|||
162866393|NCT01845077|588214239|FG000|Washout Period|Lost to Follow-up|0|||
162866394|NCT01845077|588214240|FG001|Washout Period|Lost to Follow-up|1|||
162866395|NCT01845077|588214241|FG002|Washout Period|Lost to Follow-up|0|||
162866396|NCT01845077|588214242|FG003|Washout Period|Lost to Follow-up|1|||
162866397|NCT01845077|588214243|FG004|Washout Period|Lost to Follow-up|0|||
162866398|NCT01845077|588214244|FG005|Washout Period|Lost to Follow-up|1|||
162866399|NCT01845077|588214239|FG000|Washout Period|Adverse Event|1|||
162866400|NCT01845077|588214240|FG001|Washout Period|Adverse Event|0|||
162866401|NCT01845077|588214241|FG002|Washout Period|Adverse Event|0|||
162866402|NCT01845077|588214242|FG003|Washout Period|Adverse Event|0|||
162866403|NCT01845077|588214243|FG004|Washout Period|Adverse Event|0|||
162866404|NCT01845077|588214244|FG005|Washout Period|Adverse Event|0|||
162866405|NCT01845077|588214239|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
162866406|NCT01845077|588214240|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
162866407|NCT01845077|588214241|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
162866408|NCT01845077|588214242|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
162866409|NCT01845077|588214243|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
162866410|NCT01845077|588214244|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
162866411|NCT01845077|588214239|FG000|Washout Period|Protocol Violation|0|||
162866412|NCT01845077|588214240|FG001|Washout Period|Protocol Violation|0|||
162866413|NCT01845077|588214241|FG002|Washout Period|Protocol Violation|0|||
162866414|NCT01845077|588214242|FG003|Washout Period|Protocol Violation|1|||
162866415|NCT01845077|588214243|FG004|Washout Period|Protocol Violation|1|||
162866416|NCT01845077|588214244|FG005|Washout Period|Protocol Violation|0|||
162866417|NCT00312377|588214250|FG000|Overall Study|Death|403|||
162866418|NCT00312377|588214251|FG001|Overall Study|Death|418|||
162866419|NCT00312377|588214250|FG000|Overall Study|Withdrawal by Subject|23|||
162866420|NCT00312377|588214251|FG001|Overall Study|Withdrawal by Subject|30|||
162866421|NCT00312377|588214250|FG000|Overall Study|Lost to Follow-up|9|||
162866422|NCT00312377|588214251|FG001|Overall Study|Lost to Follow-up|12|||
162866423|NCT00312377|588214250|FG000|Overall Study|Non-compliance|0|||
162866424|NCT00312377|588214251|FG001|Overall Study|Non-compliance|2|||
162866425|NCT00312377|588214250|FG000|Overall Study|Randomised but never received treatment|6|||
162866426|NCT00312377|588214251|FG001|Overall Study|Randomised but never received treatment|6|||
162866427|NCT00312377|588214250|FG000|Overall Study|Discontinue treatment survival follow up|202|||
162866428|NCT00312377|588214251|FG001|Overall Study|Discontinue treatment survival follow up|200|||
162866429|NCT00312377|588214250|FG000|Overall Study|Site ended participation in study|1|||
162866430|NCT00312377|588214251|FG001|Overall Study|Site ended participation in study|0|||
162866431|NCT00231478|588214252|FG000|Overall Study|Protocol Violation|3|||
162866432|NCT00231478|588214253|FG001|Overall Study|Protocol Violation|2|||
162866433|NCT00231478|588214252|FG000|Overall Study|Refused Treatment|1|||
162866434|NCT00231478|588214253|FG001|Overall Study|Refused Treatment|1|||
162866435|NCT00231478|588214252|FG000|Overall Study|Withdrawal by Subject|1|||
162866436|NCT00231478|588214253|FG001|Overall Study|Withdrawal by Subject|0|||
162866437|NCT00231478|588214252|FG000|Overall Study|Adverse Event|0|||
162866438|NCT00231478|588214253|FG001|Overall Study|Adverse Event|1|||
162866439|NCT00231478|588214252|FG000|Overall Study|Administrative|3|||
162866440|NCT00231478|588214253|FG001|Overall Study|Administrative|2|||
162866441|NCT01056523|588214254|FG000|Overall Study|Death|1|||
162866442|NCT01056523|588214255|FG001|Overall Study|Death|0|||
162866443|NCT01056523|588214256|FG002|Overall Study|Death|2|||
162866444|NCT01056523|588214257|FG003|Overall Study|Death|3|||
162866445|NCT01056523|588214258|FG004|Overall Study|Death|0|||
162866446|NCT01056523|588214259|FG005|Overall Study|Death|0|||
162866447|NCT01056523|588214260|FG006|Overall Study|Death|1|||
162866448|NCT00815308|588214261|FG000|Overall Study|Adverse Event|4|||
162613621|NCT02456103|587303245|FG000|Overall Study|Adverse Event|5|||
162866449|NCT00815308|588214261|FG000|Overall Study|Withdrawal by Subject|0|||
162866450|NCT00815308|588214261|FG000|Overall Study|Protocol Violation|6|||
162866451|NCT03429556|588214262|FG000|Overall Study|Lost to Follow-up|0|||
162866452|NCT03429556|588214263|FG001|Overall Study|Lost to Follow-up|1|||
162866453|NCT03429556|588214264|FG002|Overall Study|Lost to Follow-up|0|||
162866454|NCT03429556|588214265|FG003|Overall Study|Lost to Follow-up|0|||
162866455|NCT00377299|588214268|FG000|Overall Study|Lost to Follow-up|14|||
162866456|NCT00377299|588214269|FG001|Overall Study|Lost to Follow-up|19|||
162866457|NCT00377299|588214268|FG000|Overall Study|Adverse Event|0|||
162866458|NCT00377299|588214269|FG001|Overall Study|Adverse Event|1|||
162866459|NCT00377299|588214268|FG000|Overall Study|Withdrawal by Subject|5|||
162866460|NCT00377299|588214269|FG001|Overall Study|Withdrawal by Subject|4|||
162866461|NCT02209597|588214271|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
162866462|NCT02209597|588214271|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
162866463|NCT02209597|588214271|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
162866464|NCT02209597|588214271|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
162866465|NCT04799782|588214279|FG000|Washout|Physician Decision|2|||
162866466|NCT04799782|588214280|FG001|Washout|Physician Decision|0|||
162866467|NCT04799782|588214279|FG000|Washout|Withdrawal by Subject|0|||
162866468|NCT04799782|588214280|FG001|Washout|Withdrawal by Subject|2|||
162866469|NCT04799782|588214279|FG000|Washout|Lost to Follow-up|0|||
162866470|NCT04799782|588214280|FG001|Washout|Lost to Follow-up|1|||
162866471|NCT02050048|588214281|FG000|Overall Study|Lost to Follow-up|0|||
162866472|NCT02050048|588214282|FG001|Overall Study|Lost to Follow-up|1|||
162866473|NCT02050048|588214281|FG000|Overall Study|Death|1|||
162866474|NCT02050048|588214282|FG001|Overall Study|Death|0|||
162866475|NCT02050048|588214281|FG000|Overall Study|Ineligible after ERCP|4|||
162866476|NCT02050048|588214282|FG001|Overall Study|Ineligible after ERCP|1|||
162866477|NCT01589094|588214287|FG000|Overall Study|Did not receive treatment|2|||
162866478|NCT00907738|588214288|FG000|Overall Study|Adverse Event|2|||
162866479|NCT00907738|588214289|FG001|Overall Study|Adverse Event|0|||
162866480|NCT00907738|588214290|FG002|Overall Study|Adverse Event|1|||
162866481|NCT00907738|588214291|FG003|Overall Study|Adverse Event|0|||
162866482|NCT00907738|588214292|FG004|Overall Study|Adverse Event|0|||
162866483|NCT00907738|588214288|FG000|Overall Study|not specified or withdrew consent|3|||
162866484|NCT00907738|588214289|FG001|Overall Study|not specified or withdrew consent|0|||
162866485|NCT00907738|588214290|FG002|Overall Study|not specified or withdrew consent|0|||
162866486|NCT00907738|588214291|FG003|Overall Study|not specified or withdrew consent|0|||
162866487|NCT00907738|588214292|FG004|Overall Study|not specified or withdrew consent|0|||
162866488|NCT00907738|588214288|FG000|Overall Study|Disease progression|8|||
162866489|NCT00907738|588214289|FG001|Overall Study|Disease progression|1|||
162866490|NCT00907738|588214290|FG002|Overall Study|Disease progression|6|||
162866491|NCT00907738|588214291|FG003|Overall Study|Disease progression|4|||
162866492|NCT00907738|588214292|FG004|Overall Study|Disease progression|2|||
162866493|NCT05363293|588214293|FG000|Overall Study|Withdrawal by Subject|1|||
162866494|NCT05363293|588214294|FG001|Overall Study|Withdrawal by Subject|0|||
162866495|NCT05363293|588214295|FG002|Overall Study|Withdrawal by Subject|0|||
162866496|NCT05363293|588214296|FG003|Overall Study|Withdrawal by Subject|0|||
162866497|NCT05363293|588214297|FG004|Overall Study|Withdrawal by Subject|0|||
162866498|NCT05363293|588214298|FG005|Overall Study|Withdrawal by Subject|0|||
162866499|NCT05363293|588214299|FG006|Overall Study|Withdrawal by Subject|0|||
162866500|NCT05363293|588214300|FG007|Overall Study|Withdrawal by Subject|0|||
162866501|NCT05363293|588214301|FG008|Overall Study|Withdrawal by Subject|0|||
162866502|NCT05363293|588214302|FG009|Overall Study|Withdrawal by Subject|0|||
162866503|NCT04773041|588214303|FG000|Overall Study|Unable to data match|1|||
162866504|NCT04773041|588214304|FG001|Overall Study|Unable to data match|0|||
162866505|NCT04773041|588214305|FG002|Overall Study|Unable to data match|0|||
162866506|NCT01988012|588216206|FG000|Overall Study|Adverse Event|5|||
162866507|NCT01988012|588216206|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162866508|NCT01988012|588216206|FG000|Overall Study|Patient Withdrawal of Consent|4|||
162866509|NCT01988012|588216206|FG000|Overall Study|Lost to Follow-up|1|||
162866510|NCT01988012|588216206|FG000|Overall Study|Physician Decision|1|||
162866511|NCT01988012|588216206|FG000|Overall Study|Protocol Violation|1|||
162866512|NCT01058369|588216207|FG000|Overall Study|Adverse Event|1|||
162866513|NCT01058369|588216207|FG000|Overall Study|Early termination study|1|||
162866514|NCT00634543|588216212|FG000|Overall Study|Other|1|||
162866515|NCT00634543|588216213|FG001|Overall Study|Other|2|||
162866516|NCT00634543|588216212|FG000|Overall Study|Protocol Violation|3|||
162866517|NCT00634543|588216213|FG001|Overall Study|Protocol Violation|3|||
162866518|NCT00634543|588216212|FG000|Overall Study|Adverse Event|11|||
162866519|NCT00634543|588216213|FG001|Overall Study|Adverse Event|11|||
162866520|NCT00634543|588216212|FG000|Overall Study|Withdrawal by Subject|4|||
162866521|NCT00634543|588216213|FG001|Overall Study|Withdrawal by Subject|4|||
162866522|NCT00634543|588216212|FG000|Overall Study|Lost to Follow-up|0|||
162866523|NCT00634543|588216213|FG001|Overall Study|Lost to Follow-up|1|||
162866524|NCT01650779|588216215|FG000|Overall Study|Withdrawal by Subject|1|||
162866525|NCT03567291|588216217|FG000|Period I|Adverse Event|14|||
162866526|NCT03567291|588216218|FG001|Period I|Adverse Event|0|||
162866527|NCT03567291|588216219|FG002|Period I|Adverse Event|0|||
162866528|NCT03567291|588216220|FG003|Period I|Adverse Event|0|||
162866529|NCT03567291|588216217|FG000|Period I|Protocol Violation|1|||
162866530|NCT03567291|588216218|FG001|Period I|Protocol Violation|0|||
162866531|NCT03567291|588216219|FG002|Period I|Protocol Violation|0|||
162866532|NCT03567291|588216220|FG003|Period I|Protocol Violation|0|||
162866533|NCT03567291|588216217|FG000|Period I|Withdrawal by Subject|23|||
162866534|NCT03567291|588216218|FG001|Period I|Withdrawal by Subject|0|||
162866535|NCT03567291|588216219|FG002|Period I|Withdrawal by Subject|0|||
162866536|NCT03567291|588216220|FG003|Period I|Withdrawal by Subject|0|||
162866537|NCT03567291|588216217|FG000|Period I|Lost to Follow-up|2|||
162866538|NCT03567291|588216218|FG001|Period I|Lost to Follow-up|0|||
162866539|NCT03567291|588216219|FG002|Period I|Lost to Follow-up|0|||
162866540|NCT03567291|588216220|FG003|Period I|Lost to Follow-up|0|||
162959241|NCT01440803|588553503|FG001|Overall Study|Withdrawal by Subject|1|||
162959242|NCT03502811|588553505|FG000|Overall Study|Death|157|||
162959243|NCT03502811|588553505|FG000|Overall Study|Withdrawal by Subject|105|||
162959244|NCT03502811|588553505|FG000|Overall Study|Lost to Follow-up|26|||
162959245|NCT03502811|588553505|FG000|Overall Study|No Visits (Missed)|31|||
162959246|NCT03913377|588553506|FG000|Period 1|Test Article no longer available|0|||
162959247|NCT03913377|588553507|FG001|Period 1|Test Article no longer available|1|||
162959248|NCT03913377|588553508|FG002|Period 1|Test Article no longer available|0|||
162959249|NCT03913377|588553506|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
162959250|NCT03913377|588553507|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
162959251|NCT03913377|588553508|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
162959252|NCT02197416|588553511|FG000|Overall Study|Other reasons|0|||
162959253|NCT02197416|588553512|FG001|Overall Study|Other reasons|2|||
162959254|NCT02197416|588553513|FG002|Overall Study|Other reasons|5|||
162959255|NCT02197416|588553511|FG000|Overall Study|Withdrawal by Subject|0|||
162959256|NCT02197416|588553512|FG001|Overall Study|Withdrawal by Subject|2|||
162959257|NCT02197416|588553513|FG002|Overall Study|Withdrawal by Subject|1|||
162959258|NCT02197416|588553511|FG000|Overall Study|Protocol Violation|1|||
162959259|NCT02197416|588553512|FG001|Overall Study|Protocol Violation|0|||
162959260|NCT02197416|588553513|FG002|Overall Study|Protocol Violation|1|||
162959261|NCT02197416|588553511|FG000|Overall Study|Adverse Event|0|||
162959262|NCT02197416|588553512|FG001|Overall Study|Adverse Event|0|||
162959263|NCT02197416|588553513|FG002|Overall Study|Adverse Event|1|||
162959264|NCT03689400|588553514|FG000|Overall Study|Lost to Follow-up|4|||
162959265|NCT01204294|588553515|FG000|Overall Study|Adverse Event|2|||
162959266|NCT01204294|588553516|FG001|Overall Study|Adverse Event|6|||
162959267|NCT01204294|588553517|FG002|Overall Study|Adverse Event|0|||
162959268|NCT01204294|588553518|FG003|Overall Study|Adverse Event|7|||
162959269|NCT01204294|588553519|FG004|Overall Study|Adverse Event|1|||
162959270|NCT01204294|588553520|FG005|Overall Study|Adverse Event|4|||
162959271|NCT01204294|588553521|FG006|Overall Study|Adverse Event|0|||
162959272|NCT01204294|588553515|FG000|Overall Study|Protocol Violation|1|||
162959273|NCT01204294|588553516|FG001|Overall Study|Protocol Violation|0|||
162959274|NCT01204294|588553517|FG002|Overall Study|Protocol Violation|2|||
162959275|NCT01204294|588553518|FG003|Overall Study|Protocol Violation|1|||
162959276|NCT01204294|588553519|FG004|Overall Study|Protocol Violation|0|||
162959277|NCT01204294|588553520|FG005|Overall Study|Protocol Violation|0|||
162959278|NCT01204294|588553521|FG006|Overall Study|Protocol Violation|0|||
162959279|NCT01204294|588553515|FG000|Overall Study|Withdrawal by Subject|0|||
162959280|NCT01204294|588553516|FG001|Overall Study|Withdrawal by Subject|2|||
162959281|NCT01204294|588553517|FG002|Overall Study|Withdrawal by Subject|2|||
162959282|NCT01204294|588553518|FG003|Overall Study|Withdrawal by Subject|1|||
162959283|NCT01204294|588553519|FG004|Overall Study|Withdrawal by Subject|1|||
162959284|NCT01204294|588553520|FG005|Overall Study|Withdrawal by Subject|1|||
162959285|NCT01204294|588553521|FG006|Overall Study|Withdrawal by Subject|2|||
162959286|NCT01204294|588553515|FG000|Overall Study|Lack of Efficacy|0|||
162959287|NCT01204294|588553516|FG001|Overall Study|Lack of Efficacy|0|||
162959288|NCT01204294|588553517|FG002|Overall Study|Lack of Efficacy|0|||
162866541|NCT03567291|588216217|FG000|Period I|Terminated by sponsor|44|||
162866542|NCT03567291|588216218|FG001|Period I|Terminated by sponsor|0|||
162959289|NCT01204294|588553518|FG003|Overall Study|Lack of Efficacy|2|||
162959290|NCT01204294|588553519|FG004|Overall Study|Lack of Efficacy|0|||
162959291|NCT01204294|588553520|FG005|Overall Study|Lack of Efficacy|0|||
162959292|NCT01204294|588553521|FG006|Overall Study|Lack of Efficacy|0|||
162866543|NCT03567291|588216219|FG002|Period I|Terminated by sponsor|0|||
162866544|NCT03567291|588216220|FG003|Period I|Terminated by sponsor|0|||
162959293|NCT01204294|588553515|FG000|Overall Study|Other (house moving)|0|||
162866545|NCT03567291|588216217|FG000|Period I|Missing or unknown|7|||
162959294|NCT01204294|588553516|FG001|Overall Study|Other (house moving)|0|||
162959295|NCT01204294|588553517|FG002|Overall Study|Other (house moving)|1|||
162959296|NCT01204294|588553518|FG003|Overall Study|Other (house moving)|0|||
162866546|NCT03567291|588216218|FG001|Period I|Missing or unknown|0|||
162866547|NCT03567291|588216219|FG002|Period I|Missing or unknown|0|||
162866548|NCT03567291|588216220|FG003|Period I|Missing or unknown|0|||
162866549|NCT03567291|588216217|FG000|Period II|Adverse Event|0|||
162866550|NCT03567291|588216218|FG001|Period II|Adverse Event|1|||
162866551|NCT03567291|588216219|FG002|Period II|Adverse Event|0|||
162866552|NCT03567291|588216220|FG003|Period II|Adverse Event|0|||
162866553|NCT03567291|588216217|FG000|Period II|Missing or unknown|0|||
162866554|NCT03567291|588216218|FG001|Period II|Missing or unknown|2|||
162866555|NCT03567291|588216219|FG002|Period II|Missing or unknown|1|||
162866556|NCT03567291|588216220|FG003|Period II|Missing or unknown|0|||
162866557|NCT03567291|588216217|FG000|Period III|Adverse Event|0|||
162866558|NCT03567291|588216218|FG001|Period III|Adverse Event|0|||
162866559|NCT03567291|588216219|FG002|Period III|Adverse Event|0|||
162866560|NCT03567291|588216220|FG003|Period III|Adverse Event|4|||
162866561|NCT03567291|588216217|FG000|Period III|Withdrawal by Subject|0|||
162866562|NCT03567291|588216218|FG001|Period III|Withdrawal by Subject|0|||
162866563|NCT03567291|588216219|FG002|Period III|Withdrawal by Subject|0|||
162866564|NCT03567291|588216220|FG003|Period III|Withdrawal by Subject|4|||
163046334|NCT00327717|588877392|FG000|Overall Study|Withdrawal by Subject|3|||
163046335|NCT00327717|588877393|FG001|Overall Study|Withdrawal by Subject|7|||
163046336|NCT01630135|588877395|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
162866565|NCT03567291|588216217|FG000|Period III|Lost to Follow-up|0|||
162866566|NCT03567291|588216218|FG001|Period III|Lost to Follow-up|0|||
162959297|NCT01204294|588553519|FG004|Overall Study|Other (house moving)|0|||
162959298|NCT01204294|588553520|FG005|Overall Study|Other (house moving)|0|||
162959299|NCT01204294|588553521|FG006|Overall Study|Other (house moving)|0|||
162959300|NCT03128723|588553522|FG000|Overall Study|Withdrawal by Subject|2|||
162959301|NCT02075463|588553523|FG000|Overall Study|Adverse Event|3|||
162959302|NCT02075463|588553523|FG000|Overall Study|Par. reached stopping criteria|4|||
162959303|NCT02075463|588553523|FG000|Overall Study|Withdrawal by Subject|1|||
162959304|NCT00673660|588553524|FG000|Overall Study|Lost to Follow-up|107|||
162959305|NCT01527006|588553525|FG000|Core Study|Adverse Event|0|||
162959306|NCT01527006|588553526|FG001|Core Study|Adverse Event|2|||
162959307|NCT01527006|588553525|FG000|Core Study|Lost to Follow-up|0|||
162959308|NCT01527006|588553526|FG001|Core Study|Lost to Follow-up|1|||
162959309|NCT01527006|588553525|FG000|Core Study|Subject Choice|1|||
162959310|NCT01527006|588553526|FG001|Core Study|Subject Choice|0|||
162959311|NCT01527006|588553525|FG000|Core Study|Inadequate Therapeutic Effect|1|||
162959312|NCT01527006|588553526|FG001|Core Study|Inadequate Therapeutic Effect|0|||
162959313|NCT01527006|588553525|FG000|Core Study|Withdrawal by Subject|0|||
162959314|NCT01527006|588553526|FG001|Core Study|Withdrawal by Subject|1|||
162959315|NCT01527006|588553525|FG000|Core Study|Other|0|||
162959316|NCT01527006|588553526|FG001|Core Study|Other|2|||
162959317|NCT01527006|588553525|FG000|Extension Phase|Adverse Event|4|||
162959318|NCT01527006|588553526|FG001|Extension Phase|Adverse Event|2|||
162959319|NCT01527006|588553525|FG000|Extension Phase|Lost to Follow-up|0|||
162959320|NCT01527006|588553526|FG001|Extension Phase|Lost to Follow-up|1|||
162959321|NCT01527006|588553525|FG000|Extension Phase|Subject Choice|1|||
162959322|NCT01527006|588553526|FG001|Extension Phase|Subject Choice|1|||
162959323|NCT01527006|588553525|FG000|Extension Phase|Inadequate therapeutic effect|1|||
162959324|NCT01527006|588553526|FG001|Extension Phase|Inadequate therapeutic effect|1|||
162959325|NCT01527006|588553525|FG000|Extension Phase|Other|0|||
162959326|NCT01527006|588553526|FG001|Extension Phase|Other|3|||
162959327|NCT00933686|588553527|FG000|Overall Study|Protocol Violation|0|||
162959328|NCT00933686|588553528|FG001|Overall Study|Protocol Violation|1|||
162959329|NCT00933686|588553527|FG000|Overall Study|Lost to Follow-up|2|||
162959330|NCT00933686|588553528|FG001|Overall Study|Lost to Follow-up|2|||
162959331|NCT00933686|588553527|FG000|Overall Study|Withdrawal by Subject|6|||
162959332|NCT00933686|588553528|FG001|Overall Study|Withdrawal by Subject|5|||
162959333|NCT00933686|588553527|FG000|Overall Study|Adverse Event|1|||
162959334|NCT00933686|588553528|FG001|Overall Study|Adverse Event|1|||
162866567|NCT03567291|588216219|FG002|Period III|Lost to Follow-up|0|||
162866568|NCT03567291|588216220|FG003|Period III|Lost to Follow-up|1|||
162866569|NCT03567291|588216217|FG000|Period III|Terminated by sponsor|0|||
162959335|NCT00933686|588553527|FG000|Overall Study|Physician Decision|1|||
162959336|NCT00933686|588553528|FG001|Overall Study|Physician Decision|0|||
162959337|NCT00933686|588553527|FG000|Overall Study|Failure to show up at endpoint visits|0|||
162959338|NCT00933686|588553528|FG001|Overall Study|Failure to show up at endpoint visits|2|||
162866570|NCT03567291|588216218|FG001|Period III|Terminated by sponsor|0|||
163046337|NCT01630135|588877396|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
162959339|NCT01383486|588553529|FG000|Overall Study|Lost to Follow-up|10|||
162866571|NCT03567291|588216219|FG002|Period III|Terminated by sponsor|0|||
162959340|NCT01383486|588553529|FG000|Overall Study|Incomplete information for analysis|2|||
162959341|NCT01383486|588553529|FG000|Overall Study|Did not take any product|6|||
162959342|NCT00245063|588553530|FG000|Overall Study|Adverse Event|6|||
162866572|NCT03567291|588216220|FG003|Period III|Terminated by sponsor|68|||
162866573|NCT03567291|588216217|FG000|Period III|Missing or unknown|0|||
162959343|NCT00245063|588553531|FG001|Overall Study|Adverse Event|5|||
162959344|NCT00245063|588553530|FG000|Overall Study|Death|1|||
162866574|NCT03567291|588216218|FG001|Period III|Missing or unknown|0|||
162866575|NCT03567291|588216219|FG002|Period III|Missing or unknown|0|||
162866576|NCT03567291|588216220|FG003|Period III|Missing or unknown|8|||
162866577|NCT01103349|588216223|FG000|Overall Study|Adverse Event|8|||
162866578|NCT01103349|588216224|FG001|Overall Study|Adverse Event|5|||
162866579|NCT01103349|588216225|FG002|Overall Study|Adverse Event|3|||
162866580|NCT01103349|588216223|FG000|Overall Study|Consent withdrawn|1|||
162866581|NCT01103349|588216224|FG001|Overall Study|Consent withdrawn|0|||
162866582|NCT01103349|588216225|FG002|Overall Study|Consent withdrawn|0|||
162866583|NCT01103349|588216223|FG000|Overall Study|Incorrectly included in the trial|1|||
162866584|NCT01103349|588216224|FG001|Overall Study|Incorrectly included in the trial|0|||
162866585|NCT01103349|588216225|FG002|Overall Study|Incorrectly included in the trial|0|||
162866586|NCT01103349|588216223|FG000|Overall Study|Withdrawal by Subject|1|||
162866587|NCT01103349|588216224|FG001|Overall Study|Withdrawal by Subject|1|||
162866588|NCT01103349|588216225|FG002|Overall Study|Withdrawal by Subject|0|||
162866589|NCT01103349|588216223|FG000|Overall Study|did not want to take trial medication|0|||
162866590|NCT01103349|588216224|FG001|Overall Study|did not want to take trial medication|1|||
162866591|NCT01103349|588216225|FG002|Overall Study|did not want to take trial medication|0|||
162866592|NCT01103349|588216223|FG000|Overall Study|forgot to take medication|0|||
162866593|NCT01103349|588216224|FG001|Overall Study|forgot to take medication|0|||
162866594|NCT01103349|588216225|FG002|Overall Study|forgot to take medication|1|||
162959345|NCT00245063|588553531|FG001|Overall Study|Death|0|||
162959346|NCT01839279|588553534|FG000|Overall Study|Adverse Event|4|||
162959347|NCT01839279|588553535|FG001|Overall Study|Adverse Event|1|||
162959348|NCT01839279|588553536|FG002|Overall Study|Adverse Event|1|||
162959349|NCT01839279|588553534|FG000|Overall Study|Withdrawal by Subject|4|||
162959350|NCT01839279|588553535|FG001|Overall Study|Withdrawal by Subject|1|||
162959351|NCT01839279|588553536|FG002|Overall Study|Withdrawal by Subject|1|||
162959352|NCT01839279|588553534|FG000|Overall Study|Classified as 'Other'|5|||
162959353|NCT01839279|588553535|FG001|Overall Study|Classified as 'Other'|0|||
162959354|NCT01839279|588553536|FG002|Overall Study|Classified as 'Other'|0|||
162959355|NCT05919823|588553540|FG000|Pre-Treatment Period|Screen failure|1|||
162959356|NCT05919823|588553541|FG001|Pre-Treatment Period|Screen failure|0|||
162959357|NCT05919823|588553542|FG002|Pre-Treatment Period|Screen failure|0|||
162959358|NCT05919823|588553543|FG003|Pre-Treatment Period|Screen failure|0|||
162959359|NCT05919823|588553540|FG000|Pre-Treatment Period|Protocol Violation|0|||
162959360|NCT05919823|588553541|FG001|Pre-Treatment Period|Protocol Violation|1|||
162959361|NCT05919823|588553542|FG002|Pre-Treatment Period|Protocol Violation|0|||
162959362|NCT05919823|588553543|FG003|Pre-Treatment Period|Protocol Violation|0|||
162959363|NCT05919823|588553540|FG000|Double-Blind Period|Adverse Event|8|||
162959364|NCT05919823|588553541|FG001|Double-Blind Period|Adverse Event|9|||
162959365|NCT05919823|588553542|FG002|Double-Blind Period|Adverse Event|0|||
162959366|NCT05919823|588553543|FG003|Double-Blind Period|Adverse Event|0|||
162959367|NCT05919823|588553540|FG000|Double-Blind Period|Protocol Violation|2|||
162959368|NCT05919823|588553541|FG001|Double-Blind Period|Protocol Violation|1|||
162959369|NCT05919823|588553542|FG002|Double-Blind Period|Protocol Violation|0|||
162959370|NCT05919823|588553543|FG003|Double-Blind Period|Protocol Violation|0|||
162959371|NCT05919823|588553540|FG000|Double-Blind Period|Participant withdrew consent|11|||
162959372|NCT05919823|588553541|FG001|Double-Blind Period|Participant withdrew consent|7|||
162959373|NCT05919823|588553542|FG002|Double-Blind Period|Participant withdrew consent|0|||
162959374|NCT05919823|588553543|FG003|Double-Blind Period|Participant withdrew consent|0|||
162959375|NCT05919823|588553540|FG000|Double-Blind Period|Other reasons|2|||
162959376|NCT05919823|588553541|FG001|Double-Blind Period|Other reasons|3|||
162866595|NCT01736683|588216229|FG000|Overall Study|Disease Relapse|0|||
162866596|NCT01736683|588216230|FG001|Overall Study|Disease Relapse|0|||
162866597|NCT01736683|588216231|FG002|Overall Study|Disease Relapse|2|||
162866598|NCT01736683|588216232|FG003|Overall Study|Disease Relapse|1|||
162866599|NCT01736683|588216233|FG004|Overall Study|Disease Relapse|0|||
162959377|NCT05919823|588553542|FG002|Double-Blind Period|Other reasons|0|||
162959378|NCT05919823|588553543|FG003|Double-Blind Period|Other reasons|0|||
162959379|NCT05919823|588553540|FG000|Open Label Period|Adverse Event|0|||
162959380|NCT05919823|588553541|FG001|Open Label Period|Adverse Event|0|||
162959381|NCT05919823|588553542|FG002|Open Label Period|Adverse Event|2|||
162866600|NCT01736683|588216229|FG000|Overall Study|Adverse Event|0|||
162866601|NCT01736683|588216230|FG001|Overall Study|Adverse Event|2|||
162866602|NCT01736683|588216231|FG002|Overall Study|Adverse Event|2|||
162866603|NCT01736683|588216232|FG003|Overall Study|Adverse Event|3|||
162866604|NCT01736683|588216233|FG004|Overall Study|Adverse Event|2|||
162866605|NCT01736683|588216229|FG000|Overall Study|Withdrawal by Subject|0|||
162866606|NCT01736683|588216230|FG001|Overall Study|Withdrawal by Subject|0|||
162959382|NCT05919823|588553543|FG003|Open Label Period|Adverse Event|4|||
162959383|NCT05919823|588553540|FG000|Open Label Period|Lost to Follow-up|0|||
162959384|NCT05919823|588553541|FG001|Open Label Period|Lost to Follow-up|0|||
162959385|NCT05919823|588553542|FG002|Open Label Period|Lost to Follow-up|1|||
162959386|NCT05919823|588553543|FG003|Open Label Period|Lost to Follow-up|0|||
162959387|NCT05919823|588553540|FG000|Open Label Period|Protocol Violation|0|||
162959388|NCT05919823|588553541|FG001|Open Label Period|Protocol Violation|0|||
162866607|NCT01736683|588216231|FG002|Overall Study|Withdrawal by Subject|3|||
162866608|NCT01736683|588216232|FG003|Overall Study|Withdrawal by Subject|1|||
162866609|NCT01736683|588216233|FG004|Overall Study|Withdrawal by Subject|1|||
162866610|NCT01736683|588216229|FG000|Overall Study|Lack of Therapeutic Effect|7|||
162866611|NCT01736683|588216230|FG001|Overall Study|Lack of Therapeutic Effect|4|||
162866612|NCT01736683|588216231|FG002|Overall Study|Lack of Therapeutic Effect|13|||
162866613|NCT01736683|588216232|FG003|Overall Study|Lack of Therapeutic Effect|20|||
162866614|NCT01736683|588216233|FG004|Overall Study|Lack of Therapeutic Effect|1|||
162866615|NCT01736683|588216229|FG000|Overall Study|Progressive Disease|0|||
162866616|NCT01736683|588216230|FG001|Overall Study|Progressive Disease|0|||
162866617|NCT01736683|588216231|FG002|Overall Study|Progressive Disease|0|||
162866618|NCT01736683|588216232|FG003|Overall Study|Progressive Disease|1|||
162866619|NCT01736683|588216233|FG004|Overall Study|Progressive Disease|0|||
162866620|NCT01736683|588216229|FG000|Overall Study|Other|0|||
162866621|NCT01736683|588216230|FG001|Overall Study|Other|0|||
162866622|NCT01736683|588216231|FG002|Overall Study|Other|1|||
162866623|NCT01736683|588216232|FG003|Overall Study|Other|9|||
162866624|NCT01736683|588216233|FG004|Overall Study|Other|1|||
162866625|NCT00283712|588216239|FG000|Overall Study|Death|0|||
162866626|NCT00283712|588216240|FG001|Overall Study|Death|1|||
162866627|NCT00090285|588216242|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
163046338|NCT02658669|588877398|FG000|Overall Study|Lost to Follow-up|7|||
162866628|NCT00090285|588216243|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
162866629|NCT00090285|588216244|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162866630|NCT00090285|588216245|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162866631|NCT00090285|588216246|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162866632|NCT00090285|588216247|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162866633|NCT00090285|588216242|FG000|Base Study Vaccination Period|Adverse Event|2|||
162866634|NCT00090285|588216243|FG001|Base Study Vaccination Period|Adverse Event|4|||
162866635|NCT00090285|588216244|FG002|Base Study Vaccination Period|Adverse Event|0|||
162866636|NCT00090285|588216245|FG003|Base Study Vaccination Period|Adverse Event|0|||
162866637|NCT00090285|588216246|FG004|Base Study Vaccination Period|Adverse Event|0|||
162866638|NCT00090285|588216247|FG005|Base Study Vaccination Period|Adverse Event|0|||
162866639|NCT00090285|588216242|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
162866640|NCT00090285|588216243|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
162866641|NCT00090285|588216244|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
162866642|NCT00090285|588216245|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163046339|NCT02658669|588877399|FG001|Overall Study|Lost to Follow-up|5|||
162866643|NCT00090285|588216246|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
162866644|NCT00090285|588216247|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
162866645|NCT00090285|588216242|FG000|Base Study Vaccination Period|Protocol Violation|2|||
162866646|NCT00090285|588216243|FG001|Base Study Vaccination Period|Protocol Violation|3|||
162866647|NCT00090285|588216244|FG002|Base Study Vaccination Period|Protocol Violation|0|||
162866648|NCT00090285|588216245|FG003|Base Study Vaccination Period|Protocol Violation|0|||
162866649|NCT00090285|588216246|FG004|Base Study Vaccination Period|Protocol Violation|0|||
162866650|NCT00090285|588216247|FG005|Base Study Vaccination Period|Protocol Violation|0|||
162866651|NCT00090285|588216242|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
162866652|NCT00090285|588216243|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
162866653|NCT00090285|588216244|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
162866654|NCT00090285|588216245|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
162866655|NCT00090285|588216246|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
162866656|NCT00090285|588216247|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
162866657|NCT00090285|588216242|FG000|Base Study Vaccination Period|Uncooperative|2|||
162866658|NCT00090285|588216243|FG001|Base Study Vaccination Period|Uncooperative|2|||
162866659|NCT00090285|588216244|FG002|Base Study Vaccination Period|Uncooperative|0|||
162866660|NCT00090285|588216245|FG003|Base Study Vaccination Period|Uncooperative|0|||
162866661|NCT00090285|588216246|FG004|Base Study Vaccination Period|Uncooperative|0|||
162866662|NCT00090285|588216247|FG005|Base Study Vaccination Period|Uncooperative|0|||
162866663|NCT00090285|588216242|FG000|Base Study Vaccination Period|Moved|20|||
162866664|NCT00090285|588216243|FG001|Base Study Vaccination Period|Moved|21|||
162866665|NCT00090285|588216244|FG002|Base Study Vaccination Period|Moved|0|||
162866666|NCT00090285|588216245|FG003|Base Study Vaccination Period|Moved|0|||
162866667|NCT00090285|588216246|FG004|Base Study Vaccination Period|Moved|0|||
162866668|NCT00090285|588216247|FG005|Base Study Vaccination Period|Moved|0|||
162866669|NCT00090285|588216242|FG000|Base Study Vaccination Period|Site Terminated|1|||
162866670|NCT00090285|588216243|FG001|Base Study Vaccination Period|Site Terminated|0|||
162866671|NCT00090285|588216244|FG002|Base Study Vaccination Period|Site Terminated|0|||
162866672|NCT00090285|588216245|FG003|Base Study Vaccination Period|Site Terminated|0|||
162866673|NCT00090285|588216246|FG004|Base Study Vaccination Period|Site Terminated|0|||
162866674|NCT00090285|588216247|FG005|Base Study Vaccination Period|Site Terminated|0|||
162866675|NCT00090285|588216242|FG000|Base Study Vaccination Period|Other|2|||
162866676|NCT00090285|588216243|FG001|Base Study Vaccination Period|Other|2|||
162866677|NCT00090285|588216244|FG002|Base Study Vaccination Period|Other|0|||
162866678|NCT00090285|588216245|FG003|Base Study Vaccination Period|Other|0|||
162866679|NCT00090285|588216246|FG004|Base Study Vaccination Period|Other|0|||
162866680|NCT00090285|588216247|FG005|Base Study Vaccination Period|Other|0|||
162866681|NCT00090285|588216242|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
162866682|NCT00090285|588216243|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
162866683|NCT00090285|588216244|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
162866684|NCT00090285|588216245|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
162866685|NCT00090285|588216246|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
162866686|NCT00090285|588216247|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
162866687|NCT00090285|588216242|FG000|Base Study Vaccination Period|HIV positive|1|||
162866688|NCT00090285|588216243|FG001|Base Study Vaccination Period|HIV positive|1|||
162866689|NCT00090285|588216244|FG002|Base Study Vaccination Period|HIV positive|0|||
162866690|NCT00090285|588216245|FG003|Base Study Vaccination Period|HIV positive|0|||
162866691|NCT00090285|588216246|FG004|Base Study Vaccination Period|HIV positive|0|||
162866692|NCT00090285|588216247|FG005|Base Study Vaccination Period|HIV positive|0|||
162866693|NCT00090285|588216242|FG000|Base Study Follow-up Period|Adverse Event|3|||
162866694|NCT00090285|588216243|FG001|Base Study Follow-up Period|Adverse Event|10|||
162866695|NCT00090285|588216244|FG002|Base Study Follow-up Period|Adverse Event|0|||
162866696|NCT00090285|588216245|FG003|Base Study Follow-up Period|Adverse Event|0|||
162866697|NCT00090285|588216246|FG004|Base Study Follow-up Period|Adverse Event|0|||
162866698|NCT00090285|588216247|FG005|Base Study Follow-up Period|Adverse Event|0|||
162866699|NCT00090285|588216242|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
162866700|NCT00090285|588216243|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
162866701|NCT00090285|588216244|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
162866702|NCT00090285|588216245|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
162866703|NCT00090285|588216246|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
162866704|NCT00090285|588216247|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
162866705|NCT00090285|588216242|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
162866706|NCT00090285|588216243|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
162866707|NCT00090285|588216244|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
162866708|NCT00090285|588216245|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
162866709|NCT00090285|588216246|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
162866710|NCT00090285|588216247|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
162866711|NCT00090285|588216242|FG000|Base Study Follow-up Period|Moved|41|||
162866712|NCT00090285|588216243|FG001|Base Study Follow-up Period|Moved|36|||
162866713|NCT00090285|588216244|FG002|Base Study Follow-up Period|Moved|0|||
162866714|NCT00090285|588216245|FG003|Base Study Follow-up Period|Moved|0|||
162866715|NCT00090285|588216246|FG004|Base Study Follow-up Period|Moved|0|||
162866716|NCT00090285|588216247|FG005|Base Study Follow-up Period|Moved|0|||
162866717|NCT00090285|588216242|FG000|Base Study Follow-up Period|Other|2|||
162866718|NCT00090285|588216243|FG001|Base Study Follow-up Period|Other|0|||
162866719|NCT00090285|588216244|FG002|Base Study Follow-up Period|Other|0|||
162866720|NCT00090285|588216245|FG003|Base Study Follow-up Period|Other|0|||
162866721|NCT00090285|588216246|FG004|Base Study Follow-up Period|Other|0|||
162866722|NCT00090285|588216247|FG005|Base Study Follow-up Period|Other|0|||
162866723|NCT00090285|588216242|FG000|Base Study Follow-up Period|Protocol Violation|1|||
162866724|NCT00090285|588216243|FG001|Base Study Follow-up Period|Protocol Violation|0|||
162866725|NCT00090285|588216244|FG002|Base Study Follow-up Period|Protocol Violation|0|||
162866726|NCT00090285|588216245|FG003|Base Study Follow-up Period|Protocol Violation|0|||
162866727|NCT00090285|588216246|FG004|Base Study Follow-up Period|Protocol Violation|0|||
162866728|NCT00090285|588216247|FG005|Base Study Follow-up Period|Protocol Violation|0|||
162866729|NCT00090285|588216242|FG000|Base Study Follow-up Period|Uncooperative|3|||
162866730|NCT00090285|588216243|FG001|Base Study Follow-up Period|Uncooperative|4|||
162866731|NCT00090285|588216244|FG002|Base Study Follow-up Period|Uncooperative|0|||
162866732|NCT00090285|588216245|FG003|Base Study Follow-up Period|Uncooperative|0|||
162866733|NCT00090285|588216246|FG004|Base Study Follow-up Period|Uncooperative|0|||
162866734|NCT00090285|588216247|FG005|Base Study Follow-up Period|Uncooperative|0|||
162866735|NCT00090285|588216242|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
162866736|NCT00090285|588216243|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
162866737|NCT00090285|588216244|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
162866738|NCT00090285|588216245|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
162866739|NCT00090285|588216246|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
162866740|NCT00090285|588216247|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
162866741|NCT00090285|588216242|FG000|Extension 1|Adverse Event|0|||
162866742|NCT00090285|588216243|FG001|Extension 1|Adverse Event|0|||
162866743|NCT00090285|588216244|FG002|Extension 1|Adverse Event|2|||
162866744|NCT00090285|588216245|FG003|Extension 1|Adverse Event|0|||
162866745|NCT00090285|588216246|FG004|Extension 1|Adverse Event|0|||
162866746|NCT00090285|588216247|FG005|Extension 1|Adverse Event|0|||
162866747|NCT00090285|588216242|FG000|Extension 1|Lost to Follow-up|0|||
162866748|NCT00090285|588216243|FG001|Extension 1|Lost to Follow-up|0|||
162866749|NCT00090285|588216244|FG002|Extension 1|Lost to Follow-up|35|||
162866750|NCT00090285|588216245|FG003|Extension 1|Lost to Follow-up|0|||
162866751|NCT00090285|588216246|FG004|Extension 1|Lost to Follow-up|0|||
162866752|NCT00090285|588216247|FG005|Extension 1|Lost to Follow-up|0|||
162866753|NCT00090285|588216242|FG000|Extension 1|Withdrawal by Subject|0|||
162866754|NCT00090285|588216243|FG001|Extension 1|Withdrawal by Subject|0|||
162866755|NCT00090285|588216244|FG002|Extension 1|Withdrawal by Subject|13|||
162866756|NCT00090285|588216245|FG003|Extension 1|Withdrawal by Subject|1|||
162866757|NCT00090285|588216246|FG004|Extension 1|Withdrawal by Subject|0|||
162866758|NCT00090285|588216247|FG005|Extension 1|Withdrawal by Subject|0|||
162866759|NCT00090285|588216242|FG000|Extension 1|Other|0|||
162866760|NCT00090285|588216243|FG001|Extension 1|Other|0|||
162866761|NCT00090285|588216244|FG002|Extension 1|Other|4|||
162866762|NCT00090285|588216245|FG003|Extension 1|Other|0|||
162866763|NCT00090285|588216246|FG004|Extension 1|Other|0|||
162866764|NCT00090285|588216247|FG005|Extension 1|Other|0|||
162866765|NCT00090285|588216242|FG000|Extension 1|Moved|0|||
162866766|NCT00090285|588216243|FG001|Extension 1|Moved|0|||
162866767|NCT00090285|588216244|FG002|Extension 1|Moved|3|||
162866768|NCT00090285|588216245|FG003|Extension 1|Moved|0|||
162866769|NCT00090285|588216246|FG004|Extension 1|Moved|0|||
162866770|NCT00090285|588216247|FG005|Extension 1|Moved|0|||
162866771|NCT00090285|588216242|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
162866772|NCT00090285|588216243|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
162866773|NCT00090285|588216244|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
162866774|NCT00090285|588216245|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
162866775|NCT00090285|588216246|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
162866776|NCT00090285|588216247|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
162866777|NCT00090285|588216242|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
162866778|NCT00090285|588216243|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
162866779|NCT00090285|588216244|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
162866780|NCT00090285|588216245|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
162866781|NCT00090285|588216246|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
162866782|NCT00090285|588216247|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
162959389|NCT05919823|588553542|FG002|Open Label Period|Protocol Violation|0|||
162866783|NCT00090285|588216242|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
162866784|NCT00090285|588216243|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
162866785|NCT00090285|588216244|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
162866786|NCT00090285|588216245|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
162866787|NCT00090285|588216246|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
162866788|NCT00090285|588216247|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
162866789|NCT00090285|588216242|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
162866790|NCT00090285|588216243|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
162866791|NCT00090285|588216244|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
162866792|NCT00090285|588216245|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
162866793|NCT00090285|588216246|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
162866794|NCT00090285|588216247|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
162866795|NCT00907478|588216250|FG000|Overall Study|Ineligibility determined|0|||
162866796|NCT00907478|588216251|FG001|Overall Study|Ineligibility determined|0|||
162866797|NCT00907478|588216252|FG002|Overall Study|Ineligibility determined|1|||
162866798|NCT00907478|588216250|FG000|Overall Study|Noncompliance|0|||
162866799|NCT00907478|588216251|FG001|Overall Study|Noncompliance|0|||
162866800|NCT00907478|588216252|FG002|Overall Study|Noncompliance|1|||
162866801|NCT00907478|588216250|FG000|Overall Study|Adverse Event|3|||
162866802|NCT00907478|588216251|FG001|Overall Study|Adverse Event|1|||
162866803|NCT00907478|588216252|FG002|Overall Study|Adverse Event|2|||
162866804|NCT00907478|588216250|FG000|Overall Study|Withdrawal by Subject|8|||
162866805|NCT00907478|588216251|FG001|Overall Study|Withdrawal by Subject|9|||
162866806|NCT00907478|588216252|FG002|Overall Study|Withdrawal by Subject|6|||
162866807|NCT00907478|588216250|FG000|Overall Study|Requirement for alternative therapy|1|||
162866808|NCT00907478|588216251|FG001|Overall Study|Requirement for alternative therapy|2|||
162866809|NCT00907478|588216252|FG002|Overall Study|Requirement for alternative therapy|3|||
162866810|NCT00907478|588216250|FG000|Overall Study|Physician Decision|2|||
162866811|NCT00907478|588216251|FG001|Overall Study|Physician Decision|0|||
162866812|NCT00907478|588216252|FG002|Overall Study|Physician Decision|3|||
162866813|NCT00907478|588216250|FG000|Overall Study|Death|4|||
162866814|NCT00907478|588216251|FG001|Overall Study|Death|2|||
162866815|NCT00907478|588216252|FG002|Overall Study|Death|1|||
162866816|NCT00907478|588216250|FG000|Overall Study|Protocol-specified criteria|5|||
162866817|NCT00907478|588216251|FG001|Overall Study|Protocol-specified criteria|2|||
162866818|NCT00907478|588216252|FG002|Overall Study|Protocol-specified criteria|3|||
162866819|NCT00907478|588216250|FG000|Overall Study|Pregnancy|0|||
162866820|NCT00907478|588216251|FG001|Overall Study|Pregnancy|1|||
162866821|NCT00907478|588216252|FG002|Overall Study|Pregnancy|1|||
162866822|NCT00907478|588216250|FG000|Overall Study|Lost to Follow-up|1|||
162866823|NCT00907478|588216251|FG001|Overall Study|Lost to Follow-up|0|||
162866824|NCT00907478|588216252|FG002|Overall Study|Lost to Follow-up|0|||
162866825|NCT00907478|588216250|FG000|Overall Study|Other|3|||
162866826|NCT00907478|588216251|FG001|Overall Study|Other|0|||
162866827|NCT00907478|588216252|FG002|Overall Study|Other|1|||
162866828|NCT02046564|588216253|FG000|Overall Study|Adverse Event|6|||
162866829|NCT02046564|588216254|FG001|Overall Study|Adverse Event|3|||
162959390|NCT05919823|588553543|FG003|Open Label Period|Protocol Violation|1|||
162959391|NCT05919823|588553540|FG000|Open Label Period|Participant withdrew consent|0|||
162959392|NCT05919823|588553541|FG001|Open Label Period|Participant withdrew consent|0|||
162959393|NCT05919823|588553542|FG002|Open Label Period|Participant withdrew consent|8|||
162959394|NCT05919823|588553543|FG003|Open Label Period|Participant withdrew consent|6|||
162959395|NCT05919823|588553540|FG000|Open Label Period|Death|0|||
162959396|NCT05919823|588553541|FG001|Open Label Period|Death|0|||
162959397|NCT05919823|588553542|FG002|Open Label Period|Death|0|||
162959398|NCT05919823|588553543|FG003|Open Label Period|Death|1|||
162959399|NCT05919823|588553540|FG000|Open Label Period|Other reasons|0|||
162959400|NCT05919823|588553541|FG001|Open Label Period|Other reasons|0|||
162959401|NCT05919823|588553542|FG002|Open Label Period|Other reasons|9|||
162959402|NCT05919823|588553543|FG003|Open Label Period|Other reasons|5|||
162959403|NCT01648582|588553544|FG000|Overall Study|Adverse Event|6|||
162959404|NCT01648582|588553545|FG001|Overall Study|Adverse Event|11|||
162959405|NCT01648582|588553546|FG002|Overall Study|Adverse Event|2|||
162959406|NCT01648582|588553544|FG000|Overall Study|Lost to Follow-up|9|||
162959407|NCT01648582|588553545|FG001|Overall Study|Lost to Follow-up|6|||
162866830|NCT02046564|588216253|FG000|Overall Study|Physician Decision|0|||
162866831|NCT02046564|588216254|FG001|Overall Study|Physician Decision|1|||
162866832|NCT02046564|588216253|FG000|Overall Study|Protocol Violation|3|||
162866833|NCT02046564|588216254|FG001|Overall Study|Protocol Violation|1|||
162959408|NCT01648582|588553546|FG002|Overall Study|Lost to Follow-up|8|||
162959409|NCT01648582|588553544|FG000|Overall Study|Protocol Violation|1|||
162959410|NCT01648582|588553545|FG001|Overall Study|Protocol Violation|2|||
162959411|NCT01648582|588553546|FG002|Overall Study|Protocol Violation|1|||
162866834|NCT02046564|588216253|FG000|Overall Study|Withdrawal by Subject|4|||
162866835|NCT02046564|588216254|FG001|Overall Study|Withdrawal by Subject|10|||
162866836|NCT02046564|588216253|FG000|Overall Study|Subject met withdrawal criteria|2|||
162866837|NCT02046564|588216254|FG001|Overall Study|Subject met withdrawal criteria|5|||
162866838|NCT02747043|588216255|FG000|Overall Study|Other|1|||
162866839|NCT02747043|588216256|FG001|Overall Study|Other|1|||
162866840|NCT02747043|588216255|FG000|Overall Study|Adverse Event|3|||
162866841|NCT02747043|588216256|FG001|Overall Study|Adverse Event|1|||
162866842|NCT02747043|588216255|FG000|Overall Study|Withdrawal by Subject|1|||
162866843|NCT02747043|588216256|FG001|Overall Study|Withdrawal by Subject|1|||
162866844|NCT02747043|588216255|FG000|Overall Study|Physician Decision|1|||
162866845|NCT02747043|588216256|FG001|Overall Study|Physician Decision|1|||
162866846|NCT02747043|588216255|FG000|Overall Study|Protocol Violation|0|||
162866847|NCT02747043|588216256|FG001|Overall Study|Protocol Violation|1|||
162866848|NCT02747043|588216255|FG000|Overall Study|Disease progression|4|||
162866849|NCT02747043|588216256|FG001|Overall Study|Disease progression|0|||
162866850|NCT01936649|588216263|FG000|Overall Study|Withdrawal by Subject|4|||
162866851|NCT01936649|588216263|FG000|Overall Study|Physician Decision|2|||
162866852|NCT01936649|588216263|FG000|Overall Study|Protocol Violation|2|||
162866853|NCT01936649|588216263|FG000|Overall Study|Other than specified above|5|||
162866854|NCT03554005|588216268|FG000|Overall Study|Not in participant's best interest|0|||
162866855|NCT03554005|588216269|FG001|Overall Study|Not in participant's best interest|0|||
162866856|NCT03554005|588216270|FG002|Overall Study|Not in participant's best interest|0|||
162866857|NCT03554005|588216271|FG003|Overall Study|Not in participant's best interest|0|||
162866858|NCT03554005|588216272|FG004|Overall Study|Not in participant's best interest|0|||
162866859|NCT03554005|588216273|FG005|Overall Study|Not in participant's best interest|1|||
162866860|NCT03554005|588216268|FG000|Overall Study|Disease Progression|1|||
162866861|NCT03554005|588216269|FG001|Overall Study|Disease Progression|1|||
162866862|NCT03554005|588216270|FG002|Overall Study|Disease Progression|1|||
162866863|NCT03554005|588216271|FG003|Overall Study|Disease Progression|1|||
162866864|NCT03554005|588216272|FG004|Overall Study|Disease Progression|5|||
162866865|NCT03554005|588216273|FG005|Overall Study|Disease Progression|6|||
162866866|NCT03554005|588216268|FG000|Overall Study|Adverse Event|0|||
162866867|NCT03554005|588216269|FG001|Overall Study|Adverse Event|0|||
162866868|NCT03554005|588216270|FG002|Overall Study|Adverse Event|0|||
162866869|NCT03554005|588216271|FG003|Overall Study|Adverse Event|0|||
162866870|NCT03554005|588216272|FG004|Overall Study|Adverse Event|0|||
162866871|NCT03554005|588216273|FG005|Overall Study|Adverse Event|3|||
162866872|NCT03554005|588216268|FG000|Overall Study|Physician Decision|0|||
162866873|NCT03554005|588216269|FG001|Overall Study|Physician Decision|0|||
162866874|NCT03554005|588216270|FG002|Overall Study|Physician Decision|0|||
162866875|NCT03554005|588216271|FG003|Overall Study|Physician Decision|0|||
162866876|NCT03554005|588216272|FG004|Overall Study|Physician Decision|1|||
162866877|NCT03554005|588216273|FG005|Overall Study|Physician Decision|0|||
162866878|NCT03554005|588216268|FG000|Overall Study|Other|0|||
162866879|NCT03554005|588216269|FG001|Overall Study|Other|0|||
162866880|NCT03554005|588216270|FG002|Overall Study|Other|0|||
162866881|NCT03554005|588216271|FG003|Overall Study|Other|0|||
162866882|NCT03554005|588216272|FG004|Overall Study|Other|0|||
162866883|NCT03554005|588216273|FG005|Overall Study|Other|1|||
162866884|NCT00631488|588216274|FG000|Overall Study|Adverse Event|1|||
162866885|NCT00631488|588216275|FG001|Overall Study|Adverse Event|0|||
162866886|NCT00631488|588216276|FG002|Overall Study|Adverse Event|0|||
162866887|NCT00631488|588216274|FG000|Overall Study|Lost to Follow-up|2|||
162866888|NCT00631488|588216275|FG001|Overall Study|Lost to Follow-up|2|||
162866889|NCT00631488|588216276|FG002|Overall Study|Lost to Follow-up|0|||
162866890|NCT00631488|588216274|FG000|Overall Study|Physician Decision|1|||
162866891|NCT00631488|588216275|FG001|Overall Study|Physician Decision|0|||
162866892|NCT00631488|588216276|FG002|Overall Study|Physician Decision|1|||
162866893|NCT00631488|588216274|FG000|Overall Study|Protocol Violation|0|||
162866894|NCT00631488|588216275|FG001|Overall Study|Protocol Violation|0|||
162866895|NCT00631488|588216276|FG002|Overall Study|Protocol Violation|1|||
162866896|NCT02855411|588216282|FG000|Overall Study|Study terminated by sponsor|21|||
162866897|NCT02855411|588216282|FG000|Overall Study|Does not meet entrance criteria|14|||
162866898|NCT03988751|588216285|FG000|Overall Study|Withdrawal by Subject|1|||
162866899|NCT03988751|588216286|FG001|Overall Study|Withdrawal by Subject|0|||
162866900|NCT03988751|588216285|FG000|Overall Study|Protocol Violation|0|||
162866901|NCT03988751|588216286|FG001|Overall Study|Protocol Violation|1|||
162866902|NCT00844883|588216287|FG000|Overall Study|Bridged to liver transplant|3|||
162866903|NCT00844883|588216287|FG000|Overall Study|Bridged to resection|1|||
162866904|NCT01325493|588216292|FG000|Overall Study|Protocol Violation|0|||
162866905|NCT01325493|588216293|FG001|Overall Study|Protocol Violation|1|||
162866906|NCT01325493|588216292|FG000|Overall Study|loss of neuromonitoring signals|0|||
162866907|NCT01325493|588216293|FG001|Overall Study|loss of neuromonitoring signals|2|||
162866908|NCT01325493|588216292|FG000|Overall Study|Allergy|1|||
162866909|NCT01325493|588216293|FG001|Overall Study|Allergy|0|||
162866910|NCT02927171|588216294|FG000|Overall Study|Lost to Follow-up|0|||
162866911|NCT02927171|588216295|FG001|Overall Study|Lost to Follow-up|1|||
162866912|NCT02240628|588216298|FG000|Overall Study|Physician Decision|6|||
162866913|NCT02240628|588216299|FG001|Overall Study|Physician Decision|5|||
162866914|NCT04530825|588216300|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
162866915|NCT04530825|588216301|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
162866916|NCT04530825|588216302|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
162866917|NCT04530825|588216303|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
162866918|NCT04530825|588216300|FG000|Overall Study|Did not complete follow-up|3|||
162866919|NCT04530825|588216301|FG001|Overall Study|Did not complete follow-up|0|||
162866920|NCT04530825|588216302|FG002|Overall Study|Did not complete follow-up|0|||
162866921|NCT04530825|588216303|FG003|Overall Study|Did not complete follow-up|0|||
162866922|NCT00850499|588216305|FG000|Overall Study|Adverse Event|3|||
162866923|NCT00850499|588216306|FG001|Overall Study|Adverse Event|1|||
162866924|NCT00850499|588216305|FG000|Overall Study|Lack of Efficacy|0|||
162866925|NCT00850499|588216306|FG001|Overall Study|Lack of Efficacy|1|||
162866926|NCT00552305|588216307|FG000|Overall Study|Adverse Event|43|||
162866927|NCT00552305|588216307|FG000|Overall Study|Lack of Efficacy|120|||
162866928|NCT00552305|588216307|FG000|Overall Study|Lost to Follow-up|4|||
162866929|NCT00552305|588216307|FG000|Overall Study|Protocol Violation|3|||
162866930|NCT00552305|588216307|FG000|Overall Study|Withdrawal by Subject|44|||
162866931|NCT00552305|588216307|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
162866932|NCT00552305|588216307|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
162866933|NCT00552305|588216307|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
162866934|NCT00552305|588216307|FG000|Overall Study|Unsatisfactory compliance|11|||
162866935|NCT00552305|588216307|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
162866936|NCT00552305|588216307|FG000|Overall Study|AE/Other: prohibited drug required|1|||
162866937|NCT00552305|588216307|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
162866938|NCT00552305|588216307|FG000|Overall Study|Other: Site closed|4|||
162866939|NCT00552305|588216307|FG000|Overall Study|Other: Personal problems|1|||
162866940|NCT00552305|588216307|FG000|Overall Study|Other: Unable to attend visits|1|||
162866941|NCT00552305|588216307|FG000|Overall Study|Other: Subject underwent surgery|4|||
162866942|NCT00552305|588216307|FG000|Overall Study|Other: Subject became pregnant|1|||
162866943|NCT00552305|588216307|FG000|Overall Study|Other: Health problems, not drug related|1|||
162866944|NCT00552305|588216307|FG000|Overall Study|Other: Subject moved from area|2|||
162866945|NCT00552305|588216307|FG000|Overall Study|Other: Subject incarcerated|1|||
162866946|NCT00552305|588216307|FG000|Overall Study|Other: Subject went to rehab|1|||
162866947|NCT00718861|588216310|FG000|Overall Study|Withdrawal by Subject|15|||
162866948|NCT00718861|588216311|FG001|Overall Study|Withdrawal by Subject|10|||
162866949|NCT00718861|588216310|FG000|Overall Study|Adverse Event|2|||
162866950|NCT00718861|588216311|FG001|Overall Study|Adverse Event|1|||
162866951|NCT00718861|588216310|FG000|Overall Study|Lost to Follow-up|2|||
162866952|NCT00718861|588216311|FG001|Overall Study|Lost to Follow-up|1|||
162866953|NCT00718861|588216310|FG000|Overall Study|Administrative Problems|1|||
162866954|NCT00718861|588216311|FG001|Overall Study|Administrative Problems|1|||
162866955|NCT00718861|588216310|FG000|Overall Study|Death|1|||
162866956|NCT00718861|588216311|FG001|Overall Study|Death|5|||
162866957|NCT01703819|588216312|FG000|Overall Study|Adverse Event|0|||
162866958|NCT01703819|588216313|FG001|Overall Study|Adverse Event|1|||
162866959|NCT01703819|588216312|FG000|Overall Study|Withdrawal by Subject|0|||
162866960|NCT01703819|588216313|FG001|Overall Study|Withdrawal by Subject|1|||
162866961|NCT04230486|588216320|FG000|Overall Study|Screen Failure|1|||
162866962|NCT01302041|588216321|FG000|Overall Study|Death|5|||
162866963|NCT01302041|588216321|FG000|Overall Study|Withdrawal by Subject|4|||
162866964|NCT01302041|588216321|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
162866965|NCT01302041|588216321|FG000|Overall Study|Other-Miscellaneous Reason|2|||
162866966|NCT04504032|588216322|FG000|Overall Study|Adverse Event|1|||
162866967|NCT04504032|588216323|FG001|Overall Study|Adverse Event|2|||
162866968|NCT04504032|588216322|FG000|Overall Study|Lost to Follow-up|6|||
162866969|NCT04504032|588216323|FG001|Overall Study|Lost to Follow-up|9|||
162866970|NCT04504032|588216322|FG000|Overall Study|Protocol Violation|2|||
162866971|NCT04504032|588216323|FG001|Overall Study|Protocol Violation|0|||
162866972|NCT04504032|588216322|FG000|Overall Study|Study terminated by sponsor|1|||
162866973|NCT04504032|588216323|FG001|Overall Study|Study terminated by sponsor|2|||
163046340|NCT00838097|588877408|FG000|Overall Study|Ineligibility determined|6|||
163046341|NCT00838097|588877408|FG000|Overall Study|Adverse Event|2|||
163046342|NCT00838097|588877408|FG000|Overall Study|Withdrawal by Subject|3|||
163046343|NCT00838097|588877408|FG000|Overall Study|Requirement for alternative therapy|2|||
162866974|NCT04504032|588216322|FG000|Overall Study|Withdrawal by Subject|9|||
162866975|NCT04504032|588216323|FG001|Overall Study|Withdrawal by Subject|11|||
162866976|NCT04504032|588216322|FG000|Overall Study|Disease progression prior to dosing|15|||
162866977|NCT04504032|588216323|FG001|Overall Study|Disease progression prior to dosing|3|||
162866978|NCT04504032|588216322|FG000|Overall Study|Drug supply issues|1|||
162866979|NCT04504032|588216323|FG001|Overall Study|Drug supply issues|1|||
162866980|NCT04504032|588216322|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
162866981|NCT04504032|588216323|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
162866982|NCT01839188|588216324|FG000|Overall Study|Withdrawal by Subject|1|||
162866983|NCT04983901|588216325|FG000|Overall Study|Death|1|||
163046344|NCT00838097|588877408|FG000|Overall Study|Physician Decision|4|||
163046345|NCT00838097|588877408|FG000|Overall Study|Lost to Follow-up|11|||
162613622|NCT02456103|587303245|FG000|Overall Study|Abnormal Laboratory Value|2|||
163046346|NCT00838097|588877408|FG000|Overall Study|Death|6|||
162866984|NCT04983901|588216326|FG001|Overall Study|Death|4|||
162866985|NCT04983901|588216325|FG000|Overall Study|Lost to Follow-up|3|||
162866986|NCT04983901|588216326|FG001|Overall Study|Lost to Follow-up|0|||
162866987|NCT04983901|588216325|FG000|Overall Study|Protocol Violation|1|||
162866988|NCT04983901|588216326|FG001|Overall Study|Protocol Violation|0|||
162866989|NCT04983901|588216325|FG000|Overall Study|Withdrawal by Subject|1|||
162866990|NCT04983901|588216326|FG001|Overall Study|Withdrawal by Subject|2|||
162866991|NCT01671488|588216327|FG000|Overall Study|Withdrawal by Subject|1|||
162866992|NCT02416908|588216328|FG000|Dose Escalation Phase|Adverse Event|0|||
162866993|NCT02416908|588216329|FG001|Dose Escalation Phase|Adverse Event|0|||
162866994|NCT02416908|588216330|FG002|Dose Escalation Phase|Adverse Event|3|||
162866995|NCT02416908|588216331|FG003|Dose Escalation Phase|Adverse Event|0|||
162866996|NCT02416908|588216328|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
162866997|NCT02416908|588216329|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162866998|NCT02416908|588216330|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
162866999|NCT02416908|588216331|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162867000|NCT02285010|588216332|FG000|Overall Study|not abdominal hysterectomy|2|||
162867001|NCT02285010|588216333|FG001|Overall Study|not abdominal hysterectomy|0|||
162867002|NCT02285010|588216332|FG000|Overall Study|Not spinal anesthesia|3|||
162867003|NCT02285010|588216333|FG001|Overall Study|Not spinal anesthesia|1|||
162867004|NCT01164501|588216337|FG000|Overall Study|Not treated|2|||
162867005|NCT01164501|588216338|FG001|Overall Study|Not treated|0|||
162867006|NCT01164501|588216339|FG002|Overall Study|Not treated|1|||
162867007|NCT01164501|588216337|FG000|Overall Study|Adverse Event|18|||
162867008|NCT01164501|588216338|FG001|Overall Study|Adverse Event|4|||
162867009|NCT01164501|588216339|FG002|Overall Study|Adverse Event|21|||
162867010|NCT01164501|588216337|FG000|Overall Study|Lack of Efficacy|0|||
162867011|NCT01164501|588216338|FG001|Overall Study|Lack of Efficacy|0|||
162867012|NCT01164501|588216339|FG002|Overall Study|Lack of Efficacy|1|||
162867013|NCT01164501|588216337|FG000|Overall Study|Non compliant with protocol|1|||
162867014|NCT01164501|588216338|FG001|Overall Study|Non compliant with protocol|1|||
162867015|NCT01164501|588216339|FG002|Overall Study|Non compliant with protocol|4|||
162867016|NCT01164501|588216337|FG000|Overall Study|Lost to Follow-up|3|||
162867017|NCT01164501|588216338|FG001|Overall Study|Lost to Follow-up|0|||
162867018|NCT01164501|588216339|FG002|Overall Study|Lost to Follow-up|3|||
162867019|NCT01164501|588216337|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
162867020|NCT01164501|588216338|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
162867021|NCT01164501|588216339|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
162867022|NCT01164501|588216337|FG000|Overall Study|Other reason not defined above|9|||
162867023|NCT01164501|588216338|FG001|Overall Study|Other reason not defined above|1|||
162867024|NCT01164501|588216339|FG002|Overall Study|Other reason not defined above|4|||
162867025|NCT01001494|588216342|FG000|Overall Study|Adverse Event|8|||
162867026|NCT01001494|588216343|FG001|Overall Study|Adverse Event|4|||
162867027|NCT01001494|588216344|FG002|Overall Study|Adverse Event|6|||
162867028|NCT01001494|588216342|FG000|Overall Study|Protocol Violation|0|||
162867029|NCT01001494|588216343|FG001|Overall Study|Protocol Violation|1|||
162959412|NCT01648582|588553544|FG000|Overall Study|Withdrawal by Subject|15|||
162959413|NCT01648582|588553545|FG001|Overall Study|Withdrawal by Subject|17|||
162959414|NCT01648582|588553546|FG002|Overall Study|Withdrawal by Subject|17|||
162959415|NCT01648582|588553544|FG000|Overall Study|Physician Decision|0|||
162959416|NCT01648582|588553545|FG001|Overall Study|Physician Decision|1|||
162959417|NCT01648582|588553546|FG002|Overall Study|Physician Decision|3|||
162959418|NCT01648582|588553544|FG000|Overall Study|Death|1|||
162959419|NCT01648582|588553545|FG001|Overall Study|Death|0|||
162959420|NCT01648582|588553546|FG002|Overall Study|Death|0|||
162959421|NCT01648582|588553544|FG000|Overall Study|Sponsor Decision|0|||
162959422|NCT01648582|588553545|FG001|Overall Study|Sponsor Decision|1|||
162959423|NCT01648582|588553546|FG002|Overall Study|Sponsor Decision|1|||
162959424|NCT02321098|588553551|FG000|12 Weeks Treament|Lost to Follow-up|1|||
162959425|NCT02321098|588553552|FG001|12 Weeks Treament|Lost to Follow-up|1|||
162959426|NCT02321098|588553553|FG002|12 Weeks Treament|Lost to Follow-up|0|||
162959427|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
162959428|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
162959429|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
162959430|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
162959431|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
162959432|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
162959433|NCT02321098|588553551|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
162959434|NCT02321098|588553552|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
162613623|NCT02456103|587303245|FG000|Overall Study|Lost to Follow-up|1|||
162613624|NCT02456103|587303245|FG000|Overall Study|Withdrawal by Subject|24|||
162867030|NCT01001494|588216344|FG002|Overall Study|Protocol Violation|1|||
162867031|NCT01001494|588216342|FG000|Overall Study|Lost to Follow-up|2|||
162867032|NCT01001494|588216343|FG001|Overall Study|Lost to Follow-up|0|||
162867033|NCT01001494|588216344|FG002|Overall Study|Lost to Follow-up|1|||
162867034|NCT01001494|588216342|FG000|Overall Study|Withdrawal by Subject|9|||
162867035|NCT01001494|588216343|FG001|Overall Study|Withdrawal by Subject|7|||
162867036|NCT01001494|588216344|FG002|Overall Study|Withdrawal by Subject|17|||
162867037|NCT01001494|588216342|FG000|Overall Study|COPD exacerbation|3|||
162867038|NCT01001494|588216343|FG001|Overall Study|COPD exacerbation|4|||
162867039|NCT01001494|588216344|FG002|Overall Study|COPD exacerbation|5|||
162867040|NCT01001494|588216342|FG000|Overall Study|Lack of Efficacy|2|||
162867041|NCT01001494|588216343|FG001|Overall Study|Lack of Efficacy|0|||
162867042|NCT01001494|588216344|FG002|Overall Study|Lack of Efficacy|8|||
162867043|NCT01001494|588216342|FG000|Overall Study|Other|0|||
162867044|NCT01001494|588216343|FG001|Overall Study|Other|1|||
162867045|NCT01001494|588216344|FG002|Overall Study|Other|3|||
162867046|NCT02179398|588216345|FG000|Overall Study|Lack of obligatory data|3|||
162867047|NCT02179398|588216346|FG001|Overall Study|Lack of obligatory data|3|||
162867048|NCT02179398|588216345|FG000|Overall Study|Lost to Follow-up|0|||
162867049|NCT02179398|588216346|FG001|Overall Study|Lost to Follow-up|1|||
162867050|NCT00408681|588216347|FG000|Overall Study|Lack of Efficacy|2|||
162867051|NCT00408681|588216347|FG000|Overall Study|Adverse Event|7|||
162867052|NCT01787591|588216355|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
162867053|NCT01787591|588216356|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
162867054|NCT01787591|588216357|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
162867055|NCT01787591|588216358|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
162867056|NCT02489630|588216361|FG000|Overall Study|Oversedation|1|||
162867057|NCT02489630|588216362|FG001|Overall Study|Oversedation|1|||
162867058|NCT02489630|588216361|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
162867059|NCT02489630|588216362|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
162867060|NCT03067311|588216367|FG000|Overall Study|Lost to Follow-up|1|||
162867061|NCT03067311|588216368|FG001|Overall Study|Lost to Follow-up|1|||
162867062|NCT03067311|588216367|FG000|Overall Study|Moved away|1|||
162867063|NCT03067311|588216368|FG001|Overall Study|Moved away|1|||
162867064|NCT02160977|588216369|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
162867065|NCT02160977|588216370|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
162867066|NCT02160977|588216369|FG000|Three Months After Surgery|Lost to Follow-up|0|||
162867067|NCT02160977|588216370|FG001|Three Months After Surgery|Lost to Follow-up|2|||
162867068|NCT02160977|588216369|FG000|Six Months After Surgery|Lost to Follow-up|2|||
162959435|NCT02321098|588553553|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
162959436|NCT03261167|588553558|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
162959437|NCT03261167|588553559|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
162959438|NCT03261167|588553558|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
162867069|NCT02160977|588216370|FG001|Six Months After Surgery|Lost to Follow-up|1|||
162959439|NCT03261167|588553559|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
162959440|NCT03261167|588553558|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
162959441|NCT03261167|588553559|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
162867070|NCT02975349|588216371|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162613625|NCT01465191|587303246|FG000|Overall Study|Protocol Violation|6|||
162867071|NCT02975349|588216372|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162867072|NCT02975349|588216373|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162867073|NCT02975349|588216374|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162867074|NCT02975349|588216375|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162867075|NCT02975349|588216376|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162867076|NCT02975349|588216377|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162867077|NCT02975349|588216371|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162867078|NCT02975349|588216372|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867079|NCT02975349|588216373|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867080|NCT02975349|588216374|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867081|NCT02975349|588216375|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867082|NCT02975349|588216376|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867083|NCT02975349|588216377|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162867084|NCT02975349|588216371|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
162867085|NCT02975349|588216372|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
162867086|NCT02975349|588216373|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
162867087|NCT02975349|588216374|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
162867088|NCT02975349|588216375|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
162867089|NCT02975349|588216376|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
162867090|NCT02975349|588216377|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
162867091|NCT02975349|588216371|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
162867092|NCT02975349|588216372|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
162867093|NCT02975349|588216373|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
162867094|NCT02975349|588216374|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
162867095|NCT02975349|588216375|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
162867096|NCT02975349|588216376|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
162867097|NCT02975349|588216377|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
162867098|NCT02975349|588216371|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
162867099|NCT02975349|588216372|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
162867100|NCT02975349|588216373|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
162867101|NCT02975349|588216374|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
162867102|NCT02975349|588216375|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
162867103|NCT02975349|588216376|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
162867104|NCT02975349|588216377|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
162867105|NCT02975349|588216371|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867106|NCT02975349|588216372|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867107|NCT02975349|588216373|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867108|NCT02975349|588216374|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
162867109|NCT02975349|588216375|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867110|NCT02975349|588216376|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867111|NCT02975349|588216377|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
162867112|NCT02975349|588216371|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867113|NCT02975349|588216372|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
162867114|NCT02975349|588216373|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867115|NCT02975349|588216374|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867116|NCT02975349|588216375|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867117|NCT02975349|588216376|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867118|NCT02975349|588216377|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
162867119|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
162867120|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
162867121|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
162867122|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
163046347|NCT00838097|588877408|FG000|Overall Study|Protocol-specified criteria|142|||
163046348|NCT03311841|588877409|FG000|14-day Wash-out|Adverse Event|0|||
163046349|NCT03311841|588877410|FG001|14-day Wash-out|Adverse Event|1|||
163046350|NCT03311841|588877411|FG002|14-day Wash-out|Adverse Event|0|||
163046351|NCT03311841|588877412|FG003|14-day Wash-out|Adverse Event|0|||
163046352|NCT03311841|588877413|FG004|14-day Wash-out|Adverse Event|0|||
163046353|NCT03311841|588877409|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046354|NCT03311841|588877410|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046355|NCT03311841|588877411|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
163046356|NCT03311841|588877412|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
163046357|NCT03311841|588877413|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
162867123|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
163046358|NCT05464420|588877414|FG000|Overall Study|Death|0|||
163046359|NCT05464420|588877415|FG001|Overall Study|Death|0|||
163046360|NCT05464420|588877416|FG002|Overall Study|Death|0|||
162867124|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
162867125|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
162867126|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867127|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867128|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867129|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867130|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
162867131|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867132|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
162867133|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
162867134|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
162867135|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
162867136|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
162867137|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
162867138|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
162867139|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
162867140|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
162867141|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
162867142|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
162867143|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
162867144|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
162867145|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
162867146|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
162867147|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
162867148|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
162867149|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
162867150|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
162867151|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
162867152|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
162867153|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
162867154|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
162867155|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
162867156|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
162867157|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
162867158|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
162867159|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
162867160|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
162959442|NCT03261167|588553558|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
162959443|NCT03261167|588553559|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
162959444|NCT03261167|588553558|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
162959445|NCT03261167|588553559|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
162959446|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
162959447|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
162959448|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
162959449|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
162959450|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
162959451|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
162959452|NCT03199963|588553565|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
162959453|NCT03199963|588553566|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
162959454|NCT03199963|588553565|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
162959455|NCT03199963|588553566|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
162959456|NCT03199963|588553565|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
162959457|NCT03199963|588553566|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
162959458|NCT02105272|588553573|FG000|Overall Study|Adverse Event|1|||
162959459|NCT02105272|588553574|FG001|Overall Study|Adverse Event|2|||
163046361|NCT05464420|588877417|FG003|Overall Study|Death|1|||
163046362|NCT05464420|588877414|FG000|Overall Study|Lost to Follow-up|16|||
163046363|NCT05464420|588877415|FG001|Overall Study|Lost to Follow-up|11|||
163046364|NCT05464420|588877416|FG002|Overall Study|Lost to Follow-up|11|||
163046365|NCT05464420|588877417|FG003|Overall Study|Lost to Follow-up|11|||
162613626|NCT01465191|587303247|FG001|Overall Study|Protocol Violation|3|||
162613627|NCT01465191|587303248|FG002|Overall Study|Protocol Violation|3|||
162867161|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
162867162|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
162613628|NCT01465191|587303246|FG000|Overall Study|Lost to Follow-up|3|||
162613629|NCT01465191|587303247|FG001|Overall Study|Lost to Follow-up|6|||
162613630|NCT01465191|587303248|FG002|Overall Study|Lost to Follow-up|4|||
162613631|NCT03614975|587303249|FG000|Overall Study|Physician Decision|7|||
162613632|NCT03614975|587303250|FG001|Overall Study|Physician Decision|5|||
162613633|NCT03614975|587303249|FG000|Overall Study|Withdrawal by Subject|2|||
162613634|NCT03614975|587303250|FG001|Overall Study|Withdrawal by Subject|2|||
162613635|NCT03614975|587303249|FG000|Overall Study|Specimens not in lab batch shipment|1|||
162613636|NCT03614975|587303250|FG001|Overall Study|Specimens not in lab batch shipment|1|||
162613637|NCT01390220|587303251|FG000|Test Dose Phase|Adverse Event|17|||
162613638|NCT01390220|587303252|FG001|Test Dose Phase|Adverse Event|0|||
162613639|NCT01390220|587303253|FG002|Test Dose Phase|Adverse Event|0|||
162613640|NCT01390220|587303251|FG000|Test Dose Phase|Withdrawal by Subject|8|||
162613641|NCT01390220|587303252|FG001|Test Dose Phase|Withdrawal by Subject|0|||
162613642|NCT01390220|587303253|FG002|Test Dose Phase|Withdrawal by Subject|0|||
162613643|NCT01390220|587303251|FG000|Test Dose Phase|Lost to Follow-up|2|||
162613644|NCT01390220|587303252|FG001|Test Dose Phase|Lost to Follow-up|0|||
162613645|NCT01390220|587303253|FG002|Test Dose Phase|Lost to Follow-up|0|||
162613646|NCT01390220|587303251|FG000|Test Dose Phase|Protocol Violation|8|||
162613647|NCT01390220|587303252|FG001|Test Dose Phase|Protocol Violation|0|||
162613648|NCT01390220|587303253|FG002|Test Dose Phase|Protocol Violation|0|||
162613649|NCT01390220|587303251|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
162613650|NCT01390220|587303252|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
162613651|NCT01390220|587303253|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
162613652|NCT01390220|587303251|FG000|Test Dose Phase|Study/Site closure|6|||
162613653|NCT01390220|587303252|FG001|Test Dose Phase|Study/Site closure|0|||
162613654|NCT01390220|587303253|FG002|Test Dose Phase|Study/Site closure|0|||
162613655|NCT01390220|587303251|FG000|Test Dose Phase|Caregiver no longer available|5|||
162613656|NCT01390220|587303252|FG001|Test Dose Phase|Caregiver no longer available|0|||
162613657|NCT01390220|587303253|FG002|Test Dose Phase|Caregiver no longer available|0|||
162613658|NCT01390220|587303251|FG000|Test Dose Phase|Noncompliance|2|||
162613659|NCT01390220|587303252|FG001|Test Dose Phase|Noncompliance|0|||
162613660|NCT01390220|587303253|FG002|Test Dose Phase|Noncompliance|0|||
162613661|NCT01390220|587303251|FG000|Test Dose Phase|Logistical|6|||
162613662|NCT01390220|587303252|FG001|Test Dose Phase|Logistical|0|||
162613663|NCT01390220|587303253|FG002|Test Dose Phase|Logistical|0|||
162613664|NCT01390220|587303251|FG000|Comparative Phase|Withdrawal by Subject|0|||
162613665|NCT01390220|587303252|FG001|Comparative Phase|Withdrawal by Subject|1|||
162613666|NCT01390220|587303253|FG002|Comparative Phase|Withdrawal by Subject|0|||
162613667|NCT00943124|587303254|FG000|Period 1|Withdrawal by Subject|1|||
162613668|NCT00943124|587303255|FG001|Period 1|Withdrawal by Subject|1|||
162613669|NCT00943124|587303254|FG000|Period 1|Did Not Follow Study Procedures|1|||
162613670|NCT00943124|587303255|FG001|Period 1|Did Not Follow Study Procedures|0|||
162613671|NCT00943124|587303254|FG000|Period 1|Personal Reasons|0|||
162613672|NCT00943124|587303255|FG001|Period 1|Personal Reasons|1|||
162613673|NCT03059446|587303256|FG000|Overall Study|Adverse Event|11|||
162613674|NCT03059446|587303256|FG000|Overall Study|Withdrawal of Consent|16|||
162613675|NCT03059446|587303256|FG000|Overall Study|Lost to Follow-up|3|||
162613676|NCT03059446|587303256|FG000|Overall Study|Protocol Violation|1|||
162613677|NCT03059446|587303256|FG000|Overall Study|Study Terminated by Sponsor|131|||
162613678|NCT03059446|587303256|FG000|Overall Study|Reason not Specified|5|||
162613679|NCT02992132|587303257|FG000|Overall Study|Adverse Event|4|||
162613680|NCT02992132|587303258|FG001|Overall Study|Adverse Event|1|||
162613681|NCT02992132|587303259|FG002|Overall Study|Adverse Event|3|||
162706128|NCT01764386|587636540|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
162706129|NCT01764386|587636541|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
162706130|NCT02703532|587636543|FG000|Overall Study|Withdrawal by Subject|0|||
162706131|NCT02703532|587636544|FG001|Overall Study|Withdrawal by Subject|1|||
162706132|NCT02703532|587636545|FG002|Overall Study|Withdrawal by Subject|0|||
162706133|NCT02703532|587636546|FG003|Overall Study|Withdrawal by Subject|1|||
162613682|NCT02992132|587303257|FG000|Overall Study|Lack of Efficacy|2|||
162613683|NCT02992132|587303258|FG001|Overall Study|Lack of Efficacy|0|||
162613684|NCT02992132|587303259|FG002|Overall Study|Lack of Efficacy|0|||
162613685|NCT02992132|587303257|FG000|Overall Study|Non-compliance with study drug|2|||
162613686|NCT02992132|587303258|FG001|Overall Study|Non-compliance with study drug|0|||
162613687|NCT02992132|587303259|FG002|Overall Study|Non-compliance with study drug|0|||
162613688|NCT02992132|587303257|FG000|Overall Study|Progressive disease|1|||
162613689|NCT02992132|587303258|FG001|Overall Study|Progressive disease|0|||
162613690|NCT02992132|587303259|FG002|Overall Study|Progressive disease|0|||
162613691|NCT02992132|587303257|FG000|Overall Study|Protocol Violation|2|||
162613692|NCT02992132|587303258|FG001|Overall Study|Protocol Violation|2|||
162613693|NCT02992132|587303259|FG002|Overall Study|Protocol Violation|0|||
162613694|NCT02992132|587303257|FG000|Overall Study|Caregiver withdrew consent|2|||
162613695|NCT02992132|587303258|FG001|Overall Study|Caregiver withdrew consent|3|||
162613696|NCT02992132|587303259|FG002|Overall Study|Caregiver withdrew consent|2|||
162613697|NCT02992132|587303257|FG000|Overall Study|Withdrawal by Subject|0|||
162613698|NCT02992132|587303258|FG001|Overall Study|Withdrawal by Subject|2|||
162613699|NCT02992132|587303259|FG002|Overall Study|Withdrawal by Subject|1|||
162613700|NCT02992132|587303257|FG000|Overall Study|Physician Decision|0|||
162613701|NCT02992132|587303258|FG001|Overall Study|Physician Decision|0|||
162613702|NCT02992132|587303259|FG002|Overall Study|Physician Decision|1|||
162613703|NCT02448810|587303260|FG000|Overall Study|Adverse Event|0|||
162613704|NCT02448810|587303261|FG001|Overall Study|Adverse Event|0|||
162613705|NCT02448810|587303262|FG002|Overall Study|Adverse Event|1|||
162613706|NCT02448810|587303263|FG003|Overall Study|Adverse Event|0|||
162613707|NCT02448810|587303264|FG004|Overall Study|Adverse Event|0|||
162613708|NCT02448810|587303265|FG005|Overall Study|Adverse Event|0|||
162613709|NCT02448810|587303266|FG006|Overall Study|Adverse Event|0|||
162613710|NCT02448810|587303267|FG007|Overall Study|Adverse Event|0|||
162613711|NCT02448810|587303260|FG000|Overall Study|Withdrawal by Subject|0|||
162613712|NCT02448810|587303261|FG001|Overall Study|Withdrawal by Subject|0|||
162613713|NCT02448810|587303262|FG002|Overall Study|Withdrawal by Subject|1|||
162959460|NCT02105272|588553573|FG000|Overall Study|Physician Decision|0|||
162959461|NCT02105272|588553574|FG001|Overall Study|Physician Decision|1|||
162959462|NCT02105272|588553573|FG000|Overall Study|Protocol Violation|2|||
162959463|NCT02105272|588553574|FG001|Overall Study|Protocol Violation|0|||
162959464|NCT02105272|588553573|FG000|Overall Study|Withdrawal by Subject|2|||
162613714|NCT02448810|587303263|FG003|Overall Study|Withdrawal by Subject|0|||
162613715|NCT02448810|587303264|FG004|Overall Study|Withdrawal by Subject|3|||
162959465|NCT02105272|588553574|FG001|Overall Study|Withdrawal by Subject|0|||
162959466|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Adverse Event|11|||
162959467|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Adverse Event|23|||
162959468|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Adverse Event|29|||
162959469|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Adverse Event|2|||
162959470|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Adverse Event|8|||
162959471|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
162959472|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
162959473|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
162959474|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
162959475|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
162959476|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
162959477|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
162959478|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
162959479|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
162959480|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
162959481|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
162959482|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
162959483|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
162959484|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
162959485|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
162959486|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959487|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
162959488|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959489|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959490|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
162959491|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
162959492|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
162706134|NCT02703532|587636543|FG000|Overall Study|Lost to Follow-up|2|||
162613716|NCT02448810|587303265|FG005|Overall Study|Withdrawal by Subject|5|||
162613717|NCT02448810|587303266|FG006|Overall Study|Withdrawal by Subject|0|||
162613718|NCT02448810|587303267|FG007|Overall Study|Withdrawal by Subject|2|||
162613719|NCT02448810|587303260|FG000|Overall Study|Other (study terminated by sponsor)|0|||
162613720|NCT02448810|587303261|FG001|Overall Study|Other (study terminated by sponsor)|0|||
162613721|NCT02448810|587303262|FG002|Overall Study|Other (study terminated by sponsor)|0|||
162613722|NCT02448810|587303263|FG003|Overall Study|Other (study terminated by sponsor)|0|||
162613723|NCT02448810|587303264|FG004|Overall Study|Other (study terminated by sponsor)|4|||
162613724|NCT02448810|587303265|FG005|Overall Study|Other (study terminated by sponsor)|2|||
162613725|NCT02448810|587303266|FG006|Overall Study|Other (study terminated by sponsor)|2|||
162613726|NCT02448810|587303267|FG007|Overall Study|Other (study terminated by sponsor)|1|||
162613727|NCT02448810|587303260|FG000|Overall Study|Death|1|||
162613728|NCT02448810|587303261|FG001|Overall Study|Death|0|||
162613729|NCT02448810|587303262|FG002|Overall Study|Death|1|||
162613730|NCT02448810|587303263|FG003|Overall Study|Death|0|||
162613731|NCT02448810|587303264|FG004|Overall Study|Death|1|||
162613732|NCT02448810|587303265|FG005|Overall Study|Death|0|||
162613733|NCT02448810|587303266|FG006|Overall Study|Death|0|||
162613734|NCT02448810|587303267|FG007|Overall Study|Death|0|||
162613735|NCT02448810|587303260|FG000|Overall Study|Other (Progressive disease)|2|||
162613736|NCT02448810|587303261|FG001|Overall Study|Other (Progressive disease)|2|||
162613737|NCT02448810|587303262|FG002|Overall Study|Other (Progressive disease)|0|||
162613738|NCT02448810|587303263|FG003|Overall Study|Other (Progressive disease)|3|||
162613739|NCT02448810|587303264|FG004|Overall Study|Other (Progressive disease)|23|||
162613740|NCT02448810|587303265|FG005|Overall Study|Other (Progressive disease)|9|||
162613741|NCT02448810|587303266|FG006|Overall Study|Other (Progressive disease)|14|||
162867163|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
162867164|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
162867165|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
162867166|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
162867167|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
162867168|NCT02975349|588216371|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
162867169|NCT02975349|588216372|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
162867170|NCT02975349|588216373|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
162867171|NCT02975349|588216374|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
162867172|NCT02975349|588216375|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
162867173|NCT02975349|588216376|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
162867174|NCT02975349|588216377|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
162867175|NCT05270694|588218081|FG000|Overall Study|Death|1|||
162867176|NCT05270694|588218081|FG000|Overall Study|Medical issues impacted ability to participate|2|||
162867177|NCT05270694|588218081|FG000|Overall Study|Lost to Follow-up|3|||
162613742|NCT02448810|587303267|FG007|Overall Study|Other (Progressive disease)|5|||
162613743|NCT02448810|587303260|FG000|Overall Study|Lost to Follow-up|0|||
162613744|NCT02448810|587303261|FG001|Overall Study|Lost to Follow-up|1|||
162867178|NCT05270694|588218081|FG000|Overall Study|Withdrawal by Subject|3|||
162613745|NCT02448810|587303262|FG002|Overall Study|Lost to Follow-up|0|||
162867179|NCT04267562|588218084|FG000|Assessed for Eligibility|Screen Failure|64|||
162867180|NCT04267562|588218084|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
162867181|NCT04267562|588218084|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
162867182|NCT04267562|588218084|FG000|Assessed for Eligibility|Site closure|6|||
162867183|NCT04267562|588218084|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
162867184|NCT04267562|588218084|FG000|Assessed for Eligibility|Physician Decision|1|||
162867185|NCT04267562|588218084|FG000|Month 24|Elective hysterectomy|1|||
162867186|NCT04267562|588218084|FG000|Month 24|Lost to Follow-up|1|||
162867187|NCT04267562|588218084|FG000|Month 36|Elective hysterectomy|2|||
162867188|NCT04267562|588218084|FG000|Month 36|Lost to Follow-up|3|||
162867189|NCT03270085|588218090|FG000|Overall Study|Withdrawal by Subject|1|||
162867190|NCT03270085|588218091|FG001|Overall Study|Withdrawal by Subject|0|||
162867191|NCT03825042|588218092|FG000|Overall Study|Adverse Event|1|||
162867192|NCT03825042|588218093|FG001|Overall Study|Adverse Event|0|||
162867193|NCT03825042|588218092|FG000|Overall Study|Withdrawal by Subject|1|||
162867194|NCT03825042|588218093|FG001|Overall Study|Withdrawal by Subject|0|||
162867195|NCT00521339|588218096|FG000|Treatment Phase|Adverse Event|2|||
162867196|NCT00521339|588218097|FG001|Treatment Phase|Adverse Event|0|||
162867197|NCT00521339|588218098|FG002|Treatment Phase|Adverse Event|0|||
162867198|NCT00521339|588218096|FG000|Treatment Phase|Intolerability to study drug|2|||
162867199|NCT00521339|588218097|FG001|Treatment Phase|Intolerability to study drug|0|||
162867200|NCT00521339|588218098|FG002|Treatment Phase|Intolerability to study drug|0|||
162867201|NCT00521339|588218096|FG000|Treatment Phase|Lack of Efficacy|3|||
162867202|NCT00521339|588218097|FG001|Treatment Phase|Lack of Efficacy|0|||
162867203|NCT00521339|588218098|FG002|Treatment Phase|Lack of Efficacy|0|||
162867204|NCT00521339|588218096|FG000|Treatment Phase|Withdrawal by Subject|3|||
162867205|NCT00521339|588218097|FG001|Treatment Phase|Withdrawal by Subject|0|||
162613746|NCT02448810|587303263|FG003|Overall Study|Lost to Follow-up|0|||
162613747|NCT02448810|587303264|FG004|Overall Study|Lost to Follow-up|0|||
162613748|NCT02448810|587303265|FG005|Overall Study|Lost to Follow-up|0|||
162613749|NCT02448810|587303266|FG006|Overall Study|Lost to Follow-up|0|||
162613750|NCT02448810|587303267|FG007|Overall Study|Lost to Follow-up|0|||
162613751|NCT02448810|587303260|FG000|Overall Study|Other (unspecified)|0|||
162613752|NCT02448810|587303261|FG001|Overall Study|Other (unspecified)|0|||
162613753|NCT02448810|587303262|FG002|Overall Study|Other (unspecified)|0|||
162613754|NCT02448810|587303263|FG003|Overall Study|Other (unspecified)|0|||
162613755|NCT02448810|587303264|FG004|Overall Study|Other (unspecified)|0|||
162613756|NCT02448810|587303265|FG005|Overall Study|Other (unspecified)|0|||
162613757|NCT02448810|587303266|FG006|Overall Study|Other (unspecified)|2|||
162613758|NCT02448810|587303267|FG007|Overall Study|Other (unspecified)|0|||
162613759|NCT00136604|587303268|FG000|Overall Study|Lost to Follow-up|1|||
162613760|NCT00136604|587303269|FG001|Overall Study|Lost to Follow-up|0|||
162613761|NCT00136604|587303270|FG002|Overall Study|Lost to Follow-up|0|||
162613762|NCT00136604|587303271|FG003|Overall Study|Lost to Follow-up|0|||
162613763|NCT00136604|587303272|FG004|Overall Study|Lost to Follow-up|1|||
162613764|NCT00136604|587303268|FG000|Overall Study|Migrated/moved from study area|0|||
162613765|NCT00136604|587303269|FG001|Overall Study|Migrated/moved from study area|1|||
162613766|NCT00136604|587303270|FG002|Overall Study|Migrated/moved from study area|0|||
162613767|NCT00136604|587303271|FG003|Overall Study|Migrated/moved from study area|0|||
162613768|NCT00136604|587303272|FG004|Overall Study|Migrated/moved from study area|0|||
162613769|NCT04795622|587303273|FG000|Overall Study|Adverse Event|1|||
162613770|NCT04795622|587303274|FG001|Overall Study|Adverse Event|0|||
162613771|NCT04795622|587303273|FG000|Overall Study|Withdrawal by Subject|3|||
162613772|NCT04795622|587303274|FG001|Overall Study|Withdrawal by Subject|3|||
162613773|NCT04795622|587303273|FG000|Overall Study|Protocol Violation|0|||
162613774|NCT04795622|587303274|FG001|Overall Study|Protocol Violation|2|||
162613775|NCT04795622|587303273|FG000|Overall Study|Lost to Follow-up|2|||
162613776|NCT04795622|587303274|FG001|Overall Study|Lost to Follow-up|3|||
162613777|NCT04795622|587303273|FG000|Overall Study|Other|7|||
162613778|NCT04795622|587303274|FG001|Overall Study|Other|8|||
162613779|NCT00470847|587303275|FG000|Overall Study|Pt still receiving treatment|1|||
162613780|NCT03963401|587303277|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
162613781|NCT03963401|587303278|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
162613782|NCT03963401|587303279|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
162613783|NCT03963401|587303280|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
162613784|NCT03963401|587303281|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
162613785|NCT03963401|587303282|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
162613786|NCT03963401|587303277|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162613787|NCT03963401|587303278|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162613788|NCT03963401|587303279|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
162613789|NCT03963401|587303280|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
162613790|NCT03963401|587303281|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162613791|NCT03963401|587303282|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162613792|NCT03963401|587303277|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
162613793|NCT03963401|587303278|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
162613794|NCT03963401|587303279|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
162613795|NCT03963401|587303280|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
162613796|NCT03963401|587303281|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
162613797|NCT03963401|587303282|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
162613798|NCT03963401|587303277|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162613799|NCT03963401|587303278|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
162613800|NCT03963401|587303279|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162613801|NCT03963401|587303280|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162613802|NCT03963401|587303281|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162613803|NCT03963401|587303282|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162613804|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
162613805|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
162959493|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
162959494|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
162959495|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
162959496|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
162959497|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
162959498|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
162959499|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
162959500|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
162959501|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Move|0|||
162959502|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Move|1|||
162959503|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Move|0|||
162959504|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Move|0|||
162959505|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Move|0|||
162613806|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
162613807|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
162613808|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
162613809|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
162613810|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
162613811|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162613812|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
162613813|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162613814|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162613815|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162613816|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162613817|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162613818|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
162613819|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162613820|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162613821|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162613822|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
162613823|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162613824|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162613825|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162613826|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162613827|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162613828|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
162613829|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162613830|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
162613831|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
162613832|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162613833|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162613834|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
162613835|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162613836|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162613837|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162613838|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162613839|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162613840|NCT03963401|587303277|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
162613841|NCT03963401|587303278|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
162613842|NCT03963401|587303279|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
162613843|NCT03963401|587303280|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
162613844|NCT03963401|587303281|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
162613845|NCT03963401|587303282|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
162613846|NCT01610271|587303287|FG000|Overall Study|Surgery not complete|0|||
162613847|NCT01610271|587303288|FG001|Overall Study|Surgery not complete|1|||
162613848|NCT01610271|587303287|FG000|Overall Study|Prosthesis not implanted|2|||
162613849|NCT01610271|587303288|FG001|Overall Study|Prosthesis not implanted|3|||
162613850|NCT01638819|587303289|FG000|Overall Study|Lost to Follow-up|1|||
162613851|NCT01638819|587303290|FG001|Overall Study|Lost to Follow-up|0|||
162613852|NCT00923936|587303291|FG000|Overall Study|progressive disease on study|2|||
162613853|NCT00923936|587303292|FG001|Overall Study|progressive disease on study|1|||
162613854|NCT00923936|587303291|FG000|Overall Study|Adverse Event|2|||
162613855|NCT00923936|587303292|FG001|Overall Study|Adverse Event|1|||
162613856|NCT00923936|587303291|FG000|Overall Study|Lost to follow up|2|||
162613857|NCT00923936|587303292|FG001|Overall Study|Lost to follow up|0|||
162613858|NCT00923936|587303291|FG000|Overall Study|Continuing in follow up period|2|||
162613859|NCT00923936|587303292|FG001|Overall Study|Continuing in follow up period|1|||
162613860|NCT02038452|587303293|FG000|Overall Study|Withdrawal by Subject|7|||
162613861|NCT02038452|587303294|FG001|Overall Study|Withdrawal by Subject|9|||
162613862|NCT02038452|587303293|FG000|Overall Study|Lost to Follow-up|31|||
162959506|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959507|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959508|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959509|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
162959510|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
162613863|NCT02038452|587303294|FG001|Overall Study|Lost to Follow-up|28|||
162613864|NCT00986479|587303295|FG000|Period 1|Improved mood|1|||
162613865|NCT00986479|587303296|FG001|Period 1|Improved mood|0|||
162959511|NCT00318461|588553577|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
162959512|NCT00318461|588553578|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
162613866|NCT00986479|587303295|FG000|Period 1|Administrative reasons|1|||
162613867|NCT00986479|587303296|FG001|Period 1|Administrative reasons|0|||
162613868|NCT01721070|587303297|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
162613869|NCT02035475|587303298|FG000|Overall Study|Withdrawal by Subject|4|||
162613870|NCT02035475|587303298|FG000|Overall Study|Physician Decision|1|||
162613871|NCT02035475|587303298|FG000|Overall Study|Equipment Error|1|||
162613872|NCT01626495|587303304|FG000|Overall Study|Adverse Event|3|||
162613873|NCT01626495|587303304|FG000|Overall Study|Disease progression|27|||
162613874|NCT01626495|587303304|FG000|Overall Study|Withdrawal by Subject|1|||
162613875|NCT01626495|587303304|FG000|Overall Study|Administrative problem|1|||
162613876|NCT01626495|587303304|FG000|Overall Study|Death|2|||
162613877|NCT01626495|587303304|FG000|Overall Study|Physician Decision|1|||
162613878|NCT01626495|587303304|FG000|Overall Study|New cancer therapy|16|||
162613879|NCT01626495|587303304|FG000|Overall Study|Manufacturing failure|1|||
162613880|NCT00304239|587303305|FG000|Overall Study|Protocol Deviations/Violations|15|||
162613881|NCT00304239|587303306|FG001|Overall Study|Protocol Deviations/Violations|0|||
162613882|NCT00304239|587303305|FG000|Overall Study|Adverse Event|2|||
162613883|NCT00304239|587303306|FG001|Overall Study|Adverse Event|0|||
162613884|NCT05430022|587303317|FG000|Overall Study|Withdrawal by Subject|4|||
162613885|NCT05430022|587303318|FG001|Overall Study|Withdrawal by Subject|4|||
162613886|NCT05521906|587303319|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
162613887|NCT05521906|587303320|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
162613888|NCT01828320|587303322|FG000|Overall Study|Lost to Follow-up|1|||
162613889|NCT01828320|587303323|FG001|Overall Study|Lost to Follow-up|3|||
162613890|NCT01828320|587303322|FG000|Overall Study|Withdrawal by Subject|7|||
162613891|NCT01828320|587303323|FG001|Overall Study|Withdrawal by Subject|2|||
162613892|NCT00866788|587305646|FG000|Overall Study|Adverse Event|0|||
162613893|NCT00866788|587305647|FG001|Overall Study|Adverse Event|2|||
162613894|NCT00866788|587305648|FG002|Overall Study|Adverse Event|0|||
162613895|NCT00866788|587305649|FG003|Overall Study|Adverse Event|1|||
162613896|NCT00866788|587305646|FG000|Overall Study|Lost to Follow-up|1|||
162613897|NCT00866788|587305647|FG001|Overall Study|Lost to Follow-up|1|||
162613898|NCT00866788|587305648|FG002|Overall Study|Lost to Follow-up|0|||
162613899|NCT00866788|587305649|FG003|Overall Study|Lost to Follow-up|2|||
162613900|NCT00866788|587305646|FG000|Overall Study|Withdrawal by Subject|2|||
162613901|NCT00866788|587305647|FG001|Overall Study|Withdrawal by Subject|1|||
162613902|NCT00866788|587305648|FG002|Overall Study|Withdrawal by Subject|0|||
162613903|NCT00866788|587305649|FG003|Overall Study|Withdrawal by Subject|1|||
162613904|NCT00866788|587305646|FG000|Overall Study|Pregnancy|0|||
162613905|NCT00866788|587305647|FG001|Overall Study|Pregnancy|1|||
162613906|NCT00866788|587305648|FG002|Overall Study|Pregnancy|0|||
162613907|NCT00866788|587305649|FG003|Overall Study|Pregnancy|0|||
162613908|NCT00866788|587305646|FG000|Overall Study|Disease progression|3|||
162613909|NCT00866788|587305647|FG001|Overall Study|Disease progression|1|||
162613910|NCT00866788|587305648|FG002|Overall Study|Disease progression|1|||
162613911|NCT00866788|587305649|FG003|Overall Study|Disease progression|0|||
162613912|NCT00866788|587305646|FG000|Overall Study|Physician Decision|0|||
162613913|NCT00866788|587305647|FG001|Overall Study|Physician Decision|0|||
162613914|NCT00866788|587305648|FG002|Overall Study|Physician Decision|1|||
162613915|NCT00866788|587305649|FG003|Overall Study|Physician Decision|1|||
162613916|NCT02349061|587305651|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
162613917|NCT02349061|587305652|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
162613918|NCT02349061|587305653|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
162613919|NCT02349061|587305651|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
162613920|NCT02349061|587305652|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
162613921|NCT02349061|587305653|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
162613922|NCT02349061|587305651|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
162613923|NCT02349061|587305652|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
162613924|NCT02349061|587305653|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
162959513|NCT00318461|588553579|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
162613925|NCT02349061|587305651|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
162613926|NCT02349061|587305652|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
162613927|NCT02349061|587305653|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
162613928|NCT02349061|587305651|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
162613929|NCT02349061|587305652|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
162959514|NCT00318461|588553580|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
162959515|NCT00318461|588553581|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
162613930|NCT02349061|587305653|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
162613931|NCT02349061|587305651|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
162613932|NCT02349061|587305652|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
162613933|NCT02349061|587305653|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
162613934|NCT02349061|587305651|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
162613935|NCT02349061|587305652|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
162613936|NCT02349061|587305653|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
162613937|NCT02349061|587305651|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
162613938|NCT02349061|587305652|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
162706135|NCT02703532|587636544|FG001|Overall Study|Lost to Follow-up|0|||
162706136|NCT02703532|587636545|FG002|Overall Study|Lost to Follow-up|2|||
162706137|NCT02703532|587636546|FG003|Overall Study|Lost to Follow-up|0|||
162706138|NCT03738241|587636547|FG000|Overall Study|Withdrawal by Subject|0|||
162706139|NCT03738241|587636548|FG001|Overall Study|Withdrawal by Subject|0|||
162706140|NCT03738241|587636549|FG002|Overall Study|Withdrawal by Subject|0|||
162706141|NCT03738241|587636550|FG003|Overall Study|Withdrawal by Subject|0|||
162706142|NCT03738241|587636551|FG004|Overall Study|Withdrawal by Subject|0|||
162613939|NCT02349061|587305653|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
162613940|NCT02349061|587305651|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
162613941|NCT02349061|587305652|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
162613942|NCT02349061|587305653|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
162613943|NCT02349061|587305651|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
162613944|NCT02349061|587305652|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
162613945|NCT02349061|587305653|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
162613946|NCT02349061|587305651|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
162613947|NCT02349061|587305652|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
162613948|NCT02349061|587305653|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
162613949|NCT02349061|587305651|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
162613950|NCT02349061|587305652|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
162613951|NCT02349061|587305653|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
162706143|NCT03738241|587636552|FG005|Overall Study|Withdrawal by Subject|0|||
162706144|NCT03738241|587636553|FG006|Overall Study|Withdrawal by Subject|0|||
162613952|NCT02349061|587305651|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
162613953|NCT02349061|587305652|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
162613954|NCT02349061|587305653|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
162613955|NCT02095223|587305654|FG000|Overall Study|Withdrawal by Subject|1|||
162613956|NCT02095223|587305655|FG001|Overall Study|Withdrawal by Subject|0|||
162613957|NCT01397162|587305656|FG000|Overall Study|Adverse Event|4|||
162706145|NCT03738241|587636554|FG007|Overall Study|Withdrawal by Subject|0|||
162706146|NCT03738241|587636555|FG008|Overall Study|Withdrawal by Subject|0|||
162706147|NCT03738241|587636556|FG009|Overall Study|Withdrawal by Subject|1|||
162613958|NCT01397162|587305657|FG001|Overall Study|Adverse Event|0|||
162706148|NCT03738241|587636547|FG000|Overall Study|Physician Decision|0|||
162706149|NCT03738241|587636548|FG001|Overall Study|Physician Decision|0|||
162706150|NCT03738241|587636549|FG002|Overall Study|Physician Decision|0|||
162706151|NCT03738241|587636550|FG003|Overall Study|Physician Decision|0|||
162613959|NCT01397162|587305658|FG002|Overall Study|Adverse Event|0|||
162613960|NCT01397162|587305659|FG003|Overall Study|Adverse Event|0|||
162613961|NCT01397162|587305660|FG004|Overall Study|Adverse Event|0|||
162613962|NCT01397162|587305656|FG000|Overall Study|Not yet defined|3|||
162613963|NCT01397162|587305657|FG001|Overall Study|Not yet defined|4|||
162613964|NCT01397162|587305658|FG002|Overall Study|Not yet defined|3|||
162613965|NCT01397162|587305659|FG003|Overall Study|Not yet defined|5|||
162613966|NCT01397162|587305660|FG004|Overall Study|Not yet defined|3|||
162613967|NCT02339285|587305661|FG000|Overall Study|Withdrawal by Subject|0|||
162706152|NCT03738241|587636551|FG004|Overall Study|Physician Decision|0|||
162706153|NCT03738241|587636552|FG005|Overall Study|Physician Decision|0|||
162706154|NCT03738241|587636553|FG006|Overall Study|Physician Decision|0|||
162706155|NCT03738241|587636554|FG007|Overall Study|Physician Decision|0|||
162706156|NCT03738241|587636555|FG008|Overall Study|Physician Decision|1|||
162706157|NCT03738241|587636556|FG009|Overall Study|Physician Decision|0|||
162706158|NCT03738241|587636547|FG000|Overall Study|Adverse Event|1|||
162706159|NCT03738241|587636548|FG001|Overall Study|Adverse Event|0|||
162706160|NCT03738241|587636549|FG002|Overall Study|Adverse Event|0|||
162706161|NCT03738241|587636550|FG003|Overall Study|Adverse Event|0|||
162706162|NCT03738241|587636551|FG004|Overall Study|Adverse Event|0|||
162706163|NCT03738241|587636552|FG005|Overall Study|Adverse Event|0|||
162706164|NCT03738241|587636553|FG006|Overall Study|Adverse Event|0|||
162706165|NCT03738241|587636554|FG007|Overall Study|Adverse Event|0|||
162706166|NCT03738241|587636555|FG008|Overall Study|Adverse Event|0|||
162706167|NCT03738241|587636556|FG009|Overall Study|Adverse Event|0|||
162706168|NCT03169361|587636557|FG000|Overall Study|Protocol Violation|32|||
162867206|NCT00521339|588218098|FG002|Treatment Phase|Withdrawal by Subject|0|||
162867207|NCT00521339|588218096|FG000|Treatment Phase|Lost to Follow-up|1|||
162867208|NCT00521339|588218097|FG001|Treatment Phase|Lost to Follow-up|0|||
162867209|NCT00521339|588218098|FG002|Treatment Phase|Lost to Follow-up|0|||
162867210|NCT00521339|588218096|FG000|Treatment Phase|Protocol Violation|1|||
162706169|NCT02263885|587636558|FG000|Overall Study|Withdrawal by Subject|7|||
162867211|NCT00521339|588218097|FG001|Treatment Phase|Protocol Violation|0|||
162706170|NCT02263885|587636558|FG000|Overall Study|Alternative Treatment|3|||
162706171|NCT00278564|587636564|FG000|Overall Study|Lack of Efficacy|4|||
162706172|NCT00480441|587636569|FG000|Screening|Not Eligible|37|||
162706173|NCT00480441|587636570|FG001|Screening|Not Eligible|0|||
162706174|NCT00480441|587636571|FG002|Screening|Not Eligible|0|||
162867212|NCT00521339|588218098|FG002|Treatment Phase|Protocol Violation|0|||
162867213|NCT00521339|588218096|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
162867214|NCT00521339|588218097|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
162867215|NCT00521339|588218098|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
162867216|NCT00521339|588218096|FG000|Treatment Extension Phase|Death|0|||
162613968|NCT02339285|587305662|FG001|Overall Study|Withdrawal by Subject|1|||
162613969|NCT02339285|587305663|FG002|Overall Study|Withdrawal by Subject|1|||
162613970|NCT02339285|587305661|FG000|Overall Study|Lost to Follow-up|1|||
162613971|NCT02339285|587305662|FG001|Overall Study|Lost to Follow-up|1|||
162613972|NCT02339285|587305663|FG002|Overall Study|Lost to Follow-up|1|||
162613973|NCT02339285|587305661|FG000|Overall Study|Protocol Deviation|0|||
162613974|NCT02339285|587305662|FG001|Overall Study|Protocol Deviation|1|||
162613975|NCT02339285|587305663|FG002|Overall Study|Protocol Deviation|0|||
162613976|NCT01507298|587305666|FG000|Overall Study|Protocol Violation|0|||
162613977|NCT01507298|587305667|FG001|Overall Study|Protocol Violation|6|||
162613978|NCT01920555|587305668|FG000|Overall Study|Physician Decision|1|||
162613979|NCT01920555|587305669|FG001|Overall Study|Physician Decision|2|||
162613980|NCT01920555|587305670|FG002|Overall Study|Physician Decision|1|||
162613981|NCT01920555|587305671|FG003|Overall Study|Physician Decision|2|||
162613982|NCT01920555|587305672|FG004|Overall Study|Physician Decision|0|||
162613983|NCT01920555|587305668|FG000|Overall Study|Lack of Efficacy|2|||
162613984|NCT01920555|587305669|FG001|Overall Study|Lack of Efficacy|0|||
162613985|NCT01920555|587305670|FG002|Overall Study|Lack of Efficacy|0|||
162613986|NCT01920555|587305671|FG003|Overall Study|Lack of Efficacy|0|||
162613987|NCT01920555|587305672|FG004|Overall Study|Lack of Efficacy|0|||
162613988|NCT01920555|587305668|FG000|Overall Study|Travel Difficulties|1|||
162613989|NCT01920555|587305669|FG001|Overall Study|Travel Difficulties|1|||
162613990|NCT01920555|587305670|FG002|Overall Study|Travel Difficulties|0|||
162613991|NCT01920555|587305671|FG003|Overall Study|Travel Difficulties|0|||
162613992|NCT01920555|587305672|FG004|Overall Study|Travel Difficulties|1|||
162613993|NCT01920555|587305668|FG000|Overall Study|Lost to Follow-up|0|||
162613994|NCT01920555|587305669|FG001|Overall Study|Lost to Follow-up|1|||
162706175|NCT00480441|587636569|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
162706176|NCT00480441|587636570|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
162867217|NCT00521339|588218097|FG001|Treatment Extension Phase|Death|0|||
162867218|NCT00521339|588218098|FG002|Treatment Extension Phase|Death|1|||
162867219|NCT03314519|588218099|FG000|Overall Study|Protocol Violation|3|||
162867220|NCT03314519|588218100|FG001|Overall Study|Protocol Violation|2|||
162867221|NCT04003155|588218103|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
162867222|NCT04003155|588218104|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
162867223|NCT04003155|588218105|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
162867224|NCT04003155|588218106|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
162867225|NCT04003155|588218107|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
162867226|NCT04003155|588218103|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
162867227|NCT04003155|588218104|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
162867228|NCT04003155|588218105|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
162867229|NCT04003155|588218106|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
162867230|NCT04003155|588218107|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
162867231|NCT04003155|588218103|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
162867232|NCT04003155|588218104|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
162867233|NCT04003155|588218105|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
162867234|NCT04003155|588218106|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
162867235|NCT04003155|588218107|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
162867236|NCT04003155|588218103|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
162867237|NCT04003155|588218104|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
162867238|NCT04003155|588218105|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
162867239|NCT04003155|588218106|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
162867240|NCT04003155|588218107|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
162867241|NCT04003155|588218103|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
162867242|NCT04003155|588218104|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
162867243|NCT04003155|588218105|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
162867244|NCT04003155|588218106|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
162867245|NCT04003155|588218107|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
162867246|NCT04003155|588218103|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
162867247|NCT04003155|588218104|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
162867248|NCT04003155|588218105|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
162613995|NCT01920555|587305670|FG002|Overall Study|Lost to Follow-up|0|||
162613996|NCT01920555|587305671|FG003|Overall Study|Lost to Follow-up|1|||
162613997|NCT01920555|587305672|FG004|Overall Study|Lost to Follow-up|0|||
162613998|NCT00195273|587305673|FG000|Overall Study|Adverse Event|9|||
162867249|NCT04003155|588218106|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
162867250|NCT04003155|588218107|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
162867251|NCT04003155|588218103|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
162613999|NCT00195273|587305674|FG001|Overall Study|Adverse Event|9|||
162614000|NCT00195273|587305673|FG000|Overall Study|Protocol deviation|0|||
162614001|NCT00195273|587305674|FG001|Overall Study|Protocol deviation|1|||
162614002|NCT00195273|587305673|FG000|Overall Study|Lack of Efficacy|3|||
162614003|NCT00195273|587305674|FG001|Overall Study|Lack of Efficacy|1|||
162614004|NCT00195273|587305673|FG000|Overall Study|Procedural complications|9|||
162614005|NCT00195273|587305674|FG001|Overall Study|Procedural complications|3|||
162614006|NCT02367131|587305678|FG000|Overall Study|Adverse Event|64|||
162614007|NCT02367131|587305678|FG000|Overall Study|No visit since the first visit|3|||
162614008|NCT02367131|587305678|FG000|Overall Study|Request by patient|53|||
162614009|NCT02367131|587305678|FG000|Overall Study|Improvement/remission|2|||
162614010|NCT02367131|587305678|FG000|Overall Study|No change/progressive disease|78|||
162614011|NCT02367131|587305678|FG000|Overall Study|Other than stated above|20|||
162614012|NCT02367131|587305678|FG000|Overall Study|Not treated|2|||
162614013|NCT00810108|587305681|FG000|Overall Study|Withdrawal by Subject|1|||
162614014|NCT00810108|587305682|FG001|Overall Study|Withdrawal by Subject|0|||
162614015|NCT02556203|587305696|FG000|Overall Study|Withdrawal by Subject|21|||
162614016|NCT02556203|587305697|FG001|Overall Study|Withdrawal by Subject|21|||
162614017|NCT02556203|587305696|FG000|Overall Study|Lost to Follow-up|5|||
162614018|NCT02556203|587305697|FG001|Overall Study|Lost to Follow-up|5|||
162614019|NCT02556203|587305696|FG000|Overall Study|Adverse Event|1|||
162614020|NCT02556203|587305697|FG001|Overall Study|Adverse Event|0|||
162614021|NCT02943460|587305703|FG000|Blinded Study Phase|Adverse Event|3|||
162614022|NCT02943460|587305704|FG001|Blinded Study Phase|Adverse Event|0|||
162614023|NCT02943460|587305705|FG002|Blinded Study Phase|Adverse Event|0|||
162614024|NCT02943460|587305703|FG000|Blinded Study Phase|Withdrew Consent|0|||
162614025|NCT02943460|587305704|FG001|Blinded Study Phase|Withdrew Consent|1|||
162614026|NCT02943460|587305705|FG002|Blinded Study Phase|Withdrew Consent|0|||
162614027|NCT02943460|587305703|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
162614028|NCT02943460|587305704|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
162614029|NCT02943460|587305705|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
162614030|NCT02943460|587305703|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
162614031|NCT02943460|587305704|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
162614032|NCT02943460|587305705|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
162614033|NCT02943460|587305703|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
162614034|NCT02943460|587305704|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
162614035|NCT02943460|587305705|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
162614036|NCT00369122|587305706|FG000|Overall Study|Ineligible|10|||
162614037|NCT00369122|587305706|FG000|Overall Study|No protocol treatment|1|||
162614038|NCT04171765|587305707|FG000|Overall Study|Adverse Event|2|||
162614039|NCT04171765|587305708|FG001|Overall Study|Adverse Event|0|||
162614040|NCT04171765|587305709|FG002|Overall Study|Adverse Event|1|||
162614041|NCT04171765|587305710|FG003|Overall Study|Adverse Event|0|||
162614042|NCT04171765|587305707|FG000|Overall Study|Lost to Follow-up|0|||
162614043|NCT04171765|587305708|FG001|Overall Study|Lost to Follow-up|2|||
162614044|NCT04171765|587305709|FG002|Overall Study|Lost to Follow-up|2|||
162614045|NCT04171765|587305710|FG003|Overall Study|Lost to Follow-up|2|||
162614046|NCT04171765|587305707|FG000|Overall Study|Week 58 visit missed|0|||
162614047|NCT04171765|587305708|FG001|Overall Study|Week 58 visit missed|0|||
162614048|NCT04171765|587305709|FG002|Overall Study|Week 58 visit missed|1|||
162614049|NCT04171765|587305710|FG003|Overall Study|Week 58 visit missed|0|||
162614050|NCT04171765|587305707|FG000|Overall Study|Study terminated by sponsor|2|||
162614051|NCT04171765|587305708|FG001|Overall Study|Study terminated by sponsor|0|||
162614052|NCT04171765|587305709|FG002|Overall Study|Study terminated by sponsor|0|||
162614053|NCT04171765|587305710|FG003|Overall Study|Study terminated by sponsor|0|||
162614054|NCT04171765|587305707|FG000|Overall Study|Withdrawal by Subject|1|||
162614055|NCT04171765|587305708|FG001|Overall Study|Withdrawal by Subject|0|||
162614056|NCT04171765|587305709|FG002|Overall Study|Withdrawal by Subject|0|||
162614057|NCT04171765|587305710|FG003|Overall Study|Withdrawal by Subject|3|||
162614058|NCT03633617|587305711|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
162614059|NCT03633617|587305712|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
162706177|NCT00480441|587636571|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
162867252|NCT04003155|588218104|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
162867253|NCT04003155|588218105|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
162867254|NCT04003155|588218106|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
162867255|NCT04003155|588218107|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
162867256|NCT04003155|588218103|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
162614060|NCT03633617|587305713|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614061|NCT03633617|587305714|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614062|NCT03633617|587305715|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614063|NCT03633617|587305716|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614064|NCT03633617|587305717|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614065|NCT03633617|587305718|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162867257|NCT04003155|588218104|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
162867258|NCT04003155|588218105|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
162867259|NCT04003155|588218106|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
162867260|NCT04003155|588218107|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
162867261|NCT04003155|588218103|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
162867262|NCT04003155|588218104|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
162867263|NCT04003155|588218105|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
162867264|NCT04003155|588218106|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
162867265|NCT04003155|588218107|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
162867266|NCT01912872|588218108|FG000|Overall Study|Lost to Follow-up|2|||
162867267|NCT01912872|588218109|FG001|Overall Study|Lost to Follow-up|3|||
162867268|NCT01912872|588218110|FG002|Overall Study|Lost to Follow-up|5|||
162959516|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Work commitment|0|||
162959517|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Work commitment|0|||
162959518|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Work commitment|0|||
162959519|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Work commitment|0|||
162959520|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Work commitment|1|||
162959521|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Investigator decision|0|||
162867269|NCT01912872|588218111|FG003|Overall Study|Lost to Follow-up|5|||
162867270|NCT01912872|588218108|FG000|Overall Study|Other unspecified|3|||
162959522|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Investigator decision|0|||
162959523|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Investigator decision|0|||
162867271|NCT01912872|588218109|FG001|Overall Study|Other unspecified|1|||
162867272|NCT01912872|588218110|FG002|Overall Study|Other unspecified|3|||
162867273|NCT01912872|588218111|FG003|Overall Study|Other unspecified|0|||
162867274|NCT01912872|588218108|FG000|Overall Study|Informed consent withdrawn|0|||
162867275|NCT01912872|588218109|FG001|Overall Study|Informed consent withdrawn|0|||
162867276|NCT01912872|588218110|FG002|Overall Study|Informed consent withdrawn|1|||
162867277|NCT01912872|588218111|FG003|Overall Study|Informed consent withdrawn|1|||
162867278|NCT01912872|588218108|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
162867279|NCT01912872|588218109|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
162867280|NCT01912872|588218110|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
162867281|NCT01912872|588218111|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
162959524|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Investigator decision|0|||
162867282|NCT01912872|588218108|FG000|Overall Study|Protocol Violation|0|||
162867283|NCT01912872|588218109|FG001|Overall Study|Protocol Violation|0|||
162867284|NCT01912872|588218110|FG002|Overall Study|Protocol Violation|1|||
162867285|NCT01912872|588218111|FG003|Overall Study|Protocol Violation|0|||
162867286|NCT01912872|588218108|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163046366|NCT05464420|588877414|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
163046367|NCT05464420|588877415|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
163046368|NCT05464420|588877416|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
163046369|NCT05464420|588877417|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
163046370|NCT05464420|588877414|FG000|Overall Study|Withdrawal by Subject|4|||
162614066|NCT03633617|587305719|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614067|NCT03633617|587305720|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614068|NCT03633617|587305721|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162614069|NCT03633617|587305711|FG000|Part A|Unconfirmed early termination visit|1|||
162614070|NCT03633617|587305712|FG001|Part A|Unconfirmed early termination visit|0|||
162614071|NCT03633617|587305713|FG002|Part A|Unconfirmed early termination visit|0|||
162614072|NCT03633617|587305714|FG003|Part A|Unconfirmed early termination visit|0|||
162614073|NCT03633617|587305715|FG004|Part A|Unconfirmed early termination visit|0|||
162614074|NCT03633617|587305716|FG005|Part A|Unconfirmed early termination visit|0|||
162614075|NCT03633617|587305717|FG006|Part A|Unconfirmed early termination visit|0|||
162614076|NCT03633617|587305718|FG007|Part A|Unconfirmed early termination visit|0|||
162614077|NCT03633617|587305719|FG008|Part A|Unconfirmed early termination visit|0|||
162614078|NCT03633617|587305720|FG009|Part A|Unconfirmed early termination visit|0|||
162614079|NCT03633617|587305721|FG010|Part A|Unconfirmed early termination visit|0|||
162614080|NCT03633617|587305711|FG000|Part A|Adverse Event|0|||
162614081|NCT03633617|587305712|FG001|Part A|Adverse Event|1|||
162614082|NCT03633617|587305713|FG002|Part A|Adverse Event|0|||
162614083|NCT03633617|587305714|FG003|Part A|Adverse Event|0|||
162614084|NCT03633617|587305715|FG004|Part A|Adverse Event|0|||
162614085|NCT03633617|587305716|FG005|Part A|Adverse Event|0|||
162614086|NCT03633617|587305717|FG006|Part A|Adverse Event|0|||
162614087|NCT03633617|587305718|FG007|Part A|Adverse Event|0|||
162614088|NCT03633617|587305719|FG008|Part A|Adverse Event|0|||
162614089|NCT03633617|587305720|FG009|Part A|Adverse Event|0|||
163046371|NCT05464420|588877415|FG001|Overall Study|Withdrawal by Subject|8|||
162614090|NCT03633617|587305721|FG010|Part A|Adverse Event|0|||
162614091|NCT03633617|587305711|FG000|Part A|Pregnancy|1|||
162614092|NCT03633617|587305712|FG001|Part A|Pregnancy|0|||
162614093|NCT03633617|587305713|FG002|Part A|Pregnancy|0|||
162614094|NCT03633617|587305714|FG003|Part A|Pregnancy|0|||
162614095|NCT03633617|587305715|FG004|Part A|Pregnancy|0|||
162867287|NCT01912872|588218109|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162867288|NCT01912872|588218110|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162867289|NCT01912872|588218111|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162867290|NCT01912872|588218108|FG000|Overall Study|Withdrawal of study medication|0|||
162867291|NCT01912872|588218109|FG001|Overall Study|Withdrawal of study medication|0|||
162867292|NCT01912872|588218110|FG002|Overall Study|Withdrawal of study medication|0|||
162867293|NCT01912872|588218111|FG003|Overall Study|Withdrawal of study medication|2|||
162867294|NCT01912872|588218108|FG000|Overall Study|Missing|0|||
162867295|NCT01912872|588218109|FG001|Overall Study|Missing|0|||
162867296|NCT01912872|588218110|FG002|Overall Study|Missing|0|||
162867297|NCT01912872|588218111|FG003|Overall Study|Missing|1|||
162867298|NCT01277289|588218113|FG000|Overall Study|fragile vein|1|||
162867299|NCT01277289|588218114|FG001|Overall Study|fragile vein|0|||
162867300|NCT01277289|588218113|FG000|Overall Study|Physician Decision|1|||
162867301|NCT01277289|588218114|FG001|Overall Study|Physician Decision|0|||
162867302|NCT01277289|588218113|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
162867303|NCT01277289|588218114|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
162867304|NCT01277289|588218113|FG000|Overall Study|Protocol Violation|1|||
162867305|NCT01277289|588218114|FG001|Overall Study|Protocol Violation|1|||
162867306|NCT01277289|588218113|FG000|Overall Study|Adverse Event|2|||
162867307|NCT01277289|588218114|FG001|Overall Study|Adverse Event|1|||
162867308|NCT01277289|588218113|FG000|Overall Study|consent withdrawn|1|||
162867309|NCT01277289|588218114|FG001|Overall Study|consent withdrawn|1|||
162867310|NCT01277289|588218113|FG000|Overall Study|premature closure of the study|4|||
162867311|NCT01277289|588218114|FG001|Overall Study|premature closure of the study|2|||
162867312|NCT04760314|588218117|FG000|Induction Period|Withdrawal by Subject|0|||
162867313|NCT04760314|588218118|FG001|Induction Period|Withdrawal by Subject|1|||
163046372|NCT05464420|588877416|FG002|Overall Study|Withdrawal by Subject|3|||
162614096|NCT03633617|587305716|FG005|Part A|Pregnancy|0|||
162614097|NCT03633617|587305717|FG006|Part A|Pregnancy|0|||
162614098|NCT03633617|587305718|FG007|Part A|Pregnancy|0|||
162614099|NCT03633617|587305719|FG008|Part A|Pregnancy|0|||
162614100|NCT03633617|587305720|FG009|Part A|Pregnancy|0|||
162614101|NCT03633617|587305721|FG010|Part A|Pregnancy|0|||
162614102|NCT03633617|587305711|FG000|Part A|Withdrawal by Subject|0|||
162867314|NCT04760314|588218119|FG002|Induction Period|Withdrawal by Subject|1|||
162867315|NCT04760314|588218120|FG003|Induction Period|Withdrawal by Subject|0|||
162867316|NCT04760314|588218121|FG004|Induction Period|Withdrawal by Subject|0|||
162867317|NCT04760314|588218122|FG005|Induction Period|Withdrawal by Subject|0|||
162867318|NCT04760314|588218123|FG006|Induction Period|Withdrawal by Subject|0|||
162867319|NCT04760314|588218124|FG007|Induction Period|Withdrawal by Subject|0|||
162614103|NCT03633617|587305712|FG001|Part A|Withdrawal by Subject|1|||
162614104|NCT03633617|587305713|FG002|Part A|Withdrawal by Subject|0|||
162614105|NCT03633617|587305714|FG003|Part A|Withdrawal by Subject|0|||
162614106|NCT03633617|587305715|FG004|Part A|Withdrawal by Subject|0|||
162614107|NCT03633617|587305716|FG005|Part A|Withdrawal by Subject|0|||
162614108|NCT03633617|587305717|FG006|Part A|Withdrawal by Subject|0|||
162614109|NCT03633617|587305718|FG007|Part A|Withdrawal by Subject|0|||
162614110|NCT03633617|587305719|FG008|Part A|Withdrawal by Subject|0|||
162614111|NCT03633617|587305720|FG009|Part A|Withdrawal by Subject|0|||
162614112|NCT03633617|587305721|FG010|Part A|Withdrawal by Subject|0|||
162614113|NCT03633617|587305711|FG000|Part B|Adverse Event|0|||
162614114|NCT03633617|587305712|FG001|Part B|Adverse Event|0|||
162614115|NCT03633617|587305713|FG002|Part B|Adverse Event|2|||
162614116|NCT03633617|587305714|FG003|Part B|Adverse Event|2|||
162614117|NCT03633617|587305715|FG004|Part B|Adverse Event|1|||
162614118|NCT03633617|587305716|FG005|Part B|Adverse Event|0|||
162614119|NCT03633617|587305717|FG006|Part B|Adverse Event|0|||
162614120|NCT03633617|587305718|FG007|Part B|Adverse Event|0|||
162614121|NCT03633617|587305719|FG008|Part B|Adverse Event|0|||
162614122|NCT03633617|587305720|FG009|Part B|Adverse Event|0|||
162614123|NCT03633617|587305721|FG010|Part B|Adverse Event|0|||
162614124|NCT03633617|587305711|FG000|Part B|Withdrawal by Subject|0|||
162614125|NCT03633617|587305712|FG001|Part B|Withdrawal by Subject|0|||
162614126|NCT03633617|587305713|FG002|Part B|Withdrawal by Subject|1|||
162614127|NCT03633617|587305714|FG003|Part B|Withdrawal by Subject|0|||
162614128|NCT03633617|587305715|FG004|Part B|Withdrawal by Subject|2|||
162614129|NCT03633617|587305716|FG005|Part B|Withdrawal by Subject|0|||
162614130|NCT03633617|587305717|FG006|Part B|Withdrawal by Subject|0|||
162614131|NCT03633617|587305718|FG007|Part B|Withdrawal by Subject|0|||
162614132|NCT03633617|587305719|FG008|Part B|Withdrawal by Subject|0|||
162614133|NCT03633617|587305720|FG009|Part B|Withdrawal by Subject|0|||
162614134|NCT03633617|587305721|FG010|Part B|Withdrawal by Subject|0|||
162614135|NCT03633617|587305711|FG000|Part B|Lost to Follow-up|0|||
162614136|NCT03633617|587305712|FG001|Part B|Lost to Follow-up|0|||
162614137|NCT03633617|587305713|FG002|Part B|Lost to Follow-up|0|||
162614138|NCT03633617|587305714|FG003|Part B|Lost to Follow-up|0|||
162614139|NCT03633617|587305715|FG004|Part B|Lost to Follow-up|1|||
162614140|NCT03633617|587305716|FG005|Part B|Lost to Follow-up|0|||
162614141|NCT03633617|587305717|FG006|Part B|Lost to Follow-up|0|||
162614142|NCT03633617|587305718|FG007|Part B|Lost to Follow-up|0|||
162614143|NCT03633617|587305719|FG008|Part B|Lost to Follow-up|0|||
162614144|NCT03633617|587305720|FG009|Part B|Lost to Follow-up|0|||
162614145|NCT03633617|587305721|FG010|Part B|Lost to Follow-up|0|||
162614146|NCT03633617|587305711|FG000|Part B|Physician Decision|0|||
162614147|NCT03633617|587305712|FG001|Part B|Physician Decision|0|||
162614148|NCT03633617|587305713|FG002|Part B|Physician Decision|0|||
162614149|NCT03633617|587305714|FG003|Part B|Physician Decision|0|||
162614150|NCT03633617|587305715|FG004|Part B|Physician Decision|1|||
162614151|NCT03633617|587305716|FG005|Part B|Physician Decision|0|||
162614152|NCT03633617|587305717|FG006|Part B|Physician Decision|0|||
162614153|NCT03633617|587305718|FG007|Part B|Physician Decision|0|||
162614154|NCT03633617|587305719|FG008|Part B|Physician Decision|0|||
162614155|NCT03633617|587305720|FG009|Part B|Physician Decision|0|||
162614156|NCT03633617|587305721|FG010|Part B|Physician Decision|0|||
162614157|NCT03633617|587305711|FG000|Part B|COVID-19 Restrictions|0|||
162614158|NCT03633617|587305712|FG001|Part B|COVID-19 Restrictions|0|||
162614159|NCT03633617|587305713|FG002|Part B|COVID-19 Restrictions|1|||
162614160|NCT03633617|587305714|FG003|Part B|COVID-19 Restrictions|0|||
162614161|NCT03633617|587305715|FG004|Part B|COVID-19 Restrictions|0|||
162614162|NCT03633617|587305716|FG005|Part B|COVID-19 Restrictions|0|||
162867320|NCT04760314|588218125|FG008|Induction Period|Withdrawal by Subject|0|||
162867321|NCT04760314|588218126|FG009|Induction Period|Withdrawal by Subject|0|||
162867322|NCT04760314|588218127|FG010|Induction Period|Withdrawal by Subject|0|||
162867323|NCT04760314|588218117|FG000|Induction Period|Adverse Event|0|||
162867324|NCT04760314|588218118|FG001|Induction Period|Adverse Event|0|||
162614163|NCT03633617|587305717|FG006|Part B|COVID-19 Restrictions|0|||
162614164|NCT03633617|587305718|FG007|Part B|COVID-19 Restrictions|0|||
162614165|NCT03633617|587305719|FG008|Part B|COVID-19 Restrictions|0|||
162614166|NCT03633617|587305720|FG009|Part B|COVID-19 Restrictions|0|||
162614167|NCT03633617|587305721|FG010|Part B|COVID-19 Restrictions|0|||
162614168|NCT03633617|587305711|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614169|NCT03633617|587305712|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614170|NCT03633617|587305713|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
162614171|NCT03633617|587305714|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614172|NCT03633617|587305715|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614173|NCT03633617|587305716|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614174|NCT03633617|587305717|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614175|NCT03633617|587305718|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162867325|NCT04760314|588218119|FG002|Induction Period|Adverse Event|2|||
162959525|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Investigator decision|1|||
162959526|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Lack of time|1|||
162959527|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Lack of time|0|||
162959528|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Lack of time|0|||
162959529|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Lack of time|0|||
162959530|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Lack of time|0|||
162959531|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
162614176|NCT03633617|587305719|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614177|NCT03633617|587305720|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162631095|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
162959532|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
162867326|NCT04760314|588218120|FG003|Induction Period|Adverse Event|0|||
162867327|NCT04760314|588218121|FG004|Induction Period|Adverse Event|0|||
162867328|NCT04760314|588218122|FG005|Induction Period|Adverse Event|0|||
162867329|NCT04760314|588218123|FG006|Induction Period|Adverse Event|0|||
162867330|NCT04760314|588218124|FG007|Induction Period|Adverse Event|0|||
162867331|NCT04760314|588218125|FG008|Induction Period|Adverse Event|0|||
162867332|NCT04760314|588218126|FG009|Induction Period|Adverse Event|0|||
162867333|NCT04760314|588218127|FG010|Induction Period|Adverse Event|0|||
162867334|NCT04760314|588218117|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867335|NCT04760314|588218118|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867336|NCT04760314|588218119|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867337|NCT04760314|588218120|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
162867338|NCT04760314|588218121|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
162867339|NCT04760314|588218122|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
162867340|NCT04760314|588218123|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
162867341|NCT04760314|588218124|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867342|NCT04760314|588218125|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867343|NCT04760314|588218126|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867344|NCT04760314|588218127|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
162867345|NCT04760314|588218117|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867346|NCT04760314|588218118|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867347|NCT04760314|588218119|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867348|NCT04760314|588218120|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
162867349|NCT04760314|588218121|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867350|NCT04760314|588218122|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
162867351|NCT04760314|588218123|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
162867352|NCT04760314|588218124|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867353|NCT04760314|588218125|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162706178|NCT00480441|587636569|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
162706179|NCT00480441|587636570|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
162867354|NCT04760314|588218126|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867355|NCT04760314|588218127|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
162867356|NCT04760314|588218117|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867357|NCT04760314|588218118|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867358|NCT04760314|588218119|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867359|NCT04760314|588218120|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867360|NCT04760314|588218121|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
162867361|NCT04760314|588218122|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162959533|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
163046373|NCT05464420|588877417|FG003|Overall Study|Withdrawal by Subject|1|||
163046374|NCT05464420|588877414|FG000|Overall Study|Protocol Violation|0|||
163046375|NCT05464420|588877415|FG001|Overall Study|Protocol Violation|0|||
163046376|NCT05464420|588877416|FG002|Overall Study|Protocol Violation|1|||
163046377|NCT05464420|588877417|FG003|Overall Study|Protocol Violation|1|||
162867362|NCT04760314|588218123|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867363|NCT04760314|588218124|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867364|NCT04760314|588218125|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867365|NCT04760314|588218126|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867366|NCT04760314|588218127|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
162867367|NCT04760314|588218117|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
163046378|NCT05464420|588877414|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
162867368|NCT04760314|588218118|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
162867369|NCT04760314|588218119|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
162867370|NCT04760314|588218120|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
162867371|NCT04760314|588218121|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
162867372|NCT04760314|588218122|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
162867373|NCT04760314|588218123|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
162867374|NCT04760314|588218124|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
162867375|NCT04760314|588218125|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
162867376|NCT04760314|588218126|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
162959534|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
162959535|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
162959536|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959537|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959538|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959539|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
162959540|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
162959541|NCT00318461|588553577|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959542|NCT00318461|588553578|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959543|NCT00318461|588553579|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
163046379|NCT05464420|588877415|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
163046380|NCT05464420|588877416|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
163046381|NCT05464420|588877417|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
163046382|NCT01383018|588877418|FG000|Overall Study|Adverse Event|14|||
163046383|NCT01383018|588877418|FG000|Overall Study|Death|10|||
163046384|NCT01383018|588877418|FG000|Overall Study|Lost to Follow-up|5|||
163046385|NCT01383018|588877418|FG000|Overall Study|Physician Decision|5|||
163046386|NCT01383018|588877418|FG000|Overall Study|Withdrawal by Subject|9|||
163046387|NCT01383018|588877418|FG000|Overall Study|Subject not implanted|76|||
163046388|NCT01383018|588877418|FG000|Overall Study|Missed Visit|247|||
163046389|NCT01383018|588877418|FG000|Overall Study|Site closed early-not compliance related|7|||
163046390|NCT01383018|588877418|FG000|Overall Study|Patient moved away from site|1|||
163046391|NCT01383018|588877418|FG000|Overall Study|Subject Incarcerated|1|||
163046392|NCT01051817|588877419|FG000|Overall Study|Adverse Event|0|||
163046393|NCT01051817|588877420|FG001|Overall Study|Adverse Event|2|||
162706180|NCT00480441|587636571|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
162867377|NCT04760314|588218127|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
162867378|NCT04760314|588218117|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162959544|NCT00318461|588553580|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
162959545|NCT00318461|588553581|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
162959546|NCT00318461|588553577|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162867379|NCT04760314|588218118|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163046394|NCT01051817|588877419|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
163046395|NCT01051817|588877420|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
163046396|NCT01051817|588877419|FG000|Overall Study|Withdrawal by Subject|3|||
163046397|NCT01051817|588877420|FG001|Overall Study|Withdrawal by Subject|5|||
163046398|NCT01051817|588877419|FG000|Overall Study|Protocol Violation|0|||
163046399|NCT01051817|588877420|FG001|Overall Study|Protocol Violation|1|||
163046400|NCT00627926|588877421|FG000|Overall Study|Adverse Event|26|||
163046401|NCT00627926|588877422|FG001|Overall Study|Adverse Event|37|||
162614178|NCT03633617|587305721|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162614179|NCT03633617|587305711|FG000|Part C (& Follow-up)|Adverse Event|0|||
162614180|NCT03633617|587305712|FG001|Part C (& Follow-up)|Adverse Event|0|||
162614181|NCT03633617|587305713|FG002|Part C (& Follow-up)|Adverse Event|0|||
162614182|NCT03633617|587305714|FG003|Part C (& Follow-up)|Adverse Event|0|||
162614183|NCT03633617|587305715|FG004|Part C (& Follow-up)|Adverse Event|0|||
162614184|NCT03633617|587305716|FG005|Part C (& Follow-up)|Adverse Event|1|||
162614185|NCT03633617|587305717|FG006|Part C (& Follow-up)|Adverse Event|0|||
162614186|NCT03633617|587305718|FG007|Part C (& Follow-up)|Adverse Event|1|||
162614187|NCT03633617|587305719|FG008|Part C (& Follow-up)|Adverse Event|0|||
162614188|NCT03633617|587305720|FG009|Part C (& Follow-up)|Adverse Event|0|||
162614189|NCT03633617|587305721|FG010|Part C (& Follow-up)|Adverse Event|0|||
162614190|NCT03633617|587305711|FG000|Part C (& Follow-up)|Pregnancy|0|||
162614191|NCT03633617|587305712|FG001|Part C (& Follow-up)|Pregnancy|0|||
162614192|NCT03633617|587305713|FG002|Part C (& Follow-up)|Pregnancy|0|||
162614193|NCT03633617|587305714|FG003|Part C (& Follow-up)|Pregnancy|0|||
162614194|NCT03633617|587305715|FG004|Part C (& Follow-up)|Pregnancy|0|||
162614195|NCT03633617|587305716|FG005|Part C (& Follow-up)|Pregnancy|0|||
162614196|NCT03633617|587305717|FG006|Part C (& Follow-up)|Pregnancy|0|||
162614197|NCT03633617|587305718|FG007|Part C (& Follow-up)|Pregnancy|0|||
162614198|NCT03633617|587305719|FG008|Part C (& Follow-up)|Pregnancy|0|||
162614199|NCT03633617|587305720|FG009|Part C (& Follow-up)|Pregnancy|1|||
162614200|NCT03633617|587305721|FG010|Part C (& Follow-up)|Pregnancy|0|||
162614201|NCT03633617|587305711|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614202|NCT03633617|587305712|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614203|NCT03633617|587305713|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614204|NCT03633617|587305714|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614205|NCT03633617|587305715|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614206|NCT03633617|587305716|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
162614207|NCT03633617|587305717|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
162614208|NCT03633617|587305718|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
162614209|NCT03633617|587305719|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
162614210|NCT03633617|587305720|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
162614211|NCT03633617|587305721|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
162614212|NCT03633617|587305711|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
162614213|NCT03633617|587305712|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
162614214|NCT03633617|587305713|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
162614215|NCT03633617|587305714|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
162614216|NCT03633617|587305715|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
162614217|NCT03633617|587305716|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
162614218|NCT03633617|587305717|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
162614219|NCT03633617|587305718|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
162614220|NCT03633617|587305719|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
162614221|NCT03633617|587305720|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
162614222|NCT03633617|587305721|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
162614223|NCT03633617|587305711|FG000|Part C (& Follow-up)|Physician Decision|0|||
162614224|NCT03633617|587305712|FG001|Part C (& Follow-up)|Physician Decision|0|||
162614225|NCT03633617|587305713|FG002|Part C (& Follow-up)|Physician Decision|0|||
162614226|NCT03633617|587305714|FG003|Part C (& Follow-up)|Physician Decision|0|||
162614227|NCT03633617|587305715|FG004|Part C (& Follow-up)|Physician Decision|0|||
162614228|NCT03633617|587305716|FG005|Part C (& Follow-up)|Physician Decision|0|||
162614229|NCT03633617|587305717|FG006|Part C (& Follow-up)|Physician Decision|0|||
162614230|NCT03633617|587305718|FG007|Part C (& Follow-up)|Physician Decision|1|||
162614231|NCT03633617|587305719|FG008|Part C (& Follow-up)|Physician Decision|0|||
162614232|NCT03633617|587305720|FG009|Part C (& Follow-up)|Physician Decision|0|||
162614233|NCT03633617|587305721|FG010|Part C (& Follow-up)|Physician Decision|1|||
162614234|NCT03633617|587305711|FG000|Part C (& Follow-up)|COVID-19 related|0|||
162614235|NCT03633617|587305712|FG001|Part C (& Follow-up)|COVID-19 related|0|||
162614236|NCT03633617|587305713|FG002|Part C (& Follow-up)|COVID-19 related|0|||
162614237|NCT03633617|587305714|FG003|Part C (& Follow-up)|COVID-19 related|0|||
162614238|NCT03633617|587305715|FG004|Part C (& Follow-up)|COVID-19 related|0|||
162614239|NCT03633617|587305716|FG005|Part C (& Follow-up)|COVID-19 related|1|||
162614240|NCT03633617|587305717|FG006|Part C (& Follow-up)|COVID-19 related|0|||
162614241|NCT03633617|587305718|FG007|Part C (& Follow-up)|COVID-19 related|0|||
163046402|NCT00627926|588877423|FG002|Overall Study|Adverse Event|36|||
163046403|NCT00627926|588877421|FG000|Overall Study|Death|1|||
162614242|NCT03633617|587305719|FG008|Part C (& Follow-up)|COVID-19 related|0|||
162614243|NCT03633617|587305720|FG009|Part C (& Follow-up)|COVID-19 related|0|||
162614244|NCT03633617|587305721|FG010|Part C (& Follow-up)|COVID-19 related|0|||
162867380|NCT04760314|588218119|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867381|NCT04760314|588218120|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867382|NCT04760314|588218121|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867383|NCT04760314|588218122|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867384|NCT04760314|588218123|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867385|NCT04760314|588218124|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
162867386|NCT04760314|588218125|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162867387|NCT04760314|588218126|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
162867388|NCT04760314|588218127|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
162867389|NCT04760314|588218117|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867390|NCT04760314|588218118|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867391|NCT04760314|588218119|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867392|NCT04760314|588218120|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867393|NCT04760314|588218121|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867394|NCT04760314|588218122|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867395|NCT04760314|588218123|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867396|NCT04760314|588218124|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
162867397|NCT04760314|588218125|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
162867398|NCT04760314|588218126|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
162867399|NCT04760314|588218127|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162867400|NCT04760314|588218117|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867401|NCT04760314|588218118|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867402|NCT04760314|588218119|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867403|NCT04760314|588218120|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867404|NCT04760314|588218121|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867405|NCT04760314|588218122|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867406|NCT04760314|588218123|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867407|NCT04760314|588218124|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
162867408|NCT04760314|588218125|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867409|NCT04760314|588218126|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867410|NCT04760314|588218127|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162867411|NCT04760314|588218117|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867412|NCT04760314|588218118|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867413|NCT04760314|588218119|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867414|NCT04760314|588218120|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867415|NCT04760314|588218121|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867416|NCT04760314|588218122|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867417|NCT04760314|588218123|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867418|NCT04760314|588218124|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867419|NCT04760314|588218125|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
162867420|NCT04760314|588218126|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
162867421|NCT04760314|588218127|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
162867422|NCT01013883|588218130|FG000|Overall Study|Lost to Follow-up|2|||
162867423|NCT01013883|588218131|FG001|Overall Study|Lost to Follow-up|2|||
162867424|NCT01371838|588218132|FG000|Overall Study|Withdrawal by Subject|27|||
162867425|NCT01371838|588218133|FG001|Overall Study|Withdrawal by Subject|33|||
162867426|NCT01371838|588218132|FG000|Overall Study|Lost to Follow-up|10|||
162867427|NCT01371838|588218133|FG001|Overall Study|Lost to Follow-up|20|||
162867428|NCT01371838|588218132|FG000|Overall Study|Death|3|||
162867429|NCT01371838|588218133|FG001|Overall Study|Death|4|||
162867430|NCT01371838|588218132|FG000|Overall Study|Protocol Violation|3|||
162867431|NCT01371838|588218133|FG001|Overall Study|Protocol Violation|0|||
162867432|NCT01371838|588218132|FG000|Overall Study|Investigator Decision|3|||
162867433|NCT01371838|588218133|FG001|Overall Study|Investigator Decision|8|||
162867434|NCT01371838|588218132|FG000|Overall Study|Last follow-up visit not conducted|2|||
162867435|NCT01371838|588218133|FG001|Overall Study|Last follow-up visit not conducted|0|||
162867436|NCT01371838|588218132|FG000|Overall Study|Lack of therapeutic response|0|||
162867437|NCT01371838|588218133|FG001|Overall Study|Lack of therapeutic response|1|||
162867438|NCT01371838|588218132|FG000|Overall Study|Surgery|1|||
162867439|NCT01371838|588218133|FG001|Overall Study|Surgery|0|||
162867440|NCT02241512|588218136|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
162867441|NCT02241512|588218137|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
162867442|NCT00641043|588218140|FG000|Overall Study|Adverse Event|6|||
162959547|NCT00318461|588553578|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
162959548|NCT00318461|588553579|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162959549|NCT00318461|588553580|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162867443|NCT00641043|588218141|FG001|Overall Study|Adverse Event|4|||
162867444|NCT00641043|588218140|FG000|Overall Study|Protocol Violation|2|||
162867445|NCT00641043|588218141|FG001|Overall Study|Protocol Violation|3|||
162867446|NCT00641043|588218140|FG000|Overall Study|Lost to Follow-up|3|||
162867447|NCT00641043|588218141|FG001|Overall Study|Lost to Follow-up|2|||
162867448|NCT00641043|588218140|FG000|Overall Study|Withdrawal by Subject|4|||
162867449|NCT00641043|588218141|FG001|Overall Study|Withdrawal by Subject|4|||
162867450|NCT00641043|588218140|FG000|Overall Study|Other incl. lack of efficacy|4|||
162867451|NCT00641043|588218141|FG001|Overall Study|Other incl. lack of efficacy|2|||
162867452|NCT04275310|588218142|FG000|Overall Study|Non-randomized due to running out of funding|4|||
162867453|NCT04275310|588218143|FG001|Overall Study|Non-randomized due to running out of funding|0|||
162867454|NCT02345161|588218146|FG000|Overall Study|Withdrawal by Subject|25|||
162867455|NCT02345161|588218147|FG001|Overall Study|Withdrawal by Subject|33|||
162867456|NCT02345161|588218146|FG000|Overall Study|Adverse Event|16|||
162867457|NCT02345161|588218147|FG001|Overall Study|Adverse Event|19|||
162867458|NCT02345161|588218146|FG000|Overall Study|Physician Decision|4|||
162867459|NCT02345161|588218147|FG001|Overall Study|Physician Decision|4|||
162867460|NCT02345161|588218146|FG000|Overall Study|Lost to Follow-up|0|||
162867461|NCT02345161|588218147|FG001|Overall Study|Lost to Follow-up|1|||
162867462|NCT02225223|588218149|FG000|Overall Study|Death|10|||
162867463|NCT02225223|588218150|FG001|Overall Study|Death|1|||
162867464|NCT02225223|588218149|FG000|Overall Study|Lost to Follow-up|5|||
162867465|NCT02225223|588218150|FG001|Overall Study|Lost to Follow-up|0|||
162867466|NCT02225223|588218149|FG000|Overall Study|Other|1|||
162867467|NCT02225223|588218150|FG001|Overall Study|Other|2|||
162867468|NCT02225223|588218149|FG000|Overall Study|Physician Decision|1|||
162867469|NCT02225223|588218150|FG001|Overall Study|Physician Decision|0|||
162867470|NCT02225223|588218149|FG000|Overall Study|Withdrawal by Subject|2|||
162867471|NCT02225223|588218150|FG001|Overall Study|Withdrawal by Subject|2|||
162867472|NCT03666143|588218151|FG000|Overall Study|Death|158|||
162867473|NCT03666143|588218151|FG000|Overall Study|Sponsor Decision|31|||
162867474|NCT03666143|588218151|FG000|Overall Study|Withdrawal by Subject|11|||
162867475|NCT03666143|588218151|FG000|Overall Study|Lost to Follow-up|5|||
162867476|NCT03666143|588218151|FG000|Overall Study|Physician Decision|1|||
162867477|NCT03666143|588218151|FG000|Overall Study|Rolled into extension study|9|||
162867478|NCT03666143|588218151|FG000|Overall Study|Progressive Disease|1|||
162867479|NCT00972244|588218152|FG000|Overall Study|Incorrect Enrolment|1|||
162867480|NCT00972244|588218153|FG001|Overall Study|Incorrect Enrolment|0|||
162867481|NCT00972244|588218154|FG002|Overall Study|Incorrect Enrolment|0|||
162867482|NCT00972244|588218155|FG003|Overall Study|Incorrect Enrolment|0|||
162867483|NCT00972244|588218156|FG004|Overall Study|Incorrect Enrolment|0|||
162867484|NCT00972244|588218152|FG000|Overall Study|Adverse Event|0|||
162867485|NCT00972244|588218153|FG001|Overall Study|Adverse Event|1|||
162867486|NCT00972244|588218154|FG002|Overall Study|Adverse Event|1|||
162867487|NCT00972244|588218155|FG003|Overall Study|Adverse Event|0|||
162867488|NCT00972244|588218156|FG004|Overall Study|Adverse Event|0|||
162867489|NCT00972244|588218152|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
162959550|NCT00318461|588553581|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
162959551|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
162959552|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
162959553|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
162959554|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
162959555|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
162959556|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
162959557|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
162959558|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
162959559|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
162959560|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
162959561|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
163046404|NCT00627926|588877422|FG001|Overall Study|Death|0|||
163046405|NCT00627926|588877423|FG002|Overall Study|Death|0|||
163046406|NCT00627926|588877421|FG000|Overall Study|Lost to Follow-up|4|||
162614245|NCT03633617|587305711|FG000|Part C (& Follow-up)|Protocol Violation|0|||
162614246|NCT03633617|587305712|FG001|Part C (& Follow-up)|Protocol Violation|0|||
162614247|NCT03633617|587305713|FG002|Part C (& Follow-up)|Protocol Violation|0|||
162614248|NCT03633617|587305714|FG003|Part C (& Follow-up)|Protocol Violation|0|||
162614249|NCT03633617|587305715|FG004|Part C (& Follow-up)|Protocol Violation|0|||
162867490|NCT00972244|588218153|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
162867491|NCT00972244|588218154|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
162867492|NCT00972244|588218155|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
162867493|NCT00972244|588218156|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
162867494|NCT00972244|588218152|FG000|Overall Study|Withdrawal by Subject|1|||
163046407|NCT00627926|588877422|FG001|Overall Study|Lost to Follow-up|3|||
162614250|NCT03633617|587305716|FG005|Part C (& Follow-up)|Protocol Violation|0|||
162614251|NCT03633617|587305717|FG006|Part C (& Follow-up)|Protocol Violation|0|||
162867495|NCT00972244|588218153|FG001|Overall Study|Withdrawal by Subject|2|||
162867496|NCT00972244|588218154|FG002|Overall Study|Withdrawal by Subject|1|||
162867497|NCT00972244|588218155|FG003|Overall Study|Withdrawal by Subject|0|||
162867498|NCT00972244|588218156|FG004|Overall Study|Withdrawal by Subject|1|||
162867499|NCT00972244|588218152|FG000|Overall Study|Safety|0|||
162867500|NCT00972244|588218153|FG001|Overall Study|Safety|0|||
162867501|NCT00972244|588218154|FG002|Overall Study|Safety|0|||
162867502|NCT00972244|588218155|FG003|Overall Study|Safety|0|||
162867503|NCT00972244|588218156|FG004|Overall Study|Safety|1|||
162867504|NCT00972244|588218152|FG000|Overall Study|Death|1|||
162867505|NCT00972244|588218153|FG001|Overall Study|Death|0|||
162867506|NCT00972244|588218154|FG002|Overall Study|Death|0|||
162867507|NCT00972244|588218155|FG003|Overall Study|Death|0|||
162867508|NCT00972244|588218156|FG004|Overall Study|Death|0|||
162867509|NCT00972244|588218152|FG000|Overall Study|Various|0|||
162867510|NCT00972244|588218153|FG001|Overall Study|Various|0|||
162867511|NCT00972244|588218154|FG002|Overall Study|Various|0|||
162867512|NCT00972244|588218155|FG003|Overall Study|Various|0|||
162867513|NCT00972244|588218156|FG004|Overall Study|Various|2|||
162867514|NCT03648476|588218162|FG000|Overall Study|Withdrawal by Subject|2|||
162867515|NCT03648476|588218163|FG001|Overall Study|Withdrawal by Subject|1|||
162867516|NCT00907881|588218164|FG000|Overall Study|Lost to Follow-up|59|||
162867517|NCT00907881|588218164|FG000|Overall Study|Noncompliance|5|||
162867518|NCT00907881|588218164|FG000|Overall Study|Withdrawal by Subject|5|||
162867519|NCT00907881|588218164|FG000|Overall Study|Protocol Violation|1|||
162867520|NCT00907881|588218164|FG000|Overall Study|Missing discontinuation information|15|||
162867521|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
162867522|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
162867523|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
162867524|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162867525|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162867526|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162867527|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162867528|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
162867529|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
162867530|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
162867531|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
162867532|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162867533|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162867534|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162867535|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162867536|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162867537|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
162867538|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
162867539|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
162867540|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162867541|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162614252|NCT03633617|587305718|FG007|Part C (& Follow-up)|Protocol Violation|0|||
162614253|NCT03633617|587305719|FG008|Part C (& Follow-up)|Protocol Violation|0|||
162867542|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162867543|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162867544|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
162867545|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
162867546|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
163046408|NCT00627926|588877423|FG002|Overall Study|Lost to Follow-up|4|||
162867547|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867548|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867549|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867550|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867551|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867552|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
162867553|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
162867554|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
162867555|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
162867556|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162867557|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162867558|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162867559|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162867560|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
162867561|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
162867562|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
162867563|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867564|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867565|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867566|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867567|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867568|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
162867569|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
162867570|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
162867571|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867572|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867573|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867574|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867575|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867576|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
162867577|NCT01097616|588218165|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867578|NCT01097616|588218166|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867579|NCT01097616|588218167|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
162867580|NCT01097616|588218168|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867581|NCT01097616|588218169|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867582|NCT01097616|588218170|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163046409|NCT00627926|588877421|FG000|Overall Study|Withdrawal by Subject|2|||
163046410|NCT00627926|588877422|FG001|Overall Study|Withdrawal by Subject|1|||
162867583|NCT01097616|588218171|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867584|NCT01097616|588218172|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
162867585|NCT01097616|588218165|FG000|Optional DB EXT Phase|Adverse Event|0|||
162867586|NCT01097616|588218166|FG001|Optional DB EXT Phase|Adverse Event|7|||
162867587|NCT01097616|588218167|FG002|Optional DB EXT Phase|Adverse Event|2|||
162867588|NCT01097616|588218168|FG003|Optional DB EXT Phase|Adverse Event|0|||
162867589|NCT01097616|588218169|FG004|Optional DB EXT Phase|Adverse Event|0|||
162867590|NCT01097616|588218170|FG005|Optional DB EXT Phase|Adverse Event|0|||
162867591|NCT01097616|588218171|FG006|Optional DB EXT Phase|Adverse Event|0|||
162867592|NCT01097616|588218172|FG007|Optional DB EXT Phase|Adverse Event|0|||
162867593|NCT01097616|588218165|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
162867594|NCT01097616|588218166|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
162867595|NCT01097616|588218167|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
162867596|NCT01097616|588218168|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
162867597|NCT01097616|588218169|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
162614254|NCT03633617|587305720|FG009|Part C (& Follow-up)|Protocol Violation|3|||
162614255|NCT03633617|587305721|FG010|Part C (& Follow-up)|Protocol Violation|1|||
162614256|NCT03633617|587305711|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
162614257|NCT03633617|587305712|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
162614258|NCT03633617|587305713|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
162614259|NCT03633617|587305714|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
162614260|NCT03633617|587305715|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
162614261|NCT03633617|587305716|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
162614262|NCT03633617|587305717|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
162614263|NCT03633617|587305718|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
162614264|NCT03633617|587305719|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
162614265|NCT03633617|587305720|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
162614266|NCT03633617|587305721|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
162614267|NCT00809354|587305724|FG000|Overall Study|Adverse Event|32|||
162614268|NCT00809354|587305725|FG001|Overall Study|Adverse Event|45|||
162614269|NCT00809354|587305726|FG002|Overall Study|Adverse Event|37|||
162614270|NCT00809354|587305727|FG003|Overall Study|Adverse Event|53|||
162614271|NCT00809354|587305728|FG004|Overall Study|Adverse Event|26|||
162614272|NCT00809354|587305729|FG005|Overall Study|Adverse Event|33|||
162614273|NCT00809354|587305730|FG006|Overall Study|Adverse Event|44|||
162614274|NCT00809354|587305731|FG007|Overall Study|Adverse Event|40|||
162614275|NCT00809354|587305732|FG008|Overall Study|Adverse Event|46|||
162614276|NCT00809354|587305733|FG009|Overall Study|Adverse Event|26|||
162614277|NCT00809354|587305724|FG000|Overall Study|Lack of Efficacy|23|||
162614278|NCT00809354|587305725|FG001|Overall Study|Lack of Efficacy|23|||
162614279|NCT00809354|587305726|FG002|Overall Study|Lack of Efficacy|22|||
162614280|NCT00809354|587305727|FG003|Overall Study|Lack of Efficacy|15|||
162614281|NCT00809354|587305728|FG004|Overall Study|Lack of Efficacy|40|||
162614282|NCT00809354|587305729|FG005|Overall Study|Lack of Efficacy|19|||
162614283|NCT00809354|587305730|FG006|Overall Study|Lack of Efficacy|21|||
162614284|NCT00809354|587305731|FG007|Overall Study|Lack of Efficacy|15|||
162614285|NCT00809354|587305732|FG008|Overall Study|Lack of Efficacy|18|||
162614286|NCT00809354|587305733|FG009|Overall Study|Lack of Efficacy|38|||
162614287|NCT00809354|587305724|FG000|Overall Study|Lost to Follow-up|10|||
162614288|NCT00809354|587305725|FG001|Overall Study|Lost to Follow-up|11|||
162614289|NCT00809354|587305726|FG002|Overall Study|Lost to Follow-up|8|||
162614290|NCT00809354|587305727|FG003|Overall Study|Lost to Follow-up|13|||
162614291|NCT00809354|587305728|FG004|Overall Study|Lost to Follow-up|6|||
162614292|NCT00809354|587305729|FG005|Overall Study|Lost to Follow-up|2|||
162614293|NCT00809354|587305730|FG006|Overall Study|Lost to Follow-up|0|||
162614294|NCT00809354|587305731|FG007|Overall Study|Lost to Follow-up|5|||
162614295|NCT00809354|587305732|FG008|Overall Study|Lost to Follow-up|4|||
162614296|NCT00809354|587305733|FG009|Overall Study|Lost to Follow-up|0|||
162867598|NCT01097616|588218170|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
162867599|NCT01097616|588218171|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
162867600|NCT01097616|588218172|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
162867601|NCT01097616|588218165|FG000|Optional DB EXT Phase|Protocol Violation|0|||
162867602|NCT01097616|588218166|FG001|Optional DB EXT Phase|Protocol Violation|2|||
162867603|NCT01097616|588218167|FG002|Optional DB EXT Phase|Protocol Violation|3|||
162614297|NCT00809354|587305724|FG000|Overall Study|Protocol Violation|7|||
162614298|NCT00809354|587305725|FG001|Overall Study|Protocol Violation|14|||
162614299|NCT00809354|587305726|FG002|Overall Study|Protocol Violation|14|||
162614300|NCT00809354|587305727|FG003|Overall Study|Protocol Violation|12|||
162614301|NCT00809354|587305728|FG004|Overall Study|Protocol Violation|14|||
162614302|NCT00809354|587305729|FG005|Overall Study|Protocol Violation|6|||
162614303|NCT00809354|587305730|FG006|Overall Study|Protocol Violation|4|||
162614304|NCT00809354|587305731|FG007|Overall Study|Protocol Violation|6|||
162614305|NCT00809354|587305732|FG008|Overall Study|Protocol Violation|9|||
162867604|NCT01097616|588218168|FG003|Optional DB EXT Phase|Protocol Violation|0|||
162867605|NCT01097616|588218169|FG004|Optional DB EXT Phase|Protocol Violation|0|||
162614306|NCT00809354|587305733|FG009|Overall Study|Protocol Violation|3|||
162614307|NCT00809354|587305724|FG000|Overall Study|Withdrawal by Subject|32|||
162614308|NCT00809354|587305725|FG001|Overall Study|Withdrawal by Subject|27|||
162614309|NCT00809354|587305726|FG002|Overall Study|Withdrawal by Subject|31|||
162614310|NCT00809354|587305727|FG003|Overall Study|Withdrawal by Subject|33|||
162614311|NCT00809354|587305728|FG004|Overall Study|Withdrawal by Subject|34|||
162614312|NCT00809354|587305729|FG005|Overall Study|Withdrawal by Subject|29|||
162614313|NCT00809354|587305730|FG006|Overall Study|Withdrawal by Subject|27|||
162614314|NCT00809354|587305731|FG007|Overall Study|Withdrawal by Subject|19|||
162614315|NCT00809354|587305732|FG008|Overall Study|Withdrawal by Subject|18|||
162867606|NCT01097616|588218170|FG005|Optional DB EXT Phase|Protocol Violation|0|||
162867607|NCT01097616|588218171|FG006|Optional DB EXT Phase|Protocol Violation|0|||
162867608|NCT01097616|588218172|FG007|Optional DB EXT Phase|Protocol Violation|0|||
162867609|NCT01097616|588218165|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
162867610|NCT01097616|588218166|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
162867611|NCT01097616|588218167|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
162867612|NCT01097616|588218168|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
162867613|NCT01097616|588218169|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
162867614|NCT01097616|588218170|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
162867615|NCT01097616|588218171|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
162867616|NCT01097616|588218172|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
162867617|NCT01097616|588218165|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
162867618|NCT01097616|588218166|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
162867619|NCT01097616|588218167|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
162867620|NCT01097616|588218168|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
162867621|NCT01097616|588218169|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
162867622|NCT01097616|588218170|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
162867623|NCT01097616|588218171|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
162867624|NCT01097616|588218172|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
162867625|NCT01097616|588218165|FG000|Optional DB EXT Phase|Physician Decision|1|||
162867626|NCT01097616|588218166|FG001|Optional DB EXT Phase|Physician Decision|0|||
162867627|NCT01097616|588218167|FG002|Optional DB EXT Phase|Physician Decision|0|||
162867628|NCT01097616|588218168|FG003|Optional DB EXT Phase|Physician Decision|0|||
162867629|NCT01097616|588218169|FG004|Optional DB EXT Phase|Physician Decision|0|||
162867630|NCT01097616|588218170|FG005|Optional DB EXT Phase|Physician Decision|0|||
162867631|NCT01097616|588218171|FG006|Optional DB EXT Phase|Physician Decision|0|||
162867632|NCT01097616|588218172|FG007|Optional DB EXT Phase|Physician Decision|0|||
162867633|NCT01097616|588218165|FG000|DB RO Phase|Adverse Event|0|||
162867634|NCT01097616|588218166|FG001|DB RO Phase|Adverse Event|0|||
162867635|NCT01097616|588218167|FG002|DB RO Phase|Adverse Event|0|||
162867636|NCT01097616|588218168|FG003|DB RO Phase|Adverse Event|0|||
162867637|NCT01097616|588218169|FG004|DB RO Phase|Adverse Event|0|||
162959562|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
162959563|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
162959564|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
162867638|NCT01097616|588218170|FG005|DB RO Phase|Adverse Event|0|||
162867639|NCT01097616|588218171|FG006|DB RO Phase|Adverse Event|1|||
162867640|NCT01097616|588218172|FG007|DB RO Phase|Adverse Event|0|||
162867641|NCT01097616|588218165|FG000|DB RO Phase|Withdrawal by Subject|0|||
162867642|NCT01097616|588218166|FG001|DB RO Phase|Withdrawal by Subject|0|||
162867643|NCT01097616|588218167|FG002|DB RO Phase|Withdrawal by Subject|0|||
162867644|NCT01097616|588218168|FG003|DB RO Phase|Withdrawal by Subject|0|||
162867645|NCT01097616|588218169|FG004|DB RO Phase|Withdrawal by Subject|0|||
162867646|NCT01097616|588218170|FG005|DB RO Phase|Withdrawal by Subject|1|||
162867647|NCT01097616|588218171|FG006|DB RO Phase|Withdrawal by Subject|0|||
162867648|NCT01097616|588218172|FG007|DB RO Phase|Withdrawal by Subject|0|||
162867649|NCT01097616|588218165|FG000|DB RO Phase|Lost to Follow-up|0|||
162867650|NCT01097616|588218166|FG001|DB RO Phase|Lost to Follow-up|0|||
162867651|NCT01097616|588218167|FG002|DB RO Phase|Lost to Follow-up|0|||
162867652|NCT01097616|588218168|FG003|DB RO Phase|Lost to Follow-up|1|||
162867653|NCT01097616|588218169|FG004|DB RO Phase|Lost to Follow-up|1|||
162867654|NCT01097616|588218170|FG005|DB RO Phase|Lost to Follow-up|0|||
162867655|NCT01097616|588218171|FG006|DB RO Phase|Lost to Follow-up|0|||
162867656|NCT01097616|588218172|FG007|DB RO Phase|Lost to Follow-up|1|||
162867657|NCT01097616|588218165|FG000|DB RO Phase|Not Treated in RO|0|||
162867658|NCT01097616|588218166|FG001|DB RO Phase|Not Treated in RO|0|||
162867659|NCT01097616|588218167|FG002|DB RO Phase|Not Treated in RO|0|||
162867660|NCT01097616|588218168|FG003|DB RO Phase|Not Treated in RO|0|||
162867661|NCT01097616|588218169|FG004|DB RO Phase|Not Treated in RO|0|||
162867662|NCT01097616|588218170|FG005|DB RO Phase|Not Treated in RO|1|||
162867663|NCT01097616|588218171|FG006|DB RO Phase|Not Treated in RO|0|||
162867664|NCT01097616|588218172|FG007|DB RO Phase|Not Treated in RO|0|||
162867665|NCT04101422|588218175|FG000|Overall Study|Ineligible|1|||
162867666|NCT04101422|588218176|FG001|Overall Study|Ineligible|0|||
162867667|NCT04101422|588218177|FG002|Overall Study|Ineligible|9|||
162867668|NCT04101422|588218178|FG003|Overall Study|Ineligible|0|||
162867669|NCT04101422|588218175|FG000|Overall Study|Withdrawal by Subject|0|||
162867670|NCT04101422|588218176|FG001|Overall Study|Withdrawal by Subject|0|||
162867671|NCT04101422|588218177|FG002|Overall Study|Withdrawal by Subject|1|||
162867672|NCT04101422|588218178|FG003|Overall Study|Withdrawal by Subject|0|||
162867673|NCT04101422|588218175|FG000|Overall Study|Not attending to the stimuli|0|||
162867674|NCT04101422|588218176|FG001|Overall Study|Not attending to the stimuli|0|||
162867675|NCT04101422|588218177|FG002|Overall Study|Not attending to the stimuli|4|||
162867676|NCT04101422|588218178|FG003|Overall Study|Not attending to the stimuli|0|||
162867677|NCT04101422|588218175|FG000|Overall Study|Did not download app|0|||
162867678|NCT04101422|588218176|FG001|Overall Study|Did not download app|0|||
162867679|NCT04101422|588218177|FG002|Overall Study|Did not download app|0|||
162867680|NCT04101422|588218178|FG003|Overall Study|Did not download app|17|||
162867681|NCT04101422|588218175|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
162867682|NCT04101422|588218176|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
162867683|NCT04101422|588218177|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
162867684|NCT04101422|588218178|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
162867685|NCT01174784|588218179|FG000|Overall Study|Screen fails|4|||
162867686|NCT00532883|588218182|FG000|Overall Study|Adverse Event|1|||
162867687|NCT00532883|588218183|FG001|Overall Study|Adverse Event|0|||
162867688|NCT00532883|588218184|FG002|Overall Study|Adverse Event|0|||
162867689|NCT00532883|588218185|FG003|Overall Study|Adverse Event|1|||
162867690|NCT00532883|588218182|FG000|Overall Study|Lost to Follow-up|1|||
162867691|NCT00532883|588218183|FG001|Overall Study|Lost to Follow-up|1|||
162867692|NCT00532883|588218184|FG002|Overall Study|Lost to Follow-up|1|||
162867693|NCT00532883|588218185|FG003|Overall Study|Lost to Follow-up|0|||
162867694|NCT00532883|588218182|FG000|Overall Study|Withdrawal by Subject|0|||
162867695|NCT00532883|588218183|FG001|Overall Study|Withdrawal by Subject|1|||
162867696|NCT00532883|588218184|FG002|Overall Study|Withdrawal by Subject|1|||
162706181|NCT00480441|587636569|FG000|Baseline Functional MRI|physical contraindication|4|||
162706182|NCT00480441|587636570|FG001|Baseline Functional MRI|physical contraindication|0|||
162867697|NCT00532883|588218185|FG003|Overall Study|Withdrawal by Subject|0|||
162867698|NCT00532883|588218182|FG000|Overall Study|Subject was Nonadherent|0|||
162867699|NCT00532883|588218183|FG001|Overall Study|Subject was Nonadherent|1|||
162867700|NCT00532883|588218184|FG002|Overall Study|Subject was Nonadherent|1|||
162867701|NCT00532883|588218185|FG003|Overall Study|Subject was Nonadherent|0|||
162867702|NCT00532883|588218182|FG000|Overall Study|Early Study Termination|4|||
162867703|NCT00532883|588218183|FG001|Overall Study|Early Study Termination|4|||
162867704|NCT00532883|588218184|FG002|Overall Study|Early Study Termination|1|||
162867705|NCT00532883|588218185|FG003|Overall Study|Early Study Termination|4|||
162867706|NCT01214434|588218188|FG000|Overall Study|Withdrawal by Subject|1|||
162867707|NCT01214434|588218189|FG001|Overall Study|Withdrawal by Subject|0|||
162867708|NCT01214434|588218188|FG000|Overall Study|Lost to Follow-up|2|||
162867709|NCT01214434|588218189|FG001|Overall Study|Lost to Follow-up|2|||
162867710|NCT01214434|588218188|FG000|Overall Study|Site error|1|||
162867711|NCT01214434|588218189|FG001|Overall Study|Site error|0|||
162867712|NCT02075255|588218191|FG000|Overall Study|Study specific withdrawal criteria|0|||
162867713|NCT02075255|588218192|FG001|Overall Study|Study specific withdrawal criteria|1|||
162867714|NCT02075255|588218193|FG002|Overall Study|Study specific withdrawal criteria|1|||
162867715|NCT02075255|588218191|FG000|Overall Study|Withdrawal by Subject|4|||
162867716|NCT02075255|588218192|FG001|Overall Study|Withdrawal by Subject|1|||
162867717|NCT02075255|588218193|FG002|Overall Study|Withdrawal by Subject|0|||
162867718|NCT02075255|588218191|FG000|Overall Study|Lost to Follow-up|0|||
162867719|NCT02075255|588218192|FG001|Overall Study|Lost to Follow-up|0|||
162706183|NCT00480441|587636571|FG002|Baseline Functional MRI|physical contraindication|0|||
162867720|NCT02075255|588218193|FG002|Overall Study|Lost to Follow-up|1|||
162867721|NCT02075255|588218191|FG000|Overall Study|Adverse Event|0|||
162867722|NCT02075255|588218192|FG001|Overall Study|Adverse Event|0|||
162867723|NCT02075255|588218193|FG002|Overall Study|Adverse Event|1|||
162867724|NCT02075255|588218191|FG000|Overall Study|Death|0|||
162867725|NCT02075255|588218192|FG001|Overall Study|Death|2|||
162867726|NCT02075255|588218193|FG002|Overall Study|Death|0|||
162867727|NCT03792750|588218194|FG000|Overall Study|Death|3|||
162867728|NCT01879618|588218199|FG000|Overall Study|Does not meet entrance criteria|1|||
162614316|NCT00809354|587305733|FG009|Overall Study|Withdrawal by Subject|20|||
162614317|NCT00809354|587305724|FG000|Overall Study|Other|10|||
162614318|NCT00809354|587305725|FG001|Overall Study|Other|2|||
162614319|NCT00809354|587305726|FG002|Overall Study|Other|7|||
162614320|NCT00809354|587305727|FG003|Overall Study|Other|10|||
162614321|NCT00809354|587305728|FG004|Overall Study|Other|5|||
162614322|NCT00809354|587305729|FG005|Overall Study|Other|3|||
162614323|NCT00809354|587305730|FG006|Overall Study|Other|2|||
162614324|NCT00809354|587305731|FG007|Overall Study|Other|3|||
162614325|NCT00809354|587305732|FG008|Overall Study|Other|4|||
162614326|NCT00809354|587305733|FG009|Overall Study|Other|3|||
162614327|NCT00809354|587305724|FG000|Overall Study|Study terminated by sponsor|138|||
162614328|NCT00809354|587305725|FG001|Overall Study|Study terminated by sponsor|134|||
162614329|NCT00809354|587305726|FG002|Overall Study|Study terminated by sponsor|129|||
162614330|NCT00809354|587305727|FG003|Overall Study|Study terminated by sponsor|120|||
162614331|NCT00809354|587305728|FG004|Overall Study|Study terminated by sponsor|126|||
162614332|NCT00809354|587305729|FG005|Overall Study|Study terminated by sponsor|133|||
162614333|NCT00809354|587305730|FG006|Overall Study|Study terminated by sponsor|124|||
162614334|NCT00809354|587305731|FG007|Overall Study|Study terminated by sponsor|148|||
162614335|NCT00809354|587305732|FG008|Overall Study|Study terminated by sponsor|127|||
162614336|NCT00809354|587305733|FG009|Overall Study|Study terminated by sponsor|135|||
162614337|NCT00809354|587305724|FG000|Overall Study|Withdrawn due to pregnancy|0|||
162614338|NCT00809354|587305725|FG001|Overall Study|Withdrawn due to pregnancy|1|||
162614339|NCT00809354|587305726|FG002|Overall Study|Withdrawn due to pregnancy|0|||
162614340|NCT00809354|587305727|FG003|Overall Study|Withdrawn due to pregnancy|0|||
162614341|NCT00809354|587305728|FG004|Overall Study|Withdrawn due to pregnancy|0|||
162614342|NCT00809354|587305729|FG005|Overall Study|Withdrawn due to pregnancy|0|||
162614343|NCT00809354|587305730|FG006|Overall Study|Withdrawn due to pregnancy|0|||
162614344|NCT00809354|587305731|FG007|Overall Study|Withdrawn due to pregnancy|0|||
162614345|NCT00809354|587305732|FG008|Overall Study|Withdrawn due to pregnancy|0|||
162614346|NCT00809354|587305733|FG009|Overall Study|Withdrawn due to pregnancy|0|||
162614347|NCT00809354|587305724|FG000|Overall Study|Randomized but not Treated|3|||
162614348|NCT00809354|587305725|FG001|Overall Study|Randomized but not Treated|1|||
162614349|NCT00809354|587305726|FG002|Overall Study|Randomized but not Treated|6|||
162614350|NCT00809354|587305727|FG003|Overall Study|Randomized but not Treated|0|||
162614351|NCT00809354|587305728|FG004|Overall Study|Randomized but not Treated|5|||
162614352|NCT00809354|587305729|FG005|Overall Study|Randomized but not Treated|0|||
162614353|NCT00809354|587305730|FG006|Overall Study|Randomized but not Treated|1|||
162614354|NCT00809354|587305731|FG007|Overall Study|Randomized but not Treated|1|||
162867729|NCT01879618|588218199|FG000|Overall Study|Withdrawal by Subject|1|||
162867730|NCT01879618|588218199|FG000|Overall Study|Surgery;changed schedule; not available|8|||
162867731|NCT01879618|588218199|FG000|Overall Study|Protocol Violation|6|||
162867732|NCT01879618|588218199|FG000|Overall Study|Adverse Event|5|||
162867733|NCT00394914|588218200|FG000|Treatment Period|Adverse Event|0|||
162867734|NCT00394914|588218201|FG001|Treatment Period|Adverse Event|3|||
162867735|NCT00394914|588218202|FG002|Treatment Period|Adverse Event|1|||
162867736|NCT00394914|588218200|FG000|Treatment Period|Lost to Follow-up|0|||
162867737|NCT00394914|588218201|FG001|Treatment Period|Lost to Follow-up|1|||
162867738|NCT00394914|588218202|FG002|Treatment Period|Lost to Follow-up|0|||
162867739|NCT00394914|588218200|FG000|Treatment Period|Withdrawal by Subject|0|||
162867740|NCT00394914|588218201|FG001|Treatment Period|Withdrawal by Subject|2|||
162867741|NCT00394914|588218202|FG002|Treatment Period|Withdrawal by Subject|2|||
162867742|NCT00394914|588218200|FG000|Treatment Period|Noncompliance with protocol|0|||
162867743|NCT00394914|588218201|FG001|Treatment Period|Noncompliance with protocol|3|||
162867744|NCT00394914|588218202|FG002|Treatment Period|Noncompliance with protocol|2|||
162867745|NCT00394914|588218200|FG000|Treatment Period|Did not meet protocol eligibility|0|||
162867746|NCT00394914|588218201|FG001|Treatment Period|Did not meet protocol eligibility|1|||
162867747|NCT00394914|588218202|FG002|Treatment Period|Did not meet protocol eligibility|1|||
162867748|NCT00465738|588218213|FG000|Overall Study|Lost to Follow-up|2|||
162867749|NCT00465738|588218214|FG001|Overall Study|Lost to Follow-up|0|||
162867750|NCT00465738|588218213|FG000|Overall Study|Adverse Event|0|||
162867751|NCT00465738|588218214|FG001|Overall Study|Adverse Event|1|||
162867752|NCT00465738|588218213|FG000|Overall Study|Withdrawal by Subject|2|||
162867753|NCT00465738|588218214|FG001|Overall Study|Withdrawal by Subject|0|||
162867754|NCT00465738|588218213|FG000|Overall Study|Other|2|||
162614355|NCT00809354|587305732|FG008|Overall Study|Randomized but not Treated|2|||
162614356|NCT00809354|587305733|FG009|Overall Study|Randomized but not Treated|1|||
162614357|NCT00809354|587305724|FG000|Overall Study|Death|0|||
162867755|NCT00465738|588218214|FG001|Overall Study|Other|5|||
162614358|NCT00809354|587305725|FG001|Overall Study|Death|0|||
162614359|NCT00809354|587305726|FG002|Overall Study|Death|0|||
162614360|NCT00809354|587305727|FG003|Overall Study|Death|0|||
162614361|NCT00809354|587305728|FG004|Overall Study|Death|0|||
162614362|NCT00809354|587305729|FG005|Overall Study|Death|0|||
162614363|NCT00809354|587305730|FG006|Overall Study|Death|0|||
162614364|NCT00809354|587305731|FG007|Overall Study|Death|1|||
162614365|NCT00809354|587305732|FG008|Overall Study|Death|0|||
162614366|NCT00809354|587305733|FG009|Overall Study|Death|0|||
162614367|NCT04137224|587305736|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
162614368|NCT04137224|587305737|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
162614369|NCT04137224|587305736|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
162614370|NCT04137224|587305737|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
162614371|NCT04137224|587305736|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
162614372|NCT04137224|587305737|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
162614373|NCT01669928|587305738|FG000|First Intervention|Withdrawal by Subject|3|||
162614374|NCT01669928|587305739|FG001|First Intervention|Withdrawal by Subject|5|||
162614375|NCT05085730|587305748|FG000|Overall Study|Withdrawal by Subject|4|||
162614376|NCT05085730|587305748|FG000|Overall Study|Physician Decision|1|||
162614377|NCT01400815|587305749|FG000|Overall Study|Adverse Event|3|||
162614378|NCT01400815|587305750|FG001|Overall Study|Adverse Event|0|||
162614379|NCT01400815|587305749|FG000|Overall Study|Death|0|||
162614380|NCT01400815|587305750|FG001|Overall Study|Death|1|||
162614381|NCT01400815|587305749|FG000|Overall Study|Lost to Follow-up|18|||
162614382|NCT01400815|587305750|FG001|Overall Study|Lost to Follow-up|11|||
162614383|NCT01400815|587305749|FG000|Overall Study|Protocol Violation|0|||
162614384|NCT01400815|587305750|FG001|Overall Study|Protocol Violation|1|||
162614385|NCT01400815|587305749|FG000|Overall Study|Physician Decision|1|||
162614386|NCT01400815|587305750|FG001|Overall Study|Physician Decision|0|||
162614387|NCT01400815|587305749|FG000|Overall Study|Withdrawal by Subject|15|||
162614388|NCT01400815|587305750|FG001|Overall Study|Withdrawal by Subject|8|||
162614389|NCT01400815|587305749|FG000|Overall Study|Subject in jail|1|||
162614390|NCT01400815|587305750|FG001|Overall Study|Subject in jail|0|||
162614391|NCT01199731|587305752|FG000|Overall Study|Adverse Event|0|||
162614392|NCT01199731|587305753|FG001|Overall Study|Adverse Event|1|||
162614393|NCT01199731|587305754|FG002|Overall Study|Adverse Event|0|||
162614394|NCT01199731|587305752|FG000|Overall Study|Study closed/terminated|7|||
162614395|NCT01199731|587305753|FG001|Overall Study|Study closed/terminated|9|||
162614396|NCT01199731|587305754|FG002|Overall Study|Study closed/terminated|7|||
162959565|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
162959566|NCT00318461|588553577|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
162959567|NCT00318461|588553578|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
162959568|NCT00318461|588553579|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
163046411|NCT00627926|588877423|FG002|Overall Study|Withdrawal by Subject|0|||
163046412|NCT00627926|588877421|FG000|Overall Study|Lack of Efficacy|118|||
163046413|NCT00627926|588877422|FG001|Overall Study|Lack of Efficacy|40|||
163046414|NCT00627926|588877423|FG002|Overall Study|Lack of Efficacy|38|||
163046415|NCT00627926|588877421|FG000|Overall Study|Noncompliance/unspecified|8|||
163046416|NCT00627926|588877422|FG001|Overall Study|Noncompliance/unspecified|23|||
163046417|NCT00627926|588877423|FG002|Overall Study|Noncompliance/unspecified|17|||
163046418|NCT03414229|588877424|FG000|Overall Study|Adverse Event|1|||
163046419|NCT03414229|588877425|FG001|Overall Study|Adverse Event|0|||
163046420|NCT03414229|588877426|FG002|Overall Study|Adverse Event|2|||
163046421|NCT03414229|588877427|FG003|Overall Study|Adverse Event|1|||
162959569|NCT00318461|588553580|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
162959570|NCT00318461|588553581|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
162959571|NCT00505622|588553582|FG000|Overall Study|Adverse Event|5|||
162959572|NCT00505622|588553583|FG001|Overall Study|Adverse Event|6|||
162959573|NCT00505622|588553584|FG002|Overall Study|Adverse Event|4|||
162959574|NCT00505622|588553582|FG000|Overall Study|Protocol Violation|1|||
162959575|NCT00505622|588553583|FG001|Overall Study|Protocol Violation|1|||
162959576|NCT00505622|588553584|FG002|Overall Study|Protocol Violation|0|||
162959577|NCT00505622|588553582|FG000|Overall Study|Withdrawal by Subject|0|||
162959578|NCT00505622|588553583|FG001|Overall Study|Withdrawal by Subject|3|||
162959579|NCT00505622|588553584|FG002|Overall Study|Withdrawal by Subject|2|||
162959580|NCT00505622|588553582|FG000|Overall Study|Study termination by sponsor|115|||
162959581|NCT00505622|588553583|FG001|Overall Study|Study termination by sponsor|98|||
162959582|NCT00505622|588553584|FG002|Overall Study|Study termination by sponsor|90|||
163046422|NCT03414229|588877424|FG000|Overall Study|Lack of Efficacy|7|||
163046423|NCT03414229|588877425|FG001|Overall Study|Lack of Efficacy|4|||
163046424|NCT03414229|588877426|FG002|Overall Study|Lack of Efficacy|1|||
162614397|NCT01199731|587305752|FG000|Overall Study|Lost to Follow-up|0|||
162614398|NCT01199731|587305753|FG001|Overall Study|Lost to Follow-up|0|||
162614399|NCT01199731|587305754|FG002|Overall Study|Lost to Follow-up|2|||
162614400|NCT01199731|587305752|FG000|Overall Study|Physician Decision|0|||
162614401|NCT01199731|587305753|FG001|Overall Study|Physician Decision|1|||
162614402|NCT01199731|587305754|FG002|Overall Study|Physician Decision|1|||
162706184|NCT00480441|587636569|FG000|Randomization|Lost to Follow-up|0|||
163046425|NCT03414229|588877427|FG003|Overall Study|Lack of Efficacy|9|||
163046426|NCT03414229|588877424|FG000|Overall Study|Change in therapy|1|||
163046427|NCT03414229|588877425|FG001|Overall Study|Change in therapy|0|||
162614403|NCT01199731|587305752|FG000|Overall Study|Withdrawal by Subject|2|||
163046428|NCT03414229|588877426|FG002|Overall Study|Change in therapy|0|||
163046429|NCT03414229|588877427|FG003|Overall Study|Change in therapy|0|||
162867756|NCT00734929|588218215|FG000|Overall Study|Lost to Follow-up|1|||
162867757|NCT00734929|588218216|FG001|Overall Study|Lost to Follow-up|2|||
162867758|NCT00734929|588218215|FG000|Overall Study|No intervention/ screen fail|5|||
162867759|NCT00734929|588218216|FG001|Overall Study|No intervention/ screen fail|3|||
162867760|NCT01863758|588218217|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
162867761|NCT01863758|588218217|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
162867762|NCT02961764|588218218|FG000|Overall Study|Protocol Violation|0|||
162867763|NCT02961764|588218219|FG001|Overall Study|Protocol Violation|1|||
162867764|NCT02961764|588218218|FG000|Overall Study|Death|2|||
162867765|NCT02961764|588218219|FG001|Overall Study|Death|0|||
162867766|NCT02961764|588218218|FG000|Overall Study|Lost to Follow-up|35|||
162867767|NCT02961764|588218219|FG001|Overall Study|Lost to Follow-up|24|||
162867768|NCT02961764|588218218|FG000|Overall Study|Withdrawal by Subject|2|||
162959583|NCT00796653|588553585|FG000|Overall Study|Adverse Event|19|||
162959584|NCT00796653|588553586|FG001|Overall Study|Adverse Event|16|||
162959585|NCT00796653|588553587|FG002|Overall Study|Adverse Event|16|||
162959586|NCT00796653|588553588|FG003|Overall Study|Adverse Event|16|||
162959587|NCT00796653|588553585|FG000|Overall Study|Lost to Follow-up|2|||
162959588|NCT00796653|588553586|FG001|Overall Study|Lost to Follow-up|1|||
162959589|NCT00796653|588553587|FG002|Overall Study|Lost to Follow-up|2|||
162959590|NCT00796653|588553588|FG003|Overall Study|Lost to Follow-up|3|||
162959591|NCT00796653|588553585|FG000|Overall Study|Withdrawal by Subject|16|||
162959592|NCT00796653|588553586|FG001|Overall Study|Withdrawal by Subject|8|||
162959593|NCT00796653|588553587|FG002|Overall Study|Withdrawal by Subject|8|||
162959594|NCT00796653|588553588|FG003|Overall Study|Withdrawal by Subject|13|||
162959595|NCT00796653|588553585|FG000|Overall Study|Lack of Efficacy|8|||
162959596|NCT00796653|588553586|FG001|Overall Study|Lack of Efficacy|1|||
162959597|NCT00796653|588553587|FG002|Overall Study|Lack of Efficacy|3|||
162959598|NCT00796653|588553588|FG003|Overall Study|Lack of Efficacy|2|||
162959599|NCT00796653|588553585|FG000|Overall Study|Non compliance with protocol|2|||
162959600|NCT00796653|588553586|FG001|Overall Study|Non compliance with protocol|2|||
162959601|NCT00796653|588553587|FG002|Overall Study|Non compliance with protocol|0|||
162959602|NCT00796653|588553588|FG003|Overall Study|Non compliance with protocol|2|||
162959603|NCT00796653|588553585|FG000|Overall Study|Other reason not described above|4|||
162959604|NCT00796653|588553586|FG001|Overall Study|Other reason not described above|9|||
162959605|NCT00796653|588553587|FG002|Overall Study|Other reason not described above|7|||
162959606|NCT00796653|588553588|FG003|Overall Study|Other reason not described above|4|||
162959607|NCT00835692|588553590|FG000|First Intervention|Withdrawal by Subject|1|||
162959608|NCT00835692|588553591|FG001|First Intervention|Withdrawal by Subject|0|||
162959609|NCT03644550|588553592|FG000|Overall Study|Withdrawal by Subject|3|||
162959610|NCT03644550|588553592|FG000|Overall Study|Progressive disease|15|||
162959611|NCT01218867|588553593|FG000|Overall Study|Death during treatment|0|||
162959612|NCT01218867|588553594|FG001|Overall Study|Death during treatment|0|||
162959613|NCT01218867|588553595|FG002|Overall Study|Death during treatment|0|||
162959614|NCT01218867|588553596|FG003|Overall Study|Death during treatment|0|||
162959615|NCT01218867|588553597|FG004|Overall Study|Death during treatment|0|||
162959616|NCT01218867|588553598|FG005|Overall Study|Death during treatment|0|||
162959617|NCT01218867|588553599|FG006|Overall Study|Death during treatment|1|||
162959618|NCT01218867|588553600|FG007|Overall Study|Death during treatment|0|||
162959619|NCT01218867|588553601|FG008|Overall Study|Death during treatment|0|||
162959620|NCT01218867|588553602|FG009|Overall Study|Death during treatment|0|||
162959621|NCT01218867|588553603|FG010|Overall Study|Death during treatment|0|||
162959622|NCT04970810|588554723|FG000|Overall Study|deemed ineligible after randomization|3|||
162959623|NCT04970810|588554724|FG001|Overall Study|deemed ineligible after randomization|0|||
162959624|NCT04970810|588554725|FG002|Overall Study|deemed ineligible after randomization|4|||
162959625|NCT01056484|588554730|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
162959626|NCT01056484|588554731|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
162959627|NCT01056484|588554730|FG000|Randomized Controlled Trial|Physician Decision|1|||
162959628|NCT01056484|588554731|FG001|Randomized Controlled Trial|Physician Decision|0|||
162959629|NCT01056484|588554730|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
162959630|NCT01056484|588554731|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
162959631|NCT01492439|588554734|FG000|Overall Study|Withdrew from RTE|4|||
162959632|NCT01492439|588554735|FG001|Overall Study|Withdrew from RTE|9|||
162959633|NCT00716625|588554736|FG000|Overall Study|Safety was not Assessable|1|||
162959634|NCT04349267|588554737|FG000|Overall Study|Adverse Event|0|||
162959635|NCT04349267|588554738|FG001|Overall Study|Adverse Event|0|||
162959636|NCT04349267|588554739|FG002|Overall Study|Adverse Event|0|||
162959637|NCT04349267|588554740|FG003|Overall Study|Adverse Event|0|||
162959638|NCT04349267|588554741|FG004|Overall Study|Adverse Event|0|||
162959639|NCT04349267|588554742|FG005|Overall Study|Adverse Event|1|||
162959640|NCT04349267|588554743|FG006|Overall Study|Adverse Event|0|||
162959641|NCT04349267|588554737|FG000|Overall Study|Other reason|0|||
162959642|NCT04349267|588554738|FG001|Overall Study|Other reason|1|||
162959643|NCT04349267|588554739|FG002|Overall Study|Other reason|0|||
162959644|NCT04349267|588554740|FG003|Overall Study|Other reason|0|||
162867769|NCT02961764|588218219|FG001|Overall Study|Withdrawal by Subject|0|||
163046430|NCT03414229|588877424|FG000|Overall Study|Pregnancy|0|||
163046431|NCT03414229|588877425|FG001|Overall Study|Pregnancy|0|||
163046432|NCT03414229|588877426|FG002|Overall Study|Pregnancy|1|||
163046433|NCT03414229|588877427|FG003|Overall Study|Pregnancy|0|||
163046434|NCT03414229|588877424|FG000|Overall Study|Withdrawal by Subject|0|||
163046435|NCT03414229|588877425|FG001|Overall Study|Withdrawal by Subject|1|||
163046436|NCT03414229|588877426|FG002|Overall Study|Withdrawal by Subject|1|||
163046437|NCT03414229|588877427|FG003|Overall Study|Withdrawal by Subject|0|||
163046438|NCT02797678|588877449|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
163046439|NCT02797678|588877450|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
163046440|NCT02797678|588877451|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
162614404|NCT01199731|587305753|FG001|Overall Study|Withdrawal by Subject|0|||
162614405|NCT01199731|587305754|FG002|Overall Study|Withdrawal by Subject|0|||
162614406|NCT04010539|587305755|FG000|Overall Study|Withdrawal by Subject|4|||
162614407|NCT04010539|587305756|FG001|Overall Study|Withdrawal by Subject|1|||
162614408|NCT04010539|587305755|FG000|Overall Study|Physician Decision|0|||
162614409|NCT04010539|587305756|FG001|Overall Study|Physician Decision|2|||
162614410|NCT04010539|587305755|FG000|Overall Study|Lost to Follow-up|10|||
162614411|NCT04010539|587305756|FG001|Overall Study|Lost to Follow-up|14|||
162614412|NCT04010539|587305755|FG000|Overall Study|Adverse Event|3|||
162614413|NCT04010539|587305756|FG001|Overall Study|Adverse Event|0|||
162614414|NCT04010539|587305755|FG000|Overall Study|Participant Did Not Receive IP|0|||
162614415|NCT04010539|587305756|FG001|Overall Study|Participant Did Not Receive IP|1|||
162614416|NCT04010539|587305755|FG000|Overall Study|Protocol Deviation|0|||
162614417|NCT04010539|587305756|FG001|Overall Study|Protocol Deviation|1|||
162614418|NCT04010539|587305755|FG000|Overall Study|Randomized in Error/ Mistake|2|||
162614419|NCT04010539|587305756|FG001|Overall Study|Randomized in Error/ Mistake|0|||
162614420|NCT04010539|587305755|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
162614421|NCT04010539|587305756|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
162614422|NCT02028871|587305757|FG000|Overall Study|Positive urine drug screen|1|||
162614423|NCT02028871|587305758|FG001|Overall Study|Positive urine drug screen|1|||
162614424|NCT02028871|587305757|FG000|Overall Study|Withdrawal by Subject|1|||
162614425|NCT02028871|587305758|FG001|Overall Study|Withdrawal by Subject|2|||
162614426|NCT02028871|587305757|FG000|Overall Study|IV placement difficulty|1|||
162614427|NCT02028871|587305758|FG001|Overall Study|IV placement difficulty|0|||
162614428|NCT02028871|587305757|FG000|Overall Study|Current Illness|1|||
162614429|NCT02028871|587305758|FG001|Overall Study|Current Illness|0|||
162614430|NCT02314143|587305761|FG000|Overall Study|Adverse Event|0|||
162614431|NCT02314143|587305762|FG001|Overall Study|Adverse Event|6|||
162614432|NCT02314143|587305763|FG002|Overall Study|Adverse Event|4|||
162614433|NCT02314143|587305761|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
162614434|NCT02314143|587305762|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
162614435|NCT02314143|587305763|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
162614436|NCT02314143|587305761|FG000|Overall Study|Physician Decision|2|||
162614437|NCT02314143|587305762|FG001|Overall Study|Physician Decision|1|||
162614438|NCT02314143|587305763|FG002|Overall Study|Physician Decision|0|||
162614439|NCT02314143|587305761|FG000|Overall Study|Withdrawal by Subject|1|||
162614440|NCT02314143|587305762|FG001|Overall Study|Withdrawal by Subject|0|||
162614441|NCT02314143|587305763|FG002|Overall Study|Withdrawal by Subject|1|||
162614442|NCT01916967|587305776|FG000|Overall Study|Adverse Event|0|||
162614443|NCT01916967|587305777|FG001|Overall Study|Adverse Event|0|||
162614444|NCT01916967|587305778|FG002|Overall Study|Adverse Event|2|||
162614445|NCT01916967|587305776|FG000|Overall Study|Lack of Efficacy|0|||
162614446|NCT01916967|587305777|FG001|Overall Study|Lack of Efficacy|0|||
162614447|NCT01916967|587305778|FG002|Overall Study|Lack of Efficacy|6|||
162614448|NCT01916967|587305776|FG000|Overall Study|Physician Decision|0|||
162614449|NCT01916967|587305777|FG001|Overall Study|Physician Decision|0|||
162614450|NCT01916967|587305778|FG002|Overall Study|Physician Decision|1|||
162614451|NCT01916967|587305776|FG000|Overall Study|Protocol Violation|0|||
162614452|NCT01916967|587305777|FG001|Overall Study|Protocol Violation|1|||
162614453|NCT01916967|587305778|FG002|Overall Study|Protocol Violation|0|||
162614454|NCT01070043|587305781|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
162706185|NCT00480441|587636570|FG001|Randomization|Lost to Follow-up|7|||
163046441|NCT02797678|588877452|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
163046442|NCT02797678|588877449|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
163046443|NCT02797678|588877450|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
163046444|NCT02797678|588877451|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
162614455|NCT01070043|587305782|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
162614456|NCT01070043|587305783|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
162614457|NCT01070043|587305781|FG000|Double-Blind Treatment|Adverse Event|0|||
162614458|NCT01070043|587305782|FG001|Double-Blind Treatment|Adverse Event|0|||
162614459|NCT01070043|587305783|FG002|Double-Blind Treatment|Adverse Event|2|||
162614460|NCT01528215|587305784|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
162614461|NCT01528215|587305785|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
163046445|NCT02797678|588877452|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
163046446|NCT02797678|588877449|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046447|NCT02797678|588877450|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046448|NCT02797678|588877451|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
163046449|NCT02797678|588877452|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
163046450|NCT00656175|588877458|FG000|Overall Study|Adverse Event|1|||
163046451|NCT00656175|588877459|FG001|Overall Study|Adverse Event|0|||
163046452|NCT00656175|588877458|FG000|Overall Study|Transportation issues|0|||
163046453|NCT00656175|588877459|FG001|Overall Study|Transportation issues|1|||
163046454|NCT02149264|588877465|FG000|Overall Study|Withdrawal by Subject|9|||
163046455|NCT02149264|588877465|FG000|Overall Study|Adverse Event|7|||
163046456|NCT02149264|588877465|FG000|Overall Study|Physician Decision|3|||
163046457|NCT02149264|588877465|FG000|Overall Study|Protocol Violation|1|||
163046458|NCT01938846|588877469|FG000|Overall Study|Progressive disease|26|||
163046459|NCT01938846|588877470|FG001|Overall Study|Progressive disease|18|||
163046460|NCT01938846|588877471|FG002|Overall Study|Progressive disease|16|||
163046461|NCT01938846|588877469|FG000|Overall Study|Adverse Event|8|||
163046462|NCT01938846|588877470|FG001|Overall Study|Adverse Event|4|||
163046463|NCT01938846|588877471|FG002|Overall Study|Adverse Event|3|||
163046464|NCT01938846|588877469|FG000|Overall Study|Withdrawal by Subject|2|||
163046465|NCT01938846|588877470|FG001|Overall Study|Withdrawal by Subject|2|||
163046466|NCT01938846|588877471|FG002|Overall Study|Withdrawal by Subject|1|||
163046467|NCT01938846|588877469|FG000|Overall Study|Other than listed|5|||
163046468|NCT01938846|588877470|FG001|Overall Study|Other than listed|1|||
163046469|NCT01938846|588877471|FG002|Overall Study|Other than listed|4|||
163046470|NCT02499120|588877475|FG000|Overall Study|Death|52|||
163046471|NCT02499120|588877476|FG001|Overall Study|Death|43|||
163046472|NCT02499120|588877475|FG000|Overall Study|Lost to Follow-up|1|||
163046473|NCT02499120|588877476|FG001|Overall Study|Lost to Follow-up|2|||
163046474|NCT02499120|588877475|FG000|Overall Study|Participant refused further follow-up|1|||
163046475|NCT02499120|588877476|FG001|Overall Study|Participant refused further follow-up|0|||
163046476|NCT02499120|588877475|FG000|Overall Study|Withdrawal by Subject|2|||
163046477|NCT02499120|588877476|FG001|Overall Study|Withdrawal by Subject|5|||
163046478|NCT02499120|588877475|FG000|Overall Study|Other|9|||
163046479|NCT02499120|588877476|FG001|Overall Study|Other|10|||
163046480|NCT02282163|588877477|FG000|Overall Study|Protocol Violation|1|||
163046481|NCT01839916|588877478|FG000|Overall Study|Death|9|||
163046482|NCT01839916|588877478|FG000|Overall Study|Physician Decision|17|||
163046483|NCT01839916|588877478|FG000|Overall Study|Relapse|12|||
163046484|NCT01839916|588877478|FG000|Overall Study|GVHD|2|||
163046485|NCT01839916|588877478|FG000|Overall Study|Graft Failure|1|||
163046486|NCT01325350|588879272|FG000|Overall Study|Adverse Event|3|||
163046487|NCT01325350|588879273|FG001|Overall Study|Adverse Event|3|||
163046488|NCT01325350|588879274|FG002|Overall Study|Adverse Event|3|||
163046489|NCT01325350|588879275|FG003|Overall Study|Adverse Event|1|||
163046490|NCT01325350|588879276|FG004|Overall Study|Adverse Event|2|||
163046491|NCT01325350|588879272|FG000|Overall Study|Pregnancy|0|||
163046492|NCT01325350|588879273|FG001|Overall Study|Pregnancy|0|||
163046493|NCT01325350|588879274|FG002|Overall Study|Pregnancy|1|||
163046494|NCT01325350|588879275|FG003|Overall Study|Pregnancy|0|||
163046495|NCT01325350|588879276|FG004|Overall Study|Pregnancy|1|||
163046496|NCT01325350|588879272|FG000|Overall Study|Lost to Follow-up|1|||
163046497|NCT01325350|588879273|FG001|Overall Study|Lost to Follow-up|0|||
163046498|NCT01325350|588879274|FG002|Overall Study|Lost to Follow-up|5|||
162867770|NCT02369510|588218220|FG000|Overall Study|Spilled Medication|1|||
162867771|NCT02369510|588218221|FG001|Overall Study|Spilled Medication|2|||
162867772|NCT02369510|588218222|FG002|Overall Study|Spilled Medication|1|||
162867773|NCT02369510|588218220|FG000|Overall Study|Epidural Activation|1|||
162867774|NCT02369510|588218221|FG001|Overall Study|Epidural Activation|1|||
162867775|NCT02369510|588218222|FG002|Overall Study|Epidural Activation|5|||
162867776|NCT01663740|588218223|FG000|Overall Study|Lost to Follow-up|1|||
162867777|NCT01663740|588218224|FG001|Overall Study|Lost to Follow-up|4|||
162867778|NCT01663740|588218223|FG000|Overall Study|Other|9|||
162867779|NCT01663740|588218224|FG001|Overall Study|Other|2|||
162867780|NCT01663740|588218223|FG000|Overall Study|Inclusion/Exclusion not met|1|||
162867781|NCT01663740|588218224|FG001|Overall Study|Inclusion/Exclusion not met|0|||
162867782|NCT01663740|588218223|FG000|Overall Study|Death|0|||
163046499|NCT01325350|588879275|FG003|Overall Study|Lost to Follow-up|1|||
163046500|NCT01325350|588879276|FG004|Overall Study|Lost to Follow-up|5|||
163046501|NCT01325350|588879272|FG000|Overall Study|Personal Reasons|2|||
163046502|NCT01325350|588879273|FG001|Overall Study|Personal Reasons|1|||
163046503|NCT01325350|588879274|FG002|Overall Study|Personal Reasons|6|||
163046504|NCT01325350|588879275|FG003|Overall Study|Personal Reasons|5|||
163046505|NCT01325350|588879276|FG004|Overall Study|Personal Reasons|3|||
163046506|NCT01325350|588879272|FG000|Overall Study|Protocol Violation|0|||
162867783|NCT01663740|588218224|FG001|Overall Study|Death|1|||
163046507|NCT01325350|588879273|FG001|Overall Study|Protocol Violation|0|||
163046508|NCT01325350|588879274|FG002|Overall Study|Protocol Violation|0|||
162867784|NCT01663740|588218223|FG000|Overall Study|Withdrawal by Subject|2|||
163046509|NCT01325350|588879275|FG003|Overall Study|Protocol Violation|1|||
163046510|NCT01325350|588879276|FG004|Overall Study|Protocol Violation|0|||
163046511|NCT01325350|588879272|FG000|Overall Study|Withdrawal by Subject|0|||
163046512|NCT01325350|588879273|FG001|Overall Study|Withdrawal by Subject|0|||
163046513|NCT01325350|588879274|FG002|Overall Study|Withdrawal by Subject|1|||
163046514|NCT01325350|588879275|FG003|Overall Study|Withdrawal by Subject|1|||
163046515|NCT01325350|588879276|FG004|Overall Study|Withdrawal by Subject|0|||
163046516|NCT01325350|588879272|FG000|Overall Study|Did Not Receive Treatment|0|||
163046517|NCT01325350|588879273|FG001|Overall Study|Did Not Receive Treatment|1|||
163046518|NCT01325350|588879274|FG002|Overall Study|Did Not Receive Treatment|1|||
163046519|NCT01325350|588879275|FG003|Overall Study|Did Not Receive Treatment|0|||
163046520|NCT01325350|588879276|FG004|Overall Study|Did Not Receive Treatment|1|||
163046521|NCT02692586|588879277|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
163046522|NCT02692586|588879277|FG000|Overall Study|Received adjunctive thrombolytics|2|||
163046523|NCT01396083|588879281|FG000|Overall Study|Adverse Event|2|||
163046524|NCT01396083|588879282|FG001|Overall Study|Adverse Event|28|||
163046525|NCT01396083|588879281|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163046526|NCT01396083|588879282|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
163046527|NCT01396083|588879281|FG000|Overall Study|Consent withdrawn|4|||
163046528|NCT01396083|588879282|FG001|Overall Study|Consent withdrawn|5|||
163046529|NCT01396083|588879281|FG000|Overall Study|Protocol deviation(s)|0|||
163046530|NCT01396083|588879282|FG001|Overall Study|Protocol deviation(s)|1|||
163046531|NCT01396083|588879281|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163046532|NCT01396083|588879282|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163046533|NCT01396083|588879281|FG000|Overall Study|Administrative problems|1|||
163046534|NCT01396083|588879282|FG001|Overall Study|Administrative problems|0|||
163046535|NCT01396083|588879281|FG000|Overall Study|Lost to Follow-up|1|||
163046536|NCT01396083|588879282|FG001|Overall Study|Lost to Follow-up|0|||
163046537|NCT01063855|588879283|FG000|Overall Study|Adverse Event|4|||
163046538|NCT01063855|588879284|FG001|Overall Study|Adverse Event|4|||
163046539|NCT01063855|588879283|FG000|Overall Study|Death|0|||
163046540|NCT01063855|588879284|FG001|Overall Study|Death|1|||
163046541|NCT01063855|588879283|FG000|Overall Study|Lost to Follow-up|8|||
163046542|NCT01063855|588879284|FG001|Overall Study|Lost to Follow-up|4|||
163046543|NCT01063855|588879283|FG000|Overall Study|Pregnancy|1|||
163046544|NCT01063855|588879284|FG001|Overall Study|Pregnancy|0|||
163046545|NCT01063855|588879283|FG000|Overall Study|Lack of Efficacy|0|||
163046546|NCT01063855|588879284|FG001|Overall Study|Lack of Efficacy|1|||
163046547|NCT01063855|588879283|FG000|Overall Study|Withdrawal by Subject|11|||
163046548|NCT01063855|588879284|FG001|Overall Study|Withdrawal by Subject|8|||
163046549|NCT01063855|588879283|FG000|Overall Study|Reason not specified|13|||
163046550|NCT01063855|588879284|FG001|Overall Study|Reason not specified|11|||
163046551|NCT01165307|588879286|FG000|Overall Study|Lost to Follow-up|11|||
163046552|NCT01165307|588879287|FG001|Overall Study|Lost to Follow-up|3|||
163046553|NCT01165307|588879286|FG000|Overall Study|Withdrawal by Subject|2|||
163046554|NCT01165307|588879287|FG001|Overall Study|Withdrawal by Subject|0|||
163046555|NCT01165307|588879286|FG000|Overall Study|Subject not available for contact|1|||
163046556|NCT01165307|588879287|FG001|Overall Study|Subject not available for contact|0|||
163046557|NCT03234036|588879288|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
163046558|NCT03234036|588879289|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
163046559|NCT03234036|588879290|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
163046560|NCT03234036|588879291|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
163046561|NCT02683239|588879311|FG000|Overall Study|Protocol Violation|35|||
163046562|NCT02683239|588879312|FG001|Overall Study|Protocol Violation|23|||
163046563|NCT02683239|588879313|FG002|Overall Study|Protocol Violation|26|||
163046564|NCT02683239|588879314|FG003|Overall Study|Protocol Violation|4|||
163046565|NCT02683239|588879315|FG004|Overall Study|Protocol Violation|35|||
163046566|NCT02683239|588879316|FG005|Overall Study|Protocol Violation|4|||
163046567|NCT02683239|588879317|FG006|Overall Study|Protocol Violation|5|||
163046568|NCT02683239|588879311|FG000|Overall Study|Adverse Event|64|||
163046569|NCT02683239|588879312|FG001|Overall Study|Adverse Event|39|||
163046570|NCT02683239|588879313|FG002|Overall Study|Adverse Event|42|||
163046571|NCT02683239|588879314|FG003|Overall Study|Adverse Event|16|||
163046572|NCT02683239|588879315|FG004|Overall Study|Adverse Event|189|||
163046573|NCT02683239|588879316|FG005|Overall Study|Adverse Event|9|||
163046574|NCT02683239|588879317|FG006|Overall Study|Adverse Event|9|||
163046575|NCT02683239|588879311|FG000|Overall Study|Physician Decision|38|||
163046576|NCT02683239|588879312|FG001|Overall Study|Physician Decision|19|||
163046577|NCT02683239|588879313|FG002|Overall Study|Physician Decision|14|||
163046578|NCT02683239|588879314|FG003|Overall Study|Physician Decision|73|||
163046579|NCT02683239|588879315|FG004|Overall Study|Physician Decision|143|||
163046580|NCT02683239|588879316|FG005|Overall Study|Physician Decision|14|||
163046581|NCT02683239|588879317|FG006|Overall Study|Physician Decision|15|||
163046582|NCT02683239|588879311|FG000|Overall Study|Withdrawal by Subject|187|||
163046583|NCT02683239|588879312|FG001|Overall Study|Withdrawal by Subject|99|||
163046584|NCT02683239|588879313|FG002|Overall Study|Withdrawal by Subject|91|||
163046585|NCT02683239|588879314|FG003|Overall Study|Withdrawal by Subject|18|||
163046586|NCT02683239|588879315|FG004|Overall Study|Withdrawal by Subject|248|||
163046587|NCT02683239|588879316|FG005|Overall Study|Withdrawal by Subject|22|||
162867785|NCT01663740|588218224|FG001|Overall Study|Withdrawal by Subject|1|||
162867786|NCT01663740|588218223|FG000|Overall Study|No end of study status|3|||
162867787|NCT01663740|588218224|FG001|Overall Study|No end of study status|0|||
162867788|NCT02658656|588218227|FG000|Screening|Failed eligibility criteria|0|||
162867789|NCT02658656|588218228|FG001|Screening|Failed eligibility criteria|0|||
162867790|NCT02658656|588218229|FG002|Screening|Failed eligibility criteria|263|||
162867791|NCT02658656|588218227|FG000|Randomization|Withdrawal by Subject|8|||
162867792|NCT02658656|588218228|FG001|Randomization|Withdrawal by Subject|7|||
162867793|NCT02658656|588218229|FG002|Randomization|Withdrawal by Subject|0|||
162867794|NCT02658656|588218227|FG000|Randomization|Lost to Follow-up|1|||
162867795|NCT02658656|588218228|FG001|Randomization|Lost to Follow-up|3|||
162867796|NCT02658656|588218229|FG002|Randomization|Lost to Follow-up|0|||
162867797|NCT02658656|588218227|FG000|Randomization|Adverse Event|4|||
162867798|NCT02658656|588218228|FG001|Randomization|Adverse Event|0|||
162867799|NCT02658656|588218229|FG002|Randomization|Adverse Event|0|||
162867800|NCT02658656|588218227|FG000|Randomization|Administrative Termination|3|||
162867801|NCT02658656|588218228|FG001|Randomization|Administrative Termination|1|||
162867802|NCT02658656|588218229|FG002|Randomization|Administrative Termination|0|||
162867803|NCT02658656|588218227|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
162959645|NCT04349267|588554741|FG004|Overall Study|Other reason|1|||
162959646|NCT04349267|588554742|FG005|Overall Study|Other reason|1|||
162959647|NCT04349267|588554743|FG006|Overall Study|Other reason|1|||
162959648|NCT04349267|588554737|FG000|Overall Study|Disease Progression|2|||
162959649|NCT04349267|588554738|FG001|Overall Study|Disease Progression|0|||
162959650|NCT04349267|588554739|FG002|Overall Study|Disease Progression|2|||
162959651|NCT04349267|588554740|FG003|Overall Study|Disease Progression|3|||
162959652|NCT04349267|588554741|FG004|Overall Study|Disease Progression|3|||
162959653|NCT04349267|588554742|FG005|Overall Study|Disease Progression|7|||
162959654|NCT04349267|588554743|FG006|Overall Study|Disease Progression|10|||
162959655|NCT04349267|588554737|FG000|Overall Study|Participant withdrew consent|0|||
162959656|NCT04349267|588554738|FG001|Overall Study|Participant withdrew consent|1|||
162959657|NCT04349267|588554739|FG002|Overall Study|Participant withdrew consent|0|||
162959658|NCT04349267|588554740|FG003|Overall Study|Participant withdrew consent|0|||
162959659|NCT04349267|588554741|FG004|Overall Study|Participant withdrew consent|0|||
162959660|NCT04349267|588554742|FG005|Overall Study|Participant withdrew consent|0|||
162959661|NCT04349267|588554743|FG006|Overall Study|Participant withdrew consent|1|||
162959662|NCT04618211|588554744|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
162959663|NCT04618211|588554745|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
162959664|NCT04618211|588554746|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
162959665|NCT04618211|588554744|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
162959666|NCT04618211|588554745|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
162959667|NCT04618211|588554746|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
162959668|NCT04618211|588554744|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
162959669|NCT04618211|588554745|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
162959670|NCT04618211|588554746|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
162959671|NCT01244620|588554749|FG000|Overall Study|Study terminated|4|||
162959672|NCT01244620|588554750|FG001|Overall Study|Study terminated|4|||
162959673|NCT01244620|588554751|FG002|Overall Study|Study terminated|4|||
162959674|NCT01244620|588554752|FG003|Overall Study|Study terminated|4|||
162959675|NCT00466167|588554753|FG000|Overall Study|Adverse Event|8|||
162959676|NCT00466167|588554754|FG001|Overall Study|Adverse Event|8|||
162959677|NCT00466167|588554755|FG002|Overall Study|Adverse Event|7|||
162959678|NCT00466167|588554753|FG000|Overall Study|Lack of Efficacy|2|||
162959679|NCT00466167|588554754|FG001|Overall Study|Lack of Efficacy|0|||
162959680|NCT00466167|588554755|FG002|Overall Study|Lack of Efficacy|3|||
162959681|NCT00466167|588554753|FG000|Overall Study|Protocol Violation|1|||
162959682|NCT00466167|588554754|FG001|Overall Study|Protocol Violation|1|||
162959683|NCT00466167|588554755|FG002|Overall Study|Protocol Violation|2|||
162959684|NCT00466167|588554753|FG000|Overall Study|Lost to Follow-up|3|||
162959685|NCT00466167|588554754|FG001|Overall Study|Lost to Follow-up|2|||
162959686|NCT00466167|588554755|FG002|Overall Study|Lost to Follow-up|2|||
162959687|NCT00466167|588554753|FG000|Overall Study|Withdrawal by Subject|4|||
162959688|NCT00466167|588554754|FG001|Overall Study|Withdrawal by Subject|1|||
162959689|NCT00466167|588554755|FG002|Overall Study|Withdrawal by Subject|6|||
162959690|NCT00466167|588554753|FG000|Overall Study|patient did not meet inclusion criteria|1|||
162959691|NCT00466167|588554754|FG001|Overall Study|patient did not meet inclusion criteria|0|||
162867804|NCT02658656|588218228|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
162959692|NCT00466167|588554755|FG002|Overall Study|patient did not meet inclusion criteria|1|||
162959693|NCT00466167|588554753|FG000|Overall Study|Not treated|1|||
162959694|NCT00466167|588554754|FG001|Overall Study|Not treated|0|||
162959695|NCT00466167|588554755|FG002|Overall Study|Not treated|0|||
162959696|NCT03930732|588554756|FG000|Overall Study|Adverse Event|9|||
162959697|NCT03930732|588554757|FG001|Overall Study|Adverse Event|7|||
162959698|NCT03930732|588554756|FG000|Overall Study|Poor compliance to protocol|0|||
162867805|NCT02658656|588218229|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
162867806|NCT02658656|588218227|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
162867807|NCT02658656|588218228|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
162867808|NCT02658656|588218229|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
162867809|NCT02658656|588218227|FG000|Randomization|Not eligible for Randomization|1|||
162867810|NCT02658656|588218228|FG001|Randomization|Not eligible for Randomization|0|||
162867811|NCT02658656|588218229|FG002|Randomization|Not eligible for Randomization|0|||
162867812|NCT02658656|588218227|FG000|Randomization|Protocol Violation|1|||
162867813|NCT02658656|588218228|FG001|Randomization|Protocol Violation|0|||
162867814|NCT02658656|588218229|FG002|Randomization|Protocol Violation|0|||
162867815|NCT02112448|588218230|FG000|Overall Study|lab values precluding use of ketorolac|2|||
162867816|NCT02112448|588218231|FG001|Overall Study|lab values precluding use of ketorolac|2|||
162867817|NCT02112448|588218230|FG000|Overall Study|Protocol Violation|1|||
162867818|NCT02112448|588218231|FG001|Overall Study|Protocol Violation|2|||
163046588|NCT02683239|588879317|FG006|Overall Study|Withdrawal by Subject|28|||
163046589|NCT02683239|588879311|FG000|Overall Study|Lost to Follow-up|77|||
163046590|NCT02683239|588879312|FG001|Overall Study|Lost to Follow-up|24|||
163046591|NCT02683239|588879313|FG002|Overall Study|Lost to Follow-up|25|||
163046592|NCT02683239|588879314|FG003|Overall Study|Lost to Follow-up|7|||
163046593|NCT02683239|588879315|FG004|Overall Study|Lost to Follow-up|88|||
163046594|NCT02683239|588879316|FG005|Overall Study|Lost to Follow-up|8|||
163046595|NCT02683239|588879317|FG006|Overall Study|Lost to Follow-up|11|||
163046596|NCT02683239|588879311|FG000|Overall Study|Death|9|||
163046597|NCT02683239|588879312|FG001|Overall Study|Death|5|||
163046598|NCT02683239|588879313|FG002|Overall Study|Death|8|||
163046599|NCT02683239|588879314|FG003|Overall Study|Death|0|||
163046600|NCT02683239|588879315|FG004|Overall Study|Death|12|||
163046601|NCT02683239|588879316|FG005|Overall Study|Death|1|||
163046602|NCT02683239|588879317|FG006|Overall Study|Death|0|||
163046603|NCT02683239|588879311|FG000|Overall Study|Lack of Efficacy|50|||
163046604|NCT02683239|588879312|FG001|Overall Study|Lack of Efficacy|23|||
162867819|NCT02112448|588218230|FG000|Overall Study|Physician Decision|4|||
162867820|NCT02112448|588218231|FG001|Overall Study|Physician Decision|6|||
162867821|NCT02112448|588218230|FG000|Overall Study|required heparin so could not use ketoro|1|||
163046605|NCT02683239|588879313|FG002|Overall Study|Lack of Efficacy|12|||
162867822|NCT02112448|588218231|FG001|Overall Study|required heparin so could not use ketoro|0|||
162706186|NCT00480441|587636571|FG002|Randomization|Lost to Follow-up|2|||
162867823|NCT00128206|588219788|FG000|Overall Study|Lost to Follow-up|137|||
162867824|NCT00128206|588219789|FG001|Overall Study|Lost to Follow-up|118|||
162867825|NCT00128206|588219788|FG000|Overall Study|Adverse Event|0|||
162867826|NCT00128206|588219789|FG001|Overall Study|Adverse Event|2|||
162867827|NCT03032068|588219798|FG000|Overall Study|Adverse Event|1|||
162867828|NCT01597622|588219799|FG000|Overall Study|Adverse Event|7|||
162867829|NCT01597622|588219799|FG000|Overall Study|Lack of Efficacy|3|||
162867830|NCT01597622|588219799|FG000|Overall Study|Protocol Violation|1|||
162867831|NCT01597622|588219799|FG000|Overall Study|Lost to Follow-up|1|||
162867832|NCT01597622|588219799|FG000|Overall Study|Investigator Discretion|5|||
162867833|NCT01597622|588219799|FG000|Overall Study|Withdrawal by Subject|20|||
162867834|NCT01597622|588219799|FG000|Overall Study|Death|1|||
162867835|NCT00408421|588219802|FG000|Treatment Initial Randomization|Adverse Event|5|||
162867836|NCT00408421|588219803|FG001|Treatment Initial Randomization|Adverse Event|9|||
162867837|NCT00408421|588219804|FG002|Treatment Initial Randomization|Adverse Event|0|||
162867838|NCT00408421|588219802|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
162867839|NCT00408421|588219803|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
162867840|NCT00408421|588219804|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
162867841|NCT00408421|588219802|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
162867842|NCT00408421|588219803|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
162867843|NCT00408421|588219804|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
162867844|NCT00408421|588219802|FG000|Treatment Initial Randomization|Physician Decision|1|||
162867845|NCT00408421|588219803|FG001|Treatment Initial Randomization|Physician Decision|0|||
162867846|NCT00408421|588219804|FG002|Treatment Initial Randomization|Physician Decision|0|||
162867847|NCT00408421|588219802|FG000|Treatment Initial Randomization|Protocol Violation|0|||
162867848|NCT00408421|588219803|FG001|Treatment Initial Randomization|Protocol Violation|1|||
162867849|NCT00408421|588219804|FG002|Treatment Initial Randomization|Protocol Violation|0|||
162867850|NCT00408421|588219802|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
162867851|NCT00408421|588219803|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
162867852|NCT00408421|588219804|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
162867853|NCT00408421|588219802|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
162867854|NCT00408421|588219803|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
162867855|NCT00408421|588219804|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
163046606|NCT02683239|588879314|FG003|Overall Study|Lack of Efficacy|2|||
163046607|NCT02683239|588879315|FG004|Overall Study|Lack of Efficacy|29|||
163046608|NCT02683239|588879316|FG005|Overall Study|Lack of Efficacy|2|||
163046609|NCT02683239|588879317|FG006|Overall Study|Lack of Efficacy|3|||
162959699|NCT03930732|588554757|FG001|Overall Study|Poor compliance to protocol|1|||
162959700|NCT03930732|588554756|FG000|Overall Study|Withdrawal by Subject|23|||
162959701|NCT03930732|588554757|FG001|Overall Study|Withdrawal by Subject|11|||
162959702|NCT03930732|588554756|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
162959703|NCT03930732|588554757|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
162959704|NCT03930732|588554756|FG000|Overall Study|Other reason not related to COVID-19|5|||
162959705|NCT03930732|588554757|FG001|Overall Study|Other reason not related to COVID-19|8|||
162959706|NCT04128761|588554766|FG000|Overall Study|Lost to Follow-up|5|||
162959707|NCT04128761|588554767|FG001|Overall Study|Lost to Follow-up|6|||
162959708|NCT06539676|588554768|FG000|Overall Study|Early study termination|1|||
162959709|NCT06539676|588554769|FG001|Overall Study|Early study termination|0|||
162959710|NCT06539676|588554770|FG002|Overall Study|Early study termination|6|||
162959711|NCT00909038|588554777|FG000|Overall Study|Protocol Violation|187|||
162959712|NCT00909038|588554777|FG000|Overall Study|Non-evaluable Subjects|230|||
162959713|NCT00207090|588554778|FG000|Overall Study|Study drug toxicity|3|||
162959714|NCT00207090|588554778|FG000|Overall Study|Chest wall mass larger|1|||
162959715|NCT00207090|588554778|FG000|Overall Study|Disease progression/relapse|2|||
162614462|NCT01528215|587305784|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
162614463|NCT01528215|587305785|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
163046610|NCT02683239|588879311|FG000|Overall Study|Missing data|0|||
163046611|NCT02683239|588879312|FG001|Overall Study|Missing data|1|||
163046612|NCT02683239|588879313|FG002|Overall Study|Missing data|1|||
163046613|NCT02683239|588879314|FG003|Overall Study|Missing data|0|||
163046614|NCT02683239|588879315|FG004|Overall Study|Missing data|1|||
163046615|NCT02683239|588879316|FG005|Overall Study|Missing data|0|||
163046616|NCT02683239|588879317|FG006|Overall Study|Missing data|0|||
163046617|NCT00521365|588879320|FG000|Overall Study|Adverse Event|3|||
163046618|NCT00521365|588879320|FG000|Overall Study|Lost to Follow-up|6|||
163046619|NCT00521365|588879320|FG000|Overall Study|Protocol deviation|2|||
163046620|NCT00521365|588879320|FG000|Overall Study|Drug compliance|3|||
163046621|NCT00521365|588879320|FG000|Overall Study|Usage of not allowed drugs|6|||
163046622|NCT00368108|588879321|FG000|Overall Study|Adverse Event|38|||
163046623|NCT00368108|588879322|FG001|Overall Study|Adverse Event|26|||
163046624|NCT00368108|588879323|FG002|Overall Study|Adverse Event|44|||
163046625|NCT00368108|588879321|FG000|Overall Study|Abnormal Laboratory Value|0|||
163046626|NCT00368108|588879322|FG001|Overall Study|Abnormal Laboratory Value|0|||
163046627|NCT00368108|588879323|FG002|Overall Study|Abnormal Laboratory Value|3|||
163046628|NCT00368108|588879321|FG000|Overall Study|Protocol Violation|5|||
163046629|NCT00368108|588879322|FG001|Overall Study|Protocol Violation|9|||
163046630|NCT00368108|588879323|FG002|Overall Study|Protocol Violation|9|||
163046631|NCT00368108|588879321|FG000|Overall Study|Withdrawal by Subject|9|||
163046632|NCT00368108|588879322|FG001|Overall Study|Withdrawal by Subject|3|||
163046633|NCT00368108|588879323|FG002|Overall Study|Withdrawal by Subject|5|||
163046634|NCT00368108|588879321|FG000|Overall Study|Lack of Efficacy|7|||
163046635|NCT00368108|588879322|FG001|Overall Study|Lack of Efficacy|8|||
163046636|NCT00368108|588879323|FG002|Overall Study|Lack of Efficacy|5|||
163046637|NCT00368108|588879321|FG000|Overall Study|Physician Decision|2|||
163046638|NCT00368108|588879322|FG001|Overall Study|Physician Decision|0|||
163046639|NCT00368108|588879323|FG002|Overall Study|Physician Decision|1|||
163046640|NCT00368108|588879321|FG000|Overall Study|Other|3|||
163046641|NCT00368108|588879322|FG001|Overall Study|Other|7|||
163046642|NCT00368108|588879323|FG002|Overall Study|Other|1|||
163046643|NCT01718483|588879324|FG000|Overall Study|Withdrawal by Subject|14|||
163046644|NCT01718483|588879325|FG001|Overall Study|Withdrawal by Subject|12|||
163046645|NCT01718483|588879324|FG000|Overall Study|Adverse Event|5|||
163046646|NCT01718483|588879325|FG001|Overall Study|Adverse Event|12|||
163046647|NCT01718483|588879324|FG000|Overall Study|Lost to Follow-up|8|||
163046648|NCT01718483|588879325|FG001|Overall Study|Lost to Follow-up|3|||
163046649|NCT01718483|588879324|FG000|Overall Study|Protocol Violation|4|||
163046650|NCT01718483|588879325|FG001|Overall Study|Protocol Violation|2|||
163046651|NCT01718483|588879324|FG000|Overall Study|Other|1|||
163046652|NCT01718483|588879325|FG001|Overall Study|Other|4|||
163046653|NCT01718483|588879324|FG000|Overall Study|Pregnancy|1|||
163046654|NCT01718483|588879325|FG001|Overall Study|Pregnancy|1|||
162867856|NCT00408421|588219802|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
162867857|NCT00408421|588219803|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
162867858|NCT00408421|588219804|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
162867859|NCT00408421|588219802|FG000|Treatment Re-Randomization|Adverse Event|2|||
162867860|NCT00408421|588219803|FG001|Treatment Re-Randomization|Adverse Event|2|||
162867861|NCT00408421|588219804|FG002|Treatment Re-Randomization|Adverse Event|4|||
162867862|NCT00408421|588219802|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
162867863|NCT00408421|588219803|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
162867864|NCT00408421|588219804|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
162867865|NCT00408421|588219802|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
162867866|NCT00408421|588219803|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
162867867|NCT00408421|588219804|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
162867868|NCT00408421|588219802|FG000|Treatment Re-Randomization|Physician Decision|1|||
162867869|NCT00408421|588219803|FG001|Treatment Re-Randomization|Physician Decision|3|||
162867870|NCT00408421|588219804|FG002|Treatment Re-Randomization|Physician Decision|0|||
162867871|NCT00408421|588219802|FG000|Treatment Re-Randomization|Protocol Violation|1|||
162867872|NCT00408421|588219803|FG001|Treatment Re-Randomization|Protocol Violation|1|||
162867873|NCT00408421|588219804|FG002|Treatment Re-Randomization|Protocol Violation|0|||
163046655|NCT01718483|588879324|FG000|Overall Study|Lack of Efficacy|1|||
163046656|NCT01718483|588879325|FG001|Overall Study|Lack of Efficacy|0|||
163046657|NCT03442088|588879330|FG000|Overall Study|Adverse Event|1|||
163046658|NCT03442088|588879330|FG000|Overall Study|Lack of Efficacy|2|||
163046659|NCT03442088|588879330|FG000|Overall Study|Lost to Follow-up|2|||
162867874|NCT00408421|588219802|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
163046660|NCT01051557|588879333|FG000|Overall Study|Physician Decision|1|||
163046661|NCT01051557|588879334|FG001|Overall Study|Physician Decision|0|||
163046662|NCT01051557|588879335|FG002|Overall Study|Physician Decision|0|||
163046663|NCT01051557|588879336|FG003|Overall Study|Physician Decision|0|||
163046664|NCT01051557|588879337|FG004|Overall Study|Physician Decision|0|||
163046665|NCT01051557|588879338|FG005|Overall Study|Physician Decision|0|||
163046666|NCT01051557|588879339|FG006|Overall Study|Physician Decision|0|||
163046667|NCT01051557|588879333|FG000|Overall Study|disease progression|3|||
163046668|NCT01051557|588879334|FG001|Overall Study|disease progression|3|||
162867875|NCT00408421|588219803|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
162867876|NCT00408421|588219804|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
162867877|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
162867878|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
162867879|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
162867880|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
162867881|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
162867882|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
162867883|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
162867884|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
162867885|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
162867886|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
162867887|NCT00710034|588219807|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
162867888|NCT00710034|588219808|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
162867889|NCT00710034|588219807|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
162867890|NCT00710034|588219808|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
162867891|NCT00710034|588219807|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
162706187|NCT01417000|587636572|FG000|Overall Study|Death|59|||
162706188|NCT01417000|587636573|FG001|Overall Study|Death|28|||
162867892|NCT00710034|588219808|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
162867893|NCT00710034|588219807|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
162867894|NCT00710034|588219808|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
162959716|NCT00207090|588554778|FG000|Overall Study|Physician Decision|1|||
162959717|NCT03480763|588554783|FG000|Overall Study|Withdrawal by Subject|18|||
162959718|NCT03480763|588554784|FG001|Overall Study|Withdrawal by Subject|10|||
162959719|NCT03480763|588554783|FG000|Overall Study|Lost to Follow-up|4|||
162959720|NCT03480763|588554784|FG001|Overall Study|Lost to Follow-up|7|||
162959721|NCT03480763|588554783|FG000|Overall Study|non-study pneumococcal vaccine|1|||
162959722|NCT03480763|588554784|FG001|Overall Study|non-study pneumococcal vaccine|0|||
162959723|NCT03480763|588554783|FG000|Overall Study|oncological treatment|0|||
162959724|NCT03480763|588554784|FG001|Overall Study|oncological treatment|2|||
162959725|NCT03480763|588554783|FG000|Overall Study|pain with vaccination|1|||
162959726|NCT03480763|588554784|FG001|Overall Study|pain with vaccination|0|||
162959727|NCT01895335|588554785|FG000|Overall Study|Adverse Event|106|||
162959728|NCT01895335|588554785|FG000|Overall Study|Lack of Efficacy|53|||
162959729|NCT01895335|588554785|FG000|Overall Study|Poor Compliance to Protocol|11|||
162959730|NCT01895335|588554785|FG000|Overall Study|Included But Not treated|1|||
162959731|NCT01895335|588554785|FG000|Overall Study|Other than Specified Above|44|||
162959732|NCT01647828|588554786|FG000|Overall Study|Death|3|||
162959733|NCT01647828|588554787|FG001|Overall Study|Death|4|||
162959734|NCT01647828|588554788|FG002|Overall Study|Death|4|||
162959735|NCT01647828|588554789|FG003|Overall Study|Death|5|||
162959736|NCT01647828|588554790|FG004|Overall Study|Death|6|||
162959737|NCT01647828|588554791|FG005|Overall Study|Death|3|||
162959738|NCT01647828|588554792|FG006|Overall Study|Death|10|||
162959739|NCT01647828|588554793|FG007|Overall Study|Death|60|||
162959740|NCT01647828|588554794|FG008|Overall Study|Death|71|||
162959741|NCT01647828|588554786|FG000|Overall Study|Withdrawal by Subject|2|||
162959742|NCT01647828|588554787|FG001|Overall Study|Withdrawal by Subject|0|||
162959743|NCT01647828|588554788|FG002|Overall Study|Withdrawal by Subject|0|||
162959744|NCT01647828|588554789|FG003|Overall Study|Withdrawal by Subject|1|||
162959745|NCT01647828|588554790|FG004|Overall Study|Withdrawal by Subject|0|||
162959746|NCT01647828|588554791|FG005|Overall Study|Withdrawal by Subject|0|||
162959747|NCT01647828|588554792|FG006|Overall Study|Withdrawal by Subject|1|||
162959748|NCT01647828|588554793|FG007|Overall Study|Withdrawal by Subject|0|||
162959749|NCT01647828|588554794|FG008|Overall Study|Withdrawal by Subject|2|||
162959750|NCT01647828|588554786|FG000|Overall Study|Study terminated by Sponsor|0|||
162959751|NCT01647828|588554787|FG001|Overall Study|Study terminated by Sponsor|0|||
162959752|NCT01647828|588554788|FG002|Overall Study|Study terminated by Sponsor|0|||
162959753|NCT01647828|588554789|FG003|Overall Study|Study terminated by Sponsor|0|||
162959754|NCT01647828|588554790|FG004|Overall Study|Study terminated by Sponsor|0|||
162959755|NCT01647828|588554791|FG005|Overall Study|Study terminated by Sponsor|0|||
162959756|NCT01647828|588554792|FG006|Overall Study|Study terminated by Sponsor|1|||
162959757|NCT01647828|588554793|FG007|Overall Study|Study terminated by Sponsor|26|||
162959758|NCT01647828|588554794|FG008|Overall Study|Study terminated by Sponsor|16|||
162959759|NCT01647828|588554786|FG000|Overall Study|Lost to Follow-up|0|||
162959760|NCT01647828|588554787|FG001|Overall Study|Lost to Follow-up|0|||
162959761|NCT01647828|588554788|FG002|Overall Study|Lost to Follow-up|0|||
162959762|NCT01647828|588554789|FG003|Overall Study|Lost to Follow-up|0|||
162959763|NCT01647828|588554790|FG004|Overall Study|Lost to Follow-up|0|||
162959764|NCT01647828|588554791|FG005|Overall Study|Lost to Follow-up|0|||
162959765|NCT01647828|588554792|FG006|Overall Study|Lost to Follow-up|0|||
162959766|NCT01647828|588554793|FG007|Overall Study|Lost to Follow-up|2|||
162959767|NCT01647828|588554794|FG008|Overall Study|Lost to Follow-up|0|||
162706189|NCT01417000|587636572|FG000|Overall Study|Lost to Follow-up|1|||
162867895|NCT00710034|588219807|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
162867896|NCT00710034|588219808|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
162867897|NCT00710034|588219807|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
162867898|NCT00710034|588219808|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
162867899|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
162867900|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
162867901|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
162867902|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
162867903|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Death|8|||
162867904|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Death|3|||
162867905|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
162867906|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
162867907|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
162867908|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
162867909|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
162867910|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
162867911|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
162867912|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
162867913|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
162867914|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
162867915|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
162867916|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
162867917|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
162867918|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
162867919|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
162959768|NCT00115063|588554797|FG000|Overall Study|Lost to Follow-up|98|||
162867920|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
162867921|NCT00494871|588219809|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
162867922|NCT00494871|588219810|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
162867923|NCT00494871|588219809|FG000|Follow-up (FU) Period|Adverse Event|1|||
162867924|NCT00494871|588219810|FG001|Follow-up (FU) Period|Adverse Event|1|||
162867925|NCT00494871|588219809|FG000|Follow-up (FU) Period|Death|13|||
162867926|NCT00494871|588219810|FG001|Follow-up (FU) Period|Death|12|||
162867927|NCT00494871|588219809|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
162867928|NCT00494871|588219810|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
162867929|NCT00494871|588219809|FG000|Follow-up (FU) Period|Physician Decision|0|||
162867930|NCT00494871|588219810|FG001|Follow-up (FU) Period|Physician Decision|1|||
162867931|NCT00494871|588219809|FG000|Follow-up (FU) Period|Protocol Violation|1|||
162867932|NCT00494871|588219810|FG001|Follow-up (FU) Period|Protocol Violation|0|||
162867933|NCT00494871|588219809|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
162867934|NCT00494871|588219810|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
162867935|NCT00494871|588219809|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
162867936|NCT00494871|588219810|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
162867937|NCT03515538|588219823|FG000|Overall Study|Lack of Efficacy|2|||
162867938|NCT03515538|588219824|FG001|Overall Study|Lack of Efficacy|0|||
162867939|NCT03515538|588219825|FG002|Overall Study|Lack of Efficacy|2|||
162867940|NCT03515538|588219826|FG003|Overall Study|Lack of Efficacy|0|||
162867941|NCT03515538|588219823|FG000|Overall Study|Death|0|||
162867942|NCT03515538|588219824|FG001|Overall Study|Death|0|||
162867943|NCT03515538|588219825|FG002|Overall Study|Death|1|||
163046669|NCT01051557|588879335|FG002|Overall Study|disease progression|5|||
163046670|NCT01051557|588879336|FG003|Overall Study|disease progression|2|||
163046671|NCT01051557|588879337|FG004|Overall Study|disease progression|4|||
163046672|NCT01051557|588879338|FG005|Overall Study|disease progression|3|||
163046673|NCT01051557|588879339|FG006|Overall Study|disease progression|1|||
163046674|NCT01051557|588879333|FG000|Overall Study|Withdrawal by Subject|0|||
163046675|NCT01051557|588879334|FG001|Overall Study|Withdrawal by Subject|0|||
163046676|NCT01051557|588879335|FG002|Overall Study|Withdrawal by Subject|1|||
163046677|NCT01051557|588879336|FG003|Overall Study|Withdrawal by Subject|0|||
163046678|NCT01051557|588879337|FG004|Overall Study|Withdrawal by Subject|2|||
163046679|NCT01051557|588879338|FG005|Overall Study|Withdrawal by Subject|0|||
163046680|NCT01051557|588879339|FG006|Overall Study|Withdrawal by Subject|1|||
163046681|NCT01051557|588879333|FG000|Overall Study|Adverse Event|0|||
163046682|NCT01051557|588879334|FG001|Overall Study|Adverse Event|0|||
163046683|NCT01051557|588879335|FG002|Overall Study|Adverse Event|0|||
163046684|NCT01051557|588879336|FG003|Overall Study|Adverse Event|1|||
163046685|NCT01051557|588879337|FG004|Overall Study|Adverse Event|1|||
163046686|NCT01051557|588879338|FG005|Overall Study|Adverse Event|3|||
163046687|NCT01051557|588879339|FG006|Overall Study|Adverse Event|4|||
163046688|NCT00130689|588879340|FG000|Overall Study|Progressive Disease|29|||
163046689|NCT00130689|588879340|FG000|Overall Study|Death|1|||
163046690|NCT00130689|588879340|FG000|Overall Study|Clinical Deterioration|4|||
163046691|NCT00130689|588879340|FG000|Overall Study|Withdrawal by Subject|3|||
163046692|NCT00130689|588879340|FG000|Overall Study|Ineligible|6|||
163046693|NCT00766597|588879341|FG000|Overall Study|Unexpected closure of study|4|||
163046694|NCT00766597|588879341|FG000|Overall Study|Without CCR5-tropic virus|5|||
163046695|NCT00509899|588879342|FG000|Overall Study|Progressive disease|1|||
163046696|NCT00509899|588879343|FG001|Overall Study|Progressive disease|3|||
163046697|NCT00509899|588879344|FG002|Overall Study|Progressive disease|5|||
163046698|NCT00509899|588879345|FG003|Overall Study|Progressive disease|1|||
163046699|NCT00509899|588879346|FG004|Overall Study|Progressive disease|0|||
163046700|NCT00509899|588879347|FG005|Overall Study|Progressive disease|1|||
163046701|NCT00509899|588879348|FG006|Overall Study|Progressive disease|0|||
163046702|NCT00509899|588879349|FG007|Overall Study|Progressive disease|0|||
163046703|NCT00509899|588879342|FG000|Overall Study|Unacceptable Toxicity|1|||
163046704|NCT00509899|588879343|FG001|Overall Study|Unacceptable Toxicity|0|||
163046705|NCT00509899|588879344|FG002|Overall Study|Unacceptable Toxicity|0|||
163046706|NCT00509899|588879345|FG003|Overall Study|Unacceptable Toxicity|2|||
163046707|NCT00509899|588879346|FG004|Overall Study|Unacceptable Toxicity|0|||
163046708|NCT00509899|588879347|FG005|Overall Study|Unacceptable Toxicity|0|||
162867944|NCT03515538|588219826|FG003|Overall Study|Death|0|||
162867945|NCT03515538|588219823|FG000|Overall Study|Protocol Violation|0|||
163046709|NCT00509899|588879348|FG006|Overall Study|Unacceptable Toxicity|0|||
163046710|NCT00509899|588879349|FG007|Overall Study|Unacceptable Toxicity|0|||
163046711|NCT00509899|588879342|FG000|Overall Study|Withdrawal by Subject|6|||
163046712|NCT00509899|588879343|FG001|Overall Study|Withdrawal by Subject|2|||
162867946|NCT03515538|588219824|FG001|Overall Study|Protocol Violation|0|||
162867947|NCT03515538|588219825|FG002|Overall Study|Protocol Violation|0|||
162867948|NCT03515538|588219826|FG003|Overall Study|Protocol Violation|1|||
162867949|NCT03515538|588219823|FG000|Overall Study|Screen failure (baseline dropout)|0|||
162867950|NCT03515538|588219824|FG001|Overall Study|Screen failure (baseline dropout)|1|||
162867951|NCT03515538|588219825|FG002|Overall Study|Screen failure (baseline dropout)|0|||
162867952|NCT03515538|588219826|FG003|Overall Study|Screen failure (baseline dropout)|0|||
162867953|NCT03515538|588219823|FG000|Overall Study|Withdrawal by Subject|2|||
162867954|NCT03515538|588219824|FG001|Overall Study|Withdrawal by Subject|2|||
162867955|NCT03515538|588219825|FG002|Overall Study|Withdrawal by Subject|1|||
162867956|NCT03515538|588219826|FG003|Overall Study|Withdrawal by Subject|3|||
162867957|NCT03515538|588219823|FG000|Overall Study|Physician Decision|1|||
162867958|NCT03515538|588219824|FG001|Overall Study|Physician Decision|0|||
162867959|NCT03515538|588219825|FG002|Overall Study|Physician Decision|0|||
162867960|NCT03515538|588219826|FG003|Overall Study|Physician Decision|1|||
162867961|NCT03088605|588219827|FG000|Overall Study|Withdrawal by Subject|1|||
162867962|NCT03088605|588219828|FG001|Overall Study|Withdrawal by Subject|0|||
162867963|NCT02639182|588219829|FG000|Overall Study|Disease Progression|50|||
162867964|NCT02639182|588219830|FG001|Overall Study|Disease Progression|49|||
162867965|NCT02639182|588219829|FG000|Overall Study|Adverse Event|7|||
162867966|NCT02639182|588219830|FG001|Overall Study|Adverse Event|5|||
162867967|NCT02639182|588219829|FG000|Overall Study|Physician Decision|3|||
162867968|NCT02639182|588219830|FG001|Overall Study|Physician Decision|3|||
162867969|NCT02639182|588219829|FG000|Overall Study|Withdrew Consent|5|||
162867970|NCT02639182|588219830|FG001|Overall Study|Withdrew Consent|4|||
162867971|NCT02639182|588219829|FG000|Overall Study|Lost to Follow-up|0|||
162867972|NCT02639182|588219830|FG001|Overall Study|Lost to Follow-up|1|||
162867973|NCT02639182|588219829|FG000|Overall Study|Study Closure|1|||
162867974|NCT02639182|588219830|FG001|Overall Study|Study Closure|2|||
162867975|NCT02639182|588219829|FG000|Overall Study|Sponsor Ended Study|0|||
162867976|NCT02639182|588219830|FG001|Overall Study|Sponsor Ended Study|1|||
162867977|NCT02639182|588219829|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
162867978|NCT02639182|588219830|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
162867979|NCT02546856|588219831|FG000|4 Months Evaluation|Death|2|||
162867980|NCT02546856|588219832|FG001|4 Months Evaluation|Death|3|||
162867981|NCT02546856|588219831|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
162867982|NCT02546856|588219832|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
162867983|NCT02546856|588219831|FG000|4 Months Evaluation|Lost to Follow-up|3|||
162867984|NCT02546856|588219832|FG001|4 Months Evaluation|Lost to Follow-up|3|||
162867985|NCT02546856|588219831|FG000|4 Months Evaluation|Physician Decision|3|||
162867986|NCT02546856|588219832|FG001|4 Months Evaluation|Physician Decision|0|||
162867987|NCT02546856|588219831|FG000|4 Months Evaluation|Working or living abroad|5|||
162867988|NCT02546856|588219832|FG001|4 Months Evaluation|Working or living abroad|1|||
162867989|NCT02546856|588219831|FG000|4 Months Evaluation|reasons not due to titration|4|||
162867990|NCT02546856|588219832|FG001|4 Months Evaluation|reasons not due to titration|1|||
162867991|NCT02546856|588219831|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
162867992|NCT02546856|588219832|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
162867993|NCT02546856|588219831|FG000|6 Months Evaluation|Death|1|||
162867994|NCT02546856|588219832|FG001|6 Months Evaluation|Death|1|||
162867995|NCT02546856|588219831|FG000|6 Months Evaluation|Lost to Follow-up|1|||
162867996|NCT02546856|588219832|FG001|6 Months Evaluation|Lost to Follow-up|1|||
162867997|NCT02546856|588219831|FG000|6 Months Evaluation|Working or living abroad|6|||
162867998|NCT02546856|588219832|FG001|6 Months Evaluation|Working or living abroad|4|||
162867999|NCT02546856|588219831|FG000|6 Months Evaluation|reasons not due to titration|0|||
162868000|NCT02546856|588219832|FG001|6 Months Evaluation|reasons not due to titration|1|||
162868001|NCT04655586|588219837|FG000|Overall Study|Physician Decision|1|||
162868002|NCT04655586|588219838|FG001|Overall Study|Physician Decision|3|||
162868003|NCT04655586|588219839|FG002|Overall Study|Physician Decision|4|||
162868004|NCT04655586|588219837|FG000|Overall Study|Withdrawal by Subject|1|||
162959769|NCT00115063|588554798|FG001|Overall Study|Lost to Follow-up|104|||
162959770|NCT00115063|588554797|FG000|Overall Study|Death|1|||
162959771|NCT00115063|588554798|FG001|Overall Study|Death|0|||
162959772|NCT00185458|588554803|FG000|Contraception Phase|Adverse Event|37|||
162959773|NCT00185458|588554803|FG000|Contraception Phase|Lost to Follow-up|10|||
162959774|NCT00185458|588554803|FG000|Contraception Phase|Protocol Violation|2|||
162959775|NCT00185458|588554803|FG000|Contraception Phase|Physician Decision|2|||
162959776|NCT00185458|588554803|FG000|Contraception Phase|Withdrawal by Subject|7|||
162959777|NCT00185458|588554803|FG000|HRT Phase|Adverse Event|18|||
162868005|NCT04655586|588219838|FG001|Overall Study|Withdrawal by Subject|3|||
162868006|NCT04655586|588219839|FG002|Overall Study|Withdrawal by Subject|1|||
162959778|NCT00185458|588554803|FG000|HRT Phase|Lost to Follow-up|4|||
162959779|NCT00185458|588554803|FG000|HRT Phase|Protocol Violation|2|||
162868007|NCT03268746|588219841|FG000|Overall Study|Withdrawal by Subject|1|||
162868008|NCT01372878|588219842|FG000|Overall Study|Withdrawal by Subject|63|||
162868009|NCT01372878|588219842|FG000|Overall Study|Protocol Violation|17|||
162868010|NCT01372878|588219842|FG000|Overall Study|incomplete study procedure|104|||
162868011|NCT00546351|588219843|FG000|Overall Study|Adverse Event|76|||
162868012|NCT00546351|588219843|FG000|Overall Study|Lack of Efficacy|15|||
162868013|NCT00546351|588219843|FG000|Overall Study|Withdrawal by Subject|109|||
162868014|NCT00546351|588219843|FG000|Overall Study|Lost to Follow-up|9|||
162868015|NCT00546351|588219843|FG000|Overall Study|Protocol Deviation|1|||
162868016|NCT00546351|588219843|FG000|Overall Study|Unsatisfactory compliance|9|||
162868017|NCT00546351|588219843|FG000|Overall Study|Other reasons for premature termination|17|||
162868018|NCT04734873|588219845|FG000|Overall Study|Lost to Follow-up|1|||
162868019|NCT04734873|588219846|FG001|Overall Study|Lost to Follow-up|3|||
162868020|NCT04734873|588219847|FG002|Overall Study|Lost to Follow-up|2|||
162868021|NCT04734873|588219845|FG000|Overall Study|Randomized but not dosed|1|||
162868022|NCT04734873|588219846|FG001|Overall Study|Randomized but not dosed|0|||
162868023|NCT04734873|588219847|FG002|Overall Study|Randomized but not dosed|1|||
162868024|NCT02616029|588219851|FG000|Overall Study|Adverse Event|1|||
162868025|NCT02616029|588219852|FG001|Overall Study|Adverse Event|0|||
162868026|NCT02616029|588219851|FG000|Overall Study|Death|0|||
162868027|NCT02616029|588219852|FG001|Overall Study|Death|1|||
162868028|NCT02616029|588219851|FG000|Overall Study|Protocol Violation|1|||
162868029|NCT02616029|588219852|FG001|Overall Study|Protocol Violation|0|||
162868030|NCT02616029|588219851|FG000|Overall Study|Withdrew Consent|1|||
162868031|NCT02616029|588219852|FG001|Overall Study|Withdrew Consent|0|||
162868032|NCT02616029|588219851|FG000|Overall Study|Enrolled and Never Treated|1|||
162868033|NCT02616029|588219852|FG001|Overall Study|Enrolled and Never Treated|1|||
162868034|NCT00609609|588219853|FG000|Overall Study|Withdrawal by Subject|2|||
162868035|NCT00609609|588219854|FG001|Overall Study|Withdrawal by Subject|0|||
162868036|NCT00609609|588219853|FG000|Overall Study|Progression|4|||
162868037|NCT00609609|588219854|FG001|Overall Study|Progression|2|||
162868038|NCT03065530|588219855|FG000|Overall Study|Lack of Efficacy|1|||
162868039|NCT03065530|588219856|FG001|Overall Study|Lack of Efficacy|1|||
162706190|NCT01417000|587636573|FG001|Overall Study|Lost to Follow-up|0|||
162868040|NCT03065530|588219857|FG002|Overall Study|Lack of Efficacy|0|||
162868041|NCT03065530|588219858|FG003|Overall Study|Lack of Efficacy|1|||
162868042|NCT03065530|588219855|FG000|Overall Study|Protocol Violation|1|||
162868043|NCT03065530|588219856|FG001|Overall Study|Protocol Violation|0|||
162868044|NCT03065530|588219857|FG002|Overall Study|Protocol Violation|1|||
162868045|NCT03065530|588219858|FG003|Overall Study|Protocol Violation|1|||
162868046|NCT00479466|588219861|FG000|Overall Study|Adverse Event|5|||
162868047|NCT00479466|588219862|FG001|Overall Study|Adverse Event|1|||
162868048|NCT00479466|588219863|FG002|Overall Study|Adverse Event|0|||
162868049|NCT00479466|588219864|FG003|Overall Study|Adverse Event|1|||
162868050|NCT00479466|588219865|FG004|Overall Study|Adverse Event|2|||
162868051|NCT00479466|588219866|FG005|Overall Study|Adverse Event|0|||
162868052|NCT00479466|588219861|FG000|Overall Study|Hyperglycemia|0|||
162868053|NCT00479466|588219862|FG001|Overall Study|Hyperglycemia|0|||
162868054|NCT00479466|588219863|FG002|Overall Study|Hyperglycemia|0|||
162868055|NCT00479466|588219864|FG003|Overall Study|Hyperglycemia|0|||
162868056|NCT00479466|588219865|FG004|Overall Study|Hyperglycemia|0|||
162868057|NCT00479466|588219866|FG005|Overall Study|Hyperglycemia|1|||
162868058|NCT00479466|588219861|FG000|Overall Study|Lack of Efficacy|2|||
162868059|NCT00479466|588219862|FG001|Overall Study|Lack of Efficacy|0|||
162868060|NCT00479466|588219863|FG002|Overall Study|Lack of Efficacy|1|||
162868061|NCT00479466|588219864|FG003|Overall Study|Lack of Efficacy|0|||
162868062|NCT00479466|588219865|FG004|Overall Study|Lack of Efficacy|0|||
162959780|NCT00185458|588554803|FG000|HRT Phase|Withdrawal by Subject|3|||
162959781|NCT00830024|588554804|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162959782|NCT00830024|588554805|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
162959783|NCT02554890|588554806|FG000|Double-blind|Adverse Event|45|||
162959784|NCT02554890|588554807|FG001|Double-blind|Adverse Event|51|||
162959785|NCT02554890|588554806|FG000|Double-blind|Death|6|||
162959786|NCT02554890|588554807|FG001|Double-blind|Death|4|||
162959787|NCT02554890|588554806|FG000|Double-blind|Protocol Violation|1|||
162959788|NCT02554890|588554807|FG001|Double-blind|Protocol Violation|1|||
162959789|NCT02554890|588554806|FG000|Double-blind|Physician Decision|4|||
162959790|NCT02554890|588554807|FG001|Double-blind|Physician Decision|3|||
162959791|NCT02554890|588554806|FG000|Double-blind|Subject/Guardian decision|21|||
162959792|NCT02554890|588554807|FG001|Double-blind|Subject/Guardian decision|16|||
162959793|NCT02554890|588554806|FG000|Double-blind|Lost to Follow-up|7|||
162868063|NCT00479466|588219866|FG005|Overall Study|Lack of Efficacy|0|||
162868064|NCT00479466|588219861|FG000|Overall Study|Lost to Follow-up|0|||
162868065|NCT00479466|588219862|FG001|Overall Study|Lost to Follow-up|1|||
162868066|NCT00479466|588219863|FG002|Overall Study|Lost to Follow-up|1|||
162868067|NCT00479466|588219864|FG003|Overall Study|Lost to Follow-up|0|||
162868068|NCT00479466|588219865|FG004|Overall Study|Lost to Follow-up|2|||
162959794|NCT02554890|588554807|FG001|Double-blind|Lost to Follow-up|5|||
162868069|NCT00479466|588219866|FG005|Overall Study|Lost to Follow-up|2|||
162868070|NCT00479466|588219861|FG000|Overall Study|Physician Decision|2|||
162959795|NCT02554890|588554806|FG000|Double-blind|Technical problems|1|||
162959796|NCT02554890|588554807|FG001|Double-blind|Technical problems|0|||
162868071|NCT00479466|588219862|FG001|Overall Study|Physician Decision|1|||
162868072|NCT00479466|588219863|FG002|Overall Study|Physician Decision|1|||
162868073|NCT00479466|588219864|FG003|Overall Study|Physician Decision|0|||
162868074|NCT00479466|588219865|FG004|Overall Study|Physician Decision|0|||
163046713|NCT00509899|588879344|FG002|Overall Study|Withdrawal by Subject|3|||
163046714|NCT00509899|588879345|FG003|Overall Study|Withdrawal by Subject|0|||
163046715|NCT00509899|588879346|FG004|Overall Study|Withdrawal by Subject|3|||
163046716|NCT00509899|588879347|FG005|Overall Study|Withdrawal by Subject|2|||
163046717|NCT00509899|588879348|FG006|Overall Study|Withdrawal by Subject|0|||
163046718|NCT00509899|588879349|FG007|Overall Study|Withdrawal by Subject|0|||
163046719|NCT00509899|588879342|FG000|Overall Study|Physician Decision|4|||
163046720|NCT00509899|588879343|FG001|Overall Study|Physician Decision|2|||
163046721|NCT00509899|588879344|FG002|Overall Study|Physician Decision|7|||
163046722|NCT00509899|588879345|FG003|Overall Study|Physician Decision|0|||
163046723|NCT00509899|588879346|FG004|Overall Study|Physician Decision|1|||
163046724|NCT00509899|588879347|FG005|Overall Study|Physician Decision|4|||
163046725|NCT00509899|588879348|FG006|Overall Study|Physician Decision|0|||
163046726|NCT00509899|588879349|FG007|Overall Study|Physician Decision|0|||
163046727|NCT00509899|588879342|FG000|Overall Study|Intercurrent Illness|1|||
163046728|NCT00509899|588879343|FG001|Overall Study|Intercurrent Illness|0|||
163046729|NCT00509899|588879344|FG002|Overall Study|Intercurrent Illness|0|||
163046730|NCT00509899|588879345|FG003|Overall Study|Intercurrent Illness|1|||
163046731|NCT00509899|588879346|FG004|Overall Study|Intercurrent Illness|0|||
163046732|NCT00509899|588879347|FG005|Overall Study|Intercurrent Illness|1|||
163046733|NCT00509899|588879348|FG006|Overall Study|Intercurrent Illness|0|||
162706191|NCT01417000|587636572|FG000|Overall Study|Study Terminated by Sponsor|1|||
162706192|NCT01417000|587636573|FG001|Overall Study|Study Terminated by Sponsor|1|||
162706193|NCT01657682|587636574|FG000|Overall Study|Lost to Follow-up|1|||
162706194|NCT01657682|587636575|FG001|Overall Study|Lost to Follow-up|0|||
162706195|NCT01657682|587636576|FG002|Overall Study|Lost to Follow-up|0|||
162706196|NCT01657682|587636574|FG000|Overall Study|Withdrawal by Subject|0|||
163046734|NCT00509899|588879349|FG007|Overall Study|Intercurrent Illness|0|||
163046735|NCT00509899|588879342|FG000|Overall Study|Death|2|||
163046736|NCT00509899|588879343|FG001|Overall Study|Death|2|||
163046737|NCT00509899|588879344|FG002|Overall Study|Death|3|||
163046738|NCT00509899|588879345|FG003|Overall Study|Death|0|||
163046739|NCT00509899|588879346|FG004|Overall Study|Death|1|||
163046740|NCT00509899|588879347|FG005|Overall Study|Death|1|||
163046741|NCT00509899|588879348|FG006|Overall Study|Death|1|||
163046742|NCT00509899|588879349|FG007|Overall Study|Death|1|||
163046743|NCT00509899|588879342|FG000|Overall Study|Lack of Efficacy|1|||
163046744|NCT00509899|588879343|FG001|Overall Study|Lack of Efficacy|0|||
163046745|NCT00509899|588879344|FG002|Overall Study|Lack of Efficacy|2|||
163046746|NCT00509899|588879345|FG003|Overall Study|Lack of Efficacy|0|||
163046747|NCT00509899|588879346|FG004|Overall Study|Lack of Efficacy|0|||
163046748|NCT00509899|588879347|FG005|Overall Study|Lack of Efficacy|1|||
163046749|NCT00509899|588879348|FG006|Overall Study|Lack of Efficacy|0|||
163046750|NCT00509899|588879349|FG007|Overall Study|Lack of Efficacy|0|||
163046751|NCT01254656|588879350|FG000|Overall Study|Discontinued due to termination of study|40|||
163046752|NCT01254656|588879351|FG001|Overall Study|Discontinued due to termination of study|39|||
163046753|NCT01254656|588879352|FG002|Overall Study|Discontinued due to termination of study|13|||
163046754|NCT01254656|588879350|FG000|Overall Study|Lack of Efficacy|3|||
163046755|NCT01254656|588879351|FG001|Overall Study|Lack of Efficacy|0|||
163046756|NCT01254656|588879352|FG002|Overall Study|Lack of Efficacy|0|||
162614464|NCT01528215|587305784|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
163046757|NCT01254656|588879350|FG000|Overall Study|Lost to Follow-up|1|||
163046758|NCT01254656|588879351|FG001|Overall Study|Lost to Follow-up|0|||
163046759|NCT01254656|588879352|FG002|Overall Study|Lost to Follow-up|2|||
163046760|NCT01254656|588879350|FG000|Overall Study|Withdrawal by Subject|2|||
163046761|NCT01254656|588879351|FG001|Overall Study|Withdrawal by Subject|2|||
163046762|NCT01254656|588879352|FG002|Overall Study|Withdrawal by Subject|1|||
163046763|NCT01254656|588879350|FG000|Overall Study|Pregnancy|0|||
162614465|NCT01528215|587305785|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
162614466|NCT01528215|587305784|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
162614467|NCT01528215|587305785|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
162614468|NCT02337738|587305786|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
162614469|NCT02337738|587305787|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
162614470|NCT02337738|587305788|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
162614471|NCT02337738|587305786|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162614472|NCT02337738|587305787|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
162614473|NCT02337738|587305788|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
162706197|NCT01657682|587636575|FG001|Overall Study|Withdrawal by Subject|1|||
163046764|NCT01254656|588879351|FG001|Overall Study|Pregnancy|0|||
163046765|NCT01254656|588879352|FG002|Overall Study|Pregnancy|2|||
163046766|NCT01254656|588879350|FG000|Overall Study|Adverse Event|1|||
163046767|NCT01254656|588879351|FG001|Overall Study|Adverse Event|1|||
163046768|NCT01254656|588879352|FG002|Overall Study|Adverse Event|0|||
163046769|NCT01254656|588879350|FG000|Overall Study|Death|0|||
163046770|NCT01254656|588879351|FG001|Overall Study|Death|1|||
163046771|NCT01254656|588879352|FG002|Overall Study|Death|0|||
163046772|NCT02948829|588879353|FG000|Overall Study|Lost to Follow-up|2|||
162614474|NCT02337738|587305786|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
162614475|NCT02337738|587305787|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
162614476|NCT02337738|587305788|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
162614477|NCT02337738|587305786|FG000|Overall Study|Voluntary Withdrawal|10|||
163046773|NCT02948829|588879353|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
163046774|NCT02948829|588879353|FG000|Overall Study|Pregnancy|1|||
163046775|NCT02948829|588879353|FG000|Overall Study|Other: Reason not Specified|8|||
163046776|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046777|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
162614478|NCT02337738|587305787|FG001|Overall Study|Voluntary Withdrawal|5|||
162614479|NCT02337738|587305788|FG002|Overall Study|Voluntary Withdrawal|2|||
162614480|NCT02337738|587305786|FG000|Overall Study|Lack of Efficacy|2|||
162614481|NCT02337738|587305787|FG001|Overall Study|Lack of Efficacy|4|||
162614482|NCT02337738|587305788|FG002|Overall Study|Lack of Efficacy|0|||
162614483|NCT02337738|587305786|FG000|Overall Study|Investigator's Judgment|1|||
162614484|NCT02337738|587305787|FG001|Overall Study|Investigator's Judgment|1|||
162614485|NCT02337738|587305788|FG002|Overall Study|Investigator's Judgment|3|||
162614486|NCT02322021|587305789|FG000|Core Phase|Adverse Event|1|||
162614487|NCT02322021|587305790|FG001|Core Phase|Adverse Event|3|||
162614488|NCT02322021|587305791|FG002|Core Phase|Adverse Event|4|||
162614489|NCT02322021|587305792|FG003|Core Phase|Adverse Event|2|||
162614490|NCT02322021|587305793|FG004|Core Phase|Adverse Event|0|||
162614491|NCT02322021|587305789|FG000|Core Phase|Participant Choice|4|||
162614492|NCT02322021|587305790|FG001|Core Phase|Participant Choice|5|||
162614493|NCT02322021|587305791|FG002|Core Phase|Participant Choice|4|||
162614494|NCT02322021|587305792|FG003|Core Phase|Participant Choice|2|||
162614495|NCT02322021|587305793|FG004|Core Phase|Participant Choice|0|||
162614496|NCT02322021|587305789|FG000|Core Phase|Lost to Follow-up|0|||
162614497|NCT02322021|587305790|FG001|Core Phase|Lost to Follow-up|0|||
162614498|NCT02322021|587305791|FG002|Core Phase|Lost to Follow-up|0|||
162614499|NCT02322021|587305792|FG003|Core Phase|Lost to Follow-up|1|||
162614500|NCT02322021|587305793|FG004|Core Phase|Lost to Follow-up|0|||
162614501|NCT02322021|587305789|FG000|Core Phase|Other|0|||
162614502|NCT02322021|587305790|FG001|Core Phase|Other|0|||
162614503|NCT02322021|587305791|FG002|Core Phase|Other|1|||
162614504|NCT02322021|587305792|FG003|Core Phase|Other|0|||
162614505|NCT02322021|587305793|FG004|Core Phase|Other|0|||
162614506|NCT02322021|587305789|FG000|Extension Phase|Adverse Event|0|||
162614507|NCT02322021|587305790|FG001|Extension Phase|Adverse Event|0|||
162614508|NCT02322021|587305791|FG002|Extension Phase|Adverse Event|0|||
162614509|NCT02322021|587305792|FG003|Extension Phase|Adverse Event|0|||
162614510|NCT02322021|587305793|FG004|Extension Phase|Adverse Event|3|||
162614511|NCT02322021|587305789|FG000|Extension Phase|Participant Choice|0|||
162614512|NCT02322021|587305790|FG001|Extension Phase|Participant Choice|0|||
162614513|NCT02322021|587305791|FG002|Extension Phase|Participant Choice|0|||
162614514|NCT02322021|587305792|FG003|Extension Phase|Participant Choice|0|||
162614515|NCT02322021|587305793|FG004|Extension Phase|Participant Choice|6|||
162614516|NCT02322021|587305789|FG000|Extension Phase|Other|0|||
162614517|NCT02322021|587305790|FG001|Extension Phase|Other|0|||
162614518|NCT02322021|587305791|FG002|Extension Phase|Other|0|||
162614519|NCT02322021|587305792|FG003|Extension Phase|Other|0|||
162614520|NCT02322021|587305793|FG004|Extension Phase|Other|3|||
162614521|NCT02322021|587305789|FG000|Extension Phase|Lost to Follow-up|0|||
162614522|NCT02322021|587305790|FG001|Extension Phase|Lost to Follow-up|0|||
162614523|NCT02322021|587305791|FG002|Extension Phase|Lost to Follow-up|0|||
162614524|NCT02322021|587305792|FG003|Extension Phase|Lost to Follow-up|0|||
162614525|NCT02322021|587305793|FG004|Extension Phase|Lost to Follow-up|1|||
162614526|NCT02322021|587305789|FG000|Extension Phase|Study terminated by sponsor|0|||
162614527|NCT02322021|587305790|FG001|Extension Phase|Study terminated by sponsor|0|||
162614528|NCT02322021|587305791|FG002|Extension Phase|Study terminated by sponsor|0|||
162614529|NCT02322021|587305792|FG003|Extension Phase|Study terminated by sponsor|0|||
162614530|NCT02322021|587305793|FG004|Extension Phase|Study terminated by sponsor|28|||
162614531|NCT01934972|587305794|FG000|Overall Study|Withdrawal by Subject|9|||
162614532|NCT01934972|587305795|FG001|Overall Study|Withdrawal by Subject|6|||
162614533|NCT01278160|587305796|FG000|Overall Study|Adverse Event|1|||
162614534|NCT01278160|587305797|FG001|Overall Study|Adverse Event|1|||
162614535|NCT01278160|587305796|FG000|Overall Study|Lost to Follow-up|0|||
162614536|NCT01278160|587305797|FG001|Overall Study|Lost to Follow-up|1|||
162614537|NCT01278160|587305796|FG000|Overall Study|Withdrawal by Subject|3|||
162614538|NCT01278160|587305797|FG001|Overall Study|Withdrawal by Subject|2|||
162614539|NCT01278160|587305796|FG000|Overall Study|Unclassified|1|||
162614540|NCT01278160|587305797|FG001|Overall Study|Unclassified|2|||
162614541|NCT02979197|587305798|FG000|Overall Study|Adverse Event|4|||
162614542|NCT02979197|587305799|FG001|Overall Study|Adverse Event|2|||
162614543|NCT02979197|587305800|FG002|Overall Study|Adverse Event|0|||
162614544|NCT02979197|587305798|FG000|Overall Study|Protocol Violation|0|||
162614545|NCT02979197|587305799|FG001|Overall Study|Protocol Violation|1|||
162614546|NCT02979197|587305800|FG002|Overall Study|Protocol Violation|0|||
162614547|NCT02979197|587305798|FG000|Overall Study|Subject unable to commit to study dates|0|||
162868075|NCT00479466|588219866|FG005|Overall Study|Physician Decision|0|||
162868076|NCT00479466|588219861|FG000|Overall Study|Pregnancy|0|||
162868077|NCT00479466|588219862|FG001|Overall Study|Pregnancy|0|||
162868078|NCT00479466|588219863|FG002|Overall Study|Pregnancy|0|||
162868079|NCT00479466|588219864|FG003|Overall Study|Pregnancy|0|||
162868080|NCT00479466|588219865|FG004|Overall Study|Pregnancy|1|||
162868081|NCT00479466|588219866|FG005|Overall Study|Pregnancy|0|||
162868082|NCT00479466|588219861|FG000|Overall Study|Protocol Violation|1|||
162868083|NCT00479466|588219862|FG001|Overall Study|Protocol Violation|0|||
162868084|NCT00479466|588219863|FG002|Overall Study|Protocol Violation|0|||
162868085|NCT00479466|588219864|FG003|Overall Study|Protocol Violation|0|||
162868086|NCT00479466|588219865|FG004|Overall Study|Protocol Violation|0|||
162868087|NCT00479466|588219866|FG005|Overall Study|Protocol Violation|0|||
162868088|NCT00479466|588219861|FG000|Overall Study|Withdrawal by Subject|3|||
162868089|NCT00479466|588219862|FG001|Overall Study|Withdrawal by Subject|5|||
162868090|NCT00479466|588219863|FG002|Overall Study|Withdrawal by Subject|0|||
162868091|NCT00479466|588219864|FG003|Overall Study|Withdrawal by Subject|2|||
162868092|NCT00479466|588219865|FG004|Overall Study|Withdrawal by Subject|3|||
162868093|NCT00479466|588219866|FG005|Overall Study|Withdrawal by Subject|1|||
162868094|NCT01469013|588219877|FG000|Part A (Treatment Period)|Adverse Event|1|||
162868095|NCT01469013|588219878|FG001|Part A (Treatment Period)|Adverse Event|0|||
162868096|NCT01469013|588219879|FG002|Part A (Treatment Period)|Adverse Event|0|||
162868097|NCT01469013|588219880|FG003|Part A (Treatment Period)|Adverse Event|0|||
162868098|NCT01469013|588219881|FG004|Part A (Treatment Period)|Adverse Event|1|||
162868099|NCT01469013|588219882|FG005|Part A (Treatment Period)|Adverse Event|0|||
162868100|NCT01469013|588219883|FG006|Part A (Treatment Period)|Adverse Event|0|||
162868101|NCT01469013|588219884|FG007|Part A (Treatment Period)|Adverse Event|0|||
162868102|NCT01469013|588219885|FG008|Part A (Treatment Period)|Adverse Event|0|||
162868103|NCT01469013|588219886|FG009|Part A (Treatment Period)|Adverse Event|0|||
162868104|NCT01469013|588219887|FG010|Part A (Treatment Period)|Adverse Event|0|||
162868105|NCT01469013|588219888|FG011|Part A (Treatment Period)|Adverse Event|0|||
162868106|NCT01469013|588219889|FG012|Part A (Treatment Period)|Adverse Event|0|||
162868107|NCT01469013|588219877|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868108|NCT01469013|588219878|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868109|NCT01469013|588219879|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
162868110|NCT01469013|588219880|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868111|NCT01469013|588219881|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868112|NCT01469013|588219882|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868113|NCT01469013|588219883|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868114|NCT01469013|588219884|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868115|NCT01469013|588219885|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868116|NCT01469013|588219886|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868117|NCT01469013|588219887|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868118|NCT01469013|588219888|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868119|NCT01469013|588219889|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
162868120|NCT01469013|588219877|FG000|Part B (Extension Period)|Adverse Event|0|||
162868121|NCT01469013|588219878|FG001|Part B (Extension Period)|Adverse Event|0|||
162868122|NCT01469013|588219879|FG002|Part B (Extension Period)|Adverse Event|0|||
162868123|NCT01469013|588219880|FG003|Part B (Extension Period)|Adverse Event|0|||
162868124|NCT01469013|588219881|FG004|Part B (Extension Period)|Adverse Event|0|||
162868125|NCT01469013|588219882|FG005|Part B (Extension Period)|Adverse Event|2|||
162868126|NCT01469013|588219883|FG006|Part B (Extension Period)|Adverse Event|5|||
162868127|NCT01469013|588219884|FG007|Part B (Extension Period)|Adverse Event|5|||
162868128|NCT01469013|588219885|FG008|Part B (Extension Period)|Adverse Event|3|||
162868129|NCT01469013|588219886|FG009|Part B (Extension Period)|Adverse Event|3|||
162868130|NCT01469013|588219887|FG010|Part B (Extension Period)|Adverse Event|1|||
162868131|NCT01469013|588219888|FG011|Part B (Extension Period)|Adverse Event|6|||
162868132|NCT01469013|588219889|FG012|Part B (Extension Period)|Adverse Event|3|||
162868133|NCT01469013|588219877|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
162868134|NCT01469013|588219878|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
162868135|NCT01469013|588219879|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
162868136|NCT01469013|588219880|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
162868137|NCT01469013|588219881|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
162868138|NCT01469013|588219882|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
162868139|NCT01469013|588219883|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
162868140|NCT01469013|588219884|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
162868141|NCT01469013|588219885|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
162868142|NCT01469013|588219886|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
162868143|NCT01469013|588219887|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
162868144|NCT01469013|588219888|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
162868145|NCT01469013|588219889|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
162868146|NCT05232097|588219890|FG000|Overall Study|Physician Decision|1|||
162868147|NCT00425438|588219893|FG000|Overall Study|Termination by Sponsor|25|||
162868148|NCT00425438|588219894|FG001|Overall Study|Termination by Sponsor|27|||
162868149|NCT01172288|588219895|FG000|Overall Study|Adverse Event|1|||
162868150|NCT01172288|588219896|FG001|Overall Study|Adverse Event|0|||
162868151|NCT01172288|588219895|FG000|Overall Study|Protocol Violation|0|||
162868152|NCT01172288|588219896|FG001|Overall Study|Protocol Violation|1|||
162868153|NCT01327339|588219897|FG000|Overall Study|Protocol Violation|8|||
162868154|NCT02902809|588219900|FG000|Overall Study|Discontinuation of asthma program|28|||
162868155|NCT00532259|588219901|FG000|Overall Study|Withdrawal by Subject|2|||
162868156|NCT00532259|588219901|FG000|Overall Study|Adverse Event|1|||
162868157|NCT00532259|588219901|FG000|Overall Study|Death|1|||
162868158|NCT00532259|588219901|FG000|Overall Study|Lack of Efficacy|21|||
162868159|NCT00532259|588219901|FG000|Overall Study|Lost to Follow-up|3|||
162868160|NCT00532259|588219901|FG000|Overall Study|Physician Decision|3|||
162868161|NCT00532259|588219901|FG000|Overall Study|Protocol Violation|1|||
162868162|NCT00871858|588219902|FG000|Overall Study|Protocol Violation|3|||
162868163|NCT00871858|588219903|FG001|Overall Study|Protocol Violation|4|||
162868164|NCT00871858|588219902|FG000|Overall Study|Adverse Event|1|||
162868165|NCT00871858|588219903|FG001|Overall Study|Adverse Event|1|||
162868166|NCT00871858|588219902|FG000|Overall Study|Withdrawal by Subject|1|||
162868167|NCT00871858|588219903|FG001|Overall Study|Withdrawal by Subject|1|||
162868168|NCT00871858|588219902|FG000|Overall Study|Lost to Follow-up|0|||
162868169|NCT00871858|588219903|FG001|Overall Study|Lost to Follow-up|1|||
162868170|NCT02795767|588219908|FG000|Overall Study|Received Commercial Emicizumab|1|||
162868171|NCT02795767|588219909|FG001|Overall Study|Received Commercial Emicizumab|0|||
162868172|NCT02795767|588219910|FG002|Overall Study|Received Commercial Emicizumab|0|||
162868173|NCT04983940|588219911|FG000|Overall Study|Lost to Follow-up|14|||
162868174|NCT04983940|588219911|FG000|Overall Study|Lack of Efficacy|2|||
162868175|NCT01748760|588219912|FG000|Overall Study|Withdrawal by Subject|1|||
162868176|NCT01748760|588219913|FG001|Overall Study|Withdrawal by Subject|1|||
162868177|NCT01748760|588219912|FG000|Overall Study|Lost to Follow-up|5|||
162868178|NCT01748760|588219913|FG001|Overall Study|Lost to Follow-up|1|||
162868179|NCT01004146|588219915|FG000|Overall Study|Withdrawal by Subject|4|||
162868180|NCT01004146|588219916|FG001|Overall Study|Withdrawal by Subject|5|||
162868181|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Adverse Event|37|||
162868182|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Adverse Event|0|||
162868183|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Adverse Event|0|||
162868184|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Adverse Event|0|||
162868185|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Death|2|||
162868186|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Death|0|||
162868187|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Death|0|||
162868188|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Death|0|||
162868189|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
162868190|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
162868191|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
162868192|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
162868193|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
162868194|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
162868195|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
162868196|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
162868197|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
162868198|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
162868199|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
162868200|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
162868201|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
162868202|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
162868203|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
162868204|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
162868205|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Physician Decision|4|||
162868206|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Physician Decision|0|||
162868207|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Physician Decision|0|||
162868208|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Physician Decision|0|||
162868209|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Pregnancy|1|||
162868210|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Pregnancy|0|||
162868211|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Pregnancy|0|||
162868212|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Pregnancy|0|||
162868213|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
162868214|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
162868215|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
162868216|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
162868217|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
162868218|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
162959797|NCT02554890|588554806|FG000|Double-blind|Withdrawal by Subject|5|||
162868219|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
162868220|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
162868221|NCT01855789|588219925|FG000|1) Baseline up to Week 24|Other|4|||
162868222|NCT01855789|588219926|FG001|1) Baseline up to Week 24|Other|0|||
162868223|NCT01855789|588219927|FG002|1) Baseline up to Week 24|Other|0|||
162868224|NCT01855789|588219928|FG003|1) Baseline up to Week 24|Other|0|||
162868225|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
162868226|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
162868227|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
162868228|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
162868229|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
162868230|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
162868231|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
162868232|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
162868233|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
162868234|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
162868235|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
162868236|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
162868237|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
162868238|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
162868239|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
162868240|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
162868241|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
162868242|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
162868243|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
162868244|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
162868245|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
162868246|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
162868247|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
162868248|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
162868249|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
162868250|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
162868251|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
162868252|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
162868253|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
162868254|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
162868255|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
162868256|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
162868257|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
162868258|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
162868259|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
162868260|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
162868261|NCT01855789|588219925|FG000|2) Week 24 up to End of Study|Other|0|||
162868262|NCT01855789|588219926|FG001|2) Week 24 up to End of Study|Other|0|||
162868263|NCT01855789|588219927|FG002|2) Week 24 up to End of Study|Other|0|||
162868264|NCT01855789|588219928|FG003|2) Week 24 up to End of Study|Other|1|||
162868265|NCT03625986|588221471|FG000|Randomization Period|Lost to Follow-up|7|||
162868266|NCT03625986|588221472|FG001|Randomization Period|Lost to Follow-up|12|||
162868267|NCT03625986|588221471|FG000|Randomization Period|Withdrawal by Subject|10|||
162868268|NCT03625986|588221472|FG001|Randomization Period|Withdrawal by Subject|6|||
162868269|NCT01850563|588221473|FG000|Overall Study|Not eligible|3|||
162868270|NCT01850563|588221474|FG001|Overall Study|Not eligible|0|||
162868271|NCT04359823|588221475|FG000|Overall Study|Lost to Follow-up|0|||
162868272|NCT04359823|588221476|FG001|Overall Study|Lost to Follow-up|1|||
162868273|NCT04359823|588221475|FG000|Overall Study|Withdrawal by Subject|0|||
162706198|NCT01657682|587636576|FG002|Overall Study|Withdrawal by Subject|1|||
162868274|NCT04359823|588221476|FG001|Overall Study|Withdrawal by Subject|1|||
162868275|NCT03132805|588221477|FG000|Overall Study|Lost to Follow-up|142|||
162868276|NCT03132805|588221478|FG001|Overall Study|Lost to Follow-up|141|||
162868277|NCT03132805|588221479|FG002|Overall Study|Lost to Follow-up|113|||
162959798|NCT02554890|588554807|FG001|Double-blind|Withdrawal by Subject|6|||
162959799|NCT02554890|588554806|FG000|Double-blind|Noncompliance with study treatment|6|||
162868278|NCT03009539|588221480|FG000|Overall Study|Lost to Follow-up|132|||
162868279|NCT03009539|588221481|FG001|Overall Study|Lost to Follow-up|113|||
162868280|NCT03009539|588221482|FG002|Overall Study|Lost to Follow-up|132|||
162868281|NCT03009539|588221483|FG003|Overall Study|Lost to Follow-up|113|||
162868282|NCT03151148|588221484|FG000|Overall Study|Lost to Follow-up|1|||
162868283|NCT03151148|588221485|FG001|Overall Study|Lost to Follow-up|0|||
162868284|NCT03151148|588221484|FG000|Overall Study|Withdrawal by Subject|1|||
162868285|NCT03151148|588221485|FG001|Overall Study|Withdrawal by Subject|0|||
162868286|NCT04543955|588221486|FG000|Overall Study|Company cancelled study|1|||
162868287|NCT04543955|588221487|FG001|Overall Study|Company cancelled study|0|||
162868288|NCT03918642|588221488|FG000|Overall Study|Lost to Follow-up|12|||
162868289|NCT03918642|588221489|FG001|Overall Study|Lost to Follow-up|10|||
162868290|NCT01158534|588221490|FG000|Overall Study|Withdrawal by Subject|1|||
162868291|NCT01158534|588221490|FG000|Overall Study|Death|1|||
162868292|NCT01158534|588221490|FG000|Overall Study|Other|1|||
162868293|NCT01115569|588221495|FG000|Conversion/Titration Phase|Adverse Event|59|||
162868294|NCT01115569|588221496|FG001|Conversion/Titration Phase|Adverse Event|0|||
162868295|NCT01115569|588221495|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
162868296|NCT01115569|588221496|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
162868297|NCT01115569|588221495|FG000|Conversion/Titration Phase|Physician Decision|5|||
162868298|NCT01115569|588221496|FG001|Conversion/Titration Phase|Physician Decision|0|||
162868299|NCT01115569|588221495|FG000|Conversion/Titration Phase|Protocol Violation|68|||
162868300|NCT01115569|588221496|FG001|Conversion/Titration Phase|Protocol Violation|0|||
162868301|NCT01115569|588221495|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
162868302|NCT01115569|588221496|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
162868303|NCT01115569|588221495|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
162868304|NCT01115569|588221496|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
162868305|NCT01115569|588221495|FG000|Maintenance Phase|Adverse Event|0|||
162868306|NCT01115569|588221496|FG001|Maintenance Phase|Adverse Event|43|||
162868307|NCT01115569|588221495|FG000|Maintenance Phase|Lost to Follow-up|0|||
162868308|NCT01115569|588221496|FG001|Maintenance Phase|Lost to Follow-up|8|||
162868309|NCT01115569|588221495|FG000|Maintenance Phase|Physician Decision|0|||
162868310|NCT01115569|588221496|FG001|Maintenance Phase|Physician Decision|3|||
162868311|NCT01115569|588221495|FG000|Maintenance Phase|Protocol Violation|0|||
162868312|NCT01115569|588221496|FG001|Maintenance Phase|Protocol Violation|9|||
162868313|NCT01115569|588221495|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162868314|NCT01115569|588221496|FG001|Maintenance Phase|Withdrawal by Subject|27|||
162868315|NCT01115569|588221495|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
162868316|NCT01115569|588221496|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
162868317|NCT01115569|588221495|FG000|Maintenance Phase|Administrative|0|||
162868318|NCT01115569|588221496|FG001|Maintenance Phase|Administrative|1|||
162868319|NCT01228071|588221497|FG000|Overall Study|Protocol Violation|1|||
162868320|NCT01228071|588221497|FG000|Overall Study|Withdrawal by Subject|1|||
162868321|NCT04439838|588221498|FG000|Overall Study|Withdrawal by Subject|0|||
162868322|NCT04439838|588221499|FG001|Overall Study|Withdrawal by Subject|0|||
162868323|NCT04439838|588221500|FG002|Overall Study|Withdrawal by Subject|0|||
162868324|NCT04439838|588221501|FG003|Overall Study|Withdrawal by Subject|0|||
162868325|NCT04439838|588221502|FG004|Overall Study|Withdrawal by Subject|0|||
162868326|NCT04439838|588221503|FG005|Overall Study|Withdrawal by Subject|0|||
162959800|NCT02554890|588554807|FG001|Double-blind|Noncompliance with study treatment|5|||
162959801|NCT02554890|588554806|FG000|Open-label|Adverse Event|0|||
162868327|NCT04439838|588221504|FG006|Overall Study|Withdrawal by Subject|0|||
162959802|NCT02554890|588554807|FG001|Open-label|Adverse Event|30|||
162959803|NCT02554890|588554806|FG000|Open-label|Death|0|||
162959804|NCT02554890|588554807|FG001|Open-label|Death|1|||
162959805|NCT02554890|588554806|FG000|Open-label|Physician Decision|0|||
162959806|NCT02554890|588554807|FG001|Open-label|Physician Decision|1|||
162959807|NCT02554890|588554806|FG000|Open-label|Subject/Guardian decision|0|||
162959808|NCT02554890|588554807|FG001|Open-label|Subject/Guardian decision|11|||
162959809|NCT02554890|588554806|FG000|Open-label|Lost to Follow-up|0|||
162959810|NCT02554890|588554807|FG001|Open-label|Lost to Follow-up|7|||
162959811|NCT02554890|588554806|FG000|Open-label|Technical problems|0|||
162959812|NCT02554890|588554807|FG001|Open-label|Technical problems|1|||
162959813|NCT02554890|588554806|FG000|Open-label|Withdrawal by Subject|0|||
162959814|NCT02554890|588554807|FG001|Open-label|Withdrawal by Subject|1|||
162706199|NCT01657682|587636574|FG000|Overall Study|Adverse Event|0|||
162868328|NCT04439838|588221505|FG007|Overall Study|Withdrawal by Subject|0|||
162868329|NCT04439838|588221506|FG008|Overall Study|Withdrawal by Subject|1|||
162868330|NCT01781429|588221513|FG000|Overall Study|Death|0|||
162868331|NCT01781429|588221514|FG001|Overall Study|Death|0|||
162868332|NCT01781429|588221515|FG002|Overall Study|Death|0|||
162959815|NCT03649477|588554810|FG000|Overall Study|Adverse Event|2|||
162868333|NCT01781429|588221516|FG003|Overall Study|Death|0|||
162868334|NCT01781429|588221517|FG004|Overall Study|Death|0|||
162868335|NCT01781429|588221518|FG005|Overall Study|Death|0|||
162959816|NCT03649477|588554811|FG001|Overall Study|Adverse Event|0|||
162959817|NCT03649477|588554812|FG002|Overall Study|Adverse Event|0|||
162868336|NCT01781429|588221519|FG006|Overall Study|Death|0|||
162868337|NCT01781429|588221520|FG007|Overall Study|Death|0|||
162868338|NCT01781429|588221521|FG008|Overall Study|Death|0|||
162868339|NCT01781429|588221522|FG009|Overall Study|Death|1|||
162868340|NCT01781429|588221523|FG010|Overall Study|Death|0|||
162868341|NCT01781429|588221524|FG011|Overall Study|Death|0|||
162868342|NCT01781429|588221525|FG012|Overall Study|Death|1|||
162868343|NCT01781429|588221526|FG013|Overall Study|Death|0|||
162868344|NCT01781429|588221527|FG014|Overall Study|Death|1|||
162868345|NCT01781429|588221528|FG015|Overall Study|Death|0|||
162868346|NCT01781429|588221513|FG000|Overall Study|Withdrawal by Subject|0|||
162868347|NCT01781429|588221514|FG001|Overall Study|Withdrawal by Subject|0|||
162868348|NCT01781429|588221515|FG002|Overall Study|Withdrawal by Subject|0|||
162959818|NCT04544410|588554813|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
162959819|NCT04544410|588554814|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162959820|NCT04544410|588554813|FG000|Double-blind Treatment Period|Adverse Event|1|||
162959821|NCT04544410|588554814|FG001|Double-blind Treatment Period|Adverse Event|0|||
162959822|NCT04544410|588554813|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
162959823|NCT04544410|588554814|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162959824|NCT04544410|588554813|FG000|Double-blind Treatment Period|Protocol Violation|1|||
162959825|NCT04544410|588554814|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162959826|NCT04544410|588554813|FG000|Open-Label Treatment Period|Study Terminated|15|||
162959827|NCT04544410|588554814|FG001|Open-Label Treatment Period|Study Terminated|19|||
162959828|NCT04544410|588554813|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
162959829|NCT04544410|588554814|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
162959830|NCT04544410|588554813|FG000|Open-Label Treatment Period|Adverse Event|0|||
162959831|NCT04544410|588554814|FG001|Open-Label Treatment Period|Adverse Event|1|||
162959832|NCT04544410|588554813|FG000|Open-Label Treatment Period|Physician Decision|1|||
162959833|NCT04544410|588554814|FG001|Open-Label Treatment Period|Physician Decision|0|||
162959834|NCT04544410|588554813|FG000|Open-Label Treatment Period|Other|0|||
162959835|NCT04544410|588554814|FG001|Open-Label Treatment Period|Other|1|||
162959836|NCT01750294|588556173|FG000|Overall Study|Withdrawal by Subject|1|||
162959837|NCT01750294|588556173|FG000|Overall Study|Safety Endpoint|1|||
162959838|NCT01624233|588556174|FG000|Period 2 - Induction|Adverse Event|1|||
162959839|NCT01624233|588556174|FG000|Period 3 - Maintenance|Adverse Event|2|||
162959840|NCT01624233|588556174|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
162959841|NCT01624233|588556174|FG000|Period 3 - Maintenance|Physician Decision|2|||
162959842|NCT01624233|588556174|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
162959843|NCT01624233|588556174|FG000|Period 4 - Drug Free Period|Relapsed|61|||
162959844|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
162959845|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
162959846|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
162959847|NCT01624233|588556174|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
162959848|NCT01624233|588556174|FG000|Period 6: Follow-up|Adverse Event|3|||
162959849|NCT01624233|588556174|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
162959850|NCT01624233|588556174|FG000|Period 6: Follow-up|Physician Decision|1|||
162959851|NCT01624233|588556174|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
162959852|NCT03121586|588556175|FG000|Overall Study|Study terminated by sponsor|0|||
162959853|NCT03121586|588556176|FG001|Overall Study|Study terminated by sponsor|0|||
162959854|NCT03121586|588556177|FG002|Overall Study|Study terminated by sponsor|99|||
162959855|NCT03121586|588556175|FG000|Overall Study|Withdrawal by Subject|37|||
162959856|NCT03121586|588556176|FG001|Overall Study|Withdrawal by Subject|14|||
162959857|NCT03121586|588556177|FG002|Overall Study|Withdrawal by Subject|9|||
162959858|NCT03121586|588556175|FG000|Overall Study|Not further specified|6|||
162959859|NCT03121586|588556176|FG001|Overall Study|Not further specified|11|||
163046778|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
163046779|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046780|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046781|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162959860|NCT03121586|588556177|FG002|Overall Study|Not further specified|10|||
162959861|NCT03121586|588556175|FG000|Overall Study|Adverse Event|16|||
162959862|NCT03121586|588556176|FG001|Overall Study|Adverse Event|5|||
162959863|NCT03121586|588556177|FG002|Overall Study|Adverse Event|6|||
162959864|NCT03121586|588556175|FG000|Overall Study|Protocol Violation|0|||
163046782|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162868349|NCT01781429|588221516|FG003|Overall Study|Withdrawal by Subject|0|||
162868350|NCT01781429|588221517|FG004|Overall Study|Withdrawal by Subject|0|||
162868351|NCT01781429|588221518|FG005|Overall Study|Withdrawal by Subject|0|||
162868352|NCT01781429|588221519|FG006|Overall Study|Withdrawal by Subject|0|||
162868353|NCT01781429|588221520|FG007|Overall Study|Withdrawal by Subject|0|||
162959865|NCT03121586|588556176|FG001|Overall Study|Protocol Violation|5|||
162959866|NCT03121586|588556177|FG002|Overall Study|Protocol Violation|0|||
162959867|NCT03121586|588556175|FG000|Overall Study|Lack of Efficacy|3|||
162959868|NCT03121586|588556176|FG001|Overall Study|Lack of Efficacy|3|||
162959869|NCT03121586|588556177|FG002|Overall Study|Lack of Efficacy|1|||
162868354|NCT01781429|588221521|FG008|Overall Study|Withdrawal by Subject|1|||
162868355|NCT01781429|588221522|FG009|Overall Study|Withdrawal by Subject|3|||
162868356|NCT01781429|588221523|FG010|Overall Study|Withdrawal by Subject|1|||
162868357|NCT01781429|588221524|FG011|Overall Study|Withdrawal by Subject|1|||
162868358|NCT01781429|588221525|FG012|Overall Study|Withdrawal by Subject|5|||
162868359|NCT01781429|588221526|FG013|Overall Study|Withdrawal by Subject|2|||
162868360|NCT01781429|588221527|FG014|Overall Study|Withdrawal by Subject|3|||
162868361|NCT01781429|588221528|FG015|Overall Study|Withdrawal by Subject|0|||
162868362|NCT01781429|588221513|FG000|Overall Study|Disease Progression|1|||
162868363|NCT01781429|588221514|FG001|Overall Study|Disease Progression|0|||
162868364|NCT01781429|588221515|FG002|Overall Study|Disease Progression|1|||
162868365|NCT01781429|588221516|FG003|Overall Study|Disease Progression|1|||
162868366|NCT01781429|588221517|FG004|Overall Study|Disease Progression|1|||
162868367|NCT01781429|588221518|FG005|Overall Study|Disease Progression|4|||
162868368|NCT01781429|588221519|FG006|Overall Study|Disease Progression|7|||
162868369|NCT01781429|588221520|FG007|Overall Study|Disease Progression|4|||
162868370|NCT01781429|588221521|FG008|Overall Study|Disease Progression|6|||
162868371|NCT01781429|588221522|FG009|Overall Study|Disease Progression|15|||
162868372|NCT01781429|588221523|FG010|Overall Study|Disease Progression|15|||
162868373|NCT01781429|588221524|FG011|Overall Study|Disease Progression|15|||
162868374|NCT01781429|588221525|FG012|Overall Study|Disease Progression|15|||
162868375|NCT01781429|588221526|FG013|Overall Study|Disease Progression|4|||
162868376|NCT01781429|588221527|FG014|Overall Study|Disease Progression|11|||
162868377|NCT01781429|588221528|FG015|Overall Study|Disease Progression|0|||
162868378|NCT01781429|588221513|FG000|Overall Study|Unacceptable Toxicity|0|||
162868379|NCT01781429|588221514|FG001|Overall Study|Unacceptable Toxicity|0|||
162868380|NCT01781429|588221515|FG002|Overall Study|Unacceptable Toxicity|0|||
162868381|NCT01781429|588221516|FG003|Overall Study|Unacceptable Toxicity|0|||
162868382|NCT01781429|588221517|FG004|Overall Study|Unacceptable Toxicity|0|||
162868383|NCT01781429|588221518|FG005|Overall Study|Unacceptable Toxicity|0|||
162868384|NCT01781429|588221519|FG006|Overall Study|Unacceptable Toxicity|0|||
162868385|NCT01781429|588221520|FG007|Overall Study|Unacceptable Toxicity|0|||
162868386|NCT01781429|588221521|FG008|Overall Study|Unacceptable Toxicity|0|||
162868387|NCT01781429|588221522|FG009|Overall Study|Unacceptable Toxicity|0|||
162868388|NCT01781429|588221523|FG010|Overall Study|Unacceptable Toxicity|0|||
162868389|NCT01781429|588221524|FG011|Overall Study|Unacceptable Toxicity|2|||
162868390|NCT01781429|588221525|FG012|Overall Study|Unacceptable Toxicity|0|||
162868391|NCT01781429|588221526|FG013|Overall Study|Unacceptable Toxicity|0|||
162868392|NCT01781429|588221527|FG014|Overall Study|Unacceptable Toxicity|0|||
162868393|NCT01781429|588221528|FG015|Overall Study|Unacceptable Toxicity|0|||
162868394|NCT01781429|588221513|FG000|Overall Study|Patient Condition Changed|0|||
162868395|NCT01781429|588221514|FG001|Overall Study|Patient Condition Changed|0|||
162868396|NCT01781429|588221515|FG002|Overall Study|Patient Condition Changed|0|||
162868397|NCT01781429|588221516|FG003|Overall Study|Patient Condition Changed|0|||
162868398|NCT01781429|588221517|FG004|Overall Study|Patient Condition Changed|0|||
162868399|NCT01781429|588221518|FG005|Overall Study|Patient Condition Changed|0|||
162868400|NCT01781429|588221519|FG006|Overall Study|Patient Condition Changed|0|||
162868401|NCT01781429|588221520|FG007|Overall Study|Patient Condition Changed|0|||
162868402|NCT01781429|588221521|FG008|Overall Study|Patient Condition Changed|0|||
162868403|NCT01781429|588221522|FG009|Overall Study|Patient Condition Changed|4|||
162959870|NCT03121586|588556175|FG000|Overall Study|Physician Decision|2|||
162959871|NCT03121586|588556176|FG001|Overall Study|Physician Decision|2|||
162959872|NCT03121586|588556177|FG002|Overall Study|Physician Decision|0|||
162959873|NCT03121586|588556175|FG000|Overall Study|Noncompliance with study drug|5|||
162959874|NCT03121586|588556176|FG001|Overall Study|Noncompliance with study drug|3|||
162959875|NCT03121586|588556177|FG002|Overall Study|Noncompliance with study drug|5|||
162959876|NCT03121586|588556175|FG000|Overall Study|Lost to Follow-up|4|||
162959877|NCT03121586|588556176|FG001|Overall Study|Lost to Follow-up|2|||
162959878|NCT03121586|588556177|FG002|Overall Study|Lost to Follow-up|0|||
162959879|NCT03121586|588556175|FG000|Overall Study|Death|2|||
162868404|NCT01781429|588221523|FG010|Overall Study|Patient Condition Changed|0|||
162868405|NCT01781429|588221524|FG011|Overall Study|Patient Condition Changed|1|||
162868406|NCT01781429|588221525|FG012|Overall Study|Patient Condition Changed|0|||
162868407|NCT01781429|588221526|FG013|Overall Study|Patient Condition Changed|1|||
162868408|NCT01781429|588221527|FG014|Overall Study|Patient Condition Changed|0|||
162868409|NCT01781429|588221528|FG015|Overall Study|Patient Condition Changed|0|||
162868410|NCT01781429|588221513|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
162868411|NCT01781429|588221514|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
162868412|NCT01781429|588221515|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
162868413|NCT01781429|588221516|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
162868414|NCT01781429|588221517|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
162868415|NCT01781429|588221518|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
162868416|NCT01781429|588221519|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
162868417|NCT01781429|588221520|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
162959880|NCT03121586|588556176|FG001|Overall Study|Death|0|||
162959881|NCT03121586|588556177|FG002|Overall Study|Death|0|||
162706200|NCT01657682|587636575|FG001|Overall Study|Adverse Event|1|||
162706201|NCT01657682|587636576|FG002|Overall Study|Adverse Event|0|||
162868418|NCT01781429|588221521|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
162868419|NCT01781429|588221522|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
162868420|NCT01781429|588221523|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
162868421|NCT01781429|588221524|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
162868422|NCT01781429|588221525|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
162868423|NCT01781429|588221526|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
162868424|NCT01781429|588221527|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
162868425|NCT01781429|588221528|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
162868426|NCT01781429|588221513|FG000|Overall Study|Enrolled, but not treated|0|||
162868427|NCT01781429|588221514|FG001|Overall Study|Enrolled, but not treated|0|||
162868428|NCT01781429|588221515|FG002|Overall Study|Enrolled, but not treated|0|||
162868429|NCT01781429|588221516|FG003|Overall Study|Enrolled, but not treated|0|||
162868430|NCT01781429|588221517|FG004|Overall Study|Enrolled, but not treated|0|||
162868431|NCT01781429|588221518|FG005|Overall Study|Enrolled, but not treated|0|||
162868432|NCT01781429|588221519|FG006|Overall Study|Enrolled, but not treated|0|||
162868433|NCT01781429|588221520|FG007|Overall Study|Enrolled, but not treated|0|||
162868434|NCT01781429|588221521|FG008|Overall Study|Enrolled, but not treated|0|||
162868435|NCT01781429|588221522|FG009|Overall Study|Enrolled, but not treated|0|||
162868436|NCT01781429|588221523|FG010|Overall Study|Enrolled, but not treated|1|||
162868437|NCT01781429|588221524|FG011|Overall Study|Enrolled, but not treated|0|||
162868438|NCT01781429|588221525|FG012|Overall Study|Enrolled, but not treated|0|||
162868439|NCT01781429|588221526|FG013|Overall Study|Enrolled, but not treated|0|||
162868440|NCT01781429|588221527|FG014|Overall Study|Enrolled, but not treated|0|||
162868441|NCT01781429|588221528|FG015|Overall Study|Enrolled, but not treated|0|||
162868442|NCT03238248|588221529|FG000|Overall Study|Death|5|||
162868443|NCT03238248|588221529|FG000|Overall Study|Withdrawal by Subject|7|||
162868444|NCT03238248|588221529|FG000|Overall Study|Participant proceeding to transplant|10|||
162868445|NCT03238248|588221529|FG000|Overall Study|Lack of Efficacy|4|||
162868446|NCT03238248|588221529|FG000|Overall Study|Physician Decision|3|||
162868447|NCT03238248|588221529|FG000|Overall Study|Transitioning to another study|1|||
162868448|NCT03238248|588221529|FG000|Overall Study|No longer benefiting|1|||
162868449|NCT03238248|588221529|FG000|Overall Study|Other complicating disease|1|||
162868450|NCT03238248|588221529|FG000|Overall Study|Adverse Event|5|||
162868451|NCT03238248|588221529|FG000|Overall Study|Disease progression|26|||
162868452|NCT03238248|588221529|FG000|Overall Study|N/A participant is still on treatment|1|||
162868453|NCT03238248|588221529|FG000|Overall Study|Decline in condition|1|||
162868454|NCT03238248|588221529|FG000|Overall Study|Alternative therapy|2|||
162868455|NCT00130208|588221532|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
162868456|NCT00130208|588221533|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
162868457|NCT00130208|588221532|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
162868458|NCT00130208|588221533|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
162959882|NCT06381102|588556178|FG000|Washout 5 Days|Withdrawal by Subject|0|||
162959883|NCT06381102|588556179|FG001|Washout 5 Days|Withdrawal by Subject|2|||
162959884|NCT02832063|588556181|FG000|Overall Study|Adverse Event|2|||
162959885|NCT02832063|588556182|FG001|Overall Study|Adverse Event|1|||
162706202|NCT01318811|587636585|FG000|Overall Study|Physician Decision|1|||
162868459|NCT00130208|588221532|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
162868460|NCT00130208|588221533|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
162868461|NCT00130208|588221532|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
162868462|NCT00130208|588221533|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
162868463|NCT00130208|588221532|FG000|Maintenance Period (26 Weeks)|Other|1|||
162868464|NCT00130208|588221533|FG001|Maintenance Period (26 Weeks)|Other|1|||
162868465|NCT00130208|588221532|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
162868466|NCT00130208|588221533|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
162868467|NCT00130208|588221532|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
162868468|NCT00130208|588221533|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
162868469|NCT00130208|588221532|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
162868470|NCT00130208|588221533|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
162868471|NCT00130208|588221532|FG000|Washout Period (8 Weeks)|Other|1|||
162868472|NCT00130208|588221533|FG001|Washout Period (8 Weeks)|Other|1|||
162868473|NCT00986258|588221536|FG000|Observation Period|Not eligible to be dosed|11|||
162868474|NCT00986258|588221536|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
162868475|NCT00986258|588221536|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
162868476|NCT00986258|588221536|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
162868477|NCT00986258|588221536|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
162868478|NCT00986258|588221536|FG000|Titration and Optimal Dose Period|Other|1|||
162868479|NCT00986258|588221536|FG000|Maintenance Period|Adverse Event|5|||
162868480|NCT00986258|588221536|FG000|Maintenance Period|Lack of Efficacy|2|||
162868481|NCT00986258|588221536|FG000|Maintenance Period|Withdrawal by Subject|2|||
162868482|NCT03332667|588221537|FG000|Overall Study|Adverse Event|0|||
162868483|NCT03332667|588221538|FG001|Overall Study|Adverse Event|0|||
162868484|NCT03332667|588221539|FG002|Overall Study|Adverse Event|2|||
162868485|NCT03332667|588221540|FG003|Overall Study|Adverse Event|1|||
162868486|NCT03332667|588221537|FG000|Overall Study|Withdrawal by Subject|2|||
162868487|NCT03332667|588221538|FG001|Overall Study|Withdrawal by Subject|1|||
162868488|NCT03332667|588221539|FG002|Overall Study|Withdrawal by Subject|5|||
162868489|NCT03332667|588221540|FG003|Overall Study|Withdrawal by Subject|1|||
162868490|NCT03332667|588221537|FG000|Overall Study|Disease Progression or Relapse|2|||
162868491|NCT03332667|588221538|FG001|Overall Study|Disease Progression or Relapse|1|||
162868492|NCT03332667|588221539|FG002|Overall Study|Disease Progression or Relapse|3|||
162868493|NCT03332667|588221540|FG003|Overall Study|Disease Progression or Relapse|0|||
162868494|NCT03332667|588221537|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
162868495|NCT03332667|588221538|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
162868496|NCT03332667|588221539|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
162868497|NCT03332667|588221540|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
162868498|NCT03332667|588221537|FG000|Overall Study|No Treatment Received|0|||
162868499|NCT03332667|588221538|FG001|Overall Study|No Treatment Received|0|||
162868500|NCT03332667|588221539|FG002|Overall Study|No Treatment Received|1|||
162868501|NCT03332667|588221540|FG003|Overall Study|No Treatment Received|0|||
162868502|NCT01035606|588221541|FG000|Overall Study|change in health, job demands,family|3|||
162868503|NCT01035606|588221542|FG001|Overall Study|change in health, job demands,family|3|||
162868504|NCT01035606|588221543|FG002|Overall Study|change in health, job demands,family|4|||
162868505|NCT01070303|588221544|FG000|Overall Study|Adverse Event|39|||
162868506|NCT01070303|588221544|FG000|Overall Study|Withdrawal by Subject|20|||
162868507|NCT01070303|588221544|FG000|Overall Study|Lost to Follow-up|9|||
162868508|NCT01070303|588221544|FG000|Overall Study|Protocol Violation|0|||
162868509|NCT01070303|588221544|FG000|Overall Study|Lack of Efficacy|2|||
162868510|NCT01070303|588221544|FG000|Overall Study|Administrative Reason|1|||
162868511|NCT01070303|588221544|FG000|Overall Study|Other|18|||
162868512|NCT01809262|588221545|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868513|NCT01809262|588221546|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868514|NCT01809262|588221547|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868515|NCT01809262|588221548|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868516|NCT01809262|588221549|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
162868517|NCT01809262|588221550|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868518|NCT01809262|588221551|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868519|NCT01809262|588221552|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868520|NCT01809262|588221553|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868521|NCT01809262|588221554|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
162868522|NCT01809262|588221545|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868523|NCT01809262|588221546|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
162868524|NCT01809262|588221547|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868525|NCT01809262|588221548|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868526|NCT01809262|588221549|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868527|NCT01809262|588221550|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868528|NCT01809262|588221551|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868529|NCT01809262|588221552|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868530|NCT01809262|588221553|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868531|NCT01809262|588221554|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
162868532|NCT00859898|588221557|FG000|Overall Study|Lack of Efficacy|0|||
162868533|NCT00859898|588221558|FG001|Overall Study|Lack of Efficacy|1|||
162868534|NCT00859898|588221559|FG002|Overall Study|Lack of Efficacy|1|||
162868535|NCT00859898|588221557|FG000|Overall Study|Adverse Event|4|||
162868536|NCT00859898|588221558|FG001|Overall Study|Adverse Event|9|||
162868537|NCT00859898|588221559|FG002|Overall Study|Adverse Event|8|||
163046783|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162868538|NCT00859898|588221557|FG000|Overall Study|Withdrawal by Subject|11|||
162868539|NCT00859898|588221558|FG001|Overall Study|Withdrawal by Subject|8|||
162868540|NCT00859898|588221559|FG002|Overall Study|Withdrawal by Subject|11|||
162868541|NCT00859898|588221557|FG000|Overall Study|Death|0|||
162868542|NCT00859898|588221558|FG001|Overall Study|Death|0|||
162868543|NCT00859898|588221559|FG002|Overall Study|Death|1|||
162868544|NCT00859898|588221557|FG000|Overall Study|Lost to Follow-up|10|||
162868545|NCT00859898|588221558|FG001|Overall Study|Lost to Follow-up|11|||
162868546|NCT00859898|588221559|FG002|Overall Study|Lost to Follow-up|5|||
162868547|NCT00859898|588221557|FG000|Overall Study|poor/non-compliance|2|||
162868548|NCT00859898|588221558|FG001|Overall Study|poor/non-compliance|0|||
162868549|NCT00859898|588221559|FG002|Overall Study|poor/non-compliance|0|||
162868550|NCT00859898|588221557|FG000|Overall Study|No longer meets criteria|0|||
162868551|NCT00859898|588221558|FG001|Overall Study|No longer meets criteria|1|||
162868552|NCT00859898|588221559|FG002|Overall Study|No longer meets criteria|0|||
162868553|NCT00859898|588221557|FG000|Overall Study|non-specified|1|||
162868554|NCT00859898|588221558|FG001|Overall Study|non-specified|1|||
162868555|NCT00859898|588221559|FG002|Overall Study|non-specified|1|||
162868556|NCT03215264|588221560|FG000|Dose Level 2|Adverse Event|0|||
162868557|NCT03215264|588221561|FG001|Dose Level 2|Adverse Event|1|||
162868558|NCT03215264|588221562|FG002|Dose Level 2|Adverse Event|0|||
162614548|NCT02979197|587305799|FG001|Overall Study|Subject unable to commit to study dates|1|||
162614549|NCT02979197|587305800|FG002|Overall Study|Subject unable to commit to study dates|0|||
162614550|NCT02949700|587305801|FG000|Phase I|Withdrawal by Subject|1|||
162614551|NCT02949700|587305802|FG001|Phase I|Withdrawal by Subject|1|||
162614552|NCT02949700|587305803|FG002|Phase I|Withdrawal by Subject|0|||
162614553|NCT02949700|587305804|FG003|Phase I|Withdrawal by Subject|0|||
162614554|NCT02949700|587305801|FG000|Phase I|Protocol Violation|1|||
162614555|NCT02949700|587305802|FG001|Phase I|Protocol Violation|0|||
162614556|NCT02949700|587305803|FG002|Phase I|Protocol Violation|0|||
162614557|NCT02949700|587305804|FG003|Phase I|Protocol Violation|0|||
162868559|NCT03215264|588221560|FG000|Dose Level 3|Withdrawal by Subject|0|||
162868560|NCT03215264|588221561|FG001|Dose Level 3|Withdrawal by Subject|0|||
162868561|NCT03215264|588221562|FG002|Dose Level 3|Withdrawal by Subject|1|||
162868562|NCT02145156|588221563|FG000|Overall Study|No match to vaccination records|60|||
162868563|NCT02145156|588221564|FG001|Overall Study|No match to vaccination records|52|||
162868564|NCT02145156|588221565|FG002|Overall Study|No match to vaccination records|41|||
162868565|NCT02064439|588221567|FG000|Overall Study|Adverse Event|51|||
162868566|NCT02064439|588221568|FG001|Overall Study|Adverse Event|47|||
162868567|NCT02064439|588221569|FG002|Overall Study|Adverse Event|46|||
162868568|NCT02064439|588221567|FG000|Overall Study|Death|0|||
162868569|NCT02064439|588221568|FG001|Overall Study|Death|2|||
162868570|NCT02064439|588221569|FG002|Overall Study|Death|3|||
162868571|NCT02064439|588221567|FG000|Overall Study|Withdrawal by Subject|29|||
162868572|NCT02064439|588221568|FG001|Overall Study|Withdrawal by Subject|18|||
162868573|NCT02064439|588221569|FG002|Overall Study|Withdrawal by Subject|26|||
162868574|NCT02064439|588221567|FG000|Overall Study|Protocol Violation|3|||
162868575|NCT02064439|588221568|FG001|Overall Study|Protocol Violation|5|||
162868576|NCT02064439|588221569|FG002|Overall Study|Protocol Violation|3|||
162868577|NCT02064439|588221567|FG000|Overall Study|Lost to Follow-up|1|||
162868578|NCT02064439|588221568|FG001|Overall Study|Lost to Follow-up|3|||
162868579|NCT02064439|588221569|FG002|Overall Study|Lost to Follow-up|4|||
162868580|NCT02064439|588221567|FG000|Overall Study|Non-compliance with study medication|21|||
162868581|NCT02064439|588221568|FG001|Overall Study|Non-compliance with study medication|19|||
162868582|NCT02064439|588221569|FG002|Overall Study|Non-compliance with study medication|23|||
162614558|NCT02949700|587305801|FG000|Phase II|Withdrawal by Subject|0|||
162614559|NCT02949700|587305802|FG001|Phase II|Withdrawal by Subject|0|||
162614560|NCT02949700|587305803|FG002|Phase II|Withdrawal by Subject|0|||
162614561|NCT02949700|587305804|FG003|Phase II|Withdrawal by Subject|2|||
162614562|NCT02949700|587305801|FG000|Phase II|Protocol Violation|0|||
162614563|NCT02949700|587305802|FG001|Phase II|Protocol Violation|0|||
162614564|NCT02949700|587305803|FG002|Phase II|Protocol Violation|1|||
162868583|NCT02064439|588221567|FG000|Overall Study|Physician Decision|0|||
162868584|NCT02064439|588221568|FG001|Overall Study|Physician Decision|1|||
162868585|NCT02064439|588221569|FG002|Overall Study|Physician Decision|1|||
162868586|NCT02064439|588221567|FG000|Overall Study|Logistical difficulties|6|||
162868587|NCT02064439|588221568|FG001|Overall Study|Logistical difficulties|5|||
162868588|NCT02064439|588221569|FG002|Overall Study|Logistical difficulties|2|||
162868589|NCT02064439|588221567|FG000|Overall Study|Efficacy outcome reached|18|||
162868590|NCT02064439|588221568|FG001|Overall Study|Efficacy outcome reached|16|||
162868591|NCT02064439|588221569|FG002|Overall Study|Efficacy outcome reached|57|||
162868592|NCT02064439|588221567|FG000|Overall Study|Safety outcome reached|12|||
162868593|NCT02064439|588221568|FG001|Overall Study|Safety outcome reached|20|||
162868594|NCT02064439|588221569|FG002|Overall Study|Safety outcome reached|10|||
162868595|NCT02064439|588221567|FG000|Overall Study|Other|2|||
162868596|NCT02064439|588221568|FG001|Overall Study|Other|2|||
162868597|NCT02064439|588221569|FG002|Overall Study|Other|7|||
162868598|NCT02433288|588221570|FG000|Overall Study|Severe non-compliance to protocol|13|||
162868599|NCT02433288|588221571|FG001|Overall Study|Severe non-compliance to protocol|7|||
162868600|NCT02433288|588221570|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
162868601|NCT02433288|588221571|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
162868602|NCT02433288|588221570|FG000|Overall Study|Withdrawal by Subject|101|||
162868603|NCT02433288|588221571|FG001|Overall Study|Withdrawal by Subject|99|||
162868604|NCT02433288|588221570|FG000|Overall Study|Lost to Follow-up|2|||
162868605|NCT02433288|588221571|FG001|Overall Study|Lost to Follow-up|14|||
162868606|NCT02433288|588221570|FG000|Overall Study|Death|0|||
162868607|NCT02433288|588221571|FG001|Overall Study|Death|3|||
162868608|NCT00858702|588221574|FG000|Overall Study|Lack of Efficacy|1|||
162868609|NCT00858702|588221575|FG001|Overall Study|Lack of Efficacy|0|||
162868610|NCT00858702|588221574|FG000|Overall Study|Protocol Violation|1|||
162868611|NCT00858702|588221575|FG001|Overall Study|Protocol Violation|1|||
162868612|NCT00858702|588221574|FG000|Overall Study|Other|2|||
162868613|NCT00858702|588221575|FG001|Overall Study|Other|1|||
162868614|NCT00858702|588221574|FG000|Overall Study|Withdrawal by Subject|1|||
162868615|NCT00858702|588221575|FG001|Overall Study|Withdrawal by Subject|0|||
162868616|NCT01740440|588221578|FG000|Overall Study|Lost to Follow-up|3|||
162868617|NCT00367640|588221579|FG000|Overall Study|Adverse Event|3|||
162959886|NCT02832063|588556181|FG000|Overall Study|Physician Decision|5|||
162959887|NCT02832063|588556182|FG001|Overall Study|Physician Decision|7|||
162959888|NCT02832063|588556181|FG000|Overall Study|Lost to Follow-up|15|||
162868618|NCT00367640|588221580|FG001|Overall Study|Adverse Event|6|||
162959889|NCT02832063|588556182|FG001|Overall Study|Lost to Follow-up|8|||
162868619|NCT00367640|588221581|FG002|Overall Study|Adverse Event|8|||
162868620|NCT00367640|588221582|FG003|Overall Study|Adverse Event|0|||
162614565|NCT02949700|587305804|FG003|Phase II|Protocol Violation|3|||
162868621|NCT00367640|588221579|FG000|Overall Study|Withdrawal by Subject|8|||
162868622|NCT00367640|588221580|FG001|Overall Study|Withdrawal by Subject|11|||
162959890|NCT02832063|588556181|FG000|Overall Study|Withdrawal by Subject|10|||
162614566|NCT00560885|587305805|FG000|Overall Study|Death|7|||
162868623|NCT00367640|588221581|FG002|Overall Study|Withdrawal by Subject|8|||
162868624|NCT00367640|588221582|FG003|Overall Study|Withdrawal by Subject|6|||
162868625|NCT00367640|588221579|FG000|Overall Study|Any other reason not above-mentioned|7|||
162868626|NCT00367640|588221580|FG001|Overall Study|Any other reason not above-mentioned|5|||
162868627|NCT00367640|588221581|FG002|Overall Study|Any other reason not above-mentioned|3|||
162868628|NCT00367640|588221582|FG003|Overall Study|Any other reason not above-mentioned|4|||
162868629|NCT02417233|588221583|FG000|Overall Study|Death|4|||
162868630|NCT02417233|588221584|FG001|Overall Study|Death|10|||
162868631|NCT02417233|588221585|FG002|Overall Study|Death|14|||
162868632|NCT02417233|588221583|FG000|Overall Study|Lost to Follow-up|27|||
162868633|NCT02417233|588221584|FG001|Overall Study|Lost to Follow-up|39|||
162868634|NCT02417233|588221585|FG002|Overall Study|Lost to Follow-up|34|||
162868635|NCT02417233|588221583|FG000|Overall Study|Protocol Violation|2|||
162868636|NCT02417233|588221584|FG001|Overall Study|Protocol Violation|0|||
162868637|NCT02417233|588221585|FG002|Overall Study|Protocol Violation|2|||
162868638|NCT02417233|588221583|FG000|Overall Study|Withdrawal by Subject|2|||
162868639|NCT02417233|588221584|FG001|Overall Study|Withdrawal by Subject|1|||
162868640|NCT02417233|588221585|FG002|Overall Study|Withdrawal by Subject|8|||
162868641|NCT02417233|588221583|FG000|Overall Study|Relocation out of study area|1|||
162868642|NCT02417233|588221584|FG001|Overall Study|Relocation out of study area|0|||
162868643|NCT02417233|588221585|FG002|Overall Study|Relocation out of study area|1|||
162868644|NCT02417233|588221583|FG000|Overall Study|Mentally unstable|0|||
162868645|NCT02417233|588221584|FG001|Overall Study|Mentally unstable|1|||
162868646|NCT02417233|588221585|FG002|Overall Study|Mentally unstable|0|||
162868647|NCT01063751|588221586|FG000|Overall Study|Censored from analyses|42|||
162868648|NCT01063751|588221586|FG000|Overall Study|Withdrawal by Subject|34|||
162868649|NCT01063751|588221586|FG000|Overall Study|Lost to Follow-up|30|||
162868650|NCT01063751|588221586|FG000|Overall Study|Death|13|||
162868651|NCT01063751|588221586|FG000|Overall Study|Sponsored Terminated Study|60|||
162868652|NCT01063751|588221586|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
162868653|NCT01063751|588221586|FG000|Overall Study|Investigator site closed|10|||
162868654|NCT01063751|588221586|FG000|Overall Study|Revision|6|||
162868655|NCT01063751|588221586|FG000|Overall Study|Physician Decision|4|||
162868656|NCT02805907|588221587|FG000|Overall Study|Lost to Follow-up|3|||
162868657|NCT02805907|588221588|FG001|Overall Study|Lost to Follow-up|3|||
162868658|NCT03408873|588221593|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
162868659|NCT03408873|588221593|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
162868660|NCT03408873|588221593|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
162868661|NCT03408873|588221593|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
162868662|NCT03408873|588221593|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
162868663|NCT03408873|588221593|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
162868664|NCT01264965|588221599|FG000|Overall Study|Withdrawal by Subject|10|||
162868665|NCT03799718|588221601|FG000|Overall Study|Adverse Event|2|||
162868666|NCT00700752|588221602|FG000|First Intervention|Withdrawal by Subject|0|||
162868667|NCT00700752|588221603|FG001|First Intervention|Withdrawal by Subject|2|||
162868668|NCT03662334|588221604|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
162868669|NCT03662334|588221605|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
162868670|NCT01097330|588221606|FG000|Overall Study|Study terminated early|7|||
162868671|NCT01097330|588221607|FG001|Overall Study|Study terminated early|5|||
162868672|NCT03303339|588221613|FG000|Overall Study|Death|2|||
162868673|NCT03303339|588221614|FG001|Overall Study|Death|2|||
162868674|NCT03303339|588221615|FG002|Overall Study|Death|2|||
162868675|NCT03303339|588221616|FG003|Overall Study|Death|1|||
162868676|NCT03303339|588221617|FG004|Overall Study|Death|4|||
162868677|NCT03303339|588221618|FG005|Overall Study|Death|2|||
162868678|NCT03303339|588221619|FG006|Overall Study|Death|2|||
162868679|NCT03303339|588221620|FG007|Overall Study|Death|2|||
162868680|NCT03303339|588221621|FG008|Overall Study|Death|3|||
162868681|NCT03303339|588221622|FG009|Overall Study|Death|3|||
162868682|NCT03303339|588221623|FG010|Overall Study|Death|4|||
162868683|NCT03303339|588221624|FG011|Overall Study|Death|24|||
162868684|NCT03303339|588221613|FG000|Overall Study|Study Terminated by Sponsor|0|||
162868685|NCT03303339|588221614|FG001|Overall Study|Study Terminated by Sponsor|0|||
162868686|NCT03303339|588221615|FG002|Overall Study|Study Terminated by Sponsor|0|||
162868687|NCT03303339|588221616|FG003|Overall Study|Study Terminated by Sponsor|0|||
163046784|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046785|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162868688|NCT03303339|588221617|FG004|Overall Study|Study Terminated by Sponsor|0|||
162868689|NCT03303339|588221618|FG005|Overall Study|Study Terminated by Sponsor|0|||
162868690|NCT03303339|588221619|FG006|Overall Study|Study Terminated by Sponsor|0|||
162868691|NCT03303339|588221620|FG007|Overall Study|Study Terminated by Sponsor|0|||
162868692|NCT03303339|588221621|FG008|Overall Study|Study Terminated by Sponsor|1|||
162868693|NCT03303339|588221622|FG009|Overall Study|Study Terminated by Sponsor|0|||
162868694|NCT03303339|588221623|FG010|Overall Study|Study Terminated by Sponsor|1|||
162868695|NCT03303339|588221624|FG011|Overall Study|Study Terminated by Sponsor|1|||
162868696|NCT03303339|588221613|FG000|Overall Study|Withdrawal by Subject|1|||
163046786|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162868697|NCT03303339|588221614|FG001|Overall Study|Withdrawal by Subject|0|||
162868698|NCT03303339|588221615|FG002|Overall Study|Withdrawal by Subject|0|||
162868699|NCT03303339|588221616|FG003|Overall Study|Withdrawal by Subject|0|||
162868700|NCT03303339|588221617|FG004|Overall Study|Withdrawal by Subject|0|||
162868701|NCT03303339|588221618|FG005|Overall Study|Withdrawal by Subject|1|||
162868702|NCT03303339|588221619|FG006|Overall Study|Withdrawal by Subject|1|||
162868703|NCT03303339|588221620|FG007|Overall Study|Withdrawal by Subject|0|||
162868704|NCT03303339|588221621|FG008|Overall Study|Withdrawal by Subject|0|||
162868705|NCT03303339|588221622|FG009|Overall Study|Withdrawal by Subject|0|||
162868706|NCT03303339|588221623|FG010|Overall Study|Withdrawal by Subject|0|||
162868707|NCT03303339|588221624|FG011|Overall Study|Withdrawal by Subject|2|||
162868708|NCT03303339|588221613|FG000|Overall Study|Physician Decision|0|||
162868709|NCT03303339|588221614|FG001|Overall Study|Physician Decision|0|||
162868710|NCT03303339|588221615|FG002|Overall Study|Physician Decision|0|||
162868711|NCT03303339|588221616|FG003|Overall Study|Physician Decision|0|||
162868712|NCT03303339|588221617|FG004|Overall Study|Physician Decision|1|||
162868713|NCT03303339|588221618|FG005|Overall Study|Physician Decision|0|||
162868714|NCT03303339|588221619|FG006|Overall Study|Physician Decision|0|||
162868715|NCT03303339|588221620|FG007|Overall Study|Physician Decision|0|||
162868716|NCT03303339|588221621|FG008|Overall Study|Physician Decision|0|||
162868717|NCT03303339|588221622|FG009|Overall Study|Physician Decision|0|||
162868718|NCT03303339|588221623|FG010|Overall Study|Physician Decision|0|||
162868719|NCT03303339|588221624|FG011|Overall Study|Physician Decision|0|||
162868720|NCT03303339|588221613|FG000|Overall Study|Safety/Non-compliance|0|||
162868721|NCT03303339|588221614|FG001|Overall Study|Safety/Non-compliance|0|||
162868722|NCT03303339|588221615|FG002|Overall Study|Safety/Non-compliance|0|||
162868723|NCT03303339|588221616|FG003|Overall Study|Safety/Non-compliance|0|||
162868724|NCT03303339|588221617|FG004|Overall Study|Safety/Non-compliance|0|||
162868725|NCT03303339|588221618|FG005|Overall Study|Safety/Non-compliance|0|||
162868726|NCT03303339|588221619|FG006|Overall Study|Safety/Non-compliance|0|||
162868727|NCT03303339|588221620|FG007|Overall Study|Safety/Non-compliance|0|||
162868728|NCT03303339|588221621|FG008|Overall Study|Safety/Non-compliance|0|||
162868729|NCT03303339|588221622|FG009|Overall Study|Safety/Non-compliance|0|||
162868730|NCT03303339|588221623|FG010|Overall Study|Safety/Non-compliance|0|||
162868731|NCT03303339|588221624|FG011|Overall Study|Safety/Non-compliance|1|||
162868732|NCT00510692|588221626|FG000|Overall Study|Adverse Event|1|||
162868733|NCT00510692|588221627|FG001|Overall Study|Adverse Event|3|||
162868734|NCT00510692|588221626|FG000|Overall Study|Withdrawal by Subject|1|||
162868735|NCT00510692|588221627|FG001|Overall Study|Withdrawal by Subject|0|||
162868736|NCT02116972|588221628|FG000|Overall Study|Adverse Event|4|||
162868737|NCT02116972|588221629|FG001|Overall Study|Adverse Event|4|||
162868738|NCT02116972|588221630|FG002|Overall Study|Adverse Event|1|||
162868739|NCT02116972|588221628|FG000|Overall Study|Withdrawal by Subject|1|||
162868740|NCT02116972|588221629|FG001|Overall Study|Withdrawal by Subject|1|||
162868741|NCT02116972|588221630|FG002|Overall Study|Withdrawal by Subject|5|||
162868742|NCT02116972|588221628|FG000|Overall Study|Protocol Violation|1|||
162868743|NCT02116972|588221629|FG001|Overall Study|Protocol Violation|0|||
162868744|NCT02116972|588221630|FG002|Overall Study|Protocol Violation|1|||
162868745|NCT02116972|588221628|FG000|Overall Study|Lost to Follow-up|4|||
162868746|NCT02116972|588221629|FG001|Overall Study|Lost to Follow-up|3|||
162868747|NCT02116972|588221630|FG002|Overall Study|Lost to Follow-up|1|||
162868748|NCT02116972|588221628|FG000|Overall Study|Lack of Efficacy|6|||
162868749|NCT02116972|588221629|FG001|Overall Study|Lack of Efficacy|6|||
162868750|NCT02116972|588221630|FG002|Overall Study|Lack of Efficacy|5|||
162868751|NCT02116972|588221628|FG000|Overall Study|scheduling conflicts and relocation|3|||
162868752|NCT02116972|588221629|FG001|Overall Study|scheduling conflicts and relocation|3|||
162614567|NCT00560885|587305805|FG000|Overall Study|Withdrawal by Subject|1|||
162614568|NCT03148275|587305806|FG000|Overall Study|Death|6|||
162868753|NCT02116972|588221630|FG002|Overall Study|scheduling conflicts and relocation|6|||
162868754|NCT00784784|588221631|FG000|Overall Study|Withdrawal by Subject|2|||
162868755|NCT00784784|588221632|FG001|Overall Study|Withdrawal by Subject|2|||
162868756|NCT00872898|588221633|FG000|Part Two - Double Blind|Adverse Event|4|||
162868757|NCT00872898|588221634|FG001|Part Two - Double Blind|Adverse Event|3|||
162868758|NCT00872898|588221633|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
162868759|NCT00872898|588221634|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
162868760|NCT00872898|588221633|FG000|Part Two - Double Blind|Protocol Violation|1|||
162868761|NCT00872898|588221634|FG001|Part Two - Double Blind|Protocol Violation|0|||
162868762|NCT00872898|588221633|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
162868763|NCT00872898|588221634|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
162868764|NCT00872898|588221633|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
162868765|NCT00872898|588221634|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
162868766|NCT00872898|588221633|FG000|Part Two - Double Blind|Other reasons|2|||
162868767|NCT00872898|588221634|FG001|Part Two - Double Blind|Other reasons|0|||
162868768|NCT03176966|588221637|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
162868769|NCT03176966|588221638|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
162614569|NCT03148275|587305806|FG000|Overall Study|Adverse Event|3|||
162614570|NCT03148275|587305806|FG000|Overall Study|Liver transplant|2|||
162614571|NCT03148275|587305806|FG000|Overall Study|Patient decision|5|||
162614572|NCT03148275|587305806|FG000|Overall Study|transition to commercial drug|1|||
162614573|NCT03148275|587305806|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
162614574|NCT03803683|587305807|FG000|Overall Study|Lost to Follow-up|41|||
162614575|NCT03803683|587305808|FG001|Overall Study|Lost to Follow-up|18|||
162614576|NCT03803683|587305809|FG002|Overall Study|Lost to Follow-up|12|||
162614577|NCT03803683|587305807|FG000|Overall Study|Withdrawal by Subject|9|||
162614578|NCT03803683|587305808|FG001|Overall Study|Withdrawal by Subject|1|||
162614579|NCT03803683|587305809|FG002|Overall Study|Withdrawal by Subject|4|||
162868770|NCT03176966|588221637|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
162868771|NCT03176966|588221638|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
162868772|NCT03176966|588221637|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
162959891|NCT02832063|588556182|FG001|Overall Study|Withdrawal by Subject|21|||
162959892|NCT02832063|588556181|FG000|Overall Study|Other|2|||
162959893|NCT02832063|588556182|FG001|Overall Study|Other|1|||
162959894|NCT03733730|588556183|FG000|Overall Study|Lost to Follow-up|1|||
162959895|NCT03733730|588556184|FG001|Overall Study|Lost to Follow-up|32|||
162959896|NCT03733730|588556183|FG000|Overall Study|Other|1|||
162959897|NCT03733730|588556184|FG001|Overall Study|Other|0|||
162959898|NCT03733730|588556183|FG000|Overall Study|Adverse Event|0|||
162959899|NCT03733730|588556184|FG001|Overall Study|Adverse Event|4|||
162959900|NCT03733730|588556183|FG000|Overall Study|Death|0|||
162959901|NCT03733730|588556184|FG001|Overall Study|Death|5|||
162959902|NCT03733730|588556183|FG000|Overall Study|Withdrawal by Subject|0|||
162959903|NCT03733730|588556184|FG001|Overall Study|Withdrawal by Subject|8|||
162959904|NCT00772603|588556185|FG000|Overall Study|Withdrawal by Subject|11|||
162959905|NCT00772603|588556186|FG001|Overall Study|Withdrawal by Subject|10|||
162959906|NCT00772603|588556187|FG002|Overall Study|Withdrawal by Subject|6|||
162959907|NCT00772603|588556185|FG000|Overall Study|Adverse Event|37|||
162959908|NCT00772603|588556186|FG001|Overall Study|Adverse Event|18|||
162959909|NCT00772603|588556187|FG002|Overall Study|Adverse Event|10|||
162959910|NCT00772603|588556185|FG000|Overall Study|Subject Non-compliance|1|||
162959911|NCT00772603|588556186|FG001|Overall Study|Subject Non-compliance|6|||
162959912|NCT00772603|588556187|FG002|Overall Study|Subject Non-compliance|4|||
162959913|NCT00772603|588556185|FG000|Overall Study|Protocol Violation|0|||
162959914|NCT00772603|588556186|FG001|Overall Study|Protocol Violation|1|||
162959915|NCT00772603|588556187|FG002|Overall Study|Protocol Violation|1|||
162959916|NCT00772603|588556185|FG000|Overall Study|Lost to Follow-up|1|||
162614580|NCT00426231|587307309|FG000|Overall Study|Withdrawal by Subject|9|||
162614581|NCT00426231|587307310|FG001|Overall Study|Withdrawal by Subject|12|||
162614582|NCT00108433|587307311|FG000|Overall Study|Lack of Efficacy|1|||
162868773|NCT03176966|588221638|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
162868774|NCT03176966|588221637|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
162959917|NCT00772603|588556186|FG001|Overall Study|Lost to Follow-up|5|||
162959918|NCT00772603|588556187|FG002|Overall Study|Lost to Follow-up|2|||
162959919|NCT00772603|588556185|FG000|Overall Study|Physician Decision|0|||
162959920|NCT00772603|588556186|FG001|Overall Study|Physician Decision|0|||
162959921|NCT00772603|588556187|FG002|Overall Study|Physician Decision|1|||
162868775|NCT03176966|588221638|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
162868776|NCT03176966|588221637|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
162868777|NCT03176966|588221638|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
162868778|NCT03176966|588221637|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
162868779|NCT03176966|588221638|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
162868780|NCT03176966|588221637|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
162868781|NCT03176966|588221638|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
162868782|NCT01903434|588221643|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
162868783|NCT01903434|588221644|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
162868784|NCT01903434|588221643|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
162868785|NCT01903434|588221644|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
162868786|NCT00404768|588221645|FG000|Part A and B|Withdrawn due to labor progression|1|||
162868787|NCT00404768|588221646|FG001|Part A and B|Withdrawn due to labor progression|0|||
162868788|NCT00404768|588221647|FG002|Part A and B|Withdrawn due to labor progression|0|||
162868789|NCT00404768|588221648|FG003|Part A and B|Withdrawn due to labor progression|0|||
162868790|NCT00404768|588221645|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
162868791|NCT00404768|588221646|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
162868792|NCT00404768|588221647|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
162868793|NCT00404768|588221648|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
162868794|NCT00404768|588221645|FG000|Part C|Adverse Event|0|||
162868795|NCT00404768|588221646|FG001|Part C|Adverse Event|0|||
162868796|NCT00404768|588221647|FG002|Part C|Adverse Event|0|||
162868797|NCT00404768|588221648|FG003|Part C|Adverse Event|3|||
162868798|NCT00404768|588221645|FG000|Part C|Lost to Follow-up|0|||
162868799|NCT00404768|588221646|FG001|Part C|Lost to Follow-up|0|||
162868800|NCT00404768|588221647|FG002|Part C|Lost to Follow-up|3|||
162868801|NCT00404768|588221648|FG003|Part C|Lost to Follow-up|1|||
162868802|NCT00404768|588221645|FG000|Part C|Withdrawal by Subject|0|||
162868803|NCT00404768|588221646|FG001|Part C|Withdrawal by Subject|0|||
162868804|NCT00404768|588221647|FG002|Part C|Withdrawal by Subject|2|||
162868805|NCT00404768|588221648|FG003|Part C|Withdrawal by Subject|1|||
162868806|NCT00404768|588221645|FG000|Part C|Early withdrawal from study medication|0|||
162868807|NCT00404768|588221646|FG001|Part C|Early withdrawal from study medication|0|||
162868808|NCT00404768|588221647|FG002|Part C|Early withdrawal from study medication|1|||
162868809|NCT00404768|588221648|FG003|Part C|Early withdrawal from study medication|0|||
162868810|NCT00404768|588221645|FG000|Part C|Participant did not respond to therapy|0|||
162868811|NCT00404768|588221646|FG001|Part C|Participant did not respond to therapy|0|||
162868812|NCT00404768|588221647|FG002|Part C|Participant did not respond to therapy|1|||
162868813|NCT00404768|588221648|FG003|Part C|Participant did not respond to therapy|1|||
162868814|NCT00404768|588221645|FG000|Part C|Physician withdrew the study medication|0|||
162868815|NCT00404768|588221646|FG001|Part C|Physician withdrew the study medication|0|||
162868816|NCT00404768|588221647|FG002|Part C|Physician withdrew the study medication|1|||
162868817|NCT00404768|588221648|FG003|Part C|Physician withdrew the study medication|0|||
162868818|NCT00404768|588221645|FG000|Part C|Participant delivered baby|0|||
162868819|NCT00404768|588221646|FG001|Part C|Participant delivered baby|0|||
162868820|NCT00404768|588221647|FG002|Part C|Participant delivered baby|0|||
162868821|NCT00404768|588221648|FG003|Part C|Participant delivered baby|1|||
162868822|NCT00404768|588221645|FG000|Part C|Unsatisfactory uterine response to IP|0|||
162868823|NCT00404768|588221646|FG001|Part C|Unsatisfactory uterine response to IP|0|||
162868824|NCT00404768|588221647|FG002|Part C|Unsatisfactory uterine response to IP|0|||
162868825|NCT00404768|588221648|FG003|Part C|Unsatisfactory uterine response to IP|1|||
162868826|NCT00404768|588221645|FG000|Part C|Active labor|0|||
162868827|NCT00404768|588221646|FG001|Part C|Active labor|0|||
162868828|NCT00404768|588221647|FG002|Part C|Active labor|0|||
162868829|NCT00404768|588221648|FG003|Part C|Active labor|1|||
162868830|NCT00404768|588221645|FG000|Part C|Lack of Efficacy|0|||
162868831|NCT00404768|588221646|FG001|Part C|Lack of Efficacy|0|||
162868832|NCT00404768|588221647|FG002|Part C|Lack of Efficacy|0|||
162868833|NCT00404768|588221648|FG003|Part C|Lack of Efficacy|2|||
162868834|NCT00404768|588221645|FG000|Part C|Treatment failure|0|||
162868835|NCT00404768|588221646|FG001|Part C|Treatment failure|0|||
162959922|NCT00772603|588556185|FG000|Overall Study|Other|2|||
162959923|NCT00772603|588556186|FG001|Overall Study|Other|0|||
162868836|NCT00404768|588221647|FG002|Part C|Treatment failure|0|||
162959924|NCT00772603|588556187|FG002|Overall Study|Other|2|||
162959925|NCT00835575|588556188|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
162868837|NCT00404768|588221648|FG003|Part C|Treatment failure|1|||
162868838|NCT00404768|588221645|FG000|Part C|Investigator discretion|0|||
162868839|NCT00404768|588221646|FG001|Part C|Investigator discretion|0|||
162868840|NCT00404768|588221647|FG002|Part C|Investigator discretion|0|||
162868841|NCT00404768|588221648|FG003|Part C|Investigator discretion|1|||
162868842|NCT00404768|588221645|FG000|Part C|Researcher suspended study medication|0|||
162868843|NCT00404768|588221646|FG001|Part C|Researcher suspended study medication|0|||
162959926|NCT00835575|588556189|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
162868844|NCT00404768|588221647|FG002|Part C|Researcher suspended study medication|0|||
162868845|NCT00404768|588221648|FG003|Part C|Researcher suspended study medication|1|||
162868846|NCT01118143|588221649|FG000|Overall Study|Withdrawal by Subject|2|||
162868847|NCT01118143|588221650|FG001|Overall Study|Withdrawal by Subject|5|||
162868848|NCT01614769|588223607|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
162868849|NCT01614769|588223608|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
162868850|NCT01614769|588223609|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
162868851|NCT01614769|588223610|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
162868852|NCT01614769|588223611|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
162868853|NCT01614769|588223612|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
162868854|NCT01614769|588223607|FG000|Period 1|Protocol Violation|0|||
162868855|NCT01614769|588223608|FG001|Period 1|Protocol Violation|0|||
162868856|NCT01614769|588223609|FG002|Period 1|Protocol Violation|0|||
162868857|NCT01614769|588223610|FG003|Period 1|Protocol Violation|1|||
162868858|NCT01614769|588223611|FG004|Period 1|Protocol Violation|0|||
162868859|NCT01614769|588223612|FG005|Period 1|Protocol Violation|0|||
162868860|NCT01614769|588223607|FG000|Period 1|Withdrawal by Subject|1|||
162868861|NCT01614769|588223608|FG001|Period 1|Withdrawal by Subject|0|||
162868862|NCT01614769|588223609|FG002|Period 1|Withdrawal by Subject|0|||
162868863|NCT01614769|588223610|FG003|Period 1|Withdrawal by Subject|0|||
162868864|NCT01614769|588223611|FG004|Period 1|Withdrawal by Subject|0|||
162868865|NCT01614769|588223612|FG005|Period 1|Withdrawal by Subject|0|||
162868866|NCT01614769|588223607|FG000|Period 3|Withdrawal by Subject|0|||
162868867|NCT01614769|588223608|FG001|Period 3|Withdrawal by Subject|0|||
162868868|NCT01614769|588223609|FG002|Period 3|Withdrawal by Subject|1|||
162868869|NCT01614769|588223610|FG003|Period 3|Withdrawal by Subject|0|||
162868870|NCT01614769|588223611|FG004|Period 3|Withdrawal by Subject|0|||
162868871|NCT01614769|588223612|FG005|Period 3|Withdrawal by Subject|0|||
162868872|NCT00960440|588223615|FG000|Overall Study|Death|0|||
162868873|NCT00960440|588223616|FG001|Overall Study|Death|0|||
162868874|NCT00960440|588223617|FG002|Overall Study|Death|0|||
162868875|NCT00960440|588223618|FG003|Overall Study|Death|1|||
162868876|NCT00960440|588223615|FG000|Overall Study|Adverse Event|12|||
162868877|NCT00960440|588223616|FG001|Overall Study|Adverse Event|12|||
162868878|NCT00960440|588223617|FG002|Overall Study|Adverse Event|4|||
162868879|NCT00960440|588223618|FG003|Overall Study|Adverse Event|4|||
162868880|NCT00960440|588223615|FG000|Overall Study|Lack of Efficacy|2|||
162868881|NCT00960440|588223616|FG001|Overall Study|Lack of Efficacy|5|||
162868882|NCT00960440|588223617|FG002|Overall Study|Lack of Efficacy|3|||
162868883|NCT00960440|588223618|FG003|Overall Study|Lack of Efficacy|8|||
162868884|NCT00960440|588223615|FG000|Overall Study|Protocol Violation|2|||
162868885|NCT00960440|588223616|FG001|Overall Study|Protocol Violation|8|||
162868886|NCT00960440|588223617|FG002|Overall Study|Protocol Violation|3|||
162868887|NCT00960440|588223618|FG003|Overall Study|Protocol Violation|4|||
162868888|NCT00960440|588223615|FG000|Overall Study|Withdrawal by Subject|9|||
162868889|NCT00960440|588223616|FG001|Overall Study|Withdrawal by Subject|5|||
162868890|NCT00960440|588223617|FG002|Overall Study|Withdrawal by Subject|2|||
162868891|NCT00960440|588223618|FG003|Overall Study|Withdrawal by Subject|1|||
162868892|NCT00960440|588223615|FG000|Overall Study|Other|1|||
162868893|NCT00960440|588223616|FG001|Overall Study|Other|1|||
162868894|NCT00960440|588223617|FG002|Overall Study|Other|1|||
162868895|NCT00960440|588223618|FG003|Overall Study|Other|0|||
162868896|NCT03504774|588223619|FG000|Overall Study|Adverse Event|2|||
162868897|NCT03504774|588223620|FG001|Overall Study|Adverse Event|0|||
162868898|NCT03504774|588223619|FG000|Overall Study|Lost to Follow-up|0|||
162868899|NCT03504774|588223620|FG001|Overall Study|Lost to Follow-up|1|||
162868900|NCT03504774|588223619|FG000|Overall Study|Protocol Violation|11|||
162868901|NCT03504774|588223620|FG001|Overall Study|Protocol Violation|3|||
162868902|NCT03504774|588223619|FG000|Overall Study|failed wk 52 DBPCFC|1|||
162868903|NCT03504774|588223620|FG001|Overall Study|failed wk 52 DBPCFC|0|||
162868904|NCT02385123|588223621|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
162868905|NCT04498910|588223622|FG000|Overall Study|Lost to Follow-up|0|||
162868906|NCT04498910|588223623|FG001|Overall Study|Lost to Follow-up|1|||
162868907|NCT04498910|588223622|FG000|Overall Study|Withdrawal by Subject|2|||
162868908|NCT04498910|588223623|FG001|Overall Study|Withdrawal by Subject|1|||
162868909|NCT04498910|588223622|FG000|Overall Study|Adverse Event|1|||
162868910|NCT04498910|588223623|FG001|Overall Study|Adverse Event|0|||
162868911|NCT02345434|588223625|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
162868912|NCT02345434|588223626|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
162868913|NCT01188798|588223635|FG000|Overall Study|Death|0|||
162868914|NCT01188798|588223636|FG001|Overall Study|Death|1|||
162868915|NCT01188798|588223635|FG000|Overall Study|Required additional transplant|1|||
162868916|NCT01188798|588223636|FG001|Overall Study|Required additional transplant|1|||
162868917|NCT01188798|588223635|FG000|Overall Study|Protocol closure|1|||
162868918|NCT01188798|588223636|FG001|Overall Study|Protocol closure|1|||
162868919|NCT03964415|588223642|FG000|Overall Study|Sponsor's decision|1563|||
162868920|NCT03964415|588223643|FG001|Overall Study|Sponsor's decision|1528|||
162868921|NCT03964415|588223642|FG000|Overall Study|Lost to Follow-up|139|||
162868922|NCT03964415|588223643|FG001|Overall Study|Lost to Follow-up|146|||
162868923|NCT03964415|588223642|FG000|Overall Study|Withdrawal by Subject|68|||
162868924|NCT03964415|588223643|FG001|Overall Study|Withdrawal by Subject|72|||
162614583|NCT00108433|587307312|FG001|Overall Study|Lack of Efficacy|2|||
162614584|NCT00108433|587307311|FG000|Overall Study|Death|3|||
162614585|NCT00108433|587307312|FG001|Overall Study|Death|0|||
162614586|NCT00108433|587307311|FG000|Overall Study|Adverse Event|3|||
162614587|NCT00108433|587307312|FG001|Overall Study|Adverse Event|1|||
162614588|NCT00108433|587307311|FG000|Overall Study|Other|14|||
162614589|NCT00108433|587307312|FG001|Overall Study|Other|14|||
162614590|NCT01193660|587307313|FG000|Overall Study|Withdrawal by Subject|2|||
162868925|NCT03964415|588223642|FG000|Overall Study|Physician Decision|34|||
162868926|NCT03964415|588223643|FG001|Overall Study|Physician Decision|48|||
162868927|NCT03964415|588223642|FG000|Overall Study|Adverse Event|3|||
162868928|NCT03964415|588223643|FG001|Overall Study|Adverse Event|0|||
162868929|NCT03964415|588223642|FG000|Overall Study|Death|4|||
162868930|NCT03964415|588223643|FG001|Overall Study|Death|6|||
162868931|NCT03964415|588223642|FG000|Overall Study|Protocol Violation|1|||
162868932|NCT03964415|588223643|FG001|Overall Study|Protocol Violation|4|||
162868933|NCT03964415|588223642|FG000|Overall Study|Other|35|||
162868934|NCT03964415|588223643|FG001|Overall Study|Other|38|||
162868935|NCT03964415|588223642|FG000|Overall Study|Randomized but not treated|6|||
162868936|NCT03964415|588223643|FG001|Overall Study|Randomized but not treated|7|||
162868937|NCT01302769|588223644|FG000|Overall Study|Lost to Follow-up|1|||
162868938|NCT01302769|588223645|FG001|Overall Study|Lost to Follow-up|1|||
162868939|NCT01024465|588223653|FG000|Overall Study|Adverse Event|2|||
162868940|NCT01024465|588223653|FG000|Overall Study|Physician Decision|1|||
162868941|NCT01734993|588223654|FG000|Overall Study|Adverse Event|1|||
162868942|NCT01734993|588223654|FG000|Overall Study|Lack of Efficacy|1|||
162868943|NCT03078608|588223656|FG000|Overall Study|Death|1|||
162868944|NCT03078608|588223657|FG001|Overall Study|Death|2|||
162868945|NCT03078608|588223658|FG002|Overall Study|Death|0|||
162868946|NCT03078608|588223659|FG003|Overall Study|Death|0|||
162868947|NCT03078608|588223656|FG000|Overall Study|Withdrawal by Subject|8|||
162868948|NCT03078608|588223657|FG001|Overall Study|Withdrawal by Subject|1|||
162868949|NCT03078608|588223658|FG002|Overall Study|Withdrawal by Subject|0|||
162868950|NCT03078608|588223659|FG003|Overall Study|Withdrawal by Subject|0|||
162868951|NCT03078608|588223656|FG000|Overall Study|Lost to Follow-up|5|||
162868952|NCT03078608|588223657|FG001|Overall Study|Lost to Follow-up|8|||
162868953|NCT03078608|588223658|FG002|Overall Study|Lost to Follow-up|4|||
162868954|NCT03078608|588223659|FG003|Overall Study|Lost to Follow-up|1|||
162868955|NCT00723840|588223660|FG000|Overall Study|Lost to Follow-up|2|||
162868956|NCT00723840|588223660|FG000|Overall Study|Failure to return|18|||
162868957|NCT00723840|588223660|FG000|Overall Study|Withdrawal by Subject|55|||
162868958|NCT00723840|588223660|FG000|Overall Study|Serious Adverse Events|3|||
162868959|NCT00723840|588223660|FG000|Overall Study|Other Medical Event|2|||
162868960|NCT00723840|588223660|FG000|Overall Study|Unspecified reason|2|||
162868961|NCT02760407|588223667|FG000|Overall Study|Death|2|||
162614591|NCT01193660|587307314|FG001|Overall Study|Withdrawal by Subject|3|||
162868962|NCT02760407|588223668|FG001|Overall Study|Death|3|||
162868963|NCT02760407|588223669|FG002|Overall Study|Death|1|||
162868964|NCT02760407|588223670|FG003|Overall Study|Death|1|||
162868965|NCT02760407|588223667|FG000|Overall Study|Lost to Follow-up|1|||
162868966|NCT02760407|588223668|FG001|Overall Study|Lost to Follow-up|7|||
162868967|NCT02760407|588223669|FG002|Overall Study|Lost to Follow-up|4|||
162868968|NCT02760407|588223670|FG003|Overall Study|Lost to Follow-up|6|||
162868969|NCT02760407|588223667|FG000|Overall Study|Withdrawal by Subject|25|||
162868970|NCT02760407|588223668|FG001|Overall Study|Withdrawal by Subject|31|||
162868971|NCT02760407|588223669|FG002|Overall Study|Withdrawal by Subject|37|||
162868972|NCT02760407|588223670|FG003|Overall Study|Withdrawal by Subject|25|||
162868973|NCT02760407|588223667|FG000|Overall Study|Violation of Eligibility criteria|0|||
162868974|NCT02760407|588223668|FG001|Overall Study|Violation of Eligibility criteria|0|||
162868975|NCT02760407|588223669|FG002|Overall Study|Violation of Eligibility criteria|1|||
162868976|NCT02760407|588223670|FG003|Overall Study|Violation of Eligibility criteria|1|||
162868977|NCT02760407|588223667|FG000|Overall Study|Personal reasons|0|||
162868978|NCT02760407|588223668|FG001|Overall Study|Personal reasons|0|||
162868979|NCT02760407|588223669|FG002|Overall Study|Personal reasons|0|||
162868980|NCT02760407|588223670|FG003|Overall Study|Personal reasons|1|||
162868981|NCT02760407|588223667|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
162868982|NCT02760407|588223668|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
162868983|NCT02760407|588223669|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
162868984|NCT02760407|588223670|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
162868985|NCT02760407|588223667|FG000|Overall Study|Use of prohibited Medication|0|||
162868986|NCT02760407|588223668|FG001|Overall Study|Use of prohibited Medication|0|||
162868987|NCT02760407|588223669|FG002|Overall Study|Use of prohibited Medication|1|||
162868988|NCT02760407|588223670|FG003|Overall Study|Use of prohibited Medication|0|||
162868989|NCT02760407|588223667|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
162868990|NCT02760407|588223668|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
162614592|NCT01193660|587307315|FG002|Overall Study|Withdrawal by Subject|1|||
162868991|NCT02760407|588223669|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
162868992|NCT02760407|588223670|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
162868993|NCT02760407|588223667|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
162868994|NCT02760407|588223668|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
162868995|NCT02760407|588223669|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
162868996|NCT02760407|588223670|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
162868997|NCT02760407|588223667|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
162868998|NCT02760407|588223668|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
162868999|NCT02760407|588223669|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
162869000|NCT02760407|588223670|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
162869001|NCT02760407|588223667|FG000|Overall Study|Inadequately Enrolled|0|||
162869002|NCT02760407|588223668|FG001|Overall Study|Inadequately Enrolled|0|||
162869003|NCT02760407|588223669|FG002|Overall Study|Inadequately Enrolled|0|||
162869004|NCT02760407|588223670|FG003|Overall Study|Inadequately Enrolled|1|||
162869005|NCT02760407|588223667|FG000|Overall Study|Withdrawal By PI's Decision|0|||
162869006|NCT02760407|588223668|FG001|Overall Study|Withdrawal By PI's Decision|1|||
162869007|NCT02760407|588223669|FG002|Overall Study|Withdrawal By PI's Decision|0|||
162869008|NCT02760407|588223670|FG003|Overall Study|Withdrawal By PI's Decision|0|||
162869009|NCT02760407|588223667|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
162869010|NCT02760407|588223668|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
162869011|NCT02760407|588223669|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
162869012|NCT02760407|588223670|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
162869013|NCT02760407|588223667|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
162869014|NCT02760407|588223668|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
162869015|NCT02760407|588223669|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
162869016|NCT02760407|588223670|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
162869017|NCT02760407|588223667|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
162869018|NCT02760407|588223668|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
162869019|NCT02760407|588223669|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
162869020|NCT02760407|588223670|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
162869021|NCT02760407|588223667|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
162869022|NCT02760407|588223668|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
162869023|NCT02760407|588223669|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
162869024|NCT02760407|588223670|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
162869025|NCT02760407|588223667|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
162869026|NCT02760407|588223668|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
162869027|NCT02760407|588223669|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
162869028|NCT02760407|588223670|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
162869029|NCT02760407|588223667|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
162869030|NCT02760407|588223668|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
162869031|NCT02760407|588223669|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
162869032|NCT02760407|588223670|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
162869033|NCT02760407|588223667|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
162869034|NCT02760407|588223668|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
162869035|NCT02760407|588223669|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
162869036|NCT02760407|588223670|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
162869037|NCT02760407|588223667|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
162869038|NCT02760407|588223668|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
162869039|NCT02760407|588223669|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
162869040|NCT02760407|588223670|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
162869041|NCT02760407|588223667|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
162869042|NCT02760407|588223668|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
162869043|NCT02760407|588223669|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
162869044|NCT02760407|588223670|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
162869045|NCT02522377|588223671|FG000|Overall Study|Withdrawal by Subject|1|||
162869046|NCT02522377|588223672|FG001|Overall Study|Withdrawal by Subject|0|||
162869047|NCT02522377|588223671|FG000|Overall Study|Remission Achieved|3|||
162869048|NCT02522377|588223672|FG001|Overall Study|Remission Achieved|0|||
162869049|NCT01158950|588223673|FG000|1st Intervention (1 Day)|Physician Decision|1|||
162869050|NCT01158950|588223674|FG001|1st Intervention (1 Day)|Physician Decision|2|||
162869051|NCT00945191|588223675|FG000|Overall Study|Did not achieve a complete response|18|||
162869052|NCT00945191|588223675|FG000|Overall Study|Participant relocated to another state|1|||
162869053|NCT00945191|588223675|FG000|Overall Study|Disease progression|3|||
162869054|NCT00945191|588223675|FG000|Overall Study|Serious adverse event or adverse event|1|||
162869055|NCT00945191|588223675|FG000|Overall Study|Investigator's discretion|1|||
162869056|NCT01921270|588223682|FG000|Overall Study|Withdrawal by Subject|1|||
162869057|NCT02137772|588223685|FG000|Overall Study|Adverse Event|6|||
162869058|NCT02137772|588223686|FG001|Overall Study|Adverse Event|3|||
162869059|NCT02137772|588223685|FG000|Overall Study|Death|71|||
162869060|NCT02137772|588223686|FG001|Overall Study|Death|44|||
162869061|NCT02137772|588223685|FG000|Overall Study|Lost to Follow-up|8|||
162869062|NCT02137772|588223686|FG001|Overall Study|Lost to Follow-up|4|||
162869063|NCT02137772|588223685|FG000|Overall Study|Physician Decision|15|||
162869064|NCT02137772|588223686|FG001|Overall Study|Physician Decision|5|||
162869065|NCT02137772|588223685|FG000|Overall Study|Withdrawal by Subject|28|||
162869066|NCT02137772|588223686|FG001|Overall Study|Withdrawal by Subject|17|||
162869067|NCT02137772|588223685|FG000|Overall Study|Non-compliance with study drug|1|||
162869068|NCT02137772|588223686|FG001|Overall Study|Non-compliance with study drug|0|||
162869069|NCT02137772|588223685|FG000|Overall Study|Not treated|3|||
162869070|NCT02137772|588223686|FG001|Overall Study|Not treated|2|||
162869071|NCT01844700|588223687|FG000|Overall Study|Lack of Efficacy|1|||
162869072|NCT01844700|588223688|FG001|Overall Study|Lack of Efficacy|0|||
162869073|NCT01844700|588223687|FG000|Overall Study|refused medication switch|1|||
162869074|NCT01844700|588223688|FG001|Overall Study|refused medication switch|0|||
162869075|NCT01844700|588223687|FG000|Overall Study|Withdrawal by Subject|1|||
162869076|NCT01844700|588223688|FG001|Overall Study|Withdrawal by Subject|0|||
162869077|NCT01844700|588223687|FG000|Overall Study|stopped taking meds|0|||
162869078|NCT01844700|588223688|FG001|Overall Study|stopped taking meds|1|||
162869079|NCT00863928|588223689|FG000|Overall Study|Protocol Violation|26|||
162869080|NCT00863928|588223690|FG001|Overall Study|Protocol Violation|0|||
162869081|NCT00863928|588223689|FG000|Overall Study|Withdrawal by Subject|3|||
162869082|NCT00863928|588223690|FG001|Overall Study|Withdrawal by Subject|0|||
162869083|NCT00863928|588223689|FG000|Overall Study|surgery cancellation|4|||
162869084|NCT00863928|588223690|FG001|Overall Study|surgery cancellation|0|||
162869085|NCT00863928|588223689|FG000|Overall Study|medication allergy|3|||
162869086|NCT00863928|588223690|FG001|Overall Study|medication allergy|0|||
162869087|NCT03290300|588223691|FG000|Overall Study|Lost to Follow-up|3|||
162869088|NCT00864227|588223692|FG000|Overall Study|Withdrawal by Subject|1|||
162869089|NCT00864227|588223692|FG000|Overall Study|Disease Relapse/Progression|3|||
162869090|NCT02124798|588223693|FG000|Overall Study|Adverse Event|3|||
162869091|NCT02124798|588223693|FG000|Overall Study|Lost to Follow-up|1|||
162869092|NCT01797432|588223694|FG000|Overall Study|Lost to Follow-up|1|||
162869093|NCT01797432|588223694|FG000|Overall Study|Adverse Event|1|||
162869094|NCT01797432|588223694|FG000|Overall Study|Withdrawal by Subject|1|||
162869095|NCT01797432|588223694|FG000|Overall Study|lived too far from study site|1|||
162869096|NCT02792777|588223695|FG000|Overall Study|Withdrawal by Subject|2|||
162869097|NCT02792777|588223696|FG001|Overall Study|Withdrawal by Subject|0|||
162869098|NCT02792777|588223695|FG000|Overall Study|Recording malfunction|2|||
162869099|NCT02792777|588223696|FG001|Overall Study|Recording malfunction|0|||
162869100|NCT02792777|588223695|FG000|Overall Study|Later determined to be ineligible|2|||
162869101|NCT02792777|588223696|FG001|Overall Study|Later determined to be ineligible|0|||
162706203|NCT01318811|587636586|FG001|Overall Study|Physician Decision|1|||
162706204|NCT01318811|587636585|FG000|Overall Study|CRRT stopped for head CT|0|||
162706205|NCT01318811|587636586|FG001|Overall Study|CRRT stopped for head CT|1|||
162706206|NCT01318811|587636585|FG000|Overall Study|Death|0|||
162706207|NCT01318811|587636586|FG001|Overall Study|Death|1|||
162706208|NCT01318811|587636585|FG000|Overall Study|CRRT stopped for head MRI|0|||
162706209|NCT01318811|587636586|FG001|Overall Study|CRRT stopped for head MRI|1|||
162706210|NCT00811187|587636587|FG000|Overall Study|Unable to place device / procedure abort|3|||
162706211|NCT00811187|587636588|FG001|Overall Study|Unable to place device / procedure abort|3|||
162706212|NCT02825043|587636589|FG000|Overall Study|Lost to Follow-up|4|||
162706213|NCT00131911|587636590|FG000|Overall Study|Withdrawal by Subject|1|||
162706214|NCT00131911|587636591|FG001|Overall Study|Withdrawal by Subject|0|||
162706215|NCT00329303|587636592|FG000|Overall Study|Lack of Efficacy|1|||
162706216|NCT00329303|587636593|FG001|Overall Study|Lack of Efficacy|0|||
162706217|NCT00329303|587636592|FG000|Overall Study|Decision of the sponsor|0|||
162706218|NCT00329303|587636593|FG001|Overall Study|Decision of the sponsor|1|||
162706219|NCT00329303|587636592|FG000|Overall Study|Patient no longer available|1|||
162706220|NCT00329303|587636593|FG001|Overall Study|Patient no longer available|0|||
162706221|NCT00329303|587636592|FG000|Overall Study|Patient relocated|0|||
162869102|NCT02792777|588223695|FG000|Overall Study|Participant interviewed twice|1|||
162869103|NCT02792777|588223696|FG001|Overall Study|Participant interviewed twice|0|||
162869104|NCT02795156|588223697|FG000|Overall Study|Progressive Disease|22|||
162706222|NCT00329303|587636593|FG001|Overall Study|Patient relocated|1|||
162869105|NCT02795156|588223698|FG001|Overall Study|Progressive Disease|7|||
162869106|NCT02795156|588223699|FG002|Overall Study|Progressive Disease|34|||
162869107|NCT02795156|588223700|FG003|Overall Study|Progressive Disease|7|||
162869108|NCT02795156|588223697|FG000|Overall Study|Adverse Event|13|||
162869109|NCT02795156|588223698|FG001|Overall Study|Adverse Event|2|||
162869110|NCT02795156|588223699|FG002|Overall Study|Adverse Event|3|||
162869111|NCT02795156|588223700|FG003|Overall Study|Adverse Event|2|||
162869112|NCT02795156|588223697|FG000|Overall Study|Death|1|||
162869113|NCT02795156|588223698|FG001|Overall Study|Death|1|||
162869114|NCT02795156|588223699|FG002|Overall Study|Death|1|||
162869115|NCT02795156|588223700|FG003|Overall Study|Death|0|||
162869116|NCT02795156|588223697|FG000|Overall Study|Physician Decision|1|||
162869117|NCT02795156|588223698|FG001|Overall Study|Physician Decision|0|||
162959927|NCT01564394|588556192|FG000|Overall Study|Withdrawal by Subject|6|||
162959928|NCT01564394|588556193|FG001|Overall Study|Withdrawal by Subject|10|||
162959929|NCT00859521|588556194|FG000|Washout|Withdrawal by Subject|0|||
162959930|NCT00859521|588556195|FG001|Washout|Withdrawal by Subject|1|||
162959931|NCT01609257|588556196|FG000|Overall Study|Lost to Follow-up|2|||
162959932|NCT01609257|588556197|FG001|Overall Study|Lost to Follow-up|1|||
162959933|NCT01609257|588556196|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
162959934|NCT01609257|588556197|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
162959935|NCT01609257|588556196|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
162959936|NCT01609257|588556197|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
162959937|NCT02125461|588556198|FG000|Overall Study|Withdrawal by Subject|30|||
162959938|NCT02125461|588556199|FG001|Overall Study|Withdrawal by Subject|16|||
162959939|NCT02125461|588556198|FG000|Overall Study|Lost to Follow-up|8|||
162959940|NCT02125461|588556199|FG001|Overall Study|Lost to Follow-up|3|||
162959941|NCT02125461|588556198|FG000|Overall Study|Death|260|||
162959942|NCT02125461|588556199|FG001|Overall Study|Death|149|||
162959943|NCT02125461|588556198|FG000|Overall Study|Missing Termination Reason|0|||
162959944|NCT02125461|588556199|FG001|Overall Study|Missing Termination Reason|1|||
162959945|NCT03552484|588556208|FG000|Overall Study|Death|6|||
162959946|NCT03552484|588556209|FG001|Overall Study|Death|4|||
162959947|NCT03552484|588556208|FG000|Overall Study|Lost to Follow-up|0|||
162959948|NCT03552484|588556209|FG001|Overall Study|Lost to Follow-up|16|||
162959949|NCT02241551|588556210|FG000|Overall Study|Adverse Event|1|||
162959950|NCT02241551|588556211|FG001|Overall Study|Adverse Event|0|||
162959951|NCT03499353|588556212|FG000|Treatment|Adverse Event|3|||
162959952|NCT03499353|588556212|FG000|Treatment|Progressive Disease|10|||
162959953|NCT03499353|588556212|FG000|Treatment|Other|1|||
162959954|NCT03499353|588556212|FG000|Treatment|Withdrawal by Subject|2|||
162959955|NCT03499353|588556212|FG000|Long-Term Follow-up|Death|2|||
162959956|NCT03499353|588556212|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
162959957|NCT03499353|588556212|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
162959958|NCT00469898|588556219|FG000|Overall Study|Adverse Event|7|||
162959959|NCT00469898|588556219|FG000|Overall Study|Withdrawal by Subject|4|||
162959960|NCT00469898|588556219|FG000|Overall Study|Death|4|||
162959961|NCT00469898|588556219|FG000|Overall Study|Disease progression|9|||
162959962|NCT00469898|588556219|FG000|Overall Study|Decreased performance status|1|||
162959963|NCT02663349|588556222|FG000|Overall Study|Withdrawal by Subject|6|||
162959964|NCT02751424|588556230|FG000|Part 2|Adverse Event|0|||
162959965|NCT02751424|588556231|FG001|Part 2|Adverse Event|0|||
162959966|NCT02751424|588556232|FG002|Part 2|Adverse Event|0|||
162959967|NCT02751424|588556233|FG003|Part 2|Adverse Event|0|||
162959968|NCT02751424|588556234|FG004|Part 2|Adverse Event|0|||
162959969|NCT02751424|588556235|FG005|Part 2|Adverse Event|0|||
162959970|NCT02751424|588556236|FG006|Part 2|Adverse Event|0|||
162959971|NCT02751424|588556237|FG007|Part 2|Adverse Event|5|||
162959972|NCT02751424|588556238|FG008|Part 2|Adverse Event|0|||
162959973|NCT00848536|588556239|FG000|Overall Study|Adverse Event|2|||
162959974|NCT00848536|588556240|FG001|Overall Study|Adverse Event|2|||
162959975|NCT00848536|588556239|FG000|Overall Study|Withdrawal by Subject|0|||
162959976|NCT00848536|588556240|FG001|Overall Study|Withdrawal by Subject|1|||
162959977|NCT00848536|588556239|FG000|Overall Study|Protocol Violation|0|||
162959978|NCT00848536|588556240|FG001|Overall Study|Protocol Violation|1|||
162959979|NCT00848536|588556239|FG000|Overall Study|Noncompliance|1|||
162959980|NCT00848536|588556240|FG001|Overall Study|Noncompliance|0|||
162869118|NCT02795156|588223699|FG002|Overall Study|Physician Decision|1|||
162869119|NCT02795156|588223700|FG003|Overall Study|Physician Decision|0|||
162869120|NCT02795156|588223697|FG000|Overall Study|Withdrawal by Subject|2|||
162869121|NCT02795156|588223698|FG001|Overall Study|Withdrawal by Subject|0|||
162869122|NCT02795156|588223699|FG002|Overall Study|Withdrawal by Subject|3|||
162869123|NCT02795156|588223700|FG003|Overall Study|Withdrawal by Subject|0|||
162869124|NCT00638846|588223704|FG000|Overall Study|Adverse Event|0|||
162959981|NCT00848536|588556239|FG000|Overall Study|Inadequate Control of IOP|1|||
162959982|NCT00848536|588556240|FG001|Overall Study|Inadequate Control of IOP|1|||
162959983|NCT00848536|588556239|FG000|Overall Study|Patient Moved|0|||
162959984|NCT00848536|588556240|FG001|Overall Study|Patient Moved|2|||
162869125|NCT00638846|588223705|FG001|Overall Study|Adverse Event|1|||
162959985|NCT01175135|588556241|FG000|Overall Study|Adverse Event|2|||
162959986|NCT01175135|588556242|FG001|Overall Study|Adverse Event|5|||
162959987|NCT01175135|588556243|FG002|Overall Study|Adverse Event|3|||
162959988|NCT01175135|588556244|FG003|Overall Study|Adverse Event|4|||
162959989|NCT01175135|588556241|FG000|Overall Study|Death|1|||
162959990|NCT01175135|588556242|FG001|Overall Study|Death|0|||
162959991|NCT01175135|588556243|FG002|Overall Study|Death|0|||
162959992|NCT01175135|588556244|FG003|Overall Study|Death|0|||
162959993|NCT01175135|588556241|FG000|Overall Study|Lack of Efficacy|4|||
162959994|NCT01175135|588556242|FG001|Overall Study|Lack of Efficacy|5|||
162959995|NCT01175135|588556243|FG002|Overall Study|Lack of Efficacy|0|||
162959996|NCT01175135|588556244|FG003|Overall Study|Lack of Efficacy|5|||
162959997|NCT01175135|588556241|FG000|Overall Study|Lost to Follow-up|1|||
162959998|NCT01175135|588556242|FG001|Overall Study|Lost to Follow-up|2|||
162959999|NCT01175135|588556243|FG002|Overall Study|Lost to Follow-up|0|||
162960000|NCT01175135|588556244|FG003|Overall Study|Lost to Follow-up|0|||
162960001|NCT01175135|588556241|FG000|Overall Study|Protocol Violation|1|||
162960002|NCT01175135|588556242|FG001|Overall Study|Protocol Violation|1|||
162960003|NCT01175135|588556243|FG002|Overall Study|Protocol Violation|0|||
162960004|NCT01175135|588556244|FG003|Overall Study|Protocol Violation|0|||
162960005|NCT01175135|588556241|FG000|Overall Study|Withdrawal by Subject|4|||
162960006|NCT01175135|588556242|FG001|Overall Study|Withdrawal by Subject|8|||
162960007|NCT01175135|588556243|FG002|Overall Study|Withdrawal by Subject|5|||
162960008|NCT01175135|588556244|FG003|Overall Study|Withdrawal by Subject|5|||
162960009|NCT01175135|588556241|FG000|Overall Study|Other|3|||
162960010|NCT01175135|588556242|FG001|Overall Study|Other|1|||
162960011|NCT01175135|588556243|FG002|Overall Study|Other|3|||
162960012|NCT01175135|588556244|FG003|Overall Study|Other|0|||
162960013|NCT01175135|588556241|FG000|Overall Study|Randomized But Not Treated|0|||
162960014|NCT01175135|588556242|FG001|Overall Study|Randomized But Not Treated|0|||
162960015|NCT01175135|588556243|FG002|Overall Study|Randomized But Not Treated|1|||
162960016|NCT01175135|588556244|FG003|Overall Study|Randomized But Not Treated|0|||
162960017|NCT01590563|588556247|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
162960018|NCT03534193|588556250|FG000|Overall Study|Lost to Follow-up|1|||
162960019|NCT03534193|588556251|FG001|Overall Study|Lost to Follow-up|3|||
162960020|NCT02699463|588556252|FG000|Overall Study|Lost to Follow-up|11|||
162960021|NCT02699463|588556253|FG001|Overall Study|Lost to Follow-up|8|||
162960022|NCT02699463|588556252|FG000|Overall Study|Withdrawal by Subject|4|||
162960023|NCT02699463|588556253|FG001|Overall Study|Withdrawal by Subject|1|||
162960024|NCT02488239|588556254|FG000|Overall Study|Death|3|||
162960025|NCT02488239|588556254|FG000|Overall Study|Withdrawal by Subject|3|||
162960026|NCT02488239|588556254|FG000|Overall Study|Physician Decision|2|||
162960027|NCT02488239|588556254|FG000|Overall Study|Consent ineligible|1|||
162960028|NCT02488239|588556254|FG000|Overall Study|Did not undergo implant procedure|1|||
162960029|NCT04414930|588556256|FG000|Overall Study|Withdrawal by Subject|1|||
162960030|NCT04414930|588556257|FG001|Overall Study|Withdrawal by Subject|3|||
162960031|NCT05470699|588556258|FG000|Overall Study|Did not receive intervention|13|||
162960032|NCT05470699|588556258|FG000|Overall Study|Ineligible|1|||
162960033|NCT01370733|588556259|FG000|Overall Study|Withdrawal by Subject|8|||
162960034|NCT01370733|588556260|FG001|Overall Study|Withdrawal by Subject|8|||
162960035|NCT01370733|588556259|FG000|Overall Study|Lost to Follow-up|3|||
162960036|NCT01370733|588556260|FG001|Overall Study|Lost to Follow-up|0|||
162960037|NCT01370733|588556259|FG000|Overall Study|Adverse Event|2|||
162960038|NCT01370733|588556260|FG001|Overall Study|Adverse Event|4|||
162960039|NCT01370733|588556259|FG000|Overall Study|Lack of Efficacy|3|||
162960040|NCT01370733|588556260|FG001|Overall Study|Lack of Efficacy|5|||
162960041|NCT01370733|588556259|FG000|Overall Study|Physician Decision|0|||
162960042|NCT01370733|588556260|FG001|Overall Study|Physician Decision|2|||
162960043|NCT01370733|588556259|FG000|Overall Study|Protocol Violation|1|||
162960044|NCT01370733|588556260|FG001|Overall Study|Protocol Violation|3|||
162960045|NCT03325881|588556261|FG000|Overall Study|Protocol Violation|0|||
162960046|NCT03325881|588556262|FG001|Overall Study|Protocol Violation|1|||
162960047|NCT03325881|588556261|FG000|Overall Study|Withdrawal by Subject|0|||
162960048|NCT03325881|588556262|FG001|Overall Study|Withdrawal by Subject|2|||
162960049|NCT03325881|588556261|FG000|Overall Study|Lack of Efficacy|2|||
162960050|NCT03325881|588556262|FG001|Overall Study|Lack of Efficacy|0|||
162960051|NCT03325881|588556261|FG000|Overall Study|Not treated|1|||
162960052|NCT03325881|588556262|FG001|Overall Study|Not treated|0|||
162960053|NCT03676634|588556263|FG000|Overall Study|Red blood cell loss|1|||
162960054|NCT03676634|588556263|FG000|Overall Study|Out-of-limit pulse|2|||
162960055|NCT02294981|588556264|FG000|Overall Study|Lost to Follow-up|1|||
162960056|NCT00829712|588556265|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162960057|NCT00829712|588556266|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162960058|NCT01848938|588556278|FG000|Overall Study|Lost to Follow-up|1|||
162960059|NCT01848938|588556279|FG001|Overall Study|Lost to Follow-up|1|||
162960060|NCT00909753|588556282|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
162614593|NCT01193660|587307313|FG000|Overall Study|Death|1|||
162960061|NCT00909753|588556283|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
163046787|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046788|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046789|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046790|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163046791|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163046792|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
163046793|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046794|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046795|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046796|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046797|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046798|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046799|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046800|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046801|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046802|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046803|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046804|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046805|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163046806|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
163046807|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
163046808|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163046809|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046810|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046811|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046812|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046813|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046814|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046815|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046816|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046817|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046818|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046819|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046820|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163046821|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046822|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046823|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
163046824|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046825|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046826|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046827|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046828|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046829|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046830|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046831|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046832|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046833|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046834|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046835|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
163046836|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046837|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046838|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
163046839|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046840|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046841|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046842|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046843|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046844|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046845|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046846|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046847|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046848|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046849|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
162614594|NCT01193660|587307314|FG001|Overall Study|Death|0|||
162614595|NCT01193660|587307315|FG002|Overall Study|Death|0|||
162960062|NCT00909753|588556282|FG000|Period: Second Intervention|Protocol Violation|1|||
162960063|NCT00909753|588556283|FG001|Period: Second Intervention|Protocol Violation|0|||
162960064|NCT00835536|588556284|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
162960065|NCT00835536|588556285|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
162960066|NCT04827394|588556293|FG000|Overall Study|Physician Decision|0|||
162960067|NCT04827394|588556294|FG001|Overall Study|Physician Decision|2|||
162960068|NCT01154231|588556295|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
162960069|NCT01154231|588556295|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
162960070|NCT06041256|588556296|FG000|Overall Study|Withdrawal by Subject|1|||
162960071|NCT06041256|588556297|FG001|Overall Study|Withdrawal by Subject|0|||
162960072|NCT06041256|588556298|FG002|Overall Study|Withdrawal by Subject|3|||
162960073|NCT06041256|588556299|FG003|Overall Study|Withdrawal by Subject|1|||
162960074|NCT06041256|588556300|FG004|Overall Study|Withdrawal by Subject|1|||
162960075|NCT06041256|588556296|FG000|Overall Study|Rescue|17|||
162960076|NCT06041256|588556297|FG001|Overall Study|Rescue|6|||
162960077|NCT06041256|588556298|FG002|Overall Study|Rescue|9|||
162960078|NCT06041256|588556299|FG003|Overall Study|Rescue|6|||
162960079|NCT06041256|588556300|FG004|Overall Study|Rescue|2|||
162960080|NCT03578809|588557587|FG000|Overall Study|Death|0|||
162960081|NCT03578809|588557588|FG001|Overall Study|Death|2|||
162960082|NCT03578809|588557589|FG002|Overall Study|Death|0|||
162960083|NCT03578809|588557590|FG003|Overall Study|Death|1|||
162960084|NCT03578809|588557587|FG000|Overall Study|Lost to Follow-up|0|||
162960085|NCT03578809|588557588|FG001|Overall Study|Lost to Follow-up|1|||
162960086|NCT03578809|588557589|FG002|Overall Study|Lost to Follow-up|0|||
162960087|NCT03578809|588557590|FG003|Overall Study|Lost to Follow-up|0|||
162960088|NCT03578809|588557587|FG000|Overall Study|Withdrawal by Subject|3|||
162960089|NCT03578809|588557588|FG001|Overall Study|Withdrawal by Subject|5|||
162960090|NCT03578809|588557589|FG002|Overall Study|Withdrawal by Subject|2|||
162960091|NCT03578809|588557590|FG003|Overall Study|Withdrawal by Subject|0|||
162960092|NCT03578809|588557587|FG000|Overall Study|Other|3|||
162960093|NCT03578809|588557588|FG001|Overall Study|Other|6|||
162960094|NCT03578809|588557589|FG002|Overall Study|Other|2|||
162960095|NCT03578809|588557590|FG003|Overall Study|Other|8|||
162960096|NCT03599193|588557591|FG000|Overall Study|Adverse Event|0|||
162960097|NCT03599193|588557592|FG001|Overall Study|Adverse Event|2|||
162960098|NCT03599193|588557591|FG000|Overall Study|Withdrawal by Subject|1|||
162960099|NCT03599193|588557592|FG001|Overall Study|Withdrawal by Subject|0|||
162960100|NCT03599193|588557591|FG000|Overall Study|Protocol Violation|1|||
162960101|NCT03599193|588557592|FG001|Overall Study|Protocol Violation|0|||
162960102|NCT03599193|588557591|FG000|Overall Study|Lost to Follow-up|0|||
162960103|NCT03599193|588557592|FG001|Overall Study|Lost to Follow-up|1|||
162960104|NCT00835705|588557593|FG000|First Intervention|Difficulty with vein|1|||
162960105|NCT00835705|588557594|FG001|First Intervention|Difficulty with vein|0|||
162960106|NCT00835705|588557593|FG000|Second Intervention|Difficulty with vein|1|||
162960107|NCT00835705|588557594|FG001|Second Intervention|Difficulty with vein|0|||
162960108|NCT01116739|588557595|FG000|Overall Study|Child had 2 years of HS|110|||
162960109|NCT01116739|588557596|FG001|Overall Study|Child had 2 years of HS|128|||
162960110|NCT01116739|588557595|FG000|Overall Study|Withdrawal by Subject|6|||
162960111|NCT01116739|588557596|FG001|Overall Study|Withdrawal by Subject|0|||
162960112|NCT01116739|588557595|FG000|Overall Study|child too young|2|||
162960113|NCT01116739|588557596|FG001|Overall Study|child too young|6|||
162960114|NCT01116739|588557595|FG000|Overall Study|child not enrolled in head start|10|||
162960115|NCT01116739|588557596|FG001|Overall Study|child not enrolled in head start|2|||
162960116|NCT01116739|588557595|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
162960117|NCT01116739|588557596|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
162960118|NCT05090839|588557597|FG000|Overall Study|Lost to Follow-up|2|||
162960119|NCT05090839|588557598|FG001|Overall Study|Lost to Follow-up|3|||
163046850|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
163046851|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046852|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046853|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
163046854|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046855|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046856|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046857|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960120|NCT05090839|588557599|FG002|Overall Study|Lost to Follow-up|1|||
162960121|NCT05090839|588557600|FG003|Overall Study|Lost to Follow-up|1|||
162960122|NCT01987765|588557605|FG000|Overall Study|Protocol Violation|65|||
162960123|NCT01987765|588557605|FG000|Overall Study|Lost to Follow-up|37|||
162960124|NCT00443651|588557610|FG000|Overall Study|Death|1|||
162960125|NCT00443651|588557611|FG001|Overall Study|Death|5|||
162960126|NCT00443651|588557610|FG000|Overall Study|Adverse Event|5|||
162960127|NCT00443651|588557611|FG001|Overall Study|Adverse Event|6|||
162960128|NCT00443651|588557610|FG000|Overall Study|Lost to Follow-up|18|||
162614596|NCT01193660|587307313|FG000|Overall Study|Physician Decision|1|||
162614597|NCT01193660|587307314|FG001|Overall Study|Physician Decision|0|||
162614598|NCT01193660|587307315|FG002|Overall Study|Physician Decision|1|||
162614599|NCT01886716|587307316|FG000|Week 1|Lost to Follow-up|0|||
162614600|NCT01886716|587307317|FG001|Week 1|Lost to Follow-up|0|||
162614601|NCT01886716|587307318|FG002|Week 1|Lost to Follow-up|2|||
162869126|NCT00638846|588223704|FG000|Overall Study|Lost to Follow-up|3|||
162869127|NCT00638846|588223705|FG001|Overall Study|Lost to Follow-up|2|||
162869128|NCT00638846|588223704|FG000|Overall Study|lens issue|1|||
162869129|NCT00638846|588223705|FG001|Overall Study|lens issue|3|||
162869130|NCT01137435|588223706|FG000|Overall Study|Lost to Follow-up|24|||
162869131|NCT01137435|588223706|FG000|Overall Study|Off label usage|4|||
162869132|NCT00487279|588223714|FG000|Overall Study|Death|1|||
162869133|NCT00487279|588223715|FG001|Overall Study|Death|0|||
162869134|NCT00487279|588223714|FG000|Overall Study|Withdrawal by Subject|0|||
162869135|NCT00487279|588223715|FG001|Overall Study|Withdrawal by Subject|2|||
162869136|NCT02746679|588223716|FG000|Overall Study|Lost to Follow-up|4|||
162869137|NCT02746679|588223717|FG001|Overall Study|Lost to Follow-up|6|||
162869138|NCT00501852|588223718|FG000|Overall Study|Adverse Event|3|||
162869139|NCT00501852|588223718|FG000|Overall Study|Withdrawal by Subject|2|||
162869140|NCT01171521|588223721|FG000|Overall Study|Lost to Follow-up|5|||
162869141|NCT01171521|588223721|FG000|Overall Study|screen failure|1|||
162869142|NCT01416610|588223723|FG000|Overall Study|Adverse Event|4|||
162869143|NCT01416610|588223723|FG000|Overall Study|Adverse Event -Patient decision|3|||
162869144|NCT01416610|588223723|FG000|Overall Study|Lack of Efficacy|4|||
162869145|NCT01416610|588223723|FG000|Overall Study|No reason given|5|||
162869146|NCT01416610|588223723|FG000|Overall Study|Withdrawal by Subject|13|||
162960129|NCT00443651|588557611|FG001|Overall Study|Lost to Follow-up|12|||
162960130|NCT00443651|588557610|FG000|Overall Study|Patient's/Guardian's Decision|58|||
162960131|NCT00443651|588557611|FG001|Overall Study|Patient's/Guardian's Decision|30|||
162960132|NCT00443651|588557610|FG000|Overall Study|Physician Decision|13|||
162960133|NCT00443651|588557611|FG001|Overall Study|Physician Decision|4|||
162960134|NCT00443651|588557610|FG000|Overall Study|Pregnancy|0|||
162960135|NCT00443651|588557611|FG001|Overall Study|Pregnancy|1|||
162960136|NCT03606174|588557612|FG000|Overall Study|Death|37|||
162960137|NCT03606174|588557613|FG001|Overall Study|Death|15|||
162960138|NCT03606174|588557614|FG002|Overall Study|Death|15|||
162960139|NCT03606174|588557615|FG003|Overall Study|Death|7|||
162960140|NCT03606174|588557616|FG004|Overall Study|Death|35|||
162960141|NCT03606174|588557617|FG005|Overall Study|Death|12|||
162960142|NCT03606174|588557618|FG006|Overall Study|Death|35|||
162960143|NCT03606174|588557619|FG007|Overall Study|Death|8|||
162960144|NCT03606174|588557620|FG008|Overall Study|Death|5|||
162960145|NCT03606174|588557621|FG009|Overall Study|Death|3|||
162960146|NCT03606174|588557622|FG010|Overall Study|Death|0|||
162960147|NCT03606174|588557612|FG000|Overall Study|Lost to Follow-up|0|||
162960148|NCT03606174|588557613|FG001|Overall Study|Lost to Follow-up|0|||
162960149|NCT03606174|588557614|FG002|Overall Study|Lost to Follow-up|0|||
162960150|NCT03606174|588557615|FG003|Overall Study|Lost to Follow-up|0|||
163046858|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162869147|NCT01416610|588223723|FG000|Overall Study|Lost to Follow-up|7|||
162869148|NCT01416610|588223723|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
162869149|NCT00492921|588223724|FG000|Overall Study|Death|1|||
162869150|NCT00492921|588223725|FG001|Overall Study|Death|0|||
162869151|NCT00492921|588223726|FG002|Overall Study|Death|1|||
162869152|NCT00399802|588223727|FG000|Overall Study|Adverse Event|0|||
162869153|NCT00399802|588223728|FG001|Overall Study|Adverse Event|2|||
162869154|NCT00399802|588223727|FG000|Overall Study|Participant discontinued by mistake|0|||
162869155|NCT00399802|588223728|FG001|Overall Study|Participant discontinued by mistake|1|||
162869156|NCT00652093|588223729|FG000|Overall Study|Withdrawal by Subject|0|||
162869157|NCT00652093|588223730|FG001|Overall Study|Withdrawal by Subject|0|||
162960151|NCT03606174|588557616|FG004|Overall Study|Lost to Follow-up|1|||
162960152|NCT03606174|588557617|FG005|Overall Study|Lost to Follow-up|1|||
162960153|NCT03606174|588557618|FG006|Overall Study|Lost to Follow-up|0|||
162960154|NCT03606174|588557619|FG007|Overall Study|Lost to Follow-up|0|||
163046859|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960155|NCT03606174|588557620|FG008|Overall Study|Lost to Follow-up|0|||
162960156|NCT03606174|588557621|FG009|Overall Study|Lost to Follow-up|0|||
163046860|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162614602|NCT01886716|587307319|FG003|Week 1|Lost to Follow-up|2|||
162869158|NCT00652093|588223731|FG002|Overall Study|Withdrawal by Subject|1|||
162869159|NCT00652093|588223732|FG003|Overall Study|Withdrawal by Subject|0|||
162869160|NCT00652093|588223733|FG004|Overall Study|Withdrawal by Subject|1|||
162869161|NCT00652093|588223734|FG005|Overall Study|Withdrawal by Subject|0|||
162869162|NCT00652093|588223729|FG000|Overall Study|Physician Decision|0|||
162869163|NCT00652093|588223730|FG001|Overall Study|Physician Decision|0|||
162960157|NCT03606174|588557622|FG010|Overall Study|Lost to Follow-up|0|||
162614603|NCT01886716|587307316|FG000|Week 2|Lost to Follow-up|3|||
162960158|NCT03606174|588557612|FG000|Overall Study|Withdrawal by Subject|6|||
162960159|NCT03606174|588557613|FG001|Overall Study|Withdrawal by Subject|0|||
163046861|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046862|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162706223|NCT03582137|587636599|FG000|Overall Study|Adverse Event|1|||
162706224|NCT03582137|587636600|FG001|Overall Study|Adverse Event|0|||
162706225|NCT03704298|587636605|FG000|Overall Study|Death|3|||
162706226|NCT03704298|587636606|FG001|Overall Study|Death|1|||
162706227|NCT03704298|587636607|FG002|Overall Study|Death|1|||
162706228|NCT03704298|587636608|FG003|Overall Study|Death|0|||
162706229|NCT03704298|587636605|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
162706230|NCT03704298|587636606|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
162706231|NCT03704298|587636607|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
162869164|NCT00652093|588223731|FG002|Overall Study|Physician Decision|0|||
162869165|NCT00652093|588223732|FG003|Overall Study|Physician Decision|0|||
162869166|NCT00652093|588223733|FG004|Overall Study|Physician Decision|1|||
162869167|NCT00652093|588223734|FG005|Overall Study|Physician Decision|0|||
162869168|NCT01520922|588223737|FG000|Treatment Phase|Physician Decision|2|||
162869169|NCT01520922|588223738|FG001|Treatment Phase|Physician Decision|1|||
162869170|NCT01520922|588223737|FG000|Treatment Phase|Progression|0|||
162869171|NCT01520922|588223738|FG001|Treatment Phase|Progression|2|||
162869172|NCT01520922|588223737|FG000|Treatment Phase|Adverse Event|3|||
162869173|NCT01520922|588223738|FG001|Treatment Phase|Adverse Event|5|||
162869174|NCT01520922|588223737|FG000|Follow up|Lost to Follow-up|0|||
162869175|NCT01520922|588223738|FG001|Follow up|Lost to Follow-up|1|||
162869176|NCT01520922|588223737|FG000|Survival Follow-up|Withdrawal by Subject|1|||
162869177|NCT01520922|588223738|FG001|Survival Follow-up|Withdrawal by Subject|0|||
162869178|NCT01696877|588223739|FG000|Overall Study|Adverse Event|0|||
162869179|NCT01696877|588223740|FG001|Overall Study|Adverse Event|1|||
162869180|NCT01422304|588223745|FG000|Overall Study|Adverse Event|0|||
162869181|NCT01422304|588223746|FG001|Overall Study|Adverse Event|1|||
162869182|NCT01422304|588223745|FG000|Overall Study|Lost to Follow-up|14|||
162869183|NCT01422304|588223746|FG001|Overall Study|Lost to Follow-up|20|||
162869184|NCT01422304|588223745|FG000|Overall Study|Never Entered Follow-up|2|||
162869185|NCT01422304|588223746|FG001|Overall Study|Never Entered Follow-up|1|||
162869186|NCT01422304|588223745|FG000|Overall Study|Protocol Violation|1|||
162869187|NCT01422304|588223746|FG001|Overall Study|Protocol Violation|0|||
162869188|NCT01422304|588223745|FG000|Overall Study|Withdrawal by Subject|4|||
162869189|NCT01422304|588223746|FG001|Overall Study|Withdrawal by Subject|2|||
162869190|NCT01422304|588223745|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162869191|NCT01422304|588223746|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
162869192|NCT01422304|588223745|FG000|Overall Study|Not Treated|3|||
162869193|NCT01422304|588223746|FG001|Overall Study|Not Treated|11|||
162869194|NCT00469014|588223749|FG000|Initial Phase Randomization|Disease Progression|0|||
162869195|NCT00469014|588223750|FG001|Initial Phase Randomization|Disease Progression|1|||
162869196|NCT00469014|588223751|FG002|Initial Phase Randomization|Disease Progression|1|||
162869197|NCT00469014|588223752|FG003|Initial Phase Randomization|Disease Progression|0|||
162869198|NCT00469014|588223749|FG000|Initial Phase Randomization|No Response|1|||
162869199|NCT00469014|588223750|FG001|Initial Phase Randomization|No Response|0|||
162869200|NCT00469014|588223751|FG002|Initial Phase Randomization|No Response|0|||
162869201|NCT00469014|588223752|FG003|Initial Phase Randomization|No Response|1|||
162869202|NCT00469014|588223749|FG000|Adaptive Randomization|Not Evaluable|1|||
162869203|NCT00469014|588223750|FG001|Adaptive Randomization|Not Evaluable|0|||
162869204|NCT00469014|588223751|FG002|Adaptive Randomization|Not Evaluable|0|||
162869205|NCT00469014|588223752|FG003|Adaptive Randomization|Not Evaluable|1|||
162869206|NCT00469014|588223749|FG000|Adaptive Randomization|No Response|0|||
162869207|NCT00469014|588223750|FG001|Adaptive Randomization|No Response|1|||
162869208|NCT00469014|588223751|FG002|Adaptive Randomization|No Response|0|||
162869209|NCT00469014|588223752|FG003|Adaptive Randomization|No Response|0|||
162869210|NCT00469014|588223749|FG000|Adaptive Randomization|Death|0|||
162869211|NCT00469014|588223750|FG001|Adaptive Randomization|Death|0|||
162869212|NCT00469014|588223751|FG002|Adaptive Randomization|Death|1|||
162869213|NCT00469014|588223752|FG003|Adaptive Randomization|Death|0|||
162869214|NCT03461289|588223754|FG000|Overall Study|Death|1|||
162869215|NCT00564629|588223757|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
162869216|NCT00564629|588223758|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
162869217|NCT03241173|588223759|FG000|Overall Study|Death|3|||
162869218|NCT03241173|588223760|FG001|Overall Study|Death|2|||
162869219|NCT03241173|588223761|FG002|Overall Study|Death|4|||
162869220|NCT03241173|588223762|FG003|Overall Study|Death|4|||
162869221|NCT03241173|588223763|FG004|Overall Study|Death|2|||
162869222|NCT03241173|588223764|FG005|Overall Study|Death|2|||
162869223|NCT03241173|588223765|FG006|Overall Study|Death|3|||
162869224|NCT03241173|588223766|FG007|Overall Study|Death|1|||
162869225|NCT03241173|588223767|FG008|Overall Study|Death|0|||
162869226|NCT03241173|588223768|FG009|Overall Study|Death|5|||
162869227|NCT03241173|588223769|FG010|Overall Study|Death|4|||
162869228|NCT03241173|588223770|FG011|Overall Study|Death|3|||
162869229|NCT03241173|588223771|FG012|Overall Study|Death|0|||
162960160|NCT03606174|588557614|FG002|Overall Study|Withdrawal by Subject|0|||
162960161|NCT03606174|588557615|FG003|Overall Study|Withdrawal by Subject|1|||
162960162|NCT03606174|588557616|FG004|Overall Study|Withdrawal by Subject|2|||
162960163|NCT03606174|588557617|FG005|Overall Study|Withdrawal by Subject|1|||
162960164|NCT03606174|588557618|FG006|Overall Study|Withdrawal by Subject|4|||
162960165|NCT03606174|588557619|FG007|Overall Study|Withdrawal by Subject|0|||
162960166|NCT03606174|588557620|FG008|Overall Study|Withdrawal by Subject|0|||
162960167|NCT03606174|588557621|FG009|Overall Study|Withdrawal by Subject|0|||
162960168|NCT03606174|588557622|FG010|Overall Study|Withdrawal by Subject|1|||
162960169|NCT03606174|588557612|FG000|Overall Study|Study Terminated by Sponsor|5|||
162960170|NCT03606174|588557613|FG001|Overall Study|Study Terminated by Sponsor|7|||
162960171|NCT03606174|588557614|FG002|Overall Study|Study Terminated by Sponsor|3|||
162960172|NCT03606174|588557615|FG003|Overall Study|Study Terminated by Sponsor|0|||
162960173|NCT03606174|588557616|FG004|Overall Study|Study Terminated by Sponsor|11|||
162960174|NCT03606174|588557617|FG005|Overall Study|Study Terminated by Sponsor|6|||
162960175|NCT03606174|588557618|FG006|Overall Study|Study Terminated by Sponsor|12|||
162960176|NCT03606174|588557619|FG007|Overall Study|Study Terminated by Sponsor|1|||
162960177|NCT03606174|588557620|FG008|Overall Study|Study Terminated by Sponsor|3|||
162960178|NCT03606174|588557621|FG009|Overall Study|Study Terminated by Sponsor|1|||
162960179|NCT03606174|588557622|FG010|Overall Study|Study Terminated by Sponsor|2|||
162960180|NCT03606174|588557612|FG000|Overall Study|Miscellaneous|1|||
162960181|NCT03606174|588557613|FG001|Overall Study|Miscellaneous|1|||
162960182|NCT03606174|588557614|FG002|Overall Study|Miscellaneous|0|||
162960183|NCT03606174|588557615|FG003|Overall Study|Miscellaneous|1|||
162960184|NCT03606174|588557616|FG004|Overall Study|Miscellaneous|4|||
162960185|NCT03606174|588557617|FG005|Overall Study|Miscellaneous|7|||
162960186|NCT03606174|588557618|FG006|Overall Study|Miscellaneous|5|||
162960187|NCT03606174|588557619|FG007|Overall Study|Miscellaneous|0|||
162960188|NCT03606174|588557620|FG008|Overall Study|Miscellaneous|0|||
162960189|NCT03606174|588557621|FG009|Overall Study|Miscellaneous|0|||
162960190|NCT03606174|588557622|FG010|Overall Study|Miscellaneous|1|||
162960191|NCT01896934|588557625|FG000|Overall Study|Adverse Event|1|||
162960192|NCT01896934|588557625|FG000|Overall Study|Withdrawal by Subject|1|||
162960193|NCT01572662|588557627|FG000|Overall Study|Withdrawal by Subject|1|||
162960194|NCT01572662|588557628|FG001|Overall Study|Withdrawal by Subject|0|||
162960195|NCT01572662|588557627|FG000|Overall Study|Physician Decision|0|||
162960196|NCT01572662|588557628|FG001|Overall Study|Physician Decision|1|||
162960197|NCT03364192|588557629|FG000|Overall Study|Ineligible|10|||
162960198|NCT03364192|588557629|FG000|Overall Study|Withdrawal by Subject|5|||
162960199|NCT03364192|588557629|FG000|Overall Study|Lost to Follow-up|1|||
162960200|NCT04692155|588557630|FG000|Overall Study|Death|1|||
162960201|NCT04547192|588557631|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
162960202|NCT04547192|588557632|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
162960203|NCT04547192|588557633|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
162960204|NCT04547192|588557634|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
162960205|NCT04547192|588557631|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
162960206|NCT04547192|588557632|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
162960207|NCT04547192|588557633|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
162960208|NCT04547192|588557634|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
162960209|NCT04547192|588557631|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
162960210|NCT04547192|588557632|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
162960211|NCT04547192|588557633|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
162960212|NCT04547192|588557634|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
162960213|NCT04547192|588557631|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
162960214|NCT04547192|588557632|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960215|NCT04547192|588557633|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960216|NCT04547192|588557634|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
162960217|NCT04547192|588557631|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960218|NCT04547192|588557632|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960219|NCT04547192|588557633|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
162960220|NCT04547192|588557634|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
162960221|NCT01535222|588557635|FG000|Overall Study|Inclusion/exclusion|0|||
162960222|NCT01535222|588557636|FG001|Overall Study|Inclusion/exclusion|0|||
162960223|NCT01535222|588557637|FG002|Overall Study|Inclusion/exclusion|1|||
162960224|NCT01535222|588557638|FG003|Overall Study|Inclusion/exclusion|0|||
162960225|NCT01535222|588557639|FG004|Overall Study|Inclusion/exclusion|0|||
162960226|NCT01535222|588557640|FG005|Overall Study|Inclusion/exclusion|0|||
162960227|NCT00935012|588557643|FG000|Overall Study|Death|19|||
162960228|NCT00935012|588557643|FG000|Overall Study|Withdrawal by Subject|3|||
162960229|NCT00935012|588557643|FG000|Overall Study|Other|5|||
162960230|NCT00935012|588557643|FG000|Overall Study|Adverse Event|2|||
162960231|NCT01442155|588557644|FG000|Overall Study|Complete remission|35|||
162960232|NCT01442155|588557644|FG000|Overall Study|Recurrence|26|||
162960233|NCT01442155|588557644|FG000|Overall Study|Adverse Event|2|||
162960234|NCT01442155|588557644|FG000|Overall Study|Lost to Follow-up|2|||
162960235|NCT01484912|588557653|FG000|Overall Study|Withdrawal by Subject|1|||
162960236|NCT01484912|588557654|FG001|Overall Study|Withdrawal by Subject|0|||
162960237|NCT01484912|588557653|FG000|Overall Study|Physician Decision|0|||
162960238|NCT01484912|588557654|FG001|Overall Study|Physician Decision|1|||
162960239|NCT01188681|588557655|FG000|Overall Study|bladder cancer|0|||
162960240|NCT01188681|588557656|FG001|Overall Study|bladder cancer|0|||
162960241|NCT01188681|588557657|FG002|Overall Study|bladder cancer|1|||
162960242|NCT01188681|588557658|FG003|Overall Study|bladder cancer|0|||
162960243|NCT01188681|588557655|FG000|Overall Study|Withdrawal by Subject|0|||
162960244|NCT01188681|588557656|FG001|Overall Study|Withdrawal by Subject|0|||
162960245|NCT01188681|588557657|FG002|Overall Study|Withdrawal by Subject|0|||
162960246|NCT01188681|588557658|FG003|Overall Study|Withdrawal by Subject|1|||
162960247|NCT01983969|588557665|FG000|Overall Study|Disease Progression|0|||
162960248|NCT01983969|588557666|FG001|Overall Study|Disease Progression|1|||
162960249|NCT01983969|588557667|FG002|Overall Study|Disease Progression|0|||
162960250|NCT03719040|588557668|FG000|Overall Study|Withdrawal by Subject|177|||
162960251|NCT03719040|588557668|FG000|Overall Study|Lost to Follow-up|26|||
162960252|NCT00268203|588557669|FG000|Overall Study|Lost to Follow-up|92|||
162960253|NCT00268203|588557669|FG000|Overall Study|Withdrawal by Subject|9|||
162960254|NCT00268203|588557669|FG000|Overall Study|Received Other NHL Therapy|7|||
162960255|NCT00268203|588557669|FG000|Overall Study|Progressive Disease|359|||
162960256|NCT00268203|588557669|FG000|Overall Study|Death|84|||
162960257|NCT00268203|588557669|FG000|Overall Study|Reason Not Specified|34|||
162960258|NCT00268203|588557669|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
162960259|NCT04589650|588557672|FG000|Overall Study|Subject decision|6|||
162960260|NCT04589650|588557673|FG001|Overall Study|Subject decision|2|||
162960261|NCT04589650|588557674|FG002|Overall Study|Subject decision|2|||
162960262|NCT04589650|588557675|FG003|Overall Study|Subject decision|0|||
162960263|NCT04589650|588557676|FG004|Overall Study|Subject decision|0|||
162960264|NCT04589650|588557677|FG005|Overall Study|Subject decision|0|||
162960265|NCT04589650|588557672|FG000|Overall Study|Adverse Event|3|||
162960266|NCT04589650|588557673|FG001|Overall Study|Adverse Event|1|||
162960267|NCT04589650|588557674|FG002|Overall Study|Adverse Event|1|||
162960268|NCT04589650|588557675|FG003|Overall Study|Adverse Event|1|||
162960269|NCT04589650|588557676|FG004|Overall Study|Adverse Event|0|||
162960270|NCT04589650|588557677|FG005|Overall Study|Adverse Event|1|||
162960271|NCT04589650|588557672|FG000|Overall Study|Physician Decision|1|||
162960272|NCT04589650|588557673|FG001|Overall Study|Physician Decision|1|||
162960273|NCT04589650|588557674|FG002|Overall Study|Physician Decision|0|||
162960274|NCT04589650|588557675|FG003|Overall Study|Physician Decision|0|||
162960275|NCT04589650|588557676|FG004|Overall Study|Physician Decision|0|||
162960276|NCT04589650|588557677|FG005|Overall Study|Physician Decision|0|||
162960277|NCT04589650|588557672|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162960278|NCT04589650|588557673|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162960279|NCT04589650|588557674|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162960280|NCT04589650|588557675|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162960281|NCT04589650|588557676|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
162960282|NCT04589650|588557677|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
162960283|NCT04589650|588557672|FG000|Overall Study|Death|0|||
162960284|NCT04589650|588557673|FG001|Overall Study|Death|0|||
162960285|NCT04589650|588557674|FG002|Overall Study|Death|0|||
162960286|NCT04589650|588557675|FG003|Overall Study|Death|1|||
162960287|NCT04589650|588557676|FG004|Overall Study|Death|0|||
162960288|NCT04589650|588557677|FG005|Overall Study|Death|0|||
162960289|NCT04589650|588557672|FG000|Overall Study|Guardian Decision|0|||
162960290|NCT04589650|588557673|FG001|Overall Study|Guardian Decision|0|||
162960291|NCT04589650|588557674|FG002|Overall Study|Guardian Decision|0|||
162960292|NCT04589650|588557675|FG003|Overall Study|Guardian Decision|1|||
162960293|NCT04589650|588557676|FG004|Overall Study|Guardian Decision|0|||
162960294|NCT04589650|588557677|FG005|Overall Study|Guardian Decision|0|||
162960295|NCT00950989|588557678|FG000|Overall Study|Death|0|||
162960296|NCT00950989|588557679|FG001|Overall Study|Death|0|||
162960297|NCT00950989|588557680|FG002|Overall Study|Death|1|||
162960298|NCT00950989|588557681|FG003|Overall Study|Death|0|||
162960299|NCT00950989|588557678|FG000|Overall Study|Administrative Decision|0|||
162960300|NCT00950989|588557679|FG001|Overall Study|Administrative Decision|1|||
162960301|NCT00950989|588557680|FG002|Overall Study|Administrative Decision|0|||
162960302|NCT00950989|588557681|FG003|Overall Study|Administrative Decision|0|||
162960303|NCT00950989|588557678|FG000|Overall Study|Disease Progression|0|||
162960304|NCT00950989|588557679|FG001|Overall Study|Disease Progression|0|||
162960305|NCT00950989|588557680|FG002|Overall Study|Disease Progression|1|||
162960306|NCT00950989|588557681|FG003|Overall Study|Disease Progression|0|||
162960307|NCT00950989|588557678|FG000|Overall Study|Withdrawal by Subject|2|||
162960308|NCT00950989|588557679|FG001|Overall Study|Withdrawal by Subject|1|||
162960309|NCT00950989|588557680|FG002|Overall Study|Withdrawal by Subject|0|||
162960310|NCT00950989|588557681|FG003|Overall Study|Withdrawal by Subject|0|||
162960311|NCT00950989|588557678|FG000|Overall Study|Adverse Event|2|||
162960312|NCT00950989|588557679|FG001|Overall Study|Adverse Event|1|||
162960313|NCT00950989|588557680|FG002|Overall Study|Adverse Event|1|||
162960314|NCT00950989|588557681|FG003|Overall Study|Adverse Event|0|||
162960315|NCT03804983|588557682|FG000|Overall Study|Adverse Event|0|||
162960316|NCT03804983|588557683|FG001|Overall Study|Adverse Event|1|||
162960317|NCT03804983|588557682|FG000|Overall Study|Family Obligation|1|||
162960318|NCT03804983|588557683|FG001|Overall Study|Family Obligation|0|||
162960319|NCT03600376|588557684|FG000|Overall Study|Adverse Event|1|||
162960320|NCT03600376|588557685|FG001|Overall Study|Adverse Event|1|||
162960321|NCT03600376|588557684|FG000|Overall Study|Transferred to other facility|1|||
162960322|NCT03600376|588557685|FG001|Overall Study|Transferred to other facility|0|||
162960323|NCT03600376|588557684|FG000|Overall Study|Investigator Decision|0|||
162960324|NCT03600376|588557685|FG001|Overall Study|Investigator Decision|4|||
162960325|NCT03600376|588557684|FG000|Overall Study|Determined to be ineligible for study|0|||
162960326|NCT03600376|588557685|FG001|Overall Study|Determined to be ineligible for study|1|||
162960327|NCT00796562|588557689|FG000|Overall Study|Death|49|||
162960328|NCT05655520|588557690|FG000|Overall Study|Adverse Event|2|||
162960329|NCT05655520|588557691|FG001|Overall Study|Adverse Event|3|||
162960330|NCT05655520|588557690|FG000|Overall Study|Physician Decision|2|||
162960331|NCT05655520|588557691|FG001|Overall Study|Physician Decision|0|||
162960332|NCT05655520|588557690|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162960333|NCT05655520|588557691|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162960334|NCT05655520|588557690|FG000|Overall Study|Lost to Follow-up|1|||
162960335|NCT05655520|588557691|FG001|Overall Study|Lost to Follow-up|0|||
162960336|NCT05655520|588557690|FG000|Overall Study|Withdrawal by Subject|4|||
162960337|NCT05655520|588557691|FG001|Overall Study|Withdrawal by Subject|4|||
162960338|NCT05655520|588557690|FG000|Overall Study|Study Terminated by Sponsor|61|||
162960339|NCT05655520|588557691|FG001|Overall Study|Study Terminated by Sponsor|68|||
162960340|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
162960341|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
162960342|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
162960343|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
162960344|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
162960345|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
162960346|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
162960347|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
162960348|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
162960349|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
162960350|NCT00424047|588557692|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
162960351|NCT00424047|588557693|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
162960352|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Adverse Event|22|||
162960353|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Adverse Event|12|||
162960354|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Progression of disease|92|||
162960355|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Progression of disease|128|||
162960356|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
162960357|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
162960358|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
162960359|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
162960360|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Death|11|||
162960361|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Death|11|||
162960362|NCT00424047|588557692|FG000|On Study at Time of Unblinding|Other|5|||
162960363|NCT00424047|588557693|FG001|On Study at Time of Unblinding|Other|4|||
162960364|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
162960365|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
162960366|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
162960367|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
162960368|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
162960369|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
162960370|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
162960371|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
162960372|NCT00424047|588557692|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
162960373|NCT00424047|588557693|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
162960374|NCT01229150|588557697|FG000|Overall Study|Toxicity|2|||
162960375|NCT01229150|588557698|FG001|Overall Study|Toxicity|2|||
162960376|NCT01229150|588557699|FG002|Overall Study|Toxicity|0|||
162960377|NCT01229150|588557700|FG003|Overall Study|Toxicity|0|||
162960378|NCT05248204|588557701|FG000|Overall Study|Lost to Follow-up|13|||
162960379|NCT05248204|588557702|FG001|Overall Study|Lost to Follow-up|13|||
163046863|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960380|NCT05248204|588557701|FG000|Overall Study|Protocol Violation|1|||
162960381|NCT05248204|588557702|FG001|Overall Study|Protocol Violation|0|||
163046864|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162960382|NCT03100344|588557703|FG000|Overall Study|Adverse Event|0|||
162960383|NCT03100344|588557704|FG001|Overall Study|Adverse Event|3|||
162960384|NCT03100344|588557705|FG002|Overall Study|Adverse Event|2|||
162960385|NCT03100344|588557706|FG003|Overall Study|Adverse Event|3|||
162960386|NCT03100344|588557703|FG000|Overall Study|Lack of Efficacy|2|||
162960387|NCT03100344|588557704|FG001|Overall Study|Lack of Efficacy|0|||
162960388|NCT03100344|588557705|FG002|Overall Study|Lack of Efficacy|0|||
162960389|NCT03100344|588557706|FG003|Overall Study|Lack of Efficacy|0|||
162960390|NCT03100344|588557703|FG000|Overall Study|Protocol Violation|1|||
162960391|NCT03100344|588557704|FG001|Overall Study|Protocol Violation|0|||
162960392|NCT03100344|588557705|FG002|Overall Study|Protocol Violation|0|||
162960393|NCT03100344|588557706|FG003|Overall Study|Protocol Violation|0|||
162960394|NCT03100344|588557703|FG000|Overall Study|Withdrawal by Subject|10|||
162960395|NCT03100344|588557704|FG001|Overall Study|Withdrawal by Subject|7|||
162960396|NCT03100344|588557705|FG002|Overall Study|Withdrawal by Subject|4|||
162960397|NCT03100344|588557706|FG003|Overall Study|Withdrawal by Subject|8|||
162960398|NCT03100344|588557703|FG000|Overall Study|Lost to Follow-up|1|||
162960399|NCT03100344|588557704|FG001|Overall Study|Lost to Follow-up|1|||
162960400|NCT03100344|588557705|FG002|Overall Study|Lost to Follow-up|1|||
162960401|NCT03100344|588557706|FG003|Overall Study|Lost to Follow-up|1|||
162960402|NCT01010503|588557707|FG000|Overall Study|Adverse Event|1|||
162960403|NCT01010503|588557707|FG000|Overall Study|Death|1|||
162960404|NCT01963728|588557708|FG000|Overall Study|Study terminated early|0|||
162960405|NCT01963728|588557709|FG001|Overall Study|Study terminated early|1|||
162960406|NCT04406194|588558824|FG000|Period 1|Withdrawal by Subject|0|||
162960407|NCT04406194|588558825|FG001|Period 1|Withdrawal by Subject|1|||
162960408|NCT02888756|588558826|FG000|Analytical Treatment Interruption|Physician Decision|10|||
162960409|NCT02888756|588558827|FG001|Analytical Treatment Interruption|Physician Decision|6|||
162960410|NCT02888756|588558828|FG002|Analytical Treatment Interruption|Physician Decision|5|||
162960411|NCT01205035|588558832|FG000|Overall Study|Withdrawal by Subject|1|||
162960412|NCT01205035|588558833|FG001|Overall Study|Withdrawal by Subject|0|||
162960413|NCT01205035|588558832|FG000|Overall Study|Physician Decision|1|||
162960414|NCT01205035|588558833|FG001|Overall Study|Physician Decision|0|||
162960415|NCT00928057|588558834|FG000|Overall Study|Adverse Event|1|||
162960416|NCT00928057|588558835|FG001|Overall Study|Adverse Event|2|||
162960417|NCT00928057|588558834|FG000|Overall Study|Withdrawal by Subject|1|||
162960418|NCT00928057|588558835|FG001|Overall Study|Withdrawal by Subject|0|||
162960419|NCT00928057|588558834|FG000|Overall Study|Lost to Follow-up|0|||
162960420|NCT00928057|588558835|FG001|Overall Study|Lost to Follow-up|1|||
162960421|NCT00928057|588558834|FG000|Overall Study|Protocol Violation|0|||
162960422|NCT00928057|588558835|FG001|Overall Study|Protocol Violation|1|||
162960423|NCT03206749|588558836|FG000|Overall Study|Withdrawal of consent|5|||
162960424|NCT03206749|588558837|FG001|Overall Study|Withdrawal of consent|3|||
162960425|NCT03206749|588558838|FG002|Overall Study|Withdrawal of consent|6|||
162960426|NCT03206749|588558836|FG000|Overall Study|Lost to Follow-up|0|||
162960427|NCT03206749|588558837|FG001|Overall Study|Lost to Follow-up|0|||
162960428|NCT03206749|588558838|FG002|Overall Study|Lost to Follow-up|1|||
162960429|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
162960430|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
162960431|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
162960432|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
162960433|NCT00316277|588558839|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
162960434|NCT00316277|588558840|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
162960435|NCT00316277|588558839|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
162960436|NCT00316277|588558840|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
162960437|NCT00316277|588558839|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
162960438|NCT00316277|588558840|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
162960439|NCT00927069|588558841|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
162960440|NCT00927069|588558842|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
162960441|NCT00927069|588558843|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
162960442|NCT00927069|588558844|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
162960443|NCT00927069|588558841|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
162960444|NCT00927069|588558842|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
162960445|NCT00927069|588558843|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
162960446|NCT00927069|588558844|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
162960447|NCT00927069|588558841|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
162960448|NCT00927069|588558842|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
162960449|NCT00927069|588558843|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
162869230|NCT03241173|588223772|FG013|Overall Study|Death|0|||
162869231|NCT03241173|588223773|FG014|Overall Study|Death|0|||
162869232|NCT03241173|588223759|FG000|Overall Study|Withdrawal by Subject|0|||
162869233|NCT03241173|588223760|FG001|Overall Study|Withdrawal by Subject|0|||
162869234|NCT03241173|588223761|FG002|Overall Study|Withdrawal by Subject|1|||
162869235|NCT03241173|588223762|FG003|Overall Study|Withdrawal by Subject|0|||
162869236|NCT03241173|588223763|FG004|Overall Study|Withdrawal by Subject|0|||
162869237|NCT03241173|588223764|FG005|Overall Study|Withdrawal by Subject|1|||
162869238|NCT03241173|588223765|FG006|Overall Study|Withdrawal by Subject|0|||
162869239|NCT03241173|588223766|FG007|Overall Study|Withdrawal by Subject|0|||
162869240|NCT03241173|588223767|FG008|Overall Study|Withdrawal by Subject|0|||
162869241|NCT03241173|588223768|FG009|Overall Study|Withdrawal by Subject|0|||
162869242|NCT03241173|588223769|FG010|Overall Study|Withdrawal by Subject|0|||
162869243|NCT03241173|588223770|FG011|Overall Study|Withdrawal by Subject|0|||
162869244|NCT03241173|588223771|FG012|Overall Study|Withdrawal by Subject|0|||
162869245|NCT03241173|588223772|FG013|Overall Study|Withdrawal by Subject|0|||
162869246|NCT03241173|588223773|FG014|Overall Study|Withdrawal by Subject|0|||
162924353|NCT04797637|588423874|FG001|Overall Study|Withdrawal by Subject|1|||
162924354|NCT02380248|588423875|FG000|Overall Study|Lost to Follow-up|11|||
162924355|NCT02380248|588423875|FG000|Overall Study|Withdrawal by Subject|3|||
162924356|NCT03083639|588423876|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
162924357|NCT03083639|588423877|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
162924358|NCT03083639|588423876|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
162924359|NCT03083639|588423877|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
162924360|NCT00960687|588423878|FG000|Washout Period of 7 Days|Adverse Event|3|||
162924361|NCT00960687|588423879|FG001|Washout Period of 7 Days|Adverse Event|2|||
162924362|NCT00960687|588423878|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
162924363|NCT00960687|588423879|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162924364|NCT03611751|588423886|FG000|Pre-treatment|Randomized but not treated|1|||
162924365|NCT03611751|588423887|FG001|Pre-treatment|Randomized but not treated|1|||
162924366|NCT03611751|588423888|FG002|Pre-treatment|Randomized but not treated|0|||
162924367|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
162924368|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
162924369|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
162924370|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
162924371|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
162924372|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
162924373|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
162924374|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
162924375|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
162924376|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
162924377|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
162924378|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
162924379|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
162924380|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
162924381|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
162924382|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
162924383|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
162924384|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
162924385|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
162924386|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
162924387|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
162924388|NCT03611751|588423886|FG000|Treatment Week 0 - Week 16|Death|0|||
162924389|NCT03611751|588423887|FG001|Treatment Week 0 - Week 16|Death|0|||
162924390|NCT03611751|588423888|FG002|Treatment Week 0 - Week 16|Death|1|||
162924391|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
162924392|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
162924393|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
162924394|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
162924395|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
162924396|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
162924397|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
162924398|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
162924399|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
162924400|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
162924401|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
162924402|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
162924403|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
162869247|NCT03241173|588223759|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
162869248|NCT03241173|588223760|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
162869249|NCT03241173|588223761|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869250|NCT03241173|588223762|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
162869251|NCT03241173|588223763|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
162869252|NCT03241173|588223764|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
162869253|NCT03241173|588223765|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
162869254|NCT03241173|588223766|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
162869255|NCT03241173|588223767|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869256|NCT03241173|588223768|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869257|NCT03241173|588223769|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
162869258|NCT03241173|588223770|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
162869259|NCT03241173|588223771|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869260|NCT03241173|588223772|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869261|NCT03241173|588223773|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
162869262|NCT03241173|588223759|FG000|Overall Study|Lost to Follow-up|0|||
162869263|NCT03241173|588223760|FG001|Overall Study|Lost to Follow-up|0|||
162869264|NCT03241173|588223761|FG002|Overall Study|Lost to Follow-up|0|||
162869265|NCT03241173|588223762|FG003|Overall Study|Lost to Follow-up|0|||
162869266|NCT03241173|588223763|FG004|Overall Study|Lost to Follow-up|1|||
162869267|NCT03241173|588223764|FG005|Overall Study|Lost to Follow-up|0|||
162869268|NCT03241173|588223765|FG006|Overall Study|Lost to Follow-up|0|||
162869269|NCT03241173|588223766|FG007|Overall Study|Lost to Follow-up|0|||
162869270|NCT03241173|588223767|FG008|Overall Study|Lost to Follow-up|0|||
162869271|NCT03241173|588223768|FG009|Overall Study|Lost to Follow-up|1|||
162869272|NCT03241173|588223769|FG010|Overall Study|Lost to Follow-up|0|||
162869273|NCT03241173|588223770|FG011|Overall Study|Lost to Follow-up|0|||
162869274|NCT03241173|588223771|FG012|Overall Study|Lost to Follow-up|0|||
162869275|NCT03241173|588223772|FG013|Overall Study|Lost to Follow-up|0|||
162869276|NCT03241173|588223773|FG014|Overall Study|Lost to Follow-up|0|||
162869277|NCT00515463|588223774|FG000|Overall Study|Physician Decision|4|||
162869278|NCT00515463|588223775|FG001|Overall Study|Physician Decision|2|||
162869279|NCT00515463|588223774|FG000|Overall Study|Adverse Event|1|||
162869280|NCT00515463|588223775|FG001|Overall Study|Adverse Event|2|||
162869281|NCT00515463|588223774|FG000|Overall Study|Withdrawal by Subject|3|||
162869282|NCT00515463|588223775|FG001|Overall Study|Withdrawal by Subject|4|||
162869283|NCT00515463|588223774|FG000|Overall Study|Lost to Follow-up|6|||
162869284|NCT00515463|588223775|FG001|Overall Study|Lost to Follow-up|5|||
162869285|NCT00515463|588223774|FG000|Overall Study|Other|0|||
162869286|NCT00515463|588223775|FG001|Overall Study|Other|1|||
162869287|NCT01519427|588223776|FG000|Overall Study|disease progression|2|||
162869288|NCT00633139|588223782|FG000|Overall Study|Non compliance|0|||
162869289|NCT00633139|588223783|FG001|Overall Study|Non compliance|0|||
162869290|NCT00633139|588223784|FG002|Overall Study|Non compliance|1|||
162869291|NCT00633139|588223782|FG000|Overall Study|Withdrawal by Subject|0|||
162869292|NCT00633139|588223783|FG001|Overall Study|Withdrawal by Subject|1|||
162869293|NCT00633139|588223784|FG002|Overall Study|Withdrawal by Subject|0|||
162869294|NCT02269319|588223785|FG000|Overall Study|Lost to Follow-up|4|||
162869295|NCT02269319|588223786|FG001|Overall Study|Lost to Follow-up|3|||
162869296|NCT02269319|588223785|FG000|Overall Study|Adverse Event|0|||
162960450|NCT00927069|588558844|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
162960451|NCT00927069|588558841|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
162960452|NCT00927069|588558842|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
162960453|NCT00927069|588558843|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
162869297|NCT02269319|588223786|FG001|Overall Study|Adverse Event|1|||
162960454|NCT00927069|588558844|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
162869298|NCT02269319|588223785|FG000|Overall Study|Instructions not followed|1|||
162869299|NCT02269319|588223786|FG001|Overall Study|Instructions not followed|0|||
162869300|NCT01507246|588223787|FG000|Overall Study|Required different surgical procedures|2|||
162869301|NCT01507246|588223788|FG001|Overall Study|Required different surgical procedures|1|||
162869302|NCT01522651|588223791|FG000|Overall Study|Adverse Event|3|||
162869303|NCT01522651|588223792|FG001|Overall Study|Adverse Event|4|||
162869304|NCT01522651|588223793|FG002|Overall Study|Adverse Event|4|||
162869305|NCT01522651|588223794|FG003|Overall Study|Adverse Event|5|||
162869306|NCT01522651|588223795|FG004|Overall Study|Adverse Event|4|||
162869307|NCT01522651|588223791|FG000|Overall Study|Cardioversion|1|||
162869308|NCT01522651|588223792|FG001|Overall Study|Cardioversion|0|||
162869309|NCT01522651|588223793|FG002|Overall Study|Cardioversion|0|||
162869310|NCT01522651|588223794|FG003|Overall Study|Cardioversion|0|||
162869311|NCT01522651|588223795|FG004|Overall Study|Cardioversion|0|||
162869312|NCT01522651|588223791|FG000|Overall Study|Device Malfunction|0|||
162869313|NCT01522651|588223792|FG001|Overall Study|Device Malfunction|1|||
162869314|NCT01522651|588223793|FG002|Overall Study|Device Malfunction|0|||
162869315|NCT01522651|588223794|FG003|Overall Study|Device Malfunction|0|||
162869316|NCT01522651|588223795|FG004|Overall Study|Device Malfunction|0|||
162869317|NCT01522651|588223791|FG000|Overall Study|Investigator's Discretion|0|||
162869318|NCT01522651|588223792|FG001|Overall Study|Investigator's Discretion|1|||
162869319|NCT01522651|588223793|FG002|Overall Study|Investigator's Discretion|0|||
162869320|NCT01522651|588223794|FG003|Overall Study|Investigator's Discretion|0|||
162869321|NCT01522651|588223795|FG004|Overall Study|Investigator's Discretion|0|||
162869322|NCT01522651|588223791|FG000|Overall Study|Protocol Violation|3|||
162869323|NCT01522651|588223792|FG001|Overall Study|Protocol Violation|0|||
162869324|NCT01522651|588223793|FG002|Overall Study|Protocol Violation|0|||
162869325|NCT01522651|588223794|FG003|Overall Study|Protocol Violation|0|||
162869326|NCT01522651|588223795|FG004|Overall Study|Protocol Violation|0|||
162869327|NCT01522651|588223791|FG000|Overall Study|Reason Not Specified|0|||
162869328|NCT01522651|588223792|FG001|Overall Study|Reason Not Specified|0|||
162869329|NCT01522651|588223793|FG002|Overall Study|Reason Not Specified|0|||
162869330|NCT01522651|588223794|FG003|Overall Study|Reason Not Specified|1|||
162869331|NCT01522651|588223795|FG004|Overall Study|Reason Not Specified|0|||
162869332|NCT01522651|588223791|FG000|Overall Study|Participant Non-Compliance|1|||
162869333|NCT01522651|588223792|FG001|Overall Study|Participant Non-Compliance|0|||
162869334|NCT01522651|588223793|FG002|Overall Study|Participant Non-Compliance|0|||
162869335|NCT01522651|588223794|FG003|Overall Study|Participant Non-Compliance|0|||
162869336|NCT01522651|588223795|FG004|Overall Study|Participant Non-Compliance|0|||
162869337|NCT01522651|588223791|FG000|Overall Study|Withdrew Consent|1|||
162869338|NCT01522651|588223792|FG001|Overall Study|Withdrew Consent|1|||
162869339|NCT01522651|588223793|FG002|Overall Study|Withdrew Consent|0|||
162869340|NCT01522651|588223794|FG003|Overall Study|Withdrew Consent|1|||
162869341|NCT01522651|588223795|FG004|Overall Study|Withdrew Consent|1|||
162869342|NCT01522651|588223791|FG000|Overall Study|Randomized but Never Treated|0|||
162869343|NCT01522651|588223792|FG001|Overall Study|Randomized but Never Treated|1|||
162869344|NCT01522651|588223793|FG002|Overall Study|Randomized but Never Treated|0|||
162869345|NCT01522651|588223794|FG003|Overall Study|Randomized but Never Treated|1|||
162869346|NCT01522651|588223795|FG004|Overall Study|Randomized but Never Treated|1|||
162869347|NCT02115815|588225316|FG000|Overall Study|Withdrawal by Subject|2|||
162869348|NCT02115815|588225317|FG001|Overall Study|Withdrawal by Subject|0|||
162869349|NCT02115815|588225318|FG002|Overall Study|Withdrawal by Subject|0|||
162869350|NCT02115815|588225319|FG003|Overall Study|Withdrawal by Subject|0|||
162869351|NCT02115815|588225320|FG004|Overall Study|Withdrawal by Subject|0|||
162869352|NCT02115815|588225321|FG005|Overall Study|Withdrawal by Subject|0|||
162869353|NCT02115815|588225322|FG006|Overall Study|Withdrawal by Subject|0|||
162869354|NCT02115815|588225316|FG000|Overall Study|Not enough drug to dose participant|0|||
162869355|NCT02115815|588225317|FG001|Overall Study|Not enough drug to dose participant|0|||
162869356|NCT02115815|588225318|FG002|Overall Study|Not enough drug to dose participant|0|||
162869357|NCT02115815|588225319|FG003|Overall Study|Not enough drug to dose participant|0|||
162869358|NCT02115815|588225320|FG004|Overall Study|Not enough drug to dose participant|0|||
162869359|NCT02115815|588225321|FG005|Overall Study|Not enough drug to dose participant|1|||
162869360|NCT02115815|588225322|FG006|Overall Study|Not enough drug to dose participant|0|||
162960455|NCT00927069|588558841|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
162869361|NCT02115815|588225316|FG000|Overall Study|Missed appointment, randomized in error|0|||
162869362|NCT02115815|588225317|FG001|Overall Study|Missed appointment, randomized in error|0|||
162869363|NCT02115815|588225318|FG002|Overall Study|Missed appointment, randomized in error|0|||
162960456|NCT00927069|588558842|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
162614604|NCT01886716|587307317|FG001|Week 2|Lost to Follow-up|2|||
162614605|NCT01886716|587307318|FG002|Week 2|Lost to Follow-up|1|||
162869364|NCT02115815|588225319|FG003|Overall Study|Missed appointment, randomized in error|0|||
162869365|NCT02115815|588225320|FG004|Overall Study|Missed appointment, randomized in error|0|||
162960457|NCT00927069|588558843|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
162960458|NCT00927069|588558844|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
162614606|NCT01886716|587307319|FG003|Week 2|Lost to Follow-up|3|||
162869366|NCT02115815|588225321|FG005|Overall Study|Missed appointment, randomized in error|1|||
162869367|NCT02115815|588225322|FG006|Overall Study|Missed appointment, randomized in error|0|||
162869368|NCT01989546|588225323|FG000|Overall Study|Clinical Progression|1|||
162869369|NCT01989546|588225323|FG000|Overall Study|Disease progression on study|8|||
162869370|NCT02819310|588225324|FG000|Overall Study|Withdrawal by Subject|37|||
162869371|NCT02819310|588225324|FG000|Overall Study|Lost to Follow-up|16|||
162869372|NCT02819310|588225324|FG000|Overall Study|Adverse Event|13|||
162869373|NCT02819310|588225324|FG000|Overall Study|Lack of Efficacy|5|||
162869374|NCT02819310|588225324|FG000|Overall Study|Physician Decision|8|||
162869375|NCT02819310|588225324|FG000|Overall Study|Protocol Violation|30|||
162869376|NCT00059215|588225328|FG000|Overall Study|Adverse Event|5|||
162869377|NCT00059215|588225329|FG001|Overall Study|Adverse Event|5|||
162869378|NCT00059215|588225330|FG002|Overall Study|Adverse Event|9|||
162869379|NCT00059215|588225331|FG003|Overall Study|Adverse Event|9|||
162869380|NCT00059215|588225328|FG000|Overall Study|Death|0|||
162869381|NCT00059215|588225329|FG001|Overall Study|Death|0|||
162869382|NCT00059215|588225330|FG002|Overall Study|Death|3|||
162869383|NCT00059215|588225331|FG003|Overall Study|Death|0|||
162869384|NCT00059215|588225328|FG000|Overall Study|Lost to Follow-up|1|||
162869385|NCT00059215|588225329|FG001|Overall Study|Lost to Follow-up|2|||
162869386|NCT00059215|588225330|FG002|Overall Study|Lost to Follow-up|0|||
162869387|NCT00059215|588225331|FG003|Overall Study|Lost to Follow-up|0|||
162869388|NCT00059215|588225328|FG000|Overall Study|Withdrawal by Subject|4|||
162869389|NCT00059215|588225329|FG001|Overall Study|Withdrawal by Subject|4|||
162869390|NCT00059215|588225330|FG002|Overall Study|Withdrawal by Subject|1|||
162869391|NCT00059215|588225331|FG003|Overall Study|Withdrawal by Subject|3|||
162869392|NCT00059215|588225328|FG000|Overall Study|Protocol Violation|1|||
162869393|NCT00059215|588225329|FG001|Overall Study|Protocol Violation|0|||
162869394|NCT00059215|588225330|FG002|Overall Study|Protocol Violation|1|||
162869395|NCT00059215|588225331|FG003|Overall Study|Protocol Violation|0|||
162869396|NCT00059215|588225328|FG000|Overall Study|Protocol entry criteria not met|1|||
162869397|NCT00059215|588225329|FG001|Overall Study|Protocol entry criteria not met|1|||
162869398|NCT00059215|588225330|FG002|Overall Study|Protocol entry criteria not met|0|||
162869399|NCT00059215|588225331|FG003|Overall Study|Protocol entry criteria not met|2|||
162869400|NCT00059215|588225328|FG000|Overall Study|Physician Decision|1|||
162869401|NCT00059215|588225329|FG001|Overall Study|Physician Decision|2|||
162869402|NCT00059215|588225330|FG002|Overall Study|Physician Decision|1|||
162869403|NCT00059215|588225331|FG003|Overall Study|Physician Decision|1|||
162869404|NCT04494633|588225332|FG000|Overall Study|Lost to Follow-up|5|||
162869405|NCT04494633|588225333|FG001|Overall Study|Lost to Follow-up|3|||
162869406|NCT04494633|588225332|FG000|Overall Study|Protocol Violation|1|||
162869407|NCT04494633|588225333|FG001|Overall Study|Protocol Violation|1|||
162869408|NCT01254604|588225336|FG000|Overall Study|Lost to Follow-up|1|||
162869409|NCT01254604|588225337|FG001|Overall Study|Lost to Follow-up|1|||
162869410|NCT01254604|588225336|FG000|Overall Study|Protocol Violation|2|||
162869411|NCT01254604|588225337|FG001|Overall Study|Protocol Violation|2|||
162869412|NCT01254604|588225336|FG000|Overall Study|Withdrawal by Subject|2|||
162869413|NCT01254604|588225337|FG001|Overall Study|Withdrawal by Subject|4|||
162869414|NCT01254604|588225336|FG000|Overall Study|Adverse Event|3|||
162869415|NCT01254604|588225337|FG001|Overall Study|Adverse Event|2|||
162869416|NCT03074162|588225338|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
162869417|NCT03074162|588225339|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
162869418|NCT03074162|588225340|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
162869419|NCT03074162|588225341|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
162869420|NCT03074162|588225342|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
162869421|NCT03074162|588225343|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
162869422|NCT03074162|588225338|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
162869423|NCT03074162|588225339|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
162869424|NCT03074162|588225340|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
162869425|NCT03074162|588225341|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
162869426|NCT03074162|588225342|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
162960459|NCT03497130|588558845|FG000|Overall Study|Lost to Follow-up|1|||
162960460|NCT03497130|588558846|FG001|Overall Study|Lost to Follow-up|1|||
162869427|NCT03074162|588225343|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
162869428|NCT03074162|588225338|FG000|Period 3|Withdrawal by Subject|1|||
162869429|NCT03074162|588225339|FG001|Period 3|Withdrawal by Subject|0|||
162869430|NCT03074162|588225340|FG002|Period 3|Withdrawal by Subject|0|||
162869431|NCT03074162|588225341|FG003|Period 3|Withdrawal by Subject|0|||
162869432|NCT03074162|588225342|FG004|Period 3|Withdrawal by Subject|1|||
162869433|NCT03074162|588225343|FG005|Period 3|Withdrawal by Subject|0|||
162869434|NCT01958671|588225344|FG000|Overall Study|Adverse Event|1|||
162960461|NCT00418938|588558847|FG000|Overall Study|Reimbursement|1|||
162960462|NCT00418938|588558848|FG001|Overall Study|Reimbursement|0|||
162869435|NCT01958671|588225345|FG001|Overall Study|Adverse Event|1|||
162869436|NCT01958671|588225346|FG002|Overall Study|Adverse Event|5|||
162869437|NCT01958671|588225344|FG000|Overall Study|Death|1|||
162960463|NCT00418938|588558847|FG000|Overall Study|Administrative decision|3|||
162869438|NCT01958671|588225345|FG001|Overall Study|Death|0|||
162869439|NCT01958671|588225346|FG002|Overall Study|Death|0|||
162869440|NCT01958671|588225344|FG000|Overall Study|Excluded medication|0|||
162869441|NCT01958671|588225345|FG001|Overall Study|Excluded medication|0|||
162869442|NCT01958671|588225346|FG002|Overall Study|Excluded medication|1|||
162614607|NCT01886716|587307316|FG000|Week 3|Lost to Follow-up|1|||
162614608|NCT01886716|587307317|FG001|Week 3|Lost to Follow-up|1|||
162614609|NCT01886716|587307318|FG002|Week 3|Lost to Follow-up|0|||
162614610|NCT01886716|587307319|FG003|Week 3|Lost to Follow-up|1|||
162614611|NCT01051466|587307321|FG000|Overall Study|Adverse Event|1|||
162614612|NCT01051466|587307322|FG001|Overall Study|Adverse Event|0|||
162614613|NCT01051466|587307321|FG000|Overall Study|Lost to Follow-up|1|||
162614614|NCT01051466|587307322|FG001|Overall Study|Lost to Follow-up|1|||
162614615|NCT01051466|587307321|FG000|Overall Study|Withdrawal by Subject|5|||
162614616|NCT01051466|587307322|FG001|Overall Study|Withdrawal by Subject|1|||
162614617|NCT01051466|587307321|FG000|Overall Study|Entry Criteria Not Met|0|||
162614618|NCT01051466|587307322|FG001|Overall Study|Entry Criteria Not Met|3|||
162614619|NCT01051466|587307321|FG000|Overall Study|Physician Decision|1|||
162614620|NCT01051466|587307322|FG001|Overall Study|Physician Decision|0|||
162614621|NCT04806503|587307325|FG000|Overall Study|Lost to Follow-up|0|||
162614622|NCT04806503|587307326|FG001|Overall Study|Lost to Follow-up|0|||
162614623|NCT04806503|587307327|FG002|Overall Study|Lost to Follow-up|1|||
162614624|NCT04806503|587307328|FG003|Overall Study|Lost to Follow-up|0|||
162614625|NCT04806503|587307329|FG004|Overall Study|Lost to Follow-up|0|||
162614626|NCT04806503|587307325|FG000|Overall Study|Withdrawal by Subject|1|||
162614627|NCT04806503|587307326|FG001|Overall Study|Withdrawal by Subject|0|||
162614628|NCT04806503|587307327|FG002|Overall Study|Withdrawal by Subject|1|||
162614629|NCT04806503|587307328|FG003|Overall Study|Withdrawal by Subject|1|||
162614630|NCT04806503|587307329|FG004|Overall Study|Withdrawal by Subject|1|||
162614631|NCT04806503|587307325|FG000|Overall Study|Adverse Event|1|||
162614632|NCT04806503|587307326|FG001|Overall Study|Adverse Event|1|||
162614633|NCT04806503|587307327|FG002|Overall Study|Adverse Event|0|||
162614634|NCT04806503|587307328|FG003|Overall Study|Adverse Event|1|||
162614635|NCT04806503|587307329|FG004|Overall Study|Adverse Event|0|||
162614636|NCT03589469|587307330|FG000|Overall Study|Withdrawal by Subject|8|||
162614637|NCT03589469|587307330|FG000|Overall Study|Physician Decision|20|||
162614638|NCT03589469|587307330|FG000|Overall Study|Death|97|||
162614639|NCT03589469|587307330|FG000|Overall Study|Lost to Follow-up|8|||
162614640|NCT03589469|587307330|FG000|Overall Study|Miscellaneous|1|||
162614641|NCT05061966|587307333|FG000|Overall Study|Lost to Follow-up|13|||
162614642|NCT05061966|587307334|FG001|Overall Study|Lost to Follow-up|13|||
162614643|NCT03793556|587307335|FG000|Overall Study|Withdrawal by Subject|12|||
162614644|NCT03793556|587307336|FG001|Overall Study|Withdrawal by Subject|1|||
162614645|NCT03793556|587307335|FG000|Overall Study|Lost to Follow-up|1|||
162614646|NCT03793556|587307336|FG001|Overall Study|Lost to Follow-up|1|||
162614647|NCT01325623|587307337|FG000|Overall Study|Withdrawal by Subject|3|||
162614648|NCT00598702|587307338|FG000|Overall Study|Other|0|||
162614649|NCT00598702|587307339|FG001|Overall Study|Other|2|||
162614650|NCT00598702|587307340|FG002|Overall Study|Other|0|||
162614651|NCT00598702|587307341|FG003|Overall Study|Other|0|||
162614652|NCT00598702|587307342|FG004|Overall Study|Other|0|||
162614653|NCT00598702|587307343|FG005|Overall Study|Other|1|||
162614654|NCT00598702|587307344|FG006|Overall Study|Other|0|||
162614655|NCT00598702|587307345|FG007|Overall Study|Other|0|||
162614656|NCT00598702|587307338|FG000|Overall Study|Early discharge from hospital|0|||
162614657|NCT00598702|587307339|FG001|Overall Study|Early discharge from hospital|0|||
162614658|NCT00598702|587307340|FG002|Overall Study|Early discharge from hospital|2|||
162614659|NCT00598702|587307341|FG003|Overall Study|Early discharge from hospital|5|||
162614660|NCT00598702|587307342|FG004|Overall Study|Early discharge from hospital|0|||
162614661|NCT00598702|587307343|FG005|Overall Study|Early discharge from hospital|10|||
162614662|NCT00598702|587307344|FG006|Overall Study|Early discharge from hospital|1|||
162614663|NCT00598702|587307345|FG007|Overall Study|Early discharge from hospital|0|||
162614664|NCT00598702|587307338|FG000|Overall Study|Adverse Event|0|||
162614665|NCT00598702|587307339|FG001|Overall Study|Adverse Event|0|||
162614666|NCT00598702|587307340|FG002|Overall Study|Adverse Event|0|||
162614667|NCT00598702|587307341|FG003|Overall Study|Adverse Event|1|||
162614668|NCT00598702|587307342|FG004|Overall Study|Adverse Event|0|||
162614669|NCT00598702|587307343|FG005|Overall Study|Adverse Event|0|||
162614670|NCT00598702|587307344|FG006|Overall Study|Adverse Event|0|||
162614671|NCT00598702|587307345|FG007|Overall Study|Adverse Event|0|||
162614672|NCT00598702|587307338|FG000|Overall Study|Withdrawal by Subject|0|||
162614673|NCT00598702|587307339|FG001|Overall Study|Withdrawal by Subject|0|||
162614674|NCT00598702|587307340|FG002|Overall Study|Withdrawal by Subject|0|||
162869443|NCT01958671|588225344|FG000|Overall Study|Hyperglycemia|0|||
162614675|NCT00598702|587307341|FG003|Overall Study|Withdrawal by Subject|1|||
162614676|NCT00598702|587307342|FG004|Overall Study|Withdrawal by Subject|1|||
162614677|NCT00598702|587307343|FG005|Overall Study|Withdrawal by Subject|0|||
162614678|NCT00598702|587307344|FG006|Overall Study|Withdrawal by Subject|0|||
162614679|NCT00598702|587307345|FG007|Overall Study|Withdrawal by Subject|0|||
162869444|NCT01958671|588225345|FG001|Overall Study|Hyperglycemia|0|||
162869445|NCT01958671|588225346|FG002|Overall Study|Hyperglycemia|2|||
162869446|NCT01958671|588225344|FG000|Overall Study|Lost to Follow-up|7|||
162869447|NCT01958671|588225345|FG001|Overall Study|Lost to Follow-up|11|||
162869448|NCT01958671|588225346|FG002|Overall Study|Lost to Follow-up|7|||
162869449|NCT01958671|588225344|FG000|Overall Study|Non-compliance with study drug|1|||
162869450|NCT01958671|588225345|FG001|Overall Study|Non-compliance with study drug|1|||
162869451|NCT01958671|588225346|FG002|Overall Study|Non-compliance with study drug|1|||
162869452|NCT01958671|588225344|FG000|Overall Study|Pregnancy|0|||
162869453|NCT01958671|588225345|FG001|Overall Study|Pregnancy|0|||
162869454|NCT01958671|588225346|FG002|Overall Study|Pregnancy|1|||
162869455|NCT01958671|588225344|FG000|Overall Study|Protocol Violation|0|||
162869456|NCT01958671|588225345|FG001|Overall Study|Protocol Violation|1|||
162869457|NCT01958671|588225346|FG002|Overall Study|Protocol Violation|0|||
162869458|NCT01958671|588225344|FG000|Overall Study|Study site terminated by sponsor|1|||
162869459|NCT01958671|588225345|FG001|Overall Study|Study site terminated by sponsor|0|||
162869460|NCT01958671|588225346|FG002|Overall Study|Study site terminated by sponsor|1|||
162869461|NCT01958671|588225344|FG000|Overall Study|Participant moved|0|||
162869462|NCT01958671|588225345|FG001|Overall Study|Participant moved|0|||
162869463|NCT01958671|588225346|FG002|Overall Study|Participant moved|1|||
162869464|NCT01958671|588225344|FG000|Overall Study|Withdrawal by Subject|8|||
162869465|NCT01958671|588225345|FG001|Overall Study|Withdrawal by Subject|10|||
162869466|NCT01958671|588225346|FG002|Overall Study|Withdrawal by Subject|13|||
162869467|NCT02778867|588225347|FG000|Phase 1|Withdrawal by Subject|2|||
162869468|NCT02778867|588225348|FG001|Phase 1|Withdrawal by Subject|3|||
162869469|NCT02778867|588225349|FG002|Phase 1|Withdrawal by Subject|0|||
162869470|NCT02778867|588225350|FG003|Phase 1|Withdrawal by Subject|0|||
162960464|NCT00418938|588558848|FG001|Overall Study|Administrative decision|3|||
162960465|NCT00418938|588558847|FG000|Overall Study|Withdrawal by Subject|16|||
162960466|NCT00418938|588558848|FG001|Overall Study|Withdrawal by Subject|15|||
163046865|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
163046866|NCT02326272|588879354|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046867|NCT02326272|588879355|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046868|NCT02326272|588879356|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
163046869|NCT02326272|588879357|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046870|NCT02326272|588879358|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046871|NCT02326272|588879359|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046872|NCT02326272|588879360|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163058598|NCT00042289|588924238|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
162960467|NCT00418938|588558847|FG000|Overall Study|Lost to Follow-up|1|||
162960468|NCT00418938|588558848|FG001|Overall Study|Lost to Follow-up|3|||
162960469|NCT00418938|588558847|FG000|Overall Study|Adverse Event|1|||
162960470|NCT00418938|588558848|FG001|Overall Study|Adverse Event|1|||
162960471|NCT00418938|588558847|FG000|Overall Study|On-going|1|||
162960472|NCT00418938|588558848|FG001|Overall Study|On-going|1|||
162960473|NCT00418938|588558847|FG000|Overall Study|Ineligibility Determined|1|||
162960474|NCT00418938|588558848|FG001|Overall Study|Ineligibility Determined|0|||
162960475|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
162960476|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
162960477|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
162960478|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
162960479|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
162960480|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
162960481|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Death|9|||
162960482|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Death|7|||
162960483|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Death|14|||
162960484|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Death|7|||
162960485|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Death|0|||
162960486|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Death|0|||
162960487|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
162960488|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
162960489|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
162706232|NCT03704298|587636608|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
162869471|NCT02778867|588225347|FG000|Phase 2|Withdrawal by Subject|0|||
162869472|NCT02778867|588225348|FG001|Phase 2|Withdrawal by Subject|0|||
162960490|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
162960491|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
162960492|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
162960493|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Other Event|49|||
162869473|NCT02778867|588225349|FG002|Phase 2|Withdrawal by Subject|1|||
162960494|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Other Event|52|||
163046873|NCT02326272|588879361|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046874|NCT02326272|588879362|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046875|NCT02326272|588879363|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046876|NCT02326272|588879364|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046877|NCT02326272|588879365|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046878|NCT02326272|588879366|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046879|NCT02326272|588879367|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046880|NCT02326272|588879368|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163046881|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046882|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046883|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046884|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046885|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163046886|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
163046887|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
163046888|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
163046889|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163046890|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046891|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046892|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046893|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046894|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046895|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163046896|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046897|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046898|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046899|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046900|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046901|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
163046902|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046903|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046904|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046905|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
163046906|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046907|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046908|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046909|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046910|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163046911|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046912|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162614680|NCT00598702|587307338|FG000|Overall Study|Physician Decision|0|||
162960495|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Other Event|41|||
162960496|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Other Event|58|||
162960497|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Other Event|0|||
162960498|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Other Event|0|||
162960499|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
162960500|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
162960501|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
162960502|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
162960503|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
162960504|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
162960505|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
162960506|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
162960507|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
162960508|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
162960509|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
162960510|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
162960511|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
162614681|NCT00598702|587307339|FG001|Overall Study|Physician Decision|0|||
162614682|NCT00598702|587307340|FG002|Overall Study|Physician Decision|0|||
162614683|NCT00598702|587307341|FG003|Overall Study|Physician Decision|0|||
162614684|NCT00598702|587307342|FG004|Overall Study|Physician Decision|1|||
162614685|NCT00598702|587307343|FG005|Overall Study|Physician Decision|0|||
162960512|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
162960513|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
163046913|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162869474|NCT02778867|588225350|FG003|Phase 2|Withdrawal by Subject|0|||
162869475|NCT02778867|588225347|FG000|Phase 2|Physician Decision|0|||
162869476|NCT02778867|588225348|FG001|Phase 2|Physician Decision|0|||
162869477|NCT02778867|588225349|FG002|Phase 2|Physician Decision|0|||
162869478|NCT02778867|588225350|FG003|Phase 2|Physician Decision|1|||
162869479|NCT02778867|588225347|FG000|Phase 2|Adverse Event|0|||
162869480|NCT02778867|588225348|FG001|Phase 2|Adverse Event|0|||
162869481|NCT02778867|588225349|FG002|Phase 2|Adverse Event|0|||
162869482|NCT02778867|588225350|FG003|Phase 2|Adverse Event|1|||
162869483|NCT02948777|588225351|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
162869484|NCT02311478|588225353|FG000|Overall Study|Withdrawal by Subject|1|||
162869485|NCT02311478|588225353|FG000|Overall Study|Lost to Follow-up|5|||
162869486|NCT02311478|588225353|FG000|Overall Study|Failed IUD Insertion|1|||
162869487|NCT03242928|588225354|FG000|Overall Study|Adverse Event|2|||
162869488|NCT03242928|588225355|FG001|Overall Study|Adverse Event|1|||
162869489|NCT03242928|588225354|FG000|Overall Study|Lost to Follow-up|2|||
162869490|NCT03242928|588225355|FG001|Overall Study|Lost to Follow-up|0|||
162869491|NCT03242928|588225354|FG000|Overall Study|Physician Decision|0|||
162869492|NCT03242928|588225355|FG001|Overall Study|Physician Decision|1|||
162869493|NCT03242928|588225354|FG000|Overall Study|Withdrawal by Subject|5|||
162869494|NCT03242928|588225355|FG001|Overall Study|Withdrawal by Subject|3|||
162869495|NCT03276936|588225356|FG000|Overall Study|Adverse Event|4|||
162869496|NCT03276936|588225357|FG001|Overall Study|Adverse Event|2|||
162869497|NCT03276936|588225356|FG000|Overall Study|Lost to Follow-up|16|||
162869498|NCT03276936|588225357|FG001|Overall Study|Lost to Follow-up|13|||
162869499|NCT03276936|588225356|FG000|Overall Study|Withdrawal by Subject|30|||
162869500|NCT03276936|588225357|FG001|Overall Study|Withdrawal by Subject|20|||
162869501|NCT03276936|588225356|FG000|Overall Study|Not mentioned|6|||
162869502|NCT03276936|588225357|FG001|Overall Study|Not mentioned|3|||
162869503|NCT00943319|588225358|FG000|Overall Study|Death|1|||
162869504|NCT02043301|588225359|FG000|Overall Study|Discontinued|0|||
162869505|NCT02043301|588225360|FG001|Overall Study|Discontinued|1|||
162869506|NCT02043301|588225361|FG002|Overall Study|Discontinued|0|||
162869507|NCT03703375|588225365|FG000|Randomization Period|Withdrawal by Subject|0|||
162869508|NCT03703375|588225366|FG001|Randomization Period|Withdrawal by Subject|0|||
162869509|NCT03703375|588225367|FG002|Randomization Period|Withdrawal by Subject|0|||
162869510|NCT03703375|588225368|FG003|Randomization Period|Withdrawal by Subject|1|||
162869511|NCT03703375|588225365|FG000|Randomization Period|Completed safety run-in treatment|7|||
162869512|NCT03703375|588225366|FG001|Randomization Period|Completed safety run-in treatment|0|||
162869513|NCT03703375|588225367|FG002|Randomization Period|Completed safety run-in treatment|0|||
162869514|NCT03703375|588225368|FG003|Randomization Period|Completed safety run-in treatment|0|||
162869515|NCT03703375|588225365|FG000|Treatment Period|Other Reasons|0|||
162869516|NCT03703375|588225366|FG001|Treatment Period|Other Reasons|1|||
162869517|NCT03703375|588225367|FG002|Treatment Period|Other Reasons|0|||
162869518|NCT03703375|588225368|FG003|Treatment Period|Other Reasons|3|||
162869519|NCT03703375|588225365|FG000|Treatment Period|Consent Withdrawal|0|||
162869520|NCT03703375|588225366|FG001|Treatment Period|Consent Withdrawal|0|||
162869521|NCT03703375|588225367|FG002|Treatment Period|Consent Withdrawal|0|||
162869522|NCT03703375|588225368|FG003|Treatment Period|Consent Withdrawal|1|||
162869523|NCT03703375|588225365|FG000|Treatment Period|Death|1|||
162869524|NCT03703375|588225366|FG001|Treatment Period|Death|0|||
162869525|NCT03703375|588225367|FG002|Treatment Period|Death|1|||
162869526|NCT03703375|588225368|FG003|Treatment Period|Death|2|||
162869527|NCT03703375|588225365|FG000|Treatment Period|Toxicity of Study Treatment|2|||
162869528|NCT03703375|588225366|FG001|Treatment Period|Toxicity of Study Treatment|0|||
162869529|NCT03703375|588225367|FG002|Treatment Period|Toxicity of Study Treatment|4|||
162869530|NCT03703375|588225368|FG003|Treatment Period|Toxicity of Study Treatment|1|||
162869531|NCT03703375|588225365|FG000|Treatment Period|Progression|32|||
162869532|NCT03703375|588225366|FG001|Treatment Period|Progression|1|||
162869533|NCT03703375|588225367|FG002|Treatment Period|Progression|7|||
162869534|NCT03703375|588225368|FG003|Treatment Period|Progression|11|||
162614686|NCT00598702|587307344|FG006|Overall Study|Physician Decision|0|||
162869535|NCT03703375|588225365|FG000|Treatment Period|Completed treatment|7|||
162869536|NCT03703375|588225366|FG001|Treatment Period|Completed treatment|2|||
162869537|NCT03703375|588225367|FG002|Treatment Period|Completed treatment|0|||
162869538|NCT03703375|588225368|FG003|Treatment Period|Completed treatment|0|||
162869539|NCT00625365|588225369|FG000|Overall Study|Withdrawal by Subject|1|||
162869540|NCT00625365|588225369|FG000|Overall Study|No IV access|5|||
162869541|NCT00625365|588225369|FG000|Overall Study|VSD|1|||
162869542|NCT01703286|588225371|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
162869543|NCT01703286|588225372|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
162869544|NCT01703286|588225373|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
162869545|NCT01703286|588225374|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
162869546|NCT01703286|588225375|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
162869547|NCT01703286|588225376|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
162869548|NCT01703286|588225371|FG000|Period 2 Including Washout|Adverse Event|0|||
162869549|NCT01703286|588225372|FG001|Period 2 Including Washout|Adverse Event|0|||
162869550|NCT01703286|588225373|FG002|Period 2 Including Washout|Adverse Event|0|||
162869551|NCT01703286|588225374|FG003|Period 2 Including Washout|Adverse Event|1|||
162869552|NCT01703286|588225375|FG004|Period 2 Including Washout|Adverse Event|0|||
162869553|NCT01703286|588225376|FG005|Period 2 Including Washout|Adverse Event|0|||
162869554|NCT00931892|588225377|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
162869555|NCT00931892|588225378|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
162869556|NCT02207530|588225381|FG000|Overall Study|Worsening condition under investigation|78|||
162869557|NCT02207530|588225381|FG000|Overall Study|Patient decision to stop study treatment|5|||
162869558|NCT02207530|588225381|FG000|Overall Study|Adverse Event|8|||
162869559|NCT03952468|588225390|FG000|Overall Study|Death|0|||
162869560|NCT03952468|588225391|FG001|Overall Study|Death|1|||
162869561|NCT03952468|588225390|FG000|Overall Study|Adverse Event|0|||
162869562|NCT03952468|588225391|FG001|Overall Study|Adverse Event|1|||
162869563|NCT03952468|588225390|FG000|Overall Study|Physician Decision|1|||
162869564|NCT03952468|588225391|FG001|Overall Study|Physician Decision|0|||
162869565|NCT03952468|588225390|FG000|Overall Study|Lost to Follow-up|3|||
162869566|NCT03952468|588225391|FG001|Overall Study|Lost to Follow-up|4|||
162869567|NCT03952468|588225390|FG000|Overall Study|Withdrawal by Subject|2|||
162869568|NCT03952468|588225391|FG001|Overall Study|Withdrawal by Subject|1|||
162869569|NCT06094296|588225392|FG000|Overall Study|Progressive Disease|1|||
162869570|NCT06094296|588225393|FG001|Overall Study|Progressive Disease|0|||
162869571|NCT06094296|588225394|FG002|Overall Study|Progressive Disease|0|||
162869572|NCT06094296|588225395|FG003|Overall Study|Progressive Disease|0|||
162869573|NCT04964063|588225396|FG000|Overall Study|Adverse Event|4|||
162960514|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
162960515|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
162960516|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
162960517|NCT00205777|588558849|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
162960518|NCT00205777|588558850|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
162960519|NCT00205777|588558851|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
162960520|NCT00205777|588558852|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
162960521|NCT00205777|588558853|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
162960522|NCT00205777|588558854|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
162960523|NCT00205777|588558849|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
162960524|NCT00205777|588558850|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
162960525|NCT00205777|588558851|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
162960526|NCT00205777|588558852|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
162960527|NCT00205777|588558853|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
162960528|NCT00205777|588558854|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
162960529|NCT00205777|588558849|FG000|Completed Core Study, Entered SE I|Other Event|52|||
162960530|NCT00205777|588558850|FG001|Completed Core Study, Entered SE I|Other Event|46|||
162960531|NCT00205777|588558851|FG002|Completed Core Study, Entered SE I|Other Event|47|||
162960532|NCT00205777|588558852|FG003|Completed Core Study, Entered SE I|Other Event|50|||
162960533|NCT00205777|588558853|FG004|Completed Core Study, Entered SE I|Other Event|0|||
162960534|NCT00205777|588558854|FG005|Completed Core Study, Entered SE I|Other Event|0|||
162960535|NCT00205777|588558849|FG000|Study Extension I|Adverse Event|57|||
162960536|NCT00205777|588558850|FG001|Study Extension I|Adverse Event|0|||
162960537|NCT00205777|588558851|FG002|Study Extension I|Adverse Event|0|||
162960538|NCT00205777|588558852|FG003|Study Extension I|Adverse Event|61|||
162960539|NCT00205777|588558853|FG004|Study Extension I|Adverse Event|58|||
162960540|NCT00205777|588558854|FG005|Study Extension I|Adverse Event|0|||
162960541|NCT00205777|588558849|FG000|Study Extension I|Death|5|||
162960542|NCT00205777|588558850|FG001|Study Extension I|Death|0|||
162960543|NCT00205777|588558851|FG002|Study Extension I|Death|0|||
162960544|NCT00205777|588558852|FG003|Study Extension I|Death|1|||
162960545|NCT00205777|588558853|FG004|Study Extension I|Death|2|||
162869574|NCT04964063|588225396|FG000|Overall Study|Lost to Follow-up|47|||
162869575|NCT04964063|588225396|FG000|Overall Study|Withdrawal by Subject|5|||
162869576|NCT04964063|588225396|FG000|Overall Study|Baseline Tasks Expired|41|||
162614687|NCT00598702|587307345|FG007|Overall Study|Physician Decision|0|||
162869577|NCT04964063|588225396|FG000|Overall Study|Participant withdrawn in error|1|||
162869578|NCT03350750|588225400|FG000|Overall Study|Death|1|||
162869579|NCT03350750|588225401|FG001|Overall Study|Death|1|||
162869580|NCT00406315|588225403|FG000|Overall Study|Death|1|||
162869581|NCT00406315|588225403|FG000|Overall Study|Adverse Event|39|||
162869582|NCT00406315|588225403|FG000|Overall Study|Laboratory Abnormality|4|||
162869583|NCT00406315|588225403|FG000|Overall Study|Lack of Efficacy|13|||
162869584|NCT00406315|588225403|FG000|Overall Study|Other|33|||
162869585|NCT00406315|588225403|FG000|Overall Study|Lost to Follow-up|21|||
162869586|NCT00406315|588225403|FG000|Overall Study|Withdrawal by Subject|30|||
162869587|NCT01312428|588225404|FG000|Overall Study|Study Termination|3|||
162869588|NCT01312428|588225405|FG001|Overall Study|Study Termination|4|||
162869589|NCT01797783|588225408|FG000|Overall Study|Adverse Event|1|||
162869590|NCT01797783|588225409|FG001|Overall Study|Adverse Event|1|||
162869591|NCT01797783|588225408|FG000|Overall Study|Withdrawal by Subject|1|||
162869592|NCT01797783|588225409|FG001|Overall Study|Withdrawal by Subject|0|||
162869593|NCT02202031|588225411|FG000|Overall Study|Lost to Follow-up|1|||
162869594|NCT02202031|588225412|FG001|Overall Study|Lost to Follow-up|0|||
162869595|NCT02202031|588225411|FG000|Overall Study|Too Busy|1|||
162869596|NCT02202031|588225412|FG001|Overall Study|Too Busy|3|||
162869597|NCT02202031|588225411|FG000|Overall Study|Illness/Medical Reason|0|||
162869598|NCT02202031|588225412|FG001|Overall Study|Illness/Medical Reason|2|||
162869599|NCT02202031|588225411|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
162869600|NCT02202031|588225412|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
162869601|NCT02184143|588225413|FG000|Overall Study|Withdrawal by Subject|4|||
162869602|NCT02184143|588225414|FG001|Overall Study|Withdrawal by Subject|4|||
162869603|NCT02184143|588225413|FG000|Overall Study|Lost to Follow-up|5|||
162869604|NCT02184143|588225414|FG001|Overall Study|Lost to Follow-up|3|||
162869605|NCT02184143|588225413|FG000|Overall Study|Death|1|||
162869606|NCT02184143|588225414|FG001|Overall Study|Death|0|||
162869607|NCT00321984|588225416|FG000|Overall Study|Adverse Event|9|||
162869608|NCT00321984|588225417|FG001|Overall Study|Adverse Event|6|||
162869609|NCT00321984|588225418|FG002|Overall Study|Adverse Event|8|||
162869610|NCT00321984|588225416|FG000|Overall Study|Protocol Violation|0|||
162869611|NCT00321984|588225417|FG001|Overall Study|Protocol Violation|1|||
162869612|NCT00321984|588225418|FG002|Overall Study|Protocol Violation|1|||
162869613|NCT00321984|588225416|FG000|Overall Study|Lost to Follow-up|2|||
162869614|NCT00321984|588225417|FG001|Overall Study|Lost to Follow-up|4|||
162869615|NCT00321984|588225418|FG002|Overall Study|Lost to Follow-up|2|||
162869616|NCT00321984|588225416|FG000|Overall Study|Withdrawal by Subject|8|||
162869617|NCT00321984|588225417|FG001|Overall Study|Withdrawal by Subject|6|||
162869618|NCT00321984|588225418|FG002|Overall Study|Withdrawal by Subject|5|||
162869619|NCT00321984|588225416|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
162869620|NCT00321984|588225417|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
162869621|NCT00321984|588225418|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
162869622|NCT00321984|588225416|FG000|Overall Study|Lack of Efficacy|3|||
162869623|NCT00321984|588225417|FG001|Overall Study|Lack of Efficacy|1|||
162869624|NCT00321984|588225418|FG002|Overall Study|Lack of Efficacy|3|||
162869625|NCT00321984|588225416|FG000|Overall Study|Noncompliant|0|||
162869626|NCT00321984|588225417|FG001|Overall Study|Noncompliant|0|||
162869627|NCT00321984|588225418|FG002|Overall Study|Noncompliant|2|||
162869628|NCT00321984|588225416|FG000|Overall Study|Pregnancy|0|||
162869629|NCT00321984|588225417|FG001|Overall Study|Pregnancy|1|||
162869630|NCT00321984|588225418|FG002|Overall Study|Pregnancy|0|||
162614688|NCT00598702|587307338|FG000|Overall Study|Dose limiting toxicity|0|||
162614689|NCT00598702|587307339|FG001|Overall Study|Dose limiting toxicity|0|||
162614690|NCT00598702|587307340|FG002|Overall Study|Dose limiting toxicity|0|||
162614691|NCT00598702|587307341|FG003|Overall Study|Dose limiting toxicity|1|||
162614692|NCT00598702|587307342|FG004|Overall Study|Dose limiting toxicity|1|||
162614693|NCT00598702|587307343|FG005|Overall Study|Dose limiting toxicity|1|||
162614694|NCT00598702|587307344|FG006|Overall Study|Dose limiting toxicity|0|||
162614695|NCT00598702|587307345|FG007|Overall Study|Dose limiting toxicity|0|||
162614696|NCT02413372|587307349|FG000|Treatment|Lost to Follow-up|0|||
162614697|NCT02413372|587307350|FG001|Treatment|Lost to Follow-up|2|||
162869631|NCT00321984|588225416|FG000|Overall Study|Per Subject Request|1|||
162869632|NCT00321984|588225417|FG001|Overall Study|Per Subject Request|0|||
162869633|NCT00321984|588225418|FG002|Overall Study|Per Subject Request|0|||
162869634|NCT00321984|588225416|FG000|Overall Study|Per Investigator Request|1|||
162869635|NCT00321984|588225417|FG001|Overall Study|Per Investigator Request|0|||
162869636|NCT00321984|588225418|FG002|Overall Study|Per Investigator Request|0|||
162869637|NCT00321984|588225416|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
162869638|NCT00321984|588225417|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
162869639|NCT00321984|588225418|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
162869640|NCT02214186|588225419|FG000|Overall Study|Lost to Follow-up|1|||
162869641|NCT02214186|588225420|FG001|Overall Study|Lost to Follow-up|1|||
162869642|NCT02214186|588225419|FG000|Overall Study|Protocol Violation|1|||
162869643|NCT02214186|588225420|FG001|Overall Study|Protocol Violation|1|||
162869644|NCT00525148|588225426|FG000|Overall Study|Other Adverse Event|3|||
162869645|NCT00525148|588225427|FG001|Overall Study|Other Adverse Event|5|||
162869646|NCT00525148|588225428|FG002|Overall Study|Other Adverse Event|1|||
162869647|NCT00525148|588225429|FG003|Overall Study|Other Adverse Event|8|||
162869648|NCT00525148|588225426|FG000|Overall Study|Progressive disease|18|||
162869649|NCT00525148|588225427|FG001|Overall Study|Progressive disease|30|||
162869650|NCT00525148|588225428|FG002|Overall Study|Progressive disease|6|||
162869651|NCT00525148|588225429|FG003|Overall Study|Progressive disease|49|||
162869652|NCT00525148|588225426|FG000|Overall Study|Refused continuation of study medication|0|||
162869653|NCT00525148|588225427|FG001|Overall Study|Refused continuation of study medication|2|||
162869654|NCT00525148|588225428|FG002|Overall Study|Refused continuation of study medication|0|||
162869655|NCT00525148|588225429|FG003|Overall Study|Refused continuation of study medication|1|||
162869656|NCT00525148|588225426|FG000|Overall Study|Other than stated|2|||
162869657|NCT00525148|588225427|FG001|Overall Study|Other than stated|1|||
162869658|NCT00525148|588225428|FG002|Overall Study|Other than stated|0|||
162869659|NCT00525148|588225429|FG003|Overall Study|Other than stated|3|||
162869660|NCT05100199|588225430|FG000|Overall Study|Lost to Follow-up|5|||
162869661|NCT05100199|588225431|FG001|Overall Study|Lost to Follow-up|8|||
162869662|NCT05100199|588225432|FG002|Overall Study|Lost to Follow-up|3|||
162869663|NCT05100199|588225433|FG003|Overall Study|Lost to Follow-up|6|||
162869664|NCT05100199|588225430|FG000|Overall Study|Withdrawal by Subject|3|||
162869665|NCT05100199|588225431|FG001|Overall Study|Withdrawal by Subject|3|||
162869666|NCT05100199|588225432|FG002|Overall Study|Withdrawal by Subject|9|||
162869667|NCT05100199|588225433|FG003|Overall Study|Withdrawal by Subject|7|||
162869668|NCT05100199|588225430|FG000|Overall Study|Other|0|||
162869669|NCT05100199|588225431|FG001|Overall Study|Other|0|||
162869670|NCT05100199|588225432|FG002|Overall Study|Other|1|||
162869671|NCT05100199|588225433|FG003|Overall Study|Other|1|||
162869672|NCT01426386|588225434|FG000|Overall Study|Adverse Event|0|||
162869673|NCT01426386|588225435|FG001|Overall Study|Adverse Event|1|||
162869674|NCT01426386|588225436|FG002|Overall Study|Adverse Event|0|||
162869675|NCT01426386|588225437|FG003|Overall Study|Adverse Event|0|||
162869676|NCT01426386|588225438|FG004|Overall Study|Adverse Event|0|||
162869677|NCT01426386|588225439|FG005|Overall Study|Adverse Event|0|||
162869678|NCT01426386|588225434|FG000|Overall Study|Did not attend scheduled visit|1|||
162869679|NCT01426386|588225435|FG001|Overall Study|Did not attend scheduled visit|4|||
162869680|NCT01426386|588225436|FG002|Overall Study|Did not attend scheduled visit|0|||
162869681|NCT01426386|588225437|FG003|Overall Study|Did not attend scheduled visit|0|||
162869682|NCT01426386|588225438|FG004|Overall Study|Did not attend scheduled visit|2|||
162869683|NCT01426386|588225439|FG005|Overall Study|Did not attend scheduled visit|1|||
162869684|NCT01426386|588225434|FG000|Overall Study|Poor response|2|||
162869685|NCT01426386|588225435|FG001|Overall Study|Poor response|1|||
162869686|NCT01426386|588225436|FG002|Overall Study|Poor response|2|||
162869687|NCT01426386|588225437|FG003|Overall Study|Poor response|0|||
162869688|NCT01426386|588225438|FG004|Overall Study|Poor response|1|||
162869689|NCT01426386|588225439|FG005|Overall Study|Poor response|0|||
162869690|NCT01426386|588225434|FG000|Overall Study|Personal reasons|0|||
162869691|NCT01426386|588225435|FG001|Overall Study|Personal reasons|0|||
162869692|NCT01426386|588225436|FG002|Overall Study|Personal reasons|0|||
162869693|NCT01426386|588225437|FG003|Overall Study|Personal reasons|0|||
162869694|NCT01426386|588225438|FG004|Overall Study|Personal reasons|1|||
162869695|NCT01426386|588225439|FG005|Overall Study|Personal reasons|0|||
162869696|NCT03694522|588225442|FG000|Overall Study|Withdrawal by Subject|8|||
162869697|NCT03694522|588225443|FG001|Overall Study|Withdrawal by Subject|10|||
162869698|NCT03694522|588225442|FG000|Overall Study|Physician Decision|53|||
162869699|NCT03694522|588225443|FG001|Overall Study|Physician Decision|54|||
162869700|NCT03694522|588225442|FG000|Overall Study|Other|1|||
162869701|NCT03694522|588225443|FG001|Overall Study|Other|1|||
162614698|NCT02413372|587307351|FG002|Treatment|Lost to Follow-up|1|||
162869702|NCT03694522|588225442|FG000|Overall Study|Lost to Follow-up|0|||
162869703|NCT03694522|588225443|FG001|Overall Study|Lost to Follow-up|1|||
162869704|NCT00257192|588225447|FG000|Overall Study|Adverse Event|21|||
162869705|NCT00257192|588225448|FG001|Overall Study|Adverse Event|10|||
162869706|NCT00257192|588225447|FG000|Overall Study|Laboratory abnormality|1|||
162869707|NCT00257192|588225448|FG001|Overall Study|Laboratory abnormality|1|||
162869708|NCT00257192|588225447|FG000|Overall Study|Lost to Follow-up|3|||
162869709|NCT00257192|588225448|FG001|Overall Study|Lost to Follow-up|3|||
162869710|NCT00257192|588225447|FG000|Overall Study|Insufficient clinical response|18|||
162869711|NCT00257192|588225448|FG001|Overall Study|Insufficient clinical response|18|||
162869712|NCT00257192|588225447|FG000|Overall Study|Withdrawal by Subject|14|||
162614699|NCT02413372|587307349|FG000|Treatment|Withdrawal by Subject|1|||
162614700|NCT02413372|587307350|FG001|Treatment|Withdrawal by Subject|0|||
162614701|NCT02413372|587307351|FG002|Treatment|Withdrawal by Subject|0|||
162614702|NCT02413372|587307349|FG000|Follow-up|Lost to Follow-up|1|||
162614703|NCT02413372|587307350|FG001|Follow-up|Lost to Follow-up|1|||
162614704|NCT02413372|587307351|FG002|Follow-up|Lost to Follow-up|0|||
162614705|NCT02413372|587307349|FG000|Follow-up|Subject Withdrew Consent|1|||
162614706|NCT02413372|587307350|FG001|Follow-up|Subject Withdrew Consent|0|||
162614707|NCT02413372|587307351|FG002|Follow-up|Subject Withdrew Consent|1|||
162706233|NCT03704298|587636605|FG000|Overall Study|Withdrawal by Subject|1|||
162706234|NCT03704298|587636606|FG001|Overall Study|Withdrawal by Subject|0|||
162706235|NCT03704298|587636607|FG002|Overall Study|Withdrawal by Subject|0|||
162706236|NCT03704298|587636608|FG003|Overall Study|Withdrawal by Subject|0|||
162706237|NCT03704298|587636605|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162706238|NCT03704298|587636606|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
162706239|NCT03704298|587636607|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162706240|NCT03704298|587636608|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162706241|NCT00558753|587636609|FG000|Overall Study|Lost to Follow-up|5|||
162706242|NCT00558753|587636610|FG001|Overall Study|Lost to Follow-up|7|||
162706243|NCT00162942|587636611|FG000|Overall Study|Adverse Event|10|||
162706244|NCT00162942|587636612|FG001|Overall Study|Adverse Event|6|||
162706245|NCT00162942|587636611|FG000|Overall Study|Death|1|||
162706246|NCT00162942|587636612|FG001|Overall Study|Death|0|||
162706247|NCT00162942|587636611|FG000|Overall Study|Withdrawal by Subject|3|||
162706248|NCT00162942|587636612|FG001|Overall Study|Withdrawal by Subject|6|||
162706249|NCT00162942|587636611|FG000|Overall Study|Physician Decision|1|||
162706250|NCT00162942|587636612|FG001|Overall Study|Physician Decision|0|||
162706251|NCT00162942|587636611|FG000|Overall Study|Enter Open-Label Study|76|||
162706252|NCT00162942|587636612|FG001|Overall Study|Enter Open-Label Study|35|||
162706253|NCT00162942|587636611|FG000|Overall Study|Alternate Therapy|6|||
162706254|NCT00162942|587636612|FG001|Overall Study|Alternate Therapy|2|||
162706255|NCT00162942|587636611|FG000|Overall Study|Lack of Efficacy|1|||
162706256|NCT00162942|587636612|FG001|Overall Study|Lack of Efficacy|0|||
162706257|NCT00162942|587636611|FG000|Overall Study|Flare During Active Treatment|7|||
162706258|NCT00162942|587636612|FG001|Overall Study|Flare During Active Treatment|3|||
162706259|NCT00162942|587636611|FG000|Overall Study|2 or more consecutive treatments missed|1|||
162706260|NCT00162942|587636612|FG001|Overall Study|2 or more consecutive treatments missed|0|||
162706261|NCT00410384|587636613|FG000|Overall Study|Withdrawal by Subject|28|||
162706262|NCT00410384|587636614|FG001|Overall Study|Withdrawal by Subject|17|||
162706263|NCT00410384|587636615|FG002|Overall Study|Withdrawal by Subject|20|||
162706264|NCT00410384|587636613|FG000|Overall Study|Adverse Event|23|||
162706265|NCT00410384|587636614|FG001|Overall Study|Adverse Event|18|||
162706266|NCT00410384|587636615|FG002|Overall Study|Adverse Event|23|||
162706267|NCT00410384|587636613|FG000|Overall Study|Lack of Efficacy|20|||
162706268|NCT00410384|587636614|FG001|Overall Study|Lack of Efficacy|12|||
162706269|NCT00410384|587636615|FG002|Overall Study|Lack of Efficacy|17|||
162706270|NCT00410384|587636613|FG000|Overall Study|Lack of Compliance|2|||
162706271|NCT00410384|587636614|FG001|Overall Study|Lack of Compliance|2|||
162706272|NCT00410384|587636615|FG002|Overall Study|Lack of Compliance|2|||
162706273|NCT00410384|587636613|FG000|Overall Study|Lost to Follow-up|4|||
162706274|NCT00410384|587636614|FG001|Overall Study|Lost to Follow-up|6|||
162706275|NCT00410384|587636615|FG002|Overall Study|Lost to Follow-up|6|||
162614708|NCT02413372|587307349|FG000|Follow-up|Subject unable to return for visit|0|||
162614709|NCT02413372|587307350|FG001|Follow-up|Subject unable to return for visit|0|||
162614710|NCT02413372|587307351|FG002|Follow-up|Subject unable to return for visit|1|||
162614711|NCT03053271|587307361|FG000|Overall Study|Did not meet randomization criteria|3|||
162614712|NCT03053271|587307361|FG000|Overall Study|Withdrawal by Subject|1|||
162614713|NCT00580970|587307362|FG000|Pre-treatment|Non-compliance|1|||
162614714|NCT00580970|587307362|FG000|Treatment (Lovastatin)|Non-compliance|6|||
162614715|NCT00580970|587307362|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
162614716|NCT00580970|587307362|FG000|Treatment (Lovastatin)|Physician Decision|4|||
162614717|NCT00580970|587307362|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
162614718|NCT00580970|587307362|FG000|Treatment (Lovastatin)|Death|1|||
162614719|NCT03161093|587307365|FG000|Overall Study|Protocol Violation|11|||
162706276|NCT00410384|587636613|FG000|Overall Study|Protocol Violation|6|||
162706277|NCT00410384|587636614|FG001|Overall Study|Protocol Violation|6|||
162706278|NCT00410384|587636615|FG002|Overall Study|Protocol Violation|6|||
162706279|NCT00410384|587636613|FG000|Overall Study|Physician Decision|3|||
162869713|NCT00257192|588225448|FG001|Overall Study|Withdrawal by Subject|2|||
162869714|NCT00257192|588225447|FG000|Overall Study|Randomized but not treated|0|||
162869715|NCT00257192|588225448|FG001|Overall Study|Randomized but not treated|1|||
162869716|NCT00257192|588225447|FG000|Overall Study|Study terminated by sponsor|1|||
162869717|NCT00257192|588225448|FG001|Overall Study|Study terminated by sponsor|0|||
162869718|NCT00257192|588225447|FG000|Overall Study|Miscellaneous|0|||
162869719|NCT00257192|588225448|FG001|Overall Study|Miscellaneous|4|||
162869720|NCT02062151|588225449|FG000|Overall Study|screen failure|1|||
162869721|NCT01905397|588225450|FG000|Overall Study|Death|0|||
162869722|NCT01905397|588225451|FG001|Overall Study|Death|1|||
162869723|NCT01905397|588225450|FG000|Overall Study|Withdrawal by Subject|2|||
162869724|NCT01905397|588225451|FG001|Overall Study|Withdrawal by Subject|0|||
162869725|NCT01905397|588225450|FG000|Overall Study|Surgery canceled/aborted|9|||
162869726|NCT01905397|588225451|FG001|Overall Study|Surgery canceled/aborted|5|||
162869727|NCT01905397|588225450|FG000|Overall Study|Incision < 7 cm|2|||
162869728|NCT01905397|588225451|FG001|Overall Study|Incision < 7 cm|0|||
162869729|NCT01905397|588225450|FG000|Overall Study|Wrong treatment|1|||
162869730|NCT01905397|588225451|FG001|Overall Study|Wrong treatment|1|||
162869731|NCT01905397|588225450|FG000|Overall Study|Device not applied|3|||
162869732|NCT01905397|588225451|FG001|Overall Study|Device not applied|0|||
162869733|NCT01905397|588225450|FG000|Overall Study|Dressing not applied in operating room|1|||
162869734|NCT01905397|588225451|FG001|Overall Study|Dressing not applied in operating room|0|||
162869735|NCT01905397|588225450|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
162869736|NCT01905397|588225451|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
162869737|NCT04172831|588225452|FG000|Overall Study|Adverse Event|21|||
162869738|NCT04172831|588225453|FG001|Overall Study|Adverse Event|9|||
162869739|NCT04172831|588225452|FG000|Overall Study|Lack of Efficacy|2|||
162869740|NCT04172831|588225453|FG001|Overall Study|Lack of Efficacy|8|||
162869741|NCT04172831|588225452|FG000|Overall Study|Physician Decision|0|||
162869742|NCT04172831|588225453|FG001|Overall Study|Physician Decision|1|||
162869743|NCT04172831|588225452|FG000|Overall Study|Withdrawal by Subject|12|||
162869744|NCT04172831|588225453|FG001|Overall Study|Withdrawal by Subject|11|||
162869745|NCT04172831|588225452|FG000|Overall Study|Lost to Follow-up|4|||
162869746|NCT04172831|588225453|FG001|Overall Study|Lost to Follow-up|9|||
162869747|NCT04172831|588225452|FG000|Overall Study|COVID-19 related crisis|3|||
162869748|NCT04172831|588225453|FG001|Overall Study|COVID-19 related crisis|3|||
162869749|NCT04172831|588225452|FG000|Overall Study|Subject non-compliance|1|||
162869750|NCT04172831|588225453|FG001|Overall Study|Subject non-compliance|1|||
162869751|NCT04172831|588225452|FG000|Overall Study|Family emergency|1|||
162869752|NCT04172831|588225453|FG001|Overall Study|Family emergency|0|||
162869753|NCT01899144|588225459|FG000|Treatment Period 2|Other|1|||
162869754|NCT01899144|588225459|FG000|Treatment Period 3|Other|2|||
162869755|NCT01899144|588225459|FG000|Treatment Period 5|Other|1|||
162869756|NCT02021812|588225460|FG000|Overall Study|Death|8|||
162869757|NCT02021812|588225460|FG000|Overall Study|Withdrawal by Subject|3|||
162869758|NCT02021812|588225460|FG000|Overall Study|Lost to Follow-up|2|||
162869759|NCT02021812|588225460|FG000|Overall Study|Refuse to return, COVD 19|2|||
162869760|NCT02119104|588225461|FG000|Overall Study|Protocol Violation|16|||
162869761|NCT00916721|588225464|FG000|Overall Study|Lost to Follow-up|0|||
162869762|NCT00916721|588225465|FG001|Overall Study|Lost to Follow-up|1|||
162614720|NCT03161093|587307366|FG001|Overall Study|Protocol Violation|14|||
162614721|NCT03161093|587307367|FG002|Overall Study|Protocol Violation|6|||
162614722|NCT03161093|587307368|FG003|Overall Study|Protocol Violation|13|||
162614723|NCT03161093|587307369|FG004|Overall Study|Protocol Violation|1|||
162614724|NCT03161093|587307370|FG005|Overall Study|Protocol Violation|0|||
162614725|NCT03161093|587307365|FG000|Overall Study|Adverse Event|5|||
162869763|NCT00916721|588225464|FG000|Overall Study|Adverse Event|6|||
162869764|NCT00916721|588225465|FG001|Overall Study|Adverse Event|3|||
162869765|NCT00916721|588225464|FG000|Overall Study|Withdrawal by Subject|2|||
162869766|NCT00916721|588225465|FG001|Overall Study|Withdrawal by Subject|2|||
163046914|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162614726|NCT03161093|587307366|FG001|Overall Study|Adverse Event|21|||
162706280|NCT00410384|587636614|FG001|Overall Study|Physician Decision|3|||
162869767|NCT00916721|588225464|FG000|Overall Study|Protocol Violation|2|||
162869768|NCT00916721|588225465|FG001|Overall Study|Protocol Violation|4|||
162869769|NCT00798967|588225470|FG000|Overall Study|Adverse Event|2|||
162869770|NCT00798967|588225471|FG001|Overall Study|Adverse Event|3|||
163046915|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162869771|NCT00798967|588225470|FG000|Overall Study|Withdrawal by Subject|0|||
162869772|NCT00798967|588225471|FG001|Overall Study|Withdrawal by Subject|1|||
162869773|NCT00798967|588225470|FG000|Overall Study|Physician Decision|1|||
162869774|NCT00798967|588225471|FG001|Overall Study|Physician Decision|0|||
162869775|NCT00798967|588225470|FG000|Overall Study|Randomized in error by site|1|||
162869776|NCT00798967|588225471|FG001|Overall Study|Randomized in error by site|0|||
162869777|NCT04083222|588225475|FG000|Overall Study|Voluntary Withdrawal|0|||
162614727|NCT03161093|587307367|FG002|Overall Study|Adverse Event|16|||
162869778|NCT04083222|588225476|FG001|Overall Study|Voluntary Withdrawal|1|||
162869779|NCT04083222|588225475|FG000|Overall Study|Reason not Specified|0|||
162706281|NCT00410384|587636615|FG002|Overall Study|Physician Decision|4|||
162706282|NCT00410384|587636613|FG000|Overall Study|Other|3|||
162706283|NCT00410384|587636614|FG001|Overall Study|Other|8|||
162706284|NCT00410384|587636615|FG002|Overall Study|Other|4|||
162706285|NCT01167023|587636616|FG000|Overall Study|Lost to Follow-up|0|||
162706286|NCT01167023|587636617|FG001|Overall Study|Lost to Follow-up|1|||
162706287|NCT01167023|587636618|FG002|Overall Study|Lost to Follow-up|1|||
162706288|NCT01167023|587636616|FG000|Overall Study|Screen Failure|0|||
162706289|NCT01167023|587636617|FG001|Overall Study|Screen Failure|1|||
162706290|NCT01167023|587636618|FG002|Overall Study|Screen Failure|0|||
162706291|NCT01167023|587636616|FG000|Overall Study|Sponsor Decision|0|||
162706292|NCT01167023|587636617|FG001|Overall Study|Sponsor Decision|1|||
162706293|NCT01167023|587636618|FG002|Overall Study|Sponsor Decision|0|||
162706294|NCT01167023|587636616|FG000|Overall Study|Withdrawal by Subject|0|||
162706295|NCT01167023|587636617|FG001|Overall Study|Withdrawal by Subject|0|||
162706296|NCT01167023|587636618|FG002|Overall Study|Withdrawal by Subject|1|||
162706297|NCT01192295|587636621|FG000|Overall Study|Adverse Event|3|||
162706298|NCT01192295|587636622|FG001|Overall Study|Adverse Event|7|||
162706299|NCT01192295|587636621|FG000|Overall Study|Withdrawal by Subject|3|||
162706300|NCT01192295|587636622|FG001|Overall Study|Withdrawal by Subject|4|||
162706301|NCT01192295|587636621|FG000|Overall Study|Lost to Follow-up|0|||
162706302|NCT01192295|587636622|FG001|Overall Study|Lost to Follow-up|1|||
162706303|NCT01192295|587636621|FG000|Overall Study|Lack of Efficacy|0|||
162706304|NCT01192295|587636622|FG001|Overall Study|Lack of Efficacy|5|||
162706305|NCT01192295|587636621|FG000|Overall Study|Administrative|4|||
162706306|NCT01192295|587636622|FG001|Overall Study|Administrative|6|||
162706307|NCT00630539|587636623|FG000|Overall Study|Adverse Event|1|||
162706308|NCT00630539|587636624|FG001|Overall Study|Adverse Event|3|||
162706309|NCT00630539|587636625|FG002|Overall Study|Adverse Event|1|||
162706310|NCT00630539|587636626|FG003|Overall Study|Adverse Event|2|||
162706311|NCT00630539|587636623|FG000|Overall Study|Withdrawal by Subject|0|||
162706312|NCT00630539|587636624|FG001|Overall Study|Withdrawal by Subject|1|||
162706313|NCT00630539|587636625|FG002|Overall Study|Withdrawal by Subject|0|||
162706314|NCT00630539|587636626|FG003|Overall Study|Withdrawal by Subject|1|||
162706315|NCT00577629|587636638|FG000|Treatment Period|Death|1|||
162706316|NCT00577629|587636638|FG000|Long Term Follow-Up|Death|15|||
162706317|NCT00577629|587636638|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
162706318|NCT00577629|587636638|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
162706319|NCT00577629|587636638|FG000|Long Term Follow-Up|Physician Decision|1|||
162706320|NCT02929108|587636639|FG000|Overall Study|Hospice patient death|100|||
162706321|NCT02929108|587636640|FG001|Overall Study|Hospice patient death|64|||
162706322|NCT02929108|587636641|FG002|Overall Study|Hospice patient death|28|||
162706323|NCT02929108|587636642|FG003|Overall Study|Hospice patient death|46|||
162706324|NCT02929108|587636643|FG004|Overall Study|Hospice patient death|55|||
162706325|NCT02929108|587636644|FG005|Overall Study|Hospice patient death|28|||
162706326|NCT02929108|587636645|FG006|Overall Study|Hospice patient death|78|||
162706327|NCT02820051|587636650|FG000|Overall Study|Lost to Follow-up|7|||
162706328|NCT02820051|587636651|FG001|Overall Study|Lost to Follow-up|4|||
162706329|NCT01670500|587636654|FG000|Overall Study|Withdrawal by Subject|1|||
162706330|NCT01670500|587636655|FG001|Overall Study|Withdrawal by Subject|0|||
162706331|NCT04955626|587636656|FG000|Blinded Period|Lost to Follow-up|28|||
162706332|NCT04955626|587636657|FG001|Blinded Period|Lost to Follow-up|28|||
162706333|NCT04955626|587636658|FG002|Blinded Period|Lost to Follow-up|7|||
162706334|NCT04955626|587636659|FG003|Blinded Period|Lost to Follow-up|14|||
162706335|NCT04955626|587636660|FG004|Blinded Period|Lost to Follow-up|3|||
162706336|NCT04955626|587636661|FG005|Blinded Period|Lost to Follow-up|2|||
162706337|NCT04955626|587636662|FG006|Blinded Period|Lost to Follow-up|6|||
162706338|NCT04955626|587636663|FG007|Blinded Period|Lost to Follow-up|4|||
162706339|NCT04955626|587636664|FG008|Blinded Period|Lost to Follow-up|5|||
162706340|NCT04955626|587636665|FG009|Blinded Period|Lost to Follow-up|8|||
162706341|NCT04955626|587636666|FG010|Blinded Period|Lost to Follow-up|10|||
162706342|NCT04955626|587636667|FG011|Blinded Period|Lost to Follow-up|32|||
162706343|NCT04955626|587636668|FG012|Blinded Period|Lost to Follow-up|0|||
162706344|NCT04955626|587636669|FG013|Blinded Period|Lost to Follow-up|0|||
162706345|NCT04955626|587636670|FG014|Blinded Period|Lost to Follow-up|0|||
162706346|NCT04955626|587636671|FG015|Blinded Period|Lost to Follow-up|12|||
162706347|NCT04955626|587636672|FG016|Blinded Period|Lost to Follow-up|2|||
162706348|NCT04955626|587636673|FG017|Blinded Period|Lost to Follow-up|5|||
162960546|NCT00205777|588558854|FG005|Study Extension I|Death|0|||
162960547|NCT00205777|588558849|FG000|Study Extension I|Withdrawal by Subject|99|||
162706349|NCT04955626|587636674|FG018|Blinded Period|Lost to Follow-up|0|||
162706350|NCT04955626|587636675|FG019|Blinded Period|Lost to Follow-up|0|||
162706351|NCT04955626|587636676|FG020|Blinded Period|Lost to Follow-up|0|||
162960548|NCT00205777|588558850|FG001|Study Extension I|Withdrawal by Subject|0|||
162706352|NCT04955626|587636677|FG021|Blinded Period|Lost to Follow-up|0|||
162706353|NCT04955626|587636678|FG022|Blinded Period|Lost to Follow-up|0|||
162706354|NCT04955626|587636679|FG023|Blinded Period|Lost to Follow-up|0|||
162706355|NCT04955626|587636680|FG024|Blinded Period|Lost to Follow-up|3|||
162706356|NCT04955626|587636681|FG025|Blinded Period|Lost to Follow-up|1|||
162706357|NCT04955626|587636682|FG026|Blinded Period|Lost to Follow-up|2|||
162869780|NCT04083222|588225476|FG001|Overall Study|Reason not Specified|1|||
162869781|NCT03103750|588225477|FG000|Overall Study|Adverse Event|1|||
162869782|NCT03103750|588225478|FG001|Overall Study|Adverse Event|0|||
162869783|NCT03103750|588225477|FG000|Overall Study|Lost to Follow-up|1|||
162869784|NCT03103750|588225478|FG001|Overall Study|Lost to Follow-up|0|||
162869785|NCT03103750|588225477|FG000|Overall Study|PET Equipment Related|2|||
162869786|NCT03103750|588225478|FG001|Overall Study|PET Equipment Related|2|||
162869787|NCT03575468|588225482|FG000|Overall Study|Withdrawal by Subject|3|||
162869788|NCT03575468|588225483|FG001|Overall Study|Withdrawal by Subject|0|||
162869789|NCT03575468|588225482|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
162869790|NCT03575468|588225483|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
162869791|NCT03575468|588225482|FG000|Overall Study|Lost to Follow-up|13|||
162869792|NCT03575468|588225483|FG001|Overall Study|Lost to Follow-up|17|||
162924404|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
162924405|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
162924406|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
162924407|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
162924408|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
162924409|NCT03611751|588423886|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
162924410|NCT03611751|588423887|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
162924411|NCT03611751|588423888|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
162924412|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
162924413|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
162924414|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
162924415|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
162924416|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
162924417|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
162924418|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
162924419|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
162924420|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
162924421|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
162924422|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
162924423|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
162924424|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
162924425|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
162924426|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
162924427|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
162924428|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
162924429|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
162924430|NCT03611751|588423886|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
162924431|NCT03611751|588423887|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
162924432|NCT03611751|588423888|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
162924433|NCT01023022|588423889|FG000|Overall Study|Death|5|||
162924434|NCT01023022|588423889|FG000|Overall Study|Lost to Follow-up|7|||
162924435|NCT01023022|588423889|FG000|Overall Study|due to technical issues|2|||
162924436|NCT03128931|588423891|FG000|Overall Study|Physician Decision|1|||
162924437|NCT03128931|588423891|FG000|Overall Study|Equipment Issues|3|||
162924438|NCT03151226|588423892|FG000|Overall Study|Withdrawal by Subject|2|||
162924439|NCT03151226|588423892|FG000|Overall Study|not wear device correctly|1|||
162924440|NCT00903409|588423893|FG000|Overall Study|Adverse Event|11|||
162924441|NCT00903409|588423894|FG001|Overall Study|Adverse Event|9|||
162924442|NCT00903409|588423893|FG000|Overall Study|Non-compliance with Protocol|1|||
162924443|NCT00903409|588423894|FG001|Overall Study|Non-compliance with Protocol|1|||
162924444|NCT00903409|588423893|FG000|Overall Study|Laboratory Abnormality|2|||
162924445|NCT00903409|588423894|FG001|Overall Study|Laboratory Abnormality|0|||
162924446|NCT00903409|588423893|FG000|Overall Study|Withdrawal by Subject|8|||
162924447|NCT00903409|588423894|FG001|Overall Study|Withdrawal by Subject|8|||
162924448|NCT00903409|588423893|FG000|Overall Study|Other|2|||
162924449|NCT00903409|588423894|FG001|Overall Study|Other|3|||
162614728|NCT03161093|587307368|FG003|Overall Study|Adverse Event|35|||
162614729|NCT03161093|587307369|FG004|Overall Study|Adverse Event|2|||
162614730|NCT03161093|587307370|FG005|Overall Study|Adverse Event|1|||
162614731|NCT03161093|587307365|FG000|Overall Study|Lack of Efficacy|9|||
162924450|NCT00903409|588423893|FG000|Overall Study|Lost to Follow-up|2|||
162924451|NCT00903409|588423894|FG001|Overall Study|Lost to Follow-up|6|||
162924452|NCT03239340|588423895|FG000|Overall Study|Other|26|||
162924453|NCT03239340|588423895|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
162924454|NCT03239340|588423895|FG000|Overall Study|Death|40|||
162924455|NCT03239340|588423895|FG000|Overall Study|Lost to Follow-up|2|||
162924456|NCT03239340|588423895|FG000|Overall Study|Physician Decision|16|||
162924457|NCT03239340|588423895|FG000|Overall Study|Withdrawal by Subject|27|||
162924458|NCT03539952|588423897|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
162924459|NCT03539952|588423898|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
162614732|NCT03161093|587307366|FG001|Overall Study|Lack of Efficacy|13|||
162614733|NCT03161093|587307367|FG002|Overall Study|Lack of Efficacy|9|||
162614734|NCT03161093|587307368|FG003|Overall Study|Lack of Efficacy|24|||
162614735|NCT03161093|587307369|FG004|Overall Study|Lack of Efficacy|4|||
162614736|NCT03161093|587307370|FG005|Overall Study|Lack of Efficacy|1|||
162614737|NCT03161093|587307365|FG000|Overall Study|Physician Decision|0|||
162614738|NCT03161093|587307366|FG001|Overall Study|Physician Decision|1|||
162614739|NCT03161093|587307367|FG002|Overall Study|Physician Decision|0|||
162614740|NCT03161093|587307368|FG003|Overall Study|Physician Decision|2|||
162614741|NCT03161093|587307369|FG004|Overall Study|Physician Decision|17|||
162614742|NCT03161093|587307370|FG005|Overall Study|Physician Decision|15|||
162614743|NCT03161093|587307365|FG000|Overall Study|Withdrawal by Subject|24|||
162614744|NCT03161093|587307366|FG001|Overall Study|Withdrawal by Subject|73|||
162614745|NCT03161093|587307367|FG002|Overall Study|Withdrawal by Subject|44|||
162614746|NCT03161093|587307368|FG003|Overall Study|Withdrawal by Subject|97|||
162614747|NCT03161093|587307369|FG004|Overall Study|Withdrawal by Subject|11|||
162614748|NCT03161093|587307370|FG005|Overall Study|Withdrawal by Subject|10|||
162614749|NCT03161093|587307365|FG000|Overall Study|Lost to Follow-up|3|||
162614750|NCT03161093|587307366|FG001|Overall Study|Lost to Follow-up|12|||
162614751|NCT03161093|587307367|FG002|Overall Study|Lost to Follow-up|4|||
162614752|NCT03161093|587307368|FG003|Overall Study|Lost to Follow-up|7|||
162614753|NCT03161093|587307369|FG004|Overall Study|Lost to Follow-up|8|||
162614754|NCT03161093|587307370|FG005|Overall Study|Lost to Follow-up|13|||
162614755|NCT03161093|587307365|FG000|Overall Study|Death|3|||
162614756|NCT03161093|587307366|FG001|Overall Study|Death|9|||
162614757|NCT03161093|587307367|FG002|Overall Study|Death|7|||
162614758|NCT03161093|587307368|FG003|Overall Study|Death|9|||
162869793|NCT04400318|588227385|FG000|Overall Study|Adverse Event|1|||
162869794|NCT04400318|588227386|FG001|Overall Study|Adverse Event|0|||
162869795|NCT04400318|588227385|FG000|Overall Study|Withdrawal by Subject|1|||
162869796|NCT04400318|588227386|FG001|Overall Study|Withdrawal by Subject|1|||
162869797|NCT04400318|588227385|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
163046916|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163046917|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162869798|NCT04400318|588227386|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
162869799|NCT02078713|588227387|FG000|Overall Study|Lost to Follow-up|49|||
162869800|NCT02078713|588227388|FG001|Overall Study|Lost to Follow-up|55|||
162869801|NCT02078713|588227389|FG002|Overall Study|Lost to Follow-up|0|||
162869802|NCT02078713|588227390|FG003|Overall Study|Lost to Follow-up|0|||
162869803|NCT02078713|588227387|FG000|Overall Study|Pregnant at baseline|3|||
162869804|NCT02078713|588227388|FG001|Overall Study|Pregnant at baseline|5|||
162869805|NCT02078713|588227389|FG002|Overall Study|Pregnant at baseline|0|||
162960549|NCT00205777|588558851|FG002|Study Extension I|Withdrawal by Subject|0|||
162960550|NCT00205777|588558852|FG003|Study Extension I|Withdrawal by Subject|106|||
162960551|NCT00205777|588558853|FG004|Study Extension I|Withdrawal by Subject|89|||
162960552|NCT00205777|588558854|FG005|Study Extension I|Withdrawal by Subject|0|||
162960553|NCT00205777|588558849|FG000|Study Extension I|Protocol Violation|4|||
162960554|NCT00205777|588558850|FG001|Study Extension I|Protocol Violation|0|||
162960555|NCT00205777|588558851|FG002|Study Extension I|Protocol Violation|0|||
162960556|NCT00205777|588558852|FG003|Study Extension I|Protocol Violation|8|||
162960557|NCT00205777|588558853|FG004|Study Extension I|Protocol Violation|8|||
162960558|NCT00205777|588558854|FG005|Study Extension I|Protocol Violation|0|||
162960559|NCT00205777|588558849|FG000|Study Extension I|Lack of Efficacy|0|||
162960560|NCT00205777|588558850|FG001|Study Extension I|Lack of Efficacy|0|||
162960561|NCT00205777|588558851|FG002|Study Extension I|Lack of Efficacy|0|||
162960562|NCT00205777|588558852|FG003|Study Extension I|Lack of Efficacy|1|||
162960563|NCT00205777|588558853|FG004|Study Extension I|Lack of Efficacy|2|||
162960564|NCT00205777|588558854|FG005|Study Extension I|Lack of Efficacy|0|||
162960565|NCT00205777|588558849|FG000|Study Extension I|Failed to return|15|||
162960566|NCT00205777|588558850|FG001|Study Extension I|Failed to return|0|||
162960567|NCT00205777|588558851|FG002|Study Extension I|Failed to return|0|||
162960568|NCT00205777|588558852|FG003|Study Extension I|Failed to return|17|||
162960569|NCT00205777|588558853|FG004|Study Extension I|Failed to return|13|||
162960570|NCT00205777|588558854|FG005|Study Extension I|Failed to return|0|||
162960571|NCT00205777|588558849|FG000|Study Extension I|Other Event|34|||
162960572|NCT00205777|588558850|FG001|Study Extension I|Other Event|0|||
162869806|NCT02078713|588227390|FG003|Overall Study|Pregnant at baseline|0|||
162960573|NCT00205777|588558851|FG002|Study Extension I|Other Event|0|||
162614759|NCT03161093|587307369|FG004|Overall Study|Death|0|||
162614760|NCT03161093|587307370|FG005|Overall Study|Death|0|||
162614761|NCT03161093|587307365|FG000|Overall Study|Unknown - Not reported|0|||
162614762|NCT03161093|587307366|FG001|Overall Study|Unknown - Not reported|1|||
162614763|NCT03161093|587307367|FG002|Overall Study|Unknown - Not reported|0|||
162614764|NCT03161093|587307368|FG003|Overall Study|Unknown - Not reported|0|||
162614765|NCT03161093|587307369|FG004|Overall Study|Unknown - Not reported|0|||
162706358|NCT04955626|587636683|FG027|Blinded Period|Lost to Follow-up|2|||
162960574|NCT00205777|588558852|FG003|Study Extension I|Other Event|34|||
162960575|NCT00205777|588558853|FG004|Study Extension I|Other Event|29|||
162869807|NCT02078713|588227387|FG000|Overall Study|Enrolled twice|0|||
162869808|NCT02078713|588227388|FG001|Overall Study|Enrolled twice|1|||
162869809|NCT02078713|588227389|FG002|Overall Study|Enrolled twice|0|||
162869810|NCT02078713|588227390|FG003|Overall Study|Enrolled twice|0|||
162869811|NCT01793051|588227401|FG000|Overall Study|Withdrawal by Subject|6|||
162869812|NCT01793051|588227402|FG001|Overall Study|Withdrawal by Subject|4|||
162869813|NCT01793051|588227401|FG000|Overall Study|Adverse Event|0|||
162869814|NCT01793051|588227402|FG001|Overall Study|Adverse Event|2|||
162869815|NCT01793051|588227401|FG000|Overall Study|Too ill to continue|1|||
162869816|NCT01793051|588227402|FG001|Overall Study|Too ill to continue|0|||
162869817|NCT01793051|588227401|FG000|Overall Study|Switched chemo|1|||
162869818|NCT01793051|588227402|FG001|Overall Study|Switched chemo|1|||
162869819|NCT01793051|588227401|FG000|Overall Study|Lack of compliance|1|||
162869820|NCT01793051|588227402|FG001|Overall Study|Lack of compliance|0|||
162869821|NCT01793051|588227401|FG000|Overall Study|Requested to be removed from the study|1|||
162869822|NCT01793051|588227402|FG001|Overall Study|Requested to be removed from the study|1|||
162869823|NCT02421120|588227405|FG000|Overall Study|Adverse Event|1|||
162869824|NCT00372190|588227406|FG000|Overall Study|Lost to Follow-up|3|||
162869825|NCT00372190|588227407|FG001|Overall Study|Lost to Follow-up|1|||
162869826|NCT00623467|588227408|FG000|Overall Study|Lost to Follow-up|1|||
162869827|NCT00623467|588227408|FG000|Overall Study|Protocol Violation|4|||
162869828|NCT00623467|588227408|FG000|Overall Study|Withdrawal by Subject|2|||
162869829|NCT00273858|588227422|FG000|Overall Study|Not completed 24 month observation time|334|||
162869830|NCT00273858|588227422|FG000|Overall Study|Lost to Follow-up|101|||
162869831|NCT00273858|588227422|FG000|Overall Study|Withdrawal by Subject|21|||
162869832|NCT00273858|588227422|FG000|Overall Study|Adverse Event|81|||
162869833|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
162869834|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
162869835|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
162869836|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
162869837|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
162869838|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
162869839|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
162869840|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
162869841|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
162869842|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
162869843|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
162869844|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
162869845|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
162869846|NCT02232516|588227423|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
162869847|NCT02232516|588227423|FG000|Survival Follow-up|Death|15|||
162869848|NCT02232516|588227423|FG000|Survival Follow-up|Withdrawal by Subject|3|||
162869849|NCT02232516|588227423|FG000|Survival Follow-up|Lost to Follow-up|1|||
162869850|NCT02232516|588227423|FG000|Survival Follow-up|Still in follow-up|5|||
162869851|NCT01070550|588227424|FG000|Overall Study|Adverse Event|43|||
162869852|NCT01070550|588227425|FG001|Overall Study|Adverse Event|1|||
162869853|NCT01070550|588227426|FG002|Overall Study|Adverse Event|3|||
162869854|NCT01070550|588227427|FG003|Overall Study|Adverse Event|0|||
162869855|NCT01070550|588227428|FG004|Overall Study|Adverse Event|0|||
162869856|NCT01070550|588227429|FG005|Overall Study|Adverse Event|0|||
162869857|NCT01070550|588227424|FG000|Overall Study|Death|20|||
162869858|NCT01070550|588227425|FG001|Overall Study|Death|4|||
162869859|NCT01070550|588227426|FG002|Overall Study|Death|3|||
162869860|NCT01070550|588227427|FG003|Overall Study|Death|0|||
162869861|NCT01070550|588227428|FG004|Overall Study|Death|0|||
162869862|NCT01070550|588227429|FG005|Overall Study|Death|0|||
162869863|NCT01070550|588227424|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
162869864|NCT01070550|588227425|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
162869865|NCT01070550|588227426|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
162869866|NCT01070550|588227427|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162869867|NCT01070550|588227428|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162869868|NCT01070550|588227429|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162869869|NCT01070550|588227424|FG000|Overall Study|Early termination|3|||
162869870|NCT01070550|588227425|FG001|Overall Study|Early termination|0|||
162869871|NCT01070550|588227426|FG002|Overall Study|Early termination|0|||
162869872|NCT01070550|588227427|FG003|Overall Study|Early termination|0|||
162869873|NCT01070550|588227428|FG004|Overall Study|Early termination|0|||
162869874|NCT01070550|588227429|FG005|Overall Study|Early termination|0|||
162869875|NCT01070550|588227424|FG000|Overall Study|Failed to return|450|||
162869876|NCT01070550|588227425|FG001|Overall Study|Failed to return|33|||
162869877|NCT01070550|588227426|FG002|Overall Study|Failed to return|144|||
162869878|NCT01070550|588227427|FG003|Overall Study|Failed to return|40|||
162869879|NCT01070550|588227428|FG004|Overall Study|Failed to return|1|||
162869880|NCT01070550|588227429|FG005|Overall Study|Failed to return|2|||
162869881|NCT01070550|588227424|FG000|Overall Study|Incomplete treatment|2|||
162869882|NCT01070550|588227425|FG001|Overall Study|Incomplete treatment|0|||
162706359|NCT04955626|587636684|FG028|Blinded Period|Lost to Follow-up|2|||
162706360|NCT04955626|587636685|FG029|Blinded Period|Lost to Follow-up|0|||
162706361|NCT04955626|587636686|FG030|Blinded Period|Lost to Follow-up|0|||
162706362|NCT04955626|587636687|FG031|Blinded Period|Lost to Follow-up|0|||
162706363|NCT04955626|587636688|FG032|Blinded Period|Lost to Follow-up|0|||
162706364|NCT04955626|587636689|FG033|Blinded Period|Lost to Follow-up|0|||
162706365|NCT04955626|587636690|FG034|Blinded Period|Lost to Follow-up|0|||
162706366|NCT04955626|587636691|FG035|Blinded Period|Lost to Follow-up|0|||
162706367|NCT04955626|587636656|FG000|Blinded Period|Protocol Violation|5|||
162706368|NCT04955626|587636657|FG001|Blinded Period|Protocol Violation|14|||
162706369|NCT04955626|587636658|FG002|Blinded Period|Protocol Violation|0|||
162706370|NCT04955626|587636659|FG003|Blinded Period|Protocol Violation|1|||
162706371|NCT04955626|587636660|FG004|Blinded Period|Protocol Violation|2|||
162706372|NCT04955626|587636661|FG005|Blinded Period|Protocol Violation|2|||
162706373|NCT04955626|587636662|FG006|Blinded Period|Protocol Violation|0|||
162706374|NCT04955626|587636663|FG007|Blinded Period|Protocol Violation|0|||
162706375|NCT04955626|587636664|FG008|Blinded Period|Protocol Violation|0|||
162706376|NCT04955626|587636665|FG009|Blinded Period|Protocol Violation|4|||
162706377|NCT04955626|587636666|FG010|Blinded Period|Protocol Violation|6|||
162706378|NCT04955626|587636667|FG011|Blinded Period|Protocol Violation|1|||
162706379|NCT04955626|587636668|FG012|Blinded Period|Protocol Violation|0|||
162706380|NCT04955626|587636669|FG013|Blinded Period|Protocol Violation|0|||
162706381|NCT04955626|587636670|FG014|Blinded Period|Protocol Violation|2|||
162706382|NCT04955626|587636671|FG015|Blinded Period|Protocol Violation|6|||
162706383|NCT04955626|587636672|FG016|Blinded Period|Protocol Violation|4|||
162706384|NCT04955626|587636673|FG017|Blinded Period|Protocol Violation|6|||
162706385|NCT04955626|587636674|FG018|Blinded Period|Protocol Violation|0|||
162869883|NCT01070550|588227426|FG002|Overall Study|Incomplete treatment|0|||
162869884|NCT01070550|588227427|FG003|Overall Study|Incomplete treatment|0|||
162869885|NCT01070550|588227428|FG004|Overall Study|Incomplete treatment|0|||
162869886|NCT01070550|588227429|FG005|Overall Study|Incomplete treatment|0|||
162869887|NCT01070550|588227424|FG000|Overall Study|Lab test not done|22|||
162869888|NCT01070550|588227425|FG001|Overall Study|Lab test not done|3|||
162869889|NCT01070550|588227426|FG002|Overall Study|Lab test not done|4|||
162869890|NCT01070550|588227427|FG003|Overall Study|Lab test not done|1|||
162869891|NCT01070550|588227428|FG004|Overall Study|Lab test not done|0|||
162869892|NCT01070550|588227429|FG005|Overall Study|Lab test not done|1|||
162869893|NCT01070550|588227424|FG000|Overall Study|Lack of Efficacy|65|||
162869894|NCT01070550|588227425|FG001|Overall Study|Lack of Efficacy|1|||
162869895|NCT01070550|588227426|FG002|Overall Study|Lack of Efficacy|5|||
162869896|NCT01070550|588227427|FG003|Overall Study|Lack of Efficacy|5|||
162869897|NCT01070550|588227428|FG004|Overall Study|Lack of Efficacy|0|||
162869898|NCT01070550|588227429|FG005|Overall Study|Lack of Efficacy|1|||
162869899|NCT01070550|588227424|FG000|Overall Study|Miscellaneous|12|||
162869900|NCT01070550|588227425|FG001|Overall Study|Miscellaneous|2|||
162869901|NCT01070550|588227426|FG002|Overall Study|Miscellaneous|3|||
162869902|NCT01070550|588227427|FG003|Overall Study|Miscellaneous|1|||
162869903|NCT01070550|588227428|FG004|Overall Study|Miscellaneous|0|||
162869904|NCT01070550|588227429|FG005|Overall Study|Miscellaneous|0|||
162869905|NCT01070550|588227424|FG000|Overall Study|New treatment started|3|||
162869906|NCT01070550|588227425|FG001|Overall Study|New treatment started|1|||
162869907|NCT01070550|588227426|FG002|Overall Study|New treatment started|0|||
162869908|NCT01070550|588227427|FG003|Overall Study|New treatment started|2|||
162869909|NCT01070550|588227428|FG004|Overall Study|New treatment started|0|||
162869910|NCT01070550|588227429|FG005|Overall Study|New treatment started|0|||
162869911|NCT01070550|588227424|FG000|Overall Study|Non-responders|493|||
162869912|NCT01070550|588227425|FG001|Overall Study|Non-responders|4|||
162706386|NCT04955626|587636675|FG019|Blinded Period|Protocol Violation|1|||
162706387|NCT04955626|587636676|FG020|Blinded Period|Protocol Violation|0|||
162706388|NCT04955626|587636677|FG021|Blinded Period|Protocol Violation|1|||
162706389|NCT04955626|587636678|FG022|Blinded Period|Protocol Violation|0|||
162706390|NCT04955626|587636679|FG023|Blinded Period|Protocol Violation|0|||
162706391|NCT04955626|587636680|FG024|Blinded Period|Protocol Violation|4|||
162706392|NCT04955626|587636681|FG025|Blinded Period|Protocol Violation|6|||
162706393|NCT04955626|587636682|FG026|Blinded Period|Protocol Violation|5|||
162869913|NCT01070550|588227426|FG002|Overall Study|Non-responders|21|||
162869914|NCT01070550|588227427|FG003|Overall Study|Non-responders|20|||
162706394|NCT04955626|587636683|FG027|Blinded Period|Protocol Violation|3|||
162869915|NCT01070550|588227428|FG004|Overall Study|Non-responders|0|||
162869916|NCT01070550|588227429|FG005|Overall Study|Non-responders|2|||
162869917|NCT01070550|588227424|FG000|Overall Study|Not categorized|33|||
162869918|NCT01070550|588227425|FG001|Overall Study|Not categorized|2|||
162869919|NCT01070550|588227426|FG002|Overall Study|Not categorized|6|||
162706395|NCT04955626|587636684|FG028|Blinded Period|Protocol Violation|4|||
162869920|NCT01070550|588227427|FG003|Overall Study|Not categorized|1|||
162869921|NCT01070550|588227428|FG004|Overall Study|Not categorized|0|||
162869922|NCT01070550|588227429|FG005|Overall Study|Not categorized|1|||
162869923|NCT01070550|588227424|FG000|Overall Study|Protocol Violation|15|||
162869924|NCT01070550|588227425|FG001|Overall Study|Protocol Violation|1|||
162869925|NCT01070550|588227426|FG002|Overall Study|Protocol Violation|1|||
163046918|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163046919|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046920|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046921|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046922|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046923|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046924|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046925|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163046926|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046927|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046928|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046929|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046930|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046931|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
163046932|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046933|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046934|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046935|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163046936|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046937|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046938|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046939|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046940|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163046941|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046942|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046943|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046944|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046945|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046946|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046947|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046948|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
163046949|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046950|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046951|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046952|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046953|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046954|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046955|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
163046956|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046957|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046958|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046959|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046960|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046961|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
162869926|NCT01070550|588227427|FG003|Overall Study|Protocol Violation|1|||
162869927|NCT01070550|588227428|FG004|Overall Study|Protocol Violation|0|||
162869928|NCT01070550|588227429|FG005|Overall Study|Protocol Violation|0|||
162869929|NCT01070550|588227424|FG000|Overall Study|Relapse|44|||
163046962|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
163046963|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046964|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046965|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046966|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046967|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046968|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163046969|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
162869930|NCT01070550|588227425|FG001|Overall Study|Relapse|5|||
163046970|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
162869931|NCT01070550|588227426|FG002|Overall Study|Relapse|14|||
162869932|NCT01070550|588227427|FG003|Overall Study|Relapse|4|||
162869933|NCT01070550|588227428|FG004|Overall Study|Relapse|0|||
162869934|NCT01070550|588227429|FG005|Overall Study|Relapse|0|||
162869935|NCT01070550|588227424|FG000|Overall Study|Result not available|3|||
162869936|NCT01070550|588227425|FG001|Overall Study|Result not available|1|||
162869937|NCT01070550|588227426|FG002|Overall Study|Result not available|3|||
162869938|NCT01070550|588227427|FG003|Overall Study|Result not available|0|||
162869939|NCT01070550|588227428|FG004|Overall Study|Result not available|0|||
162869940|NCT01070550|588227429|FG005|Overall Study|Result not available|0|||
162869941|NCT01070550|588227424|FG000|Overall Study|Screen failure|1|||
162869942|NCT01070550|588227425|FG001|Overall Study|Screen failure|0|||
162869943|NCT01070550|588227426|FG002|Overall Study|Screen failure|0|||
162869944|NCT01070550|588227427|FG003|Overall Study|Screen failure|0|||
162869945|NCT01070550|588227428|FG004|Overall Study|Screen failure|0|||
162869946|NCT01070550|588227429|FG005|Overall Study|Screen failure|0|||
162869947|NCT01070550|588227424|FG000|Overall Study|Sponsor decision|1|||
162869948|NCT01070550|588227425|FG001|Overall Study|Sponsor decision|0|||
162869949|NCT01070550|588227426|FG002|Overall Study|Sponsor decision|0|||
162869950|NCT01070550|588227427|FG003|Overall Study|Sponsor decision|0|||
162869951|NCT01070550|588227428|FG004|Overall Study|Sponsor decision|0|||
162869952|NCT01070550|588227429|FG005|Overall Study|Sponsor decision|0|||
162869953|NCT01070550|588227424|FG000|Overall Study|Treatment duration shortened|1|||
162869954|NCT01070550|588227425|FG001|Overall Study|Treatment duration shortened|0|||
162869955|NCT01070550|588227426|FG002|Overall Study|Treatment duration shortened|0|||
162869956|NCT01070550|588227427|FG003|Overall Study|Treatment duration shortened|0|||
162869957|NCT01070550|588227428|FG004|Overall Study|Treatment duration shortened|0|||
162869958|NCT01070550|588227429|FG005|Overall Study|Treatment duration shortened|0|||
162869959|NCT01070550|588227424|FG000|Overall Study|Treatment interrupted|7|||
162869960|NCT01070550|588227425|FG001|Overall Study|Treatment interrupted|0|||
162869961|NCT01070550|588227426|FG002|Overall Study|Treatment interrupted|1|||
162869962|NCT01070550|588227427|FG003|Overall Study|Treatment interrupted|1|||
162869963|NCT01070550|588227428|FG004|Overall Study|Treatment interrupted|0|||
162869964|NCT01070550|588227429|FG005|Overall Study|Treatment interrupted|0|||
162869965|NCT01070550|588227424|FG000|Overall Study|Treatment not started|14|||
162869966|NCT01070550|588227425|FG001|Overall Study|Treatment not started|2|||
162869967|NCT01070550|588227426|FG002|Overall Study|Treatment not started|4|||
162869968|NCT01070550|588227427|FG003|Overall Study|Treatment not started|0|||
162869969|NCT01070550|588227428|FG004|Overall Study|Treatment not started|0|||
162869970|NCT01070550|588227429|FG005|Overall Study|Treatment not started|0|||
162869971|NCT01070550|588227424|FG000|Overall Study|Treatment restarted|0|||
162869972|NCT01070550|588227425|FG001|Overall Study|Treatment restarted|1|||
162869973|NCT01070550|588227426|FG002|Overall Study|Treatment restarted|0|||
162869974|NCT01070550|588227427|FG003|Overall Study|Treatment restarted|0|||
162869975|NCT01070550|588227428|FG004|Overall Study|Treatment restarted|0|||
162869976|NCT01070550|588227429|FG005|Overall Study|Treatment restarted|0|||
162869977|NCT01070550|588227424|FG000|Overall Study|Treatment stopped|3|||
162869978|NCT01070550|588227425|FG001|Overall Study|Treatment stopped|0|||
162869979|NCT01070550|588227426|FG002|Overall Study|Treatment stopped|0|||
162869980|NCT01070550|588227427|FG003|Overall Study|Treatment stopped|0|||
162869981|NCT01070550|588227428|FG004|Overall Study|Treatment stopped|0|||
162869982|NCT01070550|588227429|FG005|Overall Study|Treatment stopped|0|||
162869983|NCT01070550|588227424|FG000|Overall Study|Treatment unavailable|1|||
162869984|NCT01070550|588227425|FG001|Overall Study|Treatment unavailable|0|||
162869985|NCT01070550|588227426|FG002|Overall Study|Treatment unavailable|0|||
162869986|NCT01070550|588227427|FG003|Overall Study|Treatment unavailable|0|||
162869987|NCT01070550|588227428|FG004|Overall Study|Treatment unavailable|0|||
162869988|NCT01070550|588227429|FG005|Overall Study|Treatment unavailable|0|||
162869989|NCT01070550|588227424|FG000|Overall Study|Treatment was stopped early|7|||
162869990|NCT01070550|588227425|FG001|Overall Study|Treatment was stopped early|0|||
162869991|NCT01070550|588227426|FG002|Overall Study|Treatment was stopped early|0|||
162869992|NCT01070550|588227427|FG003|Overall Study|Treatment was stopped early|0|||
162869993|NCT01070550|588227428|FG004|Overall Study|Treatment was stopped early|0|||
162869994|NCT01070550|588227429|FG005|Overall Study|Treatment was stopped early|0|||
162869995|NCT01070550|588227424|FG000|Overall Study|Other|5|||
162869996|NCT01070550|588227425|FG001|Overall Study|Other|0|||
162869997|NCT01070550|588227426|FG002|Overall Study|Other|0|||
162869998|NCT01070550|588227427|FG003|Overall Study|Other|1|||
162869999|NCT01070550|588227428|FG004|Overall Study|Other|0|||
162870000|NCT01070550|588227429|FG005|Overall Study|Other|0|||
162870001|NCT01070550|588227424|FG000|Overall Study|Withdrawal by Subject|35|||
162870002|NCT01070550|588227425|FG001|Overall Study|Withdrawal by Subject|0|||
162870003|NCT01070550|588227426|FG002|Overall Study|Withdrawal by Subject|3|||
162870004|NCT01070550|588227427|FG003|Overall Study|Withdrawal by Subject|0|||
162870005|NCT01070550|588227428|FG004|Overall Study|Withdrawal by Subject|0|||
162870006|NCT01070550|588227429|FG005|Overall Study|Withdrawal by Subject|0|||
162870007|NCT01585961|588227431|FG000|Overall Study|Death|6|||
162870008|NCT01585961|588227431|FG000|Overall Study|Physician Decision|1|||
162870009|NCT01585961|588227431|FG000|Overall Study|Decision to use non-study catheter|1|||
162870010|NCT01585961|588227431|FG000|Overall Study|Withdrawal by Subject|1|||
162870011|NCT01585961|588227431|FG000|Overall Study|Lost to Follow-up|23|||
162870012|NCT01585961|588227431|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
162870013|NCT01258348|588227432|FG000|Overall Study|Adverse Event|1|||
162870014|NCT01258348|588227433|FG001|Overall Study|Adverse Event|1|||
162870015|NCT01258348|588227434|FG002|Overall Study|Adverse Event|3|||
162870016|NCT01258348|588227435|FG003|Overall Study|Adverse Event|2|||
162870017|NCT01258348|588227436|FG004|Overall Study|Adverse Event|4|||
162870018|NCT01258348|588227432|FG000|Overall Study|Progressive Disease|0|||
162870019|NCT01258348|588227433|FG001|Overall Study|Progressive Disease|3|||
162870020|NCT01258348|588227434|FG002|Overall Study|Progressive Disease|0|||
162870021|NCT01258348|588227435|FG003|Overall Study|Progressive Disease|2|||
162870022|NCT01258348|588227436|FG004|Overall Study|Progressive Disease|2|||
162870023|NCT01258348|588227432|FG000|Overall Study|Physician Decision|0|||
162870024|NCT01258348|588227433|FG001|Overall Study|Physician Decision|0|||
162870025|NCT01258348|588227434|FG002|Overall Study|Physician Decision|0|||
162870026|NCT01258348|588227435|FG003|Overall Study|Physician Decision|2|||
162870027|NCT01258348|588227436|FG004|Overall Study|Physician Decision|0|||
162870028|NCT01258348|588227432|FG000|Overall Study|Withdrawal by Subject|0|||
162870029|NCT01258348|588227433|FG001|Overall Study|Withdrawal by Subject|1|||
162870030|NCT01258348|588227434|FG002|Overall Study|Withdrawal by Subject|0|||
162870031|NCT01258348|588227435|FG003|Overall Study|Withdrawal by Subject|0|||
162870032|NCT01258348|588227436|FG004|Overall Study|Withdrawal by Subject|0|||
162870033|NCT01849848|588227438|FG000|Overall Study|Physician Decision|1|||
162870034|NCT01849848|588227438|FG000|Overall Study|Progression of the primary disease|3|||
162870035|NCT01505491|588227439|FG000|Overall Study|Other reason not listed|1|||
162870036|NCT01505491|588227440|FG001|Overall Study|Other reason not listed|0|||
163046971|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046972|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046973|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046974|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046975|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046976|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046977|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046978|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046979|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
163046980|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046981|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046982|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046983|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046984|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046985|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
163046986|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046987|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046988|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046989|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046990|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046991|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
163046992|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
163046993|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
163046994|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
163046995|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046996|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162870037|NCT01505491|588227441|FG002|Overall Study|Other reason not listed|0|||
162614766|NCT03161093|587307370|FG005|Overall Study|Unknown - Not reported|1|||
162614767|NCT00570765|587307371|FG000|DB Phase|Withdrawal by Subject|1|||
162614768|NCT00570765|587307372|FG001|DB Phase|Withdrawal by Subject|0|||
162614769|NCT00570765|587307373|FG002|DB Phase|Withdrawal by Subject|0|||
162614770|NCT00570765|587307374|FG003|DB Phase|Withdrawal by Subject|0|||
162614771|NCT00570765|587307371|FG000|DB Phase|Protocol Violation|0|||
162614772|NCT00570765|587307372|FG001|DB Phase|Protocol Violation|1|||
162706396|NCT04955626|587636685|FG029|Blinded Period|Protocol Violation|3|||
162870038|NCT01505491|588227439|FG000|Overall Study|Withdrawal by Subject|1|||
162870039|NCT01505491|588227440|FG001|Overall Study|Withdrawal by Subject|1|||
162870040|NCT01505491|588227441|FG002|Overall Study|Withdrawal by Subject|4|||
162870041|NCT01505491|588227439|FG000|Overall Study|Lost to Follow-up|0|||
163046997|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163046998|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162870042|NCT01505491|588227440|FG001|Overall Study|Lost to Follow-up|0|||
162614773|NCT00570765|587307373|FG002|DB Phase|Protocol Violation|0|||
162870043|NCT01505491|588227441|FG002|Overall Study|Lost to Follow-up|1|||
162870044|NCT01120093|588227450|FG000|Treatment Period 1|Adverse Event|0|||
162706397|NCT04955626|587636686|FG030|Blinded Period|Protocol Violation|0|||
162706398|NCT04955626|587636687|FG031|Blinded Period|Protocol Violation|0|||
162706399|NCT04955626|587636688|FG032|Blinded Period|Protocol Violation|0|||
162706400|NCT04955626|587636689|FG033|Blinded Period|Protocol Violation|0|||
162706401|NCT04955626|587636690|FG034|Blinded Period|Protocol Violation|0|||
162706402|NCT04955626|587636691|FG035|Blinded Period|Protocol Violation|0|||
162706403|NCT04955626|587636656|FG000|Blinded Period|Death|0|||
162706404|NCT04955626|587636657|FG001|Blinded Period|Death|2|||
162706405|NCT04955626|587636658|FG002|Blinded Period|Death|0|||
162706406|NCT04955626|587636659|FG003|Blinded Period|Death|0|||
162706407|NCT04955626|587636660|FG004|Blinded Period|Death|0|||
162706408|NCT04955626|587636661|FG005|Blinded Period|Death|0|||
162706409|NCT04955626|587636662|FG006|Blinded Period|Death|0|||
162706410|NCT04955626|587636663|FG007|Blinded Period|Death|2|||
162706411|NCT04955626|587636664|FG008|Blinded Period|Death|1|||
162706412|NCT04955626|587636665|FG009|Blinded Period|Death|1|||
162706413|NCT04955626|587636666|FG010|Blinded Period|Death|0|||
162706414|NCT04955626|587636667|FG011|Blinded Period|Death|2|||
162706415|NCT04955626|587636668|FG012|Blinded Period|Death|0|||
162706416|NCT04955626|587636669|FG013|Blinded Period|Death|0|||
162706417|NCT04955626|587636670|FG014|Blinded Period|Death|0|||
162706418|NCT04955626|587636671|FG015|Blinded Period|Death|0|||
162706419|NCT04955626|587636672|FG016|Blinded Period|Death|0|||
162706420|NCT04955626|587636673|FG017|Blinded Period|Death|0|||
162706421|NCT04955626|587636674|FG018|Blinded Period|Death|0|||
162706422|NCT04955626|587636675|FG019|Blinded Period|Death|0|||
162706423|NCT04955626|587636676|FG020|Blinded Period|Death|0|||
162706424|NCT04955626|587636677|FG021|Blinded Period|Death|0|||
162706425|NCT04955626|587636678|FG022|Blinded Period|Death|0|||
162706426|NCT04955626|587636679|FG023|Blinded Period|Death|1|||
162706427|NCT04955626|587636680|FG024|Blinded Period|Death|0|||
162706428|NCT04955626|587636681|FG025|Blinded Period|Death|0|||
162706429|NCT04955626|587636682|FG026|Blinded Period|Death|1|||
162706430|NCT04955626|587636683|FG027|Blinded Period|Death|1|||
162706431|NCT04955626|587636684|FG028|Blinded Period|Death|0|||
162706432|NCT04955626|587636685|FG029|Blinded Period|Death|1|||
162706433|NCT04955626|587636686|FG030|Blinded Period|Death|0|||
162706434|NCT04955626|587636687|FG031|Blinded Period|Death|0|||
162706435|NCT04955626|587636688|FG032|Blinded Period|Death|0|||
162706436|NCT04955626|587636689|FG033|Blinded Period|Death|0|||
162706437|NCT04955626|587636690|FG034|Blinded Period|Death|0|||
162706438|NCT04955626|587636691|FG035|Blinded Period|Death|0|||
162706439|NCT04955626|587636656|FG000|Blinded Period|Adverse Event|0|||
162706440|NCT04955626|587636657|FG001|Blinded Period|Adverse Event|1|||
162706441|NCT04955626|587636658|FG002|Blinded Period|Adverse Event|1|||
162706442|NCT04955626|587636659|FG003|Blinded Period|Adverse Event|1|||
162706443|NCT04955626|587636660|FG004|Blinded Period|Adverse Event|0|||
162706444|NCT04955626|587636661|FG005|Blinded Period|Adverse Event|0|||
162706445|NCT04955626|587636662|FG006|Blinded Period|Adverse Event|0|||
162706446|NCT04955626|587636663|FG007|Blinded Period|Adverse Event|0|||
162706447|NCT04955626|587636664|FG008|Blinded Period|Adverse Event|0|||
162706448|NCT04955626|587636665|FG009|Blinded Period|Adverse Event|1|||
162706449|NCT04955626|587636666|FG010|Blinded Period|Adverse Event|1|||
162706450|NCT04955626|587636667|FG011|Blinded Period|Adverse Event|0|||
162870045|NCT01120093|588227451|FG001|Treatment Period 1|Adverse Event|0|||
162870046|NCT01120093|588227452|FG002|Treatment Period 1|Adverse Event|1|||
162870047|NCT01120093|588227453|FG003|Treatment Period 1|Adverse Event|0|||
162870048|NCT01120093|588227454|FG004|Treatment Period 1|Adverse Event|1|||
162870049|NCT01120093|588227450|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162870050|NCT01120093|588227451|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162870051|NCT01120093|588227452|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162870052|NCT01120093|588227453|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162870053|NCT01120093|588227454|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162870054|NCT01120093|588227450|FG000|Treatment Period 2|Adverse Event|0|||
162870055|NCT01120093|588227451|FG001|Treatment Period 2|Adverse Event|0|||
162870056|NCT01120093|588227452|FG002|Treatment Period 2|Adverse Event|0|||
162870057|NCT01120093|588227453|FG003|Treatment Period 2|Adverse Event|1|||
162870058|NCT01120093|588227454|FG004|Treatment Period 2|Adverse Event|0|||
162870059|NCT01120093|588227450|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162870060|NCT01120093|588227451|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162870061|NCT01120093|588227452|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162870062|NCT01120093|588227453|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162870063|NCT01120093|588227454|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162870064|NCT01120093|588227450|FG000|Treatment Period 3|Lack of Efficacy|0|||
162870065|NCT01120093|588227451|FG001|Treatment Period 3|Lack of Efficacy|0|||
162870066|NCT01120093|588227452|FG002|Treatment Period 3|Lack of Efficacy|0|||
162870067|NCT01120093|588227453|FG003|Treatment Period 3|Lack of Efficacy|1|||
162870068|NCT01120093|588227454|FG004|Treatment Period 3|Lack of Efficacy|0|||
162870069|NCT01120093|588227450|FG000|Treatment Period 3|Adverse Event|0|||
162870070|NCT01120093|588227451|FG001|Treatment Period 3|Adverse Event|0|||
162870071|NCT01120093|588227452|FG002|Treatment Period 3|Adverse Event|0|||
162870072|NCT01120093|588227453|FG003|Treatment Period 3|Adverse Event|0|||
162870073|NCT01120093|588227454|FG004|Treatment Period 3|Adverse Event|1|||
162870074|NCT01120093|588227450|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162870075|NCT01120093|588227451|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162870076|NCT01120093|588227452|FG002|Treatment Period 3|Withdrawal by Subject|1|||
162870077|NCT01120093|588227453|FG003|Treatment Period 3|Withdrawal by Subject|0|||
162870078|NCT01120093|588227454|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162870079|NCT01120093|588227450|FG000|Treatment Period 4|Adverse Event|1|||
162870080|NCT01120093|588227451|FG001|Treatment Period 4|Adverse Event|0|||
162870081|NCT01120093|588227452|FG002|Treatment Period 4|Adverse Event|0|||
162870082|NCT01120093|588227453|FG003|Treatment Period 4|Adverse Event|0|||
162870083|NCT01120093|588227454|FG004|Treatment Period 4|Adverse Event|0|||
162870084|NCT01120093|588227450|FG000|Treatment Period 5|Adverse Event|0|||
162870085|NCT01120093|588227451|FG001|Treatment Period 5|Adverse Event|1|||
162870086|NCT01120093|588227452|FG002|Treatment Period 5|Adverse Event|0|||
162870087|NCT01120093|588227453|FG003|Treatment Period 5|Adverse Event|1|||
162870088|NCT01120093|588227454|FG004|Treatment Period 5|Adverse Event|0|||
162614774|NCT00570765|587307374|FG003|DB Phase|Protocol Violation|0|||
162614775|NCT00570765|587307371|FG000|DB Phase|Adverse Event|3|||
162614776|NCT00570765|587307372|FG001|DB Phase|Adverse Event|6|||
162614777|NCT00570765|587307373|FG002|DB Phase|Adverse Event|0|||
162614778|NCT00570765|587307374|FG003|DB Phase|Adverse Event|0|||
162614779|NCT00570765|587307371|FG000|DB Phase|Did Not Receive Study Drug|0|||
162614780|NCT00570765|587307372|FG001|DB Phase|Did Not Receive Study Drug|0|||
162614781|NCT00570765|587307373|FG002|DB Phase|Did Not Receive Study Drug|1|||
162614782|NCT00570765|587307374|FG003|DB Phase|Did Not Receive Study Drug|0|||
162614783|NCT00570765|587307371|FG000|LTSE Phase|Withdrawal by Subject|0|||
162614784|NCT00570765|587307372|FG001|LTSE Phase|Withdrawal by Subject|0|||
162614785|NCT00570765|587307373|FG002|LTSE Phase|Withdrawal by Subject|0|||
162614786|NCT00570765|587307374|FG003|LTSE Phase|Withdrawal by Subject|1|||
162614787|NCT00570765|587307371|FG000|LTSE Phase|Adverse Event|0|||
162614788|NCT00570765|587307372|FG001|LTSE Phase|Adverse Event|0|||
162870089|NCT03649321|588227459|FG000|Overall Study|Withdrawal by Subject|1|||
162870090|NCT03649321|588227460|FG001|Overall Study|Withdrawal by Subject|0|||
162870091|NCT03649321|588227459|FG000|Overall Study|Death|1|||
162870092|NCT03649321|588227460|FG001|Overall Study|Death|0|||
162870093|NCT01702363|588227461|FG000|Overall Study|Adverse Event|14|||
162614789|NCT00570765|587307373|FG002|LTSE Phase|Adverse Event|0|||
162870094|NCT01702363|588227461|FG000|Overall Study|Lack of Efficacy|4|||
162870095|NCT01702363|588227461|FG000|Overall Study|Withdrawal by Subject|2|||
162870096|NCT01525849|588227466|FG000|Overall Study|Lost to Follow-up|3|||
162870097|NCT01525849|588227467|FG001|Overall Study|Lost to Follow-up|2|||
162870098|NCT01525849|588227466|FG000|Overall Study|Withdrawal by Subject|1|||
162614790|NCT00570765|587307374|FG003|LTSE Phase|Adverse Event|7|||
162614791|NCT00570765|587307371|FG000|LTSE Phase|Physician Decision|0|||
162870099|NCT01525849|588227467|FG001|Overall Study|Withdrawal by Subject|9|||
162870100|NCT01525849|588227466|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
162614792|NCT00570765|587307372|FG001|LTSE Phase|Physician Decision|0|||
162614793|NCT00570765|587307373|FG002|LTSE Phase|Physician Decision|0|||
162614794|NCT00570765|587307374|FG003|LTSE Phase|Physician Decision|4|||
162614795|NCT01031706|587307375|FG000|Overall Study|Adverse Event|1|||
162614796|NCT01031706|587307376|FG001|Overall Study|Adverse Event|0|||
162960576|NCT00205777|588558854|FG005|Study Extension I|Other Event|0|||
162960577|NCT00205777|588558849|FG000|Study Extension I|Withdrawn as per protocol|0|||
162960578|NCT00205777|588558850|FG001|Study Extension I|Withdrawn as per protocol|0|||
162960579|NCT00205777|588558851|FG002|Study Extension I|Withdrawn as per protocol|1070|||
162960580|NCT00205777|588558852|FG003|Study Extension I|Withdrawn as per protocol|0|||
162960581|NCT00205777|588558853|FG004|Study Extension I|Withdrawn as per protocol|0|||
162960582|NCT00205777|588558854|FG005|Study Extension I|Withdrawn as per protocol|0|||
162960583|NCT00205777|588558849|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
162706451|NCT04955626|587636668|FG012|Blinded Period|Adverse Event|0|||
162706452|NCT04955626|587636669|FG013|Blinded Period|Adverse Event|0|||
162706453|NCT04955626|587636670|FG014|Blinded Period|Adverse Event|0|||
162706454|NCT04955626|587636671|FG015|Blinded Period|Adverse Event|0|||
162706455|NCT04955626|587636672|FG016|Blinded Period|Adverse Event|0|||
162706456|NCT04955626|587636673|FG017|Blinded Period|Adverse Event|0|||
162706457|NCT04955626|587636674|FG018|Blinded Period|Adverse Event|1|||
162706458|NCT04955626|587636675|FG019|Blinded Period|Adverse Event|0|||
162706459|NCT04955626|587636676|FG020|Blinded Period|Adverse Event|0|||
162706460|NCT04955626|587636677|FG021|Blinded Period|Adverse Event|0|||
162706461|NCT04955626|587636678|FG022|Blinded Period|Adverse Event|0|||
162706462|NCT04955626|587636679|FG023|Blinded Period|Adverse Event|0|||
162706463|NCT04955626|587636680|FG024|Blinded Period|Adverse Event|0|||
162706464|NCT04955626|587636681|FG025|Blinded Period|Adverse Event|0|||
162706465|NCT04955626|587636682|FG026|Blinded Period|Adverse Event|1|||
162706466|NCT04955626|587636683|FG027|Blinded Period|Adverse Event|0|||
162706467|NCT04955626|587636684|FG028|Blinded Period|Adverse Event|0|||
162706468|NCT04955626|587636685|FG029|Blinded Period|Adverse Event|0|||
162706469|NCT04955626|587636686|FG030|Blinded Period|Adverse Event|0|||
162706470|NCT04955626|587636687|FG031|Blinded Period|Adverse Event|0|||
162706471|NCT04955626|587636688|FG032|Blinded Period|Adverse Event|0|||
162706472|NCT04955626|587636689|FG033|Blinded Period|Adverse Event|0|||
162706473|NCT04955626|587636690|FG034|Blinded Period|Adverse Event|0|||
162706474|NCT04955626|587636691|FG035|Blinded Period|Adverse Event|0|||
162706475|NCT04955626|587636656|FG000|Blinded Period|No longer meets eligibility criteria|1|||
162706476|NCT04955626|587636657|FG001|Blinded Period|No longer meets eligibility criteria|2|||
162706477|NCT04955626|587636658|FG002|Blinded Period|No longer meets eligibility criteria|0|||
162706478|NCT04955626|587636659|FG003|Blinded Period|No longer meets eligibility criteria|1|||
162706479|NCT04955626|587636660|FG004|Blinded Period|No longer meets eligibility criteria|0|||
162706480|NCT04955626|587636661|FG005|Blinded Period|No longer meets eligibility criteria|0|||
162706481|NCT04955626|587636662|FG006|Blinded Period|No longer meets eligibility criteria|0|||
162706482|NCT04955626|587636663|FG007|Blinded Period|No longer meets eligibility criteria|0|||
162706483|NCT04955626|587636664|FG008|Blinded Period|No longer meets eligibility criteria|1|||
162706484|NCT04955626|587636665|FG009|Blinded Period|No longer meets eligibility criteria|0|||
162706485|NCT04955626|587636666|FG010|Blinded Period|No longer meets eligibility criteria|1|||
162706486|NCT04955626|587636667|FG011|Blinded Period|No longer meets eligibility criteria|1|||
162706487|NCT04955626|587636668|FG012|Blinded Period|No longer meets eligibility criteria|0|||
162706488|NCT04955626|587636669|FG013|Blinded Period|No longer meets eligibility criteria|0|||
162706489|NCT04955626|587636670|FG014|Blinded Period|No longer meets eligibility criteria|0|||
162706490|NCT04955626|587636671|FG015|Blinded Period|No longer meets eligibility criteria|3|||
162706491|NCT04955626|587636672|FG016|Blinded Period|No longer meets eligibility criteria|0|||
162706492|NCT04955626|587636673|FG017|Blinded Period|No longer meets eligibility criteria|2|||
162706493|NCT04955626|587636674|FG018|Blinded Period|No longer meets eligibility criteria|0|||
162706494|NCT04955626|587636675|FG019|Blinded Period|No longer meets eligibility criteria|0|||
162706495|NCT04955626|587636676|FG020|Blinded Period|No longer meets eligibility criteria|0|||
162706496|NCT04955626|587636677|FG021|Blinded Period|No longer meets eligibility criteria|0|||
162706497|NCT04955626|587636678|FG022|Blinded Period|No longer meets eligibility criteria|0|||
162706498|NCT04955626|587636679|FG023|Blinded Period|No longer meets eligibility criteria|0|||
162706499|NCT04955626|587636680|FG024|Blinded Period|No longer meets eligibility criteria|1|||
162706500|NCT04955626|587636681|FG025|Blinded Period|No longer meets eligibility criteria|0|||
162706501|NCT04955626|587636682|FG026|Blinded Period|No longer meets eligibility criteria|0|||
162706502|NCT04955626|587636683|FG027|Blinded Period|No longer meets eligibility criteria|1|||
162706503|NCT04955626|587636684|FG028|Blinded Period|No longer meets eligibility criteria|0|||
162706504|NCT04955626|587636685|FG029|Blinded Period|No longer meets eligibility criteria|0|||
162706505|NCT04955626|587636686|FG030|Blinded Period|No longer meets eligibility criteria|0|||
162706506|NCT04955626|587636687|FG031|Blinded Period|No longer meets eligibility criteria|0|||
162706507|NCT04955626|587636688|FG032|Blinded Period|No longer meets eligibility criteria|0|||
162706508|NCT04955626|587636689|FG033|Blinded Period|No longer meets eligibility criteria|0|||
162706509|NCT04955626|587636690|FG034|Blinded Period|No longer meets eligibility criteria|0|||
162706510|NCT04955626|587636691|FG035|Blinded Period|No longer meets eligibility criteria|0|||
162706511|NCT04955626|587636656|FG000|Blinded Period|Other|54|||
162870101|NCT01525849|588227467|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
162870102|NCT01525849|588227466|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
162870103|NCT01525849|588227467|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
162870104|NCT00431847|588227470|FG000|Overall Study|completion of less than two study visits|6|||
162870105|NCT00431847|588227471|FG001|Overall Study|completion of less than two study visits|3|||
162870106|NCT00431847|588227472|FG002|Overall Study|completion of less than two study visits|4|||
162870107|NCT00431847|588227473|FG003|Overall Study|completion of less than two study visits|14|||
162870108|NCT00431847|588227474|FG004|Overall Study|completion of less than two study visits|0|||
162870109|NCT00431847|588227470|FG000|Overall Study|Protocol Violation|0|||
162870110|NCT00431847|588227471|FG001|Overall Study|Protocol Violation|0|||
162870111|NCT00431847|588227472|FG002|Overall Study|Protocol Violation|0|||
162870112|NCT00431847|588227473|FG003|Overall Study|Protocol Violation|0|||
162870113|NCT00431847|588227474|FG004|Overall Study|Protocol Violation|1|||
162870114|NCT00339183|588227475|FG000|Overall Study|Adverse Event|5|||
162870115|NCT00339183|588227476|FG001|Overall Study|Adverse Event|3|||
162870116|NCT00339183|588227475|FG000|Overall Study|Withdrawal by Subject|16|||
162870117|NCT00339183|588227476|FG001|Overall Study|Withdrawal by Subject|19|||
162870118|NCT00339183|588227475|FG000|Overall Study|Physician Decision|2|||
162870119|NCT00339183|588227476|FG001|Overall Study|Physician Decision|4|||
162870120|NCT00339183|588227475|FG000|Overall Study|Lost to Follow-up|17|||
162870121|NCT00339183|588227476|FG001|Overall Study|Lost to Follow-up|17|||
162870122|NCT00339183|588227475|FG000|Overall Study|Protocol-specified criteria|12|||
162870123|NCT00339183|588227476|FG001|Overall Study|Protocol-specified criteria|8|||
162870124|NCT00339183|588227475|FG000|Overall Study|Missing reason|3|||
162870125|NCT00339183|588227476|FG001|Overall Study|Missing reason|1|||
163046999|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163047000|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163047001|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
162870126|NCT00339183|588227475|FG000|Overall Study|Other|46|||
162870127|NCT00339183|588227476|FG001|Overall Study|Other|40|||
162870128|NCT00339183|588227475|FG000|Overall Study|Ongoing|20|||
162870129|NCT00339183|588227476|FG001|Overall Study|Ongoing|13|||
162870130|NCT00793819|588227477|FG000|Overall Study|Adverse Event|8|||
162870131|NCT00793819|588227478|FG001|Overall Study|Adverse Event|4|||
162870132|NCT00793819|588227477|FG000|Overall Study|Lack of Efficacy|1|||
162870133|NCT00793819|588227478|FG001|Overall Study|Lack of Efficacy|1|||
162870134|NCT00793819|588227477|FG000|Overall Study|Withdrawal by Subject|4|||
162870135|NCT00793819|588227478|FG001|Overall Study|Withdrawal by Subject|3|||
162870136|NCT00793819|588227477|FG000|Overall Study|Lost to Follow-up|1|||
162870137|NCT00793819|588227478|FG001|Overall Study|Lost to Follow-up|1|||
162870138|NCT00002663|588227479|FG000|Overall Study|Death|4|||
162870139|NCT00002663|588227480|FG001|Overall Study|Death|1|||
162870140|NCT00002663|588227481|FG002|Overall Study|Death|1|||
162870141|NCT00002663|588227482|FG003|Overall Study|Death|0|||
162870142|NCT00002663|588227483|FG004|Overall Study|Death|0|||
162870143|NCT00002663|588227484|FG005|Overall Study|Death|13|||
162870144|NCT00002663|588227485|FG006|Overall Study|Death|0|||
162870145|NCT00002663|588227486|FG007|Overall Study|Death|1|||
162870146|NCT00002663|588227487|FG008|Overall Study|Death|1|||
162870147|NCT00002663|588227488|FG009|Overall Study|Death|1|||
162870148|NCT00002663|588227479|FG000|Overall Study|Lost to Follow-up|3|||
162870149|NCT00002663|588227480|FG001|Overall Study|Lost to Follow-up|0|||
162870150|NCT00002663|588227481|FG002|Overall Study|Lost to Follow-up|0|||
162870151|NCT00002663|588227482|FG003|Overall Study|Lost to Follow-up|1|||
162870152|NCT00002663|588227483|FG004|Overall Study|Lost to Follow-up|0|||
162870153|NCT00002663|588227484|FG005|Overall Study|Lost to Follow-up|1|||
162870154|NCT00002663|588227485|FG006|Overall Study|Lost to Follow-up|0|||
162870155|NCT00002663|588227486|FG007|Overall Study|Lost to Follow-up|0|||
162870156|NCT00002663|588227487|FG008|Overall Study|Lost to Follow-up|0|||
162870157|NCT00002663|588227488|FG009|Overall Study|Lost to Follow-up|0|||
162870158|NCT00002663|588227479|FG000|Overall Study|Other|0|||
162870159|NCT00002663|588227480|FG001|Overall Study|Other|1|||
162870160|NCT00002663|588227481|FG002|Overall Study|Other|0|||
163047002|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047003|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047004|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047005|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047006|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
163047007|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
162614797|NCT01031706|587307375|FG000|Overall Study|Withdrawal by Subject|1|||
162614798|NCT01031706|587307376|FG001|Overall Study|Withdrawal by Subject|1|||
162614799|NCT02124161|587307377|FG000|Overall Study|Other unspecified|0|||
162614800|NCT02124161|587307378|FG001|Overall Study|Other unspecified|1|||
162614801|NCT02124161|587307377|FG000|Overall Study|Death|1|||
162614802|NCT02124161|587307378|FG001|Overall Study|Death|0|||
162614803|NCT02124161|587307377|FG000|Overall Study|Protocol Violation|2|||
162614804|NCT02124161|587307378|FG001|Overall Study|Protocol Violation|1|||
162614805|NCT02124161|587307377|FG000|Overall Study|Withdrawal by Subject|1|||
162614806|NCT02124161|587307378|FG001|Overall Study|Withdrawal by Subject|2|||
162614807|NCT02124161|587307377|FG000|Overall Study|Adverse Event|2|||
162614808|NCT02124161|587307378|FG001|Overall Study|Adverse Event|0|||
162614809|NCT02124161|587307377|FG000|Overall Study|Does not meet entrance criteria|2|||
162614810|NCT02124161|587307378|FG001|Overall Study|Does not meet entrance criteria|3|||
162614811|NCT02124161|587307377|FG000|Overall Study|No longer meets eligibility criteria|5|||
162614812|NCT02124161|587307378|FG001|Overall Study|No longer meets eligibility criteria|4|||
162614813|NCT02124161|587307377|FG000|Overall Study|Lost to Follow-up|3|||
162614814|NCT02124161|587307378|FG001|Overall Study|Lost to Follow-up|4|||
162614815|NCT01954342|587307382|FG000|Overall Study|Missing data from 13-16week study visit|0|||
162614816|NCT01954342|587307383|FG001|Overall Study|Missing data from 13-16week study visit|0|||
162614817|NCT01954342|587307384|FG002|Overall Study|Missing data from 13-16week study visit|0|||
162614818|NCT01954342|587307385|FG003|Overall Study|Missing data from 13-16week study visit|1|||
162614819|NCT01954342|587307382|FG000|Overall Study|Miscarriage|0|||
162614820|NCT01954342|587307383|FG001|Overall Study|Miscarriage|0|||
162614821|NCT01954342|587307384|FG002|Overall Study|Miscarriage|0|||
162614822|NCT01954342|587307385|FG003|Overall Study|Miscarriage|3|||
162614823|NCT01954342|587307382|FG000|Overall Study|Lost to Follow-up|0|||
162614824|NCT01954342|587307383|FG001|Overall Study|Lost to Follow-up|0|||
162614825|NCT01954342|587307384|FG002|Overall Study|Lost to Follow-up|0|||
162614826|NCT01954342|587307385|FG003|Overall Study|Lost to Follow-up|5|||
162614827|NCT01954342|587307382|FG000|Overall Study|Preterm delivery|0|||
162614828|NCT01954342|587307383|FG001|Overall Study|Preterm delivery|0|||
162614829|NCT01954342|587307384|FG002|Overall Study|Preterm delivery|0|||
162614830|NCT01954342|587307385|FG003|Overall Study|Preterm delivery|3|||
162614831|NCT01954342|587307382|FG000|Overall Study|Pre-eclampsia|0|||
162614832|NCT01954342|587307383|FG001|Overall Study|Pre-eclampsia|0|||
162614833|NCT01954342|587307384|FG002|Overall Study|Pre-eclampsia|0|||
162614834|NCT01954342|587307385|FG003|Overall Study|Pre-eclampsia|4|||
162614835|NCT01954342|587307382|FG000|Overall Study|Unreliable Data|0|||
162614836|NCT01954342|587307383|FG001|Overall Study|Unreliable Data|0|||
162614837|NCT01954342|587307384|FG002|Overall Study|Unreliable Data|0|||
162614838|NCT01954342|587307385|FG003|Overall Study|Unreliable Data|2|||
162614839|NCT00984568|587307386|FG000|Overall Study|Withdrawal by Subject|1|||
162614840|NCT00984568|587307387|FG001|Overall Study|Withdrawal by Subject|2|||
162614841|NCT00984568|587307386|FG000|Overall Study|Lack of Efficacy|2|||
162614842|NCT00984568|587307387|FG001|Overall Study|Lack of Efficacy|0|||
162614843|NCT00984568|587307386|FG000|Overall Study|Adverse Event|2|||
162614844|NCT00984568|587307387|FG001|Overall Study|Adverse Event|0|||
162614845|NCT00984568|587307386|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
162614846|NCT00984568|587307387|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
162614847|NCT00984568|587307386|FG000|Overall Study|Lost to Follow-up|0|||
162614848|NCT00984568|587307387|FG001|Overall Study|Lost to Follow-up|1|||
162614849|NCT00984568|587307386|FG000|Overall Study|Opportunistic Infection|1|||
163047008|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047009|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047010|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047011|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047012|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
162706512|NCT04955626|587636657|FG001|Blinded Period|Other|3|||
162706513|NCT04955626|587636658|FG002|Blinded Period|Other|4|||
162706514|NCT04955626|587636659|FG003|Blinded Period|Other|2|||
162706515|NCT04955626|587636660|FG004|Blinded Period|Other|0|||
162706516|NCT04955626|587636661|FG005|Blinded Period|Other|0|||
162706517|NCT04955626|587636662|FG006|Blinded Period|Other|2|||
162706518|NCT04955626|587636663|FG007|Blinded Period|Other|2|||
162706519|NCT04955626|587636664|FG008|Blinded Period|Other|1|||
162706520|NCT04955626|587636665|FG009|Blinded Period|Other|0|||
162706521|NCT04955626|587636666|FG010|Blinded Period|Other|1|||
162706522|NCT04955626|587636667|FG011|Blinded Period|Other|1|||
162706523|NCT04955626|587636668|FG012|Blinded Period|Other|0|||
162706524|NCT04955626|587636669|FG013|Blinded Period|Other|0|||
162706525|NCT04955626|587636670|FG014|Blinded Period|Other|0|||
162706526|NCT04955626|587636671|FG015|Blinded Period|Other|0|||
162706527|NCT04955626|587636672|FG016|Blinded Period|Other|0|||
162706528|NCT04955626|587636673|FG017|Blinded Period|Other|1|||
162706529|NCT04955626|587636674|FG018|Blinded Period|Other|0|||
162706530|NCT04955626|587636675|FG019|Blinded Period|Other|0|||
162706531|NCT04955626|587636676|FG020|Blinded Period|Other|0|||
162706532|NCT04955626|587636677|FG021|Blinded Period|Other|0|||
162706533|NCT04955626|587636678|FG022|Blinded Period|Other|0|||
162706534|NCT04955626|587636679|FG023|Blinded Period|Other|0|||
162706535|NCT04955626|587636680|FG024|Blinded Period|Other|0|||
162706536|NCT04955626|587636681|FG025|Blinded Period|Other|0|||
162706537|NCT04955626|587636682|FG026|Blinded Period|Other|2|||
162706538|NCT04955626|587636683|FG027|Blinded Period|Other|0|||
162706539|NCT04955626|587636684|FG028|Blinded Period|Other|0|||
162706540|NCT04955626|587636685|FG029|Blinded Period|Other|0|||
162706541|NCT04955626|587636686|FG030|Blinded Period|Other|0|||
162706542|NCT04955626|587636687|FG031|Blinded Period|Other|0|||
162706543|NCT04955626|587636688|FG032|Blinded Period|Other|0|||
162706544|NCT04955626|587636689|FG033|Blinded Period|Other|0|||
162706545|NCT04955626|587636690|FG034|Blinded Period|Other|0|||
162706546|NCT04955626|587636691|FG035|Blinded Period|Other|0|||
162706547|NCT04955626|587636656|FG000|Blinded Period|Physician Decision|1|||
162706548|NCT04955626|587636657|FG001|Blinded Period|Physician Decision|1|||
162706549|NCT04955626|587636658|FG002|Blinded Period|Physician Decision|0|||
162706550|NCT04955626|587636659|FG003|Blinded Period|Physician Decision|3|||
162706551|NCT04955626|587636660|FG004|Blinded Period|Physician Decision|0|||
162706552|NCT04955626|587636661|FG005|Blinded Period|Physician Decision|0|||
162706553|NCT04955626|587636662|FG006|Blinded Period|Physician Decision|1|||
162706554|NCT04955626|587636663|FG007|Blinded Period|Physician Decision|1|||
162706555|NCT04955626|587636664|FG008|Blinded Period|Physician Decision|0|||
162706556|NCT04955626|587636665|FG009|Blinded Period|Physician Decision|0|||
162706557|NCT04955626|587636666|FG010|Blinded Period|Physician Decision|0|||
162706558|NCT04955626|587636667|FG011|Blinded Period|Physician Decision|5|||
162706559|NCT04955626|587636668|FG012|Blinded Period|Physician Decision|0|||
162706560|NCT04955626|587636669|FG013|Blinded Period|Physician Decision|0|||
162706561|NCT04955626|587636670|FG014|Blinded Period|Physician Decision|0|||
162706562|NCT04955626|587636671|FG015|Blinded Period|Physician Decision|0|||
162706563|NCT04955626|587636672|FG016|Blinded Period|Physician Decision|0|||
162706564|NCT04955626|587636673|FG017|Blinded Period|Physician Decision|0|||
162706565|NCT04955626|587636674|FG018|Blinded Period|Physician Decision|0|||
162706566|NCT04955626|587636675|FG019|Blinded Period|Physician Decision|0|||
162706567|NCT04955626|587636676|FG020|Blinded Period|Physician Decision|0|||
162706568|NCT04955626|587636677|FG021|Blinded Period|Physician Decision|0|||
162706569|NCT04955626|587636678|FG022|Blinded Period|Physician Decision|0|||
162706570|NCT04955626|587636679|FG023|Blinded Period|Physician Decision|0|||
162706571|NCT04955626|587636680|FG024|Blinded Period|Physician Decision|0|||
162706572|NCT04955626|587636681|FG025|Blinded Period|Physician Decision|0|||
162706573|NCT04955626|587636682|FG026|Blinded Period|Physician Decision|0|||
162706574|NCT04955626|587636683|FG027|Blinded Period|Physician Decision|0|||
162706575|NCT04955626|587636684|FG028|Blinded Period|Physician Decision|0|||
162706576|NCT04955626|587636685|FG029|Blinded Period|Physician Decision|0|||
162706577|NCT04955626|587636686|FG030|Blinded Period|Physician Decision|0|||
162706578|NCT04955626|587636687|FG031|Blinded Period|Physician Decision|0|||
162706579|NCT04955626|587636688|FG032|Blinded Period|Physician Decision|0|||
162706580|NCT04955626|587636689|FG033|Blinded Period|Physician Decision|0|||
162706581|NCT04955626|587636690|FG034|Blinded Period|Physician Decision|0|||
162706582|NCT04955626|587636691|FG035|Blinded Period|Physician Decision|0|||
162706583|NCT04955626|587636656|FG000|Blinded Period|Withdrawal by Subject|26|||
162706584|NCT04955626|587636657|FG001|Blinded Period|Withdrawal by Subject|62|||
162706585|NCT04955626|587636658|FG002|Blinded Period|Withdrawal by Subject|14|||
162706586|NCT04955626|587636659|FG003|Blinded Period|Withdrawal by Subject|16|||
162870161|NCT00002663|588227482|FG003|Overall Study|Other|0|||
162870162|NCT00002663|588227483|FG004|Overall Study|Other|0|||
162870163|NCT00002663|588227484|FG005|Overall Study|Other|1|||
162870164|NCT00002663|588227485|FG006|Overall Study|Other|1|||
162870165|NCT00002663|588227486|FG007|Overall Study|Other|0|||
162870166|NCT00002663|588227487|FG008|Overall Study|Other|0|||
162870167|NCT00002663|588227488|FG009|Overall Study|Other|0|||
162870168|NCT00002663|588227479|FG000|Overall Study|Physician Decision|0|||
162870169|NCT00002663|588227480|FG001|Overall Study|Physician Decision|0|||
162870170|NCT00002663|588227481|FG002|Overall Study|Physician Decision|0|||
162870171|NCT00002663|588227482|FG003|Overall Study|Physician Decision|0|||
162870172|NCT00002663|588227483|FG004|Overall Study|Physician Decision|1|||
162870173|NCT00002663|588227484|FG005|Overall Study|Physician Decision|0|||
162870174|NCT00002663|588227485|FG006|Overall Study|Physician Decision|0|||
162870175|NCT00002663|588227486|FG007|Overall Study|Physician Decision|0|||
162870176|NCT00002663|588227487|FG008|Overall Study|Physician Decision|1|||
162870177|NCT00002663|588227488|FG009|Overall Study|Physician Decision|1|||
162870178|NCT00002663|588227479|FG000|Overall Study|Adverse Event|0|||
162870179|NCT00002663|588227480|FG001|Overall Study|Adverse Event|0|||
162870180|NCT00002663|588227481|FG002|Overall Study|Adverse Event|0|||
162870181|NCT00002663|588227482|FG003|Overall Study|Adverse Event|1|||
162870182|NCT00002663|588227483|FG004|Overall Study|Adverse Event|0|||
162870183|NCT00002663|588227484|FG005|Overall Study|Adverse Event|0|||
162870184|NCT00002663|588227485|FG006|Overall Study|Adverse Event|0|||
162870185|NCT00002663|588227486|FG007|Overall Study|Adverse Event|1|||
162870186|NCT00002663|588227487|FG008|Overall Study|Adverse Event|0|||
162870187|NCT00002663|588227488|FG009|Overall Study|Adverse Event|0|||
162870188|NCT00446446|588227492|FG000|Overall Study|Death|10|||
162870189|NCT00446446|588227492|FG000|Overall Study|Withdrawal by Subject|6|||
162870190|NCT00446446|588227492|FG000|Overall Study|Other|4|||
162870191|NCT00446446|588227492|FG000|Overall Study|Disease Progession|2|||
162870192|NCT00446446|588227492|FG000|Overall Study|Adverse Event|1|||
162870193|NCT00446446|588227492|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
162870194|NCT02142894|588227493|FG000|Overall Study|Protocol Violation|8|||
162870195|NCT00611130|588227499|FG000|Overall Study|Lost to Follow-up|25|||
162870196|NCT00611130|588227500|FG001|Overall Study|Lost to Follow-up|29|||
162870197|NCT00611130|588227499|FG000|Overall Study|Protocol noncompliance|7|||
162870198|NCT00611130|588227500|FG001|Overall Study|Protocol noncompliance|6|||
162870199|NCT00611130|588227499|FG000|Overall Study|Withdrawal by Subject|6|||
162870200|NCT00611130|588227500|FG001|Overall Study|Withdrawal by Subject|5|||
162870201|NCT00611130|588227499|FG000|Overall Study|Other|5|||
162870202|NCT00611130|588227500|FG001|Overall Study|Other|4|||
162870203|NCT00611130|588227499|FG000|Overall Study|Incarceration|3|||
162870204|NCT00611130|588227500|FG001|Overall Study|Incarceration|2|||
162870205|NCT00611130|588227499|FG000|Overall Study|Administrative|1|||
162870206|NCT00611130|588227500|FG001|Overall Study|Administrative|1|||
162870207|NCT00611130|588227499|FG000|Overall Study|Adverse Event|1|||
162870208|NCT00611130|588227500|FG001|Overall Study|Adverse Event|0|||
162870209|NCT00611130|588227499|FG000|Overall Study|Death|1|||
162870210|NCT00611130|588227500|FG001|Overall Study|Death|0|||
162870211|NCT01455428|588227506|FG000|Overall Study|Protocol Violation|2|||
162870212|NCT01455428|588227507|FG001|Overall Study|Protocol Violation|1|||
162870213|NCT01455428|588227506|FG000|Overall Study|Adverse Event|6|||
162870214|NCT01455428|588227507|FG001|Overall Study|Adverse Event|2|||
162870215|NCT01455428|588227506|FG000|Overall Study|Lost to Follow-up|1|||
162870216|NCT01455428|588227507|FG001|Overall Study|Lost to Follow-up|1|||
162870217|NCT01455428|588227506|FG000|Overall Study|Withdrawal by Subject|2|||
162870218|NCT01455428|588227507|FG001|Overall Study|Withdrawal by Subject|5|||
162870219|NCT01455428|588227506|FG000|Overall Study|Did not meet entrance criteria|0|||
162870220|NCT01455428|588227507|FG001|Overall Study|Did not meet entrance criteria|2|||
162870221|NCT01455428|588227506|FG000|Overall Study|Insufficient clinical response|0|||
162870222|NCT01455428|588227507|FG001|Overall Study|Insufficient clinical response|2|||
162870223|NCT01455428|588227506|FG000|Overall Study|Did not receive treatment|1|||
162870224|NCT01455428|588227507|FG001|Overall Study|Did not receive treatment|1|||
162870225|NCT01455428|588227506|FG000|Overall Study|Other|2|||
162870226|NCT01455428|588227507|FG001|Overall Study|Other|4|||
162870227|NCT01927562|588227510|FG000|Overall Study|Lost to Follow-up|30|||
162870228|NCT01927562|588227510|FG000|Overall Study|Withdrawal by Subject|3|||
162870229|NCT01927562|588227510|FG000|Overall Study|Physician Decision|5|||
162870230|NCT00642616|588227511|FG000|Overall Study|Adverse Event|2|||
162870231|NCT00642616|588227512|FG001|Overall Study|Adverse Event|0|||
162870232|NCT00642616|588227513|FG002|Overall Study|Adverse Event|1|||
162870233|NCT00642616|588227514|FG003|Overall Study|Adverse Event|0|||
162870234|NCT00642616|588227511|FG000|Overall Study|Study Terminated by Sponsor|7|||
162870235|NCT00642616|588227512|FG001|Overall Study|Study Terminated by Sponsor|6|||
162870236|NCT00642616|588227513|FG002|Overall Study|Study Terminated by Sponsor|4|||
162870237|NCT00642616|588227514|FG003|Overall Study|Study Terminated by Sponsor|5|||
162870238|NCT00642616|588227511|FG000|Overall Study|Withdrawal by Subject|0|||
162870239|NCT00642616|588227512|FG001|Overall Study|Withdrawal by Subject|1|||
162870240|NCT00642616|588227513|FG002|Overall Study|Withdrawal by Subject|1|||
162870241|NCT00642616|588227514|FG003|Overall Study|Withdrawal by Subject|1|||
162870242|NCT00642616|588227511|FG000|Overall Study|Protocol Violation|0|||
162870243|NCT00642616|588227512|FG001|Overall Study|Protocol Violation|0|||
162870244|NCT00642616|588227513|FG002|Overall Study|Protocol Violation|2|||
162870245|NCT00642616|588227514|FG003|Overall Study|Protocol Violation|0|||
162870246|NCT00642616|588227511|FG000|Overall Study|Physician Decision|0|||
162870247|NCT00642616|588227512|FG001|Overall Study|Physician Decision|0|||
162870248|NCT00642616|588227513|FG002|Overall Study|Physician Decision|1|||
162870249|NCT00642616|588227514|FG003|Overall Study|Physician Decision|1|||
162870250|NCT02955186|588227515|FG000|Overall Study|Withdrawal by Subject|6|||
162870251|NCT02955186|588227516|FG001|Overall Study|Withdrawal by Subject|2|||
162870252|NCT02955186|588227515|FG000|Overall Study|Protocol Violation|1|||
162870253|NCT02955186|588227516|FG001|Overall Study|Protocol Violation|0|||
162870254|NCT01276847|588227518|FG000|Overall Study|Withdrawal by Subject|1|||
162870255|NCT01276847|588227519|FG001|Overall Study|Withdrawal by Subject|0|||
162870256|NCT01276847|588227520|FG002|Overall Study|Withdrawal by Subject|0|||
162870257|NCT01618656|588227521|FG000|Overall Study|Withdrawal by Subject|7|||
162870258|NCT01618656|588227522|FG001|Overall Study|Withdrawal by Subject|3|||
162870259|NCT01618656|588227521|FG000|Overall Study|Physician Decision|1|||
162870260|NCT01618656|588227522|FG001|Overall Study|Physician Decision|1|||
162870261|NCT00751881|588227523|FG000|Core Treatment Period|Not treated|1|||
162870262|NCT00751881|588227524|FG001|Core Treatment Period|Not treated|1|||
162870263|NCT00751881|588227525|FG002|Core Treatment Period|Not treated|2|||
162870264|NCT00751881|588227523|FG000|Core Treatment Period|Adverse Event|26|||
162870265|NCT00751881|588227524|FG001|Core Treatment Period|Adverse Event|54|||
162870266|NCT00751881|588227525|FG002|Core Treatment Period|Adverse Event|58|||
162870267|NCT00751881|588227523|FG000|Core Treatment Period|Lack of Efficacy|37|||
162870268|NCT00751881|588227524|FG001|Core Treatment Period|Lack of Efficacy|30|||
162870269|NCT00751881|588227525|FG002|Core Treatment Period|Lack of Efficacy|20|||
162870270|NCT00751881|588227523|FG000|Core Treatment Period|Poor compliance to protocol|15|||
162870271|NCT00751881|588227524|FG001|Core Treatment Period|Poor compliance to protocol|3|||
162870272|NCT00751881|588227525|FG002|Core Treatment Period|Poor compliance to protocol|4|||
162870273|NCT00751881|588227523|FG000|Core Treatment Period|Lost to Follow-up|6|||
162870274|NCT00751881|588227524|FG001|Core Treatment Period|Lost to Follow-up|4|||
162870275|NCT00751881|588227525|FG002|Core Treatment Period|Lost to Follow-up|3|||
162870276|NCT00751881|588227523|FG000|Core Treatment Period|Other: protocol deviation|3|||
162870277|NCT00751881|588227524|FG001|Core Treatment Period|Other: protocol deviation|3|||
162870278|NCT00751881|588227525|FG002|Core Treatment Period|Other: protocol deviation|7|||
162870279|NCT00751881|588227523|FG000|Core Treatment Period|Other: wish to parent|5|||
162870280|NCT00751881|588227524|FG001|Core Treatment Period|Other: wish to parent|7|||
162960584|NCT00205777|588558850|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960585|NCT00205777|588558851|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960586|NCT00205777|588558852|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
162960587|NCT00205777|588558853|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
162960588|NCT00205777|588558854|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
162960589|NCT00205777|588558849|FG000|Study Extension II|Adverse Event|0|||
162960590|NCT00205777|588558850|FG001|Study Extension II|Adverse Event|0|||
162960591|NCT00205777|588558851|FG002|Study Extension II|Adverse Event|0|||
162960592|NCT00205777|588558852|FG003|Study Extension II|Adverse Event|14|||
162960593|NCT00205777|588558853|FG004|Study Extension II|Adverse Event|0|||
162960594|NCT00205777|588558854|FG005|Study Extension II|Adverse Event|30|||
162960595|NCT00205777|588558849|FG000|Study Extension II|Death|0|||
162960596|NCT00205777|588558850|FG001|Study Extension II|Death|0|||
162960597|NCT00205777|588558851|FG002|Study Extension II|Death|0|||
162960598|NCT00205777|588558852|FG003|Study Extension II|Death|2|||
162960599|NCT00205777|588558853|FG004|Study Extension II|Death|0|||
162960600|NCT00205777|588558854|FG005|Study Extension II|Death|5|||
162960601|NCT00205777|588558849|FG000|Study Extension II|Withdrawal by Subject|0|||
162960602|NCT00205777|588558850|FG001|Study Extension II|Withdrawal by Subject|0|||
162960603|NCT00205777|588558851|FG002|Study Extension II|Withdrawal by Subject|0|||
162960604|NCT00205777|588558852|FG003|Study Extension II|Withdrawal by Subject|35|||
162960605|NCT00205777|588558853|FG004|Study Extension II|Withdrawal by Subject|0|||
162960606|NCT00205777|588558854|FG005|Study Extension II|Withdrawal by Subject|59|||
162960607|NCT00205777|588558849|FG000|Study Extension II|Protocol Violation|0|||
162960608|NCT00205777|588558850|FG001|Study Extension II|Protocol Violation|0|||
162960609|NCT00205777|588558851|FG002|Study Extension II|Protocol Violation|0|||
162870281|NCT00751881|588227525|FG002|Core Treatment Period|Other: wish to parent|4|||
162960610|NCT00205777|588558852|FG003|Study Extension II|Protocol Violation|1|||
162960611|NCT00205777|588558853|FG004|Study Extension II|Protocol Violation|0|||
162870282|NCT00751881|588227523|FG000|Core Treatment Period|Other: personal/family constraints|6|||
162870283|NCT00751881|588227524|FG001|Core Treatment Period|Other: personal/family constraints|7|||
162870284|NCT00751881|588227525|FG002|Core Treatment Period|Other: personal/family constraints|10|||
162870285|NCT00751881|588227523|FG000|Core Treatment Period|Other: MS treatment change|6|||
162870286|NCT00751881|588227524|FG001|Core Treatment Period|Other: MS treatment change|4|||
162870287|NCT00751881|588227525|FG002|Core Treatment Period|Other: MS treatment change|4|||
162870288|NCT00751881|588227523|FG000|Core Treatment Period|Other: tolerability complaints|2|||
162870289|NCT00751881|588227524|FG001|Core Treatment Period|Other: tolerability complaints|0|||
162870290|NCT00751881|588227525|FG002|Core Treatment Period|Other: tolerability complaints|0|||
162870291|NCT00751881|588227523|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
162870292|NCT00751881|588227524|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
162614850|NCT00984568|587307387|FG001|Overall Study|Opportunistic Infection|0|||
162614851|NCT00984568|587307386|FG000|Overall Study|Unknown Reason|1|||
162614852|NCT00984568|587307387|FG001|Overall Study|Unknown Reason|3|||
162614853|NCT01649804|587307388|FG000|Overall Study|Administrative/Other|8|||
162614854|NCT03845543|587307389|FG000|Overall Study|Death|25|||
162870293|NCT00751881|588227525|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
162870294|NCT00751881|588227523|FG000|Extension Study Period|Adverse Event|18|||
162870295|NCT00751881|588227524|FG001|Extension Study Period|Adverse Event|20|||
162870296|NCT00751881|588227525|FG002|Extension Study Period|Adverse Event|21|||
162870297|NCT00751881|588227523|FG000|Extension Study Period|Lack of Efficacy|14|||
162870298|NCT00751881|588227524|FG001|Extension Study Period|Lack of Efficacy|10|||
162614855|NCT03845543|587307389|FG000|Overall Study|Withdrawal by Subject|2|||
162614856|NCT03845543|587307389|FG000|Overall Study|Lost to Follow-up|12|||
162614857|NCT03845543|587307389|FG000|Overall Study|Adverse Event|17|||
162614858|NCT01912963|587307395|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
162614859|NCT01912963|587307396|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
162614860|NCT01912963|587307397|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
162614861|NCT01912963|587307395|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
162614862|NCT01912963|587307396|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
162614863|NCT01912963|587307397|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
162614864|NCT01912963|587307395|FG000|Overall Study|Adverse Event|0|||
162614865|NCT01912963|587307396|FG001|Overall Study|Adverse Event|1|||
162870299|NCT00751881|588227525|FG002|Extension Study Period|Lack of Efficacy|20|||
162870300|NCT00751881|588227523|FG000|Extension Study Period|Lost to Follow-up|4|||
162870301|NCT00751881|588227524|FG001|Extension Study Period|Lost to Follow-up|9|||
162870302|NCT00751881|588227525|FG002|Extension Study Period|Lost to Follow-up|6|||
162870303|NCT00751881|588227523|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
162870304|NCT00751881|588227524|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
162870305|NCT00751881|588227525|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
162870306|NCT00751881|588227523|FG000|Extension Study Period|Other than specified above|26|||
162870307|NCT00751881|588227524|FG001|Extension Study Period|Other than specified above|30|||
162870308|NCT00751881|588227525|FG002|Extension Study Period|Other than specified above|18|||
162870309|NCT04770155|588227526|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870310|NCT04770155|588227527|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870311|NCT04770155|588227528|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870312|NCT04770155|588227529|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870313|NCT04770155|588227530|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870314|NCT04770155|588227531|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870315|NCT04770155|588227532|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870316|NCT04770155|588227533|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
162870317|NCT00866294|588227534|FG000|Overall Study|Adverse Event|12|||
162870318|NCT00866294|588227535|FG001|Overall Study|Adverse Event|13|||
162870319|NCT00866294|588227536|FG002|Overall Study|Adverse Event|9|||
162870320|NCT00866294|588227534|FG000|Overall Study|Lack of Efficacy|7|||
162870321|NCT00866294|588227535|FG001|Overall Study|Lack of Efficacy|1|||
162870322|NCT00866294|588227536|FG002|Overall Study|Lack of Efficacy|0|||
162870323|NCT00866294|588227534|FG000|Overall Study|Protocol Violation|2|||
162870324|NCT00866294|588227535|FG001|Overall Study|Protocol Violation|0|||
162870325|NCT00866294|588227536|FG002|Overall Study|Protocol Violation|0|||
162870326|NCT00866294|588227534|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
162870327|NCT00866294|588227535|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162870328|NCT00866294|588227536|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162870329|NCT00866294|588227534|FG000|Overall Study|Lost to Follow-up|1|||
162870330|NCT00866294|588227535|FG001|Overall Study|Lost to Follow-up|3|||
162870331|NCT00866294|588227536|FG002|Overall Study|Lost to Follow-up|0|||
162870332|NCT00866294|588227534|FG000|Overall Study|Physician Decision|6|||
162870333|NCT00866294|588227535|FG001|Overall Study|Physician Decision|2|||
162870334|NCT00866294|588227536|FG002|Overall Study|Physician Decision|1|||
162870335|NCT00081289|588227540|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
162870336|NCT00081289|588227541|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
162870337|NCT00081289|588227540|FG000|Overall Study|Ineligible / no protocol treatment|3|||
162870338|NCT00081289|588227541|FG001|Overall Study|Ineligible / no protocol treatment|4|||
162870339|NCT01651260|588227542|FG000|Overall Study|unable to apply product|3|||
162870340|NCT01952015|588227545|FG000|Induction|Protocol Violation|1|||
162870341|NCT01952015|588227545|FG000|Maintenance|Adverse Event|2|||
162870342|NCT01952015|588227545|FG000|Treatment Period 3|Physician Decision|9|||
162870343|NCT02239094|588227546|FG000|Overall Study|Withdrawal by Subject|1|||
162870344|NCT02239094|588227546|FG000|Overall Study|Remitted before started|1|||
162870345|NCT01469052|588227551|FG000|Overall Study|Adverse Event|2|||
162870346|NCT01469052|588227552|FG001|Overall Study|Adverse Event|3|||
162870347|NCT01469052|588227553|FG002|Overall Study|Adverse Event|0|||
162870348|NCT01469052|588227554|FG003|Overall Study|Adverse Event|2|||
162870349|NCT01469052|588227555|FG004|Overall Study|Adverse Event|0|||
162870350|NCT01469052|588227556|FG005|Overall Study|Adverse Event|1|||
162870351|NCT01469052|588227551|FG000|Overall Study|Progressive disease|3|||
162870352|NCT01469052|588227552|FG001|Overall Study|Progressive disease|0|||
162870353|NCT01469052|588227553|FG002|Overall Study|Progressive disease|5|||
162870354|NCT01469052|588227554|FG003|Overall Study|Progressive disease|3|||
162870355|NCT01469052|588227555|FG004|Overall Study|Progressive disease|7|||
162870356|NCT01469052|588227556|FG005|Overall Study|Progressive disease|2|||
162870357|NCT01469052|588227551|FG000|Overall Study|Lack of Efficacy|0|||
162870358|NCT01469052|588227552|FG001|Overall Study|Lack of Efficacy|0|||
162870359|NCT01469052|588227553|FG002|Overall Study|Lack of Efficacy|0|||
162870360|NCT01469052|588227554|FG003|Overall Study|Lack of Efficacy|0|||
162870361|NCT01469052|588227555|FG004|Overall Study|Lack of Efficacy|0|||
162870362|NCT01469052|588227556|FG005|Overall Study|Lack of Efficacy|2|||
162870363|NCT01469052|588227551|FG000|Overall Study|Moved to rollover protocol|1|||
162870364|NCT01469052|588227552|FG001|Overall Study|Moved to rollover protocol|0|||
162870365|NCT01469052|588227553|FG002|Overall Study|Moved to rollover protocol|1|||
162870366|NCT01469052|588227554|FG003|Overall Study|Moved to rollover protocol|0|||
162870367|NCT01469052|588227555|FG004|Overall Study|Moved to rollover protocol|0|||
162870368|NCT01469052|588227556|FG005|Overall Study|Moved to rollover protocol|1|||
162960612|NCT00205777|588558854|FG005|Study Extension II|Protocol Violation|10|||
162870369|NCT01469052|588227551|FG000|Overall Study|Other|0|||
162870370|NCT01469052|588227552|FG001|Overall Study|Other|1|||
162870371|NCT01469052|588227553|FG002|Overall Study|Other|0|||
162870372|NCT01469052|588227554|FG003|Overall Study|Other|0|||
162870373|NCT01469052|588227555|FG004|Overall Study|Other|1|||
162870374|NCT01469052|588227556|FG005|Overall Study|Other|0|||
162870375|NCT02508701|588227557|FG000|Overall Study|Lost to Follow-up|9|||
162870376|NCT02508701|588227558|FG001|Overall Study|Lost to Follow-up|5|||
162870377|NCT02508701|588227559|FG002|Overall Study|Lost to Follow-up|5|||
162870378|NCT02508701|588227560|FG003|Overall Study|Lost to Follow-up|3|||
162870379|NCT03648996|588227562|FG000|Overall Study|Withdrawal by Subject|0|||
162870380|NCT03648996|588227563|FG001|Overall Study|Withdrawal by Subject|2|||
162870381|NCT03648996|588227564|FG002|Overall Study|Withdrawal by Subject|2|||
162870382|NCT03648996|588227562|FG000|Overall Study|Physician Decision|2|||
162870383|NCT03648996|588227563|FG001|Overall Study|Physician Decision|0|||
162870384|NCT03648996|588227564|FG002|Overall Study|Physician Decision|0|||
162870385|NCT03894904|588227569|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
162870386|NCT03894904|588227570|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
162870387|NCT03894904|588227569|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
162870388|NCT03894904|588227570|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
162870389|NCT00504166|588227573|FG000|Overall Study|Adverse Event|1|||
162870390|NCT00504166|588227574|FG001|Overall Study|Adverse Event|4|||
162870391|NCT00504166|588227573|FG000|Overall Study|Withdrawal by Subject|3|||
162870392|NCT00504166|588227574|FG001|Overall Study|Withdrawal by Subject|6|||
162870393|NCT00504166|588227573|FG000|Overall Study|Physician Decision|1|||
162870394|NCT00504166|588227574|FG001|Overall Study|Physician Decision|1|||
162870395|NCT00504166|588227573|FG000|Overall Study|Lost to Follow-up|1|||
162870396|NCT00504166|588227574|FG001|Overall Study|Lost to Follow-up|3|||
162870397|NCT00365976|588227577|FG000|Overall Study|Withdrawal by Subject|1|||
162870398|NCT00365976|588227578|FG001|Overall Study|Withdrawal by Subject|5|||
162870399|NCT01415440|588227579|FG000|Overall Study|Lost to Follow-up|0|||
162870400|NCT01415440|588227580|FG001|Overall Study|Lost to Follow-up|1|||
162960613|NCT00205777|588558849|FG000|Study Extension II|Lack of Efficacy|0|||
162706587|NCT04955626|587636660|FG004|Blinded Period|Withdrawal by Subject|1|||
162706588|NCT04955626|587636661|FG005|Blinded Period|Withdrawal by Subject|2|||
162706589|NCT04955626|587636662|FG006|Blinded Period|Withdrawal by Subject|9|||
162706590|NCT04955626|587636663|FG007|Blinded Period|Withdrawal by Subject|5|||
162706591|NCT04955626|587636664|FG008|Blinded Period|Withdrawal by Subject|3|||
162706592|NCT04955626|587636665|FG009|Blinded Period|Withdrawal by Subject|15|||
162706593|NCT04955626|587636666|FG010|Blinded Period|Withdrawal by Subject|11|||
162706594|NCT04955626|587636667|FG011|Blinded Period|Withdrawal by Subject|7|||
162706595|NCT04955626|587636668|FG012|Blinded Period|Withdrawal by Subject|2|||
162706596|NCT04955626|587636669|FG013|Blinded Period|Withdrawal by Subject|0|||
162706597|NCT04955626|587636670|FG014|Blinded Period|Withdrawal by Subject|1|||
162706598|NCT04955626|587636671|FG015|Blinded Period|Withdrawal by Subject|11|||
162706599|NCT04955626|587636672|FG016|Blinded Period|Withdrawal by Subject|2|||
162706600|NCT04955626|587636673|FG017|Blinded Period|Withdrawal by Subject|5|||
162706601|NCT04955626|587636674|FG018|Blinded Period|Withdrawal by Subject|0|||
162706602|NCT04955626|587636675|FG019|Blinded Period|Withdrawal by Subject|0|||
162706603|NCT04955626|587636676|FG020|Blinded Period|Withdrawal by Subject|1|||
162706604|NCT04955626|587636677|FG021|Blinded Period|Withdrawal by Subject|0|||
162706605|NCT04955626|587636678|FG022|Blinded Period|Withdrawal by Subject|0|||
162706606|NCT04955626|587636679|FG023|Blinded Period|Withdrawal by Subject|0|||
162706607|NCT04955626|587636680|FG024|Blinded Period|Withdrawal by Subject|5|||
162706608|NCT04955626|587636681|FG025|Blinded Period|Withdrawal by Subject|1|||
162706609|NCT04955626|587636682|FG026|Blinded Period|Withdrawal by Subject|5|||
162706610|NCT04955626|587636683|FG027|Blinded Period|Withdrawal by Subject|1|||
162706611|NCT04955626|587636684|FG028|Blinded Period|Withdrawal by Subject|4|||
162706612|NCT04955626|587636685|FG029|Blinded Period|Withdrawal by Subject|2|||
162706613|NCT04955626|587636686|FG030|Blinded Period|Withdrawal by Subject|0|||
162706614|NCT04955626|587636687|FG031|Blinded Period|Withdrawal by Subject|0|||
162706615|NCT04955626|587636688|FG032|Blinded Period|Withdrawal by Subject|0|||
162706616|NCT04955626|587636689|FG033|Blinded Period|Withdrawal by Subject|0|||
162706617|NCT04955626|587636690|FG034|Blinded Period|Withdrawal by Subject|0|||
162870401|NCT01415440|588227581|FG002|Overall Study|Lost to Follow-up|2|||
162870402|NCT01415440|588227579|FG000|Overall Study|Physician Decision|3|||
162870403|NCT01415440|588227580|FG001|Overall Study|Physician Decision|0|||
162870404|NCT01415440|588227581|FG002|Overall Study|Physician Decision|0|||
162870405|NCT01415440|588227579|FG000|Overall Study|Withdrawal by Subject|1|||
162870406|NCT01415440|588227580|FG001|Overall Study|Withdrawal by Subject|0|||
162870407|NCT01415440|588227581|FG002|Overall Study|Withdrawal by Subject|0|||
162960614|NCT00205777|588558850|FG001|Study Extension II|Lack of Efficacy|0|||
162706618|NCT04955626|587636691|FG035|Blinded Period|Withdrawal by Subject|0|||
162706619|NCT04955626|587636656|FG000|Blinded Period|Refused further study procedures|0|||
162706620|NCT04955626|587636657|FG001|Blinded Period|Refused further study procedures|0|||
162870408|NCT03090737|588227582|FG000|Overall Study|Other reasons|1|||
162870409|NCT03090737|588227582|FG000|Overall Study|Completed treatment as per protocol|17|||
162870410|NCT03090737|588227582|FG000|Overall Study|Maximum clinical benefit|2|||
162870411|NCT03090737|588227582|FG000|Overall Study|Adverse event unrelated to study drug|7|||
162870412|NCT03090737|588227582|FG000|Overall Study|Study drug toxicity|4|||
162870413|NCT03090737|588227582|FG000|Overall Study|Disease progression|98|||
162870414|NCT03596177|588227584|FG000|Single Blind Period|Withdrawal by Subject|1|||
162870415|NCT03596177|588227585|FG001|Single Blind Period|Withdrawal by Subject|1|||
162870416|NCT03596177|588227584|FG000|Single Blind Period|Other|1|||
162870417|NCT03596177|588227585|FG001|Single Blind Period|Other|0|||
162870418|NCT03596177|588227584|FG000|Double Blind Period|Withdrawal by Subject|0|||
162870419|NCT03596177|588227585|FG001|Double Blind Period|Withdrawal by Subject|1|||
162870420|NCT03596177|588227584|FG000|Double Blind Period|Other|0|||
162870421|NCT03596177|588227585|FG001|Double Blind Period|Other|4|||
162870422|NCT03596177|588227584|FG000|Double Blind Period|Death during safety follow-up|0|||
162870423|NCT03596177|588227585|FG001|Double Blind Period|Death during safety follow-up|1|||
162870424|NCT03123939|588227588|FG000|Overall Study|Lack of Efficacy|6|||
162870425|NCT03123939|588227588|FG000|Overall Study|Death|5|||
162870426|NCT03123939|588227588|FG000|Overall Study|Physician Decision|2|||
162870427|NCT03123939|588227588|FG000|Overall Study|Subject/guardian decision|2|||
162870428|NCT03123939|588227588|FG000|Overall Study|Lost to Follow-up|1|||
162870429|NCT03123939|588227588|FG000|Overall Study|New therapy for study indication|1|||
162870430|NCT03123939|588227588|FG000|Overall Study|Protocol deviation|1|||
162870431|NCT03123939|588227588|FG000|Overall Study|Progressive disease|18|||
162870432|NCT03123939|588227588|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
162870433|NCT03123939|588227588|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
162870434|NCT04191967|588229096|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
162870435|NCT04191967|588229096|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
162870436|NCT00953043|588229100|FG000|Overall Study|Withdrawal by Subject|4|||
162870437|NCT00953043|588229101|FG001|Overall Study|Withdrawal by Subject|0|||
162870438|NCT00953043|588229100|FG000|Overall Study|Physician Decision|0|||
162870439|NCT00953043|588229101|FG001|Overall Study|Physician Decision|2|||
162870440|NCT02322892|588229103|FG000|Overall Study|Surgery cancelled|1|||
162870441|NCT02322892|588229104|FG001|Overall Study|Surgery cancelled|2|||
162870442|NCT02322892|588229103|FG000|Overall Study|Met exclusion criteria|0|||
162870443|NCT02322892|588229104|FG001|Overall Study|Met exclusion criteria|1|||
162870444|NCT02322892|588229103|FG000|Overall Study|Protocol Violation|1|||
162870445|NCT02322892|588229104|FG001|Overall Study|Protocol Violation|0|||
162870446|NCT03509207|588229105|FG000|Overall Study|Death|2|||
162960615|NCT00205777|588558851|FG002|Study Extension II|Lack of Efficacy|0|||
162960616|NCT00205777|588558852|FG003|Study Extension II|Lack of Efficacy|0|||
162960617|NCT00205777|588558853|FG004|Study Extension II|Lack of Efficacy|0|||
162960618|NCT00205777|588558854|FG005|Study Extension II|Lack of Efficacy|1|||
162870447|NCT02125331|588229106|FG000|Overall Study|Protocol Violation|1|||
162870448|NCT02125331|588229107|FG001|Overall Study|Protocol Violation|0|||
162870449|NCT02125331|588229106|FG000|Overall Study|technical problem|2|||
162870450|NCT02125331|588229107|FG001|Overall Study|technical problem|0|||
162870451|NCT02125331|588229106|FG000|Overall Study|screen failure|2|||
162870452|NCT02125331|588229107|FG001|Overall Study|screen failure|0|||
162870453|NCT01432262|588229108|FG000|Overall Study|Withdrawal by Subject|2|||
162870454|NCT01432262|588229109|FG001|Overall Study|Withdrawal by Subject|1|||
162960619|NCT00205777|588558849|FG000|Study Extension II|Failed to return|0|||
162870455|NCT00165646|588229110|FG000|Overall Study|Adverse Event|1|||
162870456|NCT00165646|588229111|FG001|Overall Study|Adverse Event|1|||
162870457|NCT00165646|588229112|FG002|Overall Study|Adverse Event|1|||
162870458|NCT00165646|588229110|FG000|Overall Study|Lack of Efficacy|1|||
162870459|NCT00165646|588229111|FG001|Overall Study|Lack of Efficacy|2|||
162870460|NCT00165646|588229112|FG002|Overall Study|Lack of Efficacy|0|||
162870461|NCT00165646|588229110|FG000|Overall Study|Withdrawal by Subject|0|||
162870462|NCT00165646|588229111|FG001|Overall Study|Withdrawal by Subject|2|||
162870463|NCT00165646|588229112|FG002|Overall Study|Withdrawal by Subject|1|||
162870464|NCT00165646|588229110|FG000|Overall Study|Physician Decision|2|||
162870465|NCT00165646|588229111|FG001|Overall Study|Physician Decision|0|||
162870466|NCT00165646|588229112|FG002|Overall Study|Physician Decision|2|||
162870467|NCT00165646|588229110|FG000|Overall Study|Protocol Violation|1|||
162870468|NCT00165646|588229111|FG001|Overall Study|Protocol Violation|0|||
162870469|NCT00165646|588229112|FG002|Overall Study|Protocol Violation|0|||
162870470|NCT01675531|588229113|FG000|Overall Study|Adverse Event|9|||
162870471|NCT01675531|588229113|FG000|Overall Study|Withdrawal by Subject|7|||
162870472|NCT01675531|588229113|FG000|Overall Study|Lack of Efficacy|1|||
162870473|NCT01675531|588229113|FG000|Overall Study|Protocol Violation|8|||
162870474|NCT01623531|588229114|FG000|Overall Study|Death|1|||
162870475|NCT01623531|588229115|FG001|Overall Study|Death|0|||
162870476|NCT01623531|588229114|FG000|Overall Study|Protocol Violation|2|||
162870477|NCT01623531|588229115|FG001|Overall Study|Protocol Violation|1|||
162870478|NCT01623531|588229114|FG000|Overall Study|Missing data at primary outcome time poi|1|||
162870479|NCT01623531|588229115|FG001|Overall Study|Missing data at primary outcome time poi|1|||
162870480|NCT02834403|588229116|FG000|Overall Study|Physician Decision|2|||
162870481|NCT02834403|588229117|FG001|Overall Study|Physician Decision|1|||
162870482|NCT02834403|588229118|FG002|Overall Study|Physician Decision|2|||
162870483|NCT02834403|588229119|FG003|Overall Study|Physician Decision|1|||
162870484|NCT02834403|588229120|FG004|Overall Study|Physician Decision|1|||
162870485|NCT02834403|588229121|FG005|Overall Study|Physician Decision|2|||
162870486|NCT02834403|588229122|FG006|Overall Study|Physician Decision|12|||
162870487|NCT02834403|588229116|FG000|Overall Study|Adverse Event|0|||
162870488|NCT02834403|588229117|FG001|Overall Study|Adverse Event|0|||
162870489|NCT02834403|588229118|FG002|Overall Study|Adverse Event|0|||
162870490|NCT02834403|588229119|FG003|Overall Study|Adverse Event|0|||
162870491|NCT02834403|588229120|FG004|Overall Study|Adverse Event|1|||
162706621|NCT04955626|587636658|FG002|Blinded Period|Refused further study procedures|0|||
162706622|NCT04955626|587636659|FG003|Blinded Period|Refused further study procedures|0|||
162706623|NCT04955626|587636660|FG004|Blinded Period|Refused further study procedures|0|||
162706624|NCT04955626|587636661|FG005|Blinded Period|Refused further study procedures|0|||
162706625|NCT04955626|587636662|FG006|Blinded Period|Refused further study procedures|1|||
162706626|NCT04955626|587636663|FG007|Blinded Period|Refused further study procedures|0|||
162706627|NCT04955626|587636664|FG008|Blinded Period|Refused further study procedures|0|||
162706628|NCT04955626|587636665|FG009|Blinded Period|Refused further study procedures|0|||
162706629|NCT04955626|587636666|FG010|Blinded Period|Refused further study procedures|0|||
162706630|NCT04955626|587636667|FG011|Blinded Period|Refused further study procedures|2|||
162706631|NCT04955626|587636668|FG012|Blinded Period|Refused further study procedures|0|||
162706632|NCT04955626|587636669|FG013|Blinded Period|Refused further study procedures|0|||
162706633|NCT04955626|587636670|FG014|Blinded Period|Refused further study procedures|0|||
162706634|NCT04955626|587636671|FG015|Blinded Period|Refused further study procedures|0|||
162706635|NCT04955626|587636672|FG016|Blinded Period|Refused further study procedures|0|||
162706636|NCT04955626|587636673|FG017|Blinded Period|Refused further study procedures|0|||
162706637|NCT04955626|587636674|FG018|Blinded Period|Refused further study procedures|0|||
162706638|NCT04955626|587636675|FG019|Blinded Period|Refused further study procedures|0|||
162706639|NCT04955626|587636676|FG020|Blinded Period|Refused further study procedures|0|||
162706640|NCT04955626|587636677|FG021|Blinded Period|Refused further study procedures|0|||
162706641|NCT04955626|587636678|FG022|Blinded Period|Refused further study procedures|0|||
162706642|NCT04955626|587636679|FG023|Blinded Period|Refused further study procedures|0|||
162706643|NCT04955626|587636680|FG024|Blinded Period|Refused further study procedures|0|||
162870492|NCT02834403|588229121|FG005|Overall Study|Adverse Event|1|||
162870493|NCT02834403|588229122|FG006|Overall Study|Adverse Event|3|||
162870494|NCT02834403|588229116|FG000|Overall Study|Withdrawal by Subject|0|||
162870495|NCT02834403|588229117|FG001|Overall Study|Withdrawal by Subject|1|||
162870496|NCT02834403|588229118|FG002|Overall Study|Withdrawal by Subject|0|||
162870497|NCT02834403|588229119|FG003|Overall Study|Withdrawal by Subject|0|||
162706644|NCT04955626|587636681|FG025|Blinded Period|Refused further study procedures|0|||
162870498|NCT02834403|588229120|FG004|Overall Study|Withdrawal by Subject|1|||
162870499|NCT02834403|588229121|FG005|Overall Study|Withdrawal by Subject|0|||
162870500|NCT02834403|588229122|FG006|Overall Study|Withdrawal by Subject|0|||
162960620|NCT00205777|588558850|FG001|Study Extension II|Failed to return|0|||
162706645|NCT04955626|587636682|FG026|Blinded Period|Refused further study procedures|0|||
162706646|NCT04955626|587636683|FG027|Blinded Period|Refused further study procedures|0|||
162706647|NCT04955626|587636684|FG028|Blinded Period|Refused further study procedures|0|||
162706648|NCT04955626|587636685|FG029|Blinded Period|Refused further study procedures|0|||
162870501|NCT02834403|588229116|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
162870502|NCT02834403|588229117|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
162870503|NCT02834403|588229118|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
162870504|NCT02834403|588229119|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
162870505|NCT02834403|588229120|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
162870506|NCT02834403|588229121|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
162870507|NCT02834403|588229122|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
162870508|NCT02606045|588229123|FG000|Overall Study|Study closed before treament could begin|1|||
162870509|NCT02606045|588229124|FG001|Overall Study|Study closed before treament could begin|2|||
162870510|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
162870511|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
162870512|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162870513|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162870514|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162870515|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162870516|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162870517|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
162960621|NCT00205777|588558851|FG002|Study Extension II|Failed to return|0|||
162960622|NCT00205777|588558852|FG003|Study Extension II|Failed to return|14|||
162960623|NCT00205777|588558853|FG004|Study Extension II|Failed to return|0|||
162960624|NCT00205777|588558854|FG005|Study Extension II|Failed to return|26|||
162960625|NCT00205777|588558849|FG000|Study Extension II|Other Event|0|||
162960626|NCT00205777|588558850|FG001|Study Extension II|Other Event|0|||
162960627|NCT00205777|588558851|FG002|Study Extension II|Other Event|0|||
162960628|NCT00205777|588558852|FG003|Study Extension II|Other Event|12|||
162960629|NCT00205777|588558853|FG004|Study Extension II|Other Event|0|||
162960630|NCT00205777|588558854|FG005|Study Extension II|Other Event|20|||
162960631|NCT00205777|588558849|FG000|Study Extension II|Enrolled but not treated|0|||
162960632|NCT00205777|588558850|FG001|Study Extension II|Enrolled but not treated|0|||
162960633|NCT00205777|588558851|FG002|Study Extension II|Enrolled but not treated|0|||
162960634|NCT00205777|588558852|FG003|Study Extension II|Enrolled but not treated|71|||
162960635|NCT00205777|588558853|FG004|Study Extension II|Enrolled but not treated|0|||
162960636|NCT00205777|588558854|FG005|Study Extension II|Enrolled but not treated|131|||
162960637|NCT00700739|588558858|FG000|Overall Study|Lost to Follow-up|4|||
162960638|NCT00700739|588558859|FG001|Overall Study|Lost to Follow-up|4|||
162960639|NCT00003470|588558861|FG000|Overall Study|Not evaluable|6|||
162960640|NCT01794845|588558864|FG000|Overall Study|Withdrawal by Subject|1|||
162960641|NCT01004510|588558868|FG000|Overall Study|Adverse Event|1|||
162960642|NCT02911025|588558870|FG000|Overall Study|Lost to Follow-up|3|||
162960643|NCT00436163|588558871|FG000|Overall Study|Lost to Follow-up|2|||
162960644|NCT00436163|588558871|FG000|Overall Study|Adverse Event|1|||
162960645|NCT02597049|588558872|FG000|Overall Study|Lost to Follow-up|0|||
162960646|NCT02597049|588558873|FG001|Overall Study|Lost to Follow-up|3|||
162960647|NCT02597049|588558874|FG002|Overall Study|Lost to Follow-up|2|||
162960648|NCT02597049|588558872|FG000|Overall Study|Withdrawal by Subject|2|||
162960649|NCT02597049|588558873|FG001|Overall Study|Withdrawal by Subject|2|||
162960650|NCT02597049|588558874|FG002|Overall Study|Withdrawal by Subject|1|||
162960651|NCT02597049|588558872|FG000|Overall Study|Adverse Event|2|||
162960652|NCT02597049|588558873|FG001|Overall Study|Adverse Event|0|||
162960653|NCT02597049|588558874|FG002|Overall Study|Adverse Event|0|||
162960654|NCT02597049|588558872|FG000|Overall Study|Death|2|||
162960655|NCT02597049|588558873|FG001|Overall Study|Death|0|||
162960656|NCT02597049|588558874|FG002|Overall Study|Death|0|||
162960657|NCT02597049|588558872|FG000|Overall Study|Noncompliant with Study Visits|1|||
162960658|NCT02597049|588558873|FG001|Overall Study|Noncompliant with Study Visits|0|||
162960659|NCT02597049|588558874|FG002|Overall Study|Noncompliant with Study Visits|0|||
162960660|NCT06647173|588558880|FG000|Overall Study|Lost to Follow-up|24|||
162960661|NCT02923349|588558881|FG000|Overall Study|Other|1|||
162960662|NCT02923349|588558882|FG001|Overall Study|Other|2|||
162960663|NCT02923349|588558883|FG002|Overall Study|Other|4|||
162960664|NCT02923349|588558884|FG003|Overall Study|Other|1|||
162960665|NCT02923349|588558885|FG004|Overall Study|Other|3|||
162960666|NCT02923349|588558886|FG005|Overall Study|Other|0|||
162960667|NCT02923349|588558887|FG006|Overall Study|Other|1|||
162960668|NCT02923349|588558881|FG000|Overall Study|Withdrawal by Subject|2|||
162960669|NCT02923349|588558882|FG001|Overall Study|Withdrawal by Subject|2|||
162960670|NCT02923349|588558883|FG002|Overall Study|Withdrawal by Subject|8|||
162960671|NCT02923349|588558884|FG003|Overall Study|Withdrawal by Subject|10|||
162960672|NCT02923349|588558885|FG004|Overall Study|Withdrawal by Subject|12|||
162960673|NCT02923349|588558886|FG005|Overall Study|Withdrawal by Subject|3|||
162960674|NCT02923349|588558887|FG006|Overall Study|Withdrawal by Subject|0|||
162960675|NCT02923349|588558881|FG000|Overall Study|Physician Decision|0|||
162960676|NCT02923349|588558882|FG001|Overall Study|Physician Decision|0|||
162960677|NCT02923349|588558883|FG002|Overall Study|Physician Decision|0|||
162960678|NCT02923349|588558884|FG003|Overall Study|Physician Decision|1|||
162960679|NCT02923349|588558885|FG004|Overall Study|Physician Decision|1|||
162960680|NCT02923349|588558886|FG005|Overall Study|Physician Decision|0|||
162960681|NCT02923349|588558887|FG006|Overall Study|Physician Decision|2|||
162960682|NCT02923349|588558881|FG000|Overall Study|Lost to Follow-up|0|||
162960683|NCT02923349|588558882|FG001|Overall Study|Lost to Follow-up|0|||
162870518|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
162870519|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
162870520|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
162870521|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
162870522|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
162870523|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
162870524|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
162870525|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
162870526|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
162870527|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
162870528|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
162870529|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
162870530|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
162870531|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Other|0|||
162870532|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Other|1|||
162870533|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Other|0|||
162870534|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Other|0|||
162870535|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Other|0|||
162870536|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Other|0|||
162870537|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Other|0|||
162870538|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
162870539|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
162870540|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
162870541|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
162870542|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
162870543|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
162870544|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
162870545|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
162870546|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
162870547|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
162870548|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
162870549|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
162870550|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
162706649|NCT04955626|587636686|FG030|Blinded Period|Refused further study procedures|0|||
162706650|NCT04955626|587636687|FG031|Blinded Period|Refused further study procedures|0|||
162706651|NCT04955626|587636688|FG032|Blinded Period|Refused further study procedures|0|||
162706652|NCT04955626|587636689|FG033|Blinded Period|Refused further study procedures|0|||
162706653|NCT04955626|587636690|FG034|Blinded Period|Refused further study procedures|0|||
162706654|NCT04955626|587636691|FG035|Blinded Period|Refused further study procedures|0|||
162706655|NCT04955626|587636656|FG000|Blinded Period|Participants entered open label period|4544|||
162706656|NCT04955626|587636657|FG001|Blinded Period|Participants entered open label period|4906|||
162706657|NCT04955626|587636658|FG002|Blinded Period|Participants entered open label period|0|||
162706658|NCT04955626|587636659|FG003|Blinded Period|Participants entered open label period|0|||
162706659|NCT04955626|587636660|FG004|Blinded Period|Participants entered open label period|0|||
162706660|NCT04955626|587636661|FG005|Blinded Period|Participants entered open label period|0|||
162706661|NCT04955626|587636662|FG006|Blinded Period|Participants entered open label period|0|||
162706662|NCT04955626|587636663|FG007|Blinded Period|Participants entered open label period|0|||
162706663|NCT04955626|587636664|FG008|Blinded Period|Participants entered open label period|0|||
162706664|NCT04955626|587636665|FG009|Blinded Period|Participants entered open label period|0|||
162706665|NCT04955626|587636666|FG010|Blinded Period|Participants entered open label period|0|||
162706666|NCT04955626|587636667|FG011|Blinded Period|Participants entered open label period|0|||
162706667|NCT04955626|587636668|FG012|Blinded Period|Participants entered open label period|0|||
162706668|NCT04955626|587636669|FG013|Blinded Period|Participants entered open label period|0|||
162706669|NCT04955626|587636670|FG014|Blinded Period|Participants entered open label period|0|||
162870551|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
162870552|NCT00365716|588229125|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
162870553|NCT00365716|588229126|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
162870554|NCT00365716|588229127|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
162870555|NCT00365716|588229128|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
162870556|NCT00365716|588229129|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
162870557|NCT00365716|588229130|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
162870558|NCT00365716|588229131|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
162870559|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
162870560|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
162870561|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
162870562|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
162870563|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
162870564|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
162870565|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
162870566|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
162870567|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
162870568|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
162870569|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
162870570|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
162870571|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
162870572|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
162870573|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
162870574|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
162870575|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
162870576|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
162870577|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
162870578|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
162870579|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
162870580|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
162870581|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
162870582|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
162870583|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
162870584|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
162870585|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
162870586|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
162870587|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
162870588|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
162870589|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
162870590|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
162870591|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
162870592|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
162870593|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
162870594|NCT00365716|588229125|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
162870595|NCT00365716|588229126|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
162870596|NCT00365716|588229127|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
162870597|NCT00365716|588229128|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
162870598|NCT00365716|588229129|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
162870599|NCT00365716|588229130|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
162870600|NCT00365716|588229131|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
162870601|NCT00365716|588229125|FG000|Extension 1|Lost to Follow-up|0|||
162870602|NCT00365716|588229126|FG001|Extension 1|Lost to Follow-up|0|||
162870603|NCT00365716|588229127|FG002|Extension 1|Lost to Follow-up|0|||
162870604|NCT00365716|588229128|FG003|Extension 1|Lost to Follow-up|0|||
162870605|NCT00365716|588229129|FG004|Extension 1|Lost to Follow-up|0|||
162870606|NCT00365716|588229130|FG005|Extension 1|Lost to Follow-up|1|||
162870607|NCT00365716|588229131|FG006|Extension 1|Lost to Follow-up|0|||
162870608|NCT00365716|588229125|FG000|Extension 1|Other|0|||
162870609|NCT00365716|588229126|FG001|Extension 1|Other|0|||
162870610|NCT00365716|588229127|FG002|Extension 1|Other|0|||
162870611|NCT00365716|588229128|FG003|Extension 1|Other|0|||
162870612|NCT00365716|588229129|FG004|Extension 1|Other|0|||
162870613|NCT00365716|588229130|FG005|Extension 1|Other|9|||
162870614|NCT00365716|588229131|FG006|Extension 1|Other|0|||
162870615|NCT00365716|588229125|FG000|Extension 1|Moved|0|||
162870616|NCT00365716|588229126|FG001|Extension 1|Moved|0|||
162870617|NCT00365716|588229127|FG002|Extension 1|Moved|0|||
162870618|NCT00365716|588229128|FG003|Extension 1|Moved|0|||
162870619|NCT00365716|588229129|FG004|Extension 1|Moved|0|||
162870620|NCT00365716|588229130|FG005|Extension 1|Moved|4|||
162870621|NCT00365716|588229131|FG006|Extension 1|Moved|0|||
162960684|NCT02923349|588558883|FG002|Overall Study|Lost to Follow-up|3|||
162960685|NCT02923349|588558884|FG003|Overall Study|Lost to Follow-up|0|||
162960686|NCT02923349|588558885|FG004|Overall Study|Lost to Follow-up|1|||
162960687|NCT02923349|588558886|FG005|Overall Study|Lost to Follow-up|1|||
162870622|NCT00365716|588229125|FG000|Extension 1|Withdrawal by Subject|0|||
162870623|NCT00365716|588229126|FG001|Extension 1|Withdrawal by Subject|0|||
162870624|NCT00365716|588229127|FG002|Extension 1|Withdrawal by Subject|0|||
162870625|NCT00365716|588229128|FG003|Extension 1|Withdrawal by Subject|0|||
162870626|NCT00365716|588229129|FG004|Extension 1|Withdrawal by Subject|0|||
162870627|NCT00365716|588229130|FG005|Extension 1|Withdrawal by Subject|3|||
162870628|NCT00365716|588229131|FG006|Extension 1|Withdrawal by Subject|0|||
162870629|NCT00365716|588229125|FG000|Extension 1|Pregnancy|0|||
162870630|NCT00365716|588229126|FG001|Extension 1|Pregnancy|0|||
162870631|NCT00365716|588229127|FG002|Extension 1|Pregnancy|0|||
162960688|NCT02923349|588558887|FG006|Overall Study|Lost to Follow-up|0|||
162614866|NCT01912963|587307397|FG002|Overall Study|Adverse Event|1|||
162870632|NCT00365716|588229128|FG003|Extension 1|Pregnancy|0|||
162870633|NCT00365716|588229129|FG004|Extension 1|Pregnancy|0|||
162870634|NCT00365716|588229130|FG005|Extension 1|Pregnancy|4|||
162870635|NCT00365716|588229131|FG006|Extension 1|Pregnancy|0|||
162870636|NCT00365716|588229125|FG000|Extension 1|Protocol Violation|0|||
162870637|NCT00365716|588229126|FG001|Extension 1|Protocol Violation|0|||
162870638|NCT00365716|588229127|FG002|Extension 1|Protocol Violation|0|||
162870639|NCT00365716|588229128|FG003|Extension 1|Protocol Violation|0|||
162870640|NCT00365716|588229129|FG004|Extension 1|Protocol Violation|0|||
162870641|NCT00365716|588229130|FG005|Extension 1|Protocol Violation|1|||
162870642|NCT00365716|588229131|FG006|Extension 1|Protocol Violation|0|||
162870643|NCT00365716|588229125|FG000|Extension 2|Lost to Follow-up|0|||
162870644|NCT00365716|588229126|FG001|Extension 2|Lost to Follow-up|0|||
162870645|NCT00365716|588229127|FG002|Extension 2|Lost to Follow-up|0|||
162870646|NCT00365716|588229128|FG003|Extension 2|Lost to Follow-up|0|||
162870647|NCT00365716|588229129|FG004|Extension 2|Lost to Follow-up|0|||
162870648|NCT00365716|588229130|FG005|Extension 2|Lost to Follow-up|0|||
162870649|NCT00365716|588229131|FG006|Extension 2|Lost to Follow-up|2|||
162870650|NCT00365716|588229125|FG000|Extension 2|Other|0|||
162870651|NCT00365716|588229126|FG001|Extension 2|Other|0|||
162870652|NCT00365716|588229127|FG002|Extension 2|Other|0|||
162870653|NCT00365716|588229128|FG003|Extension 2|Other|0|||
162870654|NCT00365716|588229129|FG004|Extension 2|Other|0|||
162870655|NCT00365716|588229130|FG005|Extension 2|Other|0|||
162870656|NCT00365716|588229131|FG006|Extension 2|Other|3|||
162870657|NCT00365716|588229125|FG000|Extension 2|Withdrawal by Subject|0|||
162870658|NCT00365716|588229126|FG001|Extension 2|Withdrawal by Subject|0|||
162870659|NCT00365716|588229127|FG002|Extension 2|Withdrawal by Subject|0|||
162870660|NCT00365716|588229128|FG003|Extension 2|Withdrawal by Subject|0|||
162870661|NCT00365716|588229129|FG004|Extension 2|Withdrawal by Subject|0|||
162870662|NCT00365716|588229130|FG005|Extension 2|Withdrawal by Subject|0|||
162870663|NCT00365716|588229131|FG006|Extension 2|Withdrawal by Subject|5|||
162870664|NCT00751101|588229132|FG000|Overall Study|Withdrawal by Subject|1|||
162870665|NCT00751101|588229133|FG001|Overall Study|Withdrawal by Subject|0|||
162870666|NCT00751101|588229132|FG000|Overall Study|No HFS / Never Started Patch/|0|||
162870667|NCT00751101|588229133|FG001|Overall Study|No HFS / Never Started Patch/|4|||
162870668|NCT00751101|588229132|FG000|Overall Study|Never began capecitabine|1|||
162870669|NCT00751101|588229133|FG001|Overall Study|Never began capecitabine|0|||
162870670|NCT00751101|588229132|FG000|Overall Study|Physician Decision|0|||
162870671|NCT00751101|588229133|FG001|Overall Study|Physician Decision|1|||
162870672|NCT00789477|588229137|FG000|Overall Study|Withdrawal by Subject|2|||
162870673|NCT00789477|588229138|FG001|Overall Study|Withdrawal by Subject|1|||
162870674|NCT00789477|588229139|FG002|Overall Study|Withdrawal by Subject|3|||
162870675|NCT00789477|588229140|FG003|Overall Study|Withdrawal by Subject|2|||
162870676|NCT00789477|588229141|FG004|Overall Study|Withdrawal by Subject|3|||
162870677|NCT00789477|588229137|FG000|Overall Study|Protocol Violation|1|||
162870678|NCT00789477|588229138|FG001|Overall Study|Protocol Violation|0|||
162870679|NCT00789477|588229139|FG002|Overall Study|Protocol Violation|0|||
162870680|NCT00789477|588229140|FG003|Overall Study|Protocol Violation|1|||
162870681|NCT00789477|588229141|FG004|Overall Study|Protocol Violation|0|||
162870682|NCT00789477|588229137|FG000|Overall Study|Adverse Event|3|||
162870683|NCT00789477|588229138|FG001|Overall Study|Adverse Event|3|||
162870684|NCT00789477|588229139|FG002|Overall Study|Adverse Event|1|||
162870685|NCT00789477|588229140|FG003|Overall Study|Adverse Event|0|||
162870686|NCT00789477|588229141|FG004|Overall Study|Adverse Event|0|||
162870687|NCT00789477|588229137|FG000|Overall Study|Death|1|||
162870688|NCT00789477|588229138|FG001|Overall Study|Death|1|||
162870689|NCT00789477|588229139|FG002|Overall Study|Death|2|||
162870690|NCT00789477|588229140|FG003|Overall Study|Death|2|||
162870691|NCT00789477|588229141|FG004|Overall Study|Death|0|||
162870692|NCT00789477|588229137|FG000|Overall Study|Lost to Follow-up|0|||
162870693|NCT00789477|588229138|FG001|Overall Study|Lost to Follow-up|1|||
162870694|NCT00789477|588229139|FG002|Overall Study|Lost to Follow-up|4|||
162870695|NCT00789477|588229140|FG003|Overall Study|Lost to Follow-up|2|||
162870696|NCT00789477|588229141|FG004|Overall Study|Lost to Follow-up|4|||
162870697|NCT00789477|588229137|FG000|Overall Study|Lack of Efficacy|2|||
162870698|NCT00789477|588229138|FG001|Overall Study|Lack of Efficacy|0|||
162870699|NCT00789477|588229139|FG002|Overall Study|Lack of Efficacy|0|||
162870700|NCT00789477|588229140|FG003|Overall Study|Lack of Efficacy|0|||
162870701|NCT00789477|588229141|FG004|Overall Study|Lack of Efficacy|0|||
162870702|NCT00789477|588229137|FG000|Overall Study|Other|2|||
162870703|NCT00789477|588229138|FG001|Overall Study|Other|0|||
162870704|NCT00789477|588229139|FG002|Overall Study|Other|1|||
162870705|NCT00789477|588229140|FG003|Overall Study|Other|3|||
162870706|NCT00789477|588229141|FG004|Overall Study|Other|0|||
162870707|NCT00455858|588229142|FG000|Overall Study|Lost to Follow-up|2|||
162870708|NCT00455858|588229142|FG000|Overall Study|Protocol Violation|1|||
162870709|NCT00455858|588229142|FG000|Overall Study|Lack of Efficacy|1|||
162870710|NCT00455858|588229142|FG000|Overall Study|Well controlled FPG without insulin|1|||
162870711|NCT00455858|588229142|FG000|Overall Study|Withdrawal|1|||
162870712|NCT02092389|588229143|FG000|Overall Study|Adverse Event|1|||
162870713|NCT02092389|588229143|FG000|Overall Study|Other|5|||
162870714|NCT01242020|588229144|FG000|Overall Study|Withdrawal by Subject|2|||
162870715|NCT01242020|588229145|FG001|Overall Study|Withdrawal by Subject|0|||
162870716|NCT01242020|588229144|FG000|Overall Study|Failed screening|1|||
162870717|NCT01242020|588229145|FG001|Overall Study|Failed screening|0|||
162870718|NCT02680847|588229146|FG000|Overall Study|Other|2|||
162870719|NCT02680847|588229147|FG001|Overall Study|Other|0|||
162870720|NCT02680847|588229148|FG002|Overall Study|Other|0|||
162870721|NCT02680847|588229146|FG000|Overall Study|No longer met eligibility criteria|2|||
162870722|NCT02680847|588229147|FG001|Overall Study|No longer met eligibility criteria|2|||
162870723|NCT02680847|588229148|FG002|Overall Study|No longer met eligibility criteria|0|||
162870724|NCT02680847|588229146|FG000|Overall Study|Unwilling to participate in study|1|||
162870725|NCT02680847|588229147|FG001|Overall Study|Unwilling to participate in study|1|||
162870726|NCT02680847|588229148|FG002|Overall Study|Unwilling to participate in study|0|||
162870727|NCT02680847|588229146|FG000|Overall Study|Lack of Efficacy|0|||
162870728|NCT02680847|588229147|FG001|Overall Study|Lack of Efficacy|0|||
162870729|NCT02680847|588229148|FG002|Overall Study|Lack of Efficacy|2|||
162870730|NCT02680847|588229146|FG000|Overall Study|Adverse Event|0|||
162870731|NCT02680847|588229147|FG001|Overall Study|Adverse Event|0|||
162870732|NCT02680847|588229148|FG002|Overall Study|Adverse Event|1|||
162870733|NCT02375698|588229149|FG000|Overall Study|Withdrawal by Subject|0|||
162870734|NCT02375698|588229150|FG001|Overall Study|Withdrawal by Subject|2|||
162870735|NCT02375698|588229149|FG000|Overall Study|Physician Decision|2|||
162870736|NCT02375698|588229150|FG001|Overall Study|Physician Decision|0|||
162870737|NCT00530712|588229161|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
162870738|NCT00530712|588229161|FG000|30 Day Follow-up Visit|Missed Visit|5|||
162870739|NCT00530712|588229161|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
162870740|NCT00530712|588229161|FG000|6 Month Follow-up Visit|Missed Visit|3|||
162870741|NCT00530712|588229161|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
162870742|NCT00530712|588229161|FG000|6 Month Follow-up Visit|Death|2|||
162870743|NCT00530712|588229161|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
162870744|NCT00530712|588229161|FG000|12 Month Follow-up Visit|Missed Visit|3|||
162870745|NCT00530712|588229161|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
162870746|NCT00530712|588229161|FG000|12 Month Follow-up Visit|Death|9|||
162870747|NCT02749370|588229164|FG000|Overall Study|Withdrawal by Subject|11|||
162870748|NCT02749370|588229164|FG000|Overall Study|Lost to Follow-up|3|||
162870749|NCT03242759|588229166|FG000|Overall Study|Adverse Event|5|||
162870750|NCT03242759|588229167|FG001|Overall Study|Adverse Event|1|||
162870751|NCT03242759|588229166|FG000|Overall Study|Withdrawal by Subject|4|||
162870752|NCT03242759|588229167|FG001|Overall Study|Withdrawal by Subject|3|||
162870753|NCT03242759|588229166|FG000|Overall Study|Lost to Follow-up|3|||
162870754|NCT03242759|588229167|FG001|Overall Study|Lost to Follow-up|1|||
162870755|NCT03242759|588229166|FG000|Overall Study|Administrative problems|1|||
162870756|NCT03242759|588229167|FG001|Overall Study|Administrative problems|1|||
162870757|NCT03242759|588229166|FG000|Overall Study|Death|22|||
162870758|NCT03242759|588229167|FG001|Overall Study|Death|0|||
162870759|NCT03242759|588229166|FG000|Overall Study|Change visit schedule|0|||
162870760|NCT03242759|588229167|FG001|Overall Study|Change visit schedule|1|||
162870761|NCT01096550|588229170|FG000|Overall Study|discontinued site|10|||
162870762|NCT01096550|588229171|FG001|Overall Study|discontinued site|11|||
162870763|NCT01096550|588229170|FG000|Overall Study|non-regular treatment track at clinic|1|||
162870764|NCT01096550|588229171|FG001|Overall Study|non-regular treatment track at clinic|1|||
162870765|NCT01096550|588229170|FG000|Overall Study|clinic readmission|1|||
162870766|NCT01096550|588229171|FG001|Overall Study|clinic readmission|1|||
162870767|NCT01096550|588229170|FG000|Overall Study|Withdrawal by Subject|0|||
162870768|NCT01096550|588229171|FG001|Overall Study|Withdrawal by Subject|1|||
162870769|NCT01096550|588229170|FG000|Overall Study|non-African American participant|13|||
163047013|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047014|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047015|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163047016|NCT02326272|588879354|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047017|NCT02326272|588879355|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047018|NCT02326272|588879356|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047019|NCT02326272|588879357|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047020|NCT02326272|588879358|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
162870770|NCT01096550|588229171|FG001|Overall Study|non-African American participant|6|||
162870771|NCT01096550|588229170|FG000|Overall Study|Lost to Follow-up|12|||
162870772|NCT01096550|588229171|FG001|Overall Study|Lost to Follow-up|9|||
162870773|NCT00651118|588229172|FG000|Overall Study|Adverse Event|4|||
162870774|NCT00651118|588229173|FG001|Overall Study|Adverse Event|0|||
162870775|NCT00651118|588229174|FG002|Overall Study|Adverse Event|1|||
162870776|NCT00651118|588229175|FG003|Overall Study|Adverse Event|1|||
162870777|NCT00651118|588229172|FG000|Overall Study|Protocol Violation|2|||
162870778|NCT00651118|588229173|FG001|Overall Study|Protocol Violation|2|||
162870779|NCT00651118|588229174|FG002|Overall Study|Protocol Violation|6|||
162870780|NCT00651118|588229175|FG003|Overall Study|Protocol Violation|2|||
162870781|NCT00651118|588229172|FG000|Overall Study|Lost to Follow-up|2|||
162870782|NCT00651118|588229173|FG001|Overall Study|Lost to Follow-up|0|||
162870783|NCT00651118|588229174|FG002|Overall Study|Lost to Follow-up|1|||
162870784|NCT00651118|588229175|FG003|Overall Study|Lost to Follow-up|2|||
162870785|NCT00651118|588229172|FG000|Overall Study|administrative|1|||
162870786|NCT00651118|588229173|FG001|Overall Study|administrative|4|||
162870787|NCT00651118|588229174|FG002|Overall Study|administrative|2|||
162870788|NCT00651118|588229175|FG003|Overall Study|administrative|1|||
162870789|NCT00651118|588229172|FG000|Overall Study|Withdrawal by Subject|0|||
162870790|NCT00651118|588229173|FG001|Overall Study|Withdrawal by Subject|1|||
162870791|NCT00651118|588229174|FG002|Overall Study|Withdrawal by Subject|1|||
162870792|NCT00651118|588229175|FG003|Overall Study|Withdrawal by Subject|1|||
162870793|NCT03117049|588229176|FG000|Overall Study|Continued the follow-up period|109|||
162870794|NCT03117049|588229177|FG001|Overall Study|Continued the follow-up period|129|||
162870795|NCT03117049|588229176|FG000|Overall Study|Died|82|||
162870796|NCT03117049|588229177|FG001|Overall Study|Died|93|||
162870797|NCT03117049|588229176|FG000|Overall Study|Consent withdrawal|7|||
162870798|NCT03117049|588229177|FG001|Overall Study|Consent withdrawal|6|||
162870799|NCT03117049|588229176|FG000|Overall Study|Missing contact|3|||
162870800|NCT03117049|588229177|FG001|Overall Study|Missing contact|3|||
162870801|NCT00839098|588229180|FG000|Overall Study|Withdrawal by Subject|2|||
162870802|NCT00839098|588229181|FG001|Overall Study|Withdrawal by Subject|1|||
162870803|NCT00839098|588229182|FG002|Overall Study|Withdrawal by Subject|7|||
162870804|NCT01345786|588229183|FG000|Overall Study|Adverse Event|0|||
162870805|NCT01345786|588229184|FG001|Overall Study|Adverse Event|1|||
162870806|NCT01345786|588229185|FG002|Overall Study|Adverse Event|3|||
162870807|NCT01345786|588229186|FG003|Overall Study|Adverse Event|1|||
162870808|NCT01345786|588229183|FG000|Overall Study|Subject withdrew consent|2|||
162870809|NCT01345786|588229184|FG001|Overall Study|Subject withdrew consent|2|||
162870810|NCT01345786|588229185|FG002|Overall Study|Subject withdrew consent|1|||
162870811|NCT01345786|588229186|FG003|Overall Study|Subject withdrew consent|0|||
162870812|NCT01345786|588229183|FG000|Overall Study|Noncompliance with protocol|1|||
162870813|NCT01345786|588229184|FG001|Overall Study|Noncompliance with protocol|0|||
162870814|NCT01345786|588229185|FG002|Overall Study|Noncompliance with protocol|1|||
162870815|NCT01345786|588229186|FG003|Overall Study|Noncompliance with protocol|0|||
162870816|NCT01345786|588229183|FG000|Overall Study|Administrative|3|||
162870817|NCT01345786|588229184|FG001|Overall Study|Administrative|5|||
162870818|NCT01345786|588229185|FG002|Overall Study|Administrative|0|||
162870819|NCT01345786|588229186|FG003|Overall Study|Administrative|0|||
162870820|NCT01345786|588229183|FG000|Overall Study|Lost to Follow-up|0|||
162870821|NCT01345786|588229184|FG001|Overall Study|Lost to Follow-up|0|||
162870822|NCT01345786|588229185|FG002|Overall Study|Lost to Follow-up|0|||
162870823|NCT01345786|588229186|FG003|Overall Study|Lost to Follow-up|2|||
162870824|NCT02190435|588229187|FG000|Overall Study|First 12 patients were lead-ins|12|||
162870825|NCT02190435|588229188|FG001|Overall Study|First 12 patients were lead-ins|0|||
162870826|NCT02190435|588229187|FG000|Overall Study|3 consented screen fails|3|||
162870827|NCT02190435|588229188|FG001|Overall Study|3 consented screen fails|0|||
162870828|NCT02399475|588229197|FG000|Overall Study|Physician Decision|1|||
162870829|NCT02399475|588229198|FG001|Overall Study|Physician Decision|0|||
162870830|NCT02260193|588229199|FG000|Overall Study|Lack of Efficacy|0|||
162870831|NCT02260193|588229200|FG001|Overall Study|Lack of Efficacy|1|||
162870832|NCT02260193|588229201|FG002|Overall Study|Lack of Efficacy|6|||
162870833|NCT02260193|588229199|FG000|Overall Study|Adverse Event|3|||
162870834|NCT02260193|588229200|FG001|Overall Study|Adverse Event|4|||
162870835|NCT02260193|588229201|FG002|Overall Study|Adverse Event|1|||
162870836|NCT02260193|588229199|FG000|Overall Study|Protocol Violation|0|||
162870837|NCT02260193|588229200|FG001|Overall Study|Protocol Violation|4|||
162870838|NCT02260193|588229201|FG002|Overall Study|Protocol Violation|0|||
162870839|NCT02260193|588229199|FG000|Overall Study|Withdrawal by Subject|3|||
162870840|NCT02260193|588229200|FG001|Overall Study|Withdrawal by Subject|0|||
162870841|NCT02260193|588229201|FG002|Overall Study|Withdrawal by Subject|2|||
162870842|NCT02260193|588229199|FG000|Overall Study|Kidney Transplantation|0|||
162870843|NCT02260193|588229200|FG001|Overall Study|Kidney Transplantation|0|||
162870844|NCT02260193|588229201|FG002|Overall Study|Kidney Transplantation|1|||
162870845|NCT01963117|588229202|FG000|Overall Study|Death|1|||
162870846|NCT01070784|588229203|FG000|Overall Study|Withdrawal by Subject|6|||
162870847|NCT01070784|588229204|FG001|Overall Study|Withdrawal by Subject|9|||
162870848|NCT01070784|588229203|FG000|Overall Study|Adverse Event|14|||
162870849|NCT01070784|588229204|FG001|Overall Study|Adverse Event|9|||
162870850|NCT01780389|588229205|FG000|Overall Study|Adverse Event|1|||
162870851|NCT00935220|588229206|FG000|Overall Study|Adverse Event|1|||
162870852|NCT00935220|588229206|FG000|Overall Study|Other reason (not specified)|1|||
162870853|NCT01095250|588229207|FG000|Overall Study|administrative reasons|8|||
162870854|NCT01095250|588229208|FG001|Overall Study|administrative reasons|10|||
162870855|NCT01095250|588229209|FG002|Overall Study|administrative reasons|7|||
162870856|NCT01095250|588229210|FG003|Overall Study|administrative reasons|5|||
162870857|NCT01095250|588229207|FG000|Overall Study|Withdrawal by Subject|0|||
162870858|NCT01095250|588229208|FG001|Overall Study|Withdrawal by Subject|0|||
162870859|NCT01095250|588229209|FG002|Overall Study|Withdrawal by Subject|1|||
162870860|NCT01095250|588229210|FG003|Overall Study|Withdrawal by Subject|0|||
162870861|NCT01000064|588229211|FG000|Overall Study|Withdrawal by Subject|1|||
162870862|NCT01000064|588229212|FG001|Overall Study|Withdrawal by Subject|1|||
162870863|NCT02518620|588229213|FG000|Overall Study|Adverse Event|23|||
162870864|NCT02518620|588229214|FG001|Overall Study|Adverse Event|11|||
162870865|NCT02518620|588229213|FG000|Overall Study|Lack of Efficacy|2|||
162870866|NCT02518620|588229214|FG001|Overall Study|Lack of Efficacy|0|||
162870867|NCT02518620|588229213|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162870868|NCT02518620|588229214|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162870869|NCT02518620|588229213|FG000|Overall Study|Physician Decision|1|||
162870870|NCT02518620|588229214|FG001|Overall Study|Physician Decision|1|||
162870871|NCT02518620|588229213|FG000|Overall Study|Sponsor's Decision|0|||
162870872|NCT02518620|588229214|FG001|Overall Study|Sponsor's Decision|3|||
162870873|NCT02518620|588229213|FG000|Overall Study|Lost to Follow-up|1|||
162870874|NCT02518620|588229214|FG001|Overall Study|Lost to Follow-up|1|||
162870875|NCT02518620|588229213|FG000|Overall Study|Withdrawal by Subject|17|||
162870876|NCT02518620|588229214|FG001|Overall Study|Withdrawal by Subject|9|||
162870877|NCT02518620|588229213|FG000|Overall Study|Death|1|||
162870878|NCT02518620|588229214|FG001|Overall Study|Death|0|||
162870879|NCT02518620|588229213|FG000|Overall Study|Pregnancy Wish|3|||
162870880|NCT02518620|588229214|FG001|Overall Study|Pregnancy Wish|0|||
162870881|NCT02518620|588229213|FG000|Overall Study|Pregnancy|1|||
162870882|NCT02518620|588229214|FG001|Overall Study|Pregnancy|0|||
162870883|NCT02518620|588229213|FG000|Overall Study|Relocation|2|||
162870884|NCT02518620|588229214|FG001|Overall Study|Relocation|1|||
162870885|NCT03844633|588229218|FG000|1 Week FU|Lost to Follow-up|0|||
162870886|NCT03844633|588229219|FG001|1 Week FU|Lost to Follow-up|1|||
162870887|NCT03844633|588229220|FG002|1 Week FU|Lost to Follow-up|4|||
162870888|NCT03844633|588229218|FG000|12-month Follow-up|Lost to Follow-up|7|||
162870889|NCT03844633|588229219|FG001|12-month Follow-up|Lost to Follow-up|5|||
162870890|NCT03844633|588229220|FG002|12-month Follow-up|Lost to Follow-up|8|||
162870891|NCT02588248|588229223|FG000|Overall Study|Physician Decision|4|||
162870892|NCT02588248|588229224|FG001|Overall Study|Physician Decision|3|||
162870893|NCT01355068|588229227|FG000|First Intervention Period|Adverse Event|0|||
162870894|NCT01355068|588229228|FG001|First Intervention Period|Adverse Event|1|||
162870895|NCT01355068|588229227|FG000|First Intervention Period|Withdrawal by Subject|0|||
162870896|NCT01355068|588229228|FG001|First Intervention Period|Withdrawal by Subject|1|||
162870897|NCT00336492|588229231|FG000|Overall Study|Adverse Event|4|||
162870898|NCT00336492|588229232|FG001|Overall Study|Adverse Event|3|||
162614867|NCT01912963|587307395|FG000|Overall Study|Withdrawal by Subject|0|||
162614868|NCT01912963|587307396|FG001|Overall Study|Withdrawal by Subject|1|||
162614869|NCT01912963|587307397|FG002|Overall Study|Withdrawal by Subject|0|||
162614870|NCT01912963|587307395|FG000|Overall Study|Sought treatment locally|0|||
162870899|NCT00336492|588229233|FG002|Overall Study|Adverse Event|6|||
162870900|NCT00336492|588229231|FG000|Overall Study|Lack of Efficacy|6|||
162870901|NCT00336492|588229232|FG001|Overall Study|Lack of Efficacy|1|||
162870902|NCT00336492|588229233|FG002|Overall Study|Lack of Efficacy|4|||
162870903|NCT00336492|588229231|FG000|Overall Study|Other|5|||
162870904|NCT00336492|588229232|FG001|Overall Study|Other|0|||
162870905|NCT00336492|588229233|FG002|Overall Study|Other|1|||
162870906|NCT04229446|588229234|FG000|Overall Study|Death|12|||
162870907|NCT04229446|588229235|FG001|Overall Study|Death|10|||
162870908|NCT04229446|588229234|FG000|Overall Study|Lost to Follow-up|5|||
162870909|NCT04229446|588229235|FG001|Overall Study|Lost to Follow-up|8|||
162870910|NCT01781026|588229236|FG000|Overall Study|Lack of Efficacy|2|||
162870911|NCT00227877|588229237|FG000|Pre-visit Assessment|Technical difficulties|7|||
162870912|NCT00227877|588229238|FG001|Pre-visit Assessment|Technical difficulties|3|||
162870913|NCT00227877|588229239|FG002|Pre-visit Assessment|Technical difficulties|0|||
162870914|NCT00227877|588229240|FG003|Pre-visit Assessment|Technical difficulties|0|||
162870915|NCT00227877|588229237|FG000|Post-visit Checklist|Lost to Follow-up|24|||
162870916|NCT00227877|588229238|FG001|Post-visit Checklist|Lost to Follow-up|13|||
162870917|NCT00227877|588229239|FG002|Post-visit Checklist|Lost to Follow-up|1|||
162870918|NCT00227877|588229240|FG003|Post-visit Checklist|Lost to Follow-up|0|||
162870919|NCT00227877|588229237|FG000|3-months Follow-up|Completed late|135|||
162870920|NCT00227877|588229238|FG001|3-months Follow-up|Completed late|128|||
162870921|NCT00227877|588229239|FG002|3-months Follow-up|Completed late|34|||
162870922|NCT00227877|588229240|FG003|3-months Follow-up|Completed late|8|||
162870923|NCT00227877|588229237|FG000|3-months Follow-up|Lost to Follow-up|178|||
162870924|NCT00227877|588229238|FG001|3-months Follow-up|Lost to Follow-up|139|||
162870925|NCT00227877|588229239|FG002|3-months Follow-up|Lost to Follow-up|18|||
162870926|NCT00227877|588229240|FG003|3-months Follow-up|Lost to Follow-up|13|||
162870927|NCT00227877|588229237|FG000|12-months Follow-up|Completed late|78|||
162870928|NCT00227877|588229238|FG001|12-months Follow-up|Completed late|74|||
162870929|NCT00227877|588229239|FG002|12-months Follow-up|Completed late|1|||
162870930|NCT00227877|588229240|FG003|12-months Follow-up|Completed late|0|||
162870931|NCT00227877|588229237|FG000|12-months Follow-up|Lost to Follow-up|232|||
162870932|NCT00227877|588229238|FG001|12-months Follow-up|Lost to Follow-up|189|||
162870933|NCT00227877|588229239|FG002|12-months Follow-up|Lost to Follow-up|30|||
162870934|NCT00227877|588229240|FG003|12-months Follow-up|Lost to Follow-up|26|||
162870935|NCT03141307|588229241|FG000|In-Hospital|Withdrawal by Subject|0|||
162870936|NCT03141307|588229242|FG001|In-Hospital|Withdrawal by Subject|2|||
162870937|NCT03141307|588229241|FG000|In-Hospital|Protocol Violation|4|||
162870938|NCT03141307|588229242|FG001|In-Hospital|Protocol Violation|0|||
162870939|NCT03141307|588229241|FG000|Follow-Up|Lost to Follow-up|97|||
162870940|NCT03141307|588229242|FG001|Follow-Up|Lost to Follow-up|54|||
162870941|NCT02522481|588229248|FG000|Overall Study|discontinued|1|||
162870942|NCT02522481|588229248|FG000|Overall Study|Not dosed|2|||
162870943|NCT01937130|588231249|FG000|Overall Study|Withdrawal by Subject|0|||
162614871|NCT01912963|587307396|FG001|Overall Study|Sought treatment locally|1|||
162614872|NCT01912963|587307397|FG002|Overall Study|Sought treatment locally|0|||
162870944|NCT01937130|588231250|FG001|Overall Study|Withdrawal by Subject|0|||
162870945|NCT01937130|588231251|FG002|Overall Study|Withdrawal by Subject|0|||
162870946|NCT01937130|588231252|FG003|Overall Study|Withdrawal by Subject|1|||
162870947|NCT01937130|588231249|FG000|Overall Study|Adverse Event|0|||
162870948|NCT01937130|588231250|FG001|Overall Study|Adverse Event|1|||
162870949|NCT01937130|588231251|FG002|Overall Study|Adverse Event|0|||
162870950|NCT01937130|588231252|FG003|Overall Study|Adverse Event|1|||
162870951|NCT01937130|588231249|FG000|Overall Study|Death|1|||
162870952|NCT01937130|588231250|FG001|Overall Study|Death|1|||
162614873|NCT01336569|587307399|FG000|Overall Study|Lost to Follow-up|4|||
162614874|NCT00406354|587307402|FG000|All Randomized Patients|Protocol Violation|0|||
162870953|NCT01937130|588231251|FG002|Overall Study|Death|1|||
162870954|NCT01937130|588231252|FG003|Overall Study|Death|0|||
162870955|NCT01937130|588231249|FG000|Overall Study|Lost to Follow-up|2|||
162870956|NCT01937130|588231250|FG001|Overall Study|Lost to Follow-up|0|||
162870957|NCT01937130|588231251|FG002|Overall Study|Lost to Follow-up|2|||
162870958|NCT01937130|588231252|FG003|Overall Study|Lost to Follow-up|0|||
162870959|NCT01937130|588231249|FG000|Overall Study|Physician Decision|0|||
162870960|NCT01937130|588231250|FG001|Overall Study|Physician Decision|1|||
162870961|NCT01937130|588231251|FG002|Overall Study|Physician Decision|0|||
162870962|NCT01937130|588231252|FG003|Overall Study|Physician Decision|0|||
162870963|NCT01937130|588231249|FG000|Overall Study|Patients unable to swallow|0|||
162870964|NCT01937130|588231250|FG001|Overall Study|Patients unable to swallow|1|||
162870965|NCT01937130|588231251|FG002|Overall Study|Patients unable to swallow|0|||
162870966|NCT01937130|588231252|FG003|Overall Study|Patients unable to swallow|0|||
162870967|NCT01937130|588231249|FG000|Overall Study|Patient lost to FU due to death|2|||
162870968|NCT01937130|588231250|FG001|Overall Study|Patient lost to FU due to death|0|||
162870969|NCT01937130|588231251|FG002|Overall Study|Patient lost to FU due to death|0|||
162870970|NCT01937130|588231252|FG003|Overall Study|Patient lost to FU due to death|0|||
162870971|NCT01431144|588231253|FG000|Overall Study|Implant mobility and removal|2|||
162870972|NCT01431144|588231254|FG001|Overall Study|Implant mobility and removal|0|||
162870973|NCT00747617|588231260|FG000|Overall Study|Lost to Follow-up|3|||
162870974|NCT00747617|588231261|FG001|Overall Study|Lost to Follow-up|1|||
162870975|NCT01746732|588231262|FG000|Lead-In Period|Withdrawal by Subject|1|||
162870976|NCT01746732|588231263|FG001|Lead-In Period|Withdrawal by Subject|0|||
162870977|NCT01746732|588231264|FG002|Lead-In Period|Withdrawal by Subject|0|||
162870978|NCT01746732|588231262|FG000|Period 1|Physician Decision|0|||
162870979|NCT01746732|588231263|FG001|Period 1|Physician Decision|1|||
162870980|NCT01746732|588231264|FG002|Period 1|Physician Decision|0|||
162870981|NCT01746732|588231262|FG000|Period 2|Withdrawal by Subject|0|||
162870982|NCT01746732|588231263|FG001|Period 2|Withdrawal by Subject|0|||
162870983|NCT01746732|588231264|FG002|Period 2|Withdrawal by Subject|2|||
162870984|NCT01746732|588231262|FG000|Period 2|Adverse Event|0|||
162870985|NCT01746732|588231263|FG001|Period 2|Adverse Event|0|||
162870986|NCT01746732|588231264|FG002|Period 2|Adverse Event|1|||
162870987|NCT01746732|588231262|FG000|Period 2|Lost to Follow-up|0|||
162870988|NCT01746732|588231263|FG001|Period 2|Lost to Follow-up|0|||
162870989|NCT01746732|588231264|FG002|Period 2|Lost to Follow-up|1|||
162870990|NCT02817555|588231265|FG000|Overall Study|Death|1|||
162870991|NCT02817555|588231266|FG001|Overall Study|Death|3|||
162870992|NCT02817555|588231265|FG000|Overall Study|moved away|1|||
162870993|NCT02817555|588231266|FG001|Overall Study|moved away|0|||
162870994|NCT02817555|588231265|FG000|Overall Study|transplant|1|||
162870995|NCT02817555|588231266|FG001|Overall Study|transplant|1|||
162870996|NCT02817555|588231265|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
162870997|NCT02817555|588231266|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
162870998|NCT00137436|588231267|FG000|Overall Study|Adverse Event|13|||
162614875|NCT00406354|587307403|FG001|All Randomized Patients|Protocol Violation|0|||
162614876|NCT00406354|587307404|FG002|All Randomized Patients|Protocol Violation|1|||
162614877|NCT00406354|587307402|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
162614878|NCT00406354|587307403|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
162870999|NCT00137436|588231267|FG000|Overall Study|Death|2|||
162871000|NCT00137436|588231267|FG000|Overall Study|Lack of Efficacy|17|||
162871001|NCT00137436|588231267|FG000|Overall Study|Withdrawal by Subject|6|||
162871002|NCT00137436|588231267|FG000|Overall Study|Other|5|||
162871003|NCT04657016|588231268|FG000|Overall Study|Adverse Event|2|||
162871004|NCT04657016|588231269|FG001|Overall Study|Adverse Event|4|||
162871005|NCT04657016|588231268|FG000|Overall Study|Death|1|||
162871006|NCT04657016|588231269|FG001|Overall Study|Death|1|||
162871007|NCT04657016|588231268|FG000|Overall Study|Lost to Follow-up|24|||
162871008|NCT04657016|588231269|FG001|Overall Study|Lost to Follow-up|12|||
162871009|NCT04657016|588231268|FG000|Overall Study|Physician Decision|1|||
162871010|NCT04657016|588231269|FG001|Overall Study|Physician Decision|2|||
162871011|NCT04657016|588231268|FG000|Overall Study|Pregnancy|2|||
162871012|NCT04657016|588231269|FG001|Overall Study|Pregnancy|2|||
162871013|NCT04657016|588231268|FG000|Overall Study|Protocol Deviation|1|||
162871014|NCT04657016|588231269|FG001|Overall Study|Protocol Deviation|0|||
162871015|NCT04657016|588231268|FG000|Overall Study|Withdrawal by Subject|28|||
162871016|NCT04657016|588231269|FG001|Overall Study|Withdrawal by Subject|14|||
162871017|NCT04657016|588231268|FG000|Overall Study|Other - as reported by the investigator|6|||
162871018|NCT04657016|588231269|FG001|Overall Study|Other - as reported by the investigator|0|||
162871019|NCT00701727|588231270|FG000|First Treatment Period|Adverse Event|0|||
162871020|NCT00701727|588231271|FG001|First Treatment Period|Adverse Event|0|||
162871021|NCT00701727|588231270|FG000|First Treatment Period|Withdrawal by Subject|1|||
162871022|NCT00701727|588231271|FG001|First Treatment Period|Withdrawal by Subject|0|||
162871023|NCT00701727|588231270|FG000|First Treatment Period|sponsor decision|0|||
162871024|NCT00701727|588231271|FG001|First Treatment Period|sponsor decision|1|||
162871025|NCT00701727|588231270|FG000|First Treatment Period|Lost to Follow-up|0|||
162871026|NCT00701727|588231271|FG001|First Treatment Period|Lost to Follow-up|1|||
162871027|NCT00701727|588231270|FG000|Second Treatment Period|Withdrawal by Subject|2|||
162871028|NCT00701727|588231271|FG001|Second Treatment Period|Withdrawal by Subject|0|||
162871029|NCT01104558|588231274|FG000|Overall Study|Protocol Violation|6|||
162871030|NCT01104558|588231274|FG000|Overall Study|Missing of primary efficacy assessment|10|||
162871031|NCT01104558|588231274|FG000|Overall Study|Missing of genetic analysis results|1|||
162871032|NCT00696657|588231275|FG000|Overall Study|Protocol Violation|0|||
162871033|NCT00696657|588231276|FG001|Overall Study|Protocol Violation|0|||
162871034|NCT00696657|588231277|FG002|Overall Study|Protocol Violation|0|||
162871035|NCT00696657|588231278|FG003|Overall Study|Protocol Violation|0|||
162871036|NCT00696657|588231279|FG004|Overall Study|Protocol Violation|0|||
162871037|NCT00696657|588231280|FG005|Overall Study|Protocol Violation|1|||
162871038|NCT00696657|588231281|FG006|Overall Study|Protocol Violation|0|||
162871039|NCT00696657|588231282|FG007|Overall Study|Protocol Violation|0|||
162871040|NCT00696657|588231283|FG008|Overall Study|Protocol Violation|1|||
162871041|NCT00696657|588231275|FG000|Overall Study|Lack of Efficacy|0|||
162871042|NCT00696657|588231276|FG001|Overall Study|Lack of Efficacy|1|||
162614879|NCT00406354|587307404|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
162614880|NCT00406354|587307402|FG000|All Randomized and Treated Patients|Adverse Event|6|||
162614881|NCT00406354|587307403|FG001|All Randomized and Treated Patients|Adverse Event|2|||
162614882|NCT00406354|587307404|FG002|All Randomized and Treated Patients|Adverse Event|1|||
162614883|NCT00406354|587307402|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
162614884|NCT00406354|587307403|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
162614885|NCT00406354|587307404|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
162614886|NCT00406354|587307402|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
162614887|NCT00406354|587307403|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
162614888|NCT00406354|587307404|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
162614889|NCT00406354|587307402|FG000|All Randomized and Treated Patients|Physician Decision|0|||
162614890|NCT00406354|587307403|FG001|All Randomized and Treated Patients|Physician Decision|0|||
162871043|NCT00696657|588231277|FG002|Overall Study|Lack of Efficacy|0|||
162871044|NCT00696657|588231278|FG003|Overall Study|Lack of Efficacy|0|||
162871045|NCT00696657|588231279|FG004|Overall Study|Lack of Efficacy|0|||
162871046|NCT00696657|588231280|FG005|Overall Study|Lack of Efficacy|0|||
162871047|NCT00696657|588231281|FG006|Overall Study|Lack of Efficacy|0|||
162871048|NCT00696657|588231282|FG007|Overall Study|Lack of Efficacy|0|||
162871049|NCT00696657|588231283|FG008|Overall Study|Lack of Efficacy|0|||
162871050|NCT00696657|588231275|FG000|Overall Study|Withdrawal criteria|1|||
162871051|NCT00696657|588231276|FG001|Overall Study|Withdrawal criteria|3|||
162871052|NCT00696657|588231277|FG002|Overall Study|Withdrawal criteria|2|||
162614891|NCT00406354|587307404|FG002|All Randomized and Treated Patients|Physician Decision|1|||
162871053|NCT00696657|588231278|FG003|Overall Study|Withdrawal criteria|2|||
162871054|NCT00696657|588231279|FG004|Overall Study|Withdrawal criteria|0|||
162871055|NCT00696657|588231280|FG005|Overall Study|Withdrawal criteria|0|||
162871056|NCT00696657|588231281|FG006|Overall Study|Withdrawal criteria|1|||
162871057|NCT00696657|588231282|FG007|Overall Study|Withdrawal criteria|1|||
162871058|NCT00696657|588231283|FG008|Overall Study|Withdrawal criteria|2|||
162871059|NCT00696657|588231275|FG000|Overall Study|Unclassified|0|||
162871060|NCT00696657|588231276|FG001|Overall Study|Unclassified|1|||
162871061|NCT00696657|588231277|FG002|Overall Study|Unclassified|3|||
162871062|NCT00696657|588231278|FG003|Overall Study|Unclassified|2|||
162871063|NCT00696657|588231279|FG004|Overall Study|Unclassified|4|||
162871064|NCT00696657|588231280|FG005|Overall Study|Unclassified|2|||
162871065|NCT00696657|588231281|FG006|Overall Study|Unclassified|0|||
162871066|NCT00696657|588231282|FG007|Overall Study|Unclassified|0|||
162871067|NCT00696657|588231283|FG008|Overall Study|Unclassified|1|||
162871068|NCT00696657|588231275|FG000|Overall Study|Adverse Event|0|||
162871069|NCT00696657|588231276|FG001|Overall Study|Adverse Event|0|||
162871070|NCT00696657|588231277|FG002|Overall Study|Adverse Event|3|||
162871071|NCT00696657|588231278|FG003|Overall Study|Adverse Event|7|||
162871072|NCT00696657|588231279|FG004|Overall Study|Adverse Event|6|||
162871073|NCT00696657|588231280|FG005|Overall Study|Adverse Event|9|||
162871074|NCT00696657|588231281|FG006|Overall Study|Adverse Event|14|||
162871075|NCT00696657|588231282|FG007|Overall Study|Adverse Event|2|||
162871076|NCT00696657|588231283|FG008|Overall Study|Adverse Event|5|||
162871077|NCT00523341|588231287|FG000|Overall Study|Withdrawal by Subject|399|||
162871078|NCT00523341|588231288|FG001|Overall Study|Withdrawal by Subject|427|||
162871079|NCT00523341|588231287|FG000|Overall Study|Other|181|||
162871080|NCT00523341|588231288|FG001|Overall Study|Other|198|||
162871081|NCT00523341|588231287|FG000|Overall Study|Adverse Event|122|||
163047021|NCT02326272|588879359|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
162614892|NCT03438383|587307421|FG000|Overall Study|Protocol Violation|9|||
162614893|NCT03438383|587307422|FG001|Overall Study|Protocol Violation|3|||
162614894|NCT02435069|587307423|FG000|Dose Response - First Intervention|Adverse Event|0|||
162614895|NCT02435069|587307424|FG001|Dose Response - First Intervention|Adverse Event|1|||
162614896|NCT02435069|587307425|FG002|Dose Response - First Intervention|Adverse Event|1|||
162614897|NCT02435069|587307426|FG003|Dose Response - First Intervention|Adverse Event|0|||
162614898|NCT02435069|587307427|FG004|Dose Response - First Intervention|Adverse Event|0|||
162614899|NCT02435069|587307423|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162614900|NCT02435069|587307424|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162614901|NCT02435069|587307425|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162614902|NCT02435069|587307426|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162614903|NCT02435069|587307427|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
162614904|NCT02030938|587307432|FG000|Overall Study|Lost to Follow-up|4|||
163047022|NCT02326272|588879360|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
163047023|NCT02326272|588879361|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047024|NCT02326272|588879362|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047025|NCT02326272|588879363|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047026|NCT02326272|588879364|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047027|NCT02326272|588879365|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047028|NCT02326272|588879366|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047029|NCT02326272|588879367|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047030|NCT02326272|588879368|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
163047031|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
163047032|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
163047033|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
163047034|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
163047035|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
163047036|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
163047037|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
163047038|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
163047039|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
163047040|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
163047041|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
163047042|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
163047043|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
163047044|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
163047045|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
162614905|NCT02030938|587307432|FG000|Overall Study|Withdrawal by Subject|1|||
162614906|NCT03954132|587307434|FG000|Overall Study|Adverse Event|2|||
162871082|NCT00523341|588231288|FG001|Overall Study|Adverse Event|155|||
162871083|NCT00523341|588231287|FG000|Overall Study|Death|101|||
162871084|NCT00523341|588231288|FG001|Overall Study|Death|110|||
162871085|NCT00523341|588231287|FG000|Overall Study|Lost to Follow-up|73|||
162871086|NCT00523341|588231288|FG001|Overall Study|Lost to Follow-up|61|||
162871087|NCT00523341|588231287|FG000|Overall Study|Non-compliance|20|||
162871088|NCT00523341|588231288|FG001|Overall Study|Non-compliance|13|||
162871089|NCT00523341|588231287|FG000|Overall Study|Physician Decision|14|||
162871090|NCT00523341|588231288|FG001|Overall Study|Physician Decision|13|||
162871091|NCT00523341|588231287|FG000|Overall Study|Requirement for Alternative Therapy|4|||
162960689|NCT02923349|588558881|FG000|Overall Study|Death|1|||
162960690|NCT02923349|588558882|FG001|Overall Study|Death|0|||
162960691|NCT02923349|588558883|FG002|Overall Study|Death|2|||
162960692|NCT02923349|588558884|FG003|Overall Study|Death|4|||
162960693|NCT02923349|588558885|FG004|Overall Study|Death|2|||
162960694|NCT02923349|588558886|FG005|Overall Study|Death|3|||
162960695|NCT02923349|588558887|FG006|Overall Study|Death|0|||
162960696|NCT02751827|588558890|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
162960697|NCT02751827|588558891|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
162960698|NCT02751827|588558892|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
162960699|NCT01248728|588558893|FG000|Overall Study|Adverse Event|1|||
162960700|NCT01248728|588558894|FG001|Overall Study|Adverse Event|1|||
162960701|NCT01248728|588558893|FG000|Overall Study|Withdrawal by Subject|2|||
162960702|NCT01248728|588558894|FG001|Overall Study|Withdrawal by Subject|1|||
162960703|NCT01248728|588558893|FG000|Overall Study|Lack of Efficacy|1|||
162960704|NCT01248728|588558894|FG001|Overall Study|Lack of Efficacy|0|||
162614907|NCT03954132|587307435|FG001|Overall Study|Adverse Event|0|||
162614908|NCT03954132|587307434|FG000|Overall Study|Patient's wish|5|||
162614909|NCT03954132|587307435|FG001|Overall Study|Patient's wish|0|||
162614910|NCT03954132|587307434|FG000|Overall Study|Lost to Follow-up|10|||
162614911|NCT03954132|587307435|FG001|Overall Study|Lost to Follow-up|0|||
162614912|NCT03954132|587307434|FG000|Overall Study|Screening failure|0|||
162614913|NCT03954132|587307435|FG001|Overall Study|Screening failure|1|||
162614914|NCT03954132|587307434|FG000|Overall Study|No registration after Visit 1|5|||
162614915|NCT03954132|587307435|FG001|Overall Study|No registration after Visit 1|2|||
162614916|NCT03954132|587307434|FG000|Overall Study|Other reason than listed|2|||
162614917|NCT03954132|587307435|FG001|Overall Study|Other reason than listed|2|||
162614918|NCT03954132|587307434|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
162614919|NCT03954132|587307435|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
162614920|NCT03954132|587307434|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
162614921|NCT03954132|587307435|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
162614922|NCT00932737|587307438|FG000|Overall Study|Not treated in second episode|1|||
162614923|NCT00932737|587307439|FG001|Overall Study|Not treated in second episode|0|||
162614924|NCT00932737|587307438|FG000|Overall Study|Adverse Event|0|||
162614925|NCT00932737|587307439|FG001|Overall Study|Adverse Event|1|||
162614926|NCT05156073|587307442|FG000|Overall Study|Patient canceled appointment with PCP|1|||
162614927|NCT00973349|587307443|FG000|Overall Study|Adverse Event|0|||
162614928|NCT00973349|587307444|FG001|Overall Study|Adverse Event|0|||
162960705|NCT01841554|588558895|FG000|Overall Study|Death|7|||
162960706|NCT01841554|588558895|FG000|Overall Study|No Implantation|1|||
162960707|NCT01841554|588558895|FG000|Overall Study|Discontinued Follow Up|5|||
162960708|NCT01841554|588558895|FG000|Overall Study|Study exit due to secondary intervention|6|||
163047046|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047047|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047048|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047049|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047050|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047051|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047052|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047053|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047054|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
162960709|NCT01838681|588558896|FG000|Period A|Adverse Event|39|||
162960710|NCT01838681|588558897|FG001|Period A|Adverse Event|0|||
162960711|NCT01838681|588558898|FG002|Period A|Adverse Event|0|||
162960712|NCT01838681|588558899|FG003|Period A|Adverse Event|0|||
162960713|NCT01838681|588558896|FG000|Period A|Lack of Efficacy|21|||
163047055|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047056|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
163047057|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
163047058|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163047059|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163047060|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
163047061|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162614929|NCT00973349|587307445|FG002|Overall Study|Adverse Event|0|||
162614930|NCT00973349|587307446|FG003|Overall Study|Adverse Event|0|||
162960714|NCT01838681|588558897|FG001|Period A|Lack of Efficacy|0|||
162960715|NCT01838681|588558898|FG002|Period A|Lack of Efficacy|0|||
162960716|NCT01838681|588558899|FG003|Period A|Lack of Efficacy|0|||
162960717|NCT01838681|588558896|FG000|Period A|Early response|148|||
162614931|NCT00973349|587307447|FG004|Overall Study|Adverse Event|1|||
162614932|NCT00973349|587307448|FG005|Overall Study|Adverse Event|0|||
162960718|NCT01838681|588558897|FG001|Period A|Early response|0|||
162960719|NCT01838681|588558898|FG002|Period A|Early response|0|||
162960720|NCT01838681|588558899|FG003|Period A|Early response|0|||
162871092|NCT00523341|588231288|FG001|Overall Study|Requirement for Alternative Therapy|14|||
162871093|NCT00523341|588231287|FG000|Overall Study|Protocol Deviation|6|||
162871094|NCT00523341|588231288|FG001|Overall Study|Protocol Deviation|5|||
162871095|NCT00523341|588231287|FG000|Overall Study|Ineligibility Determined|3|||
162871096|NCT00523341|588231288|FG001|Overall Study|Ineligibility Determined|4|||
162871097|NCT00523341|588231287|FG000|Overall Study|Disease Progression|1|||
162871098|NCT00523341|588231288|FG001|Overall Study|Disease Progression|0|||
162871099|NCT02601001|588231291|FG000|Dosing Period 2|Adverse Event|0|||
162871100|NCT02601001|588231292|FG001|Dosing Period 2|Adverse Event|0|||
162871101|NCT02601001|588231293|FG002|Dosing Period 2|Adverse Event|0|||
162871102|NCT02601001|588231294|FG003|Dosing Period 2|Adverse Event|0|||
162871103|NCT02601001|588231295|FG004|Dosing Period 2|Adverse Event|0|||
162871104|NCT02601001|588231296|FG005|Dosing Period 2|Adverse Event|0|||
162871105|NCT02601001|588231297|FG006|Dosing Period 2|Adverse Event|1|||
162871106|NCT00912015|588231298|FG000|Overall Study|Lack of Efficacy|1|||
162871107|NCT00912015|588231299|FG001|Overall Study|Lack of Efficacy|0|||
162871108|NCT00912015|588231300|FG002|Overall Study|Lack of Efficacy|0|||
162871109|NCT00912015|588231301|FG003|Overall Study|Lack of Efficacy|0|||
162871110|NCT00912015|588231298|FG000|Overall Study|Withdrawal by Subject|8|||
162871111|NCT00912015|588231299|FG001|Overall Study|Withdrawal by Subject|8|||
162871112|NCT00912015|588231300|FG002|Overall Study|Withdrawal by Subject|3|||
162871113|NCT00912015|588231301|FG003|Overall Study|Withdrawal by Subject|0|||
162871114|NCT00912015|588231298|FG000|Overall Study|Protocol Violation|1|||
162871115|NCT00912015|588231299|FG001|Overall Study|Protocol Violation|0|||
162871116|NCT00912015|588231300|FG002|Overall Study|Protocol Violation|0|||
162871117|NCT00912015|588231301|FG003|Overall Study|Protocol Violation|1|||
162871118|NCT00912015|588231298|FG000|Overall Study|Adverse Event|6|||
162871119|NCT00912015|588231299|FG001|Overall Study|Adverse Event|0|||
162871120|NCT00912015|588231300|FG002|Overall Study|Adverse Event|0|||
162871121|NCT00912015|588231301|FG003|Overall Study|Adverse Event|1|||
162871122|NCT01790438|588231302|FG000|Overall Study|Adverse Event|3|||
162871123|NCT01790438|588231303|FG001|Overall Study|Adverse Event|2|||
162871124|NCT01790438|588231302|FG000|Overall Study|Death|4|||
162871125|NCT01790438|588231303|FG001|Overall Study|Death|0|||
162871126|NCT01790438|588231302|FG000|Overall Study|Lost to Follow-up|5|||
162871127|NCT01790438|588231303|FG001|Overall Study|Lost to Follow-up|2|||
162871128|NCT01790438|588231302|FG000|Overall Study|Withdrawal by Subject|13|||
162871129|NCT01790438|588231303|FG001|Overall Study|Withdrawal by Subject|2|||
162871130|NCT01790438|588231302|FG000|Overall Study|Physician Decision|3|||
162871131|NCT01790438|588231303|FG001|Overall Study|Physician Decision|1|||
162871132|NCT01790438|588231302|FG000|Overall Study|Sponsor Decision|0|||
162871133|NCT01790438|588231303|FG001|Overall Study|Sponsor Decision|3|||
162871134|NCT01790438|588231302|FG000|Overall Study|Protocol Required Discontinuation|7|||
162871135|NCT01790438|588231303|FG001|Overall Study|Protocol Required Discontinuation|1|||
162871136|NCT01356602|588231306|FG000|Overall Study|Protocol Deviation|0|||
162871137|NCT01356602|588231307|FG001|Overall Study|Protocol Deviation|1|||
162871138|NCT01356602|588231308|FG002|Overall Study|Protocol Deviation|1|||
162871139|NCT01356602|588231306|FG000|Overall Study|Administrative Problems|1|||
162871140|NCT01356602|588231307|FG001|Overall Study|Administrative Problems|4|||
162871141|NCT01356602|588231308|FG002|Overall Study|Administrative Problems|5|||
162871142|NCT01356602|588231306|FG000|Overall Study|Lost to Follow-up|4|||
162871143|NCT01356602|588231307|FG001|Overall Study|Lost to Follow-up|5|||
162871144|NCT01356602|588231308|FG002|Overall Study|Lost to Follow-up|6|||
162871145|NCT01356602|588231306|FG000|Overall Study|Withdrawal by Subject|4|||
162871146|NCT01356602|588231307|FG001|Overall Study|Withdrawal by Subject|3|||
162871147|NCT01356602|588231308|FG002|Overall Study|Withdrawal by Subject|7|||
162614933|NCT00973349|587307449|FG006|Overall Study|Adverse Event|0|||
162614934|NCT00973349|587307450|FG007|Overall Study|Adverse Event|0|||
162614935|NCT00973349|587307451|FG008|Overall Study|Adverse Event|1|||
162614936|NCT00973349|587307452|FG009|Overall Study|Adverse Event|0|||
162614937|NCT00973349|587307453|FG010|Overall Study|Adverse Event|0|||
162614938|NCT00973349|587307454|FG011|Overall Study|Adverse Event|0|||
162614939|NCT00973349|587307455|FG012|Overall Study|Adverse Event|0|||
162614940|NCT00973349|587307456|FG013|Overall Study|Adverse Event|0|||
162614941|NCT00973349|587307457|FG014|Overall Study|Adverse Event|1|||
162614942|NCT00973349|587307458|FG015|Overall Study|Adverse Event|0|||
162614943|NCT00973349|587307443|FG000|Overall Study|Withdrawal by Subject|1|||
162614944|NCT00973349|587307444|FG001|Overall Study|Withdrawal by Subject|2|||
162614945|NCT00973349|587307445|FG002|Overall Study|Withdrawal by Subject|2|||
162614946|NCT00973349|587307446|FG003|Overall Study|Withdrawal by Subject|3|||
162614947|NCT00973349|587307447|FG004|Overall Study|Withdrawal by Subject|2|||
162614948|NCT00973349|587307448|FG005|Overall Study|Withdrawal by Subject|0|||
162614949|NCT00973349|587307449|FG006|Overall Study|Withdrawal by Subject|2|||
162614950|NCT00973349|587307450|FG007|Overall Study|Withdrawal by Subject|2|||
162614951|NCT00973349|587307451|FG008|Overall Study|Withdrawal by Subject|0|||
162614952|NCT00973349|587307452|FG009|Overall Study|Withdrawal by Subject|2|||
162614953|NCT00973349|587307453|FG010|Overall Study|Withdrawal by Subject|0|||
162614954|NCT00973349|587307454|FG011|Overall Study|Withdrawal by Subject|1|||
162614955|NCT00973349|587307455|FG012|Overall Study|Withdrawal by Subject|0|||
162614956|NCT00973349|587307456|FG013|Overall Study|Withdrawal by Subject|0|||
162614957|NCT00973349|587307457|FG014|Overall Study|Withdrawal by Subject|0|||
162614958|NCT00973349|587307458|FG015|Overall Study|Withdrawal by Subject|0|||
162614959|NCT00973349|587307443|FG000|Overall Study|Lost to Follow-up|3|||
162614960|NCT00973349|587307444|FG001|Overall Study|Lost to Follow-up|1|||
162614961|NCT00973349|587307445|FG002|Overall Study|Lost to Follow-up|2|||
162614962|NCT00973349|587307446|FG003|Overall Study|Lost to Follow-up|2|||
162614963|NCT00973349|587307447|FG004|Overall Study|Lost to Follow-up|1|||
162614964|NCT00973349|587307448|FG005|Overall Study|Lost to Follow-up|3|||
162614965|NCT00973349|587307449|FG006|Overall Study|Lost to Follow-up|0|||
162614966|NCT00973349|587307450|FG007|Overall Study|Lost to Follow-up|1|||
162614967|NCT00973349|587307451|FG008|Overall Study|Lost to Follow-up|2|||
162614968|NCT00973349|587307452|FG009|Overall Study|Lost to Follow-up|1|||
162614969|NCT00973349|587307453|FG010|Overall Study|Lost to Follow-up|0|||
162614970|NCT00973349|587307454|FG011|Overall Study|Lost to Follow-up|1|||
162614971|NCT00973349|587307455|FG012|Overall Study|Lost to Follow-up|0|||
162614972|NCT00973349|587307456|FG013|Overall Study|Lost to Follow-up|0|||
162614973|NCT00973349|587307457|FG014|Overall Study|Lost to Follow-up|0|||
162614974|NCT00973349|587307458|FG015|Overall Study|Lost to Follow-up|1|||
162614975|NCT00973349|587307443|FG000|Overall Study|Inappropriate enrolment|0|||
162614976|NCT00973349|587307444|FG001|Overall Study|Inappropriate enrolment|0|||
162614977|NCT00973349|587307445|FG002|Overall Study|Inappropriate enrolment|1|||
162614978|NCT00973349|587307446|FG003|Overall Study|Inappropriate enrolment|0|||
162614979|NCT00973349|587307447|FG004|Overall Study|Inappropriate enrolment|0|||
162614980|NCT00973349|587307448|FG005|Overall Study|Inappropriate enrolment|0|||
162614981|NCT00973349|587307449|FG006|Overall Study|Inappropriate enrolment|0|||
162614982|NCT00973349|587307450|FG007|Overall Study|Inappropriate enrolment|0|||
162614983|NCT00973349|587307451|FG008|Overall Study|Inappropriate enrolment|0|||
162614984|NCT00973349|587307452|FG009|Overall Study|Inappropriate enrolment|2|||
162614985|NCT00973349|587307453|FG010|Overall Study|Inappropriate enrolment|0|||
162614986|NCT00973349|587307454|FG011|Overall Study|Inappropriate enrolment|0|||
162614987|NCT00973349|587307455|FG012|Overall Study|Inappropriate enrolment|1|||
162614988|NCT00973349|587307456|FG013|Overall Study|Inappropriate enrolment|0|||
162614989|NCT00973349|587307457|FG014|Overall Study|Inappropriate enrolment|1|||
162614990|NCT00973349|587307458|FG015|Overall Study|Inappropriate enrolment|1|||
162614991|NCT00973349|587307443|FG000|Overall Study|Protocol Violation|0|||
162614992|NCT00973349|587307444|FG001|Overall Study|Protocol Violation|0|||
162614993|NCT00973349|587307445|FG002|Overall Study|Protocol Violation|0|||
162614994|NCT00973349|587307446|FG003|Overall Study|Protocol Violation|0|||
162614995|NCT00973349|587307447|FG004|Overall Study|Protocol Violation|0|||
162614996|NCT00973349|587307448|FG005|Overall Study|Protocol Violation|0|||
162614997|NCT00973349|587307449|FG006|Overall Study|Protocol Violation|0|||
162614998|NCT00973349|587307450|FG007|Overall Study|Protocol Violation|0|||
162614999|NCT00973349|587307451|FG008|Overall Study|Protocol Violation|1|||
162615000|NCT00973349|587307452|FG009|Overall Study|Protocol Violation|0|||
162615001|NCT00973349|587307453|FG010|Overall Study|Protocol Violation|0|||
162615002|NCT00973349|587307454|FG011|Overall Study|Protocol Violation|0|||
162615003|NCT00973349|587307455|FG012|Overall Study|Protocol Violation|0|||
162615004|NCT00973349|587307456|FG013|Overall Study|Protocol Violation|0|||
162615005|NCT00973349|587307457|FG014|Overall Study|Protocol Violation|0|||
162615006|NCT00973349|587307458|FG015|Overall Study|Protocol Violation|0|||
162615007|NCT00973349|587307443|FG000|Overall Study|Unable to classify|0|||
162615008|NCT00973349|587307444|FG001|Overall Study|Unable to classify|0|||
162615009|NCT00973349|587307445|FG002|Overall Study|Unable to classify|0|||
162615010|NCT00973349|587307446|FG003|Overall Study|Unable to classify|0|||
162615011|NCT00973349|587307447|FG004|Overall Study|Unable to classify|1|||
162871148|NCT01356602|588231306|FG000|Overall Study|Lack of Efficacy|0|||
162871149|NCT01356602|588231307|FG001|Overall Study|Lack of Efficacy|1|||
162871150|NCT01356602|588231308|FG002|Overall Study|Lack of Efficacy|4|||
162871151|NCT01356602|588231306|FG000|Overall Study|Adverse Event|0|||
162871152|NCT01356602|588231307|FG001|Overall Study|Adverse Event|1|||
162871153|NCT01356602|588231308|FG002|Overall Study|Adverse Event|1|||
162615012|NCT00973349|587307448|FG005|Overall Study|Unable to classify|1|||
162871154|NCT03123354|588231309|FG000|Overall Study|Physician Decision|6|||
162871155|NCT01931462|588231310|FG000|Overall Study|Withdrawal by Subject|1|||
162871156|NCT04907539|588231311|FG000|Overall Study|Consent withdrawn|1|||
162871157|NCT04907539|588231312|FG001|Overall Study|Consent withdrawn|0|||
162871158|NCT04907539|588231311|FG000|Overall Study|Death|14|||
162871159|NCT04907539|588231312|FG001|Overall Study|Death|3|||
162871160|NCT01701583|588231313|FG000|Overall Study|Withdrawal by Subject|2|||
162871161|NCT01701583|588231314|FG001|Overall Study|Withdrawal by Subject|0|||
162871162|NCT05070429|588231320|FG000|Overall Study|Death|0|||
162871163|NCT05070429|588231321|FG001|Overall Study|Death|4|||
162871164|NCT05070429|588231320|FG000|Overall Study|Withdrawal by Subject|2|||
162871165|NCT05070429|588231321|FG001|Overall Study|Withdrawal by Subject|1|||
162871166|NCT05070429|588231320|FG000|Overall Study|Other|15|||
162871167|NCT05070429|588231321|FG001|Overall Study|Other|5|||
162871168|NCT03041116|588231322|FG000|Double-blind|Death|0|||
162871169|NCT03041116|588231323|FG001|Double-blind|Death|2|||
162871170|NCT03041116|588231322|FG000|Double-blind|Withdrawal by Subject|0|||
162871171|NCT03041116|588231323|FG001|Double-blind|Withdrawal by Subject|4|||
162871172|NCT03041116|588231322|FG000|Open-label|Death|1|||
162871173|NCT03041116|588231323|FG001|Open-label|Death|0|||
162871174|NCT03041116|588231322|FG000|Open-label|Termination of the study by Sponsor|39|||
162871175|NCT03041116|588231323|FG001|Open-label|Termination of the study by Sponsor|37|||
162871176|NCT03041116|588231322|FG000|Open-label|Withdrawal by Subject|1|||
162871177|NCT03041116|588231323|FG001|Open-label|Withdrawal by Subject|0|||
162871178|NCT01345123|588231324|FG000|Overall Study|participants no longer with health plan|79|||
162871179|NCT01345123|588231325|FG001|Overall Study|participants no longer with health plan|85|||
162871180|NCT01345123|588231326|FG002|Overall Study|participants no longer with health plan|88|||
162871181|NCT01798134|588231327|FG000|Overall Study|Lost to Follow-up|1|||
162871182|NCT01798134|588231327|FG000|Overall Study|Withdrawal by Subject|3|||
162871183|NCT01798134|588231327|FG000|Overall Study|Death|2|||
162871184|NCT01798134|588231327|FG000|Overall Study|Adverse Event|3|||
162871185|NCT01798134|588231327|FG000|Overall Study|Physician Decision|3|||
162871186|NCT01798134|588231327|FG000|Overall Study|Liver transplant/surgery|4|||
162871187|NCT02653976|588231328|FG000|Overall Study|Withdrawal by Subject|5|||
162871188|NCT02653976|588231328|FG000|Overall Study|Death|4|||
162871189|NCT02436577|588231329|FG000|Overall Study|Protocol Deviation|0|||
162871190|NCT02436577|588231330|FG001|Overall Study|Protocol Deviation|1|||
162871191|NCT02436577|588231331|FG002|Overall Study|Protocol Deviation|0|||
162871192|NCT02436577|588231332|FG003|Overall Study|Protocol Deviation|0|||
162871193|NCT02436577|588231333|FG004|Overall Study|Protocol Deviation|0|||
162871194|NCT02436577|588231334|FG005|Overall Study|Protocol Deviation|0|||
162871195|NCT01675011|588231335|FG000|Overall Study|Trial terminated by Sponsor|3|||
162871196|NCT01675011|588231336|FG001|Overall Study|Trial terminated by Sponsor|1|||
162871197|NCT00615290|588231337|FG000|Overall Study|Adverse Event|2|||
162871198|NCT00615290|588231337|FG000|Overall Study|Lost to Follow-up|3|||
162871199|NCT00615290|588231337|FG000|Overall Study|Withdrawal by Subject|1|||
162871200|NCT00615290|588231337|FG000|Overall Study|Other|2|||
162871201|NCT00366548|588231338|FG000|Infant Series|Adverse Event|1|||
162871202|NCT00366548|588231339|FG001|Infant Series|Adverse Event|3|||
162871203|NCT00366548|588231338|FG000|Infant Series|Protocol Violation|0|||
162871204|NCT00366548|588231339|FG001|Infant Series|Protocol Violation|1|||
162871205|NCT00366548|588231338|FG000|Infant Series|Withdrawal by Subject|3|||
162871206|NCT00366548|588231339|FG001|Infant Series|Withdrawal by Subject|1|||
162871207|NCT00366548|588231338|FG000|After Infant Series|Withdrawal by Subject|3|||
162871208|NCT00366548|588231339|FG001|After Infant Series|Withdrawal by Subject|1|||
162871209|NCT00366548|588231338|FG000|After Infant Series|Adverse Event|2|||
162871210|NCT00366548|588231339|FG001|After Infant Series|Adverse Event|0|||
162871211|NCT00366548|588231338|FG000|After Infant Series|Lost to Follow-up|1|||
162871212|NCT00366548|588231339|FG001|After Infant Series|Lost to Follow-up|0|||
162871213|NCT02849990|588231340|FG000|Overall Study|Adverse Event|1|||
162871214|NCT02849990|588231340|FG000|Overall Study|Withdrawal by Subject|1|||
162871215|NCT01252134|588231341|FG000|Period 1, 8 Hours|Personal Reasons|0|||
162871216|NCT01252134|588231342|FG001|Period 1, 8 Hours|Personal Reasons|1|||
162871217|NCT01252134|588231343|FG002|Period 1, 8 Hours|Personal Reasons|1|||
162871218|NCT01252134|588231344|FG003|Period 1, 8 Hours|Personal Reasons|0|||
162871219|NCT01252134|588231345|FG004|Period 1, 8 Hours|Personal Reasons|0|||
162871220|NCT01252134|588231346|FG005|Period 1, 8 Hours|Personal Reasons|0|||
162871221|NCT03650452|588231347|FG000|Overall Study|Physician Decision|1|||
162871222|NCT03650452|588231348|FG001|Overall Study|Physician Decision|0|||
162871223|NCT03650452|588231347|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
162871224|NCT03650452|588231348|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162871225|NCT03650452|588231347|FG000|Overall Study|Adverse Event|3|||
162871226|NCT03650452|588231348|FG001|Overall Study|Adverse Event|4|||
162871227|NCT03650452|588231347|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
162871228|NCT03650452|588231348|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
162871229|NCT02678741|588231350|FG000|Overall Study|Death|4|||
162871230|NCT02678741|588231350|FG000|Overall Study|Withdrawal by Subject|1|||
162871231|NCT02678741|588231350|FG000|Overall Study|ineligible|3|||
162871232|NCT02678741|588231350|FG000|Overall Study|Not RECIST Measurable|2|||
162871233|NCT02678741|588231350|FG000|Overall Study|Lack of Efficacy|10|||
162615013|NCT00973349|587307449|FG006|Overall Study|Unable to classify|0|||
162615014|NCT00973349|587307450|FG007|Overall Study|Unable to classify|0|||
162615015|NCT00973349|587307451|FG008|Overall Study|Unable to classify|0|||
162615016|NCT00973349|587307452|FG009|Overall Study|Unable to classify|1|||
162615017|NCT00973349|587307453|FG010|Overall Study|Unable to classify|0|||
162615018|NCT00973349|587307454|FG011|Overall Study|Unable to classify|0|||
162615019|NCT00973349|587307455|FG012|Overall Study|Unable to classify|0|||
162615020|NCT00973349|587307456|FG013|Overall Study|Unable to classify|0|||
162615021|NCT00973349|587307457|FG014|Overall Study|Unable to classify|0|||
162615022|NCT00973349|587307458|FG015|Overall Study|Unable to classify|0|||
162615023|NCT05597020|587307466|FG000|Washout|Forbidden medication|2|||
162615024|NCT05597020|587307467|FG001|Washout|Forbidden medication|0|||
162615025|NCT05597020|587307466|FG000|Treatment Period II|Advice from primary care physician|1|||
162615026|NCT05597020|587307467|FG001|Treatment Period II|Advice from primary care physician|0|||
162615027|NCT05597020|587307466|FG000|Treatment Period II|Subject lost investigational product|1|||
162615028|NCT05597020|587307467|FG001|Treatment Period II|Subject lost investigational product|0|||
162615029|NCT05597020|587307466|FG000|Treatment Period II|Private reasons|0|||
162615030|NCT05597020|587307467|FG001|Treatment Period II|Private reasons|1|||
162615031|NCT05736224|587307468|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
162615032|NCT01015131|587307469|FG000|Overall Study|Physician Decision|1|||
162615033|NCT01015131|587307469|FG000|Overall Study|Protocol Violation|1|||
162615034|NCT01015131|587307469|FG000|Overall Study|Withdrawal by Subject|2|||
162615035|NCT01015131|587307469|FG000|Overall Study|Other Protocol Specified Criteria|4|||
162615036|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
162615037|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615038|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615039|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615040|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615041|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615042|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162615043|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
162615044|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615045|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615046|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615047|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615048|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615049|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162615050|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
162615051|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615052|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615053|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615054|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615055|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615056|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162615057|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
162871234|NCT01795898|588231351|FG000|Overall Study|Adverse Event|27|||
162871235|NCT01795898|588231351|FG000|Overall Study|Lost to Follow-up|20|||
162871236|NCT01795898|588231351|FG000|Overall Study|Withdrawal of consent|6|||
162871237|NCT01795898|588231351|FG000|Overall Study|Diagnosed with metastasis|1|||
162871238|NCT01795898|588231351|FG000|Overall Study|No pain|1|||
162871239|NCT01795898|588231351|FG000|Overall Study|Death|1|||
162871240|NCT01795898|588231351|FG000|Overall Study|Withdrew consent & had adverse events|3|||
162871241|NCT01795898|588231351|FG000|Overall Study|Physician Decision|1|||
162871242|NCT02531373|588231362|FG000|Overall Study|Lack of Efficacy|0|||
162871243|NCT02531373|588231363|FG001|Overall Study|Lack of Efficacy|0|||
162871244|NCT02531373|588231364|FG002|Overall Study|Lack of Efficacy|0|||
162871245|NCT02531373|588231365|FG003|Overall Study|Lack of Efficacy|0|||
162871246|NCT02531373|588231366|FG004|Overall Study|Lack of Efficacy|3|||
162871247|NCT02531373|588231367|FG005|Overall Study|Lack of Efficacy|2|||
162871248|NCT02531373|588231368|FG006|Overall Study|Lack of Efficacy|4|||
162871249|NCT02531373|588231369|FG007|Overall Study|Lack of Efficacy|8|||
162871250|NCT02531373|588231370|FG008|Overall Study|Lack of Efficacy|5|||
162871251|NCT02531373|588231362|FG000|Overall Study|Lost to Follow-up|0|||
162871252|NCT02531373|588231363|FG001|Overall Study|Lost to Follow-up|0|||
162871253|NCT02531373|588231364|FG002|Overall Study|Lost to Follow-up|0|||
162871254|NCT02531373|588231365|FG003|Overall Study|Lost to Follow-up|0|||
162871255|NCT02531373|588231366|FG004|Overall Study|Lost to Follow-up|0|||
162871256|NCT02531373|588231367|FG005|Overall Study|Lost to Follow-up|2|||
162871257|NCT02531373|588231368|FG006|Overall Study|Lost to Follow-up|2|||
162871258|NCT02531373|588231369|FG007|Overall Study|Lost to Follow-up|0|||
162871259|NCT02531373|588231370|FG008|Overall Study|Lost to Follow-up|0|||
162871260|NCT02531373|588231362|FG000|Overall Study|Physician Decision|0|||
162871261|NCT02531373|588231363|FG001|Overall Study|Physician Decision|0|||
162871262|NCT02531373|588231364|FG002|Overall Study|Physician Decision|0|||
162871263|NCT02531373|588231365|FG003|Overall Study|Physician Decision|0|||
162871264|NCT02531373|588231366|FG004|Overall Study|Physician Decision|2|||
162871265|NCT02531373|588231367|FG005|Overall Study|Physician Decision|1|||
162871266|NCT02531373|588231368|FG006|Overall Study|Physician Decision|0|||
162871267|NCT02531373|588231369|FG007|Overall Study|Physician Decision|0|||
162871268|NCT02531373|588231370|FG008|Overall Study|Physician Decision|0|||
162871269|NCT02531373|588231362|FG000|Overall Study|Protocol Violation|0|||
162871270|NCT02531373|588231363|FG001|Overall Study|Protocol Violation|0|||
162871271|NCT02531373|588231364|FG002|Overall Study|Protocol Violation|0|||
162871272|NCT02531373|588231365|FG003|Overall Study|Protocol Violation|0|||
162871273|NCT02531373|588231366|FG004|Overall Study|Protocol Violation|0|||
162871274|NCT02531373|588231367|FG005|Overall Study|Protocol Violation|1|||
162871275|NCT02531373|588231368|FG006|Overall Study|Protocol Violation|1|||
162871276|NCT02531373|588231369|FG007|Overall Study|Protocol Violation|0|||
162871277|NCT02531373|588231370|FG008|Overall Study|Protocol Violation|1|||
162871278|NCT02531373|588231362|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162871279|NCT02531373|588231363|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162871280|NCT02531373|588231364|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162871281|NCT02531373|588231365|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162871282|NCT02531373|588231366|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162871283|NCT02531373|588231367|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
162871284|NCT02531373|588231368|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
162871285|NCT02531373|588231369|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
162871286|NCT02531373|588231370|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
162871287|NCT02531373|588231362|FG000|Overall Study|Withdrawal by Subject|0|||
162871288|NCT02531373|588231363|FG001|Overall Study|Withdrawal by Subject|0|||
162871289|NCT02531373|588231364|FG002|Overall Study|Withdrawal by Subject|0|||
162871290|NCT02531373|588231365|FG003|Overall Study|Withdrawal by Subject|0|||
162871291|NCT02531373|588231366|FG004|Overall Study|Withdrawal by Subject|3|||
162871292|NCT02531373|588231367|FG005|Overall Study|Withdrawal by Subject|0|||
162871293|NCT02531373|588231368|FG006|Overall Study|Withdrawal by Subject|0|||
162871294|NCT02531373|588231369|FG007|Overall Study|Withdrawal by Subject|0|||
162871295|NCT02531373|588231370|FG008|Overall Study|Withdrawal by Subject|0|||
162871296|NCT04705597|588231375|FG000|Overall Study|Death|16|||
162871297|NCT04705597|588231376|FG001|Overall Study|Death|9|||
162871298|NCT04705597|588231375|FG000|Overall Study|Lost to Follow-up|1|||
162871299|NCT04705597|588231376|FG001|Overall Study|Lost to Follow-up|0|||
162871300|NCT04705597|588231375|FG000|Overall Study|Withdrawal by Subject|1|||
162871301|NCT04705597|588231376|FG001|Overall Study|Withdrawal by Subject|2|||
162871302|NCT00390780|588231377|FG000|Overall Study|Not completed|10|||
162871303|NCT00390780|588231378|FG001|Overall Study|Not completed|4|||
162871304|NCT00390780|588231377|FG000|Overall Study|Protocol Violation|6|||
162871305|NCT00390780|588231378|FG001|Overall Study|Protocol Violation|4|||
162871306|NCT00390780|588231377|FG000|Overall Study|Lost to Follow-up|3|||
162871307|NCT00390780|588231378|FG001|Overall Study|Lost to Follow-up|6|||
162871308|NCT00390780|588231377|FG000|Overall Study|Adverse Event|2|||
162871309|NCT00390780|588231378|FG001|Overall Study|Adverse Event|3|||
162871310|NCT00390780|588231377|FG000|Overall Study|Death|1|||
162871311|NCT00390780|588231378|FG001|Overall Study|Death|3|||
162871312|NCT00390780|588231377|FG000|Overall Study|Withdrawal by Subject|1|||
162960721|NCT01838681|588558896|FG000|Period A|Withdrawal by Subject|70|||
162871313|NCT00390780|588231378|FG001|Overall Study|Withdrawal by Subject|2|||
162871314|NCT00390780|588231377|FG000|Overall Study|Inclusion criteria not satisfied|0|||
162871315|NCT00390780|588231378|FG001|Overall Study|Inclusion criteria not satisfied|2|||
162871316|NCT00390780|588231377|FG000|Overall Study|Lost to follow up and other reasons|0|||
162871317|NCT00390780|588231378|FG001|Overall Study|Lost to follow up and other reasons|1|||
162871318|NCT00390780|588231377|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
162871319|NCT00390780|588231378|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
162615058|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615059|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615060|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615061|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615062|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615063|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162615064|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
162615065|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615066|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615067|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615068|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615069|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615070|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162615071|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
162615072|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162706670|NCT04955626|587636671|FG015|Blinded Period|Participants entered open label period|0|||
162706671|NCT04955626|587636672|FG016|Blinded Period|Participants entered open label period|0|||
162706672|NCT04955626|587636673|FG017|Blinded Period|Participants entered open label period|0|||
162706673|NCT04955626|587636674|FG018|Blinded Period|Participants entered open label period|0|||
162706674|NCT04955626|587636675|FG019|Blinded Period|Participants entered open label period|0|||
162706675|NCT04955626|587636676|FG020|Blinded Period|Participants entered open label period|0|||
162706676|NCT04955626|587636677|FG021|Blinded Period|Participants entered open label period|0|||
162871320|NCT00390780|588231377|FG000|Overall Study|SAE, death|0|||
162871321|NCT00390780|588231378|FG001|Overall Study|SAE, death|1|||
162871322|NCT00305006|588231379|FG000|Overall Study|Withdrawal by Subject|1|||
162960722|NCT01838681|588558897|FG001|Period A|Withdrawal by Subject|0|||
162960723|NCT01838681|588558898|FG002|Period A|Withdrawal by Subject|0|||
162960724|NCT01838681|588558899|FG003|Period A|Withdrawal by Subject|0|||
162960725|NCT01838681|588558896|FG000|Period A|Protocol Violation|16|||
162960726|NCT01838681|588558897|FG001|Period A|Protocol Violation|0|||
162960727|NCT01838681|588558898|FG002|Period A|Protocol Violation|0|||
162960728|NCT01838681|588558899|FG003|Period A|Protocol Violation|0|||
162960729|NCT01838681|588558896|FG000|Period A|Non-compliance with IMP|6|||
162960730|NCT01838681|588558897|FG001|Period A|Non-compliance with IMP|0|||
162960731|NCT01838681|588558898|FG002|Period A|Non-compliance with IMP|0|||
162960732|NCT01838681|588558899|FG003|Period A|Non-compliance with IMP|0|||
162960733|NCT01838681|588558896|FG000|Period A|Lost to Follow-up|4|||
162960734|NCT01838681|588558897|FG001|Period A|Lost to Follow-up|0|||
162960735|NCT01838681|588558898|FG002|Period A|Lost to Follow-up|0|||
162960736|NCT01838681|588558899|FG003|Period A|Lost to Follow-up|0|||
162960737|NCT01838681|588558896|FG000|Period A|Withdrawal before treatment|4|||
162960738|NCT01838681|588558897|FG001|Period A|Withdrawal before treatment|0|||
162960739|NCT01838681|588558898|FG002|Period A|Withdrawal before treatment|0|||
162960740|NCT01838681|588558899|FG003|Period A|Withdrawal before treatment|0|||
162960741|NCT01838681|588558896|FG000|Period A|Administrative or other reasons|17|||
162960742|NCT01838681|588558897|FG001|Period A|Administrative or other reasons|0|||
162960743|NCT01838681|588558898|FG002|Period A|Administrative or other reasons|0|||
162960744|NCT01838681|588558899|FG003|Period A|Administrative or other reasons|0|||
162960745|NCT01838681|588558896|FG000|Period B/A+|Adverse Event|0|||
162960746|NCT01838681|588558897|FG001|Period B/A+|Adverse Event|13|||
162960747|NCT01838681|588558898|FG002|Period B/A+|Adverse Event|27|||
162960748|NCT01838681|588558899|FG003|Period B/A+|Adverse Event|16|||
162960749|NCT01838681|588558896|FG000|Period B/A+|Lack of Efficacy|0|||
162960750|NCT01838681|588558897|FG001|Period B/A+|Lack of Efficacy|9|||
162960751|NCT01838681|588558898|FG002|Period B/A+|Lack of Efficacy|11|||
162960752|NCT01838681|588558899|FG003|Period B/A+|Lack of Efficacy|6|||
162960753|NCT01838681|588558896|FG000|Period B/A+|Withdrawal by Subject|0|||
162960754|NCT01838681|588558897|FG001|Period B/A+|Withdrawal by Subject|28|||
162960755|NCT01838681|588558898|FG002|Period B/A+|Withdrawal by Subject|35|||
162960756|NCT01838681|588558899|FG003|Period B/A+|Withdrawal by Subject|47|||
162960757|NCT01838681|588558896|FG000|Period B/A+|Protocol Violation|0|||
162960758|NCT01838681|588558897|FG001|Period B/A+|Protocol Violation|1|||
162706677|NCT04955626|587636678|FG022|Blinded Period|Participants entered open label period|0|||
162960759|NCT01838681|588558898|FG002|Period B/A+|Protocol Violation|4|||
162960760|NCT01838681|588558899|FG003|Period B/A+|Protocol Violation|6|||
162960761|NCT01838681|588558896|FG000|Period B/A+|Non-compliance with IMP|0|||
162960762|NCT01838681|588558897|FG001|Period B/A+|Non-compliance with IMP|2|||
162960763|NCT01838681|588558898|FG002|Period B/A+|Non-compliance with IMP|3|||
162960764|NCT01838681|588558899|FG003|Period B/A+|Non-compliance with IMP|3|||
162960765|NCT01838681|588558896|FG000|Period B/A+|Lost to Follow-up|0|||
162960766|NCT01838681|588558897|FG001|Period B/A+|Lost to Follow-up|2|||
162960767|NCT01838681|588558898|FG002|Period B/A+|Lost to Follow-up|5|||
162960768|NCT01838681|588558899|FG003|Period B/A+|Lost to Follow-up|11|||
162960769|NCT01838681|588558896|FG000|Period B/A+|Withdrawal before treatment|0|||
162960770|NCT01838681|588558897|FG001|Period B/A+|Withdrawal before treatment|1|||
162960771|NCT01838681|588558898|FG002|Period B/A+|Withdrawal before treatment|0|||
162960772|NCT01838681|588558899|FG003|Period B/A+|Withdrawal before treatment|0|||
162960773|NCT01838681|588558896|FG000|Period B/A+|Administrative or other reasons|0|||
162960774|NCT01838681|588558897|FG001|Period B/A+|Administrative or other reasons|6|||
162960775|NCT01838681|588558898|FG002|Period B/A+|Administrative or other reasons|10|||
162960776|NCT01838681|588558899|FG003|Period B/A+|Administrative or other reasons|28|||
162960777|NCT01473953|588558900|FG000|Overall Study|Other|1|||
162960778|NCT01473953|588558901|FG001|Overall Study|Other|0|||
162960779|NCT01473953|588558902|FG002|Overall Study|Other|0|||
162960780|NCT01473953|588558903|FG003|Overall Study|Other|0|||
162960781|NCT01473953|588558904|FG004|Overall Study|Other|0|||
162960782|NCT00312897|588558905|FG000|Overall Study|Adverse Event|1|||
162960783|NCT00312897|588558906|FG001|Overall Study|Adverse Event|0|||
162960784|NCT00312897|588558905|FG000|Overall Study|Lost to Follow-up|2|||
162960785|NCT00312897|588558906|FG001|Overall Study|Lost to Follow-up|0|||
162960786|NCT00312897|588558905|FG000|Overall Study|Physician Decision|1|||
162960787|NCT00312897|588558906|FG001|Overall Study|Physician Decision|0|||
162960788|NCT00312897|588558905|FG000|Overall Study|Withdrawal by Subject|1|||
162960789|NCT00312897|588558906|FG001|Overall Study|Withdrawal by Subject|3|||
162960790|NCT00312897|588558905|FG000|Overall Study|Pregnancy|1|||
162960791|NCT00312897|588558906|FG001|Overall Study|Pregnancy|0|||
162960792|NCT00312897|588558905|FG000|Overall Study|discontinued prior to getting treatment|0|||
162960793|NCT00312897|588558906|FG001|Overall Study|discontinued prior to getting treatment|3|||
162960794|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
162960795|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960796|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960797|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960798|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960799|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
162960800|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
162960801|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960802|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960803|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960804|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960805|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162960806|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
162960807|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960808|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960809|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960810|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960811|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
162960812|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
162960813|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960814|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960815|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960816|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960817|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162960818|NCT00902538|588558909|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
162960819|NCT00902538|588558910|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960820|NCT00902538|588558911|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960821|NCT00902538|588558912|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960822|NCT00902538|588558913|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960823|NCT00902538|588558914|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
162960824|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
162960825|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
162960826|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
162960827|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
162871323|NCT00305006|588231380|FG001|Overall Study|Withdrawal by Subject|0|||
162871324|NCT00305006|588231379|FG000|Overall Study|Failure to complete pretest|0|||
162871325|NCT00305006|588231380|FG001|Overall Study|Failure to complete pretest|1|||
162871326|NCT01996319|588231381|FG000|Overall Study|Protocol Violation|1|||
162871327|NCT01996319|588231382|FG001|Overall Study|Protocol Violation|0|||
162871328|NCT01996319|588231381|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
162871329|NCT01996319|588231382|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
162871330|NCT01996319|588231381|FG000|Overall Study|Adverse Event|2|||
162871331|NCT01996319|588231382|FG001|Overall Study|Adverse Event|2|||
162871332|NCT01671085|588231384|FG000|Overall Study|Withdrawal by Subject|1|||
162871333|NCT01671085|588231385|FG001|Overall Study|Withdrawal by Subject|0|||
162871334|NCT00637273|588231386|FG000|Overall Study|Adverse Event|11|||
162871335|NCT00637273|588231387|FG001|Overall Study|Adverse Event|5|||
162871336|NCT00637273|588231388|FG002|Overall Study|Adverse Event|7|||
162871337|NCT00637273|588231386|FG000|Overall Study|Lost to Follow-up|8|||
162871338|NCT00637273|588231387|FG001|Overall Study|Lost to Follow-up|9|||
162871339|NCT00637273|588231388|FG002|Overall Study|Lost to Follow-up|13|||
162871340|NCT00637273|588231386|FG000|Overall Study|Protocol Violation|2|||
162871341|NCT00637273|588231387|FG001|Overall Study|Protocol Violation|4|||
162871342|NCT00637273|588231388|FG002|Overall Study|Protocol Violation|1|||
162871343|NCT00637273|588231386|FG000|Overall Study|Withdrawal of Consent|18|||
162871344|NCT00637273|588231387|FG001|Overall Study|Withdrawal of Consent|6|||
162871345|NCT00637273|588231388|FG002|Overall Study|Withdrawal of Consent|18|||
162871346|NCT00637273|588231386|FG000|Overall Study|Investigator Decision|1|||
162871347|NCT00637273|588231387|FG001|Overall Study|Investigator Decision|3|||
162871348|NCT00637273|588231388|FG002|Overall Study|Investigator Decision|1|||
162871349|NCT00637273|588231386|FG000|Overall Study|Administrative|2|||
162871350|NCT00637273|588231387|FG001|Overall Study|Administrative|0|||
162871351|NCT00637273|588231388|FG002|Overall Study|Administrative|0|||
162871352|NCT00637273|588231386|FG000|Overall Study|Loss of Glucose Control|1|||
162871353|NCT00637273|588231387|FG001|Overall Study|Loss of Glucose Control|1|||
162871354|NCT00637273|588231388|FG002|Overall Study|Loss of Glucose Control|1|||
162871355|NCT02853331|588231389|FG000|Overall Study|Death|59|||
162871356|NCT02853331|588231390|FG001|Overall Study|Death|95|||
162871357|NCT02853331|588231389|FG000|Overall Study|Withdrawal by Subject|5|||
162871358|NCT02853331|588231390|FG001|Overall Study|Withdrawal by Subject|9|||
162871359|NCT02853331|588231389|FG000|Overall Study|Ongoing in study|368|||
162871360|NCT02853331|588231390|FG001|Overall Study|Ongoing in study|325|||
162871361|NCT00844428|588231391|FG000|Screening Period|Screen Failure|3|||
162871362|NCT00844428|588231391|FG000|Extension Treatment Period|Death|1|||
162871363|NCT00844428|588231391|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
162871364|NCT01595646|588231392|FG000|Overall Study|Withdrawal by Subject|1|||
162871365|NCT01595646|588231393|FG001|Overall Study|Withdrawal by Subject|0|||
162871366|NCT01595646|588231394|FG002|Overall Study|Withdrawal by Subject|0|||
162871367|NCT01161524|588231396|FG000|Core Study (23 Weeks)|Adverse Event|3|||
162871368|NCT01161524|588231397|FG001|Core Study (23 Weeks)|Adverse Event|0|||
162871369|NCT01161524|588231398|FG002|Core Study (23 Weeks)|Adverse Event|0|||
162871370|NCT01161524|588231396|FG000|Core Study (23 Weeks)|Other|1|||
162871371|NCT01161524|588231397|FG001|Core Study (23 Weeks)|Other|0|||
162871372|NCT01161524|588231398|FG002|Core Study (23 Weeks)|Other|0|||
162871373|NCT01161524|588231396|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
162871374|NCT01161524|588231397|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
162871375|NCT01161524|588231398|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
162871376|NCT01161524|588231396|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
162871377|NCT01161524|588231397|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
162871378|NCT01161524|588231398|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
162871379|NCT01161524|588231396|FG000|Core Study (23 Weeks)|Subject Choice|3|||
162871380|NCT01161524|588231397|FG001|Core Study (23 Weeks)|Subject Choice|2|||
162871381|NCT01161524|588231398|FG002|Core Study (23 Weeks)|Subject Choice|0|||
162871382|NCT01161524|588231396|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
162871383|NCT01161524|588231397|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
162871384|NCT01161524|588231398|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
162871385|NCT01161524|588231396|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
162871386|NCT01161524|588231397|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
162871387|NCT01161524|588231398|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
162871388|NCT01161524|588231396|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
162871389|NCT01161524|588231397|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
162871390|NCT01161524|588231398|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
162871391|NCT01161524|588231396|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
162871392|NCT01161524|588231397|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
162871393|NCT01161524|588231398|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
162871394|NCT01161524|588231396|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
162871395|NCT01161524|588231397|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
162871396|NCT01161524|588231398|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
163047062|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047063|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047064|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047065|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047066|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047067|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047068|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047069|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047070|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047071|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163047072|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047073|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163047074|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162871397|NCT01632878|588231400|FG000|Screening|Physician Decision|268|||
162871398|NCT01632878|588231400|FG000|Treatment|Lost to Follow-up|41|||
162871399|NCT01632878|588231400|FG000|Treatment|Withdrawal by Subject|36|||
162871400|NCT01632878|588231400|FG000|Treatment|Physician Decision|34|||
162871401|NCT01632878|588231400|FG000|Treatment|missing information|4|||
162871402|NCT01632878|588231400|FG000|Treatment|no information on study completion|43|||
162871403|NCT02698423|588231401|FG000|Overall Study|Lost to Follow-up|19|||
162871404|NCT02698423|588231402|FG001|Overall Study|Lost to Follow-up|24|||
162871405|NCT01765764|588231403|FG000|Treatment Period|Adverse Event|1|||
162871406|NCT01765764|588231404|FG001|Treatment Period|Adverse Event|2|||
162871407|NCT01765764|588231405|FG002|Treatment Period|Adverse Event|1|||
162871408|NCT01765764|588231403|FG000|Treatment Period|Lost to Follow-up|0|||
162871409|NCT01765764|588231404|FG001|Treatment Period|Lost to Follow-up|3|||
162871410|NCT01765764|588231405|FG002|Treatment Period|Lost to Follow-up|2|||
162871411|NCT01765764|588231403|FG000|Treatment Period|Personal Reasons|1|||
162871412|NCT01765764|588231404|FG001|Treatment Period|Personal Reasons|2|||
162871413|NCT01765764|588231405|FG002|Treatment Period|Personal Reasons|1|||
162871414|NCT01765764|588231403|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
162871415|NCT01765764|588231404|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
162871416|NCT01765764|588231405|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
162871417|NCT00064662|588231408|FG000|Overall Study|Death|1|||
162871418|NCT00064662|588231409|FG001|Overall Study|Death|1|||
162871419|NCT00064662|588231408|FG000|Overall Study|Lost to Follow-up|57|||
162871420|NCT00064662|588231409|FG001|Overall Study|Lost to Follow-up|44|||
162871421|NCT00064662|588231408|FG000|Overall Study|Withdrawal by Subject|14|||
162871422|NCT00064662|588231409|FG001|Overall Study|Withdrawal by Subject|14|||
162871423|NCT00064662|588231408|FG000|Overall Study|Administratively withdrawn|2|||
162871424|NCT00064662|588231409|FG001|Overall Study|Administratively withdrawn|2|||
162871425|NCT01555463|588231412|FG000|Treatment|Adverse Event|6|||
162871426|NCT01555463|588231413|FG001|Treatment|Adverse Event|12|||
162871427|NCT01555463|588231412|FG000|Treatment|Withdrawal by Subject|24|||
162960828|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
162960829|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
162960830|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
162960831|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
162960832|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
162960833|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960834|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960835|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
162960836|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
162960837|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
162960838|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
162960839|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
162960840|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
163047075|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163047076|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047077|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047078|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047079|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
162960841|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
163047080|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
162871428|NCT01555463|588231413|FG001|Treatment|Withdrawal by Subject|36|||
162871429|NCT01555463|588231412|FG000|Treatment|Lost to Follow-up|28|||
162871430|NCT01555463|588231413|FG001|Treatment|Lost to Follow-up|23|||
162871431|NCT01555463|588231412|FG000|Treatment|Protocol Violation|4|||
162871432|NCT01555463|588231413|FG001|Treatment|Protocol Violation|5|||
162871433|NCT01555463|588231412|FG000|Treatment|Other reason|2|||
162871434|NCT01555463|588231413|FG001|Treatment|Other reason|3|||
162871435|NCT01555463|588231412|FG000|Follow up|Adverse Event|2|||
162871436|NCT01555463|588231413|FG001|Follow up|Adverse Event|5|||
162871437|NCT01555463|588231412|FG000|Follow up|Death|0|||
162871438|NCT01555463|588231413|FG001|Follow up|Death|1|||
162871439|NCT01555463|588231412|FG000|Follow up|Withdrawal by Subject|22|||
162871440|NCT01555463|588231413|FG001|Follow up|Withdrawal by Subject|22|||
162871441|NCT01555463|588231412|FG000|Follow up|Lost to Follow-up|9|||
162871442|NCT01555463|588231413|FG001|Follow up|Lost to Follow-up|10|||
162871443|NCT01555463|588231412|FG000|Follow up|Protocol Violation|2|||
162871444|NCT01555463|588231413|FG001|Follow up|Protocol Violation|4|||
162871445|NCT01555463|588231412|FG000|Follow up|Other reason|3|||
162871446|NCT01555463|588231413|FG001|Follow up|Other reason|3|||
162871447|NCT01165203|588231416|FG000|Active Phase|Serious Adverse Event|1|||
162871448|NCT01165203|588231417|FG001|Active Phase|Serious Adverse Event|0|||
162871449|NCT01165203|588231416|FG000|Active Phase|Withdrawal by Subject|2|||
162871450|NCT01165203|588231417|FG001|Active Phase|Withdrawal by Subject|1|||
162871451|NCT01165203|588231416|FG000|Active Phase|Migrated/moved from study area|0|||
162871452|NCT01165203|588231417|FG001|Active Phase|Migrated/moved from study area|1|||
162871453|NCT01165203|588231416|FG000|Active Phase|Lost to Follow-up|2|||
162871454|NCT01165203|588231417|FG001|Active Phase|Lost to Follow-up|0|||
162871455|NCT01165203|588231416|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
162871456|NCT01165203|588231417|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
162871457|NCT01165203|588231416|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
162871458|NCT01165203|588231417|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
162871459|NCT01165203|588231416|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
162871460|NCT01165203|588231417|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
162871461|NCT01165203|588231416|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
162871462|NCT01165203|588231417|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
162871463|NCT01165203|588231416|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
162871464|NCT01165203|588231417|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
162871465|NCT00620321|588232991|FG000|Overall Study|Adverse Event|1|||
162871466|NCT00620321|588232992|FG001|Overall Study|Adverse Event|1|||
162871467|NCT00620321|588232991|FG000|Overall Study|Death|1|||
162871468|NCT00620321|588232992|FG001|Overall Study|Death|1|||
162871469|NCT00620321|588232991|FG000|Overall Study|Physician Decision|0|||
162871470|NCT00620321|588232992|FG001|Overall Study|Physician Decision|7|||
162871471|NCT00620321|588232991|FG000|Overall Study|Progressive Disease|5|||
162871472|NCT00620321|588232992|FG001|Overall Study|Progressive Disease|5|||
162871473|NCT00620321|588232991|FG000|Overall Study|Sponsor Decision|0|||
162871474|NCT00620321|588232992|FG001|Overall Study|Sponsor Decision|1|||
162871475|NCT00620321|588232991|FG000|Overall Study|Withdrawal by Subject|1|||
162871476|NCT00620321|588232992|FG001|Overall Study|Withdrawal by Subject|1|||
162871477|NCT05137041|588232993|FG000|Overall Study|Lost to Follow-up|1|||
162871478|NCT05137041|588232994|FG001|Overall Study|Lost to Follow-up|1|||
162871479|NCT05137041|588232993|FG000|Overall Study|Withdrawal by Subject|0|||
162871480|NCT05137041|588232994|FG001|Overall Study|Withdrawal by Subject|2|||
162871481|NCT05137041|588232993|FG000|Overall Study|Reason not Specified|0|||
162615073|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162615074|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162871482|NCT05137041|588232994|FG001|Overall Study|Reason not Specified|1|||
162871483|NCT02433210|588232995|FG000|Overall Study|Physician Decision|1|||
162871484|NCT02433210|588232996|FG001|Overall Study|Physician Decision|0|||
162871485|NCT02433210|588232997|FG002|Overall Study|Physician Decision|0|||
162871486|NCT02090114|588232998|FG000|Overall Study|Withdrawal by Subject|3|||
162871487|NCT02090114|588232999|FG001|Overall Study|Withdrawal by Subject|6|||
162871488|NCT02090114|588233000|FG002|Overall Study|Withdrawal by Subject|2|||
162871489|NCT02090114|588233001|FG003|Overall Study|Withdrawal by Subject|1|||
162871490|NCT02090114|588232998|FG000|Overall Study|Physician Decision|5|||
162871491|NCT02090114|588232999|FG001|Overall Study|Physician Decision|0|||
162871492|NCT02090114|588233000|FG002|Overall Study|Physician Decision|1|||
163047081|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047082|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047083|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047084|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047085|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047086|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047087|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
163047088|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047089|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
162871493|NCT02090114|588233001|FG003|Overall Study|Physician Decision|1|||
163047090|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163047091|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047092|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047093|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047094|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047095|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047096|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047097|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047098|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047099|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047100|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047101|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163047102|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047103|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
163047104|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163047105|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
163047106|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047107|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047108|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047109|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047110|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047111|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047112|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047113|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047114|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047115|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047116|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047117|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
163047118|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047119|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163047120|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
163047121|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047122|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047123|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047124|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047125|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
162871494|NCT02090114|588232998|FG000|Overall Study|Adverse Event|1|||
162871495|NCT02090114|588232999|FG001|Overall Study|Adverse Event|2|||
162871496|NCT02090114|588233000|FG002|Overall Study|Adverse Event|2|||
162871497|NCT02090114|588233001|FG003|Overall Study|Adverse Event|0|||
162871498|NCT02090114|588232998|FG000|Overall Study|Progressive Disease|20|||
162871499|NCT02090114|588232999|FG001|Overall Study|Progressive Disease|21|||
162871500|NCT02090114|588233000|FG002|Overall Study|Progressive Disease|23|||
162871501|NCT02090114|588233001|FG003|Overall Study|Progressive Disease|6|||
162871502|NCT02090114|588232998|FG000|Overall Study|Death|1|||
162871503|NCT02090114|588232999|FG001|Overall Study|Death|0|||
163047126|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
162871504|NCT02090114|588233000|FG002|Overall Study|Death|1|||
163047127|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047128|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047129|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
162871505|NCT02090114|588233001|FG003|Overall Study|Death|0|||
162871506|NCT01605071|588233002|FG000|Overall Study|Withdrawal by Subject|3|||
162871507|NCT01605071|588233003|FG001|Overall Study|Withdrawal by Subject|2|||
162871508|NCT00051558|588233006|FG000|Overall Study|Adverse Event|30|||
162871509|NCT00051558|588233007|FG001|Overall Study|Adverse Event|18|||
163047130|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047131|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047132|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
163047133|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163047134|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163047135|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163047136|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047137|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047138|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047139|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047140|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047141|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047142|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047143|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047144|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047145|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047146|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047147|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
163047148|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047149|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047150|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163047151|NCT02326272|588879354|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047152|NCT02326272|588879355|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047153|NCT02326272|588879356|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047154|NCT02326272|588879357|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047155|NCT02326272|588879358|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047156|NCT02326272|588879359|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047157|NCT02326272|588879360|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047158|NCT02326272|588879361|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
162871510|NCT00051558|588233006|FG000|Overall Study|Withdrawal by Subject|29|||
162871511|NCT00051558|588233007|FG001|Overall Study|Withdrawal by Subject|42|||
162871512|NCT00051558|588233006|FG000|Overall Study|Death|9|||
162871513|NCT00051558|588233007|FG001|Overall Study|Death|15|||
162871514|NCT00051558|588233006|FG000|Overall Study|Lost to Follow-up|4|||
162871515|NCT00051558|588233007|FG001|Overall Study|Lost to Follow-up|13|||
162871516|NCT00051558|588233006|FG000|Overall Study|Protocol Violation|3|||
162871517|NCT00051558|588233007|FG001|Overall Study|Protocol Violation|4|||
162871518|NCT00051558|588233006|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
162871519|NCT00051558|588233007|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
162871520|NCT00051558|588233006|FG000|Overall Study|Sponsor Decision|6|||
162871521|NCT00051558|588233007|FG001|Overall Study|Sponsor Decision|1|||
162871522|NCT00051558|588233006|FG000|Overall Study|Other|2|||
162871523|NCT00051558|588233007|FG001|Overall Study|Other|1|||
162871524|NCT00051558|588233006|FG000|Overall Study|Significant Lab Value|2|||
162871525|NCT00051558|588233007|FG001|Overall Study|Significant Lab Value|0|||
162871526|NCT00051558|588233006|FG000|Overall Study|Physician Decision|5|||
163047159|NCT02326272|588879362|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047160|NCT02326272|588879363|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047161|NCT02326272|588879364|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047162|NCT02326272|588879365|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047163|NCT02326272|588879366|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
163047164|NCT02326272|588879367|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047165|NCT02326272|588879368|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
163047166|NCT01265394|588879386|FG000|Overall Study|Subjects withdrawn|37|||
163047167|NCT01348139|588879392|FG000|Period 1|Adverse Event|1|||
163047168|NCT01348139|588879393|FG001|Period 1|Adverse Event|0|||
163047169|NCT01348139|588879394|FG002|Period 1|Adverse Event|0|||
162871527|NCT00051558|588233007|FG001|Overall Study|Physician Decision|0|||
162871528|NCT02163993|588233009|FG000|Treatment Period|Adverse Event|0|||
162871529|NCT02163993|588233010|FG001|Treatment Period|Adverse Event|1|||
162871530|NCT02163993|588233011|FG002|Treatment Period|Adverse Event|0|||
163047170|NCT01348139|588879395|FG003|Period 1|Adverse Event|0|||
163047171|NCT01348139|588879396|FG004|Period 1|Adverse Event|0|||
163047172|NCT01348139|588879397|FG005|Period 1|Adverse Event|0|||
163047173|NCT02254772|588879398|FG000|Overall Study|Ineligible|1|||
163047174|NCT02254772|588879398|FG000|Overall Study|Withdrawal by Subject|1|||
163047175|NCT00928434|588879399|FG000|Overall Study|Adverse Event|14|||
163047176|NCT00928434|588879400|FG001|Overall Study|Adverse Event|5|||
162871531|NCT02163993|588233012|FG003|Treatment Period|Adverse Event|0|||
162871532|NCT02163993|588233013|FG004|Treatment Period|Adverse Event|1|||
162871533|NCT02163993|588233009|FG000|Treatment Period|Lost to Follow-up|2|||
162871534|NCT02163993|588233010|FG001|Treatment Period|Lost to Follow-up|3|||
162871535|NCT02163993|588233011|FG002|Treatment Period|Lost to Follow-up|1|||
162871536|NCT02163993|588233012|FG003|Treatment Period|Lost to Follow-up|3|||
162871537|NCT02163993|588233013|FG004|Treatment Period|Lost to Follow-up|1|||
162871538|NCT02163993|588233009|FG000|Treatment Period|Physician Decision|1|||
162871539|NCT02163993|588233010|FG001|Treatment Period|Physician Decision|0|||
162871540|NCT02163993|588233011|FG002|Treatment Period|Physician Decision|0|||
162871541|NCT02163993|588233012|FG003|Treatment Period|Physician Decision|0|||
162871542|NCT02163993|588233013|FG004|Treatment Period|Physician Decision|0|||
162871543|NCT02163993|588233009|FG000|Treatment Period|Protocol Violation|2|||
162871544|NCT02163993|588233010|FG001|Treatment Period|Protocol Violation|1|||
162871545|NCT02163993|588233011|FG002|Treatment Period|Protocol Violation|0|||
162871546|NCT02163993|588233012|FG003|Treatment Period|Protocol Violation|1|||
162871547|NCT02163993|588233013|FG004|Treatment Period|Protocol Violation|2|||
162871548|NCT02163993|588233009|FG000|Treatment Period|Withdrawal by Subject|6|||
162871549|NCT02163993|588233010|FG001|Treatment Period|Withdrawal by Subject|4|||
162871550|NCT02163993|588233011|FG002|Treatment Period|Withdrawal by Subject|1|||
162871551|NCT02163993|588233012|FG003|Treatment Period|Withdrawal by Subject|4|||
162871552|NCT02163993|588233013|FG004|Treatment Period|Withdrawal by Subject|1|||
162871553|NCT02163993|588233009|FG000|Treatment Period|Not treated|1|||
162871554|NCT02163993|588233010|FG001|Treatment Period|Not treated|0|||
162871555|NCT02163993|588233011|FG002|Treatment Period|Not treated|0|||
162871556|NCT02163993|588233012|FG003|Treatment Period|Not treated|1|||
162871557|NCT02163993|588233013|FG004|Treatment Period|Not treated|2|||
162871558|NCT02163993|588233009|FG000|Post-treatment Period|Adverse Event|0|||
162871559|NCT02163993|588233010|FG001|Post-treatment Period|Adverse Event|0|||
162871560|NCT02163993|588233011|FG002|Post-treatment Period|Adverse Event|1|||
162871561|NCT02163993|588233012|FG003|Post-treatment Period|Adverse Event|0|||
162871562|NCT02163993|588233013|FG004|Post-treatment Period|Adverse Event|0|||
162871563|NCT02163993|588233009|FG000|Post-treatment Period|Lost to Follow-up|2|||
162871564|NCT02163993|588233010|FG001|Post-treatment Period|Lost to Follow-up|2|||
162871565|NCT02163993|588233011|FG002|Post-treatment Period|Lost to Follow-up|3|||
162871566|NCT02163993|588233012|FG003|Post-treatment Period|Lost to Follow-up|1|||
162871567|NCT02163993|588233013|FG004|Post-treatment Period|Lost to Follow-up|0|||
162871568|NCT02163993|588233009|FG000|Post-treatment Period|Protocol Violation|0|||
162871569|NCT02163993|588233010|FG001|Post-treatment Period|Protocol Violation|0|||
162871570|NCT02163993|588233011|FG002|Post-treatment Period|Protocol Violation|0|||
162871571|NCT02163993|588233012|FG003|Post-treatment Period|Protocol Violation|0|||
162871572|NCT02163993|588233013|FG004|Post-treatment Period|Protocol Violation|1|||
162871573|NCT02163993|588233009|FG000|Post-treatment Period|Withdrawal by Subject|2|||
162871574|NCT02163993|588233010|FG001|Post-treatment Period|Withdrawal by Subject|4|||
162871575|NCT02163993|588233011|FG002|Post-treatment Period|Withdrawal by Subject|0|||
162871576|NCT02163993|588233012|FG003|Post-treatment Period|Withdrawal by Subject|1|||
162871577|NCT02163993|588233013|FG004|Post-treatment Period|Withdrawal by Subject|2|||
162871578|NCT01808118|588233014|FG000|Period 1|Adverse Event|15|||
162871579|NCT01808118|588233015|FG001|Period 1|Adverse Event|0|||
162871580|NCT01808118|588233016|FG002|Period 1|Adverse Event|0|||
162871581|NCT01808118|588233014|FG000|Period 1|Withdrew consent|24|||
162871582|NCT01808118|588233015|FG001|Period 1|Withdrew consent|0|||
162871583|NCT01808118|588233016|FG002|Period 1|Withdrew consent|0|||
162871584|NCT01808118|588233014|FG000|Period 1|Lost to Follow-up|9|||
162871585|NCT01808118|588233015|FG001|Period 1|Lost to Follow-up|0|||
162871586|NCT01808118|588233016|FG002|Period 1|Lost to Follow-up|0|||
162871587|NCT01808118|588233014|FG000|Period 1|Did not meet criteria for remission|303|||
162871588|NCT01808118|588233015|FG001|Period 1|Did not meet criteria for remission|0|||
162871589|NCT01808118|588233016|FG002|Period 1|Did not meet criteria for remission|0|||
162960842|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
162960843|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
162960844|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
162960845|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
162960846|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
162960847|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
162960848|NCT00902538|588558909|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
162871590|NCT01808118|588233014|FG000|Period 1|Enrolled in error|7|||
162871591|NCT01808118|588233015|FG001|Period 1|Enrolled in error|0|||
162871592|NCT01808118|588233016|FG002|Period 1|Enrolled in error|0|||
162871593|NCT01808118|588233014|FG000|Period 1|Did not meet inclusion criteria|3|||
162871594|NCT01808118|588233015|FG001|Period 1|Did not meet inclusion criteria|0|||
162871595|NCT01808118|588233016|FG002|Period 1|Did not meet inclusion criteria|0|||
162871596|NCT01808118|588233014|FG000|Period 1|Non-conformance with inclusion criteria|3|||
162871597|NCT01808118|588233015|FG001|Period 1|Non-conformance with inclusion criteria|0|||
162871598|NCT01808118|588233016|FG002|Period 1|Non-conformance with inclusion criteria|0|||
162871599|NCT01808118|588233014|FG000|Period 1|Investigator decision: site closure|2|||
162871600|NCT01808118|588233015|FG001|Period 1|Investigator decision: site closure|0|||
162871601|NCT01808118|588233016|FG002|Period 1|Investigator decision: site closure|0|||
162871602|NCT01808118|588233014|FG000|Period 1|Non-compliance per sponsor|1|||
162871603|NCT01808118|588233015|FG001|Period 1|Non-compliance per sponsor|0|||
162871604|NCT01808118|588233016|FG002|Period 1|Non-compliance per sponsor|0|||
162871605|NCT01808118|588233014|FG000|Period 1|Lack of Efficacy|1|||
162871606|NCT01808118|588233015|FG001|Period 1|Lack of Efficacy|0|||
162871607|NCT01808118|588233016|FG002|Period 1|Lack of Efficacy|0|||
163047177|NCT00928434|588879401|FG002|Overall Study|Adverse Event|18|||
163047178|NCT00928434|588879399|FG000|Overall Study|Protocol Violation|5|||
163047179|NCT00928434|588879400|FG001|Overall Study|Protocol Violation|0|||
163047180|NCT00928434|588879401|FG002|Overall Study|Protocol Violation|8|||
163047181|NCT00928434|588879399|FG000|Overall Study|Physician Decision|2|||
163047182|NCT00928434|588879400|FG001|Overall Study|Physician Decision|0|||
163047183|NCT00928434|588879401|FG002|Overall Study|Physician Decision|3|||
163047184|NCT00928434|588879399|FG000|Overall Study|Lost to Follow-up|1|||
162871608|NCT01808118|588233014|FG000|Period 2|Adverse Event|0|||
162871609|NCT01808118|588233015|FG001|Period 2|Adverse Event|4|||
162871610|NCT01808118|588233016|FG002|Period 2|Adverse Event|0|||
162871611|NCT01808118|588233014|FG000|Period 2|Withdrew consent|0|||
162871612|NCT01808118|588233015|FG001|Period 2|Withdrew consent|7|||
162871613|NCT01808118|588233016|FG002|Period 2|Withdrew consent|6|||
162871614|NCT01808118|588233014|FG000|Period 2|Lost to Follow-up|0|||
162871615|NCT01808118|588233015|FG001|Period 2|Lost to Follow-up|0|||
162871616|NCT01808118|588233016|FG002|Period 2|Lost to Follow-up|2|||
162871617|NCT01808118|588233014|FG000|Period 2|Investigator no longer conducting trials|0|||
162871618|NCT01808118|588233015|FG001|Period 2|Investigator no longer conducting trials|1|||
162871619|NCT01808118|588233016|FG002|Period 2|Investigator no longer conducting trials|0|||
162871620|NCT01808118|588233014|FG000|Period 2|Switched to other therapy|0|||
162871621|NCT01808118|588233015|FG001|Period 2|Switched to other therapy|1|||
162871622|NCT01808118|588233016|FG002|Period 2|Switched to other therapy|0|||
162871623|NCT03097328|588233022|FG000|Overall Study|Still on Therapy|2|||
162871624|NCT03097328|588233022|FG000|Overall Study|Progressive Disease|29|||
162871625|NCT03097328|588233022|FG000|Overall Study|Adverse Event|4|||
162871626|NCT03097328|588233022|FG000|Overall Study|Withdrawal by Subject|1|||
162871627|NCT03097328|588233022|FG000|Overall Study|Physician Decision|1|||
162871628|NCT03097328|588233022|FG000|Overall Study|Patient Decision|1|||
162871629|NCT03097328|588233022|FG000|Overall Study|Ineligible for Study Drug|1|||
162871630|NCT02023164|588233023|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
162871631|NCT02023164|588233024|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
162871632|NCT01984346|588233027|FG000|Overall Study|Physician Decision|4|||
162871633|NCT01984346|588233028|FG001|Overall Study|Physician Decision|2|||
162871634|NCT01984346|588233027|FG000|Overall Study|Withdrawal by Subject|2|||
162871635|NCT01984346|588233028|FG001|Overall Study|Withdrawal by Subject|2|||
162871636|NCT01984346|588233027|FG000|Overall Study|Enrollment Closed|8|||
162871637|NCT01984346|588233028|FG001|Overall Study|Enrollment Closed|1|||
162871638|NCT01984346|588233027|FG000|Overall Study|Insurance Coverage|1|||
162871639|NCT01984346|588233028|FG001|Overall Study|Insurance Coverage|0|||
162871640|NCT01984346|588233027|FG000|Overall Study|Intra-operative Exclusion|2|||
162871641|NCT01984346|588233028|FG001|Overall Study|Intra-operative Exclusion|0|||
162960849|NCT00902538|588558910|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
162960850|NCT00902538|588558911|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
162960851|NCT00902538|588558912|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960852|NCT00902538|588558913|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960853|NCT00902538|588558914|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162960854|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
162960855|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
162960856|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
162960857|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
163047185|NCT00928434|588879400|FG001|Overall Study|Lost to Follow-up|0|||
163047186|NCT00928434|588879401|FG002|Overall Study|Lost to Follow-up|3|||
163047187|NCT00928434|588879399|FG000|Overall Study|Withdrawal by Subject|5|||
163047188|NCT00928434|588879400|FG001|Overall Study|Withdrawal by Subject|3|||
163047189|NCT00928434|588879401|FG002|Overall Study|Withdrawal by Subject|2|||
163047190|NCT00928434|588879399|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
162871642|NCT02042404|588233029|FG000|Overall Study|Death|1|||
162871643|NCT02042404|588233030|FG001|Overall Study|Death|0|||
162871644|NCT02042404|588233029|FG000|Overall Study|Unrelated Adverse Event|3|||
162871645|NCT02042404|588233030|FG001|Overall Study|Unrelated Adverse Event|0|||
162871646|NCT02042404|588233029|FG000|Overall Study|Inability to meet time requirements|1|||
162960858|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
163047191|NCT00928434|588879400|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
163047192|NCT00928434|588879401|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
162871647|NCT02042404|588233030|FG001|Overall Study|Inability to meet time requirements|0|||
162871648|NCT03100942|588233031|FG000|Randomized Treatment Period|Withdrew Consent|4|||
162871649|NCT03100942|588233032|FG001|Randomized Treatment Period|Withdrew Consent|5|||
162871650|NCT03100942|588233033|FG002|Randomized Treatment Period|Withdrew Consent|3|||
163047193|NCT00928434|588879399|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
162871651|NCT03100942|588233034|FG003|Randomized Treatment Period|Withdrew Consent|3|||
162871652|NCT03100942|588233035|FG004|Randomized Treatment Period|Withdrew Consent|0|||
163047194|NCT00928434|588879400|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
163047195|NCT00928434|588879401|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
163047196|NCT00928434|588879399|FG000|Overall Study|Other (not meeting above criteria)|5|||
162871653|NCT03100942|588233036|FG005|Randomized Treatment Period|Withdrew Consent|0|||
163047197|NCT00928434|588879400|FG001|Overall Study|Other (not meeting above criteria)|1|||
163047198|NCT00928434|588879401|FG002|Overall Study|Other (not meeting above criteria)|2|||
163047199|NCT03006562|588879402|FG000|Overall Study|Lost to Follow-up|0|||
163047200|NCT03006562|588879403|FG001|Overall Study|Lost to Follow-up|1|||
163047201|NCT00716456|588879404|FG000|Overall Study|Adverse Event|0|||
163047202|NCT00716456|588879405|FG001|Overall Study|Adverse Event|2|||
163047203|NCT00716456|588879406|FG002|Overall Study|Adverse Event|0|||
163047204|NCT00447772|588879407|FG000|Overall Study|Lack of Efficacy|3|||
163047205|NCT00447772|588879407|FG000|Overall Study|Insufficient compliance|6|||
163047206|NCT00447772|588879407|FG000|Overall Study|Discontinuation of drug therapy|1|||
163047207|NCT00447772|588879407|FG000|Overall Study|Lost to Follow-up|9|||
163047208|NCT00447772|588879407|FG000|Overall Study|Withdrawal by Subject|1|||
163047209|NCT00447772|588879407|FG000|Overall Study|Unable to attend all study visits|2|||
163047210|NCT00447772|588879407|FG000|Overall Study|Adverse Event|1|||
163047211|NCT00447772|588879407|FG000|Overall Study|Patient relocated|1|||
163047212|NCT00447772|588879407|FG000|Overall Study|Incomplete documentation at visit 1|1|||
163047213|NCT00447772|588879407|FG000|Overall Study|Chemotherapy for lung cancer|1|||
163047214|NCT00447772|588879407|FG000|Overall Study|Premature re-injection required|1|||
163047215|NCT02427841|588879408|FG000|Overall Study|Lack of Efficacy|5|||
163047216|NCT02427841|588879408|FG000|Overall Study|Physician Decision|2|||
163047217|NCT02427841|588879408|FG000|Overall Study|Withdrawal by Subject|1|||
163047218|NCT05417412|588879409|FG000|Overall Study|Lost to Follow-up|2|||
163047219|NCT01576575|588879410|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
163047220|NCT01576575|588879410|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
163047221|NCT01576575|588879410|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
163047222|NCT01610037|588879414|FG000|All Patients|Adverse Event|27|||
163047223|NCT01610037|588879415|FG001|All Patients|Adverse Event|22|||
163047224|NCT01610037|588879416|FG002|All Patients|Adverse Event|26|||
163047225|NCT01610037|588879414|FG000|All Patients|Withdrawal by Subject|12|||
163047226|NCT01610037|588879415|FG001|All Patients|Withdrawal by Subject|10|||
163047227|NCT01610037|588879416|FG002|All Patients|Withdrawal by Subject|20|||
163047228|NCT01610037|588879414|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
163047229|NCT01610037|588879415|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
163047230|NCT01610037|588879416|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
162871654|NCT03100942|588233037|FG006|Randomized Treatment Period|Withdrew Consent|0|||
163047231|NCT01610037|588879414|FG000|All Patients|Death|4|||
163047232|NCT01610037|588879415|FG001|All Patients|Death|2|||
163047233|NCT01610037|588879416|FG002|All Patients|Death|1|||
163047234|NCT01610037|588879414|FG000|All Patients|Protocol deviation|4|||
163047235|NCT01610037|588879415|FG001|All Patients|Protocol deviation|3|||
163047236|NCT01610037|588879416|FG002|All Patients|Protocol deviation|3|||
163047237|NCT01610037|588879414|FG000|All Patients|Abnormal laboratory value|1|||
163047238|NCT01610037|588879415|FG001|All Patients|Abnormal laboratory value|1|||
163047239|NCT01610037|588879416|FG002|All Patients|Abnormal laboratory value|0|||
163047240|NCT01610037|588879414|FG000|All Patients|Administrative problems|1|||
162871655|NCT03100942|588233031|FG000|Randomized Treatment Period|Adverse Event|5|||
162871656|NCT03100942|588233032|FG001|Randomized Treatment Period|Adverse Event|2|||
162871657|NCT03100942|588233033|FG002|Randomized Treatment Period|Adverse Event|1|||
162871658|NCT03100942|588233034|FG003|Randomized Treatment Period|Adverse Event|0|||
162871659|NCT03100942|588233035|FG004|Randomized Treatment Period|Adverse Event|0|||
162871660|NCT03100942|588233036|FG005|Randomized Treatment Period|Adverse Event|0|||
162871661|NCT03100942|588233037|FG006|Randomized Treatment Period|Adverse Event|0|||
162871662|NCT03100942|588233031|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
162871663|NCT03100942|588233032|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
162871664|NCT03100942|588233033|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
162871665|NCT03100942|588233034|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
162871666|NCT03100942|588233035|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
162871667|NCT03100942|588233036|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
162871668|NCT03100942|588233037|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
162871669|NCT03100942|588233031|FG000|Randomized Treatment Period|Protocol Violation|0|||
162871670|NCT03100942|588233032|FG001|Randomized Treatment Period|Protocol Violation|1|||
162871671|NCT03100942|588233033|FG002|Randomized Treatment Period|Protocol Violation|1|||
162871672|NCT03100942|588233034|FG003|Randomized Treatment Period|Protocol Violation|1|||
162871673|NCT03100942|588233035|FG004|Randomized Treatment Period|Protocol Violation|0|||
162871674|NCT03100942|588233036|FG005|Randomized Treatment Period|Protocol Violation|0|||
162871675|NCT03100942|588233037|FG006|Randomized Treatment Period|Protocol Violation|0|||
162871676|NCT03100942|588233031|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
162871677|NCT03100942|588233032|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
162871678|NCT03100942|588233033|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
162871679|NCT03100942|588233034|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
162871680|NCT03100942|588233035|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
162871681|NCT03100942|588233036|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
162871682|NCT03100942|588233037|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
162871683|NCT03100942|588233031|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
162871684|NCT03100942|588233032|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
162960859|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
162960860|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960861|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
162960862|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960863|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960864|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960865|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
162960866|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960867|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
162960868|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960869|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960870|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960871|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
162960872|NCT00902538|588558909|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960873|NCT00902538|588558910|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
162960874|NCT00902538|588558911|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960875|NCT00902538|588558912|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960876|NCT00902538|588558913|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960877|NCT00902538|588558914|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
162960878|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960879|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960880|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
162960881|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
162960882|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
162960883|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
162960884|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960885|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960886|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162960887|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
162960888|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
162960889|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162871685|NCT03100942|588233033|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
162871686|NCT03100942|588233034|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
162871687|NCT03100942|588233035|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
162871688|NCT03100942|588233036|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
162615075|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162615076|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162615077|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162615078|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
162615079|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615080|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615081|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615082|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615083|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615084|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162615085|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
162615086|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615087|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615088|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615089|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615090|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615091|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162615092|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
162615093|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615094|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615095|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615096|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615097|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615098|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162615099|NCT04526509|587307470|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
162615100|NCT04526509|587307471|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162960890|NCT00902538|588558909|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
163047241|NCT01610037|588879415|FG001|All Patients|Administrative problems|4|||
163047242|NCT01610037|588879416|FG002|All Patients|Administrative problems|4|||
163047243|NCT01610037|588879414|FG000|All Patients|Lost to Follow-up|1|||
163047244|NCT01610037|588879415|FG001|All Patients|Lost to Follow-up|0|||
163047245|NCT01610037|588879416|FG002|All Patients|Lost to Follow-up|0|||
163047246|NCT01610037|588879414|FG000|All Patients|Abnormal test procedure result(s)|0|||
163047247|NCT01610037|588879415|FG001|All Patients|Abnormal test procedure result(s)|1|||
163047248|NCT01610037|588879416|FG002|All Patients|Abnormal test procedure result(s)|3|||
163047249|NCT01610037|588879414|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
163047250|NCT01610037|588879415|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
163047251|NCT01610037|588879416|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
162615101|NCT04526509|587307472|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162615102|NCT04526509|587307473|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162615103|NCT04526509|587307474|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162615104|NCT04526509|587307475|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162615105|NCT04526509|587307476|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162615106|NCT04526509|587307470|FG000|Enrolled|Study Terminated by Sponsor|0|||
162615107|NCT04526509|587307471|FG001|Enrolled|Study Terminated by Sponsor|0|||
162615108|NCT04526509|587307472|FG002|Enrolled|Study Terminated by Sponsor|0|||
162871689|NCT03100942|588233037|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
162871690|NCT03100942|588233031|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871691|NCT03100942|588233032|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871692|NCT03100942|588233033|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871693|NCT03100942|588233034|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871694|NCT03100942|588233035|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871695|NCT03100942|588233036|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
162871696|NCT03100942|588233037|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
162871697|NCT01876732|588233042|FG000|Overall Study|MMA was not over 800mg/dL|75|||
162871698|NCT00536731|588233043|FG000|Overall Study|Adverse Event|3|||
162871699|NCT00536731|588233044|FG001|Overall Study|Adverse Event|2|||
162871700|NCT00536731|588233045|FG002|Overall Study|Adverse Event|3|||
162871701|NCT00536731|588233043|FG000|Overall Study|Withdrawal by Subject|0|||
162871702|NCT00536731|588233044|FG001|Overall Study|Withdrawal by Subject|2|||
162871703|NCT00536731|588233045|FG002|Overall Study|Withdrawal by Subject|0|||
162871704|NCT00536731|588233043|FG000|Overall Study|Intake of prohibited conc. medication|0|||
162871705|NCT00536731|588233044|FG001|Overall Study|Intake of prohibited conc. medication|0|||
162871706|NCT00536731|588233045|FG002|Overall Study|Intake of prohibited conc. medication|1|||
162871707|NCT00536731|588233043|FG000|Overall Study|Safety reasons|0|||
162871708|NCT00536731|588233044|FG001|Overall Study|Safety reasons|0|||
162871709|NCT00536731|588233045|FG002|Overall Study|Safety reasons|1|||
162871710|NCT00536731|588233043|FG000|Overall Study|Other|1|||
162871711|NCT00536731|588233044|FG001|Overall Study|Other|1|||
162871712|NCT00536731|588233045|FG002|Overall Study|Other|0|||
162871713|NCT00718419|588233046|FG000|Overall Study|Adverse Event|2|||
162960891|NCT00902538|588558910|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960892|NCT00902538|588558911|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960893|NCT00902538|588558912|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
162960894|NCT00902538|588558913|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960895|NCT00902538|588558914|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
162960896|NCT06336356|588558915|FG000|Overall Study|Withdrawal by Subject|1|||
162960897|NCT06336356|588558916|FG001|Overall Study|Withdrawal by Subject|0|||
162960898|NCT06336356|588558915|FG000|Overall Study|Lost to Follow Up|1|||
162960899|NCT06336356|588558916|FG001|Overall Study|Lost to Follow Up|0|||
162960900|NCT00725322|588558917|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
162960901|NCT00725322|588558918|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
162960902|NCT00725322|588558917|FG000|Washout (28 Days)|Protocol Violation|0|||
162960903|NCT00725322|588558918|FG001|Washout (28 Days)|Protocol Violation|1|||
162960904|NCT05871151|588558921|FG000|Overall Study|Lost to Follow-up|1|||
162960905|NCT05871151|588558922|FG001|Overall Study|Lost to Follow-up|0|||
162960906|NCT05871151|588558921|FG000|Overall Study|Unrelated illness|0|||
162960907|NCT05871151|588558922|FG001|Overall Study|Unrelated illness|1|||
162960908|NCT03215706|588558923|FG000|Randomization|Adverse Event unrelated to study drug|1|||
162960909|NCT03215706|588558924|FG001|Randomization|Adverse Event unrelated to study drug|0|||
162960910|NCT03215706|588558923|FG000|Randomization|participant withdrew consent|1|||
162960911|NCT03215706|588558924|FG001|Randomization|participant withdrew consent|3|||
162960912|NCT03215706|588558923|FG000|Randomization|no longer meets study criteria|1|||
162960913|NCT03215706|588558924|FG001|Randomization|no longer meets study criteria|4|||
162960914|NCT03215706|588558923|FG000|Randomization|other reasons|0|||
162960915|NCT03215706|588558924|FG001|Randomization|other reasons|2|||
162960916|NCT03215706|588558923|FG000|Treatment Period|Disease Progression|184|||
162871714|NCT00718419|588233047|FG001|Overall Study|Adverse Event|1|||
162871715|NCT00718419|588233046|FG000|Overall Study|Physician Decision|1|||
162871716|NCT00718419|588233047|FG001|Overall Study|Physician Decision|6|||
162871717|NCT00718419|588233046|FG000|Overall Study|Sponsor decision|0|||
162871718|NCT00718419|588233047|FG001|Overall Study|Sponsor decision|1|||
162871719|NCT00718419|588233046|FG000|Overall Study|Withdrawal by Subject|0|||
162960917|NCT03215706|588558924|FG001|Treatment Period|Disease Progression|174|||
162960918|NCT03215706|588558923|FG000|Treatment Period|Study Drug Toxicity|70|||
162960919|NCT03215706|588558924|FG001|Treatment Period|Study Drug Toxicity|24|||
162960920|NCT03215706|588558923|FG000|Treatment Period|Death|7|||
162871720|NCT00718419|588233047|FG001|Overall Study|Withdrawal by Subject|5|||
162960921|NCT03215706|588558924|FG001|Treatment Period|Death|1|||
162960922|NCT03215706|588558923|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
162960923|NCT03215706|588558924|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
162871721|NCT00718419|588233046|FG000|Overall Study|Progressive Disease|7|||
162871722|NCT00718419|588233047|FG001|Overall Study|Progressive Disease|25|||
162871723|NCT00718419|588233046|FG000|Overall Study|Death Due to Progressive Disease|2|||
162871724|NCT00718419|588233047|FG001|Overall Study|Death Due to Progressive Disease|0|||
162871725|NCT00718419|588233046|FG000|Overall Study|Death Due to Study Drug Related|0|||
162871726|NCT00718419|588233047|FG001|Overall Study|Death Due to Study Drug Related|1|||
162871727|NCT00718419|588233046|FG000|Overall Study|Death Due to Adverse Events|1|||
162871728|NCT00718419|588233047|FG001|Overall Study|Death Due to Adverse Events|0|||
162871729|NCT04184622|588233050|FG000|Primary Treatment Period|Adverse Event|6|||
162871730|NCT04184622|588233051|FG001|Primary Treatment Period|Adverse Event|4|||
162871731|NCT04184622|588233052|FG002|Primary Treatment Period|Adverse Event|8|||
162871732|NCT04184622|588233053|FG003|Primary Treatment Period|Adverse Event|6|||
162871733|NCT04184622|588233050|FG000|Primary Treatment Period|Death|4|||
162871734|NCT04184622|588233051|FG001|Primary Treatment Period|Death|4|||
162871735|NCT04184622|588233052|FG002|Primary Treatment Period|Death|2|||
162871736|NCT04184622|588233053|FG003|Primary Treatment Period|Death|1|||
162871737|NCT04184622|588233050|FG000|Primary Treatment Period|Lost to Follow-up|41|||
163047252|NCT01610037|588879414|FG000|Treatment and Follow up Period|Death|10|||
163047253|NCT01610037|588879415|FG001|Treatment and Follow up Period|Death|5|||
163047254|NCT01610037|588879416|FG002|Treatment and Follow up Period|Death|4|||
163047255|NCT01610037|588879414|FG000|Treatment and Follow up Period|Administrative problems|1|||
163047256|NCT01610037|588879415|FG001|Treatment and Follow up Period|Administrative problems|3|||
163047257|NCT01610037|588879416|FG002|Treatment and Follow up Period|Administrative problems|2|||
163047258|NCT01610037|588879414|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
163047259|NCT01610037|588879415|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
163047260|NCT01610037|588879416|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
163047261|NCT00274742|588879417|FG000|Overall Study|Adverse Event|0|||
163047262|NCT00274742|588879418|FG001|Overall Study|Adverse Event|4|||
163047263|NCT00274742|588879419|FG002|Overall Study|Adverse Event|1|||
163047264|NCT00274742|588879420|FG003|Overall Study|Adverse Event|4|||
163047265|NCT00274742|588879421|FG004|Overall Study|Adverse Event|12|||
163047266|NCT00274742|588879422|FG005|Overall Study|Adverse Event|3|||
163047267|NCT00274742|588879417|FG000|Overall Study|Lost to Follow-up|0|||
163047268|NCT00274742|588879418|FG001|Overall Study|Lost to Follow-up|0|||
163047269|NCT00274742|588879419|FG002|Overall Study|Lost to Follow-up|0|||
163047270|NCT00274742|588879420|FG003|Overall Study|Lost to Follow-up|0|||
163047271|NCT00274742|588879421|FG004|Overall Study|Lost to Follow-up|1|||
163047272|NCT00274742|588879422|FG005|Overall Study|Lost to Follow-up|0|||
163047273|NCT00274742|588879417|FG000|Overall Study|End of Study|0|||
163047274|NCT00274742|588879418|FG001|Overall Study|End of Study|0|||
162615109|NCT04526509|587307473|FG003|Enrolled|Study Terminated by Sponsor|0|||
162960924|NCT03215706|588558923|FG000|Treatment Period|Request to D/C treatment|2|||
162960925|NCT03215706|588558924|FG001|Treatment Period|Request to D/C treatment|10|||
162960926|NCT03215706|588558923|FG000|Treatment Period|Participant withdrew consent|4|||
162960927|NCT03215706|588558924|FG001|Treatment Period|Participant withdrew consent|5|||
162960928|NCT03215706|588558923|FG000|Treatment Period|Lost to Follow-up|0|||
162960929|NCT03215706|588558924|FG001|Treatment Period|Lost to Follow-up|1|||
162960930|NCT03215706|588558923|FG000|Treatment Period|Administrative reason by sponsor|0|||
162960931|NCT03215706|588558924|FG001|Treatment Period|Administrative reason by sponsor|2|||
162960932|NCT03215706|588558923|FG000|Treatment Period|other reasons|10|||
162960933|NCT03215706|588558924|FG001|Treatment Period|other reasons|5|||
162960934|NCT03215706|588558923|FG000|Treatment Period|Not reported|1|||
162960935|NCT03215706|588558924|FG001|Treatment Period|Not reported|0|||
163047275|NCT00274742|588879419|FG002|Overall Study|End of Study|0|||
163047276|NCT00274742|588879420|FG003|Overall Study|End of Study|1|||
162871738|NCT04184622|588233051|FG001|Primary Treatment Period|Lost to Follow-up|17|||
162871739|NCT04184622|588233052|FG002|Primary Treatment Period|Lost to Follow-up|15|||
162871740|NCT04184622|588233053|FG003|Primary Treatment Period|Lost to Follow-up|13|||
162871741|NCT04184622|588233050|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
162960936|NCT03114891|588558926|FG000|First Treatment Round|Lost to Follow-up|0|||
162960937|NCT03114891|588558927|FG001|First Treatment Round|Lost to Follow-up|1|||
162960938|NCT03114891|588558928|FG002|First Treatment Round|Lost to Follow-up|1|||
162871742|NCT04184622|588233051|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
162871743|NCT04184622|588233052|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
162871744|NCT04184622|588233053|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
162871745|NCT04184622|588233050|FG000|Primary Treatment Period|Physician Decision|0|||
162871746|NCT04184622|588233051|FG001|Primary Treatment Period|Physician Decision|0|||
162871747|NCT04184622|588233052|FG002|Primary Treatment Period|Physician Decision|3|||
162871748|NCT04184622|588233053|FG003|Primary Treatment Period|Physician Decision|1|||
162871749|NCT04184622|588233050|FG000|Primary Treatment Period|Pregnancy|4|||
162871750|NCT04184622|588233051|FG001|Primary Treatment Period|Pregnancy|3|||
162871751|NCT04184622|588233052|FG002|Primary Treatment Period|Pregnancy|4|||
162871752|NCT04184622|588233053|FG003|Primary Treatment Period|Pregnancy|1|||
162871753|NCT04184622|588233050|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
162871754|NCT04184622|588233051|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
162871755|NCT04184622|588233052|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
162871756|NCT04184622|588233053|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
162871757|NCT04184622|588233050|FG000|Additional Treatment Period|Adverse Event|1|||
162871758|NCT04184622|588233051|FG001|Additional Treatment Period|Adverse Event|2|||
162871759|NCT04184622|588233052|FG002|Additional Treatment Period|Adverse Event|1|||
162871760|NCT04184622|588233053|FG003|Additional Treatment Period|Adverse Event|0|||
162871761|NCT04184622|588233050|FG000|Additional Treatment Period|Death|0|||
162871762|NCT04184622|588233051|FG001|Additional Treatment Period|Death|0|||
162871763|NCT04184622|588233052|FG002|Additional Treatment Period|Death|1|||
162871764|NCT04184622|588233053|FG003|Additional Treatment Period|Death|1|||
162871765|NCT04184622|588233050|FG000|Additional Treatment Period|Lost to Follow-up|6|||
162871766|NCT04184622|588233051|FG001|Additional Treatment Period|Lost to Follow-up|4|||
162871767|NCT04184622|588233052|FG002|Additional Treatment Period|Lost to Follow-up|8|||
162871768|NCT04184622|588233053|FG003|Additional Treatment Period|Lost to Follow-up|6|||
162871769|NCT04184622|588233050|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
162871770|NCT04184622|588233051|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
162871771|NCT04184622|588233052|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
162871772|NCT04184622|588233053|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
162871773|NCT04184622|588233050|FG000|Additional Treatment Period|Physician Decision|0|||
162871774|NCT04184622|588233051|FG001|Additional Treatment Period|Physician Decision|0|||
162871775|NCT04184622|588233052|FG002|Additional Treatment Period|Physician Decision|1|||
162871776|NCT04184622|588233053|FG003|Additional Treatment Period|Physician Decision|0|||
162871777|NCT04184622|588233050|FG000|Additional Treatment Period|Pregnancy|0|||
162871778|NCT04184622|588233051|FG001|Additional Treatment Period|Pregnancy|0|||
162871779|NCT04184622|588233052|FG002|Additional Treatment Period|Pregnancy|0|||
162871780|NCT04184622|588233053|FG003|Additional Treatment Period|Pregnancy|1|||
162871781|NCT04184622|588233050|FG000|Additional Treatment Period|Protocol deviation|0|||
162871782|NCT04184622|588233051|FG001|Additional Treatment Period|Protocol deviation|0|||
162871783|NCT04184622|588233052|FG002|Additional Treatment Period|Protocol deviation|1|||
162871784|NCT04184622|588233053|FG003|Additional Treatment Period|Protocol deviation|0|||
162871785|NCT04184622|588233050|FG000|Additional Treatment Period|Site closed|1|||
162871786|NCT04184622|588233051|FG001|Additional Treatment Period|Site closed|0|||
162871787|NCT04184622|588233052|FG002|Additional Treatment Period|Site closed|1|||
162871788|NCT04184622|588233053|FG003|Additional Treatment Period|Site closed|0|||
162871789|NCT04184622|588233050|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
162871790|NCT04184622|588233051|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
162871791|NCT04184622|588233052|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
162871792|NCT04184622|588233053|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
162871793|NCT04184622|588233050|FG000|Safety Follow-up Period|Adverse Event|6|||
162871794|NCT04184622|588233051|FG001|Safety Follow-up Period|Adverse Event|8|||
162871795|NCT04184622|588233052|FG002|Safety Follow-up Period|Adverse Event|9|||
162871796|NCT04184622|588233053|FG003|Safety Follow-up Period|Adverse Event|16|||
162871797|NCT04184622|588233050|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
162871798|NCT04184622|588233051|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
162871799|NCT04184622|588233052|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
162871800|NCT04184622|588233053|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
162871801|NCT04184622|588233050|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
162871802|NCT04184622|588233051|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
162871803|NCT04184622|588233052|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
162871804|NCT04184622|588233053|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
162871805|NCT04184622|588233050|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
162871806|NCT04184622|588233051|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
162871807|NCT04184622|588233052|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
162871808|NCT04184622|588233053|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
162871809|NCT04184622|588233050|FG000|Safety Follow-up Period|Physician Decision|1|||
162871810|NCT04184622|588233051|FG001|Safety Follow-up Period|Physician Decision|0|||
162871811|NCT04184622|588233052|FG002|Safety Follow-up Period|Physician Decision|0|||
162871812|NCT04184622|588233053|FG003|Safety Follow-up Period|Physician Decision|1|||
162871813|NCT04184622|588233050|FG000|Safety Follow-up Period|Pregnancy|1|||
162871814|NCT04184622|588233051|FG001|Safety Follow-up Period|Pregnancy|3|||
162871815|NCT04184622|588233052|FG002|Safety Follow-up Period|Pregnancy|0|||
162871816|NCT04184622|588233053|FG003|Safety Follow-up Period|Pregnancy|6|||
162871817|NCT04184622|588233050|FG000|Safety Follow-up Period|Protocol deviation|1|||
162871818|NCT04184622|588233051|FG001|Safety Follow-up Period|Protocol deviation|0|||
162871819|NCT04184622|588233052|FG002|Safety Follow-up Period|Protocol deviation|0|||
162871820|NCT04184622|588233053|FG003|Safety Follow-up Period|Protocol deviation|0|||
162871821|NCT04184622|588233050|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
162871822|NCT04184622|588233051|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
162871823|NCT04184622|588233052|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
162871824|NCT04184622|588233053|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
162871825|NCT02795988|588233054|FG000|Phase 1b|Withdrawal by Subject|0|||
162871826|NCT02795988|588233055|FG001|Phase 1b|Withdrawal by Subject|1|||
162871827|NCT02795988|588233056|FG002|Phase 1b|Withdrawal by Subject|0|||
162871828|NCT02795988|588233057|FG003|Phase 1b|Withdrawal by Subject|0|||
162871829|NCT02795988|588233058|FG004|Phase 1b|Withdrawal by Subject|0|||
162871830|NCT02795988|588233059|FG005|Phase 1b|Withdrawal by Subject|0|||
162871831|NCT02795988|588233060|FG006|Phase 1b|Withdrawal by Subject|0|||
162871832|NCT02795988|588233054|FG000|Phase 1b|Death|1|||
162871833|NCT02795988|588233055|FG001|Phase 1b|Death|2|||
162871834|NCT02795988|588233056|FG002|Phase 1b|Death|1|||
162871835|NCT02795988|588233057|FG003|Phase 1b|Death|0|||
162871836|NCT02795988|588233058|FG004|Phase 1b|Death|0|||
162871837|NCT02795988|588233059|FG005|Phase 1b|Death|0|||
162871838|NCT02795988|588233060|FG006|Phase 1b|Death|0|||
162871839|NCT02795988|588233054|FG000|Phase 1b|Physician Decision|0|||
162871840|NCT02795988|588233055|FG001|Phase 1b|Physician Decision|0|||
162871841|NCT02795988|588233056|FG002|Phase 1b|Physician Decision|1|||
162871842|NCT02795988|588233057|FG003|Phase 1b|Physician Decision|0|||
162871843|NCT02795988|588233058|FG004|Phase 1b|Physician Decision|0|||
162871844|NCT02795988|588233059|FG005|Phase 1b|Physician Decision|0|||
162871845|NCT02795988|588233060|FG006|Phase 1b|Physician Decision|0|||
162871846|NCT02795988|588233054|FG000|Phase 1b|Progressive Disease|2|||
162871847|NCT02795988|588233055|FG001|Phase 1b|Progressive Disease|2|||
162871848|NCT02795988|588233056|FG002|Phase 1b|Progressive Disease|0|||
162871849|NCT02795988|588233057|FG003|Phase 1b|Progressive Disease|0|||
162871850|NCT02795988|588233058|FG004|Phase 1b|Progressive Disease|0|||
162871851|NCT02795988|588233059|FG005|Phase 1b|Progressive Disease|0|||
162871852|NCT02795988|588233060|FG006|Phase 1b|Progressive Disease|0|||
162871853|NCT02795988|588233054|FG000|Phase 2|Withdrawal by Subject|0|||
162871854|NCT02795988|588233055|FG001|Phase 2|Withdrawal by Subject|0|||
162871855|NCT02795988|588233056|FG002|Phase 2|Withdrawal by Subject|0|||
162871856|NCT02795988|588233057|FG003|Phase 2|Withdrawal by Subject|1|||
162871857|NCT02795988|588233058|FG004|Phase 2|Withdrawal by Subject|0|||
162871858|NCT02795988|588233059|FG005|Phase 2|Withdrawal by Subject|0|||
162871859|NCT02795988|588233060|FG006|Phase 2|Withdrawal by Subject|0|||
162871860|NCT02795988|588233054|FG000|Phase 2|Death|0|||
162871861|NCT02795988|588233055|FG001|Phase 2|Death|0|||
162871862|NCT02795988|588233056|FG002|Phase 2|Death|0|||
162871863|NCT02795988|588233057|FG003|Phase 2|Death|17|||
162871864|NCT02795988|588233058|FG004|Phase 2|Death|17|||
162871865|NCT02795988|588233059|FG005|Phase 2|Death|0|||
162871866|NCT02795988|588233060|FG006|Phase 2|Death|0|||
162871867|NCT02795988|588233054|FG000|Phase 2|Other|0|||
162871868|NCT02795988|588233055|FG001|Phase 2|Other|0|||
162871869|NCT02795988|588233056|FG002|Phase 2|Other|0|||
162871870|NCT02795988|588233057|FG003|Phase 2|Other|1|||
162871871|NCT02795988|588233058|FG004|Phase 2|Other|0|||
162871872|NCT02795988|588233059|FG005|Phase 2|Other|0|||
162871873|NCT02795988|588233060|FG006|Phase 2|Other|0|||
162871874|NCT02795988|588233054|FG000|Phase 2 Extension|Death|0|||
162871875|NCT02795988|588233055|FG001|Phase 2 Extension|Death|0|||
162871876|NCT02795988|588233056|FG002|Phase 2 Extension|Death|0|||
162871877|NCT02795988|588233057|FG003|Phase 2 Extension|Death|0|||
162871878|NCT02795988|588233058|FG004|Phase 2 Extension|Death|0|||
162871879|NCT02795988|588233059|FG005|Phase 2 Extension|Death|5|||
162871880|NCT02795988|588233060|FG006|Phase 2 Extension|Death|6|||
162871881|NCT02795988|588233054|FG000|Phase 2 Extension|Other reasons|0|||
162871882|NCT02795988|588233055|FG001|Phase 2 Extension|Other reasons|0|||
162871883|NCT02795988|588233056|FG002|Phase 2 Extension|Other reasons|0|||
162871884|NCT02795988|588233057|FG003|Phase 2 Extension|Other reasons|0|||
162871885|NCT02795988|588233058|FG004|Phase 2 Extension|Other reasons|0|||
162871886|NCT02795988|588233059|FG005|Phase 2 Extension|Other reasons|2|||
162871887|NCT02795988|588233060|FG006|Phase 2 Extension|Other reasons|1|||
162871888|NCT00726323|588233061|FG000|Overall Study|Withdrawal by Subject|3|||
162871889|NCT00726323|588233062|FG001|Overall Study|Withdrawal by Subject|1|||
162871890|NCT00726323|588233061|FG000|Overall Study|Physician Decision|1|||
162871891|NCT00726323|588233062|FG001|Overall Study|Physician Decision|0|||
162871892|NCT00726323|588233061|FG000|Overall Study|Progressive disease|23|||
162871893|NCT00726323|588233062|FG001|Overall Study|Progressive disease|16|||
162871894|NCT00726323|588233061|FG000|Overall Study|Clinical progression|0|||
162871895|NCT00726323|588233062|FG001|Overall Study|Clinical progression|3|||
162871896|NCT00726323|588233061|FG000|Overall Study|Adverse Event|9|||
162871897|NCT00726323|588233062|FG001|Overall Study|Adverse Event|9|||
162871898|NCT00726323|588233061|FG000|Overall Study|Death|1|||
162871899|NCT00726323|588233062|FG001|Overall Study|Death|0|||
162871900|NCT00726323|588233061|FG000|Overall Study|Participant wished to discontinue|0|||
162871901|NCT00726323|588233062|FG001|Overall Study|Participant wished to discontinue|1|||
162871902|NCT00726323|588233061|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
162960939|NCT03114891|588558929|FG003|First Treatment Round|Lost to Follow-up|0|||
162960940|NCT03114891|588558926|FG000|First Treatment Round|Withdrawal by Subject|0|||
162960941|NCT03114891|588558927|FG001|First Treatment Round|Withdrawal by Subject|2|||
162960942|NCT03114891|588558928|FG002|First Treatment Round|Withdrawal by Subject|0|||
162960943|NCT03114891|588558929|FG003|First Treatment Round|Withdrawal by Subject|1|||
162960944|NCT03114891|588558926|FG000|3 Week Break|Lost to Follow-up|1|||
162960945|NCT03114891|588558927|FG001|3 Week Break|Lost to Follow-up|0|||
162960946|NCT03114891|588558928|FG002|3 Week Break|Lost to Follow-up|0|||
162960947|NCT03114891|588558929|FG003|3 Week Break|Lost to Follow-up|1|||
162960948|NCT03114891|588558926|FG000|3 Week Break|Withdrawal by Subject|0|||
162960949|NCT03114891|588558927|FG001|3 Week Break|Withdrawal by Subject|1|||
162960950|NCT03114891|588558928|FG002|3 Week Break|Withdrawal by Subject|0|||
162960951|NCT03114891|588558929|FG003|3 Week Break|Withdrawal by Subject|0|||
162960952|NCT03114891|588558926|FG000|Second Treatment Round|Lost to Follow-up|1|||
162960953|NCT03114891|588558927|FG001|Second Treatment Round|Lost to Follow-up|0|||
162960954|NCT03114891|588558928|FG002|Second Treatment Round|Lost to Follow-up|0|||
162960955|NCT03114891|588558929|FG003|Second Treatment Round|Lost to Follow-up|0|||
162960956|NCT03114891|588558926|FG000|Second Treatment Round|Physician Decision|1|||
162960957|NCT03114891|588558927|FG001|Second Treatment Round|Physician Decision|0|||
162960958|NCT03114891|588558928|FG002|Second Treatment Round|Physician Decision|0|||
162960959|NCT03114891|588558929|FG003|Second Treatment Round|Physician Decision|0|||
162960960|NCT03506633|588560645|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
162960961|NCT03506633|588560646|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
162960962|NCT03247686|588560651|FG000|Overall Study|Withdrawal by Subject|1|||
162960963|NCT03247686|588560652|FG001|Overall Study|Withdrawal by Subject|2|||
162960964|NCT02302716|588560653|FG000|Overall Study|Adverse Event|1|||
162960965|NCT02302716|588560654|FG001|Overall Study|Adverse Event|1|||
162960966|NCT02302716|588560653|FG000|Overall Study|Death|0|||
162960967|NCT02302716|588560654|FG001|Overall Study|Death|1|||
162960968|NCT02302716|588560653|FG000|Overall Study|Lack of Efficacy|0|||
162960969|NCT02302716|588560654|FG001|Overall Study|Lack of Efficacy|1|||
163047277|NCT00274742|588879421|FG004|Overall Study|End of Study|0|||
163047278|NCT00274742|588879422|FG005|Overall Study|End of Study|0|||
163047279|NCT00274742|588879417|FG000|Overall Study|Disease Progression|0|||
163047280|NCT00274742|588879418|FG001|Overall Study|Disease Progression|1|||
163047281|NCT00274742|588879419|FG002|Overall Study|Disease Progression|1|||
163047282|NCT00274742|588879420|FG003|Overall Study|Disease Progression|0|||
163047283|NCT00274742|588879421|FG004|Overall Study|Disease Progression|1|||
163047284|NCT00274742|588879422|FG005|Overall Study|Disease Progression|0|||
163047285|NCT00274742|588879417|FG000|Overall Study|Other|0|||
163047286|NCT00274742|588879418|FG001|Overall Study|Other|3|||
163047287|NCT00274742|588879419|FG002|Overall Study|Other|0|||
163047288|NCT00274742|588879420|FG003|Overall Study|Other|0|||
163047289|NCT00274742|588879421|FG004|Overall Study|Other|2|||
163047290|NCT00274742|588879422|FG005|Overall Study|Other|0|||
163047291|NCT00977613|588879429|FG000|Overall Study|Lost to Follow-up|16|||
163047292|NCT01598610|588879436|FG000|Overall Study|Adverse Event|1|||
163047293|NCT02989402|588879442|FG000|Overall Study|Adverse event, or serious adverse event|4|||
162871903|NCT00726323|588233062|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
162960970|NCT02302716|588560653|FG000|Overall Study|Lost to Follow-up|2|||
162960971|NCT02302716|588560654|FG001|Overall Study|Lost to Follow-up|4|||
162960972|NCT02302716|588560653|FG000|Overall Study|Physician Decision|3|||
162960973|NCT02302716|588560654|FG001|Overall Study|Physician Decision|4|||
162960974|NCT02302716|588560653|FG000|Overall Study|Withdrawal by Subject|13|||
163047294|NCT02989402|588879442|FG000|Overall Study|Death|2|||
162871904|NCT02341014|588233063|FG000|Overall Study|Adverse Event|0|||
162871905|NCT02341014|588233064|FG001|Overall Study|Adverse Event|1|||
162871906|NCT02341014|588233065|FG002|Overall Study|Adverse Event|0|||
162871907|NCT02341014|588233066|FG003|Overall Study|Adverse Event|0|||
162871908|NCT02341014|588233067|FG004|Overall Study|Adverse Event|2|||
162871909|NCT05058664|588233068|FG000|Overall Study|No follow-up data provided|4|||
162871910|NCT05058664|588233069|FG001|Overall Study|No follow-up data provided|0|||
162871911|NCT05058664|588233070|FG002|Overall Study|No follow-up data provided|2|||
162871912|NCT05058664|588233068|FG000|Overall Study|Withdrawal by Subject|0|||
162871913|NCT05058664|588233069|FG001|Overall Study|Withdrawal by Subject|0|||
162871914|NCT05058664|588233070|FG002|Overall Study|Withdrawal by Subject|1|||
162871915|NCT01617681|588233071|FG000|Period 1 Double Blind|Adverse Event|2|||
162871916|NCT01617681|588233072|FG001|Period 1 Double Blind|Adverse Event|0|||
162871917|NCT01617681|588233073|FG002|Period 1 Double Blind|Adverse Event|0|||
162871918|NCT01617681|588233074|FG003|Period 1 Double Blind|Adverse Event|2|||
162871919|NCT01617681|588233075|FG004|Period 1 Double Blind|Adverse Event|0|||
162871920|NCT01617681|588233071|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
162871921|NCT01617681|588233072|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
162871922|NCT01617681|588233073|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
162871923|NCT01617681|588233074|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
162871924|NCT01617681|588233075|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
162871925|NCT01617681|588233071|FG000|Period 2 Open Label|Adverse Event|0|||
162871926|NCT01617681|588233072|FG001|Period 2 Open Label|Adverse Event|0|||
162871927|NCT01617681|588233073|FG002|Period 2 Open Label|Adverse Event|0|||
162871928|NCT01617681|588233074|FG003|Period 2 Open Label|Adverse Event|0|||
162871929|NCT01617681|588233075|FG004|Period 2 Open Label|Adverse Event|3|||
162871930|NCT01617681|588233071|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
162871931|NCT01617681|588233072|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
162871932|NCT01617681|588233073|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
162871933|NCT01617681|588233074|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
162871934|NCT01617681|588233075|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
162871935|NCT00643487|588233084|FG000|Overall Study|Technical difficulty|3|||
162871936|NCT00109733|588233087|FG000|Overall Study|Protocol Violation|0|||
162871937|NCT00109733|588233088|FG001|Overall Study|Protocol Violation|1|||
162871938|NCT00109733|588233087|FG000|Overall Study|Stopped taking study drug|1|||
162871939|NCT00109733|588233088|FG001|Overall Study|Stopped taking study drug|1|||
162871940|NCT00109733|588233087|FG000|Overall Study|Non-compliant|0|||
162871941|NCT00109733|588233088|FG001|Overall Study|Non-compliant|1|||
162871942|NCT00109733|588233087|FG000|Overall Study|Could not commit time for study|1|||
162871943|NCT00109733|588233088|FG001|Overall Study|Could not commit time for study|1|||
162871944|NCT05628181|588233100|FG000|Overall Study|Death|2|||
162871945|NCT05628181|588233101|FG001|Overall Study|Death|4|||
162871946|NCT05628181|588233102|FG002|Overall Study|Death|0|||
162871947|NCT01234402|588233103|FG000|Overall Study|Lost to Follow-up|0|||
162871948|NCT01234402|588233104|FG001|Overall Study|Lost to Follow-up|1|||
162871949|NCT01234402|588233105|FG002|Overall Study|Lost to Follow-up|3|||
163047295|NCT02989402|588879442|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
163047296|NCT02989402|588879442|FG000|Overall Study|Lost to Follow-up|8|||
163047297|NCT02989402|588879442|FG000|Overall Study|Patient no longer on monotherapy|1|||
163047298|NCT02989402|588879442|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
163047299|NCT02989402|588879442|FG000|Overall Study|Withdrawal by Subject|7|||
163047300|NCT02989402|588879442|FG000|Overall Study|Other|2|||
163047301|NCT03066830|588879443|FG000|Overall Study|At the Participant's own Request|16|||
163047302|NCT03066830|588879444|FG001|Overall Study|At the Participant's own Request|17|||
163047303|NCT03066830|588879443|FG000|Overall Study|Other|3|||
163047304|NCT03066830|588879444|FG001|Overall Study|Other|0|||
163047305|NCT03066830|588879443|FG000|Overall Study|Poor Compliance to Protocol|1|||
163047306|NCT03066830|588879444|FG001|Overall Study|Poor Compliance to Protocol|0|||
163047307|NCT03066830|588879443|FG000|Overall Study|Adverse Event|2|||
163047308|NCT03066830|588879444|FG001|Overall Study|Adverse Event|2|||
163047309|NCT03066830|588879443|FG000|Overall Study|Lost to Follow-up|11|||
163047310|NCT03066830|588879444|FG001|Overall Study|Lost to Follow-up|3|||
162871950|NCT01234402|588233103|FG000|Overall Study|Withdrawal by Subject|1|||
162871951|NCT01234402|588233104|FG001|Overall Study|Withdrawal by Subject|3|||
162871952|NCT01234402|588233105|FG002|Overall Study|Withdrawal by Subject|4|||
162871953|NCT01234402|588233103|FG000|Overall Study|Never treated: Death|0|||
162871954|NCT01234402|588233104|FG001|Overall Study|Never treated: Death|0|||
163047311|NCT02039778|588879446|FG000|Overall Study|Death|2|||
163047312|NCT02039778|588879446|FG000|Overall Study|Withdrawal by Subject|1|||
163047313|NCT02039778|588879446|FG000|Overall Study|Never started the protocol treatment|1|||
163047314|NCT01216332|588879458|FG000|Overall Study|Withdrawal by Subject|4|||
163047315|NCT01216332|588879459|FG001|Overall Study|Withdrawal by Subject|0|||
163047316|NCT03677869|588879460|FG000|Overall Study|Withdrawal by Subject|1|||
162871955|NCT01234402|588233105|FG002|Overall Study|Never treated: Death|1|||
162871956|NCT01234402|588233103|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
162871957|NCT01234402|588233104|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
162871958|NCT01234402|588233105|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
162871959|NCT01234402|588233103|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
162871960|NCT01234402|588233104|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
162871961|NCT01234402|588233105|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
162871962|NCT02280291|588233107|FG000|Overall Study|Lost to Follow-up|2|||
162871963|NCT02280291|588233108|FG001|Overall Study|Lost to Follow-up|1|||
162871964|NCT02280291|588233109|FG002|Overall Study|Lost to Follow-up|3|||
162871965|NCT02280291|588233110|FG003|Overall Study|Lost to Follow-up|8|||
162871966|NCT02280291|588233107|FG000|Overall Study|Protocol Violation|1|||
162871967|NCT02280291|588233108|FG001|Overall Study|Protocol Violation|0|||
162871968|NCT02280291|588233109|FG002|Overall Study|Protocol Violation|0|||
162871969|NCT02280291|588233110|FG003|Overall Study|Protocol Violation|0|||
162871970|NCT02280291|588233107|FG000|Overall Study|Other|1|||
162871971|NCT02280291|588233108|FG001|Overall Study|Other|1|||
162871972|NCT02280291|588233109|FG002|Overall Study|Other|0|||
162871973|NCT02280291|588233110|FG003|Overall Study|Other|0|||
162871974|NCT03508622|588233111|FG000|Overall Study|Protocol Violation|1|||
162871975|NCT03508622|588233112|FG001|Overall Study|Protocol Violation|0|||
162871976|NCT03508622|588233111|FG000|Overall Study|Withdrawal by Subject|1|||
162871977|NCT03508622|588233112|FG001|Overall Study|Withdrawal by Subject|0|||
162871978|NCT03508622|588233111|FG000|Overall Study|Lost to Follow-up|16|||
162871979|NCT03508622|588233112|FG001|Overall Study|Lost to Follow-up|0|||
162871980|NCT03508622|588233111|FG000|Overall Study|Incomplete data|0|||
162871981|NCT03508622|588233112|FG001|Overall Study|Incomplete data|24|||
162871982|NCT00506077|588233114|FG000|Treatment Period 1|Adverse Event|2|||
162871983|NCT00506077|588233115|FG001|Treatment Period 1|Adverse Event|1|||
162871984|NCT00506077|588233114|FG000|Treatment Period 1|Lost to Follow-up|0|||
162871985|NCT00506077|588233115|FG001|Treatment Period 1|Lost to Follow-up|2|||
162871986|NCT00506077|588233114|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162871987|NCT00506077|588233115|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162871988|NCT00506077|588233114|FG000|Treatment Period 2|Adverse Event|0|||
162871989|NCT00506077|588233115|FG001|Treatment Period 2|Adverse Event|1|||
162871990|NCT00506077|588233114|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162871991|NCT00506077|588233115|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162871992|NCT00316303|588233116|FG000|Overall Study|Lost to Follow-up|11|||
162871993|NCT00316303|588233117|FG001|Overall Study|Lost to Follow-up|16|||
162871994|NCT01106534|588233120|FG000|Overall Study|Withdrawal by Subject|18|||
162871995|NCT01106534|588233120|FG000|Overall Study|Lost to Follow-up|2|||
162871996|NCT01106534|588233120|FG000|Overall Study|Death|16|||
162871997|NCT01106534|588233120|FG000|Overall Study|Physician Decision|1|||
162871998|NCT00570739|588233125|FG000|Overall Study|Adverse Event|8|||
162871999|NCT00570739|588233126|FG001|Overall Study|Adverse Event|6|||
163047317|NCT05219968|588879461|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
163047318|NCT05219968|588879462|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047319|NCT05219968|588879463|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047320|NCT05219968|588879464|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047321|NCT05219968|588879465|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
163047322|NCT05219968|588879461|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
163047323|NCT05219968|588879462|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047324|NCT05219968|588879463|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047325|NCT05219968|588879464|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047326|NCT05219968|588879465|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
163047327|NCT05219968|588879461|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
163047328|NCT05219968|588879462|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
163047329|NCT05219968|588879463|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047330|NCT05219968|588879464|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047331|NCT05219968|588879465|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
163047332|NCT05219968|588879461|FG000|Week 24 Treatment Period|Adverse Event|3|||
163047333|NCT05219968|588879462|FG001|Week 24 Treatment Period|Adverse Event|0|||
163047334|NCT05219968|588879463|FG002|Week 24 Treatment Period|Adverse Event|0|||
163047335|NCT05219968|588879464|FG003|Week 24 Treatment Period|Adverse Event|0|||
163047336|NCT05219968|588879465|FG004|Week 24 Treatment Period|Adverse Event|0|||
163047337|NCT05219968|588879461|FG000|Week 24 Treatment Period|Physician Decision|0|||
163047338|NCT05219968|588879462|FG001|Week 24 Treatment Period|Physician Decision|1|||
162872000|NCT00570739|588233127|FG002|Overall Study|Adverse Event|2|||
162872001|NCT00570739|588233128|FG003|Overall Study|Adverse Event|2|||
162872002|NCT00570739|588233125|FG000|Overall Study|Lost to Follow-up|4|||
162872003|NCT00570739|588233126|FG001|Overall Study|Lost to Follow-up|5|||
162872004|NCT00570739|588233127|FG002|Overall Study|Lost to Follow-up|4|||
162872005|NCT00570739|588233128|FG003|Overall Study|Lost to Follow-up|1|||
162872006|NCT00570739|588233125|FG000|Overall Study|Physician Decision|1|||
163047339|NCT05219968|588879463|FG002|Week 24 Treatment Period|Physician Decision|0|||
162872007|NCT00570739|588233126|FG001|Overall Study|Physician Decision|1|||
162872008|NCT00570739|588233127|FG002|Overall Study|Physician Decision|0|||
162872009|NCT00570739|588233128|FG003|Overall Study|Physician Decision|0|||
162872010|NCT00570739|588233125|FG000|Overall Study|Withdrawal by Subject|7|||
162872011|NCT00570739|588233126|FG001|Overall Study|Withdrawal by Subject|7|||
162872012|NCT00570739|588233127|FG002|Overall Study|Withdrawal by Subject|3|||
162872013|NCT00570739|588233128|FG003|Overall Study|Withdrawal by Subject|5|||
162872014|NCT00570739|588233125|FG000|Overall Study|Required restricted medication|0|||
162872015|NCT00570739|588233126|FG001|Overall Study|Required restricted medication|0|||
162872016|NCT00570739|588233127|FG002|Overall Study|Required restricted medication|1|||
162872017|NCT00570739|588233128|FG003|Overall Study|Required restricted medication|0|||
162872018|NCT00570739|588233125|FG000|Overall Study|Met discontinuation criteria|1|||
162872019|NCT00570739|588233126|FG001|Overall Study|Met discontinuation criteria|0|||
162872020|NCT00570739|588233127|FG002|Overall Study|Met discontinuation criteria|1|||
162872021|NCT00570739|588233128|FG003|Overall Study|Met discontinuation criteria|1|||
162872022|NCT00570739|588233125|FG000|Overall Study|Other|0|||
162872023|NCT00570739|588233126|FG001|Overall Study|Other|2|||
162872024|NCT00570739|588233127|FG002|Overall Study|Other|5|||
162872025|NCT00570739|588233128|FG003|Overall Study|Other|3|||
162872026|NCT00739297|588233130|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
162872027|NCT00739297|588233131|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
162872028|NCT00739297|588233132|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
162872029|NCT00739297|588233133|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
162872030|NCT00739297|588233134|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
162872031|NCT00739297|588233135|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
162872032|NCT00739297|588233136|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
162872033|NCT00739297|588233130|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
162872034|NCT00739297|588233131|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
162872035|NCT00739297|588233132|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
162872036|NCT00739297|588233133|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
162872037|NCT00739297|588233134|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
162872038|NCT00739297|588233135|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
162960975|NCT02302716|588560654|FG001|Overall Study|Withdrawal by Subject|7|||
162960976|NCT02302716|588560653|FG000|Overall Study|Protocol Violation|0|||
162960977|NCT02302716|588560654|FG001|Overall Study|Protocol Violation|1|||
162960978|NCT00830258|588560655|FG000|First Intervention|Adverse Event|1|||
162960979|NCT00830258|588560656|FG001|First Intervention|Adverse Event|0|||
162960980|NCT00830258|588560655|FG000|Washout: 7 Days|Protocol Violation|1|||
162960981|NCT00830258|588560656|FG001|Washout: 7 Days|Protocol Violation|0|||
162960982|NCT00798603|588560657|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
162960983|NCT00798603|588560657|FG000|Overall Study|Withdrawal by Subject|10|||
162960984|NCT00798603|588560657|FG000|Overall Study|Adverse Event|22|||
162960985|NCT00798603|588560657|FG000|Overall Study|Physician Decision|1|||
162960986|NCT00798603|588560657|FG000|Overall Study|Lack of insurance coverage|1|||
162960987|NCT02997176|588560662|FG000|Overall Study|Adverse Event|0|||
162960988|NCT02997176|588560663|FG001|Overall Study|Adverse Event|0|||
162960989|NCT02997176|588560664|FG002|Overall Study|Adverse Event|0|||
162960990|NCT02997176|588560665|FG003|Overall Study|Adverse Event|8|||
162960991|NCT02997176|588560662|FG000|Overall Study|Progressive Disease|1|||
162960992|NCT02997176|588560663|FG001|Overall Study|Progressive Disease|0|||
162960993|NCT02997176|588560664|FG002|Overall Study|Progressive Disease|1|||
162960994|NCT02997176|588560665|FG003|Overall Study|Progressive Disease|1|||
162960995|NCT02997176|588560662|FG000|Overall Study|Death|0|||
162960996|NCT02997176|588560663|FG001|Overall Study|Death|0|||
162960997|NCT02997176|588560664|FG002|Overall Study|Death|1|||
162960998|NCT02997176|588560665|FG003|Overall Study|Death|1|||
162960999|NCT02997176|588560662|FG000|Overall Study|Withdrawal by Subject|0|||
162961000|NCT02997176|588560663|FG001|Overall Study|Withdrawal by Subject|2|||
162961001|NCT02997176|588560664|FG002|Overall Study|Withdrawal by Subject|0|||
162961002|NCT02997176|588560665|FG003|Overall Study|Withdrawal by Subject|1|||
162961003|NCT05511935|588560666|FG000|Overall Study|Lost to Follow-up|9|||
162961004|NCT05511935|588560667|FG001|Overall Study|Lost to Follow-up|27|||
162961005|NCT04523480|588560668|FG000|Overall Study|Lost to Follow-up|30|||
162961006|NCT04523480|588560669|FG001|Overall Study|Lost to Follow-up|35|||
162961007|NCT04523480|588560670|FG002|Overall Study|Lost to Follow-up|0|||
162961008|NCT04102345|588560671|FG000|Overall Study|Withdrawal by Subject|1|||
162961009|NCT04102345|588560672|FG001|Overall Study|Withdrawal by Subject|0|||
162872039|NCT00739297|588233136|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
162872040|NCT01400971|588233137|FG000|Overall Study|Death|82|||
162872041|NCT01400971|588233137|FG000|Overall Study|Lost to Follow-up|196|||
162872042|NCT01400971|588233137|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
162872043|NCT01400971|588233137|FG000|Overall Study|Physician Decision|57|||
162961010|NCT01117623|588560675|FG000|Overall Study|Adverse Event|0|||
162961011|NCT01117623|588560676|FG001|Overall Study|Adverse Event|2|||
162961012|NCT01117623|588560677|FG002|Overall Study|Adverse Event|4|||
162961013|NCT01117623|588560678|FG003|Overall Study|Adverse Event|0|||
162961014|NCT01117623|588560679|FG004|Overall Study|Adverse Event|2|||
162961015|NCT01117623|588560680|FG005|Overall Study|Adverse Event|0|||
162872044|NCT01400971|588233137|FG000|Overall Study|Withdrawal by Subject|158|||
162872045|NCT01400971|588233137|FG000|Overall Study|Other|422|||
162872046|NCT01041573|588233144|FG000|Overall Study|Withdrawal by Subject|2|||
162872047|NCT01041573|588233145|FG001|Overall Study|Withdrawal by Subject|5|||
162872048|NCT01041573|588233146|FG002|Overall Study|Withdrawal by Subject|2|||
162872049|NCT01041573|588233147|FG003|Overall Study|Withdrawal by Subject|0|||
162872050|NCT01041573|588233144|FG000|Overall Study|Death|1|||
162872051|NCT01041573|588233145|FG001|Overall Study|Death|0|||
162872052|NCT01041573|588233146|FG002|Overall Study|Death|0|||
162961016|NCT01117623|588560681|FG006|Overall Study|Adverse Event|0|||
162872053|NCT01041573|588233147|FG003|Overall Study|Death|0|||
162961017|NCT01117623|588560682|FG007|Overall Study|Adverse Event|2|||
162961018|NCT01117623|588560675|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
162961019|NCT01117623|588560676|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
162961020|NCT01117623|588560677|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
162961021|NCT01117623|588560678|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
162961022|NCT01117623|588560679|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
162961023|NCT01117623|588560680|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
162961024|NCT01117623|588560681|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
162961025|NCT01117623|588560682|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
162961026|NCT01117623|588560675|FG000|Overall Study|Withdrawal by Subject|0|||
162961027|NCT01117623|588560676|FG001|Overall Study|Withdrawal by Subject|0|||
162961028|NCT01117623|588560677|FG002|Overall Study|Withdrawal by Subject|2|||
162961029|NCT01117623|588560678|FG003|Overall Study|Withdrawal by Subject|0|||
162961030|NCT01117623|588560679|FG004|Overall Study|Withdrawal by Subject|0|||
162961031|NCT01117623|588560680|FG005|Overall Study|Withdrawal by Subject|1|||
162961032|NCT01117623|588560681|FG006|Overall Study|Withdrawal by Subject|1|||
162961033|NCT01117623|588560682|FG007|Overall Study|Withdrawal by Subject|1|||
162961034|NCT01117623|588560675|FG000|Overall Study|Non-compliance with study medication|0|||
162961035|NCT01117623|588560676|FG001|Overall Study|Non-compliance with study medication|0|||
162961036|NCT01117623|588560677|FG002|Overall Study|Non-compliance with study medication|0|||
162961037|NCT01117623|588560678|FG003|Overall Study|Non-compliance with study medication|0|||
162961038|NCT01117623|588560679|FG004|Overall Study|Non-compliance with study medication|0|||
162961039|NCT01117623|588560680|FG005|Overall Study|Non-compliance with study medication|0|||
162961040|NCT01117623|588560681|FG006|Overall Study|Non-compliance with study medication|0|||
162961041|NCT01117623|588560682|FG007|Overall Study|Non-compliance with study medication|1|||
162961042|NCT01117623|588560675|FG000|Overall Study|Invest. text: completed all planned txs|0|||
162961043|NCT01117623|588560676|FG001|Overall Study|Invest. text: completed all planned txs|0|||
162961044|NCT01117623|588560677|FG002|Overall Study|Invest. text: completed all planned txs|0|||
162961045|NCT01117623|588560678|FG003|Overall Study|Invest. text: completed all planned txs|0|||
162961046|NCT01117623|588560679|FG004|Overall Study|Invest. text: completed all planned txs|0|||
162961047|NCT01117623|588560680|FG005|Overall Study|Invest. text: completed all planned txs|1|||
162961048|NCT01117623|588560681|FG006|Overall Study|Invest. text: completed all planned txs|0|||
162961049|NCT01117623|588560682|FG007|Overall Study|Invest. text: completed all planned txs|0|||
162961050|NCT02727192|588560689|FG000|Overall Study|Lost to Follow-up|1|||
162961051|NCT02727192|588560690|FG001|Overall Study|Lost to Follow-up|0|||
162961052|NCT02727192|588560691|FG002|Overall Study|Lost to Follow-up|0|||
162961053|NCT05497557|588560693|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
162961054|NCT05497557|588560694|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
162961055|NCT05497557|588560695|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
162961056|NCT04590027|588560697|FG000|Overall Study|Lost to Follow-up|17|||
162961057|NCT04590027|588560698|FG001|Overall Study|Lost to Follow-up|14|||
162961058|NCT04590027|588560697|FG000|Overall Study|Protocol Violation|0|||
162961059|NCT04590027|588560698|FG001|Overall Study|Protocol Violation|3|||
162961060|NCT01959672|588560702|FG000|Overall Study|Death|1|||
162961061|NCT02392195|588560703|FG000|Overall Study|Lost to Follow-up|4|||
162961062|NCT02392195|588560703|FG000|Overall Study|Withdrawal by Subject|4|||
162961063|NCT04089553|588560706|FG000|Overall Study|Death|1|||
162961064|NCT04089553|588560707|FG001|Overall Study|Death|1|||
162961065|NCT04089553|588560706|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
162961066|NCT04089553|588560707|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
162872054|NCT01041573|588233144|FG000|Overall Study|Lost to Follow-up|0|||
162872055|NCT01041573|588233145|FG001|Overall Study|Lost to Follow-up|1|||
162961067|NCT04089553|588560706|FG000|Overall Study|Withdrawal by Subject|3|||
162961068|NCT04089553|588560707|FG001|Overall Study|Withdrawal by Subject|3|||
162961069|NCT04089553|588560706|FG000|Overall Study|Physician Decision|1|||
162961070|NCT04089553|588560707|FG001|Overall Study|Physician Decision|0|||
162961071|NCT04089553|588560706|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
162961072|NCT04089553|588560707|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
162961073|NCT04089553|588560706|FG000|Overall Study|Other|1|||
162961074|NCT04089553|588560707|FG001|Overall Study|Other|0|||
162872056|NCT01041573|588233146|FG002|Overall Study|Lost to Follow-up|2|||
162872057|NCT01041573|588233147|FG003|Overall Study|Lost to Follow-up|1|||
162872058|NCT01041573|588233144|FG000|Overall Study|Adverse Event|0|||
162872059|NCT01041573|588233145|FG001|Overall Study|Adverse Event|2|||
162872060|NCT01041573|588233146|FG002|Overall Study|Adverse Event|0|||
162872061|NCT01041573|588233147|FG003|Overall Study|Adverse Event|0|||
162872062|NCT01041573|588233144|FG000|Overall Study|relocation|1|||
162872063|NCT01041573|588233145|FG001|Overall Study|relocation|4|||
162872064|NCT01041573|588233146|FG002|Overall Study|relocation|3|||
162872065|NCT01041573|588233147|FG003|Overall Study|relocation|1|||
162872066|NCT01041573|588233144|FG000|Overall Study|further blood extraction|0|||
162872067|NCT01041573|588233145|FG001|Overall Study|further blood extraction|1|||
162872068|NCT01041573|588233146|FG002|Overall Study|further blood extraction|0|||
162872069|NCT01041573|588233147|FG003|Overall Study|further blood extraction|0|||
162872070|NCT01041573|588233144|FG000|Overall Study|positive to anti-HCV|1|||
162872071|NCT01041573|588233145|FG001|Overall Study|positive to anti-HCV|0|||
162872072|NCT01041573|588233146|FG002|Overall Study|positive to anti-HCV|0|||
162872073|NCT01041573|588233147|FG003|Overall Study|positive to anti-HCV|0|||
162872074|NCT03634072|588233148|FG000|Overall Study|Early termination of overall study|1|||
162872075|NCT03634072|588233149|FG001|Overall Study|Early termination of overall study|0|||
162872076|NCT01323673|588233153|FG000|Overall Study|Adverse Event|0|||
162872077|NCT01323673|588233154|FG001|Overall Study|Adverse Event|1|||
162872078|NCT01323673|588233153|FG000|Overall Study|Lost to Follow-up|0|||
162872079|NCT01323673|588233154|FG001|Overall Study|Lost to Follow-up|1|||
162872080|NCT01323673|588233153|FG000|Overall Study|Protocol Violation|1|||
162872081|NCT01323673|588233154|FG001|Overall Study|Protocol Violation|0|||
162961075|NCT04089553|588560706|FG000|Overall Study|Adverse Event|1|||
162872082|NCT01323673|588233153|FG000|Overall Study|Withdrawal by Subject|2|||
162872083|NCT01323673|588233154|FG001|Overall Study|Withdrawal by Subject|3|||
162872084|NCT00883558|588234547|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
162872085|NCT00883558|588234548|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
162872086|NCT00883558|588234549|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
162872087|NCT00883558|588234547|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
162872088|NCT00883558|588234548|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
162872089|NCT00883558|588234549|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
162872090|NCT00883558|588234547|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
162872091|NCT00883558|588234548|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
162872092|NCT00883558|588234549|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
162872093|NCT00883558|588234547|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
162872094|NCT00883558|588234548|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
162872095|NCT00883558|588234549|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
162872096|NCT00883558|588234547|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
162872097|NCT00883558|588234548|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
162872098|NCT00883558|588234549|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
162872099|NCT00879814|588234553|FG000|Overall Study|Adverse Event|0|||
162872100|NCT00879814|588234554|FG001|Overall Study|Adverse Event|1|||
162872101|NCT00879814|588234555|FG002|Overall Study|Adverse Event|0|||
162872102|NCT00879814|588234556|FG003|Overall Study|Adverse Event|0|||
162872103|NCT00879814|588234553|FG000|Overall Study|Lost to Follow-up|1|||
162872104|NCT00879814|588234554|FG001|Overall Study|Lost to Follow-up|0|||
162872105|NCT00879814|588234555|FG002|Overall Study|Lost to Follow-up|0|||
162872106|NCT00879814|588234556|FG003|Overall Study|Lost to Follow-up|2|||
162872107|NCT00879814|588234553|FG000|Overall Study|Participant Failed to Return|0|||
162872108|NCT00879814|588234554|FG001|Overall Study|Participant Failed to Return|0|||
162872109|NCT00879814|588234555|FG002|Overall Study|Participant Failed to Return|0|||
162872110|NCT00879814|588234556|FG003|Overall Study|Participant Failed to Return|1|||
162872111|NCT00879814|588234553|FG000|Overall Study|Withdrawal by Subject|3|||
162872112|NCT00879814|588234554|FG001|Overall Study|Withdrawal by Subject|1|||
162872113|NCT00879814|588234555|FG002|Overall Study|Withdrawal by Subject|1|||
162872114|NCT00879814|588234556|FG003|Overall Study|Withdrawal by Subject|2|||
162872115|NCT00879814|588234553|FG000|Overall Study|Physician Decision|0|||
162872116|NCT00879814|588234554|FG001|Overall Study|Physician Decision|0|||
162872117|NCT00879814|588234555|FG002|Overall Study|Physician Decision|1|||
162872118|NCT00879814|588234556|FG003|Overall Study|Physician Decision|0|||
162872119|NCT00879814|588234553|FG000|Overall Study|Other|0|||
162872120|NCT00879814|588234554|FG001|Overall Study|Other|0|||
162872121|NCT00879814|588234555|FG002|Overall Study|Other|1|||
162872122|NCT00879814|588234556|FG003|Overall Study|Other|0|||
162872123|NCT01005719|588234557|FG000|Period 1|Adverse Event|0|||
162872124|NCT01005719|588234558|FG001|Period 1|Adverse Event|0|||
162872125|NCT01005719|588234559|FG002|Period 1|Adverse Event|0|||
162872126|NCT01005719|588234560|FG003|Period 1|Adverse Event|1|||
162872127|NCT01005719|588234561|FG004|Period 1|Adverse Event|0|||
162872128|NCT01005719|588234562|FG005|Period 1|Adverse Event|0|||
162872129|NCT01005719|588234557|FG000|Period 1|Delay in completing study procedures|0|||
162872130|NCT01005719|588234558|FG001|Period 1|Delay in completing study procedures|0|||
162872131|NCT01005719|588234559|FG002|Period 1|Delay in completing study procedures|0|||
162872132|NCT01005719|588234560|FG003|Period 1|Delay in completing study procedures|0|||
162872133|NCT01005719|588234561|FG004|Period 1|Delay in completing study procedures|0|||
162872134|NCT01005719|588234562|FG005|Period 1|Delay in completing study procedures|1|||
163047340|NCT05219968|588879464|FG003|Week 24 Treatment Period|Physician Decision|0|||
163047341|NCT05219968|588879465|FG004|Week 24 Treatment Period|Physician Decision|0|||
163047342|NCT05219968|588879461|FG000|Week 24 Treatment Period|Other, not specified|3|||
163047343|NCT05219968|588879462|FG001|Week 24 Treatment Period|Other, not specified|0|||
163047344|NCT05219968|588879463|FG002|Week 24 Treatment Period|Other, not specified|0|||
163047345|NCT05219968|588879464|FG003|Week 24 Treatment Period|Other, not specified|0|||
163047346|NCT05219968|588879465|FG004|Week 24 Treatment Period|Other, not specified|0|||
163047347|NCT05219968|588879461|FG000|Safety Extension Period|Treatment administration failure|0|||
162872135|NCT01005719|588234557|FG000|Period 2|Adverse Event|0|||
162872136|NCT01005719|588234558|FG001|Period 2|Adverse Event|0|||
162872137|NCT01005719|588234559|FG002|Period 2|Adverse Event|0|||
162872138|NCT01005719|588234560|FG003|Period 2|Adverse Event|0|||
162872139|NCT01005719|588234561|FG004|Period 2|Adverse Event|1|||
162872140|NCT01005719|588234562|FG005|Period 2|Adverse Event|1|||
162872141|NCT01753076|588234563|FG000|Overall Study|Adverse Event|17|||
162872142|NCT01753076|588234564|FG001|Overall Study|Adverse Event|18|||
162872143|NCT01753076|588234563|FG000|Overall Study|Lack of Efficacy|3|||
162872144|NCT01753076|588234564|FG001|Overall Study|Lack of Efficacy|1|||
162872145|NCT01753076|588234563|FG000|Overall Study|Lost to Follow-up|2|||
162872146|NCT01753076|588234564|FG001|Overall Study|Lost to Follow-up|1|||
162872147|NCT01753076|588234563|FG000|Overall Study|Physician Decision|4|||
162872148|NCT01753076|588234564|FG001|Overall Study|Physician Decision|2|||
162872149|NCT01753076|588234563|FG000|Overall Study|Withdrawal by Subject|14|||
162872150|NCT01753076|588234564|FG001|Overall Study|Withdrawal by Subject|24|||
162872151|NCT01753076|588234563|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
162872152|NCT01753076|588234564|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
162872153|NCT02985450|588234570|FG000|Overall Study|Lost to Follow-up|7|||
162872154|NCT00069576|588234571|FG000|Original Trial|Lost to Follow-up|25|||
162872155|NCT00069576|588234572|FG001|Original Trial|Lost to Follow-up|33|||
162872156|NCT00069576|588234571|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
162872157|NCT00069576|588234572|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
162872158|NCT00905307|588234573|FG000|Overall Study|Switched to Open Label Rescue|7|||
162872159|NCT00905307|588234574|FG001|Overall Study|Switched to Open Label Rescue|17|||
163047348|NCT05219968|588879462|FG001|Safety Extension Period|Treatment administration failure|0|||
163047349|NCT05219968|588879463|FG002|Safety Extension Period|Treatment administration failure|0|||
162706678|NCT04955626|587636679|FG023|Blinded Period|Participants entered open label period|0|||
162872160|NCT00905307|588234575|FG002|Overall Study|Switched to Open Label Rescue|11|||
162872161|NCT00905307|588234576|FG003|Overall Study|Switched to Open Label Rescue|11|||
162872162|NCT00905307|588234577|FG004|Overall Study|Switched to Open Label Rescue|4|||
162872163|NCT00905307|588234578|FG005|Overall Study|Switched to Open Label Rescue|15|||
162872164|NCT00905307|588234573|FG000|Overall Study|Lost to Follow-up|0|||
162872165|NCT00905307|588234574|FG001|Overall Study|Lost to Follow-up|0|||
162872166|NCT00905307|588234575|FG002|Overall Study|Lost to Follow-up|0|||
162872167|NCT00905307|588234576|FG003|Overall Study|Lost to Follow-up|0|||
162872168|NCT00905307|588234577|FG004|Overall Study|Lost to Follow-up|1|||
162872169|NCT00905307|588234578|FG005|Overall Study|Lost to Follow-up|1|||
162872170|NCT00905307|588234573|FG000|Overall Study|Adverse Event|3|||
162872171|NCT00905307|588234574|FG001|Overall Study|Adverse Event|4|||
162872172|NCT00905307|588234575|FG002|Overall Study|Adverse Event|5|||
162872173|NCT00905307|588234576|FG003|Overall Study|Adverse Event|11|||
162872174|NCT00905307|588234577|FG004|Overall Study|Adverse Event|3|||
162872175|NCT00905307|588234578|FG005|Overall Study|Adverse Event|5|||
162872176|NCT00905307|588234573|FG000|Overall Study|Withdrawal by Subject|5|||
162872177|NCT00905307|588234574|FG001|Overall Study|Withdrawal by Subject|13|||
162872178|NCT00905307|588234575|FG002|Overall Study|Withdrawal by Subject|15|||
162872179|NCT00905307|588234576|FG003|Overall Study|Withdrawal by Subject|11|||
162872180|NCT00905307|588234577|FG004|Overall Study|Withdrawal by Subject|4|||
162872181|NCT00905307|588234578|FG005|Overall Study|Withdrawal by Subject|13|||
162872182|NCT00905307|588234573|FG000|Overall Study|Protocol Violation|1|||
162872183|NCT00905307|588234574|FG001|Overall Study|Protocol Violation|0|||
162872184|NCT00905307|588234575|FG002|Overall Study|Protocol Violation|1|||
162872185|NCT00905307|588234576|FG003|Overall Study|Protocol Violation|0|||
162872186|NCT00905307|588234577|FG004|Overall Study|Protocol Violation|0|||
162872187|NCT00905307|588234578|FG005|Overall Study|Protocol Violation|0|||
162872188|NCT00905307|588234573|FG000|Overall Study|Lack of Efficacy|6|||
162872189|NCT00905307|588234574|FG001|Overall Study|Lack of Efficacy|3|||
162872190|NCT00905307|588234575|FG002|Overall Study|Lack of Efficacy|5|||
162872191|NCT00905307|588234576|FG003|Overall Study|Lack of Efficacy|4|||
162872192|NCT00905307|588234577|FG004|Overall Study|Lack of Efficacy|4|||
162872193|NCT00905307|588234578|FG005|Overall Study|Lack of Efficacy|8|||
162872194|NCT05590793|588234579|FG000|Overall Study|Withdrawal by Subject|6|||
162872195|NCT05590793|588234579|FG000|Overall Study|Physician Decision|1|||
162872196|NCT04060667|588234580|FG000|Overall Study|Lost to Follow-up|75|||
162872197|NCT04060667|588234581|FG001|Overall Study|Lost to Follow-up|10|||
162872198|NCT03015610|588234582|FG000|Overall Study|Lost to Follow-up|1|||
162872199|NCT03015610|588234583|FG001|Overall Study|Lost to Follow-up|5|||
162961076|NCT04089553|588560707|FG001|Overall Study|Adverse Event|1|||
162961077|NCT03366792|588560710|FG000|Overall Study|Withdrawal by Subject|7|||
162961078|NCT03366792|588560710|FG000|Overall Study|Lost to Follow-up|2|||
162961079|NCT03366792|588560710|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
162961080|NCT03366792|588560710|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
162961081|NCT01808651|588560711|FG000|Study Period 1|Lost to Follow-up|1|||
162961082|NCT01808651|588560712|FG001|Study Period 1|Lost to Follow-up|3|||
162961083|NCT01808651|588560713|FG002|Study Period 1|Lost to Follow-up|0|||
162961084|NCT01808651|588560711|FG000|Study Period 1|Protocol Violation|1|||
162961085|NCT01808651|588560712|FG001|Study Period 1|Protocol Violation|0|||
162961086|NCT01808651|588560713|FG002|Study Period 1|Protocol Violation|1|||
162961087|NCT01808651|588560711|FG000|Study Period 1|Physician Decision|3|||
162961088|NCT01808651|588560712|FG001|Study Period 1|Physician Decision|2|||
162961089|NCT01808651|588560713|FG002|Study Period 1|Physician Decision|0|||
162872200|NCT01603641|588234584|FG000|Overall Study|Did not Receive Treatment|3|||
162872201|NCT01603641|588234584|FG000|Overall Study|Adverse Event|1|||
162961090|NCT01808651|588560711|FG000|Study Period 1|Lack of Efficacy|2|||
162961091|NCT01808651|588560712|FG001|Study Period 1|Lack of Efficacy|1|||
162961092|NCT01808651|588560713|FG002|Study Period 1|Lack of Efficacy|0|||
162961093|NCT01808651|588560711|FG000|Study Period 1|Adverse Event|10|||
162961094|NCT01808651|588560712|FG001|Study Period 1|Adverse Event|4|||
162872202|NCT01603641|588234584|FG000|Overall Study|Lack of Efficacy|1|||
162872203|NCT01603641|588234584|FG000|Overall Study|Lost to Follow-up|6|||
162872204|NCT01603641|588234584|FG000|Overall Study|Personal Reasons|18|||
162872205|NCT01603641|588234584|FG000|Overall Study|Other Miscellaneous Reasons|6|||
162872206|NCT00114972|588234585|FG000|Overall Study|Withdrawal by Subject|40|||
162872207|NCT00114972|588234586|FG001|Overall Study|Withdrawal by Subject|7|||
162872208|NCT00114972|588234585|FG000|Overall Study|Lost to Follow-up|8|||
162872209|NCT00114972|588234586|FG001|Overall Study|Lost to Follow-up|5|||
162872210|NCT00358917|588234587|FG000|Overall Study|Adverse Event|14|||
162872211|NCT00358917|588234588|FG001|Overall Study|Adverse Event|21|||
162872212|NCT00358917|588234587|FG000|Overall Study|Withdrawal by Subject|5|||
162872213|NCT00358917|588234588|FG001|Overall Study|Withdrawal by Subject|7|||
162872214|NCT00358917|588234587|FG000|Overall Study|Lost to Follow-up|20|||
162872215|NCT00358917|588234588|FG001|Overall Study|Lost to Follow-up|17|||
162872216|NCT00358917|588234587|FG000|Overall Study|Noncompliance|12|||
162872217|NCT00358917|588234588|FG001|Overall Study|Noncompliance|11|||
162872218|NCT00358917|588234587|FG000|Overall Study|Death|2|||
162872219|NCT00358917|588234588|FG001|Overall Study|Death|3|||
162872220|NCT00358917|588234587|FG000|Overall Study|Virologic failure|11|||
162872221|NCT00358917|588234588|FG001|Overall Study|Virologic failure|8|||
162872222|NCT00358917|588234587|FG000|Overall Study|Unable to Continue Participation|2|||
162872223|NCT00358917|588234588|FG001|Overall Study|Unable to Continue Participation|2|||
162872224|NCT02086565|588234598|FG000|Overall Study|Lost to Follow-up|9|||
162872225|NCT02086565|588234599|FG001|Overall Study|Lost to Follow-up|7|||
162872226|NCT02086565|588234598|FG000|Overall Study|Withdrawal by Subject|2|||
162872227|NCT02086565|588234599|FG001|Overall Study|Withdrawal by Subject|1|||
162872228|NCT02086565|588234598|FG000|Overall Study|Death|3|||
162872229|NCT02086565|588234599|FG001|Overall Study|Death|2|||
162872230|NCT02086565|588234598|FG000|Overall Study|withdrawn by research team|2|||
162872231|NCT02086565|588234599|FG001|Overall Study|withdrawn by research team|2|||
162872232|NCT01757704|588234600|FG000|Overall Study|Protocol Violation|1|||
162872233|NCT01757704|588234601|FG001|Overall Study|Protocol Violation|3|||
162872234|NCT02890329|588234604|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
162872235|NCT02890329|588234605|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
162872236|NCT02890329|588234606|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
162872237|NCT02890329|588234607|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
162872238|NCT02890329|588234608|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
162872239|NCT02890329|588234609|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
162872240|NCT02890329|588234604|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
162872241|NCT02890329|588234605|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
162872242|NCT02890329|588234606|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
162872243|NCT02890329|588234607|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
162872244|NCT02890329|588234608|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
162872245|NCT02890329|588234609|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
162872246|NCT02890329|588234604|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162872247|NCT02890329|588234605|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162872248|NCT02890329|588234606|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162872249|NCT02890329|588234607|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
162872250|NCT02890329|588234608|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162872251|NCT02890329|588234609|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
162872252|NCT02890329|588234604|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162872253|NCT02890329|588234605|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162872254|NCT02890329|588234606|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
162872255|NCT02890329|588234607|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162872256|NCT02890329|588234608|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162872257|NCT02890329|588234609|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
162872258|NCT01035255|588234610|FG000|Overall Study|Death|724|||
162872259|NCT01035255|588234611|FG001|Overall Study|Death|844|||
162872260|NCT01035255|588234610|FG000|Overall Study|Lost to Follow-up|2|||
162872261|NCT01035255|588234611|FG001|Overall Study|Lost to Follow-up|5|||
162872262|NCT01035255|588234610|FG000|Overall Study|patient's request|15|||
162872263|NCT01035255|588234611|FG001|Overall Study|patient's request|13|||
162872264|NCT01379534|588234614|FG000|Treatment Phase|Withdrawal by Subject|2|||
162872265|NCT01379534|588234615|FG001|Treatment Phase|Withdrawal by Subject|2|||
162872266|NCT01379534|588234614|FG000|Treatment Phase|Progressive disease|13|||
162872267|NCT01379534|588234615|FG001|Treatment Phase|Progressive disease|22|||
162872268|NCT01379534|588234614|FG000|Treatment Phase|Adverse Event|7|||
162872269|NCT01379534|588234615|FG001|Treatment Phase|Adverse Event|7|||
162872270|NCT01379534|588234614|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
162872271|NCT01379534|588234615|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
162872272|NCT01379534|588234614|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
162872273|NCT01379534|588234615|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
162872274|NCT01379534|588234614|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
162872275|NCT01379534|588234615|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
162872276|NCT01379534|588234614|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
162872277|NCT01379534|588234615|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
162872278|NCT00616239|588234618|FG000|Overall Study|Withdrawal by Subject|2|||
162872279|NCT01558089|588234621|FG000|Overall Study|Adverse Event|1|||
162872280|NCT01558089|588234621|FG000|Overall Study|Lack of Efficacy|1|||
162872281|NCT01558089|588234621|FG000|Overall Study|Lost to Follow-up|5|||
162872282|NCT01558089|588234621|FG000|Overall Study|Withdrawal by Subject|6|||
162872283|NCT01597193|588234622|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
162872284|NCT01597193|588234623|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
162872285|NCT01597193|588234624|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
162872286|NCT01597193|588234625|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
162872287|NCT01597193|588234626|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
162872288|NCT01597193|588234627|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
162872289|NCT01597193|588234628|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
162872290|NCT01597193|588234622|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
162872291|NCT01597193|588234623|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
162872292|NCT01597193|588234624|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
162872293|NCT01597193|588234625|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
162872294|NCT01597193|588234626|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
162872295|NCT01597193|588234627|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
162872296|NCT01597193|588234628|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
162872297|NCT01597193|588234622|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
162872298|NCT01597193|588234623|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
162872299|NCT01597193|588234624|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
162872300|NCT01597193|588234625|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
162872301|NCT01597193|588234626|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
162872302|NCT01597193|588234627|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
162872303|NCT01597193|588234628|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
162872304|NCT01597193|588234622|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872305|NCT01597193|588234623|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872306|NCT01597193|588234624|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872307|NCT01597193|588234625|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872308|NCT01597193|588234626|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872309|NCT01597193|588234627|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
163047350|NCT05219968|588879464|FG003|Safety Extension Period|Treatment administration failure|1|||
163047351|NCT05219968|588879465|FG004|Safety Extension Period|Treatment administration failure|4|||
163047352|NCT05219968|588879461|FG000|Safety Extension Period|Bilateral dislodgement|0|||
163047353|NCT05219968|588879462|FG001|Safety Extension Period|Bilateral dislodgement|0|||
163047354|NCT05219968|588879463|FG002|Safety Extension Period|Bilateral dislodgement|4|||
162615110|NCT04526509|587307474|FG004|Enrolled|Study Terminated by Sponsor|0|||
162615111|NCT04526509|587307475|FG005|Enrolled|Study Terminated by Sponsor|0|||
162615112|NCT04526509|587307476|FG006|Enrolled|Study Terminated by Sponsor|1|||
162615113|NCT04526509|587307470|FG000|Enrolled|Death prior to lymphodepletion|0|||
162872310|NCT01597193|588234628|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
162872311|NCT01597193|588234622|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
162872312|NCT01597193|588234623|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
162872313|NCT01597193|588234624|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
162872314|NCT01597193|588234625|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
162872315|NCT01597193|588234626|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
162872316|NCT01597193|588234627|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
162872317|NCT01597193|588234628|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
162872318|NCT03184701|588234630|FG000|Overall Study|Death|3|||
162872319|NCT03184701|588234630|FG000|Overall Study|Physician Decision|3|||
162872320|NCT03184701|588234630|FG000|Overall Study|Withdrawal by Subject|6|||
162872321|NCT03184701|588234630|FG000|Overall Study|Lost to Follow-up|5|||
162615114|NCT04526509|587307471|FG001|Enrolled|Death prior to lymphodepletion|0|||
162872322|NCT00590681|588234633|FG000|Overall Study|Withdrawal by Subject|7|||
162872323|NCT00590681|588234633|FG000|Overall Study|Adverse Event|8|||
162872324|NCT00590681|588234633|FG000|Overall Study|Death|3|||
162615115|NCT04526509|587307472|FG002|Enrolled|Death prior to lymphodepletion|0|||
162615116|NCT04526509|587307473|FG003|Enrolled|Death prior to lymphodepletion|1|||
162615117|NCT04526509|587307474|FG004|Enrolled|Death prior to lymphodepletion|0|||
162872325|NCT00590681|588234633|FG000|Overall Study|Lost to Follow-up|1|||
162872326|NCT00590681|588234633|FG000|Overall Study|disease progression|1|||
162872327|NCT01259297|588234634|FG000|Double Blind Randomized Period|Death|1|||
162872328|NCT01259297|588234635|FG001|Double Blind Randomized Period|Death|1|||
162872329|NCT01259297|588234636|FG002|Double Blind Randomized Period|Death|1|||
162615118|NCT04526509|587307475|FG005|Enrolled|Death prior to lymphodepletion|0|||
162615119|NCT04526509|587307476|FG006|Enrolled|Death prior to lymphodepletion|0|||
162615120|NCT04526509|587307470|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162872330|NCT01259297|588234637|FG003|Double Blind Randomized Period|Death|2|||
162872331|NCT01259297|588234638|FG004|Double Blind Randomized Period|Death|1|||
162872332|NCT01259297|588234639|FG005|Double Blind Randomized Period|Death|5|||
162872333|NCT01259297|588234640|FG006|Double Blind Randomized Period|Death|2|||
162872334|NCT01259297|588234641|FG007|Double Blind Randomized Period|Death|1|||
162615121|NCT04526509|587307471|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162615122|NCT04526509|587307472|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162615123|NCT04526509|587307473|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
162615124|NCT04526509|587307474|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162615125|NCT04526509|587307475|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162615126|NCT04526509|587307476|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162615127|NCT04526509|587307470|FG000|Enrolled|Physician Decision|0|||
162615128|NCT04526509|587307471|FG001|Enrolled|Physician Decision|1|||
162615129|NCT04526509|587307472|FG002|Enrolled|Physician Decision|0|||
162615130|NCT04526509|587307473|FG003|Enrolled|Physician Decision|0|||
162615131|NCT04526509|587307474|FG004|Enrolled|Physician Decision|0|||
162615132|NCT04526509|587307475|FG005|Enrolled|Physician Decision|0|||
162615133|NCT04526509|587307476|FG006|Enrolled|Physician Decision|0|||
162615134|NCT02452697|587307479|FG000|Overall Study|Physician Decision|4|||
162615135|NCT02452697|587307480|FG001|Overall Study|Physician Decision|4|||
162615136|NCT02452697|587307481|FG002|Overall Study|Physician Decision|3|||
162615137|NCT02452697|587307482|FG003|Overall Study|Physician Decision|2|||
162615138|NCT02452697|587307479|FG000|Overall Study|Withdrawal by Subject|1|||
162615139|NCT02452697|587307480|FG001|Overall Study|Withdrawal by Subject|0|||
162615140|NCT02452697|587307481|FG002|Overall Study|Withdrawal by Subject|0|||
162615141|NCT02452697|587307482|FG003|Overall Study|Withdrawal by Subject|0|||
162615142|NCT02452697|587307479|FG000|Overall Study|still in follow-up|2|||
162615143|NCT02452697|587307480|FG001|Overall Study|still in follow-up|2|||
162615144|NCT02452697|587307481|FG002|Overall Study|still in follow-up|1|||
162615145|NCT02452697|587307482|FG003|Overall Study|still in follow-up|3|||
162615146|NCT01554397|587307485|FG000|Overall Study|Withdrawal by Subject|1|||
162872335|NCT01259297|588234634|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
162961095|NCT01808651|588560713|FG002|Study Period 1|Adverse Event|1|||
162615147|NCT01554397|587307486|FG001|Overall Study|Withdrawal by Subject|0|||
162615148|NCT01554397|587307485|FG000|Overall Study|Ineligible|7|||
162615149|NCT01554397|587307486|FG001|Overall Study|Ineligible|0|||
162615150|NCT04493333|587309273|FG000|Overall Study|Withdrawal by Subject|1|||
162615151|NCT04493333|587309274|FG001|Overall Study|Withdrawal by Subject|1|||
162961096|NCT01808651|588560711|FG000|Study Period 1|Participant Decision|9|||
162961097|NCT01808651|588560712|FG001|Study Period 1|Participant Decision|7|||
162961098|NCT01808651|588560713|FG002|Study Period 1|Participant Decision|3|||
162961099|NCT00841542|588560717|FG000|Period 1|Adverse Event|1|||
162961100|NCT00841542|588560718|FG001|Period 1|Adverse Event|0|||
162961101|NCT04345653|588560719|FG000|Overall Study|Withdrawal by Subject|2|||
162961102|NCT03214588|588560720|FG000|Overall Study|Adverse Event|1|||
162961103|NCT03214588|588560721|FG001|Overall Study|Adverse Event|0|||
162961104|NCT03214588|588560722|FG002|Overall Study|Adverse Event|2|||
162961105|NCT03214588|588560720|FG000|Overall Study|Reason Not Specified|0|||
162961106|NCT03214588|588560721|FG001|Overall Study|Reason Not Specified|1|||
162961107|NCT03214588|588560722|FG002|Overall Study|Reason Not Specified|0|||
162961108|NCT04631562|588560725|FG000|Overall Study|Withdrawal by Subject|0|||
162961109|NCT04631562|588560726|FG001|Overall Study|Withdrawal by Subject|0|||
162961110|NCT04631562|588560727|FG002|Overall Study|Withdrawal by Subject|0|||
162961111|NCT04631562|588560728|FG003|Overall Study|Withdrawal by Subject|0|||
162961112|NCT04631562|588560729|FG004|Overall Study|Withdrawal by Subject|0|||
162961113|NCT04631562|588560730|FG005|Overall Study|Withdrawal by Subject|0|||
162961114|NCT04631562|588560731|FG006|Overall Study|Withdrawal by Subject|0|||
162961115|NCT04631562|588560732|FG007|Overall Study|Withdrawal by Subject|1|||
162961116|NCT04631562|588560733|FG008|Overall Study|Withdrawal by Subject|0|||
162961117|NCT04631562|588560725|FG000|Overall Study|Other|0|||
162961118|NCT04631562|588560726|FG001|Overall Study|Other|0|||
162961119|NCT04631562|588560727|FG002|Overall Study|Other|0|||
162961120|NCT04631562|588560728|FG003|Overall Study|Other|0|||
162961121|NCT04631562|588560729|FG004|Overall Study|Other|0|||
162961122|NCT04631562|588560730|FG005|Overall Study|Other|0|||
162961123|NCT04631562|588560731|FG006|Overall Study|Other|0|||
162961124|NCT04631562|588560732|FG007|Overall Study|Other|0|||
162961125|NCT04631562|588560733|FG008|Overall Study|Other|1|||
162961126|NCT04631562|588560725|FG000|Overall Study|Lost to Follow-up|0|||
162961127|NCT04631562|588560726|FG001|Overall Study|Lost to Follow-up|0|||
162961128|NCT04631562|588560727|FG002|Overall Study|Lost to Follow-up|0|||
162961129|NCT04631562|588560728|FG003|Overall Study|Lost to Follow-up|1|||
162961130|NCT04631562|588560729|FG004|Overall Study|Lost to Follow-up|0|||
162961131|NCT04631562|588560730|FG005|Overall Study|Lost to Follow-up|0|||
162961132|NCT04631562|588560731|FG006|Overall Study|Lost to Follow-up|0|||
162961133|NCT04631562|588560732|FG007|Overall Study|Lost to Follow-up|0|||
162961134|NCT04631562|588560733|FG008|Overall Study|Lost to Follow-up|0|||
162961135|NCT04631562|588560725|FG000|Overall Study|Adverse Event|0|||
162961136|NCT04631562|588560726|FG001|Overall Study|Adverse Event|0|||
162961137|NCT04631562|588560727|FG002|Overall Study|Adverse Event|0|||
162961138|NCT04631562|588560728|FG003|Overall Study|Adverse Event|0|||
162961139|NCT04631562|588560729|FG004|Overall Study|Adverse Event|0|||
162961140|NCT04631562|588560730|FG005|Overall Study|Adverse Event|0|||
162961141|NCT04631562|588560731|FG006|Overall Study|Adverse Event|1|||
162961142|NCT04631562|588560732|FG007|Overall Study|Adverse Event|0|||
162961143|NCT04631562|588560733|FG008|Overall Study|Adverse Event|0|||
162961144|NCT03503318|588560736|FG000|Overall Study|Death|1|||
162961145|NCT03503318|588560737|FG001|Overall Study|Death|0|||
162961146|NCT03503318|588560738|FG002|Overall Study|Death|4|||
162961147|NCT03503318|588560736|FG000|Overall Study|Adverse Event|3|||
162961148|NCT03503318|588560737|FG001|Overall Study|Adverse Event|4|||
162961149|NCT03503318|588560738|FG002|Overall Study|Adverse Event|2|||
162961150|NCT03503318|588560736|FG000|Overall Study|Withdrawal by Subject|12|||
162961151|NCT03503318|588560737|FG001|Overall Study|Withdrawal by Subject|17|||
162961152|NCT03503318|588560738|FG002|Overall Study|Withdrawal by Subject|16|||
162961153|NCT03503318|588560736|FG000|Overall Study|Protocol Violation|5|||
162961154|NCT03503318|588560737|FG001|Overall Study|Protocol Violation|0|||
162961155|NCT03503318|588560738|FG002|Overall Study|Protocol Violation|3|||
162961156|NCT03503318|588560736|FG000|Overall Study|Lost to Follow-up|17|||
162961157|NCT03503318|588560737|FG001|Overall Study|Lost to Follow-up|15|||
162961158|NCT03503318|588560738|FG002|Overall Study|Lost to Follow-up|12|||
162961159|NCT03503318|588560736|FG000|Overall Study|Other than specified|1|||
162961160|NCT03503318|588560737|FG001|Overall Study|Other than specified|3|||
162615152|NCT04493333|587309273|FG000|Overall Study|Ineligible|0|||
162615153|NCT04493333|587309274|FG001|Overall Study|Ineligible|1|||
162615154|NCT04493333|587309273|FG000|Overall Study|Noncompliance|2|||
162615155|NCT04493333|587309274|FG001|Overall Study|Noncompliance|1|||
162615156|NCT02206048|587309280|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
162615157|NCT02925923|587309281|FG000|Overall Study|blood samples hemolyzed|0|||
162615158|NCT02925923|587309282|FG001|Overall Study|blood samples hemolyzed|2|||
162615159|NCT00282412|587309283|FG000|Overall Study|Death|2|||
162615160|NCT00697073|587309284|FG000|Overall Study|Withdrawal by Subject|2|||
162706679|NCT04955626|587636680|FG024|Blinded Period|Participants entered open label period|0|||
162706680|NCT04955626|587636681|FG025|Blinded Period|Participants entered open label period|0|||
162706681|NCT04955626|587636682|FG026|Blinded Period|Participants entered open label period|0|||
162706682|NCT04955626|587636683|FG027|Blinded Period|Participants entered open label period|0|||
162706683|NCT04955626|587636684|FG028|Blinded Period|Participants entered open label period|0|||
162706684|NCT04955626|587636685|FG029|Blinded Period|Participants entered open label period|0|||
162706685|NCT04955626|587636686|FG030|Blinded Period|Participants entered open label period|0|||
162706686|NCT04955626|587636687|FG031|Blinded Period|Participants entered open label period|0|||
162706687|NCT04955626|587636688|FG032|Blinded Period|Participants entered open label period|0|||
162706688|NCT04955626|587636689|FG033|Blinded Period|Participants entered open label period|0|||
162706689|NCT04955626|587636690|FG034|Blinded Period|Participants entered open label period|0|||
162706690|NCT04955626|587636691|FG035|Blinded Period|Participants entered open label period|0|||
162706691|NCT04955626|587636656|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
162706692|NCT04955626|587636657|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
162706693|NCT04955626|587636658|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
162706694|NCT04955626|587636659|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
162706695|NCT04955626|587636660|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
162706696|NCT04955626|587636661|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
162706697|NCT04955626|587636662|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
162706698|NCT04955626|587636663|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
162961161|NCT03503318|588560738|FG002|Overall Study|Other than specified|3|||
162961162|NCT02139826|588560741|FG000|Overall Study|Adverse Event|1|||
162961163|NCT03498560|588560743|FG000|Overall Study|Found Ineligible|2|||
162615161|NCT00697073|587309284|FG000|Overall Study|Pregnancy|1|||
162961164|NCT03498560|588560743|FG000|Overall Study|Withdrawal by Subject|14|||
162961165|NCT03498560|588560743|FG000|Overall Study|Lost to Follow-up|4|||
162961166|NCT03498560|588560743|FG000|Overall Study|Death|1|||
162961167|NCT00867360|588560744|FG000|Overall Study|Withdrawal by Subject|1|||
162961168|NCT00867360|588560745|FG001|Overall Study|Withdrawal by Subject|0|||
162961169|NCT00867360|588560744|FG000|Overall Study|Physician Decision|0|||
162961170|NCT00867360|588560745|FG001|Overall Study|Physician Decision|1|||
162872336|NCT01259297|588234635|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
162872337|NCT01259297|588234636|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
162872338|NCT01259297|588234637|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
162872339|NCT01259297|588234638|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
162872340|NCT01259297|588234639|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
162872341|NCT01259297|588234640|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163047355|NCT05219968|588879464|FG003|Safety Extension Period|Bilateral dislodgement|0|||
163047356|NCT05219968|588879465|FG004|Safety Extension Period|Bilateral dislodgement|1|||
163047357|NCT05219968|588879461|FG000|Safety Extension Period|Withdrawal by Subject|0|||
163047358|NCT05219968|588879462|FG001|Safety Extension Period|Withdrawal by Subject|0|||
163047359|NCT05219968|588879463|FG002|Safety Extension Period|Withdrawal by Subject|2|||
163047360|NCT05219968|588879464|FG003|Safety Extension Period|Withdrawal by Subject|0|||
163047361|NCT05219968|588879465|FG004|Safety Extension Period|Withdrawal by Subject|4|||
163047362|NCT05219968|588879461|FG000|Safety Extension Period|Adverse Event|0|||
163047363|NCT05219968|588879462|FG001|Safety Extension Period|Adverse Event|0|||
163047364|NCT05219968|588879463|FG002|Safety Extension Period|Adverse Event|2|||
163047365|NCT05219968|588879464|FG003|Safety Extension Period|Adverse Event|1|||
163047366|NCT05219968|588879465|FG004|Safety Extension Period|Adverse Event|1|||
163047367|NCT05219968|588879461|FG000|Safety Extension Period|Lost to Follow-up|0|||
163047368|NCT05219968|588879462|FG001|Safety Extension Period|Lost to Follow-up|0|||
163047369|NCT05219968|588879463|FG002|Safety Extension Period|Lost to Follow-up|0|||
163047370|NCT05219968|588879464|FG003|Safety Extension Period|Lost to Follow-up|1|||
163047371|NCT05219968|588879465|FG004|Safety Extension Period|Lost to Follow-up|0|||
163047372|NCT03877224|588879466|FG000|Overall Study|Death|3|||
163047373|NCT03877224|588879467|FG001|Overall Study|Death|2|||
163047374|NCT03877224|588879466|FG000|Overall Study|Withdrawal by Subject|1|||
163047375|NCT03877224|588879467|FG001|Overall Study|Withdrawal by Subject|6|||
163047376|NCT03877224|588879466|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
163047377|NCT03877224|588879467|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
163047378|NCT04587336|588879470|FG000|Overall Study|Lost to Follow-up|1|||
163047379|NCT04587336|588879471|FG001|Overall Study|Lost to Follow-up|0|||
163047380|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
163047381|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
163047382|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
163047383|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
163047384|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
163047385|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
162872342|NCT01259297|588234641|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
162872343|NCT01259297|588234634|FG000|Double Blind Randomized Period|Other reasons|0|||
162872344|NCT01259297|588234635|FG001|Double Blind Randomized Period|Other reasons|1|||
162872345|NCT01259297|588234636|FG002|Double Blind Randomized Period|Other reasons|0|||
162872346|NCT01259297|588234637|FG003|Double Blind Randomized Period|Other reasons|0|||
162872347|NCT01259297|588234638|FG004|Double Blind Randomized Period|Other reasons|1|||
162872348|NCT01259297|588234639|FG005|Double Blind Randomized Period|Other reasons|2|||
162872349|NCT01259297|588234640|FG006|Double Blind Randomized Period|Other reasons|3|||
162872350|NCT01259297|588234641|FG007|Double Blind Randomized Period|Other reasons|1|||
162872351|NCT00933335|588234642|FG000|Overall Study|Lost to Follow-up|1|||
162872352|NCT00933335|588234643|FG001|Overall Study|Lost to Follow-up|3|||
163047386|NCT01212094|588881116|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
163047387|NCT01212094|588881117|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
163047388|NCT01212094|588881118|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
163047389|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
163047390|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
163047391|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
163047392|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
163047393|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
163047394|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
163047395|NCT01212094|588881116|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
163047396|NCT01212094|588881117|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
163047397|NCT01212094|588881118|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
163047398|NCT05664581|588881122|FG000|Overall Study|Withdrawal by Subject|2|||
163047399|NCT03101150|588881123|FG000|Overall Study|Lost to Follow-up|2|||
163047400|NCT03101150|588881124|FG001|Overall Study|Lost to Follow-up|4|||
163047401|NCT03101150|588881123|FG000|Overall Study|Miscarriage|3|||
163047402|NCT03101150|588881124|FG001|Overall Study|Miscarriage|6|||
163047403|NCT01317641|588881128|FG000|Overall Study|Not treated|0|||
162872353|NCT00933335|588234642|FG000|Overall Study|Withdrawal by Subject|0|||
162872354|NCT00933335|588234643|FG001|Overall Study|Withdrawal by Subject|1|||
162872355|NCT00933335|588234642|FG000|Overall Study|Progressive Disease|0|||
162872356|NCT00933335|588234643|FG001|Overall Study|Progressive Disease|11|||
162872357|NCT00933335|588234642|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
162872358|NCT00933335|588234643|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
162872359|NCT00933335|588234642|FG000|Overall Study|Co-morbid Illness|1|||
162872360|NCT00933335|588234643|FG001|Overall Study|Co-morbid Illness|0|||
162872361|NCT02229864|588234644|FG000|Overall Study|Death|2|||
162872362|NCT02229864|588234644|FG000|Overall Study|Lost to Follow-up|1|||
162872363|NCT02650284|588234647|FG000|Overall Study|Lost to Follow-up|3|||
162872364|NCT02650284|588234648|FG001|Overall Study|Lost to Follow-up|3|||
162872365|NCT02650284|588234647|FG000|Overall Study|Consent incorrectly taken|0|||
162872366|NCT02650284|588234648|FG001|Overall Study|Consent incorrectly taken|1|||
162872367|NCT00374907|588234653|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
162872368|NCT00374907|588234654|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
162872369|NCT00374907|588234653|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
162872370|NCT00374907|588234654|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
162872371|NCT00374907|588234653|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
162872372|NCT00374907|588234654|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
162872373|NCT00374907|588234653|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
162872374|NCT00374907|588234654|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
162872375|NCT00374907|588234653|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
162872376|NCT00374907|588234654|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
162872377|NCT02815397|588234658|FG000|Overall Study|Physician Decision|2|||
162872378|NCT00085540|588234659|FG000|Overall Study|Withdrawal by Subject|0|||
162872379|NCT00085540|588234660|FG001|Overall Study|Withdrawal by Subject|1|||
162872380|NCT00085540|588234659|FG000|Overall Study|Protocol Violation|0|||
162872381|NCT00085540|588234660|FG001|Overall Study|Protocol Violation|1|||
162872382|NCT01605396|588234663|FG000|Overall Study|Adverse Event|5|||
162872383|NCT01605396|588234664|FG001|Overall Study|Adverse Event|3|||
162872384|NCT01605396|588234663|FG000|Overall Study|Lost to Follow-up|1|||
162872385|NCT01605396|588234664|FG001|Overall Study|Lost to Follow-up|0|||
162872386|NCT01605396|588234663|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163047404|NCT01317641|588881129|FG001|Overall Study|Not treated|0|||
163047405|NCT01317641|588881130|FG002|Overall Study|Not treated|0|||
163047406|NCT01317641|588881131|FG003|Overall Study|Not treated|0|||
163047407|NCT01317641|588881132|FG004|Overall Study|Not treated|0|||
163047408|NCT01317641|588881133|FG005|Overall Study|Not treated|0|||
163047409|NCT01317641|588881134|FG006|Overall Study|Not treated|0|||
163047410|NCT01317641|588881135|FG007|Overall Study|Not treated|1|||
163047411|NCT01317641|588881136|FG008|Overall Study|Not treated|1|||
163047412|NCT01317641|588881128|FG000|Overall Study|Adverse Event|0|||
163047413|NCT01317641|588881129|FG001|Overall Study|Adverse Event|1|||
163047414|NCT01317641|588881130|FG002|Overall Study|Adverse Event|0|||
163047415|NCT01317641|588881131|FG003|Overall Study|Adverse Event|1|||
163047416|NCT01317641|588881132|FG004|Overall Study|Adverse Event|0|||
163047417|NCT01317641|588881133|FG005|Overall Study|Adverse Event|0|||
163047418|NCT01317641|588881134|FG006|Overall Study|Adverse Event|2|||
163047419|NCT01317641|588881135|FG007|Overall Study|Adverse Event|1|||
163047420|NCT01317641|588881136|FG008|Overall Study|Adverse Event|0|||
163047421|NCT01317641|588881128|FG000|Overall Study|Protocol Violation|1|||
163047422|NCT01317641|588881129|FG001|Overall Study|Protocol Violation|0|||
163047423|NCT01317641|588881130|FG002|Overall Study|Protocol Violation|0|||
163047424|NCT01317641|588881131|FG003|Overall Study|Protocol Violation|0|||
163047425|NCT01317641|588881132|FG004|Overall Study|Protocol Violation|0|||
163047426|NCT01317641|588881133|FG005|Overall Study|Protocol Violation|0|||
163047427|NCT01317641|588881134|FG006|Overall Study|Protocol Violation|0|||
163047428|NCT01317641|588881135|FG007|Overall Study|Protocol Violation|0|||
163047429|NCT01317641|588881136|FG008|Overall Study|Protocol Violation|0|||
162872387|NCT01605396|588234664|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162872388|NCT01605396|588234663|FG000|Overall Study|Physician Decision|2|||
162872389|NCT01605396|588234664|FG001|Overall Study|Physician Decision|2|||
162872390|NCT01605396|588234663|FG000|Overall Study|Progressive Disease|23|||
162872391|NCT01605396|588234664|FG001|Overall Study|Progressive Disease|27|||
162872392|NCT01605396|588234663|FG000|Overall Study|Withdrawal by Subject|4|||
162872393|NCT01605396|588234664|FG001|Overall Study|Withdrawal by Subject|2|||
162872394|NCT01605396|588234663|FG000|Overall Study|Transfer Off Study|4|||
162872395|NCT01605396|588234664|FG001|Overall Study|Transfer Off Study|5|||
162872396|NCT04598165|588234665|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
162872397|NCT04598165|588234666|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
162872398|NCT04598165|588234665|FG000|Completed 6-week Follow-up|Death|2|||
162872399|NCT04598165|588234666|FG001|Completed 6-week Follow-up|Death|1|||
162872400|NCT04598165|588234665|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
162872401|NCT04598165|588234666|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
162872402|NCT04598165|588234665|FG000|Completed 6-week Follow-up|Ineligible|4|||
162872403|NCT04598165|588234666|FG001|Completed 6-week Follow-up|Ineligible|3|||
162872404|NCT04598165|588234665|FG000|Completed 6-week Follow-up|Partner refusal|0|||
162872405|NCT04598165|588234666|FG001|Completed 6-week Follow-up|Partner refusal|1|||
162872406|NCT04598165|588234665|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
162872407|NCT04598165|588234666|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
162872408|NCT00426751|588234670|FG000|Overall Study|Adverse Event|8|||
162961171|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
162961172|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
162961173|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
162961174|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
162961175|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
162961176|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
163047430|NCT01317641|588881128|FG000|Overall Study|Disease progression|0|||
163047431|NCT01317641|588881129|FG001|Overall Study|Disease progression|0|||
162615162|NCT00697073|587309284|FG000|Overall Study|non compliance and other|6|||
162615163|NCT03911713|587309285|FG000|Overall Study|Lost to Follow-up|0|||
162961177|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961178|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961179|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961180|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961181|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
162872409|NCT00426751|588234671|FG001|Overall Study|Adverse Event|1|||
162872410|NCT00426751|588234670|FG000|Overall Study|Lost to Follow-up|7|||
162872411|NCT00426751|588234671|FG001|Overall Study|Lost to Follow-up|6|||
163047432|NCT01317641|588881130|FG002|Overall Study|Disease progression|0|||
162872412|NCT00426751|588234670|FG000|Overall Study|Consent Withdrawn|0|||
163047433|NCT01317641|588881131|FG003|Overall Study|Disease progression|0|||
163047434|NCT01317641|588881132|FG004|Overall Study|Disease progression|0|||
163047435|NCT01317641|588881133|FG005|Overall Study|Disease progression|0|||
163047436|NCT01317641|588881134|FG006|Overall Study|Disease progression|0|||
163047437|NCT01317641|588881135|FG007|Overall Study|Disease progression|3|||
163047438|NCT01317641|588881136|FG008|Overall Study|Disease progression|4|||
163047439|NCT01317641|588881128|FG000|Overall Study|Withdrawal by Subject|0|||
163047440|NCT01317641|588881129|FG001|Overall Study|Withdrawal by Subject|0|||
163047441|NCT01317641|588881130|FG002|Overall Study|Withdrawal by Subject|0|||
163047442|NCT01317641|588881131|FG003|Overall Study|Withdrawal by Subject|0|||
163047443|NCT01317641|588881132|FG004|Overall Study|Withdrawal by Subject|0|||
163047444|NCT01317641|588881133|FG005|Overall Study|Withdrawal by Subject|0|||
163047445|NCT01317641|588881134|FG006|Overall Study|Withdrawal by Subject|1|||
163047446|NCT01317641|588881135|FG007|Overall Study|Withdrawal by Subject|0|||
163047447|NCT01317641|588881136|FG008|Overall Study|Withdrawal by Subject|0|||
163047448|NCT00329108|588881137|FG000|Overall Study|Adverse Event|2|||
163047449|NCT00329108|588881138|FG001|Overall Study|Adverse Event|2|||
163047450|NCT00329108|588881137|FG000|Overall Study|Lack of Efficacy|3|||
163047451|NCT00329108|588881138|FG001|Overall Study|Lack of Efficacy|3|||
163047452|NCT00329108|588881137|FG000|Overall Study|Withdrawal by Subject|0|||
163047453|NCT00329108|588881138|FG001|Overall Study|Withdrawal by Subject|2|||
163047454|NCT00329108|588881137|FG000|Overall Study|symptomatic deterioration|1|||
163047455|NCT00329108|588881138|FG001|Overall Study|symptomatic deterioration|1|||
163047456|NCT00329108|588881137|FG000|Overall Study|Subject no longer willing to participate|2|||
163047457|NCT00329108|588881138|FG001|Overall Study|Subject no longer willing to participate|2|||
163047458|NCT00329108|588881137|FG000|Overall Study|study terminated by sponsor|1|||
163047459|NCT00329108|588881138|FG001|Overall Study|study terminated by sponsor|0|||
163047460|NCT00329108|588881137|FG000|Overall Study|withdrew patient after SAE resolved|1|||
163047461|NCT00329108|588881138|FG001|Overall Study|withdrew patient after SAE resolved|0|||
163047462|NCT00329108|588881137|FG000|Overall Study|Protocol Violation|0|||
163047463|NCT00329108|588881138|FG001|Overall Study|Protocol Violation|2|||
163047464|NCT01302418|588881139|FG000|Overall Study|Protocol Violation|9|||
163047465|NCT01302418|588881139|FG000|Overall Study|Non-evaluable|9|||
163047466|NCT02787304|588881144|FG000|Overall Study|Adverse Event|9|||
163047467|NCT02787304|588881145|FG001|Overall Study|Adverse Event|3|||
163047468|NCT02787304|588881146|FG002|Overall Study|Adverse Event|8|||
163047469|NCT02787304|588881147|FG003|Overall Study|Adverse Event|1|||
163047470|NCT02787304|588881144|FG000|Overall Study|Withdrawal by Subject|1|||
163047471|NCT02787304|588881145|FG001|Overall Study|Withdrawal by Subject|4|||
163047472|NCT02787304|588881146|FG002|Overall Study|Withdrawal by Subject|0|||
163047473|NCT02787304|588881147|FG003|Overall Study|Withdrawal by Subject|0|||
163047474|NCT02787304|588881144|FG000|Overall Study|Lost to Follow-up|1|||
163047475|NCT02787304|588881145|FG001|Overall Study|Lost to Follow-up|0|||
163047476|NCT02787304|588881146|FG002|Overall Study|Lost to Follow-up|0|||
163047477|NCT02787304|588881147|FG003|Overall Study|Lost to Follow-up|1|||
163047478|NCT02787304|588881144|FG000|Overall Study|Noncompliance with study drug|0|||
163047479|NCT02787304|588881145|FG001|Overall Study|Noncompliance with study drug|0|||
163047480|NCT02787304|588881146|FG002|Overall Study|Noncompliance with study drug|1|||
163047481|NCT02787304|588881147|FG003|Overall Study|Noncompliance with study drug|0|||
163047482|NCT02787304|588881144|FG000|Overall Study|Physician Decision|0|||
163047483|NCT02787304|588881145|FG001|Overall Study|Physician Decision|0|||
163047484|NCT02787304|588881146|FG002|Overall Study|Physician Decision|1|||
163047485|NCT02787304|588881147|FG003|Overall Study|Physician Decision|0|||
163047486|NCT02787304|588881144|FG000|Overall Study|Study terminated by sponsor|25|||
163047487|NCT02787304|588881145|FG001|Overall Study|Study terminated by sponsor|31|||
163047488|NCT02787304|588881146|FG002|Overall Study|Study terminated by sponsor|31|||
163047489|NCT02787304|588881147|FG003|Overall Study|Study terminated by sponsor|32|||
163047490|NCT04771013|588881149|FG000|Overall Study|Withdrawal by Subject|2|||
163047491|NCT04771013|588881150|FG001|Overall Study|Withdrawal by Subject|0|||
163047492|NCT04771013|588881149|FG000|Overall Study|Death|0|||
163047493|NCT04771013|588881150|FG001|Overall Study|Death|5|||
163047494|NCT04771013|588881149|FG000|Overall Study|Referred to another hospital before day 20|0|||
163047495|NCT04771013|588881150|FG001|Overall Study|Referred to another hospital before day 20|1|||
163047496|NCT01051921|588881152|FG000|Overall Study|Physician Decision|9|||
162706699|NCT04955626|587636664|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
162961182|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961183|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961184|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961185|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961186|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961187|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961188|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961189|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961190|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961191|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961192|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961193|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961194|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
163047497|NCT01051921|588881152|FG000|Overall Study|Adverse Event|8|||
163047498|NCT01051921|588881152|FG000|Overall Study|Withdrawal by Subject|7|||
163047499|NCT01051921|588881152|FG000|Overall Study|Lost to Follow-up|4|||
163047500|NCT01051921|588881152|FG000|Overall Study|virological failure|1|||
163047501|NCT01051921|588881152|FG000|Overall Study|patient moved|1|||
163047502|NCT00379834|588881153|FG000|Overall Study|Time constraints|2|||
163047503|NCT01519817|588881154|FG000|Overall Study|Withdrawal by Subject|1|||
163047504|NCT01519817|588881155|FG001|Overall Study|Withdrawal by Subject|0|||
162872413|NCT00426751|588234671|FG001|Overall Study|Consent Withdrawn|1|||
162872414|NCT00426751|588234670|FG000|Overall Study|Other Reasons|7|||
162872415|NCT00426751|588234671|FG001|Overall Study|Other Reasons|12|||
162872416|NCT01721408|588234672|FG000|Overall Study|Adverse Event|6|||
162872417|NCT01721408|588234673|FG001|Overall Study|Adverse Event|1|||
162872418|NCT01721408|588234672|FG000|Overall Study|Death|1|||
162615164|NCT03911713|587309286|FG001|Overall Study|Lost to Follow-up|2|||
162872419|NCT01721408|588234673|FG001|Overall Study|Death|0|||
162872420|NCT01721408|588234672|FG000|Overall Study|Insufficient clinical response|15|||
162872421|NCT01721408|588234673|FG001|Overall Study|Insufficient clinical response|6|||
162872422|NCT01721408|588234672|FG000|Overall Study|No longer willing to participate study|9|||
162872423|NCT01721408|588234673|FG001|Overall Study|No longer willing to participate study|10|||
162872424|NCT01721408|588234672|FG000|Overall Study|Protocol Violation|0|||
162872425|NCT01721408|588234673|FG001|Overall Study|Protocol Violation|2|||
162872426|NCT01721408|588234672|FG000|Overall Study|Other|3|||
162872427|NCT01721408|588234673|FG001|Overall Study|Other|3|||
162961195|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961196|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
162961197|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961198|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
162961199|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961200|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961201|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961202|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961203|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961204|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961205|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961206|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961207|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961208|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961209|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961210|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961211|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961212|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961213|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961214|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961215|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961216|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961217|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961218|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961219|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961220|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961221|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961222|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162961223|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961224|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
162961225|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961226|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961227|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961228|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961229|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961230|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961231|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961232|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961233|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961234|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961235|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961236|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961237|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961238|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961239|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961240|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961241|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961242|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961243|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961244|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961245|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961246|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961247|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162961248|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162615165|NCT03911713|587309287|FG002|Overall Study|Lost to Follow-up|0|||
162615166|NCT03911713|587309288|FG003|Overall Study|Lost to Follow-up|0|||
162872428|NCT01721408|588234672|FG000|Overall Study|Lost to Follow-up|1|||
162872429|NCT01721408|588234673|FG001|Overall Study|Lost to Follow-up|2|||
162872430|NCT01721408|588234672|FG000|Overall Study|Does not meet entrance criteria|1|||
162872431|NCT01721408|588234673|FG001|Overall Study|Does not meet entrance criteria|0|||
162872432|NCT04160468|588234674|FG000|Overall Study|Lost to Follow-up|19|||
162872433|NCT04160468|588234675|FG001|Overall Study|Lost to Follow-up|4|||
162872434|NCT04160468|588234674|FG000|Overall Study|Randomized but not dosed|6|||
162872435|NCT04160468|588234675|FG001|Overall Study|Randomized but not dosed|0|||
162872436|NCT04160468|588234674|FG000|Overall Study|Withdrawal by Subject|4|||
162872437|NCT04160468|588234675|FG001|Overall Study|Withdrawal by Subject|1|||
162872438|NCT04160468|588234674|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
163047505|NCT01519817|588881156|FG002|Overall Study|Withdrawal by Subject|0|||
163047506|NCT01519817|588881157|FG003|Overall Study|Withdrawal by Subject|0|||
163047507|NCT01519817|588881154|FG000|Overall Study|Off study due to infection|0|||
163047508|NCT01519817|588881155|FG001|Overall Study|Off study due to infection|0|||
163047509|NCT01519817|588881156|FG002|Overall Study|Off study due to infection|0|||
163047510|NCT01519817|588881157|FG003|Overall Study|Off study due to infection|1|||
163047511|NCT01716806|588881160|FG000|Overall Study|Patient withdrawal of consent|4|||
163047512|NCT01716806|588881161|FG001|Overall Study|Patient withdrawal of consent|2|||
163047513|NCT01716806|588881162|FG002|Overall Study|Patient withdrawal of consent|4|||
163047514|NCT01716806|588881163|FG003|Overall Study|Patient withdrawal of consent|3|||
163047515|NCT01716806|588881164|FG004|Overall Study|Patient withdrawal of consent|2|||
163047516|NCT01716806|588881165|FG005|Overall Study|Patient withdrawal of consent|0|||
163047517|NCT01716806|588881160|FG000|Overall Study|Lost to Follow-up|3|||
163047518|NCT01716806|588881161|FG001|Overall Study|Lost to Follow-up|3|||
163047519|NCT01716806|588881162|FG002|Overall Study|Lost to Follow-up|0|||
163047520|NCT01716806|588881163|FG003|Overall Study|Lost to Follow-up|2|||
162706700|NCT04955626|587636665|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
162872439|NCT04160468|588234675|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
162872440|NCT04160468|588234674|FG000|Overall Study|Participant incarcerated|1|||
162872441|NCT04160468|588234675|FG001|Overall Study|Participant incarcerated|0|||
162872442|NCT03987620|588234676|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
162872443|NCT03987620|588234677|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
162872444|NCT03987620|588234676|FG000|Overall Study|Adverse Event|3|||
162872445|NCT03987620|588234677|FG001|Overall Study|Adverse Event|0|||
162872446|NCT03987620|588234676|FG000|Overall Study|Lost to Follow-up|1|||
162872447|NCT03987620|588234677|FG001|Overall Study|Lost to Follow-up|2|||
162872448|NCT03987620|588234676|FG000|Overall Study|Physician Decision|0|||
162872449|NCT03987620|588234677|FG001|Overall Study|Physician Decision|1|||
162872450|NCT03987620|588234676|FG000|Overall Study|Pregnancy|1|||
162872451|NCT03987620|588234677|FG001|Overall Study|Pregnancy|0|||
162872452|NCT03987620|588234676|FG000|Overall Study|Withdrawal by Subject|7|||
162872453|NCT03987620|588234677|FG001|Overall Study|Withdrawal by Subject|1|||
162872454|NCT03987620|588234676|FG000|Overall Study|Other|2|||
162872455|NCT03987620|588234677|FG001|Overall Study|Other|5|||
162872456|NCT01770353|588234678|FG000|Overall Study|Progressive disease|2|||
162872457|NCT01770353|588234679|FG001|Overall Study|Progressive disease|1|||
162872458|NCT01770353|588234678|FG000|Overall Study|Adverse Event|0|||
162872459|NCT01770353|588234679|FG001|Overall Study|Adverse Event|1|||
162872460|NCT01770353|588234678|FG000|Overall Study|Protocol Violation|1|||
162872461|NCT01770353|588234679|FG001|Overall Study|Protocol Violation|0|||
162872462|NCT01770353|588234678|FG000|Overall Study|Physician Decision|0|||
162872463|NCT01770353|588234679|FG001|Overall Study|Physician Decision|3|||
162872464|NCT01770353|588234678|FG000|Overall Study|Clinical deterioration|3|||
162872465|NCT01770353|588234679|FG001|Overall Study|Clinical deterioration|6|||
162872466|NCT01770353|588234678|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
162872467|NCT01770353|588234679|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
162872468|NCT05128162|588234680|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
162872469|NCT05128162|588234680|FG000|Overall Study|Physician Decision|1|||
162872470|NCT00370149|588234681|FG000|Overall Study|Physician Decision|16|||
162872471|NCT00370149|588234682|FG001|Overall Study|Physician Decision|16|||
162872472|NCT00370149|588234681|FG000|Overall Study|Protocol Violation|1|||
162872473|NCT00370149|588234682|FG001|Overall Study|Protocol Violation|0|||
162872474|NCT00370149|588234681|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
163047521|NCT01716806|588881164|FG004|Overall Study|Lost to Follow-up|1|||
162872475|NCT00370149|588234682|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
162872476|NCT00370149|588234681|FG000|Overall Study|Pre-existing infection|0|||
162872477|NCT00370149|588234682|FG001|Overall Study|Pre-existing infection|1|||
163047522|NCT01716806|588881165|FG005|Overall Study|Lost to Follow-up|0|||
163047523|NCT01716806|588881160|FG000|Overall Study|Death|13|||
162872478|NCT00370149|588234681|FG000|Overall Study|Antibiotic coated dressing placed|0|||
162872479|NCT00370149|588234682|FG001|Overall Study|Antibiotic coated dressing placed|1|||
162872480|NCT04920084|588236179|FG000|Overall Study|Adverse Event|1|||
162872481|NCT04920084|588236179|FG000|Overall Study|Lost to Follow-up|2|||
162872482|NCT04920084|588236179|FG000|Overall Study|Withdrawal by Subject|2|||
162872483|NCT01096446|588236180|FG000|Overall Study|Death|1|||
162872484|NCT01096446|588236181|FG001|Overall Study|Death|0|||
162872485|NCT01096446|588236180|FG000|Overall Study|Protocol Violation|2|||
162872486|NCT01096446|588236181|FG001|Overall Study|Protocol Violation|0|||
162872487|NCT02279524|588236183|FG000|Overall Study|Withdrawal by Subject|3|||
162872488|NCT02279524|588236184|FG001|Overall Study|Withdrawal by Subject|6|||
162872489|NCT02279524|588236185|FG002|Overall Study|Withdrawal by Subject|3|||
162872490|NCT02279524|588236183|FG000|Overall Study|Adverse Event|4|||
162872491|NCT02279524|588236184|FG001|Overall Study|Adverse Event|3|||
162872492|NCT02279524|588236185|FG002|Overall Study|Adverse Event|2|||
162872493|NCT02279524|588236183|FG000|Overall Study|Lost to Follow-up|1|||
162872494|NCT02279524|588236184|FG001|Overall Study|Lost to Follow-up|1|||
162872495|NCT02279524|588236185|FG002|Overall Study|Lost to Follow-up|0|||
162872496|NCT02279524|588236183|FG000|Overall Study|Disallowed medication|1|||
162872497|NCT02279524|588236184|FG001|Overall Study|Disallowed medication|1|||
162872498|NCT02279524|588236185|FG002|Overall Study|Disallowed medication|2|||
162872499|NCT02279524|588236183|FG000|Overall Study|Bariatric surgery|1|||
162872500|NCT02279524|588236184|FG001|Overall Study|Bariatric surgery|0|||
162872501|NCT02279524|588236185|FG002|Overall Study|Bariatric surgery|0|||
162872502|NCT01043185|588236186|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
162872503|NCT01043185|588236187|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
162872504|NCT01043185|588236188|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
162872505|NCT01043185|588236189|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
162872506|NCT01043185|588236190|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
162872507|NCT01043185|588236191|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
162872508|NCT01043185|588236192|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
162872509|NCT01043185|588236193|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
162872510|NCT01043185|588236194|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
162872511|NCT01043185|588236195|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
162872512|NCT00392171|588236200|FG000|Overall Study|Did not meet inclusion criteria|4|||
162872513|NCT00392171|588236200|FG000|Overall Study|Disease progression|101|||
162872514|NCT03488472|588236201|FG000|Overall Study|disease progression additional mets|1|||
162872515|NCT00028002|588236202|FG000|Overall Study|Withdrawal by Subject|3|||
162872516|NCT00028002|588236202|FG000|Overall Study|Ineligible|8|||
162872517|NCT00414310|588236208|FG000|Overall Study|Not treated|1|||
162872518|NCT00414310|588236209|FG001|Overall Study|Not treated|0|||
162872519|NCT01441440|588236213|FG000|Overall Study|Death|1|||
162872520|NCT01441440|588236214|FG001|Overall Study|Death|0|||
162872521|NCT01441440|588236215|FG002|Overall Study|Death|1|||
162872522|NCT01441440|588236213|FG000|Overall Study|Adverse Event|2|||
162872523|NCT01441440|588236214|FG001|Overall Study|Adverse Event|9|||
162872524|NCT01441440|588236215|FG002|Overall Study|Adverse Event|9|||
162872525|NCT01441440|588236213|FG000|Overall Study|Lost to Follow-up|0|||
162872526|NCT01441440|588236214|FG001|Overall Study|Lost to Follow-up|2|||
162872527|NCT01441440|588236215|FG002|Overall Study|Lost to Follow-up|1|||
162872528|NCT01441440|588236213|FG000|Overall Study|Withdrawal by Subject|11|||
162872529|NCT01441440|588236214|FG001|Overall Study|Withdrawal by Subject|9|||
162872530|NCT01441440|588236215|FG002|Overall Study|Withdrawal by Subject|9|||
162872531|NCT01441440|588236213|FG000|Overall Study|Pregnancy|1|||
162872532|NCT01441440|588236214|FG001|Overall Study|Pregnancy|0|||
162872533|NCT01441440|588236215|FG002|Overall Study|Pregnancy|0|||
162872534|NCT01441440|588236213|FG000|Overall Study|Lack of Efficacy|1|||
162872535|NCT01441440|588236214|FG001|Overall Study|Lack of Efficacy|0|||
162872536|NCT01441440|588236215|FG002|Overall Study|Lack of Efficacy|1|||
162872537|NCT01441440|588236213|FG000|Overall Study|Moving|0|||
162872538|NCT01441440|588236214|FG001|Overall Study|Moving|1|||
162872539|NCT01441440|588236215|FG002|Overall Study|Moving|1|||
162872540|NCT01441440|588236213|FG000|Overall Study|Work-related matter|0|||
162872541|NCT01441440|588236214|FG001|Overall Study|Work-related matter|1|||
162872542|NCT01441440|588236215|FG002|Overall Study|Work-related matter|0|||
162872543|NCT01441440|588236213|FG000|Overall Study|Difficllty in keeping the schedule|1|||
162872544|NCT01441440|588236214|FG001|Overall Study|Difficllty in keeping the schedule|1|||
162872545|NCT01441440|588236215|FG002|Overall Study|Difficllty in keeping the schedule|0|||
162872546|NCT01993329|588236216|FG000|Period 2|Adverse Event|0|||
162872547|NCT01993329|588236217|FG001|Period 2|Adverse Event|0|||
162872548|NCT01993329|588236218|FG002|Period 2|Adverse Event|0|||
162872549|NCT01993329|588236219|FG003|Period 2|Adverse Event|0|||
162872550|NCT01993329|588236220|FG004|Period 2|Adverse Event|0|||
162872551|NCT01993329|588236221|FG005|Period 2|Adverse Event|1|||
162872552|NCT01993329|588236216|FG000|Wash-out|Personal reasons|0|||
162872553|NCT01993329|588236217|FG001|Wash-out|Personal reasons|1|||
162872554|NCT01993329|588236218|FG002|Wash-out|Personal reasons|0|||
162872555|NCT01993329|588236219|FG003|Wash-out|Personal reasons|0|||
162872556|NCT01993329|588236220|FG004|Wash-out|Personal reasons|0|||
163047524|NCT01716806|588881161|FG001|Overall Study|Death|9|||
163047525|NCT01716806|588881162|FG002|Overall Study|Death|12|||
163047526|NCT01716806|588881163|FG003|Overall Study|Death|4|||
163047527|NCT01716806|588881164|FG004|Overall Study|Death|10|||
163047528|NCT01716806|588881165|FG005|Overall Study|Death|5|||
163047529|NCT01716806|588881160|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047530|NCT01716806|588881161|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047531|NCT01716806|588881162|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047532|NCT01716806|588881163|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163047533|NCT01716806|588881164|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
162706701|NCT04955626|587636666|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
162706702|NCT04955626|587636667|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
162706703|NCT04955626|587636668|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
162706704|NCT04955626|587636669|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
162706705|NCT04955626|587636670|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
162872557|NCT01993329|588236221|FG005|Wash-out|Personal reasons|0|||
162872558|NCT03539458|588236222|FG000|Overall Study|Death|1|||
162872559|NCT02750800|588236225|FG000|Overall Study|Adverse Event|18|||
162872560|NCT02750800|588236225|FG000|Overall Study|Lost to Follow-up|12|||
162872561|NCT02750800|588236225|FG000|Overall Study|Investigator decision|53|||
162872562|NCT02750800|588236225|FG000|Overall Study|Patient request|12|||
162872563|NCT02750800|588236225|FG000|Overall Study|Other, not specified|3|||
162872564|NCT00972478|588236226|FG000|Overall Study|Adverse Event|3|||
162872565|NCT00972478|588236227|FG001|Overall Study|Adverse Event|16|||
162872566|NCT00972478|588236226|FG000|Overall Study|Withdrawal by Subject|1|||
162872567|NCT00972478|588236227|FG001|Overall Study|Withdrawal by Subject|8|||
162872568|NCT00972478|588236226|FG000|Overall Study|Progression/Relapse|0|||
162872569|NCT00972478|588236227|FG001|Overall Study|Progression/Relapse|2|||
162872570|NCT00972478|588236226|FG000|Overall Study|Death|0|||
162872571|NCT00972478|588236227|FG001|Overall Study|Death|2|||
162872572|NCT00972478|588236226|FG000|Overall Study|Not protocol specified|1|||
162872573|NCT00972478|588236227|FG001|Overall Study|Not protocol specified|1|||
162872574|NCT00972478|588236226|FG000|Overall Study|Ineligible|1|||
162872575|NCT00972478|588236227|FG001|Overall Study|Ineligible|7|||
162872576|NCT00972478|588236226|FG000|Overall Study|Not start protocol treatment|1|||
162872577|NCT00972478|588236227|FG001|Overall Study|Not start protocol treatment|2|||
162872578|NCT04742907|588236234|FG000|Overall Study|Adverse Event|1|||
162872579|NCT04742907|588236235|FG001|Overall Study|Adverse Event|0|||
162872580|NCT04742907|588236236|FG002|Overall Study|Adverse Event|1|||
162961249|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961250|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961251|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
162961252|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961253|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
162961254|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961255|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961256|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961257|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961258|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961259|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961260|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961261|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961262|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961263|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961264|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961265|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961266|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961267|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961268|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961269|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961270|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961271|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961272|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961273|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162961274|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162872581|NCT04742907|588236234|FG000|Overall Study|Lost to Follow-up|3|||
162872582|NCT04742907|588236235|FG001|Overall Study|Lost to Follow-up|3|||
162872583|NCT04742907|588236236|FG002|Overall Study|Lost to Follow-up|2|||
162872584|NCT04742907|588236234|FG000|Overall Study|Physician Decision|0|||
162961275|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
163047534|NCT01716806|588881165|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
163047535|NCT01716806|588881160|FG000|Overall Study|PI decision|0|||
163047536|NCT01716806|588881161|FG001|Overall Study|PI decision|0|||
162872585|NCT04742907|588236235|FG001|Overall Study|Physician Decision|1|||
162872586|NCT04742907|588236236|FG002|Overall Study|Physician Decision|0|||
162872587|NCT04742907|588236234|FG000|Overall Study|Protocol Violation|1|||
162872588|NCT04742907|588236235|FG001|Overall Study|Protocol Violation|1|||
162872589|NCT04742907|588236236|FG002|Overall Study|Protocol Violation|1|||
162872590|NCT04742907|588236234|FG000|Overall Study|Withdrawal by Subject|5|||
162872591|NCT04742907|588236235|FG001|Overall Study|Withdrawal by Subject|6|||
162872592|NCT04742907|588236236|FG002|Overall Study|Withdrawal by Subject|4|||
162872593|NCT04742907|588236234|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
162872594|NCT04742907|588236235|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
162872595|NCT04742907|588236236|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
162872596|NCT04742907|588236234|FG000|Overall Study|Did Not Receive the Study Drug|2|||
162872597|NCT04742907|588236235|FG001|Overall Study|Did Not Receive the Study Drug|4|||
162872598|NCT04742907|588236236|FG002|Overall Study|Did Not Receive the Study Drug|4|||
162872599|NCT01428063|588236237|FG000|Overall Study|Lack of Efficacy|8|||
163047537|NCT01716806|588881162|FG002|Overall Study|PI decision|0|||
162872600|NCT01428063|588236238|FG001|Overall Study|Lack of Efficacy|4|||
162872601|NCT01428063|588236239|FG002|Overall Study|Lack of Efficacy|1|||
162872602|NCT01428063|588236237|FG000|Overall Study|Adverse Event|2|||
162872603|NCT01428063|588236238|FG001|Overall Study|Adverse Event|3|||
162872604|NCT01428063|588236239|FG002|Overall Study|Adverse Event|0|||
162872605|NCT01428063|588236237|FG000|Overall Study|Lost to Follow-up|0|||
162872606|NCT01428063|588236238|FG001|Overall Study|Lost to Follow-up|2|||
162872607|NCT01428063|588236239|FG002|Overall Study|Lost to Follow-up|0|||
162872608|NCT01428063|588236237|FG000|Overall Study|No longer meets study criteria|0|||
162872609|NCT01428063|588236238|FG001|Overall Study|No longer meets study criteria|1|||
162872610|NCT01428063|588236239|FG002|Overall Study|No longer meets study criteria|0|||
162872611|NCT01259856|588236240|FG000|Overall Study|Adverse Event|12|||
162872612|NCT01259856|588236241|FG001|Overall Study|Adverse Event|9|||
162872613|NCT01259856|588236240|FG000|Overall Study|Death|0|||
162872614|NCT01259856|588236241|FG001|Overall Study|Death|1|||
162872615|NCT01259856|588236240|FG000|Overall Study|Lack of Efficacy|3|||
162872616|NCT01259856|588236241|FG001|Overall Study|Lack of Efficacy|1|||
162872617|NCT01259856|588236240|FG000|Overall Study|Lost to Follow-up|1|||
162872618|NCT01259856|588236241|FG001|Overall Study|Lost to Follow-up|1|||
162872619|NCT01259856|588236240|FG000|Overall Study|Physician Decision|2|||
162872620|NCT01259856|588236241|FG001|Overall Study|Physician Decision|1|||
162872621|NCT01259856|588236240|FG000|Overall Study|Withdrawal by Subject|9|||
162872622|NCT01259856|588236241|FG001|Overall Study|Withdrawal by Subject|10|||
163047538|NCT01716806|588881163|FG003|Overall Study|PI decision|0|||
163047539|NCT01716806|588881164|FG004|Overall Study|PI decision|1|||
163047540|NCT01716806|588881165|FG005|Overall Study|PI decision|0|||
163047541|NCT01716806|588881160|FG000|Overall Study|Change in performance status|1|||
163047542|NCT01716806|588881161|FG001|Overall Study|Change in performance status|0|||
163047543|NCT01716806|588881162|FG002|Overall Study|Change in performance status|0|||
163047544|NCT01716806|588881163|FG003|Overall Study|Change in performance status|0|||
163047545|NCT01716806|588881164|FG004|Overall Study|Change in performance status|0|||
163047546|NCT01716806|588881165|FG005|Overall Study|Change in performance status|0|||
163047547|NCT01716806|588881160|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047548|NCT01716806|588881161|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047549|NCT01716806|588881162|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
163047550|NCT01716806|588881163|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047551|NCT01716806|588881164|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
163047552|NCT01716806|588881165|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
162872623|NCT01259856|588236240|FG000|Overall Study|Treatment never started|0|||
163047553|NCT01716806|588881160|FG000|Overall Study|Sponsor direction|7|||
163047554|NCT01716806|588881161|FG001|Overall Study|Sponsor direction|8|||
163047555|NCT01716806|588881162|FG002|Overall Study|Sponsor direction|5|||
163047556|NCT01716806|588881163|FG003|Overall Study|Sponsor direction|12|||
163047557|NCT01716806|588881164|FG004|Overall Study|Sponsor direction|16|||
162872624|NCT01259856|588236241|FG001|Overall Study|Treatment never started|6|||
163047558|NCT01716806|588881165|FG005|Overall Study|Sponsor direction|1|||
163047559|NCT02498678|588881169|FG000|Overall Study|interference from the surgical team|0|||
163047560|NCT02498678|588881170|FG001|Overall Study|interference from the surgical team|2|||
163047561|NCT01145482|588881171|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
162872625|NCT01259856|588236240|FG000|Overall Study|Study closure by sponsor|40|||
162872626|NCT01259856|588236241|FG001|Overall Study|Study closure by sponsor|41|||
162872627|NCT01259856|588236240|FG000|Overall Study|Patient developed other disease|0|||
162872628|NCT01259856|588236241|FG001|Overall Study|Patient developed other disease|1|||
162872629|NCT01259856|588236240|FG000|Overall Study|Transfer to another study|0|||
162872630|NCT01259856|588236241|FG001|Overall Study|Transfer to another study|1|||
163047562|NCT01145482|588881172|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163047563|NCT04547140|588881173|FG000|Overall Study|Adverse Event|0|||
163047564|NCT04547140|588881174|FG001|Overall Study|Adverse Event|1|||
163047565|NCT04547140|588881173|FG000|Overall Study|Withdrawal by Subject|0|||
163047566|NCT04547140|588881174|FG001|Overall Study|Withdrawal by Subject|1|||
163047567|NCT04547140|588881173|FG000|Overall Study|Lost to Follow-up|3|||
163047568|NCT04547140|588881174|FG001|Overall Study|Lost to Follow-up|1|||
163047569|NCT04547140|588881173|FG000|Overall Study|Death|2|||
163047570|NCT04547140|588881174|FG001|Overall Study|Death|1|||
163047571|NCT04547140|588881173|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
162872631|NCT01259856|588236240|FG000|Overall Study|Unknown/missing|2|||
162872632|NCT01259856|588236241|FG001|Overall Study|Unknown/missing|2|||
162872633|NCT00788775|588236242|FG000|Overall Study|Progressive Disease|8|||
162872634|NCT00788775|588236243|FG001|Overall Study|Progressive Disease|6|||
162872635|NCT00788775|588236242|FG000|Overall Study|Withdrawal by Subject|0|||
162872636|NCT00788775|588236243|FG001|Overall Study|Withdrawal by Subject|2|||
162872637|NCT00788775|588236242|FG000|Overall Study|Patient Non-Compliance|1|||
162872638|NCT00788775|588236243|FG001|Overall Study|Patient Non-Compliance|0|||
162872639|NCT00788775|588236242|FG000|Overall Study|Patient's measurable disease resected.|1|||
162872640|NCT00788775|588236243|FG001|Overall Study|Patient's measurable disease resected.|0|||
162872641|NCT04488822|588236246|FG000|Overall Study|Adverse Event|8|||
162872642|NCT04488822|588236246|FG000|Overall Study|Withdrawal by Subject|1|||
162872643|NCT03838367|588236247|FG000|Overall Study|Early termination of study|3|||
162872644|NCT03838367|588236248|FG001|Overall Study|Early termination of study|4|||
162872645|NCT03838367|588236249|FG002|Overall Study|Early termination of study|3|||
162872646|NCT03838367|588236250|FG003|Overall Study|Early termination of study|0|||
162872647|NCT03406104|588236251|FG000|Overall Study|Lost to Follow-up|2|||
162872648|NCT03406104|588236251|FG000|Overall Study|Withdrawal by Subject|2|||
162872649|NCT03406104|588236251|FG000|Overall Study|due to Covid patient did not want to travel|1|||
162872650|NCT03406104|588236251|FG000|Overall Study|Death|2|||
162872651|NCT00195260|588236262|FG000|Part 1: Dose Escalation|Adverse Event|0|||
162872652|NCT00195260|588236263|FG001|Part 1: Dose Escalation|Adverse Event|1|||
162872653|NCT00195260|588236264|FG002|Part 1: Dose Escalation|Adverse Event|0|||
162872654|NCT00195260|588236265|FG003|Part 1: Dose Escalation|Adverse Event|1|||
162872655|NCT00195260|588236266|FG004|Part 1: Dose Escalation|Adverse Event|1|||
162872656|NCT00195260|588236267|FG005|Part 1: Dose Escalation|Adverse Event|0|||
162872657|NCT00195260|588236268|FG006|Part 1: Dose Escalation|Adverse Event|3|||
162872658|NCT00195260|588236269|FG007|Part 1: Dose Escalation|Adverse Event|0|||
162872659|NCT00195260|588236270|FG008|Part 1: Dose Escalation|Adverse Event|0|||
162872660|NCT00195260|588236271|FG009|Part 1: Dose Escalation|Adverse Event|0|||
162872661|NCT00195260|588236272|FG010|Part 1: Dose Escalation|Adverse Event|0|||
162872662|NCT00195260|588236262|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872663|NCT00195260|588236263|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872664|NCT00195260|588236264|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872665|NCT00195260|588236265|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163047572|NCT04547140|588881174|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
162872666|NCT00195260|588236266|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162872667|NCT00195260|588236267|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872668|NCT00195260|588236268|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872669|NCT00195260|588236269|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
162872670|NCT00195260|588236270|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872671|NCT00195260|588236271|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872672|NCT00195260|588236272|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162872673|NCT00195260|588236262|FG000|Part 1: Dose Escalation|Death|0|||
162872674|NCT00195260|588236263|FG001|Part 1: Dose Escalation|Death|0|||
162872675|NCT00195260|588236264|FG002|Part 1: Dose Escalation|Death|0|||
162872676|NCT00195260|588236265|FG003|Part 1: Dose Escalation|Death|0|||
162872677|NCT00195260|588236266|FG004|Part 1: Dose Escalation|Death|0|||
162872678|NCT00195260|588236267|FG005|Part 1: Dose Escalation|Death|0|||
162872679|NCT00195260|588236268|FG006|Part 1: Dose Escalation|Death|0|||
162872680|NCT00195260|588236269|FG007|Part 1: Dose Escalation|Death|1|||
162872681|NCT00195260|588236270|FG008|Part 1: Dose Escalation|Death|0|||
162872682|NCT00195260|588236271|FG009|Part 1: Dose Escalation|Death|0|||
163047573|NCT04547140|588881173|FG000|Overall Study|Pregnancy|1|||
163047574|NCT04547140|588881174|FG001|Overall Study|Pregnancy|0|||
163047575|NCT04547140|588881173|FG000|Overall Study|Reason Not Specified|4|||
162872683|NCT00195260|588236272|FG010|Part 1: Dose Escalation|Death|0|||
162872684|NCT00195260|588236262|FG000|Part 1: Dose Escalation|Disease Progression|3|||
162872685|NCT00195260|588236263|FG001|Part 1: Dose Escalation|Disease Progression|2|||
162872686|NCT00195260|588236264|FG002|Part 1: Dose Escalation|Disease Progression|5|||
162872687|NCT00195260|588236265|FG003|Part 1: Dose Escalation|Disease Progression|6|||
162872688|NCT00195260|588236266|FG004|Part 1: Dose Escalation|Disease Progression|4|||
162872689|NCT00195260|588236267|FG005|Part 1: Dose Escalation|Disease Progression|6|||
162872690|NCT00195260|588236268|FG006|Part 1: Dose Escalation|Disease Progression|7|||
162872691|NCT00195260|588236269|FG007|Part 1: Dose Escalation|Disease Progression|4|||
162872692|NCT00195260|588236270|FG008|Part 1: Dose Escalation|Disease Progression|0|||
162872693|NCT00195260|588236271|FG009|Part 1: Dose Escalation|Disease Progression|0|||
162872694|NCT00195260|588236272|FG010|Part 1: Dose Escalation|Disease Progression|0|||
162872695|NCT00195260|588236262|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
162872696|NCT00195260|588236263|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
162872697|NCT00195260|588236264|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
162872698|NCT00195260|588236265|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872699|NCT00195260|588236266|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872700|NCT00195260|588236267|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
162872701|NCT00195260|588236268|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872702|NCT00195260|588236269|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872703|NCT00195260|588236270|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872704|NCT00195260|588236271|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872705|NCT00195260|588236272|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
162872706|NCT00195260|588236262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872707|NCT00195260|588236263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872708|NCT00195260|588236264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872709|NCT00195260|588236265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872710|NCT00195260|588236266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872711|NCT00195260|588236267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872712|NCT00195260|588236268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872713|NCT00195260|588236269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
162872714|NCT00195260|588236270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
162872715|NCT00195260|588236271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
162872716|NCT00195260|588236272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
162872717|NCT00195260|588236262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872718|NCT00195260|588236263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872719|NCT00195260|588236264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872720|NCT00195260|588236265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872721|NCT00195260|588236266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872722|NCT00195260|588236267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872723|NCT00195260|588236268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872724|NCT00195260|588236269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
162872725|NCT00195260|588236270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
162872726|NCT00195260|588236271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
162872727|NCT00195260|588236272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
162872728|NCT00195260|588236262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872729|NCT00195260|588236263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872730|NCT00195260|588236264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872731|NCT00195260|588236265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872732|NCT00195260|588236266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872733|NCT00195260|588236267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872734|NCT00195260|588236268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872735|NCT00195260|588236269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
162872736|NCT00195260|588236270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
162872737|NCT00195260|588236271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
162872738|NCT00195260|588236272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
162872739|NCT00195260|588236262|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872740|NCT00195260|588236263|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872741|NCT00195260|588236264|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872742|NCT00195260|588236265|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872743|NCT00195260|588236266|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872744|NCT00195260|588236267|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872745|NCT00195260|588236268|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872746|NCT00195260|588236269|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
162872747|NCT00195260|588236270|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
162872748|NCT00195260|588236271|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
162872749|NCT00195260|588236272|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
162872750|NCT02749721|588236273|FG000|Screening|Withdrawal by Subject|1|||
162872751|NCT02749721|588236273|FG000|Screening|Lost to Follow-up|2|||
162872752|NCT02749721|588236273|FG000|Screening|Protocol Violation|3|||
162872753|NCT02749721|588236273|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
162872754|NCT02749721|588236273|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
162872755|NCT00772967|588236274|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
162872756|NCT00772967|588236275|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
162872757|NCT00772967|588236276|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
163047576|NCT04547140|588881174|FG001|Overall Study|Reason Not Specified|1|||
163047577|NCT04613739|588881175|FG000|Overall Study|Lost to Follow-up|6|||
162872758|NCT00772967|588236277|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
162872759|NCT00772967|588236278|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
163047578|NCT04613739|588881176|FG001|Overall Study|Lost to Follow-up|9|||
163047579|NCT04613739|588881175|FG000|Overall Study|potentially duplicative/fraudulent|1|||
163047580|NCT04613739|588881176|FG001|Overall Study|potentially duplicative/fraudulent|3|||
163047581|NCT00048035|588881177|FG000|Core Period|Early Withdrawals|4|||
163047582|NCT00048035|588881178|FG001|Core Period|Early Withdrawals|2|||
163047583|NCT00048035|588881179|FG002|Core Period|Early Withdrawals|1|||
163047584|NCT00048035|588881180|FG003|Core Period|Early Withdrawals|1|||
163047585|NCT00048035|588881181|FG004|Core Period|Early Withdrawals|1|||
163047586|NCT00048035|588881182|FG005|Core Period|Early Withdrawals|1|||
163047587|NCT00048035|588881183|FG006|Core Period|Early Withdrawals|0|||
163047588|NCT00048035|588881184|FG007|Core Period|Early Withdrawals|0|||
163047589|NCT00048035|588881177|FG000|Extension Year 1|Early Withdrawals|0|||
163047590|NCT00048035|588881178|FG001|Extension Year 1|Early Withdrawals|0|||
163047591|NCT00048035|588881179|FG002|Extension Year 1|Early Withdrawals|0|||
163047592|NCT00048035|588881180|FG003|Extension Year 1|Early Withdrawals|0|||
163047593|NCT00048035|588881181|FG004|Extension Year 1|Early Withdrawals|0|||
162872760|NCT00772967|588236279|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
162872761|NCT00772967|588236274|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
162872762|NCT00772967|588236275|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
162872763|NCT00772967|588236276|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
162872764|NCT00772967|588236277|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
162872765|NCT00772967|588236278|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
162872766|NCT00772967|588236279|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
162872767|NCT00772967|588236274|FG000|Crossover Treatment 3|Adverse Event|0|||
162872768|NCT00772967|588236275|FG001|Crossover Treatment 3|Adverse Event|0|||
162872769|NCT00772967|588236276|FG002|Crossover Treatment 3|Adverse Event|0|||
162872770|NCT00772967|588236277|FG003|Crossover Treatment 3|Adverse Event|0|||
162872771|NCT00772967|588236278|FG004|Crossover Treatment 3|Adverse Event|1|||
162872772|NCT00772967|588236279|FG005|Crossover Treatment 3|Adverse Event|0|||
162872773|NCT00231062|588236282|FG000|Overall Study|Physician Decision|6|||
162872774|NCT00803244|588236283|FG000|Overall Study|Adverse Event|1|||
162872775|NCT00803244|588236284|FG001|Overall Study|Adverse Event|2|||
162872776|NCT00803244|588236283|FG000|Overall Study|Withdrawal by Subject|2|||
162872777|NCT00803244|588236284|FG001|Overall Study|Withdrawal by Subject|3|||
162872778|NCT00803244|588236283|FG000|Overall Study|Any other reason not above-mentioned|4|||
162872779|NCT00803244|588236284|FG001|Overall Study|Any other reason not above-mentioned|10|||
162872780|NCT03321929|588236285|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
162872781|NCT00443430|588236288|FG000|Overall Study|Lack of Efficacy|3|||
162872782|NCT00443430|588236289|FG001|Overall Study|Lack of Efficacy|3|||
162872783|NCT00443430|588236288|FG000|Overall Study|Adverse Event|1|||
162872784|NCT00443430|588236289|FG001|Overall Study|Adverse Event|1|||
162872785|NCT00053846|588236290|FG000|Overall Study|Changed mind|8|||
162872786|NCT00053846|588236291|FG001|Overall Study|Changed mind|13|||
162872787|NCT00053846|588236290|FG000|Overall Study|Became too ill|8|||
162872788|NCT00053846|588236291|FG001|Overall Study|Became too ill|7|||
162872789|NCT00053846|588236290|FG000|Overall Study|Expired|5|||
162872790|NCT00053846|588236291|FG001|Overall Study|Expired|0|||
162872791|NCT00053846|588236290|FG000|Overall Study|Became ineligible|3|||
163047594|NCT00048035|588881182|FG005|Extension Year 1|Early Withdrawals|0|||
163047595|NCT00048035|588881183|FG006|Extension Year 1|Early Withdrawals|11|||
163047596|NCT00048035|588881184|FG007|Extension Year 1|Early Withdrawals|11|||
163047597|NCT00048035|588881177|FG000|Extension Year 2|Early Withdrawals|0|||
162872792|NCT00053846|588236291|FG001|Overall Study|Became ineligible|1|||
162872793|NCT00053846|588236290|FG000|Overall Study|Did not return data|1|||
162872794|NCT00053846|588236291|FG001|Overall Study|Did not return data|2|||
162872795|NCT00053846|588236290|FG000|Overall Study|Quit due to side effects|1|||
163047598|NCT00048035|588881178|FG001|Extension Year 2|Early Withdrawals|0|||
163047599|NCT00048035|588881179|FG002|Extension Year 2|Early Withdrawals|0|||
163047600|NCT00048035|588881180|FG003|Extension Year 2|Early Withdrawals|0|||
163047601|NCT00048035|588881181|FG004|Extension Year 2|Early Withdrawals|0|||
163047602|NCT00048035|588881182|FG005|Extension Year 2|Early Withdrawals|0|||
162872796|NCT00053846|588236291|FG001|Overall Study|Quit due to side effects|3|||
162872797|NCT00053846|588236290|FG000|Overall Study|Pills too large|0|||
162872798|NCT00053846|588236291|FG001|Overall Study|Pills too large|1|||
162872799|NCT03880227|588236292|FG000|First Visit|Withdrawal by Subject|1|||
162872800|NCT03880227|588236293|FG001|First Visit|Withdrawal by Subject|0|||
162872801|NCT03880227|588236294|FG002|First Visit|Withdrawal by Subject|0|||
162872802|NCT03880227|588236295|FG003|First Visit|Withdrawal by Subject|0|||
162872803|NCT03880227|588236292|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
163047603|NCT00048035|588881183|FG006|Extension Year 2|Early Withdrawals|3|||
163047604|NCT00048035|588881184|FG007|Extension Year 2|Early Withdrawals|3|||
162872804|NCT03880227|588236293|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
162872805|NCT03880227|588236294|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
162872806|NCT03880227|588236295|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
162872807|NCT03880227|588236292|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
162872808|NCT03880227|588236293|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
162872809|NCT03880227|588236294|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
162872810|NCT03880227|588236295|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
162872811|NCT03880227|588236292|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
162872812|NCT03880227|588236293|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
162872813|NCT03880227|588236294|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
162872814|NCT03880227|588236295|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
162872815|NCT00878072|588236296|FG000|Overall Study|Withdrew consent|2|||
162872816|NCT01200511|588236304|FG000|Overall Study|Lost to Follow-up|3|||
162872817|NCT01200511|588236304|FG000|Overall Study|Withdrawal by Subject|1|||
162872818|NCT01200511|588236304|FG000|Overall Study|Adverse Event|1|||
162872819|NCT03382899|588236309|FG000|Overall Study|Ineligibility Determined|0|||
162872820|NCT03382899|588236310|FG001|Overall Study|Ineligibility Determined|1|||
162872821|NCT03382899|588236309|FG000|Overall Study|Lost to Follow-up|0|||
162872822|NCT03382899|588236310|FG001|Overall Study|Lost to Follow-up|1|||
162872823|NCT03382899|588236309|FG000|Overall Study|Sponsor's decision|31|||
162872824|NCT03382899|588236310|FG001|Overall Study|Sponsor's decision|28|||
162872825|NCT03382899|588236309|FG000|Overall Study|Withdrawal by Subject|0|||
162872826|NCT03382899|588236310|FG001|Overall Study|Withdrawal by Subject|5|||
162872827|NCT03288779|588236311|FG000|Overall Study|Withdrawal by Subject|3|||
162872828|NCT02504892|588236313|FG000|Overall Study|Adverse event-pneumonitis|2|||
162872829|NCT00524745|588236314|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
162872830|NCT00524745|588236315|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
162872831|NCT00524745|588236316|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
162872832|NCT00524745|588236317|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
162872833|NCT01413178|588236318|FG000|Overall Study|Toxicity|1|||
162872834|NCT01413178|588236319|FG001|Overall Study|Toxicity|0|||
162872835|NCT01413178|588236318|FG000|Overall Study|Ineligible|0|||
162872836|NCT01413178|588236319|FG001|Overall Study|Ineligible|2|||
162872837|NCT00576693|588236320|FG000|Overall Study|Lost to Follow-up|7|||
162872838|NCT00576693|588236321|FG001|Overall Study|Lost to Follow-up|11|||
162872839|NCT00576693|588236320|FG000|Overall Study|Withdrawal by Subject|3|||
162872840|NCT00576693|588236321|FG001|Overall Study|Withdrawal by Subject|13|||
162872841|NCT00540449|588236322|FG000|Overall Study|Adverse Event|12|||
162872842|NCT00540449|588236323|FG001|Overall Study|Adverse Event|32|||
163047605|NCT05137717|588881185|FG000|Overall Study|Death|2|||
163047606|NCT05137717|588881185|FG000|Overall Study|Withdrawal by Subject|6|||
162872843|NCT00540449|588236322|FG000|Overall Study|Sponsor's Decision|1|||
162872844|NCT00540449|588236323|FG001|Overall Study|Sponsor's Decision|1|||
162872845|NCT00540449|588236322|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
162872846|NCT00540449|588236323|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
162872847|NCT00540449|588236322|FG000|Overall Study|Lost to Follow-up|19|||
162872848|NCT00540449|588236323|FG001|Overall Study|Lost to Follow-up|17|||
162872849|NCT00540449|588236322|FG000|Overall Study|Subject Non-Compliant|7|||
162872850|NCT00540449|588236323|FG001|Overall Study|Subject Non-Compliant|5|||
162872851|NCT00540449|588236322|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
162872852|NCT00540449|588236323|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
162872853|NCT00540449|588236322|FG000|Overall Study|Withdrawal by Subject|10|||
162872854|NCT00540449|588236323|FG001|Overall Study|Withdrawal by Subject|10|||
162872855|NCT00540449|588236322|FG000|Overall Study|Other|1|||
162872856|NCT00540449|588236323|FG001|Overall Study|Other|4|||
163047607|NCT02619617|588881186|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
163047608|NCT02619617|588881187|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
162872857|NCT00705224|588236324|FG000|Overall Study|Adverse Event|1|||
162872858|NCT00705224|588236324|FG000|Overall Study|Lack of Efficacy|2|||
162872859|NCT00705224|588236324|FG000|Overall Study|Withdrawal by Subject|3|||
162872860|NCT00705224|588236324|FG000|Overall Study|Lost to Follow-up|5|||
162872861|NCT03283163|588236325|FG000|Overall Study|Lost to Follow-up|1|||
162872862|NCT03283163|588236325|FG000|Overall Study|other life commitments|6|||
162872863|NCT03283163|588236325|FG000|Overall Study|COVID-19 institution wide halting|1|||
162872864|NCT03283163|588236325|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
162872865|NCT03283163|588236325|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
162872866|NCT00237796|588236326|FG000|Overall Study|Baseline and one other ILSS required|10|||
162872867|NCT00237796|588236327|FG001|Overall Study|Baseline and one other ILSS required|5|||
162872868|NCT04238663|588236328|FG000|Overall Study|Lost to Follow-up|0|||
162872869|NCT04238663|588236329|FG001|Overall Study|Lost to Follow-up|1|||
162872870|NCT04238663|588236330|FG002|Overall Study|Lost to Follow-up|0|||
162872871|NCT02566525|588236331|FG000|Overall Study|Protocol Violation|3|||
162872872|NCT02566525|588236332|FG001|Overall Study|Protocol Violation|5|||
162872873|NCT00337467|588236333|FG000|Overall Study|Adverse Event|3|||
162872874|NCT00337467|588236333|FG000|Overall Study|Subject Withdrew Consent|2|||
162872875|NCT00337467|588236333|FG000|Overall Study|Pregnancy|1|||
162872876|NCT00337467|588236333|FG000|Overall Study|Lost to Follow-up|2|||
162872877|NCT00337467|588236333|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
162872878|NCT01187901|588236336|FG000|Overall Study|Protocol Violation|1|||
162872879|NCT01187901|588236337|FG001|Overall Study|Protocol Violation|0|||
162872880|NCT01187901|588236336|FG000|Overall Study|Lost to Follow-up|1|||
162872881|NCT01187901|588236337|FG001|Overall Study|Lost to Follow-up|2|||
162872882|NCT01187901|588236336|FG000|Overall Study|Unrelated Health Reasons|1|||
162872883|NCT01187901|588236337|FG001|Overall Study|Unrelated Health Reasons|2|||
162872884|NCT01187901|588236336|FG000|Overall Study|Suspected Allergic Reaction|1|||
162872885|NCT01187901|588236337|FG001|Overall Study|Suspected Allergic Reaction|1|||
162872886|NCT01187901|588236336|FG000|Overall Study|Adverse Event|3|||
162872887|NCT01187901|588236337|FG001|Overall Study|Adverse Event|0|||
162872888|NCT01187901|588236336|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
162872889|NCT01187901|588236337|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
162872890|NCT01187901|588236336|FG000|Overall Study|Pregnancy|0|||
162872891|NCT01187901|588236337|FG001|Overall Study|Pregnancy|2|||
162872892|NCT03141086|588236338|FG000|Overall Study|Study Terminated By Sponsor|1|||
162872893|NCT03141086|588236339|FG001|Overall Study|Study Terminated By Sponsor|1|||
162872894|NCT03141086|588236338|FG000|Overall Study|Withdrawal by Subject|0|||
162872895|NCT03141086|588236339|FG001|Overall Study|Withdrawal by Subject|1|||
162872896|NCT03141086|588236338|FG000|Overall Study|Protocol Violation|0|||
162872897|NCT03141086|588236339|FG001|Overall Study|Protocol Violation|1|||
162872898|NCT03141086|588236338|FG000|Overall Study|Adverse Event|0|||
162872899|NCT03141086|588236339|FG001|Overall Study|Adverse Event|2|||
162872900|NCT02149836|588236342|FG000|Overall Study|Withdrawal by Subject|1|||
162872901|NCT04430582|588236344|FG000|Overall Study|Found to meet exclusionary criteria|1|||
162872902|NCT04430582|588236345|FG001|Overall Study|Found to meet exclusionary criteria|0|||
162872903|NCT04430582|588236344|FG000|Overall Study|Withdrawal by Subject|0|||
162872904|NCT04430582|588236345|FG001|Overall Study|Withdrawal by Subject|1|||
162872905|NCT03607682|588236346|FG000|Overall Study|Withdrawal by Subject|1|||
162872906|NCT03607682|588236346|FG000|Overall Study|Disease progression|1|||
162872907|NCT00376688|588236347|FG000|Overall Study|Adverse Event|3|||
162872908|NCT00376688|588236347|FG000|Overall Study|Death|1|||
162872909|NCT02410902|588237306|FG000|Overall Study|Adverse Event|2|||
162872910|NCT02410902|588237307|FG001|Overall Study|Adverse Event|3|||
162872911|NCT02410902|588237306|FG000|Overall Study|Lost to Follow-up|4|||
162872912|NCT02410902|588237307|FG001|Overall Study|Lost to Follow-up|1|||
162872913|NCT02410902|588237306|FG000|Overall Study|Protocol Violation|1|||
162872914|NCT02410902|588237307|FG001|Overall Study|Protocol Violation|4|||
162872915|NCT02410902|588237306|FG000|Overall Study|Withdrawal by Subject|6|||
162872916|NCT02410902|588237307|FG001|Overall Study|Withdrawal by Subject|8|||
162872917|NCT02410902|588237306|FG000|Overall Study|Non-Compliance|8|||
162872918|NCT02410902|588237307|FG001|Overall Study|Non-Compliance|2|||
162872919|NCT00074412|588237308|FG000|Overall Study|Death|30|||
162872920|NCT00074412|588237309|FG001|Overall Study|Death|26|||
162872921|NCT00074412|588237308|FG000|Overall Study|Lost to Follow-up|52|||
162872922|NCT00074412|588237309|FG001|Overall Study|Lost to Follow-up|58|||
162872923|NCT01881620|588237310|FG000|Overall Study|Protocol Violation|4|||
162872924|NCT02561000|588237312|FG000|Overall Study|Withdrawal by Subject|2|||
162872925|NCT02561000|588237313|FG001|Overall Study|Withdrawal by Subject|3|||
162872926|NCT02561000|588237314|FG002|Overall Study|Withdrawal by Subject|0|||
162872927|NCT02561000|588237312|FG000|Overall Study|Adverse Event|0|||
163047609|NCT02619617|588881186|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
162872928|NCT02561000|588237313|FG001|Overall Study|Adverse Event|1|||
162872929|NCT02561000|588237314|FG002|Overall Study|Adverse Event|0|||
162872930|NCT03430245|588237317|FG000|Overall Study|Withdrawal by Subject|6|||
162872931|NCT03430245|588237317|FG000|Overall Study|Lost to Follow-up|1|||
162872932|NCT03656926|588237318|FG000|Overall Study|Adverse Event|5|||
162872933|NCT03656926|588237319|FG001|Overall Study|Adverse Event|4|||
162872934|NCT03656926|588237318|FG000|Overall Study|Withdrawal by Subject|7|||
162872935|NCT03656926|588237319|FG001|Overall Study|Withdrawal by Subject|2|||
162872936|NCT03656926|588237318|FG000|Overall Study|Screen fail after randomization|1|||
162872937|NCT03656926|588237319|FG001|Overall Study|Screen fail after randomization|0|||
162872938|NCT03656926|588237318|FG000|Overall Study|PI decision due to patient condition|1|||
162872939|NCT03656926|588237319|FG001|Overall Study|PI decision due to patient condition|0|||
162872940|NCT03656926|588237318|FG000|Overall Study|Patient unresponsiveness|1|||
162872941|NCT03656926|588237319|FG001|Overall Study|Patient unresponsiveness|0|||
162872942|NCT00850759|588237324|FG000|Overall Study|Lost to Follow-up|7|||
162872943|NCT00850759|588237325|FG001|Overall Study|Lost to Follow-up|5|||
162872944|NCT00850759|588237326|FG002|Overall Study|Lost to Follow-up|5|||
162872945|NCT00850759|588237327|FG003|Overall Study|Lost to Follow-up|3|||
162872946|NCT03196505|588237328|FG000|Overall Study|Physician Decision|26|||
162872947|NCT03196505|588237329|FG001|Overall Study|Physician Decision|26|||
162872948|NCT02575079|588237331|FG000|Overall Study|Death|3|||
162872949|NCT02575079|588237332|FG001|Overall Study|Death|0|||
162872950|NCT02575079|588237331|FG000|Overall Study|Withdrawal by Subject|3|||
162872951|NCT02575079|588237332|FG001|Overall Study|Withdrawal by Subject|0|||
162872952|NCT02918266|588237333|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
162872953|NCT02918266|588237334|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872954|NCT02918266|588237335|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872955|NCT02918266|588237336|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872956|NCT02918266|588237337|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872957|NCT02918266|588237338|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872958|NCT02918266|588237339|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
162872959|NCT02918266|588237340|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872960|NCT02918266|588237341|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
162872961|NCT02918266|588237342|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872962|NCT02918266|588237343|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
162872963|NCT00578864|588237346|FG000|Overall Study|Death|1|||
162872964|NCT00578864|588237347|FG001|Overall Study|Death|0|||
162872965|NCT01293032|588237351|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
162872966|NCT01293032|588237352|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
162872967|NCT01293032|588237353|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
162872968|NCT01293032|588237354|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
162872969|NCT01293032|588237351|FG000|Treatment|Adverse Event|0|||
162872970|NCT01293032|588237352|FG001|Treatment|Adverse Event|0|||
162872971|NCT01293032|588237353|FG002|Treatment|Adverse Event|1|||
162872972|NCT01293032|588237354|FG003|Treatment|Adverse Event|1|||
162872973|NCT01293032|588237351|FG000|Treatment|Withdrawal by Subject|2|||
162872974|NCT01293032|588237352|FG001|Treatment|Withdrawal by Subject|4|||
162872975|NCT01293032|588237353|FG002|Treatment|Withdrawal by Subject|0|||
162872976|NCT01293032|588237354|FG003|Treatment|Withdrawal by Subject|0|||
162872977|NCT01293032|588237351|FG000|Treatment|Disease Progression, relapse|0|||
162872978|NCT01293032|588237352|FG001|Treatment|Disease Progression, relapse|1|||
162872979|NCT01293032|588237353|FG002|Treatment|Disease Progression, relapse|0|||
162872980|NCT01293032|588237354|FG003|Treatment|Disease Progression, relapse|0|||
162872981|NCT01253044|588237355|FG000|Overall Study|Lost to Follow-up|38|||
162872982|NCT01253044|588237356|FG001|Overall Study|Lost to Follow-up|29|||
162872983|NCT01087528|588237359|FG000|Overall Study|Withdrawal by Subject|1|||
162872984|NCT01087528|588237359|FG000|Overall Study|Incomplete CE procedure|6|||
162872985|NCT03116399|588237360|FG000|Overall Study|Death|8|||
162872986|NCT03116399|588237361|FG001|Overall Study|Death|3|||
162872987|NCT03116399|588237360|FG000|Overall Study|Lost to Follow-up|7|||
162872988|NCT03116399|588237361|FG001|Overall Study|Lost to Follow-up|11|||
162872989|NCT03116399|588237360|FG000|Overall Study|Investigator Decision|1|||
162872990|NCT03116399|588237361|FG001|Overall Study|Investigator Decision|1|||
162872991|NCT03116399|588237360|FG000|Overall Study|Withdrawal by Subject|24|||
162872992|NCT03116399|588237361|FG001|Overall Study|Withdrawal by Subject|9|||
162872993|NCT00987623|588237363|FG000|Overall Study|Lost to Follow-up|2|||
162872994|NCT00987623|588237364|FG001|Overall Study|Lost to Follow-up|1|||
162872995|NCT00987623|588237363|FG000|Overall Study|Time/job conflict|2|||
162872996|NCT00987623|588237364|FG001|Overall Study|Time/job conflict|0|||
162872997|NCT00987623|588237363|FG000|Overall Study|Discomfort|1|||
162872998|NCT00987623|588237364|FG001|Overall Study|Discomfort|0|||
163047610|NCT02619617|588881187|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
163047611|NCT00483652|588881192|FG000|Double-blind Treatment Period|Protocol Violation|2|||
163047612|NCT00483652|588881193|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163047613|NCT00483652|588881192|FG000|Double-blind Treatment Period|Adverse Event|3|||
163047614|NCT00483652|588881193|FG001|Double-blind Treatment Period|Adverse Event|4|||
162872999|NCT00987623|588237363|FG000|Overall Study|Biomicroscopy|0|||
163047615|NCT00483652|588881192|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
162873000|NCT00987623|588237364|FG001|Overall Study|Biomicroscopy|1|||
162873001|NCT00987623|588237363|FG000|Overall Study|Influenza|0|||
162873002|NCT00987623|588237364|FG001|Overall Study|Influenza|1|||
162873003|NCT02691247|588237367|FG000|Overall Study|Withdrawal by Subject|1|||
162873004|NCT02691247|588237368|FG001|Overall Study|Withdrawal by Subject|2|||
162873005|NCT02691247|588237369|FG002|Overall Study|Withdrawal by Subject|2|||
162873006|NCT02691247|588237367|FG000|Overall Study|Lost to Follow-up|2|||
162873007|NCT02691247|588237368|FG001|Overall Study|Lost to Follow-up|0|||
162873008|NCT02691247|588237369|FG002|Overall Study|Lost to Follow-up|1|||
162873009|NCT01519245|588237370|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
162873010|NCT01519245|588237371|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
162615167|NCT03911713|587309289|FG004|Overall Study|Lost to Follow-up|0|||
162615168|NCT03911713|587309285|FG000|Overall Study|Other|0|||
162615169|NCT03911713|587309286|FG001|Overall Study|Other|0|||
162615170|NCT03911713|587309287|FG002|Overall Study|Other|0|||
162615171|NCT03911713|587309288|FG003|Overall Study|Other|1|||
162615172|NCT03911713|587309289|FG004|Overall Study|Other|0|||
162615173|NCT03911713|587309285|FG000|Overall Study|Randomized, Never Dosed|1|||
162615174|NCT03911713|587309286|FG001|Overall Study|Randomized, Never Dosed|0|||
162615175|NCT03911713|587309287|FG002|Overall Study|Randomized, Never Dosed|0|||
162615176|NCT03911713|587309288|FG003|Overall Study|Randomized, Never Dosed|1|||
162615177|NCT03911713|587309289|FG004|Overall Study|Randomized, Never Dosed|0|||
162706706|NCT04955626|587636671|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
162706707|NCT04955626|587636672|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
162706708|NCT04955626|587636673|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
162706709|NCT04955626|587636674|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
162706710|NCT04955626|587636675|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
162873011|NCT02873715|588237372|FG000|Overall Study|Lost to Follow-up|84|||
162873012|NCT02873715|588237373|FG001|Overall Study|Lost to Follow-up|94|||
162873013|NCT02873715|588237372|FG000|Overall Study|Withdrawal by Subject|7|||
162873014|NCT02873715|588237373|FG001|Overall Study|Withdrawal by Subject|26|||
162873015|NCT02144220|588237377|FG000|Overall Study|technology incompatibility|9|||
162873016|NCT02144220|588237377|FG000|Overall Study|Lack of Efficacy|4|||
162873017|NCT02144220|588237377|FG000|Overall Study|Physician Decision|3|||
162873018|NCT02144220|588237377|FG000|Overall Study|Withdrawal by Subject|2|||
162873019|NCT02144220|588237377|FG000|Overall Study|Protocol Violation|1|||
162873020|NCT00592501|588237380|FG000|Overall Study|Withdrawal by Subject|1|||
162873021|NCT00592501|588237380|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
162873022|NCT04590937|588237381|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
162873023|NCT01635933|588237382|FG000|Overall Study|Adverse Event|1|||
162873024|NCT01635933|588237383|FG001|Overall Study|Adverse Event|0|||
162873025|NCT01635933|588237382|FG000|Overall Study|Lost to Follow-up|0|||
162873026|NCT01635933|588237383|FG001|Overall Study|Lost to Follow-up|5|||
162873027|NCT01635933|588237382|FG000|Overall Study|Subject decision|1|||
162873028|NCT01635933|588237383|FG001|Overall Study|Subject decision|1|||
162873029|NCT01635933|588237382|FG000|Overall Study|Noncompliance|0|||
162873030|NCT01635933|588237383|FG001|Overall Study|Noncompliance|1|||
162873031|NCT01635933|588237382|FG000|Overall Study|No longer had transportation|0|||
162873032|NCT01635933|588237383|FG001|Overall Study|No longer had transportation|1|||
162873033|NCT01544595|588237384|FG000|Status at Week 68|Adverse Event|3|||
162873034|NCT01544595|588237385|FG001|Status at Week 68|Adverse Event|2|||
162873035|NCT01544595|588237386|FG002|Status at Week 68|Adverse Event|1|||
162873036|NCT01544595|588237387|FG003|Status at Week 68|Adverse Event|0|||
162873037|NCT01544595|588237388|FG004|Status at Week 68|Adverse Event|0|||
162873038|NCT01544595|588237389|FG005|Status at Week 68|Adverse Event|0|||
163047616|NCT00483652|588881193|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
162615178|NCT02203071|587309292|FG000|Overall Study|Lost to Follow-up|3|||
162706711|NCT04955626|587636676|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
162706712|NCT04955626|587636677|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
162706713|NCT04955626|587636678|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
162706714|NCT04955626|587636679|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
162706715|NCT04955626|587636680|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
162706716|NCT04955626|587636681|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
162706717|NCT04955626|587636682|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
162706718|NCT04955626|587636683|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
162706719|NCT04955626|587636684|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
162706720|NCT04955626|587636685|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
162706721|NCT04955626|587636686|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
162706722|NCT04955626|587636687|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
162706723|NCT04955626|587636688|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
162706724|NCT04955626|587636689|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
162706725|NCT04955626|587636690|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
162706726|NCT04955626|587636691|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
162706727|NCT04955626|587636656|FG000|Blinded Period|Medication error|0|||
162706728|NCT04955626|587636657|FG001|Blinded Period|Medication error|0|||
162706729|NCT04955626|587636658|FG002|Blinded Period|Medication error|0|||
162873039|NCT01544595|588237384|FG000|Status at Week 68|Lack of Efficacy|1|||
162615179|NCT02203071|587309293|FG001|Overall Study|Lost to Follow-up|1|||
162615180|NCT01845818|587309294|FG000|Overall Study|Withdrawal by Subject|0|||
162615181|NCT01845818|587309295|FG001|Overall Study|Withdrawal by Subject|1|||
162873040|NCT01544595|588237385|FG001|Status at Week 68|Lack of Efficacy|0|||
162615182|NCT01845818|587309294|FG000|Overall Study|Lost to Follow-up|7|||
162615183|NCT01845818|587309295|FG001|Overall Study|Lost to Follow-up|5|||
162873041|NCT01544595|588237386|FG002|Status at Week 68|Lack of Efficacy|0|||
162873042|NCT01544595|588237387|FG003|Status at Week 68|Lack of Efficacy|0|||
162615184|NCT01845818|587309294|FG000|Overall Study|Administrative Reasons|3|||
162961276|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
162961277|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
162961278|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
162961279|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
162961280|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961281|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961282|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961283|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961284|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961285|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961286|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961287|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961288|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961289|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961290|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961291|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961292|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961293|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961294|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961295|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961296|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961297|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961298|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961299|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961300|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162961301|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|moved|0|||
162961302|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|moved|1|||
162961303|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|moved|1|||
162961304|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|moved|0|||
162961305|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|moved|0|||
162961306|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|moved|0|||
162961307|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|moved|0|||
162961308|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|moved|0|||
162961309|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|moved|0|||
162961310|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|moved|0|||
162961311|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|moved|0|||
162961312|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|moved|0|||
162961313|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|moved|0|||
162961314|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|moved|0|||
162961315|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|moved|0|||
162961316|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|moved|0|||
162961317|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|moved|0|||
162961318|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|moved|0|||
162961319|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|moved|0|||
162961320|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|moved|0|||
162961321|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|moved|0|||
162961322|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|moved|0|||
162961323|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|moved|0|||
162961324|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|moved|0|||
162961325|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|moved|0|||
162961326|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|moved|0|||
162961327|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961328|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961329|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961330|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
162961331|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
163047617|NCT00483652|588881192|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
163047618|NCT00483652|588881193|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
163047619|NCT00891813|588881202|FG000|Overall Study|Adverse Event|3|||
163047620|NCT00891813|588881202|FG000|Overall Study|Withdrawal by Subject|1|||
163047621|NCT00891813|588881202|FG000|Overall Study|Patient Noncompliance|6|||
163047622|NCT00891813|588881202|FG000|Overall Study|Protocol Violation|2|||
163047623|NCT01723072|588881205|FG000|Overall Study|Withdrawal by Subject|7|||
163047624|NCT01723072|588881206|FG001|Overall Study|Withdrawal by Subject|13|||
163047625|NCT01723072|588881205|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
162615185|NCT01845818|587309295|FG001|Overall Study|Administrative Reasons|1|||
162615186|NCT01845818|587309294|FG000|Overall Study|Serious Adverse Event|1|||
162615187|NCT01845818|587309295|FG001|Overall Study|Serious Adverse Event|1|||
162615188|NCT01845818|587309294|FG000|Overall Study|Other|25|||
162615189|NCT01845818|587309295|FG001|Overall Study|Other|8|||
162615190|NCT01845818|587309294|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
162615191|NCT01845818|587309295|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
162615192|NCT01845818|587309294|FG000|Overall Study|No Follow-Up Data Available|4|||
162615193|NCT01845818|587309295|FG001|Overall Study|No Follow-Up Data Available|1|||
162615194|NCT02595970|587309296|FG000|Overall Study|Withdrawal by Subject|2|||
162615195|NCT02595970|587309296|FG000|Overall Study|Physician Decision|2|||
162615196|NCT02595970|587309296|FG000|Overall Study|Protocol Violation|4|||
162615197|NCT02595970|587309296|FG000|Overall Study|Adverse Event|5|||
162615198|NCT02595970|587309296|FG000|Overall Study|Lack of Efficacy|7|||
162615199|NCT02572388|587309297|FG000|Overall Study|Withdrawal by Subject|1|||
162615200|NCT02572388|587309298|FG001|Overall Study|Withdrawal by Subject|1|||
163047626|NCT01723072|588881206|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
162615201|NCT02572388|587309299|FG002|Overall Study|Withdrawal by Subject|2|||
162615202|NCT02572388|587309300|FG003|Overall Study|Withdrawal by Subject|2|||
162615203|NCT02202837|587309303|FG000|Overall Study|Enbrel treatment discontinued|36|||
162615204|NCT02202837|587309304|FG001|Overall Study|Enbrel treatment discontinued|4|||
162615205|NCT02202837|587309303|FG000|Overall Study|Other|10|||
162615206|NCT02202837|587309304|FG001|Overall Study|Other|0|||
162706730|NCT04955626|587636659|FG003|Blinded Period|Medication error|0|||
162873043|NCT01544595|588237388|FG004|Status at Week 68|Lack of Efficacy|0|||
163047627|NCT01723072|588881205|FG000|Overall Study|Other|4|||
162873044|NCT01544595|588237389|FG005|Status at Week 68|Lack of Efficacy|0|||
162873045|NCT01544595|588237384|FG000|Status at Week 68|Lost to Follow-up|1|||
163047628|NCT01723072|588881206|FG001|Overall Study|Other|3|||
163047629|NCT01841970|588881207|FG000|Overall Study|Withdrawal by Subject|1|||
163047630|NCT01841970|588881207|FG000|Overall Study|Physician Decision|2|||
162873046|NCT01544595|588237385|FG001|Status at Week 68|Lost to Follow-up|1|||
162873047|NCT01544595|588237386|FG002|Status at Week 68|Lost to Follow-up|0|||
162873048|NCT01544595|588237387|FG003|Status at Week 68|Lost to Follow-up|0|||
162873049|NCT01544595|588237388|FG004|Status at Week 68|Lost to Follow-up|0|||
162873050|NCT01544595|588237389|FG005|Status at Week 68|Lost to Follow-up|0|||
162873051|NCT01544595|588237384|FG000|Status at Week 68|Non-compliance with study treatment|1|||
162873052|NCT01544595|588237385|FG001|Status at Week 68|Non-compliance with study treatment|0|||
162873053|NCT01544595|588237386|FG002|Status at Week 68|Non-compliance with study treatment|0|||
162873054|NCT01544595|588237387|FG003|Status at Week 68|Non-compliance with study treatment|1|||
162706731|NCT04955626|587636660|FG004|Blinded Period|Medication error|0|||
162873055|NCT01544595|588237388|FG004|Status at Week 68|Non-compliance with study treatment|0|||
162873056|NCT01544595|588237389|FG005|Status at Week 68|Non-compliance with study treatment|0|||
162873057|NCT01544595|588237384|FG000|Status at Week 68|Protocol Violation|2|||
163047631|NCT01841970|588881207|FG000|Overall Study|Lost to Follow-up|8|||
163047632|NCT03075267|588881220|FG000|Overall Study|Protocol Violation|1|||
162873058|NCT01544595|588237385|FG001|Status at Week 68|Protocol Violation|0|||
163047633|NCT03075267|588881221|FG001|Overall Study|Protocol Violation|0|||
163047634|NCT03075267|588881222|FG002|Overall Study|Protocol Violation|0|||
163047635|NCT03874013|588881223|FG000|Overall Study|Adverse Event|0|||
162615207|NCT02202837|587309303|FG000|Overall Study|Lost to Follow-up|7|||
162615208|NCT02202837|587309304|FG001|Overall Study|Lost to Follow-up|1|||
162873059|NCT01544595|588237386|FG002|Status at Week 68|Protocol Violation|1|||
162873060|NCT01544595|588237387|FG003|Status at Week 68|Protocol Violation|1|||
163047636|NCT03874013|588881224|FG001|Overall Study|Adverse Event|1|||
162615209|NCT01871142|587309305|FG000|Overall Study|Adverse Event|1|||
162706732|NCT04955626|587636661|FG005|Blinded Period|Medication error|0|||
162873061|NCT01544595|588237388|FG004|Status at Week 68|Protocol Violation|0|||
162873062|NCT01544595|588237389|FG005|Status at Week 68|Protocol Violation|0|||
162873063|NCT01544595|588237384|FG000|Status at Week 68|Technical problems|1|||
162873064|NCT01544595|588237385|FG001|Status at Week 68|Technical problems|0|||
162873065|NCT01544595|588237386|FG002|Status at Week 68|Technical problems|0|||
162873066|NCT01544595|588237387|FG003|Status at Week 68|Technical problems|1|||
162873067|NCT01544595|588237388|FG004|Status at Week 68|Technical problems|0|||
162873068|NCT01544595|588237389|FG005|Status at Week 68|Technical problems|0|||
162873069|NCT01544595|588237384|FG000|Status at Week 68|Withdrawal by Subject|0|||
162873070|NCT01544595|588237385|FG001|Status at Week 68|Withdrawal by Subject|1|||
162873071|NCT01544595|588237386|FG002|Status at Week 68|Withdrawal by Subject|1|||
162873072|NCT01544595|588237387|FG003|Status at Week 68|Withdrawal by Subject|2|||
162873073|NCT01544595|588237388|FG004|Status at Week 68|Withdrawal by Subject|0|||
162873074|NCT01544595|588237389|FG005|Status at Week 68|Withdrawal by Subject|0|||
162873075|NCT01544595|588237384|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
162873076|NCT01544595|588237385|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
162873077|NCT01544595|588237386|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
162873078|NCT01544595|588237387|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
162873079|NCT01544595|588237388|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
162873080|NCT01544595|588237389|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
163047637|NCT00069823|588881238|FG000|Overall Study|Did not have follow-up diary cards|6|||
163047638|NCT00069823|588881239|FG001|Overall Study|Did not have follow-up diary cards|3|||
163047639|NCT01801111|588881240|FG000|Overall Study|Adverse Event|12|||
163047640|NCT01801111|588881240|FG000|Overall Study|Death|8|||
163047641|NCT01801111|588881240|FG000|Overall Study|Physician Decision|5|||
163047642|NCT01801111|588881240|FG000|Overall Study|Other|1|||
163047643|NCT01801111|588881240|FG000|Overall Study|Withdrawal by Subject|4|||
163047644|NCT01801111|588881240|FG000|Overall Study|Study Terminated by Sponsor|27|||
163047645|NCT01801111|588881240|FG000|Overall Study|Progressive Disease|81|||
163047646|NCT01210482|588881241|FG000|Overall Study|Protocol Violation|1|||
163047647|NCT01210482|588881241|FG000|Overall Study|Case Report Forms were not collected|18|||
163047648|NCT01210482|588881241|FG000|Overall Study|Duplicated|2|||
163047649|NCT01210482|588881241|FG000|Overall Study|No Drug Administration|28|||
163047650|NCT01223937|588881242|FG000|Overall Study|Withdrawal by Subject|3|||
163047651|NCT01223937|588881243|FG001|Overall Study|Withdrawal by Subject|2|||
163047652|NCT01223937|588881242|FG000|Overall Study|Lost to Follow-up|1|||
163047653|NCT01223937|588881243|FG001|Overall Study|Lost to Follow-up|4|||
163047654|NCT01223937|588881242|FG000|Overall Study|Adverse Event|1|||
163047655|NCT01223937|588881243|FG001|Overall Study|Adverse Event|4|||
163047656|NCT01223937|588881242|FG000|Overall Study|Protocol Violation|8|||
163047657|NCT01223937|588881243|FG001|Overall Study|Protocol Violation|7|||
163047658|NCT01223937|588881242|FG000|Overall Study|Other|4|||
163047659|NCT01223937|588881243|FG001|Overall Study|Other|1|||
162873081|NCT01544595|588237384|FG000|Status at Week 156|Withdrawal by Subject|9|||
162873082|NCT01544595|588237385|FG001|Status at Week 156|Withdrawal by Subject|10|||
162873083|NCT01544595|588237386|FG002|Status at Week 156|Withdrawal by Subject|4|||
162873084|NCT01544595|588237387|FG003|Status at Week 156|Withdrawal by Subject|9|||
162873085|NCT01544595|588237388|FG004|Status at Week 156|Withdrawal by Subject|20|||
162873086|NCT01544595|588237389|FG005|Status at Week 156|Withdrawal by Subject|6|||
162873087|NCT01544595|588237384|FG000|Status at Week 156|Adverse Event|9|||
162873088|NCT01544595|588237385|FG001|Status at Week 156|Adverse Event|11|||
162873089|NCT01544595|588237386|FG002|Status at Week 156|Adverse Event|1|||
162873090|NCT01544595|588237387|FG003|Status at Week 156|Adverse Event|3|||
162873091|NCT01544595|588237388|FG004|Status at Week 156|Adverse Event|4|||
162873092|NCT01544595|588237389|FG005|Status at Week 156|Adverse Event|2|||
162873093|NCT01544595|588237384|FG000|Status at Week 156|Lost to Follow-up|4|||
162873094|NCT01544595|588237385|FG001|Status at Week 156|Lost to Follow-up|4|||
162873095|NCT01544595|588237386|FG002|Status at Week 156|Lost to Follow-up|0|||
162873096|NCT01544595|588237387|FG003|Status at Week 156|Lost to Follow-up|1|||
162873097|NCT01544595|588237388|FG004|Status at Week 156|Lost to Follow-up|4|||
162873098|NCT01544595|588237389|FG005|Status at Week 156|Lost to Follow-up|1|||
162873099|NCT01544595|588237384|FG000|Status at Week 156|Non-compliance with study treatement|0|||
162873100|NCT01544595|588237385|FG001|Status at Week 156|Non-compliance with study treatement|1|||
163047660|NCT03284853|588881244|FG000|Overall Study|Adverse Event|40|||
162873101|NCT01544595|588237386|FG002|Status at Week 156|Non-compliance with study treatement|0|||
162873102|NCT01544595|588237387|FG003|Status at Week 156|Non-compliance with study treatement|1|||
162873103|NCT01544595|588237388|FG004|Status at Week 156|Non-compliance with study treatement|0|||
162873104|NCT01544595|588237389|FG005|Status at Week 156|Non-compliance with study treatement|1|||
162873105|NCT01544595|588237384|FG000|Status at Week 156|Physician Decision|0|||
163047661|NCT03284853|588881245|FG001|Overall Study|Adverse Event|4|||
163047662|NCT03284853|588881244|FG000|Overall Study|Withdrawal by Subject|5|||
163047663|NCT03284853|588881245|FG001|Overall Study|Withdrawal by Subject|1|||
163047664|NCT03284853|588881244|FG000|Overall Study|Lost to Follow-up|1|||
163047665|NCT03284853|588881245|FG001|Overall Study|Lost to Follow-up|0|||
162873106|NCT01544595|588237385|FG001|Status at Week 156|Physician Decision|3|||
162873107|NCT01544595|588237386|FG002|Status at Week 156|Physician Decision|1|||
162873108|NCT01544595|588237387|FG003|Status at Week 156|Physician Decision|0|||
162873109|NCT01544595|588237388|FG004|Status at Week 156|Physician Decision|0|||
162873110|NCT01544595|588237389|FG005|Status at Week 156|Physician Decision|0|||
162873111|NCT01544595|588237384|FG000|Status at Week 156|Pregnancy|2|||
162873112|NCT01544595|588237385|FG001|Status at Week 156|Pregnancy|3|||
162873113|NCT01544595|588237386|FG002|Status at Week 156|Pregnancy|0|||
162873114|NCT01544595|588237387|FG003|Status at Week 156|Pregnancy|0|||
162873115|NCT01544595|588237388|FG004|Status at Week 156|Pregnancy|0|||
162873116|NCT01544595|588237389|FG005|Status at Week 156|Pregnancy|0|||
162873117|NCT01544595|588237384|FG000|Status at Week 156|Protocol Violation|3|||
162873118|NCT01544595|588237385|FG001|Status at Week 156|Protocol Violation|1|||
162873119|NCT01544595|588237386|FG002|Status at Week 156|Protocol Violation|2|||
162873120|NCT01544595|588237387|FG003|Status at Week 156|Protocol Violation|2|||
162873121|NCT01544595|588237388|FG004|Status at Week 156|Protocol Violation|0|||
162873122|NCT01544595|588237389|FG005|Status at Week 156|Protocol Violation|0|||
162873123|NCT01544595|588237384|FG000|Status at Week 156|Technical problems|3|||
162873124|NCT01544595|588237385|FG001|Status at Week 156|Technical problems|1|||
162873125|NCT01544595|588237386|FG002|Status at Week 156|Technical problems|0|||
162873126|NCT01544595|588237387|FG003|Status at Week 156|Technical problems|1|||
162873127|NCT01544595|588237388|FG004|Status at Week 156|Technical problems|0|||
162873128|NCT01544595|588237389|FG005|Status at Week 156|Technical problems|0|||
162873129|NCT01544595|588237384|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
162873130|NCT01544595|588237385|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
162873131|NCT01544595|588237386|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
162873132|NCT01544595|588237387|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
162873133|NCT01544595|588237388|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
162873134|NCT01544595|588237389|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
162873135|NCT01544595|588237384|FG000|Status at Week 156|Lack of Efficacy|1|||
162873136|NCT01544595|588237385|FG001|Status at Week 156|Lack of Efficacy|0|||
162873137|NCT01544595|588237386|FG002|Status at Week 156|Lack of Efficacy|1|||
162873138|NCT01544595|588237387|FG003|Status at Week 156|Lack of Efficacy|4|||
162873139|NCT01544595|588237388|FG004|Status at Week 156|Lack of Efficacy|10|||
162873140|NCT01544595|588237389|FG005|Status at Week 156|Lack of Efficacy|5|||
162873141|NCT01929044|588237390|FG000|Overall Study|Adverse Event|1|||
162873142|NCT01929044|588237391|FG001|Overall Study|Adverse Event|0|||
162873143|NCT01929044|588237390|FG000|Overall Study|Protocol Violation|9|||
162873144|NCT01929044|588237391|FG001|Overall Study|Protocol Violation|14|||
162873145|NCT01929044|588237390|FG000|Overall Study|Not Treated|1|||
162873146|NCT01929044|588237391|FG001|Overall Study|Not Treated|3|||
162873147|NCT02275026|588237398|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
162873148|NCT02275026|588237398|FG000|Overall Study|Withdrawal by Subject|4|||
162873149|NCT02275026|588237398|FG000|Overall Study|Ineligible due to medical history|13|||
162873150|NCT02275026|588237398|FG000|Overall Study|MRI malfunction precluded testing|1|||
162873151|NCT02275026|588237398|FG000|Overall Study|Ineligible after MRI findings|1|||
162873152|NCT02275026|588237398|FG000|Overall Study|Lost to Follow-up|2|||
162873153|NCT02275026|588237398|FG000|Overall Study|Scanner failure|1|||
162873154|NCT02379923|588237399|FG000|Overall Study|Death|5|||
162873155|NCT03643432|588237400|FG000|Overall Study|Lost to Follow-up|1|||
162873156|NCT03643432|588237401|FG001|Overall Study|Lost to Follow-up|0|||
162873157|NCT02488759|588237402|FG000|Overall Study|Disease progression|73|||
162873158|NCT02488759|588237403|FG001|Overall Study|Disease progression|111|||
162873159|NCT02488759|588237404|FG002|Overall Study|Disease progression|62|||
162873160|NCT02488759|588237405|FG003|Overall Study|Disease progression|7|||
162873161|NCT02488759|588237406|FG004|Overall Study|Disease progression|4|||
162873162|NCT02488759|588237407|FG005|Overall Study|Disease progression|2|||
162873163|NCT02488759|588237402|FG000|Overall Study|Study drug toxicity|11|||
162873164|NCT02488759|588237403|FG001|Overall Study|Study drug toxicity|33|||
162873165|NCT02488759|588237404|FG002|Overall Study|Study drug toxicity|31|||
162873166|NCT02488759|588237405|FG003|Overall Study|Study drug toxicity|0|||
162873167|NCT02488759|588237406|FG004|Overall Study|Study drug toxicity|0|||
162873168|NCT02488759|588237407|FG005|Overall Study|Study drug toxicity|2|||
162873169|NCT02488759|588237402|FG000|Overall Study|Adverse event unrelated to study drug|9|||
162873170|NCT02488759|588237403|FG001|Overall Study|Adverse event unrelated to study drug|11|||
162873171|NCT02488759|588237404|FG002|Overall Study|Adverse event unrelated to study drug|7|||
162873172|NCT02488759|588237405|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162873173|NCT02488759|588237406|FG004|Overall Study|Adverse event unrelated to study drug|1|||
162873174|NCT02488759|588237407|FG005|Overall Study|Adverse event unrelated to study drug|0|||
162873175|NCT02488759|588237402|FG000|Overall Study|Participant request to discontinue study treatment|6|||
162873176|NCT02488759|588237403|FG001|Overall Study|Participant request to discontinue study treatment|8|||
162873177|NCT02488759|588237404|FG002|Overall Study|Participant request to discontinue study treatment|4|||
162873178|NCT02488759|588237405|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162873179|NCT02488759|588237406|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162873180|NCT02488759|588237407|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162873181|NCT02488759|588237402|FG000|Overall Study|Withdrawal by Subject|4|||
162873182|NCT02488759|588237403|FG001|Overall Study|Withdrawal by Subject|0|||
162873183|NCT02488759|588237404|FG002|Overall Study|Withdrawal by Subject|3|||
162873184|NCT02488759|588237405|FG003|Overall Study|Withdrawal by Subject|0|||
162873185|NCT02488759|588237406|FG004|Overall Study|Withdrawal by Subject|0|||
162873186|NCT02488759|588237407|FG005|Overall Study|Withdrawal by Subject|2|||
162873187|NCT02488759|588237402|FG000|Overall Study|Lost to Follow-up|0|||
162873188|NCT02488759|588237403|FG001|Overall Study|Lost to Follow-up|0|||
162873189|NCT02488759|588237404|FG002|Overall Study|Lost to Follow-up|2|||
162873190|NCT02488759|588237405|FG003|Overall Study|Lost to Follow-up|0|||
162873191|NCT02488759|588237406|FG004|Overall Study|Lost to Follow-up|0|||
162873192|NCT02488759|588237407|FG005|Overall Study|Lost to Follow-up|0|||
162873193|NCT02488759|588237402|FG000|Overall Study|Maximum clinical benefit|3|||
162873194|NCT02488759|588237403|FG001|Overall Study|Maximum clinical benefit|0|||
162873195|NCT02488759|588237404|FG002|Overall Study|Maximum clinical benefit|1|||
162873196|NCT02488759|588237405|FG003|Overall Study|Maximum clinical benefit|0|||
162873197|NCT02488759|588237406|FG004|Overall Study|Maximum clinical benefit|0|||
162873198|NCT02488759|588237407|FG005|Overall Study|Maximum clinical benefit|0|||
162873199|NCT02488759|588237402|FG000|Overall Study|Other reasons|7|||
162873200|NCT02488759|588237403|FG001|Overall Study|Other reasons|32|||
162873201|NCT02488759|588237404|FG002|Overall Study|Other reasons|23|||
162873202|NCT02488759|588237405|FG003|Overall Study|Other reasons|1|||
162873203|NCT02488759|588237406|FG004|Overall Study|Other reasons|1|||
162873204|NCT02488759|588237407|FG005|Overall Study|Other reasons|1|||
162873205|NCT01678807|588237413|FG000|Overall Study|Adverse Event|4|||
162873206|NCT01678807|588237414|FG001|Overall Study|Adverse Event|4|||
162873207|NCT01678807|588237415|FG002|Overall Study|Adverse Event|0|||
162873208|NCT01678807|588237413|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
162873209|NCT01678807|588237414|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
162873210|NCT01678807|588237415|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
162873211|NCT05281523|588237416|FG000|Overall Study|Adverse Event|1|||
162873212|NCT05281523|588237417|FG001|Overall Study|Adverse Event|1|||
162873213|NCT05281523|588237416|FG000|Overall Study|Physician Decision|1|||
162873214|NCT05281523|588237417|FG001|Overall Study|Physician Decision|1|||
162873215|NCT05281523|588237416|FG000|Overall Study|Withdrawal by Subject|5|||
162873216|NCT05281523|588237417|FG001|Overall Study|Withdrawal by Subject|15|||
162873217|NCT05281523|588237416|FG000|Overall Study|GCP violations|3|||
162873218|NCT05281523|588237417|FG001|Overall Study|GCP violations|4|||
162873219|NCT02574312|588237418|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
162873220|NCT02574312|588237419|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
162873221|NCT02326467|588239070|FG000|Overall Study|Withdrawal by Subject|1|||
162873222|NCT04467164|588239072|FG000|Washout (1 Week)|Lost to Follow-up|2|||
162873223|NCT04467164|588239073|FG001|Washout (1 Week)|Lost to Follow-up|0|||
162873224|NCT01998581|588239074|FG000|Overall Study|Refused repeat treatment|20|||
162873225|NCT01998581|588239075|FG001|Overall Study|Refused repeat treatment|4|||
162873226|NCT01998581|588239074|FG000|Overall Study|Protocol Violation|1|||
162873227|NCT01998581|588239075|FG001|Overall Study|Protocol Violation|0|||
162961332|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961333|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961334|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961335|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961336|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961337|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961338|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961339|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961340|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961341|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961342|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961343|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961344|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162873228|NCT01998581|588239074|FG000|Overall Study|Withdrawal by Subject|8|||
162873229|NCT01998581|588239075|FG001|Overall Study|Withdrawal by Subject|1|||
162873230|NCT01998581|588239074|FG000|Overall Study|Lost to Follow-up|12|||
162873231|NCT01998581|588239075|FG001|Overall Study|Lost to Follow-up|4|||
162873232|NCT01998581|588239074|FG000|Overall Study|Adverse Event|1|||
162873233|NCT01998581|588239075|FG001|Overall Study|Adverse Event|1|||
162873234|NCT01998581|588239074|FG000|Overall Study|Other reasons|3|||
162873235|NCT01998581|588239075|FG001|Overall Study|Other reasons|2|||
162873236|NCT01998581|588239074|FG000|Overall Study|Randomized but withdrew before treatment|1|||
162873237|NCT01998581|588239075|FG001|Overall Study|Randomized but withdrew before treatment|0|||
162873238|NCT02273050|588239078|FG000|Overall Study|Adverse Event|4|||
162978992|NCT01660022|588623543|FG005|First Sequence (7 Days)|Protocol Violation|1|||
162873239|NCT02273050|588239079|FG001|Overall Study|Adverse Event|3|||
162873240|NCT02273050|588239080|FG002|Overall Study|Adverse Event|3|||
162615210|NCT00231842|587309315|FG000|Overall Study|Withdrawal by Subject|3|||
162615211|NCT00231842|587309315|FG000|Overall Study|Did not complete the last 3 cycle|8|||
162615212|NCT02422303|587309316|FG000|Overall Study|Lost to Follow-up|1|||
162615213|NCT02422303|587309317|FG001|Overall Study|Lost to Follow-up|1|||
162615214|NCT00428792|587309319|FG000|Overall Study|Lack of Efficacy|1|||
162873241|NCT02273050|588239078|FG000|Overall Study|Death|0|||
162873242|NCT02273050|588239079|FG001|Overall Study|Death|0|||
162873243|NCT02273050|588239080|FG002|Overall Study|Death|1|||
162873244|NCT02273050|588239078|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
162873245|NCT02273050|588239079|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
162873246|NCT02273050|588239080|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
162873247|NCT02273050|588239078|FG000|Overall Study|Lack of Efficacy|0|||
162873248|NCT02273050|588239079|FG001|Overall Study|Lack of Efficacy|1|||
162873249|NCT02273050|588239080|FG002|Overall Study|Lack of Efficacy|1|||
162873250|NCT02273050|588239078|FG000|Overall Study|Withdrawal by Subject|17|||
162873251|NCT02273050|588239079|FG001|Overall Study|Withdrawal by Subject|14|||
162873252|NCT02273050|588239080|FG002|Overall Study|Withdrawal by Subject|16|||
162873253|NCT02273050|588239078|FG000|Overall Study|Lost to Follow-up|0|||
162873254|NCT02273050|588239079|FG001|Overall Study|Lost to Follow-up|2|||
162873255|NCT02273050|588239080|FG002|Overall Study|Lost to Follow-up|3|||
162873256|NCT02273050|588239078|FG000|Overall Study|Protocol Violation|3|||
162873257|NCT02273050|588239079|FG001|Overall Study|Protocol Violation|1|||
162873258|NCT02273050|588239080|FG002|Overall Study|Protocol Violation|4|||
162873259|NCT02273752|588239081|FG000|Overall Study|Trial was terminated early|2|||
162873260|NCT00903032|588239082|FG000|Overall Study|Withdrawal by Subject|5|||
162873261|NCT00903032|588239083|FG001|Overall Study|Withdrawal by Subject|3|||
162873262|NCT00903032|588239082|FG000|Overall Study|Lost to Follow-up|2|||
162873263|NCT00903032|588239083|FG001|Overall Study|Lost to Follow-up|2|||
162873264|NCT05619172|588239084|FG000|Safety Cohort 1|Death|7|||
162873265|NCT05619172|588239085|FG001|Safety Cohort 1|Death|0|||
162873266|NCT05619172|588239084|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
162873267|NCT05619172|588239085|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
162873268|NCT05619172|588239084|FG000|Safety Cohort 2|Death|0|||
162873269|NCT05619172|588239085|FG001|Safety Cohort 2|Death|1|||
162873270|NCT05619172|588239084|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
162873271|NCT05619172|588239085|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
162873272|NCT01429792|588239086|FG000|Overall Study|Other Reasons|67|||
162873273|NCT01429792|588239086|FG000|Overall Study|Unknown Disposition|94|||
162873274|NCT01429792|588239086|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
162873275|NCT01429792|588239086|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
162873276|NCT01429792|588239086|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
162873277|NCT01429792|588239086|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
162873278|NCT01429792|588239086|FG000|Overall Study|Withdrawal by Subject|70|||
162873279|NCT01429792|588239086|FG000|Overall Study|Lost to Follow-up|88|||
162873280|NCT04346628|588239089|FG000|Overall Study|Lost to Follow-up|4|||
162873281|NCT04346628|588239090|FG001|Overall Study|Lost to Follow-up|4|||
162873282|NCT04346628|588239089|FG000|Overall Study|Withdrew (had personal reasons)|2|||
162873283|NCT04346628|588239090|FG001|Overall Study|Withdrew (had personal reasons)|5|||
162873284|NCT04346628|588239089|FG000|Overall Study|Withdrew (medication intolerant)|0|||
162873285|NCT04346628|588239090|FG001|Overall Study|Withdrew (medication intolerant)|3|||
162873286|NCT04346628|588239089|FG000|Overall Study|Withdrew (declined intervention)|0|||
162873287|NCT04346628|588239090|FG001|Overall Study|Withdrew (declined intervention)|1|||
162873288|NCT01763905|588239091|FG000|Overall Study|Withdrawal by Subject|1|||
162873289|NCT01763905|588239092|FG001|Overall Study|Withdrawal by Subject|1|||
162873290|NCT01763905|588239093|FG002|Overall Study|Withdrawal by Subject|0|||
162873291|NCT01763905|588239094|FG003|Overall Study|Withdrawal by Subject|1|||
162961345|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961346|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961347|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961348|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961349|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961350|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162615215|NCT00428792|587309320|FG001|Overall Study|Lack of Efficacy|3|||
162615216|NCT00428792|587309319|FG000|Overall Study|Lost to Follow-up|0|||
162615217|NCT00428792|587309320|FG001|Overall Study|Lost to Follow-up|1|||
162873292|NCT01763905|588239091|FG000|Overall Study|Decision by sponsor|5|||
162873293|NCT01763905|588239092|FG001|Overall Study|Decision by sponsor|0|||
162873294|NCT01763905|588239093|FG002|Overall Study|Decision by sponsor|8|||
162873295|NCT01763905|588239094|FG003|Overall Study|Decision by sponsor|0|||
162873296|NCT01763905|588239091|FG000|Overall Study|Lost to Follow-up|0|||
162873297|NCT01763905|588239092|FG001|Overall Study|Lost to Follow-up|0|||
162615218|NCT00850343|587309321|FG000|Overall Study|Withdrawal by Subject|11|||
162615219|NCT00850343|587309322|FG001|Overall Study|Withdrawal by Subject|0|||
162873298|NCT01763905|588239093|FG002|Overall Study|Lost to Follow-up|1|||
162873299|NCT01763905|588239094|FG003|Overall Study|Lost to Follow-up|0|||
162873300|NCT03165721|588239102|FG000|Overall Study|Refused further treatment|3|||
162873301|NCT03165721|588239103|FG001|Overall Study|Refused further treatment|0|||
162873302|NCT03165721|588239104|FG002|Overall Study|Refused further treatment|0|||
162873303|NCT03165721|588239102|FG000|Overall Study|Physician Decision|1|||
162873304|NCT03165721|588239103|FG001|Overall Study|Physician Decision|0|||
163047666|NCT03284853|588881244|FG000|Overall Study|Lack of Efficacy|1|||
162615220|NCT00850343|587309323|FG002|Overall Study|Withdrawal by Subject|3|||
162615221|NCT00850343|587309324|FG003|Overall Study|Withdrawal by Subject|2|||
162615222|NCT00850343|587309321|FG000|Overall Study|Adverse Event|15|||
162615223|NCT00850343|587309322|FG001|Overall Study|Adverse Event|2|||
162615224|NCT00850343|587309323|FG002|Overall Study|Adverse Event|6|||
162615225|NCT00850343|587309324|FG003|Overall Study|Adverse Event|6|||
162615226|NCT00850343|587309321|FG000|Overall Study|Pregnancy|0|||
162615227|NCT00850343|587309322|FG001|Overall Study|Pregnancy|0|||
162615228|NCT00850343|587309323|FG002|Overall Study|Pregnancy|0|||
162615229|NCT00850343|587309324|FG003|Overall Study|Pregnancy|1|||
163047667|NCT03284853|588881245|FG001|Overall Study|Lack of Efficacy|0|||
163047668|NCT03284853|588881244|FG000|Overall Study|Disallowed Concurrent Medication|1|||
163047669|NCT03284853|588881245|FG001|Overall Study|Disallowed Concurrent Medication|1|||
163047670|NCT03284853|588881244|FG000|Overall Study|Protocol Violation|3|||
163047671|NCT03284853|588881245|FG001|Overall Study|Protocol Violation|3|||
163047672|NCT03284853|588881244|FG000|Overall Study|Death|0|||
163047673|NCT03284853|588881245|FG001|Overall Study|Death|1|||
163047674|NCT03284853|588881244|FG000|Overall Study|Other - Reason not reported in CSR|4|||
163047675|NCT03284853|588881245|FG001|Overall Study|Other - Reason not reported in CSR|3|||
163047676|NCT05176717|588881246|FG000|Overall Study|Sponsor Decision|1|||
163047677|NCT05176717|588881247|FG001|Overall Study|Sponsor Decision|2|||
163047678|NCT05176717|588881248|FG002|Overall Study|Sponsor Decision|2|||
163047679|NCT02058589|588881249|FG000|Overall Study|Serious Adverse Event|1|||
163047680|NCT02058589|588881250|FG001|Overall Study|Serious Adverse Event|1|||
163047681|NCT02058589|588881249|FG000|Overall Study|Non-Serious Adverse Event|1|||
162873305|NCT03165721|588239104|FG002|Overall Study|Physician Decision|0|||
162873306|NCT01457118|588239105|FG000|Overall Study|Adverse Event|1|||
162873307|NCT01457118|588239106|FG001|Overall Study|Adverse Event|0|||
162873308|NCT01457118|588239107|FG002|Overall Study|Adverse Event|0|||
162873309|NCT01457118|588239108|FG003|Overall Study|Adverse Event|1|||
162873310|NCT01457118|588239105|FG000|Overall Study|Clinical Progression|0|||
162873311|NCT01457118|588239106|FG001|Overall Study|Clinical Progression|1|||
162873312|NCT01457118|588239107|FG002|Overall Study|Clinical Progression|0|||
162873313|NCT01457118|588239108|FG003|Overall Study|Clinical Progression|1|||
162873314|NCT01457118|588239105|FG000|Overall Study|Physician Decision|2|||
162873315|NCT01457118|588239106|FG001|Overall Study|Physician Decision|0|||
162873316|NCT01457118|588239107|FG002|Overall Study|Physician Decision|0|||
162873317|NCT01457118|588239108|FG003|Overall Study|Physician Decision|0|||
162873318|NCT01457118|588239105|FG000|Overall Study|Progressive Disease by RECIST|12|||
162873319|NCT01457118|588239106|FG001|Overall Study|Progressive Disease by RECIST|3|||
162873320|NCT01457118|588239107|FG002|Overall Study|Progressive Disease by RECIST|1|||
162873321|NCT01457118|588239108|FG003|Overall Study|Progressive Disease by RECIST|0|||
162873322|NCT01457118|588239105|FG000|Overall Study|Withdrawal by Subject|5|||
162873323|NCT01457118|588239106|FG001|Overall Study|Withdrawal by Subject|0|||
162873324|NCT01457118|588239107|FG002|Overall Study|Withdrawal by Subject|0|||
162873325|NCT01457118|588239108|FG003|Overall Study|Withdrawal by Subject|0|||
162873326|NCT02324842|588239109|FG000|Overall Study|Lost to Follow-up|1|||
163047682|NCT02058589|588881250|FG001|Overall Study|Non-Serious Adverse Event|0|||
163047683|NCT02058589|588881249|FG000|Overall Study|Withdrawal by Subject|0|||
163047684|NCT02058589|588881250|FG001|Overall Study|Withdrawal by Subject|1|||
162615230|NCT00850343|587309321|FG000|Overall Study|Lack of Efficacy|17|||
162615231|NCT00850343|587309322|FG001|Overall Study|Lack of Efficacy|0|||
162873327|NCT02324842|588239110|FG001|Overall Study|Lost to Follow-up|1|||
162873328|NCT02324842|588239111|FG002|Overall Study|Lost to Follow-up|2|||
162873329|NCT03298412|588239114|FG000|Run-in Period|Other, Not Specified|1|||
162873330|NCT03298412|588239114|FG000|Run-in Period|Disease Progression|1|||
163047685|NCT00765817|588881252|FG000|Overall Study|Adverse Event|13|||
162615232|NCT00850343|587309323|FG002|Overall Study|Lack of Efficacy|3|||
162873331|NCT03298412|588239114|FG000|Run-in Period|Ineligibility Determined|1|||
163047686|NCT00765817|588881253|FG001|Overall Study|Adverse Event|1|||
163047687|NCT00765817|588881252|FG000|Overall Study|Death|0|||
162615233|NCT00850343|587309324|FG003|Overall Study|Lack of Efficacy|2|||
162873332|NCT03298412|588239114|FG000|Run-in Period|Decision by Sponsor|6|||
163047688|NCT00765817|588881253|FG001|Overall Study|Death|1|||
163047689|NCT00765817|588881252|FG000|Overall Study|Entry criteria not met|2|||
163047690|NCT00765817|588881253|FG001|Overall Study|Entry criteria not met|2|||
162615234|NCT00850343|587309321|FG000|Overall Study|Non-compliance with Study Procedures|1|||
162615235|NCT00850343|587309322|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162615236|NCT00850343|587309323|FG002|Overall Study|Non-compliance with Study Procedures|1|||
163047691|NCT00765817|588881252|FG000|Overall Study|Loss of glucose control|0|||
162873333|NCT03456713|588239117|FG000|Overall Study|Lost to Follow-up|1|||
162873334|NCT03456713|588239118|FG001|Overall Study|Lost to Follow-up|0|||
162873335|NCT03456713|588239119|FG002|Overall Study|Lost to Follow-up|0|||
162873336|NCT03456713|588239120|FG003|Overall Study|Lost to Follow-up|0|||
162873337|NCT01263691|588239121|FG000|Overall Study|Lost to Follow-up|1|||
162873338|NCT01263691|588239122|FG001|Overall Study|Lost to Follow-up|0|||
162873339|NCT01263691|588239123|FG002|Overall Study|Lost to Follow-up|1|||
162873340|NCT01263691|588239124|FG003|Overall Study|Lost to Follow-up|1|||
162873341|NCT01263691|588239125|FG004|Overall Study|Lost to Follow-up|0|||
162873342|NCT01263691|588239126|FG005|Overall Study|Lost to Follow-up|0|||
162873343|NCT01263691|588239121|FG000|Overall Study|Withdrawal by Subject|1|||
162873344|NCT01263691|588239122|FG001|Overall Study|Withdrawal by Subject|0|||
162873345|NCT01263691|588239123|FG002|Overall Study|Withdrawal by Subject|0|||
162873346|NCT01263691|588239124|FG003|Overall Study|Withdrawal by Subject|0|||
162873347|NCT01263691|588239125|FG004|Overall Study|Withdrawal by Subject|0|||
162873348|NCT01263691|588239126|FG005|Overall Study|Withdrawal by Subject|0|||
162873349|NCT01263691|588239121|FG000|Overall Study|Adverse Event|1|||
162873350|NCT01263691|588239122|FG001|Overall Study|Adverse Event|0|||
162873351|NCT01263691|588239123|FG002|Overall Study|Adverse Event|0|||
162873352|NCT01263691|588239124|FG003|Overall Study|Adverse Event|0|||
162873353|NCT01263691|588239125|FG004|Overall Study|Adverse Event|0|||
162873354|NCT01263691|588239126|FG005|Overall Study|Adverse Event|0|||
162873355|NCT01202227|588239127|FG000|Overall Study|Adverse Event|16|||
162873356|NCT01202227|588239127|FG000|Overall Study|Withdrawal by Subject|2|||
162873357|NCT01202227|588239127|FG000|Overall Study|Lack of Efficacy|1|||
162873358|NCT01894477|588239128|FG000|Overall Study|Protocol Violation|0|||
162873359|NCT01894477|588239129|FG001|Overall Study|Protocol Violation|1|||
162873360|NCT01894477|588239128|FG000|Overall Study|protocol changed due SC changed to cord|0|||
162873361|NCT01894477|588239129|FG001|Overall Study|protocol changed due SC changed to cord|1|||
162873362|NCT00630812|588239143|FG000|Randomisation to First Dose|Adverse Event|1|||
162873363|NCT00630812|588239144|FG001|Randomisation to First Dose|Adverse Event|1|||
162873364|NCT00630812|588239143|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
162873365|NCT00630812|588239144|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
162873366|NCT00630812|588239143|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
162873367|NCT00630812|588239144|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
162873368|NCT00630812|588239143|FG000|Randomisation to First Dose|Protocol Violation|4|||
162873369|NCT00630812|588239144|FG001|Randomisation to First Dose|Protocol Violation|1|||
162873370|NCT00630812|588239143|FG000|Double Blind Treatment Period|Adverse Event|13|||
162873371|NCT00630812|588239144|FG001|Double Blind Treatment Period|Adverse Event|5|||
162873372|NCT00630812|588239143|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
162873373|NCT00630812|588239144|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
162873374|NCT00630812|588239143|FG000|Double Blind Treatment Period|Physician Decision|2|||
162873375|NCT00630812|588239144|FG001|Double Blind Treatment Period|Physician Decision|1|||
162873376|NCT00630812|588239143|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162873377|NCT00630812|588239144|FG001|Double Blind Treatment Period|Protocol Violation|0|||
162873378|NCT00630812|588239143|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
162873379|NCT00630812|588239144|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
162873380|NCT00630812|588239143|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
162961351|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162615237|NCT00850343|587309324|FG003|Overall Study|Non-compliance with Study Procedures|1|||
162615238|NCT00850343|587309321|FG000|Overall Study|Physician Decision|2|||
162615239|NCT00850343|587309322|FG001|Overall Study|Physician Decision|1|||
162615240|NCT00850343|587309323|FG002|Overall Study|Physician Decision|1|||
162615241|NCT00850343|587309324|FG003|Overall Study|Physician Decision|1|||
162615242|NCT02468232|587309325|FG000|Core Part of Study|Adverse Event|0|||
162873381|NCT00630812|588239144|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
162873382|NCT00630812|588239143|FG000|Double Blind Treatment Period|Non-compliance|0|||
162873383|NCT00630812|588239144|FG001|Double Blind Treatment Period|Non-compliance|1|||
162873384|NCT01554956|588239145|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
162873385|NCT01554956|588239146|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
162873386|NCT01554956|588239147|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
162961352|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162961353|NCT00112437|588560746|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162615243|NCT02468232|587309326|FG001|Core Part of Study|Adverse Event|1|||
162873387|NCT01554956|588239145|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
162873388|NCT01554956|588239146|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
162873389|NCT01554956|588239147|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
162873390|NCT01554956|588239145|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
162873391|NCT01554956|588239146|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
162873392|NCT01554956|588239147|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
162873393|NCT00069095|588239148|FG000|Primary Treatment Phase|Ongoing|0|||
162873394|NCT00069095|588239149|FG001|Primary Treatment Phase|Ongoing|0|||
162873395|NCT00069095|588239150|FG002|Primary Treatment Phase|Ongoing|5|||
162873396|NCT00069095|588239151|FG003|Primary Treatment Phase|Ongoing|7|||
162873397|NCT00069095|588239152|FG004|Primary Treatment Phase|Ongoing|7|||
162873398|NCT00069095|588239153|FG005|Primary Treatment Phase|Ongoing|4|||
162873399|NCT00069095|588239148|FG000|Primary Treatment Phase|Admin/Other|29|||
162873400|NCT00069095|588239149|FG001|Primary Treatment Phase|Admin/Other|38|||
162873401|NCT00069095|588239150|FG002|Primary Treatment Phase|Admin/Other|31|||
162873402|NCT00069095|588239151|FG003|Primary Treatment Phase|Admin/Other|45|||
162873403|NCT00069095|588239152|FG004|Primary Treatment Phase|Admin/Other|48|||
162873404|NCT00069095|588239153|FG005|Primary Treatment Phase|Admin/Other|42|||
162873405|NCT00069095|588239148|FG000|Primary Treatment Phase|Adverse Event|99|||
162873406|NCT00069095|588239149|FG001|Primary Treatment Phase|Adverse Event|92|||
162873407|NCT00069095|588239150|FG002|Primary Treatment Phase|Adverse Event|71|||
162873408|NCT00069095|588239151|FG003|Primary Treatment Phase|Adverse Event|72|||
162873409|NCT00069095|588239152|FG004|Primary Treatment Phase|Adverse Event|109|||
162873410|NCT00069095|588239153|FG005|Primary Treatment Phase|Adverse Event|101|||
162873411|NCT00069095|588239148|FG000|Primary Treatment Phase|Death|14|||
162873412|NCT00069095|588239149|FG001|Primary Treatment Phase|Death|8|||
162873413|NCT00069095|588239150|FG002|Primary Treatment Phase|Death|2|||
162873414|NCT00069095|588239151|FG003|Primary Treatment Phase|Death|5|||
162873415|NCT00069095|588239152|FG004|Primary Treatment Phase|Death|8|||
162873416|NCT00069095|588239153|FG005|Primary Treatment Phase|Death|8|||
162873417|NCT00069095|588239148|FG000|Primary Treatment Phase|Failure to return|5|||
162873418|NCT00069095|588239149|FG001|Primary Treatment Phase|Failure to return|5|||
162873419|NCT00069095|588239150|FG002|Primary Treatment Phase|Failure to return|0|||
162873420|NCT00069095|588239151|FG003|Primary Treatment Phase|Failure to return|0|||
162873421|NCT00069095|588239152|FG004|Primary Treatment Phase|Failure to return|0|||
162873422|NCT00069095|588239153|FG005|Primary Treatment Phase|Failure to return|2|||
162873423|NCT00069095|588239148|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
162873424|NCT00069095|588239149|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
162873425|NCT00069095|588239150|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
162873426|NCT00069095|588239151|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
162873427|NCT00069095|588239152|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
162873428|NCT00069095|588239153|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
162873429|NCT00069095|588239148|FG000|Primary Treatment Phase|Refused treatment|15|||
162873430|NCT00069095|588239149|FG001|Primary Treatment Phase|Refused treatment|26|||
162873431|NCT00069095|588239150|FG002|Primary Treatment Phase|Refused treatment|17|||
162873432|NCT00069095|588239151|FG003|Primary Treatment Phase|Refused treatment|31|||
162873433|NCT00069095|588239152|FG004|Primary Treatment Phase|Refused treatment|24|||
162873434|NCT00069095|588239153|FG005|Primary Treatment Phase|Refused treatment|27|||
162873435|NCT00069095|588239148|FG000|Primary Treatment Phase|Withdrew|2|||
162873436|NCT00069095|588239149|FG001|Primary Treatment Phase|Withdrew|3|||
162873437|NCT00069095|588239150|FG002|Primary Treatment Phase|Withdrew|8|||
162873438|NCT00069095|588239151|FG003|Primary Treatment Phase|Withdrew|2|||
162873439|NCT00069095|588239152|FG004|Primary Treatment Phase|Withdrew|4|||
162873440|NCT00069095|588239153|FG005|Primary Treatment Phase|Withdrew|9|||
162873441|NCT00069095|588239148|FG000|Primary Treatment Phase|Other Violation|0|||
162873442|NCT00069095|588239149|FG001|Primary Treatment Phase|Other Violation|1|||
162873443|NCT00069095|588239150|FG002|Primary Treatment Phase|Other Violation|1|||
162873444|NCT00069095|588239151|FG003|Primary Treatment Phase|Other Violation|1|||
162873445|NCT00069095|588239152|FG004|Primary Treatment Phase|Other Violation|0|||
162873446|NCT00069095|588239153|FG005|Primary Treatment Phase|Other Violation|1|||
162873447|NCT00069095|588239148|FG000|Primary Treatment Phase|Violation criteria|0|||
162873448|NCT00069095|588239149|FG001|Primary Treatment Phase|Violation criteria|2|||
162873449|NCT00069095|588239150|FG002|Primary Treatment Phase|Violation criteria|4|||
162873450|NCT00069095|588239151|FG003|Primary Treatment Phase|Violation criteria|3|||
162873451|NCT00069095|588239152|FG004|Primary Treatment Phase|Violation criteria|1|||
162873452|NCT00069095|588239153|FG005|Primary Treatment Phase|Violation criteria|5|||
162873453|NCT00069095|588239148|FG000|Post-study Treatment Phase|Missing reason|1|||
162873454|NCT00069095|588239149|FG001|Post-study Treatment Phase|Missing reason|3|||
162873455|NCT00069095|588239150|FG002|Post-study Treatment Phase|Missing reason|12|||
162873456|NCT00069095|588239151|FG003|Post-study Treatment Phase|Missing reason|8|||
162873457|NCT00069095|588239152|FG004|Post-study Treatment Phase|Missing reason|18|||
162873458|NCT00069095|588239153|FG005|Post-study Treatment Phase|Missing reason|17|||
162873459|NCT00069095|588239148|FG000|Post-study Treatment Phase|Adverse Event|2|||
162873460|NCT00069095|588239149|FG001|Post-study Treatment Phase|Adverse Event|3|||
162873461|NCT00069095|588239150|FG002|Post-study Treatment Phase|Adverse Event|1|||
162873462|NCT00069095|588239151|FG003|Post-study Treatment Phase|Adverse Event|0|||
162873463|NCT00069095|588239152|FG004|Post-study Treatment Phase|Adverse Event|5|||
162873464|NCT00069095|588239153|FG005|Post-study Treatment Phase|Adverse Event|1|||
162873465|NCT00069095|588239148|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
162873466|NCT00069095|588239149|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
162873467|NCT00069095|588239150|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
162873468|NCT00069095|588239151|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
162873469|NCT00069095|588239152|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
162873470|NCT00069095|588239153|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
162873471|NCT00069095|588239148|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
162873472|NCT00069095|588239149|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
162873473|NCT00069095|588239150|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
162873474|NCT00069095|588239151|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
162873475|NCT00069095|588239152|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
162873476|NCT00069095|588239153|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
162873477|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
162873478|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
162873479|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
162873480|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
162873481|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
162873482|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
162873483|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant had complete response|1|||
162873484|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant had complete response|1|||
162873485|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant had complete response|0|||
162873486|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant had complete response|0|||
162873487|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant had complete response|0|||
162873488|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant had complete response|0|||
162873489|NCT00069095|588239148|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
162873490|NCT00069095|588239149|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
162873491|NCT00069095|588239150|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
162873492|NCT00069095|588239151|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
162873493|NCT00069095|588239152|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
162873494|NCT00069095|588239153|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
162873495|NCT00069095|588239148|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
162873496|NCT00069095|588239149|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
162873497|NCT00069095|588239150|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
162873498|NCT00069095|588239151|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
162873499|NCT00069095|588239152|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
162873500|NCT00069095|588239153|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
162873501|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
162873502|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
162873503|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
162873504|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
162873505|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
162873506|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
162873507|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
162873508|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
162873509|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
162873510|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
162873511|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
162873512|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
162873513|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
162873514|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
162873515|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
162873516|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
162873517|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
162873518|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
162873519|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
163047692|NCT00765817|588881253|FG001|Overall Study|Loss of glucose control|2|||
163047693|NCT00765817|588881252|FG000|Overall Study|Lost to Follow-up|1|||
163047694|NCT00765817|588881253|FG001|Overall Study|Lost to Follow-up|3|||
162873520|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
162873521|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
162873522|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
162873523|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
162873524|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
162873525|NCT00069095|588239148|FG000|Post-study Treatment Phase|Surgery|0|||
162873526|NCT00069095|588239149|FG001|Post-study Treatment Phase|Surgery|0|||
162873527|NCT00069095|588239150|FG002|Post-study Treatment Phase|Surgery|0|||
163047695|NCT00765817|588881252|FG000|Overall Study|Physician Decision|2|||
163047696|NCT00765817|588881253|FG001|Overall Study|Physician Decision|1|||
163047697|NCT00765817|588881252|FG000|Overall Study|Protocol Violation|1|||
163047698|NCT00765817|588881253|FG001|Overall Study|Protocol Violation|1|||
163047699|NCT00765817|588881252|FG000|Overall Study|Subject decision|7|||
163047700|NCT00765817|588881253|FG001|Overall Study|Subject decision|11|||
163047701|NCT02308228|588881254|FG000|Overall Study|Adverse Event|3|||
163047702|NCT02308228|588881255|FG001|Overall Study|Adverse Event|4|||
163047703|NCT02308228|588881254|FG000|Overall Study|Withdrawal by Subject|5|||
163047704|NCT02308228|588881255|FG001|Overall Study|Withdrawal by Subject|3|||
163047705|NCT02143024|588881256|FG000|Overall Study|Lost to Follow-up|1|||
163047706|NCT02143024|588881257|FG001|Overall Study|Lost to Follow-up|1|||
163047707|NCT02143024|588881256|FG000|Overall Study|Withdrawal by Subject|1|||
163047708|NCT02143024|588881257|FG001|Overall Study|Withdrawal by Subject|0|||
163047709|NCT06597084|588881258|FG000|Overall Study|Withdrawal by Subject|4|||
163047710|NCT06597084|588881259|FG001|Overall Study|Withdrawal by Subject|9|||
163047711|NCT06597084|588881258|FG000|Overall Study|Consent was not given by the patient until V2|0|||
163047712|NCT06597084|588881259|FG001|Overall Study|Consent was not given by the patient until V2|3|||
163047713|NCT06597084|588881258|FG000|Overall Study|Physician Decision|1|||
163047714|NCT06597084|588881259|FG001|Overall Study|Physician Decision|0|||
163047715|NCT06597084|588881258|FG000|Overall Study|Adverse Event|3|||
163047716|NCT06597084|588881259|FG001|Overall Study|Adverse Event|2|||
163047717|NCT06597084|588881258|FG000|Overall Study|Death|4|||
163047718|NCT06597084|588881259|FG001|Overall Study|Death|0|||
163047719|NCT06597084|588881258|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
163047720|NCT06597084|588881259|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
163047721|NCT06597084|588881258|FG000|Overall Study|Lost to Follow-up|4|||
163047722|NCT06597084|588881259|FG001|Overall Study|Lost to Follow-up|2|||
163047723|NCT06597084|588881258|FG000|Overall Study|Other. Not specified|1|||
163047724|NCT06597084|588881259|FG001|Overall Study|Other. Not specified|0|||
162615244|NCT02468232|587309327|FG002|Core Part of Study|Adverse Event|0|||
162615245|NCT02468232|587309328|FG003|Core Part of Study|Adverse Event|0|||
162615246|NCT02468232|587309325|FG000|Core Part of Study|Death|20|||
162615247|NCT02468232|587309326|FG001|Core Part of Study|Death|17|||
162615248|NCT02468232|587309327|FG002|Core Part of Study|Death|0|||
162615249|NCT02468232|587309328|FG003|Core Part of Study|Death|0|||
162615250|NCT02468232|587309325|FG000|Core Part of Study|Technical Problems|1|||
162615251|NCT02468232|587309326|FG001|Core Part of Study|Technical Problems|1|||
162615252|NCT02468232|587309327|FG002|Core Part of Study|Technical Problems|0|||
162615253|NCT02468232|587309328|FG003|Core Part of Study|Technical Problems|0|||
162615254|NCT02468232|587309325|FG000|OLE Part of Study|Adverse Event|0|||
162615255|NCT02468232|587309326|FG001|OLE Part of Study|Adverse Event|0|||
162615256|NCT02468232|587309327|FG002|OLE Part of Study|Adverse Event|4|||
162615257|NCT02468232|587309328|FG003|OLE Part of Study|Adverse Event|5|||
162615258|NCT02468232|587309325|FG000|OLE Part of Study|Death|0|||
162615259|NCT02468232|587309326|FG001|OLE Part of Study|Death|0|||
162615260|NCT02468232|587309327|FG002|OLE Part of Study|Death|4|||
162615261|NCT02468232|587309328|FG003|OLE Part of Study|Death|2|||
162615262|NCT02468232|587309325|FG000|OLE Part of Study|Physician Decision|0|||
162615263|NCT02468232|587309326|FG001|OLE Part of Study|Physician Decision|0|||
162615264|NCT02468232|587309327|FG002|OLE Part of Study|Physician Decision|4|||
162615265|NCT02468232|587309328|FG003|OLE Part of Study|Physician Decision|0|||
162873528|NCT00069095|588239151|FG003|Post-study Treatment Phase|Surgery|1|||
162873529|NCT00069095|588239152|FG004|Post-study Treatment Phase|Surgery|1|||
162873530|NCT00069095|588239153|FG005|Post-study Treatment Phase|Surgery|0|||
162873531|NCT00069095|588239148|FG000|Post-study Treatment Phase|Death|0|||
163047725|NCT00490971|588881264|FG000|Acute/Continuation|Adverse Event|62|||
163047726|NCT00490971|588881265|FG001|Acute/Continuation|Adverse Event|13|||
163047727|NCT00490971|588881266|FG002|Acute/Continuation|Adverse Event|0|||
163047728|NCT00490971|588881267|FG003|Acute/Continuation|Adverse Event|0|||
162615266|NCT02468232|587309325|FG000|OLE Part of Study|Subject/Guardian decision|0|||
162615267|NCT02468232|587309326|FG001|OLE Part of Study|Subject/Guardian decision|0|||
162873532|NCT00069095|588239149|FG001|Post-study Treatment Phase|Death|0|||
163047729|NCT00490971|588881268|FG004|Acute/Continuation|Adverse Event|0|||
163047730|NCT00490971|588881264|FG000|Acute/Continuation|Death|2|||
162615268|NCT02468232|587309327|FG002|OLE Part of Study|Subject/Guardian decision|2|||
162615269|NCT02468232|587309328|FG003|OLE Part of Study|Subject/Guardian decision|5|||
162873533|NCT00069095|588239150|FG002|Post-study Treatment Phase|Death|0|||
163047731|NCT00490971|588881265|FG001|Acute/Continuation|Death|0|||
162615270|NCT01973569|587309329|FG000|Overall Study|Adverse Event|9|||
162615271|NCT01973569|587309330|FG001|Overall Study|Adverse Event|2|||
162615272|NCT01973569|587309331|FG002|Overall Study|Adverse Event|4|||
162615273|NCT01973569|587309329|FG000|Overall Study|Protocol Violation|2|||
162615274|NCT01973569|587309330|FG001|Overall Study|Protocol Violation|1|||
162873534|NCT00069095|588239151|FG003|Post-study Treatment Phase|Death|0|||
162873535|NCT00069095|588239152|FG004|Post-study Treatment Phase|Death|1|||
162873536|NCT00069095|588239153|FG005|Post-study Treatment Phase|Death|0|||
162873537|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
162873538|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
162873539|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
162873540|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
162873541|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
162873542|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
162873543|NCT00069095|588239148|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
162873544|NCT00069095|588239149|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
162873545|NCT00069095|588239150|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
162706733|NCT04955626|587636662|FG006|Blinded Period|Medication error|0|||
162873546|NCT00069095|588239151|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
162873547|NCT00069095|588239152|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
162873548|NCT00069095|588239153|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
162873549|NCT00069095|588239148|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
162873550|NCT00069095|588239149|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
162873551|NCT00069095|588239150|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
162873552|NCT00069095|588239151|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
162873553|NCT00069095|588239152|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
162873554|NCT00069095|588239153|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
162873555|NCT00069095|588239148|FG000|Post-study Treatment Phase|Investigator decision|0|||
162873556|NCT00069095|588239149|FG001|Post-study Treatment Phase|Investigator decision|0|||
162873557|NCT00069095|588239150|FG002|Post-study Treatment Phase|Investigator decision|0|||
162873558|NCT00069095|588239151|FG003|Post-study Treatment Phase|Investigator decision|0|||
162873559|NCT00069095|588239152|FG004|Post-study Treatment Phase|Investigator decision|0|||
162873560|NCT00069095|588239153|FG005|Post-study Treatment Phase|Investigator decision|1|||
162873561|NCT00069095|588239148|FG000|Follow-up Phase|Death|174|||
162873562|NCT00069095|588239149|FG001|Follow-up Phase|Death|206|||
162873563|NCT00069095|588239150|FG002|Follow-up Phase|Death|120|||
162873564|NCT00069095|588239151|FG003|Follow-up Phase|Death|112|||
162873565|NCT00069095|588239152|FG004|Follow-up Phase|Death|92|||
162873566|NCT00069095|588239153|FG005|Follow-up Phase|Death|101|||
162873567|NCT05761444|588239154|FG000|Overall Study|Protocol Violation|2|||
162873568|NCT05761444|588239155|FG001|Overall Study|Protocol Violation|1|||
162873569|NCT05761444|588239154|FG000|Overall Study|Adverse Event|2|||
162873570|NCT05761444|588239155|FG001|Overall Study|Adverse Event|2|||
162873571|NCT05761444|588239154|FG000|Overall Study|Withdrawal by Subject|3|||
162873572|NCT05761444|588239155|FG001|Overall Study|Withdrawal by Subject|2|||
162873573|NCT05761444|588239154|FG000|Overall Study|Other|1|||
162873574|NCT05761444|588239155|FG001|Overall Study|Other|0|||
162615275|NCT01973569|587309331|FG002|Overall Study|Protocol Violation|3|||
162615276|NCT01973569|587309329|FG000|Overall Study|Withdrawal by Subject|7|||
162615277|NCT01973569|587309330|FG001|Overall Study|Withdrawal by Subject|5|||
162615278|NCT01973569|587309331|FG002|Overall Study|Withdrawal by Subject|2|||
162615279|NCT01973569|587309329|FG000|Overall Study|Invasive dental treatment|3|||
162615280|NCT01973569|587309330|FG001|Overall Study|Invasive dental treatment|5|||
162706734|NCT04955626|587636663|FG007|Blinded Period|Medication error|0|||
162873575|NCT05610176|588239156|FG000|Overall Study|Death|6|||
162873576|NCT01842308|588239159|FG000|Overall Study|Withdrawal by Subject|0|||
162873577|NCT01842308|588239160|FG001|Overall Study|Withdrawal by Subject|0|||
162961354|NCT00112437|588560747|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961355|NCT00112437|588560748|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961356|NCT00112437|588560749|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961357|NCT00112437|588560750|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
162961358|NCT00112437|588560751|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961359|NCT00112437|588560752|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162615281|NCT01973569|587309331|FG002|Overall Study|Invasive dental treatment|6|||
162706735|NCT04955626|587636664|FG008|Blinded Period|Medication error|0|||
162961360|NCT00112437|588560753|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961361|NCT00112437|588560754|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162615282|NCT01973569|587309329|FG000|Overall Study|Prohibited concomitant d|1|||
162706736|NCT04955626|587636665|FG009|Blinded Period|Medication error|0|||
162706737|NCT04955626|587636666|FG010|Blinded Period|Medication error|2|||
162873578|NCT01842308|588239161|FG002|Overall Study|Withdrawal by Subject|0|||
162873579|NCT01842308|588239162|FG003|Overall Study|Withdrawal by Subject|0|||
162615283|NCT01973569|587309330|FG001|Overall Study|Prohibited concomitant d|5|||
162615284|NCT01973569|587309331|FG002|Overall Study|Prohibited concomitant d|0|||
162615285|NCT01973569|587309329|FG000|Overall Study|Disease progression|0|||
162615286|NCT01973569|587309330|FG001|Overall Study|Disease progression|3|||
162615287|NCT01973569|587309331|FG002|Overall Study|Disease progression|0|||
162615288|NCT01973569|587309329|FG000|Overall Study|Other|1|||
162615289|NCT01973569|587309330|FG001|Overall Study|Other|1|||
162615290|NCT01973569|587309331|FG002|Overall Study|Other|0|||
162615291|NCT01973569|587309329|FG000|Overall Study|Did not receive study drug|6|||
162615292|NCT01973569|587309330|FG001|Overall Study|Did not receive study drug|3|||
162615293|NCT01973569|587309331|FG002|Overall Study|Did not receive study drug|3|||
162615294|NCT00371826|587309332|FG000|Core Phase (12 Months)|Adverse Event|15|||
162615295|NCT00371826|587309333|FG001|Core Phase (12 Months)|Adverse Event|4|||
162615296|NCT00371826|587309334|FG002|Core Phase (12 Months)|Adverse Event|9|||
162873580|NCT01842308|588239163|FG004|Overall Study|Withdrawal by Subject|1|||
162873581|NCT02868216|588239164|FG000|Overall Study|Death|0|||
162873582|NCT02868216|588239165|FG001|Overall Study|Death|1|||
162873583|NCT02868216|588239164|FG000|Overall Study|coronary artery bypass|1|||
162873584|NCT02868216|588239165|FG001|Overall Study|coronary artery bypass|0|||
162873585|NCT02868216|588239164|FG000|Overall Study|Withdrawal by Subject|7|||
162873586|NCT02868216|588239165|FG001|Overall Study|Withdrawal by Subject|5|||
162873587|NCT03161678|588239166|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
162873588|NCT03161678|588239167|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
162873589|NCT03161678|588239168|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162873590|NCT03161678|588239169|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
162873591|NCT03161678|588239170|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
162873592|NCT03161678|588239171|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162873593|NCT03161678|588239166|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
162873594|NCT03161678|588239167|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
162873595|NCT03161678|588239168|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
162615297|NCT00371826|587309332|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
162615298|NCT00371826|587309333|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
162873596|NCT03161678|588239169|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
162873597|NCT03161678|588239170|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
162873598|NCT03161678|588239171|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
162873599|NCT03161678|588239166|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
162873600|NCT03161678|588239167|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
162873601|NCT03161678|588239168|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
162873602|NCT03161678|588239169|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
162873603|NCT03161678|588239170|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
162873604|NCT03161678|588239171|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
162873605|NCT03161678|588239166|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
162873606|NCT03161678|588239167|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
162873607|NCT03161678|588239168|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
162873608|NCT03161678|588239169|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
162873609|NCT03161678|588239170|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
162873610|NCT03161678|588239171|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
162873611|NCT00752609|588239172|FG000|Overall Study|Adverse Event|2|||
162873612|NCT00752609|588239173|FG001|Overall Study|Adverse Event|2|||
162873613|NCT00752609|588239172|FG000|Overall Study|Withdrawal by Subject|3|||
162873614|NCT00752609|588239173|FG001|Overall Study|Withdrawal by Subject|0|||
162873615|NCT00752609|588239172|FG000|Overall Study|Physician Decision|1|||
162873616|NCT00752609|588239173|FG001|Overall Study|Physician Decision|0|||
162873617|NCT00752609|588239172|FG000|Overall Study|Death|1|||
162873618|NCT00752609|588239173|FG001|Overall Study|Death|0|||
162615299|NCT00371826|587309334|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
162615300|NCT00371826|587309332|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
162615301|NCT00371826|587309333|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
162615302|NCT00371826|587309334|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
162615303|NCT00371826|587309332|FG000|Core Phase (12 Months)|Protocol Violation|1|||
162873619|NCT00752609|588239172|FG000|Overall Study|Met exclusion criteria|1|||
162873620|NCT00752609|588239173|FG001|Overall Study|Met exclusion criteria|0|||
162873621|NCT00752609|588239172|FG000|Overall Study|Received Aranesp in error|1|||
162873622|NCT00752609|588239173|FG001|Overall Study|Received Aranesp in error|0|||
162873623|NCT00938327|588239174|FG000|Overall Study|Adverse Event|2|||
162873624|NCT00938327|588239174|FG000|Overall Study|Protocol Violation|1|||
162873625|NCT00938327|588239174|FG000|Overall Study|Withdrawal by Subject|4|||
162873626|NCT00938327|588239174|FG000|Overall Study|Lost to Follow-up|37|||
162615304|NCT00371826|587309333|FG001|Core Phase (12 Months)|Protocol Violation|0|||
162615305|NCT00371826|587309334|FG002|Core Phase (12 Months)|Protocol Violation|1|||
162615306|NCT00371826|587309332|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
162615307|NCT00371826|587309333|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
162615308|NCT00371826|587309334|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
162873627|NCT00938327|588239174|FG000|Overall Study|2nd dose received outside of the study|7|||
162873628|NCT00938327|588239174|FG000|Overall Study|Vaccine not received as out of stock|9|||
162873629|NCT01425190|588239175|FG000|Overall Study|Full dose not consumed.|1|||
162873630|NCT01425190|588239176|FG001|Overall Study|Full dose not consumed.|0|||
162873631|NCT01425190|588239177|FG002|Overall Study|Full dose not consumed.|0|||
162873632|NCT02552355|588239179|FG000|Overall Study|Adverse Event|0|||
162873633|NCT02552355|588239180|FG001|Overall Study|Adverse Event|2|||
162873634|NCT02552355|588239181|FG002|Overall Study|Adverse Event|2|||
162873635|NCT02552355|588239182|FG003|Overall Study|Adverse Event|0|||
162873636|NCT02552355|588239179|FG000|Overall Study|Withdrawal by Subject|0|||
162873637|NCT02552355|588239180|FG001|Overall Study|Withdrawal by Subject|0|||
162873638|NCT02552355|588239181|FG002|Overall Study|Withdrawal by Subject|0|||
162873639|NCT02552355|588239182|FG003|Overall Study|Withdrawal by Subject|1|||
162873640|NCT00850460|588239185|FG000|Overall Study|Lost to Follow-up|4|||
162873641|NCT00850460|588239186|FG001|Overall Study|Lost to Follow-up|4|||
162873642|NCT02084134|588239191|FG000|Overall Study|Protocol Violation|4|||
162873643|NCT02084134|588239192|FG001|Overall Study|Protocol Violation|2|||
162873644|NCT02084134|588239191|FG000|Overall Study|Death|0|||
162873645|NCT02084134|588239192|FG001|Overall Study|Death|1|||
162873646|NCT04333433|588239193|FG000|Overall Study|Withdrawal by Subject|6|||
162873647|NCT04333433|588239194|FG001|Overall Study|Withdrawal by Subject|3|||
162873648|NCT04333433|588239193|FG000|Overall Study|Death|3|||
162873649|NCT04333433|588239194|FG001|Overall Study|Death|0|||
162873650|NCT04333433|588239193|FG000|Overall Study|Lost to Follow-up|6|||
162873651|NCT04333433|588239194|FG001|Overall Study|Lost to Follow-up|1|||
162873652|NCT04333433|588239193|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
162873653|NCT04333433|588239194|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
162873654|NCT02026271|588239195|FG000|Overall Study|Adverse Event|2|||
162873655|NCT02026271|588239196|FG001|Overall Study|Adverse Event|3|||
162873656|NCT02026271|588239197|FG002|Overall Study|Adverse Event|2|||
162873657|NCT02026271|588239198|FG003|Overall Study|Adverse Event|3|||
162873658|NCT02026271|588239199|FG004|Overall Study|Adverse Event|0|||
162873659|NCT02026271|588239195|FG000|Overall Study|Withdrawal by Subject|0|||
162873660|NCT02026271|588239196|FG001|Overall Study|Withdrawal by Subject|0|||
162873661|NCT02026271|588239197|FG002|Overall Study|Withdrawal by Subject|0|||
162873662|NCT02026271|588239198|FG003|Overall Study|Withdrawal by Subject|0|||
162873663|NCT02026271|588239199|FG004|Overall Study|Withdrawal by Subject|1|||
162873664|NCT02807454|588239200|FG000|Overall Study|Adverse Event|1|||
162873665|NCT02807454|588239201|FG001|Overall Study|Adverse Event|0|||
162873666|NCT02807454|588239200|FG000|Overall Study|Withdrawal by Subject|0|||
162873667|NCT02807454|588239201|FG001|Overall Study|Withdrawal by Subject|1|||
162873668|NCT02807454|588239200|FG000|Overall Study|Progressive Disease|30|||
162873669|NCT02807454|588239201|FG001|Overall Study|Progressive Disease|3|||
162873670|NCT02807454|588239200|FG000|Overall Study|Other Reasons|1|||
162873671|NCT02807454|588239201|FG001|Overall Study|Other Reasons|1|||
162873672|NCT05468086|588239204|FG000|Overall Study|Withdrawal by Subject|3|||
162873673|NCT05468086|588239204|FG000|Overall Study|Subject was found ineligible after consent|1|||
162873674|NCT01108809|588239205|FG000|Overall Study|Adverse Event|3|||
162873675|NCT01108809|588239205|FG000|Overall Study|Lost to Follow-up|1|||
162873676|NCT00001262|588239211|FG000|Overall Study|Death|10|||
162873677|NCT00001262|588239212|FG001|Overall Study|Death|11|||
162873678|NCT00001262|588239213|FG002|Overall Study|Death|0|||
162873679|NCT00001262|588239211|FG000|Overall Study|Withdrawal by Subject|0|||
162873680|NCT00001262|588239212|FG001|Overall Study|Withdrawal by Subject|3|||
162873681|NCT00001262|588239213|FG002|Overall Study|Withdrawal by Subject|0|||
162873682|NCT00783705|588239214|FG000|Overall Study|Adverse Event|2|||
162873683|NCT00783705|588239215|FG001|Overall Study|Adverse Event|0|||
162873684|NCT00783705|588239214|FG000|Overall Study|Withdrawal by Subject|3|||
162873685|NCT00783705|588239215|FG001|Overall Study|Withdrawal by Subject|2|||
162961362|NCT00112437|588560755|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162873686|NCT00783705|588239214|FG000|Overall Study|Lost to Follow-up|1|||
162961363|NCT00112437|588560756|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162978993|NCT03545191|588623546|FG000|Overall Study|Death|1|||
162873687|NCT00783705|588239215|FG001|Overall Study|Lost to Follow-up|3|||
162873688|NCT00748540|588239217|FG000|Overall Study|Physician Decision|1|||
162873689|NCT04743635|588239218|FG000|Overall Study|Lost to Follow-up|2|||
162873690|NCT04743635|588239219|FG001|Overall Study|Lost to Follow-up|0|||
162873691|NCT00804193|588239220|FG000|Overall Study|Lack of baseline fungus|32|||
162873692|NCT00804193|588239221|FG001|Overall Study|Lack of baseline fungus|31|||
162873693|NCT00804193|588239222|FG002|Overall Study|Lack of baseline fungus|19|||
162873694|NCT00804193|588239220|FG000|Overall Study|Adverse Event|0|||
162873695|NCT00804193|588239221|FG001|Overall Study|Adverse Event|0|||
162873696|NCT00804193|588239222|FG002|Overall Study|Adverse Event|2|||
162873697|NCT00804193|588239220|FG000|Overall Study|Lack of Efficacy|1|||
162873698|NCT00804193|588239221|FG001|Overall Study|Lack of Efficacy|1|||
162873699|NCT00804193|588239222|FG002|Overall Study|Lack of Efficacy|3|||
162873700|NCT00804193|588239220|FG000|Overall Study|Protocol Violation|0|||
162615309|NCT00371826|587309332|FG000|Core Phase (12 Months)|Administrative problems|1|||
162873701|NCT00804193|588239221|FG001|Overall Study|Protocol Violation|8|||
162873702|NCT00804193|588239222|FG002|Overall Study|Protocol Violation|2|||
162873703|NCT00804193|588239220|FG000|Overall Study|Lost to Follow-up|3|||
162873704|NCT00804193|588239221|FG001|Overall Study|Lost to Follow-up|3|||
162873705|NCT00804193|588239222|FG002|Overall Study|Lost to Follow-up|4|||
162873706|NCT00804193|588239220|FG000|Overall Study|Withdrawal by Subject|3|||
162873707|NCT00804193|588239221|FG001|Overall Study|Withdrawal by Subject|1|||
162873708|NCT00804193|588239222|FG002|Overall Study|Withdrawal by Subject|2|||
162873709|NCT01193348|588239225|FG000|Screening Period|Screen Failure|5|||
162615310|NCT00371826|587309333|FG001|Core Phase (12 Months)|Administrative problems|0|||
162615311|NCT00371826|587309334|FG002|Core Phase (12 Months)|Administrative problems|8|||
162706738|NCT04955626|587636667|FG011|Blinded Period|Medication error|0|||
162706739|NCT04955626|587636668|FG012|Blinded Period|Medication error|0|||
162706740|NCT04955626|587636669|FG013|Blinded Period|Medication error|0|||
162706741|NCT04955626|587636670|FG014|Blinded Period|Medication error|0|||
162706742|NCT04955626|587636671|FG015|Blinded Period|Medication error|0|||
162706743|NCT04955626|587636672|FG016|Blinded Period|Medication error|0|||
162706744|NCT04955626|587636673|FG017|Blinded Period|Medication error|0|||
162706745|NCT04955626|587636674|FG018|Blinded Period|Medication error|0|||
162706746|NCT04955626|587636675|FG019|Blinded Period|Medication error|0|||
162706747|NCT04955626|587636676|FG020|Blinded Period|Medication error|0|||
162706748|NCT04955626|587636677|FG021|Blinded Period|Medication error|0|||
162706749|NCT04955626|587636678|FG022|Blinded Period|Medication error|0|||
162706750|NCT04955626|587636679|FG023|Blinded Period|Medication error|0|||
162706751|NCT04955626|587636680|FG024|Blinded Period|Medication error|0|||
162615312|NCT00371826|587309332|FG000|Core Phase (12 Months)|Graft Loss|0|||
162615313|NCT00371826|587309333|FG001|Core Phase (12 Months)|Graft Loss|1|||
162615314|NCT00371826|587309334|FG002|Core Phase (12 Months)|Graft Loss|0|||
162615315|NCT00371826|587309332|FG000|Extension Phase (24 Months)|Adverse Event|4|||
162615316|NCT00371826|587309333|FG001|Extension Phase (24 Months)|Adverse Event|5|||
162615317|NCT00371826|587309334|FG002|Extension Phase (24 Months)|Adverse Event|0|||
162615318|NCT00371826|587309332|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
162615319|NCT00371826|587309333|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
162615320|NCT00371826|587309334|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
162615321|NCT00371826|587309332|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
162615322|NCT00371826|587309333|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
162615323|NCT00371826|587309334|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
162615324|NCT00371826|587309332|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
162615325|NCT00371826|587309333|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
162615326|NCT00371826|587309334|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
162615327|NCT00371826|587309332|FG000|Extension Phase (24 Months)|Administrative problems|0|||
162615328|NCT00371826|587309333|FG001|Extension Phase (24 Months)|Administrative problems|0|||
162706752|NCT04955626|587636681|FG025|Blinded Period|Medication error|0|||
162873710|NCT01193348|588239225|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
162706753|NCT04955626|587636682|FG026|Blinded Period|Medication error|0|||
162706754|NCT04955626|587636683|FG027|Blinded Period|Medication error|0|||
162706755|NCT04955626|587636684|FG028|Blinded Period|Medication error|4|||
162706756|NCT04955626|587636685|FG029|Blinded Period|Medication error|0|||
162873711|NCT01193348|588239225|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
162873712|NCT01193348|588239225|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
162706757|NCT04955626|587636686|FG030|Blinded Period|Medication error|0|||
162873713|NCT01193348|588239225|FG000|Extension Treatment Period|Physician Decision|1|||
162615329|NCT00371826|587309334|FG002|Extension Phase (24 Months)|Administrative problems|2|||
162615330|NCT02436304|587309335|FG000|Overall Study|Lost to Follow-up|0|||
162706758|NCT04955626|587636687|FG031|Blinded Period|Medication error|0|||
162706759|NCT04955626|587636688|FG032|Blinded Period|Medication error|0|||
162706760|NCT04955626|587636689|FG033|Blinded Period|Medication error|0|||
162706761|NCT04955626|587636690|FG034|Blinded Period|Medication error|0|||
162706762|NCT04955626|587636691|FG035|Blinded Period|Medication error|0|||
162706763|NCT04955626|587636656|FG000|Open-Label Period|Lost to Follow-up|109|||
162706764|NCT04955626|587636657|FG001|Open-Label Period|Lost to Follow-up|41|||
162706765|NCT04955626|587636658|FG002|Open-Label Period|Lost to Follow-up|0|||
162706766|NCT04955626|587636659|FG003|Open-Label Period|Lost to Follow-up|0|||
162706767|NCT04955626|587636660|FG004|Open-Label Period|Lost to Follow-up|0|||
162706768|NCT04955626|587636661|FG005|Open-Label Period|Lost to Follow-up|0|||
162706769|NCT04955626|587636662|FG006|Open-Label Period|Lost to Follow-up|0|||
162706770|NCT04955626|587636663|FG007|Open-Label Period|Lost to Follow-up|0|||
162706771|NCT04955626|587636664|FG008|Open-Label Period|Lost to Follow-up|0|||
162706772|NCT04955626|587636665|FG009|Open-Label Period|Lost to Follow-up|0|||
162706773|NCT04955626|587636666|FG010|Open-Label Period|Lost to Follow-up|0|||
162706774|NCT04955626|587636667|FG011|Open-Label Period|Lost to Follow-up|0|||
162706775|NCT04955626|587636668|FG012|Open-Label Period|Lost to Follow-up|0|||
162706776|NCT04955626|587636669|FG013|Open-Label Period|Lost to Follow-up|0|||
162706777|NCT04955626|587636670|FG014|Open-Label Period|Lost to Follow-up|0|||
162706778|NCT04955626|587636671|FG015|Open-Label Period|Lost to Follow-up|0|||
162706779|NCT04955626|587636672|FG016|Open-Label Period|Lost to Follow-up|0|||
162706780|NCT04955626|587636673|FG017|Open-Label Period|Lost to Follow-up|0|||
162706781|NCT04955626|587636674|FG018|Open-Label Period|Lost to Follow-up|0|||
162706782|NCT04955626|587636675|FG019|Open-Label Period|Lost to Follow-up|0|||
162706783|NCT04955626|587636676|FG020|Open-Label Period|Lost to Follow-up|0|||
162706784|NCT04955626|587636677|FG021|Open-Label Period|Lost to Follow-up|0|||
162706785|NCT04955626|587636678|FG022|Open-Label Period|Lost to Follow-up|0|||
162706786|NCT04955626|587636679|FG023|Open-Label Period|Lost to Follow-up|0|||
162706787|NCT04955626|587636680|FG024|Open-Label Period|Lost to Follow-up|0|||
162706788|NCT04955626|587636681|FG025|Open-Label Period|Lost to Follow-up|0|||
162706789|NCT04955626|587636682|FG026|Open-Label Period|Lost to Follow-up|0|||
162706790|NCT04955626|587636683|FG027|Open-Label Period|Lost to Follow-up|0|||
162706791|NCT04955626|587636684|FG028|Open-Label Period|Lost to Follow-up|0|||
162706792|NCT04955626|587636685|FG029|Open-Label Period|Lost to Follow-up|0|||
162706793|NCT04955626|587636686|FG030|Open-Label Period|Lost to Follow-up|0|||
162706794|NCT04955626|587636687|FG031|Open-Label Period|Lost to Follow-up|0|||
162706795|NCT04955626|587636688|FG032|Open-Label Period|Lost to Follow-up|0|||
162706796|NCT04955626|587636689|FG033|Open-Label Period|Lost to Follow-up|0|||
162706797|NCT04955626|587636690|FG034|Open-Label Period|Lost to Follow-up|0|||
162706798|NCT04955626|587636691|FG035|Open-Label Period|Lost to Follow-up|0|||
162706799|NCT04955626|587636656|FG000|Open-Label Period|Protocol Violation|377|||
162706800|NCT04955626|587636657|FG001|Open-Label Period|Protocol Violation|48|||
162706801|NCT04955626|587636658|FG002|Open-Label Period|Protocol Violation|0|||
162706802|NCT04955626|587636659|FG003|Open-Label Period|Protocol Violation|0|||
162706803|NCT04955626|587636660|FG004|Open-Label Period|Protocol Violation|0|||
162706804|NCT04955626|587636661|FG005|Open-Label Period|Protocol Violation|0|||
162706805|NCT04955626|587636662|FG006|Open-Label Period|Protocol Violation|0|||
162706806|NCT04955626|587636663|FG007|Open-Label Period|Protocol Violation|0|||
162706807|NCT04955626|587636664|FG008|Open-Label Period|Protocol Violation|0|||
162706808|NCT04955626|587636665|FG009|Open-Label Period|Protocol Violation|0|||
162706809|NCT04955626|587636666|FG010|Open-Label Period|Protocol Violation|0|||
162706810|NCT04955626|587636667|FG011|Open-Label Period|Protocol Violation|0|||
162706811|NCT04955626|587636668|FG012|Open-Label Period|Protocol Violation|0|||
162706812|NCT04955626|587636669|FG013|Open-Label Period|Protocol Violation|0|||
162706813|NCT04955626|587636670|FG014|Open-Label Period|Protocol Violation|0|||
162706814|NCT04955626|587636671|FG015|Open-Label Period|Protocol Violation|0|||
162706815|NCT04955626|587636672|FG016|Open-Label Period|Protocol Violation|0|||
162706816|NCT04955626|587636673|FG017|Open-Label Period|Protocol Violation|0|||
162706817|NCT04955626|587636674|FG018|Open-Label Period|Protocol Violation|0|||
162706818|NCT04955626|587636675|FG019|Open-Label Period|Protocol Violation|0|||
162706819|NCT04955626|587636676|FG020|Open-Label Period|Protocol Violation|0|||
162706820|NCT04955626|587636677|FG021|Open-Label Period|Protocol Violation|0|||
162706821|NCT04955626|587636678|FG022|Open-Label Period|Protocol Violation|0|||
162706822|NCT04955626|587636679|FG023|Open-Label Period|Protocol Violation|0|||
162706823|NCT04955626|587636680|FG024|Open-Label Period|Protocol Violation|0|||
162706824|NCT04955626|587636681|FG025|Open-Label Period|Protocol Violation|0|||
162706825|NCT04955626|587636682|FG026|Open-Label Period|Protocol Violation|0|||
162706826|NCT04955626|587636683|FG027|Open-Label Period|Protocol Violation|0|||
162706827|NCT04955626|587636684|FG028|Open-Label Period|Protocol Violation|0|||
162706828|NCT04955626|587636685|FG029|Open-Label Period|Protocol Violation|0|||
162706829|NCT04955626|587636686|FG030|Open-Label Period|Protocol Violation|0|||
162706830|NCT04955626|587636687|FG031|Open-Label Period|Protocol Violation|0|||
162706831|NCT04955626|587636688|FG032|Open-Label Period|Protocol Violation|0|||
162706832|NCT04955626|587636689|FG033|Open-Label Period|Protocol Violation|0|||
162706833|NCT04955626|587636690|FG034|Open-Label Period|Protocol Violation|0|||
162615331|NCT02436304|587309336|FG001|Overall Study|Lost to Follow-up|1|||
162615332|NCT02436304|587309337|FG002|Overall Study|Lost to Follow-up|0|||
162615333|NCT02436304|587309335|FG000|Overall Study|Withdrawal by Subject|0|||
162615334|NCT02436304|587309336|FG001|Overall Study|Withdrawal by Subject|1|||
162615335|NCT02436304|587309337|FG002|Overall Study|Withdrawal by Subject|0|||
162615336|NCT02436304|587309335|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
162615337|NCT02436304|587309336|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
162615338|NCT02436304|587309337|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
162615339|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Death|1|||
162615340|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Death|1|||
162615341|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Death|0|||
162615342|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Death|0|||
162615343|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
162615344|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162615345|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162615346|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162615347|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
162615348|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
162615349|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
162615350|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
162615351|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
162615352|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
162615353|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
162615354|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
162615355|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
162615356|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
162615357|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
162615358|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
162615359|NCT04612790|587309343|FG000|DB Period (Up to 36 Weeks)|Other|1|||
162615360|NCT04612790|587309344|FG001|DB Period (Up to 36 Weeks)|Other|0|||
162615361|NCT04612790|587309345|FG002|DB Period (Up to 36 Weeks)|Other|0|||
162615362|NCT04612790|587309346|FG003|DB Period (Up to 36 Weeks)|Other|0|||
162615363|NCT04612790|587309343|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162615364|NCT04612790|587309344|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162615365|NCT04612790|587309345|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162615366|NCT04612790|587309346|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
162615367|NCT04612790|587309343|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
162615368|NCT04612790|587309344|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
162615369|NCT04612790|587309345|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
162615370|NCT04612790|587309346|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
162615371|NCT04612790|587309343|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
162615372|NCT04612790|587309344|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
162615373|NCT04612790|587309345|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
162615374|NCT04612790|587309346|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
162615375|NCT04612790|587309343|FG000|OLE Period (Up to 1 Year)|Other|0|||
162615376|NCT04612790|587309344|FG001|OLE Period (Up to 1 Year)|Other|0|||
162615377|NCT04612790|587309345|FG002|OLE Period (Up to 1 Year)|Other|0|||
162615378|NCT04612790|587309346|FG003|OLE Period (Up to 1 Year)|Other|1|||
162615379|NCT00785928|587309347|FG000|Treatment Phase|Adverse Event|1|||
162615380|NCT00785928|587309348|FG001|Treatment Phase|Adverse Event|1|||
162615381|NCT00785928|587309349|FG002|Treatment Phase|Adverse Event|2|||
162615382|NCT00785928|587309350|FG003|Treatment Phase|Adverse Event|0|||
162615383|NCT00785928|587309351|FG004|Treatment Phase|Adverse Event|0|||
162615384|NCT00785928|587309352|FG005|Treatment Phase|Adverse Event|0|||
162615385|NCT00785928|587309353|FG006|Treatment Phase|Adverse Event|2|||
162615386|NCT00785928|587309347|FG000|Treatment Phase|Inadequate Response|0|||
162615387|NCT00785928|587309348|FG001|Treatment Phase|Inadequate Response|1|||
162615388|NCT00785928|587309349|FG002|Treatment Phase|Inadequate Response|0|||
162615389|NCT00785928|587309350|FG003|Treatment Phase|Inadequate Response|0|||
162615390|NCT00785928|587309351|FG004|Treatment Phase|Inadequate Response|0|||
162615391|NCT00785928|587309352|FG005|Treatment Phase|Inadequate Response|0|||
162615392|NCT00785928|587309353|FG006|Treatment Phase|Inadequate Response|0|||
162615393|NCT00785928|587309347|FG000|Treatment Phase|Lack of Efficacy|0|||
162615394|NCT00785928|587309348|FG001|Treatment Phase|Lack of Efficacy|1|||
162615395|NCT00785928|587309349|FG002|Treatment Phase|Lack of Efficacy|1|||
162615396|NCT00785928|587309350|FG003|Treatment Phase|Lack of Efficacy|0|||
162615397|NCT00785928|587309351|FG004|Treatment Phase|Lack of Efficacy|0|||
162615398|NCT00785928|587309352|FG005|Treatment Phase|Lack of Efficacy|0|||
162615399|NCT00785928|587309353|FG006|Treatment Phase|Lack of Efficacy|0|||
162615400|NCT00785928|587309347|FG000|Treatment Phase|Physician Decision|0|||
162615401|NCT00785928|587309348|FG001|Treatment Phase|Physician Decision|0|||
162706834|NCT04955626|587636691|FG035|Open-Label Period|Protocol Violation|0|||
162615402|NCT00785928|587309349|FG002|Treatment Phase|Physician Decision|0|||
162706835|NCT04955626|587636656|FG000|Open-Label Period|Death|5|||
162706836|NCT04955626|587636657|FG001|Open-Label Period|Death|5|||
162615403|NCT00785928|587309350|FG003|Treatment Phase|Physician Decision|0|||
162615404|NCT00785928|587309351|FG004|Treatment Phase|Physician Decision|1|||
162615405|NCT00785928|587309352|FG005|Treatment Phase|Physician Decision|0|||
162615406|NCT00785928|587309353|FG006|Treatment Phase|Physician Decision|0|||
162615407|NCT00785928|587309347|FG000|Treatment Phase|Sponsor Decision|1|||
162615408|NCT00785928|587309348|FG001|Treatment Phase|Sponsor Decision|0|||
162615409|NCT00785928|587309349|FG002|Treatment Phase|Sponsor Decision|0|||
162615410|NCT00785928|587309350|FG003|Treatment Phase|Sponsor Decision|0|||
162615411|NCT00785928|587309351|FG004|Treatment Phase|Sponsor Decision|0|||
162615412|NCT00785928|587309352|FG005|Treatment Phase|Sponsor Decision|0|||
162615413|NCT00785928|587309353|FG006|Treatment Phase|Sponsor Decision|1|||
162615414|NCT00785928|587309347|FG000|Treatment Phase|Withdrawal by Subject|1|||
162615415|NCT00785928|587309348|FG001|Treatment Phase|Withdrawal by Subject|2|||
162615416|NCT00785928|587309349|FG002|Treatment Phase|Withdrawal by Subject|0|||
162615417|NCT00785928|587309350|FG003|Treatment Phase|Withdrawal by Subject|0|||
162615418|NCT00785928|587309351|FG004|Treatment Phase|Withdrawal by Subject|1|||
162615419|NCT00785928|587309352|FG005|Treatment Phase|Withdrawal by Subject|0|||
162615420|NCT00785928|587309353|FG006|Treatment Phase|Withdrawal by Subject|0|||
162615421|NCT02923427|587309360|FG000|Overall Study|convert to laparatomy|2|||
162615422|NCT02923427|587309361|FG001|Overall Study|convert to laparatomy|2|||
162615423|NCT02923427|587309360|FG000|Overall Study|destaturation|1|||
162615424|NCT02923427|587309361|FG001|Overall Study|destaturation|0|||
162615425|NCT02923427|587309360|FG000|Overall Study|can not replace LMA|1|||
162615426|NCT02923427|587309361|FG001|Overall Study|can not replace LMA|0|||
162615427|NCT01539642|587309366|FG000|Overall Study|Lack of Efficacy|20|||
162615428|NCT01539642|587309367|FG001|Overall Study|Lack of Efficacy|18|||
162615429|NCT01539642|587309366|FG000|Overall Study|Patient ready for early discharge|8|||
162615430|NCT01539642|587309367|FG001|Overall Study|Patient ready for early discharge|7|||
162615431|NCT01539642|587309366|FG000|Overall Study|Adverse Event|6|||
162615432|NCT01539642|587309367|FG001|Overall Study|Adverse Event|4|||
162615433|NCT01539642|587309366|FG000|Overall Study|Withdrawal by Subject|2|||
162615434|NCT01539642|587309367|FG001|Overall Study|Withdrawal by Subject|2|||
162615435|NCT03611010|587309368|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
162615436|NCT03611010|587309369|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162615437|NCT03611010|587309370|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162615438|NCT03611010|587309371|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162615439|NCT05021081|587309375|FG000|Phase 2|Subject enrolled in error|1|||
162615440|NCT05021081|587309376|FG001|Phase 2|Subject enrolled in error|1|||
162615441|NCT05021081|587309377|FG002|Phase 2|Subject enrolled in error|0|||
162615442|NCT03257371|587309384|FG000|Overall Study|Lost to Follow-up|1|||
162615443|NCT03387683|587309385|FG000|Overall Study|In receipt of disallowed medication|1|||
162615444|NCT03387683|587309386|FG001|Overall Study|In receipt of disallowed medication|0|||
162615445|NCT03387683|587309385|FG000|Overall Study|Did not receive treatment|1|||
162615446|NCT03387683|587309386|FG001|Overall Study|Did not receive treatment|0|||
162615447|NCT00566501|587309389|FG000|Overall Study|Adverse Event|68|||
162615448|NCT00566501|587309390|FG001|Overall Study|Adverse Event|59|||
162615449|NCT00566501|587309389|FG000|Overall Study|Medication Non-compliance|5|||
162615450|NCT00566501|587309390|FG001|Overall Study|Medication Non-compliance|0|||
162615451|NCT00566501|587309389|FG000|Overall Study|Protocol Violation|2|||
162615452|NCT00566501|587309390|FG001|Overall Study|Protocol Violation|2|||
162615453|NCT00566501|587309389|FG000|Overall Study|Request of Investigator or Sponsor|6|||
162615454|NCT00566501|587309390|FG001|Overall Study|Request of Investigator or Sponsor|7|||
162615455|NCT00566501|587309389|FG000|Overall Study|Withdrawal by Subject|33|||
162615456|NCT00566501|587309390|FG001|Overall Study|Withdrawal by Subject|30|||
162615457|NCT00566501|587309389|FG000|Overall Study|Lack of Efficacy|8|||
162615458|NCT00566501|587309390|FG001|Overall Study|Lack of Efficacy|3|||
162615459|NCT00566501|587309389|FG000|Overall Study|Other|25|||
162615460|NCT00566501|587309390|FG001|Overall Study|Other|21|||
162615461|NCT00057876|587309391|FG000|Overall Study|Adverse Event|8|||
162615462|NCT00057876|587309392|FG001|Overall Study|Adverse Event|8|||
162615463|NCT00057876|587309391|FG000|Overall Study|Death|2|||
162978994|NCT03545191|588623547|FG001|Overall Study|Death|0|||
162615464|NCT00057876|587309392|FG001|Overall Study|Death|1|||
162615465|NCT00057876|587309391|FG000|Overall Study|Withdrawal by Subject|5|||
162615466|NCT00057876|587309392|FG001|Overall Study|Withdrawal by Subject|6|||
162615467|NCT00057876|587309391|FG000|Overall Study|Lack of Efficacy|10|||
162615468|NCT00057876|587309392|FG001|Overall Study|Lack of Efficacy|8|||
162615469|NCT00057876|587309391|FG000|Overall Study|Ineligible|1|||
162615470|NCT00057876|587309392|FG001|Overall Study|Ineligible|2|||
162706837|NCT04955626|587636658|FG002|Open-Label Period|Death|0|||
162615471|NCT00057876|587309391|FG000|Overall Study|other reason|2|||
162615472|NCT00057876|587309392|FG001|Overall Study|other reason|2|||
162615473|NCT00057876|587309391|FG000|Overall Study|other complicating disease|1|||
162615474|NCT00057876|587309392|FG001|Overall Study|other complicating disease|0|||
162615475|NCT05095454|587309393|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
162706838|NCT04955626|587636659|FG003|Open-Label Period|Death|0|||
162706839|NCT04955626|587636660|FG004|Open-Label Period|Death|0|||
162978995|NCT03545191|588623548|FG002|Overall Study|Death|0|||
162615476|NCT05095454|587309394|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
162873714|NCT01193348|588239225|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
162873715|NCT00968253|588239226|FG000|Overall Study|Death|0|||
162873716|NCT00968253|588239227|FG001|Overall Study|Death|0|||
162873717|NCT00968253|588239228|FG002|Overall Study|Death|2|||
162873718|NCT00968253|588239226|FG000|Overall Study|Withdrawal by Subject|0|||
162873719|NCT00968253|588239227|FG001|Overall Study|Withdrawal by Subject|0|||
162873720|NCT00968253|588239228|FG002|Overall Study|Withdrawal by Subject|1|||
162873721|NCT00968253|588239226|FG000|Overall Study|Disease Progression|0|||
162873722|NCT00968253|588239227|FG001|Overall Study|Disease Progression|3|||
162873723|NCT00968253|588239228|FG002|Overall Study|Disease Progression|3|||
162873724|NCT00968253|588239226|FG000|Overall Study|Adverse Event|0|||
162873725|NCT00968253|588239227|FG001|Overall Study|Adverse Event|0|||
162873726|NCT00968253|588239228|FG002|Overall Study|Adverse Event|1|||
162873727|NCT03860844|588239230|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
162873728|NCT03860844|588239231|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
162873729|NCT03860844|588239232|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
162873730|NCT03860844|588239230|FG000|Overall Study|Progressive disease|5|||
162873731|NCT03860844|588239231|FG001|Overall Study|Progressive disease|3|||
162873732|NCT03860844|588239232|FG002|Overall Study|Progressive disease|4|||
162873733|NCT03860844|588239230|FG000|Overall Study|Other, Not related to COVID-19|0|||
162873734|NCT03860844|588239231|FG001|Overall Study|Other, Not related to COVID-19|1|||
162873735|NCT03860844|588239232|FG002|Overall Study|Other, Not related to COVID-19|0|||
162873736|NCT04038255|588241037|FG000|Overall Study|Lost to Follow-up|0|||
162873737|NCT04038255|588241038|FG001|Overall Study|Lost to Follow-up|9|||
162873738|NCT04038255|588241039|FG002|Overall Study|Lost to Follow-up|5|||
162873739|NCT04038255|588241037|FG000|Overall Study|Withdrawal by Subject|0|||
162873740|NCT04038255|588241038|FG001|Overall Study|Withdrawal by Subject|0|||
162873741|NCT04038255|588241039|FG002|Overall Study|Withdrawal by Subject|1|||
162873742|NCT05183867|588241040|FG000|Overall Study|Withdrawal by Subject|3|||
162873743|NCT05183867|588241041|FG001|Overall Study|Withdrawal by Subject|2|||
162873744|NCT05183867|588241042|FG002|Overall Study|Withdrawal by Subject|0|||
162873745|NCT05306873|588241045|FG000|Stage 2|Study stopped|1|||
162873746|NCT05306873|588241046|FG001|Stage 2|Study stopped|1|||
162873747|NCT05306873|588241047|FG002|Stage 2|Study stopped|0|||
162873748|NCT05306873|588241048|FG003|Stage 2|Study stopped|0|||
162873749|NCT05306873|588241045|FG000|Stage 2|Stage 2 Treatment Failure|2|||
162873750|NCT05306873|588241046|FG001|Stage 2|Stage 2 Treatment Failure|3|||
162873751|NCT05306873|588241047|FG002|Stage 2|Stage 2 Treatment Failure|0|||
162873752|NCT05306873|588241048|FG003|Stage 2|Stage 2 Treatment Failure|0|||
162615477|NCT01368432|587309395|FG000|Overall Study|Lost to Follow-up|0|||
162615478|NCT01368432|587309396|FG001|Overall Study|Lost to Follow-up|1|||
162615479|NCT00853073|587309397|FG000|Overall Study|Withdrawal by Subject|3|||
162615480|NCT00853073|587309398|FG001|Overall Study|Withdrawal by Subject|2|||
162615481|NCT02758171|587309399|FG000|Wash-out|Withdrawal by Subject|1|||
162615482|NCT02758171|587309400|FG001|Wash-out|Withdrawal by Subject|0|||
162615483|NCT02758171|587309399|FG000|Wash-out|Other reason|1|||
162615484|NCT02758171|587309400|FG001|Wash-out|Other reason|0|||
162615485|NCT01999114|587309401|FG000|Overall Study|Adverse Event|8|||
162615486|NCT01999114|587309402|FG001|Overall Study|Adverse Event|7|||
162615487|NCT01999114|587309403|FG002|Overall Study|Adverse Event|2|||
162615488|NCT01999114|587309404|FG003|Overall Study|Adverse Event|2|||
162615489|NCT01999114|587309405|FG004|Overall Study|Adverse Event|1|||
162615490|NCT01999114|587309401|FG000|Overall Study|Withdrawal by Subject|0|||
162615491|NCT01999114|587309402|FG001|Overall Study|Withdrawal by Subject|0|||
162615492|NCT01999114|587309403|FG002|Overall Study|Withdrawal by Subject|1|||
162615493|NCT01999114|587309404|FG003|Overall Study|Withdrawal by Subject|0|||
162615494|NCT01999114|587309405|FG004|Overall Study|Withdrawal by Subject|1|||
162615495|NCT01999114|587309401|FG000|Overall Study|Lost to Follow-up|0|||
162615496|NCT01999114|587309402|FG001|Overall Study|Lost to Follow-up|0|||
162615497|NCT01999114|587309403|FG002|Overall Study|Lost to Follow-up|1|||
162615498|NCT01999114|587309404|FG003|Overall Study|Lost to Follow-up|0|||
162615499|NCT01999114|587309405|FG004|Overall Study|Lost to Follow-up|0|||
162873753|NCT05306873|588241045|FG000|Stage 2|Logistical issues due to participant moving|1|||
162615500|NCT01999114|587309401|FG000|Overall Study|Administrative|0|||
162873754|NCT05306873|588241046|FG001|Stage 2|Logistical issues due to participant moving|0|||
162873755|NCT05306873|588241047|FG002|Stage 2|Logistical issues due to participant moving|0|||
162873756|NCT05306873|588241048|FG003|Stage 2|Logistical issues due to participant moving|0|||
162873757|NCT05306873|588241045|FG000|Stage 3|Stage 3 Treatment Failure|0|||
162615501|NCT01999114|587309402|FG001|Overall Study|Administrative|0|||
162615502|NCT01999114|587309403|FG002|Overall Study|Administrative|1|||
162873758|NCT05306873|588241046|FG001|Stage 3|Stage 3 Treatment Failure|0|||
162873759|NCT05306873|588241047|FG002|Stage 3|Stage 3 Treatment Failure|0|||
162873760|NCT05306873|588241048|FG003|Stage 3|Stage 3 Treatment Failure|1|||
162873761|NCT05306873|588241045|FG000|Stage 3|Study Stopped|0|||
162873762|NCT05306873|588241046|FG001|Stage 3|Study Stopped|0|||
162615503|NCT01999114|587309404|FG003|Overall Study|Administrative|1|||
162615504|NCT01999114|587309405|FG004|Overall Study|Administrative|2|||
162615505|NCT03840174|587309406|FG000|Overall Study|Withdrawal by Subject|1|||
162615506|NCT03840174|587309407|FG001|Overall Study|Withdrawal by Subject|0|||
162615507|NCT03840174|587309408|FG002|Overall Study|Withdrawal by Subject|0|||
162615508|NCT03840174|587309409|FG003|Overall Study|Withdrawal by Subject|0|||
162615509|NCT01008150|587309411|FG000|Overall Study|did not receive study drug|1|||
162615510|NCT01008150|587309412|FG001|Overall Study|did not receive study drug|1|||
162615511|NCT01008150|587309413|FG002|Overall Study|did not receive study drug|1|||
162615512|NCT01008150|587309414|FG003|Overall Study|did not receive study drug|0|||
162615513|NCT01497275|587309415|FG000|Overall Study|Death|1|||
162615514|NCT01497275|587309415|FG000|Overall Study|Adverse Event|1|||
162615515|NCT00381381|587309427|FG000|Overall Study|Adverse Event|3|||
162615516|NCT00381381|587309427|FG000|Overall Study|Lost to Follow-up|52|||
162615517|NCT00381381|587309427|FG000|Overall Study|Withdrawal by Subject|9|||
162615518|NCT00568685|587309428|FG000|Overall Study|Adverse Event|2|||
162615519|NCT00568685|587309429|FG001|Overall Study|Adverse Event|3|||
162615520|NCT00568685|587309430|FG002|Overall Study|Adverse Event|3|||
162615521|NCT00568685|587309428|FG000|Overall Study|Withdrawal by Subject|7|||
162615522|NCT00568685|587309429|FG001|Overall Study|Withdrawal by Subject|2|||
162615523|NCT00568685|587309430|FG002|Overall Study|Withdrawal by Subject|2|||
162615524|NCT00568685|587309428|FG000|Overall Study|Protocol Violation|1|||
162615525|NCT00568685|587309429|FG001|Overall Study|Protocol Violation|0|||
162615526|NCT00568685|587309430|FG002|Overall Study|Protocol Violation|0|||
162615527|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Adverse Event|10|||
162615528|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Adverse Event|0|||
162615529|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
162615530|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
162615531|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
162615532|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
162615533|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
162706840|NCT04955626|587636661|FG005|Open-Label Period|Death|0|||
162873763|NCT05306873|588241047|FG002|Stage 3|Study Stopped|1|||
162873764|NCT05306873|588241048|FG003|Stage 3|Study Stopped|0|||
162873765|NCT02614287|588241049|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
162873766|NCT02614287|588241050|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
162873767|NCT02614287|588241049|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
162873768|NCT02614287|588241050|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
162873769|NCT02614287|588241049|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
162873770|NCT02614287|588241050|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
162873771|NCT02614287|588241049|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
162873772|NCT02614287|588241050|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
162873773|NCT02614287|588241049|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
162873774|NCT02614287|588241050|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
162873775|NCT02614287|588241049|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
162873776|NCT02614287|588241050|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
162873777|NCT02614287|588241049|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
162873778|NCT02614287|588241050|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
162873779|NCT02614287|588241049|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
162873780|NCT02614287|588241050|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
162615534|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
162615535|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
162615536|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
162615537|NCT02787551|587309431|FG000|Core Period: 26 Weeks|Other than specified|3|||
162615538|NCT02787551|587309432|FG001|Core Period: 26 Weeks|Other than specified|1|||
162615539|NCT02787551|587309431|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
162615540|NCT02787551|587309432|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
162615541|NCT02787551|587309431|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
162615542|NCT02787551|587309432|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
162615543|NCT02787551|587309431|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
162615544|NCT02787551|587309432|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
162615545|NCT03799211|587309433|FG000|Overall Study|Lost to Follow-up|2|||
162615546|NCT03799211|587309434|FG001|Overall Study|Lost to Follow-up|13|||
162615547|NCT03799211|587309433|FG000|Overall Study|Withdrawal by Subject|2|||
162615548|NCT03799211|587309434|FG001|Overall Study|Withdrawal by Subject|0|||
162615549|NCT00764491|587309435|FG000|Overall Study|Lost to Follow-up|35|||
162615550|NCT00764491|587309436|FG001|Overall Study|Lost to Follow-up|17|||
162615551|NCT03139279|587309439|FG000|Overall Study|Physician Decision|2|||
162615552|NCT03139279|587309440|FG001|Overall Study|Physician Decision|0|||
162873781|NCT00418834|588241051|FG000|Overall Study|Adverse Event|16|||
162615553|NCT03139279|587309439|FG000|Overall Study|Protocol Violation|5|||
162615554|NCT03139279|587309440|FG001|Overall Study|Protocol Violation|4|||
162615555|NCT03139279|587309439|FG000|Overall Study|Withdrawal by Subject|0|||
162615556|NCT03139279|587309440|FG001|Overall Study|Withdrawal by Subject|2|||
162706841|NCT04955626|587636662|FG006|Open-Label Period|Death|0|||
162873782|NCT00418834|588241052|FG001|Overall Study|Adverse Event|9|||
162873783|NCT00418834|588241051|FG000|Overall Study|Lost to Follow-up|0|||
162873784|NCT00418834|588241052|FG001|Overall Study|Lost to Follow-up|1|||
162873785|NCT00418834|588241051|FG000|Overall Study|Protocol Violation|4|||
162873786|NCT00418834|588241052|FG001|Overall Study|Protocol Violation|3|||
162873787|NCT00418834|588241051|FG000|Overall Study|Withdrawal by Subject|3|||
162873788|NCT00418834|588241052|FG001|Overall Study|Withdrawal by Subject|7|||
162873789|NCT01953328|588241053|FG000|Overall Study|Withdrawal by Subject|0|||
162873790|NCT01953328|588241054|FG001|Overall Study|Withdrawal by Subject|0|||
162873791|NCT01953328|588241055|FG002|Overall Study|Withdrawal by Subject|0|||
162873792|NCT01953328|588241056|FG003|Overall Study|Withdrawal by Subject|0|||
162873793|NCT01953328|588241057|FG004|Overall Study|Withdrawal by Subject|1|||
162873794|NCT01953328|588241058|FG005|Overall Study|Withdrawal by Subject|0|||
162873795|NCT01953328|588241059|FG006|Overall Study|Withdrawal by Subject|0|||
162873796|NCT01953328|588241060|FG007|Overall Study|Withdrawal by Subject|0|||
162873797|NCT01953328|588241053|FG000|Overall Study|Lost to Follow-up|0|||
162873798|NCT01953328|588241054|FG001|Overall Study|Lost to Follow-up|0|||
162873799|NCT01953328|588241055|FG002|Overall Study|Lost to Follow-up|0|||
162873800|NCT01953328|588241056|FG003|Overall Study|Lost to Follow-up|0|||
162873801|NCT01953328|588241057|FG004|Overall Study|Lost to Follow-up|1|||
162873802|NCT01953328|588241058|FG005|Overall Study|Lost to Follow-up|0|||
162873803|NCT01953328|588241059|FG006|Overall Study|Lost to Follow-up|0|||
162873804|NCT01953328|588241060|FG007|Overall Study|Lost to Follow-up|0|||
162873805|NCT01755195|588241063|FG000|Overall Study|Participant noncompliance|2|||
162873806|NCT01755195|588241063|FG000|Overall Study|Switched to alternative treatment|4|||
162873807|NCT01755195|588241063|FG000|Overall Study|Withdrawal by Subject|1|||
162873808|NCT01755195|588241063|FG000|Overall Study|Participant refused to start treatment|1|||
162873809|NCT01755195|588241063|FG000|Overall Study|Participant has been consented for another trial|1|||
162873810|NCT01755195|588241063|FG000|Overall Study|Refused further treatment|3|||
162873811|NCT01755195|588241063|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
162873812|NCT05113953|588241064|FG000|Overall Study|Adverse Event|5|||
162873813|NCT05113953|588241065|FG001|Overall Study|Adverse Event|0|||
162873814|NCT05113953|588241066|FG002|Overall Study|Adverse Event|3|||
162873815|NCT05113953|588241064|FG000|Overall Study|Lost to Follow-up|3|||
162873816|NCT05113953|588241065|FG001|Overall Study|Lost to Follow-up|4|||
162873817|NCT05113953|588241066|FG002|Overall Study|Lost to Follow-up|2|||
162873818|NCT05113953|588241064|FG000|Overall Study|Non-compliance with Study Drug|1|||
162873819|NCT05113953|588241065|FG001|Overall Study|Non-compliance with Study Drug|0|||
162873820|NCT05113953|588241066|FG002|Overall Study|Non-compliance with Study Drug|0|||
162873821|NCT05113953|588241064|FG000|Overall Study|Withdrawal by Subject|2|||
162873822|NCT05113953|588241065|FG001|Overall Study|Withdrawal by Subject|6|||
162873823|NCT05113953|588241066|FG002|Overall Study|Withdrawal by Subject|4|||
162873824|NCT05113953|588241064|FG000|Overall Study|Reason not Specified|2|||
162873825|NCT05113953|588241065|FG001|Overall Study|Reason not Specified|0|||
162873826|NCT05113953|588241066|FG002|Overall Study|Reason not Specified|0|||
162873827|NCT00492856|588241068|FG000|Induction|Adverse Event|2|||
162873828|NCT00492856|588241069|FG001|Induction|Adverse Event|0|||
162873829|NCT00492856|588241070|FG002|Induction|Adverse Event|0|||
162873830|NCT00492856|588241071|FG003|Induction|Adverse Event|0|||
162873831|NCT00492856|588241068|FG000|Induction|Withdrawal by Subject|1|||
162873832|NCT00492856|588241069|FG001|Induction|Withdrawal by Subject|0|||
162873833|NCT00492856|588241070|FG002|Induction|Withdrawal by Subject|0|||
162873834|NCT00492856|588241071|FG003|Induction|Withdrawal by Subject|0|||
162873835|NCT00492856|588241068|FG000|Induction|Death|3|||
162873836|NCT00492856|588241069|FG001|Induction|Death|0|||
162873837|NCT00492856|588241070|FG002|Induction|Death|0|||
162873838|NCT00492856|588241071|FG003|Induction|Death|0|||
162873839|NCT00492856|588241068|FG000|Consolidation|Adverse Event|6|||
162873840|NCT00492856|588241069|FG001|Consolidation|Adverse Event|0|||
162873841|NCT00492856|588241070|FG002|Consolidation|Adverse Event|0|||
162873842|NCT00492856|588241071|FG003|Consolidation|Adverse Event|0|||
162873843|NCT00492856|588241068|FG000|Consolidation|Not protocol specified|2|||
162873844|NCT00492856|588241069|FG001|Consolidation|Not protocol specified|0|||
162873845|NCT00492856|588241070|FG002|Consolidation|Not protocol specified|0|||
162873846|NCT00492856|588241071|FG003|Consolidation|Not protocol specified|0|||
162873847|NCT00492856|588241068|FG000|Consolidation|Lost to Follow-up|1|||
162873848|NCT00492856|588241069|FG001|Consolidation|Lost to Follow-up|0|||
162873849|NCT00492856|588241070|FG002|Consolidation|Lost to Follow-up|0|||
162873850|NCT00492856|588241071|FG003|Consolidation|Lost to Follow-up|0|||
162873851|NCT00492856|588241068|FG000|Post-consolidation|Adverse Event|0|||
162873852|NCT00492856|588241069|FG001|Post-consolidation|Adverse Event|4|||
162873853|NCT00492856|588241070|FG002|Post-consolidation|Adverse Event|0|||
162873854|NCT00492856|588241071|FG003|Post-consolidation|Adverse Event|1|||
162873855|NCT00492856|588241068|FG000|Post-consolidation|Withdrawal by Subject|0|||
162873856|NCT00492856|588241069|FG001|Post-consolidation|Withdrawal by Subject|4|||
162873857|NCT00492856|588241070|FG002|Post-consolidation|Withdrawal by Subject|0|||
162873858|NCT00492856|588241071|FG003|Post-consolidation|Withdrawal by Subject|0|||
162873859|NCT00492856|588241068|FG000|Post-consolidation|Death|0|||
162873860|NCT00492856|588241069|FG001|Post-consolidation|Death|1|||
162873861|NCT00492856|588241070|FG002|Post-consolidation|Death|0|||
162873862|NCT00492856|588241071|FG003|Post-consolidation|Death|0|||
162873863|NCT00492856|588241068|FG000|Post-consolidation|Not protocol specified|0|||
162873864|NCT00492856|588241069|FG001|Post-consolidation|Not protocol specified|1|||
162873865|NCT00492856|588241070|FG002|Post-consolidation|Not protocol specified|0|||
162873866|NCT00492856|588241071|FG003|Post-consolidation|Not protocol specified|0|||
162873867|NCT00492856|588241068|FG000|Post-consolidation|Lost to Follow-up|0|||
162873868|NCT00492856|588241069|FG001|Post-consolidation|Lost to Follow-up|2|||
162873869|NCT00492856|588241070|FG002|Post-consolidation|Lost to Follow-up|0|||
162873870|NCT00492856|588241071|FG003|Post-consolidation|Lost to Follow-up|0|||
162873871|NCT00492856|588241068|FG000|Post-consolidation|Observation Arm|0|||
162873872|NCT00492856|588241069|FG001|Post-consolidation|Observation Arm|0|||
162873873|NCT00492856|588241070|FG002|Post-consolidation|Observation Arm|27|||
162873874|NCT00492856|588241071|FG003|Post-consolidation|Observation Arm|0|||
162873875|NCT03987919|588241072|FG000|Overall Study|Adverse Event|1|||
162873876|NCT03987919|588241073|FG001|Overall Study|Adverse Event|4|||
162873877|NCT03987919|588241074|FG002|Overall Study|Adverse Event|1|||
162873878|NCT03987919|588241075|FG003|Overall Study|Adverse Event|3|||
162873879|NCT03987919|588241072|FG000|Overall Study|Death|4|||
162873880|NCT03987919|588241073|FG001|Overall Study|Death|4|||
162873881|NCT03987919|588241074|FG002|Overall Study|Death|4|||
162873882|NCT03987919|588241075|FG003|Overall Study|Death|1|||
162873883|NCT03987919|588241072|FG000|Overall Study|Lost to Follow-up|5|||
162873884|NCT03987919|588241073|FG001|Overall Study|Lost to Follow-up|6|||
162873885|NCT03987919|588241074|FG002|Overall Study|Lost to Follow-up|8|||
162873886|NCT03987919|588241075|FG003|Overall Study|Lost to Follow-up|12|||
162873887|NCT03987919|588241072|FG000|Overall Study|Physician Decision|0|||
162961364|NCT00112437|588560757|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961365|NCT00112437|588560758|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961366|NCT00112437|588560759|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961367|NCT00112437|588560760|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961368|NCT00112437|588560761|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961369|NCT00112437|588560762|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961370|NCT00112437|588560763|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961371|NCT00112437|588560764|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961372|NCT00112437|588560765|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961373|NCT00112437|588560766|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961374|NCT00112437|588560767|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961375|NCT00112437|588560768|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961376|NCT00112437|588560769|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961377|NCT00112437|588560770|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961378|NCT00112437|588560771|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162961379|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
162961380|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
162961381|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
162961382|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
162961383|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
162961384|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
162961385|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
162615557|NCT02027376|587309443|FG000|Overall Study|Death|1|||
162615558|NCT02027376|587309444|FG001|Overall Study|Death|0|||
162615559|NCT02027376|587309445|FG002|Overall Study|Death|0|||
162615560|NCT01565642|587309446|FG000|Overall Study|Withdrawal by Subject|2|||
162615561|NCT01565642|587309447|FG001|Overall Study|Withdrawal by Subject|1|||
162873888|NCT03987919|588241073|FG001|Overall Study|Physician Decision|2|||
162873889|NCT03987919|588241074|FG002|Overall Study|Physician Decision|0|||
162873890|NCT03987919|588241075|FG003|Overall Study|Physician Decision|4|||
162873891|NCT03987919|588241072|FG000|Overall Study|Pregnancy|1|||
162873892|NCT03987919|588241073|FG001|Overall Study|Pregnancy|0|||
162873893|NCT03987919|588241074|FG002|Overall Study|Pregnancy|1|||
162873894|NCT03987919|588241075|FG003|Overall Study|Pregnancy|1|||
162873895|NCT03987919|588241072|FG000|Overall Study|Protocol Violation|0|||
162873896|NCT03987919|588241073|FG001|Overall Study|Protocol Violation|1|||
162873897|NCT03987919|588241074|FG002|Overall Study|Protocol Violation|0|||
162615562|NCT01528033|587309451|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
162873898|NCT03987919|588241075|FG003|Overall Study|Protocol Violation|0|||
162873899|NCT03987919|588241072|FG000|Overall Study|Site terminated by Sponsor|0|||
163047732|NCT00490971|588881266|FG002|Acute/Continuation|Death|0|||
163047733|NCT00490971|588881267|FG003|Acute/Continuation|Death|0|||
163047734|NCT00490971|588881268|FG004|Acute/Continuation|Death|0|||
162706842|NCT04955626|587636663|FG007|Open-Label Period|Death|0|||
162706843|NCT04955626|587636664|FG008|Open-Label Period|Death|0|||
162706844|NCT04955626|587636665|FG009|Open-Label Period|Death|0|||
162873900|NCT03987919|588241073|FG001|Overall Study|Site terminated by Sponsor|0|||
162873901|NCT03987919|588241074|FG002|Overall Study|Site terminated by Sponsor|0|||
162873902|NCT03987919|588241075|FG003|Overall Study|Site terminated by Sponsor|1|||
162873903|NCT03987919|588241072|FG000|Overall Study|Withdrawal by Subject|7|||
162873904|NCT03987919|588241073|FG001|Overall Study|Withdrawal by Subject|7|||
162873905|NCT03987919|588241074|FG002|Overall Study|Withdrawal by Subject|8|||
162873906|NCT03987919|588241075|FG003|Overall Study|Withdrawal by Subject|4|||
162873907|NCT03987919|588241072|FG000|Overall Study|Other - as reported by the investigator|1|||
162873908|NCT03987919|588241073|FG001|Overall Study|Other - as reported by the investigator|3|||
162873909|NCT03987919|588241074|FG002|Overall Study|Other - as reported by the investigator|2|||
162873910|NCT03987919|588241075|FG003|Overall Study|Other - as reported by the investigator|0|||
162873911|NCT03470922|588241081|FG000|Overall Study|Death|107|||
162873912|NCT03470922|588241082|FG001|Overall Study|Death|118|||
162873913|NCT03470922|588241081|FG000|Overall Study|Lost to Follow-up|5|||
162873914|NCT03470922|588241082|FG001|Overall Study|Lost to Follow-up|5|||
162873915|NCT03470922|588241081|FG000|Overall Study|Participant Withdrew Consent|4|||
162873916|NCT03470922|588241082|FG001|Overall Study|Participant Withdrew Consent|9|||
162873917|NCT03470922|588241081|FG000|Overall Study|Other reasons|1|||
162873918|NCT03470922|588241082|FG001|Overall Study|Other reasons|0|||
162873919|NCT03470922|588241081|FG000|Overall Study|Not reported|1|||
162873920|NCT03470922|588241082|FG001|Overall Study|Not reported|0|||
162873921|NCT02626819|588241083|FG000|Overall Study|Lost to Follow-up|3|||
162873922|NCT02626819|588241084|FG001|Overall Study|Lost to Follow-up|2|||
162873923|NCT02626819|588241083|FG000|Overall Study|Withdrawal by Subject|1|||
162873924|NCT02626819|588241084|FG001|Overall Study|Withdrawal by Subject|0|||
162873925|NCT02626819|588241083|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
162873926|NCT02626819|588241084|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
162873927|NCT02340819|588241085|FG000|Overall Study|Adverse Event|1|||
162873928|NCT02340819|588241085|FG000|Overall Study|Withdrawal by Subject|2|||
162873929|NCT02340819|588241085|FG000|Overall Study|Discontinued with other reason|1|||
162873930|NCT02361762|588241086|FG000|Overall Study|Withdrawal by Subject|0|||
162873931|NCT02361762|588241087|FG001|Overall Study|Withdrawal by Subject|1|||
162873932|NCT02361762|588241086|FG000|Overall Study|Lost to Follow-up|0|||
162873933|NCT02361762|588241087|FG001|Overall Study|Lost to Follow-up|1|||
162873934|NCT01328249|588241088|FG000|Overall Study|Adverse Event|3|||
162873935|NCT01328249|588241089|FG001|Overall Study|Adverse Event|0|||
162873936|NCT01328249|588241088|FG000|Overall Study|Disease progression|1|||
162873937|NCT01328249|588241089|FG001|Overall Study|Disease progression|0|||
162873938|NCT01328249|588241088|FG000|Overall Study|Withdrawal by Subject|1|||
162706845|NCT04955626|587636666|FG010|Open-Label Period|Death|0|||
162706846|NCT04955626|587636667|FG011|Open-Label Period|Death|0|||
162706847|NCT04955626|587636668|FG012|Open-Label Period|Death|0|||
162873939|NCT01328249|588241089|FG001|Overall Study|Withdrawal by Subject|1|||
162873940|NCT01328249|588241088|FG000|Overall Study|Moved before end of treatment visit|1|||
162873941|NCT01328249|588241089|FG001|Overall Study|Moved before end of treatment visit|0|||
162873942|NCT01328249|588241088|FG000|Overall Study|Subject choice|1|||
162873943|NCT01328249|588241089|FG001|Overall Study|Subject choice|1|||
162873944|NCT01328249|588241088|FG000|Overall Study|Protocol Violation|0|||
162873945|NCT01328249|588241089|FG001|Overall Study|Protocol Violation|1|||
162706848|NCT04955626|587636669|FG013|Open-Label Period|Death|0|||
162706849|NCT04955626|587636670|FG014|Open-Label Period|Death|0|||
162706850|NCT04955626|587636671|FG015|Open-Label Period|Death|0|||
162873946|NCT00502307|588241090|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
162873947|NCT00502307|588241091|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
162873948|NCT00502307|588241092|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
162873949|NCT00502307|588241090|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
162873950|NCT00502307|588241091|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
162873951|NCT00502307|588241092|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
162873952|NCT00502307|588241090|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
162873953|NCT00502307|588241091|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
162873954|NCT00502307|588241092|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
162873955|NCT00502307|588241090|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
162873956|NCT00502307|588241091|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
162873957|NCT00502307|588241092|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
162873958|NCT00502307|588241090|FG000|Maintenance Period|Progressive disease|80|||
162873959|NCT00502307|588241091|FG001|Maintenance Period|Progressive disease|0|||
162873960|NCT00502307|588241092|FG002|Maintenance Period|Progressive disease|0|||
162873961|NCT00502307|588241090|FG000|Maintenance Period|Discontinued due to other reasons|68|||
162873962|NCT00502307|588241091|FG001|Maintenance Period|Discontinued due to other reasons|0|||
162873963|NCT00502307|588241092|FG002|Maintenance Period|Discontinued due to other reasons|0|||
162873964|NCT02330549|588241093|FG000|Overall Study|Adverse Event|1|||
162873965|NCT02330549|588241094|FG001|Overall Study|Adverse Event|0|||
162873966|NCT02330549|588241093|FG000|Overall Study|Subject withdrew consent|2|||
162873967|NCT02330549|588241094|FG001|Overall Study|Subject withdrew consent|1|||
162873968|NCT02330549|588241093|FG000|Overall Study|Failure to meet randomization criteria|1|||
162873969|NCT02330549|588241094|FG001|Overall Study|Failure to meet randomization criteria|0|||
162873970|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
162873971|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
162873972|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
162873973|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
162873974|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
162873975|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
162873976|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
162873977|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
162873978|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
162873979|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
162873980|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
162873981|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
162873982|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
162873983|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
162873984|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
162873985|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
162873986|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
162873987|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
162873988|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
162873989|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
162873990|NCT00423085|588241095|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
162873991|NCT00423085|588241096|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
162873992|NCT00423085|588241097|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
162873993|NCT00423085|588241098|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
162873994|NCT00423085|588241095|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
162873995|NCT00423085|588241096|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
162873996|NCT00423085|588241097|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
162873997|NCT00423085|588241098|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
162873998|NCT00423085|588241095|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
162873999|NCT00423085|588241096|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
162615563|NCT01528033|587309452|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
162874000|NCT00423085|588241097|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
162874001|NCT00423085|588241098|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
162874002|NCT00423085|588241095|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
162874003|NCT00423085|588241096|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
162874004|NCT00423085|588241097|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
162874005|NCT00423085|588241098|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
162874006|NCT00423085|588241095|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
162874007|NCT00423085|588241096|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
162874008|NCT00423085|588241097|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
162874009|NCT00423085|588241098|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
162874010|NCT00423085|588241095|FG000|52-Week Open-Label Extension Phase|Death|0|||
162874011|NCT00423085|588241096|FG001|52-Week Open-Label Extension Phase|Death|0|||
162874012|NCT00423085|588241097|FG002|52-Week Open-Label Extension Phase|Death|0|||
162874013|NCT00423085|588241098|FG003|52-Week Open-Label Extension Phase|Death|2|||
162874014|NCT03331666|588241099|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
162615564|NCT01528033|587309451|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
162874015|NCT03331666|588241100|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
162874016|NCT00434512|588241101|FG000|Overall Study|Migrated/moved from study area|0|||
162874017|NCT00434512|588241102|FG001|Overall Study|Migrated/moved from study area|0|||
162874018|NCT00434512|588241103|FG002|Overall Study|Migrated/moved from study area|0|||
162874019|NCT00434512|588241104|FG003|Overall Study|Migrated/moved from study area|1|||
162874020|NCT00434512|588241105|FG004|Overall Study|Migrated/moved from study area|1|||
162874021|NCT00434512|588241106|FG005|Overall Study|Migrated/moved from study area|1|||
162874022|NCT00434512|588241101|FG000|Overall Study|Other|0|||
162874023|NCT00434512|588241102|FG001|Overall Study|Other|1|||
162874024|NCT00434512|588241103|FG002|Overall Study|Other|0|||
162874025|NCT00434512|588241104|FG003|Overall Study|Other|0|||
162874026|NCT00434512|588241105|FG004|Overall Study|Other|0|||
162874027|NCT00434512|588241106|FG005|Overall Study|Other|0|||
162874028|NCT02750813|588241109|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
162874029|NCT02750813|588241110|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
162874030|NCT02750813|588241109|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
162615565|NCT01528033|587309452|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
162615566|NCT01528033|587309451|FG000|Primary Endpoint Assessment ITT|Death|2|||
162615567|NCT01528033|587309452|FG001|Primary Endpoint Assessment ITT|Death|2|||
162615568|NCT01528033|587309451|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
162874031|NCT02750813|588241110|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
162874032|NCT02245568|588241111|FG000|Overall Study|Study terminated by Sponsor|346|||
162874033|NCT02245568|588241111|FG000|Overall Study|Adverse Event|144|||
162874034|NCT02245568|588241111|FG000|Overall Study|Lack of Efficacy|98|||
162874035|NCT02245568|588241111|FG000|Overall Study|Withdrawal by Caregiver|85|||
162874036|NCT02245568|588241111|FG000|Overall Study|Withdrawal by Subject|77|||
162874037|NCT02245568|588241111|FG000|Overall Study|Withdrawal by Legal Representative|31|||
162874038|NCT02245568|588241111|FG000|Overall Study|Missing (Site closure)|16|||
162874039|NCT02245568|588241111|FG000|Overall Study|Physician Decision|14|||
162874040|NCT02245568|588241111|FG000|Overall Study|Non-compliance with study drug|11|||
162874041|NCT02245568|588241111|FG000|Overall Study|Death|9|||
162874042|NCT02245568|588241111|FG000|Overall Study|Blue staining|6|||
162874043|NCT02245568|588241111|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
162874044|NCT02245568|588241111|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
162874045|NCT02245568|588241111|FG000|Overall Study|Lost to Follow-up|5|||
162874046|NCT00441441|588241112|FG000|Overall Study|Adverse Event|2|||
162874047|NCT00441441|588241113|FG001|Overall Study|Adverse Event|1|||
162874048|NCT00441441|588241112|FG000|Overall Study|Protocol Violation|4|||
162874049|NCT00441441|588241113|FG001|Overall Study|Protocol Violation|6|||
162874050|NCT00441441|588241112|FG000|Overall Study|Exacerbation of asthma|1|||
162874051|NCT00441441|588241113|FG001|Overall Study|Exacerbation of asthma|2|||
162874052|NCT00441441|588241112|FG000|Overall Study|Withdrawal by Subject|1|||
162874053|NCT00441441|588241113|FG001|Overall Study|Withdrawal by Subject|2|||
162874054|NCT00441441|588241112|FG000|Overall Study|Other|3|||
162874055|NCT00441441|588241113|FG001|Overall Study|Other|3|||
162874056|NCT00769704|588241120|FG000|Overall Study|Lost to Follow-up|3|||
162874057|NCT00769704|588241121|FG001|Overall Study|Lost to Follow-up|2|||
162874058|NCT00769704|588241120|FG000|Overall Study|Death|95|||
162874059|NCT00769704|588241121|FG001|Overall Study|Death|190|||
162874060|NCT00769704|588241120|FG000|Overall Study|Withdrawal by Subject|12|||
162874061|NCT00769704|588241121|FG001|Overall Study|Withdrawal by Subject|5|||
162874062|NCT00769704|588241120|FG000|Overall Study|Other|1|||
162874063|NCT00769704|588241121|FG001|Overall Study|Other|2|||
162961386|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
162961387|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
162961388|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
162961389|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
162961390|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
162961391|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
162961392|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
162961393|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
162874064|NCT00520676|588241122|FG000|Overall Study|Death|84|||
162874065|NCT00520676|588241123|FG001|Overall Study|Death|81|||
162874066|NCT00520676|588241122|FG000|Overall Study|Lost to Follow-up|6|||
162874067|NCT00520676|588241123|FG001|Overall Study|Lost to Follow-up|10|||
162961394|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
162961395|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
162961396|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
162961397|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
162961398|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
162961399|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
162874068|NCT00520676|588241122|FG000|Overall Study|Physician Decision|4|||
162874069|NCT00520676|588241123|FG001|Overall Study|Physician Decision|1|||
162874070|NCT00520676|588241122|FG000|Overall Study|Withdrawal by Subject|7|||
162874071|NCT00520676|588241123|FG001|Overall Study|Withdrawal by Subject|11|||
162615569|NCT01528033|587309452|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
162874072|NCT01533935|588241125|FG000|Overall Study|Adverse Event|5|||
162874073|NCT01533935|588241126|FG001|Overall Study|Adverse Event|7|||
162874074|NCT01533935|588241127|FG002|Overall Study|Adverse Event|1|||
162874075|NCT01533935|588241128|FG003|Overall Study|Adverse Event|5|||
162874076|NCT01533935|588241129|FG004|Overall Study|Adverse Event|3|||
162874077|NCT01533935|588241125|FG000|Overall Study|Protocol Violation|0|||
162874078|NCT01533935|588241126|FG001|Overall Study|Protocol Violation|2|||
162874079|NCT01533935|588241127|FG002|Overall Study|Protocol Violation|0|||
162874080|NCT01533935|588241128|FG003|Overall Study|Protocol Violation|0|||
162874081|NCT01533935|588241129|FG004|Overall Study|Protocol Violation|0|||
162874082|NCT01533935|588241125|FG000|Overall Study|Lost to Follow-up|0|||
162874083|NCT01533935|588241126|FG001|Overall Study|Lost to Follow-up|0|||
162874084|NCT01533935|588241127|FG002|Overall Study|Lost to Follow-up|1|||
162874085|NCT01533935|588241128|FG003|Overall Study|Lost to Follow-up|0|||
162874086|NCT01533935|588241129|FG004|Overall Study|Lost to Follow-up|0|||
162874087|NCT01533935|588241125|FG000|Overall Study|Withdrawal by Subject|0|||
162706851|NCT04955626|587636672|FG016|Open-Label Period|Death|0|||
162706852|NCT04955626|587636673|FG017|Open-Label Period|Death|0|||
162706853|NCT04955626|587636674|FG018|Open-Label Period|Death|0|||
162874088|NCT01533935|588241126|FG001|Overall Study|Withdrawal by Subject|4|||
162874089|NCT01533935|588241127|FG002|Overall Study|Withdrawal by Subject|5|||
162874090|NCT01533935|588241128|FG003|Overall Study|Withdrawal by Subject|2|||
162874091|NCT01533935|588241129|FG004|Overall Study|Withdrawal by Subject|4|||
162874092|NCT01533935|588241125|FG000|Overall Study|Other reason not defined above|1|||
162874093|NCT01533935|588241126|FG001|Overall Study|Other reason not defined above|0|||
162874094|NCT01533935|588241127|FG002|Overall Study|Other reason not defined above|1|||
162874095|NCT01533935|588241128|FG003|Overall Study|Other reason not defined above|0|||
162874096|NCT01533935|588241129|FG004|Overall Study|Other reason not defined above|1|||
162874097|NCT01727713|588241133|FG000|Overall Study|Lost to Follow-up|5|||
162874098|NCT01727713|588241133|FG000|Overall Study|Adverse Event|10|||
162874099|NCT01727713|588241133|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
162874100|NCT01727713|588241133|FG000|Overall Study|Withdrawal by Subject|13|||
162874101|NCT01727713|588241133|FG000|Overall Study|Protocol Deviation|2|||
162874102|NCT02389816|588241134|FG000|Overall Study|Randomized but Not Treated|1|||
162874103|NCT02389816|588241135|FG001|Overall Study|Randomized but Not Treated|0|||
162874104|NCT02389816|588241136|FG002|Overall Study|Randomized but Not Treated|0|||
162874105|NCT02389816|588241134|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
162874106|NCT02389816|588241135|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
162874107|NCT02389816|588241136|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
162874108|NCT02389816|588241134|FG000|Overall Study|Major Protocol Deviation|1|||
162874109|NCT02389816|588241135|FG001|Overall Study|Major Protocol Deviation|0|||
162874110|NCT02389816|588241136|FG002|Overall Study|Major Protocol Deviation|0|||
162874111|NCT02389816|588241134|FG000|Overall Study|Lost to Follow-up|1|||
162874112|NCT02389816|588241135|FG001|Overall Study|Lost to Follow-up|0|||
162874113|NCT02389816|588241136|FG002|Overall Study|Lost to Follow-up|0|||
162874114|NCT02389816|588241134|FG000|Overall Study|Withdrawal of Consent|6|||
162874115|NCT02389816|588241135|FG001|Overall Study|Withdrawal of Consent|4|||
162874116|NCT02389816|588241136|FG002|Overall Study|Withdrawal of Consent|4|||
162874117|NCT02389816|588241134|FG000|Overall Study|Lack of Efficacy|1|||
162874118|NCT02389816|588241135|FG001|Overall Study|Lack of Efficacy|0|||
162874119|NCT02389816|588241136|FG002|Overall Study|Lack of Efficacy|0|||
162874120|NCT02389816|588241134|FG000|Overall Study|Non Compliance with Study Drug|1|||
162874121|NCT02389816|588241135|FG001|Overall Study|Non Compliance with Study Drug|1|||
162874122|NCT02389816|588241136|FG002|Overall Study|Non Compliance with Study Drug|1|||
162874123|NCT02389816|588241134|FG000|Overall Study|Reason not Specified|0|||
162874124|NCT02389816|588241135|FG001|Overall Study|Reason not Specified|2|||
162874125|NCT02389816|588241136|FG002|Overall Study|Reason not Specified|0|||
162874126|NCT01217190|588241143|FG000|Second Dosing|Withdrawal by Subject|0|||
162874127|NCT01217190|588241144|FG001|Second Dosing|Withdrawal by Subject|2|||
162874128|NCT01594476|588241145|FG000|Overall Study|Protocol Violation|1|||
162874129|NCT01594476|588241146|FG001|Overall Study|Protocol Violation|3|||
162874130|NCT05114590|588241147|FG000|Overall Study|Adverse Event|1|||
162874131|NCT05114590|588241147|FG000|Overall Study|Investigator decision|1|||
162874132|NCT05114590|588241147|FG000|Overall Study|Lost to Follow-up|5|||
162874133|NCT05114590|588241147|FG000|Overall Study|Withdrawal by Subject|5|||
162874134|NCT05114590|588241147|FG000|Overall Study|Other|2|||
162874135|NCT03007953|588241148|FG000|Overall Study|Withdrawal by Subject|5|||
162874136|NCT03007953|588241149|FG001|Overall Study|Withdrawal by Subject|2|||
162874137|NCT03007953|588241148|FG000|Overall Study|Death|5|||
162874138|NCT03007953|588241149|FG001|Overall Study|Death|7|||
162874139|NCT03007953|588241148|FG000|Overall Study|Lost to Follow-up|3|||
162874140|NCT03007953|588241149|FG001|Overall Study|Lost to Follow-up|2|||
162874141|NCT03007953|588241148|FG000|Overall Study|Enrolled in Hospice|3|||
162874142|NCT03007953|588241149|FG001|Overall Study|Enrolled in Hospice|2|||
162874143|NCT02224846|588241150|FG000|Period 1 (Month 3)|Adverse Event|2|||
162874144|NCT02224846|588241151|FG001|Period 1 (Month 3)|Adverse Event|1|||
162874145|NCT02224846|588241150|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
162978996|NCT03545191|588623546|FG000|Overall Study|Adverse Event|4|||
162961400|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
162961401|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
162961402|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
162961403|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
163047735|NCT00490971|588881264|FG000|Acute/Continuation|Lack of Efficacy|106|||
163047736|NCT00490971|588881265|FG001|Acute/Continuation|Lack of Efficacy|12|||
163047737|NCT00490971|588881266|FG002|Acute/Continuation|Lack of Efficacy|0|||
163047738|NCT00490971|588881267|FG003|Acute/Continuation|Lack of Efficacy|0|||
163047739|NCT00490971|588881268|FG004|Acute/Continuation|Lack of Efficacy|0|||
163047740|NCT00490971|588881264|FG000|Acute/Continuation|Lost to Follow-up|23|||
163047741|NCT00490971|588881265|FG001|Acute/Continuation|Lost to Follow-up|7|||
163047742|NCT00490971|588881266|FG002|Acute/Continuation|Lost to Follow-up|0|||
163047743|NCT00490971|588881267|FG003|Acute/Continuation|Lost to Follow-up|0|||
162961404|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
162961405|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
163047744|NCT00490971|588881268|FG004|Acute/Continuation|Lost to Follow-up|0|||
163047745|NCT00490971|588881264|FG000|Acute/Continuation|Protocol Violation|10|||
163047746|NCT00490971|588881265|FG001|Acute/Continuation|Protocol Violation|2|||
163047747|NCT00490971|588881266|FG002|Acute/Continuation|Protocol Violation|0|||
163047748|NCT00490971|588881267|FG003|Acute/Continuation|Protocol Violation|0|||
163047749|NCT00490971|588881268|FG004|Acute/Continuation|Protocol Violation|0|||
163047750|NCT00490971|588881264|FG000|Acute/Continuation|Withdrawal by Subject|92|||
163047751|NCT00490971|588881265|FG001|Acute/Continuation|Withdrawal by Subject|24|||
163047752|NCT00490971|588881266|FG002|Acute/Continuation|Withdrawal by Subject|0|||
163047753|NCT00490971|588881267|FG003|Acute/Continuation|Withdrawal by Subject|0|||
162961406|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961407|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961408|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961409|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961410|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
162961411|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
162961412|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961413|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961414|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
162961415|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961416|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961417|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961418|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961419|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961420|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961421|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961422|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961423|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961424|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961425|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162706854|NCT04955626|587636675|FG019|Open-Label Period|Death|0|||
162961426|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961427|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961428|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961429|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961430|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162961431|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961432|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961433|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961434|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961435|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961436|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961437|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
163047754|NCT00490971|588881268|FG004|Acute/Continuation|Withdrawal by Subject|0|||
163047755|NCT00490971|588881264|FG000|Acute/Continuation|Other|11|||
163047756|NCT00490971|588881265|FG001|Acute/Continuation|Other|4|||
163047757|NCT00490971|588881266|FG002|Acute/Continuation|Other|0|||
163047758|NCT00490971|588881267|FG003|Acute/Continuation|Other|0|||
163047759|NCT00490971|588881268|FG004|Acute/Continuation|Other|0|||
163047760|NCT00490971|588881264|FG000|Maintenance|Adverse Event|0|||
163047761|NCT00490971|588881265|FG001|Maintenance|Adverse Event|0|||
163047762|NCT00490971|588881266|FG002|Maintenance|Adverse Event|4|||
163047763|NCT00490971|588881267|FG003|Maintenance|Adverse Event|5|||
163047764|NCT00490971|588881268|FG004|Maintenance|Adverse Event|7|||
163047765|NCT00490971|588881264|FG000|Maintenance|Death|0|||
163047766|NCT00490971|588881265|FG001|Maintenance|Death|0|||
163047767|NCT00490971|588881266|FG002|Maintenance|Death|0|||
163047768|NCT00490971|588881267|FG003|Maintenance|Death|2|||
163047769|NCT00490971|588881268|FG004|Maintenance|Death|0|||
163047770|NCT00490971|588881264|FG000|Maintenance|Lost to Follow-up|0|||
163047771|NCT00490971|588881265|FG001|Maintenance|Lost to Follow-up|0|||
163047772|NCT00490971|588881266|FG002|Maintenance|Lost to Follow-up|5|||
163047773|NCT00490971|588881267|FG003|Maintenance|Lost to Follow-up|8|||
163047774|NCT00490971|588881268|FG004|Maintenance|Lost to Follow-up|10|||
163047775|NCT00490971|588881264|FG000|Maintenance|Pregnancy|0|||
163047776|NCT00490971|588881265|FG001|Maintenance|Pregnancy|0|||
163047777|NCT00490971|588881266|FG002|Maintenance|Pregnancy|1|||
163047778|NCT00490971|588881267|FG003|Maintenance|Pregnancy|0|||
163047779|NCT00490971|588881268|FG004|Maintenance|Pregnancy|0|||
163047780|NCT00490971|588881264|FG000|Maintenance|Protocol Violation|0|||
163047781|NCT00490971|588881265|FG001|Maintenance|Protocol Violation|0|||
163047782|NCT00490971|588881266|FG002|Maintenance|Protocol Violation|4|||
163047783|NCT00490971|588881267|FG003|Maintenance|Protocol Violation|1|||
163047784|NCT00490971|588881268|FG004|Maintenance|Protocol Violation|1|||
163047785|NCT00490971|588881264|FG000|Maintenance|Withdrawal by Subject|0|||
163047786|NCT00490971|588881265|FG001|Maintenance|Withdrawal by Subject|0|||
163047787|NCT00490971|588881266|FG002|Maintenance|Withdrawal by Subject|26|||
163047788|NCT00490971|588881267|FG003|Maintenance|Withdrawal by Subject|28|||
163047789|NCT00490971|588881268|FG004|Maintenance|Withdrawal by Subject|18|||
163047790|NCT00490971|588881264|FG000|Maintenance|Other|0|||
163047791|NCT00490971|588881265|FG001|Maintenance|Other|0|||
163047792|NCT00490971|588881266|FG002|Maintenance|Other|11|||
163047793|NCT00490971|588881267|FG003|Maintenance|Other|9|||
163047794|NCT00490971|588881268|FG004|Maintenance|Other|3|||
163047795|NCT03999749|588881270|FG000|Overall Study|Toxicity|16|||
163047796|NCT03999749|588881270|FG000|Overall Study|Withdrawal by Subject|3|||
163047797|NCT03999749|588881270|FG000|Overall Study|Disease progression|26|||
163047798|NCT03999749|588881270|FG000|Overall Study|Physician Decision|4|||
163047799|NCT03999749|588881270|FG000|Overall Study|Death|5|||
163047800|NCT03999749|588881270|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
163047801|NCT00255164|588881271|FG000|Overall Study|Adverse Event|10|||
163047802|NCT00255164|588881272|FG001|Overall Study|Adverse Event|6|||
163047803|NCT00255164|588881273|FG002|Overall Study|Adverse Event|9|||
163047804|NCT00255164|588881271|FG000|Overall Study|Lost to Follow-up|4|||
163047805|NCT00255164|588881272|FG001|Overall Study|Lost to Follow-up|3|||
163047806|NCT00255164|588881273|FG002|Overall Study|Lost to Follow-up|4|||
163047807|NCT00255164|588881271|FG000|Overall Study|Withdrawal by Subject|18|||
163047808|NCT00255164|588881272|FG001|Overall Study|Withdrawal by Subject|17|||
163047809|NCT00255164|588881273|FG002|Overall Study|Withdrawal by Subject|8|||
163047810|NCT00255164|588881271|FG000|Overall Study|Noncompliance|0|||
163047811|NCT00255164|588881272|FG001|Overall Study|Noncompliance|1|||
163047812|NCT00255164|588881273|FG002|Overall Study|Noncompliance|2|||
163047813|NCT00255164|588881271|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
163047814|NCT00255164|588881272|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
163047815|NCT00255164|588881273|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
163047816|NCT00255164|588881271|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
163047817|NCT00255164|588881272|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
163047818|NCT00255164|588881273|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
163047819|NCT00255164|588881271|FG000|Overall Study|Possible Barrett's Esophagus|1|||
163047820|NCT00255164|588881272|FG001|Overall Study|Possible Barrett's Esophagus|3|||
163047821|NCT00255164|588881273|FG002|Overall Study|Possible Barrett's Esophagus|8|||
163047822|NCT00255164|588881271|FG000|Overall Study|Esophageal Stricture|0|||
163047823|NCT00255164|588881272|FG001|Overall Study|Esophageal Stricture|0|||
163047824|NCT00255164|588881273|FG002|Overall Study|Esophageal Stricture|1|||
163047825|NCT00255164|588881271|FG000|Overall Study|Therapeutic Failure|11|||
163047826|NCT00255164|588881272|FG001|Overall Study|Therapeutic Failure|2|||
163047827|NCT00255164|588881273|FG002|Overall Study|Therapeutic Failure|3|||
163047828|NCT00419757|588882608|FG000|Overall Study|Adverse Event|1|||
163047829|NCT00419757|588882609|FG001|Overall Study|Adverse Event|4|||
162874146|NCT02224846|588241151|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
162874147|NCT02224846|588241150|FG000|Period 1 (Month 3)|Protocol Violation|4|||
162874148|NCT02224846|588241151|FG001|Period 1 (Month 3)|Protocol Violation|8|||
162874149|NCT02224846|588241150|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
162874150|NCT02224846|588241151|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
162874151|NCT02224846|588241150|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
162874152|NCT02224846|588241151|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
162874153|NCT02224846|588241150|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
162874154|NCT02224846|588241151|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
162874155|NCT02224846|588241150|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
162874156|NCT02224846|588241151|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
162874157|NCT02224846|588241150|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
162874158|NCT02224846|588241151|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
162874159|NCT02224846|588241150|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
162874160|NCT02224846|588241151|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
162874161|NCT02224846|588241150|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
162874162|NCT02224846|588241151|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
162874163|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
162874164|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
162874165|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
162874166|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
162874167|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
162874168|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
162874169|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
162874170|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
162874171|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
162874172|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
162874173|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
162874174|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
162874175|NCT02224846|588241150|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
162874176|NCT02224846|588241151|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
162874177|NCT03196297|588241152|FG000|Main Period|Withdrawal by Subject|4|||
162874178|NCT03196297|588241152|FG000|Extension Period|Withdrawal by Subject|1|||
162874179|NCT03196297|588241152|FG000|Extension Period|Lack of Efficacy|2|||
162874180|NCT00872170|588241156|FG000|Overall Study|Adverse Event|1|||
162874181|NCT00872170|588241157|FG001|Overall Study|Adverse Event|0|||
162874182|NCT01402284|588241158|FG000|Overall Study|Withdrawal consent|2|||
162874183|NCT01402284|588241158|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
162874184|NCT01402284|588241158|FG000|Overall Study|Physician Decision|1|||
162874185|NCT01402284|588241158|FG000|Overall Study|Disease progression on study|10|||
162874186|NCT01745393|588241160|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
162874187|NCT01745393|588241161|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
162874188|NCT01745393|588241160|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
162874189|NCT01745393|588241161|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
162874190|NCT01745393|588241160|FG000|12-month Follow-up|Lost to Follow-up|6|||
162874191|NCT01745393|588241161|FG001|12-month Follow-up|Lost to Follow-up|5|||
162874192|NCT00905021|588241166|FG000|Overall Study|Adverse Event|2|||
162874193|NCT00786838|588241167|FG000|Overall Study|Physician Decision|4|||
162874194|NCT00786838|588241167|FG000|Overall Study|Death|4|||
162874195|NCT00786838|588241167|FG000|Overall Study|Adverse Event|6|||
162874196|NCT00786838|588241167|FG000|Overall Study|Progressive disease|31|||
162874197|NCT00786838|588241167|FG000|Overall Study|Withdrawal by Subject|4|||
162874198|NCT04937816|588241168|FG000|Overall Study|Study drug stopped, reason missing|5|||
162874199|NCT04937816|588241169|FG001|Overall Study|Study drug stopped, reason missing|3|||
162874200|NCT04937816|588241170|FG002|Overall Study|Study drug stopped, reason missing|4|||
162874201|NCT04937816|588241171|FG003|Overall Study|Study drug stopped, reason missing|6|||
162874202|NCT04937816|588241172|FG004|Overall Study|Study drug stopped, reason missing|1|||
162874203|NCT04937816|588241173|FG005|Overall Study|Study drug stopped, reason missing|0|||
162874204|NCT04937816|588241174|FG006|Overall Study|Study drug stopped, reason missing|0|||
162874205|NCT04937816|588241168|FG000|Overall Study|Other than stated below|173|||
162874206|NCT04937816|588241169|FG001|Overall Study|Other than stated below|143|||
162874207|NCT04937816|588241170|FG002|Overall Study|Other than stated below|125|||
162874208|NCT04937816|588241171|FG003|Overall Study|Other than stated below|44|||
162874209|NCT04937816|588241172|FG004|Overall Study|Other than stated below|45|||
162874210|NCT04937816|588241173|FG005|Overall Study|Other than stated below|28|||
162874211|NCT04937816|588241174|FG006|Overall Study|Other than stated below|31|||
162874212|NCT04937816|588241168|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
162874213|NCT04937816|588241169|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
162874214|NCT04937816|588241170|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
162874215|NCT04937816|588241171|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
162874216|NCT04937816|588241172|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
162874217|NCT04937816|588241173|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
162874218|NCT04937816|588241174|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
162874219|NCT04937816|588241168|FG000|Overall Study|Lost to Follow-up|15|||
162874220|NCT04937816|588241169|FG001|Overall Study|Lost to Follow-up|9|||
162874221|NCT04937816|588241170|FG002|Overall Study|Lost to Follow-up|6|||
162874222|NCT04937816|588241171|FG003|Overall Study|Lost to Follow-up|6|||
162874223|NCT04937816|588241172|FG004|Overall Study|Lost to Follow-up|16|||
162874224|NCT04937816|588241173|FG005|Overall Study|Lost to Follow-up|11|||
162874225|NCT04937816|588241174|FG006|Overall Study|Lost to Follow-up|17|||
162874226|NCT04937816|588241168|FG000|Overall Study|Protocol Violation|15|||
162874227|NCT04937816|588241169|FG001|Overall Study|Protocol Violation|15|||
162874228|NCT04937816|588241170|FG002|Overall Study|Protocol Violation|12|||
162874229|NCT04937816|588241171|FG003|Overall Study|Protocol Violation|30|||
162874230|NCT04937816|588241172|FG004|Overall Study|Protocol Violation|24|||
162874231|NCT04937816|588241173|FG005|Overall Study|Protocol Violation|5|||
162874232|NCT04937816|588241174|FG006|Overall Study|Protocol Violation|5|||
162874233|NCT04937816|588241168|FG000|Overall Study|Adverse Event|303|||
162874234|NCT04937816|588241169|FG001|Overall Study|Adverse Event|267|||
162874235|NCT04937816|588241170|FG002|Overall Study|Adverse Event|273|||
162874236|NCT04937816|588241171|FG003|Overall Study|Adverse Event|553|||
162874237|NCT04937816|588241172|FG004|Overall Study|Adverse Event|575|||
162874238|NCT04937816|588241173|FG005|Overall Study|Adverse Event|343|||
162874239|NCT04937816|588241174|FG006|Overall Study|Adverse Event|337|||
162874240|NCT04937816|588241168|FG000|Overall Study|Not treated|4|||
162874241|NCT04937816|588241169|FG001|Overall Study|Not treated|2|||
162874242|NCT04937816|588241170|FG002|Overall Study|Not treated|2|||
162874243|NCT04937816|588241171|FG003|Overall Study|Not treated|2|||
162874244|NCT04937816|588241172|FG004|Overall Study|Not treated|1|||
162874245|NCT04937816|588241173|FG005|Overall Study|Not treated|4|||
162874246|NCT04937816|588241174|FG006|Overall Study|Not treated|0|||
162874247|NCT00436215|588241175|FG000|Overall Study|Refused further treatment|3|||
162874248|NCT00436215|588241175|FG000|Overall Study|Small bowel obstruction|1|||
162874249|NCT05513053|588241176|FG000|Overall Study|Lost to Follow-up|9|||
162874250|NCT05513053|588241177|FG001|Overall Study|Lost to Follow-up|11|||
162874251|NCT05513053|588241176|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162874252|NCT05513053|588241177|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162874253|NCT05513053|588241176|FG000|Overall Study|Withdrawal by Subject|2|||
162874254|NCT05513053|588241177|FG001|Overall Study|Withdrawal by Subject|9|||
162874255|NCT05513053|588241176|FG000|Overall Study|Protocol Violation|6|||
162874256|NCT05513053|588241177|FG001|Overall Study|Protocol Violation|3|||
162615570|NCT01528033|587309451|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
162874257|NCT05513053|588241176|FG000|Overall Study|Adverse Event|0|||
162874258|NCT05513053|588241177|FG001|Overall Study|Adverse Event|2|||
162874259|NCT04491877|588242809|FG000|Overall Study|Protocol Deviation|1|||
162874260|NCT04491877|588242810|FG001|Overall Study|Protocol Deviation|0|||
162874261|NCT04491877|588242811|FG002|Overall Study|Protocol Deviation|2|||
162874262|NCT04491877|588242812|FG003|Overall Study|Protocol Deviation|0|||
162874263|NCT04491877|588242813|FG004|Overall Study|Protocol Deviation|0|||
162874264|NCT04491877|588242814|FG005|Overall Study|Protocol Deviation|0|||
162874265|NCT04491877|588242815|FG006|Overall Study|Protocol Deviation|1|||
162874266|NCT04491877|588242816|FG007|Overall Study|Protocol Deviation|1|||
162874267|NCT04491877|588242817|FG008|Overall Study|Protocol Deviation|0|||
162874268|NCT04491877|588242809|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162874269|NCT04491877|588242810|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162615571|NCT01528033|587309452|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
162615572|NCT01528033|587309451|FG000|Follow Up|No data available|46|||
162615573|NCT01528033|587309452|FG001|Follow Up|No data available|44|||
162615574|NCT02898116|587309455|FG000|Overall Study|Adverse Event|1|||
162874270|NCT04491877|588242811|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162874271|NCT04491877|588242812|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
162874272|NCT04491877|588242813|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162874273|NCT04491877|588242814|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
162874274|NCT04491877|588242815|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
162874275|NCT04491877|588242816|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
162874276|NCT04491877|588242817|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
162874277|NCT04491877|588242809|FG000|Overall Study|Lost to Follow-up|0|||
162874278|NCT04491877|588242810|FG001|Overall Study|Lost to Follow-up|2|||
162874279|NCT04491877|588242811|FG002|Overall Study|Lost to Follow-up|0|||
162874280|NCT04491877|588242812|FG003|Overall Study|Lost to Follow-up|0|||
162874281|NCT04491877|588242813|FG004|Overall Study|Lost to Follow-up|0|||
162874282|NCT04491877|588242814|FG005|Overall Study|Lost to Follow-up|0|||
162874283|NCT04491877|588242815|FG006|Overall Study|Lost to Follow-up|2|||
162874284|NCT04491877|588242816|FG007|Overall Study|Lost to Follow-up|1|||
163047830|NCT00419757|588882608|FG000|Overall Study|Lost to Follow-up|1|||
162874285|NCT04491877|588242817|FG008|Overall Study|Lost to Follow-up|1|||
162874286|NCT02429258|588242818|FG000|Overall Study|Withdrawal by Subject|2|||
162874287|NCT02429258|588242819|FG001|Overall Study|Withdrawal by Subject|0|||
162874288|NCT02429258|588242818|FG000|Overall Study|Protocol Violation|0|||
162874289|NCT02429258|588242819|FG001|Overall Study|Protocol Violation|1|||
162874290|NCT01520324|588242820|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
162874291|NCT00748553|588242823|FG000|Overall Study|Adverse Event|0|||
162874292|NCT00748553|588242824|FG001|Overall Study|Adverse Event|1|||
162874293|NCT00748553|588242823|FG000|Overall Study|disease progression|2|||
162874294|NCT00748553|588242824|FG001|Overall Study|disease progression|0|||
162874295|NCT00748553|588242823|FG000|Overall Study|noncompliance|1|||
162874296|NCT00748553|588242824|FG001|Overall Study|noncompliance|0|||
162874297|NCT00745368|588242826|FG000|Overall Study|Unable to provide sample|3|||
162874298|NCT00495495|588242827|FG000|Overall Study|Protocol Violation|99|||
162874299|NCT04009096|588242829|FG000|Overall Study|Withdrawal by Subject|0|||
162874300|NCT04009096|588242830|FG001|Overall Study|Withdrawal by Subject|7|||
162874301|NCT04009096|588242831|FG002|Overall Study|Withdrawal by Subject|0|||
162874302|NCT04009096|588242829|FG000|Overall Study|Physician Decision|0|||
162874303|NCT04009096|588242830|FG001|Overall Study|Physician Decision|1|||
162874304|NCT04009096|588242831|FG002|Overall Study|Physician Decision|0|||
162874305|NCT04263142|588242832|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
162874306|NCT04263142|588242833|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
162874307|NCT04263142|588242834|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
162874308|NCT04263142|588242835|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
162874309|NCT04263142|588242836|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
162874310|NCT04263142|588242832|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
162874311|NCT04263142|588242833|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
162874312|NCT04263142|588242834|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
162874313|NCT04263142|588242835|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
162874314|NCT04263142|588242836|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
162874315|NCT00450372|588242837|FG000|Overall Study|Physician Decision|1|||
162874316|NCT03010423|588242838|FG000|Overall Study|Study termination|8|||
162874317|NCT03439748|588242839|FG000|Overall Study|Withdrawal by Subject|11|||
162874318|NCT03439748|588242840|FG001|Overall Study|Withdrawal by Subject|17|||
162874319|NCT05131451|588242841|FG000|Overall Study|Protocol Violation|1|||
162874320|NCT05131451|588242842|FG001|Overall Study|Protocol Violation|0|||
162874321|NCT01856595|588242850|FG000|Overall Study|Withdrawal by Subject|0|||
162874322|NCT01856595|588242851|FG001|Overall Study|Withdrawal by Subject|1|||
162874323|NCT01856595|588242852|FG002|Overall Study|Withdrawal by Subject|0|||
162874324|NCT01856595|588242853|FG003|Overall Study|Withdrawal by Subject|0|||
162874325|NCT01856595|588242854|FG004|Overall Study|Withdrawal by Subject|0|||
162874326|NCT01856595|588242855|FG005|Overall Study|Withdrawal by Subject|0|||
162874327|NCT01856595|588242856|FG006|Overall Study|Withdrawal by Subject|1|||
162874328|NCT01856595|588242857|FG007|Overall Study|Withdrawal by Subject|0|||
162874329|NCT01856595|588242858|FG008|Overall Study|Withdrawal by Subject|0|||
162874330|NCT04426825|588242859|FG000|Overall Study|Death|17|||
162874331|NCT04426825|588242859|FG000|Overall Study|Lost to Follow-up|1|||
162874332|NCT04426825|588242859|FG000|Overall Study|Study terminated by sponsor|5|||
162874333|NCT05692154|588242866|FG000|Overall Study|Adverse Event|0|||
162874334|NCT05692154|588242867|FG001|Overall Study|Adverse Event|1|||
162874335|NCT03609359|588242870|FG000|Overall Study|Progression of primary disease (PD)|25|||
162874336|NCT03609359|588242870|FG000|Overall Study|Patient's refusal|1|||
162874337|NCT03609359|588242870|FG000|Overall Study|Physician Decision|1|||
162874338|NCT03609359|588242870|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
162874339|NCT01912729|588242871|FG000|Overall Study|Withdrawal by Subject|0|||
162874340|NCT01912729|588242872|FG001|Overall Study|Withdrawal by Subject|1|||
162874341|NCT01952834|588242873|FG000|Overall Study|Adverse Event|1|||
162874342|NCT01975272|588242874|FG000|Overall Study|Excluded after protocol amendment|1|||
162874343|NCT01975272|588242875|FG001|Overall Study|Excluded after protocol amendment|1|||
162874344|NCT01975272|588242876|FG002|Overall Study|Excluded after protocol amendment|2|||
162874345|NCT00988559|588242883|FG000|Overall Study|Withdrawal by Subject|1|||
162874346|NCT00988559|588242884|FG001|Overall Study|Withdrawal by Subject|1|||
162874347|NCT00988559|588242885|FG002|Overall Study|Withdrawal by Subject|0|||
162874348|NCT00988559|588242886|FG003|Overall Study|Withdrawal by Subject|1|||
162874349|NCT00988559|588242883|FG000|Overall Study|Pregnancy|0|||
162874350|NCT00988559|588242884|FG001|Overall Study|Pregnancy|1|||
162874351|NCT00988559|588242885|FG002|Overall Study|Pregnancy|1|||
162874352|NCT00988559|588242886|FG003|Overall Study|Pregnancy|0|||
162706855|NCT04955626|587636676|FG020|Open-Label Period|Death|0|||
162706856|NCT04955626|587636677|FG021|Open-Label Period|Death|0|||
162874353|NCT00988559|588242883|FG000|Overall Study|Lost to Follow-up|0|||
162874354|NCT00988559|588242884|FG001|Overall Study|Lost to Follow-up|0|||
162874355|NCT00988559|588242885|FG002|Overall Study|Lost to Follow-up|1|||
162874356|NCT00988559|588242886|FG003|Overall Study|Lost to Follow-up|0|||
162874357|NCT00829166|588242890|FG000|Overall Study|Death|305|||
162874358|NCT00829166|588242891|FG001|Overall Study|Death|333|||
162874359|NCT00829166|588242890|FG000|Overall Study|Lost to Follow-up|5|||
162874360|NCT00829166|588242891|FG001|Overall Study|Lost to Follow-up|4|||
162874361|NCT00829166|588242890|FG000|Overall Study|Physician's Decision|4|||
162874362|NCT00829166|588242891|FG001|Overall Study|Physician's Decision|3|||
162874363|NCT00829166|588242890|FG000|Overall Study|Subject's Decision|41|||
162874364|NCT00829166|588242891|FG001|Overall Study|Subject's Decision|55|||
162874365|NCT00829166|588242890|FG000|Overall Study|Sponsor's Decision|137|||
162874366|NCT00829166|588242891|FG001|Overall Study|Sponsor's Decision|98|||
162874367|NCT00829166|588242890|FG000|Overall Study|Reason Not Specified|3|||
162874368|NCT00829166|588242891|FG001|Overall Study|Reason Not Specified|3|||
162874369|NCT02538666|588242892|FG000|Pre-Treatment|Disease progression|1|||
162874370|NCT02538666|588242893|FG001|Pre-Treatment|Disease progression|0|||
162874371|NCT02538666|588242894|FG002|Pre-Treatment|Disease progression|0|||
162874372|NCT02538666|588242892|FG000|Pre-Treatment|no longer meets study criteria|1|||
162874373|NCT02538666|588242893|FG001|Pre-Treatment|no longer meets study criteria|0|||
162874374|NCT02538666|588242894|FG002|Pre-Treatment|no longer meets study criteria|0|||
162874375|NCT02538666|588242892|FG000|Pre-Treatment|Withdrew Consent|0|||
162874376|NCT02538666|588242893|FG001|Pre-Treatment|Withdrew Consent|1|||
162874377|NCT02538666|588242894|FG002|Pre-Treatment|Withdrew Consent|1|||
162874378|NCT02538666|588242892|FG000|Treatment|Disease progression|270|||
162874379|NCT02538666|588242893|FG001|Treatment|Disease progression|227|||
162874380|NCT02538666|588242894|FG002|Treatment|Disease progression|165|||
162874381|NCT02538666|588242892|FG000|Treatment|Study drug toxicity|1|||
162874382|NCT02538666|588242893|FG001|Treatment|Study drug toxicity|29|||
162874383|NCT02538666|588242894|FG002|Treatment|Study drug toxicity|92|||
162874384|NCT02538666|588242892|FG000|Treatment|Death|0|||
162874385|NCT02538666|588242893|FG001|Treatment|Death|2|||
162874386|NCT02538666|588242894|FG002|Treatment|Death|3|||
162874387|NCT02538666|588242892|FG000|Treatment|Adverse event unrelated to study drug|8|||
162874388|NCT02538666|588242893|FG001|Treatment|Adverse event unrelated to study drug|10|||
162874389|NCT02538666|588242894|FG002|Treatment|Adverse event unrelated to study drug|15|||
162874390|NCT02538666|588242892|FG000|Treatment|Participant request to discontinue study treatment|3|||
162874391|NCT02538666|588242893|FG001|Treatment|Participant request to discontinue study treatment|6|||
162874392|NCT02538666|588242894|FG002|Treatment|Participant request to discontinue study treatment|11|||
162874393|NCT02538666|588242892|FG000|Treatment|Participant withdrew consent|2|||
162874394|NCT02538666|588242893|FG001|Treatment|Participant withdrew consent|5|||
162874395|NCT02538666|588242894|FG002|Treatment|Participant withdrew consent|3|||
162874396|NCT02538666|588242892|FG000|Treatment|Lost to Follow-up|0|||
162874397|NCT02538666|588242893|FG001|Treatment|Lost to Follow-up|1|||
162874398|NCT02538666|588242894|FG002|Treatment|Lost to Follow-up|1|||
162874399|NCT02538666|588242892|FG000|Treatment|Maximum clinical benefit|4|||
162874400|NCT02538666|588242893|FG001|Treatment|Maximum clinical benefit|3|||
162874401|NCT02538666|588242894|FG002|Treatment|Maximum clinical benefit|4|||
162874402|NCT02538666|588242892|FG000|Treatment|Poor/non-compliance|0|||
162874403|NCT02538666|588242893|FG001|Treatment|Poor/non-compliance|1|||
162874404|NCT02538666|588242894|FG002|Treatment|Poor/non-compliance|0|||
162874405|NCT02538666|588242892|FG000|Treatment|Participant no longer meets study criteria|0|||
162874406|NCT02538666|588242893|FG001|Treatment|Participant no longer meets study criteria|2|||
162874407|NCT02538666|588242894|FG002|Treatment|Participant no longer meets study criteria|0|||
162874408|NCT02538666|588242892|FG000|Treatment|Administrative reason by sponsor|0|||
162874409|NCT02538666|588242893|FG001|Treatment|Administrative reason by sponsor|0|||
162874410|NCT02538666|588242894|FG002|Treatment|Administrative reason by sponsor|1|||
162874411|NCT02538666|588242892|FG000|Treatment|Other reasons|8|||
162874412|NCT02538666|588242893|FG001|Treatment|Other reasons|15|||
162874413|NCT02538666|588242894|FG002|Treatment|Other reasons|5|||
162874414|NCT02538666|588242892|FG000|Treatment|Not reported|2|||
162874415|NCT02538666|588242893|FG001|Treatment|Not reported|2|||
162874416|NCT02538666|588242894|FG002|Treatment|Not reported|2|||
162874417|NCT00320385|588242895|FG000|Overall Study|Lost to Follow-up|7|||
162874418|NCT00320385|588242896|FG001|Overall Study|Lost to Follow-up|10|||
162874419|NCT00320385|588242895|FG000|Overall Study|Withdrawal by Subject|6|||
162874420|NCT00320385|588242896|FG001|Overall Study|Withdrawal by Subject|7|||
162874421|NCT00320385|588242895|FG000|Overall Study|Sponsor Terminated Study|2|||
162874422|NCT00320385|588242896|FG001|Overall Study|Sponsor Terminated Study|1|||
162874423|NCT00320385|588242895|FG000|Overall Study|Investigator Decision|0|||
162874424|NCT00320385|588242896|FG001|Overall Study|Investigator Decision|1|||
162874425|NCT00320385|588242895|FG000|Overall Study|Death|1|||
162874426|NCT00320385|588242896|FG001|Overall Study|Death|2|||
162874427|NCT00320385|588242895|FG000|Overall Study|Serious Adverse Event|1|||
162874428|NCT00320385|588242896|FG001|Overall Study|Serious Adverse Event|0|||
162874429|NCT00320385|588242895|FG000|Overall Study|Withdrew Consent|1|||
162874430|NCT00320385|588242896|FG001|Overall Study|Withdrew Consent|0|||
162874431|NCT00320385|588242895|FG000|Overall Study|Adverse Event|0|||
162874432|NCT00320385|588242896|FG001|Overall Study|Adverse Event|1|||
162874433|NCT04370028|588242897|FG000|Overall Study|Withdrawal by Subject|695|||
162874434|NCT04370028|588242897|FG000|Overall Study|Protocol Violation|9|||
162874435|NCT04370028|588242897|FG000|Overall Study|Adverse Event|3|||
162874436|NCT02582749|588242904|FG000|Overall Study|Study terminated by funder|5|||
162874437|NCT02582749|588242905|FG001|Overall Study|Study terminated by funder|10|||
162874438|NCT02582749|588242904|FG000|Overall Study|Withdrawal by Subject|0|||
162874439|NCT02582749|588242905|FG001|Overall Study|Withdrawal by Subject|1|||
162874440|NCT02213198|588242906|FG000|Baseline|No show for intake|7|||
162874441|NCT02213198|588242907|FG001|Baseline|No show for intake|9|||
162874442|NCT02213198|588242906|FG000|Baseline|Withdrawal by Subject|34|||
162874443|NCT02213198|588242907|FG001|Baseline|Withdrawal by Subject|11|||
162874444|NCT02213198|588242906|FG000|Baseline|transferred out of clinic|7|||
162874445|NCT02213198|588242907|FG001|Baseline|transferred out of clinic|9|||
162874446|NCT02213198|588242906|FG000|Baseline|Lost to Follow-up|40|||
162874447|NCT02213198|588242907|FG001|Baseline|Lost to Follow-up|21|||
162874448|NCT02213198|588242906|FG000|Baseline|incarcerated,violent|0|||
162874449|NCT02213198|588242907|FG001|Baseline|incarcerated,violent|1|||
162874450|NCT02213198|588242906|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
162874451|NCT02213198|588242907|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
162874452|NCT02213198|588242906|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
162874453|NCT02213198|588242907|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
162874454|NCT02213198|588242906|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
162874455|NCT02213198|588242907|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
162874456|NCT02213198|588242906|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
162874457|NCT02213198|588242907|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
162874458|NCT02213198|588242906|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
162874459|NCT02213198|588242907|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
162874460|NCT02213198|588242906|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
162874461|NCT02213198|588242907|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
162874462|NCT01518192|588242908|FG000|Overall Study|Lost to Follow-up|29|||
162874463|NCT01518192|588242909|FG001|Overall Study|Lost to Follow-up|26|||
162874464|NCT01518192|588242910|FG002|Overall Study|Lost to Follow-up|35|||
162874465|NCT01954121|588242912|FG000|Overall Study|Lack of Efficacy|94|||
162874466|NCT01954121|588242913|FG001|Overall Study|Lack of Efficacy|41|||
162874467|NCT01954121|588242912|FG000|Overall Study|Protocol Violation|0|||
162874468|NCT01954121|588242913|FG001|Overall Study|Protocol Violation|2|||
162874469|NCT01954121|588242912|FG000|Overall Study|Lost to Follow-up|5|||
162874470|NCT01954121|588242913|FG001|Overall Study|Lost to Follow-up|6|||
162874471|NCT01954121|588242912|FG000|Overall Study|Withdrawal by Subject|18|||
162874472|NCT01954121|588242913|FG001|Overall Study|Withdrawal by Subject|12|||
162874473|NCT01954121|588242912|FG000|Overall Study|Pregnancy|1|||
162874474|NCT01954121|588242913|FG001|Overall Study|Pregnancy|1|||
162874475|NCT01954121|588242912|FG000|Overall Study|AE, serious fatal|1|||
162874476|NCT01954121|588242913|FG001|Overall Study|AE, serious fatal|0|||
162874477|NCT01954121|588242912|FG000|Overall Study|AE, non-serious non-fatal|5|||
162874478|NCT01954121|588242913|FG001|Overall Study|AE, non-serious non-fatal|22|||
162874479|NCT01954121|588242912|FG000|Overall Study|SAE, non-fatal|1|||
162874480|NCT01954121|588242913|FG001|Overall Study|SAE, non-fatal|4|||
162874481|NCT01954121|588242912|FG000|Overall Study|Non-compliant with study procedures|1|||
162874482|NCT01954121|588242913|FG001|Overall Study|Non-compliant with study procedures|0|||
162874483|NCT01954121|588242912|FG000|Overall Study|Non-compliant patient|1|||
162874484|NCT01954121|588242913|FG001|Overall Study|Non-compliant patient|1|||
162874485|NCT01954121|588242912|FG000|Overall Study|Subject did not follow instructions|0|||
162874486|NCT01954121|588242913|FG001|Overall Study|Subject did not follow instructions|2|||
162874487|NCT00601523|588242914|FG000|Overall Study|Adverse Event|42|||
162874488|NCT00601523|588242915|FG001|Overall Study|Adverse Event|14|||
162874489|NCT00601523|588242914|FG000|Overall Study|Lack of Efficacy|3|||
162874490|NCT00601523|588242915|FG001|Overall Study|Lack of Efficacy|0|||
162874491|NCT00601523|588242914|FG000|Overall Study|Protocol Violation|5|||
162874492|NCT00601523|588242915|FG001|Overall Study|Protocol Violation|1|||
162961438|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961439|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
162874493|NCT00601523|588242914|FG000|Overall Study|Lost to Follow-up|0|||
162874494|NCT00601523|588242915|FG001|Overall Study|Lost to Follow-up|1|||
162874495|NCT00601523|588242914|FG000|Overall Study|Withdrawal by Subject|18|||
162874496|NCT00601523|588242915|FG001|Overall Study|Withdrawal by Subject|9|||
162874497|NCT00601523|588242914|FG000|Overall Study|Other|9|||
162961440|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162978997|NCT03545191|588623547|FG001|Overall Study|Adverse Event|2|||
162874498|NCT00601523|588242915|FG001|Overall Study|Other|1|||
162874499|NCT01987986|588242916|FG000|Overall Study|Lost to Follow-up|1|||
162874500|NCT01987986|588242917|FG001|Overall Study|Lost to Follow-up|0|||
162874501|NCT01987986|588242918|FG002|Overall Study|Lost to Follow-up|0|||
162874502|NCT01987986|588242919|FG003|Overall Study|Lost to Follow-up|0|||
162874503|NCT01987986|588242916|FG000|Overall Study|Adverse Event|1|||
162874504|NCT01987986|588242917|FG001|Overall Study|Adverse Event|0|||
162874505|NCT01987986|588242918|FG002|Overall Study|Adverse Event|2|||
162874506|NCT01987986|588242919|FG003|Overall Study|Adverse Event|0|||
162874507|NCT03342469|588242920|FG000|Overall Study|Withdrawal by Subject|0|||
162874508|NCT03342469|588242921|FG001|Overall Study|Withdrawal by Subject|1|||
162874509|NCT03342469|588242922|FG002|Overall Study|Withdrawal by Subject|0|||
162874510|NCT03342469|588242923|FG003|Overall Study|Withdrawal by Subject|0|||
162874511|NCT05515601|588242927|FG000|Overall Study|Withdrawal by Subject|1|||
162874512|NCT05515601|588242928|FG001|Overall Study|Withdrawal by Subject|3|||
162874513|NCT05515601|588242929|FG002|Overall Study|Withdrawal by Subject|2|||
162874514|NCT05515601|588242930|FG003|Overall Study|Withdrawal by Subject|1|||
162874515|NCT05515601|588242931|FG004|Overall Study|Withdrawal by Subject|1|||
162874516|NCT05515601|588242932|FG005|Overall Study|Withdrawal by Subject|1|||
162874517|NCT05515601|588242927|FG000|Overall Study|Lost to Follow-up|0|||
162874518|NCT05515601|588242928|FG001|Overall Study|Lost to Follow-up|0|||
162874519|NCT05515601|588242929|FG002|Overall Study|Lost to Follow-up|0|||
162874520|NCT05515601|588242930|FG003|Overall Study|Lost to Follow-up|0|||
162874521|NCT05515601|588242931|FG004|Overall Study|Lost to Follow-up|1|||
162874522|NCT05515601|588242932|FG005|Overall Study|Lost to Follow-up|0|||
162874523|NCT02928406|588242933|FG000|Overall Study|Death|780|||
162874524|NCT02928406|588242933|FG000|Overall Study|Progressive disease|3|||
162874525|NCT02928406|588242933|FG000|Overall Study|Lost to Follow-up|49|||
162874526|NCT02928406|588242933|FG000|Overall Study|Non-compliance|2|||
162874527|NCT02928406|588242933|FG000|Overall Study|Withdrawal by Subject|40|||
162874528|NCT02928406|588242933|FG000|Overall Study|Study terminated by sponsor|57|||
162874529|NCT02928406|588242933|FG000|Overall Study|Physician Decision|1|||
162874530|NCT02928406|588242933|FG000|Overall Study|Various reasons|72|||
162874531|NCT00540436|588242934|FG000|First 12-Week Treatment Period|Adverse Event|1|||
162874532|NCT00540436|588242934|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
162874533|NCT00540436|588242934|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
162874534|NCT00540436|588242934|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
162874535|NCT01515306|588242935|FG000|Overall Study|Adverse Event|3|||
162874536|NCT01515306|588242936|FG001|Overall Study|Adverse Event|2|||
162874537|NCT01515306|588242935|FG000|Overall Study|Progressive Disease|19|||
162874538|NCT01515306|588242936|FG001|Overall Study|Progressive Disease|9|||
162874539|NCT01515306|588242935|FG000|Overall Study|Withdrawal by Subject|1|||
162874540|NCT01515306|588242936|FG001|Overall Study|Withdrawal by Subject|2|||
162874541|NCT01515306|588242935|FG000|Overall Study|Physician Decision|1|||
162874542|NCT01515306|588242936|FG001|Overall Study|Physician Decision|1|||
162874543|NCT02678780|588242938|FG000|Overall Study|Adverse Event|11|||
162874544|NCT02678780|588242939|FG001|Overall Study|Adverse Event|14|||
162874545|NCT02678780|588242938|FG000|Overall Study|Withdrawal by Subject|2|||
162874546|NCT02678780|588242939|FG001|Overall Study|Withdrawal by Subject|1|||
162874547|NCT02678780|588242938|FG000|Overall Study|Sponsor discontinuation|7|||
162874548|NCT02678780|588242939|FG001|Overall Study|Sponsor discontinuation|4|||
162874549|NCT02678780|588242938|FG000|Overall Study|Death|1|||
162874550|NCT02678780|588242939|FG001|Overall Study|Death|1|||
162874551|NCT02678780|588242938|FG000|Overall Study|Other|6|||
162874552|NCT02678780|588242939|FG001|Overall Study|Other|8|||
162874553|NCT01064648|588242952|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
162874554|NCT01064648|588242953|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
162874555|NCT01064648|588242954|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
162874556|NCT01064648|588242955|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
162874557|NCT01064648|588242952|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
162874558|NCT01064648|588242953|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
162874559|NCT01064648|588242954|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
162874560|NCT01064648|588242955|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
162874561|NCT01064648|588242952|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
162874562|NCT01064648|588242953|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
162874563|NCT01064648|588242954|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
162874564|NCT01064648|588242955|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
162874565|NCT01064648|588242952|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
162874566|NCT01064648|588242953|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
162874567|NCT01064648|588242954|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
162874568|NCT01064648|588242955|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
162874569|NCT01064648|588242952|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
162874570|NCT01064648|588242953|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
162874571|NCT01064648|588242954|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
163047831|NCT00419757|588882609|FG001|Overall Study|Lost to Follow-up|4|||
162706857|NCT04955626|587636678|FG022|Open-Label Period|Death|0|||
162874572|NCT01064648|588242955|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
162874573|NCT01064648|588242952|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
162874574|NCT01064648|588242953|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
162874575|NCT01064648|588242954|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
162874576|NCT01064648|588242955|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
162874577|NCT01064648|588242952|FG000|Phase II|Adverse Event|0|||
162874578|NCT01064648|588242953|FG001|Phase II|Adverse Event|0|||
162874579|NCT01064648|588242954|FG002|Phase II|Adverse Event|15|||
162874580|NCT01064648|588242955|FG003|Phase II|Adverse Event|8|||
162874581|NCT01064648|588242952|FG000|Phase II|Death|0|||
162874582|NCT01064648|588242953|FG001|Phase II|Death|0|||
162874583|NCT01064648|588242954|FG002|Phase II|Death|4|||
162874584|NCT01064648|588242955|FG003|Phase II|Death|5|||
162874585|NCT01064648|588242952|FG000|Phase II|Withdrawal by Subject|0|||
162874586|NCT01064648|588242953|FG001|Phase II|Withdrawal by Subject|0|||
162874587|NCT01064648|588242954|FG002|Phase II|Withdrawal by Subject|2|||
162874588|NCT01064648|588242955|FG003|Phase II|Withdrawal by Subject|5|||
162874589|NCT01064648|588242952|FG000|Phase II|Progression|0|||
162874590|NCT01064648|588242953|FG001|Phase II|Progression|0|||
162874591|NCT01064648|588242954|FG002|Phase II|Progression|21|||
162874592|NCT01064648|588242955|FG003|Phase II|Progression|27|||
162874593|NCT01064648|588242952|FG000|Phase II|Non-protocol specified|0|||
162874594|NCT01064648|588242953|FG001|Phase II|Non-protocol specified|0|||
162874595|NCT01064648|588242954|FG002|Phase II|Non-protocol specified|5|||
162874596|NCT01064648|588242955|FG003|Phase II|Non-protocol specified|3|||
162874597|NCT01064648|588242952|FG000|Phase II|Under Review|0|||
162874598|NCT01064648|588242953|FG001|Phase II|Under Review|0|||
162874599|NCT01064648|588242954|FG002|Phase II|Under Review|2|||
162874600|NCT01064648|588242955|FG003|Phase II|Under Review|0|||
162874601|NCT05513391|588242956|FG000|Overall Study|Adverse Event|1|||
162874602|NCT05513391|588242957|FG001|Overall Study|Adverse Event|0|||
162874603|NCT05513391|588242956|FG000|Overall Study|Protocol Deviation|0|||
162874604|NCT05513391|588242957|FG001|Overall Study|Protocol Deviation|1|||
162874605|NCT05513391|588242956|FG000|Overall Study|Withdrawal by Subject|3|||
162874606|NCT05513391|588242957|FG001|Overall Study|Withdrawal by Subject|1|||
162874607|NCT05513391|588242956|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
162874608|NCT05513391|588242957|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162874609|NCT05513391|588242956|FG000|Overall Study|Lost to Follow-up|0|||
162874610|NCT05513391|588242957|FG001|Overall Study|Lost to Follow-up|2|||
162874611|NCT02429427|588242958|FG000|Overall Study|Adverse Event|220|||
162874612|NCT02429427|588242959|FG001|Overall Study|Adverse Event|92|||
162874613|NCT02429427|588242958|FG000|Overall Study|Protocol Violation|10|||
162874614|NCT02429427|588242959|FG001|Overall Study|Protocol Violation|6|||
162874615|NCT02429427|588242958|FG000|Overall Study|Lost to Follow-up|15|||
162874616|NCT02429427|588242959|FG001|Overall Study|Lost to Follow-up|6|||
162615575|NCT02898116|587309455|FG000|Overall Study|Progressive disease|1|||
162874617|NCT02429427|588242958|FG000|Overall Study|Withdrawal by Subject|64|||
162874618|NCT02429427|588242959|FG001|Overall Study|Withdrawal by Subject|34|||
162874619|NCT02429427|588242958|FG000|Overall Study|Other|62|||
162874620|NCT02429427|588242959|FG001|Overall Study|Other|41|||
162874621|NCT00719732|588242960|FG000|Overall Study|Lost to Follow-up|20|||
162874622|NCT00719732|588242960|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
162874623|NCT00719732|588242960|FG000|Overall Study|Illness not associated with device|1|||
162874624|NCT00309777|588242965|FG000|Overall Study|Adverse Event|13|||
162874625|NCT00309777|588242966|FG001|Overall Study|Adverse Event|2|||
162874626|NCT00309777|588242967|FG002|Overall Study|Adverse Event|8|||
162874627|NCT00309777|588242968|FG003|Overall Study|Adverse Event|1|||
162874628|NCT00309777|588242965|FG000|Overall Study|Protocol Violation|4|||
162874629|NCT00309777|588242966|FG001|Overall Study|Protocol Violation|1|||
162874630|NCT00309777|588242967|FG002|Overall Study|Protocol Violation|3|||
162874631|NCT00309777|588242968|FG003|Overall Study|Protocol Violation|1|||
162874632|NCT00309777|588242965|FG000|Overall Study|Withdrawal by Subject|6|||
162874633|NCT00309777|588242966|FG001|Overall Study|Withdrawal by Subject|5|||
162874634|NCT00309777|588242967|FG002|Overall Study|Withdrawal by Subject|7|||
162874635|NCT00309777|588242968|FG003|Overall Study|Withdrawal by Subject|2|||
162615576|NCT02130024|587309456|FG000|Overall Study|Adverse Event|10|||
162615577|NCT02130024|587309457|FG001|Overall Study|Adverse Event|11|||
162615578|NCT02130024|587309456|FG000|Overall Study|Death|2|||
162615579|NCT02130024|587309457|FG001|Overall Study|Death|2|||
162874636|NCT00309777|588242965|FG000|Overall Study|Lost to Follow-up|0|||
162874637|NCT00309777|588242966|FG001|Overall Study|Lost to Follow-up|0|||
162874638|NCT00309777|588242967|FG002|Overall Study|Lost to Follow-up|1|||
162874639|NCT00309777|588242968|FG003|Overall Study|Lost to Follow-up|0|||
162615580|NCT02130024|587309456|FG000|Overall Study|Lost to Follow-up|1|||
162615581|NCT02130024|587309457|FG001|Overall Study|Lost to Follow-up|1|||
162874640|NCT00309777|588242965|FG000|Overall Study|Death|0|||
162874641|NCT00309777|588242966|FG001|Overall Study|Death|1|||
162874642|NCT00309777|588242967|FG002|Overall Study|Death|0|||
162874643|NCT00309777|588242968|FG003|Overall Study|Death|0|||
162874644|NCT00683475|588244988|FG000|Overall Study|Withdrawal by Subject|1|||
162874645|NCT00683475|588244989|FG001|Overall Study|Withdrawal by Subject|0|||
162615582|NCT02130024|587309456|FG000|Overall Study|Physician Decision|1|||
162874646|NCT00683475|588244988|FG000|Overall Study|Never Treated: Adverse Event|2|||
162874647|NCT00683475|588244989|FG001|Overall Study|Never Treated: Adverse Event|3|||
162874648|NCT00683475|588244988|FG000|Overall Study|Never Treated: Progressive Disease|1|||
162874649|NCT00683475|588244989|FG001|Overall Study|Never Treated: Progressive Disease|0|||
162874650|NCT03364335|588244996|FG000|Overall Study|Adverse Event|3|||
162874651|NCT03364335|588244997|FG001|Overall Study|Adverse Event|4|||
162874652|NCT03364335|588244998|FG002|Overall Study|Adverse Event|1|||
162874653|NCT03364335|588244999|FG003|Overall Study|Adverse Event|2|||
162874654|NCT03364335|588245000|FG004|Overall Study|Adverse Event|0|||
162874655|NCT03364335|588244996|FG000|Overall Study|Lost to Follow-up|7|||
162874656|NCT03364335|588244997|FG001|Overall Study|Lost to Follow-up|7|||
162874657|NCT03364335|588244998|FG002|Overall Study|Lost to Follow-up|10|||
162874658|NCT03364335|588244999|FG003|Overall Study|Lost to Follow-up|11|||
162874659|NCT03364335|588245000|FG004|Overall Study|Lost to Follow-up|11|||
162874660|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
162874661|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
162874662|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
162874663|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
162874664|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
162874665|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
162874666|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
162874667|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
162874668|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
162874669|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
162874670|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
162874671|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
162874672|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
162874673|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
162874674|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
162874675|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
162874676|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
162874677|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874678|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874679|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874680|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874681|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874682|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874683|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
162874684|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
162874685|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874686|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874687|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874688|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874689|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874690|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874691|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
162874692|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
162874693|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
162874694|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
162874695|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
162874696|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
162874697|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
162874698|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
162874699|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
162874700|NCT03725202|588245003|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162874701|NCT03725202|588245004|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162874702|NCT03725202|588245005|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
163047832|NCT00419757|588882608|FG000|Overall Study|Withdrawal by Subject|7|||
163047833|NCT00419757|588882609|FG001|Overall Study|Withdrawal by Subject|1|||
163047834|NCT00419757|588882608|FG000|Overall Study|Protocol Violation|2|||
162615583|NCT02130024|587309457|FG001|Overall Study|Physician Decision|3|||
162615584|NCT02130024|587309456|FG000|Overall Study|Protocol Deviation|4|||
162615585|NCT02130024|587309457|FG001|Overall Study|Protocol Deviation|0|||
163047835|NCT00419757|588882609|FG001|Overall Study|Protocol Violation|3|||
163047836|NCT00419757|588882608|FG000|Overall Study|Study specific discontinuation criteria|4|||
163047837|NCT00419757|588882609|FG001|Overall Study|Study specific discontinuation criteria|8|||
163047838|NCT00419757|588882608|FG000|Overall Study|Multiple reasons|3|||
162615586|NCT02130024|587309456|FG000|Overall Study|Site Administration Problems|1|||
162615587|NCT02130024|587309457|FG001|Overall Study|Site Administration Problems|0|||
162615588|NCT02130024|587309456|FG000|Overall Study|Subject Withdrew Consent|6|||
162615589|NCT02130024|587309457|FG001|Overall Study|Subject Withdrew Consent|14|||
162874703|NCT03725202|588245006|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163047839|NCT00419757|588882609|FG001|Overall Study|Multiple reasons|1|||
162615590|NCT03817879|587311495|FG000|Overall Study|Drop out|5|||
162615591|NCT03817879|587311496|FG001|Overall Study|Drop out|12|||
162706858|NCT04955626|587636679|FG023|Open-Label Period|Death|0|||
162706859|NCT04955626|587636680|FG024|Open-Label Period|Death|0|||
162706860|NCT04955626|587636681|FG025|Open-Label Period|Death|0|||
162706861|NCT04955626|587636682|FG026|Open-Label Period|Death|0|||
162706862|NCT04955626|587636683|FG027|Open-Label Period|Death|0|||
162706863|NCT04955626|587636684|FG028|Open-Label Period|Death|0|||
162706864|NCT04955626|587636685|FG029|Open-Label Period|Death|0|||
162706865|NCT04955626|587636686|FG030|Open-Label Period|Death|0|||
162706866|NCT04955626|587636687|FG031|Open-Label Period|Death|0|||
162706867|NCT04955626|587636688|FG032|Open-Label Period|Death|0|||
162706868|NCT04955626|587636689|FG033|Open-Label Period|Death|0|||
162706869|NCT04955626|587636690|FG034|Open-Label Period|Death|0|||
162706870|NCT04955626|587636691|FG035|Open-Label Period|Death|0|||
162706871|NCT04955626|587636656|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
162706872|NCT04955626|587636657|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
162706873|NCT04955626|587636658|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
162961441|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961442|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162706874|NCT04955626|587636659|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
162706875|NCT04955626|587636660|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
162874704|NCT03725202|588245007|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162874705|NCT03725202|588245008|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162615592|NCT03817879|587311495|FG000|Overall Study|Withdrawal by Subject|0|||
162874706|NCT03725202|588245009|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162874707|NCT03725202|588245010|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
162874708|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
162874709|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
162874710|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
162874711|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
162874712|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
162874713|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
162874714|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
162874715|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
162874716|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
162874717|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
162874718|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
162874719|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
162874720|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
162874721|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
162874722|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
162874723|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
162874724|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
162874725|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
162874726|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
162874727|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
162615593|NCT03817879|587311496|FG001|Overall Study|Withdrawal by Subject|1|||
162615594|NCT03265665|587311497|FG000|24-week Data Collection|Withdrawal by Subject|2|||
162615595|NCT03265665|587311498|FG001|24-week Data Collection|Withdrawal by Subject|2|||
162874728|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
162874729|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
162874730|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
162874731|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
162874732|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874733|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874734|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874735|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874736|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874737|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874738|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
162874739|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
162874740|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162874741|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162874742|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162874743|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162874744|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162615596|NCT03265665|587311497|FG000|24-week Data Collection|Lost to Follow-up|4|||
162615597|NCT03265665|587311498|FG001|24-week Data Collection|Lost to Follow-up|5|||
162615598|NCT03265665|587311497|FG000|36-week Data Collection|Lost to Follow-up|6|||
162615599|NCT03265665|587311498|FG001|36-week Data Collection|Lost to Follow-up|8|||
162615600|NCT01858376|587311499|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
162615601|NCT01680965|587311503|FG000|Overall Study|Death|0|||
162615602|NCT01680965|587311504|FG001|Overall Study|Death|0|||
162615603|NCT01680965|587311505|FG002|Overall Study|Death|0|||
162615604|NCT01680965|587311506|FG003|Overall Study|Death|6|||
162615605|NCT02486302|587311518|FG000|Overall Study|Discontinued prematurely|410|||
162615606|NCT02486302|587311518|FG000|Overall Study|Documentation not completed|255|||
162615607|NCT02486302|587311518|FG000|Overall Study|Excluded due to legal reasons|8|||
162615608|NCT02486302|587311518|FG000|Overall Study|Not treated|3|||
162706876|NCT04955626|587636661|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
162706877|NCT04955626|587636662|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
162706878|NCT04955626|587636663|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
162874745|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
162874746|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162615609|NCT00734474|587311523|FG000|Overall Study|Entry Criteria Not Met|0|||
162615610|NCT00734474|587311524|FG001|Overall Study|Entry Criteria Not Met|0|||
162615611|NCT00734474|587311525|FG002|Overall Study|Entry Criteria Not Met|5|||
162615612|NCT00734474|587311526|FG003|Overall Study|Entry Criteria Not Met|0|||
162615613|NCT00734474|587311527|FG004|Overall Study|Entry Criteria Not Met|3|||
162615614|NCT00734474|587311528|FG005|Overall Study|Entry Criteria Not Met|1|||
162615615|NCT00734474|587311529|FG006|Overall Study|Entry Criteria Not Met|0|||
162615616|NCT00734474|587311530|FG007|Overall Study|Entry Criteria Not Met|1|||
162615617|NCT00734474|587311531|FG008|Overall Study|Entry Criteria Not Met|1|||
162615618|NCT00734474|587311523|FG000|Overall Study|Lost to Follow-up|1|||
162615619|NCT00734474|587311524|FG001|Overall Study|Lost to Follow-up|0|||
162615620|NCT00734474|587311525|FG002|Overall Study|Lost to Follow-up|13|||
162615621|NCT00734474|587311526|FG003|Overall Study|Lost to Follow-up|0|||
162615622|NCT00734474|587311527|FG004|Overall Study|Lost to Follow-up|11|||
162615623|NCT00734474|587311528|FG005|Overall Study|Lost to Follow-up|1|||
162615624|NCT00734474|587311529|FG006|Overall Study|Lost to Follow-up|0|||
162615625|NCT00734474|587311530|FG007|Overall Study|Lost to Follow-up|9|||
162615626|NCT00734474|587311531|FG008|Overall Study|Lost to Follow-up|4|||
162615627|NCT00734474|587311523|FG000|Overall Study|Withdrawal by Subject|2|||
162615628|NCT00734474|587311524|FG001|Overall Study|Withdrawal by Subject|1|||
162615629|NCT00734474|587311525|FG002|Overall Study|Withdrawal by Subject|18|||
162615630|NCT00734474|587311526|FG003|Overall Study|Withdrawal by Subject|0|||
162615631|NCT00734474|587311527|FG004|Overall Study|Withdrawal by Subject|24|||
162615632|NCT00734474|587311528|FG005|Overall Study|Withdrawal by Subject|2|||
162615633|NCT00734474|587311529|FG006|Overall Study|Withdrawal by Subject|0|||
162615634|NCT00734474|587311530|FG007|Overall Study|Withdrawal by Subject|36|||
162874747|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
162874748|NCT03725202|588245003|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
162874749|NCT03725202|588245004|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
162874750|NCT03725202|588245005|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
162874751|NCT03725202|588245006|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
162874752|NCT03725202|588245007|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
162874753|NCT03725202|588245008|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
162874754|NCT03725202|588245009|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
162874755|NCT03725202|588245010|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
162874756|NCT00948818|588245011|FG000|Overall Study|Adverse Event|10|||
162874757|NCT00948818|588245012|FG001|Overall Study|Adverse Event|32|||
162874758|NCT00948818|588245011|FG000|Overall Study|Protocol Violation|9|||
162874759|NCT00948818|588245012|FG001|Overall Study|Protocol Violation|10|||
162874760|NCT00948818|588245011|FG000|Overall Study|Withdrawal by Subject|25|||
162874761|NCT00948818|588245012|FG001|Overall Study|Withdrawal by Subject|25|||
162874762|NCT00948818|588245011|FG000|Overall Study|Lost to Follow-up|10|||
162874763|NCT00948818|588245012|FG001|Overall Study|Lost to Follow-up|17|||
162874764|NCT00948818|588245011|FG000|Overall Study|Lack of Efficacy|4|||
162874765|NCT00948818|588245012|FG001|Overall Study|Lack of Efficacy|5|||
162874766|NCT00948818|588245011|FG000|Overall Study|Other Reason|4|||
162874767|NCT00948818|588245012|FG001|Overall Study|Other Reason|5|||
162874768|NCT02364947|588245015|FG000|Overall Study|Withdrawal by Subject|10|||
162874769|NCT02364947|588245016|FG001|Overall Study|Withdrawal by Subject|8|||
162874770|NCT02364947|588245017|FG002|Overall Study|Withdrawal by Subject|9|||
162874771|NCT02364947|588245015|FG000|Overall Study|Adverse Event|45|||
162874772|NCT02364947|588245016|FG001|Overall Study|Adverse Event|33|||
162874773|NCT02364947|588245017|FG002|Overall Study|Adverse Event|11|||
162874774|NCT02364947|588245015|FG000|Overall Study|Protocol Violation|1|||
162874775|NCT02364947|588245016|FG001|Overall Study|Protocol Violation|1|||
162874776|NCT02364947|588245017|FG002|Overall Study|Protocol Violation|1|||
162874777|NCT02364947|588245015|FG000|Overall Study|Physician Decision|3|||
162615635|NCT00734474|587311531|FG008|Overall Study|Withdrawal by Subject|21|||
162615636|NCT00734474|587311523|FG000|Overall Study|Physician Decision|0|||
162615637|NCT00734474|587311524|FG001|Overall Study|Physician Decision|0|||
162615638|NCT00734474|587311525|FG002|Overall Study|Physician Decision|4|||
162874778|NCT02364947|588245016|FG001|Overall Study|Physician Decision|2|||
162874779|NCT02364947|588245017|FG002|Overall Study|Physician Decision|5|||
162874780|NCT02364947|588245015|FG000|Overall Study|Death|0|||
162615639|NCT00734474|587311526|FG003|Overall Study|Physician Decision|1|||
162874781|NCT02364947|588245016|FG001|Overall Study|Death|1|||
162874782|NCT02364947|588245017|FG002|Overall Study|Death|0|||
162874783|NCT02702518|588245021|FG000|Overall Study|Lost to Follow-up|3|||
162961443|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162615640|NCT00734474|587311527|FG004|Overall Study|Physician Decision|11|||
162874784|NCT02702518|588245022|FG001|Overall Study|Lost to Follow-up|4|||
162874785|NCT00853489|588245023|FG000|Overall Study|Lost to Follow-up|5|||
162874786|NCT00853489|588245024|FG001|Overall Study|Lost to Follow-up|2|||
162874787|NCT01251276|588245026|FG000|Overall Study|Protocol Violation|1|||
162874788|NCT01251276|588245027|FG001|Overall Study|Protocol Violation|0|||
162874789|NCT01251276|588245026|FG000|Overall Study|Lost to Follow-up|0|||
162874790|NCT01251276|588245027|FG001|Overall Study|Lost to Follow-up|1|||
162874791|NCT00262080|588245033|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
162874792|NCT00262080|588245034|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
162874793|NCT00262080|588245035|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
162874794|NCT00262080|588245033|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
162874795|NCT00262080|588245034|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
162961444|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961445|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961446|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961447|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961448|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961449|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961450|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961451|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961452|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961453|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961454|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961455|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961456|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162961457|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961458|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961459|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961460|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961461|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961462|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961463|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
163047840|NCT03934216|588882617|FG000|Overall Study|Other Reasons|5|||
163047841|NCT03934216|588882618|FG001|Overall Study|Other Reasons|5|||
162615641|NCT00734474|587311528|FG005|Overall Study|Physician Decision|0|||
162615642|NCT00734474|587311529|FG006|Overall Study|Physician Decision|0|||
162615643|NCT00734474|587311530|FG007|Overall Study|Physician Decision|9|||
162874796|NCT00262080|588245035|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
162874797|NCT00262080|588245033|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
162874798|NCT00262080|588245034|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
162874799|NCT00262080|588245035|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
163047842|NCT03934216|588882617|FG000|Overall Study|Adverse Event|22|||
162874800|NCT00262080|588245033|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
162874801|NCT00262080|588245034|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
162874802|NCT00262080|588245035|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
162874803|NCT00262080|588245033|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
162874804|NCT00262080|588245034|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
162874805|NCT00262080|588245035|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
162874806|NCT00262080|588245033|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
162874807|NCT00262080|588245034|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
162874808|NCT00262080|588245035|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
162874809|NCT01051986|588245036|FG000|Overall Study|Death|1|||
162874810|NCT01051986|588245037|FG001|Overall Study|Death|0|||
162874811|NCT01051986|588245036|FG000|Overall Study|Withdrawal by Subject|2|||
162874812|NCT01051986|588245037|FG001|Overall Study|Withdrawal by Subject|1|||
162874813|NCT01051986|588245036|FG000|Overall Study|Protocol Violation|2|||
162874814|NCT01051986|588245037|FG001|Overall Study|Protocol Violation|3|||
162874815|NCT01725152|588245039|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
162874816|NCT01725152|588245040|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
162874817|NCT01725152|588245039|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
162874818|NCT01725152|588245040|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
162874819|NCT01725152|588245039|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
162874820|NCT01725152|588245040|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
162874821|NCT01725152|588245039|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
162874822|NCT01725152|588245040|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
162874823|NCT02044159|588245041|FG000|Overall Study|Consent declined (deferred consent)|2|||
162874824|NCT02044159|588245042|FG001|Overall Study|Consent declined (deferred consent)|4|||
162874825|NCT02044159|588245041|FG000|Overall Study|No longer eligible, drug not given|1|||
162874826|NCT02044159|588245042|FG001|Overall Study|No longer eligible, drug not given|0|||
162874827|NCT02044159|588245041|FG000|Overall Study|Nurse declined to give study drug|1|||
162874828|NCT02044159|588245042|FG001|Overall Study|Nurse declined to give study drug|0|||
162874829|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
162874830|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
162874831|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
162874832|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
162874833|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
162874834|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
162874835|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
162874836|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
162874837|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
162874838|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
162874839|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
162874840|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
162874841|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
162874842|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
162874843|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
162874844|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
162874845|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
162874846|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
162874847|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
162874848|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
162874849|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
162874850|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
162874851|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
162874852|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
162874853|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
162874854|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
162874855|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
162874856|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
162874857|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
162874858|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
162874859|NCT01111539|588245045|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
162874860|NCT01111539|588245046|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
162874861|NCT01111539|588245047|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
162874862|NCT01111539|588245048|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
162874863|NCT01111539|588245049|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
162874864|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162874865|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162874866|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
162874867|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
162874868|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
162874869|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
162874870|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
162874871|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
162874872|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
162874873|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
162874874|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
162874875|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
162874876|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
162874877|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
162874878|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
162874879|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
162874880|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
162874881|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
162874882|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
162874883|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
162874884|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
162874885|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
162874886|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
162874887|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
162874888|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
162874889|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
162874890|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
162874891|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
162874892|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
162874893|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
162874894|NCT01111539|588245045|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
162874895|NCT01111539|588245046|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
162874896|NCT01111539|588245047|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
162874897|NCT01111539|588245048|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
162874898|NCT01111539|588245049|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
162874899|NCT03580382|588245054|FG000|Overall Study|Early Termination of Study|0|||
162874900|NCT03580382|588245055|FG001|Overall Study|Early Termination of Study|3|||
162874901|NCT02808312|588245056|FG000|Overall Study|Enrolled but Never Treated|0|||
162874902|NCT02808312|588245057|FG001|Overall Study|Enrolled but Never Treated|0|||
162874903|NCT02808312|588245058|FG002|Overall Study|Enrolled but Never Treated|1|||
162874904|NCT02808312|588245059|FG003|Overall Study|Enrolled but Never Treated|0|||
162874905|NCT02808312|588245060|FG004|Overall Study|Enrolled but Never Treated|0|||
162874906|NCT03628417|588245061|FG000|Overall Study|Death|1|||
162874907|NCT03628417|588245062|FG001|Overall Study|Death|1|||
162874908|NCT02420223|588245063|FG000|Overall Study|Adverse Event|1|||
162874909|NCT02420223|588245064|FG001|Overall Study|Adverse Event|0|||
162874910|NCT02420223|588245063|FG000|Overall Study|Physician Decision|0|||
162874911|NCT02420223|588245064|FG001|Overall Study|Physician Decision|2|||
162874912|NCT01361009|588245065|FG000|Overall Study|Protocol Violation|116|||
162874913|NCT01826422|588245066|FG000|Overall Study|Withdrawal by Subject|1|||
162874914|NCT01826422|588245067|FG001|Overall Study|Withdrawal by Subject|3|||
162874915|NCT03484923|588245073|FG000|Overall Study|Adverse Event|3|||
162874916|NCT03484923|588245074|FG001|Overall Study|Adverse Event|3|||
162874917|NCT03484923|588245075|FG002|Overall Study|Adverse Event|5|||
162961464|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961465|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
162961466|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961467|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961468|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
162874918|NCT03484923|588245076|FG003|Overall Study|Adverse Event|11|||
162874919|NCT03484923|588245077|FG004|Overall Study|Adverse Event|1|||
162874920|NCT03484923|588245073|FG000|Overall Study|Death|2|||
162874921|NCT03484923|588245074|FG001|Overall Study|Death|2|||
162874922|NCT03484923|588245075|FG002|Overall Study|Death|3|||
162874923|NCT03484923|588245076|FG003|Overall Study|Death|0|||
162874924|NCT03484923|588245077|FG004|Overall Study|Death|1|||
162874925|NCT03484923|588245073|FG000|Overall Study|Physician Decision|6|||
162874926|NCT03484923|588245074|FG001|Overall Study|Physician Decision|7|||
162874927|NCT03484923|588245075|FG002|Overall Study|Physician Decision|6|||
162874928|NCT03484923|588245076|FG003|Overall Study|Physician Decision|3|||
162874929|NCT03484923|588245077|FG004|Overall Study|Physician Decision|2|||
162874930|NCT03484923|588245073|FG000|Overall Study|Progressive disease|33|||
162874931|NCT03484923|588245074|FG001|Overall Study|Progressive disease|28|||
162874932|NCT03484923|588245075|FG002|Overall Study|Progressive disease|26|||
162874933|NCT03484923|588245076|FG003|Overall Study|Progressive disease|30|||
162874934|NCT03484923|588245077|FG004|Overall Study|Progressive disease|16|||
162874935|NCT03484923|588245073|FG000|Overall Study|Subject Decision|1|||
162874936|NCT03484923|588245074|FG001|Overall Study|Subject Decision|3|||
162874937|NCT03484923|588245075|FG002|Overall Study|Subject Decision|3|||
162874938|NCT03484923|588245076|FG003|Overall Study|Subject Decision|0|||
162874939|NCT03484923|588245077|FG004|Overall Study|Subject Decision|1|||
162874940|NCT01863849|588245078|FG000|Overall Study|Lost to Follow-up|1|||
162874941|NCT01863849|588245079|FG001|Overall Study|Lost to Follow-up|0|||
162874942|NCT04402008|588245082|FG000|Overall Study|Adverse Event|0|||
162874943|NCT04402008|588245083|FG001|Overall Study|Adverse Event|0|||
162874944|NCT04402008|588245084|FG002|Overall Study|Adverse Event|0|||
162874945|NCT04402008|588245085|FG003|Overall Study|Adverse Event|1|||
162874946|NCT04402008|588245086|FG004|Overall Study|Adverse Event|0|||
162874947|NCT04402008|588245087|FG005|Overall Study|Adverse Event|0|||
162874948|NCT04402008|588245088|FG006|Overall Study|Adverse Event|0|||
162874949|NCT04402008|588245082|FG000|Overall Study|Disease Progression|3|||
162874950|NCT04402008|588245083|FG001|Overall Study|Disease Progression|2|||
162874951|NCT04402008|588245084|FG002|Overall Study|Disease Progression|3|||
162874952|NCT04402008|588245085|FG003|Overall Study|Disease Progression|3|||
162874953|NCT04402008|588245086|FG004|Overall Study|Disease Progression|4|||
162874954|NCT04402008|588245087|FG005|Overall Study|Disease Progression|3|||
162874955|NCT04402008|588245088|FG006|Overall Study|Disease Progression|10|||
162874956|NCT04402008|588245082|FG000|Overall Study|Withdrawal by Subject|0|||
162874957|NCT04402008|588245083|FG001|Overall Study|Withdrawal by Subject|1|||
162874958|NCT04402008|588245084|FG002|Overall Study|Withdrawal by Subject|0|||
162874959|NCT04402008|588245085|FG003|Overall Study|Withdrawal by Subject|0|||
162874960|NCT04402008|588245086|FG004|Overall Study|Withdrawal by Subject|1|||
162874961|NCT04402008|588245087|FG005|Overall Study|Withdrawal by Subject|0|||
162874962|NCT04402008|588245088|FG006|Overall Study|Withdrawal by Subject|0|||
162874963|NCT04402008|588245082|FG000|Overall Study|Sponsor Decision|0|||
162874964|NCT04402008|588245083|FG001|Overall Study|Sponsor Decision|0|||
162874965|NCT04402008|588245084|FG002|Overall Study|Sponsor Decision|0|||
162874966|NCT04402008|588245085|FG003|Overall Study|Sponsor Decision|0|||
162874967|NCT04402008|588245086|FG004|Overall Study|Sponsor Decision|0|||
162874968|NCT04402008|588245087|FG005|Overall Study|Sponsor Decision|0|||
162874969|NCT04402008|588245088|FG006|Overall Study|Sponsor Decision|3|||
162874970|NCT04402008|588245082|FG000|Overall Study|Death|0|||
162874971|NCT04402008|588245083|FG001|Overall Study|Death|0|||
162874972|NCT04402008|588245084|FG002|Overall Study|Death|0|||
162874973|NCT04402008|588245085|FG003|Overall Study|Death|0|||
162874974|NCT04402008|588245086|FG004|Overall Study|Death|1|||
162874975|NCT04402008|588245087|FG005|Overall Study|Death|0|||
162874976|NCT04402008|588245088|FG006|Overall Study|Death|2|||
162874977|NCT04402008|588245082|FG000|Overall Study|Other|0|||
162874978|NCT04402008|588245083|FG001|Overall Study|Other|0|||
162874979|NCT04402008|588245084|FG002|Overall Study|Other|0|||
162874980|NCT04402008|588245085|FG003|Overall Study|Other|0|||
162874981|NCT04402008|588245086|FG004|Overall Study|Other|0|||
162874982|NCT04402008|588245087|FG005|Overall Study|Other|0|||
162874983|NCT04402008|588245088|FG006|Overall Study|Other|5|||
162874984|NCT00913978|588245089|FG000|Overall Study|Surgeon choice|1|||
162874985|NCT00913978|588245090|FG001|Overall Study|Surgeon choice|3|||
162874986|NCT04716933|588245091|FG000|Overall Study|Sponsor Decision|36|||
162874987|NCT04716933|588245092|FG001|Overall Study|Sponsor Decision|33|||
162874988|NCT04716933|588245091|FG000|Overall Study|Death|65|||
162874989|NCT04716933|588245092|FG001|Overall Study|Death|67|||
162874990|NCT01327651|588245093|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
162874991|NCT01327651|588245094|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
162874992|NCT01327651|588245095|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
162874993|NCT01327651|588245096|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
162874994|NCT01327651|588245097|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
162874995|NCT01327651|588245098|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
162874996|NCT01327651|588245099|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
162874997|NCT01327651|588245100|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
162874998|NCT01327651|588245101|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
162874999|NCT01327651|588245093|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
162875000|NCT01327651|588245094|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875001|NCT01327651|588245095|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875002|NCT01327651|588245096|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875003|NCT01327651|588245097|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875004|NCT01327651|588245098|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875005|NCT01327651|588245099|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875006|NCT01327651|588245100|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875007|NCT01327651|588245101|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
162875008|NCT01327651|588245093|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
162875009|NCT01327651|588245094|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
162875010|NCT01327651|588245095|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
162875011|NCT01327651|588245096|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
162875012|NCT01327651|588245097|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
162875013|NCT01327651|588245098|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
162875014|NCT01327651|588245099|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
162875015|NCT01327651|588245100|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
162875016|NCT01327651|588245101|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
162875017|NCT01327651|588245093|FG000|Post Study Follow-up|Lost to Follow-up|0|||
162875018|NCT01327651|588245094|FG001|Post Study Follow-up|Lost to Follow-up|1|||
162875019|NCT01327651|588245095|FG002|Post Study Follow-up|Lost to Follow-up|1|||
162875020|NCT01327651|588245096|FG003|Post Study Follow-up|Lost to Follow-up|0|||
162875021|NCT01327651|588245097|FG004|Post Study Follow-up|Lost to Follow-up|0|||
162875022|NCT01327651|588245098|FG005|Post Study Follow-up|Lost to Follow-up|0|||
162875023|NCT01327651|588245099|FG006|Post Study Follow-up|Lost to Follow-up|4|||
162875024|NCT01327651|588245100|FG007|Post Study Follow-up|Lost to Follow-up|1|||
162875025|NCT01327651|588245101|FG008|Post Study Follow-up|Lost to Follow-up|2|||
162875026|NCT03249792|588245102|FG000|Arms 1, 2, and 4|Death|1|||
162875027|NCT03249792|588245103|FG001|Arms 1, 2, and 4|Death|1|||
162875028|NCT03249792|588245104|FG002|Arms 1, 2, and 4|Death|0|||
162875029|NCT03249792|588245105|FG003|Arms 1, 2, and 4|Death|2|||
162875030|NCT03249792|588245106|FG004|Arms 1, 2, and 4|Death|3|||
162875031|NCT03249792|588245107|FG005|Arms 1, 2, and 4|Death|2|||
162875032|NCT03249792|588245108|FG006|Arms 1, 2, and 4|Death|2|||
162875033|NCT03249792|588245109|FG007|Arms 1, 2, and 4|Death|4|||
162875034|NCT03249792|588245110|FG008|Arms 1, 2, and 4|Death|2|||
162875035|NCT03249792|588245111|FG009|Arms 1, 2, and 4|Death|1|||
162875036|NCT03249792|588245112|FG010|Arms 1, 2, and 4|Death|7|||
162875037|NCT03249792|588245113|FG011|Arms 1, 2, and 4|Death|7|||
162875038|NCT03249792|588245114|FG012|Arms 1, 2, and 4|Death|12|||
162875039|NCT03249792|588245115|FG013|Arms 1, 2, and 4|Death|7|||
162875040|NCT03249792|588245116|FG014|Arms 1, 2, and 4|Death|0|||
162875041|NCT03249792|588245117|FG015|Arms 1, 2, and 4|Death|4|||
162875042|NCT03249792|588245118|FG016|Arms 1, 2, and 4|Death|4|||
162875043|NCT03249792|588245119|FG017|Arms 1, 2, and 4|Death|12|||
162875044|NCT03249792|588245120|FG018|Arms 1, 2, and 4|Death|6|||
162875045|NCT03249792|588245121|FG019|Arms 1, 2, and 4|Death|4|||
162875046|NCT03249792|588245122|FG020|Arms 1, 2, and 4|Death|2|||
162875047|NCT03249792|588245123|FG021|Arms 1, 2, and 4|Death|3|||
162875048|NCT03249792|588245124|FG022|Arms 1, 2, and 4|Death|1|||
162875049|NCT03249792|588245125|FG023|Arms 1, 2, and 4|Death|1|||
162875050|NCT03249792|588245126|FG024|Arms 1, 2, and 4|Death|4|||
162875051|NCT03249792|588245127|FG025|Arms 1, 2, and 4|Death|0|||
162875052|NCT03249792|588245128|FG026|Arms 1, 2, and 4|Death|0|||
162875053|NCT03249792|588245129|FG027|Arms 1, 2, and 4|Death|0|||
162875054|NCT03249792|588245130|FG028|Arms 1, 2, and 4|Death|0|||
162875055|NCT03249792|588245131|FG029|Arms 1, 2, and 4|Death|0|||
162875056|NCT03249792|588245132|FG030|Arms 1, 2, and 4|Death|0|||
162875057|NCT03249792|588245133|FG031|Arms 1, 2, and 4|Death|0|||
162875058|NCT03249792|588245134|FG032|Arms 1, 2, and 4|Death|0|||
162875059|NCT03249792|588245102|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
163047843|NCT03934216|588882618|FG001|Overall Study|Adverse Event|11|||
162875060|NCT03249792|588245103|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875061|NCT03249792|588245104|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875062|NCT03249792|588245105|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875063|NCT03249792|588245106|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875064|NCT03249792|588245107|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875065|NCT03249792|588245108|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
162875066|NCT03249792|588245109|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875067|NCT03249792|588245110|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
162875068|NCT03249792|588245111|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875069|NCT03249792|588245112|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
162875070|NCT03249792|588245113|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
162875071|NCT03249792|588245114|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
162615644|NCT00734474|587311531|FG008|Overall Study|Physician Decision|9|||
162615645|NCT00734474|587311523|FG000|Overall Study|Adverse Event|4|||
162615646|NCT00734474|587311524|FG001|Overall Study|Adverse Event|4|||
162615647|NCT00734474|587311525|FG002|Overall Study|Adverse Event|63|||
162615648|NCT00734474|587311526|FG003|Overall Study|Adverse Event|1|||
162615649|NCT00734474|587311527|FG004|Overall Study|Adverse Event|64|||
162615650|NCT00734474|587311528|FG005|Overall Study|Adverse Event|0|||
162615651|NCT00734474|587311529|FG006|Overall Study|Adverse Event|1|||
162615652|NCT00734474|587311530|FG007|Overall Study|Adverse Event|65|||
162615653|NCT00734474|587311531|FG008|Overall Study|Adverse Event|39|||
162615654|NCT00734474|587311523|FG000|Overall Study|Protocol Violation|0|||
162615655|NCT00734474|587311524|FG001|Overall Study|Protocol Violation|0|||
162615656|NCT00734474|587311525|FG002|Overall Study|Protocol Violation|4|||
162615657|NCT00734474|587311526|FG003|Overall Study|Protocol Violation|0|||
162615658|NCT00734474|587311527|FG004|Overall Study|Protocol Violation|3|||
162615659|NCT00734474|587311528|FG005|Overall Study|Protocol Violation|0|||
162615660|NCT00734474|587311529|FG006|Overall Study|Protocol Violation|0|||
162615661|NCT00734474|587311530|FG007|Overall Study|Protocol Violation|3|||
162615662|NCT00734474|587311531|FG008|Overall Study|Protocol Violation|1|||
162615663|NCT00734474|587311523|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
162615664|NCT00734474|587311524|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
162615665|NCT00734474|587311525|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162615666|NCT00734474|587311526|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
162615667|NCT00734474|587311527|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162615668|NCT00734474|587311528|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
162615669|NCT00734474|587311529|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
162615670|NCT00734474|587311530|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162615671|NCT00734474|587311531|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162615672|NCT00734474|587311523|FG000|Overall Study|Sponsor Decision|0|||
162615673|NCT00734474|587311524|FG001|Overall Study|Sponsor Decision|0|||
162615674|NCT00734474|587311525|FG002|Overall Study|Sponsor Decision|0|||
162615675|NCT00734474|587311526|FG003|Overall Study|Sponsor Decision|0|||
162615676|NCT00734474|587311527|FG004|Overall Study|Sponsor Decision|2|||
162615677|NCT00734474|587311528|FG005|Overall Study|Sponsor Decision|0|||
162615678|NCT00734474|587311529|FG006|Overall Study|Sponsor Decision|0|||
162615679|NCT00734474|587311530|FG007|Overall Study|Sponsor Decision|0|||
162615680|NCT00734474|587311531|FG008|Overall Study|Sponsor Decision|0|||
162615681|NCT00734474|587311523|FG000|Overall Study|Death|0|||
162615682|NCT00734474|587311524|FG001|Overall Study|Death|0|||
162615683|NCT00734474|587311525|FG002|Overall Study|Death|1|||
162615684|NCT00734474|587311526|FG003|Overall Study|Death|0|||
162615685|NCT00734474|587311527|FG004|Overall Study|Death|0|||
162615686|NCT00734474|587311528|FG005|Overall Study|Death|0|||
162615687|NCT00734474|587311529|FG006|Overall Study|Death|0|||
162615688|NCT00734474|587311530|FG007|Overall Study|Death|2|||
162615689|NCT00734474|587311531|FG008|Overall Study|Death|1|||
162615690|NCT00734474|587311523|FG000|Overall Study|Lack of Efficacy|0|||
162615691|NCT00734474|587311524|FG001|Overall Study|Lack of Efficacy|0|||
162615692|NCT00734474|587311525|FG002|Overall Study|Lack of Efficacy|4|||
162615693|NCT00734474|587311526|FG003|Overall Study|Lack of Efficacy|0|||
162615694|NCT00734474|587311527|FG004|Overall Study|Lack of Efficacy|0|||
162615695|NCT00734474|587311528|FG005|Overall Study|Lack of Efficacy|0|||
162615696|NCT00734474|587311529|FG006|Overall Study|Lack of Efficacy|0|||
162615697|NCT00734474|587311530|FG007|Overall Study|Lack of Efficacy|4|||
162615698|NCT00734474|587311531|FG008|Overall Study|Lack of Efficacy|6|||
162615699|NCT02104752|587311532|FG000|Overall Study|Withdrawal by Subject|1|||
162615700|NCT02104752|587311533|FG001|Overall Study|Withdrawal by Subject|0|||
162615701|NCT02104752|587311532|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
162615702|NCT02104752|587311533|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
162615703|NCT02899299|587311534|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
162615704|NCT02899299|587311535|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
162615705|NCT02899299|587311534|FG000|Pre-treatment|Participant withdrew consent|1|||
162615706|NCT02899299|587311535|FG001|Pre-treatment|Participant withdrew consent|11|||
162615707|NCT02899299|587311534|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
162615708|NCT02899299|587311535|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
162615709|NCT02899299|587311534|FG000|Pre-treatment|Not reported|0|||
162706879|NCT04955626|587636664|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
162615710|NCT02899299|587311535|FG001|Pre-treatment|Not reported|1|||
162615711|NCT02899299|587311534|FG000|Treatment|Disease Progression|182|||
162615712|NCT02899299|587311535|FG001|Treatment|Disease Progression|43|||
162615713|NCT02899299|587311534|FG000|Treatment|Study Drug Toxicity|60|||
162615714|NCT02899299|587311535|FG001|Treatment|Study Drug Toxicity|24|||
162615715|NCT02899299|587311534|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
162615716|NCT02899299|587311535|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
162615717|NCT02899299|587311534|FG000|Treatment|Participant request to discontinue Study treatment|4|||
162615718|NCT02899299|587311535|FG001|Treatment|Participant request to discontinue Study treatment|10|||
162615719|NCT02899299|587311534|FG000|Treatment|Participant withdrew consent|6|||
162875072|NCT03249792|588245115|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
162875073|NCT03249792|588245116|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875074|NCT03249792|588245117|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875075|NCT03249792|588245118|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
162875076|NCT03249792|588245119|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875077|NCT03249792|588245120|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875078|NCT03249792|588245121|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875079|NCT03249792|588245122|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875080|NCT03249792|588245123|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875081|NCT03249792|588245124|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875082|NCT03249792|588245125|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
162875083|NCT03249792|588245126|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875084|NCT03249792|588245127|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875085|NCT03249792|588245128|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875086|NCT03249792|588245129|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875087|NCT03249792|588245130|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875088|NCT03249792|588245131|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875089|NCT03249792|588245132|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875090|NCT03249792|588245133|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875091|NCT03249792|588245134|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
162875092|NCT03249792|588245102|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
162875093|NCT03249792|588245103|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
162875094|NCT03249792|588245104|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
162875095|NCT03249792|588245105|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
162875096|NCT03249792|588245106|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
162875097|NCT03249792|588245107|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
162875098|NCT03249792|588245108|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
162875099|NCT03249792|588245109|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
162875100|NCT03249792|588245110|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
162875101|NCT03249792|588245111|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
162875102|NCT03249792|588245112|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
162875103|NCT03249792|588245113|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
162875104|NCT03249792|588245114|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
162875105|NCT03249792|588245115|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
162875106|NCT03249792|588245116|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
162875107|NCT03249792|588245117|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
162875108|NCT03249792|588245118|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
162875109|NCT03249792|588245119|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
162875110|NCT03249792|588245120|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
162875111|NCT03249792|588245121|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
162875112|NCT03249792|588245122|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
162875113|NCT03249792|588245123|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
162875114|NCT03249792|588245124|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
162875115|NCT03249792|588245125|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
162875116|NCT03249792|588245126|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
162875117|NCT03249792|588245127|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
162875118|NCT03249792|588245128|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
162875119|NCT03249792|588245129|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
162875120|NCT03249792|588245130|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
162875121|NCT03249792|588245131|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
162875122|NCT03249792|588245132|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
162875123|NCT03249792|588245133|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
162875124|NCT03249792|588245134|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
162875125|NCT03249792|588245102|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875126|NCT03249792|588245103|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875127|NCT03249792|588245104|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875128|NCT03249792|588245105|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875129|NCT03249792|588245106|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875130|NCT03249792|588245107|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875131|NCT03249792|588245108|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875132|NCT03249792|588245109|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875133|NCT03249792|588245110|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
162875134|NCT03249792|588245111|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875135|NCT03249792|588245112|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875136|NCT03249792|588245113|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875137|NCT03249792|588245114|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875138|NCT03249792|588245115|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875139|NCT03249792|588245116|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875140|NCT03249792|588245117|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875141|NCT03249792|588245118|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
162875142|NCT03249792|588245119|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
162875143|NCT03249792|588245120|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875144|NCT03249792|588245121|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
162875145|NCT03249792|588245122|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875146|NCT03249792|588245123|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875147|NCT03249792|588245124|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875148|NCT03249792|588245125|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875149|NCT03249792|588245126|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875150|NCT03249792|588245127|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875151|NCT03249792|588245128|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875152|NCT03249792|588245129|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875153|NCT03249792|588245130|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875154|NCT03249792|588245131|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875155|NCT03249792|588245132|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875156|NCT03249792|588245133|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875157|NCT03249792|588245134|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
162875158|NCT03249792|588245102|FG000|Switch Over Period|Withdrawal by Subject|0|||
162875159|NCT03249792|588245103|FG001|Switch Over Period|Withdrawal by Subject|0|||
162875160|NCT03249792|588245104|FG002|Switch Over Period|Withdrawal by Subject|0|||
162875161|NCT03249792|588245105|FG003|Switch Over Period|Withdrawal by Subject|0|||
162875162|NCT03249792|588245106|FG004|Switch Over Period|Withdrawal by Subject|0|||
162875163|NCT03249792|588245107|FG005|Switch Over Period|Withdrawal by Subject|0|||
162875164|NCT03249792|588245108|FG006|Switch Over Period|Withdrawal by Subject|0|||
162875165|NCT03249792|588245109|FG007|Switch Over Period|Withdrawal by Subject|0|||
162875166|NCT03249792|588245110|FG008|Switch Over Period|Withdrawal by Subject|0|||
162875167|NCT03249792|588245111|FG009|Switch Over Period|Withdrawal by Subject|0|||
162875168|NCT03249792|588245112|FG010|Switch Over Period|Withdrawal by Subject|0|||
162875169|NCT03249792|588245113|FG011|Switch Over Period|Withdrawal by Subject|0|||
162875170|NCT03249792|588245114|FG012|Switch Over Period|Withdrawal by Subject|0|||
162875171|NCT03249792|588245115|FG013|Switch Over Period|Withdrawal by Subject|0|||
162875172|NCT03249792|588245116|FG014|Switch Over Period|Withdrawal by Subject|0|||
162875173|NCT03249792|588245117|FG015|Switch Over Period|Withdrawal by Subject|0|||
162875174|NCT03249792|588245118|FG016|Switch Over Period|Withdrawal by Subject|0|||
162875175|NCT03249792|588245119|FG017|Switch Over Period|Withdrawal by Subject|0|||
162875176|NCT03249792|588245120|FG018|Switch Over Period|Withdrawal by Subject|0|||
162875177|NCT03249792|588245121|FG019|Switch Over Period|Withdrawal by Subject|0|||
162875178|NCT03249792|588245122|FG020|Switch Over Period|Withdrawal by Subject|0|||
162875179|NCT03249792|588245123|FG021|Switch Over Period|Withdrawal by Subject|0|||
162875180|NCT03249792|588245124|FG022|Switch Over Period|Withdrawal by Subject|0|||
162875181|NCT03249792|588245125|FG023|Switch Over Period|Withdrawal by Subject|0|||
162875182|NCT03249792|588245126|FG024|Switch Over Period|Withdrawal by Subject|0|||
162875183|NCT03249792|588245127|FG025|Switch Over Period|Withdrawal by Subject|0|||
162875184|NCT03249792|588245128|FG026|Switch Over Period|Withdrawal by Subject|0|||
162875185|NCT03249792|588245129|FG027|Switch Over Period|Withdrawal by Subject|0|||
162875186|NCT03249792|588245130|FG028|Switch Over Period|Withdrawal by Subject|0|||
162875187|NCT03249792|588245131|FG029|Switch Over Period|Withdrawal by Subject|0|||
162875188|NCT03249792|588245132|FG030|Switch Over Period|Withdrawal by Subject|0|||
162875189|NCT03249792|588245133|FG031|Switch Over Period|Withdrawal by Subject|1|||
162875190|NCT03249792|588245134|FG032|Switch Over Period|Withdrawal by Subject|0|||
162875191|NCT03249792|588245102|FG000|Switch Over Period|Progressive Disease|0|||
162875192|NCT03249792|588245103|FG001|Switch Over Period|Progressive Disease|0|||
162875193|NCT03249792|588245104|FG002|Switch Over Period|Progressive Disease|0|||
162875194|NCT03249792|588245105|FG003|Switch Over Period|Progressive Disease|0|||
162875195|NCT03249792|588245106|FG004|Switch Over Period|Progressive Disease|0|||
162875196|NCT03249792|588245107|FG005|Switch Over Period|Progressive Disease|0|||
162875197|NCT03249792|588245108|FG006|Switch Over Period|Progressive Disease|0|||
162875198|NCT03249792|588245109|FG007|Switch Over Period|Progressive Disease|0|||
162875199|NCT03249792|588245110|FG008|Switch Over Period|Progressive Disease|0|||
162875200|NCT03249792|588245111|FG009|Switch Over Period|Progressive Disease|0|||
162875201|NCT03249792|588245112|FG010|Switch Over Period|Progressive Disease|0|||
162875202|NCT03249792|588245113|FG011|Switch Over Period|Progressive Disease|0|||
162875203|NCT03249792|588245114|FG012|Switch Over Period|Progressive Disease|0|||
162875204|NCT03249792|588245115|FG013|Switch Over Period|Progressive Disease|0|||
162875205|NCT03249792|588245116|FG014|Switch Over Period|Progressive Disease|0|||
162875206|NCT03249792|588245117|FG015|Switch Over Period|Progressive Disease|0|||
162875207|NCT03249792|588245118|FG016|Switch Over Period|Progressive Disease|0|||
162875208|NCT03249792|588245119|FG017|Switch Over Period|Progressive Disease|0|||
162875209|NCT03249792|588245120|FG018|Switch Over Period|Progressive Disease|0|||
162875210|NCT03249792|588245121|FG019|Switch Over Period|Progressive Disease|0|||
162875211|NCT03249792|588245122|FG020|Switch Over Period|Progressive Disease|0|||
162875212|NCT03249792|588245123|FG021|Switch Over Period|Progressive Disease|0|||
162875213|NCT03249792|588245124|FG022|Switch Over Period|Progressive Disease|0|||
162875214|NCT03249792|588245125|FG023|Switch Over Period|Progressive Disease|0|||
162875215|NCT03249792|588245126|FG024|Switch Over Period|Progressive Disease|0|||
162875216|NCT03249792|588245127|FG025|Switch Over Period|Progressive Disease|0|||
162875217|NCT03249792|588245128|FG026|Switch Over Period|Progressive Disease|1|||
162875218|NCT03249792|588245129|FG027|Switch Over Period|Progressive Disease|0|||
162875219|NCT03249792|588245130|FG028|Switch Over Period|Progressive Disease|1|||
162875220|NCT03249792|588245131|FG029|Switch Over Period|Progressive Disease|2|||
162875221|NCT03249792|588245132|FG030|Switch Over Period|Progressive Disease|1|||
162875222|NCT03249792|588245133|FG031|Switch Over Period|Progressive Disease|0|||
162875223|NCT03249792|588245134|FG032|Switch Over Period|Progressive Disease|1|||
162875224|NCT03249792|588245102|FG000|Switch Over Period|Adverse Event|0|||
162875225|NCT03249792|588245103|FG001|Switch Over Period|Adverse Event|0|||
162875226|NCT03249792|588245104|FG002|Switch Over Period|Adverse Event|0|||
162875227|NCT03249792|588245105|FG003|Switch Over Period|Adverse Event|0|||
162875228|NCT03249792|588245106|FG004|Switch Over Period|Adverse Event|0|||
162875229|NCT03249792|588245107|FG005|Switch Over Period|Adverse Event|0|||
162875230|NCT03249792|588245108|FG006|Switch Over Period|Adverse Event|0|||
162875231|NCT03249792|588245109|FG007|Switch Over Period|Adverse Event|0|||
162875232|NCT03249792|588245110|FG008|Switch Over Period|Adverse Event|0|||
163047844|NCT03934216|588882617|FG000|Overall Study|Lack of Efficacy|8|||
162875233|NCT03249792|588245111|FG009|Switch Over Period|Adverse Event|0|||
162875234|NCT03249792|588245112|FG010|Switch Over Period|Adverse Event|0|||
162875235|NCT03249792|588245113|FG011|Switch Over Period|Adverse Event|0|||
162875236|NCT03249792|588245114|FG012|Switch Over Period|Adverse Event|0|||
162875237|NCT03249792|588245115|FG013|Switch Over Period|Adverse Event|0|||
162875238|NCT03249792|588245116|FG014|Switch Over Period|Adverse Event|0|||
162875239|NCT03249792|588245117|FG015|Switch Over Period|Adverse Event|0|||
162875240|NCT03249792|588245118|FG016|Switch Over Period|Adverse Event|0|||
162875241|NCT03249792|588245119|FG017|Switch Over Period|Adverse Event|0|||
162875242|NCT03249792|588245120|FG018|Switch Over Period|Adverse Event|0|||
162875243|NCT03249792|588245121|FG019|Switch Over Period|Adverse Event|0|||
162875244|NCT03249792|588245122|FG020|Switch Over Period|Adverse Event|0|||
162875245|NCT03249792|588245123|FG021|Switch Over Period|Adverse Event|0|||
162875246|NCT03249792|588245124|FG022|Switch Over Period|Adverse Event|0|||
162875247|NCT03249792|588245125|FG023|Switch Over Period|Adverse Event|0|||
162875248|NCT03249792|588245126|FG024|Switch Over Period|Adverse Event|0|||
162875249|NCT03249792|588245127|FG025|Switch Over Period|Adverse Event|1|||
162875250|NCT03249792|588245128|FG026|Switch Over Period|Adverse Event|0|||
162875251|NCT03249792|588245129|FG027|Switch Over Period|Adverse Event|1|||
162875252|NCT03249792|588245130|FG028|Switch Over Period|Adverse Event|0|||
162875253|NCT03249792|588245131|FG029|Switch Over Period|Adverse Event|0|||
162875254|NCT03249792|588245132|FG030|Switch Over Period|Adverse Event|0|||
162875255|NCT03249792|588245133|FG031|Switch Over Period|Adverse Event|0|||
162875256|NCT03249792|588245134|FG032|Switch Over Period|Adverse Event|0|||
162875257|NCT01409031|588245138|FG000|Overall Study|transferred to other hosp|1|||
162875258|NCT01409031|588245139|FG001|Overall Study|transferred to other hosp|0|||
162875259|NCT00532948|588245140|FG000|Overall Study|Protocol Violation|1|||
162875260|NCT00532948|588245141|FG001|Overall Study|Protocol Violation|0|||
162875261|NCT00532948|588245142|FG002|Overall Study|Protocol Violation|0|||
162875262|NCT00532948|588245140|FG000|Overall Study|Death|3|||
162875263|NCT00532948|588245141|FG001|Overall Study|Death|3|||
162875264|NCT00532948|588245142|FG002|Overall Study|Death|4|||
162875265|NCT00532948|588245140|FG000|Overall Study|Violation of selection criteria at entry|0|||
162875266|NCT00532948|588245141|FG001|Overall Study|Violation of selection criteria at entry|1|||
162875267|NCT00532948|588245142|FG002|Overall Study|Violation of selection criteria at entry|0|||
162875268|NCT00532948|588245140|FG000|Overall Study|Failure to return|0|||
162875269|NCT00532948|588245141|FG001|Overall Study|Failure to return|1|||
162875270|NCT00532948|588245142|FG002|Overall Study|Failure to return|0|||
162875271|NCT00995345|588245143|FG000|Overall Study|Withdrawal by Subject|4|||
162875272|NCT00995345|588245144|FG001|Overall Study|Withdrawal by Subject|2|||
162875273|NCT00995345|588245145|FG002|Overall Study|Withdrawal by Subject|1|||
162875274|NCT00995345|588245146|FG003|Overall Study|Withdrawal by Subject|3|||
162875275|NCT00995345|588245147|FG004|Overall Study|Withdrawal by Subject|1|||
162875276|NCT00995345|588245143|FG000|Overall Study|Adverse Event|3|||
162875277|NCT00995345|588245144|FG001|Overall Study|Adverse Event|1|||
162875278|NCT00995345|588245145|FG002|Overall Study|Adverse Event|2|||
162875279|NCT00995345|588245146|FG003|Overall Study|Adverse Event|0|||
162875280|NCT00995345|588245147|FG004|Overall Study|Adverse Event|1|||
162875281|NCT00995345|588245143|FG000|Overall Study|Lost to Follow-up|2|||
162875282|NCT00995345|588245144|FG001|Overall Study|Lost to Follow-up|2|||
162875283|NCT00995345|588245145|FG002|Overall Study|Lost to Follow-up|2|||
162875284|NCT00995345|588245146|FG003|Overall Study|Lost to Follow-up|1|||
162875285|NCT00995345|588245147|FG004|Overall Study|Lost to Follow-up|0|||
162875286|NCT00995345|588245143|FG000|Overall Study|all other reasons combined|2|||
162875287|NCT00995345|588245144|FG001|Overall Study|all other reasons combined|2|||
162875288|NCT00995345|588245145|FG002|Overall Study|all other reasons combined|2|||
162875289|NCT00995345|588245146|FG003|Overall Study|all other reasons combined|1|||
162875290|NCT00995345|588245147|FG004|Overall Study|all other reasons combined|3|||
162875291|NCT02509598|588245152|FG000|Overall Study|Withdrawal by Subject|1|||
162875292|NCT01201798|588245157|FG000|Overall Study|Adverse Event|2|||
162875293|NCT01201798|588245158|FG001|Overall Study|Adverse Event|0|||
162875294|NCT01201798|588245157|FG000|Overall Study|Lost to Follow-up|3|||
162875295|NCT01201798|588245158|FG001|Overall Study|Lost to Follow-up|5|||
162875296|NCT01201798|588245157|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
162875297|NCT01201798|588245158|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
162875298|NCT01201798|588245157|FG000|Overall Study|Noncompliance|1|||
162875299|NCT01201798|588245158|FG001|Overall Study|Noncompliance|0|||
162875300|NCT01201798|588245157|FG000|Overall Study|Protocol Violation|1|||
162875301|NCT01201798|588245158|FG001|Overall Study|Protocol Violation|1|||
162875302|NCT01201798|588245157|FG000|Overall Study|Treatment Failure|1|||
162875303|NCT01201798|588245158|FG001|Overall Study|Treatment Failure|8|||
162875304|NCT03521687|588245159|FG000|Overall Study|Adverse Event|4|||
162875305|NCT03521687|588245159|FG000|Overall Study|Physician Decision|1|||
162875306|NCT04891770|588245164|FG000|Overall Study|Withdrew consent|1|||
162875307|NCT04891770|588245165|FG001|Overall Study|Withdrew consent|3|||
162875308|NCT04891770|588245166|FG002|Overall Study|Withdrew consent|0|||
162875309|NCT04891770|588245164|FG000|Overall Study|Enrolled but never treated|0|||
162875310|NCT04891770|588245165|FG001|Overall Study|Enrolled but never treated|0|||
162875311|NCT04891770|588245166|FG002|Overall Study|Enrolled but never treated|1|||
162875312|NCT04891770|588245164|FG000|Overall Study|Investigator's discretion|0|||
162875313|NCT04891770|588245165|FG001|Overall Study|Investigator's discretion|1|||
162875314|NCT04891770|588245166|FG002|Overall Study|Investigator's discretion|0|||
162875315|NCT00740779|588245176|FG000|Overall Study|Adverse Event|4|||
162875316|NCT00740779|588245177|FG001|Overall Study|Adverse Event|6|||
162875317|NCT00740779|588245178|FG002|Overall Study|Adverse Event|3|||
162875318|NCT00740779|588245176|FG000|Overall Study|Protocol Violation|1|||
162875319|NCT00740779|588245177|FG001|Overall Study|Protocol Violation|1|||
162875320|NCT00740779|588245178|FG002|Overall Study|Protocol Violation|1|||
162875321|NCT00740779|588245176|FG000|Overall Study|Lack of Efficacy|0|||
162875322|NCT00740779|588245177|FG001|Overall Study|Lack of Efficacy|0|||
162875323|NCT00740779|588245178|FG002|Overall Study|Lack of Efficacy|2|||
162875324|NCT00740779|588245176|FG000|Overall Study|Withdrawal by Subject|2|||
162875325|NCT00740779|588245177|FG001|Overall Study|Withdrawal by Subject|4|||
162875326|NCT00740779|588245178|FG002|Overall Study|Withdrawal by Subject|2|||
162875327|NCT00740779|588245176|FG000|Overall Study|Lost to Follow-up|2|||
162875328|NCT00740779|588245177|FG001|Overall Study|Lost to Follow-up|3|||
162875329|NCT00740779|588245178|FG002|Overall Study|Lost to Follow-up|5|||
162875330|NCT01052012|588245184|FG000|Overall Study|Not treated|2|||
162875331|NCT01052012|588245185|FG001|Overall Study|Not treated|5|||
162875332|NCT01052012|588245186|FG002|Overall Study|Not treated|0|||
162875333|NCT01052012|588245187|FG003|Overall Study|Not treated|0|||
162875334|NCT01052012|588245188|FG004|Overall Study|Not treated|11|||
162875335|NCT01052012|588245189|FG005|Overall Study|Not treated|8|||
162875336|NCT01052012|588245184|FG000|Overall Study|Adverse Event|1|||
162875337|NCT01052012|588245185|FG001|Overall Study|Adverse Event|0|||
162875338|NCT01052012|588245186|FG002|Overall Study|Adverse Event|0|||
162875339|NCT01052012|588245187|FG003|Overall Study|Adverse Event|1|||
162875340|NCT01052012|588245188|FG004|Overall Study|Adverse Event|0|||
162875341|NCT01052012|588245189|FG005|Overall Study|Adverse Event|0|||
162706880|NCT04955626|587636665|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
162706881|NCT04955626|587636666|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
162875342|NCT01052012|588245184|FG000|Overall Study|Lost to Follow-up|0|||
162875343|NCT01052012|588245185|FG001|Overall Study|Lost to Follow-up|0|||
162875344|NCT01052012|588245186|FG002|Overall Study|Lost to Follow-up|0|||
162875345|NCT01052012|588245187|FG003|Overall Study|Lost to Follow-up|0|||
162875346|NCT01052012|588245188|FG004|Overall Study|Lost to Follow-up|1|||
162875347|NCT01052012|588245189|FG005|Overall Study|Lost to Follow-up|0|||
162875348|NCT01052012|588245184|FG000|Overall Study|Withdrawal by Subject|1|||
162875349|NCT01052012|588245185|FG001|Overall Study|Withdrawal by Subject|1|||
162875350|NCT01052012|588245186|FG002|Overall Study|Withdrawal by Subject|0|||
162875351|NCT01052012|588245187|FG003|Overall Study|Withdrawal by Subject|0|||
162875352|NCT01052012|588245188|FG004|Overall Study|Withdrawal by Subject|3|||
162875353|NCT01052012|588245189|FG005|Overall Study|Withdrawal by Subject|1|||
162875354|NCT01052012|588245184|FG000|Overall Study|Physician Decision|0|||
162875355|NCT01052012|588245185|FG001|Overall Study|Physician Decision|0|||
162875356|NCT01052012|588245186|FG002|Overall Study|Physician Decision|0|||
162875357|NCT01052012|588245187|FG003|Overall Study|Physician Decision|0|||
162875358|NCT01052012|588245188|FG004|Overall Study|Physician Decision|0|||
162875359|NCT01052012|588245189|FG005|Overall Study|Physician Decision|1|||
162875360|NCT01052012|588245184|FG000|Overall Study|Other|0|||
162875361|NCT01052012|588245185|FG001|Overall Study|Other|0|||
162875362|NCT01052012|588245186|FG002|Overall Study|Other|0|||
162875363|NCT01052012|588245187|FG003|Overall Study|Other|0|||
162875364|NCT01052012|588245188|FG004|Overall Study|Other|1|||
162875365|NCT01052012|588245189|FG005|Overall Study|Other|0|||
162875366|NCT01465178|588245194|FG000|Overall Study|Withdrawal by Subject|1|||
162875367|NCT01465178|588245195|FG001|Overall Study|Withdrawal by Subject|0|||
162875368|NCT04072146|588245196|FG000|Overall Study|Adverse Event|0|||
162875369|NCT04072146|588245197|FG001|Overall Study|Adverse Event|1|||
162875370|NCT01617434|588245198|FG000|Overall Study|Adverse Event|12|||
162875371|NCT01617434|588245199|FG001|Overall Study|Adverse Event|3|||
162875372|NCT01617434|588245198|FG000|Overall Study|Protocol Violation|8|||
162875373|NCT01617434|588245199|FG001|Overall Study|Protocol Violation|7|||
162875374|NCT01617434|588245198|FG000|Overall Study|Withdrawal Criteria|12|||
162875375|NCT01617434|588245199|FG001|Overall Study|Withdrawal Criteria|37|||
162875376|NCT01617434|588245198|FG000|Overall Study|Unclassified|3|||
162875377|NCT01617434|588245199|FG001|Overall Study|Unclassified|4|||
162875378|NCT02993224|588245200|FG000|Core Phase - Period 1|Adverse Event|4|||
162875379|NCT02993224|588245200|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
162875380|NCT02993224|588245200|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
162875381|NCT02993224|588245200|FG000|Core Phase- Period 2|Adverse Event|1|||
162875382|NCT02993224|588245200|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
162875383|NCT02993224|588245200|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
162875384|NCT02993224|588245200|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
162875385|NCT02993224|588245200|FG000|Extension Phase|Adverse Event|3|||
162875386|NCT02993224|588245200|FG000|Extension Phase|Withdrawal by Subject|3|||
162875387|NCT02993224|588245200|FG000|Extension Phase|Lost to Follow-up|2|||
162875388|NCT02993224|588245200|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
162615720|NCT02899299|587311535|FG001|Treatment|Participant withdrew consent|3|||
162615721|NCT02899299|587311534|FG000|Treatment|Lost to Follow-up|0|||
162615722|NCT02899299|587311535|FG001|Treatment|Lost to Follow-up|2|||
162615723|NCT02899299|587311534|FG000|Treatment|Maximum Clinical Benefit|11|||
162615724|NCT02899299|587311535|FG001|Treatment|Maximum Clinical Benefit|2|||
162875389|NCT02426658|588245213|FG000|Overall Study|Withdrawal by Subject|1|||
162875390|NCT02426658|588245213|FG000|Overall Study|Patient expired before treatment|2|||
162875391|NCT03255291|588245214|FG000|Overall Study|Determined to be ineligible|10|||
162875392|NCT03255291|588245215|FG001|Overall Study|Determined to be ineligible|12|||
162875393|NCT03255291|588245216|FG002|Overall Study|Determined to be ineligible|6|||
162875394|NCT03255291|588245217|FG003|Overall Study|Determined to be ineligible|6|||
162875395|NCT03255291|588245218|FG004|Overall Study|Determined to be ineligible|5|||
162875396|NCT03255291|588245219|FG005|Overall Study|Determined to be ineligible|10|||
162875397|NCT03255291|588245214|FG000|Overall Study|Baseline data collection issues|3|||
162875398|NCT03255291|588245215|FG001|Overall Study|Baseline data collection issues|0|||
162875399|NCT03255291|588245216|FG002|Overall Study|Baseline data collection issues|0|||
162875400|NCT03255291|588245217|FG003|Overall Study|Baseline data collection issues|0|||
162875401|NCT03255291|588245218|FG004|Overall Study|Baseline data collection issues|2|||
162875402|NCT03255291|588245219|FG005|Overall Study|Baseline data collection issues|0|||
162706882|NCT04955626|587636667|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
162706883|NCT04955626|587636668|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
162706884|NCT04955626|587636669|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
162706885|NCT04955626|587636670|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
162706886|NCT04955626|587636671|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
162706887|NCT04955626|587636672|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
162706888|NCT04955626|587636673|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
162706889|NCT04955626|587636674|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
162706890|NCT04955626|587636675|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
162706891|NCT04955626|587636676|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
162706892|NCT04955626|587636677|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
162706893|NCT04955626|587636678|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
162706894|NCT04955626|587636679|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
162706895|NCT04955626|587636680|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
162706896|NCT04955626|587636681|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
162706897|NCT04955626|587636682|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
162706898|NCT04955626|587636683|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
162706899|NCT04955626|587636684|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
162706900|NCT04955626|587636685|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
162706901|NCT04955626|587636686|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
162706902|NCT04955626|587636687|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
162706903|NCT04955626|587636688|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
162706904|NCT04955626|587636689|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
162706905|NCT04955626|587636690|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
162706906|NCT04955626|587636691|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
162706907|NCT04955626|587636656|FG000|Open-Label Period|Other|621|||
162706908|NCT04955626|587636657|FG001|Open-Label Period|Other|429|||
162706909|NCT04955626|587636658|FG002|Open-Label Period|Other|0|||
162706910|NCT04955626|587636659|FG003|Open-Label Period|Other|0|||
162706911|NCT04955626|587636660|FG004|Open-Label Period|Other|0|||
162706912|NCT04955626|587636661|FG005|Open-Label Period|Other|0|||
162706913|NCT04955626|587636662|FG006|Open-Label Period|Other|0|||
162706914|NCT04955626|587636663|FG007|Open-Label Period|Other|0|||
162706915|NCT04955626|587636664|FG008|Open-Label Period|Other|0|||
162706916|NCT04955626|587636665|FG009|Open-Label Period|Other|0|||
162706917|NCT04955626|587636666|FG010|Open-Label Period|Other|0|||
162706918|NCT04955626|587636667|FG011|Open-Label Period|Other|0|||
162706919|NCT04955626|587636668|FG012|Open-Label Period|Other|0|||
162706920|NCT04955626|587636669|FG013|Open-Label Period|Other|0|||
162706921|NCT04955626|587636670|FG014|Open-Label Period|Other|0|||
162706922|NCT04955626|587636671|FG015|Open-Label Period|Other|0|||
162706923|NCT04955626|587636672|FG016|Open-Label Period|Other|0|||
162706924|NCT04955626|587636673|FG017|Open-Label Period|Other|0|||
162706925|NCT04955626|587636674|FG018|Open-Label Period|Other|0|||
162875403|NCT03050359|588247048|FG000|Overall Study|Randomized But Not Treated|2|||
162875404|NCT03050359|588247049|FG001|Overall Study|Randomized But Not Treated|0|||
162875405|NCT03050359|588247048|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
162875406|NCT03050359|588247049|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
162875407|NCT03050359|588247048|FG000|Overall Study|Significant Protocol Deviation|2|||
162875408|NCT03050359|588247049|FG001|Overall Study|Significant Protocol Deviation|3|||
162875409|NCT03050359|588247048|FG000|Overall Study|Lost to Follow-up|2|||
162875410|NCT03050359|588247049|FG001|Overall Study|Lost to Follow-up|1|||
162875411|NCT03050359|588247048|FG000|Overall Study|Voluntary Withdrawal|4|||
162875412|NCT03050359|588247049|FG001|Overall Study|Voluntary Withdrawal|6|||
162875413|NCT03050359|588247048|FG000|Overall Study|Pregnancy|1|||
162875414|NCT03050359|588247049|FG001|Overall Study|Pregnancy|0|||
162875415|NCT03050359|588247048|FG000|Overall Study|Reason Not Specified|1|||
162875416|NCT03050359|588247049|FG001|Overall Study|Reason Not Specified|0|||
162875417|NCT02020031|588247050|FG000|Overall Study|Physician Decision|1|||
162875418|NCT02020031|588247051|FG001|Overall Study|Physician Decision|1|||
162875419|NCT00755846|588247054|FG000|Overall Study|Adverse Event|0|||
162875420|NCT00755846|588247055|FG001|Overall Study|Adverse Event|0|||
162875421|NCT00755846|588247056|FG002|Overall Study|Adverse Event|0|||
162875422|NCT00755846|588247057|FG003|Overall Study|Adverse Event|1|||
162875423|NCT00755846|588247058|FG004|Overall Study|Adverse Event|3|||
162875424|NCT00755846|588247059|FG005|Overall Study|Adverse Event|2|||
162875425|NCT00755846|588247054|FG000|Overall Study|Protocol Violation|1|||
162875426|NCT00755846|588247055|FG001|Overall Study|Protocol Violation|1|||
162875427|NCT00755846|588247056|FG002|Overall Study|Protocol Violation|1|||
162875428|NCT00755846|588247057|FG003|Overall Study|Protocol Violation|1|||
162875429|NCT00755846|588247058|FG004|Overall Study|Protocol Violation|1|||
162875430|NCT00755846|588247059|FG005|Overall Study|Protocol Violation|1|||
163047845|NCT03934216|588882618|FG001|Overall Study|Lack of Efficacy|7|||
162875431|NCT00755846|588247054|FG000|Overall Study|Lost to Follow-up|0|||
162875432|NCT00755846|588247055|FG001|Overall Study|Lost to Follow-up|2|||
162875433|NCT00755846|588247056|FG002|Overall Study|Lost to Follow-up|1|||
162875434|NCT00755846|588247057|FG003|Overall Study|Lost to Follow-up|0|||
162875435|NCT00755846|588247058|FG004|Overall Study|Lost to Follow-up|4|||
162875436|NCT00755846|588247059|FG005|Overall Study|Lost to Follow-up|2|||
162875437|NCT00755846|588247054|FG000|Overall Study|Withdrawal by Subject|2|||
162875438|NCT00755846|588247055|FG001|Overall Study|Withdrawal by Subject|3|||
162875439|NCT00755846|588247056|FG002|Overall Study|Withdrawal by Subject|5|||
162875440|NCT00755846|588247057|FG003|Overall Study|Withdrawal by Subject|2|||
162875441|NCT00755846|588247058|FG004|Overall Study|Withdrawal by Subject|0|||
162875442|NCT00755846|588247059|FG005|Overall Study|Withdrawal by Subject|1|||
162875443|NCT00755846|588247054|FG000|Overall Study|Hyperglycemic Rescue|21|||
162875444|NCT00755846|588247055|FG001|Overall Study|Hyperglycemic Rescue|7|||
162875445|NCT00755846|588247056|FG002|Overall Study|Hyperglycemic Rescue|5|||
162875446|NCT00755846|588247057|FG003|Overall Study|Hyperglycemic Rescue|8|||
162875447|NCT00755846|588247058|FG004|Overall Study|Hyperglycemic Rescue|8|||
162875448|NCT00755846|588247059|FG005|Overall Study|Hyperglycemic Rescue|7|||
162875449|NCT00755846|588247054|FG000|Overall Study|Physician Decision|1|||
162875450|NCT00755846|588247055|FG001|Overall Study|Physician Decision|3|||
162875451|NCT00755846|588247056|FG002|Overall Study|Physician Decision|0|||
162615725|NCT02899299|587311534|FG000|Treatment|Poor/Non-compliance|1|||
162615726|NCT02899299|587311535|FG001|Treatment|Poor/Non-compliance|0|||
162615727|NCT02899299|587311534|FG000|Treatment|Participant no longer meets Study criteria|4|||
162615728|NCT02899299|587311535|FG001|Treatment|Participant no longer meets Study criteria|0|||
162615729|NCT02899299|587311534|FG000|Treatment|Administrative reason by Sponsor|2|||
162615730|NCT02899299|587311535|FG001|Treatment|Administrative reason by Sponsor|0|||
162615731|NCT02899299|587311534|FG000|Treatment|Other reasons|12|||
162615732|NCT02899299|587311535|FG001|Treatment|Other reasons|2|||
162615733|NCT02899299|587311534|FG000|Treatment|Not reported|7|||
162615734|NCT02899299|587311535|FG001|Treatment|Not reported|0|||
162615735|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
162615736|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
162615737|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
162615738|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
162615739|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
162615740|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
162615741|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
162615742|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
162615743|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
162615744|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
162615745|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
162615746|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
162615747|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
162615748|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
162615749|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
162615750|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
162615751|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
162615752|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
162615753|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
162615754|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
162615755|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
162615756|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
162615757|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
162615758|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
162615759|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
162615760|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
162615761|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
162615762|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
162615763|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
162615764|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
162615765|NCT00313300|587311536|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
162615766|NCT00313300|587311537|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162875452|NCT00755846|588247057|FG003|Overall Study|Physician Decision|1|||
162875453|NCT00755846|588247058|FG004|Overall Study|Physician Decision|0|||
162875454|NCT00755846|588247059|FG005|Overall Study|Physician Decision|1|||
162875455|NCT00755846|588247054|FG000|Overall Study|Administrative Error|0|||
162875456|NCT00755846|588247055|FG001|Overall Study|Administrative Error|1|||
162615767|NCT00313300|587311538|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162615768|NCT00313300|587311539|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162875457|NCT00755846|588247056|FG002|Overall Study|Administrative Error|0|||
163047846|NCT03934216|588882617|FG000|Overall Study|Lost to Follow-up|2|||
162615769|NCT00313300|587311540|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162706926|NCT04955626|587636675|FG019|Open-Label Period|Other|0|||
162706927|NCT04955626|587636676|FG020|Open-Label Period|Other|0|||
162706928|NCT04955626|587636677|FG021|Open-Label Period|Other|0|||
162706929|NCT04955626|587636678|FG022|Open-Label Period|Other|0|||
162706930|NCT04955626|587636679|FG023|Open-Label Period|Other|0|||
162706931|NCT04955626|587636680|FG024|Open-Label Period|Other|0|||
162706932|NCT04955626|587636681|FG025|Open-Label Period|Other|0|||
162706933|NCT04955626|587636682|FG026|Open-Label Period|Other|0|||
162706934|NCT04955626|587636683|FG027|Open-Label Period|Other|0|||
162706935|NCT04955626|587636684|FG028|Open-Label Period|Other|0|||
162706936|NCT04955626|587636685|FG029|Open-Label Period|Other|0|||
162706937|NCT04955626|587636686|FG030|Open-Label Period|Other|0|||
162706938|NCT04955626|587636687|FG031|Open-Label Period|Other|0|||
162706939|NCT04955626|587636688|FG032|Open-Label Period|Other|0|||
162706940|NCT04955626|587636689|FG033|Open-Label Period|Other|0|||
162706941|NCT04955626|587636690|FG034|Open-Label Period|Other|0|||
162706942|NCT04955626|587636691|FG035|Open-Label Period|Other|0|||
162706943|NCT04955626|587636656|FG000|Open-Label Period|Physician Decision|2|||
162706944|NCT04955626|587636657|FG001|Open-Label Period|Physician Decision|0|||
162706945|NCT04955626|587636658|FG002|Open-Label Period|Physician Decision|0|||
162706946|NCT04955626|587636659|FG003|Open-Label Period|Physician Decision|0|||
162706947|NCT04955626|587636660|FG004|Open-Label Period|Physician Decision|0|||
162706948|NCT04955626|587636661|FG005|Open-Label Period|Physician Decision|0|||
162706949|NCT04955626|587636662|FG006|Open-Label Period|Physician Decision|0|||
162706950|NCT04955626|587636663|FG007|Open-Label Period|Physician Decision|0|||
162706951|NCT04955626|587636664|FG008|Open-Label Period|Physician Decision|0|||
162706952|NCT04955626|587636665|FG009|Open-Label Period|Physician Decision|0|||
162706953|NCT04955626|587636666|FG010|Open-Label Period|Physician Decision|0|||
162706954|NCT04955626|587636667|FG011|Open-Label Period|Physician Decision|0|||
162706955|NCT04955626|587636668|FG012|Open-Label Period|Physician Decision|0|||
162706956|NCT04955626|587636669|FG013|Open-Label Period|Physician Decision|0|||
162706957|NCT04955626|587636670|FG014|Open-Label Period|Physician Decision|0|||
162706958|NCT04955626|587636671|FG015|Open-Label Period|Physician Decision|0|||
162706959|NCT04955626|587636672|FG016|Open-Label Period|Physician Decision|0|||
162706960|NCT04955626|587636673|FG017|Open-Label Period|Physician Decision|0|||
162706961|NCT04955626|587636674|FG018|Open-Label Period|Physician Decision|0|||
162706962|NCT04955626|587636675|FG019|Open-Label Period|Physician Decision|0|||
162706963|NCT04955626|587636676|FG020|Open-Label Period|Physician Decision|0|||
162706964|NCT04955626|587636677|FG021|Open-Label Period|Physician Decision|0|||
162706965|NCT04955626|587636678|FG022|Open-Label Period|Physician Decision|0|||
162706966|NCT04955626|587636679|FG023|Open-Label Period|Physician Decision|0|||
162706967|NCT04955626|587636680|FG024|Open-Label Period|Physician Decision|0|||
162875458|NCT00755846|588247057|FG003|Overall Study|Administrative Error|0|||
162875459|NCT00755846|588247058|FG004|Overall Study|Administrative Error|0|||
162875460|NCT00755846|588247059|FG005|Overall Study|Administrative Error|0|||
162875461|NCT00755846|588247054|FG000|Overall Study|Participant Non-compliance|0|||
162875462|NCT00755846|588247055|FG001|Overall Study|Participant Non-compliance|0|||
162875463|NCT00755846|588247056|FG002|Overall Study|Participant Non-compliance|0|||
162875464|NCT00755846|588247057|FG003|Overall Study|Participant Non-compliance|0|||
162875465|NCT00755846|588247058|FG004|Overall Study|Participant Non-compliance|1|||
162875466|NCT00755846|588247059|FG005|Overall Study|Participant Non-compliance|0|||
162875467|NCT01597557|588247073|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
162875468|NCT01597557|588247074|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
162875469|NCT02935634|588247078|FG000|Randomization|Participant withdrew consent|0|||
162875470|NCT02935634|588247079|FG001|Randomization|Participant withdrew consent|1|||
162875471|NCT02935634|588247080|FG002|Randomization|Participant withdrew consent|0|||
162875472|NCT02935634|588247081|FG003|Randomization|Participant withdrew consent|0|||
162875473|NCT02935634|588247082|FG004|Randomization|Participant withdrew consent|0|||
162875474|NCT02935634|588247083|FG005|Randomization|Participant withdrew consent|0|||
162875475|NCT02935634|588247078|FG000|Randomization|Death|2|||
162875476|NCT02935634|588247079|FG001|Randomization|Death|1|||
163047847|NCT03934216|588882618|FG001|Overall Study|Lost to Follow-up|0|||
162706968|NCT04955626|587636681|FG025|Open-Label Period|Physician Decision|0|||
162706969|NCT04955626|587636682|FG026|Open-Label Period|Physician Decision|0|||
162706970|NCT04955626|587636683|FG027|Open-Label Period|Physician Decision|0|||
162706971|NCT04955626|587636684|FG028|Open-Label Period|Physician Decision|0|||
162706972|NCT04955626|587636685|FG029|Open-Label Period|Physician Decision|0|||
162706973|NCT04955626|587636686|FG030|Open-Label Period|Physician Decision|0|||
162706974|NCT04955626|587636687|FG031|Open-Label Period|Physician Decision|0|||
162706975|NCT04955626|587636688|FG032|Open-Label Period|Physician Decision|0|||
162875477|NCT02935634|588247080|FG002|Randomization|Death|1|||
162875478|NCT02935634|588247081|FG003|Randomization|Death|0|||
162875479|NCT02935634|588247082|FG004|Randomization|Death|0|||
162875480|NCT02935634|588247083|FG005|Randomization|Death|0|||
162875481|NCT02935634|588247078|FG000|Randomization|Other reasons|0|||
162706976|NCT04955626|587636689|FG033|Open-Label Period|Physician Decision|0|||
162706977|NCT04955626|587636690|FG034|Open-Label Period|Physician Decision|0|||
162706978|NCT04955626|587636691|FG035|Open-Label Period|Physician Decision|0|||
162875482|NCT02935634|588247079|FG001|Randomization|Other reasons|2|||
162875483|NCT02935634|588247080|FG002|Randomization|Other reasons|2|||
162875484|NCT02935634|588247081|FG003|Randomization|Other reasons|0|||
162875485|NCT02935634|588247082|FG004|Randomization|Other reasons|0|||
162875486|NCT02935634|588247083|FG005|Randomization|Other reasons|0|||
162875487|NCT02935634|588247078|FG000|Treatment: Track 1|Disease progression|15|||
162875488|NCT02935634|588247079|FG001|Treatment: Track 1|Disease progression|17|||
162875489|NCT02935634|588247080|FG002|Treatment: Track 1|Disease progression|28|||
162875490|NCT02935634|588247081|FG003|Treatment: Track 1|Disease progression|4|||
162875491|NCT02935634|588247082|FG004|Treatment: Track 1|Disease progression|6|||
162875492|NCT02935634|588247083|FG005|Treatment: Track 1|Disease progression|2|||
162875493|NCT02935634|588247078|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
162875494|NCT02935634|588247079|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
162875495|NCT02935634|588247080|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
162875496|NCT02935634|588247081|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
162875497|NCT02935634|588247082|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
162875498|NCT02935634|588247083|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
162875499|NCT02935634|588247078|FG000|Treatment: Track 1|Lost to Follow-up|1|||
162875500|NCT02935634|588247079|FG001|Treatment: Track 1|Lost to Follow-up|0|||
162875501|NCT02935634|588247080|FG002|Treatment: Track 1|Lost to Follow-up|0|||
162961469|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961470|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
162875502|NCT02935634|588247081|FG003|Treatment: Track 1|Lost to Follow-up|0|||
162875503|NCT02935634|588247082|FG004|Treatment: Track 1|Lost to Follow-up|0|||
162875504|NCT02935634|588247083|FG005|Treatment: Track 1|Lost to Follow-up|0|||
162875505|NCT02935634|588247078|FG000|Treatment: Track 1|Study drug toxicity|2|||
162875506|NCT02935634|588247079|FG001|Treatment: Track 1|Study drug toxicity|1|||
162875507|NCT02935634|588247080|FG002|Treatment: Track 1|Study drug toxicity|3|||
162875508|NCT02935634|588247081|FG003|Treatment: Track 1|Study drug toxicity|0|||
162875509|NCT02935634|588247082|FG004|Treatment: Track 1|Study drug toxicity|0|||
162875510|NCT02935634|588247083|FG005|Treatment: Track 1|Study drug toxicity|1|||
162875511|NCT02935634|588247078|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
162875512|NCT02935634|588247079|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
162875513|NCT02935634|588247080|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
162615770|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
162615771|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
162615772|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
162615773|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
162615774|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
162615775|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
162615776|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
162615777|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
162615778|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
162615779|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
162615780|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
162615781|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
162615782|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
162615783|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
162615784|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
162615785|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
162615786|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
162615787|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
162615788|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
162615789|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
162615790|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
162615791|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
162615792|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
162615793|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
162875514|NCT02935634|588247081|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
162875515|NCT02935634|588247082|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
162875516|NCT02935634|588247083|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
162875517|NCT02935634|588247078|FG000|Treatment: Track 1|Participant withdrew consent|2|||
162875518|NCT02935634|588247079|FG001|Treatment: Track 1|Participant withdrew consent|0|||
162875519|NCT02935634|588247080|FG002|Treatment: Track 1|Participant withdrew consent|1|||
162875520|NCT02935634|588247081|FG003|Treatment: Track 1|Participant withdrew consent|0|||
162875521|NCT02935634|588247082|FG004|Treatment: Track 1|Participant withdrew consent|1|||
162875522|NCT02935634|588247083|FG005|Treatment: Track 1|Participant withdrew consent|0|||
162875523|NCT02935634|588247078|FG000|Treatment: Track 1|Other reasons|0|||
162875524|NCT02935634|588247079|FG001|Treatment: Track 1|Other reasons|0|||
162875525|NCT02935634|588247080|FG002|Treatment: Track 1|Other reasons|2|||
162875526|NCT02935634|588247081|FG003|Treatment: Track 1|Other reasons|0|||
162875527|NCT02935634|588247082|FG004|Treatment: Track 1|Other reasons|0|||
162875528|NCT02935634|588247083|FG005|Treatment: Track 1|Other reasons|0|||
162875529|NCT02935634|588247078|FG000|Treatment: Track 2|Disease progression|13|||
162875530|NCT02935634|588247079|FG001|Treatment: Track 2|Disease progression|26|||
162875531|NCT02935634|588247080|FG002|Treatment: Track 2|Disease progression|20|||
162875532|NCT02935634|588247081|FG003|Treatment: Track 2|Disease progression|5|||
162875533|NCT02935634|588247082|FG004|Treatment: Track 2|Disease progression|1|||
162875534|NCT02935634|588247083|FG005|Treatment: Track 2|Disease progression|4|||
162875535|NCT02935634|588247078|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
162875536|NCT02935634|588247079|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
162875537|NCT02935634|588247080|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
162875538|NCT02935634|588247081|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
162615794|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
162615795|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
162615796|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
162875539|NCT02935634|588247082|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
162615797|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
162615798|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
162615799|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
162706979|NCT04955626|587636656|FG000|Open-Label Period|Withdrawal by Subject|135|||
162875540|NCT02935634|588247083|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
162875541|NCT02935634|588247078|FG000|Treatment: Track 2|Study drug toxicity|7|||
162875542|NCT02935634|588247079|FG001|Treatment: Track 2|Study drug toxicity|3|||
162978998|NCT03545191|588623548|FG002|Overall Study|Adverse Event|7|||
162706980|NCT04955626|587636657|FG001|Open-Label Period|Withdrawal by Subject|25|||
162875543|NCT02935634|588247080|FG002|Treatment: Track 2|Study drug toxicity|0|||
162875544|NCT02935634|588247081|FG003|Treatment: Track 2|Study drug toxicity|0|||
162875545|NCT02935634|588247082|FG004|Treatment: Track 2|Study drug toxicity|0|||
162875546|NCT02935634|588247083|FG005|Treatment: Track 2|Study drug toxicity|0|||
162875547|NCT02935634|588247078|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
162875548|NCT02935634|588247079|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
162875549|NCT02935634|588247080|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
162875550|NCT02935634|588247081|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
162875551|NCT02935634|588247082|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
162875552|NCT02935634|588247083|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
162875553|NCT02935634|588247078|FG000|Treatment: Track 2|Participant withdrew consent|0|||
162875554|NCT02935634|588247079|FG001|Treatment: Track 2|Participant withdrew consent|1|||
162875555|NCT02935634|588247080|FG002|Treatment: Track 2|Participant withdrew consent|1|||
162875556|NCT02935634|588247081|FG003|Treatment: Track 2|Participant withdrew consent|0|||
162875557|NCT02935634|588247082|FG004|Treatment: Track 2|Participant withdrew consent|1|||
162875558|NCT02935634|588247083|FG005|Treatment: Track 2|Participant withdrew consent|0|||
162875559|NCT06150573|588247086|FG000|Overall Study|Did not meet study criteria|1|||
162875560|NCT06150573|588247087|FG001|Overall Study|Did not meet study criteria|0|||
162875561|NCT06150573|588247086|FG000|Overall Study|Adverse Event|1|||
162875562|NCT06150573|588247087|FG001|Overall Study|Adverse Event|0|||
162875563|NCT06150573|588247086|FG000|Overall Study|Lost to Follow-up|0|||
162875564|NCT06150573|588247087|FG001|Overall Study|Lost to Follow-up|1|||
162875565|NCT06150573|588247086|FG000|Overall Study|Protocol Violation|0|||
162875566|NCT06150573|588247087|FG001|Overall Study|Protocol Violation|1|||
162875567|NCT06150573|588247086|FG000|Overall Study|Withdrawal by Subject|2|||
162875568|NCT06150573|588247087|FG001|Overall Study|Withdrawal by Subject|0|||
162875569|NCT00210158|588247088|FG000|Overall Study|Protocol Violation|0|||
162875570|NCT00210158|588247089|FG001|Overall Study|Protocol Violation|2|||
162875571|NCT02284906|588247094|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162875572|NCT02284906|588247095|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162875573|NCT02284906|588247096|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162875574|NCT02284906|588247094|FG000|Overall Study|Major Protocol Deviation|0|||
162875575|NCT02284906|588247095|FG001|Overall Study|Major Protocol Deviation|1|||
162875576|NCT02284906|588247096|FG002|Overall Study|Major Protocol Deviation|0|||
162875577|NCT02284906|588247094|FG000|Overall Study|Voluntary Withdrawal|2|||
162875578|NCT02284906|588247095|FG001|Overall Study|Voluntary Withdrawal|4|||
162875579|NCT02284906|588247096|FG002|Overall Study|Voluntary Withdrawal|5|||
162875580|NCT02284906|588247094|FG000|Overall Study|Study Termination|0|||
162875581|NCT02284906|588247095|FG001|Overall Study|Study Termination|11|||
162875582|NCT02284906|588247096|FG002|Overall Study|Study Termination|14|||
162875583|NCT02284906|588247094|FG000|Overall Study|Reason not Specified|1|||
162875584|NCT02284906|588247095|FG001|Overall Study|Reason not Specified|1|||
162875585|NCT02284906|588247096|FG002|Overall Study|Reason not Specified|0|||
162875586|NCT01094730|588247097|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
162875587|NCT01094730|588247098|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
162875588|NCT01094730|588247097|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
162875589|NCT01094730|588247098|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
162875590|NCT01094730|588247097|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
162875591|NCT01094730|588247098|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
162875592|NCT01094730|588247097|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
162875593|NCT01094730|588247098|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
162875594|NCT01094730|588247097|FG000|Period 2 (14 Days)|Protocol Violation|2|||
162875595|NCT01094730|588247098|FG001|Period 2 (14 Days)|Protocol Violation|0|||
162875596|NCT01094730|588247097|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
162961471|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961472|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
162875597|NCT01094730|588247098|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
162875598|NCT01094730|588247097|FG000|Period 2 (14 Days)|Adverse Event|0|||
162875599|NCT01094730|588247098|FG001|Period 2 (14 Days)|Adverse Event|1|||
162875600|NCT01094730|588247097|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
162875601|NCT01094730|588247098|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
162875602|NCT03885726|588247100|FG000|Overall Study|Staffing issues/lost interest|1|||
162875603|NCT03885726|588247100|FG000|Overall Study|Early discharge from hospital|3|||
162875604|NCT04096326|588247101|FG000|Overall Study|Withdrawal by Subject|0|||
162875605|NCT04096326|588247102|FG001|Overall Study|Withdrawal by Subject|0|||
162978999|NCT03545191|588623546|FG000|Overall Study|Other reasons|3|||
162706981|NCT04955626|587636658|FG002|Open-Label Period|Withdrawal by Subject|0|||
162875606|NCT04096326|588247103|FG002|Overall Study|Withdrawal by Subject|0|||
162875607|NCT04096326|588247104|FG003|Overall Study|Withdrawal by Subject|0|||
162875608|NCT04096326|588247105|FG004|Overall Study|Withdrawal by Subject|0|||
162875609|NCT04096326|588247106|FG005|Overall Study|Withdrawal by Subject|0|||
162875610|NCT04096326|588247107|FG006|Overall Study|Withdrawal by Subject|1|||
162875611|NCT04096326|588247108|FG007|Overall Study|Withdrawal by Subject|0|||
162875612|NCT04096326|588247109|FG008|Overall Study|Withdrawal by Subject|0|||
162875613|NCT04096326|588247110|FG009|Overall Study|Withdrawal by Subject|0|||
162875614|NCT04096326|588247101|FG000|Overall Study|Lost to Follow-up|0|||
162875615|NCT04096326|588247102|FG001|Overall Study|Lost to Follow-up|1|||
162875616|NCT04096326|588247103|FG002|Overall Study|Lost to Follow-up|0|||
162875617|NCT04096326|588247104|FG003|Overall Study|Lost to Follow-up|0|||
162875618|NCT04096326|588247105|FG004|Overall Study|Lost to Follow-up|0|||
162875619|NCT04096326|588247106|FG005|Overall Study|Lost to Follow-up|0|||
162875620|NCT04096326|588247107|FG006|Overall Study|Lost to Follow-up|0|||
162875621|NCT04096326|588247108|FG007|Overall Study|Lost to Follow-up|0|||
162875622|NCT04096326|588247109|FG008|Overall Study|Lost to Follow-up|0|||
162875623|NCT04096326|588247110|FG009|Overall Study|Lost to Follow-up|0|||
162875624|NCT04096326|588247101|FG000|Overall Study|COVID-19-related reasons|0|||
162875625|NCT04096326|588247102|FG001|Overall Study|COVID-19-related reasons|0|||
162875626|NCT04096326|588247103|FG002|Overall Study|COVID-19-related reasons|0|||
162875627|NCT04096326|588247104|FG003|Overall Study|COVID-19-related reasons|0|||
162875628|NCT04096326|588247105|FG004|Overall Study|COVID-19-related reasons|1|||
162875629|NCT04096326|588247106|FG005|Overall Study|COVID-19-related reasons|5|||
162875630|NCT04096326|588247107|FG006|Overall Study|COVID-19-related reasons|0|||
162875631|NCT04096326|588247108|FG007|Overall Study|COVID-19-related reasons|0|||
162875632|NCT04096326|588247109|FG008|Overall Study|COVID-19-related reasons|0|||
162875633|NCT04096326|588247110|FG009|Overall Study|COVID-19-related reasons|0|||
162875634|NCT04804033|588247111|FG000|Period 1: DBT Phase|Adverse Event|1|||
162875635|NCT04804033|588247112|FG001|Period 1: DBT Phase|Adverse Event|5|||
162875636|NCT04804033|588247113|FG002|Period 1: DBT Phase|Adverse Event|3|||
162875637|NCT04804033|588247114|FG003|Period 1: DBT Phase|Adverse Event|4|||
162875638|NCT04804033|588247111|FG000|Period 1: DBT Phase|Death|1|||
162875639|NCT04804033|588247112|FG001|Period 1: DBT Phase|Death|0|||
162875640|NCT04804033|588247113|FG002|Period 1: DBT Phase|Death|0|||
162875641|NCT04804033|588247114|FG003|Period 1: DBT Phase|Death|0|||
162875642|NCT04804033|588247111|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
162875643|NCT04804033|588247112|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
162875644|NCT04804033|588247113|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
162875645|NCT04804033|588247114|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
162875646|NCT04804033|588247111|FG000|Period 1: DBT Phase|Non-compliance|1|||
162875647|NCT04804033|588247112|FG001|Period 1: DBT Phase|Non-compliance|0|||
162875648|NCT04804033|588247113|FG002|Period 1: DBT Phase|Non-compliance|1|||
162875649|NCT04804033|588247114|FG003|Period 1: DBT Phase|Non-compliance|2|||
162875650|NCT04804033|588247111|FG000|Period 1: DBT Phase|Other|0|||
162875651|NCT04804033|588247112|FG001|Period 1: DBT Phase|Other|1|||
162875652|NCT04804033|588247113|FG002|Period 1: DBT Phase|Other|0|||
162875653|NCT04804033|588247114|FG003|Period 1: DBT Phase|Other|0|||
162875654|NCT04804033|588247111|FG000|Period 1: DBT Phase|Pregnancy|2|||
162875655|NCT04804033|588247112|FG001|Period 1: DBT Phase|Pregnancy|0|||
162875656|NCT04804033|588247113|FG002|Period 1: DBT Phase|Pregnancy|0|||
162875657|NCT04804033|588247114|FG003|Period 1: DBT Phase|Pregnancy|0|||
162875658|NCT04804033|588247111|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
162875659|NCT04804033|588247112|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
162875660|NCT04804033|588247113|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
162875661|NCT04804033|588247114|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
162875662|NCT04804033|588247111|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
162875663|NCT04804033|588247112|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
162706982|NCT04955626|587636659|FG003|Open-Label Period|Withdrawal by Subject|0|||
162706983|NCT04955626|587636660|FG004|Open-Label Period|Withdrawal by Subject|0|||
162706984|NCT04955626|587636661|FG005|Open-Label Period|Withdrawal by Subject|0|||
162706985|NCT04955626|587636662|FG006|Open-Label Period|Withdrawal by Subject|0|||
162706986|NCT04955626|587636663|FG007|Open-Label Period|Withdrawal by Subject|0|||
162706987|NCT04955626|587636664|FG008|Open-Label Period|Withdrawal by Subject|0|||
162706988|NCT04955626|587636665|FG009|Open-Label Period|Withdrawal by Subject|0|||
162706989|NCT04955626|587636666|FG010|Open-Label Period|Withdrawal by Subject|0|||
162706990|NCT04955626|587636667|FG011|Open-Label Period|Withdrawal by Subject|0|||
162706991|NCT04955626|587636668|FG012|Open-Label Period|Withdrawal by Subject|0|||
162706992|NCT04955626|587636669|FG013|Open-Label Period|Withdrawal by Subject|0|||
162706993|NCT04955626|587636670|FG014|Open-Label Period|Withdrawal by Subject|0|||
162706994|NCT04955626|587636671|FG015|Open-Label Period|Withdrawal by Subject|0|||
162706995|NCT04955626|587636672|FG016|Open-Label Period|Withdrawal by Subject|0|||
162706996|NCT04955626|587636673|FG017|Open-Label Period|Withdrawal by Subject|0|||
162706997|NCT04955626|587636674|FG018|Open-Label Period|Withdrawal by Subject|0|||
162706998|NCT04955626|587636675|FG019|Open-Label Period|Withdrawal by Subject|0|||
162706999|NCT04955626|587636676|FG020|Open-Label Period|Withdrawal by Subject|0|||
162707000|NCT04955626|587636677|FG021|Open-Label Period|Withdrawal by Subject|0|||
162707001|NCT04955626|587636678|FG022|Open-Label Period|Withdrawal by Subject|0|||
162707002|NCT04955626|587636679|FG023|Open-Label Period|Withdrawal by Subject|0|||
162707003|NCT04955626|587636680|FG024|Open-Label Period|Withdrawal by Subject|0|||
162707004|NCT04955626|587636681|FG025|Open-Label Period|Withdrawal by Subject|0|||
162875664|NCT04804033|588247113|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
162875665|NCT04804033|588247114|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
162875666|NCT04804033|588247111|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
162875667|NCT04804033|588247112|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
162615800|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
162615801|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
162615802|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
162615803|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
162615804|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
162615805|NCT00313300|587311536|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
162615806|NCT00313300|587311537|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
162615807|NCT00313300|587311538|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
162615808|NCT00313300|587311539|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
162615809|NCT00313300|587311540|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
162615810|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
162615811|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
162615812|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
162615813|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
162615814|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
162615815|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
162615816|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
162615817|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
162615818|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
162615819|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
162615820|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162615821|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
162615822|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
162615823|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162615824|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162615825|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
162615826|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
162615827|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
162615828|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
162615829|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
162707005|NCT04955626|587636682|FG026|Open-Label Period|Withdrawal by Subject|0|||
162707006|NCT04955626|587636683|FG027|Open-Label Period|Withdrawal by Subject|0|||
162707007|NCT04955626|587636684|FG028|Open-Label Period|Withdrawal by Subject|0|||
162875668|NCT04804033|588247113|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
162875669|NCT04804033|588247114|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
162875670|NCT04804033|588247111|FG000|Period 2: OLE Phase|Adverse Event|3|||
162875671|NCT04804033|588247112|FG001|Period 2: OLE Phase|Adverse Event|4|||
162875672|NCT04804033|588247113|FG002|Period 2: OLE Phase|Adverse Event|2|||
162875673|NCT04804033|588247114|FG003|Period 2: OLE Phase|Adverse Event|0|||
162875674|NCT04804033|588247111|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
162875675|NCT04804033|588247112|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
162875676|NCT04804033|588247113|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
162875677|NCT04804033|588247114|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
162875678|NCT04804033|588247111|FG000|Period 2: OLE Phase|Non-compliance|2|||
162615830|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162615831|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162615832|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162615833|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
162615834|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
162615835|NCT00313300|587311536|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
162615836|NCT00313300|587311537|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162615837|NCT00313300|587311538|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162615838|NCT00313300|587311539|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
162615839|NCT00313300|587311540|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162615840|NCT00639678|587311543|FG000|Overall Study|Withdrawal by Subject|3|||
162615841|NCT00639678|587311544|FG001|Overall Study|Withdrawal by Subject|0|||
162615842|NCT00639678|587311545|FG002|Overall Study|Withdrawal by Subject|4|||
162615843|NCT00639678|587311546|FG003|Overall Study|Withdrawal by Subject|0|||
162615844|NCT00639678|587311543|FG000|Overall Study|Lost to Follow-up|1|||
162615845|NCT00639678|587311544|FG001|Overall Study|Lost to Follow-up|0|||
162615846|NCT00639678|587311545|FG002|Overall Study|Lost to Follow-up|6|||
162615847|NCT00639678|587311546|FG003|Overall Study|Lost to Follow-up|0|||
162615848|NCT00639678|587311543|FG000|Overall Study|Adverse Event|0|||
162615849|NCT00639678|587311544|FG001|Overall Study|Adverse Event|1|||
162615850|NCT00639678|587311545|FG002|Overall Study|Adverse Event|0|||
162615851|NCT00639678|587311546|FG003|Overall Study|Adverse Event|0|||
162875679|NCT04804033|588247112|FG001|Period 2: OLE Phase|Non-compliance|2|||
162875680|NCT04804033|588247113|FG002|Period 2: OLE Phase|Non-compliance|0|||
162615852|NCT00639678|587311543|FG000|Overall Study|Lack of Compliance|0|||
162615853|NCT00639678|587311544|FG001|Overall Study|Lack of Compliance|0|||
162615854|NCT00639678|587311545|FG002|Overall Study|Lack of Compliance|1|||
162615855|NCT00639678|587311546|FG003|Overall Study|Lack of Compliance|0|||
162615856|NCT04540497|587311549|FG000|Overall Study|Adverse Event|0|||
162615857|NCT04540497|587311550|FG001|Overall Study|Adverse Event|2|||
162615858|NCT04540497|587311549|FG000|Overall Study|Lost to Follow-up|1|||
162615859|NCT04540497|587311550|FG001|Overall Study|Lost to Follow-up|0|||
162615860|NCT04540497|587311549|FG000|Overall Study|Withdrawal by Subject|1|||
162615861|NCT04540497|587311550|FG001|Overall Study|Withdrawal by Subject|1|||
162875681|NCT04804033|588247114|FG003|Period 2: OLE Phase|Non-compliance|1|||
162875682|NCT04804033|588247111|FG000|Period 2: OLE Phase|Other|0|||
162875683|NCT04804033|588247112|FG001|Period 2: OLE Phase|Other|2|||
162875684|NCT04804033|588247113|FG002|Period 2: OLE Phase|Other|0|||
162875685|NCT04804033|588247114|FG003|Period 2: OLE Phase|Other|0|||
162875686|NCT04804033|588247111|FG000|Period 2: OLE Phase|Physician Decision|1|||
162875687|NCT04804033|588247112|FG001|Period 2: OLE Phase|Physician Decision|1|||
162875688|NCT04804033|588247113|FG002|Period 2: OLE Phase|Physician Decision|0|||
162875689|NCT04804033|588247114|FG003|Period 2: OLE Phase|Physician Decision|0|||
162875690|NCT04804033|588247111|FG000|Period 2: OLE Phase|Pregnancy|0|||
162875691|NCT04804033|588247112|FG001|Period 2: OLE Phase|Pregnancy|0|||
162875692|NCT04804033|588247113|FG002|Period 2: OLE Phase|Pregnancy|2|||
162875693|NCT04804033|588247114|FG003|Period 2: OLE Phase|Pregnancy|0|||
162875694|NCT04804033|588247111|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
162875695|NCT04804033|588247112|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
162875696|NCT04804033|588247113|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
162875697|NCT04804033|588247114|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
162875698|NCT04804033|588247111|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
162875699|NCT04804033|588247112|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
162875700|NCT04804033|588247113|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
162875701|NCT04804033|588247114|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
162875702|NCT04804033|588247111|FG000|Period 2: OLE Phase|Not reported|0|||
162875703|NCT04804033|588247112|FG001|Period 2: OLE Phase|Not reported|2|||
162875704|NCT04804033|588247113|FG002|Period 2: OLE Phase|Not reported|0|||
162707008|NCT04955626|587636685|FG029|Open-Label Period|Withdrawal by Subject|0|||
162875705|NCT04804033|588247114|FG003|Period 2: OLE Phase|Not reported|0|||
162875706|NCT04804033|588247111|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
162615862|NCT04540497|587311549|FG000|Overall Study|Miscellaneous|2|||
162615863|NCT04540497|587311550|FG001|Overall Study|Miscellaneous|1|||
162615864|NCT05274815|587311551|FG000|Overall Study|Adverse Event|1|||
162615865|NCT05274815|587311551|FG000|Overall Study|Death|2|||
162615866|NCT05274815|587311551|FG000|Overall Study|Lost to Follow-up|4|||
162875707|NCT04804033|588247112|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
162875708|NCT04804033|588247113|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
162979000|NCT03545191|588623547|FG001|Overall Study|Other reasons|11|||
162615867|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
162615868|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
162615869|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
162615870|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
162615871|NCT05274815|587311551|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
162615872|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
162615873|NCT05274815|587311551|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
162615874|NCT05274815|587311551|FG000|Overall Study|Withdrawal by Subject|11|||
162615875|NCT04416633|587311552|FG000|Overall Study|Death|1|||
162615876|NCT04416633|587311552|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
162615877|NCT04416633|587311552|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
162615878|NCT04416633|587311552|FG000|Overall Study|Adverse Event|6|||
162875709|NCT04804033|588247114|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
162875710|NCT04804033|588247111|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
162875711|NCT04804033|588247112|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
162875712|NCT04804033|588247113|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
162875713|NCT04804033|588247114|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
162875714|NCT04804033|588247111|FG000|Period 3: Follow-up Phase|Other|0|||
162875715|NCT04804033|588247112|FG001|Period 3: Follow-up Phase|Other|1|||
162875716|NCT04804033|588247113|FG002|Period 3: Follow-up Phase|Other|2|||
162875717|NCT04804033|588247114|FG003|Period 3: Follow-up Phase|Other|1|||
162875718|NCT04804033|588247111|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
162875719|NCT04804033|588247112|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
162875720|NCT04804033|588247113|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
162875721|NCT04804033|588247114|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
162875722|NCT04804033|588247111|FG000|Period 3: Follow-up Phase|Not reported|18|||
162875723|NCT04804033|588247112|FG001|Period 3: Follow-up Phase|Not reported|15|||
162875724|NCT04804033|588247113|FG002|Period 3: Follow-up Phase|Not reported|1|||
162875725|NCT04804033|588247114|FG003|Period 3: Follow-up Phase|Not reported|4|||
162875726|NCT02496585|588247117|FG000|Overall Study|Death|3|||
162875727|NCT02496585|588247118|FG001|Overall Study|Death|0|||
162875728|NCT02496585|588247117|FG000|Overall Study|Lost to Follow-up|2|||
162875729|NCT02496585|588247118|FG001|Overall Study|Lost to Follow-up|0|||
162875730|NCT02496585|588247117|FG000|Overall Study|Withdrawal by Subject|1|||
162875731|NCT02496585|588247118|FG001|Overall Study|Withdrawal by Subject|2|||
162875732|NCT02496585|588247117|FG000|Overall Study|Progression of Malignancy|4|||
162615879|NCT04416633|587311552|FG000|Overall Study|Withdrawal by Subject|6|||
162615880|NCT03914326|587311553|FG000|Overall Study|Withdrawal by Subject|27|||
162615881|NCT03914326|587311554|FG001|Overall Study|Withdrawal by Subject|34|||
162615882|NCT03914326|587311553|FG000|Overall Study|Lost to Follow-up|43|||
162615883|NCT03914326|587311554|FG001|Overall Study|Lost to Follow-up|51|||
162615884|NCT03914326|587311553|FG000|Overall Study|Randomised more than once|0|||
162615885|NCT03914326|587311554|FG001|Overall Study|Randomised more than once|1|||
162615886|NCT03323502|587311555|FG000|Overall Study|Resident could not be linked to CMS data|594|||
162615887|NCT03323502|587311556|FG001|Overall Study|Resident could not be linked to CMS data|435|||
162615888|NCT03323502|587311555|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
162615889|NCT03323502|587311556|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
162615890|NCT03323502|587311555|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
162615891|NCT03323502|587311556|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
162707009|NCT04955626|587636686|FG030|Open-Label Period|Withdrawal by Subject|0|||
162707010|NCT04955626|587636687|FG031|Open-Label Period|Withdrawal by Subject|0|||
162707011|NCT04955626|587636688|FG032|Open-Label Period|Withdrawal by Subject|0|||
162707012|NCT04955626|587636689|FG033|Open-Label Period|Withdrawal by Subject|0|||
162707013|NCT04955626|587636690|FG034|Open-Label Period|Withdrawal by Subject|0|||
162707014|NCT04955626|587636691|FG035|Open-Label Period|Withdrawal by Subject|0|||
162707015|NCT04955626|587636656|FG000|Open-Label Period|Refused further study procedures|1|||
162707016|NCT04955626|587636657|FG001|Open-Label Period|Refused further study procedures|0|||
162707017|NCT04955626|587636658|FG002|Open-Label Period|Refused further study procedures|0|||
162707018|NCT04955626|587636659|FG003|Open-Label Period|Refused further study procedures|0|||
162707019|NCT04955626|587636660|FG004|Open-Label Period|Refused further study procedures|0|||
162707020|NCT04955626|587636661|FG005|Open-Label Period|Refused further study procedures|0|||
162707021|NCT04955626|587636662|FG006|Open-Label Period|Refused further study procedures|0|||
162707022|NCT04955626|587636663|FG007|Open-Label Period|Refused further study procedures|0|||
162707023|NCT04955626|587636664|FG008|Open-Label Period|Refused further study procedures|0|||
162875733|NCT02496585|588247118|FG001|Overall Study|Progression of Malignancy|1|||
162875734|NCT01276457|588247122|FG000|Core Study|Adverse Event|6|||
162875735|NCT01276457|588247123|FG001|Core Study|Adverse Event|3|||
162875736|NCT01276457|588247122|FG000|Core Study|Lost to Follow-up|1|||
162875737|NCT01276457|588247123|FG001|Core Study|Lost to Follow-up|2|||
162875738|NCT01276457|588247122|FG000|Core Study|Administrative problems|1|||
162875739|NCT01276457|588247123|FG001|Core Study|Administrative problems|1|||
162875740|NCT01276457|588247122|FG000|Core Study|Death|2|||
162875741|NCT01276457|588247123|FG001|Core Study|Death|2|||
162875742|NCT01276457|588247122|FG000|Core Study|Lack of Efficacy|3|||
162875743|NCT01276457|588247123|FG001|Core Study|Lack of Efficacy|12|||
162875744|NCT01276457|588247122|FG000|Extension Study|Lost to Follow-up|3|||
162615892|NCT03323502|587311555|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
162875745|NCT01276457|588247123|FG001|Extension Study|Lost to Follow-up|0|||
162875746|NCT01276457|588247122|FG000|Extension Study|Death|0|||
162875747|NCT01276457|588247123|FG001|Extension Study|Death|1|||
162875748|NCT01276457|588247122|FG000|Extension Study|Lack of Efficacy|3|||
162875749|NCT01276457|588247123|FG001|Extension Study|Lack of Efficacy|1|||
162875750|NCT05122650|588247124|FG000|Overall Study|Adverse Event|4|||
162875751|NCT05122650|588247125|FG001|Overall Study|Adverse Event|16|||
162875752|NCT05122650|588247126|FG002|Overall Study|Adverse Event|11|||
162875753|NCT05122650|588247127|FG003|Overall Study|Adverse Event|12|||
162875754|NCT05122650|588247124|FG000|Overall Study|Lack of Efficacy|0|||
162875755|NCT05122650|588247125|FG001|Overall Study|Lack of Efficacy|1|||
162961473|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961474|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
162615893|NCT03323502|587311556|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
162615894|NCT03323502|587311555|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
162615895|NCT03323502|587311556|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
162615896|NCT01675427|587311560|FG000|Overall Study|Withdrawal by Subject|7|||
162615897|NCT01675427|587311560|FG000|Overall Study|Participant Refused Sample Collection|18|||
162615898|NCT01675427|587311560|FG000|Overall Study|Sample not Collected by Mistake|2|||
162875756|NCT05122650|588247126|FG002|Overall Study|Lack of Efficacy|1|||
162961475|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961476|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961477|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961478|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961479|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961480|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
162875757|NCT05122650|588247127|FG003|Overall Study|Lack of Efficacy|2|||
162875758|NCT05122650|588247124|FG000|Overall Study|Lost to Follow-up|1|||
162875759|NCT05122650|588247125|FG001|Overall Study|Lost to Follow-up|1|||
162961481|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
162961482|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
162875760|NCT05122650|588247126|FG002|Overall Study|Lost to Follow-up|3|||
162875761|NCT05122650|588247127|FG003|Overall Study|Lost to Follow-up|0|||
162875762|NCT05122650|588247124|FG000|Overall Study|Non-compliance with study intervention|0|||
162875763|NCT05122650|588247125|FG001|Overall Study|Non-compliance with study intervention|0|||
162875764|NCT05122650|588247126|FG002|Overall Study|Non-compliance with study intervention|0|||
162875765|NCT05122650|588247127|FG003|Overall Study|Non-compliance with study intervention|2|||
162875766|NCT05122650|588247124|FG000|Overall Study|Protocol Violation|0|||
162875767|NCT05122650|588247125|FG001|Overall Study|Protocol Violation|1|||
162875768|NCT05122650|588247126|FG002|Overall Study|Protocol Violation|0|||
162875769|NCT05122650|588247127|FG003|Overall Study|Protocol Violation|1|||
162875770|NCT05122650|588247124|FG000|Overall Study|Randomized by mistake|0|||
162875771|NCT05122650|588247125|FG001|Overall Study|Randomized by mistake|0|||
162875772|NCT05122650|588247126|FG002|Overall Study|Randomized by mistake|3|||
162875773|NCT05122650|588247127|FG003|Overall Study|Randomized by mistake|2|||
162875774|NCT05122650|588247124|FG000|Overall Study|Sponsor request|0|||
162875775|NCT05122650|588247125|FG001|Overall Study|Sponsor request|1|||
162875776|NCT05122650|588247126|FG002|Overall Study|Sponsor request|1|||
162875777|NCT05122650|588247127|FG003|Overall Study|Sponsor request|2|||
162875778|NCT05122650|588247124|FG000|Overall Study|Withdrawal by Subject|3|||
162875779|NCT05122650|588247125|FG001|Overall Study|Withdrawal by Subject|7|||
162875780|NCT05122650|588247126|FG002|Overall Study|Withdrawal by Subject|4|||
162875781|NCT05122650|588247127|FG003|Overall Study|Withdrawal by Subject|8|||
162875782|NCT05122650|588247124|FG000|Overall Study|Other|5|||
162875783|NCT05122650|588247125|FG001|Overall Study|Other|0|||
162875784|NCT05122650|588247126|FG002|Overall Study|Other|0|||
162875785|NCT05122650|588247127|FG003|Overall Study|Other|0|||
162875786|NCT03280550|588247130|FG000|Overall Study|Withdrawal by Subject|2|||
162875787|NCT03280550|588247131|FG001|Overall Study|Withdrawal by Subject|2|||
162875788|NCT03280550|588247130|FG000|Overall Study|Physician Decision|0|||
162875789|NCT03280550|588247131|FG001|Overall Study|Physician Decision|1|||
162875790|NCT05896761|588247132|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
162875791|NCT05896761|588247133|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
162875792|NCT05896761|588247132|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
162875793|NCT05896761|588247133|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
162875794|NCT01318083|588247134|FG000|Overall Study|Adverse Event|4|||
162875795|NCT01318083|588247135|FG001|Overall Study|Adverse Event|1|||
162875796|NCT01318083|588247136|FG002|Overall Study|Adverse Event|2|||
162875797|NCT01318083|588247134|FG000|Overall Study|Withdrawal by Subject|1|||
162875798|NCT01318083|588247135|FG001|Overall Study|Withdrawal by Subject|0|||
162875799|NCT01318083|588247136|FG002|Overall Study|Withdrawal by Subject|2|||
162875800|NCT01318083|588247134|FG000|Overall Study|Lack of Efficacy|0|||
162875801|NCT01318083|588247135|FG001|Overall Study|Lack of Efficacy|0|||
162875802|NCT01318083|588247136|FG002|Overall Study|Lack of Efficacy|1|||
162875803|NCT01318083|588247134|FG000|Overall Study|Treatment Complications|1|||
162875804|NCT01318083|588247135|FG001|Overall Study|Treatment Complications|0|||
162875805|NCT01318083|588247136|FG002|Overall Study|Treatment Complications|0|||
162875806|NCT01318083|588247134|FG000|Overall Study|Lack of Study Medication Compliance|0|||
162875807|NCT01318083|588247135|FG001|Overall Study|Lack of Study Medication Compliance|1|||
162875808|NCT01318083|588247136|FG002|Overall Study|Lack of Study Medication Compliance|0|||
162875809|NCT02028338|588247140|FG000|Overall Study|Withdrawal by Subject|3|||
162875810|NCT02028338|588247141|FG001|Overall Study|Withdrawal by Subject|1|||
162875811|NCT02028338|588247140|FG000|Overall Study|Unable to contact participant|1|||
162875812|NCT02028338|588247141|FG001|Overall Study|Unable to contact participant|0|||
162875813|NCT03552549|588247142|FG000|Overall Study|Disease progression|25|||
162875814|NCT03552549|588247143|FG001|Overall Study|Disease progression|17|||
162875815|NCT03552549|588247142|FG000|Overall Study|Adverse event in first 12 months|12|||
162875816|NCT03552549|588247143|FG001|Overall Study|Adverse event in first 12 months|8|||
162875817|NCT03552549|588247142|FG000|Overall Study|Withdrawal by Subject|7|||
162875818|NCT03552549|588247143|FG001|Overall Study|Withdrawal by Subject|7|||
162875819|NCT03552549|588247142|FG000|Overall Study|Unknown (no reason provided)|4|||
162875820|NCT03552549|588247143|FG001|Overall Study|Unknown (no reason provided)|2|||
162875821|NCT03552549|588247142|FG000|Overall Study|Not in participant's best interest|2|||
162875822|NCT03552549|588247143|FG001|Overall Study|Not in participant's best interest|1|||
162875823|NCT03552549|588247142|FG000|Overall Study|Did not complete study treatment|2|||
162875824|NCT03552549|588247143|FG001|Overall Study|Did not complete study treatment|3|||
162875825|NCT03552549|588247142|FG000|Overall Study|Did not meet eligibility criteria|1|||
162875826|NCT03552549|588247143|FG001|Overall Study|Did not meet eligibility criteria|0|||
162875827|NCT03552549|588247142|FG000|Overall Study|Administrative|0|||
162875828|NCT03552549|588247143|FG001|Overall Study|Administrative|14|||
162875829|NCT02761993|588247152|FG000|Overall Study|Adverse Event|0|||
162875830|NCT02761993|588247153|FG001|Overall Study|Adverse Event|2|||
162875831|NCT02761993|588247154|FG002|Overall Study|Adverse Event|0|||
162875832|NCT02761993|588247152|FG000|Overall Study|Lost to Follow-up|1|||
162875833|NCT02761993|588247153|FG001|Overall Study|Lost to Follow-up|3|||
162875834|NCT02761993|588247154|FG002|Overall Study|Lost to Follow-up|2|||
162875835|NCT02761993|588247152|FG000|Overall Study|Withdrawal by Subject|1|||
162875836|NCT02761993|588247153|FG001|Overall Study|Withdrawal by Subject|1|||
162875837|NCT02761993|588247154|FG002|Overall Study|Withdrawal by Subject|2|||
162875838|NCT00256867|588247155|FG000|Overall Study|Adverse Event|0|||
162875839|NCT00256867|588247156|FG001|Overall Study|Adverse Event|1|||
162875840|NCT00256867|588247157|FG002|Overall Study|Adverse Event|1|||
162875841|NCT00256867|588247158|FG003|Overall Study|Adverse Event|1|||
162875842|NCT00256867|588247159|FG004|Overall Study|Adverse Event|2|||
162875843|NCT00256867|588247160|FG005|Overall Study|Adverse Event|2|||
162875844|NCT00256867|588247161|FG006|Overall Study|Adverse Event|1|||
162875845|NCT00256867|588247162|FG007|Overall Study|Adverse Event|4|||
162875846|NCT00256867|588247155|FG000|Overall Study|Lost to Follow-up|2|||
162875847|NCT00256867|588247156|FG001|Overall Study|Lost to Follow-up|2|||
162875848|NCT00256867|588247157|FG002|Overall Study|Lost to Follow-up|2|||
162875849|NCT00256867|588247158|FG003|Overall Study|Lost to Follow-up|3|||
162875850|NCT00256867|588247159|FG004|Overall Study|Lost to Follow-up|2|||
162875851|NCT00256867|588247160|FG005|Overall Study|Lost to Follow-up|0|||
162875852|NCT00256867|588247161|FG006|Overall Study|Lost to Follow-up|1|||
162875853|NCT00256867|588247162|FG007|Overall Study|Lost to Follow-up|2|||
162875854|NCT00256867|588247155|FG000|Overall Study|Protocol Violation|0|||
162875855|NCT00256867|588247156|FG001|Overall Study|Protocol Violation|0|||
162875856|NCT00256867|588247157|FG002|Overall Study|Protocol Violation|0|||
162875857|NCT00256867|588247158|FG003|Overall Study|Protocol Violation|1|||
162875858|NCT00256867|588247159|FG004|Overall Study|Protocol Violation|0|||
162875859|NCT00256867|588247160|FG005|Overall Study|Protocol Violation|1|||
162875860|NCT00256867|588247161|FG006|Overall Study|Protocol Violation|0|||
162875861|NCT00256867|588247162|FG007|Overall Study|Protocol Violation|1|||
162875862|NCT00256867|588247155|FG000|Overall Study|Withdrawal by Subject|0|||
162875863|NCT00256867|588247156|FG001|Overall Study|Withdrawal by Subject|0|||
162875864|NCT00256867|588247157|FG002|Overall Study|Withdrawal by Subject|1|||
162875865|NCT00256867|588247158|FG003|Overall Study|Withdrawal by Subject|1|||
162875866|NCT00256867|588247159|FG004|Overall Study|Withdrawal by Subject|2|||
162875867|NCT00256867|588247160|FG005|Overall Study|Withdrawal by Subject|2|||
162875868|NCT00256867|588247161|FG006|Overall Study|Withdrawal by Subject|3|||
162875869|NCT00256867|588247162|FG007|Overall Study|Withdrawal by Subject|2|||
162875870|NCT00256867|588247155|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875871|NCT00256867|588247156|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
162875872|NCT00256867|588247157|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875873|NCT00256867|588247158|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875874|NCT00256867|588247159|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875875|NCT00256867|588247160|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875876|NCT00256867|588247161|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162707024|NCT04955626|587636665|FG009|Open-Label Period|Refused further study procedures|0|||
162875877|NCT00256867|588247162|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
162875878|NCT00256867|588247155|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875879|NCT00256867|588247156|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875880|NCT00256867|588247157|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875881|NCT00256867|588247158|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875882|NCT00256867|588247159|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875883|NCT00256867|588247160|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875884|NCT00256867|588247161|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
162875885|NCT00256867|588247162|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
162875886|NCT00256867|588247155|FG000|Overall Study|Investigator's Decision|0|||
162875887|NCT00256867|588247156|FG001|Overall Study|Investigator's Decision|0|||
162875888|NCT00256867|588247157|FG002|Overall Study|Investigator's Decision|0|||
162875889|NCT00256867|588247158|FG003|Overall Study|Investigator's Decision|0|||
162875890|NCT00256867|588247159|FG004|Overall Study|Investigator's Decision|1|||
162615899|NCT01675427|587311560|FG000|Overall Study|Lost to Follow-up|5|||
162615900|NCT01675427|587311560|FG000|Overall Study|Other|2|||
162615901|NCT00902668|587311568|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
162615902|NCT01914757|587311569|FG000|Overall Study|Severe non-compliance to protocol|3|||
162615903|NCT01914757|587311570|FG001|Overall Study|Severe non-compliance to protocol|1|||
162615904|NCT01914757|587311571|FG002|Overall Study|Severe non-compliance to protocol|2|||
162615905|NCT01914757|587311569|FG000|Overall Study|Lost to Follow-up|5|||
162615906|NCT01914757|587311570|FG001|Overall Study|Lost to Follow-up|8|||
162615907|NCT01914757|587311571|FG002|Overall Study|Lost to Follow-up|6|||
162615908|NCT01914757|587311569|FG000|Overall Study|Withdrawal by Subject|15|||
162615909|NCT01914757|587311570|FG001|Overall Study|Withdrawal by Subject|27|||
162615910|NCT01914757|587311571|FG002|Overall Study|Withdrawal by Subject|19|||
162615911|NCT01914757|587311569|FG000|Overall Study|Death|2|||
162615912|NCT01914757|587311570|FG001|Overall Study|Death|2|||
162615913|NCT01914757|587311571|FG002|Overall Study|Death|1|||
162615914|NCT01914757|587311569|FG000|Overall Study|Adverse Event|4|||
162615915|NCT01914757|587311570|FG001|Overall Study|Adverse Event|3|||
162615916|NCT01914757|587311571|FG002|Overall Study|Adverse Event|4|||
162615917|NCT01914757|587311569|FG000|Overall Study|Study specific withdrawal criteria|0|||
162615918|NCT01914757|587311570|FG001|Overall Study|Study specific withdrawal criteria|1|||
162615919|NCT01914757|587311571|FG002|Overall Study|Study specific withdrawal criteria|0|||
162615920|NCT01914757|587311569|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162707025|NCT04955626|587636666|FG010|Open-Label Period|Refused further study procedures|0|||
162707026|NCT04955626|587636667|FG011|Open-Label Period|Refused further study procedures|0|||
162875891|NCT00256867|588247160|FG005|Overall Study|Investigator's Decision|0|||
162875892|NCT00256867|588247161|FG006|Overall Study|Investigator's Decision|0|||
162875893|NCT00256867|588247162|FG007|Overall Study|Investigator's Decision|0|||
162875894|NCT00256867|588247155|FG000|Overall Study|Non-compliance with study medication|0|||
162875895|NCT00256867|588247156|FG001|Overall Study|Non-compliance with study medication|0|||
162875896|NCT00256867|588247157|FG002|Overall Study|Non-compliance with study medication|0|||
162875897|NCT00256867|588247158|FG003|Overall Study|Non-compliance with study medication|0|||
162875898|NCT00256867|588247159|FG004|Overall Study|Non-compliance with study medication|0|||
162875899|NCT00256867|588247160|FG005|Overall Study|Non-compliance with study medication|0|||
162875900|NCT00256867|588247161|FG006|Overall Study|Non-compliance with study medication|0|||
162875901|NCT00256867|588247162|FG007|Overall Study|Non-compliance with study medication|1|||
162875902|NCT00256867|588247155|FG000|Overall Study|Participant travelled Overseas|0|||
162875903|NCT00256867|588247156|FG001|Overall Study|Participant travelled Overseas|1|||
162875904|NCT00256867|588247157|FG002|Overall Study|Participant travelled Overseas|0|||
162875905|NCT00256867|588247158|FG003|Overall Study|Participant travelled Overseas|0|||
162875906|NCT00256867|588247159|FG004|Overall Study|Participant travelled Overseas|0|||
162875907|NCT00256867|588247160|FG005|Overall Study|Participant travelled Overseas|0|||
162875908|NCT00256867|588247161|FG006|Overall Study|Participant travelled Overseas|0|||
162875909|NCT00256867|588247162|FG007|Overall Study|Participant travelled Overseas|0|||
162875910|NCT00256867|588247155|FG000|Overall Study|Participant out of assessment window|0|||
162875911|NCT00256867|588247156|FG001|Overall Study|Participant out of assessment window|0|||
162875912|NCT00256867|588247157|FG002|Overall Study|Participant out of assessment window|1|||
162875913|NCT00256867|588247158|FG003|Overall Study|Participant out of assessment window|0|||
162707027|NCT04955626|587636668|FG012|Open-Label Period|Refused further study procedures|0|||
162875914|NCT00256867|588247159|FG004|Overall Study|Participant out of assessment window|0|||
162875915|NCT00256867|588247160|FG005|Overall Study|Participant out of assessment window|0|||
162961483|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162615921|NCT01914757|587311570|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162615922|NCT01914757|587311571|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
162615923|NCT01914757|587311569|FG000|Overall Study|Other reasons|5|||
162615924|NCT01914757|587311570|FG001|Overall Study|Other reasons|9|||
162615925|NCT01914757|587311571|FG002|Overall Study|Other reasons|4|||
162615926|NCT00408629|587311574|FG000|Overall Study|Adverse Event|13|||
162875916|NCT00256867|588247161|FG006|Overall Study|Participant out of assessment window|0|||
162875917|NCT00256867|588247162|FG007|Overall Study|Participant out of assessment window|0|||
162875918|NCT00256867|588247155|FG000|Overall Study|Withdrawal by participant|0|||
162875919|NCT00256867|588247156|FG001|Overall Study|Withdrawal by participant|0|||
162875920|NCT00256867|588247157|FG002|Overall Study|Withdrawal by participant|0|||
162875921|NCT00256867|588247158|FG003|Overall Study|Withdrawal by participant|0|||
162875922|NCT00256867|588247159|FG004|Overall Study|Withdrawal by participant|0|||
162875923|NCT00256867|588247160|FG005|Overall Study|Withdrawal by participant|1|||
162875924|NCT00256867|588247161|FG006|Overall Study|Withdrawal by participant|0|||
162875925|NCT00256867|588247162|FG007|Overall Study|Withdrawal by participant|0|||
162875926|NCT00527111|588247167|FG000|Overall Study|Adverse Event|14|||
162875927|NCT00527111|588247168|FG001|Overall Study|Adverse Event|13|||
162875928|NCT00527111|588247167|FG000|Overall Study|Death|0|||
162875929|NCT00527111|588247168|FG001|Overall Study|Death|1|||
162875930|NCT00527111|588247167|FG000|Overall Study|Investigator Request|2|||
162961484|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961485|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961486|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961487|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961488|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961489|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961490|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
162961491|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
162961492|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
162961493|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961494|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961495|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961496|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961497|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961498|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961499|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961500|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162615927|NCT00408629|587311575|FG001|Overall Study|Adverse Event|27|||
162875931|NCT00527111|588247168|FG001|Overall Study|Investigator Request|1|||
162875932|NCT00527111|588247167|FG000|Overall Study|Patient Request|2|||
162875933|NCT00527111|588247168|FG001|Overall Study|Patient Request|5|||
162961501|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961502|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961503|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162875934|NCT00527111|588247167|FG000|Overall Study|Other|2|||
162875935|NCT00527111|588247168|FG001|Overall Study|Other|2|||
162875936|NCT01930799|588247172|FG000|Overall Study|Withdrawal by Subject|3|||
162875937|NCT01930799|588247172|FG000|Overall Study|Lost to Follow-up|5|||
162875938|NCT00875017|588247173|FG000|First Intervention|Withdrawal by Subject|1|||
162875939|NCT00875017|588247174|FG001|First Intervention|Withdrawal by Subject|0|||
162875940|NCT00875017|588247175|FG002|First Intervention|Withdrawal by Subject|1|||
162615928|NCT00408629|587311574|FG000|Overall Study|Withdrawal by Subject|8|||
162615929|NCT00408629|587311575|FG001|Overall Study|Withdrawal by Subject|4|||
162875941|NCT00875017|588247176|FG003|First Intervention|Withdrawal by Subject|0|||
162875942|NCT00875017|588247177|FG004|First Intervention|Withdrawal by Subject|0|||
162875943|NCT00875017|588247178|FG005|First Intervention|Withdrawal by Subject|0|||
162875944|NCT00875017|588247173|FG000|First Intervention|Adverse Event|0|||
162875945|NCT00875017|588247174|FG001|First Intervention|Adverse Event|0|||
162875946|NCT00875017|588247175|FG002|First Intervention|Adverse Event|0|||
162875947|NCT00875017|588247176|FG003|First Intervention|Adverse Event|1|||
162875948|NCT00875017|588247177|FG004|First Intervention|Adverse Event|0|||
162875949|NCT00875017|588247178|FG005|First Intervention|Adverse Event|0|||
162875950|NCT00875017|588247173|FG000|First Intervention|Problems collecting rectal effluent|1|||
162875951|NCT00875017|588247174|FG001|First Intervention|Problems collecting rectal effluent|0|||
162875952|NCT00875017|588247175|FG002|First Intervention|Problems collecting rectal effluent|0|||
162875953|NCT00875017|588247176|FG003|First Intervention|Problems collecting rectal effluent|0|||
162875954|NCT00875017|588247177|FG004|First Intervention|Problems collecting rectal effluent|0|||
162875955|NCT00875017|588247178|FG005|First Intervention|Problems collecting rectal effluent|0|||
162615930|NCT00408629|587311574|FG000|Overall Study|Lost to Follow-up|1|||
162615931|NCT00408629|587311575|FG001|Overall Study|Lost to Follow-up|1|||
162615932|NCT00408629|587311574|FG000|Overall Study|Lack of Efficacy|63|||
162615933|NCT00408629|587311575|FG001|Overall Study|Lack of Efficacy|73|||
162615934|NCT00408629|587311574|FG000|Overall Study|Protocol Violation|1|||
162875956|NCT00875017|588247173|FG000|First Intervention|Intolerance to nasogastric tube|0|||
162875957|NCT00875017|588247174|FG001|First Intervention|Intolerance to nasogastric tube|0|||
162875958|NCT00875017|588247175|FG002|First Intervention|Intolerance to nasogastric tube|0|||
162875959|NCT00875017|588247176|FG003|First Intervention|Intolerance to nasogastric tube|0|||
162875960|NCT00875017|588247177|FG004|First Intervention|Intolerance to nasogastric tube|1|||
162875961|NCT00875017|588247178|FG005|First Intervention|Intolerance to nasogastric tube|0|||
162875962|NCT00875017|588247173|FG000|Washout|Problem collecting rectal effluent|0|||
162875963|NCT00875017|588247174|FG001|Washout|Problem collecting rectal effluent|0|||
162875964|NCT00875017|588247175|FG002|Washout|Problem collecting rectal effluent|1|||
162875965|NCT00875017|588247176|FG003|Washout|Problem collecting rectal effluent|0|||
162875966|NCT00875017|588247177|FG004|Washout|Problem collecting rectal effluent|0|||
162875967|NCT00875017|588247178|FG005|Washout|Problem collecting rectal effluent|0|||
162875968|NCT00875017|588247173|FG000|Second Intervention|Adverse Event|0|||
162875969|NCT00875017|588247174|FG001|Second Intervention|Adverse Event|0|||
162615935|NCT00408629|587311575|FG001|Overall Study|Protocol Violation|5|||
162875970|NCT00875017|588247175|FG002|Second Intervention|Adverse Event|0|||
162875971|NCT00875017|588247176|FG003|Second Intervention|Adverse Event|1|||
162875972|NCT00875017|588247177|FG004|Second Intervention|Adverse Event|0|||
163047848|NCT03934216|588882617|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162615936|NCT00408629|587311574|FG000|Overall Study|Miscellaneous|11|||
162615937|NCT00408629|587311575|FG001|Overall Study|Miscellaneous|15|||
162875973|NCT00875017|588247178|FG005|Second Intervention|Adverse Event|0|||
162615938|NCT01461980|587311576|FG000|Overall Study|Other|9|||
162615939|NCT01461980|587311577|FG001|Overall Study|Other|8|||
162875974|NCT00875017|588247173|FG000|Washout|Problems collecting rectal effluent|0|||
162875975|NCT00875017|588247174|FG001|Washout|Problems collecting rectal effluent|1|||
162875976|NCT00875017|588247175|FG002|Washout|Problems collecting rectal effluent|0|||
162875977|NCT00875017|588247176|FG003|Washout|Problems collecting rectal effluent|0|||
162875978|NCT00875017|588247177|FG004|Washout|Problems collecting rectal effluent|0|||
162875979|NCT00875017|588247178|FG005|Washout|Problems collecting rectal effluent|0|||
162875980|NCT00875017|588247173|FG000|Third Intervention|Adverse Event|0|||
162875981|NCT00875017|588247174|FG001|Third Intervention|Adverse Event|1|||
162875982|NCT00875017|588247175|FG002|Third Intervention|Adverse Event|1|||
162875983|NCT00875017|588247176|FG003|Third Intervention|Adverse Event|0|||
162875984|NCT00875017|588247177|FG004|Third Intervention|Adverse Event|0|||
162875985|NCT00875017|588247178|FG005|Third Intervention|Adverse Event|0|||
162875986|NCT00875017|588247173|FG000|Washout|Withdrawal by Subject|0|||
162875987|NCT00875017|588247174|FG001|Washout|Withdrawal by Subject|0|||
162875988|NCT00875017|588247175|FG002|Washout|Withdrawal by Subject|0|||
162875989|NCT00875017|588247176|FG003|Washout|Withdrawal by Subject|0|||
162875990|NCT00875017|588247177|FG004|Washout|Withdrawal by Subject|1|||
162875991|NCT00875017|588247178|FG005|Washout|Withdrawal by Subject|0|||
162875992|NCT00875017|588247173|FG000|Fourth Intervention|Inability to comply with fasting|0|||
162875993|NCT00875017|588247174|FG001|Fourth Intervention|Inability to comply with fasting|0|||
162875994|NCT00875017|588247175|FG002|Fourth Intervention|Inability to comply with fasting|0|||
162875995|NCT00875017|588247176|FG003|Fourth Intervention|Inability to comply with fasting|0|||
162875996|NCT00875017|588247177|FG004|Fourth Intervention|Inability to comply with fasting|0|||
162875997|NCT00875017|588247178|FG005|Fourth Intervention|Inability to comply with fasting|1|||
162875998|NCT02689219|588247179|FG000|Overall Study|Death|1|||
162875999|NCT02689219|588247180|FG001|Overall Study|Death|1|||
162876000|NCT02689219|588247179|FG000|Overall Study|Disease Progression|10|||
162876001|NCT02689219|588247180|FG001|Overall Study|Disease Progression|6|||
162876002|NCT01477892|588247181|FG000|Overall Study|Withdrawal by Subject|0|||
162876003|NCT01477892|588247182|FG001|Overall Study|Withdrawal by Subject|2|||
162876004|NCT01921257|588247187|FG000|Overall Study|Adverse Event|1|||
162876005|NCT01921257|588247187|FG000|Overall Study|Protocol Violation|1|||
162876006|NCT01921257|588247187|FG000|Overall Study|Withdrawal by Subject|1|||
162876007|NCT00364845|588247188|FG000|Overall Study|Adverse Event|1|||
162876008|NCT00364845|588247189|FG001|Overall Study|Adverse Event|0|||
162876009|NCT00364845|588247188|FG000|Overall Study|Withdrawal by Subject|2|||
162876010|NCT00364845|588247189|FG001|Overall Study|Withdrawal by Subject|1|||
162876011|NCT00364845|588247188|FG000|Overall Study|Physician Decision|8|||
162876012|NCT00364845|588247189|FG001|Overall Study|Physician Decision|8|||
162876013|NCT00364845|588247188|FG000|Overall Study|Lost to Follow-up|0|||
162876014|NCT00364845|588247189|FG001|Overall Study|Lost to Follow-up|1|||
162876015|NCT00364845|588247188|FG000|Overall Study|Death|0|||
162876016|NCT00364845|588247189|FG001|Overall Study|Death|1|||
162876017|NCT01423617|588247190|FG000|Overall Study|Lost to Follow-up|0|||
162876018|NCT01423617|588247191|FG001|Overall Study|Lost to Follow-up|1|||
162876019|NCT00634244|588247192|FG000|Overall Study|Never started treatment|0|||
162876020|NCT00634244|588247193|FG001|Overall Study|Never started treatment|1|||
162876021|NCT00634244|588247194|FG002|Overall Study|Never started treatment|0|||
162876022|NCT00634244|588247192|FG000|Overall Study|Death|1|||
162876023|NCT00634244|588247193|FG001|Overall Study|Death|6|||
162876024|NCT00634244|588247194|FG002|Overall Study|Death|0|||
162876025|NCT00634244|588247192|FG000|Overall Study|Adverse Event|0|||
162876026|NCT00634244|588247193|FG001|Overall Study|Adverse Event|2|||
162876027|NCT00634244|588247194|FG002|Overall Study|Adverse Event|0|||
162876028|NCT00634244|588247192|FG000|Overall Study|Withdrawal by Subject|0|||
162876029|NCT00634244|588247193|FG001|Overall Study|Withdrawal by Subject|1|||
162961504|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961505|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961506|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162615940|NCT01461980|587311578|FG002|Overall Study|Other|6|||
162615941|NCT01461980|587311576|FG000|Overall Study|Medication error|7|||
162615942|NCT01461980|587311577|FG001|Overall Study|Medication error|5|||
162615943|NCT01461980|587311578|FG002|Overall Study|Medication error|6|||
162615944|NCT01461980|587311576|FG000|Overall Study|Adverse Event|12|||
162615945|NCT01461980|587311577|FG001|Overall Study|Adverse Event|5|||
162615946|NCT01461980|587311578|FG002|Overall Study|Adverse Event|6|||
162876030|NCT00634244|588247194|FG002|Overall Study|Withdrawal by Subject|0|||
162876031|NCT00634244|588247192|FG000|Overall Study|Physician Decision|0|||
162979001|NCT03545191|588623548|FG002|Overall Study|Other reasons|8|||
162615947|NCT01461980|587311576|FG000|Overall Study|Protocol Violation|12|||
162615948|NCT01461980|587311577|FG001|Overall Study|Protocol Violation|19|||
162876032|NCT00634244|588247193|FG001|Overall Study|Physician Decision|1|||
162876033|NCT00634244|588247194|FG002|Overall Study|Physician Decision|0|||
162876034|NCT00634244|588247192|FG000|Overall Study|Disease progression/relapse|0|||
162876035|NCT00634244|588247193|FG001|Overall Study|Disease progression/relapse|1|||
162876036|NCT00634244|588247194|FG002|Overall Study|Disease progression/relapse|0|||
162876037|NCT00634244|588247192|FG000|Overall Study|Other complicating disease|0|||
162876038|NCT00634244|588247193|FG001|Overall Study|Other complicating disease|1|||
162615949|NCT01461980|587311578|FG002|Overall Study|Protocol Violation|16|||
162615950|NCT01461980|587311576|FG000|Overall Study|No longer meets eligibility criteria|18|||
162615951|NCT01461980|587311577|FG001|Overall Study|No longer meets eligibility criteria|9|||
162615952|NCT01461980|587311578|FG002|Overall Study|No longer meets eligibility criteria|19|||
162615953|NCT01461980|587311576|FG000|Overall Study|Lost to Follow-up|52|||
162615954|NCT01461980|587311577|FG001|Overall Study|Lost to Follow-up|53|||
162615955|NCT01461980|587311578|FG002|Overall Study|Lost to Follow-up|51|||
162615956|NCT01461980|587311576|FG000|Overall Study|No longer willing to participate|52|||
162615957|NCT01461980|587311577|FG001|Overall Study|No longer willing to participate|38|||
162615958|NCT01461980|587311578|FG002|Overall Study|No longer willing to participate|54|||
162615959|NCT01461980|587311576|FG000|Overall Study|Randomized but not vaccinated|4|||
162615960|NCT01461980|587311577|FG001|Overall Study|Randomized but not vaccinated|8|||
162615961|NCT01461980|587311578|FG002|Overall Study|Randomized but not vaccinated|7|||
162615962|NCT00122109|587311579|FG000|Overall Study|Did not meet criteria|6|||
162615963|NCT00122109|587311580|FG001|Overall Study|Did not meet criteria|7|||
162615964|NCT01890746|587311583|FG000|Overall Study|Death|39|||
162615965|NCT01890746|587311584|FG001|Overall Study|Death|30|||
162615966|NCT01890746|587311583|FG000|Overall Study|Adverse Event|1|||
162615967|NCT01890746|587311584|FG001|Overall Study|Adverse Event|0|||
162615968|NCT01890746|587311583|FG000|Overall Study|Lost to Follow-up|4|||
162615969|NCT01890746|587311584|FG001|Overall Study|Lost to Follow-up|1|||
162615970|NCT01890746|587311583|FG000|Overall Study|Physician Decision|3|||
162615971|NCT01890746|587311584|FG001|Overall Study|Physician Decision|2|||
162615972|NCT01890746|587311583|FG000|Overall Study|Withdrawal by Subject|5|||
162615973|NCT01890746|587311584|FG001|Overall Study|Withdrawal by Subject|8|||
162615974|NCT00100178|587311585|FG000|Overall Study|Lost to Follow-up|0|||
162615975|NCT00100178|587311586|FG001|Overall Study|Lost to Follow-up|6|||
162615976|NCT00100178|587311587|FG002|Overall Study|Lost to Follow-up|5|||
162615977|NCT00100178|587311585|FG000|Overall Study|Adverse Event|2|||
162615978|NCT00100178|587311586|FG001|Overall Study|Adverse Event|2|||
162615979|NCT00100178|587311587|FG002|Overall Study|Adverse Event|1|||
162876039|NCT00634244|588247194|FG002|Overall Study|Other complicating disease|0|||
162876040|NCT01204658|588247196|FG000|Primary Phase|Adverse Event|0|||
162876041|NCT01204658|588247197|FG001|Primary Phase|Adverse Event|0|||
162876042|NCT01204658|588247198|FG002|Primary Phase|Adverse Event|1|||
162876043|NCT01204658|588247199|FG003|Primary Phase|Adverse Event|0|||
162876044|NCT04594239|588247204|FG000|Overall Study|Withdrawal by Subject|3|||
162876045|NCT04594239|588247205|FG001|Overall Study|Withdrawal by Subject|4|||
162876046|NCT04594239|588247206|FG002|Overall Study|Withdrawal by Subject|2|||
162876047|NCT04594239|588247207|FG003|Overall Study|Withdrawal by Subject|4|||
162876048|NCT04594239|588247204|FG000|Overall Study|Lost to Follow-up|8|||
162876049|NCT04594239|588247205|FG001|Overall Study|Lost to Follow-up|5|||
162876050|NCT04594239|588247206|FG002|Overall Study|Lost to Follow-up|4|||
162876051|NCT04594239|588247207|FG003|Overall Study|Lost to Follow-up|6|||
162876052|NCT04594239|588247204|FG000|Overall Study|Subject relocated|0|||
162876053|NCT04594239|588247205|FG001|Overall Study|Subject relocated|0|||
162876054|NCT04594239|588247206|FG002|Overall Study|Subject relocated|0|||
162876055|NCT04594239|588247207|FG003|Overall Study|Subject relocated|1|||
162876056|NCT02723604|588248860|FG000|Overall Study|ineligible|1|||
162876057|NCT02723604|588248860|FG000|Overall Study|never received treatment|1|||
162876058|NCT00111475|588248861|FG000|Overall Study|Lost to Follow-up|0|||
162876059|NCT00111475|588248862|FG001|Overall Study|Lost to Follow-up|0|||
162876060|NCT00111475|588248863|FG002|Overall Study|Lost to Follow-up|0|||
162876061|NCT00111475|588248864|FG003|Overall Study|Lost to Follow-up|0|||
162876062|NCT00111475|588248865|FG004|Overall Study|Lost to Follow-up|0|||
162876063|NCT00111475|588248866|FG005|Overall Study|Lost to Follow-up|1|||
162876064|NCT00111475|588248867|FG006|Overall Study|Lost to Follow-up|0|||
162876065|NCT00111475|588248868|FG007|Overall Study|Lost to Follow-up|0|||
162876066|NCT00111475|588248869|FG008|Overall Study|Lost to Follow-up|0|||
162876067|NCT00111475|588248870|FG009|Overall Study|Lost to Follow-up|0|||
162876068|NCT00833248|588248873|FG000|Overall Study|Adverse Event|3|||
162876069|NCT00833248|588248874|FG001|Overall Study|Adverse Event|0|||
162876070|NCT00833248|588248873|FG000|Overall Study|Protocol Violation|1|||
162615980|NCT00100178|587311585|FG000|Overall Study|Withdrawal by Subject|1|||
162876071|NCT00833248|588248874|FG001|Overall Study|Protocol Violation|2|||
162876072|NCT00833248|588248873|FG000|Overall Study|Withdrawal by Subject|0|||
162615981|NCT00100178|587311586|FG001|Overall Study|Withdrawal by Subject|1|||
162615982|NCT00100178|587311587|FG002|Overall Study|Withdrawal by Subject|1|||
162615983|NCT00100178|587311585|FG000|Overall Study|Physician Decision|6|||
162615984|NCT00100178|587311586|FG001|Overall Study|Physician Decision|1|||
162961507|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961508|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162961509|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961510|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961511|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961512|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961513|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162876073|NCT00833248|588248874|FG001|Overall Study|Withdrawal by Subject|1|||
162876074|NCT01369849|588248877|FG000|Overall Study|Ineligible prior to treatment|0|||
162876075|NCT01369849|588248878|FG001|Overall Study|Ineligible prior to treatment|0|||
162876076|NCT01369849|588248879|FG002|Overall Study|Ineligible prior to treatment|1|||
162876077|NCT01369849|588248877|FG000|Overall Study|Ineligible after receiving treatment|0|||
162876078|NCT01369849|588248878|FG001|Overall Study|Ineligible after receiving treatment|1|||
162876079|NCT01369849|588248879|FG002|Overall Study|Ineligible after receiving treatment|0|||
162876080|NCT00288860|588248882|FG000|Overall Study|Did not complete intake|4|||
162876081|NCT00288860|588248883|FG001|Overall Study|Did not complete intake|8|||
162876082|NCT00288860|588248882|FG000|Overall Study|Death|4|||
162876083|NCT00288860|588248883|FG001|Overall Study|Death|3|||
162876084|NCT00288860|588248882|FG000|Overall Study|Withdrawal by Subject|20|||
162876085|NCT00288860|588248883|FG001|Overall Study|Withdrawal by Subject|15|||
162876086|NCT00288860|588248882|FG000|Overall Study|Lost to Follow-up|74|||
162876087|NCT00288860|588248883|FG001|Overall Study|Lost to Follow-up|71|||
162876088|NCT00115349|588248890|FG000|Overall Study|Study closed due to low enrollment.|11|||
162876089|NCT00115349|588248891|FG001|Overall Study|Study closed due to low enrollment.|9|||
162876090|NCT01028651|588248896|FG000|Overall Study|Death|2|||
162876091|NCT01028651|588248896|FG000|Overall Study|Adverse Event|1|||
162876092|NCT00390416|588248898|FG000|Overall Study|Withdrawal by Subject|1|||
162876093|NCT00390416|588248898|FG000|Overall Study|Not treated|3|||
162876094|NCT01592409|588248899|FG000|Overall Study|Withdrawal by Subject|0|||
162876095|NCT01592409|588248900|FG001|Overall Study|Withdrawal by Subject|1|||
162876096|NCT01728584|588248901|FG000|Overall Study|Adverse Event|1|||
162876097|NCT01728584|588248902|FG001|Overall Study|Adverse Event|0|||
162876098|NCT01728584|588248903|FG002|Overall Study|Adverse Event|0|||
162876099|NCT01728584|588248904|FG003|Overall Study|Adverse Event|0|||
162876100|NCT01728584|588248901|FG000|Overall Study|Physician Decision|4|||
162876101|NCT01728584|588248902|FG001|Overall Study|Physician Decision|0|||
162876102|NCT01728584|588248903|FG002|Overall Study|Physician Decision|1|||
162876103|NCT01728584|588248904|FG003|Overall Study|Physician Decision|0|||
162876104|NCT01728584|588248901|FG000|Overall Study|Withdrawal by Subject|1|||
162876105|NCT01728584|588248902|FG001|Overall Study|Withdrawal by Subject|0|||
162876106|NCT01728584|588248903|FG002|Overall Study|Withdrawal by Subject|0|||
162876107|NCT01728584|588248904|FG003|Overall Study|Withdrawal by Subject|0|||
162876108|NCT01728584|588248901|FG000|Overall Study|Screen failure|1|||
162876109|NCT01728584|588248902|FG001|Overall Study|Screen failure|0|||
162876110|NCT01728584|588248903|FG002|Overall Study|Screen failure|0|||
162876111|NCT01728584|588248904|FG003|Overall Study|Screen failure|0|||
162876112|NCT01728584|588248901|FG000|Overall Study|Other reason (not specified)|1|||
162876113|NCT01728584|588248902|FG001|Overall Study|Other reason (not specified)|0|||
162876114|NCT01728584|588248903|FG002|Overall Study|Other reason (not specified)|0|||
162876115|NCT01728584|588248904|FG003|Overall Study|Other reason (not specified)|1|||
162876116|NCT05132569|588248906|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
162876117|NCT05132569|588248907|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
162876118|NCT05132569|588248906|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
162876119|NCT05132569|588248907|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
162876120|NCT05132569|588248906|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
162876121|NCT05132569|588248907|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
162876122|NCT02345252|588248922|FG000|Double-Blind Phase|Adverse Event|2|||
162876123|NCT02345252|588248923|FG001|Double-Blind Phase|Adverse Event|3|||
162876124|NCT02345252|588248922|FG000|Double-Blind Phase|Death|1|||
162876125|NCT02345252|588248923|FG001|Double-Blind Phase|Death|2|||
162876126|NCT02345252|588248922|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162876127|NCT02345252|588248923|FG001|Double-Blind Phase|Lack of Efficacy|0|||
162876128|NCT02345252|588248922|FG000|Double-Blind Phase|Investigator's Discretion|4|||
162876129|NCT02345252|588248923|FG001|Double-Blind Phase|Investigator's Discretion|6|||
162876130|NCT02345252|588248922|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
162876131|NCT02345252|588248923|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
162876132|NCT02345252|588248922|FG000|Double-Blind Phase|Protocol Violation|2|||
162876133|NCT02345252|588248923|FG001|Double-Blind Phase|Protocol Violation|1|||
162876134|NCT02345252|588248922|FG000|Double-Blind Phase|Withdrew Consent|21|||
162876135|NCT02345252|588248923|FG001|Double-Blind Phase|Withdrew Consent|23|||
162876136|NCT02345252|588248922|FG000|Double-Blind Phase|Lost to Follow-up|8|||
162876137|NCT02345252|588248923|FG001|Double-Blind Phase|Lost to Follow-up|10|||
162876138|NCT02345252|588248922|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
162876139|NCT02345252|588248923|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
162876140|NCT00471536|588248934|FG000|Overall Study|Withdrawal by Subject|1|||
162876141|NCT01188564|588248937|FG000|Double-blind Phase|randomized not treated|1|||
162876142|NCT01188564|588248938|FG001|Double-blind Phase|randomized not treated|0|||
162876143|NCT04171037|588248941|FG000|Overall Study|Lost to Follow-up|1|||
162876144|NCT04171037|588248942|FG001|Overall Study|Lost to Follow-up|0|||
162876145|NCT04171037|588248941|FG000|Overall Study|Physician Decision|3|||
162876146|NCT04171037|588248942|FG001|Overall Study|Physician Decision|3|||
162876147|NCT01934894|588248943|FG000|Overall Study|Adverse Event|1|||
162876148|NCT01934894|588248944|FG001|Overall Study|Adverse Event|2|||
162876149|NCT01934894|588248943|FG000|Overall Study|Death|2|||
162876150|NCT01934894|588248944|FG001|Overall Study|Death|0|||
162876151|NCT01934894|588248943|FG000|Overall Study|Withdrawal by Subject|0|||
162876152|NCT01934894|588248944|FG001|Overall Study|Withdrawal by Subject|1|||
162876153|NCT01934894|588248943|FG000|Overall Study|Progressive Disease|3|||
162876154|NCT01934894|588248944|FG001|Overall Study|Progressive Disease|2|||
162876155|NCT01954251|588248945|FG000|Overall Study|Adverse Event|5|||
162876156|NCT01954251|588248946|FG001|Overall Study|Adverse Event|7|||
162876157|NCT01954251|588248945|FG000|Overall Study|Lost to Follow-up|6|||
162876158|NCT01954251|588248946|FG001|Overall Study|Lost to Follow-up|6|||
162876159|NCT01954251|588248945|FG000|Overall Study|Withdrawal by Subject|2|||
162876160|NCT01954251|588248946|FG001|Overall Study|Withdrawal by Subject|6|||
162876161|NCT02864940|588248947|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
162876162|NCT02864940|588248948|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
162876163|NCT02232087|588248949|FG000|Overall Study|Withdrawal by Subject|2|||
162876164|NCT02232087|588248950|FG001|Overall Study|Withdrawal by Subject|0|||
162876165|NCT02232087|588248951|FG002|Overall Study|Withdrawal by Subject|0|||
162876166|NCT02232087|588248952|FG003|Overall Study|Withdrawal by Subject|0|||
162876167|NCT02232087|588248953|FG004|Overall Study|Withdrawal by Subject|0|||
162876168|NCT02232087|588248954|FG005|Overall Study|Withdrawal by Subject|1|||
162876169|NCT02232087|588248949|FG000|Overall Study|poor inhalation technique|0|||
162876170|NCT02232087|588248950|FG001|Overall Study|poor inhalation technique|1|||
162876171|NCT02232087|588248951|FG002|Overall Study|poor inhalation technique|0|||
162876172|NCT02232087|588248952|FG003|Overall Study|poor inhalation technique|0|||
162876173|NCT02232087|588248953|FG004|Overall Study|poor inhalation technique|0|||
162876174|NCT02232087|588248954|FG005|Overall Study|poor inhalation technique|2|||
162876175|NCT02232087|588248949|FG000|Overall Study|protocol stop criteria|0|||
162876176|NCT02232087|588248950|FG001|Overall Study|protocol stop criteria|1|||
162876177|NCT02232087|588248951|FG002|Overall Study|protocol stop criteria|0|||
162876178|NCT02232087|588248952|FG003|Overall Study|protocol stop criteria|1|||
162876179|NCT02232087|588248953|FG004|Overall Study|protocol stop criteria|0|||
162876180|NCT02232087|588248954|FG005|Overall Study|protocol stop criteria|0|||
162876181|NCT02232087|588248949|FG000|Overall Study|Adverse Event|0|||
162876182|NCT02232087|588248950|FG001|Overall Study|Adverse Event|0|||
162876183|NCT02232087|588248951|FG002|Overall Study|Adverse Event|0|||
162876184|NCT02232087|588248952|FG003|Overall Study|Adverse Event|0|||
162876185|NCT02232087|588248953|FG004|Overall Study|Adverse Event|1|||
162961514|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961515|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961516|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961517|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961518|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
162961519|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961520|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961521|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961522|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961523|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961524|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961525|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961526|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961527|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961528|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961529|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961530|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
163047849|NCT03934216|588882618|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163047850|NCT03934216|588882617|FG000|Overall Study|Pregnancy|1|||
163047851|NCT03934216|588882618|FG001|Overall Study|Pregnancy|0|||
162615985|NCT00100178|587311587|FG002|Overall Study|Physician Decision|3|||
162876186|NCT02232087|588248954|FG005|Overall Study|Adverse Event|0|||
162876187|NCT01958125|588248955|FG000|Overall Study|Missing diary data|2|||
162876188|NCT01958125|588248956|FG001|Overall Study|Missing diary data|6|||
162876189|NCT01958125|588248955|FG000|Overall Study|No headache attacks|0|||
162876190|NCT01958125|588248956|FG001|Overall Study|No headache attacks|2|||
162876191|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
162876192|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
162876193|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
162615986|NCT00631696|587311588|FG000|Overall Study|Entered, not randomized to treatment|1|||
162876194|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
162876195|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
162876196|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
162876197|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
162876198|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
162876199|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
162876200|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
162876201|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
162876202|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
162876203|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
162876204|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
162876205|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
162876206|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
163047852|NCT03934216|588882617|FG000|Overall Study|Withdrawal by Subject|18|||
163047853|NCT03934216|588882618|FG001|Overall Study|Withdrawal by Subject|6|||
163047854|NCT03934216|588882617|FG000|Overall Study|Randomized but not treated|1|||
163047855|NCT03934216|588882618|FG001|Overall Study|Randomized but not treated|1|||
162876207|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
162876208|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162876209|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
162876210|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
162876211|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
162876212|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
162876213|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
162876214|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
162876215|NCT01106625|588248957|FG000|Core Period: Baseline to Week 26|Other|8|||
162876216|NCT01106625|588248958|FG001|Core Period: Baseline to Week 26|Other|7|||
163047856|NCT00735709|588882619|FG000|Overall Study|Adverse Event|2|||
163047857|NCT00735709|588882620|FG001|Overall Study|Adverse Event|3|||
163047858|NCT00735709|588882621|FG002|Overall Study|Adverse Event|1|||
163047859|NCT00735709|588882622|FG003|Overall Study|Adverse Event|5|||
163047860|NCT00735709|588882619|FG000|Overall Study|Lack of Efficacy|8|||
163047861|NCT00735709|588882620|FG001|Overall Study|Lack of Efficacy|4|||
162876217|NCT01106625|588248959|FG002|Core Period: Baseline to Week 26|Other|4|||
162876218|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163047862|NCT00735709|588882621|FG002|Overall Study|Lack of Efficacy|2|||
163047863|NCT00735709|588882622|FG003|Overall Study|Lack of Efficacy|3|||
163047864|NCT00735709|588882619|FG000|Overall Study|Noncompliance|0|||
163047865|NCT00735709|588882620|FG001|Overall Study|Noncompliance|0|||
163047866|NCT00735709|588882621|FG002|Overall Study|Noncompliance|1|||
163047867|NCT00735709|588882622|FG003|Overall Study|Noncompliance|0|||
163047868|NCT00735709|588882619|FG000|Overall Study|Protocol deviations|1|||
163047869|NCT00735709|588882620|FG001|Overall Study|Protocol deviations|2|||
163047870|NCT00735709|588882621|FG002|Overall Study|Protocol deviations|1|||
163047871|NCT00735709|588882622|FG003|Overall Study|Protocol deviations|1|||
163047872|NCT00735709|588882619|FG000|Overall Study|Voluntary Withdrawal|1|||
163047873|NCT00735709|588882620|FG001|Overall Study|Voluntary Withdrawal|3|||
163047874|NCT00735709|588882621|FG002|Overall Study|Voluntary Withdrawal|5|||
163047875|NCT00735709|588882622|FG003|Overall Study|Voluntary Withdrawal|7|||
163047876|NCT00735709|588882619|FG000|Overall Study|Lost to Follow-up|0|||
163047877|NCT00735709|588882620|FG001|Overall Study|Lost to Follow-up|1|||
163047878|NCT00735709|588882621|FG002|Overall Study|Lost to Follow-up|1|||
163047879|NCT00735709|588882622|FG003|Overall Study|Lost to Follow-up|1|||
163047880|NCT00735709|588882619|FG000|Overall Study|Excluded medication|1|||
163047881|NCT00735709|588882620|FG001|Overall Study|Excluded medication|0|||
163047882|NCT00735709|588882621|FG002|Overall Study|Excluded medication|0|||
162876219|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
162876220|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
162876221|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
162876222|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
163047883|NCT00735709|588882622|FG003|Overall Study|Excluded medication|1|||
163047884|NCT03627832|588882624|FG000|Overall Study|Withdrawal by Subject|10|||
163047885|NCT03627832|588882625|FG001|Overall Study|Withdrawal by Subject|1|||
163047886|NCT02119299|588882629|FG000|Overall Study|Withdrawal by Subject|7|||
163047887|NCT02119299|588882629|FG000|Overall Study|Lack of Efficacy|1|||
163047888|NCT02119299|588882629|FG000|Overall Study|Pregnancy|1|||
163047889|NCT00873730|588882630|FG000|Overall Study|Protocol Deviation|5|||
163047890|NCT00873730|588882631|FG001|Overall Study|Protocol Deviation|2|||
163047891|NCT00873730|588882630|FG000|Overall Study|Adverse Event|0|||
163047892|NCT00873730|588882631|FG001|Overall Study|Adverse Event|2|||
163047893|NCT00873730|588882630|FG000|Overall Study|Withdrawal by Subject|0|||
163047894|NCT00873730|588882631|FG001|Overall Study|Withdrawal by Subject|1|||
163047895|NCT00873730|588882630|FG000|Overall Study|Sponsor decision|1|||
162876223|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
162876224|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
162876225|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162876226|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
162876227|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162876228|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
162876229|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162876230|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
162876231|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
162876232|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
162876233|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
162876234|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
162876235|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
162876236|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
162876237|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
162876238|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
162876239|NCT01106625|588248957|FG000|Extension Period: Week 26 to Week 52|Other|5|||
162876240|NCT01106625|588248958|FG001|Extension Period: Week 26 to Week 52|Other|5|||
162876241|NCT01106625|588248959|FG002|Extension Period: Week 26 to Week 52|Other|4|||
162876242|NCT01864018|588248960|FG000|Overall Study|Ineligible|3|||
162876243|NCT01864018|588248961|FG001|Overall Study|Ineligible|1|||
162876244|NCT02702193|588248962|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
162876245|NCT02702193|588248963|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
162876246|NCT02702193|588248962|FG000|4 Month Follow up|Withdrawal by Subject|1|||
162876247|NCT02702193|588248963|FG001|4 Month Follow up|Withdrawal by Subject|0|||
162876248|NCT02702193|588248962|FG000|4 Month Follow up|Lost to Follow-up|17|||
162876249|NCT02702193|588248963|FG001|4 Month Follow up|Lost to Follow-up|18|||
162876250|NCT02702193|588248962|FG000|8 Month Follow up|Withdrawal by Subject|1|||
162876251|NCT02702193|588248963|FG001|8 Month Follow up|Withdrawal by Subject|0|||
162876252|NCT02702193|588248962|FG000|8 Month Follow up|Lost to Follow-up|14|||
162876253|NCT02702193|588248963|FG001|8 Month Follow up|Lost to Follow-up|18|||
162876254|NCT02702193|588248962|FG000|12 Month Follow up|Withdrawal by Subject|1|||
162876255|NCT02702193|588248963|FG001|12 Month Follow up|Withdrawal by Subject|0|||
162876256|NCT02702193|588248962|FG000|12 Month Follow up|Lost to Follow-up|16|||
162876257|NCT02702193|588248963|FG001|12 Month Follow up|Lost to Follow-up|18|||
162876258|NCT04056455|588248965|FG000|Overall Study|Adverse Event|1|||
162876259|NCT04056455|588248966|FG001|Overall Study|Adverse Event|0|||
162876260|NCT02512068|588248967|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
162876261|NCT02512068|588248968|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
162876262|NCT02512068|588248967|FG000|Overall Study|Major Protocol Deviation|1|||
162876263|NCT02512068|588248968|FG001|Overall Study|Major Protocol Deviation|0|||
162876264|NCT02512068|588248967|FG000|Overall Study|Voluntary Withdrawal|0|||
162876265|NCT02512068|588248968|FG001|Overall Study|Voluntary Withdrawal|1|||
162876266|NCT02512068|588248967|FG000|Overall Study|Lack of Efficacy|0|||
162876267|NCT02512068|588248968|FG001|Overall Study|Lack of Efficacy|1|||
162876268|NCT02512068|588248967|FG000|Overall Study|Reason Not Specified|3|||
162876269|NCT02512068|588248968|FG001|Overall Study|Reason Not Specified|5|||
162876270|NCT05372575|588248978|FG000|Overall Study|Protocol Violation|7|||
162876271|NCT05372575|588248979|FG001|Overall Study|Protocol Violation|16|||
162876272|NCT03345836|588248980|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
162876273|NCT03345836|588248981|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
162876274|NCT03345836|588248982|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
162876275|NCT03345836|588248983|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
162876276|NCT03345836|588248984|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
162876277|NCT03345836|588248985|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
162876278|NCT03345836|588248980|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
162876279|NCT03345836|588248981|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
162876280|NCT03345836|588248982|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
162876281|NCT03345836|588248983|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
162876282|NCT03345836|588248984|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
162876283|NCT03345836|588248985|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
162876284|NCT03345836|588248980|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
162876285|NCT03345836|588248981|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
162876286|NCT03345836|588248982|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
162876287|NCT03345836|588248983|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
162876288|NCT03345836|588248984|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
162961531|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961532|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162876289|NCT03345836|588248985|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
162876290|NCT03345836|588248980|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
162876291|NCT03345836|588248981|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
162876292|NCT03345836|588248982|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
162876293|NCT03345836|588248983|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
162876294|NCT03345836|588248984|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
162876295|NCT03345836|588248985|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
162876296|NCT03345836|588248980|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
162876297|NCT03345836|588248981|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
162876298|NCT03345836|588248982|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
162876299|NCT03345836|588248983|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
162876300|NCT03345836|588248984|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
162876301|NCT03345836|588248985|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
162876302|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
162876303|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
162876304|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
162876305|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
162876306|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
162876307|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
162876308|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
162876309|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
162876310|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
162876311|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
162876312|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
162876313|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
162876314|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
162876315|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
162876316|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
162876317|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
162876318|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
162876319|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
162876320|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
162876321|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
162876322|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
162876323|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
162876324|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
162876325|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
162876326|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
162876327|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
162876328|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
162876329|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
162876330|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
162876331|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
162876332|NCT03345836|588248980|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
162876333|NCT03345836|588248981|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
162876334|NCT03345836|588248982|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
162876335|NCT03345836|588248983|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
162876336|NCT03345836|588248984|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
162876337|NCT03345836|588248985|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
162876338|NCT03510663|588248986|FG000|Overall Study|Withdrawal by Subject|0|||
162876339|NCT03510663|588248987|FG001|Overall Study|Withdrawal by Subject|1|||
162876340|NCT03510663|588248988|FG002|Overall Study|Withdrawal by Subject|0|||
162876341|NCT03510663|588248989|FG003|Overall Study|Withdrawal by Subject|0|||
162876342|NCT03510663|588248990|FG004|Overall Study|Withdrawal by Subject|0|||
162876343|NCT03510663|588248991|FG005|Overall Study|Withdrawal by Subject|0|||
162876344|NCT03510663|588248992|FG006|Overall Study|Withdrawal by Subject|0|||
162876345|NCT03510663|588248993|FG007|Overall Study|Withdrawal by Subject|0|||
162876346|NCT00222729|588248996|FG000|Overall Study|Adverse Event|3|||
162876347|NCT01915849|588248999|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
162876348|NCT01915849|588249000|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
162876349|NCT01915849|588249001|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
162876350|NCT01915849|588249002|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
162961533|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162961534|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
163047896|NCT00873730|588882631|FG001|Overall Study|Sponsor decision|0|||
162876351|NCT01915849|588248999|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
162876352|NCT01915849|588249000|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162876353|NCT01915849|588249001|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162876354|NCT01915849|588249002|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162876355|NCT01798706|588249003|FG000|Overall Study|Adverse Event|15|||
162876356|NCT01798706|588249004|FG001|Overall Study|Adverse Event|10|||
162876357|NCT01798706|588249003|FG000|Overall Study|Lack of Efficacy|0|||
162876358|NCT01798706|588249004|FG001|Overall Study|Lack of Efficacy|2|||
162876359|NCT01798706|588249003|FG000|Overall Study|Poor compliance to protocol|1|||
162876360|NCT01798706|588249004|FG001|Overall Study|Poor compliance to protocol|0|||
162876361|NCT01798706|588249003|FG000|Overall Study|Other than specified above|5|||
162876362|NCT01798706|588249004|FG001|Overall Study|Other than specified above|9|||
162876363|NCT02775864|588249005|FG000|Overall Study|Data ended end of 2010|1764|||
162876364|NCT02775864|588249006|FG001|Overall Study|Data ended end of 2010|2880|||
162876365|NCT02775864|588249007|FG002|Overall Study|Data ended end of 2010|1140|||
162876366|NCT02775864|588249008|FG003|Overall Study|Data ended end of 2010|1194|||
162876367|NCT02775864|588249005|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
162876368|NCT02775864|588249006|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
162876369|NCT02775864|588249007|FG002|Overall Study|Medicaid eligibility discontinued|720|||
162876370|NCT02775864|588249008|FG003|Overall Study|Medicaid eligibility discontinued|890|||
162876371|NCT01689207|588249009|FG000|Overall Study|Adverse Event|0|||
162876372|NCT01689207|588249010|FG001|Overall Study|Adverse Event|1|||
162876373|NCT01689207|588249011|FG002|Overall Study|Adverse Event|0|||
162876374|NCT01689207|588249012|FG003|Overall Study|Adverse Event|0|||
162876375|NCT01689207|588249013|FG004|Overall Study|Adverse Event|2|||
162876376|NCT01689207|588249014|FG005|Overall Study|Adverse Event|1|||
162876377|NCT01689207|588249015|FG006|Overall Study|Adverse Event|0|||
162876378|NCT01689207|588249016|FG007|Overall Study|Adverse Event|0|||
162876379|NCT01689207|588249017|FG008|Overall Study|Adverse Event|1|||
162876380|NCT01689207|588249018|FG009|Overall Study|Adverse Event|0|||
162876381|NCT01689207|588249019|FG010|Overall Study|Adverse Event|0|||
162876382|NCT01912768|588249020|FG000|Overall Study|Adverse Event|2|||
162876383|NCT01912768|588249021|FG001|Overall Study|Adverse Event|0|||
162876384|NCT01912768|588249020|FG000|Overall Study|Lost to Follow-up|2|||
162876385|NCT01912768|588249021|FG001|Overall Study|Lost to Follow-up|1|||
162876386|NCT01912768|588249020|FG000|Overall Study|Withdrawal by Subject|5|||
162876387|NCT01912768|588249021|FG001|Overall Study|Withdrawal by Subject|3|||
162876388|NCT01912768|588249020|FG000|Overall Study|Randomized in error|1|||
162876389|NCT01912768|588249021|FG001|Overall Study|Randomized in error|0|||
162876390|NCT04369430|588249029|FG000|Overall Study|Adverse Event|2|||
162876391|NCT04369430|588249030|FG001|Overall Study|Adverse Event|3|||
162876392|NCT04369430|588249029|FG000|Overall Study|Death|1|||
162876393|NCT04369430|588249030|FG001|Overall Study|Death|0|||
162876394|NCT04369430|588249029|FG000|Overall Study|Withdrawal by Subject|4|||
162876395|NCT04369430|588249030|FG001|Overall Study|Withdrawal by Subject|3|||
162876396|NCT04369430|588249029|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
162876397|NCT04369430|588249030|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
162876398|NCT04369430|588249029|FG000|Overall Study|Lost to Follow-up|0|||
162876399|NCT04369430|588249030|FG001|Overall Study|Lost to Follow-up|1|||
162876400|NCT04737031|588249031|FG000|Overall Study|Patients who did not have a treatment visit|0|||
162876401|NCT04737031|588249032|FG001|Overall Study|Patients who did not have a treatment visit|31|||
162876402|NCT04737031|588249033|FG002|Overall Study|Patients who did not have a treatment visit|93|||
162876403|NCT04737031|588249034|FG003|Overall Study|Patients who did not have a treatment visit|227|||
162876404|NCT03453151|588249037|FG000|Overall Study|Withdrawal by Subject|1|||
162876405|NCT03453151|588249037|FG000|Overall Study|Physician Decision|3|||
162876406|NCT00142519|588249038|FG000|Overall Study|Not Treated|7|||
162876407|NCT00142519|588249039|FG001|Overall Study|Not Treated|9|||
162876408|NCT00142519|588249038|FG000|Overall Study|Protocol Violation|1|||
162876409|NCT00142519|588249039|FG001|Overall Study|Protocol Violation|0|||
162876410|NCT00142519|588249038|FG000|Overall Study|Withdrawal by Subject|10|||
162876411|NCT00142519|588249039|FG001|Overall Study|Withdrawal by Subject|7|||
162876412|NCT01468909|588249040|FG000|Overall Study|Never Treated|2|||
162876413|NCT01468909|588249041|FG001|Overall Study|Never Treated|2|||
162876414|NCT03229759|588249045|FG000|Overall Study|Screen Failure|30|||
162961535|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
162876415|NCT00762372|588251076|FG000|Overall Study|Adverse Event|1|||
162876416|NCT00762372|588251077|FG001|Overall Study|Adverse Event|0|||
162876417|NCT00762372|588251078|FG002|Overall Study|Adverse Event|0|||
162876418|NCT01194804|588251079|FG000|Overall Study|Withdrawal by Subject|1|||
162876419|NCT02670915|588251080|FG000|Overall Study|Withdrawal by Subject|0|||
162876420|NCT02670915|588251081|FG001|Overall Study|Withdrawal by Subject|1|||
162876421|NCT02670915|588251082|FG002|Overall Study|Withdrawal by Subject|4|||
162961536|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
162876422|NCT02670915|588251080|FG000|Overall Study|Withdrawal by parent/guardian|4|||
162876423|NCT02670915|588251081|FG001|Overall Study|Withdrawal by parent/guardian|4|||
162876424|NCT02670915|588251082|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162876425|NCT02670915|588251080|FG000|Overall Study|Unclassified|0|||
162876426|NCT02670915|588251081|FG001|Overall Study|Unclassified|3|||
162876427|NCT02670915|588251082|FG002|Overall Study|Unclassified|0|||
162876428|NCT00818207|588251083|FG000|Overall Study|Adverse Event|6|||
162876429|NCT00818207|588251084|FG001|Overall Study|Adverse Event|0|||
162876430|NCT00818207|588251083|FG000|Overall Study|Lost to Follow-up|160|||
162876431|NCT00818207|588251084|FG001|Overall Study|Lost to Follow-up|146|||
162876432|NCT00818207|588251083|FG000|Overall Study|Multiple reasons|11|||
162876433|NCT00818207|588251084|FG001|Overall Study|Multiple reasons|12|||
162876434|NCT00818207|588251083|FG000|Overall Study|Withdrawal by Subject|42|||
162876435|NCT00818207|588251084|FG001|Overall Study|Withdrawal by Subject|104|||
162876436|NCT00818207|588251083|FG000|Overall Study|Death|3|||
162876437|NCT00818207|588251084|FG001|Overall Study|Death|5|||
162876438|NCT02616185|588251085|FG000|Overall Study|Death|0|||
162876439|NCT02616185|588251086|FG001|Overall Study|Death|0|||
162876440|NCT02616185|588251087|FG002|Overall Study|Death|0|||
162876441|NCT02616185|588251088|FG003|Overall Study|Death|1|||
162876442|NCT02616185|588251089|FG004|Overall Study|Death|2|||
162876443|NCT02616185|588251090|FG005|Overall Study|Death|0|||
162876444|NCT02616185|588251091|FG006|Overall Study|Death|0|||
162876445|NCT02616185|588251092|FG007|Overall Study|Death|2|||
162876446|NCT02616185|588251093|FG008|Overall Study|Death|1|||
162876447|NCT02616185|588251085|FG000|Overall Study|Study terminated by sponsor|0|||
162876448|NCT02616185|588251086|FG001|Overall Study|Study terminated by sponsor|0|||
162876449|NCT02616185|588251087|FG002|Overall Study|Study terminated by sponsor|1|||
162876450|NCT02616185|588251088|FG003|Overall Study|Study terminated by sponsor|0|||
162876451|NCT02616185|588251089|FG004|Overall Study|Study terminated by sponsor|0|||
162876452|NCT02616185|588251090|FG005|Overall Study|Study terminated by sponsor|0|||
162876453|NCT02616185|588251091|FG006|Overall Study|Study terminated by sponsor|5|||
162876454|NCT02616185|588251092|FG007|Overall Study|Study terminated by sponsor|2|||
162876455|NCT02616185|588251093|FG008|Overall Study|Study terminated by sponsor|0|||
162876456|NCT02616185|588251085|FG000|Overall Study|Participant refused further follow-up|1|||
162876457|NCT02616185|588251086|FG001|Overall Study|Participant refused further follow-up|1|||
162876458|NCT02616185|588251087|FG002|Overall Study|Participant refused further follow-up|2|||
162876459|NCT02616185|588251088|FG003|Overall Study|Participant refused further follow-up|3|||
162876460|NCT02616185|588251089|FG004|Overall Study|Participant refused further follow-up|4|||
162876461|NCT02616185|588251090|FG005|Overall Study|Participant refused further follow-up|0|||
162876462|NCT02616185|588251091|FG006|Overall Study|Participant refused further follow-up|3|||
162876463|NCT02616185|588251092|FG007|Overall Study|Participant refused further follow-up|4|||
163047897|NCT04110314|588882634|FG000|Overall Study|Did not meet inclusion criteria|35255|||
163047898|NCT04110314|588882635|FG001|Overall Study|Did not meet inclusion criteria|35104|||
163047899|NCT04110314|588882636|FG002|Overall Study|Did not meet inclusion criteria|35636|||
163047900|NCT04110314|588882637|FG003|Overall Study|Did not meet inclusion criteria|35135|||
163047901|NCT04110314|588882638|FG004|Overall Study|Did not meet inclusion criteria|35247|||
163047902|NCT04110314|588882639|FG005|Overall Study|Did not meet inclusion criteria|35727|||
163047903|NCT01711983|588882647|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
163047904|NCT01711983|588882647|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
163047905|NCT01711983|588882647|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
163047906|NCT01711983|588882647|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
163047907|NCT00737100|588882648|FG000|Overall Study|Adverse Event|6|||
163047908|NCT00737100|588882649|FG001|Overall Study|Adverse Event|5|||
163047909|NCT00737100|588882650|FG002|Overall Study|Adverse Event|3|||
163047910|NCT00737100|588882648|FG000|Overall Study|Lost to Follow-up|0|||
163047911|NCT00737100|588882649|FG001|Overall Study|Lost to Follow-up|1|||
163047912|NCT00737100|588882650|FG002|Overall Study|Lost to Follow-up|0|||
163047913|NCT00737100|588882648|FG000|Overall Study|Withdrawal by Subject|0|||
163047914|NCT00737100|588882649|FG001|Overall Study|Withdrawal by Subject|0|||
162876464|NCT02616185|588251093|FG008|Overall Study|Participant refused further follow-up|3|||
162876465|NCT02616185|588251085|FG000|Overall Study|Not reported|0|||
162876466|NCT02616185|588251086|FG001|Overall Study|Not reported|0|||
162876467|NCT02616185|588251087|FG002|Overall Study|Not reported|0|||
162876468|NCT02616185|588251088|FG003|Overall Study|Not reported|1|||
162876469|NCT02616185|588251089|FG004|Overall Study|Not reported|3|||
162876470|NCT02616185|588251090|FG005|Overall Study|Not reported|1|||
162876471|NCT02616185|588251091|FG006|Overall Study|Not reported|0|||
162876472|NCT02616185|588251092|FG007|Overall Study|Not reported|5|||
162876473|NCT02616185|588251093|FG008|Overall Study|Not reported|2|||
162876474|NCT01303380|588251094|FG000|Overall Study|Lack of compliance to study procedures|1|||
162876475|NCT00967226|588251095|FG000|Overall Study|Adverse Event|0|||
162876476|NCT00967226|588251096|FG001|Overall Study|Adverse Event|5|||
163047915|NCT00737100|588882650|FG002|Overall Study|Withdrawal by Subject|3|||
163047916|NCT00737100|588882648|FG000|Overall Study|Reason discontinued not explained above|1|||
163047917|NCT00737100|588882649|FG001|Overall Study|Reason discontinued not explained above|1|||
162876477|NCT00967226|588251095|FG000|Overall Study|Protocol Violation|2|||
162876478|NCT00967226|588251096|FG001|Overall Study|Protocol Violation|0|||
162876479|NCT00967226|588251095|FG000|Overall Study|Physician Decision|0|||
162876480|NCT00967226|588251096|FG001|Overall Study|Physician Decision|1|||
162876481|NCT01670656|588251097|FG000|Overall Study|Non-compliance with study drug|0|||
162876482|NCT01670656|588251098|FG001|Overall Study|Non-compliance with study drug|0|||
162876483|NCT01670656|588251099|FG002|Overall Study|Non-compliance with study drug|3|||
162876484|NCT01670656|588251100|FG003|Overall Study|Non-compliance with study drug|0|||
162876485|NCT01670656|588251101|FG004|Overall Study|Non-compliance with study drug|1|||
162876486|NCT01670656|588251097|FG000|Overall Study|Pregnancy|0|||
162615987|NCT00631696|587311589|FG001|Overall Study|Entered, not randomized to treatment|1|||
162615988|NCT00631696|587311588|FG000|Overall Study|Discontinued after database release date|1|||
162615989|NCT00631696|587311589|FG001|Overall Study|Discontinued after database release date|0|||
162615990|NCT00631696|587311588|FG000|Overall Study|Follow up after database release date|1|||
162615991|NCT00631696|587311589|FG001|Overall Study|Follow up after database release date|0|||
162615992|NCT00631696|587311588|FG000|Overall Study|Lost to Follow-up|7|||
162615993|NCT00631696|587311589|FG001|Overall Study|Lost to Follow-up|10|||
162615994|NCT00631696|587311588|FG000|Overall Study|Withdrawal by Subject|2|||
162615995|NCT00631696|587311589|FG001|Overall Study|Withdrawal by Subject|9|||
162615996|NCT00631696|587311588|FG000|Overall Study|Other|8|||
162615997|NCT00631696|587311589|FG001|Overall Study|Other|8|||
162615998|NCT00631696|587311588|FG000|Overall Study|Protocol Violation|9|||
162615999|NCT00631696|587311589|FG001|Overall Study|Protocol Violation|9|||
162961537|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961538|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961539|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961540|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961541|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961542|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961543|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961544|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
162961545|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961546|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961547|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961548|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961549|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961550|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961551|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961552|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961553|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961554|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961555|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961556|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961557|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961558|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961559|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961560|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
162961561|NCT00112437|588560746|FG000|Year 2 (12-Month Extension)|Moved|0|||
162961562|NCT00112437|588560747|FG001|Year 2 (12-Month Extension)|Moved|0|||
162961563|NCT00112437|588560748|FG002|Year 2 (12-Month Extension)|Moved|0|||
162961564|NCT00112437|588560749|FG003|Year 2 (12-Month Extension)|Moved|0|||
162961565|NCT00112437|588560750|FG004|Year 2 (12-Month Extension)|Moved|0|||
162961566|NCT00112437|588560751|FG005|Year 2 (12-Month Extension)|Moved|0|||
162961567|NCT00112437|588560752|FG006|Year 2 (12-Month Extension)|Moved|0|||
162961568|NCT00112437|588560753|FG007|Year 2 (12-Month Extension)|Moved|0|||
162961569|NCT00112437|588560754|FG008|Year 2 (12-Month Extension)|Moved|0|||
162616000|NCT00631696|587311588|FG000|Overall Study|Study terminated by sponsor|3|||
162616001|NCT00631696|587311589|FG001|Overall Study|Study terminated by sponsor|3|||
162616002|NCT00631696|587311588|FG000|Overall Study|Adverse Event|5|||
162616003|NCT00631696|587311589|FG001|Overall Study|Adverse Event|0|||
162876487|NCT01670656|588251098|FG001|Overall Study|Pregnancy|0|||
162876488|NCT01670656|588251099|FG002|Overall Study|Pregnancy|0|||
162876489|NCT01670656|588251100|FG003|Overall Study|Pregnancy|0|||
162876490|NCT01670656|588251101|FG004|Overall Study|Pregnancy|1|||
162876491|NCT01670656|588251097|FG000|Overall Study|Withdrawal by Subject|1|||
162876492|NCT01670656|588251098|FG001|Overall Study|Withdrawal by Subject|1|||
162961570|NCT00112437|588560755|FG009|Year 2 (12-Month Extension)|Moved|1|||
162961571|NCT00112437|588560756|FG010|Year 2 (12-Month Extension)|Moved|0|||
162961572|NCT00112437|588560757|FG011|Year 2 (12-Month Extension)|Moved|0|||
162961573|NCT00112437|588560758|FG012|Year 2 (12-Month Extension)|Moved|0|||
162961574|NCT00112437|588560759|FG013|Year 2 (12-Month Extension)|Moved|0|||
162961575|NCT00112437|588560760|FG014|Year 2 (12-Month Extension)|Moved|0|||
162961576|NCT00112437|588560761|FG015|Year 2 (12-Month Extension)|Moved|0|||
162961577|NCT00112437|588560762|FG016|Year 2 (12-Month Extension)|Moved|0|||
162961578|NCT00112437|588560763|FG017|Year 2 (12-Month Extension)|Moved|0|||
162961579|NCT00112437|588560764|FG018|Year 2 (12-Month Extension)|Moved|0|||
162961580|NCT00112437|588560765|FG019|Year 2 (12-Month Extension)|Moved|0|||
162961581|NCT00112437|588560766|FG020|Year 2 (12-Month Extension)|Moved|0|||
162961582|NCT00112437|588560767|FG021|Year 2 (12-Month Extension)|Moved|0|||
162961583|NCT00112437|588560768|FG022|Year 2 (12-Month Extension)|Moved|0|||
162961584|NCT00112437|588560769|FG023|Year 2 (12-Month Extension)|Moved|0|||
162961585|NCT00112437|588560770|FG024|Year 2 (12-Month Extension)|Moved|0|||
162961586|NCT00112437|588560771|FG025|Year 2 (12-Month Extension)|Moved|0|||
162876493|NCT01670656|588251099|FG002|Overall Study|Withdrawal by Subject|0|||
162876494|NCT01670656|588251100|FG003|Overall Study|Withdrawal by Subject|0|||
162876495|NCT01670656|588251101|FG004|Overall Study|Withdrawal by Subject|0|||
162876496|NCT01670656|588251097|FG000|Overall Study|Non-compliance with protocol|0|||
162876497|NCT01670656|588251098|FG001|Overall Study|Non-compliance with protocol|3|||
162876498|NCT01670656|588251099|FG002|Overall Study|Non-compliance with protocol|1|||
162876499|NCT01670656|588251100|FG003|Overall Study|Non-compliance with protocol|1|||
162876500|NCT01670656|588251101|FG004|Overall Study|Non-compliance with protocol|2|||
162876501|NCT01670656|588251097|FG000|Overall Study|Adverse Event|2|||
162876502|NCT01670656|588251098|FG001|Overall Study|Adverse Event|2|||
162876503|NCT01670656|588251099|FG002|Overall Study|Adverse Event|2|||
163047918|NCT00737100|588882650|FG002|Overall Study|Reason discontinued not explained above|1|||
163047919|NCT01607593|588882655|FG000|Overall Study|Adverse Event|15|||
163047920|NCT01607593|588882655|FG000|Overall Study|Lack of Efficacy|16|||
163047921|NCT01607593|588882655|FG000|Overall Study|Lost to Follow-up|25|||
162876504|NCT01670656|588251100|FG003|Overall Study|Adverse Event|3|||
162876505|NCT01670656|588251101|FG004|Overall Study|Adverse Event|3|||
162876506|NCT01670656|588251097|FG000|Overall Study|Subject withdrew consent|0|||
162876507|NCT01670656|588251098|FG001|Overall Study|Subject withdrew consent|1|||
162876508|NCT01670656|588251099|FG002|Overall Study|Subject withdrew consent|2|||
162876509|NCT01670656|588251100|FG003|Overall Study|Subject withdrew consent|1|||
162876510|NCT01670656|588251101|FG004|Overall Study|Subject withdrew consent|1|||
162876511|NCT01670656|588251097|FG000|Overall Study|Lost to Follow-up|0|||
162961587|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
162961588|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
162961589|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
162961590|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
162961591|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
163047922|NCT01607593|588882655|FG000|Overall Study|Continuation|33|||
163047923|NCT01607593|588882655|FG000|Overall Study|Other|4|||
163047924|NCT00115778|588882656|FG000|Overall Study|Withdrawal by Subject|0|||
163047925|NCT00115778|588882657|FG001|Overall Study|Withdrawal by Subject|1|||
163047926|NCT02154139|588882660|FG000|Overall Study|Injection not administered|2|||
163047927|NCT02154139|588882660|FG000|Overall Study|Other|2|||
163047928|NCT02154139|588882660|FG000|Overall Study|Investigator transferred|3|||
163047929|NCT06060496|588882661|FG000|Overall Study|Withdrawal by Subject|2|||
163047930|NCT06060496|588882661|FG000|Overall Study|Lost to Follow-up|2|||
163047931|NCT00321906|588882662|FG000|Overall Study|Adverse Event|36|||
163047932|NCT00321906|588882663|FG001|Overall Study|Adverse Event|44|||
163047933|NCT00321906|588882662|FG000|Overall Study|Death|9|||
163047934|NCT00321906|588882663|FG001|Overall Study|Death|6|||
163047935|NCT00321906|588882662|FG000|Overall Study|Lost to Follow-up|1|||
163047936|NCT00321906|588882663|FG001|Overall Study|Lost to Follow-up|2|||
163047937|NCT00321906|588882662|FG000|Overall Study|Withdrawal by Subject|0|||
163047938|NCT00321906|588882663|FG001|Overall Study|Withdrawal by Subject|4|||
163047939|NCT00149396|588882664|FG000|Overall Study|Death|15|||
163047940|NCT00149396|588882664|FG000|Overall Study|Withdrawal by Subject|1|||
163047941|NCT00149396|588882664|FG000|Overall Study|Subject noncompliance|2|||
163047942|NCT00149396|588882664|FG000|Overall Study|other treatment|5|||
163047943|NCT00807885|588882665|FG000|Overall Study|Lost to Follow-up|0|||
163047944|NCT00807885|588882666|FG001|Overall Study|Lost to Follow-up|0|||
163047945|NCT00807885|588882667|FG002|Overall Study|Lost to Follow-up|0|||
163047946|NCT00807885|588882668|FG003|Overall Study|Lost to Follow-up|0|||
163047947|NCT00807885|588882669|FG004|Overall Study|Lost to Follow-up|0|||
163047948|NCT00807885|588882670|FG005|Overall Study|Lost to Follow-up|1|||
163047949|NCT00807885|588882671|FG006|Overall Study|Lost to Follow-up|0|||
163047950|NCT00807885|588882672|FG007|Overall Study|Lost to Follow-up|0|||
163047951|NCT00807885|588882673|FG008|Overall Study|Lost to Follow-up|0|||
163047952|NCT01166750|588882675|FG000|Overall Study|Lost to Follow-up|1|||
163047953|NCT01166750|588882676|FG001|Overall Study|Lost to Follow-up|0|||
162616004|NCT03198078|587311591|FG000|Overall Study|Adverse Event|0|||
162616005|NCT03198078|587311592|FG001|Overall Study|Adverse Event|1|||
162876512|NCT01670656|588251098|FG001|Overall Study|Lost to Follow-up|0|||
162961592|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
162961593|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
162961594|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
163047954|NCT05225389|588882677|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
163047955|NCT03113968|588882678|FG000|Overall Study|Withdrawal by Subject|31|||
163047956|NCT03113968|588882679|FG001|Overall Study|Withdrawal by Subject|4|||
163047957|NCT04805671|588882680|FG000|Overall Study|Death|2|||
163047958|NCT04805671|588882681|FG001|Overall Study|Death|7|||
163047959|NCT04805671|588882680|FG000|Overall Study|Lost to Follow-up|1|||
163047960|NCT04805671|588882681|FG001|Overall Study|Lost to Follow-up|0|||
162876513|NCT01670656|588251099|FG002|Overall Study|Lost to Follow-up|0|||
162876514|NCT01670656|588251100|FG003|Overall Study|Lost to Follow-up|0|||
162876515|NCT01670656|588251101|FG004|Overall Study|Lost to Follow-up|3|||
163047961|NCT04805671|588882680|FG000|Overall Study|Withdrawal by Subject|9|||
163047962|NCT04805671|588882681|FG001|Overall Study|Withdrawal by Subject|7|||
162876516|NCT01670656|588251097|FG000|Overall Study|Subject moved|0|||
162876517|NCT01670656|588251098|FG001|Overall Study|Subject moved|0|||
162876518|NCT01670656|588251099|FG002|Overall Study|Subject moved|0|||
162876519|NCT01670656|588251100|FG003|Overall Study|Subject moved|1|||
162876520|NCT01670656|588251101|FG004|Overall Study|Subject moved|0|||
162876521|NCT00165841|588251102|FG000|Overall Study|Adverse Event|2|||
162876522|NCT00165841|588251103|FG001|Overall Study|Adverse Event|3|||
162876523|NCT00165841|588251102|FG000|Overall Study|Lack of Efficacy|6|||
162876524|NCT00165841|588251103|FG001|Overall Study|Lack of Efficacy|33|||
162876525|NCT00165841|588251102|FG000|Overall Study|Lost to Follow-up|4|||
162876526|NCT00165841|588251103|FG001|Overall Study|Lost to Follow-up|4|||
162876527|NCT00165841|588251102|FG000|Overall Study|Withdrawal by Subject|7|||
162707028|NCT04955626|587636669|FG013|Open-Label Period|Refused further study procedures|0|||
162707029|NCT04955626|587636670|FG014|Open-Label Period|Refused further study procedures|0|||
162707030|NCT04955626|587636671|FG015|Open-Label Period|Refused further study procedures|0|||
162707031|NCT04955626|587636672|FG016|Open-Label Period|Refused further study procedures|0|||
162707032|NCT04955626|587636673|FG017|Open-Label Period|Refused further study procedures|0|||
162707033|NCT04955626|587636674|FG018|Open-Label Period|Refused further study procedures|0|||
162707034|NCT04955626|587636675|FG019|Open-Label Period|Refused further study procedures|0|||
162707035|NCT04955626|587636676|FG020|Open-Label Period|Refused further study procedures|0|||
162707036|NCT04955626|587636677|FG021|Open-Label Period|Refused further study procedures|0|||
162707037|NCT04955626|587636678|FG022|Open-Label Period|Refused further study procedures|0|||
162707038|NCT04955626|587636679|FG023|Open-Label Period|Refused further study procedures|0|||
162707039|NCT04955626|587636680|FG024|Open-Label Period|Refused further study procedures|0|||
162707040|NCT04955626|587636681|FG025|Open-Label Period|Refused further study procedures|0|||
162707041|NCT04955626|587636682|FG026|Open-Label Period|Refused further study procedures|0|||
162707042|NCT04955626|587636683|FG027|Open-Label Period|Refused further study procedures|0|||
162707043|NCT04955626|587636684|FG028|Open-Label Period|Refused further study procedures|0|||
162707044|NCT04955626|587636685|FG029|Open-Label Period|Refused further study procedures|0|||
162707045|NCT04955626|587636686|FG030|Open-Label Period|Refused further study procedures|0|||
162707046|NCT04955626|587636687|FG031|Open-Label Period|Refused further study procedures|0|||
162876528|NCT00165841|588251103|FG001|Overall Study|Withdrawal by Subject|8|||
162876529|NCT00165841|588251102|FG000|Overall Study|Physician Decision|1|||
162876530|NCT00165841|588251103|FG001|Overall Study|Physician Decision|0|||
162876531|NCT00165841|588251102|FG000|Overall Study|Protocol Violation|6|||
162876532|NCT00165841|588251103|FG001|Overall Study|Protocol Violation|8|||
162876533|NCT00165841|588251102|FG000|Overall Study|Other|3|||
162876534|NCT00165841|588251103|FG001|Overall Study|Other|5|||
162876535|NCT00165841|588251102|FG000|Overall Study|Medication Noncompliance|1|||
162876536|NCT00165841|588251103|FG001|Overall Study|Medication Noncompliance|1|||
162876537|NCT00789958|588251104|FG000|Overall Study|Adverse Event|3|||
162876538|NCT00789958|588251104|FG000|Overall Study|Withdrawal by Subject|4|||
162876539|NCT00789958|588251104|FG000|Overall Study|Progression|3|||
162876540|NCT00789958|588251104|FG000|Overall Study|not protocol specified|1|||
162876541|NCT00789958|588251104|FG000|Overall Study|Not eligible/not analyzable|26|||
162876542|NCT00487084|588251105|FG000|Overall Study|Did not receive intervention|4|||
162876543|NCT00487084|588251106|FG001|Overall Study|Did not receive intervention|3|||
162876544|NCT00487084|588251107|FG002|Overall Study|Did not receive intervention|5|||
162876545|NCT03303092|588251110|FG000|Overall Study|Adverse Event|1|||
162876546|NCT03303092|588251111|FG001|Overall Study|Adverse Event|0|||
162876547|NCT03303092|588251112|FG002|Overall Study|Adverse Event|1|||
162876548|NCT03303092|588251110|FG000|Overall Study|Protocol Violation|1|||
162876549|NCT03303092|588251111|FG001|Overall Study|Protocol Violation|5|||
162876550|NCT03303092|588251112|FG002|Overall Study|Protocol Violation|1|||
162876551|NCT03303092|588251110|FG000|Overall Study|Withdrawal by Subject|1|||
162876552|NCT03303092|588251111|FG001|Overall Study|Withdrawal by Subject|1|||
162876553|NCT03303092|588251112|FG002|Overall Study|Withdrawal by Subject|3|||
162876554|NCT01995136|588251115|FG000|Overall Study|Change in residence|1|||
162876555|NCT01697267|588251116|FG000|Overall Study|Death|3|||
162876556|NCT01697267|588251117|FG001|Overall Study|Death|1|||
162876557|NCT01697267|588251116|FG000|Overall Study|Withdrawal by Subject|5|||
162876558|NCT01697267|588251117|FG001|Overall Study|Withdrawal by Subject|5|||
162876559|NCT01697267|588251116|FG000|Overall Study|Adverse Event|2|||
162876560|NCT01697267|588251117|FG001|Overall Study|Adverse Event|1|||
162876561|NCT01697267|588251116|FG000|Overall Study|Lost to Follow-up|2|||
162876562|NCT01697267|588251117|FG001|Overall Study|Lost to Follow-up|4|||
162876563|NCT01697267|588251116|FG000|Overall Study|Physician Decision|2|||
162876564|NCT01697267|588251117|FG001|Overall Study|Physician Decision|4|||
162876565|NCT01830543|588251120|FG000|Overall Study|Subject Decision|19|||
162876566|NCT01830543|588251121|FG001|Overall Study|Subject Decision|21|||
162876567|NCT01830543|588251122|FG002|Overall Study|Subject Decision|57|||
162876568|NCT01830543|588251120|FG000|Overall Study|Adverse Event|91|||
162876569|NCT01830543|588251121|FG001|Overall Study|Adverse Event|77|||
162876570|NCT01830543|588251122|FG002|Overall Study|Adverse Event|76|||
162876571|NCT01830543|588251120|FG000|Overall Study|Death|20|||
162876572|NCT01830543|588251121|FG001|Overall Study|Death|22|||
163047963|NCT04805671|588882680|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
163047964|NCT04805671|588882681|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
163047965|NCT00901342|588882682|FG000|Overall Study|Adverse Event|1|||
163047966|NCT00901342|588882682|FG000|Overall Study|Death|4|||
163047967|NCT00901342|588882682|FG000|Overall Study|Disease progression|1|||
163047968|NCT00901342|588882682|FG000|Overall Study|Withdrawal by Subject|9|||
163047969|NCT03804268|588882683|FG000|Overall Study|Adverse Event|2|||
163047970|NCT03804268|588882684|FG001|Overall Study|Adverse Event|2|||
163047971|NCT03804268|588882683|FG000|Overall Study|Withdrawal by Subject|2|||
163047972|NCT03804268|588882684|FG001|Overall Study|Withdrawal by Subject|0|||
163047973|NCT03804268|588882683|FG000|Overall Study|Lost to Follow-up|1|||
163047974|NCT03804268|588882684|FG001|Overall Study|Lost to Follow-up|0|||
163047975|NCT03804268|588882683|FG000|Overall Study|Physician Decision|2|||
163047976|NCT03804268|588882684|FG001|Overall Study|Physician Decision|0|||
163047977|NCT02849587|588882685|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
163047978|NCT02849587|588882686|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
163047979|NCT02849587|588882687|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
163047980|NCT02849587|588882685|FG000|Overall Study|Withdrawal by Subject|0|||
163047981|NCT02849587|588882686|FG001|Overall Study|Withdrawal by Subject|1|||
163047982|NCT02849587|588882687|FG002|Overall Study|Withdrawal by Subject|0|||
163047983|NCT03380377|588882688|FG000|Overall Study|Physician Decision|1|||
163047984|NCT03380377|588882688|FG000|Overall Study|Withdrawal by Subject|1|||
163047985|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
162616006|NCT03198078|587311593|FG002|Overall Study|Adverse Event|2|||
162616007|NCT03198078|587311591|FG000|Overall Study|Lack of Efficacy|0|||
162876573|NCT01830543|588251122|FG002|Overall Study|Death|22|||
162876574|NCT01830543|588251120|FG000|Overall Study|Protocol Violation|3|||
162876575|NCT01830543|588251121|FG001|Overall Study|Protocol Violation|7|||
162876576|NCT01830543|588251122|FG002|Overall Study|Protocol Violation|7|||
162876577|NCT01830543|588251120|FG000|Overall Study|Physician Decision|11|||
162876578|NCT01830543|588251121|FG001|Overall Study|Physician Decision|5|||
162876579|NCT01830543|588251122|FG002|Overall Study|Physician Decision|12|||
162876580|NCT01830543|588251120|FG000|Overall Study|Withdrawal by consent|3|||
162876581|NCT01830543|588251121|FG001|Overall Study|Withdrawal by consent|3|||
162876582|NCT01830543|588251122|FG002|Overall Study|Withdrawal by consent|3|||
162616008|NCT03198078|587311592|FG001|Overall Study|Lack of Efficacy|0|||
162876583|NCT01830543|588251120|FG000|Overall Study|Other|12|||
162876584|NCT01830543|588251121|FG001|Overall Study|Other|17|||
162876585|NCT01830543|588251122|FG002|Overall Study|Other|37|||
162876586|NCT02681055|588251127|FG000|Weeks 5-12|Adverse Event|1|||
162876587|NCT00377611|588251130|FG000|Overall Study|Adverse Event|2|||
162876588|NCT00377611|588251131|FG001|Overall Study|Adverse Event|9|||
162876589|NCT00377611|588251130|FG000|Overall Study|Protocol Violation|2|||
162876590|NCT00377611|588251131|FG001|Overall Study|Protocol Violation|0|||
162876591|NCT00377611|588251130|FG000|Overall Study|Withdrawal by Subject|0|||
162876592|NCT00377611|588251131|FG001|Overall Study|Withdrawal by Subject|5|||
162876593|NCT00377611|588251130|FG000|Overall Study|Lost to Follow-up|18|||
162876594|NCT00377611|588251131|FG001|Overall Study|Lost to Follow-up|16|||
162876595|NCT00377611|588251130|FG000|Overall Study|Other|0|||
162876596|NCT00377611|588251131|FG001|Overall Study|Other|3|||
162876597|NCT01030458|588251132|FG000|Overall Study|Lost to Follow-up|9|||
162876598|NCT01030458|588251133|FG001|Overall Study|Lost to Follow-up|10|||
162876599|NCT01030458|588251132|FG000|Overall Study|Withdrawal by Subject|2|||
162876600|NCT01030458|588251133|FG001|Overall Study|Withdrawal by Subject|3|||
162876601|NCT01030458|588251132|FG000|Overall Study|Logistical reasons|9|||
162876602|NCT01030458|588251133|FG001|Overall Study|Logistical reasons|5|||
162876603|NCT01030458|588251132|FG000|Overall Study|Moved or changed job|6|||
162876604|NCT01030458|588251133|FG001|Overall Study|Moved or changed job|13|||
162876605|NCT01030458|588251132|FG000|Overall Study|Side effect of medication|1|||
163047986|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
163047987|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
163047988|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
163047989|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
163047990|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
163047991|NCT00385918|588882689|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
163047992|NCT00385918|588882690|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
163047993|NCT00385918|588882691|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
163047994|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
163047995|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
163047996|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
162616009|NCT03198078|587311593|FG002|Overall Study|Lack of Efficacy|3|||
163047997|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Physician Decision|1|||
162876606|NCT01030458|588251133|FG001|Overall Study|Side effect of medication|1|||
162876607|NCT00839423|588251136|FG000|Overall Study|Adverse Event|4|||
162876608|NCT00839423|588251137|FG001|Overall Study|Adverse Event|3|||
162876609|NCT00839423|588251138|FG002|Overall Study|Adverse Event|7|||
162876610|NCT00839423|588251139|FG003|Overall Study|Adverse Event|16|||
162876611|NCT00839423|588251136|FG000|Overall Study|Lack of Efficacy|6|||
162876612|NCT00839423|588251137|FG001|Overall Study|Lack of Efficacy|6|||
162876613|NCT00839423|588251138|FG002|Overall Study|Lack of Efficacy|3|||
162876614|NCT00839423|588251139|FG003|Overall Study|Lack of Efficacy|2|||
162876615|NCT00839423|588251136|FG000|Overall Study|Non-compliance|0|||
162876616|NCT00839423|588251137|FG001|Overall Study|Non-compliance|0|||
162876617|NCT00839423|588251138|FG002|Overall Study|Non-compliance|0|||
162876618|NCT00839423|588251139|FG003|Overall Study|Non-compliance|1|||
162876619|NCT00839423|588251136|FG000|Overall Study|Protocol Violation|0|||
162876620|NCT00839423|588251137|FG001|Overall Study|Protocol Violation|1|||
162876621|NCT00839423|588251138|FG002|Overall Study|Protocol Violation|2|||
162876622|NCT00839423|588251139|FG003|Overall Study|Protocol Violation|0|||
162876623|NCT00839423|588251136|FG000|Overall Study|Withdrawal of consent|4|||
162876624|NCT00839423|588251137|FG001|Overall Study|Withdrawal of consent|0|||
162876625|NCT00839423|588251138|FG002|Overall Study|Withdrawal of consent|4|||
162876626|NCT00839423|588251139|FG003|Overall Study|Withdrawal of consent|1|||
162876627|NCT00839423|588251136|FG000|Overall Study|Lost to Follow-up|1|||
162876628|NCT00839423|588251137|FG001|Overall Study|Lost to Follow-up|0|||
162876629|NCT00839423|588251138|FG002|Overall Study|Lost to Follow-up|1|||
162876630|NCT00839423|588251139|FG003|Overall Study|Lost to Follow-up|0|||
162876631|NCT00839423|588251136|FG000|Overall Study|Administrative or other reasons|3|||
162876632|NCT00839423|588251137|FG001|Overall Study|Administrative or other reasons|0|||
162876633|NCT00839423|588251138|FG002|Overall Study|Administrative or other reasons|1|||
162876634|NCT00839423|588251139|FG003|Overall Study|Administrative or other reasons|0|||
162876635|NCT01071096|588251140|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
162876636|NCT01071096|588251141|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
162876637|NCT02585999|588251142|FG000|Overall Study|Lost to Follow-up|1|||
162876638|NCT02585999|588251142|FG000|Overall Study|Protocol Violation|1|||
162876639|NCT00756886|588251143|FG000|Overall Study|Lost to Follow-up|1|||
162876640|NCT00756886|588251144|FG001|Overall Study|Lost to Follow-up|0|||
162876641|NCT00756886|588251143|FG000|Overall Study|Adverse Event|0|||
162876642|NCT00756886|588251144|FG001|Overall Study|Adverse Event|3|||
162876643|NCT00756886|588251143|FG000|Overall Study|Lack of Efficacy|1|||
162876644|NCT00756886|588251144|FG001|Overall Study|Lack of Efficacy|0|||
162876645|NCT00756886|588251143|FG000|Overall Study|Ineligible|9|||
162876646|NCT00756886|588251144|FG001|Overall Study|Ineligible|4|||
163047998|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Physician Decision|0|||
162876647|NCT00871377|588251149|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162876648|NCT00871377|588251150|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162876649|NCT00871377|588251151|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
162876650|NCT00871377|588251152|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162876651|NCT00871377|588251153|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163047999|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Physician Decision|0|||
162876652|NCT00871377|588251154|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162876653|NCT00871377|588251149|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
162876654|NCT00871377|588251150|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163048000|NCT00385918|588882689|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
163048001|NCT00385918|588882690|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
162876655|NCT00871377|588251151|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163048002|NCT00385918|588882691|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
163048003|NCT00128661|588882692|FG000|Overall Study|Adverse Event|14|||
163048004|NCT00128661|588882693|FG001|Overall Study|Adverse Event|11|||
163048005|NCT00128661|588882692|FG000|Overall Study|Lost to Follow-up|10|||
163048006|NCT00128661|588882693|FG001|Overall Study|Lost to Follow-up|7|||
163048007|NCT00128661|588882692|FG000|Overall Study|Withdrawal by Subject|243|||
163048008|NCT00128661|588882693|FG001|Overall Study|Withdrawal by Subject|232|||
163048009|NCT00128661|588882692|FG000|Overall Study|Other|7|||
163048010|NCT00128661|588882693|FG001|Overall Study|Other|8|||
163048011|NCT03421379|588882694|FG000|Period 1|Withdrawal by Subject|0|||
162616010|NCT03198078|587311591|FG000|Overall Study|Lost to Follow-up|1|||
162616011|NCT03198078|587311592|FG001|Overall Study|Lost to Follow-up|0|||
162616012|NCT03198078|587311593|FG002|Overall Study|Lost to Follow-up|0|||
162616013|NCT03198078|587311591|FG000|Overall Study|Pregnancy|0|||
162876656|NCT00871377|588251152|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
162876657|NCT00871377|588251153|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
163048012|NCT03421379|588882695|FG001|Period 1|Withdrawal by Subject|1|||
163048013|NCT03421379|588882694|FG000|Period 1|Physician Decision|1|||
163048014|NCT03421379|588882695|FG001|Period 1|Physician Decision|1|||
163048015|NCT03421379|588882694|FG000|Period 1|Did not receive treatment|1|||
163048016|NCT03421379|588882695|FG001|Period 1|Did not receive treatment|2|||
163048017|NCT04010461|588882696|FG000|Overall Study|COVID based withdrawal|5|||
163048018|NCT04010461|588882696|FG000|Overall Study|Withdrawal by Subject|5|||
163048019|NCT04010461|588882696|FG000|Overall Study|Adverse Event|1|||
163048020|NCT04010461|588882696|FG000|Overall Study|No Motor Threshold obtainable|1|||
163048021|NCT04010461|588882696|FG000|Overall Study|Physician Decision|1|||
163048022|NCT03771963|588882697|FG000|Overall Study|Lost to Follow-up|22|||
163048023|NCT03771963|588882697|FG000|Overall Study|Withdrawal of Consent|10|||
163048024|NCT01026948|588882698|FG000|Overall Study|Physician Decision|8|||
163048025|NCT00102596|588882699|FG000|Part A|Screen failures|6|||
163048026|NCT00102596|588882700|FG001|Part A|Screen failures|0|||
162876658|NCT00871377|588251154|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
162876659|NCT00871377|588251149|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
162876660|NCT00871377|588251150|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876661|NCT00871377|588251151|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876662|NCT00871377|588251152|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876663|NCT00871377|588251153|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876664|NCT00871377|588251154|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876665|NCT00871377|588251149|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876666|NCT00871377|588251150|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876667|NCT00871377|588251151|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876668|NCT00871377|588251152|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
163048027|NCT00102596|588882699|FG000|Part A|Adverse Event|1|||
163048028|NCT00102596|588882700|FG001|Part A|Adverse Event|0|||
163048029|NCT01670045|588882704|FG000|Overall Study|Withdrawal by Subject|3|||
162876669|NCT00871377|588251153|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
162876670|NCT00871377|588251154|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
162876671|NCT00871377|588251149|FG000|Third Intervention (10 Weeks)|Death|0|||
163048030|NCT01670045|588882704|FG000|Overall Study|Adverse Event|1|||
163048031|NCT01670045|588882704|FG000|Overall Study|Death|1|||
163048032|NCT01670045|588882704|FG000|Overall Study|Lost to Follow-up|11|||
163048033|NCT03360019|588882705|FG000|Overall Study|Withdrawal by Subject|2|||
163048034|NCT03360019|588882706|FG001|Overall Study|Withdrawal by Subject|0|||
163048035|NCT03360019|588882707|FG002|Overall Study|Withdrawal by Subject|0|||
163048036|NCT03360019|588882705|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
163048037|NCT03360019|588882706|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
163048038|NCT03360019|588882707|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
163048039|NCT00753675|588882710|FG000|Overall Study|other reason|11|||
163048040|NCT00753675|588882711|FG001|Overall Study|other reason|12|||
163048041|NCT00753675|588882712|FG002|Overall Study|other reason|13|||
163048042|NCT00753675|588882710|FG000|Overall Study|Death|1|||
163048043|NCT00753675|588882711|FG001|Overall Study|Death|2|||
163048044|NCT00753675|588882712|FG002|Overall Study|Death|4|||
163048045|NCT00753675|588882710|FG000|Overall Study|Adverse Event|11|||
163048046|NCT00753675|588882711|FG001|Overall Study|Adverse Event|9|||
163048047|NCT00753675|588882712|FG002|Overall Study|Adverse Event|4|||
163048048|NCT00753675|588882710|FG000|Overall Study|Objective progression of disease|35|||
163048049|NCT00753675|588882711|FG001|Overall Study|Objective progression of disease|35|||
163048050|NCT00753675|588882712|FG002|Overall Study|Objective progression of disease|35|||
163048051|NCT00753675|588882710|FG000|Overall Study|Withdrawal by Subject|0|||
163048052|NCT00753675|588882711|FG001|Overall Study|Withdrawal by Subject|1|||
163048053|NCT00753675|588882712|FG002|Overall Study|Withdrawal by Subject|0|||
163048054|NCT00753675|588882710|FG000|Overall Study|Lost to Follow-up|1|||
163048055|NCT00753675|588882711|FG001|Overall Study|Lost to Follow-up|0|||
163048056|NCT00753675|588882712|FG002|Overall Study|Lost to Follow-up|0|||
162616014|NCT03198078|587311592|FG001|Overall Study|Pregnancy|1|||
162616015|NCT03198078|587311593|FG002|Overall Study|Pregnancy|0|||
162616016|NCT03198078|587311591|FG000|Overall Study|Withdrawal by Subject|1|||
162616017|NCT03198078|587311592|FG001|Overall Study|Withdrawal by Subject|0|||
162616018|NCT03198078|587311593|FG002|Overall Study|Withdrawal by Subject|2|||
162616019|NCT03198078|587311591|FG000|Overall Study|Withdrawal by Caregiver|1|||
162876672|NCT00871377|588251150|FG001|Third Intervention (10 Weeks)|Death|0|||
162876673|NCT00871377|588251151|FG002|Third Intervention (10 Weeks)|Death|0|||
162876674|NCT00871377|588251152|FG003|Third Intervention (10 Weeks)|Death|1|||
162876675|NCT00871377|588251153|FG004|Third Intervention (10 Weeks)|Death|0|||
162876676|NCT00871377|588251154|FG005|Third Intervention (10 Weeks)|Death|0|||
162876677|NCT04348656|588251155|FG000|Overall Study|Withdrawal by Subject|2|||
162876678|NCT04348656|588251156|FG001|Overall Study|Withdrawal by Subject|0|||
162876679|NCT04348656|588251155|FG000|Overall Study|Lost to Follow-up|11|||
162876680|NCT04348656|588251156|FG001|Overall Study|Lost to Follow-up|6|||
162876681|NCT05142332|588251159|FG000|Overall Study|Withdrawal by Subject|0|||
162876682|NCT05142332|588251160|FG001|Overall Study|Withdrawal by Subject|1|||
162876683|NCT05142332|588251161|FG002|Overall Study|Withdrawal by Subject|2|||
162876684|NCT05142332|588251162|FG003|Overall Study|Withdrawal by Subject|0|||
162876685|NCT05142332|588251163|FG004|Overall Study|Withdrawal by Subject|0|||
162876686|NCT05142332|588251164|FG005|Overall Study|Withdrawal by Subject|2|||
162876687|NCT05142332|588251165|FG006|Overall Study|Withdrawal by Subject|6|||
162876688|NCT05142332|588251159|FG000|Overall Study|Left ED|3|||
162876689|NCT05142332|588251160|FG001|Overall Study|Left ED|0|||
162876690|NCT05142332|588251161|FG002|Overall Study|Left ED|4|||
162876691|NCT05142332|588251162|FG003|Overall Study|Left ED|6|||
162876692|NCT05142332|588251163|FG004|Overall Study|Left ED|1|||
162876693|NCT05142332|588251164|FG005|Overall Study|Left ED|2|||
162876694|NCT05142332|588251165|FG006|Overall Study|Left ED|6|||
162876695|NCT05142332|588251159|FG000|Overall Study|Physician Decision|0|||
162876696|NCT05142332|588251160|FG001|Overall Study|Physician Decision|0|||
162876697|NCT05142332|588251161|FG002|Overall Study|Physician Decision|2|||
162876698|NCT05142332|588251162|FG003|Overall Study|Physician Decision|1|||
162876699|NCT05142332|588251163|FG004|Overall Study|Physician Decision|0|||
162876700|NCT05142332|588251164|FG005|Overall Study|Physician Decision|0|||
162876701|NCT05142332|588251165|FG006|Overall Study|Physician Decision|3|||
162876702|NCT05142332|588251159|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
162876703|NCT05142332|588251160|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
162876704|NCT05142332|588251161|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
162876705|NCT05142332|588251162|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
162876706|NCT05142332|588251163|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
162876707|NCT05142332|588251164|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
162876708|NCT05142332|588251165|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
162876709|NCT02116660|588251166|FG000|Overall Study|Deteriorating renal function|0|||
162876710|NCT02116660|588251167|FG001|Overall Study|Deteriorating renal function|1|||
162876711|NCT02116660|588251166|FG000|Overall Study|Adverse Event|1|||
162876712|NCT02116660|588251167|FG001|Overall Study|Adverse Event|1|||
162876713|NCT02116660|588251166|FG000|Overall Study|Withdrawal by Subject|0|||
162876714|NCT02116660|588251167|FG001|Overall Study|Withdrawal by Subject|2|||
162876715|NCT02116660|588251166|FG000|Overall Study|Organization reason|1|||
162876716|NCT02116660|588251167|FG001|Overall Study|Organization reason|0|||
162876717|NCT00411788|588251171|FG000|Overall Study|Protocol Violation|1|||
162876718|NCT00411788|588251171|FG000|Overall Study|Adverse Event|1|||
163048057|NCT01462110|588882713|FG000|Overall Study|Adverse Event|1|||
163048058|NCT01462110|588882714|FG001|Overall Study|Adverse Event|0|||
163048059|NCT05279131|588882715|FG000|Overall Study|Lost to Follow-up|1|||
162616020|NCT03198078|587311592|FG001|Overall Study|Withdrawal by Caregiver|3|||
163048060|NCT05279131|588882715|FG000|Overall Study|Death|1|||
163048061|NCT05279131|588882715|FG000|Overall Study|Physician Decision|1|||
163048062|NCT00964028|588882721|FG000|Overall Study|Withdrawal by Subject|0|||
162616021|NCT03198078|587311593|FG002|Overall Study|Withdrawal by Caregiver|5|||
162876719|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
162876720|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
162876721|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
162876722|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
162876723|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
162876724|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
162876725|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
162876726|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
162876727|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
162876728|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
162876729|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
162876730|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
162876731|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
162876732|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
162876733|NCT00848549|588251172|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
162876734|NCT00848549|588251173|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
162876735|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
162876736|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
162876737|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
162876738|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
162876739|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
162876740|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
162876741|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
162876742|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
162876743|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
162876744|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
162876745|NCT00848549|588251172|FG000|E2090-E044-314 (Extension Study)|Other|5|||
162876746|NCT00848549|588251173|FG001|E2090-E044-314 (Extension Study)|Other|6|||
162876747|NCT02561299|588251174|FG000|Overall Study|Death|2|||
162876748|NCT02561299|588251175|FG001|Overall Study|Death|4|||
162876749|NCT02561299|588251174|FG000|Overall Study|Lost to Follow-up|1|||
162876750|NCT02561299|588251175|FG001|Overall Study|Lost to Follow-up|0|||
162876751|NCT02561299|588251174|FG000|Overall Study|Withdrawal by Subject|2|||
162876752|NCT02561299|588251175|FG001|Overall Study|Withdrawal by Subject|2|||
162876753|NCT05631548|588251176|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
162876754|NCT05631548|588251177|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
162876755|NCT05906732|588251178|FG000|Overall Study|Withdrawal by Subject|1|||
162876756|NCT05906732|588251179|FG001|Overall Study|Withdrawal by Subject|0|||
162876757|NCT05906732|588251180|FG002|Overall Study|Withdrawal by Subject|0|||
162876758|NCT05906732|588251181|FG003|Overall Study|Withdrawal by Subject|0|||
162876759|NCT05906732|588251178|FG000|Overall Study|Physician Decision|2|||
162876760|NCT05906732|588251179|FG001|Overall Study|Physician Decision|4|||
162876761|NCT05906732|588251180|FG002|Overall Study|Physician Decision|0|||
162876762|NCT05906732|588251181|FG003|Overall Study|Physician Decision|0|||
162876763|NCT02651194|588251186|FG000|Overall Study|Lost to Follow-up|3|||
162876764|NCT02651194|588251186|FG000|Overall Study|Other|2|||
162876765|NCT02208024|588251187|FG000|Overall Study|Withdrawal by Subject|1|||
162876766|NCT00830037|588251191|FG000|Overall Study|Withdrawal by Subject|2|||
162876767|NCT00830037|588251192|FG001|Overall Study|Withdrawal by Subject|3|||
162876768|NCT00830037|588251191|FG000|Overall Study|Lost to Follow-up|1|||
162876769|NCT00830037|588251192|FG001|Overall Study|Lost to Follow-up|2|||
162876770|NCT00830037|588251191|FG000|Overall Study|Active when terminated by DSMB|15|||
162876771|NCT00830037|588251192|FG001|Overall Study|Active when terminated by DSMB|14|||
162876772|NCT01401010|588251193|FG000|Overall Study|Could not interpret assay results|1|||
162876773|NCT01401010|588251194|FG001|Overall Study|Could not interpret assay results|0|||
162876774|NCT04285346|588251197|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
162961595|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
162961596|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
162961597|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
162961598|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
162961599|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
162961600|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
162961601|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
162961602|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
162961603|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
162961604|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
162961605|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
162961606|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
162961607|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
162961608|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
162961609|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
162876775|NCT04285346|588251198|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
162876776|NCT04285346|588251197|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
162876777|NCT04285346|588251198|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
162876778|NCT04285346|588251197|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
162876779|NCT04285346|588251198|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
162707047|NCT04955626|587636688|FG032|Open-Label Period|Refused further study procedures|0|||
162707048|NCT04955626|587636689|FG033|Open-Label Period|Refused further study procedures|0|||
162707049|NCT04955626|587636690|FG034|Open-Label Period|Refused further study procedures|0|||
162707050|NCT04955626|587636691|FG035|Open-Label Period|Refused further study procedures|0|||
162707051|NCT04955626|587636656|FG000|Open-Label Period|Adverse Event|1|||
162707052|NCT04955626|587636657|FG001|Open-Label Period|Adverse Event|0|||
162707053|NCT04955626|587636658|FG002|Open-Label Period|Adverse Event|0|||
162707054|NCT04955626|587636659|FG003|Open-Label Period|Adverse Event|0|||
162707055|NCT04955626|587636660|FG004|Open-Label Period|Adverse Event|0|||
162707056|NCT04955626|587636661|FG005|Open-Label Period|Adverse Event|0|||
162707057|NCT04955626|587636662|FG006|Open-Label Period|Adverse Event|0|||
162707058|NCT04955626|587636663|FG007|Open-Label Period|Adverse Event|0|||
162707059|NCT04955626|587636664|FG008|Open-Label Period|Adverse Event|0|||
162707060|NCT04955626|587636665|FG009|Open-Label Period|Adverse Event|0|||
162707061|NCT04955626|587636666|FG010|Open-Label Period|Adverse Event|0|||
162707062|NCT04955626|587636667|FG011|Open-Label Period|Adverse Event|0|||
162707063|NCT04955626|587636668|FG012|Open-Label Period|Adverse Event|0|||
162707064|NCT04955626|587636669|FG013|Open-Label Period|Adverse Event|0|||
162707065|NCT04955626|587636670|FG014|Open-Label Period|Adverse Event|0|||
162707066|NCT04955626|587636671|FG015|Open-Label Period|Adverse Event|0|||
162707067|NCT04955626|587636672|FG016|Open-Label Period|Adverse Event|0|||
162707068|NCT04955626|587636673|FG017|Open-Label Period|Adverse Event|0|||
162707069|NCT04955626|587636674|FG018|Open-Label Period|Adverse Event|0|||
162707070|NCT04955626|587636675|FG019|Open-Label Period|Adverse Event|0|||
162707071|NCT04955626|587636676|FG020|Open-Label Period|Adverse Event|0|||
162707072|NCT04955626|587636677|FG021|Open-Label Period|Adverse Event|0|||
162707073|NCT04955626|587636678|FG022|Open-Label Period|Adverse Event|0|||
162707074|NCT04955626|587636679|FG023|Open-Label Period|Adverse Event|0|||
162707075|NCT04955626|587636680|FG024|Open-Label Period|Adverse Event|0|||
162707076|NCT04955626|587636681|FG025|Open-Label Period|Adverse Event|0|||
162707077|NCT04955626|587636682|FG026|Open-Label Period|Adverse Event|0|||
162707078|NCT04955626|587636683|FG027|Open-Label Period|Adverse Event|0|||
162707079|NCT04955626|587636684|FG028|Open-Label Period|Adverse Event|0|||
162707080|NCT04955626|587636685|FG029|Open-Label Period|Adverse Event|0|||
162707081|NCT04955626|587636686|FG030|Open-Label Period|Adverse Event|0|||
162707082|NCT04955626|587636687|FG031|Open-Label Period|Adverse Event|0|||
162707083|NCT04955626|587636688|FG032|Open-Label Period|Adverse Event|0|||
162707084|NCT04955626|587636689|FG033|Open-Label Period|Adverse Event|0|||
162707085|NCT04955626|587636690|FG034|Open-Label Period|Adverse Event|0|||
162707086|NCT04955626|587636691|FG035|Open-Label Period|Adverse Event|0|||
162707087|NCT04955626|587636656|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
162707088|NCT04955626|587636657|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
162707089|NCT04955626|587636658|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
162707090|NCT04955626|587636659|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
162707091|NCT04955626|587636660|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
162707092|NCT04955626|587636661|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
162707093|NCT04955626|587636662|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
162707094|NCT04955626|587636663|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
162707095|NCT04955626|587636664|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
162707096|NCT04955626|587636665|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
162707097|NCT04955626|587636666|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
162707098|NCT04955626|587636667|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
162707099|NCT04955626|587636668|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
162707100|NCT04955626|587636669|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
162707101|NCT04955626|587636670|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
162707102|NCT04955626|587636671|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
162707103|NCT04955626|587636672|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
162707104|NCT04955626|587636673|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
162707105|NCT04955626|587636674|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
162707106|NCT04955626|587636675|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
162707107|NCT04955626|587636676|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
162707108|NCT04955626|587636677|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
162876780|NCT00610935|588251199|FG000|Overall Study|Lost to Follow-up|0|||
162707109|NCT04955626|587636678|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
162707110|NCT04955626|587636679|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
162707111|NCT04955626|587636680|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
162707112|NCT04955626|587636681|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
162961610|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
162961611|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
162961612|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
162961613|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961614|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961615|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961616|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961617|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961618|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961619|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961620|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961621|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961622|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961623|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961624|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961625|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961626|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961627|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961628|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
162961629|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961630|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
163048063|NCT00964028|588882722|FG001|Overall Study|Withdrawal by Subject|1|||
163048064|NCT02106351|588882723|FG000|Treatment Cycle 1|Adverse Event|2|||
163048065|NCT02106351|588882724|FG001|Treatment Cycle 1|Adverse Event|0|||
163048066|NCT02106351|588882725|FG002|Treatment Cycle 1|Adverse Event|0|||
163048067|NCT02106351|588882723|FG000|Treatment Cycle 1|Consent withdrawn|1|||
163048068|NCT02106351|588882724|FG001|Treatment Cycle 1|Consent withdrawn|0|||
163048069|NCT02106351|588882725|FG002|Treatment Cycle 1|Consent withdrawn|2|||
162961631|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
163048070|NCT02106351|588882723|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
163048071|NCT02106351|588882724|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
163048072|NCT02106351|588882725|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
163048073|NCT02106351|588882723|FG000|Treatment Cycle 1|Other|0|||
163048074|NCT02106351|588882724|FG001|Treatment Cycle 1|Other|3|||
163048075|NCT02106351|588882725|FG002|Treatment Cycle 1|Other|1|||
163048076|NCT02106351|588882723|FG000|Treatment Cycle 1|Randomised but not treated|1|||
163048077|NCT02106351|588882724|FG001|Treatment Cycle 1|Randomised but not treated|0|||
162876781|NCT00610935|588251200|FG001|Overall Study|Lost to Follow-up|1|||
162876782|NCT00610935|588251199|FG000|Overall Study|Withdrawal by Subject|0|||
162876783|NCT00610935|588251200|FG001|Overall Study|Withdrawal by Subject|2|||
162876784|NCT00610935|588251199|FG000|Overall Study|Sponsor Discontinuation|1|||
163048078|NCT02106351|588882725|FG002|Treatment Cycle 1|Randomised but not treated|1|||
163048079|NCT02106351|588882723|FG000|Treatment Cycle 2|Adverse Event|0|||
163048080|NCT02106351|588882724|FG001|Treatment Cycle 2|Adverse Event|2|||
163048081|NCT02106351|588882725|FG002|Treatment Cycle 2|Adverse Event|0|||
163048082|NCT02106351|588882723|FG000|Treatment Cycle 2|Consent withdrawn|0|||
163048083|NCT02106351|588882724|FG001|Treatment Cycle 2|Consent withdrawn|1|||
163048084|NCT02106351|588882725|FG002|Treatment Cycle 2|Consent withdrawn|1|||
163048085|NCT02106351|588882723|FG000|Treatment Cycle 2|Other|0|||
163048086|NCT02106351|588882724|FG001|Treatment Cycle 2|Other|2|||
163048087|NCT02106351|588882725|FG002|Treatment Cycle 2|Other|2|||
163048088|NCT02106351|588882723|FG000|Treatment Cycle 3|Adverse Event|0|||
163048089|NCT02106351|588882724|FG001|Treatment Cycle 3|Adverse Event|1|||
163048090|NCT02106351|588882725|FG002|Treatment Cycle 3|Adverse Event|0|||
163048091|NCT02106351|588882723|FG000|Treatment Cycle 3|Consent withdrawn|0|||
163048092|NCT02106351|588882724|FG001|Treatment Cycle 3|Consent withdrawn|0|||
163048093|NCT02106351|588882725|FG002|Treatment Cycle 3|Consent withdrawn|2|||
163048094|NCT02106351|588882723|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
163048095|NCT02106351|588882724|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
163048096|NCT02106351|588882725|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
163048097|NCT02106351|588882723|FG000|Treatment Cycle 3|Other|0|||
163048098|NCT02106351|588882724|FG001|Treatment Cycle 3|Other|2|||
163048099|NCT02106351|588882725|FG002|Treatment Cycle 3|Other|3|||
163048100|NCT02106351|588882723|FG000|Treatment Cycle 4|Consent withdrawn|0|||
163048101|NCT02106351|588882724|FG001|Treatment Cycle 4|Consent withdrawn|0|||
163048102|NCT02106351|588882725|FG002|Treatment Cycle 4|Consent withdrawn|2|||
163048103|NCT02106351|588882723|FG000|Treatment Cycle 4|Other|0|||
163048104|NCT02106351|588882724|FG001|Treatment Cycle 4|Other|1|||
163048105|NCT02106351|588882725|FG002|Treatment Cycle 4|Other|0|||
163048106|NCT04754542|588882729|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
163048107|NCT04754542|588882730|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
163048108|NCT00735943|588884719|FG000|Overall Study|Lost to Follow-up|1|||
163048109|NCT00735943|588884719|FG000|Overall Study|Adverse Event|1|||
163048110|NCT03713684|588884722|FG000|Overall Study|Adverse Event|1|||
163048111|NCT03713684|588884723|FG001|Overall Study|Adverse Event|3|||
163048112|NCT03713684|588884724|FG002|Overall Study|Adverse Event|1|||
163048113|NCT03713684|588884725|FG003|Overall Study|Adverse Event|0|||
163048114|NCT03713684|588884722|FG000|Overall Study|Poor compliance to protocol|2|||
163048115|NCT03713684|588884723|FG001|Overall Study|Poor compliance to protocol|1|||
162616022|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
162616023|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
162616024|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
162616025|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
162616026|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
162616027|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
162616028|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
162616029|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
162616030|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
162616031|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
162616032|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
162616033|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
162616034|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
162616035|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
162616036|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
162707113|NCT04955626|587636682|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
163048116|NCT03713684|588884724|FG002|Overall Study|Poor compliance to protocol|0|||
163048117|NCT03713684|588884725|FG003|Overall Study|Poor compliance to protocol|1|||
163048118|NCT03713684|588884722|FG000|Overall Study|Withdrawal by Subject|14|||
163048119|NCT03713684|588884723|FG001|Overall Study|Withdrawal by Subject|6|||
163048120|NCT03713684|588884724|FG002|Overall Study|Withdrawal by Subject|14|||
162876785|NCT00610935|588251200|FG001|Overall Study|Sponsor Discontinuation|0|||
163048121|NCT03713684|588884725|FG003|Overall Study|Withdrawal by Subject|16|||
163048122|NCT03713684|588884722|FG000|Overall Study|Other than specified|69|||
163048123|NCT03713684|588884723|FG001|Overall Study|Other than specified|77|||
163048124|NCT03713684|588884724|FG002|Overall Study|Other than specified|73|||
163048125|NCT03713684|588884725|FG003|Overall Study|Other than specified|70|||
162707114|NCT04955626|587636683|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
162707115|NCT04955626|587636684|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
162707116|NCT04955626|587636685|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
162707117|NCT04955626|587636686|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
162707118|NCT04955626|587636687|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
162707119|NCT04955626|587636688|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
162707120|NCT04955626|587636689|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
162707121|NCT04955626|587636690|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
162707122|NCT04955626|587636691|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
162707123|NCT04955626|587636656|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707124|NCT04955626|587636657|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
162707125|NCT04955626|587636658|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707126|NCT04955626|587636659|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707127|NCT04955626|587636660|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707128|NCT04955626|587636661|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707129|NCT04955626|587636662|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707130|NCT04955626|587636663|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707131|NCT04955626|587636664|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707132|NCT04955626|587636665|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707133|NCT04955626|587636666|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707134|NCT04955626|587636667|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707135|NCT04955626|587636668|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707136|NCT04955626|587636669|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707137|NCT04955626|587636670|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707138|NCT04955626|587636671|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707139|NCT04955626|587636672|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707140|NCT04955626|587636673|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707141|NCT04955626|587636674|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707142|NCT04955626|587636675|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707143|NCT04955626|587636676|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707144|NCT04955626|587636677|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162876786|NCT04360187|588251203|FG000|Double-Blind Treatment|Adverse Event|9|||
162876787|NCT04360187|588251204|FG001|Double-Blind Treatment|Adverse Event|11|||
162876788|NCT04360187|588251203|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
162876789|NCT04360187|588251204|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
162876790|NCT04360187|588251203|FG000|Double-Blind Treatment|Physician Decision|1|||
162876791|NCT04360187|588251204|FG001|Double-Blind Treatment|Physician Decision|0|||
162876792|NCT04360187|588251203|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
162876793|NCT04360187|588251204|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
162876794|NCT04360187|588251203|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
162876795|NCT04360187|588251204|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
162876796|NCT04360187|588251203|FG000|Follow-Up|Lost to Follow-up|1|||
162876797|NCT04360187|588251204|FG001|Follow-Up|Lost to Follow-up|0|||
162876798|NCT02399813|588251205|FG000|Overall Study|Progressive Disease-Radiographic|2|||
162876799|NCT02399813|588251205|FG000|Overall Study|Death|20|||
162876800|NCT02399813|588251205|FG000|Overall Study|Withdrawal by Subject|3|||
162876801|NCT02399813|588251205|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
162876802|NCT02399813|588251205|FG000|Overall Study|Lost to Follow-up|2|||
162876803|NCT02399813|588251205|FG000|Overall Study|Other than specified|5|||
162876804|NCT02203838|588251208|FG000|Overall Study|Lack of Efficacy|7|||
162876805|NCT02203838|588251209|FG001|Overall Study|Lack of Efficacy|0|||
162876806|NCT02203838|588251210|FG002|Overall Study|Lack of Efficacy|1|||
162876807|NCT02203838|588251211|FG003|Overall Study|Lack of Efficacy|1|||
162876808|NCT02203838|588251208|FG000|Overall Study|Adverse Event|46|||
162876809|NCT02203838|588251209|FG001|Overall Study|Adverse Event|6|||
162876810|NCT02203838|588251210|FG002|Overall Study|Adverse Event|3|||
162876811|NCT02203838|588251211|FG003|Overall Study|Adverse Event|2|||
162876812|NCT02203838|588251208|FG000|Overall Study|Lost to Follow-up|39|||
162876813|NCT02203838|588251209|FG001|Overall Study|Lost to Follow-up|3|||
162876814|NCT02203838|588251210|FG002|Overall Study|Lost to Follow-up|2|||
162707145|NCT04955626|587636678|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707146|NCT04955626|587636679|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162876815|NCT02203838|588251211|FG003|Overall Study|Lost to Follow-up|1|||
162876816|NCT02203838|588251208|FG000|Overall Study|Protocol Violation|7|||
162876817|NCT02203838|588251209|FG001|Overall Study|Protocol Violation|3|||
162876818|NCT02203838|588251210|FG002|Overall Study|Protocol Violation|0|||
162876819|NCT02203838|588251211|FG003|Overall Study|Protocol Violation|0|||
162876820|NCT02203838|588251208|FG000|Overall Study|Withdrawal by Subject|83|||
162707147|NCT04955626|587636680|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162876821|NCT02203838|588251209|FG001|Overall Study|Withdrawal by Subject|10|||
162876822|NCT02203838|588251210|FG002|Overall Study|Withdrawal by Subject|8|||
162876823|NCT02203838|588251211|FG003|Overall Study|Withdrawal by Subject|11|||
162876824|NCT02203838|588251208|FG000|Overall Study|Physician Decision|27|||
162876825|NCT02203838|588251209|FG001|Overall Study|Physician Decision|0|||
162876826|NCT02203838|588251210|FG002|Overall Study|Physician Decision|2|||
162876827|NCT02203838|588251211|FG003|Overall Study|Physician Decision|3|||
162876828|NCT02203838|588251208|FG000|Overall Study|Other|1|||
162876829|NCT02203838|588251209|FG001|Overall Study|Other|0|||
162876830|NCT02203838|588251210|FG002|Overall Study|Other|0|||
162876831|NCT02203838|588251211|FG003|Overall Study|Other|0|||
162876832|NCT05091060|588251214|FG000|Overall Study|Lost to Follow-up|1|||
162876833|NCT02739594|588251215|FG000|Overall Study|Undesired Event|3|||
162876834|NCT02739594|588251216|FG001|Overall Study|Undesired Event|4|||
162876835|NCT02739594|588251215|FG000|Overall Study|Violation of Eligibility Criteria|1|||
162876836|NCT02739594|588251216|FG001|Overall Study|Violation of Eligibility Criteria|2|||
162876837|NCT02739594|588251215|FG000|Overall Study|Protocol Violation|5|||
162876838|NCT02739594|588251216|FG001|Overall Study|Protocol Violation|6|||
162876839|NCT02739594|588251215|FG000|Overall Study|Death|4|||
162876840|NCT02739594|588251216|FG001|Overall Study|Death|2|||
162876841|NCT02739594|588251215|FG000|Overall Study|Renal Insufficiency|4|||
162876842|NCT02739594|588251216|FG001|Overall Study|Renal Insufficiency|6|||
162876843|NCT02739594|588251215|FG000|Overall Study|Administrative Reasons|1|||
162876844|NCT02739594|588251216|FG001|Overall Study|Administrative Reasons|3|||
162876845|NCT02739594|588251215|FG000|Overall Study|Withdrawal by Subject|1|||
162876846|NCT02739594|588251216|FG001|Overall Study|Withdrawal by Subject|1|||
162876847|NCT02739594|588251215|FG000|Overall Study|Lost to Follow-up|0|||
162876848|NCT02739594|588251216|FG001|Overall Study|Lost to Follow-up|1|||
162876849|NCT02739594|588251215|FG000|Overall Study|Elevated Serum Creatinine|0|||
162876850|NCT02739594|588251216|FG001|Overall Study|Elevated Serum Creatinine|1|||
162876851|NCT02739594|588251215|FG000|Overall Study|Other|6|||
162876852|NCT02739594|588251216|FG001|Overall Study|Other|2|||
162876853|NCT00952289|588251219|FG000|All Participants|Death|9|||
162876854|NCT00952289|588251220|FG001|All Participants|Death|9|||
162876855|NCT00952289|588251219|FG000|All Participants|Adverse Event|8|||
162876856|NCT00952289|588251220|FG001|All Participants|Adverse Event|8|||
162876857|NCT00952289|588251219|FG000|All Participants|Disease progression|3|||
162876858|NCT00952289|588251220|FG001|All Participants|Disease progression|12|||
162876859|NCT00952289|588251219|FG000|All Participants|Withdrawal by Subject|1|||
162876860|NCT00952289|588251220|FG001|All Participants|Withdrawal by Subject|10|||
162876861|NCT00952289|588251219|FG000|All Participants|Data lost during site relocation|0|||
162876862|NCT00952289|588251220|FG001|All Participants|Data lost during site relocation|1|||
162876863|NCT00952289|588251219|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
162876864|NCT00952289|588251220|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
162876865|NCT00952289|588251219|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
162876866|NCT00952289|588251220|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
162876867|NCT00952289|588251219|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
162876868|NCT00952289|588251220|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
162876869|NCT00952289|588251219|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
162876870|NCT00952289|588251220|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
162876871|NCT00952289|588251219|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
163048126|NCT00528424|588884726|FG000|Overall Study|Lost to Follow-up|13|||
163048127|NCT00528424|588884726|FG000|Overall Study|Withdrew consent|2|||
163048128|NCT00528424|588884726|FG000|Overall Study|Administrative reason|2|||
163048129|NCT00528424|588884726|FG000|Overall Study|Other|12|||
163048130|NCT02515630|588884727|FG000|Overall Study|Withdrawal by Subject|5|||
163048131|NCT02515630|588884727|FG000|Overall Study|Adverse Event|4|||
163048132|NCT02515630|588884727|FG000|Overall Study|Physician Decision|4|||
163048133|NCT02515630|588884727|FG000|Overall Study|Death|2|||
163048134|NCT02515630|588884727|FG000|Overall Study|Disease Progression|1|||
162616037|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
162616038|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
163048135|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
163048136|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
163048137|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
163048138|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Death|0|||
163048139|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Death|1|||
163048140|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Death|0|||
163048141|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
163048142|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
163048143|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
162616039|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
162616040|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
162876872|NCT00952289|588251220|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
162876873|NCT03259334|588251221|FG000|Overall Study|Adverse Event|3|||
162876874|NCT03259334|588251222|FG001|Overall Study|Adverse Event|8|||
162616041|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
162616042|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
162616043|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
162616044|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
162616045|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
162616046|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Death|2|||
162616047|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Death|1|||
162616048|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Death|0|||
162616049|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Death|0|||
162616050|NCT02607930|587311596|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
162616051|NCT02607930|587311597|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162876875|NCT03259334|588251223|FG002|Overall Study|Adverse Event|5|||
162876876|NCT03259334|588251221|FG000|Overall Study|Withdrawal by Subject|4|||
162876877|NCT03259334|588251222|FG001|Overall Study|Withdrawal by Subject|2|||
162876878|NCT03259334|588251223|FG002|Overall Study|Withdrawal by Subject|4|||
162876879|NCT03259334|588251221|FG000|Overall Study|Physician Decision|1|||
162876880|NCT03259334|588251222|FG001|Overall Study|Physician Decision|0|||
162876881|NCT03259334|588251223|FG002|Overall Study|Physician Decision|0|||
162876882|NCT03259334|588251221|FG000|Overall Study|Lost to Follow-up|0|||
162876883|NCT03259334|588251222|FG001|Overall Study|Lost to Follow-up|2|||
162876884|NCT03259334|588251223|FG002|Overall Study|Lost to Follow-up|1|||
162876885|NCT03259334|588251221|FG000|Overall Study|Protocol Deviation|0|||
162876886|NCT03259334|588251222|FG001|Overall Study|Protocol Deviation|3|||
162876887|NCT03259334|588251223|FG002|Overall Study|Protocol Deviation|2|||
162616052|NCT02607930|587311598|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162876888|NCT03259334|588251221|FG000|Overall Study|Lack of Efficacy|2|||
162876889|NCT03259334|588251222|FG001|Overall Study|Lack of Efficacy|0|||
162876890|NCT03259334|588251223|FG002|Overall Study|Lack of Efficacy|1|||
162876891|NCT03259334|588251221|FG000|Overall Study|Randomized but never treated|0|||
162876892|NCT03259334|588251222|FG001|Overall Study|Randomized but never treated|2|||
162876893|NCT03259334|588251223|FG002|Overall Study|Randomized but never treated|0|||
162876894|NCT03375112|588251224|FG000|Overall Study|Withdrawal by Subject|3|||
162876895|NCT03375112|588251225|FG001|Overall Study|Withdrawal by Subject|0|||
162876896|NCT03599141|588251226|FG000|Overall Study|Lost to Follow-up|3|||
162876897|NCT03599141|588251227|FG001|Overall Study|Lost to Follow-up|1|||
162876898|NCT00777491|588251228|FG000|Overall Study|Protocol Violation|0|||
162876899|NCT00777491|588251229|FG001|Overall Study|Protocol Violation|2|||
162876900|NCT00777491|588251228|FG000|Overall Study|Did not receive any protocol treatment|2|||
162876901|NCT00777491|588251229|FG001|Overall Study|Did not receive any protocol treatment|0|||
162876902|NCT03591146|588251230|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
162876903|NCT03591146|588251231|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
162876904|NCT03591146|588251232|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
162876905|NCT03591146|588251233|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
162876906|NCT03591146|588251234|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
162876907|NCT03591146|588251230|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
162876908|NCT03591146|588251231|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
162876909|NCT03591146|588251232|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
162876910|NCT03591146|588251233|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
162876911|NCT03591146|588251234|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
162876912|NCT03591146|588251230|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
162876913|NCT03591146|588251231|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
162876914|NCT03591146|588251232|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
162876915|NCT03591146|588251233|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
162876916|NCT03591146|588251234|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
162876917|NCT03591146|588251230|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
162876918|NCT03591146|588251231|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
162876919|NCT03591146|588251232|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
162876920|NCT03591146|588251233|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
162876921|NCT03591146|588251234|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
162961632|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961633|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961634|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162616053|NCT02607930|587311599|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162616054|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162707148|NCT04955626|587636681|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162876922|NCT01511419|588251237|FG000|Dose 2|Physician Decision|1|||
162616055|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162876923|NCT01511419|588251238|FG001|Dose 2|Physician Decision|0|||
162876924|NCT00937768|588251239|FG000|Overall Study|Refused Further Treatment|3|||
162876925|NCT00937768|588251240|FG001|Overall Study|Refused Further Treatment|2|||
162876926|NCT00937768|588251239|FG000|Overall Study|Disease Progression|1|||
162876927|NCT00937768|588251240|FG001|Overall Study|Disease Progression|1|||
162876928|NCT00937768|588251239|FG000|Overall Study|Alternate Treatment|0|||
162876929|NCT00937768|588251240|FG001|Overall Study|Alternate Treatment|1|||
162876930|NCT00937768|588251239|FG000|Overall Study|No Further Funding|4|||
162876931|NCT00937768|588251240|FG001|Overall Study|No Further Funding|4|||
162876932|NCT00311181|588252832|FG000|Overall Study|Final DFTs were not obtained|96|||
162876933|NCT02669862|588252833|FG000|Overall Study|Lost to Follow-up|0|||
162876934|NCT02669862|588252834|FG001|Overall Study|Lost to Follow-up|2|||
162876935|NCT02669862|588252835|FG002|Overall Study|Lost to Follow-up|1|||
162876936|NCT02669862|588252833|FG000|Overall Study|Withdrawal by Subject|2|||
162876937|NCT02669862|588252834|FG001|Overall Study|Withdrawal by Subject|2|||
162876938|NCT02669862|588252835|FG002|Overall Study|Withdrawal by Subject|3|||
162876939|NCT02669862|588252833|FG000|Overall Study|moved|0|||
162876940|NCT02669862|588252834|FG001|Overall Study|moved|1|||
162876941|NCT02669862|588252835|FG002|Overall Study|moved|0|||
162876942|NCT02669862|588252833|FG000|Overall Study|Protocol Violation|0|||
162876943|NCT02669862|588252834|FG001|Overall Study|Protocol Violation|0|||
162876944|NCT02669862|588252835|FG002|Overall Study|Protocol Violation|1|||
162876945|NCT02294318|588252836|FG000|Overall Study|Worsening of drinking|3|||
162876946|NCT02294318|588252837|FG001|Overall Study|Worsening of drinking|0|||
162876947|NCT02294318|588252836|FG000|Overall Study|Not exposed to intervention|0|||
162876948|NCT02294318|588252837|FG001|Overall Study|Not exposed to intervention|2|||
162876949|NCT01694420|588252841|FG000|Overall Study|Lost to Follow-up|3|||
162876950|NCT00506948|588252842|FG000|Overall Study|Death|4|||
162876951|NCT00506948|588252842|FG000|Overall Study|Adverse Event|5|||
162876952|NCT00506948|588252842|FG000|Overall Study|Physician Decision|1|||
162876953|NCT02395653|588252843|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
162876954|NCT02395653|588252843|FG000|Overall Study|Consent Withdrawn at Screening|1|||
162876955|NCT02395653|588252843|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
162876956|NCT02395653|588252843|FG000|Overall Study|Investigator Decision at Screening|1|||
162876957|NCT02395653|588252843|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
162876958|NCT02395653|588252843|FG000|Overall Study|Withdrawal by Subject|1|||
162876959|NCT02395653|588252843|FG000|Overall Study|Lost to Follow-up|1|||
162876960|NCT02494778|588252844|FG000|Overall Study|Death|3|||
162876961|NCT02494778|588252844|FG000|Overall Study|Other|173|||
162876962|NCT02494778|588252844|FG000|Overall Study|Lack of Efficacy|4|||
162876963|NCT02494778|588252844|FG000|Overall Study|Adverse Event|18|||
162876964|NCT02494778|588252844|FG000|Overall Study|Withdrawal by Subject|20|||
162876965|NCT02494778|588252844|FG000|Overall Study|Lost to Follow-up|2|||
162876966|NCT02494778|588252844|FG000|Overall Study|Noncompliant with study drug admin.|1|||
162876967|NCT03621943|588252845|FG000|First Randomized Intervention|Lost to Follow-up|51|||
162876968|NCT03621943|588252846|FG001|First Randomized Intervention|Lost to Follow-up|54|||
162876969|NCT03621943|588252845|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
162876970|NCT03621943|588252846|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
162876971|NCT03621943|588252845|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
162876972|NCT03621943|588252846|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
162961635|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961636|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162616056|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
162616057|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
162616058|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
162616059|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
162616060|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
162616061|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
162876973|NCT03621943|588252845|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
162876974|NCT03621943|588252846|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
162876975|NCT02174861|588252847|FG000|Overall Study|Decision by sponsor|8|||
162876976|NCT02174861|588252847|FG000|Overall Study|Withdrawal by Subject|124|||
162876977|NCT02174861|588252847|FG000|Overall Study|Lost to Follow-up|26|||
162876978|NCT00315705|588252848|FG000|Phase 1|Refused further treatment|1|||
162876979|NCT00315705|588252848|FG000|Phase 1|Failure to achieve response|8|||
162876980|NCT00315705|588252848|FG000|Phase 1|Disease relapse|4|||
162876981|NCT00315705|588252848|FG000|Phase 1|Scheduled for transplant|9|||
162876982|NCT00315705|588252848|FG000|Phase 1|Death|3|||
162876983|NCT00315705|588252848|FG000|Phase 2|Physician Decision|4|||
162876984|NCT00315705|588252848|FG000|Phase 2|Adverse Event|1|||
162876985|NCT00315705|588252848|FG000|Phase 2|Failure to achieve response|3|||
162876986|NCT00315705|588252848|FG000|Phase 2|Disease relapse|1|||
162876987|NCT00315705|588252848|FG000|Phase 2|Scheduled for transplant|8|||
162876988|NCT00315705|588252848|FG000|Phase 2|Other|1|||
162961637|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961638|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
162961639|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961640|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961641|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961642|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162876989|NCT00315705|588252848|FG000|Phase 2|Death|7|||
162707149|NCT04955626|587636682|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707150|NCT04955626|587636683|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707151|NCT04955626|587636684|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707152|NCT04955626|587636685|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707153|NCT04955626|587636686|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707154|NCT04955626|587636687|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707155|NCT04955626|587636688|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707156|NCT04955626|587636689|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162961643|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961644|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961645|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961646|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162707157|NCT04955626|587636690|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707158|NCT04955626|587636691|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162707159|NCT03473756|587636692|FG000|Overall Study|Withdrawal by Subject|1|||
162707160|NCT03473756|587636693|FG001|Overall Study|Withdrawal by Subject|4|||
162707161|NCT03473756|587636692|FG000|Overall Study|Adverse Event|6|||
162707162|NCT03473756|587636693|FG001|Overall Study|Adverse Event|7|||
162707163|NCT03473756|587636692|FG000|Overall Study|Lack of Efficacy|3|||
162707164|NCT03473756|587636693|FG001|Overall Study|Lack of Efficacy|10|||
162707165|NCT03473756|587636692|FG000|Overall Study|Physician Decision|0|||
162707166|NCT03473756|587636693|FG001|Overall Study|Physician Decision|2|||
162707167|NCT03473756|587636692|FG000|Overall Study|End of study treatment|0|||
162707168|NCT03473756|587636693|FG001|Overall Study|End of study treatment|2|||
162707169|NCT03473756|587636692|FG000|Overall Study|Lost to Follow-up|0|||
162961647|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961648|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961649|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961650|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961651|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961652|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961653|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961654|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
162961655|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961656|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961657|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961658|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961659|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961660|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961661|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961662|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961663|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961664|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162961665|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961666|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961667|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961668|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961669|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961670|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961671|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961672|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961673|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961674|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961675|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961676|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961677|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961678|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961679|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961680|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
162961681|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961682|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961683|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961684|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961685|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961686|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961687|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961688|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
162707170|NCT03473756|587636693|FG001|Overall Study|Lost to Follow-up|1|||
162707171|NCT03714022|587636694|FG000|Overall Study|Adverse Event|1|||
162707172|NCT03714022|587636695|FG001|Overall Study|Adverse Event|0|||
162876990|NCT01346371|588252849|FG000|Overall Study|Lost to Follow-up|2|||
162876991|NCT01346371|588252850|FG001|Overall Study|Lost to Follow-up|0|||
162876992|NCT01716533|588252851|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
162876993|NCT01716533|588252852|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
162876994|NCT01716533|588252853|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
162876995|NCT01716533|588252854|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
162876996|NCT01716533|588252851|FG000|Overall Study|Withdrawal by Subject|0|||
162876997|NCT01716533|588252852|FG001|Overall Study|Withdrawal by Subject|0|||
162876998|NCT01716533|588252853|FG002|Overall Study|Withdrawal by Subject|0|||
162876999|NCT01716533|588252854|FG003|Overall Study|Withdrawal by Subject|5|||
162877000|NCT01716533|588252851|FG000|Overall Study|Death|0|||
162877001|NCT01716533|588252852|FG001|Overall Study|Death|0|||
162877002|NCT01716533|588252853|FG002|Overall Study|Death|0|||
162877003|NCT01716533|588252854|FG003|Overall Study|Death|2|||
162877004|NCT01716533|588252851|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
162877005|NCT01716533|588252852|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
162877006|NCT01716533|588252853|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
162877007|NCT01716533|588252854|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
162877008|NCT01575197|588252855|FG000|Overall Study|Migration out of study area|1|||
162877009|NCT01575197|588252856|FG001|Overall Study|Migration out of study area|5|||
162877010|NCT01575197|588252857|FG002|Overall Study|Migration out of study area|4|||
162877011|NCT01575197|588252855|FG000|Overall Study|SAE|0|||
162877012|NCT01575197|588252856|FG001|Overall Study|SAE|1|||
162877013|NCT01575197|588252857|FG002|Overall Study|SAE|0|||
162877014|NCT01575197|588252855|FG000|Overall Study|Lost to Follow-up|0|||
162877015|NCT01575197|588252856|FG001|Overall Study|Lost to Follow-up|1|||
162877016|NCT01575197|588252857|FG002|Overall Study|Lost to Follow-up|0|||
162877017|NCT01575197|588252855|FG000|Overall Study|Withdrawal by Subject|0|||
162877018|NCT01575197|588252856|FG001|Overall Study|Withdrawal by Subject|1|||
162877019|NCT01575197|588252857|FG002|Overall Study|Withdrawal by Subject|1|||
162877020|NCT01575197|588252855|FG000|Overall Study|Protocol Violation|2|||
162877021|NCT01575197|588252856|FG001|Overall Study|Protocol Violation|1|||
162877022|NCT01575197|588252857|FG002|Overall Study|Protocol Violation|1|||
162877023|NCT01000727|588252858|FG000|Overall Study|Lost to Follow-up|41|||
163048144|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
163048145|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
163048146|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
162616062|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
162616063|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
162877024|NCT01000727|588252859|FG001|Overall Study|Lost to Follow-up|43|||
162877025|NCT01000727|588252858|FG000|Overall Study|Withdrawal by Subject|111|||
162877026|NCT01000727|588252859|FG001|Overall Study|Withdrawal by Subject|109|||
162877027|NCT01000727|588252858|FG000|Overall Study|Study closed/terminated|23|||
162877028|NCT01000727|588252859|FG001|Overall Study|Study closed/terminated|24|||
162877029|NCT03196193|588252860|FG000|Overall Study|Adverse Event|1|||
162877030|NCT03196193|588252861|FG001|Overall Study|Adverse Event|0|||
162877031|NCT03196193|588252860|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
162877032|NCT03196193|588252861|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
162877033|NCT02709083|588252862|FG000|Overall Study|Original PI left institution|7|||
162877034|NCT01026389|588252863|FG000|Overall Study|Withdrawal by Subject|1|||
162877035|NCT01026389|588252864|FG001|Overall Study|Withdrawal by Subject|3|||
162877036|NCT01026389|588252863|FG000|Overall Study|change of treatment, patient moved|4|||
162877037|NCT01026389|588252864|FG001|Overall Study|change of treatment, patient moved|2|||
162877038|NCT01626352|588252868|FG000|Overall Study|Disease Progression|3|||
162961689|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961690|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
162961691|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961692|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961693|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961694|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961695|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961696|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961697|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961698|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961699|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162877039|NCT01626352|588252868|FG000|Overall Study|Intercurrent Illness|2|||
162877040|NCT01626352|588252868|FG000|Overall Study|Death|2|||
162877041|NCT01626352|588252868|FG000|Overall Study|Withdrawal by Subject|1|||
162877042|NCT01626352|588252868|FG000|Overall Study|Non-Compliance|1|||
162877043|NCT01626352|588252868|FG000|Overall Study|Never Treated|1|||
162877044|NCT03583372|588252871|FG000|Overall Study|Withdrawal by Subject|6|||
162877045|NCT03583372|588252872|FG001|Overall Study|Withdrawal by Subject|11|||
162877046|NCT03583372|588252873|FG002|Overall Study|Withdrawal by Subject|7|||
162961700|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961701|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961702|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
162707173|NCT03714022|587636694|FG000|Overall Study|Consent withdrawal|0|||
162707174|NCT03714022|587636695|FG001|Overall Study|Consent withdrawal|1|||
162707175|NCT03714022|587636694|FG000|Overall Study|Lost to Follow-up|3|||
162707176|NCT03714022|587636695|FG001|Overall Study|Lost to Follow-up|2|||
162707177|NCT02234310|587636701|FG000|Overall Study|Physician Decision|1|||
162707178|NCT02234310|587636701|FG000|Overall Study|Adverse Event|1|||
162707179|NCT02234310|587636701|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
162707180|NCT02234310|587636701|FG000|Overall Study|Withdrawal by Subject|2|||
162707181|NCT02487446|587636702|FG000|Period 1|Physician Decision|0|||
162707182|NCT02487446|587636703|FG001|Period 1|Physician Decision|1|||
162707183|NCT02487446|587636702|FG000|Period 1|Lack of Efficacy|1|||
162707184|NCT02487446|587636703|FG001|Period 1|Lack of Efficacy|0|||
162707185|NCT02487446|587636702|FG000|Period 1|Protocol deviation|3|||
162707186|NCT02487446|587636703|FG001|Period 1|Protocol deviation|2|||
162707187|NCT02487446|587636702|FG000|Period 1|Lost to Follow-up|2|||
162707188|NCT02487446|587636703|FG001|Period 1|Lost to Follow-up|0|||
162707189|NCT02487446|587636702|FG000|Period 1|Withdrawal by Subject|2|||
162707190|NCT02487446|587636703|FG001|Period 1|Withdrawal by Subject|0|||
162707191|NCT02487446|587636702|FG000|Period 1|Adverse Event|5|||
162707192|NCT02487446|587636703|FG001|Period 1|Adverse Event|5|||
162707193|NCT02487446|587636702|FG000|Washout|Lost to Follow-up|0|||
162707194|NCT02487446|587636703|FG001|Washout|Lost to Follow-up|2|||
162707195|NCT02487446|587636702|FG000|Washout|Withdrawal by Subject|1|||
162707196|NCT02487446|587636703|FG001|Washout|Withdrawal by Subject|4|||
162707197|NCT02487446|587636702|FG000|Washout|Adverse Event|2|||
162707198|NCT02487446|587636703|FG001|Washout|Adverse Event|2|||
162707199|NCT02487446|587636702|FG000|Period 2|Protocol deviation|0|||
162707200|NCT02487446|587636703|FG001|Period 2|Protocol deviation|1|||
162707201|NCT02487446|587636702|FG000|Period 2|Lost to Follow-up|1|||
162707202|NCT02487446|587636703|FG001|Period 2|Lost to Follow-up|1|||
162707203|NCT02487446|587636702|FG000|Period 2|Withdrawal by Subject|1|||
162707204|NCT02487446|587636703|FG001|Period 2|Withdrawal by Subject|1|||
162707205|NCT02487446|587636702|FG000|Period 2|Adverse Event|6|||
162707206|NCT02487446|587636703|FG001|Period 2|Adverse Event|2|||
162707207|NCT03289455|587636704|FG000|Overall Study|Death|1|||
162707208|NCT03289455|587636705|FG001|Overall Study|Death|0|||
162707209|NCT03289455|587636706|FG002|Overall Study|Death|0|||
162707210|NCT03289455|587636704|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
162707211|NCT03289455|587636705|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
162707212|NCT03289455|587636706|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
162707213|NCT03289455|587636704|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
162707214|NCT03289455|587636705|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
162707215|NCT03289455|587636706|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
162707216|NCT03289455|587636704|FG000|Overall Study|Progressive disease|3|||
162707217|NCT03289455|587636705|FG001|Overall Study|Progressive disease|4|||
162707218|NCT03289455|587636706|FG002|Overall Study|Progressive disease|5|||
162707219|NCT04951479|587636707|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
162707220|NCT03706690|587636708|FG000|Overall Study|Withdrawal by Subject|8|||
162707221|NCT03706690|587636709|FG001|Overall Study|Withdrawal by Subject|8|||
162961703|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961704|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162707222|NCT03706690|587636708|FG000|Overall Study|Death|143|||
162707223|NCT03706690|587636709|FG001|Overall Study|Death|75|||
162707224|NCT03706690|587636708|FG000|Overall Study|Ongoing at DCO|121|||
162707225|NCT03706690|587636709|FG001|Overall Study|Ongoing at DCO|52|||
162707226|NCT05617040|587636710|FG000|Overall Study|Adverse Event|0|||
162707227|NCT05617040|587636711|FG001|Overall Study|Adverse Event|1|||
162707228|NCT05617040|587636712|FG002|Overall Study|Adverse Event|0|||
162707229|NCT05617040|587636710|FG000|Overall Study|Death|0|||
162707230|NCT05617040|587636711|FG001|Overall Study|Death|0|||
162707231|NCT05617040|587636712|FG002|Overall Study|Death|1|||
162707232|NCT02711826|587636713|FG000|Overall Study|Physician Decision|0|||
162707233|NCT02711826|587636714|FG001|Overall Study|Physician Decision|0|||
162707234|NCT02711826|587636715|FG002|Overall Study|Physician Decision|0|||
162707235|NCT02711826|587636716|FG003|Overall Study|Physician Decision|1|||
162707236|NCT02711826|587636717|FG004|Overall Study|Physician Decision|0|||
162707237|NCT02711826|587636713|FG000|Overall Study|Withdrawal by Subject|0|||
162707238|NCT02711826|587636714|FG001|Overall Study|Withdrawal by Subject|1|||
162707239|NCT02711826|587636715|FG002|Overall Study|Withdrawal by Subject|0|||
162707240|NCT02711826|587636716|FG003|Overall Study|Withdrawal by Subject|4|||
162707241|NCT02711826|587636717|FG004|Overall Study|Withdrawal by Subject|0|||
162707242|NCT02711826|587636713|FG000|Overall Study|Failure to manufacture cellular product|0|||
162707243|NCT02711826|587636714|FG001|Overall Study|Failure to manufacture cellular product|0|||
162707244|NCT02711826|587636715|FG002|Overall Study|Failure to manufacture cellular product|5|||
162707245|NCT02711826|587636716|FG003|Overall Study|Failure to manufacture cellular product|0|||
162877047|NCT03583372|588252874|FG003|Overall Study|Withdrawal by Subject|8|||
162877048|NCT03583372|588252871|FG000|Overall Study|Lost to Follow-up|4|||
162877049|NCT03583372|588252872|FG001|Overall Study|Lost to Follow-up|6|||
162877050|NCT03583372|588252873|FG002|Overall Study|Lost to Follow-up|3|||
162877051|NCT03583372|588252874|FG003|Overall Study|Lost to Follow-up|2|||
162877052|NCT03583372|588252871|FG000|Overall Study|Adverse Event|1|||
162877053|NCT03583372|588252872|FG001|Overall Study|Adverse Event|3|||
162877054|NCT03583372|588252873|FG002|Overall Study|Adverse Event|4|||
162877055|NCT03583372|588252874|FG003|Overall Study|Adverse Event|4|||
162877056|NCT03583372|588252871|FG000|Overall Study|Physician Decision|0|||
162877057|NCT03583372|588252872|FG001|Overall Study|Physician Decision|1|||
162877058|NCT03583372|588252873|FG002|Overall Study|Physician Decision|1|||
162877059|NCT03583372|588252874|FG003|Overall Study|Physician Decision|1|||
162877060|NCT03583372|588252871|FG000|Overall Study|Lack of Efficacy|0|||
162877061|NCT03583372|588252872|FG001|Overall Study|Lack of Efficacy|1|||
162877062|NCT03583372|588252873|FG002|Overall Study|Lack of Efficacy|0|||
162877063|NCT03583372|588252874|FG003|Overall Study|Lack of Efficacy|1|||
162877064|NCT03583372|588252871|FG000|Overall Study|Death|1|||
162877065|NCT03583372|588252872|FG001|Overall Study|Death|0|||
162877066|NCT03583372|588252873|FG002|Overall Study|Death|0|||
162877067|NCT03583372|588252874|FG003|Overall Study|Death|0|||
162877068|NCT03583372|588252871|FG000|Overall Study|Protocol Violation|0|||
162877069|NCT03583372|588252872|FG001|Overall Study|Protocol Violation|1|||
162877070|NCT03583372|588252873|FG002|Overall Study|Protocol Violation|0|||
162877071|NCT03583372|588252874|FG003|Overall Study|Protocol Violation|0|||
162877072|NCT03583372|588252871|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
162877073|NCT03583372|588252872|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
162877074|NCT03583372|588252873|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
162877075|NCT03583372|588252874|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
162877076|NCT03583372|588252871|FG000|Overall Study|Did Not Receive Study Drug|0|||
162877077|NCT03583372|588252872|FG001|Overall Study|Did Not Receive Study Drug|1|||
162877078|NCT03583372|588252873|FG002|Overall Study|Did Not Receive Study Drug|0|||
162877079|NCT03583372|588252874|FG003|Overall Study|Did Not Receive Study Drug|0|||
162877080|NCT03583372|588252871|FG000|Overall Study|Captured as Other in the Database|1|||
162877081|NCT03583372|588252872|FG001|Overall Study|Captured as Other in the Database|2|||
162877082|NCT03583372|588252873|FG002|Overall Study|Captured as Other in the Database|4|||
162877083|NCT03583372|588252874|FG003|Overall Study|Captured as Other in the Database|1|||
162877084|NCT02796391|588252875|FG000|Overall Study|Lost to Follow-up|2|||
162877085|NCT02796391|588252876|FG001|Overall Study|Lost to Follow-up|2|||
162877086|NCT02796391|588252877|FG002|Overall Study|Lost to Follow-up|13|||
162877087|NCT02796391|588252878|FG003|Overall Study|Lost to Follow-up|8|||
162877088|NCT02796391|588252879|FG004|Overall Study|Lost to Follow-up|14|||
162877089|NCT02796391|588252880|FG005|Overall Study|Lost to Follow-up|13|||
162877090|NCT02796391|588252875|FG000|Overall Study|COVID|0|||
162877091|NCT02796391|588252876|FG001|Overall Study|COVID|0|||
162877092|NCT02796391|588252877|FG002|Overall Study|COVID|5|||
162877093|NCT02796391|588252878|FG003|Overall Study|COVID|5|||
162877094|NCT02796391|588252879|FG004|Overall Study|COVID|2|||
162877095|NCT02796391|588252880|FG005|Overall Study|COVID|4|||
162877096|NCT02796391|588252875|FG000|Overall Study|Participant did not like study cigarettes|0|||
162877097|NCT02796391|588252876|FG001|Overall Study|Participant did not like study cigarettes|0|||
162877098|NCT02796391|588252877|FG002|Overall Study|Participant did not like study cigarettes|3|||
162877099|NCT02796391|588252878|FG003|Overall Study|Participant did not like study cigarettes|0|||
162877100|NCT02796391|588252879|FG004|Overall Study|Participant did not like study cigarettes|0|||
162877101|NCT02796391|588252880|FG005|Overall Study|Participant did not like study cigarettes|0|||
162877102|NCT02796391|588252875|FG000|Overall Study|Withdrawal by Subject|1|||
162877103|NCT02796391|588252876|FG001|Overall Study|Withdrawal by Subject|1|||
162877104|NCT02796391|588252877|FG002|Overall Study|Withdrawal by Subject|4|||
162877105|NCT02796391|588252878|FG003|Overall Study|Withdrawal by Subject|3|||
162877106|NCT02796391|588252879|FG004|Overall Study|Withdrawal by Subject|4|||
162877107|NCT02796391|588252880|FG005|Overall Study|Withdrawal by Subject|3|||
162877108|NCT02796391|588252875|FG000|Overall Study|Adverse Event|0|||
162877109|NCT02796391|588252876|FG001|Overall Study|Adverse Event|0|||
162877110|NCT02796391|588252877|FG002|Overall Study|Adverse Event|0|||
162877111|NCT02796391|588252878|FG003|Overall Study|Adverse Event|1|||
162877112|NCT02796391|588252879|FG004|Overall Study|Adverse Event|0|||
162877113|NCT02796391|588252880|FG005|Overall Study|Adverse Event|0|||
162877114|NCT02796391|588252875|FG000|Overall Study|Protocol Violation|0|||
162877115|NCT02796391|588252876|FG001|Overall Study|Protocol Violation|0|||
162877116|NCT02796391|588252877|FG002|Overall Study|Protocol Violation|0|||
162877117|NCT02796391|588252878|FG003|Overall Study|Protocol Violation|1|||
162877118|NCT02796391|588252879|FG004|Overall Study|Protocol Violation|0|||
162877119|NCT02796391|588252880|FG005|Overall Study|Protocol Violation|0|||
162877120|NCT02695524|588252881|FG000|Overall Study|Lost to Follow-up|3|||
162877121|NCT02695524|588252882|FG001|Overall Study|Lost to Follow-up|2|||
162877122|NCT02695524|588252881|FG000|Overall Study|Death|0|||
162877123|NCT02695524|588252882|FG001|Overall Study|Death|1|||
162877124|NCT03446651|588252887|FG000|Overall Study|Lost to Follow-up|4|||
162877125|NCT03446651|588252888|FG001|Overall Study|Lost to Follow-up|0|||
162877126|NCT03446651|588252887|FG000|Overall Study|Open Label Participants|5|||
162877127|NCT03446651|588252888|FG001|Overall Study|Open Label Participants|0|||
162877128|NCT00343291|588252889|FG000|Overall Study|Adverse Event|13|||
162877129|NCT00343291|588252890|FG001|Overall Study|Adverse Event|13|||
162877130|NCT00343291|588252889|FG000|Overall Study|Death|3|||
162877131|NCT00343291|588252890|FG001|Overall Study|Death|2|||
162877132|NCT00343291|588252889|FG000|Overall Study|Progressive disease|33|||
162877133|NCT00343291|588252890|FG001|Overall Study|Progressive disease|34|||
162877134|NCT00343291|588252889|FG000|Overall Study|Withdrawal by Subject|0|||
162877135|NCT00343291|588252890|FG001|Overall Study|Withdrawal by Subject|2|||
162877136|NCT00343291|588252889|FG000|Overall Study|Other|8|||
162877137|NCT00343291|588252890|FG001|Overall Study|Other|5|||
162877138|NCT04831515|588252891|FG000|First Intervention|Adverse Event|0|||
162877139|NCT04831515|588252892|FG001|First Intervention|Adverse Event|1|||
162877140|NCT03712345|588252893|FG000|Overall Study|Failure to meet randomization criteria|0|||
162877141|NCT03712345|588252894|FG001|Overall Study|Failure to meet randomization criteria|0|||
162877142|NCT03712345|588252895|FG002|Overall Study|Failure to meet randomization criteria|1|||
162877143|NCT00960934|588252898|FG000|Overall Study|Adverse Event|2|||
162877144|NCT00960934|588252899|FG001|Overall Study|Adverse Event|3|||
162877145|NCT00960934|588252900|FG002|Overall Study|Adverse Event|3|||
162877146|NCT00960934|588252901|FG003|Overall Study|Adverse Event|2|||
162877147|NCT00960934|588252902|FG004|Overall Study|Adverse Event|4|||
162877148|NCT00960934|588252903|FG005|Overall Study|Adverse Event|3|||
162877149|NCT00960934|588252898|FG000|Overall Study|Lack of Efficacy|1|||
162877150|NCT00960934|588252899|FG001|Overall Study|Lack of Efficacy|0|||
162877151|NCT00960934|588252900|FG002|Overall Study|Lack of Efficacy|0|||
162877152|NCT00960934|588252901|FG003|Overall Study|Lack of Efficacy|0|||
162877153|NCT00960934|588252902|FG004|Overall Study|Lack of Efficacy|0|||
162877154|NCT00960934|588252903|FG005|Overall Study|Lack of Efficacy|0|||
162877155|NCT00960934|588252898|FG000|Overall Study|Lost to Follow-up|0|||
162877156|NCT00960934|588252899|FG001|Overall Study|Lost to Follow-up|1|||
162877157|NCT00960934|588252900|FG002|Overall Study|Lost to Follow-up|0|||
162877158|NCT00960934|588252901|FG003|Overall Study|Lost to Follow-up|0|||
162877159|NCT00960934|588252902|FG004|Overall Study|Lost to Follow-up|0|||
162877160|NCT00960934|588252903|FG005|Overall Study|Lost to Follow-up|0|||
162877161|NCT00960934|588252898|FG000|Overall Study|Other|2|||
162877162|NCT00960934|588252899|FG001|Overall Study|Other|1|||
162877163|NCT00960934|588252900|FG002|Overall Study|Other|5|||
162877164|NCT00960934|588252901|FG003|Overall Study|Other|4|||
162877165|NCT00960934|588252902|FG004|Overall Study|Other|2|||
162877166|NCT00960934|588252903|FG005|Overall Study|Other|2|||
162877167|NCT00960934|588252898|FG000|Overall Study|Physician Decision|0|||
162961705|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
162961706|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961707|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961708|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961709|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961710|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961711|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961712|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162877168|NCT00960934|588252899|FG001|Overall Study|Physician Decision|1|||
162877169|NCT00960934|588252900|FG002|Overall Study|Physician Decision|0|||
162877170|NCT00960934|588252901|FG003|Overall Study|Physician Decision|0|||
162877171|NCT00960934|588252902|FG004|Overall Study|Physician Decision|0|||
162877172|NCT00960934|588252903|FG005|Overall Study|Physician Decision|0|||
162877173|NCT00960934|588252898|FG000|Overall Study|Progressive Disease|1|||
162877174|NCT00960934|588252899|FG001|Overall Study|Progressive Disease|1|||
162877175|NCT00960934|588252900|FG002|Overall Study|Progressive Disease|0|||
162877176|NCT00960934|588252901|FG003|Overall Study|Progressive Disease|0|||
162877177|NCT00960934|588252902|FG004|Overall Study|Progressive Disease|1|||
162877178|NCT00960934|588252903|FG005|Overall Study|Progressive Disease|1|||
162877179|NCT00960934|588252898|FG000|Overall Study|Protocol Violation|3|||
162877180|NCT00960934|588252899|FG001|Overall Study|Protocol Violation|4|||
162707246|NCT02711826|587636717|FG004|Overall Study|Failure to manufacture cellular product|0|||
162707247|NCT02711826|587636713|FG000|Overall Study|Infusion canceled for active infection|0|||
162707248|NCT02711826|587636714|FG001|Overall Study|Infusion canceled for active infection|1|||
162707249|NCT02711826|587636715|FG002|Overall Study|Infusion canceled for active infection|0|||
162707250|NCT02711826|587636716|FG003|Overall Study|Infusion canceled for active infection|0|||
162707251|NCT02711826|587636717|FG004|Overall Study|Infusion canceled for active infection|0|||
162707252|NCT02711826|587636713|FG000|Overall Study|Screen failures|0|||
162707253|NCT02711826|587636714|FG001|Overall Study|Screen failures|0|||
162707254|NCT02711826|587636715|FG002|Overall Study|Screen failures|0|||
162707255|NCT02711826|587636716|FG003|Overall Study|Screen failures|4|||
162707256|NCT02711826|587636717|FG004|Overall Study|Screen failures|0|||
162707257|NCT00729690|587636718|FG000|Overall Study|IT Catheter Malfunction|0|||
162707258|NCT00729690|587636719|FG001|Overall Study|IT Catheter Malfunction|2|||
162707259|NCT00729690|587636720|FG002|Overall Study|IT Catheter Malfunction|2|||
162707260|NCT02169219|587636721|FG000|Overall Study|Lack of Efficacy|6|||
162707261|NCT02507219|587636722|FG000|Overall Study|Physician Decision|1|||
162707262|NCT02507219|587636723|FG001|Overall Study|Physician Decision|0|||
162707263|NCT02507219|587636724|FG002|Overall Study|Physician Decision|0|||
162707264|NCT02507219|587636725|FG003|Overall Study|Physician Decision|0|||
162707265|NCT02507219|587636726|FG004|Overall Study|Physician Decision|0|||
162707266|NCT02507219|587636727|FG005|Overall Study|Physician Decision|0|||
162707267|NCT02507219|587636722|FG000|Overall Study|Withdrawal by Subject|0|||
162707268|NCT02507219|587636723|FG001|Overall Study|Withdrawal by Subject|0|||
162707269|NCT02507219|587636724|FG002|Overall Study|Withdrawal by Subject|0|||
162707270|NCT02507219|587636725|FG003|Overall Study|Withdrawal by Subject|0|||
162707271|NCT02507219|587636726|FG004|Overall Study|Withdrawal by Subject|1|||
162707272|NCT02507219|587636727|FG005|Overall Study|Withdrawal by Subject|0|||
162707273|NCT02886936|587636728|FG000|Overall Study|Lost to Follow-up|4|||
162707274|NCT02886936|587636729|FG001|Overall Study|Lost to Follow-up|3|||
162707275|NCT02886936|587636730|FG002|Overall Study|Lost to Follow-up|0|||
162707276|NCT04562779|587636731|FG000|Overall Study|Lost to Follow-up|7|||
162707277|NCT04562779|587636732|FG001|Overall Study|Lost to Follow-up|5|||
162707278|NCT04562779|587636733|FG002|Overall Study|Lost to Follow-up|10|||
162707279|NCT04562779|587636731|FG000|Overall Study|Protocol Violation|2|||
162707280|NCT04562779|587636732|FG001|Overall Study|Protocol Violation|2|||
162707281|NCT04562779|587636733|FG002|Overall Study|Protocol Violation|0|||
162707282|NCT02624778|587638189|FG000|Overall Study|Lost to Follow-up|0|||
162707283|NCT02624778|587638190|FG001|Overall Study|Lost to Follow-up|0|||
162707284|NCT02624778|587638191|FG002|Overall Study|Lost to Follow-up|1|||
162707285|NCT02624778|587638192|FG003|Overall Study|Lost to Follow-up|0|||
162707286|NCT02624778|587638193|FG004|Overall Study|Lost to Follow-up|0|||
162707287|NCT02624778|587638194|FG005|Overall Study|Lost to Follow-up|0|||
162707288|NCT02624778|587638195|FG006|Overall Study|Lost to Follow-up|0|||
162707289|NCT02624778|587638196|FG007|Overall Study|Lost to Follow-up|0|||
162707290|NCT02624778|587638197|FG008|Overall Study|Lost to Follow-up|0|||
162707291|NCT02624778|587638189|FG000|Overall Study|Withdrawal by Subject|0|||
162707292|NCT02624778|587638190|FG001|Overall Study|Withdrawal by Subject|1|||
162707293|NCT02624778|587638191|FG002|Overall Study|Withdrawal by Subject|0|||
162877181|NCT00960934|588252900|FG002|Overall Study|Protocol Violation|0|||
162707294|NCT02624778|587638192|FG003|Overall Study|Withdrawal by Subject|0|||
162707295|NCT02624778|587638193|FG004|Overall Study|Withdrawal by Subject|0|||
162707296|NCT02624778|587638194|FG005|Overall Study|Withdrawal by Subject|1|||
162707297|NCT02624778|587638195|FG006|Overall Study|Withdrawal by Subject|1|||
162707298|NCT02624778|587638196|FG007|Overall Study|Withdrawal by Subject|1|||
162707299|NCT02624778|587638197|FG008|Overall Study|Withdrawal by Subject|1|||
162707300|NCT02624778|587638189|FG000|Overall Study|Adverse Event|0|||
162707301|NCT02624778|587638190|FG001|Overall Study|Adverse Event|0|||
162877182|NCT00960934|588252901|FG003|Overall Study|Protocol Violation|3|||
162877183|NCT00960934|588252902|FG004|Overall Study|Protocol Violation|3|||
162877184|NCT00960934|588252903|FG005|Overall Study|Protocol Violation|2|||
162877185|NCT00960934|588252898|FG000|Overall Study|Withdrawal by Subject|5|||
162877186|NCT00960934|588252899|FG001|Overall Study|Withdrawal by Subject|6|||
162877187|NCT00960934|588252900|FG002|Overall Study|Withdrawal by Subject|4|||
162877188|NCT00960934|588252901|FG003|Overall Study|Withdrawal by Subject|5|||
162877189|NCT00960934|588252902|FG004|Overall Study|Withdrawal by Subject|5|||
162877190|NCT00960934|588252903|FG005|Overall Study|Withdrawal by Subject|7|||
162877191|NCT00960934|588252898|FG000|Overall Study|Study Terminated by Sponsor|50|||
162877192|NCT00960934|588252899|FG001|Overall Study|Study Terminated by Sponsor|46|||
162877193|NCT00960934|588252900|FG002|Overall Study|Study Terminated by Sponsor|52|||
162877194|NCT00960934|588252901|FG003|Overall Study|Study Terminated by Sponsor|50|||
162877195|NCT00960934|588252902|FG004|Overall Study|Study Terminated by Sponsor|49|||
162877196|NCT00960934|588252903|FG005|Overall Study|Study Terminated by Sponsor|49|||
162877197|NCT02338492|588252904|FG000|Overall Study|Death|32|||
162877198|NCT02338492|588252904|FG000|Overall Study|Adverse Event|3|||
162877199|NCT02338492|588252904|FG000|Overall Study|Lost to Follow-up|4|||
162877200|NCT02338492|588252904|FG000|Overall Study|Reason not captured above|6|||
162877201|NCT04281030|588252907|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
162877202|NCT04281030|588252908|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
162877203|NCT04281030|588252907|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
162877204|NCT04281030|588252908|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
162877205|NCT01395368|588252909|FG000|Overall Study|Physician Decision|14|||
162877206|NCT01395368|588252909|FG000|Overall Study|Withdrawal by Subject|2|||
162877207|NCT00310388|588252910|FG000|Primary Reporting Phase|Adverse Event|101|||
162877208|NCT00310388|588252911|FG001|Primary Reporting Phase|Adverse Event|0|||
162877209|NCT00310388|588252910|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
162877210|NCT00310388|588252911|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
162877211|NCT00310388|588252910|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
162877212|NCT00310388|588252911|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
162877213|NCT00310388|588252910|FG000|Primary Reporting Phase|Protocol Violation|10|||
162877214|NCT00310388|588252911|FG001|Primary Reporting Phase|Protocol Violation|0|||
162877215|NCT00310388|588252910|FG000|Primary Reporting Phase|Pregnancy|3|||
162877216|NCT00310388|588252911|FG001|Primary Reporting Phase|Pregnancy|0|||
162877217|NCT00310388|588252910|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
162877218|NCT00310388|588252911|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
162877219|NCT00310388|588252910|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
162877220|NCT00310388|588252911|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
162877221|NCT00310388|588252910|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
162877222|NCT00310388|588252911|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
162877223|NCT00310388|588252910|FG000|Primary Reporting Phase|Physician Decision|2|||
162877224|NCT00310388|588252911|FG001|Primary Reporting Phase|Physician Decision|0|||
162877225|NCT00310388|588252910|FG000|Primary Reporting Phase|Request of the sponsor|19|||
162877226|NCT00310388|588252911|FG001|Primary Reporting Phase|Request of the sponsor|0|||
162877227|NCT00310388|588252910|FG000|Primary Reporting Phase|Failed to return|8|||
162877228|NCT00310388|588252911|FG001|Primary Reporting Phase|Failed to return|0|||
162877229|NCT00310388|588252910|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
162877230|NCT00310388|588252911|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
162877231|NCT00310388|588252910|FG000|Primary Reporting Phase|Participant request|2|||
162877232|NCT00310388|588252911|FG001|Primary Reporting Phase|Participant request|0|||
162877233|NCT00310388|588252910|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
162877234|NCT00310388|588252911|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
162877235|NCT00310388|588252910|FG000|Primary Reporting Phase|Discontinuation of study|1|||
162877236|NCT00310388|588252911|FG001|Primary Reporting Phase|Discontinuation of study|0|||
162877237|NCT00310388|588252910|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
162707302|NCT02624778|587638191|FG002|Overall Study|Adverse Event|0|||
163048147|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163048148|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163048149|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163048150|NCT01064414|588884730|FG000|Core Period: Baseline to Week 26|Other|4|||
162877238|NCT00310388|588252911|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
162877239|NCT00310388|588252910|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
163048151|NCT01064414|588884731|FG001|Core Period: Baseline to Week 26|Other|7|||
163048152|NCT01064414|588884732|FG002|Core Period: Baseline to Week 26|Other|2|||
162877240|NCT00310388|588252911|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
162877241|NCT00310388|588252910|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
162877242|NCT00310388|588252911|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
162877243|NCT00310388|588252910|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
162877244|NCT00310388|588252911|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
162877245|NCT00310388|588252910|FG000|Primary Reporting Phase|Participant passed away|1|||
162877246|NCT00310388|588252911|FG001|Primary Reporting Phase|Participant passed away|0|||
162877247|NCT00310388|588252910|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
162877248|NCT00310388|588252911|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
162877249|NCT00310388|588252910|FG000|Primary Reporting Phase|Missing|1|||
162877250|NCT00310388|588252911|FG001|Primary Reporting Phase|Missing|0|||
162877251|NCT00310388|588252910|FG000|Primary Reporting Phase|Other|1|||
162877252|NCT00310388|588252911|FG001|Primary Reporting Phase|Other|0|||
162877253|NCT00310388|588252910|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
162877254|NCT00310388|588252911|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
162877255|NCT00310388|588252910|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
162877256|NCT00310388|588252911|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
162877257|NCT00310388|588252910|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
162877258|NCT00310388|588252911|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
162877259|NCT00310388|588252910|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
162877260|NCT00310388|588252911|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
162877261|NCT00882999|588252916|FG000|Overall Study|Adverse Event|0|||
162877262|NCT00882999|588252917|FG001|Overall Study|Adverse Event|0|||
162877263|NCT00882999|588252918|FG002|Overall Study|Adverse Event|0|||
162877264|NCT00882999|588252919|FG003|Overall Study|Adverse Event|0|||
162877265|NCT00882999|588252920|FG004|Overall Study|Adverse Event|1|||
162877266|NCT00882999|588252921|FG005|Overall Study|Adverse Event|0|||
162877267|NCT00882999|588252922|FG006|Overall Study|Adverse Event|0|||
162877268|NCT00882999|588252916|FG000|Overall Study|Death|0|||
162877269|NCT00882999|588252917|FG001|Overall Study|Death|1|||
162877270|NCT00882999|588252918|FG002|Overall Study|Death|0|||
162877271|NCT00882999|588252919|FG003|Overall Study|Death|0|||
162877272|NCT00882999|588252920|FG004|Overall Study|Death|0|||
162877273|NCT00882999|588252921|FG005|Overall Study|Death|0|||
162877274|NCT00882999|588252922|FG006|Overall Study|Death|0|||
162877275|NCT00882999|588252916|FG000|Overall Study|Withdrawal by Subject|7|||
162877276|NCT00882999|588252917|FG001|Overall Study|Withdrawal by Subject|6|||
162877277|NCT00882999|588252918|FG002|Overall Study|Withdrawal by Subject|3|||
162877278|NCT00882999|588252919|FG003|Overall Study|Withdrawal by Subject|3|||
162877279|NCT00882999|588252920|FG004|Overall Study|Withdrawal by Subject|6|||
162877280|NCT00882999|588252921|FG005|Overall Study|Withdrawal by Subject|5|||
162877281|NCT00882999|588252922|FG006|Overall Study|Withdrawal by Subject|5|||
162877282|NCT00882999|588252916|FG000|Overall Study|Lost to Follow-up|0|||
162877283|NCT00882999|588252917|FG001|Overall Study|Lost to Follow-up|1|||
162877284|NCT00882999|588252918|FG002|Overall Study|Lost to Follow-up|1|||
162877285|NCT00882999|588252919|FG003|Overall Study|Lost to Follow-up|2|||
162877286|NCT00882999|588252920|FG004|Overall Study|Lost to Follow-up|1|||
162877287|NCT00882999|588252921|FG005|Overall Study|Lost to Follow-up|1|||
162877288|NCT00882999|588252922|FG006|Overall Study|Lost to Follow-up|2|||
163048153|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163048154|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163048155|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
163048156|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Death|0|||
163048157|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Death|1|||
163048158|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Death|0|||
162877289|NCT00882999|588252916|FG000|Overall Study|Physician Decision|1|||
162877290|NCT00882999|588252917|FG001|Overall Study|Physician Decision|0|||
162877291|NCT00882999|588252918|FG002|Overall Study|Physician Decision|0|||
162877292|NCT00882999|588252919|FG003|Overall Study|Physician Decision|0|||
162877293|NCT00882999|588252920|FG004|Overall Study|Physician Decision|0|||
162877294|NCT00882999|588252921|FG005|Overall Study|Physician Decision|1|||
162877295|NCT00882999|588252922|FG006|Overall Study|Physician Decision|1|||
162877296|NCT01757405|588252925|FG000|Overall Study|Lost to Follow-up|1|||
162877297|NCT01757405|588252926|FG001|Overall Study|Lost to Follow-up|1|||
163048159|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
163048160|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163048161|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162877298|NCT01757405|588252925|FG000|Overall Study|Withdrawal by Subject|0|||
162877299|NCT01757405|588252926|FG001|Overall Study|Withdrawal by Subject|1|||
162877300|NCT00082758|588252927|FG000|Overall Study|Adverse Event|0|||
162877301|NCT00082758|588252928|FG001|Overall Study|Adverse Event|2|||
162877302|NCT00082758|588252929|FG002|Overall Study|Adverse Event|0|||
162877303|NCT00082758|588252927|FG000|Overall Study|Lack of Efficacy|12|||
163048162|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
163048163|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162877304|NCT00082758|588252928|FG001|Overall Study|Lack of Efficacy|13|||
162877305|NCT00082758|588252929|FG002|Overall Study|Lack of Efficacy|0|||
162877306|NCT00082758|588252927|FG000|Overall Study|Physician Decision|0|||
162877307|NCT00082758|588252928|FG001|Overall Study|Physician Decision|1|||
162877308|NCT00082758|588252929|FG002|Overall Study|Physician Decision|0|||
162877309|NCT00082758|588252927|FG000|Overall Study|Withdrawal by Subject|3|||
162877310|NCT00082758|588252928|FG001|Overall Study|Withdrawal by Subject|0|||
162877311|NCT00082758|588252929|FG002|Overall Study|Withdrawal by Subject|0|||
162877312|NCT00082758|588252927|FG000|Overall Study|Protocol Violation|0|||
162877313|NCT00082758|588252928|FG001|Overall Study|Protocol Violation|1|||
162877314|NCT00082758|588252929|FG002|Overall Study|Protocol Violation|0|||
162877315|NCT00937560|588252930|FG000|Initial Treatment|Death|6|||
162877316|NCT00937560|588252930|FG000|Initial Treatment|Withdraw consent|3|||
162877317|NCT00937560|588252930|FG000|Initial Treatment|Adverse Event|1|||
162877318|NCT00937560|588252930|FG000|Initial Treatment|Lost to Follow-up|1|||
162877319|NCT00937560|588252930|FG000|Initial Treatment|No end of study page|10|||
162877320|NCT00937560|588252930|FG000|Maintenance Treatment|Death|12|||
162877321|NCT00937560|588252930|FG000|Maintenance Treatment|Withdraw consent|5|||
162877322|NCT00937560|588252930|FG000|Maintenance Treatment|According to protocol|1|||
162877323|NCT01219959|588252931|FG000|Overall Study|Adverse Event|6|||
162877324|NCT01219959|588252932|FG001|Overall Study|Adverse Event|14|||
162877325|NCT01219959|588252931|FG000|Overall Study|Physician Decision|0|||
162877326|NCT01219959|588252932|FG001|Overall Study|Physician Decision|4|||
162877327|NCT01219959|588252931|FG000|Overall Study|Withdrawal by Subject|0|||
162877328|NCT01219959|588252932|FG001|Overall Study|Withdrawal by Subject|2|||
162877329|NCT01219959|588252931|FG000|Overall Study|Renal Transplantation|0|||
162877330|NCT01219959|588252932|FG001|Overall Study|Renal Transplantation|3|||
162877331|NCT01219959|588252931|FG000|Overall Study|Other|1|||
162877332|NCT01219959|588252932|FG001|Overall Study|Other|0|||
162877333|NCT01248130|588252933|FG000|Overall Study|Protocol Violation|1|||
162877334|NCT01248130|588252934|FG001|Overall Study|Protocol Violation|0|||
162877335|NCT01248130|588252933|FG000|Overall Study|Ineligible|1|||
162877336|NCT01248130|588252934|FG001|Overall Study|Ineligible|0|||
162877337|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
162877338|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
162877339|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
162877340|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
162877341|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
162877342|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
162877343|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877344|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
162877345|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
162877346|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
162877347|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
162877348|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
162877349|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
162877350|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
162877351|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877352|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877353|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877354|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877355|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877356|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877357|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877358|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877359|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
162877360|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
162877361|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
162877362|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
162877363|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
162877364|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
162961713|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961714|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961715|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162961716|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
162877365|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
162877366|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
162877367|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
162877368|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
162877369|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162961717|NCT00112437|588560746|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163048164|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163048165|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163048166|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163048167|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163048168|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
162616064|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
162616065|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
162616066|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
162616067|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
162616068|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
162616069|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
162616070|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
162616071|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
162707303|NCT02624778|587638192|FG003|Overall Study|Adverse Event|0|||
162707304|NCT02624778|587638193|FG004|Overall Study|Adverse Event|0|||
163048169|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163048170|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163048171|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048172|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048173|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163048174|NCT01064414|588884730|FG000|Extension Period: Week 26 to Week 52|Other|5|||
163048175|NCT01064414|588884731|FG001|Extension Period: Week 26 to Week 52|Other|2|||
163048176|NCT01064414|588884732|FG002|Extension Period: Week 26 to Week 52|Other|1|||
163048177|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
163048178|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
163048179|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Death|561|||
163048180|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Death|298|||
163048181|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
163048182|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
163048183|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
162707305|NCT02624778|587638194|FG005|Overall Study|Adverse Event|0|||
162707306|NCT02624778|587638195|FG006|Overall Study|Adverse Event|0|||
162707307|NCT02624778|587638196|FG007|Overall Study|Adverse Event|0|||
162707308|NCT02624778|587638197|FG008|Overall Study|Adverse Event|2|||
162707309|NCT02624778|587638189|FG000|Overall Study|Death|0|||
162707310|NCT02624778|587638190|FG001|Overall Study|Death|0|||
162707311|NCT02624778|587638191|FG002|Overall Study|Death|0|||
162707312|NCT02624778|587638192|FG003|Overall Study|Death|0|||
162707313|NCT02624778|587638193|FG004|Overall Study|Death|0|||
162707314|NCT02624778|587638194|FG005|Overall Study|Death|0|||
162707315|NCT02624778|587638195|FG006|Overall Study|Death|1|||
162707316|NCT02624778|587638196|FG007|Overall Study|Death|0|||
162707317|NCT02624778|587638197|FG008|Overall Study|Death|0|||
162707318|NCT02624778|587638189|FG000|Overall Study|Physician Decision|0|||
162707319|NCT02624778|587638190|FG001|Overall Study|Physician Decision|0|||
162707320|NCT02624778|587638191|FG002|Overall Study|Physician Decision|0|||
162707321|NCT02624778|587638192|FG003|Overall Study|Physician Decision|0|||
162707322|NCT02624778|587638193|FG004|Overall Study|Physician Decision|0|||
162707323|NCT02624778|587638194|FG005|Overall Study|Physician Decision|0|||
162707324|NCT02624778|587638195|FG006|Overall Study|Physician Decision|0|||
162707325|NCT02624778|587638196|FG007|Overall Study|Physician Decision|3|||
162707326|NCT02624778|587638197|FG008|Overall Study|Physician Decision|3|||
162707327|NCT04091672|587638200|FG000|Overall Study|Death|6|||
162707328|NCT04091672|587638201|FG001|Overall Study|Death|6|||
162707329|NCT04091672|587638200|FG000|Overall Study|Lost to Follow-up|7|||
162707330|NCT04091672|587638201|FG001|Overall Study|Lost to Follow-up|7|||
162707331|NCT04091672|587638200|FG000|Overall Study|Withdrawal by Subject|3|||
162707332|NCT04091672|587638201|FG001|Overall Study|Withdrawal by Subject|3|||
162707333|NCT04091672|587638200|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
162707334|NCT04091672|587638201|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
162707335|NCT05296629|587638202|FG000|Overall Study|Withdrawal by Subject|3|||
162707336|NCT05296629|587638203|FG001|Overall Study|Withdrawal by Subject|10|||
162707337|NCT05296629|587638204|FG002|Overall Study|Withdrawal by Subject|4|||
162707338|NCT05296629|587638202|FG000|Overall Study|Lost to Follow-up|2|||
162707339|NCT05296629|587638203|FG001|Overall Study|Lost to Follow-up|7|||
162707340|NCT05296629|587638204|FG002|Overall Study|Lost to Follow-up|1|||
162707341|NCT05296629|587638202|FG000|Overall Study|Adverse Event|0|||
162707342|NCT05296629|587638203|FG001|Overall Study|Adverse Event|4|||
162707343|NCT05296629|587638204|FG002|Overall Study|Adverse Event|2|||
162707344|NCT05296629|587638202|FG000|Overall Study|Protocol Violation|0|||
162707345|NCT05296629|587638203|FG001|Overall Study|Protocol Violation|2|||
162707346|NCT05296629|587638204|FG002|Overall Study|Protocol Violation|0|||
162707347|NCT04610684|587638210|FG000|Study Treatment|Withdrawal by Subject|1|||
162707348|NCT04610684|587638210|FG000|Study Treatment|Disease Progression|2|||
162707349|NCT04610684|587638210|FG000|Follow up|Death|2|||
162707350|NCT04610684|587638210|FG000|Follow up|Withdrawal by Subject|1|||
162707351|NCT00359619|587638211|FG000|Overall Study|Adverse Event|0|||
162707352|NCT00359619|587638212|FG001|Overall Study|Adverse Event|0|||
162707353|NCT00359619|587638213|FG002|Overall Study|Adverse Event|1|||
162707354|NCT00359619|587638214|FG003|Overall Study|Adverse Event|0|||
162707355|NCT00359619|587638215|FG004|Overall Study|Adverse Event|0|||
162707356|NCT00359619|587638216|FG005|Overall Study|Adverse Event|0|||
162707357|NCT00359619|587638217|FG006|Overall Study|Adverse Event|1|||
162707358|NCT00359619|587638211|FG000|Overall Study|Withdrawal by Subject|3|||
162707359|NCT00359619|587638212|FG001|Overall Study|Withdrawal by Subject|1|||
162707360|NCT00359619|587638213|FG002|Overall Study|Withdrawal by Subject|4|||
162707361|NCT00359619|587638214|FG003|Overall Study|Withdrawal by Subject|2|||
162707362|NCT00359619|587638215|FG004|Overall Study|Withdrawal by Subject|2|||
162707363|NCT00359619|587638216|FG005|Overall Study|Withdrawal by Subject|0|||
162707364|NCT00359619|587638217|FG006|Overall Study|Withdrawal by Subject|3|||
162707365|NCT00359619|587638211|FG000|Overall Study|Other|1|||
162707366|NCT00359619|587638212|FG001|Overall Study|Other|0|||
162707367|NCT00359619|587638213|FG002|Overall Study|Other|0|||
162707368|NCT00359619|587638214|FG003|Overall Study|Other|0|||
162707369|NCT00359619|587638215|FG004|Overall Study|Other|0|||
162707370|NCT00359619|587638216|FG005|Overall Study|Other|0|||
163048184|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
163048185|NCT00974311|588884733|FG000|DB Phase (up to 24 Months)|Other|1|||
163048186|NCT00974311|588884734|FG001|DB Phase (up to 24 Months)|Other|0|||
163048187|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Death|14|||
163048188|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Death|21|||
163048189|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
163048190|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
163048191|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Other|15|||
163048192|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Other|2|||
163048193|NCT00974311|588884733|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
163048194|NCT00974311|588884734|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
163048195|NCT02595502|588884735|FG000|Period 1|Adverse Event|0|||
163048196|NCT02595502|588884736|FG001|Period 1|Adverse Event|1|||
163048197|NCT02595502|588884735|FG000|Period 1|Withdrawal by Subject|1|||
163048198|NCT02595502|588884736|FG001|Period 1|Withdrawal by Subject|0|||
163048199|NCT02595502|588884735|FG000|Period 1|Lost to Follow-up|0|||
163048200|NCT02595502|588884736|FG001|Period 1|Lost to Follow-up|1|||
163048201|NCT02595502|588884735|FG000|Period 2|Adverse Event|1|||
163048202|NCT02595502|588884736|FG001|Period 2|Adverse Event|1|||
163048203|NCT02595502|588884735|FG000|Period 2|Received incorrect lens at Period 1|0|||
163048204|NCT02595502|588884736|FG001|Period 2|Received incorrect lens at Period 1|1|||
163048205|NCT02595502|588884735|FG000|Period 3|Protocol Violation|0|||
163048206|NCT02595502|588884736|FG001|Period 3|Protocol Violation|1|||
163048207|NCT02595502|588884735|FG000|Period 3|Lost to Follow-up|1|||
163048208|NCT02595502|588884736|FG001|Period 3|Lost to Follow-up|0|||
163048209|NCT02595502|588884735|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
163048210|NCT02595502|588884736|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
163048211|NCT00458003|588884737|FG000|Overall Study|Non protocol spinal anesthesia|1|||
163048212|NCT00458003|588884738|FG001|Overall Study|Non protocol spinal anesthesia|1|||
163048213|NCT03286218|588884739|FG000|Qualification Phase Period 1|Adverse Event|1|||
163048214|NCT03286218|588884740|FG001|Qualification Phase Period 1|Adverse Event|0|||
163048215|NCT03286218|588884741|FG002|Qualification Phase Period 1|Adverse Event|0|||
163048216|NCT03286218|588884742|FG003|Qualification Phase Period 1|Adverse Event|0|||
163048217|NCT03286218|588884743|FG004|Qualification Phase Period 1|Adverse Event|0|||
162707371|NCT00359619|587638217|FG006|Overall Study|Other|0|||
162707372|NCT00359619|587638211|FG000|Overall Study|Lost to Follow-up|4|||
162877370|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877371|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
162877372|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
162877373|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
163048218|NCT03286218|588884744|FG005|Qualification Phase Period 1|Adverse Event|0|||
163048219|NCT03286218|588884745|FG006|Qualification Phase Period 1|Adverse Event|0|||
163048220|NCT03286218|588884746|FG007|Qualification Phase Period 1|Adverse Event|0|||
163048221|NCT03286218|588884747|FG008|Qualification Phase Period 1|Adverse Event|0|||
163048222|NCT03286218|588884748|FG009|Qualification Phase Period 1|Adverse Event|0|||
163048223|NCT03286218|588884749|FG010|Qualification Phase Period 1|Adverse Event|0|||
163048224|NCT03286218|588884750|FG011|Qualification Phase Period 1|Adverse Event|0|||
163048225|NCT03286218|588884739|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048226|NCT03286218|588884740|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
162707373|NCT00359619|587638212|FG001|Overall Study|Lost to Follow-up|4|||
162707374|NCT00359619|587638213|FG002|Overall Study|Lost to Follow-up|2|||
163048227|NCT03286218|588884741|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
162707375|NCT00359619|587638214|FG003|Overall Study|Lost to Follow-up|1|||
162707376|NCT00359619|587638215|FG004|Overall Study|Lost to Follow-up|1|||
163048228|NCT03286218|588884742|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048229|NCT03286218|588884743|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048230|NCT03286218|588884744|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048231|NCT03286218|588884745|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048232|NCT03286218|588884746|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048233|NCT03286218|588884747|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048234|NCT03286218|588884748|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048235|NCT03286218|588884749|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048236|NCT03286218|588884750|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
163048237|NCT03286218|588884739|FG000|Qualification Phase Period 2|Adverse Event|0|||
163048238|NCT03286218|588884740|FG001|Qualification Phase Period 2|Adverse Event|1|||
163048239|NCT03286218|588884741|FG002|Qualification Phase Period 2|Adverse Event|0|||
163048240|NCT03286218|588884742|FG003|Qualification Phase Period 2|Adverse Event|0|||
163048241|NCT03286218|588884743|FG004|Qualification Phase Period 2|Adverse Event|0|||
163048242|NCT03286218|588884744|FG005|Qualification Phase Period 2|Adverse Event|0|||
163048243|NCT03286218|588884745|FG006|Qualification Phase Period 2|Adverse Event|0|||
163048244|NCT03286218|588884746|FG007|Qualification Phase Period 2|Adverse Event|0|||
163048245|NCT03286218|588884747|FG008|Qualification Phase Period 2|Adverse Event|0|||
163048246|NCT03286218|588884748|FG009|Qualification Phase Period 2|Adverse Event|0|||
163048247|NCT03286218|588884749|FG010|Qualification Phase Period 2|Adverse Event|0|||
163048248|NCT03286218|588884750|FG011|Qualification Phase Period 2|Adverse Event|0|||
163048249|NCT03286218|588884739|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
163048250|NCT03286218|588884740|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
163048251|NCT03286218|588884741|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
162616072|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
162616073|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
162616074|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
162616075|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
162616076|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
162616077|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
162616078|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
163048252|NCT03286218|588884742|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048253|NCT03286218|588884743|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048254|NCT03286218|588884744|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048255|NCT03286218|588884745|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048256|NCT03286218|588884746|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048257|NCT03286218|588884747|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048258|NCT03286218|588884748|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048259|NCT03286218|588884749|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048260|NCT03286218|588884750|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
163048261|NCT03286218|588884739|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
162616079|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
162616080|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
162616081|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
162616082|NCT02607930|587311596|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162616083|NCT02607930|587311597|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162616084|NCT02607930|587311598|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
162616085|NCT02607930|587311599|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162616086|NCT01676727|587311600|FG000|Overall Study|Death|18|||
162616087|NCT01676727|587311600|FG000|Overall Study|Withdrawal by Subject|6|||
162616088|NCT01676727|587311600|FG000|Overall Study|Screening failure|5|||
162616089|NCT01676727|587311600|FG000|Overall Study|Not willing to attend 1-year visit|2|||
162616090|NCT01676727|587311600|FG000|Overall Study|Valve explanted|1|||
162616091|NCT01578330|587311601|FG000|Overall Study|Adverse Event|2|||
162616092|NCT01578330|587311601|FG000|Overall Study|Protocol Violation|5|||
162616093|NCT01134731|587311602|FG000|Overall Study|Adverse Event|3|||
162616094|NCT01134731|587311603|FG001|Overall Study|Adverse Event|2|||
162616095|NCT01134731|587311604|FG002|Overall Study|Adverse Event|1|||
162616096|NCT01134731|587311602|FG000|Overall Study|Physician Decision|2|||
162616097|NCT01134731|587311603|FG001|Overall Study|Physician Decision|2|||
162616098|NCT01134731|587311604|FG002|Overall Study|Physician Decision|2|||
162616099|NCT01134731|587311602|FG000|Overall Study|Lack of Efficacy|0|||
162616100|NCT01134731|587311603|FG001|Overall Study|Lack of Efficacy|0|||
162616101|NCT01134731|587311604|FG002|Overall Study|Lack of Efficacy|1|||
162616102|NCT01134731|587311602|FG000|Overall Study|Withdrawal by Subject|3|||
162616103|NCT01134731|587311603|FG001|Overall Study|Withdrawal by Subject|3|||
162616104|NCT01134731|587311604|FG002|Overall Study|Withdrawal by Subject|1|||
162616105|NCT01134731|587311602|FG000|Overall Study|Lost to Follow-up|5|||
163048262|NCT03286218|588884740|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
163048263|NCT03286218|588884741|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
163048264|NCT03286218|588884742|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
163048265|NCT03286218|588884743|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
163048266|NCT03286218|588884744|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
163048267|NCT03286218|588884745|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
163048268|NCT03286218|588884746|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
162707377|NCT00359619|587638216|FG005|Overall Study|Lost to Follow-up|5|||
162707378|NCT00359619|587638217|FG006|Overall Study|Lost to Follow-up|0|||
162707379|NCT00049517|587638218|FG000|Induction|Disease progression|0|||
162707380|NCT00049517|587638219|FG001|Induction|Disease progression|0|||
162707381|NCT00049517|587638220|FG002|Induction|Disease progression|0|||
162707382|NCT00049517|587638221|FG003|Induction|Disease progression|0|||
162707383|NCT00049517|587638222|FG004|Induction|Disease progression|18|||
162707384|NCT00049517|587638223|FG005|Induction|Disease progression|11|||
162707385|NCT00049517|587638218|FG000|Induction|Adverse Event|0|||
162707386|NCT00049517|587638219|FG001|Induction|Adverse Event|0|||
162707387|NCT00049517|587638220|FG002|Induction|Adverse Event|0|||
162707388|NCT00049517|587638221|FG003|Induction|Adverse Event|0|||
162707389|NCT00049517|587638222|FG004|Induction|Adverse Event|5|||
162707390|NCT00049517|587638223|FG005|Induction|Adverse Event|7|||
162707391|NCT00049517|587638218|FG000|Induction|Death|0|||
162707392|NCT00049517|587638219|FG001|Induction|Death|0|||
162707393|NCT00049517|587638220|FG002|Induction|Death|0|||
162707394|NCT00049517|587638221|FG003|Induction|Death|0|||
162707395|NCT00049517|587638222|FG004|Induction|Death|9|||
162707396|NCT00049517|587638223|FG005|Induction|Death|6|||
162707397|NCT00049517|587638218|FG000|Induction|Withdrawal by Subject|0|||
162707398|NCT00049517|587638219|FG001|Induction|Withdrawal by Subject|0|||
162707399|NCT00049517|587638220|FG002|Induction|Withdrawal by Subject|0|||
162707400|NCT00049517|587638221|FG003|Induction|Withdrawal by Subject|0|||
162707401|NCT00049517|587638222|FG004|Induction|Withdrawal by Subject|1|||
162707402|NCT00049517|587638223|FG005|Induction|Withdrawal by Subject|3|||
162707403|NCT00049517|587638218|FG000|Induction|Alternative therapy|0|||
162707404|NCT00049517|587638219|FG001|Induction|Alternative therapy|0|||
162707405|NCT00049517|587638220|FG002|Induction|Alternative therapy|0|||
162707406|NCT00049517|587638221|FG003|Induction|Alternative therapy|0|||
162707407|NCT00049517|587638222|FG004|Induction|Alternative therapy|2|||
162707408|NCT00049517|587638223|FG005|Induction|Alternative therapy|2|||
162707409|NCT00049517|587638218|FG000|Induction|Other complicating disease|0|||
162707410|NCT00049517|587638219|FG001|Induction|Other complicating disease|0|||
162707411|NCT00049517|587638220|FG002|Induction|Other complicating disease|0|||
162707412|NCT00049517|587638221|FG003|Induction|Other complicating disease|0|||
162707413|NCT00049517|587638222|FG004|Induction|Other complicating disease|3|||
162707414|NCT00049517|587638223|FG005|Induction|Other complicating disease|0|||
162707415|NCT00049517|587638218|FG000|Induction|Reasons not reported|0|||
162707416|NCT00049517|587638219|FG001|Induction|Reasons not reported|0|||
162707417|NCT00049517|587638220|FG002|Induction|Reasons not reported|0|||
162707418|NCT00049517|587638221|FG003|Induction|Reasons not reported|0|||
162707419|NCT00049517|587638222|FG004|Induction|Reasons not reported|22|||
162707420|NCT00049517|587638223|FG005|Induction|Reasons not reported|25|||
162707421|NCT00049517|587638218|FG000|Conditioning/Transplant|Disease progression|14|||
162707422|NCT00049517|587638219|FG001|Conditioning/Transplant|Disease progression|6|||
162707423|NCT00049517|587638220|FG002|Conditioning/Transplant|Disease progression|10|||
162707424|NCT00049517|587638221|FG003|Conditioning/Transplant|Disease progression|6|||
162707425|NCT00049517|587638222|FG004|Conditioning/Transplant|Disease progression|0|||
162707426|NCT00049517|587638223|FG005|Conditioning/Transplant|Disease progression|0|||
162707427|NCT00049517|587638218|FG000|Conditioning/Transplant|Adverse Event|2|||
162707428|NCT00049517|587638219|FG001|Conditioning/Transplant|Adverse Event|1|||
162707429|NCT00049517|587638220|FG002|Conditioning/Transplant|Adverse Event|4|||
162707430|NCT00049517|587638221|FG003|Conditioning/Transplant|Adverse Event|8|||
162707431|NCT00049517|587638222|FG004|Conditioning/Transplant|Adverse Event|0|||
162707432|NCT00049517|587638223|FG005|Conditioning/Transplant|Adverse Event|0|||
162707433|NCT00049517|587638218|FG000|Conditioning/Transplant|Death|1|||
162707434|NCT00049517|587638219|FG001|Conditioning/Transplant|Death|0|||
162707435|NCT00049517|587638220|FG002|Conditioning/Transplant|Death|0|||
162707436|NCT00049517|587638221|FG003|Conditioning/Transplant|Death|2|||
162707437|NCT00049517|587638222|FG004|Conditioning/Transplant|Death|0|||
162707438|NCT00049517|587638223|FG005|Conditioning/Transplant|Death|0|||
162707439|NCT00049517|587638218|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
163048269|NCT03286218|588884747|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
163048270|NCT03286218|588884748|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
162707440|NCT00049517|587638219|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
162707441|NCT00049517|587638220|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
162707442|NCT00049517|587638221|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
162707443|NCT00049517|587638222|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
162707444|NCT00049517|587638223|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
162707445|NCT00049517|587638218|FG000|Conditioning/Transplant|Alternative therapy|4|||
162877374|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877375|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877376|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877377|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877378|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877379|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877380|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877381|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877382|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
162877383|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877384|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877385|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877386|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877387|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877388|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877389|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877390|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877391|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877392|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877393|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877394|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877395|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877396|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
162877397|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877398|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877399|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877400|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877401|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877402|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877403|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877404|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877405|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
162877406|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
162877407|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
162877408|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
162877409|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
162877410|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
162877411|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
162877412|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
162877413|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
162877414|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
162877415|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
162877416|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
162877417|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
162877418|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
162877419|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
162616106|NCT01134731|587311603|FG001|Overall Study|Lost to Follow-up|4|||
162616107|NCT01134731|587311604|FG002|Overall Study|Lost to Follow-up|3|||
162616108|NCT02517866|587311606|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162616109|NCT02517866|587311607|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
162616110|NCT02517866|587311608|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163048271|NCT03286218|588884749|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
163048272|NCT03286218|588884750|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
162616111|NCT02517866|587311606|FG000|Overall Study|Significant Protocol Deviation|4|||
162616112|NCT02517866|587311607|FG001|Overall Study|Significant Protocol Deviation|1|||
162616113|NCT02517866|587311608|FG002|Overall Study|Significant Protocol Deviation|0|||
162616114|NCT02517866|587311606|FG000|Overall Study|Lost to Follow-up|1|||
162616115|NCT02517866|587311607|FG001|Overall Study|Lost to Follow-up|0|||
162616116|NCT02517866|587311608|FG002|Overall Study|Lost to Follow-up|0|||
162616117|NCT02517866|587311606|FG000|Overall Study|Voluntary Withdrawal|2|||
162877420|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
162877421|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
162877422|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
162877423|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
162877424|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
162877425|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
162616118|NCT02517866|587311607|FG001|Overall Study|Voluntary Withdrawal|2|||
162877426|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
162877427|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
162877428|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
162877429|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877430|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877431|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877432|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877433|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877434|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877435|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877436|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877437|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
162877438|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877439|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877440|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877441|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877442|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
162877443|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877444|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877445|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877446|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877447|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877448|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877449|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877450|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877451|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
162877452|NCT02052778|588252935|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877453|NCT02052778|588252936|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877454|NCT02052778|588252937|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877455|NCT02052778|588252938|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877456|NCT02052778|588252939|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877457|NCT02052778|588252940|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
162877458|NCT02052778|588252941|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877459|NCT02052778|588252942|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877460|NCT02052778|588252943|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877461|NCT02052778|588252944|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877462|NCT02052778|588252945|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877463|NCT02052778|588252946|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877464|NCT02052778|588252947|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
162877465|NCT02052778|588252948|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877466|NCT02052778|588252949|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877467|NCT02052778|588252950|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877468|NCT02052778|588252951|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877469|NCT02052778|588252952|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877470|NCT02052778|588252953|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877471|NCT02052778|588252954|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877472|NCT02052778|588252955|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877473|NCT02052778|588252956|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877474|NCT02052778|588252957|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
162877475|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877476|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877477|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877478|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877479|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877480|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877481|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877482|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877483|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877484|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877485|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877486|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877487|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877488|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877489|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
162877490|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
162877491|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
162877492|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
162877493|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
162877494|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
162877495|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
162877496|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
162877497|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
162877498|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877499|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877500|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877501|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877502|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877503|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877504|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877505|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877506|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877507|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877508|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877509|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877510|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877511|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877512|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
162877513|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
162877514|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877515|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
162877516|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
162877517|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
162877518|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
162877519|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
162877520|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
162877521|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877522|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877523|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877524|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877525|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877526|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877527|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877528|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877529|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877530|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877531|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877532|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877533|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877534|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877535|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
162877536|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
162877537|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
162877538|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877539|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
162877540|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
162877541|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877542|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877543|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
162877544|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877545|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877546|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877547|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877548|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877549|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877550|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877551|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877552|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877553|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877554|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877555|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162707446|NCT00049517|587638219|FG001|Conditioning/Transplant|Alternative therapy|4|||
162707447|NCT00049517|587638220|FG002|Conditioning/Transplant|Alternative therapy|2|||
162707448|NCT00049517|587638221|FG003|Conditioning/Transplant|Alternative therapy|1|||
162707449|NCT00049517|587638222|FG004|Conditioning/Transplant|Alternative therapy|1|||
162707450|NCT00049517|587638223|FG005|Conditioning/Transplant|Alternative therapy|0|||
162707451|NCT00049517|587638218|FG000|Conditioning/Transplant|Other complicating disease|2|||
162707452|NCT00049517|587638219|FG001|Conditioning/Transplant|Other complicating disease|0|||
162707453|NCT00049517|587638220|FG002|Conditioning/Transplant|Other complicating disease|0|||
162707454|NCT00049517|587638221|FG003|Conditioning/Transplant|Other complicating disease|4|||
162707455|NCT00049517|587638222|FG004|Conditioning/Transplant|Other complicating disease|0|||
162707456|NCT00049517|587638223|FG005|Conditioning/Transplant|Other complicating disease|1|||
162707457|NCT00049517|587638218|FG000|Conditioning/Transplant|Reasons not reported|25|||
162707458|NCT00049517|587638219|FG001|Conditioning/Transplant|Reasons not reported|31|||
162707459|NCT00049517|587638220|FG002|Conditioning/Transplant|Reasons not reported|18|||
162707460|NCT00049517|587638221|FG003|Conditioning/Transplant|Reasons not reported|15|||
162707461|NCT00049517|587638222|FG004|Conditioning/Transplant|Reasons not reported|5|||
162707462|NCT00049517|587638223|FG005|Conditioning/Transplant|Reasons not reported|5|||
162707463|NCT00852475|587638224|FG000|Overall Study|Lost to Follow-up|3|||
162707464|NCT00852475|587638225|FG001|Overall Study|Lost to Follow-up|4|||
162707465|NCT02373813|587638226|FG000|Run-In Period|Other, Not Specified|5|||
162707466|NCT02373813|587638227|FG001|Run-In Period|Other, Not Specified|0|||
162707467|NCT02373813|587638228|FG002|Run-In Period|Other, Not Specified|0|||
162877556|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877557|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877558|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
162877559|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
162877560|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877561|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877562|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877563|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877564|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877565|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877566|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162877567|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877568|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877569|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877570|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877571|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
163048273|NCT03286218|588884739|FG000|Qualification Phase Period 2|Protocol Violation|2|||
163048274|NCT03286218|588884740|FG001|Qualification Phase Period 2|Protocol Violation|0|||
163048275|NCT03286218|588884741|FG002|Qualification Phase Period 2|Protocol Violation|0|||
163048276|NCT03286218|588884742|FG003|Qualification Phase Period 2|Protocol Violation|0|||
163048277|NCT03286218|588884743|FG004|Qualification Phase Period 2|Protocol Violation|0|||
163048278|NCT03286218|588884744|FG005|Qualification Phase Period 2|Protocol Violation|0|||
163048279|NCT03286218|588884745|FG006|Qualification Phase Period 2|Protocol Violation|0|||
163048280|NCT03286218|588884746|FG007|Qualification Phase Period 2|Protocol Violation|0|||
163048281|NCT03286218|588884747|FG008|Qualification Phase Period 2|Protocol Violation|0|||
163048282|NCT03286218|588884748|FG009|Qualification Phase Period 2|Protocol Violation|0|||
163048283|NCT03286218|588884749|FG010|Qualification Phase Period 2|Protocol Violation|0|||
162877572|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877573|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877574|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877575|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877576|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877577|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877578|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877579|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877580|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877581|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
162877582|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
162877583|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877584|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877585|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877586|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
162877587|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877588|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877589|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
162877590|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
162877591|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
162877592|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
162877593|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
162877594|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
162877595|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
162877596|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
162877597|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
162877598|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
162877599|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
162877600|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
162877601|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
162877602|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
162877603|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
162877604|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
162877605|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
162877606|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
162877607|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
162877608|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
162877609|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
162877610|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
162877611|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
162877612|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
162877613|NCT02052778|588252935|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877614|NCT02052778|588252936|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877615|NCT02052778|588252937|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877616|NCT02052778|588252938|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877617|NCT02052778|588252939|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877618|NCT02052778|588252940|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163048284|NCT03286218|588884750|FG011|Qualification Phase Period 2|Protocol Violation|0|||
163048285|NCT03286218|588884739|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
163048286|NCT03286218|588884740|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
162877619|NCT02052778|588252941|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877620|NCT02052778|588252942|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877621|NCT02052778|588252943|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877622|NCT02052778|588252944|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877623|NCT02052778|588252945|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877624|NCT02052778|588252946|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877625|NCT02052778|588252947|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877626|NCT02052778|588252948|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877627|NCT02052778|588252949|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
162877628|NCT02052778|588252950|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
162877629|NCT02052778|588252951|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
162877630|NCT02052778|588252952|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877631|NCT02052778|588252953|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
162877632|NCT02052778|588252954|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877633|NCT02052778|588252955|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877634|NCT02052778|588252956|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877635|NCT02052778|588252957|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
162877636|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877637|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877638|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877639|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877640|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877641|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877642|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877643|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877644|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877645|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877646|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877647|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877648|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877649|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877650|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877651|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877652|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877653|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877654|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877655|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877656|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877657|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
162877658|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
162877659|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877660|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877661|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877662|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877663|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877664|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877665|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877666|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877667|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877668|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877669|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877670|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877671|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877672|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877673|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877674|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877675|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162707468|NCT02373813|587638229|FG003|Run-In Period|Other, Not Specified|0|||
162877676|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877677|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877678|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877679|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162961718|NCT00112437|588560747|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961719|NCT00112437|588560748|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961720|NCT00112437|588560749|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162877680|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
162877681|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
162877682|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877683|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877684|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877685|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877686|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877687|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877688|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877689|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877690|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877691|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877692|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877693|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877694|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877695|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877696|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877697|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877698|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877699|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877700|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877701|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162616119|NCT02517866|587311608|FG002|Overall Study|Voluntary Withdrawal|0|||
162616120|NCT02517866|587311606|FG000|Overall Study|Investigator Decision|2|||
162616121|NCT02517866|587311607|FG001|Overall Study|Investigator Decision|1|||
162616122|NCT02517866|587311608|FG002|Overall Study|Investigator Decision|0|||
162616123|NCT02517866|587311606|FG000|Overall Study|Reason not specified|2|||
162616124|NCT02517866|587311607|FG001|Overall Study|Reason not specified|0|||
162616125|NCT02517866|587311608|FG002|Overall Study|Reason not specified|0|||
162616126|NCT03114488|587311609|FG000|Time Period 2|Withdrawal by Subject|1|||
162616127|NCT03114488|587311610|FG001|Time Period 2|Withdrawal by Subject|3|||
162616128|NCT03711266|587311612|FG000|Overall Study|Lost to Follow-up|10|||
162616129|NCT01646073|587311615|FG000|Period A (12 Weeks)|Adverse Event|0|||
162616130|NCT01646073|587311616|FG001|Period A (12 Weeks)|Adverse Event|2|||
162616131|NCT01646073|587311615|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
162616132|NCT01646073|587311616|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
162616133|NCT01646073|587311615|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
162616134|NCT01646073|587311616|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
162616135|NCT01646073|587311615|FG000|Period A (12 Weeks)|Protocol Violation|0|||
162616136|NCT01646073|587311616|FG001|Period A (12 Weeks)|Protocol Violation|1|||
162616137|NCT01646073|587311615|FG000|Period A (12 Weeks)|Other|0|||
162616138|NCT01646073|587311616|FG001|Period A (12 Weeks)|Other|1|||
162877702|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877703|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
162877704|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
162877705|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877706|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877707|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877708|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877709|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162961721|NCT00112437|588560750|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961722|NCT00112437|588560751|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961723|NCT00112437|588560752|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961724|NCT00112437|588560753|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961725|NCT00112437|588560754|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961726|NCT00112437|588560755|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961727|NCT00112437|588560756|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
162961728|NCT00112437|588560757|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
162961729|NCT00112437|588560758|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961730|NCT00112437|588560759|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961731|NCT00112437|588560760|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961732|NCT00112437|588560761|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961733|NCT00112437|588560762|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961734|NCT00112437|588560763|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961735|NCT00112437|588560764|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961736|NCT00112437|588560765|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
163048287|NCT03286218|588884741|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048288|NCT03286218|588884742|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048289|NCT03286218|588884743|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048290|NCT03286218|588884744|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048291|NCT03286218|588884745|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048292|NCT03286218|588884746|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048293|NCT03286218|588884747|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048294|NCT03286218|588884748|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048295|NCT03286218|588884749|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048296|NCT03286218|588884750|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
163048297|NCT03286218|588884739|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
162707469|NCT02373813|587638226|FG000|Run-In Period|Withdrawal by Subject|16|||
162707470|NCT02373813|587638227|FG001|Run-In Period|Withdrawal by Subject|0|||
162707471|NCT02373813|587638228|FG002|Run-In Period|Withdrawal by Subject|0|||
162707472|NCT02373813|587638229|FG003|Run-In Period|Withdrawal by Subject|0|||
162707473|NCT02373813|587638226|FG000|Run-In Period|Decision by Sponsor|11|||
162707474|NCT02373813|587638227|FG001|Run-In Period|Decision by Sponsor|0|||
162707475|NCT02373813|587638228|FG002|Run-In Period|Decision by Sponsor|0|||
162707476|NCT02373813|587638229|FG003|Run-In Period|Decision by Sponsor|0|||
162707477|NCT02373813|587638226|FG000|Run-In Period|Protocol Violation|75|||
162707478|NCT02373813|587638227|FG001|Run-In Period|Protocol Violation|0|||
162707479|NCT02373813|587638228|FG002|Run-In Period|Protocol Violation|0|||
162707480|NCT02373813|587638229|FG003|Run-In Period|Protocol Violation|0|||
162707481|NCT02373813|587638226|FG000|Run-In Period|Lost to Follow-up|2|||
162707482|NCT02373813|587638227|FG001|Run-In Period|Lost to Follow-up|0|||
162707483|NCT02373813|587638228|FG002|Run-In Period|Lost to Follow-up|0|||
162707484|NCT02373813|587638229|FG003|Run-In Period|Lost to Follow-up|0|||
162707485|NCT02373813|587638226|FG000|Run-In Period|Adverse Event|3|||
162707486|NCT02373813|587638227|FG001|Run-In Period|Adverse Event|0|||
162707487|NCT02373813|587638228|FG002|Run-In Period|Adverse Event|0|||
162707488|NCT02373813|587638229|FG003|Run-In Period|Adverse Event|0|||
162707489|NCT02373813|587638226|FG000|Run-In Period|Noncompliance|1|||
162707490|NCT02373813|587638227|FG001|Run-In Period|Noncompliance|0|||
162707491|NCT02373813|587638228|FG002|Run-In Period|Noncompliance|0|||
162707492|NCT02373813|587638229|FG003|Run-In Period|Noncompliance|0|||
162707493|NCT02373813|587638226|FG000|Run-In Period|Ineligibility Determined|3|||
162707494|NCT02373813|587638227|FG001|Run-In Period|Ineligibility Determined|0|||
162707495|NCT02373813|587638228|FG002|Run-In Period|Ineligibility Determined|0|||
162707496|NCT02373813|587638229|FG003|Run-In Period|Ineligibility Determined|0|||
162707497|NCT02373813|587638226|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
162707498|NCT02373813|587638227|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
162707499|NCT02373813|587638228|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
162707500|NCT02373813|587638229|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
162707501|NCT02373813|587638226|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162707502|NCT02373813|587638227|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
162877710|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877711|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877712|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877713|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877714|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877715|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877716|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877717|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877718|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877719|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877720|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877721|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877722|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877723|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877724|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877725|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877726|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
162877727|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
162877728|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877729|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877730|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877731|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162707503|NCT02373813|587638228|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
162707504|NCT02373813|587638229|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
162707505|NCT02373813|587638226|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162877732|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877733|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877734|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877735|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877736|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877737|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877738|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877739|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877740|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877741|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877742|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877743|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877744|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877745|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877746|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877747|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877748|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877749|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
162877750|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
162877751|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
162877752|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
162877753|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
162877754|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
162877755|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
162877756|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
162877757|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
162877758|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
162877759|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
162877760|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
162877761|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
162877762|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
162877763|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
162877764|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
162877765|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
162877766|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
162877767|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
162877768|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
162877769|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
162877770|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
162877771|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
162877772|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
162877773|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
162877774|NCT02052778|588252935|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877775|NCT02052778|588252936|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877776|NCT02052778|588252937|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877777|NCT02052778|588252938|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877778|NCT02052778|588252939|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877779|NCT02052778|588252940|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877780|NCT02052778|588252941|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877781|NCT02052778|588252942|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877782|NCT02052778|588252943|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877783|NCT02052778|588252944|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877784|NCT02052778|588252945|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877785|NCT02052778|588252946|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877786|NCT02052778|588252947|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877787|NCT02052778|588252948|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877788|NCT02052778|588252949|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877789|NCT02052778|588252950|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877790|NCT02052778|588252951|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877791|NCT02052778|588252952|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877792|NCT02052778|588252953|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877793|NCT02052778|588252954|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877794|NCT02052778|588252955|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
162877795|NCT02052778|588252956|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
162961737|NCT00112437|588560766|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961738|NCT00112437|588560767|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162877796|NCT02052778|588252957|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
162877797|NCT01994226|588252960|FG000|Overall Study|Protocol Violation|13|||
162961739|NCT00112437|588560768|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162877798|NCT01994226|588252961|FG001|Overall Study|Protocol Violation|10|||
163048298|NCT03286218|588884740|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048299|NCT03286218|588884741|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048300|NCT03286218|588884742|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048301|NCT03286218|588884743|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048302|NCT03286218|588884744|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048303|NCT03286218|588884745|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048304|NCT03286218|588884746|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048305|NCT03286218|588884747|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048306|NCT03286218|588884748|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048307|NCT03286218|588884749|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
163048308|NCT03286218|588884750|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
163048309|NCT03286218|588884739|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048310|NCT03286218|588884740|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048311|NCT03286218|588884741|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048312|NCT03286218|588884742|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048313|NCT03286218|588884743|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048314|NCT03286218|588884744|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048315|NCT03286218|588884745|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
162616139|NCT01646073|587311615|FG000|Period B (12 Weeks)|Adverse Event|0|||
162616140|NCT01646073|587311616|FG001|Period B (12 Weeks)|Adverse Event|7|||
162616141|NCT01646073|587311615|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
162616142|NCT01646073|587311616|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
162616143|NCT01646073|587311615|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
162616144|NCT01646073|587311616|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
162616145|NCT00679055|587311619|FG000|Overall Study|Adverse Event|0|||
163048316|NCT03286218|588884746|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048317|NCT03286218|588884747|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048318|NCT03286218|588884748|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048319|NCT03286218|588884749|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
163048320|NCT03286218|588884750|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
163048321|NCT00165503|588884753|FG000|Overall Study|Death|1|||
162707506|NCT02373813|587638227|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
162707507|NCT02373813|587638228|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
162707508|NCT02373813|587638229|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162707509|NCT02373813|587638226|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162707510|NCT02373813|587638227|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
162707511|NCT02373813|587638228|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
162707512|NCT02373813|587638229|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
162707513|NCT02788656|587638230|FG000|Overall Study|Withdrawal by Subject|1|||
162877799|NCT01994226|588252960|FG000|Overall Study|Early Cessation of treatment|6|||
163048322|NCT00165503|588884753|FG000|Overall Study|Lost to Follow-up|12|||
163048323|NCT00165503|588884753|FG000|Overall Study|Unresectable|3|||
162616146|NCT00679055|587311620|FG001|Overall Study|Adverse Event|1|||
162616147|NCT00679055|587311619|FG000|Overall Study|Other|0|||
162616148|NCT00679055|587311620|FG001|Overall Study|Other|3|||
162616149|NCT00679055|587311619|FG000|Overall Study|Study Terminated|2|||
162616150|NCT00679055|587311620|FG001|Overall Study|Study Terminated|1|||
162616151|NCT00629772|587311621|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
162616152|NCT00629772|587311622|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
162616153|NCT00629772|587311621|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
162616154|NCT00629772|587311622|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
162616155|NCT01393301|587311625|FG000|Overall Study|Lost to Follow-up|5|||
162616156|NCT01393301|587311626|FG001|Overall Study|Lost to Follow-up|3|||
162616157|NCT01393301|587311625|FG000|Overall Study|Withdrawal by Subject|2|||
162616158|NCT01393301|587311626|FG001|Overall Study|Withdrawal by Subject|0|||
162616159|NCT01393301|587311625|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
162616160|NCT01393301|587311626|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
162616161|NCT03342963|587311629|FG000|Overall Study|Adverse Event|1|||
162616162|NCT03342963|587311630|FG001|Overall Study|Adverse Event|2|||
162616163|NCT03342963|587311631|FG002|Overall Study|Adverse Event|0|||
162616164|NCT03342963|587311632|FG003|Overall Study|Adverse Event|0|||
162616165|NCT03342963|587311629|FG000|Overall Study|Withdrawal by Subject|1|||
162616166|NCT03342963|587311630|FG001|Overall Study|Withdrawal by Subject|0|||
162616167|NCT03342963|587311631|FG002|Overall Study|Withdrawal by Subject|0|||
162616168|NCT03342963|587311632|FG003|Overall Study|Withdrawal by Subject|0|||
162616169|NCT01309165|587311633|FG000|Overall Study|Lost to Follow-up|4|||
162616170|NCT01309165|587311634|FG001|Overall Study|Lost to Follow-up|3|||
162616171|NCT01309165|587311633|FG000|Overall Study|Return to work|1|||
162616172|NCT01309165|587311634|FG001|Overall Study|Return to work|2|||
163048324|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Death|20|||
162616173|NCT01309165|587311633|FG000|Overall Study|Left country|0|||
162616174|NCT01309165|587311634|FG001|Overall Study|Left country|1|||
162616175|NCT01309165|587311633|FG000|Overall Study|No transportation|0|||
162616176|NCT01309165|587311634|FG001|Overall Study|No transportation|1|||
162877800|NCT01994226|588252961|FG001|Overall Study|Early Cessation of treatment|11|||
162877801|NCT02488551|588252962|FG000|Overall Study|Lost to Follow-up|4|||
162877802|NCT02488551|588252963|FG001|Overall Study|Lost to Follow-up|7|||
162877803|NCT02488551|588252964|FG002|Overall Study|Lost to Follow-up|0|||
162877804|NCT02488551|588252965|FG003|Overall Study|Lost to Follow-up|0|||
162877805|NCT02488551|588252962|FG000|Overall Study|Military Deployment|1|||
162877806|NCT02488551|588252963|FG001|Overall Study|Military Deployment|1|||
162877807|NCT02488551|588252964|FG002|Overall Study|Military Deployment|0|||
162877808|NCT02488551|588252965|FG003|Overall Study|Military Deployment|0|||
162877809|NCT00436566|588252966|FG000|Overall Study|Withdrawal by Subject|2|||
162877810|NCT00436566|588252966|FG000|Overall Study|Protocol Violation|1|||
162877811|NCT01980706|588252967|FG000|Overall Study|Withdrawal by Subject|9|||
162877812|NCT01980706|588252968|FG001|Overall Study|Withdrawal by Subject|6|||
162877813|NCT01980706|588252969|FG002|Overall Study|Withdrawal by Subject|2|||
162877814|NCT01980706|588252967|FG000|Overall Study|Adverse Event|1|||
162877815|NCT01980706|588252968|FG001|Overall Study|Adverse Event|2|||
162877816|NCT01980706|588252969|FG002|Overall Study|Adverse Event|5|||
162877817|NCT01980706|588252967|FG000|Overall Study|Lost to Follow-up|3|||
162877818|NCT01980706|588252968|FG001|Overall Study|Lost to Follow-up|4|||
162877819|NCT01980706|588252969|FG002|Overall Study|Lost to Follow-up|3|||
162877820|NCT01980706|588252967|FG000|Overall Study|miscellaneous|4|||
162877821|NCT01980706|588252968|FG001|Overall Study|miscellaneous|5|||
162877822|NCT01980706|588252969|FG002|Overall Study|miscellaneous|3|||
162877823|NCT02546674|588252970|FG000|Overall Study|Adverse Event|19|||
162877824|NCT02546674|588252970|FG000|Overall Study|Death|1|||
162877825|NCT02546674|588252970|FG000|Overall Study|Lost to Follow-up|1|||
162877826|NCT02546674|588252970|FG000|Overall Study|Physician Decision|13|||
162877827|NCT02546674|588252970|FG000|Overall Study|Pregnancy|1|||
162877828|NCT02546674|588252970|FG000|Overall Study|Progressive Disease|2|||
162877829|NCT02546674|588252970|FG000|Overall Study|Protocol Deviation|2|||
162877830|NCT02546674|588252970|FG000|Overall Study|Subject/Guardian Decision|6|||
162877831|NCT02546674|588252970|FG000|Overall Study|Withdrawal of Informed Consent|3|||
162877832|NCT02841787|588252980|FG000|Overall Study|Lost to Follow-up|1|||
162877833|NCT02841787|588252981|FG001|Overall Study|Lost to Follow-up|0|||
162877834|NCT02841787|588252982|FG002|Overall Study|Lost to Follow-up|0|||
162877835|NCT02841787|588252980|FG000|Overall Study|Symptoms dropped below threshold|1|||
162877836|NCT02841787|588252981|FG001|Overall Study|Symptoms dropped below threshold|0|||
162877837|NCT02841787|588252982|FG002|Overall Study|Symptoms dropped below threshold|0|||
162877838|NCT02841787|588252980|FG000|Overall Study|Withdrawal by Subject|1|||
162877839|NCT02841787|588252981|FG001|Overall Study|Withdrawal by Subject|4|||
162877840|NCT02841787|588252982|FG002|Overall Study|Withdrawal by Subject|0|||
162877841|NCT01474746|588252983|FG000|Overall Study|Lost to Follow-up|1|||
162877842|NCT01474746|588252984|FG001|Overall Study|Lost to Follow-up|1|||
162877843|NCT01474746|588252983|FG000|Overall Study|Withdrawal by Subject|2|||
162877844|NCT01474746|588252984|FG001|Overall Study|Withdrawal by Subject|1|||
162877845|NCT00524316|588252985|FG000|Overall Study|Withdrawal by Subject|2|||
162877846|NCT00524316|588252985|FG000|Overall Study|Adverse Event|7|||
162877847|NCT00524316|588252985|FG000|Overall Study|Disease Progression|7|||
162877848|NCT01199263|588252986|FG000|Overall Study|Ineligible|0|||
162877849|NCT01199263|588252987|FG001|Overall Study|Ineligible|2|||
162877850|NCT01199263|588252986|FG000|Overall Study|Never Treated|6|||
162877851|NCT01199263|588252987|FG001|Overall Study|Never Treated|0|||
162877852|NCT01687413|588252992|FG000|Overall Study|Withdrawal by Subject|0|||
162877853|NCT01687413|588252993|FG001|Overall Study|Withdrawal by Subject|2|||
162877854|NCT01687413|588252992|FG000|Overall Study|Not eligible|0|||
162877855|NCT01687413|588252993|FG001|Overall Study|Not eligible|2|||
162877856|NCT01687413|588252992|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
162877857|NCT01687413|588252993|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
162877858|NCT00091390|588252995|FG000|Overall Study|Protocol Violation|1|||
162877859|NCT00091390|588252995|FG000|Overall Study|No protocol treatment|3|||
162877860|NCT02349789|588254685|FG000|Overall Study|Withdrawal by Subject|2|||
162877861|NCT01116687|588254686|FG000|Overall Study|Withdrawal by Subject|4|||
162877862|NCT03497429|588254688|FG000|Overall Study|Progressive disease|3|||
162877863|NCT03497429|588254689|FG001|Overall Study|Progressive disease|4|||
162877864|NCT03497429|588254688|FG000|Overall Study|Adverse Event|0|||
162877865|NCT03497429|588254689|FG001|Overall Study|Adverse Event|2|||
162877866|NCT01215734|588254690|FG000|Overall Study|Death|0|||
162877867|NCT01215734|588254691|FG001|Overall Study|Death|1|||
162877868|NCT02622724|588254701|FG000|Overall Study|Death|51|||
162877869|NCT02622724|588254702|FG001|Overall Study|Death|53|||
162877870|NCT02622724|588254701|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
162877871|NCT02622724|588254702|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
162877872|NCT02622724|588254701|FG000|Overall Study|Early termination of study|38|||
162877873|NCT02622724|588254702|FG001|Overall Study|Early termination of study|43|||
162877874|NCT00254293|588254703|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
162877875|NCT00254293|588254704|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
162877876|NCT00254293|588254705|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
162877877|NCT00254293|588254706|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
162877878|NCT00254293|588254707|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
162877879|NCT00254293|588254708|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
162877880|NCT00254293|588254709|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
162877881|NCT00254293|588254703|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877882|NCT00254293|588254704|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877883|NCT00254293|588254705|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
162877884|NCT00254293|588254706|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877885|NCT00254293|588254707|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877886|NCT00254293|588254708|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877887|NCT00254293|588254709|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
162877888|NCT00254293|588254703|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877889|NCT00254293|588254704|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877890|NCT00254293|588254705|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
162877891|NCT00254293|588254706|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877892|NCT00254293|588254707|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877893|NCT00254293|588254708|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877894|NCT00254293|588254709|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
162877895|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Death|0|||
162877896|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Death|0|||
162877897|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Death|1|||
162877898|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Death|0|||
162877899|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Death|0|||
162877900|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Death|0|||
162877901|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Death|0|||
162877902|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
162877903|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
162877904|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
162877905|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
162877906|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
162877907|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
162877908|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
162877909|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
162877910|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
162877911|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
162877912|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
162877913|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
162877914|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
162877915|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
162877916|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877917|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877918|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
162877919|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877920|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877921|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877922|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
162877923|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877924|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877925|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
162877926|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877927|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877928|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877929|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
162877930|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
162877931|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
162877932|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
162877933|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
162877934|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
162877935|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
163048325|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Death|26|||
163048326|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
163048327|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
163048328|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
162877936|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
162877937|NCT00254293|588254703|FG000|LTE Open Label Variable SC Dosing|Other|0|||
163048329|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
163048330|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
162877938|NCT00254293|588254704|FG001|LTE Open Label Variable SC Dosing|Other|0|||
162877939|NCT00254293|588254705|FG002|LTE Open Label Variable SC Dosing|Other|2|||
162877940|NCT00254293|588254706|FG003|LTE Open Label Variable SC Dosing|Other|0|||
162877941|NCT00254293|588254707|FG004|LTE Open Label Variable SC Dosing|Other|0|||
162877942|NCT00254293|588254708|FG005|LTE Open Label Variable SC Dosing|Other|0|||
162877943|NCT00254293|588254709|FG006|LTE Open Label Variable SC Dosing|Other|0|||
162877944|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Death|0|||
162877945|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Death|0|||
162877946|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Death|0|||
162877947|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Death|0|||
162877948|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Death|0|||
162877949|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Death|0|||
162877950|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Death|3|||
162877951|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877952|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877953|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877954|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877955|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877956|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
162877957|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
162877958|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877959|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877960|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877961|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877962|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877963|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
162877964|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
162877965|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877966|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877967|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877968|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877969|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877970|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
162877971|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
162877972|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877973|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877974|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877975|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877976|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877977|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
162877978|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
162877979|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877980|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877981|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877982|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877983|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877984|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
162877985|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
162877986|NCT00254293|588254703|FG000|LTE Open Label Fixed Dosing|Other|0|||
162877987|NCT00254293|588254704|FG001|LTE Open Label Fixed Dosing|Other|0|||
162877988|NCT00254293|588254705|FG002|LTE Open Label Fixed Dosing|Other|0|||
162877989|NCT00254293|588254706|FG003|LTE Open Label Fixed Dosing|Other|0|||
163048331|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
163048332|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
163048333|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
163048334|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
163048335|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
163048336|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
163048337|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
163048338|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
162877990|NCT00254293|588254707|FG004|LTE Open Label Fixed Dosing|Other|0|||
162877991|NCT00254293|588254708|FG005|LTE Open Label Fixed Dosing|Other|0|||
162877992|NCT00254293|588254709|FG006|LTE Open Label Fixed Dosing|Other|1|||
162877993|NCT03544268|588254713|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
163048339|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
162877994|NCT03544268|588254714|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
162877995|NCT04410198|588254715|FG000|Overall Study|Death|10|||
162877996|NCT04410198|588254715|FG000|Overall Study|Withdrawal by Subject|7|||
162877997|NCT04410198|588254715|FG000|Overall Study|Transferred/Relocation|4|||
162877998|NCT04410198|588254715|FG000|Overall Study|Kidney Transplant|9|||
162877999|NCT04410198|588254715|FG000|Overall Study|Adverse Event|4|||
162878000|NCT04410198|588254715|FG000|Overall Study|Physician Decision|2|||
162878001|NCT04410198|588254715|FG000|Overall Study|Other than specified|1|||
162878002|NCT00798655|588254719|FG000|Overall Study|Did not receive at least one dose of pan|2|||
162878003|NCT01332019|588254737|FG000|Overall Study|Was Not Dosed|1|||
162878004|NCT01332019|588254738|FG001|Overall Study|Was Not Dosed|0|||
162878005|NCT01332019|588254737|FG000|Overall Study|Other|16|||
162878006|NCT01332019|588254738|FG001|Overall Study|Other|18|||
162878007|NCT01332019|588254737|FG000|Overall Study|Death|2|||
162878008|NCT01332019|588254738|FG001|Overall Study|Death|1|||
162878009|NCT01332019|588254737|FG000|Overall Study|Physician Decision|4|||
162878010|NCT01332019|588254738|FG001|Overall Study|Physician Decision|3|||
162878011|NCT01332019|588254737|FG000|Overall Study|Withdrawal by Subject|73|||
162878012|NCT01332019|588254738|FG001|Overall Study|Withdrawal by Subject|71|||
162878013|NCT01332019|588254737|FG000|Overall Study|Lost to Follow-up|4|||
162878014|NCT01332019|588254738|FG001|Overall Study|Lost to Follow-up|7|||
162878015|NCT01332019|588254737|FG000|Overall Study|Adverse Event|13|||
162878016|NCT01332019|588254738|FG001|Overall Study|Adverse Event|22|||
162878017|NCT00174785|588254739|FG000|Overall Study|Adverse Event|293|||
162878018|NCT00174785|588254740|FG001|Overall Study|Adverse Event|191|||
162878019|NCT00174785|588254739|FG000|Overall Study|Protocol Violation|14|||
162878020|NCT00174785|588254740|FG001|Overall Study|Protocol Violation|14|||
162878021|NCT00174785|588254739|FG000|Overall Study|Withdrawal by Subject|173|||
162878022|NCT00174785|588254740|FG001|Overall Study|Withdrawal by Subject|175|||
162878023|NCT00174785|588254739|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
162878024|NCT00174785|588254740|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
162878025|NCT00174785|588254739|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
162878026|NCT00174785|588254740|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
162878027|NCT00174785|588254739|FG000|Overall Study|Other prohibited medication|5|||
162878028|NCT00174785|588254740|FG001|Overall Study|Other prohibited medication|3|||
162878029|NCT00174785|588254739|FG000|Overall Study|Family request|6|||
162878030|NCT00174785|588254740|FG001|Overall Study|Family request|8|||
162878031|NCT00174785|588254739|FG000|Overall Study|Not pre-specified/Not coded|56|||
162878032|NCT00174785|588254740|FG001|Overall Study|Not pre-specified/Not coded|70|||
162878033|NCT00120289|588254741|FG000|Overall Study|Death|96|||
162878034|NCT00120289|588254742|FG001|Overall Study|Death|82|||
162878035|NCT00120289|588254741|FG000|Overall Study|Lost to Follow-up|11|||
162878036|NCT00120289|588254742|FG001|Overall Study|Lost to Follow-up|14|||
162878037|NCT00120289|588254741|FG000|Overall Study|Withdrawal by Subject|14|||
162878038|NCT00120289|588254742|FG001|Overall Study|Withdrawal by Subject|13|||
162878039|NCT02179515|588254746|FG000|Overall Study|switched to alternative treatment|0|||
162878040|NCT02179515|588254747|FG001|Overall Study|switched to alternative treatment|1|||
162878041|NCT02179515|588254748|FG002|Overall Study|switched to alternative treatment|1|||
162878042|NCT02179515|588254746|FG000|Overall Study|Death|0|||
162878043|NCT02179515|588254747|FG001|Overall Study|Death|1|||
162878044|NCT02179515|588254748|FG002|Overall Study|Death|1|||
162878045|NCT02179515|588254746|FG000|Overall Study|refused further treatment|0|||
162878046|NCT02179515|588254747|FG001|Overall Study|refused further treatment|3|||
162878047|NCT02179515|588254748|FG002|Overall Study|refused further treatment|4|||
162878048|NCT02179515|588254746|FG000|Overall Study|Disease progression on study|2|||
162878049|NCT02179515|588254747|FG001|Overall Study|Disease progression on study|11|||
162878050|NCT02179515|588254748|FG002|Overall Study|Disease progression on study|8|||
162878051|NCT00782418|588254749|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
162878052|NCT00782418|588254750|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878053|NCT00782418|588254751|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878054|NCT00782418|588254752|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878055|NCT00782418|588254753|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878056|NCT00782418|588254754|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878057|NCT00782418|588254755|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
162878058|NCT00782418|588254749|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
162878059|NCT00782418|588254750|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
162878060|NCT00782418|588254751|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
162878061|NCT00782418|588254752|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
162878062|NCT00782418|588254753|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
162878063|NCT00782418|588254754|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
162878064|NCT00782418|588254755|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
162878065|NCT01718509|588254756|FG000|Overall Study|Lost to Follow-up|18|||
162878066|NCT01718509|588254757|FG001|Overall Study|Lost to Follow-up|15|||
162878067|NCT01718509|588254756|FG000|Overall Study|Withdrawal by Subject|7|||
162878068|NCT01718509|588254757|FG001|Overall Study|Withdrawal by Subject|13|||
162878069|NCT01718509|588254756|FG000|Overall Study|Adverse Event|5|||
162878070|NCT01718509|588254757|FG001|Overall Study|Adverse Event|7|||
162878071|NCT01718509|588254756|FG000|Overall Study|Other|13|||
162878072|NCT01718509|588254757|FG001|Overall Study|Other|11|||
162878073|NCT01718509|588254756|FG000|Overall Study|Protocol Violation|4|||
162878074|NCT01718509|588254757|FG001|Overall Study|Protocol Violation|2|||
162878075|NCT01718509|588254756|FG000|Overall Study|Lack of Efficacy|1|||
162878076|NCT01718509|588254757|FG001|Overall Study|Lack of Efficacy|0|||
162878077|NCT00238303|588254758|FG000|Overall Study|Withdrawal by Subject|11|||
162878078|NCT00238303|588254759|FG001|Overall Study|Withdrawal by Subject|1|||
162878079|NCT00238303|588254760|FG002|Overall Study|Withdrawal by Subject|2|||
162878080|NCT00238303|588254758|FG000|Overall Study|Death|1|||
162878081|NCT00238303|588254759|FG001|Overall Study|Death|0|||
162878082|NCT00238303|588254760|FG002|Overall Study|Death|1|||
162878083|NCT00238303|588254758|FG000|Overall Study|Other Medical Problems|2|||
162878084|NCT00238303|588254759|FG001|Overall Study|Other Medical Problems|0|||
162878085|NCT00238303|588254760|FG002|Overall Study|Other Medical Problems|2|||
162878086|NCT00238303|588254758|FG000|Overall Study|Poor tolerance of study treatment|1|||
162878087|NCT00238303|588254759|FG001|Overall Study|Poor tolerance of study treatment|0|||
162878088|NCT00238303|588254760|FG002|Overall Study|Poor tolerance of study treatment|1|||
162878089|NCT00238303|588254758|FG000|Overall Study|Adverse Event|0|||
162878090|NCT00238303|588254759|FG001|Overall Study|Adverse Event|1|||
162878091|NCT00238303|588254760|FG002|Overall Study|Adverse Event|3|||
162878092|NCT01860534|588254762|FG000|ROP #1|Needed treatment for ROP|0|||
162878093|NCT01860534|588254763|FG001|ROP #1|Needed treatment for ROP|1|||
162878094|NCT01860534|588254762|FG000|ROP #2|discharged prior to ROP #2|1|||
162878095|NCT01860534|588254763|FG001|ROP #2|discharged prior to ROP #2|0|||
162878096|NCT03364673|588254769|FG000|Overall Study|Withdrawal by Subject|2|||
162878097|NCT03364673|588254769|FG000|Overall Study|Injury unrelated to study|3|||
162878098|NCT00779324|588254770|FG000|Overall Study|Lost to Follow-up|2|||
162878099|NCT00779324|588254771|FG001|Overall Study|Lost to Follow-up|1|||
162878100|NCT00779324|588254770|FG000|Overall Study|Withdrawal by Subject|4|||
162878101|NCT00779324|588254771|FG001|Overall Study|Withdrawal by Subject|2|||
162878102|NCT00779324|588254770|FG000|Overall Study|Missed visit|1|||
162878103|NCT00779324|588254771|FG001|Overall Study|Missed visit|1|||
162878104|NCT02207556|588254772|FG000|Overall Study|Physician Decision|1|||
162878105|NCT02207556|588254773|FG001|Overall Study|Physician Decision|0|||
162878106|NCT02207556|588254772|FG000|Overall Study|Withdrawal by Subject|1|||
162878107|NCT02207556|588254773|FG001|Overall Study|Withdrawal by Subject|0|||
162878108|NCT02207556|588254772|FG000|Overall Study|Death|0|||
162878109|NCT02207556|588254773|FG001|Overall Study|Death|5|||
162878110|NCT03558555|588254774|FG000|Overall Study|Lost to Follow-up|2|||
162878111|NCT03558555|588254775|FG001|Overall Study|Lost to Follow-up|1|||
162878112|NCT00194025|588254776|FG000|Overall Study|Adverse Event|1|||
162878113|NCT00194025|588254776|FG000|Overall Study|non-adherence with study medication|4|||
162878114|NCT01199055|588254785|FG000|Overall Study|Death|0|||
162878115|NCT01199055|588254786|FG001|Overall Study|Death|1|||
162878116|NCT01199055|588254787|FG002|Overall Study|Death|0|||
162878117|NCT01199055|588254785|FG000|Overall Study|Physician Decision|0|||
162878118|NCT01199055|588254786|FG001|Overall Study|Physician Decision|1|||
162878119|NCT01199055|588254787|FG002|Overall Study|Physician Decision|1|||
162878120|NCT01199055|588254785|FG000|Overall Study|Progressive disease|2|||
162878121|NCT01199055|588254786|FG001|Overall Study|Progressive disease|1|||
162878122|NCT01199055|588254787|FG002|Overall Study|Progressive disease|2|||
162878123|NCT01199055|588254785|FG000|Overall Study|Withdrawal by Subject|0|||
162878124|NCT01199055|588254786|FG001|Overall Study|Withdrawal by Subject|0|||
162878125|NCT01199055|588254787|FG002|Overall Study|Withdrawal by Subject|1|||
162961740|NCT00112437|588560769|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961741|NCT00112437|588560770|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961742|NCT00112437|588560771|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162961743|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162878126|NCT00511342|588254788|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
162878127|NCT00511342|588254789|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
162878128|NCT00511342|588254788|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
162878129|NCT00511342|588254789|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
162961744|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961745|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961746|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961747|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961748|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961749|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961750|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162878130|NCT00511342|588254788|FG000|Overall Study|Pregnancy|0|||
162878131|NCT00511342|588254789|FG001|Overall Study|Pregnancy|1|||
162878132|NCT00511342|588254788|FG000|Overall Study|Pregnancy wish|0|||
162878133|NCT00511342|588254789|FG001|Overall Study|Pregnancy wish|1|||
162878134|NCT00511342|588254788|FG000|Overall Study|Lost to Follow-up|1|||
162878135|NCT00511342|588254789|FG001|Overall Study|Lost to Follow-up|5|||
162878136|NCT00511342|588254788|FG000|Overall Study|Other Reason|2|||
162878137|NCT00511342|588254789|FG001|Overall Study|Other Reason|2|||
162878138|NCT02432040|588254790|FG000|Overall Study|Lack of Efficacy|3|||
162878139|NCT02432040|588254791|FG001|Overall Study|Lack of Efficacy|0|||
162878140|NCT02432040|588254790|FG000|Overall Study|Lost to Follow-up|4|||
162878141|NCT02432040|588254791|FG001|Overall Study|Lost to Follow-up|5|||
162878142|NCT02432040|588254790|FG000|Overall Study|Physician Decision|1|||
162878143|NCT02432040|588254791|FG001|Overall Study|Physician Decision|1|||
162878144|NCT00718666|588254792|FG000|Booster Phase Year 5|No active participation request|0|||
162878145|NCT00718666|588254793|FG001|Booster Phase Year 5|No active participation request|0|||
162878146|NCT00718666|588254794|FG002|Booster Phase Year 5|No active participation request|1|||
162878147|NCT00718666|588254792|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
162878148|NCT00718666|588254793|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
162878149|NCT00718666|588254794|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
162878150|NCT00718666|588254792|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
162878151|NCT00718666|588254793|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
162878152|NCT00718666|588254794|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
162878153|NCT00718666|588254792|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
162878154|NCT00718666|588254793|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
162878155|NCT00718666|588254794|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
162878156|NCT02196038|588254795|FG000|Overall Study|Death|16|||
162878157|NCT02196038|588254796|FG001|Overall Study|Death|21|||
162878158|NCT02196038|588254795|FG000|Overall Study|Withdrawal by Subject|0|||
162878159|NCT02196038|588254796|FG001|Overall Study|Withdrawal by Subject|1|||
162878160|NCT02196038|588254795|FG000|Overall Study|Lost to Follow-up|1|||
162878161|NCT02196038|588254796|FG001|Overall Study|Lost to Follow-up|0|||
162878162|NCT01766336|588254806|FG000|Overall Study|Adverse Event|11|||
162878163|NCT01766336|588254807|FG001|Overall Study|Adverse Event|8|||
163048340|NCT00643201|588884754|FG000|Randomized, Completed 6 Months of Study|Other|107|||
162878164|NCT01766336|588254806|FG000|Overall Study|Death|4|||
162878165|NCT01766336|588254807|FG001|Overall Study|Death|3|||
162878166|NCT01766336|588254806|FG000|Overall Study|Lost to Follow-up|1|||
162878167|NCT01766336|588254807|FG001|Overall Study|Lost to Follow-up|3|||
162878168|NCT01766336|588254806|FG000|Overall Study|Physician Decision|4|||
162878169|NCT01766336|588254807|FG001|Overall Study|Physician Decision|2|||
162878170|NCT01766336|588254806|FG000|Overall Study|Protocol Violation|0|||
162878171|NCT01766336|588254807|FG001|Overall Study|Protocol Violation|1|||
162878172|NCT01766336|588254806|FG000|Overall Study|Sponsor Decision|52|||
163048341|NCT00643201|588884755|FG001|Randomized, Completed 6 Months of Study|Other|107|||
163048342|NCT00643201|588884754|FG000|Completed Study Follow Up|Death|28|||
163048343|NCT00643201|588884755|FG001|Completed Study Follow Up|Death|34|||
163048344|NCT00643201|588884754|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
163048345|NCT00643201|588884755|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
163048346|NCT00643201|588884754|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
163048347|NCT00643201|588884755|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
163048348|NCT00643201|588884754|FG000|Completed Study Follow Up|non-specified|1|||
163048349|NCT00643201|588884755|FG001|Completed Study Follow Up|non-specified|0|||
163048350|NCT02346708|588884756|FG000|Overall Study|Adverse Event|2|||
163048351|NCT02346708|588884757|FG001|Overall Study|Adverse Event|0|||
163048352|NCT02346708|588884756|FG000|Overall Study|Protocol Violation|0|||
163048353|NCT02346708|588884757|FG001|Overall Study|Protocol Violation|1|||
163048354|NCT02976519|588884758|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
162878173|NCT01766336|588254807|FG001|Overall Study|Sponsor Decision|43|||
162878174|NCT01766336|588254806|FG000|Overall Study|Withdrawal by Subject|18|||
162878175|NCT01766336|588254807|FG001|Overall Study|Withdrawal by Subject|15|||
162878176|NCT03029650|588254808|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
162878177|NCT03029650|588254809|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
163048355|NCT02976519|588884759|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
163048356|NCT02976519|588884760|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048357|NCT02976519|588884761|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
162878178|NCT03029650|588254808|FG000|Washout (1 Week)|Physician Decision|0|||
162878179|NCT03029650|588254809|FG001|Washout (1 Week)|Physician Decision|1|||
162878180|NCT01814800|588254812|FG000|Overall Study|Adverse Event|2|||
162878181|NCT01814800|588254812|FG000|Overall Study|Pregnancy|1|||
162878182|NCT01814800|588254812|FG000|Overall Study|Sponsor decision|1|||
162878183|NCT01814800|588254812|FG000|Overall Study|Subject relocation|1|||
162878184|NCT02402218|588254813|FG000|Overall Study|Did not pickup study medication|12|||
163048358|NCT02976519|588884762|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163048359|NCT02976519|588884763|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
162878185|NCT02402218|588254814|FG001|Overall Study|Did not pickup study medication|9|||
162878186|NCT02402218|588254815|FG002|Overall Study|Did not pickup study medication|13|||
162878187|NCT02402218|588254813|FG000|Overall Study|Lack of Efficacy|0|||
163048360|NCT02976519|588884764|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
162878188|NCT02402218|588254814|FG001|Overall Study|Lack of Efficacy|1|||
162878189|NCT02402218|588254815|FG002|Overall Study|Lack of Efficacy|1|||
162878190|NCT02402218|588254813|FG000|Overall Study|Death|1|||
162878191|NCT02402218|588254814|FG001|Overall Study|Death|0|||
163048361|NCT02976519|588884758|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048362|NCT02976519|588884759|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048363|NCT02976519|588884760|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048364|NCT02976519|588884761|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
163048365|NCT02976519|588884762|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
162878192|NCT02402218|588254815|FG002|Overall Study|Death|0|||
162878193|NCT02402218|588254813|FG000|Overall Study|Reinfection|0|||
163048366|NCT02976519|588884763|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048367|NCT02976519|588884764|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
163048368|NCT02976519|588884758|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048369|NCT02976519|588884759|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048370|NCT02976519|588884760|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048371|NCT02976519|588884761|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048372|NCT02976519|588884762|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
163048373|NCT02976519|588884763|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
162707514|NCT02788656|587638231|FG001|Overall Study|Withdrawal by Subject|0|||
162707515|NCT03929302|587638236|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
162878194|NCT02402218|588254814|FG001|Overall Study|Reinfection|0|||
162878195|NCT02402218|588254815|FG002|Overall Study|Reinfection|1|||
162878196|NCT02402218|588254813|FG000|Overall Study|Adverse Event|0|||
162878197|NCT02402218|588254814|FG001|Overall Study|Adverse Event|2|||
162878198|NCT02402218|588254815|FG002|Overall Study|Adverse Event|1|||
162878199|NCT02402218|588254813|FG000|Overall Study|Withdrawal by Subject|1|||
162878200|NCT02402218|588254814|FG001|Overall Study|Withdrawal by Subject|1|||
162878201|NCT02402218|588254815|FG002|Overall Study|Withdrawal by Subject|1|||
162878202|NCT03827473|588254816|FG000|Overall Study|Withdrawal by Subject|1|||
162878203|NCT03827473|588254817|FG001|Overall Study|Withdrawal by Subject|0|||
162878204|NCT04436822|588254818|FG000|Overall Study|Physician Decision|2|||
162878205|NCT04436822|588254819|FG001|Overall Study|Physician Decision|0|||
162878206|NCT04436822|588254818|FG000|Overall Study|Sponsor request|1|||
162878207|NCT04436822|588254819|FG001|Overall Study|Sponsor request|0|||
162878208|NCT04436822|588254818|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162878209|NCT04436822|588254819|FG001|Overall Study|Withdrawal by parent/guardian|3|||
162878210|NCT04436822|588254818|FG000|Overall Study|Unsuccessful procedure|0|||
162878211|NCT04436822|588254819|FG001|Overall Study|Unsuccessful procedure|1|||
162878212|NCT04436822|588254818|FG000|Overall Study|Withdrawal due to Covid-19|8|||
162878213|NCT04436822|588254819|FG001|Overall Study|Withdrawal due to Covid-19|1|||
162878214|NCT04436822|588254818|FG000|Overall Study|Withdrawal by Subject|1|||
162878215|NCT04436822|588254819|FG001|Overall Study|Withdrawal by Subject|0|||
162878216|NCT04436822|588254818|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
162878217|NCT04436822|588254819|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
162878218|NCT03807739|588254820|FG000|Overall Study|Adverse Event|1|||
162707516|NCT03929302|587638237|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
162707517|NCT03929302|587638238|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
162707518|NCT03929302|587638236|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
162878219|NCT03807739|588254821|FG001|Overall Study|Adverse Event|0|||
162878220|NCT03807739|588254822|FG002|Overall Study|Adverse Event|0|||
162878221|NCT03807739|588254823|FG003|Overall Study|Adverse Event|0|||
162707519|NCT03929302|587638237|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
162707520|NCT03929302|587638238|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
162878222|NCT03807739|588254820|FG000|Overall Study|Withdrawal by Subject|1|||
162878223|NCT03807739|588254821|FG001|Overall Study|Withdrawal by Subject|0|||
162878224|NCT03807739|588254822|FG002|Overall Study|Withdrawal by Subject|0|||
162878225|NCT03807739|588254823|FG003|Overall Study|Withdrawal by Subject|0|||
162878226|NCT00488033|588254833|FG000|Overall Study|Withdrawal by Subject|1|||
162878227|NCT00488033|588254834|FG001|Overall Study|Withdrawal by Subject|0|||
162878228|NCT00369668|588254835|FG000|Overall Study|Lack of Efficacy|4|||
162878229|NCT00369668|588254836|FG001|Overall Study|Lack of Efficacy|5|||
162878230|NCT00369668|588254837|FG002|Overall Study|Lack of Efficacy|7|||
163048374|NCT02976519|588884764|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
162878231|NCT00303108|588254838|FG000|Overall Study|Adverse Event|5|||
163048375|NCT02976519|588884758|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048376|NCT02976519|588884759|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
162878232|NCT00303108|588254839|FG001|Overall Study|Adverse Event|6|||
162878233|NCT00303108|588254840|FG002|Overall Study|Adverse Event|7|||
162878234|NCT00303108|588254838|FG000|Overall Study|Patient Request|4|||
162878235|NCT00303108|588254839|FG001|Overall Study|Patient Request|2|||
162878236|NCT00303108|588254840|FG002|Overall Study|Patient Request|8|||
162878237|NCT00303108|588254838|FG000|Overall Study|Failed Entry|1|||
162878238|NCT00303108|588254839|FG001|Overall Study|Failed Entry|0|||
162878239|NCT00303108|588254840|FG002|Overall Study|Failed Entry|1|||
162878240|NCT00303108|588254838|FG000|Overall Study|ineligible|2|||
162878241|NCT00303108|588254839|FG001|Overall Study|ineligible|1|||
162878242|NCT00303108|588254840|FG002|Overall Study|ineligible|0|||
163048377|NCT02976519|588884760|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
162878243|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
162878244|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
162878245|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
162878246|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
162878247|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
162878248|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
162878249|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
162878250|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
162878251|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
162878252|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
162878253|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
162878254|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
162878255|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
162878256|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
162878257|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
162878258|NCT03855137|588254843|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
162878259|NCT03855137|588254844|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
162878260|NCT03855137|588254845|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
162878261|NCT03855137|588254843|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
162878262|NCT03855137|588254844|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
162878263|NCT03855137|588254845|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
162878264|NCT03855137|588254843|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
162878265|NCT03855137|588254844|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
162878266|NCT03855137|588254845|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
163048378|NCT02976519|588884761|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048379|NCT02976519|588884762|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163048380|NCT02976519|588884763|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
162878267|NCT03855137|588254843|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
162878268|NCT03855137|588254844|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
162878269|NCT03855137|588254845|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
162878270|NCT03855137|588254843|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
162878271|NCT03855137|588254844|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
162878272|NCT03855137|588254845|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
162878273|NCT02427477|588254846|FG000|Period 1|Adverse Event|1|||
162878274|NCT02427477|588254847|FG001|Period 1|Adverse Event|0|||
162878275|NCT02435277|588254848|FG000|Overall Study|Adverse Event|1|||
162878276|NCT02435277|588254849|FG001|Overall Study|Adverse Event|1|||
162878277|NCT02435277|588254850|FG002|Overall Study|Adverse Event|0|||
162878278|NCT02435277|588254851|FG003|Overall Study|Adverse Event|0|||
162878279|NCT02435277|588254848|FG000|Overall Study|Withdrawal by Subject|1|||
162878280|NCT02435277|588254849|FG001|Overall Study|Withdrawal by Subject|0|||
162878281|NCT02435277|588254850|FG002|Overall Study|Withdrawal by Subject|0|||
162878282|NCT02435277|588254851|FG003|Overall Study|Withdrawal by Subject|0|||
162878283|NCT00444626|588254852|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
162878284|NCT00444626|588254852|FG000|Initial Treatment Period|Adverse Event|1|||
162878285|NCT00444626|588254852|FG000|Initial Treatment Period|Lost to Follow-up|9|||
162878286|NCT00008138|588254855|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
162878287|NCT00008138|588254855|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
162878288|NCT00008138|588254855|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
162878289|NCT00008138|588254855|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
162878290|NCT00008138|588254855|FG000|Interval Debulking|Withdrawal by Subject|2|||
162878291|NCT00008138|588254855|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
162878292|NCT00008138|588254855|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
162878293|NCT00008138|588254855|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
163048381|NCT02976519|588884764|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
162878294|NCT03213626|588254856|FG000|Overall Study|Adverse Event|1|||
162878295|NCT03213626|588254856|FG000|Overall Study|Progressive Disease|6|||
162878296|NCT01005732|588254857|FG000|Overall Study|Lost to Follow-up|10|||
162878297|NCT01005732|588254857|FG000|Overall Study|Death|1|||
162878298|NCT02635737|588254858|FG000|Overall Study|Protocol Violation|1|||
162878299|NCT01552928|588254859|FG000|Period 3|Adverse Event|0|||
162878300|NCT01552928|588254860|FG001|Period 3|Adverse Event|0|||
162878301|NCT01552928|588254861|FG002|Period 3|Adverse Event|1|||
163048382|NCT02976519|588884758|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048383|NCT02976519|588884759|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
162878302|NCT01552928|588254862|FG003|Period 3|Adverse Event|0|||
162878303|NCT04973228|588254865|FG000|Overall Study|Adverse Event|2|||
162878304|NCT04973228|588254866|FG001|Overall Study|Adverse Event|3|||
163048384|NCT02976519|588884760|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
162878305|NCT04973228|588254865|FG000|Overall Study|Lack of Efficacy|1|||
162878306|NCT04973228|588254866|FG001|Overall Study|Lack of Efficacy|3|||
162878307|NCT04973228|588254865|FG000|Overall Study|Lost to Follow-up|12|||
162878308|NCT04973228|588254866|FG001|Overall Study|Lost to Follow-up|4|||
162878309|NCT04973228|588254865|FG000|Overall Study|Withdrawal by Subject|11|||
162878310|NCT04973228|588254866|FG001|Overall Study|Withdrawal by Subject|4|||
162878311|NCT04973228|588254865|FG000|Overall Study|Did not tolerate application|1|||
162878312|NCT04973228|588254866|FG001|Overall Study|Did not tolerate application|0|||
162878313|NCT04973228|588254865|FG000|Overall Study|Wanted to early terminate and use own product|0|||
162878314|NCT04973228|588254866|FG001|Overall Study|Wanted to early terminate and use own product|1|||
162878315|NCT04973228|588254865|FG000|Overall Study|Missed visits due to new work schedule|1|||
162878316|NCT04973228|588254866|FG001|Overall Study|Missed visits due to new work schedule|0|||
162878317|NCT00406640|588254875|FG000|Acute Phase|Adverse Event|18|||
162878318|NCT00406640|588254876|FG001|Acute Phase|Adverse Event|13|||
162878319|NCT00406640|588254875|FG000|Acute Phase|Failed to Return|5|||
162878320|NCT00406640|588254876|FG001|Acute Phase|Failed to Return|1|||
162878321|NCT00406640|588254875|FG000|Acute Phase|Physician Decision|0|||
162878322|NCT00406640|588254876|FG001|Acute Phase|Physician Decision|1|||
162878323|NCT00406640|588254875|FG000|Acute Phase|Lost to Follow-up|7|||
162878324|NCT00406640|588254876|FG001|Acute Phase|Lost to Follow-up|4|||
162878325|NCT00406640|588254875|FG000|Acute Phase|Protocol deviation|4|||
162878326|NCT00406640|588254876|FG001|Acute Phase|Protocol deviation|10|||
162878327|NCT00406640|588254875|FG000|Acute Phase|Protocol Violation|3|||
162878328|NCT00406640|588254876|FG001|Acute Phase|Protocol Violation|2|||
162878329|NCT00406640|588254875|FG000|Acute Phase|Withdrawal by Subject|11|||
162878330|NCT00406640|588254876|FG001|Acute Phase|Withdrawal by Subject|9|||
162878331|NCT00406640|588254875|FG000|Acute Phase|Lack of Efficacy|3|||
162878332|NCT00406640|588254876|FG001|Acute Phase|Lack of Efficacy|3|||
162878333|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
162878334|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
162878335|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Death|1|||
162878336|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Death|0|||
162878337|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
162878338|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
162878339|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
162878340|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
162878341|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
162878342|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
162878343|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|non-compliance|7|||
162878344|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|non-compliance|5|||
162878345|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
162878346|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
162878347|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
162878348|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
162878349|NCT00406640|588254875|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
162878350|NCT00406640|588254876|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
162878351|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
162878352|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
162878353|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
162878354|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
162878355|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
162878356|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
162878357|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
162878358|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
162878359|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
162878360|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
162878361|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
162878362|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
162878363|NCT00406640|588254875|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
162878364|NCT00406640|588254876|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
162878365|NCT02198651|588256698|FG000|Lead-in Period|Withdrew consent|13|||
162878366|NCT02198651|588256699|FG001|Lead-in Period|Withdrew consent|0|||
162878367|NCT02198651|588256700|FG002|Lead-in Period|Withdrew consent|0|||
162878368|NCT02198651|588256701|FG003|Lead-in Period|Withdrew consent|0|||
162878369|NCT02198651|588256702|FG004|Lead-in Period|Withdrew consent|0|||
162878370|NCT02198651|588256698|FG000|Lead-in Period|Adverse Event|2|||
162878371|NCT02198651|588256699|FG001|Lead-in Period|Adverse Event|0|||
162878372|NCT02198651|588256700|FG002|Lead-in Period|Adverse Event|0|||
162878373|NCT02198651|588256701|FG003|Lead-in Period|Adverse Event|0|||
162878374|NCT02198651|588256702|FG004|Lead-in Period|Adverse Event|0|||
162878375|NCT02198651|588256698|FG000|Lead-in Period|Other, not specified|22|||
162878376|NCT02198651|588256699|FG001|Lead-in Period|Other, not specified|0|||
162878377|NCT02198651|588256700|FG002|Lead-in Period|Other, not specified|0|||
162878378|NCT02198651|588256701|FG003|Lead-in Period|Other, not specified|0|||
162878379|NCT02198651|588256702|FG004|Lead-in Period|Other, not specified|0|||
162878380|NCT02198651|588256698|FG000|Double-blind Period|Withdrew consent|0|||
162878381|NCT02198651|588256699|FG001|Double-blind Period|Withdrew consent|4|||
162878382|NCT02198651|588256700|FG002|Double-blind Period|Withdrew consent|0|||
162878383|NCT02198651|588256701|FG003|Double-blind Period|Withdrew consent|0|||
162878384|NCT02198651|588256702|FG004|Double-blind Period|Withdrew consent|0|||
162878385|NCT02198651|588256698|FG000|Double-blind Period|Adverse Event|0|||
162878386|NCT02198651|588256699|FG001|Double-blind Period|Adverse Event|1|||
162878387|NCT02198651|588256700|FG002|Double-blind Period|Adverse Event|0|||
162878388|NCT02198651|588256701|FG003|Double-blind Period|Adverse Event|0|||
162878389|NCT02198651|588256702|FG004|Double-blind Period|Adverse Event|0|||
162878390|NCT02198651|588256698|FG000|Double-blind Period|Other, not specified|0|||
162878391|NCT02198651|588256699|FG001|Double-blind Period|Other, not specified|4|||
162878392|NCT02198651|588256700|FG002|Double-blind Period|Other, not specified|1|||
162878393|NCT02198651|588256701|FG003|Double-blind Period|Other, not specified|0|||
162878394|NCT02198651|588256702|FG004|Double-blind Period|Other, not specified|0|||
162878395|NCT02198651|588256698|FG000|Open-label Rescue Period|Withdrew consent|0|||
162878396|NCT02198651|588256699|FG001|Open-label Rescue Period|Withdrew consent|0|||
162878397|NCT02198651|588256700|FG002|Open-label Rescue Period|Withdrew consent|0|||
162878398|NCT02198651|588256701|FG003|Open-label Rescue Period|Withdrew consent|2|||
162878399|NCT02198651|588256702|FG004|Open-label Rescue Period|Withdrew consent|0|||
162878400|NCT02198651|588256698|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
162878401|NCT02198651|588256699|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
162878402|NCT02198651|588256700|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
162878403|NCT02198651|588256701|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
162878404|NCT02198651|588256702|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
162878405|NCT00786032|588256707|FG000|Overall Study|Death|4|||
162878406|NCT00786032|588256707|FG000|Overall Study|Withdrawal by Subject|14|||
162878407|NCT00786032|588256707|FG000|Overall Study|Did not complete in the timeframe|6|||
162878408|NCT02922634|588256708|FG000|Overall Study|Withdrawal by Subject|5|||
162878409|NCT02922634|588256708|FG000|Overall Study|Did not have their surgery|5|||
162878410|NCT02625324|588256709|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
162878411|NCT02625324|588256709|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
162878412|NCT02625324|588256709|FG000|6-Month Follow-up Subject Accountability|Death|5|||
162878413|NCT02625324|588256709|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
162878414|NCT02625324|588256709|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
162878415|NCT02625324|588256709|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
162878416|NCT02625324|588256709|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
162878417|NCT02625324|588256709|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
162878418|NCT02625324|588256709|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
162878419|NCT02625324|588256709|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
162878420|NCT02625324|588256709|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
162878421|NCT02625324|588256709|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
162878422|NCT02625324|588256709|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
162878423|NCT02625324|588256709|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
162878424|NCT02625324|588256709|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162878425|NCT02625324|588256709|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
162878426|NCT02625324|588256709|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162878427|NCT02457182|588256710|FG000|Overall Study|Lost to Follow-up|1|||
162878428|NCT02457182|588256711|FG001|Overall Study|Lost to Follow-up|0|||
162878429|NCT00352755|588256714|FG000|Overall Study|Physician Decision|1|||
162878430|NCT00352755|588256714|FG000|Overall Study|Adverse Event|1|||
162878431|NCT02397694|588256717|FG000|Double-Blinded Phase|Adverse Event|1|||
162878432|NCT02397694|588256718|FG001|Double-Blinded Phase|Adverse Event|0|||
162878433|NCT02397694|588256717|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
162878434|NCT02397694|588256718|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
162878435|NCT02397694|588256717|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
162878436|NCT02397694|588256718|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
162878437|NCT02397694|588256717|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
162878438|NCT02397694|588256718|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
162878439|NCT02397694|588256717|FG000|Open Label Extension Phase|Protocol Violation|1|||
162878440|NCT02397694|588256718|FG001|Open Label Extension Phase|Protocol Violation|0|||
162878441|NCT02397694|588256717|FG000|Open Label Extension Phase|Withdrew Consent|3|||
162878442|NCT02397694|588256718|FG001|Open Label Extension Phase|Withdrew Consent|1|||
162878443|NCT02397694|588256717|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
162878444|NCT02397694|588256718|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
162878445|NCT00424528|588256719|FG000|Overall Study|Adverse Event|2|||
162878446|NCT00424528|588256720|FG001|Overall Study|Adverse Event|1|||
162878447|NCT00424528|588256721|FG002|Overall Study|Adverse Event|2|||
162878448|NCT00424528|588256719|FG000|Overall Study|Protocol Violation|1|||
162878449|NCT00424528|588256720|FG001|Overall Study|Protocol Violation|1|||
162878450|NCT00424528|588256721|FG002|Overall Study|Protocol Violation|0|||
162878451|NCT00424528|588256719|FG000|Overall Study|Lost to Follow-up|0|||
162878452|NCT00424528|588256720|FG001|Overall Study|Lost to Follow-up|1|||
162878453|NCT00424528|588256721|FG002|Overall Study|Lost to Follow-up|0|||
162878454|NCT00424528|588256719|FG000|Overall Study|noncompliance with study requirements|2|||
162878455|NCT00424528|588256720|FG001|Overall Study|noncompliance with study requirements|1|||
162878456|NCT00424528|588256721|FG002|Overall Study|noncompliance with study requirements|2|||
162878457|NCT02115113|588256722|FG000|Participants in Run-in Period|Death|0|||
162878458|NCT02115113|588256723|FG001|Participants in Run-in Period|Death|0|||
162878459|NCT02115113|588256724|FG002|Participants in Run-in Period|Death|1|||
162878460|NCT02115113|588256722|FG000|Participants in Run-in Period|Administrative problems|0|||
163048385|NCT02976519|588884761|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
162878461|NCT02115113|588256723|FG001|Participants in Run-in Period|Administrative problems|0|||
162878462|NCT02115113|588256724|FG002|Participants in Run-in Period|Administrative problems|1|||
162878463|NCT02115113|588256722|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
162878464|NCT02115113|588256723|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
162878465|NCT02115113|588256724|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
162878466|NCT02115113|588256722|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
162878467|NCT02115113|588256723|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
162878468|NCT02115113|588256724|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
163048386|NCT02976519|588884762|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048387|NCT02976519|588884763|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
163048388|NCT02976519|588884764|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
163048389|NCT01781962|588884767|FG000|Overall Study|Other Miscellaneous Reasons|5|||
163048390|NCT01278342|588884770|FG000|Overall Study|Physician Decision|0|||
163048391|NCT01278342|588884771|FG001|Overall Study|Physician Decision|1|||
163048392|NCT01278342|588884772|FG002|Overall Study|Physician Decision|0|||
163048393|NCT01278342|588884770|FG000|Overall Study|Lost to Follow-up|1|||
162878469|NCT02115113|588256722|FG000|Participants Randomized|Lost to Follow-up|1|||
162878470|NCT02115113|588256723|FG001|Participants Randomized|Lost to Follow-up|0|||
162878471|NCT02115113|588256724|FG002|Participants Randomized|Lost to Follow-up|0|||
162878472|NCT02115113|588256722|FG000|Participants Randomized|Death|1|||
162878473|NCT02115113|588256723|FG001|Participants Randomized|Death|0|||
162878474|NCT02115113|588256724|FG002|Participants Randomized|Death|0|||
162878475|NCT00789191|588256728|FG000|Overall Study|Adverse Event|2|||
162878476|NCT00789191|588256729|FG001|Overall Study|Adverse Event|4|||
162878477|NCT00789191|588256728|FG000|Overall Study|Lack of Efficacy|0|||
162878478|NCT00789191|588256729|FG001|Overall Study|Lack of Efficacy|5|||
162878479|NCT00789191|588256728|FG000|Overall Study|Protocol Violation|5|||
162878480|NCT00789191|588256729|FG001|Overall Study|Protocol Violation|3|||
162878481|NCT00789191|588256728|FG000|Overall Study|Withdrawal Criteria|2|||
162878482|NCT00789191|588256729|FG001|Overall Study|Withdrawal Criteria|4|||
162878483|NCT00789191|588256728|FG000|Overall Study|Unclassified|5|||
162878484|NCT00789191|588256729|FG001|Overall Study|Unclassified|3|||
162878485|NCT01009983|588256730|FG000|Overall Study|necessary scans not completed|1|||
162878486|NCT03137121|588256742|FG000|Overall Study|Withdrawal by Subject|0|||
162878487|NCT03137121|588256743|FG001|Overall Study|Withdrawal by Subject|1|||
162878488|NCT02871401|588256744|FG000|Overall Study|Adverse Event|1|||
162878489|NCT02871401|588256745|FG001|Overall Study|Adverse Event|0|||
162878490|NCT02282982|588256746|FG000|Overall Study|Lost to Follow-up|15|||
162878491|NCT02282982|588256746|FG000|Overall Study|Withdrew consent|2|||
162878492|NCT02282982|588256746|FG000|Overall Study|Death|4|||
162878493|NCT02282982|588256746|FG000|Overall Study|Lack of product|156|||
162878494|NCT02282982|588256746|FG000|Overall Study|Palivizumab is ended|11|||
162878495|NCT02282982|588256746|FG000|Overall Study|Other, not specified|18|||
162878496|NCT02006667|588256747|FG000|Overall Study|Adverse Event|3|||
162878497|NCT02006667|588256747|FG000|Overall Study|Death|2|||
162878498|NCT02006667|588256747|FG000|Overall Study|Withdrawal by Subject|1|||
162878499|NCT02939937|588256748|FG000|Overall Study|Adverse Event|5|||
162878500|NCT02939937|588256749|FG001|Overall Study|Adverse Event|0|||
162878501|NCT02939937|588256748|FG000|Overall Study|Lost to Follow-up|1|||
162878502|NCT02939937|588256749|FG001|Overall Study|Lost to Follow-up|3|||
162878503|NCT00568958|588256751|FG000|Allocation|Withdrawal by Subject|7|||
162878504|NCT00568958|588256752|FG001|Allocation|Withdrawal by Subject|3|||
162878505|NCT00568958|588256751|FG000|Allocation|Physician Decision|2|||
162878506|NCT00568958|588256752|FG001|Allocation|Physician Decision|0|||
162878507|NCT00568958|588256751|FG000|Follow-Up|Withdrawal by Subject|6|||
162878508|NCT00568958|588256752|FG001|Follow-Up|Withdrawal by Subject|6|||
162878509|NCT00568958|588256751|FG000|Follow-Up|Physician Decision|1|||
162878510|NCT00568958|588256752|FG001|Follow-Up|Physician Decision|1|||
162878511|NCT00568958|588256751|FG000|Follow-Up|Family Emergency|1|||
162878512|NCT00568958|588256752|FG001|Follow-Up|Family Emergency|0|||
162878513|NCT00568958|588256751|FG000|Follow-Up|Adverse Event|1|||
162878514|NCT00568958|588256752|FG001|Follow-Up|Adverse Event|0|||
162878515|NCT01911845|588256759|FG000|Overall Study|Adverse Event|2|||
162878516|NCT01911845|588256759|FG000|Overall Study|Lost to Follow-up|1|||
162878517|NCT01911845|588256759|FG000|Overall Study|Other (not specified)|3|||
162878518|NCT01774344|588256760|FG000|Overall Study|Withdrawal by Subject|3|||
162878519|NCT01774344|588256761|FG001|Overall Study|Withdrawal by Subject|10|||
162878520|NCT01774344|588256760|FG000|Overall Study|Protocol Violation|0|||
162878521|NCT01774344|588256761|FG001|Overall Study|Protocol Violation|1|||
162878522|NCT01774344|588256760|FG000|Overall Study|Lost to Follow-up|4|||
162878523|NCT01774344|588256761|FG001|Overall Study|Lost to Follow-up|10|||
162878524|NCT01774344|588256760|FG000|Overall Study|End of survival follow-up not available|2|||
162878525|NCT01774344|588256761|FG001|Overall Study|End of survival follow-up not available|2|||
162878526|NCT01774344|588256760|FG000|Overall Study|Data collection finished|4|||
162878527|NCT01774344|588256761|FG001|Overall Study|Data collection finished|14|||
162878528|NCT01774344|588256760|FG000|Overall Study|Other|0|||
162878529|NCT01774344|588256761|FG001|Overall Study|Other|1|||
162878530|NCT01774344|588256760|FG000|Overall Study|Did not enter Survival Follow up|49|||
162878531|NCT01774344|588256761|FG001|Overall Study|Did not enter Survival Follow up|83|||
162878532|NCT04507867|588256767|FG000|Overall Study|Death|7|||
162878533|NCT04507867|588256768|FG001|Overall Study|Death|1|||
162878534|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
162878535|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878536|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878537|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878538|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878539|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878540|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878541|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878542|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162878543|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
162878544|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878545|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878546|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878547|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878548|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878549|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878550|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878551|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162878552|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
162878553|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878554|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878555|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878556|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878557|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878558|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878559|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878560|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162878561|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
162878562|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878563|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878564|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878565|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878566|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878567|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878568|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878569|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
162878570|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
162878571|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878572|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878573|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878574|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878575|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878576|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878577|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
163048394|NCT01278342|588884771|FG001|Overall Study|Lost to Follow-up|0|||
163048395|NCT01278342|588884772|FG002|Overall Study|Lost to Follow-up|0|||
162878578|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162878579|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
162878580|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878581|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878582|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
163048396|NCT01278342|588884770|FG000|Overall Study|Administrative problems|2|||
163048397|NCT01278342|588884771|FG001|Overall Study|Administrative problems|0|||
162707521|NCT03929302|587638236|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
162878583|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878584|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878585|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878586|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878587|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162878588|NCT02175771|588256771|FG000|Run-In Period (Pre-assignment)|Other|8|||
162878589|NCT02175771|588256772|FG001|Run-In Period (Pre-assignment)|Other|0|||
162878590|NCT02175771|588256773|FG002|Run-In Period (Pre-assignment)|Other|0|||
162878591|NCT02175771|588256774|FG003|Run-In Period (Pre-assignment)|Other|0|||
162878592|NCT02175771|588256775|FG004|Run-In Period (Pre-assignment)|Other|0|||
162878593|NCT02175771|588256776|FG005|Run-In Period (Pre-assignment)|Other|0|||
162878594|NCT02175771|588256777|FG006|Run-In Period (Pre-assignment)|Other|0|||
162878595|NCT02175771|588256778|FG007|Run-In Period (Pre-assignment)|Other|0|||
162878596|NCT02175771|588256779|FG008|Run-In Period (Pre-assignment)|Other|0|||
162878597|NCT02175771|588256771|FG000|Treatment Period|Adverse Event|0|||
162878598|NCT02175771|588256772|FG001|Treatment Period|Adverse Event|2|||
162878599|NCT02175771|588256773|FG002|Treatment Period|Adverse Event|1|||
162878600|NCT02175771|588256774|FG003|Treatment Period|Adverse Event|1|||
162878601|NCT02175771|588256775|FG004|Treatment Period|Adverse Event|1|||
162878602|NCT02175771|588256776|FG005|Treatment Period|Adverse Event|3|||
162878603|NCT02175771|588256777|FG006|Treatment Period|Adverse Event|2|||
162878604|NCT02175771|588256778|FG007|Treatment Period|Adverse Event|0|||
162878605|NCT02175771|588256779|FG008|Treatment Period|Adverse Event|1|||
162878606|NCT02175771|588256771|FG000|Treatment Period|Withdrawal by Subject|0|||
162878607|NCT02175771|588256772|FG001|Treatment Period|Withdrawal by Subject|9|||
162878608|NCT02175771|588256773|FG002|Treatment Period|Withdrawal by Subject|3|||
162878609|NCT02175771|588256774|FG003|Treatment Period|Withdrawal by Subject|6|||
162878610|NCT02175771|588256775|FG004|Treatment Period|Withdrawal by Subject|2|||
162878611|NCT02175771|588256776|FG005|Treatment Period|Withdrawal by Subject|4|||
162878612|NCT02175771|588256777|FG006|Treatment Period|Withdrawal by Subject|2|||
162878613|NCT02175771|588256778|FG007|Treatment Period|Withdrawal by Subject|9|||
162878614|NCT02175771|588256779|FG008|Treatment Period|Withdrawal by Subject|2|||
162878615|NCT02175771|588256771|FG000|Treatment Period|Noncompliance|0|||
162878616|NCT02175771|588256772|FG001|Treatment Period|Noncompliance|1|||
162878617|NCT02175771|588256773|FG002|Treatment Period|Noncompliance|2|||
162878618|NCT02175771|588256774|FG003|Treatment Period|Noncompliance|0|||
162878619|NCT02175771|588256775|FG004|Treatment Period|Noncompliance|0|||
162878620|NCT02175771|588256776|FG005|Treatment Period|Noncompliance|0|||
162878621|NCT02175771|588256777|FG006|Treatment Period|Noncompliance|0|||
162878622|NCT02175771|588256778|FG007|Treatment Period|Noncompliance|0|||
162878623|NCT02175771|588256779|FG008|Treatment Period|Noncompliance|1|||
162878624|NCT02175771|588256771|FG000|Treatment Period|Protocol Violation|0|||
162878625|NCT02175771|588256772|FG001|Treatment Period|Protocol Violation|0|||
162878626|NCT02175771|588256773|FG002|Treatment Period|Protocol Violation|0|||
162878627|NCT02175771|588256774|FG003|Treatment Period|Protocol Violation|0|||
163048398|NCT01278342|588884772|FG002|Overall Study|Administrative problems|0|||
162878628|NCT02175771|588256775|FG004|Treatment Period|Protocol Violation|0|||
162878629|NCT02175771|588256776|FG005|Treatment Period|Protocol Violation|0|||
162878630|NCT02175771|588256777|FG006|Treatment Period|Protocol Violation|0|||
162878631|NCT02175771|588256778|FG007|Treatment Period|Protocol Violation|1|||
162878632|NCT02175771|588256779|FG008|Treatment Period|Protocol Violation|0|||
162878633|NCT02175771|588256771|FG000|Treatment Period|Disease progression|0|||
162878634|NCT02175771|588256772|FG001|Treatment Period|Disease progression|0|||
162878635|NCT02175771|588256773|FG002|Treatment Period|Disease progression|0|||
162878636|NCT02175771|588256774|FG003|Treatment Period|Disease progression|0|||
163048399|NCT01278342|588884770|FG000|Overall Study|Other|1|||
162878637|NCT02175771|588256775|FG004|Treatment Period|Disease progression|0|||
162878638|NCT02175771|588256776|FG005|Treatment Period|Disease progression|0|||
162878639|NCT02175771|588256777|FG006|Treatment Period|Disease progression|0|||
162878640|NCT02175771|588256778|FG007|Treatment Period|Disease progression|2|||
162878641|NCT02175771|588256779|FG008|Treatment Period|Disease progression|0|||
162878642|NCT02175771|588256771|FG000|Treatment Period|Lost to Follow-up|0|||
162878643|NCT02175771|588256772|FG001|Treatment Period|Lost to Follow-up|3|||
162878644|NCT02175771|588256773|FG002|Treatment Period|Lost to Follow-up|1|||
162878645|NCT02175771|588256774|FG003|Treatment Period|Lost to Follow-up|3|||
162878646|NCT02175771|588256775|FG004|Treatment Period|Lost to Follow-up|1|||
162878647|NCT02175771|588256776|FG005|Treatment Period|Lost to Follow-up|2|||
162878648|NCT02175771|588256777|FG006|Treatment Period|Lost to Follow-up|1|||
162878649|NCT02175771|588256778|FG007|Treatment Period|Lost to Follow-up|2|||
162878650|NCT02175771|588256779|FG008|Treatment Period|Lost to Follow-up|2|||
162878651|NCT02175771|588256771|FG000|Treatment Period|Lack of Efficacy|0|||
162878652|NCT02175771|588256772|FG001|Treatment Period|Lack of Efficacy|0|||
162878653|NCT02175771|588256773|FG002|Treatment Period|Lack of Efficacy|0|||
162878654|NCT02175771|588256774|FG003|Treatment Period|Lack of Efficacy|0|||
162878655|NCT02175771|588256775|FG004|Treatment Period|Lack of Efficacy|0|||
162878656|NCT02175771|588256776|FG005|Treatment Period|Lack of Efficacy|1|||
162878657|NCT02175771|588256777|FG006|Treatment Period|Lack of Efficacy|0|||
162878658|NCT02175771|588256778|FG007|Treatment Period|Lack of Efficacy|1|||
162878659|NCT02175771|588256779|FG008|Treatment Period|Lack of Efficacy|0|||
162878660|NCT02175771|588256771|FG000|Treatment Period|Other|0|||
162878661|NCT02175771|588256772|FG001|Treatment Period|Other|1|||
162878662|NCT02175771|588256773|FG002|Treatment Period|Other|0|||
162878663|NCT02175771|588256774|FG003|Treatment Period|Other|3|||
162878664|NCT02175771|588256775|FG004|Treatment Period|Other|1|||
162878665|NCT02175771|588256776|FG005|Treatment Period|Other|0|||
162878666|NCT02175771|588256777|FG006|Treatment Period|Other|0|||
162878667|NCT02175771|588256778|FG007|Treatment Period|Other|2|||
162878668|NCT02175771|588256779|FG008|Treatment Period|Other|0|||
162878669|NCT00502320|588256780|FG000|Overall Study|Lost to Follow-up|1|||
162878670|NCT00502320|588256781|FG001|Overall Study|Lost to Follow-up|1|||
162878671|NCT00502320|588256780|FG000|Overall Study|Withdrew Consent|1|||
162878672|NCT00502320|588256781|FG001|Overall Study|Withdrew Consent|0|||
162878673|NCT00502320|588256780|FG000|Overall Study|No longer met criteria|1|||
162878674|NCT00502320|588256781|FG001|Overall Study|No longer met criteria|0|||
162878675|NCT00502320|588256780|FG000|Overall Study|Screen Failure|0|||
162878676|NCT00502320|588256781|FG001|Overall Study|Screen Failure|1|||
162878677|NCT00502320|588256780|FG000|Overall Study|Adverse Event|3|||
162878678|NCT00502320|588256781|FG001|Overall Study|Adverse Event|5|||
162878679|NCT00543569|588256785|FG000|Overall Study|Death|2|||
162878680|NCT00543569|588256786|FG001|Overall Study|Death|2|||
162878681|NCT00543569|588256787|FG002|Overall Study|Death|3|||
163048400|NCT01278342|588884771|FG001|Overall Study|Other|0|||
163048401|NCT01278342|588884772|FG002|Overall Study|Other|0|||
163048402|NCT00473655|588884780|FG000|Overall Study|Lost to Follow-up|9|||
163048403|NCT00473655|588884781|FG001|Overall Study|Lost to Follow-up|5|||
163048404|NCT00473655|588884782|FG002|Overall Study|Lost to Follow-up|8|||
163048405|NCT04556760|588884790|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048406|NCT04556760|588884791|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
163048407|NCT04556760|588884792|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048408|NCT04556760|588884793|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048409|NCT04556760|588884794|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
163048410|NCT04556760|588884795|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
162878682|NCT00543569|588256788|FG003|Overall Study|Death|1|||
162878683|NCT00543569|588256785|FG000|Overall Study|Lost to Follow-up|0|||
162878684|NCT00543569|588256786|FG001|Overall Study|Lost to Follow-up|0|||
162878685|NCT00543569|588256787|FG002|Overall Study|Lost to Follow-up|1|||
162878686|NCT00543569|588256788|FG003|Overall Study|Lost to Follow-up|1|||
162878687|NCT00543569|588256785|FG000|Overall Study|Miscellaneous Reasons|7|||
162878688|NCT00543569|588256786|FG001|Overall Study|Miscellaneous Reasons|3|||
162878689|NCT00543569|588256787|FG002|Overall Study|Miscellaneous Reasons|11|||
162878690|NCT00543569|588256788|FG003|Overall Study|Miscellaneous Reasons|4|||
162878691|NCT00543569|588256785|FG000|Overall Study|Randomized but never received study drug|3|||
162878692|NCT00543569|588256786|FG001|Overall Study|Randomized but never received study drug|3|||
162878693|NCT00543569|588256787|FG002|Overall Study|Randomized but never received study drug|5|||
162878694|NCT00543569|588256788|FG003|Overall Study|Randomized but never received study drug|3|||
163048411|NCT04556760|588884790|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048412|NCT04556760|588884791|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163058599|NCT00042289|588924239|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
162878695|NCT00862849|588256790|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
162878696|NCT00862849|588256791|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
162878697|NCT00862849|588256792|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
162878698|NCT00862849|588256793|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
162878699|NCT00862849|588256794|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
162878700|NCT00862849|588256795|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
162878701|NCT00862849|588256790|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
162878702|NCT00862849|588256791|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
162878703|NCT00862849|588256792|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
162878704|NCT00862849|588256793|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
162878705|NCT00862849|588256794|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
162878706|NCT00862849|588256795|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
162878707|NCT00617409|588256796|FG000|Overall Study|Withdrawal by Subject|4|||
162878708|NCT00617409|588256797|FG001|Overall Study|Withdrawal by Subject|1|||
162878709|NCT00617409|588256798|FG002|Overall Study|Withdrawal by Subject|2|||
162878710|NCT00617409|588256796|FG000|Overall Study|Adverse Event|0|||
162878711|NCT00617409|588256797|FG001|Overall Study|Adverse Event|2|||
162878712|NCT00617409|588256798|FG002|Overall Study|Adverse Event|3|||
162878713|NCT00617409|588256796|FG000|Overall Study|Disease Progression|8|||
162878714|NCT00617409|588256797|FG001|Overall Study|Disease Progression|8|||
162878715|NCT00617409|588256798|FG002|Overall Study|Disease Progression|18|||
162878716|NCT00617409|588256796|FG000|Overall Study|Death|3|||
162878717|NCT00617409|588256797|FG001|Overall Study|Death|5|||
162878718|NCT00617409|588256798|FG002|Overall Study|Death|4|||
162878719|NCT00617409|588256796|FG000|Overall Study|Alternative Therapy|1|||
162878720|NCT00617409|588256797|FG001|Overall Study|Alternative Therapy|2|||
162878721|NCT00617409|588256798|FG002|Overall Study|Alternative Therapy|0|||
162878722|NCT02124707|588256807|FG000|Overall Study|Adverse Event|5|||
162878723|NCT02124707|588256807|FG000|Overall Study|Physician Decision|1|||
162878724|NCT02124707|588256807|FG000|Overall Study|Death|1|||
162878725|NCT01363713|588256810|FG000|Overall Study|Adverse Event|1|||
162878726|NCT01363713|588256810|FG000|Overall Study|Protocol Violation|3|||
162878727|NCT01363713|588256810|FG000|Overall Study|Withdrawal by Subject|2|||
162878728|NCT04544709|588256814|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
162878729|NCT03135028|588256815|FG000|Overall Study|Death|6|||
162878730|NCT03135028|588256815|FG000|Overall Study|Study Terminated by Sponsor|2|||
162878731|NCT03135028|588256815|FG000|Overall Study|Withdrew Consent|1|||
162878732|NCT00496873|588256816|FG000|Overall Study|Ineligible|2|||
162878733|NCT00496873|588256816|FG000|Overall Study|Death|2|||
162878734|NCT00496873|588256816|FG000|Overall Study|Withdrawal by Subject|3|||
162878735|NCT02065869|588256817|FG000|Overall Study|Death|7|||
162878736|NCT02065869|588256817|FG000|Overall Study|Disease relapse|16|||
162878737|NCT02065869|588256817|FG000|Overall Study|Lost to Follow-up|4|||
162878738|NCT02065869|588256817|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
162878739|NCT02065869|588256817|FG000|Overall Study|Withdrawal by Subject|1|||
162878740|NCT01842620|588256818|FG000|Period 1|Withdrawal by Subject|1|||
162878741|NCT01842620|588256819|FG001|Period 1|Withdrawal by Subject|0|||
162878742|NCT02371759|588256820|FG000|Overall Study|Protocol Violation|3|||
162878743|NCT02371759|588256821|FG001|Overall Study|Protocol Violation|1|||
162878744|NCT02371759|588256822|FG002|Overall Study|Protocol Violation|1|||
162878745|NCT02371759|588256823|FG003|Overall Study|Protocol Violation|0|||
162878746|NCT02371759|588256824|FG004|Overall Study|Protocol Violation|3|||
162878747|NCT02371759|588256825|FG005|Overall Study|Protocol Violation|1|||
162878748|NCT02371759|588256826|FG006|Overall Study|Protocol Violation|0|||
162878749|NCT02371759|588256827|FG007|Overall Study|Protocol Violation|3|||
162878750|NCT02371759|588256820|FG000|Overall Study|Withdrawal by Subject|0|||
162878751|NCT02371759|588256821|FG001|Overall Study|Withdrawal by Subject|0|||
162878752|NCT02371759|588256822|FG002|Overall Study|Withdrawal by Subject|0|||
162961751|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961752|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961753|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961754|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162878753|NCT02371759|588256823|FG003|Overall Study|Withdrawal by Subject|0|||
162878754|NCT02371759|588256824|FG004|Overall Study|Withdrawal by Subject|0|||
162878755|NCT02371759|588256825|FG005|Overall Study|Withdrawal by Subject|0|||
162878756|NCT02371759|588256826|FG006|Overall Study|Withdrawal by Subject|0|||
162878757|NCT02371759|588256827|FG007|Overall Study|Withdrawal by Subject|1|||
162878758|NCT03136185|588256831|FG000|Overall Study|Adverse Event|0|||
162878759|NCT03136185|588256832|FG001|Overall Study|Adverse Event|1|||
162878760|NCT03136185|588256833|FG002|Overall Study|Adverse Event|3|||
162878761|NCT03136185|588256834|FG003|Overall Study|Adverse Event|1|||
162878762|NCT03136185|588256835|FG004|Overall Study|Adverse Event|2|||
162878763|NCT03136185|588256836|FG005|Overall Study|Adverse Event|2|||
162878764|NCT03136185|588256837|FG006|Overall Study|Adverse Event|5|||
162878765|NCT03136185|588256838|FG007|Overall Study|Adverse Event|1|||
162878766|NCT03136185|588256839|FG008|Overall Study|Adverse Event|1|||
162878767|NCT03136185|588256831|FG000|Overall Study|Death|0|||
162878768|NCT03136185|588256832|FG001|Overall Study|Death|0|||
162878769|NCT03136185|588256833|FG002|Overall Study|Death|0|||
162878770|NCT03136185|588256834|FG003|Overall Study|Death|1|||
162878771|NCT03136185|588256835|FG004|Overall Study|Death|1|||
162878772|NCT03136185|588256836|FG005|Overall Study|Death|0|||
162878773|NCT03136185|588256837|FG006|Overall Study|Death|1|||
162878774|NCT03136185|588256838|FG007|Overall Study|Death|0|||
162878775|NCT03136185|588256839|FG008|Overall Study|Death|0|||
162878776|NCT03136185|588256831|FG000|Overall Study|Physician Decision|3|||
162878777|NCT03136185|588256832|FG001|Overall Study|Physician Decision|1|||
162878778|NCT03136185|588256833|FG002|Overall Study|Physician Decision|1|||
162878779|NCT03136185|588256834|FG003|Overall Study|Physician Decision|2|||
162878780|NCT03136185|588256835|FG004|Overall Study|Physician Decision|1|||
162878781|NCT03136185|588256836|FG005|Overall Study|Physician Decision|2|||
162878782|NCT03136185|588256837|FG006|Overall Study|Physician Decision|1|||
162878783|NCT03136185|588256838|FG007|Overall Study|Physician Decision|0|||
162878784|NCT03136185|588256839|FG008|Overall Study|Physician Decision|1|||
162878785|NCT03136185|588256831|FG000|Overall Study|Protocol Defined Disease Progression|0|||
162878786|NCT03136185|588256832|FG001|Overall Study|Protocol Defined Disease Progression|0|||
162878787|NCT03136185|588256833|FG002|Overall Study|Protocol Defined Disease Progression|1|||
162878788|NCT03136185|588256834|FG003|Overall Study|Protocol Defined Disease Progression|0|||
162878789|NCT03136185|588256835|FG004|Overall Study|Protocol Defined Disease Progression|0|||
162878790|NCT03136185|588256836|FG005|Overall Study|Protocol Defined Disease Progression|1|||
162878791|NCT03136185|588256837|FG006|Overall Study|Protocol Defined Disease Progression|0|||
162878792|NCT03136185|588256838|FG007|Overall Study|Protocol Defined Disease Progression|1|||
162878793|NCT03136185|588256839|FG008|Overall Study|Protocol Defined Disease Progression|1|||
162878794|NCT03136185|588256831|FG000|Overall Study|Withdrawal by Subject|1|||
162878795|NCT03136185|588256832|FG001|Overall Study|Withdrawal by Subject|0|||
162878796|NCT03136185|588256833|FG002|Overall Study|Withdrawal by Subject|1|||
162878797|NCT03136185|588256834|FG003|Overall Study|Withdrawal by Subject|1|||
162878798|NCT03136185|588256835|FG004|Overall Study|Withdrawal by Subject|1|||
162878799|NCT03136185|588256836|FG005|Overall Study|Withdrawal by Subject|1|||
162878800|NCT03136185|588256837|FG006|Overall Study|Withdrawal by Subject|2|||
162878801|NCT03136185|588256838|FG007|Overall Study|Withdrawal by Subject|3|||
162878802|NCT03136185|588256839|FG008|Overall Study|Withdrawal by Subject|3|||
162878803|NCT03136185|588256831|FG000|Overall Study|Not Reported|4|||
162878804|NCT03136185|588256832|FG001|Overall Study|Not Reported|1|||
162878805|NCT03136185|588256833|FG002|Overall Study|Not Reported|0|||
162878806|NCT03136185|588256834|FG003|Overall Study|Not Reported|1|||
162878807|NCT03136185|588256835|FG004|Overall Study|Not Reported|0|||
162878808|NCT03136185|588256836|FG005|Overall Study|Not Reported|2|||
162878809|NCT03136185|588256837|FG006|Overall Study|Not Reported|1|||
162878810|NCT03136185|588256838|FG007|Overall Study|Not Reported|1|||
162878811|NCT03136185|588256839|FG008|Overall Study|Not Reported|0|||
162878812|NCT05118386|588256843|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
162878813|NCT05118386|588256844|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
162878814|NCT05118386|588256845|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
162878815|NCT05118386|588256846|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
162878816|NCT05118386|588256847|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
162878817|NCT05118386|588256848|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
162878818|NCT05118386|588256843|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
162878819|NCT05118386|588256844|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
162878820|NCT05118386|588256845|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
162878821|NCT05118386|588256846|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
162878822|NCT05118386|588256847|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
162878823|NCT05118386|588256848|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
162878824|NCT00894413|588256849|FG000|Overall Study|Physician Decision|0|||
162878825|NCT00894413|588256850|FG001|Overall Study|Physician Decision|2|||
162878826|NCT00894413|588256849|FG000|Overall Study|Adverse Event|0|||
162878827|NCT00894413|588256850|FG001|Overall Study|Adverse Event|2|||
162878828|NCT00894413|588256849|FG000|Overall Study|Withdrawal by Subject|0|||
162878829|NCT00894413|588256850|FG001|Overall Study|Withdrawal by Subject|4|||
162878830|NCT01067508|588256857|FG000|Overall Study|Physician Decision|0|||
162878831|NCT01067508|588256858|FG001|Overall Study|Physician Decision|1|||
162878832|NCT01067508|588256857|FG000|Overall Study|Withdrawal by Subject|0|||
162878833|NCT01067508|588256858|FG001|Overall Study|Withdrawal by Subject|1|||
162878834|NCT00632463|588256863|FG000|Overall Study|Adverse Event|0|||
162878835|NCT00632463|588256864|FG001|Overall Study|Adverse Event|1|||
162878836|NCT00632463|588256865|FG002|Overall Study|Adverse Event|0|||
162878837|NCT02065622|588256866|FG000|Induction Study|Adverse Event|13|||
162878838|NCT02065622|588256867|FG001|Induction Study|Adverse Event|19|||
162878839|NCT02065622|588256868|FG002|Induction Study|Adverse Event|0|||
162878840|NCT02065622|588256869|FG003|Induction Study|Adverse Event|0|||
162878841|NCT02065622|588256870|FG004|Induction Study|Adverse Event|0|||
162878842|NCT02065622|588256866|FG000|Induction Study|Withdrawal by Subject|3|||
162878843|NCT02065622|588256867|FG001|Induction Study|Withdrawal by Subject|5|||
162878844|NCT02065622|588256868|FG002|Induction Study|Withdrawal by Subject|0|||
162878845|NCT02065622|588256869|FG003|Induction Study|Withdrawal by Subject|0|||
162878846|NCT02065622|588256870|FG004|Induction Study|Withdrawal by Subject|0|||
162878847|NCT02065622|588256866|FG000|Induction Study|Lost to Follow-up|1|||
162878848|NCT02065622|588256867|FG001|Induction Study|Lost to Follow-up|0|||
162878849|NCT02065622|588256868|FG002|Induction Study|Lost to Follow-up|0|||
162878850|NCT02065622|588256869|FG003|Induction Study|Lost to Follow-up|0|||
162878851|NCT02065622|588256870|FG004|Induction Study|Lost to Follow-up|0|||
162878852|NCT02065622|588256866|FG000|Induction Study|Lack of Efficacy|22|||
162878853|NCT02065622|588256867|FG001|Induction Study|Lack of Efficacy|27|||
162878854|NCT02065622|588256868|FG002|Induction Study|Lack of Efficacy|0|||
162878855|NCT02065622|588256869|FG003|Induction Study|Lack of Efficacy|0|||
162878856|NCT02065622|588256870|FG004|Induction Study|Lack of Efficacy|0|||
162878857|NCT02065622|588256866|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
162878858|NCT02065622|588256867|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
162878859|NCT02065622|588256868|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
162878860|NCT02065622|588256869|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
162878861|NCT02065622|588256870|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
162878862|NCT02065622|588256866|FG000|Induction Study|Subject Noncompliance|1|||
162878863|NCT02065622|588256867|FG001|Induction Study|Subject Noncompliance|1|||
162878864|NCT02065622|588256868|FG002|Induction Study|Subject Noncompliance|0|||
162878865|NCT02065622|588256869|FG003|Induction Study|Subject Noncompliance|0|||
162878866|NCT02065622|588256870|FG004|Induction Study|Subject Noncompliance|0|||
162878867|NCT02065622|588256866|FG000|Induction Study|Other, Not Specified|3|||
162878868|NCT02065622|588256867|FG001|Induction Study|Other, Not Specified|2|||
162878869|NCT02065622|588256868|FG002|Induction Study|Other, Not Specified|0|||
162878870|NCT02065622|588256869|FG003|Induction Study|Other, Not Specified|0|||
162878871|NCT02065622|588256870|FG004|Induction Study|Other, Not Specified|0|||
162878872|NCT02065622|588256866|FG000|Maintenance Study|Adverse Event|0|||
162878873|NCT02065622|588256867|FG001|Maintenance Study|Adverse Event|0|||
162878874|NCT02065622|588256868|FG002|Maintenance Study|Adverse Event|25|||
162878875|NCT02065622|588256869|FG003|Maintenance Study|Adverse Event|22|||
162878876|NCT02065622|588256870|FG004|Maintenance Study|Adverse Event|11|||
162878877|NCT02065622|588256866|FG000|Maintenance Study|Withdrawal by Subject|0|||
162878878|NCT02065622|588256867|FG001|Maintenance Study|Withdrawal by Subject|0|||
162878879|NCT02065622|588256868|FG002|Maintenance Study|Withdrawal by Subject|11|||
162878880|NCT02065622|588256869|FG003|Maintenance Study|Withdrawal by Subject|5|||
162878881|NCT02065622|588256870|FG004|Maintenance Study|Withdrawal by Subject|7|||
162878882|NCT02065622|588256866|FG000|Maintenance Study|Lost to Follow-up|0|||
162878883|NCT02065622|588256867|FG001|Maintenance Study|Lost to Follow-up|0|||
162878884|NCT02065622|588256868|FG002|Maintenance Study|Lost to Follow-up|4|||
162878885|NCT02065622|588256869|FG003|Maintenance Study|Lost to Follow-up|1|||
162878886|NCT02065622|588256870|FG004|Maintenance Study|Lost to Follow-up|1|||
162878887|NCT02065622|588256866|FG000|Maintenance Study|Lack of Efficacy|0|||
162878888|NCT02065622|588256867|FG001|Maintenance Study|Lack of Efficacy|0|||
162878889|NCT02065622|588256868|FG002|Maintenance Study|Lack of Efficacy|70|||
162878890|NCT02065622|588256869|FG003|Maintenance Study|Lack of Efficacy|55|||
162878891|NCT02065622|588256870|FG004|Maintenance Study|Lack of Efficacy|19|||
162878892|NCT02065622|588256866|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
162878893|NCT02065622|588256867|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
162878894|NCT02065622|588256868|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
162878895|NCT02065622|588256869|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
162878896|NCT02065622|588256870|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
162878897|NCT02065622|588256866|FG000|Maintenance Study|Subject Non-Compliance|0|||
162878898|NCT02065622|588256867|FG001|Maintenance Study|Subject Non-Compliance|0|||
162878899|NCT02065622|588256868|FG002|Maintenance Study|Subject Non-Compliance|1|||
162878900|NCT02065622|588256869|FG003|Maintenance Study|Subject Non-Compliance|3|||
162878901|NCT02065622|588256870|FG004|Maintenance Study|Subject Non-Compliance|2|||
162878902|NCT02065622|588256866|FG000|Maintenance Study|Other, Not Specified|0|||
162878903|NCT02065622|588256867|FG001|Maintenance Study|Other, Not Specified|0|||
162878904|NCT02065622|588256868|FG002|Maintenance Study|Other, Not Specified|6|||
162878905|NCT02065622|588256869|FG003|Maintenance Study|Other, Not Specified|14|||
162878906|NCT02065622|588256870|FG004|Maintenance Study|Other, Not Specified|2|||
162878907|NCT02065622|588256866|FG000|Maintenance Study|Unknown Reason|0|||
162878908|NCT02065622|588256867|FG001|Maintenance Study|Unknown Reason|0|||
162878909|NCT02065622|588256868|FG002|Maintenance Study|Unknown Reason|0|||
162878910|NCT02065622|588256869|FG003|Maintenance Study|Unknown Reason|1|||
162878911|NCT02065622|588256870|FG004|Maintenance Study|Unknown Reason|0|||
162878912|NCT00488618|588256879|FG000|Overall Study|Adverse Event|13|||
162878913|NCT00488618|588256880|FG001|Overall Study|Adverse Event|17|||
162878914|NCT00488618|588256879|FG000|Overall Study|Insufficient Therapeutic Response|18|||
162878915|NCT00488618|588256880|FG001|Overall Study|Insufficient Therapeutic Response|11|||
162878916|NCT00488618|588256879|FG000|Overall Study|Protocol Violation|0|||
162878917|NCT00488618|588256880|FG001|Overall Study|Protocol Violation|2|||
162878918|NCT00488618|588256879|FG000|Overall Study|Withdrawal of Consent|15|||
162878919|NCT00488618|588256880|FG001|Overall Study|Withdrawal of Consent|13|||
162878920|NCT00488618|588256879|FG000|Overall Study|Lost to Follow-up|1|||
162878921|NCT00488618|588256880|FG001|Overall Study|Lost to Follow-up|0|||
162878922|NCT00296725|588258983|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
162878923|NCT00296725|588258983|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
162878924|NCT00296725|588258983|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
162878925|NCT00356863|588258984|FG000|Overall Study|Death|16|||
162878926|NCT00356863|588258985|FG001|Overall Study|Death|32|||
162878927|NCT00356863|588258984|FG000|Overall Study|Lost to Follow-up|76|||
162878928|NCT00356863|588258985|FG001|Overall Study|Lost to Follow-up|43|||
162878929|NCT00836277|588258993|FG000|Overall Study|Not evaluable for response|6|||
162878930|NCT00333619|588258994|FG000|Overall Study|Death|12|||
162878931|NCT00333619|588258995|FG001|Overall Study|Death|6|||
162878932|NCT00333619|588258994|FG000|Overall Study|Withdrawal by Subject|6|||
162878933|NCT00333619|588258995|FG001|Overall Study|Withdrawal by Subject|1|||
162878934|NCT00333619|588258994|FG000|Overall Study|Lost to Follow-up|3|||
162878935|NCT00333619|588258995|FG001|Overall Study|Lost to Follow-up|3|||
162878936|NCT00280150|588258996|FG000|Overall Study|Adverse Event|0|||
162878937|NCT00280150|588258997|FG001|Overall Study|Adverse Event|1|||
162878938|NCT00280150|588258998|FG002|Overall Study|Adverse Event|2|||
162878939|NCT00280150|588258999|FG003|Overall Study|Adverse Event|3|||
162878940|NCT00280150|588258996|FG000|Overall Study|Lack of Efficacy|0|||
162878941|NCT00280150|588258997|FG001|Overall Study|Lack of Efficacy|0|||
162878942|NCT00280150|588258998|FG002|Overall Study|Lack of Efficacy|0|||
162878943|NCT00280150|588258999|FG003|Overall Study|Lack of Efficacy|3|||
162878944|NCT00280150|588258996|FG000|Overall Study|Physician Decision|0|||
162878945|NCT00280150|588258997|FG001|Overall Study|Physician Decision|0|||
162878946|NCT00280150|588258998|FG002|Overall Study|Physician Decision|0|||
162878947|NCT00280150|588258999|FG003|Overall Study|Physician Decision|1|||
162878948|NCT00280150|588258996|FG000|Overall Study|Protocol Violation|0|||
162878949|NCT00280150|588258997|FG001|Overall Study|Protocol Violation|0|||
162878950|NCT00280150|588258998|FG002|Overall Study|Protocol Violation|0|||
162878951|NCT00280150|588258999|FG003|Overall Study|Protocol Violation|1|||
162878952|NCT00280150|588258996|FG000|Overall Study|Withdrawal by Subject|0|||
162878953|NCT00280150|588258997|FG001|Overall Study|Withdrawal by Subject|0|||
162878954|NCT00280150|588258998|FG002|Overall Study|Withdrawal by Subject|0|||
162878955|NCT00280150|588258999|FG003|Overall Study|Withdrawal by Subject|1|||
162878956|NCT00280150|588258996|FG000|Overall Study|Did not get consolidation therapy|3|||
162878957|NCT00280150|588258997|FG001|Overall Study|Did not get consolidation therapy|0|||
162878958|NCT00280150|588258998|FG002|Overall Study|Did not get consolidation therapy|3|||
162878959|NCT00280150|588258999|FG003|Overall Study|Did not get consolidation therapy|0|||
162878960|NCT00280150|588258996|FG000|Overall Study|Declining Performance Status|0|||
162878961|NCT00280150|588258997|FG001|Overall Study|Declining Performance Status|0|||
162878962|NCT00280150|588258998|FG002|Overall Study|Declining Performance Status|0|||
162878963|NCT00280150|588258999|FG003|Overall Study|Declining Performance Status|1|||
162878964|NCT05254613|588259003|FG000|Overall Study|Lost to Follow-up|0|||
162878965|NCT05254613|588259004|FG001|Overall Study|Lost to Follow-up|0|||
162878966|NCT05254613|588259005|FG002|Overall Study|Lost to Follow-up|1|||
162878967|NCT01944969|588259007|FG000|Overall Study|Adverse Event|1|||
162878968|NCT01944969|588259007|FG000|Overall Study|Lack of Efficacy|1|||
162878969|NCT01944969|588259007|FG000|Overall Study|Non-compliance with IMP|1|||
162878970|NCT01944969|588259007|FG000|Overall Study|Administrative or other reasons|23|||
162878971|NCT01104584|588259008|FG000|Overall Study|Study drug never administered|21|||
162878972|NCT01104584|588259008|FG000|Overall Study|Study prematurely discontinued|2|||
162878973|NCT02370498|588259009|FG000|Overall Study|Adverse Event|10|||
162878974|NCT02370498|588259010|FG001|Overall Study|Adverse Event|8|||
162878975|NCT02370498|588259009|FG000|Overall Study|Death|263|||
162878976|NCT02370498|588259010|FG001|Overall Study|Death|265|||
162878977|NCT02370498|588259009|FG000|Overall Study|Protocol Violation|1|||
162878978|NCT02370498|588259010|FG001|Overall Study|Protocol Violation|2|||
162878979|NCT02370498|588259009|FG000|Overall Study|Withdrawal by Subject|7|||
163048413|NCT04556760|588884792|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048414|NCT04556760|588884793|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
162878980|NCT02370498|588259010|FG001|Overall Study|Withdrawal by Subject|12|||
162878981|NCT02370498|588259009|FG000|Overall Study|Sponsor's decision|15|||
162878982|NCT02370498|588259010|FG001|Overall Study|Sponsor's decision|9|||
162878983|NCT02387372|588259014|FG000|Overall Study|Not Treated|1|||
162878984|NCT02387372|588259015|FG001|Overall Study|Not Treated|0|||
162878985|NCT01576016|588259016|FG000|Lead Safety|Death|132|||
162878986|NCT01576016|588259017|FG001|Lead Safety|Death|0|||
162878987|NCT01576016|588259016|FG000|Lead Safety|Withdrawal by Subject|81|||
162878988|NCT01576016|588259017|FG001|Lead Safety|Withdrawal by Subject|0|||
162878989|NCT01576016|588259016|FG000|Lead Safety|System Explanted without Replacement|24|||
162878990|NCT01576016|588259017|FG001|Lead Safety|System Explanted without Replacement|0|||
162878991|NCT01576016|588259016|FG000|Lead Safety|Physician Decision|14|||
162878992|NCT01576016|588259017|FG001|Lead Safety|Physician Decision|0|||
162878993|NCT01576016|588259016|FG000|Lead Safety|Lost to Follow-up|13|||
162878994|NCT01576016|588259017|FG001|Lead Safety|Lost to Follow-up|0|||
162878995|NCT01576016|588259016|FG000|Lead Safety|Unsuccessful implant|2|||
162878996|NCT01576016|588259017|FG001|Lead Safety|Unsuccessful implant|0|||
162878997|NCT01576016|588259016|FG000|Lead Safety|Sponsor request|1|||
162878998|NCT01576016|588259017|FG001|Lead Safety|Sponsor request|0|||
162878999|NCT01576016|588259016|FG000|Lead Safety|Device replaced with CRT-D|1|||
162879000|NCT01576016|588259017|FG001|Lead Safety|Device replaced with CRT-D|0|||
162879001|NCT01576016|588259016|FG000|Lead Safety|Patient on Palliative Care|1|||
162879002|NCT01576016|588259017|FG001|Lead Safety|Patient on Palliative Care|0|||
162879003|NCT01576016|588259016|FG000|Lead Safety|Patient noncompliance|1|||
162879004|NCT01576016|588259017|FG001|Lead Safety|Patient noncompliance|0|||
162879005|NCT01576016|588259016|FG000|Lead Safety|Too far from study site|1|||
162879006|NCT01576016|588259017|FG001|Lead Safety|Too far from study site|0|||
162879007|NCT01576016|588259016|FG000|Lead Safety|System deactivated|1|||
162879008|NCT01576016|588259017|FG001|Lead Safety|System deactivated|0|||
162879009|NCT01576016|588259016|FG000|Lead Safety|Patient no longer followed by study PI|1|||
162879010|NCT01576016|588259017|FG001|Lead Safety|Patient no longer followed by study PI|0|||
162879011|NCT01576016|588259016|FG000|MRI Safety|Withdrawal by Subject|0|||
162879012|NCT01576016|588259017|FG001|MRI Safety|Withdrawal by Subject|10|||
162879013|NCT01576016|588259016|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
162879014|NCT01576016|588259017|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
162879015|NCT01576016|588259016|FG000|MRI Safety|Has not yet completed MRI scan|0|||
162879016|NCT01576016|588259017|FG001|MRI Safety|Has not yet completed MRI scan|56|||
162879017|NCT01576016|588259016|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
162879018|NCT01576016|588259017|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
162879019|NCT02504268|588259026|FG000|Overall Study|Adverse Event|18|||
162879020|NCT02504268|588259027|FG001|Overall Study|Adverse Event|8|||
162879021|NCT02504268|588259028|FG002|Overall Study|Adverse Event|14|||
162879022|NCT02504268|588259029|FG003|Overall Study|Adverse Event|0|||
162879023|NCT02504268|588259030|FG004|Overall Study|Adverse Event|0|||
162879024|NCT02504268|588259031|FG005|Overall Study|Adverse Event|0|||
162879025|NCT02504268|588259032|FG006|Overall Study|Adverse Event|0|||
162879026|NCT02504268|588259033|FG007|Overall Study|Adverse Event|0|||
162879027|NCT02504268|588259034|FG008|Overall Study|Adverse Event|0|||
162879028|NCT02504268|588259026|FG000|Overall Study|Withdrawal of Consent|11|||
162879029|NCT02504268|588259027|FG001|Overall Study|Withdrawal of Consent|10|||
162879030|NCT02504268|588259028|FG002|Overall Study|Withdrawal of Consent|3|||
162879031|NCT02504268|588259029|FG003|Overall Study|Withdrawal of Consent|0|||
162879032|NCT02504268|588259030|FG004|Overall Study|Withdrawal of Consent|0|||
162879033|NCT02504268|588259031|FG005|Overall Study|Withdrawal of Consent|0|||
162879034|NCT02504268|588259032|FG006|Overall Study|Withdrawal of Consent|0|||
162879035|NCT02504268|588259033|FG007|Overall Study|Withdrawal of Consent|0|||
162879036|NCT02504268|588259034|FG008|Overall Study|Withdrawal of Consent|0|||
162879037|NCT02504268|588259026|FG000|Overall Study|Pregnancy|2|||
162879038|NCT02504268|588259027|FG001|Overall Study|Pregnancy|0|||
162879039|NCT02504268|588259028|FG002|Overall Study|Pregnancy|0|||
162879040|NCT02504268|588259029|FG003|Overall Study|Pregnancy|0|||
162879041|NCT02504268|588259030|FG004|Overall Study|Pregnancy|0|||
162879042|NCT02504268|588259031|FG005|Overall Study|Pregnancy|0|||
162879043|NCT02504268|588259032|FG006|Overall Study|Pregnancy|0|||
162879044|NCT02504268|588259033|FG007|Overall Study|Pregnancy|0|||
162879045|NCT02504268|588259034|FG008|Overall Study|Pregnancy|0|||
162879046|NCT02504268|588259026|FG000|Overall Study|Lost to Follow-up|3|||
162879047|NCT02504268|588259027|FG001|Overall Study|Lost to Follow-up|6|||
162879048|NCT02504268|588259028|FG002|Overall Study|Lost to Follow-up|4|||
162879049|NCT02504268|588259029|FG003|Overall Study|Lost to Follow-up|0|||
162879050|NCT02504268|588259030|FG004|Overall Study|Lost to Follow-up|0|||
162879051|NCT02504268|588259031|FG005|Overall Study|Lost to Follow-up|0|||
162879052|NCT02504268|588259032|FG006|Overall Study|Lost to Follow-up|0|||
162879053|NCT02504268|588259033|FG007|Overall Study|Lost to Follow-up|0|||
162879054|NCT02504268|588259034|FG008|Overall Study|Lost to Follow-up|0|||
162879055|NCT02504268|588259026|FG000|Overall Study|Death|1|||
162879056|NCT02504268|588259027|FG001|Overall Study|Death|1|||
162879057|NCT02504268|588259028|FG002|Overall Study|Death|0|||
162879058|NCT02504268|588259029|FG003|Overall Study|Death|0|||
162879059|NCT02504268|588259030|FG004|Overall Study|Death|0|||
162879060|NCT02504268|588259031|FG005|Overall Study|Death|0|||
162879061|NCT02504268|588259032|FG006|Overall Study|Death|0|||
162879062|NCT02504268|588259033|FG007|Overall Study|Death|0|||
162879063|NCT02504268|588259034|FG008|Overall Study|Death|0|||
162879064|NCT02504268|588259026|FG000|Overall Study|Subject Request to Discontinue|11|||
162879065|NCT02504268|588259027|FG001|Overall Study|Subject Request to Discontinue|3|||
162879066|NCT02504268|588259028|FG002|Overall Study|Subject Request to Discontinue|6|||
162879067|NCT02504268|588259029|FG003|Overall Study|Subject Request to Discontinue|0|||
162879068|NCT02504268|588259030|FG004|Overall Study|Subject Request to Discontinue|0|||
162707522|NCT03929302|587638237|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
162707523|NCT03929302|587638238|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
162879069|NCT02504268|588259031|FG005|Overall Study|Subject Request to Discontinue|0|||
162879070|NCT02504268|588259032|FG006|Overall Study|Subject Request to Discontinue|0|||
162879071|NCT02504268|588259033|FG007|Overall Study|Subject Request to Discontinue|0|||
162879072|NCT02504268|588259034|FG008|Overall Study|Subject Request to Discontinue|0|||
162879073|NCT02504268|588259026|FG000|Overall Study|No Longer Meets Study Criteria|2|||
162879074|NCT02504268|588259027|FG001|Overall Study|No Longer Meets Study Criteria|3|||
162879075|NCT02504268|588259028|FG002|Overall Study|No Longer Meets Study Criteria|0|||
162879076|NCT02504268|588259029|FG003|Overall Study|No Longer Meets Study Criteria|0|||
162879077|NCT02504268|588259030|FG004|Overall Study|No Longer Meets Study Criteria|0|||
162879078|NCT02504268|588259031|FG005|Overall Study|No Longer Meets Study Criteria|0|||
162879079|NCT02504268|588259032|FG006|Overall Study|No Longer Meets Study Criteria|0|||
162879080|NCT02504268|588259033|FG007|Overall Study|No Longer Meets Study Criteria|0|||
162879081|NCT02504268|588259034|FG008|Overall Study|No Longer Meets Study Criteria|0|||
162879082|NCT02504268|588259026|FG000|Overall Study|Lack of Efficacy|11|||
162879083|NCT02504268|588259027|FG001|Overall Study|Lack of Efficacy|35|||
162879084|NCT02504268|588259028|FG002|Overall Study|Lack of Efficacy|9|||
162879085|NCT02504268|588259029|FG003|Overall Study|Lack of Efficacy|0|||
162879086|NCT02504268|588259030|FG004|Overall Study|Lack of Efficacy|0|||
162879087|NCT02504268|588259031|FG005|Overall Study|Lack of Efficacy|0|||
162879088|NCT02504268|588259032|FG006|Overall Study|Lack of Efficacy|0|||
162879089|NCT02504268|588259033|FG007|Overall Study|Lack of Efficacy|0|||
162879090|NCT02504268|588259034|FG008|Overall Study|Lack of Efficacy|0|||
162879091|NCT02504268|588259026|FG000|Overall Study|Poor/Non-Compliance|3|||
162879092|NCT02504268|588259027|FG001|Overall Study|Poor/Non-Compliance|2|||
162879093|NCT02504268|588259028|FG002|Overall Study|Poor/Non-Compliance|3|||
162879094|NCT02504268|588259029|FG003|Overall Study|Poor/Non-Compliance|0|||
162879095|NCT02504268|588259030|FG004|Overall Study|Poor/Non-Compliance|0|||
162879096|NCT02504268|588259031|FG005|Overall Study|Poor/Non-Compliance|0|||
162879097|NCT02504268|588259032|FG006|Overall Study|Poor/Non-Compliance|0|||
162879098|NCT02504268|588259033|FG007|Overall Study|Poor/Non-Compliance|0|||
162879099|NCT02504268|588259034|FG008|Overall Study|Poor/Non-Compliance|0|||
162879100|NCT02504268|588259026|FG000|Overall Study|Not Disclosed|1|||
162879101|NCT02504268|588259027|FG001|Overall Study|Not Disclosed|0|||
162879102|NCT02504268|588259028|FG002|Overall Study|Not Disclosed|2|||
162879103|NCT02504268|588259029|FG003|Overall Study|Not Disclosed|0|||
162879104|NCT02504268|588259030|FG004|Overall Study|Not Disclosed|0|||
162879105|NCT02504268|588259031|FG005|Overall Study|Not Disclosed|0|||
162879106|NCT02504268|588259032|FG006|Overall Study|Not Disclosed|0|||
162879107|NCT02504268|588259033|FG007|Overall Study|Not Disclosed|0|||
162879108|NCT02504268|588259034|FG008|Overall Study|Not Disclosed|0|||
162879109|NCT03198754|588259039|FG000|Overall Study|Withdrawal by Subject|5|||
162879110|NCT03198754|588259040|FG001|Overall Study|Withdrawal by Subject|4|||
162879111|NCT03198754|588259039|FG000|Overall Study|Lost to Follow-up|4|||
162879112|NCT03198754|588259040|FG001|Overall Study|Lost to Follow-up|3|||
162879113|NCT03198754|588259039|FG000|Overall Study|Ineligible|2|||
162879114|NCT03198754|588259040|FG001|Overall Study|Ineligible|1|||
162879115|NCT03247413|588259046|FG000|Overall Study|Lost to Follow-up|28|||
162879116|NCT00668200|588259047|FG000|Overall Study|Withdrawal by Subject|2|||
162879117|NCT00668200|588259047|FG000|Overall Study|Lost to Follow-up|1|||
162879118|NCT00642746|588259048|FG000|Overall Study|Patient unevaluable|1|||
162879119|NCT00642746|588259049|FG001|Overall Study|Patient unevaluable|0|||
162879120|NCT00424294|588259053|FG000|Overall Study|Adverse Event|4|||
162879121|NCT00424294|588259054|FG001|Overall Study|Adverse Event|10|||
162879122|NCT00424294|588259053|FG000|Overall Study|Lack of Efficacy|2|||
162879123|NCT00424294|588259054|FG001|Overall Study|Lack of Efficacy|1|||
162879124|NCT00424294|588259053|FG000|Overall Study|Withdrawal by Subject|1|||
162879125|NCT00424294|588259054|FG001|Overall Study|Withdrawal by Subject|2|||
162879126|NCT00424294|588259053|FG000|Overall Study|Other|0|||
162879127|NCT00424294|588259054|FG001|Overall Study|Other|2|||
162879128|NCT00424294|588259053|FG000|Overall Study|Randomized but not Treated|1|||
162879129|NCT00424294|588259054|FG001|Overall Study|Randomized but not Treated|0|||
162879130|NCT01496430|588259055|FG000|Overall Study|Adverse Event|0|||
162879131|NCT01496430|588259056|FG001|Overall Study|Adverse Event|0|||
162707524|NCT04454567|587638239|FG000|Overall Study|Study Terminated by Sponsor|1|||
162707525|NCT04454567|587638240|FG001|Overall Study|Study Terminated by Sponsor|1|||
162707526|NCT02757885|587638245|FG000|Overall Study|Screen Failures|4|||
162707527|NCT00664521|587638246|FG000|Overall Study|Adverse Event|4|||
162707528|NCT00664521|587638247|FG001|Overall Study|Adverse Event|1|||
162707529|NCT00664521|587638246|FG000|Overall Study|Lost to Follow-up|1|||
162707530|NCT00664521|587638247|FG001|Overall Study|Lost to Follow-up|0|||
162707531|NCT00664521|587638246|FG000|Overall Study|Other|1|||
162707532|NCT00664521|587638247|FG001|Overall Study|Other|0|||
162707533|NCT02459964|587638248|FG000|Overall Study|Withdrawal by Subject|0|||
162707534|NCT02459964|587638249|FG001|Overall Study|Withdrawal by Subject|0|||
162707535|NCT02459964|587638250|FG002|Overall Study|Withdrawal by Subject|1|||
162707536|NCT02459964|587638248|FG000|Overall Study|Abnormal EKG changes|0|||
162707537|NCT02459964|587638249|FG001|Overall Study|Abnormal EKG changes|0|||
162707538|NCT02459964|587638250|FG002|Overall Study|Abnormal EKG changes|1|||
162707539|NCT01175707|587638251|FG000|Overall Study|Adverse Event|4|||
162707540|NCT01175707|587638252|FG001|Overall Study|Adverse Event|6|||
162707541|NCT01456780|587638253|FG000|Overall Study|Lost to Follow-up|3|||
162707542|NCT01456780|587638254|FG001|Overall Study|Lost to Follow-up|3|||
162707543|NCT01456780|587638255|FG002|Overall Study|Lost to Follow-up|0|||
162707544|NCT04531540|587638264|FG000|Overall Study|Adverse Event|1|||
162707545|NCT04531540|587638264|FG000|Overall Study|Protocol Violation|3|||
162707546|NCT04531540|587638264|FG000|Overall Study|Withdrawal by Subject|4|||
162707547|NCT04531540|587638264|FG000|Overall Study|Found to be Ineligible|1|||
162707548|NCT02688621|587638267|FG000|Overall Study|Pregnancy|1|||
162707549|NCT02688621|587638268|FG001|Overall Study|Pregnancy|3|||
162707550|NCT02688621|587638267|FG000|Overall Study|Lost to Follow-up|38|||
162707551|NCT02688621|587638268|FG001|Overall Study|Lost to Follow-up|15|||
162707552|NCT02688621|587638267|FG000|Overall Study|Withdrawal by Subject|1|||
162707553|NCT02688621|587638268|FG001|Overall Study|Withdrawal by Subject|0|||
162707554|NCT03239210|587638271|FG000|Overall Study|Lost to Follow-up|2|||
162707555|NCT03239210|587638272|FG001|Overall Study|Lost to Follow-up|2|||
162707556|NCT03239210|587638271|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
162707557|NCT03239210|587638272|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
162707558|NCT03239210|587638271|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
162707559|NCT03239210|587638272|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
162707560|NCT01575860|587638273|FG000|Overall Study|Withdrawal by Subject|1|||
162707561|NCT01575860|587638273|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
162707562|NCT05349864|587638278|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
162707563|NCT05349864|587638279|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
162707564|NCT00984282|587638280|FG000|Double Blind Treatment|Adverse Event|40|||
162879132|NCT01496430|588259057|FG002|Overall Study|Adverse Event|1|||
162879133|NCT01496430|588259055|FG000|Overall Study|Major Protocol Deviation|0|||
162879134|NCT01496430|588259056|FG001|Overall Study|Major Protocol Deviation|0|||
162879135|NCT01496430|588259057|FG002|Overall Study|Major Protocol Deviation|1|||
162879136|NCT01496430|588259055|FG000|Overall Study|Lost to Follow-up|2|||
162879137|NCT01496430|588259056|FG001|Overall Study|Lost to Follow-up|3|||
162879138|NCT01496430|588259057|FG002|Overall Study|Lost to Follow-up|1|||
162879139|NCT01496430|588259055|FG000|Overall Study|Voluntary Withdrawal|2|||
162879140|NCT01496430|588259056|FG001|Overall Study|Voluntary Withdrawal|1|||
162879141|NCT01496430|588259057|FG002|Overall Study|Voluntary Withdrawal|6|||
162879142|NCT01496430|588259055|FG000|Overall Study|Principal Investigator Discretion|0|||
162879143|NCT01496430|588259056|FG001|Overall Study|Principal Investigator Discretion|1|||
162879144|NCT01496430|588259057|FG002|Overall Study|Principal Investigator Discretion|1|||
162879145|NCT01496430|588259055|FG000|Overall Study|Other|2|||
162707565|NCT00984282|587638281|FG001|Double Blind Treatment|Adverse Event|6|||
162707566|NCT00984282|587638280|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
162707567|NCT00984282|587638281|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
162707568|NCT00984282|587638280|FG000|Double Blind Treatment|Physician Decision|1|||
162707569|NCT00984282|587638281|FG001|Double Blind Treatment|Physician Decision|2|||
162707570|NCT00984282|587638280|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
162707571|NCT00984282|587638281|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
162707572|NCT00984282|587638280|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
162707573|NCT00984282|587638281|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
162879146|NCT01496430|588259056|FG001|Overall Study|Other|0|||
162879147|NCT01496430|588259057|FG002|Overall Study|Other|0|||
162879148|NCT01100307|588259058|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
162879149|NCT01100307|588259059|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
162879150|NCT01100307|588259058|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
162879151|NCT01100307|588259059|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
162879152|NCT01100307|588259058|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
162879153|NCT01100307|588259059|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
162879154|NCT01100307|588259058|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
162879155|NCT01100307|588259059|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
162879156|NCT01100307|588259058|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
162879157|NCT01100307|588259059|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
162879158|NCT01100307|588259058|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
162879159|NCT01100307|588259059|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
162879160|NCT02108951|588259060|FG000|Overall Study|Lost to Follow-up|1|||
162879161|NCT02108951|588259060|FG000|Overall Study|Patient's/guardian's decision|1|||
162879162|NCT02108951|588259060|FG000|Overall Study|Study Terminated by Sponsor|14|||
162879163|NCT00997321|588259061|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
163048415|NCT04556760|588884794|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048416|NCT04556760|588884795|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163048417|NCT02513550|588884796|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
163048418|NCT02513550|588884797|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
163048419|NCT02513550|588884798|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
163048420|NCT02513550|588884799|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
163048421|NCT02513550|588884800|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
162879164|NCT00997321|588259062|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
162879165|NCT01151579|588259071|FG000|Overall Study|Physician Decision|3|||
162879166|NCT01151579|588259072|FG001|Overall Study|Physician Decision|1|||
162879167|NCT01151579|588259071|FG000|Overall Study|Withdrawal by Subject|3|||
162879168|NCT01151579|588259072|FG001|Overall Study|Withdrawal by Subject|2|||
162879169|NCT01151579|588259071|FG000|Overall Study|Not meet inclusion criteria|6|||
162879170|NCT01151579|588259072|FG001|Overall Study|Not meet inclusion criteria|4|||
162879171|NCT00608530|588259073|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
162879172|NCT00608530|588259074|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
162879173|NCT00608530|588259075|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
162879174|NCT00608530|588259076|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
162879175|NCT00608530|588259073|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
162879176|NCT00608530|588259074|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
162879177|NCT00608530|588259075|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
162879178|NCT00608530|588259076|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
162879179|NCT00608530|588259073|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
162879180|NCT00608530|588259074|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
162879181|NCT00608530|588259075|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
162879182|NCT00608530|588259076|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
162879183|NCT00608530|588259073|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
162879184|NCT00608530|588259074|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
162879185|NCT00608530|588259075|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
162879186|NCT00608530|588259076|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
162879187|NCT00608530|588259073|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
162879188|NCT00608530|588259074|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
162879189|NCT00608530|588259075|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
162879190|NCT00608530|588259076|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
162879191|NCT00608530|588259073|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
162879192|NCT00608530|588259074|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
162879193|NCT00608530|588259075|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
162879194|NCT00608530|588259076|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
162879195|NCT00077610|588259077|FG000|Overall Study|Adverse Event|9|||
162879196|NCT00077610|588259078|FG001|Overall Study|Adverse Event|7|||
162879197|NCT00077610|588259079|FG002|Overall Study|Adverse Event|1|||
162879198|NCT00077610|588259077|FG000|Overall Study|Lost to Follow-up|0|||
162879199|NCT00077610|588259078|FG001|Overall Study|Lost to Follow-up|1|||
162879200|NCT00077610|588259079|FG002|Overall Study|Lost to Follow-up|2|||
162879201|NCT00077610|588259077|FG000|Overall Study|Withdrawal by Subject|4|||
162879202|NCT00077610|588259078|FG001|Overall Study|Withdrawal by Subject|10|||
162879203|NCT00077610|588259079|FG002|Overall Study|Withdrawal by Subject|6|||
162879204|NCT00077610|588259077|FG000|Overall Study|Death|17|||
162879205|NCT00077610|588259078|FG001|Overall Study|Death|13|||
162879206|NCT00077610|588259079|FG002|Overall Study|Death|13|||
162879207|NCT00077610|588259077|FG000|Overall Study|Renal transplant|12|||
162879208|NCT00077610|588259078|FG001|Overall Study|Renal transplant|15|||
162879209|NCT00077610|588259079|FG002|Overall Study|Renal transplant|11|||
162879210|NCT00077610|588259077|FG000|Overall Study|Withdrew from dialysis care|5|||
162879211|NCT00077610|588259078|FG001|Overall Study|Withdrew from dialysis care|0|||
162879212|NCT00077610|588259079|FG002|Overall Study|Withdrew from dialysis care|3|||
162879213|NCT00077610|588259077|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162879214|NCT00077610|588259078|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162879215|NCT00077610|588259079|FG002|Overall Study|Insufficient Therapeutic Response|0|||
162879216|NCT00077610|588259077|FG000|Overall Study|Multiple blood transfusions|0|||
162879217|NCT00077610|588259078|FG001|Overall Study|Multiple blood transfusions|0|||
162879218|NCT00077610|588259079|FG002|Overall Study|Multiple blood transfusions|1|||
162879219|NCT00077610|588259077|FG000|Overall Study|Principal Investigator's decision|1|||
162879220|NCT00077610|588259078|FG001|Overall Study|Principal Investigator's decision|0|||
162879221|NCT00077610|588259079|FG002|Overall Study|Principal Investigator's decision|1|||
162879222|NCT00077610|588259077|FG000|Overall Study|Worsening of health condition|1|||
162879223|NCT00077610|588259078|FG001|Overall Study|Worsening of health condition|1|||
162879224|NCT00077610|588259079|FG002|Overall Study|Worsening of health condition|0|||
162879225|NCT00077610|588259077|FG000|Overall Study|Given Epogen in hospital|1|||
162879226|NCT00077610|588259078|FG001|Overall Study|Given Epogen in hospital|0|||
162879227|NCT00077610|588259079|FG002|Overall Study|Given Epogen in hospital|0|||
162879228|NCT00077610|588259077|FG000|Overall Study|Transferred to other unit|0|||
162879229|NCT00077610|588259078|FG001|Overall Study|Transferred to other unit|0|||
162879230|NCT00077610|588259079|FG002|Overall Study|Transferred to other unit|1|||
162879231|NCT00077610|588259077|FG000|Overall Study|Transferred to nursing home|0|||
162879232|NCT00077610|588259078|FG001|Overall Study|Transferred to nursing home|0|||
162879233|NCT00077610|588259079|FG002|Overall Study|Transferred to nursing home|1|||
162879234|NCT00077610|588259077|FG000|Overall Study|Transfer to satellite unit|1|||
162879235|NCT00077610|588259078|FG001|Overall Study|Transfer to satellite unit|0|||
162879236|NCT00077610|588259079|FG002|Overall Study|Transfer to satellite unit|0|||
162879237|NCT00077610|588259077|FG000|Overall Study|Transfer to other center for surgery|1|||
162879238|NCT00077610|588259078|FG001|Overall Study|Transfer to other center for surgery|0|||
162879239|NCT00077610|588259079|FG002|Overall Study|Transfer to other center for surgery|0|||
162879240|NCT00077610|588259077|FG000|Overall Study|Change in dialysis modality|1|||
162879241|NCT00077610|588259078|FG001|Overall Study|Change in dialysis modality|0|||
162879242|NCT00077610|588259079|FG002|Overall Study|Change in dialysis modality|0|||
162879243|NCT00077610|588259077|FG000|Overall Study|Relocation|0|||
162879244|NCT00077610|588259078|FG001|Overall Study|Relocation|8|||
162879245|NCT00077610|588259079|FG002|Overall Study|Relocation|5|||
162879246|NCT00077610|588259077|FG000|Overall Study|Financial issues|0|||
162879247|NCT00077610|588259078|FG001|Overall Study|Financial issues|1|||
162879248|NCT00077610|588259079|FG002|Overall Study|Financial issues|0|||
162879249|NCT00077610|588259077|FG000|Overall Study|Sponsors decision to withdraw|0|||
162879250|NCT00077610|588259078|FG001|Overall Study|Sponsors decision to withdraw|0|||
162879251|NCT00077610|588259079|FG002|Overall Study|Sponsors decision to withdraw|1|||
162879252|NCT00305253|588259083|FG000|Overall Study|Withdrawal by Subject|0|||
162879253|NCT00305253|588259084|FG001|Overall Study|Withdrawal by Subject|1|||
162879254|NCT01357915|588259087|FG000|Overall Study|Lost to Follow-up|3|||
162879255|NCT01357915|588259088|FG001|Overall Study|Lost to Follow-up|0|||
162879256|NCT01098461|588259089|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
162879257|NCT01098461|588259090|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
162879258|NCT01098461|588259091|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
162961755|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961756|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961757|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961758|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961759|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961760|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961761|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961762|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961763|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
162961764|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
163048422|NCT02513550|588884801|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
162879259|NCT01098461|588259092|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
162879260|NCT01098461|588259089|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
162879261|NCT01098461|588259090|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
162879262|NCT01098461|588259091|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
162961765|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961766|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162879263|NCT01098461|588259092|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
162879264|NCT01098461|588259089|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
162879265|NCT01098461|588259090|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
162879266|NCT01098461|588259091|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
162879267|NCT01098461|588259092|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
162879268|NCT01098461|588259089|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
162879269|NCT01098461|588259090|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
162879270|NCT01098461|588259091|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
162879271|NCT01098461|588259092|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
162879272|NCT01098461|588259089|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
162879273|NCT01098461|588259090|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
162879274|NCT01098461|588259091|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
162879275|NCT01098461|588259092|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
162879276|NCT01098461|588259089|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
162879277|NCT01098461|588259090|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
162879278|NCT01098461|588259091|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
162879279|NCT01098461|588259092|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
162879280|NCT01098461|588259089|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
162879281|NCT01098461|588259090|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
162879282|NCT01098461|588259091|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
162879283|NCT01098461|588259092|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
162879284|NCT02662985|588259093|FG000|Treatment Period 1|Adverse Event|0|||
162879285|NCT02662985|588259094|FG001|Treatment Period 1|Adverse Event|2|||
162879286|NCT02662985|588259093|FG000|Treatment Period 1|Protocol Violation|0|||
162879287|NCT02662985|588259094|FG001|Treatment Period 1|Protocol Violation|1|||
162879288|NCT02662985|588259093|FG000|Treatment Period 1|Physician Decision|1|||
162879289|NCT02662985|588259094|FG001|Treatment Period 1|Physician Decision|0|||
162879290|NCT02662985|588259093|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162879291|NCT02662985|588259094|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162879292|NCT02662985|588259093|FG000|Treatment Period 2|Lack of Efficacy|0|||
162879293|NCT02662985|588259094|FG001|Treatment Period 2|Lack of Efficacy|1|||
162879294|NCT02662985|588259093|FG000|Treatment Period 2|Lost to Follow-up|1|||
162879295|NCT02662985|588259094|FG001|Treatment Period 2|Lost to Follow-up|0|||
162879296|NCT02662985|588259093|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
162879297|NCT02662985|588259094|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
162879298|NCT02662985|588259093|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
162879299|NCT02662985|588259094|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
162879300|NCT02662985|588259093|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
162879301|NCT02662985|588259094|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
162879302|NCT02662985|588259093|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
162879303|NCT02662985|588259094|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
162879304|NCT02662985|588259093|FG000|Treatment Period 3 (Extension Period)|Death|0|||
162879305|NCT02662985|588259094|FG001|Treatment Period 3 (Extension Period)|Death|1|||
162879306|NCT01153763|588259095|FG000|Overall Study|Study Closed|16|||
162879307|NCT01153763|588259095|FG000|Overall Study|Lost to Follow-up|1|||
162879308|NCT01153763|588259095|FG000|Overall Study|Physician Decision|2|||
162879309|NCT01153763|588259095|FG000|Overall Study|Withdrawal by Subject|2|||
162879310|NCT01486784|588259096|FG000|Overall Study|Withdrawal by Subject|0|||
162879311|NCT01486784|588259097|FG001|Overall Study|Withdrawal by Subject|0|||
162879312|NCT01486784|588259098|FG002|Overall Study|Withdrawal by Subject|1|||
162879313|NCT01486784|588259099|FG003|Overall Study|Withdrawal by Subject|0|||
162879314|NCT01486784|588259100|FG004|Overall Study|Withdrawal by Subject|1|||
162879315|NCT01486784|588259101|FG005|Overall Study|Withdrawal by Subject|2|||
162879316|NCT01486784|588259096|FG000|Overall Study|Subject did not meet entry criteria|0|||
162879317|NCT01486784|588259097|FG001|Overall Study|Subject did not meet entry criteria|0|||
162879318|NCT01486784|588259098|FG002|Overall Study|Subject did not meet entry criteria|0|||
162879319|NCT01486784|588259099|FG003|Overall Study|Subject did not meet entry criteria|0|||
162879320|NCT01486784|588259100|FG004|Overall Study|Subject did not meet entry criteria|1|||
162879321|NCT01486784|588259101|FG005|Overall Study|Subject did not meet entry criteria|0|||
162879322|NCT01486784|588259096|FG000|Overall Study|Death|0|||
162879323|NCT01486784|588259097|FG001|Overall Study|Death|0|||
162879324|NCT01486784|588259098|FG002|Overall Study|Death|0|||
162879325|NCT01486784|588259099|FG003|Overall Study|Death|0|||
162879326|NCT01486784|588259100|FG004|Overall Study|Death|0|||
162879327|NCT01486784|588259101|FG005|Overall Study|Death|1|||
162879328|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
162879329|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
162879330|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Death|2|||
162879331|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Death|1|||
162879332|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
162961767|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162961768|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162879333|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
162879334|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
162879335|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
162879336|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
162961769|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162879337|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
162879338|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
162879339|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
162879340|NCT03633227|588259102|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
162879341|NCT03633227|588259103|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
162879342|NCT03633227|588259102|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
162879343|NCT03633227|588259103|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
162879344|NCT03633227|588259102|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
162879345|NCT03633227|588259103|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
162879346|NCT03633227|588259102|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
162879347|NCT03633227|588259103|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
162879348|NCT03633227|588259102|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
162879349|NCT03633227|588259103|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
162879350|NCT03633227|588259102|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
162879351|NCT03633227|588259103|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
162879352|NCT03491553|588259104|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
162879353|NCT03491553|588259105|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
162879354|NCT03491553|588259106|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
162879355|NCT03491553|588259107|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
162879356|NCT03491553|588259108|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
162879357|NCT03491553|588259109|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
162879358|NCT03491553|588259104|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
162879359|NCT03491553|588259105|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
162879360|NCT03491553|588259106|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
162879361|NCT03491553|588259107|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
162879362|NCT03491553|588259108|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
162879363|NCT03491553|588259109|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
162879364|NCT01479374|588259117|FG000|Overall Study|Adverse Event|2|||
162879365|NCT01479374|588259118|FG001|Overall Study|Adverse Event|1|||
162879366|NCT01479374|588259119|FG002|Overall Study|Adverse Event|0|||
162879367|NCT01479374|588259117|FG000|Overall Study|Lost to Follow-up|1|||
162879368|NCT01479374|588259118|FG001|Overall Study|Lost to Follow-up|2|||
162879369|NCT01479374|588259119|FG002|Overall Study|Lost to Follow-up|0|||
162879370|NCT01479374|588259117|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
162879371|NCT01479374|588259118|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
162879372|NCT01479374|588259119|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
162879373|NCT01479374|588259117|FG000|Overall Study|Other|0|||
162879374|NCT01479374|588259118|FG001|Overall Study|Other|4|||
162879375|NCT01479374|588259119|FG002|Overall Study|Other|5|||
162879376|NCT01606761|588259120|FG000|Prior to Week 24|Lost to Follow-up|0|||
162879377|NCT01606761|588259121|FG001|Prior to Week 24|Lost to Follow-up|3|||
162879378|NCT01606761|588259122|FG002|Prior to Week 24|Lost to Follow-up|2|||
162879379|NCT01606761|588259123|FG003|Prior to Week 24|Lost to Follow-up|0|||
162879380|NCT01606761|588259124|FG004|Prior to Week 24|Lost to Follow-up|0|||
162879381|NCT01606761|588259120|FG000|Prior to Week 24|Withdrawal by Subject|12|||
162879382|NCT01606761|588259121|FG001|Prior to Week 24|Withdrawal by Subject|10|||
163048423|NCT02513550|588884796|FG000|Double Blind Treatment Period|Adverse Event|5|||
162879383|NCT01606761|588259122|FG002|Prior to Week 24|Withdrawal by Subject|9|||
162879384|NCT01606761|588259123|FG003|Prior to Week 24|Withdrawal by Subject|0|||
162879385|NCT01606761|588259124|FG004|Prior to Week 24|Withdrawal by Subject|0|||
162879386|NCT01606761|588259120|FG000|Prior to Week 24|Adverse Event|11|||
162879387|NCT01606761|588259121|FG001|Prior to Week 24|Adverse Event|18|||
162879388|NCT01606761|588259122|FG002|Prior to Week 24|Adverse Event|22|||
162879389|NCT01606761|588259123|FG003|Prior to Week 24|Adverse Event|0|||
162879390|NCT01606761|588259124|FG004|Prior to Week 24|Adverse Event|0|||
162879391|NCT01606761|588259120|FG000|Prior to Week 24|Lack of Efficacy|15|||
162879392|NCT01606761|588259121|FG001|Prior to Week 24|Lack of Efficacy|14|||
163048424|NCT02513550|588884797|FG001|Double Blind Treatment Period|Adverse Event|13|||
163048425|NCT02513550|588884798|FG002|Double Blind Treatment Period|Adverse Event|17|||
163048426|NCT02513550|588884799|FG003|Double Blind Treatment Period|Adverse Event|0|||
163048427|NCT02513550|588884800|FG004|Double Blind Treatment Period|Adverse Event|1|||
163048428|NCT02513550|588884801|FG005|Double Blind Treatment Period|Adverse Event|0|||
163048429|NCT02513550|588884796|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
162879393|NCT01606761|588259122|FG002|Prior to Week 24|Lack of Efficacy|8|||
162879394|NCT01606761|588259123|FG003|Prior to Week 24|Lack of Efficacy|0|||
162879395|NCT01606761|588259124|FG004|Prior to Week 24|Lack of Efficacy|0|||
162879396|NCT01606761|588259120|FG000|Prior to Week 24|Physician Decision|0|||
162879397|NCT01606761|588259121|FG001|Prior to Week 24|Physician Decision|3|||
162879398|NCT01606761|588259122|FG002|Prior to Week 24|Physician Decision|1|||
162879399|NCT01606761|588259123|FG003|Prior to Week 24|Physician Decision|0|||
162879400|NCT01606761|588259124|FG004|Prior to Week 24|Physician Decision|0|||
162879401|NCT01606761|588259120|FG000|Prior to Week 24|Other|4|||
163048430|NCT02513550|588884797|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
162879402|NCT01606761|588259121|FG001|Prior to Week 24|Other|7|||
162879403|NCT01606761|588259122|FG002|Prior to Week 24|Other|5|||
162879404|NCT01606761|588259123|FG003|Prior to Week 24|Other|0|||
162879405|NCT01606761|588259124|FG004|Prior to Week 24|Other|0|||
162879406|NCT01606761|588259120|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
162879407|NCT01606761|588259121|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
162879408|NCT01606761|588259122|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
162879409|NCT01606761|588259123|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
162879410|NCT01606761|588259124|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
162879411|NCT01606761|588259120|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
162879412|NCT01606761|588259121|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
162879413|NCT01606761|588259122|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
162879414|NCT01606761|588259123|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
162879415|NCT01606761|588259124|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
162879416|NCT01606761|588259120|FG000|Week 24 to Week 52|Adverse Event|0|||
162879417|NCT01606761|588259121|FG001|Week 24 to Week 52|Adverse Event|11|||
162879418|NCT01606761|588259122|FG002|Week 24 to Week 52|Adverse Event|14|||
162879419|NCT01606761|588259123|FG003|Week 24 to Week 52|Adverse Event|3|||
162879420|NCT01606761|588259124|FG004|Week 24 to Week 52|Adverse Event|15|||
162879421|NCT01606761|588259120|FG000|Week 24 to Week 52|Death|0|||
162879422|NCT01606761|588259121|FG001|Week 24 to Week 52|Death|0|||
162879423|NCT01606761|588259122|FG002|Week 24 to Week 52|Death|2|||
162879424|NCT01606761|588259123|FG003|Week 24 to Week 52|Death|1|||
162879425|NCT01606761|588259124|FG004|Week 24 to Week 52|Death|0|||
162879426|NCT01606761|588259120|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
162879427|NCT01606761|588259121|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
162879428|NCT01606761|588259122|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
162879429|NCT01606761|588259123|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
162879430|NCT01606761|588259124|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
162879431|NCT01606761|588259120|FG000|Week 24 to Week 52|Physician Decision|0|||
162879432|NCT01606761|588259121|FG001|Week 24 to Week 52|Physician Decision|1|||
162879433|NCT01606761|588259122|FG002|Week 24 to Week 52|Physician Decision|1|||
162879434|NCT01606761|588259123|FG003|Week 24 to Week 52|Physician Decision|0|||
162879435|NCT01606761|588259124|FG004|Week 24 to Week 52|Physician Decision|0|||
162879436|NCT01606761|588259120|FG000|Week 24 to Week 52|Other|0|||
162879437|NCT01606761|588259121|FG001|Week 24 to Week 52|Other|1|||
162879438|NCT01606761|588259122|FG002|Week 24 to Week 52|Other|5|||
162879439|NCT01606761|588259123|FG003|Week 24 to Week 52|Other|2|||
162879440|NCT01606761|588259124|FG004|Week 24 to Week 52|Other|2|||
162879441|NCT01606761|588259120|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
162879442|NCT01606761|588259121|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
162879443|NCT01606761|588259122|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
162879444|NCT01606761|588259123|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
162879445|NCT01606761|588259124|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
162879446|NCT01606761|588259120|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
162879447|NCT01606761|588259121|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
162879448|NCT01606761|588259122|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
162879449|NCT01606761|588259123|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
162879450|NCT01606761|588259124|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
162879451|NCT01606761|588259120|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
162879452|NCT01606761|588259121|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
162879453|NCT01606761|588259122|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
162879454|NCT01606761|588259123|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
162879455|NCT01606761|588259124|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
162879456|NCT01606761|588259120|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
162879457|NCT01606761|588259121|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
162879458|NCT01606761|588259122|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
162879459|NCT01606761|588259123|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
162961770|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162879460|NCT01606761|588259124|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
162879461|NCT00992446|588259132|FG000|Overall Study|Disease Progression|1|||
162879462|NCT00992446|588259132|FG000|Overall Study|Withdrawal by Subject|2|||
162879463|NCT00992446|588259132|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
162879464|NCT03073213|588260819|FG000|Multiple Dose Period|Protocol Violation|0|||
162879465|NCT03073213|588260820|FG001|Multiple Dose Period|Protocol Violation|0|||
162961771|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162879466|NCT03073213|588260821|FG002|Multiple Dose Period|Protocol Violation|1|||
162879467|NCT01120379|588260840|FG000|One Year Timepoint|Withdrawal by Subject|41|||
162879468|NCT01120379|588260840|FG000|One Year Timepoint|Lost to Follow-up|115|||
162879469|NCT01120379|588260840|FG000|One Year Timepoint|Death|108|||
162879470|NCT01120379|588260840|FG000|One Year Timepoint|Physician Decision|9|||
162879471|NCT01120379|588260840|FG000|One Year Timepoint|Any other reason for early termination|5|||
162879472|NCT01120379|588260840|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
162879473|NCT01120379|588260840|FG000|Two Year Timepoint|Lost to Follow-up|87|||
162879474|NCT01120379|588260840|FG000|Two Year Timepoint|Death|123|||
162879475|NCT01120379|588260840|FG000|Two Year Timepoint|Physician Decision|12|||
162879476|NCT01120379|588260840|FG000|Two Year Timepoint|Any other reason for early termination|4|||
162879477|NCT01120379|588260840|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
162879478|NCT01120379|588260840|FG000|Three Year Timepoint|Lost to Follow-up|43|||
162879479|NCT01120379|588260840|FG000|Three Year Timepoint|Death|120|||
162879480|NCT01120379|588260840|FG000|Three Year Timepoint|Physician Decision|9|||
162879481|NCT01120379|588260840|FG000|Three Year Timepoint|Any other reason for early termination|17|||
162879482|NCT01120379|588260840|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
162879483|NCT01120379|588260840|FG000|Four Year Timepoint|Lost to Follow-up|10|||
162879484|NCT01120379|588260840|FG000|Four Year Timepoint|Death|131|||
162879485|NCT01120379|588260840|FG000|Four Year Timepoint|Physician Decision|5|||
162879486|NCT01120379|588260840|FG000|Four Year Timepoint|Any other reason for early termination|217|||
162879487|NCT03162055|588260841|FG000|Overall Study|Adverse Event|6|||
162879488|NCT03162055|588260842|FG001|Overall Study|Adverse Event|5|||
162879489|NCT03162055|588260841|FG000|Overall Study|Death|3|||
162879490|NCT03162055|588260842|FG001|Overall Study|Death|3|||
162879491|NCT03162055|588260841|FG000|Overall Study|Lost to Follow-up|0|||
162879492|NCT03162055|588260842|FG001|Overall Study|Lost to Follow-up|1|||
162879493|NCT03162055|588260841|FG000|Overall Study|Study-specific withdrawal criteria|22|||
162879494|NCT03162055|588260842|FG001|Overall Study|Study-specific withdrawal criteria|14|||
162879495|NCT03162055|588260841|FG000|Overall Study|Withdrawal by Subject|17|||
162879496|NCT03162055|588260842|FG001|Overall Study|Withdrawal by Subject|2|||
162879497|NCT03162055|588260841|FG000|Overall Study|Did not receive treatment|2|||
162879498|NCT03162055|588260842|FG001|Overall Study|Did not receive treatment|0|||
162879499|NCT03162055|588260841|FG000|Overall Study|Incorrect randomization|4|||
162879500|NCT03162055|588260842|FG001|Overall Study|Incorrect randomization|3|||
162879501|NCT03162055|588260841|FG000|Overall Study|Other|8|||
162879502|NCT03162055|588260842|FG001|Overall Study|Other|15|||
162879503|NCT04031404|588260843|FG000|Baseline|Lost to Follow-up|0|||
162879504|NCT04031404|588260844|FG001|Baseline|Lost to Follow-up|1|||
162879505|NCT04031404|588260843|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
162879506|NCT04031404|588260844|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
162879507|NCT04031404|588260843|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
162879508|NCT04031404|588260844|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
162879509|NCT04031404|588260843|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
162879510|NCT04031404|588260844|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
162879511|NCT04031404|588260843|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
162879512|NCT04031404|588260844|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
162879513|NCT01993615|588260848|FG000|Overall Study|Death|1|||
162879514|NCT01993615|588260849|FG001|Overall Study|Death|0|||
162879515|NCT02064205|588260852|FG000|Overall Study|Withdrawal by Subject|1|||
162879516|NCT01354353|588260856|FG000|Overall Study|Adverse Event|1|||
162879517|NCT01354353|588260857|FG001|Overall Study|Adverse Event|0|||
162879518|NCT01354353|588260858|FG002|Overall Study|Adverse Event|0|||
162879519|NCT01354353|588260859|FG003|Overall Study|Adverse Event|4|||
162879520|NCT01354353|588260860|FG004|Overall Study|Adverse Event|0|||
162879521|NCT01354353|588260861|FG005|Overall Study|Adverse Event|5|||
162879522|NCT01354353|588260856|FG000|Overall Study|Entry Criteria Not Met|0|||
162879523|NCT01354353|588260857|FG001|Overall Study|Entry Criteria Not Met|0|||
162879524|NCT01354353|588260858|FG002|Overall Study|Entry Criteria Not Met|0|||
162879525|NCT01354353|588260859|FG003|Overall Study|Entry Criteria Not Met|1|||
162879526|NCT01354353|588260860|FG004|Overall Study|Entry Criteria Not Met|1|||
162879527|NCT01354353|588260861|FG005|Overall Study|Entry Criteria Not Met|0|||
162879528|NCT01354353|588260856|FG000|Overall Study|Physician Decision|0|||
162879529|NCT01354353|588260857|FG001|Overall Study|Physician Decision|1|||
162879530|NCT01354353|588260858|FG002|Overall Study|Physician Decision|1|||
162879531|NCT01354353|588260859|FG003|Overall Study|Physician Decision|0|||
162879532|NCT01354353|588260860|FG004|Overall Study|Physician Decision|0|||
162879533|NCT01354353|588260861|FG005|Overall Study|Physician Decision|0|||
162879534|NCT01354353|588260856|FG000|Overall Study|Withdrawal by Subject|2|||
162879535|NCT01354353|588260857|FG001|Overall Study|Withdrawal by Subject|0|||
162879536|NCT01354353|588260858|FG002|Overall Study|Withdrawal by Subject|1|||
162879537|NCT01354353|588260859|FG003|Overall Study|Withdrawal by Subject|0|||
162879538|NCT01354353|588260860|FG004|Overall Study|Withdrawal by Subject|0|||
162879539|NCT01354353|588260861|FG005|Overall Study|Withdrawal by Subject|1|||
162879540|NCT05674344|588260862|FG000|Overall Study|Screen Fail|21|||
162879541|NCT05674344|588260862|FG000|Overall Study|Incomplete study procedures|3|||
162879542|NCT00111917|588260863|FG000|Overall Study|Withdrawal by Subject|1|||
162879543|NCT00111917|588260864|FG001|Overall Study|Withdrawal by Subject|1|||
162879544|NCT01640925|588260865|FG000|Overall Study|Withdrawal by Subject|1|||
162879545|NCT01640925|588260866|FG001|Overall Study|Withdrawal by Subject|0|||
162879546|NCT01640925|588260865|FG000|Overall Study|Previously enrolled in this trial|13|||
162879547|NCT01640925|588260866|FG001|Overall Study|Previously enrolled in this trial|11|||
162879548|NCT02156492|588260867|FG000|Period 1|No Reason Given|0|||
162879549|NCT02156492|588260868|FG001|Period 1|No Reason Given|1|||
162879550|NCT02156492|588260869|FG002|Period 1|No Reason Given|0|||
162879551|NCT02156492|588260867|FG000|Period 3|Adverse Event|0|||
162879552|NCT02156492|588260868|FG001|Period 3|Adverse Event|1|||
162879553|NCT02156492|588260869|FG002|Period 3|Adverse Event|0|||
162879554|NCT04017442|588260874|FG000|Overall Study|Withdrawal by Subject|0|||
162879555|NCT04017442|588260875|FG001|Overall Study|Withdrawal by Subject|3|||
162879556|NCT04017442|588260874|FG000|Overall Study|Lost to Follow-up|21|||
162879557|NCT04017442|588260875|FG001|Overall Study|Lost to Follow-up|19|||
162879558|NCT03225716|588260876|FG000|Overall Study|Withdrawal by Subject|2|||
162879559|NCT03225716|588260877|FG001|Overall Study|Withdrawal by Subject|2|||
162879560|NCT03225716|588260878|FG002|Overall Study|Withdrawal by Subject|0|||
162879561|NCT03225716|588260876|FG000|Overall Study|Lack of Efficacy|1|||
162879562|NCT03225716|588260877|FG001|Overall Study|Lack of Efficacy|0|||
162879563|NCT03225716|588260878|FG002|Overall Study|Lack of Efficacy|0|||
162879564|NCT03225716|588260876|FG000|Overall Study|Adverse Event|2|||
162879565|NCT03225716|588260877|FG001|Overall Study|Adverse Event|0|||
162879566|NCT03225716|588260878|FG002|Overall Study|Adverse Event|1|||
162879567|NCT03225716|588260876|FG000|Overall Study|Study early termination by Sponsor|0|||
162879568|NCT03225716|588260877|FG001|Overall Study|Study early termination by Sponsor|0|||
162879569|NCT03225716|588260878|FG002|Overall Study|Study early termination by Sponsor|2|||
162879570|NCT00848250|588260879|FG000|Overall Study|surgery was completed without cardiopulm|0|||
162879571|NCT00848250|588260880|FG001|Overall Study|surgery was completed without cardiopulm|1|||
162879572|NCT02883049|588260888|FG000|Induction|Adverse Event|52|||
162879573|NCT02883049|588260889|FG001|Induction|Adverse Event|2|||
162879574|NCT02883049|588260890|FG002|Induction|Adverse Event|0|||
162879575|NCT02883049|588260891|FG003|Induction|Adverse Event|0|||
162879576|NCT02883049|588260892|FG004|Induction|Adverse Event|0|||
162879577|NCT02883049|588260893|FG005|Induction|Adverse Event|0|||
162879578|NCT02883049|588260894|FG006|Induction|Adverse Event|0|||
162879579|NCT02883049|588260895|FG007|Induction|Adverse Event|0|||
162879580|NCT02883049|588260896|FG008|Induction|Adverse Event|0|||
162879581|NCT02883049|588260897|FG009|Induction|Adverse Event|0|||
162879582|NCT02883049|588260898|FG010|Induction|Adverse Event|0|||
162879583|NCT02883049|588260899|FG011|Induction|Adverse Event|0|||
162879584|NCT02883049|588260900|FG012|Induction|Adverse Event|0|||
162879585|NCT02883049|588260901|FG013|Induction|Adverse Event|0|||
162879586|NCT02883049|588260902|FG014|Induction|Adverse Event|0|||
162879587|NCT02883049|588260903|FG015|Induction|Adverse Event|0|||
162879588|NCT02883049|588260888|FG000|Induction|Death|76|||
162879589|NCT02883049|588260889|FG001|Induction|Death|8|||
162879590|NCT02883049|588260890|FG002|Induction|Death|0|||
162879591|NCT02883049|588260891|FG003|Induction|Death|0|||
162879592|NCT02883049|588260892|FG004|Induction|Death|0|||
162879593|NCT02883049|588260893|FG005|Induction|Death|0|||
162879594|NCT02883049|588260894|FG006|Induction|Death|0|||
162879595|NCT02883049|588260895|FG007|Induction|Death|0|||
162879596|NCT02883049|588260896|FG008|Induction|Death|0|||
162879597|NCT02883049|588260897|FG009|Induction|Death|0|||
162879598|NCT02883049|588260898|FG010|Induction|Death|0|||
162879599|NCT02883049|588260899|FG011|Induction|Death|0|||
162879600|NCT02883049|588260900|FG012|Induction|Death|0|||
162879601|NCT02883049|588260901|FG013|Induction|Death|0|||
162879602|NCT02883049|588260902|FG014|Induction|Death|0|||
162879603|NCT02883049|588260903|FG015|Induction|Death|0|||
162961772|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961773|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961774|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961775|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961776|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961777|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961778|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162879604|NCT02883049|588260888|FG000|Induction|Lost to Follow-up|2|||
162879605|NCT02883049|588260889|FG001|Induction|Lost to Follow-up|0|||
162879606|NCT02883049|588260890|FG002|Induction|Lost to Follow-up|0|||
162879607|NCT02883049|588260891|FG003|Induction|Lost to Follow-up|0|||
162879608|NCT02883049|588260892|FG004|Induction|Lost to Follow-up|0|||
162879609|NCT02883049|588260893|FG005|Induction|Lost to Follow-up|0|||
162961779|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961780|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162879610|NCT02883049|588260894|FG006|Induction|Lost to Follow-up|0|||
162879611|NCT02883049|588260895|FG007|Induction|Lost to Follow-up|0|||
162879612|NCT02883049|588260896|FG008|Induction|Lost to Follow-up|0|||
162879613|NCT02883049|588260897|FG009|Induction|Lost to Follow-up|0|||
162879614|NCT02883049|588260898|FG010|Induction|Lost to Follow-up|0|||
162879615|NCT02883049|588260899|FG011|Induction|Lost to Follow-up|0|||
162879616|NCT02883049|588260900|FG012|Induction|Lost to Follow-up|0|||
162879617|NCT02883049|588260901|FG013|Induction|Lost to Follow-up|0|||
162879618|NCT02883049|588260902|FG014|Induction|Lost to Follow-up|0|||
162879619|NCT02883049|588260903|FG015|Induction|Lost to Follow-up|0|||
162879620|NCT02883049|588260888|FG000|Induction|Physician Decision|1407|||
162879621|NCT02883049|588260889|FG001|Induction|Physician Decision|8|||
162879622|NCT02883049|588260890|FG002|Induction|Physician Decision|0|||
162879623|NCT02883049|588260891|FG003|Induction|Physician Decision|0|||
162879624|NCT02883049|588260892|FG004|Induction|Physician Decision|0|||
162879625|NCT02883049|588260893|FG005|Induction|Physician Decision|0|||
162879626|NCT02883049|588260894|FG006|Induction|Physician Decision|0|||
162879627|NCT02883049|588260895|FG007|Induction|Physician Decision|0|||
162879628|NCT02883049|588260896|FG008|Induction|Physician Decision|0|||
162879629|NCT02883049|588260897|FG009|Induction|Physician Decision|0|||
162879630|NCT02883049|588260898|FG010|Induction|Physician Decision|0|||
162879631|NCT02883049|588260899|FG011|Induction|Physician Decision|0|||
162879632|NCT02883049|588260900|FG012|Induction|Physician Decision|0|||
162879633|NCT02883049|588260901|FG013|Induction|Physician Decision|0|||
162879634|NCT02883049|588260902|FG014|Induction|Physician Decision|0|||
162879635|NCT02883049|588260903|FG015|Induction|Physician Decision|0|||
162879636|NCT02883049|588260888|FG000|Induction|Protocol Violation|6|||
162879637|NCT02883049|588260889|FG001|Induction|Protocol Violation|0|||
162879638|NCT02883049|588260890|FG002|Induction|Protocol Violation|0|||
162879639|NCT02883049|588260891|FG003|Induction|Protocol Violation|0|||
162879640|NCT02883049|588260892|FG004|Induction|Protocol Violation|0|||
162879641|NCT02883049|588260893|FG005|Induction|Protocol Violation|0|||
162879642|NCT02883049|588260894|FG006|Induction|Protocol Violation|0|||
162879643|NCT02883049|588260895|FG007|Induction|Protocol Violation|0|||
162879644|NCT02883049|588260896|FG008|Induction|Protocol Violation|0|||
162961781|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961782|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961783|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961784|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961785|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961786|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961787|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961788|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961789|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
162879645|NCT02883049|588260897|FG009|Induction|Protocol Violation|0|||
162879646|NCT02883049|588260898|FG010|Induction|Protocol Violation|0|||
162961790|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961791|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961792|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961793|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961794|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
162961795|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961796|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162879647|NCT02883049|588260899|FG011|Induction|Protocol Violation|0|||
162961797|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162879648|NCT02883049|588260900|FG012|Induction|Protocol Violation|0|||
162879649|NCT02883049|588260901|FG013|Induction|Protocol Violation|0|||
162879650|NCT02883049|588260902|FG014|Induction|Protocol Violation|0|||
162879651|NCT02883049|588260903|FG015|Induction|Protocol Violation|0|||
162879652|NCT02883049|588260888|FG000|Induction|Withdrawal by Subject|6|||
162879653|NCT02883049|588260889|FG001|Induction|Withdrawal by Subject|0|||
162879654|NCT02883049|588260890|FG002|Induction|Withdrawal by Subject|0|||
162879655|NCT02883049|588260891|FG003|Induction|Withdrawal by Subject|0|||
162879656|NCT02883049|588260892|FG004|Induction|Withdrawal by Subject|0|||
162879657|NCT02883049|588260893|FG005|Induction|Withdrawal by Subject|0|||
162879658|NCT02883049|588260894|FG006|Induction|Withdrawal by Subject|0|||
162879659|NCT02883049|588260895|FG007|Induction|Withdrawal by Subject|0|||
162879660|NCT02883049|588260896|FG008|Induction|Withdrawal by Subject|0|||
162879661|NCT02883049|588260897|FG009|Induction|Withdrawal by Subject|0|||
162879662|NCT02883049|588260898|FG010|Induction|Withdrawal by Subject|0|||
162879663|NCT02883049|588260899|FG011|Induction|Withdrawal by Subject|0|||
162879664|NCT02883049|588260900|FG012|Induction|Withdrawal by Subject|0|||
162879665|NCT02883049|588260901|FG013|Induction|Withdrawal by Subject|0|||
162879666|NCT02883049|588260902|FG014|Induction|Withdrawal by Subject|0|||
162879667|NCT02883049|588260903|FG015|Induction|Withdrawal by Subject|0|||
162879668|NCT02883049|588260888|FG000|Induction|Ineligible|35|||
162879669|NCT02883049|588260889|FG001|Induction|Ineligible|1|||
162879670|NCT02883049|588260890|FG002|Induction|Ineligible|0|||
162879671|NCT02883049|588260891|FG003|Induction|Ineligible|0|||
162879672|NCT02883049|588260892|FG004|Induction|Ineligible|0|||
162879673|NCT02883049|588260893|FG005|Induction|Ineligible|0|||
162879674|NCT02883049|588260894|FG006|Induction|Ineligible|0|||
162879675|NCT02883049|588260895|FG007|Induction|Ineligible|0|||
162879676|NCT02883049|588260896|FG008|Induction|Ineligible|0|||
162879677|NCT02883049|588260897|FG009|Induction|Ineligible|0|||
162879678|NCT02883049|588260898|FG010|Induction|Ineligible|0|||
162879679|NCT02883049|588260899|FG011|Induction|Ineligible|0|||
162879680|NCT02883049|588260900|FG012|Induction|Ineligible|0|||
162879681|NCT02883049|588260901|FG013|Induction|Ineligible|0|||
162879682|NCT02883049|588260902|FG014|Induction|Ineligible|0|||
162879683|NCT02883049|588260903|FG015|Induction|Ineligible|0|||
162879684|NCT02883049|588260888|FG000|Induction|Refusal of further protocol therapy|466|||
162879685|NCT02883049|588260889|FG001|Induction|Refusal of further protocol therapy|2|||
162879686|NCT02883049|588260890|FG002|Induction|Refusal of further protocol therapy|0|||
162879687|NCT02883049|588260891|FG003|Induction|Refusal of further protocol therapy|0|||
162879688|NCT02883049|588260892|FG004|Induction|Refusal of further protocol therapy|0|||
162879689|NCT02883049|588260893|FG005|Induction|Refusal of further protocol therapy|0|||
162879690|NCT02883049|588260894|FG006|Induction|Refusal of further protocol therapy|0|||
162879691|NCT02883049|588260895|FG007|Induction|Refusal of further protocol therapy|0|||
162879692|NCT02883049|588260896|FG008|Induction|Refusal of further protocol therapy|0|||
162879693|NCT02883049|588260897|FG009|Induction|Refusal of further protocol therapy|0|||
162879694|NCT02883049|588260898|FG010|Induction|Refusal of further protocol therapy|0|||
162879695|NCT02883049|588260899|FG011|Induction|Refusal of further protocol therapy|0|||
162879696|NCT02883049|588260900|FG012|Induction|Refusal of further protocol therapy|0|||
162879697|NCT02883049|588260901|FG013|Induction|Refusal of further protocol therapy|0|||
162879698|NCT02883049|588260902|FG014|Induction|Refusal of further protocol therapy|0|||
162879699|NCT02883049|588260903|FG015|Induction|Refusal of further protocol therapy|0|||
162879700|NCT02883049|588260888|FG000|Induction|Identified as Ph+ patients|279|||
162879701|NCT02883049|588260889|FG001|Induction|Identified as Ph+ patients|1|||
162879702|NCT02883049|588260890|FG002|Induction|Identified as Ph+ patients|0|||
162879703|NCT02883049|588260891|FG003|Induction|Identified as Ph+ patients|0|||
162879704|NCT02883049|588260892|FG004|Induction|Identified as Ph+ patients|0|||
162879705|NCT02883049|588260893|FG005|Induction|Identified as Ph+ patients|0|||
162879706|NCT02883049|588260894|FG006|Induction|Identified as Ph+ patients|0|||
162879707|NCT02883049|588260895|FG007|Induction|Identified as Ph+ patients|0|||
162879708|NCT02883049|588260896|FG008|Induction|Identified as Ph+ patients|0|||
162879709|NCT02883049|588260897|FG009|Induction|Identified as Ph+ patients|0|||
162879710|NCT02883049|588260898|FG010|Induction|Identified as Ph+ patients|0|||
162879711|NCT02883049|588260899|FG011|Induction|Identified as Ph+ patients|0|||
162879712|NCT02883049|588260900|FG012|Induction|Identified as Ph+ patients|0|||
162879713|NCT02883049|588260901|FG013|Induction|Identified as Ph+ patients|0|||
162879714|NCT02883049|588260902|FG014|Induction|Identified as Ph+ patients|0|||
162879715|NCT02883049|588260903|FG015|Induction|Identified as Ph+ patients|0|||
163048431|NCT02513550|588884798|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
162879716|NCT02883049|588260888|FG000|Induction|M3 Marrow at Day29|8|||
162879717|NCT02883049|588260889|FG001|Induction|M3 Marrow at Day29|1|||
162879718|NCT02883049|588260890|FG002|Induction|M3 Marrow at Day29|0|||
162879719|NCT02883049|588260891|FG003|Induction|M3 Marrow at Day29|0|||
162879720|NCT02883049|588260892|FG004|Induction|M3 Marrow at Day29|0|||
162879721|NCT02883049|588260893|FG005|Induction|M3 Marrow at Day29|0|||
162879722|NCT02883049|588260894|FG006|Induction|M3 Marrow at Day29|0|||
162879723|NCT02883049|588260895|FG007|Induction|M3 Marrow at Day29|0|||
162879724|NCT02883049|588260896|FG008|Induction|M3 Marrow at Day29|0|||
162879725|NCT02883049|588260897|FG009|Induction|M3 Marrow at Day29|0|||
162879726|NCT02883049|588260898|FG010|Induction|M3 Marrow at Day29|0|||
162879727|NCT02883049|588260899|FG011|Induction|M3 Marrow at Day29|0|||
162879728|NCT02883049|588260900|FG012|Induction|M3 Marrow at Day29|0|||
162879729|NCT02883049|588260901|FG013|Induction|M3 Marrow at Day29|0|||
162879730|NCT02883049|588260902|FG014|Induction|M3 Marrow at Day29|0|||
162879731|NCT02883049|588260903|FG015|Induction|M3 Marrow at Day29|0|||
162879732|NCT02883049|588260888|FG000|Induction|Inevaluable|33|||
162879733|NCT02883049|588260889|FG001|Induction|Inevaluable|1|||
162879734|NCT02883049|588260890|FG002|Induction|Inevaluable|0|||
162879735|NCT02883049|588260891|FG003|Induction|Inevaluable|0|||
162879736|NCT02883049|588260892|FG004|Induction|Inevaluable|0|||
162879737|NCT02883049|588260893|FG005|Induction|Inevaluable|0|||
162879738|NCT02883049|588260894|FG006|Induction|Inevaluable|0|||
162879739|NCT02883049|588260895|FG007|Induction|Inevaluable|0|||
162879740|NCT02883049|588260896|FG008|Induction|Inevaluable|0|||
162879741|NCT02883049|588260897|FG009|Induction|Inevaluable|0|||
162879742|NCT02883049|588260898|FG010|Induction|Inevaluable|0|||
162879743|NCT02883049|588260899|FG011|Induction|Inevaluable|0|||
162879744|NCT02883049|588260900|FG012|Induction|Inevaluable|0|||
162879745|NCT02883049|588260901|FG013|Induction|Inevaluable|0|||
162879746|NCT02883049|588260902|FG014|Induction|Inevaluable|0|||
162879747|NCT02883049|588260903|FG015|Induction|Inevaluable|0|||
162879748|NCT02883049|588260888|FG000|Induction|Identified as VHR at end of Induction|244|||
162879749|NCT02883049|588260889|FG001|Induction|Identified as VHR at end of Induction|0|||
162879750|NCT02883049|588260890|FG002|Induction|Identified as VHR at end of Induction|0|||
162879751|NCT02883049|588260891|FG003|Induction|Identified as VHR at end of Induction|0|||
162879752|NCT02883049|588260892|FG004|Induction|Identified as VHR at end of Induction|0|||
162879753|NCT02883049|588260893|FG005|Induction|Identified as VHR at end of Induction|0|||
162879754|NCT02883049|588260894|FG006|Induction|Identified as VHR at end of Induction|0|||
162879755|NCT02883049|588260895|FG007|Induction|Identified as VHR at end of Induction|0|||
162879756|NCT02883049|588260896|FG008|Induction|Identified as VHR at end of Induction|0|||
162879757|NCT02883049|588260897|FG009|Induction|Identified as VHR at end of Induction|0|||
162879758|NCT02883049|588260898|FG010|Induction|Identified as VHR at end of Induction|0|||
162879759|NCT02883049|588260899|FG011|Induction|Identified as VHR at end of Induction|0|||
162879760|NCT02883049|588260900|FG012|Induction|Identified as VHR at end of Induction|0|||
162879761|NCT02883049|588260901|FG013|Induction|Identified as VHR at end of Induction|0|||
162879762|NCT02883049|588260902|FG014|Induction|Identified as VHR at end of Induction|0|||
162879763|NCT02883049|588260903|FG015|Induction|Identified as VHR at end of Induction|0|||
162879764|NCT02883049|588260888|FG000|Induction|Moved to another non-COG institution|3|||
162879765|NCT02883049|588260889|FG001|Induction|Moved to another non-COG institution|0|||
162879766|NCT02883049|588260890|FG002|Induction|Moved to another non-COG institution|0|||
162879767|NCT02883049|588260891|FG003|Induction|Moved to another non-COG institution|0|||
162879768|NCT02883049|588260892|FG004|Induction|Moved to another non-COG institution|0|||
162879769|NCT02883049|588260893|FG005|Induction|Moved to another non-COG institution|0|||
162879770|NCT02883049|588260894|FG006|Induction|Moved to another non-COG institution|0|||
162879771|NCT02883049|588260895|FG007|Induction|Moved to another non-COG institution|0|||
162879772|NCT02883049|588260896|FG008|Induction|Moved to another non-COG institution|0|||
162879773|NCT02883049|588260897|FG009|Induction|Moved to another non-COG institution|0|||
162879774|NCT02883049|588260898|FG010|Induction|Moved to another non-COG institution|0|||
162879775|NCT02883049|588260899|FG011|Induction|Moved to another non-COG institution|0|||
162879776|NCT02883049|588260900|FG012|Induction|Moved to another non-COG institution|0|||
162879777|NCT02883049|588260901|FG013|Induction|Moved to another non-COG institution|0|||
162879778|NCT02883049|588260902|FG014|Induction|Moved to another non-COG institution|0|||
162879779|NCT02883049|588260903|FG015|Induction|Moved to another non-COG institution|0|||
162879780|NCT02883049|588260888|FG000|Induction|Randomization closed|41|||
162879781|NCT02883049|588260889|FG001|Induction|Randomization closed|0|||
162879782|NCT02883049|588260890|FG002|Induction|Randomization closed|0|||
162879783|NCT02883049|588260891|FG003|Induction|Randomization closed|0|||
162879784|NCT02883049|588260892|FG004|Induction|Randomization closed|0|||
162879785|NCT02883049|588260893|FG005|Induction|Randomization closed|0|||
162879786|NCT02883049|588260894|FG006|Induction|Randomization closed|0|||
162879787|NCT02883049|588260895|FG007|Induction|Randomization closed|0|||
162879788|NCT02883049|588260896|FG008|Induction|Randomization closed|0|||
162879789|NCT02883049|588260897|FG009|Induction|Randomization closed|0|||
162879790|NCT02883049|588260898|FG010|Induction|Randomization closed|0|||
162879791|NCT02883049|588260899|FG011|Induction|Randomization closed|0|||
162879792|NCT02883049|588260900|FG012|Induction|Randomization closed|0|||
162879793|NCT02883049|588260901|FG013|Induction|Randomization closed|0|||
162879794|NCT02883049|588260902|FG014|Induction|Randomization closed|0|||
162879795|NCT02883049|588260903|FG015|Induction|Randomization closed|0|||
162879796|NCT02883049|588260888|FG000|Induction|MRD negative|36|||
162879797|NCT02883049|588260889|FG001|Induction|MRD negative|0|||
162879798|NCT02883049|588260890|FG002|Induction|MRD negative|0|||
162879799|NCT02883049|588260891|FG003|Induction|MRD negative|0|||
162879800|NCT02883049|588260892|FG004|Induction|MRD negative|0|||
162879801|NCT02883049|588260893|FG005|Induction|MRD negative|0|||
162879802|NCT02883049|588260894|FG006|Induction|MRD negative|0|||
162879803|NCT02883049|588260895|FG007|Induction|MRD negative|0|||
162879804|NCT02883049|588260896|FG008|Induction|MRD negative|0|||
162879805|NCT02883049|588260897|FG009|Induction|MRD negative|0|||
162707574|NCT00984282|587638280|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
162707575|NCT00984282|587638281|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
162707576|NCT00984282|587638280|FG000|Double Blind Treatment|Lost to Follow-up|3|||
162707577|NCT00984282|587638281|FG001|Double Blind Treatment|Lost to Follow-up|0|||
162707578|NCT00984282|587638280|FG000|Double Blind Treatment|Death|8|||
162707579|NCT00984282|587638281|FG001|Double Blind Treatment|Death|4|||
162707580|NCT00984282|587638280|FG000|Double Blind Treatment|Not treated|0|||
162961798|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961799|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961800|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162707581|NCT00984282|587638281|FG001|Double Blind Treatment|Not treated|1|||
162707582|NCT00984282|587638280|FG000|Double Blind Treatment|Switched to commercial drug|6|||
162707583|NCT00984282|587638281|FG001|Double Blind Treatment|Switched to commercial drug|1|||
162707584|NCT00984282|587638280|FG000|Double Blind Treatment|protocol driven decision point|1|||
162707585|NCT00984282|587638281|FG001|Double Blind Treatment|protocol driven decision point|1|||
162707586|NCT00984282|587638280|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
162707587|NCT00984282|587638281|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
162707588|NCT00984282|587638280|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
162879806|NCT02883049|588260898|FG010|Induction|MRD negative|0|||
162879807|NCT02883049|588260899|FG011|Induction|MRD negative|0|||
162879808|NCT02883049|588260900|FG012|Induction|MRD negative|0|||
162879809|NCT02883049|588260901|FG013|Induction|MRD negative|0|||
162879810|NCT02883049|588260902|FG014|Induction|MRD negative|0|||
162879811|NCT02883049|588260903|FG015|Induction|MRD negative|0|||
162879812|NCT02883049|588260888|FG000|Induction|Identified as HR patients|165|||
162879813|NCT02883049|588260889|FG001|Induction|Identified as HR patients|0|||
162879814|NCT02883049|588260890|FG002|Induction|Identified as HR patients|0|||
162879815|NCT02883049|588260891|FG003|Induction|Identified as HR patients|0|||
162879816|NCT02883049|588260892|FG004|Induction|Identified as HR patients|0|||
162879817|NCT02883049|588260893|FG005|Induction|Identified as HR patients|0|||
162879818|NCT02883049|588260894|FG006|Induction|Identified as HR patients|0|||
162879819|NCT02883049|588260895|FG007|Induction|Identified as HR patients|0|||
162879820|NCT02883049|588260896|FG008|Induction|Identified as HR patients|0|||
162879821|NCT02883049|588260897|FG009|Induction|Identified as HR patients|0|||
162879822|NCT02883049|588260898|FG010|Induction|Identified as HR patients|0|||
162879823|NCT02883049|588260899|FG011|Induction|Identified as HR patients|0|||
162879824|NCT02883049|588260900|FG012|Induction|Identified as HR patients|0|||
162879825|NCT02883049|588260901|FG013|Induction|Identified as HR patients|0|||
162879826|NCT02883049|588260902|FG014|Induction|Identified as HR patients|0|||
162879827|NCT02883049|588260903|FG015|Induction|Identified as HR patients|0|||
162879828|NCT02883049|588260888|FG000|Induction|Developed SMN|0|||
162879829|NCT02883049|588260889|FG001|Induction|Developed SMN|1|||
162879830|NCT02883049|588260890|FG002|Induction|Developed SMN|0|||
162879831|NCT02883049|588260891|FG003|Induction|Developed SMN|0|||
162879832|NCT02883049|588260892|FG004|Induction|Developed SMN|0|||
162707589|NCT00984282|587638281|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
162707590|NCT00984282|587638280|FG000|Open-label Treatment|Adverse Event|20|||
162879833|NCT02883049|588260893|FG005|Induction|Developed SMN|0|||
162879834|NCT02883049|588260894|FG006|Induction|Developed SMN|0|||
162879835|NCT02883049|588260895|FG007|Induction|Developed SMN|0|||
162879836|NCT02883049|588260896|FG008|Induction|Developed SMN|0|||
162879837|NCT02883049|588260897|FG009|Induction|Developed SMN|0|||
162879838|NCT02883049|588260898|FG010|Induction|Developed SMN|0|||
162879839|NCT02883049|588260899|FG011|Induction|Developed SMN|0|||
162879840|NCT02883049|588260900|FG012|Induction|Developed SMN|0|||
162879841|NCT02883049|588260901|FG013|Induction|Developed SMN|0|||
162879842|NCT02883049|588260902|FG014|Induction|Developed SMN|0|||
162879843|NCT02883049|588260903|FG015|Induction|Developed SMN|0|||
162961801|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961802|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162707591|NCT00984282|587638281|FG001|Open-label Treatment|Adverse Event|30|||
162707592|NCT00984282|587638280|FG000|Open-label Treatment|Withdrawal by Subject|6|||
162961803|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162707593|NCT00984282|587638281|FG001|Open-label Treatment|Withdrawal by Subject|21|||
162961804|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162879844|NCT02883049|588260888|FG000|Induction|Enrolled onto another COG study|72|||
162879845|NCT02883049|588260889|FG001|Induction|Enrolled onto another COG study|0|||
162707594|NCT00984282|587638280|FG000|Open-label Treatment|Death|7|||
162879846|NCT02883049|588260890|FG002|Induction|Enrolled onto another COG study|0|||
162879847|NCT02883049|588260891|FG003|Induction|Enrolled onto another COG study|0|||
162707595|NCT00984282|587638281|FG001|Open-label Treatment|Death|15|||
162707596|NCT00984282|587638280|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
162879848|NCT02883049|588260892|FG004|Induction|Enrolled onto another COG study|0|||
162879849|NCT02883049|588260893|FG005|Induction|Enrolled onto another COG study|0|||
162879850|NCT02883049|588260894|FG006|Induction|Enrolled onto another COG study|0|||
162879851|NCT02883049|588260895|FG007|Induction|Enrolled onto another COG study|0|||
162879852|NCT02883049|588260896|FG008|Induction|Enrolled onto another COG study|0|||
162879853|NCT02883049|588260897|FG009|Induction|Enrolled onto another COG study|0|||
162879854|NCT02883049|588260898|FG010|Induction|Enrolled onto another COG study|0|||
162879855|NCT02883049|588260899|FG011|Induction|Enrolled onto another COG study|0|||
162879856|NCT02883049|588260900|FG012|Induction|Enrolled onto another COG study|0|||
162879857|NCT02883049|588260901|FG013|Induction|Enrolled onto another COG study|0|||
162879858|NCT02883049|588260902|FG014|Induction|Enrolled onto another COG study|0|||
162879859|NCT02883049|588260903|FG015|Induction|Enrolled onto another COG study|0|||
162879860|NCT02883049|588260888|FG000|Induction|Incomplete induction data|17|||
162879861|NCT02883049|588260889|FG001|Induction|Incomplete induction data|0|||
162879862|NCT02883049|588260890|FG002|Induction|Incomplete induction data|0|||
162879863|NCT02883049|588260891|FG003|Induction|Incomplete induction data|0|||
162879864|NCT02883049|588260892|FG004|Induction|Incomplete induction data|0|||
162879865|NCT02883049|588260893|FG005|Induction|Incomplete induction data|0|||
162879866|NCT02883049|588260894|FG006|Induction|Incomplete induction data|0|||
162879867|NCT02883049|588260895|FG007|Induction|Incomplete induction data|0|||
162879868|NCT02883049|588260896|FG008|Induction|Incomplete induction data|0|||
162879869|NCT02883049|588260897|FG009|Induction|Incomplete induction data|0|||
162879870|NCT02883049|588260898|FG010|Induction|Incomplete induction data|0|||
162879871|NCT02883049|588260899|FG011|Induction|Incomplete induction data|0|||
162879872|NCT02883049|588260900|FG012|Induction|Incomplete induction data|0|||
162879873|NCT02883049|588260901|FG013|Induction|Incomplete induction data|0|||
162879874|NCT02883049|588260902|FG014|Induction|Incomplete induction data|0|||
162879875|NCT02883049|588260903|FG015|Induction|Incomplete induction data|0|||
162616177|NCT01309165|587311633|FG000|Overall Study|Admitted to hospital for second stroke|1|||
162616178|NCT01309165|587311634|FG001|Overall Study|Admitted to hospital for second stroke|0|||
162616179|NCT01739309|587311635|FG000|Overall Study|Adverse Event|1|||
162616180|NCT01739309|587311635|FG000|Overall Study|Withdrawal by Subject|1|||
162616181|NCT00178633|587311636|FG000|Overall Study|Lost to Follow-up|6|||
162616182|NCT04810481|587311638|FG000|Overall Study|Disqualified data sets|10|||
162616183|NCT04810481|587311639|FG001|Overall Study|Disqualified data sets|28|||
162616184|NCT01484132|587311643|FG000|Overall Study|Lost to Follow-up|8|||
162616185|NCT01484132|587311643|FG000|Overall Study|Difficulty with time commitment|2|||
162616186|NCT01484132|587311643|FG000|Overall Study|Ineligible|1|||
162707597|NCT00984282|587638281|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
162707598|NCT00984282|587638280|FG000|Open-label Treatment|Lost to Follow-up|1|||
162879876|NCT02883049|588260888|FG000|Post Induction|Adverse Event|0|||
162879877|NCT02883049|588260889|FG001|Post Induction|Adverse Event|0|||
162879878|NCT02883049|588260890|FG002|Post Induction|Adverse Event|0|||
162879879|NCT02883049|588260891|FG003|Post Induction|Adverse Event|7|||
162879880|NCT02883049|588260892|FG004|Post Induction|Adverse Event|8|||
162879881|NCT02883049|588260893|FG005|Post Induction|Adverse Event|3|||
162879882|NCT02883049|588260894|FG006|Post Induction|Adverse Event|4|||
162879883|NCT02883049|588260895|FG007|Post Induction|Adverse Event|5|||
162879884|NCT02883049|588260896|FG008|Post Induction|Adverse Event|6|||
162879885|NCT02883049|588260897|FG009|Post Induction|Adverse Event|7|||
162961805|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961806|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961807|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961808|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961809|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961810|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961811|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961812|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961813|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961814|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961815|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961816|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
162961817|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961818|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961819|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961820|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162961821|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961822|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961823|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961824|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961825|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961826|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961827|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961828|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961829|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
162616187|NCT01484132|587311643|FG000|Overall Study|No pre-treatment urine sample collected|1|||
162879886|NCT02883049|588260898|FG010|Post Induction|Adverse Event|2|||
162879887|NCT02883049|588260899|FG011|Post Induction|Adverse Event|2|||
162616188|NCT01484132|587311643|FG000|Overall Study|No post-treatment urine sample collected|10|||
162616189|NCT03538431|587311644|FG000|Overall Study|Physician Decision|0|||
162616190|NCT03538431|587311645|FG001|Overall Study|Physician Decision|1|||
162616191|NCT03538431|587311644|FG000|Overall Study|Withdrawal by Subject|1|||
162616192|NCT03538431|587311645|FG001|Overall Study|Withdrawal by Subject|0|||
162616193|NCT00620464|587311646|FG000|Overall Study|Adverse Event|15|||
162616194|NCT00620464|587311647|FG001|Overall Study|Adverse Event|17|||
162616195|NCT00620464|587311646|FG000|Overall Study|Lost to Follow-up|1|||
162616196|NCT00620464|587311647|FG001|Overall Study|Lost to Follow-up|1|||
162879888|NCT02883049|588260900|FG012|Post Induction|Adverse Event|0|||
162616197|NCT00620464|587311646|FG000|Overall Study|Planning Pregnancy|1|||
162616198|NCT00620464|587311647|FG001|Overall Study|Planning Pregnancy|4|||
162616199|NCT00620464|587311646|FG000|Overall Study|Personal|2|||
162616200|NCT00620464|587311647|FG001|Overall Study|Personal|2|||
162879889|NCT02883049|588260901|FG013|Post Induction|Adverse Event|0|||
162879890|NCT02883049|588260902|FG014|Post Induction|Adverse Event|5|||
162879891|NCT02883049|588260903|FG015|Post Induction|Adverse Event|2|||
162879892|NCT02883049|588260888|FG000|Post Induction|Death|0|||
162879893|NCT02883049|588260889|FG001|Post Induction|Death|0|||
162879894|NCT02883049|588260890|FG002|Post Induction|Death|0|||
162879895|NCT02883049|588260891|FG003|Post Induction|Death|9|||
162879896|NCT02883049|588260892|FG004|Post Induction|Death|9|||
162879897|NCT02883049|588260893|FG005|Post Induction|Death|0|||
162879898|NCT02883049|588260894|FG006|Post Induction|Death|1|||
162879899|NCT02883049|588260895|FG007|Post Induction|Death|6|||
162879900|NCT02883049|588260896|FG008|Post Induction|Death|5|||
162879901|NCT02883049|588260897|FG009|Post Induction|Death|3|||
162879902|NCT02883049|588260898|FG010|Post Induction|Death|1|||
162879903|NCT02883049|588260899|FG011|Post Induction|Death|0|||
162879904|NCT02883049|588260900|FG012|Post Induction|Death|1|||
162879905|NCT02883049|588260901|FG013|Post Induction|Death|1|||
162879906|NCT02883049|588260902|FG014|Post Induction|Death|10|||
162879907|NCT02883049|588260903|FG015|Post Induction|Death|2|||
162879908|NCT02883049|588260888|FG000|Post Induction|Lost to Follow-up|0|||
162879909|NCT02883049|588260889|FG001|Post Induction|Lost to Follow-up|0|||
162879910|NCT02883049|588260890|FG002|Post Induction|Lost to Follow-up|0|||
162879911|NCT02883049|588260891|FG003|Post Induction|Lost to Follow-up|0|||
162879912|NCT02883049|588260892|FG004|Post Induction|Lost to Follow-up|1|||
162879913|NCT02883049|588260893|FG005|Post Induction|Lost to Follow-up|1|||
162879914|NCT02883049|588260894|FG006|Post Induction|Lost to Follow-up|0|||
162879915|NCT02883049|588260895|FG007|Post Induction|Lost to Follow-up|0|||
162879916|NCT02883049|588260896|FG008|Post Induction|Lost to Follow-up|3|||
162879917|NCT02883049|588260897|FG009|Post Induction|Lost to Follow-up|0|||
162879918|NCT02883049|588260898|FG010|Post Induction|Lost to Follow-up|1|||
162879919|NCT02883049|588260899|FG011|Post Induction|Lost to Follow-up|0|||
162879920|NCT02883049|588260900|FG012|Post Induction|Lost to Follow-up|0|||
162879921|NCT02883049|588260901|FG013|Post Induction|Lost to Follow-up|0|||
162879922|NCT02883049|588260902|FG014|Post Induction|Lost to Follow-up|0|||
162879923|NCT02883049|588260903|FG015|Post Induction|Lost to Follow-up|0|||
162879924|NCT02883049|588260888|FG000|Post Induction|Physician Decision|0|||
162879925|NCT02883049|588260889|FG001|Post Induction|Physician Decision|0|||
162879926|NCT02883049|588260890|FG002|Post Induction|Physician Decision|0|||
162879927|NCT02883049|588260891|FG003|Post Induction|Physician Decision|27|||
162879928|NCT02883049|588260892|FG004|Post Induction|Physician Decision|27|||
162879929|NCT02883049|588260893|FG005|Post Induction|Physician Decision|23|||
162879930|NCT02883049|588260894|FG006|Post Induction|Physician Decision|30|||
162879931|NCT02883049|588260895|FG007|Post Induction|Physician Decision|56|||
162879932|NCT02883049|588260896|FG008|Post Induction|Physician Decision|85|||
162879933|NCT02883049|588260897|FG009|Post Induction|Physician Decision|12|||
162879934|NCT02883049|588260898|FG010|Post Induction|Physician Decision|5|||
162879935|NCT02883049|588260899|FG011|Post Induction|Physician Decision|14|||
162879936|NCT02883049|588260900|FG012|Post Induction|Physician Decision|1|||
162879937|NCT02883049|588260901|FG013|Post Induction|Physician Decision|11|||
162879938|NCT02883049|588260902|FG014|Post Induction|Physician Decision|19|||
162879939|NCT02883049|588260903|FG015|Post Induction|Physician Decision|5|||
162879940|NCT02883049|588260888|FG000|Post Induction|Protocol Violation|0|||
162879941|NCT02883049|588260889|FG001|Post Induction|Protocol Violation|0|||
162879942|NCT02883049|588260890|FG002|Post Induction|Protocol Violation|0|||
162879943|NCT02883049|588260891|FG003|Post Induction|Protocol Violation|0|||
162879944|NCT02883049|588260892|FG004|Post Induction|Protocol Violation|0|||
162879945|NCT02883049|588260893|FG005|Post Induction|Protocol Violation|0|||
162879946|NCT02883049|588260894|FG006|Post Induction|Protocol Violation|0|||
162879947|NCT02883049|588260895|FG007|Post Induction|Protocol Violation|1|||
162879948|NCT02883049|588260896|FG008|Post Induction|Protocol Violation|0|||
162879949|NCT02883049|588260897|FG009|Post Induction|Protocol Violation|0|||
162879950|NCT02883049|588260898|FG010|Post Induction|Protocol Violation|0|||
162879951|NCT02883049|588260899|FG011|Post Induction|Protocol Violation|0|||
162879952|NCT02883049|588260900|FG012|Post Induction|Protocol Violation|0|||
162879953|NCT02883049|588260901|FG013|Post Induction|Protocol Violation|0|||
162879954|NCT02883049|588260902|FG014|Post Induction|Protocol Violation|0|||
162879955|NCT02883049|588260903|FG015|Post Induction|Protocol Violation|0|||
162879956|NCT02883049|588260888|FG000|Post Induction|Withdrawal by Subject|0|||
162879957|NCT02883049|588260889|FG001|Post Induction|Withdrawal by Subject|0|||
162879958|NCT02883049|588260890|FG002|Post Induction|Withdrawal by Subject|0|||
162879959|NCT02883049|588260891|FG003|Post Induction|Withdrawal by Subject|5|||
162879960|NCT02883049|588260892|FG004|Post Induction|Withdrawal by Subject|2|||
162879961|NCT02883049|588260893|FG005|Post Induction|Withdrawal by Subject|1|||
162879962|NCT02883049|588260894|FG006|Post Induction|Withdrawal by Subject|0|||
162961830|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961831|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961832|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961833|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961834|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961835|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961836|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961837|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961838|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961839|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961840|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961841|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961842|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
162961843|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
162879963|NCT02883049|588260895|FG007|Post Induction|Withdrawal by Subject|0|||
162879964|NCT02883049|588260896|FG008|Post Induction|Withdrawal by Subject|2|||
162879965|NCT02883049|588260897|FG009|Post Induction|Withdrawal by Subject|0|||
162879966|NCT02883049|588260898|FG010|Post Induction|Withdrawal by Subject|1|||
162879967|NCT02883049|588260899|FG011|Post Induction|Withdrawal by Subject|1|||
162879968|NCT02883049|588260900|FG012|Post Induction|Withdrawal by Subject|0|||
162879969|NCT02883049|588260901|FG013|Post Induction|Withdrawal by Subject|0|||
162879970|NCT02883049|588260902|FG014|Post Induction|Withdrawal by Subject|1|||
162879971|NCT02883049|588260903|FG015|Post Induction|Withdrawal by Subject|0|||
163048432|NCT02513550|588884799|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
163048433|NCT02513550|588884800|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
163048434|NCT02513550|588884801|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
163048435|NCT02513550|588884796|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
163048436|NCT02513550|588884797|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
162879972|NCT02883049|588260888|FG000|Post Induction|Ineligible|0|||
162879973|NCT02883049|588260889|FG001|Post Induction|Ineligible|0|||
162879974|NCT02883049|588260890|FG002|Post Induction|Ineligible|2|||
162879975|NCT02883049|588260891|FG003|Post Induction|Ineligible|0|||
162879976|NCT02883049|588260892|FG004|Post Induction|Ineligible|0|||
162879977|NCT02883049|588260893|FG005|Post Induction|Ineligible|0|||
162879978|NCT02883049|588260894|FG006|Post Induction|Ineligible|1|||
162879979|NCT02883049|588260895|FG007|Post Induction|Ineligible|0|||
162879980|NCT02883049|588260896|FG008|Post Induction|Ineligible|0|||
162879981|NCT02883049|588260897|FG009|Post Induction|Ineligible|0|||
162879982|NCT02883049|588260898|FG010|Post Induction|Ineligible|1|||
162879983|NCT02883049|588260899|FG011|Post Induction|Ineligible|0|||
162879984|NCT02883049|588260900|FG012|Post Induction|Ineligible|0|||
162879985|NCT02883049|588260901|FG013|Post Induction|Ineligible|0|||
162879986|NCT02883049|588260902|FG014|Post Induction|Ineligible|0|||
162879987|NCT02883049|588260903|FG015|Post Induction|Ineligible|1|||
162879988|NCT02883049|588260888|FG000|Post Induction|Refusal of further protocol therapy|0|||
162879989|NCT02883049|588260889|FG001|Post Induction|Refusal of further protocol therapy|0|||
162879990|NCT02883049|588260890|FG002|Post Induction|Refusal of further protocol therapy|0|||
162879991|NCT02883049|588260891|FG003|Post Induction|Refusal of further protocol therapy|11|||
162879992|NCT02883049|588260892|FG004|Post Induction|Refusal of further protocol therapy|15|||
162879993|NCT02883049|588260893|FG005|Post Induction|Refusal of further protocol therapy|9|||
162879994|NCT02883049|588260894|FG006|Post Induction|Refusal of further protocol therapy|13|||
162879995|NCT02883049|588260895|FG007|Post Induction|Refusal of further protocol therapy|5|||
162879996|NCT02883049|588260896|FG008|Post Induction|Refusal of further protocol therapy|21|||
162879997|NCT02883049|588260897|FG009|Post Induction|Refusal of further protocol therapy|7|||
162879998|NCT02883049|588260898|FG010|Post Induction|Refusal of further protocol therapy|0|||
162879999|NCT02883049|588260899|FG011|Post Induction|Refusal of further protocol therapy|7|||
162880000|NCT02883049|588260900|FG012|Post Induction|Refusal of further protocol therapy|3|||
162880001|NCT02883049|588260901|FG013|Post Induction|Refusal of further protocol therapy|0|||
162880002|NCT02883049|588260902|FG014|Post Induction|Refusal of further protocol therapy|4|||
162880003|NCT02883049|588260903|FG015|Post Induction|Refusal of further protocol therapy|1|||
162880004|NCT02883049|588260888|FG000|Post Induction|Inevaluable|0|||
162880005|NCT02883049|588260889|FG001|Post Induction|Inevaluable|0|||
162880006|NCT02883049|588260890|FG002|Post Induction|Inevaluable|0|||
162880007|NCT02883049|588260891|FG003|Post Induction|Inevaluable|1|||
162880008|NCT02883049|588260892|FG004|Post Induction|Inevaluable|1|||
162880009|NCT02883049|588260893|FG005|Post Induction|Inevaluable|2|||
162880010|NCT02883049|588260894|FG006|Post Induction|Inevaluable|7|||
162880011|NCT02883049|588260895|FG007|Post Induction|Inevaluable|6|||
162880012|NCT02883049|588260896|FG008|Post Induction|Inevaluable|4|||
162880013|NCT02883049|588260897|FG009|Post Induction|Inevaluable|4|||
162880014|NCT02883049|588260898|FG010|Post Induction|Inevaluable|1|||
162880015|NCT02883049|588260899|FG011|Post Induction|Inevaluable|1|||
162880016|NCT02883049|588260900|FG012|Post Induction|Inevaluable|2|||
162880017|NCT02883049|588260901|FG013|Post Induction|Inevaluable|0|||
162880018|NCT02883049|588260902|FG014|Post Induction|Inevaluable|0|||
162880019|NCT02883049|588260903|FG015|Post Induction|Inevaluable|1|||
162880020|NCT02883049|588260888|FG000|Post Induction|Moved to another non-COG institution|0|||
162880021|NCT02883049|588260889|FG001|Post Induction|Moved to another non-COG institution|0|||
162880022|NCT02883049|588260890|FG002|Post Induction|Moved to another non-COG institution|0|||
162880023|NCT02883049|588260891|FG003|Post Induction|Moved to another non-COG institution|0|||
162880024|NCT02883049|588260892|FG004|Post Induction|Moved to another non-COG institution|0|||
162880025|NCT02883049|588260893|FG005|Post Induction|Moved to another non-COG institution|0|||
163048437|NCT02513550|588884798|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
163048438|NCT02513550|588884799|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
163048439|NCT02513550|588884800|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163048440|NCT02513550|588884801|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
163048441|NCT02513550|588884796|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163048442|NCT02513550|588884797|FG001|Double Blind Treatment Period|Protocol Violation|1|||
162880026|NCT02883049|588260894|FG006|Post Induction|Moved to another non-COG institution|0|||
162880027|NCT02883049|588260895|FG007|Post Induction|Moved to another non-COG institution|2|||
162880028|NCT02883049|588260896|FG008|Post Induction|Moved to another non-COG institution|2|||
162880029|NCT02883049|588260897|FG009|Post Induction|Moved to another non-COG institution|0|||
162880030|NCT02883049|588260898|FG010|Post Induction|Moved to another non-COG institution|0|||
162880031|NCT02883049|588260899|FG011|Post Induction|Moved to another non-COG institution|1|||
162880032|NCT02883049|588260900|FG012|Post Induction|Moved to another non-COG institution|0|||
162880033|NCT02883049|588260901|FG013|Post Induction|Moved to another non-COG institution|0|||
162880034|NCT02883049|588260902|FG014|Post Induction|Moved to another non-COG institution|0|||
162880035|NCT02883049|588260903|FG015|Post Induction|Moved to another non-COG institution|0|||
162880036|NCT02883049|588260888|FG000|Post Induction|Randomization closed|0|||
162880037|NCT02883049|588260889|FG001|Post Induction|Randomization closed|0|||
162880038|NCT02883049|588260890|FG002|Post Induction|Randomization closed|0|||
162880039|NCT02883049|588260891|FG003|Post Induction|Randomization closed|0|||
162880040|NCT02883049|588260892|FG004|Post Induction|Randomization closed|0|||
162880041|NCT02883049|588260893|FG005|Post Induction|Randomization closed|0|||
162880042|NCT02883049|588260894|FG006|Post Induction|Randomization closed|0|||
162880043|NCT02883049|588260895|FG007|Post Induction|Randomization closed|20|||
162880044|NCT02883049|588260896|FG008|Post Induction|Randomization closed|0|||
162880045|NCT02883049|588260897|FG009|Post Induction|Randomization closed|0|||
162880046|NCT02883049|588260898|FG010|Post Induction|Randomization closed|0|||
162880047|NCT02883049|588260899|FG011|Post Induction|Randomization closed|0|||
162880048|NCT02883049|588260900|FG012|Post Induction|Randomization closed|0|||
162880049|NCT02883049|588260901|FG013|Post Induction|Randomization closed|0|||
162880050|NCT02883049|588260902|FG014|Post Induction|Randomization closed|0|||
162880051|NCT02883049|588260903|FG015|Post Induction|Randomization closed|0|||
162880052|NCT02883049|588260888|FG000|Post Induction|MRD negative|0|||
162880053|NCT02883049|588260889|FG001|Post Induction|MRD negative|0|||
162880054|NCT02883049|588260890|FG002|Post Induction|MRD negative|0|||
162880055|NCT02883049|588260891|FG003|Post Induction|MRD negative|0|||
162880056|NCT02883049|588260892|FG004|Post Induction|MRD negative|0|||
162880057|NCT02883049|588260893|FG005|Post Induction|MRD negative|0|||
162880058|NCT02883049|588260894|FG006|Post Induction|MRD negative|0|||
162880059|NCT02883049|588260895|FG007|Post Induction|MRD negative|11|||
162880060|NCT02883049|588260896|FG008|Post Induction|MRD negative|0|||
162880061|NCT02883049|588260897|FG009|Post Induction|MRD negative|0|||
162880062|NCT02883049|588260898|FG010|Post Induction|MRD negative|0|||
162880063|NCT02883049|588260899|FG011|Post Induction|MRD negative|0|||
162880064|NCT02883049|588260900|FG012|Post Induction|MRD negative|0|||
162880065|NCT02883049|588260901|FG013|Post Induction|MRD negative|0|||
162880066|NCT02883049|588260902|FG014|Post Induction|MRD negative|0|||
162880067|NCT02883049|588260903|FG015|Post Induction|MRD negative|0|||
162880068|NCT02883049|588260888|FG000|Post Induction|Developed SMN|0|||
162880069|NCT02883049|588260889|FG001|Post Induction|Developed SMN|0|||
162880070|NCT02883049|588260890|FG002|Post Induction|Developed SMN|0|||
162880071|NCT02883049|588260891|FG003|Post Induction|Developed SMN|0|||
162880072|NCT02883049|588260892|FG004|Post Induction|Developed SMN|1|||
162880073|NCT02883049|588260893|FG005|Post Induction|Developed SMN|0|||
162880074|NCT02883049|588260894|FG006|Post Induction|Developed SMN|1|||
162880075|NCT02883049|588260895|FG007|Post Induction|Developed SMN|0|||
162880076|NCT02883049|588260896|FG008|Post Induction|Developed SMN|0|||
162880077|NCT02883049|588260897|FG009|Post Induction|Developed SMN|0|||
162880078|NCT02883049|588260898|FG010|Post Induction|Developed SMN|1|||
162880079|NCT02883049|588260899|FG011|Post Induction|Developed SMN|1|||
162880080|NCT02883049|588260900|FG012|Post Induction|Developed SMN|0|||
162880081|NCT02883049|588260901|FG013|Post Induction|Developed SMN|0|||
162880082|NCT02883049|588260902|FG014|Post Induction|Developed SMN|1|||
162880083|NCT02883049|588260903|FG015|Post Induction|Developed SMN|0|||
162880084|NCT02883049|588260888|FG000|Post Induction|Enrolled onto another COG study|0|||
162880085|NCT02883049|588260889|FG001|Post Induction|Enrolled onto another COG study|0|||
162880086|NCT02883049|588260890|FG002|Post Induction|Enrolled onto another COG study|0|||
162880087|NCT02883049|588260891|FG003|Post Induction|Enrolled onto another COG study|1|||
162880088|NCT02883049|588260892|FG004|Post Induction|Enrolled onto another COG study|1|||
162880089|NCT02883049|588260893|FG005|Post Induction|Enrolled onto another COG study|0|||
162880090|NCT02883049|588260894|FG006|Post Induction|Enrolled onto another COG study|0|||
162880091|NCT02883049|588260895|FG007|Post Induction|Enrolled onto another COG study|4|||
162880092|NCT02883049|588260896|FG008|Post Induction|Enrolled onto another COG study|0|||
162880093|NCT02883049|588260897|FG009|Post Induction|Enrolled onto another COG study|0|||
162880094|NCT02883049|588260898|FG010|Post Induction|Enrolled onto another COG study|0|||
162880095|NCT02883049|588260899|FG011|Post Induction|Enrolled onto another COG study|2|||
162880096|NCT02883049|588260900|FG012|Post Induction|Enrolled onto another COG study|0|||
162880097|NCT02883049|588260901|FG013|Post Induction|Enrolled onto another COG study|1|||
162880098|NCT02883049|588260902|FG014|Post Induction|Enrolled onto another COG study|0|||
162880099|NCT02883049|588260903|FG015|Post Induction|Enrolled onto another COG study|0|||
162880100|NCT02883049|588260888|FG000|Post Induction|Recurrent leukemia|0|||
162880101|NCT02883049|588260889|FG001|Post Induction|Recurrent leukemia|0|||
162880102|NCT02883049|588260890|FG002|Post Induction|Recurrent leukemia|0|||
162880103|NCT02883049|588260891|FG003|Post Induction|Recurrent leukemia|17|||
162880104|NCT02883049|588260892|FG004|Post Induction|Recurrent leukemia|12|||
162880105|NCT02883049|588260893|FG005|Post Induction|Recurrent leukemia|4|||
162880106|NCT02883049|588260894|FG006|Post Induction|Recurrent leukemia|1|||
162880107|NCT02883049|588260895|FG007|Post Induction|Recurrent leukemia|13|||
162880108|NCT02883049|588260896|FG008|Post Induction|Recurrent leukemia|27|||
162880109|NCT02883049|588260897|FG009|Post Induction|Recurrent leukemia|5|||
162880110|NCT02883049|588260898|FG010|Post Induction|Recurrent leukemia|3|||
162880111|NCT02883049|588260899|FG011|Post Induction|Recurrent leukemia|12|||
162880112|NCT02883049|588260900|FG012|Post Induction|Recurrent leukemia|1|||
162880113|NCT02883049|588260901|FG013|Post Induction|Recurrent leukemia|1|||
162880114|NCT02883049|588260902|FG014|Post Induction|Recurrent leukemia|9|||
162880115|NCT02883049|588260903|FG015|Post Induction|Recurrent leukemia|3|||
162880116|NCT02883049|588260888|FG000|Post Induction|Induction Failure|0|||
162880117|NCT02883049|588260889|FG001|Post Induction|Induction Failure|0|||
162880118|NCT02883049|588260890|FG002|Post Induction|Induction Failure|0|||
162880119|NCT02883049|588260891|FG003|Post Induction|Induction Failure|0|||
162880120|NCT02883049|588260892|FG004|Post Induction|Induction Failure|0|||
162880121|NCT02883049|588260893|FG005|Post Induction|Induction Failure|0|||
162880122|NCT02883049|588260894|FG006|Post Induction|Induction Failure|0|||
162880123|NCT02883049|588260895|FG007|Post Induction|Induction Failure|2|||
162880124|NCT02883049|588260896|FG008|Post Induction|Induction Failure|2|||
162880125|NCT02883049|588260897|FG009|Post Induction|Induction Failure|0|||
162880126|NCT02883049|588260898|FG010|Post Induction|Induction Failure|0|||
162880127|NCT02883049|588260899|FG011|Post Induction|Induction Failure|0|||
162880128|NCT02883049|588260900|FG012|Post Induction|Induction Failure|0|||
162880129|NCT02883049|588260901|FG013|Post Induction|Induction Failure|2|||
162880130|NCT02883049|588260902|FG014|Post Induction|Induction Failure|0|||
162880131|NCT02883049|588260903|FG015|Post Induction|Induction Failure|0|||
162880132|NCT03421964|588260906|FG000|Overall Study|Lost to Follow-up|11|||
162880133|NCT03421964|588260907|FG001|Overall Study|Lost to Follow-up|21|||
162880134|NCT03421964|588260906|FG000|Overall Study|Withdrawal by Subject|9|||
162880135|NCT03421964|588260907|FG001|Overall Study|Withdrawal by Subject|3|||
162880136|NCT03421964|588260906|FG000|Overall Study|Incarcerated|1|||
162880137|NCT03421964|588260907|FG001|Overall Study|Incarcerated|0|||
162880138|NCT03421964|588260906|FG000|Overall Study|Inpt Treatment Facility|1|||
162880139|NCT03421964|588260907|FG001|Overall Study|Inpt Treatment Facility|1|||
162880140|NCT03421964|588260906|FG000|Overall Study|Virtual Platform Issues|1|||
162880141|NCT03421964|588260907|FG001|Overall Study|Virtual Platform Issues|1|||
162880142|NCT02106455|588260915|FG000|Overall Study|Case Report Form Uncollected|6|||
162880143|NCT02106455|588260915|FG000|Overall Study|Protocol Deviation|2|||
162880144|NCT03364608|588260916|FG000|Overall Study|Withdrawal by Subject|4|||
162880145|NCT03364608|588260916|FG000|Overall Study|Protocol Violation|2|||
162880146|NCT03364608|588260916|FG000|Overall Study|Lost to Follow-up|2|||
162880147|NCT03888391|588260917|FG000|Overall Study|Lost to Follow-up|15|||
162880148|NCT03654755|588260923|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
162880149|NCT03654755|588260924|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
162880150|NCT03654755|588260925|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
162880151|NCT03654755|588260923|FG000|Overall Study|Withdrawal by Subject|2|||
162880152|NCT03654755|588260924|FG001|Overall Study|Withdrawal by Subject|4|||
162880153|NCT03654755|588260925|FG002|Overall Study|Withdrawal by Subject|8|||
162880154|NCT03654755|588260923|FG000|Overall Study|Lost to Follow-up|1|||
162880155|NCT03654755|588260924|FG001|Overall Study|Lost to Follow-up|3|||
162880156|NCT03654755|588260925|FG002|Overall Study|Lost to Follow-up|7|||
162880157|NCT03654755|588260923|FG000|Overall Study|Physician Decision|0|||
162880158|NCT03654755|588260924|FG001|Overall Study|Physician Decision|1|||
162880159|NCT03654755|588260925|FG002|Overall Study|Physician Decision|0|||
162880160|NCT03654755|588260923|FG000|Overall Study|Adverse Event|0|||
162961844|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961845|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961846|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
162961847|NCT00112437|588560746|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961848|NCT00112437|588560747|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048443|NCT02513550|588884798|FG002|Double Blind Treatment Period|Protocol Violation|4|||
162961849|NCT00112437|588560748|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
163048444|NCT02513550|588884799|FG003|Double Blind Treatment Period|Protocol Violation|0|||
163048445|NCT02513550|588884800|FG004|Double Blind Treatment Period|Protocol Violation|0|||
163048446|NCT02513550|588884801|FG005|Double Blind Treatment Period|Protocol Violation|0|||
163048447|NCT02513550|588884796|FG000|Double Blind Treatment Period|Physician Decision|2|||
163048448|NCT02513550|588884797|FG001|Double Blind Treatment Period|Physician Decision|0|||
162880161|NCT03654755|588260924|FG001|Overall Study|Adverse Event|0|||
162880162|NCT03654755|588260925|FG002|Overall Study|Adverse Event|4|||
162880163|NCT03654755|588260923|FG000|Overall Study|Lack of Efficacy|0|||
162880164|NCT03654755|588260924|FG001|Overall Study|Lack of Efficacy|0|||
162880165|NCT03654755|588260925|FG002|Overall Study|Lack of Efficacy|1|||
162880166|NCT00992784|588260926|FG000|Overall Study|Adverse Event|2|||
162880167|NCT00992784|588260927|FG001|Overall Study|Adverse Event|1|||
162961850|NCT00112437|588560749|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162880168|NCT00992784|588260928|FG002|Overall Study|Adverse Event|0|||
162880169|NCT00992784|588260926|FG000|Overall Study|Withdrawal by Subject|1|||
162880170|NCT00992784|588260927|FG001|Overall Study|Withdrawal by Subject|1|||
162880171|NCT00992784|588260928|FG002|Overall Study|Withdrawal by Subject|1|||
162961851|NCT00112437|588560750|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162880172|NCT05373706|588260937|FG000|Overall Study|Lost to Follow-up|2|||
162880173|NCT05373706|588260938|FG001|Overall Study|Lost to Follow-up|2|||
162880174|NCT03442829|588260939|FG000|Overall Study|Scheduling clash|3|||
162880175|NCT03442829|588260940|FG001|Overall Study|Scheduling clash|1|||
162880176|NCT03442829|588260939|FG000|Overall Study|Illness unrelated to study|1|||
162880177|NCT03442829|588260940|FG001|Overall Study|Illness unrelated to study|1|||
162880178|NCT05086289|588260941|FG000|Overall Study|Adverse Event|4|||
162880179|NCT05086289|588260942|FG001|Overall Study|Adverse Event|2|||
162880180|NCT05086289|588260941|FG000|Overall Study|Lost to Follow-up|2|||
162880181|NCT05086289|588260942|FG001|Overall Study|Lost to Follow-up|0|||
162880182|NCT05086289|588260941|FG000|Overall Study|Non-compliance with study drug|2|||
163048449|NCT02513550|588884798|FG002|Double Blind Treatment Period|Physician Decision|4|||
163048450|NCT02513550|588884799|FG003|Double Blind Treatment Period|Physician Decision|0|||
163048451|NCT02513550|588884800|FG004|Double Blind Treatment Period|Physician Decision|0|||
163048452|NCT02513550|588884801|FG005|Double Blind Treatment Period|Physician Decision|0|||
163048453|NCT02513550|588884796|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
163048454|NCT02513550|588884797|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
163048455|NCT02513550|588884798|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
163048456|NCT02513550|588884799|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
163048457|NCT02513550|588884800|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
163048458|NCT02513550|588884801|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
162880183|NCT05086289|588260942|FG001|Overall Study|Non-compliance with study drug|1|||
162880184|NCT05086289|588260941|FG000|Overall Study|Physician Decision|2|||
162880185|NCT05086289|588260942|FG001|Overall Study|Physician Decision|0|||
162880186|NCT05086289|588260941|FG000|Overall Study|Withdrawal by Subject|5|||
162880187|NCT05086289|588260942|FG001|Overall Study|Withdrawal by Subject|2|||
162880188|NCT01996748|588260948|FG000|Overall Study|Personal reason|1|||
162880189|NCT01996748|588260949|FG001|Overall Study|Personal reason|0|||
162880190|NCT01996748|588260948|FG000|Overall Study|Physician Decision|2|||
162880191|NCT01996748|588260949|FG001|Overall Study|Physician Decision|0|||
162880192|NCT01996748|588260948|FG000|Overall Study|Adverse Event|1|||
162880193|NCT01996748|588260949|FG001|Overall Study|Adverse Event|4|||
162880194|NCT01996748|588260948|FG000|Overall Study|Withdrawal by Subject|0|||
162880195|NCT01996748|588260949|FG001|Overall Study|Withdrawal by Subject|1|||
162880196|NCT01996748|588260948|FG000|Overall Study|Lost to Follow-up|4|||
162880197|NCT01996748|588260949|FG001|Overall Study|Lost to Follow-up|1|||
162880198|NCT03628508|588260950|FG000|Overall Study|Lost to Follow-up|1|||
162880199|NCT03238235|588260951|FG000|Overall Study|Adverse Event|2|||
162880200|NCT03238235|588260952|FG001|Overall Study|Adverse Event|0|||
162880201|NCT03238235|588260951|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
162880202|NCT03238235|588260952|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
162880203|NCT00243230|588260957|FG000|Double-Blind Period|Adverse Event|0|||
162880204|NCT00243230|588260958|FG001|Double-Blind Period|Adverse Event|2|||
162880205|NCT00243230|588260959|FG002|Double-Blind Period|Adverse Event|2|||
163048459|NCT02513550|588884796|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048460|NCT02513550|588884797|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048461|NCT02513550|588884798|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
163048462|NCT02513550|588884799|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048463|NCT02513550|588884800|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048464|NCT02513550|588884801|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
163048465|NCT02513550|588884796|FG000|Double Blind Treatment Period|Due to personal business|2|||
163048466|NCT02513550|588884797|FG001|Double Blind Treatment Period|Due to personal business|0|||
162880206|NCT00243230|588260960|FG003|Double-Blind Period|Adverse Event|0|||
162880207|NCT00243230|588260957|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162880208|NCT00243230|588260958|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162880209|NCT00243230|588260959|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162880210|NCT00243230|588260960|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162880211|NCT00243230|588260957|FG000|Double-Blind Period|Protocol Violation|0|||
162880212|NCT00243230|588260958|FG001|Double-Blind Period|Protocol Violation|0|||
162880213|NCT00243230|588260959|FG002|Double-Blind Period|Protocol Violation|1|||
162880214|NCT00243230|588260960|FG003|Double-Blind Period|Protocol Violation|0|||
162880215|NCT00243230|588260957|FG000|Double-Blind Period|Randomized but Not Treated|0|||
162880216|NCT00243230|588260958|FG001|Double-Blind Period|Randomized but Not Treated|0|||
162880217|NCT00243230|588260959|FG002|Double-Blind Period|Randomized but Not Treated|2|||
162880218|NCT00243230|588260960|FG003|Double-Blind Period|Randomized but Not Treated|0|||
162880219|NCT00243230|588260957|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
162880220|NCT00243230|588260958|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
163048467|NCT02513550|588884798|FG002|Double Blind Treatment Period|Due to personal business|1|||
163048468|NCT02513550|588884799|FG003|Double Blind Treatment Period|Due to personal business|0|||
163048469|NCT02513550|588884800|FG004|Double Blind Treatment Period|Due to personal business|0|||
162707599|NCT00984282|587638281|FG001|Open-label Treatment|Lost to Follow-up|1|||
162880221|NCT00243230|588260959|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
162880222|NCT00243230|588260960|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
162880223|NCT00243230|588260957|FG000|Open Label Period|Adverse Event|0|||
162880224|NCT00243230|588260958|FG001|Open Label Period|Adverse Event|0|||
162880225|NCT00243230|588260959|FG002|Open Label Period|Adverse Event|0|||
162880226|NCT00243230|588260960|FG003|Open Label Period|Adverse Event|2|||
162880227|NCT00243230|588260957|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
162880228|NCT00243230|588260958|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
162880229|NCT00243230|588260959|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
162880230|NCT00243230|588260960|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
162880231|NCT00243230|588260957|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
162880232|NCT00243230|588260958|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
162880233|NCT00243230|588260959|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
162880234|NCT00243230|588260960|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
162880235|NCT00243230|588260957|FG000|Open Label Period|Lost to Follow-up|0|||
162880236|NCT00243230|588260958|FG001|Open Label Period|Lost to Follow-up|0|||
162880237|NCT00243230|588260959|FG002|Open Label Period|Lost to Follow-up|0|||
162880238|NCT00243230|588260960|FG003|Open Label Period|Lost to Follow-up|2|||
162880239|NCT00243230|588260957|FG000|Open Label Period|Withdrawal by Subject|0|||
162880240|NCT00243230|588260958|FG001|Open Label Period|Withdrawal by Subject|0|||
162880241|NCT00243230|588260959|FG002|Open Label Period|Withdrawal by Subject|0|||
162880242|NCT00243230|588260960|FG003|Open Label Period|Withdrawal by Subject|2|||
162880243|NCT00243230|588260957|FG000|Open Label Period|Protocol Violation|0|||
162880244|NCT00243230|588260958|FG001|Open Label Period|Protocol Violation|0|||
162880245|NCT00243230|588260959|FG002|Open Label Period|Protocol Violation|0|||
162880246|NCT00243230|588260960|FG003|Open Label Period|Protocol Violation|2|||
162880247|NCT00243230|588260957|FG000|Open Label Period|Administrative Reason|0|||
162880248|NCT00243230|588260958|FG001|Open Label Period|Administrative Reason|0|||
162880249|NCT00243230|588260959|FG002|Open Label Period|Administrative Reason|0|||
162880250|NCT00243230|588260960|FG003|Open Label Period|Administrative Reason|63|||
162880251|NCT03011840|588260962|FG000|Overall Study|Not received PIL in post PIL phase|0|||
162880252|NCT03011840|588260963|FG001|Overall Study|Not received PIL in post PIL phase|21|||
162880253|NCT03201198|588260969|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
162880254|NCT03201198|588260970|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
162880255|NCT03201198|588260969|FG000|Overall Study|Withdrawal by Subject|2|||
162880256|NCT03201198|588260970|FG001|Overall Study|Withdrawal by Subject|3|||
162880257|NCT00471445|588260971|FG000|Overall Study|Withdrawal by Subject|1|||
162880258|NCT00471445|588260972|FG001|Overall Study|Withdrawal by Subject|1|||
162880259|NCT00471445|588260971|FG000|Overall Study|Ineligible|1|||
162880260|NCT00471445|588260972|FG001|Overall Study|Ineligible|0|||
162880261|NCT00471445|588260971|FG000|Overall Study|Protocol Violation|0|||
162880262|NCT00471445|588260972|FG001|Overall Study|Protocol Violation|1|||
162880263|NCT04715230|588260973|FG000|Overall Study|Withdrawal by Subject|1|||
162880264|NCT04715230|588260974|FG001|Overall Study|Withdrawal by Subject|0|||
162880265|NCT04715230|588260975|FG002|Overall Study|Withdrawal by Subject|0|||
162880266|NCT04715230|588260973|FG000|Overall Study|Lost to Follow-up|0|||
162880267|NCT04715230|588260974|FG001|Overall Study|Lost to Follow-up|5|||
162880268|NCT04715230|588260975|FG002|Overall Study|Lost to Follow-up|1|||
162880269|NCT02596711|588260982|FG000|Overall Study|Lost to Follow-up|1|||
162880270|NCT02596711|588260983|FG001|Overall Study|Lost to Follow-up|2|||
162880271|NCT02596711|588260984|FG002|Overall Study|Lost to Follow-up|3|||
162880272|NCT00586924|588260985|FG000|Overall Study|Adverse event/serious adverse event|0|||
162880273|NCT00586924|588260986|FG001|Overall Study|Adverse event/serious adverse event|0|||
162880274|NCT00586924|588260987|FG002|Overall Study|Adverse event/serious adverse event|0|||
162880275|NCT00586924|588260988|FG003|Overall Study|Adverse event/serious adverse event|1|||
162880276|NCT00586924|588260989|FG004|Overall Study|Adverse event/serious adverse event|0|||
162880277|NCT00586924|588260990|FG005|Overall Study|Adverse event/serious adverse event|2|||
162880278|NCT00586924|588260985|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
162880279|NCT00586924|588260986|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
162880280|NCT00586924|588260987|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
162880281|NCT00586924|588260988|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
162880282|NCT00586924|588260989|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
162880283|NCT00586924|588260990|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
162880284|NCT00586924|588260985|FG000|Overall Study|Disease progression|0|||
162880285|NCT00586924|588260986|FG001|Overall Study|Disease progression|0|||
162880286|NCT00586924|588260987|FG002|Overall Study|Disease progression|0|||
162880287|NCT00586924|588260988|FG003|Overall Study|Disease progression|1|||
162880288|NCT00586924|588260989|FG004|Overall Study|Disease progression|1|||
162880289|NCT00586924|588260990|FG005|Overall Study|Disease progression|0|||
162880290|NCT00586924|588260985|FG000|Overall Study|Development of neutralizing antibodies|2|||
162880291|NCT00586924|588260986|FG001|Overall Study|Development of neutralizing antibodies|2|||
162880292|NCT00586924|588260987|FG002|Overall Study|Development of neutralizing antibodies|2|||
162880293|NCT00586924|588260988|FG003|Overall Study|Development of neutralizing antibodies|0|||
162880294|NCT00586924|588260989|FG004|Overall Study|Development of neutralizing antibodies|0|||
162880295|NCT00586924|588260990|FG005|Overall Study|Development of neutralizing antibodies|22|||
162880296|NCT00586924|588260985|FG000|Overall Study|Complete response|0|||
162880297|NCT00586924|588260986|FG001|Overall Study|Complete response|1|||
162880298|NCT00586924|588260987|FG002|Overall Study|Complete response|0|||
162880299|NCT00586924|588260988|FG003|Overall Study|Complete response|0|||
162880300|NCT00586924|588260989|FG004|Overall Study|Complete response|2|||
162880301|NCT00586924|588260990|FG005|Overall Study|Complete response|2|||
162880302|NCT00586924|588260985|FG000|Overall Study|Other|1|||
162880303|NCT00586924|588260986|FG001|Overall Study|Other|0|||
162880304|NCT00586924|588260987|FG002|Overall Study|Other|1|||
162880305|NCT00586924|588260988|FG003|Overall Study|Other|1|||
162880306|NCT00586924|588260989|FG004|Overall Study|Other|1|||
162880307|NCT00586924|588260990|FG005|Overall Study|Other|6|||
162880308|NCT01767194|588260994|FG000|Overall Study|Adverse Event|1|||
162880309|NCT01767194|588260995|FG001|Overall Study|Adverse Event|1|||
162880310|NCT01767194|588260994|FG000|Overall Study|Death|0|||
162880311|NCT01767194|588260995|FG001|Overall Study|Death|1|||
162880312|NCT01767194|588260994|FG000|Overall Study|Lack of Efficacy|12|||
162707600|NCT00984282|587638280|FG000|Open-label Treatment|Patient convenience|1|||
162880313|NCT01767194|588260995|FG001|Overall Study|Lack of Efficacy|11|||
162880314|NCT01767194|588260994|FG000|Overall Study|Physician Decision|2|||
162880315|NCT01767194|588260995|FG001|Overall Study|Physician Decision|23|||
162880316|NCT01767194|588260994|FG000|Overall Study|Withdrawal by Subject|0|||
162880317|NCT01767194|588260995|FG001|Overall Study|Withdrawal by Subject|1|||
162880318|NCT01767194|588260994|FG000|Overall Study|Ineligible|1|||
162880319|NCT01767194|588260995|FG001|Overall Study|Ineligible|1|||
162880320|NCT01767194|588260994|FG000|Overall Study|Refusal by patient/parent|2|||
162880321|NCT01767194|588260995|FG001|Overall Study|Refusal by patient/parent|4|||
162880322|NCT01767194|588260994|FG000|Overall Study|Criteria not met on time for next cycle|0|||
162880323|NCT01767194|588260995|FG001|Overall Study|Criteria not met on time for next cycle|1|||
162880324|NCT04191577|588260999|FG000|Overall Study|Withdrawal by Subject|2|||
162880325|NCT04191577|588261000|FG001|Overall Study|Withdrawal by Subject|2|||
162880326|NCT04191577|588261001|FG002|Overall Study|Withdrawal by Subject|1|||
162880327|NCT04191577|588260999|FG000|Overall Study|Physician Decision|1|||
162880328|NCT04191577|588261000|FG001|Overall Study|Physician Decision|1|||
162880329|NCT04191577|588261001|FG002|Overall Study|Physician Decision|0|||
162880330|NCT04191577|588260999|FG000|Overall Study|Adverse Event|0|||
162880331|NCT04191577|588261000|FG001|Overall Study|Adverse Event|0|||
162880332|NCT04191577|588261001|FG002|Overall Study|Adverse Event|1|||
162880333|NCT04191577|588260999|FG000|Overall Study|Death|0|||
162880334|NCT04191577|588261000|FG001|Overall Study|Death|0|||
162880335|NCT04191577|588261001|FG002|Overall Study|Death|1|||
162880336|NCT01927744|588262409|FG000|Overall Study|Death|2|||
162880337|NCT01927744|588262410|FG001|Overall Study|Death|9|||
162880338|NCT00369967|588262411|FG000|Overall Study|Lost to Follow-up|23|||
162880339|NCT00369967|588262412|FG001|Overall Study|Lost to Follow-up|12|||
162880340|NCT00605722|588262417|FG000|Overall Study|Adverse Event|6|||
162880341|NCT00605722|588262417|FG000|Overall Study|Insufficient therapeutic response|44|||
162880342|NCT00605722|588262417|FG000|Overall Study|Failure to return|1|||
162880343|NCT00831441|588262421|FG000|Randomized|Death|82|||
162880344|NCT00831441|588262422|FG001|Randomized|Death|81|||
162880345|NCT00831441|588262421|FG000|Randomized|Adverse Event|248|||
162880346|NCT00831441|588262422|FG001|Randomized|Adverse Event|321|||
162880347|NCT00831441|588262421|FG000|Randomized|Emergency procedure|2|||
162880348|NCT00831441|588262422|FG001|Randomized|Emergency procedure|2|||
162880349|NCT00831441|588262421|FG000|Randomized|Elective procedure|26|||
162880350|NCT00831441|588262422|FG001|Randomized|Elective procedure|25|||
162880351|NCT00831441|588262421|FG000|Randomized|Physician Decision|26|||
162880352|NCT00831441|588262422|FG001|Randomized|Physician Decision|35|||
162880353|NCT00831441|588262421|FG000|Randomized|No longer met criteria|13|||
162880354|NCT00831441|588262422|FG001|Randomized|No longer met criteria|19|||
162880355|NCT00831441|588262421|FG000|Randomized|Withdrawal by Subject|178|||
162880356|NCT00831441|588262422|FG001|Randomized|Withdrawal by Subject|212|||
162880357|NCT00831441|588262421|FG000|Randomized|Lost to Follow-up|26|||
162880358|NCT00831441|588262422|FG001|Randomized|Lost to Follow-up|35|||
162880359|NCT00831441|588262421|FG000|Randomized|Administrative reason by sponsor|2780|||
162880360|NCT00831441|588262422|FG001|Randomized|Administrative reason by sponsor|2671|||
162880361|NCT00831441|588262421|FG000|Randomized|poor/non-compliance|30|||
162880362|NCT00831441|588262422|FG001|Randomized|poor/non-compliance|38|||
162880363|NCT00831441|588262421|FG000|Randomized|non-specified|276|||
162880364|NCT00831441|588262422|FG001|Randomized|non-specified|266|||
162880365|NCT00831441|588262421|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
162880366|NCT00831441|588262422|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
162880367|NCT00831441|588262421|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
162880368|NCT00831441|588262422|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
162880369|NCT00831441|588262421|FG000|Follow Up (30 Days)|Death|63|||
162880370|NCT00831441|588262422|FG001|Follow Up (30 Days)|Death|86|||
162880371|NCT00831441|588262421|FG000|Follow Up (30 Days)|non-specified|16|||
162880372|NCT00831441|588262422|FG001|Follow Up (30 Days)|non-specified|26|||
162880373|NCT00831441|588262421|FG000|Follow Up (30 Days)|missing end of study status|0|||
162880374|NCT00831441|588262422|FG001|Follow Up (30 Days)|missing end of study status|1|||
162880375|NCT00485589|588262428|FG000|Overall Study|Death|2|||
163048470|NCT02513550|588884801|FG005|Double Blind Treatment Period|Due to personal business|0|||
163048471|NCT02513550|588884796|FG000|Double Blind Treatment Period|Death|1|||
162880376|NCT00485589|588262429|FG001|Overall Study|Death|2|||
162880377|NCT00485589|588262430|FG002|Overall Study|Death|0|||
163048472|NCT02513550|588884797|FG001|Double Blind Treatment Period|Death|0|||
162880378|NCT00485589|588262428|FG000|Overall Study|Failure to return|6|||
162880379|NCT00485589|588262429|FG001|Overall Study|Failure to return|5|||
162880380|NCT00485589|588262430|FG002|Overall Study|Failure to return|1|||
163048473|NCT02513550|588884798|FG002|Double Blind Treatment Period|Death|2|||
162880381|NCT00485589|588262428|FG000|Overall Study|Protocol Violation|1|||
162880382|NCT00485589|588262429|FG001|Overall Study|Protocol Violation|0|||
162880383|NCT00485589|588262430|FG002|Overall Study|Protocol Violation|0|||
162880384|NCT00485589|588262428|FG000|Overall Study|Violation of selection criteria at entry|0|||
162880385|NCT00485589|588262429|FG001|Overall Study|Violation of selection criteria at entry|3|||
162880386|NCT00485589|588262430|FG002|Overall Study|Violation of selection criteria at entry|1|||
162880387|NCT00485589|588262428|FG000|Overall Study|Administrative/Other|1|||
162880388|NCT00485589|588262429|FG001|Overall Study|Administrative/Other|2|||
162880389|NCT00485589|588262430|FG002|Overall Study|Administrative/Other|1|||
162880390|NCT00485589|588262428|FG000|Overall Study|Insufficient therapeutic response|10|||
162880391|NCT00485589|588262429|FG001|Overall Study|Insufficient therapeutic response|3|||
162880392|NCT00485589|588262430|FG002|Overall Study|Insufficient therapeutic response|1|||
162880393|NCT00485589|588262428|FG000|Overall Study|Refused treatment/did not cooperate|1|||
162880394|NCT00485589|588262429|FG001|Overall Study|Refused treatment/did not cooperate|0|||
162880395|NCT00485589|588262430|FG002|Overall Study|Refused treatment/did not cooperate|2|||
162880396|NCT00485589|588262428|FG000|Overall Study|Withdrawal by Subject|3|||
162880397|NCT00485589|588262429|FG001|Overall Study|Withdrawal by Subject|2|||
162880398|NCT00485589|588262430|FG002|Overall Study|Withdrawal by Subject|2|||
162880399|NCT00485589|588262428|FG000|Overall Study|Adverse Event|3|||
162880400|NCT00485589|588262429|FG001|Overall Study|Adverse Event|3|||
162880401|NCT00485589|588262430|FG002|Overall Study|Adverse Event|10|||
162880402|NCT01205451|588262435|FG000|Overall Study|Lost to Follow-up|1|||
162880403|NCT01205451|588262436|FG001|Overall Study|Lost to Follow-up|1|||
162880404|NCT01205451|588262435|FG000|Overall Study|Withdrawal by Subject|5|||
162880405|NCT01205451|588262436|FG001|Overall Study|Withdrawal by Subject|9|||
162880406|NCT02226146|588262440|FG000|Overall Study|Received rescue therapy|1|||
162880407|NCT02226146|588262440|FG000|Overall Study|Withdrawal by Subject|2|||
162880408|NCT05464836|588262441|FG000|Overall Study|Progression of Disease|1|||
162880409|NCT05464836|588262441|FG000|Overall Study|Physician Decision|1|||
162880410|NCT01522976|588262442|FG000|Overall Study|Ineligible|4|||
162880411|NCT01522976|588262443|FG001|Overall Study|Ineligible|0|||
162880412|NCT01522976|588262444|FG002|Overall Study|Ineligible|1|||
162880413|NCT01522976|588262442|FG000|Overall Study|Death|7|||
162880414|NCT01522976|588262443|FG001|Overall Study|Death|6|||
162880415|NCT01522976|588262444|FG002|Overall Study|Death|2|||
162880416|NCT01522976|588262442|FG000|Overall Study|Still on treatment|9|||
162880417|NCT01522976|588262443|FG001|Overall Study|Still on treatment|9|||
162880418|NCT01522976|588262444|FG002|Overall Study|Still on treatment|6|||
162880419|NCT01522976|588262442|FG000|Overall Study|Disease progression|28|||
162880420|NCT01522976|588262443|FG001|Overall Study|Disease progression|30|||
162880421|NCT01522976|588262444|FG002|Overall Study|Disease progression|25|||
162880422|NCT01522976|588262442|FG000|Overall Study|Adverse Event|17|||
162880423|NCT01522976|588262443|FG001|Overall Study|Adverse Event|7|||
162880424|NCT01522976|588262444|FG002|Overall Study|Adverse Event|18|||
162880425|NCT01522976|588262442|FG000|Overall Study|Refusal unrelated to adverse event|10|||
162880426|NCT01522976|588262443|FG001|Overall Study|Refusal unrelated to adverse event|13|||
162880427|NCT01522976|588262444|FG002|Overall Study|Refusal unrelated to adverse event|14|||
162880428|NCT01522976|588262442|FG000|Overall Study|Not protocol specified|22|||
162880429|NCT01522976|588262443|FG001|Overall Study|Not protocol specified|27|||
162880430|NCT01522976|588262444|FG002|Overall Study|Not protocol specified|27|||
162880431|NCT02938585|588262445|FG000|Overall Study|Withdrawal by parent or guardian|0|||
162880432|NCT02938585|588262446|FG001|Overall Study|Withdrawal by parent or guardian|1|||
162880433|NCT02938585|588262447|FG002|Overall Study|Withdrawal by parent or guardian|0|||
162880434|NCT02938585|588262448|FG003|Overall Study|Withdrawal by parent or guardian|0|||
162880435|NCT02938585|588262445|FG000|Overall Study|Withdrawal by Subject|0|||
162880436|NCT02938585|588262446|FG001|Overall Study|Withdrawal by Subject|0|||
162880437|NCT02938585|588262447|FG002|Overall Study|Withdrawal by Subject|0|||
162880438|NCT02938585|588262448|FG003|Overall Study|Withdrawal by Subject|5|||
162880439|NCT00213980|588262449|FG000|Overall Study|Withdrawal by Subject|3|||
162880440|NCT00213980|588262450|FG001|Overall Study|Withdrawal by Subject|1|||
162880441|NCT00213980|588262449|FG000|Overall Study|Adverse Event|1|||
162880442|NCT00213980|588262450|FG001|Overall Study|Adverse Event|1|||
162880443|NCT00213980|588262449|FG000|Overall Study|Disease progression|0|||
162880444|NCT00213980|588262450|FG001|Overall Study|Disease progression|2|||
162880445|NCT00213980|588262449|FG000|Overall Study|Developed ovarian cancer|1|||
162880446|NCT00213980|588262450|FG001|Overall Study|Developed ovarian cancer|0|||
162880447|NCT00213980|588262449|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
162880448|NCT00213980|588262450|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
162880449|NCT03607838|588262451|FG000|Overall Study|Lack of Efficacy|14|||
162880450|NCT03607838|588262452|FG001|Overall Study|Lack of Efficacy|20|||
162880451|NCT03607838|588262451|FG000|Overall Study|Withdrawal by Subject|13|||
162880452|NCT03607838|588262452|FG001|Overall Study|Withdrawal by Subject|8|||
162961852|NCT00112437|588560751|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162880453|NCT03607838|588262451|FG000|Overall Study|Lost to Follow-up|6|||
162880454|NCT03607838|588262452|FG001|Overall Study|Lost to Follow-up|11|||
162880455|NCT03607838|588262451|FG000|Overall Study|Adverse Event|2|||
162880456|NCT03607838|588262452|FG001|Overall Study|Adverse Event|2|||
162880457|NCT03607838|588262451|FG000|Overall Study|Physician Decision|2|||
162880458|NCT03607838|588262452|FG001|Overall Study|Physician Decision|0|||
162880459|NCT03607838|588262451|FG000|Overall Study|Failure to meet randomization criteria|1|||
162880460|NCT03607838|588262452|FG001|Overall Study|Failure to meet randomization criteria|2|||
162880461|NCT03607838|588262451|FG000|Overall Study|Pregnancy|1|||
162880462|NCT03607838|588262452|FG001|Overall Study|Pregnancy|0|||
162880463|NCT03607838|588262451|FG000|Overall Study|Protocol Violation|1|||
162880464|NCT03607838|588262452|FG001|Overall Study|Protocol Violation|0|||
162880465|NCT03607838|588262451|FG000|Overall Study|Due to work|1|||
162880466|NCT03607838|588262452|FG001|Overall Study|Due to work|0|||
162961853|NCT00112437|588560752|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961854|NCT00112437|588560753|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961855|NCT00112437|588560754|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961856|NCT00112437|588560755|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162707601|NCT00984282|587638281|FG001|Open-label Treatment|Patient convenience|0|||
162707602|NCT00984282|587638280|FG000|Open-label Treatment|Non-compliant with study medication|1|||
162707603|NCT00984282|587638281|FG001|Open-label Treatment|Non-compliant with study medication|0|||
162707604|NCT00984282|587638280|FG000|Open-label Treatment|Target lesion removed|0|||
162707605|NCT00984282|587638281|FG001|Open-label Treatment|Target lesion removed|1|||
162707606|NCT00984282|587638280|FG000|Open-label Treatment|Protocol driven decision point|1|||
162707607|NCT00984282|587638281|FG001|Open-label Treatment|Protocol driven decision point|1|||
162880467|NCT03607838|588262451|FG000|Overall Study|Litigation|0|||
162880468|NCT03607838|588262452|FG001|Overall Study|Litigation|1|||
162880469|NCT03607838|588262451|FG000|Overall Study|Temperature excursion for study drug|0|||
162880470|NCT03607838|588262452|FG001|Overall Study|Temperature excursion for study drug|1|||
162880471|NCT03607838|588262451|FG000|Overall Study|Change of mind|0|||
162880472|NCT03607838|588262452|FG001|Overall Study|Change of mind|1|||
162880473|NCT02411201|588262453|FG000|Overall Study|Adverse Event|2|||
162880474|NCT02411201|588262453|FG000|Overall Study|Withdrawal by Subject|2|||
162880475|NCT02411201|588262453|FG000|Overall Study|Age group completed|2|||
162880476|NCT01260467|588262454|FG000|Overall Study|Withdrawal by Subject|2|||
162880477|NCT00798694|588262455|FG000|Overall Study|Lost to Follow-up|1|||
162880478|NCT00798694|588262456|FG001|Overall Study|Lost to Follow-up|1|||
162880479|NCT00798694|588262455|FG000|Overall Study|Physician Decision|1|||
162880480|NCT00798694|588262456|FG001|Overall Study|Physician Decision|0|||
162880481|NCT01163253|588262462|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
162880482|NCT01163253|588262463|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
162880483|NCT01163253|588262462|FG000|Overall Study|Study Terminated by Sponsor|978|||
162880484|NCT01163253|588262463|FG001|Overall Study|Study Terminated by Sponsor|349|||
162880485|NCT01163253|588262462|FG000|Overall Study|Protocol Violation|43|||
162880486|NCT01163253|588262463|FG001|Overall Study|Protocol Violation|12|||
162880487|NCT01163253|588262462|FG000|Overall Study|Withdrawal by Subject|199|||
162880488|NCT01163253|588262463|FG001|Overall Study|Withdrawal by Subject|50|||
162880489|NCT01163253|588262462|FG000|Overall Study|Medication Error|1|||
162880490|NCT01163253|588262463|FG001|Overall Study|Medication Error|0|||
162880491|NCT01163253|588262462|FG000|Overall Study|Lost to Follow-up|125|||
162880492|NCT01163253|588262463|FG001|Overall Study|Lost to Follow-up|23|||
162880493|NCT01163253|588262462|FG000|Overall Study|Insufficient Clinical Response|423|||
162880494|NCT01163253|588262463|FG001|Overall Study|Insufficient Clinical Response|29|||
162880495|NCT01163253|588262462|FG000|Overall Study|Adverse Event|300|||
162880496|NCT01163253|588262463|FG001|Overall Study|Adverse Event|78|||
162880497|NCT01163253|588262462|FG000|Overall Study|Death|17|||
162880498|NCT01163253|588262463|FG001|Overall Study|Death|5|||
162880499|NCT01163253|588262462|FG000|Overall Study|Ongoing|13|||
162880500|NCT01163253|588262463|FG001|Overall Study|Ongoing|4|||
162880501|NCT01163253|588262462|FG000|Overall Study|Other Unspecified|170|||
162880502|NCT01163253|588262463|FG001|Overall Study|Other Unspecified|34|||
162880503|NCT03025217|588262469|FG000|Overall Study|Pregnancy|1|||
162880504|NCT03025217|588262469|FG000|Overall Study|Lost to Follow-up|1|||
162880505|NCT03025217|588262469|FG000|Overall Study|Not eligible, poor English|2|||
162880506|NCT00781599|588262472|FG000|Overall Study|Lost to Follow-up|7|||
162880507|NCT00781599|588262473|FG001|Overall Study|Lost to Follow-up|4|||
162880508|NCT01088438|588262474|FG000|Overall Study|Withdrawal by Subject|11|||
162880509|NCT01088438|588262475|FG001|Overall Study|Withdrawal by Subject|6|||
162880510|NCT01088438|588262474|FG000|Overall Study|Lost to Follow-up|18|||
162880511|NCT01088438|588262475|FG001|Overall Study|Lost to Follow-up|30|||
162880512|NCT01952730|588262478|FG000|Overall Study|FDA shut down core lab used by study|1|||
162880513|NCT00976950|588262483|FG000|Overall Study|Adverse Event|3|||
162880514|NCT00976950|588262483|FG000|Overall Study|Events with no relationship to Aptivus|3|||
162880515|NCT01514188|588262486|FG000|Overall Study|Adverse Event|3|||
162880516|NCT01514188|588262487|FG001|Overall Study|Adverse Event|5|||
162880517|NCT01514188|588262486|FG000|Overall Study|Withdrawal by Subject|2|||
162880518|NCT01514188|588262487|FG001|Overall Study|Withdrawal by Subject|4|||
162880519|NCT01514188|588262486|FG000|Overall Study|Protocol Violation|2|||
162880520|NCT01514188|588262487|FG001|Overall Study|Protocol Violation|4|||
162880521|NCT01514188|588262486|FG000|Overall Study|Physician Decision|0|||
162880522|NCT01514188|588262487|FG001|Overall Study|Physician Decision|2|||
162880523|NCT01514188|588262486|FG000|Overall Study|Disease Progression|13|||
162880524|NCT01514188|588262487|FG001|Overall Study|Disease Progression|14|||
162880525|NCT01514188|588262486|FG000|Overall Study|Death|1|||
162880526|NCT01514188|588262487|FG001|Overall Study|Death|3|||
162880527|NCT01514188|588262486|FG000|Overall Study|Other|2|||
162880528|NCT01514188|588262487|FG001|Overall Study|Other|1|||
162880529|NCT01019486|588262488|FG000|Overall Study|Withdrawal by Subject|1|||
162707608|NCT00984282|587638280|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
162707609|NCT00984282|587638281|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
162707610|NCT00984282|587638280|FG000|Open-label Treatment|Switched to commercial drug|6|||
162880530|NCT01019486|588262489|FG001|Overall Study|Withdrawal by Subject|1|||
162880531|NCT01019486|588262490|FG002|Overall Study|Withdrawal by Subject|1|||
162880532|NCT02932332|588262491|FG000|Overall Study|Withdrawal by Subject|1|||
162880533|NCT02932332|588262492|FG001|Overall Study|Withdrawal by Subject|1|||
162961857|NCT00112437|588560756|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162880534|NCT02932332|588262493|FG002|Overall Study|Withdrawal by Subject|0|||
162880535|NCT02932332|588262494|FG003|Overall Study|Withdrawal by Subject|1|||
162880536|NCT02932332|588262491|FG000|Overall Study|Chest pain|0|||
162880537|NCT02932332|588262492|FG001|Overall Study|Chest pain|0|||
162880538|NCT02932332|588262493|FG002|Overall Study|Chest pain|0|||
162880539|NCT02932332|588262494|FG003|Overall Study|Chest pain|1|||
162880540|NCT02932332|588262491|FG000|Overall Study|Not Dyspneic cough|1|||
162880541|NCT02932332|588262492|FG001|Overall Study|Not Dyspneic cough|2|||
162880542|NCT02932332|588262493|FG002|Overall Study|Not Dyspneic cough|1|||
162880543|NCT02932332|588262494|FG003|Overall Study|Not Dyspneic cough|0|||
162880544|NCT02605447|588262500|FG000|Overall Study|Death|66|||
162880545|NCT02605447|588262500|FG000|Overall Study|Physician Decision|1|||
162880546|NCT02605447|588262500|FG000|Overall Study|Lost to Follow-up|24|||
162880547|NCT02605447|588262500|FG000|Overall Study|Withdrawal by Subject|10|||
162880548|NCT02605447|588262500|FG000|Overall Study|Not disclosed|1|||
162880549|NCT02237157|588262501|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
162880550|NCT02237157|588262502|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
162880551|NCT02237157|588262503|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
162880552|NCT02237157|588262504|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
162880553|NCT02237157|588262501|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
162880554|NCT02237157|588262502|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
162880555|NCT02237157|588262503|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
162880556|NCT02237157|588262504|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
162880557|NCT04533815|588262509|FG000|Overall Study|Adverse Event|2|||
162880558|NCT04533815|588262509|FG000|Overall Study|Site withdrew|5|||
162880559|NCT02045212|588262510|FG000|Overall Study|Adverse Event|0|||
162880560|NCT02045212|588262511|FG001|Overall Study|Adverse Event|1|||
162880561|NCT02045212|588262510|FG000|Overall Study|Withdrawal by Subject|1|||
162880562|NCT02045212|588262511|FG001|Overall Study|Withdrawal by Subject|0|||
162880563|NCT02045212|588262510|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
162880564|NCT02045212|588262511|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
162880565|NCT00488592|588262512|FG000|Overall Study|Withdrawal by Subject|1|||
162880566|NCT00488592|588262512|FG000|Overall Study|Disease progression|1|||
162880567|NCT00488592|588262512|FG000|Overall Study|Enrolled but not treated|1|||
162880568|NCT00441103|588262513|FG000|Overall Study|Adverse Event|2|||
162880569|NCT00441103|588262514|FG001|Overall Study|Adverse Event|1|||
162880570|NCT00441103|588262513|FG000|Overall Study|Death|1|||
162880571|NCT00441103|588262514|FG001|Overall Study|Death|0|||
162880572|NCT00441103|588262513|FG000|Overall Study|Disease Progression|2|||
162880573|NCT00441103|588262514|FG001|Overall Study|Disease Progression|0|||
162880574|NCT00441103|588262513|FG000|Overall Study|Lost to Follow-up|1|||
162880575|NCT00441103|588262514|FG001|Overall Study|Lost to Follow-up|0|||
162880576|NCT00441103|588262513|FG000|Overall Study|Protocol Violation|1|||
162880577|NCT00441103|588262514|FG001|Overall Study|Protocol Violation|0|||
162880578|NCT00441103|588262513|FG000|Overall Study|Participant unable to use Rebiject II|1|||
162880579|NCT00441103|588262514|FG001|Overall Study|Participant unable to use Rebiject II|0|||
162880580|NCT00441103|588262513|FG000|Overall Study|Participant refused MRI|1|||
162880581|NCT00441103|588262514|FG001|Overall Study|Participant refused MRI|0|||
162880582|NCT00441103|588262513|FG000|Overall Study|Inclusion criteria absent|1|||
162880583|NCT00441103|588262514|FG001|Overall Study|Inclusion criteria absent|0|||
162880584|NCT00441103|588262513|FG000|Overall Study|Non-compliant|0|||
162880585|NCT00441103|588262514|FG001|Overall Study|Non-compliant|1|||
162880586|NCT00441103|588262513|FG000|Overall Study|Participant decided to withdraw|1|||
162880587|NCT00441103|588262514|FG001|Overall Study|Participant decided to withdraw|0|||
162880588|NCT00441103|588262513|FG000|Overall Study|Participant's reason|0|||
162880589|NCT00441103|588262514|FG001|Overall Study|Participant's reason|1|||
162880590|NCT00441103|588262513|FG000|Overall Study|Participant decided to stop|0|||
162880591|NCT00441103|588262514|FG001|Overall Study|Participant decided to stop|1|||
162961858|NCT00112437|588560757|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961859|NCT00112437|588560758|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162880592|NCT00515008|588262515|FG000|Overall Study|Lost to Follow-up|1|||
162880593|NCT00515008|588262516|FG001|Overall Study|Lost to Follow-up|0|||
162880594|NCT00515008|588262515|FG000|Overall Study|Declined|0|||
162880595|NCT00515008|588262516|FG001|Overall Study|Declined|3|||
162880596|NCT00515008|588262515|FG000|Overall Study|Left the Boston Area|1|||
162880597|NCT00515008|588262516|FG001|Overall Study|Left the Boston Area|1|||
162880598|NCT00515008|588262515|FG000|Overall Study|Scheduling conflict|1|||
162880599|NCT00515008|588262516|FG001|Overall Study|Scheduling conflict|0|||
162880600|NCT05836818|588262517|FG000|Overall Study|Physician Decision|1|||
162880601|NCT05836818|588262518|FG001|Overall Study|Physician Decision|1|||
162880602|NCT05836818|588262519|FG002|Overall Study|Physician Decision|0|||
162880603|NCT05836818|588262517|FG000|Overall Study|Withdrawal by Subject|0|||
162880604|NCT05836818|588262518|FG001|Overall Study|Withdrawal by Subject|0|||
162880605|NCT05836818|588262519|FG002|Overall Study|Withdrawal by Subject|1|||
162880606|NCT05836818|588262517|FG000|Overall Study|Later found to be previously vaccinated|0|||
162880607|NCT05836818|588262518|FG001|Overall Study|Later found to be previously vaccinated|1|||
162880608|NCT05836818|588262519|FG002|Overall Study|Later found to be previously vaccinated|3|||
162880609|NCT05836818|588262517|FG000|Overall Study|Pregnancy|0|||
162880610|NCT05836818|588262518|FG001|Overall Study|Pregnancy|1|||
162880611|NCT05836818|588262519|FG002|Overall Study|Pregnancy|0|||
162880612|NCT05836818|588262517|FG000|Overall Study|Allergic to vaccines|0|||
162880613|NCT05836818|588262518|FG001|Overall Study|Allergic to vaccines|1|||
162880614|NCT05836818|588262519|FG002|Overall Study|Allergic to vaccines|0|||
162880615|NCT03738566|588262520|FG000|Initial Study Phase|Withdrawal by Subject|1|||
162880616|NCT03738566|588262521|FG001|Initial Study Phase|Withdrawal by Subject|1|||
162880617|NCT03738566|588262522|FG002|Initial Study Phase|Withdrawal by Subject|2|||
162880618|NCT03738566|588262523|FG003|Initial Study Phase|Withdrawal by Subject|0|||
162880619|NCT03738566|588262520|FG000|Initial Study Phase|Death|0|||
162880620|NCT03738566|588262521|FG001|Initial Study Phase|Death|1|||
162880621|NCT03738566|588262522|FG002|Initial Study Phase|Death|0|||
162880622|NCT03738566|588262523|FG003|Initial Study Phase|Death|0|||
162880623|NCT03738566|588262520|FG000|Initial Study Phase|Treatment failure|5|||
162880624|NCT03738566|588262521|FG001|Initial Study Phase|Treatment failure|0|||
162880625|NCT03738566|588262522|FG002|Initial Study Phase|Treatment failure|0|||
162880626|NCT03738566|588262523|FG003|Initial Study Phase|Treatment failure|0|||
162880627|NCT03738566|588262520|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
162880628|NCT03738566|588262521|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
162880629|NCT03738566|588262522|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
162880630|NCT03738566|588262523|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
162880631|NCT03126539|588262532|FG000|Overall Study|Lost to Follow-up|1|||
162880632|NCT03126539|588262533|FG001|Overall Study|Lost to Follow-up|1|||
162880633|NCT03126539|588262534|FG002|Overall Study|Lost to Follow-up|1|||
162880634|NCT03126539|588262535|FG003|Overall Study|Lost to Follow-up|0|||
162880635|NCT03126539|588262536|FG004|Overall Study|Lost to Follow-up|0|||
162880636|NCT01627067|588262537|FG000|Overall Study|Screen Failure|1|||
162880637|NCT00926796|588262538|FG000|Overall Study|Did not receive randomized treatment|4|||
162880638|NCT00926796|588262539|FG001|Overall Study|Did not receive randomized treatment|7|||
162880639|NCT00926796|588262538|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
162880640|NCT00926796|588262539|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
162880641|NCT00926796|588262538|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
162880642|NCT00926796|588262539|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
162880643|NCT00926796|588262538|FG000|Overall Study|Adverse Event|7|||
162880644|NCT00926796|588262539|FG001|Overall Study|Adverse Event|14|||
162880645|NCT00926796|588262538|FG000|Overall Study|Lost to Follow-up|22|||
162880646|NCT00926796|588262539|FG001|Overall Study|Lost to Follow-up|13|||
162880647|NCT00926796|588262538|FG000|Overall Study|Protocol Violation|15|||
162880648|NCT00926796|588262539|FG001|Overall Study|Protocol Violation|11|||
162880649|NCT00926796|588262538|FG000|Overall Study|Withdrawal by Subject|1|||
162880650|NCT00926796|588262539|FG001|Overall Study|Withdrawal by Subject|0|||
162880651|NCT01331239|588262541|FG000|Part II: Core Study|Adverse Event|0|||
162880652|NCT01331239|588262542|FG001|Part II: Core Study|Adverse Event|3|||
162880653|NCT01331239|588262543|FG002|Part II: Core Study|Adverse Event|0|||
162880654|NCT01331239|588262541|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
162880655|NCT01331239|588262542|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
162880656|NCT01331239|588262543|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
163048474|NCT02513550|588884799|FG003|Double Blind Treatment Period|Death|0|||
163048475|NCT02513550|588884800|FG004|Double Blind Treatment Period|Death|0|||
163048476|NCT02513550|588884801|FG005|Double Blind Treatment Period|Death|0|||
163048477|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
163048478|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
162880657|NCT01331239|588262541|FG000|Part II: Core Study|Withdrawal by Subject|0|||
162880658|NCT01331239|588262542|FG001|Part II: Core Study|Withdrawal by Subject|2|||
162880659|NCT01331239|588262543|FG002|Part II: Core Study|Withdrawal by Subject|0|||
162880660|NCT01331239|588262541|FG000|Part II: Core Study|Administrative problems|0|||
162880661|NCT01331239|588262542|FG001|Part II: Core Study|Administrative problems|1|||
162880662|NCT01331239|588262543|FG002|Part II: Core Study|Administrative problems|0|||
163048479|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
163048480|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163048481|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162880663|NCT00621855|588262544|FG000|Overall Study|Adverse Event|32|||
162880664|NCT00621855|588262545|FG001|Overall Study|Adverse Event|31|||
162880665|NCT00621855|588262546|FG002|Overall Study|Adverse Event|48|||
162880666|NCT00621855|588262547|FG003|Overall Study|Adverse Event|34|||
162880667|NCT00621855|588262548|FG004|Overall Study|Adverse Event|31|||
162880668|NCT00621855|588262544|FG000|Overall Study|Lost to Follow-up|0|||
162880669|NCT00621855|588262545|FG001|Overall Study|Lost to Follow-up|1|||
162880670|NCT00621855|588262546|FG002|Overall Study|Lost to Follow-up|3|||
162880671|NCT00621855|588262547|FG003|Overall Study|Lost to Follow-up|4|||
162880672|NCT00621855|588262548|FG004|Overall Study|Lost to Follow-up|1|||
162880673|NCT00621855|588262544|FG000|Overall Study|Protocol Violation|16|||
162880674|NCT00621855|588262545|FG001|Overall Study|Protocol Violation|8|||
162880675|NCT00621855|588262546|FG002|Overall Study|Protocol Violation|6|||
162880676|NCT00621855|588262547|FG003|Overall Study|Protocol Violation|7|||
162880677|NCT00621855|588262548|FG004|Overall Study|Protocol Violation|8|||
162880678|NCT00621855|588262544|FG000|Overall Study|Withdrawal by Subject|16|||
162880679|NCT00621855|588262545|FG001|Overall Study|Withdrawal by Subject|11|||
162880680|NCT00621855|588262546|FG002|Overall Study|Withdrawal by Subject|13|||
162880681|NCT00621855|588262547|FG003|Overall Study|Withdrawal by Subject|13|||
162880682|NCT00621855|588262548|FG004|Overall Study|Withdrawal by Subject|9|||
162880683|NCT00621855|588262544|FG000|Overall Study|Other|9|||
162880684|NCT00621855|588262545|FG001|Overall Study|Other|7|||
162880685|NCT00621855|588262546|FG002|Overall Study|Other|6|||
162880686|NCT00621855|588262547|FG003|Overall Study|Other|5|||
162880687|NCT00621855|588262548|FG004|Overall Study|Other|4|||
162880688|NCT00621855|588262544|FG000|Overall Study|Patients did not receive study drug|3|||
162880689|NCT00621855|588262545|FG001|Overall Study|Patients did not receive study drug|3|||
162880690|NCT00621855|588262546|FG002|Overall Study|Patients did not receive study drug|5|||
162880691|NCT00621855|588262547|FG003|Overall Study|Patients did not receive study drug|4|||
162880692|NCT00621855|588262548|FG004|Overall Study|Patients did not receive study drug|2|||
162880693|NCT02112994|588262549|FG000|Overall Study|Progressive Disease|0|||
162880694|NCT02112994|588262550|FG001|Overall Study|Progressive Disease|0|||
162880695|NCT02112994|588262551|FG002|Overall Study|Progressive Disease|1|||
162880696|NCT02112994|588262549|FG000|Overall Study|Pregnancy|0|||
162880697|NCT02112994|588262550|FG001|Overall Study|Pregnancy|1|||
162880698|NCT02112994|588262551|FG002|Overall Study|Pregnancy|1|||
162880699|NCT02112994|588262549|FG000|Overall Study|Liver Transplant|0|||
162880700|NCT02112994|588262550|FG001|Overall Study|Liver Transplant|1|||
162880701|NCT02112994|588262551|FG002|Overall Study|Liver Transplant|0|||
162880702|NCT02112994|588262549|FG000|Overall Study|Withdrawal by Subject|0|||
162880703|NCT02112994|588262550|FG001|Overall Study|Withdrawal by Subject|0|||
162880704|NCT02112994|588262551|FG002|Overall Study|Withdrawal by Subject|1|||
162880705|NCT01274338|588263996|FG000|Overall Study|Lack of Efficacy|72|||
162880706|NCT01274338|588263997|FG001|Overall Study|Lack of Efficacy|108|||
162880707|NCT01274338|588263998|FG002|Overall Study|Lack of Efficacy|116|||
162880708|NCT01274338|588263999|FG003|Overall Study|Lack of Efficacy|0|||
162880709|NCT01274338|588264000|FG004|Overall Study|Lack of Efficacy|0|||
162880710|NCT01274338|588264001|FG005|Overall Study|Lack of Efficacy|0|||
162880711|NCT01274338|588263996|FG000|Overall Study|Adverse Event|272|||
162880712|NCT01274338|588263997|FG001|Overall Study|Adverse Event|105|||
162880713|NCT01274338|588263998|FG002|Overall Study|Adverse Event|180|||
162880714|NCT01274338|588263999|FG003|Overall Study|Adverse Event|1|||
162880715|NCT01274338|588264000|FG004|Overall Study|Adverse Event|0|||
162880716|NCT01274338|588264001|FG005|Overall Study|Adverse Event|0|||
162880717|NCT01274338|588263996|FG000|Overall Study|Death|8|||
162880718|NCT01274338|588263997|FG001|Overall Study|Death|1|||
162880719|NCT01274338|588263998|FG002|Overall Study|Death|0|||
162880720|NCT01274338|588263999|FG003|Overall Study|Death|0|||
162880721|NCT01274338|588264000|FG004|Overall Study|Death|0|||
162880722|NCT01274338|588264001|FG005|Overall Study|Death|0|||
163048482|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163048483|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
162880723|NCT01274338|588263996|FG000|Overall Study|Withdrawal by Subject|27|||
162880724|NCT01274338|588263997|FG001|Overall Study|Withdrawal by Subject|99|||
162880725|NCT01274338|588263998|FG002|Overall Study|Withdrawal by Subject|17|||
162880726|NCT01274338|588263999|FG003|Overall Study|Withdrawal by Subject|0|||
162880727|NCT01274338|588264000|FG004|Overall Study|Withdrawal by Subject|0|||
162880728|NCT01274338|588264001|FG005|Overall Study|Withdrawal by Subject|0|||
162880729|NCT01274338|588263996|FG000|Overall Study|Did not start treatment|8|||
162880730|NCT01274338|588263997|FG001|Overall Study|Did not start treatment|116|||
162880731|NCT01274338|588263998|FG002|Overall Study|Did not start treatment|7|||
162880732|NCT01274338|588263999|FG003|Overall Study|Did not start treatment|0|||
162880733|NCT01274338|588264000|FG004|Overall Study|Did not start treatment|0|||
162880734|NCT01274338|588264001|FG005|Overall Study|Did not start treatment|0|||
162880735|NCT01274338|588263996|FG000|Overall Study|Alternative therapy|0|||
162880736|NCT01274338|588263997|FG001|Overall Study|Alternative therapy|1|||
162880737|NCT01274338|588263998|FG002|Overall Study|Alternative therapy|0|||
162880738|NCT01274338|588263999|FG003|Overall Study|Alternative therapy|0|||
162880739|NCT01274338|588264000|FG004|Overall Study|Alternative therapy|0|||
162880740|NCT01274338|588264001|FG005|Overall Study|Alternative therapy|0|||
162880741|NCT01274338|588263996|FG000|Overall Study|Other complicating diseases|0|||
162880742|NCT01274338|588263997|FG001|Overall Study|Other complicating diseases|3|||
162880743|NCT01274338|588263998|FG002|Overall Study|Other complicating diseases|1|||
162880744|NCT01274338|588263999|FG003|Overall Study|Other complicating diseases|0|||
162880745|NCT01274338|588264000|FG004|Overall Study|Other complicating diseases|0|||
163048484|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
163048485|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
163048486|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
162880746|NCT01274338|588264001|FG005|Overall Study|Other complicating diseases|0|||
162880747|NCT01274338|588263996|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
162880748|NCT01274338|588263997|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
162880749|NCT01274338|588263998|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
162880750|NCT01274338|588263999|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
162880751|NCT01274338|588264000|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
162880752|NCT01274338|588264001|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
162880753|NCT01274338|588263996|FG000|Overall Study|Pregnancy|0|||
162880754|NCT01274338|588263997|FG001|Overall Study|Pregnancy|0|||
162880755|NCT01274338|588263998|FG002|Overall Study|Pregnancy|1|||
162880756|NCT01274338|588263999|FG003|Overall Study|Pregnancy|0|||
162880757|NCT01274338|588264000|FG004|Overall Study|Pregnancy|0|||
162880758|NCT01274338|588264001|FG005|Overall Study|Pregnancy|0|||
162880759|NCT01274338|588263996|FG000|Overall Study|Reason not reported|12|||
162880760|NCT01274338|588263997|FG001|Overall Study|Reason not reported|21|||
162880761|NCT01274338|588263998|FG002|Overall Study|Reason not reported|3|||
162880762|NCT01274338|588263999|FG003|Overall Study|Reason not reported|0|||
162880763|NCT01274338|588264000|FG004|Overall Study|Reason not reported|1|||
162880764|NCT01274338|588264001|FG005|Overall Study|Reason not reported|0|||
162880765|NCT02924688|588264003|FG000|Overall Study|Adverse Event|9|||
162880766|NCT02924688|588264004|FG001|Overall Study|Adverse Event|3|||
162880767|NCT02924688|588264005|FG002|Overall Study|Adverse Event|2|||
162880768|NCT02924688|588264006|FG003|Overall Study|Adverse Event|2|||
162880769|NCT02924688|588264007|FG004|Overall Study|Adverse Event|3|||
162880770|NCT02924688|588264008|FG005|Overall Study|Adverse Event|2|||
162880771|NCT02924688|588264003|FG000|Overall Study|Lack of Efficacy|2|||
162880772|NCT02924688|588264004|FG001|Overall Study|Lack of Efficacy|3|||
162880773|NCT02924688|588264005|FG002|Overall Study|Lack of Efficacy|4|||
162880774|NCT02924688|588264006|FG003|Overall Study|Lack of Efficacy|2|||
162880775|NCT02924688|588264007|FG004|Overall Study|Lack of Efficacy|1|||
162880776|NCT02924688|588264008|FG005|Overall Study|Lack of Efficacy|1|||
162880777|NCT02924688|588264003|FG000|Overall Study|Protocol Violation|3|||
162880778|NCT02924688|588264004|FG001|Overall Study|Protocol Violation|7|||
162880779|NCT02924688|588264005|FG002|Overall Study|Protocol Violation|5|||
162880780|NCT02924688|588264006|FG003|Overall Study|Protocol Violation|6|||
162880781|NCT02924688|588264007|FG004|Overall Study|Protocol Violation|2|||
162880782|NCT02924688|588264008|FG005|Overall Study|Protocol Violation|2|||
162880783|NCT02924688|588264003|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
162880784|NCT02924688|588264004|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
162880785|NCT02924688|588264005|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
162880786|NCT02924688|588264006|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
162880787|NCT02924688|588264007|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
162880788|NCT02924688|588264008|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
163048487|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
163048488|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
162880789|NCT02924688|588264003|FG000|Overall Study|Lost to Follow-up|2|||
162880790|NCT02924688|588264004|FG001|Overall Study|Lost to Follow-up|4|||
162880791|NCT02924688|588264005|FG002|Overall Study|Lost to Follow-up|2|||
162880792|NCT02924688|588264006|FG003|Overall Study|Lost to Follow-up|4|||
162880793|NCT02924688|588264007|FG004|Overall Study|Lost to Follow-up|2|||
162880794|NCT02924688|588264008|FG005|Overall Study|Lost to Follow-up|4|||
162880795|NCT02924688|588264003|FG000|Overall Study|Physician Decision|2|||
162880796|NCT02924688|588264004|FG001|Overall Study|Physician Decision|1|||
162880797|NCT02924688|588264005|FG002|Overall Study|Physician Decision|0|||
162880798|NCT02924688|588264006|FG003|Overall Study|Physician Decision|1|||
162880799|NCT02924688|588264007|FG004|Overall Study|Physician Decision|1|||
162880800|NCT02924688|588264008|FG005|Overall Study|Physician Decision|1|||
162880801|NCT02924688|588264003|FG000|Overall Study|Withdrawal by Subject|14|||
162880802|NCT02924688|588264004|FG001|Overall Study|Withdrawal by Subject|13|||
162880803|NCT02924688|588264005|FG002|Overall Study|Withdrawal by Subject|9|||
162880804|NCT02924688|588264006|FG003|Overall Study|Withdrawal by Subject|12|||
162880805|NCT02924688|588264007|FG004|Overall Study|Withdrawal by Subject|13|||
162880806|NCT02924688|588264008|FG005|Overall Study|Withdrawal by Subject|14|||
163048489|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
162880807|NCT03072719|588264009|FG000|Overall Study|Adverse Event|1|||
162880808|NCT03072719|588264010|FG001|Overall Study|Adverse Event|1|||
162880809|NCT02586233|588264011|FG000|Overall Study|Randomized but did not receive treatment|0|||
162880810|NCT02586233|588264012|FG001|Overall Study|Randomized but did not receive treatment|1|||
162880811|NCT02586233|588264013|FG002|Overall Study|Randomized but did not receive treatment|0|||
162880812|NCT02586233|588264014|FG003|Overall Study|Randomized but did not receive treatment|0|||
162880813|NCT02586233|588264015|FG004|Overall Study|Randomized but did not receive treatment|0|||
162880814|NCT02586233|588264016|FG005|Overall Study|Randomized but did not receive treatment|2|||
162880815|NCT02586233|588264017|FG006|Overall Study|Randomized but did not receive treatment|2|||
162880816|NCT02586233|588264011|FG000|Overall Study|Death|0|||
162880817|NCT02586233|588264012|FG001|Overall Study|Death|1|||
162880818|NCT02586233|588264013|FG002|Overall Study|Death|0|||
162880819|NCT02586233|588264014|FG003|Overall Study|Death|0|||
162880820|NCT02586233|588264015|FG004|Overall Study|Death|2|||
162880821|NCT02586233|588264016|FG005|Overall Study|Death|0|||
162880822|NCT02586233|588264017|FG006|Overall Study|Death|0|||
162880823|NCT01708941|588264020|FG000|Overall Study|Adverse Event|4|||
162880824|NCT01708941|588264021|FG001|Overall Study|Adverse Event|6|||
162880825|NCT01708941|588264022|FG002|Overall Study|Adverse Event|1|||
162880826|NCT01708941|588264023|FG003|Overall Study|Adverse Event|0|||
162880827|NCT01708941|588264020|FG000|Overall Study|Death|1|||
162880828|NCT01708941|588264021|FG001|Overall Study|Death|1|||
162880829|NCT01708941|588264022|FG002|Overall Study|Death|2|||
162880830|NCT01708941|588264023|FG003|Overall Study|Death|14|||
162880831|NCT01708941|588264020|FG000|Overall Study|Withdrawal by Subject|1|||
162880832|NCT01708941|588264021|FG001|Overall Study|Withdrawal by Subject|0|||
162880833|NCT01708941|588264022|FG002|Overall Study|Withdrawal by Subject|3|||
162880834|NCT01708941|588264023|FG003|Overall Study|Withdrawal by Subject|4|||
162880835|NCT01708941|588264020|FG000|Overall Study|Disease progression|9|||
162880836|NCT01708941|588264021|FG001|Overall Study|Disease progression|10|||
162880837|NCT01708941|588264022|FG002|Overall Study|Disease progression|8|||
162880838|NCT01708941|588264023|FG003|Overall Study|Disease progression|0|||
162880839|NCT01708941|588264020|FG000|Overall Study|Alternative therapy|0|||
162880840|NCT01708941|588264021|FG001|Overall Study|Alternative therapy|0|||
162880841|NCT01708941|588264022|FG002|Overall Study|Alternative therapy|2|||
162880842|NCT01708941|588264023|FG003|Overall Study|Alternative therapy|0|||
162880843|NCT01708941|588264020|FG000|Overall Study|Ineligible and never started treatment|1|||
162880844|NCT01708941|588264021|FG001|Overall Study|Ineligible and never started treatment|0|||
162880845|NCT01708941|588264022|FG002|Overall Study|Ineligible and never started treatment|1|||
162880846|NCT01708941|588264023|FG003|Overall Study|Ineligible and never started treatment|0|||
162880847|NCT01708941|588264020|FG000|Overall Study|Never started treatment|2|||
162880848|NCT01708941|588264021|FG001|Overall Study|Never started treatment|1|||
162880849|NCT01708941|588264022|FG002|Overall Study|Never started treatment|0|||
162880850|NCT01708941|588264023|FG003|Overall Study|Never started treatment|0|||
162880851|NCT01708941|588264020|FG000|Overall Study|Ineligible|0|||
162880852|NCT01708941|588264021|FG001|Overall Study|Ineligible|0|||
162880853|NCT01708941|588264022|FG002|Overall Study|Ineligible|2|||
162880854|NCT01708941|588264023|FG003|Overall Study|Ineligible|0|||
162880855|NCT00229203|588264024|FG000|Overall Study|Progressive disease|18|||
162880856|NCT00229203|588264025|FG001|Overall Study|Progressive disease|9|||
162880857|NCT00229203|588264024|FG000|Overall Study|Toxicity|6|||
162880858|NCT00229203|588264025|FG001|Overall Study|Toxicity|1|||
162880859|NCT00229203|588264024|FG000|Overall Study|Death|4|||
162880860|NCT00229203|588264025|FG001|Overall Study|Death|2|||
162880861|NCT00229203|588264024|FG000|Overall Study|Other|3|||
162880862|NCT00229203|588264025|FG001|Overall Study|Other|3|||
162880863|NCT00229203|588264024|FG000|Overall Study|Withdrawal by Subject|1|||
162880864|NCT00229203|588264025|FG001|Overall Study|Withdrawal by Subject|4|||
162880865|NCT03457103|588264026|FG000|Overall Study|illness/hospitalization|4|||
162880866|NCT03457103|588264027|FG001|Overall Study|illness/hospitalization|2|||
162880867|NCT03457103|588264026|FG000|Overall Study|Lost to Follow-up|2|||
162880868|NCT03457103|588264027|FG001|Overall Study|Lost to Follow-up|1|||
162880869|NCT03457103|588264026|FG000|Overall Study|Withdrawal by Subject|1|||
162880870|NCT03457103|588264027|FG001|Overall Study|Withdrawal by Subject|2|||
162880871|NCT03457103|588264026|FG000|Overall Study|financial/ insurance issues|1|||
162880872|NCT03457103|588264027|FG001|Overall Study|financial/ insurance issues|1|||
162880873|NCT03004469|588264028|FG000|Overall Study|Adverse Event|6|||
162880874|NCT03004469|588264029|FG001|Overall Study|Adverse Event|4|||
162880875|NCT03004469|588264030|FG002|Overall Study|Adverse Event|6|||
162880876|NCT03004469|588264028|FG000|Overall Study|Lack of Efficacy|1|||
162880877|NCT03004469|588264029|FG001|Overall Study|Lack of Efficacy|0|||
162880878|NCT03004469|588264030|FG002|Overall Study|Lack of Efficacy|1|||
162880879|NCT03004469|588264028|FG000|Overall Study|Lost to Follow-up|23|||
162880880|NCT03004469|588264029|FG001|Overall Study|Lost to Follow-up|14|||
162880881|NCT03004469|588264030|FG002|Overall Study|Lost to Follow-up|6|||
162880882|NCT03004469|588264028|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163048490|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
162880883|NCT03004469|588264029|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162880884|NCT03004469|588264030|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162880885|NCT03004469|588264028|FG000|Overall Study|Protocol Violation|0|||
162880886|NCT03004469|588264029|FG001|Overall Study|Protocol Violation|0|||
162880887|NCT03004469|588264030|FG002|Overall Study|Protocol Violation|1|||
162880888|NCT03004469|588264028|FG000|Overall Study|Withdrawal by Subject|29|||
163048491|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
162880889|NCT03004469|588264029|FG001|Overall Study|Withdrawal by Subject|27|||
162880890|NCT03004469|588264030|FG002|Overall Study|Withdrawal by Subject|10|||
162880891|NCT03004469|588264028|FG000|Overall Study|Other unspecified reason|0|||
162880892|NCT03004469|588264029|FG001|Overall Study|Other unspecified reason|4|||
162880893|NCT03004469|588264030|FG002|Overall Study|Other unspecified reason|1|||
162880894|NCT01397552|588264031|FG000|Overall Study|Adverse Event|1|||
162880895|NCT01397552|588264032|FG001|Overall Study|Adverse Event|0|||
162880896|NCT01397552|588264031|FG000|Overall Study|Withdrawal by Subject|2|||
162880897|NCT01397552|588264032|FG001|Overall Study|Withdrawal by Subject|1|||
162880898|NCT00423735|588264033|FG000|Overall Study|Ineligible / No protocol treatment|8|||
162880899|NCT00423735|588264034|FG001|Overall Study|Ineligible / No protocol treatment|6|||
162880900|NCT00423735|588264035|FG002|Overall Study|Ineligible / No protocol treatment|0|||
162880901|NCT00579501|588264038|FG000|Overall Study|Death|1|||
162880902|NCT00579501|588264038|FG000|Overall Study|End of neoadjuvant therapy|25|||
162880903|NCT00579501|588264038|FG000|Overall Study|toxicity|1|||
162880904|NCT00579501|588264038|FG000|Overall Study|Secondary lesion|1|||
162880905|NCT00579501|588264038|FG000|Overall Study|Radiation therapy before surgery|1|||
162880906|NCT00190983|588264039|FG000|Overall Study|Inevaluable (never treated)|2|||
162880907|NCT02287402|588264040|FG000|Treatment Period|Adverse Event|17|||
162880908|NCT02287402|588264040|FG000|Treatment Period|Voluntary Withdrawal|10|||
162880909|NCT02287402|588264040|FG000|Follow-up|Lost to Follow-up|1|||
162880910|NCT02287402|588264040|FG000|Follow-up|Voluntary Withdrawal|2|||
162880911|NCT02130427|588264044|FG000|Overall Study|Imaging results not interpretable|30|||
162880912|NCT03150095|588264045|FG000|Overall Study|Death|0|||
162880913|NCT03150095|588264046|FG001|Overall Study|Death|1|||
162880914|NCT03150095|588264045|FG000|Overall Study|Lost to Follow-up|1|||
162880915|NCT03150095|588264046|FG001|Overall Study|Lost to Follow-up|1|||
162880916|NCT03150095|588264045|FG000|Overall Study|Withdrawal by Subject|4|||
162880917|NCT03150095|588264046|FG001|Overall Study|Withdrawal by Subject|0|||
162880918|NCT03150095|588264045|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
162880919|NCT03150095|588264046|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
162880920|NCT04032171|588264048|FG000|Overall Study|Study Termination|1|||
162880921|NCT04032171|588264049|FG001|Overall Study|Study Termination|0|||
162880922|NCT00089479|588264059|FG000|Overall Study|Death|108|||
162880923|NCT00089479|588264060|FG001|Overall Study|Death|75|||
162880924|NCT00089479|588264059|FG000|Overall Study|Withdrawal by Subject|86|||
162880925|NCT00089479|588264060|FG001|Overall Study|Withdrawal by Subject|107|||
162880926|NCT00089479|588264059|FG000|Overall Study|Lost to Follow-up|137|||
162880927|NCT00089479|588264060|FG001|Overall Study|Lost to Follow-up|107|||
162880928|NCT00289185|588264063|FG000|Overall Study|Withdrawal by Subject|4|||
162880929|NCT00289185|588264064|FG001|Overall Study|Withdrawal by Subject|8|||
162880930|NCT00289185|588264063|FG000|Overall Study|Lost to Follow-up|23|||
162880931|NCT00289185|588264064|FG001|Overall Study|Lost to Follow-up|17|||
162880932|NCT00289185|588264063|FG000|Overall Study|Death|1|||
162880933|NCT00289185|588264064|FG001|Overall Study|Death|1|||
162880934|NCT03337152|588264066|FG000|Overall Study|Physician Decision|1|||
162880935|NCT03337152|588264067|FG001|Overall Study|Physician Decision|0|||
162880936|NCT03337152|588264066|FG000|Overall Study|Lost to Follow-up|1|||
162880937|NCT03337152|588264067|FG001|Overall Study|Lost to Follow-up|3|||
162880938|NCT03337152|588264066|FG000|Overall Study|Adverse Event|3|||
162880939|NCT03337152|588264067|FG001|Overall Study|Adverse Event|1|||
162880940|NCT03337152|588264066|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
162880941|NCT03337152|588264067|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
162880942|NCT00421343|588264068|FG000|Overall Study|Death|1|||
162880943|NCT00421343|588264068|FG000|Overall Study|Withdrawal by Subject|2|||
162880944|NCT00421343|588264068|FG000|Overall Study|Lost to Follow-up|3|||
162880945|NCT00678587|588264069|FG000|Overall Study|Adverse Event|3|||
162880946|NCT00678587|588264070|FG001|Overall Study|Adverse Event|3|||
162880947|NCT00678587|588264069|FG000|Overall Study|Lack of Efficacy|1|||
162880948|NCT00678587|588264070|FG001|Overall Study|Lack of Efficacy|0|||
162880949|NCT00678587|588264069|FG000|Overall Study|Protocol Violation|2|||
162880950|NCT00678587|588264070|FG001|Overall Study|Protocol Violation|1|||
162880951|NCT00678587|588264069|FG000|Overall Study|Study Closed/Terminated|1|||
162880952|NCT00678587|588264070|FG001|Overall Study|Study Closed/Terminated|0|||
162880953|NCT00678587|588264069|FG000|Overall Study|Lost to Follow-up|3|||
162880954|NCT00678587|588264070|FG001|Overall Study|Lost to Follow-up|5|||
162880955|NCT00678587|588264069|FG000|Overall Study|Investigator Discretion|2|||
162880956|NCT00678587|588264070|FG001|Overall Study|Investigator Discretion|6|||
163048492|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162880957|NCT00678587|588264069|FG000|Overall Study|Withdrew Consent|8|||
162880958|NCT00678587|588264070|FG001|Overall Study|Withdrew Consent|3|||
162880959|NCT01069523|588264071|FG000|Overall Study|Withdrawal by Subject|4|||
162880960|NCT01069523|588264072|FG001|Overall Study|Withdrawal by Subject|7|||
162880961|NCT01875367|588264073|FG000|Overall Study|Not complete at least 2 questionaries|4|||
162880962|NCT01875367|588264074|FG001|Overall Study|Not complete at least 2 questionaries|2|||
162880963|NCT01875367|588264073|FG000|Overall Study|Not receive study treatment|1|||
162880964|NCT01875367|588264074|FG001|Overall Study|Not receive study treatment|0|||
162880965|NCT02951988|588264075|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
162880966|NCT02951988|588264076|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
162880967|NCT02951988|588264077|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
162880968|NCT02951988|588264078|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
162880969|NCT02951988|588264075|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
162880970|NCT02951988|588264076|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
162880971|NCT02951988|588264077|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
162880972|NCT02951988|588264078|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
162880973|NCT02951988|588264075|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
162880974|NCT02951988|588264076|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
162880975|NCT02951988|588264077|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
162880976|NCT02951988|588264078|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
162880977|NCT02951988|588264075|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
162880978|NCT02951988|588264076|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
162880979|NCT02951988|588264077|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
162880980|NCT02951988|588264078|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
162880981|NCT02951988|588264075|FG000|Open-Label Treatment Period|Protocol Violation|22|||
162880982|NCT02951988|588264076|FG001|Open-Label Treatment Period|Protocol Violation|0|||
162880983|NCT02951988|588264077|FG002|Open-Label Treatment Period|Protocol Violation|0|||
162880984|NCT02951988|588264078|FG003|Open-Label Treatment Period|Protocol Violation|0|||
162880985|NCT02951988|588264075|FG000|Open-Label Treatment Period|Pregnancy|2|||
162880986|NCT02951988|588264076|FG001|Open-Label Treatment Period|Pregnancy|0|||
162880987|NCT02951988|588264077|FG002|Open-Label Treatment Period|Pregnancy|0|||
162880988|NCT02951988|588264078|FG003|Open-Label Treatment Period|Pregnancy|0|||
162880989|NCT02951988|588264075|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
162880990|NCT02951988|588264076|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
162880991|NCT02951988|588264077|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
162880992|NCT02951988|588264078|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
162880993|NCT02951988|588264075|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
162880994|NCT02951988|588264076|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
162880995|NCT02951988|588264077|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
162880996|NCT02951988|588264078|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
162880997|NCT02951988|588264075|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
162880998|NCT02951988|588264076|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162880999|NCT02951988|588264077|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
162881000|NCT02951988|588264078|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
162881001|NCT02951988|588264075|FG000|Open-Label Treatment Period|Adverse Event|45|||
162881002|NCT02951988|588264076|FG001|Open-Label Treatment Period|Adverse Event|0|||
162881003|NCT02951988|588264077|FG002|Open-Label Treatment Period|Adverse Event|0|||
162881004|NCT02951988|588264078|FG003|Open-Label Treatment Period|Adverse Event|0|||
162881005|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
162881006|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
162881007|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
162881008|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
162881009|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
162881010|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
162881011|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
162881012|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
162881013|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
162881014|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
162881015|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
162881016|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
162881017|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162881018|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
162881019|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
162881020|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
162881021|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Pregnancy|0|||
162881022|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Pregnancy|1|||
162881023|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Pregnancy|1|||
162881024|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Pregnancy|0|||
162881025|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162881026|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
162881027|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
162881028|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
162881029|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162881030|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
162881031|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
162881032|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
162881033|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162881034|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Adverse Event|8|||
162881035|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Adverse Event|3|||
162881036|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Adverse Event|6|||
162881037|NCT02951988|588264075|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
162881038|NCT02951988|588264076|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
162881039|NCT02951988|588264077|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
162881040|NCT02951988|588264078|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
162881041|NCT00516269|588264079|FG000|Overall Study|Adverse Event|2|||
162881042|NCT00516269|588264080|FG001|Overall Study|Adverse Event|1|||
162881043|NCT00516269|588264079|FG000|Overall Study|Lost to Follow-up|0|||
162881044|NCT00516269|588264080|FG001|Overall Study|Lost to Follow-up|1|||
162881045|NCT00516269|588264079|FG000|Overall Study|Protocol Violation|0|||
162881046|NCT00516269|588264080|FG001|Overall Study|Protocol Violation|1|||
162881047|NCT04570657|588264083|FG000|Overall Study|Adverse Event|0|||
162881048|NCT04570657|588264084|FG001|Overall Study|Adverse Event|0|||
162881049|NCT04570657|588264085|FG002|Overall Study|Adverse Event|1|||
162881050|NCT04570657|588264083|FG000|Overall Study|Lost to Follow-up|0|||
162881051|NCT04570657|588264084|FG001|Overall Study|Lost to Follow-up|0|||
162881052|NCT04570657|588264085|FG002|Overall Study|Lost to Follow-up|1|||
162881053|NCT04570657|588264083|FG000|Overall Study|Physician Decision|0|||
162881054|NCT04570657|588264084|FG001|Overall Study|Physician Decision|1|||
162881055|NCT04570657|588264085|FG002|Overall Study|Physician Decision|0|||
162881056|NCT04570657|588264083|FG000|Overall Study|Withdrawal by Subject|1|||
162881057|NCT04570657|588264084|FG001|Overall Study|Withdrawal by Subject|2|||
162881058|NCT04570657|588264085|FG002|Overall Study|Withdrawal by Subject|2|||
162881059|NCT01079962|588264086|FG000|Overall Study|Adverse Event|2|||
162881060|NCT01079962|588264087|FG001|Overall Study|Adverse Event|2|||
162881061|NCT01079962|588264086|FG000|Overall Study|Withdrawal by Subject|5|||
162881062|NCT01079962|588264087|FG001|Overall Study|Withdrawal by Subject|7|||
162881063|NCT01079962|588264086|FG000|Overall Study|Protocol Violation|2|||
162881064|NCT01079962|588264087|FG001|Overall Study|Protocol Violation|2|||
162881065|NCT01079962|588264086|FG000|Overall Study|No blood pressure (BP) control|3|||
162881066|NCT01079962|588264087|FG001|Overall Study|No blood pressure (BP) control|0|||
162881067|NCT01079962|588264086|FG000|Overall Study|Inclusion/exclusion criteria|1|||
162881068|NCT01079962|588264087|FG001|Overall Study|Inclusion/exclusion criteria|3|||
162881069|NCT01079962|588264086|FG000|Overall Study|Participant not returning for next visit|1|||
162881070|NCT01079962|588264087|FG001|Overall Study|Participant not returning for next visit|0|||
162881071|NCT01079962|588264086|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
162881072|NCT01079962|588264087|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
162881073|NCT01072539|588264088|FG000|Overall Study|Treated prior to the Site Initiation|1|||
162881074|NCT01072539|588264088|FG000|Overall Study|Protocol Violation|2|||
162881075|NCT00946530|588264089|FG000|Overall Study|Withdrawal by Subject|0|||
162881076|NCT00946530|588264090|FG001|Overall Study|Withdrawal by Subject|3|||
162881077|NCT00946530|588264091|FG002|Overall Study|Withdrawal by Subject|0|||
162881078|NCT00946530|588264092|FG003|Overall Study|Withdrawal by Subject|3|||
162881079|NCT00946530|588264089|FG000|Overall Study|Physician Decision|1|||
162881080|NCT00946530|588264090|FG001|Overall Study|Physician Decision|1|||
162881081|NCT00946530|588264091|FG002|Overall Study|Physician Decision|1|||
162881082|NCT00946530|588264092|FG003|Overall Study|Physician Decision|1|||
162881083|NCT04167306|588264093|FG000|Overall Study|Lost to Follow-up|2|||
162881084|NCT04167306|588264094|FG001|Overall Study|Lost to Follow-up|2|||
162881085|NCT04167306|588264095|FG002|Overall Study|Lost to Follow-up|5|||
162881086|NCT04167306|588264096|FG003|Overall Study|Lost to Follow-up|5|||
162881087|NCT04167306|588264093|FG000|Overall Study|Adverse Event|13|||
162881088|NCT04167306|588264094|FG001|Overall Study|Adverse Event|14|||
162881089|NCT04167306|588264095|FG002|Overall Study|Adverse Event|5|||
162881090|NCT04167306|588264096|FG003|Overall Study|Adverse Event|4|||
162881091|NCT04167306|588264093|FG000|Overall Study|Withdrawal by Subject|4|||
162881092|NCT04167306|588264094|FG001|Overall Study|Withdrawal by Subject|6|||
162881093|NCT04167306|588264095|FG002|Overall Study|Withdrawal by Subject|8|||
162881094|NCT04167306|588264096|FG003|Overall Study|Withdrawal by Subject|3|||
162881095|NCT04167306|588264093|FG000|Overall Study|covid|1|||
162881096|NCT04167306|588264094|FG001|Overall Study|covid|1|||
162881097|NCT04167306|588264095|FG002|Overall Study|covid|2|||
162881098|NCT04167306|588264096|FG003|Overall Study|covid|1|||
162881099|NCT04167306|588264093|FG000|Overall Study|concomitant medication|0|||
162881100|NCT04167306|588264094|FG001|Overall Study|concomitant medication|0|||
162881101|NCT04167306|588264095|FG002|Overall Study|concomitant medication|0|||
162881102|NCT04167306|588264096|FG003|Overall Study|concomitant medication|1|||
162881103|NCT04167306|588264093|FG000|Overall Study|Alcohol treatment|0|||
162881104|NCT04167306|588264094|FG001|Overall Study|Alcohol treatment|4|||
163048493|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163048494|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163048495|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
163048496|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
163048497|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
163048498|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
163048499|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
163048500|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
163048501|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
163048502|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
163048503|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
163048504|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
163048505|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
163048506|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
163048507|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Death|0|||
163048508|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Death|0|||
163048509|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Death|1|||
163048510|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Death|0|||
163048511|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Death|0|||
163048512|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Death|0|||
163048513|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048514|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048515|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
163048516|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048517|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048518|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
163048519|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048520|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048521|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
163048522|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048523|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048524|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
163048525|NCT02513550|588884796|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
162616201|NCT00620464|587311646|FG000|Overall Study|Used prohibited medication|1|||
162616202|NCT00620464|587311647|FG001|Overall Study|Used prohibited medication|0|||
162616203|NCT05394350|587311648|FG000|Overall Study|Death|2|||
162616204|NCT05394350|587311649|FG001|Overall Study|Death|2|||
162616205|NCT05394350|587311650|FG002|Overall Study|Death|4|||
162616206|NCT05394350|587311651|FG003|Overall Study|Death|0|||
162616207|NCT05394350|587311652|FG004|Overall Study|Death|1|||
162616208|NCT05394350|587311653|FG005|Overall Study|Death|0|||
162616209|NCT05394350|587311648|FG000|Overall Study|Study terminated by sponsor|1|||
162616210|NCT05394350|587311649|FG001|Overall Study|Study terminated by sponsor|1|||
162616211|NCT05394350|587311650|FG002|Overall Study|Study terminated by sponsor|7|||
162616212|NCT05394350|587311651|FG003|Overall Study|Study terminated by sponsor|3|||
162616213|NCT05394350|587311652|FG004|Overall Study|Study terminated by sponsor|2|||
162616214|NCT05394350|587311653|FG005|Overall Study|Study terminated by sponsor|4|||
162616215|NCT02024555|587311654|FG000|Overall Study|Lost to Follow-up|1|||
163048526|NCT02513550|588884797|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048527|NCT02513550|588884798|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
163048528|NCT02513550|588884799|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048529|NCT02513550|588884800|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048530|NCT02513550|588884801|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
163048531|NCT02849743|588884802|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
163048532|NCT02849743|588884803|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
163048533|NCT02849743|588884802|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163048534|NCT02849743|588884803|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163048535|NCT02168491|588884806|FG000|Overall Study|Withdrawal by Subject|1|||
163048536|NCT00809445|588884807|FG000|1 Month Follow-up|Lost contact|1|||
163048537|NCT00809445|588884808|FG001|1 Month Follow-up|Lost contact|2|||
163048538|NCT00809445|588884809|FG002|1 Month Follow-up|Lost contact|1|||
163048539|NCT00809445|588884807|FG000|1 Month Follow-up|Withdrew consent|1|||
163048540|NCT00809445|588884808|FG001|1 Month Follow-up|Withdrew consent|1|||
163048541|NCT00809445|588884809|FG002|1 Month Follow-up|Withdrew consent|1|||
163048542|NCT00809445|588884807|FG000|1 Month Follow-up|Death|0|||
163048543|NCT00809445|588884808|FG001|1 Month Follow-up|Death|1|||
163048544|NCT00809445|588884809|FG002|1 Month Follow-up|Death|1|||
162616216|NCT02024555|587311655|FG001|Overall Study|Lost to Follow-up|1|||
162616217|NCT02024555|587311654|FG000|Overall Study|Withdrawal by Subject|5|||
162616218|NCT02024555|587311655|FG001|Overall Study|Withdrawal by Subject|1|||
162616219|NCT02887859|587311656|FG000|Overall Study|Ongoing|6|||
162616220|NCT02887859|587311656|FG000|Overall Study|Adverse Event|7|||
162881105|NCT04167306|588264095|FG002|Overall Study|Alcohol treatment|3|||
162881106|NCT04167306|588264096|FG003|Overall Study|Alcohol treatment|2|||
162881107|NCT04167306|588264093|FG000|Overall Study|non-compliance|0|||
162881108|NCT04167306|588264094|FG001|Overall Study|non-compliance|0|||
162881109|NCT04167306|588264095|FG002|Overall Study|non-compliance|1|||
162881110|NCT04167306|588264096|FG003|Overall Study|non-compliance|0|||
162881111|NCT04167306|588264093|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
162881112|NCT04167306|588264094|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
162881113|NCT04167306|588264095|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
162881114|NCT04167306|588264096|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
162881115|NCT03731364|588264097|FG000|Overall Study|Adverse Event|0|||
162881116|NCT03731364|588264098|FG001|Overall Study|Adverse Event|0|||
162881117|NCT03731364|588264099|FG002|Overall Study|Adverse Event|1|||
162881118|NCT03731364|588264100|FG003|Overall Study|Adverse Event|2|||
162881119|NCT03731364|588264101|FG004|Overall Study|Adverse Event|1|||
162881120|NCT04387136|588264102|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
162881121|NCT04387136|588264103|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
162881122|NCT00417976|588264104|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
162881123|NCT00417976|588264104|FG000|Overall Study|Treatment -related toxicity|2|||
162881124|NCT02358369|588264105|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
162881125|NCT02358369|588264106|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
162881126|NCT02358369|588264107|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
162881127|NCT02358369|588264108|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
162881128|NCT02358369|588264109|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
162881129|NCT02358369|588264105|FG000|Treatment Period A/B|Adverse Event|0|||
162881130|NCT02358369|588264106|FG001|Treatment Period A/B|Adverse Event|0|||
162881131|NCT02358369|588264107|FG002|Treatment Period A/B|Adverse Event|1|||
162881132|NCT02358369|588264108|FG003|Treatment Period A/B|Adverse Event|2|||
162881133|NCT02358369|588264109|FG004|Treatment Period A/B|Adverse Event|0|||
162881134|NCT02358369|588264105|FG000|Treatment Period A/B|Death|0|||
162881135|NCT02358369|588264106|FG001|Treatment Period A/B|Death|0|||
162881136|NCT02358369|588264107|FG002|Treatment Period A/B|Death|1|||
162881137|NCT02358369|588264108|FG003|Treatment Period A/B|Death|0|||
162881138|NCT02358369|588264109|FG004|Treatment Period A/B|Death|0|||
162881139|NCT02358369|588264105|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
162881140|NCT02358369|588264106|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
162881141|NCT02358369|588264107|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
162881142|NCT02358369|588264108|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
162881143|NCT02358369|588264109|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
162881144|NCT02358369|588264105|FG000|Treatment Period C|Adverse Event|0|||
162881145|NCT02358369|588264106|FG001|Treatment Period C|Adverse Event|0|||
162881146|NCT02358369|588264107|FG002|Treatment Period C|Adverse Event|0|||
162881147|NCT02358369|588264108|FG003|Treatment Period C|Adverse Event|0|||
162881148|NCT02358369|588264109|FG004|Treatment Period C|Adverse Event|7|||
162881149|NCT03655717|588264110|FG000|Overall Study|Withdrawal by Subject|4|||
162881150|NCT03655717|588264111|FG001|Overall Study|Withdrawal by Subject|8|||
162881151|NCT03655717|588264112|FG002|Overall Study|Withdrawal by Subject|1|||
162881152|NCT03655717|588264113|FG003|Overall Study|Withdrawal by Subject|0|||
162881153|NCT03655717|588264114|FG004|Overall Study|Withdrawal by Subject|0|||
162881154|NCT03655717|588264115|FG005|Overall Study|Withdrawal by Subject|1|||
162881155|NCT03655717|588264116|FG006|Overall Study|Withdrawal by Subject|3|||
162881156|NCT03655717|588264117|FG007|Overall Study|Withdrawal by Subject|1|||
162881157|NCT03655717|588264118|FG008|Overall Study|Withdrawal by Subject|2|||
162881158|NCT03655717|588264119|FG009|Overall Study|Withdrawal by Subject|0|||
162881159|NCT03655717|588264120|FG010|Overall Study|Withdrawal by Subject|0|||
162961860|NCT00112437|588560759|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961861|NCT00112437|588560760|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961862|NCT00112437|588560761|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961863|NCT00112437|588560762|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961864|NCT00112437|588560763|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961865|NCT00112437|588560764|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961866|NCT00112437|588560765|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961867|NCT00112437|588560766|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
162961868|NCT00112437|588560767|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
162707611|NCT00984282|587638281|FG001|Open-label Treatment|Switched to commercial drug|7|||
162707612|NCT00984282|587638280|FG000|Open-label Treatment|Physician Decision|1|||
162881160|NCT03655717|588264121|FG011|Overall Study|Withdrawal by Subject|1|||
162881161|NCT03655717|588264122|FG012|Overall Study|Withdrawal by Subject|0|||
162881162|NCT03655717|588264123|FG013|Overall Study|Withdrawal by Subject|3|||
162881163|NCT03655717|588264124|FG014|Overall Study|Withdrawal by Subject|0|||
162881164|NCT03655717|588264125|FG015|Overall Study|Withdrawal by Subject|1|||
162881165|NCT03655717|588264126|FG016|Overall Study|Withdrawal by Subject|0|||
162881166|NCT03655717|588264127|FG017|Overall Study|Withdrawal by Subject|0|||
162881167|NCT03655717|588264128|FG018|Overall Study|Withdrawal by Subject|1|||
162881168|NCT03655717|588264129|FG019|Overall Study|Withdrawal by Subject|0|||
162881169|NCT03655717|588264130|FG020|Overall Study|Withdrawal by Subject|0|||
162881170|NCT03655717|588264131|FG021|Overall Study|Withdrawal by Subject|1|||
162881171|NCT03655717|588264132|FG022|Overall Study|Withdrawal by Subject|2|||
162881172|NCT03655717|588264133|FG023|Overall Study|Withdrawal by Subject|1|||
162881173|NCT03655717|588264134|FG024|Overall Study|Withdrawal by Subject|1|||
162881174|NCT03655717|588264135|FG025|Overall Study|Withdrawal by Subject|0|||
162881175|NCT03655717|588264110|FG000|Overall Study|Physician Decision|3|||
162881176|NCT03655717|588264111|FG001|Overall Study|Physician Decision|3|||
162881177|NCT03655717|588264112|FG002|Overall Study|Physician Decision|0|||
162881178|NCT03655717|588264113|FG003|Overall Study|Physician Decision|0|||
162881179|NCT03655717|588264114|FG004|Overall Study|Physician Decision|0|||
162881180|NCT03655717|588264115|FG005|Overall Study|Physician Decision|0|||
162881181|NCT03655717|588264116|FG006|Overall Study|Physician Decision|0|||
162881182|NCT03655717|588264117|FG007|Overall Study|Physician Decision|0|||
162881183|NCT03655717|588264118|FG008|Overall Study|Physician Decision|0|||
162881184|NCT03655717|588264119|FG009|Overall Study|Physician Decision|1|||
162881185|NCT03655717|588264120|FG010|Overall Study|Physician Decision|0|||
162881186|NCT03655717|588264121|FG011|Overall Study|Physician Decision|0|||
162881187|NCT03655717|588264122|FG012|Overall Study|Physician Decision|0|||
162881188|NCT03655717|588264123|FG013|Overall Study|Physician Decision|0|||
162881189|NCT03655717|588264124|FG014|Overall Study|Physician Decision|0|||
162881190|NCT03655717|588264125|FG015|Overall Study|Physician Decision|0|||
162881191|NCT03655717|588264126|FG016|Overall Study|Physician Decision|0|||
162881192|NCT03655717|588264127|FG017|Overall Study|Physician Decision|0|||
162881193|NCT03655717|588264128|FG018|Overall Study|Physician Decision|0|||
162881194|NCT03655717|588264129|FG019|Overall Study|Physician Decision|1|||
162881195|NCT03655717|588264130|FG020|Overall Study|Physician Decision|0|||
162881196|NCT03655717|588264131|FG021|Overall Study|Physician Decision|0|||
162881197|NCT03655717|588264132|FG022|Overall Study|Physician Decision|0|||
162881198|NCT03655717|588264133|FG023|Overall Study|Physician Decision|1|||
162881199|NCT03655717|588264134|FG024|Overall Study|Physician Decision|0|||
162881200|NCT03655717|588264135|FG025|Overall Study|Physician Decision|0|||
162881201|NCT03655717|588264110|FG000|Overall Study|Lost to Follow-up|3|||
162881202|NCT03655717|588264111|FG001|Overall Study|Lost to Follow-up|1|||
162881203|NCT03655717|588264112|FG002|Overall Study|Lost to Follow-up|0|||
162881204|NCT03655717|588264113|FG003|Overall Study|Lost to Follow-up|1|||
162881205|NCT03655717|588264114|FG004|Overall Study|Lost to Follow-up|0|||
162881206|NCT03655717|588264115|FG005|Overall Study|Lost to Follow-up|1|||
162881207|NCT03655717|588264116|FG006|Overall Study|Lost to Follow-up|0|||
162881208|NCT03655717|588264117|FG007|Overall Study|Lost to Follow-up|0|||
162881209|NCT03655717|588264118|FG008|Overall Study|Lost to Follow-up|0|||
162881210|NCT03655717|588264119|FG009|Overall Study|Lost to Follow-up|0|||
162881211|NCT03655717|588264120|FG010|Overall Study|Lost to Follow-up|0|||
162881212|NCT03655717|588264121|FG011|Overall Study|Lost to Follow-up|1|||
162881213|NCT03655717|588264122|FG012|Overall Study|Lost to Follow-up|0|||
162881214|NCT03655717|588264123|FG013|Overall Study|Lost to Follow-up|0|||
162881215|NCT03655717|588264124|FG014|Overall Study|Lost to Follow-up|0|||
162881216|NCT03655717|588264125|FG015|Overall Study|Lost to Follow-up|0|||
162881217|NCT03655717|588264126|FG016|Overall Study|Lost to Follow-up|0|||
162881218|NCT03655717|588264127|FG017|Overall Study|Lost to Follow-up|0|||
162881219|NCT03655717|588264128|FG018|Overall Study|Lost to Follow-up|0|||
162881220|NCT03655717|588264129|FG019|Overall Study|Lost to Follow-up|0|||
162881221|NCT03655717|588264130|FG020|Overall Study|Lost to Follow-up|0|||
162881222|NCT03655717|588264131|FG021|Overall Study|Lost to Follow-up|0|||
162881223|NCT03655717|588264132|FG022|Overall Study|Lost to Follow-up|0|||
162881224|NCT03655717|588264133|FG023|Overall Study|Lost to Follow-up|0|||
162881225|NCT03655717|588264134|FG024|Overall Study|Lost to Follow-up|0|||
162881226|NCT03655717|588264135|FG025|Overall Study|Lost to Follow-up|0|||
162881227|NCT01185249|588264136|FG000|Overall Study|Patients discharged or change in status|42|||
162961869|NCT00112437|588560768|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162881228|NCT01973452|588264137|FG000|Overall Study|Lack of Efficacy|0|||
162881229|NCT01973452|588264138|FG001|Overall Study|Lack of Efficacy|1|||
162881230|NCT01973452|588264137|FG000|Overall Study|Lost to Follow-up|1|||
162881231|NCT01973452|588264138|FG001|Overall Study|Lost to Follow-up|0|||
162881232|NCT01973452|588264137|FG000|Overall Study|Withdrawal by Subject|10|||
162961870|NCT00112437|588560769|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162881233|NCT01973452|588264138|FG001|Overall Study|Withdrawal by Subject|9|||
162881234|NCT01973452|588264137|FG000|Overall Study|Ineligible|1|||
162881235|NCT01973452|588264138|FG001|Overall Study|Ineligible|1|||
162881236|NCT01973452|588264137|FG000|Overall Study|Surgery canceled by participant|5|||
162881237|NCT01973452|588264138|FG001|Overall Study|Surgery canceled by participant|3|||
162881238|NCT00064350|588264140|FG000|Induction Treatment|Disease Progression|5|||
162881239|NCT00064350|588264141|FG001|Induction Treatment|Disease Progression|1|||
162881240|NCT00064350|588264142|FG002|Induction Treatment|Disease Progression|110|||
162881241|NCT00064350|588264140|FG000|Induction Treatment|Adverse Event|0|||
162881242|NCT00064350|588264141|FG001|Induction Treatment|Adverse Event|2|||
162881243|NCT00064350|588264142|FG002|Induction Treatment|Adverse Event|49|||
162881244|NCT00064350|588264140|FG000|Induction Treatment|Death|0|||
162881245|NCT00064350|588264141|FG001|Induction Treatment|Death|0|||
162881246|NCT00064350|588264142|FG002|Induction Treatment|Death|9|||
162881247|NCT00064350|588264140|FG000|Induction Treatment|Withdrawal by Subject|0|||
162881248|NCT00064350|588264141|FG001|Induction Treatment|Withdrawal by Subject|0|||
162881249|NCT00064350|588264142|FG002|Induction Treatment|Withdrawal by Subject|21|||
162881250|NCT00064350|588264140|FG000|Induction Treatment|Ineligible or never started treatment|3|||
162881251|NCT00064350|588264141|FG001|Induction Treatment|Ineligible or never started treatment|6|||
162881252|NCT00064350|588264142|FG002|Induction Treatment|Ineligible or never started treatment|34|||
162881253|NCT00064350|588264140|FG000|Induction Treatment|Other|0|||
162881254|NCT00064350|588264141|FG001|Induction Treatment|Other|0|||
162881255|NCT00064350|588264142|FG002|Induction Treatment|Other|13|||
162881256|NCT00064350|588264140|FG000|Randomization|Adverse Event|8|||
162881257|NCT00064350|588264141|FG001|Randomization|Adverse Event|3|||
162881258|NCT00064350|588264142|FG002|Randomization|Adverse Event|0|||
162881259|NCT00064350|588264140|FG000|Randomization|Death|3|||
162881260|NCT00064350|588264141|FG001|Randomization|Death|0|||
162881261|NCT00064350|588264142|FG002|Randomization|Death|0|||
162881262|NCT00064350|588264140|FG000|Randomization|Withdrawal by Subject|1|||
162881263|NCT00064350|588264141|FG001|Randomization|Withdrawal by Subject|0|||
162881264|NCT00064350|588264142|FG002|Randomization|Withdrawal by Subject|0|||
162881265|NCT00064350|588264140|FG000|Randomization|Ineligible or never started treatment|9|||
162881266|NCT00064350|588264141|FG001|Randomization|Ineligible or never started treatment|15|||
162881267|NCT00064350|588264142|FG002|Randomization|Ineligible or never started treatment|0|||
162881268|NCT00064350|588264140|FG000|Randomization|Other|5|||
162881269|NCT00064350|588264141|FG001|Randomization|Other|0|||
162881270|NCT00064350|588264142|FG002|Randomization|Other|0|||
162881271|NCT00064350|588264140|FG000|Cross-Over|Adverse Event|0|||
162881272|NCT00064350|588264141|FG001|Cross-Over|Adverse Event|1|||
162881273|NCT00064350|588264142|FG002|Cross-Over|Adverse Event|0|||
162881274|NCT00064350|588264140|FG000|Cross-Over|Death|1|||
162881275|NCT00064350|588264141|FG001|Cross-Over|Death|3|||
162881276|NCT00064350|588264142|FG002|Cross-Over|Death|0|||
162881277|NCT00064350|588264140|FG000|Cross-Over|Withdrawal by Subject|2|||
162881278|NCT00064350|588264141|FG001|Cross-Over|Withdrawal by Subject|2|||
162881279|NCT00064350|588264142|FG002|Cross-Over|Withdrawal by Subject|0|||
162881280|NCT00064350|588264140|FG000|Cross-Over|Ineligible or never started treatment|3|||
162881281|NCT00064350|588264141|FG001|Cross-Over|Ineligible or never started treatment|6|||
162881282|NCT00064350|588264142|FG002|Cross-Over|Ineligible or never started treatment|0|||
162881283|NCT00064350|588264140|FG000|Cross-Over|Other|0|||
162881284|NCT00064350|588264141|FG001|Cross-Over|Other|2|||
162881285|NCT00064350|588264142|FG002|Cross-Over|Other|0|||
162881286|NCT00115765|588264143|FG000|Overall Study|Withdrawal by Subject|22|||
162881287|NCT00115765|588264144|FG001|Overall Study|Withdrawal by Subject|53|||
162881288|NCT00115765|588264145|FG002|Overall Study|Withdrawal by Subject|76|||
162881289|NCT00115765|588264146|FG003|Overall Study|Withdrawal by Subject|15|||
162881290|NCT00115765|588264143|FG000|Overall Study|Physician Decision|4|||
163048545|NCT00809445|588884807|FG000|1 Month Follow-up|Incarcerated|0|||
163048546|NCT00809445|588884808|FG001|1 Month Follow-up|Incarcerated|0|||
162961871|NCT00112437|588560770|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961872|NCT00112437|588560771|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162961873|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961874|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961875|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961876|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961877|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961878|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961879|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961880|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961881|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961882|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961883|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162881291|NCT00115765|588264144|FG001|Overall Study|Physician Decision|15|||
162881292|NCT00115765|588264145|FG002|Overall Study|Physician Decision|18|||
162881293|NCT00115765|588264146|FG003|Overall Study|Physician Decision|13|||
162881294|NCT00115765|588264143|FG000|Overall Study|Lost to Follow-up|3|||
163048547|NCT00809445|588884809|FG002|1 Month Follow-up|Incarcerated|1|||
162961884|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162881295|NCT00115765|588264144|FG001|Overall Study|Lost to Follow-up|20|||
162881296|NCT00115765|588264145|FG002|Overall Study|Lost to Follow-up|18|||
162881297|NCT00115765|588264146|FG003|Overall Study|Lost to Follow-up|1|||
162881298|NCT00115765|588264143|FG000|Overall Study|Other|6|||
162881299|NCT00115765|588264144|FG001|Overall Study|Other|12|||
162881300|NCT00115765|588264145|FG002|Overall Study|Other|9|||
162881301|NCT00115765|588264146|FG003|Overall Study|Other|2|||
162961885|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162707613|NCT00984282|587638281|FG001|Open-label Treatment|Physician Decision|0|||
162707614|NCT00984282|587638280|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
162707615|NCT00984282|587638281|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
162707616|NCT00984282|587638280|FG000|Long Term Follow-up|Death|27|||
162707617|NCT00984282|587638281|FG001|Long Term Follow-up|Death|68|||
162707618|NCT00984282|587638280|FG000|Long Term Follow-up|Lost to Follow-up|3|||
162707619|NCT00984282|587638281|FG001|Long Term Follow-up|Lost to Follow-up|6|||
162707620|NCT00984282|587638280|FG000|Long Term Follow-up|Protocol driven decision point|25|||
162707621|NCT00984282|587638281|FG001|Long Term Follow-up|Protocol driven decision point|26|||
162707622|NCT00984282|587638280|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
162707623|NCT00984282|587638281|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
162707624|NCT00984282|587638280|FG000|Long Term Follow-up|Switched to commercial drug|4|||
162707625|NCT00984282|587638281|FG001|Long Term Follow-up|Switched to commercial drug|2|||
162707626|NCT00984282|587638280|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
162707627|NCT00984282|587638281|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
162707628|NCT02223793|587638282|FG000|Overall Study|Lost to Follow-up|10|||
162707629|NCT02223793|587638283|FG001|Overall Study|Lost to Follow-up|1|||
162707630|NCT02223793|587638284|FG002|Overall Study|Lost to Follow-up|2|||
162707631|NCT02223793|587638282|FG000|Overall Study|Withdrawal by Subject|3|||
162707632|NCT02223793|587638283|FG001|Overall Study|Withdrawal by Subject|2|||
162707633|NCT02223793|587638284|FG002|Overall Study|Withdrawal by Subject|3|||
163048548|NCT00809445|588884807|FG000|6 Month Follow-up|Lost contact|16|||
163048549|NCT00809445|588884808|FG001|6 Month Follow-up|Lost contact|14|||
163048550|NCT00809445|588884809|FG002|6 Month Follow-up|Lost contact|14|||
163048551|NCT00809445|588884807|FG000|6 Month Follow-up|Death|2|||
163048552|NCT00809445|588884808|FG001|6 Month Follow-up|Death|1|||
163048553|NCT00809445|588884809|FG002|6 Month Follow-up|Death|1|||
163048554|NCT00809445|588884807|FG000|6 Month Follow-up|Incarcerated|6|||
163048555|NCT00809445|588884808|FG001|6 Month Follow-up|Incarcerated|8|||
163048556|NCT00809445|588884809|FG002|6 Month Follow-up|Incarcerated|8|||
163048557|NCT00809445|588884807|FG000|6 Month Follow-up|Withdrew consent|0|||
163048558|NCT00809445|588884808|FG001|6 Month Follow-up|Withdrew consent|0|||
163048559|NCT00809445|588884809|FG002|6 Month Follow-up|Withdrew consent|1|||
163048560|NCT04919317|588884810|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
163048561|NCT04919317|588884811|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
163048562|NCT04919317|588884810|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
163048563|NCT04919317|588884811|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
163048564|NCT01566604|588884812|FG000|Overall Study|Patient's inability to use the device|1|||
163048565|NCT01566604|588884813|FG001|Overall Study|Patient's inability to use the device|0|||
163048566|NCT01566604|588884812|FG000|Overall Study|Administrative problems|1|||
163048567|NCT01566604|588884813|FG001|Overall Study|Administrative problems|0|||
163048568|NCT01566604|588884812|FG000|Overall Study|Lack of Efficacy|1|||
163048569|NCT01566604|588884813|FG001|Overall Study|Lack of Efficacy|2|||
163048570|NCT01566604|588884812|FG000|Overall Study|Protocol deviation|2|||
163048571|NCT01566604|588884813|FG001|Overall Study|Protocol deviation|0|||
163048572|NCT01566604|588884812|FG000|Overall Study|Abnormal laboratory value|2|||
163048573|NCT01566604|588884813|FG001|Overall Study|Abnormal laboratory value|0|||
162707634|NCT02223793|587638282|FG000|Overall Study|Moved/studycenter unable to participate|4|||
162707635|NCT02223793|587638283|FG001|Overall Study|Moved/studycenter unable to participate|6|||
162707636|NCT02223793|587638284|FG002|Overall Study|Moved/studycenter unable to participate|8|||
162707637|NCT02321540|587638287|FG000|Overall Study|Death|0|||
162707638|NCT02321540|587638288|FG001|Overall Study|Death|1|||
163048574|NCT01566604|588884812|FG000|Overall Study|Death|4|||
163048575|NCT01566604|588884813|FG001|Overall Study|Death|1|||
163048576|NCT01566604|588884812|FG000|Overall Study|Adverse Event|4|||
163048577|NCT01566604|588884813|FG001|Overall Study|Adverse Event|2|||
163048578|NCT01566604|588884812|FG000|Overall Study|Withdrawal by Subject|9|||
163048579|NCT01566604|588884813|FG001|Overall Study|Withdrawal by Subject|6|||
163048580|NCT01443858|588884820|FG000|Overall Study|Withdrawal by Subject|9|||
163048581|NCT01443858|588884821|FG001|Overall Study|Withdrawal by Subject|8|||
163048582|NCT01443858|588884822|FG002|Overall Study|Withdrawal by Subject|5|||
163048583|NCT01443858|588884820|FG000|Overall Study|Lack of Efficacy|1|||
162707639|NCT02321540|587638287|FG000|Overall Study|Progression|3|||
162707640|NCT02321540|587638288|FG001|Overall Study|Progression|9|||
162707641|NCT03606460|587638289|FG000|Overall Study|Lost to Follow-up|1|||
162707642|NCT03606460|587638290|FG001|Overall Study|Lost to Follow-up|8|||
162707643|NCT00003377|587638291|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
162707644|NCT00003377|587638292|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
162707645|NCT00003377|587638293|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
162707646|NCT00003377|587638294|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
163048584|NCT01443858|588884821|FG001|Overall Study|Lack of Efficacy|0|||
163048585|NCT01443858|588884822|FG002|Overall Study|Lack of Efficacy|0|||
163048586|NCT01443858|588884820|FG000|Overall Study|Lost to Follow-up|5|||
163048587|NCT01443858|588884821|FG001|Overall Study|Lost to Follow-up|5|||
163048588|NCT01443858|588884822|FG002|Overall Study|Lost to Follow-up|2|||
163048589|NCT02221648|588884825|FG000|Overall Study|Withdrawal by Subject|3|||
163048590|NCT02221648|588884826|FG001|Overall Study|Withdrawal by Subject|3|||
163048591|NCT00810069|588884829|FG000|Lead-in Period I|Adverse Event|43|||
162707647|NCT00003377|587638295|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
162707648|NCT00003377|587638291|FG000|Period II|Ureteral stent complications|0|||
162707649|NCT00003377|587638292|FG001|Period II|Ureteral stent complications|0|||
162707650|NCT00003377|587638293|FG002|Period II|Ureteral stent complications|0|||
162881302|NCT01683071|588264149|FG000|Part 1|Lack of Efficacy|1|||
162881303|NCT01683071|588264150|FG001|Part 1|Lack of Efficacy|0|||
162881304|NCT01683071|588264151|FG002|Part 1|Lack of Efficacy|0|||
162881305|NCT01683071|588264152|FG003|Part 1|Lack of Efficacy|3|||
162881306|NCT01683071|588264153|FG004|Part 1|Lack of Efficacy|0|||
162881307|NCT01683071|588264154|FG005|Part 1|Lack of Efficacy|0|||
162881308|NCT01683071|588264149|FG000|Part 1|Withdrawal by Subject|1|||
162881309|NCT01683071|588264150|FG001|Part 1|Withdrawal by Subject|2|||
162881310|NCT01683071|588264151|FG002|Part 1|Withdrawal by Subject|2|||
162881311|NCT01683071|588264152|FG003|Part 1|Withdrawal by Subject|1|||
162881312|NCT01683071|588264153|FG004|Part 1|Withdrawal by Subject|0|||
162881313|NCT01683071|588264154|FG005|Part 1|Withdrawal by Subject|0|||
162881314|NCT01683071|588264149|FG000|Part 1|Surgery Cancelled|1|||
162881315|NCT01683071|588264150|FG001|Part 1|Surgery Cancelled|0|||
162881316|NCT01683071|588264151|FG002|Part 1|Surgery Cancelled|0|||
162881317|NCT01683071|588264152|FG003|Part 1|Surgery Cancelled|0|||
162881318|NCT01683071|588264153|FG004|Part 1|Surgery Cancelled|0|||
162881319|NCT01683071|588264154|FG005|Part 1|Surgery Cancelled|0|||
162881320|NCT01683071|588264149|FG000|Part 1|Did not receive study drug|1|||
162881321|NCT01683071|588264150|FG001|Part 1|Did not receive study drug|0|||
162881322|NCT01683071|588264151|FG002|Part 1|Did not receive study drug|0|||
162881323|NCT01683071|588264152|FG003|Part 1|Did not receive study drug|1|||
163048592|NCT00810069|588884830|FG001|Lead-in Period I|Adverse Event|0|||
163048593|NCT00810069|588884831|FG002|Lead-in Period I|Adverse Event|0|||
163048594|NCT00810069|588884829|FG000|Lead-in Period I|Lack of Efficacy|1|||
163048595|NCT00810069|588884830|FG001|Lead-in Period I|Lack of Efficacy|0|||
163048596|NCT00810069|588884831|FG002|Lead-in Period I|Lack of Efficacy|0|||
162616221|NCT02887859|587311656|FG000|Overall Study|Death|1|||
162881324|NCT01683071|588264153|FG004|Part 1|Did not receive study drug|0|||
162881325|NCT01683071|588264154|FG005|Part 1|Did not receive study drug|0|||
162881326|NCT01683071|588264149|FG000|Part 1|Early termination; met exclusion criteria|0|||
162881327|NCT01683071|588264150|FG001|Part 1|Early termination; met exclusion criteria|2|||
162881328|NCT01683071|588264151|FG002|Part 1|Early termination; met exclusion criteria|1|||
162881329|NCT01683071|588264152|FG003|Part 1|Early termination; met exclusion criteria|0|||
162881330|NCT01683071|588264153|FG004|Part 1|Early termination; met exclusion criteria|0|||
162881331|NCT01683071|588264154|FG005|Part 1|Early termination; met exclusion criteria|0|||
162881332|NCT01683071|588264149|FG000|Part 2|Lack of Efficacy|0|||
162881333|NCT01683071|588264150|FG001|Part 2|Lack of Efficacy|0|||
162881334|NCT01683071|588264151|FG002|Part 2|Lack of Efficacy|0|||
162881335|NCT01683071|588264152|FG003|Part 2|Lack of Efficacy|0|||
162881336|NCT01683071|588264153|FG004|Part 2|Lack of Efficacy|3|||
162881337|NCT01683071|588264154|FG005|Part 2|Lack of Efficacy|4|||
162881338|NCT01683071|588264149|FG000|Part 2|Lost to Follow-up|0|||
162881339|NCT01683071|588264150|FG001|Part 2|Lost to Follow-up|0|||
162881340|NCT01683071|588264151|FG002|Part 2|Lost to Follow-up|0|||
162881341|NCT01683071|588264152|FG003|Part 2|Lost to Follow-up|0|||
162881342|NCT01683071|588264153|FG004|Part 2|Lost to Follow-up|2|||
162881343|NCT01683071|588264154|FG005|Part 2|Lost to Follow-up|0|||
162881344|NCT01683071|588264149|FG000|Part 2|Withdrawal by Subject|0|||
162881345|NCT01683071|588264150|FG001|Part 2|Withdrawal by Subject|0|||
162881346|NCT01683071|588264151|FG002|Part 2|Withdrawal by Subject|0|||
162881347|NCT01683071|588264152|FG003|Part 2|Withdrawal by Subject|0|||
162881348|NCT01683071|588264153|FG004|Part 2|Withdrawal by Subject|3|||
162881349|NCT01683071|588264154|FG005|Part 2|Withdrawal by Subject|3|||
162881350|NCT01683071|588264149|FG000|Part 2|Surgery cancelled|0|||
162881351|NCT01683071|588264150|FG001|Part 2|Surgery cancelled|0|||
162881352|NCT01683071|588264151|FG002|Part 2|Surgery cancelled|0|||
162881353|NCT01683071|588264152|FG003|Part 2|Surgery cancelled|0|||
162881354|NCT01683071|588264153|FG004|Part 2|Surgery cancelled|4|||
162881355|NCT01683071|588264154|FG005|Part 2|Surgery cancelled|2|||
162881356|NCT01683071|588264149|FG000|Part 2|Did not receive study drug|0|||
162881357|NCT01683071|588264150|FG001|Part 2|Did not receive study drug|0|||
162881358|NCT01683071|588264151|FG002|Part 2|Did not receive study drug|0|||
162881359|NCT01683071|588264152|FG003|Part 2|Did not receive study drug|0|||
162881360|NCT01683071|588264153|FG004|Part 2|Did not receive study drug|2|||
162881361|NCT01683071|588264154|FG005|Part 2|Did not receive study drug|1|||
162881362|NCT01683071|588264149|FG000|Part 2|Met exclusion criterion|0|||
162881363|NCT01683071|588264150|FG001|Part 2|Met exclusion criterion|0|||
162881364|NCT01683071|588264151|FG002|Part 2|Met exclusion criterion|0|||
162881365|NCT01683071|588264152|FG003|Part 2|Met exclusion criterion|0|||
162881366|NCT01683071|588264153|FG004|Part 2|Met exclusion criterion|1|||
162881367|NCT01683071|588264154|FG005|Part 2|Met exclusion criterion|1|||
162881368|NCT01683071|588264149|FG000|Part 2|Protocol deviation|0|||
162881369|NCT01683071|588264150|FG001|Part 2|Protocol deviation|0|||
162881370|NCT01683071|588264151|FG002|Part 2|Protocol deviation|0|||
162881371|NCT01683071|588264152|FG003|Part 2|Protocol deviation|0|||
162881372|NCT01683071|588264153|FG004|Part 2|Protocol deviation|1|||
162881373|NCT01683071|588264154|FG005|Part 2|Protocol deviation|2|||
162881374|NCT01683071|588264149|FG000|Part 2|Withdrawal by investigator decision|0|||
162881375|NCT01683071|588264150|FG001|Part 2|Withdrawal by investigator decision|0|||
162881376|NCT01683071|588264151|FG002|Part 2|Withdrawal by investigator decision|0|||
162881377|NCT01683071|588264152|FG003|Part 2|Withdrawal by investigator decision|0|||
162616222|NCT02887859|587311656|FG000|Overall Study|Physician Decision|1|||
162881378|NCT01683071|588264153|FG004|Part 2|Withdrawal by investigator decision|1|||
162881379|NCT01683071|588264154|FG005|Part 2|Withdrawal by investigator decision|2|||
162881380|NCT03707158|588264155|FG000|Midtreatment|Lost to Follow-up|16|||
162881381|NCT03707158|588264156|FG001|Midtreatment|Lost to Follow-up|7|||
162881382|NCT03707158|588264155|FG000|Midtreatment|Withdrawal by Subject|28|||
162881383|NCT03707158|588264156|FG001|Midtreatment|Withdrawal by Subject|19|||
162881384|NCT03707158|588264155|FG000|Posttreatment|Lost to Follow-up|0|||
163048597|NCT00810069|588884829|FG000|Lead-in Period I|Lost to Follow-up|19|||
163048598|NCT00810069|588884830|FG001|Lead-in Period I|Lost to Follow-up|0|||
162881385|NCT03707158|588264156|FG001|Posttreatment|Lost to Follow-up|5|||
162881386|NCT03707158|588264155|FG000|Follow-up|Lost to Follow-up|19|||
162881387|NCT03707158|588264156|FG001|Follow-up|Lost to Follow-up|18|||
162881388|NCT03707158|588264155|FG000|Follow-up|Withdrawal by Subject|13|||
162881389|NCT03707158|588264156|FG001|Follow-up|Withdrawal by Subject|6|||
163048599|NCT00810069|588884831|FG002|Lead-in Period I|Lost to Follow-up|0|||
163048600|NCT00810069|588884829|FG000|Lead-in Period I|Physician Decision|1|||
162616223|NCT00492050|587311657|FG000|Overall Study|Adverse Event|1|||
162881390|NCT01454401|588264159|FG000|Overall Study|Death|1|||
162881391|NCT01454401|588264159|FG000|Overall Study|hospitalised|1|||
162881392|NCT01454401|588264159|FG000|Overall Study|osteomyelitis|2|||
162881393|NCT01454401|588264159|FG000|Overall Study|non-adherence|1|||
162881394|NCT01968187|588264160|FG000|Overall Study|Adverse Event|0|||
162881395|NCT01968187|588264161|FG001|Overall Study|Adverse Event|1|||
162881396|NCT01968187|588264160|FG000|Overall Study|Randomized but not treated|1|||
162881397|NCT01968187|588264161|FG001|Overall Study|Randomized but not treated|0|||
162881398|NCT00430521|588264162|FG000|Overall Study|Adverse Event|0|||
162881399|NCT00430521|588264163|FG001|Overall Study|Adverse Event|0|||
162881400|NCT00430521|588264164|FG002|Overall Study|Adverse Event|0|||
162881401|NCT00430521|588264165|FG003|Overall Study|Adverse Event|0|||
162881402|NCT00430521|588264166|FG004|Overall Study|Adverse Event|0|||
162881403|NCT00430521|588264167|FG005|Overall Study|Adverse Event|2|||
162881404|NCT00430521|588264168|FG006|Overall Study|Adverse Event|1|||
162881405|NCT00430521|588264169|FG007|Overall Study|Adverse Event|0|||
162881406|NCT00430521|588264162|FG000|Overall Study|Lost to Follow-up|7|||
162881407|NCT00430521|588264163|FG001|Overall Study|Lost to Follow-up|8|||
162881408|NCT00430521|588264164|FG002|Overall Study|Lost to Follow-up|3|||
162881409|NCT00430521|588264165|FG003|Overall Study|Lost to Follow-up|5|||
162881410|NCT00430521|588264166|FG004|Overall Study|Lost to Follow-up|5|||
162881411|NCT00430521|588264167|FG005|Overall Study|Lost to Follow-up|2|||
162881412|NCT00430521|588264168|FG006|Overall Study|Lost to Follow-up|8|||
162881413|NCT00430521|588264169|FG007|Overall Study|Lost to Follow-up|10|||
162881414|NCT00430521|588264162|FG000|Overall Study|Pregnancy|0|||
162881415|NCT00430521|588264163|FG001|Overall Study|Pregnancy|0|||
162881416|NCT00430521|588264164|FG002|Overall Study|Pregnancy|0|||
162881417|NCT00430521|588264165|FG003|Overall Study|Pregnancy|0|||
162881418|NCT00430521|588264166|FG004|Overall Study|Pregnancy|0|||
162881419|NCT00430521|588264167|FG005|Overall Study|Pregnancy|0|||
162881420|NCT00430521|588264168|FG006|Overall Study|Pregnancy|1|||
162881421|NCT00430521|588264169|FG007|Overall Study|Pregnancy|0|||
162881422|NCT00430521|588264162|FG000|Overall Study|Vaccine Expired|0|||
162881423|NCT00430521|588264163|FG001|Overall Study|Vaccine Expired|0|||
162881424|NCT00430521|588264164|FG002|Overall Study|Vaccine Expired|0|||
162881425|NCT00430521|588264165|FG003|Overall Study|Vaccine Expired|0|||
162881426|NCT00430521|588264166|FG004|Overall Study|Vaccine Expired|0|||
162881427|NCT00430521|588264167|FG005|Overall Study|Vaccine Expired|1|||
162881428|NCT00430521|588264168|FG006|Overall Study|Vaccine Expired|0|||
162881429|NCT00430521|588264169|FG007|Overall Study|Vaccine Expired|0|||
162881430|NCT00430521|588264162|FG000|Overall Study|Protocol Violation|1|||
162881431|NCT00430521|588264163|FG001|Overall Study|Protocol Violation|0|||
162881432|NCT00430521|588264164|FG002|Overall Study|Protocol Violation|0|||
162881433|NCT00430521|588264165|FG003|Overall Study|Protocol Violation|0|||
162881434|NCT00430521|588264166|FG004|Overall Study|Protocol Violation|0|||
162881435|NCT00430521|588264167|FG005|Overall Study|Protocol Violation|0|||
162881436|NCT00430521|588264168|FG006|Overall Study|Protocol Violation|0|||
162881437|NCT00430521|588264169|FG007|Overall Study|Protocol Violation|0|||
162881438|NCT00430521|588264162|FG000|Overall Study|Withdrawal by Subject|3|||
162881439|NCT00430521|588264163|FG001|Overall Study|Withdrawal by Subject|1|||
162881440|NCT00430521|588264164|FG002|Overall Study|Withdrawal by Subject|0|||
162881441|NCT00430521|588264165|FG003|Overall Study|Withdrawal by Subject|3|||
162881442|NCT00430521|588264166|FG004|Overall Study|Withdrawal by Subject|0|||
162881443|NCT00430521|588264167|FG005|Overall Study|Withdrawal by Subject|0|||
162881444|NCT00430521|588264168|FG006|Overall Study|Withdrawal by Subject|0|||
162881445|NCT00430521|588264169|FG007|Overall Study|Withdrawal by Subject|2|||
162881446|NCT03675737|588264170|FG000|Overall Study|Death|593|||
162881447|NCT03675737|588264171|FG001|Overall Study|Death|660|||
162881448|NCT03675737|588264170|FG000|Overall Study|Lost to Follow-up|1|||
162881449|NCT03675737|588264171|FG001|Overall Study|Lost to Follow-up|5|||
162881450|NCT03675737|588264170|FG000|Overall Study|Physician Decision|1|||
162881451|NCT03675737|588264171|FG001|Overall Study|Physician Decision|0|||
162881452|NCT03675737|588264170|FG000|Overall Study|Withdrawal by Subject|14|||
162881453|NCT03675737|588264171|FG001|Overall Study|Withdrawal by Subject|12|||
162881454|NCT03675737|588264170|FG000|Overall Study|Ongoing in Study|181|||
162881455|NCT03675737|588264171|FG001|Overall Study|Ongoing in Study|112|||
162881456|NCT03422133|588264172|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
162881457|NCT03422133|588264173|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
162881458|NCT04247815|588266329|FG000|Overall Study|Adverse Event|1|||
162881459|NCT04247815|588266330|FG001|Overall Study|Adverse Event|0|||
162881460|NCT04247815|588266329|FG000|Overall Study|Withdrawal by Subject|1|||
162881461|NCT04247815|588266330|FG001|Overall Study|Withdrawal by Subject|0|||
162881462|NCT04247815|588266329|FG000|Overall Study|Protocol Violation|0|||
162881463|NCT04247815|588266330|FG001|Overall Study|Protocol Violation|1|||
162881464|NCT02394808|588266331|FG000|Period 1|Unsatisfactory lens fitting|0|||
162881465|NCT02394808|588266332|FG001|Period 1|Unsatisfactory lens fitting|1|||
162881466|NCT02394808|588266331|FG000|Period 2|Lost to Follow-up|1|||
162881467|NCT02394808|588266332|FG001|Period 2|Lost to Follow-up|0|||
162881468|NCT02108600|588266333|FG000|Overall Study|Withdrawal by Subject|2|||
162881469|NCT02108600|588266334|FG001|Overall Study|Withdrawal by Subject|0|||
162881470|NCT02108600|588266333|FG000|Overall Study|Lost to Follow-up|1|||
162881471|NCT02108600|588266334|FG001|Overall Study|Lost to Follow-up|1|||
162881472|NCT01295580|588266337|FG000|Overall Study|Protocol Violation|4|||
162881473|NCT01295580|588266338|FG001|Overall Study|Protocol Violation|2|||
162881474|NCT01295580|588266337|FG000|Overall Study|Withdrawal by Subject|1|||
162881475|NCT01295580|588266338|FG001|Overall Study|Withdrawal by Subject|4|||
162881476|NCT01295580|588266337|FG000|Overall Study|Adverse Event|2|||
162881477|NCT01295580|588266338|FG001|Overall Study|Adverse Event|1|||
162881478|NCT01295580|588266337|FG000|Overall Study|Lost to Follow-up|1|||
162881479|NCT01295580|588266338|FG001|Overall Study|Lost to Follow-up|0|||
162881480|NCT01295580|588266337|FG000|Overall Study|Lack of Efficacy|1|||
162881481|NCT01295580|588266338|FG001|Overall Study|Lack of Efficacy|0|||
162881482|NCT01295580|588266337|FG000|Overall Study|Other: inconvenience|1|||
162881483|NCT01295580|588266338|FG001|Overall Study|Other: inconvenience|0|||
162881484|NCT01295580|588266337|FG000|Overall Study|Other: family objection|0|||
162881485|NCT01295580|588266338|FG001|Overall Study|Other: family objection|1|||
162881486|NCT03943953|588266339|FG000|Trial of ITG 1|Lost to Follow-up|19|||
162881487|NCT03943953|588266340|FG001|Trial of ITG 1|Lost to Follow-up|1|||
162881488|NCT03943953|588266339|FG000|Trial of ITG 2|Lost to Follow-up|8|||
162881489|NCT03943953|588266340|FG001|Trial of ITG 2|Lost to Follow-up|0|||
162881490|NCT03943953|588266339|FG000|Trial of ITG 3|Lost to Follow-up|2|||
162881491|NCT03943953|588266340|FG001|Trial of ITG 3|Lost to Follow-up|0|||
162881492|NCT03943953|588266339|FG000|Trial of ITG 4|Lost to Follow-up|2|||
162881493|NCT03943953|588266340|FG001|Trial of ITG 4|Lost to Follow-up|0|||
162881494|NCT01742078|588266341|FG000|Overall Study|Withdrawal by Subject|0|||
162881495|NCT01742078|588266342|FG001|Overall Study|Withdrawal by Subject|0|||
162881496|NCT01742078|588266343|FG002|Overall Study|Withdrawal by Subject|0|||
162881497|NCT01742078|588266344|FG003|Overall Study|Withdrawal by Subject|1|||
162881498|NCT01742078|588266345|FG004|Overall Study|Withdrawal by Subject|0|||
162881499|NCT01742078|588266346|FG005|Overall Study|Withdrawal by Subject|0|||
162881500|NCT01742078|588266347|FG006|Overall Study|Withdrawal by Subject|0|||
162881501|NCT01742078|588266348|FG007|Overall Study|Withdrawal by Subject|0|||
162881502|NCT01742078|588266349|FG008|Overall Study|Withdrawal by Subject|0|||
162881503|NCT01124448|588266350|FG000|Overall Study|Lost to Follow-up|0|||
162881504|NCT01124448|588266351|FG001|Overall Study|Lost to Follow-up|3|||
162881505|NCT01124448|588266350|FG000|Overall Study|Protocol Violation|2|||
162881506|NCT01124448|588266351|FG001|Overall Study|Protocol Violation|0|||
162881507|NCT05025787|588266357|FG000|Overall Study|Lack of Efficacy|0|||
162881508|NCT05025787|588266358|FG001|Overall Study|Lack of Efficacy|1|||
162881509|NCT05025787|588266357|FG000|Overall Study|Adverse Event|2|||
162881510|NCT05025787|588266358|FG001|Overall Study|Adverse Event|4|||
162881511|NCT05025787|588266357|FG000|Overall Study|Non compliance|0|||
162881512|NCT05025787|588266358|FG001|Overall Study|Non compliance|1|||
162881513|NCT05025787|588266357|FG000|Overall Study|Protocol Violation|3|||
162881514|NCT05025787|588266358|FG001|Overall Study|Protocol Violation|1|||
162881515|NCT05025787|588266357|FG000|Overall Study|Stopping criteria met|1|||
162881516|NCT05025787|588266358|FG001|Overall Study|Stopping criteria met|1|||
162881517|NCT05025787|588266357|FG000|Overall Study|Withdrawal by Subject|3|||
162616224|NCT00492050|587311657|FG000|Overall Study|Lack of Efficacy|1|||
162881518|NCT05025787|588266358|FG001|Overall Study|Withdrawal by Subject|1|||
162881519|NCT03471767|588266359|FG000|Overall Study|Withdrawal by Subject|3|||
162881520|NCT03471767|588266360|FG001|Overall Study|Withdrawal by Subject|1|||
162881521|NCT03471767|588266359|FG000|Overall Study|Adverse Event|1|||
162881522|NCT03471767|588266360|FG001|Overall Study|Adverse Event|0|||
162881523|NCT03471767|588266359|FG000|Overall Study|Lost to Follow-up|1|||
162881524|NCT03471767|588266360|FG001|Overall Study|Lost to Follow-up|0|||
162616225|NCT00492050|587311657|FG000|Overall Study|Withdrawal by Subject|3|||
162616226|NCT00492050|587311657|FG000|Overall Study|Unable to collect SCT|2|||
162616227|NCT00492050|587311657|FG000|Overall Study|Progressive Disease|2|||
162616228|NCT04246372|587313371|FG000|Overall Study|Adverse Event|1|||
162616229|NCT04246372|587313371|FG000|Overall Study|Withdrawal by Subject|1|||
162616230|NCT04246372|587313371|FG000|Overall Study|Protocol Violation|2|||
162616231|NCT04246372|587313371|FG000|Overall Study|Physician Decision|1|||
162616232|NCT00257608|587313373|FG000|Chemotherapy Phase|Adverse Event|138|||
162616233|NCT00257608|587313374|FG001|Chemotherapy Phase|Adverse Event|0|||
162616234|NCT00257608|587313375|FG002|Chemotherapy Phase|Adverse Event|0|||
162616235|NCT00257608|587313373|FG000|Chemotherapy Phase|Disease progression|139|||
162881525|NCT03471767|588266359|FG000|Overall Study|PI Withdrawal|1|||
162881526|NCT03471767|588266360|FG001|Overall Study|PI Withdrawal|3|||
162881527|NCT05600309|588266361|FG000|Overall Study|Death|41|||
162616236|NCT00257608|587313374|FG001|Chemotherapy Phase|Disease progression|0|||
162881528|NCT05600309|588266362|FG001|Overall Study|Death|38|||
162881529|NCT05600309|588266361|FG000|Overall Study|Sponsor Decision|9|||
162881530|NCT05600309|588266362|FG001|Overall Study|Sponsor Decision|6|||
162881531|NCT00807846|588266363|FG000|Overall Study|Adverse Event|5|||
162881532|NCT00807846|588266364|FG001|Overall Study|Adverse Event|0|||
162881533|NCT00807846|588266363|FG000|Overall Study|Lack of Efficacy|2|||
162881534|NCT00807846|588266364|FG001|Overall Study|Lack of Efficacy|0|||
162881535|NCT00807846|588266363|FG000|Overall Study|Protocol Violation|2|||
162881536|NCT00807846|588266364|FG001|Overall Study|Protocol Violation|1|||
162881537|NCT00807846|588266363|FG000|Overall Study|Withdrawal by Subject|2|||
162881538|NCT00807846|588266364|FG001|Overall Study|Withdrawal by Subject|1|||
162881539|NCT00807846|588266363|FG000|Overall Study|Other|1|||
162881540|NCT00807846|588266364|FG001|Overall Study|Other|2|||
162961886|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961887|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961888|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162707651|NCT00003377|587638294|FG003|Period II|Ureteral stent complications|0|||
162881541|NCT01081873|588266365|FG000|Overall Study|Death|86|||
162961889|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961890|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961891|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961892|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961893|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961894|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961895|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
162961896|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
162961897|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
162961898|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
162961899|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Death|0|||
162961900|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Death|0|||
162961901|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Death|0|||
162961902|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Death|0|||
162961903|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Death|0|||
162961904|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Death|0|||
162961905|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Death|0|||
162961906|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Death|0|||
162961907|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Death|0|||
162961908|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Death|0|||
162961909|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Death|0|||
162961910|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Death|0|||
162961911|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Death|0|||
162961912|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Death|0|||
162961913|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Death|0|||
162961914|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Death|0|||
162961915|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Death|0|||
162961916|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Death|0|||
162961917|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Death|0|||
162961918|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Death|0|||
162961919|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Death|0|||
162961920|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Death|0|||
162961921|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Death|0|||
162961922|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Death|2|||
162961923|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Death|0|||
162961924|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Death|0|||
162961925|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961926|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961927|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961928|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961929|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961930|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961931|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961932|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961933|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961934|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961935|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961936|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961937|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162707652|NCT00003377|587638295|FG004|Period II|Ureteral stent complications|1|||
162881542|NCT01081873|588266365|FG000|Overall Study|Withdrawal by Subject|10|||
162881543|NCT01081873|588266365|FG000|Overall Study|Lost to Follow-up|142|||
162961938|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961939|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961940|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961941|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961942|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961943|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162881544|NCT01081873|588266365|FG000|Overall Study|Progression of prostate cancer|13|||
162881545|NCT01081873|588266365|FG000|Overall Study|Other|47|||
162881546|NCT02491073|588266366|FG000|Overall Study|screen failure|1|||
162881547|NCT02491073|588266367|FG001|Overall Study|screen failure|0|||
162881548|NCT03977727|588266368|FG000|Second Treatment|Lost to Follow-up|0|||
162881549|NCT03977727|588266369|FG001|Second Treatment|Lost to Follow-up|3|||
162881550|NCT01419665|588266370|FG000|Combination Treatment|Adverse Event|7|||
162881551|NCT01419665|588266371|FG001|Combination Treatment|Adverse Event|10|||
162881552|NCT01419665|588266370|FG000|Combination Treatment|Physician Decision|5|||
162881553|NCT01419665|588266371|FG001|Combination Treatment|Physician Decision|8|||
162881554|NCT01419665|588266370|FG000|Combination Treatment|Protocol Violation|6|||
162881555|NCT01419665|588266371|FG001|Combination Treatment|Protocol Violation|2|||
162881556|NCT01419665|588266370|FG000|Combination Treatment|disease progression|10|||
162881557|NCT01419665|588266371|FG001|Combination Treatment|disease progression|9|||
162881558|NCT01419665|588266370|FG000|Combination Treatment|Death|5|||
162881559|NCT01419665|588266371|FG001|Combination Treatment|Death|7|||
162881560|NCT01419665|588266370|FG000|Combination Treatment|administrative problems|0|||
162881561|NCT01419665|588266371|FG001|Combination Treatment|administrative problems|1|||
162881562|NCT01419665|588266370|FG000|Combination Treatment|Withdrawal by Subject|5|||
162881563|NCT01419665|588266371|FG001|Combination Treatment|Withdrawal by Subject|4|||
162881564|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
162881565|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
162881566|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
162881567|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
162881568|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
162881569|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
162881570|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
162881571|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
162881572|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
162881573|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
162881574|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
162881575|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
162881576|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Death|1|||
162881577|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Death|2|||
162881578|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
162881579|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
162881580|NCT01419665|588266370|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
162881581|NCT01419665|588266371|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
162881582|NCT01419665|588266370|FG000|Open Label Phase|Death|1|||
162881583|NCT01419665|588266371|FG001|Open Label Phase|Death|0|||
162881584|NCT01419665|588266370|FG000|Open Label Phase|disease progression|0|||
162881585|NCT01419665|588266371|FG001|Open Label Phase|disease progression|1|||
162881586|NCT01655823|588266372|FG000|Overall Study|Lost to Follow-up|0|||
162881587|NCT01655823|588266373|FG001|Overall Study|Lost to Follow-up|1|||
162881588|NCT01655823|588266374|FG002|Overall Study|Lost to Follow-up|0|||
162881589|NCT01655823|588266375|FG003|Overall Study|Lost to Follow-up|0|||
162881590|NCT01655823|588266376|FG004|Overall Study|Lost to Follow-up|1|||
162881591|NCT01655823|588266372|FG000|Overall Study|Withdrawal by Subject|0|||
162881592|NCT01655823|588266373|FG001|Overall Study|Withdrawal by Subject|1|||
162881593|NCT01655823|588266374|FG002|Overall Study|Withdrawal by Subject|0|||
162881594|NCT01655823|588266375|FG003|Overall Study|Withdrawal by Subject|1|||
162881595|NCT01655823|588266376|FG004|Overall Study|Withdrawal by Subject|0|||
162881596|NCT02632110|588266384|FG000|Overall Study|Withdrawal by Subject|1|||
162881597|NCT02632110|588266385|FG001|Overall Study|Withdrawal by Subject|1|||
162881598|NCT02632110|588266386|FG002|Overall Study|Withdrawal by Subject|0|||
162881599|NCT02632110|588266387|FG003|Overall Study|Withdrawal by Subject|0|||
162881600|NCT02632110|588266388|FG004|Overall Study|Withdrawal by Subject|1|||
162881601|NCT02632110|588266389|FG005|Overall Study|Withdrawal by Subject|1|||
162961944|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162881602|NCT02632110|588266390|FG006|Overall Study|Withdrawal by Subject|3|||
162881603|NCT02632110|588266391|FG007|Overall Study|Withdrawal by Subject|3|||
162881604|NCT02632110|588266392|FG008|Overall Study|Withdrawal by Subject|1|||
162961945|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
163048601|NCT00810069|588884830|FG001|Lead-in Period I|Physician Decision|0|||
163048602|NCT00810069|588884831|FG002|Lead-in Period I|Physician Decision|0|||
163048603|NCT00810069|588884829|FG000|Lead-in Period I|Protocol Violation|1|||
163048604|NCT00810069|588884830|FG001|Lead-in Period I|Protocol Violation|0|||
163048605|NCT00810069|588884831|FG002|Lead-in Period I|Protocol Violation|0|||
162881605|NCT02632110|588266393|FG009|Overall Study|Withdrawal by Subject|1|||
162881606|NCT03352414|588266394|FG000|Overall Study|Ineligible by operative criteria|12|||
162881607|NCT03352414|588266395|FG001|Overall Study|Ineligible by operative criteria|10|||
162881608|NCT00403559|588266402|FG000|Overall Study|Adverse Event|0|||
162881609|NCT00403559|588266403|FG001|Overall Study|Adverse Event|1|||
162881610|NCT00403559|588266402|FG000|Overall Study|Lost to Follow-up|3|||
162881611|NCT00403559|588266403|FG001|Overall Study|Lost to Follow-up|3|||
162881612|NCT00403559|588266402|FG000|Overall Study|Withdrawal by Subject|1|||
162881613|NCT00403559|588266403|FG001|Overall Study|Withdrawal by Subject|0|||
163048606|NCT00810069|588884829|FG000|Lead-in Period I|Withdrawal by Subject|46|||
163048607|NCT00810069|588884830|FG001|Lead-in Period I|Withdrawal by Subject|0|||
163048608|NCT00810069|588884831|FG002|Lead-in Period I|Withdrawal by Subject|0|||
163048609|NCT00810069|588884829|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
162881614|NCT02768194|588266404|FG000|Period 1|Adverse Event|0|||
162881615|NCT02768194|588266405|FG001|Period 1|Adverse Event|0|||
162881616|NCT02768194|588266406|FG002|Period 1|Adverse Event|0|||
162881617|NCT02768194|588266407|FG003|Period 1|Adverse Event|1|||
162881618|NCT02768194|588266408|FG004|Period 1|Adverse Event|0|||
162881619|NCT02768194|588266409|FG005|Period 1|Adverse Event|0|||
162881620|NCT02768194|588266404|FG000|Period 2|Other (Reason not specified)|1|||
162881621|NCT02768194|588266405|FG001|Period 2|Other (Reason not specified)|0|||
162881622|NCT02768194|588266406|FG002|Period 2|Other (Reason not specified)|0|||
162881623|NCT02768194|588266407|FG003|Period 2|Other (Reason not specified)|0|||
162881624|NCT02768194|588266408|FG004|Period 2|Other (Reason not specified)|0|||
162881625|NCT02768194|588266409|FG005|Period 2|Other (Reason not specified)|0|||
162881626|NCT02768194|588266404|FG000|Period 3|Other (Reason not specified)|0|||
162881627|NCT02768194|588266405|FG001|Period 3|Other (Reason not specified)|1|||
162881628|NCT02768194|588266406|FG002|Period 3|Other (Reason not specified)|0|||
162881629|NCT02768194|588266407|FG003|Period 3|Other (Reason not specified)|0|||
162881630|NCT02768194|588266408|FG004|Period 3|Other (Reason not specified)|0|||
162881631|NCT02768194|588266409|FG005|Period 3|Other (Reason not specified)|0|||
162881632|NCT01982773|588266413|FG000|Overall Study|Withdrawal by Subject|1|||
162881633|NCT01982773|588266414|FG001|Overall Study|Withdrawal by Subject|3|||
162881634|NCT01982773|588266413|FG000|Overall Study|Lost to Follow-up|7|||
162881635|NCT01982773|588266414|FG001|Overall Study|Lost to Follow-up|1|||
162881636|NCT01029886|588266415|FG000|Overall Study|Adverse Event|12|||
162881637|NCT01029886|588266416|FG001|Overall Study|Adverse Event|25|||
162881638|NCT01029886|588266415|FG000|Overall Study|Lost to Follow-up|1|||
162881639|NCT01029886|588266416|FG001|Overall Study|Lost to Follow-up|0|||
162881640|NCT01029886|588266415|FG000|Overall Study|Physician Decision|2|||
162881641|NCT01029886|588266416|FG001|Overall Study|Physician Decision|6|||
162881642|NCT01029886|588266415|FG000|Overall Study|Protocol Violation|17|||
162881643|NCT01029886|588266416|FG001|Overall Study|Protocol Violation|5|||
162881644|NCT01029886|588266415|FG000|Overall Study|Withdrawal by Subject|8|||
162881645|NCT01029886|588266416|FG001|Overall Study|Withdrawal by Subject|18|||
162881646|NCT01029886|588266415|FG000|Overall Study|Entry Criteria Not Met|13|||
162881647|NCT01029886|588266416|FG001|Overall Study|Entry Criteria Not Met|5|||
162881648|NCT01029886|588266415|FG000|Overall Study|Sponsor Decision|1|||
162881649|NCT01029886|588266416|FG001|Overall Study|Sponsor Decision|0|||
162881650|NCT01029886|588266415|FG000|Overall Study|Loss Glucose Control|7|||
162881651|NCT01029886|588266416|FG001|Overall Study|Loss Glucose Control|1|||
162881652|NCT03294681|588266417|FG000|Overall Study|Withdrawal by Subject|1|||
162881653|NCT01553916|588266418|FG000|Overall Study|Withdrawal by Subject|2|||
162881654|NCT01553916|588266418|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
162881655|NCT03089216|588266419|FG000|Overall Study|Adverse Event|0|||
162881656|NCT03089216|588266420|FG001|Overall Study|Adverse Event|0|||
162881657|NCT03089216|588266421|FG002|Overall Study|Adverse Event|0|||
162881658|NCT03089216|588266422|FG003|Overall Study|Adverse Event|1|||
162881659|NCT02720016|588266425|FG000|Overall Study|Separation of couple|6|||
162881660|NCT02720016|588266426|FG001|Overall Study|Separation of couple|8|||
162881661|NCT02720016|588266427|FG002|Overall Study|Separation of couple|2|||
162881662|NCT02720016|588266425|FG000|Overall Study|Withdrawal by Subject|6|||
162881663|NCT02720016|588266426|FG001|Overall Study|Withdrawal by Subject|6|||
162881664|NCT02720016|588266427|FG002|Overall Study|Withdrawal by Subject|4|||
162881665|NCT02720016|588266425|FG000|Overall Study|Scheduling issues|2|||
162881666|NCT02720016|588266426|FG001|Overall Study|Scheduling issues|4|||
162881667|NCT02720016|588266427|FG002|Overall Study|Scheduling issues|7|||
162881668|NCT02720016|588266425|FG000|Overall Study|Childcare|2|||
162881669|NCT02720016|588266426|FG001|Overall Study|Childcare|0|||
162881670|NCT02720016|588266427|FG002|Overall Study|Childcare|2|||
162881671|NCT02720016|588266425|FG000|Overall Study|Withdrawal by PI|2|||
162881672|NCT02720016|588266426|FG001|Overall Study|Withdrawal by PI|2|||
162881673|NCT02720016|588266427|FG002|Overall Study|Withdrawal by PI|0|||
162881674|NCT02720016|588266425|FG000|Overall Study|Moved away|2|||
162961946|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961947|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961948|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961949|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162961950|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
163048610|NCT00810069|588884830|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
163048611|NCT00810069|588884831|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
163048612|NCT00810069|588884829|FG000|Lead-in Period I|Randomization criteria not met|158|||
163048613|NCT00810069|588884830|FG001|Lead-in Period I|Randomization criteria not met|0|||
163048614|NCT00810069|588884831|FG002|Lead-in Period I|Randomization criteria not met|0|||
163048615|NCT00810069|588884829|FG000|Double-Blind Period II|Adverse Event|0|||
163048616|NCT00810069|588884830|FG001|Double-Blind Period II|Adverse Event|9|||
163048617|NCT00810069|588884831|FG002|Double-Blind Period II|Adverse Event|8|||
163048618|NCT00810069|588884829|FG000|Double-Blind Period II|Lack of Efficacy|0|||
163048619|NCT00810069|588884830|FG001|Double-Blind Period II|Lack of Efficacy|7|||
163048620|NCT00810069|588884831|FG002|Double-Blind Period II|Lack of Efficacy|12|||
163048621|NCT00810069|588884829|FG000|Double-Blind Period II|Lost to Follow-up|0|||
162881675|NCT02720016|588266426|FG001|Overall Study|Moved away|0|||
162881676|NCT02720016|588266427|FG002|Overall Study|Moved away|0|||
162881677|NCT02720016|588266425|FG000|Overall Study|Not Primary Health Concern|0|||
162881678|NCT02720016|588266426|FG001|Overall Study|Not Primary Health Concern|0|||
162881679|NCT02720016|588266427|FG002|Overall Study|Not Primary Health Concern|2|||
162881680|NCT02720016|588266425|FG000|Overall Study|Transportation issues|0|||
162881681|NCT02720016|588266426|FG001|Overall Study|Transportation issues|0|||
162881682|NCT02720016|588266427|FG002|Overall Study|Transportation issues|1|||
162881683|NCT02720016|588266425|FG000|Overall Study|Other|0|||
162881684|NCT02720016|588266426|FG001|Overall Study|Other|0|||
163048622|NCT00810069|588884830|FG001|Double-Blind Period II|Lost to Follow-up|9|||
163048623|NCT00810069|588884831|FG002|Double-Blind Period II|Lost to Follow-up|9|||
163048624|NCT00810069|588884829|FG000|Double-Blind Period II|Physician Decision|0|||
163048625|NCT00810069|588884830|FG001|Double-Blind Period II|Physician Decision|0|||
162881685|NCT02720016|588266427|FG002|Overall Study|Other|2|||
162881686|NCT04501679|588266428|FG000|Overall Study|Pregnancy|0|||
162881687|NCT04501679|588266429|FG001|Overall Study|Pregnancy|1|||
162881688|NCT04501679|588266428|FG000|Overall Study|Adverse Event|4|||
162881689|NCT04501679|588266429|FG001|Overall Study|Adverse Event|2|||
162881690|NCT04501679|588266428|FG000|Overall Study|Withdrawal by Subject|2|||
162881691|NCT04501679|588266429|FG001|Overall Study|Withdrawal by Subject|0|||
162881692|NCT04501679|588266428|FG000|Overall Study|Physician Decision|1|||
162881693|NCT04501679|588266429|FG001|Overall Study|Physician Decision|0|||
162881694|NCT04501679|588266428|FG000|Overall Study|Lost to Follow-up|2|||
162881695|NCT04501679|588266429|FG001|Overall Study|Lost to Follow-up|0|||
162881696|NCT02121756|588266433|FG000|Overall Study|Adverse Event|3|||
162881697|NCT02121756|588266434|FG001|Overall Study|Adverse Event|0|||
162881698|NCT02121756|588266433|FG000|Overall Study|Protocol Violation|1|||
162881699|NCT02121756|588266434|FG001|Overall Study|Protocol Violation|1|||
162881700|NCT02121756|588266433|FG000|Overall Study|Physician Decision|2|||
162881701|NCT02121756|588266434|FG001|Overall Study|Physician Decision|1|||
162881702|NCT05319080|588266435|FG000|Overall Study|Withdrawal by Subject|2|||
162881703|NCT05319080|588266435|FG000|Overall Study|Physician Decision|4|||
163048626|NCT00810069|588884831|FG002|Double-Blind Period II|Physician Decision|1|||
163048627|NCT00810069|588884829|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
163048628|NCT00810069|588884830|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
163048629|NCT00810069|588884831|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
163048630|NCT00810069|588884829|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
163048631|NCT00810069|588884830|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
163048632|NCT00810069|588884831|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
163048633|NCT00810069|588884829|FG000|Double-Blind Period II|Clinical relapse|0|||
163048634|NCT00810069|588884830|FG001|Double-Blind Period II|Clinical relapse|3|||
162881704|NCT00751114|588266436|FG000|Overall Study|Adverse Event|2|||
162961951|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Other|0|||
162961952|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Other|0|||
162961953|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Other|0|||
162961954|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Other|0|||
162961955|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Other|0|||
162961956|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Other|0|||
162961957|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Other|0|||
162961958|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Other|0|||
163048635|NCT00810069|588884831|FG002|Double-Blind Period II|Clinical relapse|0|||
162881705|NCT00751114|588266437|FG001|Overall Study|Adverse Event|4|||
162881706|NCT00751114|588266436|FG000|Overall Study|Protocol Violation|8|||
162881707|NCT00751114|588266437|FG001|Overall Study|Protocol Violation|9|||
162881708|NCT00751114|588266436|FG000|Overall Study|Withdrawal by Subject|9|||
162881709|NCT00751114|588266437|FG001|Overall Study|Withdrawal by Subject|4|||
162881710|NCT00751114|588266436|FG000|Overall Study|Lost to Follow-up|4|||
162881711|NCT00751114|588266437|FG001|Overall Study|Lost to Follow-up|7|||
162881712|NCT00751114|588266436|FG000|Overall Study|Lack of Efficacy|0|||
162881713|NCT00751114|588266437|FG001|Overall Study|Lack of Efficacy|7|||
162881714|NCT00751114|588266436|FG000|Overall Study|Not Treated|13|||
162881715|NCT00751114|588266437|FG001|Overall Study|Not Treated|1|||
162881716|NCT00751114|588266436|FG000|Overall Study|Out of country for 2 months|1|||
162881717|NCT00751114|588266437|FG001|Overall Study|Out of country for 2 months|0|||
162881718|NCT00751114|588266436|FG000|Overall Study|Move to another city|1|||
162881719|NCT00751114|588266437|FG001|Overall Study|Move to another city|0|||
162881720|NCT03259490|588266438|FG000|Period 1|Withdrawal by Subject|0|||
162881721|NCT03259490|588266439|FG001|Period 1|Withdrawal by Subject|1|||
162881722|NCT03259490|588266438|FG000|Period 2|Protocol Violation|1|||
162881723|NCT03259490|588266439|FG001|Period 2|Protocol Violation|0|||
162881724|NCT03095521|588266440|FG000|Overall Study|Withdrawal by Subject|0|||
162881725|NCT03095521|588266441|FG001|Overall Study|Withdrawal by Subject|1|||
162881726|NCT03095521|588266440|FG000|Overall Study|Lost to Follow-up|0|||
162881727|NCT03095521|588266441|FG001|Overall Study|Lost to Follow-up|1|||
162881728|NCT01536119|588266446|FG000|Overall Study|Lost to Follow-up|17|||
162881729|NCT01536119|588266447|FG001|Overall Study|Lost to Follow-up|14|||
162881730|NCT00448916|588266448|FG000|Overall Study|Adverse Event|2|||
162881731|NCT00448916|588266449|FG001|Overall Study|Adverse Event|2|||
162881732|NCT00448916|588266450|FG002|Overall Study|Adverse Event|3|||
162881733|NCT00448916|588266451|FG003|Overall Study|Adverse Event|2|||
162881734|NCT00448916|588266448|FG000|Overall Study|Lack of Efficacy|1|||
162881735|NCT00448916|588266449|FG001|Overall Study|Lack of Efficacy|0|||
162881736|NCT00448916|588266450|FG002|Overall Study|Lack of Efficacy|2|||
162881737|NCT00448916|588266451|FG003|Overall Study|Lack of Efficacy|1|||
162881738|NCT00448916|588266448|FG000|Overall Study|Withdrawal by Subject|3|||
162881739|NCT00448916|588266449|FG001|Overall Study|Withdrawal by Subject|3|||
162881740|NCT00448916|588266450|FG002|Overall Study|Withdrawal by Subject|1|||
162881741|NCT00448916|588266451|FG003|Overall Study|Withdrawal by Subject|1|||
162881742|NCT00448916|588266448|FG000|Overall Study|Other|1|||
162881743|NCT00448916|588266449|FG001|Overall Study|Other|0|||
162881744|NCT00448916|588266450|FG002|Overall Study|Other|0|||
162881745|NCT00448916|588266451|FG003|Overall Study|Other|0|||
162881746|NCT00448916|588266448|FG000|Overall Study|Lost to Follow-up|0|||
162881747|NCT00448916|588266449|FG001|Overall Study|Lost to Follow-up|1|||
162881748|NCT00448916|588266450|FG002|Overall Study|Lost to Follow-up|0|||
162881749|NCT00448916|588266451|FG003|Overall Study|Lost to Follow-up|1|||
162881750|NCT00448916|588266448|FG000|Overall Study|Protocol Violation|0|||
162881751|NCT00448916|588266449|FG001|Overall Study|Protocol Violation|0|||
162881752|NCT00448916|588266450|FG002|Overall Study|Protocol Violation|0|||
162881753|NCT00448916|588266451|FG003|Overall Study|Protocol Violation|1|||
162881754|NCT02365584|588266452|FG000|Overall Study|Adverse Event|2|||
162881755|NCT02365584|588266453|FG001|Overall Study|Adverse Event|2|||
162881756|NCT02365584|588266452|FG000|Overall Study|Withdrawal by Subject|1|||
162881757|NCT02365584|588266453|FG001|Overall Study|Withdrawal by Subject|0|||
162881758|NCT02365584|588266452|FG000|Overall Study|Disease Progression|9|||
162881759|NCT02365584|588266453|FG001|Overall Study|Disease Progression|12|||
162881760|NCT03521193|588266454|FG000|Overall Study|Withdrawal by Subject|8|||
162881761|NCT03521193|588266455|FG001|Overall Study|Withdrawal by Subject|0|||
162881762|NCT03521193|588266454|FG000|Overall Study|non compliant to ASA treatment|8|||
162881763|NCT03521193|588266455|FG001|Overall Study|non compliant to ASA treatment|0|||
162881764|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
162881765|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
162881766|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
162881767|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
162881768|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
162881769|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
162881770|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
162881771|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
162881772|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
162881773|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
162881774|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
162881775|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
162881776|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
162881777|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
162881778|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
162881779|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
162881780|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Missing|3|||
162881781|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Missing|1|||
162881782|NCT00838916|588266456|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
162881783|NCT00838916|588266457|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
162881784|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
162881785|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
162881786|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
162961959|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Other|0|||
162961960|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Other|0|||
162961961|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Other|0|||
162961962|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Other|0|||
162961963|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Other|0|||
162961964|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Other|0|||
162961965|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Other|0|||
162961966|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Other|0|||
162961967|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Other|0|||
162961968|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Other|0|||
162961969|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Other|0|||
162961970|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Other|0|||
162961971|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Other|0|||
162961972|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Other|0|||
162961973|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Other|0|||
162961974|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Other|0|||
162961975|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Other|1|||
162961976|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Other|0|||
162961977|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961978|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961979|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961980|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961981|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961982|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961983|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961984|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961985|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961986|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961987|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961988|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961989|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
163048636|NCT00810069|588884829|FG000|Double-Blind Period II|Protocol Violation|0|||
162961990|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961991|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
163048637|NCT00810069|588884830|FG001|Double-Blind Period II|Protocol Violation|7|||
163048638|NCT00810069|588884831|FG002|Double-Blind Period II|Protocol Violation|6|||
163048639|NCT02899065|588884834|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
162881787|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
162881788|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
162881789|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
162881790|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
162881791|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
162881792|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
162881793|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
162881794|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
162881795|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
162881796|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
162881797|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
162881798|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
162881799|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
162881800|NCT00838916|588266456|FG000|Follow-up Period (8 Weeks)|Missing|3|||
162881801|NCT00838916|588266457|FG001|Follow-up Period (8 Weeks)|Missing|0|||
162881802|NCT01927419|588266458|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
162881803|NCT01927419|588266459|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
162881804|NCT01927419|588266458|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
162881805|NCT01927419|588266459|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
162881806|NCT01927419|588266458|FG000|Treatment Period|Disease progression|17|||
162881807|NCT01927419|588266459|FG001|Treatment Period|Disease progression|20|||
162881808|NCT01927419|588266458|FG000|Treatment Period|Study drug toxicity|48|||
162881809|NCT01927419|588266459|FG001|Treatment Period|Study drug toxicity|10|||
162881810|NCT01927419|588266458|FG000|Treatment Period|Death|0|||
162881811|NCT01927419|588266459|FG001|Treatment Period|Death|1|||
162881812|NCT01927419|588266458|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
162881813|NCT01927419|588266459|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
162881814|NCT01927419|588266458|FG000|Treatment Period|Participant request to discontinue|12|||
162881815|NCT01927419|588266459|FG001|Treatment Period|Participant request to discontinue|4|||
162881816|NCT01927419|588266458|FG000|Treatment Period|Withdrawal by Subject|1|||
162881817|NCT01927419|588266459|FG001|Treatment Period|Withdrawal by Subject|1|||
162881818|NCT01927419|588266458|FG000|Treatment Period|Maximum Clinical Benefit|6|||
162881819|NCT01927419|588266459|FG001|Treatment Period|Maximum Clinical Benefit|2|||
162881820|NCT01927419|588266458|FG000|Treatment Period|Other reasons|3|||
162881821|NCT01927419|588266459|FG001|Treatment Period|Other reasons|4|||
162881822|NCT01927419|588266458|FG000|Treatment Period|Not Reported|1|||
162881823|NCT01927419|588266459|FG001|Treatment Period|Not Reported|1|||
162881824|NCT01935336|588266462|FG000|Overall Study|Adverse Event|1|||
162881825|NCT01935336|588266463|FG001|Overall Study|Adverse Event|0|||
162881826|NCT01935336|588266464|FG002|Overall Study|Adverse Event|0|||
162881827|NCT01935336|588266465|FG003|Overall Study|Adverse Event|0|||
162881828|NCT01935336|588266462|FG000|Overall Study|Progressive disease|5|||
162881829|NCT01935336|588266463|FG001|Overall Study|Progressive disease|3|||
162881830|NCT01935336|588266464|FG002|Overall Study|Progressive disease|47|||
162881831|NCT01935336|588266465|FG003|Overall Study|Progressive disease|66|||
162881832|NCT02773238|588266467|FG000|Overall Study|Lack of Efficacy|4|||
162881833|NCT03260205|588266470|FG000|Overall Study|Adverse Event|2|||
162881834|NCT03260205|588266471|FG001|Overall Study|Adverse Event|0|||
162881835|NCT03260205|588266472|FG002|Overall Study|Adverse Event|2|||
162881836|NCT03260205|588266473|FG003|Overall Study|Adverse Event|2|||
162881837|NCT03260205|588266474|FG004|Overall Study|Adverse Event|4|||
162881838|NCT03260205|588266470|FG000|Overall Study|Lost to Follow-up|2|||
162881839|NCT03260205|588266471|FG001|Overall Study|Lost to Follow-up|2|||
162881840|NCT03260205|588266472|FG002|Overall Study|Lost to Follow-up|1|||
162881841|NCT03260205|588266473|FG003|Overall Study|Lost to Follow-up|1|||
162881842|NCT03260205|588266474|FG004|Overall Study|Lost to Follow-up|5|||
162881843|NCT03260205|588266470|FG000|Overall Study|Protocol Violation|0|||
162881844|NCT03260205|588266471|FG001|Overall Study|Protocol Violation|0|||
162881845|NCT03260205|588266472|FG002|Overall Study|Protocol Violation|2|||
162881846|NCT03260205|588266473|FG003|Overall Study|Protocol Violation|0|||
162881847|NCT03260205|588266474|FG004|Overall Study|Protocol Violation|1|||
162881848|NCT03260205|588266470|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
162881849|NCT03260205|588266471|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
162881850|NCT03260205|588266472|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
163048640|NCT02899065|588884835|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
163048641|NCT02899065|588884834|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
162881851|NCT03260205|588266473|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
162881852|NCT03260205|588266474|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
162881853|NCT03260205|588266470|FG000|Overall Study|Other: Unspecified|0|||
162881854|NCT03260205|588266471|FG001|Overall Study|Other: Unspecified|0|||
162881855|NCT03260205|588266472|FG002|Overall Study|Other: Unspecified|3|||
162881856|NCT03260205|588266473|FG003|Overall Study|Other: Unspecified|1|||
162881857|NCT03260205|588266474|FG004|Overall Study|Other: Unspecified|1|||
162881858|NCT03260205|588266470|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
162881859|NCT03260205|588266471|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
162881860|NCT03260205|588266472|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
162881861|NCT03260205|588266473|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
162881862|NCT03260205|588266474|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
162881863|NCT00479557|588266475|FG000|Overall Study|Death|0|||
162881864|NCT00479557|588266476|FG001|Overall Study|Death|0|||
162881865|NCT00479557|588266477|FG002|Overall Study|Death|0|||
162881866|NCT00479557|588266478|FG003|Overall Study|Death|0|||
162881867|NCT00479557|588266479|FG004|Overall Study|Death|0|||
162881868|NCT00479557|588266480|FG005|Overall Study|Death|1|||
162881869|NCT00479557|588266481|FG006|Overall Study|Death|0|||
162881870|NCT00479557|588266475|FG000|Overall Study|Lack of Efficacy|1|||
162881871|NCT00479557|588266476|FG001|Overall Study|Lack of Efficacy|0|||
162881872|NCT00479557|588266477|FG002|Overall Study|Lack of Efficacy|0|||
162881873|NCT00479557|588266478|FG003|Overall Study|Lack of Efficacy|0|||
162881874|NCT00479557|588266479|FG004|Overall Study|Lack of Efficacy|0|||
162881875|NCT00479557|588266480|FG005|Overall Study|Lack of Efficacy|0|||
163048642|NCT02899065|588884835|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
162881876|NCT00479557|588266481|FG006|Overall Study|Lack of Efficacy|0|||
162881877|NCT00479557|588266475|FG000|Overall Study|Lost to Follow-up|0|||
162881878|NCT00479557|588266476|FG001|Overall Study|Lost to Follow-up|2|||
162881879|NCT00479557|588266477|FG002|Overall Study|Lost to Follow-up|0|||
162881880|NCT00479557|588266478|FG003|Overall Study|Lost to Follow-up|2|||
163048643|NCT02899065|588884834|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
163048644|NCT02899065|588884835|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
163048645|NCT00186485|588884836|FG000|Overall Study|Lost to Follow-up|3|||
163048646|NCT00426764|588884837|FG000|Overall Study|Protocol Violation|1|||
162881881|NCT00479557|588266479|FG004|Overall Study|Lost to Follow-up|0|||
162881882|NCT00479557|588266480|FG005|Overall Study|Lost to Follow-up|0|||
162881883|NCT00479557|588266481|FG006|Overall Study|Lost to Follow-up|0|||
162881884|NCT00479557|588266475|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162881885|NCT00479557|588266476|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162881886|NCT00479557|588266477|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
162881887|NCT00479557|588266478|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
162881888|NCT00479557|588266479|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162961992|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961993|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961994|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961995|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961996|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961997|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162881889|NCT00479557|588266480|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162881890|NCT00479557|588266481|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162881891|NCT00479557|588266475|FG000|Overall Study|AE not related to Study Drug|1|||
162881892|NCT00479557|588266476|FG001|Overall Study|AE not related to Study Drug|3|||
162881893|NCT00479557|588266477|FG002|Overall Study|AE not related to Study Drug|0|||
162881894|NCT00479557|588266478|FG003|Overall Study|AE not related to Study Drug|0|||
162881895|NCT00479557|588266479|FG004|Overall Study|AE not related to Study Drug|2|||
162881896|NCT00479557|588266480|FG005|Overall Study|AE not related to Study Drug|2|||
162881897|NCT00479557|588266481|FG006|Overall Study|AE not related to Study Drug|1|||
162961998|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162961999|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962000|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
162962001|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962002|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
162962003|NCT00112437|588560746|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962004|NCT00112437|588560747|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962005|NCT00112437|588560748|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962006|NCT00112437|588560749|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962007|NCT00112437|588560750|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962008|NCT00112437|588560751|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962009|NCT00112437|588560752|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962010|NCT00112437|588560753|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962011|NCT00112437|588560754|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962012|NCT00112437|588560755|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
163048647|NCT00426764|588884837|FG000|Overall Study|Withdrawal by Subject|4|||
163048648|NCT00426764|588884837|FG000|Overall Study|Physician Decision|6|||
162881898|NCT00479557|588266475|FG000|Overall Study|Caregiver Request|2|||
162881899|NCT00479557|588266476|FG001|Overall Study|Caregiver Request|2|||
162881900|NCT00479557|588266477|FG002|Overall Study|Caregiver Request|2|||
162881901|NCT00479557|588266478|FG003|Overall Study|Caregiver Request|0|||
162881902|NCT00479557|588266479|FG004|Overall Study|Caregiver Request|1|||
162881903|NCT00479557|588266480|FG005|Overall Study|Caregiver Request|2|||
162881904|NCT00479557|588266481|FG006|Overall Study|Caregiver Request|0|||
162881905|NCT00479557|588266475|FG000|Overall Study|Investigator Request|0|||
162881906|NCT00479557|588266476|FG001|Overall Study|Investigator Request|0|||
162881907|NCT00479557|588266477|FG002|Overall Study|Investigator Request|1|||
162881908|NCT00479557|588266478|FG003|Overall Study|Investigator Request|0|||
162881909|NCT00479557|588266479|FG004|Overall Study|Investigator Request|0|||
162881910|NCT00479557|588266480|FG005|Overall Study|Investigator Request|0|||
162881911|NCT00479557|588266481|FG006|Overall Study|Investigator Request|0|||
162881912|NCT00479557|588266475|FG000|Overall Study|Subject Request|3|||
162881913|NCT00479557|588266476|FG001|Overall Study|Subject Request|0|||
162881914|NCT00479557|588266477|FG002|Overall Study|Subject Request|1|||
162881915|NCT00479557|588266478|FG003|Overall Study|Subject Request|1|||
162881916|NCT00479557|588266479|FG004|Overall Study|Subject Request|1|||
162881917|NCT00479557|588266480|FG005|Overall Study|Subject Request|4|||
162881918|NCT00479557|588266481|FG006|Overall Study|Subject Request|1|||
162881919|NCT00479557|588266475|FG000|Overall Study|Other|2|||
162881920|NCT00479557|588266476|FG001|Overall Study|Other|3|||
162881921|NCT00479557|588266477|FG002|Overall Study|Other|1|||
162881922|NCT00479557|588266478|FG003|Overall Study|Other|0|||
162881923|NCT00479557|588266479|FG004|Overall Study|Other|0|||
162881924|NCT00479557|588266480|FG005|Overall Study|Other|3|||
162881925|NCT00479557|588266481|FG006|Overall Study|Other|0|||
162881926|NCT01511107|588266484|FG000|Overall Study|Ineligible|3|||
162881927|NCT01511107|588266485|FG001|Overall Study|Ineligible|2|||
162881928|NCT01511107|588266484|FG000|Overall Study|Lost to Follow-up|10|||
162881929|NCT01511107|588266485|FG001|Overall Study|Lost to Follow-up|19|||
162881930|NCT01511107|588266484|FG000|Overall Study|Withdrawal by Subject|9|||
162881931|NCT01511107|588266485|FG001|Overall Study|Withdrawal by Subject|20|||
162881932|NCT05371912|588266486|FG000|Overall Study|Lost to Follow-up|3|||
162881933|NCT05371912|588266487|FG001|Overall Study|Lost to Follow-up|2|||
162881934|NCT04752189|588266488|FG000|Overall Study|Withdrawal by Subject|0|||
162881935|NCT04752189|588266489|FG001|Overall Study|Withdrawal by Subject|150|||
162881936|NCT04752189|588266488|FG000|Overall Study|Lost to Follow-up|261|||
162881937|NCT04752189|588266489|FG001|Overall Study|Lost to Follow-up|126|||
162881938|NCT00975195|588266490|FG000|Overall Study|Adverse Event|108|||
162881939|NCT00975195|588266491|FG001|Overall Study|Adverse Event|101|||
162881940|NCT00975195|588266490|FG000|Overall Study|Lack of Efficacy|6|||
162881941|NCT00975195|588266491|FG001|Overall Study|Lack of Efficacy|6|||
162881942|NCT00975195|588266490|FG000|Overall Study|Protocol Violation|27|||
162881943|NCT00975195|588266491|FG001|Overall Study|Protocol Violation|23|||
162881944|NCT00975195|588266490|FG000|Overall Study|Lost to Follow-up|9|||
162881945|NCT00975195|588266491|FG001|Overall Study|Lost to Follow-up|7|||
162881946|NCT00975195|588266490|FG000|Overall Study|Withdrawal by Subject|48|||
162881947|NCT00975195|588266491|FG001|Overall Study|Withdrawal by Subject|61|||
162881948|NCT00975195|588266490|FG000|Overall Study|Other reason not defined above|29|||
162881949|NCT00975195|588266491|FG001|Overall Study|Other reason not defined above|33|||
162881950|NCT00975195|588266490|FG000|Overall Study|Not treated|1|||
162881951|NCT00975195|588266491|FG001|Overall Study|Not treated|2|||
162881952|NCT02180724|588268091|FG000|Overall Study|Death|26|||
162881953|NCT02180724|588268092|FG001|Overall Study|Death|1|||
162881954|NCT02180724|588268091|FG000|Overall Study|Lost to Follow-up|3|||
162881955|NCT02180724|588268092|FG001|Overall Study|Lost to Follow-up|1|||
162881956|NCT02180724|588268091|FG000|Overall Study|Withdrawal by Subject|4|||
162881957|NCT02180724|588268092|FG001|Overall Study|Withdrawal by Subject|2|||
162881958|NCT02180724|588268091|FG000|Overall Study|PI Decision|5|||
162881959|NCT02180724|588268092|FG001|Overall Study|PI Decision|2|||
162881960|NCT02180724|588268091|FG000|Overall Study|Study terminated by sponsor|54|||
162881961|NCT02180724|588268092|FG001|Overall Study|Study terminated by sponsor|8|||
162881962|NCT05195359|588268093|FG000|Overall Study|Lost to Follow-up|124|||
162881963|NCT05195359|588268094|FG001|Overall Study|Lost to Follow-up|34|||
162881964|NCT01146951|588268095|FG000|Overall Study|Adverse Event|4|||
162881965|NCT01146951|588268096|FG001|Overall Study|Adverse Event|1|||
162881966|NCT01747811|588268100|FG000|Overall Study|Lack of Efficacy|2|||
162881967|NCT01747811|588268101|FG001|Overall Study|Lack of Efficacy|4|||
162881968|NCT01517412|588268102|FG000|Overall Study|Adverse Event|10|||
162881969|NCT01517412|588268103|FG001|Overall Study|Adverse Event|11|||
162881970|NCT01517412|588268102|FG000|Overall Study|Lack of Efficacy|10|||
162881971|NCT01517412|588268103|FG001|Overall Study|Lack of Efficacy|5|||
162881972|NCT01517412|588268102|FG000|Overall Study|Poor compliance to protocol|8|||
162881973|NCT01517412|588268103|FG001|Overall Study|Poor compliance to protocol|3|||
162881974|NCT01517412|588268102|FG000|Overall Study|Other than specified above|8|||
162881975|NCT01517412|588268103|FG001|Overall Study|Other than specified above|5|||
162881976|NCT01253187|588268104|FG000|Period 2|Withdrawal by Subject|0|||
162881977|NCT01253187|588268105|FG001|Period 2|Withdrawal by Subject|0|||
162881978|NCT01253187|588268106|FG002|Period 2|Withdrawal by Subject|0|||
162881979|NCT01253187|588268107|FG003|Period 2|Withdrawal by Subject|0|||
162881980|NCT01253187|588268108|FG004|Period 2|Withdrawal by Subject|1|||
162881981|NCT01253187|588268109|FG005|Period 2|Withdrawal by Subject|0|||
162881982|NCT01253187|588268104|FG000|Period 3|Pregnancy|1|||
162881983|NCT01253187|588268105|FG001|Period 3|Pregnancy|0|||
162881984|NCT01253187|588268106|FG002|Period 3|Pregnancy|0|||
162881985|NCT01253187|588268107|FG003|Period 3|Pregnancy|0|||
163048649|NCT00426764|588884837|FG000|Overall Study|Compassionate Use|1|||
163048650|NCT00426764|588884837|FG000|Overall Study|Progressive Disease|83|||
163048651|NCT00426764|588884837|FG000|Overall Study|Adverse Event|24|||
163048652|NCT00426764|588884837|FG000|Overall Study|Other|1|||
163048653|NCT00426764|588884837|FG000|Overall Study|Death|1|||
163048654|NCT00426764|588884837|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
163048655|NCT01922258|588884838|FG000|Overall Study|Lost to Follow-up|1|||
163048656|NCT01922258|588884839|FG001|Overall Study|Lost to Follow-up|1|||
163048657|NCT01922258|588884838|FG000|Overall Study|Adverse Event|9|||
163048658|NCT01922258|588884839|FG001|Overall Study|Adverse Event|2|||
163048659|NCT01922258|588884838|FG000|Overall Study|Met Withdrawal Criteria|0|||
163048660|NCT01922258|588884839|FG001|Overall Study|Met Withdrawal Criteria|4|||
163048661|NCT01922258|588884838|FG000|Overall Study|Withdrawn by the Investigator|1|||
163048662|NCT01922258|588884839|FG001|Overall Study|Withdrawn by the Investigator|4|||
163048663|NCT01922258|588884838|FG000|Overall Study|Withdrawal by participant|5|||
163048664|NCT01922258|588884839|FG001|Overall Study|Withdrawal by participant|5|||
163048665|NCT02417753|588884840|FG000|Overall Study|Death|1|||
163048666|NCT01261390|588884841|FG000|Overall Study|Significant Concurrent Illness|1|||
163048667|NCT01261390|588884842|FG001|Overall Study|Significant Concurrent Illness|0|||
163048668|NCT01261390|588884843|FG002|Overall Study|Significant Concurrent Illness|1|||
163048669|NCT01261390|588884844|FG003|Overall Study|Significant Concurrent Illness|0|||
163048670|NCT01261390|588884841|FG000|Overall Study|Dissatisfaction with Treatment|2|||
163048671|NCT01261390|588884842|FG001|Overall Study|Dissatisfaction with Treatment|1|||
163048672|NCT01261390|588884843|FG002|Overall Study|Dissatisfaction with Treatment|1|||
163048673|NCT01261390|588884844|FG003|Overall Study|Dissatisfaction with Treatment|2|||
163048674|NCT01261390|588884841|FG000|Overall Study|Relocation|0|||
163048675|NCT01261390|588884842|FG001|Overall Study|Relocation|1|||
162881986|NCT01253187|588268108|FG004|Period 3|Pregnancy|0|||
162881987|NCT01253187|588268109|FG005|Period 3|Pregnancy|0|||
162881988|NCT01253187|588268104|FG000|Period 3|difficulty with blood sampling|0|||
162881989|NCT01253187|588268105|FG001|Period 3|difficulty with blood sampling|1|||
162881990|NCT01253187|588268106|FG002|Period 3|difficulty with blood sampling|0|||
162881991|NCT01253187|588268107|FG003|Period 3|difficulty with blood sampling|0|||
162881992|NCT01253187|588268108|FG004|Period 3|difficulty with blood sampling|0|||
162881993|NCT01253187|588268109|FG005|Period 3|difficulty with blood sampling|0|||
162881994|NCT01253187|588268104|FG000|Period 3|non-compliance|0|||
162881995|NCT01253187|588268105|FG001|Period 3|non-compliance|0|||
162881996|NCT01253187|588268106|FG002|Period 3|non-compliance|0|||
162881997|NCT01253187|588268107|FG003|Period 3|non-compliance|0|||
162881998|NCT01253187|588268108|FG004|Period 3|non-compliance|1|||
162881999|NCT01253187|588268109|FG005|Period 3|non-compliance|0|||
162882000|NCT03569449|588268110|FG000|Overall Study|Lost to Follow-up|0|||
162882001|NCT03569449|588268111|FG001|Overall Study|Lost to Follow-up|1|||
162882002|NCT03569449|588268112|FG002|Overall Study|Lost to Follow-up|0|||
162882003|NCT03569449|588268113|FG003|Overall Study|Lost to Follow-up|2|||
162882004|NCT03569449|588268114|FG004|Overall Study|Lost to Follow-up|0|||
162882005|NCT03569449|588268115|FG005|Overall Study|Lost to Follow-up|0|||
162882006|NCT03569449|588268116|FG006|Overall Study|Lost to Follow-up|0|||
162882007|NCT03569449|588268117|FG007|Overall Study|Lost to Follow-up|0|||
162882008|NCT03569449|588268118|FG008|Overall Study|Lost to Follow-up|0|||
162882009|NCT03569449|588268119|FG009|Overall Study|Lost to Follow-up|0|||
162882010|NCT03569449|588268120|FG010|Overall Study|Lost to Follow-up|0|||
162882011|NCT03569449|588268121|FG011|Overall Study|Lost to Follow-up|0|||
162882012|NCT03569449|588268122|FG012|Overall Study|Lost to Follow-up|0|||
162882013|NCT03569449|588268123|FG013|Overall Study|Lost to Follow-up|0|||
162882014|NCT03569449|588268124|FG014|Overall Study|Lost to Follow-up|1|||
162882015|NCT03569449|588268125|FG015|Overall Study|Lost to Follow-up|0|||
162882016|NCT03569449|588268110|FG000|Overall Study|Withdrawal by Subject|0|||
162882017|NCT03569449|588268111|FG001|Overall Study|Withdrawal by Subject|1|||
162882018|NCT03569449|588268112|FG002|Overall Study|Withdrawal by Subject|0|||
162882019|NCT03569449|588268113|FG003|Overall Study|Withdrawal by Subject|0|||
162882020|NCT03569449|588268114|FG004|Overall Study|Withdrawal by Subject|1|||
162882021|NCT03569449|588268115|FG005|Overall Study|Withdrawal by Subject|0|||
162882022|NCT03569449|588268116|FG006|Overall Study|Withdrawal by Subject|0|||
162882023|NCT03569449|588268117|FG007|Overall Study|Withdrawal by Subject|0|||
162882024|NCT03569449|588268118|FG008|Overall Study|Withdrawal by Subject|0|||
162882025|NCT03569449|588268119|FG009|Overall Study|Withdrawal by Subject|0|||
162882026|NCT03569449|588268120|FG010|Overall Study|Withdrawal by Subject|0|||
162882027|NCT03569449|588268121|FG011|Overall Study|Withdrawal by Subject|0|||
163048676|NCT01261390|588884843|FG002|Overall Study|Relocation|0|||
163048677|NCT01261390|588884844|FG003|Overall Study|Relocation|0|||
162882028|NCT03569449|588268122|FG012|Overall Study|Withdrawal by Subject|0|||
162882029|NCT03569449|588268123|FG013|Overall Study|Withdrawal by Subject|0|||
162882030|NCT03569449|588268124|FG014|Overall Study|Withdrawal by Subject|0|||
162882031|NCT03569449|588268125|FG015|Overall Study|Withdrawal by Subject|0|||
162882032|NCT04124692|588268126|FG000|Overall Study|Medical reason|0|||
163048678|NCT01261390|588884841|FG000|Overall Study|Loss of Interest in the Study|3|||
163048679|NCT01261390|588884842|FG001|Overall Study|Loss of Interest in the Study|1|||
162882033|NCT04124692|588268127|FG001|Overall Study|Medical reason|1|||
162882034|NCT04124692|588268126|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
162882035|NCT04124692|588268127|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
162882036|NCT04124692|588268126|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
162882037|NCT04124692|588268127|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
162882038|NCT04124692|588268126|FG000|Overall Study|Lost to Follow-up|2|||
162882039|NCT04124692|588268127|FG001|Overall Study|Lost to Follow-up|4|||
162882040|NCT04124692|588268126|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
162882041|NCT04124692|588268127|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
162882042|NCT05136170|588268137|FG000|Overall Study|Withdrawal by Subject|2|||
162882043|NCT05136170|588268138|FG001|Overall Study|Withdrawal by Subject|2|||
162882044|NCT05136170|588268137|FG000|Overall Study|Can no longer make office visits|1|||
162882045|NCT05136170|588268138|FG001|Overall Study|Can no longer make office visits|0|||
162882046|NCT04393038|588268139|FG000|Overall Study|Adverse Event|11|||
162882047|NCT04393038|588268140|FG001|Overall Study|Adverse Event|2|||
162882048|NCT04393038|588268139|FG000|Overall Study|Protocol Violation|1|||
162882049|NCT04393038|588268140|FG001|Overall Study|Protocol Violation|0|||
162882050|NCT04393038|588268139|FG000|Overall Study|Death|6|||
162882051|NCT04393038|588268140|FG001|Overall Study|Death|4|||
162882052|NCT04393038|588268139|FG000|Overall Study|Withdrawal by Subject|24|||
162882053|NCT04393038|588268140|FG001|Overall Study|Withdrawal by Subject|8|||
162882054|NCT04393038|588268139|FG000|Overall Study|Lost to Follow-up|5|||
162882055|NCT04393038|588268140|FG001|Overall Study|Lost to Follow-up|4|||
162882056|NCT04393038|588268139|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
162882057|NCT04393038|588268140|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
162882058|NCT04393038|588268139|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
162882059|NCT04393038|588268140|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
162882060|NCT05168813|588268141|FG000|Part A (Open-label)|Lost to Follow-up|21|||
162882061|NCT05168813|588268142|FG001|Part A (Open-label)|Lost to Follow-up|39|||
162882062|NCT05168813|588268143|FG002|Part A (Open-label)|Lost to Follow-up|8|||
162882063|NCT05168813|588268144|FG003|Part A (Open-label)|Lost to Follow-up|26|||
162882064|NCT05168813|588268145|FG004|Part A (Open-label)|Lost to Follow-up|0|||
162882065|NCT05168813|588268146|FG005|Part A (Open-label)|Lost to Follow-up|0|||
162882066|NCT05168813|588268141|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
162882067|NCT05168813|588268142|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
162882068|NCT05168813|588268143|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
162882069|NCT05168813|588268144|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
162882070|NCT05168813|588268145|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
162882071|NCT05168813|588268146|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
162882072|NCT05168813|588268141|FG000|Part A (Open-label)|Death|23|||
162882073|NCT05168813|588268142|FG001|Part A (Open-label)|Death|28|||
162882074|NCT05168813|588268143|FG002|Part A (Open-label)|Death|1|||
162882075|NCT05168813|588268144|FG003|Part A (Open-label)|Death|9|||
162882076|NCT05168813|588268145|FG004|Part A (Open-label)|Death|0|||
162882077|NCT05168813|588268146|FG005|Part A (Open-label)|Death|0|||
162882078|NCT05168813|588268141|FG000|Part A (Open-label)|Physician Decision|0|||
162882079|NCT05168813|588268142|FG001|Part A (Open-label)|Physician Decision|1|||
162882080|NCT05168813|588268143|FG002|Part A (Open-label)|Physician Decision|0|||
162882081|NCT05168813|588268144|FG003|Part A (Open-label)|Physician Decision|2|||
162882082|NCT05168813|588268145|FG004|Part A (Open-label)|Physician Decision|0|||
162882083|NCT05168813|588268146|FG005|Part A (Open-label)|Physician Decision|0|||
162882084|NCT05168813|588268141|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
162882085|NCT05168813|588268142|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
162882086|NCT05168813|588268143|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
162882087|NCT05168813|588268144|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
162882088|NCT05168813|588268145|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
162882089|NCT05168813|588268146|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
162882090|NCT05168813|588268141|FG000|Part A (Open-label)|Protocol Violation|0|||
162882091|NCT05168813|588268142|FG001|Part A (Open-label)|Protocol Violation|1|||
162882092|NCT05168813|588268143|FG002|Part A (Open-label)|Protocol Violation|0|||
162882093|NCT05168813|588268144|FG003|Part A (Open-label)|Protocol Violation|0|||
162882094|NCT05168813|588268145|FG004|Part A (Open-label)|Protocol Violation|0|||
162882095|NCT05168813|588268146|FG005|Part A (Open-label)|Protocol Violation|0|||
162882096|NCT05168813|588268141|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
162882097|NCT05168813|588268142|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
162962013|NCT00112437|588560756|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162882098|NCT05168813|588268143|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
162882099|NCT05168813|588268144|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
162882100|NCT05168813|588268145|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
162882101|NCT05168813|588268146|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
162882102|NCT05168813|588268141|FG000|Part A (Open-label)|Other|0|||
162882103|NCT05168813|588268142|FG001|Part A (Open-label)|Other|1|||
162882104|NCT05168813|588268143|FG002|Part A (Open-label)|Other|0|||
162882105|NCT05168813|588268144|FG003|Part A (Open-label)|Other|0|||
162882106|NCT05168813|588268145|FG004|Part A (Open-label)|Other|0|||
162882107|NCT05168813|588268146|FG005|Part A (Open-label)|Other|0|||
162882108|NCT05168813|588268141|FG000|Part B (Blinded)|Lost to Follow-up|0|||
162882109|NCT05168813|588268142|FG001|Part B (Blinded)|Lost to Follow-up|0|||
162882110|NCT05168813|588268143|FG002|Part B (Blinded)|Lost to Follow-up|0|||
162882111|NCT05168813|588268144|FG003|Part B (Blinded)|Lost to Follow-up|0|||
162882112|NCT05168813|588268145|FG004|Part B (Blinded)|Lost to Follow-up|219|||
162882113|NCT05168813|588268146|FG005|Part B (Blinded)|Lost to Follow-up|88|||
162882114|NCT05168813|588268141|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
162882115|NCT05168813|588268142|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
162882116|NCT05168813|588268143|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
162882117|NCT05168813|588268144|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
162882118|NCT05168813|588268145|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
162882119|NCT05168813|588268146|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
162882120|NCT05168813|588268141|FG000|Part B (Blinded)|Death|0|||
162882121|NCT05168813|588268142|FG001|Part B (Blinded)|Death|0|||
162882122|NCT05168813|588268143|FG002|Part B (Blinded)|Death|0|||
162882123|NCT05168813|588268144|FG003|Part B (Blinded)|Death|0|||
162882124|NCT05168813|588268145|FG004|Part B (Blinded)|Death|63|||
162882125|NCT05168813|588268146|FG005|Part B (Blinded)|Death|19|||
162882126|NCT05168813|588268141|FG000|Part B (Blinded)|Physician Decision|0|||
162882127|NCT05168813|588268142|FG001|Part B (Blinded)|Physician Decision|0|||
162882128|NCT05168813|588268143|FG002|Part B (Blinded)|Physician Decision|0|||
162882129|NCT05168813|588268144|FG003|Part B (Blinded)|Physician Decision|0|||
162882130|NCT05168813|588268145|FG004|Part B (Blinded)|Physician Decision|6|||
162882131|NCT05168813|588268146|FG005|Part B (Blinded)|Physician Decision|1|||
162882132|NCT05168813|588268141|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
162882133|NCT05168813|588268142|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
162882134|NCT05168813|588268143|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
162882135|NCT05168813|588268144|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
162882136|NCT05168813|588268145|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
162882137|NCT05168813|588268146|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
162882138|NCT05168813|588268141|FG000|Part B (Blinded)|Pregnancy|0|||
162882139|NCT05168813|588268142|FG001|Part B (Blinded)|Pregnancy|0|||
162882140|NCT05168813|588268143|FG002|Part B (Blinded)|Pregnancy|0|||
162882141|NCT05168813|588268144|FG003|Part B (Blinded)|Pregnancy|0|||
162882142|NCT05168813|588268145|FG004|Part B (Blinded)|Pregnancy|1|||
162882143|NCT05168813|588268146|FG005|Part B (Blinded)|Pregnancy|0|||
162882144|NCT05168813|588268141|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
162882145|NCT05168813|588268142|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
162882146|NCT05168813|588268143|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
162882147|NCT05168813|588268144|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
162882148|NCT05168813|588268145|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
162882149|NCT05168813|588268146|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
162882150|NCT05168813|588268141|FG000|Part B (Blinded)|Other|0|||
162882151|NCT05168813|588268142|FG001|Part B (Blinded)|Other|0|||
162882152|NCT05168813|588268143|FG002|Part B (Blinded)|Other|0|||
162882153|NCT05168813|588268144|FG003|Part B (Blinded)|Other|0|||
162882154|NCT05168813|588268145|FG004|Part B (Blinded)|Other|41|||
162882155|NCT05168813|588268146|FG005|Part B (Blinded)|Other|27|||
162882156|NCT02492997|588268148|FG000|Overall Study|Withdrawal by Subject|1|||
163048680|NCT01261390|588884843|FG002|Overall Study|Loss of Interest in the Study|0|||
162882157|NCT02492997|588268149|FG001|Overall Study|Withdrawal by Subject|0|||
162882158|NCT02492997|588268148|FG000|Overall Study|Gained Weight|1|||
162882159|NCT02492997|588268149|FG001|Overall Study|Gained Weight|0|||
162882160|NCT02492997|588268148|FG000|Overall Study|Lost to Follow-up|0|||
163048681|NCT01261390|588884844|FG003|Overall Study|Loss of Interest in the Study|0|||
163048682|NCT01261390|588884841|FG000|Overall Study|Lost to Follow-up|1|||
163048683|NCT01261390|588884842|FG001|Overall Study|Lost to Follow-up|6|||
162882161|NCT02492997|588268149|FG001|Overall Study|Lost to Follow-up|1|||
162882162|NCT01089582|588268150|FG000|Overall Study|Death|2|||
162882163|NCT01089582|588268150|FG000|Overall Study|Adverse Event|15|||
162882164|NCT01089582|588268150|FG000|Overall Study|Lost to Follow-up|8|||
162882165|NCT01089582|588268150|FG000|Overall Study|Other|4|||
162882166|NCT01089582|588268150|FG000|Overall Study|Withdrawal by Subject|1|||
162882167|NCT04069156|588268151|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
162882168|NCT04069156|588268152|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
162882169|NCT04069156|588268151|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
162882170|NCT04069156|588268152|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
163048684|NCT01261390|588884843|FG002|Overall Study|Lost to Follow-up|5|||
163048685|NCT01261390|588884844|FG003|Overall Study|Lost to Follow-up|6|||
163048686|NCT02782741|588884846|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
163048687|NCT02782741|588884847|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
163048688|NCT02782741|588884848|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
163048689|NCT02782741|588884846|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
163048690|NCT02782741|588884847|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
163048691|NCT02782741|588884848|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
163048692|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
163048693|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
163048694|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
163048695|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
162616237|NCT00257608|587313375|FG002|Chemotherapy Phase|Disease progression|0|||
162616238|NCT00257608|587313373|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
162616239|NCT00257608|587313374|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
162616240|NCT00257608|587313375|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
162616241|NCT00257608|587313373|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
162616242|NCT00257608|587313374|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162616243|NCT00257608|587313375|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162616244|NCT00257608|587313373|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
162616245|NCT00257608|587313374|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
162616246|NCT00257608|587313375|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
162707653|NCT04541186|587638299|FG000|Main Study|Adverse Event|0|||
162882171|NCT04069156|588268151|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
162882172|NCT04069156|588268152|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
162882173|NCT04069156|588268151|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
162882174|NCT04069156|588268152|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
162882175|NCT03806179|588268161|FG000|Overall Study|Progressive disease|0|||
162882176|NCT03806179|588268162|FG001|Overall Study|Progressive disease|2|||
162882177|NCT05822830|588268163|FG000|Overall Study|Adverse Event|6|||
162882178|NCT05822830|588268164|FG001|Overall Study|Adverse Event|6|||
162882179|NCT05822830|588268163|FG000|Overall Study|Assigned Treatment by Mistake|5|||
162962014|NCT00112437|588560757|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962015|NCT00112437|588560758|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962016|NCT00112437|588560759|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962017|NCT00112437|588560760|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962018|NCT00112437|588560761|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962019|NCT00112437|588560762|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962020|NCT00112437|588560763|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962021|NCT00112437|588560764|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962022|NCT00112437|588560765|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962023|NCT00112437|588560766|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962024|NCT00112437|588560767|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962025|NCT00112437|588560768|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
162962026|NCT00112437|588560769|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
162962027|NCT00112437|588560770|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162962028|NCT00112437|588560771|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
162962029|NCT01824576|588560773|FG000|Overall Study|Device deficiency|2|||
162962030|NCT03218787|588560779|FG000|Overall Study|Lost to Follow-up|12|||
162962031|NCT03218787|588560779|FG000|Overall Study|Withdrawal by Subject|72|||
162962032|NCT03218787|588560779|FG000|Overall Study|Physician Decision|11|||
162962033|NCT03218787|588560779|FG000|Overall Study|Death|111|||
162962034|NCT02896296|588560780|FG000|Overall Study|Adverse Event|1|||
162962035|NCT02896296|588560780|FG000|Overall Study|Lost to Follow-up|19|||
162962036|NCT02896296|588560780|FG000|Overall Study|Pregnancy|1|||
162962037|NCT02896296|588560780|FG000|Overall Study|Physician Decision|2|||
162962038|NCT02896296|588560780|FG000|Overall Study|Withdrawal by Subject|10|||
162962039|NCT02896296|588560780|FG000|Overall Study|Site closing|7|||
162962040|NCT02896296|588560780|FG000|Overall Study|Incarceration|1|||
162962041|NCT02896296|588560780|FG000|Overall Study|Relocation|1|||
162962042|NCT01120028|588560783|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962043|NCT01120028|588560784|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
162962044|NCT01120028|588560785|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962045|NCT01120028|588560786|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162962046|NCT01120028|588560783|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
162962047|NCT01120028|588560784|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
162962048|NCT01120028|588560785|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
162962049|NCT01120028|588560786|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
163048696|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
163048697|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
163048698|NCT02782741|588884846|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
162616247|NCT00257608|587313373|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
162616248|NCT00257608|587313374|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
162616249|NCT00257608|587313375|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
162616250|NCT00257608|587313373|FG000|Chemotherapy Phase|Physician Decision|28|||
162616251|NCT00257608|587313374|FG001|Chemotherapy Phase|Physician Decision|0|||
162616252|NCT00257608|587313375|FG002|Chemotherapy Phase|Physician Decision|0|||
162882180|NCT05822830|588268164|FG001|Overall Study|Assigned Treatment by Mistake|3|||
162882181|NCT05822830|588268163|FG000|Overall Study|Lost to Follow-up|16|||
162882182|NCT05822830|588268164|FG001|Overall Study|Lost to Follow-up|18|||
162882183|NCT05822830|588268163|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162882184|NCT05822830|588268164|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162882185|NCT05822830|588268163|FG000|Overall Study|Participant was Out of the Country|0|||
162882186|NCT05822830|588268164|FG001|Overall Study|Participant was Out of the Country|1|||
162882187|NCT05822830|588268163|FG000|Overall Study|Pregnancy|1|||
162882188|NCT05822830|588268164|FG001|Overall Study|Pregnancy|2|||
162882189|NCT05822830|588268163|FG000|Overall Study|Withdrawal by Subject|27|||
162882190|NCT05822830|588268164|FG001|Overall Study|Withdrawal by Subject|26|||
162962050|NCT03250117|588560787|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
162962051|NCT03250117|588560788|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962052|NCT03250117|588560789|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962053|NCT03250117|588560790|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
162962054|NCT04063878|588560791|FG000|Overall Study|Withdrawal by Subject|2|||
162962055|NCT04063878|588560791|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
162962056|NCT00147498|588560792|FG000|Overall Study|Adverse Event|1|||
162962057|NCT00147498|588560793|FG001|Overall Study|Adverse Event|6|||
162962058|NCT00147498|588560794|FG002|Overall Study|Adverse Event|7|||
162962059|NCT00147498|588560795|FG003|Overall Study|Adverse Event|3|||
162962060|NCT00147498|588560792|FG000|Overall Study|Lack of Efficacy|1|||
162962061|NCT00147498|588560793|FG001|Overall Study|Lack of Efficacy|1|||
162962062|NCT00147498|588560794|FG002|Overall Study|Lack of Efficacy|1|||
162962063|NCT00147498|588560795|FG003|Overall Study|Lack of Efficacy|8|||
162962064|NCT00147498|588560792|FG000|Overall Study|Laboratory abnormality|0|||
162962065|NCT00147498|588560793|FG001|Overall Study|Laboratory abnormality|0|||
162962066|NCT00147498|588560794|FG002|Overall Study|Laboratory abnormality|2|||
162962067|NCT00147498|588560795|FG003|Overall Study|Laboratory abnormality|0|||
162962068|NCT00147498|588560792|FG000|Overall Study|Participant defaulted|0|||
162962069|NCT00147498|588560793|FG001|Overall Study|Participant defaulted|1|||
162962070|NCT00147498|588560794|FG002|Overall Study|Participant defaulted|4|||
162962071|NCT00147498|588560795|FG003|Overall Study|Participant defaulted|3|||
162962072|NCT00147498|588560792|FG000|Overall Study|Other|1|||
162962073|NCT00147498|588560793|FG001|Overall Study|Other|1|||
162962074|NCT00147498|588560794|FG002|Overall Study|Other|3|||
162962075|NCT00147498|588560795|FG003|Overall Study|Other|3|||
162962076|NCT04633564|588560796|FG000|Period 1|Adverse Event|28|||
162962077|NCT04633564|588560797|FG001|Period 1|Adverse Event|19|||
162962078|NCT04633564|588560796|FG000|Period 1|Death|8|||
162962079|NCT04633564|588560797|FG001|Period 1|Death|7|||
162962080|NCT04633564|588560796|FG000|Period 1|Lost to Follow-up|3|||
162962081|NCT04633564|588560797|FG001|Period 1|Lost to Follow-up|5|||
162962082|NCT04633564|588560796|FG000|Period 1|Physician Decision|4|||
162962083|NCT04633564|588560797|FG001|Period 1|Physician Decision|12|||
162962084|NCT04633564|588560796|FG000|Period 1|Protocol Violation|0|||
162962085|NCT04633564|588560797|FG001|Period 1|Protocol Violation|1|||
162962086|NCT04633564|588560796|FG000|Period 1|Withdrawal by Subject|10|||
162962087|NCT04633564|588560797|FG001|Period 1|Withdrawal by Subject|8|||
162962088|NCT04633564|588560796|FG000|Period 1|Progressive disease|47|||
162962089|NCT04633564|588560797|FG001|Period 1|Progressive disease|51|||
162962090|NCT04633564|588560796|FG000|Period 1|Terminated by Sponsor|8|||
162962091|NCT04633564|588560797|FG001|Period 1|Terminated by Sponsor|6|||
162962092|NCT04633564|588560796|FG000|Period 2|Adverse Event|3|||
162962093|NCT04633564|588560797|FG001|Period 2|Adverse Event|4|||
162962094|NCT04633564|588560796|FG000|Period 2|Death|0|||
162962095|NCT04633564|588560797|FG001|Period 2|Death|2|||
162962096|NCT04633564|588560796|FG000|Period 2|Lost to Follow-up|0|||
162962097|NCT04633564|588560797|FG001|Period 2|Lost to Follow-up|1|||
162962098|NCT04633564|588560796|FG000|Period 2|Physician Decision|2|||
162962099|NCT04633564|588560797|FG001|Period 2|Physician Decision|4|||
162962100|NCT04633564|588560796|FG000|Period 2|Withdrawal by Subject|5|||
162962101|NCT04633564|588560797|FG001|Period 2|Withdrawal by Subject|1|||
162616253|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Adverse Event|0|||
162616254|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Adverse Event|34|||
162707654|NCT04541186|587638300|FG001|Main Study|Adverse Event|0|||
162882191|NCT03368664|588268165|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
162962102|NCT04633564|588560796|FG000|Period 2|Progressive Disease|74|||
162962103|NCT04633564|588560797|FG001|Period 2|Progressive Disease|82|||
162616255|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Adverse Event|38|||
162616256|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Disease progression|0|||
162882192|NCT03368664|588268165|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
162882193|NCT03368664|588268165|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
162882194|NCT03368664|588268165|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
162882195|NCT05441592|588268166|FG000|Overall Study|Lost to Follow-up|1|||
162882196|NCT05441592|588268167|FG001|Overall Study|Lost to Follow-up|5|||
162882197|NCT01021852|588268168|FG000|Treatment Period 1|Adverse Event|3|||
162882198|NCT01021852|588268169|FG001|Treatment Period 1|Adverse Event|1|||
162882199|NCT01021852|588268170|FG002|Treatment Period 1|Adverse Event|1|||
162882200|NCT01021852|588268171|FG003|Treatment Period 1|Adverse Event|0|||
162882201|NCT01021852|588268172|FG004|Treatment Period 1|Adverse Event|2|||
162882202|NCT01021852|588268173|FG005|Treatment Period 1|Adverse Event|2|||
162882203|NCT01021852|588268174|FG006|Treatment Period 1|Adverse Event|0|||
162882204|NCT01021852|588268175|FG007|Treatment Period 1|Adverse Event|0|||
162882205|NCT01021852|588268168|FG000|Treatment Period 1|Pregnancy|0|||
162882206|NCT01021852|588268169|FG001|Treatment Period 1|Pregnancy|0|||
162882207|NCT01021852|588268170|FG002|Treatment Period 1|Pregnancy|1|||
162882208|NCT01021852|588268171|FG003|Treatment Period 1|Pregnancy|0|||
162882209|NCT01021852|588268172|FG004|Treatment Period 1|Pregnancy|0|||
162882210|NCT01021852|588268173|FG005|Treatment Period 1|Pregnancy|0|||
162882211|NCT01021852|588268174|FG006|Treatment Period 1|Pregnancy|0|||
162882212|NCT01021852|588268175|FG007|Treatment Period 1|Pregnancy|0|||
162882213|NCT01021852|588268168|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162882214|NCT01021852|588268169|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162882215|NCT01021852|588268170|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162616257|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Disease progression|204|||
162882216|NCT01021852|588268171|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162882217|NCT01021852|588268172|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162882218|NCT01021852|588268173|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162882219|NCT01021852|588268174|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162882220|NCT01021852|588268175|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162882221|NCT01021852|588268168|FG000|Treatment Period 1|Not Treated|0|||
162882222|NCT01021852|588268169|FG001|Treatment Period 1|Not Treated|0|||
162882223|NCT01021852|588268170|FG002|Treatment Period 1|Not Treated|0|||
162882224|NCT01021852|588268171|FG003|Treatment Period 1|Not Treated|2|||
162882225|NCT01021852|588268172|FG004|Treatment Period 1|Not Treated|0|||
162882226|NCT01021852|588268173|FG005|Treatment Period 1|Not Treated|0|||
162882227|NCT01021852|588268174|FG006|Treatment Period 1|Not Treated|0|||
162882228|NCT01021852|588268175|FG007|Treatment Period 1|Not Treated|0|||
162882229|NCT01021852|588268168|FG000|Washout Period-Placebo|Adverse Event|0|||
162882230|NCT01021852|588268169|FG001|Washout Period-Placebo|Adverse Event|0|||
162882231|NCT01021852|588268170|FG002|Washout Period-Placebo|Adverse Event|0|||
162882232|NCT01021852|588268171|FG003|Washout Period-Placebo|Adverse Event|1|||
162882233|NCT01021852|588268172|FG004|Washout Period-Placebo|Adverse Event|0|||
162882234|NCT01021852|588268173|FG005|Washout Period-Placebo|Adverse Event|1|||
162882235|NCT01021852|588268174|FG006|Washout Period-Placebo|Adverse Event|0|||
162882236|NCT01021852|588268175|FG007|Washout Period-Placebo|Adverse Event|0|||
162882237|NCT01021852|588268168|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
162882238|NCT01021852|588268169|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
162882239|NCT01021852|588268170|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
162882240|NCT01021852|588268171|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
162882241|NCT01021852|588268172|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
162882242|NCT01021852|588268173|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
162882243|NCT01021852|588268174|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
162882244|NCT01021852|588268175|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
162882245|NCT01021852|588268168|FG000|Washout Period-Placebo|Protocol Violation|0|||
162882246|NCT01021852|588268169|FG001|Washout Period-Placebo|Protocol Violation|0|||
162882247|NCT01021852|588268170|FG002|Washout Period-Placebo|Protocol Violation|0|||
162882248|NCT01021852|588268171|FG003|Washout Period-Placebo|Protocol Violation|0|||
162882249|NCT01021852|588268172|FG004|Washout Period-Placebo|Protocol Violation|0|||
162882250|NCT01021852|588268173|FG005|Washout Period-Placebo|Protocol Violation|0|||
162882251|NCT01021852|588268174|FG006|Washout Period-Placebo|Protocol Violation|1|||
162616258|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Disease progression|168|||
162882252|NCT01021852|588268175|FG007|Washout Period-Placebo|Protocol Violation|0|||
162882253|NCT01021852|588268168|FG000|Washout Period-No Drug|Adverse Event|1|||
162882254|NCT01021852|588268169|FG001|Washout Period-No Drug|Adverse Event|0|||
162882255|NCT01021852|588268170|FG002|Washout Period-No Drug|Adverse Event|0|||
162882256|NCT01021852|588268171|FG003|Washout Period-No Drug|Adverse Event|0|||
162882257|NCT01021852|588268172|FG004|Washout Period-No Drug|Adverse Event|0|||
162882258|NCT01021852|588268173|FG005|Washout Period-No Drug|Adverse Event|1|||
162962104|NCT04633564|588560796|FG000|Period 2|Terminated by Sponsor|9|||
162962105|NCT04633564|588560797|FG001|Period 2|Terminated by Sponsor|3|||
162962106|NCT01279486|588560798|FG000|Overall Study|Lost to Follow-up|1|||
162962107|NCT04198363|588560799|FG000|Overall Study|Adverse Event|1|||
162962108|NCT04198363|588560800|FG001|Overall Study|Adverse Event|1|||
163048699|NCT02782741|588884847|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
163048700|NCT02782741|588884848|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
162882259|NCT01021852|588268174|FG006|Washout Period-No Drug|Adverse Event|0|||
162882260|NCT01021852|588268175|FG007|Washout Period-No Drug|Adverse Event|0|||
162882261|NCT01021852|588268168|FG000|Treatment Period 2|Adverse Event|0|||
162882262|NCT01021852|588268169|FG001|Treatment Period 2|Adverse Event|1|||
162882263|NCT01021852|588268170|FG002|Treatment Period 2|Adverse Event|0|||
162882264|NCT01021852|588268171|FG003|Treatment Period 2|Adverse Event|0|||
162882265|NCT01021852|588268172|FG004|Treatment Period 2|Adverse Event|1|||
162882266|NCT01021852|588268173|FG005|Treatment Period 2|Adverse Event|0|||
162882267|NCT01021852|588268174|FG006|Treatment Period 2|Adverse Event|1|||
163048701|NCT01951417|588884849|FG000|Overall Study|Withdrawal by Subject|1|||
163048702|NCT01951417|588884849|FG000|Overall Study|Protocol Violation|2|||
163048703|NCT01951417|588884849|FG000|Overall Study|Lost to Follow-up|6|||
163048704|NCT01497067|588884851|FG000|Overall Study|Lost to Follow-up|56|||
163048705|NCT01497067|588884851|FG000|Overall Study|Adverse Event|3|||
163048706|NCT01497067|588884851|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
163048707|NCT01497067|588884851|FG000|Overall Study|Other|13|||
163048708|NCT01275144|588884852|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
163048709|NCT01275144|588884853|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
163048710|NCT05116202|588884854|FG000|Overall Study|Study Terminated by Sponsor|21|||
163048711|NCT05116202|588884855|FG001|Overall Study|Study Terminated by Sponsor|38|||
163048712|NCT05116202|588884856|FG002|Overall Study|Study Terminated by Sponsor|17|||
163048713|NCT05116202|588884857|FG003|Overall Study|Study Terminated by Sponsor|18|||
163048714|NCT05116202|588884858|FG004|Overall Study|Study Terminated by Sponsor|0|||
163048715|NCT05116202|588884854|FG000|Overall Study|Withdrawal by Subject|0|||
163048716|NCT05116202|588884855|FG001|Overall Study|Withdrawal by Subject|1|||
163048717|NCT05116202|588884856|FG002|Overall Study|Withdrawal by Subject|1|||
162882268|NCT01021852|588268175|FG007|Treatment Period 2|Adverse Event|0|||
163048718|NCT05116202|588884857|FG003|Overall Study|Withdrawal by Subject|1|||
163048719|NCT05116202|588884858|FG004|Overall Study|Withdrawal by Subject|1|||
163048720|NCT05116202|588884854|FG000|Overall Study|Lost to Follow-up|0|||
163048721|NCT05116202|588884855|FG001|Overall Study|Lost to Follow-up|0|||
163048722|NCT05116202|588884856|FG002|Overall Study|Lost to Follow-up|0|||
163048723|NCT05116202|588884857|FG003|Overall Study|Lost to Follow-up|0|||
163048724|NCT05116202|588884858|FG004|Overall Study|Lost to Follow-up|2|||
163048725|NCT05116202|588884854|FG000|Overall Study|Death|1|||
163048726|NCT05116202|588884855|FG001|Overall Study|Death|1|||
163048727|NCT05116202|588884856|FG002|Overall Study|Death|2|||
163048728|NCT05116202|588884857|FG003|Overall Study|Death|1|||
163048729|NCT05116202|588884858|FG004|Overall Study|Death|5|||
163048730|NCT02864407|588884865|FG000|Overall Study|Protocol Violation|3|||
163048731|NCT02864407|588884865|FG000|Overall Study|Lost to Follow-up|115|||
163048732|NCT02864407|588884865|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
163048733|NCT02864407|588884865|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
163048734|NCT02864407|588884865|FG000|Overall Study|Consent prior to the contract date|1|||
163048735|NCT00096538|588884873|FG000|Overall Study|Withdrawal by Subject|1|||
163048736|NCT02686164|588884874|FG000|Overall Study|Adverse Event|1|||
163048737|NCT02686164|588884874|FG000|Overall Study|Withdrawal of consent|1|||
163048738|NCT02686164|588884874|FG000|Overall Study|Clinical progression|1|||
163048739|NCT01827592|588884882|FG000|Overall Study|Adverse Event|11|||
163048740|NCT01827592|588884883|FG001|Overall Study|Adverse Event|9|||
163048741|NCT01827592|588884884|FG002|Overall Study|Adverse Event|2|||
163048742|NCT01827592|588884882|FG000|Overall Study|Physician Decision|0|||
163048743|NCT01827592|588884883|FG001|Overall Study|Physician Decision|2|||
163048744|NCT01827592|588884884|FG002|Overall Study|Physician Decision|1|||
163048745|NCT01827592|588884882|FG000|Overall Study|Protocol Violation|2|||
163048746|NCT01827592|588884883|FG001|Overall Study|Protocol Violation|1|||
163048747|NCT01827592|588884884|FG002|Overall Study|Protocol Violation|0|||
163048748|NCT01827592|588884882|FG000|Overall Study|Lost to Follow-up|1|||
162882269|NCT01021852|588268168|FG000|Treatment Period 2|Lack of Efficacy|0|||
163048749|NCT01827592|588884883|FG001|Overall Study|Lost to Follow-up|2|||
163048750|NCT01827592|588884884|FG002|Overall Study|Lost to Follow-up|2|||
163048751|NCT01827592|588884882|FG000|Overall Study|Withdrawal by Subject|12|||
163048752|NCT01827592|588884883|FG001|Overall Study|Withdrawal by Subject|11|||
163048753|NCT01827592|588884884|FG002|Overall Study|Withdrawal by Subject|11|||
163048754|NCT01827592|588884882|FG000|Overall Study|Patient's substantial non-compliance|1|||
163048755|NCT01827592|588884883|FG001|Overall Study|Patient's substantial non-compliance|1|||
163048756|NCT01827592|588884884|FG002|Overall Study|Patient's substantial non-compliance|6|||
163048757|NCT01827592|588884882|FG000|Overall Study|Trial terminated by Sponsor|47|||
162962109|NCT04198363|588560799|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
162962110|NCT04198363|588560800|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
162962111|NCT04198363|588560799|FG000|Overall Study|Reason not Specified|1|||
162962112|NCT04198363|588560800|FG001|Overall Study|Reason not Specified|0|||
162962113|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Subject request|8|||
162962114|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Subject request|11|||
162962115|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
162962116|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
162962117|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
162962118|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
162962119|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
162962120|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
162962121|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
162962122|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
162962123|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
162962124|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
162962125|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Death|1|||
162962126|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Death|0|||
162962127|NCT00521586|588562582|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
162962128|NCT00521586|588562583|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
162962129|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
162962130|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
162962131|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
162962132|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
162962133|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
162962134|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
162962135|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
162962136|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
162962137|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
162962138|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
162962139|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
162962140|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
162962141|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
162962142|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
162962143|NCT00521586|588562582|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
162962144|NCT00521586|588562583|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
162962145|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
162962146|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
162962147|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
162962148|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
162962149|NCT00521586|588562582|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
162962150|NCT00521586|588562583|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
162962151|NCT00529763|588562584|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163048758|NCT01827592|588884883|FG001|Overall Study|Trial terminated by Sponsor|53|||
163048759|NCT01827592|588884884|FG002|Overall Study|Trial terminated by Sponsor|51|||
163048760|NCT01827592|588884882|FG000|Overall Study|Others|0|||
163048761|NCT01827592|588884883|FG001|Overall Study|Others|1|||
163048762|NCT01827592|588884884|FG002|Overall Study|Others|3|||
162962152|NCT00529763|588562585|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
162962153|NCT00529763|588562586|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
162962154|NCT00529763|588562584|FG000|Overall Study|Death|1|||
162962155|NCT00529763|588562585|FG001|Overall Study|Death|1|||
162962156|NCT00529763|588562586|FG002|Overall Study|Death|1|||
162962157|NCT00529763|588562584|FG000|Overall Study|Disease Progression|10|||
162962158|NCT00529763|588562585|FG001|Overall Study|Disease Progression|16|||
162962159|NCT00529763|588562586|FG002|Overall Study|Disease Progression|11|||
162962160|NCT00529763|588562584|FG000|Overall Study|Lost to Follow-up|1|||
162962161|NCT00529763|588562585|FG001|Overall Study|Lost to Follow-up|2|||
162962162|NCT00529763|588562586|FG002|Overall Study|Lost to Follow-up|3|||
162962163|NCT00529763|588562584|FG000|Overall Study|Stem Cell Transplant|0|||
162962164|NCT00529763|588562585|FG001|Overall Study|Stem Cell Transplant|3|||
162962165|NCT00529763|588562586|FG002|Overall Study|Stem Cell Transplant|1|||
162962166|NCT00529763|588562584|FG000|Overall Study|Study Drug Toxicity|3|||
162962167|NCT00529763|588562585|FG001|Overall Study|Study Drug Toxicity|6|||
162962168|NCT00529763|588562586|FG002|Overall Study|Study Drug Toxicity|4|||
162962169|NCT00529763|588562584|FG000|Overall Study|Participant Withdrew Consent|2|||
162962170|NCT00529763|588562585|FG001|Overall Study|Participant Withdrew Consent|3|||
162962171|NCT00529763|588562586|FG002|Overall Study|Participant Withdrew Consent|4|||
162962172|NCT00529763|588562584|FG000|Overall Study|Other reasons|2|||
162962173|NCT00529763|588562585|FG001|Overall Study|Other reasons|0|||
162962174|NCT00529763|588562586|FG002|Overall Study|Other reasons|2|||
163048763|NCT02324361|588884885|FG000|Overall Study|Lost to Follow-up|5|||
162962175|NCT00529763|588562584|FG000|Overall Study|Participant request to discontinue treatment|1|||
162962176|NCT00529763|588562585|FG001|Overall Study|Participant request to discontinue treatment|1|||
162962177|NCT00529763|588562586|FG002|Overall Study|Participant request to discontinue treatment|3|||
162962178|NCT03669250|588562587|FG000|Overall Study|Adverse Event|0|||
162962179|NCT03669250|588562588|FG001|Overall Study|Adverse Event|0|||
162962180|NCT03669250|588562589|FG002|Overall Study|Adverse Event|0|||
162962181|NCT03669250|588562590|FG003|Overall Study|Adverse Event|0|||
162962182|NCT03669250|588562591|FG004|Overall Study|Adverse Event|1|||
162962183|NCT03669250|588562592|FG005|Overall Study|Adverse Event|0|||
162962184|NCT03669250|588562587|FG000|Overall Study|Withdrawal by Subject|0|||
162962185|NCT03669250|588562588|FG001|Overall Study|Withdrawal by Subject|1|||
162962186|NCT03669250|588562589|FG002|Overall Study|Withdrawal by Subject|0|||
162962187|NCT03669250|588562590|FG003|Overall Study|Withdrawal by Subject|1|||
162962188|NCT03669250|588562591|FG004|Overall Study|Withdrawal by Subject|0|||
162962189|NCT03669250|588562592|FG005|Overall Study|Withdrawal by Subject|0|||
162962190|NCT00828321|588562593|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
162962191|NCT00828321|588562594|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
162962192|NCT00828321|588562593|FG000|Second Intervention|Protocol Violation|0|||
162962193|NCT00828321|588562594|FG001|Second Intervention|Protocol Violation|1|||
162962194|NCT01015287|588562595|FG000|Overall Study|Death|21|||
162962195|NCT01015287|588562596|FG001|Overall Study|Death|16|||
162962196|NCT01015287|588562595|FG000|Overall Study|Adverse Event|1|||
162962197|NCT01015287|588562596|FG001|Overall Study|Adverse Event|0|||
162962198|NCT01015287|588562595|FG000|Overall Study|Sponsor Decision|3|||
162962199|NCT01015287|588562596|FG001|Overall Study|Sponsor Decision|7|||
162962200|NCT01015287|588562595|FG000|Overall Study|Physician Decision|19|||
162962201|NCT01015287|588562596|FG001|Overall Study|Physician Decision|21|||
162962202|NCT01015287|588562595|FG000|Overall Study|Withdrawal by Subject|14|||
162962203|NCT01015287|588562596|FG001|Overall Study|Withdrawal by Subject|19|||
162962204|NCT01015287|588562595|FG000|Overall Study|Entry Criteria not Met|11|||
162962205|NCT01015287|588562596|FG001|Overall Study|Entry Criteria not Met|14|||
162962206|NCT01015287|588562595|FG000|Overall Study|Lost to Follow-up|2|||
162962207|NCT01015287|588562596|FG001|Overall Study|Lost to Follow-up|1|||
162962208|NCT01015287|588562595|FG000|Overall Study|Protocol Violation|1|||
162962209|NCT01015287|588562596|FG001|Overall Study|Protocol Violation|1|||
162962210|NCT01592240|588562597|FG000|Overall Study|Adverse Event|1|||
162962211|NCT01592240|588562598|FG001|Overall Study|Adverse Event|0|||
162962212|NCT01592240|588562599|FG002|Overall Study|Adverse Event|0|||
162962213|NCT01592240|588562600|FG003|Overall Study|Adverse Event|1|||
162962214|NCT01592240|588562601|FG004|Overall Study|Adverse Event|1|||
162962215|NCT01592240|588562602|FG005|Overall Study|Adverse Event|0|||
162962216|NCT01592240|588562603|FG006|Overall Study|Adverse Event|0|||
162962217|NCT01592240|588562597|FG000|Overall Study|Death|0|||
162962218|NCT01592240|588562598|FG001|Overall Study|Death|1|||
162962219|NCT01592240|588562599|FG002|Overall Study|Death|0|||
162962220|NCT01592240|588562600|FG003|Overall Study|Death|0|||
162962221|NCT01592240|588562601|FG004|Overall Study|Death|0|||
162962222|NCT01592240|588562602|FG005|Overall Study|Death|0|||
162962223|NCT01592240|588562603|FG006|Overall Study|Death|0|||
162962224|NCT01592240|588562597|FG000|Overall Study|Lost to Follow-up|1|||
162962225|NCT01592240|588562598|FG001|Overall Study|Lost to Follow-up|3|||
162962226|NCT01592240|588562599|FG002|Overall Study|Lost to Follow-up|1|||
162962227|NCT01592240|588562600|FG003|Overall Study|Lost to Follow-up|0|||
162962228|NCT01592240|588562601|FG004|Overall Study|Lost to Follow-up|3|||
162962229|NCT01592240|588562602|FG005|Overall Study|Lost to Follow-up|2|||
163048764|NCT02324361|588884886|FG001|Overall Study|Lost to Follow-up|2|||
163048765|NCT00003471|588884897|FG000|Overall Study|Not evaluable|4|||
163048766|NCT00715403|588884902|FG000|Overall Study|Progressive disease|0|||
163048767|NCT00715403|588884903|FG001|Overall Study|Progressive disease|1|||
163048768|NCT00715403|588884904|FG002|Overall Study|Progressive disease|3|||
163048769|NCT00715403|588884905|FG003|Overall Study|Progressive disease|9|||
163048770|NCT00715403|588884906|FG004|Overall Study|Progressive disease|5|||
163048771|NCT00715403|588884907|FG005|Overall Study|Progressive disease|14|||
163048772|NCT00715403|588884908|FG006|Overall Study|Progressive disease|1|||
163048773|NCT00715403|588884902|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048774|NCT00715403|588884903|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048775|NCT00715403|588884904|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
162707655|NCT04541186|587638301|FG002|Main Study|Adverse Event|4|||
162962230|NCT01592240|588562603|FG006|Overall Study|Lost to Follow-up|0|||
162962231|NCT01592240|588562597|FG000|Overall Study|Protocol Violation|0|||
163048776|NCT00715403|588884905|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
162707656|NCT04541186|587638302|FG003|Main Study|Adverse Event|0|||
162962232|NCT01592240|588562598|FG001|Overall Study|Protocol Violation|0|||
162962233|NCT01592240|588562599|FG002|Overall Study|Protocol Violation|0|||
162962234|NCT01592240|588562600|FG003|Overall Study|Protocol Violation|0|||
162962235|NCT01592240|588562601|FG004|Overall Study|Protocol Violation|0|||
162962236|NCT01592240|588562602|FG005|Overall Study|Protocol Violation|1|||
162962237|NCT01592240|588562603|FG006|Overall Study|Protocol Violation|0|||
163048777|NCT00715403|588884906|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
162882270|NCT01021852|588268169|FG001|Treatment Period 2|Lack of Efficacy|0|||
162882271|NCT01021852|588268170|FG002|Treatment Period 2|Lack of Efficacy|0|||
162882272|NCT01021852|588268171|FG003|Treatment Period 2|Lack of Efficacy|0|||
162882273|NCT01021852|588268172|FG004|Treatment Period 2|Lack of Efficacy|0|||
162882274|NCT01021852|588268173|FG005|Treatment Period 2|Lack of Efficacy|1|||
162882275|NCT01021852|588268174|FG006|Treatment Period 2|Lack of Efficacy|0|||
162882276|NCT01021852|588268175|FG007|Treatment Period 2|Lack of Efficacy|0|||
162882277|NCT01021852|588268168|FG000|Treatment Period 2|Physician Decision|0|||
162882278|NCT01021852|588268169|FG001|Treatment Period 2|Physician Decision|0|||
162882279|NCT01021852|588268170|FG002|Treatment Period 2|Physician Decision|1|||
162962238|NCT01592240|588562597|FG000|Overall Study|Withdrawal by Subject|0|||
162707657|NCT04541186|587638303|FG004|Main Study|Adverse Event|0|||
162707658|NCT04541186|587638299|FG000|Main Study|Investigator Decision|0|||
163048778|NCT00715403|588884907|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
163048779|NCT00715403|588884908|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
163048780|NCT00715403|588884902|FG000|Overall Study|Other Adverse Event than DLT|1|||
163048781|NCT00715403|588884903|FG001|Overall Study|Other Adverse Event than DLT|0|||
162882280|NCT01021852|588268171|FG003|Treatment Period 2|Physician Decision|0|||
162882281|NCT01021852|588268172|FG004|Treatment Period 2|Physician Decision|0|||
162882282|NCT01021852|588268173|FG005|Treatment Period 2|Physician Decision|0|||
162882283|NCT01021852|588268174|FG006|Treatment Period 2|Physician Decision|0|||
162882284|NCT01021852|588268175|FG007|Treatment Period 2|Physician Decision|0|||
162882285|NCT01021852|588268168|FG000|Treatment Period 2|Protocol Violation|0|||
162882286|NCT01021852|588268169|FG001|Treatment Period 2|Protocol Violation|0|||
162882287|NCT01021852|588268170|FG002|Treatment Period 2|Protocol Violation|0|||
162882288|NCT01021852|588268171|FG003|Treatment Period 2|Protocol Violation|0|||
162882289|NCT01021852|588268172|FG004|Treatment Period 2|Protocol Violation|1|||
162882290|NCT01021852|588268173|FG005|Treatment Period 2|Protocol Violation|0|||
162882291|NCT01021852|588268174|FG006|Treatment Period 2|Protocol Violation|1|||
162882292|NCT01021852|588268175|FG007|Treatment Period 2|Protocol Violation|0|||
162882293|NCT01021852|588268168|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162882294|NCT01021852|588268169|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162882295|NCT01021852|588268170|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162882296|NCT01021852|588268171|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162882297|NCT01021852|588268172|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162882298|NCT01021852|588268173|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162882299|NCT01021852|588268174|FG006|Treatment Period 2|Withdrawal by Subject|1|||
162882300|NCT01021852|588268175|FG007|Treatment Period 2|Withdrawal by Subject|2|||
162882301|NCT01371981|588268176|FG000|Overall Study|Adverse Event|12|||
162882302|NCT01371981|588268177|FG001|Overall Study|Adverse Event|17|||
162882303|NCT01371981|588268178|FG002|Overall Study|Adverse Event|0|||
162882304|NCT01371981|588268179|FG003|Overall Study|Adverse Event|4|||
162882305|NCT01371981|588268180|FG004|Overall Study|Adverse Event|1|||
162882306|NCT01371981|588268181|FG005|Overall Study|Adverse Event|0|||
162882307|NCT01371981|588268176|FG000|Overall Study|Death|22|||
162882308|NCT01371981|588268177|FG001|Overall Study|Death|16|||
162882309|NCT01371981|588268178|FG002|Overall Study|Death|0|||
162882310|NCT01371981|588268179|FG003|Overall Study|Death|0|||
162882311|NCT01371981|588268180|FG004|Overall Study|Death|2|||
162882312|NCT01371981|588268181|FG005|Overall Study|Death|2|||
162882313|NCT01371981|588268176|FG000|Overall Study|Lack of Efficacy|69|||
162882314|NCT01371981|588268177|FG001|Overall Study|Lack of Efficacy|61|||
162882315|NCT01371981|588268178|FG002|Overall Study|Lack of Efficacy|4|||
162882316|NCT01371981|588268179|FG003|Overall Study|Lack of Efficacy|8|||
162882317|NCT01371981|588268180|FG004|Overall Study|Lack of Efficacy|5|||
162882318|NCT01371981|588268181|FG005|Overall Study|Lack of Efficacy|0|||
162882319|NCT01371981|588268176|FG000|Overall Study|Physician Decision|48|||
162882320|NCT01371981|588268177|FG001|Overall Study|Physician Decision|63|||
162882321|NCT01371981|588268178|FG002|Overall Study|Physician Decision|1|||
162882322|NCT01371981|588268179|FG003|Overall Study|Physician Decision|7|||
162882323|NCT01371981|588268180|FG004|Overall Study|Physician Decision|14|||
162882324|NCT01371981|588268181|FG005|Overall Study|Physician Decision|3|||
162882325|NCT01371981|588268176|FG000|Overall Study|Withdrawal by Subject|12|||
162882326|NCT01371981|588268177|FG001|Overall Study|Withdrawal by Subject|19|||
162882327|NCT01371981|588268178|FG002|Overall Study|Withdrawal by Subject|1|||
162882328|NCT01371981|588268179|FG003|Overall Study|Withdrawal by Subject|2|||
162882329|NCT01371981|588268180|FG004|Overall Study|Withdrawal by Subject|10|||
162882330|NCT01371981|588268181|FG005|Overall Study|Withdrawal by Subject|3|||
162882331|NCT01371981|588268176|FG000|Overall Study|Ineligible|19|||
162882332|NCT01371981|588268177|FG001|Overall Study|Ineligible|13|||
162882333|NCT01371981|588268178|FG002|Overall Study|Ineligible|0|||
162882334|NCT01371981|588268179|FG003|Overall Study|Ineligible|0|||
162882335|NCT01371981|588268180|FG004|Overall Study|Ineligible|0|||
162882336|NCT01371981|588268181|FG005|Overall Study|Ineligible|4|||
162882337|NCT01371981|588268176|FG000|Overall Study|Did not start treatment|2|||
163048782|NCT00715403|588884904|FG002|Overall Study|Other Adverse Event than DLT|0|||
162882338|NCT01371981|588268177|FG001|Overall Study|Did not start treatment|3|||
162882339|NCT01371981|588268178|FG002|Overall Study|Did not start treatment|0|||
163048783|NCT00715403|588884905|FG003|Overall Study|Other Adverse Event than DLT|0|||
162882340|NCT01371981|588268179|FG003|Overall Study|Did not start treatment|0|||
162882341|NCT01371981|588268180|FG004|Overall Study|Did not start treatment|0|||
162882342|NCT01371981|588268181|FG005|Overall Study|Did not start treatment|2|||
162882343|NCT01025817|588268182|FG000|Completed Study Medication|Adverse Event|66|||
162882344|NCT01025817|588268183|FG001|Completed Study Medication|Adverse Event|39|||
162882345|NCT01025817|588268182|FG000|Completed Study Medication|Protocol Deviation|9|||
162882346|NCT01025817|588268183|FG001|Completed Study Medication|Protocol Deviation|8|||
162882347|NCT01025817|588268182|FG000|Completed Study Medication|Withdrawal by Subject|8|||
162882348|NCT01025817|588268183|FG001|Completed Study Medication|Withdrawal by Subject|9|||
162882349|NCT01025817|588268182|FG000|Completed Study Medication|Administrative problems|7|||
163048784|NCT00715403|588884906|FG004|Overall Study|Other Adverse Event than DLT|0|||
162882350|NCT01025817|588268183|FG001|Completed Study Medication|Administrative problems|5|||
162882351|NCT01025817|588268182|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
162882352|NCT01025817|588268183|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
162882353|NCT01025817|588268182|FG000|Completed Study Medication|Abnormal test procedure|4|||
162882354|NCT01025817|588268183|FG001|Completed Study Medication|Abnormal test procedure|0|||
162882355|NCT01025817|588268182|FG000|Completed Study Medication|Graft loss|2|||
162882356|NCT01025817|588268183|FG001|Completed Study Medication|Graft loss|5|||
162882357|NCT01025817|588268182|FG000|Completed Study Medication|Death|2|||
162882358|NCT01025817|588268183|FG001|Completed Study Medication|Death|2|||
162882359|NCT01025817|588268182|FG000|Completed Study Medication|Abnormal lab values|0|||
162882360|NCT01025817|588268183|FG001|Completed Study Medication|Abnormal lab values|2|||
162882361|NCT01025817|588268182|FG000|Completed Study Medication|Subject no longer required study drug|0|||
162882362|NCT01025817|588268183|FG001|Completed Study Medication|Subject no longer required study drug|1|||
162882363|NCT01025817|588268182|FG000|Completed Study Medication|Lost to Follow-up|0|||
162882364|NCT01025817|588268183|FG001|Completed Study Medication|Lost to Follow-up|1|||
162882365|NCT01025817|588268182|FG000|Completed Study|Withdrawal by Subject|8|||
162882366|NCT01025817|588268183|FG001|Completed Study|Withdrawal by Subject|16|||
162882367|NCT01025817|588268182|FG000|Completed Study|Death|6|||
162882368|NCT01025817|588268183|FG001|Completed Study|Death|5|||
162882369|NCT01025817|588268182|FG000|Completed Study|Missing|2|||
162882370|NCT01025817|588268183|FG001|Completed Study|Missing|0|||
162882371|NCT01025817|588268182|FG000|Completed Study|Lost to Follow-up|0|||
162882372|NCT01025817|588268183|FG001|Completed Study|Lost to Follow-up|1|||
162882373|NCT01153893|588268186|FG000|Overall Study|Adverse Event|1|||
162882374|NCT01153893|588268187|FG001|Overall Study|Adverse Event|0|||
162882375|NCT01165021|588268189|FG000|Overall Study|Death|1|||
162882376|NCT04799405|588268191|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
162962239|NCT01592240|588562598|FG001|Overall Study|Withdrawal by Subject|4|||
162962240|NCT01592240|588562599|FG002|Overall Study|Withdrawal by Subject|4|||
162962241|NCT01592240|588562600|FG003|Overall Study|Withdrawal by Subject|1|||
162962242|NCT01592240|588562601|FG004|Overall Study|Withdrawal by Subject|3|||
162962243|NCT01592240|588562602|FG005|Overall Study|Withdrawal by Subject|0|||
162962244|NCT01592240|588562603|FG006|Overall Study|Withdrawal by Subject|2|||
162962245|NCT01592240|588562597|FG000|Overall Study|Other|0|||
162962246|NCT01592240|588562598|FG001|Overall Study|Other|3|||
162962247|NCT01592240|588562599|FG002|Overall Study|Other|1|||
162962248|NCT01592240|588562600|FG003|Overall Study|Other|1|||
162962249|NCT01592240|588562601|FG004|Overall Study|Other|0|||
162962250|NCT01592240|588562602|FG005|Overall Study|Other|0|||
162962251|NCT01592240|588562603|FG006|Overall Study|Other|1|||
162962252|NCT01592240|588562597|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162962253|NCT01592240|588562598|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
162962254|NCT01592240|588562599|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
162962255|NCT01592240|588562600|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
162962256|NCT01592240|588562601|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
162962257|NCT01592240|588562602|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
162962258|NCT01592240|588562603|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
162962259|NCT00488774|588562604|FG000|Overall Study|Withdrawal of consent|2|||
162962260|NCT00488774|588562605|FG001|Overall Study|Withdrawal of consent|2|||
162962261|NCT00488774|588562606|FG002|Overall Study|Withdrawal of consent|2|||
162962262|NCT00488774|588562607|FG003|Overall Study|Withdrawal of consent|0|||
162962263|NCT00488774|588562604|FG000|Overall Study|Other|6|||
162962264|NCT00488774|588562605|FG001|Overall Study|Other|3|||
162962265|NCT00488774|588562606|FG002|Overall Study|Other|2|||
162962266|NCT00488774|588562607|FG003|Overall Study|Other|2|||
162962267|NCT00488774|588562604|FG000|Overall Study|Lost to Follow-up|0|||
162962268|NCT00488774|588562605|FG001|Overall Study|Lost to Follow-up|0|||
162962269|NCT00488774|588562606|FG002|Overall Study|Lost to Follow-up|1|||
162962270|NCT00488774|588562607|FG003|Overall Study|Lost to Follow-up|1|||
162962271|NCT05523895|588562608|FG000|Overall Study|Adverse Event|2|||
162962272|NCT05523895|588562609|FG001|Overall Study|Adverse Event|1|||
162962273|NCT05523895|588562610|FG002|Overall Study|Adverse Event|1|||
162962274|NCT05523895|588562608|FG000|Overall Study|Lost to Follow-up|0|||
162962275|NCT05523895|588562609|FG001|Overall Study|Lost to Follow-up|1|||
162962276|NCT05523895|588562610|FG002|Overall Study|Lost to Follow-up|2|||
162962277|NCT05523895|588562608|FG000|Overall Study|Noncompliance with study drug|1|||
162882377|NCT01029002|588268192|FG000|Overall Study|Lost to Follow-up|2|||
162882378|NCT01029002|588268193|FG001|Overall Study|Lost to Follow-up|4|||
162882379|NCT02683525|588268194|FG000|Overall Study|Lost to Follow-up|1|||
162962278|NCT05523895|588562609|FG001|Overall Study|Noncompliance with study drug|1|||
162882380|NCT02683525|588268194|FG000|Overall Study|Physician Decision|1|||
162962279|NCT05523895|588562610|FG002|Overall Study|Noncompliance with study drug|1|||
162962280|NCT05523895|588562608|FG000|Overall Study|Protocol Violation|0|||
162962281|NCT05523895|588562609|FG001|Overall Study|Protocol Violation|2|||
162962282|NCT05523895|588562610|FG002|Overall Study|Protocol Violation|0|||
162882381|NCT02683525|588268194|FG000|Overall Study|Disease Progression|6|||
162882382|NCT01008995|588268195|FG000|Controlled Period|Adverse Event|1|||
162882383|NCT01008995|588268196|FG001|Controlled Period|Adverse Event|2|||
162882384|NCT01008995|588268197|FG002|Controlled Period|Adverse Event|0|||
162882385|NCT01008995|588268198|FG003|Controlled Period|Adverse Event|0|||
162882386|NCT01008995|588268195|FG000|Controlled Period|Other|2|||
162882387|NCT01008995|588268196|FG001|Controlled Period|Other|1|||
162882388|NCT01008995|588268197|FG002|Controlled Period|Other|0|||
162882389|NCT01008995|588268198|FG003|Controlled Period|Other|0|||
162882390|NCT01008995|588268195|FG000|After Controlled Period|Adverse Event|0|||
162882391|NCT01008995|588268196|FG001|After Controlled Period|Adverse Event|0|||
162882392|NCT01008995|588268197|FG002|After Controlled Period|Adverse Event|1|||
162882393|NCT01008995|588268198|FG003|After Controlled Period|Adverse Event|1|||
162882394|NCT01008995|588268195|FG000|After Controlled Period|Other|0|||
162882395|NCT01008995|588268196|FG001|After Controlled Period|Other|0|||
162882396|NCT01008995|588268197|FG002|After Controlled Period|Other|1|||
162882397|NCT01008995|588268198|FG003|After Controlled Period|Other|0|||
162882398|NCT00115804|588268203|FG000|Overall Study|Adverse Event|2|||
162882399|NCT01737840|588268204|FG000|Overall Study|Diagnosed with an other pathology|2|||
162882400|NCT01737840|588268205|FG001|Overall Study|Diagnosed with an other pathology|2|||
162882401|NCT00547378|588268208|FG000|Randomized Cohort|Withdrawal by Subject|7|||
162882402|NCT00547378|588268209|FG001|Randomized Cohort|Withdrawal by Subject|5|||
162882403|NCT00547378|588268210|FG002|Randomized Cohort|Withdrawal by Subject|0|||
162882404|NCT00547378|588268208|FG000|Randomized Cohort|Death|0|||
162882405|NCT00547378|588268209|FG001|Randomized Cohort|Death|1|||
162882406|NCT00547378|588268210|FG002|Randomized Cohort|Death|0|||
162882407|NCT00547378|588268208|FG000|Randomized Cohort|Lost to Follow-up|1|||
162882408|NCT00547378|588268209|FG001|Randomized Cohort|Lost to Follow-up|0|||
162882409|NCT00547378|588268210|FG002|Randomized Cohort|Lost to Follow-up|0|||
162882410|NCT00547378|588268208|FG000|Randomized Cohort|Adverse Event|1|||
162882411|NCT00547378|588268209|FG001|Randomized Cohort|Adverse Event|0|||
162882412|NCT00547378|588268210|FG002|Randomized Cohort|Adverse Event|0|||
162882413|NCT00547378|588268208|FG000|Randomized Cohort|Other reasons|2|||
162882414|NCT00547378|588268209|FG001|Randomized Cohort|Other reasons|0|||
162882415|NCT00547378|588268210|FG002|Randomized Cohort|Other reasons|0|||
162882416|NCT00547378|588268208|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
162882417|NCT00547378|588268209|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
162882418|NCT00547378|588268210|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
163048785|NCT00715403|588884907|FG005|Overall Study|Other Adverse Event than DLT|2|||
163048786|NCT00715403|588884908|FG006|Overall Study|Other Adverse Event than DLT|0|||
163048787|NCT00715403|588884902|FG000|Overall Study|Protocol Violation|0|||
163048788|NCT00715403|588884903|FG001|Overall Study|Protocol Violation|0|||
163048789|NCT00715403|588884904|FG002|Overall Study|Protocol Violation|0|||
163048790|NCT00715403|588884905|FG003|Overall Study|Protocol Violation|0|||
163048791|NCT00715403|588884906|FG004|Overall Study|Protocol Violation|0|||
163048792|NCT00715403|588884907|FG005|Overall Study|Protocol Violation|1|||
163048793|NCT00715403|588884908|FG006|Overall Study|Protocol Violation|0|||
163048794|NCT00715403|588884902|FG000|Overall Study|Other reason not defined above|0|||
163048795|NCT00715403|588884903|FG001|Overall Study|Other reason not defined above|0|||
163048796|NCT00715403|588884904|FG002|Overall Study|Other reason not defined above|1|||
163048797|NCT00715403|588884905|FG003|Overall Study|Other reason not defined above|0|||
163048798|NCT00715403|588884906|FG004|Overall Study|Other reason not defined above|1|||
163048799|NCT00715403|588884907|FG005|Overall Study|Other reason not defined above|1|||
163048800|NCT00715403|588884908|FG006|Overall Study|Other reason not defined above|0|||
163048801|NCT01386606|588886888|FG000|Overall Study|Adverse Event|0|||
163048802|NCT01386606|588886889|FG001|Overall Study|Adverse Event|1|||
163048803|NCT01386606|588886890|FG002|Overall Study|Adverse Event|0|||
163048804|NCT01386606|588886891|FG003|Overall Study|Adverse Event|0|||
163048805|NCT01386606|588886888|FG000|Overall Study|Withdrawal by Subject|0|||
163048806|NCT01386606|588886889|FG001|Overall Study|Withdrawal by Subject|1|||
163048807|NCT01386606|588886890|FG002|Overall Study|Withdrawal by Subject|1|||
163048808|NCT01386606|588886891|FG003|Overall Study|Withdrawal by Subject|0|||
163048809|NCT01386606|588886888|FG000|Overall Study|Protocol Violation|1|||
163048810|NCT01386606|588886889|FG001|Overall Study|Protocol Violation|0|||
162882419|NCT00547378|588268208|FG000|All Implanted Cohort|Adverse Event|4|||
162882420|NCT00547378|588268209|FG001|All Implanted Cohort|Adverse Event|10|||
163048811|NCT01386606|588886890|FG002|Overall Study|Protocol Violation|1|||
163048812|NCT01386606|588886891|FG003|Overall Study|Protocol Violation|1|||
163048813|NCT01386606|588886888|FG000|Overall Study|Lost to Follow-up|2|||
163048814|NCT01386606|588886889|FG001|Overall Study|Lost to Follow-up|0|||
163048815|NCT01386606|588886890|FG002|Overall Study|Lost to Follow-up|0|||
162882421|NCT00547378|588268210|FG002|All Implanted Cohort|Adverse Event|17|||
162882422|NCT00547378|588268208|FG000|All Implanted Cohort|Lost to Follow-up|0|||
162882423|NCT00547378|588268209|FG001|All Implanted Cohort|Lost to Follow-up|1|||
162882424|NCT00547378|588268210|FG002|All Implanted Cohort|Lost to Follow-up|14|||
162882425|NCT00547378|588268208|FG000|All Implanted Cohort|Death|3|||
163048816|NCT01386606|588886891|FG003|Overall Study|Lost to Follow-up|0|||
163048817|NCT01386606|588886888|FG000|Overall Study|Subject incarcerated|0|||
162962283|NCT05523895|588562608|FG000|Overall Study|Withdrawal by Subject|1|||
162962284|NCT05523895|588562609|FG001|Overall Study|Withdrawal by Subject|3|||
162962285|NCT05523895|588562610|FG002|Overall Study|Withdrawal by Subject|1|||
162962286|NCT05523895|588562608|FG000|Overall Study|Not further specified|0|||
162962287|NCT05523895|588562609|FG001|Overall Study|Not further specified|3|||
162962288|NCT05523895|588562610|FG002|Overall Study|Not further specified|1|||
162962289|NCT03674892|588562611|FG000|Overall Study|Lack of Efficacy|5|||
162962290|NCT03674892|588562611|FG000|Overall Study|Lost to Follow-up|3|||
162962291|NCT03674892|588562611|FG000|Overall Study|Migraine|2|||
162962292|NCT03674892|588562611|FG000|Overall Study|Excessive Tearing|1|||
162962293|NCT03674892|588562611|FG000|Overall Study|Increased Eye Pain|1|||
162962294|NCT03674892|588562611|FG000|Overall Study|Increased Facial Pain|1|||
162962295|NCT03674892|588562611|FG000|Overall Study|Sinus Irritation|1|||
162962296|NCT03674892|588562611|FG000|Overall Study|Sinus Infection|1|||
162962297|NCT05099380|588562612|FG000|Overall Study|Subject enrolled in error|1|||
162962298|NCT05099380|588562613|FG001|Overall Study|Subject enrolled in error|0|||
162962299|NCT05099380|588562612|FG000|Overall Study|Study Procedure|1|||
162962300|NCT05099380|588562613|FG001|Overall Study|Study Procedure|0|||
162962301|NCT05099380|588562612|FG000|Overall Study|Protocol Violation|1|||
162962302|NCT05099380|588562613|FG001|Overall Study|Protocol Violation|0|||
162962303|NCT05099380|588562612|FG000|Overall Study|Adverse Event|1|||
162962304|NCT05099380|588562613|FG001|Overall Study|Adverse Event|1|||
162962305|NCT05099380|588562612|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
162962306|NCT05099380|588562613|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
163048818|NCT01386606|588886889|FG001|Overall Study|Subject incarcerated|1|||
163048819|NCT01386606|588886890|FG002|Overall Study|Subject incarcerated|0|||
163048820|NCT01386606|588886891|FG003|Overall Study|Subject incarcerated|0|||
163048821|NCT01386606|588886888|FG000|Overall Study|Unable to draw PK|1|||
163048822|NCT01386606|588886889|FG001|Overall Study|Unable to draw PK|0|||
163048823|NCT01386606|588886890|FG002|Overall Study|Unable to draw PK|0|||
163048824|NCT01386606|588886891|FG003|Overall Study|Unable to draw PK|0|||
163048825|NCT01386606|588886888|FG000|Overall Study|T levels too high|0|||
163048826|NCT01386606|588886889|FG001|Overall Study|T levels too high|1|||
163048827|NCT01386606|588886890|FG002|Overall Study|T levels too high|1|||
163048828|NCT01386606|588886891|FG003|Overall Study|T levels too high|0|||
163048829|NCT00593814|588886893|FG000|Overall Study|Death|7|||
163048830|NCT00593814|588886894|FG001|Overall Study|Death|0|||
163048831|NCT00593814|588886893|FG000|Overall Study|Withdrawal by Subject|7|||
163048832|NCT00593814|588886894|FG001|Overall Study|Withdrawal by Subject|0|||
163048833|NCT00593814|588886893|FG000|Overall Study|Lost to Follow-up|7|||
163048834|NCT00593814|588886894|FG001|Overall Study|Lost to Follow-up|0|||
163048835|NCT00593814|588886893|FG000|Overall Study|Physician Decision|3|||
163048836|NCT00593814|588886894|FG001|Overall Study|Physician Decision|0|||
163048837|NCT02723188|588886897|FG000|Overall Study|Withdrawal by Subject|1|||
163048838|NCT02723188|588886898|FG001|Overall Study|Withdrawal by Subject|0|||
163048839|NCT02723188|588886899|FG002|Overall Study|Withdrawal by Subject|0|||
163048840|NCT03110354|588886903|FG000|Overall Study|Death|1|||
163048841|NCT03110354|588886904|FG001|Overall Study|Death|0|||
163048842|NCT03110354|588886905|FG002|Overall Study|Death|0|||
163048843|NCT03110354|588886906|FG003|Overall Study|Death|1|||
163048844|NCT03110354|588886907|FG004|Overall Study|Death|0|||
163048845|NCT03110354|588886903|FG000|Overall Study|Start of new therapy|0|||
163048846|NCT03110354|588886904|FG001|Overall Study|Start of new therapy|0|||
163048847|NCT03110354|588886905|FG002|Overall Study|Start of new therapy|0|||
163048848|NCT03110354|588886906|FG003|Overall Study|Start of new therapy|0|||
163048849|NCT03110354|588886907|FG004|Overall Study|Start of new therapy|1|||
163048850|NCT03110354|588886903|FG000|Overall Study|Failure to achieve response|2|||
163048851|NCT03110354|588886904|FG001|Overall Study|Failure to achieve response|3|||
163048852|NCT03110354|588886905|FG002|Overall Study|Failure to achieve response|0|||
163048853|NCT03110354|588886906|FG003|Overall Study|Failure to achieve response|2|||
163048854|NCT03110354|588886907|FG004|Overall Study|Failure to achieve response|1|||
163048855|NCT03110354|588886903|FG000|Overall Study|Progressive disease|1|||
162962307|NCT03276754|588562616|FG000|Overall Study|Withdrawal of informed consent|4|||
163048856|NCT03110354|588886904|FG001|Overall Study|Progressive disease|1|||
162962308|NCT03276754|588562616|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
162962309|NCT03276754|588562616|FG000|Overall Study|Lost to Follow-up|27|||
162962310|NCT03276754|588562616|FG000|Overall Study|No data reported at Month 24|31|||
163048857|NCT03110354|588886905|FG002|Overall Study|Progressive disease|3|||
163048858|NCT03110354|588886906|FG003|Overall Study|Progressive disease|4|||
162962311|NCT03276754|588562616|FG000|Overall Study|Death|39|||
162962312|NCT00545792|588562617|FG000|Overall Study|Withdrawal by Subject|1|||
162962313|NCT05041361|588562618|FG000|Overall Study|Lost to Follow-up|1|||
163048859|NCT03110354|588886907|FG004|Overall Study|Progressive disease|2|||
163048860|NCT03110354|588886903|FG000|Overall Study|Adverse Event|0|||
163048861|NCT03110354|588886904|FG001|Overall Study|Adverse Event|0|||
163048862|NCT03110354|588886905|FG002|Overall Study|Adverse Event|0|||
163048863|NCT03110354|588886906|FG003|Overall Study|Adverse Event|2|||
163048864|NCT03110354|588886907|FG004|Overall Study|Adverse Event|2|||
163048865|NCT03110354|588886903|FG000|Overall Study|Other|0|||
163048866|NCT03110354|588886904|FG001|Overall Study|Other|0|||
163048867|NCT03110354|588886905|FG002|Overall Study|Other|0|||
163048868|NCT03110354|588886906|FG003|Overall Study|Other|1|||
163048869|NCT03110354|588886907|FG004|Overall Study|Other|1|||
163048870|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
162882426|NCT00547378|588268209|FG001|All Implanted Cohort|Death|1|||
162882427|NCT00547378|588268210|FG002|All Implanted Cohort|Death|4|||
162882428|NCT00547378|588268208|FG000|All Implanted Cohort|Physician Decision|0|||
162882429|NCT00547378|588268209|FG001|All Implanted Cohort|Physician Decision|2|||
162882430|NCT00547378|588268210|FG002|All Implanted Cohort|Physician Decision|6|||
163048871|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
163048872|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
163048873|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
163048874|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
163048875|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
163048876|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
163048877|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
163048878|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
163048879|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
163048880|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
163048881|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
163048882|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
163048883|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
163048884|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
163048885|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
163048886|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
163048887|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
163048888|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
163048889|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
163048890|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
162707659|NCT04541186|587638300|FG001|Main Study|Investigator Decision|0|||
162882431|NCT00547378|588268208|FG000|All Implanted Cohort|Site closure|2|||
162882432|NCT00547378|588268209|FG001|All Implanted Cohort|Site closure|0|||
162882433|NCT00547378|588268210|FG002|All Implanted Cohort|Site closure|1|||
162882434|NCT00547378|588268208|FG000|All Implanted Cohort|Other reasons|1|||
163048891|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
163048892|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
163048893|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
163048894|NCT01198002|588886914|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
163048895|NCT01198002|588886915|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
163048896|NCT01198002|588886916|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
163048897|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
163048898|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
163048899|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
163048900|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
163048901|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
163048902|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
163048903|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
163048904|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
163048905|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
163048906|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
163048907|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
163048908|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
163048909|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
163048910|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
163048911|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
163048912|NCT01198002|588886914|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
163048913|NCT01198002|588886915|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
163048914|NCT01198002|588886916|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
163048915|NCT01307787|588886917|FG000|Overall Study|Withdrawal by Subject|2|||
163048916|NCT01307787|588886918|FG001|Overall Study|Withdrawal by Subject|0|||
163048917|NCT03353792|588886922|FG000|Overall Study|Lost to Follow-up|1|||
163048918|NCT03353792|588886923|FG001|Overall Study|Lost to Follow-up|0|||
163048919|NCT03353792|588886922|FG000|Overall Study|Participant Unable to Manage Device|1|||
163048920|NCT03353792|588886923|FG001|Overall Study|Participant Unable to Manage Device|0|||
163048921|NCT01965327|588886924|FG000|Overall Study|Physician Decision|2|||
163048922|NCT02452047|588886926|FG000|Overall Study|Adverse Event|0|||
163048923|NCT02452047|588886927|FG001|Overall Study|Adverse Event|1|||
163048924|NCT02452047|588886928|FG002|Overall Study|Adverse Event|1|||
163048925|NCT02452047|588886926|FG000|Overall Study|Death|1|||
163048926|NCT02452047|588886927|FG001|Overall Study|Death|3|||
163048927|NCT02452047|588886928|FG002|Overall Study|Death|1|||
163048928|NCT02452047|588886926|FG000|Overall Study|Physician Decision|1|||
163048929|NCT02452047|588886927|FG001|Overall Study|Physician Decision|0|||
163048930|NCT02452047|588886928|FG002|Overall Study|Physician Decision|0|||
163048931|NCT02452047|588886926|FG000|Overall Study|Lost to Follow-up|1|||
163048932|NCT02452047|588886927|FG001|Overall Study|Lost to Follow-up|1|||
163048933|NCT02452047|588886928|FG002|Overall Study|Lost to Follow-up|0|||
163048934|NCT02452047|588886926|FG000|Overall Study|Withdrawal by Subject|1|||
163048935|NCT02452047|588886927|FG001|Overall Study|Withdrawal by Subject|0|||
163048936|NCT02452047|588886928|FG002|Overall Study|Withdrawal by Subject|0|||
163048937|NCT02185417|588886931|FG000|Overall Study|Death|448|||
163048938|NCT02185417|588886932|FG001|Overall Study|Death|446|||
163048939|NCT02185417|588886933|FG002|Overall Study|Death|0|||
163048940|NCT02185417|588886931|FG000|Overall Study|Withdrawal by Subject|7|||
163048941|NCT02185417|588886932|FG001|Overall Study|Withdrawal by Subject|12|||
163048942|NCT02185417|588886933|FG002|Overall Study|Withdrawal by Subject|0|||
163048943|NCT03131167|588886936|FG000|Overall Study|Other (Unspecified)|0|||
163048944|NCT03131167|588886937|FG001|Overall Study|Other (Unspecified)|0|||
163048945|NCT03131167|588886938|FG002|Overall Study|Other (Unspecified)|0|||
163048946|NCT03131167|588886939|FG003|Overall Study|Other (Unspecified)|0|||
163048947|NCT03131167|588886940|FG004|Overall Study|Other (Unspecified)|0|||
163048948|NCT03131167|588886941|FG005|Overall Study|Other (Unspecified)|1|||
162882435|NCT00547378|588268209|FG001|All Implanted Cohort|Other reasons|0|||
162882436|NCT00547378|588268210|FG002|All Implanted Cohort|Other reasons|1|||
162882437|NCT01449682|588268211|FG000|Overall Study|Death|0|||
162882438|NCT01449682|588268212|FG001|Overall Study|Death|1|||
162882439|NCT01449682|588268211|FG000|Overall Study|Adverse Event|1|||
162882440|NCT01449682|588268212|FG001|Overall Study|Adverse Event|0|||
162882441|NCT04863014|588268213|FG000|Overall Study|Lost to Follow-up|3|||
162882442|NCT04863014|588268214|FG001|Overall Study|Lost to Follow-up|2|||
162882443|NCT04863014|588268213|FG000|Overall Study|Subject Decision|0|||
162882444|NCT04863014|588268214|FG001|Overall Study|Subject Decision|4|||
162882445|NCT04633473|588268215|FG000|Overall Study|Withdrawal by Subject|6|||
162882446|NCT01822691|588268220|FG000|Overall Study|Withdrawal by Subject|2|||
162882447|NCT00819585|588268221|FG000|Core Study|Adverse Event|2|||
162882448|NCT00819585|588268222|FG001|Core Study|Adverse Event|1|||
162882449|NCT00819585|588268223|FG002|Core Study|Adverse Event|1|||
162882450|NCT00819585|588268224|FG003|Core Study|Adverse Event|4|||
162882451|NCT00819585|588268225|FG004|Core Study|Adverse Event|1|||
162882452|NCT00819585|588268226|FG005|Core Study|Adverse Event|0|||
162882453|NCT00819585|588268227|FG006|Core Study|Adverse Event|2|||
162882454|NCT00819585|588268228|FG007|Core Study|Adverse Event|0|||
162882455|NCT00819585|588268229|FG008|Core Study|Adverse Event|0|||
162882456|NCT00819585|588268230|FG009|Core Study|Adverse Event|0|||
162882457|NCT00819585|588268231|FG010|Core Study|Adverse Event|0|||
162882458|NCT00819585|588268221|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
162882459|NCT00819585|588268222|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
162882460|NCT00819585|588268223|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
162882461|NCT00819585|588268224|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
162882462|NCT00819585|588268225|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
162882463|NCT00819585|588268226|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
162882464|NCT00819585|588268227|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
162882465|NCT00819585|588268228|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
162882466|NCT00819585|588268229|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
162882467|NCT00819585|588268230|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
162882468|NCT00819585|588268231|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
162882469|NCT00819585|588268221|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882470|NCT00819585|588268222|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
162882471|NCT00819585|588268223|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882472|NCT00819585|588268224|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882473|NCT00819585|588268225|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882474|NCT00819585|588268226|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882475|NCT00819585|588268227|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
162882476|NCT00819585|588268228|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882477|NCT00819585|588268229|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882478|NCT00819585|588268230|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
163048949|NCT03131167|588886942|FG006|Overall Study|Other (Unspecified)|0|||
162882479|NCT00819585|588268231|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
162882480|NCT00819585|588268221|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
162882481|NCT00819585|588268222|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
162882482|NCT00819585|588268223|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
162882483|NCT00819585|588268224|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
163048950|NCT03131167|588886943|FG007|Overall Study|Other (Unspecified)|0|||
162882484|NCT00819585|588268225|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
162882485|NCT00819585|588268226|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
162882486|NCT00819585|588268227|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
162882487|NCT00819585|588268228|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
162882488|NCT00819585|588268229|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
162882489|NCT00819585|588268230|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
163048951|NCT03131167|588886944|FG008|Overall Study|Other (Unspecified)|0|||
163048952|NCT03131167|588886945|FG009|Overall Study|Other (Unspecified)|0|||
162882490|NCT00819585|588268231|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
162882491|NCT00819585|588268221|FG000|Core Study|Subject Withdrew Consent|0|||
162882492|NCT00819585|588268222|FG001|Core Study|Subject Withdrew Consent|3|||
162882493|NCT00819585|588268223|FG002|Core Study|Subject Withdrew Consent|2|||
162882494|NCT00819585|588268224|FG003|Core Study|Subject Withdrew Consent|1|||
162882495|NCT00819585|588268225|FG004|Core Study|Subject Withdrew Consent|0|||
162882496|NCT00819585|588268226|FG005|Core Study|Subject Withdrew Consent|0|||
162882497|NCT00819585|588268227|FG006|Core Study|Subject Withdrew Consent|3|||
162882498|NCT00819585|588268228|FG007|Core Study|Subject Withdrew Consent|0|||
162882499|NCT00819585|588268229|FG008|Core Study|Subject Withdrew Consent|0|||
162882500|NCT00819585|588268230|FG009|Core Study|Subject Withdrew Consent|0|||
162882501|NCT00819585|588268231|FG010|Core Study|Subject Withdrew Consent|0|||
162882502|NCT00819585|588268221|FG000|Core Study|Lost to Follow-up|2|||
162882503|NCT00819585|588268222|FG001|Core Study|Lost to Follow-up|1|||
162882504|NCT00819585|588268223|FG002|Core Study|Lost to Follow-up|2|||
162882505|NCT00819585|588268224|FG003|Core Study|Lost to Follow-up|0|||
162882506|NCT00819585|588268225|FG004|Core Study|Lost to Follow-up|1|||
162882507|NCT00819585|588268226|FG005|Core Study|Lost to Follow-up|1|||
162882508|NCT00819585|588268227|FG006|Core Study|Lost to Follow-up|1|||
162882509|NCT00819585|588268228|FG007|Core Study|Lost to Follow-up|0|||
162882510|NCT00819585|588268229|FG008|Core Study|Lost to Follow-up|0|||
162882511|NCT00819585|588268230|FG009|Core Study|Lost to Follow-up|0|||
162882512|NCT00819585|588268231|FG010|Core Study|Lost to Follow-up|0|||
162882513|NCT00819585|588268221|FG000|Core Study|Administrative Problems|0|||
162882514|NCT00819585|588268222|FG001|Core Study|Administrative Problems|0|||
162882515|NCT00819585|588268223|FG002|Core Study|Administrative Problems|0|||
162882516|NCT00819585|588268224|FG003|Core Study|Administrative Problems|0|||
162882517|NCT00819585|588268225|FG004|Core Study|Administrative Problems|0|||
162882518|NCT00819585|588268226|FG005|Core Study|Administrative Problems|0|||
162882519|NCT00819585|588268227|FG006|Core Study|Administrative Problems|2|||
162882520|NCT00819585|588268228|FG007|Core Study|Administrative Problems|0|||
162882521|NCT00819585|588268229|FG008|Core Study|Administrative Problems|0|||
162882522|NCT00819585|588268230|FG009|Core Study|Administrative Problems|0|||
162882523|NCT00819585|588268231|FG010|Core Study|Administrative Problems|0|||
162882524|NCT00819585|588268221|FG000|Core Study|Death|0|||
162882525|NCT00819585|588268222|FG001|Core Study|Death|0|||
162882526|NCT00819585|588268223|FG002|Core Study|Death|0|||
162882527|NCT00819585|588268224|FG003|Core Study|Death|0|||
162882528|NCT00819585|588268225|FG004|Core Study|Death|0|||
162882529|NCT00819585|588268226|FG005|Core Study|Death|0|||
162882530|NCT00819585|588268227|FG006|Core Study|Death|1|||
162882531|NCT00819585|588268228|FG007|Core Study|Death|0|||
162882532|NCT00819585|588268229|FG008|Core Study|Death|0|||
162882533|NCT00819585|588268230|FG009|Core Study|Death|0|||
162882534|NCT00819585|588268231|FG010|Core Study|Death|0|||
162882535|NCT00819585|588268221|FG000|Core Study|Protocol Violation|0|||
162882536|NCT00819585|588268222|FG001|Core Study|Protocol Violation|0|||
162882537|NCT00819585|588268223|FG002|Core Study|Protocol Violation|1|||
162882538|NCT00819585|588268224|FG003|Core Study|Protocol Violation|0|||
162882539|NCT00819585|588268225|FG004|Core Study|Protocol Violation|0|||
162882540|NCT00819585|588268226|FG005|Core Study|Protocol Violation|1|||
162882541|NCT00819585|588268227|FG006|Core Study|Protocol Violation|3|||
162882542|NCT00819585|588268228|FG007|Core Study|Protocol Violation|0|||
162882543|NCT00819585|588268229|FG008|Core Study|Protocol Violation|0|||
162882544|NCT00819585|588268230|FG009|Core Study|Protocol Violation|0|||
162882545|NCT00819585|588268231|FG010|Core Study|Protocol Violation|0|||
162882546|NCT00819585|588268221|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
162882547|NCT00819585|588268222|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
162882548|NCT00819585|588268223|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
162882549|NCT00819585|588268224|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
162882550|NCT00819585|588268225|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
162882551|NCT00819585|588268226|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
162882552|NCT00819585|588268227|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
162882553|NCT00819585|588268228|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
162882554|NCT00819585|588268229|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
162882555|NCT00819585|588268230|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
162882556|NCT00819585|588268231|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
162882557|NCT00819585|588268221|FG000|Extension Study|Subject Withdrew Consent|0|||
162882558|NCT00819585|588268222|FG001|Extension Study|Subject Withdrew Consent|0|||
162962314|NCT05041361|588562619|FG001|Overall Study|Lost to Follow-up|3|||
162962315|NCT01642277|588562620|FG000|Overall Study|Adverse Event|10|||
162882559|NCT00819585|588268223|FG002|Extension Study|Subject Withdrew Consent|0|||
162882560|NCT00819585|588268224|FG003|Extension Study|Subject Withdrew Consent|0|||
162882561|NCT00819585|588268225|FG004|Extension Study|Subject Withdrew Consent|0|||
162882562|NCT00819585|588268226|FG005|Extension Study|Subject Withdrew Consent|0|||
162882563|NCT00819585|588268227|FG006|Extension Study|Subject Withdrew Consent|0|||
162882564|NCT00819585|588268228|FG007|Extension Study|Subject Withdrew Consent|0|||
162882565|NCT00819585|588268229|FG008|Extension Study|Subject Withdrew Consent|3|||
162962316|NCT01642277|588562621|FG001|Overall Study|Adverse Event|0|||
163048953|NCT03131167|588886946|FG010|Overall Study|Other (Unspecified)|0|||
163048954|NCT03131167|588886947|FG011|Overall Study|Other (Unspecified)|0|||
163048955|NCT03131167|588886948|FG012|Overall Study|Other (Unspecified)|0|||
163048956|NCT00243919|588886961|FG000|Overall Study|Death|3|||
163048957|NCT00243919|588886962|FG001|Overall Study|Death|4|||
163048958|NCT00243919|588886963|FG002|Overall Study|Death|6|||
163048959|NCT00243919|588886961|FG000|Overall Study|Withdrawal by Subject|6|||
163048960|NCT00243919|588886962|FG001|Overall Study|Withdrawal by Subject|6|||
163048961|NCT00243919|588886963|FG002|Overall Study|Withdrawal by Subject|2|||
163048962|NCT00243919|588886961|FG000|Overall Study|Lost to Follow-up|6|||
163048963|NCT00243919|588886962|FG001|Overall Study|Lost to Follow-up|7|||
163048964|NCT00243919|588886963|FG002|Overall Study|Lost to Follow-up|3|||
163048965|NCT00243919|588886961|FG000|Overall Study|Administrative Error|1|||
163048966|NCT00243919|588886962|FG001|Overall Study|Administrative Error|0|||
163048967|NCT00243919|588886963|FG002|Overall Study|Administrative Error|0|||
163048968|NCT00243919|588886961|FG000|Overall Study|Physician Decision|1|||
163048969|NCT00243919|588886962|FG001|Overall Study|Physician Decision|1|||
163048970|NCT00243919|588886963|FG002|Overall Study|Physician Decision|0|||
163048971|NCT04176939|588886968|FG000|Overall Study|Withdrawal by Subject|5|||
163048972|NCT04176939|588886968|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
163048973|NCT04176939|588886968|FG000|Overall Study|Lost to Follow-up|2|||
163048974|NCT04176939|588886968|FG000|Overall Study|Unspecified reason|4|||
163048975|NCT04176939|588886968|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
163048976|NCT02157519|588886969|FG000|Overall Study|Death|3|||
163048977|NCT02157519|588886970|FG001|Overall Study|Death|1|||
163048978|NCT02157519|588886969|FG000|Overall Study|Withdrawal by Subject|7|||
163048979|NCT02157519|588886970|FG001|Overall Study|Withdrawal by Subject|0|||
163048980|NCT02157519|588886969|FG000|Overall Study|Lost to Follow-up|1|||
163048981|NCT02157519|588886970|FG001|Overall Study|Lost to Follow-up|0|||
163048982|NCT01656395|588886971|FG000|Overall Study|Adverse Event|1|||
163048983|NCT01656395|588886972|FG001|Overall Study|Adverse Event|14|||
163048984|NCT01656395|588886973|FG002|Overall Study|Adverse Event|5|||
163048985|NCT01656395|588886974|FG003|Overall Study|Adverse Event|4|||
163048986|NCT01656395|588886975|FG004|Overall Study|Adverse Event|5|||
163048987|NCT01656395|588886976|FG005|Overall Study|Adverse Event|7|||
163048988|NCT01656395|588886977|FG006|Overall Study|Adverse Event|0|||
163048989|NCT01656395|588886978|FG007|Overall Study|Adverse Event|0|||
163048990|NCT01656395|588886971|FG000|Overall Study|Lack of Efficacy|1|||
163048991|NCT01656395|588886972|FG001|Overall Study|Lack of Efficacy|8|||
163048992|NCT01656395|588886973|FG002|Overall Study|Lack of Efficacy|6|||
163048993|NCT01656395|588886974|FG003|Overall Study|Lack of Efficacy|1|||
163048994|NCT01656395|588886975|FG004|Overall Study|Lack of Efficacy|1|||
163048995|NCT01656395|588886976|FG005|Overall Study|Lack of Efficacy|6|||
163048996|NCT01656395|588886977|FG006|Overall Study|Lack of Efficacy|0|||
163048997|NCT01656395|588886978|FG007|Overall Study|Lack of Efficacy|0|||
163048998|NCT01656395|588886971|FG000|Overall Study|Lost to Follow-up|1|||
163048999|NCT01656395|588886972|FG001|Overall Study|Lost to Follow-up|0|||
163049000|NCT01656395|588886973|FG002|Overall Study|Lost to Follow-up|0|||
163049001|NCT01656395|588886974|FG003|Overall Study|Lost to Follow-up|0|||
163049002|NCT01656395|588886975|FG004|Overall Study|Lost to Follow-up|0|||
163049003|NCT01656395|588886976|FG005|Overall Study|Lost to Follow-up|0|||
163049004|NCT01656395|588886977|FG006|Overall Study|Lost to Follow-up|0|||
163049005|NCT01656395|588886978|FG007|Overall Study|Lost to Follow-up|0|||
163049006|NCT01656395|588886971|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163049007|NCT01656395|588886972|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163049008|NCT01656395|588886973|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163049009|NCT01656395|588886974|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163049010|NCT01656395|588886975|FG004|Overall Study|Non-Compliance with Study Drug|1|||
163049011|NCT01656395|588886976|FG005|Overall Study|Non-Compliance with Study Drug|1|||
163049012|NCT01656395|588886977|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163049013|NCT01656395|588886978|FG007|Overall Study|Non-Compliance with Study Drug|0|||
163049014|NCT01656395|588886971|FG000|Overall Study|Other|0|||
163049015|NCT01656395|588886972|FG001|Overall Study|Other|0|||
163049016|NCT01656395|588886973|FG002|Overall Study|Other|1|||
163049017|NCT01656395|588886974|FG003|Overall Study|Other|0|||
163049018|NCT01656395|588886975|FG004|Overall Study|Other|0|||
163049019|NCT01656395|588886976|FG005|Overall Study|Other|1|||
163049020|NCT01656395|588886977|FG006|Overall Study|Other|0|||
163049021|NCT01656395|588886978|FG007|Overall Study|Other|0|||
163049022|NCT01656395|588886971|FG000|Overall Study|Physician Decision|2|||
163049023|NCT01656395|588886972|FG001|Overall Study|Physician Decision|3|||
163049024|NCT01656395|588886973|FG002|Overall Study|Physician Decision|3|||
163049025|NCT01656395|588886974|FG003|Overall Study|Physician Decision|2|||
163049026|NCT01656395|588886975|FG004|Overall Study|Physician Decision|3|||
163049027|NCT01656395|588886976|FG005|Overall Study|Physician Decision|3|||
163049028|NCT01656395|588886977|FG006|Overall Study|Physician Decision|0|||
163049029|NCT01656395|588886978|FG007|Overall Study|Physician Decision|0|||
163049030|NCT01656395|588886971|FG000|Overall Study|Pregnancy|0|||
163049031|NCT01656395|588886972|FG001|Overall Study|Pregnancy|0|||
163049032|NCT01656395|588886973|FG002|Overall Study|Pregnancy|1|||
163049033|NCT01656395|588886974|FG003|Overall Study|Pregnancy|0|||
163049034|NCT01656395|588886975|FG004|Overall Study|Pregnancy|0|||
163049035|NCT01656395|588886976|FG005|Overall Study|Pregnancy|0|||
163049036|NCT01656395|588886977|FG006|Overall Study|Pregnancy|0|||
163049037|NCT01656395|588886978|FG007|Overall Study|Pregnancy|0|||
163049038|NCT01656395|588886971|FG000|Overall Study|Progressive Disease|0|||
163049039|NCT01656395|588886972|FG001|Overall Study|Progressive Disease|0|||
163049040|NCT01656395|588886973|FG002|Overall Study|Progressive Disease|0|||
163049041|NCT01656395|588886974|FG003|Overall Study|Progressive Disease|0|||
163049042|NCT01656395|588886975|FG004|Overall Study|Progressive Disease|0|||
163049043|NCT01656395|588886976|FG005|Overall Study|Progressive Disease|1|||
163049044|NCT01656395|588886977|FG006|Overall Study|Progressive Disease|0|||
163049045|NCT01656395|588886978|FG007|Overall Study|Progressive Disease|0|||
163049046|NCT01656395|588886971|FG000|Overall Study|Protocol Violation|6|||
163049047|NCT01656395|588886972|FG001|Overall Study|Protocol Violation|6|||
163049048|NCT01656395|588886973|FG002|Overall Study|Protocol Violation|9|||
163049049|NCT01656395|588886974|FG003|Overall Study|Protocol Violation|2|||
163049050|NCT01656395|588886975|FG004|Overall Study|Protocol Violation|4|||
163049051|NCT01656395|588886976|FG005|Overall Study|Protocol Violation|10|||
163049052|NCT01656395|588886977|FG006|Overall Study|Protocol Violation|0|||
163049053|NCT01656395|588886978|FG007|Overall Study|Protocol Violation|0|||
163049054|NCT01656395|588886971|FG000|Overall Study|Screen Failure|2|||
163049055|NCT01656395|588886972|FG001|Overall Study|Screen Failure|1|||
163049056|NCT01656395|588886973|FG002|Overall Study|Screen Failure|7|||
163049057|NCT01656395|588886974|FG003|Overall Study|Screen Failure|1|||
163049058|NCT01656395|588886975|FG004|Overall Study|Screen Failure|0|||
163049059|NCT01656395|588886976|FG005|Overall Study|Screen Failure|8|||
163049060|NCT01656395|588886977|FG006|Overall Study|Screen Failure|0|||
163049061|NCT01656395|588886978|FG007|Overall Study|Screen Failure|0|||
163049062|NCT01656395|588886971|FG000|Overall Study|Withdrawal by Subject|3|||
163049063|NCT01656395|588886972|FG001|Overall Study|Withdrawal by Subject|1|||
163049064|NCT01656395|588886973|FG002|Overall Study|Withdrawal by Subject|4|||
163049065|NCT01656395|588886974|FG003|Overall Study|Withdrawal by Subject|2|||
163049066|NCT01656395|588886975|FG004|Overall Study|Withdrawal by Subject|0|||
163049067|NCT01656395|588886976|FG005|Overall Study|Withdrawal by Subject|3|||
163049068|NCT01656395|588886977|FG006|Overall Study|Withdrawal by Subject|0|||
163049069|NCT01656395|588886978|FG007|Overall Study|Withdrawal by Subject|0|||
163049070|NCT00230048|588886983|FG000|Overall Study|Lost to Follow-up|13|||
163049071|NCT00230048|588886984|FG001|Overall Study|Lost to Follow-up|18|||
162882566|NCT00819585|588268230|FG009|Extension Study|Subject Withdrew Consent|0|||
162882567|NCT00819585|588268231|FG010|Extension Study|Subject Withdrew Consent|1|||
162882568|NCT00819585|588268221|FG000|Extension Study|Lost to Follow-up|0|||
162882569|NCT00819585|588268222|FG001|Extension Study|Lost to Follow-up|0|||
162882570|NCT00819585|588268223|FG002|Extension Study|Lost to Follow-up|0|||
162882571|NCT00819585|588268224|FG003|Extension Study|Lost to Follow-up|0|||
162882572|NCT00819585|588268225|FG004|Extension Study|Lost to Follow-up|0|||
162882573|NCT00819585|588268226|FG005|Extension Study|Lost to Follow-up|0|||
162882574|NCT00819585|588268227|FG006|Extension Study|Lost to Follow-up|0|||
162882575|NCT00819585|588268228|FG007|Extension Study|Lost to Follow-up|0|||
162882576|NCT00819585|588268229|FG008|Extension Study|Lost to Follow-up|2|||
162882577|NCT00819585|588268230|FG009|Extension Study|Lost to Follow-up|1|||
162882578|NCT00819585|588268231|FG010|Extension Study|Lost to Follow-up|1|||
162882579|NCT00819585|588268221|FG000|Extension Study|Death|0|||
162882580|NCT00819585|588268222|FG001|Extension Study|Death|0|||
162882581|NCT00819585|588268223|FG002|Extension Study|Death|0|||
163049072|NCT00676403|588886985|FG000|Overall Study|Adverse Event|1|||
163049073|NCT00676403|588886986|FG001|Overall Study|Adverse Event|2|||
163049074|NCT00676403|588886987|FG002|Overall Study|Adverse Event|0|||
163049075|NCT00676403|588886988|FG003|Overall Study|Adverse Event|5|||
162882582|NCT00819585|588268224|FG003|Extension Study|Death|0|||
162882583|NCT00819585|588268225|FG004|Extension Study|Death|0|||
163049076|NCT00676403|588886989|FG004|Overall Study|Adverse Event|1|||
163049077|NCT00676403|588886990|FG005|Overall Study|Adverse Event|2|||
163049078|NCT00676403|588886985|FG000|Overall Study|Lost to Follow-up|0|||
163049079|NCT00676403|588886986|FG001|Overall Study|Lost to Follow-up|0|||
163049080|NCT00676403|588886987|FG002|Overall Study|Lost to Follow-up|0|||
163049081|NCT00676403|588886988|FG003|Overall Study|Lost to Follow-up|0|||
163049082|NCT00676403|588886989|FG004|Overall Study|Lost to Follow-up|0|||
163049083|NCT00676403|588886990|FG005|Overall Study|Lost to Follow-up|1|||
162616259|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
162616260|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
162616261|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
162616262|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162616263|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
162616264|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
162616265|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
162616266|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
162616267|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
162616268|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
162616269|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
162616270|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
162616271|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
162616272|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
162616273|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
162616274|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Physician Decision|0|||
162616275|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Physician Decision|8|||
162616276|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Physician Decision|11|||
162616277|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
162616278|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
162616279|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
162616280|NCT00257608|587313373|FG000|Post Chemotherapy Phase|Not treated|0|||
162616281|NCT00257608|587313374|FG001|Post Chemotherapy Phase|Not treated|4|||
162616282|NCT00257608|587313375|FG002|Post Chemotherapy Phase|Not treated|7|||
162616283|NCT03673046|587313376|FG000|Overall Study|Adverse Event|1|||
162616284|NCT03673046|587313377|FG001|Overall Study|Adverse Event|1|||
162616285|NCT03673046|587313376|FG000|Overall Study|Withdrawal by Subject|8|||
162616286|NCT03673046|587313377|FG001|Overall Study|Withdrawal by Subject|2|||
162616287|NCT01896050|587313378|FG000|Overall Study|Adverse Event|37|||
162616288|NCT01896050|587313379|FG001|Overall Study|Adverse Event|2|||
162616289|NCT01896050|587313378|FG000|Overall Study|Death|1|||
162616290|NCT01896050|587313379|FG001|Overall Study|Death|0|||
162616291|NCT00392015|587313381|FG000|Overall Study|Lost to Follow-up|2|||
162616292|NCT00392015|587313382|FG001|Overall Study|Lost to Follow-up|0|||
162616293|NCT00392015|587313383|FG002|Overall Study|Lost to Follow-up|2|||
162616294|NCT00392015|587313384|FG003|Overall Study|Lost to Follow-up|1|||
162616295|NCT00392015|587313385|FG004|Overall Study|Lost to Follow-up|1|||
162616296|NCT00392015|587313386|FG005|Overall Study|Lost to Follow-up|0|||
162616297|NCT00392015|587313381|FG000|Overall Study|Withdrawal by Subject|0|||
162616298|NCT00392015|587313382|FG001|Overall Study|Withdrawal by Subject|0|||
162616299|NCT00392015|587313383|FG002|Overall Study|Withdrawal by Subject|2|||
162616300|NCT00392015|587313384|FG003|Overall Study|Withdrawal by Subject|0|||
162616301|NCT00392015|587313385|FG004|Overall Study|Withdrawal by Subject|0|||
162616302|NCT00392015|587313386|FG005|Overall Study|Withdrawal by Subject|0|||
162616303|NCT00392015|587313381|FG000|Overall Study|Adverse Event|0|||
162616304|NCT00392015|587313382|FG001|Overall Study|Adverse Event|0|||
162616305|NCT00392015|587313383|FG002|Overall Study|Adverse Event|0|||
162616306|NCT00392015|587313384|FG003|Overall Study|Adverse Event|0|||
162616307|NCT00392015|587313385|FG004|Overall Study|Adverse Event|1|||
162616308|NCT00392015|587313386|FG005|Overall Study|Adverse Event|0|||
162616309|NCT00392015|587313381|FG000|Overall Study|Previous trial recipient|0|||
162616310|NCT00392015|587313382|FG001|Overall Study|Previous trial recipient|0|||
162616311|NCT00392015|587313383|FG002|Overall Study|Previous trial recipient|0|||
162616312|NCT00392015|587313384|FG003|Overall Study|Previous trial recipient|0|||
162616313|NCT00392015|587313385|FG004|Overall Study|Previous trial recipient|1|||
162616314|NCT00392015|587313386|FG005|Overall Study|Previous trial recipient|0|||
162707660|NCT04541186|587638301|FG002|Main Study|Investigator Decision|1|||
162616315|NCT03693300|587313387|FG000|Overall Study|Withdrawal by Subject|6|||
162707661|NCT04541186|587638302|FG003|Main Study|Investigator Decision|1|||
162707662|NCT04541186|587638303|FG004|Main Study|Investigator Decision|0|||
162707663|NCT04541186|587638299|FG000|Main Study|Withdrawal by Subject|1|||
162707664|NCT04541186|587638300|FG001|Main Study|Withdrawal by Subject|1|||
162707665|NCT04541186|587638301|FG002|Main Study|Withdrawal by Subject|0|||
163049084|NCT00676403|588886985|FG000|Overall Study|Reason Unspecified|1|||
163049085|NCT00676403|588886986|FG001|Overall Study|Reason Unspecified|0|||
162616316|NCT03693300|587313388|FG001|Overall Study|Withdrawal by Subject|0|||
162616317|NCT03693300|587313387|FG000|Overall Study|Death|50|||
162616318|NCT03693300|587313388|FG001|Overall Study|Death|2|||
163049086|NCT00676403|588886987|FG002|Overall Study|Reason Unspecified|1|||
163049087|NCT00676403|588886988|FG003|Overall Study|Reason Unspecified|0|||
163049088|NCT00676403|588886989|FG004|Overall Study|Reason Unspecified|0|||
163049089|NCT00676403|588886990|FG005|Overall Study|Reason Unspecified|1|||
163049090|NCT00676403|588886985|FG000|Overall Study|Withdrawal by Subject|0|||
163049091|NCT00676403|588886986|FG001|Overall Study|Withdrawal by Subject|0|||
163049092|NCT00676403|588886987|FG002|Overall Study|Withdrawal by Subject|0|||
163049093|NCT00676403|588886988|FG003|Overall Study|Withdrawal by Subject|0|||
163049094|NCT00676403|588886989|FG004|Overall Study|Withdrawal by Subject|0|||
163049095|NCT00676403|588886990|FG005|Overall Study|Withdrawal by Subject|1|||
163049096|NCT03225170|588886991|FG000|Overall Study|Lost to Follow-up|4|||
163049097|NCT03225170|588886992|FG001|Overall Study|Lost to Follow-up|4|||
163049098|NCT03225170|588886993|FG002|Overall Study|Lost to Follow-up|0|||
163049099|NCT03225170|588886991|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
163049100|NCT03225170|588886992|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
163049101|NCT03225170|588886993|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
163049102|NCT00661089|588886995|FG000|Overall Study|1 subject withdrawal|0|||
163049103|NCT00661089|588886996|FG001|Overall Study|1 subject withdrawal|1|||
163049104|NCT00661089|588886995|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
163049105|NCT00661089|588886996|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
163049106|NCT01272908|588886999|FG000|Initial Treatment Period|Adverse Event|1|||
163049107|NCT01272908|588886999|FG000|Initial Treatment Period|Lack of Efficacy|5|||
163049108|NCT01272908|588886999|FG000|Initial Treatment Period|Protocol Violation|1|||
163049109|NCT01272908|588886999|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163049110|NCT01272908|588886999|FG000|Re-Treatment Period|Adverse Event|2|||
163049111|NCT01272908|588886999|FG000|Re-Treatment Period|Lack of Efficacy|3|||
163049112|NCT01272908|588886999|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
163049113|NCT00971867|588887001|FG000|Overall Study|Adverse Event|4|||
163049114|NCT00971867|588887001|FG000|Overall Study|Participant Withdrew Consent|1|||
163049115|NCT00971867|588887001|FG000|Overall Study|Disease Progression|6|||
163049116|NCT00905424|588887008|FG000|Overall Study|Lost to Follow-up|3|||
163049117|NCT00905424|588887009|FG001|Overall Study|Lost to Follow-up|3|||
163049118|NCT00905424|588887008|FG000|Overall Study|Withdrawal by Subject|1|||
163049119|NCT00905424|588887009|FG001|Overall Study|Withdrawal by Subject|2|||
163049120|NCT00905424|588887008|FG000|Overall Study|Adverse Event|4|||
163049121|NCT00905424|588887009|FG001|Overall Study|Adverse Event|2|||
163049122|NCT00905424|588887008|FG000|Overall Study|Non-compliance with study medication|2|||
163049123|NCT00905424|588887009|FG001|Overall Study|Non-compliance with study medication|0|||
163049124|NCT00905424|588887008|FG000|Overall Study|Sponsor decision|1|||
163049125|NCT00905424|588887009|FG001|Overall Study|Sponsor decision|0|||
163049126|NCT00905424|588887008|FG000|Overall Study|Positive urine drug screen|0|||
163049127|NCT00905424|588887009|FG001|Overall Study|Positive urine drug screen|1|||
163049128|NCT00905424|588887008|FG000|Overall Study|Non-adherence to visit schedule|0|||
163049129|NCT00905424|588887009|FG001|Overall Study|Non-adherence to visit schedule|1|||
163049130|NCT00379899|588887011|FG000|Overall Study|Adverse Event|7|||
163049131|NCT00379899|588887012|FG001|Overall Study|Adverse Event|3|||
163049132|NCT00379899|588887011|FG000|Overall Study|Death|10|||
163049133|NCT00379899|588887012|FG001|Overall Study|Death|10|||
163049134|NCT00379899|588887011|FG000|Overall Study|Lost to Follow-up|2|||
163049135|NCT00379899|588887012|FG001|Overall Study|Lost to Follow-up|4|||
163049136|NCT00379899|588887011|FG000|Overall Study|Physician Decision|3|||
163049137|NCT00379899|588887012|FG001|Overall Study|Physician Decision|4|||
163049138|NCT00379899|588887011|FG000|Overall Study|Withdrawal by Subject|5|||
163049139|NCT00379899|588887012|FG001|Overall Study|Withdrawal by Subject|5|||
163049140|NCT00379899|588887011|FG000|Overall Study|Ineligibility determined|0|||
163049141|NCT00379899|588887012|FG001|Overall Study|Ineligibility determined|1|||
163049142|NCT00379899|588887011|FG000|Overall Study|Noncompliance|1|||
163049143|NCT00379899|588887012|FG001|Overall Study|Noncompliance|1|||
163049144|NCT00379899|588887011|FG000|Overall Study|Parathyroidectomy|0|||
163049145|NCT00379899|588887012|FG001|Overall Study|Parathyroidectomy|2|||
162882584|NCT00819585|588268226|FG005|Extension Study|Death|0|||
162882585|NCT00819585|588268227|FG006|Extension Study|Death|0|||
162882586|NCT00819585|588268228|FG007|Extension Study|Death|0|||
162882587|NCT00819585|588268229|FG008|Extension Study|Death|2|||
162882588|NCT00819585|588268230|FG009|Extension Study|Death|0|||
163049146|NCT00379899|588887011|FG000|Overall Study|Renal transplantation|5|||
163049147|NCT00379899|588887012|FG001|Overall Study|Renal transplantation|4|||
163049148|NCT00379899|588887011|FG000|Overall Study|Coronary artery bypass graft|1|||
163049149|NCT00379899|588887012|FG001|Overall Study|Coronary artery bypass graft|1|||
163049150|NCT00379899|588887011|FG000|Overall Study|Other protocol-specified criteria|3|||
163049151|NCT00379899|588887012|FG001|Overall Study|Other protocol-specified criteria|4|||
162616319|NCT03693300|587313387|FG000|Overall Study|Lost to Follow-up|2|||
163049152|NCT00379899|588887011|FG000|Overall Study|Other|3|||
163049153|NCT00379899|588887012|FG001|Overall Study|Other|1|||
163049154|NCT02716779|588887015|FG000|Monotherapy|Adverse Event|0|||
162882589|NCT00819585|588268231|FG010|Extension Study|Death|0|||
162882590|NCT01877382|588268232|FG000|Dose Escalation|Progressive disease|2|||
162882591|NCT01877382|588268233|FG001|Dose Escalation|Progressive disease|0|||
162882592|NCT01877382|588268234|FG002|Dose Escalation|Progressive disease|1|||
162882593|NCT01877382|588268235|FG003|Dose Escalation|Progressive disease|6|||
162882594|NCT01877382|588268236|FG004|Dose Escalation|Progressive disease|1|||
162882595|NCT01877382|588268237|FG005|Dose Escalation|Progressive disease|0|||
162882596|NCT01877382|588268238|FG006|Dose Escalation|Progressive disease|3|||
162882597|NCT01877382|588268239|FG007|Dose Escalation|Progressive disease|10|||
162882598|NCT01877382|588268240|FG008|Dose Escalation|Progressive disease|4|||
162882599|NCT01877382|588268241|FG009|Dose Escalation|Progressive disease|2|||
162882600|NCT01877382|588268242|FG010|Dose Escalation|Progressive disease|3|||
162882601|NCT01877382|588268243|FG011|Dose Escalation|Progressive disease|3|||
162882602|NCT01877382|588268244|FG012|Dose Escalation|Progressive disease|13|||
162882603|NCT01877382|588268245|FG013|Dose Escalation|Progressive disease|1|||
162882604|NCT01877382|588268246|FG014|Dose Escalation|Progressive disease|0|||
162882605|NCT01877382|588268232|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
162882606|NCT01877382|588268233|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882607|NCT01877382|588268234|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882608|NCT01877382|588268235|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
162882609|NCT01877382|588268236|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882610|NCT01877382|588268237|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882611|NCT01877382|588268238|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
162882612|NCT01877382|588268239|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882613|NCT01877382|588268240|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162962317|NCT01642277|588562620|FG000|Overall Study|Physician Decision|2|||
162962318|NCT01642277|588562621|FG001|Overall Study|Physician Decision|0|||
162962319|NCT01642277|588562620|FG000|Overall Study|Protocol Violation|1|||
162962320|NCT01642277|588562621|FG001|Overall Study|Protocol Violation|0|||
162962321|NCT01642277|588562620|FG000|Overall Study|Withdrawal by Subject|11|||
162962322|NCT01642277|588562621|FG001|Overall Study|Withdrawal by Subject|0|||
162962323|NCT03679598|588562622|FG000|Overall Study|Adverse Event|2|||
162962324|NCT03679598|588562623|FG001|Overall Study|Adverse Event|0|||
162962325|NCT03605342|588562624|FG000|Overall Study|Withdrawal by Subject|9|||
162962326|NCT03605342|588562625|FG001|Overall Study|Withdrawal by Subject|7|||
162962327|NCT03605342|588562624|FG000|Overall Study|Lost to Follow-up|1|||
162962328|NCT03605342|588562625|FG001|Overall Study|Lost to Follow-up|1|||
162962329|NCT02842853|588562628|FG000|Overall Study|Non-compliance with the protocol|3|||
162962330|NCT02842853|588562629|FG001|Overall Study|Non-compliance with the protocol|7|||
162962331|NCT02842853|588562630|FG002|Overall Study|Non-compliance with the protocol|2|||
162962332|NCT02842853|588562631|FG003|Overall Study|Non-compliance with the protocol|5|||
162962333|NCT02842853|588562628|FG000|Overall Study|Subject met exclusion criteria|0|||
162962334|NCT02842853|588562629|FG001|Overall Study|Subject met exclusion criteria|1|||
162962335|NCT02842853|588562630|FG002|Overall Study|Subject met exclusion criteria|0|||
162962336|NCT02842853|588562631|FG003|Overall Study|Subject met exclusion criteria|0|||
162962337|NCT02842853|588562628|FG000|Overall Study|Withdrawal by Subject|11|||
162962338|NCT02842853|588562629|FG001|Overall Study|Withdrawal by Subject|13|||
162962339|NCT02842853|588562630|FG002|Overall Study|Withdrawal by Subject|9|||
162962340|NCT02842853|588562631|FG003|Overall Study|Withdrawal by Subject|8|||
162962341|NCT02842853|588562628|FG000|Overall Study|Lost to Follow-up|9|||
162962342|NCT02842853|588562629|FG001|Overall Study|Lost to Follow-up|13|||
162962343|NCT02842853|588562630|FG002|Overall Study|Lost to Follow-up|10|||
162962344|NCT02842853|588562631|FG003|Overall Study|Lost to Follow-up|11|||
162962345|NCT00918645|588562642|FG000|Overall Study|Withdrawal by Subject|1|||
162962346|NCT05133180|588562643|FG000|Overall Study|Withdrawal of consent|1|||
162962347|NCT05133180|588562644|FG001|Overall Study|Withdrawal of consent|1|||
162962348|NCT05133180|588562643|FG000|Overall Study|Lost to Follow-up|1|||
163049155|NCT02716779|588887016|FG001|Monotherapy|Adverse Event|1|||
163049156|NCT02716779|588887017|FG002|Monotherapy|Adverse Event|1|||
163049157|NCT02716779|588887015|FG000|Combination Therapy|Adverse Event|0|||
163049158|NCT02716779|588887016|FG001|Combination Therapy|Adverse Event|2|||
163049159|NCT02716779|588887017|FG002|Combination Therapy|Adverse Event|1|||
162962349|NCT05133180|588562644|FG001|Overall Study|Lost to Follow-up|1|||
162962350|NCT05133180|588562643|FG000|Overall Study|Documented disease progression|0|||
162962351|NCT05133180|588562644|FG001|Overall Study|Documented disease progression|1|||
162962352|NCT04723693|588562645|FG000|Overall Study|Withdrawal by Subject|2|||
162962353|NCT02157974|588562646|FG000|Overall Study|Withdrawal by Subject|0|||
162962354|NCT02157974|588562647|FG001|Overall Study|Withdrawal by Subject|1|||
162962355|NCT02157974|588562648|FG002|Overall Study|Withdrawal by Subject|0|||
162962356|NCT02157974|588562649|FG003|Overall Study|Withdrawal by Subject|0|||
162962357|NCT02157974|588562650|FG004|Overall Study|Withdrawal by Subject|0|||
163049160|NCT00101868|588887030|FG000|Overall Study|Death|10|||
163049161|NCT00101868|588887031|FG001|Overall Study|Death|10|||
163049162|NCT00101868|588887030|FG000|Overall Study|Withdrawal by Subject|8|||
163049163|NCT00101868|588887031|FG001|Overall Study|Withdrawal by Subject|9|||
163049164|NCT00101868|588887030|FG000|Overall Study|Protocol Violation|3|||
163049165|NCT00101868|588887031|FG001|Overall Study|Protocol Violation|0|||
163049166|NCT00101868|588887030|FG000|Overall Study|Lost to Follow-up|8|||
163049167|NCT00101868|588887031|FG001|Overall Study|Lost to Follow-up|13|||
163049168|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
163049169|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
163049170|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
163049171|NCT04001803|588887032|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
163049172|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
163049173|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
163049174|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
163049175|NCT04001803|588887032|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
163049176|NCT04001803|588887032|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
163049177|NCT04001803|588887032|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
163049178|NCT01931397|588887035|FG000|Overall Study|Physician Decision|2|||
162616320|NCT03693300|587313388|FG001|Overall Study|Lost to Follow-up|0|||
162616321|NCT02742441|587313389|FG000|Overall Study|Lost to Follow-up|4|||
163049179|NCT01931397|588887035|FG000|Overall Study|Withdrawal by Subject|8|||
163049180|NCT01931397|588887035|FG000|Overall Study|moved out of state|1|||
163049181|NCT00520039|588887038|FG000|Overall Study|Exclusion criteria met at first visit|7|||
163049182|NCT00520039|588887039|FG001|Overall Study|Exclusion criteria met at first visit|5|||
163049183|NCT02329327|588887043|FG000|Overall Study|Death|78|||
163049184|NCT02329327|588887044|FG001|Overall Study|Death|0|||
163049185|NCT02329327|588887043|FG000|Overall Study|Withdrawal by Subject|3|||
163049186|NCT02329327|588887044|FG001|Overall Study|Withdrawal by Subject|0|||
163049187|NCT02329327|588887043|FG000|Overall Study|Lost to Follow-up|4|||
163049188|NCT02329327|588887044|FG001|Overall Study|Lost to Follow-up|0|||
163049189|NCT03560869|588887045|FG000|Overall Study|Withdrawal by Subject|3|||
163049190|NCT03560869|588887046|FG001|Overall Study|Withdrawal by Subject|4|||
163049191|NCT03560869|588887045|FG000|Overall Study|Screening failure|4|||
163049192|NCT03560869|588887046|FG001|Overall Study|Screening failure|4|||
163049193|NCT03560869|588887045|FG000|Overall Study|Withdrawal by PI|0|||
163049194|NCT03560869|588887046|FG001|Overall Study|Withdrawal by PI|1|||
163049195|NCT02493517|588887047|FG000|Overall Study|Protocol Violation|1|||
163049196|NCT02493517|588887048|FG001|Overall Study|Protocol Violation|2|||
163049197|NCT02493517|588887047|FG000|Overall Study|Withdrawal by Subject|1|||
163049198|NCT02493517|588887048|FG001|Overall Study|Withdrawal by Subject|2|||
163049199|NCT02493517|588887047|FG000|Overall Study|Adverse Event|0|||
163049200|NCT02493517|588887048|FG001|Overall Study|Adverse Event|2|||
163049201|NCT02493517|588887047|FG000|Overall Study|Missed study visit|0|||
163049202|NCT02493517|588887048|FG001|Overall Study|Missed study visit|1|||
163049203|NCT01367249|588887049|FG000|Overall Study|Withdrawal by Subject|6|||
163049204|NCT01367249|588887050|FG001|Overall Study|Withdrawal by Subject|6|||
163049205|NCT01367249|588887049|FG000|Overall Study|Other|3|||
163049206|NCT01367249|588887050|FG001|Overall Study|Other|10|||
163049207|NCT03718429|588887051|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
163049208|NCT03718429|588887052|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
163049209|NCT03718429|588887053|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
163049210|NCT03718429|588887054|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
163049211|NCT05404711|588887055|FG000|Completed Study Visit|Withdrawal by Subject|1|||
162962358|NCT02157974|588562646|FG000|Overall Study|Screen Failure|0|||
162962359|NCT02157974|588562647|FG001|Overall Study|Screen Failure|1|||
162962360|NCT02157974|588562648|FG002|Overall Study|Screen Failure|0|||
162962361|NCT02157974|588562649|FG003|Overall Study|Screen Failure|0|||
162962362|NCT02157974|588562650|FG004|Overall Study|Screen Failure|0|||
162962363|NCT02157974|588562646|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962364|NCT02157974|588562647|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
162962365|NCT02157974|588562648|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962366|NCT02157974|588562649|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
163049212|NCT05404711|588887055|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
163049213|NCT05404711|588887055|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
163049214|NCT05404711|588887055|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
163049215|NCT05404711|588887055|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
163049216|NCT05404711|588887055|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
163049217|NCT00325819|588887056|FG000|Overall Study|Study product lost in mail|2|||
163049218|NCT00325819|588887057|FG001|Overall Study|Study product lost in mail|1|||
162616322|NCT02742441|587313390|FG001|Overall Study|Lost to Follow-up|4|||
162616323|NCT02742441|587313389|FG000|Overall Study|Withdrawal by Subject|2|||
162616324|NCT02742441|587313390|FG001|Overall Study|Withdrawal by Subject|2|||
162616325|NCT02742441|587313389|FG000|Overall Study|Adverse Event|0|||
163049219|NCT00325819|588887056|FG000|Overall Study|Did not take a dose of study product|4|||
163049220|NCT00325819|588887057|FG001|Overall Study|Did not take a dose of study product|9|||
163049221|NCT00325819|588887056|FG000|Overall Study|Lost to Follow-up|3|||
163049222|NCT00325819|588887057|FG001|Overall Study|Lost to Follow-up|3|||
163049223|NCT02346877|588887058|FG000|Overall Study|Adverse Event|1|||
163049224|NCT02346877|588887059|FG001|Overall Study|Adverse Event|0|||
163049225|NCT02346877|588887058|FG000|Overall Study|Administrative Decision|1|||
163049226|NCT02346877|588887059|FG001|Overall Study|Administrative Decision|0|||
163049227|NCT02346877|588887058|FG000|Overall Study|Sponsor Decision|12|||
163049228|NCT02346877|588887059|FG001|Overall Study|Sponsor Decision|0|||
163049229|NCT02346877|588887058|FG000|Overall Study|Missing|5|||
162707666|NCT04541186|587638302|FG003|Main Study|Withdrawal by Subject|0|||
162707667|NCT04541186|587638303|FG004|Main Study|Withdrawal by Subject|0|||
162882614|NCT01877382|588268241|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882615|NCT01877382|588268242|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882616|NCT01877382|588268243|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882617|NCT01877382|588268244|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882618|NCT01877382|588268245|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882619|NCT01877382|588268246|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882620|NCT01877382|588268232|FG000|Dose Escalation|Clinical progression|0|||
162882621|NCT01877382|588268233|FG001|Dose Escalation|Clinical progression|1|||
162882622|NCT01877382|588268234|FG002|Dose Escalation|Clinical progression|0|||
162882623|NCT01877382|588268235|FG003|Dose Escalation|Clinical progression|2|||
162882624|NCT01877382|588268236|FG004|Dose Escalation|Clinical progression|0|||
162882625|NCT01877382|588268237|FG005|Dose Escalation|Clinical progression|0|||
162882626|NCT01877382|588268238|FG006|Dose Escalation|Clinical progression|1|||
162882627|NCT01877382|588268239|FG007|Dose Escalation|Clinical progression|0|||
162882628|NCT01877382|588268240|FG008|Dose Escalation|Clinical progression|0|||
162882629|NCT01877382|588268241|FG009|Dose Escalation|Clinical progression|1|||
162882630|NCT01877382|588268242|FG010|Dose Escalation|Clinical progression|0|||
162882631|NCT01877382|588268243|FG011|Dose Escalation|Clinical progression|0|||
162882632|NCT01877382|588268244|FG012|Dose Escalation|Clinical progression|2|||
162882633|NCT01877382|588268245|FG013|Dose Escalation|Clinical progression|1|||
162882634|NCT01877382|588268246|FG014|Dose Escalation|Clinical progression|0|||
162882635|NCT01877382|588268232|FG000|Dose Escalation|Adverse Event|0|||
162882636|NCT01877382|588268233|FG001|Dose Escalation|Adverse Event|0|||
162882637|NCT01877382|588268234|FG002|Dose Escalation|Adverse Event|0|||
162882638|NCT01877382|588268235|FG003|Dose Escalation|Adverse Event|4|||
162882639|NCT01877382|588268236|FG004|Dose Escalation|Adverse Event|1|||
162882640|NCT01877382|588268237|FG005|Dose Escalation|Adverse Event|2|||
162882641|NCT01877382|588268238|FG006|Dose Escalation|Adverse Event|1|||
162882642|NCT01877382|588268239|FG007|Dose Escalation|Adverse Event|2|||
163049230|NCT02346877|588887059|FG001|Overall Study|Missing|0|||
163049231|NCT02481050|588888885|FG000|Overall Study|Adverse Event|1|||
163049232|NCT02481050|588888885|FG000|Overall Study|Disease Progression|47|||
163049233|NCT02481050|588888885|FG000|Overall Study|Withdrawal by Subject|7|||
163049234|NCT02481050|588888885|FG000|Overall Study|Other|3|||
163049235|NCT01548599|588888888|FG000|Overall Study|Lost to Follow-up|0|||
163049236|NCT01548599|588888889|FG001|Overall Study|Lost to Follow-up|1|||
163049237|NCT01548599|588888888|FG000|Overall Study|Withdrawal by Subject|4|||
163049238|NCT01548599|588888889|FG001|Overall Study|Withdrawal by Subject|0|||
163049239|NCT01548599|588888888|FG000|Overall Study|Death|2|||
163049240|NCT01548599|588888889|FG001|Overall Study|Death|1|||
163049241|NCT02188160|588888890|FG000|Overall Study|Adverse Event|1|||
163049242|NCT02188160|588888891|FG001|Overall Study|Adverse Event|0|||
163049243|NCT02188160|588888890|FG000|Overall Study|Use of an excluded medication|0|||
163049244|NCT02188160|588888891|FG001|Overall Study|Use of an excluded medication|1|||
163049245|NCT01022203|588888896|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
163049246|NCT01022203|588888897|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
163049247|NCT01022203|588888896|FG000|Post Treatment Assessment|Physician Decision|2|||
163049248|NCT01022203|588888897|FG001|Post Treatment Assessment|Physician Decision|0|||
162882643|NCT01877382|588268240|FG008|Dose Escalation|Adverse Event|0|||
162882644|NCT01877382|588268241|FG009|Dose Escalation|Adverse Event|0|||
162882645|NCT01877382|588268242|FG010|Dose Escalation|Adverse Event|0|||
163049249|NCT01022203|588888896|FG000|Post Treatment Assessment|Adverse Event|0|||
163049250|NCT01022203|588888897|FG001|Post Treatment Assessment|Adverse Event|2|||
163049251|NCT01022203|588888896|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
163049252|NCT01022203|588888897|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
162882646|NCT01877382|588268243|FG011|Dose Escalation|Adverse Event|0|||
162882647|NCT01877382|588268244|FG012|Dose Escalation|Adverse Event|1|||
163049253|NCT03638128|588888898|FG000|Overall Study|Withdrawal by Subject|1|||
163049254|NCT03638128|588888899|FG001|Overall Study|Withdrawal by Subject|7|||
163049255|NCT03638128|588888900|FG002|Overall Study|Withdrawal by Subject|6|||
163049256|NCT03638128|588888898|FG000|Overall Study|Sponsor Decision|15|||
163049257|NCT03638128|588888899|FG001|Overall Study|Sponsor Decision|12|||
162882648|NCT01877382|588268245|FG013|Dose Escalation|Adverse Event|0|||
162882649|NCT01877382|588268246|FG014|Dose Escalation|Adverse Event|0|||
162882650|NCT01877382|588268232|FG000|Dose Escalation|Withdrawal by Subject|0|||
162882651|NCT01877382|588268233|FG001|Dose Escalation|Withdrawal by Subject|0|||
162882652|NCT01877382|588268234|FG002|Dose Escalation|Withdrawal by Subject|0|||
162882653|NCT01877382|588268235|FG003|Dose Escalation|Withdrawal by Subject|0|||
162882654|NCT01877382|588268236|FG004|Dose Escalation|Withdrawal by Subject|0|||
162882655|NCT01877382|588268237|FG005|Dose Escalation|Withdrawal by Subject|3|||
162882656|NCT01877382|588268238|FG006|Dose Escalation|Withdrawal by Subject|2|||
162882657|NCT01877382|588268239|FG007|Dose Escalation|Withdrawal by Subject|1|||
162882658|NCT01877382|588268240|FG008|Dose Escalation|Withdrawal by Subject|1|||
162882659|NCT01877382|588268241|FG009|Dose Escalation|Withdrawal by Subject|0|||
162882660|NCT01877382|588268242|FG010|Dose Escalation|Withdrawal by Subject|0|||
162882661|NCT01877382|588268243|FG011|Dose Escalation|Withdrawal by Subject|0|||
162882662|NCT01877382|588268244|FG012|Dose Escalation|Withdrawal by Subject|0|||
162882663|NCT01877382|588268245|FG013|Dose Escalation|Withdrawal by Subject|0|||
162882664|NCT01877382|588268246|FG014|Dose Escalation|Withdrawal by Subject|0|||
162882665|NCT01877382|588268232|FG000|Dose Escalation|Protocol Violation|0|||
162882666|NCT01877382|588268233|FG001|Dose Escalation|Protocol Violation|0|||
162882667|NCT01877382|588268234|FG002|Dose Escalation|Protocol Violation|0|||
162882668|NCT01877382|588268235|FG003|Dose Escalation|Protocol Violation|0|||
162882669|NCT01877382|588268236|FG004|Dose Escalation|Protocol Violation|0|||
162882670|NCT01877382|588268237|FG005|Dose Escalation|Protocol Violation|0|||
162882671|NCT01877382|588268238|FG006|Dose Escalation|Protocol Violation|1|||
162882672|NCT01877382|588268239|FG007|Dose Escalation|Protocol Violation|0|||
162882673|NCT01877382|588268240|FG008|Dose Escalation|Protocol Violation|0|||
162882674|NCT01877382|588268241|FG009|Dose Escalation|Protocol Violation|0|||
162882675|NCT01877382|588268242|FG010|Dose Escalation|Protocol Violation|0|||
162882676|NCT01877382|588268243|FG011|Dose Escalation|Protocol Violation|0|||
162882677|NCT01877382|588268244|FG012|Dose Escalation|Protocol Violation|0|||
162882678|NCT01877382|588268245|FG013|Dose Escalation|Protocol Violation|0|||
162882679|NCT01877382|588268246|FG014|Dose Escalation|Protocol Violation|0|||
162882680|NCT01877382|588268232|FG000|Dose Escalation|Study terminated by sponsor|0|||
162882681|NCT01877382|588268233|FG001|Dose Escalation|Study terminated by sponsor|0|||
162882682|NCT01877382|588268234|FG002|Dose Escalation|Study terminated by sponsor|0|||
162882683|NCT01877382|588268235|FG003|Dose Escalation|Study terminated by sponsor|0|||
162882684|NCT01877382|588268236|FG004|Dose Escalation|Study terminated by sponsor|0|||
162882685|NCT01877382|588268237|FG005|Dose Escalation|Study terminated by sponsor|0|||
162962367|NCT02157974|588562650|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
162962368|NCT00216736|588562652|FG000|Overall Study|Lost to Follow-up|1|||
162962369|NCT00216736|588562653|FG001|Overall Study|Lost to Follow-up|1|||
162962370|NCT00807495|588562654|FG000|Overall Study|Adverse Event|6|||
162962371|NCT00807495|588562655|FG001|Overall Study|Adverse Event|3|||
162962372|NCT00807495|588562656|FG002|Overall Study|Adverse Event|1|||
162962373|NCT00807495|588562657|FG003|Overall Study|Adverse Event|1|||
162962374|NCT00807495|588562658|FG004|Overall Study|Adverse Event|2|||
162962375|NCT00807495|588562654|FG000|Overall Study|Withdrawal by Patient|2|||
162962376|NCT00807495|588562655|FG001|Overall Study|Withdrawal by Patient|0|||
162962377|NCT00807495|588562656|FG002|Overall Study|Withdrawal by Patient|1|||
162962378|NCT00807495|588562657|FG003|Overall Study|Withdrawal by Patient|0|||
162962379|NCT00807495|588562658|FG004|Overall Study|Withdrawal by Patient|0|||
162962380|NCT00807495|588562654|FG000|Overall Study|Reason Not Specified|0|||
162962381|NCT00807495|588562655|FG001|Overall Study|Reason Not Specified|3|||
162962382|NCT00807495|588562656|FG002|Overall Study|Reason Not Specified|2|||
162962383|NCT00807495|588562657|FG003|Overall Study|Reason Not Specified|0|||
162962384|NCT00807495|588562658|FG004|Overall Study|Reason Not Specified|3|||
162962385|NCT00463684|588562663|FG000|Overall Study|Withdrawal by Subject|1|||
162962386|NCT00463684|588562663|FG000|Overall Study|Lost to Follow-up|3|||
162962387|NCT01906372|588562664|FG000|Overall Study|Withdrawal by Subject|2|||
162962388|NCT03629054|588562665|FG000|Period 2 (4 Days)|Not treated|0|||
162962389|NCT03629054|588562666|FG001|Period 2 (4 Days)|Not treated|1|||
162962390|NCT03808376|588562667|FG000|Overall Study|Withdrawal by Subject|10|||
162962391|NCT02462837|588562668|FG000|Overall Study|pt developed hives|1|||
162962392|NCT02462837|588562669|FG001|Overall Study|pt developed hives|0|||
162962393|NCT02462837|588562668|FG000|Overall Study|Withdrawal by Subject|1|||
162882686|NCT01877382|588268238|FG006|Dose Escalation|Study terminated by sponsor|0|||
162882687|NCT01877382|588268239|FG007|Dose Escalation|Study terminated by sponsor|1|||
162962394|NCT02462837|588562669|FG001|Overall Study|Withdrawal by Subject|0|||
162962395|NCT00924638|588562673|FG000|Overall Study|Death|3|||
162962396|NCT00924638|588562674|FG001|Overall Study|Death|2|||
162882688|NCT01877382|588268240|FG008|Dose Escalation|Study terminated by sponsor|1|||
162882689|NCT01877382|588268241|FG009|Dose Escalation|Study terminated by sponsor|0|||
162882690|NCT01877382|588268242|FG010|Dose Escalation|Study terminated by sponsor|0|||
162882691|NCT01877382|588268243|FG011|Dose Escalation|Study terminated by sponsor|0|||
162962397|NCT00924638|588562673|FG000|Overall Study|Lost to Follow-up|1|||
162882692|NCT01877382|588268244|FG012|Dose Escalation|Study terminated by sponsor|3|||
162882693|NCT01877382|588268245|FG013|Dose Escalation|Study terminated by sponsor|0|||
162882694|NCT01877382|588268246|FG014|Dose Escalation|Study terminated by sponsor|0|||
162882695|NCT01877382|588268232|FG000|Dose Escalation|Death|0|||
162882696|NCT01877382|588268233|FG001|Dose Escalation|Death|0|||
162882697|NCT01877382|588268234|FG002|Dose Escalation|Death|0|||
162882698|NCT01877382|588268235|FG003|Dose Escalation|Death|0|||
162882699|NCT01877382|588268236|FG004|Dose Escalation|Death|0|||
162882700|NCT01877382|588268237|FG005|Dose Escalation|Death|0|||
162882701|NCT01877382|588268238|FG006|Dose Escalation|Death|0|||
162882702|NCT01877382|588268239|FG007|Dose Escalation|Death|1|||
162882703|NCT01877382|588268240|FG008|Dose Escalation|Death|0|||
162882704|NCT01877382|588268241|FG009|Dose Escalation|Death|0|||
162882705|NCT01877382|588268242|FG010|Dose Escalation|Death|0|||
162882706|NCT01877382|588268243|FG011|Dose Escalation|Death|0|||
162882707|NCT01877382|588268244|FG012|Dose Escalation|Death|1|||
162882708|NCT01877382|588268245|FG013|Dose Escalation|Death|1|||
162882709|NCT01877382|588268246|FG014|Dose Escalation|Death|0|||
162882710|NCT01877382|588268232|FG000|Dose Expansion|Progressive disease|0|||
162882711|NCT01877382|588268233|FG001|Dose Expansion|Progressive disease|0|||
162882712|NCT01877382|588268234|FG002|Dose Expansion|Progressive disease|0|||
162882713|NCT01877382|588268235|FG003|Dose Expansion|Progressive disease|0|||
162882714|NCT01877382|588268236|FG004|Dose Expansion|Progressive disease|0|||
162882715|NCT01877382|588268237|FG005|Dose Expansion|Progressive disease|0|||
162882716|NCT01877382|588268238|FG006|Dose Expansion|Progressive disease|0|||
162882717|NCT01877382|588268239|FG007|Dose Expansion|Progressive disease|0|||
162882718|NCT01877382|588268240|FG008|Dose Expansion|Progressive disease|0|||
162882719|NCT01877382|588268241|FG009|Dose Expansion|Progressive disease|0|||
162882720|NCT01877382|588268242|FG010|Dose Expansion|Progressive disease|0|||
162882721|NCT01877382|588268243|FG011|Dose Expansion|Progressive disease|0|||
162882722|NCT01877382|588268244|FG012|Dose Expansion|Progressive disease|0|||
162882723|NCT01877382|588268245|FG013|Dose Expansion|Progressive disease|0|||
162882724|NCT01877382|588268246|FG014|Dose Expansion|Progressive disease|11|||
162882725|NCT01877382|588268232|FG000|Dose Expansion|Clinical progression|0|||
162882726|NCT01877382|588268233|FG001|Dose Expansion|Clinical progression|0|||
162882727|NCT01877382|588268234|FG002|Dose Expansion|Clinical progression|0|||
162882728|NCT01877382|588268235|FG003|Dose Expansion|Clinical progression|0|||
162882729|NCT01877382|588268236|FG004|Dose Expansion|Clinical progression|0|||
162882730|NCT01877382|588268237|FG005|Dose Expansion|Clinical progression|0|||
162882731|NCT01877382|588268238|FG006|Dose Expansion|Clinical progression|0|||
162882732|NCT01877382|588268239|FG007|Dose Expansion|Clinical progression|0|||
162882733|NCT01877382|588268240|FG008|Dose Expansion|Clinical progression|0|||
162962398|NCT00924638|588562674|FG001|Overall Study|Lost to Follow-up|1|||
162962399|NCT00924638|588562673|FG000|Overall Study|Withdrawal by Subject|5|||
162962400|NCT00924638|588562674|FG001|Overall Study|Withdrawal by Subject|7|||
162962401|NCT00924638|588562673|FG000|Overall Study|Physician Decision|3|||
162962402|NCT00924638|588562674|FG001|Overall Study|Physician Decision|3|||
162962403|NCT01316055|588562675|FG000|Overall Study|Lost to Follow-up|1|||
162962404|NCT01316055|588562676|FG001|Overall Study|Lost to Follow-up|0|||
162962405|NCT01316055|588562677|FG002|Overall Study|Lost to Follow-up|0|||
162962406|NCT02679729|588562679|FG000|Overall Study|Lost to Follow-up|0|||
162962407|NCT02679729|588562680|FG001|Overall Study|Lost to Follow-up|1|||
162962408|NCT02679729|588562681|FG002|Overall Study|Lost to Follow-up|0|||
162962409|NCT02679729|588562682|FG003|Overall Study|Lost to Follow-up|0|||
162962410|NCT02679729|588562683|FG004|Overall Study|Lost to Follow-up|1|||
162962411|NCT02679729|588562684|FG005|Overall Study|Lost to Follow-up|0|||
162962412|NCT02679729|588562685|FG006|Overall Study|Lost to Follow-up|0|||
162962413|NCT02679729|588562686|FG007|Overall Study|Lost to Follow-up|0|||
162962414|NCT02679729|588562687|FG008|Overall Study|Lost to Follow-up|0|||
162962415|NCT02679729|588562679|FG000|Overall Study|Participant decision|0|||
162962416|NCT02679729|588562680|FG001|Overall Study|Participant decision|1|||
162962417|NCT02679729|588562681|FG002|Overall Study|Participant decision|0|||
162962418|NCT02679729|588562682|FG003|Overall Study|Participant decision|0|||
162962419|NCT02679729|588562683|FG004|Overall Study|Participant decision|0|||
162962420|NCT02679729|588562684|FG005|Overall Study|Participant decision|0|||
162962421|NCT02679729|588562685|FG006|Overall Study|Participant decision|1|||
162962422|NCT02679729|588562686|FG007|Overall Study|Participant decision|0|||
162962423|NCT02679729|588562687|FG008|Overall Study|Participant decision|0|||
162962424|NCT00748566|588562688|FG000|Overall Study|Adverse Event|49|||
162962425|NCT00748566|588562688|FG000|Overall Study|Death|1|||
162962426|NCT00748566|588562688|FG000|Overall Study|Lack of Efficacy|12|||
162962427|NCT00748566|588562688|FG000|Overall Study|Lost to Follow-up|1|||
162962428|NCT00748566|588562688|FG000|Overall Study|Protocol Violation|13|||
162962429|NCT00748566|588562688|FG000|Overall Study|Withdrawal by Subject|22|||
162962430|NCT00748566|588562688|FG000|Overall Study|Study terminated by sponsor|5|||
162962431|NCT00748566|588562688|FG000|Overall Study|Other|9|||
162962432|NCT00989950|588562689|FG000|Randomized Phase|Protocol Violation|1|||
162962433|NCT00989950|588562690|FG001|Randomized Phase|Protocol Violation|0|||
162962434|NCT00989950|588562691|FG002|Randomized Phase|Protocol Violation|0|||
162962435|NCT00989950|588562692|FG003|Randomized Phase|Protocol Violation|0|||
162962436|NCT00989950|588562689|FG000|Randomized Phase|Adverse Event|0|||
162962437|NCT00989950|588562690|FG001|Randomized Phase|Adverse Event|1|||
162962438|NCT00989950|588562691|FG002|Randomized Phase|Adverse Event|0|||
162962439|NCT00989950|588562692|FG003|Randomized Phase|Adverse Event|0|||
162962440|NCT00624286|588562695|FG000|Overall Study|Protocol Deviation|7|||
162962441|NCT00624286|588562696|FG001|Overall Study|Protocol Deviation|9|||
162962442|NCT00624286|588562695|FG000|Overall Study|Adverse Event|6|||
162962443|NCT00624286|588562696|FG001|Overall Study|Adverse Event|3|||
162962444|NCT00624286|588562695|FG000|Overall Study|Withdrawal by Subject|5|||
162962445|NCT00624286|588562696|FG001|Overall Study|Withdrawal by Subject|4|||
162962446|NCT00624286|588562695|FG000|Overall Study|Lost to Follow-up|3|||
162962447|NCT00624286|588562696|FG001|Overall Study|Lost to Follow-up|2|||
162962448|NCT00624286|588562695|FG000|Overall Study|Administrative problems|3|||
162962449|NCT00624286|588562696|FG001|Overall Study|Administrative problems|0|||
162962450|NCT00624286|588562695|FG000|Overall Study|Lack of Efficacy|1|||
162962451|NCT00624286|588562696|FG001|Overall Study|Lack of Efficacy|6|||
162962452|NCT00624286|588562695|FG000|Overall Study|Not stated|0|||
162962453|NCT00624286|588562696|FG001|Overall Study|Not stated|1|||
162962454|NCT00624286|588562695|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162962455|NCT00624286|588562696|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162962456|NCT00624286|588562695|FG000|Overall Study|Death|0|||
162962457|NCT00624286|588562696|FG001|Overall Study|Death|1|||
162962458|NCT02845336|588562700|FG000|Overall Study|Lost to Follow-up|3|||
162962459|NCT02845336|588562701|FG001|Overall Study|Lost to Follow-up|1|||
162962460|NCT02845336|588562700|FG000|Overall Study|Inability to get medication|2|||
162962461|NCT02845336|588562701|FG001|Overall Study|Inability to get medication|0|||
162962462|NCT03488108|588562702|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
162962463|NCT03488108|588562703|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162962464|NCT03488108|588562702|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
162962465|NCT03488108|588562703|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
162962466|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Refused|1|||
162962467|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Refused|3|||
163049258|NCT03638128|588888900|FG002|Overall Study|Sponsor Decision|19|||
162962468|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Medical|0|||
162962469|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Medical|1|||
162962470|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
162962471|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
162962472|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
162962473|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
162962474|NCT02054715|588562705|FG000|Baseline/Follow-up 1|No Reason|0|||
162616326|NCT02742441|587313390|FG001|Overall Study|Adverse Event|2|||
162616327|NCT00537238|587313391|FG000|Overall Study|Death|1|||
162616328|NCT00537238|587313392|FG001|Overall Study|Death|2|||
162882734|NCT01877382|588268241|FG009|Dose Expansion|Clinical progression|0|||
162882735|NCT01877382|588268242|FG010|Dose Expansion|Clinical progression|0|||
162882736|NCT01877382|588268243|FG011|Dose Expansion|Clinical progression|0|||
162882737|NCT01877382|588268244|FG012|Dose Expansion|Clinical progression|0|||
162882738|NCT01877382|588268245|FG013|Dose Expansion|Clinical progression|0|||
162882739|NCT01877382|588268246|FG014|Dose Expansion|Clinical progression|6|||
162882740|NCT01877382|588268232|FG000|Dose Expansion|Adverse Event|0|||
162882741|NCT01877382|588268233|FG001|Dose Expansion|Adverse Event|0|||
162882742|NCT01877382|588268234|FG002|Dose Expansion|Adverse Event|0|||
162882743|NCT01877382|588268235|FG003|Dose Expansion|Adverse Event|0|||
162882744|NCT01877382|588268236|FG004|Dose Expansion|Adverse Event|0|||
162882745|NCT01877382|588268237|FG005|Dose Expansion|Adverse Event|0|||
162882746|NCT01877382|588268238|FG006|Dose Expansion|Adverse Event|0|||
162882747|NCT01877382|588268239|FG007|Dose Expansion|Adverse Event|0|||
162882748|NCT01877382|588268240|FG008|Dose Expansion|Adverse Event|0|||
162882749|NCT01877382|588268241|FG009|Dose Expansion|Adverse Event|0|||
162882750|NCT01877382|588268242|FG010|Dose Expansion|Adverse Event|0|||
162882751|NCT01877382|588268243|FG011|Dose Expansion|Adverse Event|0|||
162882752|NCT01877382|588268244|FG012|Dose Expansion|Adverse Event|0|||
162882753|NCT01877382|588268245|FG013|Dose Expansion|Adverse Event|0|||
162882754|NCT01877382|588268246|FG014|Dose Expansion|Adverse Event|1|||
162882755|NCT01877382|588268232|FG000|Dose Expansion|Death|0|||
162882756|NCT01877382|588268233|FG001|Dose Expansion|Death|0|||
162882757|NCT01877382|588268234|FG002|Dose Expansion|Death|0|||
162882758|NCT01877382|588268235|FG003|Dose Expansion|Death|0|||
162882759|NCT01877382|588268236|FG004|Dose Expansion|Death|0|||
162882760|NCT01877382|588268237|FG005|Dose Expansion|Death|0|||
162962475|NCT02054715|588562706|FG001|Baseline/Follow-up 1|No Reason|1|||
162962476|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
162616329|NCT00537238|587313391|FG000|Overall Study|Adverse Event|31|||
162616330|NCT00537238|587313392|FG001|Overall Study|Adverse Event|22|||
162616331|NCT00537238|587313391|FG000|Overall Study|Lack of Efficacy|20|||
162616332|NCT00537238|587313392|FG001|Overall Study|Lack of Efficacy|21|||
162616333|NCT00537238|587313391|FG000|Overall Study|Lost to Follow-up|12|||
162616334|NCT00537238|587313392|FG001|Overall Study|Lost to Follow-up|8|||
162616335|NCT00537238|587313391|FG000|Overall Study|Withdrawal by Subject|51|||
162616336|NCT00537238|587313392|FG001|Overall Study|Withdrawal by Subject|47|||
162616337|NCT00537238|587313391|FG000|Overall Study|Protocol Violation|15|||
162616338|NCT00537238|587313392|FG001|Overall Study|Protocol Violation|19|||
162616339|NCT00537238|587313391|FG000|Overall Study|Does not meet entrance criteria|0|||
162616340|NCT00537238|587313392|FG001|Overall Study|Does not meet entrance criteria|2|||
162616341|NCT00537238|587313391|FG000|Overall Study|Other|44|||
162616342|NCT00537238|587313392|FG001|Overall Study|Other|52|||
162616343|NCT01824342|587313395|FG000|Overall Study|Withdrawal by Subject|0|||
162616344|NCT01824342|587313396|FG001|Overall Study|Withdrawal by Subject|3|||
162616345|NCT01824342|587313395|FG000|Overall Study|Adverse Event|1|||
162616346|NCT01824342|587313396|FG001|Overall Study|Adverse Event|1|||
162616347|NCT01824342|587313395|FG000|Overall Study|Disease Progression|1|||
162616348|NCT01824342|587313396|FG001|Overall Study|Disease Progression|1|||
162616349|NCT01824342|587313395|FG000|Overall Study|Physician Decision|5|||
162616350|NCT01824342|587313396|FG001|Overall Study|Physician Decision|0|||
162616351|NCT01824342|587313395|FG000|Overall Study|Death|2|||
162616352|NCT01824342|587313396|FG001|Overall Study|Death|0|||
162616353|NCT01926015|587313397|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162616354|NCT01926015|587313398|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162616355|NCT01926015|587313397|FG000|Overall Study|Randomized not treated|2|||
162616356|NCT01926015|587313398|FG001|Overall Study|Randomized not treated|0|||
162962477|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
162962478|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Ineligible|3|||
162962479|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Ineligible|0|||
162962480|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Hospitalization|1|||
162962481|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Hospitalization|0|||
162962482|NCT02054715|588562705|FG000|Baseline/Follow-up 1|Changed Mind|1|||
162962483|NCT02054715|588562706|FG001|Baseline/Follow-up 1|Changed Mind|0|||
162962484|NCT02054715|588562705|FG000|Follow-up 2|Lost to Followup|3|||
162962485|NCT02054715|588562706|FG001|Follow-up 2|Lost to Followup|1|||
162882761|NCT01877382|588268238|FG006|Dose Expansion|Death|0|||
162882762|NCT01877382|588268239|FG007|Dose Expansion|Death|0|||
162882763|NCT01877382|588268240|FG008|Dose Expansion|Death|0|||
162882764|NCT01877382|588268241|FG009|Dose Expansion|Death|0|||
162882765|NCT01877382|588268242|FG010|Dose Expansion|Death|0|||
162882766|NCT01877382|588268243|FG011|Dose Expansion|Death|0|||
162882767|NCT01877382|588268244|FG012|Dose Expansion|Death|0|||
162882768|NCT01877382|588268245|FG013|Dose Expansion|Death|0|||
162882769|NCT01877382|588268246|FG014|Dose Expansion|Death|1|||
162962486|NCT02054715|588562705|FG000|Follow-up 2|Refused|3|||
162962487|NCT02054715|588562706|FG001|Follow-up 2|Refused|2|||
162962488|NCT02054715|588562705|FG000|Follow-up 2|Followup Not Completed|3|||
162616357|NCT01364649|587313399|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
162616358|NCT01364649|587313400|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
162616359|NCT01364649|587313399|FG000|Overall Study|Lack of Efficacy|6|||
162616360|NCT01364649|587313400|FG001|Overall Study|Lack of Efficacy|0|||
162882770|NCT01877382|588268232|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882771|NCT01877382|588268233|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882772|NCT01877382|588268234|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882773|NCT01877382|588268235|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882774|NCT01877382|588268236|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882775|NCT01877382|588268237|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882776|NCT01877382|588268238|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882777|NCT01877382|588268239|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882778|NCT01877382|588268240|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882779|NCT01877382|588268241|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882780|NCT01877382|588268242|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882781|NCT01877382|588268243|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882782|NCT01877382|588268244|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882783|NCT01877382|588268245|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
162882784|NCT01877382|588268246|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
162882785|NCT03423979|588268247|FG000|Overall Study|Death|5|||
162882786|NCT03423979|588268247|FG000|Overall Study|Adverse Event|4|||
162882787|NCT03423979|588268247|FG000|Overall Study|Withdrawal by Subject|3|||
162882788|NCT03423979|588268247|FG000|Overall Study|Lost to Follow-up|16|||
162882789|NCT00808249|588268250|FG000|Overall Study|Adverse Event|4|||
162882790|NCT00808249|588268251|FG001|Overall Study|Adverse Event|7|||
162882791|NCT00808249|588268252|FG002|Overall Study|Adverse Event|10|||
162882792|NCT00808249|588268253|FG003|Overall Study|Adverse Event|6|||
162882793|NCT00808249|588268250|FG000|Overall Study|Lost to Follow-up|2|||
162882794|NCT00808249|588268251|FG001|Overall Study|Lost to Follow-up|3|||
162882795|NCT00808249|588268252|FG002|Overall Study|Lost to Follow-up|3|||
162882796|NCT00808249|588268253|FG003|Overall Study|Lost to Follow-up|5|||
162882797|NCT00808249|588268250|FG000|Overall Study|Withdrawal by Subject|4|||
162882798|NCT00808249|588268251|FG001|Overall Study|Withdrawal by Subject|0|||
162882799|NCT00808249|588268252|FG002|Overall Study|Withdrawal by Subject|2|||
162882800|NCT00808249|588268253|FG003|Overall Study|Withdrawal by Subject|4|||
162882801|NCT00808249|588268250|FG000|Overall Study|Protocol Violation|3|||
162882802|NCT00808249|588268251|FG001|Overall Study|Protocol Violation|3|||
162882803|NCT00808249|588268252|FG002|Overall Study|Protocol Violation|3|||
162882804|NCT00808249|588268253|FG003|Overall Study|Protocol Violation|0|||
162882805|NCT00808249|588268250|FG000|Overall Study|Lack of Efficacy|1|||
162882806|NCT00808249|588268251|FG001|Overall Study|Lack of Efficacy|1|||
163049259|NCT03638128|588888898|FG000|Overall Study|Lost to Follow-up|0|||
163049260|NCT03638128|588888899|FG001|Overall Study|Lost to Follow-up|0|||
163049261|NCT03638128|588888900|FG002|Overall Study|Lost to Follow-up|1|||
163049262|NCT03163446|588888901|FG000|Overall Study|Unable to return for Day 180 visit|2|||
163049263|NCT03163446|588888902|FG001|Overall Study|Unable to return for Day 180 visit|0|||
163049264|NCT03163446|588888901|FG000|Overall Study|Withdrawal by Subject|2|||
163049265|NCT03163446|588888902|FG001|Overall Study|Withdrawal by Subject|6|||
163049266|NCT03163446|588888901|FG000|Overall Study|Death|16|||
162882807|NCT00808249|588268252|FG002|Overall Study|Lack of Efficacy|0|||
162882808|NCT00808249|588268253|FG003|Overall Study|Lack of Efficacy|0|||
162616361|NCT01364649|587313399|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
162616362|NCT01364649|587313400|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
162882809|NCT00808249|588268250|FG000|Overall Study|study specific discontinuation criteria|1|||
162882810|NCT00808249|588268251|FG001|Overall Study|study specific discontinuation criteria|0|||
162882811|NCT00808249|588268252|FG002|Overall Study|study specific discontinuation criteria|1|||
162882812|NCT00808249|588268253|FG003|Overall Study|study specific discontinuation criteria|0|||
163049267|NCT03163446|588888902|FG001|Overall Study|Death|5|||
163049268|NCT03163446|588888901|FG000|Overall Study|Lost to Follow-up|6|||
163049269|NCT03163446|588888902|FG001|Overall Study|Lost to Follow-up|5|||
163049270|NCT03163446|588888901|FG000|Overall Study|Physician Decision|1|||
163049271|NCT03163446|588888902|FG001|Overall Study|Physician Decision|1|||
163049272|NCT03163446|588888901|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
163049273|NCT03163446|588888902|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
163049274|NCT00611806|588888904|FG000|Overall Study|Withdrawal by Subject|8|||
162616363|NCT01364649|587313399|FG000|Overall Study|Protocol Deviations|4|||
162616364|NCT01364649|587313400|FG001|Overall Study|Protocol Deviations|8|||
162882813|NCT00808249|588268250|FG000|Overall Study|All other reasons|2|||
162882814|NCT00808249|588268251|FG001|Overall Study|All other reasons|1|||
162882815|NCT00808249|588268252|FG002|Overall Study|All other reasons|3|||
162882816|NCT00808249|588268253|FG003|Overall Study|All other reasons|1|||
162882817|NCT05108805|588268257|FG000|Overall Study|T-cell expansion was not successful.|5|||
162882818|NCT04095286|588268258|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882819|NCT04095286|588268259|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
162882820|NCT04095286|588268260|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882821|NCT04095286|588268261|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882822|NCT04095286|588268262|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882823|NCT04095286|588268263|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882824|NCT04095286|588268258|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
162882825|NCT04095286|588268259|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
162882826|NCT04095286|588268260|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
162882827|NCT04095286|588268261|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
162882828|NCT04095286|588268262|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
162882829|NCT04095286|588268263|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
162882830|NCT04095286|588268258|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
162882831|NCT04095286|588268259|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
162882832|NCT04095286|588268260|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
162882833|NCT04095286|588268261|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
162882834|NCT04095286|588268262|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
162882835|NCT04095286|588268263|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
162882836|NCT04095286|588268258|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882837|NCT04095286|588268259|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882838|NCT04095286|588268260|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
162882839|NCT04095286|588268261|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882840|NCT04095286|588268262|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882841|NCT04095286|588268263|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
162882842|NCT04095286|588268258|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
162882843|NCT04095286|588268259|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
162882844|NCT04095286|588268260|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
162882845|NCT04095286|588268261|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
162882846|NCT04095286|588268262|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
162882847|NCT04095286|588268263|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
162882848|NCT02509494|588268264|FG000|Overall Study|Lost to Follow-up|8|||
162882849|NCT02509494|588268265|FG001|Overall Study|Lost to Follow-up|47|||
162882850|NCT02509494|588268266|FG002|Overall Study|Lost to Follow-up|19|||
162882851|NCT02509494|588268267|FG003|Overall Study|Lost to Follow-up|6|||
162882852|NCT02509494|588268268|FG004|Overall Study|Lost to Follow-up|3|||
162882853|NCT02509494|588268269|FG005|Overall Study|Lost to Follow-up|3|||
162882854|NCT02509494|588268270|FG006|Overall Study|Lost to Follow-up|1|||
162882855|NCT02509494|588268271|FG007|Overall Study|Lost to Follow-up|3|||
162882856|NCT02509494|588268272|FG008|Overall Study|Lost to Follow-up|1|||
162882857|NCT02509494|588268264|FG000|Overall Study|Physician Decision|2|||
162882858|NCT02509494|588268265|FG001|Overall Study|Physician Decision|1|||
162882859|NCT02509494|588268266|FG002|Overall Study|Physician Decision|0|||
162882860|NCT02509494|588268267|FG003|Overall Study|Physician Decision|0|||
162882861|NCT02509494|588268268|FG004|Overall Study|Physician Decision|0|||
162882862|NCT02509494|588268269|FG005|Overall Study|Physician Decision|0|||
162882863|NCT02509494|588268270|FG006|Overall Study|Physician Decision|0|||
162882864|NCT02509494|588268271|FG007|Overall Study|Physician Decision|0|||
162882865|NCT02509494|588268272|FG008|Overall Study|Physician Decision|0|||
162882866|NCT02509494|588268264|FG000|Overall Study|Withdrawal by Subject|4|||
162882867|NCT02509494|588268265|FG001|Overall Study|Withdrawal by Subject|17|||
162882868|NCT02509494|588268266|FG002|Overall Study|Withdrawal by Subject|7|||
162882869|NCT02509494|588268267|FG003|Overall Study|Withdrawal by Subject|5|||
162882870|NCT02509494|588268268|FG004|Overall Study|Withdrawal by Subject|0|||
162882871|NCT02509494|588268269|FG005|Overall Study|Withdrawal by Subject|6|||
163049275|NCT00611806|588888905|FG001|Overall Study|Withdrawal by Subject|2|||
163049276|NCT00611806|588888904|FG000|Overall Study|Adverse Event|2|||
162707668|NCT04541186|587638299|FG000|Main Study|COVID-19-related Dose Interruption|0|||
162707669|NCT04541186|587638300|FG001|Main Study|COVID-19-related Dose Interruption|0|||
162707670|NCT04541186|587638301|FG002|Main Study|COVID-19-related Dose Interruption|0|||
162882872|NCT02509494|588268270|FG006|Overall Study|Withdrawal by Subject|1|||
162882873|NCT02509494|588268271|FG007|Overall Study|Withdrawal by Subject|2|||
162882874|NCT02509494|588268272|FG008|Overall Study|Withdrawal by Subject|1|||
162882875|NCT02509494|588268264|FG000|Overall Study|Death|0|||
162882876|NCT02509494|588268265|FG001|Overall Study|Death|1|||
162882877|NCT02509494|588268266|FG002|Overall Study|Death|0|||
162882878|NCT02509494|588268267|FG003|Overall Study|Death|0|||
162882879|NCT02509494|588268268|FG004|Overall Study|Death|1|||
162707671|NCT04541186|587638302|FG003|Main Study|COVID-19-related Dose Interruption|0|||
162707672|NCT04541186|587638303|FG004|Main Study|COVID-19-related Dose Interruption|1|||
163049277|NCT00611806|588888905|FG001|Overall Study|Adverse Event|1|||
162882880|NCT02509494|588268269|FG005|Overall Study|Death|0|||
162882881|NCT02509494|588268270|FG006|Overall Study|Death|0|||
162882882|NCT02509494|588268271|FG007|Overall Study|Death|1|||
162882883|NCT02509494|588268272|FG008|Overall Study|Death|0|||
162882884|NCT02509494|588268264|FG000|Overall Study|Other|0|||
162882885|NCT02509494|588268265|FG001|Overall Study|Other|4|||
162882886|NCT02509494|588268266|FG002|Overall Study|Other|5|||
162882887|NCT02509494|588268267|FG003|Overall Study|Other|0|||
162882888|NCT02509494|588268268|FG004|Overall Study|Other|0|||
162882889|NCT02509494|588268269|FG005|Overall Study|Other|0|||
162882890|NCT02509494|588268270|FG006|Overall Study|Other|0|||
162882891|NCT02509494|588268271|FG007|Overall Study|Other|0|||
162882892|NCT02509494|588268272|FG008|Overall Study|Other|0|||
162882893|NCT02509494|588268264|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162882894|NCT02509494|588268265|FG001|Overall Study|Non-Compliance With Study Drug|11|||
162882895|NCT02509494|588268266|FG002|Overall Study|Non-Compliance With Study Drug|7|||
162882896|NCT02509494|588268267|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162882897|NCT02509494|588268268|FG004|Overall Study|Non-Compliance With Study Drug|1|||
162882898|NCT02509494|588268269|FG005|Overall Study|Non-Compliance With Study Drug|2|||
162882899|NCT02509494|588268270|FG006|Overall Study|Non-Compliance With Study Drug|1|||
162882900|NCT02509494|588268271|FG007|Overall Study|Non-Compliance With Study Drug|1|||
162882901|NCT02509494|588268272|FG008|Overall Study|Non-Compliance With Study Drug|0|||
162882902|NCT03003403|588268273|FG000|Overall Study|Ineligible|8|||
162882903|NCT03003403|588268274|FG001|Overall Study|Ineligible|7|||
162882904|NCT03003403|588268273|FG000|Overall Study|Withdrawal by Subject|3|||
162882905|NCT03003403|588268274|FG001|Overall Study|Withdrawal by Subject|1|||
162882906|NCT05084053|588269953|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
162882907|NCT05084053|588269954|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
162882908|NCT05084053|588269955|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
162882909|NCT05084053|588269956|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
162882910|NCT05084053|588269953|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
162882911|NCT05084053|588269954|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
162882912|NCT05084053|588269955|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
162882913|NCT05084053|588269956|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
162882914|NCT05084053|588269953|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
162882915|NCT05084053|588269954|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
162882916|NCT05084053|588269955|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
162882917|NCT05084053|588269956|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
162882918|NCT01255306|588269960|FG000|Overall Study|Physician Decision|1|||
162882919|NCT01255306|588269961|FG001|Overall Study|Physician Decision|1|||
162882920|NCT01179347|588269966|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
162882921|NCT01179347|588269967|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
162882922|NCT01179347|588269966|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
162882923|NCT01179347|588269967|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
162882924|NCT01179347|588269966|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
162882925|NCT01179347|588269967|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
162882926|NCT01179347|588269966|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
162882927|NCT01179347|588269967|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
162882928|NCT01179347|588269966|FG000|Double-blind Period (12 Weeks)|Other|2|||
162882929|NCT01179347|588269967|FG001|Double-blind Period (12 Weeks)|Other|4|||
162882930|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
162882931|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
162882932|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
162882933|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
162882934|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
162882935|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
162882936|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
162882937|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
162882938|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
162882939|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
162882940|NCT01179347|588269966|FG000|Open-label Period (12 Weeks)|Other|7|||
162882941|NCT01179347|588269967|FG001|Open-label Period (12 Weeks)|Other|4|||
162882942|NCT01677624|588269969|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
162882943|NCT01617655|588269973|FG000|Overall Study|Adverse Event|2|||
162882944|NCT01617655|588269974|FG001|Overall Study|Adverse Event|3|||
162882945|NCT01617655|588269973|FG000|Overall Study|Poor compliance to protocol|1|||
162882946|NCT01617655|588269974|FG001|Overall Study|Poor compliance to protocol|4|||
162882947|NCT01617655|588269973|FG000|Overall Study|Participants moved|0|||
162882948|NCT01617655|588269974|FG001|Overall Study|Participants moved|4|||
162962489|NCT02054715|588562706|FG001|Follow-up 2|Followup Not Completed|4|||
162707673|NCT04541186|587638299|FG000|Main Study|Randomized in Error Not Treated|0|||
162962490|NCT02054715|588562705|FG000|Follow-up 2|Ineligible|4|||
162707674|NCT04541186|587638300|FG001|Main Study|Randomized in Error Not Treated|0|||
162882949|NCT01617655|588269973|FG000|Overall Study|Consent withdrawn by participant|1|||
162962491|NCT02054715|588562706|FG001|Follow-up 2|Ineligible|5|||
162882950|NCT01617655|588269974|FG001|Overall Study|Consent withdrawn by participant|1|||
162616365|NCT01364649|587313399|FG000|Overall Study|Withdrawal of Consent|9|||
162616366|NCT01364649|587313400|FG001|Overall Study|Withdrawal of Consent|7|||
162616367|NCT01364649|587313399|FG000|Overall Study|Lost to Follow-up|12|||
162616368|NCT01364649|587313400|FG001|Overall Study|Lost to Follow-up|13|||
162616369|NCT01364649|587313399|FG000|Overall Study|Other|4|||
162616370|NCT01364649|587313400|FG001|Overall Study|Other|1|||
162616371|NCT01826604|587313401|FG000|Overall Study|Lost to Follow-up|8|||
162616372|NCT01826604|587313402|FG001|Overall Study|Lost to Follow-up|9|||
162616373|NCT06132659|587313403|FG000|Overall Study|Lost to Follow-up|0|||
162616374|NCT06132659|587313404|FG001|Overall Study|Lost to Follow-up|1|||
162882951|NCT01617655|588269973|FG000|Overall Study|Last visit outside protocol visit window|1|||
162882952|NCT01617655|588269974|FG001|Overall Study|Last visit outside protocol visit window|10|||
162882953|NCT01617655|588269973|FG000|Overall Study|Site closure|3|||
162882954|NCT01617655|588269974|FG001|Overall Study|Site closure|5|||
162882955|NCT01617655|588269973|FG000|Overall Study|Other than specified above|1|||
162882956|NCT01617655|588269974|FG001|Overall Study|Other than specified above|2|||
162882957|NCT01175213|588269975|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
162882958|NCT01175213|588269976|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
162882959|NCT01175213|588269975|FG000|IGSC, 10%/rHuPH20|Death|1|||
162882960|NCT01175213|588269976|FG001|IGSC, 10%/rHuPH20|Death|0|||
162882961|NCT01175213|588269975|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
162882962|NCT01175213|588269976|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
162882963|NCT01175213|588269975|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
162882964|NCT01175213|588269976|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
162882965|NCT01175213|588269975|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
162882966|NCT01175213|588269976|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
162882967|NCT01175213|588269975|FG000|Safety Follow-up|Adverse Event|1|||
162882968|NCT01175213|588269976|FG001|Safety Follow-up|Adverse Event|0|||
162882969|NCT05279898|588269984|FG000|Overall Study|Withdrawal by Subject|1|||
162882970|NCT05279898|588269985|FG001|Overall Study|Withdrawal by Subject|0|||
162882971|NCT05279898|588269984|FG000|Overall Study|Physician Decision|1|||
162882972|NCT05279898|588269985|FG001|Overall Study|Physician Decision|1|||
162882973|NCT04580394|588269986|FG000|First Intervention|Incorrectly Randomized|1|||
162962492|NCT02054715|588562705|FG000|Follow-up 2|Death|3|||
162962493|NCT02054715|588562706|FG001|Follow-up 2|Death|3|||
162962494|NCT02054715|588562705|FG000|Follow-up 2|Hospitalization|0|||
162962495|NCT02054715|588562706|FG001|Follow-up 2|Hospitalization|2|||
162962496|NCT02054715|588562705|FG000|Follow-up 2|Changed MD/Facility|0|||
162962497|NCT02054715|588562706|FG001|Follow-up 2|Changed MD/Facility|1|||
162962498|NCT02054715|588562705|FG000|Follow-up 2|Changed Mind|0|||
162962499|NCT02054715|588562706|FG001|Follow-up 2|Changed Mind|1|||
162962500|NCT02054715|588562705|FG000|Follow-up 2|No Reason|2|||
162962501|NCT02054715|588562706|FG001|Follow-up 2|No Reason|0|||
162962502|NCT02054715|588562705|FG000|Follow-up 2|Treatment Change or Delay|1|||
162962503|NCT02054715|588562706|FG001|Follow-up 2|Treatment Change or Delay|0|||
162962504|NCT01442376|588562711|FG000|Overall Study|Adverse Event|0|||
162962505|NCT01442376|588562712|FG001|Overall Study|Adverse Event|3|||
162962506|NCT01442376|588562713|FG002|Overall Study|Adverse Event|2|||
162962507|NCT01442376|588562711|FG000|Overall Study|Death|0|||
162962508|NCT01442376|588562712|FG001|Overall Study|Death|1|||
162962509|NCT01442376|588562713|FG002|Overall Study|Death|1|||
162962510|NCT01442376|588562711|FG000|Overall Study|Withdrawal of consent|0|||
162962511|NCT01442376|588562712|FG001|Overall Study|Withdrawal of consent|0|||
162962512|NCT01442376|588562713|FG002|Overall Study|Withdrawal of consent|1|||
162962513|NCT01442376|588562711|FG000|Overall Study|Patients not treated|2|||
162962514|NCT01442376|588562712|FG001|Overall Study|Patients not treated|3|||
162962515|NCT01442376|588562713|FG002|Overall Study|Patients not treated|1|||
162962516|NCT01442376|588562711|FG000|Overall Study|Not eligible for subsequent cycles|1|||
162962517|NCT01442376|588562712|FG001|Overall Study|Not eligible for subsequent cycles|2|||
162962518|NCT01442376|588562713|FG002|Overall Study|Not eligible for subsequent cycles|0|||
162962519|NCT04404725|588562714|FG000|First Intervention|Withdrawal by Subject|0|||
162962520|NCT04404725|588562715|FG001|First Intervention|Withdrawal by Subject|2|||
162616375|NCT06132659|587313405|FG002|Overall Study|Lost to Follow-up|0|||
162616376|NCT03615326|587313406|FG000|Overall Study|Death|266|||
162616377|NCT03615326|587313407|FG001|Overall Study|Death|286|||
162882974|NCT04580394|588269986|FG000|First Intervention|Physician Decision|1|||
162882975|NCT04580394|588269986|FG000|First Intervention|Lost to Follow-up|1|||
162882976|NCT04580394|588269986|FG000|Washout (One Week)|Withdrawal by Subject|1|||
162882977|NCT04580394|588269986|FG000|Washout (One Week)|Adverse Event|1|||
162962521|NCT04404725|588562714|FG000|Second Intervention|Adverse Event|1|||
162962522|NCT04404725|588562715|FG001|Second Intervention|Adverse Event|1|||
162962523|NCT04404725|588562714|FG000|Second Intervention|Withdrawal by Subject|0|||
162962524|NCT04404725|588562715|FG001|Second Intervention|Withdrawal by Subject|1|||
162962525|NCT01075516|588562716|FG000|Overall Study|Death|5|||
162962526|NCT01075516|588562717|FG001|Overall Study|Death|9|||
162962527|NCT01075516|588562716|FG000|Overall Study|Lost to Follow-up|10|||
162962528|NCT01075516|588562717|FG001|Overall Study|Lost to Follow-up|2|||
162962529|NCT01075516|588562716|FG000|Overall Study|Withdrawal by Subject|3|||
162882978|NCT04580394|588269986|FG000|Washout (One Week)|Withdrawal by Subject|2|||
162882979|NCT04580394|588269986|FG000|Third Intervention|Adverse Event|1|||
162882980|NCT04580394|588269986|FG000|Third Intervention|Withdrawal by Subject|1|||
162882981|NCT04580394|588269986|FG000|Washout (One Week)|Withdrawal by Subject|2|||
162882982|NCT03201965|588269995|FG000|Overall Study|Death|5|||
162882983|NCT03201965|588269996|FG001|Overall Study|Death|65|||
162882984|NCT03201965|588269997|FG002|Overall Study|Death|47|||
163049278|NCT00611806|588888904|FG000|Overall Study|Lost to Follow-up|6|||
163049279|NCT00611806|588888905|FG001|Overall Study|Lost to Follow-up|0|||
163049280|NCT00903201|588888906|FG000|Overall Study|Adverse Event|1|||
163049281|NCT00903201|588888907|FG001|Overall Study|Adverse Event|4|||
163049282|NCT00903201|588888908|FG002|Overall Study|Adverse Event|0|||
163049283|NCT00903201|588888906|FG000|Overall Study|Protocol Violation|2|||
163049284|NCT00903201|588888907|FG001|Overall Study|Protocol Violation|1|||
163049285|NCT00903201|588888908|FG002|Overall Study|Protocol Violation|0|||
163049286|NCT00903201|588888906|FG000|Overall Study|Lost to Follow-up|0|||
163049287|NCT00903201|588888907|FG001|Overall Study|Lost to Follow-up|1|||
163049288|NCT00903201|588888908|FG002|Overall Study|Lost to Follow-up|0|||
163049289|NCT00903201|588888906|FG000|Overall Study|Physician Decision|1|||
163049290|NCT00903201|588888907|FG001|Overall Study|Physician Decision|0|||
163049291|NCT00903201|588888908|FG002|Overall Study|Physician Decision|1|||
163049292|NCT00903201|588888906|FG000|Overall Study|Withdrawal by Subject|1|||
163049293|NCT00903201|588888907|FG001|Overall Study|Withdrawal by Subject|0|||
163049294|NCT00903201|588888908|FG002|Overall Study|Withdrawal by Subject|1|||
163049295|NCT01094288|588888911|FG000|Overall Study|Adverse Event|0|||
163049296|NCT01094288|588888912|FG001|Overall Study|Adverse Event|3|||
163049297|NCT01094288|588888913|FG002|Overall Study|Adverse Event|1|||
163049298|NCT01094288|588888914|FG003|Overall Study|Adverse Event|1|||
163049299|NCT01094288|588888915|FG004|Overall Study|Adverse Event|0|||
163049300|NCT01094288|588888916|FG005|Overall Study|Adverse Event|0|||
163049301|NCT01094288|588888917|FG006|Overall Study|Adverse Event|0|||
163049302|NCT01094288|588888918|FG007|Overall Study|Adverse Event|0|||
163049303|NCT01094288|588888911|FG000|Overall Study|Withdrawal by Subject|0|||
163049304|NCT01094288|588888912|FG001|Overall Study|Withdrawal by Subject|1|||
163049305|NCT01094288|588888913|FG002|Overall Study|Withdrawal by Subject|2|||
163049306|NCT01094288|588888914|FG003|Overall Study|Withdrawal by Subject|0|||
163049307|NCT01094288|588888915|FG004|Overall Study|Withdrawal by Subject|0|||
163049308|NCT01094288|588888916|FG005|Overall Study|Withdrawal by Subject|0|||
163049309|NCT01094288|588888917|FG006|Overall Study|Withdrawal by Subject|0|||
163049310|NCT01094288|588888918|FG007|Overall Study|Withdrawal by Subject|2|||
163049311|NCT01094288|588888911|FG000|Overall Study|Initiation of Alternative Therapy|0|||
163049312|NCT01094288|588888912|FG001|Overall Study|Initiation of Alternative Therapy|0|||
163049313|NCT01094288|588888913|FG002|Overall Study|Initiation of Alternative Therapy|1|||
163049314|NCT01094288|588888914|FG003|Overall Study|Initiation of Alternative Therapy|0|||
163049315|NCT01094288|588888915|FG004|Overall Study|Initiation of Alternative Therapy|0|||
163049316|NCT01094288|588888916|FG005|Overall Study|Initiation of Alternative Therapy|0|||
163049317|NCT01094288|588888917|FG006|Overall Study|Initiation of Alternative Therapy|0|||
163049318|NCT01094288|588888918|FG007|Overall Study|Initiation of Alternative Therapy|0|||
163049319|NCT01094288|588888911|FG000|Overall Study|Reason not Specified|2|||
163049320|NCT01094288|588888912|FG001|Overall Study|Reason not Specified|3|||
163049321|NCT01094288|588888913|FG002|Overall Study|Reason not Specified|0|||
163049322|NCT01094288|588888914|FG003|Overall Study|Reason not Specified|1|||
163049323|NCT01094288|588888915|FG004|Overall Study|Reason not Specified|0|||
163049324|NCT01094288|588888916|FG005|Overall Study|Reason not Specified|0|||
163049325|NCT01094288|588888917|FG006|Overall Study|Reason not Specified|0|||
163049326|NCT01094288|588888918|FG007|Overall Study|Reason not Specified|0|||
163049327|NCT01094288|588888911|FG000|Overall Study|Ongoing Participants|0|||
163049328|NCT01094288|588888912|FG001|Overall Study|Ongoing Participants|3|||
163049329|NCT01094288|588888913|FG002|Overall Study|Ongoing Participants|0|||
163049330|NCT01094288|588888914|FG003|Overall Study|Ongoing Participants|0|||
162882985|NCT03201965|588269995|FG000|Overall Study|Lost to Follow-up|0|||
162882986|NCT03201965|588269996|FG001|Overall Study|Lost to Follow-up|6|||
163049331|NCT01094288|588888915|FG004|Overall Study|Ongoing Participants|0|||
163049332|NCT01094288|588888916|FG005|Overall Study|Ongoing Participants|0|||
163049333|NCT01094288|588888917|FG006|Overall Study|Ongoing Participants|0|||
163049334|NCT01094288|588888918|FG007|Overall Study|Ongoing Participants|0|||
163049335|NCT00945243|588888919|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
163049336|NCT00754741|588888920|FG000|Overall Study|Died or disenrolled|57|||
163049337|NCT00754741|588888921|FG001|Overall Study|Died or disenrolled|69|||
163049338|NCT00754741|588888922|FG002|Overall Study|Died or disenrolled|54|||
163049339|NCT04152200|588888923|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
163049340|NCT04152200|588888924|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
163049341|NCT04969289|588888925|FG000|Overall Study|Lost to Follow-up|13|||
163049342|NCT04969289|588888926|FG001|Overall Study|Lost to Follow-up|9|||
163049343|NCT02699996|588888927|FG000|Overall Study|Withdrawal by Subject|5|||
163049344|NCT02699996|588888928|FG001|Overall Study|Withdrawal by Subject|2|||
163049345|NCT04069715|588888929|FG000|Overall Study|Lost to Follow-up|1|||
163049346|NCT04069715|588888930|FG001|Overall Study|Lost to Follow-up|1|||
163049347|NCT04069715|588888929|FG000|Overall Study|Physician Decision|1|||
163049348|NCT04069715|588888930|FG001|Overall Study|Physician Decision|1|||
163049349|NCT04069715|588888929|FG000|Overall Study|Withdrawal by Subject|3|||
163049350|NCT04069715|588888930|FG001|Overall Study|Withdrawal by Subject|3|||
163049351|NCT02486692|588888933|FG000|Overall Study|did not login for randomization|4|||
163049352|NCT02486692|588888934|FG001|Overall Study|did not login for randomization|7|||
163049353|NCT02063672|588888935|FG000|Overall Study|Ongoing Follow-up|27|||
163049354|NCT02063672|588888936|FG001|Overall Study|Ongoing Follow-up|14|||
163049355|NCT02063672|588888935|FG000|Overall Study|Death|5|||
163049356|NCT02063672|588888936|FG001|Overall Study|Death|3|||
163049357|NCT02063672|588888935|FG000|Overall Study|Lost to Follow-up|1|||
163049358|NCT02063672|588888936|FG001|Overall Study|Lost to Follow-up|3|||
163049359|NCT02063672|588888935|FG000|Overall Study|Withdrawal by Subject|2|||
163049360|NCT02063672|588888936|FG001|Overall Study|Withdrawal by Subject|2|||
163049361|NCT01294423|588888938|FG000|Overall Study|Adverse Event|1|||
163049362|NCT01294423|588888939|FG001|Overall Study|Adverse Event|2|||
163049363|NCT01294423|588888940|FG002|Overall Study|Adverse Event|3|||
163049364|NCT01294423|588888938|FG000|Overall Study|Withdrawal by Subject|1|||
163049365|NCT01294423|588888939|FG001|Overall Study|Withdrawal by Subject|2|||
163049366|NCT01294423|588888940|FG002|Overall Study|Withdrawal by Subject|2|||
163049367|NCT01294423|588888938|FG000|Overall Study|subject no longer meets study criteria|2|||
163049368|NCT01294423|588888939|FG001|Overall Study|subject no longer meets study criteria|5|||
162616378|NCT03615326|587313408|FG002|Overall Study|Death|14|||
162616379|NCT03615326|587313409|FG003|Overall Study|Death|17|||
163049369|NCT01294423|588888940|FG002|Overall Study|subject no longer meets study criteria|2|||
163049370|NCT01294423|588888938|FG000|Overall Study|poor/non-compliance|1|||
163049371|NCT01294423|588888939|FG001|Overall Study|poor/non-compliance|0|||
163049372|NCT01294423|588888940|FG002|Overall Study|poor/non-compliance|1|||
162616380|NCT03615326|587313406|FG000|Overall Study|Lost to Follow-up|0|||
162616381|NCT03615326|587313407|FG001|Overall Study|Lost to Follow-up|1|||
163049373|NCT01241279|588888941|FG000|Overall Study|Lost to Follow-up|0|||
163049374|NCT01241279|588888942|FG001|Overall Study|Lost to Follow-up|1|||
163049375|NCT01484951|588888943|FG000|Overall Study|Adverse Event|3|||
163049376|NCT01484951|588888943|FG000|Overall Study|Personal Reasons|1|||
163049377|NCT01484951|588888943|FG000|Overall Study|Non-Compliance|1|||
163049378|NCT02026141|588888945|FG000|Overall Study|Protocol Violation|0|||
163049379|NCT02026141|588888946|FG001|Overall Study|Protocol Violation|1|||
163049380|NCT02169505|588888947|FG000|Overall Study|Withdrawal by Subject|1|||
163049381|NCT01248455|588888948|FG000|Overall Study|switched to alternate treatment|1|||
163049382|NCT02735980|588888949|FG000|Overall Study|Adverse Event|0|||
163049383|NCT02735980|588888950|FG001|Overall Study|Adverse Event|4|||
163049384|NCT02735980|588888951|FG002|Overall Study|Adverse Event|1|||
163049385|NCT02735980|588888949|FG000|Overall Study|Death|5|||
163049386|NCT02735980|588888950|FG001|Overall Study|Death|4|||
162616382|NCT03615326|587313408|FG002|Overall Study|Lost to Follow-up|0|||
162616383|NCT03615326|587313409|FG003|Overall Study|Lost to Follow-up|0|||
162616384|NCT03615326|587313406|FG000|Overall Study|Withdrawal by Subject|1|||
162616385|NCT03615326|587313407|FG001|Overall Study|Withdrawal by Subject|3|||
162616386|NCT03615326|587313408|FG002|Overall Study|Withdrawal by Subject|0|||
162616387|NCT03615326|587313409|FG003|Overall Study|Withdrawal by Subject|0|||
163049387|NCT02735980|588888951|FG002|Overall Study|Death|0|||
163049388|NCT02735980|588888949|FG000|Overall Study|Physician Decision|3|||
163049389|NCT02735980|588888950|FG001|Overall Study|Physician Decision|1|||
163049390|NCT02735980|588888951|FG002|Overall Study|Physician Decision|0|||
163049391|NCT02735980|588888949|FG000|Overall Study|Screen failure|1|||
162616388|NCT03615326|587313406|FG000|Overall Study|Participants Ongoing|83|||
162616389|NCT03615326|587313407|FG001|Overall Study|Participants Ongoing|58|||
162616390|NCT03615326|587313408|FG002|Overall Study|Participants Ongoing|6|||
162616391|NCT03615326|587313409|FG003|Overall Study|Participants Ongoing|3|||
162616392|NCT03794583|587313410|FG000|Overall Study|Death|8|||
162616393|NCT03794583|587313410|FG000|Overall Study|Study Terminated by Sponsor|24|||
162616394|NCT03794583|587313410|FG000|Overall Study|Withdrawal by Subject|9|||
163049392|NCT02735980|588888950|FG001|Overall Study|Screen failure|0|||
162882987|NCT03201965|588269997|FG002|Overall Study|Lost to Follow-up|0|||
162882988|NCT03201965|588269995|FG000|Overall Study|Withdrawal by Subject|3|||
162882989|NCT03201965|588269996|FG001|Overall Study|Withdrawal by Subject|23|||
162882990|NCT03201965|588269997|FG002|Overall Study|Withdrawal by Subject|8|||
162616395|NCT02497612|587313411|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
162616396|NCT02497612|587313412|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
162616397|NCT02497612|587313413|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
162616398|NCT02497612|587313414|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
162616399|NCT02497612|587313411|FG000|Overall Study|Participant's request|2|||
162616400|NCT02497612|587313412|FG001|Overall Study|Participant's request|3|||
162616401|NCT02497612|587313413|FG002|Overall Study|Participant's request|4|||
162616402|NCT02497612|587313414|FG003|Overall Study|Participant's request|1|||
162616403|NCT02497612|587313411|FG000|Overall Study|Investigator's judgement|1|||
162616404|NCT02497612|587313412|FG001|Overall Study|Investigator's judgement|0|||
162616405|NCT02497612|587313413|FG002|Overall Study|Investigator's judgement|0|||
162616406|NCT02497612|587313414|FG003|Overall Study|Investigator's judgement|2|||
162616407|NCT02497612|587313411|FG000|Overall Study|Adverse Event|3|||
162616408|NCT02497612|587313412|FG001|Overall Study|Adverse Event|1|||
162616409|NCT02497612|587313413|FG002|Overall Study|Adverse Event|4|||
162616410|NCT02497612|587313414|FG003|Overall Study|Adverse Event|1|||
162616411|NCT02497612|587313411|FG000|Overall Study|Lost to Follow-up|1|||
162616412|NCT02497612|587313412|FG001|Overall Study|Lost to Follow-up|1|||
162616413|NCT02497612|587313413|FG002|Overall Study|Lost to Follow-up|0|||
162616414|NCT02497612|587313414|FG003|Overall Study|Lost to Follow-up|1|||
162616415|NCT02497612|587313411|FG000|Overall Study|Other unspecified|1|||
162616416|NCT02497612|587313412|FG001|Overall Study|Other unspecified|1|||
162616417|NCT02497612|587313413|FG002|Overall Study|Other unspecified|2|||
162616418|NCT02497612|587313414|FG003|Overall Study|Other unspecified|0|||
162616419|NCT02497612|587313411|FG000|Overall Study|Not eligible|1|||
162616420|NCT02497612|587313412|FG001|Overall Study|Not eligible|0|||
162616421|NCT02497612|587313413|FG002|Overall Study|Not eligible|0|||
162616422|NCT02497612|587313414|FG003|Overall Study|Not eligible|1|||
162616423|NCT02651467|587313415|FG000|Overall Study|Withdrawal by Subject|0|||
162616424|NCT02651467|587313416|FG001|Overall Study|Withdrawal by Subject|0|||
162616425|NCT02651467|587313417|FG002|Overall Study|Withdrawal by Subject|2|||
162616426|NCT02651467|587313415|FG000|Overall Study|Other (Not specified)|1|||
162616427|NCT02651467|587313416|FG001|Overall Study|Other (Not specified)|0|||
162616428|NCT02651467|587313417|FG002|Overall Study|Other (Not specified)|2|||
162616429|NCT02477839|587313418|FG000|Overall Study|Adverse Event|0|||
162616430|NCT02477839|587313419|FG001|Overall Study|Adverse Event|1|||
162616431|NCT02477839|587313418|FG000|Overall Study|Protocol Violation|0|||
162616432|NCT02477839|587313419|FG001|Overall Study|Protocol Violation|2|||
162616433|NCT02477839|587313418|FG000|Overall Study|Withdrawal by Subject|3|||
162616434|NCT02477839|587313419|FG001|Overall Study|Withdrawal by Subject|3|||
162616435|NCT02477839|587313418|FG000|Overall Study|Participant had PGS during V6|0|||
162616436|NCT02477839|587313419|FG001|Overall Study|Participant had PGS during V6|1|||
162616437|NCT02477839|587313418|FG000|Overall Study|Parents decided to stop medication|0|||
162616438|NCT02477839|587313419|FG001|Overall Study|Parents decided to stop medication|1|||
162616439|NCT02477839|587313418|FG000|Overall Study|Lack of tolerability|0|||
162616440|NCT02477839|587313419|FG001|Overall Study|Lack of tolerability|1|||
162616441|NCT02477839|587313418|FG000|Overall Study|Exclusion criterion|0|||
162616442|NCT02477839|587313419|FG001|Overall Study|Exclusion criterion|1|||
162616443|NCT01439568|587313422|FG000|Overall Study|Lost to Follow-up|1|||
162616444|NCT01439568|587313423|FG001|Overall Study|Lost to Follow-up|0|||
162616445|NCT01439568|587313422|FG000|Overall Study|Withdrawal by Subject|2|||
162616446|NCT01439568|587313423|FG001|Overall Study|Withdrawal by Subject|2|||
162616447|NCT01050543|587313424|FG000|Overall Study|Withdrawal by Subject|0|||
162616448|NCT01050543|587313425|FG001|Overall Study|Withdrawal by Subject|2|||
162616449|NCT01050543|587313424|FG000|Overall Study|Protocol Violation|0|||
162616450|NCT01050543|587313425|FG001|Overall Study|Protocol Violation|1|||
162616451|NCT01050543|587313424|FG000|Overall Study|Administrative|4|||
162616452|NCT01050543|587313425|FG001|Overall Study|Administrative|1|||
162616453|NCT01950169|587313428|FG000|Overall Study|Withdrawal by Subject|2|||
162616454|NCT01950169|587313429|FG001|Overall Study|Withdrawal by Subject|8|||
162616455|NCT01950169|587313430|FG002|Overall Study|Withdrawal by Subject|1|||
162616456|NCT01950169|587313428|FG000|Overall Study|Death|1|||
162616457|NCT01950169|587313429|FG001|Overall Study|Death|0|||
162616458|NCT01950169|587313430|FG002|Overall Study|Death|0|||
162616459|NCT00437320|587313431|FG000|Overall Study|Participant request|2|||
162882991|NCT03201965|588269995|FG000|Overall Study|Sponsor's Decision|20|||
162616460|NCT00437320|587313432|FG001|Overall Study|Participant request|1|||
162616461|NCT00437320|587313433|FG002|Overall Study|Participant request|4|||
162616462|NCT01938573|587313434|FG000|Overall Study|Lack of Efficacy|1|||
162616463|NCT01938573|587313435|FG001|Overall Study|Lack of Efficacy|0|||
162616464|NCT01938573|587313434|FG000|Overall Study|Operation at other hospital|1|||
162616465|NCT01938573|587313435|FG001|Overall Study|Operation at other hospital|0|||
162882992|NCT03201965|588269996|FG001|Overall Study|Sponsor's Decision|99|||
163049393|NCT02735980|588888951|FG002|Overall Study|Screen failure|0|||
162616466|NCT00737438|587313436|FG000|Overall Study|Withdrawal by Subject|2|||
162616467|NCT00737438|587313436|FG000|Overall Study|Patient ineligible|1|||
162616468|NCT02410551|587313437|FG000|Overall Study|Adverse Event|1|||
162616469|NCT02410551|587313437|FG000|Overall Study|Withdrawal by Subject|1|||
162616470|NCT02410551|587313437|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
162616471|NCT05469113|587313438|FG000|Period 2|Adverse Event|0|||
162616472|NCT05469113|587313439|FG001|Period 2|Adverse Event|3|||
162616473|NCT05447897|587313440|FG000|Overall Study|Did not participate in survey|2|||
162616474|NCT04553679|587313441|FG000|Overall Study|Withdrawal by Subject|2|||
162616475|NCT04553679|587313442|FG001|Overall Study|Withdrawal by Subject|0|||
163049394|NCT02735980|588888949|FG000|Overall Study|Withdrawal by Subject|1|||
163049395|NCT02735980|588888950|FG001|Overall Study|Withdrawal by Subject|2|||
163049396|NCT02735980|588888951|FG002|Overall Study|Withdrawal by Subject|0|||
162616476|NCT04553679|587313441|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
162616477|NCT04553679|587313442|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
162616478|NCT01230710|587313444|FG000|Overall Study|Disease Progression|41|||
162616479|NCT01230710|587313444|FG000|Overall Study|Lost to Follow-up|3|||
162616480|NCT01230710|587313444|FG000|Overall Study|Death|4|||
162616481|NCT01230710|587313444|FG000|Overall Study|Withdrawal of Consent|1|||
162616482|NCT02905149|587313445|FG000|Overall Study|Lost to Follow-up|2|||
162616483|NCT02905149|587313446|FG001|Overall Study|Lost to Follow-up|0|||
162616484|NCT00747812|587313447|FG000|Overall Study|Research Site Staff Relocation|5|||
162616485|NCT00747812|587313448|FG001|Overall Study|Research Site Staff Relocation|3|||
162616486|NCT01708161|587313451|FG000|Overall Study|Adverse Event|1|||
163049397|NCT00917124|588888955|FG000|Overall Study|Protocol Violation|4|||
163049398|NCT00917124|588888956|FG001|Overall Study|Protocol Violation|6|||
163049399|NCT01783743|588888957|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
163049400|NCT01783743|588888958|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
163049401|NCT01783743|588888957|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
163049402|NCT01783743|588888958|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
163049403|NCT01783743|588888957|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
163049404|NCT01783743|588888958|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
163049405|NCT00126594|588888973|FG000|Overall Study|Ineligible|2|||
163049406|NCT00126594|588888974|FG001|Overall Study|Ineligible|0|||
163049407|NCT00126594|588888973|FG000|Overall Study|Withdrawal by Subject|0|||
163049408|NCT00126594|588888974|FG001|Overall Study|Withdrawal by Subject|4|||
163049409|NCT00126594|588888973|FG000|Overall Study|Physician Decision|1|||
163049410|NCT00126594|588888974|FG001|Overall Study|Physician Decision|3|||
163049411|NCT00126594|588888973|FG000|Overall Study|Adverse Event|7|||
162882993|NCT03201965|588269997|FG002|Overall Study|Sponsor's Decision|140|||
162882994|NCT03589326|588269998|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
162882995|NCT03589326|588269999|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
162882996|NCT03589326|588269998|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
162882997|NCT03589326|588269999|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
162882998|NCT03589326|588269998|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
162882999|NCT03589326|588269999|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
162883000|NCT03589326|588269998|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
162883001|NCT03589326|588269999|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
163049412|NCT00126594|588888974|FG001|Overall Study|Adverse Event|5|||
163049413|NCT00126594|588888973|FG000|Overall Study|Non-compliance|0|||
163049414|NCT00126594|588888974|FG001|Overall Study|Non-compliance|1|||
163049415|NCT00126594|588888973|FG000|Overall Study|Disease Progression|29|||
163049416|NCT00126594|588888974|FG001|Overall Study|Disease Progression|24|||
163049417|NCT00983372|588888975|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
163049418|NCT00983372|588888975|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
163049419|NCT00983372|588888975|FG000|Diltiazem ER Alone|Adverse Event|1|||
163049420|NCT05635045|588888976|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049421|NCT05635045|588888977|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049422|NCT05635045|588888978|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
163049423|NCT05635045|588888979|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
163049424|NCT01585246|588888995|FG000|Overall Study|Lost to Follow-up|0|||
163049425|NCT01585246|588888996|FG001|Overall Study|Lost to Follow-up|0|||
163049426|NCT01585246|588888997|FG002|Overall Study|Lost to Follow-up|2|||
163049427|NCT01585246|588888998|FG003|Overall Study|Lost to Follow-up|1|||
163049428|NCT01585246|588888999|FG004|Overall Study|Lost to Follow-up|0|||
163049429|NCT01585246|588888995|FG000|Overall Study|Protocol Violation|0|||
163049430|NCT01585246|588888996|FG001|Overall Study|Protocol Violation|0|||
163049431|NCT01585246|588888997|FG002|Overall Study|Protocol Violation|0|||
163049432|NCT01585246|588888998|FG003|Overall Study|Protocol Violation|0|||
162616487|NCT01708161|587313452|FG001|Overall Study|Adverse Event|3|||
162616488|NCT01708161|587313453|FG002|Overall Study|Adverse Event|4|||
162707675|NCT04541186|587638301|FG002|Main Study|Randomized in Error Not Treated|1|||
162707676|NCT04541186|587638302|FG003|Main Study|Randomized in Error Not Treated|0|||
162707677|NCT04541186|587638303|FG004|Main Study|Randomized in Error Not Treated|0|||
162707678|NCT04541186|587638299|FG000|Fibrate Expansion Study|Other than Specified|0|||
162707679|NCT04541186|587638300|FG001|Fibrate Expansion Study|Other than Specified|0|||
162707680|NCT04541186|587638301|FG002|Fibrate Expansion Study|Other than Specified|0|||
162707681|NCT04541186|587638302|FG003|Fibrate Expansion Study|Other than Specified|0|||
162707682|NCT04541186|587638303|FG004|Fibrate Expansion Study|Other than Specified|1|||
162707683|NCT00303303|587638306|FG000|Overall Study|Withdrawal by Subject|0|||
162707684|NCT00303303|587638307|FG001|Overall Study|Withdrawal by Subject|0|||
162883002|NCT03589326|588269998|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
162883003|NCT03589326|588269999|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
162883004|NCT02493426|588270002|FG000|Overall Study|Withdrawal by Subject|0|||
162883005|NCT02493426|588270003|FG001|Overall Study|Withdrawal by Subject|1|||
162883006|NCT00603980|588270005|FG000|Study Qualification|Protocol Violation|3|||
162883007|NCT00603980|588270005|FG000|Study Qualification|Inconsistent data reporting|13|||
162883008|NCT00603980|588270005|FG000|Main Study|14th subject completed trial|1|||
163049433|NCT01585246|588888999|FG004|Overall Study|Protocol Violation|1|||
163049434|NCT01585246|588888995|FG000|Overall Study|Withdrawal by Subject|0|||
163049435|NCT01585246|588888996|FG001|Overall Study|Withdrawal by Subject|0|||
163049436|NCT01585246|588888997|FG002|Overall Study|Withdrawal by Subject|1|||
163049437|NCT01585246|588888998|FG003|Overall Study|Withdrawal by Subject|2|||
163049438|NCT01585246|588888999|FG004|Overall Study|Withdrawal by Subject|1|||
163049439|NCT01585246|588888995|FG000|Overall Study|Other|0|||
163049440|NCT01585246|588888996|FG001|Overall Study|Other|1|||
163049441|NCT01585246|588888997|FG002|Overall Study|Other|1|||
163049442|NCT01585246|588888998|FG003|Overall Study|Other|1|||
163049443|NCT01585246|588888999|FG004|Overall Study|Other|0|||
163049444|NCT04396626|588889000|FG000|Overall Study|Premature termination of study|975|||
162707685|NCT00303303|587638308|FG002|Overall Study|Withdrawal by Subject|1|||
162707686|NCT00058058|587638309|FG000|Overall Study|Withdrawal by Subject|4|||
162707687|NCT00058058|587638309|FG000|Overall Study|Ineligible|20|||
162707688|NCT00058058|587638309|FG000|Overall Study|Claustrophobic|5|||
162707689|NCT00058058|587638309|FG000|Overall Study|technical issues|6|||
162707690|NCT00058058|587638309|FG000|Overall Study|Poor positioning, illness,pain|3|||
162707691|NCT03085017|587638310|FG000|Overall Study|Death|0|||
162707692|NCT03085017|587638311|FG001|Overall Study|Death|3|||
163049445|NCT02111174|588889001|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
162707693|NCT00582790|587638312|FG000|Overall Study|Rapid progression of disease|1|||
162707694|NCT02680756|587638317|FG000|Overall Study|Adverse Event|10|||
162707695|NCT02680756|587638318|FG001|Overall Study|Adverse Event|2|||
162707696|NCT02680756|587638317|FG000|Overall Study|Lost to Follow-up|7|||
162707697|NCT02680756|587638318|FG001|Overall Study|Lost to Follow-up|6|||
162707698|NCT02680756|587638317|FG000|Overall Study|Withdrawal by Subject|5|||
162707699|NCT02680756|587638318|FG001|Overall Study|Withdrawal by Subject|5|||
162707700|NCT02680756|587638317|FG000|Overall Study|Physician Decision|4|||
163049446|NCT02111174|588889002|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
163049447|NCT02111174|588889001|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
162707701|NCT02680756|587638318|FG001|Overall Study|Physician Decision|1|||
162707702|NCT02680756|587638317|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
162707703|NCT02680756|587638318|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
162707704|NCT02680756|587638317|FG000|Overall Study|Blood transfusion for any reason|0|||
162707705|NCT02680756|587638318|FG001|Overall Study|Blood transfusion for any reason|1|||
162707706|NCT02680756|587638317|FG000|Overall Study|Death|1|||
162707707|NCT02680756|587638318|FG001|Overall Study|Death|0|||
162707708|NCT02680756|587638317|FG000|Overall Study|Protocol Violation|1|||
162707709|NCT02680756|587638318|FG001|Overall Study|Protocol Violation|0|||
162707710|NCT02680756|587638317|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
162707711|NCT02680756|587638318|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
162707712|NCT02680756|587638317|FG000|Overall Study|None of above or not recorded|3|||
162707713|NCT02680756|587638318|FG001|Overall Study|None of above or not recorded|2|||
162707714|NCT02374957|587638319|FG000|Overall Study|Patient did not complete forms correctly|1|||
162707715|NCT02374957|587638320|FG001|Overall Study|Patient did not complete forms correctly|0|||
162707716|NCT00748969|587638321|FG000|Overall Study|Withdrawal by Subject|1|||
162707717|NCT00748969|587638322|FG001|Overall Study|Withdrawal by Subject|0|||
162707718|NCT00748969|587638321|FG000|Overall Study|Withdrawal by Subject|0|||
162707719|NCT00748969|587638322|FG001|Overall Study|Withdrawal by Subject|1|||
162707720|NCT03532178|587638323|FG000|First Period|Withdrawal by Subject|1|||
162707721|NCT03532178|587638324|FG001|First Period|Withdrawal by Subject|3|||
162707722|NCT03532178|587638323|FG000|First Period|technical issues in data collection Technical issues|0|||
162707723|NCT03532178|587638324|FG001|First Period|technical issues in data collection Technical issues|1|||
162883009|NCT01577160|588270006|FG000|Overall Study|Adverse Event|9|||
162883010|NCT01577160|588270006|FG000|Overall Study|Lack of Efficacy|15|||
162883011|NCT01577160|588270006|FG000|Overall Study|Lost to Follow-up|40|||
162616489|NCT01708161|587313454|FG003|Overall Study|Adverse Event|2|||
162616490|NCT01708161|587313455|FG004|Overall Study|Adverse Event|3|||
162883012|NCT01577160|588270006|FG000|Overall Study|Withdrawal by Subject|18|||
162883013|NCT01577160|588270006|FG000|Overall Study|Subject Uncooperative|7|||
162883014|NCT01577160|588270006|FG000|Overall Study|Other|9|||
162883015|NCT01341652|588270007|FG000|Overall Study|Incorrect Random Assignment|0|||
162883016|NCT01341652|588270008|FG001|Overall Study|Incorrect Random Assignment|1|||
162883017|NCT01341652|588270007|FG000|Overall Study|ineligible; presence metastatic disease|0|||
162883018|NCT01341652|588270008|FG001|Overall Study|ineligible; presence metastatic disease|1|||
162883019|NCT02618928|588270011|FG000|Overall Study|Failure to Return|28|||
162883020|NCT02618928|588270011|FG000|Overall Study|Insufficient Virological Response|1|||
162883021|NCT02618928|588270011|FG000|Overall Study|Withdrawal by Subject|2|||
162883022|NCT02618928|588270011|FG000|Overall Study|Death|3|||
162883023|NCT02618928|588270011|FG000|Overall Study|Other|11|||
162883024|NCT02618928|588270011|FG000|Overall Study|Missing|6|||
162883025|NCT02618928|588270011|FG000|Overall Study|Treatment Never Started|7|||
162883026|NCT01096849|588270016|FG000|Overall Study|Consent Withdrawn|1|||
162883027|NCT01096849|588270017|FG001|Overall Study|Consent Withdrawn|4|||
162883028|NCT01096849|588270018|FG002|Overall Study|Consent Withdrawn|2|||
162883029|NCT01096849|588270016|FG000|Overall Study|Lack of Efficacy|0|||
162883030|NCT01096849|588270017|FG001|Overall Study|Lack of Efficacy|2|||
162883031|NCT01096849|588270018|FG002|Overall Study|Lack of Efficacy|0|||
162883032|NCT01096849|588270016|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
162962530|NCT01075516|588562717|FG001|Overall Study|Withdrawal by Subject|5|||
162962531|NCT02252016|588562718|FG000|Overall Study|Lost to Follow-up|2|||
162962532|NCT02252016|588562719|FG001|Overall Study|Lost to Follow-up|1|||
162616491|NCT01708161|587313456|FG005|Overall Study|Adverse Event|0|||
162616492|NCT01708161|587313451|FG000|Overall Study|Death|0|||
162883033|NCT01096849|588270017|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
162883034|NCT01096849|588270018|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
162962533|NCT02252016|588562718|FG000|Overall Study|Physician Decision|1|||
162962534|NCT02252016|588562719|FG001|Overall Study|Physician Decision|0|||
162962535|NCT02252016|588562718|FG000|Overall Study|Withdrawal by Subject|0|||
162962536|NCT02252016|588562719|FG001|Overall Study|Withdrawal by Subject|2|||
162962537|NCT00674128|588562720|FG000|Overall Study|Withdrawal by Subject|25|||
162962538|NCT00674128|588562721|FG001|Overall Study|Withdrawal by Subject|23|||
162962539|NCT01825798|588562724|FG000|Overall Study|Adverse Event|1|||
162962540|NCT01825798|588562725|FG001|Overall Study|Adverse Event|5|||
162962541|NCT01825798|588562724|FG000|Overall Study|Lost to Follow-up|1|||
162962542|NCT01825798|588562725|FG001|Overall Study|Lost to Follow-up|0|||
162962543|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
162962544|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
162962545|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
162962546|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962547|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962548|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
162962549|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
162962550|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962551|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962552|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962553|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962554|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
162962555|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
162962556|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
162962557|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962558|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962559|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962560|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
162962561|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
162962562|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962563|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
162962564|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962565|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962566|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
162962567|NCT01559363|588562731|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962568|NCT01559363|588562732|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
162962569|NCT01559363|588562733|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162616493|NCT01708161|587313452|FG001|Overall Study|Death|0|||
162883035|NCT01096849|588270016|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
162962570|NCT01559363|588562734|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962571|NCT01559363|588562735|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962572|NCT01559363|588562736|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162962573|NCT01559363|588562731|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
163049448|NCT02111174|588889002|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
163049449|NCT02111174|588889001|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
163049450|NCT02111174|588889002|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
163049451|NCT02111174|588889001|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
163049452|NCT02111174|588889002|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
163049453|NCT01657162|588889003|FG000|Overall Study|Adverse Event|26|||
163049454|NCT01657162|588889004|FG001|Overall Study|Adverse Event|36|||
163049455|NCT01657162|588889003|FG000|Overall Study|Withdrawal by Subject|13|||
163049456|NCT01657162|588889004|FG001|Overall Study|Withdrawal by Subject|13|||
163049457|NCT01657162|588889003|FG000|Overall Study|Continuing Significant Deterioration|9|||
162707724|NCT03532178|587638323|FG000|Second Period|Withdrawal by Subject|1|||
163049458|NCT01657162|588889004|FG001|Overall Study|Continuing Significant Deterioration|3|||
163049459|NCT01657162|588889003|FG000|Overall Study|Refusal of Treatment|4|||
162883036|NCT01096849|588270017|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
162883037|NCT01096849|588270018|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
162883038|NCT01096849|588270016|FG000|Overall Study|Administrative Reasons|0|||
162883039|NCT01096849|588270017|FG001|Overall Study|Administrative Reasons|1|||
162883040|NCT01096849|588270018|FG002|Overall Study|Administrative Reasons|2|||
162883041|NCT01096849|588270016|FG000|Overall Study|Lost to Follow-up|1|||
162883042|NCT01096849|588270017|FG001|Overall Study|Lost to Follow-up|3|||
162883043|NCT01096849|588270018|FG002|Overall Study|Lost to Follow-up|1|||
162883044|NCT02998554|588270019|FG000|Overall Study|Adverse Event|8|||
163049460|NCT01657162|588889004|FG001|Overall Study|Refusal of Treatment|6|||
162707725|NCT03532178|587638324|FG001|Second Period|Withdrawal by Subject|1|||
162883045|NCT02998554|588270020|FG001|Overall Study|Adverse Event|3|||
162883046|NCT02998554|588270019|FG000|Overall Study|Protocol deviation|1|||
162883047|NCT02998554|588270020|FG001|Overall Study|Protocol deviation|0|||
162883048|NCT02998554|588270019|FG000|Overall Study|Withdrawal by Subject|2|||
162883049|NCT02998554|588270020|FG001|Overall Study|Withdrawal by Subject|6|||
162883050|NCT02998554|588270019|FG000|Overall Study|Lost to Follow-up|0|||
162883051|NCT02998554|588270020|FG001|Overall Study|Lost to Follow-up|1|||
162883052|NCT02998554|588270019|FG000|Overall Study|Lack of Efficacy|0|||
162883053|NCT02998554|588270020|FG001|Overall Study|Lack of Efficacy|1|||
162883054|NCT00118482|588270021|FG000|Overall Study|Lost to Follow-up|7|||
162883055|NCT00118482|588270022|FG001|Overall Study|Lost to Follow-up|7|||
162883056|NCT00118482|588270021|FG000|Overall Study|Withdrawal by Subject|23|||
162883057|NCT00118482|588270022|FG001|Overall Study|Withdrawal by Subject|22|||
162883058|NCT04146467|588270024|FG000|Overall Study|Adverse Event|0|||
162883059|NCT04146467|588270025|FG001|Overall Study|Adverse Event|1|||
162883060|NCT04146467|588270024|FG000|Overall Study|Lost to Follow-up|0|||
163049461|NCT01657162|588889003|FG000|Overall Study|Lost to Follow-up|3|||
163049462|NCT01657162|588889004|FG001|Overall Study|Lost to Follow-up|4|||
162883061|NCT04146467|588270025|FG001|Overall Study|Lost to Follow-up|2|||
162883062|NCT02128763|588270027|FG000|Overall Study|Death|1|||
162707726|NCT03532178|587638323|FG000|Second Period|Technical issues|0|||
162883063|NCT02128763|588270028|FG001|Overall Study|Death|0|||
162883064|NCT02128763|588270027|FG000|Overall Study|Lost to Follow-up|19|||
162883065|NCT02128763|588270028|FG001|Overall Study|Lost to Follow-up|16|||
162883066|NCT02953782|588270029|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
162883067|NCT02953782|588270030|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
162883068|NCT02953782|588270031|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
162883069|NCT02953782|588270032|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
162883070|NCT02953782|588270033|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
162883071|NCT02953782|588270034|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
162883072|NCT02953782|588270035|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
162883073|NCT02953782|588270036|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
162883074|NCT02953782|588270029|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
162883075|NCT02953782|588270030|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
162883076|NCT02953782|588270031|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
162883077|NCT02953782|588270032|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
162883078|NCT02953782|588270033|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
162883079|NCT02953782|588270034|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163049463|NCT01657162|588889003|FG000|Overall Study|Death|2|||
163049464|NCT01657162|588889004|FG001|Overall Study|Death|3|||
163049465|NCT01657162|588889003|FG000|Overall Study|Inability to Complete Study Procedures|1|||
163049466|NCT01657162|588889004|FG001|Overall Study|Inability to Complete Study Procedures|7|||
163049467|NCT01657162|588889003|FG000|Overall Study|Protocol Violation|1|||
163049468|NCT01657162|588889004|FG001|Overall Study|Protocol Violation|0|||
162616494|NCT01708161|587313453|FG002|Overall Study|Death|0|||
162616495|NCT01708161|587313454|FG003|Overall Study|Death|1|||
162616496|NCT01708161|587313455|FG004|Overall Study|Death|0|||
162616497|NCT01708161|587313456|FG005|Overall Study|Death|1|||
162616498|NCT01708161|587313451|FG000|Overall Study|Withdrawal by Subject|0|||
162616499|NCT01708161|587313452|FG001|Overall Study|Withdrawal by Subject|1|||
162616500|NCT01708161|587313453|FG002|Overall Study|Withdrawal by Subject|1|||
162616501|NCT01708161|587313454|FG003|Overall Study|Withdrawal by Subject|0|||
162616502|NCT01708161|587313455|FG004|Overall Study|Withdrawal by Subject|0|||
162616503|NCT01708161|587313456|FG005|Overall Study|Withdrawal by Subject|0|||
162616504|NCT01708161|587313451|FG000|Overall Study|Administrative problems|0|||
162616505|NCT01708161|587313452|FG001|Overall Study|Administrative problems|1|||
162616506|NCT01708161|587313453|FG002|Overall Study|Administrative problems|0|||
162883080|NCT02953782|588270035|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163049469|NCT01657162|588889003|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
163049470|NCT01657162|588889004|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
163049471|NCT01657162|588889003|FG000|Overall Study|Other than Specified|0|||
163049472|NCT01657162|588889004|FG001|Overall Study|Other than Specified|2|||
163049473|NCT02600923|588889005|FG000|Overall Study|Death|10|||
163049474|NCT02600923|588889005|FG000|Overall Study|Adverse Event|3|||
163049475|NCT02600923|588889005|FG000|Overall Study|Global deterioration of health status|2|||
163049476|NCT02600923|588889005|FG000|Overall Study|Insufficient clinical response|6|||
163049477|NCT02600923|588889005|FG000|Overall Study|Lost to Follow-up|1|||
163049478|NCT02600923|588889005|FG000|Overall Study|Withdrawal by Subject|5|||
163049479|NCT02600923|588889005|FG000|Overall Study|Objective progression or relapse|50|||
163049480|NCT02600923|588889005|FG000|Overall Study|Study terminated by Sponsor|53|||
163049481|NCT02600923|588889005|FG000|Overall Study|Not treated|1|||
163049482|NCT00792909|588889006|FG000|Overall Study|Withdrawal by Subject|0|||
163049483|NCT00792909|588889007|FG001|Overall Study|Withdrawal by Subject|1|||
162883081|NCT02953782|588270036|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163049484|NCT00792909|588889008|FG002|Overall Study|Withdrawal by Subject|0|||
162616507|NCT01708161|587313454|FG003|Overall Study|Administrative problems|0|||
163049485|NCT04157088|588889010|FG000|Overall Study|Study terminated by sponsor|23|||
162883082|NCT02953782|588270029|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
162883083|NCT02953782|588270030|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
162883084|NCT02953782|588270031|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
162883085|NCT02953782|588270032|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
162883086|NCT02953782|588270033|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
162883087|NCT02953782|588270034|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
162883088|NCT02953782|588270035|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
162883089|NCT02953782|588270036|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
162883090|NCT02953782|588270029|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
163049486|NCT04157088|588889010|FG000|Overall Study|Withdrawal by Subject|4|||
163049487|NCT04157088|588889010|FG000|Overall Study|Lost to Follow-up|2|||
163049488|NCT04157088|588889010|FG000|Overall Study|Death|1|||
163049489|NCT02421419|588889011|FG000|Overall Study|Physician Decision|0|||
163049490|NCT02421419|588889012|FG001|Overall Study|Physician Decision|0|||
163049491|NCT02421419|588889013|FG002|Overall Study|Physician Decision|1|||
163049492|NCT01747499|588889015|FG000|Overall Study|Steroid refractory aGvHD|1|||
163049493|NCT01747499|588889016|FG001|Overall Study|Steroid refractory aGvHD|0|||
163049494|NCT01747499|588889017|FG002|Overall Study|Steroid refractory aGvHD|0|||
163049495|NCT01747499|588889018|FG003|Overall Study|Steroid refractory aGvHD|1|||
163049496|NCT01747499|588889019|FG004|Overall Study|Steroid refractory aGvHD|4|||
163049497|NCT01747499|588889015|FG000|Overall Study|Physician Decision|0|||
163049498|NCT01747499|588889016|FG001|Overall Study|Physician Decision|1|||
163049499|NCT01747499|588889017|FG002|Overall Study|Physician Decision|0|||
163049500|NCT01747499|588889018|FG003|Overall Study|Physician Decision|0|||
163049501|NCT01747499|588889019|FG004|Overall Study|Physician Decision|2|||
163049502|NCT01747499|588889015|FG000|Overall Study|Death|0|||
163049503|NCT01747499|588889016|FG001|Overall Study|Death|0|||
163049504|NCT01747499|588889017|FG002|Overall Study|Death|0|||
163049505|NCT01747499|588889018|FG003|Overall Study|Death|1|||
163049506|NCT01747499|588889019|FG004|Overall Study|Death|1|||
162616508|NCT01708161|587313455|FG004|Overall Study|Administrative problems|0|||
162616509|NCT01708161|587313456|FG005|Overall Study|Administrative problems|0|||
162616510|NCT01708161|587313451|FG000|Overall Study|Disease progression|3|||
162616511|NCT01708161|587313452|FG001|Overall Study|Disease progression|5|||
162616512|NCT01708161|587313453|FG002|Overall Study|Disease progression|5|||
162616513|NCT01708161|587313454|FG003|Overall Study|Disease progression|13|||
162616514|NCT01708161|587313455|FG004|Overall Study|Disease progression|3|||
162616515|NCT01708161|587313456|FG005|Overall Study|Disease progression|0|||
162616516|NCT01986140|587313458|FG000|Overall Study|Withdrawal by Subject|31|||
162616517|NCT01986140|587313459|FG001|Overall Study|Withdrawal by Subject|25|||
162616518|NCT01986140|587313458|FG000|Overall Study|alternative treatment|1|||
162616519|NCT01986140|587313459|FG001|Overall Study|alternative treatment|1|||
162616520|NCT01986140|587313458|FG000|Overall Study|found not eligible|3|||
162616521|NCT01986140|587313459|FG001|Overall Study|found not eligible|0|||
162616522|NCT01986140|587313458|FG000|Overall Study|Adverse Event|0|||
162616523|NCT01986140|587313459|FG001|Overall Study|Adverse Event|1|||
162616524|NCT01986140|587313458|FG000|Overall Study|progression disease|0|||
162616525|NCT01986140|587313459|FG001|Overall Study|progression disease|1|||
162616526|NCT01069627|587313475|FG000|Overall Study|Disease progression|7|||
162616527|NCT01069627|587313475|FG000|Overall Study|Adverse Event|12|||
162616528|NCT01069627|587313475|FG000|Overall Study|Protocol Violation|1|||
162616529|NCT02963935|587313476|FG000|Overall Study|Adverse Event|12|||
162616530|NCT02963935|587313477|FG001|Overall Study|Adverse Event|6|||
162707727|NCT03532178|587638324|FG001|Second Period|Technical issues|1|||
162707728|NCT01113463|587638328|FG000|Overall Study|Physician Decision|5|||
162707729|NCT00372528|587638329|FG000|Overall Study|Lack of Efficacy|1|||
162707730|NCT00372528|587638329|FG000|Overall Study|Adverse Event|1|||
163049507|NCT01747499|588889015|FG000|Overall Study|Withdrawal by Subject|0|||
163049508|NCT01747499|588889016|FG001|Overall Study|Withdrawal by Subject|0|||
163049509|NCT01747499|588889017|FG002|Overall Study|Withdrawal by Subject|0|||
163049510|NCT01747499|588889018|FG003|Overall Study|Withdrawal by Subject|0|||
163049511|NCT01747499|588889019|FG004|Overall Study|Withdrawal by Subject|6|||
163049512|NCT01747499|588889015|FG000|Overall Study|Developed AML and death|0|||
163049513|NCT01747499|588889016|FG001|Overall Study|Developed AML and death|0|||
163049514|NCT01747499|588889017|FG002|Overall Study|Developed AML and death|0|||
162616531|NCT02963935|587313476|FG000|Overall Study|Protocol Violation|2|||
162616532|NCT02963935|587313477|FG001|Overall Study|Protocol Violation|1|||
162616533|NCT02963935|587313476|FG000|Overall Study|Lack of Efficacy|0|||
162616534|NCT02963935|587313477|FG001|Overall Study|Lack of Efficacy|2|||
162616535|NCT02963935|587313476|FG000|Overall Study|Lost to Follow-up|1|||
162616536|NCT02963935|587313477|FG001|Overall Study|Lost to Follow-up|6|||
163049515|NCT01747499|588889018|FG003|Overall Study|Developed AML and death|0|||
163049516|NCT01747499|588889019|FG004|Overall Study|Developed AML and death|1|||
163049517|NCT01747499|588889015|FG000|Overall Study|Determined not to be eligible|0|||
163049518|NCT01747499|588889016|FG001|Overall Study|Determined not to be eligible|0|||
162616537|NCT02963935|587313476|FG000|Overall Study|Unclassified|13|||
162707731|NCT00372528|587638329|FG000|Overall Study|Study Terminated by Sponsor|18|||
162707732|NCT00372528|587638329|FG000|Overall Study|Other|1|||
162707733|NCT00562965|587638330|FG000|Overall Study|Withdrawal by Subject|0|||
162707734|NCT00562965|587638331|FG001|Overall Study|Withdrawal by Subject|1|||
162707735|NCT00562965|587638330|FG000|Overall Study|Death|2|||
162707736|NCT00562965|587638331|FG001|Overall Study|Death|4|||
162962574|NCT01559363|588562732|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962575|NCT01559363|588562733|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962576|NCT01559363|588562734|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
162962577|NCT01559363|588562735|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
162962578|NCT01559363|588562736|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
162962579|NCT01559363|588562731|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962580|NCT01559363|588562732|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962581|NCT01559363|588562733|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962582|NCT01559363|588562734|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
162962583|NCT01559363|588562735|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962584|NCT01559363|588562736|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162962585|NCT00834873|588562737|FG000|First Intervention|Adverse Event|0|||
162962586|NCT00834873|588562738|FG001|First Intervention|Adverse Event|1|||
162962587|NCT01653704|588562742|FG000|Overall Study|Technical failure during recording|1|||
162962588|NCT01653704|588562743|FG001|Overall Study|Technical failure during recording|1|||
162962589|NCT01653704|588562742|FG000|Overall Study|Performance not reflective of training|1|||
162962590|NCT01653704|588562743|FG001|Overall Study|Performance not reflective of training|0|||
162962591|NCT03966911|588562744|FG000|Overall Study|Adverse Event|1|||
162962592|NCT03966911|588562745|FG001|Overall Study|Adverse Event|1|||
162962593|NCT03966911|588562744|FG000|Overall Study|Withdrawal by Subject|8|||
162962594|NCT03966911|588562745|FG001|Overall Study|Withdrawal by Subject|2|||
162962595|NCT03966911|588562744|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
162962596|NCT03966911|588562745|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
162962597|NCT00985751|588562746|FG000|Overall Study|Adverse Event|0|||
162962598|NCT00985751|588562747|FG001|Overall Study|Adverse Event|0|||
162962599|NCT00985751|588562748|FG002|Overall Study|Adverse Event|0|||
162962600|NCT00985751|588562749|FG003|Overall Study|Adverse Event|0|||
162962601|NCT00985751|588562750|FG004|Overall Study|Adverse Event|1|||
162962602|NCT01899053|588562751|FG000|Overall Study|Progressive Disease|4|||
162962603|NCT01899053|588562752|FG001|Overall Study|Progressive Disease|0|||
162962604|NCT01899053|588562753|FG002|Overall Study|Progressive Disease|3|||
162962605|NCT01899053|588562754|FG003|Overall Study|Progressive Disease|0|||
162962606|NCT01899053|588562755|FG004|Overall Study|Progressive Disease|3|||
162962607|NCT01899053|588562756|FG005|Overall Study|Progressive Disease|1|||
162962608|NCT01899053|588562757|FG006|Overall Study|Progressive Disease|1|||
162962609|NCT01899053|588562758|FG007|Overall Study|Progressive Disease|1|||
162962610|NCT01899053|588562759|FG008|Overall Study|Progressive Disease|4|||
162962611|NCT01899053|588562760|FG009|Overall Study|Progressive Disease|3|||
162962612|NCT01899053|588562761|FG010|Overall Study|Progressive Disease|12|||
162962613|NCT01899053|588562762|FG011|Overall Study|Progressive Disease|5|||
162962614|NCT01899053|588562763|FG012|Overall Study|Progressive Disease|8|||
162962615|NCT01899053|588562764|FG013|Overall Study|Progressive Disease|17|||
162962616|NCT01899053|588562751|FG000|Overall Study|Adverse Event|1|||
162962617|NCT01899053|588562752|FG001|Overall Study|Adverse Event|1|||
162962618|NCT01899053|588562753|FG002|Overall Study|Adverse Event|1|||
162962619|NCT01899053|588562754|FG003|Overall Study|Adverse Event|3|||
162962620|NCT01899053|588562755|FG004|Overall Study|Adverse Event|1|||
162962621|NCT01899053|588562756|FG005|Overall Study|Adverse Event|1|||
162962622|NCT01899053|588562757|FG006|Overall Study|Adverse Event|1|||
162707737|NCT00562965|587638330|FG000|Overall Study|Lost to Follow-up|1|||
162707738|NCT00562965|587638331|FG001|Overall Study|Lost to Follow-up|0|||
162707739|NCT00562965|587638330|FG000|Overall Study|Other|0|||
162962623|NCT01899053|588562758|FG007|Overall Study|Adverse Event|0|||
162962624|NCT01899053|588562759|FG008|Overall Study|Adverse Event|2|||
162962625|NCT01899053|588562760|FG009|Overall Study|Adverse Event|0|||
162962626|NCT01899053|588562761|FG010|Overall Study|Adverse Event|3|||
162962627|NCT01899053|588562762|FG011|Overall Study|Adverse Event|1|||
162962628|NCT01899053|588562763|FG012|Overall Study|Adverse Event|2|||
162962629|NCT01899053|588562764|FG013|Overall Study|Adverse Event|2|||
162962630|NCT01899053|588562751|FG000|Overall Study|Reason Not Specified|0|||
162962631|NCT01899053|588562752|FG001|Overall Study|Reason Not Specified|0|||
162962632|NCT01899053|588562753|FG002|Overall Study|Reason Not Specified|0|||
162883091|NCT02953782|588270030|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
162883092|NCT02953782|588270031|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
162883093|NCT02953782|588270032|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
162883094|NCT02953782|588270033|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
162883095|NCT02953782|588270034|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
162883096|NCT02953782|588270035|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
162883097|NCT02953782|588270036|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
162883098|NCT02953782|588270029|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
162883099|NCT02953782|588270030|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
162883100|NCT02953782|588270031|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
162883101|NCT02953782|588270032|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
162883102|NCT02953782|588270033|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
162883103|NCT02953782|588270034|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
162883104|NCT02953782|588270035|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
162883105|NCT02953782|588270036|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
162883106|NCT02953782|588270029|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
162883107|NCT02953782|588270030|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
162883108|NCT02953782|588270031|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
162883109|NCT02953782|588270032|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
162962633|NCT01899053|588562754|FG003|Overall Study|Reason Not Specified|0|||
162962634|NCT01899053|588562755|FG004|Overall Study|Reason Not Specified|0|||
162962635|NCT01899053|588562756|FG005|Overall Study|Reason Not Specified|0|||
162962636|NCT01899053|588562757|FG006|Overall Study|Reason Not Specified|1|||
162962637|NCT01899053|588562758|FG007|Overall Study|Reason Not Specified|0|||
162962638|NCT01899053|588562759|FG008|Overall Study|Reason Not Specified|0|||
162962639|NCT01899053|588562760|FG009|Overall Study|Reason Not Specified|0|||
162962640|NCT01899053|588562761|FG010|Overall Study|Reason Not Specified|0|||
162962641|NCT01899053|588562762|FG011|Overall Study|Reason Not Specified|0|||
162962642|NCT01899053|588562763|FG012|Overall Study|Reason Not Specified|1|||
162962643|NCT01899053|588562764|FG013|Overall Study|Reason Not Specified|0|||
162962644|NCT01899053|588562751|FG000|Overall Study|Withdrawal by Subject|1|||
162962645|NCT01899053|588562752|FG001|Overall Study|Withdrawal by Subject|1|||
162962646|NCT01899053|588562753|FG002|Overall Study|Withdrawal by Subject|2|||
162962647|NCT01899053|588562754|FG003|Overall Study|Withdrawal by Subject|0|||
162962648|NCT01899053|588562755|FG004|Overall Study|Withdrawal by Subject|2|||
162962649|NCT01899053|588562756|FG005|Overall Study|Withdrawal by Subject|0|||
162962650|NCT01899053|588562757|FG006|Overall Study|Withdrawal by Subject|0|||
162962651|NCT01899053|588562758|FG007|Overall Study|Withdrawal by Subject|1|||
162962652|NCT01899053|588562759|FG008|Overall Study|Withdrawal by Subject|0|||
162962653|NCT01899053|588562760|FG009|Overall Study|Withdrawal by Subject|0|||
162962654|NCT01899053|588562761|FG010|Overall Study|Withdrawal by Subject|0|||
162962655|NCT01899053|588562762|FG011|Overall Study|Withdrawal by Subject|0|||
162962656|NCT01899053|588562763|FG012|Overall Study|Withdrawal by Subject|1|||
162962657|NCT01899053|588562764|FG013|Overall Study|Withdrawal by Subject|1|||
162962658|NCT01899053|588562751|FG000|Overall Study|Protocol Violation|0|||
162962659|NCT01899053|588562752|FG001|Overall Study|Protocol Violation|0|||
162962660|NCT01899053|588562753|FG002|Overall Study|Protocol Violation|1|||
162962661|NCT01899053|588562754|FG003|Overall Study|Protocol Violation|0|||
162962662|NCT01899053|588562755|FG004|Overall Study|Protocol Violation|0|||
162962663|NCT01899053|588562756|FG005|Overall Study|Protocol Violation|0|||
162962664|NCT01899053|588562757|FG006|Overall Study|Protocol Violation|0|||
162962665|NCT01899053|588562758|FG007|Overall Study|Protocol Violation|0|||
162962666|NCT01899053|588562759|FG008|Overall Study|Protocol Violation|0|||
162962667|NCT01899053|588562760|FG009|Overall Study|Protocol Violation|0|||
162962668|NCT01899053|588562761|FG010|Overall Study|Protocol Violation|0|||
162962669|NCT01899053|588562762|FG011|Overall Study|Protocol Violation|0|||
162962670|NCT01899053|588562763|FG012|Overall Study|Protocol Violation|0|||
162962671|NCT01899053|588562764|FG013|Overall Study|Protocol Violation|0|||
162616538|NCT02963935|587313477|FG001|Overall Study|Unclassified|22|||
162616539|NCT03911154|587313478|FG000|Overall Study|Withdrawal by Subject|1|||
162616540|NCT05055128|587313479|FG000|Overall Study|Adverse Event|0|||
162616541|NCT05055128|587313480|FG001|Overall Study|Adverse Event|0|||
162616542|NCT05055128|587313481|FG002|Overall Study|Adverse Event|0|||
162616543|NCT05055128|587313482|FG003|Overall Study|Adverse Event|1|||
162616544|NCT05055128|587313483|FG004|Overall Study|Adverse Event|1|||
162616545|NCT05055128|587313479|FG000|Overall Study|Protocol Violation|0|||
162616546|NCT05055128|587313480|FG001|Overall Study|Protocol Violation|0|||
162616547|NCT05055128|587313481|FG002|Overall Study|Protocol Violation|0|||
162616548|NCT05055128|587313482|FG003|Overall Study|Protocol Violation|1|||
162616549|NCT05055128|587313483|FG004|Overall Study|Protocol Violation|0|||
162616550|NCT05055128|587313479|FG000|Overall Study|Withdrawal by Subject|5|||
162616551|NCT05055128|587313480|FG001|Overall Study|Withdrawal by Subject|2|||
162616552|NCT05055128|587313481|FG002|Overall Study|Withdrawal by Subject|2|||
162616553|NCT05055128|587313482|FG003|Overall Study|Withdrawal by Subject|4|||
162616554|NCT05055128|587313483|FG004|Overall Study|Withdrawal by Subject|2|||
162616555|NCT05055128|587313479|FG000|Overall Study|Randomized By Mistake|0|||
162616556|NCT05055128|587313480|FG001|Overall Study|Randomized By Mistake|1|||
162616557|NCT05055128|587313481|FG002|Overall Study|Randomized By Mistake|0|||
162616558|NCT05055128|587313482|FG003|Overall Study|Randomized By Mistake|0|||
162616559|NCT05055128|587313483|FG004|Overall Study|Randomized By Mistake|0|||
162616560|NCT05055128|587313479|FG000|Overall Study|Other|1|||
162616561|NCT05055128|587313480|FG001|Overall Study|Other|0|||
162616562|NCT05055128|587313481|FG002|Overall Study|Other|0|||
162962672|NCT01899053|588562751|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962673|NCT01899053|588562752|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962674|NCT01899053|588562753|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962675|NCT01899053|588562754|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962676|NCT01899053|588562755|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962677|NCT01899053|588562756|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962678|NCT01899053|588562757|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962679|NCT01899053|588562758|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962680|NCT01899053|588562759|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962681|NCT01899053|588562760|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962682|NCT01899053|588562761|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
162962683|NCT01899053|588562762|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962684|NCT01899053|588562763|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962685|NCT01899053|588562764|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
162962686|NCT01899053|588562751|FG000|Overall Study|Symptomatic Deterioration|0|||
162962687|NCT01899053|588562752|FG001|Overall Study|Symptomatic Deterioration|0|||
162962688|NCT01899053|588562753|FG002|Overall Study|Symptomatic Deterioration|0|||
162962689|NCT01899053|588562754|FG003|Overall Study|Symptomatic Deterioration|0|||
162962690|NCT01899053|588562755|FG004|Overall Study|Symptomatic Deterioration|0|||
162962691|NCT01899053|588562756|FG005|Overall Study|Symptomatic Deterioration|1|||
162962692|NCT01899053|588562757|FG006|Overall Study|Symptomatic Deterioration|0|||
162962693|NCT01899053|588562758|FG007|Overall Study|Symptomatic Deterioration|1|||
162962694|NCT01899053|588562759|FG008|Overall Study|Symptomatic Deterioration|0|||
162962695|NCT01899053|588562760|FG009|Overall Study|Symptomatic Deterioration|0|||
162962696|NCT01899053|588562761|FG010|Overall Study|Symptomatic Deterioration|0|||
162962697|NCT01899053|588562762|FG011|Overall Study|Symptomatic Deterioration|1|||
162962698|NCT01899053|588562763|FG012|Overall Study|Symptomatic Deterioration|2|||
162962699|NCT01899053|588562764|FG013|Overall Study|Symptomatic Deterioration|0|||
162962700|NCT03500094|588562768|FG000|Overall Study|Withdrawal by Subject|1|||
162616563|NCT05055128|587313482|FG003|Overall Study|Other|0|||
162616564|NCT05055128|587313483|FG004|Overall Study|Other|0|||
162616565|NCT00292318|587313485|FG000|Overall Study|Study terminated by officials|2|||
162616566|NCT00292318|587313486|FG001|Overall Study|Study terminated by officials|1|||
162616567|NCT01822496|587313487|FG000|Overall Study|Protocol Violation|2|||
162616568|NCT01822496|587313488|FG001|Overall Study|Protocol Violation|2|||
162616569|NCT01822496|587313489|FG002|Overall Study|Protocol Violation|0|||
162616570|NCT01822496|587313490|FG003|Overall Study|Protocol Violation|1|||
162616571|NCT01822496|587313487|FG000|Overall Study|Withdrawal by Subject|0|||
162616572|NCT01822496|587313488|FG001|Overall Study|Withdrawal by Subject|0|||
162616573|NCT01822496|587313489|FG002|Overall Study|Withdrawal by Subject|0|||
162616574|NCT01822496|587313490|FG003|Overall Study|Withdrawal by Subject|3|||
162707740|NCT00562965|587638331|FG001|Overall Study|Other|1|||
162707741|NCT00761774|587638332|FG000|Overall Study|Adverse Event|17|||
162707742|NCT00761774|587638332|FG000|Overall Study|Lack of Efficacy|37|||
162707743|NCT00761774|587638332|FG000|Overall Study|Lost to Follow-up|2|||
162707744|NCT00761774|587638332|FG000|Overall Study|Withdrawal by Subject|9|||
162707745|NCT00761774|587638332|FG000|Overall Study|Non-compliance|4|||
162707746|NCT00761774|587638332|FG000|Overall Study|End of study|2|||
162707747|NCT00761774|587638332|FG000|Overall Study|Reclassification of seizures|1|||
162707748|NCT00761774|587638332|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
162707749|NCT00761774|587638332|FG000|Overall Study|Sponsor decision|1|||
162707750|NCT00761774|587638332|FG000|Overall Study|Investigator clinical judgement|1|||
162707751|NCT00761774|587638332|FG000|Overall Study|Patient moved out of study area|1|||
162707752|NCT00761774|587638332|FG000|Overall Study|Coordinator leaving site|1|||
162707753|NCT00761774|587638332|FG000|Overall Study|Subject IP non-compliance|1|||
162707754|NCT00761774|587638332|FG000|Overall Study|IP stopped by hospital physician|1|||
162707755|NCT01648283|587638333|FG000|Overall Study|Withdrawal by Subject|14|||
162707756|NCT01124617|587638334|FG000|Overall Study|Adverse Event|5|||
162707757|NCT01124617|587638335|FG001|Overall Study|Adverse Event|2|||
162707758|NCT01124617|587638334|FG000|Overall Study|Lack of Efficacy|2|||
162707759|NCT01124617|587638335|FG001|Overall Study|Lack of Efficacy|1|||
162707760|NCT01124617|587638334|FG000|Overall Study|Protocol Violation|1|||
162707761|NCT01124617|587638335|FG001|Overall Study|Protocol Violation|1|||
162707762|NCT01124617|587638334|FG000|Overall Study|Withdrawal by Subject|9|||
162707763|NCT01124617|587638335|FG001|Overall Study|Withdrawal by Subject|1|||
162707764|NCT01124617|587638334|FG000|Overall Study|Other|2|||
162707765|NCT01124617|587638335|FG001|Overall Study|Other|1|||
162707766|NCT01354938|587638339|FG000|Overall Study|Lost to Follow-up|1|||
162707767|NCT01253200|587638340|FG000|Overall Study|Death|1|||
162707768|NCT01253200|587638341|FG001|Overall Study|Death|0|||
162707769|NCT01253200|587638342|FG002|Overall Study|Death|0|||
162707770|NCT01253200|587638343|FG003|Overall Study|Death|0|||
162707771|NCT01253200|587638344|FG004|Overall Study|Death|0|||
162707772|NCT01253200|587638340|FG000|Overall Study|Lost to Follow-up|1|||
162707773|NCT01253200|587638341|FG001|Overall Study|Lost to Follow-up|1|||
162707774|NCT01253200|587638342|FG002|Overall Study|Lost to Follow-up|0|||
162616575|NCT01631812|587313491|FG000|Overall Study|Adverse Event|25|||
162616576|NCT01631812|587313491|FG000|Overall Study|Lack of Efficacy|5|||
162707775|NCT01253200|587638343|FG003|Overall Study|Lost to Follow-up|0|||
162707776|NCT01253200|587638344|FG004|Overall Study|Lost to Follow-up|0|||
162707777|NCT01253200|587638340|FG000|Overall Study|Withdrawal by Subject|2|||
162707778|NCT01253200|587638341|FG001|Overall Study|Withdrawal by Subject|0|||
162707779|NCT01253200|587638342|FG002|Overall Study|Withdrawal by Subject|0|||
162707780|NCT01253200|587638343|FG003|Overall Study|Withdrawal by Subject|0|||
162707781|NCT01253200|587638344|FG004|Overall Study|Withdrawal by Subject|0|||
162707782|NCT01253200|587638340|FG000|Overall Study|Protocol Violation|1|||
162883110|NCT02953782|588270033|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
162883111|NCT02953782|588270034|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
162883112|NCT02953782|588270035|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
162883113|NCT02953782|588270036|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
162883114|NCT02953782|588270029|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
162883115|NCT02953782|588270030|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
162883116|NCT02953782|588270031|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
162883117|NCT02953782|588270032|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
162883118|NCT02953782|588270033|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
162883119|NCT02953782|588270034|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
162883120|NCT02953782|588270035|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
162883121|NCT02953782|588270036|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
162883122|NCT02953782|588270029|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883123|NCT02953782|588270030|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883124|NCT02953782|588270031|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883125|NCT02953782|588270032|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883126|NCT02953782|588270033|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883127|NCT02953782|588270034|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883128|NCT02953782|588270035|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
163049519|NCT01747499|588889017|FG002|Overall Study|Determined not to be eligible|0|||
163049520|NCT01747499|588889018|FG003|Overall Study|Determined not to be eligible|0|||
163049521|NCT01747499|588889019|FG004|Overall Study|Determined not to be eligible|1|||
163049522|NCT01676701|588889020|FG000|Overall Study|Protocol Violation|1|||
163049523|NCT01676701|588889021|FG001|Overall Study|Protocol Violation|0|||
163049524|NCT01676701|588889020|FG000|Overall Study|Sponsor Decision|3|||
163049525|NCT01676701|588889021|FG001|Overall Study|Sponsor Decision|4|||
163049526|NCT00196105|588889022|FG000|Overall Study|Lost to Follow-up|4|||
163049527|NCT00196105|588889023|FG001|Overall Study|Lost to Follow-up|5|||
163049528|NCT00196105|588889024|FG002|Overall Study|Lost to Follow-up|7|||
163049529|NCT02227784|588889028|FG000|Double-Blind Phase|Adverse Event|3|||
163049530|NCT02227784|588889029|FG001|Double-Blind Phase|Adverse Event|2|||
163049531|NCT02227784|588889030|FG002|Double-Blind Phase|Adverse Event|1|||
163049532|NCT02227784|588889031|FG003|Double-Blind Phase|Adverse Event|3|||
163049533|NCT02227784|588889032|FG004|Double-Blind Phase|Adverse Event|0|||
163049534|NCT02227784|588889028|FG000|Double-Blind Phase|Physician Decision|1|||
163049535|NCT02227784|588889029|FG001|Double-Blind Phase|Physician Decision|0|||
163049536|NCT02227784|588889030|FG002|Double-Blind Phase|Physician Decision|0|||
163049537|NCT02227784|588889031|FG003|Double-Blind Phase|Physician Decision|1|||
163049538|NCT02227784|588889032|FG004|Double-Blind Phase|Physician Decision|0|||
163049539|NCT02227784|588889028|FG000|Double-Blind Phase|Protocol Violation|0|||
163049540|NCT02227784|588889029|FG001|Double-Blind Phase|Protocol Violation|0|||
163049541|NCT02227784|588889030|FG002|Double-Blind Phase|Protocol Violation|1|||
163049542|NCT02227784|588889031|FG003|Double-Blind Phase|Protocol Violation|1|||
163049543|NCT02227784|588889032|FG004|Double-Blind Phase|Protocol Violation|0|||
163049544|NCT02227784|588889028|FG000|Double-Blind Phase|Sponsor Decision|34|||
163049545|NCT02227784|588889029|FG001|Double-Blind Phase|Sponsor Decision|15|||
163049546|NCT02227784|588889030|FG002|Double-Blind Phase|Sponsor Decision|14|||
163049547|NCT02227784|588889031|FG003|Double-Blind Phase|Sponsor Decision|32|||
163049548|NCT02227784|588889032|FG004|Double-Blind Phase|Sponsor Decision|0|||
163049549|NCT02227784|588889028|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163049550|NCT02227784|588889029|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
163049551|NCT02227784|588889030|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
163049552|NCT02227784|588889031|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
163049553|NCT02227784|588889032|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163049554|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049555|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049556|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049557|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
163049558|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
163049559|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Death|0|||
163049560|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Death|0|||
163049561|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Death|0|||
163049562|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Death|0|||
163049563|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Death|1|||
163049564|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049565|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049566|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049567|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163049568|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
163049569|NCT02227784|588889028|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049570|NCT02227784|588889029|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049571|NCT02227784|588889030|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049572|NCT02227784|588889031|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163049573|NCT02227784|588889032|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
162616577|NCT01631812|587313491|FG000|Overall Study|Withdrawal by Subject|4|||
162616578|NCT01631812|587313491|FG000|Overall Study|Physician Decision|3|||
162616579|NCT00543543|587313492|FG000|Base Study|Adverse Event|1|||
162616580|NCT00543543|587313493|FG001|Base Study|Adverse Event|11|||
162616581|NCT00543543|587313494|FG002|Base Study|Adverse Event|0|||
162616582|NCT00543543|587313495|FG003|Base Study|Adverse Event|5|||
162883129|NCT02953782|588270036|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
162883130|NCT01934192|588270039|FG000|Overall Study|Protocol Violation|0|||
162883131|NCT01934192|588270040|FG001|Overall Study|Protocol Violation|0|||
162883132|NCT01934192|588270041|FG002|Overall Study|Protocol Violation|0|||
163049574|NCT04058028|588889033|FG000|Overall Study|Withdrawal of Consent from Study|12|||
163049575|NCT04058028|588889034|FG001|Overall Study|Withdrawal of Consent from Study|8|||
163049576|NCT04058028|588889035|FG002|Overall Study|Withdrawal of Consent from Study|6|||
163049577|NCT04058028|588889036|FG003|Overall Study|Withdrawal of Consent from Study|7|||
163049578|NCT04058028|588889033|FG000|Overall Study|Decision by Sponsor|13|||
163049579|NCT04058028|588889034|FG001|Overall Study|Decision by Sponsor|4|||
163049580|NCT04058028|588889035|FG002|Overall Study|Decision by Sponsor|1|||
163049581|NCT04058028|588889036|FG003|Overall Study|Decision by Sponsor|35|||
163049582|NCT04058028|588889033|FG000|Overall Study|Lost to Follow-up|1|||
163049583|NCT04058028|588889034|FG001|Overall Study|Lost to Follow-up|1|||
162616583|NCT00543543|587313492|FG000|Base Study|Lost to Follow-up|12|||
162616584|NCT00543543|587313493|FG001|Base Study|Lost to Follow-up|749|||
162707783|NCT01253200|587638341|FG001|Overall Study|Protocol Violation|4|||
162707784|NCT01253200|587638342|FG002|Overall Study|Protocol Violation|0|||
162707785|NCT01253200|587638343|FG003|Overall Study|Protocol Violation|0|||
162616585|NCT00543543|587313494|FG002|Base Study|Lost to Follow-up|9|||
162616586|NCT00543543|587313495|FG003|Base Study|Lost to Follow-up|701|||
162616587|NCT00543543|587313492|FG000|Base Study|Physician Decision|0|||
162616588|NCT00543543|587313493|FG001|Base Study|Physician Decision|4|||
162616589|NCT00543543|587313494|FG002|Base Study|Physician Decision|0|||
162616590|NCT00543543|587313495|FG003|Base Study|Physician Decision|7|||
162616591|NCT00543543|587313492|FG000|Base Study|Protocol Violation|0|||
162616592|NCT00543543|587313493|FG001|Base Study|Protocol Violation|6|||
162616593|NCT00543543|587313494|FG002|Base Study|Protocol Violation|0|||
162616594|NCT00543543|587313495|FG003|Base Study|Protocol Violation|6|||
162616595|NCT00543543|587313492|FG000|Base Study|Withdrawal by Subject|7|||
162616596|NCT00543543|587313493|FG001|Base Study|Withdrawal by Subject|482|||
162616597|NCT00543543|587313494|FG002|Base Study|Withdrawal by Subject|5|||
162616598|NCT00543543|587313495|FG003|Base Study|Withdrawal by Subject|503|||
162616599|NCT00543543|587313492|FG000|Extension Study|Adverse Event|0|||
162616600|NCT00543543|587313493|FG001|Extension Study|Adverse Event|0|||
162616601|NCT00543543|587313494|FG002|Extension Study|Adverse Event|0|||
162616602|NCT00543543|587313495|FG003|Extension Study|Adverse Event|5|||
162616603|NCT00543543|587313492|FG000|Extension Study|Lost to Follow-up|0|||
162616604|NCT00543543|587313493|FG001|Extension Study|Lost to Follow-up|0|||
162616605|NCT00543543|587313494|FG002|Extension Study|Lost to Follow-up|0|||
162616606|NCT00543543|587313495|FG003|Extension Study|Lost to Follow-up|77|||
162616607|NCT00543543|587313492|FG000|Extension Study|Physician Decision|0|||
162616608|NCT00543543|587313493|FG001|Extension Study|Physician Decision|0|||
162616609|NCT00543543|587313494|FG002|Extension Study|Physician Decision|0|||
162707786|NCT01253200|587638344|FG004|Overall Study|Protocol Violation|5|||
162707787|NCT01253200|587638340|FG000|Overall Study|intents|10|||
162707788|NCT01253200|587638341|FG001|Overall Study|intents|10|||
162962701|NCT03500094|588562768|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
162962702|NCT03500094|588562768|FG000|Overall Study|Lost to Follow-up|1|||
162962703|NCT01891357|588562769|FG000|Overall Study|Protocol Violation|3|||
162962704|NCT00640341|588564627|FG000|Overall Study|Adverse Event|0|||
162962705|NCT00640341|588564628|FG001|Overall Study|Adverse Event|0|||
162962706|NCT00640341|588564629|FG002|Overall Study|Adverse Event|1|||
162962707|NCT00640341|588564627|FG000|Overall Study|Positive Slit Lamp Findings|0|||
162962708|NCT00640341|588564628|FG001|Overall Study|Positive Slit Lamp Findings|0|||
162962709|NCT00640341|588564629|FG002|Overall Study|Positive Slit Lamp Findings|1|||
162962710|NCT00640341|588564627|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
162962711|NCT00640341|588564628|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
162962712|NCT00640341|588564629|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
162962713|NCT00640341|588564627|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
162962714|NCT00640341|588564628|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
162962715|NCT00640341|588564629|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
162962716|NCT00640341|588564627|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
162962717|NCT00640341|588564628|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
162962718|NCT00640341|588564629|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
162962719|NCT00640341|588564627|FG000|Overall Study|Lost to Follow-up|2|||
162962720|NCT00640341|588564628|FG001|Overall Study|Lost to Follow-up|0|||
162962721|NCT00640341|588564629|FG002|Overall Study|Lost to Follow-up|0|||
162962722|NCT00640341|588564627|FG000|Overall Study|Withdrawal by Subject|4|||
162962723|NCT00640341|588564628|FG001|Overall Study|Withdrawal by Subject|0|||
162962724|NCT00640341|588564629|FG002|Overall Study|Withdrawal by Subject|1|||
162962725|NCT00640341|588564627|FG000|Overall Study|Unacceptable Lens Movement|1|||
162616610|NCT00543543|587313495|FG003|Extension Study|Physician Decision|7|||
162616611|NCT00543543|587313492|FG000|Extension Study|Pregnancy|0|||
162707789|NCT01253200|587638342|FG002|Overall Study|intents|1|||
162962726|NCT00640341|588564628|FG001|Overall Study|Unacceptable Lens Movement|0|||
162707790|NCT01253200|587638343|FG003|Overall Study|intents|3|||
162962727|NCT00640341|588564629|FG002|Overall Study|Unacceptable Lens Movement|0|||
162962728|NCT00640341|588564627|FG000|Overall Study|Poor fit/Uncomfortable|4|||
162707791|NCT01253200|587638344|FG004|Overall Study|intents|0|||
162616612|NCT00543543|587313493|FG001|Extension Study|Pregnancy|0|||
162616613|NCT00543543|587313494|FG002|Extension Study|Pregnancy|0|||
162616614|NCT00543543|587313495|FG003|Extension Study|Pregnancy|6|||
162616615|NCT00543543|587313492|FG000|Extension Study|Protocol Violation|0|||
162616616|NCT00543543|587313493|FG001|Extension Study|Protocol Violation|0|||
162616617|NCT00543543|587313494|FG002|Extension Study|Protocol Violation|0|||
162616618|NCT00543543|587313495|FG003|Extension Study|Protocol Violation|11|||
162616619|NCT00543543|587313492|FG000|Extension Study|Withdrawal by Subject|0|||
162707792|NCT01253200|587638340|FG000|Overall Study|Attempts|6|||
162707793|NCT01253200|587638341|FG001|Overall Study|Attempts|4|||
162707794|NCT01253200|587638342|FG002|Overall Study|Attempts|1|||
162707795|NCT01253200|587638343|FG003|Overall Study|Attempts|2|||
162616620|NCT00543543|587313493|FG001|Extension Study|Withdrawal by Subject|0|||
162616621|NCT00543543|587313494|FG002|Extension Study|Withdrawal by Subject|0|||
162616622|NCT00543543|587313495|FG003|Extension Study|Withdrawal by Subject|120|||
162616623|NCT00945555|587313496|FG000|Overall Study|Referred to another hospital|5|||
162616624|NCT00945555|587313496|FG000|Overall Study|Worsening condition, intensive care unit|1|||
162616625|NCT00945555|587313496|FG000|Overall Study|Withdrawal by Subject|2|||
162616626|NCT00945555|587313496|FG000|Overall Study|Participant continued treatment at home|1|||
162616627|NCT00945555|587313496|FG000|Overall Study|Death|18|||
162616628|NCT00945555|587313496|FG000|Overall Study|Other|1|||
162616629|NCT04502979|587313497|FG000|Overall Study|Lost to Follow-up|1|||
162616630|NCT04502979|587313498|FG001|Overall Study|Lost to Follow-up|3|||
162616631|NCT04502979|587313497|FG000|Overall Study|Withdrawal by Subject|2|||
162616632|NCT04502979|587313498|FG001|Overall Study|Withdrawal by Subject|1|||
162616633|NCT00586625|587313502|FG000|Overall Study|Adverse Event|6|||
162616634|NCT00586625|587313503|FG001|Overall Study|Adverse Event|6|||
162616635|NCT00586625|587313502|FG000|Overall Study|Protocol Violation|3|||
162616636|NCT00586625|587313503|FG001|Overall Study|Protocol Violation|0|||
162616637|NCT00586625|587313502|FG000|Overall Study|Withdrawal by Subject|32|||
162616638|NCT00586625|587313503|FG001|Overall Study|Withdrawal by Subject|10|||
162616639|NCT00586625|587313502|FG000|Overall Study|Subject non-compliance|0|||
162616640|NCT00586625|587313503|FG001|Overall Study|Subject non-compliance|1|||
162616641|NCT00586625|587313502|FG000|Overall Study|Subject unable to return for visit|2|||
162616642|NCT00586625|587313503|FG001|Overall Study|Subject unable to return for visit|0|||
162616643|NCT02906332|587313505|FG000|Overall Study|Withdrawal by Subject|1|||
162616644|NCT00165984|587313506|FG000|Overall Study|Death|15|||
162616645|NCT01686828|587313510|FG000|Overall Study|Physician Decision|1|||
162616646|NCT01686828|587313511|FG001|Overall Study|Physician Decision|0|||
162616647|NCT01686828|587313512|FG002|Overall Study|Physician Decision|0|||
162616648|NCT01686828|587313513|FG003|Overall Study|Physician Decision|0|||
162616649|NCT01686828|587313510|FG000|Overall Study|New Job|0|||
162616650|NCT01686828|587313511|FG001|Overall Study|New Job|1|||
162616651|NCT01686828|587313512|FG002|Overall Study|New Job|0|||
162616652|NCT01686828|587313513|FG003|Overall Study|New Job|0|||
162616653|NCT01686828|587313510|FG000|Overall Study|Weight Loss|0|||
162616654|NCT01686828|587313511|FG001|Overall Study|Weight Loss|0|||
162616655|NCT01686828|587313512|FG002|Overall Study|Weight Loss|1|||
162616656|NCT01686828|587313513|FG003|Overall Study|Weight Loss|0|||
162616657|NCT02734433|587313514|FG000|Overall Study|Disease progression|1|||
162616658|NCT02734433|587313515|FG001|Overall Study|Disease progression|5|||
162616659|NCT02734433|587313514|FG000|Overall Study|Clinical progression|0|||
162616660|NCT02734433|587313515|FG001|Overall Study|Clinical progression|1|||
162616661|NCT02734433|587313514|FG000|Overall Study|Withdrawal by Subject|1|||
162616662|NCT02734433|587313515|FG001|Overall Study|Withdrawal by Subject|2|||
162616663|NCT03698331|587313518|FG000|Overall Study|Adverse Event|2|||
162616664|NCT03698331|587313519|FG001|Overall Study|Adverse Event|3|||
162616665|NCT03698331|587313518|FG000|Overall Study|Withdrawal by Subject|1|||
162616666|NCT03698331|587313519|FG001|Overall Study|Withdrawal by Subject|1|||
162616667|NCT03698331|587313518|FG000|Overall Study|Lost to Follow-up|0|||
162616668|NCT03698331|587313519|FG001|Overall Study|Lost to Follow-up|2|||
162616669|NCT03698331|587313518|FG000|Overall Study|Non-compliance with study drug|1|||
162616670|NCT03698331|587313519|FG001|Overall Study|Non-compliance with study drug|0|||
162616671|NCT04916769|587313521|FG000|Period 1|Physician Decision|0|||
162616672|NCT04916769|587313522|FG001|Period 1|Physician Decision|0|||
162883133|NCT01934192|588270042|FG003|Overall Study|Protocol Violation|1|||
162883134|NCT01934192|588270039|FG000|Overall Study|Other: reached stopping criteria|6|||
162883135|NCT01934192|588270040|FG001|Overall Study|Other: reached stopping criteria|5|||
162883136|NCT01934192|588270041|FG002|Overall Study|Other: reached stopping criteria|1|||
162883137|NCT01934192|588270042|FG003|Overall Study|Other: reached stopping criteria|0|||
162883138|NCT01934192|588270039|FG000|Overall Study|Physician Decision|3|||
162883139|NCT01934192|588270040|FG001|Overall Study|Physician Decision|2|||
162883140|NCT01934192|588270041|FG002|Overall Study|Physician Decision|0|||
162883141|NCT01934192|588270042|FG003|Overall Study|Physician Decision|0|||
162883142|NCT01189435|588270043|FG000|Overall Study|Withdrawal by Subject|1|||
162883143|NCT01189435|588270043|FG000|Overall Study|Physician Decision|1|||
162883144|NCT02357849|588270044|FG000|Overall Study|Withdrawal by Subject|2|||
162616673|NCT04916769|587313523|FG002|Period 1|Physician Decision|0|||
162616674|NCT04916769|587313524|FG003|Period 1|Physician Decision|0|||
162616675|NCT04916769|587313525|FG004|Period 1|Physician Decision|0|||
162616676|NCT04916769|587313526|FG005|Period 1|Physician Decision|1|||
162616677|NCT04916769|587313521|FG000|Period 2|Physician Decision|0|||
162616678|NCT04916769|587313522|FG001|Period 2|Physician Decision|1|||
162616679|NCT04916769|587313523|FG002|Period 2|Physician Decision|0|||
162616680|NCT04916769|587313524|FG003|Period 2|Physician Decision|0|||
162616681|NCT04916769|587313525|FG004|Period 2|Physician Decision|0|||
162616682|NCT04916769|587313526|FG005|Period 2|Physician Decision|0|||
162616683|NCT04941456|587313527|FG000|Overall Study|Withdrawal by Subject|1|||
162616684|NCT04941456|587313528|FG001|Overall Study|Withdrawal by Subject|0|||
162616685|NCT04941456|587313527|FG000|Overall Study|Protocol Violation|1|||
162707796|NCT01253200|587638344|FG004|Overall Study|Attempts|0|||
162707797|NCT02049437|587638345|FG000|Period 1|Adverse Event|1|||
162883145|NCT02357849|588270045|FG001|Overall Study|Withdrawal by Subject|3|||
162883146|NCT03105700|588270046|FG000|Overall Study|screen fail|3|||
162883147|NCT03105700|588270046|FG000|Overall Study|Lost to Follow-up|4|||
162883148|NCT01253421|588270049|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
162883149|NCT01253421|588270050|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
162883150|NCT01253421|588270051|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
162883151|NCT01253421|588270052|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
162883152|NCT01253421|588270053|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
162883153|NCT01253421|588270049|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
162883154|NCT01253421|588270050|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
162883155|NCT01253421|588270051|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
162883156|NCT01253421|588270052|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
162883157|NCT01253421|588270053|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
162883158|NCT01253421|588270049|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
162883159|NCT01253421|588270050|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
162883160|NCT01253421|588270051|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
162883161|NCT01253421|588270052|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
162883162|NCT01253421|588270053|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
162883163|NCT01253421|588270049|FG000|Assessment and Scheduling|Physician Decision|1|||
162883164|NCT01253421|588270050|FG001|Assessment and Scheduling|Physician Decision|0|||
162883165|NCT01253421|588270051|FG002|Assessment and Scheduling|Physician Decision|0|||
162883166|NCT01253421|588270052|FG003|Assessment and Scheduling|Physician Decision|0|||
162883167|NCT01253421|588270053|FG004|Assessment and Scheduling|Physician Decision|0|||
162883168|NCT01253421|588270049|FG000|Drug+Scanning Visit|Physician Decision|0|||
162883169|NCT01253421|588270050|FG001|Drug+Scanning Visit|Physician Decision|0|||
162883170|NCT01253421|588270051|FG002|Drug+Scanning Visit|Physician Decision|0|||
162883171|NCT01253421|588270052|FG003|Drug+Scanning Visit|Physician Decision|0|||
162883172|NCT01253421|588270053|FG004|Drug+Scanning Visit|Physician Decision|1|||
162883173|NCT04105244|588270054|FG000|Overall Study|Withdrawal by Subject|10|||
162962729|NCT00640341|588564628|FG001|Overall Study|Poor fit/Uncomfortable|0|||
162962730|NCT00640341|588564629|FG002|Overall Study|Poor fit/Uncomfortable|0|||
162962731|NCT00640341|588564627|FG000|Overall Study|Ineligable at Baseline|5|||
162962732|NCT00640341|588564628|FG001|Overall Study|Ineligable at Baseline|3|||
162962733|NCT00640341|588564629|FG002|Overall Study|Ineligable at Baseline|2|||
162962734|NCT00640341|588564627|FG000|Overall Study|Adverse event and positive slit lamp|1|||
162962735|NCT00640341|588564628|FG001|Overall Study|Adverse event and positive slit lamp|0|||
162962736|NCT00640341|588564629|FG002|Overall Study|Adverse event and positive slit lamp|0|||
162962737|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
162962738|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
162962739|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
162962740|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
162962741|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
162962742|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
162962743|NCT01541215|588564632|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
162962744|NCT01541215|588564633|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
162962745|NCT01541215|588564632|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
162962746|NCT01541215|588564633|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
162962747|NCT01541215|588564632|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
162962748|NCT01541215|588564633|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
162962749|NCT02316223|588564637|FG000|Overall Study|Lack of Efficacy|0|||
162883174|NCT04105244|588270055|FG001|Overall Study|Withdrawal by Subject|12|||
162883175|NCT04105244|588270054|FG000|Overall Study|Lost to Follow-up|20|||
162962750|NCT02316223|588564638|FG001|Overall Study|Lack of Efficacy|1|||
162707798|NCT02049437|587638346|FG001|Period 1|Adverse Event|1|||
162883176|NCT04105244|588270055|FG001|Overall Study|Lost to Follow-up|15|||
162616686|NCT04941456|587313528|FG001|Overall Study|Protocol Violation|0|||
162616687|NCT05628103|587313531|FG000|Overall Study|Adverse Event|7|||
162616688|NCT05628103|587313531|FG000|Overall Study|Withdrawal by Subject|3|||
162616689|NCT05628103|587313531|FG000|Overall Study|Lost to Follow-up|3|||
162883177|NCT04105244|588270054|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
162883178|NCT04105244|588270055|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
162883179|NCT04105244|588270054|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
162883180|NCT04105244|588270055|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
162883181|NCT01608724|588270057|FG000|Overall Study|Withdrawal by Subject|131|||
162883182|NCT01608724|588270057|FG000|Overall Study|Lost to Follow-up|41|||
162883183|NCT01608724|588270057|FG000|Overall Study|Study-specific discontinuation criteria|32|||
162883184|NCT01608724|588270057|FG000|Overall Study|Adverse Event|29|||
162616690|NCT05628103|587313531|FG000|Overall Study|Lack of Efficacy|1|||
162616691|NCT05628103|587313531|FG000|Overall Study|Non-Compliance With Study Drug|4|||
162616692|NCT04840888|587313532|FG000|Period 1|Withdrawal by Subject|0|||
162616693|NCT04840888|587313533|FG001|Period 1|Withdrawal by Subject|0|||
162616694|NCT04840888|587313534|FG002|Period 1|Withdrawal by Subject|0|||
162616695|NCT04840888|587313535|FG003|Period 1|Withdrawal by Subject|0|||
162616696|NCT04840888|587313536|FG004|Period 1|Withdrawal by Subject|1|||
162616697|NCT04840888|587313537|FG005|Period 1|Withdrawal by Subject|0|||
162616698|NCT04840888|587313532|FG000|Period 1|Adverse Event|0|||
162616699|NCT04840888|587313533|FG001|Period 1|Adverse Event|0|||
162616700|NCT04840888|587313534|FG002|Period 1|Adverse Event|1|||
162616701|NCT04840888|587313535|FG003|Period 1|Adverse Event|1|||
162616702|NCT04840888|587313536|FG004|Period 1|Adverse Event|10|||
162616703|NCT04840888|587313537|FG005|Period 1|Adverse Event|1|||
162616704|NCT02718300|587313538|FG000|Overall Study|Death|4|||
162616705|NCT02718300|587313539|FG001|Overall Study|Death|5|||
162616706|NCT02718300|587313540|FG002|Overall Study|Death|17|||
162616707|NCT02718300|587313538|FG000|Overall Study|Lost to Follow-up|1|||
162616708|NCT02718300|587313539|FG001|Overall Study|Lost to Follow-up|0|||
162883185|NCT01608724|588270057|FG000|Overall Study|Protocol Violation|6|||
162962751|NCT02316223|588564639|FG002|Overall Study|Lack of Efficacy|1|||
162962752|NCT02316223|588564637|FG000|Overall Study|Lost to Follow-up|27|||
162962753|NCT02316223|588564638|FG001|Overall Study|Lost to Follow-up|34|||
162962754|NCT02316223|588564639|FG002|Overall Study|Lost to Follow-up|36|||
162962755|NCT02316223|588564637|FG000|Overall Study|COPD Diagnosis|3|||
162962756|NCT02316223|588564638|FG001|Overall Study|COPD Diagnosis|2|||
162962757|NCT02316223|588564639|FG002|Overall Study|COPD Diagnosis|3|||
162962758|NCT02316223|588564637|FG000|Overall Study|Reside outside study area|1|||
162962759|NCT02316223|588564638|FG001|Overall Study|Reside outside study area|1|||
162962760|NCT02316223|588564639|FG002|Overall Study|Reside outside study area|1|||
162962761|NCT02316223|588564637|FG000|Overall Study|No asthma|2|||
162962762|NCT02316223|588564638|FG001|Overall Study|No asthma|0|||
162962763|NCT02316223|588564639|FG002|Overall Study|No asthma|0|||
162962764|NCT02316223|588564637|FG000|Overall Study|Discontinued by PI|11|||
162962765|NCT02316223|588564638|FG001|Overall Study|Discontinued by PI|19|||
162962766|NCT02316223|588564639|FG002|Overall Study|Discontinued by PI|3|||
162962767|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
162962768|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
162962769|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962770|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962771|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962772|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
162962773|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
162962774|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
162962775|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962776|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962777|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962778|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
162962779|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
162962780|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962781|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962782|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162616709|NCT02718300|587313540|FG002|Overall Study|Lost to Follow-up|2|||
162616710|NCT02718300|587313538|FG000|Overall Study|Physician Decision|1|||
162616711|NCT02718300|587313539|FG001|Overall Study|Physician Decision|0|||
162616712|NCT02718300|587313540|FG002|Overall Study|Physician Decision|2|||
162962783|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162962784|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
162616713|NCT02718300|587313538|FG000|Overall Study|Study Terminated by Sponsor|6|||
162616714|NCT02718300|587313539|FG001|Overall Study|Study Terminated by Sponsor|3|||
162616715|NCT02718300|587313540|FG002|Overall Study|Study Terminated by Sponsor|4|||
162616716|NCT02718300|587313538|FG000|Overall Study|Withdrawal by Subject|0|||
163049584|NCT04058028|588889035|FG002|Overall Study|Lost to Follow-up|1|||
163049585|NCT04058028|588889036|FG003|Overall Study|Lost to Follow-up|0|||
163049586|NCT04058028|588889033|FG000|Overall Study|Death|0|||
163049587|NCT04058028|588889034|FG001|Overall Study|Death|1|||
163049588|NCT04058028|588889035|FG002|Overall Study|Death|0|||
163049589|NCT04058028|588889036|FG003|Overall Study|Death|0|||
163049590|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
163049591|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
163049592|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Adverse Event|57|||
163049593|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Adverse Event|49|||
163049594|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
163049595|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
163049596|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Site closure|3|||
163049597|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Site closure|2|||
163049598|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
163049599|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
163049600|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Physician Decision|48|||
163049601|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Physician Decision|38|||
163049602|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
163049603|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
163049604|NCT01705977|588889037|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
163049605|NCT01705977|588889038|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
163049606|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
163049607|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
163049608|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
163049609|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
163049610|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
163049611|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
163049612|NCT01705977|588889037|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
163049613|NCT01705977|588889038|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
163049614|NCT00248651|588889041|FG000|Overall Study|Withdrawal by Subject|28|||
163049615|NCT00248651|588889042|FG001|Overall Study|Withdrawal by Subject|40|||
163049616|NCT00248651|588889043|FG002|Overall Study|Withdrawal by Subject|32|||
163049617|NCT00828113|588889044|FG000|Overall Study|Withdrawal by Subject|27|||
163049618|NCT00828113|588889045|FG001|Overall Study|Withdrawal by Subject|26|||
163049619|NCT00828113|588889044|FG000|Overall Study|Lost to Follow-up|3|||
163049620|NCT00828113|588889045|FG001|Overall Study|Lost to Follow-up|5|||
163049621|NCT01365130|588889046|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
163049622|NCT05607576|588889048|FG000|Overall Study|immediate sensor error|2|||
163049623|NCT05607576|588889048|FG000|Overall Study|Physician Decision|2|||
163049624|NCT01683604|588889055|FG000|Overall Study|Adverse Event|2|||
163049625|NCT01683604|588889055|FG000|Overall Study|Lack of Efficacy|1|||
163049626|NCT01683604|588889055|FG000|Overall Study|Other|2|||
163049627|NCT03430856|588889056|FG000|Overall Study|Adverse Event|0|||
163049628|NCT03430856|588889057|FG001|Overall Study|Adverse Event|1|||
163049629|NCT03430856|588889058|FG002|Overall Study|Adverse Event|0|||
163049630|NCT03430856|588889056|FG000|Overall Study|Rescue criteria|1|||
163049631|NCT03430856|588889057|FG001|Overall Study|Rescue criteria|1|||
163049632|NCT03430856|588889058|FG002|Overall Study|Rescue criteria|0|||
163049633|NCT03430856|588889056|FG000|Overall Study|Voluntary withdrawal of consent|1|||
163049634|NCT03430856|588889057|FG001|Overall Study|Voluntary withdrawal of consent|1|||
163049635|NCT03430856|588889058|FG002|Overall Study|Voluntary withdrawal of consent|1|||
163049636|NCT02357459|588890867|FG000|Overall Study|Adverse Event|0|||
163049637|NCT02357459|588890868|FG001|Overall Study|Adverse Event|1|||
163049638|NCT02357459|588890869|FG002|Overall Study|Adverse Event|1|||
163049639|NCT02357459|588890867|FG000|Overall Study|Withdrawal by Subject|5|||
163049640|NCT02357459|588890868|FG001|Overall Study|Withdrawal by Subject|3|||
163049641|NCT02357459|588890869|FG002|Overall Study|Withdrawal by Subject|3|||
163049642|NCT02357459|588890867|FG000|Overall Study|Physician Decision|0|||
163049643|NCT02357459|588890868|FG001|Overall Study|Physician Decision|2|||
163049644|NCT02357459|588890869|FG002|Overall Study|Physician Decision|0|||
163049645|NCT02357459|588890867|FG000|Overall Study|Protocol Violation|1|||
163049646|NCT02357459|588890868|FG001|Overall Study|Protocol Violation|1|||
163049647|NCT02357459|588890869|FG002|Overall Study|Protocol Violation|0|||
163049648|NCT02357459|588890867|FG000|Overall Study|Lost to Follow-up|1|||
163049649|NCT02357459|588890868|FG001|Overall Study|Lost to Follow-up|3|||
163049650|NCT02357459|588890869|FG002|Overall Study|Lost to Follow-up|0|||
163049651|NCT02357459|588890867|FG000|Overall Study|Lack of Efficacy|7|||
163049652|NCT02357459|588890868|FG001|Overall Study|Lack of Efficacy|4|||
162707799|NCT02049437|587638345|FG000|Period 1|Adverse Event|1|||
163049653|NCT02357459|588890869|FG002|Overall Study|Lack of Efficacy|4|||
163049654|NCT02357459|588890867|FG000|Overall Study|Patient Relocated|2|||
162707800|NCT02049437|587638346|FG001|Period 1|Adverse Event|0|||
163049655|NCT02357459|588890868|FG001|Overall Study|Patient Relocated|0|||
162707801|NCT01163149|587638352|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
162707802|NCT01163149|587638353|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162707803|NCT01163149|587638354|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
162707804|NCT01163149|587638352|FG000|Extension Treatment Period|Adverse Event|0|||
162707805|NCT01163149|587638353|FG001|Extension Treatment Period|Adverse Event|1|||
162707806|NCT01163149|587638354|FG002|Extension Treatment Period|Adverse Event|0|||
162707807|NCT01163149|587638352|FG000|Extension Treatment Period|Noncompliance|0|||
162707808|NCT01163149|587638353|FG001|Extension Treatment Period|Noncompliance|0|||
162707809|NCT01163149|587638354|FG002|Extension Treatment Period|Noncompliance|1|||
162707810|NCT01700530|587638355|FG000|Overall Study|Withdrawal by Subject|0|||
162707811|NCT01700530|587638356|FG001|Overall Study|Withdrawal by Subject|3|||
162707812|NCT01700530|587638357|FG002|Overall Study|Withdrawal by Subject|1|||
162707813|NCT00578227|587638359|FG000|Overall Study|Lost to Follow-up|0|||
162707814|NCT00578227|587638360|FG001|Overall Study|Lost to Follow-up|1|||
162707815|NCT00578227|587638361|FG002|Overall Study|Lost to Follow-up|1|||
162707816|NCT00578227|587638359|FG000|Overall Study|Withdrawal by Subject|5|||
162707817|NCT00578227|587638360|FG001|Overall Study|Withdrawal by Subject|1|||
162707818|NCT00578227|587638361|FG002|Overall Study|Withdrawal by Subject|3|||
162707819|NCT04978363|587640591|FG000|Overall Study|Other medical issues unrelated to the study|0|||
162707820|NCT04978363|587640592|FG001|Overall Study|Other medical issues unrelated to the study|0|||
162707821|NCT04978363|587640593|FG002|Overall Study|Other medical issues unrelated to the study|0|||
162707822|NCT04978363|587640594|FG003|Overall Study|Other medical issues unrelated to the study|0|||
162707823|NCT04978363|587640595|FG004|Overall Study|Other medical issues unrelated to the study|1|||
162707824|NCT04978363|587640596|FG005|Overall Study|Other medical issues unrelated to the study|0|||
163049656|NCT02357459|588890869|FG002|Overall Study|Patient Relocated|0|||
163049657|NCT02357459|588890867|FG000|Overall Study|Instruction from PCP|1|||
163049658|NCT02357459|588890868|FG001|Overall Study|Instruction from PCP|0|||
163049659|NCT02357459|588890869|FG002|Overall Study|Instruction from PCP|0|||
163049660|NCT02357459|588890867|FG000|Overall Study|Incarceration|0|||
163049661|NCT02357459|588890868|FG001|Overall Study|Incarceration|0|||
163049662|NCT02357459|588890869|FG002|Overall Study|Incarceration|1|||
163049663|NCT02357459|588890867|FG000|Overall Study|Pre-planned Knee surgery|0|||
163049664|NCT02357459|588890868|FG001|Overall Study|Pre-planned Knee surgery|0|||
163049665|NCT02357459|588890869|FG002|Overall Study|Pre-planned Knee surgery|2|||
163049666|NCT02357459|588890867|FG000|Overall Study|Job Commitments|0|||
163049667|NCT02357459|588890868|FG001|Overall Study|Job Commitments|0|||
163049668|NCT02357459|588890869|FG002|Overall Study|Job Commitments|1|||
163049669|NCT03246347|588890870|FG000|Overall Study|On Study|23|||
163049670|NCT00916578|588890871|FG000|Overall Study|Physician Decision|2|||
163049671|NCT00916578|588890871|FG000|Overall Study|Withdrawal by Subject|3|||
163049672|NCT00916578|588890871|FG000|Overall Study|Insurance Denial|2|||
163049673|NCT01228591|588890874|FG000|Baseline|Lack of Efficacy|1|||
163049674|NCT01228591|588890875|FG001|Baseline|Lack of Efficacy|2|||
163049675|NCT02611882|588890876|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
163049676|NCT02611882|588890877|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
163049677|NCT02611882|588890878|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
163049678|NCT01389232|588890879|FG000|Overall Study|Had scaffold removed|15|||
163049679|NCT01389232|588890879|FG000|Overall Study|Personal reasons|2|||
163049680|NCT01389232|588890879|FG000|Overall Study|Adverse Event|1|||
163049681|NCT01389232|588890879|FG000|Overall Study|Death|1|||
163049682|NCT01317940|588890880|FG000|Overall Study|Death|1|||
163049683|NCT01317940|588890881|FG001|Overall Study|Death|0|||
163049684|NCT01317940|588890882|FG002|Overall Study|Death|1|||
163049685|NCT01317940|588890883|FG003|Overall Study|Death|0|||
163049686|NCT01317940|588890884|FG004|Overall Study|Death|0|||
163049687|NCT01317940|588890885|FG005|Overall Study|Death|0|||
163049688|NCT01317940|588890880|FG000|Overall Study|Lost to Follow-up|0|||
163049689|NCT01317940|588890881|FG001|Overall Study|Lost to Follow-up|0|||
162707825|NCT04978363|587640597|FG006|Overall Study|Other medical issues unrelated to the study|0|||
162707826|NCT04978363|587640598|FG007|Overall Study|Other medical issues unrelated to the study|0|||
162707827|NCT04978363|587640599|FG008|Overall Study|Other medical issues unrelated to the study|0|||
162707828|NCT04978363|587640600|FG009|Overall Study|Other medical issues unrelated to the study|0|||
162707829|NCT04978363|587640601|FG010|Overall Study|Other medical issues unrelated to the study|0|||
163049690|NCT01317940|588890882|FG002|Overall Study|Lost to Follow-up|1|||
163049691|NCT01317940|588890883|FG003|Overall Study|Lost to Follow-up|1|||
163049692|NCT01317940|588890884|FG004|Overall Study|Lost to Follow-up|1|||
163049693|NCT01317940|588890885|FG005|Overall Study|Lost to Follow-up|0|||
162707830|NCT04978363|587640591|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
162707831|NCT04978363|587640592|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
163049694|NCT01317940|588890880|FG000|Overall Study|Change in therapy plan|0|||
163049695|NCT01317940|588890881|FG001|Overall Study|Change in therapy plan|0|||
163049696|NCT01317940|588890882|FG002|Overall Study|Change in therapy plan|3|||
163049697|NCT01317940|588890883|FG003|Overall Study|Change in therapy plan|0|||
163049698|NCT01317940|588890884|FG004|Overall Study|Change in therapy plan|0|||
163049699|NCT01317940|588890885|FG005|Overall Study|Change in therapy plan|0|||
162707832|NCT04978363|587640593|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
162707833|NCT04978363|587640594|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
162707834|NCT04978363|587640595|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
162707835|NCT04978363|587640596|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
162707836|NCT04978363|587640597|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
162707837|NCT04978363|587640598|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
162707838|NCT04978363|587640599|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
162707839|NCT04978363|587640600|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
162707840|NCT04978363|587640601|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
162707841|NCT04978363|587640591|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707842|NCT04978363|587640592|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
162707843|NCT04978363|587640593|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707844|NCT04978363|587640594|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707845|NCT04978363|587640595|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707846|NCT04978363|587640596|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707847|NCT04978363|587640597|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707848|NCT04978363|587640598|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707849|NCT04978363|587640599|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707850|NCT04978363|587640600|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707851|NCT04978363|587640601|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162707852|NCT01251614|587640602|FG000|Overall Study|Adverse Event|1|||
162707853|NCT01251614|587640603|FG001|Overall Study|Adverse Event|0|||
162707854|NCT01251614|587640604|FG002|Overall Study|Adverse Event|1|||
162707855|NCT01251614|587640602|FG000|Overall Study|Lack of Efficacy|1|||
162707856|NCT01251614|587640603|FG001|Overall Study|Lack of Efficacy|9|||
162707857|NCT01251614|587640604|FG002|Overall Study|Lack of Efficacy|4|||
162707858|NCT01251614|587640602|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
162707859|NCT01251614|587640603|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
162707860|NCT01251614|587640604|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
162707861|NCT01251614|587640602|FG000|Overall Study|Pregnancy|0|||
162707862|NCT01251614|587640603|FG001|Overall Study|Pregnancy|0|||
162707863|NCT01251614|587640604|FG002|Overall Study|Pregnancy|2|||
162707864|NCT01251614|587640602|FG000|Overall Study|Loss of Disease Control|0|||
162707865|NCT01251614|587640603|FG001|Overall Study|Loss of Disease Control|1|||
162707866|NCT01251614|587640604|FG002|Overall Study|Loss of Disease Control|0|||
162707867|NCT01251614|587640602|FG000|Overall Study|Withdrawal by Subject|0|||
162707868|NCT01251614|587640603|FG001|Overall Study|Withdrawal by Subject|2|||
162707869|NCT01251614|587640604|FG002|Overall Study|Withdrawal by Subject|1|||
162707870|NCT01251614|587640602|FG000|Overall Study|Lost to Follow-up|0|||
162707871|NCT01251614|587640603|FG001|Overall Study|Lost to Follow-up|1|||
162707872|NCT01251614|587640604|FG002|Overall Study|Lost to Follow-up|0|||
162707873|NCT01876043|587640606|FG000|Overall Study|Death|1|||
162707874|NCT01876043|587640606|FG000|Overall Study|Withdrawal by Subject|1|||
162707875|NCT01211665|587640607|FG000|Overall Study|Withdrawal by Subject|1|||
162707876|NCT01211665|587640608|FG001|Overall Study|Withdrawal by Subject|0|||
162707877|NCT01211665|587640607|FG000|Overall Study|Death|1|||
162707878|NCT01211665|587640608|FG001|Overall Study|Death|0|||
162707879|NCT00498186|587640611|FG000|Overall Study|Protocol Violation|10|||
162707880|NCT00498186|587640611|FG000|Overall Study|Lack of Efficacy|31|||
162707881|NCT00498186|587640611|FG000|Overall Study|Adverse Event|89|||
162707882|NCT00498186|587640611|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
162707883|NCT00498186|587640611|FG000|Overall Study|Withdrawal by Subject|18|||
162707884|NCT00498186|587640611|FG000|Overall Study|Lost to Follow-up|3|||
162707885|NCT00498186|587640611|FG000|Overall Study|Other|10|||
162707886|NCT03302156|587640612|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
162707887|NCT03302156|587640613|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
162707888|NCT03302156|587640614|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
162707889|NCT03635112|587640616|FG000|Overall Study|Adverse Event|5|||
162883186|NCT01608724|588270057|FG000|Overall Study|bood sugar too high, etc.|3|||
162883187|NCT01608724|588270057|FG000|Overall Study|Safety reasons|1|||
162883188|NCT00099359|588270058|FG000|Overall Study|Death|11|||
162707890|NCT03635112|587640617|FG001|Overall Study|Adverse Event|9|||
162707891|NCT03635112|587640618|FG002|Overall Study|Adverse Event|14|||
162707892|NCT03635112|587640616|FG000|Overall Study|Lost to Follow-up|1|||
162707893|NCT03635112|587640617|FG001|Overall Study|Lost to Follow-up|0|||
162707894|NCT03635112|587640618|FG002|Overall Study|Lost to Follow-up|1|||
162883189|NCT00099359|588270059|FG001|Overall Study|Death|15|||
162883190|NCT00099359|588270060|FG002|Overall Study|Death|17|||
162883191|NCT00099359|588270058|FG000|Overall Study|Withdrawal by Subject|19|||
162883192|NCT00099359|588270059|FG001|Overall Study|Withdrawal by Subject|19|||
162883193|NCT00099359|588270060|FG002|Overall Study|Withdrawal by Subject|23|||
163049700|NCT02371616|588890887|FG000|Overall Study|Protocol Violation|2|||
162883194|NCT00099359|588270058|FG000|Overall Study|Lost to Follow-up|15|||
162883195|NCT00099359|588270059|FG001|Overall Study|Lost to Follow-up|24|||
162883196|NCT00099359|588270060|FG002|Overall Study|Lost to Follow-up|24|||
162883197|NCT00099359|588270058|FG000|Overall Study|moved out of area|9|||
162883198|NCT00099359|588270059|FG001|Overall Study|moved out of area|7|||
162883199|NCT00099359|588270060|FG002|Overall Study|moved out of area|4|||
162883200|NCT00717366|588270061|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
162883201|NCT00717366|588270062|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
162883202|NCT00717366|588270061|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
162883203|NCT00717366|588270062|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
162883204|NCT00717366|588270061|FG000|Core Study Period (20 Weeks)|Death|0|||
162883205|NCT00717366|588270062|FG001|Core Study Period (20 Weeks)|Death|1|||
162883206|NCT00717366|588270061|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
162883207|NCT00717366|588270062|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
162883208|NCT00717366|588270061|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
162883209|NCT00717366|588270062|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
162883210|NCT00717366|588270061|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
162883211|NCT00717366|588270062|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
162883212|NCT00717366|588270061|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
162883213|NCT00717366|588270062|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
162962785|NCT03234907|588564641|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
162962786|NCT03234907|588564642|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
162962787|NCT03234907|588564643|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962788|NCT03234907|588564644|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962789|NCT03234907|588564645|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962790|NCT03234907|588564646|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
162962791|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962792|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962793|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
162962794|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
163049701|NCT02371616|588890888|FG001|Overall Study|Protocol Violation|1|||
163049702|NCT02371616|588890887|FG000|Overall Study|Adverse Event|0|||
163049703|NCT02371616|588890888|FG001|Overall Study|Adverse Event|1|||
163049704|NCT02371616|588890887|FG000|Overall Study|Withdrawal of Consent|1|||
163049705|NCT02371616|588890888|FG001|Overall Study|Withdrawal of Consent|0|||
163049706|NCT02371616|588890887|FG000|Overall Study|Other (Not specified)|1|||
162616717|NCT02718300|587313539|FG001|Overall Study|Withdrawal by Subject|4|||
162616718|NCT02718300|587313540|FG002|Overall Study|Withdrawal by Subject|3|||
162616719|NCT02718300|587313538|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
162616720|NCT02718300|587313539|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
162616721|NCT02718300|587313540|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
162616722|NCT05741528|587313541|FG000|Overall Study|Withdrawal by Subject|11|||
162616723|NCT05741528|587313541|FG000|Overall Study|Lost to Follow-up|3|||
162616724|NCT05741528|587313541|FG000|Overall Study|Adverse Event|2|||
162616725|NCT05741528|587313541|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162616726|NCT05741528|587313541|FG000|Overall Study|Reason Not Specified|1|||
162616727|NCT04063384|587315065|FG000|Overall Study|placebo manipulation issue|1|||
162616728|NCT04063384|587315066|FG001|Overall Study|placebo manipulation issue|2|||
162616729|NCT04063384|587315067|FG002|Overall Study|placebo manipulation issue|1|||
162616730|NCT04063384|587315068|FG003|Overall Study|placebo manipulation issue|1|||
162616731|NCT03894046|587315074|FG000|Overall Study|Protocol Violation|1|||
162616732|NCT03894046|587315075|FG001|Overall Study|Protocol Violation|0|||
162616733|NCT03894046|587315076|FG002|Overall Study|Protocol Violation|0|||
162616734|NCT03894046|587315074|FG000|Overall Study|Adverse Event|0|||
162616735|NCT03894046|587315075|FG001|Overall Study|Adverse Event|1|||
162616736|NCT03894046|587315076|FG002|Overall Study|Adverse Event|0|||
162616737|NCT03894046|587315074|FG000|Overall Study|Withdrawal by Subject|2|||
162616738|NCT03894046|587315075|FG001|Overall Study|Withdrawal by Subject|3|||
162616739|NCT03894046|587315076|FG002|Overall Study|Withdrawal by Subject|1|||
162616740|NCT03894046|587315074|FG000|Overall Study|Death|15|||
162616741|NCT03894046|587315075|FG001|Overall Study|Death|21|||
162616742|NCT03894046|587315076|FG002|Overall Study|Death|4|||
162616743|NCT03894046|587315074|FG000|Overall Study|No growth of ABC|2|||
162616744|NCT03894046|587315075|FG001|Overall Study|No growth of ABC|1|||
162616745|NCT03894046|587315076|FG002|Overall Study|No growth of ABC|0|||
162616746|NCT03894046|587315074|FG000|Overall Study|Physician Decision|1|||
162616747|NCT03894046|587315075|FG001|Overall Study|Physician Decision|1|||
162616748|NCT03894046|587315076|FG002|Overall Study|Physician Decision|1|||
162616749|NCT03894046|587315074|FG000|Overall Study|Prohibited concomitant medication|1|||
162616750|NCT03894046|587315075|FG001|Overall Study|Prohibited concomitant medication|0|||
162616751|NCT03894046|587315076|FG002|Overall Study|Prohibited concomitant medication|0|||
162616752|NCT03894046|587315074|FG000|Overall Study|Transferred to other arm/group|1|||
163049707|NCT02371616|588890888|FG001|Overall Study|Other (Not specified)|5|||
163049708|NCT01921517|588890891|FG000|Overall Study|Lost to Follow-up|5|||
163049709|NCT01921517|588890892|FG001|Overall Study|Lost to Follow-up|0|||
163049710|NCT01921517|588890891|FG000|Overall Study|Newly diagnosed health concern|2|||
163049711|NCT01921517|588890892|FG001|Overall Study|Newly diagnosed health concern|0|||
163049712|NCT01921517|588890891|FG000|Overall Study|Physician Decision|0|||
163049713|NCT01921517|588890892|FG001|Overall Study|Physician Decision|2|||
163049714|NCT01921517|588890891|FG000|Overall Study|Withdrawal by Subject|7|||
163049715|NCT01921517|588890892|FG001|Overall Study|Withdrawal by Subject|3|||
163049716|NCT01921517|588890891|FG000|Overall Study|Subject missed final imaging|1|||
163049717|NCT01921517|588890892|FG001|Overall Study|Subject missed final imaging|4|||
163049718|NCT03205150|588890893|FG000|Overall Study|Protocol deviation|1|||
163049719|NCT03205150|588890894|FG001|Overall Study|Protocol deviation|3|||
163049720|NCT03205150|588890895|FG002|Overall Study|Protocol deviation|0|||
163049721|NCT03205150|588890893|FG000|Overall Study|Patient/guardian decision|0|||
163049722|NCT03205150|588890894|FG001|Overall Study|Patient/guardian decision|3|||
163049723|NCT03205150|588890895|FG002|Overall Study|Patient/guardian decision|0|||
163049724|NCT03205150|588890893|FG000|Overall Study|Adverse Event|1|||
163049725|NCT03205150|588890894|FG001|Overall Study|Adverse Event|1|||
163049726|NCT03205150|588890895|FG002|Overall Study|Adverse Event|1|||
163049727|NCT03205150|588890893|FG000|Overall Study|Lost to Follow-up|0|||
163049728|NCT03205150|588890894|FG001|Overall Study|Lost to Follow-up|0|||
163049729|NCT03205150|588890895|FG002|Overall Study|Lost to Follow-up|1|||
163049730|NCT01095835|588890896|FG000|Overall Study|Adverse Event|8|||
163049731|NCT01095835|588890897|FG001|Overall Study|Adverse Event|6|||
163049732|NCT01095835|588890898|FG002|Overall Study|Adverse Event|6|||
163049733|NCT01095835|588890896|FG000|Overall Study|Lack of Efficacy|0|||
163049734|NCT01095835|588890897|FG001|Overall Study|Lack of Efficacy|1|||
163049735|NCT01095835|588890898|FG002|Overall Study|Lack of Efficacy|0|||
163049736|NCT01095835|588890896|FG000|Overall Study|Physician Decision|0|||
163049737|NCT01095835|588890897|FG001|Overall Study|Physician Decision|0|||
163049738|NCT01095835|588890898|FG002|Overall Study|Physician Decision|1|||
163049739|NCT01095835|588890896|FG000|Overall Study|Withdrawal by Subject|1|||
163049740|NCT01095835|588890897|FG001|Overall Study|Withdrawal by Subject|3|||
163049741|NCT01095835|588890898|FG002|Overall Study|Withdrawal by Subject|0|||
163049742|NCT01095835|588890896|FG000|Overall Study|Non study compliance|0|||
163049743|NCT01095835|588890897|FG001|Overall Study|Non study compliance|0|||
163049744|NCT01095835|588890898|FG002|Overall Study|Non study compliance|1|||
163049745|NCT01095835|588890896|FG000|Overall Study|Protocol Violation|1|||
163049746|NCT01095835|588890897|FG001|Overall Study|Protocol Violation|2|||
163049747|NCT01095835|588890898|FG002|Overall Study|Protocol Violation|0|||
163049748|NCT03028142|588890899|FG000|Overall Study|Adverse Event|1|||
163049749|NCT03028142|588890900|FG001|Overall Study|Adverse Event|1|||
163049750|NCT03028142|588890901|FG002|Overall Study|Adverse Event|0|||
163049751|NCT03028142|588890902|FG003|Overall Study|Adverse Event|0|||
163049752|NCT03028142|588890903|FG004|Overall Study|Adverse Event|0|||
163049753|NCT03028142|588890904|FG005|Overall Study|Adverse Event|1|||
163049754|NCT03028142|588890899|FG000|Overall Study|Withdrawal by Subject|0|||
163049755|NCT03028142|588890900|FG001|Overall Study|Withdrawal by Subject|0|||
163049756|NCT03028142|588890901|FG002|Overall Study|Withdrawal by Subject|0|||
163049757|NCT03028142|588890902|FG003|Overall Study|Withdrawal by Subject|0|||
163049758|NCT03028142|588890903|FG004|Overall Study|Withdrawal by Subject|1|||
163049759|NCT03028142|588890904|FG005|Overall Study|Withdrawal by Subject|0|||
163049760|NCT00116688|588890908|FG000|Overall Study|Protocol deviation|1|||
163049761|NCT00116688|588890909|FG001|Overall Study|Protocol deviation|0|||
163049762|NCT00116688|588890908|FG000|Overall Study|Noncompliance|3|||
163049763|NCT00116688|588890909|FG001|Overall Study|Noncompliance|1|||
162707895|NCT03635112|587640616|FG000|Overall Study|Physician Decision|5|||
162883214|NCT02104804|588270065|FG000|Overall Study|Did not take study medication|0|||
162883215|NCT02104804|588270066|FG001|Overall Study|Did not take study medication|1|||
162883216|NCT02104804|588270065|FG000|Overall Study|Study specific discontinuation criteria|6|||
162883217|NCT02104804|588270066|FG001|Overall Study|Study specific discontinuation criteria|1|||
162883218|NCT02104804|588270065|FG000|Overall Study|Other listed|2|||
162883219|NCT02104804|588270066|FG001|Overall Study|Other listed|1|||
163049764|NCT00116688|588890908|FG000|Overall Study|Adverse Event|11|||
163049765|NCT00116688|588890909|FG001|Overall Study|Adverse Event|0|||
163049766|NCT00116688|588890908|FG000|Overall Study|Withdrawal by Subject|26|||
162883220|NCT02104804|588270065|FG000|Overall Study|Protocol Violation|0|||
162883221|NCT02104804|588270066|FG001|Overall Study|Protocol Violation|1|||
163049767|NCT00116688|588890909|FG001|Overall Study|Withdrawal by Subject|2|||
163049768|NCT00116688|588890908|FG000|Overall Study|Requirement for alternative therapy|11|||
163049769|NCT00116688|588890909|FG001|Overall Study|Requirement for alternative therapy|1|||
163049770|NCT00116688|588890908|FG000|Overall Study|Physician Decision|7|||
162883222|NCT02104804|588270065|FG000|Overall Study|Adverse Event|4|||
163049771|NCT00116688|588890909|FG001|Overall Study|Physician Decision|0|||
163049772|NCT00116688|588890908|FG000|Overall Study|Lost to Follow-up|3|||
163049773|NCT00116688|588890909|FG001|Overall Study|Lost to Follow-up|0|||
162883223|NCT02104804|588270066|FG001|Overall Study|Adverse Event|3|||
163049774|NCT00116688|588890908|FG000|Overall Study|Death|15|||
163049775|NCT00116688|588890909|FG001|Overall Study|Death|0|||
163049776|NCT00116688|588890908|FG000|Overall Study|Protocol-specified criteria|3|||
163049777|NCT00116688|588890909|FG001|Overall Study|Protocol-specified criteria|0|||
163049778|NCT00116688|588890908|FG000|Overall Study|Pregnancy|1|||
163049779|NCT00116688|588890909|FG001|Overall Study|Pregnancy|0|||
163049780|NCT00116688|588890908|FG000|Overall Study|Other|11|||
163049781|NCT00116688|588890909|FG001|Overall Study|Other|0|||
163049782|NCT01775670|588890911|FG000|Overall Study|Lost to Follow-up|1|||
163049783|NCT01775670|588890912|FG001|Overall Study|Lost to Follow-up|1|||
163049784|NCT01298700|588890914|FG000|Overall Study|Adverse Event|50|||
163049785|NCT01298700|588890915|FG001|Overall Study|Adverse Event|51|||
163049786|NCT01298700|588890914|FG000|Overall Study|Lack of Efficacy|9|||
163049787|NCT01298700|588890915|FG001|Overall Study|Lack of Efficacy|14|||
163049788|NCT01298700|588890914|FG000|Overall Study|Lost to Follow-up|5|||
163049789|NCT01298700|588890915|FG001|Overall Study|Lost to Follow-up|2|||
163049790|NCT01298700|588890914|FG000|Overall Study|Withdrawal by Subject|12|||
163049791|NCT01298700|588890915|FG001|Overall Study|Withdrawal by Subject|9|||
163049792|NCT01298700|588890914|FG000|Overall Study|Protocol Violation|6|||
163049793|NCT01298700|588890915|FG001|Overall Study|Protocol Violation|4|||
163049794|NCT01298700|588890914|FG000|Overall Study|Other Miscellaneous Reasons|16|||
163049795|NCT01298700|588890915|FG001|Overall Study|Other Miscellaneous Reasons|15|||
163049796|NCT01298700|588890914|FG000|Overall Study|Did not Receive Study Drug|3|||
163049797|NCT01298700|588890915|FG001|Overall Study|Did not Receive Study Drug|5|||
163049798|NCT04006145|588890918|FG000|Overall Study|Lost to Follow-up|0|||
163049799|NCT04006145|588890919|FG001|Overall Study|Lost to Follow-up|1|||
163049800|NCT04006145|588890918|FG000|Overall Study|Other|1|||
163049801|NCT04006145|588890919|FG001|Overall Study|Other|2|||
163049802|NCT01001429|588890920|FG000|Overall Study|surgery cancelled|0|||
163049803|NCT01001429|588890921|FG001|Overall Study|surgery cancelled|1|||
163049804|NCT02812186|588890924|FG000|Period 1|Post randomization screen failure|5|||
163049805|NCT02812186|588890925|FG001|Period 1|Post randomization screen failure|9|||
163049806|NCT02812186|588890924|FG000|Period 1|nonevaluable data sets|6|||
163049807|NCT02812186|588890925|FG001|Period 1|nonevaluable data sets|6|||
162616753|NCT03894046|587315075|FG001|Overall Study|Transferred to other arm/group|1|||
162616754|NCT03894046|587315076|FG002|Overall Study|Transferred to other arm/group|0|||
162616755|NCT03270644|587315077|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
162616756|NCT03270644|587315077|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
162616757|NCT02476201|587315078|FG000|Overall Study|Unable to program MPP|9|||
162616758|NCT02476201|587315078|FG000|Overall Study|Study echo not performed|5|||
162616759|NCT02476201|587315078|FG000|Overall Study|Adverse Event|4|||
162616760|NCT02476201|587315078|FG000|Overall Study|Death|2|||
162616761|NCT02476201|587315078|FG000|Overall Study|Lost to Follow-up|2|||
162616762|NCT02476201|587315078|FG000|Overall Study|MPP programmed to OFF|2|||
162616763|NCT02476201|587315078|FG000|Overall Study|Withdrawal by Subject|1|||
162616764|NCT02476201|587315078|FG000|Overall Study|Unsuccessful implant|1|||
162616765|NCT00333801|587315079|FG000|Overall Study|Moved to another state|5|||
162616766|NCT00333801|587315080|FG001|Overall Study|Moved to another state|3|||
162616767|NCT00333801|587315079|FG000|Overall Study|Lost to Follow-up|2|||
162616768|NCT00333801|587315080|FG001|Overall Study|Lost to Follow-up|0|||
162616769|NCT00333801|587315079|FG000|Overall Study|Incarcerated|1|||
162616770|NCT00333801|587315080|FG001|Overall Study|Incarcerated|2|||
162616771|NCT00333801|587315079|FG000|Overall Study|Withdrawal by Subject|0|||
162616772|NCT00333801|587315080|FG001|Overall Study|Withdrawal by Subject|1|||
162616773|NCT00777205|587315081|FG000|Overall Study|Lost to Follow-up|25|||
162616774|NCT00777205|587315082|FG001|Overall Study|Lost to Follow-up|9|||
162616775|NCT00777205|587315081|FG000|Overall Study|Withdrawal by Subject|6|||
162883224|NCT02104804|588270065|FG000|Overall Study|Withdrawal by Subject|4|||
162883225|NCT02104804|588270066|FG001|Overall Study|Withdrawal by Subject|12|||
162883226|NCT00645567|588270067|FG000|Overall Study|Adverse Event|1|||
162883227|NCT01364233|588270068|FG000|Overall Study|Lost to Follow-up|1|||
162883228|NCT00406783|588270069|FG000|Overall Study|Adverse Event|4|||
162883229|NCT00406783|588270070|FG001|Overall Study|Adverse Event|4|||
162883230|NCT00406783|588270069|FG000|Overall Study|Treatment Failure|2|||
162883231|NCT00406783|588270070|FG001|Overall Study|Treatment Failure|3|||
162883232|NCT00406783|588270069|FG000|Overall Study|Lost to Follow-up|3|||
163049808|NCT00010257|588890926|FG000|Overall Study|Withdrawal by Subject|1|||
162883233|NCT00406783|588270070|FG001|Overall Study|Lost to Follow-up|0|||
162883234|NCT00406783|588270069|FG000|Overall Study|Withdrawal by Subject|1|||
163049809|NCT00010257|588890927|FG001|Overall Study|Withdrawal by Subject|0|||
163049810|NCT00643760|588890930|FG000|Overall Study|Adverse Event|11|||
163049811|NCT00643760|588890931|FG001|Overall Study|Adverse Event|5|||
163049812|NCT00643760|588890932|FG002|Overall Study|Adverse Event|12|||
163049813|NCT00643760|588890933|FG003|Overall Study|Adverse Event|21|||
162616776|NCT00777205|587315082|FG001|Overall Study|Withdrawal by Subject|4|||
162616777|NCT00777205|587315081|FG000|Overall Study|Death|0|||
162616778|NCT00777205|587315082|FG001|Overall Study|Death|2|||
162616779|NCT00777205|587315081|FG000|Overall Study|Protocol Violation|0|||
163049814|NCT00643760|588890934|FG004|Overall Study|Adverse Event|6|||
162883235|NCT00406783|588270070|FG001|Overall Study|Withdrawal by Subject|4|||
162883236|NCT00406783|588270069|FG000|Overall Study|Protocol Violation|4|||
162883237|NCT00406783|588270070|FG001|Overall Study|Protocol Violation|4|||
162883238|NCT02034474|588270071|FG000|Overall Study|Adverse Event|3|||
162883239|NCT02034474|588270072|FG001|Overall Study|Adverse Event|2|||
162883240|NCT02034474|588270071|FG000|Overall Study|Withdrawal by Subject|1|||
162883241|NCT02034474|588270072|FG001|Overall Study|Withdrawal by Subject|2|||
162883242|NCT01391819|588270073|FG000|Overall Study|Withdrawal by Subject|56|||
162883243|NCT01391819|588270073|FG000|Overall Study|Migrated/moved from study area|82|||
162883244|NCT01391819|588270073|FG000|Overall Study|Lost to Follow-up|252|||
162883245|NCT01391819|588270073|FG000|Overall Study|Death|3|||
162883246|NCT01391819|588270073|FG000|Overall Study|Other|9|||
162883247|NCT00995670|588270075|FG000|Overall Study|Failed arterial cannulation|1|||
162883248|NCT00995670|588270076|FG001|Overall Study|Failed arterial cannulation|0|||
162883249|NCT00995670|588270077|FG002|Overall Study|Failed arterial cannulation|3|||
162883250|NCT00675103|588270078|FG000|Overall Study|Lack of Efficacy|2|||
162883251|NCT00675103|588270078|FG000|Overall Study|Adverse Event|1|||
162707896|NCT03635112|587640617|FG001|Overall Study|Physician Decision|7|||
162707897|NCT03635112|587640618|FG002|Overall Study|Physician Decision|5|||
162707898|NCT03635112|587640616|FG000|Overall Study|Protocol Violation|0|||
162707899|NCT03635112|587640617|FG001|Overall Study|Protocol Violation|0|||
162707900|NCT03635112|587640618|FG002|Overall Study|Protocol Violation|1|||
162707901|NCT03635112|587640616|FG000|Overall Study|Study Terminated by Sponsor|11|||
162707902|NCT03635112|587640617|FG001|Overall Study|Study Terminated by Sponsor|17|||
162707903|NCT03635112|587640618|FG002|Overall Study|Study Terminated by Sponsor|21|||
162707904|NCT03635112|587640616|FG000|Overall Study|Withdrawal by Subject|4|||
162707905|NCT03635112|587640617|FG001|Overall Study|Withdrawal by Subject|9|||
162707906|NCT03635112|587640618|FG002|Overall Study|Withdrawal by Subject|7|||
162707907|NCT03635112|587640616|FG000|Overall Study|Miscellaneous|0|||
162707908|NCT03635112|587640617|FG001|Overall Study|Miscellaneous|0|||
162707909|NCT03635112|587640618|FG002|Overall Study|Miscellaneous|1|||
162707910|NCT03283553|587640623|FG000|Patient Participant Flow|Death|5|||
162707911|NCT03283553|587640624|FG001|Patient Participant Flow|Death|10|||
162707912|NCT03283553|587640623|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
162707913|NCT03283553|587640624|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
162707914|NCT03283553|587640623|FG000|Patient Participant Flow|Lost to Follow-up|1|||
162707915|NCT03283553|587640624|FG001|Patient Participant Flow|Lost to Follow-up|1|||
162707916|NCT03283553|587640623|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
162707917|NCT03283553|587640624|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
162707918|NCT03283553|587640623|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
162707919|NCT03283553|587640624|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
162707920|NCT03283553|587640623|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
162707921|NCT03283553|587640624|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
162707922|NCT03686683|587640625|FG000|Overall Study|Withdrawal by Subject|52|||
162707923|NCT03686683|587640626|FG001|Overall Study|Withdrawal by Subject|32|||
162707924|NCT03686683|587640625|FG000|Overall Study|Lost to Follow-up|23|||
162707925|NCT03686683|587640626|FG001|Overall Study|Lost to Follow-up|19|||
162707926|NCT03686683|587640625|FG000|Overall Study|Adverse Event|1|||
162707927|NCT03686683|587640626|FG001|Overall Study|Adverse Event|0|||
162707928|NCT03686683|587640625|FG000|Overall Study|Death|10|||
162707929|NCT03686683|587640626|FG001|Overall Study|Death|5|||
162707930|NCT03686683|587640625|FG000|Overall Study|Progressive Disease|1|||
162707931|NCT03686683|587640626|FG001|Overall Study|Progressive Disease|1|||
162707932|NCT03686683|587640625|FG000|Overall Study|Noncompliance|1|||
162707933|NCT03686683|587640626|FG001|Overall Study|Noncompliance|0|||
162707934|NCT03686683|587640625|FG000|Overall Study|Physician Decision|1|||
162883252|NCT01810042|588270081|FG000|Overall Study|Lost to Follow-up|10|||
162883253|NCT01208038|588270084|FG000|Overall Study|Withdrawal by Subject|1|||
162883254|NCT04092816|588272341|FG000|Overall Study|Lost to Follow-up|1|||
162883255|NCT04092816|588272342|FG001|Overall Study|Lost to Follow-up|2|||
162707935|NCT03686683|587640626|FG001|Overall Study|Physician Decision|1|||
162707936|NCT03686683|587640625|FG000|Overall Study|Screen fail post-randomization|1|||
162883256|NCT01337167|588272343|FG000|Infant Series|Adverse Event|1|||
162883257|NCT01337167|588272344|FG001|Infant Series|Adverse Event|1|||
162883258|NCT01337167|588272343|FG000|Infant Series|Death|1|||
162883259|NCT01337167|588272344|FG001|Infant Series|Death|1|||
162707937|NCT03686683|587640626|FG001|Overall Study|Screen fail post-randomization|0|||
162707938|NCT03686683|587640625|FG000|Overall Study|Protocol Violation|3|||
162707939|NCT03686683|587640626|FG001|Overall Study|Protocol Violation|0|||
162707940|NCT03686683|587640625|FG000|Overall Study|No data available|1|||
162707941|NCT03686683|587640626|FG001|Overall Study|No data available|0|||
162707942|NCT01770860|587640627|FG000|Overall Study|Withdrawal by Subject|4|||
162883260|NCT01337167|588272343|FG000|Infant Series|Lost to Follow-up|13|||
162707943|NCT01770860|587640627|FG000|Overall Study|Lost to Follow-up|1|||
162883261|NCT01337167|588272344|FG001|Infant Series|Lost to Follow-up|7|||
162883262|NCT01337167|588272343|FG000|Infant Series|Non-compliance with study drug|2|||
162883263|NCT01337167|588272344|FG001|Infant Series|Non-compliance with study drug|1|||
162883264|NCT01337167|588272343|FG000|Infant Series|Physician Decision|3|||
162883265|NCT01337167|588272344|FG001|Infant Series|Physician Decision|1|||
162883266|NCT01337167|588272343|FG000|Infant Series|Protocol Violation|22|||
162883267|NCT01337167|588272344|FG001|Infant Series|Protocol Violation|9|||
162883268|NCT01337167|588272343|FG000|Infant Series|Withdrawal by Subject|15|||
162883269|NCT01337167|588272344|FG001|Infant Series|Withdrawal by Subject|4|||
162883270|NCT01337167|588272343|FG000|Infant Series|Randomized but not vaccinated|5|||
162883271|NCT01337167|588272344|FG001|Infant Series|Randomized but not vaccinated|3|||
162883272|NCT01337167|588272343|FG000|Interim Period|Lost to Follow-up|51|||
162883273|NCT01337167|588272344|FG001|Interim Period|Lost to Follow-up|23|||
162883274|NCT01337167|588272343|FG000|Interim Period|Non-compliance with study drug|1|||
162883275|NCT01337167|588272344|FG001|Interim Period|Non-compliance with study drug|0|||
162883276|NCT01337167|588272343|FG000|Interim Period|Physician Decision|6|||
162883277|NCT01337167|588272344|FG001|Interim Period|Physician Decision|3|||
162883278|NCT01337167|588272343|FG000|Interim Period|Protocol Violation|5|||
162883279|NCT01337167|588272344|FG001|Interim Period|Protocol Violation|3|||
162883280|NCT01337167|588272343|FG000|Interim Period|Withdrawal by Subject|18|||
162883281|NCT01337167|588272344|FG001|Interim Period|Withdrawal by Subject|10|||
162883282|NCT01337167|588272343|FG000|Interim Period|Other protocol criterion not met|0|||
162883283|NCT01337167|588272344|FG001|Interim Period|Other protocol criterion not met|1|||
162883284|NCT01337167|588272343|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
162883285|NCT01337167|588272344|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
162883286|NCT01337167|588272343|FG000|Toddler Vaccinations|Protocol Violation|0|||
162883287|NCT01337167|588272344|FG001|Toddler Vaccinations|Protocol Violation|1|||
162883288|NCT01337167|588272343|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
162883289|NCT01337167|588272344|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
162883290|NCT03833817|588272345|FG000|Overall Study|Withdrawal by Subject|3|||
162883291|NCT03833817|588272346|FG001|Overall Study|Withdrawal by Subject|3|||
162883292|NCT03833817|588272345|FG000|Overall Study|Lost to Follow-up|3|||
162883293|NCT03833817|588272346|FG001|Overall Study|Lost to Follow-up|3|||
162883294|NCT02126670|588272349|FG000|Overall Study|Withdrawal by Subject|1|||
162883295|NCT02126670|588272350|FG001|Overall Study|Withdrawal by Subject|0|||
162883296|NCT02126670|588272351|FG002|Overall Study|Withdrawal by Subject|0|||
162883297|NCT02126670|588272352|FG003|Overall Study|Withdrawal by Subject|1|||
162883298|NCT03363919|588272357|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
162883299|NCT03363919|588272358|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
162883300|NCT03363919|588272357|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
162883301|NCT03363919|588272358|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
162883302|NCT01975246|588272359|FG000|Overall Study|Adverse Event|2|||
162883303|NCT01975246|588272360|FG001|Overall Study|Adverse Event|1|||
162883304|NCT01975246|588272359|FG000|Overall Study|Lack of Efficacy|1|||
162883305|NCT01975246|588272360|FG001|Overall Study|Lack of Efficacy|0|||
162883306|NCT01975246|588272359|FG000|Overall Study|Protocol Violation|1|||
162883307|NCT01975246|588272360|FG001|Overall Study|Protocol Violation|0|||
162883308|NCT01975246|588272359|FG000|Overall Study|Other than stated|0|||
162883309|NCT01975246|588272360|FG001|Overall Study|Other than stated|1|||
162616780|NCT00777205|587315082|FG001|Overall Study|Protocol Violation|56|||
162616781|NCT02633501|587315086|FG000|Overall Study|Adverse Event|0|||
162616782|NCT02633501|587315087|FG001|Overall Study|Adverse Event|0|||
162616783|NCT02633501|587315088|FG002|Overall Study|Adverse Event|1|||
162616784|NCT02633501|587315089|FG003|Overall Study|Adverse Event|0|||
162616785|NCT02633501|587315090|FG004|Overall Study|Adverse Event|1|||
162616786|NCT02633501|587315091|FG005|Overall Study|Adverse Event|1|||
162616787|NCT02633501|587315086|FG000|Overall Study|Withdrawal by Subject|2|||
162616788|NCT02633501|587315087|FG001|Overall Study|Withdrawal by Subject|1|||
162616789|NCT02633501|587315088|FG002|Overall Study|Withdrawal by Subject|2|||
162616790|NCT02633501|587315089|FG003|Overall Study|Withdrawal by Subject|2|||
162616791|NCT02633501|587315090|FG004|Overall Study|Withdrawal by Subject|1|||
162616792|NCT02633501|587315091|FG005|Overall Study|Withdrawal by Subject|3|||
162616793|NCT02633501|587315086|FG000|Overall Study|Various other reasons|0|||
162616794|NCT02633501|587315087|FG001|Overall Study|Various other reasons|2|||
162616795|NCT02633501|587315088|FG002|Overall Study|Various other reasons|4|||
162616796|NCT02633501|587315089|FG003|Overall Study|Various other reasons|1|||
162616797|NCT02633501|587315090|FG004|Overall Study|Various other reasons|7|||
162616798|NCT02633501|587315091|FG005|Overall Study|Various other reasons|11|||
162616799|NCT02633501|587315086|FG000|Overall Study|Lost to Follow-up|0|||
162616800|NCT02633501|587315087|FG001|Overall Study|Lost to Follow-up|0|||
162616801|NCT02633501|587315088|FG002|Overall Study|Lost to Follow-up|0|||
162616802|NCT02633501|587315089|FG003|Overall Study|Lost to Follow-up|1|||
162616803|NCT02633501|587315090|FG004|Overall Study|Lost to Follow-up|2|||
162616804|NCT02633501|587315091|FG005|Overall Study|Lost to Follow-up|0|||
162616805|NCT01104155|587315093|FG000|Overall Study|Adverse Event|15|||
162616806|NCT01104155|587315094|FG001|Overall Study|Adverse Event|8|||
162616807|NCT01104155|587315093|FG000|Overall Study|Participant choice|6|||
162616808|NCT01104155|587315094|FG001|Overall Study|Participant choice|5|||
162616809|NCT01104155|587315093|FG000|Overall Study|Withdrawal of consent|1|||
162616810|NCT01104155|587315094|FG001|Overall Study|Withdrawal of consent|1|||
162616811|NCT01104155|587315093|FG000|Overall Study|Other|3|||
162616812|NCT01104155|587315094|FG001|Overall Study|Other|4|||
162616813|NCT00464269|587315097|FG000|Overall Study|Lack of Efficacy|1|||
162616814|NCT00464269|587315098|FG001|Overall Study|Lack of Efficacy|0|||
162616815|NCT00464269|587315099|FG002|Overall Study|Lack of Efficacy|0|||
162616816|NCT00464269|587315100|FG003|Overall Study|Lack of Efficacy|0|||
162616817|NCT00464269|587315097|FG000|Overall Study|Lost to Follow-up|0|||
162616818|NCT00464269|587315098|FG001|Overall Study|Lost to Follow-up|4|||
162616819|NCT00464269|587315099|FG002|Overall Study|Lost to Follow-up|0|||
162616820|NCT00464269|587315100|FG003|Overall Study|Lost to Follow-up|1|||
162616821|NCT00464269|587315097|FG000|Overall Study|Withdrawal by Subject|0|||
162707944|NCT01770860|587640627|FG000|Overall Study|Administrative decision made by the PI|1|||
162883310|NCT01646398|588272361|FG000|Overall Study|Withdrawal by Subject|1|||
162883311|NCT01646398|588272362|FG001|Overall Study|Withdrawal by Subject|0|||
162962795|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
162962796|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
162962797|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
162962798|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
162962799|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
162962800|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
162962801|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
162962802|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
162962803|NCT03234907|588564641|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962804|NCT03234907|588564642|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962805|NCT03234907|588564643|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
162962806|NCT03234907|588564644|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
162962807|NCT03234907|588564645|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
162616822|NCT00464269|587315098|FG001|Overall Study|Withdrawal by Subject|2|||
162616823|NCT00464269|587315099|FG002|Overall Study|Withdrawal by Subject|1|||
162616824|NCT00464269|587315100|FG003|Overall Study|Withdrawal by Subject|1|||
162616825|NCT00464269|587315097|FG000|Overall Study|Other reason|3|||
162616826|NCT00464269|587315098|FG001|Overall Study|Other reason|3|||
162616827|NCT00464269|587315099|FG002|Overall Study|Other reason|1|||
162883312|NCT01827319|588272363|FG000|Overall Study|Lost to Follow-up|3|||
162883313|NCT00574119|588272364|FG000|Overall Study|Adverse Event|1|||
162962808|NCT03234907|588564646|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
163049815|NCT00643760|588890930|FG000|Overall Study|Lack of Efficacy|3|||
163049816|NCT00643760|588890931|FG001|Overall Study|Lack of Efficacy|1|||
163049817|NCT00643760|588890932|FG002|Overall Study|Lack of Efficacy|0|||
163049818|NCT00643760|588890933|FG003|Overall Study|Lack of Efficacy|4|||
163049819|NCT00643760|588890934|FG004|Overall Study|Lack of Efficacy|3|||
163049820|NCT00643760|588890930|FG000|Overall Study|Protocol Violation|7|||
163049821|NCT00643760|588890931|FG001|Overall Study|Protocol Violation|6|||
163049822|NCT00643760|588890932|FG002|Overall Study|Protocol Violation|4|||
163049823|NCT00643760|588890933|FG003|Overall Study|Protocol Violation|4|||
163049824|NCT00643760|588890934|FG004|Overall Study|Protocol Violation|6|||
163049825|NCT00643760|588890930|FG000|Overall Study|Lost to Follow-up|6|||
163049826|NCT00643760|588890931|FG001|Overall Study|Lost to Follow-up|2|||
163049827|NCT00643760|588890932|FG002|Overall Study|Lost to Follow-up|1|||
163049828|NCT00643760|588890933|FG003|Overall Study|Lost to Follow-up|3|||
163049829|NCT00643760|588890934|FG004|Overall Study|Lost to Follow-up|3|||
163049830|NCT00643760|588890930|FG000|Overall Study|Investigator Discretion|0|||
163049831|NCT00643760|588890931|FG001|Overall Study|Investigator Discretion|0|||
163049832|NCT00643760|588890932|FG002|Overall Study|Investigator Discretion|0|||
163049833|NCT00643760|588890933|FG003|Overall Study|Investigator Discretion|2|||
163049834|NCT00643760|588890934|FG004|Overall Study|Investigator Discretion|0|||
163049835|NCT00643760|588890930|FG000|Overall Study|Withdrawal by Subject|3|||
163049836|NCT00643760|588890931|FG001|Overall Study|Withdrawal by Subject|1|||
163049837|NCT00643760|588890932|FG002|Overall Study|Withdrawal by Subject|2|||
163049838|NCT00643760|588890933|FG003|Overall Study|Withdrawal by Subject|4|||
163049839|NCT00643760|588890934|FG004|Overall Study|Withdrawal by Subject|1|||
163049840|NCT00789321|588890938|FG000|Overall Study|Adverse Event|0|||
163049841|NCT00789321|588890939|FG001|Overall Study|Adverse Event|1|||
163049842|NCT00104052|588890940|FG000|Overall Study|Adverse Event|1|||
163049843|NCT00104052|588890940|FG000|Overall Study|Lack of Efficacy|26|||
163049844|NCT00104052|588890940|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
163049845|NCT01162343|588890941|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
163049846|NCT01162343|588890941|FG000|Overall Study|Refused psychiatrist assessment|12|||
163049847|NCT02771275|588890942|FG000|Overall Study|Reoperation|3|||
163049848|NCT02771275|588890942|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
163049849|NCT05556148|588890943|FG000|Overall Study|Early Termination|29|||
163049850|NCT05556148|588890943|FG000|Overall Study|Baseline Tasks Expired|4|||
163049851|NCT05556148|588890943|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
163049852|NCT05556148|588890943|FG000|Overall Study|No Longer Wished to Participate|1|||
163049853|NCT05556148|588890943|FG000|Overall Study|Bacterial Conjunctivitis|1|||
163049854|NCT03191799|588890944|FG000|Overall Study|Withdrawal by Subject|4|||
163049855|NCT03191799|588890944|FG000|Overall Study|Physician Decision|2|||
163049856|NCT03191799|588890944|FG000|Overall Study|Lost to Follow-up|1|||
163049857|NCT03191799|588890944|FG000|Overall Study|Death|2|||
163049858|NCT01239797|588890945|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
163049859|NCT01239797|588890946|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
163049860|NCT01239797|588890945|FG000|Randomized Participants|Participant withdrew consent|1|||
163049861|NCT01239797|588890946|FG001|Randomized Participants|Participant withdrew consent|7|||
163049862|NCT01239797|588890945|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
163049863|NCT01239797|588890946|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
163049864|NCT01239797|588890945|FG000|Treated Participants|Disease progression|185|||
163049865|NCT01239797|588890946|FG001|Treated Participants|Disease progression|185|||
163049866|NCT01239797|588890945|FG000|Treated Participants|Study drug toxicity|39|||
163049867|NCT01239797|588890946|FG001|Treated Participants|Study drug toxicity|45|||
163049868|NCT01239797|588890945|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
163049869|NCT01239797|588890946|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
163049870|NCT01239797|588890945|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
163049871|NCT01239797|588890946|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
163049872|NCT01239797|588890945|FG000|Treated Participants|Administrative reason by sponsor|13|||
163049873|NCT01239797|588890946|FG001|Treated Participants|Administrative reason by sponsor|4|||
163049874|NCT01239797|588890945|FG000|Treated Participants|Other reasons|14|||
163049875|NCT01239797|588890946|FG001|Treated Participants|Other reasons|14|||
163049876|NCT01239797|588890945|FG000|Treated Participants|Participant withdrew consent|6|||
163049877|NCT01239797|588890946|FG001|Treated Participants|Participant withdrew consent|11|||
163049878|NCT01239797|588890945|FG000|Treated Participants|Death|1|||
163049879|NCT01239797|588890946|FG001|Treated Participants|Death|1|||
163049880|NCT01239797|588890945|FG000|Treated Participants|Participant no longer meets study criteria|1|||
163049881|NCT01239797|588890946|FG001|Treated Participants|Participant no longer meets study criteria|1|||
163049882|NCT01239797|588890945|FG000|Treated Participants|Poor/non-compliance|0|||
163049883|NCT01239797|588890946|FG001|Treated Participants|Poor/non-compliance|1|||
163049884|NCT02631941|588890949|FG000|Overall Study|Physician Decision|0|||
163049885|NCT02631941|588890950|FG001|Overall Study|Physician Decision|1|||
163049886|NCT02631941|588890951|FG002|Overall Study|Physician Decision|0|||
163049887|NCT02631941|588890952|FG003|Overall Study|Physician Decision|0|||
163049888|NCT02631941|588890953|FG004|Overall Study|Physician Decision|0|||
163049889|NCT02631941|588890954|FG005|Overall Study|Physician Decision|0|||
163049890|NCT02631941|588890955|FG006|Overall Study|Physician Decision|0|||
163049891|NCT02631941|588890956|FG007|Overall Study|Physician Decision|0|||
163049892|NCT02631941|588890957|FG008|Overall Study|Physician Decision|0|||
163049893|NCT02631941|588890958|FG009|Overall Study|Physician Decision|0|||
163049894|NCT02631941|588890949|FG000|Overall Study|Adverse Event|0|||
162707945|NCT05124899|587640628|FG000|Overall Study|Lost to Follow-up|3|||
163049895|NCT02631941|588890950|FG001|Overall Study|Adverse Event|1|||
163049896|NCT02631941|588890951|FG002|Overall Study|Adverse Event|0|||
163049897|NCT02631941|588890952|FG003|Overall Study|Adverse Event|0|||
163049898|NCT02631941|588890953|FG004|Overall Study|Adverse Event|0|||
163049899|NCT02631941|588890954|FG005|Overall Study|Adverse Event|0|||
163049900|NCT02631941|588890955|FG006|Overall Study|Adverse Event|0|||
163049901|NCT02631941|588890956|FG007|Overall Study|Adverse Event|0|||
163049902|NCT02631941|588890957|FG008|Overall Study|Adverse Event|0|||
163049903|NCT02631941|588890958|FG009|Overall Study|Adverse Event|0|||
163049904|NCT02631941|588890949|FG000|Overall Study|Withdrawal by Subject|0|||
163049905|NCT02631941|588890950|FG001|Overall Study|Withdrawal by Subject|0|||
163049906|NCT02631941|588890951|FG002|Overall Study|Withdrawal by Subject|0|||
163049907|NCT02631941|588890952|FG003|Overall Study|Withdrawal by Subject|0|||
163049908|NCT02631941|588890953|FG004|Overall Study|Withdrawal by Subject|1|||
163049909|NCT02631941|588890954|FG005|Overall Study|Withdrawal by Subject|0|||
163049910|NCT02631941|588890955|FG006|Overall Study|Withdrawal by Subject|0|||
163049911|NCT02631941|588890956|FG007|Overall Study|Withdrawal by Subject|1|||
163049912|NCT02631941|588890957|FG008|Overall Study|Withdrawal by Subject|0|||
163049913|NCT02631941|588890958|FG009|Overall Study|Withdrawal by Subject|0|||
163049914|NCT02631941|588890949|FG000|Overall Study|Lost to Follow-up|0|||
163049915|NCT02631941|588890950|FG001|Overall Study|Lost to Follow-up|0|||
163049916|NCT02631941|588890951|FG002|Overall Study|Lost to Follow-up|0|||
163049917|NCT02631941|588890952|FG003|Overall Study|Lost to Follow-up|0|||
163049918|NCT02631941|588890953|FG004|Overall Study|Lost to Follow-up|0|||
163049919|NCT02631941|588890954|FG005|Overall Study|Lost to Follow-up|0|||
163049920|NCT02631941|588890955|FG006|Overall Study|Lost to Follow-up|0|||
163049921|NCT02631941|588890956|FG007|Overall Study|Lost to Follow-up|0|||
163049922|NCT02631941|588890957|FG008|Overall Study|Lost to Follow-up|1|||
163049923|NCT02631941|588890958|FG009|Overall Study|Lost to Follow-up|0|||
163049924|NCT02087774|588890959|FG000|Overall Study|Were absent day of data collection|8|||
163049925|NCT02087774|588890960|FG001|Overall Study|Were absent day of data collection|20|||
163049926|NCT00731822|588890962|FG000|Overall Study|Adverse Event|2|||
163049927|NCT00731822|588890963|FG001|Overall Study|Adverse Event|1|||
163049928|NCT00731822|588890962|FG000|Overall Study|Protocol Violation|1|||
163049929|NCT00731822|588890963|FG001|Overall Study|Protocol Violation|0|||
163049930|NCT00731822|588890962|FG000|Overall Study|Lost to Follow-up|1|||
163049931|NCT00731822|588890963|FG001|Overall Study|Lost to Follow-up|0|||
163049932|NCT04073303|588890964|FG000|Overall Study|Adverse Event|0|||
163049933|NCT04073303|588890965|FG001|Overall Study|Adverse Event|2|||
163049934|NCT04073303|588890964|FG000|Overall Study|Withdrawal by Subject|16|||
163049935|NCT04073303|588890965|FG001|Overall Study|Withdrawal by Subject|36|||
163049936|NCT04073303|588890964|FG000|Overall Study|Lost to Follow-up|6|||
163049937|NCT04073303|588890965|FG001|Overall Study|Lost to Follow-up|1|||
163049938|NCT04073303|588890964|FG000|Overall Study|Protocol Deviation|0|||
163049939|NCT04073303|588890965|FG001|Overall Study|Protocol Deviation|4|||
163049940|NCT04073303|588890964|FG000|Overall Study|Other|1|||
162883314|NCT00574119|588272364|FG000|Overall Study|Protocol Violation|1|||
163049941|NCT04073303|588890965|FG001|Overall Study|Other|1|||
163049942|NCT01867008|588890966|FG000|Overall Study|Withdrawal by Subject|1|||
163049943|NCT01158261|588890967|FG000|Overall Study|Lost to Follow-up|9|||
163049944|NCT01158261|588890967|FG000|Overall Study|Death|7|||
163049945|NCT01158261|588890967|FG000|Overall Study|Withdrawal by Subject|1|||
163049946|NCT03143101|588890968|FG000|Overall Study|Withdrawal by Subject|0|||
163049947|NCT03143101|588890969|FG001|Overall Study|Withdrawal by Subject|1|||
163049948|NCT03143101|588890970|FG002|Overall Study|Withdrawal by Subject|0|||
163049949|NCT03143101|588890968|FG000|Overall Study|Lost to Follow-up|2|||
163049950|NCT03143101|588890969|FG001|Overall Study|Lost to Follow-up|2|||
163049951|NCT03143101|588890970|FG002|Overall Study|Lost to Follow-up|0|||
163049952|NCT05227118|588890971|FG000|Overall Study|Adverse Event|0|||
162962809|NCT02986139|588564649|FG000|Overall Study|Sponsor Decision|1|||
163049953|NCT05227118|588890972|FG001|Overall Study|Adverse Event|0|||
163049954|NCT05227118|588890973|FG002|Overall Study|Adverse Event|1|||
163049955|NCT05227118|588890974|FG003|Overall Study|Adverse Event|0|||
163049956|NCT05227118|588890971|FG000|Overall Study|Withdrawal by Subject|0|||
163049957|NCT05227118|588890972|FG001|Overall Study|Withdrawal by Subject|0|||
163049958|NCT05227118|588890973|FG002|Overall Study|Withdrawal by Subject|2|||
163049959|NCT05227118|588890974|FG003|Overall Study|Withdrawal by Subject|0|||
163049960|NCT03727841|588890977|FG000|Overall Study|Physician Decision|3|||
163049961|NCT03727841|588890978|FG001|Overall Study|Physician Decision|1|||
163049962|NCT03126786|588890979|FG000|Overall Study|Adverse Event|3|||
163049963|NCT03126786|588890980|FG001|Overall Study|Adverse Event|0|||
163049964|NCT03126786|588890979|FG000|Overall Study|Lost to Follow-up|0|||
163049965|NCT03126786|588890980|FG001|Overall Study|Lost to Follow-up|1|||
163049966|NCT03126786|588890979|FG000|Overall Study|Withdrawal by Subject|3|||
163049967|NCT03126786|588890980|FG001|Overall Study|Withdrawal by Subject|1|||
163049968|NCT01601496|588890981|FG000|Overall Study|Physician Decision|1|||
163049969|NCT01601496|588890981|FG000|Overall Study|Withdrawal by Subject|1|||
163049970|NCT01601496|588890981|FG000|Overall Study|Lost to Follow-up|6|||
163049971|NCT01601496|588890981|FG000|Overall Study|Death|4|||
163049972|NCT01601496|588890981|FG000|Overall Study|Other: patient refusal to continue|3|||
163049973|NCT03243305|588890982|FG000|Overall Study|Lost to Follow-up|250|||
163049974|NCT03243305|588890982|FG000|Overall Study|Withdrawal by Subject|170|||
163049975|NCT03243305|588890982|FG000|Overall Study|Pregnancy|104|||
163049976|NCT03243305|588890982|FG000|Overall Study|Non-Compliance with Study Drug|38|||
162962810|NCT02986139|588564650|FG001|Overall Study|Sponsor Decision|2|||
162962811|NCT02986139|588564649|FG000|Overall Study|Withdrawal by Subject|0|||
162962812|NCT02986139|588564650|FG001|Overall Study|Withdrawal by Subject|1|||
162962813|NCT02986139|588564649|FG000|Overall Study|Lost to Follow-up|0|||
162962814|NCT02986139|588564650|FG001|Overall Study|Lost to Follow-up|1|||
163049977|NCT03243305|588890982|FG000|Overall Study|Adverse Event|23|||
163049978|NCT03243305|588890982|FG000|Overall Study|No sexually active|26|||
163049979|NCT03243305|588890982|FG000|Overall Study|Physician Decision|22|||
163049980|NCT03243305|588890982|FG000|Overall Study|Protocol Violation|22|||
163049981|NCT03243305|588890982|FG000|Overall Study|Study method no longer primary method|12|||
163049982|NCT03243305|588890982|FG000|Overall Study|Study Terminated by Sponsor|1|||
163049983|NCT03243305|588890982|FG000|Overall Study|Early terminations|267|||
163049984|NCT02689804|588890983|FG000|Overall Study|Withdrawal by Subject|2|||
162962815|NCT02583048|588564651|FG000|Overall Study|Withdrawal by Subject|0|||
162962816|NCT02583048|588564652|FG001|Overall Study|Withdrawal by Subject|1|||
162962817|NCT02583048|588564653|FG002|Overall Study|Withdrawal by Subject|0|||
162962818|NCT02583048|588564651|FG000|Overall Study|Failed to meet eligibility criterion|0|||
162962819|NCT02583048|588564652|FG001|Overall Study|Failed to meet eligibility criterion|0|||
162962820|NCT02583048|588564653|FG002|Overall Study|Failed to meet eligibility criterion|1|||
162962821|NCT00414726|588564657|FG000|Overall Study|Withdrawal by Subject|0|||
162962822|NCT00414726|588564658|FG001|Overall Study|Withdrawal by Subject|1|||
162962823|NCT02107196|588564659|FG000|12-week Treatment Period|Adverse Event|6|||
162962824|NCT02107196|588564660|FG001|12-week Treatment Period|Adverse Event|3|||
162962825|NCT02107196|588564659|FG000|12-week Treatment Period|Lack of Efficacy|2|||
162962826|NCT02107196|588564660|FG001|12-week Treatment Period|Lack of Efficacy|1|||
162962827|NCT02107196|588564659|FG000|12-week Treatment Period|Lost to Follow-up|3|||
162962828|NCT02107196|588564660|FG001|12-week Treatment Period|Lost to Follow-up|6|||
162962829|NCT02107196|588564659|FG000|12-week Treatment Period|Physician Decision|0|||
162962830|NCT02107196|588564660|FG001|12-week Treatment Period|Physician Decision|1|||
162962831|NCT02107196|588564659|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
162962832|NCT02107196|588564660|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
163049985|NCT02689804|588890984|FG001|Overall Study|Withdrawal by Subject|0|||
163049986|NCT00227539|588890985|FG000|Overall Study|Protocol Violation|1|||
163049987|NCT00673257|588890986|FG000|Overall Study|Withdrawal by Subject|4|||
163049988|NCT00673257|588890986|FG000|Overall Study|Unable to obtain specimen|1|||
163049989|NCT04552132|588890989|FG000|Overall Study|Lost to Follow-up|4|||
163049990|NCT04552132|588890990|FG001|Overall Study|Lost to Follow-up|3|||
163049991|NCT04552132|588890989|FG000|Overall Study|Protocol Violation|1|||
163049992|NCT04552132|588890990|FG001|Overall Study|Protocol Violation|0|||
162962833|NCT02107196|588564659|FG000|12-week Treatment Period|Protocol Violation|7|||
162962834|NCT02107196|588564660|FG001|12-week Treatment Period|Protocol Violation|8|||
162962835|NCT02107196|588564659|FG000|12-week Treatment Period|Reason Missing|11|||
162962836|NCT02107196|588564660|FG001|12-week Treatment Period|Reason Missing|8|||
162707946|NCT03432533|587640633|FG000|Overall Study|Lost to Follow-up|1|||
162883315|NCT00574119|588272364|FG000|Overall Study|Withdrawal by Subject|1|||
162883316|NCT00574119|588272364|FG000|Overall Study|Physician Decision|1|||
162883317|NCT03287245|588272365|FG000|Overall Study|Study terminated by sponsor|3|||
162883318|NCT03287245|588272366|FG001|Overall Study|Study terminated by sponsor|0|||
162883319|NCT03287245|588272367|FG002|Overall Study|Study terminated by sponsor|3|||
162883320|NCT03287245|588272368|FG003|Overall Study|Study terminated by sponsor|1|||
162883321|NCT03287245|588272365|FG000|Overall Study|Adverse Event|1|||
162883322|NCT03287245|588272366|FG001|Overall Study|Adverse Event|0|||
162883323|NCT03287245|588272367|FG002|Overall Study|Adverse Event|0|||
162883324|NCT03287245|588272368|FG003|Overall Study|Adverse Event|0|||
162883325|NCT03287245|588272365|FG000|Overall Study|Withdrawal by Subject|8|||
162883326|NCT03287245|588272366|FG001|Overall Study|Withdrawal by Subject|3|||
162883327|NCT03287245|588272367|FG002|Overall Study|Withdrawal by Subject|3|||
162883328|NCT03287245|588272368|FG003|Overall Study|Withdrawal by Subject|0|||
162962837|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
162962838|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
162962839|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
162962840|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162962841|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
162962842|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
162962843|NCT02107196|588564659|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
162962844|NCT02107196|588564660|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
162962845|NCT00691704|588564663|FG000|Induction Therapy|Disease Progression|1|||
162962846|NCT00691704|588564663|FG000|Induction Therapy|Active Hepatitis|1|||
162962847|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
162962848|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
162962849|NCT00691704|588564663|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
162962850|NCT01993186|588564664|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
162962851|NCT01993186|588564665|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
162962852|NCT01993186|588564664|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
162962853|NCT01993186|588564665|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
162883329|NCT03287245|588272365|FG000|Overall Study|Physician Decision|3|||
162883330|NCT03287245|588272366|FG001|Overall Study|Physician Decision|2|||
162616828|NCT00464269|587315100|FG003|Overall Study|Other reason|1|||
162616829|NCT00464269|587315097|FG000|Overall Study|AE, serious fatal|0|||
162616830|NCT00464269|587315098|FG001|Overall Study|AE, serious fatal|0|||
162616831|NCT00464269|587315099|FG002|Overall Study|AE, serious fatal|1|||
162616832|NCT00464269|587315100|FG003|Overall Study|AE, serious fatal|1|||
162616833|NCT00464269|587315097|FG000|Overall Study|SAE, non-fatal|0|||
162616834|NCT00464269|587315098|FG001|Overall Study|SAE, non-fatal|0|||
162616835|NCT00464269|587315099|FG002|Overall Study|SAE, non-fatal|0|||
162616836|NCT00464269|587315100|FG003|Overall Study|SAE, non-fatal|1|||
162616837|NCT00464269|587315097|FG000|Overall Study|AE, non-serious non-fatal|2|||
162616838|NCT00464269|587315098|FG001|Overall Study|AE, non-serious non-fatal|8|||
162616839|NCT00464269|587315099|FG002|Overall Study|AE, non-serious non-fatal|3|||
162707947|NCT03432533|587640634|FG001|Overall Study|Lost to Follow-up|2|||
162883331|NCT03287245|588272367|FG002|Overall Study|Physician Decision|0|||
162883332|NCT03287245|588272368|FG003|Overall Study|Physician Decision|0|||
162883333|NCT02862548|588272369|FG000|Randomized Phase (Up to Week 48)|Death|0|||
162883334|NCT02862548|588272370|FG001|Randomized Phase (Up to Week 48)|Death|1|||
162883335|NCT02862548|588272369|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
162883336|NCT02862548|588272370|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
162883337|NCT02862548|588272369|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
162883338|NCT02862548|588272370|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
162883339|NCT02862548|588272369|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
162883340|NCT02862548|588272370|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
162883341|NCT00880763|588272371|FG000|Extension Period (Part 2)|Adverse Event|0|||
162883342|NCT00880763|588272372|FG001|Extension Period (Part 2)|Adverse Event|0|||
162883343|NCT00880763|588272373|FG002|Extension Period (Part 2)|Adverse Event|1|||
162883344|NCT00880763|588272374|FG003|Extension Period (Part 2)|Adverse Event|1|||
162883345|NCT00880763|588272371|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
162883346|NCT00880763|588272372|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
162883347|NCT00880763|588272373|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
162883348|NCT00880763|588272374|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
162883349|NCT00880763|588272371|FG000|Extension Period (Part 2)|Physician Decision|0|||
162883350|NCT00880763|588272372|FG001|Extension Period (Part 2)|Physician Decision|1|||
162883351|NCT00880763|588272373|FG002|Extension Period (Part 2)|Physician Decision|1|||
162883352|NCT00880763|588272374|FG003|Extension Period (Part 2)|Physician Decision|0|||
162883353|NCT00880763|588272371|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
162883354|NCT00880763|588272372|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
162883355|NCT00880763|588272373|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
162883356|NCT00880763|588272374|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
162883357|NCT03057951|588272381|FG000|Overall Study|Adverse Event|553|||
162883358|NCT03057951|588272382|FG001|Overall Study|Adverse Event|575|||
162883359|NCT03057951|588272381|FG000|Overall Study|Protocol Violation|30|||
162883360|NCT03057951|588272382|FG001|Overall Study|Protocol Violation|24|||
162883361|NCT03057951|588272381|FG000|Overall Study|Lost to Follow-up|6|||
162883362|NCT03057951|588272382|FG001|Overall Study|Lost to Follow-up|16|||
162883363|NCT03057951|588272381|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
162883364|NCT03057951|588272382|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
162883365|NCT03057951|588272381|FG000|Overall Study|Study drug stopped, reason missing|6|||
162883366|NCT03057951|588272382|FG001|Overall Study|Study drug stopped, reason missing|1|||
162883367|NCT03057951|588272381|FG000|Overall Study|Medical advice|6|||
162883368|NCT03057951|588272382|FG001|Overall Study|Medical advice|2|||
162883369|NCT03057951|588272381|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
162883370|NCT03057951|588272382|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
162962854|NCT01993186|588564664|FG000|Open-Label Extension Period|Other, Not Specified|0|||
162962855|NCT01993186|588564665|FG001|Open-Label Extension Period|Other, Not Specified|1|||
162962856|NCT01993186|588564664|FG000|Open-Label Extension Period|Adverse Event|1|||
162962857|NCT01993186|588564665|FG001|Open-Label Extension Period|Adverse Event|0|||
162962858|NCT01993186|588564664|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
162962859|NCT01993186|588564665|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
162962860|NCT01993186|588564664|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
162962861|NCT01993186|588564665|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
162962862|NCT01993186|588564664|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
162962863|NCT01993186|588564665|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
162962864|NCT02451696|588564667|FG000|Overall Study|Surgery postponed|1|||
162962865|NCT02451696|588564668|FG001|Overall Study|Surgery postponed|0|||
162962866|NCT00198133|588564669|FG000|Overall Study|Disease progression|2|||
162962867|NCT00198133|588564670|FG001|Overall Study|Disease progression|5|||
162962868|NCT00198133|588564669|FG000|Overall Study|Adverse Event|1|||
162962869|NCT00198133|588564670|FG001|Overall Study|Adverse Event|3|||
162962870|NCT00198133|588564669|FG000|Overall Study|Withdrawal by Subject|1|||
162962871|NCT00198133|588564670|FG001|Overall Study|Withdrawal by Subject|0|||
162962872|NCT00198133|588564669|FG000|Overall Study|Physician Decision|1|||
162616840|NCT00464269|587315100|FG003|Overall Study|AE, non-serious non-fatal|4|||
162616841|NCT00464269|587315097|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162883371|NCT03057951|588272381|FG000|Overall Study|Investigator decision|2|||
162962873|NCT00198133|588564670|FG001|Overall Study|Physician Decision|0|||
162962874|NCT01557751|588564671|FG000|Overall Study|Physician Decision|3|||
162962875|NCT02752074|588564672|FG000|Overall Study|Lost to Follow-up|1|||
162962876|NCT02752074|588564673|FG001|Overall Study|Lost to Follow-up|4|||
162962877|NCT02752074|588564672|FG000|Overall Study|Death|146|||
162962878|NCT02752074|588564673|FG001|Overall Study|Death|129|||
162883372|NCT03057951|588272382|FG001|Overall Study|Investigator decision|0|||
162883373|NCT03057951|588272381|FG000|Overall Study|Patient decision|5|||
162883374|NCT03057951|588272382|FG001|Overall Study|Patient decision|2|||
162883375|NCT03057951|588272381|FG000|Overall Study|Not attending study visits|3|||
162883376|NCT03057951|588272382|FG001|Overall Study|Not attending study visits|0|||
162883377|NCT03057951|588272381|FG000|Overall Study|Patient moved away|3|||
162883378|NCT03057951|588272382|FG001|Overall Study|Patient moved away|4|||
162883379|NCT03057951|588272381|FG000|Overall Study|Other reason than stated above|23|||
162883380|NCT03057951|588272382|FG001|Overall Study|Other reason than stated above|29|||
162883381|NCT03057951|588272381|FG000|Overall Study|Not treated|2|||
162883382|NCT03057951|588272382|FG001|Overall Study|Not treated|1|||
162883383|NCT00696436|588272383|FG000|Overall Study|Adverse Event|7|||
162883384|NCT00696436|588272384|FG001|Overall Study|Adverse Event|9|||
162883385|NCT00696436|588272385|FG002|Overall Study|Adverse Event|8|||
162883386|NCT00696436|588272386|FG003|Overall Study|Adverse Event|6|||
162883387|NCT00696436|588272387|FG004|Overall Study|Adverse Event|4|||
162883388|NCT00696436|588272383|FG000|Overall Study|Protocol Violation|3|||
162883389|NCT00696436|588272384|FG001|Overall Study|Protocol Violation|2|||
162883390|NCT00696436|588272385|FG002|Overall Study|Protocol Violation|2|||
162883391|NCT00696436|588272386|FG003|Overall Study|Protocol Violation|0|||
162883392|NCT00696436|588272387|FG004|Overall Study|Protocol Violation|1|||
162883393|NCT00696436|588272383|FG000|Overall Study|Lost to Follow-up|1|||
162883394|NCT00696436|588272384|FG001|Overall Study|Lost to Follow-up|6|||
162883395|NCT00696436|588272385|FG002|Overall Study|Lost to Follow-up|2|||
162883396|NCT00696436|588272386|FG003|Overall Study|Lost to Follow-up|4|||
162883397|NCT00696436|588272387|FG004|Overall Study|Lost to Follow-up|3|||
162883398|NCT00696436|588272383|FG000|Overall Study|Withdrawal by Subject|4|||
162883399|NCT00696436|588272384|FG001|Overall Study|Withdrawal by Subject|11|||
162883400|NCT00696436|588272385|FG002|Overall Study|Withdrawal by Subject|5|||
162883401|NCT00696436|588272386|FG003|Overall Study|Withdrawal by Subject|7|||
162883402|NCT00696436|588272387|FG004|Overall Study|Withdrawal by Subject|1|||
162883403|NCT00696436|588272383|FG000|Overall Study|Lack of Efficacy|3|||
162883404|NCT00696436|588272384|FG001|Overall Study|Lack of Efficacy|1|||
162883405|NCT00696436|588272385|FG002|Overall Study|Lack of Efficacy|5|||
162883406|NCT00696436|588272386|FG003|Overall Study|Lack of Efficacy|2|||
162883407|NCT00696436|588272387|FG004|Overall Study|Lack of Efficacy|4|||
162883408|NCT00696436|588272383|FG000|Overall Study|Participant Unavailability|2|||
162883409|NCT00696436|588272384|FG001|Overall Study|Participant Unavailability|0|||
162883410|NCT00696436|588272385|FG002|Overall Study|Participant Unavailability|2|||
162883411|NCT00696436|588272386|FG003|Overall Study|Participant Unavailability|1|||
162883412|NCT00696436|588272387|FG004|Overall Study|Participant Unavailability|0|||
162883413|NCT00696436|588272383|FG000|Overall Study|Administrative Error|2|||
162883414|NCT00696436|588272384|FG001|Overall Study|Administrative Error|0|||
162883415|NCT00696436|588272385|FG002|Overall Study|Administrative Error|2|||
162883416|NCT00696436|588272386|FG003|Overall Study|Administrative Error|0|||
162883417|NCT00696436|588272387|FG004|Overall Study|Administrative Error|0|||
162883418|NCT00696436|588272383|FG000|Overall Study|Participant Non-compliance|0|||
162883419|NCT00696436|588272384|FG001|Overall Study|Participant Non-compliance|0|||
162883420|NCT00696436|588272385|FG002|Overall Study|Participant Non-compliance|1|||
162883421|NCT00696436|588272386|FG003|Overall Study|Participant Non-compliance|2|||
162883422|NCT00696436|588272387|FG004|Overall Study|Participant Non-compliance|0|||
162883423|NCT00696436|588272383|FG000|Overall Study|Administrative Decision|1|||
162883424|NCT00696436|588272384|FG001|Overall Study|Administrative Decision|0|||
162883425|NCT00696436|588272385|FG002|Overall Study|Administrative Decision|0|||
162883426|NCT00696436|588272386|FG003|Overall Study|Administrative Decision|0|||
162883427|NCT00696436|588272387|FG004|Overall Study|Administrative Decision|0|||
162883428|NCT00696436|588272383|FG000|Overall Study|Missing|0|||
162883429|NCT00696436|588272384|FG001|Overall Study|Missing|1|||
162962879|NCT02752074|588564672|FG000|Overall Study|Withdrawal by Subject|9|||
162962880|NCT02752074|588564673|FG001|Overall Study|Withdrawal by Subject|10|||
162883430|NCT00696436|588272385|FG002|Overall Study|Missing|1|||
162883431|NCT00696436|588272386|FG003|Overall Study|Missing|0|||
162883432|NCT00696436|588272387|FG004|Overall Study|Missing|0|||
162883433|NCT01293006|588272392|FG000|Period 2|Lost to Follow-up|1|||
162883434|NCT01293006|588272393|FG001|Period 2|Lost to Follow-up|0|||
162883435|NCT01293006|588272394|FG002|Period 2|Lost to Follow-up|0|||
162883436|NCT01293006|588272395|FG003|Period 2|Lost to Follow-up|0|||
162883437|NCT00600028|588272403|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162962881|NCT00840216|588564674|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162962882|NCT00840216|588564675|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
162883438|NCT00600028|588272404|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
162883439|NCT00600028|588272403|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
162707948|NCT03432533|587640633|FG000|Overall Study|Withdrawal by Subject|14|||
162707949|NCT03432533|587640634|FG001|Overall Study|Withdrawal by Subject|9|||
162707950|NCT00916006|587640641|FG000|Overall Study|Adverse Event|1|||
162707951|NCT00916006|587640642|FG001|Overall Study|Adverse Event|1|||
162707952|NCT00916006|587640641|FG000|Overall Study|Withdrawal by Subject|2|||
162707953|NCT00916006|587640642|FG001|Overall Study|Withdrawal by Subject|5|||
162707954|NCT00916006|587640641|FG000|Overall Study|Protocol Violation|0|||
162707955|NCT00916006|587640642|FG001|Overall Study|Protocol Violation|1|||
162707956|NCT01605136|587640645|FG000|Study Period|Withdrawal by Subject|2|||
162883440|NCT00600028|588272404|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
162883441|NCT00600028|588272403|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
162883442|NCT00600028|588272404|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
162883443|NCT01830816|588272405|FG000|Overall Study|Progressive Disease|12|||
162883444|NCT01830816|588272406|FG001|Overall Study|Progressive Disease|7|||
162883445|NCT01830816|588272407|FG002|Overall Study|Progressive Disease|7|||
162883446|NCT01830816|588272405|FG000|Overall Study|Adverse Event|3|||
162883447|NCT01830816|588272406|FG001|Overall Study|Adverse Event|4|||
162883448|NCT01830816|588272407|FG002|Overall Study|Adverse Event|0|||
162883449|NCT01830816|588272405|FG000|Overall Study|Study Terminated by Sponsor|1|||
162883450|NCT01830816|588272406|FG001|Overall Study|Study Terminated by Sponsor|1|||
162883451|NCT01830816|588272407|FG002|Overall Study|Study Terminated by Sponsor|0|||
162883452|NCT01830816|588272405|FG000|Overall Study|Withdrawal by Subject|1|||
162883453|NCT01830816|588272406|FG001|Overall Study|Withdrawal by Subject|1|||
162883454|NCT01830816|588272407|FG002|Overall Study|Withdrawal by Subject|0|||
162883455|NCT01830816|588272405|FG000|Overall Study|Lost to Follow-up|0|||
162883456|NCT01830816|588272406|FG001|Overall Study|Lost to Follow-up|1|||
162883457|NCT01830816|588272407|FG002|Overall Study|Lost to Follow-up|0|||
162883458|NCT01830816|588272405|FG000|Overall Study|Symptomatic Deterioration|1|||
162883459|NCT01830816|588272406|FG001|Overall Study|Symptomatic Deterioration|0|||
162883460|NCT01830816|588272407|FG002|Overall Study|Symptomatic Deterioration|0|||
162883461|NCT01830816|588272405|FG000|Overall Study|Reason not Specified|2|||
162883462|NCT01830816|588272406|FG001|Overall Study|Reason not Specified|0|||
162883463|NCT01830816|588272407|FG002|Overall Study|Reason not Specified|0|||
162883464|NCT01754922|588272413|FG000|Overall Study|Adverse Event|0|||
162883465|NCT01754922|588272414|FG001|Overall Study|Adverse Event|1|||
162707957|NCT01605136|587640646|FG001|Study Period|Withdrawal by Subject|0|||
162883466|NCT01885078|588272417|FG000|Treatment Period|Adverse Event|52|||
162883467|NCT01885078|588272418|FG001|Treatment Period|Adverse Event|136|||
162883468|NCT01885078|588272419|FG002|Treatment Period|Adverse Event|30|||
162883469|NCT01885078|588272420|FG003|Treatment Period|Adverse Event|73|||
162883470|NCT01885078|588272421|FG004|Treatment Period|Adverse Event|17|||
162883471|NCT01885078|588272422|FG005|Treatment Period|Adverse Event|72|||
162883472|NCT01885078|588272423|FG006|Treatment Period|Adverse Event|24|||
162883473|NCT01885078|588272424|FG007|Treatment Period|Adverse Event|5|||
162883474|NCT01885078|588272425|FG008|Treatment Period|Adverse Event|0|||
162707958|NCT01605136|587640645|FG000|Study Period|Physician Decision|1|||
162883475|NCT01885078|588272426|FG009|Treatment Period|Adverse Event|0|||
162883476|NCT01885078|588272417|FG000|Treatment Period|Death|13|||
162883477|NCT01885078|588272418|FG001|Treatment Period|Death|33|||
162883478|NCT01885078|588272419|FG002|Treatment Period|Death|5|||
162883479|NCT01885078|588272420|FG003|Treatment Period|Death|9|||
162883480|NCT01885078|588272421|FG004|Treatment Period|Death|2|||
162883481|NCT01885078|588272422|FG005|Treatment Period|Death|10|||
162883482|NCT01885078|588272423|FG006|Treatment Period|Death|3|||
162883483|NCT01885078|588272424|FG007|Treatment Period|Death|2|||
162883484|NCT01885078|588272425|FG008|Treatment Period|Death|0|||
162883485|NCT01885078|588272426|FG009|Treatment Period|Death|0|||
162883486|NCT01885078|588272417|FG000|Treatment Period|Lack of Efficacy|12|||
162883487|NCT01885078|588272418|FG001|Treatment Period|Lack of Efficacy|33|||
162883488|NCT01885078|588272419|FG002|Treatment Period|Lack of Efficacy|10|||
163049993|NCT00570401|588890991|FG000|Overall Study|Adverse Event|2|||
163049994|NCT05616013|588890997|FG000|Overall Study|Adverse Event|6|||
163049995|NCT05616013|588890998|FG001|Overall Study|Adverse Event|12|||
163049996|NCT05616013|588890999|FG002|Overall Study|Adverse Event|8|||
163049997|NCT05616013|588891000|FG003|Overall Study|Adverse Event|4|||
163049998|NCT05616013|588891001|FG004|Overall Study|Adverse Event|6|||
163049999|NCT05616013|588891002|FG005|Overall Study|Adverse Event|8|||
163050000|NCT05616013|588891003|FG006|Overall Study|Adverse Event|3|||
163050001|NCT05616013|588891004|FG007|Overall Study|Adverse Event|6|||
163050002|NCT05616013|588891005|FG008|Overall Study|Adverse Event|1|||
163050003|NCT05616013|588890997|FG000|Overall Study|Lost to Follow-up|5|||
163050004|NCT05616013|588890998|FG001|Overall Study|Lost to Follow-up|4|||
163050005|NCT05616013|588890999|FG002|Overall Study|Lost to Follow-up|3|||
163050006|NCT05616013|588891000|FG003|Overall Study|Lost to Follow-up|2|||
163050007|NCT05616013|588891001|FG004|Overall Study|Lost to Follow-up|0|||
163050008|NCT05616013|588891002|FG005|Overall Study|Lost to Follow-up|5|||
163050009|NCT05616013|588891003|FG006|Overall Study|Lost to Follow-up|2|||
163050010|NCT05616013|588891004|FG007|Overall Study|Lost to Follow-up|1|||
163050011|NCT05616013|588891005|FG008|Overall Study|Lost to Follow-up|2|||
163050012|NCT05616013|588890997|FG000|Overall Study|Non-compliance with study requirements|2|||
163050013|NCT05616013|588890998|FG001|Overall Study|Non-compliance with study requirements|2|||
163050014|NCT05616013|588890999|FG002|Overall Study|Non-compliance with study requirements|2|||
163050015|NCT05616013|588891000|FG003|Overall Study|Non-compliance with study requirements|3|||
163050016|NCT05616013|588891001|FG004|Overall Study|Non-compliance with study requirements|0|||
163050017|NCT05616013|588891002|FG005|Overall Study|Non-compliance with study requirements|2|||
163050018|NCT05616013|588891003|FG006|Overall Study|Non-compliance with study requirements|1|||
163050019|NCT05616013|588891004|FG007|Overall Study|Non-compliance with study requirements|1|||
163050020|NCT05616013|588891005|FG008|Overall Study|Non-compliance with study requirements|4|||
163050021|NCT05616013|588890997|FG000|Overall Study|Withdrawal by Subject|11|||
163050022|NCT05616013|588890998|FG001|Overall Study|Withdrawal by Subject|9|||
163050023|NCT05616013|588890999|FG002|Overall Study|Withdrawal by Subject|8|||
163050024|NCT05616013|588891000|FG003|Overall Study|Withdrawal by Subject|6|||
163050025|NCT05616013|588891001|FG004|Overall Study|Withdrawal by Subject|3|||
163050026|NCT05616013|588891002|FG005|Overall Study|Withdrawal by Subject|4|||
163050027|NCT05616013|588891003|FG006|Overall Study|Withdrawal by Subject|6|||
163050028|NCT05616013|588891004|FG007|Overall Study|Withdrawal by Subject|5|||
163050029|NCT05616013|588891005|FG008|Overall Study|Withdrawal by Subject|4|||
163050030|NCT05616013|588890997|FG000|Overall Study|Physician Decision|0|||
163050031|NCT05616013|588890998|FG001|Overall Study|Physician Decision|0|||
163050032|NCT05616013|588890999|FG002|Overall Study|Physician Decision|1|||
163050033|NCT05616013|588891000|FG003|Overall Study|Physician Decision|0|||
163050034|NCT05616013|588891001|FG004|Overall Study|Physician Decision|0|||
162883489|NCT01885078|588272420|FG003|Treatment Period|Lack of Efficacy|23|||
162883490|NCT01885078|588272421|FG004|Treatment Period|Lack of Efficacy|24|||
162883491|NCT01885078|588272422|FG005|Treatment Period|Lack of Efficacy|58|||
162883492|NCT01885078|588272423|FG006|Treatment Period|Lack of Efficacy|9|||
162883493|NCT01885078|588272424|FG007|Treatment Period|Lack of Efficacy|5|||
162883494|NCT01885078|588272425|FG008|Treatment Period|Lack of Efficacy|0|||
162883495|NCT01885078|588272426|FG009|Treatment Period|Lack of Efficacy|0|||
162883496|NCT01885078|588272417|FG000|Treatment Period|Lost to Follow-up|16|||
162883497|NCT01885078|588272418|FG001|Treatment Period|Lost to Follow-up|19|||
162883498|NCT01885078|588272419|FG002|Treatment Period|Lost to Follow-up|7|||
162883499|NCT01885078|588272420|FG003|Treatment Period|Lost to Follow-up|9|||
162883500|NCT01885078|588272421|FG004|Treatment Period|Lost to Follow-up|2|||
162883501|NCT01885078|588272422|FG005|Treatment Period|Lost to Follow-up|8|||
162883502|NCT01885078|588272423|FG006|Treatment Period|Lost to Follow-up|2|||
162883503|NCT01885078|588272424|FG007|Treatment Period|Lost to Follow-up|0|||
162883504|NCT01885078|588272425|FG008|Treatment Period|Lost to Follow-up|0|||
162883505|NCT01885078|588272426|FG009|Treatment Period|Lost to Follow-up|0|||
162883506|NCT01885078|588272417|FG000|Treatment Period|Physician Decision|19|||
162883507|NCT01885078|588272418|FG001|Treatment Period|Physician Decision|21|||
163050035|NCT05616013|588891002|FG005|Overall Study|Physician Decision|1|||
163050036|NCT05616013|588891003|FG006|Overall Study|Physician Decision|3|||
163050037|NCT05616013|588891004|FG007|Overall Study|Physician Decision|0|||
162883508|NCT01885078|588272419|FG002|Treatment Period|Physician Decision|5|||
163050038|NCT05616013|588891005|FG008|Overall Study|Physician Decision|0|||
163050039|NCT05616013|588890997|FG000|Overall Study|Protocol Violation|0|||
163050040|NCT05616013|588890998|FG001|Overall Study|Protocol Violation|0|||
163050041|NCT05616013|588890999|FG002|Overall Study|Protocol Violation|0|||
163050042|NCT05616013|588891000|FG003|Overall Study|Protocol Violation|0|||
163050043|NCT05616013|588891001|FG004|Overall Study|Protocol Violation|0|||
163050044|NCT05616013|588891002|FG005|Overall Study|Protocol Violation|0|||
163050045|NCT05616013|588891003|FG006|Overall Study|Protocol Violation|1|||
163050046|NCT05616013|588891004|FG007|Overall Study|Protocol Violation|0|||
163050047|NCT05616013|588891005|FG008|Overall Study|Protocol Violation|2|||
163050048|NCT05616013|588890997|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
163050049|NCT05616013|588890998|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050050|NCT05616013|588890999|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050051|NCT05616013|588891000|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050052|NCT05616013|588891001|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050053|NCT05616013|588891002|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050054|NCT05616013|588891003|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050055|NCT05616013|588891004|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050056|NCT05616013|588891005|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
163050057|NCT05616013|588890997|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
163050058|NCT05616013|588890998|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050059|NCT05616013|588890999|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050060|NCT05616013|588891000|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050061|NCT05616013|588891001|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050062|NCT05616013|588891002|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050063|NCT05616013|588891003|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050064|NCT05616013|588891004|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050065|NCT05616013|588891005|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
163050066|NCT05616013|588890997|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
163050067|NCT05616013|588890998|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050068|NCT05616013|588890999|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050069|NCT05616013|588891000|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050070|NCT05616013|588891001|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050071|NCT05616013|588891002|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050072|NCT05616013|588891003|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050073|NCT05616013|588891004|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050074|NCT05616013|588891005|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
163050075|NCT05616013|588890997|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050076|NCT05616013|588890998|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
163050077|NCT05616013|588890999|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050078|NCT05616013|588891000|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050079|NCT05616013|588891001|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050080|NCT05616013|588891002|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050081|NCT05616013|588891003|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050082|NCT05616013|588891004|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050083|NCT05616013|588891005|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
163050084|NCT05616013|588890997|FG000|Overall Study|Participant Decision, Time Constraints|0|||
163050085|NCT05616013|588890998|FG001|Overall Study|Participant Decision, Time Constraints|1|||
163050086|NCT05616013|588890999|FG002|Overall Study|Participant Decision, Time Constraints|0|||
163050087|NCT05616013|588891000|FG003|Overall Study|Participant Decision, Time Constraints|0|||
163050088|NCT05616013|588891001|FG004|Overall Study|Participant Decision, Time Constraints|0|||
163050089|NCT05616013|588891002|FG005|Overall Study|Participant Decision, Time Constraints|0|||
163050090|NCT05616013|588891003|FG006|Overall Study|Participant Decision, Time Constraints|0|||
163050091|NCT05616013|588891004|FG007|Overall Study|Participant Decision, Time Constraints|0|||
163050092|NCT05616013|588891005|FG008|Overall Study|Participant Decision, Time Constraints|0|||
163050093|NCT05616013|588890997|FG000|Overall Study|Prohibited Concomitant Medication|0|||
163050094|NCT05616013|588890998|FG001|Overall Study|Prohibited Concomitant Medication|0|||
163050095|NCT05616013|588890999|FG002|Overall Study|Prohibited Concomitant Medication|1|||
163050096|NCT05616013|588891000|FG003|Overall Study|Prohibited Concomitant Medication|0|||
163050097|NCT05616013|588891001|FG004|Overall Study|Prohibited Concomitant Medication|0|||
162883509|NCT01885078|588272420|FG003|Treatment Period|Physician Decision|12|||
162883510|NCT01885078|588272421|FG004|Treatment Period|Physician Decision|9|||
162883511|NCT01885078|588272422|FG005|Treatment Period|Physician Decision|24|||
162883512|NCT01885078|588272423|FG006|Treatment Period|Physician Decision|4|||
162883513|NCT01885078|588272424|FG007|Treatment Period|Physician Decision|3|||
162883514|NCT01885078|588272425|FG008|Treatment Period|Physician Decision|0|||
162883515|NCT01885078|588272426|FG009|Treatment Period|Physician Decision|0|||
162883516|NCT01885078|588272417|FG000|Treatment Period|Protocol Violation|3|||
162883517|NCT01885078|588272418|FG001|Treatment Period|Protocol Violation|5|||
162883518|NCT01885078|588272419|FG002|Treatment Period|Protocol Violation|0|||
162883519|NCT01885078|588272420|FG003|Treatment Period|Protocol Violation|3|||
162883520|NCT01885078|588272421|FG004|Treatment Period|Protocol Violation|1|||
162883521|NCT01885078|588272422|FG005|Treatment Period|Protocol Violation|6|||
162883522|NCT01885078|588272423|FG006|Treatment Period|Protocol Violation|0|||
162883523|NCT01885078|588272424|FG007|Treatment Period|Protocol Violation|0|||
162883524|NCT01885078|588272425|FG008|Treatment Period|Protocol Violation|0|||
162883525|NCT01885078|588272426|FG009|Treatment Period|Protocol Violation|0|||
162883526|NCT01885078|588272417|FG000|Treatment Period|Sponsor Decision|245|||
162883527|NCT01885078|588272418|FG001|Treatment Period|Sponsor Decision|648|||
162883528|NCT01885078|588272419|FG002|Treatment Period|Sponsor Decision|49|||
162883529|NCT01885078|588272420|FG003|Treatment Period|Sponsor Decision|90|||
162883530|NCT01885078|588272421|FG004|Treatment Period|Sponsor Decision|20|||
162883531|NCT01885078|588272422|FG005|Treatment Period|Sponsor Decision|38|||
162883532|NCT01885078|588272423|FG006|Treatment Period|Sponsor Decision|162|||
162883533|NCT01885078|588272424|FG007|Treatment Period|Sponsor Decision|3|||
162883534|NCT01885078|588272425|FG008|Treatment Period|Sponsor Decision|0|||
162883535|NCT01885078|588272426|FG009|Treatment Period|Sponsor Decision|0|||
162883536|NCT01885078|588272417|FG000|Treatment Period|Withdrawal by Subject|72|||
162883537|NCT01885078|588272418|FG001|Treatment Period|Withdrawal by Subject|132|||
162883538|NCT01885078|588272419|FG002|Treatment Period|Withdrawal by Subject|25|||
162883539|NCT01885078|588272420|FG003|Treatment Period|Withdrawal by Subject|63|||
162883540|NCT01885078|588272421|FG004|Treatment Period|Withdrawal by Subject|15|||
162883541|NCT01885078|588272422|FG005|Treatment Period|Withdrawal by Subject|34|||
162883542|NCT01885078|588272423|FG006|Treatment Period|Withdrawal by Subject|17|||
162883543|NCT01885078|588272424|FG007|Treatment Period|Withdrawal by Subject|10|||
162883544|NCT01885078|588272425|FG008|Treatment Period|Withdrawal by Subject|0|||
162883545|NCT01885078|588272426|FG009|Treatment Period|Withdrawal by Subject|0|||
162883546|NCT01885078|588272417|FG000|Treatment Period|Other|0|||
162883547|NCT01885078|588272418|FG001|Treatment Period|Other|0|||
162883548|NCT01885078|588272419|FG002|Treatment Period|Other|0|||
162883549|NCT01885078|588272420|FG003|Treatment Period|Other|1|||
162883550|NCT01885078|588272421|FG004|Treatment Period|Other|0|||
162883551|NCT01885078|588272422|FG005|Treatment Period|Other|0|||
162883552|NCT01885078|588272423|FG006|Treatment Period|Other|0|||
162883553|NCT01885078|588272424|FG007|Treatment Period|Other|0|||
162883554|NCT01885078|588272425|FG008|Treatment Period|Other|0|||
162883555|NCT01885078|588272426|FG009|Treatment Period|Other|0|||
162883556|NCT01885078|588272417|FG000|Step-down Period|Sponsor Decision|0|||
162883557|NCT01885078|588272418|FG001|Step-down Period|Sponsor Decision|0|||
162883558|NCT01885078|588272419|FG002|Step-down Period|Sponsor Decision|0|||
162883559|NCT01885078|588272420|FG003|Step-down Period|Sponsor Decision|0|||
162883560|NCT01885078|588272421|FG004|Step-down Period|Sponsor Decision|0|||
162883561|NCT01885078|588272422|FG005|Step-down Period|Sponsor Decision|0|||
162883562|NCT01885078|588272423|FG006|Step-down Period|Sponsor Decision|0|||
162883563|NCT01885078|588272424|FG007|Step-down Period|Sponsor Decision|0|||
162883564|NCT01885078|588272425|FG008|Step-down Period|Sponsor Decision|1|||
162883565|NCT01885078|588272426|FG009|Step-down Period|Sponsor Decision|1|||
162883566|NCT01885078|588272417|FG000|Step-down Period|Adverse Event|0|||
162883567|NCT01885078|588272418|FG001|Step-down Period|Adverse Event|0|||
162883568|NCT01885078|588272419|FG002|Step-down Period|Adverse Event|0|||
162883569|NCT01885078|588272420|FG003|Step-down Period|Adverse Event|0|||
162883570|NCT01885078|588272421|FG004|Step-down Period|Adverse Event|0|||
162883571|NCT01885078|588272422|FG005|Step-down Period|Adverse Event|0|||
162883572|NCT01885078|588272423|FG006|Step-down Period|Adverse Event|0|||
162883573|NCT01885078|588272424|FG007|Step-down Period|Adverse Event|0|||
162883574|NCT01885078|588272425|FG008|Step-down Period|Adverse Event|29|||
162883575|NCT01885078|588272426|FG009|Step-down Period|Adverse Event|38|||
162883576|NCT01885078|588272417|FG000|Step-down Period|Withdrawal by Subject|0|||
162883577|NCT01885078|588272418|FG001|Step-down Period|Withdrawal by Subject|0|||
162883578|NCT01885078|588272419|FG002|Step-down Period|Withdrawal by Subject|0|||
162883579|NCT01885078|588272420|FG003|Step-down Period|Withdrawal by Subject|0|||
162883580|NCT01885078|588272421|FG004|Step-down Period|Withdrawal by Subject|0|||
162883581|NCT01885078|588272422|FG005|Step-down Period|Withdrawal by Subject|0|||
162883582|NCT01885078|588272423|FG006|Step-down Period|Withdrawal by Subject|0|||
162883583|NCT01885078|588272424|FG007|Step-down Period|Withdrawal by Subject|0|||
162883584|NCT01885078|588272425|FG008|Step-down Period|Withdrawal by Subject|25|||
162883585|NCT01885078|588272426|FG009|Step-down Period|Withdrawal by Subject|15|||
162883586|NCT01885078|588272417|FG000|Step-down Period|Physician Decision|0|||
162883587|NCT01885078|588272418|FG001|Step-down Period|Physician Decision|0|||
162883588|NCT01885078|588272419|FG002|Step-down Period|Physician Decision|0|||
162883589|NCT01885078|588272420|FG003|Step-down Period|Physician Decision|0|||
162883590|NCT01885078|588272421|FG004|Step-down Period|Physician Decision|0|||
162883591|NCT01885078|588272422|FG005|Step-down Period|Physician Decision|0|||
162962883|NCT01380782|588564677|FG000|Overall Study|Adverse Event|0|||
162883592|NCT01885078|588272423|FG006|Step-down Period|Physician Decision|0|||
162883593|NCT01885078|588272424|FG007|Step-down Period|Physician Decision|0|||
162883594|NCT01885078|588272425|FG008|Step-down Period|Physician Decision|7|||
162883595|NCT01885078|588272426|FG009|Step-down Period|Physician Decision|2|||
162883596|NCT01885078|588272417|FG000|Step-down Period|Death|0|||
162883597|NCT01885078|588272418|FG001|Step-down Period|Death|0|||
162883598|NCT01885078|588272419|FG002|Step-down Period|Death|0|||
162883599|NCT01885078|588272420|FG003|Step-down Period|Death|0|||
162883600|NCT01885078|588272421|FG004|Step-down Period|Death|0|||
162883601|NCT01885078|588272422|FG005|Step-down Period|Death|0|||
162883602|NCT01885078|588272423|FG006|Step-down Period|Death|0|||
162883603|NCT01885078|588272424|FG007|Step-down Period|Death|0|||
162883604|NCT01885078|588272425|FG008|Step-down Period|Death|4|||
162883605|NCT01885078|588272426|FG009|Step-down Period|Death|3|||
162883606|NCT01885078|588272417|FG000|Step-down Period|Lost to Follow-up|0|||
162883607|NCT01885078|588272418|FG001|Step-down Period|Lost to Follow-up|0|||
162883608|NCT01885078|588272419|FG002|Step-down Period|Lost to Follow-up|0|||
162883609|NCT01885078|588272420|FG003|Step-down Period|Lost to Follow-up|0|||
162883610|NCT01885078|588272421|FG004|Step-down Period|Lost to Follow-up|0|||
162883611|NCT01885078|588272422|FG005|Step-down Period|Lost to Follow-up|0|||
162883612|NCT01885078|588272423|FG006|Step-down Period|Lost to Follow-up|0|||
162883613|NCT01885078|588272424|FG007|Step-down Period|Lost to Follow-up|0|||
162883614|NCT01885078|588272425|FG008|Step-down Period|Lost to Follow-up|1|||
162883615|NCT01885078|588272426|FG009|Step-down Period|Lost to Follow-up|1|||
162883616|NCT01885078|588272417|FG000|Step-down Period|Lack of Efficacy|0|||
162883617|NCT01885078|588272418|FG001|Step-down Period|Lack of Efficacy|0|||
162883618|NCT01885078|588272419|FG002|Step-down Period|Lack of Efficacy|0|||
162883619|NCT01885078|588272420|FG003|Step-down Period|Lack of Efficacy|0|||
162883620|NCT01885078|588272421|FG004|Step-down Period|Lack of Efficacy|0|||
162883621|NCT01885078|588272422|FG005|Step-down Period|Lack of Efficacy|0|||
162883622|NCT01885078|588272423|FG006|Step-down Period|Lack of Efficacy|0|||
162883623|NCT01885078|588272424|FG007|Step-down Period|Lack of Efficacy|0|||
162883624|NCT01885078|588272425|FG008|Step-down Period|Lack of Efficacy|1|||
162883625|NCT01885078|588272426|FG009|Step-down Period|Lack of Efficacy|0|||
162883626|NCT01885078|588272417|FG000|Step-down Period|Protocol Violation|0|||
162883627|NCT01885078|588272418|FG001|Step-down Period|Protocol Violation|0|||
162883628|NCT01885078|588272419|FG002|Step-down Period|Protocol Violation|0|||
162883629|NCT01885078|588272420|FG003|Step-down Period|Protocol Violation|0|||
162883630|NCT01885078|588272421|FG004|Step-down Period|Protocol Violation|0|||
162883631|NCT01885078|588272422|FG005|Step-down Period|Protocol Violation|0|||
162962884|NCT01380782|588564678|FG001|Overall Study|Adverse Event|1|||
162962885|NCT01380782|588564679|FG002|Overall Study|Adverse Event|0|||
162962886|NCT01380782|588564680|FG003|Overall Study|Adverse Event|0|||
162962887|NCT01380782|588564677|FG000|Overall Study|Death|1|||
162962888|NCT01380782|588564678|FG001|Overall Study|Death|0|||
162962889|NCT01380782|588564679|FG002|Overall Study|Death|0|||
162962890|NCT01380782|588564680|FG003|Overall Study|Death|0|||
162962891|NCT01380782|588564677|FG000|Overall Study|Lack of Efficacy|10|||
162962892|NCT01380782|588564678|FG001|Overall Study|Lack of Efficacy|9|||
162962893|NCT01380782|588564679|FG002|Overall Study|Lack of Efficacy|10|||
162962894|NCT01380782|588564680|FG003|Overall Study|Lack of Efficacy|3|||
162962895|NCT01380782|588564677|FG000|Overall Study|Physician Decision|1|||
162962896|NCT01380782|588564678|FG001|Overall Study|Physician Decision|0|||
162962897|NCT01380782|588564679|FG002|Overall Study|Physician Decision|0|||
162962898|NCT01380782|588564680|FG003|Overall Study|Physician Decision|0|||
162962899|NCT01380782|588564677|FG000|Overall Study|Withdrawal by Subject|0|||
162962900|NCT01380782|588564678|FG001|Overall Study|Withdrawal by Subject|0|||
162962901|NCT01380782|588564679|FG002|Overall Study|Withdrawal by Subject|1|||
162962902|NCT01380782|588564680|FG003|Overall Study|Withdrawal by Subject|1|||
162962903|NCT01403194|588564684|FG000|Overall Study|Screen Failure|2|||
162962904|NCT01403194|588564684|FG000|Overall Study|Lost to Follow-up|8|||
162962905|NCT04474405|588564685|FG000|Overall Study|Withdrawal by Subject|0|||
162962906|NCT04474405|588564686|FG001|Overall Study|Withdrawal by Subject|0|||
162962907|NCT04474405|588564687|FG002|Overall Study|Withdrawal by Subject|1|||
162962908|NCT04474405|588564688|FG003|Overall Study|Withdrawal by Subject|0|||
162962909|NCT04474405|588564689|FG004|Overall Study|Withdrawal by Subject|1|||
162962910|NCT04474405|588564690|FG005|Overall Study|Withdrawal by Subject|0|||
162962911|NCT04474405|588564685|FG000|Overall Study|Other|0|||
162962912|NCT04474405|588564686|FG001|Overall Study|Other|0|||
162883632|NCT01885078|588272423|FG006|Step-down Period|Protocol Violation|0|||
162883633|NCT01885078|588272424|FG007|Step-down Period|Protocol Violation|0|||
162883634|NCT01885078|588272425|FG008|Step-down Period|Protocol Violation|1|||
162883635|NCT01885078|588272426|FG009|Step-down Period|Protocol Violation|1|||
162883636|NCT02680587|588272427|FG000|Overall Study|Withdrawal by Subject|1|||
162883637|NCT02680587|588272428|FG001|Overall Study|Withdrawal by Subject|0|||
162883638|NCT00571688|588272432|FG000|Overall Study|Lost to Follow-up|3|||
162883639|NCT00571688|588272433|FG001|Overall Study|Lost to Follow-up|6|||
162962913|NCT04474405|588564687|FG002|Overall Study|Other|0|||
162962914|NCT04474405|588564688|FG003|Overall Study|Other|0|||
162962915|NCT04474405|588564689|FG004|Overall Study|Other|3|||
162962916|NCT04474405|588564690|FG005|Overall Study|Other|0|||
162962917|NCT00274651|588564691|FG000|Overall Study|Adverse Event|6|||
162962918|NCT00274651|588564692|FG001|Overall Study|Adverse Event|3|||
162962919|NCT00274651|588564691|FG000|Overall Study|Lack of Efficacy|13|||
162883640|NCT00571688|588272432|FG000|Overall Study|subject did not tolerate Consta|1|||
162883641|NCT00571688|588272433|FG001|Overall Study|subject did not tolerate Consta|0|||
162883642|NCT00571688|588272432|FG000|Overall Study|subject moved out of the area|1|||
162883643|NCT00571688|588272433|FG001|Overall Study|subject moved out of the area|0|||
162883644|NCT01194869|588272434|FG000|Overall Study|Disease Progression|2|||
162883645|NCT01194869|588272434|FG000|Overall Study|Toxicity|2|||
162883646|NCT00259740|588272438|FG000|Overall Study|Physician Decision|1|||
162883647|NCT00259740|588272439|FG001|Overall Study|Physician Decision|1|||
162883648|NCT00259740|588272438|FG000|Overall Study|Adverse Event|0|||
162883649|NCT00259740|588272439|FG001|Overall Study|Adverse Event|2|||
162883650|NCT00259740|588272438|FG000|Overall Study|Withdrawal by Subject|2|||
162883651|NCT00259740|588272439|FG001|Overall Study|Withdrawal by Subject|6|||
162883652|NCT00259740|588272438|FG000|Overall Study|Death|1|||
162883653|NCT00259740|588272439|FG001|Overall Study|Death|1|||
162883654|NCT00259740|588272438|FG000|Overall Study|Disease progression|19|||
162883655|NCT00259740|588272439|FG001|Overall Study|Disease progression|36|||
162883656|NCT00259740|588272438|FG000|Overall Study|Ongoing|17|||
162883657|NCT00259740|588272439|FG001|Overall Study|Ongoing|3|||
162883658|NCT00259740|588272438|FG000|Overall Study|Other|3|||
162883659|NCT00259740|588272439|FG001|Overall Study|Other|0|||
162883660|NCT00259740|588272438|FG000|Overall Study|Requirement for alternative therapy|0|||
162883661|NCT00259740|588272439|FG001|Overall Study|Requirement for alternative therapy|4|||
162883662|NCT01844830|588272444|FG000|Overall Study|Withdrawal by Subject|1|||
162883663|NCT01844830|588272445|FG001|Overall Study|Withdrawal by Subject|0|||
162883664|NCT04735393|588272449|FG000|Overall Study|Lost to Follow-up|46|||
162883665|NCT04735393|588272450|FG001|Overall Study|Lost to Follow-up|24|||
162883666|NCT04735393|588272449|FG000|Overall Study|Physician Decision|2|||
162883667|NCT04735393|588272450|FG001|Overall Study|Physician Decision|1|||
162883668|NCT04735393|588272449|FG000|Overall Study|Not Detailed|1|||
162883669|NCT04735393|588272450|FG001|Overall Study|Not Detailed|2|||
162883670|NCT04735393|588272449|FG000|Overall Study|Withdrawal by Subject|71|||
162883671|NCT04735393|588272450|FG001|Overall Study|Withdrawal by Subject|28|||
162883672|NCT04735393|588272449|FG000|Overall Study|Adverse Event|56|||
162883673|NCT04735393|588272450|FG001|Overall Study|Adverse Event|7|||
162883674|NCT04735393|588272449|FG000|Overall Study|Protocol Violation|6|||
162883675|NCT04735393|588272450|FG001|Overall Study|Protocol Violation|1|||
162883676|NCT04735393|588272449|FG000|Overall Study|Trial terminated by Sponsor|49|||
162883677|NCT04735393|588272450|FG001|Overall Study|Trial terminated by Sponsor|29|||
162883678|NCT00209170|588272451|FG000|Overall Study|Adverse Event|0|||
162883679|NCT00209170|588272452|FG001|Overall Study|Adverse Event|1|||
162883680|NCT00209170|588272451|FG000|Overall Study|Withdrawal by Subject|2|||
162883681|NCT00209170|588272452|FG001|Overall Study|Withdrawal by Subject|1|||
162883682|NCT00209170|588272451|FG000|Overall Study|Lack of Efficacy|0|||
162883683|NCT00209170|588272452|FG001|Overall Study|Lack of Efficacy|1|||
162883684|NCT03224104|588272456|FG000|Overall Study|Lack of Efficacy|2|||
162883685|NCT03224104|588272457|FG001|Overall Study|Lack of Efficacy|6|||
162883686|NCT03224104|588272458|FG002|Overall Study|Lack of Efficacy|3|||
162883687|NCT03224104|588272459|FG003|Overall Study|Lack of Efficacy|4|||
162883688|NCT03224104|588272460|FG004|Overall Study|Lack of Efficacy|42|||
162883689|NCT03224104|588272456|FG000|Overall Study|Withdrawal by Subject|0|||
162883690|NCT03224104|588272457|FG001|Overall Study|Withdrawal by Subject|2|||
162883691|NCT03224104|588272458|FG002|Overall Study|Withdrawal by Subject|0|||
162883692|NCT03224104|588272459|FG003|Overall Study|Withdrawal by Subject|1|||
162883693|NCT03224104|588272460|FG004|Overall Study|Withdrawal by Subject|3|||
162883694|NCT03224104|588272456|FG000|Overall Study|Death|0|||
162883695|NCT03224104|588272457|FG001|Overall Study|Death|1|||
162883696|NCT03224104|588272458|FG002|Overall Study|Death|0|||
162883697|NCT03224104|588272459|FG003|Overall Study|Death|0|||
162883698|NCT03224104|588272460|FG004|Overall Study|Death|0|||
162883699|NCT03224104|588272456|FG000|Overall Study|Adverse Event|1|||
162883700|NCT03224104|588272457|FG001|Overall Study|Adverse Event|0|||
162962920|NCT00274651|588564692|FG001|Overall Study|Lack of Efficacy|6|||
162962921|NCT00274651|588564691|FG000|Overall Study|Death|1|||
162962922|NCT00274651|588564692|FG001|Overall Study|Death|3|||
162616842|NCT00464269|587315098|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162883701|NCT03224104|588272458|FG002|Overall Study|Adverse Event|0|||
162883702|NCT03224104|588272459|FG003|Overall Study|Adverse Event|1|||
162883703|NCT03224104|588272460|FG004|Overall Study|Adverse Event|3|||
162883704|NCT03224104|588272456|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
162883705|NCT03224104|588272457|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
162883706|NCT03224104|588272458|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
162883707|NCT03224104|588272459|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
162883708|NCT03224104|588272460|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
162883709|NCT03224104|588272456|FG000|Overall Study|Treatment ongoing|0|||
162883710|NCT03224104|588272457|FG001|Overall Study|Treatment ongoing|0|||
162883711|NCT03224104|588272458|FG002|Overall Study|Treatment ongoing|0|||
162883712|NCT03224104|588272459|FG003|Overall Study|Treatment ongoing|0|||
162883713|NCT03224104|588272460|FG004|Overall Study|Treatment ongoing|1|||
162962923|NCT00274651|588564691|FG000|Overall Study|Withdrawal by Subject|0|||
162883714|NCT04397718|588272461|FG000|Overall Study|Death|7|||
162883715|NCT04397718|588272462|FG001|Overall Study|Death|11|||
162883716|NCT04397718|588272461|FG000|Overall Study|Lost to Follow-up|0|||
162883717|NCT04397718|588272462|FG001|Overall Study|Lost to Follow-up|4|||
162883718|NCT06087328|588272463|FG000|28-Day Treatment|Lost to Follow-up|7|||
162883719|NCT06087328|588272464|FG001|28-Day Treatment|Lost to Follow-up|3|||
162883720|NCT06087328|588272465|FG002|28-Day Treatment|Lost to Follow-up|4|||
162883721|NCT06087328|588272463|FG000|1-month Follow-up|Lost to Follow-up|0|||
162883722|NCT06087328|588272464|FG001|1-month Follow-up|Lost to Follow-up|1|||
162883723|NCT06087328|588272465|FG002|1-month Follow-up|Lost to Follow-up|1|||
162883724|NCT01778127|588272468|FG000|Overall Study|Lost to Follow-up|5|||
162883725|NCT01778127|588272469|FG001|Overall Study|Lost to Follow-up|1|||
162883726|NCT01778127|588272470|FG002|Overall Study|Lost to Follow-up|2|||
162883727|NCT01778127|588272468|FG000|Overall Study|Withdrawal by Subject|3|||
162883728|NCT01778127|588272469|FG001|Overall Study|Withdrawal by Subject|1|||
162883729|NCT01778127|588272470|FG002|Overall Study|Withdrawal by Subject|4|||
162883730|NCT01348425|588272474|FG000|Overall Study|Imaging was not taken.|1|||
162883731|NCT01348425|588272475|FG001|Overall Study|Imaging was not taken.|1|||
162883732|NCT01968954|588272481|FG000|Overall Study|Adverse Event|6|||
162883733|NCT01968954|588272482|FG001|Overall Study|Adverse Event|3|||
162883734|NCT01968954|588272481|FG000|Overall Study|Death|1|||
162883735|NCT01968954|588272482|FG001|Overall Study|Death|2|||
162883736|NCT01968954|588272481|FG000|Overall Study|Lost to Follow-up|6|||
162883737|NCT01968954|588272482|FG001|Overall Study|Lost to Follow-up|4|||
162883738|NCT01968954|588272481|FG000|Overall Study|Withdrawal by Subject|20|||
162883739|NCT01968954|588272482|FG001|Overall Study|Withdrawal by Subject|23|||
162883740|NCT01968954|588272481|FG000|Overall Study|Other|7|||
162883741|NCT01968954|588272482|FG001|Overall Study|Other|8|||
162883742|NCT01968954|588272481|FG000|Overall Study|Protocol Violation|0|||
162883743|NCT01968954|588272482|FG001|Overall Study|Protocol Violation|1|||
162883744|NCT01968954|588272481|FG000|Overall Study|Did not met inclusion criteria|0|||
162883745|NCT01968954|588272482|FG001|Overall Study|Did not met inclusion criteria|2|||
162883746|NCT00434122|588272488|FG000|Overall Study|Non-compliance with protocol|0|||
162883747|NCT00434122|588272489|FG001|Overall Study|Non-compliance with protocol|1|||
162883748|NCT00434122|588272488|FG000|Overall Study|loss of subject contact|1|||
162883749|NCT00434122|588272489|FG001|Overall Study|loss of subject contact|1|||
162883750|NCT00434122|588272488|FG000|Overall Study|Personal reasons|1|||
162883751|NCT00434122|588272489|FG001|Overall Study|Personal reasons|1|||
162883752|NCT00434122|588272488|FG000|Overall Study|Large follicle size|2|||
162883753|NCT00434122|588272489|FG001|Overall Study|Large follicle size|2|||
162883754|NCT00434122|588272488|FG000|Overall Study|Low follicular response.|1|||
162883755|NCT00434122|588272489|FG001|Overall Study|Low follicular response.|2|||
162883756|NCT00434122|588272488|FG000|Overall Study|Travelling of subject.|1|||
162883757|NCT00434122|588272489|FG001|Overall Study|Travelling of subject.|0|||
162883758|NCT00255086|588272490|FG000|Overall Study|Adverse Event|1|||
162883759|NCT00255086|588272491|FG001|Overall Study|Adverse Event|1|||
162883760|NCT00255086|588272490|FG000|Overall Study|Protocol Violation|1|||
162883761|NCT00255086|588272491|FG001|Overall Study|Protocol Violation|1|||
162883762|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
162883763|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
162883764|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
162883765|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
162883766|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
162883767|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
162883768|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
162616843|NCT00464269|587315099|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
162883769|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
162883770|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
162883771|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
162883772|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
162883773|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
162883774|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
162883775|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
162883776|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
162883777|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
162883778|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
162883779|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
162883780|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
162883781|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
162883782|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
162883783|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
162883784|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
162883785|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
162883786|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
162883787|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
162883788|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
162883789|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
162883790|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
162883791|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
162883792|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
162883793|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
162883794|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
162883795|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
162883796|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
162883797|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
162883798|NCT01963208|588272493|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
162883799|NCT01963208|588272494|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
162883800|NCT01963208|588272495|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
162883801|NCT01963208|588272496|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
162962924|NCT00274651|588564692|FG001|Overall Study|Withdrawal by Subject|1|||
162962925|NCT00274651|588564691|FG000|Overall Study|Physician Decision|8|||
162962926|NCT00274651|588564692|FG001|Overall Study|Physician Decision|7|||
162962927|NCT03446768|588564693|FG000|Overall Study|Withdrawal by Subject|0|||
162962928|NCT03446768|588564694|FG001|Overall Study|Withdrawal by Subject|1|||
162962929|NCT01604941|588564698|FG000|Overall Study|Adverse Event|1|||
162962930|NCT01604941|588564699|FG001|Overall Study|Adverse Event|2|||
162962931|NCT01604941|588564700|FG002|Overall Study|Adverse Event|0|||
162962932|NCT01604941|588564701|FG003|Overall Study|Adverse Event|0|||
162962933|NCT01604941|588564702|FG004|Overall Study|Adverse Event|1|||
162962934|NCT01604941|588564703|FG005|Overall Study|Adverse Event|5|||
162962935|NCT01604941|588564698|FG000|Overall Study|Non-compliance|1|||
162962936|NCT01604941|588564699|FG001|Overall Study|Non-compliance|0|||
162962937|NCT01604941|588564700|FG002|Overall Study|Non-compliance|0|||
162962938|NCT01604941|588564701|FG003|Overall Study|Non-compliance|0|||
162962939|NCT01604941|588564702|FG004|Overall Study|Non-compliance|0|||
162962940|NCT01604941|588564703|FG005|Overall Study|Non-compliance|0|||
162962941|NCT01604941|588564698|FG000|Overall Study|Participant Decision|0|||
162962942|NCT01604941|588564699|FG001|Overall Study|Participant Decision|0|||
162962943|NCT01604941|588564700|FG002|Overall Study|Participant Decision|0|||
162962944|NCT01604941|588564701|FG003|Overall Study|Participant Decision|0|||
162962945|NCT01604941|588564702|FG004|Overall Study|Participant Decision|0|||
162962946|NCT01604941|588564703|FG005|Overall Study|Participant Decision|2|||
162962947|NCT01604941|588564698|FG000|Overall Study|Early Study Termination|9|||
162962948|NCT01604941|588564699|FG001|Overall Study|Early Study Termination|2|||
162962949|NCT01604941|588564700|FG002|Overall Study|Early Study Termination|3|||
162962950|NCT01604941|588564701|FG003|Overall Study|Early Study Termination|3|||
162962951|NCT01604941|588564702|FG004|Overall Study|Early Study Termination|0|||
162962952|NCT01604941|588564703|FG005|Overall Study|Early Study Termination|0|||
162962953|NCT01410227|588564704|FG000|Overall Study|Adverse Event|1|||
162962954|NCT01410227|588564705|FG001|Overall Study|Adverse Event|0|||
162962955|NCT01410227|588564706|FG002|Overall Study|Adverse Event|0|||
162962956|NCT01410227|588564707|FG003|Overall Study|Adverse Event|0|||
163050098|NCT05616013|588891002|FG005|Overall Study|Prohibited Concomitant Medication|0|||
163050099|NCT05616013|588891003|FG006|Overall Study|Prohibited Concomitant Medication|0|||
162962957|NCT01410227|588564704|FG000|Overall Study|Withdrawal by Subject|3|||
163050100|NCT05616013|588891004|FG007|Overall Study|Prohibited Concomitant Medication|0|||
163050101|NCT05616013|588891005|FG008|Overall Study|Prohibited Concomitant Medication|0|||
162883802|NCT01963208|588272497|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
162962958|NCT01410227|588564705|FG001|Overall Study|Withdrawal by Subject|0|||
162962959|NCT01410227|588564706|FG002|Overall Study|Withdrawal by Subject|1|||
163050102|NCT05616013|588890997|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
162962960|NCT01410227|588564707|FG003|Overall Study|Withdrawal by Subject|0|||
162962961|NCT01410227|588564704|FG000|Overall Study|Pregnancy|0|||
162962962|NCT01410227|588564705|FG001|Overall Study|Pregnancy|0|||
162962963|NCT01410227|588564706|FG002|Overall Study|Pregnancy|0|||
162962964|NCT01410227|588564707|FG003|Overall Study|Pregnancy|1|||
162962965|NCT01410227|588564704|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962966|NCT01410227|588564705|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962967|NCT01410227|588564706|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
162883803|NCT01963208|588272498|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
162883804|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
162883805|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
162883806|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
162883807|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
162883808|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
162883809|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
162883810|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
162883811|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
162883812|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
162883813|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
162883814|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
162883815|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
162883816|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
162883817|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
162962968|NCT01410227|588564707|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
162962969|NCT00606281|588564708|FG000|Overall Study|Adverse Event|11|||
162962970|NCT00606281|588564709|FG001|Overall Study|Adverse Event|12|||
162962971|NCT00606281|588564708|FG000|Overall Study|Death|1|||
162962972|NCT00606281|588564709|FG001|Overall Study|Death|0|||
162962973|NCT00606281|588564708|FG000|Overall Study|Lack of Efficacy|28|||
162962974|NCT00606281|588564709|FG001|Overall Study|Lack of Efficacy|35|||
162962975|NCT00606281|588564708|FG000|Overall Study|Physician Decision|0|||
162962976|NCT00606281|588564709|FG001|Overall Study|Physician Decision|1|||
162962977|NCT00606281|588564708|FG000|Overall Study|Protocol Violation|3|||
162962978|NCT00606281|588564709|FG001|Overall Study|Protocol Violation|3|||
162962979|NCT00606281|588564708|FG000|Overall Study|Withdrawal by Subject|11|||
162962980|NCT00606281|588564709|FG001|Overall Study|Withdrawal by Subject|13|||
162962981|NCT00606281|588564708|FG000|Overall Study|Progression to depressive phase|1|||
162962982|NCT00606281|588564709|FG001|Overall Study|Progression to depressive phase|1|||
162962983|NCT00606281|588564708|FG000|Overall Study|Change of residence or other commitments|1|||
162962984|NCT00606281|588564709|FG001|Overall Study|Change of residence or other commitments|1|||
162962985|NCT00540423|588564711|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162962986|NCT00540423|588564712|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162962987|NCT00540423|588564713|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162962988|NCT00540423|588564711|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
162962989|NCT00540423|588564712|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162962990|NCT00540423|588564713|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
162962991|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
162962992|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
162962993|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
162962994|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
162962995|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162962996|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
162962997|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
162962998|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
162962999|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162963000|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
162963001|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162963002|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162963003|NCT03131895|588564714|FG000|Washout Period (at Least 5 Days)|Other|0|||
162963004|NCT03131895|588564715|FG001|Washout Period (at Least 5 Days)|Other|0|||
162963005|NCT03131895|588564716|FG002|Washout Period (at Least 5 Days)|Other|2|||
162963006|NCT03131895|588564717|FG003|Washout Period (at Least 5 Days)|Other|0|||
162963007|NCT03131895|588564714|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963008|NCT03131895|588564715|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
162963009|NCT03131895|588564716|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963010|NCT03131895|588564717|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
162963011|NCT03131895|588564714|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
162963012|NCT03131895|588564715|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963013|NCT03131895|588564716|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963014|NCT03131895|588564717|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
162963015|NCT02213263|588564722|FG000|Overall Study|Insufficient clinical response|4|||
162963016|NCT02213263|588564723|FG001|Overall Study|Insufficient clinical response|3|||
162963017|NCT02213263|588564722|FG000|Overall Study|Lost to Follow-up|0|||
162616844|NCT00464269|587315100|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162883818|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
162963018|NCT02213263|588564723|FG001|Overall Study|Lost to Follow-up|1|||
162883819|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
162883820|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
162883821|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
162883822|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
162883823|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
162883824|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
162883825|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
162883826|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
162883827|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
162883828|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
162883829|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
162883830|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
162883831|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
162883832|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
162883833|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
162883834|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
162883835|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
162883836|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
162883837|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
162883838|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
162883839|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
162883840|NCT01963208|588272493|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
162883841|NCT01963208|588272494|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
162883842|NCT01963208|588272495|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
162883843|NCT01963208|588272496|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
162883844|NCT01963208|588272497|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
162883845|NCT01963208|588272498|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
162883846|NCT00438399|588272499|FG000|Overall Study|Lost to Follow-up|2|||
162883847|NCT00438399|588272500|FG001|Overall Study|Lost to Follow-up|2|||
162883848|NCT00438399|588272501|FG002|Overall Study|Lost to Follow-up|1|||
162883849|NCT00438399|588272502|FG003|Overall Study|Lost to Follow-up|1|||
162883850|NCT00438399|588272503|FG004|Overall Study|Lost to Follow-up|1|||
162883851|NCT00438399|588272504|FG005|Overall Study|Lost to Follow-up|1|||
162883852|NCT00438399|588272499|FG000|Overall Study|Adverse Event|0|||
162883853|NCT00438399|588272500|FG001|Overall Study|Adverse Event|0|||
162883854|NCT00438399|588272501|FG002|Overall Study|Adverse Event|1|||
162883855|NCT00438399|588272502|FG003|Overall Study|Adverse Event|1|||
162883856|NCT00438399|588272503|FG004|Overall Study|Adverse Event|0|||
162883857|NCT00438399|588272504|FG005|Overall Study|Adverse Event|1|||
162883858|NCT00438399|588272499|FG000|Overall Study|Withdrawal by Subject|5|||
162883859|NCT00438399|588272500|FG001|Overall Study|Withdrawal by Subject|6|||
162883860|NCT00438399|588272501|FG002|Overall Study|Withdrawal by Subject|3|||
162883861|NCT00438399|588272502|FG003|Overall Study|Withdrawal by Subject|2|||
162883862|NCT00438399|588272503|FG004|Overall Study|Withdrawal by Subject|2|||
162883863|NCT00438399|588272504|FG005|Overall Study|Withdrawal by Subject|2|||
162883864|NCT00438399|588272499|FG000|Overall Study|Protocol Violation|0|||
162883865|NCT00438399|588272500|FG001|Overall Study|Protocol Violation|0|||
162883866|NCT00438399|588272501|FG002|Overall Study|Protocol Violation|1|||
162883867|NCT00438399|588272502|FG003|Overall Study|Protocol Violation|0|||
162883868|NCT00438399|588272503|FG004|Overall Study|Protocol Violation|0|||
162883869|NCT00438399|588272504|FG005|Overall Study|Protocol Violation|1|||
162883870|NCT00438399|588272499|FG000|Overall Study|Subje stopped study|0|||
162883871|NCT00438399|588272500|FG001|Overall Study|Subje stopped study|0|||
162883872|NCT00438399|588272501|FG002|Overall Study|Subje stopped study|1|||
162883873|NCT00438399|588272502|FG003|Overall Study|Subje stopped study|0|||
162883874|NCT00438399|588272503|FG004|Overall Study|Subje stopped study|0|||
162883875|NCT00438399|588272504|FG005|Overall Study|Subje stopped study|0|||
162883876|NCT00438399|588272499|FG000|Overall Study|Pregnancy|0|||
162883877|NCT00438399|588272500|FG001|Overall Study|Pregnancy|0|||
162883878|NCT00438399|588272501|FG002|Overall Study|Pregnancy|0|||
162963019|NCT02213263|588564722|FG000|Overall Study|No longer willing to participate|3|||
162883879|NCT00438399|588272502|FG003|Overall Study|Pregnancy|0|||
162883880|NCT00438399|588272503|FG004|Overall Study|Pregnancy|0|||
162883881|NCT00438399|588272504|FG005|Overall Study|Pregnancy|1|||
162883882|NCT00438399|588272499|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
162883883|NCT00438399|588272500|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
162883884|NCT00438399|588272501|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
162883885|NCT00438399|588272502|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
162883886|NCT00438399|588272503|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
162883887|NCT00438399|588272504|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
162883888|NCT03334396|588272506|FG000|Overall Study|Adverse Event|1|||
162883889|NCT03334396|588272507|FG001|Overall Study|Adverse Event|0|||
162883890|NCT03334396|588272508|FG002|Overall Study|Adverse Event|1|||
162883891|NCT03334396|588272509|FG003|Overall Study|Adverse Event|0|||
162883892|NCT03334396|588272510|FG004|Overall Study|Adverse Event|0|||
162883893|NCT03334396|588272511|FG005|Overall Study|Adverse Event|0|||
162883894|NCT03334396|588272512|FG006|Overall Study|Adverse Event|0|||
162883895|NCT03334396|588272513|FG007|Overall Study|Adverse Event|0|||
162883896|NCT03334396|588272506|FG000|Overall Study|Lack of Efficacy|10|||
162883897|NCT03334396|588272507|FG001|Overall Study|Lack of Efficacy|4|||
162883898|NCT03334396|588272508|FG002|Overall Study|Lack of Efficacy|1|||
162883899|NCT03334396|588272509|FG003|Overall Study|Lack of Efficacy|3|||
162883900|NCT03334396|588272510|FG004|Overall Study|Lack of Efficacy|1|||
163050103|NCT05616013|588890998|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050104|NCT05616013|588890999|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
163050105|NCT05616013|588891000|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
162883901|NCT03334396|588272511|FG005|Overall Study|Lack of Efficacy|0|||
162883902|NCT03334396|588272512|FG006|Overall Study|Lack of Efficacy|0|||
162883903|NCT03334396|588272513|FG007|Overall Study|Lack of Efficacy|1|||
162883904|NCT03334396|588272506|FG000|Overall Study|Lost to Follow-up|0|||
162883905|NCT03334396|588272507|FG001|Overall Study|Lost to Follow-up|0|||
162883906|NCT03334396|588272508|FG002|Overall Study|Lost to Follow-up|1|||
162883907|NCT03334396|588272509|FG003|Overall Study|Lost to Follow-up|0|||
162883908|NCT03334396|588272510|FG004|Overall Study|Lost to Follow-up|0|||
162883909|NCT03334396|588272511|FG005|Overall Study|Lost to Follow-up|0|||
162883910|NCT03334396|588272512|FG006|Overall Study|Lost to Follow-up|1|||
162883911|NCT03334396|588272513|FG007|Overall Study|Lost to Follow-up|0|||
162883912|NCT03334396|588272506|FG000|Overall Study|Physician Decision|1|||
162883913|NCT03334396|588272507|FG001|Overall Study|Physician Decision|0|||
162883914|NCT03334396|588272508|FG002|Overall Study|Physician Decision|0|||
162883915|NCT03334396|588272509|FG003|Overall Study|Physician Decision|0|||
162883916|NCT03334396|588272510|FG004|Overall Study|Physician Decision|0|||
162883917|NCT03334396|588272511|FG005|Overall Study|Physician Decision|0|||
162883918|NCT03334396|588272512|FG006|Overall Study|Physician Decision|0|||
162883919|NCT03334396|588272513|FG007|Overall Study|Physician Decision|0|||
162883920|NCT03334396|588272506|FG000|Overall Study|Withdrawal by Subject|10|||
162883921|NCT03334396|588272507|FG001|Overall Study|Withdrawal by Subject|5|||
162883922|NCT03334396|588272508|FG002|Overall Study|Withdrawal by Subject|7|||
162883923|NCT03334396|588272509|FG003|Overall Study|Withdrawal by Subject|2|||
162883924|NCT03334396|588272510|FG004|Overall Study|Withdrawal by Subject|2|||
162883925|NCT03334396|588272511|FG005|Overall Study|Withdrawal by Subject|1|||
162883926|NCT03334396|588272512|FG006|Overall Study|Withdrawal by Subject|2|||
162883927|NCT03334396|588272513|FG007|Overall Study|Withdrawal by Subject|0|||
162883928|NCT03334396|588272506|FG000|Overall Study|Pregnancy|0|||
162883929|NCT03334396|588272507|FG001|Overall Study|Pregnancy|1|||
162883930|NCT03334396|588272508|FG002|Overall Study|Pregnancy|0|||
162883931|NCT03334396|588272509|FG003|Overall Study|Pregnancy|0|||
162883932|NCT03334396|588272510|FG004|Overall Study|Pregnancy|0|||
162883933|NCT03334396|588272511|FG005|Overall Study|Pregnancy|0|||
162883934|NCT03334396|588272512|FG006|Overall Study|Pregnancy|0|||
162883935|NCT03334396|588272513|FG007|Overall Study|Pregnancy|0|||
162883936|NCT03334396|588272506|FG000|Overall Study|Ineligible|0|||
162883937|NCT03334396|588272507|FG001|Overall Study|Ineligible|1|||
162883938|NCT03334396|588272508|FG002|Overall Study|Ineligible|0|||
162883939|NCT03334396|588272509|FG003|Overall Study|Ineligible|0|||
162883940|NCT03334396|588272510|FG004|Overall Study|Ineligible|0|||
162883941|NCT03334396|588272511|FG005|Overall Study|Ineligible|0|||
162883942|NCT03334396|588272512|FG006|Overall Study|Ineligible|0|||
162883943|NCT03334396|588272513|FG007|Overall Study|Ineligible|0|||
162883944|NCT03334396|588272506|FG000|Overall Study|Started New Job|1|||
162883945|NCT03334396|588272507|FG001|Overall Study|Started New Job|0|||
162883946|NCT03334396|588272508|FG002|Overall Study|Started New Job|0|||
162883947|NCT03334396|588272509|FG003|Overall Study|Started New Job|0|||
162883948|NCT03334396|588272510|FG004|Overall Study|Started New Job|0|||
162883949|NCT03334396|588272511|FG005|Overall Study|Started New Job|0|||
162883950|NCT03334396|588272512|FG006|Overall Study|Started New Job|0|||
162883951|NCT03334396|588272513|FG007|Overall Study|Started New Job|0|||
162883952|NCT03488251|588272514|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
162883953|NCT03488251|588272515|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
162883954|NCT03488251|588272516|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
162883955|NCT03488251|588272517|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
162883956|NCT03488251|588272514|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
162883957|NCT03488251|588272515|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
162883958|NCT03488251|588272516|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
162883959|NCT03488251|588272517|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
162883960|NCT03488251|588272514|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
162883961|NCT03488251|588272515|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
162883962|NCT03488251|588272516|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
162883963|NCT03488251|588272517|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
162883964|NCT03488251|588272514|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
162883965|NCT03488251|588272515|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
162883966|NCT03488251|588272516|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
162883967|NCT03488251|588272517|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
163050106|NCT05616013|588891001|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050107|NCT05616013|588891002|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050108|NCT05616013|588891003|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050109|NCT05616013|588891004|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050110|NCT05616013|588891005|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
163050111|NCT05616013|588890997|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050112|NCT05616013|588890998|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050113|NCT05616013|588890999|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050114|NCT05616013|588891000|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
163050115|NCT05616013|588891001|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163058600|NCT00042289|588924240|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
162883968|NCT03488251|588272514|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
162883969|NCT03488251|588272515|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
162883970|NCT03488251|588272516|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
162883971|NCT03488251|588272517|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
162883972|NCT03600714|588272518|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
162883973|NCT00592553|588272520|FG000|Overall Study|Protocol Noncompliance|1|||
162883974|NCT00592553|588272521|FG001|Overall Study|Protocol Noncompliance|0|||
162883975|NCT00592553|588272522|FG002|Overall Study|Protocol Noncompliance|0|||
162883976|NCT03829332|588272523|FG000|Overall Study|Death|225|||
162883977|NCT03829332|588272524|FG001|Overall Study|Death|230|||
162883978|NCT03829332|588272523|FG000|Overall Study|Lost to Follow-up|1|||
162883979|NCT03829332|588272524|FG001|Overall Study|Lost to Follow-up|3|||
162883980|NCT03829332|588272523|FG000|Overall Study|Physician Decision|1|||
162883981|NCT03829332|588272524|FG001|Overall Study|Physician Decision|0|||
162883982|NCT03829332|588272523|FG000|Overall Study|Sponsor Decision|71|||
162883983|NCT03829332|588272524|FG001|Overall Study|Sponsor Decision|72|||
162883984|NCT03829332|588272523|FG000|Overall Study|Withdrawal by Subject|11|||
162883985|NCT03829332|588272524|FG001|Overall Study|Withdrawal by Subject|9|||
162883986|NCT01283997|588274459|FG000|Overall Study|Physician Decision|8|||
162883987|NCT01283997|588274460|FG001|Overall Study|Physician Decision|10|||
162883988|NCT01283997|588274459|FG000|Overall Study|Withdrawal by Subject|3|||
162883989|NCT01283997|588274460|FG001|Overall Study|Withdrawal by Subject|2|||
162883990|NCT01283997|588274459|FG000|Overall Study|Physically unable to continue|0|||
162883991|NCT01283997|588274460|FG001|Overall Study|Physically unable to continue|1|||
162883992|NCT01283997|588274459|FG000|Overall Study|Progressive disease|1|||
162883993|NCT01283997|588274460|FG001|Overall Study|Progressive disease|0|||
162883994|NCT01283997|588274459|FG000|Overall Study|Other|4|||
162883995|NCT01283997|588274460|FG001|Overall Study|Other|4|||
162883996|NCT02109744|588274461|FG000|Overall Study|Death|1|||
162883997|NCT02109744|588274462|FG001|Overall Study|Death|1|||
162883998|NCT02109744|588274461|FG000|Overall Study|no marrow exam|1|||
162883999|NCT02109744|588274462|FG001|Overall Study|no marrow exam|0|||
162884000|NCT04095442|588274466|FG000|Overall Study|Lost to Follow-up|0|||
162884001|NCT04095442|588274467|FG001|Overall Study|Lost to Follow-up|1|||
162884002|NCT04095442|588274466|FG000|Overall Study|Screen failure|1|||
162884003|NCT04095442|588274467|FG001|Overall Study|Screen failure|0|||
162884004|NCT00884221|588274472|FG000|Overall Study|Withdrawal by Subject|0|||
162884005|NCT00884221|588274473|FG001|Overall Study|Withdrawal by Subject|3|||
162707959|NCT01605136|587640646|FG001|Study Period|Physician Decision|1|||
162884006|NCT00884221|588274472|FG000|Overall Study|Adverse Event|6|||
162884007|NCT00884221|588274473|FG001|Overall Study|Adverse Event|3|||
162884008|NCT00884221|588274472|FG000|Overall Study|Protocol Violation|16|||
162884009|NCT00884221|588274473|FG001|Overall Study|Protocol Violation|13|||
162884010|NCT00884221|588274472|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
162884011|NCT00884221|588274473|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
162884012|NCT00255034|588274474|FG000|Overall Study|Withdrawal by Subject|15|||
162884013|NCT00255034|588274475|FG001|Overall Study|Withdrawal by Subject|38|||
162884014|NCT01263093|588274476|FG000|Washout|Physician Decision|1|||
162884015|NCT01263093|588274477|FG001|Washout|Physician Decision|0|||
162884016|NCT01263093|588274476|FG000|Period 2|Adverse Event|1|||
162884017|NCT01263093|588274477|FG001|Period 2|Adverse Event|0|||
162884018|NCT00424346|588274478|FG000|Core Study|Adverse Event|5|||
162884019|NCT00424346|588274479|FG001|Core Study|Adverse Event|3|||
162884020|NCT00424346|588274480|FG002|Core Study|Adverse Event|1|||
162884021|NCT00424346|588274481|FG003|Core Study|Adverse Event|1|||
162884022|NCT00424346|588274478|FG000|Core Study|Abnormal Laboratory Values|0|||
162884023|NCT00424346|588274479|FG001|Core Study|Abnormal Laboratory Values|1|||
162884024|NCT00424346|588274480|FG002|Core Study|Abnormal Laboratory Values|0|||
162884025|NCT00424346|588274481|FG003|Core Study|Abnormal Laboratory Values|0|||
162884026|NCT00424346|588274478|FG000|Core Study|Lack of Efficacy|1|||
162884027|NCT00424346|588274479|FG001|Core Study|Lack of Efficacy|3|||
162884028|NCT00424346|588274480|FG002|Core Study|Lack of Efficacy|0|||
162884029|NCT00424346|588274481|FG003|Core Study|Lack of Efficacy|4|||
162884030|NCT00424346|588274478|FG000|Core Study|Withdrawal by Subject|1|||
162884031|NCT00424346|588274479|FG001|Core Study|Withdrawal by Subject|0|||
162884032|NCT00424346|588274480|FG002|Core Study|Withdrawal by Subject|0|||
162884033|NCT00424346|588274481|FG003|Core Study|Withdrawal by Subject|2|||
162884034|NCT00424346|588274478|FG000|Core Study|Lost to Follow-up|1|||
162884035|NCT00424346|588274479|FG001|Core Study|Lost to Follow-up|1|||
162884036|NCT00424346|588274480|FG002|Core Study|Lost to Follow-up|0|||
162884037|NCT00424346|588274481|FG003|Core Study|Lost to Follow-up|0|||
162884038|NCT00424346|588274478|FG000|Core Study|Administrative Problems|1|||
162884039|NCT00424346|588274479|FG001|Core Study|Administrative Problems|0|||
162884040|NCT00424346|588274480|FG002|Core Study|Administrative Problems|1|||
162884041|NCT00424346|588274481|FG003|Core Study|Administrative Problems|0|||
162884042|NCT00424346|588274478|FG000|Core Study|Protocol Violation|0|||
162884043|NCT00424346|588274479|FG001|Core Study|Protocol Violation|0|||
162884044|NCT00424346|588274480|FG002|Core Study|Protocol Violation|2|||
162884045|NCT00424346|588274481|FG003|Core Study|Protocol Violation|0|||
162884046|NCT00424346|588274478|FG000|Extension Phase|Adverse Event|0|||
162884047|NCT00424346|588274479|FG001|Extension Phase|Adverse Event|9|||
162884048|NCT00424346|588274480|FG002|Extension Phase|Adverse Event|5|||
162884049|NCT00424346|588274481|FG003|Extension Phase|Adverse Event|4|||
162884050|NCT00424346|588274478|FG000|Extension Phase|Lack of Efficacy|0|||
162884051|NCT00424346|588274479|FG001|Extension Phase|Lack of Efficacy|16|||
162884052|NCT00424346|588274480|FG002|Extension Phase|Lack of Efficacy|14|||
162884053|NCT00424346|588274481|FG003|Extension Phase|Lack of Efficacy|11|||
162884054|NCT00424346|588274478|FG000|Extension Phase|Withdrawal by Subject|0|||
162884055|NCT00424346|588274479|FG001|Extension Phase|Withdrawal by Subject|5|||
162884056|NCT00424346|588274480|FG002|Extension Phase|Withdrawal by Subject|3|||
162884057|NCT00424346|588274481|FG003|Extension Phase|Withdrawal by Subject|4|||
162884058|NCT00424346|588274478|FG000|Extension Phase|Lost to Follow-up|0|||
162884059|NCT00424346|588274479|FG001|Extension Phase|Lost to Follow-up|2|||
162884060|NCT00424346|588274480|FG002|Extension Phase|Lost to Follow-up|0|||
162884061|NCT00424346|588274481|FG003|Extension Phase|Lost to Follow-up|0|||
162884062|NCT00424346|588274478|FG000|Extension Phase|Administrative Problems|0|||
162884063|NCT00424346|588274479|FG001|Extension Phase|Administrative Problems|69|||
162884064|NCT00424346|588274480|FG002|Extension Phase|Administrative Problems|32|||
162884065|NCT00424346|588274481|FG003|Extension Phase|Administrative Problems|35|||
162884066|NCT00424346|588274478|FG000|Extension Phase|Death|0|||
162884067|NCT00424346|588274479|FG001|Extension Phase|Death|0|||
162884068|NCT00424346|588274480|FG002|Extension Phase|Death|0|||
162884069|NCT00424346|588274481|FG003|Extension Phase|Death|1|||
162884070|NCT00424346|588274478|FG000|Extension Phase|Protocol Violation|0|||
162884071|NCT00424346|588274479|FG001|Extension Phase|Protocol Violation|1|||
162884072|NCT00424346|588274480|FG002|Extension Phase|Protocol Violation|1|||
162884073|NCT00424346|588274481|FG003|Extension Phase|Protocol Violation|0|||
162884074|NCT00571519|588274482|FG000|Overall Study|Subject withdrew consent|0|||
162963020|NCT02213263|588564723|FG001|Overall Study|No longer willing to participate|4|||
162963021|NCT02213263|588564722|FG000|Overall Study|Progressive disease|20|||
162963022|NCT02213263|588564723|FG001|Overall Study|Progressive disease|14|||
162963023|NCT02213263|588564722|FG000|Overall Study|Protocol Violation|0|||
162963024|NCT02213263|588564723|FG001|Overall Study|Protocol Violation|1|||
162963025|NCT02213263|588564722|FG000|Overall Study|Adverse Event|1|||
162884075|NCT00571519|588274483|FG001|Overall Study|Subject withdrew consent|1|||
162884076|NCT00571519|588274484|FG002|Overall Study|Subject withdrew consent|0|||
162884077|NCT00571519|588274485|FG003|Overall Study|Subject withdrew consent|2|||
162884078|NCT00571519|588274486|FG004|Overall Study|Subject withdrew consent|1|||
162884079|NCT00571519|588274487|FG005|Overall Study|Subject withdrew consent|1|||
162884080|NCT00571519|588274488|FG006|Overall Study|Subject withdrew consent|2|||
162884081|NCT00571519|588274482|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
162884082|NCT00571519|588274483|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
162884083|NCT00571519|588274484|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
162884084|NCT00571519|588274485|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
162884085|NCT00571519|588274486|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
162884086|NCT00571519|588274487|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
162884087|NCT00571519|588274488|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
162884088|NCT00571519|588274482|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884089|NCT00571519|588274483|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
162884090|NCT00571519|588274484|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884091|NCT00571519|588274485|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884092|NCT00571519|588274486|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884093|NCT00571519|588274487|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884094|NCT00571519|588274488|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
162884095|NCT00571519|588274482|FG000|Overall Study|Termination of study by Sponsor|2|||
162884096|NCT00571519|588274483|FG001|Overall Study|Termination of study by Sponsor|7|||
162884097|NCT00571519|588274484|FG002|Overall Study|Termination of study by Sponsor|10|||
162884098|NCT00571519|588274485|FG003|Overall Study|Termination of study by Sponsor|24|||
162884099|NCT00571519|588274486|FG004|Overall Study|Termination of study by Sponsor|8|||
162884100|NCT00571519|588274487|FG005|Overall Study|Termination of study by Sponsor|9|||
162884101|NCT00571519|588274488|FG006|Overall Study|Termination of study by Sponsor|22|||
162884102|NCT00571519|588274482|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884103|NCT00571519|588274483|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884104|NCT00571519|588274484|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
162884105|NCT00571519|588274485|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884106|NCT00571519|588274486|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884107|NCT00571519|588274487|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884108|NCT00571519|588274488|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
162884109|NCT03947255|588274490|FG000|Overall Study|Study Closure by Sponsor|2|||
162884110|NCT03947255|588274491|FG001|Overall Study|Study Closure by Sponsor|2|||
162884111|NCT03947255|588274490|FG000|Overall Study|Withdrawal by Subject|2|||
162884112|NCT03947255|588274491|FG001|Overall Study|Withdrawal by Subject|2|||
162884113|NCT03947255|588274490|FG000|Overall Study|Lost to Follow-up|2|||
162884114|NCT03947255|588274491|FG001|Overall Study|Lost to Follow-up|0|||
162884115|NCT03947255|588274490|FG000|Overall Study|Death|0|||
162884116|NCT03947255|588274491|FG001|Overall Study|Death|2|||
162884117|NCT02499575|588274492|FG000|Overall Study|Protocol Violation|0|||
162884118|NCT02499575|588274493|FG001|Overall Study|Protocol Violation|1|||
162884119|NCT02701192|588274496|FG000|Overall Study|Protocol Violation|2|||
162884120|NCT02701192|588274496|FG000|Overall Study|Lost to Follow-up|4|||
162884121|NCT01245764|588274497|FG000|Study Phase A|Other|3|||
162884122|NCT01245764|588274498|FG001|Study Phase A|Other|2|||
162884123|NCT01245764|588274499|FG002|Study Phase A|Other|3|||
162884124|NCT01245764|588274500|FG003|Study Phase A|Other|1|||
162884125|NCT01245764|588274497|FG000|Study Phase A|Protocol Violation|6|||
162884126|NCT01245764|588274498|FG001|Study Phase A|Protocol Violation|3|||
162884127|NCT01245764|588274499|FG002|Study Phase A|Protocol Violation|2|||
162884128|NCT01245764|588274500|FG003|Study Phase A|Protocol Violation|2|||
162884129|NCT01245764|588274497|FG000|Study Phase A|Lost to Follow-up|0|||
162884130|NCT01245764|588274498|FG001|Study Phase A|Lost to Follow-up|0|||
162884131|NCT01245764|588274499|FG002|Study Phase A|Lost to Follow-up|5|||
162884132|NCT01245764|588274500|FG003|Study Phase A|Lost to Follow-up|0|||
162884133|NCT02475850|588274501|FG000|Overall Study|Death|155|||
162884134|NCT02475850|588274502|FG001|Overall Study|Death|141|||
162884135|NCT02475850|588274501|FG000|Overall Study|Lost to Follow-up|217|||
162884136|NCT02475850|588274502|FG001|Overall Study|Lost to Follow-up|188|||
162884137|NCT02475850|588274501|FG000|Overall Study|Withdrawal by Subject|221|||
162884138|NCT02475850|588274502|FG001|Overall Study|Withdrawal by Subject|155|||
162884139|NCT03434418|588274504|FG000|Overall Study|Disease Progression|11|||
162884140|NCT03434418|588274504|FG000|Overall Study|Adverse Event|2|||
162884141|NCT03434418|588274504|FG000|Overall Study|Physician Decision|1|||
162884142|NCT03434418|588274504|FG000|Overall Study|Decline in Performance Status (PS)|1|||
162884143|NCT03039738|588274506|FG000|Overall Study|Incomplete data sets|54|||
162884144|NCT03039738|588274507|FG001|Overall Study|Incomplete data sets|0|||
162884145|NCT01494987|588274508|FG000|Overall Study|Adverse Event|6|||
162884146|NCT01494987|588274509|FG001|Overall Study|Adverse Event|5|||
162884147|NCT01494987|588274508|FG000|Overall Study|Hyperglycemia|6|||
162884148|NCT01494987|588274509|FG001|Overall Study|Hyperglycemia|4|||
162884149|NCT01494987|588274508|FG000|Overall Study|Investigator's Discretion|1|||
162884150|NCT01494987|588274509|FG001|Overall Study|Investigator's Discretion|2|||
162884151|NCT01494987|588274508|FG000|Overall Study|Lost to Follow-up|1|||
162884152|NCT01494987|588274509|FG001|Overall Study|Lost to Follow-up|1|||
162884153|NCT01494987|588274508|FG000|Overall Study|Protocol Violation|3|||
162884154|NCT01494987|588274509|FG001|Overall Study|Protocol Violation|3|||
162884155|NCT01494987|588274508|FG000|Overall Study|Subject Non-Compliance|9|||
162884156|NCT01494987|588274509|FG001|Overall Study|Subject Non-Compliance|10|||
162884157|NCT01494987|588274508|FG000|Overall Study|Subject Withdrew Consent|2|||
162884158|NCT01494987|588274509|FG001|Overall Study|Subject Withdrew Consent|3|||
162884159|NCT02716194|588274510|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
162884160|NCT02716194|588274511|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
163050116|NCT05616013|588891002|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050117|NCT05616013|588891003|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050118|NCT05616013|588891004|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050119|NCT05616013|588891005|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
163050120|NCT05616013|588890997|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050121|NCT05616013|588890998|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050122|NCT05616013|588890999|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050123|NCT05616013|588891000|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050124|NCT05616013|588891001|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050125|NCT05616013|588891002|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050126|NCT05616013|588891003|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
163050127|NCT05616013|588891004|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050128|NCT05616013|588891005|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
163050129|NCT05616013|588890997|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050130|NCT05616013|588890998|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050131|NCT05616013|588890999|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050132|NCT05616013|588891000|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050133|NCT05616013|588891001|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050134|NCT05616013|588891002|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050135|NCT05616013|588891003|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050136|NCT05616013|588891004|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
163050137|NCT05616013|588891005|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
163050138|NCT05616013|588890997|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050139|NCT05616013|588890998|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
162884161|NCT02716194|588274512|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
163050140|NCT05616013|588890999|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050141|NCT05616013|588891000|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050142|NCT05616013|588891001|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050143|NCT05616013|588891002|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050144|NCT05616013|588891003|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050145|NCT05616013|588891004|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
163050146|NCT05616013|588891005|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
163050147|NCT05067972|588891006|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050148|NCT05067972|588891007|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050149|NCT05067972|588891008|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050150|NCT05067972|588891009|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050151|NCT05067972|588891010|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050152|NCT05067972|588891011|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
163050153|NCT05067972|588891012|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
163050154|NCT05067972|588891006|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
163050155|NCT05067972|588891007|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
163050156|NCT05067972|588891008|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
163050157|NCT05067972|588891009|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
163050158|NCT05067972|588891010|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
163050159|NCT05067972|588891011|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
162884162|NCT00363051|588274516|FG000|Overall Study|Adminstrative problems|1|||
162884163|NCT00363051|588274517|FG001|Overall Study|Adminstrative problems|1|||
162884164|NCT00363051|588274516|FG000|Overall Study|Adverse Event|21|||
162884165|NCT00363051|588274517|FG001|Overall Study|Adverse Event|12|||
162884166|NCT00363051|588274516|FG000|Overall Study|New Cancer Therapy|2|||
162884167|NCT00363051|588274517|FG001|Overall Study|New Cancer Therapy|1|||
162884168|NCT00363051|588274516|FG000|Overall Study|Withdrawal by Subject|11|||
162884169|NCT00363051|588274517|FG001|Overall Study|Withdrawal by Subject|3|||
163050160|NCT05067972|588891012|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
163050161|NCT05067972|588891006|FG000|Part 1: Treatment|Progressive Disease|3|||
163050162|NCT05067972|588891007|FG001|Part 1: Treatment|Progressive Disease|3|||
163050163|NCT05067972|588891008|FG002|Part 1: Treatment|Progressive Disease|4|||
163050164|NCT05067972|588891009|FG003|Part 1: Treatment|Progressive Disease|2|||
162884170|NCT00363051|588274516|FG000|Overall Study|Lost to Follow-up|0|||
162884171|NCT00363051|588274517|FG001|Overall Study|Lost to Follow-up|1|||
162884172|NCT00363051|588274516|FG000|Overall Study|Protocol Violation|0|||
162884173|NCT00363051|588274517|FG001|Overall Study|Protocol Violation|2|||
162884174|NCT00363051|588274516|FG000|Overall Study|Death|3|||
162884175|NCT00363051|588274517|FG001|Overall Study|Death|2|||
162884176|NCT02759562|588274518|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
162884177|NCT02759562|588274519|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
162884178|NCT02759562|588274518|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
162963026|NCT02213263|588564723|FG001|Overall Study|Adverse Event|3|||
162963027|NCT00731939|588564724|FG000|Overall Study|Adverse Event|6|||
162963028|NCT00731939|588564724|FG000|Overall Study|Lost to Follow-up|15|||
162963029|NCT00731939|588564724|FG000|Overall Study|Not implanted with study device|9|||
162963030|NCT00731939|588564724|FG000|Overall Study|Withdrawal by Subject|2|||
162963031|NCT00731939|588564724|FG000|Overall Study|Did not meet enrollment criteria|2|||
162963032|NCT05752721|588564725|FG000|Overall Study|Lost to Follow-up|22|||
162963033|NCT05752721|588564726|FG001|Overall Study|Lost to Follow-up|20|||
162963034|NCT05752721|588564725|FG000|Overall Study|Withdrawal by Subject|15|||
162963035|NCT05752721|588564726|FG001|Overall Study|Withdrawal by Subject|12|||
162963036|NCT00263588|588564727|FG000|Overall Study|Death|54|||
162963037|NCT00263588|588564728|FG001|Overall Study|Death|90|||
162963038|NCT00263588|588564727|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
162963039|NCT00263588|588564728|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
162963040|NCT00263588|588564727|FG000|Overall Study|Lost to Follow-up|7|||
162963041|NCT00263588|588564728|FG001|Overall Study|Lost to Follow-up|10|||
163050165|NCT05067972|588891010|FG004|Part 1: Treatment|Progressive Disease|3|||
163050166|NCT05067972|588891011|FG005|Part 1: Treatment|Progressive Disease|0|||
163050167|NCT05067972|588891012|FG006|Part 1: Treatment|Progressive Disease|2|||
163050168|NCT05067972|588891006|FG000|Part 1: Treatment|Physician Decision|0|||
163050169|NCT05067972|588891007|FG001|Part 1: Treatment|Physician Decision|0|||
163050170|NCT05067972|588891008|FG002|Part 1: Treatment|Physician Decision|0|||
163050171|NCT05067972|588891009|FG003|Part 1: Treatment|Physician Decision|1|||
163050172|NCT05067972|588891010|FG004|Part 1: Treatment|Physician Decision|0|||
163050173|NCT05067972|588891011|FG005|Part 1: Treatment|Physician Decision|0|||
163050174|NCT05067972|588891012|FG006|Part 1: Treatment|Physician Decision|0|||
163050175|NCT05067972|588891006|FG000|Part 1: Treatment|Death|0|||
163050176|NCT05067972|588891007|FG001|Part 1: Treatment|Death|0|||
163050177|NCT05067972|588891008|FG002|Part 1: Treatment|Death|0|||
162616845|NCT00747461|587315101|FG000|Overall Study|study terminated by sponsor|5|||
162616846|NCT02149875|587315102|FG000|Overall Study|Lost to Follow-up|3|||
163050178|NCT05067972|588891009|FG003|Part 1: Treatment|Death|2|||
163050179|NCT05067972|588891010|FG004|Part 1: Treatment|Death|0|||
163050180|NCT05067972|588891011|FG005|Part 1: Treatment|Death|0|||
163050181|NCT05067972|588891012|FG006|Part 1: Treatment|Death|0|||
162616847|NCT02149875|587315103|FG001|Overall Study|Lost to Follow-up|4|||
162616848|NCT02149875|587315104|FG002|Overall Study|Lost to Follow-up|5|||
162884179|NCT02759562|588274519|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
162884180|NCT02293993|588274520|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
162884181|NCT02293993|588274521|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
162884182|NCT02293993|588274522|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
162884183|NCT02293993|588274523|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
162884184|NCT02293993|588274520|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
162884185|NCT02293993|588274521|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
162884186|NCT02293993|588274522|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
162884187|NCT02293993|588274523|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
162884188|NCT02293993|588274520|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
162884189|NCT02293993|588274521|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
162884190|NCT02293993|588274522|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
162884191|NCT02293993|588274523|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
162884192|NCT02293993|588274520|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
162884193|NCT02293993|588274521|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
162884194|NCT02293993|588274522|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
162884195|NCT02293993|588274523|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
162884196|NCT02293993|588274520|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
162884197|NCT02293993|588274521|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
162963042|NCT00263588|588564727|FG000|Overall Study|Withdrawal by Subject|3|||
162963043|NCT00263588|588564728|FG001|Overall Study|Withdrawal by Subject|4|||
162963044|NCT00263588|588564727|FG000|Overall Study|Protocol Violation|0|||
162963045|NCT00263588|588564728|FG001|Overall Study|Protocol Violation|1|||
162963046|NCT00263588|588564727|FG000|Overall Study|Investigator decision|7|||
163050182|NCT05067972|588891006|FG000|Part 1: Treatment|Adverse Event|0|||
163050183|NCT05067972|588891007|FG001|Part 1: Treatment|Adverse Event|0|||
163050184|NCT05067972|588891008|FG002|Part 1: Treatment|Adverse Event|0|||
163050185|NCT05067972|588891009|FG003|Part 1: Treatment|Adverse Event|0|||
163050186|NCT05067972|588891010|FG004|Part 1: Treatment|Adverse Event|0|||
163050187|NCT05067972|588891011|FG005|Part 1: Treatment|Adverse Event|2|||
163050188|NCT05067972|588891012|FG006|Part 1: Treatment|Adverse Event|1|||
163050189|NCT05067972|588891006|FG000|Part 1: Follow-up|Adverse Event|0|||
162616849|NCT02149875|587315102|FG000|Overall Study|Withdrawal by Subject|3|||
162616850|NCT02149875|587315103|FG001|Overall Study|Withdrawal by Subject|2|||
162616851|NCT02149875|587315104|FG002|Overall Study|Withdrawal by Subject|2|||
162616852|NCT02149875|587315102|FG000|Overall Study|Physician Decision|1|||
162616853|NCT02149875|587315103|FG001|Overall Study|Physician Decision|2|||
162616854|NCT02149875|587315104|FG002|Overall Study|Physician Decision|2|||
162884198|NCT02293993|588274522|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
162884199|NCT02293993|588274523|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
163050190|NCT05067972|588891007|FG001|Part 1: Follow-up|Adverse Event|0|||
163050191|NCT05067972|588891008|FG002|Part 1: Follow-up|Adverse Event|0|||
163050192|NCT05067972|588891009|FG003|Part 1: Follow-up|Adverse Event|0|||
163050193|NCT05067972|588891010|FG004|Part 1: Follow-up|Adverse Event|0|||
163050194|NCT05067972|588891011|FG005|Part 1: Follow-up|Adverse Event|1|||
163050195|NCT05067972|588891012|FG006|Part 1: Follow-up|Adverse Event|0|||
163050196|NCT05067972|588891006|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
163050197|NCT05067972|588891007|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
163050198|NCT05067972|588891008|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
163050199|NCT05067972|588891009|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
163050200|NCT05067972|588891010|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
163050201|NCT05067972|588891011|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
163050202|NCT05067972|588891012|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
163050203|NCT05067972|588891006|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050204|NCT05067972|588891007|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050205|NCT05067972|588891008|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050206|NCT05067972|588891009|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050207|NCT05067972|588891010|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050208|NCT05067972|588891011|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
163050209|NCT05067972|588891012|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
163050210|NCT05067972|588891006|FG000|Part 1: Follow-up|Physician Decision|0|||
163050211|NCT05067972|588891007|FG001|Part 1: Follow-up|Physician Decision|0|||
163050212|NCT05067972|588891008|FG002|Part 1: Follow-up|Physician Decision|0|||
163050213|NCT05067972|588891009|FG003|Part 1: Follow-up|Physician Decision|1|||
163050214|NCT05067972|588891010|FG004|Part 1: Follow-up|Physician Decision|0|||
163050215|NCT05067972|588891011|FG005|Part 1: Follow-up|Physician Decision|0|||
163050216|NCT05067972|588891012|FG006|Part 1: Follow-up|Physician Decision|0|||
163050217|NCT05067972|588891006|FG000|Part 1: Follow-up|Death|1|||
163050218|NCT05067972|588891007|FG001|Part 1: Follow-up|Death|2|||
163050219|NCT05067972|588891008|FG002|Part 1: Follow-up|Death|1|||
163050220|NCT05067972|588891009|FG003|Part 1: Follow-up|Death|0|||
163050221|NCT05067972|588891010|FG004|Part 1: Follow-up|Death|1|||
163050222|NCT05067972|588891011|FG005|Part 1: Follow-up|Death|0|||
163050223|NCT05067972|588891012|FG006|Part 1: Follow-up|Death|1|||
163050224|NCT04391842|588891014|FG000|Overall Study|Withdrawal by Subject|2|||
163050225|NCT00810199|588891015|FG000|Overall Study|Adverse Event|24|||
163050226|NCT00810199|588891016|FG001|Overall Study|Adverse Event|26|||
163050227|NCT00810199|588891015|FG000|Overall Study|Death|4|||
163050228|NCT00810199|588891016|FG001|Overall Study|Death|6|||
163050229|NCT00810199|588891015|FG000|Overall Study|Withdrew consent|9|||
163050230|NCT00810199|588891016|FG001|Overall Study|Withdrew consent|12|||
163050231|NCT00810199|588891015|FG000|Overall Study|Insufficient therapeutic response|5|||
163050232|NCT00810199|588891016|FG001|Overall Study|Insufficient therapeutic response|14|||
163050233|NCT00810199|588891015|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
163050234|NCT00810199|588891016|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
163050235|NCT00810199|588891015|FG000|Overall Study|Administrative/Other|5|||
162884200|NCT00205699|588274524|FG000|Overall Study|Lost to Follow-up|1|||
162884201|NCT00205699|588274525|FG001|Overall Study|Lost to Follow-up|3|||
162884202|NCT00205699|588274526|FG002|Overall Study|Lost to Follow-up|5|||
162884203|NCT00205699|588274524|FG000|Overall Study|Adverse Event|1|||
163050236|NCT00810199|588891016|FG001|Overall Study|Administrative/Other|6|||
163050237|NCT00810199|588891015|FG000|Overall Study|Protocol Violation|2|||
163050238|NCT00810199|588891016|FG001|Overall Study|Protocol Violation|6|||
163050239|NCT00810199|588891015|FG000|Overall Study|Failure to return|1|||
163050240|NCT00810199|588891016|FG001|Overall Study|Failure to return|4|||
163050241|NCT00810199|588891015|FG000|Overall Study|Did not receive study drug|2|||
162616855|NCT00299182|587315105|FG000|Overall Study|Withdrawal by Subject|0|||
162616856|NCT00299182|587315106|FG001|Overall Study|Withdrawal by Subject|0|||
162616857|NCT00299182|587315107|FG002|Overall Study|Withdrawal by Subject|1|||
162616858|NCT00299182|587315108|FG003|Overall Study|Withdrawal by Subject|0|||
162616859|NCT00299182|587315109|FG004|Overall Study|Withdrawal by Subject|1|||
162884204|NCT00205699|588274525|FG001|Overall Study|Adverse Event|0|||
163050242|NCT00810199|588891016|FG001|Overall Study|Did not receive study drug|1|||
163050243|NCT00992017|588891017|FG000|Overall Study|Lost to Follow-up|2|||
163050244|NCT00992017|588891017|FG000|Overall Study|Withdrawal by Subject|2|||
163050245|NCT00992017|588891017|FG000|Overall Study|Unable to get to clinic|5|||
163050246|NCT00992017|588891017|FG000|Overall Study|Not adhere to study requirements|1|||
163050247|NCT01691378|588891018|FG000|Overall Study|Withdrawal by Subject|2|||
163050248|NCT01691378|588891019|FG001|Overall Study|Withdrawal by Subject|0|||
163050249|NCT01691378|588891018|FG000|Overall Study|Lost to Follow-up|5|||
163050250|NCT01691378|588891019|FG001|Overall Study|Lost to Follow-up|2|||
163050251|NCT04877990|588891024|FG000|Treatment|Other reasons|3|||
163050252|NCT04877990|588891025|FG001|Treatment|Other reasons|1|||
163050253|NCT04877990|588891024|FG000|Treatment|Administrative reasons by sponsor|17|||
163050254|NCT04877990|588891025|FG001|Treatment|Administrative reasons by sponsor|33|||
163050255|NCT04877990|588891024|FG000|Treatment|Withdrawal by Subject|2|||
163050256|NCT04877990|588891025|FG001|Treatment|Withdrawal by Subject|6|||
163050257|NCT04877990|588891024|FG000|Treatment|Adverse Event|2|||
162884205|NCT00205699|588274526|FG002|Overall Study|Adverse Event|0|||
162884206|NCT00205699|588274524|FG000|Overall Study|Withdrawal by Subject|1|||
162884207|NCT00205699|588274525|FG001|Overall Study|Withdrawal by Subject|2|||
162884208|NCT00205699|588274526|FG002|Overall Study|Withdrawal by Subject|1|||
162884209|NCT00205699|588274524|FG000|Overall Study|Lack of Efficacy|0|||
162884210|NCT00205699|588274525|FG001|Overall Study|Lack of Efficacy|1|||
162884211|NCT00205699|588274526|FG002|Overall Study|Lack of Efficacy|0|||
162884212|NCT01957709|588274527|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
163050258|NCT04877990|588891025|FG001|Treatment|Adverse Event|1|||
163050259|NCT04235504|588891026|FG000|Study Phase|Withdrawal by Subject|5|||
163050260|NCT04235504|588891027|FG001|Study Phase|Withdrawal by Subject|2|||
163050261|NCT04235504|588891028|FG002|Study Phase|Withdrawal by Subject|0|||
162884213|NCT03587584|588274528|FG000|Overall Study|SOC deviations|4|||
162884214|NCT03587584|588274529|FG001|Overall Study|SOC deviations|6|||
162884215|NCT03587584|588274528|FG000|Overall Study|Incomplete data|0|||
162884216|NCT03587584|588274529|FG001|Overall Study|Incomplete data|3|||
162884217|NCT00830115|588274530|FG000|Overall Study|Adverse Event|2|||
163050262|NCT04235504|588891029|FG003|Study Phase|Withdrawal by Subject|0|||
163050263|NCT04235504|588891026|FG000|Continuation Phase|Withdrawal by Subject|0|||
163050264|NCT04235504|588891027|FG001|Continuation Phase|Withdrawal by Subject|4|||
163050265|NCT04235504|588891028|FG002|Continuation Phase|Withdrawal by Subject|0|||
163050266|NCT04235504|588891029|FG003|Continuation Phase|Withdrawal by Subject|0|||
162884218|NCT00830115|588274530|FG000|Overall Study|Improvement/recovery|1|||
162884219|NCT01207388|588274537|FG000|Overall Study|Death|67|||
162884220|NCT01207388|588274537|FG000|Overall Study|Withdrawal by Subject|1|||
162884221|NCT01677507|588274538|FG000|Initial Assignment|Adverse Event|0|||
162884222|NCT01677507|588274539|FG001|Initial Assignment|Adverse Event|1|||
162884223|NCT01677507|588274538|FG000|Initial Assignment|Protocol Violation|0|||
162884224|NCT01677507|588274539|FG001|Initial Assignment|Protocol Violation|1|||
162884225|NCT01677507|588274538|FG000|Second Assigment|Withdrawal by Subject|2|||
162884226|NCT01677507|588274539|FG001|Second Assigment|Withdrawal by Subject|2|||
162884227|NCT01677507|588274538|FG000|Second Assigment|Adverse Event|1|||
163050267|NCT04235504|588891026|FG000|Continuation Phase|Adverse Event|0|||
163050268|NCT04235504|588891027|FG001|Continuation Phase|Adverse Event|1|||
163050269|NCT04235504|588891028|FG002|Continuation Phase|Adverse Event|0|||
163050270|NCT04235504|588891029|FG003|Continuation Phase|Adverse Event|0|||
162884228|NCT01677507|588274539|FG001|Second Assigment|Adverse Event|3|||
162884229|NCT00469209|588274540|FG000|Overall Study|Adverse Event|1|||
162884230|NCT00469209|588274541|FG001|Overall Study|Adverse Event|0|||
163050271|NCT04235504|588891026|FG000|Continuation Phase|Physician Decision|1|||
162884231|NCT00469209|588274542|FG002|Overall Study|Adverse Event|1|||
162884232|NCT01586156|588274545|FG000|Overall Study|Pregnancy|0|||
162884233|NCT01586156|588274546|FG001|Overall Study|Pregnancy|1|||
162884234|NCT01586156|588274547|FG002|Overall Study|Pregnancy|0|||
162884235|NCT04465396|588274548|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
162884236|NCT04465396|588274549|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
162884237|NCT04465396|588274550|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
162884238|NCT04465396|588274551|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
162884239|NCT00349752|588274553|FG000|Overall Study|Adverse Event|8|||
162884240|NCT00349752|588274554|FG001|Overall Study|Adverse Event|12|||
162884241|NCT00349752|588274553|FG000|Overall Study|Lack of Efficacy|37|||
162884242|NCT00349752|588274554|FG001|Overall Study|Lack of Efficacy|42|||
162884243|NCT00349752|588274553|FG000|Overall Study|Lost to Follow-up|4|||
162884244|NCT00349752|588274554|FG001|Overall Study|Lost to Follow-up|2|||
162884245|NCT00349752|588274553|FG000|Overall Study|Personal reasons|6|||
162884246|NCT00349752|588274554|FG001|Overall Study|Personal reasons|5|||
162963047|NCT00263588|588564728|FG001|Overall Study|Investigator decision|15|||
162963048|NCT00263588|588564727|FG000|Overall Study|Sponsor terminated study|0|||
162963049|NCT00263588|588564728|FG001|Overall Study|Sponsor terminated study|1|||
162963050|NCT02622386|588564735|FG000|First Assignment|Withdrawal by Subject|3|||
162963051|NCT02622386|588564736|FG001|First Assignment|Withdrawal by Subject|2|||
162963052|NCT02622386|588564735|FG000|Washout|Withdrawal by Subject|4|||
162963053|NCT02622386|588564736|FG001|Washout|Withdrawal by Subject|4|||
162963054|NCT02622386|588564735|FG000|Second Assignment|Withdrawal by Subject|0|||
162963055|NCT02622386|588564736|FG001|Second Assignment|Withdrawal by Subject|2|||
162963056|NCT05274763|588564738|FG000|Overall Study|Lost to Follow-up|1|||
162963057|NCT01075282|588564740|FG000|Overall Study|Withdrawal by Subject|11|||
162963058|NCT01075282|588564741|FG001|Overall Study|Withdrawal by Subject|7|||
162963059|NCT01075282|588564742|FG002|Overall Study|Withdrawal by Subject|11|||
162963060|NCT01075282|588564740|FG000|Overall Study|Adverse Event|9|||
162963061|NCT01075282|588564741|FG001|Overall Study|Adverse Event|8|||
162963062|NCT01075282|588564742|FG002|Overall Study|Adverse Event|5|||
162963063|NCT01075282|588564740|FG000|Overall Study|Entry Criteria Not Met|3|||
162963064|NCT01075282|588564741|FG001|Overall Study|Entry Criteria Not Met|2|||
162963065|NCT01075282|588564742|FG002|Overall Study|Entry Criteria Not Met|0|||
162963066|NCT01075282|588564740|FG000|Overall Study|Lost to Follow-up|3|||
162963067|NCT01075282|588564741|FG001|Overall Study|Lost to Follow-up|3|||
162963068|NCT01075282|588564742|FG002|Overall Study|Lost to Follow-up|3|||
162963069|NCT01075282|588564740|FG000|Overall Study|Physician Decision|3|||
162963070|NCT01075282|588564741|FG001|Overall Study|Physician Decision|3|||
162963071|NCT01075282|588564742|FG002|Overall Study|Physician Decision|3|||
162963072|NCT01075282|588564740|FG000|Overall Study|Lack of Efficacy|1|||
162963073|NCT01075282|588564741|FG001|Overall Study|Lack of Efficacy|1|||
162963074|NCT01075282|588564742|FG002|Overall Study|Lack of Efficacy|0|||
162963075|NCT01075282|588564740|FG000|Overall Study|Treatment Non-compliance|1|||
162963076|NCT01075282|588564741|FG001|Overall Study|Treatment Non-compliance|2|||
162963077|NCT01075282|588564742|FG002|Overall Study|Treatment Non-compliance|2|||
162963078|NCT01075282|588564740|FG000|Overall Study|Protocol Violation|0|||
162963079|NCT01075282|588564741|FG001|Overall Study|Protocol Violation|2|||
162963080|NCT01075282|588564742|FG002|Overall Study|Protocol Violation|1|||
162963081|NCT01075282|588564740|FG000|Overall Study|Death|0|||
162963082|NCT01075282|588564741|FG001|Overall Study|Death|1|||
162963083|NCT01075282|588564742|FG002|Overall Study|Death|2|||
162963084|NCT00367133|588564743|FG000|2 Years|Death|20|||
162963085|NCT00367133|588564744|FG001|2 Years|Death|12|||
162963086|NCT00367133|588564745|FG002|2 Years|Death|12|||
162963087|NCT00367133|588564743|FG000|2 Years|Dropped|34|||
162963088|NCT00367133|588564744|FG001|2 Years|Dropped|19|||
162963089|NCT00367133|588564745|FG002|2 Years|Dropped|33|||
162963090|NCT00367133|588564743|FG000|2 Years|Missed visit|4|||
162963091|NCT00367133|588564744|FG001|2 Years|Missed visit|5|||
162963092|NCT00367133|588564745|FG002|2 Years|Missed visit|4|||
162963093|NCT00847535|588564746|FG000|Overall Study|Withdrawal by Subject|2|||
162963094|NCT00847535|588564747|FG001|Overall Study|Withdrawal by Subject|1|||
162963095|NCT00847535|588564748|FG002|Overall Study|Withdrawal by Subject|1|||
162963096|NCT00847535|588564746|FG000|Overall Study|Lost to Follow-up|0|||
162963097|NCT00847535|588564747|FG001|Overall Study|Lost to Follow-up|1|||
162963098|NCT00847535|588564748|FG002|Overall Study|Lost to Follow-up|0|||
162963099|NCT00906399|588564749|FG000|Year 1|Randomized But Not Treated|0|||
162884247|NCT00349752|588274553|FG000|Overall Study|Other: Required exclusionary medication|0|||
162884248|NCT00349752|588274554|FG001|Overall Study|Other: Required exclusionary medication|1|||
162963100|NCT00906399|588564750|FG001|Year 1|Randomized But Not Treated|1|||
162963101|NCT00906399|588564751|FG002|Year 1|Randomized But Not Treated|3|||
162963102|NCT00906399|588564752|FG003|Year 1|Randomized But Not Treated|0|||
162963103|NCT00906399|588564753|FG004|Year 1|Randomized But Not Treated|0|||
162963104|NCT00906399|588564754|FG005|Year 1|Randomized But Not Treated|0|||
162963105|NCT00906399|588564755|FG006|Year 1|Randomized But Not Treated|0|||
162616860|NCT00299182|587315110|FG005|Overall Study|Withdrawal by Subject|2|||
162884249|NCT00349752|588274553|FG000|Overall Study|Other: Non compliance|0|||
162884250|NCT00349752|588274554|FG001|Overall Study|Other: Non compliance|1|||
162884251|NCT00349752|588274553|FG000|Overall Study|Other: Patient stopped steroids|0|||
162884252|NCT00349752|588274554|FG001|Overall Study|Other: Patient stopped steroids|1|||
162884253|NCT00349752|588274553|FG000|Overall Study|Other: Patient's steroid use|1|||
162884254|NCT00349752|588274554|FG001|Overall Study|Other: Patient's steroid use|0|||
162884255|NCT00349752|588274553|FG000|Overall Study|Other: Ineligible|1|||
162884256|NCT00349752|588274554|FG001|Overall Study|Other: Ineligible|0|||
162884257|NCT00349752|588274553|FG000|Overall Study|Other: Inadvertently unblinded|1|||
162884258|NCT00349752|588274554|FG001|Overall Study|Other: Inadvertently unblinded|0|||
162884259|NCT00349752|588274553|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
162884260|NCT00349752|588274554|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
162884261|NCT05294211|588274555|FG000|Overall Study|Withdrawal by Subject|3|||
162884262|NCT05294211|588274555|FG000|Overall Study|Physician Decision|2|||
162884263|NCT05294211|588274555|FG000|Overall Study|Progressed to active labor|1|||
162884264|NCT05294211|588274555|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
162884265|NCT05294211|588274555|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
162884266|NCT01842607|588274557|FG000|Overall Study|Adverse Event|11|||
162884267|NCT01842607|588274557|FG000|Overall Study|Lack of Efficacy|19|||
162884268|NCT01842607|588274557|FG000|Overall Study|Protocol Violation|8|||
162884269|NCT01842607|588274557|FG000|Overall Study|Protocol defined stopping criteria|2|||
162884270|NCT01842607|588274557|FG000|Overall Study|Lost to Follow-up|3|||
162884271|NCT01842607|588274557|FG000|Overall Study|Physician Decision|9|||
162884272|NCT01842607|588274557|FG000|Overall Study|Withdrawal by Subject|14|||
162884273|NCT00012012|588274558|FG000|Overall Study|Protocol Violation|1|||
162884274|NCT00012012|588274559|FG001|Overall Study|Protocol Violation|1|||
162884275|NCT00012012|588274558|FG000|Overall Study|Withdrawal by Subject|0|||
162884276|NCT00012012|588274559|FG001|Overall Study|Withdrawal by Subject|2|||
162884277|NCT02159469|588274560|FG000|Overall Study|Missing Completion status|1|||
162884278|NCT02159469|588274560|FG000|Overall Study|Adverse Event|5|||
162884279|NCT02159469|588274560|FG000|Overall Study|Non-compliance|2|||
162884280|NCT02159469|588274560|FG000|Overall Study|Withdrawal by Subject|9|||
162884281|NCT02159469|588274560|FG000|Overall Study|Lost to Follow-up|1|||
162884282|NCT02159469|588274560|FG000|Overall Study|Sponsor's request|2|||
162884283|NCT02159469|588274560|FG000|Overall Study|Met Stopping Criteria|3|||
162884284|NCT02159469|588274560|FG000|Overall Study|Other|1|||
162884285|NCT02159469|588274560|FG000|Overall Study|Multiple|29|||
162884286|NCT03629041|588274566|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
162884287|NCT03629041|588274567|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
162884288|NCT03629041|588274568|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
162884289|NCT03629041|588274569|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
162884290|NCT03730194|588274570|FG000|First Stage Treatment|Withdrawal by Subject|1|||
162884291|NCT03730194|588274571|FG001|First Stage Treatment|Withdrawal by Subject|1|||
162884292|NCT03730194|588274572|FG002|First Stage Treatment|Withdrawal by Subject|0|||
162884293|NCT03730194|588274573|FG003|First Stage Treatment|Withdrawal by Subject|0|||
162884294|NCT03730194|588274574|FG004|First Stage Treatment|Withdrawal by Subject|0|||
162884295|NCT03730194|588274575|FG005|First Stage Treatment|Withdrawal by Subject|0|||
162884296|NCT03730194|588274570|FG000|First Stage Treatment|Protocol Violation|3|||
162884297|NCT03730194|588274571|FG001|First Stage Treatment|Protocol Violation|3|||
162884298|NCT03730194|588274572|FG002|First Stage Treatment|Protocol Violation|0|||
162884299|NCT03730194|588274573|FG003|First Stage Treatment|Protocol Violation|0|||
162884300|NCT03730194|588274574|FG004|First Stage Treatment|Protocol Violation|0|||
162884301|NCT03730194|588274575|FG005|First Stage Treatment|Protocol Violation|0|||
162884302|NCT01766817|588274578|FG000|Overall Study|Drug-related adverse event|1|||
162884303|NCT01766817|588274579|FG001|Overall Study|Drug-related adverse event|2|||
162884304|NCT01766817|588274580|FG002|Overall Study|Drug-related adverse event|1|||
162884305|NCT01766817|588274578|FG000|Overall Study|Drug-unrelated adverse event|3|||
162963106|NCT00906399|588564749|FG000|Year 1|Adverse Event|4|||
162963107|NCT00906399|588564750|FG001|Year 1|Adverse Event|22|||
162963108|NCT00906399|588564751|FG002|Year 1|Adverse Event|24|||
162963109|NCT00906399|588564752|FG003|Year 1|Adverse Event|0|||
162616861|NCT00299182|587315111|FG006|Overall Study|Withdrawal by Subject|0|||
162884306|NCT01766817|588274579|FG001|Overall Study|Drug-unrelated adverse event|3|||
162884307|NCT01766817|588274580|FG002|Overall Study|Drug-unrelated adverse event|3|||
162884308|NCT01766817|588274578|FG000|Overall Study|Death|1|||
162884309|NCT01766817|588274579|FG001|Overall Study|Death|1|||
162884310|NCT01766817|588274580|FG002|Overall Study|Death|0|||
162884311|NCT01766817|588274578|FG000|Overall Study|Unable to take study drug|0|||
162884312|NCT01766817|588274579|FG001|Overall Study|Unable to take study drug|1|||
162884313|NCT01766817|588274580|FG002|Overall Study|Unable to take study drug|0|||
162884314|NCT01766817|588274578|FG000|Overall Study|Withdrawal by Subject|2|||
162884315|NCT01766817|588274579|FG001|Overall Study|Withdrawal by Subject|0|||
162963110|NCT00906399|588564753|FG004|Year 1|Adverse Event|0|||
162963111|NCT00906399|588564754|FG005|Year 1|Adverse Event|0|||
163050272|NCT04235504|588891027|FG001|Continuation Phase|Physician Decision|2|||
163050273|NCT04235504|588891028|FG002|Continuation Phase|Physician Decision|1|||
163050274|NCT04235504|588891029|FG003|Continuation Phase|Physician Decision|0|||
163050275|NCT04888494|588891031|FG000|Overall Study|Lost to Follow-up|2|||
163050276|NCT04888494|588891032|FG001|Overall Study|Lost to Follow-up|3|||
163050277|NCT04888494|588891031|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
163050278|NCT04888494|588891032|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
163050279|NCT00565604|588891034|FG000|Overall Study|Failure to treat|2|||
163050280|NCT00565604|588891034|FG000|Overall Study|Lost to Follow-up|2|||
163050281|NCT03652818|588893506|FG000|Overall Study|Adverse Event|1|||
163050282|NCT03652818|588893507|FG001|Overall Study|Adverse Event|0|||
163050283|NCT03652818|588893508|FG002|Overall Study|Adverse Event|0|||
163050284|NCT03652818|588893509|FG003|Overall Study|Adverse Event|0|||
163050285|NCT03652818|588893510|FG004|Overall Study|Adverse Event|0|||
163050286|NCT03652818|588893506|FG000|Overall Study|Physician Decision|1|||
163050287|NCT03652818|588893507|FG001|Overall Study|Physician Decision|0|||
163050288|NCT03652818|588893508|FG002|Overall Study|Physician Decision|0|||
163050289|NCT03652818|588893509|FG003|Overall Study|Physician Decision|0|||
163050290|NCT03652818|588893510|FG004|Overall Study|Physician Decision|0|||
163050291|NCT03652818|588893506|FG000|Overall Study|Lost to Follow-up|0|||
163050292|NCT03652818|588893507|FG001|Overall Study|Lost to Follow-up|1|||
163050293|NCT03652818|588893508|FG002|Overall Study|Lost to Follow-up|2|||
163050294|NCT03652818|588893509|FG003|Overall Study|Lost to Follow-up|1|||
163050295|NCT03652818|588893510|FG004|Overall Study|Lost to Follow-up|1|||
163050296|NCT01699750|588893516|FG000|Overall Study|Withdrew Consent|0|||
163050297|NCT01699750|588893517|FG001|Overall Study|Withdrew Consent|1|||
163050298|NCT01699750|588893516|FG000|Overall Study|Other|0|||
163050299|NCT01699750|588893517|FG001|Overall Study|Other|2|||
163050300|NCT01868646|588893520|FG000|Overall Study|Do not meet inclusion criteria|3|||
163050301|NCT01868646|588893521|FG001|Overall Study|Do not meet inclusion criteria|5|||
163050302|NCT01831427|588893522|FG000|Overall Study|Adverse Event|0|||
163050303|NCT01831427|588893523|FG001|Overall Study|Adverse Event|1|||
163050304|NCT01831427|588893524|FG002|Overall Study|Adverse Event|0|||
163050305|NCT01831427|588893525|FG003|Overall Study|Adverse Event|0|||
163050306|NCT01831427|588893526|FG004|Overall Study|Adverse Event|0|||
163050307|NCT01831427|588893527|FG005|Overall Study|Adverse Event|1|||
163050308|NCT01831427|588893528|FG006|Overall Study|Adverse Event|0|||
163050309|NCT01831427|588893529|FG007|Overall Study|Adverse Event|1|||
163050310|NCT01831427|588893530|FG008|Overall Study|Adverse Event|0|||
163050311|NCT01831427|588893531|FG009|Overall Study|Adverse Event|0|||
163050312|NCT01831427|588893532|FG010|Overall Study|Adverse Event|2|||
163050313|NCT01831427|588893522|FG000|Overall Study|Investigator's Discretion|0|||
162884316|NCT01766817|588274580|FG002|Overall Study|Withdrawal by Subject|3|||
162884317|NCT01766817|588274578|FG000|Overall Study|Subject non-compliance|0|||
162884318|NCT01766817|588274579|FG001|Overall Study|Subject non-compliance|1|||
162884319|NCT01766817|588274580|FG002|Overall Study|Subject non-compliance|2|||
162884320|NCT01766817|588274578|FG000|Overall Study|Physician Decision|3|||
162884321|NCT01766817|588274579|FG001|Overall Study|Physician Decision|3|||
162884322|NCT01766817|588274580|FG002|Overall Study|Physician Decision|4|||
162884323|NCT01766817|588274578|FG000|Overall Study|Other|1|||
163050314|NCT01831427|588893523|FG001|Overall Study|Investigator's Discretion|0|||
163050315|NCT01831427|588893524|FG002|Overall Study|Investigator's Discretion|0|||
163050316|NCT01831427|588893525|FG003|Overall Study|Investigator's Discretion|1|||
163050317|NCT01831427|588893526|FG004|Overall Study|Investigator's Discretion|0|||
163050318|NCT01831427|588893527|FG005|Overall Study|Investigator's Discretion|0|||
163050319|NCT01831427|588893528|FG006|Overall Study|Investigator's Discretion|0|||
163050320|NCT01831427|588893529|FG007|Overall Study|Investigator's Discretion|0|||
162884324|NCT01766817|588274579|FG001|Overall Study|Other|0|||
162884325|NCT01766817|588274580|FG002|Overall Study|Other|0|||
162884326|NCT03814590|588274581|FG000|Overall Study|Adverse Event|0|||
162884327|NCT03814590|588274582|FG001|Overall Study|Adverse Event|0|||
162884328|NCT03814590|588274583|FG002|Overall Study|Adverse Event|0|||
162884329|NCT03814590|588274584|FG003|Overall Study|Adverse Event|0|||
163050321|NCT01831427|588893530|FG008|Overall Study|Investigator's Discretion|0|||
163050322|NCT01831427|588893531|FG009|Overall Study|Investigator's Discretion|0|||
163050323|NCT01831427|588893532|FG010|Overall Study|Investigator's Discretion|0|||
163050324|NCT01831427|588893522|FG000|Overall Study|Withdrew Consent|0|||
163050325|NCT01831427|588893523|FG001|Overall Study|Withdrew Consent|0|||
163050326|NCT01831427|588893524|FG002|Overall Study|Withdrew Consent|0|||
163050327|NCT01831427|588893525|FG003|Overall Study|Withdrew Consent|0|||
163050328|NCT01831427|588893526|FG004|Overall Study|Withdrew Consent|0|||
163050329|NCT01831427|588893527|FG005|Overall Study|Withdrew Consent|0|||
163050330|NCT01831427|588893528|FG006|Overall Study|Withdrew Consent|2|||
162884330|NCT03814590|588274585|FG004|Overall Study|Adverse Event|0|||
162884331|NCT03814590|588274586|FG005|Overall Study|Adverse Event|1|||
162884332|NCT03814590|588274587|FG006|Overall Study|Adverse Event|1|||
162884333|NCT03814590|588274588|FG007|Overall Study|Adverse Event|1|||
162884334|NCT03814590|588274589|FG008|Overall Study|Adverse Event|0|||
162884335|NCT03814590|588274590|FG009|Overall Study|Adverse Event|0|||
162884336|NCT03814590|588274591|FG010|Overall Study|Adverse Event|1|||
162884337|NCT03814590|588274592|FG011|Overall Study|Adverse Event|0|||
162884338|NCT03814590|588274593|FG012|Overall Study|Adverse Event|3|||
162884339|NCT03814590|588274594|FG013|Overall Study|Adverse Event|0|||
162884340|NCT03814590|588274581|FG000|Overall Study|Lost to Follow-up|0|||
162884341|NCT03814590|588274582|FG001|Overall Study|Lost to Follow-up|2|||
162884342|NCT03814590|588274583|FG002|Overall Study|Lost to Follow-up|1|||
162884343|NCT03814590|588274584|FG003|Overall Study|Lost to Follow-up|0|||
162884344|NCT03814590|588274585|FG004|Overall Study|Lost to Follow-up|1|||
162884345|NCT03814590|588274586|FG005|Overall Study|Lost to Follow-up|1|||
162884346|NCT03814590|588274587|FG006|Overall Study|Lost to Follow-up|1|||
162884347|NCT03814590|588274588|FG007|Overall Study|Lost to Follow-up|1|||
162884348|NCT03814590|588274589|FG008|Overall Study|Lost to Follow-up|0|||
162884349|NCT03814590|588274590|FG009|Overall Study|Lost to Follow-up|0|||
163050331|NCT01831427|588893529|FG007|Overall Study|Withdrew Consent|0|||
162707960|NCT01605136|587640645|FG000|Study Period|Lost to Follow-up|0|||
162884350|NCT03814590|588274591|FG010|Overall Study|Lost to Follow-up|1|||
162884351|NCT03814590|588274592|FG011|Overall Study|Lost to Follow-up|0|||
162884352|NCT03814590|588274593|FG012|Overall Study|Lost to Follow-up|0|||
162884353|NCT03814590|588274594|FG013|Overall Study|Lost to Follow-up|1|||
162884354|NCT03814590|588274581|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884355|NCT03814590|588274582|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884356|NCT03814590|588274583|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884357|NCT03814590|588274584|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884358|NCT03814590|588274585|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884359|NCT03814590|588274586|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884360|NCT03814590|588274587|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884361|NCT03814590|588274588|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884362|NCT03814590|588274589|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884363|NCT03814590|588274590|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
162884364|NCT03814590|588274591|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884365|NCT03814590|588274592|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884366|NCT03814590|588274593|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884367|NCT03814590|588274594|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
162884368|NCT03814590|588274581|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884369|NCT03814590|588274582|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884370|NCT03814590|588274583|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884371|NCT03814590|588274584|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884372|NCT03814590|588274585|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884373|NCT03814590|588274586|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
162884374|NCT03814590|588274587|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
162884375|NCT03814590|588274588|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
162884376|NCT03814590|588274589|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884377|NCT03814590|588274590|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
162884378|NCT03814590|588274591|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
162884379|NCT03814590|588274592|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
162884380|NCT03814590|588274593|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
162884381|NCT03814590|588274594|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
162884382|NCT03814590|588274581|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884383|NCT03814590|588274582|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884384|NCT03814590|588274583|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884385|NCT03814590|588274584|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884386|NCT03814590|588274585|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163050332|NCT01831427|588893530|FG008|Overall Study|Withdrew Consent|0|||
162884387|NCT03814590|588274586|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884388|NCT03814590|588274587|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884389|NCT03814590|588274588|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162884390|NCT03814590|588274589|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884391|NCT03814590|588274590|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162884392|NCT03814590|588274591|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884393|NCT03814590|588274592|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884394|NCT03814590|588274593|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884395|NCT03814590|588274594|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162884396|NCT03814590|588274581|FG000|Overall Study|UNKNOWN REASON|0|||
162884397|NCT03814590|588274582|FG001|Overall Study|UNKNOWN REASON|0|||
162884398|NCT03814590|588274583|FG002|Overall Study|UNKNOWN REASON|0|||
162884399|NCT03814590|588274584|FG003|Overall Study|UNKNOWN REASON|0|||
162884400|NCT03814590|588274585|FG004|Overall Study|UNKNOWN REASON|0|||
162884401|NCT03814590|588274586|FG005|Overall Study|UNKNOWN REASON|0|||
162884402|NCT03814590|588274587|FG006|Overall Study|UNKNOWN REASON|0|||
162884403|NCT03814590|588274588|FG007|Overall Study|UNKNOWN REASON|1|||
162884404|NCT03814590|588274589|FG008|Overall Study|UNKNOWN REASON|0|||
162884405|NCT03814590|588274590|FG009|Overall Study|UNKNOWN REASON|0|||
162884406|NCT03814590|588274591|FG010|Overall Study|UNKNOWN REASON|0|||
162884407|NCT03814590|588274592|FG011|Overall Study|UNKNOWN REASON|0|||
162884408|NCT03814590|588274593|FG012|Overall Study|UNKNOWN REASON|0|||
162884409|NCT03814590|588274594|FG013|Overall Study|UNKNOWN REASON|0|||
162884410|NCT03519516|588274597|FG000|Overall Study|Adverse Event|0|||
162884411|NCT03519516|588274598|FG001|Overall Study|Adverse Event|1|||
162884412|NCT01244191|588274601|FG000|Overall Study|Progressive disease|295|||
162884413|NCT01244191|588274602|FG001|Overall Study|Progressive disease|350|||
162884414|NCT01244191|588274601|FG000|Overall Study|Clinical disease progression|54|||
162884415|NCT01244191|588274602|FG001|Overall Study|Clinical disease progression|36|||
162884416|NCT01244191|588274601|FG000|Overall Study|Adverse Event|65|||
162884417|NCT01244191|588274602|FG001|Overall Study|Adverse Event|48|||
162884418|NCT01244191|588274601|FG000|Overall Study|Death|22|||
162884419|NCT01244191|588274602|FG001|Overall Study|Death|29|||
162884420|NCT01244191|588274601|FG000|Overall Study|Lost to Follow-up|0|||
162884421|NCT01244191|588274602|FG001|Overall Study|Lost to Follow-up|2|||
162884422|NCT01244191|588274601|FG000|Overall Study|Protocol Violation|1|||
162884423|NCT01244191|588274602|FG001|Overall Study|Protocol Violation|2|||
162884424|NCT01244191|588274601|FG000|Overall Study|Withdrawal by Subject|31|||
162884425|NCT01244191|588274602|FG001|Overall Study|Withdrawal by Subject|23|||
162884426|NCT01244191|588274601|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
162884427|NCT01244191|588274602|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
162884428|NCT01752842|588274603|FG000|Overall Study|Adverse Event|3|||
162884429|NCT01752842|588274604|FG001|Overall Study|Adverse Event|0|||
162884430|NCT01752842|588274603|FG000|Overall Study|Withdrawal by Subject|0|||
162884431|NCT01752842|588274604|FG001|Overall Study|Withdrawal by Subject|2|||
162884432|NCT02164513|588274605|FG000|Overall Study|Adverse Event|162|||
162884433|NCT02164513|588274606|FG001|Overall Study|Adverse Event|180|||
162884434|NCT02164513|588274607|FG002|Overall Study|Adverse Event|111|||
162884435|NCT02164513|588274605|FG000|Overall Study|Other: Study Closed or terminated|5|||
162884436|NCT02164513|588274606|FG001|Overall Study|Other: Study Closed or terminated|2|||
162884437|NCT02164513|588274607|FG002|Overall Study|Other: Study Closed or terminated|4|||
162884438|NCT02164513|588274605|FG000|Overall Study|Lost to Follow-up|30|||
162884439|NCT02164513|588274606|FG001|Overall Study|Lost to Follow-up|36|||
162884440|NCT02164513|588274607|FG002|Overall Study|Lost to Follow-up|22|||
162884441|NCT02164513|588274605|FG000|Overall Study|Physician Decision|47|||
162884442|NCT02164513|588274606|FG001|Overall Study|Physician Decision|57|||
162884443|NCT02164513|588274607|FG002|Overall Study|Physician Decision|28|||
162884444|NCT02164513|588274605|FG000|Overall Study|Withdrawal by Subject|192|||
162884445|NCT02164513|588274606|FG001|Overall Study|Withdrawal by Subject|261|||
162884446|NCT02164513|588274607|FG002|Overall Study|Withdrawal by Subject|130|||
162884447|NCT02164513|588274605|FG000|Overall Study|Other: Reason not provided by site|1|||
162884448|NCT02164513|588274606|FG001|Overall Study|Other: Reason not provided by site|0|||
162884449|NCT02164513|588274607|FG002|Overall Study|Other: Reason not provided by site|0|||
162884450|NCT05301322|588274608|FG000|Overall Study|Adverse Event|7|||
162963112|NCT00906399|588564755|FG006|Year 1|Adverse Event|0|||
162963113|NCT00906399|588564749|FG000|Year 1|Lost to Follow-up|4|||
162963114|NCT00906399|588564750|FG001|Year 1|Lost to Follow-up|4|||
162963115|NCT00906399|588564751|FG002|Year 1|Lost to Follow-up|2|||
162884451|NCT05301322|588274609|FG001|Overall Study|Adverse Event|3|||
162963116|NCT00906399|588564752|FG003|Year 1|Lost to Follow-up|0|||
162884452|NCT05301322|588274608|FG000|Overall Study|Death|0|||
162884453|NCT05301322|588274609|FG001|Overall Study|Death|1|||
162884454|NCT05301322|588274608|FG000|Overall Study|Lost to Follow-up|2|||
162884455|NCT05301322|588274609|FG001|Overall Study|Lost to Follow-up|1|||
162884456|NCT05301322|588274608|FG000|Overall Study|Protocol Violation|3|||
162884457|NCT05301322|588274609|FG001|Overall Study|Protocol Violation|1|||
162884458|NCT05301322|588274608|FG000|Overall Study|Withdrawal by Subject|3|||
162884459|NCT05301322|588274609|FG001|Overall Study|Withdrawal by Subject|0|||
162884460|NCT05301322|588274608|FG000|Overall Study|Other|4|||
162884461|NCT05301322|588274609|FG001|Overall Study|Other|0|||
162884462|NCT04971785|588274610|FG000|Overall Study|Withdrew Consent|5|||
162884463|NCT04971785|588274611|FG001|Overall Study|Withdrew Consent|5|||
162884464|NCT04971785|588274612|FG002|Overall Study|Withdrew Consent|17|||
162884465|NCT04971785|588274613|FG003|Overall Study|Withdrew Consent|7|||
162884466|NCT04971785|588274610|FG000|Overall Study|Adverse Event|7|||
162884467|NCT04971785|588274611|FG001|Overall Study|Adverse Event|8|||
162884468|NCT04971785|588274612|FG002|Overall Study|Adverse Event|6|||
162884469|NCT04971785|588274613|FG003|Overall Study|Adverse Event|3|||
162884470|NCT04971785|588274610|FG000|Overall Study|Lost to Follow-up|2|||
162884471|NCT04971785|588274611|FG001|Overall Study|Lost to Follow-up|1|||
162884472|NCT04971785|588274612|FG002|Overall Study|Lost to Follow-up|6|||
162884473|NCT04971785|588274613|FG003|Overall Study|Lost to Follow-up|7|||
162884474|NCT04971785|588274610|FG000|Overall Study|Protocol Violation|3|||
162884475|NCT04971785|588274611|FG001|Overall Study|Protocol Violation|1|||
162884476|NCT04971785|588274612|FG002|Overall Study|Protocol Violation|1|||
162884477|NCT04971785|588274613|FG003|Overall Study|Protocol Violation|2|||
162884478|NCT04971785|588274610|FG000|Overall Study|Investigator's Discretion|3|||
162884479|NCT04971785|588274611|FG001|Overall Study|Investigator's Discretion|1|||
162884480|NCT04971785|588274612|FG002|Overall Study|Investigator's Discretion|1|||
162884481|NCT04971785|588274613|FG003|Overall Study|Investigator's Discretion|0|||
162884482|NCT04971785|588274610|FG000|Overall Study|Randomized but Never Treated|1|||
162884483|NCT04971785|588274611|FG001|Overall Study|Randomized but Never Treated|2|||
162884484|NCT04971785|588274612|FG002|Overall Study|Randomized but Never Treated|0|||
162884485|NCT04971785|588274613|FG003|Overall Study|Randomized but Never Treated|1|||
162884486|NCT04971785|588274610|FG000|Overall Study|Death|0|||
162884487|NCT04971785|588274611|FG001|Overall Study|Death|1|||
162884488|NCT04971785|588274612|FG002|Overall Study|Death|1|||
162884489|NCT04971785|588274613|FG003|Overall Study|Death|0|||
162884490|NCT04971785|588274610|FG000|Overall Study|Site Terminated by Sponsor|1|||
162884491|NCT04971785|588274611|FG001|Overall Study|Site Terminated by Sponsor|1|||
162884492|NCT04971785|588274612|FG002|Overall Study|Site Terminated by Sponsor|0|||
162884493|NCT04971785|588274613|FG003|Overall Study|Site Terminated by Sponsor|0|||
162884494|NCT00646113|588275892|FG000|Overall Study|Lost to Follow-up|5|||
162884495|NCT00646113|588275892|FG000|Overall Study|Adverse Event|3|||
162884496|NCT05458011|588275893|FG000|DB Period (12 Weeks)|Adverse Event|2|||
162884497|NCT05458011|588275894|FG001|DB Period (12 Weeks)|Adverse Event|1|||
162884498|NCT05458011|588275895|FG002|DB Period (12 Weeks)|Adverse Event|1|||
162884499|NCT05458011|588275893|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
162884500|NCT05458011|588275894|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
162884501|NCT05458011|588275895|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
162884502|NCT05458011|588275893|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
162884503|NCT05458011|588275894|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
162884504|NCT05458011|588275895|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
162884505|NCT05458011|588275893|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
162884506|NCT05458011|588275894|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
162884507|NCT05458011|588275895|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
162884508|NCT05458011|588275893|FG000|OL Period (12 Weeks)|Adverse Event|1|||
162884509|NCT05458011|588275894|FG001|OL Period (12 Weeks)|Adverse Event|2|||
162884510|NCT05458011|588275895|FG002|OL Period (12 Weeks)|Adverse Event|1|||
162884511|NCT05458011|588275893|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
162884512|NCT05458011|588275894|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
162884513|NCT05458011|588275895|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
162884514|NCT02690207|588275902|FG000|Overall Study|Lost to Follow-up|48|||
162884515|NCT02690207|588275902|FG000|Overall Study|Withdrawal by Subject|46|||
162884516|NCT02690207|588275902|FG000|Overall Study|Protocol Violation|2|||
162884517|NCT02690207|588275902|FG000|Overall Study|Serious adverse event|110|||
162884518|NCT02690207|588275902|FG000|Overall Study|Non-serious Adverse Event|18|||
162884519|NCT02690207|588275902|FG000|Overall Study|Migrated/moved from study area|5|||
162884520|NCT02690207|588275902|FG000|Overall Study|Suspected HZ Episode|1|||
162963117|NCT00906399|588564753|FG004|Year 1|Lost to Follow-up|0|||
162707961|NCT01605136|587640646|FG001|Study Period|Lost to Follow-up|2|||
162884521|NCT02690207|588275902|FG000|Overall Study|Other reasons for withdrawal|23|||
162884522|NCT04656418|588275905|FG000|Overall Study|Withdrawal by Subject|1|||
162884523|NCT04656418|588275906|FG001|Overall Study|Withdrawal by Subject|3|||
162884524|NCT02586077|588275907|FG000|Overall Study|Withdrawal by Subject|1|||
162884525|NCT02586077|588275907|FG000|Overall Study|Physician Decision|4|||
162884526|NCT02586077|588275907|FG000|Overall Study|Lost to Follow-up|3|||
163050333|NCT01831427|588893531|FG009|Overall Study|Withdrew Consent|1|||
163050334|NCT01831427|588893532|FG010|Overall Study|Withdrew Consent|1|||
162884527|NCT00003476|588275909|FG000|Overall Study|Not evaluable|1|||
162884528|NCT02667457|588275910|FG000|Overall Study|Withdrawal by Subject|1|||
163050335|NCT01249417|588893535|FG000|Randomised Population|Study treatment not received|0|||
163050336|NCT01249417|588893536|FG001|Randomised Population|Study treatment not received|0|||
163050337|NCT01249417|588893537|FG002|Randomised Population|Study treatment not received|2|||
163050338|NCT01249417|588893535|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
163050339|NCT01249417|588893536|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
163050340|NCT01249417|588893537|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
163050341|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Other|0|||
163050342|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Other|0|||
163050343|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Other|1|||
162884529|NCT02667457|588275911|FG001|Overall Study|Withdrawal by Subject|0|||
162884530|NCT02667457|588275910|FG000|Overall Study|Other Reason|0|||
162884531|NCT02667457|588275911|FG001|Overall Study|Other Reason|2|||
162884532|NCT03097614|588275913|FG000|Overall Study|Adverse Event|3|||
162884533|NCT00603733|588275917|FG000|Active Phase ITT|Adverse Event|8|||
162884534|NCT00603733|588275918|FG001|Active Phase ITT|Adverse Event|7|||
162884535|NCT00603733|588275917|FG000|Active Phase ITT|Withdrawal by Subject|0|||
162884536|NCT00603733|588275918|FG001|Active Phase ITT|Withdrawal by Subject|3|||
162884537|NCT00603733|588275917|FG000|Active Phase ITT|Lost to Follow-up|0|||
162884538|NCT00603733|588275918|FG001|Active Phase ITT|Lost to Follow-up|1|||
162884539|NCT00603733|588275917|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
162884540|NCT00603733|588275918|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
162884541|NCT00603733|588275917|FG000|Active Phase ITT|Lack of Efficacy|1|||
162884542|NCT00603733|588275918|FG001|Active Phase ITT|Lack of Efficacy|2|||
162884543|NCT00603733|588275917|FG000|Active Phase ITT|Subject moved, site closed|1|||
162884544|NCT00603733|588275918|FG001|Active Phase ITT|Subject moved, site closed|1|||
162884545|NCT00603733|588275917|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
162884546|NCT00603733|588275918|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
162884547|NCT00603733|588275917|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
162884548|NCT00603733|588275918|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
162884549|NCT00603733|588275917|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
162884550|NCT00603733|588275918|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
162884551|NCT00603733|588275917|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
162884552|NCT00603733|588275918|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
162884553|NCT00603733|588275917|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
162884554|NCT00603733|588275918|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
162884555|NCT00603733|588275917|FG000|Maintenance Phase ITT|Adverse Event|3|||
162884556|NCT00603733|588275918|FG001|Maintenance Phase ITT|Adverse Event|6|||
162884557|NCT00603733|588275917|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
162884558|NCT00603733|588275918|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
163050344|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
163050345|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
163050346|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
163050347|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
163050348|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
163050349|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
163050350|NCT01249417|588893535|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
163050351|NCT01249417|588893536|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
163050352|NCT01249417|588893537|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
163050353|NCT01854697|588893538|FG000|Overall Study|Adverse Event|1|||
163050354|NCT01854697|588893539|FG001|Overall Study|Adverse Event|0|||
163050355|NCT01854697|588893540|FG002|Overall Study|Adverse Event|0|||
163050356|NCT01854697|588893541|FG003|Overall Study|Adverse Event|0|||
163050357|NCT01854697|588893542|FG004|Overall Study|Adverse Event|1|||
163050358|NCT01854697|588893538|FG000|Overall Study|Lost to Follow-up|4|||
163050359|NCT01854697|588893539|FG001|Overall Study|Lost to Follow-up|1|||
163050360|NCT01854697|588893540|FG002|Overall Study|Lost to Follow-up|1|||
163050361|NCT01854697|588893541|FG003|Overall Study|Lost to Follow-up|2|||
163050362|NCT01854697|588893542|FG004|Overall Study|Lost to Follow-up|0|||
163050363|NCT01854697|588893538|FG000|Overall Study|To enter another AbbVie study|1|||
163050364|NCT01854697|588893539|FG001|Overall Study|To enter another AbbVie study|0|||
163050365|NCT01854697|588893540|FG002|Overall Study|To enter another AbbVie study|0|||
163050366|NCT01854697|588893541|FG003|Overall Study|To enter another AbbVie study|0|||
163050367|NCT01854697|588893542|FG004|Overall Study|To enter another AbbVie study|1|||
163050368|NCT01854697|588893538|FG000|Overall Study|Withdrew Consent|0|||
163050369|NCT01854697|588893539|FG001|Overall Study|Withdrew Consent|1|||
163050370|NCT01854697|588893540|FG002|Overall Study|Withdrew Consent|0|||
163050371|NCT01854697|588893541|FG003|Overall Study|Withdrew Consent|1|||
162884559|NCT00603733|588275917|FG000|Maintenance Phase ITT|Protocol Violation|1|||
162884560|NCT00603733|588275918|FG001|Maintenance Phase ITT|Protocol Violation|1|||
163050372|NCT01854697|588893542|FG004|Overall Study|Withdrew Consent|0|||
163050373|NCT01854697|588893538|FG000|Overall Study|Other|0|||
163050374|NCT01854697|588893539|FG001|Overall Study|Other|1|||
163050375|NCT01854697|588893540|FG002|Overall Study|Other|1|||
163050376|NCT01854697|588893541|FG003|Overall Study|Other|0|||
163050377|NCT01854697|588893542|FG004|Overall Study|Other|0|||
163050378|NCT01171898|588893547|FG000|Overall Study|Death|0|||
163050379|NCT01171898|588893548|FG001|Overall Study|Death|0|||
163050380|NCT01171898|588893549|FG002|Overall Study|Death|2|||
163050381|NCT01171898|588893550|FG003|Overall Study|Death|0|||
163050382|NCT01171898|588893547|FG000|Overall Study|Lost to Follow-up|0|||
163050383|NCT01171898|588893548|FG001|Overall Study|Lost to Follow-up|1|||
163050384|NCT01171898|588893549|FG002|Overall Study|Lost to Follow-up|1|||
163050385|NCT01171898|588893550|FG003|Overall Study|Lost to Follow-up|1|||
163050386|NCT01171898|588893547|FG000|Overall Study|Withdrawal by Subject|1|||
163050387|NCT01171898|588893548|FG001|Overall Study|Withdrawal by Subject|4|||
163050388|NCT01171898|588893549|FG002|Overall Study|Withdrawal by Subject|6|||
163050389|NCT01171898|588893550|FG003|Overall Study|Withdrawal by Subject|3|||
163050390|NCT01171898|588893547|FG000|Overall Study|Terminated by Sponsor|1|||
163050391|NCT01171898|588893548|FG001|Overall Study|Terminated by Sponsor|0|||
163050392|NCT01171898|588893549|FG002|Overall Study|Terminated by Sponsor|0|||
163050393|NCT01171898|588893550|FG003|Overall Study|Terminated by Sponsor|0|||
163050394|NCT01171898|588893547|FG000|Overall Study|Ongoing|1|||
163050395|NCT01171898|588893548|FG001|Overall Study|Ongoing|9|||
163050396|NCT01171898|588893549|FG002|Overall Study|Ongoing|3|||
163050397|NCT01171898|588893550|FG003|Overall Study|Ongoing|0|||
163050398|NCT01171898|588893547|FG000|Overall Study|Other|1|||
163050399|NCT01171898|588893548|FG001|Overall Study|Other|5|||
163050400|NCT01171898|588893549|FG002|Overall Study|Other|0|||
163050401|NCT01171898|588893550|FG003|Overall Study|Other|2|||
163050402|NCT00468585|588893551|FG000|Overall Study|Patient not treated|1|||
163050403|NCT00468585|588893552|FG001|Overall Study|Patient not treated|0|||
163050404|NCT00468585|588893553|FG002|Overall Study|Patient not treated|1|||
163050405|NCT00468585|588893554|FG003|Overall Study|Patient not treated|0|||
163050406|NCT00468585|588893551|FG000|Overall Study|Patient found to be ineligible|0|||
163050407|NCT00468585|588893552|FG001|Overall Study|Patient found to be ineligible|0|||
163050408|NCT00468585|588893553|FG002|Overall Study|Patient found to be ineligible|1|||
163050409|NCT00468585|588893554|FG003|Overall Study|Patient found to be ineligible|0|||
163050410|NCT00468585|588893551|FG000|Overall Study|Adverse Event|0|||
163050411|NCT00468585|588893552|FG001|Overall Study|Adverse Event|0|||
163050412|NCT00468585|588893553|FG002|Overall Study|Adverse Event|1|||
163050413|NCT00468585|588893554|FG003|Overall Study|Adverse Event|0|||
162884561|NCT00603733|588275917|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
162884562|NCT00603733|588275918|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
162884563|NCT00603733|588275917|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
162884564|NCT00603733|588275918|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
162884565|NCT00603733|588275917|FG000|Maintenance Phase ITT|Physician Decision|0|||
162884566|NCT00603733|588275918|FG001|Maintenance Phase ITT|Physician Decision|1|||
162884567|NCT00603733|588275917|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
162884568|NCT00603733|588275918|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
162884569|NCT02700919|588275919|FG000|Overall Study|Physician Decision|1|||
162884570|NCT02700919|588275920|FG001|Overall Study|Physician Decision|0|||
162884571|NCT02700919|588275921|FG002|Overall Study|Physician Decision|0|||
162884572|NCT02700919|588275919|FG000|Overall Study|Protocol Violation|1|||
162884573|NCT02700919|588275920|FG001|Overall Study|Protocol Violation|0|||
162884574|NCT02700919|588275921|FG002|Overall Study|Protocol Violation|0|||
162884575|NCT02700919|588275919|FG000|Overall Study|Adverse Event|1|||
162884576|NCT02700919|588275920|FG001|Overall Study|Adverse Event|3|||
162884577|NCT02700919|588275921|FG002|Overall Study|Adverse Event|1|||
162884578|NCT02700919|588275919|FG000|Overall Study|Withdrawal by Subject|5|||
162884579|NCT02700919|588275920|FG001|Overall Study|Withdrawal by Subject|8|||
162884580|NCT02700919|588275921|FG002|Overall Study|Withdrawal by Subject|2|||
162884581|NCT02700919|588275919|FG000|Overall Study|Lost to Follow-up|2|||
162884582|NCT02700919|588275920|FG001|Overall Study|Lost to Follow-up|0|||
162884583|NCT02700919|588275921|FG002|Overall Study|Lost to Follow-up|0|||
162884584|NCT02700919|588275919|FG000|Overall Study|Other|2|||
162884585|NCT02700919|588275920|FG001|Overall Study|Other|1|||
162884586|NCT02700919|588275921|FG002|Overall Study|Other|1|||
162884587|NCT00912340|588275925|FG000|Overall Study|Adverse Event|2|||
162884588|NCT00912340|588275926|FG001|Overall Study|Adverse Event|4|||
162884589|NCT00912340|588275927|FG002|Overall Study|Adverse Event|0|||
162884590|NCT00912340|588275925|FG000|Overall Study|Protocol revised to remove arm|0|||
162884591|NCT00912340|588275926|FG001|Overall Study|Protocol revised to remove arm|0|||
162884592|NCT00912340|588275927|FG002|Overall Study|Protocol revised to remove arm|4|||
162884593|NCT00436982|588275932|FG000|Overall Study|Withdrawal by Subject|3|||
162884594|NCT00436982|588275933|FG001|Overall Study|Withdrawal by Subject|1|||
162884595|NCT00436982|588275932|FG000|Overall Study|Did not receive allocated intervention|0|||
162884596|NCT00436982|588275933|FG001|Overall Study|Did not receive allocated intervention|1|||
162884597|NCT00436982|588275932|FG000|Overall Study|no RSA data|1|||
162884598|NCT00436982|588275933|FG001|Overall Study|no RSA data|2|||
162884599|NCT00953225|588275937|FG000|Overall Study|Withdrawal by Subject|2|||
162884600|NCT00953225|588275938|FG001|Overall Study|Withdrawal by Subject|0|||
162884601|NCT02254551|588275939|FG000|Dose Escalation|Physician Decision|1|||
162884602|NCT02254551|588275939|FG000|Dose Escalation|Dose-limiting toxicity|2|||
162884603|NCT02215616|588275940|FG000|Overall Study|Sponsor requested to stop study drug|0|||
162884604|NCT02215616|588275941|FG001|Overall Study|Sponsor requested to stop study drug|0|||
162884605|NCT02215616|588275942|FG002|Overall Study|Sponsor requested to stop study drug|1|||
162884606|NCT02215616|588275943|FG003|Overall Study|Sponsor requested to stop study drug|4|||
162884607|NCT02215616|588275940|FG000|Overall Study|Death|1|||
162884608|NCT02215616|588275941|FG001|Overall Study|Death|0|||
162884609|NCT02215616|588275942|FG002|Overall Study|Death|0|||
162963118|NCT00906399|588564754|FG005|Year 1|Lost to Follow-up|0|||
162963119|NCT00906399|588564755|FG006|Year 1|Lost to Follow-up|0|||
162884610|NCT02215616|588275943|FG003|Overall Study|Death|0|||
162884611|NCT02215616|588275940|FG000|Overall Study|Adverse Event|7|||
162884612|NCT02215616|588275941|FG001|Overall Study|Adverse Event|4|||
162884613|NCT02215616|588275942|FG002|Overall Study|Adverse Event|9|||
162884614|NCT02215616|588275943|FG003|Overall Study|Adverse Event|2|||
162884615|NCT02215616|588275940|FG000|Overall Study|Withdrawal by Subject|1|||
162884616|NCT02215616|588275941|FG001|Overall Study|Withdrawal by Subject|8|||
162884617|NCT02215616|588275942|FG002|Overall Study|Withdrawal by Subject|2|||
162884618|NCT02215616|588275943|FG003|Overall Study|Withdrawal by Subject|5|||
162884619|NCT02215616|588275940|FG000|Overall Study|Non-compliance|0|||
162884620|NCT02215616|588275941|FG001|Overall Study|Non-compliance|2|||
162963120|NCT00906399|588564749|FG000|Year 1|Withdrawal by Subject|30|||
162884621|NCT02215616|588275942|FG002|Overall Study|Non-compliance|1|||
162884622|NCT02215616|588275943|FG003|Overall Study|Non-compliance|0|||
162884623|NCT02215616|588275940|FG000|Overall Study|Protocol Violation|0|||
162884624|NCT02215616|588275941|FG001|Overall Study|Protocol Violation|2|||
162884625|NCT02215616|588275942|FG002|Overall Study|Protocol Violation|0|||
162884626|NCT02215616|588275943|FG003|Overall Study|Protocol Violation|0|||
162884627|NCT02215616|588275940|FG000|Overall Study|Lost to Follow-up|1|||
162884628|NCT02215616|588275941|FG001|Overall Study|Lost to Follow-up|1|||
162884629|NCT02215616|588275942|FG002|Overall Study|Lost to Follow-up|0|||
162884630|NCT02215616|588275943|FG003|Overall Study|Lost to Follow-up|1|||
162884631|NCT02215616|588275940|FG000|Overall Study|Other than specified|1|||
162884632|NCT02215616|588275941|FG001|Overall Study|Other than specified|0|||
162884633|NCT02215616|588275942|FG002|Overall Study|Other than specified|1|||
162884634|NCT02215616|588275943|FG003|Overall Study|Other than specified|1|||
162884635|NCT04058158|588275944|FG000|Period 1|Death|1|||
162884636|NCT04058158|588275945|FG001|Period 1|Death|0|||
162884637|NCT04058158|588275944|FG000|Period 1|Adverse Event|1|||
162884638|NCT04058158|588275945|FG001|Period 1|Adverse Event|1|||
162884639|NCT04058158|588275944|FG000|Period 1|Pregnancy|0|||
162884640|NCT04058158|588275945|FG001|Period 1|Pregnancy|1|||
162884641|NCT01634113|588275946|FG000|Overall Study|Not treated|0|||
162884642|NCT01634113|588275947|FG001|Overall Study|Not treated|0|||
162884643|NCT01634113|588275948|FG002|Overall Study|Not treated|1|||
162884644|NCT00520299|588275951|FG000|Overall Study|Withdrawal by Subject|0|||
162884645|NCT00520299|588275952|FG001|Overall Study|Withdrawal by Subject|0|||
162884646|NCT00520299|588275953|FG002|Overall Study|Withdrawal by Subject|2|||
162884647|NCT00520299|588275951|FG000|Overall Study|Progressive disease|0|||
162884648|NCT00520299|588275952|FG001|Overall Study|Progressive disease|3|||
162884649|NCT00520299|588275953|FG002|Overall Study|Progressive disease|4|||
162884650|NCT01352845|588275954|FG000|Overall Study|Lost to Follow-up|313|||
162884651|NCT01352845|588275955|FG001|Overall Study|Lost to Follow-up|92|||
162884652|NCT01352845|588275954|FG000|Overall Study|No Longer Willing to Participate|205|||
162884653|NCT01352845|588275955|FG001|Overall Study|No Longer Willing to Participate|58|||
162884654|NCT01352845|588275954|FG000|Overall Study|Withdrawal by Subject|48|||
162884655|NCT01352845|588275955|FG001|Overall Study|Withdrawal by Subject|16|||
162884656|NCT01352845|588275954|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
162884657|NCT01352845|588275955|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
162884658|NCT01352845|588275954|FG000|Overall Study|Pregnancy|27|||
162884659|NCT01352845|588275955|FG001|Overall Study|Pregnancy|7|||
162884660|NCT01352845|588275954|FG000|Overall Study|Adverse Event|22|||
162884661|NCT01352845|588275955|FG001|Overall Study|Adverse Event|6|||
162884662|NCT01352845|588275954|FG000|Overall Study|Other|17|||
162884663|NCT01352845|588275955|FG001|Overall Study|Other|7|||
162884664|NCT01352845|588275954|FG000|Overall Study|Protocol Violation|12|||
162884665|NCT01352845|588275955|FG001|Overall Study|Protocol Violation|6|||
162884666|NCT01352845|588275954|FG000|Overall Study|Death|3|||
162884667|NCT01352845|588275955|FG001|Overall Study|Death|0|||
162884668|NCT02062463|588275956|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
162884669|NCT02062463|588275957|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
162884670|NCT02062463|588275958|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
162884671|NCT02062463|588275959|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
162884672|NCT02062463|588275956|FG000|Stage 2|Adverse Event|0|||
162884673|NCT02062463|588275957|FG001|Stage 2|Adverse Event|0|||
162884674|NCT02062463|588275958|FG002|Stage 2|Adverse Event|12|||
162884675|NCT02062463|588275959|FG003|Stage 2|Adverse Event|20|||
162884676|NCT02062463|588275956|FG000|Stage 2|Lack of Efficacy|0|||
162884677|NCT02062463|588275957|FG001|Stage 2|Lack of Efficacy|0|||
162884678|NCT02062463|588275958|FG002|Stage 2|Lack of Efficacy|3|||
162884679|NCT02062463|588275959|FG003|Stage 2|Lack of Efficacy|4|||
162884680|NCT02062463|588275956|FG000|Stage 2|Lost to Follow-up|0|||
162884681|NCT02062463|588275957|FG001|Stage 2|Lost to Follow-up|0|||
162884682|NCT02062463|588275958|FG002|Stage 2|Lost to Follow-up|20|||
162884683|NCT02062463|588275959|FG003|Stage 2|Lost to Follow-up|20|||
162884684|NCT02062463|588275956|FG000|Stage 2|Non-Compliance|0|||
162884685|NCT02062463|588275957|FG001|Stage 2|Non-Compliance|0|||
162884686|NCT02062463|588275958|FG002|Stage 2|Non-Compliance|0|||
162884687|NCT02062463|588275959|FG003|Stage 2|Non-Compliance|1|||
162884688|NCT02062463|588275956|FG000|Stage 2|Other than specified|0|||
162884689|NCT02062463|588275957|FG001|Stage 2|Other than specified|0|||
162884690|NCT02062463|588275958|FG002|Stage 2|Other than specified|3|||
162884691|NCT02062463|588275959|FG003|Stage 2|Other than specified|1|||
162884692|NCT02062463|588275956|FG000|Stage 2|Withdrawal by Subject|0|||
162884693|NCT02062463|588275957|FG001|Stage 2|Withdrawal by Subject|0|||
163050414|NCT00468585|588893551|FG000|Overall Study|Withdrawal by Subject|0|||
162884694|NCT02062463|588275958|FG002|Stage 2|Withdrawal by Subject|15|||
162884695|NCT02062463|588275959|FG003|Stage 2|Withdrawal by Subject|10|||
162884696|NCT01956240|588275968|FG000|Overall Study|Lost to Follow-up|6|||
162884697|NCT01956240|588275969|FG001|Overall Study|Lost to Follow-up|20|||
162884698|NCT01956240|588275968|FG000|Overall Study|Adverse Event|17|||
162884699|NCT01956240|588275969|FG001|Overall Study|Adverse Event|4|||
162884700|NCT03172481|588275973|FG000|Double-blind|Withdrawal by Subject|1|||
163050415|NCT00468585|588893552|FG001|Overall Study|Withdrawal by Subject|0|||
163050416|NCT00468585|588893553|FG002|Overall Study|Withdrawal by Subject|2|||
163050417|NCT00468585|588893554|FG003|Overall Study|Withdrawal by Subject|1|||
163050418|NCT03769649|588893555|FG000|Overall Study|Lost to Follow-up|4|||
163050419|NCT03322293|588893556|FG000|Overall Study|Lost to Follow-up|0|||
163050420|NCT03322293|588893557|FG001|Overall Study|Lost to Follow-up|0|||
163050421|NCT03322293|588893558|FG002|Overall Study|Lost to Follow-up|1|||
163050422|NCT00853762|588893561|FG000|Overall Study|Premature Termination|16|||
163050423|NCT00853762|588893562|FG001|Overall Study|Premature Termination|15|||
163050424|NCT00853762|588893563|FG002|Overall Study|Premature Termination|14|||
163050425|NCT00853762|588893564|FG003|Overall Study|Premature Termination|21|||
163050426|NCT00853762|588893561|FG000|Overall Study|Protocol Violation|0|||
163050427|NCT00853762|588893562|FG001|Overall Study|Protocol Violation|0|||
163050428|NCT00853762|588893563|FG002|Overall Study|Protocol Violation|0|||
163050429|NCT00853762|588893564|FG003|Overall Study|Protocol Violation|1|||
163050430|NCT00853762|588893561|FG000|Overall Study|Withdrawal by Subject|0|||
163050431|NCT00853762|588893562|FG001|Overall Study|Withdrawal by Subject|0|||
163050432|NCT00853762|588893563|FG002|Overall Study|Withdrawal by Subject|1|||
163050433|NCT00853762|588893564|FG003|Overall Study|Withdrawal by Subject|0|||
162884701|NCT03172481|588275974|FG001|Double-blind|Withdrawal by Subject|0|||
162884702|NCT01061736|588275976|FG000|Overall Study|Dose regimen not selected|0|||
162884703|NCT01061736|588275977|FG001|Overall Study|Dose regimen not selected|0|||
162884704|NCT01061736|588275978|FG002|Overall Study|Dose regimen not selected|0|||
162884705|NCT01061736|588275979|FG003|Overall Study|Dose regimen not selected|0|||
162884706|NCT01061736|588275980|FG004|Overall Study|Dose regimen not selected|0|||
162884707|NCT01061736|588275981|FG005|Overall Study|Dose regimen not selected|0|||
162884708|NCT01061736|588275982|FG006|Overall Study|Dose regimen not selected|79|||
162884709|NCT01061736|588275983|FG007|Overall Study|Dose regimen not selected|0|||
162884710|NCT01061736|588275984|FG008|Overall Study|Dose regimen not selected|0|||
162884711|NCT01061736|588275985|FG009|Overall Study|Dose regimen not selected|0|||
162884712|NCT01061736|588275976|FG000|Overall Study|Adverse Event|13|||
162884713|NCT01061736|588275977|FG001|Overall Study|Adverse Event|1|||
162884714|NCT01061736|588275978|FG002|Overall Study|Adverse Event|3|||
162884715|NCT01061736|588275979|FG003|Overall Study|Adverse Event|2|||
162884716|NCT01061736|588275980|FG004|Overall Study|Adverse Event|4|||
162884717|NCT01061736|588275981|FG005|Overall Study|Adverse Event|1|||
162884718|NCT01061736|588275982|FG006|Overall Study|Adverse Event|4|||
162884719|NCT01061736|588275983|FG007|Overall Study|Adverse Event|63|||
162884720|NCT01061736|588275984|FG008|Overall Study|Adverse Event|67|||
162884721|NCT01061736|588275985|FG009|Overall Study|Adverse Event|34|||
162884722|NCT01061736|588275976|FG000|Overall Study|Lack of Efficacy|0|||
162884723|NCT01061736|588275977|FG001|Overall Study|Lack of Efficacy|2|||
162884724|NCT01061736|588275978|FG002|Overall Study|Lack of Efficacy|1|||
162884725|NCT01061736|588275979|FG003|Overall Study|Lack of Efficacy|1|||
162884726|NCT01061736|588275980|FG004|Overall Study|Lack of Efficacy|1|||
162884727|NCT01061736|588275981|FG005|Overall Study|Lack of Efficacy|2|||
162884728|NCT01061736|588275982|FG006|Overall Study|Lack of Efficacy|1|||
162884729|NCT01061736|588275983|FG007|Overall Study|Lack of Efficacy|9|||
162884730|NCT01061736|588275984|FG008|Overall Study|Lack of Efficacy|9|||
162884731|NCT01061736|588275985|FG009|Overall Study|Lack of Efficacy|10|||
162884732|NCT01061736|588275976|FG000|Overall Study|Poor compliance to protocol|0|||
162884733|NCT01061736|588275977|FG001|Overall Study|Poor compliance to protocol|0|||
162884734|NCT01061736|588275978|FG002|Overall Study|Poor compliance to protocol|0|||
162884735|NCT01061736|588275979|FG003|Overall Study|Poor compliance to protocol|0|||
162884736|NCT01061736|588275980|FG004|Overall Study|Poor compliance to protocol|0|||
162884737|NCT01061736|588275981|FG005|Overall Study|Poor compliance to protocol|0|||
162884738|NCT01061736|588275982|FG006|Overall Study|Poor compliance to protocol|0|||
163050434|NCT00853762|588893561|FG000|Overall Study|Other|0|||
163050435|NCT00853762|588893562|FG001|Overall Study|Other|2|||
163050436|NCT00853762|588893563|FG002|Overall Study|Other|0|||
163050437|NCT00853762|588893564|FG003|Overall Study|Other|0|||
163050438|NCT00853762|588893561|FG000|Overall Study|Randomised but not Treated|0|||
163050439|NCT00853762|588893562|FG001|Overall Study|Randomised but not Treated|2|||
162884739|NCT01061736|588275983|FG007|Overall Study|Poor compliance to protocol|2|||
162884740|NCT01061736|588275984|FG008|Overall Study|Poor compliance to protocol|5|||
163050440|NCT00853762|588893563|FG002|Overall Study|Randomised but not Treated|2|||
162884741|NCT01061736|588275985|FG009|Overall Study|Poor compliance to protocol|9|||
163050441|NCT00853762|588893564|FG003|Overall Study|Randomised but not Treated|0|||
163050442|NCT02000921|588893571|FG000|Overall Study|Withdrawal by Subject|3|||
162884742|NCT01061736|588275976|FG000|Overall Study|Not treated|0|||
162884743|NCT01061736|588275977|FG001|Overall Study|Not treated|0|||
162884744|NCT01061736|588275978|FG002|Overall Study|Not treated|0|||
162884745|NCT01061736|588275979|FG003|Overall Study|Not treated|0|||
162884746|NCT01061736|588275980|FG004|Overall Study|Not treated|1|||
162884747|NCT01061736|588275981|FG005|Overall Study|Not treated|0|||
162884748|NCT01061736|588275982|FG006|Overall Study|Not treated|0|||
162884749|NCT01061736|588275983|FG007|Overall Study|Not treated|2|||
163050443|NCT02000921|588893572|FG001|Overall Study|Withdrawal by Subject|10|||
163050444|NCT02000921|588893573|FG002|Overall Study|Withdrawal by Subject|5|||
163050445|NCT02000921|588893571|FG000|Overall Study|Lost to Follow-up|2|||
163050446|NCT02000921|588893572|FG001|Overall Study|Lost to Follow-up|4|||
163050447|NCT02000921|588893573|FG002|Overall Study|Lost to Follow-up|5|||
163050448|NCT02000921|588893571|FG000|Overall Study|Physician Decision|0|||
163050449|NCT02000921|588893572|FG001|Overall Study|Physician Decision|2|||
163050450|NCT02000921|588893573|FG002|Overall Study|Physician Decision|0|||
163050451|NCT03933449|588893574|FG000|Overall Study|Adverse Event|6|||
163050452|NCT03933449|588893575|FG001|Overall Study|Adverse Event|4|||
163050453|NCT03933449|588893574|FG000|Overall Study|Death|55|||
163050454|NCT03933449|588893575|FG001|Overall Study|Death|57|||
163050455|NCT03933449|588893574|FG000|Overall Study|Sponsor Decision|1|||
163050456|NCT03933449|588893575|FG001|Overall Study|Sponsor Decision|0|||
163050457|NCT00719901|588893578|FG000|Overall Study|Adverse Event|5|||
163050458|NCT00719901|588893578|FG000|Overall Study|Withdrawal by Subject|1|||
163050459|NCT00719901|588893578|FG000|Overall Study|Alternate Treatment|1|||
163050460|NCT00719901|588893578|FG000|Overall Study|Disease Progression|3|||
163050461|NCT00719901|588893578|FG000|Overall Study|Availability of Study Drug|1|||
163050462|NCT02858401|588893579|FG000|Overall Study|Withdrew Consent|0|||
163050463|NCT02858401|588893580|FG001|Overall Study|Withdrew Consent|0|||
162884750|NCT01061736|588275984|FG008|Overall Study|Not treated|1|||
162884751|NCT01061736|588275985|FG009|Overall Study|Not treated|0|||
162884752|NCT01061736|588275976|FG000|Overall Study|Other than specified above|0|||
162884753|NCT01061736|588275977|FG001|Overall Study|Other than specified above|1|||
162884754|NCT01061736|588275978|FG002|Overall Study|Other than specified above|2|||
162884755|NCT01061736|588275979|FG003|Overall Study|Other than specified above|0|||
162884756|NCT01061736|588275980|FG004|Overall Study|Other than specified above|1|||
162884757|NCT01061736|588275981|FG005|Overall Study|Other than specified above|0|||
162884758|NCT01061736|588275982|FG006|Overall Study|Other than specified above|0|||
163050464|NCT02858401|588893581|FG002|Overall Study|Withdrew Consent|0|||
163050465|NCT02858401|588893582|FG003|Overall Study|Withdrew Consent|0|||
163050466|NCT02858401|588893583|FG004|Overall Study|Withdrew Consent|0|||
163050467|NCT02858401|588893584|FG005|Overall Study|Withdrew Consent|1|||
163050468|NCT02858401|588893585|FG006|Overall Study|Withdrew Consent|0|||
163050469|NCT02858401|588893579|FG000|Overall Study|Lost to Follow-up|0|||
163050470|NCT02858401|588893580|FG001|Overall Study|Lost to Follow-up|1|||
163050471|NCT02858401|588893581|FG002|Overall Study|Lost to Follow-up|0|||
163050472|NCT02858401|588893582|FG003|Overall Study|Lost to Follow-up|0|||
163050473|NCT02858401|588893583|FG004|Overall Study|Lost to Follow-up|0|||
163050474|NCT02858401|588893584|FG005|Overall Study|Lost to Follow-up|0|||
163050475|NCT02858401|588893585|FG006|Overall Study|Lost to Follow-up|0|||
163050476|NCT01268267|588893586|FG000|Overall Study|Protocol Violation|1|||
163050477|NCT01418339|588893588|FG000|Overall Study|Adverse Event|5|||
163050478|NCT01418339|588893589|FG001|Overall Study|Adverse Event|2|||
163050479|NCT01418339|588893588|FG000|Overall Study|Subject Withdrew Consent|1|||
163050480|NCT01418339|588893589|FG001|Overall Study|Subject Withdrew Consent|2|||
163050481|NCT01418339|588893588|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
163050482|NCT01418339|588893589|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
163050483|NCT02219685|588893590|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
163050484|NCT02219685|588893591|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
163050485|NCT02219685|588893590|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
162884759|NCT01061736|588275983|FG007|Overall Study|Other than specified above|18|||
162884760|NCT01061736|588275984|FG008|Overall Study|Other than specified above|15|||
162884761|NCT01061736|588275985|FG009|Overall Study|Other than specified above|21|||
163050486|NCT02219685|588893591|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
162884762|NCT01925612|588275986|FG000|Overall Study|Progressive Disease|1|||
162884763|NCT01925612|588275987|FG001|Overall Study|Progressive Disease|1|||
162884764|NCT01925612|588275988|FG002|Overall Study|Progressive Disease|1|||
162884765|NCT01925612|588275989|FG003|Overall Study|Progressive Disease|0|||
162884766|NCT01925612|588275990|FG004|Overall Study|Progressive Disease|0|||
162884767|NCT01925612|588275986|FG000|Overall Study|Adverse Event|3|||
162884768|NCT01925612|588275987|FG001|Overall Study|Adverse Event|3|||
163050487|NCT02869789|588893592|FG000|Overall Study|Disease progression|184|||
163050488|NCT02869789|588893593|FG001|Overall Study|Disease progression|109|||
163050489|NCT02869789|588893594|FG002|Overall Study|Disease progression|260|||
163050490|NCT02869789|588893595|FG003|Overall Study|Disease progression|19|||
163050491|NCT02869789|588893592|FG000|Overall Study|Study drug toxicity|90|||
163050492|NCT02869789|588893593|FG001|Overall Study|Study drug toxicity|32|||
163050493|NCT02869789|588893594|FG002|Overall Study|Study drug toxicity|55|||
163050494|NCT02869789|588893595|FG003|Overall Study|Study drug toxicity|14|||
163050495|NCT02869789|588893592|FG000|Overall Study|Death|7|||
162884769|NCT01925612|588275988|FG002|Overall Study|Adverse Event|0|||
162884770|NCT01925612|588275989|FG003|Overall Study|Adverse Event|1|||
162707962|NCT01605136|587640645|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
162884771|NCT01925612|588275990|FG004|Overall Study|Adverse Event|2|||
162884772|NCT01093755|588275992|FG000|Overall Study|Withdrawal by Subject|3|||
162884773|NCT01093755|588275993|FG001|Overall Study|Withdrawal by Subject|4|||
163050496|NCT02869789|588893593|FG001|Overall Study|Death|3|||
163050497|NCT02869789|588893594|FG002|Overall Study|Death|5|||
163050498|NCT02869789|588893595|FG003|Overall Study|Death|1|||
163050499|NCT02869789|588893592|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
163050500|NCT02869789|588893593|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
163050501|NCT02869789|588893594|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
163050502|NCT02869789|588893595|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
163050503|NCT02869789|588893592|FG000|Overall Study|Participant request to discontinue study treatment|10|||
163050504|NCT02869789|588893593|FG001|Overall Study|Participant request to discontinue study treatment|5|||
162884774|NCT03115112|588275994|FG000|Overall Study|Adverse Event|5|||
162884775|NCT03115112|588275995|FG001|Overall Study|Adverse Event|1|||
162884776|NCT03115112|588275994|FG000|Overall Study|Withdrawal by Subject|4|||
162884777|NCT03115112|588275995|FG001|Overall Study|Withdrawal by Subject|2|||
162884778|NCT03115112|588275994|FG000|Overall Study|Lost to Follow-up|0|||
162884779|NCT03115112|588275995|FG001|Overall Study|Lost to Follow-up|1|||
162884780|NCT03115112|588275994|FG000|Overall Study|Death|1|||
162884781|NCT03115112|588275995|FG001|Overall Study|Death|0|||
162884782|NCT03115112|588275994|FG000|Overall Study|Pregnancy|1|||
162884783|NCT03115112|588275995|FG001|Overall Study|Pregnancy|0|||
162884784|NCT03115112|588275994|FG000|Overall Study|Site closure|1|||
162884785|NCT03115112|588275995|FG001|Overall Study|Site closure|1|||
162884786|NCT01610076|588275996|FG000|Overall Study|Technical issue with video|0|||
162963121|NCT00906399|588564750|FG001|Year 1|Withdrawal by Subject|32|||
162963122|NCT00906399|588564751|FG002|Year 1|Withdrawal by Subject|36|||
162963123|NCT00906399|588564752|FG003|Year 1|Withdrawal by Subject|0|||
162963124|NCT00906399|588564753|FG004|Year 1|Withdrawal by Subject|0|||
162963125|NCT00906399|588564754|FG005|Year 1|Withdrawal by Subject|0|||
162963126|NCT00906399|588564755|FG006|Year 1|Withdrawal by Subject|0|||
162963127|NCT00906399|588564749|FG000|Year 1|Physician Decision|0|||
162963128|NCT00906399|588564750|FG001|Year 1|Physician Decision|1|||
162963129|NCT00906399|588564751|FG002|Year 1|Physician Decision|3|||
162963130|NCT00906399|588564752|FG003|Year 1|Physician Decision|0|||
162963131|NCT00906399|588564753|FG004|Year 1|Physician Decision|0|||
162963132|NCT00906399|588564754|FG005|Year 1|Physician Decision|0|||
162963133|NCT00906399|588564755|FG006|Year 1|Physician Decision|0|||
162963134|NCT00906399|588564749|FG000|Year 1|Death|2|||
162963135|NCT00906399|588564750|FG001|Year 1|Death|1|||
162963136|NCT00906399|588564751|FG002|Year 1|Death|1|||
162963137|NCT00906399|588564752|FG003|Year 1|Death|0|||
162963138|NCT00906399|588564753|FG004|Year 1|Death|0|||
162963139|NCT00906399|588564754|FG005|Year 1|Death|0|||
162963140|NCT00906399|588564755|FG006|Year 1|Death|0|||
162963141|NCT00906399|588564749|FG000|Year 1|Other|4|||
162963142|NCT00906399|588564750|FG001|Year 1|Other|2|||
162963143|NCT00906399|588564751|FG002|Year 1|Other|7|||
162963144|NCT00906399|588564752|FG003|Year 1|Other|0|||
162963145|NCT00906399|588564753|FG004|Year 1|Other|0|||
162963146|NCT00906399|588564754|FG005|Year 1|Other|0|||
162963147|NCT00906399|588564755|FG006|Year 1|Other|0|||
162963148|NCT00906399|588564749|FG000|Year 2|Adverse Event|0|||
162963149|NCT00906399|588564750|FG001|Year 2|Adverse Event|0|||
162963150|NCT00906399|588564751|FG002|Year 2|Adverse Event|0|||
162963151|NCT00906399|588564752|FG003|Year 2|Adverse Event|9|||
162963152|NCT00906399|588564753|FG004|Year 2|Adverse Event|8|||
162963153|NCT00906399|588564754|FG005|Year 2|Adverse Event|11|||
162963154|NCT00906399|588564755|FG006|Year 2|Adverse Event|6|||
162963155|NCT00906399|588564749|FG000|Year 2|Lost to Follow-up|0|||
162963156|NCT00906399|588564750|FG001|Year 2|Lost to Follow-up|0|||
162963157|NCT00906399|588564751|FG002|Year 2|Lost to Follow-up|0|||
162963158|NCT00906399|588564752|FG003|Year 2|Lost to Follow-up|1|||
162963159|NCT00906399|588564753|FG004|Year 2|Lost to Follow-up|4|||
162963160|NCT00906399|588564754|FG005|Year 2|Lost to Follow-up|2|||
162963161|NCT00906399|588564755|FG006|Year 2|Lost to Follow-up|4|||
162963162|NCT00906399|588564749|FG000|Year 2|Withdrawal by Subject|0|||
162963163|NCT00906399|588564750|FG001|Year 2|Withdrawal by Subject|0|||
162963164|NCT00906399|588564751|FG002|Year 2|Withdrawal by Subject|0|||
162963165|NCT00906399|588564752|FG003|Year 2|Withdrawal by Subject|17|||
162963166|NCT00906399|588564753|FG004|Year 2|Withdrawal by Subject|18|||
162963167|NCT00906399|588564754|FG005|Year 2|Withdrawal by Subject|27|||
162963168|NCT00906399|588564755|FG006|Year 2|Withdrawal by Subject|13|||
162963169|NCT00906399|588564749|FG000|Year 2|Physician Decision|0|||
162963170|NCT00906399|588564750|FG001|Year 2|Physician Decision|0|||
162963171|NCT00906399|588564751|FG002|Year 2|Physician Decision|0|||
162963172|NCT00906399|588564752|FG003|Year 2|Physician Decision|0|||
162963173|NCT00906399|588564753|FG004|Year 2|Physician Decision|2|||
162963174|NCT00906399|588564754|FG005|Year 2|Physician Decision|6|||
162963175|NCT00906399|588564755|FG006|Year 2|Physician Decision|3|||
162963176|NCT00906399|588564749|FG000|Year 2|Death|0|||
162963177|NCT00906399|588564750|FG001|Year 2|Death|0|||
162963178|NCT00906399|588564751|FG002|Year 2|Death|0|||
162963179|NCT00906399|588564752|FG003|Year 2|Death|1|||
162963180|NCT00906399|588564753|FG004|Year 2|Death|0|||
162963181|NCT00906399|588564754|FG005|Year 2|Death|0|||
162884787|NCT01610076|588275997|FG001|Overall Study|Technical issue with video|1|||
162884788|NCT01610076|588275996|FG000|Overall Study|Lost to Follow-up|3|||
162884789|NCT01610076|588275997|FG001|Overall Study|Lost to Follow-up|4|||
162884790|NCT02168803|588276001|FG000|Overall Study|Lost to Follow-up|1|||
162884791|NCT02168803|588276002|FG001|Overall Study|Lost to Follow-up|0|||
162884792|NCT02168803|588276003|FG002|Overall Study|Lost to Follow-up|1|||
162884793|NCT02168803|588276001|FG000|Overall Study|Withdrawal by Subject|1|||
162884794|NCT02168803|588276002|FG001|Overall Study|Withdrawal by Subject|1|||
162884795|NCT02168803|588276003|FG002|Overall Study|Withdrawal by Subject|2|||
162884796|NCT02168803|588276001|FG000|Overall Study|Physician Decision|0|||
162884797|NCT02168803|588276002|FG001|Overall Study|Physician Decision|1|||
162884798|NCT02168803|588276003|FG002|Overall Study|Physician Decision|0|||
162884799|NCT02168803|588276001|FG000|Overall Study|Adverse Event|0|||
162884800|NCT02168803|588276002|FG001|Overall Study|Adverse Event|1|||
162884801|NCT02168803|588276003|FG002|Overall Study|Adverse Event|1|||
162884802|NCT02168803|588276001|FG000|Overall Study|Death|0|||
162884803|NCT02168803|588276002|FG001|Overall Study|Death|0|||
162884804|NCT02168803|588276003|FG002|Overall Study|Death|1|||
162884805|NCT02168803|588276001|FG000|Overall Study|Sponsor Decision|0|||
162884806|NCT02168803|588276002|FG001|Overall Study|Sponsor Decision|0|||
162884807|NCT02168803|588276003|FG002|Overall Study|Sponsor Decision|1|||
162884808|NCT01107405|588276004|FG000|Overall Study|Adverse Event|1|||
162884809|NCT01107405|588276005|FG001|Overall Study|Adverse Event|1|||
162884810|NCT01107405|588276006|FG002|Overall Study|Adverse Event|0|||
162884811|NCT01107405|588276007|FG003|Overall Study|Adverse Event|0|||
162884812|NCT01107405|588276008|FG004|Overall Study|Adverse Event|2|||
162884813|NCT01107405|588276004|FG000|Overall Study|Withdrawal by Subject|1|||
162884814|NCT01107405|588276005|FG001|Overall Study|Withdrawal by Subject|0|||
162884815|NCT01107405|588276006|FG002|Overall Study|Withdrawal by Subject|1|||
162884816|NCT01107405|588276007|FG003|Overall Study|Withdrawal by Subject|2|||
162884817|NCT01107405|588276008|FG004|Overall Study|Withdrawal by Subject|1|||
162884818|NCT01107405|588276004|FG000|Overall Study|Protocol Violation|0|||
162884819|NCT01107405|588276005|FG001|Overall Study|Protocol Violation|0|||
162884820|NCT01107405|588276006|FG002|Overall Study|Protocol Violation|1|||
162884821|NCT01107405|588276007|FG003|Overall Study|Protocol Violation|1|||
162884822|NCT01107405|588276008|FG004|Overall Study|Protocol Violation|0|||
162884823|NCT01895452|588276015|FG000|Overall Study|Adverse Event|1|||
162884824|NCT01895452|588276016|FG001|Overall Study|Adverse Event|4|||
162884825|NCT01895452|588276015|FG000|Overall Study|Lost to Follow-up|1|||
162884826|NCT01895452|588276016|FG001|Overall Study|Lost to Follow-up|5|||
162884827|NCT01895452|588276015|FG000|Overall Study|Pregnancy|0|||
162884828|NCT01895452|588276016|FG001|Overall Study|Pregnancy|1|||
162884829|NCT01895452|588276015|FG000|Overall Study|Withdrawal by Subject|2|||
162884830|NCT01895452|588276016|FG001|Overall Study|Withdrawal by Subject|14|||
162884831|NCT01895452|588276015|FG000|Overall Study|Underlying disease|0|||
162884832|NCT01895452|588276016|FG001|Overall Study|Underlying disease|3|||
162884833|NCT01895452|588276015|FG000|Overall Study|Noncompliance with study drug|0|||
162884834|NCT01895452|588276016|FG001|Overall Study|Noncompliance with study drug|1|||
162884835|NCT00980343|588276017|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
162884836|NCT00980343|588276018|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
162884837|NCT01188538|588276023|FG000|Overall Study|Lost to Follow-up|0|||
162884838|NCT01188538|588276024|FG001|Overall Study|Lost to Follow-up|1|||
162884839|NCT01170702|588276027|FG000|Overall Study|Exclusion criteria met after consent|1|||
162884840|NCT01170702|588276028|FG001|Overall Study|Exclusion criteria met after consent|2|||
162884841|NCT01170702|588276029|FG002|Overall Study|Exclusion criteria met after consent|0|||
162884842|NCT01170702|588276030|FG003|Overall Study|Exclusion criteria met after consent|2|||
162884843|NCT04999969|588276031|FG000|Overall Study|Death|76|||
162884844|NCT04999969|588276031|FG000|Overall Study|Progressive Disease|1|||
162884845|NCT04999969|588276031|FG000|Overall Study|Withdrawal by Subject|8|||
162884846|NCT06964165|588276033|FG000|Overall Study|Death|4|||
162884847|NCT06964165|588276034|FG001|Overall Study|Death|4|||
162884848|NCT06964165|588276033|FG000|Overall Study|Physician Decision|1|||
162884849|NCT06964165|588276034|FG001|Overall Study|Physician Decision|1|||
162884850|NCT06964165|588276033|FG000|Overall Study|Withdrawal by Subject|0|||
162884851|NCT06964165|588276034|FG001|Overall Study|Withdrawal by Subject|2|||
162884852|NCT06964165|588276033|FG000|Overall Study|Study terminated by sponsor|12|||
162884853|NCT06964165|588276034|FG001|Overall Study|Study terminated by sponsor|10|||
162884854|NCT06964165|588276033|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
162884855|NCT06964165|588276034|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
162884856|NCT06964165|588276033|FG000|Overall Study|Participant removed due to non-compliance|0|||
162884857|NCT06964165|588276034|FG001|Overall Study|Participant removed due to non-compliance|1|||
162963182|NCT00906399|588564755|FG006|Year 2|Death|3|||
162963183|NCT00906399|588564749|FG000|Year 2|Other|0|||
162963184|NCT00906399|588564750|FG001|Year 2|Other|0|||
162963185|NCT00906399|588564751|FG002|Year 2|Other|0|||
162963186|NCT00906399|588564752|FG003|Year 2|Other|2|||
162963187|NCT00906399|588564753|FG004|Year 2|Other|3|||
162963188|NCT00906399|588564754|FG005|Year 2|Other|1|||
162884858|NCT00085917|588276035|FG000|Overall Study|Adverse Event|4|||
162884859|NCT00085917|588276036|FG001|Overall Study|Adverse Event|3|||
162884860|NCT01464788|588276037|FG000|Overall Study|Lost to Follow-up|0|||
162884861|NCT01464788|588276038|FG001|Overall Study|Lost to Follow-up|1|||
162884862|NCT01464788|588276039|FG002|Overall Study|Lost to Follow-up|0|||
162884863|NCT01464788|588276037|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
162884864|NCT01464788|588276038|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
162884865|NCT01464788|588276039|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
162884866|NCT01551758|588276040|FG000|Overall Study|Adverse Event|29|||
162884867|NCT01551758|588276041|FG001|Overall Study|Adverse Event|43|||
162884868|NCT01551758|588276040|FG000|Overall Study|Lack of Efficacy|0|||
162884869|NCT01551758|588276041|FG001|Overall Study|Lack of Efficacy|1|||
162884870|NCT01551758|588276040|FG000|Overall Study|Protocol Violation|5|||
162884871|NCT01551758|588276041|FG001|Overall Study|Protocol Violation|6|||
162884872|NCT01551758|588276040|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
162884873|NCT01551758|588276041|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
162884874|NCT01551758|588276040|FG000|Overall Study|Lost to Follow-up|29|||
162884875|NCT01551758|588276041|FG001|Overall Study|Lost to Follow-up|25|||
162884876|NCT01551758|588276040|FG000|Overall Study|Physician Decision|9|||
162884877|NCT01551758|588276041|FG001|Overall Study|Physician Decision|3|||
162884878|NCT01551758|588276040|FG000|Overall Study|Withdrawal by Subject|14|||
162884879|NCT01551758|588276041|FG001|Overall Study|Withdrawal by Subject|17|||
162884880|NCT05584202|588276046|FG000|Overall Study|Withdrawal of Consent|3|||
162884881|NCT05584202|588276047|FG001|Overall Study|Withdrawal of Consent|2|||
162884882|NCT05584202|588276046|FG000|Overall Study|Lost to Follow-up|2|||
162884883|NCT05584202|588276047|FG001|Overall Study|Lost to Follow-up|1|||
162884884|NCT05584202|588276046|FG000|Overall Study|Death|0|||
162884885|NCT05584202|588276047|FG001|Overall Study|Death|1|||
162884886|NCT03297216|588277864|FG000|Overall Study|Death|0|||
162884887|NCT03297216|588277865|FG001|Overall Study|Death|1|||
162884888|NCT03297216|588277864|FG000|Overall Study|Miscarriage|0|||
162884889|NCT03297216|588277865|FG001|Overall Study|Miscarriage|2|||
162884890|NCT03297216|588277864|FG000|Overall Study|Lost to Follow-up|3|||
162884891|NCT03297216|588277865|FG001|Overall Study|Lost to Follow-up|2|||
162884892|NCT00781963|588277866|FG000|Overall Study|Death|3|||
162884893|NCT00781963|588277867|FG001|Overall Study|Death|0|||
162884894|NCT00781963|588277866|FG000|Overall Study|Lost to Follow-up|2|||
162884895|NCT00781963|588277867|FG001|Overall Study|Lost to Follow-up|1|||
162884896|NCT00781963|588277866|FG000|Overall Study|Withdrawal by Subject|3|||
162884897|NCT00781963|588277867|FG001|Overall Study|Withdrawal by Subject|1|||
162884898|NCT00781963|588277866|FG000|Overall Study|Refused follow-up|9|||
162884899|NCT00781963|588277867|FG001|Overall Study|Refused follow-up|0|||
162884900|NCT01653158|588277874|FG000|Overall Study|Death|0|||
162884901|NCT01653158|588277875|FG001|Overall Study|Death|0|||
162884902|NCT01653158|588277876|FG002|Overall Study|Death|0|||
162884903|NCT01653158|588277877|FG003|Overall Study|Death|1|||
162884904|NCT01653158|588277878|FG004|Overall Study|Death|0|||
162884905|NCT01653158|588277879|FG005|Overall Study|Death|0|||
162884906|NCT01653158|588277880|FG006|Overall Study|Death|0|||
162963189|NCT00906399|588564755|FG006|Year 2|Other|0|||
162963190|NCT02471807|588564766|FG000|Overall Study|Death|14|||
162963191|NCT02471807|588564766|FG000|Overall Study|Withdrawal by Subject|2|||
162963192|NCT02471807|588564766|FG000|Overall Study|Explant|5|||
162963193|NCT02471807|588564766|FG000|Overall Study|Lost to Follow-up|1|||
162963194|NCT02055547|588564768|FG000|Overall Study|Protocol Violation|0|||
162963195|NCT02055547|588564769|FG001|Overall Study|Protocol Violation|0|||
162963196|NCT02055547|588564770|FG002|Overall Study|Protocol Violation|1|||
162963197|NCT02055547|588564771|FG003|Overall Study|Protocol Violation|0|||
162963198|NCT02055547|588564772|FG004|Overall Study|Protocol Violation|0|||
162963199|NCT02055547|588564773|FG005|Overall Study|Protocol Violation|0|||
162963200|NCT02055547|588564774|FG006|Overall Study|Protocol Violation|1|||
162963201|NCT02055547|588564775|FG007|Overall Study|Protocol Violation|0|||
162884907|NCT01653158|588277881|FG007|Overall Study|Death|2|||
162884908|NCT01653158|588277874|FG000|Overall Study|Adverse Event|0|||
162884909|NCT01653158|588277875|FG001|Overall Study|Adverse Event|0|||
162884910|NCT01653158|588277876|FG002|Overall Study|Adverse Event|0|||
162884911|NCT01653158|588277877|FG003|Overall Study|Adverse Event|1|||
162884912|NCT01653158|588277878|FG004|Overall Study|Adverse Event|0|||
162884913|NCT01653158|588277879|FG005|Overall Study|Adverse Event|0|||
162884914|NCT01653158|588277880|FG006|Overall Study|Adverse Event|0|||
162963202|NCT02055547|588564776|FG008|Overall Study|Protocol Violation|0|||
162963203|NCT02055547|588564777|FG009|Overall Study|Protocol Violation|0|||
163050505|NCT02869789|588893594|FG002|Overall Study|Participant request to discontinue study treatment|5|||
162884915|NCT01653158|588277881|FG007|Overall Study|Adverse Event|3|||
162884916|NCT01653158|588277874|FG000|Overall Study|Other|0|||
162884917|NCT01653158|588277875|FG001|Overall Study|Other|0|||
162884918|NCT01653158|588277876|FG002|Overall Study|Other|0|||
162884919|NCT01653158|588277877|FG003|Overall Study|Other|0|||
162884920|NCT01653158|588277878|FG004|Overall Study|Other|0|||
162884921|NCT01653158|588277879|FG005|Overall Study|Other|0|||
162884922|NCT01653158|588277880|FG006|Overall Study|Other|0|||
162884923|NCT01653158|588277881|FG007|Overall Study|Other|1|||
162884924|NCT01653158|588277874|FG000|Overall Study|Progressive disease|0|||
162884925|NCT01653158|588277875|FG001|Overall Study|Progressive disease|0|||
162884926|NCT01653158|588277876|FG002|Overall Study|Progressive disease|0|||
162884927|NCT01653158|588277877|FG003|Overall Study|Progressive disease|0|||
162884928|NCT01653158|588277878|FG004|Overall Study|Progressive disease|1|||
162884929|NCT01653158|588277879|FG005|Overall Study|Progressive disease|1|||
162884930|NCT01653158|588277880|FG006|Overall Study|Progressive disease|2|||
162884931|NCT01653158|588277881|FG007|Overall Study|Progressive disease|9|||
162884932|NCT01653158|588277874|FG000|Overall Study|Withdrawal by Subject|1|||
162884933|NCT01653158|588277875|FG001|Overall Study|Withdrawal by Subject|0|||
162884934|NCT01653158|588277876|FG002|Overall Study|Withdrawal by Subject|0|||
162884935|NCT01653158|588277877|FG003|Overall Study|Withdrawal by Subject|0|||
162884936|NCT01653158|588277878|FG004|Overall Study|Withdrawal by Subject|0|||
162884937|NCT01653158|588277879|FG005|Overall Study|Withdrawal by Subject|0|||
162884938|NCT01653158|588277880|FG006|Overall Study|Withdrawal by Subject|0|||
162884939|NCT01653158|588277881|FG007|Overall Study|Withdrawal by Subject|0|||
162884940|NCT02310906|588277890|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
162884941|NCT02310906|588277891|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
162884942|NCT02310906|588277892|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
162884943|NCT02310906|588277893|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
162884944|NCT02310906|588277890|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
162884945|NCT02310906|588277891|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
162884946|NCT02310906|588277892|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
162884947|NCT02310906|588277893|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
162884948|NCT02310906|588277890|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
162884949|NCT02310906|588277891|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
162884950|NCT02310906|588277892|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
162884951|NCT02310906|588277893|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
162884952|NCT02310906|588277890|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
162884953|NCT02310906|588277891|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
162884954|NCT02310906|588277892|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
162884955|NCT02310906|588277893|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
162884956|NCT00433446|588277894|FG000|Overall Study|Adverse Event|4|||
162884957|NCT00433446|588277894|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
162884958|NCT00433446|588277894|FG000|Overall Study|Progression|44|||
162884959|NCT00433446|588277894|FG000|Overall Study|Other - Not Protocol specified|3|||
162884960|NCT00433446|588277894|FG000|Overall Study|Ineligible|9|||
162884961|NCT02899377|588277895|FG000|Overall Study|Adverse Event|1|||
162884962|NCT02899377|588277896|FG001|Overall Study|Adverse Event|0|||
162884963|NCT01231607|588277900|FG000|Overall Study|Adverse Event|0|||
162884964|NCT01231607|588277901|FG001|Overall Study|Adverse Event|8|||
162884965|NCT01231607|588277902|FG002|Overall Study|Adverse Event|4|||
162884966|NCT01231607|588277903|FG003|Overall Study|Adverse Event|4|||
162884967|NCT01231607|588277904|FG004|Overall Study|Adverse Event|5|||
162884968|NCT01231607|588277900|FG000|Overall Study|Lost to Follow-up|13|||
162884969|NCT01231607|588277901|FG001|Overall Study|Lost to Follow-up|11|||
162884970|NCT01231607|588277902|FG002|Overall Study|Lost to Follow-up|10|||
162884971|NCT01231607|588277903|FG003|Overall Study|Lost to Follow-up|10|||
162884972|NCT01231607|588277904|FG004|Overall Study|Lost to Follow-up|4|||
163050506|NCT02869789|588893595|FG003|Overall Study|Participant request to discontinue study treatment|3|||
163050507|NCT02869789|588893592|FG000|Overall Study|Withdrawal by Subject|5|||
163050508|NCT02869789|588893593|FG001|Overall Study|Withdrawal by Subject|2|||
163050509|NCT02869789|588893594|FG002|Overall Study|Withdrawal by Subject|7|||
163050510|NCT02869789|588893595|FG003|Overall Study|Withdrawal by Subject|2|||
163050511|NCT02869789|588893592|FG000|Overall Study|Lost to Follow-up|0|||
162884973|NCT01231607|588277900|FG000|Overall Study|Physician Decision|4|||
162884974|NCT01231607|588277901|FG001|Overall Study|Physician Decision|4|||
162884975|NCT01231607|588277902|FG002|Overall Study|Physician Decision|3|||
162884976|NCT01231607|588277903|FG003|Overall Study|Physician Decision|5|||
162884977|NCT01231607|588277904|FG004|Overall Study|Physician Decision|4|||
162884978|NCT01231607|588277900|FG000|Overall Study|Protocol Violation|3|||
163050512|NCT02869789|588893593|FG001|Overall Study|Lost to Follow-up|0|||
163050513|NCT02869789|588893594|FG002|Overall Study|Lost to Follow-up|2|||
162884979|NCT01231607|588277901|FG001|Overall Study|Protocol Violation|2|||
162884980|NCT01231607|588277902|FG002|Overall Study|Protocol Violation|0|||
163050514|NCT02869789|588893595|FG003|Overall Study|Lost to Follow-up|0|||
163050515|NCT02869789|588893592|FG000|Overall Study|Maximum clinical benefit|5|||
163050516|NCT02869789|588893593|FG001|Overall Study|Maximum clinical benefit|2|||
163050517|NCT02869789|588893594|FG002|Overall Study|Maximum clinical benefit|1|||
163050518|NCT02869789|588893595|FG003|Overall Study|Maximum clinical benefit|0|||
163050519|NCT02869789|588893592|FG000|Overall Study|Poor/Non-compliance|0|||
163050520|NCT02869789|588893593|FG001|Overall Study|Poor/Non-compliance|2|||
163050521|NCT02869789|588893594|FG002|Overall Study|Poor/Non-compliance|1|||
163050522|NCT02869789|588893595|FG003|Overall Study|Poor/Non-compliance|0|||
163050523|NCT02869789|588893592|FG000|Overall Study|Participant no longer meets study criteria|0|||
163050524|NCT02869789|588893593|FG001|Overall Study|Participant no longer meets study criteria|1|||
163050525|NCT02869789|588893594|FG002|Overall Study|Participant no longer meets study criteria|1|||
163050526|NCT02869789|588893595|FG003|Overall Study|Participant no longer meets study criteria|0|||
163050527|NCT02869789|588893592|FG000|Overall Study|Administrative reason by sponsor|0|||
163050528|NCT02869789|588893593|FG001|Overall Study|Administrative reason by sponsor|0|||
163050529|NCT02869789|588893594|FG002|Overall Study|Administrative reason by sponsor|1|||
163050530|NCT02869789|588893595|FG003|Overall Study|Administrative reason by sponsor|0|||
163050531|NCT02869789|588893592|FG000|Overall Study|Other reasons|4|||
163050532|NCT02869789|588893593|FG001|Overall Study|Other reasons|8|||
163050533|NCT02869789|588893594|FG002|Overall Study|Other reasons|6|||
163050534|NCT02869789|588893595|FG003|Overall Study|Other reasons|0|||
163050535|NCT00297648|588893596|FG000|Overall Study|Adverse Event|13|||
163050536|NCT00297648|588893596|FG000|Overall Study|Lack of Efficacy|18|||
163050537|NCT00297648|588893596|FG000|Overall Study|Lost to Follow-up|1|||
163050538|NCT00297648|588893596|FG000|Overall Study|Withdrawal by Subject|3|||
163050539|NCT00297648|588893596|FG000|Overall Study|Other: Incompliance|1|||
163050540|NCT01529606|588893598|FG000|Overall Study|Lost to Follow-up|21|||
163050541|NCT01529606|588893599|FG001|Overall Study|Lost to Follow-up|18|||
163050542|NCT01746862|588893600|FG000|Overall Study|Withdrawal by Subject|1|||
163050543|NCT01746862|588893601|FG001|Overall Study|Withdrawal by Subject|1|||
163050544|NCT01746862|588893600|FG000|Overall Study|Protocol Violation|1|||
162884981|NCT01231607|588277903|FG003|Overall Study|Protocol Violation|2|||
162884982|NCT01231607|588277904|FG004|Overall Study|Protocol Violation|2|||
162884983|NCT01231607|588277900|FG000|Overall Study|Withdrawal by Subject|9|||
162884984|NCT01231607|588277901|FG001|Overall Study|Withdrawal by Subject|9|||
162884985|NCT01231607|588277902|FG002|Overall Study|Withdrawal by Subject|14|||
162884986|NCT01231607|588277903|FG003|Overall Study|Withdrawal by Subject|17|||
162884987|NCT01231607|588277904|FG004|Overall Study|Withdrawal by Subject|9|||
162884988|NCT03779334|588277908|FG000|Overall Study|Withdrawal by Subject|3|||
162884989|NCT03779334|588277909|FG001|Overall Study|Withdrawal by Subject|0|||
162884990|NCT03779334|588277910|FG002|Overall Study|Withdrawal by Subject|0|||
162884991|NCT03779334|588277908|FG000|Overall Study|Ongoing in Study|5|||
162884992|NCT03779334|588277909|FG001|Overall Study|Ongoing in Study|13|||
162884993|NCT03779334|588277910|FG002|Overall Study|Ongoing in Study|5|||
162884994|NCT04321252|588277917|FG000|Overall Study|Withdrawal by Subject|0|||
162884995|NCT04321252|588277918|FG001|Overall Study|Withdrawal by Subject|0|||
162884996|NCT04321252|588277919|FG002|Overall Study|Withdrawal by Subject|0|||
162884997|NCT04321252|588277920|FG003|Overall Study|Withdrawal by Subject|0|||
162884998|NCT04321252|588277921|FG004|Overall Study|Withdrawal by Subject|0|||
162884999|NCT04321252|588277922|FG005|Overall Study|Withdrawal by Subject|1|||
162885000|NCT04321252|588277923|FG006|Overall Study|Withdrawal by Subject|0|||
162885001|NCT04321252|588277924|FG007|Overall Study|Withdrawal by Subject|0|||
162885002|NCT04321252|588277925|FG008|Overall Study|Withdrawal by Subject|0|||
162885003|NCT06245044|588277926|FG000|No MI help|Technical issues|18|||
162885004|NCT01082367|588277929|FG000|Double-blind Period|Administrative problems|0|||
163050545|NCT01746862|588893601|FG001|Overall Study|Protocol Violation|0|||
163050546|NCT01746862|588893600|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
163050547|NCT01746862|588893601|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
163050548|NCT01746862|588893600|FG000|Overall Study|Entered puberty during the study|1|||
163050549|NCT01746862|588893601|FG001|Overall Study|Entered puberty during the study|0|||
162707963|NCT01605136|587640646|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
162707964|NCT01072929|587640647|FG000|Overall Study|Adverse Event|8|||
162885005|NCT01082367|588277930|FG001|Double-blind Period|Administrative problems|1|||
162885006|NCT01082367|588277929|FG000|Double-blind Period|Lack of Efficacy|5|||
162885007|NCT01082367|588277930|FG001|Double-blind Period|Lack of Efficacy|11|||
162885008|NCT01082367|588277929|FG000|Double-blind Period|Adverse Event|0|||
162885009|NCT01082367|588277930|FG001|Double-blind Period|Adverse Event|1|||
162885010|NCT01082367|588277929|FG000|Follow-up (F-U) Period|Administrative problems|1|||
163050550|NCT04742673|588893602|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
163050551|NCT04742673|588893603|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
163050552|NCT05209880|588893619|FG000|1-Month Follow-up|Spoke with Doctor|5|||
163050553|NCT05209880|588893620|FG001|1-Month Follow-up|Spoke with Doctor|5|||
163050554|NCT05209880|588893619|FG000|1-Month Follow-up|Lost to Follow-up|7|||
162707965|NCT01072929|587640648|FG001|Overall Study|Adverse Event|11|||
162885011|NCT01082367|588277930|FG001|Follow-up (F-U) Period|Administrative problems|0|||
162885012|NCT01082367|588277929|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
162885013|NCT01082367|588277930|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
162885014|NCT01082367|588277929|FG000|Follow-up (F-U) Period|Adverse Event|0|||
162885015|NCT01082367|588277930|FG001|Follow-up (F-U) Period|Adverse Event|1|||
162885016|NCT00098020|588277933|FG000|Overall Study|Adverse Event|2|||
162885017|NCT00098020|588277933|FG000|Overall Study|Lost to Follow-up|1|||
162885018|NCT00098020|588277933|FG000|Overall Study|elevated liver enzymes|1|||
162885019|NCT00098020|588277933|FG000|Overall Study|Low urine PCR|1|||
162885020|NCT00098020|588277933|FG000|Overall Study|Low epidermal growth factor receptor|1|||
162885021|NCT00865189|588277940|FG000|Overall Study|Other|1|||
162885022|NCT00865189|588277941|FG001|Overall Study|Other|2|||
162885023|NCT00865189|588277940|FG000|Overall Study|Death|4|||
162885024|NCT00865189|588277941|FG001|Overall Study|Death|11|||
162885025|NCT00865189|588277940|FG000|Overall Study|Lost to Follow-up|6|||
162885026|NCT00865189|588277941|FG001|Overall Study|Lost to Follow-up|6|||
162885027|NCT00865189|588277940|FG000|Overall Study|Withdrawal by Subject|1|||
162885028|NCT00865189|588277941|FG001|Overall Study|Withdrawal by Subject|0|||
162885029|NCT01658579|588277943|FG000|Treatment Period A|Other|0|||
162885030|NCT01658579|588277944|FG001|Treatment Period A|Other|0|||
162885031|NCT01658579|588277945|FG002|Treatment Period A|Other|1|||
162885032|NCT01658579|588277946|FG003|Treatment Period A|Other|1|||
162885033|NCT01658579|588277943|FG000|Treatment Period A|Adverse Event|1|||
162885034|NCT01658579|588277944|FG001|Treatment Period A|Adverse Event|0|||
162885035|NCT01658579|588277945|FG002|Treatment Period A|Adverse Event|0|||
162885036|NCT01658579|588277946|FG003|Treatment Period A|Adverse Event|0|||
162885037|NCT01658579|588277943|FG000|Treatment Period B|Other|0|||
162885038|NCT01658579|588277944|FG001|Treatment Period B|Other|0|||
162885039|NCT01658579|588277945|FG002|Treatment Period B|Other|0|||
162885040|NCT01658579|588277946|FG003|Treatment Period B|Other|1|||
162885041|NCT02767856|588277957|FG000|Overall Study|Lost to Follow-up|9|||
162885042|NCT02767856|588277958|FG001|Overall Study|Lost to Follow-up|1|||
162885043|NCT02767856|588277957|FG000|Overall Study|Withdrawal by Subject|2|||
162885044|NCT02767856|588277958|FG001|Overall Study|Withdrawal by Subject|1|||
162885045|NCT00418379|588277963|FG000|Year 1|Adverse Event|9|||
162885046|NCT00418379|588277964|FG001|Year 1|Adverse Event|15|||
162885047|NCT00418379|588277965|FG002|Year 1|Adverse Event|3|||
162885048|NCT00418379|588277963|FG000|Year 1|Withdrawal by Subject|7|||
162885049|NCT00418379|588277964|FG001|Year 1|Withdrawal by Subject|8|||
162885050|NCT00418379|588277965|FG002|Year 1|Withdrawal by Subject|5|||
162885051|NCT00418379|588277963|FG000|Year 1|Any other reason not above-mentioned|2|||
162885052|NCT00418379|588277964|FG001|Year 1|Any other reason not above-mentioned|5|||
162885053|NCT00418379|588277965|FG002|Year 1|Any other reason not above-mentioned|7|||
162885054|NCT00418379|588277963|FG000|Year 2|Adverse Event|5|||
162885055|NCT00418379|588277964|FG001|Year 2|Adverse Event|2|||
162885056|NCT00418379|588277965|FG002|Year 2|Adverse Event|1|||
162885057|NCT00418379|588277963|FG000|Year 2|Withdrawal by Subject|1|||
162885058|NCT00418379|588277964|FG001|Year 2|Withdrawal by Subject|1|||
162885059|NCT00418379|588277965|FG002|Year 2|Withdrawal by Subject|3|||
162885060|NCT00418379|588277963|FG000|Year 2|Any other reason not above-mentioned|2|||
162885061|NCT00418379|588277964|FG001|Year 2|Any other reason not above-mentioned|1|||
162885062|NCT00418379|588277965|FG002|Year 2|Any other reason not above-mentioned|6|||
162885063|NCT00418379|588277963|FG000|Year 3|Withdrawal by Subject|1|||
162963204|NCT02055547|588564778|FG010|Overall Study|Protocol Violation|0|||
162963205|NCT02055547|588564779|FG011|Overall Study|Protocol Violation|0|||
162963206|NCT02055547|588564780|FG012|Overall Study|Protocol Violation|0|||
162963207|NCT02055547|588564781|FG013|Overall Study|Protocol Violation|0|||
162963208|NCT02055547|588564782|FG014|Overall Study|Protocol Violation|0|||
162963209|NCT02055547|588564783|FG015|Overall Study|Protocol Violation|0|||
162963210|NCT02055547|588564784|FG016|Overall Study|Protocol Violation|0|||
162963211|NCT02055547|588564785|FG017|Overall Study|Protocol Violation|0|||
162963212|NCT02055547|588564786|FG018|Overall Study|Protocol Violation|0|||
162963213|NCT02055547|588564768|FG000|Overall Study|Physician Decision|0|||
162963214|NCT02055547|588564769|FG001|Overall Study|Physician Decision|1|||
162963215|NCT02055547|588564770|FG002|Overall Study|Physician Decision|1|||
162963216|NCT02055547|588564771|FG003|Overall Study|Physician Decision|0|||
162963217|NCT02055547|588564772|FG004|Overall Study|Physician Decision|1|||
162963218|NCT02055547|588564773|FG005|Overall Study|Physician Decision|0|||
162963219|NCT02055547|588564774|FG006|Overall Study|Physician Decision|0|||
162963220|NCT02055547|588564775|FG007|Overall Study|Physician Decision|0|||
162963221|NCT02055547|588564776|FG008|Overall Study|Physician Decision|0|||
162963222|NCT02055547|588564777|FG009|Overall Study|Physician Decision|1|||
162963223|NCT02055547|588564778|FG010|Overall Study|Physician Decision|1|||
162885064|NCT00418379|588277964|FG001|Year 3|Withdrawal by Subject|1|||
162885065|NCT00418379|588277965|FG002|Year 3|Withdrawal by Subject|2|||
162885066|NCT00418379|588277963|FG000|Year 3|Any other reason not above-mentioned|2|||
162963224|NCT02055547|588564779|FG011|Overall Study|Physician Decision|0|||
162963225|NCT02055547|588564780|FG012|Overall Study|Physician Decision|0|||
162963226|NCT02055547|588564781|FG013|Overall Study|Physician Decision|0|||
162963227|NCT02055547|588564782|FG014|Overall Study|Physician Decision|0|||
162963228|NCT02055547|588564783|FG015|Overall Study|Physician Decision|0|||
163050555|NCT05209880|588893620|FG001|1-Month Follow-up|Lost to Follow-up|9|||
163050556|NCT05209880|588893619|FG000|1-Month Follow-up|Discontinued|0|||
162885067|NCT00418379|588277964|FG001|Year 3|Any other reason not above-mentioned|1|||
162885068|NCT00418379|588277965|FG002|Year 3|Any other reason not above-mentioned|1|||
162885069|NCT00418379|588277963|FG000|Year 4|Adverse Event|0|||
162885070|NCT00418379|588277964|FG001|Year 4|Adverse Event|1|||
162885071|NCT00418379|588277965|FG002|Year 4|Adverse Event|0|||
162885072|NCT00418379|588277963|FG000|Year 4|Withdrawal by Subject|2|||
162885073|NCT00418379|588277964|FG001|Year 4|Withdrawal by Subject|3|||
162885074|NCT00418379|588277965|FG002|Year 4|Withdrawal by Subject|2|||
162885075|NCT00418379|588277963|FG000|Year 4|Any other reason not above-mentioned|1|||
162885076|NCT00418379|588277964|FG001|Year 4|Any other reason not above-mentioned|1|||
163050557|NCT05209880|588893620|FG001|1-Month Follow-up|Discontinued|1|||
163050558|NCT05209880|588893619|FG000|3-Month Follow-up|Spoke with Doctor|17|||
163050559|NCT05209880|588893620|FG001|3-Month Follow-up|Spoke with Doctor|7|||
163050560|NCT05209880|588893619|FG000|3-Month Follow-up|Lost to Follow-up|8|||
163050561|NCT05209880|588893620|FG001|3-Month Follow-up|Lost to Follow-up|10|||
163050562|NCT05209880|588893619|FG000|3-Month Follow-up|Discontinued|1|||
163050563|NCT05209880|588893620|FG001|3-Month Follow-up|Discontinued|3|||
163050564|NCT05209880|588893619|FG000|6-Month Follow-up|Spoke with Doctor|25|||
163050565|NCT05209880|588893620|FG001|6-Month Follow-up|Spoke with Doctor|14|||
163050566|NCT05209880|588893619|FG000|6-Month Follow-up|Lost to Follow-up|9|||
162885077|NCT00418379|588277965|FG002|Year 4|Any other reason not above-mentioned|0|||
162885078|NCT00418379|588277963|FG000|Year 5|Adverse Event|0|||
162885079|NCT00418379|588277964|FG001|Year 5|Adverse Event|1|||
162885080|NCT00418379|588277965|FG002|Year 5|Adverse Event|0|||
162885081|NCT00418379|588277963|FG000|Year 5|Any other reason not above-mentioned|2|||
162885082|NCT00418379|588277964|FG001|Year 5|Any other reason not above-mentioned|4|||
162885083|NCT00418379|588277965|FG002|Year 5|Any other reason not above-mentioned|3|||
162885084|NCT00843843|588277966|FG000|Overall Study|Physician Decision|1|||
162885085|NCT00843843|588277967|FG001|Overall Study|Physician Decision|1|||
162885086|NCT00843843|588277966|FG000|Overall Study|Protocol Violation|1|||
162885087|NCT00843843|588277967|FG001|Overall Study|Protocol Violation|1|||
162885088|NCT00565058|588277968|FG000|Overall Study|Adverse Event|1|||
162885089|NCT00565058|588277969|FG001|Overall Study|Adverse Event|0|||
162885090|NCT00400712|588277988|FG000|Overall Study|Death|1|||
162885091|NCT00400712|588277989|FG001|Overall Study|Death|0|||
162885092|NCT00400712|588277988|FG000|Overall Study|Withdrawal by Subject|11|||
162885093|NCT00400712|588277989|FG001|Overall Study|Withdrawal by Subject|12|||
162885094|NCT00400712|588277988|FG000|Overall Study|Physician Decision|5|||
162885095|NCT00400712|588277989|FG001|Overall Study|Physician Decision|4|||
162885096|NCT02670330|588277990|FG000|Overall Study|Protocol Deviation|1|||
162885097|NCT02670330|588277991|FG001|Overall Study|Protocol Deviation|0|||
162885098|NCT02670330|588277990|FG000|Overall Study|Study Terminated By Sponsor|36|||
162885099|NCT02670330|588277991|FG001|Overall Study|Study Terminated By Sponsor|43|||
163050567|NCT05209880|588893620|FG001|6-Month Follow-up|Lost to Follow-up|14|||
163050568|NCT05209880|588893619|FG000|6-Month Follow-up|Discontinued|1|||
163050569|NCT05209880|588893620|FG001|6-Month Follow-up|Discontinued|3|||
163050570|NCT03834493|588893621|FG000|Overall Study|Participants Ongoing|311|||
163050571|NCT03834493|588893622|FG001|Overall Study|Participants Ongoing|324|||
163050572|NCT03834493|588893621|FG000|Overall Study|Withdrawal by Subject|20|||
163050573|NCT03834493|588893622|FG001|Overall Study|Withdrawal by Subject|17|||
163050574|NCT03834493|588893621|FG000|Overall Study|Physician Decision|1|||
163050575|NCT03834493|588893622|FG001|Overall Study|Physician Decision|0|||
163050576|NCT03834493|588893621|FG000|Overall Study|Death|289|||
163050577|NCT03834493|588893622|FG001|Overall Study|Death|282|||
163050578|NCT04003103|588893623|FG000|Overall Study|Death|1|||
163050579|NCT04003103|588893624|FG001|Overall Study|Death|0|||
163050580|NCT04003103|588893625|FG002|Overall Study|Death|0|||
162707966|NCT01072929|587640649|FG002|Overall Study|Adverse Event|2|||
162885100|NCT02670330|588277990|FG000|Overall Study|Adverse Event|1|||
162885101|NCT02670330|588277991|FG001|Overall Study|Adverse Event|3|||
162885102|NCT02670330|588277990|FG000|Overall Study|Withdrawal by Subject|34|||
162885103|NCT02670330|588277991|FG001|Overall Study|Withdrawal by Subject|29|||
162885104|NCT02670330|588277990|FG000|Overall Study|Lost to Follow-up|3|||
162885105|NCT02670330|588277991|FG001|Overall Study|Lost to Follow-up|2|||
162885106|NCT00634114|588277992|FG000|Overall Study|Adverse Event|6|||
162885107|NCT00634114|588277993|FG001|Overall Study|Adverse Event|8|||
162885108|NCT00634114|588277994|FG002|Overall Study|Adverse Event|3|||
162885109|NCT00634114|588277992|FG000|Overall Study|Withdrawal by Subject|9|||
162885110|NCT00634114|588277993|FG001|Overall Study|Withdrawal by Subject|6|||
162885111|NCT00634114|588277994|FG002|Overall Study|Withdrawal by Subject|11|||
162885112|NCT00634114|588277992|FG000|Overall Study|Lost to Follow-up|0|||
163050581|NCT04003103|588893623|FG000|Overall Study|Lost to Follow-up|4|||
163050582|NCT04003103|588893624|FG001|Overall Study|Lost to Follow-up|3|||
163050583|NCT04003103|588893625|FG002|Overall Study|Lost to Follow-up|2|||
163050584|NCT04003103|588893623|FG000|Overall Study|Withdrawal by Subject|10|||
163050585|NCT04003103|588893624|FG001|Overall Study|Withdrawal by Subject|1|||
163050586|NCT04003103|588893625|FG002|Overall Study|Withdrawal by Subject|1|||
162885113|NCT00634114|588277993|FG001|Overall Study|Lost to Follow-up|0|||
162885114|NCT00634114|588277994|FG002|Overall Study|Lost to Follow-up|1|||
162885115|NCT00634114|588277992|FG000|Overall Study|Protocol Violation|3|||
162885116|NCT00634114|588277993|FG001|Overall Study|Protocol Violation|3|||
162885117|NCT00634114|588277994|FG002|Overall Study|Protocol Violation|1|||
162885118|NCT00634114|588277992|FG000|Overall Study|Pregnancy|1|||
162885119|NCT00634114|588277993|FG001|Overall Study|Pregnancy|0|||
162885120|NCT00634114|588277994|FG002|Overall Study|Pregnancy|0|||
162885121|NCT00634114|588277992|FG000|Overall Study|Incorrect enrolment|0|||
162885122|NCT00634114|588277993|FG001|Overall Study|Incorrect enrolment|1|||
162885123|NCT00634114|588277994|FG002|Overall Study|Incorrect enrolment|0|||
162885124|NCT00634114|588277992|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
162885125|NCT00634114|588277993|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
162885126|NCT00634114|588277994|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
162885127|NCT00634114|588277992|FG000|Overall Study|Difficult to continue|3|||
162885128|NCT00634114|588277993|FG001|Overall Study|Difficult to continue|1|||
162885129|NCT00634114|588277994|FG002|Overall Study|Difficult to continue|1|||
162885130|NCT00634114|588277992|FG000|Overall Study|Other reason|1|||
162885131|NCT00634114|588277993|FG001|Overall Study|Other reason|1|||
162885132|NCT00634114|588277994|FG002|Overall Study|Other reason|1|||
162885133|NCT03670641|588277999|FG000|Overall Study|Lost to Follow-up|3|||
162885134|NCT00125190|588278005|FG000|Overall Study|Subject/Parent Decision|7|||
162885135|NCT00125190|588278005|FG000|Overall Study|Non-compliance|2|||
162885136|NCT00125190|588278005|FG000|Overall Study|Adverse Event|1|||
162885137|NCT00125190|588278005|FG000|Overall Study|Other|1|||
162885138|NCT00125190|588278005|FG000|Overall Study|Lost to Follow-up|4|||
162885139|NCT00916370|588278006|FG000|Overall Study|Death|3|||
162885140|NCT00916370|588278007|FG001|Overall Study|Death|1|||
162885141|NCT00916370|588278006|FG000|Overall Study|Withdrawal by Subject|2|||
162885142|NCT00916370|588278007|FG001|Overall Study|Withdrawal by Subject|0|||
162885143|NCT00916370|588278006|FG000|Overall Study|Physician Decision|0|||
162885144|NCT00916370|588278007|FG001|Overall Study|Physician Decision|1|||
162885145|NCT00414960|588278009|FG000|Overall Study|Adverse Event|4|||
162885146|NCT00414960|588278010|FG001|Overall Study|Adverse Event|0|||
162885147|NCT00414960|588278009|FG000|Overall Study|Withdrawal by Subject|3|||
162885148|NCT00414960|588278010|FG001|Overall Study|Withdrawal by Subject|0|||
162885149|NCT00414960|588278009|FG000|Overall Study|Physician Decision|0|||
162885150|NCT00414960|588278010|FG001|Overall Study|Physician Decision|1|||
162885151|NCT01318512|588278011|FG000|Maintenance Period (6 Months)|Death|2|||
162885152|NCT01318512|588278011|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
162885153|NCT00363246|588278012|FG000|Overall Study|Death|40|||
162885154|NCT00363246|588278012|FG000|Overall Study|Withdrawal by Subject|19|||
162885155|NCT00363246|588278012|FG000|Overall Study|Lost to Follow-up|14|||
162885156|NCT00363246|588278012|FG000|Overall Study|Bad health|6|||
162885157|NCT00363246|588278012|FG000|Overall Study|Stopped using wheelchair|11|||
162885158|NCT00363246|588278012|FG000|Overall Study|Subject expressed security concerns|2|||
162885159|NCT00363246|588278012|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
162885160|NCT00264849|588278015|FG000|Overall Study|Adverse Event|7|||
162885161|NCT00264849|588278016|FG001|Overall Study|Adverse Event|2|||
162885162|NCT00264849|588278015|FG000|Overall Study|Withdrawal by Subject|7|||
162885163|NCT00264849|588278016|FG001|Overall Study|Withdrawal by Subject|11|||
162885164|NCT00264849|588278015|FG000|Overall Study|Protocol Violation|5|||
162885165|NCT00264849|588278016|FG001|Overall Study|Protocol Violation|3|||
162885166|NCT00264849|588278015|FG000|Overall Study|Lack of Efficacy|1|||
162885167|NCT00264849|588278016|FG001|Overall Study|Lack of Efficacy|6|||
162885168|NCT00264849|588278015|FG000|Overall Study|Lost to Follow-up|0|||
162885169|NCT00264849|588278016|FG001|Overall Study|Lost to Follow-up|2|||
162885170|NCT00264849|588278015|FG000|Overall Study|Death|0|||
162885171|NCT00264849|588278016|FG001|Overall Study|Death|1|||
162885172|NCT00264849|588278015|FG000|Overall Study|Administrative Problems|2|||
162885173|NCT00264849|588278016|FG001|Overall Study|Administrative Problems|0|||
162885174|NCT02756650|588278019|FG000|Overall Study|Physician Decision|1|||
162885175|NCT02756650|588278019|FG000|Overall Study|Adverse Event|1|||
162963229|NCT02055547|588564784|FG016|Overall Study|Physician Decision|0|||
162963230|NCT02055547|588564785|FG017|Overall Study|Physician Decision|0|||
162963231|NCT02055547|588564786|FG018|Overall Study|Physician Decision|0|||
162963232|NCT02055547|588564768|FG000|Overall Study|Adverse Event|0|||
162963233|NCT02055547|588564769|FG001|Overall Study|Adverse Event|0|||
162963234|NCT02055547|588564770|FG002|Overall Study|Adverse Event|0|||
162963235|NCT02055547|588564771|FG003|Overall Study|Adverse Event|0|||
162885176|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
162885177|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
162885178|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
162885179|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
162885180|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
162885181|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
162963236|NCT02055547|588564772|FG004|Overall Study|Adverse Event|0|||
162963237|NCT02055547|588564773|FG005|Overall Study|Adverse Event|0|||
163050587|NCT04003103|588893623|FG000|Overall Study|Status not recorded|0|||
163050588|NCT04003103|588893624|FG001|Overall Study|Status not recorded|2|||
162885182|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162885183|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162885184|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
162885185|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
162885186|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
162885187|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
162885188|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162963238|NCT02055547|588564774|FG006|Overall Study|Adverse Event|1|||
163050589|NCT04003103|588893625|FG002|Overall Study|Status not recorded|0|||
163050590|NCT04144322|588893632|FG000|Overall Study|Lack of Efficacy|2|||
163050591|NCT04144322|588893633|FG001|Overall Study|Lack of Efficacy|2|||
163050592|NCT02277028|588893634|FG000|Overall Study|Lost to Follow-up|1|||
163050593|NCT02277028|588893635|FG001|Overall Study|Lost to Follow-up|0|||
163050594|NCT02277028|588893634|FG000|Overall Study|Withdrawal by Subject|0|||
163050595|NCT02277028|588893635|FG001|Overall Study|Withdrawal by Subject|1|||
163050596|NCT02718911|588893636|FG000|Overall Study|Adverse Event|0|||
163050597|NCT02718911|588893637|FG001|Overall Study|Adverse Event|0|||
163050598|NCT02718911|588893638|FG002|Overall Study|Adverse Event|0|||
163050599|NCT02718911|588893639|FG003|Overall Study|Adverse Event|0|||
163050600|NCT02718911|588893640|FG004|Overall Study|Adverse Event|0|||
163050601|NCT02718911|588893641|FG005|Overall Study|Adverse Event|0|||
163050602|NCT02718911|588893642|FG006|Overall Study|Adverse Event|0|||
163050603|NCT02718911|588893643|FG007|Overall Study|Adverse Event|0|||
163050604|NCT02718911|588893644|FG008|Overall Study|Adverse Event|0|||
163050605|NCT02718911|588893645|FG009|Overall Study|Adverse Event|2|||
163050606|NCT02718911|588893636|FG000|Overall Study|Death|2|||
163050607|NCT02718911|588893637|FG001|Overall Study|Death|3|||
163050608|NCT02718911|588893638|FG002|Overall Study|Death|1|||
163050609|NCT02718911|588893639|FG003|Overall Study|Death|0|||
163050610|NCT02718911|588893640|FG004|Overall Study|Death|1|||
163050611|NCT02718911|588893641|FG005|Overall Study|Death|3|||
163050612|NCT02718911|588893642|FG006|Overall Study|Death|1|||
163050613|NCT02718911|588893643|FG007|Overall Study|Death|1|||
163050614|NCT02718911|588893644|FG008|Overall Study|Death|4|||
163050615|NCT02718911|588893645|FG009|Overall Study|Death|3|||
163050616|NCT02718911|588893636|FG000|Overall Study|Lost to Follow-up|0|||
163050617|NCT02718911|588893637|FG001|Overall Study|Lost to Follow-up|0|||
163050618|NCT02718911|588893638|FG002|Overall Study|Lost to Follow-up|0|||
163050619|NCT02718911|588893639|FG003|Overall Study|Lost to Follow-up|0|||
163050620|NCT02718911|588893640|FG004|Overall Study|Lost to Follow-up|0|||
163050621|NCT02718911|588893641|FG005|Overall Study|Lost to Follow-up|0|||
163050622|NCT02718911|588893642|FG006|Overall Study|Lost to Follow-up|0|||
163050623|NCT02718911|588893643|FG007|Overall Study|Lost to Follow-up|0|||
163050624|NCT02718911|588893644|FG008|Overall Study|Lost to Follow-up|1|||
163050625|NCT02718911|588893645|FG009|Overall Study|Lost to Follow-up|0|||
163050626|NCT02718911|588893636|FG000|Overall Study|Physician Decision|2|||
163050627|NCT02718911|588893637|FG001|Overall Study|Physician Decision|0|||
163050628|NCT02718911|588893638|FG002|Overall Study|Physician Decision|1|||
163050629|NCT02718911|588893639|FG003|Overall Study|Physician Decision|1|||
163050630|NCT02718911|588893640|FG004|Overall Study|Physician Decision|0|||
162963239|NCT02055547|588564775|FG007|Overall Study|Adverse Event|0|||
162963240|NCT02055547|588564776|FG008|Overall Study|Adverse Event|1|||
162963241|NCT02055547|588564777|FG009|Overall Study|Adverse Event|0|||
162963242|NCT02055547|588564778|FG010|Overall Study|Adverse Event|0|||
162963243|NCT02055547|588564779|FG011|Overall Study|Adverse Event|0|||
162963244|NCT02055547|588564780|FG012|Overall Study|Adverse Event|0|||
162963245|NCT02055547|588564781|FG013|Overall Study|Adverse Event|0|||
162963246|NCT02055547|588564782|FG014|Overall Study|Adverse Event|0|||
162963247|NCT02055547|588564783|FG015|Overall Study|Adverse Event|0|||
162963248|NCT02055547|588564784|FG016|Overall Study|Adverse Event|0|||
162963249|NCT02055547|588564785|FG017|Overall Study|Adverse Event|0|||
162963250|NCT02055547|588564786|FG018|Overall Study|Adverse Event|0|||
162963251|NCT02055547|588564768|FG000|Overall Study|Withdrawal by Subject|0|||
163050631|NCT02718911|588893641|FG005|Overall Study|Physician Decision|0|||
163050632|NCT02718911|588893642|FG006|Overall Study|Physician Decision|0|||
163050633|NCT02718911|588893643|FG007|Overall Study|Physician Decision|1|||
163050634|NCT02718911|588893644|FG008|Overall Study|Physician Decision|2|||
162963252|NCT02055547|588564769|FG001|Overall Study|Withdrawal by Subject|0|||
162963253|NCT02055547|588564770|FG002|Overall Study|Withdrawal by Subject|0|||
163050635|NCT02718911|588893645|FG009|Overall Study|Physician Decision|1|||
163050636|NCT02718911|588893636|FG000|Overall Study|Withdrawal by Subject|0|||
163050637|NCT02718911|588893637|FG001|Overall Study|Withdrawal by Subject|0|||
163050638|NCT02718911|588893638|FG002|Overall Study|Withdrawal by Subject|0|||
163050639|NCT02718911|588893639|FG003|Overall Study|Withdrawal by Subject|0|||
163050640|NCT02718911|588893640|FG004|Overall Study|Withdrawal by Subject|1|||
163050641|NCT02718911|588893641|FG005|Overall Study|Withdrawal by Subject|0|||
163050642|NCT02718911|588893642|FG006|Overall Study|Withdrawal by Subject|0|||
162885189|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
162885190|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
162885191|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
162885192|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
162885193|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
162885194|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
162885195|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
162885196|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
162885197|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
162885198|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
162885199|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
162885200|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
162885201|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
162885202|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
162885203|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
162885204|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
162885205|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
162885206|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162885207|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
162885208|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
162885209|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
162885210|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
162885211|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
162885212|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
162885213|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
162885214|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
162885215|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
162885216|NCT00383721|588278020|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
162885217|NCT00383721|588278021|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
162885218|NCT00383721|588278022|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
162885219|NCT00383721|588278023|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
162885220|NCT00383721|588278024|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
162885221|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
162885222|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
162885223|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
162885224|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
162885225|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
162885226|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
162885227|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
162885228|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
162885229|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162885230|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
162963254|NCT02055547|588564771|FG003|Overall Study|Withdrawal by Subject|0|||
162963255|NCT02055547|588564772|FG004|Overall Study|Withdrawal by Subject|0|||
162616862|NCT00299182|587315105|FG000|Overall Study|Chemotherapy Changed|0|||
162616863|NCT00299182|587315106|FG001|Overall Study|Chemotherapy Changed|0|||
162616864|NCT00299182|587315107|FG002|Overall Study|Chemotherapy Changed|1|||
162616865|NCT00299182|587315108|FG003|Overall Study|Chemotherapy Changed|0|||
162616866|NCT00299182|587315109|FG004|Overall Study|Chemotherapy Changed|1|||
162616867|NCT00299182|587315110|FG005|Overall Study|Chemotherapy Changed|0|||
162616868|NCT00299182|587315111|FG006|Overall Study|Chemotherapy Changed|1|||
162616869|NCT00299182|587315105|FG000|Overall Study|Adverse Event|0|||
162616870|NCT00299182|587315106|FG001|Overall Study|Adverse Event|0|||
162616871|NCT00299182|587315107|FG002|Overall Study|Adverse Event|0|||
162616872|NCT00299182|587315108|FG003|Overall Study|Adverse Event|0|||
162616873|NCT00299182|587315109|FG004|Overall Study|Adverse Event|0|||
162616874|NCT00299182|587315110|FG005|Overall Study|Adverse Event|1|||
162616875|NCT00299182|587315111|FG006|Overall Study|Adverse Event|0|||
162616876|NCT00299182|587315105|FG000|Overall Study|Not Eligible|0|||
162616877|NCT00299182|587315106|FG001|Overall Study|Not Eligible|0|||
162616878|NCT00299182|587315107|FG002|Overall Study|Not Eligible|0|||
162616879|NCT00299182|587315108|FG003|Overall Study|Not Eligible|0|||
162616880|NCT00299182|587315109|FG004|Overall Study|Not Eligible|1|||
162616881|NCT00299182|587315110|FG005|Overall Study|Not Eligible|0|||
162616882|NCT00299182|587315111|FG006|Overall Study|Not Eligible|0|||
162616883|NCT00771316|587315114|FG000|Overall Study|Adverse Event|0|||
162616884|NCT00771316|587315115|FG001|Overall Study|Adverse Event|1|||
162885231|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
162885232|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162885233|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162885234|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162885235|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162885236|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
162885237|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
162885238|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
162885239|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
162885240|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
162885241|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162885242|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162885243|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162885244|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162885245|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
162885246|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
162885247|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162885248|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162885249|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
162885250|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
162885251|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162885252|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162885253|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162885254|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162885255|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162885256|NCT00383721|588278020|FG000|26-Week Treatment Safety Extension|Administrative|1|||
162885257|NCT00383721|588278021|FG001|26-Week Treatment Safety Extension|Administrative|2|||
162885258|NCT00383721|588278022|FG002|26-Week Treatment Safety Extension|Administrative|3|||
162885259|NCT00383721|588278023|FG003|26-Week Treatment Safety Extension|Administrative|1|||
162885260|NCT00383721|588278024|FG004|26-Week Treatment Safety Extension|Administrative|0|||
162885261|NCT00132314|588279608|FG000|Overall Study|Lost to Follow-up|70|||
162885262|NCT00132314|588279609|FG001|Overall Study|Lost to Follow-up|62|||
162885263|NCT00132314|588279608|FG000|Overall Study|Lacked SSN|1|||
163050643|NCT02718911|588893643|FG007|Overall Study|Withdrawal by Subject|0|||
163050644|NCT02718911|588893644|FG008|Overall Study|Withdrawal by Subject|1|||
163050645|NCT02718911|588893645|FG009|Overall Study|Withdrawal by Subject|4|||
162885264|NCT00132314|588279609|FG001|Overall Study|Lacked SSN|3|||
162885265|NCT00132314|588279608|FG000|Overall Study|Refused intervention at baseline|2|||
162885266|NCT00132314|588279609|FG001|Overall Study|Refused intervention at baseline|7|||
162885267|NCT03819218|588279623|FG000|Overall Study|Protocol Violation|1|||
162885268|NCT04116073|588279624|FG000|Overall Study|Withdrawal by Subject|2|||
162885269|NCT04116073|588279624|FG000|Overall Study|failed to maintained eligibility|1|||
162885270|NCT01453998|588279628|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
162885271|NCT01453998|588279629|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
162885272|NCT01453998|588279630|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
162885273|NCT01840228|588279637|FG000|Overall Study|Lost to Follow-up|1|||
162885274|NCT01840228|588279638|FG001|Overall Study|Lost to Follow-up|1|||
162885275|NCT00712933|588279639|FG000|Overall Study|Adverse Event|69|||
162885276|NCT00712933|588279639|FG000|Overall Study|Lack of Efficacy|6|||
162885277|NCT00712933|588279639|FG000|Overall Study|Lost to Follow-up|22|||
162885278|NCT00712933|588279639|FG000|Overall Study|Non-compliance with study drug|13|||
162885279|NCT00712933|588279639|FG000|Overall Study|Other Pregnancy|37|||
162885280|NCT00712933|588279639|FG000|Overall Study|Sponsor decision|14|||
162885281|NCT00712933|588279639|FG000|Overall Study|Withdrew consent|4|||
162885282|NCT00712933|588279639|FG000|Overall Study|Hip replacement surgery|1|||
162885283|NCT00712933|588279639|FG000|Overall Study|Involved in Clinical research|3|||
162885284|NCT00712933|588279639|FG000|Overall Study|Participant hospitalized|1|||
162885285|NCT00712933|588279639|FG000|Overall Study|Participant travelled overseas|2|||
162885286|NCT00712933|588279639|FG000|Overall Study|Death of patient|1|||
162885287|NCT00712933|588279639|FG000|Overall Study|Other Physician decision|1|||
162885288|NCT00712933|588279639|FG000|Overall Study|Not committed to contraception|1|||
162885289|NCT00712933|588279639|FG000|Overall Study|Participant received medication|1|||
162885290|NCT00712933|588279639|FG000|Overall Study|Physician Decision|36|||
162885291|NCT00712933|588279639|FG000|Overall Study|Protocol Violation|4|||
162885292|NCT00712933|588279639|FG000|Overall Study|Withdrawal by Subject|151|||
162885293|NCT02022033|588279645|FG000|Overall Study|Physician Decision|1|||
162885294|NCT01429077|588279646|FG000|Overall Study|Lost to Follow-up|0|||
162885295|NCT01429077|588279647|FG001|Overall Study|Lost to Follow-up|3|||
162885296|NCT01413542|588279649|FG000|Overall Study|Physician Decision|1|||
162885297|NCT01413542|588279650|FG001|Overall Study|Physician Decision|0|||
162885298|NCT01413542|588279651|FG002|Overall Study|Physician Decision|3|||
162885299|NCT01413542|588279652|FG003|Overall Study|Physician Decision|0|||
162885300|NCT01413542|588279649|FG000|Overall Study|Adverse Event|0|||
162885301|NCT01413542|588279650|FG001|Overall Study|Adverse Event|0|||
162885302|NCT01413542|588279651|FG002|Overall Study|Adverse Event|0|||
163050646|NCT02718911|588893636|FG000|Overall Study|Reason Not Collected|0|||
163050647|NCT02718911|588893637|FG001|Overall Study|Reason Not Collected|0|||
163050648|NCT02718911|588893638|FG002|Overall Study|Reason Not Collected|1|||
163050649|NCT02718911|588893639|FG003|Overall Study|Reason Not Collected|0|||
163050650|NCT02718911|588893640|FG004|Overall Study|Reason Not Collected|0|||
163050651|NCT02718911|588893641|FG005|Overall Study|Reason Not Collected|0|||
163050652|NCT02718911|588893642|FG006|Overall Study|Reason Not Collected|2|||
163050653|NCT02718911|588893643|FG007|Overall Study|Reason Not Collected|1|||
163050654|NCT02718911|588893644|FG008|Overall Study|Reason Not Collected|4|||
163050655|NCT02718911|588893645|FG009|Overall Study|Reason Not Collected|9|||
163050656|NCT04817332|588893646|FG000|Overall Study|Lost to Follow-up|3|||
163050657|NCT04817332|588893647|FG001|Overall Study|Lost to Follow-up|3|||
163050658|NCT04817332|588893646|FG000|Overall Study|Protocol Violation|2|||
163050659|NCT04817332|588893647|FG001|Overall Study|Protocol Violation|0|||
163050660|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
163050661|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
163050662|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
163050663|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
163050664|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
163050665|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
163050666|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
162616885|NCT00771316|587315114|FG000|Overall Study|Patient withdrew consent|1|||
162885303|NCT01413542|588279652|FG003|Overall Study|Adverse Event|1|||
162885304|NCT01879319|588279657|FG000|Overall Study|Withdrawal by Subject|1|||
162885305|NCT01879319|588279658|FG001|Overall Study|Withdrawal by Subject|0|||
162885306|NCT01879319|588279657|FG000|Overall Study|Lost to Follow-up|1|||
162885307|NCT01879319|588279658|FG001|Overall Study|Lost to Follow-up|5|||
162885308|NCT05590767|588279659|FG000|Overall Study|Protocol Violation|1|||
162885309|NCT05590767|588279659|FG000|Overall Study|surgery canceled|1|||
162885310|NCT05590767|588279659|FG000|Overall Study|interscalene brachial block not performed|1|||
162885311|NCT00084929|588279660|FG000|Overall Study|ineligible - medical contraindication|1|||
162885312|NCT00084929|588279660|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
163050667|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
163050668|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
162616886|NCT00771316|587315115|FG001|Overall Study|Patient withdrew consent|0|||
162616887|NCT00771316|587315114|FG000|Overall Study|Discontinued due to early termination|1|||
162616888|NCT00771316|587315115|FG001|Overall Study|Discontinued due to early termination|0|||
162616889|NCT03643159|587315116|FG000|Overall Study|Adverse Event|1|||
162616890|NCT03643159|587315116|FG000|Overall Study|Withdrawal by Subject|1|||
162616891|NCT04308304|587315119|FG000|Overall Study|Withdrawal by Subject|4|||
162616892|NCT04308304|587315120|FG001|Overall Study|Withdrawal by Subject|0|||
162616893|NCT04308304|587315119|FG000|Overall Study|Protocol Violation|1|||
162885313|NCT00084929|588279660|FG000|Overall Study|Ineligible - Medical history|6|||
162885314|NCT00084929|588279660|FG000|Overall Study|Withdrawal by Subject|10|||
162885315|NCT00084929|588279660|FG000|Overall Study|Missing/incomplete CTC exam|9|||
162885316|NCT00084929|588279660|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
162885317|NCT00664209|588279662|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
162885318|NCT00664209|588279662|FG000|Study Treatment Period|Physician Decision|4|||
162885319|NCT00664209|588279662|FG000|Study Treatment Period|Withdrawal by Subject|2|||
162885320|NCT00091026|588279663|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
162885321|NCT00091026|588279664|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
162885322|NCT00091026|588279663|FG000|Overall Study|Patient withdrew and never received trea|0|||
162885323|NCT00091026|588279664|FG001|Overall Study|Patient withdrew and never received trea|2|||
162885324|NCT00091026|588279663|FG000|Overall Study|Unknown-never received treatment|0|||
162885325|NCT00091026|588279664|FG001|Overall Study|Unknown-never received treatment|1|||
162885326|NCT00065442|588279665|FG000|Overall Study|Lost to Follow-up|1|||
162885327|NCT00065442|588279666|FG001|Overall Study|Lost to Follow-up|1|||
162885328|NCT00065442|588279665|FG000|Overall Study|Death|121|||
162885329|NCT00065442|588279666|FG001|Overall Study|Death|210|||
162885330|NCT00065442|588279665|FG000|Overall Study|Withdrawal by Subject|3|||
162885331|NCT00065442|588279666|FG001|Overall Study|Withdrawal by Subject|9|||
162885332|NCT01797965|588279667|FG000|Overall Study|Adverse Event|104|||
162885333|NCT01797965|588279668|FG001|Overall Study|Adverse Event|129|||
162885334|NCT01797965|588279669|FG002|Overall Study|Adverse Event|4|||
162885335|NCT01797965|588279670|FG003|Overall Study|Adverse Event|21|||
162885336|NCT01797965|588279667|FG000|Overall Study|Lost to Follow-up|9|||
162616894|NCT04308304|587315120|FG001|Overall Study|Protocol Violation|0|||
162616895|NCT03945266|587315125|FG000|Overall Study|Withdrawal by Subject|1|||
162616896|NCT03945266|587315126|FG001|Overall Study|Withdrawal by Subject|0|||
162616897|NCT03945266|587315125|FG000|Overall Study|Miscarriage|0|||
162616898|NCT03945266|587315126|FG001|Overall Study|Miscarriage|2|||
162616899|NCT03945266|587315125|FG000|Overall Study|Lost to Follow-up|1|||
162616900|NCT03945266|587315126|FG001|Overall Study|Lost to Follow-up|0|||
162885337|NCT01797965|588279668|FG001|Overall Study|Lost to Follow-up|8|||
162885338|NCT01797965|588279669|FG002|Overall Study|Lost to Follow-up|1|||
162885339|NCT01797965|588279670|FG003|Overall Study|Lost to Follow-up|2|||
162885340|NCT01797965|588279667|FG000|Overall Study|Consent withdrawn|130|||
162885341|NCT01797965|588279668|FG001|Overall Study|Consent withdrawn|117|||
162885342|NCT01797965|588279669|FG002|Overall Study|Consent withdrawn|3|||
162885343|NCT01797965|588279670|FG003|Overall Study|Consent withdrawn|35|||
162707967|NCT01072929|587640647|FG000|Overall Study|Lack of Efficacy|7|||
162707968|NCT01072929|587640648|FG001|Overall Study|Lack of Efficacy|4|||
162707969|NCT01072929|587640649|FG002|Overall Study|Lack of Efficacy|0|||
162707970|NCT01072929|587640647|FG000|Overall Study|Withdrawal by Subject|7|||
162707971|NCT01072929|587640648|FG001|Overall Study|Withdrawal by Subject|15|||
162707972|NCT01072929|587640649|FG002|Overall Study|Withdrawal by Subject|3|||
162707973|NCT01072929|587640647|FG000|Overall Study|Protocol Violation|13|||
162707974|NCT01072929|587640648|FG001|Overall Study|Protocol Violation|11|||
162707975|NCT01072929|587640649|FG002|Overall Study|Protocol Violation|2|||
162707976|NCT01072929|587640647|FG000|Overall Study|Lost to Follow-up|8|||
162707977|NCT01072929|587640648|FG001|Overall Study|Lost to Follow-up|4|||
162707978|NCT01072929|587640649|FG002|Overall Study|Lost to Follow-up|1|||
162885344|NCT01797965|588279667|FG000|Overall Study|Investigator decision|21|||
162885345|NCT01797965|588279668|FG001|Overall Study|Investigator decision|15|||
162885346|NCT01797965|588279669|FG002|Overall Study|Investigator decision|0|||
162885347|NCT01797965|588279670|FG003|Overall Study|Investigator decision|0|||
162885348|NCT01797965|588279667|FG000|Overall Study|Death|2|||
162707979|NCT01072929|587640647|FG000|Overall Study|Noncompliance with study medication|0|||
162885349|NCT01797965|588279668|FG001|Overall Study|Death|4|||
162885350|NCT01797965|588279669|FG002|Overall Study|Death|0|||
162885351|NCT01797965|588279670|FG003|Overall Study|Death|0|||
162885352|NCT01797965|588279667|FG000|Overall Study|Disease progression, defined by protocol|3|||
162885353|NCT01797965|588279668|FG001|Overall Study|Disease progression, defined by protocol|1|||
162885354|NCT01797965|588279669|FG002|Overall Study|Disease progression, defined by protocol|0|||
162885355|NCT01797965|588279670|FG003|Overall Study|Disease progression, defined by protocol|0|||
162885356|NCT01797965|588279667|FG000|Overall Study|Reason Not Specified|280|||
162885357|NCT01797965|588279668|FG001|Overall Study|Reason Not Specified|295|||
162885358|NCT01797965|588279669|FG002|Overall Study|Reason Not Specified|0|||
162885359|NCT01797965|588279670|FG003|Overall Study|Reason Not Specified|15|||
162885360|NCT01764256|588279671|FG000|Received All Vaccinations|Adverse Event|1|||
162885361|NCT01764256|588279672|FG001|Received All Vaccinations|Adverse Event|1|||
162885362|NCT01764256|588279673|FG002|Received All Vaccinations|Adverse Event|0|||
162885363|NCT01764256|588279674|FG003|Received All Vaccinations|Adverse Event|0|||
162885364|NCT01764256|588279671|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
162885365|NCT01764256|588279672|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
162885366|NCT01764256|588279673|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
162885367|NCT01764256|588279674|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
162885368|NCT01764256|588279671|FG000|Received All Vaccinations|Lost to Follow-up|1|||
162885369|NCT01764256|588279672|FG001|Received All Vaccinations|Lost to Follow-up|0|||
162885370|NCT01764256|588279673|FG002|Received All Vaccinations|Lost to Follow-up|0|||
162885371|NCT01764256|588279674|FG003|Received All Vaccinations|Lost to Follow-up|0|||
162885372|NCT01764256|588279671|FG000|Completed Study|Lost to Follow-up|0|||
162885373|NCT01764256|588279672|FG001|Completed Study|Lost to Follow-up|0|||
162885374|NCT01764256|588279673|FG002|Completed Study|Lost to Follow-up|0|||
162885375|NCT01764256|588279674|FG003|Completed Study|Lost to Follow-up|1|||
162885376|NCT00304915|588279675|FG000|Overall Study|Lost to Follow-up|11|||
162885377|NCT00304915|588279676|FG001|Overall Study|Lost to Follow-up|11|||
162963256|NCT02055547|588564773|FG005|Overall Study|Withdrawal by Subject|1|||
162963257|NCT02055547|588564774|FG006|Overall Study|Withdrawal by Subject|0|||
162963258|NCT02055547|588564775|FG007|Overall Study|Withdrawal by Subject|0|||
162707980|NCT01072929|587640648|FG001|Overall Study|Noncompliance with study medication|3|||
162707981|NCT01072929|587640649|FG002|Overall Study|Noncompliance with study medication|0|||
162707982|NCT01072929|587640647|FG000|Overall Study|Noncompliance with study procedures|1|||
162885378|NCT00304915|588279675|FG000|Overall Study|Death|4|||
162885379|NCT00304915|588279676|FG001|Overall Study|Death|5|||
162885380|NCT00304915|588279675|FG000|Overall Study|Withdrawal by Subject|3|||
162885381|NCT00304915|588279676|FG001|Overall Study|Withdrawal by Subject|0|||
162885382|NCT02029638|588279677|FG000|Overall Study|Death|0|||
162885383|NCT02029638|588279678|FG001|Overall Study|Death|0|||
162885384|NCT02029638|588279679|FG002|Overall Study|Death|1|||
162885385|NCT02029638|588279677|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
162963259|NCT02055547|588564776|FG008|Overall Study|Withdrawal by Subject|1|||
162707983|NCT01072929|587640648|FG001|Overall Study|Noncompliance with study procedures|0|||
162707984|NCT01072929|587640649|FG002|Overall Study|Noncompliance with study procedures|1|||
162707985|NCT01072929|587640647|FG000|Overall Study|Other|0|||
162707986|NCT01072929|587640648|FG001|Overall Study|Other|3|||
162885386|NCT02029638|588279678|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
162885387|NCT02029638|588279679|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
162885388|NCT05489081|588279683|FG000|Overall Study|student left classroom|0|||
162885389|NCT05489081|588279684|FG001|Overall Study|student left classroom|1|||
162885390|NCT05489081|588279683|FG000|Overall Study|teacher left school|0|||
162885391|NCT05489081|588279684|FG001|Overall Study|teacher left school|2|||
162885392|NCT00712322|588279688|FG000|Overall Study|Protocol deviation|0|||
162885393|NCT00712322|588279689|FG001|Overall Study|Protocol deviation|1|||
162885394|NCT00712322|588279690|FG002|Overall Study|Protocol deviation|0|||
162885395|NCT00973921|588279692|FG000|Overall Study|IVUS results were not available|9|||
162885396|NCT04404010|588279693|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
162885397|NCT04404010|588279694|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
162885398|NCT04348591|588279701|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
162885399|NCT04348591|588279702|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
162885400|NCT04348591|588279701|FG000|Imaging Session (120 Min)|Physician Decision|0|||
162885401|NCT04348591|588279702|FG001|Imaging Session (120 Min)|Physician Decision|1|||
162885402|NCT04348591|588279701|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
162885403|NCT04348591|588279702|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
162885404|NCT00622869|588279703|FG000|Overall Study|Subject Withdrew Consent|13|||
162885405|NCT00622869|588279704|FG001|Overall Study|Subject Withdrew Consent|17|||
162885406|NCT00622869|588279705|FG002|Overall Study|Subject Withdrew Consent|11|||
162885407|NCT00622869|588279703|FG000|Overall Study|Administrative Problems|11|||
162885408|NCT00622869|588279704|FG001|Overall Study|Administrative Problems|17|||
162885409|NCT00622869|588279705|FG002|Overall Study|Administrative Problems|13|||
162885410|NCT00622869|588279703|FG000|Overall Study|Death|12|||
162885411|NCT00622869|588279704|FG001|Overall Study|Death|15|||
162885412|NCT00622869|588279705|FG002|Overall Study|Death|10|||
162885413|NCT00622869|588279703|FG000|Overall Study|Lost to Follow-up|2|||
162885414|NCT00622869|588279704|FG001|Overall Study|Lost to Follow-up|4|||
162885415|NCT00622869|588279705|FG002|Overall Study|Lost to Follow-up|2|||
162885416|NCT00622869|588279703|FG000|Overall Study|Graft Loss|5|||
162885417|NCT00622869|588279704|FG001|Overall Study|Graft Loss|3|||
162885418|NCT00622869|588279705|FG002|Overall Study|Graft Loss|2|||
162885419|NCT00622869|588279703|FG000|Overall Study|Missing|0|||
162963260|NCT02055547|588564777|FG009|Overall Study|Withdrawal by Subject|0|||
162963261|NCT02055547|588564778|FG010|Overall Study|Withdrawal by Subject|0|||
162963262|NCT02055547|588564779|FG011|Overall Study|Withdrawal by Subject|0|||
162963263|NCT02055547|588564780|FG012|Overall Study|Withdrawal by Subject|0|||
162963264|NCT02055547|588564781|FG013|Overall Study|Withdrawal by Subject|1|||
162963265|NCT02055547|588564782|FG014|Overall Study|Withdrawal by Subject|0|||
162963266|NCT02055547|588564783|FG015|Overall Study|Withdrawal by Subject|1|||
162963267|NCT02055547|588564784|FG016|Overall Study|Withdrawal by Subject|0|||
162963268|NCT02055547|588564785|FG017|Overall Study|Withdrawal by Subject|0|||
162963269|NCT02055547|588564786|FG018|Overall Study|Withdrawal by Subject|0|||
162963270|NCT02055547|588564768|FG000|Overall Study|Lost to Follow-up|0|||
162963271|NCT02055547|588564769|FG001|Overall Study|Lost to Follow-up|0|||
162963272|NCT02055547|588564770|FG002|Overall Study|Lost to Follow-up|1|||
162963273|NCT02055547|588564771|FG003|Overall Study|Lost to Follow-up|0|||
162963274|NCT02055547|588564772|FG004|Overall Study|Lost to Follow-up|0|||
162963275|NCT02055547|588564773|FG005|Overall Study|Lost to Follow-up|0|||
162963276|NCT02055547|588564774|FG006|Overall Study|Lost to Follow-up|0|||
162963277|NCT02055547|588564775|FG007|Overall Study|Lost to Follow-up|0|||
162963278|NCT02055547|588564776|FG008|Overall Study|Lost to Follow-up|0|||
162963279|NCT02055547|588564777|FG009|Overall Study|Lost to Follow-up|0|||
162963280|NCT02055547|588564778|FG010|Overall Study|Lost to Follow-up|0|||
162963281|NCT02055547|588564779|FG011|Overall Study|Lost to Follow-up|0|||
162963282|NCT02055547|588564780|FG012|Overall Study|Lost to Follow-up|0|||
162963283|NCT02055547|588564781|FG013|Overall Study|Lost to Follow-up|0|||
162963284|NCT02055547|588564782|FG014|Overall Study|Lost to Follow-up|0|||
162963285|NCT02055547|588564783|FG015|Overall Study|Lost to Follow-up|0|||
162963286|NCT02055547|588564784|FG016|Overall Study|Lost to Follow-up|0|||
162963287|NCT02055547|588564785|FG017|Overall Study|Lost to Follow-up|0|||
162963288|NCT02055547|588564786|FG018|Overall Study|Lost to Follow-up|0|||
162707987|NCT01072929|587640649|FG002|Overall Study|Other|0|||
162707988|NCT02806336|587640650|FG000|Overall Study|Physician Decision|1|||
162885420|NCT00622869|588279704|FG001|Overall Study|Missing|1|||
162885421|NCT00622869|588279705|FG002|Overall Study|Missing|1|||
162885422|NCT03722784|588279708|FG000|Overall Study|Withdrawal by Subject|1|||
162885423|NCT03722784|588279709|FG001|Overall Study|Withdrawal by Subject|0|||
162885424|NCT03722784|588279708|FG000|Overall Study|Physician Decision|1|||
162885425|NCT03722784|588279709|FG001|Overall Study|Physician Decision|1|||
162885426|NCT03722784|588279708|FG000|Overall Study|Protocol Violation|0|||
162707989|NCT02806336|587640651|FG001|Overall Study|Physician Decision|0|||
162885427|NCT03722784|588279709|FG001|Overall Study|Protocol Violation|1|||
162885428|NCT00910429|588279712|FG000|Overall Study|Death|18|||
162885429|NCT00910429|588279713|FG001|Overall Study|Death|12|||
162885430|NCT00910429|588279712|FG000|Overall Study|Withdrawal by Subject|3|||
162885431|NCT00910429|588279713|FG001|Overall Study|Withdrawal by Subject|2|||
162885432|NCT00910429|588279712|FG000|Overall Study|Protocol Violation|1|||
162885433|NCT00910429|588279713|FG001|Overall Study|Protocol Violation|0|||
162707990|NCT02806336|587640650|FG000|Overall Study|Withdrawal by Subject|2|||
162885434|NCT00910429|588279712|FG000|Overall Study|Lost to Follow-up|2|||
162885435|NCT00910429|588279713|FG001|Overall Study|Lost to Follow-up|1|||
162885436|NCT00910429|588279712|FG000|Overall Study|Adverse Event|10|||
162885437|NCT00910429|588279713|FG001|Overall Study|Adverse Event|5|||
162885438|NCT00910429|588279712|FG000|Overall Study|Drug non-compliance|1|||
162885439|NCT00910429|588279713|FG001|Overall Study|Drug non-compliance|0|||
162885440|NCT00910429|588279712|FG000|Overall Study|Lack of Efficacy|4|||
162885441|NCT00910429|588279713|FG001|Overall Study|Lack of Efficacy|1|||
162885442|NCT01317615|588279714|FG000|Overall Study|Disease progression|25|||
162885443|NCT01317615|588279714|FG000|Overall Study|New cancer therapy|5|||
162885444|NCT01317615|588279714|FG000|Overall Study|Death|6|||
162885445|NCT01317615|588279714|FG000|Overall Study|Withdrawal by Subject|5|||
162885446|NCT01317615|588279714|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162885447|NCT01317615|588279714|FG000|Overall Study|Adverse Event|7|||
162885448|NCT02648724|588279718|FG000|Overall Study|Withdrawal by Subject|0|||
162885449|NCT02648724|588279719|FG001|Overall Study|Withdrawal by Subject|1|||
162885450|NCT02648724|588279720|FG002|Overall Study|Withdrawal by Subject|1|||
162885451|NCT02648724|588279721|FG003|Overall Study|Withdrawal by Subject|0|||
162885452|NCT02648724|588279722|FG004|Overall Study|Withdrawal by Subject|1|||
162885453|NCT02648724|588279723|FG005|Overall Study|Withdrawal by Subject|0|||
162885454|NCT02648724|588279724|FG006|Overall Study|Withdrawal by Subject|0|||
162885455|NCT02648724|588279718|FG000|Overall Study|Progressive disease|2|||
162885456|NCT02648724|588279719|FG001|Overall Study|Progressive disease|2|||
162885457|NCT02648724|588279720|FG002|Overall Study|Progressive disease|2|||
162885458|NCT02648724|588279721|FG003|Overall Study|Progressive disease|3|||
162885459|NCT02648724|588279722|FG004|Overall Study|Progressive disease|22|||
162885460|NCT02648724|588279723|FG005|Overall Study|Progressive disease|7|||
162885461|NCT02648724|588279724|FG006|Overall Study|Progressive disease|8|||
162885462|NCT02648724|588279718|FG000|Overall Study|Other reason (unknown)|1|||
162885463|NCT02648724|588279719|FG001|Overall Study|Other reason (unknown)|0|||
162885464|NCT02648724|588279720|FG002|Overall Study|Other reason (unknown)|0|||
162885465|NCT02648724|588279721|FG003|Overall Study|Other reason (unknown)|0|||
162885466|NCT02648724|588279722|FG004|Overall Study|Other reason (unknown)|0|||
162885467|NCT02648724|588279723|FG005|Overall Study|Other reason (unknown)|0|||
162885468|NCT02648724|588279724|FG006|Overall Study|Other reason (unknown)|0|||
162885469|NCT02648724|588279718|FG000|Overall Study|Protocol Violation|0|||
162885470|NCT02648724|588279719|FG001|Overall Study|Protocol Violation|0|||
162885471|NCT02648724|588279720|FG002|Overall Study|Protocol Violation|0|||
162885472|NCT02648724|588279721|FG003|Overall Study|Protocol Violation|0|||
162885473|NCT02648724|588279722|FG004|Overall Study|Protocol Violation|1|||
162885474|NCT02648724|588279723|FG005|Overall Study|Protocol Violation|0|||
162885475|NCT02648724|588279724|FG006|Overall Study|Protocol Violation|0|||
162885476|NCT02648724|588279718|FG000|Overall Study|Death|0|||
162885477|NCT02648724|588279719|FG001|Overall Study|Death|0|||
162885478|NCT02648724|588279720|FG002|Overall Study|Death|0|||
162885479|NCT02648724|588279721|FG003|Overall Study|Death|0|||
162885480|NCT02648724|588279722|FG004|Overall Study|Death|0|||
162885481|NCT02648724|588279723|FG005|Overall Study|Death|0|||
162885482|NCT02648724|588279724|FG006|Overall Study|Death|3|||
162885483|NCT02648724|588279718|FG000|Overall Study|Physician Decision|0|||
162885484|NCT02648724|588279719|FG001|Overall Study|Physician Decision|0|||
162885485|NCT02648724|588279720|FG002|Overall Study|Physician Decision|0|||
162885486|NCT02648724|588279721|FG003|Overall Study|Physician Decision|0|||
162885487|NCT02648724|588279722|FG004|Overall Study|Physician Decision|1|||
162885488|NCT02648724|588279723|FG005|Overall Study|Physician Decision|0|||
162885489|NCT02648724|588279724|FG006|Overall Study|Physician Decision|1|||
162885490|NCT02648724|588279718|FG000|Overall Study|Transferred to named patient program|0|||
162885491|NCT02648724|588279719|FG001|Overall Study|Transferred to named patient program|0|||
162707991|NCT02806336|587640651|FG001|Overall Study|Withdrawal by Subject|4|||
162707992|NCT02806336|587640650|FG000|Overall Study|COVID-19 research shut down|3|||
162707993|NCT02806336|587640651|FG001|Overall Study|COVID-19 research shut down|4|||
162707994|NCT02806336|587640650|FG000|Overall Study|Lack of Efficacy|0|||
162707995|NCT02806336|587640651|FG001|Overall Study|Lack of Efficacy|1|||
162885492|NCT02648724|588279720|FG002|Overall Study|Transferred to named patient program|0|||
162885493|NCT02648724|588279721|FG003|Overall Study|Transferred to named patient program|0|||
162885494|NCT02648724|588279722|FG004|Overall Study|Transferred to named patient program|0|||
162885495|NCT02648724|588279723|FG005|Overall Study|Transferred to named patient program|1|||
162885496|NCT02648724|588279724|FG006|Overall Study|Transferred to named patient program|0|||
162885497|NCT00302718|588279725|FG000|Overall Study|Participant left the hospital|1|||
162885498|NCT00302718|588279726|FG001|Overall Study|Participant left the hospital|0|||
162885499|NCT00302718|588279727|FG002|Overall Study|Participant left the hospital|0|||
162885500|NCT00302718|588279728|FG003|Overall Study|Participant left the hospital|1|||
162885501|NCT00302718|588279725|FG000|Overall Study|Withdrawal by Subject|0|||
162885502|NCT00302718|588279726|FG001|Overall Study|Withdrawal by Subject|1|||
162885503|NCT00302718|588279727|FG002|Overall Study|Withdrawal by Subject|0|||
162885504|NCT00302718|588279728|FG003|Overall Study|Withdrawal by Subject|0|||
162885505|NCT00302718|588279725|FG000|Overall Study|Participant left primary care setting|0|||
162885506|NCT00302718|588279726|FG001|Overall Study|Participant left primary care setting|0|||
162885507|NCT00302718|588279727|FG002|Overall Study|Participant left primary care setting|2|||
162885508|NCT00302718|588279728|FG003|Overall Study|Participant left primary care setting|1|||
162885509|NCT00738374|588279729|FG000|Induction Treatment Phase|Adverse Event|14|||
162885510|NCT00738374|588279730|FG001|Induction Treatment Phase|Adverse Event|0|||
162885511|NCT00738374|588279731|FG002|Induction Treatment Phase|Adverse Event|0|||
162885512|NCT00738374|588279732|FG003|Induction Treatment Phase|Adverse Event|0|||
162885513|NCT00738374|588279729|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
162885514|NCT00738374|588279730|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
162885515|NCT00738374|588279731|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
162885516|NCT00738374|588279732|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
162885517|NCT00738374|588279729|FG000|Induction Treatment Phase|Physician Decision|2|||
162885518|NCT00738374|588279730|FG001|Induction Treatment Phase|Physician Decision|0|||
162885519|NCT00738374|588279731|FG002|Induction Treatment Phase|Physician Decision|0|||
162885520|NCT00738374|588279732|FG003|Induction Treatment Phase|Physician Decision|0|||
162885521|NCT00738374|588279729|FG000|Induction Treatment Phase|Protocol Violation|2|||
162885522|NCT00738374|588279730|FG001|Induction Treatment Phase|Protocol Violation|0|||
162885523|NCT00738374|588279731|FG002|Induction Treatment Phase|Protocol Violation|0|||
162885524|NCT00738374|588279732|FG003|Induction Treatment Phase|Protocol Violation|0|||
162885525|NCT00738374|588279729|FG000|Induction Treatment Phase|Non-compliance|1|||
162885526|NCT00738374|588279730|FG001|Induction Treatment Phase|Non-compliance|0|||
162885527|NCT00738374|588279731|FG002|Induction Treatment Phase|Non-compliance|0|||
162885528|NCT00738374|588279732|FG003|Induction Treatment Phase|Non-compliance|0|||
162885529|NCT00738374|588279729|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
162885530|NCT00738374|588279730|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
162885531|NCT00738374|588279731|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
162885532|NCT00738374|588279732|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
162885533|NCT00738374|588279729|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
162885534|NCT00738374|588279730|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
162885535|NCT00738374|588279731|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
162885536|NCT00738374|588279732|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
162885537|NCT00738374|588279729|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
162885538|NCT00738374|588279730|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
162885539|NCT00738374|588279731|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
162885540|NCT00738374|588279732|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
162885541|NCT00738374|588279729|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
162885542|NCT00738374|588279730|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
162885543|NCT00738374|588279731|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
162885544|NCT00738374|588279732|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
162885545|NCT00738374|588279729|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
162885546|NCT00738374|588279730|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
162885547|NCT00738374|588279731|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
162885548|NCT00738374|588279732|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
162885549|NCT00738374|588279729|FG000|Maintenance Treatment/Observation Phase|Other|0|||
162885550|NCT00738374|588279730|FG001|Maintenance Treatment/Observation Phase|Other|1|||
162885551|NCT00738374|588279731|FG002|Maintenance Treatment/Observation Phase|Other|0|||
162885552|NCT00738374|588279732|FG003|Maintenance Treatment/Observation Phase|Other|0|||
162885553|NCT00632541|588279733|FG000|Overall Study|Adverse Event|7|||
162885554|NCT02927873|588279735|FG000|Overall Study|Lost to Follow-up|0|||
162885555|NCT02927873|588279736|FG001|Overall Study|Lost to Follow-up|1|||
162885556|NCT02927873|588279737|FG002|Overall Study|Lost to Follow-up|0|||
162885557|NCT02927873|588279738|FG003|Overall Study|Lost to Follow-up|0|||
162885558|NCT02927873|588279739|FG004|Overall Study|Lost to Follow-up|0|||
162885559|NCT02927873|588279740|FG005|Overall Study|Lost to Follow-up|0|||
162885560|NCT02927873|588279735|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162885561|NCT02927873|588279736|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
162885562|NCT02927873|588279737|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162963289|NCT01456221|588564787|FG000|Overall Study|Withdrawal by Subject|56|||
162963290|NCT01456221|588564788|FG001|Overall Study|Withdrawal by Subject|49|||
162963291|NCT01456221|588564787|FG000|Overall Study|Lost to Follow-up|1|||
162963292|NCT01456221|588564788|FG001|Overall Study|Lost to Follow-up|4|||
162616934|NCT03805646|587315147|FG000|Overall Study|Death|40|||
162616935|NCT03805646|587315148|FG001|Overall Study|Death|49|||
162616936|NCT03805646|587315147|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
162616937|NCT03805646|587315148|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
162616938|NCT04452344|587315150|FG000|Overall Study|Withdrawal by Subject|3|||
162616939|NCT04452344|587315151|FG001|Overall Study|Withdrawal by Subject|6|||
162616940|NCT04452344|587315150|FG000|Overall Study|Adverse Event|1|||
162616941|NCT04452344|587315151|FG001|Overall Study|Adverse Event|2|||
162616942|NCT04452344|587315150|FG000|Overall Study|Lost to Follow-up|2|||
162885563|NCT02927873|588279738|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162885564|NCT02927873|588279739|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162885565|NCT02927873|588279740|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162885566|NCT02927873|588279735|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162885567|NCT02927873|588279736|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162885568|NCT02927873|588279737|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162616943|NCT04452344|587315151|FG001|Overall Study|Lost to Follow-up|2|||
162616944|NCT04452344|587315150|FG000|Overall Study|No Post-Op Visit|6|||
162885569|NCT02927873|588279738|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162885570|NCT02927873|588279739|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162885571|NCT02927873|588279740|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162885572|NCT02927873|588279735|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
162885573|NCT02927873|588279736|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
162885574|NCT02927873|588279737|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
162885575|NCT02927873|588279738|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
162885576|NCT02927873|588279739|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
162885577|NCT02927873|588279740|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
162885578|NCT02927873|588279735|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
162885579|NCT02927873|588279736|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162885580|NCT02927873|588279737|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162885581|NCT02927873|588279738|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162885582|NCT02927873|588279739|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162885583|NCT02927873|588279740|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162885584|NCT02927873|588279735|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
162885585|NCT02927873|588279736|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
162885586|NCT02927873|588279737|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
162885587|NCT02927873|588279738|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
162885588|NCT02927873|588279739|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
162885589|NCT02927873|588279740|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
162885590|NCT00393913|588279741|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
162885591|NCT00393913|588279741|FG000|Initial Assessment|Withdrawal by Subject|16|||
162885592|NCT00393913|588279741|FG000|CPAP|Withdrawal by Subject|3|||
162885593|NCT00393913|588279741|FG000|CPAP|Physician Decision|1|||
162885594|NCT00393913|588279741|FG000|CPAP|TEchnical problem with CPAP|3|||
162885595|NCT01518244|588279742|FG000|Overall Study|Adverse Event|3|||
162885596|NCT04900038|588279744|FG000|Overall Study|Adverse Event|1|||
162885597|NCT04900038|588279745|FG001|Overall Study|Adverse Event|0|||
162885598|NCT04900038|588279746|FG002|Overall Study|Adverse Event|1|||
162885599|NCT04900038|588279747|FG003|Overall Study|Adverse Event|1|||
162885600|NCT04900038|588279744|FG000|Overall Study|Withdrawal by Subject|0|||
162885601|NCT04900038|588279745|FG001|Overall Study|Withdrawal by Subject|1|||
162885602|NCT04900038|588279746|FG002|Overall Study|Withdrawal by Subject|0|||
162885603|NCT04900038|588279747|FG003|Overall Study|Withdrawal by Subject|0|||
162885604|NCT04900038|588279744|FG000|Overall Study|Study terminated by sponsor|18|||
162885605|NCT04900038|588279745|FG001|Overall Study|Study terminated by sponsor|15|||
162885606|NCT04900038|588279746|FG002|Overall Study|Study terminated by sponsor|17|||
162885607|NCT04900038|588279747|FG003|Overall Study|Study terminated by sponsor|14|||
162885608|NCT04900038|588279744|FG000|Overall Study|Protocol Deviation|1|||
162885609|NCT04900038|588279745|FG001|Overall Study|Protocol Deviation|1|||
162616945|NCT04452344|587315151|FG001|Overall Study|No Post-Op Visit|7|||
162616946|NCT05171777|587315152|FG000|Treatment Crossover Period|Adverse Event|9|||
162616947|NCT05171777|587315153|FG001|Treatment Crossover Period|Adverse Event|6|||
162885610|NCT04900038|588279746|FG002|Overall Study|Protocol Deviation|0|||
162707996|NCT04824131|587640652|FG000|CAB LA Oral Phase|Adverse Event|1|||
162885611|NCT04900038|588279747|FG003|Overall Study|Protocol Deviation|0|||
162885612|NCT04900038|588279744|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
162885613|NCT04900038|588279745|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
162885614|NCT04900038|588279746|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
162885615|NCT04900038|588279747|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
162885616|NCT04900038|588279744|FG000|Overall Study|Lost to Follow-up|0|||
162885617|NCT04900038|588279745|FG001|Overall Study|Lost to Follow-up|0|||
162885618|NCT04900038|588279746|FG002|Overall Study|Lost to Follow-up|0|||
162885619|NCT04900038|588279747|FG003|Overall Study|Lost to Follow-up|1|||
162885620|NCT00077376|588279752|FG000|Overall Study|Adverse Event|8|||
162885621|NCT00077376|588279752|FG000|Overall Study|Withdrawal by Subject|2|||
162885622|NCT00077376|588279752|FG000|Overall Study|Death|1|||
162885623|NCT00077376|588279752|FG000|Overall Study|Physician Decision|1|||
162885624|NCT00077376|588279752|FG000|Overall Study|Alternative therapy|5|||
162885625|NCT00077376|588279752|FG000|Overall Study|Complicating disease|1|||
162885626|NCT00077376|588279752|FG000|Overall Study|Still on treatment|1|||
162885627|NCT00077376|588279752|FG000|Overall Study|Symptomatic deterioration|1|||
162885628|NCT00077376|588279752|FG000|Overall Study|Surgery|1|||
162885629|NCT00077376|588279752|FG000|Overall Study|Insurance ran out|1|||
162885630|NCT05757427|588279753|FG000|Overall Study|Adverse Event|1|||
162885631|NCT05757427|588279753|FG000|Overall Study|Device deficiency|1|||
162885632|NCT05757427|588279753|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
162885633|NCT05757427|588279753|FG000|Overall Study|MWBI scan of only 1 breast|3|||
162885634|NCT05757427|588279753|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
162885635|NCT02017899|588281886|FG000|Overall Study|Withdrawal by Subject|0|||
162885636|NCT02017899|588281887|FG001|Overall Study|Withdrawal by Subject|0|||
162885637|NCT02017899|588281888|FG002|Overall Study|Withdrawal by Subject|0|||
162885638|NCT02017899|588281889|FG003|Overall Study|Withdrawal by Subject|1|||
162885639|NCT02017899|588281890|FG004|Overall Study|Withdrawal by Subject|1|||
162885640|NCT02017899|588281891|FG005|Overall Study|Withdrawal by Subject|0|||
162885641|NCT02843178|588281893|FG000|Overall Study|Lost to Follow-up|8|||
162885642|NCT02843178|588281894|FG001|Overall Study|Lost to Follow-up|8|||
162885643|NCT02843178|588281895|FG002|Overall Study|Lost to Follow-up|6|||
162885644|NCT02843178|588281896|FG003|Overall Study|Lost to Follow-up|3|||
162885645|NCT02843178|588281893|FG000|Overall Study|Withdrawal by Subject|0|||
162885646|NCT02843178|588281894|FG001|Overall Study|Withdrawal by Subject|0|||
162963293|NCT01456221|588564787|FG000|Overall Study|Received medication|3|||
162963294|NCT01456221|588564788|FG001|Overall Study|Received medication|2|||
162963295|NCT01456221|588564787|FG000|Overall Study|Incomplete data|4|||
162616948|NCT05171777|587315154|FG002|Treatment Crossover Period|Adverse Event|0|||
162616949|NCT05171777|587315155|FG003|Treatment Crossover Period|Adverse Event|0|||
162616950|NCT05171777|587315152|FG000|Treatment Crossover Period|Death|5|||
162616951|NCT05171777|587315153|FG001|Treatment Crossover Period|Death|5|||
162616952|NCT05171777|587315154|FG002|Treatment Crossover Period|Death|0|||
162616953|NCT05171777|587315155|FG003|Treatment Crossover Period|Death|0|||
162616954|NCT05171777|587315152|FG000|Treatment Crossover Period|Disease Relapse|1|||
162616955|NCT05171777|587315153|FG001|Treatment Crossover Period|Disease Relapse|0|||
162616956|NCT05171777|587315154|FG002|Treatment Crossover Period|Disease Relapse|0|||
162616957|NCT05171777|587315155|FG003|Treatment Crossover Period|Disease Relapse|0|||
162616958|NCT05171777|587315152|FG000|Treatment Crossover Period|Reason not Specified|1|||
162616959|NCT05171777|587315153|FG001|Treatment Crossover Period|Reason not Specified|1|||
162616960|NCT05171777|587315154|FG002|Treatment Crossover Period|Reason not Specified|0|||
162616961|NCT05171777|587315155|FG003|Treatment Crossover Period|Reason not Specified|0|||
162616962|NCT05171777|587315152|FG000|Treatment Crossover Period|Physician Decision|0|||
162885647|NCT02843178|588281895|FG002|Overall Study|Withdrawal by Subject|1|||
162885648|NCT02843178|588281896|FG003|Overall Study|Withdrawal by Subject|1|||
162885649|NCT02420795|588281903|FG000|Overall Study|Withdrawal by Subject|1|||
162885650|NCT02420795|588281904|FG001|Overall Study|Withdrawal by Subject|0|||
162885651|NCT02420795|588281905|FG002|Overall Study|Withdrawal by Subject|0|||
162885652|NCT02420795|588281903|FG000|Overall Study|Adverse Event|1|||
162885653|NCT02420795|588281904|FG001|Overall Study|Adverse Event|0|||
162885654|NCT02420795|588281905|FG002|Overall Study|Adverse Event|0|||
162885655|NCT02420795|588281903|FG000|Overall Study|Progressive disease|2|||
162885656|NCT02420795|588281904|FG001|Overall Study|Progressive disease|2|||
162885657|NCT02420795|588281905|FG002|Overall Study|Progressive disease|4|||
162885658|NCT02420795|588281903|FG000|Overall Study|Death|0|||
162885659|NCT02420795|588281904|FG001|Overall Study|Death|0|||
162885660|NCT02420795|588281905|FG002|Overall Study|Death|1|||
162885661|NCT00949910|588281908|FG000|Overall Study|Progressive Disease|3750|||
162885662|NCT00949910|588281908|FG000|Overall Study|Symptomatic Deterioration|1088|||
162885663|NCT00949910|588281908|FG000|Overall Study|Lost to Follow-up|100|||
162885664|NCT00949910|588281908|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
162885665|NCT00949910|588281908|FG000|Overall Study|Participant Refusal|390|||
162885666|NCT00949910|588281908|FG000|Overall Study|Death Due to Malignant Disease|456|||
162963296|NCT01456221|588564788|FG001|Overall Study|Incomplete data|2|||
162963297|NCT01986647|588564790|FG000|Overall Study|Lost to Follow-up|4|||
162616963|NCT05171777|587315153|FG001|Treatment Crossover Period|Physician Decision|1|||
162616964|NCT05171777|587315154|FG002|Treatment Crossover Period|Physician Decision|0|||
162616965|NCT05171777|587315155|FG003|Treatment Crossover Period|Physician Decision|0|||
162616966|NCT05171777|587315152|FG000|Treatment Crossover Period|Progressive Disease|14|||
162616967|NCT05171777|587315153|FG001|Treatment Crossover Period|Progressive Disease|10|||
162616968|NCT05171777|587315154|FG002|Treatment Crossover Period|Progressive Disease|0|||
162616969|NCT05171777|587315155|FG003|Treatment Crossover Period|Progressive Disease|0|||
162616970|NCT05171777|587315152|FG000|Treatment Crossover Period|Protocol Violation|0|||
162616971|NCT05171777|587315153|FG001|Treatment Crossover Period|Protocol Violation|2|||
162616972|NCT05171777|587315154|FG002|Treatment Crossover Period|Protocol Violation|0|||
162616973|NCT05171777|587315155|FG003|Treatment Crossover Period|Protocol Violation|0|||
162616974|NCT05171777|587315152|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
162616975|NCT05171777|587315153|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
162616976|NCT05171777|587315154|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
162616977|NCT05171777|587315155|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
162616978|NCT05171777|587315152|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
162616979|NCT05171777|587315153|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
162616980|NCT05171777|587315154|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
162616981|NCT05171777|587315155|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
162616982|NCT05171777|587315152|FG000|Treatment Continuation Period|Adverse Event|0|||
162616983|NCT05171777|587315153|FG001|Treatment Continuation Period|Adverse Event|0|||
162616984|NCT05171777|587315154|FG002|Treatment Continuation Period|Adverse Event|3|||
162616985|NCT05171777|587315155|FG003|Treatment Continuation Period|Adverse Event|6|||
162616986|NCT05171777|587315152|FG000|Treatment Continuation Period|Death|0|||
162616987|NCT05171777|587315153|FG001|Treatment Continuation Period|Death|0|||
162616988|NCT05171777|587315154|FG002|Treatment Continuation Period|Death|1|||
162616989|NCT05171777|587315155|FG003|Treatment Continuation Period|Death|3|||
162616990|NCT05171777|587315152|FG000|Treatment Continuation Period|Disease Relapse|0|||
162616991|NCT05171777|587315153|FG001|Treatment Continuation Period|Disease Relapse|0|||
162616992|NCT05171777|587315154|FG002|Treatment Continuation Period|Disease Relapse|1|||
162616993|NCT05171777|587315155|FG003|Treatment Continuation Period|Disease Relapse|0|||
162616994|NCT05171777|587315152|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
162616995|NCT05171777|587315153|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
162616996|NCT05171777|587315154|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
162616997|NCT05171777|587315155|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
162616998|NCT05171777|587315152|FG000|Treatment Continuation Period|Physician Decision|0|||
162616999|NCT05171777|587315153|FG001|Treatment Continuation Period|Physician Decision|0|||
162617000|NCT05171777|587315154|FG002|Treatment Continuation Period|Physician Decision|0|||
162617001|NCT05171777|587315155|FG003|Treatment Continuation Period|Physician Decision|4|||
162617002|NCT05171777|587315152|FG000|Treatment Continuation Period|Progressive Disease|0|||
162617003|NCT05171777|587315153|FG001|Treatment Continuation Period|Progressive Disease|0|||
162617004|NCT05171777|587315154|FG002|Treatment Continuation Period|Progressive Disease|6|||
162617005|NCT05171777|587315155|FG003|Treatment Continuation Period|Progressive Disease|20|||
162617006|NCT05171777|587315152|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
162617007|NCT05171777|587315153|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
162617008|NCT05171777|587315154|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
162617009|NCT05171777|587315155|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
162617010|NCT05171777|587315152|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
162617011|NCT05171777|587315153|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
162617012|NCT05171777|587315154|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
162617013|NCT05171777|587315155|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
162885667|NCT00949910|588281908|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
162885668|NCT00949910|588281908|FG000|Overall Study|Death Due to Adverse Event|115|||
162885669|NCT00949910|588281908|FG000|Overall Study|Death Due to Toxicity|3|||
162885670|NCT00949910|588281908|FG000|Overall Study|Death from Unknown Cause|5|||
162617014|NCT05171777|587315152|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
162885671|NCT00949910|588281908|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
162885672|NCT00949910|588281908|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
162885673|NCT00949910|588281908|FG000|Overall Study|Switched to Commercial Treatment|4|||
162885674|NCT00949910|588281908|FG000|Overall Study|Violation of Eligibility|23|||
162885675|NCT00949910|588281908|FG000|Overall Study|Logistical Reasons|13|||
162963298|NCT01986647|588564791|FG001|Overall Study|Lost to Follow-up|1|||
162617015|NCT05171777|587315153|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
162617016|NCT05171777|587315154|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
162617017|NCT05171777|587315155|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
162617018|NCT02364713|587315156|FG000|Overall Study|Ineligible|2|||
162617019|NCT02364713|587315157|FG001|Overall Study|Ineligible|2|||
162885676|NCT00949910|588281908|FG000|Overall Study|Non-Compliance|10|||
162885677|NCT00949910|588281908|FG000|Overall Study|Prolonged Dosing Interruption|4|||
162885678|NCT00949910|588281908|FG000|Overall Study|Adverse Event|83|||
162885679|NCT00949910|588281908|FG000|Overall Study|Serious Adverse Event|6|||
162885680|NCT00949910|588281908|FG000|Overall Study|Physician/Participant Decision|7|||
162885681|NCT00949910|588281908|FG000|Overall Study|Other|4|||
162885682|NCT00949910|588281908|FG000|Overall Study|No Data|9|||
162885683|NCT00971425|588281909|FG000|Overall Study|Adverse Event|1|||
162885684|NCT00971425|588281910|FG001|Overall Study|Adverse Event|1|||
162885685|NCT00971425|588281909|FG000|Overall Study|Withdrawal by Subject|0|||
162885686|NCT00971425|588281910|FG001|Overall Study|Withdrawal by Subject|1|||
162885687|NCT02528253|588281913|FG000|Overall Study|Adverse Event|3|||
162885688|NCT02528253|588281914|FG001|Overall Study|Adverse Event|4|||
162885689|NCT02528253|588281915|FG002|Overall Study|Adverse Event|4|||
162885690|NCT02528253|588281916|FG003|Overall Study|Adverse Event|8|||
162885691|NCT02528253|588281917|FG004|Overall Study|Adverse Event|18|||
162885692|NCT02528253|588281913|FG000|Overall Study|Death|2|||
162885693|NCT02528253|588281914|FG001|Overall Study|Death|2|||
162885694|NCT02528253|588281915|FG002|Overall Study|Death|1|||
162885695|NCT02528253|588281916|FG003|Overall Study|Death|0|||
162885696|NCT02528253|588281917|FG004|Overall Study|Death|1|||
162885697|NCT02528253|588281913|FG000|Overall Study|Insufficient clinical response|7|||
162885698|NCT02528253|588281914|FG001|Overall Study|Insufficient clinical response|10|||
162885699|NCT02528253|588281915|FG002|Overall Study|Insufficient clinical response|13|||
162885700|NCT02528253|588281916|FG003|Overall Study|Insufficient clinical response|12|||
162885701|NCT02528253|588281917|FG004|Overall Study|Insufficient clinical response|16|||
162885702|NCT02528253|588281913|FG000|Overall Study|Lost to Follow-up|16|||
162885703|NCT02528253|588281914|FG001|Overall Study|Lost to Follow-up|9|||
162885704|NCT02528253|588281915|FG002|Overall Study|Lost to Follow-up|31|||
162885705|NCT02528253|588281916|FG003|Overall Study|Lost to Follow-up|16|||
162885706|NCT02528253|588281917|FG004|Overall Study|Lost to Follow-up|34|||
162885707|NCT02528253|588281913|FG000|Overall Study|Other|21|||
162885708|NCT02528253|588281914|FG001|Overall Study|Other|22|||
162885709|NCT02528253|588281915|FG002|Overall Study|Other|58|||
162885710|NCT02528253|588281916|FG003|Overall Study|Other|52|||
162885711|NCT02528253|588281917|FG004|Overall Study|Other|76|||
162885712|NCT02528253|588281913|FG000|Overall Study|Withdrawal by Subject|25|||
162885713|NCT02528253|588281914|FG001|Overall Study|Withdrawal by Subject|20|||
162885714|NCT02528253|588281915|FG002|Overall Study|Withdrawal by Subject|29|||
162885715|NCT02528253|588281916|FG003|Overall Study|Withdrawal by Subject|48|||
162885716|NCT02528253|588281917|FG004|Overall Study|Withdrawal by Subject|73|||
162885717|NCT02528253|588281913|FG000|Overall Study|Protocol Violation|1|||
162885718|NCT02528253|588281914|FG001|Overall Study|Protocol Violation|2|||
162885719|NCT02528253|588281915|FG002|Overall Study|Protocol Violation|4|||
162885720|NCT02528253|588281916|FG003|Overall Study|Protocol Violation|0|||
162885721|NCT02528253|588281917|FG004|Overall Study|Protocol Violation|4|||
162885722|NCT02528253|588281913|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
162885723|NCT02528253|588281914|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
162885724|NCT02528253|588281915|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
162617020|NCT04686786|587315158|FG000|Overall Study|Adverse Event|9|||
162617021|NCT04686786|587315158|FG000|Overall Study|Death|1|||
162617022|NCT04686786|587315158|FG000|Overall Study|Lack of Efficacy|25|||
162617023|NCT04686786|587315158|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
162617024|NCT04686786|587315158|FG000|Overall Study|Study Terminated by Sponsor|14|||
163050669|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
162617025|NCT04686786|587315158|FG000|Overall Study|Withdrawal by Subject|15|||
162617026|NCT04686786|587315158|FG000|Overall Study|Other than specified|1|||
162885725|NCT02528253|588281916|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
162885726|NCT02528253|588281917|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
162885727|NCT00505752|588281918|FG000|Overall Study|Adverse Event|1|||
162885728|NCT00505752|588281919|FG001|Overall Study|Adverse Event|0|||
162885729|NCT00505752|588281920|FG002|Overall Study|Adverse Event|1|||
162885730|NCT00505752|588281921|FG003|Overall Study|Adverse Event|0|||
162885731|NCT00505752|588281918|FG000|Overall Study|Lost to Follow-up|1|||
162885732|NCT00505752|588281919|FG001|Overall Study|Lost to Follow-up|0|||
162885733|NCT00505752|588281920|FG002|Overall Study|Lost to Follow-up|0|||
162885734|NCT00505752|588281921|FG003|Overall Study|Lost to Follow-up|0|||
162885735|NCT00505752|588281918|FG000|Overall Study|Lack of ovarian response|1|||
162885736|NCT00505752|588281919|FG001|Overall Study|Lack of ovarian response|3|||
162885737|NCT00505752|588281920|FG002|Overall Study|Lack of ovarian response|0|||
162885738|NCT00505752|588281921|FG003|Overall Study|Lack of ovarian response|0|||
162885739|NCT00505752|588281918|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162885740|NCT00505752|588281919|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162885741|NCT00505752|588281920|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
162885742|NCT00505752|588281921|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162885743|NCT00505752|588281918|FG000|Overall Study|No oocytes retrieved|0|||
162617027|NCT02719327|587315163|FG000|Overall Study|Withdrawal by Subject|11|||
162617028|NCT02719327|587315164|FG001|Overall Study|Withdrawal by Subject|8|||
162885744|NCT00505752|588281919|FG001|Overall Study|No oocytes retrieved|2|||
162885745|NCT00505752|588281920|FG002|Overall Study|No oocytes retrieved|0|||
162885746|NCT00505752|588281921|FG003|Overall Study|No oocytes retrieved|1|||
162885747|NCT00505752|588281918|FG000|Overall Study|No Fertilization|1|||
162885748|NCT00505752|588281919|FG001|Overall Study|No Fertilization|1|||
162885749|NCT00505752|588281920|FG002|Overall Study|No Fertilization|2|||
162885750|NCT00505752|588281921|FG003|Overall Study|No Fertilization|1|||
162885751|NCT00505752|588281918|FG000|Overall Study|All embryos/blastocysts discarded|0|||
162885752|NCT00505752|588281919|FG001|Overall Study|All embryos/blastocysts discarded|0|||
162885753|NCT00505752|588281920|FG002|Overall Study|All embryos/blastocysts discarded|1|||
162885754|NCT00505752|588281921|FG003|Overall Study|All embryos/blastocysts discarded|1|||
162885755|NCT00505752|588281918|FG000|Overall Study|Other|1|||
162885756|NCT00505752|588281919|FG001|Overall Study|Other|2|||
162885757|NCT00505752|588281920|FG002|Overall Study|Other|1|||
162885758|NCT00505752|588281921|FG003|Overall Study|Other|2|||
162885759|NCT01624506|588281922|FG000|Overall Study|Lost to Follow-up|29|||
162885760|NCT01624506|588281923|FG001|Overall Study|Lost to Follow-up|15|||
162885761|NCT01624506|588281922|FG000|Overall Study|Withdrawal by Subject|9|||
162885762|NCT01624506|588281923|FG001|Overall Study|Withdrawal by Subject|2|||
162885763|NCT01624506|588281922|FG000|Overall Study|Death|1|||
162885764|NCT01624506|588281923|FG001|Overall Study|Death|0|||
162885765|NCT01624506|588281922|FG000|Overall Study|LINX explants|23|||
162885766|NCT01624506|588281923|FG001|Overall Study|LINX explants|0|||
162885767|NCT01624506|588281922|FG000|Overall Study|Adverse Event|3|||
162885768|NCT01624506|588281923|FG001|Overall Study|Adverse Event|0|||
162885769|NCT00225147|588281925|FG000|Open-label Phase|Lost to Follow-up|0|||
162885770|NCT00225147|588281926|FG001|Open-label Phase|Lost to Follow-up|0|||
162885771|NCT00225147|588281927|FG002|Open-label Phase|Lost to Follow-up|0|||
162885772|NCT00225147|588281928|FG003|Open-label Phase|Lost to Follow-up|4|||
162885773|NCT00225147|588281925|FG000|Open-label Phase|Withdrawal by Subject|0|||
162885774|NCT00225147|588281926|FG001|Open-label Phase|Withdrawal by Subject|0|||
162885775|NCT00225147|588281927|FG002|Open-label Phase|Withdrawal by Subject|0|||
162885776|NCT00225147|588281928|FG003|Open-label Phase|Withdrawal by Subject|6|||
162885777|NCT04019795|588281929|FG000|Overall Study|Withdrawal by Subject|1|||
162885778|NCT04019795|588281930|FG001|Overall Study|Withdrawal by Subject|2|||
162885779|NCT04019795|588281931|FG002|Overall Study|Withdrawal by Subject|2|||
162885780|NCT04019795|588281932|FG003|Overall Study|Withdrawal by Subject|1|||
162885781|NCT04019795|588281929|FG000|Overall Study|Lost to Follow-up|0|||
162885782|NCT04019795|588281930|FG001|Overall Study|Lost to Follow-up|1|||
162885783|NCT04019795|588281931|FG002|Overall Study|Lost to Follow-up|1|||
162885784|NCT04019795|588281932|FG003|Overall Study|Lost to Follow-up|2|||
162885785|NCT04019795|588281929|FG000|Overall Study|Treatment non-compliance|3|||
162885786|NCT04019795|588281930|FG001|Overall Study|Treatment non-compliance|1|||
162885787|NCT04019795|588281931|FG002|Overall Study|Treatment non-compliance|2|||
162885788|NCT04019795|588281932|FG003|Overall Study|Treatment non-compliance|0|||
162885789|NCT04019795|588281929|FG000|Overall Study|Physician Decision|0|||
162885790|NCT04019795|588281930|FG001|Overall Study|Physician Decision|0|||
162885791|NCT04019795|588281931|FG002|Overall Study|Physician Decision|1|||
162885792|NCT04019795|588281932|FG003|Overall Study|Physician Decision|0|||
162885793|NCT04019795|588281929|FG000|Overall Study|Adverse Event|1|||
162885794|NCT04019795|588281930|FG001|Overall Study|Adverse Event|0|||
162885795|NCT04019795|588281931|FG002|Overall Study|Adverse Event|0|||
162885796|NCT04019795|588281932|FG003|Overall Study|Adverse Event|0|||
162885797|NCT03625141|588281933|FG000|Overall Study|Adverse Event|0|||
162885798|NCT03625141|588281934|FG001|Overall Study|Adverse Event|2|||
162885799|NCT03625141|588281933|FG000|Overall Study|Study Terminated By Sponsor|1|||
162885800|NCT03625141|588281934|FG001|Overall Study|Study Terminated By Sponsor|13|||
162885801|NCT03625141|588281933|FG000|Overall Study|Withdrawal by Subject|3|||
162885802|NCT03625141|588281934|FG001|Overall Study|Withdrawal by Subject|0|||
162885803|NCT03625141|588281933|FG000|Overall Study|Withdrawal Of Consent|0|||
162707997|NCT04824131|587640652|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
162885804|NCT03625141|588281934|FG001|Overall Study|Withdrawal Of Consent|1|||
162885805|NCT03625141|588281933|FG000|Overall Study|Death|11|||
162885806|NCT03625141|588281934|FG001|Overall Study|Death|47|||
162885807|NCT03625141|588281933|FG000|Overall Study|Progressive Disease|0|||
162885808|NCT03625141|588281934|FG001|Overall Study|Progressive Disease|2|||
162885809|NCT03250377|588281935|FG000|Overall Study|Adverse Event|2|||
162885810|NCT03250377|588281936|FG001|Overall Study|Adverse Event|4|||
162963299|NCT01986647|588564792|FG002|Overall Study|Lost to Follow-up|4|||
162885811|NCT03250377|588281937|FG002|Overall Study|Adverse Event|0|||
162885812|NCT03250377|588281938|FG003|Overall Study|Adverse Event|4|||
162885813|NCT03250377|588281935|FG000|Overall Study|Lack of Efficacy|5|||
162885814|NCT03250377|588281936|FG001|Overall Study|Lack of Efficacy|14|||
162885815|NCT03250377|588281937|FG002|Overall Study|Lack of Efficacy|1|||
162885816|NCT03250377|588281938|FG003|Overall Study|Lack of Efficacy|3|||
162885817|NCT03250377|588281935|FG000|Overall Study|Protocol Violation|0|||
162885818|NCT03250377|588281936|FG001|Overall Study|Protocol Violation|2|||
162885819|NCT03250377|588281937|FG002|Overall Study|Protocol Violation|0|||
162885820|NCT03250377|588281938|FG003|Overall Study|Protocol Violation|1|||
162885821|NCT03250377|588281935|FG000|Overall Study|Lost to Follow-up|0|||
162885822|NCT03250377|588281936|FG001|Overall Study|Lost to Follow-up|1|||
162885823|NCT03250377|588281937|FG002|Overall Study|Lost to Follow-up|0|||
162885824|NCT03250377|588281938|FG003|Overall Study|Lost to Follow-up|0|||
162885825|NCT03250377|588281935|FG000|Overall Study|Withdrawal by Subject|7|||
162885826|NCT03250377|588281936|FG001|Overall Study|Withdrawal by Subject|7|||
162885827|NCT03250377|588281937|FG002|Overall Study|Withdrawal by Subject|0|||
162885828|NCT03250377|588281938|FG003|Overall Study|Withdrawal by Subject|4|||
162885829|NCT03250377|588281935|FG000|Overall Study|Investigator's Judgment|1|||
162885830|NCT03250377|588281936|FG001|Overall Study|Investigator's Judgment|0|||
162885831|NCT03250377|588281937|FG002|Overall Study|Investigator's Judgment|0|||
162885832|NCT03250377|588281938|FG003|Overall Study|Investigator's Judgment|0|||
162885833|NCT03250377|588281935|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
162885834|NCT03250377|588281936|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
162885835|NCT03250377|588281937|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
162885836|NCT03250377|588281938|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
162885837|NCT03250377|588281935|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
162885838|NCT03250377|588281936|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
162885839|NCT03250377|588281937|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
162885840|NCT03250377|588281938|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
162885841|NCT03250377|588281935|FG000|Overall Study|Epilepsy Surgery|0|||
162885842|NCT03250377|588281936|FG001|Overall Study|Epilepsy Surgery|1|||
162885843|NCT03250377|588281937|FG002|Overall Study|Epilepsy Surgery|2|||
162885844|NCT03250377|588281938|FG003|Overall Study|Epilepsy Surgery|0|||
162885845|NCT03250377|588281935|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
162885846|NCT03250377|588281936|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
162885847|NCT03250377|588281937|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
162963300|NCT01986647|588564793|FG003|Overall Study|Lost to Follow-up|4|||
162963301|NCT01986647|588564790|FG000|Overall Study|Withdrawal by Subject|1|||
162963302|NCT01986647|588564791|FG001|Overall Study|Withdrawal by Subject|3|||
162963303|NCT01986647|588564792|FG002|Overall Study|Withdrawal by Subject|2|||
162963304|NCT01986647|588564793|FG003|Overall Study|Withdrawal by Subject|3|||
162963305|NCT01986647|588564790|FG000|Overall Study|Health|5|||
162963306|NCT01986647|588564791|FG001|Overall Study|Health|3|||
162963307|NCT01986647|588564792|FG002|Overall Study|Health|6|||
162963308|NCT01986647|588564793|FG003|Overall Study|Health|4|||
162963309|NCT01960296|588564794|FG000|Overall Study|Postponed surgery|1|||
162963310|NCT01960296|588564795|FG001|Overall Study|Postponed surgery|0|||
162963311|NCT01960296|588564794|FG000|Overall Study|Received different procedure|1|||
162963312|NCT01960296|588564795|FG001|Overall Study|Received different procedure|3|||
162963313|NCT02003391|588564796|FG000|Overall Study|Withdrawal by Subject|2|||
162617029|NCT04340193|587315165|FG000|Overall Study|Other reason|0|||
162617030|NCT04340193|587315166|FG001|Overall Study|Other reason|0|||
162617031|NCT04340193|587315167|FG002|Overall Study|Other reason|1|||
162617032|NCT04340193|587315165|FG000|Overall Study|Disease recurrence|0|||
162617033|NCT04340193|587315166|FG001|Overall Study|Disease recurrence|1|||
162617034|NCT04340193|587315167|FG002|Overall Study|Disease recurrence|0|||
162617035|NCT04340193|587315165|FG000|Overall Study|Study drug toxicity|1|||
162617036|NCT04340193|587315166|FG001|Overall Study|Study drug toxicity|0|||
162617037|NCT04340193|587315167|FG002|Overall Study|Study drug toxicity|0|||
162617038|NCT04340193|587315165|FG000|Overall Study|Disease progression|1|||
162617039|NCT04340193|587315166|FG001|Overall Study|Disease progression|2|||
162617040|NCT04340193|587315167|FG002|Overall Study|Disease progression|3|||
162617041|NCT04340193|587315165|FG000|Overall Study|Administrative reasons by sponsor|0|||
162617042|NCT04340193|587315166|FG001|Overall Study|Administrative reasons by sponsor|1|||
162617043|NCT04340193|587315167|FG002|Overall Study|Administrative reasons by sponsor|0|||
162617044|NCT04340193|587315165|FG000|Overall Study|Adverse Event|1|||
162617045|NCT04340193|587315166|FG001|Overall Study|Adverse Event|1|||
162617046|NCT04340193|587315167|FG002|Overall Study|Adverse Event|0|||
162617047|NCT03924869|587315168|FG000|Overall Study|Death|73|||
162617048|NCT03924869|587315169|FG001|Overall Study|Death|62|||
162617049|NCT03924869|587315168|FG000|Overall Study|Lost to Follow-up|3|||
162885848|NCT03250377|588281938|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
162885849|NCT03250377|588281935|FG000|Overall Study|Request From The Sponsor|0|||
162885850|NCT03250377|588281936|FG001|Overall Study|Request From The Sponsor|1|||
162885851|NCT03250377|588281937|FG002|Overall Study|Request From The Sponsor|0|||
162885852|NCT03250377|588281938|FG003|Overall Study|Request From The Sponsor|0|||
162963314|NCT02003391|588564797|FG001|Overall Study|Withdrawal by Subject|1|||
162617050|NCT03924869|587315169|FG001|Overall Study|Lost to Follow-up|0|||
162617051|NCT03924869|587315168|FG000|Overall Study|Physician Decision|0|||
162617052|NCT03924869|587315169|FG001|Overall Study|Physician Decision|3|||
162617053|NCT03924869|587315168|FG000|Overall Study|Withdrawal by Subject|7|||
162707998|NCT04824131|587640652|FG000|Step 3|Withdrawal by Subject|2|||
162617054|NCT03924869|587315169|FG001|Overall Study|Withdrawal by Subject|3|||
162617055|NCT03924869|587315168|FG000|Overall Study|Study Terminated By Sponsor|144|||
162617056|NCT03924869|587315169|FG001|Overall Study|Study Terminated By Sponsor|153|||
162617057|NCT03001882|587315172|FG000|Overall Study|Death|1|||
162617058|NCT03001882|587315173|FG001|Overall Study|Death|0|||
162617059|NCT03001882|587315174|FG002|Overall Study|Death|0|||
162617060|NCT03001882|587315175|FG003|Overall Study|Death|3|||
162617061|NCT03001882|587315172|FG000|Overall Study|Participant withdrew consent|0|||
162617062|NCT03001882|587315173|FG001|Overall Study|Participant withdrew consent|1|||
162617063|NCT03001882|587315174|FG002|Overall Study|Participant withdrew consent|0|||
162617064|NCT03001882|587315175|FG003|Overall Study|Participant withdrew consent|5|||
162617065|NCT03001882|587315172|FG000|Overall Study|Other reasons|1|||
162617066|NCT03001882|587315173|FG001|Overall Study|Other reasons|2|||
162617067|NCT03001882|587315174|FG002|Overall Study|Other reasons|0|||
162617068|NCT03001882|587315175|FG003|Overall Study|Other reasons|5|||
162617069|NCT03001882|587315172|FG000|Overall Study|Administrative reason by sponsor|0|||
162617070|NCT03001882|587315173|FG001|Overall Study|Administrative reason by sponsor|0|||
162617071|NCT03001882|587315174|FG002|Overall Study|Administrative reason by sponsor|0|||
162617072|NCT03001882|587315175|FG003|Overall Study|Administrative reason by sponsor|1|||
162617073|NCT03001882|587315172|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162617074|NCT03001882|587315173|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
162617075|NCT03001882|587315174|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162617076|NCT03001882|587315175|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
162617077|NCT03001882|587315172|FG000|Overall Study|Not reported|0|||
162617078|NCT03001882|587315173|FG001|Overall Study|Not reported|0|||
162617079|NCT03001882|587315174|FG002|Overall Study|Not reported|0|||
162617080|NCT03001882|587315175|FG003|Overall Study|Not reported|6|||
162617081|NCT03001882|587315172|FG000|Overall Study|Maximum clinical benefit|2|||
162617082|NCT03001882|587315173|FG001|Overall Study|Maximum clinical benefit|3|||
162617083|NCT03001882|587315174|FG002|Overall Study|Maximum clinical benefit|0|||
162617084|NCT03001882|587315175|FG003|Overall Study|Maximum clinical benefit|10|||
162617085|NCT03001882|587315172|FG000|Overall Study|AE unrelated to study drug|3|||
162617086|NCT03001882|587315173|FG001|Overall Study|AE unrelated to study drug|3|||
162617087|NCT03001882|587315174|FG002|Overall Study|AE unrelated to study drug|0|||
162617088|NCT03001882|587315175|FG003|Overall Study|AE unrelated to study drug|11|||
162617089|NCT03001882|587315172|FG000|Overall Study|Study Drug Toxicity|8|||
162617090|NCT03001882|587315173|FG001|Overall Study|Study Drug Toxicity|5|||
162617091|NCT03001882|587315174|FG002|Overall Study|Study Drug Toxicity|0|||
162617092|NCT03001882|587315175|FG003|Overall Study|Study Drug Toxicity|37|||
162617093|NCT03001882|587315172|FG000|Overall Study|Disease progression|16|||
162617094|NCT03001882|587315173|FG001|Overall Study|Disease progression|14|||
162617095|NCT03001882|587315174|FG002|Overall Study|Disease progression|1|||
162885853|NCT03250377|588281935|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
162885854|NCT03250377|588281936|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
162617096|NCT03001882|587315175|FG003|Overall Study|Disease progression|90|||
162617097|NCT05268055|587315177|FG000|Overall Study|Lost to Follow-up|68|||
162617098|NCT05268055|587315178|FG001|Overall Study|Lost to Follow-up|68|||
162617099|NCT05268055|587315177|FG000|Overall Study|Withdrawal by Subject|12|||
162617100|NCT05268055|587315178|FG001|Overall Study|Withdrawal by Subject|8|||
162617101|NCT03507400|587315179|FG000|Overall Study|discontinued|5|||
162617102|NCT03507400|587315180|FG001|Overall Study|discontinued|1|||
162617103|NCT03507400|587315179|FG000|Overall Study|Lost to Follow-up|8|||
162617104|NCT03507400|587315180|FG001|Overall Study|Lost to Follow-up|6|||
162617105|NCT03507400|587315179|FG000|Overall Study|Protocol Violation|0|||
162617106|NCT03507400|587315180|FG001|Overall Study|Protocol Violation|1|||
162617107|NCT01555983|587315181|FG000|Overall Study|Withdrawal by Subject|1|||
162617108|NCT01555983|587315182|FG001|Overall Study|Withdrawal by Subject|0|||
162617109|NCT01555983|587315183|FG002|Overall Study|Withdrawal by Subject|0|||
162617110|NCT01555983|587315184|FG003|Overall Study|Withdrawal by Subject|0|||
162617111|NCT01555983|587315185|FG004|Overall Study|Withdrawal by Subject|1|||
162617112|NCT01555983|587315186|FG005|Overall Study|Withdrawal by Subject|1|||
162617113|NCT04026711|587315190|FG000|Overall Study|Withdrawal by Subject|1|||
162885855|NCT03250377|588281937|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
162885856|NCT03250377|588281938|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
162617114|NCT04026711|587315191|FG001|Overall Study|Withdrawal by Subject|0|||
162617115|NCT04026711|587315190|FG000|Overall Study|mental health crisis|1|||
162617116|NCT04026711|587315191|FG001|Overall Study|mental health crisis|0|||
162617117|NCT05985395|587315192|FG000|Overall Study|Physician Decision|2|||
162617118|NCT05985395|587315193|FG001|Overall Study|Physician Decision|1|||
162617119|NCT05985395|587315192|FG000|Overall Study|Withdrawal by Subject|1|||
162617120|NCT05985395|587315193|FG001|Overall Study|Withdrawal by Subject|0|||
162617121|NCT04823650|587315194|FG000|Overall Study|Withdrawal by Subject|0|||
162617122|NCT04823650|587315195|FG001|Overall Study|Withdrawal by Subject|0|||
162617123|NCT04823650|587315196|FG002|Overall Study|Withdrawal by Subject|0|||
162617124|NCT04823650|587315197|FG003|Overall Study|Withdrawal by Subject|0|||
162617125|NCT04823650|587315198|FG004|Overall Study|Withdrawal by Subject|1|||
162617126|NCT04823650|587315199|FG005|Overall Study|Withdrawal by Subject|0|||
162617127|NCT02699697|587316118|FG000|Overall Study|Death|18|||
162617128|NCT02699697|587316119|FG001|Overall Study|Death|15|||
162617129|NCT02699697|587316118|FG000|Overall Study|Physician Decision|0|||
162617130|NCT02699697|587316119|FG001|Overall Study|Physician Decision|1|||
162617131|NCT02699697|587316118|FG000|Overall Study|Lost to Follow-up|2|||
162617132|NCT02699697|587316119|FG001|Overall Study|Lost to Follow-up|3|||
162617133|NCT02699697|587316118|FG000|Overall Study|Refused to follow up|1|||
162617134|NCT02699697|587316119|FG001|Overall Study|Refused to follow up|1|||
162617135|NCT02699697|587316118|FG000|Overall Study|Entered hospice care|5|||
162617136|NCT02699697|587316119|FG001|Overall Study|Entered hospice care|2|||
162617137|NCT02699697|587316118|FG000|Overall Study|Missing reason for discontinuation|6|||
162617138|NCT02699697|587316119|FG001|Overall Study|Missing reason for discontinuation|5|||
162617139|NCT02362035|587316120|FG000|Overall Study|Death|67|||
162617140|NCT02362035|587316120|FG000|Overall Study|Lost to Follow-up|3|||
162617141|NCT02362035|587316120|FG000|Overall Study|Adverse Event|1|||
162617142|NCT02362035|587316120|FG000|Overall Study|Physician Decision|1|||
162617143|NCT02362035|587316120|FG000|Overall Study|Subject started another cancer therapy|10|||
162617144|NCT02362035|587316120|FG000|Overall Study|Study terminated by sponsor|45|||
162617145|NCT02362035|587316120|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
162617146|NCT02362035|587316120|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
162617147|NCT02362035|587316120|FG000|Overall Study|Disease progression|11|||
162617148|NCT02362035|587316120|FG000|Overall Study|Withdrawal by Subject|20|||
162617149|NCT00004635|587316121|FG000|Period One|refused|2|||
162617150|NCT00004635|587316122|FG001|Period One|refused|1|||
162617151|NCT00004635|587316121|FG000|Period One|Withdrawal by Subject|1|||
162617152|NCT00004635|587316122|FG001|Period One|Withdrawal by Subject|1|||
162617153|NCT00004635|587316121|FG000|Period One|Protocol Violation|1|||
162617154|NCT00004635|587316122|FG001|Period One|Protocol Violation|0|||
162617155|NCT00004635|587316121|FG000|Period One|PSA did not go <5 ng/mL|1|||
162617156|NCT00004635|587316122|FG001|Period One|PSA did not go <5 ng/mL|0|||
162617157|NCT00004635|587316121|FG000|Period One|second malignancy|1|||
162617158|NCT00004635|587316122|FG001|Period One|second malignancy|0|||
162617159|NCT00004635|587316121|FG000|Period One|progressed|0|||
162617160|NCT00004635|587316122|FG001|Period One|progressed|2|||
162617161|NCT00004635|587316121|FG000|Period One|health problem|0|||
162617162|NCT00004635|587316122|FG001|Period One|health problem|1|||
162617163|NCT00004635|587316121|FG000|Period One|discrepancy in data entry|0|||
162617164|NCT00004635|587316122|FG001|Period One|discrepancy in data entry|1|||
162617165|NCT00004635|587316121|FG000|Period Two|progression|2|||
162617166|NCT00004635|587316122|FG001|Period Two|progression|3|||
162617167|NCT00004635|587316121|FG000|Period Two|Adverse Event|1|||
162617168|NCT00004635|587316122|FG001|Period Two|Adverse Event|0|||
162617169|NCT00004635|587316121|FG000|Period Two|refused|0|||
162617170|NCT00004635|587316122|FG001|Period Two|refused|2|||
162617171|NCT00004635|587316121|FG000|Period Two|health problem|1|||
162885857|NCT03250377|588281935|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
162885858|NCT03250377|588281936|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
162885859|NCT03250377|588281937|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
162885860|NCT03250377|588281938|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
162617172|NCT00004635|587316122|FG001|Period Two|health problem|1|||
162617173|NCT00004635|587316121|FG000|Period Two|travel issues|0|||
162885861|NCT03250377|588281935|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
162617174|NCT00004635|587316122|FG001|Period Two|travel issues|1|||
162617175|NCT00004635|587316121|FG000|Period Two|secondary malignancy|1|||
162617176|NCT00004635|587316122|FG001|Period Two|secondary malignancy|1|||
162617177|NCT00004635|587316121|FG000|Period Two|Lost to Follow-up|1|||
162617178|NCT00004635|587316122|FG001|Period Two|Lost to Follow-up|0|||
162617179|NCT00004635|587316121|FG000|Period Two|discrepancy in data entry|0|||
162617180|NCT00004635|587316122|FG001|Period Two|discrepancy in data entry|1|||
162617181|NCT00354614|587316123|FG000|Overall Study|Lack of Efficacy|28|||
162617182|NCT00191906|587316124|FG000|Study Period II|Adverse Event|0|||
162617183|NCT00191906|587316125|FG001|Study Period II|Adverse Event|1|||
162617184|NCT00191906|587316126|FG002|Study Period II|Adverse Event|0|||
162617185|NCT00191906|587316127|FG003|Study Period II|Adverse Event|0|||
162617186|NCT00191906|587316124|FG000|Study Period II|Withdrawal by Subject|0|||
162617187|NCT00191906|587316125|FG001|Study Period II|Withdrawal by Subject|3|||
162617188|NCT00191906|587316126|FG002|Study Period II|Withdrawal by Subject|0|||
162617189|NCT00191906|587316127|FG003|Study Period II|Withdrawal by Subject|0|||
162617190|NCT00191906|587316124|FG000|Study Period II|Parent/Caregiver Decision|0|||
162617191|NCT00191906|587316125|FG001|Study Period II|Parent/Caregiver Decision|1|||
162617192|NCT00191906|587316126|FG002|Study Period II|Parent/Caregiver Decision|0|||
162617193|NCT00191906|587316127|FG003|Study Period II|Parent/Caregiver Decision|0|||
162617194|NCT00191906|587316124|FG000|Study Period II|Entry Criteria Exclusion|0|||
162617195|NCT00191906|587316125|FG001|Study Period II|Entry Criteria Exclusion|0|||
162885862|NCT03250377|588281936|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
162885863|NCT03250377|588281937|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
162885864|NCT03250377|588281938|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
162885865|NCT03250377|588281935|FG000|Overall Study|Pregnancy Event|0|||
162885866|NCT03250377|588281936|FG001|Overall Study|Pregnancy Event|1|||
162885867|NCT03250377|588281937|FG002|Overall Study|Pregnancy Event|0|||
162885868|NCT03250377|588281938|FG003|Overall Study|Pregnancy Event|0|||
162885869|NCT03250377|588281935|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
162885870|NCT03250377|588281936|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
162885871|NCT03250377|588281937|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
162885872|NCT03250377|588281938|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
162885873|NCT03250377|588281935|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
162885874|NCT03250377|588281936|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
162885875|NCT03250377|588281937|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
162885876|NCT03250377|588281938|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
162885877|NCT03250377|588281935|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
162885878|NCT03250377|588281936|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
162885879|NCT03250377|588281937|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
162885880|NCT03250377|588281938|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
162885881|NCT03250377|588281935|FG000|Overall Study|Patient requested to change hospital|0|||
162885882|NCT03250377|588281936|FG001|Overall Study|Patient requested to change hospital|0|||
162885883|NCT03250377|588281937|FG002|Overall Study|Patient requested to change hospital|0|||
162885884|NCT03250377|588281938|FG003|Overall Study|Patient requested to change hospital|1|||
162885885|NCT03250377|588281935|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
162885886|NCT03250377|588281936|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
162885887|NCT03250377|588281937|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
162885888|NCT03250377|588281938|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
162885889|NCT01114373|588281939|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
162885890|NCT01114373|588281940|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
162885891|NCT01114373|588281939|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
162885892|NCT01114373|588281940|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
162885893|NCT01114373|588281939|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
162885894|NCT01114373|588281940|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
162885895|NCT01114373|588281939|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
162885896|NCT01114373|588281940|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
162885897|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
162885898|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
162885899|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
162885900|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
162885901|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
162885902|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
162885903|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
162885904|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
162885905|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
162885906|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
162885907|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
162885908|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
162885909|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
162885910|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
162885911|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
162885912|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162885913|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162885914|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162707999|NCT03008122|587640658|FG000|Overall Study|Physician Decision|3|||
162885915|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
162885916|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
162885917|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
162885918|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
162885919|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
162885920|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
162885921|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
162885922|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
162885923|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
162885924|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
162885925|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
162885926|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
162885927|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
162885928|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
162885929|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
162885930|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
162885931|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
162885932|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
162885933|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
162885934|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
162885935|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
162885936|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
162885937|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
162885938|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
162885939|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
162885940|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
162885941|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
162885942|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
162885943|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
162885944|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
162885945|NCT03444870|588281941|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
162885946|NCT03444870|588281942|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
162885947|NCT03444870|588281943|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
162885948|NCT03444870|588281944|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
162885949|NCT03444870|588281945|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
162885950|NCT03444870|588281946|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
162885951|NCT03444870|588281941|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162885952|NCT03444870|588281942|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162885953|NCT03444870|588281943|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162885954|NCT03444870|588281944|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162885955|NCT03444870|588281945|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
162885956|NCT03444870|588281946|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162885957|NCT03444870|588281941|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
162885958|NCT03444870|588281942|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
162885959|NCT03444870|588281943|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
162885960|NCT03444870|588281944|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
162885961|NCT03444870|588281945|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
162885962|NCT03444870|588281946|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
162885963|NCT03444870|588281941|FG000|Open-Label Extension (OLE) Period|Death|0|||
162885964|NCT03444870|588281942|FG001|Open-Label Extension (OLE) Period|Death|0|||
162885965|NCT03444870|588281943|FG002|Open-Label Extension (OLE) Period|Death|0|||
162885966|NCT03444870|588281944|FG003|Open-Label Extension (OLE) Period|Death|0|||
162885967|NCT03444870|588281945|FG004|Open-Label Extension (OLE) Period|Death|1|||
162885968|NCT03444870|588281946|FG005|Open-Label Extension (OLE) Period|Death|0|||
162885969|NCT02034552|588281947|FG000|Overall Study|Never treated|3|||
162885970|NCT02034552|588281948|FG001|Overall Study|Never treated|2|||
162885971|NCT02034552|588281949|FG002|Overall Study|Never treated|0|||
162885972|NCT02034552|588281947|FG000|Overall Study|Radiological progression|3|||
162885973|NCT02034552|588281948|FG001|Overall Study|Radiological progression|5|||
162885974|NCT02034552|588281949|FG002|Overall Study|Radiological progression|4|||
162885975|NCT02034552|588281947|FG000|Overall Study|AE not assoc. with disease progression|1|||
162885976|NCT02034552|588281948|FG001|Overall Study|AE not assoc. with disease progression|4|||
162885977|NCT02034552|588281949|FG002|Overall Study|AE not assoc. with disease progression|2|||
162885978|NCT02034552|588281947|FG000|Overall Study|AE associated with disease progression|0|||
162885979|NCT02034552|588281948|FG001|Overall Study|AE associated with disease progression|1|||
162885980|NCT02034552|588281949|FG002|Overall Study|AE associated with disease progression|0|||
162885981|NCT02034552|588281947|FG000|Overall Study|Withdrawal by Subject|2|||
162885982|NCT02034552|588281948|FG001|Overall Study|Withdrawal by Subject|1|||
162885983|NCT02034552|588281949|FG002|Overall Study|Withdrawal by Subject|1|||
162963315|NCT02003391|588564796|FG000|Overall Study|Protocol Violation|0|||
162617196|NCT00191906|587316126|FG002|Study Period II|Entry Criteria Exclusion|1|||
162963316|NCT02003391|588564797|FG001|Overall Study|Protocol Violation|1|||
162617197|NCT00191906|587316127|FG003|Study Period II|Entry Criteria Exclusion|0|||
162617198|NCT00191906|587316124|FG000|Study Period III|Adverse Event|1|||
162617199|NCT00191906|587316125|FG001|Study Period III|Adverse Event|0|||
162617200|NCT00191906|587316126|FG002|Study Period III|Adverse Event|0|||
162617201|NCT00191906|587316127|FG003|Study Period III|Adverse Event|0|||
162885984|NCT02034552|588281947|FG000|Overall Study|Non-compliance with study drug|0|||
162885985|NCT02034552|588281948|FG001|Overall Study|Non-compliance with study drug|0|||
162885986|NCT02034552|588281949|FG002|Overall Study|Non-compliance with study drug|1|||
162885987|NCT02034552|588281947|FG000|Overall Study|Clinical progression|5|||
162885988|NCT02034552|588281948|FG001|Overall Study|Clinical progression|7|||
162885989|NCT02034552|588281949|FG002|Overall Study|Clinical progression|9|||
162885990|NCT02501902|588281952|FG000|Overall Study|Subject Refused Further Follow-up|0|||
162885991|NCT02501902|588281953|FG001|Overall Study|Subject Refused Further Follow-up|0|||
162885992|NCT02501902|588281954|FG002|Overall Study|Subject Refused Further Follow-up|0|||
162885993|NCT02501902|588281955|FG003|Overall Study|Subject Refused Further Follow-up|0|||
162885994|NCT02501902|588281956|FG004|Overall Study|Subject Refused Further Follow-up|0|||
162885995|NCT02501902|588281957|FG005|Overall Study|Subject Refused Further Follow-up|0|||
162885996|NCT02501902|588281958|FG006|Overall Study|Subject Refused Further Follow-up|0|||
162885997|NCT02501902|588281959|FG007|Overall Study|Subject Refused Further Follow-up|1|||
162885998|NCT02501902|588281952|FG000|Overall Study|Study Terminated by Sponsor|0|||
162885999|NCT02501902|588281953|FG001|Overall Study|Study Terminated by Sponsor|3|||
162886000|NCT02501902|588281954|FG002|Overall Study|Study Terminated by Sponsor|0|||
162886001|NCT02501902|588281955|FG003|Overall Study|Study Terminated by Sponsor|1|||
162886002|NCT02501902|588281956|FG004|Overall Study|Study Terminated by Sponsor|1|||
162886003|NCT02501902|588281957|FG005|Overall Study|Study Terminated by Sponsor|0|||
162886004|NCT02501902|588281958|FG006|Overall Study|Study Terminated by Sponsor|2|||
162886005|NCT02501902|588281959|FG007|Overall Study|Study Terminated by Sponsor|4|||
162886006|NCT02501902|588281952|FG000|Overall Study|Death|3|||
162886007|NCT02501902|588281953|FG001|Overall Study|Death|4|||
162886008|NCT02501902|588281954|FG002|Overall Study|Death|4|||
162886009|NCT02501902|588281955|FG003|Overall Study|Death|10|||
162886010|NCT02501902|588281956|FG004|Overall Study|Death|10|||
162886011|NCT02501902|588281957|FG005|Overall Study|Death|11|||
162886012|NCT02501902|588281958|FG006|Overall Study|Death|7|||
162886013|NCT02501902|588281959|FG007|Overall Study|Death|15|||
162886014|NCT02267278|588281960|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
162886015|NCT02267278|588281960|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
162886016|NCT02267278|588281960|FG000|Overall Study|Developed new cancer diagnoses|2|||
162886017|NCT02267278|588281960|FG000|Overall Study|prescribed prohibited medication|1|||
162886018|NCT02513771|588281961|FG000|Overall Study|Lost to Follow-up|1|||
162886019|NCT02513771|588281962|FG001|Overall Study|Lost to Follow-up|1|||
162886020|NCT02513771|588281961|FG000|Overall Study|Not being able to get to clinic|1|||
162886021|NCT02513771|588281962|FG001|Overall Study|Not being able to get to clinic|0|||
162886022|NCT00650091|588281963|FG000|Amended Study Design|Withdrawal by Subject|12|||
162886023|NCT00650091|588281964|FG001|Amended Study Design|Withdrawal by Subject|11|||
162886024|NCT00650091|588281965|FG002|Amended Study Design|Withdrawal by Subject|0|||
162886025|NCT00650091|588281963|FG000|Amended Study Design|Physician Decision|5|||
162886026|NCT00650091|588281964|FG001|Amended Study Design|Physician Decision|0|||
162886027|NCT00650091|588281965|FG002|Amended Study Design|Physician Decision|0|||
162886028|NCT00650091|588281963|FG000|Amended Study Design|Adverse Event|1|||
162886029|NCT00650091|588281964|FG001|Amended Study Design|Adverse Event|4|||
162886030|NCT00650091|588281965|FG002|Amended Study Design|Adverse Event|0|||
162886031|NCT00650091|588281963|FG000|Amended Study Design|Lung transplantation|4|||
162886032|NCT00650091|588281964|FG001|Amended Study Design|Lung transplantation|2|||
162886033|NCT00650091|588281965|FG002|Amended Study Design|Lung transplantation|0|||
162886034|NCT00650091|588281963|FG000|Amended Study Design|Other|1|||
162886035|NCT00650091|588281964|FG001|Amended Study Design|Other|3|||
162886036|NCT00650091|588281965|FG002|Amended Study Design|Other|0|||
162886037|NCT04295356|588281972|FG000|Overall Study|Physician Decision|1|||
162886038|NCT04295356|588281973|FG001|Overall Study|Physician Decision|0|||
162886039|NCT04295356|588281972|FG000|Overall Study|Lost to Follow-up|0|||
162886040|NCT04295356|588281973|FG001|Overall Study|Lost to Follow-up|3|||
162886041|NCT04295356|588281972|FG000|Overall Study|Protocol Violation|0|||
162886042|NCT04295356|588281973|FG001|Overall Study|Protocol Violation|1|||
162886043|NCT01280266|588281974|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
162886044|NCT01280266|588281975|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
162963317|NCT02003391|588564796|FG000|Overall Study|Adverse Event|1|||
162617202|NCT00191906|587316124|FG000|Study Period III|Lost to Follow-up|0|||
162617203|NCT00191906|587316125|FG001|Study Period III|Lost to Follow-up|1|||
162617204|NCT00191906|587316126|FG002|Study Period III|Lost to Follow-up|0|||
162617205|NCT00191906|587316127|FG003|Study Period III|Lost to Follow-up|0|||
162617206|NCT00191906|587316124|FG000|Study Period III|Parent/Caregiver Decision|1|||
162617207|NCT00191906|587316125|FG001|Study Period III|Parent/Caregiver Decision|0|||
162886045|NCT01280266|588281974|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
162886046|NCT01280266|588281975|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
162886047|NCT04268004|588281989|FG000|Overall Study|Excluded from analyses|0|||
162886048|NCT04268004|588281990|FG001|Overall Study|Excluded from analyses|1|||
162886049|NCT03495453|588281991|FG000|Overall Study|Withdrawal by Subject|0|||
162617208|NCT00191906|587316126|FG002|Study Period III|Parent/Caregiver Decision|0|||
162886050|NCT03495453|588281992|FG001|Overall Study|Withdrawal by Subject|1|||
162886051|NCT01360762|588281995|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
162886052|NCT01360762|588281995|FG000|Main Study Period (12-month Treatment)|Death|5|||
162886053|NCT01360762|588281995|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
162963318|NCT02003391|588564797|FG001|Overall Study|Adverse Event|0|||
162886054|NCT01360762|588281995|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
162886055|NCT01360762|588281995|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
162886056|NCT01360762|588281995|FG000|Whole Study Period|Lost to Follow-up|10|||
162886057|NCT01360762|588281995|FG000|Whole Study Period|Death|7|||
162886058|NCT01360762|588281995|FG000|Whole Study Period|Patient relapsed|18|||
162886059|NCT01360762|588281995|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
162886060|NCT01103778|588281996|FG000|Overall Study|Lost to Follow-up|1|||
162886061|NCT01103778|588281996|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
162886062|NCT01103778|588281996|FG000|Overall Study|Screen failure|1|||
162886063|NCT04724733|588281997|FG000|Overall Study|Lost to Follow-up|1|||
162886064|NCT04724733|588281998|FG001|Overall Study|Lost to Follow-up|1|||
162886065|NCT04724733|588281999|FG002|Overall Study|Lost to Follow-up|1|||
162886066|NCT03067129|588282000|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
162886067|NCT03067129|588282001|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
162886068|NCT03067129|588282002|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
162886069|NCT03067129|588282003|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
162886070|NCT03067129|588282000|FG000|Overall Study|Withdrawal by Subject|0|||
162886071|NCT03067129|588282001|FG001|Overall Study|Withdrawal by Subject|0|||
162886072|NCT03067129|588282002|FG002|Overall Study|Withdrawal by Subject|1|||
162886073|NCT03067129|588282003|FG003|Overall Study|Withdrawal by Subject|2|||
162886074|NCT03067129|588282000|FG000|Overall Study|Lost to Follow-up|5|||
162886075|NCT03067129|588282001|FG001|Overall Study|Lost to Follow-up|5|||
162886076|NCT03067129|588282002|FG002|Overall Study|Lost to Follow-up|4|||
162886077|NCT03067129|588282003|FG003|Overall Study|Lost to Follow-up|3|||
162886078|NCT03372603|588282004|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
162886079|NCT03372603|588282005|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
162886080|NCT03372603|588282004|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
162886081|NCT03372603|588282005|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
162886082|NCT03084718|588282006|FG000|Overall Study|Withdrawal by Subject|4|||
162886083|NCT03084718|588282007|FG001|Overall Study|Withdrawal by Subject|3|||
162886084|NCT03084718|588282008|FG002|Overall Study|Withdrawal by Subject|4|||
162886085|NCT03084718|588282009|FG003|Overall Study|Withdrawal by Subject|0|||
162886086|NCT03084718|588282010|FG004|Overall Study|Withdrawal by Subject|0|||
162886087|NCT03084718|588282006|FG000|Overall Study|Physician Decision|1|||
162886088|NCT03084718|588282007|FG001|Overall Study|Physician Decision|0|||
162886089|NCT03084718|588282008|FG002|Overall Study|Physician Decision|0|||
162886090|NCT03084718|588282009|FG003|Overall Study|Physician Decision|0|||
162886091|NCT03084718|588282010|FG004|Overall Study|Physician Decision|0|||
162886092|NCT03084718|588282006|FG000|Overall Study|Adverse Event|3|||
162886093|NCT03084718|588282007|FG001|Overall Study|Adverse Event|5|||
162886094|NCT03084718|588282008|FG002|Overall Study|Adverse Event|5|||
162886095|NCT03084718|588282009|FG003|Overall Study|Adverse Event|8|||
162886096|NCT03084718|588282010|FG004|Overall Study|Adverse Event|2|||
162886097|NCT03084718|588282006|FG000|Overall Study|Lack of Efficacy|2|||
162886098|NCT03084718|588282007|FG001|Overall Study|Lack of Efficacy|0|||
162886099|NCT03084718|588282008|FG002|Overall Study|Lack of Efficacy|1|||
162886100|NCT03084718|588282009|FG003|Overall Study|Lack of Efficacy|4|||
162886101|NCT03084718|588282010|FG004|Overall Study|Lack of Efficacy|0|||
162886102|NCT03084718|588282006|FG000|Overall Study|Lost to Follow-up|0|||
162886103|NCT03084718|588282007|FG001|Overall Study|Lost to Follow-up|1|||
162886104|NCT03084718|588282008|FG002|Overall Study|Lost to Follow-up|0|||
162886105|NCT03084718|588282009|FG003|Overall Study|Lost to Follow-up|0|||
162886106|NCT03084718|588282010|FG004|Overall Study|Lost to Follow-up|2|||
162886107|NCT03084718|588282006|FG000|Overall Study|Protocol Violation|0|||
162886108|NCT03084718|588282007|FG001|Overall Study|Protocol Violation|0|||
162886109|NCT03084718|588282008|FG002|Overall Study|Protocol Violation|1|||
162886110|NCT03084718|588282009|FG003|Overall Study|Protocol Violation|0|||
162886111|NCT03084718|588282010|FG004|Overall Study|Protocol Violation|0|||
162886112|NCT03084718|588282006|FG000|Overall Study|Death|0|||
162886113|NCT03084718|588282007|FG001|Overall Study|Death|1|||
162886114|NCT03084718|588282008|FG002|Overall Study|Death|0|||
162886115|NCT03084718|588282009|FG003|Overall Study|Death|0|||
162886116|NCT03084718|588282010|FG004|Overall Study|Death|0|||
162886117|NCT03084718|588282006|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
162886118|NCT03084718|588282007|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
162886119|NCT03084718|588282008|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
162924460|NCT03539952|588423897|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
162924461|NCT03539952|588423898|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
162924462|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
162924463|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
162924464|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
162924465|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
162886120|NCT03084718|588282009|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
162886121|NCT03084718|588282010|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
162617209|NCT00191906|587316127|FG003|Study Period III|Parent/Caregiver Decision|0|||
162617210|NCT00191906|587316124|FG000|Study Period III|Lack of Efficacy|3|||
162617211|NCT00191906|587316125|FG001|Study Period III|Lack of Efficacy|3|||
162617212|NCT00191906|587316126|FG002|Study Period III|Lack of Efficacy|0|||
162617213|NCT00191906|587316127|FG003|Study Period III|Lack of Efficacy|0|||
162617214|NCT00573937|587316128|FG000|Overall Study|Study Terminated|0|||
162617215|NCT00573937|587316129|FG001|Overall Study|Study Terminated|1|||
162617216|NCT01797731|587316135|FG000|Overall Study|Didn't have proper radiographs required|3|||
162617217|NCT01797731|587316136|FG001|Overall Study|Didn't have proper radiographs required|3|||
162617218|NCT01604408|587316137|FG000|Treatment Period 1|Protocol Violation|0|||
162708000|NCT03008122|587640659|FG001|Overall Study|Physician Decision|2|||
162886122|NCT03341923|588282011|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
162886123|NCT03341923|588282012|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
162708001|NCT03008122|587640660|FG002|Overall Study|Physician Decision|0|||
162708002|NCT03008122|587640658|FG000|Overall Study|Withdrawal by Subject|1|||
162708003|NCT03008122|587640659|FG001|Overall Study|Withdrawal by Subject|3|||
162708004|NCT03008122|587640660|FG002|Overall Study|Withdrawal by Subject|0|||
162708005|NCT03008122|587640658|FG000|Overall Study|Lost to Follow-up|4|||
162708006|NCT03008122|587640659|FG001|Overall Study|Lost to Follow-up|8|||
162708007|NCT03008122|587640660|FG002|Overall Study|Lost to Follow-up|3|||
162708008|NCT03008122|587640658|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
162708009|NCT03008122|587640659|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162708010|NCT03008122|587640660|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
162708011|NCT03008122|587640658|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
162886124|NCT02806947|588282013|FG000|Overall Study|Withdrawal by Subject|5|||
162886125|NCT02806947|588282014|FG001|Overall Study|Withdrawal by Subject|1|||
162886126|NCT03986190|588282015|FG000|Overall Study|Withdrawal by Subject|12|||
162886127|NCT03986190|588282016|FG001|Overall Study|Withdrawal by Subject|0|||
162886128|NCT04511819|588282017|FG000|Overall Study|Non-compliance with study drug|5|||
162886129|NCT04511819|588282018|FG001|Overall Study|Non-compliance with study drug|1|||
162886130|NCT04511819|588282017|FG000|Overall Study|Withdrawal by Subject|0|||
162886131|NCT04511819|588282018|FG001|Overall Study|Withdrawal by Subject|3|||
162886132|NCT04511819|588282017|FG000|Overall Study|Adverse Event|0|||
162886133|NCT04511819|588282018|FG001|Overall Study|Adverse Event|1|||
162886134|NCT04511819|588282017|FG000|Overall Study|Protocol deviation|1|||
162886135|NCT04511819|588282018|FG001|Overall Study|Protocol deviation|0|||
162886136|NCT04929613|588282019|FG000|Overall Study|Withdrawal by Subject|12|||
162886137|NCT00844649|588282028|FG000|Overall Study|Progressive Disease|196|||
162886138|NCT00844649|588282029|FG001|Overall Study|Progressive Disease|245|||
162886139|NCT00844649|588282028|FG000|Overall Study|Adverse Event|128|||
162886140|NCT00844649|588282029|FG001|Overall Study|Adverse Event|73|||
162886141|NCT00844649|588282028|FG000|Overall Study|Physician Decision|25|||
162886142|NCT00844649|588282029|FG001|Overall Study|Physician Decision|18|||
162886143|NCT00844649|588282028|FG000|Overall Study|Protocol Violation|10|||
162617219|NCT01604408|587316138|FG001|Treatment Period 1|Protocol Violation|1|||
162617220|NCT01604408|587316137|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162617221|NCT01604408|587316138|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162617222|NCT01604408|587316137|FG000|Treatment Period 2|Protocol Violation|1|||
162617223|NCT01604408|587316138|FG001|Treatment Period 2|Protocol Violation|0|||
162617224|NCT01604408|587316137|FG000|Treatment Period 2|Adverse Event|0|||
162617225|NCT01604408|587316138|FG001|Treatment Period 2|Adverse Event|1|||
162617226|NCT01604408|587316137|FG000|Treatment Period 3|Protocol Violation|1|||
162617227|NCT01604408|587316138|FG001|Treatment Period 3|Protocol Violation|1|||
162617228|NCT01604408|587316137|FG000|Treatment Period 3|Adverse Event|0|||
162617229|NCT01604408|587316138|FG001|Treatment Period 3|Adverse Event|3|||
162617230|NCT01604408|587316137|FG000|Treatment Period 3|Withdrawal by Subject|3|||
162617231|NCT01604408|587316138|FG001|Treatment Period 3|Withdrawal by Subject|1|||
162617232|NCT01604408|587316137|FG000|Treatment Period 3|Sponsor Decision|1|||
162617233|NCT01604408|587316138|FG001|Treatment Period 3|Sponsor Decision|0|||
162886144|NCT00844649|588282029|FG001|Overall Study|Protocol Violation|6|||
162886145|NCT00844649|588282028|FG000|Overall Study|Withdrawal by Subject|28|||
162886146|NCT00844649|588282029|FG001|Overall Study|Withdrawal by Subject|39|||
162886147|NCT00844649|588282028|FG000|Overall Study|Other|7|||
162886148|NCT00844649|588282029|FG001|Overall Study|Other|10|||
162886149|NCT00844649|588282028|FG000|Overall Study|Withdrew prior to starting treatment|11|||
162886150|NCT00844649|588282029|FG001|Overall Study|Withdrew prior to starting treatment|27|||
162886151|NCT01594333|588282030|FG000|Overall Study|Death|96|||
162886152|NCT01594333|588282031|FG001|Overall Study|Death|83|||
162886153|NCT01594333|588282030|FG000|Overall Study|Lost to Follow-up|5|||
162886154|NCT01594333|588282031|FG001|Overall Study|Lost to Follow-up|5|||
162886155|NCT01594333|588282030|FG000|Overall Study|Withdrawal by Subject|60|||
162886156|NCT01594333|588282031|FG001|Overall Study|Withdrawal by Subject|63|||
162886157|NCT00589979|588282032|FG000|Run-In Period|Adverse Event|5|||
162886158|NCT00589979|588282033|FG001|Run-In Period|Adverse Event|0|||
162886159|NCT00589979|588282034|FG002|Run-In Period|Adverse Event|0|||
162886160|NCT00589979|588282032|FG000|Run-In Period|Protocol Violation|3|||
162886161|NCT00589979|588282033|FG001|Run-In Period|Protocol Violation|0|||
162886162|NCT00589979|588282034|FG002|Run-In Period|Protocol Violation|0|||
162886163|NCT00589979|588282032|FG000|Run-In Period|Did not qualify for randomization|54|||
162886164|NCT00589979|588282033|FG001|Run-In Period|Did not qualify for randomization|0|||
162886165|NCT00589979|588282034|FG002|Run-In Period|Did not qualify for randomization|0|||
162886166|NCT00589979|588282032|FG000|Run-In Period|Withdrawal by Subject|10|||
162617234|NCT01604408|587316137|FG000|Treatment Period 4|Death|1|||
162617235|NCT01604408|587316138|FG001|Treatment Period 4|Death|0|||
162617236|NCT01604408|587316137|FG000|Treatment Period 4|Withdrawal by Subject|2|||
162708012|NCT03008122|587640659|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
162708013|NCT03008122|587640660|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
162708014|NCT03008122|587640658|FG000|Overall Study|Death|0|||
162886167|NCT00589979|588282033|FG001|Run-In Period|Withdrawal by Subject|0|||
162886168|NCT00589979|588282034|FG002|Run-In Period|Withdrawal by Subject|0|||
162886169|NCT00589979|588282032|FG000|Run-In Period|Informed Consent Withdrawn|4|||
162886170|NCT00589979|588282033|FG001|Run-In Period|Informed Consent Withdrawn|0|||
162886171|NCT00589979|588282034|FG002|Run-In Period|Informed Consent Withdrawn|0|||
162886172|NCT00589979|588282032|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
162886173|NCT00589979|588282033|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
162886174|NCT00589979|588282034|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
162886175|NCT00589979|588282032|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
162886176|NCT00589979|588282033|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
162886177|NCT00589979|588282034|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
162886178|NCT00589979|588282032|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
162886179|NCT00589979|588282033|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
162886180|NCT00589979|588282034|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
162886181|NCT00589979|588282032|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
162886182|NCT00589979|588282033|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
162886183|NCT00589979|588282034|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
162886184|NCT00589979|588282032|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
162886185|NCT00589979|588282033|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
162886186|NCT00589979|588282034|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
162886187|NCT00589979|588282032|FG000|Double-Blind Treatment Period 2|Other|0|||
162886188|NCT00589979|588282033|FG001|Double-Blind Treatment Period 2|Other|0|||
162886189|NCT00589979|588282034|FG002|Double-Blind Treatment Period 2|Other|1|||
162886190|NCT00589979|588282032|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
162886191|NCT00589979|588282033|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
162886192|NCT00589979|588282034|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
162886193|NCT00589979|588282032|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
162886194|NCT00589979|588282033|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
162886195|NCT00589979|588282034|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
162886196|NCT01153841|588282035|FG000|Overall Study|Adverse Event|1|||
162886197|NCT01153841|588282036|FG001|Overall Study|Adverse Event|0|||
162886198|NCT01153841|588282035|FG000|Overall Study|Withdrawal by Subject|1|||
162886199|NCT01153841|588282036|FG001|Overall Study|Withdrawal by Subject|0|||
162886200|NCT01153841|588282035|FG000|Overall Study|Protocol Violation|2|||
162886201|NCT01153841|588282036|FG001|Overall Study|Protocol Violation|0|||
162886202|NCT01153841|588282035|FG000|Overall Study|Lost to Follow-up|2|||
162963319|NCT02611323|588564798|FG000|Overall Study|Death|3|||
162963320|NCT02611323|588564799|FG001|Overall Study|Death|1|||
162963321|NCT02611323|588564800|FG002|Overall Study|Death|0|||
162963322|NCT02611323|588564801|FG003|Overall Study|Death|0|||
162963323|NCT02611323|588564802|FG004|Overall Study|Death|1|||
162963324|NCT02611323|588564803|FG005|Overall Study|Death|1|||
162617237|NCT01604408|587316138|FG001|Treatment Period 4|Withdrawal by Subject|1|||
162617238|NCT01604408|587316137|FG000|Treatment Period 4|Adverse Event|0|||
162617239|NCT01604408|587316138|FG001|Treatment Period 4|Adverse Event|1|||
162617240|NCT01604408|587316137|FG000|Treatment Period 5|Adverse Event|4|||
162617241|NCT01604408|587316138|FG001|Treatment Period 5|Adverse Event|0|||
162617242|NCT01604408|587316137|FG000|Treatment Period 6|Lost to Follow-up|0|||
162617243|NCT01604408|587316138|FG001|Treatment Period 6|Lost to Follow-up|1|||
162617244|NCT01604408|587316137|FG000|Treatment Period 6|Adverse Event|2|||
162886203|NCT01153841|588282036|FG001|Overall Study|Lost to Follow-up|0|||
162886204|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
162963325|NCT02611323|588564804|FG006|Overall Study|Death|8|||
162963326|NCT02611323|588564805|FG007|Overall Study|Death|0|||
162963327|NCT02611323|588564806|FG008|Overall Study|Death|4|||
162963328|NCT02611323|588564807|FG009|Overall Study|Death|6|||
162617245|NCT01604408|587316138|FG001|Treatment Period 6|Adverse Event|0|||
162708015|NCT03008122|587640659|FG001|Overall Study|Death|0|||
162708016|NCT03008122|587640660|FG002|Overall Study|Death|1|||
162963329|NCT02611323|588564808|FG010|Overall Study|Death|26|||
162963330|NCT02611323|588564798|FG000|Overall Study|Lost to Follow-up|1|||
162963331|NCT02611323|588564799|FG001|Overall Study|Lost to Follow-up|0|||
162708017|NCT04159896|587640661|FG000|Overall Study|Lack of Efficacy|7|||
162708018|NCT04159896|587640661|FG000|Overall Study|Withdrawal by Subject|1|||
162886205|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
162886206|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
162886207|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
162886208|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
162886209|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
162886210|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Death|1|||
162886211|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Death|3|||
162886212|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
162886213|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
162886214|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
162886215|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
162886216|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
162886217|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
162886218|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
162886219|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
162886220|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
162886221|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
162886222|NCT02553317|588282040|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
162886223|NCT02553317|588282041|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
162886224|NCT02120157|588282042|FG000|Overall Study|Death|8|||
162886225|NCT01599754|588282043|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
162886226|NCT01599754|588282044|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
162886227|NCT01599754|588282043|FG000|Overall Study|Participant noncompliance|4|||
162886228|NCT01599754|588282044|FG001|Overall Study|Participant noncompliance|4|||
162886229|NCT01599754|588282043|FG000|Overall Study|Lost to Follow-up|13|||
162886230|NCT01599754|588282044|FG001|Overall Study|Lost to Follow-up|6|||
162886231|NCT01599754|588282043|FG000|Overall Study|Death|31|||
162886232|NCT01599754|588282044|FG001|Overall Study|Death|33|||
162886233|NCT01599754|588282043|FG000|Overall Study|Adverse Event|3|||
162886234|NCT01599754|588282044|FG001|Overall Study|Adverse Event|2|||
162886235|NCT01599754|588282043|FG000|Overall Study|Investigator decision|1|||
162886236|NCT01599754|588282044|FG001|Overall Study|Investigator decision|3|||
162886237|NCT01599754|588282043|FG000|Overall Study|Withdrawal by Subject|24|||
162886238|NCT01599754|588282044|FG001|Overall Study|Withdrawal by Subject|25|||
162886239|NCT01599754|588282043|FG000|Overall Study|Study terminated by sponsor|282|||
162886240|NCT01599754|588282044|FG001|Overall Study|Study terminated by sponsor|285|||
162886241|NCT00242580|588282045|FG000|Overall Study|Adverse Event|3|||
162886242|NCT00242580|588282046|FG001|Overall Study|Adverse Event|0|||
162886243|NCT00242580|588282047|FG002|Overall Study|Adverse Event|2|||
162886244|NCT00242580|588282045|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162886245|NCT00242580|588282046|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
162886246|NCT00242580|588282047|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
162886247|NCT00242580|588282045|FG000|Overall Study|Protocol Violation|0|||
162886248|NCT00242580|588282046|FG001|Overall Study|Protocol Violation|0|||
162886249|NCT00242580|588282047|FG002|Overall Study|Protocol Violation|1|||
162886250|NCT00242580|588282045|FG000|Overall Study|Subject withdrew consent|2|||
162886251|NCT00242580|588282046|FG001|Overall Study|Subject withdrew consent|2|||
162886252|NCT00242580|588282047|FG002|Overall Study|Subject withdrew consent|5|||
162886253|NCT00242580|588282045|FG000|Overall Study|Lost to Follow-up|0|||
162886254|NCT00242580|588282046|FG001|Overall Study|Lost to Follow-up|3|||
162886255|NCT00242580|588282047|FG002|Overall Study|Lost to Follow-up|0|||
162886256|NCT00242580|588282045|FG000|Overall Study|Death|1|||
162886257|NCT00242580|588282046|FG001|Overall Study|Death|2|||
162886258|NCT00242580|588282047|FG002|Overall Study|Death|1|||
162886259|NCT03666858|588282050|FG000|Cohort 1|Adverse Event|1|||
162886260|NCT03666858|588282051|FG001|Cohort 1|Adverse Event|0|||
162886261|NCT03666858|588282050|FG000|Cohort 2|Adverse Event|0|||
162886262|NCT03666858|588282051|FG001|Cohort 2|Adverse Event|1|||
162886263|NCT03282357|588282052|FG000|Overall Study|Lost to Follow-up|3|||
162886264|NCT03282357|588282052|FG000|Overall Study|Withdrawal by Subject|4|||
162886265|NCT03282357|588282052|FG000|Overall Study|Adverse Event|1|||
162886266|NCT03282357|588282052|FG000|Overall Study|Other|9|||
162963332|NCT02611323|588564800|FG002|Overall Study|Lost to Follow-up|0|||
162963333|NCT02611323|588564801|FG003|Overall Study|Lost to Follow-up|0|||
162963334|NCT02611323|588564802|FG004|Overall Study|Lost to Follow-up|0|||
162886267|NCT03550131|588282053|FG000|Overall Study|Lost to Follow-up|16|||
162886268|NCT03550131|588282054|FG001|Overall Study|Lost to Follow-up|24|||
162886269|NCT03550131|588282053|FG000|Overall Study|Withdrawal by Subject|36|||
162886270|NCT03550131|588282054|FG001|Overall Study|Withdrawal by Subject|28|||
162886271|NCT03550131|588282053|FG000|Overall Study|Illness of dyad member|10|||
162886272|NCT03550131|588282054|FG001|Overall Study|Illness of dyad member|2|||
162886273|NCT03550131|588282053|FG000|Overall Study|Death of person with dementia|4|||
162963335|NCT02611323|588564803|FG005|Overall Study|Lost to Follow-up|0|||
162963336|NCT02611323|588564804|FG006|Overall Study|Lost to Follow-up|3|||
162886274|NCT03550131|588282054|FG001|Overall Study|Death of person with dementia|8|||
162886275|NCT00594204|588282057|FG000|Overall Study|Adverse Event|15|||
162886276|NCT00594204|588282058|FG001|Overall Study|Adverse Event|3|||
162886277|NCT00594204|588282057|FG000|Overall Study|Lost to Follow-up|9|||
162886278|NCT00594204|588282058|FG001|Overall Study|Lost to Follow-up|5|||
162886279|NCT00594204|588282057|FG000|Overall Study|Withdrawal by Subject|23|||
162886280|NCT00594204|588282058|FG001|Overall Study|Withdrawal by Subject|29|||
162886281|NCT00594204|588282057|FG000|Overall Study|Other|4|||
162886282|NCT00594204|588282058|FG001|Overall Study|Other|3|||
162886283|NCT00594204|588282057|FG000|Overall Study|Lack of Efficacy|3|||
162886284|NCT00594204|588282058|FG001|Overall Study|Lack of Efficacy|4|||
162886285|NCT00594204|588282057|FG000|Overall Study|Randomized but not treated|4|||
162886286|NCT00594204|588282058|FG001|Overall Study|Randomized but not treated|1|||
162886287|NCT01740388|588282059|FG000|Overall Study|Withdrawal by Subject|1|||
162886288|NCT01740388|588282060|FG001|Overall Study|Withdrawal by Subject|2|||
162886289|NCT01740388|588282059|FG000|Overall Study|Lost to Follow-up|2|||
162886290|NCT01740388|588282060|FG001|Overall Study|Lost to Follow-up|0|||
162886291|NCT01740388|588282059|FG000|Overall Study|Physician Decision|2|||
162886292|NCT01740388|588282060|FG001|Overall Study|Physician Decision|6|||
162886293|NCT01740388|588282059|FG000|Overall Study|Subjects missing data, completed|41|||
162886294|NCT01740388|588282060|FG001|Overall Study|Subjects missing data, completed|36|||
162886295|NCT03927911|588283541|FG000|Overall Study|problems with eDiary|0|||
162886296|NCT03927911|588283542|FG001|Overall Study|problems with eDiary|1|||
162886297|NCT03927911|588283543|FG002|Overall Study|problems with eDiary|0|||
162886298|NCT03927911|588283544|FG003|Overall Study|problems with eDiary|1|||
162886299|NCT03927911|588283545|FG004|Overall Study|problems with eDiary|0|||
162886300|NCT03927911|588283546|FG005|Overall Study|problems with eDiary|4|||
162886301|NCT03927911|588283541|FG000|Overall Study|Adverse Event|0|||
162886302|NCT03927911|588283542|FG001|Overall Study|Adverse Event|0|||
162886303|NCT03927911|588283543|FG002|Overall Study|Adverse Event|0|||
162886304|NCT03927911|588283544|FG003|Overall Study|Adverse Event|0|||
162886305|NCT03927911|588283545|FG004|Overall Study|Adverse Event|0|||
162886306|NCT03927911|588283546|FG005|Overall Study|Adverse Event|1|||
162886307|NCT03927911|588283541|FG000|Overall Study|not treated -study terminated by sponsor|0|||
162886308|NCT03927911|588283542|FG001|Overall Study|not treated -study terminated by sponsor|1|||
162886309|NCT03927911|588283543|FG002|Overall Study|not treated -study terminated by sponsor|0|||
162886310|NCT03927911|588283544|FG003|Overall Study|not treated -study terminated by sponsor|0|||
162886311|NCT03927911|588283545|FG004|Overall Study|not treated -study terminated by sponsor|0|||
162886312|NCT03927911|588283546|FG005|Overall Study|not treated -study terminated by sponsor|0|||
162886313|NCT03927911|588283541|FG000|Overall Study|Surgery cancelled|0|||
162886314|NCT03927911|588283542|FG001|Overall Study|Surgery cancelled|0|||
162886315|NCT03927911|588283543|FG002|Overall Study|Surgery cancelled|0|||
162886316|NCT03927911|588283544|FG003|Overall Study|Surgery cancelled|1|||
162886317|NCT03927911|588283545|FG004|Overall Study|Surgery cancelled|0|||
162886318|NCT03927911|588283546|FG005|Overall Study|Surgery cancelled|1|||
162886319|NCT03927911|588283541|FG000|Overall Study|Protocol Violation|0|||
162886320|NCT03927911|588283542|FG001|Overall Study|Protocol Violation|0|||
162886321|NCT03927911|588283543|FG002|Overall Study|Protocol Violation|0|||
162886322|NCT03927911|588283544|FG003|Overall Study|Protocol Violation|0|||
162886323|NCT03927911|588283545|FG004|Overall Study|Protocol Violation|0|||
162886324|NCT03927911|588283546|FG005|Overall Study|Protocol Violation|1|||
162886325|NCT02658968|588283547|FG000|Received Rituximab|Adverse Event|0|||
162963337|NCT02611323|588564805|FG007|Overall Study|Lost to Follow-up|0|||
162963338|NCT02611323|588564806|FG008|Overall Study|Lost to Follow-up|0|||
162963339|NCT02611323|588564807|FG009|Overall Study|Lost to Follow-up|0|||
162963340|NCT02611323|588564808|FG010|Overall Study|Lost to Follow-up|2|||
162963341|NCT02611323|588564798|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963342|NCT02611323|588564799|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
162886326|NCT02658968|588283548|FG001|Received Rituximab|Adverse Event|0|||
162886327|NCT02658968|588283549|FG002|Received Rituximab|Adverse Event|0|||
162886328|NCT02658968|588283550|FG003|Received Rituximab|Adverse Event|0|||
162886329|NCT02658968|588283551|FG004|Received Rituximab|Adverse Event|1|||
162963343|NCT02611323|588564800|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963344|NCT02611323|588564801|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963345|NCT02611323|588564802|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963346|NCT02611323|588564803|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963347|NCT02611323|588564804|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963348|NCT02611323|588564805|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963349|NCT02611323|588564806|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963350|NCT02611323|588564807|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
162963351|NCT02611323|588564808|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
162963352|NCT02611323|588564798|FG000|Overall Study|Progressive Disease|0|||
162886330|NCT02658968|588283547|FG000|Received Rituximab|Progressive disease|0|||
162886331|NCT02658968|588283548|FG001|Received Rituximab|Progressive disease|0|||
162886332|NCT02658968|588283549|FG002|Received Rituximab|Progressive disease|0|||
162708019|NCT04159896|587640661|FG000|Overall Study|Adverse Event|1|||
162708020|NCT04159896|587640661|FG000|Overall Study|A transient ischaemic attack|1|||
162708021|NCT01222247|587640663|FG000|Overall Study|Lost to Follow-up|2|||
162708022|NCT01222247|587640664|FG001|Overall Study|Lost to Follow-up|2|||
162708023|NCT04736056|587640667|FG000|Overall Study|Death|0|||
162708024|NCT04736056|587640668|FG001|Overall Study|Death|0|||
162708025|NCT04736056|587640669|FG002|Overall Study|Death|0|||
162708026|NCT04736056|587640670|FG003|Overall Study|Death|1|||
162708027|NCT04736056|587640667|FG000|Overall Study|Lost to Follow-up|1|||
162708028|NCT04736056|587640668|FG001|Overall Study|Lost to Follow-up|0|||
162708029|NCT04736056|587640669|FG002|Overall Study|Lost to Follow-up|1|||
162708030|NCT04736056|587640670|FG003|Overall Study|Lost to Follow-up|1|||
162708031|NCT04736056|587640667|FG000|Overall Study|Withdrawal by Subject|2|||
162708032|NCT04736056|587640668|FG001|Overall Study|Withdrawal by Subject|0|||
162708033|NCT04736056|587640669|FG002|Overall Study|Withdrawal by Subject|0|||
162708034|NCT04736056|587640670|FG003|Overall Study|Withdrawal by Subject|0|||
162708035|NCT04736056|587640667|FG000|Overall Study|Physician Decision|1|||
162708036|NCT04736056|587640668|FG001|Overall Study|Physician Decision|0|||
162708037|NCT04736056|587640669|FG002|Overall Study|Physician Decision|1|||
162708038|NCT04736056|587640670|FG003|Overall Study|Physician Decision|0|||
162708039|NCT04529538|587640671|FG000|Overall Study|Lost to Follow-up|3|||
162708040|NCT04529538|587640672|FG001|Overall Study|Lost to Follow-up|2|||
162708041|NCT04529538|587640673|FG002|Overall Study|Lost to Follow-up|1|||
162708042|NCT04529538|587640674|FG003|Overall Study|Lost to Follow-up|0|||
162708043|NCT04529538|587640675|FG004|Overall Study|Lost to Follow-up|1|||
162708044|NCT04529538|587640676|FG005|Overall Study|Lost to Follow-up|1|||
162708045|NCT04529538|587640677|FG006|Overall Study|Lost to Follow-up|2|||
162708046|NCT04529538|587640678|FG007|Overall Study|Lost to Follow-up|0|||
162708047|NCT04529538|587640671|FG000|Overall Study|Not eligible at enrollment|0|||
162708048|NCT04529538|587640672|FG001|Overall Study|Not eligible at enrollment|1|||
162708049|NCT04529538|587640673|FG002|Overall Study|Not eligible at enrollment|2|||
162708050|NCT04529538|587640674|FG003|Overall Study|Not eligible at enrollment|1|||
162708051|NCT04529538|587640675|FG004|Overall Study|Not eligible at enrollment|0|||
162708052|NCT04529538|587640676|FG005|Overall Study|Not eligible at enrollment|0|||
162708053|NCT04529538|587640677|FG006|Overall Study|Not eligible at enrollment|0|||
162708054|NCT04529538|587640678|FG007|Overall Study|Not eligible at enrollment|1|||
162708055|NCT04529538|587640671|FG000|Overall Study|Withdrawal by Subject|0|||
162886333|NCT02658968|588283550|FG003|Received Rituximab|Progressive disease|0|||
162886334|NCT02658968|588283551|FG004|Received Rituximab|Progressive disease|1|||
162886335|NCT02658968|588283547|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
162886336|NCT02658968|588283548|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
162886337|NCT02658968|588283549|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
162886338|NCT02658968|588283550|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
162886339|NCT02658968|588283551|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
162886340|NCT02658968|588283547|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
162886341|NCT02658968|588283548|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
162886342|NCT02658968|588283549|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
162886343|NCT02658968|588283550|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
162886344|NCT02658968|588283551|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
162886345|NCT02658968|588283547|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
162886346|NCT02658968|588283548|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
162886347|NCT02658968|588283549|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
162886348|NCT02658968|588283550|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
162886349|NCT02658968|588283551|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
162886350|NCT02658968|588283547|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
162886351|NCT02658968|588283548|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
162886352|NCT02658968|588283549|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
162886353|NCT02658968|588283550|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
162886354|NCT02658968|588283551|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
162886355|NCT02658968|588283547|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
162886356|NCT02658968|588283548|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
162886357|NCT02658968|588283549|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
162886358|NCT02658968|588283550|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
162708056|NCT04529538|587640672|FG001|Overall Study|Withdrawal by Subject|1|||
162708057|NCT04529538|587640673|FG002|Overall Study|Withdrawal by Subject|1|||
162708058|NCT04529538|587640674|FG003|Overall Study|Withdrawal by Subject|2|||
162708059|NCT04529538|587640675|FG004|Overall Study|Withdrawal by Subject|0|||
162708060|NCT04529538|587640676|FG005|Overall Study|Withdrawal by Subject|2|||
162708061|NCT04529538|587640677|FG006|Overall Study|Withdrawal by Subject|3|||
162708062|NCT04529538|587640678|FG007|Overall Study|Withdrawal by Subject|0|||
162708063|NCT04529538|587640671|FG000|Overall Study|Other|0|||
163050670|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
162886359|NCT02658968|588283551|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
162886360|NCT01149343|588283552|FG000|Overall Study|Withdrawal by Subject|1|||
162886361|NCT01149343|588283553|FG001|Overall Study|Withdrawal by Subject|1|||
162886362|NCT01149343|588283554|FG002|Overall Study|Withdrawal by Subject|1|||
162886363|NCT01149343|588283555|FG003|Overall Study|Withdrawal by Subject|5|||
162886364|NCT01149343|588283552|FG000|Overall Study|Death|10|||
162886365|NCT01149343|588283553|FG001|Overall Study|Death|13|||
162886366|NCT01149343|588283554|FG002|Overall Study|Death|18|||
162886367|NCT01149343|588283555|FG003|Overall Study|Death|18|||
162886368|NCT01149343|588283552|FG000|Overall Study|Lost to Follow-up|1|||
162886369|NCT01149343|588283553|FG001|Overall Study|Lost to Follow-up|0|||
162886370|NCT01149343|588283554|FG002|Overall Study|Lost to Follow-up|0|||
162886371|NCT01149343|588283555|FG003|Overall Study|Lost to Follow-up|1|||
162886372|NCT01149343|588283552|FG000|Overall Study|Other|8|||
162886373|NCT01149343|588283553|FG001|Overall Study|Other|10|||
162886374|NCT01149343|588283554|FG002|Overall Study|Other|2|||
162886375|NCT01149343|588283555|FG003|Overall Study|Other|14|||
162886376|NCT01149343|588283552|FG000|Overall Study|Sponsor study termination|0|||
162886377|NCT01149343|588283553|FG001|Overall Study|Sponsor study termination|0|||
162886378|NCT01149343|588283554|FG002|Overall Study|Sponsor study termination|0|||
162886379|NCT01149343|588283555|FG003|Overall Study|Sponsor study termination|2|||
162886380|NCT01149343|588283552|FG000|Overall Study|Recurrence / Progressive disease|0|||
162886381|NCT01149343|588283553|FG001|Overall Study|Recurrence / Progressive disease|0|||
162886382|NCT01149343|588283554|FG002|Overall Study|Recurrence / Progressive disease|1|||
162886383|NCT01149343|588283555|FG003|Overall Study|Recurrence / Progressive disease|0|||
162886384|NCT03472040|588283572|FG000|Overall Study|Physician Decision|0|||
162886385|NCT03472040|588283573|FG001|Overall Study|Physician Decision|3|||
162886386|NCT03472040|588283572|FG000|Overall Study|Withdrawal by Subject|10|||
162886387|NCT03472040|588283573|FG001|Overall Study|Withdrawal by Subject|23|||
162886388|NCT03472040|588283572|FG000|Overall Study|Perceived Lack of Efficacy|29|||
162886389|NCT03472040|588283573|FG001|Overall Study|Perceived Lack of Efficacy|30|||
162886390|NCT03472040|588283572|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
162886391|NCT03472040|588283573|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
162886392|NCT03472040|588283572|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
162886393|NCT03472040|588283573|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
162886394|NCT03472040|588283572|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
162886395|NCT03472040|588283573|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
162886396|NCT03472040|588283572|FG000|Overall Study|Subject Non-compliance|2|||
162886397|NCT03472040|588283573|FG001|Overall Study|Subject Non-compliance|5|||
162886398|NCT03472040|588283572|FG000|Overall Study|Discontinuation due to Rash|0|||
162886399|NCT03472040|588283573|FG001|Overall Study|Discontinuation due to Rash|1|||
162886400|NCT03472040|588283572|FG000|Overall Study|Subsequent Ineligibility|0|||
162886401|NCT03472040|588283573|FG001|Overall Study|Subsequent Ineligibility|2|||
162886402|NCT03472040|588283572|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
162886403|NCT03472040|588283573|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
162886404|NCT02769832|588283574|FG000|Overall Study|Death|30|||
162886405|NCT02197897|588283575|FG000|Overall Study|not eligible|1|||
162886406|NCT00168064|588283577|FG000|Overall Study|Adverse Event|26|||
162886407|NCT00168064|588283578|FG001|Overall Study|Adverse Event|22|||
162886408|NCT00168064|588283577|FG000|Overall Study|Withdrawal by Subject|3|||
162886409|NCT00168064|588283578|FG001|Overall Study|Withdrawal by Subject|4|||
162886410|NCT00168064|588283577|FG000|Overall Study|Lack of Efficacy|4|||
162617246|NCT01604408|587316137|FG000|Treatment Period 6|Sponsor decision|0|||
162886411|NCT00168064|588283578|FG001|Overall Study|Lack of Efficacy|4|||
162886412|NCT00168064|588283577|FG000|Overall Study|Lost to Follow-up|4|||
162617247|NCT01604408|587316138|FG001|Treatment Period 6|Sponsor decision|1|||
162617248|NCT01604408|587316137|FG000|Observation Period|Adverse Event|1|||
162617249|NCT01604408|587316138|FG001|Observation Period|Adverse Event|1|||
162886413|NCT00168064|588283578|FG001|Overall Study|Lost to Follow-up|3|||
162886414|NCT00168064|588283577|FG000|Overall Study|Non-compliance|2|||
162886415|NCT00168064|588283578|FG001|Overall Study|Non-compliance|3|||
162886416|NCT00168064|588283577|FG000|Overall Study|Concurrent Illness|4|||
162886417|NCT00168064|588283578|FG001|Overall Study|Concurrent Illness|3|||
162886418|NCT00168064|588283577|FG000|Overall Study|Subject's Best interest|2|||
163050671|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
163050672|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
162886419|NCT00168064|588283578|FG001|Overall Study|Subject's Best interest|2|||
162886420|NCT00168064|588283577|FG000|Overall Study|Various|4|||
162886421|NCT00168064|588283578|FG001|Overall Study|Various|3|||
162886422|NCT03428997|588283585|FG000|Overall Study|Sponsor decision.|1|||
162886423|NCT03428997|588283585|FG000|Overall Study|Withdrawal by Subject|3|||
162886424|NCT03428997|588283585|FG000|Overall Study|Lost to Follow-up|4|||
162886425|NCT00510068|588283589|FG000|Double-blind Period|Disease progression|98|||
162886426|NCT00510068|588283590|FG001|Double-blind Period|Disease progression|169|||
162963353|NCT02611323|588564799|FG001|Overall Study|Progressive Disease|0|||
162617250|NCT01604408|587316137|FG000|Observation Period|Withdrawal by Subject|0|||
162617251|NCT01604408|587316138|FG001|Observation Period|Withdrawal by Subject|2|||
162617252|NCT00722423|587316142|FG000|Overall Study|Protocol Violation|0|||
162617253|NCT00722423|587316143|FG001|Overall Study|Protocol Violation|1|||
162617254|NCT01189604|587316145|FG000|Overall Study|Impossible to visit|0|||
162617255|NCT01189604|587316146|FG001|Overall Study|Impossible to visit|0|||
162617256|NCT01189604|587316147|FG002|Overall Study|Impossible to visit|0|||
162617257|NCT01189604|587316148|FG003|Overall Study|Impossible to visit|0|||
162617258|NCT01189604|587316149|FG004|Overall Study|Impossible to visit|0|||
162617259|NCT01189604|587316150|FG005|Overall Study|Impossible to visit|1|||
162617260|NCT01189604|587316151|FG006|Overall Study|Impossible to visit|0|||
162617261|NCT01189604|587316145|FG000|Overall Study|Adverse Event|0|||
162617262|NCT01189604|587316146|FG001|Overall Study|Adverse Event|1|||
162617263|NCT01189604|587316147|FG002|Overall Study|Adverse Event|0|||
162617264|NCT01189604|587316148|FG003|Overall Study|Adverse Event|0|||
162617265|NCT01189604|587316149|FG004|Overall Study|Adverse Event|2|||
162617266|NCT01189604|587316150|FG005|Overall Study|Adverse Event|0|||
162617267|NCT01189604|587316151|FG006|Overall Study|Adverse Event|1|||
162617268|NCT01189604|587316145|FG000|Overall Study|Withdrawal by Subject|1|||
162617269|NCT01189604|587316146|FG001|Overall Study|Withdrawal by Subject|0|||
162617270|NCT01189604|587316147|FG002|Overall Study|Withdrawal by Subject|0|||
162617271|NCT01189604|587316148|FG003|Overall Study|Withdrawal by Subject|0|||
162617272|NCT01189604|587316149|FG004|Overall Study|Withdrawal by Subject|0|||
162617273|NCT01189604|587316150|FG005|Overall Study|Withdrawal by Subject|0|||
162617274|NCT01189604|587316151|FG006|Overall Study|Withdrawal by Subject|0|||
162617275|NCT03945214|587316152|FG000|Overall Study|Lost to Follow-up|3|||
162617276|NCT03945214|587316153|FG001|Overall Study|Lost to Follow-up|4|||
162617277|NCT03945214|587316154|FG002|Overall Study|Lost to Follow-up|7|||
162617278|NCT03945214|587316155|FG003|Overall Study|Lost to Follow-up|4|||
162617279|NCT04102098|587316166|FG000|Main Study Period|Ongoing in study|302|||
162617280|NCT04102098|587316167|FG001|Main Study Period|Ongoing in study|291|||
162617281|NCT04102098|587316166|FG000|Main Study Period|Death|20|||
162617282|NCT04102098|587316167|FG001|Main Study Period|Death|27|||
162617283|NCT04102098|587316166|FG000|Main Study Period|Lost to Follow-up|1|||
162617284|NCT04102098|587316167|FG001|Main Study Period|Lost to Follow-up|1|||
162617285|NCT04102098|587316166|FG000|Main Study Period|Physician Decision|0|||
162617286|NCT04102098|587316167|FG001|Main Study Period|Physician Decision|1|||
162617287|NCT04102098|587316166|FG000|Main Study Period|Withdrawal by Subject|11|||
162617288|NCT04102098|587316167|FG001|Main Study Period|Withdrawal by Subject|14|||
162617289|NCT04102098|587316166|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
162617290|NCT04102098|587316167|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
162617291|NCT04102098|587316166|FG000|Crossover: AS Who Crossed Over|Death|11|||
162617292|NCT04102098|587316167|FG001|Crossover: AS Who Crossed Over|Death|0|||
162617293|NCT04102098|587316166|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
162617294|NCT04102098|587316167|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
162617295|NCT03150173|587316170|FG000|Overall Study|Lost to Follow-up|13|||
162617296|NCT03150173|587316171|FG001|Overall Study|Lost to Follow-up|5|||
162617297|NCT01756053|587316173|FG000|Period 1 (10 Days)|Protocol Violation|1|||
162617298|NCT01756053|587316174|FG001|Period 1 (10 Days)|Protocol Violation|1|||
162617299|NCT01756053|587316173|FG000|Period 2 (10 Days)|Protocol Violation|0|||
162617300|NCT01756053|587316174|FG001|Period 2 (10 Days)|Protocol Violation|2|||
162617301|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
162617302|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
162617303|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Physician Decision|1|||
162617304|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Physician Decision|0|||
162617305|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
162617306|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
162963354|NCT02611323|588564800|FG002|Overall Study|Progressive Disease|0|||
162963355|NCT02611323|588564801|FG003|Overall Study|Progressive Disease|0|||
162963356|NCT02611323|588564802|FG004|Overall Study|Progressive Disease|0|||
162963357|NCT02611323|588564803|FG005|Overall Study|Progressive Disease|0|||
162963358|NCT02611323|588564804|FG006|Overall Study|Progressive Disease|0|||
162963359|NCT02611323|588564805|FG007|Overall Study|Progressive Disease|0|||
162617307|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
162617308|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
162617309|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Adverse Event|15|||
162963360|NCT02611323|588564806|FG008|Overall Study|Progressive Disease|0|||
162963361|NCT02611323|588564807|FG009|Overall Study|Progressive Disease|0|||
162617310|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Adverse Event|0|||
162617311|NCT03277690|587316175|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
162617312|NCT03277690|587316176|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
162617313|NCT03277690|587316175|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
162617314|NCT03277690|587316176|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
162963362|NCT02611323|588564808|FG010|Overall Study|Progressive Disease|1|||
162963363|NCT02611323|588564798|FG000|Overall Study|Withdrawal by Subject|1|||
162963364|NCT02611323|588564799|FG001|Overall Study|Withdrawal by Subject|0|||
162963365|NCT02611323|588564800|FG002|Overall Study|Withdrawal by Subject|0|||
162963366|NCT02611323|588564801|FG003|Overall Study|Withdrawal by Subject|0|||
162963367|NCT02611323|588564802|FG004|Overall Study|Withdrawal by Subject|0|||
162963368|NCT02611323|588564803|FG005|Overall Study|Withdrawal by Subject|0|||
162963369|NCT02611323|588564804|FG006|Overall Study|Withdrawal by Subject|0|||
162963370|NCT02611323|588564805|FG007|Overall Study|Withdrawal by Subject|1|||
162617315|NCT02853344|587316179|FG000|Overall Study|Lost to Follow-up|1|||
162617316|NCT02853344|587316180|FG001|Overall Study|Lost to Follow-up|1|||
162617317|NCT02853344|587316179|FG000|Overall Study|Withdrawal by Subject|2|||
162886427|NCT00510068|588283589|FG000|Double-blind Period|Final primary analysis|52|||
162886428|NCT00510068|588283590|FG001|Double-blind Period|Final primary analysis|18|||
162886429|NCT00510068|588283589|FG000|Double-blind Period|Adverse Event|37|||
162886430|NCT00510068|588283590|FG001|Double-blind Period|Adverse Event|7|||
162886431|NCT00510068|588283589|FG000|Double-blind Period|Withdrawal by Subject|8|||
162886432|NCT00510068|588283590|FG001|Double-blind Period|Withdrawal by Subject|6|||
162886433|NCT00510068|588283589|FG000|Double-blind Period|Death|4|||
162886434|NCT00510068|588283590|FG001|Double-blind Period|Death|3|||
162886435|NCT00510068|588283589|FG000|Double-blind Period|Abnormal test result (s)|1|||
162886436|NCT00510068|588283590|FG001|Double-blind Period|Abnormal test result (s)|0|||
162886437|NCT00510068|588283589|FG000|Double-blind Period|Lost to Follow-up|1|||
162886438|NCT00510068|588283590|FG001|Double-blind Period|Lost to Follow-up|0|||
162886439|NCT00510068|588283589|FG000|Double-blind Period|Protocol Violation|6|||
162886440|NCT00510068|588283590|FG001|Double-blind Period|Protocol Violation|0|||
162886441|NCT00510068|588283589|FG000|Open-label Period|Disease Progression|124|||
162886442|NCT00510068|588283590|FG001|Open-label Period|Disease Progression|0|||
162886443|NCT00510068|588283589|FG000|Open-label Period|Adverse Event|46|||
162886444|NCT00510068|588283590|FG001|Open-label Period|Adverse Event|0|||
162886445|NCT00510068|588283589|FG000|Open-label Period|Withdrawal by Subject|21|||
162886446|NCT00510068|588283590|FG001|Open-label Period|Withdrawal by Subject|0|||
162886447|NCT00510068|588283589|FG000|Open-label Period|Administrative problems|17|||
162886448|NCT00510068|588283590|FG001|Open-label Period|Administrative problems|0|||
162886449|NCT00510068|588283589|FG000|Open-label Period|Death|7|||
162886450|NCT00510068|588283590|FG001|Open-label Period|Death|0|||
162886451|NCT00510068|588283589|FG000|Open-label Period|New cancer therapy|7|||
162886452|NCT00510068|588283590|FG001|Open-label Period|New cancer therapy|0|||
162886453|NCT00510068|588283589|FG000|Open-label Period|Protocol Violation|2|||
162886454|NCT00510068|588283590|FG001|Open-label Period|Protocol Violation|0|||
162886455|NCT00510068|588283589|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
162886456|NCT00510068|588283590|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
162886457|NCT01354431|588283592|FG000|Pre-Treatment Period|Not reported|1|||
162886458|NCT01354431|588283593|FG001|Pre-Treatment Period|Not reported|0|||
162886459|NCT01354431|588283594|FG002|Pre-Treatment Period|Not reported|0|||
162886460|NCT01354431|588283592|FG000|Treatment Period|Disease Progression|50|||
162886461|NCT01354431|588283593|FG001|Treatment Period|Disease Progression|40|||
162886462|NCT01354431|588283594|FG002|Treatment Period|Disease Progression|44|||
162886463|NCT01354431|588283592|FG000|Treatment Period|Study Drug Toxicity|5|||
162886464|NCT01354431|588283593|FG001|Treatment Period|Study Drug Toxicity|8|||
162886465|NCT01354431|588283594|FG002|Treatment Period|Study Drug Toxicity|4|||
162886466|NCT01354431|588283592|FG000|Treatment Period|Death|0|||
162963371|NCT02611323|588564806|FG008|Overall Study|Withdrawal by Subject|0|||
162963372|NCT02611323|588564807|FG009|Overall Study|Withdrawal by Subject|1|||
162963373|NCT02611323|588564808|FG010|Overall Study|Withdrawal by Subject|0|||
162617318|NCT02853344|587316180|FG001|Overall Study|Withdrawal by Subject|4|||
162617319|NCT02853344|587316179|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
162617320|NCT02853344|587316180|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
162617321|NCT02853344|587316179|FG000|Overall Study|Death|70|||
162708064|NCT04529538|587640672|FG001|Overall Study|Other|1|||
162886467|NCT01354431|588283593|FG001|Treatment Period|Death|1|||
162886468|NCT01354431|588283594|FG002|Treatment Period|Death|0|||
162886469|NCT01354431|588283592|FG000|Treatment Period|AE unrelated to study drug|1|||
162886470|NCT01354431|588283593|FG001|Treatment Period|AE unrelated to study drug|2|||
162886471|NCT01354431|588283594|FG002|Treatment Period|AE unrelated to study drug|5|||
162886472|NCT01354431|588283592|FG000|Treatment Period|Participant request to discontinue|2|||
162886473|NCT01354431|588283593|FG001|Treatment Period|Participant request to discontinue|2|||
162963374|NCT00243347|588564809|FG000|Overall Study|Lack of Efficacy|4|||
162617322|NCT02853344|587316180|FG001|Overall Study|Death|112|||
162708065|NCT04529538|587640673|FG002|Overall Study|Other|0|||
162708066|NCT04529538|587640674|FG003|Overall Study|Other|0|||
162708067|NCT04529538|587640675|FG004|Overall Study|Other|0|||
162886474|NCT01354431|588283594|FG002|Treatment Period|Participant request to discontinue|1|||
162886475|NCT01354431|588283592|FG000|Treatment Period|Participant withdrew consent|0|||
162886476|NCT01354431|588283593|FG001|Treatment Period|Participant withdrew consent|1|||
162963375|NCT00243347|588564809|FG000|Overall Study|Adverse Event|2|||
162708068|NCT04529538|587640676|FG005|Overall Study|Other|0|||
162963376|NCT00243347|588564809|FG000|Overall Study|Death|1|||
162886477|NCT01354431|588283594|FG002|Treatment Period|Participant withdrew consent|0|||
162886478|NCT01354431|588283592|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
162886479|NCT01354431|588283593|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
162886480|NCT01354431|588283594|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
162886481|NCT03176277|588283595|FG000|Part A Dose Escalation Study|Adverse Event|1|||
162886482|NCT03176277|588283596|FG001|Part A Dose Escalation Study|Adverse Event|0|||
162617323|NCT02955797|587316190|FG000|Overall Study|Protocol Violation|1|||
162617324|NCT02955797|587316191|FG001|Overall Study|Protocol Violation|0|||
162886483|NCT03176277|588283597|FG002|Part A Dose Escalation Study|Adverse Event|1|||
162886484|NCT03176277|588283598|FG003|Part A Dose Escalation Study|Adverse Event|0|||
162886485|NCT03176277|588283595|FG000|Part A Dose Escalation Study|Physician Decision|1|||
162886486|NCT03176277|588283596|FG001|Part A Dose Escalation Study|Physician Decision|1|||
162886487|NCT03176277|588283597|FG002|Part A Dose Escalation Study|Physician Decision|2|||
162886488|NCT03176277|588283598|FG003|Part A Dose Escalation Study|Physician Decision|0|||
162886489|NCT03176277|588283595|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
162886490|NCT03176277|588283596|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
162886491|NCT03176277|588283597|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
162886492|NCT03176277|588283598|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
162886493|NCT03176277|588283595|FG000|Part A Dose Escalation Study|Progressive disease|3|||
162886494|NCT03176277|588283596|FG001|Part A Dose Escalation Study|Progressive disease|1|||
162886495|NCT03176277|588283597|FG002|Part A Dose Escalation Study|Progressive disease|3|||
162886496|NCT03176277|588283598|FG003|Part A Dose Escalation Study|Progressive disease|0|||
162886497|NCT02802878|588283599|FG000|Overall Study|Withdrawal by Subject|3|||
162963377|NCT00243347|588564809|FG000|Overall Study|Withdrawal by Subject|5|||
162617325|NCT02955797|587316192|FG002|Overall Study|Protocol Violation|0|||
162617326|NCT02955797|587316193|FG003|Overall Study|Protocol Violation|1|||
162963378|NCT00243347|588564809|FG000|Overall Study|Condition worsened|7|||
162963379|NCT02011945|588564815|FG000|Overall Study|Participant requested to Discontinue|0|||
162963380|NCT02011945|588564816|FG001|Overall Study|Participant requested to Discontinue|1|||
162963381|NCT02011945|588564817|FG002|Overall Study|Participant requested to Discontinue|1|||
162963382|NCT02011945|588564815|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
162963383|NCT02011945|588564816|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
162963384|NCT02011945|588564817|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
162963385|NCT02011945|588564815|FG000|Overall Study|Study Drug Toxicity|0|||
162963386|NCT02011945|588564816|FG001|Overall Study|Study Drug Toxicity|0|||
162963387|NCT02011945|588564817|FG002|Overall Study|Study Drug Toxicity|1|||
162963388|NCT02011945|588564815|FG000|Overall Study|Treatment Failure|0|||
162963389|NCT02011945|588564816|FG001|Overall Study|Treatment Failure|7|||
162963390|NCT02011945|588564817|FG002|Overall Study|Treatment Failure|6|||
162963391|NCT02011945|588564815|FG000|Overall Study|No Longer Meets Study Criteria|1|||
162963392|NCT02011945|588564816|FG001|Overall Study|No Longer Meets Study Criteria|0|||
162963393|NCT02011945|588564817|FG002|Overall Study|No Longer Meets Study Criteria|0|||
162963394|NCT02011945|588564815|FG000|Overall Study|Proceeded to stem cell transplant|0|||
162963395|NCT02011945|588564816|FG001|Overall Study|Proceeded to stem cell transplant|0|||
162617327|NCT02955797|587316190|FG000|Overall Study|Withdrawal by Subject|2|||
162617328|NCT02955797|587316191|FG001|Overall Study|Withdrawal by Subject|2|||
162617329|NCT02955797|587316192|FG002|Overall Study|Withdrawal by Subject|0|||
162617330|NCT02955797|587316193|FG003|Overall Study|Withdrawal by Subject|1|||
162617331|NCT02955797|587316190|FG000|Overall Study|Lost to Follow-up|0|||
162617332|NCT02955797|587316191|FG001|Overall Study|Lost to Follow-up|1|||
162617333|NCT02955797|587316192|FG002|Overall Study|Lost to Follow-up|0|||
162617334|NCT02955797|587316193|FG003|Overall Study|Lost to Follow-up|0|||
162963396|NCT02011945|588564817|FG002|Overall Study|Proceeded to stem cell transplant|1|||
162963397|NCT02011945|588564815|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
162963398|NCT02011945|588564816|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
162963399|NCT02011945|588564817|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
162963400|NCT03531827|588564818|FG000|Overall Study|Adverse Event|2|||
162963401|NCT03531827|588564819|FG001|Overall Study|Adverse Event|0|||
162708069|NCT04529538|587640677|FG006|Overall Study|Other|0|||
162963402|NCT03531827|588564818|FG000|Overall Study|Progressive disease|1|||
162963403|NCT03531827|588564819|FG001|Overall Study|Progressive disease|0|||
162886498|NCT02802878|588283600|FG001|Overall Study|Withdrawal by Subject|3|||
162963404|NCT00258856|588566468|FG000|Overall Study|Lost to Follow-up|1|||
162617335|NCT03131453|587316195|FG000|Overall Study|Study terminated by Sponsor|424|||
162963405|NCT00258856|588566469|FG001|Overall Study|Lost to Follow-up|0|||
162963406|NCT00258856|588566470|FG002|Overall Study|Lost to Follow-up|2|||
162963407|NCT00258856|588566471|FG003|Overall Study|Lost to Follow-up|0|||
162963408|NCT00258856|588566468|FG000|Overall Study|Non-compliance|2|||
162963409|NCT00258856|588566469|FG001|Overall Study|Non-compliance|0|||
162963410|NCT00258856|588566470|FG002|Overall Study|Non-compliance|0|||
162963411|NCT00258856|588566471|FG003|Overall Study|Non-compliance|1|||
162963412|NCT02488109|588566477|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
162963413|NCT02488109|588566478|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
162617336|NCT03131453|587316196|FG001|Overall Study|Study terminated by Sponsor|222|||
162617337|NCT03131453|587316197|FG002|Overall Study|Study terminated by Sponsor|438|||
162617338|NCT03131453|587316195|FG000|Overall Study|Withdrawal by Subject|18|||
162617339|NCT03131453|587316196|FG001|Overall Study|Withdrawal by Subject|7|||
162617340|NCT03131453|587316197|FG002|Overall Study|Withdrawal by Subject|13|||
162617341|NCT03131453|587316195|FG000|Overall Study|Adverse Event|10|||
162617342|NCT03131453|587316196|FG001|Overall Study|Adverse Event|3|||
162886499|NCT02802878|588283599|FG000|Overall Study|Protocol Violation|1|||
162886500|NCT02802878|588283600|FG001|Overall Study|Protocol Violation|0|||
162886501|NCT00702052|588283601|FG000|Overall Study|Adverse Event|23|||
162886502|NCT00702052|588283601|FG000|Overall Study|Disease Progression|30|||
162886503|NCT00702052|588283601|FG000|Overall Study|Withdrawal by Subject|5|||
162886504|NCT00101192|588283602|FG000|Overall Study|Ineligible|6|||
162886505|NCT00101192|588283602|FG000|Overall Study|Inevaluable|1|||
162886506|NCT03691610|588283603|FG000|Overall Study|Adverse Event|0|||
162886507|NCT03691610|588283604|FG001|Overall Study|Adverse Event|1|||
162886508|NCT03691610|588283605|FG002|Overall Study|Adverse Event|0|||
162886509|NCT03691610|588283606|FG003|Overall Study|Adverse Event|0|||
162886510|NCT03691610|588283603|FG000|Overall Study|Protocol Deviation|15|||
162886511|NCT03691610|588283604|FG001|Overall Study|Protocol Deviation|8|||
162886512|NCT03691610|588283605|FG002|Overall Study|Protocol Deviation|1|||
162886513|NCT03691610|588283606|FG003|Overall Study|Protocol Deviation|2|||
162886514|NCT03691610|588283603|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
162886515|NCT03691610|588283604|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
162886516|NCT03691610|588283605|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
162886517|NCT03691610|588283606|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
162886518|NCT03691610|588283603|FG000|Overall Study|Lost to Follow-up|20|||
162886519|NCT03691610|588283604|FG001|Overall Study|Lost to Follow-up|11|||
162886520|NCT03691610|588283605|FG002|Overall Study|Lost to Follow-up|5|||
162886521|NCT03691610|588283606|FG003|Overall Study|Lost to Follow-up|2|||
162886522|NCT00536978|588283607|FG000|Overall Study|Not eligible for Adback Infusion|22|||
162886523|NCT03970395|588283608|FG000|Overall Study|Withdrawal by Subject|3|||
162886524|NCT03970395|588283609|FG001|Overall Study|Withdrawal by Subject|4|||
162886525|NCT03970395|588283608|FG000|Overall Study|Lost to Follow-up|4|||
162886526|NCT03970395|588283609|FG001|Overall Study|Lost to Follow-up|8|||
162886527|NCT02921919|588283610|FG000|Overall Study|Other|5|||
162886528|NCT02921919|588283611|FG001|Overall Study|Other|6|||
162886529|NCT02921919|588283610|FG000|Overall Study|Lost to Follow-up|0|||
162886530|NCT02921919|588283611|FG001|Overall Study|Lost to Follow-up|1|||
162886531|NCT02921919|588283610|FG000|Overall Study|Withdrawal by Subject|5|||
162886532|NCT02921919|588283611|FG001|Overall Study|Withdrawal by Subject|1|||
162617343|NCT03131453|587316197|FG002|Overall Study|Adverse Event|3|||
162617344|NCT03131453|587316195|FG000|Overall Study|Lost to Follow-up|1|||
162617345|NCT03131453|587316196|FG001|Overall Study|Lost to Follow-up|0|||
162617346|NCT03131453|587316197|FG002|Overall Study|Lost to Follow-up|1|||
162617347|NCT03131453|587316195|FG000|Overall Study|Physician Decision|1|||
162617348|NCT03131453|587316196|FG001|Overall Study|Physician Decision|0|||
162617349|NCT03131453|587316197|FG002|Overall Study|Physician Decision|1|||
162617350|NCT03131453|587316195|FG000|Overall Study|Non-compliance with study treatment|1|||
162617351|NCT03131453|587316196|FG001|Overall Study|Non-compliance with study treatment|0|||
162617352|NCT03131453|587316197|FG002|Overall Study|Non-compliance with study treatment|0|||
162617353|NCT03131453|587316195|FG000|Overall Study|Technical problems|1|||
162617354|NCT03131453|587316196|FG001|Overall Study|Technical problems|0|||
162617355|NCT03131453|587316197|FG002|Overall Study|Technical problems|0|||
162617356|NCT03131453|587316195|FG000|Overall Study|Protocol deviation|0|||
162617357|NCT03131453|587316196|FG001|Overall Study|Protocol deviation|1|||
162617358|NCT03131453|587316197|FG002|Overall Study|Protocol deviation|0|||
162617359|NCT02081183|587316198|FG000|Overall Study|Lost to Follow-up|0|||
162617360|NCT02081183|587316199|FG001|Overall Study|Lost to Follow-up|1|||
162617361|NCT02081183|587316198|FG000|Overall Study|Protocol Violation|1|||
162617362|NCT02081183|587316199|FG001|Overall Study|Protocol Violation|0|||
162617363|NCT02081183|587316198|FG000|Overall Study|Other|3|||
162886533|NCT02921919|588283610|FG000|Overall Study|Disease Progression|47|||
162886534|NCT02921919|588283611|FG001|Overall Study|Disease Progression|38|||
162886535|NCT02921919|588283610|FG000|Overall Study|Physician Decision|3|||
162886536|NCT02921919|588283611|FG001|Overall Study|Physician Decision|2|||
162886537|NCT02921919|588283610|FG000|Overall Study|Adverse Event|6|||
162886538|NCT02921919|588283611|FG001|Overall Study|Adverse Event|4|||
162963414|NCT02488109|588566477|FG000|12-month Follow-Up|Lost to Follow-up|4|||
162617364|NCT02081183|587316199|FG001|Overall Study|Other|3|||
162617365|NCT04043728|587316200|FG000|Overall Study|Lost to Follow-up|1|||
162617366|NCT04043728|587316201|FG001|Overall Study|Lost to Follow-up|2|||
162886539|NCT04664855|588283612|FG000|Overall Study|Withdrawal by Subject|0|||
162963415|NCT02488109|588566478|FG001|12-month Follow-Up|Lost to Follow-up|7|||
162617367|NCT04043728|587316202|FG002|Overall Study|Lost to Follow-up|0|||
162617368|NCT02840721|587316203|FG000|Treatment Period|Adverse Event|1|||
162617369|NCT02840721|587316203|FG000|Follow-Up|Lack of Efficacy|1|||
162617370|NCT02840721|587316203|FG000|Follow-Up|Withdrawal by Subject|4|||
162617371|NCT02840721|587316203|FG000|Follow-Up|Withdrawal of Consent|2|||
162886540|NCT04664855|588283613|FG001|Overall Study|Withdrawal by Subject|2|||
163050673|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050674|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050675|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050676|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050677|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163050678|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
163050679|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050680|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050681|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050682|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163050683|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
162886541|NCT01086150|588283621|FG000|Overall Study|Withdrawal by Subject|0|||
162886542|NCT01086150|588283622|FG001|Overall Study|Withdrawal by Subject|4|||
162886543|NCT01086150|588283623|FG002|Overall Study|Withdrawal by Subject|1|||
162886544|NCT01086150|588283621|FG000|Overall Study|Lost to Follow-up|0|||
162886545|NCT01086150|588283622|FG001|Overall Study|Lost to Follow-up|1|||
162886546|NCT01086150|588283623|FG002|Overall Study|Lost to Follow-up|0|||
162886547|NCT01086150|588283621|FG000|Overall Study|Screen Failure|0|||
162886548|NCT01086150|588283622|FG001|Overall Study|Screen Failure|1|||
162886549|NCT01086150|588283623|FG002|Overall Study|Screen Failure|0|||
162886550|NCT00870818|588283625|FG000|Overall Study|Lost to Follow-up|3|||
162886551|NCT00870818|588283626|FG001|Overall Study|Lost to Follow-up|2|||
162886552|NCT00870818|588283627|FG002|Overall Study|Lost to Follow-up|1|||
162886553|NCT00870818|588283628|FG003|Overall Study|Lost to Follow-up|0|||
162886554|NCT00870818|588283629|FG004|Overall Study|Lost to Follow-up|0|||
162886555|NCT00870818|588283625|FG000|Overall Study|Withdrawal by Subject|0|||
162886556|NCT00870818|588283626|FG001|Overall Study|Withdrawal by Subject|0|||
162886557|NCT00870818|588283627|FG002|Overall Study|Withdrawal by Subject|1|||
162886558|NCT00870818|588283628|FG003|Overall Study|Withdrawal by Subject|2|||
162886559|NCT00870818|588283629|FG004|Overall Study|Withdrawal by Subject|0|||
162886560|NCT00870818|588283625|FG000|Overall Study|Terminated by sponsor|29|||
162886561|NCT00870818|588283626|FG001|Overall Study|Terminated by sponsor|70|||
162886562|NCT00870818|588283627|FG002|Overall Study|Terminated by sponsor|36|||
162886563|NCT00870818|588283628|FG003|Overall Study|Terminated by sponsor|36|||
162886564|NCT00870818|588283629|FG004|Overall Study|Terminated by sponsor|38|||
162886565|NCT00870818|588283625|FG000|Overall Study|Other|0|||
162886566|NCT00870818|588283626|FG001|Overall Study|Other|1|||
162886567|NCT00870818|588283627|FG002|Overall Study|Other|0|||
162886568|NCT00870818|588283628|FG003|Overall Study|Other|0|||
162886569|NCT00870818|588283629|FG004|Overall Study|Other|0|||
162886570|NCT00178464|588283630|FG000|Overall Study|Withdrawal by Subject|1|||
162886571|NCT00178464|588283630|FG000|Overall Study|Physician Decision|1|||
162886572|NCT01529385|588283631|FG000|Overall Study|Lost to Follow-up|2|||
162886573|NCT01529385|588283632|FG001|Overall Study|Lost to Follow-up|1|||
162886574|NCT01401465|588283633|FG000|Treatment Period 1|Adverse Event|4|||
162886575|NCT01401465|588283634|FG001|Treatment Period 1|Adverse Event|1|||
162886576|NCT01401465|588283633|FG000|Treatment Period 1|Pregnancy|0|||
162886577|NCT01401465|588283634|FG001|Treatment Period 1|Pregnancy|1|||
162886578|NCT01401465|588283633|FG000|Treatment Period 1|Protocol Violation|5|||
162886579|NCT01401465|588283634|FG001|Treatment Period 1|Protocol Violation|0|||
162886580|NCT01401465|588283633|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162886581|NCT01401465|588283634|FG001|Treatment Period 1|Withdrawal by Subject|4|||
162886582|NCT01401465|588283633|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
163050684|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
163050685|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050686|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050687|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050688|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050689|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050690|NCT01435759|588893654|FG000|Antidepressant Lead-in Phase|Other|119|||
162886583|NCT01401465|588283634|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
162886584|NCT01401465|588283633|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
162886585|NCT01401465|588283634|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
162886586|NCT01401465|588283633|FG000|Treatment Period 1|Scheduling Difficulties|1|||
162886587|NCT01401465|588283634|FG001|Treatment Period 1|Scheduling Difficulties|1|||
162886588|NCT01401465|588283633|FG000|Treatment Period 2|Lost to Follow-up|0|||
162886589|NCT01401465|588283634|FG001|Treatment Period 2|Lost to Follow-up|1|||
162886590|NCT01401465|588283633|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162886591|NCT01401465|588283634|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162886592|NCT01115738|588283635|FG000|Overall Study|Death|1|||
162617372|NCT05535972|587316207|FG000|Overall Study|Withdrawal by Subject|31|||
162617373|NCT05535972|587316207|FG000|Overall Study|Lost to Follow-up|5|||
162617374|NCT05535972|587316207|FG000|Overall Study|Adverse Event|6|||
162617375|NCT05535972|587316207|FG000|Overall Study|Protocol Deviation|2|||
162617376|NCT02649894|587316208|FG000|Overall Study|Adverse Event|1|||
162617377|NCT02649894|587316209|FG001|Overall Study|Adverse Event|0|||
162617378|NCT02649894|587316208|FG000|Overall Study|Physician Decision|0|||
162617379|NCT02649894|587316209|FG001|Overall Study|Physician Decision|1|||
162617380|NCT02649894|587316208|FG000|Overall Study|Withdrawal by Subject|5|||
162617381|NCT02649894|587316209|FG001|Overall Study|Withdrawal by Subject|2|||
162617382|NCT02649894|587316208|FG000|Overall Study|Lost to Follow-up|2|||
162617383|NCT02649894|587316209|FG001|Overall Study|Lost to Follow-up|1|||
162617384|NCT02649894|587316208|FG000|Overall Study|Death|30|||
162617385|NCT02649894|587316209|FG001|Overall Study|Death|7|||
162617386|NCT02649894|587316208|FG000|Overall Study|Other, not specified|6|||
162617387|NCT02649894|587316209|FG001|Overall Study|Other, not specified|0|||
162617388|NCT04590963|587316210|FG000|Overall Study|Death|118|||
162617389|NCT04590963|587316211|FG001|Overall Study|Death|59|||
162617390|NCT04590963|587316210|FG000|Overall Study|Lost to Follow-up|1|||
162617391|NCT04590963|587316211|FG001|Overall Study|Lost to Follow-up|1|||
162617392|NCT04590963|587316210|FG000|Overall Study|Progressive disease|0|||
162617393|NCT04590963|587316211|FG001|Overall Study|Progressive disease|1|||
162617394|NCT04590963|587316210|FG000|Overall Study|Study terminated by sponsor|103|||
162617395|NCT04590963|587316211|FG001|Overall Study|Study terminated by sponsor|50|||
162617396|NCT04590963|587316210|FG000|Overall Study|Withdrawal by Subject|15|||
162617397|NCT04590963|587316211|FG001|Overall Study|Withdrawal by Subject|8|||
162617398|NCT04590963|587316210|FG000|Overall Study|Ongoing at data cut-off|9|||
162617399|NCT04590963|587316211|FG001|Overall Study|Ongoing at data cut-off|4|||
162617400|NCT04590963|587316210|FG000|Overall Study|Screen failure|1|||
162617401|NCT04590963|587316211|FG001|Overall Study|Screen failure|0|||
162617402|NCT01736124|587316212|FG000|Post-intervention Assessment|Death|2|||
162617403|NCT01736124|587316213|FG001|Post-intervention Assessment|Death|2|||
162617404|NCT01736124|587316212|FG000|Post-intervention Assessment|lost computer access|1|||
162617405|NCT01736124|587316213|FG001|Post-intervention Assessment|lost computer access|1|||
162617406|NCT01736124|587316212|FG000|Post-intervention Assessment|Moved away|3|||
162617407|NCT01736124|587316213|FG001|Post-intervention Assessment|Moved away|1|||
162617408|NCT01736124|587316212|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
162617409|NCT01736124|587316213|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
162617410|NCT01736124|587316212|FG000|Post-intervention Assessment|Illness|3|||
162617411|NCT01736124|587316213|FG001|Post-intervention Assessment|Illness|2|||
162617412|NCT01736124|587316212|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
162617413|NCT01736124|587316213|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
162617414|NCT01736124|587316212|FG000|Post-intervention Assessment|Temporarily away|3|||
162617415|NCT01736124|587316213|FG001|Post-intervention Assessment|Temporarily away|1|||
162617416|NCT01736124|587316212|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
162617417|NCT01736124|587316213|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
162617418|NCT01736124|587316212|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
162617419|NCT01736124|587316213|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
162617420|NCT01736124|587316212|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
162617421|NCT01736124|587316213|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
162617422|NCT01736124|587316212|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
162617423|NCT01736124|587316213|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
162617424|NCT01736124|587316212|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
162617425|NCT01736124|587316213|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
162617426|NCT01736124|587316212|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
162617427|NCT01736124|587316213|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
162886593|NCT01115738|588283636|FG001|Overall Study|Death|0|||
162886594|NCT01115738|588283637|FG002|Overall Study|Death|0|||
162886595|NCT01115738|588283635|FG000|Overall Study|Lost to Follow-up|0|||
162886596|NCT01115738|588283636|FG001|Overall Study|Lost to Follow-up|0|||
162886597|NCT01115738|588283637|FG002|Overall Study|Lost to Follow-up|1|||
162617428|NCT01736124|587316212|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
162617429|NCT01736124|587316213|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
162617430|NCT01736124|587316212|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
162617431|NCT01736124|587316213|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
162617432|NCT01736124|587316212|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
162617433|NCT01736124|587316213|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
162617434|NCT04176705|587316215|FG000|Overall Study|Withdrawal by Subject|4|||
162617435|NCT04176705|587316216|FG001|Overall Study|Withdrawal by Subject|4|||
162617436|NCT04176705|587316215|FG000|Overall Study|Death|1|||
162617437|NCT04176705|587316216|FG001|Overall Study|Death|1|||
162617438|NCT04176705|587316215|FG000|Overall Study|Lost to Follow-up|3|||
162617439|NCT04176705|587316216|FG001|Overall Study|Lost to Follow-up|3|||
162617440|NCT02628769|587316217|FG000|First Intervention|Adverse Event|1|||
162617441|NCT02628769|587316218|FG001|First Intervention|Adverse Event|0|||
162886598|NCT01115738|588283635|FG000|Overall Study|Physician Decision|18|||
162886599|NCT01115738|588283636|FG001|Overall Study|Physician Decision|15|||
162886600|NCT01115738|588283637|FG002|Overall Study|Physician Decision|17|||
162886601|NCT01115738|588283635|FG000|Overall Study|Withdrawal by Subject|6|||
162886602|NCT01115738|588283636|FG001|Overall Study|Withdrawal by Subject|6|||
162886603|NCT01115738|588283637|FG002|Overall Study|Withdrawal by Subject|9|||
162886604|NCT02702011|588283645|FG000|Overall Study|Withdrawal by Subject|0|||
162886605|NCT02702011|588283646|FG001|Overall Study|Withdrawal by Subject|1|||
162886606|NCT02702011|588283647|FG002|Overall Study|Withdrawal by Subject|0|||
162886607|NCT02702011|588283648|FG003|Overall Study|Withdrawal by Subject|0|||
162886608|NCT02721251|588283649|FG000|Overall Study|Withdrawal by Subject|8|||
162886609|NCT02721251|588283650|FG001|Overall Study|Withdrawal by Subject|7|||
162886610|NCT02721251|588283651|FG002|Overall Study|Withdrawal by Subject|9|||
162886611|NCT02721251|588283649|FG000|Overall Study|poor adherence|2|||
162886612|NCT02721251|588283650|FG001|Overall Study|poor adherence|2|||
162886613|NCT02721251|588283651|FG002|Overall Study|poor adherence|2|||
162886614|NCT02921763|588283652|FG000|Overall Study|Adverse Event|4|||
162886615|NCT02921763|588283652|FG000|Overall Study|Lost to Follow-up|4|||
162886616|NCT02921763|588283652|FG000|Overall Study|Lack of Efficacy|3|||
162886617|NCT02921763|588283652|FG000|Overall Study|Protocol Violation|2|||
162886618|NCT02921763|588283652|FG000|Overall Study|Withdrawal by Subject|2|||
162886619|NCT02921763|588283652|FG000|Overall Study|Physician Decision|1|||
162886620|NCT02921763|588283652|FG000|Overall Study|No data obtained|2|||
162886621|NCT04142216|588283655|FG000|Overall Study|Hospitalization|0|||
162886622|NCT04142216|588283656|FG001|Overall Study|Hospitalization|2|||
162886623|NCT04142216|588283655|FG000|Overall Study|Death|3|||
162886624|NCT04142216|588283656|FG001|Overall Study|Death|1|||
162886625|NCT04142216|588283655|FG000|Overall Study|Referral to another hemodialysis unit|3|||
162886626|NCT04142216|588283656|FG001|Overall Study|Referral to another hemodialysis unit|2|||
162886627|NCT04142216|588283655|FG000|Overall Study|Use of clove|0|||
162886628|NCT04142216|588283656|FG001|Overall Study|Use of clove|1|||
162886629|NCT01582971|588283659|FG000|Overall Study|Death|2|||
162886630|NCT01582971|588283660|FG001|Overall Study|Death|1|||
162886631|NCT01582971|588283659|FG000|Overall Study|Lost to Follow-up|18|||
162886632|NCT01582971|588283660|FG001|Overall Study|Lost to Follow-up|21|||
162886633|NCT01582971|588283659|FG000|Overall Study|Withdrawal by Subject|4|||
162886634|NCT01582971|588283660|FG001|Overall Study|Withdrawal by Subject|2|||
162886635|NCT01582971|588283659|FG000|Overall Study|Other|15|||
162886636|NCT01582971|588283660|FG001|Overall Study|Other|13|||
162886637|NCT02007954|588283663|FG000|Overall Study|Received liver transplant|3|||
162886638|NCT02007954|588283663|FG000|Overall Study|Switch in treatment modality|2|||
162886639|NCT02007954|588283663|FG000|Overall Study|Disease progression and unrelated AE|1|||
162886640|NCT02007954|588283663|FG000|Overall Study|Death|1|||
162886641|NCT01054976|588283666|FG000|Overall Study|Adverse Event|16|||
162886642|NCT01054976|588283666|FG000|Overall Study|Uncooperative participations to study|7|||
162963416|NCT03969641|588566481|FG000|Overall Study|Lost to Follow-up|5|||
162963417|NCT03969641|588566482|FG001|Overall Study|Lost to Follow-up|3|||
162963418|NCT03969641|588566481|FG000|Overall Study|Withdrawal by Subject|1|||
162963419|NCT03969641|588566482|FG001|Overall Study|Withdrawal by Subject|2|||
162963420|NCT03969641|588566481|FG000|Overall Study|Found to be ineligible|1|||
162963421|NCT03969641|588566482|FG001|Overall Study|Found to be ineligible|1|||
162963422|NCT03969641|588566481|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
162963423|NCT03969641|588566482|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
162963424|NCT03969641|588566481|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
162963425|NCT03969641|588566482|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
162963426|NCT03969641|588566481|FG000|Overall Study|Elective termination|0|||
162963427|NCT03969641|588566482|FG001|Overall Study|Elective termination|1|||
162963428|NCT00754052|588566493|FG000|Overall Study|Study terminated by Sponsor|5|||
162963429|NCT00754052|588566494|FG001|Overall Study|Study terminated by Sponsor|3|||
162963430|NCT00557245|588566497|FG000|Overall Study|Lost to Follow-up|7|||
162963431|NCT00557245|588566498|FG001|Overall Study|Lost to Follow-up|8|||
162963432|NCT00557245|588566499|FG002|Overall Study|Lost to Follow-up|10|||
162963433|NCT00557245|588566497|FG000|Overall Study|Ineligible|5|||
162886643|NCT01054976|588283666|FG000|Overall Study|Withdrawal by Subject|4|||
162886644|NCT01054976|588283666|FG000|Overall Study|Other|8|||
162708070|NCT04529538|587640678|FG007|Overall Study|Other|0|||
162886645|NCT01641991|588283667|FG000|Overall Study|Physician Decision|0|||
162886646|NCT01641991|588283668|FG001|Overall Study|Physician Decision|1|||
162963434|NCT00557245|588566498|FG001|Overall Study|Ineligible|4|||
162963435|NCT00557245|588566499|FG002|Overall Study|Ineligible|2|||
162886647|NCT01641991|588283669|FG002|Overall Study|Physician Decision|7|||
162886648|NCT01641991|588283670|FG003|Overall Study|Physician Decision|5|||
162963436|NCT02658019|588566500|FG000|Overall Study|Adverse Event|1|||
162963437|NCT00516295|588566504|FG000|Overall Study|Lack of Efficacy|2|||
162886649|NCT01641991|588283667|FG000|Overall Study|Withdrawal by Subject|4|||
162886650|NCT01641991|588283668|FG001|Overall Study|Withdrawal by Subject|2|||
162886651|NCT01641991|588283669|FG002|Overall Study|Withdrawal by Subject|1|||
162963438|NCT00516295|588566505|FG001|Overall Study|Lack of Efficacy|0|||
162886652|NCT01641991|588283670|FG003|Overall Study|Withdrawal by Subject|5|||
162886653|NCT01641991|588283667|FG000|Overall Study|Adverse Event|2|||
162886654|NCT01641991|588283668|FG001|Overall Study|Adverse Event|1|||
162886655|NCT01641991|588283669|FG002|Overall Study|Adverse Event|2|||
162886656|NCT01641991|588283670|FG003|Overall Study|Adverse Event|1|||
162886657|NCT01641991|588283667|FG000|Overall Study|Lost to Follow-up|0|||
162886658|NCT01641991|588283668|FG001|Overall Study|Lost to Follow-up|2|||
162886659|NCT01641991|588283669|FG002|Overall Study|Lost to Follow-up|3|||
162886660|NCT01641991|588283670|FG003|Overall Study|Lost to Follow-up|1|||
162886661|NCT01641991|588283667|FG000|Overall Study|Protocol Violation|1|||
162886662|NCT01641991|588283668|FG001|Overall Study|Protocol Violation|1|||
162886663|NCT01641991|588283669|FG002|Overall Study|Protocol Violation|3|||
162886664|NCT01641991|588283670|FG003|Overall Study|Protocol Violation|0|||
162886665|NCT01641991|588283667|FG000|Overall Study|Pregnancy|0|||
162886666|NCT01641991|588283668|FG001|Overall Study|Pregnancy|0|||
162886667|NCT01641991|588283669|FG002|Overall Study|Pregnancy|1|||
162886668|NCT01641991|588283670|FG003|Overall Study|Pregnancy|0|||
162886669|NCT01641991|588283667|FG000|Overall Study|no longer eligible|2|||
162886670|NCT01641991|588283668|FG001|Overall Study|no longer eligible|1|||
162886671|NCT01641991|588283669|FG002|Overall Study|no longer eligible|0|||
162886672|NCT01641991|588283670|FG003|Overall Study|no longer eligible|4|||
162886673|NCT00475540|588283674|FG000|36 Months|Lost to Follow-up|4|||
162886674|NCT00475540|588283675|FG001|36 Months|Lost to Follow-up|4|||
162886675|NCT00475540|588283674|FG000|36 Months|Death|1|||
162886676|NCT00475540|588283675|FG001|36 Months|Death|2|||
162886677|NCT00475540|588283674|FG000|36 Months|Censored due to reoperation|3|||
162886678|NCT00475540|588283675|FG001|36 Months|Censored due to reoperation|0|||
162886679|NCT02394795|588283678|FG000|Overall Study|Adverse Event|92|||
162886680|NCT02394795|588283679|FG001|Overall Study|Adverse Event|70|||
162886681|NCT02394795|588283678|FG000|Overall Study|Lost to Follow-up|0|||
162886682|NCT02394795|588283679|FG001|Overall Study|Lost to Follow-up|1|||
162886683|NCT02394795|588283678|FG000|Overall Study|Withdrawal by Subject|17|||
162886684|NCT02394795|588283679|FG001|Overall Study|Withdrawal by Subject|26|||
162886685|NCT02394795|588283678|FG000|Overall Study|Lack of Efficacy|181|||
162886686|NCT02394795|588283679|FG001|Overall Study|Lack of Efficacy|211|||
162886687|NCT02394795|588283678|FG000|Overall Study|Death|4|||
162886688|NCT02394795|588283679|FG001|Overall Study|Death|5|||
162886689|NCT02394795|588283678|FG000|Overall Study|Physician Decision|109|||
162886690|NCT02394795|588283679|FG001|Overall Study|Physician Decision|93|||
162886691|NCT03245723|588283686|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
162886692|NCT03245723|588283687|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
162886693|NCT03245723|588283686|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
162886694|NCT03245723|588283687|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
162886695|NCT03245723|588283686|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
162886696|NCT03245723|588283687|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
162886697|NCT03245723|588283686|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
162886698|NCT03245723|588283687|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
162886699|NCT03784027|588283690|FG000|Period 1|Withdrawal by Subject|0|||
162886700|NCT03784027|588283691|FG001|Period 1|Withdrawal by Subject|1|||
162886701|NCT01512108|588284891|FG000|Overall Study|Adverse Event|9|||
162886702|NCT01512108|588284892|FG001|Overall Study|Adverse Event|4|||
162886703|NCT01512108|588284891|FG000|Overall Study|Protocol Violation|1|||
162886704|NCT01512108|588284892|FG001|Overall Study|Protocol Violation|2|||
162886705|NCT01512108|588284891|FG000|Overall Study|Withdrawal Criteria|1|||
162886706|NCT01512108|588284892|FG001|Overall Study|Withdrawal Criteria|0|||
162886707|NCT01512108|588284891|FG000|Overall Study|Unclassified|11|||
162886708|NCT01512108|588284892|FG001|Overall Study|Unclassified|3|||
162963439|NCT00516295|588566506|FG002|Overall Study|Lack of Efficacy|0|||
162963440|NCT00516295|588566504|FG000|Overall Study|Ineligible|1|||
162963441|NCT00516295|588566505|FG001|Overall Study|Ineligible|0|||
162886709|NCT03287869|588284897|FG000|Overall Study|Adverse Event|14|||
162886710|NCT03287869|588284898|FG001|Overall Study|Adverse Event|12|||
162886711|NCT03287869|588284897|FG000|Overall Study|Lack of Efficacy|1|||
162886712|NCT03287869|588284898|FG001|Overall Study|Lack of Efficacy|0|||
162886713|NCT03287869|588284897|FG000|Overall Study|Lost to Follow-up|13|||
162886714|NCT03287869|588284898|FG001|Overall Study|Lost to Follow-up|19|||
162886715|NCT03287869|588284897|FG000|Overall Study|Non-Compliance With Study Drug|5|||
162886716|NCT03287869|588284898|FG001|Overall Study|Non-Compliance With Study Drug|9|||
162886717|NCT03287869|588284897|FG000|Overall Study|Progressive Disease|1|||
162886718|NCT03287869|588284898|FG001|Overall Study|Progressive Disease|0|||
162886719|NCT03287869|588284897|FG000|Overall Study|Protocol Deviation|2|||
162886720|NCT03287869|588284898|FG001|Overall Study|Protocol Deviation|1|||
162886721|NCT03287869|588284897|FG000|Overall Study|Withdrawal by Subject|36|||
162886722|NCT03287869|588284898|FG001|Overall Study|Withdrawal by Subject|43|||
162963442|NCT00516295|588566506|FG002|Overall Study|Ineligible|0|||
162886723|NCT03287869|588284897|FG000|Overall Study|Early Closure of the Site|0|||
162886724|NCT03287869|588284898|FG001|Overall Study|Early Closure of the Site|1|||
162886725|NCT03287869|588284897|FG000|Overall Study|Physician Decision|5|||
162886726|NCT03287869|588284898|FG001|Overall Study|Physician Decision|5|||
162886727|NCT03287869|588284897|FG000|Overall Study|Reason not Specified|6|||
162886728|NCT03287869|588284898|FG001|Overall Study|Reason not Specified|3|||
162886729|NCT04847141|588284899|FG000|Overall Study|Adverse Event|1|||
162886730|NCT04847141|588284900|FG001|Overall Study|Adverse Event|0|||
162886731|NCT04847141|588284901|FG002|Overall Study|Adverse Event|1|||
162886732|NCT04847141|588284899|FG000|Overall Study|Withdrawal by Subject|2|||
162886733|NCT04847141|588284900|FG001|Overall Study|Withdrawal by Subject|4|||
162886734|NCT04847141|588284901|FG002|Overall Study|Withdrawal by Subject|3|||
162886735|NCT04847141|588284899|FG000|Overall Study|Lost to Follow-up|7|||
162886736|NCT04847141|588284900|FG001|Overall Study|Lost to Follow-up|5|||
162886737|NCT04847141|588284901|FG002|Overall Study|Lost to Follow-up|7|||
162886738|NCT04847141|588284899|FG000|Overall Study|Reason not Specified|0|||
162886739|NCT04847141|588284900|FG001|Overall Study|Reason not Specified|1|||
162886740|NCT04847141|588284901|FG002|Overall Study|Reason not Specified|0|||
162886741|NCT00324740|588284902|FG000|Overall Study|Withdrawal by Subject|1|||
162886742|NCT00324740|588284903|FG001|Overall Study|Withdrawal by Subject|0|||
162886743|NCT00324740|588284904|FG002|Overall Study|Withdrawal by Subject|1|||
162886744|NCT01357980|588284909|FG000|Overall Study|Lack of Efficacy|0|||
162886745|NCT01357980|588284910|FG001|Overall Study|Lack of Efficacy|1|||
162886746|NCT01357980|588284911|FG002|Overall Study|Lack of Efficacy|0|||
162886747|NCT01357980|588284912|FG003|Overall Study|Lack of Efficacy|0|||
162886748|NCT01357980|588284909|FG000|Overall Study|Consent withdrawn|0|||
162886749|NCT01357980|588284910|FG001|Overall Study|Consent withdrawn|0|||
162886750|NCT01357980|588284911|FG002|Overall Study|Consent withdrawn|1|||
162886751|NCT01357980|588284912|FG003|Overall Study|Consent withdrawn|0|||
162886752|NCT04507776|588284913|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
162886753|NCT00094835|588284917|FG000|Overall Study|Physician Decision|1|||
162886754|NCT00094835|588284918|FG001|Overall Study|Physician Decision|0|||
162886755|NCT00094835|588284919|FG002|Overall Study|Physician Decision|0|||
162886756|NCT00094835|588284920|FG003|Overall Study|Physician Decision|0|||
162886757|NCT00094835|588284921|FG004|Overall Study|Physician Decision|0|||
162886758|NCT00094835|588284922|FG005|Overall Study|Physician Decision|1|||
162886759|NCT00094835|588284923|FG006|Overall Study|Physician Decision|0|||
162886760|NCT00094835|588284917|FG000|Overall Study|Withdrawal by Subject|0|||
162886761|NCT00094835|588284918|FG001|Overall Study|Withdrawal by Subject|0|||
162886762|NCT00094835|588284919|FG002|Overall Study|Withdrawal by Subject|0|||
162886763|NCT00094835|588284920|FG003|Overall Study|Withdrawal by Subject|0|||
162886764|NCT00094835|588284921|FG004|Overall Study|Withdrawal by Subject|0|||
162886765|NCT00094835|588284922|FG005|Overall Study|Withdrawal by Subject|0|||
162886766|NCT00094835|588284923|FG006|Overall Study|Withdrawal by Subject|1|||
162886767|NCT00094835|588284917|FG000|Overall Study|Lost to Follow-up|0|||
162886768|NCT00094835|588284918|FG001|Overall Study|Lost to Follow-up|0|||
162886769|NCT00094835|588284919|FG002|Overall Study|Lost to Follow-up|0|||
162886770|NCT00094835|588284920|FG003|Overall Study|Lost to Follow-up|0|||
162886771|NCT00094835|588284921|FG004|Overall Study|Lost to Follow-up|1|||
162886772|NCT00094835|588284922|FG005|Overall Study|Lost to Follow-up|0|||
162886773|NCT00094835|588284923|FG006|Overall Study|Lost to Follow-up|0|||
162886774|NCT00094835|588284917|FG000|Overall Study|Death|1|||
162886775|NCT00094835|588284918|FG001|Overall Study|Death|0|||
162886776|NCT00094835|588284919|FG002|Overall Study|Death|0|||
162886777|NCT00094835|588284920|FG003|Overall Study|Death|0|||
162886778|NCT00094835|588284921|FG004|Overall Study|Death|1|||
162886779|NCT00094835|588284922|FG005|Overall Study|Death|0|||
162886780|NCT00094835|588284923|FG006|Overall Study|Death|0|||
162886781|NCT00094835|588284917|FG000|Overall Study|Non-compliance|1|||
162886782|NCT00094835|588284918|FG001|Overall Study|Non-compliance|2|||
162963443|NCT00660660|588566509|FG000|Overall Study|Adverse Event|1|||
162963444|NCT00660660|588566510|FG001|Overall Study|Adverse Event|0|||
162963445|NCT00660660|588566509|FG000|Overall Study|Lost to Follow-up|0|||
162963446|NCT00660660|588566510|FG001|Overall Study|Lost to Follow-up|6|||
162963447|NCT00660660|588566509|FG000|Overall Study|Lack of Efficacy|0|||
162963448|NCT00660660|588566510|FG001|Overall Study|Lack of Efficacy|2|||
162963449|NCT00660660|588566509|FG000|Overall Study|Withdrawal by Subject|3|||
162963450|NCT00660660|588566510|FG001|Overall Study|Withdrawal by Subject|0|||
162886783|NCT00094835|588284919|FG002|Overall Study|Non-compliance|2|||
162886784|NCT00094835|588284920|FG003|Overall Study|Non-compliance|0|||
162886785|NCT00094835|588284921|FG004|Overall Study|Non-compliance|2|||
162886786|NCT00094835|588284922|FG005|Overall Study|Non-compliance|2|||
162886787|NCT00094835|588284923|FG006|Overall Study|Non-compliance|1|||
162886788|NCT00094835|588284917|FG000|Overall Study|Other|1|||
162886789|NCT00094835|588284918|FG001|Overall Study|Other|1|||
162886790|NCT00094835|588284919|FG002|Overall Study|Other|1|||
162886791|NCT00094835|588284920|FG003|Overall Study|Other|1|||
162886792|NCT00094835|588284921|FG004|Overall Study|Other|0|||
162886793|NCT00094835|588284922|FG005|Overall Study|Other|0|||
162886794|NCT00094835|588284923|FG006|Overall Study|Other|0|||
162886795|NCT00387348|588284924|FG000|Overall Study|Death|1|||
162886796|NCT00387348|588284925|FG001|Overall Study|Death|1|||
162886797|NCT00387348|588284926|FG002|Overall Study|Death|0|||
162886798|NCT00387348|588284924|FG000|Overall Study|Physician Decision|1|||
162886799|NCT00387348|588284925|FG001|Overall Study|Physician Decision|0|||
162886800|NCT00387348|588284926|FG002|Overall Study|Physician Decision|1|||
162886801|NCT00387348|588284924|FG000|Overall Study|Withdrawal by Subject|0|||
162886802|NCT00387348|588284925|FG001|Overall Study|Withdrawal by Subject|2|||
162886803|NCT00387348|588284926|FG002|Overall Study|Withdrawal by Subject|2|||
162886804|NCT00387348|588284924|FG000|Overall Study|Adverse Event|1|||
162886805|NCT00387348|588284925|FG001|Overall Study|Adverse Event|0|||
162886806|NCT00387348|588284926|FG002|Overall Study|Adverse Event|1|||
162886807|NCT03628599|588284927|FG000|Overall Study|Adverse Event|0|||
162886808|NCT03628599|588284928|FG001|Overall Study|Adverse Event|1|||
162886809|NCT05905601|588284933|FG000|Overall Study|Lost to Follow-up|1|||
162886810|NCT05905601|588284934|FG001|Overall Study|Lost to Follow-up|3|||
162886811|NCT03024255|588284935|FG000|Overall Study|Adverse Event|1|||
162886812|NCT03024255|588284936|FG001|Overall Study|Adverse Event|4|||
162886813|NCT03024255|588284937|FG002|Overall Study|Adverse Event|8|||
162886814|NCT03024255|588284938|FG003|Overall Study|Adverse Event|0|||
162886815|NCT03024255|588284935|FG000|Overall Study|Withdrawal by Subject|3|||
162886816|NCT03024255|588284936|FG001|Overall Study|Withdrawal by Subject|1|||
162886817|NCT03024255|588284937|FG002|Overall Study|Withdrawal by Subject|0|||
162886818|NCT03024255|588284938|FG003|Overall Study|Withdrawal by Subject|3|||
162886819|NCT03024255|588284935|FG000|Overall Study|Protocol Violation|0|||
162886820|NCT03024255|588284936|FG001|Overall Study|Protocol Violation|0|||
162886821|NCT03024255|588284937|FG002|Overall Study|Protocol Violation|2|||
162886822|NCT03024255|588284938|FG003|Overall Study|Protocol Violation|0|||
162886823|NCT03024255|588284935|FG000|Overall Study|Lost to Follow-up|1|||
162886824|NCT03024255|588284936|FG001|Overall Study|Lost to Follow-up|2|||
162886825|NCT03024255|588284937|FG002|Overall Study|Lost to Follow-up|1|||
162886826|NCT03024255|588284938|FG003|Overall Study|Lost to Follow-up|1|||
162886827|NCT03024255|588284935|FG000|Overall Study|Lack of Efficacy|1|||
162886828|NCT03024255|588284936|FG001|Overall Study|Lack of Efficacy|0|||
162886829|NCT03024255|588284937|FG002|Overall Study|Lack of Efficacy|0|||
162886830|NCT03024255|588284938|FG003|Overall Study|Lack of Efficacy|0|||
162886831|NCT03024255|588284935|FG000|Overall Study|Protocol Noncompliance|1|||
162886832|NCT03024255|588284936|FG001|Overall Study|Protocol Noncompliance|1|||
162886833|NCT03024255|588284937|FG002|Overall Study|Protocol Noncompliance|0|||
162886834|NCT03024255|588284938|FG003|Overall Study|Protocol Noncompliance|1|||
162886835|NCT00868166|588284943|FG000|Overall Study|Death|58|||
162886836|NCT00868166|588284944|FG001|Overall Study|Death|65|||
162886837|NCT00868166|588284943|FG000|Overall Study|Withdrawal by Subject|33|||
162886838|NCT00868166|588284944|FG001|Overall Study|Withdrawal by Subject|25|||
162886839|NCT00868166|588284943|FG000|Overall Study|Protocol Violation|1|||
162886840|NCT00868166|588284944|FG001|Overall Study|Protocol Violation|0|||
162886841|NCT00868166|588284943|FG000|Overall Study|Lost to Follow-up|1|||
162886842|NCT00868166|588284944|FG001|Overall Study|Lost to Follow-up|3|||
162886843|NCT00868166|588284943|FG000|Overall Study|Adverse Event|9|||
162886844|NCT00868166|588284944|FG001|Overall Study|Adverse Event|10|||
162886845|NCT00868166|588284943|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
162886846|NCT00868166|588284944|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
162886847|NCT00868166|588284943|FG000|Overall Study|Non-compliance with IMP|1|||
162886848|NCT00868166|588284944|FG001|Overall Study|Non-compliance with IMP|1|||
162886849|NCT01779648|588284953|FG000|Overall Study|Protocol Violation|1|||
162886850|NCT01779648|588284954|FG001|Overall Study|Protocol Violation|0|||
162886851|NCT01797445|588284955|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
162886852|NCT01797445|588284956|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
162886853|NCT01797445|588284955|FG000|Double-Blind Phase|Adverse Event|3|||
162886854|NCT01797445|588284956|FG001|Double-Blind Phase|Adverse Event|0|||
162886855|NCT01797445|588284955|FG000|Double-Blind Phase|Death|5|||
162886856|NCT01797445|588284956|FG001|Double-Blind Phase|Death|4|||
162886857|NCT01797445|588284955|FG000|Double-Blind Phase|Pregnancy|0|||
162708071|NCT04529538|587640671|FG000|Overall Study|Adverse Event|0|||
162886858|NCT01797445|588284956|FG001|Double-Blind Phase|Pregnancy|1|||
162886859|NCT01797445|588284955|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162886860|NCT01797445|588284956|FG001|Double-Blind Phase|Lack of Efficacy|2|||
162708072|NCT04529538|587640672|FG001|Overall Study|Adverse Event|0|||
162886861|NCT01797445|588284955|FG000|Double-Blind Phase|Investigator's Discretion|15|||
162886862|NCT01797445|588284956|FG001|Double-Blind Phase|Investigator's Discretion|17|||
162886863|NCT01797445|588284955|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
162886864|NCT01797445|588284956|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
162886865|NCT01797445|588284955|FG000|Double-Blind Phase|Protocol Violation|0|||
162886866|NCT01797445|588284956|FG001|Double-Blind Phase|Protocol Violation|1|||
162886867|NCT01797445|588284955|FG000|Double-Blind Phase|Withdrew Consent|20|||
162886868|NCT01797445|588284956|FG001|Double-Blind Phase|Withdrew Consent|35|||
162886869|NCT01797445|588284955|FG000|Double-Blind Phase|Lost to Follow-up|34|||
162886870|NCT01797445|588284956|FG001|Double-Blind Phase|Lost to Follow-up|26|||
162886871|NCT01797445|588284955|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
162886872|NCT01797445|588284956|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
162886873|NCT01204697|588284957|FG000|Overall Study|Death|26|||
162886874|NCT01204697|588284958|FG001|Overall Study|Death|27|||
162708073|NCT04529538|587640673|FG002|Overall Study|Adverse Event|0|||
162708074|NCT04529538|587640674|FG003|Overall Study|Adverse Event|1|||
162708075|NCT04529538|587640675|FG004|Overall Study|Adverse Event|0|||
162708076|NCT04529538|587640676|FG005|Overall Study|Adverse Event|0|||
162708077|NCT04529538|587640677|FG006|Overall Study|Adverse Event|0|||
162708078|NCT04529538|587640678|FG007|Overall Study|Adverse Event|0|||
162708079|NCT04529538|587640671|FG000|Overall Study|Protocol Deviation|0|||
162708080|NCT04529538|587640672|FG001|Overall Study|Protocol Deviation|0|||
162708081|NCT04529538|587640673|FG002|Overall Study|Protocol Deviation|0|||
162708082|NCT04529538|587640674|FG003|Overall Study|Protocol Deviation|1|||
162708083|NCT04529538|587640675|FG004|Overall Study|Protocol Deviation|0|||
162708084|NCT04529538|587640676|FG005|Overall Study|Protocol Deviation|0|||
162708085|NCT04529538|587640677|FG006|Overall Study|Protocol Deviation|0|||
162708086|NCT04529538|587640678|FG007|Overall Study|Protocol Deviation|0|||
162708087|NCT04529538|587640671|FG000|Overall Study|Physician Decision|0|||
162708088|NCT04529538|587640672|FG001|Overall Study|Physician Decision|0|||
162708089|NCT04529538|587640673|FG002|Overall Study|Physician Decision|0|||
162708090|NCT04529538|587640674|FG003|Overall Study|Physician Decision|0|||
162708091|NCT04529538|587640675|FG004|Overall Study|Physician Decision|0|||
162708092|NCT04529538|587640676|FG005|Overall Study|Physician Decision|1|||
162708093|NCT04529538|587640677|FG006|Overall Study|Physician Decision|0|||
162708094|NCT04529538|587640678|FG007|Overall Study|Physician Decision|1|||
162708095|NCT02223182|587640680|FG000|Double-Blind Period|Adverse Event|0|||
162708096|NCT02223182|587640681|FG001|Double-Blind Period|Adverse Event|2|||
162708097|NCT02223182|587640682|FG002|Double-Blind Period|Adverse Event|1|||
162708098|NCT02223182|587640683|FG003|Double-Blind Period|Adverse Event|0|||
163050691|NCT01435759|588893655|FG001|Antidepressant Lead-in Phase|Other|0|||
163050692|NCT01435759|588893656|FG002|Antidepressant Lead-in Phase|Other|0|||
162708099|NCT02223182|587640680|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162708100|NCT02223182|587640681|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162708101|NCT02223182|587640682|FG002|Double-Blind Period|Withdrawal by Subject|1|||
163050693|NCT01435759|588893657|FG003|Antidepressant Lead-in Phase|Other|0|||
163050694|NCT01435759|588893658|FG004|Antidepressant Lead-in Phase|Other|0|||
163050695|NCT01435759|588893659|FG005|Antidepressant Lead-in Phase|Other|0|||
163050696|NCT01435759|588893654|FG000|Double-blind Phase|Adverse Event|7|||
163050697|NCT01435759|588893655|FG001|Double-blind Phase|Adverse Event|0|||
163050698|NCT01435759|588893656|FG002|Double-blind Phase|Adverse Event|1|||
163050699|NCT01435759|588893657|FG003|Double-blind Phase|Adverse Event|1|||
163050700|NCT01435759|588893658|FG004|Double-blind Phase|Adverse Event|1|||
162708102|NCT02223182|587640683|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162708103|NCT02223182|587640680|FG000|Double-Blind Period|Lost to Follow-up|0|||
162708104|NCT02223182|587640681|FG001|Double-Blind Period|Lost to Follow-up|1|||
162886875|NCT01204697|588284957|FG000|Overall Study|Lost to Follow-up|3|||
162886876|NCT01204697|588284958|FG001|Overall Study|Lost to Follow-up|4|||
162886877|NCT01204697|588284957|FG000|Overall Study|Withdrawal by Subject|2|||
162886878|NCT01204697|588284958|FG001|Overall Study|Withdrawal by Subject|4|||
162886879|NCT01204697|588284957|FG000|Overall Study|Randomized, but not treated|0|||
162886880|NCT01204697|588284958|FG001|Overall Study|Randomized, but not treated|1|||
162886881|NCT03939637|588284959|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
162886882|NCT03939637|588284960|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
162886883|NCT03939637|588284959|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
162886884|NCT03939637|588284960|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
162886885|NCT04190186|588284961|FG000|Overall Study|ILR is no longer functioning|0|||
162886886|NCT04190186|588284962|FG001|Overall Study|ILR is no longer functioning|1|||
162886887|NCT04190186|588284961|FG000|Overall Study|Lost to Follow-up|0|||
162886888|NCT04190186|588284962|FG001|Overall Study|Lost to Follow-up|1|||
162886889|NCT04190186|588284961|FG000|Overall Study|Withdrawal by Subject|2|||
162886890|NCT04190186|588284962|FG001|Overall Study|Withdrawal by Subject|0|||
162886891|NCT04190186|588284961|FG000|Overall Study|Subject choice to explant|1|||
162708105|NCT02223182|587640682|FG002|Double-Blind Period|Lost to Follow-up|0|||
162708106|NCT02223182|587640683|FG003|Double-Blind Period|Lost to Follow-up|0|||
162708107|NCT02223182|587640680|FG000|Double-Blind Period|Non Compliance|0|||
162708108|NCT02223182|587640681|FG001|Double-Blind Period|Non Compliance|0|||
162886892|NCT04190186|588284962|FG001|Overall Study|Subject choice to explant|0|||
163050701|NCT01435759|588893659|FG005|Double-blind Phase|Adverse Event|3|||
162886893|NCT04190186|588284961|FG000|Overall Study|Physician Decision|0|||
162886894|NCT04190186|588284962|FG001|Overall Study|Physician Decision|1|||
162708109|NCT02223182|587640682|FG002|Double-Blind Period|Non Compliance|0|||
162708110|NCT02223182|587640683|FG003|Double-Blind Period|Non Compliance|1|||
162708111|NCT02223182|587640680|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
162617442|NCT02628769|587316217|FG000|First Intervention|Withdrawal by Subject|0|||
162617443|NCT02628769|587316218|FG001|First Intervention|Withdrawal by Subject|1|||
162617444|NCT02628769|587316217|FG000|Second Intervention|Adverse Event|2|||
162617445|NCT02628769|587316218|FG001|Second Intervention|Adverse Event|0|||
162617446|NCT02628769|587316217|FG000|Second Intervention|Physician Decision|0|||
162617447|NCT02628769|587316218|FG001|Second Intervention|Physician Decision|1|||
162617448|NCT01467583|587316219|FG000|Overall Study|Death|1|||
162617449|NCT01467583|587316220|FG001|Overall Study|Death|1|||
162617450|NCT01467583|587316221|FG002|Overall Study|Death|0|||
162617451|NCT01467583|587316219|FG000|Overall Study|Withdrawal by Subject|1|||
162617452|NCT01467583|587316220|FG001|Overall Study|Withdrawal by Subject|0|||
162617453|NCT01467583|587316221|FG002|Overall Study|Withdrawal by Subject|0|||
162617454|NCT01467583|587316219|FG000|Overall Study|Protocol Violation|0|||
162617455|NCT01467583|587316220|FG001|Overall Study|Protocol Violation|0|||
162617456|NCT01467583|587316221|FG002|Overall Study|Protocol Violation|2|||
162617457|NCT05274165|587316222|FG000|Overall Study|Withdrawal by Subject|3|||
162617458|NCT05274165|587316223|FG001|Overall Study|Withdrawal by Subject|3|||
162617459|NCT00717093|587317712|FG000|Overall Study|Adverse Event|19|||
162617460|NCT00717093|587317713|FG001|Overall Study|Adverse Event|9|||
162617461|NCT00717093|587317712|FG000|Overall Study|Lack of Efficacy|3|||
162617462|NCT00717093|587317713|FG001|Overall Study|Lack of Efficacy|13|||
162617463|NCT00717093|587317712|FG000|Overall Study|Lost to Follow-up|9|||
162617464|NCT00717093|587317713|FG001|Overall Study|Lost to Follow-up|6|||
162617465|NCT00717093|587317712|FG000|Overall Study|Withdrawal by Subject|12|||
162617466|NCT00717093|587317713|FG001|Overall Study|Withdrawal by Subject|19|||
162617467|NCT00717093|587317712|FG000|Overall Study|Other|0|||
162617468|NCT00717093|587317713|FG001|Overall Study|Other|1|||
162617469|NCT00717093|587317712|FG000|Overall Study|Randomized but not treated|1|||
162617470|NCT00717093|587317713|FG001|Overall Study|Randomized but not treated|0|||
162617471|NCT00217620|587317714|FG000|Overall Study|Adverse Event|2|||
162617472|NCT00217620|587317714|FG000|Overall Study|Progression|31|||
162617473|NCT00217620|587317714|FG000|Overall Study|Not Protocol Specified|4|||
162617474|NCT00217620|587317714|FG000|Overall Study|Ineligible|13|||
162617475|NCT00217620|587317714|FG000|Overall Study|Never received treatment|1|||
162617476|NCT01314703|587317730|FG000|Overall Study|screen failure and closed enrollment|8|||
162617477|NCT04195906|587317734|FG000|Part 1|Adverse Event|3|||
162617478|NCT04195906|587317735|FG001|Part 1|Adverse Event|7|||
162617479|NCT04195906|587317734|FG000|Part 1|Withdrawal by Subject|0|||
162617480|NCT04195906|587317735|FG001|Part 1|Withdrawal by Subject|1|||
162617481|NCT04195906|587317734|FG000|Part 2|Adverse Event|1|||
162617482|NCT04195906|587317735|FG001|Part 2|Adverse Event|1|||
162617483|NCT04195906|587317734|FG000|Part 2|Withdrawal by Subject|0|||
162617484|NCT04195906|587317735|FG001|Part 2|Withdrawal by Subject|3|||
162617485|NCT04195906|587317734|FG000|Part 2|Other|1|||
162617486|NCT04195906|587317735|FG001|Part 2|Other|3|||
162617487|NCT02024529|587317737|FG000|Overall Study|Withdrawal by Subject|11|||
162617488|NCT02024529|587317738|FG001|Overall Study|Withdrawal by Subject|21|||
162617489|NCT02024529|587317737|FG000|Overall Study|Lost to Follow-up|2|||
162617490|NCT02024529|587317738|FG001|Overall Study|Lost to Follow-up|4|||
162617491|NCT00691301|587317739|FG000|Overall Study|Adverse Event|10|||
162617492|NCT00691301|587317739|FG000|Overall Study|Death|2|||
162617493|NCT00691301|587317739|FG000|Overall Study|Lack of Efficacy|32|||
162617494|NCT00691301|587317739|FG000|Overall Study|Withdrawal by Subject|4|||
162617495|NCT00691301|587317739|FG000|Overall Study|Concurrent illness|2|||
162617496|NCT00691301|587317739|FG000|Overall Study|other reason|3|||
162617497|NCT00691301|587317739|FG000|Overall Study|Did not initiate study treatment|1|||
162617498|NCT02642029|587317740|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
162617499|NCT02642029|587317741|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162617500|NCT02642029|587317742|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162617501|NCT02642029|587317743|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162617502|NCT02642029|587317744|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162617503|NCT02642029|587317745|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162617504|NCT02642029|587317740|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162617505|NCT02642029|587317741|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
162617506|NCT02642029|587317742|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162617507|NCT02642029|587317743|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162617508|NCT02642029|587317744|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162708112|NCT02223182|587640681|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162617509|NCT02642029|587317745|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162617510|NCT02642029|587317740|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162617511|NCT02642029|587317741|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162617512|NCT02642029|587317742|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162617513|NCT02642029|587317743|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162617514|NCT02642029|587317744|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
162617515|NCT02642029|587317745|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162708113|NCT02223182|587640682|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162708114|NCT02223182|587640683|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162708115|NCT02223182|587640680|FG000|Open-Label 500 Period|Adverse Event|1|||
162708116|NCT02223182|587640681|FG001|Open-Label 500 Period|Adverse Event|0|||
162708117|NCT02223182|587640682|FG002|Open-Label 500 Period|Adverse Event|2|||
162708118|NCT02223182|587640683|FG003|Open-Label 500 Period|Adverse Event|1|||
162708119|NCT02223182|587640680|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
162708120|NCT02223182|587640681|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
162708121|NCT02223182|587640682|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
162708122|NCT02223182|587640683|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
162708123|NCT02223182|587640680|FG000|Open-Label 500 Period|Physician Decision|0|||
162708124|NCT02223182|587640681|FG001|Open-Label 500 Period|Physician Decision|0|||
162708125|NCT02223182|587640682|FG002|Open-Label 500 Period|Physician Decision|0|||
162708126|NCT02223182|587640683|FG003|Open-Label 500 Period|Physician Decision|1|||
162708127|NCT02223182|587640680|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162708128|NCT02223182|587640681|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162708129|NCT02223182|587640682|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
162708130|NCT02223182|587640683|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162708131|NCT02223182|587640680|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
162708132|NCT02223182|587640681|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
162708133|NCT02223182|587640682|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
162708134|NCT02223182|587640683|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
162708135|NCT02223182|587640680|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
162708136|NCT02223182|587640681|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
162708137|NCT02223182|587640682|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
162886895|NCT04190186|588284961|FG000|Overall Study|Study was stopped|4|||
162886896|NCT04190186|588284962|FG001|Overall Study|Study was stopped|5|||
162886897|NCT00830804|588284963|FG000|Overall Study|Lost to Follow-up|4|||
162886898|NCT00830804|588284963|FG000|Overall Study|Death|1|||
162886899|NCT00830804|588284963|FG000|Overall Study|Unable to get to clinic|7|||
162886900|NCT00830804|588284963|FG000|Overall Study|Consent withdrawn|2|||
162886901|NCT00830804|588284963|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
162886902|NCT01397448|588284965|FG000|Overall Study|Adverse Event|4|||
162886903|NCT01397448|588284966|FG001|Overall Study|Adverse Event|4|||
162886904|NCT01397448|588284967|FG002|Overall Study|Adverse Event|6|||
162886905|NCT01397448|588284965|FG000|Overall Study|Withdrawal by Subject|4|||
162886906|NCT01397448|588284966|FG001|Overall Study|Withdrawal by Subject|4|||
162886907|NCT01397448|588284967|FG002|Overall Study|Withdrawal by Subject|3|||
162886908|NCT01397448|588284965|FG000|Overall Study|Lack of Efficacy|2|||
162886909|NCT01397448|588284966|FG001|Overall Study|Lack of Efficacy|0|||
162886910|NCT01397448|588284967|FG002|Overall Study|Lack of Efficacy|5|||
162886911|NCT01397448|588284965|FG000|Overall Study|Other|8|||
162886912|NCT01397448|588284966|FG001|Overall Study|Other|7|||
162886913|NCT01397448|588284967|FG002|Overall Study|Other|4|||
162886914|NCT02180217|588284974|FG000|Overall Study|Adverse Event|3|||
162886915|NCT02180217|588284975|FG001|Overall Study|Adverse Event|2|||
162886916|NCT02180217|588284976|FG002|Overall Study|Adverse Event|22|||
162886917|NCT02180217|588284974|FG000|Overall Study|Death|1|||
162886918|NCT02180217|588284975|FG001|Overall Study|Death|1|||
162886919|NCT02180217|588284976|FG002|Overall Study|Death|0|||
162886920|NCT02180217|588284974|FG000|Overall Study|Withdrawal by Subject|1|||
162886921|NCT02180217|588284975|FG001|Overall Study|Withdrawal by Subject|1|||
162886922|NCT02180217|588284976|FG002|Overall Study|Withdrawal by Subject|4|||
162886923|NCT02180217|588284974|FG000|Overall Study|Subject/Guardian decision|5|||
162886924|NCT02180217|588284975|FG001|Overall Study|Subject/Guardian decision|3|||
162886925|NCT02180217|588284976|FG002|Overall Study|Subject/Guardian decision|6|||
162886926|NCT02180217|588284974|FG000|Overall Study|Physician Decision|1|||
162886927|NCT02180217|588284975|FG001|Overall Study|Physician Decision|1|||
162886928|NCT02180217|588284976|FG002|Overall Study|Physician Decision|6|||
162886929|NCT02180217|588284974|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162886930|NCT02180217|588284975|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162886931|NCT02180217|588284976|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162886932|NCT00776555|588284977|FG000|Overall Study|Study terminated|3|||
162886933|NCT00776555|588284978|FG001|Overall Study|Study terminated|0|||
162886934|NCT03483116|588284982|FG000|Overall Study|Adverse Event|0|||
162886935|NCT03483116|588284983|FG001|Overall Study|Adverse Event|1|||
162708138|NCT02223182|587640683|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
162708139|NCT02223182|587640680|FG000|Open-Label 300 Period|Non Compliance|0|||
162708140|NCT02223182|587640681|FG001|Open-Label 300 Period|Non Compliance|2|||
162708141|NCT02223182|587640682|FG002|Open-Label 300 Period|Non Compliance|1|||
162886936|NCT03483116|588284984|FG002|Overall Study|Adverse Event|0|||
162886937|NCT03483116|588284985|FG003|Overall Study|Adverse Event|1|||
162886938|NCT03483116|588284982|FG000|Overall Study|Protocol Violation|1|||
162886939|NCT03483116|588284983|FG001|Overall Study|Protocol Violation|0|||
162886940|NCT03483116|588284984|FG002|Overall Study|Protocol Violation|0|||
162886941|NCT03483116|588284985|FG003|Overall Study|Protocol Violation|7|||
162886942|NCT03483116|588284982|FG000|Overall Study|Lost to Follow-up|9|||
162886943|NCT03483116|588284983|FG001|Overall Study|Lost to Follow-up|4|||
162886944|NCT03483116|588284984|FG002|Overall Study|Lost to Follow-up|9|||
162886945|NCT03483116|588284985|FG003|Overall Study|Lost to Follow-up|5|||
162886946|NCT03483116|588284982|FG000|Overall Study|Death|1|||
162886947|NCT03483116|588284983|FG001|Overall Study|Death|0|||
162886948|NCT03483116|588284984|FG002|Overall Study|Death|2|||
162708142|NCT02223182|587640683|FG003|Open-Label 300 Period|Non Compliance|0|||
162886949|NCT03483116|588284985|FG003|Overall Study|Death|1|||
162708143|NCT04956692|587640690|FG000|Overall Study|Death|115|||
162886950|NCT03483116|588284982|FG000|Overall Study|Withdrawal by Subject|14|||
162886951|NCT03483116|588284983|FG001|Overall Study|Withdrawal by Subject|16|||
162886952|NCT03483116|588284984|FG002|Overall Study|Withdrawal by Subject|14|||
162886953|NCT03483116|588284985|FG003|Overall Study|Withdrawal by Subject|16|||
162886954|NCT03483116|588284982|FG000|Overall Study|Unknown other reason|3|||
162886955|NCT03483116|588284983|FG001|Overall Study|Unknown other reason|2|||
162886956|NCT03483116|588284984|FG002|Overall Study|Unknown other reason|1|||
162886957|NCT03483116|588284985|FG003|Overall Study|Unknown other reason|1|||
162886958|NCT01181102|588284986|FG000|Overall Study|Adverse Event|28|||
162886959|NCT01181102|588284987|FG001|Overall Study|Adverse Event|26|||
162886960|NCT01181102|588284986|FG000|Overall Study|Lack of Efficacy|3|||
162708144|NCT04956692|587640691|FG001|Overall Study|Death|47|||
162886961|NCT01181102|588284987|FG001|Overall Study|Lack of Efficacy|1|||
162886962|NCT01181102|588284986|FG000|Overall Study|Lost to Follow-up|2|||
162886963|NCT01181102|588284987|FG001|Overall Study|Lost to Follow-up|0|||
162886964|NCT01181102|588284986|FG000|Overall Study|Physician Decision|3|||
162886965|NCT01181102|588284987|FG001|Overall Study|Physician Decision|1|||
162617516|NCT02642029|587317740|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
162617517|NCT02642029|587317741|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
162617518|NCT02642029|587317742|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
162617519|NCT02642029|587317743|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
162617520|NCT02642029|587317744|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
162617521|NCT02642029|587317745|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
162617522|NCT02642029|587317740|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
162617523|NCT02642029|587317741|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162617524|NCT02642029|587317742|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162617525|NCT02642029|587317743|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162617526|NCT02642029|587317744|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162617527|NCT02642029|587317745|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162617528|NCT02642029|587317740|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
162617529|NCT02642029|587317741|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162617530|NCT02642029|587317742|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162617531|NCT02642029|587317743|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162617532|NCT02642029|587317744|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162617533|NCT02642029|587317745|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162617534|NCT01823146|587317746|FG000|Overall Study|Withdrawal by Subject|0|||
162617535|NCT01823146|587317747|FG001|Overall Study|Withdrawal by Subject|1|||
162617536|NCT01823146|587317746|FG000|Overall Study|Lost to Follow-up|2|||
162617537|NCT01823146|587317747|FG001|Overall Study|Lost to Follow-up|1|||
162617538|NCT00463580|587317748|FG000|Overall Study|Lost to Follow-up|1|||
162617539|NCT00463580|587317749|FG001|Overall Study|Lost to Follow-up|0|||
162617540|NCT00463580|587317748|FG000|Overall Study|Schedule conflict|2|||
162617541|NCT00463580|587317749|FG001|Overall Study|Schedule conflict|0|||
162963451|NCT00660660|588566509|FG000|Overall Study|Incorrect enrollment and other|0|||
162963452|NCT00660660|588566510|FG001|Overall Study|Incorrect enrollment and other|1|||
162963453|NCT00660660|588566509|FG000|Overall Study|New medication after randomization|1|||
162963454|NCT00660660|588566510|FG001|Overall Study|New medication after randomization|0|||
162963455|NCT02651987|588566511|FG000|Overall Study|Adverse Event|2|||
162963456|NCT02651987|588566512|FG001|Overall Study|Adverse Event|2|||
162963457|NCT02651987|588566511|FG000|Overall Study|Consent Withdrawn|2|||
162963458|NCT02651987|588566512|FG001|Overall Study|Consent Withdrawn|0|||
162963459|NCT02651987|588566511|FG000|Overall Study|Local PD|0|||
162963460|NCT02651987|588566512|FG001|Overall Study|Local PD|2|||
162963461|NCT02651987|588566511|FG000|Overall Study|Investigator Decision|1|||
162963462|NCT02651987|588566512|FG001|Overall Study|Investigator Decision|1|||
162963463|NCT01630616|588566513|FG000|Overall Study|Adverse Event|0|||
162963464|NCT01630616|588566514|FG001|Overall Study|Adverse Event|0|||
162963465|NCT01630616|588566515|FG002|Overall Study|Adverse Event|0|||
162963466|NCT01630616|588566516|FG003|Overall Study|Adverse Event|1|||
162963467|NCT01630616|588566517|FG004|Overall Study|Adverse Event|0|||
162963468|NCT01630616|588566518|FG005|Overall Study|Adverse Event|0|||
162963469|NCT01630616|588566513|FG000|Overall Study|Withdrawal by Subject|0|||
162963470|NCT01630616|588566514|FG001|Overall Study|Withdrawal by Subject|0|||
162963471|NCT01630616|588566515|FG002|Overall Study|Withdrawal by Subject|0|||
162963472|NCT01630616|588566516|FG003|Overall Study|Withdrawal by Subject|2|||
162963473|NCT01630616|588566517|FG004|Overall Study|Withdrawal by Subject|0|||
163050702|NCT01435759|588893654|FG000|Double-blind Phase|Protocol Violation|2|||
162963474|NCT01630616|588566518|FG005|Overall Study|Withdrawal by Subject|0|||
162963475|NCT02725515|588566519|FG000|Overall Study|Refused infusion (no study treatment)|1|||
162963476|NCT02725515|588566520|FG001|Overall Study|Refused infusion (no study treatment)|0|||
162963477|NCT02725515|588566519|FG000|Overall Study|Loss of Improvement per Protocol|14|||
162963478|NCT02725515|588566520|FG001|Overall Study|Loss of Improvement per Protocol|25|||
162963479|NCT02725515|588566519|FG000|Overall Study|Withdrawal by Subject|2|||
162963480|NCT02725515|588566520|FG001|Overall Study|Withdrawal by Subject|1|||
162963481|NCT02725515|588566519|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162963482|NCT02725515|588566520|FG001|Overall Study|Non-Compliance With Study Drug|3|||
162617542|NCT00463580|587317748|FG000|Overall Study|Medical/psychiatric complications|0|||
162617543|NCT00463580|587317749|FG001|Overall Study|Medical/psychiatric complications|2|||
162886966|NCT01181102|588284986|FG000|Overall Study|Protocol Violation|5|||
162886967|NCT01181102|588284987|FG001|Overall Study|Protocol Violation|6|||
162886968|NCT01181102|588284986|FG000|Overall Study|Withdrawal by Subject|10|||
162886969|NCT01181102|588284987|FG001|Overall Study|Withdrawal by Subject|12|||
162886970|NCT00239837|588284992|FG000|Overall Study|Lost to Follow-up|3|||
162886971|NCT00239837|588284993|FG001|Overall Study|Lost to Follow-up|7|||
162886972|NCT01838590|588284994|FG000|Overall Study|Lack of Efficacy|12|||
162886973|NCT01838590|588284995|FG001|Overall Study|Lack of Efficacy|4|||
162886974|NCT01838590|588284994|FG000|Overall Study|Lost to Follow-up|0|||
162886975|NCT01838590|588284995|FG001|Overall Study|Lost to Follow-up|1|||
162886976|NCT04685499|588284996|FG000|Overall Study|Study Terminated Early|1|||
162886977|NCT01232894|588284997|FG000|Overall Study|Lost to Follow-up|0|||
162886978|NCT01232894|588284998|FG001|Overall Study|Lost to Follow-up|1|||
162886979|NCT01232894|588284997|FG000|Overall Study|Death|1|||
162617544|NCT01426438|587317750|FG000|Overall Study|Lost to Follow-up|1|||
162617545|NCT01426438|587317751|FG001|Overall Study|Lost to Follow-up|3|||
162617546|NCT01426438|587317750|FG000|Overall Study|Off study Treatment|9|||
162617547|NCT01426438|587317751|FG001|Overall Study|Off study Treatment|3|||
162617548|NCT01426438|587317750|FG000|Overall Study|Poor scan quality|3|||
162617549|NCT01426438|587317751|FG001|Overall Study|Poor scan quality|2|||
162617550|NCT01426438|587317750|FG000|Overall Study|Missed Scan|2|||
162886980|NCT01232894|588284998|FG001|Overall Study|Death|0|||
162886981|NCT01232894|588284997|FG000|Overall Study|Protocol Violation|1|||
162963483|NCT02725515|588566519|FG000|Overall Study|Lost to Follow-up|1|||
162617551|NCT01426438|587317751|FG001|Overall Study|Missed Scan|2|||
162886982|NCT01232894|588284998|FG001|Overall Study|Protocol Violation|1|||
162886983|NCT01232894|588284997|FG000|Overall Study|Withdrawal by Subject|8|||
162886984|NCT01232894|588284998|FG001|Overall Study|Withdrawal by Subject|5|||
162617552|NCT01788046|587317752|FG000|Overall Study|Withdrawal by Subject|12|||
162886985|NCT01232894|588284997|FG000|Overall Study|Physician Decision|2|||
162886986|NCT01232894|588284998|FG001|Overall Study|Physician Decision|1|||
162886987|NCT01996904|588285001|FG000|Overall Study|Lost to Follow-up|38|||
162886988|NCT01996904|588285002|FG001|Overall Study|Lost to Follow-up|27|||
162886989|NCT00929734|588285004|FG000|Overall Study|Lost to Follow-up|2|||
162886990|NCT00929734|588285005|FG001|Overall Study|Lost to Follow-up|1|||
162886991|NCT00929734|588285004|FG000|Overall Study|Withdrawal by Subject|0|||
162886992|NCT00929734|588285005|FG001|Overall Study|Withdrawal by Subject|2|||
162886993|NCT00980980|588285006|FG000|Overall Study|Withdrawal by Hospital|0|||
162886994|NCT00980980|588285007|FG001|Overall Study|Withdrawal by Hospital|1|||
162886995|NCT00980980|588285008|FG002|Overall Study|Withdrawal by Hospital|0|||
162886996|NCT00121992|588285009|FG000|Overall Study|Treatment not received|2|||
162886997|NCT00121992|588285010|FG001|Overall Study|Treatment not received|11|||
162886998|NCT03076190|588285011|FG000|Overall Study|Lost to Follow-up|9|||
162886999|NCT03076190|588285012|FG001|Overall Study|Lost to Follow-up|34|||
162887000|NCT03076190|588285011|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
162887001|NCT03076190|588285012|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
162887002|NCT01441115|588285013|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
162887003|NCT02260648|588285016|FG000|Overall Study|Adverse Event|3|||
162887004|NCT02260648|588285017|FG001|Overall Study|Adverse Event|0|||
162887005|NCT02260648|588285018|FG002|Overall Study|Adverse Event|1|||
162887006|NCT02260648|588285016|FG000|Overall Study|Withdrawal by Subject|1|||
162887007|NCT02260648|588285017|FG001|Overall Study|Withdrawal by Subject|1|||
162887008|NCT02260648|588285018|FG002|Overall Study|Withdrawal by Subject|0|||
162887009|NCT02260648|588285016|FG000|Overall Study|Protocol Violation|1|||
162887010|NCT02260648|588285017|FG001|Overall Study|Protocol Violation|0|||
162887011|NCT02260648|588285018|FG002|Overall Study|Protocol Violation|0|||
162887012|NCT02260648|588285016|FG000|Overall Study|Discontinue Due to Study Termination|13|||
162887013|NCT02260648|588285017|FG001|Overall Study|Discontinue Due to Study Termination|12|||
162887014|NCT02260648|588285018|FG002|Overall Study|Discontinue Due to Study Termination|7|||
162887015|NCT04093258|588285019|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
162887016|NCT04093258|588285020|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
162617553|NCT01788046|587317753|FG001|Overall Study|Withdrawal by Subject|12|||
162617554|NCT01788046|587317752|FG000|Overall Study|Lost to Follow-up|12|||
162887017|NCT01890512|588285021|FG000|Overall Study|Physician Decision|1|||
162887018|NCT01890512|588285021|FG000|Overall Study|Withdrawal by Subject|1|||
162887019|NCT01890512|588285021|FG000|Overall Study|Protocol Violation|1|||
162887020|NCT00805545|588285022|FG000|Overall Study|Protocol Violation|3|||
162887021|NCT00805545|588285023|FG001|Overall Study|Protocol Violation|2|||
162887022|NCT00805545|588285022|FG000|Overall Study|Protocol Violation|3|||
162887023|NCT00805545|588285023|FG001|Overall Study|Protocol Violation|1|||
162887024|NCT03543358|588285024|FG000|Overall Study|Death|1|||
162887025|NCT03543358|588285025|FG001|Overall Study|Death|0|||
162887026|NCT03543358|588285024|FG000|Overall Study|Disease Progression|1|||
162887027|NCT03543358|588285025|FG001|Overall Study|Disease Progression|0|||
162887028|NCT03543358|588285024|FG000|Overall Study|Parent Study Closure|1|||
162887029|NCT03543358|588285025|FG001|Overall Study|Parent Study Closure|0|||
162887030|NCT00986427|588285026|FG000|Overall Study|Lost to Follow-up|2|||
162887031|NCT00986427|588285027|FG001|Overall Study|Lost to Follow-up|0|||
162887032|NCT00986427|588285026|FG000|Overall Study|Lack of Efficacy|1|||
162887033|NCT00986427|588285027|FG001|Overall Study|Lack of Efficacy|0|||
162887034|NCT00986427|588285026|FG000|Overall Study|Withdrawal by Subject|1|||
162887035|NCT00986427|588285027|FG001|Overall Study|Withdrawal by Subject|0|||
162887036|NCT02379390|588285028|FG000|Overall Study|Adverse Event|1|||
162887037|NCT02379390|588285029|FG001|Overall Study|Adverse Event|1|||
162887038|NCT02379390|588285028|FG000|Overall Study|Investigator's decision|1|||
162887039|NCT02379390|588285029|FG001|Overall Study|Investigator's decision|0|||
162887040|NCT02379390|588285028|FG000|Overall Study|Study Termination|0|||
162887041|NCT02379390|588285029|FG001|Overall Study|Study Termination|1|||
162887042|NCT00575094|588285030|FG000|Overall Study|Adverse Event|2|||
162887043|NCT00575094|588285030|FG000|Overall Study|Withdrawal by Subject|1|||
162887044|NCT00643604|588285031|FG000|Overall Study|Death|1|||
162887045|NCT01164865|588285035|FG000|Overall Study|Lost to Follow-up|2|||
162887046|NCT01164865|588285036|FG001|Overall Study|Lost to Follow-up|1|||
162887047|NCT06025396|588286529|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
162887048|NCT06025396|588286530|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
162887049|NCT06025396|588286531|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
162887050|NCT06025396|588286532|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
162887051|NCT06025396|588286533|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
162887052|NCT06025396|588286529|FG000|Overall Study|Withdrawal by Subject|0|||
162887053|NCT06025396|588286530|FG001|Overall Study|Withdrawal by Subject|1|||
162887054|NCT06025396|588286531|FG002|Overall Study|Withdrawal by Subject|1|||
162617555|NCT01788046|587317753|FG001|Overall Study|Lost to Follow-up|19|||
162887055|NCT06025396|588286532|FG003|Overall Study|Withdrawal by Subject|0|||
162887056|NCT06025396|588286533|FG004|Overall Study|Withdrawal by Subject|0|||
162887057|NCT05691829|588286534|FG000|Overall Study|Physician Decision|2|||
162887058|NCT05691829|588286534|FG000|Overall Study|Eligibility criteria not met|3|||
162887059|NCT06422377|588286535|FG000|Overall Study|Study Terminated by Sponsor|1|||
162887060|NCT00453180|588286536|FG000|Overall Study|Lost to Follow-up|2|||
162887061|NCT00453180|588286537|FG001|Overall Study|Lost to Follow-up|1|||
162887062|NCT00453180|588286536|FG000|Overall Study|Adverse Event|1|||
162887063|NCT00453180|588286537|FG001|Overall Study|Adverse Event|2|||
162887064|NCT00804843|588286538|FG000|Overall Study|Protocol Violation|1|||
162617556|NCT01788046|587317752|FG000|Overall Study|Death|7|||
162617557|NCT01788046|587317753|FG001|Overall Study|Death|5|||
162617558|NCT01788046|587317752|FG000|Overall Study|Protocol Specified Criteria|25|||
162617559|NCT01788046|587317753|FG001|Overall Study|Protocol Specified Criteria|1|||
162617560|NCT01495975|587317757|FG000|Overall Study|Lost to Follow-up|1|||
162617561|NCT01495975|587317758|FG001|Overall Study|Lost to Follow-up|0|||
162617562|NCT00808483|587317761|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
162617563|NCT00808483|587317762|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
162617564|NCT00808483|587317761|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
162617565|NCT00808483|587317762|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
162617566|NCT00808483|587317761|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
162617567|NCT00808483|587317762|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
162617568|NCT02038881|587317763|FG000|Overall Study|Withdrawal by Subject|0|||
162617569|NCT02038881|587317764|FG001|Overall Study|Withdrawal by Subject|0|||
162617570|NCT02038881|587317765|FG002|Overall Study|Withdrawal by Subject|1|||
162617571|NCT02038881|587317763|FG000|Overall Study|Lost to Follow-up|2|||
162617572|NCT02038881|587317764|FG001|Overall Study|Lost to Follow-up|0|||
162617573|NCT02038881|587317765|FG002|Overall Study|Lost to Follow-up|0|||
162617574|NCT02038881|587317763|FG000|Overall Study|incarcerated|1|||
162617575|NCT02038881|587317764|FG001|Overall Study|incarcerated|0|||
162617576|NCT02038881|587317765|FG002|Overall Study|incarcerated|0|||
162617577|NCT00333840|587317766|FG000|First-line Treatment Period|Adverse Event|38|||
162617578|NCT00333840|587317767|FG001|First-line Treatment Period|Adverse Event|37|||
162617579|NCT00333840|587317768|FG002|First-line Treatment Period|Adverse Event|0|||
162617580|NCT00333840|587317769|FG003|First-line Treatment Period|Adverse Event|0|||
162617581|NCT00333840|587317766|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
162617582|NCT00333840|587317767|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
162617583|NCT00333840|587317768|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
162617584|NCT00333840|587317769|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
162617585|NCT00333840|587317766|FG000|First-line Treatment Period|Abnormal procedure|2|||
162617586|NCT00333840|587317767|FG001|First-line Treatment Period|Abnormal procedure|0|||
162617587|NCT00333840|587317768|FG002|First-line Treatment Period|Abnormal procedure|0|||
162617588|NCT00333840|587317769|FG003|First-line Treatment Period|Abnormal procedure|0|||
162617589|NCT00333840|587317766|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
162617590|NCT00333840|587317767|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
162617591|NCT00333840|587317768|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162617592|NCT00333840|587317769|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162617593|NCT00333840|587317766|FG000|First-line Treatment Period|No longer required study drug|21|||
162617594|NCT00333840|587317767|FG001|First-line Treatment Period|No longer required study drug|8|||
162617595|NCT00333840|587317768|FG002|First-line Treatment Period|No longer required study drug|0|||
162617596|NCT00333840|587317769|FG003|First-line Treatment Period|No longer required study drug|0|||
162887065|NCT00804843|588286539|FG001|Overall Study|Protocol Violation|0|||
162887066|NCT00804843|588286538|FG000|Overall Study|Adverse Event|8|||
162887067|NCT00804843|588286539|FG001|Overall Study|Adverse Event|5|||
162963484|NCT02725515|588566520|FG001|Overall Study|Lost to Follow-up|1|||
162963485|NCT02725515|588566519|FG000|Overall Study|Adverse Event|7|||
162963486|NCT02725515|588566520|FG001|Overall Study|Adverse Event|2|||
162963487|NCT02725515|588566519|FG000|Overall Study|No Documented Disease Improvement|0|||
162963488|NCT02725515|588566520|FG001|Overall Study|No Documented Disease Improvement|1|||
162617597|NCT00333840|587317766|FG000|First-line Treatment Period|Protocol Violation|17|||
162617598|NCT00333840|587317767|FG001|First-line Treatment Period|Protocol Violation|17|||
162617599|NCT00333840|587317768|FG002|First-line Treatment Period|Protocol Violation|0|||
162617600|NCT00333840|587317769|FG003|First-line Treatment Period|Protocol Violation|0|||
162617601|NCT00333840|587317766|FG000|First-line Treatment Period|Subject withdrew consent|57|||
162617602|NCT00333840|587317767|FG001|First-line Treatment Period|Subject withdrew consent|77|||
162617603|NCT00333840|587317768|FG002|First-line Treatment Period|Subject withdrew consent|0|||
162617604|NCT00333840|587317769|FG003|First-line Treatment Period|Subject withdrew consent|0|||
162617605|NCT00333840|587317766|FG000|First-line Treatment Period|Lost to Follow-up|15|||
162617606|NCT00333840|587317767|FG001|First-line Treatment Period|Lost to Follow-up|6|||
162887068|NCT00804843|588286538|FG000|Overall Study|Withdrawal by Subject|1|||
162887069|NCT00804843|588286539|FG001|Overall Study|Withdrawal by Subject|2|||
162963489|NCT02725515|588566519|FG000|Overall Study|Completed Study Under Original Protocol|0|||
162963490|NCT02725515|588566520|FG001|Overall Study|Completed Study Under Original Protocol|1|||
162963491|NCT02725515|588566519|FG000|Overall Study|Lack of Response|0|||
162963492|NCT02725515|588566520|FG001|Overall Study|Lack of Response|1|||
162963493|NCT00640393|588566526|FG000|Part 1|Lost to Follow-up|2|||
162887070|NCT03326869|588286545|FG000|Overall Study|Study data has been lost to natural disa|1|||
162887071|NCT03326869|588286546|FG001|Overall Study|Study data has been lost to natural disa|1|||
162887072|NCT01002742|588286549|FG000|Overall Study|Determined to be ineligible|0|||
162887073|NCT01002742|588286550|FG001|Overall Study|Determined to be ineligible|1|||
162887074|NCT00562640|588286551|FG000|Overall Study|Death|0|||
162887075|NCT00562640|588286552|FG001|Overall Study|Death|1|||
162887076|NCT00562640|588286553|FG002|Overall Study|Death|1|||
162887077|NCT00562640|588286554|FG003|Overall Study|Death|0|||
162887078|NCT05263921|588286555|FG000|Overall Study|Other: family emergency.|0|||
162887079|NCT05263921|588286556|FG001|Overall Study|Other: family emergency.|0|||
162887080|NCT05263921|588286557|FG002|Overall Study|Other: family emergency.|1|||
162887081|NCT05263921|588286558|FG003|Overall Study|Other: family emergency.|0|||
162887082|NCT01297309|588286563|FG000|Overall Study|Eligibility failure|2|||
162887083|NCT01297309|588286563|FG000|Overall Study|Screen failure|2|||
162887084|NCT01297309|588286563|FG000|Overall Study|Withdrawal by Subject|5|||
162887085|NCT01297309|588286563|FG000|Overall Study|Adverse Event|1|||
162887086|NCT01297309|588286563|FG000|Overall Study|Investigator Decision|2|||
162887087|NCT01297309|588286563|FG000|Overall Study|Death|1|||
162887088|NCT01297309|588286563|FG000|Overall Study|Participant not entering extensionperiod|1|||
162887089|NCT02670928|588286564|FG000|Overall Study|Adverse Event|3|||
162887090|NCT02670928|588286565|FG001|Overall Study|Adverse Event|1|||
162887091|NCT02670928|588286564|FG000|Overall Study|Withdrawal by Subject|4|||
162887092|NCT02670928|588286565|FG001|Overall Study|Withdrawal by Subject|0|||
162887093|NCT02670928|588286564|FG000|Overall Study|Lost to Follow-up|1|||
162887094|NCT02670928|588286565|FG001|Overall Study|Lost to Follow-up|0|||
162887095|NCT02670928|588286564|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
162887096|NCT02670928|588286565|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
162887097|NCT02678312|588286566|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
162887098|NCT02678312|588286567|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
162887099|NCT02678312|588286568|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
162887100|NCT02678312|588286569|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
162887101|NCT02678312|588286570|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
162887102|NCT02678312|588286566|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
162887103|NCT02678312|588286567|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
162887104|NCT02678312|588286568|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
162887105|NCT02678312|588286569|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
162887106|NCT02678312|588286570|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
162887107|NCT02678312|588286566|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
162887108|NCT02678312|588286567|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
162887109|NCT02678312|588286568|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
162887110|NCT02678312|588286569|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
162887111|NCT02678312|588286570|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
162887112|NCT02678312|588286566|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
162887113|NCT02678312|588286567|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
162887114|NCT02678312|588286568|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
162887115|NCT02678312|588286569|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
162887116|NCT02678312|588286570|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
162887117|NCT02678312|588286566|FG000|Part 2 Double Blind Epoch|Death|0|||
162887118|NCT02678312|588286567|FG001|Part 2 Double Blind Epoch|Death|0|||
162887119|NCT02678312|588286568|FG002|Part 2 Double Blind Epoch|Death|0|||
162887120|NCT02678312|588286569|FG003|Part 2 Double Blind Epoch|Death|8|||
162887121|NCT02678312|588286570|FG004|Part 2 Double Blind Epoch|Death|12|||
162887122|NCT02678312|588286566|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
162887123|NCT02678312|588286567|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
162887124|NCT02678312|588286568|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
162887125|NCT02678312|588286569|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
162887126|NCT02678312|588286570|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
162887127|NCT02678312|588286566|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
162887128|NCT02678312|588286567|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
162708145|NCT04956692|587640690|FG000|Overall Study|Lost to Follow-up|0|||
162887129|NCT02678312|588286568|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
162887130|NCT02678312|588286569|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
162887131|NCT02678312|588286570|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
162887132|NCT02678312|588286566|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
162887133|NCT02678312|588286567|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
162887134|NCT02678312|588286568|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
162887135|NCT02678312|588286569|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
162887136|NCT02678312|588286570|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
162887137|NCT00656084|588286571|FG000|Overall Study|Adverse Event|4|||
162887138|NCT00656084|588286571|FG000|Overall Study|Withdrawal by Subject|1|||
162887139|NCT00656084|588286571|FG000|Overall Study|Patient Request|1|||
162887140|NCT00656084|588286571|FG000|Overall Study|Investigator Request|1|||
162887141|NCT02591238|588286572|FG000|Overall Study|Pregnancy|1|||
162887142|NCT02591238|588286573|FG001|Overall Study|Pregnancy|0|||
162887143|NCT02591238|588286574|FG002|Overall Study|Pregnancy|0|||
162887144|NCT02591238|588286575|FG003|Overall Study|Pregnancy|0|||
162887145|NCT02591238|588286572|FG000|Overall Study|Withdrawal by Subject|0|||
162887146|NCT02591238|588286573|FG001|Overall Study|Withdrawal by Subject|0|||
162887147|NCT02591238|588286574|FG002|Overall Study|Withdrawal by Subject|0|||
162887148|NCT02591238|588286575|FG003|Overall Study|Withdrawal by Subject|1|||
162887149|NCT02591238|588286572|FG000|Overall Study|influenza|0|||
162887150|NCT02591238|588286573|FG001|Overall Study|influenza|0|||
162887151|NCT02591238|588286574|FG002|Overall Study|influenza|0|||
162887152|NCT02591238|588286575|FG003|Overall Study|influenza|1|||
162887153|NCT02591238|588286572|FG000|Overall Study|personal circumstances|0|||
162887154|NCT02591238|588286573|FG001|Overall Study|personal circumstances|0|||
162887155|NCT02591238|588286574|FG002|Overall Study|personal circumstances|0|||
162887156|NCT02591238|588286575|FG003|Overall Study|personal circumstances|1|||
162887157|NCT02591238|588286572|FG000|Overall Study|personal circumstances|0|||
162887158|NCT02591238|588286573|FG001|Overall Study|personal circumstances|1|||
162887159|NCT02591238|588286574|FG002|Overall Study|personal circumstances|0|||
162887160|NCT02591238|588286575|FG003|Overall Study|personal circumstances|0|||
162887161|NCT00640146|588286579|FG000|Overall Study|Adverse Event|2|||
162887162|NCT00640146|588286580|FG001|Overall Study|Adverse Event|0|||
162887163|NCT00640146|588286579|FG000|Overall Study|Lost to Follow-up|0|||
162887164|NCT00640146|588286580|FG001|Overall Study|Lost to Follow-up|1|||
162887165|NCT00640146|588286579|FG000|Overall Study|Lack of Efficacy|0|||
162887166|NCT00640146|588286580|FG001|Overall Study|Lack of Efficacy|1|||
162887167|NCT00640146|588286579|FG000|Overall Study|Withdrawal by Subject|1|||
162887168|NCT00640146|588286580|FG001|Overall Study|Withdrawal by Subject|1|||
162887169|NCT00640146|588286579|FG000|Overall Study|Randomized but not treated|1|||
162887170|NCT00640146|588286580|FG001|Overall Study|Randomized but not treated|3|||
162887171|NCT00525785|588286584|FG000|Overall Study|Withdrawal by Subject|1|||
162887172|NCT00525785|588286584|FG000|Overall Study|Lack of Efficacy|1|||
162887173|NCT00525785|588286584|FG000|Overall Study|Physician Decision|1|||
162887174|NCT02455388|588286585|FG000|Overall Study|Protocol Violation|1|||
162887175|NCT02455388|588286586|FG001|Overall Study|Protocol Violation|0|||
162887176|NCT02455388|588286587|FG002|Overall Study|Protocol Violation|4|||
162887177|NCT02455388|588286585|FG000|Overall Study|Withdrawal by Subject|0|||
162887178|NCT02455388|588286586|FG001|Overall Study|Withdrawal by Subject|0|||
162887179|NCT02455388|588286587|FG002|Overall Study|Withdrawal by Subject|7|||
162887180|NCT04624672|588286589|FG000|Overall Study|Early Study Closure|2|||
162963494|NCT00640393|588566527|FG001|Part 1|Lost to Follow-up|0|||
162887181|NCT04624672|588286590|FG001|Overall Study|Early Study Closure|1|||
162887182|NCT01415908|588286595|FG000|Overall Study|Withdrawal by Subject|1|||
162963495|NCT00640393|588566528|FG002|Part 1|Lost to Follow-up|0|||
162887183|NCT01415908|588286596|FG001|Overall Study|Withdrawal by Subject|0|||
162887184|NCT02119026|588286602|FG000|1st-line Treatment|Adverse Event|9|||
163050703|NCT01435759|588893655|FG001|Double-blind Phase|Protocol Violation|0|||
163050704|NCT01435759|588893656|FG002|Double-blind Phase|Protocol Violation|1|||
162887185|NCT02119026|588286603|FG001|1st-line Treatment|Adverse Event|14|||
162887186|NCT02119026|588286602|FG000|1st-line Treatment|Physician Decision|3|||
162887187|NCT02119026|588286603|FG001|1st-line Treatment|Physician Decision|8|||
162887188|NCT02119026|588286602|FG000|1st-line Treatment|Withdrawal by Subject|4|||
162887189|NCT02119026|588286603|FG001|1st-line Treatment|Withdrawal by Subject|10|||
162887190|NCT02119026|588286602|FG000|1st-line Treatment|Patient condition or compliance|6|||
162887191|NCT02119026|588286603|FG001|1st-line Treatment|Patient condition or compliance|4|||
162887192|NCT02119026|588286602|FG000|1st-line Treatment|Surgery of metastases|2|||
162887193|NCT02119026|588286603|FG001|1st-line Treatment|Surgery of metastases|1|||
162887194|NCT02119026|588286602|FG000|1st-line Treatment|Death|2|||
162887195|NCT02119026|588286603|FG001|1st-line Treatment|Death|1|||
162887196|NCT02119026|588286602|FG000|2nd-line Treatment|Lost to Follow-up|2|||
162887197|NCT02119026|588286603|FG001|2nd-line Treatment|Lost to Follow-up|0|||
162887198|NCT02119026|588286602|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
162887199|NCT02119026|588286603|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
162887200|NCT02119026|588286602|FG000|2nd-line Treatment|Adverse Event|4|||
162887201|NCT02119026|588286603|FG001|2nd-line Treatment|Adverse Event|1|||
162887202|NCT01373918|588286604|FG000|Overall Study|Physician Decision|0|||
162887203|NCT01373918|588286605|FG001|Overall Study|Physician Decision|1|||
162887204|NCT01143714|588286608|FG000|Overall Study|Adverse Event|4|||
162887205|NCT01143714|588286609|FG001|Overall Study|Adverse Event|2|||
162887206|NCT01143714|588286608|FG000|Overall Study|Withdrawal by Subject|1|||
162887207|NCT01143714|588286609|FG001|Overall Study|Withdrawal by Subject|0|||
162887208|NCT01143714|588286608|FG000|Overall Study|Subject non-compliance|0|||
162887209|NCT01143714|588286609|FG001|Overall Study|Subject non-compliance|1|||
162887210|NCT01143714|588286608|FG000|Overall Study|wound closed = deemed healed|1|||
162887211|NCT01143714|588286609|FG001|Overall Study|wound closed = deemed healed|0|||
162887212|NCT01143714|588286608|FG000|Overall Study|wound size increased|1|||
162887213|NCT01143714|588286609|FG001|Overall Study|wound size increased|0|||
162887214|NCT03783442|588286613|FG000|Overall Study|Death|252|||
162887215|NCT03783442|588286614|FG001|Overall Study|Death|268|||
162887216|NCT03783442|588286613|FG000|Overall Study|Withdrawal by Subject|19|||
162887217|NCT03783442|588286614|FG001|Overall Study|Withdrawal by Subject|21|||
162887218|NCT03783442|588286613|FG000|Overall Study|Lost to Follow-up|7|||
162887219|NCT03783442|588286614|FG001|Overall Study|Lost to Follow-up|6|||
162887220|NCT03783442|588286613|FG000|Overall Study|Sponsor Ended Study|48|||
162887221|NCT03783442|588286614|FG001|Overall Study|Sponsor Ended Study|28|||
162887222|NCT02016898|588286615|FG000|Overall Study|Death|1|||
162887223|NCT02016898|588286616|FG001|Overall Study|Death|1|||
162887224|NCT02016898|588286615|FG000|Overall Study|Lost to Follow-up|4|||
162887225|NCT02016898|588286616|FG001|Overall Study|Lost to Follow-up|4|||
162887226|NCT01381718|588286617|FG000|Overall Study|Withdrawal by Subject|2|||
162887227|NCT01381718|588286618|FG001|Overall Study|Withdrawal by Subject|5|||
162887228|NCT01381718|588286617|FG000|Overall Study|Lost to Follow-up|3|||
162887229|NCT01381718|588286618|FG001|Overall Study|Lost to Follow-up|5|||
162887230|NCT01381718|588286617|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
162887231|NCT01381718|588286618|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
162887232|NCT03017846|588286621|FG000|Overall Study|Lost to Follow-up|3|||
162887233|NCT03017846|588286621|FG000|Overall Study|Adverse Event|2|||
162887234|NCT02505542|588286622|FG000|Part A: Open-Label Period|Adverse Event|31|||
162887235|NCT02505542|588286623|FG001|Part A: Open-Label Period|Adverse Event|0|||
162887236|NCT02505542|588286624|FG002|Part A: Open-Label Period|Adverse Event|0|||
162887237|NCT02505542|588286625|FG003|Part A: Open-Label Period|Adverse Event|0|||
162887238|NCT02505542|588286622|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
162887239|NCT02505542|588286623|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
163050705|NCT01435759|588893657|FG003|Double-blind Phase|Protocol Violation|2|||
162617607|NCT00333840|587317768|FG002|First-line Treatment Period|Lost to Follow-up|0|||
162887240|NCT02505542|588286624|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
162887241|NCT02505542|588286625|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
162887242|NCT02505542|588286622|FG000|Part A: Open-Label Period|Protocol Violation|1|||
162887243|NCT02505542|588286623|FG001|Part A: Open-Label Period|Protocol Violation|0|||
162887244|NCT02505542|588286624|FG002|Part A: Open-Label Period|Protocol Violation|0|||
162887245|NCT02505542|588286625|FG003|Part A: Open-Label Period|Protocol Violation|0|||
162887246|NCT02505542|588286622|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
162887247|NCT02505542|588286623|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
162887248|NCT02505542|588286624|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
162887249|NCT02505542|588286625|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
162887250|NCT02505542|588286622|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
162887251|NCT02505542|588286623|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
162887252|NCT02505542|588286624|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
162887253|NCT02505542|588286625|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
162887254|NCT02505542|588286622|FG000|Part A: Open-Label Period|New medical history available|1|||
162708146|NCT04956692|587640691|FG001|Overall Study|Lost to Follow-up|1|||
162708147|NCT04956692|587640690|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
162708148|NCT04956692|587640691|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162708149|NCT04956692|587640690|FG000|Overall Study|Withdrawal by Subject|5|||
162708150|NCT04956692|587640691|FG001|Overall Study|Withdrawal by Subject|2|||
162708151|NCT04956692|587640690|FG000|Overall Study|Ongoing in Study|236|||
162708152|NCT04956692|587640691|FG001|Overall Study|Ongoing in Study|123|||
162708153|NCT02099539|587640696|FG000|Overall Study|Progressive Disease|3|||
162708154|NCT02099539|587640697|FG001|Overall Study|Progressive Disease|2|||
162708155|NCT02099539|587640698|FG002|Overall Study|Progressive Disease|2|||
162708156|NCT02099539|587640699|FG003|Overall Study|Progressive Disease|1|||
162708157|NCT02099539|587640700|FG004|Overall Study|Progressive Disease|4|||
162708158|NCT02099539|587640701|FG005|Overall Study|Progressive Disease|2|||
162708159|NCT02099539|587640702|FG006|Overall Study|Progressive Disease|0|||
162708160|NCT02099539|587640696|FG000|Overall Study|Adverse Event|0|||
162708161|NCT02099539|587640697|FG001|Overall Study|Adverse Event|0|||
162708162|NCT02099539|587640698|FG002|Overall Study|Adverse Event|1|||
162708163|NCT02099539|587640699|FG003|Overall Study|Adverse Event|1|||
162708164|NCT02099539|587640700|FG004|Overall Study|Adverse Event|0|||
162708165|NCT02099539|587640701|FG005|Overall Study|Adverse Event|0|||
162708166|NCT02099539|587640702|FG006|Overall Study|Adverse Event|0|||
162708167|NCT02099539|587640696|FG000|Overall Study|Physician Decision|0|||
162708168|NCT02099539|587640697|FG001|Overall Study|Physician Decision|0|||
162708169|NCT02099539|587640698|FG002|Overall Study|Physician Decision|0|||
162708170|NCT02099539|587640699|FG003|Overall Study|Physician Decision|0|||
162708171|NCT02099539|587640700|FG004|Overall Study|Physician Decision|0|||
162708172|NCT02099539|587640701|FG005|Overall Study|Physician Decision|1|||
162708173|NCT02099539|587640702|FG006|Overall Study|Physician Decision|0|||
162708174|NCT01449721|587640704|FG000|Overall Study|Physician Decision|0|||
162708175|NCT01449721|587640705|FG001|Overall Study|Physician Decision|1|||
162708176|NCT01449721|587640704|FG000|Overall Study|Physician Decision|0|||
162963496|NCT00640393|588566526|FG000|Part 1|Withdrawal by Subject|3|||
162963497|NCT00640393|588566527|FG001|Part 1|Withdrawal by Subject|0|||
162963498|NCT00640393|588566528|FG002|Part 1|Withdrawal by Subject|0|||
162963499|NCT00640393|588566526|FG000|Randomization|Withdrawn per protocol|17|||
162963500|NCT00640393|588566527|FG001|Randomization|Withdrawn per protocol|0|||
162963501|NCT00640393|588566528|FG002|Randomization|Withdrawn per protocol|0|||
162963502|NCT00640393|588566526|FG000|Randomization|Never randomized by site|2|||
162963503|NCT00640393|588566527|FG001|Randomization|Never randomized by site|0|||
162963504|NCT00640393|588566528|FG002|Randomization|Never randomized by site|0|||
162963505|NCT00640393|588566526|FG000|Part 2|Lost to Follow-up|0|||
162708177|NCT01449721|587640705|FG001|Overall Study|Physician Decision|1|||
162708178|NCT02148718|587640706|FG000|Overall Study|Protocol Violation|26|||
162708179|NCT02148718|587640706|FG000|Overall Study|Discontinued Study Prematurely|5|||
162708180|NCT00333788|587640713|FG000|Overall Study|Adverse Event|44|||
162708181|NCT00333788|587640713|FG000|Overall Study|Lack of Efficacy|80|||
162963506|NCT00640393|588566527|FG001|Part 2|Lost to Follow-up|2|||
162963507|NCT00640393|588566528|FG002|Part 2|Lost to Follow-up|2|||
162963508|NCT00640393|588566526|FG000|Part 2|Withdrawal by Subject|0|||
162963509|NCT00640393|588566527|FG001|Part 2|Withdrawal by Subject|6|||
162963510|NCT00640393|588566528|FG002|Part 2|Withdrawal by Subject|1|||
162963511|NCT00640393|588566526|FG000|Part 2|Non-adherence|0|||
162963512|NCT00640393|588566527|FG001|Part 2|Non-adherence|1|||
162708182|NCT00333788|587640713|FG000|Overall Study|Lost to Follow-up|2|||
162887255|NCT02505542|588286623|FG001|Part A: Open-Label Period|New medical history available|0|||
162887256|NCT02505542|588286624|FG002|Part A: Open-Label Period|New medical history available|0|||
162887257|NCT02505542|588286625|FG003|Part A: Open-Label Period|New medical history available|0|||
162887258|NCT02505542|588286622|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
162887259|NCT02505542|588286623|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
162887260|NCT02505542|588286624|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
162887261|NCT02505542|588286625|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
162887262|NCT02505542|588286622|FG000|Part A: Open-Label Period|Pregnancy|2|||
162887263|NCT02505542|588286623|FG001|Part A: Open-Label Period|Pregnancy|0|||
162887264|NCT02505542|588286624|FG002|Part A: Open-Label Period|Pregnancy|0|||
162887265|NCT02505542|588286625|FG003|Part A: Open-Label Period|Pregnancy|0|||
162887266|NCT02505542|588286622|FG000|Part A: Open-Label Period|Sponsor directive|1|||
162887267|NCT02505542|588286623|FG001|Part A: Open-Label Period|Sponsor directive|0|||
162887268|NCT02505542|588286624|FG002|Part A: Open-Label Period|Sponsor directive|0|||
162887269|NCT02505542|588286625|FG003|Part A: Open-Label Period|Sponsor directive|0|||
162887270|NCT02505542|588286622|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
162887271|NCT02505542|588286623|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
162887272|NCT02505542|588286624|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
162887273|NCT02505542|588286625|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
162887274|NCT02505542|588286622|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
162887275|NCT02505542|588286623|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
162887276|NCT02505542|588286624|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
162887277|NCT02505542|588286625|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
162887278|NCT02505542|588286622|FG000|Part A: Open-Label Period|Non-compliance|1|||
162887279|NCT02505542|588286623|FG001|Part A: Open-Label Period|Non-compliance|0|||
162887280|NCT02505542|588286624|FG002|Part A: Open-Label Period|Non-compliance|0|||
162887281|NCT02505542|588286625|FG003|Part A: Open-Label Period|Non-compliance|0|||
162887282|NCT02505542|588286622|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
162887283|NCT02505542|588286623|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
162887284|NCT02505542|588286624|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
162887285|NCT02505542|588286625|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
162887286|NCT02505542|588286622|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
162887287|NCT02505542|588286623|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
162887288|NCT02505542|588286624|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
162887289|NCT02505542|588286625|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
162887290|NCT02505542|588286622|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
162887291|NCT02505542|588286623|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
162887292|NCT02505542|588286624|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
162887293|NCT02505542|588286625|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
162887294|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Adverse Event|0|||
162887295|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Adverse Event|0|||
162887296|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Adverse Event|1|||
162887297|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Adverse Event|3|||
162887298|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
162887299|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
162887300|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
162887301|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
162887302|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
162887303|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
162887304|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
162887305|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
162887306|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
162887307|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
162887308|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
162887309|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
162887310|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
162887311|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
162887312|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
162887313|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
162887314|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
162887315|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
162887316|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
162887317|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
162887318|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
162887319|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
162887320|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
162887321|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
162887322|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Miscalculation|0|||
162887323|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Miscalculation|1|||
162887324|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Miscalculation|0|||
162887325|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Miscalculation|0|||
162887326|NCT02505542|588286622|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
162887327|NCT02505542|588286623|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
162887328|NCT02505542|588286624|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
162887329|NCT02505542|588286625|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
162617608|NCT00333840|587317769|FG003|First-line Treatment Period|Lost to Follow-up|0|||
162617609|NCT00333840|587317766|FG000|First-line Treatment Period|Administrative problems|12|||
162617610|NCT00333840|587317767|FG001|First-line Treatment Period|Administrative problems|6|||
162617611|NCT00333840|587317768|FG002|First-line Treatment Period|Administrative problems|0|||
162617612|NCT00333840|587317769|FG003|First-line Treatment Period|Administrative problems|0|||
162617613|NCT00333840|587317766|FG000|First-line Treatment Period|Death|19|||
162617614|NCT00333840|587317767|FG001|First-line Treatment Period|Death|2|||
162617615|NCT00333840|587317768|FG002|First-line Treatment Period|Death|0|||
162617616|NCT00333840|587317769|FG003|First-line Treatment Period|Death|0|||
162617617|NCT00333840|587317766|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
162617618|NCT00333840|587317767|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
162617619|NCT00333840|587317768|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
162617620|NCT00333840|587317769|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
162617621|NCT00333840|587317766|FG000|Second-line Treatment Period|Adverse Event|0|||
162617622|NCT00333840|587317767|FG001|Second-line Treatment Period|Adverse Event|0|||
162617623|NCT00333840|587317768|FG002|Second-line Treatment Period|Adverse Event|3|||
162617624|NCT00333840|587317769|FG003|Second-line Treatment Period|Adverse Event|34|||
162617625|NCT00333840|587317766|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162617626|NCT00333840|587317767|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162887330|NCT00992186|588286628|FG000|Overall Study|Withdrawal by Subject|2|||
162887331|NCT00992186|588286628|FG000|Overall Study|Protocol Violation|1|||
162887332|NCT00992186|588286628|FG000|Overall Study|Physician Decision|1|||
162887333|NCT00992186|588286628|FG000|Overall Study|Adverse Event|9|||
162887334|NCT00992186|588286628|FG000|Overall Study|Progressive Disease|30|||
162887335|NCT00992186|588286628|FG000|Overall Study|Refusal To Receive Study Agent|3|||
162887336|NCT01438307|588286634|FG000|Overall Study|Death|1|||
162887337|NCT01438307|588286635|FG001|Overall Study|Death|1|||
162887338|NCT00171314|588286636|FG000|Overall Study|Adverse Event|44|||
162887339|NCT00171314|588286637|FG001|Overall Study|Adverse Event|41|||
162887340|NCT00171314|588286636|FG000|Overall Study|Lack of Efficacy|19|||
162887341|NCT00171314|588286637|FG001|Overall Study|Lack of Efficacy|14|||
162887342|NCT00171314|588286636|FG000|Overall Study|Withdrawal by Subject|9|||
162887343|NCT00171314|588286637|FG001|Overall Study|Withdrawal by Subject|6|||
162887344|NCT00171314|588286636|FG000|Overall Study|Abnormal Test Procedure Results|9|||
162887345|NCT00171314|588286637|FG001|Overall Study|Abnormal Test Procedure Results|3|||
162887346|NCT00171314|588286636|FG000|Overall Study|Protocol Violation|3|||
162887347|NCT00171314|588286637|FG001|Overall Study|Protocol Violation|7|||
162887348|NCT00171314|588286636|FG000|Overall Study|Administrative Problems|4|||
162887349|NCT00171314|588286637|FG001|Overall Study|Administrative Problems|3|||
162887350|NCT00171314|588286636|FG000|Overall Study|Lost to Follow-up|1|||
162887351|NCT00171314|588286637|FG001|Overall Study|Lost to Follow-up|3|||
162887352|NCT00171314|588286636|FG000|Overall Study|Death|2|||
162887353|NCT00171314|588286637|FG001|Overall Study|Death|1|||
162617627|NCT00333840|587317768|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162617628|NCT00333840|587317769|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
162617629|NCT00333840|587317766|FG000|Second-line Treatment Period|Abnormal procedure|0|||
162617630|NCT00333840|587317767|FG001|Second-line Treatment Period|Abnormal procedure|0|||
162617631|NCT00333840|587317768|FG002|Second-line Treatment Period|Abnormal procedure|0|||
162617632|NCT00333840|587317769|FG003|Second-line Treatment Period|Abnormal procedure|1|||
162617633|NCT00333840|587317766|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162617634|NCT00333840|587317767|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162887354|NCT02378883|588286638|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
162887355|NCT02378883|588286638|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
162887356|NCT02378883|588286638|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
162887357|NCT02378883|588286638|FG000|30 Day Follow-Up|Physician Decision|2|||
162887358|NCT02378883|588286638|FG000|30 Day Follow-Up|Missed Visit|2|||
162887359|NCT02378883|588286638|FG000|30 Day Follow-Up|Death|1|||
162887360|NCT02378883|588286638|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
162887361|NCT02378883|588286638|FG000|12 Months Follow-Up|Death|2|||
162963513|NCT00640393|588566528|FG002|Part 2|Non-adherence|0|||
162963514|NCT00640393|588566526|FG000|Part 2|Adverse Event|0|||
162963515|NCT00640393|588566527|FG001|Part 2|Adverse Event|1|||
162887362|NCT00318565|588286639|FG000|Overall Study|Excluded per protocol|24|||
162887363|NCT01588353|588286640|FG000|Step2|Withdrawal by Subject|0|||
162887364|NCT01588353|588286641|FG001|Step2|Withdrawal by Subject|1|||
162887365|NCT01588353|588286642|FG002|Step2|Withdrawal by Subject|0|||
162887366|NCT01588353|588286640|FG000|Step3|Adverse Event|0|||
162887367|NCT01588353|588286641|FG001|Step3|Adverse Event|0|||
162887368|NCT01588353|588286642|FG002|Step3|Adverse Event|2|||
162887369|NCT00493467|588286643|FG000|Overall Study|Death|1|||
162887370|NCT01409993|588286648|FG000|Overall Study|Adverse Event|4|||
162887371|NCT01409993|588286649|FG001|Overall Study|Adverse Event|4|||
162887372|NCT01409993|588286650|FG002|Overall Study|Adverse Event|3|||
162887373|NCT01409993|588286651|FG003|Overall Study|Adverse Event|1|||
162887374|NCT01409993|588286648|FG000|Overall Study|Withdrawal by Subject|0|||
162887375|NCT01409993|588286649|FG001|Overall Study|Withdrawal by Subject|0|||
162887376|NCT01409993|588286650|FG002|Overall Study|Withdrawal by Subject|0|||
162887377|NCT01409993|588286651|FG003|Overall Study|Withdrawal by Subject|4|||
162887378|NCT01409993|588286648|FG000|Overall Study|Lost to Follow-up|0|||
162887379|NCT01409993|588286649|FG001|Overall Study|Lost to Follow-up|1|||
162963516|NCT00640393|588566528|FG002|Part 2|Adverse Event|0|||
162617635|NCT00333840|587317768|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
162617636|NCT00333840|587317769|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
162617637|NCT00333840|587317766|FG000|Second-line Treatment Period|No longer required study drug|0|||
162617638|NCT00333840|587317767|FG001|Second-line Treatment Period|No longer required study drug|0|||
162617639|NCT00333840|587317768|FG002|Second-line Treatment Period|No longer required study drug|1|||
162617640|NCT00333840|587317769|FG003|Second-line Treatment Period|No longer required study drug|14|||
162617641|NCT00333840|587317766|FG000|Second-line Treatment Period|Protocol Violation|0|||
162617642|NCT00333840|587317767|FG001|Second-line Treatment Period|Protocol Violation|0|||
162617643|NCT00333840|587317768|FG002|Second-line Treatment Period|Protocol Violation|1|||
162617644|NCT00333840|587317769|FG003|Second-line Treatment Period|Protocol Violation|10|||
162617645|NCT00333840|587317766|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
162617646|NCT00333840|587317767|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
162617647|NCT00333840|587317768|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
162617648|NCT00333840|587317769|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
162617649|NCT00333840|587317766|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
162708183|NCT00333788|587640713|FG000|Overall Study|Withdrawal by Subject|24|||
162708184|NCT00333788|587640713|FG000|Overall Study|Other: Non-compliance|2|||
162963517|NCT01701063|588566529|FG000|Overall Study|Lost to Follow-up|0|||
162963518|NCT01701063|588566530|FG001|Overall Study|Lost to Follow-up|1|||
162963519|NCT01701063|588566531|FG002|Overall Study|Lost to Follow-up|0|||
162963520|NCT01701063|588566529|FG000|Overall Study|Withdrawal by Subject|0|||
162963521|NCT01701063|588566530|FG001|Overall Study|Withdrawal by Subject|0|||
162963522|NCT01701063|588566531|FG002|Overall Study|Withdrawal by Subject|1|||
162963523|NCT01701063|588566529|FG000|Overall Study|Other|0|||
162963524|NCT01701063|588566530|FG001|Overall Study|Other|0|||
162963525|NCT01701063|588566531|FG002|Overall Study|Other|1|||
162963526|NCT03428750|588566532|FG000|Overall Study|Withdrawal by Subject|11|||
162963527|NCT03428750|588566533|FG001|Overall Study|Withdrawal by Subject|10|||
162963528|NCT03428750|588566532|FG000|Overall Study|Lost to Follow-up|3|||
162963529|NCT03428750|588566533|FG001|Overall Study|Lost to Follow-up|9|||
162963530|NCT03428750|588566532|FG000|Overall Study|Adverse Event|9|||
162963531|NCT03428750|588566533|FG001|Overall Study|Adverse Event|1|||
162963532|NCT03428750|588566532|FG000|Overall Study|Protocol Violation|1|||
162963533|NCT03428750|588566533|FG001|Overall Study|Protocol Violation|0|||
162963534|NCT03428750|588566532|FG000|Overall Study|Administrative|0|||
163050706|NCT01435759|588893658|FG004|Double-blind Phase|Protocol Violation|0|||
162708185|NCT00333788|587640713|FG000|Overall Study|Other: Moved|2|||
162887380|NCT01409993|588286650|FG002|Overall Study|Lost to Follow-up|0|||
162887381|NCT01409993|588286651|FG003|Overall Study|Lost to Follow-up|0|||
162887382|NCT03074149|588286654|FG000|Overall Study|Reason unknown|22|||
162887383|NCT03074149|588286655|FG001|Overall Study|Reason unknown|35|||
162887384|NCT03074149|588286654|FG000|Overall Study|Death|10|||
162887385|NCT03074149|588286655|FG001|Overall Study|Death|45|||
162887386|NCT00830960|588286656|FG000|Overall Study|Death|5|||
162887387|NCT00830960|588286657|FG001|Overall Study|Death|4|||
162963535|NCT03428750|588566533|FG001|Overall Study|Administrative|1|||
162963536|NCT01919112|588566534|FG000|Secondary Analysis-day 30|Death|1|||
162963537|NCT01919112|588566535|FG001|Secondary Analysis-day 30|Death|1|||
162963538|NCT01919112|588566536|FG002|Secondary Analysis-day 30|Death|1|||
162963539|NCT01919112|588566534|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
162963540|NCT01919112|588566535|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
162963541|NCT01919112|588566536|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
162963542|NCT00835666|588566539|FG000|Washout|Protocol Violation|1|||
162963543|NCT00835666|588566540|FG001|Washout|Protocol Violation|0|||
162963544|NCT00835666|588566539|FG000|Washout|Withdrawal by Subject|1|||
162963545|NCT00835666|588566540|FG001|Washout|Withdrawal by Subject|0|||
162963546|NCT00635648|588566541|FG000|Overall Study|Adverse Event|12|||
162963547|NCT00635648|588566541|FG000|Overall Study|Withdrawal by Subject|9|||
162887388|NCT00830960|588286658|FG002|Overall Study|Death|3|||
162887389|NCT00830960|588286659|FG003|Overall Study|Death|2|||
162887390|NCT00830960|588286660|FG004|Overall Study|Death|6|||
162887391|NCT00830960|588286661|FG005|Overall Study|Death|1|||
162887392|NCT00830960|588286656|FG000|Overall Study|Lost to Follow-up|1|||
162887393|NCT00830960|588286657|FG001|Overall Study|Lost to Follow-up|1|||
162887394|NCT00830960|588286658|FG002|Overall Study|Lost to Follow-up|1|||
162887395|NCT00830960|588286659|FG003|Overall Study|Lost to Follow-up|0|||
162887396|NCT00830960|588286660|FG004|Overall Study|Lost to Follow-up|0|||
162887397|NCT00830960|588286661|FG005|Overall Study|Lost to Follow-up|1|||
162887398|NCT00830960|588286656|FG000|Overall Study|Withdrawal by Subject|19|||
162887399|NCT00830960|588286657|FG001|Overall Study|Withdrawal by Subject|19|||
162887400|NCT00830960|588286658|FG002|Overall Study|Withdrawal by Subject|18|||
162887401|NCT00830960|588286659|FG003|Overall Study|Withdrawal by Subject|23|||
162887402|NCT00830960|588286660|FG004|Overall Study|Withdrawal by Subject|16|||
162887403|NCT00830960|588286661|FG005|Overall Study|Withdrawal by Subject|21|||
162887404|NCT00830960|588286656|FG000|Overall Study|Sponsor Decision|1|||
162887405|NCT00830960|588286657|FG001|Overall Study|Sponsor Decision|2|||
162887406|NCT00830960|588286658|FG002|Overall Study|Sponsor Decision|3|||
162887407|NCT00830960|588286659|FG003|Overall Study|Sponsor Decision|4|||
162887408|NCT00830960|588286660|FG004|Overall Study|Sponsor Decision|5|||
162887409|NCT00830960|588286661|FG005|Overall Study|Sponsor Decision|7|||
162887410|NCT00830960|588286656|FG000|Overall Study|No study drug received|7|||
162887411|NCT00830960|588286657|FG001|Overall Study|No study drug received|2|||
162887412|NCT00830960|588286658|FG002|Overall Study|No study drug received|4|||
162887413|NCT00830960|588286659|FG003|Overall Study|No study drug received|3|||
162887414|NCT00830960|588286660|FG004|Overall Study|No study drug received|5|||
162887415|NCT00830960|588286661|FG005|Overall Study|No study drug received|7|||
162887416|NCT01504971|588286663|FG000|Overall Study|Physician Decision|13|||
162887417|NCT01309841|588286668|FG000|Overall Study|Other|0|||
162887418|NCT01309841|588286669|FG001|Overall Study|Other|1|||
162887419|NCT01309841|588286670|FG002|Overall Study|Other|1|||
162887420|NCT01309841|588286668|FG000|Overall Study|Lost to Follow-up|7|||
162887421|NCT01309841|588286669|FG001|Overall Study|Lost to Follow-up|6|||
162887422|NCT01309841|588286670|FG002|Overall Study|Lost to Follow-up|4|||
162887423|NCT01309841|588286668|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
162887424|NCT01309841|588286669|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
162887425|NCT01309841|588286670|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
162887426|NCT01309841|588286668|FG000|Overall Study|Lack of Efficacy|0|||
162887427|NCT01309841|588286669|FG001|Overall Study|Lack of Efficacy|0|||
162887428|NCT01309841|588286670|FG002|Overall Study|Lack of Efficacy|2|||
162887429|NCT01309841|588286668|FG000|Overall Study|Adverse Event|9|||
162887430|NCT01309841|588286669|FG001|Overall Study|Adverse Event|22|||
162887431|NCT01309841|588286670|FG002|Overall Study|Adverse Event|11|||
162887432|NCT01309841|588286668|FG000|Overall Study|Death|1|||
162887433|NCT01309841|588286669|FG001|Overall Study|Death|0|||
162887434|NCT01309841|588286670|FG002|Overall Study|Death|0|||
162887435|NCT01309841|588286668|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162963548|NCT00635648|588566541|FG000|Overall Study|Physician Decision|4|||
162963549|NCT00635648|588566541|FG000|Overall Study|Rapid progression of baseline disease|4|||
162963550|NCT00635648|588566541|FG000|Overall Study|Use of other antifungal agent needed|1|||
162963551|NCT00635648|588566541|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
162963552|NCT00635648|588566541|FG000|Overall Study|Noncompliance with protocol|1|||
162963553|NCT00635648|588566541|FG000|Overall Study|Other reason|2|||
162963554|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
162963555|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
162887436|NCT01309841|588286669|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162887437|NCT01309841|588286670|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
162887438|NCT01309841|588286668|FG000|Overall Study|Withdrawal by Subject|17|||
162887439|NCT01309841|588286669|FG001|Overall Study|Withdrawal by Subject|6|||
162887440|NCT01309841|588286670|FG002|Overall Study|Withdrawal by Subject|13|||
162887441|NCT01309841|588286668|FG000|Overall Study|Did Not Receive Treatment|2|||
162887442|NCT01309841|588286669|FG001|Overall Study|Did Not Receive Treatment|0|||
162887443|NCT01309841|588286670|FG002|Overall Study|Did Not Receive Treatment|1|||
162887444|NCT01309841|588286668|FG000|Overall Study|Severe non-compliance with protocol|0|||
162887445|NCT01309841|588286669|FG001|Overall Study|Severe non-compliance with protocol|5|||
162963556|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
162963557|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
162963558|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
162963559|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
162963560|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
162887446|NCT01309841|588286670|FG002|Overall Study|Severe non-compliance with protocol|2|||
162887447|NCT02475395|588286671|FG000|Overall Study|Protocol Violation|30|||
162708186|NCT00333788|587640713|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
162887448|NCT02475395|588286672|FG001|Overall Study|Protocol Violation|3|||
162887449|NCT01681576|588286673|FG000|Period 1|Adverse Event|1|||
162887450|NCT01681576|588286674|FG001|Period 1|Adverse Event|0|||
162887451|NCT01681576|588286673|FG000|Period 1|Protocol Deviation|1|||
162887452|NCT01681576|588286674|FG001|Period 1|Protocol Deviation|0|||
162887453|NCT01681576|588286673|FG000|Period 2|subject/guardian decision|3|||
162708187|NCT00333788|587640713|FG000|Overall Study|Other: Investigator decision|1|||
162887454|NCT01681576|588286674|FG001|Period 2|subject/guardian decision|1|||
162887455|NCT01681576|588286673|FG000|Period 2|Non-compliance with study treatment|1|||
162887456|NCT01681576|588286674|FG001|Period 2|Non-compliance with study treatment|0|||
162887457|NCT03448224|588286675|FG000|Overall Study|Provided same answer to every question|1|||
162887458|NCT03448224|588286676|FG001|Overall Study|Provided same answer to every question|0|||
162887459|NCT03103906|588286680|FG000|Overall Study|Adverse Event|2|||
162887460|NCT03103906|588286681|FG001|Overall Study|Adverse Event|3|||
162887461|NCT03103906|588286680|FG000|Overall Study|Other|2|||
162887462|NCT03103906|588286681|FG001|Overall Study|Other|0|||
162887463|NCT00764478|588286682|FG000|Overall Study|Adverse Event|1|||
162887464|NCT00764478|588286683|FG001|Overall Study|Adverse Event|1|||
162887465|NCT00764478|588286684|FG002|Overall Study|Adverse Event|1|||
162887466|NCT00764478|588286682|FG000|Overall Study|Withdrawal by Subject|7|||
162887467|NCT00764478|588286683|FG001|Overall Study|Withdrawal by Subject|12|||
162887468|NCT00764478|588286684|FG002|Overall Study|Withdrawal by Subject|1|||
162887469|NCT00764478|588286682|FG000|Overall Study|Lost to Follow-up|7|||
162887470|NCT00764478|588286683|FG001|Overall Study|Lost to Follow-up|8|||
162887471|NCT00764478|588286684|FG002|Overall Study|Lost to Follow-up|5|||
162887472|NCT00764478|588286682|FG000|Overall Study|Protocol Violation|0|||
162887473|NCT00764478|588286683|FG001|Overall Study|Protocol Violation|1|||
162887474|NCT00764478|588286684|FG002|Overall Study|Protocol Violation|1|||
162887475|NCT00862121|588286685|FG000|Overall Study|Adverse Event|1|||
162887476|NCT00862121|588286686|FG001|Overall Study|Adverse Event|2|||
162887477|NCT00862121|588286685|FG000|Overall Study|Lack of Efficacy|0|||
162887478|NCT00862121|588286686|FG001|Overall Study|Lack of Efficacy|3|||
162887479|NCT00862121|588286685|FG000|Overall Study|Protocol Violation|0|||
162887480|NCT00862121|588286686|FG001|Overall Study|Protocol Violation|1|||
162887481|NCT00862121|588286685|FG000|Overall Study|Exclusion criterion violation|0|||
162887482|NCT00862121|588286686|FG001|Overall Study|Exclusion criterion violation|1|||
162887483|NCT00862121|588286685|FG000|Overall Study|Incorrect randomisation|0|||
162887484|NCT00862121|588286686|FG001|Overall Study|Incorrect randomisation|1|||
162887485|NCT01195363|588286688|FG000|Overall Study|Lost to Follow-up|7|||
162887486|NCT01195363|588286689|FG001|Overall Study|Lost to Follow-up|4|||
162887487|NCT01195363|588286688|FG000|Overall Study|Adverse Event|3|||
162887488|NCT01195363|588286689|FG001|Overall Study|Adverse Event|1|||
162887489|NCT01195363|588286688|FG000|Overall Study|Lack of Efficacy|0|||
162887490|NCT01195363|588286689|FG001|Overall Study|Lack of Efficacy|4|||
162887491|NCT01195363|588286688|FG000|Overall Study|incarceration|1|||
162887492|NCT01195363|588286689|FG001|Overall Study|incarceration|0|||
162963561|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
162963562|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
162963563|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
162963564|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
162963565|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
162963566|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
162963567|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
162963568|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
162963569|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
162963570|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
162963571|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
162963572|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
162963573|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
162887493|NCT00377429|588286692|FG000|Overall Study|Withdrawal by Subject|5|||
162887494|NCT00377429|588286692|FG000|Overall Study|Adverse Event|8|||
162887495|NCT00377429|588286692|FG000|Overall Study|Physician Decision|1|||
162887496|NCT00377429|588286692|FG000|Overall Study|Patient non-compliance|1|||
162887497|NCT01136746|588289062|FG000|Overall Study|Lost to Follow-up|0|||
162887498|NCT01136746|588289063|FG001|Overall Study|Lost to Follow-up|2|||
162887499|NCT01136746|588289062|FG000|Overall Study|Protocol Violation|2|||
162887500|NCT01136746|588289063|FG001|Overall Study|Protocol Violation|1|||
162887501|NCT01136746|588289062|FG000|Overall Study|Death|1|||
162887502|NCT01136746|588289063|FG001|Overall Study|Death|0|||
162887503|NCT00092677|588289069|FG000|Overall Study|Lost to Follow-up|0|||
162887504|NCT00092677|588289070|FG001|Overall Study|Lost to Follow-up|2|||
162887505|NCT00092677|588289069|FG000|Overall Study|Adminstrative|5|||
162887506|NCT00092677|588289070|FG001|Overall Study|Adminstrative|9|||
162887507|NCT00010803|588289075|FG000|Overall Study|Withdrawal by Subject|97|||
162887508|NCT00010803|588289076|FG001|Overall Study|Withdrawal by Subject|98|||
162887509|NCT02685995|588289077|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
162887510|NCT02685995|588289078|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
162887511|NCT01188096|588289079|FG000|Overall Study|progression of disease|4|||
162887512|NCT01188096|588289079|FG000|Overall Study|Withdrawal by Subject|2|||
162887513|NCT02384395|588289080|FG000|Overall Study|Physician Decision|4|||
162887514|NCT02384395|588289080|FG000|Overall Study|Withdrawal by Subject|3|||
162887515|NCT02384395|588289080|FG000|Overall Study|Lost to Follow-up|3|||
162887516|NCT03485222|588289081|FG000|Overall Study|Death|0|||
162887517|NCT03485222|588289082|FG001|Overall Study|Death|1|||
162887518|NCT03485222|588289081|FG000|Overall Study|Lost to Follow-up|2|||
162887519|NCT03485222|588289082|FG001|Overall Study|Lost to Follow-up|1|||
162887520|NCT00688545|588289083|FG000|Overall Study|Lost to Follow-up|1|||
162887521|NCT00688545|588289084|FG001|Overall Study|Lost to Follow-up|4|||
162887522|NCT00688545|588289083|FG000|Overall Study|Insurance/cost of drug|0|||
162887523|NCT00688545|588289084|FG001|Overall Study|Insurance/cost of drug|1|||
162887524|NCT00688545|588289083|FG000|Overall Study|Withdrawal by Subject|2|||
162887525|NCT00688545|588289084|FG001|Overall Study|Withdrawal by Subject|3|||
162887526|NCT00688545|588289083|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
162887527|NCT00688545|588289084|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
162887528|NCT01878097|588289085|FG000|Baseline|Surveys not fully completed|2497|||
162887529|NCT01878097|588289086|FG001|Baseline|Surveys not fully completed|1800|||
162887530|NCT01878097|588289085|FG000|Implementation Year 1|Surveys not fully completed|3202|||
162887531|NCT01878097|588289086|FG001|Implementation Year 1|Surveys not fully completed|2549|||
162887532|NCT01878097|588289085|FG000|Implementation Year 2|Surveys not fully completed|3281|||
162887533|NCT01878097|588289086|FG001|Implementation Year 2|Surveys not fully completed|2841|||
162887534|NCT01878097|588289085|FG000|Implementation Year 3|Surveys not fully completed|3494|||
162887535|NCT01878097|588289086|FG001|Implementation Year 3|Surveys not fully completed|2980|||
162887536|NCT01878097|588289085|FG000|Implementation Year 4|Surveys not fully completed|3604|||
162887537|NCT01878097|588289086|FG001|Implementation Year 4|Surveys not fully completed|3007|||
162887538|NCT01595438|588289089|FG000|Overall Study|Lost to Follow-up|20|||
162887539|NCT01595438|588289090|FG001|Overall Study|Lost to Follow-up|20|||
162887540|NCT01595438|588289089|FG000|Overall Study|Withdrawal by Subject|12|||
162887541|NCT01595438|588289090|FG001|Overall Study|Withdrawal by Subject|12|||
162887542|NCT01595438|588289089|FG000|Overall Study|Other Eligibility criteria|11|||
162887543|NCT01595438|588289090|FG001|Overall Study|Other Eligibility criteria|9|||
162887544|NCT00985738|588289091|FG000|Overall Study|Study closed prematurely|8|||
162887545|NCT00985738|588289092|FG001|Overall Study|Study closed prematurely|8|||
162887546|NCT00340834|588289098|FG000|Core Phase of Study|Adverse Event|26|||
162887547|NCT00340834|588289099|FG001|Core Phase of Study|Adverse Event|9|||
162887548|NCT00340834|588289100|FG002|Core Phase of Study|Adverse Event|9|||
162887549|NCT00340834|588289101|FG003|Core Phase of Study|Adverse Event|0|||
162887550|NCT00340834|588289102|FG004|Core Phase of Study|Adverse Event|0|||
162887551|NCT00340834|588289098|FG000|Core Phase of Study|Withdrawal by Subject|11|||
162887552|NCT00340834|588289099|FG001|Core Phase of Study|Withdrawal by Subject|9|||
162887553|NCT00340834|588289100|FG002|Core Phase of Study|Withdrawal by Subject|16|||
162887554|NCT00340834|588289101|FG003|Core Phase of Study|Withdrawal by Subject|0|||
162887555|NCT00340834|588289102|FG004|Core Phase of Study|Withdrawal by Subject|0|||
162887556|NCT00340834|588289098|FG000|Core Phase of Study|Administrative Problems|6|||
162887557|NCT00340834|588289099|FG001|Core Phase of Study|Administrative Problems|2|||
162887558|NCT00340834|588289100|FG002|Core Phase of Study|Administrative Problems|7|||
162887559|NCT00340834|588289101|FG003|Core Phase of Study|Administrative Problems|0|||
162887560|NCT00340834|588289102|FG004|Core Phase of Study|Administrative Problems|0|||
162887561|NCT00340834|588289098|FG000|Core Phase of Study|Lack of Efficacy|3|||
162887562|NCT00340834|588289099|FG001|Core Phase of Study|Lack of Efficacy|3|||
162887563|NCT00340834|588289100|FG002|Core Phase of Study|Lack of Efficacy|7|||
162887564|NCT00340834|588289101|FG003|Core Phase of Study|Lack of Efficacy|0|||
162887565|NCT00340834|588289102|FG004|Core Phase of Study|Lack of Efficacy|0|||
162887566|NCT00340834|588289098|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
162887567|NCT00340834|588289099|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
162887568|NCT00340834|588289100|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
162887569|NCT00340834|588289101|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
162887570|NCT00340834|588289102|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
162887571|NCT00340834|588289098|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
162887572|NCT00340834|588289099|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
162887573|NCT00340834|588289100|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
162887574|NCT00340834|588289101|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
162887575|NCT00340834|588289102|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
162887576|NCT00340834|588289098|FG000|Core Phase of Study|Lost to Follow-up|1|||
162887577|NCT00340834|588289099|FG001|Core Phase of Study|Lost to Follow-up|1|||
162887578|NCT00340834|588289100|FG002|Core Phase of Study|Lost to Follow-up|4|||
162887579|NCT00340834|588289101|FG003|Core Phase of Study|Lost to Follow-up|0|||
162887580|NCT00340834|588289102|FG004|Core Phase of Study|Lost to Follow-up|0|||
162887581|NCT00340834|588289098|FG000|Core Phase of Study|Death|2|||
162887582|NCT00340834|588289099|FG001|Core Phase of Study|Death|0|||
162887583|NCT00340834|588289100|FG002|Core Phase of Study|Death|0|||
162887584|NCT00340834|588289101|FG003|Core Phase of Study|Death|0|||
162887585|NCT00340834|588289102|FG004|Core Phase of Study|Death|0|||
162887586|NCT00340834|588289098|FG000|Core Phase of Study|Protocol Violation|0|||
162887587|NCT00340834|588289099|FG001|Core Phase of Study|Protocol Violation|0|||
162887588|NCT00340834|588289100|FG002|Core Phase of Study|Protocol Violation|2|||
162887589|NCT00340834|588289101|FG003|Core Phase of Study|Protocol Violation|0|||
162887590|NCT00340834|588289102|FG004|Core Phase of Study|Protocol Violation|0|||
162887591|NCT00340834|588289098|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
162887592|NCT00340834|588289099|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
162887593|NCT00340834|588289100|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
162887594|NCT00340834|588289101|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
162887595|NCT00340834|588289102|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
162887596|NCT00340834|588289098|FG000|Extension Phase of Study|Subject withdrew consent|26|||
162887597|NCT00340834|588289099|FG001|Extension Phase of Study|Subject withdrew consent|31|||
162887598|NCT00340834|588289100|FG002|Extension Phase of Study|Subject withdrew consent|0|||
162887599|NCT00340834|588289101|FG003|Extension Phase of Study|Subject withdrew consent|12|||
162887600|NCT00340834|588289102|FG004|Extension Phase of Study|Subject withdrew consent|15|||
162887601|NCT00340834|588289098|FG000|Extension Phase of Study|Adverse Event|21|||
162887602|NCT00340834|588289099|FG001|Extension Phase of Study|Adverse Event|22|||
162887603|NCT00340834|588289100|FG002|Extension Phase of Study|Adverse Event|0|||
162887604|NCT00340834|588289101|FG003|Extension Phase of Study|Adverse Event|19|||
162887605|NCT00340834|588289102|FG004|Extension Phase of Study|Adverse Event|7|||
162887606|NCT00340834|588289098|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
162887607|NCT00340834|588289099|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
162887608|NCT00340834|588289100|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
162887609|NCT00340834|588289101|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
162887610|NCT00340834|588289102|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
162887611|NCT00340834|588289098|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
162887612|NCT00340834|588289099|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
162887613|NCT00340834|588289100|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
162887614|NCT00340834|588289101|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
162887615|NCT00340834|588289102|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
162887616|NCT00340834|588289098|FG000|Extension Phase of Study|Lost to Follow-up|1|||
162887617|NCT00340834|588289099|FG001|Extension Phase of Study|Lost to Follow-up|1|||
162887618|NCT00340834|588289100|FG002|Extension Phase of Study|Lost to Follow-up|0|||
162887619|NCT00340834|588289101|FG003|Extension Phase of Study|Lost to Follow-up|2|||
162887620|NCT00340834|588289102|FG004|Extension Phase of Study|Lost to Follow-up|3|||
162887621|NCT00340834|588289098|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
162887622|NCT00340834|588289099|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
162887623|NCT00340834|588289100|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
162887624|NCT00340834|588289101|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
162887625|NCT00340834|588289102|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
162887626|NCT00340834|588289098|FG000|Extension Phase of Study|Administrative problems|3|||
162887627|NCT00340834|588289099|FG001|Extension Phase of Study|Administrative problems|0|||
162887628|NCT00340834|588289100|FG002|Extension Phase of Study|Administrative problems|0|||
162887629|NCT00340834|588289101|FG003|Extension Phase of Study|Administrative problems|1|||
162887630|NCT00340834|588289102|FG004|Extension Phase of Study|Administrative problems|1|||
163050707|NCT01435759|588893659|FG005|Double-blind Phase|Protocol Violation|1|||
163050708|NCT01435759|588893654|FG000|Double-blind Phase|Withdrawal by Subject|17|||
163050709|NCT01435759|588893655|FG001|Double-blind Phase|Withdrawal by Subject|4|||
163050710|NCT01435759|588893656|FG002|Double-blind Phase|Withdrawal by Subject|3|||
163050711|NCT01435759|588893657|FG003|Double-blind Phase|Withdrawal by Subject|4|||
163050712|NCT01435759|588893658|FG004|Double-blind Phase|Withdrawal by Subject|2|||
163050713|NCT01435759|588893659|FG005|Double-blind Phase|Withdrawal by Subject|2|||
163050714|NCT01435759|588893654|FG000|Double-blind Phase|Lost to Follow-up|31|||
162708188|NCT00333788|587640713|FG000|Overall Study|Other: Quality of life concern|1|||
162887631|NCT00340834|588289098|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
162887632|NCT00340834|588289099|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
162887633|NCT00340834|588289100|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
162887634|NCT00340834|588289101|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
162887635|NCT00340834|588289102|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
162887636|NCT00340834|588289098|FG000|Extension Phase of Study|Protocol Violation|3|||
162887637|NCT00340834|588289099|FG001|Extension Phase of Study|Protocol Violation|0|||
162887638|NCT00340834|588289100|FG002|Extension Phase of Study|Protocol Violation|0|||
162887639|NCT00340834|588289101|FG003|Extension Phase of Study|Protocol Violation|0|||
162887640|NCT00340834|588289102|FG004|Extension Phase of Study|Protocol Violation|0|||
162887641|NCT00340834|588289098|FG000|Extension Phase of Study|Death|0|||
162887642|NCT00340834|588289099|FG001|Extension Phase of Study|Death|0|||
162887643|NCT00340834|588289100|FG002|Extension Phase of Study|Death|0|||
162887644|NCT00340834|588289101|FG003|Extension Phase of Study|Death|0|||
162887645|NCT00340834|588289102|FG004|Extension Phase of Study|Death|1|||
162887646|NCT00291499|588289103|FG000|Overall Study|Adverse Event|3|||
162887647|NCT00291499|588289104|FG001|Overall Study|Adverse Event|8|||
162887648|NCT00291499|588289103|FG000|Overall Study|Change to other therapy|2|||
162887649|NCT00291499|588289104|FG001|Overall Study|Change to other therapy|1|||
162887650|NCT00291499|588289103|FG000|Overall Study|Intercurrent illness|1|||
162887651|NCT00291499|588289104|FG001|Overall Study|Intercurrent illness|0|||
162887652|NCT00291499|588289103|FG000|Overall Study|Protocol Violation|2|||
162887653|NCT00291499|588289104|FG001|Overall Study|Protocol Violation|2|||
162887654|NCT00291499|588289103|FG000|Overall Study|Other reasons|1|||
162887655|NCT00291499|588289104|FG001|Overall Study|Other reasons|4|||
162887656|NCT02786836|588289105|FG000|Overall Study|Death|1|||
162887657|NCT02786836|588289105|FG000|Overall Study|Lack of Efficacy|2|||
162887658|NCT02786836|588289105|FG000|Overall Study|Protocol Violation|3|||
162887659|NCT02786836|588289105|FG000|Overall Study|Withdrawal by Subject|3|||
162887660|NCT02786836|588289105|FG000|Overall Study|Liver Transplantation|2|||
162887661|NCT02786836|588289105|FG000|Overall Study|Device or Pharmacy Issues|3|||
162887662|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
162887663|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
162887664|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
162887665|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
162887666|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
162887667|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
162887668|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
162887669|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
162887670|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
162887671|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
162887672|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
162887673|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
162887674|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
162887675|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
162887676|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
162887677|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
162887678|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
162887679|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
162887680|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
162887681|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
162887682|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
162887683|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
163050715|NCT01435759|588893655|FG001|Double-blind Phase|Lost to Follow-up|1|||
163050716|NCT01435759|588893656|FG002|Double-blind Phase|Lost to Follow-up|2|||
163050717|NCT01435759|588893657|FG003|Double-blind Phase|Lost to Follow-up|0|||
163050718|NCT01435759|588893658|FG004|Double-blind Phase|Lost to Follow-up|3|||
162887684|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
162887685|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
162887686|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
162887687|NCT01457924|588289113|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
162887688|NCT01457924|588289114|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
162887689|NCT01457924|588289115|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
163050719|NCT01435759|588893659|FG005|Double-blind Phase|Lost to Follow-up|3|||
163050720|NCT01435759|588893654|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
163050721|NCT01435759|588893655|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
162708189|NCT00333788|587640713|FG000|Overall Study|Other: Sponsor decision|1|||
162887690|NCT01457924|588289116|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
162887691|NCT01457924|588289117|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
162887692|NCT01457924|588289113|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
162887693|NCT01457924|588289114|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
162887694|NCT01457924|588289115|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
162887695|NCT01457924|588289116|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
162887696|NCT01457924|588289117|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
162887697|NCT01457924|588289113|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
162887698|NCT01457924|588289114|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
162887699|NCT01457924|588289115|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
162887700|NCT01457924|588289116|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
162887701|NCT01457924|588289117|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
162887702|NCT01457924|588289113|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
162887703|NCT01457924|588289114|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
162887704|NCT01457924|588289115|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
162887705|NCT01457924|588289116|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
162887706|NCT01457924|588289117|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
162887707|NCT01457924|588289113|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
162887708|NCT01457924|588289114|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
162887709|NCT01457924|588289115|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
162887710|NCT01457924|588289116|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
162887711|NCT01457924|588289117|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
162887712|NCT01457924|588289113|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
162887713|NCT01457924|588289114|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
162887714|NCT01457924|588289115|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
162887715|NCT01457924|588289116|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
162887716|NCT01457924|588289117|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
162887717|NCT01457924|588289113|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
162887718|NCT01457924|588289114|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
162887719|NCT01457924|588289115|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
162887720|NCT01457924|588289116|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
162887721|NCT01457924|588289117|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
162887722|NCT01457924|588289113|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
162887723|NCT01457924|588289114|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
162887724|NCT01457924|588289115|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
162887725|NCT01457924|588289116|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
162887726|NCT01457924|588289117|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
162887727|NCT02855450|588289118|FG000|Overall Study|Adverse Event|1|||
162887728|NCT02855450|588289119|FG001|Overall Study|Adverse Event|0|||
162887729|NCT02855450|588289118|FG000|Overall Study|Lost to Follow-up|4|||
162887730|NCT02855450|588289119|FG001|Overall Study|Lost to Follow-up|0|||
162887731|NCT00936117|588289121|FG000|Overall Study|Adverse Event|7|||
162887732|NCT00936117|588289121|FG000|Overall Study|Unable to continue oral medication|3|||
162887733|NCT04581863|588289122|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
162887734|NCT04581863|588289123|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
162887735|NCT01803711|588289132|FG000|Overall Study|Adverse Event|1|||
162887736|NCT01803711|588289133|FG001|Overall Study|Adverse Event|1|||
162887737|NCT00225212|588289134|FG000|Overall Study|Disease progression|2|||
162887738|NCT00225212|588289134|FG000|Overall Study|Death|1|||
162887739|NCT00225212|588289134|FG000|Overall Study|Adverse Event|2|||
162887740|NCT00225212|588289134|FG000|Overall Study|Intercurrent illness|1|||
162887741|NCT05159362|588289137|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
162887742|NCT05159362|588289138|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
162887743|NCT05159362|588289139|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
162887744|NCT01376245|588289140|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
162887745|NCT01376245|588289141|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
162887746|NCT01376245|588289142|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
162963574|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
162963575|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
162963576|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
162887747|NCT01376245|588289143|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
162963577|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
162963578|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
162963579|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
162887748|NCT01376245|588289144|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
162887749|NCT01376245|588289140|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
162887750|NCT01376245|588289141|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
162887751|NCT01376245|588289142|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
162887752|NCT01376245|588289143|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
162887753|NCT01376245|588289144|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
162887754|NCT01376245|588289140|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
162887755|NCT01376245|588289141|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
162887756|NCT01376245|588289142|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
162887757|NCT01376245|588289143|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
162887758|NCT01376245|588289144|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
162887759|NCT01376245|588289140|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
162887760|NCT01376245|588289141|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
162887761|NCT01376245|588289142|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
162887762|NCT01376245|588289143|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
162887763|NCT01376245|588289144|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
162887764|NCT01376245|588289140|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
162887765|NCT01376245|588289141|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
162887766|NCT01376245|588289142|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
162887767|NCT01376245|588289143|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
162887768|NCT01376245|588289144|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
162887769|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
162887770|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
162887771|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
162887772|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
162887773|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
162887774|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
162887775|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
162887776|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
162887777|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
162887778|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
162887779|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162887780|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
162887781|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162887782|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
162887783|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
162887784|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
162887785|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
162887786|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
162887787|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
162887788|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
162887789|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162887790|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
162887791|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162887792|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
162887793|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
162887794|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
162887795|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
162887796|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
162887797|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
162887798|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
162887799|NCT01376245|588289140|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162887800|NCT01376245|588289141|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
162887801|NCT01376245|588289142|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
162887802|NCT01376245|588289143|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
162887803|NCT01376245|588289144|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
162887804|NCT01357889|588289145|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
162887805|NCT01357889|588289146|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
162887806|NCT01357889|588289145|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
162887807|NCT01357889|588289146|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
162963580|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
162963581|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
162963582|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
162887808|NCT01357889|588289145|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
162887809|NCT01357889|588289146|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
162887810|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
162887811|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
162887812|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
162887813|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
162887814|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
162887815|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
162887816|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
162887817|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
162887818|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
162887819|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
162887820|NCT01357889|588289145|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
162887821|NCT01357889|588289146|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
162887822|NCT01357889|588289145|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
162887823|NCT01357889|588289146|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
162887824|NCT01357889|588289145|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
162887825|NCT01357889|588289146|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
162887826|NCT01357889|588289145|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
162887827|NCT01357889|588289146|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
162887828|NCT01357889|588289145|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
162887829|NCT01357889|588289146|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
162887830|NCT01335698|588289147|FG000|Treatment Stage 1|Lack of Efficacy|3|||
162887831|NCT01335698|588289148|FG001|Treatment Stage 1|Lack of Efficacy|1|||
162887832|NCT01335698|588289149|FG002|Treatment Stage 1|Lack of Efficacy|3|||
162887833|NCT01335698|588289150|FG003|Treatment Stage 1|Lack of Efficacy|3|||
162887834|NCT01335698|588289151|FG004|Treatment Stage 1|Lack of Efficacy|1|||
162887835|NCT01335698|588289147|FG000|Treatment Stage 1|Adverse Event|1|||
162887836|NCT01335698|588289148|FG001|Treatment Stage 1|Adverse Event|2|||
162887837|NCT01335698|588289149|FG002|Treatment Stage 1|Adverse Event|2|||
162887838|NCT01335698|588289150|FG003|Treatment Stage 1|Adverse Event|1|||
162887839|NCT01335698|588289151|FG004|Treatment Stage 1|Adverse Event|1|||
162887840|NCT01335698|588289147|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
162887841|NCT01335698|588289148|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
162887842|NCT01335698|588289149|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
162887843|NCT01335698|588289150|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
162887844|NCT01335698|588289151|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
162887845|NCT01335698|588289147|FG000|Treatment Stage 1|Lost to Follow-up|1|||
162887846|NCT01335698|588289148|FG001|Treatment Stage 1|Lost to Follow-up|1|||
162887847|NCT01335698|588289149|FG002|Treatment Stage 1|Lost to Follow-up|0|||
162887848|NCT01335698|588289150|FG003|Treatment Stage 1|Lost to Follow-up|0|||
162887849|NCT01335698|588289151|FG004|Treatment Stage 1|Lost to Follow-up|0|||
162887850|NCT01335698|588289147|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
162887851|NCT01335698|588289148|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
162887852|NCT01335698|588289149|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
162887853|NCT01335698|588289150|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
162887854|NCT01335698|588289151|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
162887855|NCT01335698|588289147|FG000|Treatment Stage 1|No longer meets study criteria|1|||
162887856|NCT01335698|588289148|FG001|Treatment Stage 1|No longer meets study criteria|1|||
162887857|NCT01335698|588289149|FG002|Treatment Stage 1|No longer meets study criteria|0|||
162887858|NCT01335698|588289150|FG003|Treatment Stage 1|No longer meets study criteria|1|||
162887859|NCT01335698|588289151|FG004|Treatment Stage 1|No longer meets study criteria|0|||
162887860|NCT01335698|588289147|FG000|Treatment Stage 1|Other|1|||
162887861|NCT01335698|588289148|FG001|Treatment Stage 1|Other|0|||
162887862|NCT01335698|588289149|FG002|Treatment Stage 1|Other|0|||
162887863|NCT01335698|588289150|FG003|Treatment Stage 1|Other|1|||
162887864|NCT01335698|588289151|FG004|Treatment Stage 1|Other|0|||
162887865|NCT01335698|588289147|FG000|Treatment Stage 2|Lack of Efficacy|2|||
162887866|NCT01335698|588289148|FG001|Treatment Stage 2|Lack of Efficacy|1|||
162887867|NCT01335698|588289149|FG002|Treatment Stage 2|Lack of Efficacy|3|||
162887868|NCT01335698|588289150|FG003|Treatment Stage 2|Lack of Efficacy|1|||
162887869|NCT01335698|588289151|FG004|Treatment Stage 2|Lack of Efficacy|0|||
162887870|NCT01335698|588289147|FG000|Treatment Stage 2|Adverse Event|2|||
162887871|NCT01335698|588289148|FG001|Treatment Stage 2|Adverse Event|0|||
162887872|NCT01335698|588289149|FG002|Treatment Stage 2|Adverse Event|0|||
162887873|NCT01335698|588289150|FG003|Treatment Stage 2|Adverse Event|3|||
162887874|NCT01335698|588289151|FG004|Treatment Stage 2|Adverse Event|0|||
162887875|NCT01335698|588289147|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
162887876|NCT01335698|588289148|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
162887877|NCT01335698|588289149|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
162887878|NCT01335698|588289150|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
162887879|NCT01335698|588289151|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
162887880|NCT01335698|588289147|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
162887881|NCT01335698|588289148|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
162887882|NCT01335698|588289149|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
162887883|NCT01335698|588289150|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
162887884|NCT01335698|588289151|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
162887885|NCT01335698|588289147|FG000|Treatment Stage 2|Lost to Follow-up|1|||
162887886|NCT01335698|588289148|FG001|Treatment Stage 2|Lost to Follow-up|0|||
162887887|NCT01335698|588289149|FG002|Treatment Stage 2|Lost to Follow-up|0|||
162887888|NCT01335698|588289150|FG003|Treatment Stage 2|Lost to Follow-up|0|||
162887889|NCT01335698|588289151|FG004|Treatment Stage 2|Lost to Follow-up|0|||
162887890|NCT01335698|588289147|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
162887891|NCT01335698|588289148|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
162887892|NCT01335698|588289149|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
162887893|NCT01335698|588289150|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
162887894|NCT01335698|588289151|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
162887895|NCT01335698|588289147|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
162887896|NCT01335698|588289148|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
162887897|NCT01335698|588289149|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
162887898|NCT01335698|588289150|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
162887899|NCT01335698|588289151|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
162887900|NCT01335698|588289147|FG000|Treatment Stage 2|Switched to another formulation|1|||
162887901|NCT01335698|588289148|FG001|Treatment Stage 2|Switched to another formulation|1|||
162887902|NCT01335698|588289149|FG002|Treatment Stage 2|Switched to another formulation|0|||
162887903|NCT01335698|588289150|FG003|Treatment Stage 2|Switched to another formulation|0|||
162887904|NCT01335698|588289151|FG004|Treatment Stage 2|Switched to another formulation|0|||
162887905|NCT01170221|588289152|FG000|Overall Study|Lost to Follow-up|22|||
162887906|NCT01170221|588289153|FG001|Overall Study|Lost to Follow-up|21|||
162887907|NCT01170221|588289152|FG000|Overall Study|Withdrawal by Subject|9|||
162887908|NCT01170221|588289153|FG001|Overall Study|Withdrawal by Subject|7|||
162887909|NCT01170221|588289152|FG000|Overall Study|Subject completed only screening and LFU|1|||
162887910|NCT01170221|588289153|FG001|Overall Study|Subject completed only screening and LFU|0|||
162887911|NCT01170221|588289152|FG000|Overall Study|Randomized but not treated|1|||
162887912|NCT01170221|588289153|FG001|Overall Study|Randomized but not treated|0|||
162887913|NCT02693691|588289154|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
162887914|NCT02693691|588289154|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
162887915|NCT02693691|588289154|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
162887916|NCT02693691|588289154|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
162887917|NCT02693691|588289154|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
162887918|NCT02693691|588289154|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
162887919|NCT02693691|588289154|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
162887920|NCT00416312|588289155|FG000|Overall Study|tumors not visible on imaging|2|||
162887921|NCT00050960|588289156|FG000|Overall Study|Progressive Disease|137|||
162887922|NCT00050960|588289157|FG001|Overall Study|Progressive Disease|93|||
162887923|NCT00050960|588289156|FG000|Overall Study|Stable Disease|19|||
162887924|NCT00050960|588289157|FG001|Overall Study|Stable Disease|48|||
162887925|NCT00050960|588289156|FG000|Overall Study|Partial Response|14|||
162887926|NCT00050960|588289157|FG001|Overall Study|Partial Response|19|||
162887927|NCT00050960|588289156|FG000|Overall Study|Complete Response|0|||
162887928|NCT00050960|588289157|FG001|Overall Study|Complete Response|2|||
162887929|NCT00050960|588289156|FG000|Overall Study|Adverse Event|62|||
162887930|NCT00050960|588289157|FG001|Overall Study|Adverse Event|61|||
162887931|NCT00050960|588289156|FG000|Overall Study|Lost to Follow-up|0|||
162887932|NCT00050960|588289157|FG001|Overall Study|Lost to Follow-up|1|||
162887933|NCT00050960|588289156|FG000|Overall Study|Withdrawal by Subject|23|||
162887934|NCT00050960|588289157|FG001|Overall Study|Withdrawal by Subject|18|||
162887935|NCT00050960|588289156|FG000|Overall Study|Administrative|31|||
162887936|NCT00050960|588289157|FG001|Overall Study|Administrative|46|||
162887937|NCT00050960|588289156|FG000|Overall Study|Non-compliance|3|||
162887938|NCT00050960|588289157|FG001|Overall Study|Non-compliance|1|||
162887939|NCT00050960|588289156|FG000|Overall Study|Death|13|||
162887940|NCT00050960|588289157|FG001|Overall Study|Death|15|||
162887941|NCT02727660|588289158|FG000|Overall Study|Lack of Efficacy|40|||
162887942|NCT02727660|588289159|FG001|Overall Study|Lack of Efficacy|40|||
162887943|NCT02727660|588289160|FG002|Overall Study|Lack of Efficacy|70|||
162887944|NCT02727660|588289158|FG000|Overall Study|Adverse Event|28|||
162887945|NCT02727660|588289159|FG001|Overall Study|Adverse Event|21|||
162887946|NCT02727660|588289160|FG002|Overall Study|Adverse Event|32|||
162887947|NCT02727660|588289158|FG000|Overall Study|Withdrawal by Subject|26|||
162887948|NCT02727660|588289159|FG001|Overall Study|Withdrawal by Subject|25|||
162887949|NCT02727660|588289160|FG002|Overall Study|Withdrawal by Subject|30|||
162887950|NCT02727660|588289158|FG000|Overall Study|Physician Decision|3|||
162887951|NCT02727660|588289159|FG001|Overall Study|Physician Decision|8|||
162887952|NCT02727660|588289160|FG002|Overall Study|Physician Decision|14|||
162887953|NCT02727660|588289158|FG000|Overall Study|Lost to Follow-up|5|||
162887954|NCT02727660|588289159|FG001|Overall Study|Lost to Follow-up|9|||
162887955|NCT02727660|588289160|FG002|Overall Study|Lost to Follow-up|8|||
162887956|NCT02727660|588289158|FG000|Overall Study|Protocol Violation|7|||
162887957|NCT02727660|588289159|FG001|Overall Study|Protocol Violation|5|||
162887958|NCT02727660|588289160|FG002|Overall Study|Protocol Violation|5|||
162887959|NCT02727660|588289158|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
162887960|NCT02727660|588289159|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
162887961|NCT02727660|588289160|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
162887962|NCT02727660|588289158|FG000|Overall Study|Administrative Reasons|2|||
162887963|NCT02727660|588289159|FG001|Overall Study|Administrative Reasons|3|||
162887964|NCT02727660|588289160|FG002|Overall Study|Administrative Reasons|4|||
162887965|NCT00764946|588289165|FG000|Overall Study|Lack of Efficacy|1|||
162887966|NCT00764946|588289166|FG001|Overall Study|Lack of Efficacy|0|||
162887967|NCT00764946|588289167|FG002|Overall Study|Lack of Efficacy|0|||
162887968|NCT00764946|588289165|FG000|Overall Study|Lost to Follow-up|3|||
162887969|NCT00764946|588289166|FG001|Overall Study|Lost to Follow-up|4|||
162887970|NCT00764946|588289167|FG002|Overall Study|Lost to Follow-up|0|||
162887971|NCT00764946|588289165|FG000|Overall Study|Physician Decision|2|||
162887972|NCT00764946|588289166|FG001|Overall Study|Physician Decision|4|||
162887973|NCT00764946|588289167|FG002|Overall Study|Physician Decision|0|||
162887974|NCT00764946|588289165|FG000|Overall Study|Adverse Event|3|||
162887975|NCT00764946|588289166|FG001|Overall Study|Adverse Event|2|||
162887976|NCT00764946|588289167|FG002|Overall Study|Adverse Event|1|||
162887977|NCT00764946|588289165|FG000|Overall Study|Withdrawal by Subject|3|||
162887978|NCT00764946|588289166|FG001|Overall Study|Withdrawal by Subject|6|||
162887979|NCT00764946|588289167|FG002|Overall Study|Withdrawal by Subject|2|||
162887980|NCT00764946|588289165|FG000|Overall Study|Never Treated|1|||
162887981|NCT00764946|588289166|FG001|Overall Study|Never Treated|1|||
162887982|NCT00764946|588289167|FG002|Overall Study|Never Treated|1|||
162887983|NCT01162304|588289168|FG000|Overall Study|Beck scale to high|11|||
162887984|NCT01315847|588289169|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
162887985|NCT01315847|588289170|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
162887986|NCT01315847|588289169|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
162887987|NCT01315847|588289170|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
162887988|NCT02940626|588289171|FG000|Overall Study|Death|40|||
162617650|NCT00333840|587317767|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
162617651|NCT00333840|587317768|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
162617652|NCT00333840|587317769|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
162617653|NCT00333840|587317766|FG000|Second-line Treatment Period|Administrative problems|0|||
162617654|NCT00333840|587317767|FG001|Second-line Treatment Period|Administrative problems|0|||
162617655|NCT00333840|587317768|FG002|Second-line Treatment Period|Administrative problems|0|||
162617656|NCT00333840|587317769|FG003|Second-line Treatment Period|Administrative problems|7|||
162617657|NCT00333840|587317766|FG000|Second-line Treatment Period|Death|0|||
162617658|NCT00333840|587317767|FG001|Second-line Treatment Period|Death|0|||
162617659|NCT00333840|587317768|FG002|Second-line Treatment Period|Death|0|||
162617660|NCT00333840|587317769|FG003|Second-line Treatment Period|Death|9|||
162617661|NCT02357979|587317770|FG000|Overall Study|Lost to Follow-up|5|||
162617662|NCT02357979|587317771|FG001|Overall Study|Lost to Follow-up|5|||
162617663|NCT01453725|587317772|FG000|Overall Study|Adverse Event|3|||
162617664|NCT01453725|587317773|FG001|Overall Study|Adverse Event|3|||
162617665|NCT01453725|587317772|FG000|Overall Study|Lost to Follow-up|4|||
162617666|NCT01453725|587317773|FG001|Overall Study|Lost to Follow-up|0|||
162617667|NCT01453725|587317772|FG000|Overall Study|Non-compliance With Protocol|1|||
162617668|NCT01453725|587317773|FG001|Overall Study|Non-compliance With Protocol|2|||
162617669|NCT01453725|587317772|FG000|Overall Study|Protocol Violation|1|||
162617670|NCT01453725|587317773|FG001|Overall Study|Protocol Violation|0|||
162617671|NCT01453725|587317772|FG000|Overall Study|Withdrawal by Subject|2|||
162617672|NCT01453725|587317773|FG001|Overall Study|Withdrawal by Subject|3|||
162617673|NCT01453725|587317772|FG000|Overall Study|Pregnancy Wish|0|||
162617674|NCT01453725|587317773|FG001|Overall Study|Pregnancy Wish|2|||
162617675|NCT01453725|587317772|FG000|Overall Study|Pregnancy|1|||
162617676|NCT01453725|587317773|FG001|Overall Study|Pregnancy|0|||
162708190|NCT00333788|587640713|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
162887989|NCT02940626|588289172|FG001|Overall Study|Death|32|||
162887990|NCT02940626|588289171|FG000|Overall Study|Lost to Follow-up|5|||
162887991|NCT02940626|588289172|FG001|Overall Study|Lost to Follow-up|2|||
162887992|NCT02940626|588289171|FG000|Overall Study|Withdrawal by Subject|1|||
162887993|NCT02940626|588289172|FG001|Overall Study|Withdrawal by Subject|0|||
162887994|NCT02940626|588289171|FG000|Overall Study|Transfer to Hospice Care|1|||
162887995|NCT02940626|588289172|FG001|Overall Study|Transfer to Hospice Care|0|||
162887996|NCT02940626|588289171|FG000|Overall Study|Prohibited Concomitant Medication|0|||
162617677|NCT01453725|587317772|FG000|Overall Study|Physician Decision|1|||
162617678|NCT01453725|587317773|FG001|Overall Study|Physician Decision|1|||
162617679|NCT03449901|587317781|FG000|Overall Study|Progression|57|||
162617680|NCT03449901|587317782|FG001|Overall Study|Progression|12|||
162887997|NCT02940626|588289172|FG001|Overall Study|Prohibited Concomitant Medication|1|||
162887998|NCT00585923|588289174|FG000|Overall Study|Physician decided not to continue|31|||
163050722|NCT01435759|588893656|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050723|NCT01435759|588893657|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050724|NCT01435759|588893658|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
163050725|NCT01435759|588893659|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
163050726|NCT01435759|588893654|FG000|Double-blind Phase|Other|8|||
163050727|NCT01435759|588893655|FG001|Double-blind Phase|Other|2|||
163050728|NCT01435759|588893656|FG002|Double-blind Phase|Other|0|||
163050729|NCT01435759|588893657|FG003|Double-blind Phase|Other|2|||
163050730|NCT01435759|588893658|FG004|Double-blind Phase|Other|0|||
163050731|NCT01435759|588893659|FG005|Double-blind Phase|Other|0|||
163050732|NCT00427908|588893660|FG000|Primary Phase|Lost to Follow-up|4|||
163050733|NCT00427908|588893661|FG001|Primary Phase|Lost to Follow-up|0|||
163050734|NCT00427908|588893662|FG002|Primary Phase|Lost to Follow-up|2|||
163050735|NCT00427908|588893663|FG003|Primary Phase|Lost to Follow-up|0|||
163050736|NCT00427908|588893660|FG000|Primary Phase|Withdrawal by Subject|1|||
163050737|NCT00427908|588893661|FG001|Primary Phase|Withdrawal by Subject|2|||
163050738|NCT00427908|588893662|FG002|Primary Phase|Withdrawal by Subject|1|||
163050739|NCT00427908|588893663|FG003|Primary Phase|Withdrawal by Subject|0|||
163050740|NCT00427908|588893660|FG000|Primary Phase|Adverse Event|0|||
163050741|NCT00427908|588893661|FG001|Primary Phase|Adverse Event|1|||
163050742|NCT00427908|588893662|FG002|Primary Phase|Adverse Event|0|||
162617681|NCT03449901|587317781|FG000|Overall Study|Adverse Event|3|||
162617682|NCT03449901|587317782|FG001|Overall Study|Adverse Event|0|||
162617683|NCT03449901|587317781|FG000|Overall Study|Death|6|||
163050743|NCT00427908|588893663|FG003|Primary Phase|Adverse Event|0|||
163050744|NCT01710020|588893664|FG000|Period 1|Protocol Violation|1|||
163050745|NCT01764841|588893665|FG000|Overall Study|Logistical Difficulties|0|||
163050746|NCT01764841|588893666|FG001|Overall Study|Logistical Difficulties|1|||
163050747|NCT01764841|588893667|FG002|Overall Study|Logistical Difficulties|0|||
163050748|NCT01764841|588893668|FG003|Overall Study|Logistical Difficulties|0|||
163050749|NCT01764841|588893665|FG000|Overall Study|Death|3|||
163050750|NCT01764841|588893666|FG001|Overall Study|Death|0|||
163050751|NCT01764841|588893667|FG002|Overall Study|Death|1|||
163050752|NCT01764841|588893668|FG003|Overall Study|Death|4|||
163050753|NCT01764841|588893665|FG000|Overall Study|No Follow Up|1|||
163050754|NCT01764841|588893666|FG001|Overall Study|No Follow Up|0|||
163050755|NCT01764841|588893667|FG002|Overall Study|No Follow Up|1|||
163050756|NCT01764841|588893668|FG003|Overall Study|No Follow Up|0|||
163050757|NCT01764841|588893665|FG000|Overall Study|Protocol Violation|0|||
163050758|NCT01764841|588893666|FG001|Overall Study|Protocol Violation|1|||
163050759|NCT01764841|588893667|FG002|Overall Study|Protocol Violation|0|||
163050760|NCT01764841|588893668|FG003|Overall Study|Protocol Violation|0|||
163050761|NCT01764841|588893665|FG000|Overall Study|Withdrawal by Subject|16|||
163050762|NCT01764841|588893666|FG001|Overall Study|Withdrawal by Subject|24|||
163050763|NCT01764841|588893667|FG002|Overall Study|Withdrawal by Subject|11|||
163050764|NCT01764841|588893668|FG003|Overall Study|Withdrawal by Subject|15|||
163050765|NCT01764841|588893665|FG000|Overall Study|Lost to Follow-up|3|||
163050766|NCT01764841|588893666|FG001|Overall Study|Lost to Follow-up|0|||
163050767|NCT01764841|588893667|FG002|Overall Study|Lost to Follow-up|1|||
163050768|NCT01764841|588893668|FG003|Overall Study|Lost to Follow-up|0|||
162617684|NCT03449901|587317782|FG001|Overall Study|Death|2|||
162617685|NCT03449901|587317781|FG000|Overall Study|Withdrawal by Subject|12|||
162617686|NCT03449901|587317782|FG001|Overall Study|Withdrawal by Subject|1|||
162617687|NCT03449901|587317781|FG000|Overall Study|Physician Decision|1|||
162617688|NCT03449901|587317782|FG001|Overall Study|Physician Decision|0|||
162617689|NCT03449901|587317781|FG000|Overall Study|Patient elected for surgical intervention|1|||
162617690|NCT03449901|587317782|FG001|Overall Study|Patient elected for surgical intervention|0|||
162617691|NCT03449901|587317781|FG000|Overall Study|Patient off for other complicating disease|1|||
162617692|NCT03449901|587317782|FG001|Overall Study|Patient off for other complicating disease|0|||
162617693|NCT03755791|587317785|FG000|Overall Study|Did not receive any study treatment|3|||
162617694|NCT03755791|587317786|FG001|Overall Study|Did not receive any study treatment|0|||
162617695|NCT03755791|587317787|FG002|Overall Study|Did not receive any study treatment|10|||
162617696|NCT03755791|587317785|FG000|Overall Study|Radiographic progression|204|||
162708191|NCT00333788|587640713|FG000|Overall Study|Other: Medical monitor decision|1|||
162708192|NCT00333788|587640713|FG000|Overall Study|Other: Physician decision|1|||
163050769|NCT02115607|588893669|FG000|Overall Study|Withdrawal by Subject|1|||
163050770|NCT04863872|588893672|FG000|Overall Study|Withdrawal by Subject|4|||
163050771|NCT04863872|588893673|FG001|Overall Study|Withdrawal by Subject|15|||
162708193|NCT00333788|587640713|FG000|Overall Study|Other: Signed consent for another study|1|||
163050772|NCT04863872|588893672|FG000|Overall Study|Death|5|||
163050773|NCT04863872|588893673|FG001|Overall Study|Death|2|||
163050774|NCT04863872|588893672|FG000|Overall Study|Lost to Follow-up|2|||
163050775|NCT04863872|588893673|FG001|Overall Study|Lost to Follow-up|1|||
162617697|NCT03755791|587317786|FG001|Overall Study|Radiographic progression|92|||
162617698|NCT03755791|587317787|FG002|Overall Study|Radiographic progression|115|||
163050776|NCT00549549|588893674|FG000|Overall Study|Adverse Event|5|||
163050777|NCT00549549|588893675|FG001|Overall Study|Adverse Event|3|||
163050778|NCT00549549|588893676|FG002|Overall Study|Adverse Event|1|||
163050779|NCT00549549|588893677|FG003|Overall Study|Adverse Event|9|||
163050780|NCT00549549|588893674|FG000|Overall Study|Lack of Efficacy|9|||
163050781|NCT00549549|588893675|FG001|Overall Study|Lack of Efficacy|6|||
163050782|NCT00549549|588893676|FG002|Overall Study|Lack of Efficacy|4|||
163050783|NCT00549549|588893677|FG003|Overall Study|Lack of Efficacy|2|||
163050784|NCT00549549|588893674|FG000|Overall Study|Lost to Follow-up|1|||
163050785|NCT00549549|588893675|FG001|Overall Study|Lost to Follow-up|0|||
162708194|NCT00114959|587640714|FG000|Overall Study|Lack of Efficacy|6|||
162708195|NCT00114959|587640714|FG000|Overall Study|Physician Decision|1|||
162708196|NCT00114959|587640714|FG000|Overall Study|Death|1|||
162708197|NCT01007552|587640721|FG000|Overall Study|Withdrawal by Subject|1|||
162708198|NCT03212365|587640737|FG000|Overall Study|Discharged prior to Xa level|12|||
162708199|NCT03212365|587640738|FG001|Overall Study|Discharged prior to Xa level|8|||
162708200|NCT03212365|587640737|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
162708201|NCT03212365|587640738|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
162708202|NCT03212365|587640737|FG000|Overall Study|Refused study medication|3|||
162708203|NCT03212365|587640738|FG001|Overall Study|Refused study medication|0|||
162708204|NCT03212365|587640737|FG000|Overall Study|Initiated heparin infusion on floor|1|||
162708205|NCT03212365|587640738|FG001|Overall Study|Initiated heparin infusion on floor|1|||
162708206|NCT03212365|587640737|FG000|Overall Study|Unexpected return to OR|1|||
162708207|NCT03212365|587640738|FG001|Overall Study|Unexpected return to OR|1|||
162708208|NCT03212365|587640737|FG000|Overall Study|Medication distribution error|1|||
162708209|NCT03212365|587640738|FG001|Overall Study|Medication distribution error|0|||
162708210|NCT03212365|587640737|FG000|Overall Study|Required epidural placement|1|||
162708211|NCT03212365|587640738|FG001|Overall Study|Required epidural placement|0|||
162708212|NCT03212365|587640737|FG000|Overall Study|Withdrawal by Subject|0|||
163050786|NCT00549549|588893676|FG002|Overall Study|Lost to Follow-up|1|||
163050787|NCT00549549|588893677|FG003|Overall Study|Lost to Follow-up|2|||
163050788|NCT00549549|588893674|FG000|Overall Study|Withdrawal by Subject|0|||
163050789|NCT00549549|588893675|FG001|Overall Study|Withdrawal by Subject|4|||
163050790|NCT00549549|588893676|FG002|Overall Study|Withdrawal by Subject|1|||
163050791|NCT00549549|588893677|FG003|Overall Study|Withdrawal by Subject|0|||
163050792|NCT00549549|588893674|FG000|Overall Study|Other|9|||
163050793|NCT00549549|588893675|FG001|Overall Study|Other|9|||
163050794|NCT00549549|588893676|FG002|Overall Study|Other|9|||
163050795|NCT00549549|588893677|FG003|Overall Study|Other|11|||
163050796|NCT00549549|588893674|FG000|Overall Study|Randomized but not treated|0|||
163050797|NCT00549549|588893675|FG001|Overall Study|Randomized but not treated|0|||
163050798|NCT00549549|588893676|FG002|Overall Study|Randomized but not treated|1|||
163050799|NCT00549549|588893677|FG003|Overall Study|Randomized but not treated|1|||
163050800|NCT02155699|588893678|FG000|Overall Study|Withdrawal by Subject|0|||
163050801|NCT02155699|588893679|FG001|Overall Study|Withdrawal by Subject|3|||
162617699|NCT03755791|587317785|FG000|Overall Study|Adverse Event|140|||
162617700|NCT03755791|587317786|FG001|Overall Study|Adverse Event|60|||
162617701|NCT03755791|587317787|FG002|Overall Study|Adverse Event|51|||
162617702|NCT03755791|587317785|FG000|Overall Study|Lack of Efficacy|12|||
162617703|NCT03755791|587317786|FG001|Overall Study|Lack of Efficacy|6|||
162617704|NCT03755791|587317787|FG002|Overall Study|Lack of Efficacy|6|||
162617705|NCT03755791|587317785|FG000|Overall Study|Withdrawal by Subject|26|||
162617706|NCT03755791|587317786|FG001|Overall Study|Withdrawal by Subject|23|||
162617707|NCT03755791|587317787|FG002|Overall Study|Withdrawal by Subject|24|||
162617708|NCT03755791|587317785|FG000|Overall Study|Sponsor decision,|41|||
162617709|NCT03755791|587317786|FG001|Overall Study|Sponsor decision,|5|||
162617710|NCT03755791|587317787|FG002|Overall Study|Sponsor decision,|7|||
162617711|NCT03755791|587317785|FG000|Overall Study|Lost to Follow-up|1|||
162617712|NCT03755791|587317786|FG001|Overall Study|Lost to Follow-up|0|||
162617713|NCT03755791|587317787|FG002|Overall Study|Lost to Follow-up|2|||
162617714|NCT03755791|587317785|FG000|Overall Study|Protocol Violation|0|||
162617715|NCT03755791|587317786|FG001|Overall Study|Protocol Violation|0|||
162617716|NCT03755791|587317787|FG002|Overall Study|Protocol Violation|2|||
162617717|NCT03755791|587317785|FG000|Overall Study|Other than specified|5|||
162617718|NCT03755791|587317786|FG001|Overall Study|Other than specified|2|||
162617719|NCT03755791|587317787|FG002|Overall Study|Other than specified|0|||
162617720|NCT03605212|587317793|FG000|Treatment Period|Adverse Event|1|||
162617721|NCT03605212|587317794|FG001|Treatment Period|Adverse Event|0|||
162617722|NCT03605212|587317795|FG002|Treatment Period|Adverse Event|0|||
162617723|NCT03605212|587317796|FG003|Treatment Period|Adverse Event|0|||
162617724|NCT03605212|587317797|FG004|Treatment Period|Adverse Event|0|||
162617725|NCT03605212|587317793|FG000|Treatment Period|Physician Decision|0|||
162708213|NCT03212365|587640738|FG001|Overall Study|Withdrawal by Subject|1|||
162617726|NCT03605212|587317794|FG001|Treatment Period|Physician Decision|0|||
162617727|NCT03605212|587317795|FG002|Treatment Period|Physician Decision|0|||
162617728|NCT03605212|587317796|FG003|Treatment Period|Physician Decision|0|||
163050802|NCT02155699|588893680|FG002|Overall Study|Withdrawal by Subject|6|||
162617729|NCT03605212|587317797|FG004|Treatment Period|Physician Decision|1|||
162617730|NCT01254292|587317798|FG000|Comparative Phase|Adverse Event|25|||
162708214|NCT03212365|587640737|FG000|Overall Study|developed acute renal failure|0|||
163050803|NCT02155699|588893681|FG003|Overall Study|Withdrawal by Subject|1|||
162708215|NCT03212365|587640738|FG001|Overall Study|developed acute renal failure|1|||
162708216|NCT00333138|587640739|FG000|Core Study (6 Months)|Adverse Event|4|||
162708217|NCT00333138|587640740|FG001|Core Study (6 Months)|Adverse Event|5|||
162708218|NCT00333138|587640741|FG002|Core Study (6 Months)|Adverse Event|8|||
162708219|NCT00333138|587640739|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
162708220|NCT00333138|587640740|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
162708221|NCT00333138|587640741|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
162708222|NCT00333138|587640739|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
162708223|NCT00333138|587640740|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
162708224|NCT00333138|587640741|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
162708225|NCT00333138|587640739|FG000|Core Study (6 Months)|Protocol Violation|1|||
162708226|NCT00333138|587640740|FG001|Core Study (6 Months)|Protocol Violation|0|||
162708227|NCT00333138|587640741|FG002|Core Study (6 Months)|Protocol Violation|1|||
162708228|NCT00333138|587640739|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
162708229|NCT00333138|587640740|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
162708230|NCT00333138|587640741|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
162708231|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
162708232|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
162708233|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
162708234|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
162708235|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
162708236|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
162708237|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
162708238|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
162708239|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
162708240|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
162708241|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
162708242|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
162708243|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
162708244|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
162887999|NCT00585923|588289175|FG001|Overall Study|Physician decided not to continue|33|||
162888000|NCT01324622|588289176|FG000|Overall Study|Lost to Follow-up|7|||
162888001|NCT01324622|588289177|FG001|Overall Study|Lost to Follow-up|7|||
162888002|NCT01324622|588289176|FG000|Overall Study|Death|1|||
162888003|NCT01324622|588289177|FG001|Overall Study|Death|0|||
162888004|NCT01324622|588289176|FG000|Overall Study|Lack of Efficacy|1|||
162888005|NCT01324622|588289177|FG001|Overall Study|Lack of Efficacy|0|||
162888006|NCT00878215|588289178|FG000|Overall Study|Determined to be ineligible|0|||
162888007|NCT00878215|588289179|FG001|Overall Study|Determined to be ineligible|10|||
162888008|NCT00878215|588289180|FG002|Overall Study|Determined to be ineligible|0|||
162888009|NCT00878215|588289181|FG003|Overall Study|Determined to be ineligible|0|||
162888010|NCT00138424|588289182|FG000|Overall Study|Physician Decision|0|||
162888011|NCT00138424|588289183|FG001|Overall Study|Physician Decision|1|||
162888012|NCT00138424|588289184|FG002|Overall Study|Physician Decision|0|||
162888013|NCT00138424|588289185|FG003|Overall Study|Physician Decision|0|||
162888014|NCT00413062|588289192|FG000|Overall Study|Adverse event/serious adverse event|289|||
162888015|NCT00413062|588289193|FG001|Overall Study|Adverse event/serious adverse event|56|||
162888016|NCT00413062|588289192|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
162888017|NCT00413062|588289193|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
162888018|NCT00413062|588289192|FG000|Overall Study|Withdrawal of informed consent|111|||
162888019|NCT00413062|588289193|FG001|Overall Study|Withdrawal of informed consent|36|||
162888020|NCT00413062|588289192|FG000|Overall Study|Pregnancy|15|||
162888021|NCT00413062|588289193|FG001|Overall Study|Pregnancy|5|||
162888022|NCT00413062|588289192|FG000|Overall Study|Pregnancy wish|17|||
162888023|NCT00413062|588289193|FG001|Overall Study|Pregnancy wish|6|||
162888024|NCT00413062|588289192|FG000|Overall Study|Lost to Follow-up|175|||
162888025|NCT00413062|588289193|FG001|Overall Study|Lost to Follow-up|73|||
162888026|NCT00413062|588289192|FG000|Overall Study|Other reason|70|||
162708245|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
162708246|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
162708247|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
162708248|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
162888027|NCT00413062|588289193|FG001|Overall Study|Other reason|34|||
162888028|NCT02176291|588289194|FG000|Overall Study|Death|1|||
162888029|NCT02176291|588289195|FG001|Overall Study|Death|0|||
162888030|NCT02176291|588289194|FG000|Overall Study|non compliance with protocol|2|||
162888031|NCT02176291|588289195|FG001|Overall Study|non compliance with protocol|0|||
162888032|NCT02176291|588289194|FG000|Overall Study|Withdrawal by Subject|2|||
162888033|NCT02176291|588289195|FG001|Overall Study|Withdrawal by Subject|0|||
162888034|NCT02815293|588289196|FG000|Overall Study|Study termination by sponsor|10|||
162888035|NCT02815293|588289197|FG001|Overall Study|Study termination by sponsor|7|||
162888036|NCT02815293|588289198|FG002|Overall Study|Study termination by sponsor|0|||
162888037|NCT02815293|588289196|FG000|Overall Study|Participants not randomized|0|||
162888038|NCT02815293|588289197|FG001|Overall Study|Participants not randomized|0|||
162888039|NCT02815293|588289198|FG002|Overall Study|Participants not randomized|18|||
162888040|NCT02815293|588289196|FG000|Overall Study|Adverse Event|0|||
162888041|NCT02815293|588289197|FG001|Overall Study|Adverse Event|1|||
162888042|NCT02815293|588289198|FG002|Overall Study|Adverse Event|0|||
162888043|NCT00006604|588289199|FG000|Overall Study|Met study objective - no further FU|1|||
162888044|NCT00006604|588289200|FG001|Overall Study|Met study objective - no further FU|0|||
162888045|NCT00006604|588289201|FG002|Overall Study|Met study objective - no further FU|0|||
162888046|NCT00006604|588289202|FG003|Overall Study|Met study objective - no further FU|0|||
162888047|NCT00006604|588289203|FG004|Overall Study|Met study objective - no further FU|0|||
162888048|NCT00006604|588289204|FG005|Overall Study|Met study objective - no further FU|0|||
162888049|NCT00006604|588289205|FG006|Overall Study|Met study objective - no further FU|0|||
162888050|NCT00006604|588289206|FG007|Overall Study|Met study objective - no further FU|0|||
162888051|NCT00006604|588289207|FG008|Overall Study|Met study objective - no further FU|0|||
162888052|NCT00006604|588289208|FG009|Overall Study|Met study objective - no further FU|0|||
162888053|NCT00006604|588289209|FG010|Overall Study|Met study objective - no further FU|0|||
162888054|NCT00006604|588289210|FG011|Overall Study|Met study objective - no further FU|0|||
162888055|NCT00006604|588289211|FG012|Overall Study|Met study objective - no further FU|0|||
162888056|NCT00006604|588289212|FG013|Overall Study|Met study objective - no further FU|0|||
162888057|NCT00006604|588289213|FG014|Overall Study|Met study objective - no further FU|1|||
162888058|NCT00006604|588289214|FG015|Overall Study|Met study objective - no further FU|1|||
162888059|NCT00006604|588289215|FG016|Overall Study|Met study objective - no further FU|0|||
162888060|NCT00006604|588289199|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
162888061|NCT00006604|588289200|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
162888062|NCT00006604|588289201|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
162888063|NCT00006604|588289202|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
162888064|NCT00006604|588289203|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
162888065|NCT00006604|588289204|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
162888066|NCT00006604|588289205|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
162888067|NCT00006604|588289206|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
162888068|NCT00006604|588289207|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
162888069|NCT00006604|588289208|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
162888070|NCT00006604|588289209|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
162888071|NCT00006604|588289210|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
162888072|NCT00006604|588289211|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
162888073|NCT00006604|588289212|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
162888074|NCT00006604|588289213|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
162888075|NCT00006604|588289214|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
162888076|NCT00006604|588289215|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
162888077|NCT00006604|588289199|FG000|Overall Study|Death|0|||
162888078|NCT00006604|588289200|FG001|Overall Study|Death|0|||
162888079|NCT00006604|588289201|FG002|Overall Study|Death|0|||
162888080|NCT00006604|588289202|FG003|Overall Study|Death|0|||
162888081|NCT00006604|588289203|FG004|Overall Study|Death|0|||
162888082|NCT00006604|588289204|FG005|Overall Study|Death|0|||
162888083|NCT00006604|588289205|FG006|Overall Study|Death|0|||
162888084|NCT00006604|588289206|FG007|Overall Study|Death|0|||
162888085|NCT00006604|588289207|FG008|Overall Study|Death|0|||
162888086|NCT00006604|588289208|FG009|Overall Study|Death|1|||
162888087|NCT00006604|588289209|FG010|Overall Study|Death|1|||
162888088|NCT00006604|588289210|FG011|Overall Study|Death|1|||
162888089|NCT00006604|588289211|FG012|Overall Study|Death|0|||
162888090|NCT00006604|588289212|FG013|Overall Study|Death|0|||
162888091|NCT00006604|588289213|FG014|Overall Study|Death|0|||
162888092|NCT00006604|588289214|FG015|Overall Study|Death|0|||
162888093|NCT00006604|588289215|FG016|Overall Study|Death|0|||
162888094|NCT00006604|588289199|FG000|Overall Study|Severe debilitation, unable to continue|0|||
162888095|NCT00006604|588289200|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162963583|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
162963584|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
162963585|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
162963586|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
162963587|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
162963588|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
162963589|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
162888096|NCT00006604|588289201|FG002|Overall Study|Severe debilitation, unable to continue|0|||
162888097|NCT00006604|588289202|FG003|Overall Study|Severe debilitation, unable to continue|0|||
162888098|NCT00006604|588289203|FG004|Overall Study|Severe debilitation, unable to continue|0|||
162963590|NCT04194801|588566542|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
162888099|NCT00006604|588289204|FG005|Overall Study|Severe debilitation, unable to continue|0|||
162888100|NCT00006604|588289205|FG006|Overall Study|Severe debilitation, unable to continue|3|||
162888101|NCT00006604|588289206|FG007|Overall Study|Severe debilitation, unable to continue|0|||
162888102|NCT00006604|588289207|FG008|Overall Study|Severe debilitation, unable to continue|0|||
162888103|NCT00006604|588289208|FG009|Overall Study|Severe debilitation, unable to continue|5|||
162888104|NCT00006604|588289209|FG010|Overall Study|Severe debilitation, unable to continue|0|||
162888105|NCT00006604|588289210|FG011|Overall Study|Severe debilitation, unable to continue|2|||
162888106|NCT00006604|588289211|FG012|Overall Study|Severe debilitation, unable to continue|1|||
162888107|NCT00006604|588289212|FG013|Overall Study|Severe debilitation, unable to continue|0|||
162888108|NCT00006604|588289213|FG014|Overall Study|Severe debilitation, unable to continue|2|||
162888109|NCT00006604|588289214|FG015|Overall Study|Severe debilitation, unable to continue|0|||
162888110|NCT00006604|588289215|FG016|Overall Study|Severe debilitation, unable to continue|0|||
162888111|NCT00006604|588289199|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
162888112|NCT00006604|588289200|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
162888113|NCT00006604|588289201|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
162888114|NCT00006604|588289202|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
162888115|NCT00006604|588289203|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
162888116|NCT00006604|588289204|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
162888117|NCT00006604|588289205|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
162888118|NCT00006604|588289206|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
162888119|NCT00006604|588289207|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
162888120|NCT00006604|588289208|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
162888121|NCT00006604|588289209|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
162888122|NCT00006604|588289210|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
162888123|NCT00006604|588289211|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
162888124|NCT00006604|588289212|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
162888125|NCT00006604|588289213|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
162888126|NCT00006604|588289214|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
162888127|NCT00006604|588289215|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
162888128|NCT00006604|588289199|FG000|Overall Study|Site closing|0|||
162888129|NCT00006604|588289200|FG001|Overall Study|Site closing|0|||
162888130|NCT00006604|588289201|FG002|Overall Study|Site closing|1|||
162888131|NCT00006604|588289202|FG003|Overall Study|Site closing|1|||
162888132|NCT00006604|588289203|FG004|Overall Study|Site closing|0|||
162888133|NCT00006604|588289204|FG005|Overall Study|Site closing|0|||
162888134|NCT00006604|588289205|FG006|Overall Study|Site closing|0|||
162888135|NCT00006604|588289206|FG007|Overall Study|Site closing|1|||
162888136|NCT00006604|588289207|FG008|Overall Study|Site closing|0|||
162888137|NCT00006604|588289208|FG009|Overall Study|Site closing|0|||
162888138|NCT00006604|588289209|FG010|Overall Study|Site closing|0|||
162888139|NCT00006604|588289210|FG011|Overall Study|Site closing|1|||
162888140|NCT00006604|588289211|FG012|Overall Study|Site closing|1|||
162888141|NCT00006604|588289212|FG013|Overall Study|Site closing|1|||
162963591|NCT04194801|588566543|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
162963592|NCT04194801|588566544|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
162963593|NCT04194801|588566542|FG000|Part Ib/II End of Study|Death|2|||
162963594|NCT04194801|588566543|FG001|Part Ib/II End of Study|Death|3|||
162963595|NCT04194801|588566544|FG002|Part Ib/II End of Study|Death|3|||
162963596|NCT04194801|588566542|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
162963597|NCT04194801|588566543|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
162963598|NCT04194801|588566544|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
162963599|NCT04194801|588566542|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
162963600|NCT04194801|588566543|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
162888142|NCT00006604|588289213|FG014|Overall Study|Site closing|0|||
162888143|NCT00006604|588289214|FG015|Overall Study|Site closing|0|||
162888144|NCT00006604|588289215|FG016|Overall Study|Site closing|1|||
162888145|NCT00006604|588289199|FG000|Overall Study|Withdrawal by Subject|1|||
162888146|NCT00006604|588289200|FG001|Overall Study|Withdrawal by Subject|0|||
162888147|NCT00006604|588289201|FG002|Overall Study|Withdrawal by Subject|2|||
162888148|NCT00006604|588289202|FG003|Overall Study|Withdrawal by Subject|0|||
162888149|NCT00006604|588289203|FG004|Overall Study|Withdrawal by Subject|1|||
162888150|NCT00006604|588289204|FG005|Overall Study|Withdrawal by Subject|2|||
162963601|NCT04194801|588566544|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
162963602|NCT04194801|588566542|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
162963603|NCT04194801|588566543|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
162963604|NCT04194801|588566544|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
162888151|NCT00006604|588289205|FG006|Overall Study|Withdrawal by Subject|2|||
162963605|NCT04194801|588566542|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
162888152|NCT00006604|588289206|FG007|Overall Study|Withdrawal by Subject|0|||
162888153|NCT00006604|588289207|FG008|Overall Study|Withdrawal by Subject|1|||
162888154|NCT00006604|588289208|FG009|Overall Study|Withdrawal by Subject|3|||
162888155|NCT00006604|588289209|FG010|Overall Study|Withdrawal by Subject|2|||
162888156|NCT00006604|588289210|FG011|Overall Study|Withdrawal by Subject|0|||
162888157|NCT00006604|588289211|FG012|Overall Study|Withdrawal by Subject|1|||
162888158|NCT00006604|588289212|FG013|Overall Study|Withdrawal by Subject|2|||
162888159|NCT00006604|588289213|FG014|Overall Study|Withdrawal by Subject|1|||
162888160|NCT00006604|588289214|FG015|Overall Study|Withdrawal by Subject|0|||
162888161|NCT00006604|588289215|FG016|Overall Study|Withdrawal by Subject|1|||
162888162|NCT00006604|588289199|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
162888163|NCT00006604|588289200|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
162888164|NCT00006604|588289201|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
162888165|NCT00006604|588289202|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
162888166|NCT00006604|588289203|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
162888167|NCT00006604|588289204|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
162888168|NCT00006604|588289205|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
162888169|NCT00006604|588289206|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
162888170|NCT00006604|588289207|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
162888171|NCT00006604|588289208|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
162888172|NCT00006604|588289209|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
162888173|NCT00006604|588289210|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
162888174|NCT00006604|588289211|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
162888175|NCT00006604|588289212|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
162888176|NCT00006604|588289213|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
162888177|NCT00006604|588289214|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
162888178|NCT00006604|588289215|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
162888179|NCT00006604|588289199|FG000|Overall Study|Lost to Follow-up|0|||
162888180|NCT00006604|588289200|FG001|Overall Study|Lost to Follow-up|0|||
162888181|NCT00006604|588289201|FG002|Overall Study|Lost to Follow-up|0|||
162888182|NCT00006604|588289202|FG003|Overall Study|Lost to Follow-up|0|||
162888183|NCT00006604|588289203|FG004|Overall Study|Lost to Follow-up|0|||
162888184|NCT00006604|588289204|FG005|Overall Study|Lost to Follow-up|0|||
162888185|NCT00006604|588289205|FG006|Overall Study|Lost to Follow-up|0|||
162888186|NCT00006604|588289206|FG007|Overall Study|Lost to Follow-up|1|||
162888187|NCT00006604|588289207|FG008|Overall Study|Lost to Follow-up|0|||
162888188|NCT00006604|588289208|FG009|Overall Study|Lost to Follow-up|2|||
162888189|NCT00006604|588289209|FG010|Overall Study|Lost to Follow-up|0|||
162888190|NCT00006604|588289210|FG011|Overall Study|Lost to Follow-up|0|||
162888191|NCT00006604|588289211|FG012|Overall Study|Lost to Follow-up|0|||
162888192|NCT00006604|588289212|FG013|Overall Study|Lost to Follow-up|0|||
162888193|NCT00006604|588289213|FG014|Overall Study|Lost to Follow-up|0|||
162888194|NCT00006604|588289214|FG015|Overall Study|Lost to Follow-up|1|||
162888195|NCT00006604|588289215|FG016|Overall Study|Lost to Follow-up|3|||
162888196|NCT00006604|588289199|FG000|Overall Study|Other Reason|0|||
162888197|NCT00006604|588289200|FG001|Overall Study|Other Reason|0|||
162888198|NCT00006604|588289201|FG002|Overall Study|Other Reason|0|||
162888199|NCT00006604|588289202|FG003|Overall Study|Other Reason|0|||
162888200|NCT00006604|588289203|FG004|Overall Study|Other Reason|0|||
162888201|NCT00006604|588289204|FG005|Overall Study|Other Reason|1|||
162888202|NCT00006604|588289205|FG006|Overall Study|Other Reason|0|||
162888203|NCT00006604|588289206|FG007|Overall Study|Other Reason|0|||
162888204|NCT00006604|588289207|FG008|Overall Study|Other Reason|0|||
162888205|NCT00006604|588289208|FG009|Overall Study|Other Reason|1|||
162617731|NCT01254292|587317799|FG001|Comparative Phase|Adverse Event|25|||
162888206|NCT00006604|588289209|FG010|Overall Study|Other Reason|0|||
162888207|NCT00006604|588289210|FG011|Overall Study|Other Reason|0|||
162888208|NCT00006604|588289211|FG012|Overall Study|Other Reason|0|||
162888209|NCT00006604|588289212|FG013|Overall Study|Other Reason|0|||
162888210|NCT00006604|588289213|FG014|Overall Study|Other Reason|0|||
162888211|NCT00006604|588289214|FG015|Overall Study|Other Reason|0|||
162888212|NCT00006604|588289215|FG016|Overall Study|Other Reason|0|||
162888213|NCT02431468|588289216|FG000|Overall Study|Adverse Event|2|||
162888214|NCT02431468|588289217|FG001|Overall Study|Adverse Event|4|||
162888215|NCT02431468|588289218|FG002|Overall Study|Adverse Event|5|||
162617732|NCT01254292|587317798|FG000|Comparative Phase|Lost to Follow-up|3|||
162888216|NCT02431468|588289216|FG000|Overall Study|Withdrawal by Subject|4|||
162888217|NCT02431468|588289217|FG001|Overall Study|Withdrawal by Subject|12|||
162888218|NCT02431468|588289218|FG002|Overall Study|Withdrawal by Subject|2|||
162888219|NCT02431468|588289216|FG000|Overall Study|noncompliance, investigator termination,|2|||
162888220|NCT02431468|588289217|FG001|Overall Study|noncompliance, investigator termination,|2|||
162888221|NCT02431468|588289218|FG002|Overall Study|noncompliance, investigator termination,|2|||
162888222|NCT01361919|588289219|FG000|Overall Study|technical issues|10|||
162963606|NCT04194801|588566543|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
162617733|NCT01254292|587317799|FG001|Comparative Phase|Lost to Follow-up|21|||
162888223|NCT01361919|588289220|FG001|Overall Study|technical issues|12|||
162888224|NCT01361919|588289221|FG002|Overall Study|technical issues|10|||
162888225|NCT01056341|588289222|FG000|Overall Study|Treatment Intolerance|0|||
162888226|NCT01056341|588289223|FG001|Overall Study|Treatment Intolerance|2|||
162888227|NCT01056341|588289224|FG002|Overall Study|Treatment Intolerance|0|||
162888228|NCT01056341|588289225|FG003|Overall Study|Treatment Intolerance|2|||
162888229|NCT01056341|588289226|FG004|Overall Study|Treatment Intolerance|0|||
162888230|NCT01056341|588289222|FG000|Overall Study|Lack of Efficacy|32|||
162888231|NCT01056341|588289223|FG001|Overall Study|Lack of Efficacy|30|||
162888232|NCT01056341|588289224|FG002|Overall Study|Lack of Efficacy|7|||
162888233|NCT01056341|588289225|FG003|Overall Study|Lack of Efficacy|25|||
162888234|NCT01056341|588289226|FG004|Overall Study|Lack of Efficacy|9|||
162888235|NCT01056341|588289222|FG000|Overall Study|Other reasons|4|||
162888236|NCT01056341|588289223|FG001|Overall Study|Other reasons|4|||
162888237|NCT01056341|588289224|FG002|Overall Study|Other reasons|8|||
162888238|NCT01056341|588289225|FG003|Overall Study|Other reasons|9|||
162888239|NCT01056341|588289226|FG004|Overall Study|Other reasons|5|||
162888240|NCT03454412|588289227|FG000|Baseline Assesment|Physician Decision|12|||
162888241|NCT01167582|588289230|FG000|Overall Study|Lost to Follow-up|0|||
162888242|NCT01167582|588289231|FG001|Overall Study|Lost to Follow-up|1|||
162888243|NCT03956225|588289232|FG000|Overall Study|Lack of Efficacy|1|||
162888244|NCT03956225|588289233|FG001|Overall Study|Lack of Efficacy|1|||
162888245|NCT03956225|588289232|FG000|Overall Study|Lost to Follow-up|0|||
162888246|NCT03956225|588289233|FG001|Overall Study|Lost to Follow-up|1|||
162888247|NCT03956225|588289232|FG000|Overall Study|Withdrawal by Subject|2|||
162888248|NCT03956225|588289233|FG001|Overall Study|Withdrawal by Subject|1|||
162888249|NCT03956225|588289232|FG000|Overall Study|Other Reasons|2|||
162888250|NCT03956225|588289233|FG001|Overall Study|Other Reasons|1|||
162888251|NCT00567541|588289234|FG000|Overall Study|Adverse Event|0|||
162888252|NCT00567541|588289235|FG001|Overall Study|Adverse Event|1|||
162888253|NCT01182337|588289238|FG000|Overall Study|Withdrawal by Subject|3|||
162888254|NCT01182337|588289239|FG001|Overall Study|Withdrawal by Subject|1|||
162888255|NCT01182337|588289238|FG000|Overall Study|Lost to Follow-up|0|||
162888256|NCT01182337|588289239|FG001|Overall Study|Lost to Follow-up|1|||
162888257|NCT02157506|588289240|FG000|Overall Study|Adverse Event|0|||
162888258|NCT02157506|588289241|FG001|Overall Study|Adverse Event|1|||
162888259|NCT02157506|588289242|FG002|Overall Study|Adverse Event|0|||
162888260|NCT02157506|588289243|FG003|Overall Study|Adverse Event|0|||
162888261|NCT02157506|588289244|FG004|Overall Study|Adverse Event|0|||
162888262|NCT02157506|588289240|FG000|Overall Study|Lost to Follow-up|0|||
162888263|NCT02157506|588289241|FG001|Overall Study|Lost to Follow-up|0|||
162888264|NCT02157506|588289242|FG002|Overall Study|Lost to Follow-up|1|||
162888265|NCT02157506|588289243|FG003|Overall Study|Lost to Follow-up|0|||
162888266|NCT02157506|588289244|FG004|Overall Study|Lost to Follow-up|0|||
162888267|NCT03498287|588289250|FG000|Overall Study|Withdrawal by Subject|3|||
162888268|NCT03498287|588289251|FG001|Overall Study|Withdrawal by Subject|0|||
162888269|NCT03498287|588289250|FG000|Overall Study|Protocol Violation|0|||
162888270|NCT03498287|588289251|FG001|Overall Study|Protocol Violation|4|||
162888271|NCT03498287|588289250|FG000|Overall Study|Adverse Event|0|||
162888272|NCT03498287|588289251|FG001|Overall Study|Adverse Event|1|||
162963607|NCT04194801|588566544|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
162963608|NCT00294047|588566545|FG000|Month 48|Adverse Event|28|||
162963609|NCT00294047|588566546|FG001|Month 48|Adverse Event|13|||
162963610|NCT00294047|588566545|FG000|Month 48|Protocol Violation|4|||
162963611|NCT00294047|588566546|FG001|Month 48|Protocol Violation|4|||
162963612|NCT00294047|588566545|FG000|Month 48|Withdrawal by Subject|111|||
162963613|NCT00294047|588566546|FG001|Month 48|Withdrawal by Subject|115|||
162963614|NCT00294047|588566545|FG000|Month 48|Lost to Follow-up|272|||
162963615|NCT00294047|588566546|FG001|Month 48|Lost to Follow-up|287|||
162963616|NCT00294047|588566545|FG000|Month 48|Other|10|||
162963617|NCT00294047|588566546|FG001|Month 48|Other|14|||
162963618|NCT00294047|588566545|FG000|Month 84|Adverse Event|4|||
162963619|NCT00294047|588566546|FG001|Month 84|Adverse Event|2|||
162963620|NCT00294047|588566545|FG000|Month 84|Protocol Violation|1|||
162963621|NCT00294047|588566546|FG001|Month 84|Protocol Violation|1|||
162963622|NCT00294047|588566545|FG000|Month 84|Withdrawal by Subject|33|||
162888273|NCT04169061|588289252|FG000|Overall Study|Adverse Event|2|||
162888274|NCT04169061|588289252|FG000|Overall Study|Death|1|||
162888275|NCT04169061|588289252|FG000|Overall Study|Withdrawal by Subject|1|||
162888276|NCT04169061|588289252|FG000|Overall Study|Protocol Violation|1|||
162888277|NCT01763866|588289255|FG000|Overall Study|Withdrawal by Subject|2|||
162888278|NCT01763866|588289256|FG001|Overall Study|Withdrawal by Subject|1|||
162888279|NCT01763866|588289257|FG002|Overall Study|Withdrawal by Subject|4|||
162888280|NCT01763866|588289258|FG003|Overall Study|Withdrawal by Subject|0|||
162888281|NCT01763866|588289259|FG004|Overall Study|Withdrawal by Subject|0|||
162888282|NCT01763866|588289260|FG005|Overall Study|Withdrawal by Subject|3|||
162888283|NCT01763866|588289261|FG006|Overall Study|Withdrawal by Subject|4|||
162888284|NCT01763866|588289262|FG007|Overall Study|Withdrawal by Subject|0|||
162888285|NCT01763866|588289263|FG008|Overall Study|Withdrawal by Subject|1|||
162963623|NCT00294047|588566546|FG001|Month 84|Withdrawal by Subject|31|||
162888286|NCT01763866|588289264|FG009|Overall Study|Withdrawal by Subject|1|||
162888287|NCT01763866|588289265|FG010|Overall Study|Withdrawal by Subject|2|||
162888288|NCT01763866|588289266|FG011|Overall Study|Withdrawal by Subject|2|||
162888289|NCT01763866|588289267|FG012|Overall Study|Withdrawal by Subject|2|||
162888290|NCT01763866|588289268|FG013|Overall Study|Withdrawal by Subject|0|||
162888291|NCT01763866|588289269|FG014|Overall Study|Withdrawal by Subject|6|||
162888292|NCT01763866|588289270|FG015|Overall Study|Withdrawal by Subject|3|||
162888293|NCT01763866|588289271|FG016|Overall Study|Withdrawal by Subject|0|||
162888294|NCT01763866|588289272|FG017|Overall Study|Withdrawal by Subject|1|||
162888295|NCT01763866|588289273|FG018|Overall Study|Withdrawal by Subject|1|||
162888296|NCT01763866|588289274|FG019|Overall Study|Withdrawal by Subject|1|||
162888297|NCT01763866|588289275|FG020|Overall Study|Withdrawal by Subject|2|||
162888298|NCT01763866|588289276|FG021|Overall Study|Withdrawal by Subject|1|||
162888299|NCT01763866|588289277|FG022|Overall Study|Withdrawal by Subject|2|||
162888300|NCT01763866|588289278|FG023|Overall Study|Withdrawal by Subject|1|||
162888301|NCT01763866|588289255|FG000|Overall Study|Decision by sponsor|0|||
162888302|NCT01763866|588289256|FG001|Overall Study|Decision by sponsor|0|||
162888303|NCT01763866|588289257|FG002|Overall Study|Decision by sponsor|1|||
162888304|NCT01763866|588289258|FG003|Overall Study|Decision by sponsor|0|||
162888305|NCT01763866|588289259|FG004|Overall Study|Decision by sponsor|2|||
162888306|NCT01763866|588289260|FG005|Overall Study|Decision by sponsor|0|||
162888307|NCT01763866|588289261|FG006|Overall Study|Decision by sponsor|2|||
162888308|NCT01763866|588289262|FG007|Overall Study|Decision by sponsor|0|||
162888309|NCT01763866|588289263|FG008|Overall Study|Decision by sponsor|2|||
162888310|NCT01763866|588289264|FG009|Overall Study|Decision by sponsor|0|||
162888311|NCT01763866|588289265|FG010|Overall Study|Decision by sponsor|6|||
162888312|NCT01763866|588289266|FG011|Overall Study|Decision by sponsor|0|||
162888313|NCT01763866|588289267|FG012|Overall Study|Decision by sponsor|1|||
162888314|NCT01763866|588289268|FG013|Overall Study|Decision by sponsor|0|||
162888315|NCT01763866|588289269|FG014|Overall Study|Decision by sponsor|5|||
162888316|NCT01763866|588289270|FG015|Overall Study|Decision by sponsor|0|||
162888317|NCT01763866|588289271|FG016|Overall Study|Decision by sponsor|0|||
162888318|NCT01763866|588289272|FG017|Overall Study|Decision by sponsor|0|||
162888319|NCT01763866|588289273|FG018|Overall Study|Decision by sponsor|4|||
162888320|NCT01763866|588289274|FG019|Overall Study|Decision by sponsor|0|||
162888321|NCT01763866|588289275|FG020|Overall Study|Decision by sponsor|2|||
162888322|NCT01763866|588289276|FG021|Overall Study|Decision by sponsor|0|||
162888323|NCT01763866|588289277|FG022|Overall Study|Decision by sponsor|1|||
162888324|NCT01763866|588289278|FG023|Overall Study|Decision by sponsor|0|||
162888325|NCT01763866|588289255|FG000|Overall Study|Lost to Follow-up|0|||
162888326|NCT01763866|588289256|FG001|Overall Study|Lost to Follow-up|0|||
162888327|NCT01763866|588289257|FG002|Overall Study|Lost to Follow-up|0|||
162888328|NCT01763866|588289258|FG003|Overall Study|Lost to Follow-up|0|||
162888329|NCT01763866|588289259|FG004|Overall Study|Lost to Follow-up|0|||
162888330|NCT01763866|588289260|FG005|Overall Study|Lost to Follow-up|0|||
162888331|NCT01763866|588289261|FG006|Overall Study|Lost to Follow-up|1|||
162888332|NCT01763866|588289262|FG007|Overall Study|Lost to Follow-up|0|||
162888333|NCT01763866|588289263|FG008|Overall Study|Lost to Follow-up|0|||
162888334|NCT01763866|588289264|FG009|Overall Study|Lost to Follow-up|0|||
162888335|NCT01763866|588289265|FG010|Overall Study|Lost to Follow-up|0|||
162888336|NCT01763866|588289266|FG011|Overall Study|Lost to Follow-up|0|||
162888337|NCT01763866|588289267|FG012|Overall Study|Lost to Follow-up|1|||
162888338|NCT01763866|588289268|FG013|Overall Study|Lost to Follow-up|0|||
162888339|NCT01763866|588289269|FG014|Overall Study|Lost to Follow-up|1|||
162888340|NCT01763866|588289270|FG015|Overall Study|Lost to Follow-up|0|||
162888341|NCT01763866|588289271|FG016|Overall Study|Lost to Follow-up|0|||
162888342|NCT01763866|588289272|FG017|Overall Study|Lost to Follow-up|0|||
162888343|NCT01763866|588289273|FG018|Overall Study|Lost to Follow-up|1|||
162888344|NCT01763866|588289274|FG019|Overall Study|Lost to Follow-up|1|||
162888345|NCT01763866|588289275|FG020|Overall Study|Lost to Follow-up|0|||
162888346|NCT01763866|588289276|FG021|Overall Study|Lost to Follow-up|0|||
162888347|NCT01763866|588289277|FG022|Overall Study|Lost to Follow-up|0|||
162888348|NCT01763866|588289278|FG023|Overall Study|Lost to Follow-up|1|||
162888349|NCT01763866|588289255|FG000|Overall Study|Death|0|||
162888350|NCT01763866|588289256|FG001|Overall Study|Death|0|||
162888351|NCT01763866|588289257|FG002|Overall Study|Death|0|||
162888352|NCT01763866|588289258|FG003|Overall Study|Death|0|||
162888353|NCT01763866|588289259|FG004|Overall Study|Death|0|||
162888354|NCT01763866|588289260|FG005|Overall Study|Death|0|||
162888355|NCT01763866|588289261|FG006|Overall Study|Death|0|||
162888356|NCT01763866|588289262|FG007|Overall Study|Death|0|||
162888357|NCT01763866|588289263|FG008|Overall Study|Death|0|||
162888358|NCT01763866|588289264|FG009|Overall Study|Death|0|||
162888359|NCT01763866|588289265|FG010|Overall Study|Death|0|||
162888360|NCT01763866|588289266|FG011|Overall Study|Death|0|||
162888361|NCT01763866|588289267|FG012|Overall Study|Death|0|||
162888362|NCT01763866|588289268|FG013|Overall Study|Death|0|||
162888363|NCT01763866|588289269|FG014|Overall Study|Death|0|||
162888364|NCT01763866|588289270|FG015|Overall Study|Death|0|||
162888365|NCT01763866|588289271|FG016|Overall Study|Death|1|||
162888366|NCT01763866|588289272|FG017|Overall Study|Death|0|||
162888367|NCT01763866|588289273|FG018|Overall Study|Death|0|||
162888368|NCT01763866|588289274|FG019|Overall Study|Death|0|||
162888369|NCT01763866|588289275|FG020|Overall Study|Death|0|||
162888370|NCT01763866|588289276|FG021|Overall Study|Death|0|||
162888371|NCT01763866|588289277|FG022|Overall Study|Death|0|||
162888372|NCT01763866|588289278|FG023|Overall Study|Death|0|||
162888373|NCT02939599|588289283|FG000|Overall Study|Adverse Event|1|||
162888374|NCT02939599|588289284|FG001|Overall Study|Adverse Event|0|||
162888375|NCT02939599|588289283|FG000|Overall Study|Study Terminated By Sponsor|2|||
162888376|NCT02939599|588289284|FG001|Overall Study|Study Terminated By Sponsor|2|||
162888377|NCT01669811|588289285|FG000|Overall Study|Investigator decision|0|||
162888378|NCT01669811|588289286|FG001|Overall Study|Investigator decision|1|||
162888379|NCT01669811|588289285|FG000|Overall Study|Withdrawal by Subject|1|||
162888380|NCT01669811|588289286|FG001|Overall Study|Withdrawal by Subject|2|||
162888381|NCT01669811|588289285|FG000|Overall Study|Adverse Event|2|||
162888382|NCT01669811|588289286|FG001|Overall Study|Adverse Event|6|||
162888383|NCT01669811|588289285|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162888384|NCT01669811|588289286|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162888385|NCT03288493|588289291|FG000|Overall Study|Withdrawal by Subject|4|||
162888386|NCT03288493|588289292|FG001|Overall Study|Withdrawal by Subject|0|||
162888387|NCT03288493|588289293|FG002|Overall Study|Withdrawal by Subject|0|||
162888388|NCT03288493|588289294|FG003|Overall Study|Withdrawal by Subject|0|||
162888389|NCT03288493|588289295|FG004|Overall Study|Withdrawal by Subject|0|||
162888390|NCT03288493|588289296|FG005|Overall Study|Withdrawal by Subject|2|||
162888391|NCT03288493|588289297|FG006|Overall Study|Withdrawal by Subject|0|||
162888392|NCT03288493|588289291|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
162888393|NCT03288493|588289292|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
162888394|NCT03288493|588289293|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
162888395|NCT03288493|588289294|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
162888396|NCT03288493|588289295|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
162888397|NCT03288493|588289296|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
162888398|NCT03288493|588289297|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
162888399|NCT03288493|588289291|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
162888400|NCT03288493|588289292|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
162888401|NCT03288493|588289293|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
162888402|NCT03288493|588289294|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
162888403|NCT03288493|588289295|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
162888404|NCT03288493|588289296|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
162888405|NCT03288493|588289297|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
162888406|NCT03288493|588289291|FG000|Overall Study|Death|2|||
162888407|NCT03288493|588289292|FG001|Overall Study|Death|0|||
162888408|NCT03288493|588289293|FG002|Overall Study|Death|0|||
162888409|NCT03288493|588289294|FG003|Overall Study|Death|0|||
162888410|NCT03288493|588289295|FG004|Overall Study|Death|0|||
162888411|NCT03288493|588289296|FG005|Overall Study|Death|0|||
162888412|NCT03288493|588289297|FG006|Overall Study|Death|0|||
162888413|NCT03288493|588289291|FG000|Overall Study|other reason not listed above|2|||
162888414|NCT03288493|588289292|FG001|Overall Study|other reason not listed above|0|||
162617734|NCT01254292|587317798|FG000|Comparative Phase|Pregnancy|2|||
162617735|NCT01254292|587317799|FG001|Comparative Phase|Pregnancy|6|||
162617736|NCT01254292|587317798|FG000|Comparative Phase|Withdrawal by Subject|20|||
162617737|NCT01254292|587317799|FG001|Comparative Phase|Withdrawal by Subject|21|||
162617738|NCT01254292|587317798|FG000|Comparative Phase|Protocol Violation|1|||
162617739|NCT01254292|587317799|FG001|Comparative Phase|Protocol Violation|2|||
162617740|NCT01254292|587317798|FG000|Comparative Phase|Wish for pregnancy|4|||
162888415|NCT03288493|588289293|FG002|Overall Study|other reason not listed above|0|||
162888416|NCT03288493|588289294|FG003|Overall Study|other reason not listed above|0|||
162888417|NCT03288493|588289295|FG004|Overall Study|other reason not listed above|0|||
162888418|NCT03288493|588289296|FG005|Overall Study|other reason not listed above|0|||
162888419|NCT03288493|588289297|FG006|Overall Study|other reason not listed above|0|||
162888420|NCT00093470|588290915|FG000|Overall Study|Disease progression|39|||
162888421|NCT00093470|588290916|FG001|Overall Study|Disease progression|0|||
162888422|NCT00093470|588290915|FG000|Overall Study|Adverse Event|15|||
162888423|NCT00093470|588290916|FG001|Overall Study|Adverse Event|0|||
162888424|NCT00093470|588290915|FG000|Overall Study|Death|2|||
162888425|NCT00093470|588290916|FG001|Overall Study|Death|0|||
162888426|NCT00093470|588290915|FG000|Overall Study|Withdrawal by Subject|8|||
162888427|NCT00093470|588290916|FG001|Overall Study|Withdrawal by Subject|0|||
162888428|NCT00093470|588290915|FG000|Overall Study|Alternative therapy|2|||
162888429|NCT00093470|588290916|FG001|Overall Study|Alternative therapy|0|||
162888430|NCT00093470|588290915|FG000|Overall Study|Other complicating disease|3|||
162888431|NCT00093470|588290916|FG001|Overall Study|Other complicating disease|0|||
162888432|NCT00093470|588290915|FG000|Overall Study|Physician Decision|2|||
162888433|NCT00093470|588290916|FG001|Overall Study|Physician Decision|0|||
162888434|NCT00093470|588290915|FG000|Overall Study|Never started treatment|1|||
162888435|NCT00093470|588290916|FG001|Overall Study|Never started treatment|0|||
162888436|NCT00093470|588290915|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
162888437|NCT00093470|588290916|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
162888438|NCT01019252|588290922|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
162888439|NCT01019252|588290923|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
162888440|NCT01019252|588290922|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
162888441|NCT01019252|588290923|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
162888442|NCT01019252|588290922|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
162888443|NCT01019252|588290923|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
162888444|NCT01019252|588290922|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
162888445|NCT01019252|588290923|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
162888446|NCT02514772|588290924|FG000|Overall Study|Adverse Event|1|||
162888447|NCT02514772|588290925|FG001|Overall Study|Adverse Event|0|||
162888448|NCT02514772|588290924|FG000|Overall Study|Death|0|||
162888449|NCT02514772|588290925|FG001|Overall Study|Death|1|||
162888450|NCT02514772|588290924|FG000|Overall Study|Withdrawal by Subject|2|||
162888451|NCT02514772|588290925|FG001|Overall Study|Withdrawal by Subject|1|||
162888452|NCT00877006|588290926|FG000|Treatment Period|Death|2|||
162888453|NCT00877006|588290927|FG001|Treatment Period|Death|1|||
162888454|NCT00877006|588290926|FG000|Treatment Period|Adverse Event|10|||
162888455|NCT00877006|588290927|FG001|Treatment Period|Adverse Event|3|||
162888456|NCT00877006|588290926|FG000|Treatment Period|Withdrawal by Subject|2|||
162888457|NCT00877006|588290927|FG001|Treatment Period|Withdrawal by Subject|3|||
162888458|NCT00877006|588290926|FG000|Treatment Period|Protocol Violation|1|||
162888459|NCT00877006|588290927|FG001|Treatment Period|Protocol Violation|0|||
162888460|NCT00877006|588290926|FG000|Treatment Period|Lost to Follow-up|0|||
162888461|NCT00877006|588290927|FG001|Treatment Period|Lost to Follow-up|1|||
162888462|NCT00877006|588290926|FG000|Treatment Period|Disease Progression|1|||
162888463|NCT00877006|588290927|FG001|Treatment Period|Disease Progression|2|||
162888464|NCT00877006|588290926|FG000|Treatment Period|Started New Treatment Regimen|2|||
162888465|NCT00877006|588290927|FG001|Treatment Period|Started New Treatment Regimen|5|||
162888466|NCT00877006|588290926|FG000|Treatment Period|Other|4|||
162888467|NCT00877006|588290927|FG001|Treatment Period|Other|4|||
162888468|NCT00877006|588290926|FG000|Treatment Period|Randomized but Not Treated|3|||
162888469|NCT00877006|588290927|FG001|Treatment Period|Randomized but Not Treated|8|||
162888470|NCT00877006|588290926|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
162888471|NCT00877006|588290927|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
162888472|NCT00877006|588290926|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
162888473|NCT00877006|588290927|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
162888474|NCT00877006|588290926|FG000|Long-Term Follow-up Period|Death|26|||
162888475|NCT00877006|588290927|FG001|Long-Term Follow-up Period|Death|18|||
162888476|NCT00877006|588290926|FG000|Long-Term Follow-up Period|Other|7|||
162888477|NCT00877006|588290927|FG001|Long-Term Follow-up Period|Other|9|||
162888478|NCT04671342|588290928|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
162888479|NCT04671342|588290928|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
162888480|NCT04671342|588290928|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
162888481|NCT04671342|588290928|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
162888482|NCT04671342|588290928|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
162888483|NCT04671342|588290928|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
162888484|NCT03583606|588290929|FG000|Overall Study|Lost to Follow-up|0|||
162888485|NCT03583606|588290930|FG001|Overall Study|Lost to Follow-up|1|||
162888486|NCT03583606|588290931|FG002|Overall Study|Lost to Follow-up|0|||
162888487|NCT03583606|588290929|FG000|Overall Study|Ineligible at baseline|1|||
162888488|NCT03583606|588290930|FG001|Overall Study|Ineligible at baseline|0|||
162888489|NCT03583606|588290931|FG002|Overall Study|Ineligible at baseline|0|||
162888490|NCT00817206|588290932|FG000|Overall Study|Adverse Event|10|||
162888491|NCT00817206|588290933|FG001|Overall Study|Adverse Event|3|||
162888492|NCT00817206|588290932|FG000|Overall Study|Protocol Violation|0|||
162963624|NCT00294047|588566545|FG000|Month 84|Lost to Follow-up|187|||
162888493|NCT00817206|588290933|FG001|Overall Study|Protocol Violation|2|||
162888494|NCT00817206|588290932|FG000|Overall Study|Lost to Follow-up|0|||
162888495|NCT00817206|588290933|FG001|Overall Study|Lost to Follow-up|1|||
162888496|NCT00817206|588290932|FG000|Overall Study|Death|2|||
162888497|NCT00817206|588290933|FG001|Overall Study|Death|0|||
162888498|NCT00817206|588290932|FG000|Overall Study|Withdrawal by Subject|7|||
162888499|NCT00817206|588290933|FG001|Overall Study|Withdrawal by Subject|3|||
162888500|NCT00817206|588290932|FG000|Overall Study|Physician Decision|2|||
162888501|NCT00817206|588290933|FG001|Overall Study|Physician Decision|0|||
162888502|NCT00126581|588290934|FG000|Overall Study|Adverse Event|3|||
162888503|NCT00126581|588290935|FG001|Overall Study|Adverse Event|7|||
162888504|NCT00126581|588290934|FG000|Overall Study|Death|3|||
162888505|NCT00126581|588290935|FG001|Overall Study|Death|2|||
162888506|NCT00126581|588290934|FG000|Overall Study|Withdrawal by Subject|1|||
162888507|NCT00126581|588290935|FG001|Overall Study|Withdrawal by Subject|4|||
162888508|NCT00126581|588290934|FG000|Overall Study|Alternative therapy|3|||
162888509|NCT00126581|588290935|FG001|Overall Study|Alternative therapy|3|||
162888510|NCT00126581|588290934|FG000|Overall Study|Other illness/MD discretion|3|||
162888511|NCT00126581|588290935|FG001|Overall Study|Other illness/MD discretion|4|||
162888512|NCT00793182|588290936|FG000|Overall Study|Adverse Event|0|||
162888513|NCT00793182|588290937|FG001|Overall Study|Adverse Event|1|||
162888514|NCT03728140|588290938|FG000|Overall Study|Abnormal embryo transfer operation|10|||
162888515|NCT03728140|588290939|FG001|Overall Study|Abnormal embryo transfer operation|7|||
162888516|NCT02273037|588290941|FG000|Overall Study|Lost to Follow-up|1|||
162888517|NCT02273037|588290942|FG001|Overall Study|Lost to Follow-up|0|||
162888518|NCT02273037|588290941|FG000|Overall Study|Delivered before monitoring initiated|1|||
162888519|NCT02273037|588290942|FG001|Overall Study|Delivered before monitoring initiated|3|||
162888520|NCT02273037|588290941|FG000|Overall Study|Breech delivery|2|||
162888521|NCT02273037|588290942|FG001|Overall Study|Breech delivery|3|||
162888522|NCT02273037|588290941|FG000|Overall Study|Multiple delivery|2|||
162888523|NCT02273037|588290942|FG001|Overall Study|Multiple delivery|2|||
162888524|NCT02273037|588290941|FG000|Overall Study|Other complication|2|||
162888525|NCT02273037|588290942|FG001|Overall Study|Other complication|0|||
162888526|NCT00851253|588290943|FG000|Overall Study|Disease Progression|1|||
162888527|NCT00851253|588290944|FG001|Overall Study|Disease Progression|0|||
162888528|NCT03657810|588290949|FG000|Overall Study|Adverse Event|0|||
162888529|NCT03657810|588290950|FG001|Overall Study|Adverse Event|1|||
162888530|NCT03657810|588290951|FG002|Overall Study|Adverse Event|0|||
162888531|NCT03657810|588290949|FG000|Overall Study|Lack of Efficacy|4|||
162888532|NCT03657810|588290950|FG001|Overall Study|Lack of Efficacy|1|||
162888533|NCT03657810|588290951|FG002|Overall Study|Lack of Efficacy|3|||
162888534|NCT03657810|588290949|FG000|Overall Study|Protocol Violation|1|||
162888535|NCT03657810|588290950|FG001|Overall Study|Protocol Violation|0|||
162888536|NCT03657810|588290951|FG002|Overall Study|Protocol Violation|0|||
162888537|NCT03657810|588290949|FG000|Overall Study|Lost to Follow-up|0|||
162888538|NCT03657810|588290950|FG001|Overall Study|Lost to Follow-up|1|||
162888539|NCT03657810|588290951|FG002|Overall Study|Lost to Follow-up|0|||
162888540|NCT03657810|588290949|FG000|Overall Study|Not provided|0|||
162888541|NCT03657810|588290950|FG001|Overall Study|Not provided|1|||
162888542|NCT03657810|588290951|FG002|Overall Study|Not provided|0|||
162888543|NCT00574496|588290955|FG000|Overall Study|Withdrawal by Subject|1|||
162888544|NCT01969799|588290956|FG000|Overall Study|Adverse Event|0|||
162888545|NCT01969799|588290957|FG001|Overall Study|Adverse Event|1|||
162888546|NCT01969799|588290956|FG000|Overall Study|Death|16|||
162888547|NCT01969799|588290957|FG001|Overall Study|Death|11|||
162888548|NCT01969799|588290956|FG000|Overall Study|Lost to Follow-up|0|||
162888549|NCT01969799|588290957|FG001|Overall Study|Lost to Follow-up|2|||
162888550|NCT01969799|588290956|FG000|Overall Study|Physician Decision|1|||
162888551|NCT01969799|588290957|FG001|Overall Study|Physician Decision|0|||
162888552|NCT02227108|588290960|FG000|Overall Study|Did not receive treatment|2|||
162888553|NCT02227108|588290960|FG000|Overall Study|Other|3|||
162888554|NCT02227108|588290960|FG000|Overall Study|Progressive disease|17|||
162888555|NCT02227108|588290960|FG000|Overall Study|Initiation of alternative therapy|2|||
162888556|NCT02227108|588290960|FG000|Overall Study|Investigator discretion|1|||
162963625|NCT00294047|588566546|FG001|Month 84|Lost to Follow-up|190|||
162963626|NCT00294047|588566545|FG000|Month 84|Absent Cervix|2|||
162963627|NCT00294047|588566546|FG001|Month 84|Absent Cervix|0|||
162963628|NCT00294047|588566545|FG000|Month 84|Work related reasons|4|||
162963629|NCT00294047|588566546|FG001|Month 84|Work related reasons|2|||
162963630|NCT00294047|588566545|FG000|Month 84|Center closed, subject did not transfer|1|||
162963631|NCT00294047|588566546|FG001|Month 84|Center closed, subject did not transfer|0|||
162888557|NCT02227108|588290960|FG000|Overall Study|Adverse Event|6|||
162888558|NCT02486952|588290961|FG000|Overall Study|Not Started Induction Therapy|3|||
162888559|NCT02486952|588290961|FG000|Overall Study|Adverse Event|1|||
162888560|NCT02486952|588290961|FG000|Overall Study|Death|15|||
162963632|NCT00294047|588566545|FG000|Month 84|Family problems|2|||
162888561|NCT02486952|588290961|FG000|Overall Study|Lack of Efficacy|3|||
162888562|NCT02486952|588290961|FG000|Overall Study|Lost to Follow-up|26|||
162888563|NCT02486952|588290961|FG000|Overall Study|Other|2|||
162888564|NCT03589885|588290962|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
162888565|NCT03589885|588290963|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
162888566|NCT03589885|588290964|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
162888567|NCT03589885|588290965|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
162888568|NCT03589885|588290966|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
162888569|NCT03589885|588290962|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
162888570|NCT03589885|588290963|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
162888571|NCT03589885|588290964|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
162888572|NCT03589885|588290965|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
162888573|NCT03589885|588290966|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
162888574|NCT03589885|588290962|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
162888575|NCT03589885|588290963|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
162888576|NCT03589885|588290964|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
162888577|NCT03589885|588290965|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
162888578|NCT03589885|588290966|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
162888579|NCT03589885|588290962|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
162888580|NCT03589885|588290963|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
162888581|NCT03589885|588290964|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
162888582|NCT03589885|588290965|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
162888583|NCT03589885|588290966|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
162888584|NCT03589885|588290962|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
162888585|NCT03589885|588290963|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
162888586|NCT03589885|588290964|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
162888587|NCT03589885|588290965|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
162888588|NCT03589885|588290966|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
162888589|NCT03589885|588290962|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
162888590|NCT03589885|588290963|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
162888591|NCT03589885|588290964|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
162888592|NCT03589885|588290965|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
162888593|NCT03589885|588290966|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
162888594|NCT03589885|588290962|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
162888595|NCT03589885|588290963|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
162888596|NCT03589885|588290964|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
162888597|NCT03589885|588290965|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
162888598|NCT03589885|588290966|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
162888599|NCT03589885|588290962|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
162888600|NCT03589885|588290963|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
162888601|NCT03589885|588290964|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
162888602|NCT03589885|588290965|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
162888603|NCT03589885|588290966|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
162888604|NCT04111107|588290967|FG000|Overall Study|Withdrawal by Subject|6|||
162888605|NCT04111107|588290967|FG000|Overall Study|Declining Health|5|||
162888606|NCT01928485|588290968|FG000|Overall Study|Physician Decision|0|||
162888607|NCT01928485|588290969|FG001|Overall Study|Physician Decision|1|||
162888608|NCT00039741|588290970|FG000|Overall Study|Death|0|||
162888609|NCT00039741|588290971|FG001|Overall Study|Death|1|||
162888610|NCT00039741|588290972|FG002|Overall Study|Death|0|||
162888611|NCT00039741|588290973|FG003|Overall Study|Death|0|||
162888612|NCT00039741|588290970|FG000|Overall Study|Lost to Follow-up|3|||
162888613|NCT00039741|588290971|FG001|Overall Study|Lost to Follow-up|1|||
162888614|NCT00039741|588290972|FG002|Overall Study|Lost to Follow-up|5|||
162888615|NCT00039741|588290973|FG003|Overall Study|Lost to Follow-up|2|||
162888616|NCT00039741|588290970|FG000|Overall Study|Confounding medical condition|1|||
162888617|NCT00039741|588290971|FG001|Overall Study|Confounding medical condition|0|||
162888618|NCT00039741|588290972|FG002|Overall Study|Confounding medical condition|0|||
162888619|NCT00039741|588290973|FG003|Overall Study|Confounding medical condition|0|||
162888620|NCT00039741|588290970|FG000|Overall Study|Not able to get to clinic|5|||
162888621|NCT00039741|588290971|FG001|Overall Study|Not able to get to clinic|2|||
162888622|NCT00039741|588290972|FG002|Overall Study|Not able to get to clinic|0|||
162888623|NCT00039741|588290973|FG003|Overall Study|Not able to get to clinic|3|||
162888624|NCT00039741|588290970|FG000|Overall Study|Moved|3|||
162888625|NCT00039741|588290971|FG001|Overall Study|Moved|2|||
162888626|NCT00039741|588290972|FG002|Overall Study|Moved|3|||
162888627|NCT00039741|588290973|FG003|Overall Study|Moved|6|||
162888628|NCT00039741|588290970|FG000|Overall Study|Non-compliance with protocol|1|||
162888629|NCT00039741|588290971|FG001|Overall Study|Non-compliance with protocol|0|||
162888630|NCT00039741|588290972|FG002|Overall Study|Non-compliance with protocol|1|||
162888631|NCT00039741|588290973|FG003|Overall Study|Non-compliance with protocol|0|||
162888632|NCT00039741|588290970|FG000|Overall Study|Withdrew consent|0|||
162888633|NCT00039741|588290971|FG001|Overall Study|Withdrew consent|5|||
162888634|NCT00039741|588290972|FG002|Overall Study|Withdrew consent|0|||
162888635|NCT00039741|588290973|FG003|Overall Study|Withdrew consent|1|||
162888636|NCT00039741|588290970|FG000|Overall Study|Missed final visit|2|||
162888637|NCT00039741|588290971|FG001|Overall Study|Missed final visit|1|||
162888638|NCT00039741|588290972|FG002|Overall Study|Missed final visit|2|||
162888639|NCT00039741|588290973|FG003|Overall Study|Missed final visit|2|||
162888640|NCT00946881|588290976|FG000|First Treatment|Withdrawal by Subject|1|||
162888641|NCT00946881|588290976|FG000|First Treatment|Patient relocated to another state|1|||
162888642|NCT00946881|588290976|FG000|Retreatment|Withdrawal by Subject|1|||
162888643|NCT00293423|588290977|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
162888644|NCT00293423|588290978|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
162888645|NCT00293423|588290977|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
162888646|NCT00293423|588290978|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
162888647|NCT00293423|588290977|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
162888648|NCT00293423|588290978|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
162888649|NCT00293423|588290977|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
162888650|NCT00293423|588290978|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
162888651|NCT00293423|588290977|FG000|Surgical Resection|processing error during surgical resection|1|||
162888652|NCT00293423|588290978|FG001|Surgical Resection|processing error during surgical resection|0|||
162888653|NCT00293423|588290977|FG000|Surgical Resection|Withdrawal by Subject|4|||
162888654|NCT00293423|588290978|FG001|Surgical Resection|Withdrawal by Subject|0|||
162888655|NCT00293423|588290977|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
162963633|NCT00294047|588566546|FG001|Month 84|Family problems|2|||
162963634|NCT00294047|588566545|FG000|Month 84|Lack of time|3|||
162963635|NCT00294047|588566546|FG001|Month 84|Lack of time|1|||
162963636|NCT00294047|588566545|FG000|Month 84|Personal reason|2|||
162963637|NCT00294047|588566546|FG001|Month 84|Personal reason|4|||
162963638|NCT00294047|588566545|FG000|Month 84|Subject does not want male physician|1|||
162963639|NCT00294047|588566546|FG001|Month 84|Subject does not want male physician|0|||
162963640|NCT00294047|588566545|FG000|Month 84|Transport reimbursement delayed|0|||
162963641|NCT00294047|588566546|FG001|Month 84|Transport reimbursement delayed|1|||
162963642|NCT00294047|588566545|FG000|Month 84|Unable to reach study site|1|||
162963643|NCT00294047|588566546|FG001|Month 84|Unable to reach study site|0|||
162963644|NCT00294047|588566545|FG000|Month 84|Under investigation locally|1|||
162963645|NCT00294047|588566546|FG001|Month 84|Under investigation locally|0|||
162617741|NCT01254292|587317799|FG001|Comparative Phase|Wish for pregnancy|6|||
162617742|NCT01254292|587317798|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
162617743|NCT01254292|587317799|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
162617744|NCT01254292|587317798|FG000|LCS12 Extension Phase|Adverse Event|9|||
162617745|NCT01254292|587317799|FG001|LCS12 Extension Phase|Adverse Event|0|||
163050804|NCT02155699|588893678|FG000|Overall Study|Lost to Follow-up|0|||
163050805|NCT02155699|588893679|FG001|Overall Study|Lost to Follow-up|0|||
163050806|NCT02155699|588893680|FG002|Overall Study|Lost to Follow-up|0|||
163050807|NCT02155699|588893681|FG003|Overall Study|Lost to Follow-up|3|||
162617746|NCT01254292|587317798|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
162617747|NCT01254292|587317799|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
162617748|NCT01254292|587317798|FG000|LCS12 Extension Phase|Other unknown|4|||
162617749|NCT01254292|587317799|FG001|LCS12 Extension Phase|Other unknown|0|||
162617750|NCT01254292|587317798|FG000|LCS12 Extension Phase|Pregnancy|2|||
162617751|NCT01254292|587317799|FG001|LCS12 Extension Phase|Pregnancy|0|||
162617752|NCT01254292|587317798|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
162617753|NCT01254292|587317799|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
162617754|NCT00285818|587317800|FG000|Overall Study|Withdrawal by Subject|3|||
162617755|NCT00285818|587317801|FG001|Overall Study|Withdrawal by Subject|2|||
162617756|NCT00285818|587317800|FG000|Overall Study|Lost to Follow-up|1|||
162617757|NCT00285818|587317801|FG001|Overall Study|Lost to Follow-up|0|||
162617758|NCT02083081|587317802|FG000|Overall Study|Lost to Follow-up|31|||
162617759|NCT02083081|587317803|FG001|Overall Study|Lost to Follow-up|9|||
162617760|NCT03109847|587317811|FG000|Overall Study|Withdrawal by Subject|1|||
162617761|NCT03109847|587317812|FG001|Overall Study|Withdrawal by Subject|0|||
162617762|NCT01268150|587317813|FG000|Treatment Phase|Progression of disease|18|||
162617763|NCT01268150|587317813|FG000|Treatment Phase|Adverse Event|3|||
162617764|NCT01268150|587317813|FG000|Treatment Phase|Withdrawal by Subject|3|||
162617765|NCT01268150|587317813|FG000|Treatment Phase|Other|4|||
162617766|NCT01268150|587317813|FG000|Extension Phase|Adverse Event|3|||
162617767|NCT01268150|587317813|FG000|Extension Phase|Disease progression|18|||
162617768|NCT01268150|587317813|FG000|Extension Phase|Other|6|||
162617769|NCT01672736|587317814|FG000|Overall Study|Available drug expired on 31 May 16|3|||
162617770|NCT04209348|587317815|FG000|Overall Study|Lost to Follow-up|1|||
162617771|NCT04209348|587317816|FG001|Overall Study|Lost to Follow-up|0|||
162617772|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
162617773|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
162617774|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Death|1|||
162617775|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Death|0|||
162617776|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
162617777|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
162617778|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
162617779|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
162617780|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
162617781|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
162617782|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
162617783|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
162617784|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
162617785|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
162617786|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
162617787|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
162617788|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
162617789|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
162617790|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
162617791|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
162617792|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
162617793|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
162617794|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
162617795|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
162617796|NCT02927262|587317817|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
162617797|NCT02927262|587317818|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
162617798|NCT02927262|587317817|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
162617799|NCT02927262|587317818|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
162888656|NCT00293423|588290978|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
162888657|NCT03571256|588290983|FG000|Overall Study|Adverse Event|3|||
162888658|NCT03571256|588290984|FG001|Overall Study|Adverse Event|0|||
162888659|NCT03571256|588290985|FG002|Overall Study|Adverse Event|1|||
162888660|NCT03571256|588290983|FG000|Overall Study|Withdrawal by Subject|3|||
162888661|NCT03571256|588290984|FG001|Overall Study|Withdrawal by Subject|1|||
162888662|NCT03571256|588290985|FG002|Overall Study|Withdrawal by Subject|1|||
162617800|NCT02927262|587317817|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
162617801|NCT02927262|587317818|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
162617802|NCT02927262|587317817|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
162617803|NCT02927262|587317818|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
162617804|NCT02913612|587317819|FG000|Overall Study|Lost to Follow-up|6|||
162617805|NCT02913612|587317820|FG001|Overall Study|Lost to Follow-up|5|||
162888663|NCT03571256|588290983|FG000|Overall Study|Other than specified|0|||
162617806|NCT02913612|587317821|FG002|Overall Study|Lost to Follow-up|2|||
162617807|NCT02913612|587317822|FG003|Overall Study|Lost to Follow-up|0|||
162617808|NCT02913612|587317819|FG000|Overall Study|Physician Decision|1|||
162617809|NCT02913612|587317820|FG001|Overall Study|Physician Decision|4|||
162617810|NCT02913612|587317821|FG002|Overall Study|Physician Decision|1|||
162617811|NCT02913612|587317822|FG003|Overall Study|Physician Decision|0|||
162617812|NCT02913612|587317819|FG000|Overall Study|Withdrawal by Subject|2|||
162617813|NCT02913612|587317820|FG001|Overall Study|Withdrawal by Subject|4|||
162617814|NCT02913612|587317821|FG002|Overall Study|Withdrawal by Subject|0|||
162617815|NCT02913612|587317822|FG003|Overall Study|Withdrawal by Subject|0|||
162617816|NCT02913612|587317819|FG000|Overall Study|Hemangioma resolved|1|||
162617817|NCT02913612|587317820|FG001|Overall Study|Hemangioma resolved|0|||
162617818|NCT02913612|587317821|FG002|Overall Study|Hemangioma resolved|0|||
162617819|NCT02913612|587317822|FG003|Overall Study|Hemangioma resolved|0|||
162617820|NCT02913612|587317819|FG000|Overall Study|Local IRB decision|1|||
162617821|NCT02913612|587317820|FG001|Overall Study|Local IRB decision|0|||
162617822|NCT02913612|587317821|FG002|Overall Study|Local IRB decision|0|||
162617823|NCT02913612|587317822|FG003|Overall Study|Local IRB decision|0|||
162617824|NCT02913612|587317819|FG000|Overall Study|Study drug non-compliance|1|||
162617825|NCT02913612|587317820|FG001|Overall Study|Study drug non-compliance|1|||
162617826|NCT02913612|587317821|FG002|Overall Study|Study drug non-compliance|0|||
162617827|NCT02913612|587317822|FG003|Overall Study|Study drug non-compliance|0|||
162617828|NCT02913612|587317819|FG000|Overall Study|Insurance issues|0|||
162617829|NCT02913612|587317820|FG001|Overall Study|Insurance issues|1|||
162617830|NCT02913612|587317821|FG002|Overall Study|Insurance issues|0|||
162617831|NCT02913612|587317822|FG003|Overall Study|Insurance issues|0|||
162617832|NCT02913612|587317819|FG000|Overall Study|Needed to treat second hemangioma|0|||
162617833|NCT02913612|587317820|FG001|Overall Study|Needed to treat second hemangioma|1|||
162617834|NCT02913612|587317821|FG002|Overall Study|Needed to treat second hemangioma|0|||
162617835|NCT02913612|587317822|FG003|Overall Study|Needed to treat second hemangioma|0|||
162617836|NCT02913612|587317819|FG000|Overall Study|Study completion criteria not met|0|||
162617837|NCT02913612|587317820|FG001|Overall Study|Study completion criteria not met|1|||
162617838|NCT02913612|587317821|FG002|Overall Study|Study completion criteria not met|0|||
162617839|NCT02913612|587317822|FG003|Overall Study|Study completion criteria not met|0|||
162617840|NCT02913612|587317819|FG000|Overall Study|Ineligible|0|||
162617841|NCT02913612|587317820|FG001|Overall Study|Ineligible|1|||
162617842|NCT02913612|587317821|FG002|Overall Study|Ineligible|0|||
162617843|NCT02913612|587317822|FG003|Overall Study|Ineligible|0|||
162617844|NCT04251273|587317823|FG000|Overall Study|Lost to Follow-up|331|||
162617845|NCT04251273|587317824|FG001|Overall Study|Lost to Follow-up|290|||
162617846|NCT04402060|587317825|FG000|Overall Study|Death|1|||
162617847|NCT04402060|587317826|FG001|Overall Study|Death|12|||
162888664|NCT03571256|588290984|FG001|Overall Study|Other than specified|1|||
162888665|NCT03571256|588290985|FG002|Overall Study|Other than specified|1|||
162888666|NCT03571256|588290983|FG000|Overall Study|Protocol Violation|0|||
162888667|NCT03571256|588290984|FG001|Overall Study|Protocol Violation|1|||
162888668|NCT03571256|588290985|FG002|Overall Study|Protocol Violation|1|||
162888669|NCT02270684|588290986|FG000|Overall Study|Lost to Follow-up|0|||
162617848|NCT04402060|587317827|FG002|Overall Study|Death|7|||
162617849|NCT04402060|587317825|FG000|Overall Study|Adverse Event|0|||
162617850|NCT04402060|587317826|FG001|Overall Study|Adverse Event|0|||
162888670|NCT02270684|588290987|FG001|Overall Study|Lost to Follow-up|3|||
162888671|NCT02270684|588290986|FG000|Overall Study|Study terminated|1|||
162888672|NCT02270684|588290987|FG001|Overall Study|Study terminated|0|||
162888673|NCT02247401|588290988|FG000|Overall Study|Adverse Event|1|||
162617851|NCT04402060|587317827|FG002|Overall Study|Adverse Event|1|||
162617852|NCT04402060|587317825|FG000|Overall Study|Withdrawal by Subject|0|||
162617853|NCT04402060|587317826|FG001|Overall Study|Withdrawal by Subject|1|||
162617854|NCT04402060|587317827|FG002|Overall Study|Withdrawal by Subject|2|||
162617855|NCT04402060|587317825|FG000|Overall Study|Sponsor Request|0|||
162617856|NCT04402060|587317826|FG001|Overall Study|Sponsor Request|2|||
162617857|NCT04402060|587317827|FG002|Overall Study|Sponsor Request|0|||
162888674|NCT02247401|588290989|FG001|Overall Study|Adverse Event|0|||
162617858|NCT04402060|587317825|FG000|Overall Study|Physician Decision|0|||
162617859|NCT04402060|587317826|FG001|Overall Study|Physician Decision|0|||
162617860|NCT04402060|587317827|FG002|Overall Study|Physician Decision|1|||
162617861|NCT04402060|587317825|FG000|Overall Study|Other|0|||
163050808|NCT02155699|588893678|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
162617862|NCT04402060|587317826|FG001|Overall Study|Other|1|||
162617863|NCT04402060|587317827|FG002|Overall Study|Other|0|||
162617864|NCT00936611|587317828|FG000|Overall Study|Progressive Disease|3|||
162617865|NCT00936611|587317828|FG000|Overall Study|New Systemic Therapy|22|||
162617866|NCT00936611|587317828|FG000|Overall Study|Lost to Follow-up|1|||
162617867|NCT00936611|587317828|FG000|Overall Study|Withdrawal by Subject|2|||
162617868|NCT00936611|587317828|FG000|Overall Study|Still on Follow-up|1|||
162617869|NCT00936611|587317828|FG000|Overall Study|Still on Active Therapy|7|||
162617870|NCT00936611|587317828|FG000|Overall Study|Ineligible for Study Drug|3|||
162617871|NCT02282358|587317837|FG000|Overall Study|Nonevaluable|1|||
162888675|NCT02247401|588290990|FG002|Overall Study|Adverse Event|0|||
162888676|NCT02247401|588290988|FG000|Overall Study|Withdrawal by Subject|4|||
162888677|NCT02247401|588290989|FG001|Overall Study|Withdrawal by Subject|1|||
162888678|NCT02247401|588290990|FG002|Overall Study|Withdrawal by Subject|1|||
162888679|NCT02247401|588290988|FG000|Overall Study|Lost to Follow-up|1|||
162888680|NCT02247401|588290989|FG001|Overall Study|Lost to Follow-up|1|||
162888681|NCT02247401|588290990|FG002|Overall Study|Lost to Follow-up|1|||
162888682|NCT02807363|588290991|FG000|Dosing Period|Adverse Event|0|||
162888683|NCT02807363|588290992|FG001|Dosing Period|Adverse Event|1|||
162888684|NCT02807363|588290993|FG002|Dosing Period|Adverse Event|0|||
162888685|NCT02807363|588290994|FG003|Dosing Period|Adverse Event|0|||
162888686|NCT02188719|588290996|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
162888687|NCT02188719|588290997|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
162888688|NCT02188719|588290998|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
162888689|NCT02188719|588290999|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
162888690|NCT00192036|588291000|FG000|Overall Study|Protocol Violation|3|||
162888691|NCT00192036|588291000|FG000|Overall Study|Adverse Event|6|||
162888692|NCT00192036|588291000|FG000|Overall Study|Patient/Physician Perception|1|||
162888693|NCT00192036|588291000|FG000|Overall Study|Objective Tumor Progression|4|||
162963646|NCT00294047|588566545|FG000|Month 84|Visit missed|0|||
162963647|NCT00294047|588566546|FG001|Month 84|Visit missed|1|||
162963648|NCT00294047|588566545|FG000|Month 84|No consent for Month 84 Follow-up|731|||
162963649|NCT00294047|588566546|FG001|Month 84|No consent for Month 84 Follow-up|754|||
162963650|NCT00506831|588566547|FG000|Overall Study|Death|1|||
162963651|NCT00506831|588566547|FG000|Overall Study|Withdrawal by Subject|1|||
162963652|NCT00608322|588566553|FG000|Overall Study|Death|2|||
162963653|NCT00608322|588566554|FG001|Overall Study|Death|1|||
162963654|NCT04002648|588566555|FG000|Overall Study|Lost to Follow-up|2|||
162963655|NCT04002648|588566556|FG001|Overall Study|Lost to Follow-up|0|||
162963656|NCT02280863|588566567|FG000|Integrated Platform|Met stopping criteria|0|||
162963657|NCT02280863|588566568|FG001|Integrated Platform|Met stopping criteria|1|||
162963658|NCT03158727|588566571|FG000|Overall Study|Withdrawal by Subject|2|||
162963659|NCT03158727|588566572|FG001|Overall Study|Withdrawal by Subject|6|||
162963660|NCT03158727|588566571|FG000|Overall Study|Death|11|||
162963661|NCT03158727|588566572|FG001|Overall Study|Death|12|||
162963662|NCT03158727|588566571|FG000|Overall Study|Lost to Follow-up|1|||
162963663|NCT03158727|588566572|FG001|Overall Study|Lost to Follow-up|0|||
162963664|NCT03158727|588566571|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
162963665|NCT03158727|588566572|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
162963666|NCT03158727|588566571|FG000|Overall Study|Visit 11 not done by mistake|0|||
162963667|NCT03158727|588566572|FG001|Overall Study|Visit 11 not done by mistake|1|||
162963668|NCT03158727|588566571|FG000|Overall Study|Enrolled, not treated|1|||
162963669|NCT03158727|588566572|FG001|Overall Study|Enrolled, not treated|0|||
162963670|NCT00985439|588566573|FG000|Overall Study|Adverse Event|0|||
162963671|NCT00985439|588566574|FG001|Overall Study|Adverse Event|0|||
162963672|NCT00985439|588566575|FG002|Overall Study|Adverse Event|1|||
162963673|NCT00985439|588566576|FG003|Overall Study|Adverse Event|0|||
162963674|NCT01174186|588566577|FG000|Overall Study|Lost to Follow-up|0|||
162617872|NCT01898208|587317838|FG000|Overall Study|Positive blood culture|17|||
162617873|NCT01898208|587317839|FG001|Overall Study|Positive blood culture|23|||
162617874|NCT01898208|587317840|FG002|Overall Study|Positive blood culture|15|||
162617875|NCT01898208|587317838|FG000|Overall Study|Death/comfort care within 24 hours|10|||
162888694|NCT00192036|588291000|FG000|Overall Study|Clinical Disease Progression|1|||
162888695|NCT00192036|588291000|FG000|Overall Study|Death|1|||
162888696|NCT00192036|588291000|FG000|Overall Study|Unknown or Not Specified|5|||
162963675|NCT01174186|588566578|FG001|Overall Study|Lost to Follow-up|1|||
162963676|NCT01174186|588566577|FG000|Overall Study|Withdrawal by Subject|0|||
162963677|NCT01174186|588566578|FG001|Overall Study|Withdrawal by Subject|2|||
162963678|NCT00918684|588566579|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
162963679|NCT00918684|588566579|FG000|Treatment Phase|Lack of Efficacy|6|||
162963680|NCT00918684|588566579|FG000|Treatment Phase|Lost to Follow-up|2|||
162617876|NCT01898208|587317839|FG001|Overall Study|Death/comfort care within 24 hours|9|||
162617877|NCT01898208|587317840|FG002|Overall Study|Death/comfort care within 24 hours|8|||
162617878|NCT01898208|587317838|FG000|Overall Study|Negative Gram Stain|6|||
162617879|NCT01898208|587317839|FG001|Overall Study|Negative Gram Stain|9|||
162617880|NCT01898208|587317840|FG002|Overall Study|Negative Gram Stain|6|||
162617881|NCT01898208|587317838|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
162617882|NCT01898208|587317839|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
162617883|NCT01898208|587317840|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
162617884|NCT01898208|587317838|FG000|Overall Study|System/Technical Error|1|||
162617885|NCT01898208|587317839|FG001|Overall Study|System/Technical Error|2|||
162617886|NCT01898208|587317840|FG002|Overall Study|System/Technical Error|3|||
162617887|NCT01898208|587317838|FG000|Overall Study|Lost to Follow-up|3|||
162617888|NCT01898208|587317839|FG001|Overall Study|Lost to Follow-up|1|||
162617889|NCT01898208|587317840|FG002|Overall Study|Lost to Follow-up|1|||
162617890|NCT03780543|587317842|FG000|Overall Study|Adverse Event|1|||
162617891|NCT03780543|587317843|FG001|Overall Study|Adverse Event|0|||
162617892|NCT03780543|587317844|FG002|Overall Study|Adverse Event|2|||
162617893|NCT03780543|587317842|FG000|Overall Study|Lost to Follow-up|2|||
162617894|NCT03780543|587317843|FG001|Overall Study|Lost to Follow-up|0|||
162617895|NCT03780543|587317844|FG002|Overall Study|Lost to Follow-up|1|||
162617896|NCT03780543|587317842|FG000|Overall Study|Study terminated by Sponsor|8|||
162617897|NCT03780543|587317843|FG001|Overall Study|Study terminated by Sponsor|7|||
162617898|NCT03780543|587317844|FG002|Overall Study|Study terminated by Sponsor|13|||
162617899|NCT03780543|587317842|FG000|Overall Study|Withdrawal by Subject|1|||
162617900|NCT03780543|587317843|FG001|Overall Study|Withdrawal by Subject|8|||
162617901|NCT03780543|587317844|FG002|Overall Study|Withdrawal by Subject|1|||
162617902|NCT03780543|587317842|FG000|Overall Study|Noncompliance with study drug|1|||
162617903|NCT03780543|587317843|FG001|Overall Study|Noncompliance with study drug|0|||
162617904|NCT03780543|587317844|FG002|Overall Study|Noncompliance with study drug|0|||
162617905|NCT01033851|587317845|FG000|Overall Study|Withdrawal by Subject|3|||
162617906|NCT01033851|587317846|FG001|Overall Study|Withdrawal by Subject|7|||
162617907|NCT02158975|587317847|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
163050809|NCT02155699|588893679|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
163050810|NCT02155699|588893680|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
163050811|NCT02155699|588893681|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
162617908|NCT02728596|587317850|FG000|Overall Study|Refusal unrelated to adverse event|3|||
162617909|NCT02728596|587317851|FG001|Overall Study|Refusal unrelated to adverse event|6|||
162617910|NCT02728596|587317852|FG002|Overall Study|Refusal unrelated to adverse event|7|||
162617911|NCT02728596|587317853|FG003|Overall Study|Refusal unrelated to adverse event|7|||
162617912|NCT02728596|587317850|FG000|Overall Study|Death|44|||
162617913|NCT02728596|587317851|FG001|Overall Study|Death|42|||
162617914|NCT02728596|587317852|FG002|Overall Study|Death|123|||
162617915|NCT02728596|587317853|FG003|Overall Study|Death|68|||
162617916|NCT04430738|587317854|FG000|Phase 1: Dose Escalation|Death|1|||
162617917|NCT04430738|587317855|FG001|Phase 1: Dose Escalation|Death|4|||
162617918|NCT04430738|587317856|FG002|Phase 1: Dose Escalation|Death|4|||
162617919|NCT04430738|587317857|FG003|Phase 1: Dose Escalation|Death|1|||
162617920|NCT04430738|587317858|FG004|Phase 1: Dose Escalation|Death|6|||
162617921|NCT04430738|587317859|FG005|Phase 1: Dose Escalation|Death|0|||
162617922|NCT04430738|587317854|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
162617923|NCT04430738|587317855|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162617924|NCT04430738|587317856|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
162617925|NCT04430738|587317857|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162617926|NCT04430738|587317858|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162617927|NCT04430738|587317859|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
162617928|NCT04430738|587317854|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162617929|NCT04430738|587317855|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
162617930|NCT04430738|587317856|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162617931|NCT04430738|587317857|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
162617932|NCT04430738|587317858|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162617933|NCT04430738|587317859|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162617934|NCT04430738|587317854|FG000|Phase 1: Dose Escalation|Other|1|||
162617935|NCT04430738|587317855|FG001|Phase 1: Dose Escalation|Other|0|||
162708249|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
162617936|NCT04430738|587317856|FG002|Phase 1: Dose Escalation|Other|0|||
162617937|NCT04430738|587317857|FG003|Phase 1: Dose Escalation|Other|0|||
162617938|NCT04430738|587317858|FG004|Phase 1: Dose Escalation|Other|0|||
162617939|NCT04430738|587317859|FG005|Phase 1: Dose Escalation|Other|0|||
162617940|NCT04430738|587317854|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162617941|NCT04430738|587317855|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162617942|NCT04430738|587317856|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162617943|NCT04430738|587317857|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162617944|NCT04430738|587317858|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162617945|NCT04430738|587317859|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
162617946|NCT04430738|587317854|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162617947|NCT04430738|587317855|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162617948|NCT04430738|587317856|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162617949|NCT04430738|587317857|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162617950|NCT04430738|587317858|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162617951|NCT04430738|587317859|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
162617952|NCT04102189|587317861|FG000|Overall Study|Withdrawal by Subject|1|||
162617953|NCT04102189|587317862|FG001|Overall Study|Withdrawal by Subject|2|||
162617954|NCT04102189|587317861|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162617955|NCT04102189|587317862|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162617956|NCT04102189|587317861|FG000|Overall Study|Lost to Follow-up|1|||
162617957|NCT04102189|587317862|FG001|Overall Study|Lost to Follow-up|0|||
162617958|NCT01543698|587319678|FG000|Phase 1b|Disease progression|2|||
162617959|NCT01543698|587319679|FG001|Phase 1b|Disease progression|4|||
162888697|NCT03371732|588291001|FG000|Overall Study|Withdrawal by Subject|9|||
162888698|NCT03371732|588291002|FG001|Overall Study|Withdrawal by Subject|3|||
162888699|NCT03371732|588291001|FG000|Overall Study|Refusal to continue|3|||
162888700|NCT03371732|588291002|FG001|Overall Study|Refusal to continue|4|||
162888701|NCT00599027|588291005|FG000|Overall Study|Withdrawal by Subject|1|||
162888702|NCT00599027|588291006|FG001|Overall Study|Withdrawal by Subject|1|||
162888703|NCT00599027|588291005|FG000|Overall Study|Adverse Event|0|||
162888704|NCT00599027|588291006|FG001|Overall Study|Adverse Event|1|||
162888705|NCT00599027|588291005|FG000|Overall Study|Treatment Failure|0|||
162888706|NCT00599027|588291006|FG001|Overall Study|Treatment Failure|1|||
162888707|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
162888708|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
162888709|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
162888710|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
162888711|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
162888712|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
162888713|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
162888714|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
162888715|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
162888716|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
162888717|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
162888718|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
162888719|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
162888720|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
162888721|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
162888722|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
162888723|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
162888724|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
162888725|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
162888726|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
162888727|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
162888728|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
162888729|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
162617960|NCT01543698|587319680|FG002|Phase 1b|Disease progression|3|||
162617961|NCT01543698|587319681|FG003|Phase 1b|Disease progression|2|||
162617962|NCT01543698|587319682|FG004|Phase 1b|Disease progression|10|||
162617963|NCT01543698|587319683|FG005|Phase 1b|Disease progression|6|||
162617964|NCT01543698|587319684|FG006|Phase 1b|Disease progression|5|||
162617965|NCT01543698|587319685|FG007|Phase 1b|Disease progression|3|||
162617966|NCT01543698|587319686|FG008|Phase 1b|Disease progression|4|||
162617967|NCT01543698|587319687|FG009|Phase 1b|Disease progression|5|||
162617968|NCT01543698|587319688|FG010|Phase 1b|Disease progression|1|||
162617969|NCT01543698|587319689|FG011|Phase 1b|Disease progression|0|||
162617970|NCT01543698|587319690|FG012|Phase 1b|Disease progression|0|||
162617971|NCT01543698|587319691|FG013|Phase 1b|Disease progression|0|||
162617972|NCT01543698|587319692|FG014|Phase 1b|Disease progression|0|||
162617973|NCT01543698|587319678|FG000|Phase 1b|Death|0|||
162617974|NCT01543698|587319679|FG001|Phase 1b|Death|0|||
162617975|NCT01543698|587319680|FG002|Phase 1b|Death|1|||
162617976|NCT01543698|587319681|FG003|Phase 1b|Death|1|||
162617977|NCT01543698|587319682|FG004|Phase 1b|Death|0|||
162617978|NCT01543698|587319683|FG005|Phase 1b|Death|0|||
162617979|NCT01543698|587319684|FG006|Phase 1b|Death|0|||
162617980|NCT01543698|587319685|FG007|Phase 1b|Death|0|||
162617981|NCT01543698|587319686|FG008|Phase 1b|Death|0|||
163050812|NCT05547386|588893682|FG000|Overall Study|Withdrawal by Subject|7|||
163050813|NCT02573259|588893691|FG000|Overall Study|Death|1|||
163050814|NCT02573259|588893692|FG001|Overall Study|Death|6|||
163050815|NCT02573259|588893693|FG002|Overall Study|Death|5|||
163050816|NCT02573259|588893694|FG003|Overall Study|Death|6|||
163050817|NCT02573259|588893695|FG004|Overall Study|Death|9|||
163050818|NCT02573259|588893696|FG005|Overall Study|Death|32|||
163050819|NCT02573259|588893697|FG006|Overall Study|Death|21|||
163050820|NCT02573259|588893691|FG000|Overall Study|Lost to Follow-up|0|||
163050821|NCT02573259|588893692|FG001|Overall Study|Lost to Follow-up|0|||
163050822|NCT02573259|588893693|FG002|Overall Study|Lost to Follow-up|0|||
162708250|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
162708251|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
162708252|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
162708253|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
163050823|NCT02573259|588893694|FG003|Overall Study|Lost to Follow-up|0|||
163050824|NCT02573259|588893695|FG004|Overall Study|Lost to Follow-up|0|||
163050825|NCT02573259|588893696|FG005|Overall Study|Lost to Follow-up|2|||
163050826|NCT02573259|588893697|FG006|Overall Study|Lost to Follow-up|1|||
163050827|NCT02573259|588893691|FG000|Overall Study|Participant refused further follow-up|0|||
163050828|NCT02573259|588893692|FG001|Overall Study|Participant refused further follow-up|2|||
163050829|NCT02573259|588893693|FG002|Overall Study|Participant refused further follow-up|1|||
163050830|NCT02573259|588893694|FG003|Overall Study|Participant refused further follow-up|0|||
162617982|NCT01543698|587319687|FG009|Phase 1b|Death|0|||
162617983|NCT01543698|587319688|FG010|Phase 1b|Death|1|||
162617984|NCT01543698|587319689|FG011|Phase 1b|Death|0|||
162617985|NCT01543698|587319690|FG012|Phase 1b|Death|0|||
162617986|NCT01543698|587319691|FG013|Phase 1b|Death|0|||
162617987|NCT01543698|587319692|FG014|Phase 1b|Death|0|||
162617988|NCT01543698|587319678|FG000|Phase 1b|Withdrawal by Subject|0|||
162617989|NCT01543698|587319679|FG001|Phase 1b|Withdrawal by Subject|1|||
162617990|NCT01543698|587319680|FG002|Phase 1b|Withdrawal by Subject|0|||
162617991|NCT01543698|587319681|FG003|Phase 1b|Withdrawal by Subject|1|||
162617992|NCT01543698|587319682|FG004|Phase 1b|Withdrawal by Subject|0|||
162617993|NCT01543698|587319683|FG005|Phase 1b|Withdrawal by Subject|0|||
162617994|NCT01543698|587319684|FG006|Phase 1b|Withdrawal by Subject|1|||
162617995|NCT01543698|587319685|FG007|Phase 1b|Withdrawal by Subject|0|||
162617996|NCT01543698|587319686|FG008|Phase 1b|Withdrawal by Subject|0|||
162617997|NCT01543698|587319687|FG009|Phase 1b|Withdrawal by Subject|0|||
162617998|NCT01543698|587319688|FG010|Phase 1b|Withdrawal by Subject|0|||
162617999|NCT01543698|587319689|FG011|Phase 1b|Withdrawal by Subject|0|||
162618000|NCT01543698|587319690|FG012|Phase 1b|Withdrawal by Subject|0|||
162618001|NCT01543698|587319691|FG013|Phase 1b|Withdrawal by Subject|0|||
162618002|NCT01543698|587319692|FG014|Phase 1b|Withdrawal by Subject|0|||
162618003|NCT01543698|587319678|FG000|Phase 1b|Adverse Event|1|||
162618004|NCT01543698|587319679|FG001|Phase 1b|Adverse Event|0|||
162618005|NCT01543698|587319680|FG002|Phase 1b|Adverse Event|0|||
162618006|NCT01543698|587319681|FG003|Phase 1b|Adverse Event|1|||
162618007|NCT01543698|587319682|FG004|Phase 1b|Adverse Event|2|||
162618008|NCT01543698|587319683|FG005|Phase 1b|Adverse Event|2|||
162618009|NCT01543698|587319684|FG006|Phase 1b|Adverse Event|0|||
162618010|NCT01543698|587319685|FG007|Phase 1b|Adverse Event|0|||
162618011|NCT01543698|587319686|FG008|Phase 1b|Adverse Event|1|||
162618012|NCT01543698|587319687|FG009|Phase 1b|Adverse Event|1|||
162618013|NCT01543698|587319688|FG010|Phase 1b|Adverse Event|2|||
162618014|NCT01543698|587319689|FG011|Phase 1b|Adverse Event|0|||
162618015|NCT01543698|587319690|FG012|Phase 1b|Adverse Event|0|||
162618016|NCT01543698|587319691|FG013|Phase 1b|Adverse Event|0|||
162618017|NCT01543698|587319692|FG014|Phase 1b|Adverse Event|0|||
162618018|NCT01543698|587319678|FG000|Phase 1b|Administrative problems|1|||
162618019|NCT01543698|587319679|FG001|Phase 1b|Administrative problems|0|||
162618020|NCT01543698|587319680|FG002|Phase 1b|Administrative problems|0|||
162618021|NCT01543698|587319681|FG003|Phase 1b|Administrative problems|0|||
162618022|NCT01543698|587319682|FG004|Phase 1b|Administrative problems|1|||
162618023|NCT01543698|587319683|FG005|Phase 1b|Administrative problems|0|||
162618024|NCT01543698|587319684|FG006|Phase 1b|Administrative problems|0|||
162618025|NCT01543698|587319685|FG007|Phase 1b|Administrative problems|1|||
162618026|NCT01543698|587319686|FG008|Phase 1b|Administrative problems|0|||
162618027|NCT01543698|587319687|FG009|Phase 1b|Administrative problems|0|||
162618028|NCT01543698|587319688|FG010|Phase 1b|Administrative problems|2|||
162618029|NCT01543698|587319689|FG011|Phase 1b|Administrative problems|0|||
162618030|NCT01543698|587319690|FG012|Phase 1b|Administrative problems|0|||
162618031|NCT01543698|587319691|FG013|Phase 1b|Administrative problems|0|||
162618032|NCT01543698|587319692|FG014|Phase 1b|Administrative problems|0|||
162618033|NCT01543698|587319678|FG000|Phase 1b|Protocol Violation|2|||
162618034|NCT01543698|587319679|FG001|Phase 1b|Protocol Violation|0|||
162618035|NCT01543698|587319680|FG002|Phase 1b|Protocol Violation|0|||
162618036|NCT01543698|587319681|FG003|Phase 1b|Protocol Violation|0|||
162618037|NCT01543698|587319682|FG004|Phase 1b|Protocol Violation|0|||
162888730|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
162888731|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
162888732|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
162888733|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
162888734|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
163050831|NCT02573259|588893695|FG004|Overall Study|Participant refused further follow-up|3|||
162618038|NCT01543698|587319683|FG005|Phase 1b|Protocol Violation|0|||
162618039|NCT01543698|587319684|FG006|Phase 1b|Protocol Violation|0|||
162618040|NCT01543698|587319685|FG007|Phase 1b|Protocol Violation|0|||
162618041|NCT01543698|587319686|FG008|Phase 1b|Protocol Violation|0|||
162618042|NCT01543698|587319687|FG009|Phase 1b|Protocol Violation|0|||
162618043|NCT01543698|587319688|FG010|Phase 1b|Protocol Violation|0|||
162618044|NCT01543698|587319689|FG011|Phase 1b|Protocol Violation|0|||
162618045|NCT01543698|587319690|FG012|Phase 1b|Protocol Violation|0|||
162618046|NCT01543698|587319691|FG013|Phase 1b|Protocol Violation|0|||
162618047|NCT01543698|587319692|FG014|Phase 1b|Protocol Violation|0|||
162618048|NCT01543698|587319678|FG000|Phase 2|Protocol Violation|0|||
162618049|NCT01543698|587319679|FG001|Phase 2|Protocol Violation|0|||
162618050|NCT01543698|587319680|FG002|Phase 2|Protocol Violation|0|||
162618051|NCT01543698|587319681|FG003|Phase 2|Protocol Violation|0|||
162618052|NCT01543698|587319682|FG004|Phase 2|Protocol Violation|0|||
162618053|NCT01543698|587319683|FG005|Phase 2|Protocol Violation|0|||
162618054|NCT01543698|587319684|FG006|Phase 2|Protocol Violation|0|||
162618055|NCT01543698|587319685|FG007|Phase 2|Protocol Violation|0|||
162618056|NCT01543698|587319686|FG008|Phase 2|Protocol Violation|0|||
162618057|NCT01543698|587319687|FG009|Phase 2|Protocol Violation|0|||
162618058|NCT01543698|587319688|FG010|Phase 2|Protocol Violation|0|||
162618059|NCT01543698|587319689|FG011|Phase 2|Protocol Violation|0|||
162618060|NCT01543698|587319690|FG012|Phase 2|Protocol Violation|1|||
162618061|NCT01543698|587319691|FG013|Phase 2|Protocol Violation|0|||
162618062|NCT01543698|587319692|FG014|Phase 2|Protocol Violation|0|||
162618063|NCT01543698|587319678|FG000|Phase 2|Disease progression|0|||
162618064|NCT01543698|587319679|FG001|Phase 2|Disease progression|0|||
162618065|NCT01543698|587319680|FG002|Phase 2|Disease progression|0|||
162618066|NCT01543698|587319681|FG003|Phase 2|Disease progression|0|||
162618067|NCT01543698|587319682|FG004|Phase 2|Disease progression|0|||
162618068|NCT01543698|587319683|FG005|Phase 2|Disease progression|0|||
162618069|NCT01543698|587319684|FG006|Phase 2|Disease progression|0|||
162618070|NCT01543698|587319685|FG007|Phase 2|Disease progression|0|||
162618071|NCT01543698|587319686|FG008|Phase 2|Disease progression|0|||
162618072|NCT01543698|587319687|FG009|Phase 2|Disease progression|0|||
162618073|NCT01543698|587319688|FG010|Phase 2|Disease progression|0|||
162618074|NCT01543698|587319689|FG011|Phase 2|Disease progression|10|||
162618075|NCT01543698|587319690|FG012|Phase 2|Disease progression|21|||
162618076|NCT01543698|587319691|FG013|Phase 2|Disease progression|30|||
162618077|NCT01543698|587319692|FG014|Phase 2|Disease progression|25|||
162618078|NCT01543698|587319678|FG000|Phase 2|Death|0|||
162618079|NCT01543698|587319679|FG001|Phase 2|Death|0|||
162618080|NCT01543698|587319680|FG002|Phase 2|Death|0|||
162618081|NCT01543698|587319681|FG003|Phase 2|Death|0|||
162618082|NCT01543698|587319682|FG004|Phase 2|Death|0|||
162618083|NCT01543698|587319683|FG005|Phase 2|Death|0|||
162618084|NCT01543698|587319684|FG006|Phase 2|Death|0|||
162618085|NCT01543698|587319685|FG007|Phase 2|Death|0|||
162618086|NCT01543698|587319686|FG008|Phase 2|Death|0|||
162618087|NCT01543698|587319687|FG009|Phase 2|Death|0|||
162618088|NCT01543698|587319688|FG010|Phase 2|Death|0|||
162618089|NCT01543698|587319689|FG011|Phase 2|Death|0|||
162618090|NCT01543698|587319690|FG012|Phase 2|Death|1|||
162618091|NCT01543698|587319691|FG013|Phase 2|Death|1|||
162618092|NCT01543698|587319692|FG014|Phase 2|Death|1|||
162618093|NCT01543698|587319678|FG000|Phase 2|Administrative problems|0|||
162618094|NCT01543698|587319679|FG001|Phase 2|Administrative problems|0|||
162618095|NCT01543698|587319680|FG002|Phase 2|Administrative problems|0|||
162618096|NCT01543698|587319681|FG003|Phase 2|Administrative problems|0|||
162618097|NCT01543698|587319682|FG004|Phase 2|Administrative problems|0|||
162618098|NCT01543698|587319683|FG005|Phase 2|Administrative problems|0|||
162618099|NCT01543698|587319684|FG006|Phase 2|Administrative problems|0|||
162618100|NCT01543698|587319685|FG007|Phase 2|Administrative problems|0|||
162618101|NCT01543698|587319686|FG008|Phase 2|Administrative problems|0|||
162618102|NCT01543698|587319687|FG009|Phase 2|Administrative problems|0|||
162618103|NCT01543698|587319688|FG010|Phase 2|Administrative problems|0|||
162618104|NCT01543698|587319689|FG011|Phase 2|Administrative problems|0|||
162618105|NCT01543698|587319690|FG012|Phase 2|Administrative problems|0|||
162618106|NCT01543698|587319691|FG013|Phase 2|Administrative problems|3|||
162618107|NCT01543698|587319692|FG014|Phase 2|Administrative problems|1|||
162618108|NCT01543698|587319678|FG000|Phase 2|Withdrawal by Subject|0|||
162618109|NCT01543698|587319679|FG001|Phase 2|Withdrawal by Subject|0|||
162618110|NCT01543698|587319680|FG002|Phase 2|Withdrawal by Subject|0|||
162618111|NCT01543698|587319681|FG003|Phase 2|Withdrawal by Subject|0|||
162618112|NCT01543698|587319682|FG004|Phase 2|Withdrawal by Subject|0|||
162963681|NCT00918684|588566579|FG000|Treatment Phase|Physician Decision|8|||
162963682|NCT00918684|588566579|FG000|Treatment Phase|Protocol Violation|1|||
162963683|NCT00918684|588566579|FG000|Treatment Phase|Withdrawal by Subject|8|||
162963684|NCT00402103|588566580|FG000|Overall Study|Adverse Event|60|||
162963685|NCT00402103|588566581|FG001|Overall Study|Adverse Event|7|||
162963686|NCT00402103|588566580|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162963687|NCT00402103|588566581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162618113|NCT01543698|587319683|FG005|Phase 2|Withdrawal by Subject|0|||
162618114|NCT01543698|587319684|FG006|Phase 2|Withdrawal by Subject|0|||
162618115|NCT01543698|587319685|FG007|Phase 2|Withdrawal by Subject|0|||
162618116|NCT01543698|587319686|FG008|Phase 2|Withdrawal by Subject|0|||
162618117|NCT01543698|587319687|FG009|Phase 2|Withdrawal by Subject|0|||
163050832|NCT02573259|588893696|FG005|Overall Study|Participant refused further follow-up|20|||
163050833|NCT02573259|588893697|FG006|Overall Study|Participant refused further follow-up|7|||
162618118|NCT01543698|587319688|FG010|Phase 2|Withdrawal by Subject|0|||
162618119|NCT01543698|587319689|FG011|Phase 2|Withdrawal by Subject|0|||
162618120|NCT01543698|587319690|FG012|Phase 2|Withdrawal by Subject|0|||
162618121|NCT01543698|587319691|FG013|Phase 2|Withdrawal by Subject|3|||
162618122|NCT01543698|587319692|FG014|Phase 2|Withdrawal by Subject|1|||
162618123|NCT01543698|587319678|FG000|Phase 2|Adverse Event|0|||
162618124|NCT01543698|587319679|FG001|Phase 2|Adverse Event|0|||
162618125|NCT01543698|587319680|FG002|Phase 2|Adverse Event|0|||
162618126|NCT01543698|587319681|FG003|Phase 2|Adverse Event|0|||
162618127|NCT01543698|587319682|FG004|Phase 2|Adverse Event|0|||
162618128|NCT01543698|587319683|FG005|Phase 2|Adverse Event|0|||
162618129|NCT01543698|587319684|FG006|Phase 2|Adverse Event|0|||
162618130|NCT01543698|587319685|FG007|Phase 2|Adverse Event|0|||
162963688|NCT00402103|588566580|FG000|Overall Study|Condition no longer requires study drug|2|||
162618131|NCT01543698|587319686|FG008|Phase 2|Adverse Event|0|||
162618132|NCT01543698|587319687|FG009|Phase 2|Adverse Event|0|||
162618133|NCT01543698|587319688|FG010|Phase 2|Adverse Event|0|||
162618134|NCT01543698|587319689|FG011|Phase 2|Adverse Event|1|||
162618135|NCT01543698|587319690|FG012|Phase 2|Adverse Event|3|||
162618136|NCT01543698|587319691|FG013|Phase 2|Adverse Event|5|||
162618137|NCT01543698|587319692|FG014|Phase 2|Adverse Event|14|||
162618138|NCT00316719|587319693|FG000|Overall Study|Adverse Event|0|||
162618139|NCT00316719|587319694|FG001|Overall Study|Adverse Event|6|||
162618140|NCT00316719|587319693|FG000|Overall Study|Consent withdrawn|2|||
162618141|NCT00316719|587319694|FG001|Overall Study|Consent withdrawn|0|||
162618142|NCT01863953|587319695|FG000|Overall Study|Adverse Event|0|||
162618143|NCT01863953|587319696|FG001|Overall Study|Adverse Event|0|||
162618144|NCT01863953|587319697|FG002|Overall Study|Adverse Event|1|||
162618145|NCT00573183|587319698|FG000|Overall Study|Lost to Follow-up|52|||
162618146|NCT00573183|587319699|FG001|Overall Study|Lost to Follow-up|50|||
162618147|NCT00573183|587319698|FG000|Overall Study|Withdrawal by Subject|8|||
162618148|NCT00573183|587319699|FG001|Overall Study|Withdrawal by Subject|2|||
162618149|NCT00573183|587319698|FG000|Overall Study|Death|0|||
162618150|NCT00573183|587319699|FG001|Overall Study|Death|1|||
162618151|NCT00573183|587319698|FG000|Overall Study|Adverse Event|2|||
162618152|NCT00573183|587319699|FG001|Overall Study|Adverse Event|0|||
162618153|NCT00573183|587319698|FG000|Overall Study|Incarceration|5|||
162618154|NCT00573183|587319699|FG001|Overall Study|Incarceration|8|||
162618155|NCT00573183|587319698|FG000|Overall Study|Other|5|||
162618156|NCT00573183|587319699|FG001|Overall Study|Other|2|||
162618157|NCT05439941|587319700|FG000|Overall Study|Lack of Efficacy|8|||
162618158|NCT05439941|587319701|FG001|Overall Study|Lack of Efficacy|5|||
162618159|NCT05439941|587319702|FG002|Overall Study|Lack of Efficacy|3|||
162618160|NCT05439941|587319700|FG000|Overall Study|Treatment Failure|0|||
162618161|NCT05439941|587319701|FG001|Overall Study|Treatment Failure|1|||
162618162|NCT05439941|587319702|FG002|Overall Study|Treatment Failure|0|||
162618163|NCT05439941|587319700|FG000|Overall Study|Adverse Event|1|||
162618164|NCT05439941|587319701|FG001|Overall Study|Adverse Event|3|||
162618165|NCT05439941|587319702|FG002|Overall Study|Adverse Event|0|||
162618166|NCT05439941|587319700|FG000|Overall Study|Adverse Event - Parent Study|1|||
162618167|NCT05439941|587319701|FG001|Overall Study|Adverse Event - Parent Study|0|||
162618168|NCT05439941|587319702|FG002|Overall Study|Adverse Event - Parent Study|0|||
162618169|NCT05439941|587319700|FG000|Overall Study|Pregnancy|1|||
162618170|NCT05439941|587319701|FG001|Overall Study|Pregnancy|0|||
162618171|NCT05439941|587319702|FG002|Overall Study|Pregnancy|0|||
162618172|NCT05439941|587319700|FG000|Overall Study|Withdrawal by Subject|9|||
162618173|NCT05439941|587319701|FG001|Overall Study|Withdrawal by Subject|6|||
162618174|NCT05439941|587319702|FG002|Overall Study|Withdrawal by Subject|10|||
162618175|NCT05439941|587319700|FG000|Overall Study|Non-Compliance|1|||
162618176|NCT05439941|587319701|FG001|Overall Study|Non-Compliance|1|||
162618177|NCT05439941|587319702|FG002|Overall Study|Non-Compliance|1|||
162618178|NCT05439941|587319700|FG000|Overall Study|Lost to Follow-up|2|||
162618179|NCT05439941|587319701|FG001|Overall Study|Lost to Follow-up|2|||
162618180|NCT05439941|587319702|FG002|Overall Study|Lost to Follow-up|0|||
162618181|NCT05439941|587319700|FG000|Overall Study|Physician Decision|1|||
162618182|NCT05439941|587319701|FG001|Overall Study|Physician Decision|0|||
162618183|NCT05439941|587319702|FG002|Overall Study|Physician Decision|0|||
162618184|NCT05439941|587319700|FG000|Overall Study|Trial Termination by Sponsor|78|||
162618185|NCT05439941|587319701|FG001|Overall Study|Trial Termination by Sponsor|83|||
162708254|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
162708255|NCT00333138|587640739|FG000|Extension Study (Month6 to End of Study)|Death|0|||
162963689|NCT00402103|588566581|FG001|Overall Study|Condition no longer requires study drug|0|||
162963690|NCT00402103|588566580|FG000|Overall Study|Protocol Deviation|8|||
162963691|NCT00402103|588566581|FG001|Overall Study|Protocol Deviation|0|||
162963692|NCT00402103|588566580|FG000|Overall Study|Patient withdrew consent|12|||
162963693|NCT00402103|588566581|FG001|Overall Study|Patient withdrew consent|1|||
162963694|NCT00402103|588566580|FG000|Overall Study|Lost to Follow-up|6|||
162963695|NCT00402103|588566581|FG001|Overall Study|Lost to Follow-up|3|||
162963696|NCT00402103|588566580|FG000|Overall Study|Administrative problems|2|||
163050834|NCT02573259|588893691|FG000|Overall Study|Other|0|||
163050835|NCT02573259|588893692|FG001|Overall Study|Other|0|||
162618186|NCT05439941|587319702|FG002|Overall Study|Trial Termination by Sponsor|65|||
162618187|NCT05439941|587319700|FG000|Overall Study|Other than Reasons Listed|2|||
162618188|NCT05439941|587319701|FG001|Overall Study|Other than Reasons Listed|1|||
162618189|NCT05439941|587319702|FG002|Overall Study|Other than Reasons Listed|0|||
162618190|NCT02336373|587319705|FG000|Overall Study|Protocol closed early|4|||
162618191|NCT02336373|587319705|FG000|Overall Study|Physician Decision|14|||
162618192|NCT04798781|587319708|FG000|Overall Study|Withdrawal by Subject|1|||
162618193|NCT00615108|587319711|FG000|Overall Study|Adverse Event|122|||
162618194|NCT00615108|587319711|FG000|Overall Study|Other|370|||
162618195|NCT00615108|587319711|FG000|Overall Study|Lost to Follow-up|15|||
162618196|NCT00676338|587319712|FG000|Overall Study|Adverse Event|6|||
162618197|NCT00676338|587319713|FG001|Overall Study|Adverse Event|6|||
162618198|NCT00676338|587319714|FG002|Overall Study|Adverse Event|5|||
162618199|NCT00676338|587319715|FG003|Overall Study|Adverse Event|1|||
162618200|NCT00676338|587319712|FG000|Overall Study|Lost to Follow-up|4|||
162618201|NCT00676338|587319713|FG001|Overall Study|Lost to Follow-up|1|||
162618202|NCT00676338|587319714|FG002|Overall Study|Lost to Follow-up|3|||
162618203|NCT00676338|587319715|FG003|Overall Study|Lost to Follow-up|4|||
162618204|NCT00676338|587319712|FG000|Overall Study|Physician Decision|3|||
162618205|NCT00676338|587319713|FG001|Overall Study|Physician Decision|3|||
162618206|NCT00676338|587319714|FG002|Overall Study|Physician Decision|2|||
162618207|NCT00676338|587319715|FG003|Overall Study|Physician Decision|3|||
162618208|NCT00676338|587319712|FG000|Overall Study|Protocol Violation|5|||
162618209|NCT00676338|587319713|FG001|Overall Study|Protocol Violation|9|||
162963697|NCT00402103|588566581|FG001|Overall Study|Administrative problems|0|||
162963698|NCT00484679|588566582|FG000|Overall Study|Withdrawal by Subject|3|||
162963699|NCT00418145|588566585|FG000|Overall Study|study terminated|6|||
162963700|NCT00472212|588566586|FG000|Overall Study|Lost to Follow-up|6|||
162963701|NCT00472212|588566587|FG001|Overall Study|Lost to Follow-up|4|||
162963702|NCT00425308|588566588|FG000|Overall Study|Adverse Event|2|||
162963703|NCT00425308|588566589|FG001|Overall Study|Adverse Event|1|||
162618210|NCT00676338|587319714|FG002|Overall Study|Protocol Violation|2|||
162618211|NCT00676338|587319715|FG003|Overall Study|Protocol Violation|5|||
162618212|NCT00676338|587319712|FG000|Overall Study|Withdrawal by Subject|17|||
162618213|NCT00676338|587319713|FG001|Overall Study|Withdrawal by Subject|9|||
162618214|NCT00676338|587319714|FG002|Overall Study|Withdrawal by Subject|12|||
162618215|NCT00676338|587319715|FG003|Overall Study|Withdrawal by Subject|6|||
162618216|NCT00676338|587319712|FG000|Overall Study|Entry Criteria Not Met|0|||
162618217|NCT00676338|587319713|FG001|Overall Study|Entry Criteria Not Met|2|||
162618218|NCT00676338|587319714|FG002|Overall Study|Entry Criteria Not Met|1|||
162618219|NCT00676338|587319715|FG003|Overall Study|Entry Criteria Not Met|1|||
162618220|NCT00676338|587319712|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162618221|NCT00676338|587319713|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162618222|NCT00676338|587319714|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
162618223|NCT00676338|587319715|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162618224|NCT02122458|587319716|FG000|Overall Study|Withdrawal by Subject|0|||
162618225|NCT02122458|587319717|FG001|Overall Study|Withdrawal by Subject|0|||
162618226|NCT02122458|587319718|FG002|Overall Study|Withdrawal by Subject|0|||
162618227|NCT02122458|587319719|FG003|Overall Study|Withdrawal by Subject|4|||
162618228|NCT02122458|587319720|FG004|Overall Study|Withdrawal by Subject|4|||
162963704|NCT00425308|588566588|FG000|Overall Study|Withdrawal by Subject|1|||
162963705|NCT00425308|588566589|FG001|Overall Study|Withdrawal by Subject|0|||
162963706|NCT00425308|588566588|FG000|Overall Study|Death|1|||
162618229|NCT02122458|587319721|FG005|Overall Study|Withdrawal by Subject|4|||
162963707|NCT00425308|588566589|FG001|Overall Study|Death|0|||
162963708|NCT01252953|588566591|FG000|Overall Study|Withdrawal by Subject|16|||
162963709|NCT01252953|588566592|FG001|Overall Study|Withdrawal by Subject|17|||
162963710|NCT01252953|588566591|FG000|Overall Study|Lost to Follow-up|22|||
162963711|NCT01252953|588566592|FG001|Overall Study|Lost to Follow-up|21|||
162963712|NCT00101439|588566599|FG000|Period 2|Withdrawal by Subject|0|||
162618230|NCT02122458|587319722|FG006|Overall Study|Withdrawal by Subject|0|||
162618231|NCT02122458|587319716|FG000|Overall Study|Lost to Follow-up|1|||
162618232|NCT02122458|587319717|FG001|Overall Study|Lost to Follow-up|3|||
162618233|NCT02122458|587319718|FG002|Overall Study|Lost to Follow-up|0|||
162618234|NCT02122458|587319719|FG003|Overall Study|Lost to Follow-up|7|||
162618235|NCT02122458|587319720|FG004|Overall Study|Lost to Follow-up|5|||
162618236|NCT02122458|587319721|FG005|Overall Study|Lost to Follow-up|15|||
162618237|NCT02122458|587319722|FG006|Overall Study|Lost to Follow-up|1|||
162618238|NCT02122458|587319716|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
162618239|NCT02122458|587319717|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618240|NCT02122458|587319718|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618241|NCT02122458|587319719|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618242|NCT02122458|587319720|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618243|NCT02122458|587319721|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618244|NCT02122458|587319722|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
162618245|NCT02122458|587319716|FG000|Overall Study|Adverse Event|1|||
162618246|NCT02122458|587319717|FG001|Overall Study|Adverse Event|0|||
162618247|NCT02122458|587319718|FG002|Overall Study|Adverse Event|0|||
162963713|NCT00101439|588566600|FG001|Period 2|Withdrawal by Subject|2|||
162963714|NCT00863330|588566606|FG000|Overall Study|study terminated early due to administra|6|||
162963715|NCT02272803|588566607|FG000|Overall Study|Disease progression|16|||
162963716|NCT02272803|588566608|FG001|Overall Study|Disease progression|8|||
162963717|NCT02272803|588566607|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
162963718|NCT02272803|588566608|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
162963719|NCT02272803|588566607|FG000|Overall Study|Study drug toxicity|4|||
162963720|NCT02272803|588566608|FG001|Overall Study|Study drug toxicity|9|||
162963721|NCT02272803|588566607|FG000|Overall Study|Participant request to discontinue study treatment|3|||
162963722|NCT02272803|588566608|FG001|Overall Study|Participant request to discontinue study treatment|7|||
162963723|NCT02272803|588566607|FG000|Overall Study|Maximum clinical benefit|4|||
162963724|NCT02272803|588566608|FG001|Overall Study|Maximum clinical benefit|2|||
162963725|NCT02272803|588566607|FG000|Overall Study|Poor/non-compliance|2|||
162963726|NCT02272803|588566608|FG001|Overall Study|Poor/non-compliance|2|||
162963727|NCT02272803|588566607|FG000|Overall Study|Withdrawal by Subject|2|||
162963728|NCT02272803|588566608|FG001|Overall Study|Withdrawal by Subject|1|||
162963729|NCT02272803|588566607|FG000|Overall Study|Death|0|||
162963730|NCT02272803|588566608|FG001|Overall Study|Death|1|||
162963731|NCT02272803|588566607|FG000|Overall Study|Other reasons|1|||
162963732|NCT02272803|588566608|FG001|Overall Study|Other reasons|3|||
162963733|NCT02272803|588566607|FG000|Overall Study|Administrative reason by sponsor|5|||
162963734|NCT02272803|588566608|FG001|Overall Study|Administrative reason by sponsor|4|||
162963735|NCT03067987|588566610|FG000|Overall Study|Lost to Follow-up|7|||
162963736|NCT03067987|588566611|FG001|Overall Study|Lost to Follow-up|10|||
162963737|NCT03067987|588566610|FG000|Overall Study|Protocol Violation|1|||
162963738|NCT03067987|588566611|FG001|Overall Study|Protocol Violation|2|||
162963739|NCT03067987|588566610|FG000|Overall Study|Withdrawal by Subject|2|||
162963740|NCT03067987|588566611|FG001|Overall Study|Withdrawal by Subject|1|||
162963741|NCT03733145|588566612|FG000|Overall Study|screenfail|3|||
162963742|NCT03733145|588566613|FG001|Overall Study|screenfail|3|||
162963743|NCT03733145|588566614|FG002|Overall Study|screenfail|2|||
162963744|NCT00829764|588566615|FG000|First Intervention|Adverse Event|1|||
162963745|NCT00829764|588566616|FG001|First Intervention|Adverse Event|0|||
162963746|NCT00829764|588566615|FG000|First Intervention|Withdrawal by Subject|1|||
162963747|NCT00829764|588566616|FG001|First Intervention|Withdrawal by Subject|1|||
162963748|NCT00183196|588567878|FG000|Overall Study|Withdrawal by Subject|18|||
162963749|NCT00183196|588567879|FG001|Overall Study|Withdrawal by Subject|11|||
162963750|NCT00183196|588567880|FG002|Overall Study|Withdrawal by Subject|13|||
162963751|NCT00183196|588567878|FG000|Overall Study|Adverse Event|1|||
162963752|NCT00183196|588567879|FG001|Overall Study|Adverse Event|2|||
162963753|NCT00183196|588567880|FG002|Overall Study|Adverse Event|2|||
162963754|NCT00183196|588567878|FG000|Overall Study|Legal event|1|||
162963755|NCT00183196|588567879|FG001|Overall Study|Legal event|1|||
162963756|NCT00183196|588567880|FG002|Overall Study|Legal event|1|||
162963757|NCT00183196|588567878|FG000|Overall Study|Required more intensive care|0|||
162963758|NCT00183196|588567879|FG001|Overall Study|Required more intensive care|1|||
162963759|NCT00183196|588567880|FG002|Overall Study|Required more intensive care|2|||
162963760|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
162963761|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
162963762|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
162963763|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
162963764|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
162963765|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
162963766|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
162963767|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
162963768|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
162963769|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
162963770|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
162963771|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
162963772|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
162963773|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
162618248|NCT02122458|587319719|FG003|Overall Study|Adverse Event|0|||
162618249|NCT02122458|587319720|FG004|Overall Study|Adverse Event|0|||
162618250|NCT02122458|587319721|FG005|Overall Study|Adverse Event|0|||
162618251|NCT02122458|587319722|FG006|Overall Study|Adverse Event|0|||
162618252|NCT02122458|587319716|FG000|Overall Study|Experimental Error|0|||
162618253|NCT02122458|587319717|FG001|Overall Study|Experimental Error|0|||
162618254|NCT02122458|587319718|FG002|Overall Study|Experimental Error|0|||
162618255|NCT02122458|587319719|FG003|Overall Study|Experimental Error|0|||
162618256|NCT02122458|587319720|FG004|Overall Study|Experimental Error|3|||
162618257|NCT02122458|587319721|FG005|Overall Study|Experimental Error|0|||
162618258|NCT02122458|587319722|FG006|Overall Study|Experimental Error|0|||
162618259|NCT02122458|587319716|FG000|Overall Study|Deployed or Moved|0|||
162618260|NCT02122458|587319717|FG001|Overall Study|Deployed or Moved|0|||
162618261|NCT02122458|587319718|FG002|Overall Study|Deployed or Moved|0|||
162618262|NCT02122458|587319719|FG003|Overall Study|Deployed or Moved|0|||
162618263|NCT02122458|587319720|FG004|Overall Study|Deployed or Moved|1|||
162618264|NCT02122458|587319721|FG005|Overall Study|Deployed or Moved|0|||
162618265|NCT02122458|587319722|FG006|Overall Study|Deployed or Moved|0|||
162618266|NCT02122458|587319716|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
162618267|NCT02122458|587319717|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
162618268|NCT02122458|587319718|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
162618269|NCT02122458|587319719|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
162618270|NCT02122458|587319720|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
162618271|NCT02122458|587319721|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
162618272|NCT02122458|587319722|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
162618273|NCT02122458|587319716|FG000|Overall Study|Noncompliance|0|||
162618274|NCT02122458|587319717|FG001|Overall Study|Noncompliance|1|||
162618275|NCT02122458|587319718|FG002|Overall Study|Noncompliance|0|||
162618276|NCT02122458|587319719|FG003|Overall Study|Noncompliance|0|||
162618277|NCT02122458|587319720|FG004|Overall Study|Noncompliance|0|||
162618278|NCT02122458|587319721|FG005|Overall Study|Noncompliance|0|||
162618279|NCT02122458|587319722|FG006|Overall Study|Noncompliance|0|||
162618280|NCT00412542|587319723|FG000|Overall Study|Withdrawal by Subject|0|||
162618281|NCT00412542|587319724|FG001|Overall Study|Withdrawal by Subject|2|||
162618282|NCT00412542|587319723|FG000|Overall Study|Not Eligible|0|||
162618283|NCT00412542|587319724|FG001|Overall Study|Not Eligible|1|||
162618284|NCT02833350|587319725|FG000|Overall Study|Adverse Event|0|||
162618285|NCT02833350|587319726|FG001|Overall Study|Adverse Event|3|||
162618286|NCT02833350|587319727|FG002|Overall Study|Adverse Event|4|||
162618287|NCT02833350|587319728|FG003|Overall Study|Adverse Event|4|||
162618288|NCT02833350|587319729|FG004|Overall Study|Adverse Event|1|||
162618289|NCT02833350|587319730|FG005|Overall Study|Adverse Event|0|||
162618290|NCT02833350|587319731|FG006|Overall Study|Adverse Event|1|||
162618291|NCT02833350|587319725|FG000|Overall Study|Death|0|||
162618292|NCT02833350|587319726|FG001|Overall Study|Death|0|||
162618293|NCT02833350|587319727|FG002|Overall Study|Death|1|||
162618294|NCT02833350|587319728|FG003|Overall Study|Death|0|||
162618295|NCT02833350|587319729|FG004|Overall Study|Death|0|||
162618296|NCT02833350|587319730|FG005|Overall Study|Death|0|||
162618297|NCT02833350|587319731|FG006|Overall Study|Death|0|||
162618298|NCT02833350|587319725|FG000|Overall Study|Lack of Efficacy|0|||
162618299|NCT02833350|587319726|FG001|Overall Study|Lack of Efficacy|2|||
162618300|NCT02833350|587319727|FG002|Overall Study|Lack of Efficacy|1|||
162618301|NCT02833350|587319728|FG003|Overall Study|Lack of Efficacy|4|||
162618302|NCT02833350|587319729|FG004|Overall Study|Lack of Efficacy|0|||
162618303|NCT02833350|587319730|FG005|Overall Study|Lack of Efficacy|1|||
162618304|NCT02833350|587319731|FG006|Overall Study|Lack of Efficacy|1|||
162618305|NCT02833350|587319725|FG000|Overall Study|Lost to Follow-up|0|||
162618306|NCT02833350|587319726|FG001|Overall Study|Lost to Follow-up|1|||
162618307|NCT02833350|587319727|FG002|Overall Study|Lost to Follow-up|0|||
162618308|NCT02833350|587319728|FG003|Overall Study|Lost to Follow-up|0|||
162618309|NCT02833350|587319729|FG004|Overall Study|Lost to Follow-up|0|||
162618310|NCT02833350|587319730|FG005|Overall Study|Lost to Follow-up|0|||
162618311|NCT02833350|587319731|FG006|Overall Study|Lost to Follow-up|1|||
162618312|NCT02833350|587319725|FG000|Overall Study|Withdrawal by Subject|3|||
162618313|NCT02833350|587319726|FG001|Overall Study|Withdrawal by Subject|3|||
162618314|NCT02833350|587319727|FG002|Overall Study|Withdrawal by Subject|2|||
162618315|NCT02833350|587319728|FG003|Overall Study|Withdrawal by Subject|0|||
162618316|NCT02833350|587319729|FG004|Overall Study|Withdrawal by Subject|2|||
162618317|NCT02833350|587319730|FG005|Overall Study|Withdrawal by Subject|0|||
162618318|NCT02833350|587319731|FG006|Overall Study|Withdrawal by Subject|2|||
162618319|NCT00075218|587319732|FG000|Double-Blind Treatment|Adverse Event|23|||
162618320|NCT00075218|587319733|FG001|Double-Blind Treatment|Adverse Event|4|||
162618321|NCT00075218|587319734|FG002|Double-Blind Treatment|Adverse Event|0|||
162618322|NCT00075218|587319732|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
162618323|NCT00075218|587319733|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
162618324|NCT00075218|587319734|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
162618325|NCT00075218|587319732|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
163050836|NCT02573259|588893693|FG002|Overall Study|Other|0|||
162618326|NCT00075218|587319733|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
162618327|NCT00075218|587319734|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
162618328|NCT00075218|587319732|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
162618329|NCT00075218|587319733|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
162618330|NCT00075218|587319734|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
162618331|NCT00075218|587319732|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
162618332|NCT00075218|587319733|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
162618333|NCT00075218|587319734|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
162618334|NCT00075218|587319732|FG000|Double-Blind Treatment|No study medication taken|2|||
162618335|NCT00075218|587319733|FG001|Double-Blind Treatment|No study medication taken|0|||
162618336|NCT00075218|587319734|FG002|Double-Blind Treatment|No study medication taken|0|||
162618337|NCT00075218|587319732|FG000|Open-Label Treatment|Lack of Efficacy|0|||
162618338|NCT00075218|587319733|FG001|Open-Label Treatment|Lack of Efficacy|0|||
162618339|NCT00075218|587319734|FG002|Open-Label Treatment|Lack of Efficacy|174|||
162618340|NCT00075218|587319732|FG000|Open-Label Treatment|Adverse Event|0|||
162618341|NCT00075218|587319733|FG001|Open-Label Treatment|Adverse Event|0|||
162618342|NCT00075218|587319734|FG002|Open-Label Treatment|Adverse Event|51|||
162618343|NCT00075218|587319732|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
162618344|NCT00075218|587319733|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
162618345|NCT00075218|587319734|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
162618346|NCT00075218|587319732|FG000|Open-Label Treatment|Decision of Sponsor|0|||
162618347|NCT00075218|587319733|FG001|Open-Label Treatment|Decision of Sponsor|0|||
162618348|NCT00075218|587319734|FG002|Open-Label Treatment|Decision of Sponsor|8|||
162618349|NCT00075218|587319732|FG000|Open-Label Treatment|Protocol Violation|0|||
162618350|NCT00075218|587319733|FG001|Open-Label Treatment|Protocol Violation|0|||
162618351|NCT00075218|587319734|FG002|Open-Label Treatment|Protocol Violation|1|||
162618352|NCT00075218|587319732|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
162618353|NCT00075218|587319733|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
162618354|NCT00075218|587319734|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
162618355|NCT00131508|587319735|FG000|Overall Study|Disease progression|0|||
162618356|NCT00131508|587319736|FG001|Overall Study|Disease progression|2|||
162618357|NCT00131508|587319735|FG000|Overall Study|Non-Compliance|2|||
162618358|NCT00131508|587319736|FG001|Overall Study|Non-Compliance|4|||
162618359|NCT00131508|587319735|FG000|Overall Study|Withdrawal by Subject|1|||
162618360|NCT00131508|587319736|FG001|Overall Study|Withdrawal by Subject|2|||
162618361|NCT03643575|587319737|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
162618362|NCT03643575|587319738|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
162618363|NCT03643575|587319739|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
162618364|NCT03643575|587319740|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
162618365|NCT03643575|587319741|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
162618366|NCT03643575|587319742|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
162618367|NCT03643575|587319737|FG000|Washout: 7 Days|Adverse Event|1|||
162618368|NCT03643575|587319738|FG001|Washout: 7 Days|Adverse Event|0|||
162618369|NCT03643575|587319739|FG002|Washout: 7 Days|Adverse Event|0|||
162618370|NCT03643575|587319740|FG003|Washout: 7 Days|Adverse Event|0|||
162618371|NCT03643575|587319741|FG004|Washout: 7 Days|Adverse Event|0|||
162618372|NCT03643575|587319742|FG005|Washout: 7 Days|Adverse Event|0|||
162618373|NCT03643575|587319737|FG000|Washout: 7 Days|Non compliance check in|0|||
162618374|NCT03643575|587319738|FG001|Washout: 7 Days|Non compliance check in|1|||
162618375|NCT03643575|587319739|FG002|Washout: 7 Days|Non compliance check in|0|||
162618376|NCT03643575|587319740|FG003|Washout: 7 Days|Non compliance check in|0|||
162618377|NCT03643575|587319741|FG004|Washout: 7 Days|Non compliance check in|0|||
162708256|NCT00333138|587640740|FG001|Extension Study (Month6 to End of Study)|Death|1|||
162708257|NCT00333138|587640741|FG002|Extension Study (Month6 to End of Study)|Death|0|||
162708258|NCT03005288|587640742|FG000|Overall Study|Withdrawal by Subject|7|||
162708259|NCT03005288|587640743|FG001|Overall Study|Withdrawal by Subject|5|||
162618378|NCT03643575|587319742|FG005|Washout: 7 Days|Non compliance check in|0|||
162618379|NCT00875979|587319743|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
162618380|NCT00875979|587319744|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
162618381|NCT00875979|587319743|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
162618382|NCT00875979|587319744|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
162618383|NCT00875979|587319743|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
162618384|NCT00875979|587319744|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
162618385|NCT00875979|587319743|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
162618386|NCT00875979|587319744|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
162618387|NCT00875979|587319743|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
162618388|NCT00875979|587319744|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
162618389|NCT00875979|587319743|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
162618390|NCT00875979|587319744|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
162618391|NCT00875979|587319743|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
162618392|NCT00875979|587319744|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
162618393|NCT00875979|587319743|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
162618394|NCT00875979|587319744|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
162618395|NCT00875979|587319743|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
162618396|NCT00875979|587319744|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
162618397|NCT01696695|587319746|FG000|Overall Study|Disease progression|373|||
162618398|NCT01696695|587319746|FG000|Overall Study|Death|29|||
162618399|NCT01696695|587319746|FG000|Overall Study|Adverse Event|74|||
162618400|NCT01696695|587319746|FG000|Overall Study|Withdrawal by Subject|92|||
162618401|NCT01696695|587319746|FG000|Overall Study|Lost to Follow-up|48|||
162618402|NCT01696695|587319746|FG000|Overall Study|Other|74|||
162618403|NCT01696695|587319746|FG000|Overall Study|Major Protocol Violation|192|||
162618404|NCT01904058|587319752|FG000|Overall Study|Adverse Event|2|||
162618405|NCT01904058|587319753|FG001|Overall Study|Adverse Event|0|||
162618406|NCT01904058|587319754|FG002|Overall Study|Adverse Event|0|||
162618407|NCT01904058|587319755|FG003|Overall Study|Adverse Event|0|||
162618408|NCT01904058|587319752|FG000|Overall Study|Withdrawal by Subject|1|||
162618409|NCT01904058|587319753|FG001|Overall Study|Withdrawal by Subject|0|||
162618410|NCT01904058|587319754|FG002|Overall Study|Withdrawal by Subject|1|||
162618411|NCT01904058|587319755|FG003|Overall Study|Withdrawal by Subject|0|||
162618412|NCT01904058|587319752|FG000|Overall Study|Pregnancy|0|||
162618413|NCT01904058|587319753|FG001|Overall Study|Pregnancy|0|||
162618414|NCT01904058|587319754|FG002|Overall Study|Pregnancy|0|||
162618415|NCT01904058|587319755|FG003|Overall Study|Pregnancy|1|||
162618416|NCT04041375|587319759|FG000|Intervention Phase|Withdrawal by Subject|2|||
162618417|NCT04041375|587319760|FG001|Intervention Phase|Withdrawal by Subject|2|||
162618418|NCT04041375|587319759|FG000|Follow-up Phase|Death|2|||
162618419|NCT04041375|587319760|FG001|Follow-up Phase|Death|0|||
162618420|NCT04041375|587319759|FG000|Follow-up Phase|Lost to Follow-up|2|||
162618421|NCT04041375|587319760|FG001|Follow-up Phase|Lost to Follow-up|1|||
162618422|NCT04041375|587319759|FG000|Follow-up Phase|Too ill|3|||
162618423|NCT04041375|587319760|FG001|Follow-up Phase|Too ill|0|||
162618424|NCT02404220|587319766|FG000|Overall Study|Adverse Event|0|||
162618425|NCT02404220|587319767|FG001|Overall Study|Adverse Event|0|||
162618426|NCT02404220|587319768|FG002|Overall Study|Adverse Event|1|||
162618427|NCT02404220|587319769|FG003|Overall Study|Adverse Event|0|||
162618428|NCT02404220|587319766|FG000|Overall Study|Death|5|||
162618429|NCT02404220|587319767|FG001|Overall Study|Death|5|||
162618430|NCT02404220|587319768|FG002|Overall Study|Death|3|||
162618431|NCT02404220|587319769|FG003|Overall Study|Death|8|||
162618432|NCT02404220|587319766|FG000|Overall Study|Progressive Disease|0|||
162618433|NCT02404220|587319767|FG001|Overall Study|Progressive Disease|0|||
162618434|NCT02404220|587319768|FG002|Overall Study|Progressive Disease|1|||
162618435|NCT02404220|587319769|FG003|Overall Study|Progressive Disease|1|||
162618436|NCT02404220|587319766|FG000|Overall Study|Study Terminated by Sponsor|0|||
162618437|NCT02404220|587319767|FG001|Overall Study|Study Terminated by Sponsor|0|||
162618438|NCT02404220|587319768|FG002|Overall Study|Study Terminated by Sponsor|2|||
162618439|NCT02404220|587319769|FG003|Overall Study|Study Terminated by Sponsor|1|||
162618440|NCT02404220|587319766|FG000|Overall Study|Withdrawal by Subject|0|||
162618441|NCT02404220|587319767|FG001|Overall Study|Withdrawal by Subject|1|||
162618442|NCT02404220|587319768|FG002|Overall Study|Withdrawal by Subject|0|||
162618443|NCT02404220|587319769|FG003|Overall Study|Withdrawal by Subject|0|||
162618444|NCT02404220|587319766|FG000|Overall Study|Enrolled but Never Treated|0|||
162618445|NCT02404220|587319767|FG001|Overall Study|Enrolled but Never Treated|2|||
162618446|NCT02404220|587319768|FG002|Overall Study|Enrolled but Never Treated|0|||
162618447|NCT02404220|587319769|FG003|Overall Study|Enrolled but Never Treated|0|||
162618448|NCT00395733|587319770|FG000|Period 2|Withdrawal by Subject|1|||
162618449|NCT00395733|587319771|FG001|Period 2|Withdrawal by Subject|2|||
162618450|NCT00395733|587319770|FG000|Period 2|Protocol Violation|0|||
162618451|NCT00395733|587319771|FG001|Period 2|Protocol Violation|1|||
162618452|NCT00395733|587319770|FG000|Period 2|Adverse Event|0|||
162618453|NCT00395733|587319771|FG001|Period 2|Adverse Event|2|||
162618454|NCT00395733|587319770|FG000|Period 2|Technical problems|1|||
162618455|NCT00395733|587319771|FG001|Period 2|Technical problems|0|||
162618456|NCT01147172|587319777|FG000|Overall Study|Withdrawal by Subject|2|||
162618457|NCT01147172|587319777|FG000|Overall Study|Lost to Follow-up|2|||
162618458|NCT01697358|587319778|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
162618459|NCT01697358|587319779|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
162618460|NCT01697358|587319778|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
162618461|NCT01697358|587319779|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
162618462|NCT01697358|587319778|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
162618463|NCT01697358|587319779|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
162618464|NCT01697358|587319778|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
162618465|NCT01697358|587319779|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
162618466|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
162618467|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
162618468|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
162618469|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
162618470|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
162618471|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
162618472|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
162618473|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
162618474|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
162618475|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
162618476|NCT01697358|587319778|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
162618477|NCT01697358|587319779|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
162618478|NCT02507973|587319782|FG000|Overall Study|Adverse Event|1|||
162618479|NCT02711345|587319783|FG000|Overall Study|Adverse Event|0|||
162618480|NCT02711345|587319784|FG001|Overall Study|Adverse Event|0|||
162618481|NCT02711345|587319785|FG002|Overall Study|Adverse Event|0|||
162618482|NCT02711345|587319786|FG003|Overall Study|Adverse Event|1|||
162618483|NCT02711345|587319787|FG004|Overall Study|Adverse Event|1|||
162618484|NCT02711345|587319788|FG005|Overall Study|Adverse Event|2|||
162618485|NCT02711345|587319789|FG006|Overall Study|Adverse Event|1|||
162618486|NCT02711345|587319790|FG007|Overall Study|Adverse Event|0|||
162618487|NCT02711345|587319791|FG008|Overall Study|Adverse Event|0|||
162618488|NCT02711345|587319792|FG009|Overall Study|Adverse Event|2|||
162618489|NCT02711345|587319783|FG000|Overall Study|Physician Decision|0|||
162618490|NCT02711345|587319784|FG001|Overall Study|Physician Decision|0|||
162618491|NCT02711345|587319785|FG002|Overall Study|Physician Decision|1|||
162618492|NCT02711345|587319786|FG003|Overall Study|Physician Decision|0|||
162618493|NCT02711345|587319787|FG004|Overall Study|Physician Decision|0|||
162618494|NCT02711345|587319788|FG005|Overall Study|Physician Decision|0|||
162618495|NCT02711345|587319789|FG006|Overall Study|Physician Decision|0|||
162618496|NCT02711345|587319790|FG007|Overall Study|Physician Decision|0|||
162618497|NCT02711345|587319791|FG008|Overall Study|Physician Decision|1|||
162618498|NCT02711345|587319792|FG009|Overall Study|Physician Decision|0|||
162618499|NCT02711345|587319783|FG000|Overall Study|Progressive disease|1|||
162618500|NCT02711345|587319784|FG001|Overall Study|Progressive disease|3|||
162618501|NCT02711345|587319785|FG002|Overall Study|Progressive disease|5|||
162618502|NCT02711345|587319786|FG003|Overall Study|Progressive disease|3|||
162618503|NCT02711345|587319787|FG004|Overall Study|Progressive disease|7|||
162618504|NCT02711345|587319788|FG005|Overall Study|Progressive disease|2|||
162618505|NCT02711345|587319789|FG006|Overall Study|Progressive disease|8|||
162618506|NCT02711345|587319790|FG007|Overall Study|Progressive disease|4|||
162618507|NCT02711345|587319791|FG008|Overall Study|Progressive disease|5|||
162618508|NCT02711345|587319792|FG009|Overall Study|Progressive disease|6|||
162618509|NCT02711345|587319783|FG000|Overall Study|Subject/guardian decision|0|||
162618510|NCT02711345|587319784|FG001|Overall Study|Subject/guardian decision|0|||
162618511|NCT02711345|587319785|FG002|Overall Study|Subject/guardian decision|0|||
162618512|NCT02711345|587319786|FG003|Overall Study|Subject/guardian decision|0|||
162618513|NCT02711345|587319787|FG004|Overall Study|Subject/guardian decision|0|||
162618514|NCT02711345|587319788|FG005|Overall Study|Subject/guardian decision|2|||
162618515|NCT02711345|587319789|FG006|Overall Study|Subject/guardian decision|3|||
162618516|NCT02711345|587319790|FG007|Overall Study|Subject/guardian decision|1|||
162618517|NCT02711345|587319791|FG008|Overall Study|Subject/guardian decision|0|||
162618518|NCT02711345|587319792|FG009|Overall Study|Subject/guardian decision|4|||
162618519|NCT02711345|587319783|FG000|Overall Study|Death|1|||
162618520|NCT02711345|587319784|FG001|Overall Study|Death|0|||
162618521|NCT02711345|587319785|FG002|Overall Study|Death|0|||
162618522|NCT02711345|587319786|FG003|Overall Study|Death|0|||
162618523|NCT02711345|587319787|FG004|Overall Study|Death|0|||
162618524|NCT02711345|587319788|FG005|Overall Study|Death|0|||
162618525|NCT02711345|587319789|FG006|Overall Study|Death|0|||
162618526|NCT02711345|587319790|FG007|Overall Study|Death|1|||
162618527|NCT02711345|587319791|FG008|Overall Study|Death|0|||
162618528|NCT02711345|587319792|FG009|Overall Study|Death|0|||
162618529|NCT00961649|587319793|FG000|Overall Study|Adverse Event|4|||
162618530|NCT00961649|587319794|FG001|Overall Study|Adverse Event|0|||
162618531|NCT00961649|587319795|FG002|Overall Study|Adverse Event|0|||
162618532|NCT00961649|587319796|FG003|Overall Study|Adverse Event|2|||
162618533|NCT00961649|587319793|FG000|Overall Study|Inadequate control of IOP|0|||
162618534|NCT00961649|587319794|FG001|Overall Study|Inadequate control of IOP|0|||
162618535|NCT00961649|587319795|FG002|Overall Study|Inadequate control of IOP|0|||
162618536|NCT00961649|587319796|FG003|Overall Study|Inadequate control of IOP|1|||
162618537|NCT00961649|587319793|FG000|Overall Study|Patient has travel plans during holidays|0|||
162618538|NCT00961649|587319794|FG001|Overall Study|Patient has travel plans during holidays|0|||
162708260|NCT03005288|587640742|FG000|Overall Study|Lost to Follow-up|0|||
162708261|NCT03005288|587640743|FG001|Overall Study|Lost to Follow-up|1|||
162708262|NCT03005288|587640742|FG000|Overall Study|Adverse Event|5|||
162708263|NCT03005288|587640743|FG001|Overall Study|Adverse Event|0|||
162708264|NCT03005288|587640742|FG000|Overall Study|Protocol deviation|0|||
162708265|NCT03005288|587640743|FG001|Overall Study|Protocol deviation|1|||
162708266|NCT03005288|587640742|FG000|Overall Study|Physician Decision|0|||
162708267|NCT03005288|587640743|FG001|Overall Study|Physician Decision|1|||
162708268|NCT04011033|587640744|FG000|Overall Study|Physician Decision|2|||
162708269|NCT04011033|587640745|FG001|Overall Study|Physician Decision|3|||
162708270|NCT04011033|587640744|FG000|Overall Study|Withdrawal by Subject|1|||
162708271|NCT04011033|587640745|FG001|Overall Study|Withdrawal by Subject|0|||
162708272|NCT01823341|587640746|FG000|Overall Study|Failed run-in|7|||
162708273|NCT01823341|587640746|FG000|Overall Study|Withdrawal by Subject|7|||
162708274|NCT01823341|587640746|FG000|Overall Study|Adverse Event|1|||
162708275|NCT01342887|587640747|FG000|Overall Study|Death|2|||
162708276|NCT00663962|587640748|FG000|Overall Study|somnolence|1|||
162708277|NCT00663962|587640749|FG001|Overall Study|somnolence|0|||
162708278|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Adverse Event|5|||
162708279|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Adverse Event|13|||
162708280|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Adverse Event|0|||
162708281|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
162708282|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
162708283|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
162708284|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
162708285|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
162708286|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
162708287|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
162708288|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
162708289|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
162708290|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
162708291|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
162708292|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
162708293|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162708294|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
162708295|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
162708296|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Physician Decision|2|||
162708297|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Physician Decision|3|||
162708298|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Physician Decision|0|||
162708299|NCT01449929|587640765|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
162708300|NCT01449929|587640766|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
162708301|NCT01449929|587640767|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
162708302|NCT01449929|587640765|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
162708303|NCT01449929|587640766|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
162708304|NCT01449929|587640767|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
162708305|NCT01449929|587640765|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
162708306|NCT01449929|587640766|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
162708307|NCT01449929|587640767|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
162708308|NCT01449929|587640765|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
163050837|NCT02573259|588893694|FG003|Overall Study|Other|0|||
162618539|NCT00961649|587319795|FG002|Overall Study|Patient has travel plans during holidays|1|||
162618540|NCT00961649|587319796|FG003|Overall Study|Patient has travel plans during holidays|0|||
162618541|NCT00961649|587319793|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
162618542|NCT00961649|587319794|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
162618543|NCT00961649|587319795|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
162618544|NCT00961649|587319796|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
162618545|NCT00961649|587319793|FG000|Overall Study|Study terminated by sponsor|4|||
162618546|NCT00961649|587319794|FG001|Overall Study|Study terminated by sponsor|4|||
162618547|NCT00961649|587319795|FG002|Overall Study|Study terminated by sponsor|4|||
162618548|NCT00961649|587319796|FG003|Overall Study|Study terminated by sponsor|1|||
162618549|NCT02155881|587319797|FG000|Overall Study|Withdrawal by Subject|0|||
162618550|NCT02155881|587319798|FG001|Overall Study|Withdrawal by Subject|2|||
162618551|NCT02155881|587319797|FG000|Overall Study|Inappropriately randomized|2|||
162618552|NCT02155881|587319798|FG001|Overall Study|Inappropriately randomized|2|||
162618553|NCT04357782|587319799|FG000|Overall Study|Discharged from hospital|1|||
162618554|NCT04357782|587319800|FG001|Overall Study|Discharged from hospital|0|||
162618555|NCT04357782|587319799|FG000|Overall Study|Death|0|||
162618556|NCT04357782|587319800|FG001|Overall Study|Death|2|||
162618557|NCT01786148|587319801|FG000|Overall Study|Lost to Follow-up|21|||
162618558|NCT01786148|587319802|FG001|Overall Study|Lost to Follow-up|13|||
162618559|NCT01786148|587319801|FG000|Overall Study|Death|0|||
162618560|NCT01786148|587319802|FG001|Overall Study|Death|1|||
162618561|NCT01786148|587319801|FG000|Overall Study|Withdrawal by Subject|0|||
162618562|NCT01786148|587319802|FG001|Overall Study|Withdrawal by Subject|7|||
162618563|NCT01786148|587319801|FG000|Overall Study|Incarceration|1|||
162618564|NCT01786148|587319802|FG001|Overall Study|Incarceration|1|||
162618565|NCT00338104|587319803|FG000|Overall Study|Protocol Violation|2|||
162618566|NCT00338104|587319804|FG001|Overall Study|Protocol Violation|1|||
162618567|NCT00338104|587319805|FG002|Overall Study|Protocol Violation|3|||
162618568|NCT02362269|587319808|FG000|Overall Study|Moved|1|||
162618569|NCT02362269|587319809|FG001|Overall Study|Moved|0|||
162618570|NCT02362269|587319808|FG000|Overall Study|Lost to Follow-up|0|||
162618571|NCT02362269|587319809|FG001|Overall Study|Lost to Follow-up|6|||
162618572|NCT03841448|587319810|FG000|Double-blind Treatment (DBT) Period|Death|1|||
162618573|NCT03841448|587319811|FG001|Double-blind Treatment (DBT) Period|Death|1|||
162618574|NCT03841448|587319812|FG002|Double-blind Treatment (DBT) Period|Death|0|||
162618575|NCT03841448|587319813|FG003|Double-blind Treatment (DBT) Period|Death|0|||
162618576|NCT03841448|587319810|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
162618577|NCT03841448|587319811|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
162618578|NCT03841448|587319812|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
162618579|NCT03841448|587319813|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
162618580|NCT03841448|587319810|FG000|Open-Label Extension (OLE) Period|Death|0|||
162618581|NCT03841448|587319811|FG001|Open-Label Extension (OLE) Period|Death|0|||
162618582|NCT03841448|587319812|FG002|Open-Label Extension (OLE) Period|Death|0|||
162618583|NCT03841448|587319813|FG003|Open-Label Extension (OLE) Period|Death|1|||
162618584|NCT03841448|587319810|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
162618585|NCT03841448|587319811|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
162618586|NCT03841448|587319812|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
162618587|NCT03841448|587319813|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
162618588|NCT03841448|587319810|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
162618589|NCT03841448|587319811|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
162618590|NCT03841448|587319812|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
162618591|NCT03841448|587319813|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
162618592|NCT03841448|587319810|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
162618593|NCT03841448|587319811|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
162618594|NCT03841448|587319812|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
162618595|NCT03841448|587319813|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
162618596|NCT04068610|587319814|FG000|Overall Study|Death|4|||
162618597|NCT04068610|587319815|FG001|Overall Study|Death|8|||
162618598|NCT04068610|587319816|FG002|Overall Study|Death|13|||
162618599|NCT04068610|587319814|FG000|Overall Study|Lost to Follow-up|0|||
162618600|NCT04068610|587319815|FG001|Overall Study|Lost to Follow-up|2|||
162618601|NCT04068610|587319816|FG002|Overall Study|Lost to Follow-up|0|||
162618602|NCT04068610|587319814|FG000|Overall Study|Withdrawal by Subject|0|||
162618603|NCT04068610|587319815|FG001|Overall Study|Withdrawal by Subject|4|||
162618604|NCT04068610|587319816|FG002|Overall Study|Withdrawal by Subject|2|||
162618605|NCT04068610|587319814|FG000|Overall Study|Other|3|||
162618606|NCT04068610|587319815|FG001|Overall Study|Other|12|||
162618607|NCT04068610|587319816|FG002|Overall Study|Other|11|||
162888735|NCT00476996|588291010|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
162618608|NCT00072176|587319817|FG000|Overall Study|Withdrawal by Subject|1|||
162888736|NCT00476996|588291011|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
162618609|NCT00072176|587319818|FG001|Overall Study|Withdrawal by Subject|0|||
162618610|NCT00072176|587319817|FG000|Overall Study|Protocol Violation|0|||
162708309|NCT01449929|587640766|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
162888737|NCT00476996|588291012|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
162888738|NCT00476996|588291013|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
162888739|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
162888740|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
162618611|NCT00072176|587319818|FG001|Overall Study|Protocol Violation|1|||
162618612|NCT02586064|587319819|FG000|Overall Study|Other Obligations|6|||
162618613|NCT02586064|587319820|FG001|Overall Study|Other Obligations|6|||
162618614|NCT02586064|587319819|FG000|Overall Study|Other|3|||
162618615|NCT02586064|587319820|FG001|Overall Study|Other|7|||
162618616|NCT02586064|587319819|FG000|Overall Study|Never Started|3|||
162618617|NCT02586064|587319820|FG001|Overall Study|Never Started|3|||
162618618|NCT02586064|587319819|FG000|Overall Study|Lost Interest|1|||
162618619|NCT02586064|587319820|FG001|Overall Study|Lost Interest|4|||
162618620|NCT02586064|587319819|FG000|Overall Study|Miscellaneous Life Issues|0|||
162618621|NCT02586064|587319820|FG001|Overall Study|Miscellaneous Life Issues|5|||
162618622|NCT02586064|587319819|FG000|Overall Study|Infrequent Attendance|2|||
162618623|NCT02586064|587319820|FG001|Overall Study|Infrequent Attendance|1|||
162618624|NCT02586064|587319819|FG000|Overall Study|Timed Out|2|||
162618625|NCT02586064|587319820|FG001|Overall Study|Timed Out|0|||
162618626|NCT02586064|587319819|FG000|Overall Study|AUD relapse|0|||
162618627|NCT02586064|587319820|FG001|Overall Study|AUD relapse|2|||
162618628|NCT02586064|587319819|FG000|Overall Study|Legal Issue|1|||
162618629|NCT02586064|587319820|FG001|Overall Study|Legal Issue|0|||
162618630|NCT04815031|587319821|FG000|Overall Study|No adverse event information (missing information)|33|||
163050838|NCT02573259|588893695|FG004|Overall Study|Other|1|||
163050839|NCT02573259|588893696|FG005|Overall Study|Other|4|||
163050840|NCT02573259|588893697|FG006|Overall Study|Other|5|||
163050841|NCT00751140|588893698|FG000|Overall Study|benign angioma excluded from analysis|1|||
163050842|NCT00808067|588893699|FG000|Overall Study|Major/minor bleed|30|||
163050843|NCT00808067|588893700|FG001|Overall Study|Major/minor bleed|44|||
163050844|NCT00808067|588893699|FG000|Overall Study|Outcome event - other|33|||
163050845|NCT00808067|588893700|FG001|Overall Study|Outcome event - other|25|||
163050846|NCT00808067|588893699|FG000|Overall Study|Adverse Event|111|||
163050847|NCT00808067|588893700|FG001|Overall Study|Adverse Event|121|||
163050848|NCT00808067|588893699|FG000|Overall Study|Hospitalization (not including surgery)|18|||
163050849|NCT00808067|588893700|FG001|Overall Study|Hospitalization (not including surgery)|17|||
163050850|NCT00808067|588893699|FG000|Overall Study|Hospitalization due to surgery|37|||
163050851|NCT00808067|588893700|FG001|Overall Study|Hospitalization due to surgery|40|||
163050852|NCT00808067|588893699|FG000|Overall Study|Reduced creatinine clearance|53|||
163050853|NCT00808067|588893700|FG001|Overall Study|Reduced creatinine clearance|55|||
163050854|NCT00808067|588893699|FG000|Overall Study|Elevated LFT results|7|||
163050855|NCT00808067|588893700|FG001|Overall Study|Elevated LFT results|3|||
163050856|NCT00808067|588893699|FG000|Overall Study|Patient refused to take study medication|65|||
163050857|NCT00808067|588893700|FG001|Overall Study|Patient refused to take study medication|76|||
163050858|NCT00808067|588893699|FG000|Overall Study|Missing|1|||
163050859|NCT00808067|588893700|FG001|Overall Study|Missing|0|||
163050860|NCT00808067|588893699|FG000|Overall Study|Death|1|||
163050861|NCT00808067|588893700|FG001|Overall Study|Death|1|||
162618631|NCT00484094|587319822|FG000|Overall Study|Discontinued|39|||
162618632|NCT00484094|587319822|FG000|Overall Study|Other|3|||
162618633|NCT03594994|587319823|FG000|Overall Study|Adverse Event|1|||
162618634|NCT03594994|587319824|FG001|Overall Study|Adverse Event|0|||
162618635|NCT03594994|587319823|FG000|Overall Study|Withdrawal by Subject|0|||
162618636|NCT03594994|587319824|FG001|Overall Study|Withdrawal by Subject|1|||
162618637|NCT00309985|587319826|FG000|Overall Study|Disease progression|12|||
162618638|NCT00309985|587319827|FG001|Overall Study|Disease progression|0|||
162618639|NCT00309985|587319826|FG000|Overall Study|Adverse Event|30|||
162618640|NCT00309985|587319827|FG001|Overall Study|Adverse Event|0|||
162618641|NCT00309985|587319826|FG000|Overall Study|Death|2|||
162618642|NCT00309985|587319827|FG001|Overall Study|Death|0|||
163050862|NCT00808067|588893699|FG000|Overall Study|Procedure|6|||
162618643|NCT00309985|587319826|FG000|Overall Study|Withdrawal by Subject|5|||
162618644|NCT00309985|587319827|FG001|Overall Study|Withdrawal by Subject|1|||
163050863|NCT00808067|588893700|FG001|Overall Study|Procedure|7|||
163050864|NCT00808067|588893699|FG000|Overall Study|Withdrawal by Subject|21|||
163050865|NCT00808067|588893700|FG001|Overall Study|Withdrawal by Subject|25|||
163050866|NCT00808067|588893699|FG000|Overall Study|Site closed|4|||
163050867|NCT00808067|588893700|FG001|Overall Study|Site closed|3|||
162618645|NCT00309985|587319826|FG000|Overall Study|Physician Decision|3|||
162618646|NCT00309985|587319827|FG001|Overall Study|Physician Decision|0|||
162618647|NCT00309985|587319826|FG000|Overall Study|Never started treatment|7|||
162618648|NCT00309985|587319827|FG001|Overall Study|Never started treatment|0|||
162618649|NCT00309985|587319826|FG000|Overall Study|Complicating disease|1|||
162618650|NCT00309985|587319827|FG001|Overall Study|Complicating disease|0|||
162618651|NCT00309985|587319826|FG000|Overall Study|Non-compliance|1|||
162618652|NCT00309985|587319827|FG001|Overall Study|Non-compliance|0|||
162618653|NCT00309985|587319826|FG000|Overall Study|Chemotherapy discontinued only|1|||
162618654|NCT00309985|587319827|FG001|Overall Study|Chemotherapy discontinued only|0|||
162618655|NCT03672643|587319828|FG000|Overall Study|Adverse Event|3|||
162618656|NCT03672643|587319828|FG000|Overall Study|Death|2|||
162618657|NCT03672643|587319828|FG000|Overall Study|Withdrawal by Subject|1|||
162618658|NCT03672643|587319828|FG000|Overall Study|Progressive disease|11|||
162618659|NCT03672643|587319828|FG000|Overall Study|Global deterioration of health status|1|||
162618660|NCT03672643|587319828|FG000|Overall Study|Refused further treatment|7|||
162618661|NCT03672643|587319828|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
162618662|NCT01950390|587319831|FG000|Overall Study|Never started treatment|3|||
162618663|NCT01950390|587319832|FG001|Overall Study|Never started treatment|2|||
162618664|NCT01950390|587319831|FG000|Overall Study|Disease progression|45|||
162618665|NCT01950390|587319832|FG001|Overall Study|Disease progression|52|||
162618666|NCT01950390|587319831|FG000|Overall Study|Adverse Event|22|||
162618667|NCT01950390|587319832|FG001|Overall Study|Adverse Event|16|||
162618668|NCT01950390|587319831|FG000|Overall Study|Death|5|||
162618669|NCT01950390|587319832|FG001|Overall Study|Death|3|||
162618670|NCT01950390|587319831|FG000|Overall Study|Withdrawal by Subject|5|||
162618671|NCT01950390|587319832|FG001|Overall Study|Withdrawal by Subject|1|||
162618672|NCT01950390|587319831|FG000|Overall Study|Alternative therapy|0|||
162618673|NCT01950390|587319832|FG001|Overall Study|Alternative therapy|3|||
162618674|NCT01950390|587319831|FG000|Overall Study|Complicating disease|1|||
162618675|NCT01950390|587319832|FG001|Overall Study|Complicating disease|0|||
162618676|NCT01950390|587319831|FG000|Overall Study|On treatment|1|||
162618677|NCT01950390|587319832|FG001|Overall Study|On treatment|0|||
162618678|NCT01950390|587319831|FG000|Overall Study|Symptomatic deterioration|2|||
162618679|NCT01950390|587319832|FG001|Overall Study|Symptomatic deterioration|1|||
162618680|NCT01950390|587319831|FG000|Overall Study|Physician Decision|0|||
162618681|NCT01950390|587319832|FG001|Overall Study|Physician Decision|4|||
162618682|NCT01950390|587319831|FG000|Overall Study|Lack of clinical benefit|0|||
162618683|NCT01950390|587319832|FG001|Overall Study|Lack of clinical benefit|1|||
162618684|NCT01950390|587319831|FG000|Overall Study|Maintained PR and moved to observation only|0|||
162618685|NCT01950390|587319832|FG001|Overall Study|Maintained PR and moved to observation only|1|||
162618686|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Adverse Event|16|||
162618687|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Adverse Event|17|||
162618688|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Adverse Event|13|||
162618689|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Adverse Event|18|||
162888741|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
162618690|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Adverse Event|0|||
162618691|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Adverse Event|0|||
162618692|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Adverse Event|0|||
162888742|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
162888743|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
162888744|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
162888745|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
162888746|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
162888747|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Death|0|||
162888748|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Death|0|||
162888749|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Death|0|||
162888750|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Death|7|||
162888751|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
162888752|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
162888753|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
162888754|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
162888755|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
162888756|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
162888757|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
162888758|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
162888759|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
162888760|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
162888761|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
162888762|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
162888763|NCT00476996|588291010|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
162888764|NCT00476996|588291011|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
162888765|NCT00476996|588291012|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
162888766|NCT00476996|588291013|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
162888767|NCT02133742|588291029|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
162618693|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Adverse Event|0|||
162618694|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
162618695|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
162618696|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
162618697|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
162888768|NCT02133742|588291029|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
162888769|NCT02133742|588291029|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
163050868|NCT00808067|588893699|FG000|Overall Study|Physician Decision|47|||
163050869|NCT00808067|588893700|FG001|Overall Study|Physician Decision|38|||
163050870|NCT00808067|588893699|FG000|Overall Study|Protocol Violation|3|||
163050871|NCT00808067|588893700|FG001|Overall Study|Protocol Violation|11|||
163050872|NCT00808067|588893699|FG000|Overall Study|Patient elected|7|||
163050873|NCT00808067|588893700|FG001|Overall Study|Patient elected|9|||
163050874|NCT00808067|588893699|FG000|Overall Study|Site closed for cause|19|||
163050875|NCT00808067|588893700|FG001|Overall Study|Site closed for cause|19|||
163050876|NCT00808067|588893699|FG000|Overall Study|Other reason not defined above|5|||
163050877|NCT00808067|588893700|FG001|Overall Study|Other reason not defined above|5|||
163050878|NCT00808067|588893699|FG000|Overall Study|Excluded from analysis|13|||
163050879|NCT00808067|588893700|FG001|Overall Study|Excluded from analysis|19|||
163050880|NCT01107925|588893703|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
163050881|NCT01107925|588893704|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050882|NCT01107925|588893705|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050883|NCT01107925|588893706|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050884|NCT01107925|588893707|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
163050885|NCT01107925|588893708|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
163050886|NCT01107925|588893703|FG000|Period 2|Withdrawal by Subject|0|||
163050887|NCT01107925|588893704|FG001|Period 2|Withdrawal by Subject|1|||
163050888|NCT01107925|588893705|FG002|Period 2|Withdrawal by Subject|0|||
163050889|NCT01107925|588893706|FG003|Period 2|Withdrawal by Subject|0|||
163050890|NCT01107925|588893707|FG004|Period 2|Withdrawal by Subject|0|||
163050891|NCT01107925|588893708|FG005|Period 2|Withdrawal by Subject|1|||
163050892|NCT01817075|588893710|FG000|Overall Study|Adverse Event|7|||
163050893|NCT01817075|588893711|FG001|Overall Study|Adverse Event|5|||
163050894|NCT01817075|588893710|FG000|Overall Study|Physician Decision|9|||
163050895|NCT01817075|588893711|FG001|Overall Study|Physician Decision|12|||
163050896|NCT01817075|588893710|FG000|Overall Study|Withdrawal by Subject|31|||
163050897|NCT01817075|588893711|FG001|Overall Study|Withdrawal by Subject|15|||
163050898|NCT01817075|588893710|FG000|Overall Study|Received Sorafenib after enrollment|0|||
163050899|NCT01817075|588893711|FG001|Overall Study|Received Sorafenib after enrollment|1|||
163050900|NCT01817075|588893710|FG000|Overall Study|Ineligible|0|||
163050901|NCT01817075|588893711|FG001|Overall Study|Ineligible|2|||
163050902|NCT04157517|588893712|FG000|Overall Study|Death|1|||
163050903|NCT04157517|588893713|FG001|Overall Study|Death|2|||
163050904|NCT04157517|588893714|FG002|Overall Study|Death|2|||
163050905|NCT04157517|588893715|FG003|Overall Study|Death|3|||
163050906|NCT04157517|588893716|FG004|Overall Study|Death|3|||
163050907|NCT04157517|588893717|FG005|Overall Study|Death|4|||
163050908|NCT04157517|588893718|FG006|Overall Study|Death|1|||
163050909|NCT04157517|588893719|FG007|Overall Study|Death|2|||
163050910|NCT04157517|588893720|FG008|Overall Study|Death|4|||
163050911|NCT04157517|588893721|FG009|Overall Study|Death|0|||
163050912|NCT04157517|588893712|FG000|Overall Study|Withdrawal by Subject|1|||
163050913|NCT04157517|588893713|FG001|Overall Study|Withdrawal by Subject|1|||
163050914|NCT04157517|588893714|FG002|Overall Study|Withdrawal by Subject|1|||
163050915|NCT04157517|588893715|FG003|Overall Study|Withdrawal by Subject|0|||
163050916|NCT04157517|588893716|FG004|Overall Study|Withdrawal by Subject|0|||
163050917|NCT04157517|588893717|FG005|Overall Study|Withdrawal by Subject|1|||
162888770|NCT02133742|588291029|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
162888771|NCT02133742|588291029|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
162888772|NCT03479216|588291032|FG000|Overall Study|Withdrawal by Subject|3|||
162888773|NCT03479216|588291033|FG001|Overall Study|Withdrawal by Subject|2|||
162888774|NCT03479216|588291032|FG000|Overall Study|Physician Decision|2|||
162888775|NCT03479216|588291033|FG001|Overall Study|Physician Decision|3|||
162888776|NCT02031432|588291036|FG000|Overall Study|Protocol Violation|1|||
162888777|NCT02031432|588291036|FG000|Overall Study|Lack of Efficacy|5|||
162888778|NCT02031432|588291036|FG000|Overall Study|Cancer Progression|2|||
162888779|NCT02031432|588291036|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
162888780|NCT02031432|588291036|FG000|Overall Study|Adverse Event|8|||
163050918|NCT04157517|588893718|FG006|Overall Study|Withdrawal by Subject|0|||
163050919|NCT04157517|588893719|FG007|Overall Study|Withdrawal by Subject|0|||
163050920|NCT04157517|588893720|FG008|Overall Study|Withdrawal by Subject|1|||
163050921|NCT04157517|588893721|FG009|Overall Study|Withdrawal by Subject|0|||
163050922|NCT04157517|588893712|FG000|Overall Study|Other|1|||
163050923|NCT04157517|588893713|FG001|Overall Study|Other|0|||
163050924|NCT04157517|588893714|FG002|Overall Study|Other|0|||
163050925|NCT04157517|588893715|FG003|Overall Study|Other|0|||
162618698|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
162618699|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
162888781|NCT02031432|588291036|FG000|Overall Study|Withdrawal by Subject|5|||
163050926|NCT04157517|588893716|FG004|Overall Study|Other|0|||
163050927|NCT04157517|588893717|FG005|Overall Study|Other|1|||
163050928|NCT04157517|588893718|FG006|Overall Study|Other|2|||
163050929|NCT04157517|588893719|FG007|Overall Study|Other|7|||
163050930|NCT04157517|588893720|FG008|Overall Study|Other|7|||
163050931|NCT04157517|588893721|FG009|Overall Study|Other|0|||
163050932|NCT01395810|588893728|FG000|Overall Study|Adverse Event|0|||
163050933|NCT01395810|588893729|FG001|Overall Study|Adverse Event|1|||
163050934|NCT01395810|588893730|FG002|Overall Study|Adverse Event|0|||
163050935|NCT01395810|588893731|FG003|Overall Study|Adverse Event|0|||
163050936|NCT01395810|588893728|FG000|Overall Study|Lack of Efficacy|0|||
163050937|NCT01395810|588893729|FG001|Overall Study|Lack of Efficacy|1|||
163050938|NCT01395810|588893730|FG002|Overall Study|Lack of Efficacy|0|||
163050939|NCT01395810|588893731|FG003|Overall Study|Lack of Efficacy|0|||
163050940|NCT01395810|588893728|FG000|Overall Study|Withdrawal criteria|0|||
163050941|NCT01395810|588893729|FG001|Overall Study|Withdrawal criteria|2|||
163050942|NCT01395810|588893730|FG002|Overall Study|Withdrawal criteria|0|||
163050943|NCT01395810|588893731|FG003|Overall Study|Withdrawal criteria|0|||
163050944|NCT01395810|588893728|FG000|Overall Study|Unclassified|2|||
163050945|NCT01395810|588893729|FG001|Overall Study|Unclassified|0|||
163050946|NCT01395810|588893730|FG002|Overall Study|Unclassified|0|||
163050947|NCT01395810|588893731|FG003|Overall Study|Unclassified|0|||
163050948|NCT00830219|588895326|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163050949|NCT00830219|588895327|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
163050950|NCT01130272|588895328|FG000|Overall Study|Adverse Event|2|||
163050951|NCT01130272|588895329|FG001|Overall Study|Adverse Event|5|||
163050952|NCT01130272|588895330|FG002|Overall Study|Adverse Event|6|||
163050953|NCT01130272|588895331|FG003|Overall Study|Adverse Event|22|||
163050954|NCT01130272|588895332|FG004|Overall Study|Adverse Event|7|||
162888782|NCT02031432|588291036|FG000|Overall Study|Lost to Follow-up|1|||
163050955|NCT01130272|588895328|FG000|Overall Study|IVRS-confirmed constipation|0|||
163050956|NCT01130272|588895329|FG001|Overall Study|IVRS-confirmed constipation|1|||
163050957|NCT01130272|588895330|FG002|Overall Study|IVRS-confirmed constipation|1|||
163050958|NCT01130272|588895331|FG003|Overall Study|IVRS-confirmed constipation|2|||
163050959|NCT01130272|588895332|FG004|Overall Study|IVRS-confirmed constipation|0|||
163050960|NCT01130272|588895328|FG000|Overall Study|Rescue medications due to diarrhea|3|||
162618700|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
162618701|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
162618702|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
162618703|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
162618704|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
162618705|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
162618706|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
162618707|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
162618708|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
163050961|NCT01130272|588895329|FG001|Overall Study|Rescue medications due to diarrhea|5|||
163050962|NCT01130272|588895330|FG002|Overall Study|Rescue medications due to diarrhea|8|||
163050963|NCT01130272|588895331|FG003|Overall Study|Rescue medications due to diarrhea|8|||
163050964|NCT01130272|588895332|FG004|Overall Study|Rescue medications due to diarrhea|6|||
163050965|NCT01130272|588895328|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
163050966|NCT01130272|588895329|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
163050967|NCT01130272|588895330|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
163050968|NCT01130272|588895331|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
163050969|NCT01130272|588895332|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
163050970|NCT01130272|588895328|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050971|NCT01130272|588895329|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050972|NCT01130272|588895330|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163050973|NCT01130272|588895331|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
163050974|NCT01130272|588895332|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
162618709|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
162618710|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
162618711|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
162618712|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
162618713|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
162618714|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
162618715|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
162618716|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
162618717|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
162618718|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
163050975|NCT01130272|588895328|FG000|Overall Study|Protocol Violation|0|||
163050976|NCT01130272|588895329|FG001|Overall Study|Protocol Violation|0|||
163050977|NCT01130272|588895330|FG002|Overall Study|Protocol Violation|3|||
163050978|NCT01130272|588895331|FG003|Overall Study|Protocol Violation|5|||
163050979|NCT01130272|588895332|FG004|Overall Study|Protocol Violation|5|||
163050980|NCT01130272|588895328|FG000|Overall Study|Lost to Follow-up|4|||
163050981|NCT01130272|588895329|FG001|Overall Study|Lost to Follow-up|3|||
163050982|NCT01130272|588895330|FG002|Overall Study|Lost to Follow-up|4|||
162618719|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162618720|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
162618721|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
162618722|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162618723|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162618724|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162618725|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162618726|NCT02975336|587321391|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
162618727|NCT02975336|587321392|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
162618728|NCT02975336|587321393|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
162618729|NCT02975336|587321394|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
162618730|NCT02975336|587321395|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
162618731|NCT02975336|587321396|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
162618732|NCT02975336|587321397|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
162618733|NCT02975336|587321398|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
162618734|NCT02975336|587321391|FG000|LTE (104 Weeks)|Adverse Event|0|||
162618735|NCT02975336|587321392|FG001|LTE (104 Weeks)|Adverse Event|0|||
162618736|NCT02975336|587321393|FG002|LTE (104 Weeks)|Adverse Event|0|||
162618737|NCT02975336|587321394|FG003|LTE (104 Weeks)|Adverse Event|0|||
162618738|NCT02975336|587321395|FG004|LTE (104 Weeks)|Adverse Event|7|||
162618739|NCT02975336|587321396|FG005|LTE (104 Weeks)|Adverse Event|4|||
162618740|NCT02975336|587321397|FG006|LTE (104 Weeks)|Adverse Event|2|||
162618741|NCT02975336|587321398|FG007|LTE (104 Weeks)|Adverse Event|0|||
162618742|NCT02975336|587321391|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
162618743|NCT02975336|587321392|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
162618744|NCT02975336|587321393|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
162618745|NCT02975336|587321394|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
162888783|NCT02031432|588291036|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
162888784|NCT02031432|588291036|FG000|Overall Study|Death|10|||
162888785|NCT02148211|588291037|FG000|Overall Study|Lost to Follow-up|352|||
163050983|NCT01130272|588895331|FG003|Overall Study|Lost to Follow-up|7|||
163050984|NCT01130272|588895332|FG004|Overall Study|Lost to Follow-up|6|||
163050985|NCT01130272|588895328|FG000|Overall Study|Withdrawal by Subject|4|||
163050986|NCT01130272|588895329|FG001|Overall Study|Withdrawal by Subject|11|||
163050987|NCT01130272|588895330|FG002|Overall Study|Withdrawal by Subject|10|||
163050988|NCT01130272|588895331|FG003|Overall Study|Withdrawal by Subject|9|||
163050989|NCT01130272|588895332|FG004|Overall Study|Withdrawal by Subject|8|||
163050990|NCT01130272|588895328|FG000|Overall Study|Physician Decision|1|||
163050991|NCT01130272|588895329|FG001|Overall Study|Physician Decision|1|||
163050992|NCT01130272|588895330|FG002|Overall Study|Physician Decision|0|||
163050993|NCT01130272|588895331|FG003|Overall Study|Physician Decision|1|||
163050994|NCT01130272|588895332|FG004|Overall Study|Physician Decision|2|||
163050995|NCT01130272|588895328|FG000|Overall Study|Sponsor decision|6|||
163050996|NCT01130272|588895329|FG001|Overall Study|Sponsor decision|15|||
163050997|NCT01130272|588895330|FG002|Overall Study|Sponsor decision|16|||
163050998|NCT01130272|588895331|FG003|Overall Study|Sponsor decision|13|||
163050999|NCT01130272|588895332|FG004|Overall Study|Sponsor decision|16|||
163051000|NCT01130272|588895328|FG000|Overall Study|Study arm discontinued|38|||
163051001|NCT01130272|588895329|FG001|Overall Study|Study arm discontinued|0|||
163051002|NCT01130272|588895330|FG002|Overall Study|Study arm discontinued|0|||
163051003|NCT01130272|588895331|FG003|Overall Study|Study arm discontinued|0|||
163051004|NCT01130272|588895332|FG004|Overall Study|Study arm discontinued|0|||
162618746|NCT02975336|587321395|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
162618747|NCT02975336|587321396|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
162618748|NCT02975336|587321397|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
162618749|NCT02975336|587321398|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
162618750|NCT02975336|587321391|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
162888786|NCT01617187|588291039|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
163051005|NCT00641056|588895333|FG000|Overall Study|Adverse Event|12|||
163051006|NCT00641056|588895334|FG001|Overall Study|Adverse Event|2|||
163051007|NCT00641056|588895333|FG000|Overall Study|Lost to Follow-up|2|||
163051008|NCT00641056|588895334|FG001|Overall Study|Lost to Follow-up|1|||
163051009|NCT00641056|588895333|FG000|Overall Study|Physician Decision|3|||
163051010|NCT00641056|588895334|FG001|Overall Study|Physician Decision|1|||
163051011|NCT00641056|588895333|FG000|Overall Study|Protocol Violation|2|||
163051012|NCT00641056|588895334|FG001|Overall Study|Protocol Violation|0|||
163051013|NCT00641056|588895333|FG000|Overall Study|Entry Criteria Not Met|3|||
163051014|NCT00641056|588895334|FG001|Overall Study|Entry Criteria Not Met|0|||
163051015|NCT00641056|588895333|FG000|Overall Study|Subject Decision|6|||
163051016|NCT00641056|588895334|FG001|Overall Study|Subject Decision|19|||
163051017|NCT00641056|588895333|FG000|Overall Study|Sponsor Decision|1|||
163051018|NCT00641056|588895334|FG001|Overall Study|Sponsor Decision|2|||
163051019|NCT00239720|588895336|FG000|Overall Study|Adverse Event|1|||
163051020|NCT00239720|588895337|FG001|Overall Study|Adverse Event|0|||
163051021|NCT00239720|588895336|FG000|Overall Study|Lost to Follow-up|0|||
163051022|NCT00239720|588895337|FG001|Overall Study|Lost to Follow-up|1|||
163051023|NCT01811732|588895338|FG000|Overall Study|Lost to Follow-up|24|||
163051024|NCT01811732|588895339|FG001|Overall Study|Lost to Follow-up|30|||
163051025|NCT01811732|588895338|FG000|Overall Study|Withdrawal by Subject|16|||
163051026|NCT01811732|588895339|FG001|Overall Study|Withdrawal by Subject|10|||
163051027|NCT01811732|588895338|FG000|Overall Study|Adverse Event|3|||
163051028|NCT01811732|588895339|FG001|Overall Study|Adverse Event|9|||
163051029|NCT01811732|588895338|FG000|Overall Study|Lack of Efficacy|3|||
163051030|NCT01811732|588895339|FG001|Overall Study|Lack of Efficacy|1|||
163051031|NCT01811732|588895338|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
163051032|NCT01811732|588895339|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
163051033|NCT01811732|588895338|FG000|Overall Study|Physician Decision|2|||
163051034|NCT01811732|588895339|FG001|Overall Study|Physician Decision|0|||
163051035|NCT01811732|588895338|FG000|Overall Study|Death|1|||
163051036|NCT01811732|588895339|FG001|Overall Study|Death|1|||
163051037|NCT01811732|588895338|FG000|Overall Study|Insufficient venous access|0|||
163051038|NCT01811732|588895339|FG001|Overall Study|Insufficient venous access|1|||
163051039|NCT01811732|588895338|FG000|Overall Study|Protocol Violation|0|||
163051040|NCT01811732|588895339|FG001|Overall Study|Protocol Violation|1|||
163051041|NCT01811732|588895338|FG000|Overall Study|Subject incarcerated|1|||
163051042|NCT01811732|588895339|FG001|Overall Study|Subject incarcerated|2|||
163051043|NCT01811732|588895338|FG000|Overall Study|Admitted to another facility|1|||
163051044|NCT01811732|588895339|FG001|Overall Study|Admitted to another facility|0|||
163051045|NCT01811732|588895338|FG000|Overall Study|Correct study drug not available on site|1|||
163051046|NCT01811732|588895339|FG001|Overall Study|Correct study drug not available on site|0|||
163051047|NCT01405560|588895340|FG000|Overall Study|Physician Decision|1|||
163051048|NCT00896493|588895343|FG000|Overall Study|Early disease relapse|3|||
163051049|NCT00536510|588895344|FG000|Overall Study|Adverse Event|27|||
163051050|NCT00536510|588895345|FG001|Overall Study|Adverse Event|4|||
163051051|NCT00536510|588895344|FG000|Overall Study|Lost to Follow-up|11|||
163051052|NCT00536510|588895345|FG001|Overall Study|Lost to Follow-up|8|||
163051053|NCT00536510|588895344|FG000|Overall Study|Protocol Violation|4|||
163051054|NCT00536510|588895345|FG001|Overall Study|Protocol Violation|5|||
163051055|NCT00536510|588895344|FG000|Overall Study|Withdrawal by Subject|16|||
163051056|NCT00536510|588895345|FG001|Overall Study|Withdrawal by Subject|9|||
163051057|NCT00536510|588895344|FG000|Overall Study|Flushing with Product|20|||
163051058|NCT00536510|588895345|FG001|Overall Study|Flushing with Product|0|||
163051059|NCT00536510|588895344|FG000|Overall Study|Laboratory Adverse Event|2|||
163051060|NCT00536510|588895345|FG001|Overall Study|Laboratory Adverse Event|1|||
162618751|NCT02975336|587321392|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
162618752|NCT02975336|587321393|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
162618753|NCT02975336|587321394|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
162618754|NCT02975336|587321395|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
163051061|NCT00536510|588895344|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
162618755|NCT02975336|587321396|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
162618756|NCT02975336|587321397|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
162618757|NCT02975336|587321398|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
162618758|NCT02975336|587321391|FG000|LTE (104 Weeks)|Other|0|||
162618759|NCT02975336|587321392|FG001|LTE (104 Weeks)|Other|0|||
162618760|NCT02975336|587321393|FG002|LTE (104 Weeks)|Other|0|||
162618761|NCT02975336|587321394|FG003|LTE (104 Weeks)|Other|0|||
162618762|NCT02975336|587321395|FG004|LTE (104 Weeks)|Other|55|||
162618763|NCT02975336|587321396|FG005|LTE (104 Weeks)|Other|63|||
162618764|NCT02975336|587321397|FG006|LTE (104 Weeks)|Other|76|||
163051062|NCT00536510|588895345|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
163051063|NCT02035553|588895346|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
163051064|NCT02035553|588895347|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
163051065|NCT02035553|588895346|FG000|Overall Study|Adverse Event|10|||
163051066|NCT02035553|588895347|FG001|Overall Study|Adverse Event|6|||
163051067|NCT02035553|588895346|FG000|Overall Study|Physician Decision|3|||
163051068|NCT02035553|588895347|FG001|Overall Study|Physician Decision|2|||
162618765|NCT02975336|587321398|FG007|LTE (104 Weeks)|Other|72|||
162618766|NCT02008318|587321401|FG000|Overall Study|Adverse Event|4|||
162618767|NCT02008318|587321402|FG001|Overall Study|Adverse Event|0|||
163051069|NCT02035553|588895346|FG000|Overall Study|Lack of Efficacy|1|||
162618768|NCT02008318|587321401|FG000|Overall Study|Physician Decision|2|||
162618769|NCT02008318|587321402|FG001|Overall Study|Physician Decision|0|||
162618770|NCT02008318|587321401|FG000|Overall Study|Progressive Disease|2|||
162618771|NCT02008318|587321402|FG001|Overall Study|Progressive Disease|0|||
162618772|NCT02008318|587321401|FG000|Overall Study|Protocol Violation|1|||
162618773|NCT02008318|587321402|FG001|Overall Study|Protocol Violation|1|||
162618774|NCT02008318|587321401|FG000|Overall Study|Withdrawal by Subject|3|||
162618775|NCT02008318|587321402|FG001|Overall Study|Withdrawal by Subject|0|||
162618776|NCT02281773|587321403|FG000|Overall Study|Adverse Event|6|||
162618777|NCT02281773|587321404|FG001|Overall Study|Adverse Event|1|||
162618778|NCT02281773|587321405|FG002|Overall Study|Adverse Event|4|||
162618779|NCT02281773|587321406|FG003|Overall Study|Adverse Event|8|||
162618780|NCT02281773|587321407|FG004|Overall Study|Adverse Event|9|||
162618781|NCT02281773|587321403|FG000|Overall Study|Protocol Violation|1|||
162618782|NCT02281773|587321404|FG001|Overall Study|Protocol Violation|0|||
162618783|NCT02281773|587321405|FG002|Overall Study|Protocol Violation|0|||
162618784|NCT02281773|587321406|FG003|Overall Study|Protocol Violation|2|||
162618785|NCT02281773|587321407|FG004|Overall Study|Protocol Violation|2|||
162618786|NCT02281773|587321403|FG000|Overall Study|Lost to Follow-up|2|||
162618787|NCT02281773|587321404|FG001|Overall Study|Lost to Follow-up|2|||
162618788|NCT02281773|587321405|FG002|Overall Study|Lost to Follow-up|6|||
162618789|NCT02281773|587321406|FG003|Overall Study|Lost to Follow-up|2|||
162618790|NCT02281773|587321407|FG004|Overall Study|Lost to Follow-up|10|||
162618791|NCT02281773|587321403|FG000|Overall Study|Withdrawal by Subject|2|||
162618792|NCT02281773|587321404|FG001|Overall Study|Withdrawal by Subject|8|||
162618793|NCT02281773|587321405|FG002|Overall Study|Withdrawal by Subject|6|||
162618794|NCT02281773|587321406|FG003|Overall Study|Withdrawal by Subject|6|||
162618795|NCT02281773|587321407|FG004|Overall Study|Withdrawal by Subject|8|||
162618796|NCT02281773|587321403|FG000|Overall Study|Other Reason|0|||
162618797|NCT02281773|587321404|FG001|Overall Study|Other Reason|4|||
162618798|NCT02281773|587321405|FG002|Overall Study|Other Reason|2|||
162618799|NCT02281773|587321406|FG003|Overall Study|Other Reason|3|||
162618800|NCT02281773|587321407|FG004|Overall Study|Other Reason|1|||
162618801|NCT00385762|587321408|FG000|Overall Study|Adverse Event|1|||
162618802|NCT00385762|587321408|FG000|Overall Study|Lost to Follow-up|1|||
162618803|NCT01856907|587321416|FG000|Overall Study|Pregnancy|0|||
162618804|NCT01856907|587321417|FG001|Overall Study|Pregnancy|1|||
162618805|NCT01856907|587321418|FG002|Overall Study|Pregnancy|0|||
162618806|NCT01856907|587321416|FG000|Overall Study|Pregnancy|0|||
162618807|NCT01856907|587321417|FG001|Overall Study|Pregnancy|1|||
162618808|NCT01856907|587321418|FG002|Overall Study|Pregnancy|0|||
162618809|NCT01856907|587321416|FG000|Overall Study|Withdrawal by Subject|0|||
162618810|NCT01856907|587321417|FG001|Overall Study|Withdrawal by Subject|1|||
162618811|NCT01856907|587321418|FG002|Overall Study|Withdrawal by Subject|0|||
162618812|NCT01436396|587321419|FG000|Overall Study|Protocol Violation|7|||
163051070|NCT02035553|588895347|FG001|Overall Study|Lack of Efficacy|1|||
163051071|NCT02035553|588895346|FG000|Overall Study|Withdrawal by Subject|4|||
163051072|NCT02035553|588895347|FG001|Overall Study|Withdrawal by Subject|7|||
163051073|NCT02035553|588895346|FG000|Overall Study|Non-compliance with Study Drug|0|||
163051074|NCT02035553|588895347|FG001|Overall Study|Non-compliance with Study Drug|1|||
163051075|NCT02035553|588895346|FG000|Overall Study|Lost to Follow-up|0|||
163051076|NCT02035553|588895347|FG001|Overall Study|Lost to Follow-up|1|||
163051077|NCT02035553|588895346|FG000|Overall Study|Other Reason|0|||
163051078|NCT02035553|588895347|FG001|Overall Study|Other Reason|4|||
163051079|NCT04539964|588895348|FG000|Overall Study|device malfunction|1|||
163051080|NCT04539964|588895349|FG001|Overall Study|device malfunction|0|||
163051081|NCT04539964|588895348|FG000|Overall Study|Withdrawal by Subject|1|||
163051082|NCT04539964|588895349|FG001|Overall Study|Withdrawal by Subject|2|||
163051083|NCT04539964|588895348|FG000|Overall Study|Adverse Event|0|||
163051084|NCT04539964|588895349|FG001|Overall Study|Adverse Event|2|||
163051085|NCT01674725|588895350|FG000|Overall Study|Adverse Event|1|||
163051086|NCT01674725|588895351|FG001|Overall Study|Adverse Event|0|||
162618813|NCT01436396|587321420|FG001|Overall Study|Protocol Violation|5|||
162618814|NCT01436396|587321419|FG000|Overall Study|Adverse Event|1|||
162618815|NCT01436396|587321420|FG001|Overall Study|Adverse Event|2|||
162618816|NCT01436396|587321419|FG000|Overall Study|Withdrawal by Subject|19|||
162618817|NCT01436396|587321420|FG001|Overall Study|Withdrawal by Subject|29|||
162618818|NCT01436396|587321419|FG000|Overall Study|Serious adverse event|2|||
163051087|NCT01674725|588895350|FG000|Overall Study|Did not receive study drug|1|||
163051088|NCT01674725|588895351|FG001|Overall Study|Did not receive study drug|0|||
162618819|NCT01436396|587321420|FG001|Overall Study|Serious adverse event|3|||
162618820|NCT01436396|587321419|FG000|Overall Study|Lost to Follow-up|3|||
162618821|NCT01436396|587321420|FG001|Overall Study|Lost to Follow-up|3|||
162618822|NCT04674644|587321422|FG000|Overall Study|with missing data|37|||
162618823|NCT03469934|587321423|FG000|Overall Study|Withdrawal by Subject|0|||
162618824|NCT03469934|587321424|FG001|Overall Study|Withdrawal by Subject|1|||
162618825|NCT01024231|587321426|FG000|Overall Study|Other Reasons|1|||
162618826|NCT01024231|587321427|FG001|Overall Study|Other Reasons|2|||
163051089|NCT01674725|588895350|FG000|Overall Study|Withdrawal by Subject|1|||
162618827|NCT01024231|587321428|FG002|Overall Study|Other Reasons|0|||
162618828|NCT01024231|587321429|FG003|Overall Study|Other Reasons|0|||
162618829|NCT01024231|587321430|FG004|Overall Study|Other Reasons|2|||
162618830|NCT01024231|587321431|FG005|Overall Study|Other Reasons|0|||
162618831|NCT01024231|587321432|FG006|Overall Study|Other Reasons|1|||
162618832|NCT01024231|587321426|FG000|Overall Study|Maximum Clinical Benefit|1|||
162618833|NCT01024231|587321427|FG001|Overall Study|Maximum Clinical Benefit|2|||
162618834|NCT01024231|587321428|FG002|Overall Study|Maximum Clinical Benefit|0|||
162618835|NCT01024231|587321429|FG003|Overall Study|Maximum Clinical Benefit|1|||
162618836|NCT01024231|587321430|FG004|Overall Study|Maximum Clinical Benefit|1|||
162618837|NCT01024231|587321431|FG005|Overall Study|Maximum Clinical Benefit|0|||
162618838|NCT01024231|587321432|FG006|Overall Study|Maximum Clinical Benefit|0|||
162618839|NCT01024231|587321426|FG000|Overall Study|Disease Progression|3|||
162618840|NCT01024231|587321427|FG001|Overall Study|Disease Progression|1|||
162618841|NCT01024231|587321428|FG002|Overall Study|Disease Progression|3|||
162618842|NCT01024231|587321429|FG003|Overall Study|Disease Progression|0|||
162618843|NCT01024231|587321430|FG004|Overall Study|Disease Progression|4|||
162618844|NCT01024231|587321431|FG005|Overall Study|Disease Progression|11|||
162618845|NCT01024231|587321432|FG006|Overall Study|Disease Progression|6|||
162618846|NCT01024231|587321426|FG000|Overall Study|AE unrelated to Study Drug|0|||
162618847|NCT01024231|587321427|FG001|Overall Study|AE unrelated to Study Drug|1|||
162618848|NCT01024231|587321428|FG002|Overall Study|AE unrelated to Study Drug|0|||
162618849|NCT01024231|587321429|FG003|Overall Study|AE unrelated to Study Drug|0|||
162618850|NCT01024231|587321430|FG004|Overall Study|AE unrelated to Study Drug|0|||
162618851|NCT01024231|587321431|FG005|Overall Study|AE unrelated to Study Drug|0|||
162618852|NCT01024231|587321432|FG006|Overall Study|AE unrelated to Study Drug|0|||
162618853|NCT01024231|587321426|FG000|Overall Study|No longer meets criteria|0|||
162618854|NCT01024231|587321427|FG001|Overall Study|No longer meets criteria|0|||
162618855|NCT01024231|587321428|FG002|Overall Study|No longer meets criteria|0|||
162618856|NCT01024231|587321429|FG003|Overall Study|No longer meets criteria|0|||
162618857|NCT01024231|587321430|FG004|Overall Study|No longer meets criteria|1|||
162618858|NCT01024231|587321431|FG005|Overall Study|No longer meets criteria|0|||
162618859|NCT01024231|587321432|FG006|Overall Study|No longer meets criteria|1|||
162618860|NCT01024231|587321426|FG000|Overall Study|Study Drug Toxicity|1|||
162618861|NCT01024231|587321427|FG001|Overall Study|Study Drug Toxicity|6|||
162708310|NCT01449929|587640767|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
162708311|NCT03253653|587640768|FG000|Overall Study|Withdrawal by Subject|4|||
162963774|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
162963775|NCT00385736|588567881|FG000|Efficacy Analysis Set - Induction|Other|0|||
162618862|NCT01024231|587321428|FG002|Overall Study|Study Drug Toxicity|6|||
162618863|NCT01024231|587321429|FG003|Overall Study|Study Drug Toxicity|4|||
162618864|NCT01024231|587321430|FG004|Overall Study|Study Drug Toxicity|2|||
162618865|NCT01024231|587321431|FG005|Overall Study|Study Drug Toxicity|0|||
162618866|NCT01024231|587321432|FG006|Overall Study|Study Drug Toxicity|7|||
162618867|NCT01024231|587321426|FG000|Overall Study|Death|6|||
162963776|NCT00385736|588567882|FG001|Efficacy Analysis Set - Induction|Other|0|||
162963777|NCT00385736|588567883|FG002|Efficacy Analysis Set - Induction|Other|1|||
162963778|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
162963779|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
162963780|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
162963781|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
162963782|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
162963783|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
162618868|NCT01024231|587321427|FG001|Overall Study|Death|2|||
162618869|NCT01024231|587321428|FG002|Overall Study|Death|1|||
162618870|NCT01024231|587321429|FG003|Overall Study|Death|0|||
162618871|NCT01024231|587321430|FG004|Overall Study|Death|4|||
162618872|NCT01024231|587321431|FG005|Overall Study|Death|3|||
162618873|NCT01024231|587321432|FG006|Overall Study|Death|5|||
162618874|NCT01024231|587321426|FG000|Overall Study|Lost to Follow-up|0|||
162618875|NCT01024231|587321427|FG001|Overall Study|Lost to Follow-up|0|||
162618876|NCT01024231|587321428|FG002|Overall Study|Lost to Follow-up|0|||
162618877|NCT01024231|587321429|FG003|Overall Study|Lost to Follow-up|0|||
162618878|NCT01024231|587321430|FG004|Overall Study|Lost to Follow-up|0|||
162618879|NCT01024231|587321431|FG005|Overall Study|Lost to Follow-up|0|||
162618880|NCT01024231|587321432|FG006|Overall Study|Lost to Follow-up|1|||
162618881|NCT01024231|587321426|FG000|Overall Study|Withdrew Consent|0|||
162963784|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
162963785|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
162963786|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
162963787|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
162618882|NCT01024231|587321427|FG001|Overall Study|Withdrew Consent|1|||
163051090|NCT01674725|588895351|FG001|Overall Study|Withdrawal by Subject|0|||
163051091|NCT01674725|588895350|FG000|Overall Study|Lost to Follow-up|0|||
163051092|NCT01674725|588895351|FG001|Overall Study|Lost to Follow-up|1|||
163051093|NCT03102762|588895352|FG000|Overall Study|Lost to Follow-up|1|||
163051094|NCT03102762|588895353|FG001|Overall Study|Lost to Follow-up|0|||
163051095|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
163051096|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051097|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051098|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051099|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
163051100|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
163051101|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051102|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051103|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051104|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
163051105|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
163051106|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163051107|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
163051108|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
162618883|NCT01024231|587321428|FG002|Overall Study|Withdrew Consent|0|||
162618884|NCT01024231|587321429|FG003|Overall Study|Withdrew Consent|0|||
162618885|NCT01024231|587321430|FG004|Overall Study|Withdrew Consent|0|||
162618886|NCT01024231|587321431|FG005|Overall Study|Withdrew Consent|0|||
162618887|NCT01024231|587321432|FG006|Overall Study|Withdrew Consent|0|||
162618888|NCT01024231|587321426|FG000|Overall Study|Continuing on Treatment|0|||
162708312|NCT03253653|587640769|FG001|Overall Study|Withdrawal by Subject|1|||
162708313|NCT03253653|587640768|FG000|Overall Study|Protocol Violation|0|||
162618889|NCT01024231|587321427|FG001|Overall Study|Continuing on Treatment|0|||
162708314|NCT03253653|587640769|FG001|Overall Study|Protocol Violation|5|||
162618890|NCT01024231|587321428|FG002|Overall Study|Continuing on Treatment|0|||
162618891|NCT01024231|587321429|FG003|Overall Study|Continuing on Treatment|0|||
162618892|NCT01024231|587321430|FG004|Overall Study|Continuing on Treatment|3|||
162618893|NCT01024231|587321431|FG005|Overall Study|Continuing on Treatment|2|||
162618894|NCT01024231|587321432|FG006|Overall Study|Continuing on Treatment|0|||
162618895|NCT02761733|587321434|FG000|Overall Study|Death|3|||
162618896|NCT02761733|587321435|FG001|Overall Study|Death|5|||
162618897|NCT02761733|587321436|FG002|Overall Study|Death|1|||
162618898|NCT02761733|587321437|FG003|Overall Study|Death|1|||
162618899|NCT02761733|587321434|FG000|Overall Study|Lost to Follow-up|6|||
162618900|NCT02761733|587321435|FG001|Overall Study|Lost to Follow-up|7|||
162618901|NCT02761733|587321436|FG002|Overall Study|Lost to Follow-up|0|||
162618902|NCT02761733|587321437|FG003|Overall Study|Lost to Follow-up|3|||
162618903|NCT02761733|587321434|FG000|Overall Study|Physician Decision|4|||
162618904|NCT02761733|587321435|FG001|Overall Study|Physician Decision|0|||
162618905|NCT02761733|587321436|FG002|Overall Study|Physician Decision|0|||
162618906|NCT02761733|587321437|FG003|Overall Study|Physician Decision|0|||
162618907|NCT02761733|587321434|FG000|Overall Study|Withdrawal by Subject|2|||
162618908|NCT02761733|587321435|FG001|Overall Study|Withdrawal by Subject|0|||
162618909|NCT02761733|587321436|FG002|Overall Study|Withdrawal by Subject|0|||
162618910|NCT02761733|587321437|FG003|Overall Study|Withdrawal by Subject|0|||
162618911|NCT02761733|587321434|FG000|Overall Study|Discharged from Study Site|10|||
162618912|NCT02761733|587321435|FG001|Overall Study|Discharged from Study Site|9|||
162618913|NCT02761733|587321436|FG002|Overall Study|Discharged from Study Site|25|||
162618914|NCT02761733|587321437|FG003|Overall Study|Discharged from Study Site|11|||
162618915|NCT02761733|587321434|FG000|Overall Study|Cognitive Impairment|5|||
162618916|NCT02761733|587321435|FG001|Overall Study|Cognitive Impairment|0|||
162618917|NCT02761733|587321436|FG002|Overall Study|Cognitive Impairment|1|||
162618918|NCT02761733|587321437|FG003|Overall Study|Cognitive Impairment|0|||
162618919|NCT00669396|587321438|FG000|Overall Study|Lost to Follow-up|10|||
162618920|NCT00669396|587321439|FG001|Overall Study|Lost to Follow-up|12|||
162618921|NCT01262573|587321440|FG000|Overall Study|Withdrawal by Subject|0|||
162618922|NCT01262573|587321441|FG001|Overall Study|Withdrawal by Subject|1|||
162618923|NCT00810693|587321442|FG000|Treatment Period|Adverse Event|8|||
162618924|NCT00810693|587321443|FG001|Treatment Period|Adverse Event|1|||
162618925|NCT00810693|587321444|FG002|Treatment Period|Adverse Event|7|||
162618926|NCT00810693|587321442|FG000|Treatment Period|Death|0|||
162618927|NCT00810693|587321443|FG001|Treatment Period|Death|1|||
162618928|NCT00810693|587321444|FG002|Treatment Period|Death|2|||
162618929|NCT00810693|587321442|FG000|Treatment Period|Lack of Efficacy|0|||
162618930|NCT00810693|587321443|FG001|Treatment Period|Lack of Efficacy|0|||
162618931|NCT00810693|587321444|FG002|Treatment Period|Lack of Efficacy|1|||
162618932|NCT00810693|587321442|FG000|Treatment Period|Lost to Follow-up|1|||
162888787|NCT01617187|588291040|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
162888788|NCT01617187|588291041|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
162888789|NCT01617187|588291042|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
162888790|NCT01617187|588291039|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
162888791|NCT01617187|588291040|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
162888792|NCT01617187|588291041|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
162888793|NCT01617187|588291042|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
162888794|NCT01617187|588291039|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
162888795|NCT01617187|588291040|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
162888796|NCT01617187|588291041|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
162888797|NCT01617187|588291042|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
162888798|NCT01617187|588291039|FG000|Treatment Through Study Completion|Adverse Event|1|||
162888799|NCT01617187|588291040|FG001|Treatment Through Study Completion|Adverse Event|1|||
162888800|NCT01617187|588291041|FG002|Treatment Through Study Completion|Adverse Event|0|||
162888801|NCT01617187|588291042|FG003|Treatment Through Study Completion|Adverse Event|1|||
162888802|NCT01617187|588291039|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
162888803|NCT01617187|588291040|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
162888804|NCT01617187|588291041|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
162888805|NCT01617187|588291042|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
162888806|NCT01617187|588291039|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
163051109|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
162618933|NCT00810693|587321443|FG001|Treatment Period|Lost to Follow-up|0|||
162618934|NCT00810693|587321444|FG002|Treatment Period|Lost to Follow-up|0|||
162708315|NCT00079937|587642746|FG000|Overall Study|Adverse Event|2|||
162618935|NCT00810693|587321442|FG000|Treatment Period|Non-compliance|1|||
162618936|NCT00810693|587321443|FG001|Treatment Period|Non-compliance|0|||
162618937|NCT00810693|587321444|FG002|Treatment Period|Non-compliance|0|||
162618938|NCT00810693|587321442|FG000|Treatment Period|Protocol Violation|1|||
162618939|NCT00810693|587321443|FG001|Treatment Period|Protocol Violation|2|||
162618940|NCT00810693|587321444|FG002|Treatment Period|Protocol Violation|2|||
163051110|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
163051111|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051112|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051113|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051114|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
163051115|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
163051116|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051117|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051118|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051119|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
163051120|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
163051121|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051122|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051123|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051124|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
163051125|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
163051126|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051127|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051128|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051129|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
163051130|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
163051131|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051132|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051133|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051134|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163051135|NCT02709746|588895354|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
163051136|NCT02709746|588895355|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051137|NCT02709746|588895356|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051138|NCT02709746|588895357|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051139|NCT02709746|588895358|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
163051140|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051141|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
163051142|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051143|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
163051144|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
163051145|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
163051146|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
163051147|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
163051148|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
163051149|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
163051150|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
163051151|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
163051152|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
163051153|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
163051154|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
163051155|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
163051156|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
163051157|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
163051158|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
163051159|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
163051160|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
163051161|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
163051162|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
163051163|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
163051164|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
163051165|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
163051166|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
162708316|NCT00079937|587642747|FG001|Overall Study|Adverse Event|1|||
162963788|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
162963789|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
162963790|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
162963791|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
162963792|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
162963793|NCT00385736|588567881|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
162963794|NCT00385736|588567882|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
162963795|NCT00385736|588567883|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
162963796|NCT00385736|588567881|FG000|Safety Analysis Set|Adverse Event|23|||
162963797|NCT00385736|588567882|FG001|Safety Analysis Set|Adverse Event|15|||
162963798|NCT00385736|588567883|FG002|Safety Analysis Set|Adverse Event|23|||
162963799|NCT00385736|588567881|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
162963800|NCT00385736|588567882|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
162963801|NCT00385736|588567883|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
162963802|NCT00385736|588567881|FG000|Safety Analysis Set|Lost to Follow-up|0|||
162963803|NCT00385736|588567882|FG001|Safety Analysis Set|Lost to Follow-up|2|||
162963804|NCT00385736|588567883|FG002|Safety Analysis Set|Lost to Follow-up|2|||
162963805|NCT00385736|588567881|FG000|Safety Analysis Set|Lack of Efficacy|38|||
162963806|NCT00385736|588567882|FG001|Safety Analysis Set|Lack of Efficacy|16|||
162963807|NCT00385736|588567883|FG002|Safety Analysis Set|Lack of Efficacy|31|||
162963808|NCT00385736|588567881|FG000|Safety Analysis Set|Protocol Violation|2|||
162963809|NCT00385736|588567882|FG001|Safety Analysis Set|Protocol Violation|1|||
162963810|NCT00385736|588567883|FG002|Safety Analysis Set|Protocol Violation|6|||
162963811|NCT00385736|588567881|FG000|Safety Analysis Set|Other|1|||
162963812|NCT00385736|588567882|FG001|Safety Analysis Set|Other|4|||
162963813|NCT00385736|588567883|FG002|Safety Analysis Set|Other|4|||
162963814|NCT03602339|588567890|FG000|Overall Study|Withdrawal by Subject|9|||
162963815|NCT03602339|588567890|FG000|Overall Study|Physician Decision|2|||
162963816|NCT03602339|588567890|FG000|Overall Study|Other reason|4|||
162963817|NCT00829452|588567895|FG000|First Intervention|Withdrawal by Subject|0|||
162963818|NCT00829452|588567896|FG001|First Intervention|Withdrawal by Subject|1|||
162963819|NCT00829452|588567895|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
162963820|NCT00829452|588567896|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
162963821|NCT00829452|588567895|FG000|Second Intervention|Physician Decision|0|||
162963822|NCT00829452|588567896|FG001|Second Intervention|Physician Decision|1|||
162963823|NCT02615249|588567897|FG000|Overall Study|Withdrawal by Subject|1|||
162963824|NCT05098743|588567908|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
162963825|NCT05098743|588567909|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
162963826|NCT05098743|588567908|FG000|Overall Study|Lost to Follow-up|1|||
162963827|NCT05098743|588567909|FG001|Overall Study|Lost to Follow-up|2|||
162963828|NCT04060251|588567910|FG000|Overall Study|Study terminated due to low enrollment.|7|||
162963829|NCT04060251|588567911|FG001|Overall Study|Study terminated due to low enrollment.|5|||
162963830|NCT04060251|588567912|FG002|Overall Study|Study terminated due to low enrollment.|7|||
162963831|NCT04060251|588567910|FG000|Overall Study|Adverse Event|1|||
162963832|NCT04060251|588567911|FG001|Overall Study|Adverse Event|1|||
162963833|NCT04060251|588567912|FG002|Overall Study|Adverse Event|0|||
162963834|NCT00487435|588567913|FG000|Overall Study|Adverse Event|146|||
162963835|NCT00487435|588567913|FG000|Overall Study|Death|2|||
162963836|NCT00487435|588567913|FG000|Overall Study|Lack of Efficacy|33|||
162963837|NCT00487435|588567913|FG000|Overall Study|Lost to Follow-up|54|||
162963838|NCT00487435|588567913|FG000|Overall Study|Pregnancy|2|||
162963839|NCT00487435|588567913|FG000|Overall Study|Withdrawal by Subject|132|||
162963840|NCT00487435|588567913|FG000|Overall Study|Resolution Of Pain|1|||
162963841|NCT00487435|588567913|FG000|Overall Study|Study Medication Non-Compliant|32|||
162963842|NCT00487435|588567913|FG000|Overall Study|Other|83|||
162963843|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
162963844|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
162963845|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
162963846|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
162963847|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
162963848|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
162963849|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
162963850|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
162618941|NCT00810693|587321442|FG000|Treatment Period|Withdrawal by Subject|6|||
162618942|NCT00810693|587321443|FG001|Treatment Period|Withdrawal by Subject|2|||
162618943|NCT00810693|587321444|FG002|Treatment Period|Withdrawal by Subject|3|||
162618944|NCT00810693|587321442|FG000|Treatment Period|Not treated|0|||
162618945|NCT00810693|587321443|FG001|Treatment Period|Not treated|1|||
162618946|NCT00810693|587321444|FG002|Treatment Period|Not treated|1|||
162618947|NCT00810693|587321442|FG000|Follow-up Period (FUP)|Adverse Event|3|||
162618948|NCT00810693|587321443|FG001|Follow-up Period (FUP)|Adverse Event|1|||
162618949|NCT00810693|587321444|FG002|Follow-up Period (FUP)|Adverse Event|1|||
162618950|NCT00810693|587321442|FG000|Follow-up Period (FUP)|Death|2|||
162618951|NCT00810693|587321443|FG001|Follow-up Period (FUP)|Death|0|||
162618952|NCT00810693|587321444|FG002|Follow-up Period (FUP)|Death|1|||
162618953|NCT00810693|587321442|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
162618954|NCT00810693|587321443|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
162618955|NCT00810693|587321444|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
162618956|NCT00810693|587321442|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
162618957|NCT00810693|587321443|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
162618958|NCT00810693|587321444|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
162618959|NCT00810693|587321442|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
162618960|NCT00810693|587321443|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
162618961|NCT00810693|587321444|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
162618962|NCT04295772|587321447|FG000|Overall Study|Protocol Violation|1|||
162618963|NCT04295772|587321448|FG001|Overall Study|Protocol Violation|0|||
162618964|NCT04295772|587321447|FG000|Overall Study|Ongoing for safety monitoring|14|||
162618965|NCT04295772|587321448|FG001|Overall Study|Ongoing for safety monitoring|1|||
162618966|NCT04295772|587321447|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
162618967|NCT04295772|587321448|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
162618968|NCT00331422|587321449|FG000|Overall Study|Did not receive entire study regimen|5|||
162618969|NCT02345226|587321450|FG000|Double-Blind Phase|Adverse Event|5|||
162618970|NCT02345226|587321451|FG001|Double-Blind Phase|Adverse Event|6|||
162618971|NCT02345226|587321450|FG000|Double-Blind Phase|Death|3|||
162618972|NCT02345226|587321451|FG001|Double-Blind Phase|Death|0|||
162618973|NCT02345226|587321450|FG000|Double-Blind Phase|Pregnancy|0|||
162618974|NCT02345226|587321451|FG001|Double-Blind Phase|Pregnancy|1|||
162618975|NCT02345226|587321450|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162618976|NCT02345226|587321451|FG001|Double-Blind Phase|Lack of Efficacy|0|||
162618977|NCT02345226|587321450|FG000|Double-Blind Phase|Investigator's Discretion|4|||
162618978|NCT02345226|587321451|FG001|Double-Blind Phase|Investigator's Discretion|3|||
162618979|NCT02345226|587321450|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
162618980|NCT02345226|587321451|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
162618981|NCT02345226|587321450|FG000|Double-Blind Phase|Withdrew Consent|41|||
162618982|NCT02345226|587321451|FG001|Double-Blind Phase|Withdrew Consent|39|||
162618983|NCT02345226|587321450|FG000|Double-Blind Phase|Lost to Follow-up|12|||
162618984|NCT02345226|587321451|FG001|Double-Blind Phase|Lost to Follow-up|16|||
162618985|NCT02345226|587321450|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
162618986|NCT02345226|587321451|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
162618987|NCT02345226|587321450|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162618988|NCT02345226|587321451|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
162618989|NCT03386474|587321459|FG000|Overall Study|Death|1|||
162618990|NCT03386474|587321460|FG001|Overall Study|Death|0|||
162708317|NCT00079937|587642746|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162618991|NCT03386474|587321459|FG000|Overall Study|Adverse Event|0|||
162618992|NCT03386474|587321460|FG001|Overall Study|Adverse Event|1|||
162618993|NCT00066729|587321462|FG000|Overall Study|Lost to Follow-up|1|||
162618994|NCT00066729|587321462|FG000|Overall Study|Disease progression|1|||
162618995|NCT02349542|587321465|FG000|Overall Study|Withdrawal by Subject|5|||
162618996|NCT03896165|587321468|FG000|Overall Study|Withdrawal by Subject|2|||
162618997|NCT01163266|587321469|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
162618998|NCT01163266|587321470|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
162618999|NCT01163266|587321471|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
162888807|NCT01617187|588291040|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
162888808|NCT01617187|588291041|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
162888809|NCT01617187|588291042|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
162888810|NCT01617187|588291039|FG000|Treatment Through Study Completion|Protocol Violation|1|||
162888811|NCT01617187|588291040|FG001|Treatment Through Study Completion|Protocol Violation|0|||
162888812|NCT01617187|588291041|FG002|Treatment Through Study Completion|Protocol Violation|0|||
162888813|NCT01617187|588291042|FG003|Treatment Through Study Completion|Protocol Violation|1|||
162888814|NCT01265420|588291043|FG000|Overall Study|Lost to Follow-up|1|||
162888815|NCT03337139|588291047|FG000|Phase I|Withdrawal by Subject|10|||
162888816|NCT03337139|588291048|FG001|Phase I|Withdrawal by Subject|0|||
162888817|NCT02554253|588291049|FG000|Overall Study|ineligible after enrollment|1|||
162888818|NCT02554253|588291050|FG001|Overall Study|ineligible after enrollment|0|||
162888819|NCT02554253|588291049|FG000|Overall Study|converted to transcatheter procedure|0|||
162619000|NCT01163266|587321469|FG000|Overall Study|Lack of Efficacy|1|||
162619001|NCT01163266|587321470|FG001|Overall Study|Lack of Efficacy|3|||
162619002|NCT01163266|587321471|FG002|Overall Study|Lack of Efficacy|1|||
162619003|NCT01163266|587321469|FG000|Overall Study|Noncompliance with Study Drug|0|||
162619004|NCT01163266|587321470|FG001|Overall Study|Noncompliance with Study Drug|2|||
162619005|NCT01163266|587321471|FG002|Overall Study|Noncompliance with Study Drug|0|||
162619006|NCT01163266|587321469|FG000|Overall Study|Protocol Deviations|2|||
162619007|NCT01163266|587321470|FG001|Overall Study|Protocol Deviations|2|||
162619008|NCT01163266|587321471|FG002|Overall Study|Protocol Deviations|5|||
162619009|NCT01163266|587321469|FG000|Overall Study|Withdrawal of Consent|5|||
162619010|NCT01163266|587321470|FG001|Overall Study|Withdrawal of Consent|7|||
162619011|NCT01163266|587321471|FG002|Overall Study|Withdrawal of Consent|3|||
162619012|NCT01163266|587321469|FG000|Overall Study|Lost to Follow-up|7|||
162619013|NCT01163266|587321470|FG001|Overall Study|Lost to Follow-up|7|||
162619014|NCT01163266|587321471|FG002|Overall Study|Lost to Follow-up|10|||
162619015|NCT01163266|587321469|FG000|Overall Study|Other|1|||
162619016|NCT01163266|587321470|FG001|Overall Study|Other|1|||
162619017|NCT01163266|587321471|FG002|Overall Study|Other|2|||
162619018|NCT02919696|587321472|FG000|Overall Study|Adverse Event|1|||
162619019|NCT02919696|587321473|FG001|Overall Study|Adverse Event|2|||
162619020|NCT02919696|587321472|FG000|Overall Study|Withdrawal by Subject|2|||
162619021|NCT02919696|587321473|FG001|Overall Study|Withdrawal by Subject|1|||
162619022|NCT02919696|587321472|FG000|Overall Study|Sponsor Decision|1|||
162619023|NCT02919696|587321473|FG001|Overall Study|Sponsor Decision|1|||
162619024|NCT02919696|587321472|FG000|Overall Study|Never Treated|0|||
162619025|NCT02919696|587321473|FG001|Overall Study|Never Treated|1|||
162619026|NCT03181893|587321474|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619027|NCT03181893|587321475|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
162619028|NCT03181893|587321476|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619029|NCT03181893|587321477|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619030|NCT03181893|587321478|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619031|NCT03181893|587321479|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619032|NCT03181893|587321480|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619033|NCT03181893|587321481|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619034|NCT03181893|587321482|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619035|NCT03181893|587321483|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619036|NCT03181893|587321484|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162619037|NCT03181893|587321474|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
162619038|NCT03181893|587321475|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
162619039|NCT03181893|587321476|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619040|NCT03181893|587321477|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619041|NCT03181893|587321478|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619042|NCT03181893|587321479|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619043|NCT03181893|587321480|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619044|NCT03181893|587321481|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162888820|NCT02554253|588291050|FG001|Overall Study|converted to transcatheter procedure|1|||
162888821|NCT02554253|588291049|FG000|Overall Study|received both drugs|0|||
162619045|NCT03181893|587321482|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619046|NCT03181893|587321483|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619047|NCT03181893|587321484|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162619048|NCT03181893|587321474|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619049|NCT03181893|587321475|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619050|NCT03181893|587321476|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619051|NCT03181893|587321477|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619052|NCT03181893|587321478|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619053|NCT03181893|587321479|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162888822|NCT02554253|588291050|FG001|Overall Study|received both drugs|1|||
162619054|NCT03181893|587321480|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619055|NCT03181893|587321481|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
162619056|NCT03181893|587321482|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
162619057|NCT03181893|587321483|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162888823|NCT02559206|588291057|FG000|Overall Study|Adverse Event|0|||
162888824|NCT02559206|588291058|FG001|Overall Study|Adverse Event|4|||
162888825|NCT02559206|588291059|FG002|Overall Study|Adverse Event|1|||
162888826|NCT02559206|588291060|FG003|Overall Study|Adverse Event|5|||
162888827|NCT02559206|588291061|FG004|Overall Study|Adverse Event|3|||
162619058|NCT03181893|587321484|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162619059|NCT03181893|587321474|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619060|NCT03181893|587321475|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619061|NCT03181893|587321476|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619062|NCT03181893|587321477|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619063|NCT03181893|587321478|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619064|NCT03181893|587321479|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619065|NCT03181893|587321480|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619066|NCT03181893|587321481|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619067|NCT03181893|587321482|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619068|NCT03181893|587321483|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
162619069|NCT03181893|587321484|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162619070|NCT03181893|587321474|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619071|NCT03181893|587321475|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619072|NCT03181893|587321476|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619073|NCT03181893|587321477|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619074|NCT03181893|587321478|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619075|NCT03181893|587321479|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619076|NCT03181893|587321480|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619077|NCT03181893|587321481|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619078|NCT03181893|587321482|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619079|NCT03181893|587321483|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162619080|NCT03181893|587321484|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
162619081|NCT04128371|587321485|FG000|Overall Study|Lack of Efficacy|1|||
162619082|NCT03021304|587321487|FG000|Overall Study|Lack of Efficacy|1|||
162619083|NCT01361568|587321490|FG000|Overall Study|Adverse Event|0|||
162619084|NCT01361568|587321491|FG001|Overall Study|Adverse Event|0|||
162619085|NCT01361568|587321492|FG002|Overall Study|Adverse Event|0|||
162888828|NCT02559206|588291062|FG005|Overall Study|Adverse Event|0|||
162888829|NCT02559206|588291063|FG006|Overall Study|Adverse Event|1|||
162888830|NCT02559206|588291064|FG007|Overall Study|Adverse Event|0|||
162888831|NCT02559206|588291057|FG000|Overall Study|Protocol Violation|1|||
162888832|NCT02559206|588291058|FG001|Overall Study|Protocol Violation|0|||
162888833|NCT02559206|588291059|FG002|Overall Study|Protocol Violation|1|||
162888834|NCT02559206|588291060|FG003|Overall Study|Protocol Violation|0|||
162888835|NCT02559206|588291061|FG004|Overall Study|Protocol Violation|0|||
162888836|NCT02559206|588291062|FG005|Overall Study|Protocol Violation|2|||
162888837|NCT02559206|588291063|FG006|Overall Study|Protocol Violation|0|||
162888838|NCT02559206|588291064|FG007|Overall Study|Protocol Violation|0|||
162888839|NCT02559206|588291057|FG000|Overall Study|Withdrawal by Subject|3|||
162888840|NCT02559206|588291058|FG001|Overall Study|Withdrawal by Subject|3|||
162888841|NCT02559206|588291059|FG002|Overall Study|Withdrawal by Subject|1|||
162888842|NCT02559206|588291060|FG003|Overall Study|Withdrawal by Subject|3|||
162888843|NCT02559206|588291061|FG004|Overall Study|Withdrawal by Subject|5|||
162888844|NCT02559206|588291062|FG005|Overall Study|Withdrawal by Subject|4|||
162888845|NCT02559206|588291063|FG006|Overall Study|Withdrawal by Subject|1|||
162888846|NCT02559206|588291064|FG007|Overall Study|Withdrawal by Subject|2|||
162963851|NCT01087502|588567920|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
162888847|NCT02559206|588291057|FG000|Overall Study|Lost to Follow-up|3|||
162888848|NCT02559206|588291058|FG001|Overall Study|Lost to Follow-up|5|||
162888849|NCT02559206|588291059|FG002|Overall Study|Lost to Follow-up|3|||
162963852|NCT01087502|588567921|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
162963853|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
162963854|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
162963855|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
162619086|NCT01361568|587321493|FG003|Overall Study|Adverse Event|0|||
162619087|NCT01361568|587321494|FG004|Overall Study|Adverse Event|1|||
162619088|NCT01361568|587321495|FG005|Overall Study|Adverse Event|0|||
162619089|NCT01361568|587321490|FG000|Overall Study|Physician Decision|0|||
162619090|NCT01361568|587321491|FG001|Overall Study|Physician Decision|0|||
162619091|NCT01361568|587321492|FG002|Overall Study|Physician Decision|0|||
162619092|NCT01361568|587321493|FG003|Overall Study|Physician Decision|0|||
162619093|NCT01361568|587321494|FG004|Overall Study|Physician Decision|0|||
162963856|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
162888850|NCT02559206|588291060|FG003|Overall Study|Lost to Follow-up|3|||
162888851|NCT02559206|588291061|FG004|Overall Study|Lost to Follow-up|2|||
162888852|NCT02559206|588291062|FG005|Overall Study|Lost to Follow-up|5|||
162888853|NCT02559206|588291063|FG006|Overall Study|Lost to Follow-up|1|||
162963857|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
162963858|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
162619094|NCT01361568|587321495|FG005|Overall Study|Physician Decision|1|||
162619095|NCT01361568|587321490|FG000|Overall Study|Withdrawal by Subject|2|||
162888854|NCT02559206|588291064|FG007|Overall Study|Lost to Follow-up|4|||
162888855|NCT02559206|588291057|FG000|Overall Study|Lack of Efficacy|1|||
163051167|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
163051168|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
163051169|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
163051170|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
162619096|NCT01361568|587321491|FG001|Overall Study|Withdrawal by Subject|1|||
162619097|NCT01361568|587321492|FG002|Overall Study|Withdrawal by Subject|0|||
162619098|NCT01361568|587321493|FG003|Overall Study|Withdrawal by Subject|0|||
162619099|NCT01361568|587321494|FG004|Overall Study|Withdrawal by Subject|0|||
162619100|NCT01361568|587321495|FG005|Overall Study|Withdrawal by Subject|1|||
162619101|NCT03308786|587321496|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
162619102|NCT00761631|587321497|FG000|Overall Study|Parent/legal guardian request|8|||
162619103|NCT00761631|587321498|FG001|Overall Study|Parent/legal guardian request|3|||
162619104|NCT00761631|587321499|FG002|Overall Study|Parent/legal guardian request|8|||
162619105|NCT00761631|587321500|FG003|Overall Study|Parent/legal guardian request|0|||
162619106|NCT00761631|587321501|FG004|Overall Study|Parent/legal guardian request|5|||
162619107|NCT00761631|587321502|FG005|Overall Study|Parent/legal guardian request|0|||
162619108|NCT00761631|587321497|FG000|Overall Study|Lost to Follow-up|2|||
162619109|NCT00761631|587321498|FG001|Overall Study|Lost to Follow-up|4|||
162619110|NCT00761631|587321499|FG002|Overall Study|Lost to Follow-up|7|||
162619111|NCT00761631|587321500|FG003|Overall Study|Lost to Follow-up|1|||
162619112|NCT00761631|587321501|FG004|Overall Study|Lost to Follow-up|6|||
162619113|NCT00761631|587321502|FG005|Overall Study|Lost to Follow-up|1|||
162619114|NCT00761631|587321497|FG000|Overall Study|Protocol Violation|2|||
162619115|NCT00761631|587321498|FG001|Overall Study|Protocol Violation|0|||
162619116|NCT00761631|587321499|FG002|Overall Study|Protocol Violation|0|||
162619117|NCT00761631|587321500|FG003|Overall Study|Protocol Violation|1|||
162619118|NCT00761631|587321501|FG004|Overall Study|Protocol Violation|5|||
162619119|NCT00761631|587321502|FG005|Overall Study|Protocol Violation|1|||
162619120|NCT00761631|587321497|FG000|Overall Study|Randomized, not treated|1|||
162619121|NCT00761631|587321498|FG001|Overall Study|Randomized, not treated|0|||
162619122|NCT00761631|587321499|FG002|Overall Study|Randomized, not treated|0|||
162619123|NCT00761631|587321500|FG003|Overall Study|Randomized, not treated|0|||
162619124|NCT00761631|587321501|FG004|Overall Study|Randomized, not treated|0|||
162619125|NCT00761631|587321502|FG005|Overall Study|Randomized, not treated|0|||
162619126|NCT00761631|587321497|FG000|Overall Study|Failed to return|1|||
162619127|NCT00761631|587321498|FG001|Overall Study|Failed to return|0|||
162619128|NCT00761631|587321499|FG002|Overall Study|Failed to return|1|||
162619129|NCT00761631|587321500|FG003|Overall Study|Failed to return|1|||
162619130|NCT00761631|587321501|FG004|Overall Study|Failed to return|5|||
162619131|NCT00761631|587321502|FG005|Overall Study|Failed to return|2|||
162619132|NCT00761631|587321497|FG000|Overall Study|Physician Decision|1|||
162619133|NCT00761631|587321498|FG001|Overall Study|Physician Decision|0|||
162619134|NCT00761631|587321499|FG002|Overall Study|Physician Decision|0|||
162619135|NCT00761631|587321500|FG003|Overall Study|Physician Decision|0|||
162619136|NCT00761631|587321501|FG004|Overall Study|Physician Decision|0|||
162619137|NCT00761631|587321502|FG005|Overall Study|Physician Decision|0|||
162619138|NCT00761631|587321497|FG000|Overall Study|Other|0|||
162619139|NCT00761631|587321498|FG001|Overall Study|Other|0|||
162619140|NCT00761631|587321499|FG002|Overall Study|Other|0|||
162619141|NCT00761631|587321500|FG003|Overall Study|Other|0|||
162619142|NCT00761631|587321501|FG004|Overall Study|Other|1|||
162619143|NCT00761631|587321502|FG005|Overall Study|Other|1|||
162619144|NCT01999868|587321503|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
162619145|NCT01999868|587321504|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
162708318|NCT00079937|587642747|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162708319|NCT00079937|587642746|FG000|Overall Study|Subject no longer requires study drug|3|||
162888856|NCT02559206|588291058|FG001|Overall Study|Lack of Efficacy|0|||
162888857|NCT02559206|588291059|FG002|Overall Study|Lack of Efficacy|3|||
162888858|NCT02559206|588291060|FG003|Overall Study|Lack of Efficacy|2|||
162888859|NCT02559206|588291061|FG004|Overall Study|Lack of Efficacy|2|||
163051171|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163051172|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
162619146|NCT01999868|587321505|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
162619147|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
162619148|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
162619149|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
162619150|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
162619151|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
162619152|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
162619153|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
162708320|NCT00079937|587642747|FG001|Overall Study|Subject no longer requires study drug|0|||
162619154|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
162619155|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
162708321|NCT00079937|587642746|FG000|Overall Study|Protocol Violation|8|||
162708322|NCT00079937|587642747|FG001|Overall Study|Protocol Violation|6|||
162708323|NCT00079937|587642746|FG000|Overall Study|Withdrawal by Subject|21|||
162708324|NCT00079937|587642747|FG001|Overall Study|Withdrawal by Subject|7|||
162708325|NCT00079937|587642746|FG000|Overall Study|Lost to Follow-up|12|||
162708326|NCT00079937|587642747|FG001|Overall Study|Lost to Follow-up|5|||
162708327|NCT00079937|587642746|FG000|Overall Study|Administrative problems|22|||
162708328|NCT00079937|587642747|FG001|Overall Study|Administrative problems|11|||
162708329|NCT02857283|587642748|FG000|First Exposure|Withdrawal by Subject|1|||
162708330|NCT02857283|587642749|FG001|First Exposure|Withdrawal by Subject|0|||
162708331|NCT00093795|587642750|FG000|Overall Study|No follow up data|20|||
162708332|NCT00093795|587642751|FG001|Overall Study|No follow up data|16|||
162708333|NCT00093795|587642752|FG002|Overall Study|No follow up data|17|||
162888860|NCT02559206|588291062|FG005|Overall Study|Lack of Efficacy|3|||
162888861|NCT02559206|588291063|FG006|Overall Study|Lack of Efficacy|3|||
162888862|NCT02559206|588291064|FG007|Overall Study|Lack of Efficacy|3|||
162888863|NCT02559206|588291057|FG000|Overall Study|Other Not Specified|0|||
162888864|NCT02559206|588291058|FG001|Overall Study|Other Not Specified|0|||
162888865|NCT02559206|588291059|FG002|Overall Study|Other Not Specified|0|||
162888866|NCT02559206|588291060|FG003|Overall Study|Other Not Specified|1|||
162888867|NCT02559206|588291061|FG004|Overall Study|Other Not Specified|0|||
162888868|NCT02559206|588291062|FG005|Overall Study|Other Not Specified|0|||
162888869|NCT02559206|588291063|FG006|Overall Study|Other Not Specified|0|||
162888870|NCT02559206|588291064|FG007|Overall Study|Other Not Specified|0|||
162888871|NCT01561560|588291065|FG000|First Two Weeks of Wear|Time/job conflict|0|||
162888872|NCT01561560|588291066|FG001|First Two Weeks of Wear|Time/job conflict|1|||
162888873|NCT01561560|588291065|FG000|First Two Weeks of Wear|Adverse Event|0|||
162888874|NCT01561560|588291066|FG001|First Two Weeks of Wear|Adverse Event|1|||
162888875|NCT01561560|588291065|FG000|Second Two Weeks of Wear|Adverse Event|0|||
162888876|NCT01561560|588291066|FG001|Second Two Weeks of Wear|Adverse Event|1|||
162888877|NCT03862131|588291067|FG000|Overall Study|Lost to Follow-up|1|||
162888878|NCT03862131|588291068|FG001|Overall Study|Lost to Follow-up|0|||
162888879|NCT03862131|588291069|FG002|Overall Study|Lost to Follow-up|1|||
162888880|NCT03862131|588291067|FG000|Overall Study|Determined to be ineligible|0|||
162888881|NCT03862131|588291068|FG001|Overall Study|Determined to be ineligible|0|||
162888882|NCT03862131|588291069|FG002|Overall Study|Determined to be ineligible|5|||
162888883|NCT03862131|588291067|FG000|Overall Study|Death|4|||
162888884|NCT03862131|588291068|FG001|Overall Study|Death|4|||
162888885|NCT03862131|588291069|FG002|Overall Study|Death|0|||
162888886|NCT03862131|588291067|FG000|Overall Study|Withdrawal by Subject|5|||
162888887|NCT03862131|588291068|FG001|Overall Study|Withdrawal by Subject|3|||
162888888|NCT03862131|588291069|FG002|Overall Study|Withdrawal by Subject|0|||
162888889|NCT03862131|588291067|FG000|Overall Study|Physician Decision|0|||
162888890|NCT03862131|588291068|FG001|Overall Study|Physician Decision|1|||
162888891|NCT03862131|588291069|FG002|Overall Study|Physician Decision|0|||
162888892|NCT01871896|588291072|FG000|Overall Study|Lost to Follow-up|1|||
162888893|NCT05406440|588293027|FG000|Overall Study|Lost to Follow-up|0|||
162888894|NCT05406440|588293028|FG001|Overall Study|Lost to Follow-up|0|||
162888895|NCT05406440|588293029|FG002|Overall Study|Lost to Follow-up|0|||
162888896|NCT05406440|588293030|FG003|Overall Study|Lost to Follow-up|0|||
162888897|NCT05406440|588293031|FG004|Overall Study|Lost to Follow-up|2|||
162888898|NCT05406440|588293032|FG005|Overall Study|Lost to Follow-up|0|||
162888899|NCT05406440|588293033|FG006|Overall Study|Lost to Follow-up|0|||
162888900|NCT05406440|588293027|FG000|Overall Study|Physician Decision|0|||
162888901|NCT05406440|588293028|FG001|Overall Study|Physician Decision|0|||
162888902|NCT05406440|588293029|FG002|Overall Study|Physician Decision|0|||
162888903|NCT05406440|588293030|FG003|Overall Study|Physician Decision|0|||
162888904|NCT05406440|588293031|FG004|Overall Study|Physician Decision|1|||
162888905|NCT05406440|588293032|FG005|Overall Study|Physician Decision|0|||
163051173|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
163051174|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
162708334|NCT00613301|587642753|FG000|Overall Study|Adverse Event|49|||
162888906|NCT05406440|588293033|FG006|Overall Study|Physician Decision|0|||
162888907|NCT05406440|588293027|FG000|Overall Study|Withdrawal by Subject|0|||
162888908|NCT05406440|588293028|FG001|Overall Study|Withdrawal by Subject|0|||
162708335|NCT00613301|587642753|FG000|Overall Study|Lost to Follow-up|88|||
162888909|NCT05406440|588293029|FG002|Overall Study|Withdrawal by Subject|0|||
162888910|NCT05406440|588293030|FG003|Overall Study|Withdrawal by Subject|0|||
162888911|NCT05406440|588293031|FG004|Overall Study|Withdrawal by Subject|0|||
162888912|NCT05406440|588293032|FG005|Overall Study|Withdrawal by Subject|2|||
162888913|NCT05406440|588293033|FG006|Overall Study|Withdrawal by Subject|0|||
162708336|NCT00613301|587642753|FG000|Overall Study|Withdrawal by Subject|5|||
162888914|NCT01412151|588293034|FG000|Week 0 - 306 - Treatment Period|Death|1|||
162888915|NCT01412151|588293034|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
162888916|NCT01412151|588293034|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
162708337|NCT00613301|587642753|FG000|Overall Study|Death|6|||
162708338|NCT00613301|587642753|FG000|Overall Study|Lack of Efficacy|13|||
162888917|NCT01412151|588293034|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
162888918|NCT03127852|588293035|FG000|Overall Study|Withdrawal by Subject|4|||
162888919|NCT03127852|588293036|FG001|Overall Study|Withdrawal by Subject|1|||
162888920|NCT03127852|588293035|FG000|Overall Study|Death|1|||
162888921|NCT03127852|588293036|FG001|Overall Study|Death|1|||
162888922|NCT03621189|588293037|FG000|Overall Study|Withdrawal by Subject|0|||
162888923|NCT03621189|588293038|FG001|Overall Study|Withdrawal by Subject|3|||
162888924|NCT03621189|588293037|FG000|Overall Study|Physician Decision|0|||
162888925|NCT03621189|588293038|FG001|Overall Study|Physician Decision|2|||
162888926|NCT01824693|588293039|FG000|Overall Study|Death|0|||
162888927|NCT01824693|588293040|FG001|Overall Study|Death|1|||
162888928|NCT01824693|588293041|FG002|Overall Study|Death|0|||
162888929|NCT01824693|588293039|FG000|Overall Study|Physician Decision|1|||
162888930|NCT01824693|588293040|FG001|Overall Study|Physician Decision|1|||
162888931|NCT01824693|588293041|FG002|Overall Study|Physician Decision|1|||
162888932|NCT01824693|588293039|FG000|Overall Study|Withdrawal by Subject|0|||
162888933|NCT01824693|588293040|FG001|Overall Study|Withdrawal by Subject|0|||
162888934|NCT01824693|588293041|FG002|Overall Study|Withdrawal by Subject|1|||
162888935|NCT01824693|588293039|FG000|Overall Study|Progressive Disease|0|||
162888936|NCT01824693|588293040|FG001|Overall Study|Progressive Disease|5|||
162888937|NCT01824693|588293041|FG002|Overall Study|Progressive Disease|0|||
162888938|NCT01824693|588293039|FG000|Overall Study|Ineligible|0|||
162888939|NCT01824693|588293040|FG001|Overall Study|Ineligible|0|||
162888940|NCT01824693|588293041|FG002|Overall Study|Ineligible|3|||
162888941|NCT01824693|588293039|FG000|Overall Study|No Transplant Planned|0|||
162888942|NCT01824693|588293040|FG001|Overall Study|No Transplant Planned|0|||
162888943|NCT01824693|588293041|FG002|Overall Study|No Transplant Planned|10|||
162888944|NCT02150213|588293042|FG000|Overall Study|Lost to Follow-up|1|||
162888945|NCT02150213|588293042|FG000|Overall Study|Withdrawal by Subject|1|||
162888946|NCT03488238|588293043|FG000|Overall Study|Equipment malfunction|1|||
162888947|NCT03488238|588293043|FG000|Overall Study|Adverse Event|1|||
162888948|NCT01432457|588293044|FG000|Overall Study|Adverse Event|7|||
162888949|NCT01432457|588293045|FG001|Overall Study|Adverse Event|10|||
162888950|NCT01432457|588293046|FG002|Overall Study|Adverse Event|16|||
162888951|NCT01432457|588293044|FG000|Overall Study|Lack of Efficacy|2|||
162888952|NCT01432457|588293045|FG001|Overall Study|Lack of Efficacy|1|||
162888953|NCT01432457|588293046|FG002|Overall Study|Lack of Efficacy|1|||
162888954|NCT01432457|588293044|FG000|Overall Study|Lost to Follow-up|11|||
162888955|NCT01432457|588293045|FG001|Overall Study|Lost to Follow-up|15|||
162888956|NCT01432457|588293046|FG002|Overall Study|Lost to Follow-up|20|||
162888957|NCT01432457|588293044|FG000|Overall Study|Protocol Violation|3|||
162888958|NCT01432457|588293045|FG001|Overall Study|Protocol Violation|2|||
162888959|NCT01432457|588293046|FG002|Overall Study|Protocol Violation|6|||
162888960|NCT01432457|588293044|FG000|Overall Study|Withdrawal by Subject|6|||
162888961|NCT01432457|588293045|FG001|Overall Study|Withdrawal by Subject|11|||
162888962|NCT01432457|588293046|FG002|Overall Study|Withdrawal by Subject|9|||
162888963|NCT01432457|588293044|FG000|Overall Study|Reasons not defined|2|||
162888964|NCT01432457|588293045|FG001|Overall Study|Reasons not defined|3|||
162888965|NCT01432457|588293046|FG002|Overall Study|Reasons not defined|4|||
162888966|NCT01432457|588293044|FG000|Overall Study|Did not take study drug|6|||
162888967|NCT01432457|588293045|FG001|Overall Study|Did not take study drug|6|||
162888968|NCT01432457|588293046|FG002|Overall Study|Did not take study drug|3|||
162888969|NCT03382262|588293047|FG000|Overall Study|Physician Decision|0|||
162888970|NCT03382262|588293048|FG001|Overall Study|Physician Decision|0|||
162888971|NCT03382262|588293049|FG002|Overall Study|Physician Decision|1|||
162888972|NCT03382262|588293050|FG003|Overall Study|Physician Decision|0|||
162888973|NCT03382262|588293047|FG000|Overall Study|Withdrawal by Subject|0|||
162963859|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
162963860|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
162963861|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
162963862|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
162963863|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
162963864|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
162963865|NCT01087502|588567920|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
162888974|NCT03382262|588293048|FG001|Overall Study|Withdrawal by Subject|0|||
162888975|NCT03382262|588293049|FG002|Overall Study|Withdrawal by Subject|0|||
162888976|NCT03382262|588293050|FG003|Overall Study|Withdrawal by Subject|1|||
162888977|NCT02966353|588293051|FG000|Overall Study|Withdrawal by Subject|7|||
162888978|NCT02966353|588293051|FG000|Overall Study|Adverse Event|4|||
162888979|NCT02966353|588293051|FG000|Overall Study|Death|4|||
162963866|NCT01087502|588567921|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
162963867|NCT01151618|588567922|FG000|Overall Study|Adverse Event|2|||
162888980|NCT02966353|588293051|FG000|Overall Study|Physician Decision|3|||
162888981|NCT02966353|588293051|FG000|Overall Study|Progressive disease|2|||
162888982|NCT02966353|588293051|FG000|Overall Study|Protocol deviation|2|||
162888983|NCT01090102|588293052|FG000|First 12 Weeks|Withdrawal by Subject|1|||
162888984|NCT01090102|588293053|FG001|First 12 Weeks|Withdrawal by Subject|1|||
162888985|NCT01090102|588293052|FG000|First 12 Weeks|Adverse Event|2|||
162888986|NCT01090102|588293053|FG001|First 12 Weeks|Adverse Event|0|||
162888987|NCT01090102|588293052|FG000|First 12 Weeks|Death|1|||
162888988|NCT01090102|588293053|FG001|First 12 Weeks|Death|1|||
162888989|NCT01090102|588293052|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
162888990|NCT01090102|588293053|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
162888991|NCT03518034|588293056|FG000|Overall Study|Not Treated|5|||
162888992|NCT03518034|588293057|FG001|Overall Study|Not Treated|1|||
162888993|NCT03518034|588293056|FG000|Overall Study|Withdrawal by Subject|309|||
162888994|NCT03518034|588293057|FG001|Overall Study|Withdrawal by Subject|351|||
162888995|NCT03518034|588293056|FG000|Overall Study|Lost to Follow-up|446|||
162888996|NCT03518034|588293057|FG001|Overall Study|Lost to Follow-up|458|||
162888997|NCT03518034|588293056|FG000|Overall Study|Adverse Event|138|||
162888998|NCT03518034|588293057|FG001|Overall Study|Adverse Event|130|||
162888999|NCT03518034|588293056|FG000|Overall Study|Lack of Efficacy|11|||
162889000|NCT03518034|588293057|FG001|Overall Study|Lack of Efficacy|23|||
162889001|NCT03518034|588293056|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
162889002|NCT03518034|588293057|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
162889003|NCT03518034|588293056|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
162889004|NCT03518034|588293057|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
162889005|NCT03518034|588293056|FG000|Overall Study|Other, Not Specified|84|||
162889006|NCT03518034|588293057|FG001|Overall Study|Other, Not Specified|53|||
162889007|NCT03518034|588293056|FG000|Overall Study|Reason Missing|2|||
162889008|NCT03518034|588293057|FG001|Overall Study|Reason Missing|3|||
162889009|NCT01527110|588293058|FG000|Overall Study|Adverse Event|1|||
162889010|NCT02007252|588293059|FG000|Overall Study|Administrative problems|3|||
162889011|NCT02007252|588293060|FG001|Overall Study|Administrative problems|7|||
162889012|NCT02007252|588293059|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162889013|NCT02007252|588293060|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162889014|NCT02007252|588293059|FG000|Overall Study|Adverse Event|7|||
162889015|NCT02007252|588293060|FG001|Overall Study|Adverse Event|4|||
162889016|NCT00367341|588293061|FG000|Overall Study|Physician Decision|1|||
162889017|NCT00367341|588293062|FG001|Overall Study|Physician Decision|0|||
162889018|NCT00367341|588293061|FG000|Overall Study|Protocol Violation|1|||
162889019|NCT00367341|588293062|FG001|Overall Study|Protocol Violation|0|||
162889020|NCT03325556|588293063|FG000|Open-label Period|Lack of Response in OL period|70|||
162889021|NCT03325556|588293064|FG001|Open-label Period|Lack of Response in OL period|0|||
162889022|NCT03325556|588293065|FG002|Open-label Period|Lack of Response in OL period|0|||
162889023|NCT03325556|588293063|FG000|Open-label Period|Adverse Event|27|||
162889024|NCT03325556|588293064|FG001|Open-label Period|Adverse Event|0|||
162889025|NCT03325556|588293065|FG002|Open-label Period|Adverse Event|0|||
162889026|NCT03325556|588293063|FG000|Open-label Period|Death|1|||
162889027|NCT03325556|588293064|FG001|Open-label Period|Death|0|||
162889028|NCT03325556|588293065|FG002|Open-label Period|Death|0|||
162889029|NCT03325556|588293063|FG000|Open-label Period|Lost to Follow-up|1|||
162889030|NCT03325556|588293064|FG001|Open-label Period|Lost to Follow-up|0|||
162889031|NCT03325556|588293065|FG002|Open-label Period|Lost to Follow-up|0|||
162889032|NCT03325556|588293063|FG000|Open-label Period|Non-compliance with study drug|5|||
162889033|NCT03325556|588293064|FG001|Open-label Period|Non-compliance with study drug|0|||
162889034|NCT03325556|588293065|FG002|Open-label Period|Non-compliance with study drug|0|||
162889035|NCT03325556|588293063|FG000|Open-label Period|Use of prohibited medication|1|||
162889036|NCT03325556|588293064|FG001|Open-label Period|Use of prohibited medication|0|||
162889037|NCT03325556|588293065|FG002|Open-label Period|Use of prohibited medication|0|||
162889038|NCT03325556|588293063|FG000|Open-label Period|Protocol Violation|4|||
162889039|NCT03325556|588293064|FG001|Open-label Period|Protocol Violation|0|||
162889040|NCT03325556|588293065|FG002|Open-label Period|Protocol Violation|0|||
162889041|NCT03325556|588293063|FG000|Open-label Period|Withdrawal by Subject|17|||
162889042|NCT03325556|588293064|FG001|Open-label Period|Withdrawal by Subject|0|||
162889043|NCT03325556|588293065|FG002|Open-label Period|Withdrawal by Subject|0|||
162889044|NCT03325556|588293063|FG000|Open-label Period|Not otherwise specified|8|||
162889045|NCT03325556|588293064|FG001|Open-label Period|Not otherwise specified|0|||
162889046|NCT03325556|588293065|FG002|Open-label Period|Not otherwise specified|0|||
162889047|NCT03325556|588293063|FG000|Open-label Period|Administrative discont. at study termination|41|||
162889048|NCT03325556|588293064|FG001|Open-label Period|Administrative discont. at study termination|0|||
162889049|NCT03325556|588293065|FG002|Open-label Period|Administrative discont. at study termination|0|||
162889050|NCT03325556|588293063|FG000|Double-blind Period|Relapse|0|||
162889051|NCT03325556|588293064|FG001|Double-blind Period|Relapse|15|||
162889052|NCT03325556|588293065|FG002|Double-blind Period|Relapse|34|||
162889053|NCT03325556|588293063|FG000|Double-blind Period|Adverse Event|0|||
162889054|NCT03325556|588293064|FG001|Double-blind Period|Adverse Event|3|||
162889055|NCT03325556|588293065|FG002|Double-blind Period|Adverse Event|1|||
162889056|NCT03325556|588293063|FG000|Double-blind Period|Noncompliance with study drug|0|||
162889057|NCT03325556|588293064|FG001|Double-blind Period|Noncompliance with study drug|0|||
162889058|NCT03325556|588293065|FG002|Double-blind Period|Noncompliance with study drug|1|||
162889059|NCT03325556|588293063|FG000|Double-blind Period|Use of prohibited medication|0|||
162889060|NCT03325556|588293064|FG001|Double-blind Period|Use of prohibited medication|1|||
162889061|NCT03325556|588293065|FG002|Double-blind Period|Use of prohibited medication|0|||
162889062|NCT03325556|588293063|FG000|Double-blind Period|Physician Decision|0|||
162889063|NCT03325556|588293064|FG001|Double-blind Period|Physician Decision|0|||
162889064|NCT03325556|588293065|FG002|Double-blind Period|Physician Decision|1|||
162889065|NCT03325556|588293063|FG000|Double-blind Period|Withdrawal by Subject|0|||
162889066|NCT03325556|588293064|FG001|Double-blind Period|Withdrawal by Subject|6|||
162889067|NCT03325556|588293065|FG002|Double-blind Period|Withdrawal by Subject|4|||
162889068|NCT03325556|588293063|FG000|Double-blind Period|Not otherwise specified|0|||
162889069|NCT03325556|588293064|FG001|Double-blind Period|Not otherwise specified|1|||
162889070|NCT03325556|588293065|FG002|Double-blind Period|Not otherwise specified|5|||
162889071|NCT03325556|588293063|FG000|Double-blind Period|Administrative discont. at study termination|0|||
162889072|NCT03325556|588293064|FG001|Double-blind Period|Administrative discont. at study termination|35|||
162889073|NCT03325556|588293065|FG002|Double-blind Period|Administrative discont. at study termination|31|||
162889074|NCT01705587|588293066|FG000|Overall Study|Withdrawal by Subject|0|||
162889075|NCT01705587|588293067|FG001|Overall Study|Withdrawal by Subject|1|||
162889076|NCT00762268|588293068|FG000|Overall Study|Withdrawal by Subject|3|||
162889077|NCT00762268|588293069|FG001|Overall Study|Withdrawal by Subject|3|||
162708339|NCT00613301|587642753|FG000|Overall Study|Physician Decision|2|||
162708340|NCT00613301|587642753|FG000|Overall Study|No data was collected|53|||
162708341|NCT00613301|587642753|FG000|Overall Study|Irregularly enrolled patients|12|||
162708342|NCT01684046|587642756|FG000|Period 1, First 30 Days|Adverse Event|0|||
162708343|NCT01684046|587642757|FG001|Period 1, First 30 Days|Adverse Event|2|||
162708344|NCT00587288|587642758|FG000|Overall Study|Adverse Event|0|||
162708345|NCT00587288|587642759|FG001|Overall Study|Adverse Event|1|||
162708346|NCT00587288|587642758|FG000|Overall Study|Lack of Efficacy|2|||
162708347|NCT00587288|587642759|FG001|Overall Study|Lack of Efficacy|8|||
162708348|NCT00587288|587642758|FG000|Overall Study|Protocol Violation|1|||
162708349|NCT00587288|587642759|FG001|Overall Study|Protocol Violation|0|||
162708350|NCT00762463|587642760|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
162708351|NCT00762463|587642761|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
162708352|NCT00762463|587642762|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
162708353|NCT00762463|587642763|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
162708354|NCT00762463|587642760|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
162708355|NCT00762463|587642761|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
162708356|NCT00762463|587642762|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
162708357|NCT00762463|587642763|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
162708358|NCT00762463|587642760|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
162708359|NCT00762463|587642761|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
162708360|NCT00762463|587642762|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
162708361|NCT00762463|587642763|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
162708362|NCT00762463|587642760|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
162708363|NCT00762463|587642761|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
162708364|NCT00762463|587642762|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
162708365|NCT00762463|587642763|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
162708366|NCT00762463|587642760|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
162708367|NCT00762463|587642761|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
162708368|NCT00762463|587642762|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
162708369|NCT00762463|587642763|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
162889078|NCT03892707|588293078|FG000|Overall Study|Screen failure|6|||
162889079|NCT03892707|588293079|FG001|Overall Study|Screen failure|0|||
162889080|NCT03892707|588293078|FG000|Overall Study|Pain resolution|0|||
162889081|NCT03892707|588293079|FG001|Overall Study|Pain resolution|4|||
162889082|NCT03892707|588293078|FG000|Overall Study|Withdrawal by Subject|0|||
162889083|NCT03892707|588293079|FG001|Overall Study|Withdrawal by Subject|1|||
162889084|NCT03892707|588293078|FG000|Overall Study|Other (long business trip)|0|||
162889085|NCT03892707|588293079|FG001|Overall Study|Other (long business trip)|1|||
162889086|NCT05224076|588293082|FG000|Overall Study|Lost to Follow-up|24|||
162889087|NCT01807949|588293084|FG000|Overall Study|Adverse Event|1|||
162889088|NCT01807949|588293085|FG001|Overall Study|Adverse Event|2|||
162889089|NCT01807949|588293086|FG002|Overall Study|Adverse Event|2|||
162889090|NCT01807949|588293084|FG000|Overall Study|Withdrawal by Subject|1|||
162889091|NCT01807949|588293085|FG001|Overall Study|Withdrawal by Subject|2|||
162889092|NCT01807949|588293086|FG002|Overall Study|Withdrawal by Subject|2|||
162889093|NCT01807949|588293084|FG000|Overall Study|Non-Compliance|0|||
162963868|NCT01151618|588567922|FG000|Overall Study|Withdrawal by Subject|7|||
162963869|NCT00868998|588567923|FG000|Overall Study|Screen Failure|1|||
162963870|NCT00868998|588567923|FG000|Overall Study|Withdrawal by Subject|1|||
162963871|NCT00868998|588567923|FG000|Overall Study|Progression of disease|2|||
162963872|NCT00868998|588567923|FG000|Overall Study|Death|1|||
162889094|NCT01807949|588293085|FG001|Overall Study|Non-Compliance|0|||
162889095|NCT01807949|588293086|FG002|Overall Study|Non-Compliance|1|||
162889096|NCT01807949|588293084|FG000|Overall Study|Undefined|0|||
162889097|NCT01807949|588293085|FG001|Overall Study|Undefined|1|||
162889098|NCT01807949|588293086|FG002|Overall Study|Undefined|2|||
162889099|NCT01807949|588293084|FG000|Overall Study|Randomized But Not Treated|0|||
162889100|NCT01807949|588293085|FG001|Overall Study|Randomized But Not Treated|2|||
162889101|NCT01807949|588293086|FG002|Overall Study|Randomized But Not Treated|2|||
162889102|NCT04325906|588293089|FG000|Overall Study|Withdrawal by Subject|2|||
162889103|NCT04325906|588293090|FG001|Overall Study|Withdrawal by Subject|0|||
162889104|NCT00881361|588293091|FG000|Overall Study|Terminated prior to surgery|27|||
162889105|NCT00881361|588293092|FG001|Overall Study|Terminated prior to surgery|7|||
162889106|NCT00881361|588293093|FG002|Overall Study|Terminated prior to surgery|0|||
162889107|NCT00881361|588293091|FG000|Overall Study|Ineligible|17|||
162889108|NCT00881361|588293092|FG001|Overall Study|Ineligible|2|||
162889109|NCT00881361|588293093|FG002|Overall Study|Ineligible|2|||
162889110|NCT02141217|588293094|FG000|Overall Study|Adverse Event|1|||
162889111|NCT02141217|588293095|FG001|Overall Study|Adverse Event|2|||
162889112|NCT02141217|588293094|FG000|Overall Study|Protocol Violation|1|||
162889113|NCT02141217|588293095|FG001|Overall Study|Protocol Violation|4|||
162889114|NCT02141217|588293094|FG000|Overall Study|Withdrawal by Subject|6|||
162889115|NCT02141217|588293095|FG001|Overall Study|Withdrawal by Subject|0|||
162889116|NCT02141217|588293094|FG000|Overall Study|Lost to Follow-up|1|||
162889117|NCT02141217|588293095|FG001|Overall Study|Lost to Follow-up|1|||
162889118|NCT02141217|588293094|FG000|Overall Study|Physician Decision|1|||
162889119|NCT02141217|588293095|FG001|Overall Study|Physician Decision|0|||
162889120|NCT02141217|588293094|FG000|Overall Study|Surgical Intervention|1|||
162889121|NCT02141217|588293095|FG001|Overall Study|Surgical Intervention|1|||
162889122|NCT01628393|588293100|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
162889123|NCT01628393|588293101|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162889124|NCT01628393|588293102|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162889125|NCT01628393|588293103|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162889126|NCT01628393|588293104|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
162889127|NCT01628393|588293100|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
162889128|NCT01628393|588293101|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
162889129|NCT01628393|588293102|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
162889130|NCT01628393|588293103|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
162889131|NCT01628393|588293104|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
162889132|NCT01628393|588293100|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
162889133|NCT01628393|588293101|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
162963873|NCT01483820|588567925|FG000|Overall Study|Lack of Efficacy|6|||
162963874|NCT01483820|588567925|FG000|Overall Study|Adverse Event|1|||
162963875|NCT01483820|588567925|FG000|Overall Study|Death|1|||
162963876|NCT00474188|588567929|FG000|Overall Study|Withdrawal by Subject|1|||
162963877|NCT00474188|588567929|FG000|Overall Study|Study discontinued by sponsor|5|||
162963878|NCT05412121|588567930|FG000|Overall Study|Withdrawal by Subject|4|||
162963879|NCT05412121|588567930|FG000|Overall Study|Physician Decision|1|||
162963880|NCT05412121|588567930|FG000|Overall Study|Lost to Follow-up|5|||
162963881|NCT03541252|588567931|FG000|Overall Study|Withdrawal by Subject|1|||
162963882|NCT01962298|588567938|FG000|Overall Study|Protocol Violation|1|||
162963883|NCT01962298|588567939|FG001|Overall Study|Protocol Violation|0|||
162963884|NCT01962298|588567940|FG002|Overall Study|Protocol Violation|1|||
162963885|NCT01962298|588567941|FG003|Overall Study|Protocol Violation|1|||
162963886|NCT01962298|588567942|FG004|Overall Study|Protocol Violation|0|||
162963887|NCT01962298|588567938|FG000|Overall Study|Data quality insufficient|2|||
162963888|NCT01962298|588567939|FG001|Overall Study|Data quality insufficient|0|||
162963889|NCT01962298|588567940|FG002|Overall Study|Data quality insufficient|3|||
162963890|NCT01962298|588567941|FG003|Overall Study|Data quality insufficient|1|||
162963891|NCT01962298|588567942|FG004|Overall Study|Data quality insufficient|4|||
162963892|NCT01962298|588567938|FG000|Overall Study|Insufficient data|0|||
162963893|NCT01962298|588567939|FG001|Overall Study|Insufficient data|2|||
163051175|NCT02709746|588895354|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
163051176|NCT02709746|588895355|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
162889134|NCT01628393|588293102|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
162889135|NCT01628393|588293103|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
162889136|NCT01628393|588293104|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
162889137|NCT01628393|588293100|FG000|Blinded Active Extension Period|Adverse Event|0|||
162889138|NCT01628393|588293101|FG001|Blinded Active Extension Period|Adverse Event|1|||
162889139|NCT01628393|588293102|FG002|Blinded Active Extension Period|Adverse Event|0|||
162963894|NCT01962298|588567940|FG002|Overall Study|Insufficient data|1|||
162963895|NCT01962298|588567941|FG003|Overall Study|Insufficient data|0|||
162963896|NCT01962298|588567942|FG004|Overall Study|Insufficient data|1|||
163051177|NCT02709746|588895356|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
162963897|NCT01962298|588567938|FG000|Overall Study|Incorrect data recorded|0|||
162963898|NCT01962298|588567939|FG001|Overall Study|Incorrect data recorded|1|||
162963899|NCT01962298|588567940|FG002|Overall Study|Incorrect data recorded|0|||
162963900|NCT01962298|588567941|FG003|Overall Study|Incorrect data recorded|0|||
162963901|NCT01962298|588567942|FG004|Overall Study|Incorrect data recorded|0|||
162963902|NCT01962298|588567938|FG000|Overall Study|Physician Decision|0|||
162963903|NCT01962298|588567939|FG001|Overall Study|Physician Decision|1|||
162963904|NCT01962298|588567940|FG002|Overall Study|Physician Decision|0|||
162963905|NCT01962298|588567941|FG003|Overall Study|Physician Decision|0|||
162963906|NCT01962298|588567942|FG004|Overall Study|Physician Decision|1|||
162963907|NCT01576705|588567943|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
162963908|NCT01576705|588567944|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
162963909|NCT01576705|588567945|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
162963910|NCT01576705|588567946|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
162963911|NCT01576705|588567943|FG000|Overall Study|invalid ICF|0|||
162963912|NCT01576705|588567944|FG001|Overall Study|invalid ICF|1|||
162963913|NCT01576705|588567945|FG002|Overall Study|invalid ICF|0|||
162963914|NCT01576705|588567946|FG003|Overall Study|invalid ICF|0|||
162963915|NCT03727139|588567947|FG000|Overall Study|Protocol Violation|60|||
162963916|NCT00566722|588567948|FG000|Overall Study|Adverse Event|0|||
162963917|NCT00566722|588567949|FG001|Overall Study|Adverse Event|1|||
162963918|NCT00566722|588567950|FG002|Overall Study|Adverse Event|0|||
162963919|NCT00566722|588567948|FG000|Overall Study|Withdrawal by Subject|0|||
162963920|NCT00566722|588567949|FG001|Overall Study|Withdrawal by Subject|0|||
162963921|NCT00566722|588567950|FG002|Overall Study|Withdrawal by Subject|1|||
162963922|NCT00566722|588567948|FG000|Overall Study|Lost to Follow-up|1|||
162963923|NCT00566722|588567949|FG001|Overall Study|Lost to Follow-up|1|||
162963924|NCT00566722|588567950|FG002|Overall Study|Lost to Follow-up|1|||
162963925|NCT00566722|588567948|FG000|Overall Study|Lack of Efficacy|1|||
162963926|NCT00566722|588567949|FG001|Overall Study|Lack of Efficacy|2|||
162963927|NCT00566722|588567950|FG002|Overall Study|Lack of Efficacy|4|||
162963928|NCT00566722|588567948|FG000|Overall Study|Did not meet exclusion criteria|0|||
162963929|NCT00566722|588567949|FG001|Overall Study|Did not meet exclusion criteria|0|||
162963930|NCT00566722|588567950|FG002|Overall Study|Did not meet exclusion criteria|2|||
162963931|NCT00566722|588567948|FG000|Overall Study|Serious adverse event|0|||
162963932|NCT00566722|588567949|FG001|Overall Study|Serious adverse event|1|||
162963933|NCT00566722|588567950|FG002|Overall Study|Serious adverse event|0|||
162963934|NCT00566722|588567948|FG000|Overall Study|Noncompliant with drug administration|0|||
162963935|NCT00566722|588567949|FG001|Overall Study|Noncompliant with drug administration|0|||
162963936|NCT00566722|588567950|FG002|Overall Study|Noncompliant with drug administration|1|||
162963937|NCT00858403|588567951|FG000|Overall Study|Withdrawal by Subject|1|||
162889140|NCT01628393|588293103|FG003|Blinded Active Extension Period|Adverse Event|2|||
162889141|NCT01628393|588293104|FG004|Blinded Active Extension Period|Adverse Event|2|||
162889142|NCT01628393|588293100|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
162889143|NCT01628393|588293101|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
162889144|NCT01628393|588293102|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
162889145|NCT01628393|588293103|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
162889146|NCT01628393|588293104|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
162889147|NCT01628393|588293100|FG000|Blinded Active Extension Period|Physician Decision|0|||
162889148|NCT01628393|588293101|FG001|Blinded Active Extension Period|Physician Decision|3|||
162889149|NCT01628393|588293102|FG002|Blinded Active Extension Period|Physician Decision|0|||
162889150|NCT01628393|588293103|FG003|Blinded Active Extension Period|Physician Decision|1|||
162889151|NCT01628393|588293104|FG004|Blinded Active Extension Period|Physician Decision|0|||
162889152|NCT01628393|588293100|FG000|Blinded Active Extension Period|Protocol Violation|0|||
162889153|NCT01628393|588293101|FG001|Blinded Active Extension Period|Protocol Violation|0|||
162889154|NCT01628393|588293102|FG002|Blinded Active Extension Period|Protocol Violation|2|||
162889155|NCT01628393|588293103|FG003|Blinded Active Extension Period|Protocol Violation|1|||
162889156|NCT01628393|588293104|FG004|Blinded Active Extension Period|Protocol Violation|0|||
162889157|NCT01628393|588293100|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
162889158|NCT01628393|588293101|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
162889159|NCT01628393|588293102|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
162889160|NCT01628393|588293103|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
162889161|NCT01628393|588293104|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
162889162|NCT04603391|588293109|FG000|First Intervention (4 Days)|Adverse Event|1|||
162889163|NCT04603391|588293110|FG001|First Intervention (4 Days)|Adverse Event|0|||
162889164|NCT04603391|588293109|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
162889165|NCT04603391|588293110|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
162889166|NCT02759861|588293113|FG000|Overall Study|Death|1|||
162889167|NCT02151682|588293114|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
162889168|NCT02151682|588293115|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
162889169|NCT02151682|588293116|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
162889170|NCT02151682|588293117|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
162889171|NCT02151682|588293118|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
162889172|NCT02151682|588293119|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
162889173|NCT02151682|588293114|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
162889174|NCT02151682|588293115|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
162889175|NCT02151682|588293116|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
162889176|NCT02151682|588293117|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
162889177|NCT02151682|588293118|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
162889178|NCT02151682|588293119|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
162889179|NCT02151682|588293114|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
162889180|NCT02151682|588293115|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
162889181|NCT02151682|588293116|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
162889182|NCT02151682|588293117|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
162889183|NCT02151682|588293118|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
162889184|NCT02151682|588293119|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
162889185|NCT02151682|588293114|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
162889186|NCT02151682|588293115|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
162889187|NCT02151682|588293116|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
162889188|NCT02151682|588293117|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
162889189|NCT02151682|588293118|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
162889190|NCT02151682|588293119|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
162889191|NCT02151682|588293114|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
162889192|NCT02151682|588293115|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
162889193|NCT02151682|588293116|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
162889194|NCT02151682|588293117|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
162889195|NCT02151682|588293118|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
162889196|NCT02151682|588293119|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
162889197|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
162889198|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
162889199|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
162889200|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
162963938|NCT00858403|588567951|FG000|Overall Study|Death|3|||
162889201|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
162889202|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
162889203|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
162889204|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
162889205|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
162889206|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
162889207|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
162889208|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
162889209|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
162889210|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
162889211|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
162889212|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
162889213|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
162889214|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
162889215|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
162889216|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
162889217|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
162889218|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
162889219|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
162889220|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
162889221|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
162889222|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
162889223|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
162889224|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
162889225|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
162889226|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
162889227|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
162889228|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
162889229|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
162889230|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
162889231|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
162889232|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
162889233|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
162889234|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
162889235|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
162889236|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
162889237|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
162889238|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
162889239|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
162889240|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
162889241|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
162889242|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
163051178|NCT02709746|588895357|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
163051179|NCT02709746|588895358|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
163051180|NCT03074695|588895359|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
163051181|NCT03074695|588895360|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
163051182|NCT03074695|588895359|FG000|Overall Study|Research staff not available|1|||
163051183|NCT03074695|588895360|FG001|Overall Study|Research staff not available|2|||
163051184|NCT03074695|588895359|FG000|Overall Study|Did not receive neuraxial block|2|||
163051185|NCT03074695|588895360|FG001|Overall Study|Did not receive neuraxial block|2|||
163051186|NCT00902577|588895361|FG000|Overall Study|Withdrawal by Subject|6|||
163051187|NCT00902577|588895361|FG000|Overall Study|FMISO production failure|2|||
163051188|NCT01232790|588895362|FG000|Randomization|Withdrawal by Subject|2|||
163051189|NCT01232790|588895363|FG001|Randomization|Withdrawal by Subject|0|||
163051190|NCT01232790|588895362|FG000|Randomization|Protocol Violation|0|||
163051191|NCT01232790|588895363|FG001|Randomization|Protocol Violation|1|||
163051192|NCT01232790|588895362|FG000|Randomization|Physician Decision|0|||
162889243|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
162889244|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
163051193|NCT01232790|588895363|FG001|Randomization|Physician Decision|1|||
163051194|NCT01232790|588895362|FG000|Initial Assessment|Withdrawal by Subject|0|||
162889245|NCT02151682|588293114|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
162889246|NCT02151682|588293115|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
162889247|NCT02151682|588293116|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
162889248|NCT02151682|588293117|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
162889249|NCT02151682|588293118|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
162889250|NCT02151682|588293119|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
162889251|NCT02151682|588293114|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
162889252|NCT02151682|588293115|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
162889253|NCT02151682|588293116|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
162889254|NCT02151682|588293117|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
162889255|NCT02151682|588293118|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
162889256|NCT02151682|588293119|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
162889257|NCT02151682|588293114|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
162889258|NCT02151682|588293115|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
162889259|NCT02151682|588293116|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
162889260|NCT02151682|588293117|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
162889261|NCT02151682|588293118|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
162889262|NCT02151682|588293119|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
162889263|NCT02151682|588293114|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
162889264|NCT02151682|588293115|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
162889265|NCT02151682|588293116|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
162889266|NCT02151682|588293117|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
162889267|NCT02151682|588293118|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
162889268|NCT02151682|588293119|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
162889269|NCT02151682|588293114|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
162889270|NCT02151682|588293115|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
162889271|NCT02151682|588293116|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
162889272|NCT02151682|588293117|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
162889273|NCT02151682|588293118|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
162889274|NCT02151682|588293119|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
162889275|NCT02988219|588293120|FG000|Overall Study|Lack of Efficacy|1|||
162889276|NCT02988219|588293121|FG001|Overall Study|Lack of Efficacy|1|||
162889277|NCT02988219|588293120|FG000|Overall Study|Withdrawal by Subject|0|||
162889278|NCT02988219|588293121|FG001|Overall Study|Withdrawal by Subject|2|||
162889279|NCT01306032|588293122|FG000|First Intervention|Adverse Event|1|||
162889280|NCT01306032|588293123|FG001|First Intervention|Adverse Event|0|||
162889281|NCT01306032|588293124|FG002|First Intervention|Adverse Event|1|||
162889282|NCT01306032|588293125|FG003|First Intervention|Adverse Event|0|||
162889283|NCT01306032|588293126|FG004|First Intervention|Adverse Event|0|||
162889284|NCT01306032|588293127|FG005|First Intervention|Adverse Event|1|||
162889285|NCT01306032|588293122|FG000|First Intervention|Withdrawal by Subject|0|||
162889286|NCT01306032|588293123|FG001|First Intervention|Withdrawal by Subject|2|||
162889287|NCT01306032|588293124|FG002|First Intervention|Withdrawal by Subject|0|||
162889288|NCT01306032|588293125|FG003|First Intervention|Withdrawal by Subject|1|||
162889289|NCT01306032|588293126|FG004|First Intervention|Withdrawal by Subject|0|||
162889290|NCT01306032|588293127|FG005|First Intervention|Withdrawal by Subject|0|||
162889291|NCT01306032|588293122|FG000|First Intervention|Death|0|||
162889292|NCT01306032|588293123|FG001|First Intervention|Death|0|||
162889293|NCT01306032|588293124|FG002|First Intervention|Death|1|||
162889294|NCT01306032|588293125|FG003|First Intervention|Death|0|||
162889295|NCT01306032|588293126|FG004|First Intervention|Death|0|||
162889296|NCT01306032|588293127|FG005|First Intervention|Death|0|||
162889297|NCT01306032|588293122|FG000|First Intervention|Ineligible|0|||
162889298|NCT01306032|588293123|FG001|First Intervention|Ineligible|0|||
162889299|NCT01306032|588293124|FG002|First Intervention|Ineligible|0|||
162889300|NCT01306032|588293125|FG003|First Intervention|Ineligible|0|||
162963939|NCT00858403|588567951|FG000|Overall Study|Disease Progression|1|||
162963940|NCT02264977|588567952|FG000|Overall Study|Death|3|||
162963941|NCT02264977|588567952|FG000|Overall Study|Physician Decision|1|||
162963942|NCT02264977|588567952|FG000|Overall Study|Refuse to return|1|||
162963943|NCT03573544|588567953|FG000|Overall Study|Adverse Event|0|||
162963944|NCT03573544|588567954|FG001|Overall Study|Adverse Event|0|||
162963945|NCT03573544|588567955|FG002|Overall Study|Adverse Event|0|||
162963946|NCT03573544|588567956|FG003|Overall Study|Adverse Event|3|||
162963947|NCT03573544|588567957|FG004|Overall Study|Adverse Event|1|||
162889301|NCT01306032|588293126|FG004|First Intervention|Ineligible|0|||
162963948|NCT03573544|588567958|FG005|Overall Study|Adverse Event|0|||
162889302|NCT01306032|588293127|FG005|First Intervention|Ineligible|1|||
162889303|NCT01306032|588293122|FG000|First Intervention|Progressive disease|0|||
162963949|NCT03573544|588567959|FG006|Overall Study|Adverse Event|2|||
162963950|NCT03573544|588567960|FG007|Overall Study|Adverse Event|0|||
162963951|NCT03573544|588567953|FG000|Overall Study|Physician Decision|0|||
162963952|NCT03573544|588567954|FG001|Overall Study|Physician Decision|0|||
162889304|NCT01306032|588293123|FG001|First Intervention|Progressive disease|0|||
162889305|NCT01306032|588293124|FG002|First Intervention|Progressive disease|0|||
162889306|NCT01306032|588293125|FG003|First Intervention|Progressive disease|0|||
162889307|NCT01306032|588293126|FG004|First Intervention|Progressive disease|2|||
162889308|NCT01306032|588293127|FG005|First Intervention|Progressive disease|0|||
162889309|NCT01306032|588293122|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
162889310|NCT01306032|588293123|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
162889311|NCT01306032|588293124|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
162889312|NCT01306032|588293125|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
162889313|NCT01306032|588293126|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
162889314|NCT01306032|588293127|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
162889315|NCT01306032|588293122|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
162889316|NCT01306032|588293123|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
162889317|NCT01306032|588293124|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
162889318|NCT01306032|588293125|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
162889319|NCT01306032|588293126|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
162889320|NCT01306032|588293127|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
162889321|NCT01213264|588293128|FG000|Overall Study|Adverse Event|1|||
162889322|NCT01213264|588293129|FG001|Overall Study|Adverse Event|0|||
162889323|NCT01213264|588293130|FG002|Overall Study|Adverse Event|0|||
162889324|NCT01213264|588293128|FG000|Overall Study|Lost to Follow-up|1|||
162889325|NCT01213264|588293129|FG001|Overall Study|Lost to Follow-up|2|||
162889326|NCT01213264|588293130|FG002|Overall Study|Lost to Follow-up|6|||
162889327|NCT01522443|588293133|FG000|Overall Study|No longer receiving clinical benefit|36|||
162889328|NCT01522443|588293134|FG001|Overall Study|No longer receiving clinical benefit|28|||
162889329|NCT01522443|588293133|FG000|Overall Study|Adverse Event|10|||
162889330|NCT01522443|588293134|FG001|Overall Study|Adverse Event|15|||
162889331|NCT01522443|588293133|FG000|Overall Study|Withdrawal by Subject|5|||
162889332|NCT01522443|588293134|FG001|Overall Study|Withdrawal by Subject|8|||
162889333|NCT01522443|588293133|FG000|Overall Study|No study treatment given|1|||
162889334|NCT01522443|588293134|FG001|Overall Study|No study treatment given|1|||
162889335|NCT01522443|588293133|FG000|Overall Study|Other|1|||
162889336|NCT01522443|588293134|FG001|Overall Study|Other|3|||
162889337|NCT03260894|588293135|FG000|Overall Study|Death|6|||
162889338|NCT03260894|588293136|FG001|Overall Study|Death|8|||
162889339|NCT03260894|588293135|FG000|Overall Study|Withdrawal by Subject|4|||
162889340|NCT03260894|588293136|FG001|Overall Study|Withdrawal by Subject|11|||
162889341|NCT03260894|588293135|FG000|Overall Study|On-going at clinical cut off date|36|||
162889342|NCT03260894|588293136|FG001|Overall Study|On-going at clinical cut off date|31|||
162889343|NCT00973622|588293137|FG000|Overall Study|did not attend MRI|14|||
162889344|NCT00973622|588293138|FG001|Overall Study|did not attend MRI|3|||
162889345|NCT00973622|588293137|FG000|Overall Study|did not pass MRI screen|6|||
162889346|NCT00973622|588293138|FG001|Overall Study|did not pass MRI screen|0|||
162889347|NCT00973622|588293137|FG000|Overall Study|did not complete rTMS sessions|11|||
162889348|NCT00973622|588293138|FG001|Overall Study|did not complete rTMS sessions|2|||
162889349|NCT00555568|588293139|FG000|Overall Study|Lost to Follow-up|26|||
162889350|NCT00555568|588293140|FG001|Overall Study|Lost to Follow-up|16|||
162889351|NCT00555568|588293141|FG002|Overall Study|Lost to Follow-up|16|||
162889352|NCT06000501|588293142|FG000|Overall Study|Screen failure|3|||
162889353|NCT06000501|588293142|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
162889354|NCT06000501|588293142|FG000|Overall Study|Physician Decision|4|||
162889355|NCT06000501|588293142|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
162889356|NCT06000501|588293142|FG000|Overall Study|Scheduling issues|2|||
162889357|NCT01700985|588293143|FG000|Overall Study|Incarcerated|0|||
162889358|NCT01700985|588293144|FG001|Overall Study|Incarcerated|1|||
162889359|NCT02677220|588293145|FG000|Overall Study|Adverse Event|1|||
162889360|NCT00067470|588293146|FG000|Overall Study|Withdrawal by Subject|0|||
162889361|NCT00067470|588293147|FG001|Overall Study|Withdrawal by Subject|1|||
162889362|NCT01148693|588293148|FG000|Overall Study|Attempts for cannulation were failed|13|||
162889363|NCT01148693|588293149|FG001|Overall Study|Attempts for cannulation were failed|10|||
162889364|NCT01074658|588293150|FG000|Overall Study|No implant attempted|19|||
162889365|NCT00050622|588293151|FG000|Overall Study|Adverse Event|1|||
162889366|NCT01342952|588293152|FG000|Overall Study|Adverse Event|0|||
162889367|NCT01342952|588293153|FG001|Overall Study|Adverse Event|5|||
162889368|NCT01342952|588293154|FG002|Overall Study|Adverse Event|1|||
162889369|NCT01342952|588293155|FG003|Overall Study|Adverse Event|0|||
162889370|NCT01342952|588293152|FG000|Overall Study|Lost to Follow-up|0|||
162889371|NCT01342952|588293153|FG001|Overall Study|Lost to Follow-up|2|||
162889372|NCT01342952|588293154|FG002|Overall Study|Lost to Follow-up|0|||
162889373|NCT01342952|588293155|FG003|Overall Study|Lost to Follow-up|0|||
162889374|NCT01342952|588293152|FG000|Overall Study|Withdrawal by Subject|1|||
162889375|NCT01342952|588293153|FG001|Overall Study|Withdrawal by Subject|1|||
162889376|NCT01342952|588293154|FG002|Overall Study|Withdrawal by Subject|0|||
162889377|NCT01342952|588293155|FG003|Overall Study|Withdrawal by Subject|0|||
162889378|NCT01342952|588293152|FG000|Overall Study|Physician Decision|3|||
162889379|NCT01342952|588293153|FG001|Overall Study|Physician Decision|3|||
162889380|NCT01342952|588293154|FG002|Overall Study|Physician Decision|1|||
162889381|NCT01342952|588293155|FG003|Overall Study|Physician Decision|0|||
162889382|NCT00426556|588293156|FG000|Phase I - Core Phase|Disease Progression|0|||
162889383|NCT00426556|588293157|FG001|Phase I - Core Phase|Disease Progression|6|||
162889384|NCT00426556|588293158|FG002|Phase I - Core Phase|Disease Progression|2|||
162889385|NCT00426556|588293159|FG003|Phase I - Core Phase|Disease Progression|0|||
162889386|NCT00426556|588293156|FG000|Phase I - Core Phase|Adverse Event|1|||
162889387|NCT00426556|588293157|FG001|Phase I - Core Phase|Adverse Event|3|||
162889388|NCT00426556|588293158|FG002|Phase I - Core Phase|Adverse Event|1|||
162889389|NCT00426556|588293159|FG003|Phase I - Core Phase|Adverse Event|0|||
162889390|NCT00426556|588293156|FG000|Phase I - Core Phase|Death|0|||
162889391|NCT00426556|588293157|FG001|Phase I - Core Phase|Death|1|||
162889392|NCT00426556|588293158|FG002|Phase I - Core Phase|Death|0|||
162889393|NCT00426556|588293159|FG003|Phase I - Core Phase|Death|0|||
162889394|NCT00426556|588293156|FG000|Phase I - Extension Phase|Adverse Event|0|||
162889395|NCT00426556|588293157|FG001|Phase I - Extension Phase|Adverse Event|1|||
162889396|NCT00426556|588293158|FG002|Phase I - Extension Phase|Adverse Event|1|||
162889397|NCT00426556|588293159|FG003|Phase I - Extension Phase|Adverse Event|0|||
162889398|NCT00426556|588293156|FG000|Phase I - Extension Phase|Disease Progression|5|||
162889399|NCT00426556|588293157|FG001|Phase I - Extension Phase|Disease Progression|5|||
162889400|NCT00426556|588293158|FG002|Phase I - Extension Phase|Disease Progression|6|||
162889401|NCT00426556|588293159|FG003|Phase I - Extension Phase|Disease Progression|0|||
162889402|NCT00426556|588293156|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
162889403|NCT00426556|588293157|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
162889404|NCT00426556|588293158|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
162889405|NCT00426556|588293159|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
162889406|NCT00426556|588293156|FG000|Phase II - Core Phase|Disease Progression|0|||
162889407|NCT00426556|588293157|FG001|Phase II - Core Phase|Disease Progression|0|||
162889408|NCT00426556|588293158|FG002|Phase II - Core Phase|Disease Progression|0|||
162889409|NCT00426556|588293159|FG003|Phase II - Core Phase|Disease Progression|16|||
162889410|NCT00426556|588293156|FG000|Phase II - Core Phase|Adverse Event|0|||
162889411|NCT00426556|588293157|FG001|Phase II - Core Phase|Adverse Event|0|||
162889412|NCT00426556|588293158|FG002|Phase II - Core Phase|Adverse Event|0|||
162889413|NCT00426556|588293159|FG003|Phase II - Core Phase|Adverse Event|8|||
162889414|NCT00426556|588293156|FG000|Phase II - Extension Phase|Disease Progression|0|||
162619156|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
162619157|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
162619158|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
162619159|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
162619160|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
162619161|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
162619162|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
162619163|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
162619164|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
162619165|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
162619166|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
162619167|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
162889415|NCT00426556|588293157|FG001|Phase II - Extension Phase|Disease Progression|0|||
162889416|NCT00426556|588293158|FG002|Phase II - Extension Phase|Disease Progression|0|||
162889417|NCT00426556|588293159|FG003|Phase II - Extension Phase|Disease Progression|21|||
162889418|NCT00426556|588293156|FG000|Phase II - Extension Phase|Adverse Event|0|||
162889419|NCT00426556|588293157|FG001|Phase II - Extension Phase|Adverse Event|0|||
162889420|NCT00426556|588293158|FG002|Phase II - Extension Phase|Adverse Event|0|||
162889421|NCT00426556|588293159|FG003|Phase II - Extension Phase|Adverse Event|2|||
162889422|NCT03970824|588293163|FG000|Overall Study|Withdrawal by Subject|1|||
162889423|NCT03970824|588293164|FG001|Overall Study|Withdrawal by Subject|1|||
162889424|NCT03970824|588293165|FG002|Overall Study|Withdrawal by Subject|3|||
162889425|NCT03970824|588293163|FG000|Overall Study|Lost to Follow-up|0|||
162889426|NCT03970824|588293164|FG001|Overall Study|Lost to Follow-up|2|||
162889427|NCT03970824|588293165|FG002|Overall Study|Lost to Follow-up|1|||
162889428|NCT03970824|588293163|FG000|Overall Study|Adverse Event|1|||
162889429|NCT03970824|588293164|FG001|Overall Study|Adverse Event|0|||
162889430|NCT03970824|588293165|FG002|Overall Study|Adverse Event|0|||
162889431|NCT01192204|588293168|FG000|Overall Study|could not keep recall appointments|1|||
162889432|NCT01192204|588293169|FG001|Overall Study|could not keep recall appointments|0|||
162889433|NCT02146248|588293170|FG000|Overall Study|Withdrawal by Subject|2|||
162889434|NCT00425100|588293171|FG000|Overall Study|Adverse Event|36|||
162889435|NCT00425100|588293171|FG000|Overall Study|Lack of Efficacy|4|||
162889436|NCT00425100|588293171|FG000|Overall Study|Lost to Follow-up|2|||
162889437|NCT00425100|588293171|FG000|Overall Study|Protocol Violation|4|||
162889438|NCT00425100|588293171|FG000|Overall Study|Withdrawal by Subject|7|||
162889439|NCT03699631|588293175|FG000|Overall Study|Adverse Event|3|||
162889440|NCT02219087|588293176|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
162889441|NCT02219087|588293177|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
162889442|NCT05127421|588293178|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
162889443|NCT05127421|588293179|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
162889444|NCT05127421|588293180|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
162889445|NCT05127421|588293181|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
162889446|NCT05127421|588293178|FG000|4-Week Double-Blind Period|Physician Decision|1|||
162889447|NCT05127421|588293179|FG001|4-Week Double-Blind Period|Physician Decision|0|||
162889448|NCT05127421|588293180|FG002|4-Week Double-Blind Period|Physician Decision|0|||
162889449|NCT05127421|588293181|FG003|4-Week Double-Blind Period|Physician Decision|0|||
162889450|NCT05127421|588293178|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
162889451|NCT05127421|588293179|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
162889452|NCT05127421|588293180|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
162889453|NCT05127421|588293181|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
162889454|NCT05127421|588293178|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
162889455|NCT05127421|588293179|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
162889456|NCT05127421|588293180|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
162889457|NCT05127421|588293181|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
162889458|NCT05127421|588293178|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
162889459|NCT05127421|588293179|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
162889460|NCT05127421|588293180|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
162889461|NCT05127421|588293181|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
162889462|NCT05127421|588293178|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
162889463|NCT05127421|588293179|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
162889464|NCT05127421|588293180|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
162889465|NCT05127421|588293181|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
162889466|NCT05127421|588293178|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
162889467|NCT05127421|588293179|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
162889468|NCT05127421|588293180|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
162889469|NCT05127421|588293181|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
162889470|NCT05127421|588293178|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
162889471|NCT05127421|588293179|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
162889472|NCT05127421|588293180|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
162889473|NCT05127421|588293181|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
162889474|NCT00618449|588293182|FG000|Overall Study|Lost to Follow-up|98|||
162889475|NCT00618449|588293183|FG001|Overall Study|Lost to Follow-up|110|||
162889476|NCT01714817|588293184|FG000|Year 1 Period|Lack of Efficacy|11|||
162889477|NCT01714817|588293185|FG001|Year 1 Period|Lack of Efficacy|9|||
162889478|NCT01714817|588293184|FG000|Year 1 Period|Adverse Event|20|||
162889479|NCT01714817|588293185|FG001|Year 1 Period|Adverse Event|17|||
162963953|NCT03573544|588567955|FG002|Overall Study|Physician Decision|0|||
162963954|NCT03573544|588567956|FG003|Overall Study|Physician Decision|0|||
162963955|NCT03573544|588567957|FG004|Overall Study|Physician Decision|0|||
162963956|NCT03573544|588567958|FG005|Overall Study|Physician Decision|0|||
162963957|NCT03573544|588567959|FG006|Overall Study|Physician Decision|1|||
162963958|NCT03573544|588567960|FG007|Overall Study|Physician Decision|0|||
162889480|NCT01714817|588293184|FG000|Year 1 Period|Withdrawal by Subject|6|||
163051195|NCT01232790|588895363|FG001|Initial Assessment|Withdrawal by Subject|1|||
162889481|NCT01714817|588293185|FG001|Year 1 Period|Withdrawal by Subject|7|||
162889482|NCT01714817|588293184|FG000|Year 1 Period|Death|1|||
162889483|NCT01714817|588293185|FG001|Year 1 Period|Death|1|||
162889484|NCT01714817|588293184|FG000|Year 1 Period|Lost to Follow-up|0|||
162889485|NCT01714817|588293185|FG001|Year 1 Period|Lost to Follow-up|2|||
162889486|NCT01714817|588293184|FG000|Year 1 Period|Poor / non-compliance|0|||
162889487|NCT01714817|588293185|FG001|Year 1 Period|Poor / non-compliance|1|||
162963959|NCT03573544|588567953|FG000|Overall Study|Withdrawal by Subject|2|||
162963960|NCT03573544|588567954|FG001|Overall Study|Withdrawal by Subject|0|||
162963961|NCT03573544|588567955|FG002|Overall Study|Withdrawal by Subject|0|||
162708370|NCT00762463|587642760|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162708371|NCT00762463|587642761|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162708372|NCT00762463|587642762|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
162708373|NCT00762463|587642763|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162708374|NCT00762463|587642760|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
162708375|NCT00762463|587642761|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
162708376|NCT00762463|587642762|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
162708377|NCT00762463|587642763|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
162708378|NCT00762463|587642760|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
162708379|NCT00762463|587642761|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
162708380|NCT00762463|587642762|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
162708381|NCT00762463|587642763|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
162708382|NCT00797862|587642764|FG000|Overall Study|Adverse Event|86|||
162708383|NCT00797862|587642765|FG001|Overall Study|Adverse Event|44|||
162708384|NCT00797862|587642766|FG002|Overall Study|Adverse Event|58|||
162708385|NCT00797862|587642764|FG000|Overall Study|Abnormal Test Procedure Result|0|||
162708386|NCT00797862|587642765|FG001|Overall Study|Abnormal Test Procedure Result|1|||
162708387|NCT00797862|587642766|FG002|Overall Study|Abnormal Test Procedure Result|1|||
162708388|NCT00797862|587642764|FG000|Overall Study|Lack of Efficacy|1|||
162708389|NCT00797862|587642765|FG001|Overall Study|Lack of Efficacy|7|||
162708390|NCT00797862|587642766|FG002|Overall Study|Lack of Efficacy|6|||
162708391|NCT00797862|587642764|FG000|Overall Study|No longer required study medication|1|||
162708392|NCT00797862|587642765|FG001|Overall Study|No longer required study medication|0|||
162708393|NCT00797862|587642766|FG002|Overall Study|No longer required study medication|0|||
162708394|NCT00797862|587642764|FG000|Overall Study|Withdrawal by Subject|14|||
162708395|NCT00797862|587642765|FG001|Overall Study|Withdrawal by Subject|7|||
162708396|NCT00797862|587642766|FG002|Overall Study|Withdrawal by Subject|7|||
162708397|NCT00797862|587642764|FG000|Overall Study|Lost to Follow-up|11|||
162708398|NCT00797862|587642765|FG001|Overall Study|Lost to Follow-up|0|||
162708399|NCT00797862|587642766|FG002|Overall Study|Lost to Follow-up|5|||
162708400|NCT00797862|587642764|FG000|Overall Study|Administrative Problem|4|||
162708401|NCT00797862|587642765|FG001|Overall Study|Administrative Problem|0|||
162708402|NCT00797862|587642766|FG002|Overall Study|Administrative Problem|0|||
162708403|NCT00797862|587642764|FG000|Overall Study|Protocol Violation|4|||
162708404|NCT00797862|587642765|FG001|Overall Study|Protocol Violation|6|||
162708405|NCT00797862|587642766|FG002|Overall Study|Protocol Violation|8|||
162708406|NCT00797862|587642764|FG000|Overall Study|Mis-randomized|3|||
162708407|NCT00797862|587642765|FG001|Overall Study|Mis-randomized|3|||
162708408|NCT00797862|587642766|FG002|Overall Study|Mis-randomized|1|||
162708409|NCT00531479|587642767|FG000|Overall Study|Death|68|||
162708410|NCT00531479|587642768|FG001|Overall Study|Death|71|||
162708411|NCT00531479|587642767|FG000|Overall Study|Lost to Follow-up|0|||
162708412|NCT00531479|587642768|FG001|Overall Study|Lost to Follow-up|2|||
162708413|NCT00531479|587642767|FG000|Overall Study|Other|0|||
162708414|NCT00531479|587642768|FG001|Overall Study|Other|1|||
162889488|NCT01714817|588293184|FG000|Year 1 Period|Pregnancy|2|||
162889489|NCT01714817|588293185|FG001|Year 1 Period|Pregnancy|0|||
162889490|NCT01714817|588293184|FG000|Year 1 Period|Participant no longer meets criteria|6|||
162889491|NCT01714817|588293185|FG001|Year 1 Period|Participant no longer meets criteria|2|||
162889492|NCT01714817|588293184|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
162889493|NCT01714817|588293185|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
162889494|NCT01714817|588293184|FG000|Year 1 Period|Change in Concomitant Medication|0|||
162889495|NCT01714817|588293185|FG001|Year 1 Period|Change in Concomitant Medication|1|||
162889496|NCT01714817|588293184|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
162889497|NCT01714817|588293185|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
162889498|NCT01714817|588293184|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
162889499|NCT01714817|588293185|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
162889500|NCT01714817|588293184|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
162889501|NCT01714817|588293185|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
162963962|NCT03573544|588567956|FG003|Overall Study|Withdrawal by Subject|1|||
162963963|NCT03573544|588567957|FG004|Overall Study|Withdrawal by Subject|1|||
162963964|NCT03573544|588567958|FG005|Overall Study|Withdrawal by Subject|1|||
162963965|NCT03573544|588567959|FG006|Overall Study|Withdrawal by Subject|0|||
162963966|NCT03573544|588567960|FG007|Overall Study|Withdrawal by Subject|1|||
162708415|NCT00531479|587642767|FG000|Overall Study|Withdrawal by Subject|6|||
162708416|NCT00531479|587642768|FG001|Overall Study|Withdrawal by Subject|6|||
162708417|NCT00531479|587642767|FG000|Overall Study|Did not receive treatment|2|||
162963967|NCT03573544|588567953|FG000|Overall Study|Disease progression|3|||
162708418|NCT00531479|587642768|FG001|Overall Study|Did not receive treatment|3|||
162889502|NCT01714817|588293184|FG000|Year 2 Period|Lack of Efficacy|4|||
162963968|NCT03573544|588567954|FG001|Overall Study|Disease progression|3|||
162963969|NCT03573544|588567955|FG002|Overall Study|Disease progression|6|||
162963970|NCT03573544|588567956|FG003|Overall Study|Disease progression|4|||
162708419|NCT05074498|587642773|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162889503|NCT01714817|588293185|FG001|Year 2 Period|Lack of Efficacy|12|||
162889504|NCT01714817|588293184|FG000|Year 2 Period|Adverse Event|7|||
162889505|NCT01714817|588293185|FG001|Year 2 Period|Adverse Event|6|||
162889506|NCT01714817|588293184|FG000|Year 2 Period|Participant request to stop treatment|4|||
162889507|NCT01714817|588293185|FG001|Year 2 Period|Participant request to stop treatment|4|||
162889508|NCT01714817|588293184|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
162889509|NCT01714817|588293185|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
162889510|NCT01714817|588293184|FG000|Year 2 Period|Participant withdrew consent|1|||
162889511|NCT01714817|588293185|FG001|Year 2 Period|Participant withdrew consent|5|||
162889512|NCT01714817|588293184|FG000|Year 2 Period|Participant no longer meets criteria|1|||
162889513|NCT01714817|588293185|FG001|Year 2 Period|Participant no longer meets criteria|4|||
162889514|NCT01714817|588293184|FG000|Year 2 Period|Lost to Follow-up|2|||
162889515|NCT01714817|588293185|FG001|Year 2 Period|Lost to Follow-up|0|||
162889516|NCT01714817|588293184|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
162889517|NCT01714817|588293185|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
162889518|NCT01714817|588293184|FG000|Year 2 Period|Pregnancy|1|||
162889519|NCT01714817|588293185|FG001|Year 2 Period|Pregnancy|1|||
162889520|NCT01714817|588293184|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
162889521|NCT01714817|588293185|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
162889522|NCT01714817|588293184|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
162889523|NCT01714817|588293185|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
162889524|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
162889525|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
162889526|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
162889527|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
162889528|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
162889529|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
162889530|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
162889531|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
162889532|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
162889533|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
162889534|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
162889535|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
162889536|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162889537|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
162889538|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
162619168|NCT01999868|587321503|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
162619169|NCT01999868|587321504|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
162619170|NCT01999868|587321505|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
162619171|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
162619172|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
162619173|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
162619174|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
162619175|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
162619176|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
162619177|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
162619178|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
162619179|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
162619180|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
162619181|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
162619182|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
162619183|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
162619184|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
162619185|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
162619186|NCT01999868|587321503|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
162619187|NCT01999868|587321504|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
162619188|NCT01999868|587321505|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
162619189|NCT00289016|587321506|FG000|Overall Study|Disease Progression|29|||
162619190|NCT00289016|587321506|FG000|Overall Study|Death|2|||
162708420|NCT05074498|587642774|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162889539|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
162889540|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
162889541|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
162924466|NCT03539952|588423897|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
162963971|NCT03573544|588567957|FG004|Overall Study|Disease progression|5|||
163051196|NCT01232790|588895362|FG000|First Crossover|Withdrawal by Subject|1|||
163051197|NCT01232790|588895363|FG001|First Crossover|Withdrawal by Subject|0|||
162889542|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
162889543|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
162889544|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
162889545|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
162889546|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
162889547|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
162889548|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
162889549|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
162889550|NCT01714817|588293184|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
162889551|NCT01714817|588293185|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
162889552|NCT01374217|588293186|FG000|Overall Study|Lack of Efficacy|13|||
162889553|NCT02555657|588293187|FG000|Overall Study|Death|274|||
162889554|NCT02555657|588293188|FG001|Overall Study|Death|262|||
162889555|NCT02555657|588293187|FG000|Overall Study|Physician Decision|0|||
162889556|NCT02555657|588293188|FG001|Overall Study|Physician Decision|1|||
162889557|NCT02555657|588293187|FG000|Overall Study|Sponsor Decision|27|||
162889558|NCT02555657|588293188|FG001|Overall Study|Sponsor Decision|15|||
162889559|NCT02555657|588293187|FG000|Overall Study|Withdrawal by Subject|11|||
162889560|NCT02555657|588293188|FG001|Overall Study|Withdrawal by Subject|32|||
162889561|NCT00405821|588293191|FG000|Overall Study|Death|5|||
162889562|NCT00405821|588293192|FG001|Overall Study|Death|7|||
162889563|NCT00405821|588293191|FG000|Overall Study|Lost to Follow-up|7|||
162889564|NCT00405821|588293192|FG001|Overall Study|Lost to Follow-up|7|||
162889565|NCT00405821|588293191|FG000|Overall Study|Protocol Violation|1|||
162889566|NCT00405821|588293192|FG001|Overall Study|Protocol Violation|0|||
162889567|NCT00405821|588293191|FG000|Overall Study|initiated ART|9|||
162889568|NCT00405821|588293192|FG001|Overall Study|initiated ART|8|||
162889569|NCT01770145|588295257|FG000|Baseline|Adverse Event|20|||
163051198|NCT01232790|588895362|FG000|Second Crossover|Withdrawal by Subject|1|||
163051199|NCT01232790|588895363|FG001|Second Crossover|Withdrawal by Subject|2|||
162889570|NCT01770145|588295257|FG000|Baseline|Withdrawal by Subject|1|||
162889571|NCT01770145|588295257|FG000|Baseline|Lost to Follow-up|1|||
162889572|NCT01770145|588295257|FG000|Baseline|Unable to define optimal dose|4|||
162889573|NCT01770145|588295257|FG000|Treatment|Adverse Event|3|||
162889574|NCT01770145|588295257|FG000|Treatment|Withdrawal by Subject|1|||
162889575|NCT01102140|588295258|FG000|Overall Study|Lost to Follow-up|1|||
162889576|NCT01102140|588295259|FG001|Overall Study|Lost to Follow-up|0|||
162889577|NCT01102140|588295258|FG000|Overall Study|Investigator terminated study|2|||
162889578|NCT01102140|588295259|FG001|Overall Study|Investigator terminated study|2|||
162889579|NCT04134728|588295265|FG000|Overall Study|Adverse Event|3|||
162889580|NCT04134728|588295266|FG001|Overall Study|Adverse Event|2|||
162889581|NCT04134728|588295267|FG002|Overall Study|Adverse Event|9|||
162889582|NCT04134728|588295268|FG003|Overall Study|Adverse Event|0|||
162889583|NCT04134728|588295269|FG004|Overall Study|Adverse Event|0|||
162889584|NCT04134728|588295270|FG005|Overall Study|Adverse Event|0|||
162889585|NCT04134728|588295265|FG000|Overall Study|Lack of Efficacy|3|||
162889586|NCT04134728|588295266|FG001|Overall Study|Lack of Efficacy|3|||
162889587|NCT04134728|588295267|FG002|Overall Study|Lack of Efficacy|1|||
162889588|NCT04134728|588295268|FG003|Overall Study|Lack of Efficacy|2|||
162889589|NCT04134728|588295269|FG004|Overall Study|Lack of Efficacy|0|||
163051200|NCT00083915|588895364|FG000|Overall Study|Death|6|||
162889590|NCT04134728|588295270|FG005|Overall Study|Lack of Efficacy|0|||
163051201|NCT00083915|588895365|FG001|Overall Study|Death|3|||
163051202|NCT00083915|588895364|FG000|Overall Study|Physician Decision|11|||
163051203|NCT00083915|588895365|FG001|Overall Study|Physician Decision|6|||
163051204|NCT00083915|588895364|FG000|Overall Study|Withdrawal by Subject|8|||
162889591|NCT04134728|588295265|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
162889592|NCT04134728|588295266|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162889593|NCT04134728|588295267|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
162889594|NCT04134728|588295268|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162889595|NCT04134728|588295269|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162889596|NCT04134728|588295270|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162889597|NCT04134728|588295265|FG000|Overall Study|Protocol Deviation|0|||
162889598|NCT04134728|588295266|FG001|Overall Study|Protocol Deviation|0|||
163051205|NCT00083915|588895365|FG001|Overall Study|Withdrawal by Subject|3|||
162708421|NCT05074498|587642775|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162708422|NCT05074498|587642776|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
162889599|NCT04134728|588295267|FG002|Overall Study|Protocol Deviation|1|||
162889600|NCT04134728|588295268|FG003|Overall Study|Protocol Deviation|0|||
162889601|NCT04134728|588295269|FG004|Overall Study|Protocol Deviation|0|||
162889602|NCT04134728|588295270|FG005|Overall Study|Protocol Deviation|0|||
162889603|NCT04134728|588295265|FG000|Overall Study|Informed Consent Withdrawn|3|||
162889604|NCT04134728|588295266|FG001|Overall Study|Informed Consent Withdrawn|6|||
163051206|NCT00083915|588895364|FG000|Overall Study|disease progression|18|||
163051207|NCT00083915|588895365|FG001|Overall Study|disease progression|23|||
163051208|NCT00083915|588895364|FG000|Overall Study|Failure to collect|3|||
163051209|NCT00083915|588895365|FG001|Overall Study|Failure to collect|0|||
163051210|NCT00083915|588895364|FG000|Overall Study|No response|3|||
163051211|NCT00083915|588895365|FG001|Overall Study|No response|1|||
163051212|NCT00083915|588895364|FG000|Overall Study|Insurance issues|1|||
163051213|NCT00083915|588895365|FG001|Overall Study|Insurance issues|1|||
163051214|NCT04456686|588895369|FG000|Overall Study|Adverse Event|2|||
163051215|NCT04456686|588895370|FG001|Overall Study|Adverse Event|1|||
163051216|NCT04456686|588895369|FG000|Overall Study|Lack of Efficacy|3|||
163051217|NCT04456686|588895370|FG001|Overall Study|Lack of Efficacy|1|||
163051218|NCT04456686|588895369|FG000|Overall Study|Withdrew consent|3|||
163051219|NCT04456686|588895370|FG001|Overall Study|Withdrew consent|1|||
163051220|NCT04456686|588895369|FG000|Overall Study|Physician Decision|2|||
163051221|NCT04456686|588895370|FG001|Overall Study|Physician Decision|2|||
163051222|NCT04456686|588895369|FG000|Overall Study|Withdrawal by Subject|5|||
163051223|NCT04456686|588895370|FG001|Overall Study|Withdrawal by Subject|1|||
163051224|NCT04456686|588895369|FG000|Overall Study|Protocol Violation|0|||
163051225|NCT04456686|588895370|FG001|Overall Study|Protocol Violation|1|||
163051226|NCT03722576|588895373|FG000|Overall Study|Withdrawal by Subject|3|||
163051227|NCT03722576|588895373|FG000|Overall Study|Adverse Event|2|||
163051228|NCT03722576|588895373|FG000|Overall Study|Physician Decision|1|||
163051229|NCT03722576|588895373|FG000|Overall Study|Lost to Follow-up|1|||
163051230|NCT02059239|588895377|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
163051231|NCT02059239|588895378|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
163051232|NCT02059239|588895377|FG000|Overall Study|Physician Decision|1|||
163051233|NCT02059239|588895378|FG001|Overall Study|Physician Decision|0|||
163051234|NCT01408706|588895380|FG000|Overall Study|Physician Decision|1|||
163051235|NCT01408706|588895381|FG001|Overall Study|Physician Decision|0|||
162889605|NCT04134728|588295267|FG002|Overall Study|Informed Consent Withdrawn|8|||
162889606|NCT04134728|588295268|FG003|Overall Study|Informed Consent Withdrawn|1|||
162889607|NCT04134728|588295269|FG004|Overall Study|Informed Consent Withdrawn|1|||
162889608|NCT04134728|588295270|FG005|Overall Study|Informed Consent Withdrawn|0|||
162889609|NCT04134728|588295265|FG000|Overall Study|Physician Decision|2|||
162889610|NCT04134728|588295266|FG001|Overall Study|Physician Decision|0|||
162889611|NCT04134728|588295267|FG002|Overall Study|Physician Decision|0|||
162889612|NCT04134728|588295268|FG003|Overall Study|Physician Decision|0|||
162889613|NCT04134728|588295269|FG004|Overall Study|Physician Decision|0|||
162889614|NCT04134728|588295270|FG005|Overall Study|Physician Decision|0|||
162889615|NCT04134728|588295265|FG000|Overall Study|Lost to Follow-up|1|||
162889616|NCT04134728|588295266|FG001|Overall Study|Lost to Follow-up|2|||
162889617|NCT04134728|588295267|FG002|Overall Study|Lost to Follow-up|1|||
162889618|NCT04134728|588295268|FG003|Overall Study|Lost to Follow-up|0|||
162889619|NCT04134728|588295269|FG004|Overall Study|Lost to Follow-up|0|||
162889620|NCT04134728|588295270|FG005|Overall Study|Lost to Follow-up|1|||
162889621|NCT04134728|588295265|FG000|Overall Study|Investigator Site Closed|0|||
162889622|NCT04134728|588295266|FG001|Overall Study|Investigator Site Closed|1|||
162889623|NCT04134728|588295267|FG002|Overall Study|Investigator Site Closed|1|||
162889624|NCT04134728|588295268|FG003|Overall Study|Investigator Site Closed|0|||
162889625|NCT04134728|588295269|FG004|Overall Study|Investigator Site Closed|0|||
162889626|NCT04134728|588295270|FG005|Overall Study|Investigator Site Closed|0|||
162889627|NCT00801892|588295271|FG000|Main Study Period|Withdrawal by Subject|0|||
162889628|NCT00801892|588295272|FG001|Main Study Period|Withdrawal by Subject|1|||
162889629|NCT00801892|588295271|FG000|Sham Crossover Period|Lost to Follow-up|0|||
162889630|NCT00801892|588295272|FG001|Sham Crossover Period|Lost to Follow-up|2|||
163051236|NCT02204917|588895382|FG000|Overall Study|Protocol Violation|1|||
162708423|NCT05074498|587642777|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162708424|NCT05074498|587642778|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162708425|NCT05074498|587642773|FG000|Part 1 (Upto Day 104)|Other|1|||
162708426|NCT05074498|587642774|FG001|Part 1 (Upto Day 104)|Other|0|||
162708427|NCT05074498|587642775|FG002|Part 1 (Upto Day 104)|Other|0|||
162708428|NCT05074498|587642776|FG003|Part 1 (Upto Day 104)|Other|0|||
162889631|NCT01175590|588295278|FG000|Overall Study|Lost to Follow-up|1|||
163051237|NCT02048722|588895383|FG000|2 Cycles of Treatment|Adverse Event|2|||
163051238|NCT02048722|588895383|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
163051239|NCT02048722|588895383|FG000|2 Cycles of Treatment|Progressive Disease|2|||
162708429|NCT05074498|587642777|FG004|Part 1 (Upto Day 104)|Other|0|||
162889632|NCT01175590|588295279|FG001|Overall Study|Lost to Follow-up|0|||
162889633|NCT01175590|588295278|FG000|Overall Study|Withdrawal by Subject|0|||
162889634|NCT01175590|588295279|FG001|Overall Study|Withdrawal by Subject|2|||
162889635|NCT01175590|588295278|FG000|Overall Study|Adverse Event|4|||
163051240|NCT02048722|588895383|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
163051241|NCT02048722|588895383|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
163051242|NCT02048722|588895383|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
163051243|NCT03575702|588895386|FG000|Overall Study|Withdrawal by Subject|1|||
162708430|NCT05074498|587642778|FG005|Part 1 (Upto Day 104)|Other|0|||
162889636|NCT01175590|588295279|FG001|Overall Study|Adverse Event|0|||
162889637|NCT01175590|588295278|FG000|Overall Study|Physician Decision|1|||
162889638|NCT01175590|588295279|FG001|Overall Study|Physician Decision|4|||
162889639|NCT01175590|588295278|FG000|Overall Study|Lack of Efficacy|1|||
162889640|NCT01175590|588295279|FG001|Overall Study|Lack of Efficacy|1|||
162889641|NCT01175590|588295278|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
162889642|NCT01175590|588295279|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
162889643|NCT01175590|588295278|FG000|Overall Study|Treated not as randomized|3|||
162889644|NCT01175590|588295279|FG001|Overall Study|Treated not as randomized|2|||
162889645|NCT01175590|588295278|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
162889646|NCT01175590|588295279|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
162889647|NCT01175590|588295278|FG000|Overall Study|Protocol Violation|0|||
162889648|NCT01175590|588295279|FG001|Overall Study|Protocol Violation|1|||
162889649|NCT02062398|588295280|FG000|Overall Study|Implant removal|1|||
162889650|NCT03351478|588295281|FG000|Overall Study|At the subject's own request|11|||
162889651|NCT03351478|588295282|FG001|Overall Study|At the subject's own request|12|||
162889652|NCT03351478|588295283|FG002|Overall Study|At the subject's own request|5|||
162889653|NCT03351478|588295281|FG000|Overall Study|Adverse Event|1|||
162889654|NCT03351478|588295282|FG001|Overall Study|Adverse Event|2|||
162889655|NCT03351478|588295283|FG002|Overall Study|Adverse Event|1|||
162889656|NCT03351478|588295281|FG000|Overall Study|Poor compliance to protocol|1|||
162889657|NCT03351478|588295282|FG001|Overall Study|Poor compliance to protocol|0|||
162889658|NCT03351478|588295283|FG002|Overall Study|Poor compliance to protocol|0|||
162889659|NCT03351478|588295281|FG000|Overall Study|Reason not Specified|1|||
162889660|NCT03351478|588295282|FG001|Overall Study|Reason not Specified|3|||
162889661|NCT03351478|588295283|FG002|Overall Study|Reason not Specified|0|||
162889662|NCT03351478|588295281|FG000|Overall Study|Lost to Follow-up|0|||
162889663|NCT03351478|588295282|FG001|Overall Study|Lost to Follow-up|0|||
162889664|NCT03351478|588295283|FG002|Overall Study|Lost to Follow-up|1|||
162889665|NCT03911869|588295284|FG000|Safety Lead-in Phase|Death|7|||
162619191|NCT00289016|587321506|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
162619192|NCT00289016|587321506|FG000|Overall Study|Withdrawal by Subject|2|||
162619193|NCT00289016|587321506|FG000|Overall Study|Adverse Event|1|||
162619194|NCT00289016|587321506|FG000|Overall Study|Other|1|||
162889666|NCT03911869|588295285|FG001|Safety Lead-in Phase|Death|0|||
162889667|NCT03911869|588295286|FG002|Safety Lead-in Phase|Death|0|||
162889668|NCT03911869|588295284|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
162889669|NCT03911869|588295285|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
162889670|NCT03911869|588295286|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
162889671|NCT03911869|588295284|FG000|Safety Lead-in Phase|Other|1|||
162889672|NCT03911869|588295285|FG001|Safety Lead-in Phase|Other|0|||
162889673|NCT03911869|588295286|FG002|Safety Lead-in Phase|Other|0|||
162889674|NCT03911869|588295284|FG000|Phase 2|Death|0|||
162889675|NCT03911869|588295285|FG001|Phase 2|Death|3|||
162889676|NCT03911869|588295286|FG002|Phase 2|Death|0|||
162889677|NCT01106391|588295288|FG000|Overall Study|Death|12|||
162889678|NCT01106391|588295288|FG000|Overall Study|Withdrawal by Subject|7|||
162889679|NCT01387074|588295289|FG000|Overall Study|Lost to Follow-up|7|||
162889680|NCT01387074|588295289|FG000|Overall Study|Lack of Efficacy|1|||
162889681|NCT00150345|588295290|FG000|Overall Study|Death|5|||
162889682|NCT00150345|588295291|FG001|Overall Study|Death|2|||
162619195|NCT03553927|587321507|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
162619196|NCT03553927|587321508|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
162619197|NCT03553927|587321507|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
162889683|NCT00150345|588295290|FG000|Overall Study|Adverse Event|8|||
162889684|NCT00150345|588295291|FG001|Overall Study|Adverse Event|6|||
162889685|NCT00150345|588295290|FG000|Overall Study|Lack of Efficacy|5|||
162889686|NCT00150345|588295291|FG001|Overall Study|Lack of Efficacy|4|||
162889687|NCT00150345|588295290|FG000|Overall Study|Withdrawal by Subject|3|||
162889688|NCT00150345|588295291|FG001|Overall Study|Withdrawal by Subject|4|||
162889689|NCT00150345|588295290|FG000|Overall Study|Laboratory abnormality|1|||
162889690|NCT00150345|588295291|FG001|Overall Study|Laboratory abnormality|2|||
162889691|NCT00150345|588295290|FG000|Overall Study|Other|12|||
162889692|NCT00150345|588295291|FG001|Overall Study|Other|14|||
162889693|NCT01392742|588295292|FG000|Overall Study|Premature study termination|42|||
162889694|NCT01392742|588295292|FG000|Overall Study|Failure to return|35|||
162963972|NCT03573544|588567958|FG005|Overall Study|Disease progression|7|||
162963973|NCT03573544|588567959|FG006|Overall Study|Disease progression|6|||
162963974|NCT03573544|588567960|FG007|Overall Study|Disease progression|7|||
162963975|NCT03105297|588567964|FG000|Baseline Phase (Day 1)|Other|21|||
162963976|NCT03105297|588567964|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
162963977|NCT03105297|588567964|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
162963978|NCT00714051|588567965|FG000|Overall Study|Withdrawal by Subject|1|||
162963979|NCT00714051|588567966|FG001|Overall Study|Withdrawal by Subject|0|||
162963980|NCT00714051|588567965|FG000|Overall Study|Death|0|||
162963981|NCT00714051|588567966|FG001|Overall Study|Death|1|||
162963982|NCT00227370|588567967|FG000|Overall Study|Withdrawal by Subject|1|||
162963983|NCT00227370|588567968|FG001|Overall Study|Withdrawal by Subject|2|||
162708431|NCT05074498|587642773|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162708432|NCT05074498|587642774|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162708433|NCT05074498|587642775|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162889695|NCT01392742|588295292|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
162889696|NCT01392742|588295292|FG000|Overall Study|Lost to Follow-up|34|||
162889697|NCT01392742|588295292|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
162963984|NCT00227370|588567967|FG000|Overall Study|Death|3|||
162963985|NCT00227370|588567968|FG001|Overall Study|Death|4|||
162963986|NCT00227370|588567967|FG000|Overall Study|Adverse Event|6|||
162963987|NCT00227370|588567968|FG001|Overall Study|Adverse Event|11|||
162963988|NCT00227370|588567967|FG000|Overall Study|Physician Decision|9|||
162963989|NCT00227370|588567968|FG001|Overall Study|Physician Decision|6|||
162963990|NCT00227370|588567967|FG000|Overall Study|Other reasons|2|||
162963991|NCT00227370|588567968|FG001|Overall Study|Other reasons|1|||
162963992|NCT03846193|588567969|FG000|Overall Study|Physician Decision|0|||
162963993|NCT03846193|588567970|FG001|Overall Study|Physician Decision|0|||
162963994|NCT03846193|588567971|FG002|Overall Study|Physician Decision|1|||
162963995|NCT03846193|588567972|FG003|Overall Study|Physician Decision|0|||
162889698|NCT01392742|588295292|FG000|Overall Study|ITR and Protocol deviation|1|||
162889699|NCT01392742|588295292|FG000|Overall Study|Adverse event/intercurrent illness|17|||
162889700|NCT01392742|588295292|FG000|Overall Study|Protocol Violation|14|||
162889701|NCT01392742|588295292|FG000|Overall Study|Other|3|||
162889702|NCT01392742|588295292|FG000|Overall Study|Missing information|13|||
162889703|NCT01998958|588295293|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162963996|NCT03846193|588567973|FG004|Overall Study|Physician Decision|0|||
162963997|NCT03846193|588567969|FG000|Overall Study|Lost to Follow-up|0|||
162963998|NCT03846193|588567970|FG001|Overall Study|Lost to Follow-up|0|||
162889704|NCT01998958|588295294|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
162963999|NCT03846193|588567971|FG002|Overall Study|Lost to Follow-up|0|||
162964000|NCT03846193|588567972|FG003|Overall Study|Lost to Follow-up|0|||
162889705|NCT01998958|588295295|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889706|NCT01998958|588295296|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162964001|NCT03846193|588567973|FG004|Overall Study|Lost to Follow-up|1|||
162889707|NCT01998958|588295297|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889708|NCT01998958|588295298|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889709|NCT01998958|588295299|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162964002|NCT03846193|588567969|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162889710|NCT01998958|588295300|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889711|NCT01998958|588295301|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889712|NCT01998958|588295302|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889713|NCT01998958|588295303|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889714|NCT01998958|588295304|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889715|NCT01998958|588295305|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889716|NCT01998958|588295306|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889717|NCT01998958|588295307|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889718|NCT01998958|588295308|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889719|NCT01998958|588295309|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889720|NCT01998958|588295310|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889721|NCT01998958|588295311|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889722|NCT01998958|588295312|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889723|NCT01998958|588295313|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889724|NCT01998958|588295314|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889725|NCT01998958|588295315|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162964003|NCT03846193|588567970|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964004|NCT03846193|588567971|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964005|NCT03846193|588567972|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
162964006|NCT03846193|588567973|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162964007|NCT01390948|588567974|FG000|Overall Study|End of Study|1|||
162964008|NCT01390948|588567975|FG001|Overall Study|End of Study|0|||
162964009|NCT01390948|588567976|FG002|Overall Study|End of Study|0|||
162964010|NCT01390948|588567974|FG000|Overall Study|Withdrew consent|2|||
162964011|NCT01390948|588567975|FG001|Overall Study|Withdrew consent|2|||
162964012|NCT01390948|588567976|FG002|Overall Study|Withdrew consent|0|||
162964013|NCT01390948|588567974|FG000|Overall Study|Progressive Disease|2|||
162964014|NCT01390948|588567975|FG001|Overall Study|Progressive Disease|5|||
162964015|NCT01390948|588567976|FG002|Overall Study|Progressive Disease|0|||
162964016|NCT01390948|588567974|FG000|Overall Study|Death during follow-up|10|||
162964017|NCT01390948|588567975|FG001|Overall Study|Death during follow-up|11|||
162964018|NCT01390948|588567976|FG002|Overall Study|Death during follow-up|1|||
162964019|NCT03961204|588567977|FG000|Overall Study|Withdrawal by Subject|2|||
162964020|NCT03961204|588567977|FG000|Overall Study|Lost to Follow-up|3|||
162964021|NCT03961204|588567977|FG000|Overall Study|Other|1|||
162964022|NCT03961204|588567977|FG000|Overall Study|Missing|1|||
162964023|NCT02218216|588567978|FG000|Overall Study|Study terminated before completed|6|||
162964024|NCT02218216|588567979|FG001|Overall Study|Study terminated before completed|0|||
162964025|NCT02218216|588567980|FG002|Overall Study|Study terminated before completed|0|||
162964026|NCT05740098|588567985|FG000|Overall Study|Lost to Follow-up|26|||
162619198|NCT03553927|587321508|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
162619199|NCT03350620|587321512|FG000|Stage 2|Adverse Event|0|||
162619200|NCT03350620|587321513|FG001|Stage 2|Adverse Event|1|||
162619201|NCT03350620|587321514|FG002|Stage 2|Adverse Event|1|||
162619202|NCT03350620|587321512|FG000|Stage 2|Lack of Efficacy|0|||
162619203|NCT03350620|587321513|FG001|Stage 2|Lack of Efficacy|2|||
162619204|NCT03350620|587321514|FG002|Stage 2|Lack of Efficacy|0|||
162619205|NCT03350620|587321512|FG000|Stage 2|Lost to Follow-up|1|||
162619206|NCT03350620|587321513|FG001|Stage 2|Lost to Follow-up|2|||
162708434|NCT05074498|587642776|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162708435|NCT05074498|587642777|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
162708436|NCT05074498|587642778|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162708437|NCT05074498|587642773|FG000|Part 2 (Upto Day 104)|Death|0|||
162708438|NCT05074498|587642774|FG001|Part 2 (Upto Day 104)|Death|0|||
162708439|NCT05074498|587642775|FG002|Part 2 (Upto Day 104)|Death|0|||
162708440|NCT05074498|587642776|FG003|Part 2 (Upto Day 104)|Death|0|||
162708441|NCT05074498|587642777|FG004|Part 2 (Upto Day 104)|Death|1|||
162708442|NCT05074498|587642778|FG005|Part 2 (Upto Day 104)|Death|0|||
162708443|NCT05074498|587642773|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162964027|NCT05740098|588567986|FG001|Overall Study|Lost to Follow-up|17|||
162964028|NCT05740098|588567987|FG002|Overall Study|Lost to Follow-up|21|||
162964029|NCT02452463|588567988|FG000|Overall Study|Death|1|||
162708444|NCT05074498|587642774|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162964030|NCT02452463|588567989|FG001|Overall Study|Death|0|||
162964031|NCT02452463|588567990|FG002|Overall Study|Death|0|||
162964032|NCT02452463|588567988|FG000|Overall Study|Study Suspended|1|||
162964033|NCT02452463|588567989|FG001|Overall Study|Study Suspended|0|||
162619207|NCT03350620|587321514|FG002|Stage 2|Lost to Follow-up|2|||
162619208|NCT03350620|587321512|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
162708445|NCT05074498|587642775|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162889726|NCT01998958|588295316|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889727|NCT01998958|588295317|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889728|NCT01998958|588295318|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889729|NCT01998958|588295319|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889730|NCT01998958|588295320|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889731|NCT01998958|588295321|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889732|NCT01998958|588295322|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889733|NCT01998958|588295323|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889734|NCT01998958|588295324|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
162889735|NCT01998958|588295293|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889736|NCT01998958|588295294|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
162889737|NCT01998958|588295295|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889738|NCT01998958|588295296|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889739|NCT01998958|588295297|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889740|NCT01998958|588295298|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889741|NCT01998958|588295299|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889742|NCT01998958|588295300|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889743|NCT01998958|588295301|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889744|NCT01998958|588295302|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889745|NCT01998958|588295303|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889746|NCT01998958|588295304|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889747|NCT01998958|588295305|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889748|NCT01998958|588295306|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889749|NCT01998958|588295307|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889750|NCT01998958|588295308|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889751|NCT01998958|588295309|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889752|NCT01998958|588295310|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889753|NCT01998958|588295311|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889754|NCT01998958|588295312|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889755|NCT01998958|588295313|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162964034|NCT02452463|588567990|FG002|Overall Study|Study Suspended|0|||
162964035|NCT02452463|588567988|FG000|Overall Study|Recommended by DSMB|0|||
162964036|NCT02452463|588567989|FG001|Overall Study|Recommended by DSMB|1|||
162889756|NCT01998958|588295314|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889757|NCT01998958|588295315|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889758|NCT01998958|588295316|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162619209|NCT03350620|587321513|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
162619210|NCT03350620|587321514|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
162619211|NCT00566111|587321515|FG000|Overall Study|Adverse Event|0|||
162619212|NCT00566111|587321516|FG001|Overall Study|Adverse Event|2|||
162619213|NCT03774082|587321518|FG000|Overall Study|Death|6|||
162619214|NCT03774082|587321519|FG001|Overall Study|Death|3|||
162619215|NCT03774082|587321520|FG002|Overall Study|Death|2|||
162619216|NCT03774082|587321518|FG000|Overall Study|Subject decision|0|||
162619217|NCT03774082|587321519|FG001|Overall Study|Subject decision|3|||
162619218|NCT03774082|587321520|FG002|Overall Study|Subject decision|0|||
162619219|NCT03774082|587321518|FG000|Overall Study|Lost to Follow-up|2|||
162619220|NCT03774082|587321519|FG001|Overall Study|Lost to Follow-up|0|||
162619221|NCT03774082|587321520|FG002|Overall Study|Lost to Follow-up|0|||
162619222|NCT03774082|587321518|FG000|Overall Study|Guardian decision|0|||
162619223|NCT03774082|587321519|FG001|Overall Study|Guardian decision|0|||
162619224|NCT03774082|587321520|FG002|Overall Study|Guardian decision|1|||
162619225|NCT03774082|587321518|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
162619226|NCT03774082|587321519|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
162619227|NCT03774082|587321520|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
162619228|NCT05938920|587321521|FG000|Overall Study|Adverse Event|1|||
162619229|NCT05938920|587321522|FG001|Overall Study|Adverse Event|3|||
162619230|NCT05938920|587321523|FG002|Overall Study|Adverse Event|2|||
162619231|NCT05938920|587321524|FG003|Overall Study|Adverse Event|1|||
162619232|NCT05938920|587321521|FG000|Overall Study|Death|0|||
162619233|NCT05938920|587321522|FG001|Overall Study|Death|1|||
162619234|NCT05938920|587321523|FG002|Overall Study|Death|0|||
162619235|NCT05938920|587321524|FG003|Overall Study|Death|0|||
162889759|NCT01998958|588295317|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889760|NCT01998958|588295318|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889761|NCT01998958|588295319|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162619236|NCT05938920|587321521|FG000|Overall Study|Lost to Follow-up|0|||
162619237|NCT05938920|587321522|FG001|Overall Study|Lost to Follow-up|0|||
162619238|NCT05938920|587321523|FG002|Overall Study|Lost to Follow-up|1|||
162619239|NCT05938920|587321524|FG003|Overall Study|Lost to Follow-up|0|||
162619240|NCT05938920|587321521|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
162708446|NCT05074498|587642776|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162889762|NCT01998958|588295320|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889763|NCT01998958|588295321|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889764|NCT01998958|588295322|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889765|NCT01998958|588295323|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889766|NCT01998958|588295324|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
162889767|NCT01998958|588295293|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
162889768|NCT01998958|588295294|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
162889769|NCT01998958|588295295|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
162889770|NCT01998958|588295296|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
162889771|NCT01998958|588295297|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
162964037|NCT02452463|588567990|FG002|Overall Study|Recommended by DSMB|0|||
162964038|NCT02452463|588567988|FG000|Overall Study|Withdrawal by Subject|0|||
162964039|NCT02452463|588567989|FG001|Overall Study|Withdrawal by Subject|1|||
162964040|NCT02452463|588567990|FG002|Overall Study|Withdrawal by Subject|0|||
162964041|NCT01073631|588567991|FG000|Overall Study|Death|82|||
162619241|NCT05938920|587321522|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162619242|NCT05938920|587321523|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162619243|NCT05938920|587321524|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162619244|NCT05938920|587321521|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162619245|NCT05938920|587321522|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162619246|NCT05938920|587321523|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
162619247|NCT05938920|587321524|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162619248|NCT05938920|587321521|FG000|Overall Study|Participant Refused to Come In|0|||
162619249|NCT05938920|587321522|FG001|Overall Study|Participant Refused to Come In|0|||
162619250|NCT05938920|587321523|FG002|Overall Study|Participant Refused to Come In|1|||
162619251|NCT05938920|587321524|FG003|Overall Study|Participant Refused to Come In|0|||
162619252|NCT01251861|587321525|FG000|Overall Study|Disease progression|6|||
162619253|NCT01251861|587321526|FG001|Overall Study|Disease progression|6|||
162619254|NCT01251861|587321525|FG000|Overall Study|Adverse Event|2|||
162619255|NCT01251861|587321526|FG001|Overall Study|Adverse Event|17|||
162619256|NCT01251861|587321525|FG000|Overall Study|Withdrawal by Subject|2|||
162619257|NCT01251861|587321526|FG001|Overall Study|Withdrawal by Subject|2|||
162619258|NCT01251861|587321525|FG000|Overall Study|Alternative therapy|1|||
162619259|NCT01251861|587321526|FG001|Overall Study|Alternative therapy|0|||
162619260|NCT01251861|587321525|FG000|Overall Study|Other complicating disease|0|||
162619261|NCT01251861|587321526|FG001|Overall Study|Other complicating disease|1|||
162619262|NCT01251861|587321525|FG000|Overall Study|Physician Decision|1|||
162619263|NCT01251861|587321526|FG001|Overall Study|Physician Decision|0|||
162619264|NCT01251861|587321525|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
162619265|NCT01251861|587321526|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
162619266|NCT01251861|587321525|FG000|Overall Study|Other|1|||
162619267|NCT01251861|587321526|FG001|Overall Study|Other|0|||
162619268|NCT01251861|587321525|FG000|Overall Study|Never started therapy|4|||
162619269|NCT01251861|587321526|FG001|Overall Study|Never started therapy|1|||
162708447|NCT05074498|587642777|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
162889772|NCT01998958|588295298|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
162889773|NCT01998958|588295299|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
162889774|NCT01998958|588295300|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
162964042|NCT01073631|588567991|FG000|Overall Study|Adverse Event|24|||
162889775|NCT01998958|588295301|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
162889776|NCT01998958|588295302|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
162889777|NCT01998958|588295303|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
162889778|NCT01998958|588295304|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
162889779|NCT01998958|588295305|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
162889780|NCT01998958|588295306|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
162889781|NCT01998958|588295307|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
162889782|NCT01998958|588295308|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
162889783|NCT01998958|588295309|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
162889784|NCT01998958|588295310|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
162889785|NCT01998958|588295311|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
162889786|NCT01998958|588295312|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
162889787|NCT01998958|588295313|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
162889788|NCT01998958|588295314|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
162889789|NCT01998958|588295315|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
162889790|NCT01998958|588295316|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
162889791|NCT01998958|588295317|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
162889792|NCT01998958|588295318|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
162889793|NCT01998958|588295319|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
162889794|NCT01998958|588295320|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
162889795|NCT01998958|588295321|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
162889796|NCT01998958|588295322|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
162889797|NCT01998958|588295323|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
162889798|NCT01998958|588295324|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
162889799|NCT01998958|588295293|FG000|Period 1 (Panel A and B)|Other|1|||
162889800|NCT01998958|588295294|FG001|Period 1 (Panel A and B)|Other|0|||
162889801|NCT01998958|588295295|FG002|Period 1 (Panel A and B)|Other|0|||
162889802|NCT01998958|588295296|FG003|Period 1 (Panel A and B)|Other|0|||
162889803|NCT01998958|588295297|FG004|Period 1 (Panel A and B)|Other|0|||
162889804|NCT01998958|588295298|FG005|Period 1 (Panel A and B)|Other|0|||
162889805|NCT01998958|588295299|FG006|Period 1 (Panel A and B)|Other|0|||
162889806|NCT01998958|588295300|FG007|Period 1 (Panel A and B)|Other|0|||
163051244|NCT03575702|588895387|FG001|Overall Study|Withdrawal by Subject|1|||
163051245|NCT03575702|588895386|FG000|Overall Study|Lost to Follow-up|1|||
163051246|NCT03575702|588895387|FG001|Overall Study|Lost to Follow-up|2|||
163051247|NCT03575702|588895386|FG000|Overall Study|Protocol Violation|0|||
162889807|NCT01998958|588295301|FG008|Period 1 (Panel A and B)|Other|0|||
163051248|NCT03575702|588895387|FG001|Overall Study|Protocol Violation|1|||
162889808|NCT01998958|588295302|FG009|Period 1 (Panel A and B)|Other|0|||
162889809|NCT01998958|588295303|FG010|Period 1 (Panel A and B)|Other|0|||
162889810|NCT01998958|588295304|FG011|Period 1 (Panel A and B)|Other|0|||
162964043|NCT01073631|588567991|FG000|Overall Study|Other|63|||
162964044|NCT01131260|588567996|FG000|Overall Study|Randomization error|5|||
162964045|NCT01131260|588567997|FG001|Overall Study|Randomization error|1|||
162964046|NCT01131260|588567996|FG000|Overall Study|Declined to continue participation|8|||
162964047|NCT01131260|588567997|FG001|Overall Study|Declined to continue participation|13|||
162964048|NCT01131260|588567996|FG000|Overall Study|Physician Decision|22|||
162964049|NCT01131260|588567997|FG001|Overall Study|Physician Decision|24|||
162619270|NCT01251861|587321525|FG000|Overall Study|Potential interaction of drugs|0|||
162964050|NCT01131260|588567996|FG000|Overall Study|Technical problems|7|||
162964051|NCT01131260|588567997|FG001|Overall Study|Technical problems|6|||
162964052|NCT01131260|588567996|FG000|Overall Study|Staff error|2|||
162964053|NCT01131260|588567997|FG001|Overall Study|Staff error|1|||
162964054|NCT01131260|588567996|FG000|Overall Study|Ineligible|0|||
162964055|NCT01131260|588567997|FG001|Overall Study|Ineligible|2|||
162964056|NCT01494532|588568002|FG000|Overall Study|Adverse Event|4|||
162964057|NCT01494532|588568003|FG001|Overall Study|Adverse Event|1|||
162964058|NCT01494532|588568004|FG002|Overall Study|Adverse Event|8|||
162964059|NCT01494532|588568005|FG003|Overall Study|Adverse Event|6|||
162964060|NCT01494532|588568006|FG004|Overall Study|Adverse Event|5|||
162964061|NCT01494532|588568007|FG005|Overall Study|Adverse Event|0|||
162964062|NCT01494532|588568002|FG000|Overall Study|Lack of Efficacy|0|||
162964063|NCT01494532|588568003|FG001|Overall Study|Lack of Efficacy|0|||
162964064|NCT01494532|588568004|FG002|Overall Study|Lack of Efficacy|0|||
162619271|NCT01251861|587321526|FG001|Overall Study|Potential interaction of drugs|1|||
162619272|NCT01816074|587322774|FG000|Phase 1|Time commitment issues|0|||
162619273|NCT01816074|587322775|FG001|Phase 1|Time commitment issues|0|||
162619274|NCT01816074|587322776|FG002|Phase 1|Time commitment issues|1|||
162619275|NCT01816074|587322777|FG003|Phase 1|Time commitment issues|0|||
162619276|NCT01816074|587322774|FG000|Phase 2|Time commitment Issues|0|||
162619277|NCT01816074|587322775|FG001|Phase 2|Time commitment Issues|2|||
162619278|NCT01816074|587322776|FG002|Phase 2|Time commitment Issues|0|||
162619279|NCT01816074|587322777|FG003|Phase 2|Time commitment Issues|0|||
162619280|NCT01816074|587322774|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
162619281|NCT01816074|587322775|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
162619282|NCT01816074|587322776|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
162619283|NCT01816074|587322777|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
162619284|NCT01816074|587322774|FG000|Phase 2|Physician Decision|0|||
162619285|NCT01816074|587322775|FG001|Phase 2|Physician Decision|0|||
162619286|NCT01816074|587322776|FG002|Phase 2|Physician Decision|0|||
162619287|NCT01816074|587322777|FG003|Phase 2|Physician Decision|1|||
162619288|NCT01816074|587322774|FG000|Phase 2|Withdrawal by Subject|1|||
162619289|NCT01816074|587322775|FG001|Phase 2|Withdrawal by Subject|0|||
162619290|NCT01816074|587322776|FG002|Phase 2|Withdrawal by Subject|0|||
162619291|NCT01816074|587322777|FG003|Phase 2|Withdrawal by Subject|0|||
162619292|NCT03355365|587322781|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
162619293|NCT03355365|587322782|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
162619294|NCT03355365|587322781|FG000|Year 1, First Intervention|Protocol Violation|1|||
162619295|NCT03355365|587322782|FG001|Year 1, First Intervention|Protocol Violation|0|||
162619296|NCT03355365|587322781|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
162619297|NCT03355365|587322782|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
162619298|NCT03355365|587322781|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
162619299|NCT03355365|587322782|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
162619300|NCT03355365|587322781|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
162619301|NCT03355365|587322782|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
162619302|NCT03355365|587322781|FG000|Year 2, Crossover Intervention|severe COVID|0|||
162619303|NCT03355365|587322782|FG001|Year 2, Crossover Intervention|severe COVID|1|||
162619304|NCT03355365|587322781|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
162619305|NCT03355365|587322782|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
162619306|NCT01303861|587322786|FG000|Overall Study|Lost to Follow-up|34|||
162619307|NCT01303861|587322787|FG001|Overall Study|Lost to Follow-up|14|||
162619308|NCT01303861|587322788|FG002|Overall Study|Lost to Follow-up|27|||
162619309|NCT01303861|587322789|FG003|Overall Study|Lost to Follow-up|31|||
162619310|NCT01303861|587322786|FG000|Overall Study|Lack of Efficacy|3|||
162619311|NCT01303861|587322787|FG001|Overall Study|Lack of Efficacy|2|||
162619312|NCT01303861|587322788|FG002|Overall Study|Lack of Efficacy|1|||
162619313|NCT01303861|587322789|FG003|Overall Study|Lack of Efficacy|0|||
162619314|NCT01303861|587322786|FG000|Overall Study|Withdrawal by Subject|16|||
162619315|NCT01303861|587322787|FG001|Overall Study|Withdrawal by Subject|8|||
162619316|NCT01303861|587322788|FG002|Overall Study|Withdrawal by Subject|8|||
162619317|NCT01303861|587322789|FG003|Overall Study|Withdrawal by Subject|23|||
162619318|NCT01303861|587322786|FG000|Overall Study|Adverse Event|4|||
162619319|NCT01303861|587322787|FG001|Overall Study|Adverse Event|1|||
162964065|NCT01494532|588568005|FG003|Overall Study|Lack of Efficacy|0|||
162964066|NCT01494532|588568006|FG004|Overall Study|Lack of Efficacy|2|||
162619320|NCT01303861|587322788|FG002|Overall Study|Adverse Event|0|||
162619321|NCT01303861|587322789|FG003|Overall Study|Adverse Event|5|||
162619322|NCT01303861|587322786|FG000|Overall Study|Pregnancy|1|||
162889811|NCT01998958|588295305|FG012|Period 1 (Panel A and B)|Other|0|||
162889812|NCT01998958|588295306|FG013|Period 1 (Panel A and B)|Other|0|||
162889813|NCT01998958|588295307|FG014|Period 1 (Panel A and B)|Other|0|||
162889814|NCT01998958|588295308|FG015|Period 1 (Panel A and B)|Other|0|||
162889815|NCT01998958|588295309|FG016|Period 1 (Panel A and B)|Other|0|||
162889816|NCT01998958|588295310|FG017|Period 1 (Panel A and B)|Other|0|||
162889817|NCT01998958|588295311|FG018|Period 1 (Panel A and B)|Other|0|||
162889818|NCT01998958|588295312|FG019|Period 1 (Panel A and B)|Other|0|||
162889819|NCT01998958|588295313|FG020|Period 1 (Panel A and B)|Other|0|||
162889820|NCT01998958|588295314|FG021|Period 1 (Panel A and B)|Other|0|||
162889821|NCT01998958|588295315|FG022|Period 1 (Panel A and B)|Other|0|||
162889822|NCT01998958|588295316|FG023|Period 1 (Panel A and B)|Other|0|||
162889823|NCT01998958|588295317|FG024|Period 1 (Panel A and B)|Other|0|||
162889824|NCT01998958|588295318|FG025|Period 1 (Panel A and B)|Other|0|||
162889825|NCT01998958|588295319|FG026|Period 1 (Panel A and B)|Other|0|||
162889826|NCT01998958|588295320|FG027|Period 1 (Panel A and B)|Other|0|||
162889827|NCT01998958|588295321|FG028|Period 1 (Panel A and B)|Other|0|||
162889828|NCT01998958|588295322|FG029|Period 1 (Panel A and B)|Other|0|||
162889829|NCT01998958|588295323|FG030|Period 1 (Panel A and B)|Other|0|||
162889830|NCT01998958|588295324|FG031|Period 1 (Panel A and B)|Other|0|||
162889831|NCT01998958|588295293|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
162889832|NCT01998958|588295294|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
162889833|NCT01998958|588295295|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
162889834|NCT01998958|588295296|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
162889835|NCT01998958|588295297|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
162889836|NCT01998958|588295298|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
162889837|NCT01998958|588295299|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
162889838|NCT01998958|588295300|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
162889839|NCT01998958|588295301|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
162889840|NCT01998958|588295302|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
162889841|NCT01998958|588295303|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
162889842|NCT01998958|588295304|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
162889843|NCT01998958|588295305|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
162889844|NCT01998958|588295306|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
162889845|NCT01998958|588295307|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
162889846|NCT01998958|588295308|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
162889847|NCT01998958|588295309|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
162889848|NCT01998958|588295310|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
162889849|NCT01998958|588295311|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
162889850|NCT01998958|588295312|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
162964067|NCT01494532|588568007|FG005|Overall Study|Lack of Efficacy|0|||
162964068|NCT01494532|588568002|FG000|Overall Study|Protocol deviation|2|||
162964069|NCT01494532|588568003|FG001|Overall Study|Protocol deviation|1|||
162964070|NCT01494532|588568004|FG002|Overall Study|Protocol deviation|3|||
162964071|NCT01494532|588568005|FG003|Overall Study|Protocol deviation|2|||
162964072|NCT01494532|588568006|FG004|Overall Study|Protocol deviation|3|||
162964073|NCT01494532|588568007|FG005|Overall Study|Protocol deviation|0|||
162964074|NCT01494532|588568002|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162964075|NCT01494532|588568003|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162964076|NCT01494532|588568004|FG002|Overall Study|Protocol-defined stopping criteria|1|||
162964077|NCT01494532|588568005|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162964078|NCT01494532|588568006|FG004|Overall Study|Protocol-defined stopping criteria|0|||
162964079|NCT01494532|588568007|FG005|Overall Study|Protocol-defined stopping criteria|0|||
162964080|NCT01494532|588568002|FG000|Overall Study|Lost to Follow-up|1|||
162964081|NCT01494532|588568003|FG001|Overall Study|Lost to Follow-up|0|||
162964082|NCT01494532|588568004|FG002|Overall Study|Lost to Follow-up|0|||
162964083|NCT01494532|588568005|FG003|Overall Study|Lost to Follow-up|2|||
162964084|NCT01494532|588568006|FG004|Overall Study|Lost to Follow-up|0|||
162964085|NCT01494532|588568007|FG005|Overall Study|Lost to Follow-up|0|||
162964086|NCT01494532|588568002|FG000|Overall Study|Physician Decision|0|||
162964087|NCT01494532|588568003|FG001|Overall Study|Physician Decision|1|||
163051249|NCT03575702|588895386|FG000|Overall Study|Patient non compliance|4|||
163051250|NCT03575702|588895387|FG001|Overall Study|Patient non compliance|0|||
162619323|NCT01303861|587322787|FG001|Overall Study|Pregnancy|0|||
162889851|NCT01998958|588295313|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
162889852|NCT01998958|588295314|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
162889853|NCT01998958|588295315|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
162889854|NCT01998958|588295316|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
162964088|NCT01494532|588568004|FG002|Overall Study|Physician Decision|1|||
162964089|NCT01494532|588568005|FG003|Overall Study|Physician Decision|2|||
162964090|NCT01494532|588568006|FG004|Overall Study|Physician Decision|0|||
162964091|NCT01494532|588568007|FG005|Overall Study|Physician Decision|0|||
162964092|NCT01494532|588568002|FG000|Overall Study|Withdrawal by Subject|3|||
162964093|NCT01494532|588568003|FG001|Overall Study|Withdrawal by Subject|1|||
162889855|NCT01998958|588295317|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
162889856|NCT01998958|588295318|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
162889857|NCT01998958|588295319|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
162889858|NCT01998958|588295320|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
162889859|NCT01998958|588295321|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
162889860|NCT01998958|588295322|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
162889861|NCT01998958|588295323|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
162889862|NCT01998958|588295324|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
162889863|NCT01998958|588295293|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889864|NCT01998958|588295294|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889865|NCT01998958|588295295|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889866|NCT01998958|588295296|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889867|NCT01998958|588295297|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889868|NCT01998958|588295298|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889869|NCT01998958|588295299|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889870|NCT01998958|588295300|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889871|NCT01998958|588295301|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889872|NCT01998958|588295302|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889873|NCT01998958|588295303|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889874|NCT01998958|588295304|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889875|NCT01998958|588295305|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889876|NCT01998958|588295306|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889877|NCT01998958|588295307|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
162889878|NCT01998958|588295308|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889879|NCT01998958|588295309|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162619324|NCT01303861|587322788|FG002|Overall Study|Pregnancy|0|||
162619325|NCT01303861|587322789|FG003|Overall Study|Pregnancy|0|||
162619326|NCT03650556|587322803|FG000|Overall Study|Death|2|||
162619327|NCT03650556|587322803|FG000|Overall Study|Withdrawal by Subject|20|||
162619328|NCT03650556|587322803|FG000|Overall Study|Physician Decision|2|||
162619329|NCT03650556|587322803|FG000|Overall Study|Lost to Follow-up|8|||
162619330|NCT03650556|587322803|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
162619331|NCT03650556|587322803|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
162619332|NCT01500031|587322807|FG000|Overall Study|Death|1|||
162619333|NCT01500031|587322807|FG000|Overall Study|Withdrawal by Subject|4|||
162619334|NCT01147640|587322808|FG000|Overall Study|Adverse Event|2|||
162619335|NCT01147640|587322809|FG001|Overall Study|Adverse Event|0|||
162619336|NCT01147640|587322808|FG000|Overall Study|Physician Decision|1|||
162619337|NCT01147640|587322809|FG001|Overall Study|Physician Decision|0|||
162619338|NCT01147640|587322808|FG000|Overall Study|Withdrawal by Subject|1|||
162619339|NCT01147640|587322809|FG001|Overall Study|Withdrawal by Subject|0|||
162619340|NCT01147640|587322808|FG000|Overall Study|Lost to Follow-up|0|||
162619341|NCT01147640|587322809|FG001|Overall Study|Lost to Follow-up|1|||
162619342|NCT01147640|587322808|FG000|Overall Study|Didn't meet eligibility criteria|1|||
162619343|NCT01147640|587322809|FG001|Overall Study|Didn't meet eligibility criteria|0|||
162619344|NCT00091442|587322810|FG000|Overall Study|Progressive Disease|220|||
162619345|NCT00091442|587322811|FG001|Overall Study|Progressive Disease|189|||
162619346|NCT00091442|587322810|FG000|Overall Study|Physician Decision|61|||
162619347|NCT00091442|587322811|FG001|Overall Study|Physician Decision|58|||
162619348|NCT00091442|587322810|FG000|Overall Study|Withdrawal by Subject|38|||
162619349|NCT00091442|587322811|FG001|Overall Study|Withdrawal by Subject|46|||
162619350|NCT00091442|587322810|FG000|Overall Study|Adverse Event|29|||
162619351|NCT00091442|587322811|FG001|Overall Study|Adverse Event|48|||
162619352|NCT00091442|587322810|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
162619353|NCT00091442|587322811|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
162619354|NCT00091442|587322810|FG000|Overall Study|Death|9|||
162619355|NCT00091442|587322811|FG001|Overall Study|Death|7|||
162619356|NCT00091442|587322810|FG000|Overall Study|Lost to Follow-up|1|||
162619357|NCT00091442|587322811|FG001|Overall Study|Lost to Follow-up|3|||
162619358|NCT00091442|587322810|FG000|Overall Study|Other|2|||
162619359|NCT00091442|587322811|FG001|Overall Study|Other|6|||
162619360|NCT00917501|587322812|FG000|Overall Study|Lost to Follow-up|4|||
162889880|NCT01998958|588295310|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889881|NCT01998958|588295311|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
162889882|NCT01998958|588295312|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889883|NCT01998958|588295313|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889884|NCT01998958|588295314|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889885|NCT01998958|588295315|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889886|NCT01998958|588295316|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889887|NCT01998958|588295317|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889888|NCT01998958|588295318|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162619361|NCT00917501|587322813|FG001|Overall Study|Lost to Follow-up|1|||
162889889|NCT01998958|588295319|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889890|NCT01998958|588295320|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162619362|NCT00917501|587322812|FG000|Overall Study|Withdrawal by Subject|3|||
162619363|NCT00917501|587322813|FG001|Overall Study|Withdrawal by Subject|1|||
162619364|NCT00917501|587322812|FG000|Overall Study|Lack of Efficacy|1|||
162619365|NCT00917501|587322813|FG001|Overall Study|Lack of Efficacy|2|||
162619366|NCT00917501|587322812|FG000|Overall Study|trouble swollowing capsules|0|||
162619367|NCT00917501|587322813|FG001|Overall Study|trouble swollowing capsules|1|||
162619368|NCT00986830|587322818|FG000|Overall Study|Death|1|||
162619369|NCT00986830|587322818|FG000|Overall Study|Lost to Follow-up|1|||
162619370|NCT00986830|587322818|FG000|Overall Study|Lack of Efficacy|1|||
162619371|NCT00986830|587322818|FG000|Overall Study|Unable to access sinus with device|5|||
162619372|NCT00845858|587322819|FG000|Overall Study|Withdrawal by Subject|5|||
162619373|NCT00845858|587322820|FG001|Overall Study|Withdrawal by Subject|1|||
162619374|NCT00845858|587322821|FG002|Overall Study|Withdrawal by Subject|1|||
162619375|NCT00845858|587322819|FG000|Overall Study|Adverse Event|3|||
162619376|NCT00845858|587322820|FG001|Overall Study|Adverse Event|8|||
162619377|NCT00845858|587322821|FG002|Overall Study|Adverse Event|4|||
162619378|NCT00845858|587322819|FG000|Overall Study|Protocol Violation|0|||
162619379|NCT00845858|587322820|FG001|Overall Study|Protocol Violation|0|||
162619380|NCT00845858|587322821|FG002|Overall Study|Protocol Violation|1|||
162619381|NCT00845858|587322819|FG000|Overall Study|not eligible|0|||
162619382|NCT00845858|587322820|FG001|Overall Study|not eligible|3|||
162619383|NCT00845858|587322821|FG002|Overall Study|not eligible|2|||
162619384|NCT00850070|587322822|FG000|Overall Study|Lack of Efficacy|1|||
162619385|NCT00850070|587322823|FG001|Overall Study|Lack of Efficacy|1|||
162619386|NCT00850070|587322822|FG000|Overall Study|Adverse Event|2|||
162619387|NCT00850070|587322823|FG001|Overall Study|Adverse Event|0|||
162619388|NCT00216476|587322828|FG000|Overall Study|Withdrawal by Subject|59|||
162619389|NCT00216476|587322829|FG001|Overall Study|Withdrawal by Subject|72|||
162619390|NCT00216476|587322830|FG002|Overall Study|Withdrawal by Subject|9|||
162619391|NCT00216476|587322828|FG000|Overall Study|Lost to Follow-up|10|||
162619392|NCT00216476|587322829|FG001|Overall Study|Lost to Follow-up|9|||
162619393|NCT00216476|587322830|FG002|Overall Study|Lost to Follow-up|1|||
162619394|NCT00216476|587322828|FG000|Overall Study|Adverse Event|6|||
162619395|NCT00216476|587322829|FG001|Overall Study|Adverse Event|10|||
162619396|NCT00216476|587322830|FG002|Overall Study|Adverse Event|1|||
162619397|NCT00216476|587322828|FG000|Overall Study|Lack of Efficacy|4|||
162619398|NCT00216476|587322829|FG001|Overall Study|Lack of Efficacy|3|||
162619399|NCT00216476|587322830|FG002|Overall Study|Lack of Efficacy|0|||
162619400|NCT00216476|587322828|FG000|Overall Study|Death|2|||
162619401|NCT00216476|587322829|FG001|Overall Study|Death|0|||
162619402|NCT00216476|587322830|FG002|Overall Study|Death|0|||
162619403|NCT00216476|587322828|FG000|Overall Study|Pregnancy|0|||
162619404|NCT00216476|587322829|FG001|Overall Study|Pregnancy|1|||
162619405|NCT00216476|587322830|FG002|Overall Study|Pregnancy|1|||
162619406|NCT00216476|587322828|FG000|Overall Study|Other|0|||
162619407|NCT00216476|587322829|FG001|Overall Study|Other|0|||
162619408|NCT00216476|587322830|FG002|Overall Study|Other|1|||
162619409|NCT00216476|587322828|FG000|Overall Study|Refuses Injection|11|||
162619410|NCT00216476|587322829|FG001|Overall Study|Refuses Injection|0|||
162619411|NCT00216476|587322830|FG002|Overall Study|Refuses Injection|0|||
162619412|NCT00216476|587322828|FG000|Overall Study|No Further Need for Treatment|3|||
162619413|NCT00216476|587322829|FG001|Overall Study|No Further Need for Treatment|4|||
162619414|NCT00216476|587322830|FG002|Overall Study|No Further Need for Treatment|1|||
162619415|NCT00216476|587322828|FG000|Overall Study|Non-compliance|0|||
162619416|NCT00216476|587322829|FG001|Overall Study|Non-compliance|4|||
162619417|NCT00216476|587322830|FG002|Overall Study|Non-compliance|1|||
162619418|NCT00216476|587322828|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
162619419|NCT00216476|587322829|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
162708448|NCT05074498|587642778|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
162889891|NCT01998958|588295321|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889892|NCT01998958|588295322|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889893|NCT01998958|588295323|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889894|NCT01998958|588295324|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
162889895|NCT01998958|588295293|FG000|Open Label Phase (Optional)|Adverse Event|0|||
162889896|NCT01998958|588295294|FG001|Open Label Phase (Optional)|Adverse Event|0|||
162889897|NCT01998958|588295295|FG002|Open Label Phase (Optional)|Adverse Event|0|||
162889898|NCT01998958|588295296|FG003|Open Label Phase (Optional)|Adverse Event|0|||
162889899|NCT01998958|588295297|FG004|Open Label Phase (Optional)|Adverse Event|0|||
162889900|NCT01998958|588295298|FG005|Open Label Phase (Optional)|Adverse Event|0|||
162889901|NCT01998958|588295299|FG006|Open Label Phase (Optional)|Adverse Event|0|||
162889902|NCT01998958|588295300|FG007|Open Label Phase (Optional)|Adverse Event|0|||
162964094|NCT01494532|588568004|FG002|Overall Study|Withdrawal by Subject|4|||
162889903|NCT01998958|588295301|FG008|Open Label Phase (Optional)|Adverse Event|0|||
162889904|NCT01998958|588295302|FG009|Open Label Phase (Optional)|Adverse Event|0|||
162619420|NCT00216476|587322830|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
162619421|NCT00216476|587322828|FG000|Overall Study|Administrative Reasons|1|||
162619422|NCT00216476|587322829|FG001|Overall Study|Administrative Reasons|1|||
162619423|NCT00216476|587322830|FG002|Overall Study|Administrative Reasons|0|||
162619424|NCT00216476|587322828|FG000|Overall Study|Protocol Deviation|5|||
162619425|NCT00216476|587322829|FG001|Overall Study|Protocol Deviation|1|||
162619426|NCT00216476|587322830|FG002|Overall Study|Protocol Deviation|0|||
162619427|NCT00216476|587322828|FG000|Overall Study|Patient Moved|2|||
162619428|NCT00216476|587322829|FG001|Overall Study|Patient Moved|2|||
162619429|NCT00216476|587322830|FG002|Overall Study|Patient Moved|0|||
162619430|NCT01522248|587322833|FG000|Overall Study|Lost to Follow-up|1|||
162619431|NCT01522248|587322834|FG001|Overall Study|Lost to Follow-up|0|||
162619432|NCT02191137|587322836|FG000|Treatment|Death|4|||
162619433|NCT02191137|587322836|FG000|Treatment|Withdrawal by Subject|3|||
162619434|NCT02191137|587322836|FG000|Treatment|Adverse Event|2|||
162619435|NCT02191137|587322836|FG000|Treatment|Other|1|||
162619436|NCT02191137|587322836|FG000|Follow-up|Lost to Follow-up|2|||
162619437|NCT02191137|587322836|FG000|Follow-up|Ongoing/unknown|2|||
162619438|NCT02191137|587322836|FG000|Follow-up|Adverse Event|1|||
162619439|NCT01332331|587322837|FG000|Overall Study|Lost to Follow-up|0|||
162619440|NCT01332331|587322838|FG001|Overall Study|Lost to Follow-up|1|||
162619441|NCT01332331|587322837|FG000|Overall Study|Adverse Event|1|||
162619442|NCT01332331|587322838|FG001|Overall Study|Adverse Event|1|||
162619443|NCT01332331|587322837|FG000|Overall Study|Physician Decision|1|||
162619444|NCT01332331|587322838|FG001|Overall Study|Physician Decision|0|||
162619445|NCT00538291|587322839|FG000|Overall Study|Adverse Event|2|||
162619446|NCT00538291|587322839|FG000|Overall Study|Withdrawal by Subject|1|||
162619447|NCT00694707|587322840|FG000|Overall Study|Did Not Receive Treatment|0|||
162619448|NCT00694707|587322841|FG001|Overall Study|Did Not Receive Treatment|0|||
162619449|NCT00694707|587322842|FG002|Overall Study|Did Not Receive Treatment|1|||
162619450|NCT00694707|587322843|FG003|Overall Study|Did Not Receive Treatment|1|||
162619451|NCT00694707|587322844|FG004|Overall Study|Did Not Receive Treatment|1|||
162619452|NCT00694707|587322840|FG000|Overall Study|Adverse Event|22|||
162619453|NCT00694707|587322841|FG001|Overall Study|Adverse Event|14|||
162619454|NCT00694707|587322842|FG002|Overall Study|Adverse Event|8|||
162619455|NCT00694707|587322843|FG003|Overall Study|Adverse Event|12|||
162619456|NCT00694707|587322844|FG004|Overall Study|Adverse Event|13|||
162619457|NCT00694707|587322840|FG000|Overall Study|Insufficient Therapeutic Response|33|||
162619458|NCT00694707|587322841|FG001|Overall Study|Insufficient Therapeutic Response|18|||
162619459|NCT00694707|587322842|FG002|Overall Study|Insufficient Therapeutic Response|17|||
162619460|NCT00694707|587322843|FG003|Overall Study|Insufficient Therapeutic Response|15|||
162619461|NCT00694707|587322844|FG004|Overall Study|Insufficient Therapeutic Response|10|||
162619462|NCT00694707|587322840|FG000|Overall Study|Protocol Violation|1|||
162619463|NCT00694707|587322841|FG001|Overall Study|Protocol Violation|2|||
162619464|NCT00694707|587322842|FG002|Overall Study|Protocol Violation|1|||
162619465|NCT00694707|587322843|FG003|Overall Study|Protocol Violation|3|||
162619466|NCT00694707|587322844|FG004|Overall Study|Protocol Violation|1|||
162619467|NCT00694707|587322840|FG000|Overall Study|Withdrawal of Consent|14|||
162619468|NCT00694707|587322841|FG001|Overall Study|Withdrawal of Consent|18|||
162619469|NCT00694707|587322842|FG002|Overall Study|Withdrawal of Consent|22|||
162619470|NCT00694707|587322843|FG003|Overall Study|Withdrawal of Consent|16|||
162619471|NCT00694707|587322844|FG004|Overall Study|Withdrawal of Consent|15|||
162619472|NCT00694707|587322840|FG000|Overall Study|Lost to Follow-up|0|||
162619473|NCT00694707|587322841|FG001|Overall Study|Lost to Follow-up|1|||
162619474|NCT00694707|587322842|FG002|Overall Study|Lost to Follow-up|2|||
162619475|NCT00694707|587322843|FG003|Overall Study|Lost to Follow-up|0|||
162619476|NCT00694707|587322844|FG004|Overall Study|Lost to Follow-up|0|||
162619477|NCT00694707|587322840|FG000|Overall Study|Jeopardizing Parole Status|1|||
162619478|NCT00694707|587322841|FG001|Overall Study|Jeopardizing Parole Status|0|||
162619479|NCT00694707|587322842|FG002|Overall Study|Jeopardizing Parole Status|0|||
162619480|NCT00694707|587322843|FG003|Overall Study|Jeopardizing Parole Status|0|||
162619481|NCT00694707|587322844|FG004|Overall Study|Jeopardizing Parole Status|0|||
162619482|NCT00694707|587322840|FG000|Overall Study|Death in the Family|1|||
162619483|NCT00694707|587322841|FG001|Overall Study|Death in the Family|0|||
162619484|NCT00694707|587322842|FG002|Overall Study|Death in the Family|0|||
162619485|NCT00694707|587322843|FG003|Overall Study|Death in the Family|0|||
162619486|NCT00694707|587322844|FG004|Overall Study|Death in the Family|0|||
162619487|NCT00694707|587322840|FG000|Overall Study|Arrest by Police|0|||
162619488|NCT00694707|587322841|FG001|Overall Study|Arrest by Police|1|||
162619489|NCT00694707|587322842|FG002|Overall Study|Arrest by Police|0|||
162619490|NCT00694707|587322843|FG003|Overall Study|Arrest by Police|0|||
162619491|NCT00694707|587322844|FG004|Overall Study|Arrest by Police|0|||
162619492|NCT00694707|587322840|FG000|Overall Study|Administrative Reasons|0|||
162619493|NCT00694707|587322841|FG001|Overall Study|Administrative Reasons|1|||
162619494|NCT00694707|587322842|FG002|Overall Study|Administrative Reasons|0|||
162619495|NCT00694707|587322843|FG003|Overall Study|Administrative Reasons|2|||
162619496|NCT00694707|587322844|FG004|Overall Study|Administrative Reasons|0|||
162889905|NCT01998958|588295303|FG010|Open Label Phase (Optional)|Adverse Event|0|||
162889906|NCT01998958|588295304|FG011|Open Label Phase (Optional)|Adverse Event|0|||
162889907|NCT01998958|588295305|FG012|Open Label Phase (Optional)|Adverse Event|0|||
162619497|NCT00694707|587322840|FG000|Overall Study|Notification of Past Head Injury|0|||
162619498|NCT00694707|587322841|FG001|Overall Study|Notification of Past Head Injury|0|||
162619499|NCT00694707|587322842|FG002|Overall Study|Notification of Past Head Injury|0|||
162619500|NCT00694707|587322843|FG003|Overall Study|Notification of Past Head Injury|1|||
162619501|NCT00694707|587322844|FG004|Overall Study|Notification of Past Head Injury|0|||
162619502|NCT03096483|587322846|FG000|Overall Study|Withdrawal by site|1|||
162889908|NCT01998958|588295306|FG013|Open Label Phase (Optional)|Adverse Event|0|||
162889909|NCT01998958|588295307|FG014|Open Label Phase (Optional)|Adverse Event|0|||
162889910|NCT01998958|588295308|FG015|Open Label Phase (Optional)|Adverse Event|0|||
162889911|NCT01998958|588295309|FG016|Open Label Phase (Optional)|Adverse Event|0|||
162889912|NCT01998958|588295310|FG017|Open Label Phase (Optional)|Adverse Event|0|||
162889913|NCT01998958|588295311|FG018|Open Label Phase (Optional)|Adverse Event|0|||
162889914|NCT01998958|588295312|FG019|Open Label Phase (Optional)|Adverse Event|0|||
162889915|NCT01998958|588295313|FG020|Open Label Phase (Optional)|Adverse Event|0|||
162889916|NCT01998958|588295314|FG021|Open Label Phase (Optional)|Adverse Event|0|||
162889917|NCT01998958|588295315|FG022|Open Label Phase (Optional)|Adverse Event|0|||
162889918|NCT01998958|588295316|FG023|Open Label Phase (Optional)|Adverse Event|1|||
162889919|NCT01998958|588295317|FG024|Open Label Phase (Optional)|Adverse Event|0|||
162889920|NCT01998958|588295318|FG025|Open Label Phase (Optional)|Adverse Event|0|||
162889921|NCT01998958|588295319|FG026|Open Label Phase (Optional)|Adverse Event|0|||
162889922|NCT01998958|588295320|FG027|Open Label Phase (Optional)|Adverse Event|0|||
162889923|NCT01998958|588295321|FG028|Open Label Phase (Optional)|Adverse Event|0|||
162889924|NCT01998958|588295322|FG029|Open Label Phase (Optional)|Adverse Event|0|||
162889925|NCT01998958|588295323|FG030|Open Label Phase (Optional)|Adverse Event|0|||
162889926|NCT01998958|588295324|FG031|Open Label Phase (Optional)|Adverse Event|0|||
162889927|NCT01998958|588295293|FG000|Open Label Phase (Optional)|Other|0|||
162889928|NCT01998958|588295294|FG001|Open Label Phase (Optional)|Other|0|||
162889929|NCT01998958|588295295|FG002|Open Label Phase (Optional)|Other|0|||
162889930|NCT01998958|588295296|FG003|Open Label Phase (Optional)|Other|0|||
162889931|NCT01998958|588295297|FG004|Open Label Phase (Optional)|Other|0|||
162889932|NCT01998958|588295298|FG005|Open Label Phase (Optional)|Other|0|||
162889933|NCT01998958|588295299|FG006|Open Label Phase (Optional)|Other|0|||
162889934|NCT01998958|588295300|FG007|Open Label Phase (Optional)|Other|0|||
162889935|NCT01998958|588295301|FG008|Open Label Phase (Optional)|Other|0|||
162889936|NCT01998958|588295302|FG009|Open Label Phase (Optional)|Other|0|||
162889937|NCT01998958|588295303|FG010|Open Label Phase (Optional)|Other|0|||
162889938|NCT01998958|588295304|FG011|Open Label Phase (Optional)|Other|0|||
162889939|NCT01998958|588295305|FG012|Open Label Phase (Optional)|Other|0|||
162889940|NCT01998958|588295306|FG013|Open Label Phase (Optional)|Other|0|||
162889941|NCT01998958|588295307|FG014|Open Label Phase (Optional)|Other|0|||
162889942|NCT01998958|588295308|FG015|Open Label Phase (Optional)|Other|0|||
162889943|NCT01998958|588295309|FG016|Open Label Phase (Optional)|Other|0|||
162889944|NCT01998958|588295310|FG017|Open Label Phase (Optional)|Other|0|||
162889945|NCT01998958|588295311|FG018|Open Label Phase (Optional)|Other|0|||
162889946|NCT01998958|588295312|FG019|Open Label Phase (Optional)|Other|0|||
162889947|NCT01998958|588295313|FG020|Open Label Phase (Optional)|Other|0|||
162889948|NCT01998958|588295314|FG021|Open Label Phase (Optional)|Other|0|||
162889949|NCT01998958|588295315|FG022|Open Label Phase (Optional)|Other|5|||
162889950|NCT01998958|588295316|FG023|Open Label Phase (Optional)|Other|1|||
162889951|NCT01998958|588295317|FG024|Open Label Phase (Optional)|Other|0|||
162889952|NCT01998958|588295318|FG025|Open Label Phase (Optional)|Other|0|||
162889953|NCT01998958|588295319|FG026|Open Label Phase (Optional)|Other|0|||
162889954|NCT01998958|588295320|FG027|Open Label Phase (Optional)|Other|0|||
162889955|NCT01998958|588295321|FG028|Open Label Phase (Optional)|Other|0|||
162889956|NCT01998958|588295322|FG029|Open Label Phase (Optional)|Other|0|||
162889957|NCT01998958|588295323|FG030|Open Label Phase (Optional)|Other|0|||
162889958|NCT01998958|588295324|FG031|Open Label Phase (Optional)|Other|0|||
162889959|NCT01998958|588295293|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889960|NCT01998958|588295294|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889961|NCT01998958|588295295|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889962|NCT01998958|588295296|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
162619503|NCT00369707|587322847|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
162619504|NCT00369707|587322847|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
162619505|NCT00369707|587322847|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
162619506|NCT00369707|587322847|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
162619507|NCT00369707|587322847|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
162889963|NCT01998958|588295297|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889964|NCT01998958|588295298|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889965|NCT01998958|588295299|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889966|NCT01998958|588295300|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889967|NCT01998958|588295301|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889968|NCT01998958|588295302|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889969|NCT01998958|588295303|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
162964095|NCT01494532|588568005|FG003|Overall Study|Withdrawal by Subject|3|||
162964096|NCT01494532|588568006|FG004|Overall Study|Withdrawal by Subject|2|||
162964097|NCT01494532|588568007|FG005|Overall Study|Withdrawal by Subject|0|||
162964098|NCT00679081|588568008|FG000|Overall Study|Lost to Follow-up|1|||
162964099|NCT01404988|588568013|FG000|Overall Study|Death|2|||
162619508|NCT00369707|587322847|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
162889970|NCT01998958|588295304|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
162964100|NCT01404988|588568014|FG001|Overall Study|Death|0|||
162964101|NCT01404988|588568015|FG002|Overall Study|Death|2|||
162619509|NCT00369707|587322847|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
162619510|NCT00369707|587322847|FG000|Follow up for 2 Years After Treatment|Death|1|||
162619511|NCT00369707|587322847|FG000|Follow up for 2 Years After Treatment|Other|2|||
162619512|NCT05224141|587322848|FG000|Overall Study|Ongoing|75|||
162619513|NCT05224141|587322849|FG001|Overall Study|Ongoing|88|||
162619514|NCT05224141|587322848|FG000|Overall Study|Withdrawal by Subject|2|||
162619515|NCT05224141|587322849|FG001|Overall Study|Withdrawal by Subject|4|||
162619516|NCT05224141|587322848|FG000|Overall Study|Death|153|||
162964102|NCT01404988|588568013|FG000|Overall Study|Adverse Event|1|||
162619517|NCT05224141|587322849|FG001|Overall Study|Death|138|||
162619518|NCT02046733|587322850|FG000|Overall Study|never initiated 'treatment visits'|6|||
162619519|NCT02046733|587322851|FG001|Overall Study|never initiated 'treatment visits'|0|||
162619520|NCT04515394|587322862|FG000|Overall Study|Participant did not receive treatment|1|||
162619521|NCT00199875|587322863|FG000|Overall Study|Withdrawal by Subject|0|||
162619522|NCT00199875|587322864|FG001|Overall Study|Withdrawal by Subject|0|||
162619523|NCT00199875|587322865|FG002|Overall Study|Withdrawal by Subject|0|||
162619524|NCT00199875|587322866|FG003|Overall Study|Withdrawal by Subject|0|||
162619525|NCT00199875|587322867|FG004|Overall Study|Withdrawal by Subject|1|||
162619526|NCT01691898|587322869|FG000|Overall Study|Death|34|||
162619527|NCT01691898|587322870|FG001|Overall Study|Death|32|||
162619528|NCT01691898|587322871|FG002|Overall Study|Death|6|||
162619529|NCT01691898|587322872|FG003|Overall Study|Death|3|||
162619530|NCT01691898|587322873|FG004|Overall Study|Death|8|||
162619531|NCT01691898|587322874|FG005|Overall Study|Death|31|||
162619532|NCT01691898|587322869|FG000|Overall Study|Adverse Event|0|||
162619533|NCT01691898|587322870|FG001|Overall Study|Adverse Event|1|||
162619534|NCT01691898|587322871|FG002|Overall Study|Adverse Event|0|||
162619535|NCT01691898|587322872|FG003|Overall Study|Adverse Event|1|||
162619536|NCT01691898|587322873|FG004|Overall Study|Adverse Event|1|||
162964103|NCT01404988|588568014|FG001|Overall Study|Adverse Event|0|||
162964104|NCT01404988|588568015|FG002|Overall Study|Adverse Event|0|||
162964105|NCT01404988|588568013|FG000|Overall Study|Withdrawal by Subject|2|||
162964106|NCT01404988|588568014|FG001|Overall Study|Withdrawal by Subject|2|||
162964107|NCT01404988|588568015|FG002|Overall Study|Withdrawal by Subject|0|||
162964108|NCT01404988|588568013|FG000|Overall Study|Lost to Follow-up|1|||
162964109|NCT01404988|588568014|FG001|Overall Study|Lost to Follow-up|2|||
162964110|NCT01404988|588568015|FG002|Overall Study|Lost to Follow-up|1|||
162964111|NCT04594252|588568016|FG000|Overall Study|Adverse Event|0|||
162964112|NCT04594252|588568017|FG001|Overall Study|Adverse Event|2|||
162964113|NCT01691430|588569673|FG000|Overall Study|Death|17|||
162964114|NCT01691430|588569674|FG001|Overall Study|Death|16|||
162964115|NCT01691430|588569673|FG000|Overall Study|Withdrawal by Subject|5|||
162964116|NCT01691430|588569674|FG001|Overall Study|Withdrawal by Subject|1|||
162964117|NCT01691430|588569673|FG000|Overall Study|Lost to Follow-up|0|||
162964118|NCT01691430|588569674|FG001|Overall Study|Lost to Follow-up|3|||
162964119|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
162964120|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
162964121|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964122|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964123|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
162964124|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
162964125|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964126|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964127|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964128|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
162964129|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
162964130|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
162964131|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
162964132|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
162964133|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
162708449|NCT05074498|587642773|FG000|Part 2 (Upto Day 104)|Other|0|||
162708450|NCT05074498|587642774|FG001|Part 2 (Upto Day 104)|Other|0|||
162708451|NCT05074498|587642775|FG002|Part 2 (Upto Day 104)|Other|0|||
162708452|NCT05074498|587642776|FG003|Part 2 (Upto Day 104)|Other|0|||
162708453|NCT05074498|587642777|FG004|Part 2 (Upto Day 104)|Other|1|||
162964134|NCT01109849|588569675|FG000|Initial Randomization: ADHD Treatment|move away|2|||
162964135|NCT01109849|588569676|FG001|Initial Randomization: ADHD Treatment|move away|7|||
162964136|NCT01109849|588569677|FG002|Initial Randomization: ADHD Treatment|move away|0|||
163051251|NCT00490035|588895388|FG000|Overall Study|AE, non-serious non-fatal|3|||
162619537|NCT01691898|587322874|FG005|Overall Study|Adverse Event|0|||
162619538|NCT01691898|587322869|FG000|Overall Study|Progression of Disease|1|||
162619539|NCT01691898|587322870|FG001|Overall Study|Progression of Disease|2|||
162619540|NCT01691898|587322871|FG002|Overall Study|Progression of Disease|1|||
162619541|NCT01691898|587322872|FG003|Overall Study|Progression of Disease|0|||
162619542|NCT01691898|587322873|FG004|Overall Study|Progression of Disease|0|||
162708454|NCT05074498|587642778|FG005|Part 2 (Upto Day 104)|Other|0|||
162708455|NCT01306331|587642780|FG000|Overall Study|Adverse Event|28|||
162708456|NCT01306331|587642781|FG001|Overall Study|Adverse Event|25|||
162708457|NCT01306331|587642780|FG000|Overall Study|Lost to Follow-up|321|||
162708458|NCT01306331|587642781|FG001|Overall Study|Lost to Follow-up|323|||
162708459|NCT01306331|587642780|FG000|Overall Study|Physician Decision|26|||
162708460|NCT01306331|587642781|FG001|Overall Study|Physician Decision|22|||
162708461|NCT01306331|587642780|FG000|Overall Study|Pregnancy|136|||
162708462|NCT01306331|587642781|FG001|Overall Study|Pregnancy|151|||
162708463|NCT01306331|587642780|FG000|Overall Study|Protocol Violation|154|||
162708464|NCT01306331|587642781|FG001|Overall Study|Protocol Violation|124|||
162708465|NCT01306331|587642780|FG000|Overall Study|Withdrawal by Subject|163|||
162708466|NCT01306331|587642781|FG001|Overall Study|Withdrawal by Subject|152|||
162708467|NCT01306331|587642780|FG000|Overall Study|Not sexually active|29|||
162708468|NCT01306331|587642781|FG001|Overall Study|Not sexually active|28|||
162708469|NCT01306331|587642780|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
162708470|NCT01306331|587642781|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
162708471|NCT01306331|587642780|FG000|Overall Study|Other|34|||
162708472|NCT01306331|587642781|FG001|Overall Study|Other|32|||
162708473|NCT00172185|587642788|FG000|Overall Study|Adverse Event|0|||
162708474|NCT00172185|587642789|FG001|Overall Study|Adverse Event|1|||
162708475|NCT00172185|587642790|FG002|Overall Study|Adverse Event|3|||
162708476|NCT00172185|587642791|FG003|Overall Study|Adverse Event|4|||
162708477|NCT00172185|587642788|FG000|Overall Study|Physician Decision|0|||
162708478|NCT00172185|587642789|FG001|Overall Study|Physician Decision|0|||
162708479|NCT00172185|587642790|FG002|Overall Study|Physician Decision|1|||
162708480|NCT00172185|587642791|FG003|Overall Study|Physician Decision|0|||
162708481|NCT00172185|587642788|FG000|Overall Study|SPONSOR Decision|0|||
162708482|NCT00172185|587642789|FG001|Overall Study|SPONSOR Decision|1|||
162708483|NCT00172185|587642790|FG002|Overall Study|SPONSOR Decision|0|||
162708484|NCT00172185|587642791|FG003|Overall Study|SPONSOR Decision|0|||
162708485|NCT00172185|587642788|FG000|Overall Study|Withdrawal by Subject|0|||
162708486|NCT00172185|587642789|FG001|Overall Study|Withdrawal by Subject|0|||
162708487|NCT00172185|587642790|FG002|Overall Study|Withdrawal by Subject|1|||
162708488|NCT00172185|587642791|FG003|Overall Study|Withdrawal by Subject|0|||
162708489|NCT01677936|587642792|FG000|Overall Study|Lost to Follow-up|4|||
162708490|NCT01677936|587642793|FG001|Overall Study|Lost to Follow-up|1|||
162708491|NCT01677936|587642792|FG000|Overall Study|Protocol Violation|3|||
162708492|NCT01677936|587642793|FG001|Overall Study|Protocol Violation|0|||
162708493|NCT01677936|587642792|FG000|Overall Study|Adverse Event|1|||
162708494|NCT01677936|587642793|FG001|Overall Study|Adverse Event|0|||
162708495|NCT01677936|587642792|FG000|Overall Study|Lost to Follow-up|1|||
162708496|NCT01677936|587642793|FG001|Overall Study|Lost to Follow-up|0|||
162708497|NCT01677936|587642792|FG000|Overall Study|Protocol Violation|0|||
162708498|NCT01677936|587642793|FG001|Overall Study|Protocol Violation|4|||
162708499|NCT02790606|587642796|FG000|Overall Study|Death|27|||
162708500|NCT02790606|587642796|FG000|Overall Study|Lost to Follow-up|4|||
162708501|NCT02790606|587642796|FG000|Overall Study|Physician Decision|3|||
162708502|NCT02790606|587642796|FG000|Overall Study|Withdrawal by Subject|1|||
162708503|NCT02735915|587642797|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
162708504|NCT02735915|587642797|FG000|Overall Study|Withdrawal following SAE|2|||
162708505|NCT02735915|587642797|FG000|Overall Study|Withdrawal by Subject|1|||
162708506|NCT05328973|587642798|FG000|Overall Study|Withdrawal by Subject|0|||
162889971|NCT01998958|588295305|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889972|NCT01998958|588295306|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889973|NCT01998958|588295307|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889974|NCT01998958|588295308|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889975|NCT01998958|588295309|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889976|NCT01998958|588295310|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889977|NCT01998958|588295311|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
162708507|NCT05328973|587642799|FG001|Overall Study|Withdrawal by Subject|1|||
162708508|NCT00409708|587642805|FG000|Treatment|Abnormal test procedure result(s)|1|||
162708509|NCT00409708|587642806|FG001|Treatment|Abnormal test procedure result(s)|0|||
162889978|NCT01998958|588295312|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
162964137|NCT01109849|588569678|FG003|Initial Randomization: ADHD Treatment|move away|0|||
162708510|NCT00409708|587642805|FG000|Treatment|Lack of Efficacy|0|||
162708511|NCT00409708|587642806|FG001|Treatment|Lack of Efficacy|1|||
162708512|NCT00409708|587642805|FG000|Treatment|Protocol Violation|6|||
162708513|NCT00409708|587642806|FG001|Treatment|Protocol Violation|2|||
162964138|NCT01109849|588569679|FG004|Initial Randomization: ADHD Treatment|move away|0|||
162964139|NCT01109849|588569675|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
162964140|NCT01109849|588569676|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
162964141|NCT01109849|588569677|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162964142|NCT01109849|588569678|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162964143|NCT01109849|588569679|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162708514|NCT00409708|587642805|FG000|Treatment|Withdrawal by Subject|3|||
162708515|NCT00409708|587642806|FG001|Treatment|Withdrawal by Subject|8|||
162619543|NCT01691898|587322874|FG005|Overall Study|Progression of Disease|1|||
162619544|NCT01691898|587322869|FG000|Overall Study|Lost to Follow-up|3|||
162619545|NCT01691898|587322870|FG001|Overall Study|Lost to Follow-up|1|||
162619546|NCT01691898|587322871|FG002|Overall Study|Lost to Follow-up|0|||
162619547|NCT01691898|587322872|FG003|Overall Study|Lost to Follow-up|0|||
162619548|NCT01691898|587322873|FG004|Overall Study|Lost to Follow-up|1|||
162619549|NCT01691898|587322874|FG005|Overall Study|Lost to Follow-up|0|||
162619550|NCT01691898|587322869|FG000|Overall Study|Withdrawal by Subject|9|||
162619551|NCT01691898|587322870|FG001|Overall Study|Withdrawal by Subject|8|||
162619552|NCT01691898|587322871|FG002|Overall Study|Withdrawal by Subject|2|||
162619553|NCT01691898|587322872|FG003|Overall Study|Withdrawal by Subject|1|||
162619554|NCT01691898|587322873|FG004|Overall Study|Withdrawal by Subject|3|||
162619555|NCT01691898|587322874|FG005|Overall Study|Withdrawal by Subject|3|||
162619556|NCT01691898|587322869|FG000|Overall Study|Non-Compliance|0|||
162619557|NCT01691898|587322870|FG001|Overall Study|Non-Compliance|0|||
162619558|NCT01691898|587322871|FG002|Overall Study|Non-Compliance|0|||
162619559|NCT01691898|587322872|FG003|Overall Study|Non-Compliance|0|||
162619560|NCT01691898|587322873|FG004|Overall Study|Non-Compliance|1|||
162619561|NCT01691898|587322874|FG005|Overall Study|Non-Compliance|0|||
162619562|NCT01013350|587322875|FG000|Overall Study|Lost to Follow-up|15|||
162619563|NCT01013350|587322876|FG001|Overall Study|Lost to Follow-up|95|||
162619564|NCT01013350|587322875|FG000|Overall Study|Adverse Event|0|||
162619565|NCT01013350|587322876|FG001|Overall Study|Adverse Event|1|||
162619566|NCT01013350|587322875|FG000|Overall Study|Physician Decision|4|||
162619567|NCT01013350|587322876|FG001|Overall Study|Physician Decision|20|||
163051252|NCT00490035|588895389|FG001|Overall Study|AE, non-serious non-fatal|4|||
163051253|NCT00490035|588895390|FG002|Overall Study|AE, non-serious non-fatal|4|||
163051254|NCT00490035|588895391|FG003|Overall Study|AE, non-serious non-fatal|5|||
162619568|NCT01013350|587322875|FG000|Overall Study|Withdrawal by Subject|15|||
162619569|NCT01013350|587322876|FG001|Overall Study|Withdrawal by Subject|38|||
162619570|NCT01013350|587322875|FG000|Overall Study|Death|3|||
162619571|NCT01013350|587322876|FG001|Overall Study|Death|5|||
163051255|NCT00490035|588895388|FG000|Overall Study|Lost to Follow-up|2|||
163051256|NCT00490035|588895389|FG001|Overall Study|Lost to Follow-up|0|||
162889979|NCT01998958|588295313|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889980|NCT01998958|588295314|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889981|NCT01998958|588295315|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
162889982|NCT01998958|588295316|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889983|NCT01998958|588295317|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889984|NCT01998958|588295318|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889985|NCT01998958|588295319|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889986|NCT01998958|588295320|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889987|NCT01998958|588295321|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889988|NCT01998958|588295322|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889989|NCT01998958|588295323|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889990|NCT01998958|588295324|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
162889991|NCT01998958|588295293|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889992|NCT01998958|588295294|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889993|NCT01998958|588295295|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
163051257|NCT00490035|588895390|FG002|Overall Study|Lost to Follow-up|1|||
163051258|NCT00490035|588895391|FG003|Overall Study|Lost to Follow-up|0|||
162619572|NCT01013350|587322875|FG000|Overall Study|Participant entered interventional study|0|||
162619573|NCT01013350|587322876|FG001|Overall Study|Participant entered interventional study|8|||
162619574|NCT01013350|587322875|FG000|Overall Study|Other|1|||
162619575|NCT01013350|587322876|FG001|Overall Study|Other|25|||
162619576|NCT02019277|587322877|FG000|Overall Study|Withdrawal by Subject|3|||
162619577|NCT02019277|587322877|FG000|Overall Study|Death|7|||
162619578|NCT02019277|587322877|FG000|Overall Study|Did no Cooperate|1|||
163051259|NCT00490035|588895388|FG000|Overall Study|Withdrawal by Subject|2|||
163051260|NCT00490035|588895389|FG001|Overall Study|Withdrawal by Subject|1|||
163051261|NCT00490035|588895390|FG002|Overall Study|Withdrawal by Subject|1|||
163051262|NCT00490035|588895391|FG003|Overall Study|Withdrawal by Subject|0|||
163051263|NCT00490035|588895388|FG000|Overall Study|Other reason|0|||
163051264|NCT00490035|588895389|FG001|Overall Study|Other reason|1|||
163051265|NCT00490035|588895390|FG002|Overall Study|Other reason|3|||
163051266|NCT00490035|588895391|FG003|Overall Study|Other reason|1|||
163051267|NCT00490035|588895388|FG000|Overall Study|AE, serious fatal|1|||
163051268|NCT00490035|588895389|FG001|Overall Study|AE, serious fatal|0|||
163051269|NCT00490035|588895390|FG002|Overall Study|AE, serious fatal|0|||
163051270|NCT00490035|588895391|FG003|Overall Study|AE, serious fatal|0|||
163051271|NCT00490035|588895388|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163051272|NCT00490035|588895389|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163051273|NCT00490035|588895390|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
163051274|NCT00490035|588895391|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
162619579|NCT02019277|587322877|FG000|Overall Study|Adverse Event|1|||
162619580|NCT03725852|587322878|FG000|Overall Study|Death|1|||
162619581|NCT03725852|587322879|FG001|Overall Study|Death|0|||
162619582|NCT03725852|587322878|FG000|Overall Study|Withdrawal by Subject|1|||
162619583|NCT03725852|587322879|FG001|Overall Study|Withdrawal by Subject|0|||
162619584|NCT03725852|587322878|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
162619585|NCT03725852|587322879|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
162619586|NCT01297920|587322885|FG000|Overall Study|Adverse Event|42|||
162619587|NCT01297920|587322886|FG001|Overall Study|Adverse Event|10|||
162619588|NCT01297920|587322887|FG002|Overall Study|Adverse Event|38|||
162619589|NCT01297920|587322885|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
162619590|NCT01297920|587322886|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
162619591|NCT01297920|587322887|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
162619592|NCT01297920|587322885|FG000|Overall Study|Noncompliance|1|||
162619593|NCT01297920|587322886|FG001|Overall Study|Noncompliance|0|||
162619594|NCT01297920|587322887|FG002|Overall Study|Noncompliance|0|||
162619595|NCT01297920|587322885|FG000|Overall Study|Protocol Violation|1|||
162619596|NCT01297920|587322886|FG001|Overall Study|Protocol Violation|3|||
162619597|NCT01297920|587322887|FG002|Overall Study|Protocol Violation|0|||
162619598|NCT01297920|587322885|FG000|Overall Study|Inadequate Control of IOP|7|||
162619599|NCT01297920|587322886|FG001|Overall Study|Inadequate Control of IOP|9|||
162619600|NCT01297920|587322887|FG002|Overall Study|Inadequate Control of IOP|17|||
162619601|NCT01297920|587322885|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
162619602|NCT01297920|587322886|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
162619603|NCT01297920|587322887|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
162619604|NCT01710046|587322888|FG000|Overall Study|Lost to Follow-up|1|||
162619605|NCT01710046|587322889|FG001|Overall Study|Lost to Follow-up|0|||
162619606|NCT02215096|587322890|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
162619607|NCT02215096|587322891|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
162619608|NCT02215096|587322892|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
162619609|NCT02215096|587322893|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
162619610|NCT02215096|587322894|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
162619611|NCT02215096|587322890|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162619612|NCT02215096|587322891|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162619613|NCT02215096|587322892|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
163051275|NCT00490035|588895388|FG000|Overall Study|AE of unknown type|0|||
162619614|NCT02215096|587322893|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162619615|NCT02215096|587322894|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
162619616|NCT02215096|587322890|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162619617|NCT02215096|587322891|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162619618|NCT02215096|587322892|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162619619|NCT02215096|587322893|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
162619620|NCT02215096|587322894|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162619621|NCT02215096|587322890|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
162619622|NCT02215096|587322891|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
162619623|NCT02215096|587322892|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
162619624|NCT02215096|587322893|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
163051276|NCT00490035|588895389|FG001|Overall Study|AE of unknown type|0|||
163051277|NCT00490035|588895390|FG002|Overall Study|AE of unknown type|2|||
162619625|NCT02215096|587322894|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
162619626|NCT00370071|587322895|FG000|Overall Study|Withdrawal by Subject|2|||
162619627|NCT01787331|587322896|FG000|Overall Study|Physician Decision|1|||
162619628|NCT01787331|587322896|FG000|Overall Study|Withdrawal by Subject|1|||
162619629|NCT00319501|587322899|FG000|Double-blind Period|Withdrawal by Subject|0|||
162619630|NCT00319501|587322900|FG001|Double-blind Period|Withdrawal by Subject|3|||
162619631|NCT00319501|587322899|FG000|Double-blind Period|Sponsor Request|1|||
162619632|NCT00319501|587322900|FG001|Double-blind Period|Sponsor Request|0|||
162619633|NCT00319501|587322899|FG000|Double-blind Period|Did not receive treatment|42|||
162619634|NCT00319501|587322900|FG001|Double-blind Period|Did not receive treatment|29|||
162619635|NCT00319501|587322899|FG000|Open-label Period|Adverse Event|5|||
162619636|NCT00319501|587322900|FG001|Open-label Period|Adverse Event|0|||
162619637|NCT00319501|587322899|FG000|Open-label Period|Protocol Violation|6|||
162619638|NCT00319501|587322900|FG001|Open-label Period|Protocol Violation|0|||
162619639|NCT00319501|587322899|FG000|Open-label Period|Withdrawal by Subject|38|||
162619640|NCT00319501|587322900|FG001|Open-label Period|Withdrawal by Subject|0|||
162619641|NCT00319501|587322899|FG000|Open-label Period|Principal Investigator decision|6|||
162619642|NCT00319501|587322900|FG001|Open-label Period|Principal Investigator decision|0|||
162619643|NCT00319501|587322899|FG000|Open-label Period|Sponsor request|12|||
162619644|NCT00319501|587322900|FG001|Open-label Period|Sponsor request|0|||
162619645|NCT00319501|587322899|FG000|Open-label Period|Lost to Follow-up|5|||
162619646|NCT00319501|587322900|FG001|Open-label Period|Lost to Follow-up|0|||
162619647|NCT00319501|587322899|FG000|Open-label Period|Did not receive treatment|33|||
162619648|NCT00319501|587322900|FG001|Open-label Period|Did not receive treatment|0|||
162619649|NCT00319501|587322899|FG000|Open-label Period|Other|11|||
162619650|NCT00319501|587322900|FG001|Open-label Period|Other|0|||
162619651|NCT00319501|587322899|FG000|Open-label Extension Period|Adverse Event|2|||
162619652|NCT00319501|587322900|FG001|Open-label Extension Period|Adverse Event|0|||
162619653|NCT00319501|587322899|FG000|Open-label Extension Period|Did not receive treatment|18|||
162619654|NCT00319501|587322900|FG001|Open-label Extension Period|Did not receive treatment|0|||
162619655|NCT00319501|587322899|FG000|Open-label Extension Period|Other|1|||
162619656|NCT00319501|587322900|FG001|Open-label Extension Period|Other|0|||
162619657|NCT00319501|587322899|FG000|Open-label Extension Period|Principal investigator decision|2|||
162619658|NCT00319501|587322900|FG001|Open-label Extension Period|Principal investigator decision|0|||
162964144|NCT01109849|588569675|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
162964145|NCT01109849|588569676|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
162964146|NCT01109849|588569677|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
162964147|NCT01109849|588569678|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
162964148|NCT01109849|588569679|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
162964149|NCT02485158|588569683|FG000|Overall Study|Withdrawal by Subject|3|||
162964150|NCT02485158|588569683|FG000|Overall Study|expected drug side effect|1|||
162964151|NCT01098851|588569684|FG000|Overall Study|Equipment failure|1|||
162964152|NCT01098851|588569685|FG001|Overall Study|Equipment failure|0|||
162964153|NCT03087786|588569686|FG000|Overall Study|Withdrawal by Subject|2|||
162964154|NCT03087786|588569687|FG001|Overall Study|Withdrawal by Subject|0|||
162964155|NCT04661202|588569688|FG000|Overall Study|Withdrawal by Subject|1|||
162964156|NCT04661202|588569689|FG001|Overall Study|Withdrawal by Subject|1|||
162964157|NCT04661202|588569688|FG000|Overall Study|Lack of Efficacy|2|||
162964158|NCT04661202|588569689|FG001|Overall Study|Lack of Efficacy|0|||
162964159|NCT02313558|588569690|FG000|Overall Study|Withdrawal by Subject|2|||
162964160|NCT02313558|588569691|FG001|Overall Study|Withdrawal by Subject|0|||
162964161|NCT02313558|588569690|FG000|Overall Study|Lost to Follow-up|4|||
162964162|NCT02313558|588569691|FG001|Overall Study|Lost to Follow-up|4|||
162964163|NCT04158687|588569694|FG000|Overall Study|Adverse Event|2|||
162964164|NCT04158687|588569695|FG001|Overall Study|Adverse Event|3|||
162964165|NCT04158687|588569696|FG002|Overall Study|Adverse Event|0|||
162964166|NCT04158687|588569697|FG003|Overall Study|Adverse Event|3|||
162964167|NCT04158687|588569694|FG000|Overall Study|Lost to Follow-up|5|||
162964168|NCT04158687|588569695|FG001|Overall Study|Lost to Follow-up|12|||
162619659|NCT00319501|587322899|FG000|Open-label Extension Period|Sponsor request|26|||
162619660|NCT00319501|587322900|FG001|Open-label Extension Period|Sponsor request|0|||
162619661|NCT00319501|587322899|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
162964169|NCT04158687|588569696|FG002|Overall Study|Lost to Follow-up|4|||
162619662|NCT00319501|587322900|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
162619663|NCT00667875|587322902|FG000|Overall Study|Adverse Event|0|||
162619664|NCT00667875|587322903|FG001|Overall Study|Adverse Event|2|||
162964170|NCT04158687|588569697|FG003|Overall Study|Lost to Follow-up|5|||
162964171|NCT04158687|588569694|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
162964172|NCT04158687|588569695|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
162964173|NCT04158687|588569696|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
162964174|NCT04158687|588569697|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
162619665|NCT00667875|587322904|FG002|Overall Study|Adverse Event|6|||
162619666|NCT00667875|587322902|FG000|Overall Study|Withdrawal by Subject|10|||
162619667|NCT00667875|587322903|FG001|Overall Study|Withdrawal by Subject|9|||
162619668|NCT00667875|587322904|FG002|Overall Study|Withdrawal by Subject|7|||
162619669|NCT00450255|587322905|FG000|Overall Study|Prior RFA ablation of liver|1|||
162619670|NCT00531934|587324829|FG000|Overall Study|Adverse Event|4|||
162619671|NCT00531934|587324830|FG001|Overall Study|Adverse Event|8|||
162619672|NCT00531934|587324829|FG000|Overall Study|Progression|52|||
162619673|NCT00531934|587324830|FG001|Overall Study|Progression|42|||
162619674|NCT00531934|587324829|FG000|Overall Study|Death|7|||
162619675|NCT00531934|587324830|FG001|Overall Study|Death|10|||
162619676|NCT00531934|587324829|FG000|Overall Study|Withdrawal by Subject|1|||
162619677|NCT00531934|587324830|FG001|Overall Study|Withdrawal by Subject|1|||
162619678|NCT00531934|587324829|FG000|Overall Study|Other|2|||
162619679|NCT00531934|587324830|FG001|Overall Study|Other|2|||
162619680|NCT00150709|587324831|FG000|Overall Study|Protocol Violation|7|||
162619681|NCT00150709|587324832|FG001|Overall Study|Protocol Violation|8|||
162619682|NCT00150709|587324833|FG002|Overall Study|Protocol Violation|3|||
162619683|NCT00150709|587324834|FG003|Overall Study|Protocol Violation|1|||
162619684|NCT00150709|587324831|FG000|Overall Study|Adverse Event|8|||
162619685|NCT00150709|587324832|FG001|Overall Study|Adverse Event|2|||
162619686|NCT00150709|587324833|FG002|Overall Study|Adverse Event|2|||
162619687|NCT00150709|587324834|FG003|Overall Study|Adverse Event|3|||
162619688|NCT00150709|587324831|FG000|Overall Study|Lack of Efficacy|6|||
162619689|NCT00150709|587324832|FG001|Overall Study|Lack of Efficacy|11|||
162619690|NCT00150709|587324833|FG002|Overall Study|Lack of Efficacy|9|||
162619691|NCT00150709|587324834|FG003|Overall Study|Lack of Efficacy|0|||
162619692|NCT00150709|587324831|FG000|Overall Study|Withdrawal by Subject|7|||
162619693|NCT00150709|587324832|FG001|Overall Study|Withdrawal by Subject|10|||
162619694|NCT00150709|587324833|FG002|Overall Study|Withdrawal by Subject|5|||
162619695|NCT00150709|587324834|FG003|Overall Study|Withdrawal by Subject|0|||
162619696|NCT00150709|587324831|FG000|Overall Study|Lost to Follow-up|3|||
162619697|NCT00150709|587324832|FG001|Overall Study|Lost to Follow-up|2|||
162619698|NCT00150709|587324833|FG002|Overall Study|Lost to Follow-up|0|||
162619699|NCT00150709|587324834|FG003|Overall Study|Lost to Follow-up|0|||
162619700|NCT00150709|587324831|FG000|Overall Study|Sponsor decision|0|||
162619701|NCT00150709|587324832|FG001|Overall Study|Sponsor decision|0|||
162619702|NCT00150709|587324833|FG002|Overall Study|Sponsor decision|0|||
162619703|NCT00150709|587324834|FG003|Overall Study|Sponsor decision|1|||
162889994|NCT01998958|588295296|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889995|NCT01998958|588295297|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889996|NCT01998958|588295298|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889997|NCT01998958|588295299|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889998|NCT01998958|588295300|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
162889999|NCT01998958|588295301|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890000|NCT01998958|588295302|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890001|NCT01998958|588295303|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890002|NCT01998958|588295304|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890003|NCT01998958|588295305|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890004|NCT01998958|588295306|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890005|NCT01998958|588295307|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890006|NCT01998958|588295308|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890007|NCT01998958|588295309|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890008|NCT01998958|588295310|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890009|NCT01998958|588295311|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890010|NCT01998958|588295312|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890011|NCT01998958|588295313|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890012|NCT01998958|588295314|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
162890013|NCT01998958|588295315|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
162890014|NCT01998958|588295316|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890015|NCT01998958|588295317|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890016|NCT01998958|588295318|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
162619704|NCT00150709|587324831|FG000|Overall Study|Site/Investigator discontinued the study|5|||
162619705|NCT00150709|587324832|FG001|Overall Study|Site/Investigator discontinued the study|5|||
162708516|NCT00409708|587642805|FG000|Treatment|Lost to Follow-up|0|||
162708517|NCT00409708|587642806|FG001|Treatment|Lost to Follow-up|6|||
162890017|NCT01998958|588295319|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890018|NCT01998958|588295320|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890019|NCT01998958|588295321|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890020|NCT01998958|588295322|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890021|NCT01998958|588295323|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
162890022|NCT01998958|588295324|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
162619706|NCT00150709|587324833|FG002|Overall Study|Site/Investigator discontinued the study|2|||
162619707|NCT00150709|587324834|FG003|Overall Study|Site/Investigator discontinued the study|0|||
162619708|NCT00150709|587324831|FG000|Overall Study|Decision of parent(s)|1|||
162619709|NCT00150709|587324832|FG001|Overall Study|Decision of parent(s)|2|||
162619710|NCT00150709|587324833|FG002|Overall Study|Decision of parent(s)|0|||
162619711|NCT00150709|587324834|FG003|Overall Study|Decision of parent(s)|0|||
162890023|NCT01998958|588295293|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890024|NCT01998958|588295294|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890025|NCT01998958|588295295|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890026|NCT01998958|588295296|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890027|NCT01998958|588295297|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890028|NCT01998958|588295298|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890029|NCT01998958|588295299|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890030|NCT01998958|588295300|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890031|NCT01998958|588295301|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890032|NCT01998958|588295302|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162619712|NCT00150709|587324831|FG000|Overall Study|Decision of parent(s) and investigator|3|||
162890033|NCT01998958|588295303|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162964175|NCT04158687|588569694|FG000|Overall Study|Non-Compliance with Study Medication|2|||
162964176|NCT04158687|588569695|FG001|Overall Study|Non-Compliance with Study Medication|2|||
162964177|NCT04158687|588569696|FG002|Overall Study|Non-Compliance with Study Medication|3|||
162964178|NCT04158687|588569697|FG003|Overall Study|Non-Compliance with Study Medication|0|||
162619713|NCT00150709|587324832|FG001|Overall Study|Decision of parent(s) and investigator|0|||
162619714|NCT00150709|587324833|FG002|Overall Study|Decision of parent(s) and investigator|0|||
162619715|NCT00150709|587324834|FG003|Overall Study|Decision of parent(s) and investigator|0|||
162619716|NCT00150709|587324831|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
162619717|NCT00150709|587324832|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
162619718|NCT00150709|587324833|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
162619719|NCT00150709|587324834|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
162619720|NCT00150709|587324831|FG000|Overall Study|Investigator decision|1|||
162619721|NCT00150709|587324832|FG001|Overall Study|Investigator decision|0|||
162619722|NCT00150709|587324833|FG002|Overall Study|Investigator decision|0|||
162619723|NCT00150709|587324834|FG003|Overall Study|Investigator decision|1|||
162619724|NCT00150709|587324831|FG000|Overall Study|Subject relocated|2|||
162619725|NCT00150709|587324832|FG001|Overall Study|Subject relocated|2|||
162619726|NCT00150709|587324833|FG002|Overall Study|Subject relocated|1|||
162619727|NCT00150709|587324834|FG003|Overall Study|Subject relocated|0|||
162619728|NCT00150709|587324831|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
162619729|NCT00150709|587324832|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
162619730|NCT00150709|587324833|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
162619731|NCT00150709|587324834|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
162619732|NCT00150709|587324831|FG000|Overall Study|Convenience|0|||
162619733|NCT00150709|587324832|FG001|Overall Study|Convenience|1|||
162619734|NCT00150709|587324833|FG002|Overall Study|Convenience|0|||
162619735|NCT00150709|587324834|FG003|Overall Study|Convenience|0|||
162890034|NCT01998958|588295304|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890035|NCT01998958|588295305|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162619736|NCT00150709|587324831|FG000|Overall Study|Subject entered new drug study|0|||
162619737|NCT00150709|587324832|FG001|Overall Study|Subject entered new drug study|1|||
162619738|NCT00150709|587324833|FG002|Overall Study|Subject entered new drug study|0|||
162619739|NCT00150709|587324834|FG003|Overall Study|Subject entered new drug study|0|||
162619740|NCT00150709|587324831|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
162619741|NCT00150709|587324832|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
162619742|NCT00150709|587324833|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
162619743|NCT00150709|587324834|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
162619744|NCT00150709|587324831|FG000|Overall Study|Lack of ease of swallowing|0|||
162619745|NCT00150709|587324832|FG001|Overall Study|Lack of ease of swallowing|1|||
162619746|NCT00150709|587324833|FG002|Overall Study|Lack of ease of swallowing|0|||
162619747|NCT00150709|587324834|FG003|Overall Study|Lack of ease of swallowing|0|||
162619748|NCT04092582|587324835|FG000|Overall Study|Death|1|||
162619749|NCT04092582|587324836|FG001|Overall Study|Death|1|||
162619750|NCT04092582|587324835|FG000|Overall Study|Withdrawal by Subject|4|||
162619751|NCT04092582|587324836|FG001|Overall Study|Withdrawal by Subject|1|||
162619752|NCT04092582|587324835|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
162619753|NCT04092582|587324836|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
162619754|NCT03019185|587324841|FG000|Overall Study|Lost to Follow-up|3|||
162619755|NCT03019185|587324842|FG001|Overall Study|Lost to Follow-up|0|||
162619756|NCT03019185|587324843|FG002|Overall Study|Lost to Follow-up|2|||
162619757|NCT03019185|587324841|FG000|Overall Study|Withdrawal by Subject|1|||
162619758|NCT03019185|587324842|FG001|Overall Study|Withdrawal by Subject|1|||
162619759|NCT03019185|587324843|FG002|Overall Study|Withdrawal by Subject|0|||
162619760|NCT03019185|587324841|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
162619761|NCT03019185|587324842|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
162619762|NCT03019185|587324843|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
162619763|NCT03019185|587324841|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
162619764|NCT03019185|587324842|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
162619765|NCT03019185|587324843|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
162619766|NCT02764333|587324849|FG000|Overall Study|Ineligible|1|||
162619767|NCT01200524|587324852|FG000|Overall Study|Withdrawal by Subject|1|||
162708518|NCT00409708|587642805|FG000|Treatment|Administrative problems|5|||
162890036|NCT01998958|588295306|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890037|NCT01998958|588295307|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890038|NCT01998958|588295308|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890039|NCT01998958|588295309|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890040|NCT01998958|588295310|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890041|NCT01998958|588295311|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890042|NCT01998958|588295312|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890043|NCT01998958|588295313|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890044|NCT01998958|588295314|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
162890045|NCT01998958|588295315|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
162890046|NCT01998958|588295316|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
162964179|NCT04158687|588569694|FG000|Overall Study|Investigator Decision|0|||
162964180|NCT04158687|588569695|FG001|Overall Study|Investigator Decision|0|||
162708519|NCT00409708|587642806|FG001|Treatment|Administrative problems|0|||
162708520|NCT00409708|587642805|FG000|Washout|Lack of Efficacy|9|||
162708521|NCT00409708|587642806|FG001|Washout|Lack of Efficacy|1|||
162708522|NCT00409708|587642805|FG000|Washout|Protocol Violation|0|||
162890047|NCT01998958|588295317|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890048|NCT01998958|588295318|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890049|NCT01998958|588295319|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890050|NCT01998958|588295320|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890051|NCT01998958|588295321|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890052|NCT01998958|588295322|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890053|NCT01998958|588295323|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890054|NCT01998958|588295324|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162890055|NCT02432703|588295325|FG000|Overall Study|Adverse Event|1|||
162890056|NCT02432703|588295326|FG001|Overall Study|Adverse Event|4|||
162964181|NCT04158687|588569696|FG002|Overall Study|Investigator Decision|2|||
162964182|NCT04158687|588569697|FG003|Overall Study|Investigator Decision|0|||
162964183|NCT04158687|588569694|FG000|Overall Study|Protocol Violation|0|||
162619768|NCT01200524|587324853|FG001|Overall Study|Withdrawal by Subject|1|||
162619769|NCT01200524|587324854|FG002|Overall Study|Withdrawal by Subject|3|||
162619770|NCT01200524|587324852|FG000|Overall Study|Adverse Event|1|||
162619771|NCT01200524|587324853|FG001|Overall Study|Adverse Event|0|||
162619772|NCT01200524|587324854|FG002|Overall Study|Adverse Event|0|||
162619773|NCT01200524|587324852|FG000|Overall Study|Non availability of study nurse|0|||
162619774|NCT01200524|587324853|FG001|Overall Study|Non availability of study nurse|0|||
162619775|NCT01200524|587324854|FG002|Overall Study|Non availability of study nurse|1|||
162619776|NCT01868503|587324855|FG000|Overall Study|Withdrawal by Subject|1|||
162619777|NCT01868503|587324855|FG000|Overall Study|Protocol Violation|1|||
162619778|NCT03917459|587324862|FG000|Overall Study|Adverse Event|1|||
162890057|NCT02432703|588295325|FG000|Overall Study|Lack of Efficacy|1|||
162890058|NCT02432703|588295326|FG001|Overall Study|Lack of Efficacy|0|||
162890059|NCT02432703|588295325|FG000|Overall Study|Lost to Follow-up|5|||
162890060|NCT02432703|588295326|FG001|Overall Study|Lost to Follow-up|3|||
162890061|NCT02432703|588295325|FG000|Overall Study|Withdrawal by Subject|9|||
162890062|NCT02432703|588295326|FG001|Overall Study|Withdrawal by Subject|6|||
162890063|NCT02432703|588295325|FG000|Overall Study|Other|6|||
162890064|NCT02432703|588295326|FG001|Overall Study|Other|5|||
162890065|NCT02137837|588295330|FG000|Overall Study|Adverse Event|0|||
162890066|NCT02137837|588295331|FG001|Overall Study|Adverse Event|2|||
162890067|NCT02137837|588295332|FG002|Overall Study|Adverse Event|1|||
162890068|NCT02137837|588295330|FG000|Overall Study|Refusal unrelated to adverse event|2|||
162890069|NCT02137837|588295331|FG001|Overall Study|Refusal unrelated to adverse event|2|||
162890070|NCT02137837|588295332|FG002|Overall Study|Refusal unrelated to adverse event|1|||
162890071|NCT02137837|588295330|FG000|Overall Study|Progression/relapse|9|||
162890072|NCT02137837|588295331|FG001|Overall Study|Progression/relapse|7|||
162890073|NCT02137837|588295332|FG002|Overall Study|Progression/relapse|7|||
162890074|NCT02137837|588295330|FG000|Overall Study|Not protocol specified|2|||
162890075|NCT02137837|588295331|FG001|Overall Study|Not protocol specified|1|||
162890076|NCT02137837|588295332|FG002|Overall Study|Not protocol specified|3|||
162890077|NCT01329341|588295333|FG000|Overall Study|Withdrawal by Subject|44|||
162890078|NCT00448760|588295334|FG000|Overall Study|Death|3|||
162890079|NCT00561340|588295335|FG000|Overall Study|refused to drink pediasure|6|||
162890080|NCT00561340|588295336|FG001|Overall Study|refused to drink pediasure|0|||
162890081|NCT00618995|588295338|FG000|Period 1|Adverse Event|0|||
162619779|NCT03917459|587324863|FG001|Overall Study|Adverse Event|0|||
162619780|NCT03917459|587324862|FG000|Overall Study|Withdrawal by Subject|0|||
162619781|NCT03917459|587324863|FG001|Overall Study|Withdrawal by Subject|1|||
162619782|NCT00736944|587324864|FG000|Induction|Death|1|||
162619783|NCT00736944|587324864|FG000|Definitive Treatment|Physician Decision|1|||
162619784|NCT00491764|587324865|FG000|Overall Study|Adverse Event|1|||
162619785|NCT00491764|587324866|FG001|Overall Study|Adverse Event|2|||
162619786|NCT00491764|587324867|FG002|Overall Study|Adverse Event|4|||
162619787|NCT00491764|587324868|FG003|Overall Study|Adverse Event|4|||
162619788|NCT00491764|587324869|FG004|Overall Study|Adverse Event|0|||
162619789|NCT00491764|587324870|FG005|Overall Study|Adverse Event|1|||
162890082|NCT00618995|588295339|FG001|Period 1|Adverse Event|0|||
162890083|NCT00618995|588295340|FG002|Period 1|Adverse Event|1|||
162890084|NCT00618995|588295341|FG003|Period 1|Adverse Event|0|||
162890085|NCT00618995|588295338|FG000|Period 1|Protocol Violation|0|||
162890086|NCT00618995|588295339|FG001|Period 1|Protocol Violation|1|||
162890087|NCT00618995|588295340|FG002|Period 1|Protocol Violation|1|||
162890088|NCT00618995|588295341|FG003|Period 1|Protocol Violation|0|||
162890089|NCT00618995|588295338|FG000|Period 2|Protocol Violation|0|||
162890090|NCT00618995|588295339|FG001|Period 2|Protocol Violation|0|||
162890091|NCT00618995|588295340|FG002|Period 2|Protocol Violation|1|||
162890092|NCT00618995|588295341|FG003|Period 2|Protocol Violation|0|||
162890093|NCT00618995|588295338|FG000|Period 4|Adverse Event|1|||
162890094|NCT00618995|588295339|FG001|Period 4|Adverse Event|0|||
162890095|NCT00618995|588295340|FG002|Period 4|Adverse Event|0|||
162890096|NCT00618995|588295341|FG003|Period 4|Adverse Event|0|||
162890097|NCT00290589|588295343|FG000|Overall Study|Lost to Follow-up|2|||
162890098|NCT00290589|588295344|FG001|Overall Study|Lost to Follow-up|2|||
162890099|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
162890100|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
162890101|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
162890102|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
162890103|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
162890104|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
162890105|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
162890106|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
162890107|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
162964184|NCT04158687|588569695|FG001|Overall Study|Protocol Violation|2|||
162964185|NCT04158687|588569696|FG002|Overall Study|Protocol Violation|1|||
162619790|NCT00491764|587324865|FG000|Overall Study|Lost to Follow-up|0|||
162890108|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
162890109|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
163051278|NCT00490035|588895391|FG003|Overall Study|AE of unknown type|0|||
163051279|NCT02127658|588895392|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
163051280|NCT02127658|588895393|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
163051281|NCT02127658|588895392|FG000|Overall Study|Withdrawal by Subject|0|||
163051282|NCT02127658|588895393|FG001|Overall Study|Withdrawal by Subject|2|||
163051283|NCT02127658|588895392|FG000|Overall Study|Physician Decision|0|||
163051284|NCT02127658|588895393|FG001|Overall Study|Physician Decision|1|||
163051285|NCT05559905|588895394|FG000|Overall Study|Withdrawal by Subject|1|||
163051286|NCT05559905|588895395|FG001|Overall Study|Withdrawal by Subject|0|||
163051287|NCT05559905|588895396|FG002|Overall Study|Withdrawal by Subject|0|||
163051288|NCT05559905|588895394|FG000|Overall Study|Not Reported|1|||
163051289|NCT05559905|588895395|FG001|Overall Study|Not Reported|0|||
163051290|NCT05559905|588895396|FG002|Overall Study|Not Reported|0|||
163051291|NCT05276973|588895397|FG000|Overall Study|Treated and DLT unevaluable|1|||
163051292|NCT05276973|588895398|FG001|Overall Study|Treated and DLT unevaluable|1|||
163051293|NCT05276973|588895399|FG002|Overall Study|Treated and DLT unevaluable|0|||
163051294|NCT03180736|588895400|FG000|Overall Study|Adverse Event|3|||
163051295|NCT03180736|588895401|FG001|Overall Study|Adverse Event|4|||
163051296|NCT03180736|588895400|FG000|Overall Study|Death|10|||
163051297|NCT03180736|588895401|FG001|Overall Study|Death|7|||
162619791|NCT00491764|587324866|FG001|Overall Study|Lost to Follow-up|1|||
162619792|NCT00491764|587324867|FG002|Overall Study|Lost to Follow-up|0|||
162619793|NCT00491764|587324868|FG003|Overall Study|Lost to Follow-up|1|||
162619794|NCT00491764|587324869|FG004|Overall Study|Lost to Follow-up|0|||
162619795|NCT00491764|587324870|FG005|Overall Study|Lost to Follow-up|3|||
162619796|NCT00491764|587324865|FG000|Overall Study|Withdrawal by Subject|2|||
162619797|NCT00491764|587324866|FG001|Overall Study|Withdrawal by Subject|3|||
162619798|NCT00491764|587324867|FG002|Overall Study|Withdrawal by Subject|1|||
162619799|NCT00491764|587324868|FG003|Overall Study|Withdrawal by Subject|2|||
162619800|NCT00491764|587324869|FG004|Overall Study|Withdrawal by Subject|2|||
162619801|NCT00491764|587324870|FG005|Overall Study|Withdrawal by Subject|4|||
162619802|NCT00491764|587324865|FG000|Overall Study|Non Compliance with the Protocol|1|||
162619803|NCT00491764|587324866|FG001|Overall Study|Non Compliance with the Protocol|0|||
162619804|NCT00491764|587324867|FG002|Overall Study|Non Compliance with the Protocol|0|||
162619805|NCT00491764|587324868|FG003|Overall Study|Non Compliance with the Protocol|0|||
162619806|NCT00491764|587324869|FG004|Overall Study|Non Compliance with the Protocol|0|||
162619807|NCT00491764|587324870|FG005|Overall Study|Non Compliance with the Protocol|0|||
162619808|NCT00491764|587324865|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
162619809|NCT00491764|587324866|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
162619810|NCT00491764|587324867|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
162619811|NCT00491764|587324868|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
162619812|NCT00491764|587324869|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
162619813|NCT00491764|587324870|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
162619814|NCT00491764|587324865|FG000|Overall Study|Administrative|1|||
162619815|NCT00491764|587324866|FG001|Overall Study|Administrative|0|||
162619816|NCT00491764|587324867|FG002|Overall Study|Administrative|2|||
162619817|NCT00491764|587324868|FG003|Overall Study|Administrative|1|||
162619818|NCT00491764|587324869|FG004|Overall Study|Administrative|0|||
162619819|NCT00491764|587324870|FG005|Overall Study|Administrative|0|||
162619820|NCT00894166|587324871|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
162619821|NCT00894166|587324872|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
162619822|NCT00894166|587324873|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
162619823|NCT00894166|587324874|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
162619824|NCT00894166|587324875|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
162619825|NCT00894166|587324876|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
162619826|NCT00894166|587324877|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
162619827|NCT00894166|587324878|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
162619828|NCT00894166|587324871|FG000|Overall Study|Death|0|||
162619829|NCT00894166|587324872|FG001|Overall Study|Death|0|||
162619830|NCT00894166|587324873|FG002|Overall Study|Death|0|||
162619831|NCT00894166|587324874|FG003|Overall Study|Death|1|||
162619832|NCT00894166|587324875|FG004|Overall Study|Death|0|||
162619833|NCT00894166|587324876|FG005|Overall Study|Death|0|||
162619834|NCT00894166|587324877|FG006|Overall Study|Death|0|||
162619835|NCT00894166|587324878|FG007|Overall Study|Death|0|||
162619836|NCT01601132|587324879|FG000|Overall Study|Patient withdrew consent|1|||
162619837|NCT01601132|587324879|FG000|Overall Study|Protocol deviation|1|||
162619838|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Adverse Event|3|||
162619839|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Adverse Event|0|||
162619840|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
162619841|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
162619842|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
162619843|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
162619844|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Physician Decision|0|||
163051298|NCT03180736|588895400|FG000|Overall Study|Withdrawal by Subject|5|||
163051299|NCT03180736|588895401|FG001|Overall Study|Withdrawal by Subject|12|||
162619845|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Physician Decision|2|||
162619846|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
162619847|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
162619848|NCT02110238|587324880|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
162619849|NCT02110238|587324881|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
162619850|NCT02110238|587324880|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
162619851|NCT02110238|587324881|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
162619852|NCT02110238|587324880|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
162619853|NCT02110238|587324881|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
162619854|NCT02110238|587324880|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
162619855|NCT02110238|587324881|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
162619856|NCT02110238|587324880|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
162619857|NCT02110238|587324881|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
162619858|NCT02110238|587324880|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
162619859|NCT02110238|587324881|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
162619860|NCT03228433|587324886|FG000|Overall Study|Lost to Follow-up|1|||
162619861|NCT03228433|587324887|FG001|Overall Study|Lost to Follow-up|0|||
162619862|NCT03228433|587324888|FG002|Overall Study|Lost to Follow-up|0|||
162619863|NCT03228433|587324889|FG003|Overall Study|Lost to Follow-up|0|||
162619864|NCT03228433|587324890|FG004|Overall Study|Lost to Follow-up|0|||
162619865|NCT03228433|587324891|FG005|Overall Study|Lost to Follow-up|0|||
162619866|NCT03228433|587324886|FG000|Overall Study|Positive alcohol test|0|||
162619867|NCT03228433|587324887|FG001|Overall Study|Positive alcohol test|0|||
162619868|NCT03228433|587324888|FG002|Overall Study|Positive alcohol test|0|||
162619869|NCT03228433|587324889|FG003|Overall Study|Positive alcohol test|1|||
162619870|NCT03228433|587324890|FG004|Overall Study|Positive alcohol test|0|||
162619871|NCT03228433|587324891|FG005|Overall Study|Positive alcohol test|0|||
162619872|NCT03626168|587324894|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162619873|NCT03626168|587324895|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
162619874|NCT03626168|587324894|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
162619875|NCT03626168|587324895|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
162619876|NCT03626168|587324894|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162619877|NCT03626168|587324895|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
162619878|NCT01419626|587324896|FG000|Overall Study|Protocol Violation|3|||
162619879|NCT01419626|587324897|FG001|Overall Study|Protocol Violation|2|||
162619880|NCT01419626|587324898|FG002|Overall Study|Protocol Violation|2|||
162619881|NCT01419626|587324896|FG000|Overall Study|Withdrawal by Subject|1|||
162619882|NCT01419626|587324897|FG001|Overall Study|Withdrawal by Subject|0|||
162619883|NCT01419626|587324898|FG002|Overall Study|Withdrawal by Subject|0|||
162619884|NCT01419626|587324896|FG000|Overall Study|Lost to Follow-up|0|||
162619885|NCT01419626|587324897|FG001|Overall Study|Lost to Follow-up|1|||
162619886|NCT01419626|587324898|FG002|Overall Study|Lost to Follow-up|1|||
162619887|NCT04738734|587324908|FG000|Overall Study|Withdrawal by Subject|2|||
162619888|NCT04738734|587324909|FG001|Overall Study|Withdrawal by Subject|4|||
162890110|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
162619889|NCT04738734|587324908|FG000|Overall Study|Lost to Follow-up|5|||
162619890|NCT04738734|587324909|FG001|Overall Study|Lost to Follow-up|2|||
162619891|NCT04738734|587324908|FG000|Overall Study|Physician Decision|0|||
162619892|NCT04738734|587324909|FG001|Overall Study|Physician Decision|1|||
162619893|NCT04738734|587324908|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
162619894|NCT04738734|587324909|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
162619895|NCT04093414|587324910|FG000|3 Month Follow up|Physician Decision|0|||
162619896|NCT04093414|587324911|FG001|3 Month Follow up|Physician Decision|1|||
162619897|NCT04093414|587324910|FG000|6month Follow up|Physician Decision|1|||
162619898|NCT04093414|587324911|FG001|6month Follow up|Physician Decision|3|||
162619899|NCT03452228|587324912|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162619900|NCT03452228|587324913|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
162619901|NCT03452228|587324914|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162619902|NCT03452228|587324912|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162964186|NCT04158687|588569697|FG003|Overall Study|Protocol Violation|0|||
162619903|NCT03452228|587324913|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162619904|NCT03452228|587324914|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162619905|NCT03452228|587324912|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
162619906|NCT03452228|587324913|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
162619907|NCT03452228|587324914|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
162619908|NCT03452228|587324912|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162619909|NCT03452228|587324913|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162619910|NCT03452228|587324914|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
162964187|NCT04158687|588569694|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
162964188|NCT04158687|588569695|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
162890111|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
162890112|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
162890113|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
162890114|NCT03814005|588295346|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
162890115|NCT03814005|588295347|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
162890116|NCT03814005|588295348|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
162890117|NCT00965146|588295349|FG000|Overall Study|Death|7|||
162890118|NCT00965146|588295349|FG000|Overall Study|Lost to Follow-up|22|||
162890119|NCT00965146|588295349|FG000|Overall Study|Withdrawal by Subject|17|||
162890120|NCT00965146|588295349|FG000|Overall Study|Unable to return|1|||
162890121|NCT00965146|588295349|FG000|Overall Study|Unwilling to return|11|||
162890122|NCT00965146|588295349|FG000|Overall Study|Intercurrent illness|1|||
162890123|NCT00965146|588295349|FG000|Overall Study|Revision / Removal of Study Implant|6|||
162890124|NCT00965146|588295349|FG000|Overall Study|Overall Study Termination|145|||
162890125|NCT05067452|588295350|FG000|Overall Study|Lost to Follow-up|0|||
162890126|NCT05067452|588295351|FG001|Overall Study|Lost to Follow-up|4|||
162890127|NCT01135017|588295352|FG000|Overall Study|Adverse Event|3|||
162890128|NCT01135017|588295353|FG001|Overall Study|Adverse Event|8|||
162890129|NCT01135017|588295352|FG000|Overall Study|Other than above|3|||
162890130|NCT01135017|588295353|FG001|Overall Study|Other than above|4|||
162890131|NCT00432562|588295354|FG000|Overall Study|Death|3|||
162619911|NCT03212690|587324915|FG000|Overall Study|Protocol Violation|1|||
162619912|NCT03208127|587324917|FG000|Overall Study|Death|1|||
162890132|NCT00432562|588295355|FG001|Overall Study|Death|0|||
162890133|NCT04311177|588295358|FG000|Overall Study|Adverse Event|3|||
162890134|NCT04311177|588295359|FG001|Overall Study|Adverse Event|1|||
162890135|NCT04311177|588295358|FG000|Overall Study|Physician Decision|4|||
162890136|NCT04311177|588295359|FG001|Overall Study|Physician Decision|3|||
162890137|NCT04311177|588295358|FG000|Overall Study|Withdrawal by Subject|1|||
162890138|NCT04311177|588295359|FG001|Overall Study|Withdrawal by Subject|0|||
162890139|NCT00964158|588295360|FG000|Overall Study|Lost to Follow-up|0|||
162890140|NCT00964158|588295361|FG001|Overall Study|Lost to Follow-up|1|||
162890141|NCT00964158|588295362|FG002|Overall Study|Lost to Follow-up|2|||
162890142|NCT00964158|588295360|FG000|Overall Study|Withdrawal by Subject|0|||
162890143|NCT00964158|588295361|FG001|Overall Study|Withdrawal by Subject|0|||
162890144|NCT00964158|588295362|FG002|Overall Study|Withdrawal by Subject|6|||
162890145|NCT00507416|588295363|FG000|Overall Study|Adverse Event|58|||
162890146|NCT00507416|588295364|FG001|Overall Study|Adverse Event|67|||
162890147|NCT00507416|588295365|FG002|Overall Study|Adverse Event|65|||
162890148|NCT00507416|588295363|FG000|Overall Study|Protocol Violation|1|||
162890149|NCT00507416|588295364|FG001|Overall Study|Protocol Violation|2|||
162890150|NCT00507416|588295365|FG002|Overall Study|Protocol Violation|0|||
162890151|NCT00507416|588295363|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
162619913|NCT01254331|587324922|FG000|Initial Phase|Adverse Event|3|||
162890152|NCT00507416|588295364|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
162890153|NCT00507416|588295365|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
162890154|NCT00507416|588295363|FG000|Overall Study|Progressive Disease|20|||
162890155|NCT00507416|588295364|FG001|Overall Study|Progressive Disease|10|||
162890156|NCT00507416|588295365|FG002|Overall Study|Progressive Disease|13|||
162890157|NCT00507416|588295363|FG000|Overall Study|Patient declined further treatment|18|||
162619914|NCT01254331|587324922|FG000|Initial Phase|Withdrawal by Subject|1|||
162619915|NCT01254331|587324922|FG000|Initial Phase|Pregnancy|1|||
162619916|NCT01254331|587324922|FG000|Extension Phase|Lack of Efficacy|1|||
162619917|NCT01254331|587324922|FG000|Extension Phase|Lost to Follow-up|3|||
162619918|NCT01011738|587324923|FG000|Overall Study|Death|12|||
162619919|NCT01011738|587324924|FG001|Overall Study|Death|3|||
162619920|NCT01011738|587324925|FG002|Overall Study|Death|0|||
162619921|NCT01011738|587324923|FG000|Overall Study|Unknown reasons|312|||
162619922|NCT01011738|587324924|FG001|Overall Study|Unknown reasons|291|||
162619923|NCT01011738|587324925|FG002|Overall Study|Unknown reasons|17|||
162619924|NCT00287365|587324926|FG000|Overall Study|sample not acquired|13|||
162619925|NCT00968864|587324927|FG000|Overall Study|Protocol exception/ not evaluable|1|||
162619926|NCT01346969|587324928|FG000|Overall Study|Withdrawal by Subject|0|||
162619927|NCT01346969|587324929|FG001|Overall Study|Withdrawal by Subject|0|||
162619928|NCT01346969|587324930|FG002|Overall Study|Withdrawal by Subject|1|||
162619929|NCT01346969|587324931|FG003|Overall Study|Withdrawal by Subject|0|||
162619930|NCT01346969|587324928|FG000|Overall Study|Lost to Follow-up|1|||
162619931|NCT01346969|587324929|FG001|Overall Study|Lost to Follow-up|0|||
162619932|NCT01346969|587324930|FG002|Overall Study|Lost to Follow-up|2|||
162619933|NCT01346969|587324931|FG003|Overall Study|Lost to Follow-up|0|||
162619934|NCT01346969|587324928|FG000|Overall Study|Physician Decision|0|||
162890158|NCT00507416|588295364|FG001|Overall Study|Patient declined further treatment|14|||
162890159|NCT00507416|588295365|FG002|Overall Study|Patient declined further treatment|11|||
162890160|NCT00507416|588295363|FG000|Overall Study|Other|11|||
162890161|NCT00507416|588295364|FG001|Overall Study|Other|16|||
162890162|NCT00507416|588295365|FG002|Overall Study|Other|13|||
162890163|NCT00507416|588295363|FG000|Overall Study|Did not Receive Study Treatment|3|||
162890164|NCT00507416|588295364|FG001|Overall Study|Did not Receive Study Treatment|9|||
162890165|NCT00507416|588295365|FG002|Overall Study|Did not Receive Study Treatment|4|||
162890166|NCT03101514|588295366|FG000|Overall Study|Withdrawal by Subject|4|||
162890167|NCT03101514|588295366|FG000|Overall Study|Protocol Violation|2|||
162890168|NCT03101514|588295366|FG000|Overall Study|patient's information was incomplete|1|||
162890169|NCT03695393|588295375|FG000|Overall Study|Death|3|||
162890170|NCT03695393|588295376|FG001|Overall Study|Death|1|||
162890171|NCT03695393|588295375|FG000|Overall Study|Lost to Follow-up|0|||
162890172|NCT03695393|588295376|FG001|Overall Study|Lost to Follow-up|1|||
162890173|NCT04585451|588295377|FG000|Overall Study|Withdrawal by Subject|26|||
162890174|NCT04585451|588295378|FG001|Overall Study|Withdrawal by Subject|0|||
162890175|NCT00966693|588295379|FG000|Overall Study|Adverse Event|0|||
162619935|NCT01346969|587324929|FG001|Overall Study|Physician Decision|0|||
162619936|NCT01346969|587324930|FG002|Overall Study|Physician Decision|0|||
162619937|NCT01346969|587324931|FG003|Overall Study|Physician Decision|1|||
162619938|NCT01346969|587324928|FG000|Overall Study|Randomized but not treated|1|||
162619939|NCT01346969|587324929|FG001|Overall Study|Randomized but not treated|0|||
162619940|NCT01346969|587324930|FG002|Overall Study|Randomized but not treated|0|||
162619941|NCT01346969|587324931|FG003|Overall Study|Randomized but not treated|0|||
162619942|NCT01967173|587324932|FG000|Overall Study|Lost to Follow-up|5|||
162619943|NCT01967173|587324933|FG001|Overall Study|Lost to Follow-up|3|||
162619944|NCT01967173|587324934|FG002|Overall Study|Lost to Follow-up|2|||
162619945|NCT01967173|587324935|FG003|Overall Study|Lost to Follow-up|4|||
162619946|NCT01967173|587324936|FG004|Overall Study|Lost to Follow-up|8|||
162619947|NCT01967173|587324937|FG005|Overall Study|Lost to Follow-up|12|||
162619948|NCT01967173|587324938|FG006|Overall Study|Lost to Follow-up|6|||
162619949|NCT01967173|587324939|FG007|Overall Study|Lost to Follow-up|8|||
162619950|NCT01967173|587324932|FG000|Overall Study|Physician Decision|2|||
162619951|NCT01967173|587324933|FG001|Overall Study|Physician Decision|0|||
162619952|NCT01967173|587324934|FG002|Overall Study|Physician Decision|2|||
162619953|NCT01967173|587324935|FG003|Overall Study|Physician Decision|1|||
162708523|NCT00409708|587642806|FG001|Washout|Protocol Violation|1|||
162619954|NCT01967173|587324936|FG004|Overall Study|Physician Decision|1|||
162619955|NCT01967173|587324937|FG005|Overall Study|Physician Decision|1|||
162708524|NCT00409708|587642805|FG000|Washout|Withdrawal by Subject|11|||
162619956|NCT01967173|587324938|FG006|Overall Study|Physician Decision|1|||
162619957|NCT01967173|587324939|FG007|Overall Study|Physician Decision|0|||
162619958|NCT01967173|587324932|FG000|Overall Study|Lack of Efficacy|2|||
162619959|NCT01967173|587324933|FG001|Overall Study|Lack of Efficacy|0|||
162619960|NCT01967173|587324934|FG002|Overall Study|Lack of Efficacy|2|||
162619961|NCT01967173|587324935|FG003|Overall Study|Lack of Efficacy|2|||
162619962|NCT01967173|587324936|FG004|Overall Study|Lack of Efficacy|0|||
162708525|NCT00409708|587642806|FG001|Washout|Withdrawal by Subject|5|||
162619963|NCT01967173|587324937|FG005|Overall Study|Lack of Efficacy|1|||
162619964|NCT01967173|587324938|FG006|Overall Study|Lack of Efficacy|0|||
162619965|NCT01967173|587324939|FG007|Overall Study|Lack of Efficacy|2|||
162619966|NCT01967173|587324932|FG000|Overall Study|Pregnancy|0|||
162619967|NCT01967173|587324933|FG001|Overall Study|Pregnancy|0|||
162890176|NCT00966693|588295380|FG001|Overall Study|Adverse Event|0|||
162890177|NCT00966693|588295381|FG002|Overall Study|Adverse Event|1|||
162890178|NCT00966693|588295382|FG003|Overall Study|Adverse Event|2|||
162890179|NCT00966693|588295379|FG000|Overall Study|Death|0|||
162890180|NCT00966693|588295380|FG001|Overall Study|Death|0|||
162890181|NCT00966693|588295381|FG002|Overall Study|Death|1|||
162890182|NCT00966693|588295382|FG003|Overall Study|Death|0|||
162890183|NCT00966693|588295379|FG000|Overall Study|Withdrawal by Subject|1|||
162890184|NCT00966693|588295380|FG001|Overall Study|Withdrawal by Subject|0|||
162890185|NCT00966693|588295381|FG002|Overall Study|Withdrawal by Subject|0|||
162890186|NCT00966693|588295382|FG003|Overall Study|Withdrawal by Subject|5|||
162890187|NCT00966693|588295379|FG000|Overall Study|Disease Progression|0|||
162890188|NCT00966693|588295380|FG001|Overall Study|Disease Progression|0|||
162890189|NCT00966693|588295381|FG002|Overall Study|Disease Progression|1|||
162890190|NCT00966693|588295382|FG003|Overall Study|Disease Progression|16|||
162890191|NCT01578785|588295383|FG000|Overall Study|Withdrawal by Subject|0|||
162890192|NCT01578785|588295384|FG001|Overall Study|Withdrawal by Subject|1|||
162890193|NCT01578785|588295383|FG000|Overall Study|Study terminated by sponsor|59|||
162890194|NCT01578785|588295384|FG001|Overall Study|Study terminated by sponsor|118|||
162890195|NCT02581982|588295385|FG000|Overall Study|Lack of Efficacy|12|||
162890196|NCT02581982|588295385|FG000|Overall Study|Adverse Event|3|||
162890197|NCT02581982|588295385|FG000|Overall Study|Physician Decision|1|||
162890198|NCT01769469|588295386|FG000|Overall Study|Consent Withdrawn|5|||
162890199|NCT01769469|588295386|FG000|Overall Study|Moved Out Of Area|3|||
162619968|NCT01967173|587324934|FG002|Overall Study|Pregnancy|0|||
162619969|NCT01967173|587324935|FG003|Overall Study|Pregnancy|0|||
162890200|NCT01769469|588295386|FG000|Overall Study|Lost to Follow-up|17|||
162619970|NCT01967173|587324936|FG004|Overall Study|Pregnancy|0|||
162890201|NCT01769469|588295386|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
162890202|NCT01769469|588295386|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
162619971|NCT01967173|587324937|FG005|Overall Study|Pregnancy|0|||
162619972|NCT01967173|587324938|FG006|Overall Study|Pregnancy|1|||
162619973|NCT01967173|587324939|FG007|Overall Study|Pregnancy|1|||
162619974|NCT01967173|587324932|FG000|Overall Study|Adverse Event|0|||
162619975|NCT01967173|587324933|FG001|Overall Study|Adverse Event|0|||
162619976|NCT01967173|587324934|FG002|Overall Study|Adverse Event|0|||
162619977|NCT01967173|587324935|FG003|Overall Study|Adverse Event|0|||
162619978|NCT01967173|587324936|FG004|Overall Study|Adverse Event|0|||
162619979|NCT01967173|587324937|FG005|Overall Study|Adverse Event|0|||
162619980|NCT01967173|587324938|FG006|Overall Study|Adverse Event|0|||
162619981|NCT01967173|587324939|FG007|Overall Study|Adverse Event|1|||
162619982|NCT01967173|587324932|FG000|Overall Study|Withdrawal by Subject|15|||
162619983|NCT01967173|587324933|FG001|Overall Study|Withdrawal by Subject|14|||
162619984|NCT01967173|587324934|FG002|Overall Study|Withdrawal by Subject|10|||
162619985|NCT01967173|587324935|FG003|Overall Study|Withdrawal by Subject|7|||
162619986|NCT01967173|587324936|FG004|Overall Study|Withdrawal by Subject|8|||
162619987|NCT01967173|587324937|FG005|Overall Study|Withdrawal by Subject|9|||
162619988|NCT01967173|587324938|FG006|Overall Study|Withdrawal by Subject|10|||
162619989|NCT01967173|587324939|FG007|Overall Study|Withdrawal by Subject|12|||
162619990|NCT03666624|587324942|FG000|Overall Study|participant grieving over recent death of parent|1|||
162619991|NCT03666624|587324943|FG001|Overall Study|participant grieving over recent death of parent|0|||
162619992|NCT05213481|587324944|FG000|Overall Study|Adverse Event|3|||
162619993|NCT05213481|587324944|FG000|Overall Study|Lost to Follow-up|1|||
162619994|NCT00447005|587324946|FG000|Overall Study|Adverse Event|1|||
162619995|NCT00447005|587324946|FG000|Overall Study|Lack of Efficacy|11|||
162619996|NCT00423514|587324947|FG000|Overall Study|Ineligible|1|||
162619997|NCT00423514|587324948|FG001|Overall Study|Ineligible|0|||
162619998|NCT00397215|587324949|FG000|Month 0 (Day 0)|Adverse Event|0|||
162619999|NCT00397215|587324950|FG001|Month 0 (Day 0)|Adverse Event|1|||
162620000|NCT00397215|587324951|FG002|Month 0 (Day 0)|Adverse Event|0|||
162620001|NCT00397215|587324952|FG003|Month 0 (Day 0)|Adverse Event|0|||
162620002|NCT00397215|587324949|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
162620003|NCT00397215|587324950|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
162620004|NCT00397215|587324951|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
162620005|NCT00397215|587324952|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
162620006|NCT00397215|587324949|FG000|Month 0 (Day 0)|Other|4|||
162620007|NCT00397215|587324950|FG001|Month 0 (Day 0)|Other|1|||
162620008|NCT00397215|587324951|FG002|Month 0 (Day 0)|Other|3|||
162620009|NCT00397215|587324952|FG003|Month 0 (Day 0)|Other|3|||
162620010|NCT00397215|587324949|FG000|Month 6 (Day 180)|Adverse Event|0|||
162620011|NCT00397215|587324950|FG001|Month 6 (Day 180)|Adverse Event|3|||
162620012|NCT00397215|587324951|FG002|Month 6 (Day 180)|Adverse Event|2|||
162620013|NCT00397215|587324952|FG003|Month 6 (Day 180)|Adverse Event|0|||
162964189|NCT04158687|588569696|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
162964190|NCT04158687|588569697|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
162964191|NCT04158687|588569694|FG000|Overall Study|Reason not Specified|3|||
162620014|NCT00397215|587324949|FG000|Month 6 (Day 180)|Other|2|||
162620015|NCT00397215|587324950|FG001|Month 6 (Day 180)|Other|0|||
162620016|NCT00397215|587324951|FG002|Month 6 (Day 180)|Other|3|||
162620017|NCT00397215|587324952|FG003|Month 6 (Day 180)|Other|0|||
162620018|NCT02128932|587324953|FG000|Overall Study|Withdrawal by Subject|11|||
162620019|NCT02128932|587324954|FG001|Overall Study|Withdrawal by Subject|7|||
162620020|NCT02128932|587324955|FG002|Overall Study|Withdrawal by Subject|8|||
162620021|NCT02128932|587324953|FG000|Overall Study|Death|2|||
162620022|NCT02128932|587324954|FG001|Overall Study|Death|0|||
162620023|NCT02128932|587324955|FG002|Overall Study|Death|2|||
162620024|NCT02128932|587324953|FG000|Overall Study|Lost to Follow-up|2|||
162620025|NCT02128932|587324954|FG001|Overall Study|Lost to Follow-up|1|||
162620026|NCT02128932|587324955|FG002|Overall Study|Lost to Follow-up|1|||
162620027|NCT02128932|587324953|FG000|Overall Study|No reason for withdrawal|12|||
162620028|NCT02128932|587324954|FG001|Overall Study|No reason for withdrawal|11|||
162620029|NCT02128932|587324955|FG002|Overall Study|No reason for withdrawal|7|||
162620030|NCT03685123|587324960|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
162620031|NCT03685123|587324961|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
162620032|NCT03685123|587324962|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
162620033|NCT03685123|587324960|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
162708526|NCT00409708|587642805|FG000|Washout|Lost to Follow-up|1|||
162964192|NCT04158687|588569695|FG001|Overall Study|Reason not Specified|2|||
162964193|NCT04158687|588569696|FG002|Overall Study|Reason not Specified|4|||
162620034|NCT03685123|587324961|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
162620035|NCT03685123|587324962|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
162620036|NCT03685123|587324960|FG000|Weight Loss Phase|Lost to Follow-up|1|||
162620037|NCT03685123|587324961|FG001|Weight Loss Phase|Lost to Follow-up|0|||
162620038|NCT03685123|587324962|FG002|Weight Loss Phase|Lost to Follow-up|0|||
162620039|NCT03685123|587324960|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
162620040|NCT03685123|587324961|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
162620041|NCT03685123|587324962|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
162620042|NCT03685123|587324960|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
162620043|NCT03685123|587324961|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
162620044|NCT03685123|587324962|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
162620045|NCT03685123|587324960|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
162708527|NCT00409708|587642806|FG001|Washout|Lost to Follow-up|3|||
162708528|NCT00946114|587642807|FG000|Overall Study|Death|5|||
162708529|NCT00946114|587642808|FG001|Overall Study|Death|2|||
162708530|NCT00946114|587642807|FG000|Overall Study|Other|1|||
162708531|NCT00946114|587642808|FG001|Overall Study|Other|0|||
162708532|NCT00946114|587642807|FG000|Overall Study|Withdrawal by Subject|2|||
162708533|NCT00946114|587642808|FG001|Overall Study|Withdrawal by Subject|0|||
162708534|NCT00723294|587642809|FG000|Overall Study|Lobular histology|2|||
162708535|NCT00723294|587642809|FG000|Overall Study|>25% intraductal component|1|||
162708536|NCT00723294|587642809|FG000|Overall Study|No MRI tumor enhancement|1|||
162708537|NCT00723294|587642809|FG000|Overall Study|1.0-Tesla MRI|1|||
162708538|NCT00723294|587642809|FG000|Overall Study|No cryoabalation|2|||
162708539|NCT00723294|587642809|FG000|Overall Study|Did not undergo surgery|1|||
162708540|NCT00723294|587642809|FG000|Overall Study|Treated prior to registration|1|||
162708541|NCT00723294|587642809|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
162708542|NCT00723294|587642809|FG000|Overall Study|Benign lesion|1|||
162708543|NCT00723294|587642809|FG000|Overall Study|Withdrawal by Subject|1|||
162708544|NCT00723294|587642809|FG000|Overall Study|No treatment due to probe failure|1|||
162708545|NCT00088465|587642810|FG000|Overall Study|Withdrawal by Subject|290|||
162708546|NCT00088465|587642810|FG000|Overall Study|Adverse Event|77|||
162708547|NCT00088465|587642810|FG000|Overall Study|Lost to Follow-up|57|||
162708548|NCT00088465|587642810|FG000|Overall Study|Physician Decision|45|||
162708549|NCT00088465|587642810|FG000|Overall Study|Sponsor Decision|37|||
162708550|NCT00088465|587642810|FG000|Overall Study|Lack of Efficacy|27|||
162708551|NCT00088465|587642810|FG000|Overall Study|Protocol Violation|17|||
162708552|NCT00088465|587642810|FG000|Overall Study|Death|11|||
162708553|NCT04565249|587642811|FG000|Overall Study|Death|0|||
162708554|NCT04565249|587642812|FG001|Overall Study|Death|0|||
162708555|NCT04565249|587642813|FG002|Overall Study|Death|0|||
162708556|NCT04565249|587642814|FG003|Overall Study|Death|1|||
162708557|NCT03613129|587642817|FG000|Pre-treatment Assessment|Protocol Violation|2|||
162708558|NCT03613129|587642818|FG001|Pre-treatment Assessment|Protocol Violation|0|||
162708559|NCT03613129|587642819|FG002|Pre-treatment Assessment|Protocol Violation|0|||
162708560|NCT03613129|587642820|FG003|Pre-treatment Assessment|Protocol Violation|0|||
162708561|NCT03613129|587642821|FG004|Pre-treatment Assessment|Protocol Violation|0|||
162708562|NCT03613129|587642817|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
162708563|NCT03613129|587642818|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
162708564|NCT03613129|587642819|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
162708565|NCT03613129|587642820|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
162708566|NCT03613129|587642821|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
162708567|NCT02334306|587642822|FG000|Double-blind Period|Adverse Event|0|||
162708568|NCT02334306|587642823|FG001|Double-blind Period|Adverse Event|1|||
162708569|NCT02334306|587642822|FG000|Double-blind Period|Withdrawal by Subject|1|||
162708570|NCT02334306|587642823|FG001|Double-blind Period|Withdrawal by Subject|1|||
162708571|NCT01687270|587642824|FG000|Overall Study|Lack of Efficacy|11|||
162708572|NCT01687270|587642824|FG000|Overall Study|Lost to Follow-up|1|||
162708573|NCT02390557|587642825|FG000|Wave 2|Survey non-respondent|72|||
162620046|NCT03685123|587324961|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
162620047|NCT03685123|587324962|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
162620048|NCT01254630|587324963|FG000|Overall Study|Adverse Event|36|||
162620049|NCT01254630|587324964|FG001|Overall Study|Adverse Event|15|||
162620050|NCT01254630|587324965|FG002|Overall Study|Adverse Event|40|||
162620051|NCT01254630|587324966|FG003|Overall Study|Adverse Event|8|||
162620052|NCT01254630|587324963|FG000|Overall Study|Death|461|||
162620053|NCT01254630|587324964|FG001|Overall Study|Death|151|||
162620054|NCT01254630|587324965|FG002|Overall Study|Death|478|||
162620055|NCT01254630|587324966|FG003|Overall Study|Death|139|||
162620056|NCT01254630|587324963|FG000|Overall Study|Lost to Follow-up|80|||
162708574|NCT02390557|587642826|FG001|Wave 2|Survey non-respondent|41|||
162708575|NCT02390557|587642827|FG002|Wave 2|Survey non-respondent|23|||
162708576|NCT00920686|587642833|FG000|Overall Study|Lost to Follow-up|2|||
162708577|NCT00920686|587642834|FG001|Overall Study|Lost to Follow-up|3|||
162708578|NCT00920686|587642835|FG002|Overall Study|Lost to Follow-up|1|||
162708579|NCT00920686|587642833|FG000|Overall Study|Study drug dosing criteria not met|17|||
162708580|NCT00920686|587642834|FG001|Overall Study|Study drug dosing criteria not met|19|||
162620057|NCT01254630|587324964|FG001|Overall Study|Lost to Follow-up|26|||
162708581|NCT00920686|587642835|FG002|Overall Study|Study drug dosing criteria not met|12|||
162708582|NCT03006341|587642836|FG000|Overall Study|Not linked in the EMR|25069|||
162708583|NCT03006341|587642837|FG001|Overall Study|Not linked in the EMR|67505|||
162708584|NCT03006341|587642838|FG002|Overall Study|Not linked in the EMR|30993|||
162708585|NCT03006341|587642839|FG003|Overall Study|Not linked in the EMR|10685|||
162708586|NCT04337489|587642840|FG000|Overall Study|Withdrawal by Subject|1|||
162964194|NCT04158687|588569697|FG003|Overall Study|Reason not Specified|4|||
162620058|NCT01254630|587324965|FG002|Overall Study|Lost to Follow-up|89|||
162620059|NCT01254630|587324966|FG003|Overall Study|Lost to Follow-up|32|||
162620060|NCT01254630|587324963|FG000|Overall Study|Physician Decision|24|||
162620061|NCT01254630|587324964|FG001|Overall Study|Physician Decision|8|||
162620062|NCT01254630|587324965|FG002|Overall Study|Physician Decision|16|||
162620063|NCT01254630|587324966|FG003|Overall Study|Physician Decision|7|||
162620064|NCT01254630|587324963|FG000|Overall Study|Withdrawal by Subject|201|||
162620065|NCT01254630|587324964|FG001|Overall Study|Withdrawal by Subject|94|||
162620066|NCT01254630|587324965|FG002|Overall Study|Withdrawal by Subject|188|||
162620067|NCT01254630|587324966|FG003|Overall Study|Withdrawal by Subject|89|||
162620068|NCT01254630|587324963|FG000|Overall Study|Study terminated by sponsor|0|||
162620069|NCT01254630|587324964|FG001|Overall Study|Study terminated by sponsor|994|||
162620070|NCT01254630|587324965|FG002|Overall Study|Study terminated by sponsor|0|||
162620071|NCT01254630|587324966|FG003|Overall Study|Study terminated by sponsor|1010|||
162620072|NCT01254630|587324963|FG000|Overall Study|Status not recorded|0|||
162620073|NCT01254630|587324964|FG001|Overall Study|Status not recorded|0|||
162620074|NCT01254630|587324965|FG002|Overall Study|Status not recorded|1|||
162620075|NCT01254630|587324966|FG003|Overall Study|Status not recorded|0|||
162620076|NCT02959983|587324967|FG000|Overall Study|Protocol Violation|0|||
162620077|NCT02959983|587324968|FG001|Overall Study|Protocol Violation|1|||
162620078|NCT02959983|587324967|FG000|Overall Study|Lack of Efficacy|0|||
162620079|NCT02959983|587324968|FG001|Overall Study|Lack of Efficacy|1|||
162620080|NCT02959983|587324967|FG000|Overall Study|Lost to Follow-up|12|||
162620081|NCT02959983|587324968|FG001|Overall Study|Lost to Follow-up|9|||
162620082|NCT02959983|587324967|FG000|Overall Study|Other|1|||
162620083|NCT02959983|587324968|FG001|Overall Study|Other|1|||
162620084|NCT02959983|587324967|FG000|Overall Study|Physician Decision|1|||
162620085|NCT02959983|587324968|FG001|Overall Study|Physician Decision|0|||
162620086|NCT02959983|587324967|FG000|Overall Study|Adverse Event|5|||
162620087|NCT02959983|587324968|FG001|Overall Study|Adverse Event|1|||
162620088|NCT02959983|587324967|FG000|Overall Study|Withdrawal by Subject|7|||
162620089|NCT02959983|587324968|FG001|Overall Study|Withdrawal by Subject|12|||
162620090|NCT03439657|587324973|FG000|Overall Study|Adverse Event|2|||
162620091|NCT03439657|587324974|FG001|Overall Study|Adverse Event|3|||
162620092|NCT03439657|587324973|FG000|Overall Study|Lost to Follow-up|1|||
162620093|NCT03439657|587324974|FG001|Overall Study|Lost to Follow-up|0|||
162620094|NCT03439657|587324973|FG000|Overall Study|Protocol Violation|1|||
162620095|NCT03439657|587324974|FG001|Overall Study|Protocol Violation|1|||
162620096|NCT03439657|587324973|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
162620097|NCT03439657|587324974|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
162620098|NCT02925117|587324976|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
162620099|NCT02925117|587324977|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
162620100|NCT02925117|587324978|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
162620101|NCT02925117|587324979|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
162620102|NCT02925117|587324980|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620103|NCT02925117|587324981|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620104|NCT02925117|587324982|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620105|NCT02925117|587324983|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620106|NCT02925117|587324984|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620107|NCT02925117|587324985|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162964195|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
162964196|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
162964197|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
162964198|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
162964199|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
162964200|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
162964201|NCT02906917|588569703|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
162964202|NCT02906917|588569704|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
162964203|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
162964204|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
162964205|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
162964206|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
162964207|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
162964208|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
162964209|NCT02906917|588569703|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
162964210|NCT02906917|588569704|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
162620108|NCT02925117|587324986|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620109|NCT02925117|587324987|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162620110|NCT02925117|587324976|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
162620111|NCT02925117|587324977|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
162620112|NCT02925117|587324978|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
162620113|NCT02925117|587324979|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162964211|NCT00687739|588569705|FG000|Overall Study|Lost to Follow-up|2|||
162620114|NCT02925117|587324980|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620115|NCT02925117|587324981|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162964212|NCT00687739|588569706|FG001|Overall Study|Lost to Follow-up|2|||
162620116|NCT02925117|587324982|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620117|NCT02925117|587324983|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620118|NCT02925117|587324984|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620119|NCT02925117|587324985|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620120|NCT02925117|587324986|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620121|NCT02925117|587324987|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162620122|NCT02925117|587324976|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
162620123|NCT02925117|587324977|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
162620124|NCT02925117|587324978|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620125|NCT02925117|587324979|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620126|NCT02925117|587324980|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620127|NCT02925117|587324981|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620128|NCT02925117|587324982|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620129|NCT02925117|587324983|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620130|NCT02925117|587324984|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620131|NCT02925117|587324985|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620132|NCT02925117|587324986|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620133|NCT02925117|587324987|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162620134|NCT02925117|587324976|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
162620135|NCT02925117|587324977|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
162620136|NCT02925117|587324978|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
162620137|NCT02925117|587324979|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
162620138|NCT02925117|587324980|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
162620139|NCT02925117|587324981|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
162620140|NCT02925117|587324982|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
162620141|NCT02925117|587324983|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
162620142|NCT02925117|587324984|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
162620143|NCT02925117|587324985|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
162620144|NCT02925117|587324986|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
162620145|NCT02925117|587324987|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
162620146|NCT02925117|587324976|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620147|NCT02925117|587324977|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620148|NCT02925117|587324978|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620149|NCT02925117|587324979|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620150|NCT02925117|587324980|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620151|NCT02925117|587324981|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
162620152|NCT02925117|587324982|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620153|NCT02925117|587324983|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620154|NCT02925117|587324984|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620155|NCT02925117|587324985|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162620156|NCT02925117|587324986|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
162620157|NCT02925117|587324987|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
162620158|NCT02925117|587324976|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162964213|NCT00687739|588569707|FG002|Overall Study|Lost to Follow-up|1|||
162964214|NCT00687739|588569708|FG003|Overall Study|Lost to Follow-up|2|||
162964215|NCT00687739|588569705|FG000|Overall Study|Adverse Event|0|||
162964216|NCT00687739|588569706|FG001|Overall Study|Adverse Event|1|||
162964217|NCT00687739|588569707|FG002|Overall Study|Adverse Event|1|||
162964218|NCT00687739|588569708|FG003|Overall Study|Adverse Event|0|||
162964219|NCT02043132|588569713|FG000|Overall Study|Lost to Follow-up|1|||
162964220|NCT02043132|588569714|FG001|Overall Study|Lost to Follow-up|1|||
162964221|NCT02043132|588569713|FG000|Overall Study|screen failures|4|||
162964222|NCT02043132|588569714|FG001|Overall Study|screen failures|8|||
162964223|NCT02554877|588569715|FG000|Overall Study|Adverse Event|2|||
162964224|NCT02554877|588569716|FG001|Overall Study|Adverse Event|0|||
162964225|NCT02554877|588569717|FG002|Overall Study|Adverse Event|0|||
162964226|NCT02554877|588569718|FG003|Overall Study|Adverse Event|1|||
162964227|NCT02554877|588569715|FG000|Overall Study|Lost to Follow-up|1|||
162964228|NCT02554877|588569716|FG001|Overall Study|Lost to Follow-up|1|||
162964229|NCT02554877|588569717|FG002|Overall Study|Lost to Follow-up|1|||
162964230|NCT02554877|588569718|FG003|Overall Study|Lost to Follow-up|2|||
162964231|NCT02554877|588569715|FG000|Overall Study|Did not meet entrance criteria|0|||
162964232|NCT02554877|588569716|FG001|Overall Study|Did not meet entrance criteria|0|||
162964233|NCT02554877|588569717|FG002|Overall Study|Did not meet entrance criteria|1|||
162964234|NCT02554877|588569718|FG003|Overall Study|Did not meet entrance criteria|0|||
162964235|NCT02554877|588569715|FG000|Overall Study|No longer met eligibility criteria|1|||
162964236|NCT02554877|588569716|FG001|Overall Study|No longer met eligibility criteria|0|||
162964237|NCT02554877|588569717|FG002|Overall Study|No longer met eligibility criteria|1|||
162964238|NCT02554877|588569718|FG003|Overall Study|No longer met eligibility criteria|1|||
162964239|NCT02554877|588569715|FG000|Overall Study|Protocol Violation|3|||
162964240|NCT02554877|588569716|FG001|Overall Study|Protocol Violation|1|||
162964241|NCT02554877|588569717|FG002|Overall Study|Protocol Violation|1|||
162964242|NCT02554877|588569718|FG003|Overall Study|Protocol Violation|0|||
162708587|NCT02950545|587642841|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162964243|NCT02554877|588569715|FG000|Overall Study|Other|1|||
162964244|NCT02554877|588569716|FG001|Overall Study|Other|3|||
162964245|NCT02554877|588569717|FG002|Overall Study|Other|0|||
162964246|NCT02554877|588569718|FG003|Overall Study|Other|3|||
163051300|NCT03180736|588895400|FG000|Overall Study|Lost to Follow-up|1|||
163051301|NCT03180736|588895401|FG001|Overall Study|Lost to Follow-up|0|||
163051302|NCT03180736|588895400|FG000|Overall Study|Lack of Efficacy|66|||
163051303|NCT03180736|588895401|FG001|Overall Study|Lack of Efficacy|87|||
163051304|NCT03180736|588895400|FG000|Overall Study|Physician Decision|4|||
163051305|NCT03180736|588895401|FG001|Overall Study|Physician Decision|7|||
163051306|NCT03180736|588895400|FG000|Overall Study|randomized but not treated|2|||
163051307|NCT03180736|588895401|FG001|Overall Study|randomized but not treated|3|||
163051308|NCT03258593|588895402|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
163051309|NCT03258593|588895403|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
163051310|NCT03258593|588895404|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
162620159|NCT02925117|587324977|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162620160|NCT02925117|587324978|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162620161|NCT02925117|587324979|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162620162|NCT02925117|587324980|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162620163|NCT02925117|587324981|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
162620164|NCT02925117|587324982|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
162620165|NCT02925117|587324983|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
162620166|NCT02925117|587324984|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162620167|NCT02925117|587324985|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162620168|NCT02925117|587324986|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162620169|NCT02925117|587324987|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162620170|NCT02925117|587324976|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620171|NCT02925117|587324977|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620172|NCT02925117|587324978|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620173|NCT02925117|587324979|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620174|NCT02925117|587324980|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162620175|NCT02925117|587324981|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
162620176|NCT02925117|587324982|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162620177|NCT02925117|587324983|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162620178|NCT02925117|587324984|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162620179|NCT02925117|587324985|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620180|NCT02925117|587324986|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162620181|NCT02925117|587324987|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162620182|NCT02925117|587324976|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
162620183|NCT02925117|587324977|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
162620184|NCT02925117|587324978|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
162620185|NCT02925117|587324979|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
162620186|NCT02925117|587324980|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
162620187|NCT02925117|587324981|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
162620188|NCT02925117|587324982|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
162620189|NCT02925117|587324983|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
162620190|NCT02925117|587324984|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
162620191|NCT02925117|587324985|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
162620192|NCT02925117|587324986|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
162620193|NCT02925117|587324987|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
162620194|NCT04032652|587324988|FG000|Overall Study|The study was terminated and the PI has|1|||
162620195|NCT04032652|587324989|FG001|Overall Study|The study was terminated and the PI has|1|||
162620196|NCT02663908|587324990|FG000|Overall Study|Withdrawal by Subject|8|||
162620197|NCT02663908|587324991|FG001|Overall Study|Withdrawal by Subject|5|||
162620198|NCT02663908|587324990|FG000|Overall Study|Lost to Follow-up|1|||
162620199|NCT02663908|587324991|FG001|Overall Study|Lost to Follow-up|5|||
162620200|NCT02663908|587324990|FG000|Overall Study|Adverse Event|13|||
162620201|NCT02663908|587324991|FG001|Overall Study|Adverse Event|11|||
162620202|NCT02663908|587324990|FG000|Overall Study|Protocol Violation|1|||
162620203|NCT02663908|587324991|FG001|Overall Study|Protocol Violation|2|||
162620204|NCT02663908|587324990|FG000|Overall Study|Lack of therapeutic response|2|||
162620205|NCT02663908|587324991|FG001|Overall Study|Lack of therapeutic response|0|||
162620206|NCT02663908|587324990|FG000|Overall Study|COVID-19|1|||
162620207|NCT02663908|587324991|FG001|Overall Study|COVID-19|0|||
162620208|NCT02663908|587324990|FG000|Overall Study|Site closed|1|||
162620209|NCT02663908|587324991|FG001|Overall Study|Site closed|0|||
162620210|NCT02663908|587324990|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
162620211|NCT02663908|587324991|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
162620212|NCT02663908|587324990|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
162620213|NCT02663908|587324991|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
162620214|NCT02663908|587324990|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
162620215|NCT02663908|587324991|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
162620216|NCT02663908|587324990|FG000|Overall Study|Death|1|||
162620217|NCT02663908|587324991|FG001|Overall Study|Death|0|||
162620218|NCT02663908|587324990|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
163051311|NCT03258593|588895405|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
163051312|NCT03258593|588895402|FG000|Run-In Maintenance Phase|Disease progression|3|||
162620219|NCT02663908|587324991|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
162620220|NCT02663908|587324990|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
162620221|NCT02663908|587324991|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
162620222|NCT02004522|587324992|FG000|Overall Study|Adverse Event|55|||
162620223|NCT02004522|587324993|FG001|Overall Study|Adverse Event|6|||
162620224|NCT02004522|587324992|FG000|Overall Study|Withdrawal by Subject|13|||
162620225|NCT02004522|587324993|FG001|Overall Study|Withdrawal by Subject|7|||
162620226|NCT02004522|587324992|FG000|Overall Study|Death|12|||
162620227|NCT02004522|587324993|FG001|Overall Study|Death|3|||
162620228|NCT02004522|587324992|FG000|Overall Study|Physician Decision|3|||
162620229|NCT02004522|587324993|FG001|Overall Study|Physician Decision|4|||
162620230|NCT02004522|587324992|FG000|Overall Study|Protocol Violation|1|||
162620231|NCT02004522|587324993|FG001|Overall Study|Protocol Violation|0|||
162620232|NCT02004522|587324992|FG000|Overall Study|Other is reason listed by PI|4|||
162620233|NCT02004522|587324993|FG001|Overall Study|Other is reason listed by PI|1|||
162620234|NCT02004522|587324992|FG000|Overall Study|Never Dosed|2|||
162620235|NCT02004522|587324993|FG001|Overall Study|Never Dosed|4|||
162620236|NCT02004522|587324992|FG000|Overall Study|Disease Progression|35|||
162620237|NCT02004522|587324993|FG001|Overall Study|Disease Progression|31|||
162620238|NCT02004522|587324992|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
162620239|NCT02004522|587324993|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
162620240|NCT02764697|587324997|FG000|Overall Study|Lack of Efficacy|3|||
162620241|NCT00302107|587325000|FG000|Overall Study|Lost to Follow-up|6|||
162620242|NCT00302107|587325001|FG001|Overall Study|Lost to Follow-up|5|||
162620243|NCT00302107|587325000|FG000|Overall Study|Protocol Violation|1|||
162620244|NCT00302107|587325001|FG001|Overall Study|Protocol Violation|0|||
162620245|NCT00302107|587325000|FG000|Overall Study|Relocation|0|||
162620246|NCT00302107|587325001|FG001|Overall Study|Relocation|1|||
162620247|NCT00302107|587325000|FG000|Overall Study|Withdrawal by Subject|0|||
162620248|NCT00302107|587325001|FG001|Overall Study|Withdrawal by Subject|3|||
162620249|NCT00302107|587325000|FG000|Overall Study|Adverse Event|1|||
162620250|NCT00302107|587325001|FG001|Overall Study|Adverse Event|0|||
162620251|NCT00437983|587325002|FG000|Overall Study|Adverse Event|6|||
162620252|NCT00437983|587325003|FG001|Overall Study|Adverse Event|6|||
162620253|NCT00437983|587325002|FG000|Overall Study|Protocol Violation|2|||
162620254|NCT00437983|587325003|FG001|Overall Study|Protocol Violation|1|||
162620255|NCT00437983|587325002|FG000|Overall Study|Withdrawal by Subject|5|||
162620256|NCT00437983|587325003|FG001|Overall Study|Withdrawal by Subject|6|||
162620257|NCT01798004|587327157|FG000|Overall Study|Death|2|||
162620258|NCT01798004|587327157|FG000|Overall Study|Lack of Efficacy|8|||
162620259|NCT01798004|587327157|FG000|Overall Study|Physician Decision|25|||
162620260|NCT01798004|587327157|FG000|Overall Study|Withdrawal by Subject|4|||
162620261|NCT01798004|587327157|FG000|Overall Study|Ineligible|4|||
162620262|NCT01798004|587327157|FG000|Overall Study|Patient/parent refusal|7|||
162620263|NCT01798004|587327157|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
162620264|NCT01798004|587327157|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
162620265|NCT03320057|587327158|FG000|Overall Study|Lost to Follow-up|4|||
162620266|NCT03320057|587327159|FG001|Overall Study|Lost to Follow-up|17|||
162620267|NCT03320057|587327158|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
162620268|NCT03320057|587327159|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
162620269|NCT06956170|587327160|FG000|Overall Study|Death|2|||
162620270|NCT06956170|587327161|FG001|Overall Study|Death|1|||
162620271|NCT06956170|587327160|FG000|Overall Study|Withdrawal by Subject|1|||
162620272|NCT06956170|587327161|FG001|Overall Study|Withdrawal by Subject|0|||
162620273|NCT06956170|587327160|FG000|Overall Study|Ongoing|7|||
162620274|NCT06956170|587327161|FG001|Overall Study|Ongoing|10|||
162620275|NCT02323113|587327162|FG000|Overall Study|Adverse Event|3|||
162620276|NCT02323113|587327163|FG001|Overall Study|Adverse Event|3|||
162620277|NCT02323113|587327164|FG002|Overall Study|Adverse Event|2|||
162620278|NCT02323113|587327165|FG003|Overall Study|Adverse Event|5|||
162620279|NCT02323113|587327166|FG004|Overall Study|Adverse Event|8|||
162620280|NCT02323113|587327167|FG005|Overall Study|Adverse Event|3|||
162890203|NCT02713789|588295398|FG000|Overall Study|Lost to Follow-up|0|||
162620281|NCT02323113|587327168|FG006|Overall Study|Adverse Event|6|||
162620282|NCT02323113|587327169|FG007|Overall Study|Adverse Event|0|||
162620283|NCT02323113|587327162|FG000|Overall Study|Progressive Disease|0|||
162620284|NCT02323113|587327163|FG001|Overall Study|Progressive Disease|1|||
162620285|NCT02323113|587327164|FG002|Overall Study|Progressive Disease|1|||
162620286|NCT02323113|587327165|FG003|Overall Study|Progressive Disease|0|||
162620287|NCT02323113|587327166|FG004|Overall Study|Progressive Disease|0|||
162620288|NCT02323113|587327167|FG005|Overall Study|Progressive Disease|3|||
162620289|NCT02323113|587327168|FG006|Overall Study|Progressive Disease|0|||
162620290|NCT02323113|587327169|FG007|Overall Study|Progressive Disease|0|||
162620291|NCT02323113|587327162|FG000|Overall Study|Symptomatic Deterioration|0|||
162620292|NCT02323113|587327163|FG001|Overall Study|Symptomatic Deterioration|0|||
162620293|NCT02323113|587327164|FG002|Overall Study|Symptomatic Deterioration|1|||
162890204|NCT02713789|588295399|FG001|Overall Study|Lost to Follow-up|1|||
162620294|NCT02323113|587327165|FG003|Overall Study|Symptomatic Deterioration|0|||
162620295|NCT02323113|587327166|FG004|Overall Study|Symptomatic Deterioration|1|||
162620296|NCT02323113|587327167|FG005|Overall Study|Symptomatic Deterioration|0|||
162620297|NCT02323113|587327168|FG006|Overall Study|Symptomatic Deterioration|0|||
162620298|NCT02323113|587327169|FG007|Overall Study|Symptomatic Deterioration|0|||
162620299|NCT02323113|587327162|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
162620300|NCT02323113|587327163|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
162620301|NCT02323113|587327164|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162620302|NCT02323113|587327165|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162620303|NCT02323113|587327166|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
162620304|NCT02323113|587327167|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
162620305|NCT02323113|587327168|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162620306|NCT02323113|587327169|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
162620307|NCT02323113|587327162|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620308|NCT02323113|587327163|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
162620309|NCT02323113|587327164|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620310|NCT02323113|587327165|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620311|NCT02323113|587327166|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620312|NCT02323113|587327167|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620313|NCT02323113|587327168|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620314|NCT02323113|587327169|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162620315|NCT02280304|587327174|FG000|Overall Study|Lost to Follow-up|7|||
162620316|NCT02280304|587327175|FG001|Overall Study|Lost to Follow-up|8|||
162620317|NCT04805541|587327176|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
162620318|NCT00713323|587327187|FG000|Overall Study|Adverse Event|75|||
162620319|NCT00713323|587327187|FG000|Overall Study|Withdrawal by Subject|15|||
162620320|NCT00713323|587327187|FG000|Overall Study|Lost to Follow-up|11|||
162620321|NCT00713323|587327187|FG000|Overall Study|Lack of Efficacy|36|||
162620322|NCT00713323|587327187|FG000|Overall Study|Low creatine clearance at screening|1|||
162620323|NCT00713323|587327187|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
162620324|NCT00713323|587327187|FG000|Overall Study|Surgery cured allodynic pain|1|||
162620325|NCT00713323|587327187|FG000|Overall Study|Pain free|1|||
162620326|NCT00713323|587327187|FG000|Overall Study|Non-compliance|1|||
162620327|NCT00713323|587327187|FG000|Overall Study|Pain resolved|1|||
162620328|NCT00713323|587327187|FG000|Overall Study|Subject travelling to USA|1|||
162620329|NCT00713323|587327187|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
162620330|NCT00713323|587327187|FG000|Overall Study|Treatment that may interact with Sativex|1|||
162620331|NCT05154578|587327188|FG000|Overall Study|Withdrawal by Subject|2|||
162620332|NCT05154578|587327189|FG001|Overall Study|Withdrawal by Subject|3|||
162620333|NCT05154578|587327190|FG002|Overall Study|Withdrawal by Subject|2|||
162620334|NCT05154578|587327191|FG003|Overall Study|Withdrawal by Subject|4|||
162620335|NCT05154578|587327192|FG004|Overall Study|Withdrawal by Subject|0|||
162620336|NCT05154578|587327188|FG000|Overall Study|Lost to Follow-up|0|||
162620337|NCT05154578|587327189|FG001|Overall Study|Lost to Follow-up|1|||
162620338|NCT05154578|587327190|FG002|Overall Study|Lost to Follow-up|0|||
162620339|NCT05154578|587327191|FG003|Overall Study|Lost to Follow-up|3|||
162620340|NCT05154578|587327192|FG004|Overall Study|Lost to Follow-up|0|||
162620341|NCT05154578|587327188|FG000|Overall Study|Adverse Event|0|||
162620342|NCT05154578|587327189|FG001|Overall Study|Adverse Event|0|||
162620343|NCT05154578|587327190|FG002|Overall Study|Adverse Event|0|||
162620344|NCT05154578|587327191|FG003|Overall Study|Adverse Event|1|||
162620345|NCT05154578|587327192|FG004|Overall Study|Adverse Event|0|||
162620346|NCT05154578|587327188|FG000|Overall Study|Relocated to another province|0|||
162620347|NCT05154578|587327189|FG001|Overall Study|Relocated to another province|0|||
162620348|NCT05154578|587327190|FG002|Overall Study|Relocated to another province|1|||
162620349|NCT05154578|587327191|FG003|Overall Study|Relocated to another province|0|||
162620350|NCT05154578|587327192|FG004|Overall Study|Relocated to another province|1|||
162620351|NCT05154578|587327188|FG000|Overall Study|Baby loss|0|||
162620352|NCT05154578|587327189|FG001|Overall Study|Baby loss|1|||
162620353|NCT05154578|587327190|FG002|Overall Study|Baby loss|0|||
162620354|NCT05154578|587327191|FG003|Overall Study|Baby loss|0|||
162620355|NCT05154578|587327192|FG004|Overall Study|Baby loss|0|||
162620356|NCT01146912|587327193|FG000|Overall Study|Already received influenza vaccination|817|||
162620357|NCT01146912|587327194|FG001|Overall Study|Already received influenza vaccination|822|||
162620358|NCT01146912|587327195|FG002|Overall Study|Already received influenza vaccination|13|||
162620359|NCT01146912|587327196|FG003|Overall Study|Already received influenza vaccination|15|||
162890205|NCT02713789|588295400|FG002|Overall Study|Lost to Follow-up|1|||
162890206|NCT00141037|588295408|FG000|Overall Study|Physician Decision|1|||
162890207|NCT00141037|588295409|FG001|Overall Study|Physician Decision|2|||
162890208|NCT00141037|588295408|FG000|Overall Study|Lost to Follow-up|3|||
162620360|NCT01146912|587327197|FG004|Overall Study|Already received influenza vaccination|41|||
162620361|NCT01146912|587327198|FG005|Overall Study|Already received influenza vaccination|61|||
162620362|NCT01146912|587327199|FG006|Overall Study|Already received influenza vaccination|56|||
162620363|NCT01146912|587327200|FG007|Overall Study|Already received influenza vaccination|0|||
162620364|NCT01146912|587327193|FG000|Overall Study|< 14 weeks gestational age|0|||
162620365|NCT01146912|587327194|FG001|Overall Study|< 14 weeks gestational age|0|||
162620366|NCT01146912|587327195|FG002|Overall Study|< 14 weeks gestational age|3|||
162620367|NCT01146912|587327196|FG003|Overall Study|< 14 weeks gestational age|2|||
162620368|NCT01146912|587327197|FG004|Overall Study|< 14 weeks gestational age|0|||
162620369|NCT01146912|587327198|FG005|Overall Study|< 14 weeks gestational age|0|||
162620370|NCT01146912|587327199|FG006|Overall Study|< 14 weeks gestational age|0|||
162620371|NCT01146912|587327200|FG007|Overall Study|< 14 weeks gestational age|0|||
162620372|NCT01146912|587327193|FG000|Overall Study|Duplicate patient|0|||
162620373|NCT01146912|587327194|FG001|Overall Study|Duplicate patient|0|||
162620374|NCT01146912|587327195|FG002|Overall Study|Duplicate patient|1|||
162620375|NCT01146912|587327196|FG003|Overall Study|Duplicate patient|0|||
162620376|NCT01146912|587327197|FG004|Overall Study|Duplicate patient|0|||
162620377|NCT01146912|587327198|FG005|Overall Study|Duplicate patient|0|||
162620378|NCT01146912|587327199|FG006|Overall Study|Duplicate patient|0|||
162620379|NCT01146912|587327200|FG007|Overall Study|Duplicate patient|0|||
162620380|NCT02980783|587327201|FG000|Overall Study|Lost to Follow-up|1|||
162620381|NCT00880542|587327202|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
162620382|NCT00880542|587327202|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
162620383|NCT00880542|587327202|FG000|REP: Surgical Resection|progressive disease|1|||
162620384|NCT05047770|587327203|FG000|Overall Study|Withdrawal by Subject|15|||
162620385|NCT05047770|587327204|FG001|Overall Study|Withdrawal by Subject|10|||
162620386|NCT05047770|587327205|FG002|Overall Study|Withdrawal by Subject|6|||
162620387|NCT05047770|587327206|FG003|Overall Study|Withdrawal by Subject|12|||
162620388|NCT05047770|587327203|FG000|Overall Study|Lost to Follow-up|7|||
162620389|NCT05047770|587327204|FG001|Overall Study|Lost to Follow-up|5|||
162620390|NCT05047770|587327205|FG002|Overall Study|Lost to Follow-up|12|||
162890209|NCT00141037|588295409|FG001|Overall Study|Lost to Follow-up|1|||
162890210|NCT00141037|588295408|FG000|Overall Study|Protocol Violation|0|||
162890211|NCT00141037|588295409|FG001|Overall Study|Protocol Violation|2|||
162890212|NCT00141037|588295408|FG000|Overall Study|Withdrawal by Subject|2|||
162890213|NCT00141037|588295409|FG001|Overall Study|Withdrawal by Subject|1|||
162890214|NCT00141037|588295408|FG000|Overall Study|Other|0|||
162890215|NCT00141037|588295409|FG001|Overall Study|Other|1|||
162890216|NCT00141037|588295408|FG000|Overall Study|Moved from area|1|||
162890217|NCT00141037|588295409|FG001|Overall Study|Moved from area|7|||
162890218|NCT00141037|588295408|FG000|Overall Study|Graft Failure|3|||
162890219|NCT00141037|588295409|FG001|Overall Study|Graft Failure|4|||
162890220|NCT00888615|588295410|FG000|Overall Study|No treatment|2|||
162890221|NCT00861380|588295411|FG000|Overall Study|Withdrawal Information not recorded|8427|||
162890222|NCT00861380|588295412|FG001|Overall Study|Withdrawal Information not recorded|9112|||
162890223|NCT00861380|588295413|FG002|Overall Study|Withdrawal Information not recorded|8872|||
162890224|NCT00861380|588295414|FG003|Overall Study|Withdrawal Information not recorded|3689|||
162890225|NCT00861380|588295415|FG004|Overall Study|Withdrawal Information not recorded|1812|||
162890226|NCT00861380|588295416|FG005|Overall Study|Withdrawal Information not recorded|6249|||
162890227|NCT00861380|588295417|FG006|Overall Study|Withdrawal Information not recorded|3020|||
162890228|NCT00637377|588295418|FG000|Overall Study|Adverse Event|2|||
162890229|NCT00637377|588295419|FG001|Overall Study|Adverse Event|6|||
162890230|NCT00637377|588295420|FG002|Overall Study|Adverse Event|8|||
162890231|NCT00637377|588295421|FG003|Overall Study|Adverse Event|9|||
162890232|NCT00637377|588295418|FG000|Overall Study|Death|1|||
162890233|NCT00637377|588295419|FG001|Overall Study|Death|3|||
162890234|NCT00637377|588295420|FG002|Overall Study|Death|2|||
162890235|NCT00637377|588295421|FG003|Overall Study|Death|1|||
162890236|NCT00637377|588295418|FG000|Overall Study|Lack of Efficacy|0|||
162890237|NCT00637377|588295419|FG001|Overall Study|Lack of Efficacy|0|||
162890238|NCT00637377|588295420|FG002|Overall Study|Lack of Efficacy|1|||
162890239|NCT00637377|588295421|FG003|Overall Study|Lack of Efficacy|1|||
162890240|NCT00637377|588295418|FG000|Overall Study|Lost to Follow-up|4|||
162890241|NCT00637377|588295419|FG001|Overall Study|Lost to Follow-up|1|||
162890242|NCT00637377|588295420|FG002|Overall Study|Lost to Follow-up|2|||
162890243|NCT00637377|588295421|FG003|Overall Study|Lost to Follow-up|2|||
162890244|NCT00637377|588295418|FG000|Overall Study|Protocol Violation|2|||
162890245|NCT00637377|588295419|FG001|Overall Study|Protocol Violation|1|||
162890246|NCT00637377|588295420|FG002|Overall Study|Protocol Violation|1|||
162890247|NCT00637377|588295421|FG003|Overall Study|Protocol Violation|0|||
162890248|NCT00637377|588295418|FG000|Overall Study|Withdrawal by Subject|11|||
162890249|NCT00637377|588295419|FG001|Overall Study|Withdrawal by Subject|15|||
162890250|NCT00637377|588295420|FG002|Overall Study|Withdrawal by Subject|13|||
162890251|NCT00637377|588295421|FG003|Overall Study|Withdrawal by Subject|11|||
162890252|NCT00637377|588295418|FG000|Overall Study|Other (no further information available)|7|||
162890253|NCT00637377|588295419|FG001|Overall Study|Other (no further information available)|6|||
162890254|NCT00637377|588295420|FG002|Overall Study|Other (no further information available)|10|||
162620391|NCT05047770|587327206|FG003|Overall Study|Lost to Follow-up|13|||
162620392|NCT05047770|587327203|FG000|Overall Study|Other|1|||
162620393|NCT05047770|587327204|FG001|Overall Study|Other|0|||
162620394|NCT05047770|587327205|FG002|Overall Study|Other|1|||
162620395|NCT05047770|587327206|FG003|Overall Study|Other|0|||
162620396|NCT01772160|587327207|FG000|Overall Study|Death|3|||
162620397|NCT01772160|587327207|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
162620398|NCT01772160|587327207|FG000|Overall Study|Consent withdrawal|3|||
162620399|NCT01772160|587327207|FG000|Overall Study|Migrated / moved from the study area|4|||
162620400|NCT01772160|587327207|FG000|Overall Study|Lost to Follow-up|30|||
162620401|NCT01772160|587327207|FG000|Overall Study|Other|5|||
162620402|NCT02202980|587327208|FG000|Overall Study|Lack of Efficacy|1|||
162620403|NCT02202980|587327209|FG001|Overall Study|Lack of Efficacy|0|||
162620404|NCT02202980|587327210|FG002|Overall Study|Lack of Efficacy|7|||
162620405|NCT02202980|587327211|FG003|Overall Study|Lack of Efficacy|0|||
162620406|NCT02202980|587327212|FG004|Overall Study|Lack of Efficacy|3|||
162620407|NCT02202980|587327213|FG005|Overall Study|Lack of Efficacy|1|||
162620408|NCT02202980|587327214|FG006|Overall Study|Lack of Efficacy|11|||
162620409|NCT02202980|587327215|FG007|Overall Study|Lack of Efficacy|2|||
162620410|NCT02202980|587327216|FG008|Overall Study|Lack of Efficacy|2|||
162620411|NCT02202980|587327217|FG009|Overall Study|Lack of Efficacy|0|||
162620412|NCT02202980|587327218|FG010|Overall Study|Lack of Efficacy|0|||
162620413|NCT02202980|587327219|FG011|Overall Study|Lack of Efficacy|3|||
162620414|NCT02202980|587327220|FG012|Overall Study|Lack of Efficacy|10|||
162620415|NCT02202980|587327221|FG013|Overall Study|Lack of Efficacy|0|||
162620416|NCT02202980|587327208|FG000|Overall Study|Protocol Violation|0|||
162620417|NCT02202980|587327209|FG001|Overall Study|Protocol Violation|0|||
162620418|NCT02202980|587327210|FG002|Overall Study|Protocol Violation|0|||
162620419|NCT02202980|587327211|FG003|Overall Study|Protocol Violation|3|||
162620420|NCT02202980|587327212|FG004|Overall Study|Protocol Violation|3|||
162620421|NCT02202980|587327213|FG005|Overall Study|Protocol Violation|0|||
162620422|NCT02202980|587327214|FG006|Overall Study|Protocol Violation|0|||
162620423|NCT02202980|587327215|FG007|Overall Study|Protocol Violation|0|||
162620424|NCT02202980|587327216|FG008|Overall Study|Protocol Violation|0|||
162620425|NCT02202980|587327217|FG009|Overall Study|Protocol Violation|0|||
162620426|NCT02202980|587327218|FG010|Overall Study|Protocol Violation|0|||
162620427|NCT02202980|587327219|FG011|Overall Study|Protocol Violation|0|||
162620428|NCT02202980|587327220|FG012|Overall Study|Protocol Violation|0|||
162620429|NCT02202980|587327221|FG013|Overall Study|Protocol Violation|0|||
162620430|NCT02202980|587327208|FG000|Overall Study|Lost to Follow-up|0|||
162620431|NCT02202980|587327209|FG001|Overall Study|Lost to Follow-up|1|||
162620432|NCT02202980|587327210|FG002|Overall Study|Lost to Follow-up|1|||
162620433|NCT02202980|587327211|FG003|Overall Study|Lost to Follow-up|1|||
162620434|NCT02202980|587327212|FG004|Overall Study|Lost to Follow-up|0|||
162620435|NCT02202980|587327213|FG005|Overall Study|Lost to Follow-up|0|||
162620436|NCT02202980|587327214|FG006|Overall Study|Lost to Follow-up|0|||
162620437|NCT02202980|587327215|FG007|Overall Study|Lost to Follow-up|1|||
162620438|NCT02202980|587327216|FG008|Overall Study|Lost to Follow-up|1|||
162620439|NCT02202980|587327217|FG009|Overall Study|Lost to Follow-up|0|||
162620440|NCT02202980|587327218|FG010|Overall Study|Lost to Follow-up|0|||
162620441|NCT02202980|587327219|FG011|Overall Study|Lost to Follow-up|0|||
162620442|NCT02202980|587327220|FG012|Overall Study|Lost to Follow-up|1|||
162620443|NCT02202980|587327221|FG013|Overall Study|Lost to Follow-up|0|||
162620444|NCT02202980|587327208|FG000|Overall Study|Withdrew Consent|0|||
162620445|NCT02202980|587327209|FG001|Overall Study|Withdrew Consent|1|||
162620446|NCT02202980|587327210|FG002|Overall Study|Withdrew Consent|2|||
162620447|NCT02202980|587327211|FG003|Overall Study|Withdrew Consent|0|||
162620448|NCT02202980|587327212|FG004|Overall Study|Withdrew Consent|0|||
162620449|NCT02202980|587327213|FG005|Overall Study|Withdrew Consent|0|||
162620450|NCT02202980|587327214|FG006|Overall Study|Withdrew Consent|0|||
162620451|NCT02202980|587327215|FG007|Overall Study|Withdrew Consent|0|||
162620452|NCT02202980|587327216|FG008|Overall Study|Withdrew Consent|1|||
162620453|NCT02202980|587327217|FG009|Overall Study|Withdrew Consent|0|||
162620454|NCT02202980|587327218|FG010|Overall Study|Withdrew Consent|0|||
162620455|NCT02202980|587327219|FG011|Overall Study|Withdrew Consent|0|||
162620456|NCT02202980|587327220|FG012|Overall Study|Withdrew Consent|0|||
162620457|NCT02202980|587327221|FG013|Overall Study|Withdrew Consent|0|||
162620458|NCT01952145|587327222|FG000|Overall Study|Protocol Violation|2|||
162620459|NCT01952145|587327223|FG001|Overall Study|Protocol Violation|1|||
162620460|NCT01952145|587327222|FG000|Overall Study|Death|0|||
162620461|NCT01952145|587327223|FG001|Overall Study|Death|1|||
162620462|NCT01952145|587327222|FG000|Overall Study|Adverse Event|9|||
162620463|NCT01952145|587327223|FG001|Overall Study|Adverse Event|0|||
162620464|NCT01952145|587327222|FG000|Overall Study|Withdrawal Criteria|16|||
162620465|NCT01952145|587327223|FG001|Overall Study|Withdrawal Criteria|11|||
162620466|NCT01952145|587327222|FG000|Overall Study|Unclassified|1|||
162620467|NCT01952145|587327223|FG001|Overall Study|Unclassified|1|||
162620468|NCT01540838|587327227|FG000|Overall Study|Open nasogastric tube|9|||
162620469|NCT01540838|587327228|FG001|Overall Study|Open nasogastric tube|7|||
162620470|NCT01540838|587327227|FG000|Overall Study|Treatment doses missing|8|||
162620471|NCT01540838|587327228|FG001|Overall Study|Treatment doses missing|12|||
162620472|NCT01540838|587327227|FG000|Overall Study|Additional antibiotic treatment|1|||
162620473|NCT01540838|587327228|FG001|Overall Study|Additional antibiotic treatment|2|||
162620474|NCT01540838|587327227|FG000|Overall Study|Died before treatment initiation|1|||
162620475|NCT01540838|587327228|FG001|Overall Study|Died before treatment initiation|1|||
162620476|NCT01540838|587327227|FG000|Overall Study|Not BM. Other treatment|3|||
162620477|NCT01540838|587327228|FG001|Overall Study|Not BM. Other treatment|1|||
162620478|NCT02130570|587327229|FG000|Overall Study|Death|3|||
162620479|NCT02130570|587327230|FG001|Overall Study|Death|5|||
162620480|NCT02130570|587327229|FG000|Overall Study|Withdrawal by Subject|6|||
162620481|NCT02130570|587327230|FG001|Overall Study|Withdrawal by Subject|3|||
162620482|NCT02130570|587327229|FG000|Overall Study|Part of practice that discontinued study|0|||
162620483|NCT02130570|587327230|FG001|Overall Study|Part of practice that discontinued study|5|||
162620484|NCT02808650|587327240|FG000|Overall Study|Death|0|||
162620485|NCT02808650|587327241|FG001|Overall Study|Death|0|||
162620486|NCT02808650|587327242|FG002|Overall Study|Death|0|||
162620487|NCT02808650|587327243|FG003|Overall Study|Death|0|||
162620488|NCT02808650|587327244|FG004|Overall Study|Death|1|||
162620489|NCT02808650|587327240|FG000|Overall Study|Lack of Efficacy|5|||
162620490|NCT02808650|587327241|FG001|Overall Study|Lack of Efficacy|5|||
162620491|NCT02808650|587327242|FG002|Overall Study|Lack of Efficacy|6|||
162620492|NCT02808650|587327243|FG003|Overall Study|Lack of Efficacy|5|||
162620493|NCT02808650|587327244|FG004|Overall Study|Lack of Efficacy|4|||
162620494|NCT02808650|587327240|FG000|Overall Study|Physician Decision|1|||
162620495|NCT02808650|587327241|FG001|Overall Study|Physician Decision|1|||
162620496|NCT02808650|587327242|FG002|Overall Study|Physician Decision|0|||
162620497|NCT02808650|587327243|FG003|Overall Study|Physician Decision|0|||
162620498|NCT02808650|587327244|FG004|Overall Study|Physician Decision|0|||
162620499|NCT02808650|587327240|FG000|Overall Study|Withdrawal by Subject|0|||
162620500|NCT02808650|587327241|FG001|Overall Study|Withdrawal by Subject|0|||
162620501|NCT02808650|587327242|FG002|Overall Study|Withdrawal by Subject|0|||
162620502|NCT02808650|587327243|FG003|Overall Study|Withdrawal by Subject|1|||
162620503|NCT02808650|587327244|FG004|Overall Study|Withdrawal by Subject|1|||
162620504|NCT04889222|587327250|FG000|Overall Study|Did not meet eligibility criteria|8|||
162620505|NCT04889222|587327250|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
163051313|NCT03258593|588895403|FG001|Run-In Maintenance Phase|Disease progression|0|||
163051314|NCT03258593|588895404|FG002|Run-In Maintenance Phase|Disease progression|0|||
163051315|NCT03258593|588895405|FG003|Run-In Maintenance Phase|Disease progression|0|||
163051316|NCT03258593|588895402|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051317|NCT03258593|588895403|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
163051318|NCT03258593|588895404|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051319|NCT03258593|588895405|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
163051320|NCT03258593|588895402|FG000|Expansion Maintenance Phase|Physician Decision|0|||
163051321|NCT03258593|588895403|FG001|Expansion Maintenance Phase|Physician Decision|1|||
163051322|NCT03258593|588895404|FG002|Expansion Maintenance Phase|Physician Decision|0|||
163051323|NCT03258593|588895405|FG003|Expansion Maintenance Phase|Physician Decision|0|||
163051324|NCT05457257|588895412|FG000|Overall Study|Withdrawal by Subject|0|||
162620506|NCT04889222|587327250|FG000|Overall Study|Did not proceed due to time constraints|5|||
162620507|NCT01180647|587327251|FG000|Overall Study|Lost to Follow-up|5|||
162620508|NCT01180647|587327252|FG001|Overall Study|Lost to Follow-up|6|||
162620509|NCT00071396|587327259|FG000|Overall Study|Withdrawal by Subject|1|||
162620510|NCT00071396|587327259|FG000|Overall Study|Physician Decision|2|||
162620511|NCT04545554|587327260|FG000|Overall Study|Withdrawal by Subject|0|||
162620512|NCT04545554|587327261|FG001|Overall Study|Withdrawal by Subject|0|||
162620513|NCT04545554|587327262|FG002|Overall Study|Withdrawal by Subject|0|||
162620514|NCT04545554|587327263|FG003|Overall Study|Withdrawal by Subject|1|||
162620515|NCT04545554|587327264|FG004|Overall Study|Withdrawal by Subject|0|||
162620516|NCT04545554|587327265|FG005|Overall Study|Withdrawal by Subject|0|||
162620517|NCT02639546|587327266|FG000|Overall Study|Death|2|||
162620518|NCT02639546|587327267|FG001|Overall Study|Death|2|||
162620519|NCT02639546|587327268|FG002|Overall Study|Death|1|||
162620520|NCT02639546|587327269|FG003|Overall Study|Death|2|||
162620521|NCT02639546|587327270|FG004|Overall Study|Death|2|||
162620522|NCT02639546|587327271|FG005|Overall Study|Death|2|||
162620523|NCT02639546|587327272|FG006|Overall Study|Death|0|||
162620524|NCT02639546|587327273|FG007|Overall Study|Death|0|||
162620525|NCT02639546|587327266|FG000|Overall Study|Lost to Follow-up|0|||
162620526|NCT02639546|587327267|FG001|Overall Study|Lost to Follow-up|0|||
162620527|NCT02639546|587327268|FG002|Overall Study|Lost to Follow-up|1|||
162620528|NCT02639546|587327269|FG003|Overall Study|Lost to Follow-up|0|||
162620529|NCT02639546|587327270|FG004|Overall Study|Lost to Follow-up|1|||
162620530|NCT02639546|587327271|FG005|Overall Study|Lost to Follow-up|1|||
162620531|NCT02639546|587327272|FG006|Overall Study|Lost to Follow-up|0|||
162620532|NCT02639546|587327273|FG007|Overall Study|Lost to Follow-up|1|||
162620533|NCT02639546|587327266|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
162620534|NCT02639546|587327267|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
162620535|NCT02639546|587327268|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
162620536|NCT02639546|587327269|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
162620537|NCT02639546|587327270|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
162620538|NCT02639546|587327271|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
162620539|NCT02639546|587327272|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
162620540|NCT02639546|587327273|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
163051325|NCT05457257|588895413|FG001|Overall Study|Withdrawal by Subject|2|||
163051326|NCT05457257|588895412|FG000|Overall Study|Death|10|||
163051327|NCT05457257|588895413|FG001|Overall Study|Death|3|||
163051328|NCT05457257|588895412|FG000|Overall Study|Ongoing|19|||
163051329|NCT05457257|588895413|FG001|Overall Study|Ongoing|9|||
163051330|NCT02131064|588895418|FG000|Overall Study|Death|5|||
163051331|NCT02131064|588895419|FG001|Overall Study|Death|6|||
163051332|NCT02131064|588895418|FG000|Overall Study|Lost to Follow-up|4|||
163051333|NCT02131064|588895419|FG001|Overall Study|Lost to Follow-up|8|||
163051334|NCT02131064|588895418|FG000|Overall Study|Withdrawal by Subject|14|||
163051335|NCT02131064|588895419|FG001|Overall Study|Withdrawal by Subject|18|||
163051336|NCT02131064|588895418|FG000|Overall Study|Other|2|||
163051337|NCT02131064|588895419|FG001|Overall Study|Other|2|||
163051338|NCT00593918|588895422|FG000|Overall Study|Withdrawal by Subject|5|||
163051339|NCT00593918|588895423|FG001|Overall Study|Withdrawal by Subject|24|||
163051340|NCT00871234|588895430|FG000|Overall Study|Adverse Event|2|||
163051341|NCT00871234|588895430|FG000|Overall Study|Lost to Follow-up|3|||
162620541|NCT02639546|587327266|FG000|Overall Study|Study Terminated By Sponsor|0|||
162620542|NCT02639546|587327267|FG001|Overall Study|Study Terminated By Sponsor|2|||
162620543|NCT02639546|587327268|FG002|Overall Study|Study Terminated By Sponsor|3|||
162620544|NCT02639546|587327269|FG003|Overall Study|Study Terminated By Sponsor|4|||
162620545|NCT02639546|587327270|FG004|Overall Study|Study Terminated By Sponsor|4|||
162620546|NCT02639546|587327271|FG005|Overall Study|Study Terminated By Sponsor|3|||
162620547|NCT02639546|587327272|FG006|Overall Study|Study Terminated By Sponsor|3|||
163051342|NCT04344301|588895432|FG000|Overall Study|Withdrawal by Subject|1|||
163051343|NCT04344301|588895433|FG001|Overall Study|Withdrawal by Subject|0|||
163051344|NCT04344301|588895432|FG000|Overall Study|Death|0|||
163051345|NCT04344301|588895433|FG001|Overall Study|Death|1|||
162620548|NCT02639546|587327273|FG007|Overall Study|Study Terminated By Sponsor|9|||
163051346|NCT00072410|588895434|FG000|Overall Study|Progressive disease|0|||
162620549|NCT02639546|587327266|FG000|Overall Study|Withdrawal by Subject|2|||
162620550|NCT02639546|587327267|FG001|Overall Study|Withdrawal by Subject|2|||
162620551|NCT02639546|587327268|FG002|Overall Study|Withdrawal by Subject|1|||
162620552|NCT02639546|587327269|FG003|Overall Study|Withdrawal by Subject|0|||
162620553|NCT02639546|587327270|FG004|Overall Study|Withdrawal by Subject|0|||
162620554|NCT02639546|587327271|FG005|Overall Study|Withdrawal by Subject|1|||
162620555|NCT02639546|587327272|FG006|Overall Study|Withdrawal by Subject|2|||
162620556|NCT02639546|587327273|FG007|Overall Study|Withdrawal by Subject|1|||
162620557|NCT02478372|587327274|FG000|Overall Study|Protocol Violation|12|||
162620558|NCT02478372|587327275|FG001|Overall Study|Protocol Violation|8|||
162620559|NCT02478372|587327274|FG000|Overall Study|Lost to Follow-up|1|||
162620560|NCT02478372|587327275|FG001|Overall Study|Lost to Follow-up|4|||
162620561|NCT02478372|587327274|FG000|Overall Study|Death|0|||
162620562|NCT02478372|587327275|FG001|Overall Study|Death|2|||
162620563|NCT00116428|587327276|FG000|Overall Study|Withdrawal by Subject|2|||
162620564|NCT00116428|587327277|FG001|Overall Study|Withdrawal by Subject|5|||
162620565|NCT00116428|587327276|FG000|Overall Study|Did not meet inclusion criteria|1|||
162620566|NCT00116428|587327277|FG001|Overall Study|Did not meet inclusion criteria|0|||
162620567|NCT01032174|587327278|FG000|Overall Study|Adverse Event|0|||
162620568|NCT01032174|587327279|FG001|Overall Study|Adverse Event|1|||
162620569|NCT00113087|587327280|FG000|Overall Study|Death or Transplant|14|||
162620570|NCT00113087|587327281|FG001|Overall Study|Death or Transplant|16|||
162620571|NCT00113087|587327280|FG000|Overall Study|Family or MD withdrew subject|10|||
162620572|NCT00113087|587327281|FG001|Overall Study|Family or MD withdrew subject|5|||
162620573|NCT00386607|587327282|FG000|Core|Adverse Event|40|||
162620574|NCT00386607|587327283|FG001|Core|Adverse Event|0|||
162620575|NCT00386607|587327282|FG000|Core|Abnormal laboratory value(s)|3|||
162620576|NCT00386607|587327283|FG001|Core|Abnormal laboratory value(s)|0|||
162620577|NCT00386607|587327282|FG000|Core|Unsatisfactory therapeutic effect|23|||
162620578|NCT00386607|587327283|FG001|Core|Unsatisfactory therapeutic effect|0|||
162620579|NCT00386607|587327282|FG000|Core|Condition no longer requires study drug|4|||
162620580|NCT00386607|587327283|FG001|Core|Condition no longer requires study drug|0|||
162620581|NCT00386607|587327282|FG000|Core|Patient withdrew consent|15|||
162620582|NCT00386607|587327283|FG001|Core|Patient withdrew consent|0|||
162620583|NCT00386607|587327282|FG000|Core|Lost to Follow-up|23|||
162620584|NCT00386607|587327283|FG001|Core|Lost to Follow-up|0|||
162620585|NCT00386607|587327282|FG000|Core|Administrative problems|1|||
162620586|NCT00386607|587327283|FG001|Core|Administrative problems|0|||
162620587|NCT00386607|587327282|FG000|Core|Protocol Deviation|6|||
162620588|NCT00386607|587327283|FG001|Core|Protocol Deviation|0|||
162620589|NCT00386607|587327282|FG000|Extension|Adverse Event|0|||
162620590|NCT00386607|587327283|FG001|Extension|Adverse Event|6|||
162620591|NCT00386607|587327282|FG000|Extension|Abnormal laboratory value(s)|0|||
162620592|NCT00386607|587327283|FG001|Extension|Abnormal laboratory value(s)|1|||
162620593|NCT00386607|587327282|FG000|Extension|Administrative problems|0|||
162620594|NCT00386607|587327283|FG001|Extension|Administrative problems|1|||
162620595|NCT00386607|587327282|FG000|Extension|Lost to Follow-up|0|||
162620596|NCT00386607|587327283|FG001|Extension|Lost to Follow-up|3|||
162620597|NCT00386607|587327282|FG000|Extension|Patient withdrew consent|0|||
162620598|NCT00386607|587327283|FG001|Extension|Patient withdrew consent|5|||
162620599|NCT00386607|587327282|FG000|Extension|Unsatisfactory therapeutic effect|0|||
162620600|NCT00386607|587327283|FG001|Extension|Unsatisfactory therapeutic effect|1|||
162620601|NCT02713204|587327284|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
162620602|NCT02713204|587327285|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620603|NCT02713204|587327286|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
162620604|NCT02713204|587327287|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620605|NCT02713204|587327288|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620606|NCT02713204|587327289|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620607|NCT02713204|587327290|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620608|NCT02713204|587327291|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162620609|NCT02713204|587327284|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620610|NCT02713204|587327285|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620611|NCT02713204|587327286|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
162620612|NCT02713204|587327287|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620613|NCT02713204|587327288|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620614|NCT02713204|587327289|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162964247|NCT02554877|588569715|FG000|Overall Study|Insufficient clinical response|4|||
162620615|NCT02713204|587327290|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620616|NCT02713204|587327291|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162620617|NCT02713204|587327284|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620618|NCT02713204|587327285|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
162620619|NCT02713204|587327286|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620620|NCT02713204|587327287|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620621|NCT02713204|587327288|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620622|NCT02713204|587327289|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620623|NCT02713204|587327290|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620624|NCT02713204|587327291|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162620625|NCT02713204|587327284|FG000|From Week 12 up to Week 36|Adverse Event|1|||
162620626|NCT02713204|587327285|FG001|From Week 12 up to Week 36|Adverse Event|0|||
162620627|NCT02713204|587327286|FG002|From Week 12 up to Week 36|Adverse Event|0|||
162620628|NCT02713204|587327287|FG003|From Week 12 up to Week 36|Adverse Event|1|||
162620629|NCT02713204|587327288|FG004|From Week 12 up to Week 36|Adverse Event|1|||
162620630|NCT02713204|587327289|FG005|From Week 12 up to Week 36|Adverse Event|0|||
162620631|NCT02713204|587327290|FG006|From Week 12 up to Week 36|Adverse Event|2|||
162620632|NCT02713204|587327291|FG007|From Week 12 up to Week 36|Adverse Event|1|||
162620633|NCT02713204|587327284|FG000|From Week 12 up to Week 36|Death|0|||
162620634|NCT02713204|587327285|FG001|From Week 12 up to Week 36|Death|0|||
162620635|NCT02713204|587327286|FG002|From Week 12 up to Week 36|Death|0|||
162620636|NCT02713204|587327287|FG003|From Week 12 up to Week 36|Death|1|||
162620637|NCT02713204|587327288|FG004|From Week 12 up to Week 36|Death|0|||
162620638|NCT02713204|587327289|FG005|From Week 12 up to Week 36|Death|1|||
162620639|NCT02713204|587327290|FG006|From Week 12 up to Week 36|Death|0|||
162620640|NCT02713204|587327291|FG007|From Week 12 up to Week 36|Death|3|||
162620641|NCT02713204|587327284|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620642|NCT02713204|587327285|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620643|NCT02713204|587327286|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620644|NCT02713204|587327287|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
162620645|NCT02713204|587327288|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620646|NCT02713204|587327289|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620647|NCT02713204|587327290|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620648|NCT02713204|587327291|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
162620649|NCT02713204|587327284|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
162620650|NCT02713204|587327285|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
162620651|NCT02713204|587327286|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
162620652|NCT02713204|587327287|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
162620653|NCT02713204|587327288|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
162620654|NCT02713204|587327289|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
162620655|NCT02713204|587327290|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
162620656|NCT02713204|587327291|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
162620657|NCT00474760|587327295|FG000|Overall Study|Death|0|||
162620658|NCT00474760|587327296|FG001|Overall Study|Death|0|||
162620659|NCT00474760|587327297|FG002|Overall Study|Death|0|||
162620660|NCT00474760|587327298|FG003|Overall Study|Death|0|||
162620661|NCT00474760|587327299|FG004|Overall Study|Death|2|||
162620662|NCT00474760|587327300|FG005|Overall Study|Death|0|||
162620663|NCT00474760|587327301|FG006|Overall Study|Death|0|||
162620664|NCT00474760|587327295|FG000|Overall Study|Adverse Event|0|||
162620665|NCT00474760|587327296|FG001|Overall Study|Adverse Event|0|||
162620666|NCT00474760|587327297|FG002|Overall Study|Adverse Event|0|||
162620667|NCT00474760|587327298|FG003|Overall Study|Adverse Event|0|||
162620668|NCT00474760|587327299|FG004|Overall Study|Adverse Event|1|||
162620669|NCT00474760|587327300|FG005|Overall Study|Adverse Event|7|||
162620670|NCT00474760|587327301|FG006|Overall Study|Adverse Event|0|||
162620671|NCT00474760|587327295|FG000|Overall Study|Laboratory abnormality|0|||
162620672|NCT00474760|587327296|FG001|Overall Study|Laboratory abnormality|0|||
162620673|NCT00474760|587327297|FG002|Overall Study|Laboratory abnormality|0|||
162620674|NCT00474760|587327298|FG003|Overall Study|Laboratory abnormality|0|||
162620675|NCT00474760|587327299|FG004|Overall Study|Laboratory abnormality|0|||
162620676|NCT00474760|587327300|FG005|Overall Study|Laboratory abnormality|1|||
162620677|NCT00474760|587327301|FG006|Overall Study|Laboratory abnormality|0|||
162620678|NCT00474760|587327295|FG000|Overall Study|Withdrawal by Subject|0|||
162620679|NCT00474760|587327296|FG001|Overall Study|Withdrawal by Subject|0|||
162620680|NCT00474760|587327297|FG002|Overall Study|Withdrawal by Subject|0|||
162620681|NCT00474760|587327298|FG003|Overall Study|Withdrawal by Subject|1|||
162620682|NCT00474760|587327299|FG004|Overall Study|Withdrawal by Subject|0|||
162620683|NCT00474760|587327300|FG005|Overall Study|Withdrawal by Subject|1|||
162620684|NCT00474760|587327301|FG006|Overall Study|Withdrawal by Subject|1|||
162620685|NCT00474760|587327295|FG000|Overall Study|Other|0|||
162620686|NCT00474760|587327296|FG001|Overall Study|Other|1|||
162620687|NCT00474760|587327297|FG002|Overall Study|Other|0|||
162620688|NCT00474760|587327298|FG003|Overall Study|Other|0|||
162620689|NCT00474760|587327299|FG004|Overall Study|Other|1|||
162620690|NCT00474760|587327300|FG005|Overall Study|Other|0|||
162620691|NCT00474760|587327301|FG006|Overall Study|Other|0|||
162620692|NCT00474760|587327295|FG000|Overall Study|Progressive disease|3|||
162620693|NCT00474760|587327296|FG001|Overall Study|Progressive disease|2|||
162620694|NCT00474760|587327297|FG002|Overall Study|Progressive disease|3|||
162620695|NCT00474760|587327298|FG003|Overall Study|Progressive disease|2|||
162620696|NCT00474760|587327299|FG004|Overall Study|Progressive disease|8|||
162620697|NCT00474760|587327300|FG005|Overall Study|Progressive disease|20|||
162620698|NCT00474760|587327301|FG006|Overall Study|Progressive disease|7|||
162620699|NCT00474760|587327295|FG000|Overall Study|Terminated by sponsor|0|||
162620700|NCT00474760|587327296|FG001|Overall Study|Terminated by sponsor|0|||
162620701|NCT00474760|587327297|FG002|Overall Study|Terminated by sponsor|0|||
162620702|NCT00474760|587327298|FG003|Overall Study|Terminated by sponsor|0|||
162620703|NCT00474760|587327299|FG004|Overall Study|Terminated by sponsor|0|||
162620704|NCT00474760|587327300|FG005|Overall Study|Terminated by sponsor|0|||
162620705|NCT00474760|587327301|FG006|Overall Study|Terminated by sponsor|2|||
162620706|NCT01927627|587327303|FG000|Overall Study|Adverse Event|3|||
162620707|NCT01927627|587327303|FG000|Overall Study|Lack of Efficacy|1|||
162620708|NCT01927627|587327303|FG000|Overall Study|Financial Concerns|1|||
162620709|NCT02635776|587327304|FG000|Overall Study|Physician Decision|1|||
162620710|NCT02635776|587327305|FG001|Overall Study|Physician Decision|0|||
162620711|NCT02635776|587327304|FG000|Overall Study|Adverse Event|51|||
162620712|NCT02635776|587327305|FG001|Overall Study|Adverse Event|3|||
162620713|NCT02635776|587327304|FG000|Overall Study|Withdrawal by Subject|41|||
162620714|NCT02635776|587327305|FG001|Overall Study|Withdrawal by Subject|7|||
162620715|NCT02635776|587327304|FG000|Overall Study|Lost to Follow-up|4|||
162620716|NCT02635776|587327305|FG001|Overall Study|Lost to Follow-up|0|||
162620717|NCT02635776|587327304|FG000|Overall Study|Other reasons|5|||
162620718|NCT02635776|587327305|FG001|Overall Study|Other reasons|1|||
162620719|NCT00660673|587327306|FG000|Overall Study|Adverse Event|84|||
162620720|NCT00660673|587327306|FG000|Overall Study|Lack of Efficacy|7|||
162620721|NCT00660673|587327306|FG000|Overall Study|Withdrawal by Subject|22|||
162620722|NCT00660673|587327306|FG000|Overall Study|Administrative|2|||
162620723|NCT00660673|587327306|FG000|Overall Study|Protocol Violation|2|||
162620724|NCT00579098|587327307|FG000|Overall Study|Lost to Follow-up|2|||
162620725|NCT00579098|587327308|FG001|Overall Study|Lost to Follow-up|0|||
162620726|NCT00579098|587327307|FG000|Overall Study|Adverse Event|2|||
162620727|NCT00579098|587327308|FG001|Overall Study|Adverse Event|3|||
162620728|NCT00579098|587327307|FG000|Overall Study|Withdrawal by Subject|2|||
162620729|NCT00579098|587327308|FG001|Overall Study|Withdrawal by Subject|3|||
162620730|NCT00579098|587327307|FG000|Overall Study|AF returned after ablation|3|||
162620731|NCT00579098|587327308|FG001|Overall Study|AF returned after ablation|2|||
162620732|NCT00633750|587327315|FG000|Overall Study|Adverse Event|2|||
162620733|NCT00633750|587327315|FG000|Overall Study|Withdrawal by Subject|3|||
162620734|NCT01903031|587327316|FG000|Overall Study|Not Able to Attend Clinic|1|||
162620735|NCT01903031|587327317|FG001|Overall Study|Not Able to Attend Clinic|1|||
162620736|NCT01903031|587327318|FG002|Overall Study|Not Able to Attend Clinic|0|||
162620737|NCT01903031|587327316|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
162620738|NCT01903031|587327317|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
162620739|NCT01903031|587327318|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
162620740|NCT01903031|587327316|FG000|Overall Study|Adverse Event|0|||
162620741|NCT01903031|587327317|FG001|Overall Study|Adverse Event|1|||
162620742|NCT01903031|587327318|FG002|Overall Study|Adverse Event|0|||
162620743|NCT01903031|587327316|FG000|Overall Study|Withdrawal by Subject|0|||
162620744|NCT01903031|587327317|FG001|Overall Study|Withdrawal by Subject|1|||
162620745|NCT01903031|587327318|FG002|Overall Study|Withdrawal by Subject|1|||
162620746|NCT01903031|587327316|FG000|Overall Study|Protocol Violation|0|||
162620747|NCT01903031|587327317|FG001|Overall Study|Protocol Violation|0|||
162620748|NCT01903031|587327318|FG002|Overall Study|Protocol Violation|2|||
162620749|NCT01903031|587327316|FG000|Overall Study|Lost to Follow-up|0|||
162620750|NCT01903031|587327317|FG001|Overall Study|Lost to Follow-up|0|||
162620751|NCT01903031|587327318|FG002|Overall Study|Lost to Follow-up|1|||
162620752|NCT01903031|587327316|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
162620753|NCT01903031|587327317|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
162620754|NCT01903031|587327318|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
162620755|NCT01811225|587327319|FG000|Treatment Period 1|Adverse Event|2|||
162620756|NCT01811225|587327320|FG001|Treatment Period 1|Adverse Event|3|||
162620757|NCT01811225|587327319|FG000|Treatment Period 1|Lost to Follow-up|12|||
162620758|NCT01811225|587327320|FG001|Treatment Period 1|Lost to Follow-up|8|||
162620759|NCT01811225|587327319|FG000|Treatment Period 1|transporation|1|||
162620760|NCT01811225|587327320|FG001|Treatment Period 1|transporation|0|||
162620761|NCT01811225|587327319|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
162620762|NCT01811225|587327320|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
162620763|NCT01811225|587327319|FG000|Treatment Period 2|Lost to Follow-up|1|||
162620764|NCT01811225|587327320|FG001|Treatment Period 2|Lost to Follow-up|2|||
163051347|NCT00072410|588895435|FG001|Overall Study|Progressive disease|3|||
162620765|NCT01811225|587327319|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
162620766|NCT01811225|587327320|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
162620767|NCT03000569|587327321|FG000|Overall Study|Withdrawal by Subject|1|||
162620768|NCT03000569|587327322|FG001|Overall Study|Withdrawal by Subject|0|||
162620769|NCT02298023|587327323|FG000|Overall Study|Withdrawal by Subject|1|||
162620770|NCT02298023|587327324|FG001|Overall Study|Withdrawal by Subject|0|||
162620771|NCT02298023|587327325|FG002|Overall Study|Withdrawal by Subject|0|||
162620772|NCT00492531|587327333|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
162620773|NCT00492531|587327334|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
162620774|NCT04122534|587327335|FG000|Overall Study|Lost to Follow-up|4|||
162620775|NCT01790932|587327341|FG000|Overall Study|Disease Progression|41|||
162890255|NCT00637377|588295421|FG003|Overall Study|Other (no further information available)|5|||
162890256|NCT01293084|588295423|FG000|Overall Study|Physician Decision|3|||
162890257|NCT01293084|588295423|FG000|Overall Study|Withdrawal by Subject|2|||
162890258|NCT04186663|588295424|FG000|Overall Study|Lost to Follow-up|1|||
162890259|NCT04186663|588295424|FG000|Overall Study|Unable to complete blood draw|3|||
163051348|NCT03160716|588895436|FG000|Overall Study|Lost to Follow-up|1|||
162620776|NCT01790932|587327341|FG000|Overall Study|Adverse Event|7|||
162620777|NCT01790932|587327341|FG000|Overall Study|Physician Decision|1|||
162620778|NCT01790932|587327341|FG000|Overall Study|Withdrawal by Subject|1|||
162620779|NCT01441180|587327347|FG000|Overall Study|Lost to Follow-up|1|||
162620780|NCT01441180|587327348|FG001|Overall Study|Lost to Follow-up|1|||
162620781|NCT01441180|587327349|FG002|Overall Study|Lost to Follow-up|1|||
162708588|NCT02950545|587642842|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163051349|NCT01628848|588895437|FG000|Overall Study|Adverse Event|9|||
162620782|NCT01441180|587327347|FG000|Overall Study|Discontinued|0|||
162620783|NCT01441180|587327348|FG001|Overall Study|Discontinued|0|||
162620784|NCT01441180|587327349|FG002|Overall Study|Discontinued|2|||
162620785|NCT01558739|587327352|FG000|Overall Study|Adverse Event|7|||
162708589|NCT02950545|587642843|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162708590|NCT02950545|587642844|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162708591|NCT02950545|587642845|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162708592|NCT02950545|587642846|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
162708593|NCT02950545|587642841|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162708594|NCT02950545|587642842|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162708595|NCT02950545|587642843|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162708596|NCT02950545|587642844|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162708597|NCT02950545|587642845|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162708598|NCT02950545|587642846|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162708599|NCT02950545|587642841|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162708600|NCT02950545|587642842|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162708601|NCT02950545|587642843|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162708602|NCT02950545|587642844|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162708603|NCT02950545|587642845|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
162708604|NCT02950545|587642846|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162708605|NCT02950545|587642841|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
162708606|NCT02950545|587642842|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162708607|NCT02950545|587642843|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162708608|NCT02950545|587642844|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162708609|NCT02950545|587642845|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162708610|NCT02950545|587642846|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162708611|NCT02950545|587642841|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162708612|NCT02950545|587642842|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162708613|NCT02950545|587642843|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162708614|NCT02950545|587642844|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162708615|NCT02950545|587642845|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162708616|NCT02950545|587642846|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
162708617|NCT04296942|587642847|FG000|Overall Study|Study closure by sponsor|1|||
162708618|NCT04296942|587642848|FG001|Overall Study|Study closure by sponsor|0|||
162708619|NCT04296942|587642849|FG002|Overall Study|Study closure by sponsor|0|||
162708620|NCT03255941|587642850|FG000|Overall Study|Not eligible or refused injection|37|||
162708621|NCT03255941|587642851|FG001|Overall Study|Not eligible or refused injection|44|||
162708622|NCT03255941|587642852|FG002|Overall Study|Not eligible or refused injection|5|||
162890260|NCT01375647|588296780|FG000|Overall Study|Lost to Follow-up|3|||
162890261|NCT01375647|588296781|FG001|Overall Study|Lost to Follow-up|3|||
162890262|NCT01375647|588296782|FG002|Overall Study|Lost to Follow-up|7|||
162620786|NCT01558739|587327352|FG000|Overall Study|Withdrawal by Subject|2|||
162620787|NCT01558739|587327352|FG000|Overall Study|Death|3|||
162620788|NCT01558739|587327352|FG000|Overall Study|Disease Progression|4|||
163051350|NCT01628848|588895438|FG001|Overall Study|Adverse Event|7|||
162620789|NCT01558739|587327352|FG000|Overall Study|Protocol Violation|1|||
162620790|NCT01402011|587327357|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
162620791|NCT01402011|587327358|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
162620792|NCT01402011|587327359|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
162620793|NCT01402011|587327357|FG000|Active Treatment Period|Withdrawal by Subject|1|||
162620794|NCT01402011|587327358|FG001|Active Treatment Period|Withdrawal by Subject|3|||
162620795|NCT01402011|587327359|FG002|Active Treatment Period|Withdrawal by Subject|0|||
162620796|NCT01402011|587327357|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
162620797|NCT01402011|587327358|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
162620798|NCT01402011|587327359|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
162620799|NCT02612129|587327360|FG000|Single Dose Treatment Period|Screening Failure|1|||
162620800|NCT02612129|587327361|FG001|Single Dose Treatment Period|Screening Failure|0|||
162620801|NCT02612129|587327362|FG002|Single Dose Treatment Period|Screening Failure|0|||
162620802|NCT02612129|587327360|FG000|Continuous Treatment Period|Early Escape|0|||
162620803|NCT02612129|587327361|FG001|Continuous Treatment Period|Early Escape|2|||
162620804|NCT02612129|587327362|FG002|Continuous Treatment Period|Early Escape|0|||
162620805|NCT02612129|587327360|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
162620806|NCT02612129|587327361|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
162620807|NCT02612129|587327362|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
162620808|NCT02612129|587327360|FG000|Continuous Treatment Period|Safety Reasons|0|||
162620809|NCT02612129|587327361|FG001|Continuous Treatment Period|Safety Reasons|3|||
162620810|NCT02612129|587327362|FG002|Continuous Treatment Period|Safety Reasons|0|||
162620811|NCT02612129|587327360|FG000|Continuous Treatment Period|Death|0|||
162620812|NCT02612129|587327361|FG001|Continuous Treatment Period|Death|1|||
162620813|NCT02612129|587327362|FG002|Continuous Treatment Period|Death|0|||
162620814|NCT02612129|587327360|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
162620815|NCT02612129|587327361|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
162620816|NCT02612129|587327362|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
162708623|NCT03255941|587642853|FG003|Overall Study|Not eligible or refused injection|6|||
162708624|NCT03255941|587642850|FG000|Overall Study|Did not complete exit interview|1|||
162708625|NCT03255941|587642851|FG001|Overall Study|Did not complete exit interview|2|||
162708626|NCT03255941|587642852|FG002|Overall Study|Did not complete exit interview|0|||
162708627|NCT03255941|587642853|FG003|Overall Study|Did not complete exit interview|0|||
162708628|NCT00335153|587642865|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
162708629|NCT00335153|587642865|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
162708630|NCT00335153|587642865|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
162708631|NCT00335153|587642865|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
162964248|NCT02554877|588569716|FG001|Overall Study|Insufficient clinical response|0|||
162964249|NCT02554877|588569717|FG002|Overall Study|Insufficient clinical response|0|||
162964250|NCT02554877|588569718|FG003|Overall Study|Insufficient clinical response|0|||
162964251|NCT02554877|588569715|FG000|Overall Study|No longer willing to participate|0|||
162964252|NCT02554877|588569716|FG001|Overall Study|No longer willing to participate|2|||
162708632|NCT00335153|587642865|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
162708633|NCT00335153|587642865|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
162708634|NCT00335153|587642865|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
162708635|NCT00335153|587642865|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
162708636|NCT00335153|587642865|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
162708637|NCT00335153|587642865|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
162708638|NCT01528709|587642866|FG000|Overall Study|Death|2|||
162708639|NCT01528709|587642867|FG001|Overall Study|Death|0|||
162708640|NCT01528709|587642866|FG000|Overall Study|Withdrawal by Subject|10|||
162708641|NCT01528709|587642867|FG001|Overall Study|Withdrawal by Subject|15|||
162964253|NCT02554877|588569717|FG002|Overall Study|No longer willing to participate|2|||
162964254|NCT02554877|588569718|FG003|Overall Study|No longer willing to participate|0|||
162964255|NCT03827395|588569719|FG000|Overall Study|Lost to Follow-up|1|||
162964256|NCT03827395|588569720|FG001|Overall Study|Lost to Follow-up|0|||
162964257|NCT03827395|588569719|FG000|Overall Study|Protocol Violation|1|||
162964258|NCT03827395|588569720|FG001|Overall Study|Protocol Violation|0|||
162964259|NCT03827395|588569719|FG000|Overall Study|Became ineligible after enrollment|1|||
162620817|NCT02557295|587327363|FG000|Overall Study|Withdrawal by Subject|9|||
162620818|NCT02557295|587327364|FG001|Overall Study|Withdrawal by Subject|2|||
162620819|NCT02557295|587327365|FG002|Overall Study|Withdrawal by Subject|4|||
162620820|NCT02557295|587327366|FG003|Overall Study|Withdrawal by Subject|0|||
162620821|NCT02557295|587327367|FG004|Overall Study|Withdrawal by Subject|0|||
162620822|NCT02557295|587327368|FG005|Overall Study|Withdrawal by Subject|0|||
162620823|NCT02557295|587327369|FG006|Overall Study|Withdrawal by Subject|15|||
162708642|NCT01528709|587642866|FG000|Overall Study|allergy|1|||
162620824|NCT02557295|587327370|FG007|Overall Study|Withdrawal by Subject|1|||
162708643|NCT01528709|587642867|FG001|Overall Study|allergy|0|||
162708644|NCT00945477|587642868|FG000|Overall Study|Adverse Event|3|||
162708645|NCT00945477|587642868|FG000|Overall Study|Lack of Efficacy|2|||
162708646|NCT00945477|587642868|FG000|Overall Study|Withdrawal by Subject|1|||
162708647|NCT00797225|587642869|FG000|Weeks 1 to 12|Adverse Event|0|||
162708648|NCT00797225|587642870|FG001|Weeks 1 to 12|Adverse Event|0|||
162708649|NCT00797225|587642871|FG002|Weeks 1 to 12|Adverse Event|1|||
162708650|NCT00797225|587642872|FG003|Weeks 1 to 12|Adverse Event|0|||
162708651|NCT00797225|587642873|FG004|Weeks 1 to 12|Adverse Event|0|||
162708652|NCT00797225|587642874|FG005|Weeks 1 to 12|Adverse Event|0|||
162708653|NCT00797225|587642875|FG006|Weeks 1 to 12|Adverse Event|0|||
162708654|NCT00797225|587642876|FG007|Weeks 1 to 12|Adverse Event|0|||
162708655|NCT00797225|587642869|FG000|Weeks 1 to 12|Non-compliance|0|||
162708656|NCT00797225|587642870|FG001|Weeks 1 to 12|Non-compliance|1|||
162708657|NCT00797225|587642871|FG002|Weeks 1 to 12|Non-compliance|0|||
162708658|NCT00797225|587642872|FG003|Weeks 1 to 12|Non-compliance|0|||
162708659|NCT00797225|587642873|FG004|Weeks 1 to 12|Non-compliance|0|||
162620825|NCT02557295|587327371|FG008|Overall Study|Withdrawal by Subject|3|||
162620826|NCT02557295|587327363|FG000|Overall Study|Disease Progression|0|||
162620827|NCT02557295|587327364|FG001|Overall Study|Disease Progression|0|||
162620828|NCT02557295|587327365|FG002|Overall Study|Disease Progression|0|||
162620829|NCT02557295|587327366|FG003|Overall Study|Disease Progression|0|||
162620830|NCT02557295|587327367|FG004|Overall Study|Disease Progression|0|||
162620831|NCT02557295|587327368|FG005|Overall Study|Disease Progression|0|||
162620832|NCT02557295|587327369|FG006|Overall Study|Disease Progression|1|||
162620833|NCT02557295|587327370|FG007|Overall Study|Disease Progression|0|||
162620834|NCT02557295|587327371|FG008|Overall Study|Disease Progression|0|||
162708660|NCT00797225|587642874|FG005|Weeks 1 to 12|Non-compliance|0|||
162708661|NCT00797225|587642875|FG006|Weeks 1 to 12|Non-compliance|0|||
162708662|NCT00797225|587642876|FG007|Weeks 1 to 12|Non-compliance|0|||
162708663|NCT00797225|587642869|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
162708664|NCT00797225|587642870|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
162708665|NCT00797225|587642871|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
162708666|NCT00797225|587642872|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
162708667|NCT00797225|587642873|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
162708668|NCT00797225|587642874|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
162708669|NCT00797225|587642875|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
162708670|NCT00797225|587642876|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
162708671|NCT00797225|587642869|FG000|Weeks 1 to 12|Sponsor Decision|1|||
162708672|NCT00797225|587642870|FG001|Weeks 1 to 12|Sponsor Decision|0|||
162708673|NCT00797225|587642871|FG002|Weeks 1 to 12|Sponsor Decision|0|||
162708674|NCT00797225|587642872|FG003|Weeks 1 to 12|Sponsor Decision|0|||
162708675|NCT00797225|587642873|FG004|Weeks 1 to 12|Sponsor Decision|0|||
162890263|NCT01375647|588296783|FG003|Overall Study|Lost to Follow-up|10|||
162890264|NCT01375647|588296780|FG000|Overall Study|Death|1|||
162890265|NCT01375647|588296781|FG001|Overall Study|Death|2|||
162890266|NCT01375647|588296782|FG002|Overall Study|Death|1|||
162890267|NCT01375647|588296783|FG003|Overall Study|Death|0|||
162890268|NCT01375647|588296780|FG000|Overall Study|Withdrawal by Subject|17|||
162890269|NCT01375647|588296781|FG001|Overall Study|Withdrawal by Subject|20|||
162890270|NCT01375647|588296782|FG002|Overall Study|Withdrawal by Subject|26|||
162964260|NCT03827395|588569720|FG001|Overall Study|Became ineligible after enrollment|2|||
162620835|NCT02557295|587327363|FG000|Overall Study|Lack of Efficacy|24|||
162620836|NCT02557295|587327364|FG001|Overall Study|Lack of Efficacy|1|||
162708676|NCT00797225|587642874|FG005|Weeks 1 to 12|Sponsor Decision|0|||
162708677|NCT00797225|587642875|FG006|Weeks 1 to 12|Sponsor Decision|0|||
162890271|NCT01375647|588296783|FG003|Overall Study|Withdrawal by Subject|14|||
162890272|NCT01375647|588296780|FG000|Overall Study|Physician Decision|1|||
162620837|NCT02557295|587327365|FG002|Overall Study|Lack of Efficacy|3|||
162890273|NCT01375647|588296781|FG001|Overall Study|Physician Decision|0|||
162620838|NCT02557295|587327366|FG003|Overall Study|Lack of Efficacy|0|||
162620839|NCT02557295|587327367|FG004|Overall Study|Lack of Efficacy|0|||
162620840|NCT02557295|587327368|FG005|Overall Study|Lack of Efficacy|0|||
162620841|NCT02557295|587327369|FG006|Overall Study|Lack of Efficacy|12|||
162620842|NCT02557295|587327370|FG007|Overall Study|Lack of Efficacy|1|||
162620843|NCT02557295|587327371|FG008|Overall Study|Lack of Efficacy|0|||
162620844|NCT02557295|587327363|FG000|Overall Study|Adverse Event|16|||
162620845|NCT02557295|587327364|FG001|Overall Study|Adverse Event|2|||
162620846|NCT02557295|587327365|FG002|Overall Study|Adverse Event|3|||
162620847|NCT02557295|587327366|FG003|Overall Study|Adverse Event|0|||
162620848|NCT02557295|587327367|FG004|Overall Study|Adverse Event|0|||
162620849|NCT02557295|587327368|FG005|Overall Study|Adverse Event|0|||
162620850|NCT02557295|587327369|FG006|Overall Study|Adverse Event|2|||
162620851|NCT02557295|587327370|FG007|Overall Study|Adverse Event|1|||
162620852|NCT02557295|587327371|FG008|Overall Study|Adverse Event|1|||
162620853|NCT02557295|587327363|FG000|Overall Study|Lost to Follow-up|4|||
162620854|NCT02557295|587327364|FG001|Overall Study|Lost to Follow-up|0|||
162620855|NCT02557295|587327365|FG002|Overall Study|Lost to Follow-up|0|||
162620856|NCT02557295|587327366|FG003|Overall Study|Lost to Follow-up|0|||
162620857|NCT02557295|587327367|FG004|Overall Study|Lost to Follow-up|0|||
162620858|NCT02557295|587327368|FG005|Overall Study|Lost to Follow-up|0|||
162620859|NCT02557295|587327369|FG006|Overall Study|Lost to Follow-up|9|||
162620860|NCT02557295|587327370|FG007|Overall Study|Lost to Follow-up|0|||
162620861|NCT02557295|587327371|FG008|Overall Study|Lost to Follow-up|0|||
162620862|NCT02557295|587327363|FG000|Overall Study|Study Close|54|||
162620863|NCT02557295|587327364|FG001|Overall Study|Study Close|3|||
162620864|NCT02557295|587327365|FG002|Overall Study|Study Close|5|||
162620865|NCT02557295|587327366|FG003|Overall Study|Study Close|3|||
162620866|NCT02557295|587327367|FG004|Overall Study|Study Close|0|||
162620867|NCT02557295|587327368|FG005|Overall Study|Study Close|0|||
162620868|NCT02557295|587327369|FG006|Overall Study|Study Close|37|||
162620869|NCT02557295|587327370|FG007|Overall Study|Study Close|3|||
162620870|NCT02557295|587327371|FG008|Overall Study|Study Close|19|||
162620871|NCT02557295|587327363|FG000|Overall Study|except for study close|4|||
162620872|NCT02557295|587327364|FG001|Overall Study|except for study close|0|||
162620873|NCT02557295|587327365|FG002|Overall Study|except for study close|0|||
162620874|NCT02557295|587327366|FG003|Overall Study|except for study close|0|||
162620875|NCT02557295|587327367|FG004|Overall Study|except for study close|0|||
162620876|NCT02557295|587327368|FG005|Overall Study|except for study close|0|||
162620877|NCT02557295|587327369|FG006|Overall Study|except for study close|5|||
162620878|NCT02557295|587327370|FG007|Overall Study|except for study close|1|||
162620879|NCT02557295|587327371|FG008|Overall Study|except for study close|0|||
162620880|NCT01066000|587327372|FG000|Overall Study|Protocol Violation|4|||
162620881|NCT01066000|587327372|FG000|Overall Study|Death|3|||
162620882|NCT01066000|587327372|FG000|Overall Study|Withdrawal by Subject|1|||
162620883|NCT01066000|587327372|FG000|Overall Study|Adverse Event|1|||
162620884|NCT01386008|587327373|FG000|Overall Study|exited w/o incident /study discontinued|17|||
162620885|NCT01386008|587327373|FG000|Overall Study|Adverse Event|3|||
162620886|NCT01067976|587327374|FG000|Overall Study|Study drug never administered|20|||
162620887|NCT01067976|587327374|FG000|Overall Study|Study prematurely discontinued|2|||
162620888|NCT04449861|587327375|FG000|Overall Study|Withdrawal by Subject|4|||
162620889|NCT04449861|587327375|FG000|Overall Study|Lost to Follow-up|5|||
162620890|NCT04449861|587327375|FG000|Overall Study|Death|112|||
162620891|NCT00976677|587327376|FG000|Overall Study|Adverse Event|1|||
162620892|NCT00976677|587327377|FG001|Overall Study|Adverse Event|0|||
162620893|NCT00976677|587327376|FG000|Overall Study|Withdrawal by Subject|0|||
162620894|NCT00976677|587327377|FG001|Overall Study|Withdrawal by Subject|2|||
162620895|NCT00976677|587327376|FG000|Overall Study|Disease progression|1|||
162620896|NCT00976677|587327377|FG001|Overall Study|Disease progression|1|||
162620897|NCT00976677|587327376|FG000|Overall Study|Trial unblinded|2|||
162620898|NCT00976677|587327377|FG001|Overall Study|Trial unblinded|2|||
162620899|NCT00976677|587327376|FG000|Overall Study|Unknown/Missing|1|||
162620900|NCT00976677|587327377|FG001|Overall Study|Unknown/Missing|0|||
162620901|NCT03487549|587327382|FG000|Overall Study|Protocol Violation|0|||
162620902|NCT03487549|587327383|FG001|Overall Study|Protocol Violation|1|||
162620903|NCT03487549|587327382|FG000|Overall Study|Lost to Follow-up|2|||
162620904|NCT03487549|587327383|FG001|Overall Study|Lost to Follow-up|1|||
162620905|NCT03487549|587327382|FG000|Overall Study|Withdrawal by Subject|2|||
162620906|NCT03487549|587327383|FG001|Overall Study|Withdrawal by Subject|0|||
162620907|NCT01313858|587328700|FG000|Overall Study|Premature Treatment Termination|251|||
162620908|NCT01313858|587328701|FG001|Overall Study|Premature Treatment Termination|219|||
162620909|NCT01313858|587328702|FG002|Overall Study|Premature Treatment Termination|191|||
162620910|NCT01313858|587328700|FG000|Overall Study|Lost to Follow-up|35|||
162620911|NCT01313858|587328701|FG001|Overall Study|Lost to Follow-up|51|||
162620912|NCT01313858|587328702|FG002|Overall Study|Lost to Follow-up|47|||
162620913|NCT03689530|587328706|FG000|Overall Study|Withdrawal by Subject|53|||
162620914|NCT03689530|587328707|FG001|Overall Study|Withdrawal by Subject|16|||
162620915|NCT01392443|587328708|FG000|Overall Study|Disease progression|30|||
162620916|NCT01392443|587328708|FG000|Overall Study|Adverse Event|24|||
162620917|NCT01392443|587328708|FG000|Overall Study|Death|7|||
162620918|NCT01392443|587328708|FG000|Overall Study|Withdrawal by Subject|5|||
162620919|NCT01392443|587328708|FG000|Overall Study|Lost to Follow-up|1|||
162620920|NCT01392443|587328708|FG000|Overall Study|Protocol Violation|1|||
162620921|NCT01977794|587328709|FG000|Overall Study|Adverse Event|2|||
162620922|NCT01977794|587328710|FG001|Overall Study|Adverse Event|2|||
162620923|NCT01977794|587328709|FG000|Overall Study|Lost to Follow-up|2|||
162620924|NCT01977794|587328710|FG001|Overall Study|Lost to Follow-up|1|||
162620925|NCT01977794|587328709|FG000|Overall Study|Protocol Violation|1|||
162620926|NCT01977794|587328710|FG001|Overall Study|Protocol Violation|0|||
162620927|NCT01977794|587328709|FG000|Overall Study|Death|1|||
162620928|NCT01977794|587328710|FG001|Overall Study|Death|1|||
162620929|NCT01977794|587328709|FG000|Overall Study|Withdrew consent|2|||
162620930|NCT01977794|587328710|FG001|Overall Study|Withdrew consent|1|||
162620931|NCT01977794|587328709|FG000|Overall Study|Other|0|||
162620932|NCT01977794|587328710|FG001|Overall Study|Other|1|||
162620933|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
162620934|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
162620935|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
162620936|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
162620937|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
162620938|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
162620939|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
162620940|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
162620941|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
162620942|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620943|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620944|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620945|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620946|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620947|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620948|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162620949|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
162620950|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620951|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162708678|NCT00797225|587642876|FG007|Weeks 1 to 12|Sponsor Decision|0|||
162890274|NCT01375647|588296782|FG002|Overall Study|Physician Decision|0|||
162890275|NCT01375647|588296783|FG003|Overall Study|Physician Decision|0|||
162890276|NCT03788967|588296786|FG000|Overall Study|Lost to Follow-up|14|||
162620952|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620953|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620954|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620955|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620956|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162620957|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
162890277|NCT03788967|588296787|FG001|Overall Study|Lost to Follow-up|10|||
162890278|NCT03788967|588296786|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
162890279|NCT03788967|588296787|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
162964261|NCT01537887|588569721|FG000|Period 1|Physician Decision|0|||
162620958|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162964262|NCT01537887|588569722|FG001|Period 1|Physician Decision|0|||
162964263|NCT01537887|588569723|FG002|Period 1|Physician Decision|0|||
162964264|NCT01537887|588569724|FG003|Period 1|Physician Decision|0|||
162964265|NCT01537887|588569725|FG004|Period 1|Physician Decision|1|||
162964266|NCT01537887|588569726|FG005|Period 1|Physician Decision|1|||
162964267|NCT01537887|588569721|FG000|Period 1|Did not receive treatment|0|||
162964268|NCT01537887|588569722|FG001|Period 1|Did not receive treatment|0|||
162964269|NCT01537887|588569723|FG002|Period 1|Did not receive treatment|1|||
162964270|NCT01537887|588569724|FG003|Period 1|Did not receive treatment|0|||
162964271|NCT01537887|588569725|FG004|Period 1|Did not receive treatment|0|||
162964272|NCT01537887|588569726|FG005|Period 1|Did not receive treatment|0|||
162964273|NCT01537887|588569721|FG000|Period 2|Withdrawal by Subject|0|||
162964274|NCT01537887|588569722|FG001|Period 2|Withdrawal by Subject|1|||
162620959|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620960|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620961|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620962|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620963|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620964|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162620965|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
162620966|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620967|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620968|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620969|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620970|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620971|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620972|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162620973|NCT00533897|587328713|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
162620974|NCT00533897|587328714|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620975|NCT00533897|587328715|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620976|NCT00533897|587328716|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620977|NCT00533897|587328717|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620978|NCT00533897|587328718|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620979|NCT00533897|587328719|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620980|NCT00533897|587328720|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162620981|NCT00533897|587328713|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620982|NCT00533897|587328714|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
162620983|NCT00533897|587328715|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
162620984|NCT00533897|587328716|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620985|NCT00533897|587328717|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620986|NCT00533897|587328718|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620987|NCT00533897|587328719|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620988|NCT00533897|587328720|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162620989|NCT00533897|587328713|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620990|NCT00533897|587328714|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620991|NCT00533897|587328715|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
162620992|NCT00533897|587328716|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620993|NCT00533897|587328717|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620994|NCT00533897|587328718|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620995|NCT00533897|587328719|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620996|NCT00533897|587328720|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162620997|NCT00533897|587328713|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162620998|NCT00533897|587328714|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162620999|NCT00533897|587328715|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162621000|NCT00533897|587328716|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162621001|NCT00533897|587328717|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162621002|NCT00533897|587328718|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
162708679|NCT00797225|587642869|FG000|Weeks 13 to 24|Non-compliance|0|||
162964275|NCT01537887|588569723|FG002|Period 2|Withdrawal by Subject|0|||
162964276|NCT01537887|588569724|FG003|Period 2|Withdrawal by Subject|0|||
162964277|NCT01537887|588569725|FG004|Period 2|Withdrawal by Subject|0|||
162964278|NCT01537887|588569726|FG005|Period 2|Withdrawal by Subject|0|||
162621003|NCT00533897|587328719|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162621004|NCT00533897|587328720|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162621005|NCT00533897|587328713|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621006|NCT00533897|587328714|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621007|NCT00533897|587328715|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621008|NCT00533897|587328716|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621009|NCT00533897|587328717|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621010|NCT00533897|587328718|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
162621011|NCT00533897|587328719|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621012|NCT00533897|587328720|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162621013|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162621014|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162890280|NCT03788967|588296786|FG000|Overall Study|Participant Withdrawal of Consent|13|||
162890281|NCT03788967|588296787|FG001|Overall Study|Participant Withdrawal of Consent|5|||
162890282|NCT03788967|588296786|FG000|Overall Study|Adverse Event|1|||
162621015|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162621016|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162621017|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162621018|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162621019|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
162621020|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
162621021|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Death|0|||
162621022|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Death|0|||
162621023|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Death|0|||
162621024|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Death|0|||
162621025|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Death|0|||
162621026|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Death|0|||
162621027|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Death|1|||
162621028|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Death|3|||
162621029|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621030|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621031|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621032|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621033|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621034|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
162621035|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
162621036|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
162621037|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621038|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621039|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621040|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621041|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621042|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621043|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
162621044|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162621045|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Adverse Event|0|||
162621046|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Adverse Event|0|||
162621047|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Adverse Event|0|||
162621048|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Adverse Event|0|||
162621049|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Adverse Event|0|||
162621050|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Adverse Event|0|||
162621051|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Adverse Event|2|||
162621052|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Adverse Event|5|||
162621053|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Pregnancy|0|||
162621054|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Pregnancy|0|||
162621055|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Pregnancy|0|||
162621056|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Pregnancy|0|||
162621057|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Pregnancy|0|||
162621058|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Pregnancy|0|||
162621059|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Pregnancy|0|||
162621060|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Pregnancy|2|||
162621061|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621062|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621063|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621064|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621065|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621066|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
162621067|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
162621068|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
162621069|NCT00533897|587328713|FG000|Long Term Extension (LTE)|Other|0|||
162621070|NCT00533897|587328714|FG001|Long Term Extension (LTE)|Other|0|||
162621071|NCT00533897|587328715|FG002|Long Term Extension (LTE)|Other|0|||
162621072|NCT00533897|587328716|FG003|Long Term Extension (LTE)|Other|0|||
162621073|NCT00533897|587328717|FG004|Long Term Extension (LTE)|Other|0|||
162621074|NCT00533897|587328718|FG005|Long Term Extension (LTE)|Other|0|||
162621075|NCT00533897|587328719|FG006|Long Term Extension (LTE)|Other|1|||
162621076|NCT00533897|587328720|FG007|Long Term Extension (LTE)|Other|6|||
162621077|NCT01546207|587328723|FG000|Overall Study|Death|1|||
162621078|NCT01626456|587328724|FG000|Overall Study|Withdrawal by Subject|21|||
162621079|NCT01626456|587328725|FG001|Overall Study|Withdrawal by Subject|46|||
162621080|NCT01626456|587328724|FG000|Overall Study|Adverse Event|2|||
162621081|NCT01626456|587328725|FG001|Overall Study|Adverse Event|27|||
162621082|NCT01626456|587328724|FG000|Overall Study|Lost to Follow-up|2|||
162621083|NCT01626456|587328725|FG001|Overall Study|Lost to Follow-up|27|||
162621084|NCT01626456|587328724|FG000|Overall Study|Lack of Efficacy|6|||
162621085|NCT01626456|587328725|FG001|Overall Study|Lack of Efficacy|7|||
162621086|NCT01626456|587328724|FG000|Overall Study|Physician Decision|1|||
162621087|NCT01626456|587328725|FG001|Overall Study|Physician Decision|4|||
162621088|NCT01626456|587328724|FG000|Overall Study|Protocol Violation|1|||
162621089|NCT01626456|587328725|FG001|Overall Study|Protocol Violation|1|||
162621090|NCT01626456|587328724|FG000|Overall Study|Site Closure|2|||
162621091|NCT01626456|587328725|FG001|Overall Study|Site Closure|3|||
162621092|NCT01626456|587328724|FG000|Overall Study|Incarceration|0|||
162621093|NCT01626456|587328725|FG001|Overall Study|Incarceration|2|||
162621094|NCT00506662|587328726|FG000|Overall Study|Adverse Event|0|||
162621095|NCT00506662|587328727|FG001|Overall Study|Adverse Event|2|||
162621096|NCT00506662|587328726|FG000|Overall Study|Lack of Efficacy|1|||
162890283|NCT03788967|588296787|FG001|Overall Study|Adverse Event|1|||
162890284|NCT03788967|588296786|FG000|Overall Study|COVID-19|1|||
162890285|NCT03788967|588296787|FG001|Overall Study|COVID-19|2|||
162964279|NCT01537887|588569721|FG000|Period 3|Adverse Event|0|||
162964280|NCT01537887|588569722|FG001|Period 3|Adverse Event|0|||
162964281|NCT01537887|588569723|FG002|Period 3|Adverse Event|1|||
162964282|NCT01537887|588569724|FG003|Period 3|Adverse Event|0|||
162964283|NCT01537887|588569725|FG004|Period 3|Adverse Event|0|||
162964284|NCT01537887|588569726|FG005|Period 3|Adverse Event|0|||
162964285|NCT01537887|588569721|FG000|Period 3|Withdrawal by Subject|0|||
162964286|NCT01537887|588569722|FG001|Period 3|Withdrawal by Subject|1|||
162964287|NCT01537887|588569723|FG002|Period 3|Withdrawal by Subject|0|||
162964288|NCT01537887|588569724|FG003|Period 3|Withdrawal by Subject|0|||
162964289|NCT01537887|588569725|FG004|Period 3|Withdrawal by Subject|0|||
162964290|NCT01537887|588569726|FG005|Period 3|Withdrawal by Subject|0|||
162964291|NCT01370083|588569727|FG000|Overall Study|Lost to Follow-up|2|||
162964292|NCT01370083|588569728|FG001|Overall Study|Lost to Follow-up|0|||
162964293|NCT01370083|588569727|FG000|Overall Study|Adverse Event|0|||
162964294|NCT01370083|588569728|FG001|Overall Study|Adverse Event|1|||
162964295|NCT02450539|588569731|FG000|Overall Study|Withdrawal by Subject|12|||
162964296|NCT02450539|588569732|FG001|Overall Study|Withdrawal by Subject|6|||
162964297|NCT02450539|588569731|FG000|Overall Study|Lost to Follow-up|4|||
162964298|NCT02450539|588569732|FG001|Overall Study|Lost to Follow-up|1|||
162964299|NCT00585286|588569733|FG000|Overall Study|Lost to Follow-up|1|||
162964300|NCT03358147|588569735|FG000|Overall Study|Withdrawal by Subject|13|||
162964301|NCT03358147|588569736|FG001|Overall Study|Withdrawal by Subject|19|||
162964302|NCT03358147|588569737|FG002|Overall Study|Withdrawal by Subject|16|||
162964303|NCT03358147|588569738|FG003|Overall Study|Withdrawal by Subject|10|||
162964304|NCT03358147|588569739|FG004|Overall Study|Withdrawal by Subject|5|||
162964305|NCT03358147|588569735|FG000|Overall Study|Adverse Event|3|||
162964306|NCT03358147|588569736|FG001|Overall Study|Adverse Event|9|||
162964307|NCT03358147|588569737|FG002|Overall Study|Adverse Event|7|||
162964308|NCT03358147|588569738|FG003|Overall Study|Adverse Event|5|||
162964309|NCT03358147|588569739|FG004|Overall Study|Adverse Event|2|||
162964310|NCT03358147|588569735|FG000|Overall Study|Lost to Follow-up|4|||
162964311|NCT03358147|588569736|FG001|Overall Study|Lost to Follow-up|3|||
162964312|NCT03358147|588569737|FG002|Overall Study|Lost to Follow-up|7|||
162964313|NCT03358147|588569738|FG003|Overall Study|Lost to Follow-up|6|||
162964314|NCT03358147|588569739|FG004|Overall Study|Lost to Follow-up|4|||
162964315|NCT03358147|588569735|FG000|Overall Study|Major Protocol Deviation|11|||
162621097|NCT00506662|587328727|FG001|Overall Study|Lack of Efficacy|0|||
162621098|NCT00506662|587328726|FG000|Overall Study|Protocol Violation|2|||
162890286|NCT01316939|588296790|FG000|Overall Study|Study closed/terminated|26|||
162890287|NCT01316939|588296791|FG001|Overall Study|Study closed/terminated|25|||
162890288|NCT01316939|588296792|FG002|Overall Study|Study closed/terminated|23|||
162890289|NCT01316939|588296790|FG000|Overall Study|Lack of Efficacy|24|||
162890290|NCT01316939|588296791|FG001|Overall Study|Lack of Efficacy|25|||
162890291|NCT01316939|588296792|FG002|Overall Study|Lack of Efficacy|25|||
162890292|NCT01316939|588296790|FG000|Overall Study|Adverse Event|9|||
162890293|NCT01316939|588296791|FG001|Overall Study|Adverse Event|12|||
162890294|NCT01316939|588296792|FG002|Overall Study|Adverse Event|11|||
162890295|NCT01316939|588296790|FG000|Overall Study|Withdrawal by Subject|1|||
162964316|NCT03358147|588569736|FG001|Overall Study|Major Protocol Deviation|3|||
162964317|NCT03358147|588569737|FG002|Overall Study|Major Protocol Deviation|2|||
162964318|NCT03358147|588569738|FG003|Overall Study|Major Protocol Deviation|3|||
162964319|NCT03358147|588569739|FG004|Overall Study|Major Protocol Deviation|1|||
162964320|NCT03358147|588569735|FG000|Overall Study|Protocol specified criteria|2|||
162964321|NCT03358147|588569736|FG001|Overall Study|Protocol specified criteria|3|||
162964322|NCT03358147|588569737|FG002|Overall Study|Protocol specified criteria|0|||
162964323|NCT03358147|588569738|FG003|Overall Study|Protocol specified criteria|3|||
162621099|NCT00506662|587328727|FG001|Overall Study|Protocol Violation|4|||
162621100|NCT00506662|587328726|FG000|Overall Study|Trial terminated|10|||
162708680|NCT00797225|587642870|FG001|Weeks 13 to 24|Non-compliance|2|||
162890296|NCT01316939|588296791|FG001|Overall Study|Withdrawal by Subject|3|||
162890297|NCT01316939|588296792|FG002|Overall Study|Withdrawal by Subject|6|||
162964324|NCT03358147|588569739|FG004|Overall Study|Protocol specified criteria|1|||
162621101|NCT00506662|587328727|FG001|Overall Study|Trial terminated|16|||
162621102|NCT00506662|587328726|FG000|Overall Study|Not recorded|4|||
162621103|NCT00506662|587328727|FG001|Overall Study|Not recorded|6|||
162621104|NCT04015336|587328729|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
162621105|NCT00491075|587328730|FG000|Overall Study|Withdrawal by Subject|1|||
162621106|NCT00491075|587328730|FG000|Overall Study|Physician Decision|1|||
162621107|NCT01603355|587328731|FG000|Overall Study|Lack of Efficacy|2|||
162621108|NCT00246753|587328732|FG000|Overall Study|Withdrawal by Subject|2|||
162621109|NCT00246753|587328732|FG000|Overall Study|Physician Decision|2|||
162621110|NCT00246753|587328732|FG000|Overall Study|Adverse Event|2|||
162621111|NCT00246753|587328732|FG000|Overall Study|Unacceptable toxicity|2|||
162621112|NCT01065597|587328735|FG000|Overall Study|Adverse Event|1|||
162621113|NCT00619177|587328737|FG000|Overall Study|Adverse Event|18|||
162621114|NCT00619177|587328737|FG000|Overall Study|Lost to Follow-up|2|||
162621115|NCT00619177|587328737|FG000|Overall Study|Lack of Efficacy|1|||
162621116|NCT00619177|587328737|FG000|Overall Study|Missing termination information|481|||
162621117|NCT00619177|587328737|FG000|Overall Study|Not specified reasons|6|||
162621118|NCT01281137|587328742|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
162621119|NCT01281137|587328743|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
162621120|NCT01281137|587328742|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
162621121|NCT01281137|587328743|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
162621122|NCT01281137|587328742|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
162621123|NCT01281137|587328743|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
162621124|NCT01281137|587328742|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
162621125|NCT01281137|587328743|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
162621126|NCT01281137|587328742|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
162621127|NCT01281137|587328743|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
162621128|NCT00788073|587328744|FG000|STX209 Then Placebo|Adverse Event|1|||
162621129|NCT00788073|587328745|FG001|STX209 Then Placebo|Adverse Event|0|||
162621130|NCT00788073|587328744|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
162621131|NCT00788073|587328745|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
162621132|NCT00788073|587328744|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
162621133|NCT00788073|587328745|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
162621134|NCT00788073|587328744|FG000|STX209 Then Placebo|unable to return due to travel|0|||
162621135|NCT00788073|587328745|FG001|STX209 Then Placebo|unable to return due to travel|1|||
162621136|NCT00788073|587328744|FG000|Placebo Then STX209|Adverse Event|2|||
162621137|NCT00788073|587328745|FG001|Placebo Then STX209|Adverse Event|0|||
162621138|NCT00788073|587328744|FG000|Placebo Then STX209|Protocol Violation|0|||
162621139|NCT00788073|587328745|FG001|Placebo Then STX209|Protocol Violation|1|||
162621140|NCT03608254|587328746|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
162621141|NCT03608254|587328746|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
162621142|NCT00910273|587328747|FG000|Overall Study|Lack of Efficacy|6|||
162621143|NCT00910273|587328748|FG001|Overall Study|Lack of Efficacy|9|||
162964325|NCT03358147|588569735|FG000|Overall Study|Physician Decision|1|||
162964326|NCT03358147|588569736|FG001|Overall Study|Physician Decision|0|||
162964327|NCT03358147|588569737|FG002|Overall Study|Physician Decision|1|||
162964328|NCT03358147|588569738|FG003|Overall Study|Physician Decision|6|||
162621144|NCT00910273|587328747|FG000|Overall Study|Adverse Event|1|||
162621145|NCT00910273|587328748|FG001|Overall Study|Adverse Event|1|||
162621146|NCT00910273|587328747|FG000|Overall Study|Withdrawal by Subject|1|||
162621147|NCT00910273|587328748|FG001|Overall Study|Withdrawal by Subject|0|||
162621148|NCT00910273|587328747|FG000|Overall Study|Discontinuation of study by sponsor|8|||
162621149|NCT00910273|587328748|FG001|Overall Study|Discontinuation of study by sponsor|2|||
162621150|NCT00910273|587328747|FG000|Overall Study|Protocol Violation|1|||
162621151|NCT00910273|587328748|FG001|Overall Study|Protocol Violation|0|||
162621152|NCT00910273|587328747|FG000|Overall Study|Lost to Follow-up|1|||
162621153|NCT00910273|587328748|FG001|Overall Study|Lost to Follow-up|1|||
162621154|NCT03540030|587328749|FG000|Overall Study|Withdrawal by Subject|2|||
162621155|NCT03540030|587328750|FG001|Overall Study|Withdrawal by Subject|1|||
162621156|NCT03540030|587328749|FG000|Overall Study|screen fail|7|||
162621157|NCT03540030|587328750|FG001|Overall Study|screen fail|1|||
162621158|NCT03540030|587328749|FG000|Overall Study|never had surgery after signing consent|9|||
162621159|NCT03540030|587328750|FG001|Overall Study|never had surgery after signing consent|1|||
162621160|NCT00569270|587328751|FG000|Period: First Intervention|Protocol Violation|0|||
162621161|NCT00569270|587328752|FG001|Period: First Intervention|Protocol Violation|1|||
162621162|NCT04729621|587328757|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
162621163|NCT04729621|587328758|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
162621164|NCT04729621|587328759|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162621165|NCT04729621|587328760|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162621166|NCT04729621|587328761|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162621167|NCT04729621|587328757|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
162621168|NCT04729621|587328758|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
162621169|NCT04729621|587328759|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162621170|NCT04729621|587328760|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162621171|NCT04729621|587328761|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162621172|NCT04729621|587328757|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
162621173|NCT04729621|587328758|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
162621174|NCT04729621|587328759|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162621175|NCT04729621|587328760|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162621176|NCT04729621|587328761|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162621177|NCT04729621|587328757|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162621178|NCT04729621|587328758|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162621179|NCT04729621|587328759|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
162621180|NCT04729621|587328760|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
162621181|NCT04729621|587328761|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
162621182|NCT04729621|587328757|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162621183|NCT04729621|587328758|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162621184|NCT04729621|587328759|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162621185|NCT04729621|587328760|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
162621186|NCT04729621|587328761|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162621187|NCT04729621|587328757|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
162621188|NCT04729621|587328758|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
162621189|NCT04729621|587328759|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
162621190|NCT04729621|587328760|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
162621191|NCT04729621|587328761|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
162621192|NCT01449539|587328765|FG000|Overall Study|Withdrawal by Subject|3|||
162621193|NCT01449539|587328765|FG000|Overall Study|Toxicity not study related|1|||
162621194|NCT01387789|587328766|FG000|Overall Study|Adverse Event|5|||
162621195|NCT01387789|587328766|FG000|Overall Study|Lack of Efficacy|2|||
162621196|NCT01387789|587328766|FG000|Overall Study|Lost to Follow-up|1|||
162621197|NCT00913380|587328769|FG000|Clinical Outcomes|Lost to Follow-up|6|||
162621198|NCT00913380|587328770|FG001|Clinical Outcomes|Lost to Follow-up|6|||
162621199|NCT01788228|587328775|FG000|Overall Study|Migrated/moved from study area|1|||
162621200|NCT01788228|587328776|FG001|Overall Study|Migrated/moved from study area|0|||
162621201|NCT02187744|587328777|FG000|Study|Participant refused further follow-up|1|||
162621202|NCT02187744|587328778|FG001|Study|Participant refused further follow-up|0|||
162621203|NCT02187744|587328777|FG000|Study|Other|2|||
162964329|NCT03358147|588569739|FG004|Overall Study|Physician Decision|1|||
162964330|NCT03358147|588569735|FG000|Overall Study|Administrative reasons|0|||
162621204|NCT02187744|587328778|FG001|Study|Other|1|||
162621205|NCT02187744|587328777|FG000|Study|Lost to Follow-up|0|||
162621206|NCT02187744|587328778|FG001|Study|Lost to Follow-up|2|||
162621207|NCT02187744|587328777|FG000|Study|Related adverse event, not serious|0|||
162621208|NCT02187744|587328778|FG001|Study|Related adverse event, not serious|2|||
162621209|NCT02187744|587328777|FG000|Study|Death|1|||
162621210|NCT02187744|587328778|FG001|Study|Death|0|||
162621211|NCT02187744|587328777|FG000|Study|Related adverse event, serious non-fatal|0|||
163051351|NCT01628848|588895437|FG000|Overall Study|Lack of Efficacy|0|||
162621212|NCT02187744|587328778|FG001|Study|Related adverse event, serious non-fatal|1|||
162621213|NCT02187744|587328777|FG000|Treatment|Death|1|||
162621214|NCT02187744|587328778|FG001|Treatment|Death|0|||
162621215|NCT02187744|587328777|FG000|Treatment|Related adverse event, serious non-fatal|0|||
162621216|NCT02187744|587328778|FG001|Treatment|Related adverse event, serious non-fatal|1|||
162621217|NCT02187744|587328777|FG000|Treatment|Related adverse event, not serious|0|||
162621218|NCT02187744|587328778|FG001|Treatment|Related adverse event, not serious|2|||
162621219|NCT02187744|587328777|FG000|Treatment|Lost to Follow-up|0|||
162621220|NCT02187744|587328778|FG001|Treatment|Lost to Follow-up|1|||
162621221|NCT02187744|587328777|FG000|Treatment|Other|2|||
162621222|NCT02187744|587328778|FG001|Treatment|Other|0|||
162621223|NCT02187744|587328777|FG000|Treatment|Participant refused continued treatment|1|||
162621224|NCT02187744|587328778|FG001|Treatment|Participant refused continued treatment|1|||
162621225|NCT01972568|587328779|FG000|Overall Study|Other events|3|||
162621226|NCT01972568|587328780|FG001|Overall Study|Other events|0|||
162621227|NCT01972568|587328781|FG002|Overall Study|Other events|0|||
162621228|NCT01972568|587328779|FG000|Overall Study|Lack of Efficacy|0|||
162621229|NCT01972568|587328780|FG001|Overall Study|Lack of Efficacy|1|||
162621230|NCT01972568|587328781|FG002|Overall Study|Lack of Efficacy|2|||
162621231|NCT01972568|587328779|FG000|Overall Study|Protocol Violation|1|||
162621232|NCT01972568|587328780|FG001|Overall Study|Protocol Violation|2|||
162621233|NCT01972568|587328781|FG002|Overall Study|Protocol Violation|2|||
162621234|NCT01972568|587328779|FG000|Overall Study|Withdrawal by Subject|6|||
162621235|NCT01972568|587328780|FG001|Overall Study|Withdrawal by Subject|3|||
162621236|NCT01972568|587328781|FG002|Overall Study|Withdrawal by Subject|7|||
162621237|NCT01972568|587328779|FG000|Overall Study|Lost to Follow-up|1|||
162621238|NCT01972568|587328780|FG001|Overall Study|Lost to Follow-up|0|||
162621239|NCT01972568|587328781|FG002|Overall Study|Lost to Follow-up|0|||
162621240|NCT01972568|587328779|FG000|Overall Study|Adverse Event|5|||
162621241|NCT01972568|587328780|FG001|Overall Study|Adverse Event|6|||
162621242|NCT01972568|587328781|FG002|Overall Study|Adverse Event|5|||
162621243|NCT02059408|587328785|FG000|Overall Study|Did not get tested|0|||
162621244|NCT02059408|587328786|FG001|Overall Study|Did not get tested|330|||
162621245|NCT02059408|587328787|FG002|Overall Study|Did not get tested|358|||
162621246|NCT04223973|587328793|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
162621247|NCT04223973|587328794|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
162621248|NCT04223973|587328793|FG000|Overall Study|Adverse Event|4|||
162621249|NCT04223973|587328794|FG001|Overall Study|Adverse Event|0|||
162621250|NCT04223973|587328793|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
162621251|NCT04223973|587328794|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
162890298|NCT01316939|588296790|FG000|Overall Study|Physician Decision|2|||
162890299|NCT01316939|588296791|FG001|Overall Study|Physician Decision|2|||
162890300|NCT01316939|588296792|FG002|Overall Study|Physician Decision|1|||
162890301|NCT01316939|588296790|FG000|Overall Study|Lost to Follow-up|0|||
162890302|NCT01316939|588296791|FG001|Overall Study|Lost to Follow-up|0|||
162890303|NCT01316939|588296792|FG002|Overall Study|Lost to Follow-up|2|||
162890304|NCT01316939|588296790|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
162890305|NCT01316939|588296791|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
162964331|NCT03358147|588569736|FG001|Overall Study|Administrative reasons|1|||
162964332|NCT03358147|588569737|FG002|Overall Study|Administrative reasons|0|||
162621252|NCT04223973|587328793|FG000|Overall Study|Physician Decision|1|||
162621253|NCT04223973|587328794|FG001|Overall Study|Physician Decision|1|||
162621254|NCT04223973|587328793|FG000|Overall Study|Withdrawal by Subject|0|||
162621255|NCT04223973|587328794|FG001|Overall Study|Withdrawal by Subject|1|||
162621256|NCT00594659|587328795|FG000|Overall Study|Lost to Follow-up|13|||
162621257|NCT00594659|587328796|FG001|Overall Study|Lost to Follow-up|9|||
162621258|NCT00594659|587328797|FG002|Overall Study|Lost to Follow-up|7|||
162621259|NCT00142298|587328799|FG000|Overall Study|Adverse Event|10|||
162621260|NCT00142298|587328800|FG001|Overall Study|Adverse Event|10|||
162621261|NCT00142298|587328801|FG002|Overall Study|Adverse Event|1|||
162621262|NCT00142298|587328802|FG003|Overall Study|Adverse Event|5|||
162621263|NCT00142298|587328803|FG004|Overall Study|Adverse Event|2|||
162621264|NCT00142298|587328804|FG005|Overall Study|Adverse Event|2|||
162621265|NCT00142298|587328805|FG006|Overall Study|Adverse Event|0|||
162621266|NCT00142298|587328806|FG007|Overall Study|Adverse Event|0|||
162621267|NCT00142298|587328807|FG008|Overall Study|Adverse Event|0|||
162621268|NCT00142298|587328808|FG009|Overall Study|Adverse Event|0|||
162621269|NCT00142298|587328799|FG000|Overall Study|Clinical disease progression|1|||
162621270|NCT00142298|587328800|FG001|Overall Study|Clinical disease progression|0|||
162621271|NCT00142298|587328801|FG002|Overall Study|Clinical disease progression|0|||
162621272|NCT00142298|587328802|FG003|Overall Study|Clinical disease progression|0|||
162621273|NCT00142298|587328803|FG004|Overall Study|Clinical disease progression|0|||
162621274|NCT00142298|587328804|FG005|Overall Study|Clinical disease progression|0|||
162621275|NCT00142298|587328805|FG006|Overall Study|Clinical disease progression|0|||
162621276|NCT00142298|587328806|FG007|Overall Study|Clinical disease progression|0|||
162964333|NCT03358147|588569738|FG003|Overall Study|Administrative reasons|3|||
162890306|NCT01316939|588296792|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
162890307|NCT01316939|588296790|FG000|Overall Study|Protocol Violation|0|||
162890308|NCT01316939|588296791|FG001|Overall Study|Protocol Violation|1|||
162890309|NCT01316939|588296792|FG002|Overall Study|Protocol Violation|0|||
162890310|NCT02715804|588296793|FG000|Overall Study|Death|222|||
162890311|NCT02715804|588296794|FG001|Overall Study|Death|106|||
162890312|NCT02715804|588296793|FG000|Overall Study|Withdrawal by Subject|5|||
162708681|NCT00797225|587642871|FG002|Weeks 13 to 24|Non-compliance|0|||
162890313|NCT02715804|588296794|FG001|Overall Study|Withdrawal by Subject|4|||
162890314|NCT02715804|588296793|FG000|Overall Study|Other than specified|2|||
162890315|NCT02715804|588296794|FG001|Overall Study|Other than specified|3|||
162890316|NCT01625611|588296795|FG000|Overall Study|No adlib drinks Lab 1|3|||
162890317|NCT01625611|588296796|FG001|Overall Study|No adlib drinks Lab 1|0|||
162890318|NCT01625611|588296795|FG000|Overall Study|Technical issues with PET|1|||
162890319|NCT01625611|588296796|FG001|Overall Study|Technical issues with PET|0|||
162890320|NCT01625611|588296795|FG000|Overall Study|Unable to complete study procedures|1|||
162890321|NCT01625611|588296796|FG001|Overall Study|Unable to complete study procedures|0|||
162890322|NCT01625611|588296795|FG000|Overall Study|Withdrawal by Subject|3|||
162890323|NCT01625611|588296796|FG001|Overall Study|Withdrawal by Subject|0|||
162890324|NCT00948194|588296797|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
162890325|NCT00948194|588296798|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
162890326|NCT01281189|588296805|FG000|Overall Study|Adverse Event|7|||
162890327|NCT01281189|588296806|FG001|Overall Study|Adverse Event|9|||
162890328|NCT01281189|588296805|FG000|Overall Study|Lost to Follow-up|6|||
162890329|NCT01281189|588296806|FG001|Overall Study|Lost to Follow-up|4|||
162890330|NCT01281189|588296805|FG000|Overall Study|Withdrawal by Subject|21|||
162890331|NCT01281189|588296806|FG001|Overall Study|Withdrawal by Subject|24|||
162890332|NCT01281189|588296805|FG000|Overall Study|Physician Decision|2|||
162890333|NCT01281189|588296806|FG001|Overall Study|Physician Decision|3|||
162890334|NCT01281189|588296805|FG000|Overall Study|Death|103|||
162890335|NCT01281189|588296806|FG001|Overall Study|Death|91|||
162890336|NCT01281189|588296805|FG000|Overall Study|Other|8|||
162890337|NCT01281189|588296806|FG001|Overall Study|Other|12|||
162890338|NCT00527072|588296809|FG000|Overall Study|Adverse Event|13|||
162890339|NCT00527072|588296809|FG000|Overall Study|Lack of Efficacy|11|||
162890340|NCT00527072|588296809|FG000|Overall Study|Lost to Follow-up|3|||
162890341|NCT00527072|588296809|FG000|Overall Study|Protocol Violation|2|||
162890342|NCT00527072|588296809|FG000|Overall Study|Withdrawal by Subject|7|||
162890343|NCT02657434|588296810|FG000|Overall Study|Study Terminated By Sponsor|64|||
162890344|NCT02657434|588296811|FG001|Overall Study|Study Terminated By Sponsor|82|||
162890345|NCT02657434|588296810|FG000|Overall Study|Death|189|||
162890346|NCT02657434|588296811|FG001|Overall Study|Death|190|||
162890347|NCT02657434|588296810|FG000|Overall Study|Lost to Follow-up|2|||
162890348|NCT02657434|588296811|FG001|Overall Study|Lost to Follow-up|2|||
162890349|NCT02657434|588296810|FG000|Overall Study|Randomization by Error|2|||
162890350|NCT02657434|588296811|FG001|Overall Study|Randomization by Error|0|||
162890351|NCT02657434|588296810|FG000|Overall Study|Withdrawal by Subject|28|||
162890352|NCT02657434|588296811|FG001|Overall Study|Withdrawal by Subject|17|||
162890353|NCT02657434|588296810|FG000|Overall Study|Protocol Violation|1|||
162890354|NCT02657434|588296811|FG001|Overall Study|Protocol Violation|0|||
162890355|NCT02657434|588296810|FG000|Overall Study|Physician Decision|0|||
162890356|NCT02657434|588296811|FG001|Overall Study|Physician Decision|1|||
162890357|NCT00608881|588296812|FG000|Overall Study|Death|22|||
162890358|NCT00608881|588296813|FG001|Overall Study|Death|13|||
162890359|NCT00608881|588296812|FG000|Overall Study|Adverse Event|5|||
162890360|NCT00608881|588296813|FG001|Overall Study|Adverse Event|3|||
162890361|NCT00608881|588296812|FG000|Overall Study|Lost to Follow-up|28|||
162621277|NCT00142298|587328807|FG008|Overall Study|Clinical disease progression|0|||
162621278|NCT00142298|587328808|FG009|Overall Study|Clinical disease progression|0|||
162621279|NCT00142298|587328799|FG000|Overall Study|Death|1|||
162621280|NCT00142298|587328800|FG001|Overall Study|Death|1|||
162621281|NCT00142298|587328801|FG002|Overall Study|Death|1|||
162621282|NCT00142298|587328802|FG003|Overall Study|Death|0|||
162621283|NCT00142298|587328803|FG004|Overall Study|Death|0|||
162621284|NCT00142298|587328804|FG005|Overall Study|Death|6|||
162621285|NCT00142298|587328805|FG006|Overall Study|Death|0|||
162621286|NCT00142298|587328806|FG007|Overall Study|Death|0|||
162621287|NCT00142298|587328807|FG008|Overall Study|Death|0|||
162621288|NCT00142298|587328808|FG009|Overall Study|Death|0|||
162621289|NCT00142298|587328799|FG000|Overall Study|Lack of Efficacy|44|||
162621290|NCT00142298|587328800|FG001|Overall Study|Lack of Efficacy|62|||
162621291|NCT00142298|587328801|FG002|Overall Study|Lack of Efficacy|9|||
162621292|NCT00142298|587328802|FG003|Overall Study|Lack of Efficacy|12|||
162621293|NCT00142298|587328803|FG004|Overall Study|Lack of Efficacy|1|||
162621294|NCT00142298|587328804|FG005|Overall Study|Lack of Efficacy|0|||
162621295|NCT00142298|587328805|FG006|Overall Study|Lack of Efficacy|0|||
162621296|NCT00142298|587328806|FG007|Overall Study|Lack of Efficacy|1|||
162621297|NCT00142298|587328807|FG008|Overall Study|Lack of Efficacy|0|||
162621298|NCT00142298|587328808|FG009|Overall Study|Lack of Efficacy|0|||
163051352|NCT01628848|588895438|FG001|Overall Study|Lack of Efficacy|4|||
162621299|NCT00142298|587328799|FG000|Overall Study|Non-compliance|15|||
162621300|NCT00142298|587328800|FG001|Overall Study|Non-compliance|13|||
162621301|NCT00142298|587328801|FG002|Overall Study|Non-compliance|0|||
162621302|NCT00142298|587328802|FG003|Overall Study|Non-compliance|6|||
162621303|NCT00142298|587328803|FG004|Overall Study|Non-compliance|1|||
162621304|NCT00142298|587328804|FG005|Overall Study|Non-compliance|0|||
162621305|NCT00142298|587328805|FG006|Overall Study|Non-compliance|0|||
162621306|NCT00142298|587328806|FG007|Overall Study|Non-compliance|3|||
162621307|NCT00142298|587328807|FG008|Overall Study|Non-compliance|3|||
162621308|NCT00142298|587328808|FG009|Overall Study|Non-compliance|0|||
162621309|NCT00142298|587328799|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
162621310|NCT00142298|587328800|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
162621311|NCT00142298|587328801|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
162621312|NCT00142298|587328802|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
162621313|NCT00142298|587328803|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
162621314|NCT00142298|587328804|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
162621315|NCT00142298|587328805|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
162621316|NCT00142298|587328806|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
162621317|NCT00142298|587328807|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
162621318|NCT00142298|587328808|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
162621319|NCT00142298|587328799|FG000|Overall Study|Pregnancy|4|||
162621320|NCT00142298|587328800|FG001|Overall Study|Pregnancy|4|||
162621321|NCT00142298|587328801|FG002|Overall Study|Pregnancy|2|||
162621322|NCT00142298|587328802|FG003|Overall Study|Pregnancy|3|||
162621323|NCT00142298|587328803|FG004|Overall Study|Pregnancy|0|||
162621324|NCT00142298|587328804|FG005|Overall Study|Pregnancy|0|||
162621325|NCT00142298|587328805|FG006|Overall Study|Pregnancy|0|||
162621326|NCT00142298|587328806|FG007|Overall Study|Pregnancy|0|||
162621327|NCT00142298|587328807|FG008|Overall Study|Pregnancy|1|||
162621328|NCT00142298|587328808|FG009|Overall Study|Pregnancy|0|||
162621329|NCT00142298|587328799|FG000|Overall Study|Virologic breakthrough|19|||
162621330|NCT00142298|587328800|FG001|Overall Study|Virologic breakthrough|23|||
162621331|NCT00142298|587328801|FG002|Overall Study|Virologic breakthrough|9|||
162621332|NCT00142298|587328802|FG003|Overall Study|Virologic breakthrough|7|||
162621333|NCT00142298|587328803|FG004|Overall Study|Virologic breakthrough|2|||
162621334|NCT00142298|587328804|FG005|Overall Study|Virologic breakthrough|3|||
162621335|NCT00142298|587328805|FG006|Overall Study|Virologic breakthrough|3|||
162621336|NCT00142298|587328806|FG007|Overall Study|Virologic breakthrough|0|||
162621337|NCT00142298|587328807|FG008|Overall Study|Virologic breakthrough|0|||
162621338|NCT00142298|587328808|FG009|Overall Study|Virologic breakthrough|0|||
162621339|NCT00142298|587328799|FG000|Overall Study|Other- not specified|0|||
162621340|NCT00142298|587328800|FG001|Overall Study|Other- not specified|3|||
162621341|NCT00142298|587328801|FG002|Overall Study|Other- not specified|0|||
162621342|NCT00142298|587328802|FG003|Overall Study|Other- not specified|1|||
162621343|NCT00142298|587328803|FG004|Overall Study|Other- not specified|0|||
162621344|NCT00142298|587328804|FG005|Overall Study|Other- not specified|0|||
162621345|NCT00142298|587328805|FG006|Overall Study|Other- not specified|0|||
162621346|NCT00142298|587328806|FG007|Overall Study|Other- not specified|0|||
162621347|NCT00142298|587328807|FG008|Overall Study|Other- not specified|0|||
162621348|NCT00142298|587328808|FG009|Overall Study|Other- not specified|0|||
162621349|NCT00142298|587328799|FG000|Overall Study|Lost to Follow-up|0|||
162621350|NCT00142298|587328800|FG001|Overall Study|Lost to Follow-up|0|||
162621351|NCT00142298|587328801|FG002|Overall Study|Lost to Follow-up|0|||
162621352|NCT00142298|587328802|FG003|Overall Study|Lost to Follow-up|0|||
162621353|NCT00142298|587328803|FG004|Overall Study|Lost to Follow-up|0|||
162621354|NCT00142298|587328804|FG005|Overall Study|Lost to Follow-up|0|||
162621355|NCT00142298|587328805|FG006|Overall Study|Lost to Follow-up|2|||
162621356|NCT00142298|587328806|FG007|Overall Study|Lost to Follow-up|0|||
162621357|NCT00142298|587328807|FG008|Overall Study|Lost to Follow-up|0|||
162621358|NCT00142298|587328808|FG009|Overall Study|Lost to Follow-up|0|||
162621359|NCT00142298|587328799|FG000|Overall Study|Treatment Failure|0|||
162621360|NCT00142298|587328800|FG001|Overall Study|Treatment Failure|0|||
162621361|NCT00142298|587328801|FG002|Overall Study|Treatment Failure|0|||
162621362|NCT00142298|587328802|FG003|Overall Study|Treatment Failure|0|||
162621363|NCT00142298|587328803|FG004|Overall Study|Treatment Failure|0|||
162621364|NCT00142298|587328804|FG005|Overall Study|Treatment Failure|2|||
162621365|NCT00142298|587328805|FG006|Overall Study|Treatment Failure|2|||
162621366|NCT00142298|587328806|FG007|Overall Study|Treatment Failure|0|||
162621367|NCT00142298|587328807|FG008|Overall Study|Treatment Failure|0|||
162621368|NCT00142298|587328808|FG009|Overall Study|Treatment Failure|0|||
162621369|NCT02423772|587328811|FG000|Overall Study|Lost to Follow-up|3|||
162621370|NCT02423772|587328812|FG001|Overall Study|Lost to Follow-up|3|||
162621371|NCT02423772|587328811|FG000|Overall Study|Did not begin intervention|2|||
162621372|NCT02423772|587328812|FG001|Overall Study|Did not begin intervention|5|||
162621373|NCT01193842|587328813|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162621374|NCT01193842|587328814|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
162621375|NCT01193842|587328815|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162621376|NCT01193842|587328816|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162621377|NCT01193842|587328817|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162621378|NCT01193842|587328813|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
162621379|NCT01193842|587328814|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162621380|NCT01193842|587328815|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162621381|NCT01193842|587328816|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162964334|NCT03358147|588569739|FG004|Overall Study|Administrative reasons|0|||
162964335|NCT03358147|588569735|FG000|Overall Study|Lack of Efficacy|0|||
162964336|NCT03358147|588569736|FG001|Overall Study|Lack of Efficacy|1|||
162964337|NCT03358147|588569737|FG002|Overall Study|Lack of Efficacy|1|||
162964338|NCT03358147|588569738|FG003|Overall Study|Lack of Efficacy|0|||
162964339|NCT03358147|588569739|FG004|Overall Study|Lack of Efficacy|0|||
162964340|NCT02072096|588569742|FG000|Overall Study|Lack of Efficacy|18|||
162964341|NCT02072096|588569743|FG001|Overall Study|Lack of Efficacy|29|||
162964342|NCT02072096|588569742|FG000|Overall Study|Protocol Violation|7|||
162964343|NCT02072096|588569743|FG001|Overall Study|Protocol Violation|7|||
162964344|NCT02072096|588569742|FG000|Overall Study|Withdrawal by Subject|5|||
162964345|NCT02072096|588569743|FG001|Overall Study|Withdrawal by Subject|7|||
162964346|NCT02072096|588569742|FG000|Overall Study|Adverse Event|5|||
162964347|NCT02072096|588569743|FG001|Overall Study|Adverse Event|2|||
162964348|NCT02072096|588569742|FG000|Overall Study|No Reason Provided|4|||
162964349|NCT02072096|588569743|FG001|Overall Study|No Reason Provided|2|||
162964350|NCT02072096|588569742|FG000|Overall Study|Death|2|||
162964351|NCT02072096|588569743|FG001|Overall Study|Death|0|||
162964352|NCT02072096|588569742|FG000|Overall Study|Physician Decision|0|||
162964353|NCT02072096|588569743|FG001|Overall Study|Physician Decision|1|||
162964354|NCT02072096|588569742|FG000|Overall Study|Study Terminated by Sponsor|43|||
162964355|NCT02072096|588569743|FG001|Overall Study|Study Terminated by Sponsor|30|||
162964356|NCT02072096|588569742|FG000|Overall Study|Lost to Follow-up|1|||
162964357|NCT02072096|588569743|FG001|Overall Study|Lost to Follow-up|0|||
162964358|NCT03236311|588569744|FG000|Overall Study|Study terminated by sponsor|0|||
162964359|NCT03236311|588569745|FG001|Overall Study|Study terminated by sponsor|2|||
162964360|NCT03236311|588569744|FG000|Overall Study|Adverse Event|0|||
162964361|NCT03236311|588569745|FG001|Overall Study|Adverse Event|1|||
162964362|NCT00669162|588569746|FG000|Overall Study|Withdrawal by Subject|1|||
162964363|NCT02704091|588569747|FG000|Overall Study|Adverse Event|4|||
162964364|NCT02704091|588569748|FG001|Overall Study|Adverse Event|3|||
162964365|NCT02704091|588569747|FG000|Overall Study|Protocol Violation|5|||
162964366|NCT02704091|588569748|FG001|Overall Study|Protocol Violation|3|||
162964367|NCT02704091|588569747|FG000|Overall Study|Consent withdrawn|4|||
162964368|NCT02704091|588569748|FG001|Overall Study|Consent withdrawn|4|||
162964369|NCT02704091|588569747|FG000|Overall Study|Lost to Follow-up|13|||
162964370|NCT02704091|588569748|FG001|Overall Study|Lost to Follow-up|5|||
162964371|NCT02704091|588569747|FG000|Overall Study|Other|2|||
162964372|NCT02704091|588569748|FG001|Overall Study|Other|8|||
162964373|NCT02412852|588569749|FG000|Overall Study|Withdrawal by Subject|0|||
162964374|NCT02412852|588569750|FG001|Overall Study|Withdrawal by Subject|1|||
162964375|NCT02412852|588569751|FG002|Overall Study|Withdrawal by Subject|0|||
162964376|NCT02412852|588569752|FG003|Overall Study|Withdrawal by Subject|0|||
162964377|NCT02412852|588569749|FG000|Overall Study|Physician Decision|0|||
162964378|NCT02412852|588569750|FG001|Overall Study|Physician Decision|0|||
162964379|NCT02412852|588569751|FG002|Overall Study|Physician Decision|0|||
162964380|NCT02412852|588569752|FG003|Overall Study|Physician Decision|1|||
162964381|NCT01051349|588569753|FG000|Overall Study|Adverse Event|88|||
162708682|NCT00797225|587642872|FG003|Weeks 13 to 24|Non-compliance|0|||
162964382|NCT01051349|588569753|FG000|Overall Study|Consent Withdrawn|54|||
162964383|NCT01051349|588569753|FG000|Overall Study|Investigator Decision|6|||
162964384|NCT01051349|588569753|FG000|Overall Study|Lost to Follow-up|6|||
162964385|NCT01051349|588569753|FG000|Overall Study|Subject non-compliance|7|||
162964386|NCT01051349|588569753|FG000|Overall Study|Reason not Specified|12|||
162964387|NCT02336074|588569761|FG000|Overall Study|Adverse Event|0|||
162964388|NCT02336074|588569762|FG001|Overall Study|Adverse Event|2|||
162964389|NCT05604014|588569763|FG000|Overall Study|Lost to Follow-up|13|||
162964390|NCT01266902|588569764|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
162964391|NCT01266902|588569765|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
162964392|NCT01266902|588569766|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
162964393|NCT01266902|588569764|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
162964394|NCT01266902|588569765|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
162621382|NCT01193842|587328817|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162621383|NCT01193842|587328813|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162621384|NCT01193842|587328814|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162621385|NCT01193842|587328815|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
162621386|NCT01193842|587328816|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162621387|NCT01193842|587328817|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162621388|NCT01193842|587328813|FG000|Phase II: Randomized Groups|Death|0|||
162621389|NCT01193842|587328814|FG001|Phase II: Randomized Groups|Death|0|||
162621390|NCT01193842|587328815|FG002|Phase II: Randomized Groups|Death|0|||
162621391|NCT01193842|587328816|FG003|Phase II: Randomized Groups|Death|1|||
162621392|NCT01193842|587328817|FG004|Phase II: Randomized Groups|Death|1|||
162621393|NCT01193842|587328813|FG000|Phase II: Randomized Groups|Adverse Event|0|||
162621394|NCT01193842|587328814|FG001|Phase II: Randomized Groups|Adverse Event|0|||
162621395|NCT01193842|587328815|FG002|Phase II: Randomized Groups|Adverse Event|0|||
162621396|NCT01193842|587328816|FG003|Phase II: Randomized Groups|Adverse Event|5|||
162621397|NCT01193842|587328817|FG004|Phase II: Randomized Groups|Adverse Event|3|||
162621398|NCT01193842|587328813|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162621399|NCT01193842|587328814|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162621400|NCT01193842|587328815|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162621401|NCT01193842|587328816|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
162621402|NCT01193842|587328817|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
162621403|NCT01193842|587328813|FG000|Phase II: Randomized Groups|Ineligible|0|||
162621404|NCT01193842|587328814|FG001|Phase II: Randomized Groups|Ineligible|0|||
162621405|NCT01193842|587328815|FG002|Phase II: Randomized Groups|Ineligible|0|||
162621406|NCT01193842|587328816|FG003|Phase II: Randomized Groups|Ineligible|0|||
162621407|NCT01193842|587328817|FG004|Phase II: Randomized Groups|Ineligible|1|||
162621408|NCT01193842|587328813|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162621409|NCT01193842|587328814|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162621410|NCT01193842|587328815|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162621411|NCT01193842|587328816|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
162621412|NCT01193842|587328817|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
162621413|NCT06238362|587328819|FG000|Overall Study|Insufficient total sleep time|1|||
162621414|NCT06238362|587328820|FG001|Overall Study|Insufficient total sleep time|0|||
162621415|NCT06238362|587328819|FG000|Overall Study|Inadequate signal quality|1|||
162621416|NCT06238362|587328820|FG001|Overall Study|Inadequate signal quality|0|||
162621417|NCT01995825|587330503|FG000|Overall Study|Withdrawal by Subject|1|||
162621418|NCT01995825|587330504|FG001|Overall Study|Withdrawal by Subject|0|||
162621419|NCT01367002|587330505|FG000|Overall Study|Withdrawal by Subject|1|||
162621420|NCT01367002|587330506|FG001|Overall Study|Withdrawal by Subject|0|||
162621421|NCT01367002|587330505|FG000|Overall Study|Physician Decision|0|||
162621422|NCT01367002|587330506|FG001|Overall Study|Physician Decision|2|||
162621423|NCT00354744|587330509|FG000|Overall Study|Adverse Event|2|||
162621424|NCT00354744|587330509|FG000|Overall Study|Death|2|||
162621425|NCT00354744|587330509|FG000|Overall Study|Lack of Efficacy|11|||
162621426|NCT00354744|587330509|FG000|Overall Study|Lost to Follow-up|2|||
162621427|NCT00354744|587330509|FG000|Overall Study|Physician Decision|11|||
162621428|NCT00354744|587330509|FG000|Overall Study|Withdrawal by Subject|14|||
162621429|NCT00541931|587330510|FG000|Overall Study|Adverse Event|1|||
162621430|NCT00541931|587330511|FG001|Overall Study|Adverse Event|0|||
162621431|NCT00541931|587330510|FG000|Overall Study|Lost to Follow-up|3|||
162621432|NCT00541931|587330511|FG001|Overall Study|Lost to Follow-up|3|||
162621433|NCT00541931|587330510|FG000|Overall Study|Withdrawal by Subject|1|||
162621434|NCT00541931|587330511|FG001|Overall Study|Withdrawal by Subject|0|||
162621435|NCT00541931|587330510|FG000|Overall Study|Transportation Issue|0|||
162621436|NCT00541931|587330511|FG001|Overall Study|Transportation Issue|1|||
162621437|NCT03094169|587330515|FG000|Overall Study|Lack of Efficacy|0|||
162621438|NCT03094169|587330516|FG001|Overall Study|Lack of Efficacy|0|||
162621439|NCT03094169|587330517|FG002|Overall Study|Lack of Efficacy|0|||
162621440|NCT03094169|587330518|FG003|Overall Study|Lack of Efficacy|0|||
162621441|NCT03094169|587330519|FG004|Overall Study|Lack of Efficacy|0|||
162964395|NCT01266902|588569766|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
162964396|NCT01266902|588569764|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
163051353|NCT01628848|588895437|FG000|Overall Study|Withdrawal by Subject|0|||
163051354|NCT01628848|588895438|FG001|Overall Study|Withdrawal by Subject|2|||
163051355|NCT01628848|588895437|FG000|Overall Study|Physician Decision|3|||
163051356|NCT01628848|588895438|FG001|Overall Study|Physician Decision|1|||
163051357|NCT01939314|588895440|FG000|Overall Study|Withdrawal by Subject|3|||
163051358|NCT01939314|588895441|FG001|Overall Study|Withdrawal by Subject|1|||
163051359|NCT01939314|588895440|FG000|Overall Study|Protocol Violation|1|||
163051360|NCT01939314|588895441|FG001|Overall Study|Protocol Violation|0|||
163051361|NCT01939314|588895440|FG000|Overall Study|Pregnancy|0|||
163051362|NCT01939314|588895441|FG001|Overall Study|Pregnancy|1|||
163051363|NCT01939314|588895440|FG000|Overall Study|Lost to Follow-up|5|||
163051364|NCT01939314|588895441|FG001|Overall Study|Lost to Follow-up|6|||
163051365|NCT00735007|588895442|FG000|Overall Study|Adverse Event|4|||
163051366|NCT00735007|588895442|FG000|Overall Study|Protocol Violation|1|||
163051367|NCT03311945|588895443|FG000|Overall Study|Adverse Event|2|||
163051368|NCT03311945|588895443|FG000|Overall Study|Lack of Efficacy|1|||
163051369|NCT03839394|588895444|FG000|Overall Study|Lost to Follow-up|6|||
162621442|NCT03094169|587330520|FG005|Overall Study|Lack of Efficacy|0|||
162621443|NCT03094169|587330521|FG006|Overall Study|Lack of Efficacy|0|||
162621444|NCT03094169|587330522|FG007|Overall Study|Lack of Efficacy|21|||
162621445|NCT03094169|587330515|FG000|Overall Study|Adverse Event|0|||
162621446|NCT03094169|587330516|FG001|Overall Study|Adverse Event|0|||
162621447|NCT03094169|587330517|FG002|Overall Study|Adverse Event|0|||
163051370|NCT03839394|588895445|FG001|Overall Study|Lost to Follow-up|8|||
163051371|NCT03839394|588895444|FG000|Overall Study|Withdrawal by Subject|0|||
163051372|NCT03839394|588895445|FG001|Overall Study|Withdrawal by Subject|2|||
163051373|NCT01945944|588895454|FG000|Overall Study|Adverse Event|0|||
163051374|NCT01945944|588895455|FG001|Overall Study|Adverse Event|2|||
163051375|NCT01945944|588895454|FG000|Overall Study|Physician Decision|1|||
163051376|NCT01945944|588895455|FG001|Overall Study|Physician Decision|0|||
163051377|NCT01945944|588895454|FG000|Overall Study|Withdrawal by Subject|0|||
163051378|NCT01945944|588895455|FG001|Overall Study|Withdrawal by Subject|1|||
163051379|NCT04376515|588895458|FG000|Overall Study|Found to have been vaccinated before study start|6|||
162621448|NCT03094169|587330518|FG003|Overall Study|Adverse Event|0|||
162621449|NCT03094169|587330519|FG004|Overall Study|Adverse Event|0|||
162621450|NCT03094169|587330520|FG005|Overall Study|Adverse Event|0|||
162621451|NCT03094169|587330521|FG006|Overall Study|Adverse Event|0|||
162621452|NCT03094169|587330522|FG007|Overall Study|Adverse Event|2|||
162621453|NCT03094169|587330515|FG000|Overall Study|Withdrawal by Subject|0|||
162621454|NCT03094169|587330516|FG001|Overall Study|Withdrawal by Subject|0|||
162621455|NCT03094169|587330517|FG002|Overall Study|Withdrawal by Subject|0|||
163051380|NCT04376515|588895459|FG001|Overall Study|Found to have been vaccinated before study start|6|||
163051381|NCT04579380|588897109|FG000|Overall Study|Death|9|||
162621456|NCT03094169|587330518|FG003|Overall Study|Withdrawal by Subject|0|||
162621457|NCT03094169|587330519|FG004|Overall Study|Withdrawal by Subject|0|||
162621458|NCT03094169|587330520|FG005|Overall Study|Withdrawal by Subject|0|||
162621459|NCT03094169|587330521|FG006|Overall Study|Withdrawal by Subject|1|||
162621460|NCT03094169|587330522|FG007|Overall Study|Withdrawal by Subject|1|||
162621461|NCT03094169|587330515|FG000|Overall Study|Trial Termination|0|||
162621462|NCT03094169|587330516|FG001|Overall Study|Trial Termination|0|||
162621463|NCT03094169|587330517|FG002|Overall Study|Trial Termination|0|||
162621464|NCT03094169|587330518|FG003|Overall Study|Trial Termination|0|||
162621465|NCT03094169|587330519|FG004|Overall Study|Trial Termination|0|||
162621466|NCT03094169|587330520|FG005|Overall Study|Trial Termination|0|||
162621467|NCT03094169|587330521|FG006|Overall Study|Trial Termination|0|||
162621468|NCT03094169|587330522|FG007|Overall Study|Trial Termination|1|||
162621469|NCT00617851|587330523|FG000|Overall Study|Death|0|||
162621470|NCT00617851|587330524|FG001|Overall Study|Death|0|||
162621471|NCT00617851|587330525|FG002|Overall Study|Death|0|||
162621472|NCT00617851|587330526|FG003|Overall Study|Death|1|||
162621473|NCT00617851|587330523|FG000|Overall Study|Withdrawal by Subject|14|||
162621474|NCT00617851|587330524|FG001|Overall Study|Withdrawal by Subject|7|||
162621475|NCT00617851|587330525|FG002|Overall Study|Withdrawal by Subject|12|||
162621476|NCT00617851|587330526|FG003|Overall Study|Withdrawal by Subject|4|||
162890362|NCT00608881|588296813|FG001|Overall Study|Lost to Follow-up|14|||
162890363|NCT00608881|588296812|FG000|Overall Study|Withdrawal by Subject|18|||
162890364|NCT00608881|588296813|FG001|Overall Study|Withdrawal by Subject|29|||
162890365|NCT00608881|588296812|FG000|Overall Study|Physician Decision|5|||
162890366|NCT00608881|588296813|FG001|Overall Study|Physician Decision|5|||
162890367|NCT00608881|588296812|FG000|Overall Study|Institutionalized|1|||
162890368|NCT00608881|588296813|FG001|Overall Study|Institutionalized|2|||
162890369|NCT00510484|588296814|FG000|Wash-out Period|Adverse Event|0|||
162890370|NCT00510484|588296815|FG001|Wash-out Period|Adverse Event|1|||
162890371|NCT01590212|588296816|FG000|Overall Study|Withdrawal by Subject|2|||
163051382|NCT04579380|588897110|FG001|Overall Study|Death|22|||
163051383|NCT04579380|588897111|FG002|Overall Study|Death|22|||
163051384|NCT04579380|588897112|FG003|Overall Study|Death|17|||
162621477|NCT00617851|587330523|FG000|Overall Study|Lost to Follow-up|27|||
162890372|NCT01590212|588296817|FG001|Overall Study|Withdrawal by Subject|2|||
163051385|NCT04579380|588897113|FG004|Overall Study|Death|6|||
162621478|NCT00617851|587330524|FG001|Overall Study|Lost to Follow-up|29|||
162621479|NCT00617851|587330525|FG002|Overall Study|Lost to Follow-up|31|||
162621480|NCT00617851|587330526|FG003|Overall Study|Lost to Follow-up|19|||
162621481|NCT00617851|587330523|FG000|Overall Study|Inappropriate Enrollment|5|||
162621482|NCT00617851|587330524|FG001|Overall Study|Inappropriate Enrollment|4|||
162621483|NCT00617851|587330525|FG002|Overall Study|Inappropriate Enrollment|1|||
162621484|NCT00617851|587330526|FG003|Overall Study|Inappropriate Enrollment|1|||
162621485|NCT00617851|587330523|FG000|Overall Study|Unable to classify|1|||
162621486|NCT00617851|587330524|FG001|Overall Study|Unable to classify|0|||
162621487|NCT00617851|587330525|FG002|Overall Study|Unable to classify|1|||
162621488|NCT00617851|587330526|FG003|Overall Study|Unable to classify|0|||
162621489|NCT05350410|587330529|FG000|Overall Study|Withdrawal by Subject|1|||
162621490|NCT03750955|587330536|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
162621491|NCT03750955|587330537|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
162621492|NCT03750955|587330536|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
162621493|NCT03750955|587330537|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
162621494|NCT00697788|587330543|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621495|NCT00697788|587330544|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
162621496|NCT00697788|587330545|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621497|NCT00697788|587330546|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621498|NCT00697788|587330547|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621499|NCT00697788|587330548|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621500|NCT00697788|587330549|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621501|NCT00697788|587330550|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162621502|NCT00697788|587330543|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621503|NCT00697788|587330544|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621504|NCT00697788|587330545|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621505|NCT00697788|587330546|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621506|NCT00697788|587330547|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
162621507|NCT00697788|587330548|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621508|NCT00697788|587330549|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621509|NCT00697788|587330550|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162621510|NCT00142935|587330552|FG000|Overall Study|Other reason|1|||
162621511|NCT00142935|587330553|FG001|Overall Study|Other reason|1|||
162621512|NCT00142935|587330554|FG002|Overall Study|Other reason|1|||
162621513|NCT00142935|587330552|FG000|Overall Study|Lost to Follow-up|2|||
162621514|NCT00142935|587330553|FG001|Overall Study|Lost to Follow-up|5|||
162621515|NCT00142935|587330554|FG002|Overall Study|Lost to Follow-up|5|||
162621516|NCT00142935|587330552|FG000|Overall Study|Death|0|||
162621517|NCT00142935|587330553|FG001|Overall Study|Death|2|||
162621518|NCT00142935|587330554|FG002|Overall Study|Death|1|||
162621519|NCT01180985|587330559|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
162621520|NCT01180985|587330560|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
162621521|NCT00705289|587330561|FG000|Overall Study|Subject or treating physician's choice|131|||
162621522|NCT01030536|587330562|FG000|Overall Study|Withdrawal by Subject|0|||
162621523|NCT01030536|587330563|FG001|Overall Study|Withdrawal by Subject|0|||
162621524|NCT01030536|587330564|FG002|Overall Study|Withdrawal by Subject|1|||
162621525|NCT01030536|587330565|FG003|Overall Study|Withdrawal by Subject|0|||
162621526|NCT01030536|587330566|FG004|Overall Study|Withdrawal by Subject|0|||
162621527|NCT01030536|587330562|FG000|Overall Study|undefined|1|||
162621528|NCT01030536|587330563|FG001|Overall Study|undefined|0|||
162621529|NCT01030536|587330564|FG002|Overall Study|undefined|1|||
162621530|NCT01030536|587330565|FG003|Overall Study|undefined|1|||
162621531|NCT01030536|587330566|FG004|Overall Study|undefined|0|||
162621532|NCT01030536|587330562|FG000|Overall Study|Adverse Event|0|||
162621533|NCT01030536|587330563|FG001|Overall Study|Adverse Event|3|||
162621534|NCT01030536|587330564|FG002|Overall Study|Adverse Event|1|||
162621535|NCT01030536|587330565|FG003|Overall Study|Adverse Event|0|||
162621536|NCT01030536|587330566|FG004|Overall Study|Adverse Event|1|||
162621537|NCT01030536|587330562|FG000|Overall Study|Progressive disease|6|||
162621538|NCT01030536|587330563|FG001|Overall Study|Progressive disease|2|||
162621539|NCT01030536|587330564|FG002|Overall Study|Progressive disease|3|||
162621540|NCT01030536|587330565|FG003|Overall Study|Progressive disease|2|||
162621541|NCT01030536|587330566|FG004|Overall Study|Progressive disease|0|||
162621542|NCT01030536|587330562|FG000|Overall Study|Death|0|||
162621543|NCT01030536|587330563|FG001|Overall Study|Death|1|||
162621544|NCT01030536|587330564|FG002|Overall Study|Death|0|||
162621545|NCT01030536|587330565|FG003|Overall Study|Death|0|||
162621546|NCT01030536|587330566|FG004|Overall Study|Death|0|||
162621547|NCT03345914|587330571|FG000|Overall Study|Transition to another study at week 16|80|||
162621548|NCT03345914|587330572|FG001|Overall Study|Transition to another study at week 16|86|||
162621549|NCT03345914|587330573|FG002|Overall Study|Transition to another study at week 16|78|||
162621550|NCT03345914|587330571|FG000|Overall Study|Transition to OLE during follow-up|37|||
162621551|NCT03345914|587330572|FG001|Overall Study|Transition to OLE during follow-up|33|||
162621552|NCT03345914|587330573|FG002|Overall Study|Transition to OLE during follow-up|39|||
162964397|NCT01266902|588569765|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
162964398|NCT01266902|588569766|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
162964399|NCT01266902|588569764|FG000|Period 1 (Main Study)|Adverse Event|3|||
162964400|NCT01266902|588569765|FG001|Period 1 (Main Study)|Adverse Event|11|||
162964401|NCT01266902|588569766|FG002|Period 1 (Main Study)|Adverse Event|0|||
162964402|NCT01266902|588569764|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
162964403|NCT01266902|588569765|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
162964404|NCT01266902|588569766|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
162964405|NCT01266902|588569764|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
162964406|NCT01266902|588569765|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
162964407|NCT01266902|588569766|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
162964408|NCT01266902|588569764|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
162964409|NCT01266902|588569765|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
162964410|NCT01266902|588569766|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
162964411|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
162964412|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
162964413|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
162964414|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
162964415|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
162964416|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
162964417|NCT01266902|588569764|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
162964418|NCT01266902|588569765|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
162964419|NCT01266902|588569766|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
162964420|NCT02121184|588569767|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
162964421|NCT02121184|588569768|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
162964422|NCT02121184|588569767|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
162964423|NCT02121184|588569768|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
162964424|NCT02121184|588569767|FG000|Overall Study|Emergency cesarean section required|0|||
162964425|NCT02121184|588569768|FG001|Overall Study|Emergency cesarean section required|2|||
162964426|NCT02121184|588569767|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
162964427|NCT02121184|588569768|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
162964428|NCT00840203|588569769|FG000|First Intervention|Protocol Violation|1|||
162964429|NCT00840203|588569770|FG001|First Intervention|Protocol Violation|1|||
162964430|NCT00840203|588569769|FG000|Washout|Protocol Violation|1|||
162964431|NCT00840203|588569770|FG001|Washout|Protocol Violation|0|||
162964432|NCT04567329|588569773|FG000|Overall Study|Withdrawal by Subject|5|||
162964433|NCT04567329|588569774|FG001|Overall Study|Withdrawal by Subject|6|||
162964434|NCT04567329|588569773|FG000|Overall Study|Protocol Violation|2|||
162964435|NCT04567329|588569774|FG001|Overall Study|Protocol Violation|3|||
162964436|NCT04567329|588569773|FG000|Overall Study|Discontinued|2|||
162964437|NCT04567329|588569774|FG001|Overall Study|Discontinued|2|||
162964438|NCT04567329|588569773|FG000|Overall Study|Lost to Follow-up|0|||
162964439|NCT04567329|588569774|FG001|Overall Study|Lost to Follow-up|1|||
162964440|NCT04567329|588569773|FG000|Overall Study|Lack of Efficacy|0|||
162964441|NCT04567329|588569774|FG001|Overall Study|Lack of Efficacy|1|||
162964442|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
162964443|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
162964444|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
162964445|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
162964446|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
162964447|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
162964448|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
162964449|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
162964450|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
162621553|NCT03345914|587330571|FG000|Overall Study|Physician Decision|0|||
162621554|NCT03345914|587330572|FG001|Overall Study|Physician Decision|1|||
162621555|NCT03345914|587330573|FG002|Overall Study|Physician Decision|1|||
162621556|NCT03345914|587330571|FG000|Overall Study|Withdrawal by Subject|5|||
162621557|NCT03345914|587330572|FG001|Overall Study|Withdrawal by Subject|1|||
162621558|NCT03345914|587330573|FG002|Overall Study|Withdrawal by Subject|2|||
162621559|NCT03345914|587330571|FG000|Overall Study|Other|1|||
162621560|NCT03345914|587330572|FG001|Overall Study|Other|1|||
162621561|NCT03345914|587330573|FG002|Overall Study|Other|1|||
162621562|NCT03345914|587330571|FG000|Overall Study|Ongoing|0|||
162621563|NCT03345914|587330572|FG001|Overall Study|Ongoing|0|||
162621564|NCT03345914|587330573|FG002|Overall Study|Ongoing|1|||
162621565|NCT02601027|587330576|FG000|Registration to Surgery|Withdrawal by Subject|20|||
162621566|NCT02601027|587330577|FG001|Registration to Surgery|Withdrawal by Subject|10|||
162621567|NCT01330030|587330578|FG000|Overall Study|Lost to Follow-up|16|||
162621568|NCT01330030|587330579|FG001|Overall Study|Lost to Follow-up|17|||
162621569|NCT01365052|587330580|FG000|Overall Study|Adverse Event|4|||
162621570|NCT01365052|587330581|FG001|Overall Study|Adverse Event|4|||
162621571|NCT02248701|587330584|FG000|Overall Study|Withdrawal by Subject|2|||
162621572|NCT02248701|587330585|FG001|Overall Study|Withdrawal by Subject|1|||
162621573|NCT02248701|587330584|FG000|Overall Study|Physician Decision|0|||
162621574|NCT02248701|587330585|FG001|Overall Study|Physician Decision|1|||
162621575|NCT02248701|587330584|FG000|Overall Study|Adverse Event|1|||
162621576|NCT02248701|587330585|FG001|Overall Study|Adverse Event|0|||
162621577|NCT02248701|587330584|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
162621578|NCT02248701|587330585|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
162621579|NCT00885846|587330588|FG000|Overall Study|Withdrawal by Subject|2|||
162621580|NCT00885846|587330589|FG001|Overall Study|Withdrawal by Subject|5|||
162621581|NCT00885846|587330590|FG002|Overall Study|Withdrawal by Subject|2|||
162621582|NCT00074984|587330591|FG000|Overall Study|Death|1|||
162621583|NCT00074984|587330592|FG001|Overall Study|Death|2|||
162621584|NCT00074984|587330591|FG000|Overall Study|Withdrawal by Subject|2|||
162621585|NCT00074984|587330592|FG001|Overall Study|Withdrawal by Subject|3|||
162621586|NCT00074984|587330591|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
162621587|NCT00074984|587330592|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
162621588|NCT03758443|587330593|FG000|Induction Period|Adverse Event|2|||
162621589|NCT03758443|587330594|FG001|Induction Period|Adverse Event|4|||
162621590|NCT03758443|587330595|FG002|Induction Period|Adverse Event|2|||
162621591|NCT03758443|587330596|FG003|Induction Period|Adverse Event|3|||
162621592|NCT03758443|587330593|FG000|Induction Period|Physician Decision|1|||
162621593|NCT03758443|587330594|FG001|Induction Period|Physician Decision|1|||
162621594|NCT03758443|587330595|FG002|Induction Period|Physician Decision|3|||
162621595|NCT03758443|587330596|FG003|Induction Period|Physician Decision|0|||
162621596|NCT03758443|587330593|FG000|Induction Period|Protocol Violation|0|||
162621597|NCT03758443|587330594|FG001|Induction Period|Protocol Violation|0|||
162621598|NCT03758443|587330595|FG002|Induction Period|Protocol Violation|0|||
162621599|NCT03758443|587330596|FG003|Induction Period|Protocol Violation|1|||
162621600|NCT03758443|587330593|FG000|Induction Period|Withdrawal by Subject|3|||
162621601|NCT03758443|587330594|FG001|Induction Period|Withdrawal by Subject|2|||
162621602|NCT03758443|587330595|FG002|Induction Period|Withdrawal by Subject|2|||
162621603|NCT03758443|587330596|FG003|Induction Period|Withdrawal by Subject|4|||
162621604|NCT03758443|587330593|FG000|Extended Induction Period|Adverse Event|1|||
162621605|NCT03758443|587330594|FG001|Extended Induction Period|Adverse Event|1|||
162621606|NCT03758443|587330595|FG002|Extended Induction Period|Adverse Event|0|||
162621607|NCT03758443|587330596|FG003|Extended Induction Period|Adverse Event|1|||
162621608|NCT03758443|587330593|FG000|Extended Induction Period|Lost to Follow-up|1|||
162621609|NCT03758443|587330594|FG001|Extended Induction Period|Lost to Follow-up|0|||
162621610|NCT03758443|587330595|FG002|Extended Induction Period|Lost to Follow-up|0|||
162621611|NCT03758443|587330596|FG003|Extended Induction Period|Lost to Follow-up|0|||
162621612|NCT03758443|587330593|FG000|Extended Induction Period|Physician Decision|2|||
162621613|NCT03758443|587330594|FG001|Extended Induction Period|Physician Decision|1|||
162621614|NCT03758443|587330595|FG002|Extended Induction Period|Physician Decision|2|||
162621615|NCT03758443|587330596|FG003|Extended Induction Period|Physician Decision|2|||
162621616|NCT03758443|587330593|FG000|Extended Induction Period|Protocol Violation|0|||
162621617|NCT03758443|587330594|FG001|Extended Induction Period|Protocol Violation|0|||
162621618|NCT03758443|587330595|FG002|Extended Induction Period|Protocol Violation|0|||
162621619|NCT03758443|587330596|FG003|Extended Induction Period|Protocol Violation|1|||
162621620|NCT03758443|587330593|FG000|Extended Induction Period|Withdrawal by Subject|8|||
162621621|NCT03758443|587330594|FG001|Extended Induction Period|Withdrawal by Subject|1|||
162621622|NCT03758443|587330595|FG002|Extended Induction Period|Withdrawal by Subject|7|||
162621623|NCT03758443|587330596|FG003|Extended Induction Period|Withdrawal by Subject|3|||
162621624|NCT03758443|587330593|FG000|Extended Induction Period|Miscellaneous|1|||
162621625|NCT03758443|587330594|FG001|Extended Induction Period|Miscellaneous|0|||
162621626|NCT03758443|587330595|FG002|Extended Induction Period|Miscellaneous|0|||
162621627|NCT03758443|587330596|FG003|Extended Induction Period|Miscellaneous|0|||
162621628|NCT03758443|587330593|FG000|Maintenance Period|Adverse Event|1|||
162621629|NCT03758443|587330594|FG001|Maintenance Period|Adverse Event|2|||
162621630|NCT03758443|587330595|FG002|Maintenance Period|Adverse Event|0|||
162621631|NCT03758443|587330596|FG003|Maintenance Period|Adverse Event|0|||
162621632|NCT03758443|587330593|FG000|Maintenance Period|Lost to Follow-up|0|||
162621633|NCT03758443|587330594|FG001|Maintenance Period|Lost to Follow-up|0|||
162890373|NCT01590212|588296818|FG002|Overall Study|Withdrawal by Subject|2|||
162890374|NCT01590212|588296816|FG000|Overall Study|Lost to Follow-up|1|||
162890375|NCT01590212|588296817|FG001|Overall Study|Lost to Follow-up|2|||
162890376|NCT01590212|588296818|FG002|Overall Study|Lost to Follow-up|3|||
162621634|NCT03758443|587330595|FG002|Maintenance Period|Lost to Follow-up|0|||
162621635|NCT03758443|587330596|FG003|Maintenance Period|Lost to Follow-up|1|||
162621636|NCT03758443|587330593|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
162621637|NCT03758443|587330594|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
162621638|NCT03758443|587330595|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
162621639|NCT03758443|587330596|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
162621640|NCT03758443|587330593|FG000|Maintenance Period|Protocol Violation|0|||
162621641|NCT03758443|587330594|FG001|Maintenance Period|Protocol Violation|1|||
162621642|NCT03758443|587330595|FG002|Maintenance Period|Protocol Violation|0|||
162621643|NCT03758443|587330596|FG003|Maintenance Period|Protocol Violation|0|||
162621644|NCT03758443|587330593|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
162621645|NCT03758443|587330594|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
162621646|NCT03758443|587330595|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
162621647|NCT03758443|587330596|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
162621648|NCT03758443|587330593|FG000|Maintenance Period|Withdrawal by Subject|1|||
162621649|NCT03758443|587330594|FG001|Maintenance Period|Withdrawal by Subject|0|||
162621650|NCT03758443|587330595|FG002|Maintenance Period|Withdrawal by Subject|1|||
162621651|NCT03758443|587330596|FG003|Maintenance Period|Withdrawal by Subject|1|||
162621652|NCT03758443|587330593|FG000|Maintenance Period|Miscellaneous|0|||
162621653|NCT03758443|587330594|FG001|Maintenance Period|Miscellaneous|0|||
162621654|NCT03758443|587330595|FG002|Maintenance Period|Miscellaneous|1|||
162621655|NCT03758443|587330596|FG003|Maintenance Period|Miscellaneous|0|||
162621656|NCT03080454|587330597|FG000|Baseline|Adverse Event|2|||
162621657|NCT03080454|587330597|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
162621658|NCT03080454|587330597|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
162621659|NCT02747875|587330598|FG000|Overall Study|Physician Decision|1|||
162621660|NCT02747875|587330599|FG001|Overall Study|Physician Decision|0|||
162621661|NCT02747875|587330598|FG000|Overall Study|Adverse Event|0|||
162621662|NCT02747875|587330599|FG001|Overall Study|Adverse Event|1|||
162621663|NCT03863197|587330600|FG000|Overall Study|Lost to Follow-up|2|||
162621664|NCT03863197|587330601|FG001|Overall Study|Lost to Follow-up|3|||
162621665|NCT03863197|587330600|FG000|Overall Study|Withdrawal by Subject|4|||
162621666|NCT03863197|587330601|FG001|Overall Study|Withdrawal by Subject|0|||
162621667|NCT03863197|587330600|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
162621668|NCT03863197|587330601|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
162621669|NCT01781975|587330602|FG000|Overall Study|Death|1|||
162621670|NCT01781975|587330603|FG001|Overall Study|Death|0|||
162621671|NCT01781975|587330602|FG000|Overall Study|Withdrawal by Subject|1|||
162621672|NCT01781975|587330603|FG001|Overall Study|Withdrawal by Subject|1|||
162621673|NCT01622231|587330604|FG000|Overall Study|Physician Decision|1|||
162621674|NCT01622231|587330604|FG000|Overall Study|Withdrawal by Subject|1|||
162621675|NCT01058655|587330605|FG000|Overall Study|Withdrawal by Subject|1|||
162621676|NCT01058655|587330606|FG001|Overall Study|Withdrawal by Subject|0|||
162621677|NCT01058655|587330607|FG002|Overall Study|Withdrawal by Subject|3|||
162621678|NCT01058655|587330608|FG003|Overall Study|Withdrawal by Subject|4|||
162621679|NCT01058655|587330605|FG000|Overall Study|Prolonged Treatment Delay|0|||
162621680|NCT01058655|587330606|FG001|Overall Study|Prolonged Treatment Delay|0|||
162621681|NCT01058655|587330607|FG002|Overall Study|Prolonged Treatment Delay|0|||
162621682|NCT01058655|587330608|FG003|Overall Study|Prolonged Treatment Delay|2|||
162621683|NCT01058655|587330605|FG000|Overall Study|Symptomatic Deterioration|0|||
162621684|NCT01058655|587330606|FG001|Overall Study|Symptomatic Deterioration|0|||
162621685|NCT01058655|587330607|FG002|Overall Study|Symptomatic Deterioration|0|||
162621686|NCT01058655|587330608|FG003|Overall Study|Symptomatic Deterioration|1|||
162621687|NCT01058655|587330605|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
162621688|NCT01058655|587330606|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
162621689|NCT01058655|587330607|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
162621690|NCT01058655|587330608|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
162621691|NCT01058655|587330605|FG000|Overall Study|Death|0|||
162621692|NCT01058655|587330606|FG001|Overall Study|Death|1|||
163051386|NCT04579380|588897114|FG005|Overall Study|Death|21|||
163051387|NCT04579380|588897115|FG006|Overall Study|Death|10|||
163051388|NCT04579380|588897116|FG007|Overall Study|Death|11|||
163051389|NCT04579380|588897117|FG008|Overall Study|Death|25|||
163051390|NCT04579380|588897109|FG000|Overall Study|Withdrawal by Subject|0|||
162621693|NCT01058655|587330607|FG002|Overall Study|Death|1|||
162621694|NCT01058655|587330608|FG003|Overall Study|Death|0|||
162621695|NCT01058655|587330605|FG000|Overall Study|Disease Progression|1|||
162621696|NCT01058655|587330606|FG001|Overall Study|Disease Progression|2|||
162621697|NCT01058655|587330607|FG002|Overall Study|Disease Progression|4|||
162621698|NCT01058655|587330608|FG003|Overall Study|Disease Progression|24|||
162621699|NCT01058655|587330605|FG000|Overall Study|Other|0|||
162621700|NCT01058655|587330606|FG001|Overall Study|Other|0|||
162621701|NCT01058655|587330607|FG002|Overall Study|Other|0|||
162621702|NCT01058655|587330608|FG003|Overall Study|Other|4|||
162621703|NCT04545060|587330609|FG000|Overall Study|Adverse Event|0|||
163051391|NCT04579380|588897110|FG001|Overall Study|Withdrawal by Subject|3|||
163051392|NCT04579380|588897111|FG002|Overall Study|Withdrawal by Subject|4|||
162621704|NCT04545060|587330610|FG001|Overall Study|Adverse Event|1|||
162621705|NCT04545060|587330609|FG000|Overall Study|Death|0|||
162621706|NCT04545060|587330610|FG001|Overall Study|Death|5|||
162621707|NCT04545060|587330609|FG000|Overall Study|Lost to Follow-up|10|||
162621708|NCT04545060|587330610|FG001|Overall Study|Lost to Follow-up|13|||
162621709|NCT04545060|587330609|FG000|Overall Study|Physician Decision|3|||
162621710|NCT04545060|587330610|FG001|Overall Study|Physician Decision|0|||
162621711|NCT04545060|587330609|FG000|Overall Study|Withdrawal by Subject|17|||
162621712|NCT04545060|587330610|FG001|Overall Study|Withdrawal by Subject|22|||
162621713|NCT02846324|587330611|FG000|Overall Study|Other|1|||
162621714|NCT02846324|587330612|FG001|Overall Study|Other|0|||
162621715|NCT02846324|587330613|FG002|Overall Study|Other|0|||
162621716|NCT02846324|587330614|FG003|Overall Study|Other|0|||
162621717|NCT02846324|587330611|FG000|Overall Study|Withdrawal by Subject|1|||
162621718|NCT02846324|587330612|FG001|Overall Study|Withdrawal by Subject|0|||
162621719|NCT02846324|587330613|FG002|Overall Study|Withdrawal by Subject|4|||
162621720|NCT02846324|587330614|FG003|Overall Study|Withdrawal by Subject|0|||
162621721|NCT00810355|587330624|FG000|Overall Study|Lost to Follow-up|13|||
162621722|NCT00810355|587330625|FG001|Overall Study|Lost to Follow-up|17|||
162621723|NCT00810355|587330626|FG002|Overall Study|Lost to Follow-up|11|||
162621724|NCT00810355|587330624|FG000|Overall Study|Withdrawal by Subject|1|||
162621725|NCT00810355|587330625|FG001|Overall Study|Withdrawal by Subject|0|||
162621726|NCT00810355|587330626|FG002|Overall Study|Withdrawal by Subject|0|||
162621727|NCT00657358|587330627|FG000|Overall Study|Lack of Efficacy|6|||
162621728|NCT00400764|587330628|FG000|Phase Ib|Adverse Event|1|||
162621729|NCT00400764|587330629|FG001|Phase Ib|Adverse Event|0|||
162621730|NCT00400764|587330630|FG002|Phase Ib|Adverse Event|0|||
162621731|NCT00400764|587330631|FG003|Phase Ib|Adverse Event|0|||
162621732|NCT00400764|587330632|FG004|Phase Ib|Adverse Event|0|||
162621733|NCT00400764|587330628|FG000|Phase Ib|Death|1|||
162621734|NCT00400764|587330629|FG001|Phase Ib|Death|0|||
162621735|NCT00400764|587330630|FG002|Phase Ib|Death|0|||
162621736|NCT00400764|587330631|FG003|Phase Ib|Death|0|||
162621737|NCT00400764|587330632|FG004|Phase Ib|Death|0|||
162621738|NCT00400764|587330628|FG000|Phase Ib|Disease Progression|4|||
162621739|NCT00400764|587330629|FG001|Phase Ib|Disease Progression|4|||
162621740|NCT00400764|587330630|FG002|Phase Ib|Disease Progression|0|||
162621741|NCT00400764|587330631|FG003|Phase Ib|Disease Progression|0|||
162621742|NCT00400764|587330632|FG004|Phase Ib|Disease Progression|0|||
162621743|NCT00400764|587330628|FG000|Phase II|Death|0|||
162621744|NCT00400764|587330629|FG001|Phase II|Death|0|||
162621745|NCT00400764|587330630|FG002|Phase II|Death|1|||
162621746|NCT00400764|587330631|FG003|Phase II|Death|2|||
162621747|NCT00400764|587330632|FG004|Phase II|Death|0|||
162621748|NCT00400764|587330628|FG000|Phase II|Lost to Follow-up|0|||
162621749|NCT00400764|587330629|FG001|Phase II|Lost to Follow-up|0|||
162621750|NCT00400764|587330630|FG002|Phase II|Lost to Follow-up|1|||
162621751|NCT00400764|587330631|FG003|Phase II|Lost to Follow-up|0|||
162621752|NCT00400764|587330632|FG004|Phase II|Lost to Follow-up|0|||
162621753|NCT00400764|587330628|FG000|Phase II|Physician Decision|0|||
162621754|NCT00400764|587330629|FG001|Phase II|Physician Decision|0|||
162621755|NCT00400764|587330630|FG002|Phase II|Physician Decision|1|||
162621756|NCT00400764|587330631|FG003|Phase II|Physician Decision|1|||
162621757|NCT00400764|587330632|FG004|Phase II|Physician Decision|0|||
162621758|NCT00400764|587330628|FG000|Phase II|Sponsor's decision to terminate|0|||
162621759|NCT00400764|587330629|FG001|Phase II|Sponsor's decision to terminate|0|||
162621760|NCT00400764|587330630|FG002|Phase II|Sponsor's decision to terminate|18|||
162621761|NCT00400764|587330631|FG003|Phase II|Sponsor's decision to terminate|22|||
162621762|NCT00400764|587330632|FG004|Phase II|Sponsor's decision to terminate|11|||
162621763|NCT00400764|587330628|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
162621764|NCT00400764|587330629|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
162621765|NCT00400764|587330630|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
162621766|NCT00400764|587330631|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
162621767|NCT00400764|587330632|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
162621768|NCT00400764|587330628|FG000|Phase II|Withdrawal by Subject|0|||
162621769|NCT00400764|587330629|FG001|Phase II|Withdrawal by Subject|0|||
162621770|NCT00400764|587330630|FG002|Phase II|Withdrawal by Subject|1|||
162621771|NCT00400764|587330631|FG003|Phase II|Withdrawal by Subject|1|||
162621772|NCT00400764|587330632|FG004|Phase II|Withdrawal by Subject|0|||
162621773|NCT00347360|587330635|FG000|Overall Study|Adverse Event|1|||
162621774|NCT00347360|587330636|FG001|Overall Study|Adverse Event|2|||
162621775|NCT00347360|587330637|FG002|Overall Study|Adverse Event|0|||
162621776|NCT00347360|587330638|FG003|Overall Study|Adverse Event|4|||
162621777|NCT00347360|587330639|FG004|Overall Study|Adverse Event|1|||
162621778|NCT00347360|587330640|FG005|Overall Study|Adverse Event|2|||
162621779|NCT00347360|587330641|FG006|Overall Study|Adverse Event|2|||
162621780|NCT00347360|587330642|FG007|Overall Study|Adverse Event|0|||
162621781|NCT00347360|587330643|FG008|Overall Study|Adverse Event|2|||
162621782|NCT00347360|587330644|FG009|Overall Study|Adverse Event|3|||
162621783|NCT00347360|587330645|FG010|Overall Study|Adverse Event|3|||
162621784|NCT00347360|587330646|FG011|Overall Study|Adverse Event|1|||
162621785|NCT00347360|587330647|FG012|Overall Study|Adverse Event|3|||
162621786|NCT00347360|587330648|FG013|Overall Study|Adverse Event|2|||
162621787|NCT00347360|587330649|FG014|Overall Study|Adverse Event|2|||
162621788|NCT00347360|587330635|FG000|Overall Study|Lost to Follow-up|0|||
162621789|NCT00347360|587330636|FG001|Overall Study|Lost to Follow-up|0|||
162621790|NCT00347360|587330637|FG002|Overall Study|Lost to Follow-up|0|||
162621791|NCT00347360|587330638|FG003|Overall Study|Lost to Follow-up|2|||
162621792|NCT00347360|587330639|FG004|Overall Study|Lost to Follow-up|1|||
162621793|NCT00347360|587330640|FG005|Overall Study|Lost to Follow-up|1|||
162621794|NCT00347360|587330641|FG006|Overall Study|Lost to Follow-up|0|||
162621795|NCT00347360|587330642|FG007|Overall Study|Lost to Follow-up|1|||
162621796|NCT00347360|587330643|FG008|Overall Study|Lost to Follow-up|1|||
162621797|NCT00347360|587330644|FG009|Overall Study|Lost to Follow-up|2|||
162621798|NCT00347360|587330645|FG010|Overall Study|Lost to Follow-up|0|||
162621799|NCT00347360|587330646|FG011|Overall Study|Lost to Follow-up|0|||
162621800|NCT00347360|587330647|FG012|Overall Study|Lost to Follow-up|1|||
162621801|NCT00347360|587330648|FG013|Overall Study|Lost to Follow-up|0|||
162621802|NCT00347360|587330649|FG014|Overall Study|Lost to Follow-up|0|||
162621803|NCT00347360|587330635|FG000|Overall Study|Protocol Violation|2|||
162621804|NCT00347360|587330636|FG001|Overall Study|Protocol Violation|3|||
162621805|NCT00347360|587330637|FG002|Overall Study|Protocol Violation|1|||
162621806|NCT00347360|587330638|FG003|Overall Study|Protocol Violation|2|||
162621807|NCT00347360|587330639|FG004|Overall Study|Protocol Violation|1|||
162621808|NCT00347360|587330640|FG005|Overall Study|Protocol Violation|2|||
162621809|NCT00347360|587330641|FG006|Overall Study|Protocol Violation|0|||
162621810|NCT00347360|587330642|FG007|Overall Study|Protocol Violation|0|||
162621811|NCT00347360|587330643|FG008|Overall Study|Protocol Violation|1|||
162621812|NCT00347360|587330644|FG009|Overall Study|Protocol Violation|2|||
162621813|NCT00347360|587330645|FG010|Overall Study|Protocol Violation|0|||
162621814|NCT00347360|587330646|FG011|Overall Study|Protocol Violation|0|||
162621815|NCT00347360|587330647|FG012|Overall Study|Protocol Violation|0|||
162621816|NCT00347360|587330648|FG013|Overall Study|Protocol Violation|1|||
162621817|NCT00347360|587330649|FG014|Overall Study|Protocol Violation|0|||
162621818|NCT00347360|587330635|FG000|Overall Study|Withdrawal by Subject|0|||
162621819|NCT00347360|587330636|FG001|Overall Study|Withdrawal by Subject|1|||
162621820|NCT00347360|587330637|FG002|Overall Study|Withdrawal by Subject|2|||
162621821|NCT00347360|587330638|FG003|Overall Study|Withdrawal by Subject|4|||
162621822|NCT00347360|587330639|FG004|Overall Study|Withdrawal by Subject|1|||
162621823|NCT00347360|587330640|FG005|Overall Study|Withdrawal by Subject|2|||
162621824|NCT00347360|587330641|FG006|Overall Study|Withdrawal by Subject|1|||
162621825|NCT00347360|587330642|FG007|Overall Study|Withdrawal by Subject|1|||
162621826|NCT00347360|587330643|FG008|Overall Study|Withdrawal by Subject|1|||
162890377|NCT02533401|588296819|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
162890378|NCT02533401|588296819|FG000|Overall Study|Death|5|||
162890379|NCT02533401|588296819|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
162890380|NCT02533401|588296819|FG000|Overall Study|Lost to Follow-up|1|||
162890381|NCT02533401|588296819|FG000|Overall Study|Violation of Selection Criteria|1|||
162890382|NCT04897594|588296824|FG000|Overall Study|Lost to Follow-up|0|||
162890383|NCT04897594|588296825|FG001|Overall Study|Lost to Follow-up|1|||
162890384|NCT04897594|588296826|FG002|Overall Study|Lost to Follow-up|1|||
162890385|NCT04897594|588296824|FG000|Overall Study|Sponsor Decision|0|||
162890386|NCT04897594|588296825|FG001|Overall Study|Sponsor Decision|0|||
162890387|NCT04897594|588296826|FG002|Overall Study|Sponsor Decision|1|||
162964451|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
162621827|NCT00347360|587330644|FG009|Overall Study|Withdrawal by Subject|1|||
162621828|NCT00347360|587330645|FG010|Overall Study|Withdrawal by Subject|0|||
162621829|NCT00347360|587330646|FG011|Overall Study|Withdrawal by Subject|3|||
162621830|NCT00347360|587330647|FG012|Overall Study|Withdrawal by Subject|4|||
162621831|NCT00347360|587330648|FG013|Overall Study|Withdrawal by Subject|2|||
162621832|NCT00347360|587330649|FG014|Overall Study|Withdrawal by Subject|1|||
162621833|NCT00347360|587330635|FG000|Overall Study|Lack of Efficacy|1|||
162890388|NCT04897594|588296824|FG000|Overall Study|Withdrawal by Subject|1|||
162890389|NCT04897594|588296825|FG001|Overall Study|Withdrawal by Subject|0|||
162890390|NCT04897594|588296826|FG002|Overall Study|Withdrawal by Subject|1|||
162890391|NCT02147691|588296829|FG000|Overall Study|Withdrawal by Subject|2|||
162621834|NCT00347360|587330636|FG001|Overall Study|Lack of Efficacy|1|||
162890392|NCT02147691|588296830|FG001|Overall Study|Withdrawal by Subject|0|||
162890393|NCT02147691|588296829|FG000|Overall Study|Adverse Event|2|||
162621835|NCT00347360|587330637|FG002|Overall Study|Lack of Efficacy|3|||
162621836|NCT00347360|587330638|FG003|Overall Study|Lack of Efficacy|1|||
162621837|NCT00347360|587330639|FG004|Overall Study|Lack of Efficacy|0|||
162621838|NCT00347360|587330640|FG005|Overall Study|Lack of Efficacy|1|||
162621839|NCT00347360|587330641|FG006|Overall Study|Lack of Efficacy|0|||
162621840|NCT00347360|587330642|FG007|Overall Study|Lack of Efficacy|1|||
162621841|NCT00347360|587330643|FG008|Overall Study|Lack of Efficacy|1|||
162621842|NCT00347360|587330644|FG009|Overall Study|Lack of Efficacy|0|||
162621843|NCT00347360|587330645|FG010|Overall Study|Lack of Efficacy|0|||
162621844|NCT00347360|587330646|FG011|Overall Study|Lack of Efficacy|0|||
162621845|NCT00347360|587330647|FG012|Overall Study|Lack of Efficacy|0|||
162621846|NCT00347360|587330648|FG013|Overall Study|Lack of Efficacy|0|||
162621847|NCT00347360|587330649|FG014|Overall Study|Lack of Efficacy|0|||
162621848|NCT00347360|587330635|FG000|Overall Study|Reason not listed/blank|1|||
162621849|NCT00347360|587330636|FG001|Overall Study|Reason not listed/blank|0|||
162621850|NCT00347360|587330637|FG002|Overall Study|Reason not listed/blank|0|||
162621851|NCT00347360|587330638|FG003|Overall Study|Reason not listed/blank|0|||
162890394|NCT02147691|588296830|FG001|Overall Study|Adverse Event|0|||
162890395|NCT02147691|588296829|FG000|Overall Study|Lost to Follow-up|0|||
162890396|NCT02147691|588296830|FG001|Overall Study|Lost to Follow-up|1|||
162890397|NCT01181141|588296833|FG000|Overall Study|Adverse Event|2|||
162890398|NCT01181141|588296834|FG001|Overall Study|Adverse Event|1|||
162890399|NCT01181141|588296833|FG000|Overall Study|Lack of Efficacy|1|||
162890400|NCT01181141|588296834|FG001|Overall Study|Lack of Efficacy|0|||
162890401|NCT01181141|588296833|FG000|Overall Study|Lost to Follow-up|1|||
162890402|NCT01181141|588296834|FG001|Overall Study|Lost to Follow-up|1|||
162890403|NCT01181141|588296833|FG000|Overall Study|Physician Decision|2|||
162890404|NCT01181141|588296834|FG001|Overall Study|Physician Decision|0|||
162890405|NCT01181141|588296833|FG000|Overall Study|Protocol Violation|3|||
162964452|NCT01438060|588569776|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
162621852|NCT00347360|587330639|FG004|Overall Study|Reason not listed/blank|0|||
162621853|NCT00347360|587330640|FG005|Overall Study|Reason not listed/blank|0|||
162621854|NCT00347360|587330641|FG006|Overall Study|Reason not listed/blank|1|||
162890406|NCT01181141|588296834|FG001|Overall Study|Protocol Violation|1|||
162621855|NCT00347360|587330642|FG007|Overall Study|Reason not listed/blank|0|||
162621856|NCT00347360|587330643|FG008|Overall Study|Reason not listed/blank|0|||
162621857|NCT00347360|587330644|FG009|Overall Study|Reason not listed/blank|0|||
162621858|NCT00347360|587330645|FG010|Overall Study|Reason not listed/blank|0|||
162621859|NCT00347360|587330646|FG011|Overall Study|Reason not listed/blank|0|||
162621860|NCT00347360|587330647|FG012|Overall Study|Reason not listed/blank|0|||
162621861|NCT00347360|587330648|FG013|Overall Study|Reason not listed/blank|1|||
162621862|NCT00347360|587330649|FG014|Overall Study|Reason not listed/blank|0|||
162621863|NCT00347360|587330635|FG000|Overall Study|Per sponsors instruction|0|||
162621864|NCT00347360|587330636|FG001|Overall Study|Per sponsors instruction|1|||
162621865|NCT00347360|587330637|FG002|Overall Study|Per sponsors instruction|0|||
162621866|NCT00347360|587330638|FG003|Overall Study|Per sponsors instruction|0|||
162621867|NCT00347360|587330639|FG004|Overall Study|Per sponsors instruction|0|||
162621868|NCT00347360|587330640|FG005|Overall Study|Per sponsors instruction|0|||
162621869|NCT00347360|587330641|FG006|Overall Study|Per sponsors instruction|0|||
162621870|NCT00347360|587330642|FG007|Overall Study|Per sponsors instruction|0|||
162621871|NCT00347360|587330643|FG008|Overall Study|Per sponsors instruction|0|||
162621872|NCT00347360|587330644|FG009|Overall Study|Per sponsors instruction|0|||
162621873|NCT00347360|587330645|FG010|Overall Study|Per sponsors instruction|0|||
162621874|NCT00347360|587330646|FG011|Overall Study|Per sponsors instruction|0|||
162621875|NCT00347360|587330647|FG012|Overall Study|Per sponsors instruction|0|||
162621876|NCT00347360|587330648|FG013|Overall Study|Per sponsors instruction|0|||
162621877|NCT00347360|587330649|FG014|Overall Study|Per sponsors instruction|0|||
162621878|NCT00347360|587330635|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
162621879|NCT00347360|587330636|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
162621880|NCT00347360|587330637|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
162621881|NCT00347360|587330638|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
162621882|NCT00347360|587330639|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
162621883|NCT00347360|587330640|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
162621884|NCT00347360|587330641|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
162621885|NCT00347360|587330642|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
162621886|NCT00347360|587330643|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
162621887|NCT00347360|587330644|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
162621888|NCT00347360|587330645|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
162621889|NCT00347360|587330646|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
162621890|NCT00347360|587330647|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
162621891|NCT00347360|587330648|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
162621892|NCT00347360|587330649|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
162621893|NCT00347360|587330635|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
162621894|NCT00347360|587330636|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
162621895|NCT00347360|587330637|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
162890407|NCT01181141|588296833|FG000|Overall Study|Withdrawal by Subject|3|||
162890408|NCT01181141|588296834|FG001|Overall Study|Withdrawal by Subject|1|||
162890409|NCT01665768|588296835|FG000|Overall Study|Adverse Event|3|||
162890410|NCT01665768|588296835|FG000|Overall Study|Lack of Efficacy|19|||
162890411|NCT01665768|588296835|FG000|Overall Study|Withdrawal by Subject|1|||
162890412|NCT00118911|588296836|FG000|Overall Study|Withdrawal by Subject|2|||
162890413|NCT00118911|588296837|FG001|Overall Study|Withdrawal by Subject|5|||
162890414|NCT05014542|588296838|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
162890415|NCT05014542|588296839|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
163051393|NCT04579380|588897112|FG003|Overall Study|Withdrawal by Subject|0|||
163051394|NCT04579380|588897113|FG004|Overall Study|Withdrawal by Subject|1|||
162621896|NCT00347360|587330638|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
162621897|NCT00347360|587330639|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
162621898|NCT00347360|587330640|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
162890416|NCT05014542|588296838|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
162621899|NCT00347360|587330641|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
162621900|NCT00347360|587330642|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
162621901|NCT00347360|587330643|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
162621902|NCT00347360|587330644|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
162621903|NCT00347360|587330645|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
162621904|NCT00347360|587330646|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
162621905|NCT00347360|587330647|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
162621906|NCT00347360|587330648|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
162621907|NCT00347360|587330649|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
162621908|NCT00347360|587330635|FG000|Overall Study|Abnormal lab values|0|||
162621909|NCT00347360|587330636|FG001|Overall Study|Abnormal lab values|0|||
162621910|NCT00347360|587330637|FG002|Overall Study|Abnormal lab values|0|||
162621911|NCT00347360|587330638|FG003|Overall Study|Abnormal lab values|0|||
162621912|NCT00347360|587330639|FG004|Overall Study|Abnormal lab values|0|||
162621913|NCT00347360|587330640|FG005|Overall Study|Abnormal lab values|0|||
162621914|NCT00347360|587330641|FG006|Overall Study|Abnormal lab values|1|||
162621915|NCT00347360|587330642|FG007|Overall Study|Abnormal lab values|0|||
162621916|NCT00347360|587330643|FG008|Overall Study|Abnormal lab values|0|||
162621917|NCT00347360|587330644|FG009|Overall Study|Abnormal lab values|0|||
162621918|NCT00347360|587330645|FG010|Overall Study|Abnormal lab values|0|||
162621919|NCT00347360|587330646|FG011|Overall Study|Abnormal lab values|0|||
162621920|NCT00347360|587330647|FG012|Overall Study|Abnormal lab values|0|||
162621921|NCT00347360|587330648|FG013|Overall Study|Abnormal lab values|0|||
162621922|NCT00347360|587330649|FG014|Overall Study|Abnormal lab values|0|||
162621923|NCT00347360|587330635|FG000|Overall Study|PI recommended early withdrawal|0|||
162621924|NCT00347360|587330636|FG001|Overall Study|PI recommended early withdrawal|0|||
162621925|NCT00347360|587330637|FG002|Overall Study|PI recommended early withdrawal|0|||
162621926|NCT00347360|587330638|FG003|Overall Study|PI recommended early withdrawal|0|||
162621927|NCT00347360|587330639|FG004|Overall Study|PI recommended early withdrawal|0|||
162621928|NCT00347360|587330640|FG005|Overall Study|PI recommended early withdrawal|0|||
162621929|NCT00347360|587330641|FG006|Overall Study|PI recommended early withdrawal|0|||
162621930|NCT00347360|587330642|FG007|Overall Study|PI recommended early withdrawal|0|||
162621931|NCT00347360|587330643|FG008|Overall Study|PI recommended early withdrawal|0|||
162621932|NCT00347360|587330644|FG009|Overall Study|PI recommended early withdrawal|1|||
162621933|NCT00347360|587330645|FG010|Overall Study|PI recommended early withdrawal|0|||
162621934|NCT00347360|587330646|FG011|Overall Study|PI recommended early withdrawal|0|||
162621935|NCT00347360|587330647|FG012|Overall Study|PI recommended early withdrawal|0|||
162621936|NCT00347360|587330648|FG013|Overall Study|PI recommended early withdrawal|0|||
162890417|NCT05014542|588296839|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
162890418|NCT05014542|588296838|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
162890419|NCT05014542|588296839|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
162890420|NCT05014542|588296838|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
162890421|NCT05014542|588296839|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
162890422|NCT03496662|588296840|FG000|Overall Study|Adverse Event|0|||
162890423|NCT03496662|588296841|FG001|Overall Study|Adverse Event|0|||
162890424|NCT03496662|588296842|FG002|Overall Study|Adverse Event|4|||
162890425|NCT03496662|588296840|FG000|Overall Study|Withdrawal by Subject|1|||
162890426|NCT03496662|588296841|FG001|Overall Study|Withdrawal by Subject|0|||
162890427|NCT03496662|588296842|FG002|Overall Study|Withdrawal by Subject|2|||
162890428|NCT03496662|588296840|FG000|Overall Study|Death|0|||
162890429|NCT03496662|588296841|FG001|Overall Study|Death|0|||
162621937|NCT00347360|587330649|FG014|Overall Study|PI recommended early withdrawal|0|||
162621938|NCT00347360|587330635|FG000|Overall Study|Did not meet criteria before ABPM|0|||
162621939|NCT00347360|587330636|FG001|Overall Study|Did not meet criteria before ABPM|0|||
162621940|NCT00347360|587330637|FG002|Overall Study|Did not meet criteria before ABPM|0|||
162621941|NCT00347360|587330638|FG003|Overall Study|Did not meet criteria before ABPM|0|||
162621942|NCT00347360|587330639|FG004|Overall Study|Did not meet criteria before ABPM|0|||
162621943|NCT00347360|587330640|FG005|Overall Study|Did not meet criteria before ABPM|0|||
162621944|NCT00347360|587330641|FG006|Overall Study|Did not meet criteria before ABPM|0|||
162621945|NCT00347360|587330642|FG007|Overall Study|Did not meet criteria before ABPM|0|||
162621946|NCT00347360|587330643|FG008|Overall Study|Did not meet criteria before ABPM|0|||
162621947|NCT00347360|587330644|FG009|Overall Study|Did not meet criteria before ABPM|0|||
162621948|NCT00347360|587330645|FG010|Overall Study|Did not meet criteria before ABPM|1|||
162621949|NCT00347360|587330646|FG011|Overall Study|Did not meet criteria before ABPM|0|||
162621950|NCT00347360|587330647|FG012|Overall Study|Did not meet criteria before ABPM|0|||
162621951|NCT00347360|587330648|FG013|Overall Study|Did not meet criteria before ABPM|0|||
162621952|NCT00347360|587330649|FG014|Overall Study|Did not meet criteria before ABPM|0|||
162621953|NCT00347360|587330635|FG000|Overall Study|Randomized in error|0|||
162890430|NCT03496662|588296842|FG002|Overall Study|Death|2|||
162890431|NCT03496662|588296840|FG000|Overall Study|Noncompliance|0|||
162890432|NCT03496662|588296841|FG001|Overall Study|Noncompliance|0|||
162890433|NCT03496662|588296842|FG002|Overall Study|Noncompliance|1|||
162890434|NCT01467661|588296843|FG000|Overall Study|Adverse Event|16|||
162621954|NCT00347360|587330636|FG001|Overall Study|Randomized in error|0|||
162621955|NCT00347360|587330637|FG002|Overall Study|Randomized in error|0|||
162621956|NCT00347360|587330638|FG003|Overall Study|Randomized in error|0|||
162621957|NCT00347360|587330639|FG004|Overall Study|Randomized in error|0|||
162621958|NCT00347360|587330640|FG005|Overall Study|Randomized in error|0|||
162621959|NCT00347360|587330641|FG006|Overall Study|Randomized in error|0|||
162621960|NCT00347360|587330642|FG007|Overall Study|Randomized in error|0|||
162621961|NCT00347360|587330643|FG008|Overall Study|Randomized in error|0|||
162621962|NCT00347360|587330644|FG009|Overall Study|Randomized in error|0|||
162621963|NCT00347360|587330645|FG010|Overall Study|Randomized in error|0|||
162621964|NCT00347360|587330646|FG011|Overall Study|Randomized in error|1|||
162621965|NCT00347360|587330647|FG012|Overall Study|Randomized in error|0|||
162621966|NCT00347360|587330648|FG013|Overall Study|Randomized in error|0|||
162621967|NCT00347360|587330649|FG014|Overall Study|Randomized in error|0|||
162621968|NCT00347360|587330635|FG000|Overall Study|Failed inclusion criteria #4|0|||
162621969|NCT00347360|587330636|FG001|Overall Study|Failed inclusion criteria #4|0|||
162621970|NCT00347360|587330637|FG002|Overall Study|Failed inclusion criteria #4|0|||
162621971|NCT00347360|587330638|FG003|Overall Study|Failed inclusion criteria #4|0|||
162621972|NCT00347360|587330639|FG004|Overall Study|Failed inclusion criteria #4|0|||
162621973|NCT00347360|587330640|FG005|Overall Study|Failed inclusion criteria #4|0|||
162621974|NCT00347360|587330641|FG006|Overall Study|Failed inclusion criteria #4|0|||
162621975|NCT00347360|587330642|FG007|Overall Study|Failed inclusion criteria #4|0|||
162621976|NCT00347360|587330643|FG008|Overall Study|Failed inclusion criteria #4|0|||
162621977|NCT00347360|587330644|FG009|Overall Study|Failed inclusion criteria #4|0|||
162621978|NCT00347360|587330645|FG010|Overall Study|Failed inclusion criteria #4|0|||
162621979|NCT00347360|587330646|FG011|Overall Study|Failed inclusion criteria #4|1|||
162621980|NCT00347360|587330647|FG012|Overall Study|Failed inclusion criteria #4|0|||
162621981|NCT00347360|587330648|FG013|Overall Study|Failed inclusion criteria #4|0|||
162621982|NCT00347360|587330649|FG014|Overall Study|Failed inclusion criteria #4|0|||
162621983|NCT00347360|587330635|FG000|Overall Study|Prolonged duration between visits|0|||
162621984|NCT00347360|587330636|FG001|Overall Study|Prolonged duration between visits|0|||
162621985|NCT00347360|587330637|FG002|Overall Study|Prolonged duration between visits|0|||
162621986|NCT00347360|587330638|FG003|Overall Study|Prolonged duration between visits|0|||
162621987|NCT00347360|587330639|FG004|Overall Study|Prolonged duration between visits|0|||
162621988|NCT00347360|587330640|FG005|Overall Study|Prolonged duration between visits|0|||
162621989|NCT00347360|587330641|FG006|Overall Study|Prolonged duration between visits|0|||
162621990|NCT00347360|587330642|FG007|Overall Study|Prolonged duration between visits|0|||
162621991|NCT00347360|587330643|FG008|Overall Study|Prolonged duration between visits|0|||
162621992|NCT00347360|587330644|FG009|Overall Study|Prolonged duration between visits|0|||
162621993|NCT00347360|587330645|FG010|Overall Study|Prolonged duration between visits|0|||
162621994|NCT00347360|587330646|FG011|Overall Study|Prolonged duration between visits|0|||
162621995|NCT00347360|587330647|FG012|Overall Study|Prolonged duration between visits|1|||
162621996|NCT00347360|587330648|FG013|Overall Study|Prolonged duration between visits|0|||
162621997|NCT00347360|587330649|FG014|Overall Study|Prolonged duration between visits|0|||
162621998|NCT00347360|587330635|FG000|Overall Study|Subject left town, ran out of study drug|0|||
162621999|NCT00347360|587330636|FG001|Overall Study|Subject left town, ran out of study drug|0|||
162622000|NCT00347360|587330637|FG002|Overall Study|Subject left town, ran out of study drug|0|||
162622001|NCT00347360|587330638|FG003|Overall Study|Subject left town, ran out of study drug|0|||
162622002|NCT00347360|587330639|FG004|Overall Study|Subject left town, ran out of study drug|0|||
162622003|NCT00347360|587330640|FG005|Overall Study|Subject left town, ran out of study drug|0|||
162622004|NCT00347360|587330641|FG006|Overall Study|Subject left town, ran out of study drug|0|||
162622005|NCT00347360|587330642|FG007|Overall Study|Subject left town, ran out of study drug|0|||
162622006|NCT00347360|587330643|FG008|Overall Study|Subject left town, ran out of study drug|0|||
162622007|NCT00347360|587330644|FG009|Overall Study|Subject left town, ran out of study drug|0|||
162622008|NCT00347360|587330645|FG010|Overall Study|Subject left town, ran out of study drug|0|||
162622009|NCT00347360|587330646|FG011|Overall Study|Subject left town, ran out of study drug|0|||
162622010|NCT00347360|587330647|FG012|Overall Study|Subject left town, ran out of study drug|0|||
162622011|NCT00347360|587330648|FG013|Overall Study|Subject left town, ran out of study drug|1|||
162622012|NCT00347360|587330649|FG014|Overall Study|Subject left town, ran out of study drug|0|||
162622013|NCT00347360|587330635|FG000|Overall Study|Subject refuse to sign updated consent|0|||
162622014|NCT00347360|587330636|FG001|Overall Study|Subject refuse to sign updated consent|0|||
162622015|NCT00347360|587330637|FG002|Overall Study|Subject refuse to sign updated consent|0|||
162622016|NCT00347360|587330638|FG003|Overall Study|Subject refuse to sign updated consent|0|||
162622017|NCT00347360|587330639|FG004|Overall Study|Subject refuse to sign updated consent|0|||
162622018|NCT00347360|587330640|FG005|Overall Study|Subject refuse to sign updated consent|0|||
162622019|NCT00347360|587330641|FG006|Overall Study|Subject refuse to sign updated consent|0|||
162622020|NCT00347360|587330642|FG007|Overall Study|Subject refuse to sign updated consent|0|||
162622021|NCT00347360|587330643|FG008|Overall Study|Subject refuse to sign updated consent|0|||
162622022|NCT00347360|587330644|FG009|Overall Study|Subject refuse to sign updated consent|0|||
162622023|NCT00347360|587330645|FG010|Overall Study|Subject refuse to sign updated consent|0|||
162622024|NCT00347360|587330646|FG011|Overall Study|Subject refuse to sign updated consent|0|||
162622025|NCT00347360|587330647|FG012|Overall Study|Subject refuse to sign updated consent|0|||
162622026|NCT00347360|587330648|FG013|Overall Study|Subject refuse to sign updated consent|0|||
162622027|NCT00347360|587330649|FG014|Overall Study|Subject refuse to sign updated consent|1|||
162622028|NCT00347360|587330635|FG000|Overall Study|Visits conflicted with new job|0|||
162622029|NCT00347360|587330636|FG001|Overall Study|Visits conflicted with new job|0|||
162622030|NCT00347360|587330637|FG002|Overall Study|Visits conflicted with new job|0|||
162622031|NCT00347360|587330638|FG003|Overall Study|Visits conflicted with new job|0|||
162622032|NCT00347360|587330639|FG004|Overall Study|Visits conflicted with new job|0|||
162622033|NCT00347360|587330640|FG005|Overall Study|Visits conflicted with new job|0|||
162622034|NCT00347360|587330641|FG006|Overall Study|Visits conflicted with new job|1|||
162622035|NCT00347360|587330642|FG007|Overall Study|Visits conflicted with new job|0|||
162622036|NCT00347360|587330643|FG008|Overall Study|Visits conflicted with new job|0|||
162622037|NCT00347360|587330644|FG009|Overall Study|Visits conflicted with new job|0|||
162622038|NCT00347360|587330645|FG010|Overall Study|Visits conflicted with new job|0|||
162622039|NCT00347360|587330646|FG011|Overall Study|Visits conflicted with new job|0|||
162622040|NCT00347360|587330647|FG012|Overall Study|Visits conflicted with new job|0|||
162622041|NCT00347360|587330648|FG013|Overall Study|Visits conflicted with new job|0|||
162622042|NCT00347360|587330649|FG014|Overall Study|Visits conflicted with new job|0|||
162622043|NCT03113071|587330650|FG000|Overall Study|Withdrawal by Subject|1|||
162622044|NCT03113071|587330651|FG001|Overall Study|Withdrawal by Subject|0|||
162622045|NCT02369016|587330654|FG000|Overall Study|AE associated with clinical disease progression|2|||
162622046|NCT02369016|587330655|FG001|Overall Study|AE associated with clinical disease progression|1|||
162622047|NCT02369016|587330654|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
162622048|NCT02369016|587330655|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
162622049|NCT02369016|587330654|FG000|Overall Study|Progressive disease - clinical progression|1|||
162622050|NCT02369016|587330655|FG001|Overall Study|Progressive disease - clinical progression|4|||
162622051|NCT02369016|587330654|FG000|Overall Study|withdrawal by patient|4|||
162622052|NCT02369016|587330655|FG001|Overall Study|withdrawal by patient|0|||
162622053|NCT02369016|587330654|FG000|Overall Study|Progressive disease - radiological progression|6|||
162622054|NCT02369016|587330655|FG001|Overall Study|Progressive disease - radiological progression|2|||
162622055|NCT01187433|587330656|FG000|Overall Study|Protocol Violation|6|||
162622056|NCT01187433|587330657|FG001|Overall Study|Protocol Violation|2|||
162622057|NCT01187433|587330656|FG000|Overall Study|Withdrawal by Subject|5|||
162622058|NCT01187433|587330657|FG001|Overall Study|Withdrawal by Subject|2|||
162622059|NCT04203797|587330658|FG000|Overall Study|Adverse Event|1|||
162622060|NCT04203797|587330659|FG001|Overall Study|Adverse Event|0|||
162622061|NCT04203797|587330658|FG000|Overall Study|Did not complete End of Study follow-up|1|||
162622062|NCT04203797|587330659|FG001|Overall Study|Did not complete End of Study follow-up|0|||
162622063|NCT00621959|587330660|FG000|Overall Study|Adverse Event|4|||
162622064|NCT00621959|587330661|FG001|Overall Study|Adverse Event|2|||
162622065|NCT00621959|587330660|FG000|Overall Study|Lack of Efficacy|1|||
162622066|NCT00621959|587330661|FG001|Overall Study|Lack of Efficacy|1|||
162622067|NCT00621959|587330660|FG000|Overall Study|Lost to Follow-up|0|||
162622068|NCT00621959|587330661|FG001|Overall Study|Lost to Follow-up|2|||
162622069|NCT00621959|587330660|FG000|Overall Study|Withdrawal by Subject|1|||
162622070|NCT00621959|587330661|FG001|Overall Study|Withdrawal by Subject|1|||
162622071|NCT00621959|587330660|FG000|Overall Study|Other|1|||
162622072|NCT00621959|587330661|FG001|Overall Study|Other|3|||
162622073|NCT00242216|587330662|FG000|Overall Study|Lost to Follow-up|12|||
162622074|NCT00242216|587330663|FG001|Overall Study|Lost to Follow-up|17|||
162622075|NCT00242216|587330662|FG000|Overall Study|Death|4|||
162622076|NCT00242216|587330663|FG001|Overall Study|Death|2|||
162622077|NCT00242216|587330662|FG000|Overall Study|Lack of Efficacy|1|||
162622078|NCT00242216|587330663|FG001|Overall Study|Lack of Efficacy|2|||
162622079|NCT00242216|587330662|FG000|Overall Study|no medicaiton dispensed|1|||
162622080|NCT00242216|587330663|FG001|Overall Study|no medicaiton dispensed|1|||
162622081|NCT02484690|587330664|FG000|Overall Study|Adverse Event|1|||
162964453|NCT01438060|588569777|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
162964454|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
162964455|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
162964456|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
162622082|NCT02484690|587330665|FG001|Overall Study|Adverse Event|3|||
162622083|NCT02484690|587330666|FG002|Overall Study|Adverse Event|0|||
162622084|NCT02484690|587330667|FG003|Overall Study|Adverse Event|0|||
162622085|NCT02484690|587330668|FG004|Overall Study|Adverse Event|5|||
162622086|NCT02484690|587330664|FG000|Overall Study|Death|0|||
162622087|NCT02484690|587330665|FG001|Overall Study|Death|0|||
162622088|NCT02484690|587330666|FG002|Overall Study|Death|0|||
162622089|NCT02484690|587330667|FG003|Overall Study|Death|0|||
162622090|NCT02484690|587330668|FG004|Overall Study|Death|1|||
162622091|NCT02484690|587330664|FG000|Overall Study|Withdrawal by Subject|1|||
162964457|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
162622092|NCT02484690|587330665|FG001|Overall Study|Withdrawal by Subject|3|||
162622093|NCT02484690|587330666|FG002|Overall Study|Withdrawal by Subject|1|||
162622094|NCT02484690|587330667|FG003|Overall Study|Withdrawal by Subject|2|||
162622095|NCT02484690|587330668|FG004|Overall Study|Withdrawal by Subject|0|||
162622096|NCT02484690|587330664|FG000|Overall Study|Physician Decision|2|||
162622097|NCT02484690|587330665|FG001|Overall Study|Physician Decision|0|||
162622098|NCT02484690|587330666|FG002|Overall Study|Physician Decision|1|||
162622099|NCT02484690|587330667|FG003|Overall Study|Physician Decision|0|||
162622100|NCT02484690|587330668|FG004|Overall Study|Physician Decision|0|||
163051395|NCT04579380|588897114|FG005|Overall Study|Withdrawal by Subject|2|||
163051396|NCT04579380|588897115|FG006|Overall Study|Withdrawal by Subject|0|||
163051397|NCT04579380|588897116|FG007|Overall Study|Withdrawal by Subject|1|||
163051398|NCT04579380|588897117|FG008|Overall Study|Withdrawal by Subject|2|||
163051399|NCT04579380|588897109|FG000|Overall Study|Ongoing|2|||
163051400|NCT04579380|588897110|FG001|Overall Study|Ongoing|6|||
163051401|NCT04579380|588897111|FG002|Overall Study|Ongoing|4|||
163051402|NCT04579380|588897112|FG003|Overall Study|Ongoing|8|||
163051403|NCT04579380|588897113|FG004|Overall Study|Ongoing|5|||
163051404|NCT04579380|588897114|FG005|Overall Study|Ongoing|8|||
163051405|NCT04579380|588897115|FG006|Overall Study|Ongoing|3|||
163051406|NCT04579380|588897116|FG007|Overall Study|Ongoing|19|||
163051407|NCT04579380|588897117|FG008|Overall Study|Ongoing|6|||
163051408|NCT04113694|588897118|FG000|Overall Study|Adverse Event|2|||
163051409|NCT04113694|588897118|FG000|Overall Study|Lost to Follow-up|2|||
163051410|NCT04113694|588897118|FG000|Overall Study|Withdrawal by Subject|6|||
163051411|NCT04113694|588897118|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
163051412|NCT05630196|588897121|FG000|Overall Study|Adverse Event|2|||
163051413|NCT05630196|588897122|FG001|Overall Study|Adverse Event|1|||
163051414|NCT05630196|588897121|FG000|Overall Study|Lost to Follow-up|1|||
163051415|NCT05630196|588897122|FG001|Overall Study|Lost to Follow-up|1|||
163051416|NCT05630196|588897121|FG000|Overall Study|Protocol Violation|2|||
163051417|NCT05630196|588897122|FG001|Overall Study|Protocol Violation|3|||
163051418|NCT05630196|588897121|FG000|Overall Study|Physician Decision|1|||
163051419|NCT05630196|588897122|FG001|Overall Study|Physician Decision|0|||
163051420|NCT05630196|588897121|FG000|Overall Study|Withdrawal by Subject|3|||
163051421|NCT05630196|588897122|FG001|Overall Study|Withdrawal by Subject|4|||
163051422|NCT03973996|588897124|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051423|NCT03973996|588897125|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051424|NCT03973996|588897126|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163051425|NCT03973996|588897127|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
163051426|NCT04070989|588897128|FG000|Overall Study|Death|1|||
163051427|NCT04070989|588897129|FG001|Overall Study|Death|0|||
163051428|NCT04070989|588897130|FG002|Overall Study|Death|0|||
163051429|NCT04070989|588897128|FG000|Overall Study|Study Terminated by Sponsor|7|||
163051430|NCT04070989|588897129|FG001|Overall Study|Study Terminated by Sponsor|8|||
163051431|NCT04070989|588897130|FG002|Overall Study|Study Terminated by Sponsor|23|||
163051432|NCT04070989|588897128|FG000|Overall Study|Withdrawal by Subject|0|||
163051433|NCT04070989|588897129|FG001|Overall Study|Withdrawal by Subject|1|||
163051434|NCT04070989|588897130|FG002|Overall Study|Withdrawal by Subject|0|||
162622101|NCT02484690|587330664|FG000|Overall Study|Lost to Follow-up|0|||
162622102|NCT02484690|587330665|FG001|Overall Study|Lost to Follow-up|0|||
162622103|NCT02484690|587330666|FG002|Overall Study|Lost to Follow-up|1|||
162622104|NCT02484690|587330667|FG003|Overall Study|Lost to Follow-up|0|||
162890435|NCT01467661|588296843|FG000|Overall Study|Withdrawal by Subject|1|||
162890436|NCT01467661|588296843|FG000|Overall Study|Lack of Efficacy|3|||
162890437|NCT01467661|588296843|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
162890438|NCT00691093|588296844|FG000|Overall Study|Adverse Event|1|||
162890439|NCT00691093|588296844|FG000|Overall Study|Lost to Follow-up|1|||
162890440|NCT00691093|588296844|FG000|Overall Study|Lack of Efficacy|1|||
162890441|NCT00691093|588296844|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
162890442|NCT03395223|588296847|FG000|Overall Study|Lost to Follow-up|3|||
162890443|NCT03395223|588296847|FG000|Overall Study|Other|1|||
162890444|NCT00810810|588296848|FG000|Overall Study|Withdrawal by Subject|0|||
162890445|NCT00810810|588296849|FG001|Overall Study|Withdrawal by Subject|8|||
162890446|NCT00810810|588296850|FG002|Overall Study|Withdrawal by Subject|10|||
162890447|NCT00810810|588296851|FG003|Overall Study|Withdrawal by Subject|8|||
162890448|NCT00810810|588296848|FG000|Overall Study|Physician Decision|0|||
162890449|NCT00810810|588296849|FG001|Overall Study|Physician Decision|3|||
162890450|NCT00810810|588296850|FG002|Overall Study|Physician Decision|1|||
162890451|NCT00810810|588296851|FG003|Overall Study|Physician Decision|5|||
162890452|NCT01896856|588296852|FG000|Overall Study|Transportation issues / Non-compliance|0|||
163051435|NCT04070989|588897128|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
162890453|NCT01896856|588296853|FG001|Overall Study|Transportation issues / Non-compliance|0|||
162890454|NCT01896856|588296854|FG002|Overall Study|Transportation issues / Non-compliance|1|||
163051436|NCT04070989|588897129|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
163051437|NCT04070989|588897130|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
162622105|NCT02484690|587330668|FG004|Overall Study|Lost to Follow-up|0|||
162622106|NCT03360747|587330669|FG000|Overall Study|Voluntary Withdrawal|1|||
162622107|NCT01759511|587330670|FG000|Overall Study|Adverse Event|4|||
162622108|NCT01759511|587330670|FG000|Overall Study|Death|2|||
162622109|NCT01759511|587330670|FG000|Overall Study|Lack of Efficacy|2|||
162622110|NCT01759511|587330670|FG000|Overall Study|Physician Decision|1|||
162622111|NCT01759511|587330670|FG000|Overall Study|Progressive Disease|5|||
162622112|NCT01759511|587330670|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
162622113|NCT01759511|587330670|FG000|Overall Study|Study Terminated by Sponsor|13|||
162622114|NCT01759511|587330670|FG000|Overall Study|Withdrawal by Subject|3|||
162622115|NCT02569671|587330678|FG000|Overall Study|Lost to Follow-up|2|||
162622116|NCT02569671|587330679|FG001|Overall Study|Lost to Follow-up|1|||
162622117|NCT02569671|587330678|FG000|Overall Study|Withdrawal by Subject|1|||
162622118|NCT02569671|587330679|FG001|Overall Study|Withdrawal by Subject|3|||
162622119|NCT01757535|587330680|FG000|Overall Study|Disease Relapse|151|||
162622120|NCT01757535|587330681|FG001|Overall Study|Disease Relapse|181|||
162622121|NCT01757535|587330680|FG000|Overall Study|Other Reasons|28|||
162622122|NCT01757535|587330681|FG001|Overall Study|Other Reasons|27|||
163051438|NCT04070989|588897128|FG000|Overall Study|Other|1|||
163051439|NCT04070989|588897129|FG001|Overall Study|Other|1|||
163051440|NCT04070989|588897130|FG002|Overall Study|Other|0|||
163051441|NCT06088784|588897131|FG000|Overall Study|Adverse Event|0|||
163051442|NCT06088784|588897132|FG001|Overall Study|Adverse Event|0|||
163051443|NCT06088784|588897133|FG002|Overall Study|Adverse Event|0|||
163051444|NCT06088784|588897134|FG003|Overall Study|Adverse Event|0|||
163051445|NCT06088784|588897135|FG004|Overall Study|Adverse Event|0|||
163051446|NCT06088784|588897136|FG005|Overall Study|Adverse Event|0|||
163051447|NCT06088784|588897137|FG006|Overall Study|Adverse Event|3|||
163051448|NCT06088784|588897138|FG007|Overall Study|Adverse Event|0|||
163051449|NCT06088784|588897139|FG008|Overall Study|Adverse Event|0|||
163051450|NCT06088784|588897140|FG009|Overall Study|Adverse Event|0|||
163051451|NCT06088784|588897141|FG010|Overall Study|Adverse Event|0|||
163051452|NCT06088784|588897142|FG011|Overall Study|Adverse Event|0|||
163051453|NCT06088784|588897131|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051454|NCT06088784|588897132|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
162622123|NCT01757535|587330680|FG000|Overall Study|Adverse Event|31|||
162622124|NCT01757535|587330681|FG001|Overall Study|Adverse Event|11|||
162622125|NCT01757535|587330680|FG000|Overall Study|Withdrew Consent|19|||
162622126|NCT01757535|587330681|FG001|Overall Study|Withdrew Consent|13|||
162622127|NCT01757535|587330680|FG000|Overall Study|Physician Decision|7|||
162622128|NCT01757535|587330681|FG001|Overall Study|Physician Decision|0|||
163051455|NCT06088784|588897133|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051456|NCT06088784|588897134|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
162622129|NCT01757535|587330680|FG000|Overall Study|Death|2|||
162622130|NCT01757535|587330681|FG001|Overall Study|Death|2|||
162622131|NCT00589290|587330682|FG000|Overall Study|Withdrawal by Subject|1|||
162622132|NCT03730012|587330684|FG000|Overall Study|Adverse Event|0|||
162622133|NCT03730012|587330685|FG001|Overall Study|Adverse Event|1|||
162622134|NCT03730012|587330684|FG000|Overall Study|Lack of Efficacy|1|||
162622135|NCT03730012|587330685|FG001|Overall Study|Lack of Efficacy|5|||
162622136|NCT03730012|587330684|FG000|Overall Study|Withdrawal by Subject|0|||
162622137|NCT03730012|587330685|FG001|Overall Study|Withdrawal by Subject|1|||
162622138|NCT03730012|587330684|FG000|Overall Study|Miscellaneous|2|||
162622139|NCT03730012|587330685|FG001|Overall Study|Miscellaneous|1|||
162622140|NCT00403234|587332361|FG000|Overall Study|Withdrawal by Subject|0|||
162622141|NCT00403234|587332362|FG001|Overall Study|Withdrawal by Subject|1|||
162890455|NCT01896856|588296855|FG003|Overall Study|Transportation issues / Non-compliance|0|||
162890456|NCT01896856|588296856|FG004|Overall Study|Transportation issues / Non-compliance|0|||
162890457|NCT01896856|588296857|FG005|Overall Study|Transportation issues / Non-compliance|0|||
162890458|NCT01156532|588296858|FG000|Overall Study|Family Reasons|1|||
162890459|NCT01156532|588296858|FG000|Overall Study|Lost to Follow-up|1|||
162890460|NCT02563925|588296861|FG000|Overall Study|Withdrawal by Subject|2|||
162890461|NCT00282867|588296865|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
162890462|NCT00282867|588296866|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
162890463|NCT00282867|588296867|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
162890464|NCT00673894|588296880|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
163051457|NCT06088784|588897135|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051458|NCT06088784|588897136|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
162622142|NCT00403234|587332363|FG002|Overall Study|Withdrawal by Subject|0|||
162622143|NCT00403234|587332364|FG003|Overall Study|Withdrawal by Subject|0|||
162622144|NCT00403234|587332361|FG000|Overall Study|Adverse Event|1|||
162622145|NCT00403234|587332362|FG001|Overall Study|Adverse Event|0|||
162622146|NCT00403234|587332363|FG002|Overall Study|Adverse Event|1|||
162622147|NCT00403234|587332364|FG003|Overall Study|Adverse Event|0|||
162622148|NCT00560105|587332367|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
162622149|NCT00560105|587332368|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
162622150|NCT03539081|587332369|FG000|Overall Study|Withdrawal by Subject|2|||
162622151|NCT03539081|587332370|FG001|Overall Study|Withdrawal by Subject|3|||
162890465|NCT00673894|588296881|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
162890466|NCT00673894|588296880|FG000|First Intervention 4 Weeks|Adverse Event|1|||
162890467|NCT00673894|588296881|FG001|First Intervention 4 Weeks|Adverse Event|0|||
162890468|NCT01688635|588296889|FG000|Washout 1|Withdrawal by Subject|1|||
162890469|NCT01688635|588296890|FG001|Washout 1|Withdrawal by Subject|0|||
162890470|NCT01688635|588296889|FG000|Washout 1|Adverse Event|0|||
162890471|NCT01688635|588296890|FG001|Washout 1|Adverse Event|1|||
162890472|NCT01688635|588296889|FG000|Washout 1|Physician Decision|0|||
162890473|NCT01688635|588296890|FG001|Washout 1|Physician Decision|1|||
162890474|NCT01688635|588296889|FG000|Washout 2|Physician Decision|1|||
162890475|NCT01688635|588296890|FG001|Washout 2|Physician Decision|0|||
162890476|NCT01688635|588296889|FG000|Washout 2|Withdrawal by Subject|1|||
162890477|NCT01688635|588296890|FG001|Washout 2|Withdrawal by Subject|0|||
162890478|NCT01688635|588296889|FG000|Washout 2|Sponsor Decision|1|||
162890479|NCT01688635|588296890|FG001|Washout 2|Sponsor Decision|2|||
162890480|NCT01688635|588296889|FG000|Washout 3|Withdrawal by Subject|1|||
162890481|NCT01688635|588296890|FG001|Washout 3|Withdrawal by Subject|0|||
162890482|NCT02726113|588296894|FG000|Total Enrollment|Physician Decision|0|||
162890483|NCT02726113|588296895|FG001|Total Enrollment|Physician Decision|1|||
162890484|NCT02726113|588296894|FG000|Total Enrollment|Protocol Violation|1|||
162890485|NCT02726113|588296895|FG001|Total Enrollment|Protocol Violation|0|||
162890486|NCT02726113|588296894|FG000|Total Enrollment|Withdrawal by Subject|2|||
162890487|NCT02726113|588296895|FG001|Total Enrollment|Withdrawal by Subject|1|||
162890488|NCT02726113|588296894|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
162890489|NCT02726113|588296895|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
162890490|NCT02726113|588296894|FG000|Genomic Analysis|Protocol Violation|1|||
162890491|NCT02726113|588296895|FG001|Genomic Analysis|Protocol Violation|0|||
162622152|NCT03539081|587332371|FG002|Overall Study|Withdrawal by Subject|0|||
162622153|NCT03539081|587332369|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
162622154|NCT03539081|587332370|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
162622155|NCT03539081|587332371|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
162622156|NCT02555683|587332375|FG000|Overall Study|Physician Decision|1|||
162622157|NCT02555683|587332376|FG001|Overall Study|Physician Decision|0|||
162622158|NCT02555683|587332377|FG002|Overall Study|Physician Decision|2|||
162622159|NCT02555683|587332375|FG000|Overall Study|Lost to Follow-up|2|||
162622160|NCT02555683|587332376|FG001|Overall Study|Lost to Follow-up|1|||
162622161|NCT02555683|587332377|FG002|Overall Study|Lost to Follow-up|2|||
162622162|NCT02555683|587332375|FG000|Overall Study|Technical Problems|1|||
162622163|NCT02555683|587332376|FG001|Overall Study|Technical Problems|1|||
162622164|NCT02555683|587332377|FG002|Overall Study|Technical Problems|0|||
162622165|NCT02555683|587332375|FG000|Overall Study|Protocol deviation|0|||
162622166|NCT02555683|587332376|FG001|Overall Study|Protocol deviation|1|||
162622167|NCT02555683|587332377|FG002|Overall Study|Protocol deviation|0|||
162622168|NCT02555683|587332375|FG000|Overall Study|Lack of Efficacy|2|||
162622169|NCT02555683|587332376|FG001|Overall Study|Lack of Efficacy|0|||
162622170|NCT02555683|587332377|FG002|Overall Study|Lack of Efficacy|0|||
162622171|NCT02555683|587332375|FG000|Overall Study|Death|0|||
162622172|NCT02555683|587332376|FG001|Overall Study|Death|1|||
162622173|NCT02555683|587332377|FG002|Overall Study|Death|2|||
162622174|NCT02555683|587332375|FG000|Overall Study|Adverse Event|1|||
162622175|NCT02555683|587332376|FG001|Overall Study|Adverse Event|0|||
162622176|NCT02555683|587332377|FG002|Overall Study|Adverse Event|1|||
162622177|NCT02555683|587332375|FG000|Overall Study|Subject/guardian decision|12|||
162622178|NCT02555683|587332376|FG001|Overall Study|Subject/guardian decision|12|||
162622179|NCT02555683|587332377|FG002|Overall Study|Subject/guardian decision|22|||
162622180|NCT02555683|587332375|FG000|Overall Study|Death post Treatment/safety period|0|||
162622181|NCT02555683|587332376|FG001|Overall Study|Death post Treatment/safety period|1|||
162622182|NCT02555683|587332377|FG002|Overall Study|Death post Treatment/safety period|0|||
162622183|NCT04622306|587332381|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162622184|NCT04622306|587332382|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162622185|NCT04622306|587332383|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
162622186|NCT04622306|587332384|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
162622187|NCT04622306|587332385|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162622188|NCT04622306|587332386|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
162622189|NCT04622306|587332381|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162622190|NCT04622306|587332382|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162622191|NCT04622306|587332383|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
162622192|NCT04622306|587332384|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
162622193|NCT04622306|587332385|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162622194|NCT04622306|587332386|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162622195|NCT01896102|587332390|FG000|Overall Study|Death|1|||
162622196|NCT01896102|587332390|FG000|Overall Study|Participant to receive allogenic transplant|2|||
162622197|NCT01145625|587332391|FG000|Overall Study|Lost to Follow-up|8|||
162622198|NCT01145625|587332392|FG001|Overall Study|Lost to Follow-up|9|||
162622199|NCT01145625|587332391|FG000|Overall Study|Adverse Event|6|||
162622200|NCT01145625|587332392|FG001|Overall Study|Adverse Event|4|||
162622201|NCT01145625|587332391|FG000|Overall Study|Protocol Violation|3|||
162622202|NCT01145625|587332392|FG001|Overall Study|Protocol Violation|1|||
162622203|NCT01145625|587332391|FG000|Overall Study|Withdrawal by Subject|7|||
162622204|NCT01145625|587332392|FG001|Overall Study|Withdrawal by Subject|16|||
162622205|NCT01145625|587332391|FG000|Overall Study|Pregnancy|0|||
162622206|NCT01145625|587332392|FG001|Overall Study|Pregnancy|1|||
162622207|NCT04289623|587332394|FG000|Wave 1 Emails|Email was not delivered|268|||
162622208|NCT04289623|587332395|FG001|Wave 1 Emails|Email was not delivered|257|||
162622209|NCT04289623|587332396|FG002|Wave 1 Emails|Email was not delivered|0|||
162708683|NCT00797225|587642873|FG004|Weeks 13 to 24|Non-compliance|0|||
162964458|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
162964459|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
162622210|NCT04289623|587332397|FG003|Wave 1 Emails|Email was not delivered|0|||
162622211|NCT04289623|587332398|FG004|Wave 1 Emails|Email was not delivered|0|||
162622212|NCT04289623|587332399|FG005|Wave 1 Emails|Email was not delivered|0|||
162622213|NCT00696800|587332406|FG000|Overall Study|Adverse Event|16|||
162622214|NCT00696800|587332407|FG001|Overall Study|Adverse Event|3|||
162622215|NCT00696800|587332406|FG000|Overall Study|Insufficient compliance with medication|2|||
162622216|NCT00696800|587332407|FG001|Overall Study|Insufficient compliance with medication|1|||
162622217|NCT00696800|587332406|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
162622218|NCT00696800|587332407|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
162622219|NCT00696800|587332406|FG000|Overall Study|Insufficient ovarian response|4|||
162622220|NCT00696800|587332407|FG001|Overall Study|Insufficient ovarian response|1|||
162964460|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
162964461|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
162964462|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
162964463|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
162964464|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
162964465|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
162622221|NCT00696800|587332406|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
162622222|NCT00696800|587332407|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
162622223|NCT00696800|587332406|FG000|Overall Study|Too high ovarian response|6|||
162622224|NCT00696800|587332407|FG001|Overall Study|Too high ovarian response|1|||
162622225|NCT00696800|587332406|FG000|Overall Study|No/too few/bad quality oocytes|4|||
162622226|NCT00696800|587332407|FG001|Overall Study|No/too few/bad quality oocytes|3|||
162622227|NCT00696800|587332406|FG000|Overall Study|No/abnormal fertilization|11|||
162622228|NCT00696800|587332407|FG001|Overall Study|No/abnormal fertilization|13|||
162622229|NCT00696800|587332406|FG000|Overall Study|No/too few/bad quality embryos|24|||
162622230|NCT00696800|587332407|FG001|Overall Study|No/too few/bad quality embryos|18|||
162622231|NCT00696800|587332406|FG000|Overall Study|Other Reasons|5|||
162622232|NCT00696800|587332407|FG001|Overall Study|Other Reasons|3|||
162622233|NCT00696800|587332406|FG000|Overall Study|Not treated|1|||
162622234|NCT00696800|587332407|FG001|Overall Study|Not treated|2|||
162622235|NCT00762385|587332408|FG000|First Intervention|Lens Issue|1|||
162622236|NCT00762385|587332409|FG001|First Intervention|Lens Issue|1|||
162622237|NCT00762385|587332408|FG000|First Intervention|Lost to Follow-up|0|||
162622238|NCT00762385|587332409|FG001|First Intervention|Lost to Follow-up|2|||
162622239|NCT00762385|587332408|FG000|First Intervention|Ineligible|1|||
162622240|NCT00762385|587332409|FG001|First Intervention|Ineligible|0|||
162622241|NCT00762385|587332408|FG000|First Intervention|Protocol Violation|0|||
162622242|NCT00762385|587332409|FG001|First Intervention|Protocol Violation|1|||
162622243|NCT00762385|587332408|FG000|Second Intervention|Protocol Violation|3|||
162622244|NCT00762385|587332409|FG001|Second Intervention|Protocol Violation|3|||
162622245|NCT00591344|587332413|FG000|Overall Study|Transportation issues|1|||
162622246|NCT00591344|587332414|FG001|Overall Study|Transportation issues|0|||
162622247|NCT00591344|587332413|FG000|Overall Study|Moved out of state|1|||
162622248|NCT00591344|587332414|FG001|Overall Study|Moved out of state|0|||
162622249|NCT00591344|587332413|FG000|Overall Study|Medical complications|1|||
162622250|NCT00591344|587332414|FG001|Overall Study|Medical complications|3|||
162622251|NCT00591344|587332413|FG000|Overall Study|Underwent DBS|2|||
162622252|NCT00591344|587332414|FG001|Overall Study|Underwent DBS|2|||
162622253|NCT00591344|587332413|FG000|Overall Study|Death|0|||
162622254|NCT00591344|587332414|FG001|Overall Study|Death|1|||
162622255|NCT00591344|587332413|FG000|Overall Study|Lost to Follow-up|0|||
162622256|NCT00591344|587332414|FG001|Overall Study|Lost to Follow-up|1|||
162622257|NCT00591344|587332413|FG000|Overall Study|Did not want to come off medication|0|||
162622258|NCT00591344|587332414|FG001|Overall Study|Did not want to come off medication|1|||
162622259|NCT00493025|587332415|FG000|Overall Study|Physician Decision|19|||
162622260|NCT02939079|587332422|FG000|Overall Study|Adverse Event|2|||
162622261|NCT02939079|587332423|FG001|Overall Study|Adverse Event|1|||
162622262|NCT02939079|587332422|FG000|Overall Study|Lost to Follow-up|0|||
162622263|NCT02939079|587332423|FG001|Overall Study|Lost to Follow-up|2|||
162622264|NCT02939079|587332422|FG000|Overall Study|Protocol Violation|1|||
162622265|NCT02939079|587332423|FG001|Overall Study|Protocol Violation|0|||
162622266|NCT02939079|587332422|FG000|Overall Study|Withdrawal by Subject|0|||
162622267|NCT02939079|587332423|FG001|Overall Study|Withdrawal by Subject|1|||
162622268|NCT02939079|587332422|FG000|Overall Study|relapse during the study|1|||
162622269|NCT02939079|587332423|FG001|Overall Study|relapse during the study|1|||
162622270|NCT01609231|587332424|FG000|Overall Study|Adverse Event|1|||
162622271|NCT01609231|587332425|FG001|Overall Study|Adverse Event|3|||
162622272|NCT01609231|587332424|FG000|Overall Study|Physician Decision|1|||
162622273|NCT01609231|587332425|FG001|Overall Study|Physician Decision|0|||
162622274|NCT01609231|587332424|FG000|Overall Study|Withdrawal by Subject|1|||
162622275|NCT01609231|587332425|FG001|Overall Study|Withdrawal by Subject|0|||
162622276|NCT00973674|587332426|FG000|Overall Study|Protocol Violation|2|||
163051459|NCT06088784|588897137|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
163051460|NCT06088784|588897138|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
162622277|NCT00973674|587332427|FG001|Overall Study|Protocol Violation|0|||
162622278|NCT00494299|587332434|FG000|Overall Study|Adverse Event|93|||
162622279|NCT00494299|587332435|FG001|Overall Study|Adverse Event|13|||
162890492|NCT02726113|588296894|FG000|Genomic Analysis|Withdrawal by Subject|2|||
163051461|NCT06088784|588897139|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
162622280|NCT00494299|587332434|FG000|Overall Study|Lost to Follow-up|1|||
162622281|NCT00494299|587332435|FG001|Overall Study|Lost to Follow-up|0|||
162622282|NCT00494299|587332434|FG000|Overall Study|Physician Decision|0|||
162622283|NCT00494299|587332435|FG001|Overall Study|Physician Decision|2|||
162622284|NCT00494299|587332434|FG000|Overall Study|Protocol Violation|1|||
162622285|NCT00494299|587332435|FG001|Overall Study|Protocol Violation|2|||
162622286|NCT00494299|587332434|FG000|Overall Study|Withdrawal by Subject|8|||
162622287|NCT00494299|587332435|FG001|Overall Study|Withdrawal by Subject|3|||
162622288|NCT00494299|587332434|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
162622289|NCT00494299|587332435|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
162622290|NCT00494299|587332434|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
162622291|NCT00494299|587332435|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
162622292|NCT00494299|587332434|FG000|Overall Study|Site Closed by Sponsor|6|||
162622293|NCT00494299|587332435|FG001|Overall Study|Site Closed by Sponsor|0|||
162622294|NCT00494299|587332434|FG000|Overall Study|Protocol Driven Decision Point|11|||
162622295|NCT00494299|587332435|FG001|Overall Study|Protocol Driven Decision Point|22|||
162622296|NCT00516074|587332444|FG000|Overall Study|Adverse Event|0|||
162622297|NCT00516074|587332445|FG001|Overall Study|Adverse Event|1|||
162622298|NCT00516074|587332444|FG000|Overall Study|Subject Decision|4|||
162622299|NCT00516074|587332445|FG001|Overall Study|Subject Decision|2|||
162622300|NCT00516074|587332444|FG000|Overall Study|Loss of Glucose Control|2|||
162622301|NCT00516074|587332445|FG001|Overall Study|Loss of Glucose Control|0|||
162622302|NCT03822182|587332448|FG000|Overall Study|Protocol Violation|0|||
162622303|NCT03822182|587332449|FG001|Overall Study|Protocol Violation|1|||
162622304|NCT03822182|587332450|FG002|Overall Study|Protocol Violation|1|||
162622305|NCT01484275|587332451|FG000|Overall Study|Study terminated by sponsor|28|||
162622306|NCT01484275|587332452|FG001|Overall Study|Study terminated by sponsor|32|||
162622307|NCT01484275|587332451|FG000|Overall Study|Other|10|||
162622308|NCT01484275|587332452|FG001|Overall Study|Other|0|||
162622309|NCT01484275|587332451|FG000|Overall Study|Death|3|||
162622310|NCT01484275|587332452|FG001|Overall Study|Death|4|||
162622311|NCT01484275|587332451|FG000|Overall Study|Withdrawal by Subject|1|||
162622312|NCT01484275|587332452|FG001|Overall Study|Withdrawal by Subject|5|||
162622313|NCT01484275|587332451|FG000|Overall Study|Lost to Follow-up|1|||
162622314|NCT01484275|587332452|FG001|Overall Study|Lost to Follow-up|1|||
162622315|NCT04154930|587332453|FG000|Overall Study|Withdrawal by Subject|15|||
162622316|NCT04154930|587332454|FG001|Overall Study|Withdrawal by Subject|6|||
162622317|NCT04154930|587332453|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
162622318|NCT04154930|587332454|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
162622319|NCT04154930|587332453|FG000|Overall Study|Lost to Follow-up|14|||
162622320|NCT04154930|587332454|FG001|Overall Study|Lost to Follow-up|6|||
163051462|NCT06088784|588897140|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051463|NCT06088784|588897141|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051464|NCT06088784|588897142|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
163051465|NCT05556616|588897145|FG000|Overall Study|Withdrawal by Subject|1|||
163051466|NCT05556616|588897146|FG001|Overall Study|Withdrawal by Subject|0|||
163051467|NCT05556616|588897147|FG002|Overall Study|Withdrawal by Subject|0|||
163051468|NCT05556616|588897148|FG003|Overall Study|Withdrawal by Subject|0|||
163051469|NCT05556616|588897149|FG004|Overall Study|Withdrawal by Subject|0|||
163051470|NCT05556616|588897150|FG005|Overall Study|Withdrawal by Subject|0|||
163051471|NCT05556616|588897151|FG006|Overall Study|Withdrawal by Subject|0|||
163051472|NCT05556616|588897145|FG000|Overall Study|Death|0|||
163051473|NCT05556616|588897146|FG001|Overall Study|Death|0|||
163051474|NCT05556616|588897147|FG002|Overall Study|Death|2|||
163051475|NCT05556616|588897148|FG003|Overall Study|Death|1|||
163051476|NCT05556616|588897149|FG004|Overall Study|Death|0|||
163051477|NCT05556616|588897150|FG005|Overall Study|Death|0|||
163051478|NCT05556616|588897151|FG006|Overall Study|Death|0|||
163051479|NCT05556616|588897145|FG000|Overall Study|Study Terminated by Sponsor|0|||
163051480|NCT05556616|588897146|FG001|Overall Study|Study Terminated by Sponsor|3|||
162622321|NCT04154930|587332453|FG000|Overall Study|Other|6|||
162622322|NCT04154930|587332454|FG001|Overall Study|Other|0|||
162622323|NCT02020577|587332458|FG000|Overall Study|Progressive disease|3|||
162622324|NCT02020577|587332459|FG001|Overall Study|Progressive disease|38|||
162622325|NCT02020577|587332458|FG000|Overall Study|Other AE or clinical progression|0|||
162622326|NCT02020577|587332459|FG001|Overall Study|Other AE or clinical progression|15|||
162622327|NCT02020577|587332458|FG000|Overall Study|Withdrawal by Subject|0|||
162622328|NCT02020577|587332459|FG001|Overall Study|Withdrawal by Subject|1|||
162622329|NCT02020577|587332458|FG000|Overall Study|Other than stated above|0|||
162622330|NCT02020577|587332459|FG001|Overall Study|Other than stated above|1|||
162622331|NCT03113916|587332463|FG000|Overall Study|Withdrawal by Subject|9|||
162622332|NCT03113916|587332464|FG001|Overall Study|Withdrawal by Subject|7|||
162622333|NCT03113916|587332463|FG000|Overall Study|Pregnancy|1|||
163051481|NCT05556616|588897147|FG002|Overall Study|Study Terminated by Sponsor|0|||
162622334|NCT03113916|587332464|FG001|Overall Study|Pregnancy|3|||
162622335|NCT03113916|587332463|FG000|Overall Study|Lost to Follow-up|1|||
162622336|NCT03113916|587332464|FG001|Overall Study|Lost to Follow-up|2|||
162622337|NCT01758523|587332466|FG000|Overall Study|Adverse Event|2|||
162622338|NCT01758523|587332467|FG001|Overall Study|Adverse Event|1|||
162622339|NCT01758523|587332466|FG000|Overall Study|Lack of Efficacy|4|||
162622340|NCT01758523|587332467|FG001|Overall Study|Lack of Efficacy|2|||
162890493|NCT02726113|588296895|FG001|Genomic Analysis|Withdrawal by Subject|1|||
162890494|NCT02726113|588296894|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
162890495|NCT02726113|588296895|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
162890496|NCT03549117|588296898|FG000|Overall Study|Withdrawal by Subject|1|||
162890497|NCT03549117|588296899|FG001|Overall Study|Withdrawal by Subject|0|||
162890498|NCT03820726|588296900|FG000|Overall Study|Other than listed|23|||
162890499|NCT03820726|588296900|FG000|Overall Study|Withdrawal by Subject|37|||
162890500|NCT03820726|588296900|FG000|Overall Study|Lost to Follow-up|3|||
162964466|NCT01438060|588569776|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
162964467|NCT01438060|588569777|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
162964468|NCT01438060|588569776|FG000|On Study Beyond Week 140|Adverse Event|0|||
162964469|NCT01438060|588569777|FG001|On Study Beyond Week 140|Adverse Event|2|||
162964470|NCT01438060|588569776|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
162964471|NCT01438060|588569777|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
162964472|NCT01438060|588569776|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
162964473|NCT01438060|588569777|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
162964474|NCT01438060|588569776|FG000|On Study Beyond Week 140|Death|0|||
162964475|NCT01438060|588569777|FG001|On Study Beyond Week 140|Death|1|||
162964476|NCT01438060|588569776|FG000|On Study Beyond Week 140|Other Reason|0|||
162964477|NCT01438060|588569777|FG001|On Study Beyond Week 140|Other Reason|3|||
162964478|NCT01964950|588569778|FG000|Overall Study|Protocol Violation|25|||
162964479|NCT01190865|588569787|FG000|Overall Study|Withdrawal by Subject|1|||
162964480|NCT01190865|588569787|FG000|Overall Study|Non-compliance|2|||
162964481|NCT00875524|588569788|FG000|Overall Study|Serious adverse event|0|||
162964482|NCT00875524|588569789|FG001|Overall Study|Serious adverse event|1|||
162622341|NCT01758523|587332466|FG000|Overall Study|Lost to Follow-up|3|||
162622342|NCT01758523|587332467|FG001|Overall Study|Lost to Follow-up|4|||
162622343|NCT01758523|587332466|FG000|Overall Study|Withdrawal by Subject|12|||
162622344|NCT01758523|587332467|FG001|Overall Study|Withdrawal by Subject|7|||
162622345|NCT01893203|587332468|FG000|Overall Study|Withdrawal by Subject|1|||
162622346|NCT00722800|587332469|FG000|Overall Study|Withdrawal by Subject|1|||
162622347|NCT00722800|587332470|FG001|Overall Study|Withdrawal by Subject|0|||
162622348|NCT00722800|587332469|FG000|Overall Study|Physician Decision|1|||
162622349|NCT00722800|587332470|FG001|Overall Study|Physician Decision|0|||
162622350|NCT02130297|587332475|FG000|Overall Study|Lost to Follow-up|4|||
162622351|NCT00508755|587332484|FG000|Overall Study|Withdrawal by Subject|1|||
162622352|NCT00957580|587332485|FG000|Overall Study|Ongoing at data cut-off|0|||
162622353|NCT00957580|587332486|FG001|Overall Study|Ongoing at data cut-off|1|||
162622354|NCT00957580|587332487|FG002|Overall Study|Ongoing at data cut-off|0|||
162622355|NCT00957580|587332485|FG000|Overall Study|Enrolled but not treated|0|||
162622356|NCT00957580|587332486|FG001|Overall Study|Enrolled but not treated|1|||
162622357|NCT00957580|587332487|FG002|Overall Study|Enrolled but not treated|0|||
162964483|NCT00875524|588569788|FG000|Overall Study|Protocol Violation|4|||
162964484|NCT00875524|588569789|FG001|Overall Study|Protocol Violation|0|||
162964485|NCT00875524|588569788|FG000|Overall Study|Lost to Follow-up|1|||
162964486|NCT00875524|588569789|FG001|Overall Study|Lost to Follow-up|0|||
162964487|NCT00875524|588569788|FG000|Overall Study|Withdrawal by Subject|3|||
162964488|NCT00875524|588569789|FG001|Overall Study|Withdrawal by Subject|5|||
162964489|NCT00574847|588569799|FG000|Overall Study|Adverse Event|2|||
162964490|NCT00574847|588569800|FG001|Overall Study|Adverse Event|0|||
162890501|NCT03820726|588296900|FG000|Overall Study|Protocol deviation|1|||
162890502|NCT03820726|588296900|FG000|Overall Study|Adverse Event|146|||
162622358|NCT00945893|587332488|FG000|Overall Study|Lost to Follow-up|2|||
162622359|NCT00945893|587332489|FG001|Overall Study|Lost to Follow-up|8|||
162622360|NCT00945893|587332488|FG000|Overall Study|Withdrawal of consent|1|||
162622361|NCT00945893|587332489|FG001|Overall Study|Withdrawal of consent|2|||
162622362|NCT01611155|587332490|FG000|Overall Study|Adverse Event|1|||
162622363|NCT01611155|587332491|FG001|Overall Study|Adverse Event|1|||
162622364|NCT01611155|587332490|FG000|Overall Study|Refused further treatment|6|||
162622365|NCT01611155|587332491|FG001|Overall Study|Refused further treatment|4|||
162622366|NCT01611155|587332490|FG000|Overall Study|Disease progression|1|||
162622367|NCT01611155|587332491|FG001|Overall Study|Disease progression|0|||
162622368|NCT01611155|587332490|FG000|Overall Study|Withdrawal by Subject|1|||
162622369|NCT01611155|587332491|FG001|Overall Study|Withdrawal by Subject|0|||
162622370|NCT01611155|587332490|FG000|Overall Study|Alternative treatment|0|||
162622371|NCT01611155|587332491|FG001|Overall Study|Alternative treatment|1|||
162622372|NCT01611155|587332490|FG000|Overall Study|Ineligible patient|0|||
162622373|NCT01611155|587332491|FG001|Overall Study|Ineligible patient|1|||
162622374|NCT01602120|587332492|FG000|Overall Study|Adverse Event|3|||
162622375|NCT01602120|587332493|FG001|Overall Study|Adverse Event|6|||
162622376|NCT01602120|587332494|FG002|Overall Study|Adverse Event|0|||
162622377|NCT01602120|587332495|FG003|Overall Study|Adverse Event|2|||
162622378|NCT01602120|587332492|FG000|Overall Study|Death|0|||
162622379|NCT01602120|587332493|FG001|Overall Study|Death|4|||
162622380|NCT01602120|587332494|FG002|Overall Study|Death|0|||
162622381|NCT01602120|587332495|FG003|Overall Study|Death|0|||
162622382|NCT01602120|587332492|FG000|Overall Study|Lost to Follow-up|0|||
162622383|NCT01602120|587332493|FG001|Overall Study|Lost to Follow-up|1|||
162622384|NCT01602120|587332494|FG002|Overall Study|Lost to Follow-up|0|||
162622385|NCT01602120|587332495|FG003|Overall Study|Lost to Follow-up|1|||
162622386|NCT01602120|587332492|FG000|Overall Study|Protocol Violation|1|||
162622387|NCT01602120|587332493|FG001|Overall Study|Protocol Violation|1|||
162622388|NCT01602120|587332494|FG002|Overall Study|Protocol Violation|0|||
162622389|NCT01602120|587332495|FG003|Overall Study|Protocol Violation|0|||
162622390|NCT01602120|587332492|FG000|Overall Study|Non-compliance|0|||
162622391|NCT01602120|587332493|FG001|Overall Study|Non-compliance|3|||
162622392|NCT01602120|587332494|FG002|Overall Study|Non-compliance|0|||
162622393|NCT01602120|587332495|FG003|Overall Study|Non-compliance|1|||
162622394|NCT01602120|587332492|FG000|Overall Study|Withdrawal by Subject|8|||
162622395|NCT01602120|587332493|FG001|Overall Study|Withdrawal by Subject|17|||
162622396|NCT01602120|587332494|FG002|Overall Study|Withdrawal by Subject|0|||
162622397|NCT01602120|587332495|FG003|Overall Study|Withdrawal by Subject|3|||
162622398|NCT01602120|587332492|FG000|Overall Study|Study Terminated by Sponsor|12|||
162622399|NCT01602120|587332493|FG001|Overall Study|Study Terminated by Sponsor|24|||
162622400|NCT01602120|587332494|FG002|Overall Study|Study Terminated by Sponsor|17|||
162622401|NCT01602120|587332495|FG003|Overall Study|Study Terminated by Sponsor|44|||
162622402|NCT01602120|587332492|FG000|Overall Study|Physician Decision|2|||
162622403|NCT01602120|587332493|FG001|Overall Study|Physician Decision|3|||
162622404|NCT01602120|587332494|FG002|Overall Study|Physician Decision|0|||
162622405|NCT01602120|587332495|FG003|Overall Study|Physician Decision|0|||
162622406|NCT01602120|587332492|FG000|Overall Study|Unspecified Reason|3|||
162622407|NCT01602120|587332493|FG001|Overall Study|Unspecified Reason|1|||
162622408|NCT01602120|587332494|FG002|Overall Study|Unspecified Reason|0|||
162622409|NCT01602120|587332495|FG003|Overall Study|Unspecified Reason|2|||
162622410|NCT04502433|587332498|FG000|Overall Study|Death|2|||
162622411|NCT04502433|587332499|FG001|Overall Study|Death|4|||
162622412|NCT04502433|587332498|FG000|Overall Study|Lost to Follow-up|1|||
162622413|NCT04502433|587332499|FG001|Overall Study|Lost to Follow-up|0|||
162622414|NCT04502433|587332498|FG000|Overall Study|Physician Decision|0|||
162622415|NCT04502433|587332499|FG001|Overall Study|Physician Decision|1|||
162622416|NCT01681472|587332500|FG000|Overall Study|Adverse Event|0|||
162622417|NCT01681472|587332501|FG001|Overall Study|Adverse Event|1|||
162622418|NCT01681472|587332502|FG002|Overall Study|Adverse Event|0|||
162622419|NCT01681472|587332503|FG003|Overall Study|Adverse Event|0|||
162622420|NCT01696071|587332518|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
162622421|NCT01696071|587332519|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
162622422|NCT00678080|587332523|FG000|Overall Study|Physician Decision|2|||
162622423|NCT00678080|587332524|FG001|Overall Study|Physician Decision|0|||
162622424|NCT00678080|587332523|FG000|Overall Study|Lost to Follow-up|1|||
162622425|NCT00678080|587332524|FG001|Overall Study|Lost to Follow-up|0|||
162622426|NCT00678080|587332523|FG000|Overall Study|Withdrawal by Subject|0|||
162622427|NCT00678080|587332524|FG001|Overall Study|Withdrawal by Subject|1|||
162622428|NCT04439201|587332527|FG000|Overall Study|Ineligible|2|||
162622429|NCT04439201|587332527|FG000|Overall Study|Never start protocol therapy|1|||
162622430|NCT04439201|587332527|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
162622431|NCT04439201|587332527|FG000|Overall Study|Mutation status not confirmed|4|||
162622432|NCT04439201|587332527|FG000|Overall Study|Adverse Event|1|||
162622433|NCT04439201|587332527|FG000|Overall Study|Death|7|||
162622434|NCT04439201|587332527|FG000|Overall Study|Withdrawal by Subject|2|||
162622435|NCT04439201|587332527|FG000|Overall Study|Disease progression|20|||
162622436|NCT04439201|587332527|FG000|Overall Study|Alternative therapy|1|||
162622437|NCT04439201|587332527|FG000|Overall Study|Physician Decision|1|||
162890503|NCT03820726|588296900|FG000|Overall Study|Not treated|1|||
162890504|NCT00719862|588296908|FG000|Overall Study|Adverse Event|1|||
162890505|NCT00719862|588296909|FG001|Overall Study|Adverse Event|2|||
162890506|NCT00719862|588296908|FG000|Overall Study|Lack of Efficacy|3|||
162890507|NCT00719862|588296909|FG001|Overall Study|Lack of Efficacy|0|||
162890508|NCT00719862|588296908|FG000|Overall Study|Non-Compliance|1|||
162890509|NCT00719862|588296909|FG001|Overall Study|Non-Compliance|0|||
162890510|NCT00719862|588296908|FG000|Overall Study|Withdrawal by Subject|1|||
162890511|NCT00719862|588296909|FG001|Overall Study|Withdrawal by Subject|0|||
162890512|NCT00719862|588296908|FG000|Overall Study|Lost to Follow-up|0|||
162890513|NCT00719862|588296909|FG001|Overall Study|Lost to Follow-up|1|||
162890514|NCT00719862|588296908|FG000|Overall Study|Other|2|||
162890515|NCT00719862|588296909|FG001|Overall Study|Other|3|||
162890516|NCT01736254|588296911|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
162890517|NCT01736254|588296911|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
162890518|NCT00107172|588299110|FG000|Overall Study|Withdrawal by Subject|1|||
162890519|NCT00107172|588299111|FG001|Overall Study|Withdrawal by Subject|0|||
162890520|NCT00107172|588299110|FG000|Overall Study|Death|0|||
162890521|NCT00107172|588299111|FG001|Overall Study|Death|2|||
162890522|NCT00107172|588299110|FG000|Overall Study|Other Reason|4|||
162890523|NCT00107172|588299111|FG001|Overall Study|Other Reason|3|||
162890524|NCT04268303|588299112|FG000|Overall Study|Lost to Follow-up|1|||
162890525|NCT04268303|588299113|FG001|Overall Study|Lost to Follow-up|1|||
162890526|NCT04268303|588299114|FG002|Overall Study|Lost to Follow-up|2|||
162890527|NCT04268303|588299112|FG000|Overall Study|Withdrawal by Subject|0|||
162890528|NCT04268303|588299113|FG001|Overall Study|Withdrawal by Subject|1|||
162890529|NCT04268303|588299114|FG002|Overall Study|Withdrawal by Subject|1|||
162890530|NCT04268303|588299112|FG000|Overall Study|Adverse Event|2|||
162890531|NCT04268303|588299113|FG001|Overall Study|Adverse Event|0|||
162890532|NCT04268303|588299114|FG002|Overall Study|Adverse Event|0|||
162890533|NCT00355134|588299115|FG000|Core Phase|Withdrawal by Subject|35|||
162890534|NCT00355134|588299116|FG001|Core Phase|Withdrawal by Subject|24|||
162890535|NCT00355134|588299117|FG002|Core Phase|Withdrawal by Subject|35|||
162890536|NCT00355134|588299118|FG003|Core Phase|Withdrawal by Subject|0|||
162890537|NCT00355134|588299119|FG004|Core Phase|Withdrawal by Subject|0|||
162890538|NCT00355134|588299115|FG000|Core Phase|Adverse Event|28|||
162890539|NCT00355134|588299116|FG001|Core Phase|Adverse Event|22|||
162890540|NCT00355134|588299117|FG002|Core Phase|Adverse Event|16|||
162890541|NCT00355134|588299118|FG003|Core Phase|Adverse Event|0|||
162890542|NCT00355134|588299119|FG004|Core Phase|Adverse Event|0|||
162890543|NCT00355134|588299115|FG000|Core Phase|Lost to Follow-up|17|||
162890544|NCT00355134|588299116|FG001|Core Phase|Lost to Follow-up|13|||
162890545|NCT00355134|588299117|FG002|Core Phase|Lost to Follow-up|21|||
162890546|NCT00355134|588299118|FG003|Core Phase|Lost to Follow-up|0|||
162890547|NCT00355134|588299119|FG004|Core Phase|Lost to Follow-up|0|||
162890548|NCT00355134|588299115|FG000|Core Phase|Abnormal laboratory value(s)|19|||
162890549|NCT00355134|588299116|FG001|Core Phase|Abnormal laboratory value(s)|14|||
162890550|NCT00355134|588299117|FG002|Core Phase|Abnormal laboratory value(s)|2|||
162890551|NCT00355134|588299118|FG003|Core Phase|Abnormal laboratory value(s)|0|||
162890552|NCT00355134|588299119|FG004|Core Phase|Abnormal laboratory value(s)|0|||
162890553|NCT00355134|588299115|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
162890554|NCT00355134|588299116|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
162890555|NCT00355134|588299117|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
162890556|NCT00355134|588299118|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
162890557|NCT00355134|588299119|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
162890558|NCT00355134|588299115|FG000|Core Phase|Administrative problems|5|||
162890559|NCT00355134|588299116|FG001|Core Phase|Administrative problems|3|||
162890560|NCT00355134|588299117|FG002|Core Phase|Administrative problems|5|||
162890561|NCT00355134|588299118|FG003|Core Phase|Administrative problems|0|||
162890562|NCT00355134|588299119|FG004|Core Phase|Administrative problems|0|||
162890563|NCT00355134|588299115|FG000|Core Phase|Protocol Violation|3|||
162890564|NCT00355134|588299116|FG001|Core Phase|Protocol Violation|2|||
162890565|NCT00355134|588299117|FG002|Core Phase|Protocol Violation|2|||
162890566|NCT00355134|588299118|FG003|Core Phase|Protocol Violation|0|||
162890567|NCT00355134|588299119|FG004|Core Phase|Protocol Violation|0|||
162890568|NCT00355134|588299115|FG000|Core Phase|Abnormal test procedure result(s)|1|||
162890569|NCT00355134|588299116|FG001|Core Phase|Abnormal test procedure result(s)|2|||
162890570|NCT00355134|588299117|FG002|Core Phase|Abnormal test procedure result(s)|1|||
162890571|NCT00355134|588299118|FG003|Core Phase|Abnormal test procedure result(s)|0|||
162890572|NCT00355134|588299119|FG004|Core Phase|Abnormal test procedure result(s)|0|||
162890573|NCT00355134|588299115|FG000|Core Phase|Condition no longer requires study drug|1|||
162890574|NCT00355134|588299116|FG001|Core Phase|Condition no longer requires study drug|0|||
162890575|NCT00355134|588299117|FG002|Core Phase|Condition no longer requires study drug|1|||
162890576|NCT00355134|588299118|FG003|Core Phase|Condition no longer requires study drug|0|||
162890577|NCT00355134|588299119|FG004|Core Phase|Condition no longer requires study drug|0|||
162890578|NCT00355134|588299115|FG000|Extension Phase|Withdrawal by Subject|7|||
162890579|NCT00355134|588299116|FG001|Extension Phase|Withdrawal by Subject|11|||
162890580|NCT00355134|588299117|FG002|Extension Phase|Withdrawal by Subject|0|||
162890581|NCT00355134|588299118|FG003|Extension Phase|Withdrawal by Subject|7|||
162890582|NCT00355134|588299119|FG004|Extension Phase|Withdrawal by Subject|5|||
162890583|NCT00355134|588299115|FG000|Extension Phase|Adverse Event|13|||
162890584|NCT00355134|588299116|FG001|Extension Phase|Adverse Event|9|||
162890585|NCT00355134|588299117|FG002|Extension Phase|Adverse Event|0|||
162890586|NCT00355134|588299118|FG003|Extension Phase|Adverse Event|3|||
162890587|NCT00355134|588299119|FG004|Extension Phase|Adverse Event|5|||
162890588|NCT00355134|588299115|FG000|Extension Phase|Lost to Follow-up|2|||
162890589|NCT00355134|588299116|FG001|Extension Phase|Lost to Follow-up|6|||
162890590|NCT00355134|588299117|FG002|Extension Phase|Lost to Follow-up|0|||
162890591|NCT00355134|588299118|FG003|Extension Phase|Lost to Follow-up|2|||
162890592|NCT00355134|588299119|FG004|Extension Phase|Lost to Follow-up|4|||
162890593|NCT00355134|588299115|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
162890594|NCT00355134|588299116|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
162890595|NCT00355134|588299117|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
162890596|NCT00355134|588299118|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
162890597|NCT00355134|588299119|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
162890598|NCT00355134|588299115|FG000|Extension Phase|Administrative problems|2|||
162890599|NCT00355134|588299116|FG001|Extension Phase|Administrative problems|4|||
162890600|NCT00355134|588299117|FG002|Extension Phase|Administrative problems|0|||
162890601|NCT00355134|588299118|FG003|Extension Phase|Administrative problems|1|||
162890602|NCT00355134|588299119|FG004|Extension Phase|Administrative problems|1|||
162890603|NCT00355134|588299115|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
162890604|NCT00355134|588299116|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
162890605|NCT00355134|588299117|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
162890606|NCT00355134|588299118|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
162890607|NCT00355134|588299119|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
162890608|NCT00355134|588299115|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
162890609|NCT00355134|588299116|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
162890610|NCT00355134|588299117|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
162890611|NCT00355134|588299118|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
162890612|NCT00355134|588299119|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
162890613|NCT00355134|588299115|FG000|Extension Phase|Protocol Violation|0|||
162890614|NCT00355134|588299116|FG001|Extension Phase|Protocol Violation|0|||
162890615|NCT00355134|588299117|FG002|Extension Phase|Protocol Violation|0|||
162890616|NCT00355134|588299118|FG003|Extension Phase|Protocol Violation|1|||
162890617|NCT00355134|588299119|FG004|Extension Phase|Protocol Violation|0|||
162890618|NCT04432376|588299120|FG000|Double-blind Treatment Period|Adverse Event|2|||
162890619|NCT04432376|588299121|FG001|Double-blind Treatment Period|Adverse Event|6|||
162890620|NCT04432376|588299122|FG002|Double-blind Treatment Period|Adverse Event|0|||
162890621|NCT04432376|588299120|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
162890622|NCT04432376|588299121|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
162890623|NCT04432376|588299122|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
162890624|NCT04432376|588299120|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
162964491|NCT00574847|588569799|FG000|Overall Study|Death|1|||
162964492|NCT00574847|588569800|FG001|Overall Study|Death|0|||
162964493|NCT00574847|588569799|FG000|Overall Study|Withdrawal by Subject|2|||
162964494|NCT00574847|588569800|FG001|Overall Study|Withdrawal by Subject|2|||
162964495|NCT00574847|588569799|FG000|Overall Study|Physician Decision|1|||
162964496|NCT00574847|588569800|FG001|Overall Study|Physician Decision|0|||
162964497|NCT00574847|588569799|FG000|Overall Study|Did not receive medication (declined)|2|||
162622438|NCT05136690|587332528|FG000|Period 1|Withdrawal by Subject|0|||
162622439|NCT05136690|587332529|FG001|Period 1|Withdrawal by Subject|1|||
162622440|NCT05136690|587332528|FG000|Period 2|Lost to Follow-up|0|||
162622441|NCT05136690|587332529|FG001|Period 2|Lost to Follow-up|3|||
162622442|NCT05136690|587332528|FG000|Period 2|Withdrawal by Subject|0|||
162622443|NCT05136690|587332529|FG001|Period 2|Withdrawal by Subject|1|||
162622444|NCT01453361|587332530|FG000|Overall Study|Disease Progression|6|||
162622445|NCT01453361|587332530|FG000|Overall Study|Screen-Failures|10|||
162890625|NCT04432376|588299121|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162890626|NCT04432376|588299122|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162890627|NCT04432376|588299120|FG000|Double-blind Treatment Period|Protocol Violation|0|||
162890628|NCT04432376|588299121|FG001|Double-blind Treatment Period|Protocol Violation|1|||
162890629|NCT04432376|588299122|FG002|Double-blind Treatment Period|Protocol Violation|0|||
162890630|NCT04432376|588299120|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
162890631|NCT04432376|588299121|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
162964498|NCT00574847|588569800|FG001|Overall Study|Did not receive medication (declined)|5|||
162964499|NCT00957021|588569801|FG000|Overall Study|Death|5|||
162708684|NCT00797225|587642874|FG005|Weeks 13 to 24|Non-compliance|0|||
162890632|NCT04432376|588299122|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
162890633|NCT03706040|588299123|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
162890634|NCT03706040|588299124|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
162890635|NCT03706040|588299125|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
162890636|NCT03706040|588299126|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
162890637|NCT03706040|588299127|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
162890638|NCT03706040|588299128|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
162890639|NCT03706040|588299129|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
162890640|NCT03706040|588299123|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
162890641|NCT03706040|588299124|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
162890642|NCT03706040|588299125|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
162890643|NCT03706040|588299126|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
162890644|NCT03706040|588299127|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
162890645|NCT03706040|588299128|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
162890646|NCT03706040|588299129|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
162890647|NCT03706040|588299123|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
162890648|NCT03706040|588299124|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
162890649|NCT03706040|588299125|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
162890650|NCT03706040|588299126|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
162890651|NCT03706040|588299127|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
162890652|NCT03706040|588299128|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
162890653|NCT03706040|588299129|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
162890654|NCT03706040|588299123|FG000|Period A (Week 0 to Week 16)|Other|2|||
162890655|NCT03706040|588299124|FG001|Period A (Week 0 to Week 16)|Other|0|||
162890656|NCT03706040|588299125|FG002|Period A (Week 0 to Week 16)|Other|2|||
162890657|NCT03706040|588299126|FG003|Period A (Week 0 to Week 16)|Other|0|||
162890658|NCT03706040|588299127|FG004|Period A (Week 0 to Week 16)|Other|0|||
162890659|NCT03706040|588299128|FG005|Period A (Week 0 to Week 16)|Other|0|||
162890660|NCT03706040|588299129|FG006|Period A (Week 0 to Week 16)|Other|0|||
162890661|NCT03706040|588299123|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
162890662|NCT03706040|588299124|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
162890663|NCT03706040|588299125|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
162890664|NCT03706040|588299126|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
162890665|NCT03706040|588299127|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
162890666|NCT03706040|588299128|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
162890667|NCT03706040|588299129|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
162890668|NCT03706040|588299123|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
162890669|NCT03706040|588299124|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
162890670|NCT03706040|588299125|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
162890671|NCT03706040|588299126|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
162890672|NCT03706040|588299127|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
162890673|NCT03706040|588299128|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
162890674|NCT03706040|588299129|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
162890675|NCT03706040|588299123|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
162890676|NCT03706040|588299124|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
162890677|NCT03706040|588299125|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
162890678|NCT03706040|588299126|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
162890679|NCT03706040|588299127|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
162890680|NCT03706040|588299128|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
162890681|NCT03706040|588299129|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
162890682|NCT03706040|588299123|FG000|Period B (Week 16 to Week 52)|Other|0|||
162890683|NCT03706040|588299124|FG001|Period B (Week 16 to Week 52)|Other|0|||
162890684|NCT03706040|588299125|FG002|Period B (Week 16 to Week 52)|Other|0|||
162890685|NCT03706040|588299126|FG003|Period B (Week 16 to Week 52)|Other|4|||
162890686|NCT03706040|588299127|FG004|Period B (Week 16 to Week 52)|Other|5|||
162890687|NCT03706040|588299128|FG005|Period B (Week 16 to Week 52)|Other|23|||
162890688|NCT03706040|588299129|FG006|Period B (Week 16 to Week 52)|Other|17|||
162890689|NCT00927758|588299130|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
162890690|NCT00927758|588299131|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
162890691|NCT00927758|588299132|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
162890692|NCT00927758|588299133|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
162890693|NCT00927758|588299134|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
162890694|NCT00927758|588299135|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
162890695|NCT00927758|588299130|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
162890696|NCT00927758|588299131|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
162890697|NCT00927758|588299132|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
162890698|NCT00927758|588299133|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
162890699|NCT00927758|588299134|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
162890700|NCT00927758|588299135|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
162964500|NCT00957021|588569801|FG000|Overall Study|Lost to Follow-up|8|||
162890701|NCT00439725|588299136|FG000|Treatment Period|Withdrawal by Subject|22|||
162890702|NCT00439725|588299137|FG001|Treatment Period|Withdrawal by Subject|19|||
162890703|NCT00439725|588299136|FG000|Treatment Period|Study terminated by sponsor|156|||
162890704|NCT00439725|588299137|FG001|Treatment Period|Study terminated by sponsor|148|||
162890705|NCT00439725|588299136|FG000|Treatment Period|Site closed by investigator|1|||
162890706|NCT00439725|588299137|FG001|Treatment Period|Site closed by investigator|2|||
162890707|NCT00439725|588299136|FG000|Treatment Period|Adverse Event|39|||
162890708|NCT00439725|588299137|FG001|Treatment Period|Adverse Event|18|||
162890709|NCT00439725|588299136|FG000|Treatment Period|Physician Decision|1|||
162890710|NCT00439725|588299137|FG001|Treatment Period|Physician Decision|1|||
162890711|NCT00439725|588299136|FG000|Treatment Period|Protocol Violation|2|||
162890712|NCT00439725|588299137|FG001|Treatment Period|Protocol Violation|1|||
162890713|NCT00439725|588299136|FG000|Treatment Period|Clinical endpoint reached|6|||
162890714|NCT00439725|588299137|FG001|Treatment Period|Clinical endpoint reached|50|||
162890715|NCT00439725|588299136|FG000|Treatment Period|Technical problems|1|||
162890716|NCT00439725|588299137|FG001|Treatment Period|Technical problems|0|||
162890717|NCT00439725|588299136|FG000|Treatment Period|Lost to Follow-up|1|||
162890718|NCT00439725|588299137|FG001|Treatment Period|Lost to Follow-up|1|||
162890719|NCT00439725|588299136|FG000|Treatment Period|Participant convenience|1|||
162890720|NCT00439725|588299137|FG001|Treatment Period|Participant convenience|0|||
162890721|NCT00439725|588299136|FG000|Treatment Period|Protocol driven decision point|1|||
162890722|NCT00439725|588299137|FG001|Treatment Period|Protocol driven decision point|1|||
162890723|NCT00439725|588299136|FG000|Treatment Period|Death|1|||
162890724|NCT00439725|588299137|FG001|Treatment Period|Death|1|||
162890725|NCT00439725|588299136|FG000|Treatment Period|Participant did not receive treatment|4|||
162890726|NCT00439725|588299137|FG001|Treatment Period|Participant did not receive treatment|4|||
162890727|NCT00439725|588299136|FG000|Observational Period|Withdrawal by Subject|2|||
162890728|NCT00439725|588299137|FG001|Observational Period|Withdrawal by Subject|2|||
162890729|NCT00439725|588299136|FG000|Observational Period|Lost to Follow-up|0|||
162890730|NCT00439725|588299137|FG001|Observational Period|Lost to Follow-up|1|||
162890731|NCT00439725|588299136|FG000|Observational Period|Death|0|||
162890732|NCT00439725|588299137|FG001|Observational Period|Death|2|||
162890733|NCT00439725|588299136|FG000|Observational Period|Study termination by sponsor|1|||
162890734|NCT00439725|588299137|FG001|Observational Period|Study termination by sponsor|1|||
162890735|NCT00439725|588299136|FG000|Observational Period|Clinical endpoint reached|3|||
162890736|NCT00439725|588299137|FG001|Observational Period|Clinical endpoint reached|1|||
162890737|NCT00439725|588299136|FG000|Observational Period|Technical problems|1|||
162890738|NCT00439725|588299137|FG001|Observational Period|Technical problems|0|||
162890739|NCT00439725|588299136|FG000|Observational Period|Participant convenience|1|||
162890740|NCT00439725|588299137|FG001|Observational Period|Participant convenience|0|||
162890741|NCT02848313|588299138|FG000|Overall Study|Adverse Event|1|||
162890742|NCT02848313|588299139|FG001|Overall Study|Adverse Event|2|||
162890743|NCT02848313|588299138|FG000|Overall Study|Lack of Efficacy|0|||
162890744|NCT02848313|588299139|FG001|Overall Study|Lack of Efficacy|1|||
162890745|NCT02848313|588299138|FG000|Overall Study|Withdrawal by Subject|1|||
162890746|NCT02848313|588299139|FG001|Overall Study|Withdrawal by Subject|1|||
162890747|NCT02848313|588299138|FG000|Overall Study|Lost to follow up|1|||
162890748|NCT02848313|588299139|FG001|Overall Study|Lost to follow up|0|||
162890749|NCT03510910|588299140|FG000|Overall Study|Incomplete Survey|2|||
162890750|NCT03510910|588299141|FG001|Overall Study|Incomplete Survey|3|||
162890751|NCT03984812|588299142|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890752|NCT03984812|588299143|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890753|NCT03984812|588299144|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
162890754|NCT03984812|588299145|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890755|NCT03984812|588299146|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890756|NCT03984812|588299147|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890757|NCT03984812|588299148|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890758|NCT03984812|588299149|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890759|NCT03984812|588299150|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890760|NCT03984812|588299151|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890761|NCT03984812|588299152|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
162890762|NCT01673490|588299153|FG000|Overall Study|Lost to Follow-up|1|||
162890763|NCT01673490|588299153|FG000|Overall Study|Adverse Event|3|||
162890764|NCT01673490|588299153|FG000|Overall Study|Withdrawal by Subject|3|||
162890765|NCT00379236|588299154|FG000|Double-blind|Adverse Event|11|||
162890766|NCT00379236|588299155|FG001|Double-blind|Adverse Event|6|||
162890767|NCT00379236|588299156|FG002|Double-blind|Adverse Event|0|||
162890768|NCT00379236|588299154|FG000|Double-blind|Protocol Violation|3|||
162890769|NCT00379236|588299155|FG001|Double-blind|Protocol Violation|3|||
162890770|NCT00379236|588299156|FG002|Double-blind|Protocol Violation|0|||
162890771|NCT00379236|588299154|FG000|Double-blind|Withdrawal by Subject|12|||
162890772|NCT00379236|588299155|FG001|Double-blind|Withdrawal by Subject|13|||
162890773|NCT00379236|588299156|FG002|Double-blind|Withdrawal by Subject|0|||
162890774|NCT00379236|588299154|FG000|Double-blind|Lost to Follow-up|4|||
162890775|NCT00379236|588299155|FG001|Double-blind|Lost to Follow-up|3|||
162890776|NCT00379236|588299156|FG002|Double-blind|Lost to Follow-up|0|||
162890777|NCT00379236|588299154|FG000|Double-blind|Use of exclusionary medication|1|||
162890778|NCT00379236|588299155|FG001|Double-blind|Use of exclusionary medication|2|||
162890779|NCT00379236|588299156|FG002|Double-blind|Use of exclusionary medication|0|||
162890780|NCT00379236|588299154|FG000|Double-blind|Other|3|||
162890781|NCT00379236|588299155|FG001|Double-blind|Other|7|||
162890782|NCT00379236|588299156|FG002|Double-blind|Other|0|||
162890783|NCT00379236|588299154|FG000|Double-blind|Data could not be retrieved|2|||
162890784|NCT00379236|588299155|FG001|Double-blind|Data could not be retrieved|2|||
162890785|NCT00379236|588299156|FG002|Double-blind|Data could not be retrieved|0|||
162890786|NCT00379236|588299154|FG000|Open-label Extension|Adverse Event|0|||
162890787|NCT00379236|588299155|FG001|Open-label Extension|Adverse Event|0|||
162890788|NCT00379236|588299156|FG002|Open-label Extension|Adverse Event|13|||
162890789|NCT00379236|588299154|FG000|Open-label Extension|Protocol Violation|0|||
162890790|NCT00379236|588299155|FG001|Open-label Extension|Protocol Violation|0|||
162890791|NCT00379236|588299156|FG002|Open-label Extension|Protocol Violation|7|||
162890792|NCT00379236|588299154|FG000|Open-label Extension|Withdrawal by Subject|0|||
162890793|NCT00379236|588299155|FG001|Open-label Extension|Withdrawal by Subject|0|||
162890794|NCT00379236|588299156|FG002|Open-label Extension|Withdrawal by Subject|13|||
162890795|NCT00379236|588299154|FG000|Open-label Extension|Lost to Follow-up|0|||
162890796|NCT00379236|588299155|FG001|Open-label Extension|Lost to Follow-up|0|||
162890797|NCT00379236|588299156|FG002|Open-label Extension|Lost to Follow-up|12|||
162890798|NCT00379236|588299154|FG000|Open-label Extension|Use of exclusionary medication|0|||
162890799|NCT00379236|588299155|FG001|Open-label Extension|Use of exclusionary medication|0|||
162890800|NCT00379236|588299156|FG002|Open-label Extension|Use of exclusionary medication|3|||
162890801|NCT00379236|588299154|FG000|Open-label Extension|Other|0|||
162890802|NCT00379236|588299155|FG001|Open-label Extension|Other|0|||
162890803|NCT00379236|588299156|FG002|Open-label Extension|Other|7|||
162890804|NCT02940860|588299164|FG000|Overall Study|Non-serious AE|1|||
162890805|NCT02940860|588299165|FG001|Overall Study|Non-serious AE|2|||
162890806|NCT02940860|588299164|FG000|Overall Study|Serious AE|7|||
162890807|NCT02940860|588299165|FG001|Overall Study|Serious AE|3|||
162890808|NCT02940860|588299164|FG000|Overall Study|Withdrawal by Subject|19|||
162890809|NCT02940860|588299165|FG001|Overall Study|Withdrawal by Subject|9|||
162890810|NCT02940860|588299164|FG000|Overall Study|Lost to Follow-up|13|||
162890811|NCT02940860|588299165|FG001|Overall Study|Lost to Follow-up|7|||
162890812|NCT02940860|588299164|FG000|Overall Study|Physician Decision|5|||
162890813|NCT02940860|588299165|FG001|Overall Study|Physician Decision|3|||
162890814|NCT02940860|588299164|FG000|Overall Study|Sponsor Decision|0|||
162890815|NCT02940860|588299165|FG001|Overall Study|Sponsor Decision|1|||
162890816|NCT02940860|588299164|FG000|Overall Study|Protocol Violation|0|||
162890817|NCT02940860|588299165|FG001|Overall Study|Protocol Violation|2|||
162890818|NCT02940860|588299164|FG000|Overall Study|Death|3|||
162890819|NCT02940860|588299165|FG001|Overall Study|Death|2|||
162890820|NCT02940860|588299164|FG000|Overall Study|Moved, poor venous access, transport|6|||
162890821|NCT02940860|588299165|FG001|Overall Study|Moved, poor venous access, transport|4|||
162890822|NCT02940860|588299164|FG000|Overall Study|Not treated|2|||
162890823|NCT02940860|588299165|FG001|Overall Study|Not treated|2|||
162890824|NCT04914819|588299166|FG000|Overall Study|Pregnancy|3|||
162890825|NCT04914819|588299167|FG001|Overall Study|Pregnancy|1|||
162890826|NCT04914819|588299166|FG000|Overall Study|Discontinued study|4|||
162890827|NCT04914819|588299167|FG001|Overall Study|Discontinued study|1|||
162890828|NCT04914819|588299166|FG000|Overall Study|Lost to Follow-up|7|||
162890829|NCT04914819|588299167|FG001|Overall Study|Lost to Follow-up|0|||
162890830|NCT02431793|588299171|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
162890831|NCT02431793|588299172|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
162890832|NCT02431793|588299173|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
162890833|NCT02431793|588299171|FG000|Overall Study|Withdrawal by Subject|7|||
162890834|NCT02431793|588299172|FG001|Overall Study|Withdrawal by Subject|5|||
162890835|NCT02431793|588299173|FG002|Overall Study|Withdrawal by Subject|5|||
162890836|NCT02431793|588299171|FG000|Overall Study|Lost to Follow-up|101|||
162890837|NCT02431793|588299172|FG001|Overall Study|Lost to Follow-up|122|||
162890838|NCT02431793|588299173|FG002|Overall Study|Lost to Follow-up|104|||
162890839|NCT00233324|588299174|FG000|Main Study|Death|68|||
162890840|NCT00233324|588299175|FG001|Main Study|Death|60|||
162890841|NCT00233324|588299176|FG002|Main Study|Death|62|||
162890842|NCT00233324|588299177|FG003|Main Study|Death|47|||
162890843|NCT00233324|588299174|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
162622446|NCT01752985|587332531|FG000|Treatment Period|Subject request to discontinue treatment|1|||
162622447|NCT01752985|587332532|FG001|Treatment Period|Subject request to discontinue treatment|0|||
162890844|NCT00233324|588299175|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
162890845|NCT00233324|588299176|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
162890846|NCT00233324|588299177|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
162890847|NCT00233324|588299174|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
162890848|NCT00233324|588299175|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
162890849|NCT00233324|588299176|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
162890850|NCT00233324|588299177|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
162890851|NCT01711541|588299184|FG000|Overall Study|Cancel prior to treatment|0|||
162890852|NCT01711541|588299185|FG001|Overall Study|Cancel prior to treatment|0|||
162890853|NCT01711541|588299186|FG002|Overall Study|Cancel prior to treatment|0|||
162890854|NCT01711541|588299187|FG003|Overall Study|Cancel prior to treatment|1|||
162890855|NCT01711541|588299188|FG004|Overall Study|Cancel prior to treatment|0|||
162890856|NCT01711541|588299184|FG000|Overall Study|Ineligible|0|||
162890857|NCT01711541|588299185|FG001|Overall Study|Ineligible|1|||
162890858|NCT01711541|588299186|FG002|Overall Study|Ineligible|0|||
162890859|NCT01711541|588299187|FG003|Overall Study|Ineligible|0|||
162890860|NCT01711541|588299188|FG004|Overall Study|Ineligible|0|||
162890861|NCT00728936|588299189|FG000|Overall Study|Withdrawal by Subject|0|||
162890862|NCT00728936|588299190|FG001|Overall Study|Withdrawal by Subject|0|||
162890863|NCT00728936|588299191|FG002|Overall Study|Withdrawal by Subject|0|||
162890864|NCT00728936|588299192|FG003|Overall Study|Withdrawal by Subject|0|||
162890865|NCT00728936|588299193|FG004|Overall Study|Withdrawal by Subject|0|||
162890866|NCT00728936|588299194|FG005|Overall Study|Withdrawal by Subject|1|||
162890867|NCT00728936|588299195|FG006|Overall Study|Withdrawal by Subject|0|||
162890868|NCT00438464|588299196|FG000|Overall Study|Terminated Early|14|||
162890869|NCT00438464|588299197|FG001|Overall Study|Terminated Early|5|||
162890870|NCT00438464|588299196|FG000|Overall Study|Incomplete data submission|0|||
162890871|NCT00438464|588299197|FG001|Overall Study|Incomplete data submission|2|||
162890872|NCT03943446|588299198|FG000|Overall Study|Lost to Follow-up|0|||
162890873|NCT03943446|588299199|FG001|Overall Study|Lost to Follow-up|0|||
162890874|NCT03943446|588299200|FG002|Overall Study|Lost to Follow-up|1|||
162890875|NCT03943446|588299198|FG000|Overall Study|Withdrawal by Subject|1|||
162890876|NCT03943446|588299199|FG001|Overall Study|Withdrawal by Subject|1|||
162890877|NCT03943446|588299200|FG002|Overall Study|Withdrawal by Subject|2|||
162890878|NCT03943446|588299198|FG000|Overall Study|Study Terminated by Sponsor|1|||
162890879|NCT03943446|588299199|FG001|Overall Study|Study Terminated by Sponsor|2|||
162890880|NCT03943446|588299200|FG002|Overall Study|Study Terminated by Sponsor|1|||
162890881|NCT03943446|588299198|FG000|Overall Study|Reason not Specified|5|||
162890882|NCT03943446|588299199|FG001|Overall Study|Reason not Specified|1|||
162890883|NCT03943446|588299200|FG002|Overall Study|Reason not Specified|3|||
162890884|NCT02707601|588299203|FG000|Overall Study|Death|0|||
162890885|NCT02707601|588299204|FG001|Overall Study|Death|1|||
162964501|NCT00957021|588569801|FG000|Overall Study|Withdrawal by Subject|34|||
162964502|NCT00957021|588569801|FG000|Overall Study|No 2 yr ROM data|35|||
162708685|NCT00797225|587642875|FG006|Weeks 13 to 24|Non-compliance|0|||
162964503|NCT00957021|588569801|FG000|Overall Study|Revised study component by 2 yr visit|8|||
162964504|NCT00957021|588569801|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
162964505|NCT00957021|588569801|FG000|Overall Study|Surgery Cancelled|9|||
162964506|NCT00957021|588569801|FG000|Overall Study|Termination due to language issue|2|||
162964507|NCT00819169|588569805|FG000|Overall Study|Withdrawal by Subject|2|||
162964508|NCT00819169|588569806|FG001|Overall Study|Withdrawal by Subject|0|||
162964509|NCT00819169|588569807|FG002|Overall Study|Withdrawal by Subject|0|||
162964510|NCT00819169|588569808|FG003|Overall Study|Withdrawal by Subject|1|||
162964511|NCT00819169|588569809|FG004|Overall Study|Withdrawal by Subject|1|||
162964512|NCT00819169|588569810|FG005|Overall Study|Withdrawal by Subject|1|||
162964513|NCT00819169|588569811|FG006|Overall Study|Withdrawal by Subject|5|||
162890886|NCT02707601|588299203|FG000|Overall Study|Lack of Efficacy|0|||
162890887|NCT02707601|588299204|FG001|Overall Study|Lack of Efficacy|1|||
162890888|NCT02707601|588299203|FG000|Overall Study|Investigator's Discretion|1|||
162890889|NCT02707601|588299204|FG001|Overall Study|Investigator's Discretion|0|||
162890890|NCT02707601|588299203|FG000|Overall Study|Withdrew Consent|0|||
162890891|NCT02707601|588299204|FG001|Overall Study|Withdrew Consent|1|||
162890892|NCT02707601|588299203|FG000|Overall Study|Lost to Follow-up|1|||
162890893|NCT02707601|588299204|FG001|Overall Study|Lost to Follow-up|1|||
162890894|NCT02707601|588299203|FG000|Overall Study|Participants Randomized but Not Treated|2|||
162890895|NCT02707601|588299204|FG001|Overall Study|Participants Randomized but Not Treated|0|||
162890896|NCT03004976|588299210|FG000|Overall Study|Lost to Follow-up|7|||
162890897|NCT03004976|588299211|FG001|Overall Study|Lost to Follow-up|5|||
162890898|NCT03004976|588299210|FG000|Overall Study|Physician Decision|1|||
162890899|NCT03004976|588299211|FG001|Overall Study|Physician Decision|0|||
162890900|NCT03004976|588299210|FG000|Overall Study|Withdrawal by Subject|1|||
162890901|NCT03004976|588299211|FG001|Overall Study|Withdrawal by Subject|0|||
162890902|NCT03004976|588299210|FG000|Overall Study|Death|4|||
162890903|NCT03004976|588299211|FG001|Overall Study|Death|1|||
162890904|NCT01117012|588299212|FG000|Overall Study|Adverse Event|0|||
162890905|NCT01117012|588299213|FG001|Overall Study|Adverse Event|1|||
162890906|NCT01117012|588299212|FG000|Overall Study|Death|1|||
162890907|NCT01117012|588299213|FG001|Overall Study|Death|1|||
162890908|NCT01117012|588299212|FG000|Overall Study|Withdrawal by Subject|3|||
162890909|NCT01117012|588299213|FG001|Overall Study|Withdrawal by Subject|0|||
162890910|NCT01117012|588299212|FG000|Overall Study|Undefined|4|||
162890911|NCT01117012|588299213|FG001|Overall Study|Undefined|3|||
162890912|NCT00493974|588299217|FG000|Overall Study|Death|1|||
162890913|NCT00493974|588299218|FG001|Overall Study|Death|2|||
162890914|NCT00493974|588299217|FG000|Overall Study|Withdrawal by Subject|8|||
162890915|NCT00493974|588299218|FG001|Overall Study|Withdrawal by Subject|6|||
162890916|NCT00493974|588299217|FG000|Overall Study|Lost to Follow-up|4|||
162890917|NCT00493974|588299218|FG001|Overall Study|Lost to Follow-up|6|||
162890918|NCT00326417|588299219|FG000|Overall Study|Withdrawal by Subject|0|||
162890919|NCT00326417|588299220|FG001|Overall Study|Withdrawal by Subject|0|||
162890920|NCT00326417|588299221|FG002|Overall Study|Withdrawal by Subject|1|||
162890921|NCT00326417|588299222|FG003|Overall Study|Withdrawal by Subject|0|||
162890922|NCT00326417|588299219|FG000|Overall Study|Arm Closed|7|||
162890923|NCT00326417|588299220|FG001|Overall Study|Arm Closed|0|||
162890924|NCT00326417|588299221|FG002|Overall Study|Arm Closed|0|||
162890925|NCT00326417|588299222|FG003|Overall Study|Arm Closed|3|||
162890926|NCT00326417|588299219|FG000|Overall Study|Death|7|||
162890927|NCT00326417|588299220|FG001|Overall Study|Death|0|||
162890928|NCT00326417|588299221|FG002|Overall Study|Death|0|||
162890929|NCT00326417|588299222|FG003|Overall Study|Death|0|||
162890930|NCT00844285|588299223|FG000|Overall Study|Other|0|||
162890931|NCT00844285|588299224|FG001|Overall Study|Other|1|||
162890932|NCT00844285|588299225|FG002|Overall Study|Other|0|||
162890933|NCT00844285|588299223|FG000|Overall Study|Other than specified|95|||
162964514|NCT00819169|588569812|FG007|Overall Study|Withdrawal by Subject|1|||
162964515|NCT00819169|588569813|FG008|Overall Study|Withdrawal by Subject|4|||
162964516|NCT00819169|588569805|FG000|Overall Study|Lost to Follow-up|0|||
162964517|NCT00819169|588569806|FG001|Overall Study|Lost to Follow-up|2|||
162964518|NCT00819169|588569807|FG002|Overall Study|Lost to Follow-up|0|||
162964519|NCT00819169|588569808|FG003|Overall Study|Lost to Follow-up|1|||
162964520|NCT00819169|588569809|FG004|Overall Study|Lost to Follow-up|0|||
162964521|NCT00819169|588569810|FG005|Overall Study|Lost to Follow-up|6|||
162964522|NCT00819169|588569811|FG006|Overall Study|Lost to Follow-up|2|||
162964523|NCT00819169|588569812|FG007|Overall Study|Lost to Follow-up|2|||
162964524|NCT00819169|588569813|FG008|Overall Study|Lost to Follow-up|1|||
162964525|NCT00819169|588569805|FG000|Overall Study|Death|1|||
162964526|NCT00819169|588569806|FG001|Overall Study|Death|1|||
162964527|NCT00819169|588569807|FG002|Overall Study|Death|3|||
162964528|NCT00819169|588569808|FG003|Overall Study|Death|8|||
162964529|NCT00819169|588569809|FG004|Overall Study|Death|5|||
162964530|NCT00819169|588569810|FG005|Overall Study|Death|7|||
162964531|NCT00819169|588569811|FG006|Overall Study|Death|9|||
162964532|NCT00819169|588569812|FG007|Overall Study|Death|4|||
162964533|NCT00819169|588569813|FG008|Overall Study|Death|7|||
162964534|NCT00819169|588569805|FG000|Overall Study|Ineligibility determined|0|||
162964535|NCT00819169|588569806|FG001|Overall Study|Ineligibility determined|0|||
162964536|NCT00819169|588569807|FG002|Overall Study|Ineligibility determined|0|||
162964537|NCT00819169|588569808|FG003|Overall Study|Ineligibility determined|2|||
162964538|NCT00819169|588569809|FG004|Overall Study|Ineligibility determined|0|||
162964539|NCT00819169|588569810|FG005|Overall Study|Ineligibility determined|0|||
162964540|NCT00819169|588569811|FG006|Overall Study|Ineligibility determined|0|||
162964541|NCT00819169|588569812|FG007|Overall Study|Ineligibility determined|0|||
162890934|NCT00844285|588299224|FG001|Overall Study|Other than specified|129|||
162890935|NCT00844285|588299225|FG002|Overall Study|Other than specified|12|||
162890936|NCT00844285|588299223|FG000|Overall Study|Site closure|256|||
162890937|NCT00844285|588299224|FG001|Overall Study|Site closure|450|||
162890938|NCT00844285|588299225|FG002|Overall Study|Site closure|50|||
162890939|NCT00844285|588299223|FG000|Overall Study|Follow-up < 8 years|16|||
162890940|NCT00844285|588299224|FG001|Overall Study|Follow-up < 8 years|23|||
162890941|NCT00844285|588299225|FG002|Overall Study|Follow-up < 8 years|4|||
162890942|NCT00844285|588299223|FG000|Overall Study|Protocol Violation|26|||
162890943|NCT00844285|588299224|FG001|Overall Study|Protocol Violation|28|||
162890944|NCT00844285|588299225|FG002|Overall Study|Protocol Violation|54|||
162890945|NCT00844285|588299223|FG000|Overall Study|Death|22|||
162890946|NCT00844285|588299224|FG001|Overall Study|Death|21|||
162890947|NCT00844285|588299225|FG002|Overall Study|Death|8|||
162890948|NCT00844285|588299223|FG000|Overall Study|Withdrew Consent|344|||
162890949|NCT00844285|588299224|FG001|Overall Study|Withdrew Consent|466|||
162890950|NCT00844285|588299225|FG002|Overall Study|Withdrew Consent|70|||
162890951|NCT00844285|588299223|FG000|Overall Study|Lost to Follow-up|330|||
162890952|NCT00844285|588299224|FG001|Overall Study|Lost to Follow-up|486|||
162890953|NCT00844285|588299225|FG002|Overall Study|Lost to Follow-up|74|||
162890954|NCT04682353|588299230|FG000|Overall Study|Lost to Follow-up|0|||
162890955|NCT04682353|588299231|FG001|Overall Study|Lost to Follow-up|1|||
162890956|NCT04682353|588299232|FG002|Overall Study|Lost to Follow-up|0|||
162890957|NCT04682353|588299233|FG003|Overall Study|Lost to Follow-up|1|||
162890958|NCT04682353|588299230|FG000|Overall Study|Personal reasons|0|||
162890959|NCT04682353|588299231|FG001|Overall Study|Personal reasons|1|||
162890960|NCT04682353|588299232|FG002|Overall Study|Personal reasons|0|||
162890961|NCT04682353|588299233|FG003|Overall Study|Personal reasons|0|||
162890962|NCT01586806|588299234|FG000|Overall Study|Protocol Violation|0|||
162890963|NCT01586806|588299235|FG001|Overall Study|Protocol Violation|1|||
162890964|NCT01586806|588299236|FG002|Overall Study|Protocol Violation|0|||
162890965|NCT01586806|588299234|FG000|Overall Study|Withdrawal by Subject|1|||
162890966|NCT01586806|588299235|FG001|Overall Study|Withdrawal by Subject|0|||
162890967|NCT01586806|588299236|FG002|Overall Study|Withdrawal by Subject|0|||
162890968|NCT01586806|588299234|FG000|Overall Study|Lost to Follow-up|2|||
162890969|NCT01586806|588299235|FG001|Overall Study|Lost to Follow-up|3|||
162890970|NCT01586806|588299236|FG002|Overall Study|Lost to Follow-up|2|||
162890971|NCT00555906|588299237|FG000|Phase 1|Objective Progression or Relapse|3|||
162890972|NCT00555906|588299238|FG001|Phase 1|Objective Progression or Relapse|5|||
162890973|NCT00555906|588299239|FG002|Phase 1|Objective Progression or Relapse|3|||
162890974|NCT00555906|588299240|FG003|Phase 1|Objective Progression or Relapse|1|||
162890975|NCT00555906|588299241|FG004|Phase 1|Objective Progression or Relapse|0|||
162890976|NCT00555906|588299237|FG000|Phase 1|Global Deterioration of Health Status|0|||
162890977|NCT00555906|588299238|FG001|Phase 1|Global Deterioration of Health Status|1|||
162890978|NCT00555906|588299239|FG002|Phase 1|Global Deterioration of Health Status|1|||
162890979|NCT00555906|588299240|FG003|Phase 1|Global Deterioration of Health Status|1|||
162890980|NCT00555906|588299241|FG004|Phase 1|Global Deterioration of Health Status|0|||
162890981|NCT00555906|588299237|FG000|Phase 1|Adverse Event|0|||
162890982|NCT00555906|588299238|FG001|Phase 1|Adverse Event|0|||
162890983|NCT00555906|588299239|FG002|Phase 1|Adverse Event|3|||
162890984|NCT00555906|588299240|FG003|Phase 1|Adverse Event|2|||
162890985|NCT00555906|588299241|FG004|Phase 1|Adverse Event|0|||
162890986|NCT00555906|588299237|FG000|Phase 1|Withdrawal by Subject|0|||
162890987|NCT00555906|588299238|FG001|Phase 1|Withdrawal by Subject|0|||
162890988|NCT00555906|588299239|FG002|Phase 1|Withdrawal by Subject|0|||
162890989|NCT00555906|588299240|FG003|Phase 1|Withdrawal by Subject|1|||
162890990|NCT00555906|588299241|FG004|Phase 1|Withdrawal by Subject|0|||
162890991|NCT00555906|588299237|FG000|Phase 2|Adverse Event|0|||
162890992|NCT00555906|588299238|FG001|Phase 2|Adverse Event|0|||
163051482|NCT05556616|588897148|FG003|Overall Study|Study Terminated by Sponsor|0|||
163051483|NCT05556616|588897149|FG004|Overall Study|Study Terminated by Sponsor|0|||
163051484|NCT05556616|588897150|FG005|Overall Study|Study Terminated by Sponsor|0|||
163051485|NCT05556616|588897151|FG006|Overall Study|Study Terminated by Sponsor|0|||
163051486|NCT03256578|588897152|FG000|Overall Study|Excluded Post Randomization|66|||
163051487|NCT03256578|588897153|FG001|Overall Study|Excluded Post Randomization|56|||
163051488|NCT05428436|588897154|FG000|Period 1 - 2 washout|Adverse Event|1|||
163051489|NCT05428436|588897155|FG001|Period 1 - 2 washout|Adverse Event|0|||
163051490|NCT05428436|588897156|FG002|Period 1 - 2 washout|Adverse Event|0|||
162890993|NCT00555906|588299239|FG002|Phase 2|Adverse Event|0|||
162890994|NCT00555906|588299240|FG003|Phase 2|Adverse Event|0|||
162890995|NCT00555906|588299241|FG004|Phase 2|Adverse Event|4|||
162890996|NCT00555906|588299237|FG000|Phase 2|Global Deterioration of Health Status|0|||
162890997|NCT00555906|588299238|FG001|Phase 2|Global Deterioration of Health Status|0|||
162890998|NCT00555906|588299239|FG002|Phase 2|Global Deterioration of Health Status|0|||
162890999|NCT00555906|588299240|FG003|Phase 2|Global Deterioration of Health Status|0|||
162891000|NCT00555906|588299241|FG004|Phase 2|Global Deterioration of Health Status|2|||
162891001|NCT00555906|588299237|FG000|Phase 2|Objective Progression or Relapse|0|||
162891002|NCT00555906|588299238|FG001|Phase 2|Objective Progression or Relapse|0|||
162891003|NCT00555906|588299239|FG002|Phase 2|Objective Progression or Relapse|0|||
162891004|NCT00555906|588299240|FG003|Phase 2|Objective Progression or Relapse|0|||
162891005|NCT00555906|588299241|FG004|Phase 2|Objective Progression or Relapse|16|||
162891006|NCT00555906|588299237|FG000|Phase 2|Withdrawal by Subject|0|||
162891007|NCT00555906|588299238|FG001|Phase 2|Withdrawal by Subject|0|||
162891008|NCT00555906|588299239|FG002|Phase 2|Withdrawal by Subject|0|||
162891009|NCT00555906|588299240|FG003|Phase 2|Withdrawal by Subject|0|||
162891010|NCT00555906|588299241|FG004|Phase 2|Withdrawal by Subject|2|||
162891011|NCT00555906|588299237|FG000|Phase 2|Other|0|||
162891012|NCT00555906|588299238|FG001|Phase 2|Other|0|||
162891013|NCT00555906|588299239|FG002|Phase 2|Other|0|||
162891014|NCT00555906|588299240|FG003|Phase 2|Other|0|||
162964542|NCT00819169|588569813|FG008|Overall Study|Ineligibility determined|1|||
162964543|NCT00819169|588569805|FG000|Overall Study|Adverse Event|0|||
162964544|NCT00819169|588569806|FG001|Overall Study|Adverse Event|0|||
162964545|NCT00819169|588569807|FG002|Overall Study|Adverse Event|0|||
162964546|NCT00819169|588569808|FG003|Overall Study|Adverse Event|0|||
162964547|NCT00819169|588569809|FG004|Overall Study|Adverse Event|1|||
162964548|NCT00819169|588569810|FG005|Overall Study|Adverse Event|0|||
162964549|NCT00819169|588569811|FG006|Overall Study|Adverse Event|0|||
162964550|NCT00819169|588569812|FG007|Overall Study|Adverse Event|0|||
162964551|NCT00819169|588569813|FG008|Overall Study|Adverse Event|0|||
163051491|NCT03964207|588897157|FG000|First Treatment|Withdrawal by Subject|1|||
163051492|NCT03964207|588897158|FG001|First Treatment|Withdrawal by Subject|2|||
163051493|NCT03964207|588897157|FG000|First Treatment|Protocol Violation|1|||
163051494|NCT03964207|588897158|FG001|First Treatment|Protocol Violation|0|||
163051495|NCT03964207|588897157|FG000|First Treatment|Lost to Follow-up|1|||
163051496|NCT03964207|588897158|FG001|First Treatment|Lost to Follow-up|0|||
163051497|NCT03964207|588897157|FG000|Second Treatment|Lost to Follow-up|0|||
163051498|NCT03964207|588897158|FG001|Second Treatment|Lost to Follow-up|1|||
163051499|NCT03964207|588897157|FG000|Second Treatment|Adverse Event|1|||
163051500|NCT03964207|588897158|FG001|Second Treatment|Adverse Event|2|||
163051501|NCT00001566|588897163|FG000|Overall Study|patients' choice to discontinue protocol|3|||
162622448|NCT01752985|587332533|FG002|Treatment Period|Subject request to discontinue treatment|1|||
162622449|NCT01752985|587332531|FG000|Treatment Period|Subject no longer meets study criteria|0|||
162622450|NCT01752985|587332532|FG001|Treatment Period|Subject no longer meets study criteria|1|||
162622451|NCT01752985|587332533|FG002|Treatment Period|Subject no longer meets study criteria|1|||
162622452|NCT01752985|587332531|FG000|Treatment Period|Adverse Event|2|||
162622453|NCT01752985|587332532|FG001|Treatment Period|Adverse Event|1|||
162622454|NCT01752985|587332533|FG002|Treatment Period|Adverse Event|2|||
162891015|NCT00555906|588299241|FG004|Phase 2|Other|6|||
162891016|NCT00555906|588299237|FG000|Phase 2|Randomized but not Treated|0|||
162891017|NCT00555906|588299238|FG001|Phase 2|Randomized but not Treated|0|||
162891018|NCT00555906|588299239|FG002|Phase 2|Randomized but not Treated|0|||
162891019|NCT00555906|588299240|FG003|Phase 2|Randomized but not Treated|0|||
162891020|NCT00555906|588299241|FG004|Phase 2|Randomized but not Treated|2|||
162964552|NCT00819169|588569805|FG000|Overall Study|Administrative Decision|0|||
163051502|NCT00001566|588897163|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
163051503|NCT00001566|588897163|FG000|Overall Study|Death|13|||
163051504|NCT00001566|588897163|FG000|Overall Study|Lost to Follow-up|1|||
162891021|NCT02193828|588299242|FG000|Overall Study|Withdrawal by Subject|0|||
162891022|NCT02193828|588299243|FG001|Overall Study|Withdrawal by Subject|0|||
162891023|NCT02193828|588299244|FG002|Overall Study|Withdrawal by Subject|1|||
162891024|NCT02193828|588299245|FG003|Overall Study|Withdrawal by Subject|1|||
162891025|NCT00862654|588299246|FG000|Overall Study|Lack of Efficacy|1|||
162964553|NCT00819169|588569806|FG001|Overall Study|Administrative Decision|0|||
162964554|NCT00819169|588569807|FG002|Overall Study|Administrative Decision|0|||
162964555|NCT00819169|588569808|FG003|Overall Study|Administrative Decision|0|||
163051505|NCT00001566|588897163|FG000|Overall Study|unable to complete initial apheresis|1|||
163051506|NCT01290718|588897164|FG000|Overall Study|Early termination of the study|4|||
163051507|NCT00433836|588897166|FG000|Overall Study|Adverse Event|7|||
163051508|NCT00433836|588897167|FG001|Overall Study|Adverse Event|0|||
163051509|NCT00433836|588897166|FG000|Overall Study|Lost to Follow-up|3|||
163051510|NCT00433836|588897167|FG001|Overall Study|Lost to Follow-up|0|||
163051511|NCT00433836|588897166|FG000|Overall Study|Withdrawal by Subject|2|||
162891026|NCT00862654|588299247|FG001|Overall Study|Lack of Efficacy|0|||
162891027|NCT00862654|588299248|FG002|Overall Study|Lack of Efficacy|1|||
162891028|NCT00862654|588299249|FG003|Overall Study|Lack of Efficacy|0|||
162891029|NCT00862654|588299246|FG000|Overall Study|Lost to Follow-up|1|||
162891030|NCT00862654|588299247|FG001|Overall Study|Lost to Follow-up|2|||
162891031|NCT00862654|588299248|FG002|Overall Study|Lost to Follow-up|1|||
162891032|NCT00862654|588299249|FG003|Overall Study|Lost to Follow-up|3|||
162891033|NCT00862654|588299246|FG000|Overall Study|Adverse Event|0|||
162891034|NCT00862654|588299247|FG001|Overall Study|Adverse Event|1|||
162891035|NCT00862654|588299248|FG002|Overall Study|Adverse Event|1|||
162891036|NCT00862654|588299249|FG003|Overall Study|Adverse Event|0|||
162891037|NCT00862654|588299246|FG000|Overall Study|Pregnancy|1|||
162891038|NCT00862654|588299247|FG001|Overall Study|Pregnancy|1|||
162891039|NCT00862654|588299248|FG002|Overall Study|Pregnancy|0|||
162891040|NCT00862654|588299249|FG003|Overall Study|Pregnancy|0|||
162891041|NCT00862654|588299246|FG000|Overall Study|Withdrawal by Subject|2|||
162891042|NCT00862654|588299247|FG001|Overall Study|Withdrawal by Subject|2|||
162891043|NCT00862654|588299248|FG002|Overall Study|Withdrawal by Subject|2|||
162891044|NCT00862654|588299249|FG003|Overall Study|Withdrawal by Subject|3|||
162891045|NCT00862654|588299246|FG000|Overall Study|Subject mistake|0|||
162891046|NCT00862654|588299247|FG001|Overall Study|Subject mistake|1|||
162891047|NCT00862654|588299248|FG002|Overall Study|Subject mistake|0|||
162891048|NCT00862654|588299249|FG003|Overall Study|Subject mistake|0|||
162891049|NCT00862654|588299246|FG000|Overall Study|Familly constraint|0|||
162891050|NCT00862654|588299247|FG001|Overall Study|Familly constraint|1|||
162891051|NCT00862654|588299248|FG002|Overall Study|Familly constraint|0|||
162891052|NCT00862654|588299249|FG003|Overall Study|Familly constraint|0|||
162891053|NCT00862654|588299246|FG000|Overall Study|Never used study drugs|1|||
162891054|NCT00862654|588299247|FG001|Overall Study|Never used study drugs|0|||
162891055|NCT00862654|588299248|FG002|Overall Study|Never used study drugs|0|||
162891056|NCT00862654|588299249|FG003|Overall Study|Never used study drugs|0|||
162891057|NCT00862654|588299246|FG000|Overall Study|Included after end of inclusions|0|||
162891058|NCT00862654|588299247|FG001|Overall Study|Included after end of inclusions|0|||
162891059|NCT00862654|588299248|FG002|Overall Study|Included after end of inclusions|1|||
162891060|NCT00862654|588299249|FG003|Overall Study|Included after end of inclusions|0|||
162891061|NCT03219567|588299250|FG000|Overall Study|Withdrawal by Subject|0|||
162891062|NCT03219567|588299251|FG001|Overall Study|Withdrawal by Subject|1|||
162891063|NCT01313208|588299252|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
162891064|NCT01313208|588299253|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
162891065|NCT01313208|588299252|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
162891066|NCT01313208|588299253|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
162891067|NCT01313208|588299252|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
162891068|NCT01313208|588299253|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
162891069|NCT01313208|588299252|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
162891070|NCT01313208|588299253|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
162891071|NCT01313208|588299252|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
162891072|NCT01313208|588299253|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
162891073|NCT01313208|588299252|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
162891074|NCT01313208|588299253|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
162891075|NCT01313208|588299252|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
162891076|NCT01313208|588299253|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
162891077|NCT01313208|588299252|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
162891078|NCT01313208|588299253|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
162891079|NCT01313208|588299252|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
162891080|NCT01313208|588299253|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
163051512|NCT00433836|588897167|FG001|Overall Study|Withdrawal by Subject|1|||
163051513|NCT00433836|588897166|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162891081|NCT01151540|588299255|FG000|Overall Study|Other|2|||
162891082|NCT01151540|588299255|FG000|Overall Study|Adverse event, non-fatal|4|||
162891083|NCT01151540|588299255|FG000|Overall Study|Withdrawal by Subject|7|||
162891084|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
163051514|NCT00433836|588897167|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162891085|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
162891086|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
162891087|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
163051515|NCT00433836|588897166|FG000|Overall Study|Protocol Violation|0|||
162622455|NCT01752985|587332531|FG000|Treatment Period|Withdrawal by Subject|1|||
162891088|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
162891089|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
162891090|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
162891091|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
162891092|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
162891093|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
162891094|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
162891095|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
162891096|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
162891097|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
162891098|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
162891099|NCT01412060|588299259|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
162891100|NCT01412060|588299260|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
162891101|NCT01412060|588299261|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
162891102|NCT01412060|588299259|FG000|Period Between RIP and SP|Adverse Event|4|||
162891103|NCT01412060|588299260|FG001|Period Between RIP and SP|Adverse Event|0|||
162891104|NCT01412060|588299261|FG002|Period Between RIP and SP|Adverse Event|0|||
162891105|NCT01412060|588299259|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
162891106|NCT01412060|588299260|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
162891107|NCT01412060|588299261|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
162891108|NCT01412060|588299259|FG000|Period Between RIP and SP|Protocol Violation|2|||
162891109|NCT01412060|588299260|FG001|Period Between RIP and SP|Protocol Violation|0|||
162891110|NCT01412060|588299261|FG002|Period Between RIP and SP|Protocol Violation|0|||
162891111|NCT01412060|588299259|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
162891112|NCT01412060|588299260|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
162891113|NCT01412060|588299261|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
162891114|NCT01412060|588299259|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
162891115|NCT01412060|588299260|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
162891116|NCT01412060|588299261|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
162891117|NCT01412060|588299259|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
162891118|NCT01412060|588299260|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
162891119|NCT01412060|588299261|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
162891120|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
162891121|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
162891122|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
162891123|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
162891124|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
162891125|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
162891126|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
162891127|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
162891128|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
162891129|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
162891130|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
162891131|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
162891132|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
162891133|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
162891134|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
162891135|NCT01412060|588299259|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
162891136|NCT01412060|588299260|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
162891137|NCT01412060|588299261|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
162891138|NCT01412060|588299259|FG000|Period Between SP and DBP|Protocol Violation|2|||
162891139|NCT01412060|588299260|FG001|Period Between SP and DBP|Protocol Violation|0|||
162891140|NCT01412060|588299261|FG002|Period Between SP and DBP|Protocol Violation|0|||
162891141|NCT01412060|588299259|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
162891142|NCT01412060|588299260|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
162891143|NCT01412060|588299261|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
162891144|NCT01412060|588299259|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
162891145|NCT01412060|588299260|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
163051516|NCT00433836|588897167|FG001|Overall Study|Protocol Violation|2|||
162622456|NCT01752985|587332532|FG001|Treatment Period|Withdrawal by Subject|1|||
162622457|NCT01752985|587332533|FG002|Treatment Period|Withdrawal by Subject|0|||
162891146|NCT01412060|588299261|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
162891147|NCT01412060|588299259|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
162891148|NCT01412060|588299260|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
162891149|NCT01412060|588299261|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
162891150|NCT01412060|588299259|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
162891151|NCT01412060|588299260|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
162891152|NCT01412060|588299261|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
162891153|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
162891154|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
162891155|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
162891156|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
162891157|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
162891158|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
162891159|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
162891160|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
162891161|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
162891162|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
162891163|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
162891164|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
162891165|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
162891166|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
162891167|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
162891168|NCT01412060|588299259|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
162891169|NCT01412060|588299260|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
162891170|NCT01412060|588299261|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
162891171|NCT00004732|588299262|FG000|Overall Study|Withdrawal by Subject|36|||
162891172|NCT00004732|588299263|FG001|Overall Study|Withdrawal by Subject|64|||
162891173|NCT00004732|588299262|FG000|Overall Study|Lost to Follow-up|33|||
162622458|NCT01752985|587332531|FG000|Treatment Period|Lost to Follow-up|0|||
162622459|NCT01752985|587332532|FG001|Treatment Period|Lost to Follow-up|0|||
162891174|NCT00004732|588299263|FG001|Overall Study|Lost to Follow-up|47|||
162891175|NCT02674685|588299264|FG000|Overall Study|Withdrawal by Subject|4|||
162891176|NCT01181778|588299265|FG000|Overall Study|Physician Decision|48|||
162891177|NCT02661464|588299266|FG000|Overall Study|Lost to Follow-up|28|||
162891178|NCT02661464|588299267|FG001|Overall Study|Lost to Follow-up|0|||
162891179|NCT02661464|588299268|FG002|Overall Study|Lost to Follow-up|0|||
162891180|NCT02661464|588299269|FG003|Overall Study|Lost to Follow-up|0|||
162891181|NCT02661464|588299266|FG000|Overall Study|Withdrawal by Subject|3|||
162891182|NCT02661464|588299267|FG001|Overall Study|Withdrawal by Subject|1|||
162891183|NCT02661464|588299268|FG002|Overall Study|Withdrawal by Subject|0|||
162891184|NCT02661464|588299269|FG003|Overall Study|Withdrawal by Subject|0|||
162891185|NCT02661464|588299266|FG000|Overall Study|Participants terminated prematurely|288|||
162891186|NCT02661464|588299267|FG001|Overall Study|Participants terminated prematurely|52|||
162891187|NCT02661464|588299268|FG002|Overall Study|Participants terminated prematurely|1|||
162891188|NCT02661464|588299269|FG003|Overall Study|Participants terminated prematurely|1|||
162891189|NCT02661464|588299266|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
162891190|NCT02661464|588299267|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
162891191|NCT02661464|588299268|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
162622460|NCT01752985|587332533|FG002|Treatment Period|Lost to Follow-up|1|||
162891192|NCT02661464|588299269|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
162891193|NCT03148756|588299271|FG000|Overall Study|Study Terminated|0|||
162891194|NCT03148756|588299272|FG001|Overall Study|Study Terminated|1|||
162891195|NCT05567393|588299273|FG000|Overall Study|Voluntary Withdrawal|0|||
162891196|NCT05567393|588299274|FG001|Overall Study|Voluntary Withdrawal|0|||
162891197|NCT05567393|588299275|FG002|Overall Study|Voluntary Withdrawal|0|||
162891198|NCT05567393|588299276|FG003|Overall Study|Voluntary Withdrawal|0|||
162891199|NCT05567393|588299277|FG004|Overall Study|Voluntary Withdrawal|0|||
162891200|NCT05567393|588299278|FG005|Overall Study|Voluntary Withdrawal|0|||
162622461|NCT01516437|587333916|FG000|Overall Study|Reason not specified|0|||
162891201|NCT05567393|588299279|FG006|Overall Study|Voluntary Withdrawal|0|||
162891202|NCT05567393|588299280|FG007|Overall Study|Voluntary Withdrawal|0|||
162964556|NCT00819169|588569809|FG004|Overall Study|Administrative Decision|1|||
162964557|NCT00819169|588569810|FG005|Overall Study|Administrative Decision|2|||
162964558|NCT00819169|588569811|FG006|Overall Study|Administrative Decision|0|||
162964559|NCT00819169|588569812|FG007|Overall Study|Administrative Decision|2|||
162964560|NCT00819169|588569813|FG008|Overall Study|Administrative Decision|0|||
162622462|NCT01516437|587333917|FG001|Overall Study|Reason not specified|0|||
162964561|NCT02637141|588569817|FG000|Overall Study|Adverse Event|1|||
162964562|NCT02637141|588569818|FG001|Overall Study|Adverse Event|1|||
162891203|NCT05567393|588299281|FG008|Overall Study|Voluntary Withdrawal|0|||
162891204|NCT05567393|588299282|FG009|Overall Study|Voluntary Withdrawal|0|||
162891205|NCT05567393|588299283|FG010|Overall Study|Voluntary Withdrawal|0|||
162891206|NCT05567393|588299284|FG011|Overall Study|Voluntary Withdrawal|0|||
162891207|NCT05567393|588299285|FG012|Overall Study|Voluntary Withdrawal|0|||
162891208|NCT05567393|588299286|FG013|Overall Study|Voluntary Withdrawal|1|||
162891209|NCT05567393|588299287|FG014|Overall Study|Voluntary Withdrawal|0|||
162891210|NCT05567393|588299288|FG015|Overall Study|Voluntary Withdrawal|0|||
162891211|NCT05567393|588299289|FG016|Overall Study|Voluntary Withdrawal|0|||
162891212|NCT05567393|588299290|FG017|Overall Study|Voluntary Withdrawal|0|||
162891213|NCT01924299|588299294|FG000|Period 2|Withdrawal by Subject|1|||
162891214|NCT01924299|588299295|FG001|Period 2|Withdrawal by Subject|0|||
162891215|NCT01924299|588299294|FG000|Period 2|Adverse Event|0|||
162891216|NCT01924299|588299295|FG001|Period 2|Adverse Event|1|||
162891217|NCT02177175|588299296|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
162891218|NCT02177175|588299297|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
162891219|NCT04199793|588299298|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
162891220|NCT04199793|588299299|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
162891221|NCT04199793|588299298|FG000|Overall Study|Withdrawal by Subject|1|||
162891222|NCT04199793|588299299|FG001|Overall Study|Withdrawal by Subject|1|||
162891223|NCT00628758|588299300|FG000|Overall Study|Adverse Event|2|||
162891224|NCT00628758|588299301|FG001|Overall Study|Adverse Event|3|||
162891225|NCT00628758|588299300|FG000|Overall Study|Withdrawal by Subject|6|||
162891226|NCT00628758|588299301|FG001|Overall Study|Withdrawal by Subject|3|||
162891227|NCT00628758|588299300|FG000|Overall Study|Death|1|||
162891228|NCT00628758|588299301|FG001|Overall Study|Death|0|||
162891229|NCT00628758|588299300|FG000|Overall Study|Protocol Violation|5|||
162891230|NCT00628758|588299301|FG001|Overall Study|Protocol Violation|1|||
162891231|NCT00628758|588299300|FG000|Overall Study|Lost to Follow-up|25|||
162891232|NCT00628758|588299301|FG001|Overall Study|Lost to Follow-up|31|||
162891233|NCT00628758|588299300|FG000|Overall Study|Pregnancy|2|||
162891234|NCT00628758|588299301|FG001|Overall Study|Pregnancy|2|||
162891235|NCT00628758|588299300|FG000|Overall Study|Investigator Moved|3|||
162891236|NCT00628758|588299301|FG001|Overall Study|Investigator Moved|0|||
162891237|NCT00628758|588299300|FG000|Overall Study|Treatment Failure|0|||
162891238|NCT00628758|588299301|FG001|Overall Study|Treatment Failure|2|||
162891239|NCT02983799|588299306|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
162891240|NCT02983799|588299307|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
162891241|NCT02983799|588299308|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
162891242|NCT02983799|588299309|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
162891243|NCT02983799|588299310|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
162891244|NCT02983799|588299306|FG000|Overall Study|Death|20|||
162891245|NCT02983799|588299307|FG001|Overall Study|Death|5|||
162891246|NCT02983799|588299308|FG002|Overall Study|Death|23|||
162891247|NCT02983799|588299309|FG003|Overall Study|Death|47|||
162891248|NCT02983799|588299310|FG004|Overall Study|Death|7|||
162891249|NCT02983799|588299306|FG000|Overall Study|Withdrawal by Subject|1|||
162891250|NCT02983799|588299307|FG001|Overall Study|Withdrawal by Subject|0|||
162891251|NCT02983799|588299308|FG002|Overall Study|Withdrawal by Subject|3|||
162891252|NCT02983799|588299309|FG003|Overall Study|Withdrawal by Subject|4|||
162891253|NCT02983799|588299310|FG004|Overall Study|Withdrawal by Subject|1|||
162891254|NCT02983799|588299306|FG000|Overall Study|Protocol Violation|0|||
162891255|NCT02983799|588299307|FG001|Overall Study|Protocol Violation|1|||
162891256|NCT02983799|588299308|FG002|Overall Study|Protocol Violation|0|||
162891257|NCT02983799|588299309|FG003|Overall Study|Protocol Violation|0|||
162891258|NCT02983799|588299310|FG004|Overall Study|Protocol Violation|1|||
162891259|NCT02983799|588299306|FG000|Overall Study|Lost to Follow-up|1|||
162891260|NCT02983799|588299307|FG001|Overall Study|Lost to Follow-up|0|||
162891261|NCT02983799|588299308|FG002|Overall Study|Lost to Follow-up|1|||
162891262|NCT02983799|588299309|FG003|Overall Study|Lost to Follow-up|0|||
162891263|NCT02983799|588299310|FG004|Overall Study|Lost to Follow-up|0|||
162622463|NCT01516437|587333918|FG002|Overall Study|Reason not specified|1|||
162622464|NCT01516437|587333919|FG003|Overall Study|Reason not specified|1|||
162622465|NCT01550289|587333920|FG000|Overall Study|Protocol Violation|1|||
162622466|NCT01550289|587333921|FG001|Overall Study|Protocol Violation|0|||
162622467|NCT01550289|587333920|FG000|Overall Study|Lost to Follow-up|1|||
162622468|NCT01550289|587333921|FG001|Overall Study|Lost to Follow-up|1|||
162891264|NCT01184846|588299316|FG000|Overall Study|Adverse Event|2|||
162891265|NCT01184846|588299316|FG000|Overall Study|Insufficient response|1|||
162891266|NCT02293902|588299325|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
162622469|NCT01550289|587333920|FG000|Overall Study|Withdrawal by Subject|11|||
162891267|NCT02293902|588299326|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
162891268|NCT02293902|588299327|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
162891269|NCT02293902|588299328|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
162891270|NCT02293902|588299329|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
162891271|NCT02293902|588299325|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
162622470|NCT01550289|587333921|FG001|Overall Study|Withdrawal by Subject|3|||
162891272|NCT02293902|588299326|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
162891273|NCT02293902|588299327|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
162891274|NCT02293902|588299328|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
162891275|NCT02293902|588299329|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
162891276|NCT02293902|588299325|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
162891277|NCT02293902|588299326|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
162891278|NCT02293902|588299327|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
162891279|NCT02293902|588299328|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
162891280|NCT02293902|588299329|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
162891281|NCT02293902|588299325|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
162891282|NCT02293902|588299326|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
162891283|NCT02293902|588299327|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
162891284|NCT02293902|588299328|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
162891285|NCT02293902|588299329|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
162891286|NCT02293902|588299325|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
162891287|NCT02293902|588299326|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
162891288|NCT02293902|588299327|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
162891289|NCT02293902|588299328|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
162891290|NCT02293902|588299329|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
162891291|NCT04021706|588301055|FG000|Overall Study|Adverse Event|2|||
162891292|NCT04021706|588301056|FG001|Overall Study|Adverse Event|0|||
162891293|NCT04021706|588301055|FG000|Overall Study|Withdrawal by Subject|1|||
162891294|NCT04021706|588301056|FG001|Overall Study|Withdrawal by Subject|2|||
162891295|NCT04021706|588301055|FG000|Overall Study|Physician Decision|1|||
162891296|NCT04021706|588301056|FG001|Overall Study|Physician Decision|0|||
162891297|NCT00859573|588301057|FG000|Overall Study|Withdrawal by Subject|4|||
162891298|NCT00859573|588301058|FG001|Overall Study|Withdrawal by Subject|1|||
162891299|NCT00859573|588301057|FG000|Overall Study|Physician Decision|1|||
162891300|NCT00859573|588301058|FG001|Overall Study|Physician Decision|1|||
162891301|NCT01135394|588301070|FG000|Screening|Lost to Follow-up|2|||
162891302|NCT01135394|588301070|FG000|Screening|Withdrawal by Subject|10|||
162891303|NCT01135394|588301070|FG000|Screening|Screening failure|16|||
162891304|NCT01135394|588301070|FG000|Screening|Physician Decision|5|||
162891305|NCT01135394|588301070|FG000|Baseline Assessment|Withdrawal by Subject|9|||
162891306|NCT01135394|588301070|FG000|Baseline Assessment|Physician Decision|3|||
162891307|NCT01135394|588301070|FG000|Baseline Assessment|Lost to Follow-up|2|||
162891308|NCT01135394|588301070|FG000|Baseline Assessment|Adverse Event|1|||
162891309|NCT01135394|588301070|FG000|Study Treatment|Withdrawal by Subject|1|||
162891310|NCT01135394|588301070|FG000|Study Treatment|Physician Decision|1|||
162891311|NCT01135394|588301070|FG000|Study Treatment|Adverse Event|2|||
162891312|NCT00462488|588301071|FG000|Overall Study|Protocol Violation|1|||
162891313|NCT00462488|588301072|FG001|Overall Study|Protocol Violation|0|||
162891314|NCT00462488|588301071|FG000|Overall Study|Lack of Efficacy|19|||
162891315|NCT00462488|588301072|FG001|Overall Study|Lack of Efficacy|17|||
162891316|NCT01742091|588301077|FG000|Overall Study|Adverse Event|0|||
162891317|NCT01742091|588301078|FG001|Overall Study|Adverse Event|0|||
162891318|NCT01742091|588301079|FG002|Overall Study|Adverse Event|0|||
162891319|NCT01742091|588301080|FG003|Overall Study|Adverse Event|0|||
162891320|NCT01742091|588301081|FG004|Overall Study|Adverse Event|1|||
162891321|NCT01742091|588301082|FG005|Overall Study|Adverse Event|0|||
162891322|NCT01742091|588301077|FG000|Overall Study|Physician Decision|0|||
162891323|NCT01742091|588301078|FG001|Overall Study|Physician Decision|0|||
162891324|NCT01742091|588301079|FG002|Overall Study|Physician Decision|0|||
162891325|NCT01742091|588301080|FG003|Overall Study|Physician Decision|0|||
162964563|NCT02637141|588569819|FG002|Overall Study|Adverse Event|0|||
162964564|NCT02637141|588569817|FG000|Overall Study|Withdrawal by Subject|1|||
162964565|NCT02637141|588569818|FG001|Overall Study|Withdrawal by Subject|1|||
162964566|NCT02637141|588569819|FG002|Overall Study|Withdrawal by Subject|1|||
162964567|NCT01155531|588569823|FG000|Overall Study|Adverse Event|0|||
162964568|NCT01155531|588569824|FG001|Overall Study|Adverse Event|0|||
162964569|NCT01155531|588569825|FG002|Overall Study|Adverse Event|1|||
162964570|NCT01155531|588569826|FG003|Overall Study|Adverse Event|0|||
162964571|NCT01155531|588569823|FG000|Overall Study|Lost to Follow-up|0|||
162891326|NCT01742091|588301081|FG004|Overall Study|Physician Decision|0|||
162891327|NCT01742091|588301082|FG005|Overall Study|Physician Decision|1|||
162622471|NCT02025621|587333922|FG000|Overall Study|Withdrawal by Subject|1|||
162891328|NCT01742091|588301077|FG000|Overall Study|Withdrawal by Subject|0|||
162891329|NCT01742091|588301078|FG001|Overall Study|Withdrawal by Subject|0|||
162964572|NCT01155531|588569824|FG001|Overall Study|Lost to Follow-up|0|||
162891330|NCT01742091|588301079|FG002|Overall Study|Withdrawal by Subject|0|||
162891331|NCT01742091|588301080|FG003|Overall Study|Withdrawal by Subject|1|||
162891332|NCT01742091|588301081|FG004|Overall Study|Withdrawal by Subject|0|||
162891333|NCT01742091|588301082|FG005|Overall Study|Withdrawal by Subject|0|||
162964573|NCT01155531|588569825|FG002|Overall Study|Lost to Follow-up|0|||
162964574|NCT01155531|588569826|FG003|Overall Study|Lost to Follow-up|1|||
162891334|NCT01742091|588301077|FG000|Overall Study|Lost to Follow-up|0|||
162891335|NCT01742091|588301078|FG001|Overall Study|Lost to Follow-up|0|||
162891336|NCT01742091|588301079|FG002|Overall Study|Lost to Follow-up|0|||
162891337|NCT01742091|588301080|FG003|Overall Study|Lost to Follow-up|0|||
162891338|NCT01742091|588301081|FG004|Overall Study|Lost to Follow-up|0|||
162891339|NCT01742091|588301082|FG005|Overall Study|Lost to Follow-up|1|||
162891340|NCT02088541|588301083|FG000|Overall Study|Adverse Event|3|||
162891341|NCT02088541|588301084|FG001|Overall Study|Adverse Event|0|||
162891342|NCT02088541|588301085|FG002|Overall Study|Adverse Event|3|||
162891343|NCT02088541|588301086|FG003|Overall Study|Adverse Event|3|||
162891344|NCT02088541|588301087|FG004|Overall Study|Adverse Event|0|||
162891345|NCT02088541|588301083|FG000|Overall Study|Death|51|||
162891346|NCT02088541|588301084|FG001|Overall Study|Death|21|||
162891347|NCT02088541|588301085|FG002|Overall Study|Death|85|||
162891348|NCT02088541|588301086|FG003|Overall Study|Death|28|||
162891349|NCT02088541|588301087|FG004|Overall Study|Death|38|||
162891350|NCT02088541|588301083|FG000|Overall Study|Lost to Follow-up|2|||
162891351|NCT02088541|588301084|FG001|Overall Study|Lost to Follow-up|0|||
162891352|NCT02088541|588301085|FG002|Overall Study|Lost to Follow-up|1|||
162891353|NCT02088541|588301086|FG003|Overall Study|Lost to Follow-up|0|||
162891354|NCT02088541|588301087|FG004|Overall Study|Lost to Follow-up|0|||
162891355|NCT02088541|588301083|FG000|Overall Study|Physician Decision|2|||
162891356|NCT02088541|588301084|FG001|Overall Study|Physician Decision|1|||
162891357|NCT02088541|588301085|FG002|Overall Study|Physician Decision|2|||
162891358|NCT02088541|588301086|FG003|Overall Study|Physician Decision|0|||
162891359|NCT02088541|588301087|FG004|Overall Study|Physician Decision|2|||
162891360|NCT02088541|588301083|FG000|Overall Study|Disease progression|7|||
162891361|NCT02088541|588301084|FG001|Overall Study|Disease progression|1|||
162891362|NCT02088541|588301085|FG002|Overall Study|Disease progression|2|||
162891363|NCT02088541|588301086|FG003|Overall Study|Disease progression|3|||
162891364|NCT02088541|588301087|FG004|Overall Study|Disease progression|1|||
162891365|NCT02088541|588301083|FG000|Overall Study|Study terminated by sponsor|1|||
162891366|NCT02088541|588301084|FG001|Overall Study|Study terminated by sponsor|1|||
162891367|NCT02088541|588301085|FG002|Overall Study|Study terminated by sponsor|12|||
162891368|NCT02088541|588301086|FG003|Overall Study|Study terminated by sponsor|2|||
162891369|NCT02088541|588301087|FG004|Overall Study|Study terminated by sponsor|6|||
162891370|NCT02088541|588301083|FG000|Overall Study|Withdrawal by Subject|3|||
162891371|NCT02088541|588301084|FG001|Overall Study|Withdrawal by Subject|2|||
162891372|NCT02088541|588301085|FG002|Overall Study|Withdrawal by Subject|9|||
162891373|NCT02088541|588301086|FG003|Overall Study|Withdrawal by Subject|7|||
162891374|NCT02088541|588301087|FG004|Overall Study|Withdrawal by Subject|10|||
162891375|NCT02088541|588301083|FG000|Overall Study|Other|2|||
162891376|NCT02088541|588301084|FG001|Overall Study|Other|1|||
162891377|NCT02088541|588301085|FG002|Overall Study|Other|3|||
162891378|NCT02088541|588301086|FG003|Overall Study|Other|1|||
162891379|NCT02088541|588301087|FG004|Overall Study|Other|1|||
162891380|NCT05742841|588301088|FG000|Overall Study|Withdrawal by Subject|1|||
162891381|NCT05742841|588301088|FG000|Overall Study|Lost to Follow-up|1|||
162891382|NCT03750240|588301090|FG000|Overall Study|Technical Difficulties|2|||
162891383|NCT02905825|588301096|FG000|Overall Study|Protocol Violation|11|||
162891384|NCT02905825|588301096|FG000|Overall Study|Device Malfunction|1|||
162891385|NCT05355818|588301097|FG000|Overall Study|Adverse Event|1|||
162891386|NCT05355818|588301098|FG001|Overall Study|Adverse Event|1|||
162891387|NCT05355818|588301097|FG000|Overall Study|Lack of Efficacy|2|||
162891388|NCT05355818|588301098|FG001|Overall Study|Lack of Efficacy|1|||
162891389|NCT05355818|588301097|FG000|Overall Study|Lost to Follow-up|0|||
162891390|NCT05355818|588301098|FG001|Overall Study|Lost to Follow-up|1|||
162891391|NCT01563107|588301099|FG000|Overall Study|Physician Decision|0|||
162891392|NCT01563107|588301100|FG001|Overall Study|Physician Decision|1|||
162891393|NCT01563107|588301101|FG002|Overall Study|Physician Decision|1|||
162891394|NCT01563107|588301102|FG003|Overall Study|Physician Decision|3|||
162891395|NCT01563107|588301099|FG000|Overall Study|Withdrawal by Subject|1|||
162891396|NCT01563107|588301100|FG001|Overall Study|Withdrawal by Subject|2|||
162891397|NCT01563107|588301101|FG002|Overall Study|Withdrawal by Subject|1|||
162891398|NCT01563107|588301102|FG003|Overall Study|Withdrawal by Subject|2|||
162891399|NCT00063986|588301105|FG000|Overall Study|Withdrawal by Subject|1|||
162891400|NCT00063986|588301105|FG000|Overall Study|Ineligible|1|||
162891401|NCT00063986|588301105|FG000|Overall Study|Intra-operatively ineligible|4|||
162891402|NCT01601704|588301106|FG000|Overall Study|Randomized but not dispensed study med|1|||
162891403|NCT01601704|588301107|FG001|Overall Study|Randomized but not dispensed study med|4|||
162891404|NCT00247273|588301110|FG000|Overall Study|Adverse Event|85|||
162891405|NCT00247273|588301111|FG001|Overall Study|Adverse Event|80|||
162891406|NCT00247273|588301110|FG000|Overall Study|Physician Decision|6|||
162891407|NCT00247273|588301111|FG001|Overall Study|Physician Decision|3|||
162891408|NCT00247273|588301110|FG000|Overall Study|Lost to Follow-up|7|||
162622472|NCT02025621|587333923|FG001|Overall Study|Withdrawal by Subject|0|||
162891409|NCT00247273|588301111|FG001|Overall Study|Lost to Follow-up|7|||
162891410|NCT00247273|588301110|FG000|Overall Study|Withdrawal by Subject|46|||
162891411|NCT00247273|588301111|FG001|Overall Study|Withdrawal by Subject|47|||
162891412|NCT00247273|588301110|FG000|Overall Study|Did not take any study drug|2|||
162891413|NCT00247273|588301111|FG001|Overall Study|Did not take any study drug|0|||
162891414|NCT03276572|588301112|FG000|Overall Study|In follow-up|0|||
162891415|NCT03276572|588301113|FG001|Overall Study|In follow-up|0|||
162891416|NCT03276572|588301114|FG002|Overall Study|In follow-up|0|||
162891417|NCT03276572|588301115|FG003|Overall Study|In follow-up|0|||
162891418|NCT03276572|588301116|FG004|Overall Study|In follow-up|0|||
162891419|NCT03276572|588301117|FG005|Overall Study|In follow-up|1|||
162891420|NCT03276572|588301118|FG006|Overall Study|In follow-up|1|||
162891421|NCT03276572|588301112|FG000|Overall Study|Lost to Follow-up|0|||
162891422|NCT03276572|588301113|FG001|Overall Study|Lost to Follow-up|0|||
162891423|NCT03276572|588301114|FG002|Overall Study|Lost to Follow-up|0|||
162891424|NCT03276572|588301115|FG003|Overall Study|Lost to Follow-up|0|||
162891425|NCT03276572|588301116|FG004|Overall Study|Lost to Follow-up|0|||
162891426|NCT03276572|588301117|FG005|Overall Study|Lost to Follow-up|0|||
162891427|NCT03276572|588301118|FG006|Overall Study|Lost to Follow-up|1|||
162891428|NCT02580240|588301131|FG000|Overall Study|Physician Decision|2|||
162891429|NCT02580240|588301132|FG001|Overall Study|Physician Decision|0|||
162891430|NCT01709708|588301133|FG000|Overall Study|Protocol Violation|1|||
162891431|NCT01709708|588301134|FG001|Overall Study|Protocol Violation|2|||
162891432|NCT00511108|588301137|FG000|Overall Study|Adverse Event|2|||
162891433|NCT00511108|588301138|FG001|Overall Study|Adverse Event|0|||
162891434|NCT00511108|588301139|FG002|Overall Study|Adverse Event|1|||
162891435|NCT00511108|588301140|FG003|Overall Study|Adverse Event|2|||
162891436|NCT00511108|588301137|FG000|Overall Study|Lost to Follow-up|0|||
162891437|NCT00511108|588301138|FG001|Overall Study|Lost to Follow-up|2|||
162891438|NCT00511108|588301139|FG002|Overall Study|Lost to Follow-up|1|||
162891439|NCT00511108|588301140|FG003|Overall Study|Lost to Follow-up|0|||
162891440|NCT00511108|588301137|FG000|Overall Study|Physician Decision|0|||
162891441|NCT00511108|588301138|FG001|Overall Study|Physician Decision|0|||
162891442|NCT00511108|588301139|FG002|Overall Study|Physician Decision|0|||
162891443|NCT00511108|588301140|FG003|Overall Study|Physician Decision|1|||
162891444|NCT00511108|588301137|FG000|Overall Study|Withdrawal by Subject|4|||
162891445|NCT00511108|588301138|FG001|Overall Study|Withdrawal by Subject|0|||
162891446|NCT00511108|588301139|FG002|Overall Study|Withdrawal by Subject|3|||
162891447|NCT00511108|588301140|FG003|Overall Study|Withdrawal by Subject|2|||
162891448|NCT02954952|588301141|FG000|Overall Study|Withdrawal by Subject|1|||
162891449|NCT02954952|588301142|FG001|Overall Study|Withdrawal by Subject|0|||
162891450|NCT02954952|588301143|FG002|Overall Study|Withdrawal by Subject|0|||
162891451|NCT02954952|588301141|FG000|Overall Study|No data collected|0|||
162891452|NCT02954952|588301142|FG001|Overall Study|No data collected|1|||
162891453|NCT02954952|588301143|FG002|Overall Study|No data collected|0|||
162891454|NCT02911519|588301144|FG000|Overall Study|Lost to Follow-up|2|||
162891455|NCT02911519|588301145|FG001|Overall Study|Lost to Follow-up|2|||
162891456|NCT02911519|588301144|FG000|Overall Study|Death|0|||
162891457|NCT02911519|588301145|FG001|Overall Study|Death|2|||
162891458|NCT00810043|588301146|FG000|Overall Study|Withdrawal by Subject|1|||
162891459|NCT00810043|588301147|FG001|Overall Study|Withdrawal by Subject|0|||
162891460|NCT00810043|588301148|FG002|Overall Study|Withdrawal by Subject|2|||
162891461|NCT00810043|588301146|FG000|Overall Study|Lost to Follow-up|1|||
162891462|NCT00810043|588301147|FG001|Overall Study|Lost to Follow-up|0|||
162891463|NCT00810043|588301148|FG002|Overall Study|Lost to Follow-up|0|||
162891464|NCT00810043|588301146|FG000|Overall Study|Physician Decision|0|||
162891465|NCT00810043|588301147|FG001|Overall Study|Physician Decision|0|||
162891466|NCT00810043|588301148|FG002|Overall Study|Physician Decision|2|||
162891467|NCT00810043|588301146|FG000|Overall Study|Death|2|||
162622473|NCT02025621|587333922|FG000|Overall Study|Death|0|||
162622474|NCT02025621|587333923|FG001|Overall Study|Death|1|||
162622475|NCT02025621|587333922|FG000|Overall Study|No longer eligible|10|||
162622476|NCT02025621|587333923|FG001|Overall Study|No longer eligible|15|||
162622477|NCT02025621|587333922|FG000|Overall Study|Surgery initiated before infusion|3|||
162622478|NCT02025621|587333923|FG001|Overall Study|Surgery initiated before infusion|3|||
162622479|NCT00739674|587333924|FG000|Overall Study|Screening failures|19|||
162622480|NCT00739674|587333925|FG001|Overall Study|Screening failures|17|||
162622481|NCT00739674|587333924|FG000|Overall Study|Site 212 removal|19|||
162891468|NCT00810043|588301147|FG001|Overall Study|Death|0|||
162891469|NCT00810043|588301148|FG002|Overall Study|Death|0|||
162891470|NCT00810043|588301146|FG000|Overall Study|Unrelated medical problem|0|||
162891471|NCT00810043|588301147|FG001|Overall Study|Unrelated medical problem|1|||
162891472|NCT00810043|588301148|FG002|Overall Study|Unrelated medical problem|0|||
162891473|NCT00810043|588301146|FG000|Overall Study|Non-medical problem|0|||
162622482|NCT00739674|587333925|FG001|Overall Study|Site 212 removal|13|||
162891474|NCT00810043|588301147|FG001|Overall Study|Non-medical problem|0|||
162891475|NCT00810043|588301148|FG002|Overall Study|Non-medical problem|1|||
162891476|NCT00810043|588301146|FG000|Overall Study|No longer met enrollment criteria|0|||
162891477|NCT00810043|588301147|FG001|Overall Study|No longer met enrollment criteria|0|||
162891478|NCT00810043|588301148|FG002|Overall Study|No longer met enrollment criteria|3|||
162891479|NCT02001688|588301149|FG000|Overall Study|Withdrawal by Subject|0|||
162891480|NCT02001688|588301150|FG001|Overall Study|Withdrawal by Subject|0|||
162891481|NCT02001688|588301151|FG002|Overall Study|Withdrawal by Subject|1|||
162891482|NCT02001688|588301149|FG000|Overall Study|Adverse Event|0|||
162891483|NCT02001688|588301150|FG001|Overall Study|Adverse Event|1|||
162891484|NCT02001688|588301151|FG002|Overall Study|Adverse Event|0|||
162891485|NCT01675141|588301155|FG000|Overall Study|Lenalidomide outside NIH|3|||
162891486|NCT01675141|588301155|FG000|Overall Study|Withdrawal by Subject|3|||
162891487|NCT01675141|588301155|FG000|Overall Study|Physician Decision|4|||
162964575|NCT01155531|588569823|FG000|Overall Study|Withdrawal by Subject|1|||
162622483|NCT00739674|587333924|FG000|Overall Study|No follow-up data|33|||
162622484|NCT00739674|587333925|FG001|Overall Study|No follow-up data|18|||
162622485|NCT00739674|587333924|FG000|Overall Study|Dietician consultation >30 days|1|||
162622486|NCT00739674|587333925|FG001|Overall Study|Dietician consultation >30 days|9|||
162622487|NCT00739674|587333924|FG000|Overall Study|Adverse Event|22|||
162622488|NCT00739674|587333925|FG001|Overall Study|Adverse Event|13|||
162622489|NCT00739674|587333924|FG000|Overall Study|Death|1|||
162622490|NCT00739674|587333925|FG001|Overall Study|Death|0|||
162622491|NCT00739674|587333924|FG000|Overall Study|Lack of Efficacy|1|||
162622492|NCT00739674|587333925|FG001|Overall Study|Lack of Efficacy|0|||
162622493|NCT00739674|587333924|FG000|Overall Study|Lost to Follow-up|52|||
162622494|NCT00739674|587333925|FG001|Overall Study|Lost to Follow-up|30|||
162622495|NCT00739674|587333924|FG000|Overall Study|Protocol Violation|5|||
162622496|NCT00739674|587333925|FG001|Overall Study|Protocol Violation|5|||
162622497|NCT00739674|587333924|FG000|Overall Study|Withdrawal by Subject|9|||
162622498|NCT00739674|587333925|FG001|Overall Study|Withdrawal by Subject|9|||
162622499|NCT00739674|587333924|FG000|Overall Study|Reason missing|2|||
162622500|NCT00739674|587333925|FG001|Overall Study|Reason missing|0|||
162622501|NCT00739674|587333924|FG000|Overall Study|Clinic closed|6|||
162622502|NCT00739674|587333925|FG001|Overall Study|Clinic closed|4|||
162622503|NCT00739674|587333924|FG000|Overall Study|Patient moved|3|||
162622504|NCT00739674|587333925|FG001|Overall Study|Patient moved|2|||
162622505|NCT00739674|587333924|FG000|Overall Study|Non compliant|4|||
162622506|NCT00739674|587333925|FG001|Overall Study|Non compliant|0|||
162622507|NCT00739674|587333924|FG000|Overall Study|Unable to attend visit|3|||
162622508|NCT00739674|587333925|FG001|Overall Study|Unable to attend visit|1|||
162622509|NCT00739674|587333924|FG000|Overall Study|Home monitoring off meds|1|||
162622510|NCT00739674|587333925|FG001|Overall Study|Home monitoring off meds|0|||
162891488|NCT01675141|588301155|FG000|Overall Study|No treatment, per protocol|1|||
162891489|NCT00105183|588301159|FG000|Overall Study|Death|19|||
162891490|NCT00105183|588301160|FG001|Overall Study|Death|13|||
162964576|NCT01155531|588569824|FG001|Overall Study|Withdrawal by Subject|0|||
162964577|NCT01155531|588569825|FG002|Overall Study|Withdrawal by Subject|1|||
162964578|NCT01155531|588569826|FG003|Overall Study|Withdrawal by Subject|0|||
162622511|NCT00739674|587333924|FG000|Overall Study|Erectile dysfunction|0|||
162622512|NCT00739674|587333925|FG001|Overall Study|Erectile dysfunction|1|||
162622513|NCT01897454|587333927|FG000|Overall Study|Withdrawal by Subject|1|||
162891491|NCT00105183|588301161|FG002|Overall Study|Death|15|||
162622514|NCT02195583|587333929|FG000|Overall Study|Lost to Follow-up|1|||
162622515|NCT02195583|587333929|FG000|Overall Study|Withdrawal by Subject|4|||
162622516|NCT02195583|587333929|FG000|Overall Study|Adverse Event|2|||
162622517|NCT02195583|587333929|FG000|Overall Study|Other Reason|2|||
162622518|NCT01560403|587333930|FG000|Overall Study|Lost to Follow-up|0|||
162622519|NCT01560403|587333931|FG001|Overall Study|Lost to Follow-up|1|||
162622520|NCT00983437|587333933|FG000|Overall Study|Adverse Event|9|||
162891492|NCT00105183|588301159|FG000|Overall Study|Withdrawal by Subject|1|||
162891493|NCT00105183|588301160|FG001|Overall Study|Withdrawal by Subject|1|||
162964579|NCT02705716|588569827|FG000|Overall Study|Adverse Event|0|||
162891494|NCT00105183|588301161|FG002|Overall Study|Withdrawal by Subject|4|||
162891495|NCT00105183|588301159|FG000|Overall Study|Physician Decision|1|||
162891496|NCT00105183|588301160|FG001|Overall Study|Physician Decision|2|||
162891497|NCT00105183|588301161|FG002|Overall Study|Physician Decision|3|||
162891498|NCT00105183|588301159|FG000|Overall Study|Lost to Follow-up|0|||
162891499|NCT00105183|588301160|FG001|Overall Study|Lost to Follow-up|1|||
162891500|NCT00105183|588301161|FG002|Overall Study|Lost to Follow-up|1|||
162891501|NCT00105183|588301159|FG000|Overall Study|Other reason|1|||
162891502|NCT00105183|588301160|FG001|Overall Study|Other reason|2|||
162891503|NCT00105183|588301161|FG002|Overall Study|Other reason|0|||
162891504|NCT00270998|588301167|FG000|3 Month Follow-up|Adverse Event|1|||
162891505|NCT00270998|588301168|FG001|3 Month Follow-up|Adverse Event|0|||
162891506|NCT00270998|588301169|FG002|3 Month Follow-up|Adverse Event|0|||
162891507|NCT00270998|588301167|FG000|3 Month Follow-up|Lack of Efficacy|1|||
162891508|NCT00270998|588301168|FG001|3 Month Follow-up|Lack of Efficacy|2|||
162891509|NCT00270998|588301169|FG002|3 Month Follow-up|Lack of Efficacy|1|||
162891510|NCT00270998|588301167|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
162891511|NCT00270998|588301168|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
162891512|NCT00270998|588301169|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
162891513|NCT00270998|588301167|FG000|3 Month Follow-up|Pessary did not fit|12|||
162891514|NCT00270998|588301168|FG001|3 Month Follow-up|Pessary did not fit|0|||
162891515|NCT00270998|588301169|FG002|3 Month Follow-up|Pessary did not fit|0|||
162891516|NCT00270998|588301167|FG000|3 Month Follow-up|Personal/family health|1|||
162891517|NCT00270998|588301168|FG001|3 Month Follow-up|Personal/family health|1|||
162891518|NCT00270998|588301169|FG002|3 Month Follow-up|Personal/family health|0|||
162622521|NCT00983437|587333933|FG000|Overall Study|Lack of Efficacy|1|||
162622522|NCT00983437|587333933|FG000|Overall Study|Withdrawal by Subject|8|||
162622523|NCT00983437|587333933|FG000|Overall Study|Noncompliance to Study Procedures|1|||
162622524|NCT00983437|587333933|FG000|Overall Study|Lost to Follow-up|2|||
162622525|NCT00983437|587333933|FG000|Overall Study|Other Reason|26|||
162622526|NCT04019288|587333934|FG000|Overall Study|Death|1|||
162622527|NCT04019288|587333935|FG001|Overall Study|Death|0|||
162622528|NCT04019288|587333936|FG002|Overall Study|Death|0|||
162622529|NCT00094172|587333937|FG000|Overall Study|Adverse Event|0|||
162622530|NCT00094172|587333938|FG001|Overall Study|Adverse Event|1|||
162622531|NCT00094172|587333937|FG000|Overall Study|Lost to Follow-up|2|||
162622532|NCT00094172|587333938|FG001|Overall Study|Lost to Follow-up|0|||
162622533|NCT00094172|587333937|FG000|Overall Study|Protocol Violation|0|||
162622534|NCT00094172|587333938|FG001|Overall Study|Protocol Violation|1|||
162622535|NCT00094172|587333937|FG000|Overall Study|Withdrawal by Subject|10|||
162622536|NCT00094172|587333938|FG001|Overall Study|Withdrawal by Subject|5|||
162622537|NCT00094172|587333937|FG000|Overall Study|Primary endpoint met.|1|||
162622538|NCT00094172|587333938|FG001|Overall Study|Primary endpoint met.|0|||
162622539|NCT00094172|587333937|FG000|Overall Study|Started other MS therapy due to disease|1|||
162622540|NCT00094172|587333938|FG001|Overall Study|Started other MS therapy due to disease|0|||
162622541|NCT00289133|587333946|FG000|Overall Study|Non-study device implanted|12|||
162622542|NCT00289133|587333947|FG001|Overall Study|Non-study device implanted|0|||
162622543|NCT00289133|587333946|FG000|Overall Study|Protocol Violation|32|||
162622544|NCT00289133|587333947|FG001|Overall Study|Protocol Violation|38|||
162622545|NCT00289133|587333946|FG000|Overall Study|Withdrawal by Subject|9|||
162622546|NCT00289133|587333947|FG001|Overall Study|Withdrawal by Subject|10|||
162622547|NCT00289133|587333946|FG000|Overall Study|Death|5|||
162622548|NCT00289133|587333947|FG001|Overall Study|Death|10|||
162622549|NCT00289133|587333946|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
162622550|NCT00289133|587333947|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
162622551|NCT00289133|587333946|FG000|Overall Study|Physician Decision|41|||
162622552|NCT00289133|587333947|FG001|Overall Study|Physician Decision|45|||
162622553|NCT00289133|587333946|FG000|Overall Study|Revision|8|||
162622554|NCT00289133|587333947|FG001|Overall Study|Revision|6|||
162891519|NCT00270998|588301167|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
162891520|NCT00270998|588301168|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
162891521|NCT00270998|588301169|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
162891522|NCT00270998|588301167|FG000|12 Month Follow-up|Lack of Efficacy|5|||
162891523|NCT00270998|588301168|FG001|12 Month Follow-up|Lack of Efficacy|4|||
162622555|NCT00289133|587333946|FG000|Overall Study|Lost to Follow-up|92|||
162891524|NCT00270998|588301169|FG002|12 Month Follow-up|Lack of Efficacy|3|||
162891525|NCT00270998|588301167|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
162622556|NCT00289133|587333947|FG001|Overall Study|Lost to Follow-up|115|||
162622557|NCT03372096|587333953|FG000|Overall Study|Study Closed|8|||
162622558|NCT00040365|587333954|FG000|Overall Study|Death|1|||
162622559|NCT00040365|587333954|FG000|Overall Study|Progressive disease|7|||
162622560|NCT00040365|587333954|FG000|Overall Study|Lost to Follow-up|3|||
162622561|NCT01397890|587333963|FG000|Overall Study|Withdrawal by Subject|7|||
162622562|NCT01397890|587333964|FG001|Overall Study|Withdrawal by Subject|11|||
162622563|NCT01397890|587333963|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
162891526|NCT00270998|588301168|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
162891527|NCT00270998|588301169|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
162891528|NCT00270998|588301167|FG000|12 Month Follow-up|Pessary did not fit|1|||
162891529|NCT00270998|588301168|FG001|12 Month Follow-up|Pessary did not fit|0|||
162891530|NCT00270998|588301169|FG002|12 Month Follow-up|Pessary did not fit|0|||
162891531|NCT00270998|588301167|FG000|12 Month Follow-up|Personal/family health|0|||
162891532|NCT00270998|588301168|FG001|12 Month Follow-up|Personal/family health|5|||
162891533|NCT00270998|588301169|FG002|12 Month Follow-up|Personal/family health|1|||
162622564|NCT01397890|587333964|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
162622565|NCT01397890|587333963|FG000|Overall Study|Death|2|||
162622566|NCT01397890|587333964|FG001|Overall Study|Death|3|||
162622567|NCT01397890|587333963|FG000|Overall Study|Lost to Follow-up|1|||
162622568|NCT01397890|587333964|FG001|Overall Study|Lost to Follow-up|4|||
162622569|NCT01397890|587333963|FG000|Overall Study|Condition under Investigation Worsened|1|||
162622570|NCT01397890|587333964|FG001|Overall Study|Condition under Investigation Worsened|3|||
162622571|NCT01397890|587333963|FG000|Overall Study|Adverse Event|1|||
162622572|NCT01397890|587333964|FG001|Overall Study|Adverse Event|2|||
162622573|NCT01397890|587333963|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
162622574|NCT01397890|587333964|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
162622575|NCT01397890|587333963|FG000|Overall Study|Others|2|||
162622576|NCT01397890|587333964|FG001|Overall Study|Others|1|||
162622577|NCT02763462|587333968|FG000|Overall Study|Protocol Violation|6|||
162622578|NCT00129272|587333969|FG000|Overall Study|Lost to Follow-up|12|||
162622579|NCT00129272|587333970|FG001|Overall Study|Lost to Follow-up|11|||
162622580|NCT00129272|587333969|FG000|Overall Study|Withdrawal by Subject|5|||
162622581|NCT00129272|587333970|FG001|Overall Study|Withdrawal by Subject|11|||
162622582|NCT00675948|587333972|FG000|Overall Study|Adverse Event|23|||
162622583|NCT00675948|587333973|FG001|Overall Study|Adverse Event|1|||
162622584|NCT00675948|587333972|FG000|Overall Study|Lack of Efficacy|3|||
162622585|NCT00675948|587333973|FG001|Overall Study|Lack of Efficacy|0|||
162622586|NCT00675948|587333972|FG000|Overall Study|Withdrawal by Subject|7|||
162622587|NCT00675948|587333973|FG001|Overall Study|Withdrawal by Subject|0|||
162622588|NCT00675948|587333972|FG000|Overall Study|Lost to Follow-up|2|||
162622589|NCT00675948|587333973|FG001|Overall Study|Lost to Follow-up|0|||
162622590|NCT00675948|587333972|FG000|Overall Study|Protocol Violation|1|||
162622591|NCT00675948|587333973|FG001|Overall Study|Protocol Violation|0|||
162622592|NCT00675948|587333972|FG000|Overall Study|Pain under control|1|||
162622593|NCT00675948|587333973|FG001|Overall Study|Pain under control|0|||
162622594|NCT00675948|587333972|FG000|Overall Study|Sponsor decision|0|||
162622595|NCT00675948|587333973|FG001|Overall Study|Sponsor decision|1|||
162622596|NCT00675948|587333972|FG000|Overall Study|Patient died|1|||
162622597|NCT00675948|587333973|FG001|Overall Study|Patient died|0|||
162622598|NCT00675948|587333972|FG000|Overall Study|Patient unable to comply with diaries|1|||
162622599|NCT00675948|587333973|FG001|Overall Study|Patient unable to comply with diaries|0|||
162622600|NCT00675948|587333972|FG000|Overall Study|Patient feels unable to take medication|0|||
162622601|NCT00675948|587333973|FG001|Overall Study|Patient feels unable to take medication|1|||
162622602|NCT02100514|587333974|FG000|Treatment Period|Adverse Event|0|||
162622603|NCT02100514|587333975|FG001|Treatment Period|Adverse Event|5|||
162622604|NCT02100514|587333976|FG002|Treatment Period|Adverse Event|0|||
162622605|NCT02100514|587333977|FG003|Treatment Period|Adverse Event|0|||
162622606|NCT02100514|587333978|FG004|Treatment Period|Adverse Event|0|||
162622607|NCT02100514|587333974|FG000|Treatment Period|Death|2|||
162622608|NCT02100514|587333975|FG001|Treatment Period|Death|2|||
162622609|NCT02100514|587333976|FG002|Treatment Period|Death|0|||
162622610|NCT02100514|587333977|FG003|Treatment Period|Death|0|||
162622611|NCT02100514|587333978|FG004|Treatment Period|Death|0|||
162622612|NCT02100514|587333974|FG000|Treatment Period|Lost to Follow-up|5|||
162622613|NCT02100514|587333975|FG001|Treatment Period|Lost to Follow-up|17|||
162622614|NCT02100514|587333976|FG002|Treatment Period|Lost to Follow-up|0|||
162622615|NCT02100514|587333977|FG003|Treatment Period|Lost to Follow-up|0|||
162622616|NCT02100514|587333978|FG004|Treatment Period|Lost to Follow-up|0|||
162622617|NCT02100514|587333974|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
162622618|NCT02100514|587333975|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
162622619|NCT02100514|587333976|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
162622620|NCT02100514|587333977|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
162891534|NCT00270998|588301167|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
162891535|NCT00270998|588301168|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
162891536|NCT00270998|588301169|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
162622621|NCT02100514|587333978|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
162622622|NCT02100514|587333974|FG000|Treatment Period|Protocol Violation|1|||
162622623|NCT02100514|587333975|FG001|Treatment Period|Protocol Violation|1|||
162622624|NCT02100514|587333976|FG002|Treatment Period|Protocol Violation|0|||
162891537|NCT02443805|588301176|FG000|Overall Study|Adverse Event|100|||
162622625|NCT02100514|587333977|FG003|Treatment Period|Protocol Violation|0|||
162622626|NCT02100514|587333978|FG004|Treatment Period|Protocol Violation|0|||
162622627|NCT02100514|587333974|FG000|Treatment Period|Withdrawal by Subject|12|||
162622628|NCT02100514|587333975|FG001|Treatment Period|Withdrawal by Subject|37|||
162622629|NCT02100514|587333976|FG002|Treatment Period|Withdrawal by Subject|0|||
162622630|NCT02100514|587333977|FG003|Treatment Period|Withdrawal by Subject|0|||
162622631|NCT02100514|587333978|FG004|Treatment Period|Withdrawal by Subject|0|||
162891538|NCT02443805|588301177|FG001|Overall Study|Adverse Event|18|||
162891539|NCT02443805|588301176|FG000|Overall Study|Withdrawal by Subject|73|||
162891540|NCT02443805|588301177|FG001|Overall Study|Withdrawal by Subject|74|||
162891541|NCT02443805|588301176|FG000|Overall Study|Lost to Follow-up|19|||
162891542|NCT02443805|588301177|FG001|Overall Study|Lost to Follow-up|14|||
162891543|NCT02443805|588301176|FG000|Overall Study|Pregnancy|6|||
162891544|NCT02443805|588301177|FG001|Overall Study|Pregnancy|5|||
162891545|NCT02443805|588301176|FG000|Overall Study|Protocol Violation|2|||
162891546|NCT02443805|588301177|FG001|Overall Study|Protocol Violation|4|||
162891547|NCT02443805|588301176|FG000|Overall Study|Lack of Efficacy|1|||
162891548|NCT02443805|588301177|FG001|Overall Study|Lack of Efficacy|1|||
162891549|NCT02443805|588301176|FG000|Overall Study|Non-compliance with study drug|6|||
162891550|NCT02443805|588301177|FG001|Overall Study|Non-compliance with study drug|4|||
162891551|NCT02443805|588301176|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162891552|NCT02443805|588301177|FG001|Overall Study|Withdrawal by parent/guardian|5|||
162891553|NCT02443805|588301176|FG000|Overall Study|Any other reason not above-mentioned|3|||
162891554|NCT02443805|588301177|FG001|Overall Study|Any other reason not above-mentioned|2|||
162891555|NCT00961116|588301178|FG000|Washout Period of 7 Days|Adverse Event|1|||
162891556|NCT00961116|588301179|FG001|Washout Period of 7 Days|Adverse Event|1|||
162891557|NCT00961116|588301178|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
162891558|NCT00961116|588301179|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162891559|NCT00961116|588301178|FG000|Washout Period of 7 Days|Protocol Violation|0|||
162891560|NCT00961116|588301179|FG001|Washout Period of 7 Days|Protocol Violation|1|||
162891561|NCT00968708|588301180|FG000|Overall Study|Adverse Event|169|||
162891562|NCT00968708|588301181|FG001|Overall Study|Adverse Event|150|||
162891563|NCT00968708|588301180|FG000|Overall Study|Major Protocol Deviation|0|||
162891564|NCT00968708|588301181|FG001|Overall Study|Major Protocol Deviation|1|||
162891565|NCT00968708|588301180|FG000|Overall Study|Lost to Follow-up|19|||
162891566|NCT00968708|588301181|FG001|Overall Study|Lost to Follow-up|11|||
162891567|NCT00968708|588301180|FG000|Overall Study|Voluntary Withdrawal|104|||
162891568|NCT00968708|588301181|FG001|Overall Study|Voluntary Withdrawal|101|||
162891569|NCT00968708|588301180|FG000|Overall Study|Investigator Discretion|0|||
162964580|NCT02705716|588569828|FG001|Overall Study|Adverse Event|1|||
162964581|NCT02705716|588569827|FG000|Overall Study|Protocol Violation|3|||
162964582|NCT02705716|588569828|FG001|Overall Study|Protocol Violation|0|||
162964583|NCT02705716|588569827|FG000|Overall Study|Withdrawal of Consent|1|||
162964584|NCT02705716|588569828|FG001|Overall Study|Withdrawal of Consent|1|||
162891570|NCT00968708|588301181|FG001|Overall Study|Investigator Discretion|1|||
162891571|NCT00968708|588301180|FG000|Overall Study|Other|26|||
162891572|NCT00968708|588301181|FG001|Overall Study|Other|34|||
162891573|NCT02708966|588301182|FG000|Overall Study|Lost to Follow-up|2|||
162964585|NCT00562718|588569829|FG000|Overall Study|Death|1|||
162964586|NCT00562718|588569829|FG000|Overall Study|Withdrawal by Subject|3|||
162622632|NCT02100514|587333974|FG000|Treatment Period|Other|9|||
162964587|NCT00562718|588569829|FG000|Overall Study|Adverse Event|4|||
162964588|NCT00562718|588569829|FG000|Overall Study|Lack of Efficacy|2|||
162708686|NCT00797225|587642876|FG007|Weeks 13 to 24|Non-compliance|0|||
162891574|NCT02708966|588301183|FG001|Overall Study|Lost to Follow-up|2|||
162891575|NCT00389441|588301184|FG000|Overall Study|Adverse Event|7|||
162891576|NCT00389441|588301184|FG000|Overall Study|Death|4|||
162891577|NCT00389441|588301184|FG000|Overall Study|Lost to Follow-up|2|||
162891578|NCT00389441|588301184|FG000|Overall Study|Withdrawal by Subject|4|||
162891579|NCT00389441|588301184|FG000|Overall Study|Physician Decision|1|||
162891580|NCT00389441|588301184|FG000|Overall Study|Protocol Violation|1|||
162891581|NCT00389441|588301184|FG000|Overall Study|Global deterioration of health status|4|||
162891582|NCT00389441|588301184|FG000|Overall Study|Objective progression or relapse|26|||
162891583|NCT00389441|588301184|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
162891584|NCT00389441|588301184|FG000|Overall Study|Clinical progression|1|||
162964589|NCT00562718|588569829|FG000|Overall Study|not stated|1|||
162964590|NCT04025021|588569830|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
162964591|NCT04025021|588569831|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
162964592|NCT01663896|588569832|FG000|Overall Study|Various reasons|43|||
162964593|NCT00842309|588569833|FG000|Overall Study|Withdrawal by Subject|3|||
162964594|NCT00842309|588569834|FG001|Overall Study|Withdrawal by Subject|1|||
162964595|NCT02670551|588569835|FG000|Overall Study|Adverse Event|4|||
162964596|NCT02670551|588569836|FG001|Overall Study|Adverse Event|7|||
162964597|NCT02670551|588569837|FG002|Overall Study|Adverse Event|9|||
162964598|NCT02670551|588569835|FG000|Overall Study|Lack of Efficacy|2|||
162964599|NCT02670551|588569836|FG001|Overall Study|Lack of Efficacy|0|||
162964600|NCT02670551|588569837|FG002|Overall Study|Lack of Efficacy|3|||
162964601|NCT02670551|588569835|FG000|Overall Study|Withdrawal of Consent|6|||
162964602|NCT02670551|588569836|FG001|Overall Study|Withdrawal of Consent|3|||
162891585|NCT01981109|588301185|FG000|Overall Study|Death|36|||
162891586|NCT01981109|588301185|FG000|Overall Study|Withdrawal by Subject|40|||
162891587|NCT01981109|588301185|FG000|Overall Study|Lost to Follow-up|9|||
162891588|NCT01981109|588301185|FG000|Overall Study|No Discontinuation Documentation|37|||
162891589|NCT01981109|588301185|FG000|Overall Study|Study Termination|100|||
162891590|NCT01981109|588301185|FG000|Overall Study|No data available|2|||
162891591|NCT03407170|588301186|FG000|Overall Study|Adverse Event|1|||
162891592|NCT00105560|588301188|FG000|Overall Study|Lost to Follow-up|1|||
162891593|NCT00636441|588301189|FG000|Overall Study|Adverse Event|0|||
162891594|NCT00636441|588301190|FG001|Overall Study|Adverse Event|1|||
162891595|NCT00636441|588301191|FG002|Overall Study|Adverse Event|1|||
162891596|NCT00636441|588301192|FG003|Overall Study|Adverse Event|0|||
162891597|NCT00636441|588301193|FG004|Overall Study|Adverse Event|0|||
162891598|NCT00636441|588301194|FG005|Overall Study|Adverse Event|1|||
162891599|NCT00636441|588301195|FG006|Overall Study|Adverse Event|0|||
162891600|NCT00636441|588301189|FG000|Overall Study|Late, ineligible|0|||
162891601|NCT00636441|588301190|FG001|Overall Study|Late, ineligible|0|||
162891602|NCT00636441|588301191|FG002|Overall Study|Late, ineligible|0|||
162891603|NCT00636441|588301192|FG003|Overall Study|Late, ineligible|0|||
162891604|NCT00636441|588301193|FG004|Overall Study|Late, ineligible|0|||
162891605|NCT00636441|588301194|FG005|Overall Study|Late, ineligible|0|||
162891606|NCT00636441|588301195|FG006|Overall Study|Late, ineligible|1|||
162891607|NCT00636441|588301189|FG000|Overall Study|Screen Failure|0|||
162891608|NCT00636441|588301190|FG001|Overall Study|Screen Failure|0|||
162964603|NCT02670551|588569837|FG002|Overall Study|Withdrawal of Consent|8|||
162964604|NCT02670551|588569835|FG000|Overall Study|Lost to Follow-up|5|||
162891609|NCT00636441|588301191|FG002|Overall Study|Screen Failure|0|||
162891610|NCT00636441|588301192|FG003|Overall Study|Screen Failure|0|||
162891611|NCT00636441|588301193|FG004|Overall Study|Screen Failure|0|||
162891612|NCT00636441|588301194|FG005|Overall Study|Screen Failure|0|||
162891613|NCT00636441|588301195|FG006|Overall Study|Screen Failure|17|||
162891614|NCT00305604|588301197|FG000|Overall Study|Adverse Event|6|||
162891615|NCT00305604|588301198|FG001|Overall Study|Adverse Event|3|||
162964605|NCT02670551|588569836|FG001|Overall Study|Lost to Follow-up|7|||
162964606|NCT02670551|588569837|FG002|Overall Study|Lost to Follow-up|6|||
162964607|NCT02670551|588569835|FG000|Overall Study|Protocol Violation|1|||
162964608|NCT02670551|588569836|FG001|Overall Study|Protocol Violation|0|||
162622633|NCT02100514|587333975|FG001|Treatment Period|Other|11|||
162622634|NCT02100514|587333976|FG002|Treatment Period|Other|0|||
162622635|NCT02100514|587333977|FG003|Treatment Period|Other|0|||
162622636|NCT02100514|587333978|FG004|Treatment Period|Other|0|||
162891616|NCT00305604|588301197|FG000|Overall Study|Lack of Efficacy|11|||
162891617|NCT00305604|588301198|FG001|Overall Study|Lack of Efficacy|18|||
162891618|NCT00305604|588301197|FG000|Overall Study|Lost to Follow-up|0|||
162891619|NCT00305604|588301198|FG001|Overall Study|Lost to Follow-up|4|||
162891620|NCT00305604|588301197|FG000|Overall Study|Protocol Violation|2|||
162891621|NCT00305604|588301198|FG001|Overall Study|Protocol Violation|1|||
162891622|NCT00305604|588301197|FG000|Overall Study|Withdrawal by Subject|12|||
162891623|NCT00305604|588301198|FG001|Overall Study|Withdrawal by Subject|21|||
162891624|NCT00305604|588301197|FG000|Overall Study|Patient moved|1|||
162891625|NCT00305604|588301198|FG001|Overall Study|Patient moved|0|||
162891626|NCT02559713|588301202|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
162891627|NCT01767519|588301204|FG000|Overall Study|Other Reasons|4|||
162891628|NCT01767519|588301205|FG001|Overall Study|Other Reasons|4|||
162891629|NCT01767519|588301206|FG002|Overall Study|Other Reasons|2|||
162891630|NCT01767519|588301204|FG000|Overall Study|Protocol Violation|0|||
162891631|NCT01767519|588301205|FG001|Overall Study|Protocol Violation|3|||
162891632|NCT01767519|588301206|FG002|Overall Study|Protocol Violation|0|||
162891633|NCT01767519|588301204|FG000|Overall Study|Personal Reasons|1|||
162891634|NCT01767519|588301205|FG001|Overall Study|Personal Reasons|0|||
162964609|NCT02670551|588569837|FG002|Overall Study|Protocol Violation|0|||
162964610|NCT02670551|588569835|FG000|Overall Study|Noncompliance with study drug|3|||
162964611|NCT02670551|588569836|FG001|Overall Study|Noncompliance with study drug|3|||
162964612|NCT02670551|588569837|FG002|Overall Study|Noncompliance with study drug|2|||
162964613|NCT02670551|588569835|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162964614|NCT02670551|588569836|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162964615|NCT02670551|588569837|FG002|Overall Study|Other Miscellaneous Reasons|3|||
162964616|NCT02670551|588569835|FG000|Overall Study|Did Not Receive Treatment|5|||
162964617|NCT02670551|588569836|FG001|Overall Study|Did Not Receive Treatment|3|||
162964618|NCT02670551|588569837|FG002|Overall Study|Did Not Receive Treatment|0|||
162964619|NCT04476277|588569838|FG000|Overall Study|Withdrawal by Subject|0|||
162964620|NCT04476277|588569839|FG001|Overall Study|Withdrawal by Subject|0|||
162964621|NCT04476277|588569840|FG002|Overall Study|Withdrawal by Subject|1|||
162964622|NCT04476277|588569841|FG003|Overall Study|Withdrawal by Subject|0|||
162964623|NCT00849797|588569842|FG000|First Intervention|bad veins|1|||
162964624|NCT00849797|588569843|FG001|First Intervention|bad veins|0|||
162964625|NCT00849797|588569842|FG000|First Intervention|Adverse Event|0|||
162964626|NCT00849797|588569843|FG001|First Intervention|Adverse Event|1|||
162964627|NCT00849797|588569842|FG000|Washout: One Week|Withdrawal by Subject|0|||
162964628|NCT00849797|588569843|FG001|Washout: One Week|Withdrawal by Subject|2|||
162964629|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
162964630|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
162964631|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
162964632|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
162964633|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
162964634|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
162964635|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
162964636|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
162964637|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
162964638|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
162964639|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
162964640|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
162964641|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
162964642|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
162964643|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
162964644|NCT01139762|588569847|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
162964645|NCT01139762|588569848|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
162964646|NCT01139762|588569849|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
162622637|NCT02100514|587333974|FG000|Extension Period|Withdrew consent|0|||
162622638|NCT02100514|587333975|FG001|Extension Period|Withdrew consent|0|||
162622639|NCT02100514|587333976|FG002|Extension Period|Withdrew consent|2|||
162622640|NCT02100514|587333977|FG003|Extension Period|Withdrew consent|0|||
162622641|NCT02100514|587333978|FG004|Extension Period|Withdrew consent|0|||
162622642|NCT00319553|587333979|FG000|Overall Study|Protocol Violation|1|||
162891635|NCT01767519|588301206|FG002|Overall Study|Personal Reasons|0|||
162891636|NCT01767519|588301204|FG000|Overall Study|Lost to Follow-up|3|||
162891637|NCT01767519|588301205|FG001|Overall Study|Lost to Follow-up|1|||
162891638|NCT01767519|588301206|FG002|Overall Study|Lost to Follow-up|2|||
162891639|NCT01767519|588301204|FG000|Overall Study|Lack of Efficacy|1|||
162964647|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
162964648|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
162964649|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
162622643|NCT00319553|587333980|FG001|Overall Study|Protocol Violation|2|||
162622644|NCT00319553|587333979|FG000|Overall Study|Lost to Follow-up|2|||
162622645|NCT00319553|587333980|FG001|Overall Study|Lost to Follow-up|1|||
162622646|NCT00319553|587333979|FG000|Overall Study|Withdrawal by Subject|1|||
162891640|NCT01767519|588301205|FG001|Overall Study|Lack of Efficacy|0|||
162891641|NCT01767519|588301206|FG002|Overall Study|Lack of Efficacy|0|||
162891642|NCT01767519|588301204|FG000|Overall Study|Adverse Event|5|||
162891643|NCT01767519|588301205|FG001|Overall Study|Adverse Event|5|||
162891644|NCT01767519|588301206|FG002|Overall Study|Adverse Event|1|||
162891645|NCT01021813|588301207|FG000|DB Treatment Phase|Adverse Event|60|||
162891646|NCT01021813|588301208|FG001|DB Treatment Phase|Adverse Event|22|||
162891647|NCT01021813|588301209|FG002|DB Treatment Phase|Adverse Event|0|||
162891648|NCT01021813|588301210|FG003|DB Treatment Phase|Adverse Event|0|||
162891649|NCT01021813|588301211|FG004|DB Treatment Phase|Adverse Event|0|||
162891650|NCT01021813|588301207|FG000|DB Treatment Phase|Lack of Efficacy|44|||
162891651|NCT01021813|588301208|FG001|DB Treatment Phase|Lack of Efficacy|28|||
162891652|NCT01021813|588301209|FG002|DB Treatment Phase|Lack of Efficacy|0|||
162891653|NCT01021813|588301210|FG003|DB Treatment Phase|Lack of Efficacy|0|||
162891654|NCT01021813|588301211|FG004|DB Treatment Phase|Lack of Efficacy|0|||
162891655|NCT01021813|588301207|FG000|DB Treatment Phase|Lost to Follow-up|14|||
162891656|NCT01021813|588301208|FG001|DB Treatment Phase|Lost to Follow-up|12|||
162891657|NCT01021813|588301209|FG002|DB Treatment Phase|Lost to Follow-up|0|||
162891658|NCT01021813|588301210|FG003|DB Treatment Phase|Lost to Follow-up|0|||
162891659|NCT01021813|588301211|FG004|DB Treatment Phase|Lost to Follow-up|0|||
162891660|NCT01021813|588301207|FG000|DB Treatment Phase|Physician Decision|17|||
162891661|NCT01021813|588301208|FG001|DB Treatment Phase|Physician Decision|8|||
162891662|NCT01021813|588301209|FG002|DB Treatment Phase|Physician Decision|0|||
162891663|NCT01021813|588301210|FG003|DB Treatment Phase|Physician Decision|0|||
162891664|NCT01021813|588301211|FG004|DB Treatment Phase|Physician Decision|0|||
162891665|NCT01021813|588301207|FG000|DB Treatment Phase|Pregnancy|1|||
162891666|NCT01021813|588301208|FG001|DB Treatment Phase|Pregnancy|0|||
162891667|NCT01021813|588301209|FG002|DB Treatment Phase|Pregnancy|0|||
162891668|NCT01021813|588301210|FG003|DB Treatment Phase|Pregnancy|0|||
162891669|NCT01021813|588301211|FG004|DB Treatment Phase|Pregnancy|0|||
162891670|NCT01021813|588301207|FG000|DB Treatment Phase|Protocol Violation|4|||
162891671|NCT01021813|588301208|FG001|DB Treatment Phase|Protocol Violation|3|||
162891672|NCT01021813|588301209|FG002|DB Treatment Phase|Protocol Violation|0|||
162891673|NCT01021813|588301210|FG003|DB Treatment Phase|Protocol Violation|0|||
162891674|NCT01021813|588301211|FG004|DB Treatment Phase|Protocol Violation|0|||
162891675|NCT01021813|588301207|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
162891676|NCT01021813|588301208|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
162891677|NCT01021813|588301209|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
162891678|NCT01021813|588301210|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
162891679|NCT01021813|588301211|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
162891680|NCT01021813|588301207|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
162622647|NCT00319553|587333980|FG001|Overall Study|Withdrawal by Subject|1|||
162891681|NCT01021813|588301208|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
162891682|NCT01021813|588301209|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
162891683|NCT01021813|588301210|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
162891684|NCT01021813|588301211|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
162891685|NCT01021813|588301207|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
162891686|NCT01021813|588301208|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
162891687|NCT01021813|588301209|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
162964650|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Death|0|||
162622648|NCT01751178|587333981|FG000|Overall Study|Adverse Event|2|||
162891688|NCT01021813|588301210|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
162891689|NCT01021813|588301211|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
162891690|NCT01021813|588301207|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
162891691|NCT01021813|588301208|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
162891692|NCT01021813|588301209|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
162891693|NCT01021813|588301210|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
162964651|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Death|1|||
162891694|NCT01021813|588301211|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
162891695|NCT01021813|588301207|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
162964652|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Death|1|||
162622649|NCT01751178|587333982|FG001|Overall Study|Adverse Event|0|||
162891696|NCT01021813|588301208|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
162891697|NCT01021813|588301209|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
162891698|NCT01021813|588301210|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
162891699|NCT01021813|588301211|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
162891700|NCT01021813|588301207|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
162891701|NCT01021813|588301208|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
162891702|NCT01021813|588301209|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
162891703|NCT01021813|588301210|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
162891704|NCT01021813|588301211|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
162891705|NCT02261883|588301213|FG000|Overall Study|Death|3|||
162891706|NCT02261883|588301214|FG001|Overall Study|Death|2|||
162891707|NCT02261883|588301213|FG000|Overall Study|Physician Decision|1|||
162891708|NCT02261883|588301214|FG001|Overall Study|Physician Decision|0|||
162891709|NCT02261883|588301213|FG000|Overall Study|Protocol Violation|1|||
162891710|NCT02261883|588301214|FG001|Overall Study|Protocol Violation|0|||
162891711|NCT02261883|588301213|FG000|Overall Study|Withdrawal by Subject|0|||
162891712|NCT02261883|588301214|FG001|Overall Study|Withdrawal by Subject|1|||
162891713|NCT02261883|588301213|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
162891714|NCT02261883|588301214|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
162891715|NCT01626989|588301224|FG000|Screening Period|Screen Failure|15|||
162891716|NCT01626989|588301225|FG001|Screening Period|Screen Failure|0|||
162891717|NCT01626989|588301226|FG002|Screening Period|Screen Failure|0|||
162891718|NCT01626989|588301224|FG000|Screening Period|Withdrawal by Subject|2|||
162891719|NCT01626989|588301225|FG001|Screening Period|Withdrawal by Subject|0|||
162891720|NCT01626989|588301226|FG002|Screening Period|Withdrawal by Subject|0|||
162891721|NCT03366844|588303545|FG000|Overall Study|Physician Decision|1|||
162891722|NCT03366844|588303545|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
162891723|NCT02332798|588303548|FG000|Overall Study|Unwilling to Participate in Study|0|||
162891724|NCT02332798|588303549|FG001|Overall Study|Unwilling to Participate in Study|1|||
162891725|NCT02332798|588303550|FG002|Overall Study|Unwilling to Participate in Study|1|||
162891726|NCT02332798|588303548|FG000|Overall Study|Positive Urine Drug Test|0|||
162891727|NCT02332798|588303549|FG001|Overall Study|Positive Urine Drug Test|1|||
162891728|NCT02332798|588303550|FG002|Overall Study|Positive Urine Drug Test|0|||
162891729|NCT02332798|588303548|FG000|Overall Study|Abnormal Laboratory Findings|1|||
162891730|NCT02332798|588303549|FG001|Overall Study|Abnormal Laboratory Findings|0|||
162891731|NCT02332798|588303550|FG002|Overall Study|Abnormal Laboratory Findings|0|||
162891732|NCT00595868|588303551|FG000|Overall Study|Lost to Follow-up|45|||
162891733|NCT00595868|588303552|FG001|Overall Study|Lost to Follow-up|50|||
162891734|NCT02688153|588303553|FG000|Overall Study|Death|7|||
162891735|NCT02688153|588303554|FG001|Overall Study|Death|5|||
162891736|NCT02688153|588303553|FG000|Overall Study|Withdrawal by Subject|4|||
162891737|NCT02688153|588303554|FG001|Overall Study|Withdrawal by Subject|2|||
162891738|NCT02688153|588303553|FG000|Overall Study|Valve Explant|1|||
162891739|NCT02688153|588303554|FG001|Overall Study|Valve Explant|0|||
162891740|NCT02688153|588303553|FG000|Overall Study|Conversion to Commercial Valve|3|||
162891741|NCT02688153|588303554|FG001|Overall Study|Conversion to Commercial Valve|0|||
162891742|NCT02687711|588303555|FG000|Overall Study|Adverse Event|89|||
162891743|NCT02687711|588303555|FG000|Overall Study|Lack of Efficacy|70|||
162891744|NCT02687711|588303555|FG000|Overall Study|Lost to Follow-up|20|||
162891745|NCT02687711|588303555|FG000|Overall Study|Consent withdrawn|15|||
162891746|NCT02687711|588303555|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
162891747|NCT02687711|588303555|FG000|Overall Study|Too expensive|4|||
162891748|NCT02687711|588303555|FG000|Overall Study|Participant moved abroad|1|||
162891749|NCT02687711|588303555|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
162891750|NCT02687711|588303555|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
162891751|NCT02687711|588303555|FG000|Overall Study|Disliked taste|1|||
162891752|NCT02687711|588303555|FG000|Overall Study|Low mood|1|||
162891753|NCT02687711|588303555|FG000|Overall Study|Side effects|1|||
162891754|NCT02687711|588303555|FG000|Overall Study|Change of Hospital|1|||
162891755|NCT02687711|588303555|FG000|Overall Study|Liver Encephalopathy|1|||
162891756|NCT02687711|588303555|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
162891757|NCT02687711|588303555|FG000|Overall Study|Withdrawn due to intake interruption|1|||
162891758|NCT02687711|588303555|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
162891759|NCT02687711|588303555|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
162891760|NCT02687711|588303555|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
162891761|NCT02971007|588303557|FG000|Overall Study|Adverse Event|1|||
162891762|NCT02971007|588303558|FG001|Overall Study|Adverse Event|0|||
162891763|NCT02971007|588303559|FG002|Overall Study|Adverse Event|0|||
162891764|NCT02971007|588303557|FG000|Overall Study|Lost to Follow-up|0|||
162891765|NCT02971007|588303558|FG001|Overall Study|Lost to Follow-up|1|||
162891766|NCT02971007|588303559|FG002|Overall Study|Lost to Follow-up|1|||
162891767|NCT02971007|588303557|FG000|Overall Study|Withdrawal by Subject|0|||
162891768|NCT02971007|588303558|FG001|Overall Study|Withdrawal by Subject|1|||
162891769|NCT02971007|588303559|FG002|Overall Study|Withdrawal by Subject|0|||
162891770|NCT02971007|588303557|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
162891771|NCT02971007|588303558|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
162891772|NCT02971007|588303559|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
162891773|NCT02971007|588303557|FG000|Overall Study|Patient discontinued study drug|0|||
162891774|NCT02971007|588303558|FG001|Overall Study|Patient discontinued study drug|1|||
162891775|NCT02971007|588303559|FG002|Overall Study|Patient discontinued study drug|0|||
162891776|NCT02471586|588303560|FG000|Overall Study|Lost to Follow-up|3|||
162891777|NCT02471586|588303561|FG001|Overall Study|Lost to Follow-up|8|||
162891778|NCT02471586|588303562|FG002|Overall Study|Lost to Follow-up|4|||
162622650|NCT01751178|587333983|FG002|Overall Study|Adverse Event|0|||
162622651|NCT01751178|587333981|FG000|Overall Study|Other Reason (unknown)|1|||
162622652|NCT01751178|587333982|FG001|Overall Study|Other Reason (unknown)|0|||
162622653|NCT01751178|587333983|FG002|Overall Study|Other Reason (unknown)|2|||
162622654|NCT04138810|587333984|FG000|Overall Study|Withdrawal by Subject|0|||
162622655|NCT04138810|587333985|FG001|Overall Study|Withdrawal by Subject|1|||
162622656|NCT04138810|587333984|FG000|Overall Study|Subject cancelled surgery|1|||
162622657|NCT04138810|587333985|FG001|Overall Study|Subject cancelled surgery|0|||
162891779|NCT02471586|588303560|FG000|Overall Study|Death|2|||
162891780|NCT02471586|588303561|FG001|Overall Study|Death|2|||
162891781|NCT02471586|588303562|FG002|Overall Study|Death|0|||
162891782|NCT00607919|588303563|FG000|Acute Phase|Adverse Event|9|||
162891783|NCT00607919|588303564|FG001|Acute Phase|Adverse Event|2|||
162891784|NCT00607919|588303563|FG000|Acute Phase|Entry Criteria Not Met|1|||
162891785|NCT00607919|588303564|FG001|Acute Phase|Entry Criteria Not Met|1|||
162891786|NCT00607919|588303563|FG000|Acute Phase|Lack of Efficacy|1|||
162891787|NCT00607919|588303564|FG001|Acute Phase|Lack of Efficacy|2|||
162891788|NCT00607919|588303563|FG000|Acute Phase|Lost to Follow-up|9|||
162891789|NCT00607919|588303564|FG001|Acute Phase|Lost to Follow-up|3|||
162891790|NCT00607919|588303563|FG000|Acute Phase|Parent/Caregiver Decision|6|||
162891791|NCT00607919|588303564|FG001|Acute Phase|Parent/Caregiver Decision|4|||
162891792|NCT00607919|588303563|FG000|Acute Phase|Protocol Violation|5|||
162891793|NCT00607919|588303564|FG001|Acute Phase|Protocol Violation|1|||
162891794|NCT00607919|588303563|FG000|Acute Phase|Withdrawal by Subject|3|||
162891795|NCT00607919|588303564|FG001|Acute Phase|Withdrawal by Subject|3|||
162891796|NCT00607919|588303563|FG000|Open-Label Phase|Adverse Event|1|||
162891797|NCT00607919|588303564|FG001|Open-Label Phase|Adverse Event|5|||
162891798|NCT00607919|588303563|FG000|Open-Label Phase|Lost to Follow-up|4|||
162891799|NCT00607919|588303564|FG001|Open-Label Phase|Lost to Follow-up|1|||
162891800|NCT00607919|588303563|FG000|Open-Label Phase|Protocol Violation|2|||
162891801|NCT00607919|588303564|FG001|Open-Label Phase|Protocol Violation|2|||
162891802|NCT00607919|588303563|FG000|Open-Label Phase|Withdrawal by Subject|2|||
162891803|NCT00607919|588303564|FG001|Open-Label Phase|Withdrawal by Subject|2|||
162891804|NCT00607919|588303563|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
162891805|NCT00607919|588303564|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
162891806|NCT00239356|588303570|FG000|Overall Study|Lack of Efficacy|1|||
162891807|NCT00239356|588303571|FG001|Overall Study|Lack of Efficacy|0|||
162891808|NCT00239356|588303570|FG000|Overall Study|Adverse Event|6|||
162622658|NCT03641339|587333988|FG000|Overall Study|Physician Decision|1|||
162622659|NCT03641339|587333989|FG001|Overall Study|Physician Decision|0|||
162622660|NCT03641339|587333990|FG002|Overall Study|Physician Decision|0|||
162622661|NCT03641339|587333991|FG003|Overall Study|Physician Decision|0|||
162622662|NCT03641339|587333992|FG004|Overall Study|Physician Decision|0|||
162622663|NCT03641339|587333993|FG005|Overall Study|Physician Decision|0|||
162622664|NCT03641339|587333988|FG000|Overall Study|Withdrawal by Subject|0|||
162891809|NCT00239356|588303571|FG001|Overall Study|Adverse Event|0|||
162891810|NCT00239356|588303570|FG000|Overall Study|Withdrawal by Subject|15|||
162891811|NCT00239356|588303571|FG001|Overall Study|Withdrawal by Subject|6|||
162891812|NCT00239356|588303570|FG000|Overall Study|Lost to Follow-up|3|||
162891813|NCT00239356|588303571|FG001|Overall Study|Lost to Follow-up|0|||
162891814|NCT00239356|588303570|FG000|Overall Study|poor/non-compliance|2|||
162891815|NCT00239356|588303571|FG001|Overall Study|poor/non-compliance|0|||
162891816|NCT00239356|588303570|FG000|Overall Study|Pregnancy|1|||
162891817|NCT00239356|588303571|FG001|Overall Study|Pregnancy|0|||
162891818|NCT00239356|588303570|FG000|Overall Study|Administrative reason|0|||
162891819|NCT00239356|588303571|FG001|Overall Study|Administrative reason|1|||
162891820|NCT00239356|588303570|FG000|Overall Study|Drug available on market|11|||
162891821|NCT00239356|588303571|FG001|Overall Study|Drug available on market|2|||
162891822|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
162891823|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
162891824|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
162891825|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
162891826|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
162891827|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
162891828|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
162891829|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
162891830|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
162891831|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
162891832|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
162891833|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
162891834|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
162891835|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
162891836|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
162891837|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
162891838|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
162891839|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
162891840|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
162891841|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
162891842|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
162891843|NCT01001572|588303572|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
162891844|NCT01001572|588303573|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
162891845|NCT01001572|588303574|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
162891846|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
162891847|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
162891848|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
162891849|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
162891850|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
162891851|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
162891852|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
162891853|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
162891854|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
162891855|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
162891856|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
162891857|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
162891858|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
162891859|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
162891860|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
162891861|NCT01001572|588303572|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162891862|NCT01001572|588303573|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162891863|NCT01001572|588303574|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
162891864|NCT01237223|588303577|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
162891865|NCT01237223|588303578|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
162891866|NCT01237223|588303579|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
162891867|NCT01237223|588303580|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
162891868|NCT01237223|588303581|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
162891869|NCT01237223|588303582|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
162891870|NCT01237223|588303577|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
162891871|NCT01237223|588303578|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
162891872|NCT01237223|588303579|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
162891873|NCT01237223|588303580|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
162891874|NCT01237223|588303581|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
162891875|NCT01237223|588303582|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
162891876|NCT01237223|588303577|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
162891877|NCT01237223|588303578|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
162891878|NCT01237223|588303579|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
162891879|NCT01237223|588303580|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
162891880|NCT01237223|588303581|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
162891881|NCT01237223|588303582|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
162891882|NCT01237223|588303577|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
162891883|NCT01237223|588303578|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
162891884|NCT01237223|588303579|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
162891885|NCT01237223|588303580|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
162891886|NCT01237223|588303581|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
162891887|NCT01237223|588303582|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
162891888|NCT01237223|588303577|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
162891889|NCT01237223|588303578|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
162891890|NCT01237223|588303579|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
162891891|NCT01237223|588303580|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
162891892|NCT01237223|588303581|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
162891893|NCT01237223|588303582|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
162891894|NCT01237223|588303577|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
162891895|NCT01237223|588303578|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
162891896|NCT01237223|588303579|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
162891897|NCT01237223|588303580|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
162891898|NCT01237223|588303581|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
162891899|NCT01237223|588303582|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
162891900|NCT01237223|588303577|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
162891901|NCT01237223|588303578|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
162891902|NCT01237223|588303579|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
162891903|NCT01237223|588303580|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
162891904|NCT01237223|588303581|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
162891905|NCT01237223|588303582|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
162891906|NCT01237223|588303577|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
162891907|NCT01237223|588303578|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
162891908|NCT01237223|588303579|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
162891909|NCT01237223|588303580|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
162622665|NCT03641339|587333989|FG001|Overall Study|Withdrawal by Subject|2|||
162622666|NCT03641339|587333990|FG002|Overall Study|Withdrawal by Subject|0|||
162622667|NCT03641339|587333991|FG003|Overall Study|Withdrawal by Subject|2|||
162622668|NCT03641339|587333992|FG004|Overall Study|Withdrawal by Subject|0|||
162622669|NCT03641339|587333993|FG005|Overall Study|Withdrawal by Subject|1|||
162622670|NCT02329080|587333994|FG000|Overall Study|Adverse Event|1|||
162622671|NCT02329080|587333994|FG000|Overall Study|Death|4|||
162622672|NCT02329080|587333994|FG000|Overall Study|Lack of Efficacy|22|||
162622673|NCT02329080|587333994|FG000|Overall Study|Lost to Follow-up|1|||
162622674|NCT02329080|587333994|FG000|Overall Study|Physician Decision|2|||
162622675|NCT02329080|587333994|FG000|Overall Study|Partial response|4|||
162622676|NCT02329080|587333994|FG000|Overall Study|Complete response|4|||
162622677|NCT00413244|587333996|FG000|Overall Study|Withdrawal by Subject|10|||
162622678|NCT00413244|587333997|FG001|Overall Study|Withdrawal by Subject|1|||
162622679|NCT02319837|587334000|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
162622680|NCT02319837|587334001|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
162622681|NCT02319837|587334002|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
162622682|NCT02319837|587334000|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
162622683|NCT02319837|587334001|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
162622684|NCT02319837|587334002|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
162622685|NCT02319837|587334000|FG000|Study Treatment Phase|Adverse Event|73|||
162622686|NCT02319837|587334001|FG001|Study Treatment Phase|Adverse Event|36|||
162622687|NCT02319837|587334002|FG002|Study Treatment Phase|Adverse Event|63|||
162622688|NCT02319837|587334000|FG000|Study Treatment Phase|Development of castration resistance|0|||
162622689|NCT02319837|587334001|FG001|Study Treatment Phase|Development of castration resistance|2|||
162622690|NCT02319837|587334002|FG002|Study Treatment Phase|Development of castration resistance|0|||
162622691|NCT02319837|587334000|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
162622692|NCT02319837|587334001|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
162622693|NCT02319837|587334002|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
162622694|NCT02319837|587334000|FG000|Study Treatment Phase|Protocol Violation|2|||
162622695|NCT02319837|587334001|FG001|Study Treatment Phase|Protocol Violation|2|||
162622696|NCT02319837|587334002|FG002|Study Treatment Phase|Protocol Violation|1|||
162622697|NCT02319837|587334000|FG000|Study Treatment Phase|Lost to Follow-up|0|||
162622698|NCT02319837|587334001|FG001|Study Treatment Phase|Lost to Follow-up|1|||
162622699|NCT02319837|587334002|FG002|Study Treatment Phase|Lost to Follow-up|0|||
162622700|NCT02319837|587334000|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
162631096|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162622701|NCT02319837|587334001|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
162622702|NCT02319837|587334002|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
162622703|NCT02319837|587334000|FG000|Study Treatment Phase|Other|0|||
162622704|NCT02319837|587334001|FG001|Study Treatment Phase|Other|1|||
162622705|NCT02319837|587334002|FG002|Study Treatment Phase|Other|0|||
162622706|NCT02319837|587334000|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
162622707|NCT02319837|587334001|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
162622708|NCT02319837|587334002|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
162622709|NCT02319837|587334000|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
162622710|NCT02319837|587334001|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
162622711|NCT02319837|587334002|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
162631097|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162891910|NCT01237223|588303581|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
162891911|NCT01237223|588303582|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
162891912|NCT01237223|588303577|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
162891913|NCT01237223|588303578|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
162891914|NCT01237223|588303579|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
162891915|NCT01237223|588303580|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
162891916|NCT01237223|588303581|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
162891917|NCT01237223|588303582|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
162891918|NCT01237223|588303577|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
162891919|NCT01237223|588303578|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
162891920|NCT01237223|588303579|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
162891921|NCT01237223|588303580|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
162891922|NCT01237223|588303581|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
162891923|NCT01237223|588303582|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
162891924|NCT00724815|588303585|FG000|Overall Study|Randomized, not treated|31|||
162891925|NCT00724815|588303586|FG001|Overall Study|Randomized, not treated|30|||
162891926|NCT00724815|588303585|FG000|Overall Study|Adverse Event|5|||
162891927|NCT00724815|588303586|FG001|Overall Study|Adverse Event|3|||
162891928|NCT00724815|588303585|FG000|Overall Study|Lost to Follow-up|4|||
162891929|NCT00724815|588303586|FG001|Overall Study|Lost to Follow-up|1|||
162891930|NCT00724815|588303585|FG000|Overall Study|Other Various|3|||
162891931|NCT00724815|588303586|FG001|Overall Study|Other Various|5|||
162891932|NCT00443846|588303587|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
162891933|NCT00443846|588303588|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
162891934|NCT00443846|588303587|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
162891935|NCT00443846|588303588|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
162891936|NCT00443846|588303587|FG000|Overall Study|Adverse Event|0|||
162891937|NCT00443846|588303588|FG001|Overall Study|Adverse Event|1|||
162891938|NCT00443846|588303587|FG000|Overall Study|Personal reason|8|||
162891939|NCT00443846|588303588|FG001|Overall Study|Personal reason|3|||
162891940|NCT00443846|588303587|FG000|Overall Study|Lost to Follow-up|1|||
162891941|NCT00443846|588303588|FG001|Overall Study|Lost to Follow-up|2|||
162891942|NCT00445341|588303592|FG000|Overall Study|refused further treatment|1|||
162891943|NCT00445341|588303592|FG000|Overall Study|taken off treatment too early|1|||
162891944|NCT00641706|588303593|FG000|Overall Study|Adverse Event|2|||
162891945|NCT00641706|588303594|FG001|Overall Study|Adverse Event|1|||
162891946|NCT00641706|588303593|FG000|Overall Study|Withdrawal by Subject|6|||
162891947|NCT00641706|588303594|FG001|Overall Study|Withdrawal by Subject|1|||
162891948|NCT00641706|588303593|FG000|Overall Study|Clinical Decline|1|||
162891949|NCT00641706|588303594|FG001|Overall Study|Clinical Decline|0|||
162891950|NCT00641706|588303593|FG000|Overall Study|Lead Investigator Decision|0|||
162891951|NCT00641706|588303594|FG001|Overall Study|Lead Investigator Decision|1|||
162891952|NCT00109772|588303595|FG000|Double-blind Treatment|Adverse Event|14|||
162891953|NCT00109772|588303596|FG001|Double-blind Treatment|Adverse Event|5|||
162891954|NCT00109772|588303595|FG000|Double-blind Treatment|Lack of Efficacy|1|||
162891955|NCT00109772|588303596|FG001|Double-blind Treatment|Lack of Efficacy|0|||
162891956|NCT00109772|588303595|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
162891957|NCT00109772|588303596|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
162891958|NCT00109772|588303595|FG000|Double-blind Treatment|Lost to Follow-up|2|||
162891959|NCT00109772|588303596|FG001|Double-blind Treatment|Lost to Follow-up|3|||
162891960|NCT00109772|588303595|FG000|Double-blind Treatment|Protocol Violation|0|||
162891961|NCT00109772|588303596|FG001|Double-blind Treatment|Protocol Violation|1|||
162891962|NCT00109772|588303595|FG000|Double-blind Treatment|Other|0|||
162891963|NCT00109772|588303596|FG001|Double-blind Treatment|Other|4|||
162891964|NCT00109772|588303595|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
162891965|NCT00109772|588303596|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
162891966|NCT00109772|588303595|FG000|Open-label Extension|Adverse Event|10|||
162891967|NCT00109772|588303596|FG001|Open-label Extension|Adverse Event|19|||
162891968|NCT00109772|588303595|FG000|Open-label Extension|Lack of Efficacy|19|||
162891969|NCT00109772|588303596|FG001|Open-label Extension|Lack of Efficacy|11|||
162891970|NCT00109772|588303595|FG000|Open-label Extension|Withdrawal by Subject|9|||
162891971|NCT00109772|588303596|FG001|Open-label Extension|Withdrawal by Subject|6|||
162891972|NCT00109772|588303595|FG000|Open-label Extension|Lost to Follow-up|1|||
162891973|NCT00109772|588303596|FG001|Open-label Extension|Lost to Follow-up|0|||
162891974|NCT00109772|588303595|FG000|Open-label Extension|Death|0|||
162891975|NCT00109772|588303596|FG001|Open-label Extension|Death|1|||
162891976|NCT00109772|588303595|FG000|Open-label Extension|Protocol Violation|2|||
162891977|NCT00109772|588303596|FG001|Open-label Extension|Protocol Violation|2|||
162891978|NCT00109772|588303595|FG000|Open-label Extension|Other|4|||
162891979|NCT00109772|588303596|FG001|Open-label Extension|Other|10|||
162891980|NCT05441540|588303601|FG000|Overall Study|Withdrawal by Subject|2|||
162891981|NCT00813917|588303602|FG000|Overall Study|Adverse Event|0|||
162891982|NCT00813917|588303603|FG001|Overall Study|Adverse Event|1|||
162891983|NCT00813917|588303602|FG000|Overall Study|Withdrawal by Subject|3|||
162891984|NCT00813917|588303603|FG001|Overall Study|Withdrawal by Subject|4|||
162891985|NCT00813917|588303602|FG000|Overall Study|Lost to Follow-up|3|||
162891986|NCT00813917|588303603|FG001|Overall Study|Lost to Follow-up|1|||
162891987|NCT01359046|588303604|FG000|Overall Study|Did not receive allocated intervention|6|||
162891988|NCT01359046|588303605|FG001|Overall Study|Did not receive allocated intervention|6|||
162891989|NCT01359046|588303604|FG000|Overall Study|Physician Decision|1|||
162891990|NCT01359046|588303605|FG001|Overall Study|Physician Decision|11|||
162891991|NCT03862495|588303608|FG000|Overall Study|Lost to Follow-up|37|||
162891992|NCT03862495|588303609|FG001|Overall Study|Lost to Follow-up|35|||
162891993|NCT00615914|588303610|FG000|Overall Study|Adverse Event|274|||
162891994|NCT00615914|588303610|FG000|Overall Study|Death|20|||
162891995|NCT00615914|588303610|FG000|Overall Study|Lack of Efficacy|59|||
162891996|NCT00615914|588303610|FG000|Overall Study|Lost to Follow-up|187|||
162891997|NCT00615914|588303610|FG000|Overall Study|Withdrawal by Subject|16|||
162891998|NCT00615914|588303610|FG000|Overall Study|Physician Decision|4|||
162891999|NCT00615914|588303610|FG000|Overall Study|No data was collected.|65|||
162892000|NCT00615914|588303610|FG000|Overall Study|No treatment|2|||
163051517|NCT00433836|588897166|FG000|Overall Study|Condition no longer requires study drug|0|||
162631098|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162892001|NCT00615914|588303610|FG000|Overall Study|Irregularly enrolled patients|10|||
162892002|NCT00064077|588303611|FG000|Overall Study|Improper prior treatment|1|||
162892003|NCT00064077|588303612|FG001|Overall Study|Improper prior treatment|0|||
162892004|NCT00064077|588303613|FG002|Overall Study|Improper prior treatment|0|||
162892005|NCT00064077|588303614|FG003|Overall Study|Improper prior treatment|0|||
162892006|NCT00064077|588303611|FG000|Overall Study|Poor risk|2|||
162892007|NCT00064077|588303612|FG001|Overall Study|Poor risk|0|||
162892008|NCT00064077|588303613|FG002|Overall Study|Poor risk|1|||
162892009|NCT00064077|588303614|FG003|Overall Study|Poor risk|1|||
162892010|NCT00064077|588303611|FG000|Overall Study|Pathology|10|||
162892011|NCT00064077|588303612|FG001|Overall Study|Pathology|7|||
162892012|NCT00064077|588303613|FG002|Overall Study|Pathology|3|||
162892013|NCT00064077|588303614|FG003|Overall Study|Pathology|4|||
162892014|NCT00064077|588303611|FG000|Overall Study|No surgery|0|||
162892015|NCT00064077|588303612|FG001|Overall Study|No surgery|0|||
162892016|NCT00064077|588303613|FG002|Overall Study|No surgery|1|||
162892017|NCT00064077|588303614|FG003|Overall Study|No surgery|0|||
162892018|NCT00064077|588303611|FG000|Overall Study|No tumor|0|||
162892019|NCT00064077|588303612|FG001|Overall Study|No tumor|0|||
162892020|NCT00064077|588303613|FG002|Overall Study|No tumor|1|||
162892021|NCT00064077|588303614|FG003|Overall Study|No tumor|0|||
162892022|NCT00064077|588303611|FG000|Overall Study|Other reasons|2|||
162892023|NCT00064077|588303612|FG001|Overall Study|Other reasons|2|||
162892024|NCT00064077|588303613|FG002|Overall Study|Other reasons|1|||
162892025|NCT00064077|588303614|FG003|Overall Study|Other reasons|2|||
162892026|NCT03037307|588303615|FG000|Period 1|Did Not Meet Study Criteria|0|||
162892027|NCT03037307|588303616|FG001|Period 1|Did Not Meet Study Criteria|0|||
162892028|NCT03037307|588303617|FG002|Period 1|Did Not Meet Study Criteria|0|||
162892029|NCT03037307|588303618|FG003|Period 1|Did Not Meet Study Criteria|1|||
162892030|NCT03037307|588303619|FG004|Period 1|Did Not Meet Study Criteria|0|||
162892031|NCT03037307|588303620|FG005|Period 1|Did Not Meet Study Criteria|0|||
162892032|NCT04397796|588303621|FG000|Overall Study|Death|3|||
162892033|NCT04397796|588303622|FG001|Overall Study|Death|1|||
162892034|NCT04075396|588303627|FG000|Overall Study|Death|11|||
162892035|NCT04075396|588303628|FG001|Overall Study|Death|9|||
162892036|NCT04075396|588303627|FG000|Overall Study|Withdrawal by Subject|1|||
162892037|NCT04075396|588303628|FG001|Overall Study|Withdrawal by Subject|2|||
162892038|NCT04075396|588303627|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
162892039|NCT04075396|588303628|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
162892040|NCT04075396|588303627|FG000|Overall Study|Enrolled but not-treated|0|||
162892041|NCT04075396|588303628|FG001|Overall Study|Enrolled but not-treated|1|||
162892042|NCT04737759|588303631|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
162892043|NCT04737759|588303632|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
162892044|NCT04737759|588303631|FG000|Overall Study|Death|2|||
162892045|NCT04737759|588303632|FG001|Overall Study|Death|0|||
162892046|NCT04737759|588303631|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
162892047|NCT04737759|588303632|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
162892048|NCT04737759|588303631|FG000|Overall Study|Lost to Follow-up|4|||
162892049|NCT04737759|588303632|FG001|Overall Study|Lost to Follow-up|12|||
162892050|NCT01484561|588303633|FG000|Overall Study|Lack of Efficacy|3|||
162892051|NCT01484561|588303634|FG001|Overall Study|Lack of Efficacy|1|||
162892052|NCT01484561|588303633|FG000|Overall Study|Lost to Follow-up|1|||
162892053|NCT01484561|588303634|FG001|Overall Study|Lost to Follow-up|0|||
162892054|NCT01484561|588303633|FG000|Overall Study|Withdrawal by Subject|3|||
162892055|NCT01484561|588303634|FG001|Overall Study|Withdrawal by Subject|0|||
162892056|NCT01484561|588303633|FG000|Overall Study|Other|1|||
162892057|NCT01484561|588303634|FG001|Overall Study|Other|1|||
162892058|NCT01484561|588303633|FG000|Overall Study|Adverse Event|1|||
162892059|NCT01484561|588303634|FG001|Overall Study|Adverse Event|4|||
162892060|NCT03371251|588303635|FG000|Overall Study|Withdrawal by Subject|1|||
162892061|NCT03371251|588303636|FG001|Overall Study|Withdrawal by Subject|0|||
162892062|NCT03371251|588303637|FG002|Overall Study|Withdrawal by Subject|1|||
162892063|NCT03371251|588303638|FG003|Overall Study|Withdrawal by Subject|0|||
162892064|NCT03371251|588303639|FG004|Overall Study|Withdrawal by Subject|2|||
162892065|NCT03371251|588303640|FG005|Overall Study|Withdrawal by Subject|2|||
162892066|NCT03371251|588303635|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
162892067|NCT03371251|588303636|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
162892068|NCT03371251|588303637|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
162892069|NCT03371251|588303638|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
162892070|NCT03371251|588303639|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
162892071|NCT03371251|588303640|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
162892072|NCT03371251|588303635|FG000|Overall Study|Adverse Event|0|||
162622712|NCT02319837|587334000|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
162892073|NCT03371251|588303636|FG001|Overall Study|Adverse Event|0|||
162892074|NCT03371251|588303637|FG002|Overall Study|Adverse Event|0|||
162892075|NCT03371251|588303638|FG003|Overall Study|Adverse Event|0|||
162892076|NCT03371251|588303639|FG004|Overall Study|Adverse Event|1|||
162622713|NCT02319837|587334001|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
162622714|NCT02319837|587334002|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
162622715|NCT02319837|587334000|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
162622716|NCT02319837|587334001|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
162622717|NCT02319837|587334002|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
162622718|NCT02319837|587334000|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
162622719|NCT02319837|587334001|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
162622720|NCT02319837|587334002|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
162622721|NCT02319837|587334000|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
162622722|NCT02319837|587334001|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
162622723|NCT02319837|587334002|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
162622724|NCT02319837|587334000|FG000|Long-Term Follow-Up Phase|Death|33|||
162622725|NCT02319837|587334001|FG001|Long-Term Follow-Up Phase|Death|54|||
162622726|NCT02319837|587334002|FG002|Long-Term Follow-Up Phase|Death|42|||
162622727|NCT02435147|587334003|FG000|Overall Study|non-evaluable DXA scan|11|||
162622728|NCT00839852|587334006|FG000|Overall Study|Adverse Event|10|||
162622729|NCT00839852|587334006|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162622730|NCT00839852|587334006|FG000|Overall Study|Protocol Violation|9|||
162622731|NCT00839852|587334006|FG000|Overall Study|Withdrawal of Consent|16|||
162622732|NCT00839852|587334006|FG000|Overall Study|Lost to Follow-up|7|||
162622733|NCT00839852|587334006|FG000|Overall Study|Lack of Compliance While in Jail|1|||
162622734|NCT00839852|587334006|FG000|Overall Study|Pregnancy|1|||
162892077|NCT03371251|588303640|FG005|Overall Study|Adverse Event|0|||
162892078|NCT03371251|588303635|FG000|Overall Study|Decision by Sponsor|0|||
162622735|NCT03082261|587334007|FG000|Overall Study|Death|4|||
162622736|NCT03082261|587334007|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
162622737|NCT03082261|587334007|FG000|Overall Study|Insurance denial|1|||
162622738|NCT03082261|587334007|FG000|Overall Study|Peripheral lead added|1|||
162622739|NCT03082261|587334007|FG000|Overall Study|Withdrawal by Subject|40|||
162622740|NCT03082261|587334007|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
162622741|NCT03082261|587334007|FG000|Overall Study|Subject implanted with device other than study device|1|||
162622742|NCT03082261|587334007|FG000|Overall Study|Lost to Follow-up|14|||
162622743|NCT03082261|587334007|FG000|Overall Study|Subject moved to a different state|1|||
162622744|NCT03082261|587334007|FG000|Overall Study|Subject non-compliance|2|||
162622745|NCT03082261|587334007|FG000|Overall Study|Subject participation terminated by investigator|9|||
162622746|NCT03082261|587334007|FG000|Overall Study|Subject participation terminated by sponsor|4|||
162622747|NCT03082261|587334007|FG000|Overall Study|System explant|19|||
162622748|NCT03082261|587334007|FG000|Overall Study|Unable to place lead(s)|2|||
162622749|NCT03082261|587334007|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
162622750|NCT01313312|587334011|FG000|Overall Study|Adverse Event|5|||
162622751|NCT01313312|587334011|FG000|Overall Study|Withdrawal by Subject|18|||
162622752|NCT01313312|587334011|FG000|Overall Study|Lack of Efficacy|3|||
162622753|NCT01313312|587334011|FG000|Overall Study|Investigator Decision|1|||
162622754|NCT01313312|587334011|FG000|Overall Study|Observational Phase|1|||
162622755|NCT01313312|587334011|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
162622756|NCT01313312|587334011|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
162622757|NCT01206166|587334019|FG000|Overall Study|No evaluable data|2|||
162622758|NCT01206166|587334020|FG001|Overall Study|No evaluable data|3|||
162622759|NCT02716805|587334021|FG000|Overall Study|Progressive disease|2|||
162622760|NCT02716805|587334022|FG001|Overall Study|Progressive disease|0|||
162622761|NCT02716805|587334023|FG002|Overall Study|Progressive disease|0|||
162622762|NCT02716805|587334024|FG003|Overall Study|Progressive disease|0|||
162622763|NCT00066365|587334025|FG000|Overall Study|Adverse Event|1|||
162622764|NCT00066365|587334026|FG001|Overall Study|Adverse Event|0|||
162622765|NCT00066365|587334025|FG000|Overall Study|Lack of Efficacy|15|||
162622766|NCT00066365|587334026|FG001|Overall Study|Lack of Efficacy|12|||
162622767|NCT00066365|587334025|FG000|Overall Study|Physician Decision|1|||
162622768|NCT00066365|587334026|FG001|Overall Study|Physician Decision|0|||
162622769|NCT00066365|587334025|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
162622770|NCT00066365|587334026|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
162622771|NCT00066365|587334025|FG000|Overall Study|Ineligible|4|||
162622772|NCT00066365|587334026|FG001|Overall Study|Ineligible|2|||
162622773|NCT00467857|587334029|FG000|Overall Study|Adverse Event|1|||
162622774|NCT00467857|587334030|FG001|Overall Study|Adverse Event|0|||
162622775|NCT00467857|587334029|FG000|Overall Study|Withdrew consent|2|||
162892079|NCT03371251|588303636|FG001|Overall Study|Decision by Sponsor|0|||
162892080|NCT03371251|588303637|FG002|Overall Study|Decision by Sponsor|0|||
162964653|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
162964654|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
162964655|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
162964656|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
162964657|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
162964658|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
162964659|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
162964660|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
162964661|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
162964662|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
162964663|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
162964664|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
162964665|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
162964666|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
162964667|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
162964668|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
162964669|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
162964670|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
162964671|NCT01139762|588569847|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
162964672|NCT01139762|588569848|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
162964673|NCT01139762|588569849|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
162964674|NCT01675596|588569850|FG000|Overall Study|Death|6|||
162964675|NCT01675596|588569850|FG000|Overall Study|Exit with other reason|1|||
162964676|NCT01675596|588569850|FG000|Overall Study|Missed Visit|1|||
162964677|NCT01018862|588569855|FG000|Overall Study|Adverse Event|2|||
162964678|NCT01018862|588569856|FG001|Overall Study|Adverse Event|0|||
162964679|NCT01018862|588569857|FG002|Overall Study|Adverse Event|6|||
162964680|NCT01018862|588569855|FG000|Overall Study|Lack of Efficacy|1|||
162964681|NCT01018862|588569856|FG001|Overall Study|Lack of Efficacy|0|||
162964682|NCT01018862|588569857|FG002|Overall Study|Lack of Efficacy|2|||
162964683|NCT01018862|588569855|FG000|Overall Study|Lost to Follow-up|3|||
162964684|NCT01018862|588569856|FG001|Overall Study|Lost to Follow-up|1|||
162622776|NCT00467857|587334030|FG001|Overall Study|Withdrew consent|0|||
162622777|NCT00467857|587334029|FG000|Overall Study|Death|0|||
162622778|NCT00467857|587334030|FG001|Overall Study|Death|1|||
162622779|NCT00467857|587334029|FG000|Overall Study|Discharged from court service|0|||
162622780|NCT00467857|587334030|FG001|Overall Study|Discharged from court service|1|||
162622781|NCT00467857|587334029|FG000|Overall Study|Emergency care required|0|||
162964685|NCT01018862|588569857|FG002|Overall Study|Lost to Follow-up|0|||
162964686|NCT01018862|588569855|FG000|Overall Study|Protocol Violation|1|||
162964687|NCT01018862|588569856|FG001|Overall Study|Protocol Violation|3|||
162964688|NCT01018862|588569857|FG002|Overall Study|Protocol Violation|3|||
162964689|NCT01018862|588569855|FG000|Overall Study|Withdrawal by Subject|1|||
162964690|NCT01018862|588569856|FG001|Overall Study|Withdrawal by Subject|2|||
162964691|NCT01018862|588569857|FG002|Overall Study|Withdrawal by Subject|1|||
162964692|NCT01018862|588569855|FG000|Overall Study|administrative problems|5|||
162964693|NCT01018862|588569856|FG001|Overall Study|administrative problems|4|||
162964694|NCT01018862|588569857|FG002|Overall Study|administrative problems|4|||
162964695|NCT01968031|588569861|FG000|Overall Study|Adverse Event|13|||
162964696|NCT01968031|588569862|FG001|Overall Study|Adverse Event|10|||
162964697|NCT01968031|588569863|FG002|Overall Study|Adverse Event|22|||
162964698|NCT01968031|588569861|FG000|Overall Study|Withdrawal by Subject|3|||
162964699|NCT01968031|588569862|FG001|Overall Study|Withdrawal by Subject|7|||
162964700|NCT01968031|588569863|FG002|Overall Study|Withdrawal by Subject|3|||
162964701|NCT01968031|588569861|FG000|Overall Study|Did not meet entry criteria|1|||
162964702|NCT01968031|588569862|FG001|Overall Study|Did not meet entry criteria|1|||
162964703|NCT01968031|588569863|FG002|Overall Study|Did not meet entry criteria|1|||
162964704|NCT01968031|588569861|FG000|Overall Study|Noncompliance|0|||
162622782|NCT00467857|587334030|FG001|Overall Study|Emergency care required|1|||
162622783|NCT00467857|587334029|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
162622784|NCT00467857|587334030|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
162622785|NCT00467857|587334029|FG000|Overall Study|Discontinuation reason missing|0|||
162964705|NCT01968031|588569862|FG001|Overall Study|Noncompliance|0|||
162964706|NCT01968031|588569863|FG002|Overall Study|Noncompliance|2|||
162622786|NCT00467857|587334030|FG001|Overall Study|Discontinuation reason missing|3|||
162622787|NCT03576495|587334032|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
162622788|NCT03576495|587334033|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
162964707|NCT01968031|588569861|FG000|Overall Study|Failed inclusion criteria|0|||
162964708|NCT01968031|588569862|FG001|Overall Study|Failed inclusion criteria|2|||
162964709|NCT01968031|588569863|FG002|Overall Study|Failed inclusion criteria|0|||
162964710|NCT01968031|588569861|FG000|Overall Study|Death|0|||
162964711|NCT01968031|588569862|FG001|Overall Study|Death|0|||
162964712|NCT01968031|588569863|FG002|Overall Study|Death|1|||
162708687|NCT00797225|587642869|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
162708688|NCT00797225|587642870|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
162708689|NCT00797225|587642871|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
162708690|NCT00797225|587642872|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
162708691|NCT00797225|587642873|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
162708692|NCT00797225|587642874|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
162708693|NCT00797225|587642875|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
162708694|NCT00797225|587642876|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
162708695|NCT00797225|587642869|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
162708696|NCT00797225|587642870|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
162708697|NCT00797225|587642871|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
162708698|NCT00797225|587642872|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
162708699|NCT00797225|587642873|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
162708700|NCT00797225|587642874|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
162708701|NCT00797225|587642875|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
162708702|NCT00797225|587642876|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
162708703|NCT00797225|587642869|FG000|Weeks 13 to 24|Adverse Event|0|||
162708704|NCT00797225|587642870|FG001|Weeks 13 to 24|Adverse Event|1|||
162708705|NCT00797225|587642871|FG002|Weeks 13 to 24|Adverse Event|0|||
162708706|NCT00797225|587642872|FG003|Weeks 13 to 24|Adverse Event|0|||
162708707|NCT00797225|587642873|FG004|Weeks 13 to 24|Adverse Event|0|||
162708708|NCT00797225|587642874|FG005|Weeks 13 to 24|Adverse Event|0|||
162708709|NCT00797225|587642875|FG006|Weeks 13 to 24|Adverse Event|1|||
162708710|NCT00797225|587642876|FG007|Weeks 13 to 24|Adverse Event|0|||
162708711|NCT00797225|587642869|FG000|Weeks 13 to 24|Sponsor Decision|0|||
162892081|NCT03371251|588303638|FG003|Overall Study|Decision by Sponsor|0|||
162892082|NCT03371251|588303639|FG004|Overall Study|Decision by Sponsor|2|||
162892083|NCT03371251|588303640|FG005|Overall Study|Decision by Sponsor|0|||
162892084|NCT00294684|588303641|FG000|Overall Study|Lost to Follow-up|5|||
162892085|NCT00294684|588303642|FG001|Overall Study|Lost to Follow-up|8|||
162892086|NCT02260388|588303647|FG000|Overall Study|Lost to Follow-up|2|||
162892087|NCT02260388|588303648|FG001|Overall Study|Lost to Follow-up|8|||
162708712|NCT00797225|587642870|FG001|Weeks 13 to 24|Sponsor Decision|0|||
162708713|NCT00797225|587642871|FG002|Weeks 13 to 24|Sponsor Decision|0|||
162708714|NCT00797225|587642872|FG003|Weeks 13 to 24|Sponsor Decision|0|||
162708715|NCT00797225|587642873|FG004|Weeks 13 to 24|Sponsor Decision|0|||
162708716|NCT00797225|587642874|FG005|Weeks 13 to 24|Sponsor Decision|0|||
162708717|NCT00797225|587642875|FG006|Weeks 13 to 24|Sponsor Decision|1|||
162708718|NCT00797225|587642876|FG007|Weeks 13 to 24|Sponsor Decision|0|||
162708719|NCT04833855|587642880|FG000|Overall Study|Decision by sponsor|0|||
162708720|NCT04833855|587642881|FG001|Overall Study|Decision by sponsor|1|||
162708721|NCT04833855|587642882|FG002|Overall Study|Decision by sponsor|0|||
162708722|NCT04833855|587642883|FG003|Overall Study|Decision by sponsor|0|||
162708723|NCT04833855|587642880|FG000|Overall Study|Withdrawal by Subject|4|||
162892088|NCT02260388|588303649|FG002|Overall Study|Lost to Follow-up|3|||
162892089|NCT02260388|588303650|FG003|Overall Study|Lost to Follow-up|4|||
162892090|NCT01248364|588303651|FG000|Overall Study|Adverse Event|0|||
162892091|NCT01248364|588303652|FG001|Overall Study|Adverse Event|1|||
162892092|NCT01248364|588303653|FG002|Overall Study|Adverse Event|0|||
162892093|NCT01248364|588303654|FG003|Overall Study|Adverse Event|0|||
162892094|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
162892095|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
162892096|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
162892097|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
162892098|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
162892099|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
162892100|NCT00996593|588303656|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
162892101|NCT00996593|588303656|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
162892102|NCT00996593|588303656|FG000|Long-Term Follow-Up|Site Closed|1|||
162892103|NCT01033487|588303657|FG000|Fourth Intervention Period|Adverse Event|0|||
162892104|NCT01033487|588303658|FG001|Fourth Intervention Period|Adverse Event|0|||
162892105|NCT01033487|588303659|FG002|Fourth Intervention Period|Adverse Event|0|||
162892106|NCT01033487|588303660|FG003|Fourth Intervention Period|Adverse Event|0|||
162892107|NCT01033487|588303661|FG004|Fourth Intervention Period|Adverse Event|0|||
162892108|NCT01033487|588303662|FG005|Fourth Intervention Period|Adverse Event|0|||
162892109|NCT01033487|588303663|FG006|Fourth Intervention Period|Adverse Event|0|||
162964713|NCT01968031|588569861|FG000|Overall Study|Prohibited concomitant medication|1|||
162892110|NCT01033487|588303664|FG007|Fourth Intervention Period|Adverse Event|0|||
162892111|NCT01033487|588303665|FG008|Fourth Intervention Period|Adverse Event|1|||
162892112|NCT01033487|588303666|FG009|Fourth Intervention Period|Adverse Event|0|||
162892113|NCT02849626|588303667|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
162892114|NCT02849626|588303668|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
162892115|NCT02849626|588303669|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
162892116|NCT02849626|588303670|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
162892117|NCT02849626|588303667|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
162892118|NCT02849626|588303668|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
162892119|NCT02849626|588303669|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
162892120|NCT02849626|588303670|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
162892121|NCT02849626|588303667|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
162892122|NCT02849626|588303668|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
163051518|NCT00433836|588897167|FG001|Overall Study|Condition no longer requires study drug|1|||
163051519|NCT00433836|588897166|FG000|Overall Study|Abnormal laboratory values|0|||
163051520|NCT00433836|588897167|FG001|Overall Study|Abnormal laboratory values|1|||
163051521|NCT00748241|588897168|FG000|Overall Study|Implant failure|1|||
163051522|NCT00748241|588897168|FG000|Overall Study|Lost to Follow-up|5|||
162622789|NCT05306977|587334035|FG000|Overall Study|Withdrawal by Subject|1|||
162622790|NCT02628938|587334039|FG000|Overall Study|Did not attend the follow up recall|2|||
162622791|NCT02628938|587334040|FG001|Overall Study|Did not attend the follow up recall|2|||
162622792|NCT02628938|587334041|FG002|Overall Study|Did not attend the follow up recall|1|||
162622793|NCT02628938|587334039|FG000|Overall Study|Failure to comply with the instructions|3|||
162622794|NCT02628938|587334040|FG001|Overall Study|Failure to comply with the instructions|0|||
162622795|NCT02628938|587334041|FG002|Overall Study|Failure to comply with the instructions|3|||
162622796|NCT02058693|587334042|FG000|Phase 1|Withdrawal by Subject|3|||
162622797|NCT02058693|587334043|FG001|Phase 1|Withdrawal by Subject|2|||
162622798|NCT02058693|587334042|FG000|Phase 1|Adverse Event|0|||
162622799|NCT02058693|587334043|FG001|Phase 1|Adverse Event|1|||
162622800|NCT02058693|587334042|FG000|Phase 1|Lack of Efficacy|1|||
162622801|NCT02058693|587334043|FG001|Phase 1|Lack of Efficacy|0|||
162622802|NCT02058693|587334042|FG000|Phase 1|Physician Decision|1|||
162622803|NCT02058693|587334043|FG001|Phase 1|Physician Decision|1|||
162622804|NCT02058693|587334042|FG000|Phase 2|Withdrawal by Subject|0|||
162622805|NCT02058693|587334043|FG001|Phase 2|Withdrawal by Subject|2|||
162622806|NCT00241358|587334044|FG000|Overall Study|Determined to be not ineligible|0|||
162622807|NCT00241358|587334045|FG001|Overall Study|Determined to be not ineligible|1|||
162622808|NCT00241358|587334046|FG002|Overall Study|Determined to be not ineligible|1|||
162622809|NCT03855228|587334047|FG000|Overall Study|Adverse Event|2|||
162622810|NCT03855228|587334048|FG001|Overall Study|Adverse Event|4|||
162622811|NCT03855228|587334049|FG002|Overall Study|Adverse Event|4|||
162622812|NCT03855228|587334050|FG003|Overall Study|Adverse Event|8|||
162622813|NCT03855228|587334047|FG000|Overall Study|Treatment Failure|1|||
162622814|NCT03855228|587334048|FG001|Overall Study|Treatment Failure|2|||
162622815|NCT03855228|587334049|FG002|Overall Study|Treatment Failure|1|||
162622816|NCT03855228|587334050|FG003|Overall Study|Treatment Failure|8|||
162622817|NCT03855228|587334047|FG000|Overall Study|Lost to Follow-up|0|||
162622818|NCT03855228|587334048|FG001|Overall Study|Lost to Follow-up|0|||
162622819|NCT03855228|587334049|FG002|Overall Study|Lost to Follow-up|0|||
162622820|NCT03855228|587334050|FG003|Overall Study|Lost to Follow-up|1|||
162622821|NCT03855228|587334047|FG000|Overall Study|Protocol Violation|0|||
162622822|NCT03855228|587334048|FG001|Overall Study|Protocol Violation|1|||
162622823|NCT03855228|587334049|FG002|Overall Study|Protocol Violation|2|||
162622824|NCT03855228|587334050|FG003|Overall Study|Protocol Violation|1|||
162622825|NCT03855228|587334047|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
163051523|NCT00748241|588897168|FG000|Overall Study|Death|2|||
163051524|NCT01240382|588897169|FG000|Overall Study|Adverse Event|2|||
163051525|NCT01240382|588897170|FG001|Overall Study|Adverse Event|1|||
163051526|NCT01240382|588897169|FG000|Overall Study|Lack of Efficacy|0|||
163051527|NCT01240382|588897170|FG001|Overall Study|Lack of Efficacy|2|||
163051528|NCT01240382|588897169|FG000|Overall Study|Fear of adverse events|0|||
163051529|NCT01240382|588897170|FG001|Overall Study|Fear of adverse events|1|||
163051530|NCT02643693|588897171|FG000|Overall Study|Physician Decision|0|||
163051531|NCT02643693|588897172|FG001|Overall Study|Physician Decision|1|||
162622826|NCT03855228|587334048|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
162622827|NCT03855228|587334049|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
163051532|NCT02643693|588897173|FG002|Overall Study|Physician Decision|0|||
163051533|NCT02643693|588897174|FG003|Overall Study|Physician Decision|0|||
162622828|NCT03855228|587334050|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
162622829|NCT00590135|587334051|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
162622830|NCT00300274|587334052|FG000|Overall Study|Withdrawal by Subject|12|||
162622831|NCT00300274|587334053|FG001|Overall Study|Withdrawal by Subject|3|||
162622832|NCT00300274|587334054|FG002|Overall Study|Withdrawal by Subject|14|||
162622833|NCT00300274|587334052|FG000|Overall Study|Lost to Follow-up|3|||
162622834|NCT00300274|587334053|FG001|Overall Study|Lost to Follow-up|4|||
162622835|NCT00300274|587334054|FG002|Overall Study|Lost to Follow-up|5|||
162622836|NCT00300274|587334052|FG000|Overall Study|Death|31|||
162622837|NCT00300274|587334053|FG001|Overall Study|Death|20|||
163051534|NCT02643693|588897175|FG004|Overall Study|Physician Decision|0|||
163051535|NCT02643693|588897176|FG005|Overall Study|Physician Decision|0|||
163051536|NCT02643693|588897171|FG000|Overall Study|Withdrawal by Subject|0|||
163051537|NCT02643693|588897172|FG001|Overall Study|Withdrawal by Subject|1|||
163051538|NCT02643693|588897173|FG002|Overall Study|Withdrawal by Subject|0|||
163051539|NCT02643693|588897174|FG003|Overall Study|Withdrawal by Subject|0|||
163051540|NCT02643693|588897175|FG004|Overall Study|Withdrawal by Subject|0|||
163051541|NCT02643693|588897176|FG005|Overall Study|Withdrawal by Subject|0|||
163051542|NCT02643693|588897171|FG000|Overall Study|Protocol Adherence Issues|2|||
163051543|NCT02643693|588897172|FG001|Overall Study|Protocol Adherence Issues|0|||
163051544|NCT02643693|588897173|FG002|Overall Study|Protocol Adherence Issues|1|||
163051545|NCT02643693|588897174|FG003|Overall Study|Protocol Adherence Issues|0|||
163051546|NCT02643693|588897175|FG004|Overall Study|Protocol Adherence Issues|0|||
163051547|NCT02643693|588897176|FG005|Overall Study|Protocol Adherence Issues|1|||
163051548|NCT01222104|588897177|FG000|Overall Study|Lost to Follow-up|37|||
163051549|NCT01222104|588897177|FG000|Overall Study|Death|10|||
163051550|NCT00888654|588897178|FG000|Overall Study|Problems swallowing oral meds.|1|||
163051551|NCT00888654|588897178|FG000|Overall Study|Not enough oral meds before surgery|3|||
163051552|NCT00888654|588897178|FG000|Overall Study|Surgery aborted|2|||
163051553|NCT00888654|588897178|FG000|Overall Study|Withdrawal by Subject|1|||
163051554|NCT00888654|588897178|FG000|Overall Study|Inelig. due to contraindication of med|1|||
163051555|NCT00888654|588897178|FG000|Overall Study|Change in surg date|1|||
163051556|NCT00888654|588897178|FG000|Overall Study|Stopped meds due to headaches|1|||
163051557|NCT03669549|588897183|FG000|Overall Study|Adverse Event|4|||
163051558|NCT03669549|588897183|FG000|Overall Study|Withdrawal by Subject|1|||
163051559|NCT03669549|588897183|FG000|Overall Study|Study terminated by the Sponsor|1|||
163051560|NCT00698815|588897185|FG000|Overall Study|Death|1|||
163051561|NCT00698815|588897186|FG001|Overall Study|Death|2|||
163051562|NCT00698815|588897187|FG002|Overall Study|Death|4|||
163051563|NCT00698815|588897185|FG000|Overall Study|Withdrawal by Subject|6|||
163051564|NCT00698815|588897186|FG001|Overall Study|Withdrawal by Subject|3|||
163051565|NCT00698815|588897187|FG002|Overall Study|Withdrawal by Subject|2|||
163051566|NCT00698815|588897185|FG000|Overall Study|MD discretion|2|||
163051567|NCT00698815|588897186|FG001|Overall Study|MD discretion|7|||
163051568|NCT00698815|588897187|FG002|Overall Study|MD discretion|2|||
163051569|NCT00698815|588897185|FG000|Overall Study|Did not receive protocol treatment|1|||
163051570|NCT00698815|588897186|FG001|Overall Study|Did not receive protocol treatment|2|||
163051571|NCT00698815|588897187|FG002|Overall Study|Did not receive protocol treatment|2|||
163051572|NCT00706004|588897188|FG000|Overall Study|Did not meet eligibility criteria|2|||
163051573|NCT02674516|588897189|FG000|Overall Study|Lost to Follow-up|3|||
163051574|NCT02674516|588897190|FG001|Overall Study|Lost to Follow-up|0|||
163051575|NCT02674516|588897189|FG000|Overall Study|Protocol Violation|0|||
163051576|NCT02674516|588897190|FG001|Overall Study|Protocol Violation|4|||
163051577|NCT02674516|588897189|FG000|Overall Study|Knowledge of study hypothesis|1|||
163051578|NCT02674516|588897190|FG001|Overall Study|Knowledge of study hypothesis|0|||
163051579|NCT01064479|588897191|FG000|Overall Study|Death|10|||
163051580|NCT01064479|588897192|FG001|Overall Study|Death|11|||
163051581|NCT01064479|588897191|FG000|Overall Study|Withdrawal by Subject|2|||
163051582|NCT01064479|588897192|FG001|Overall Study|Withdrawal by Subject|2|||
163051583|NCT01064479|588897191|FG000|Overall Study|Disease progression|1|||
163051584|NCT01064479|588897192|FG001|Overall Study|Disease progression|1|||
163051585|NCT01064479|588897191|FG000|Overall Study|Toxicity|1|||
163051586|NCT01064479|588897192|FG001|Overall Study|Toxicity|1|||
163051587|NCT01064479|588897191|FG000|Overall Study|Other|1|||
162622838|NCT00300274|587334054|FG002|Overall Study|Death|25|||
162622839|NCT00300274|587334052|FG000|Overall Study|Re-transplant|0|||
162622840|NCT00300274|587334053|FG001|Overall Study|Re-transplant|0|||
162622841|NCT00300274|587334054|FG002|Overall Study|Re-transplant|1|||
162622842|NCT02400333|587335342|FG000|Overall Study|Withdrawal by Subject|0|||
163051588|NCT01064479|588897192|FG001|Overall Study|Other|2|||
163051589|NCT00705757|588897199|FG000|Overall Study|Lack of Efficacy|5|||
162622843|NCT02400333|587335343|FG001|Overall Study|Withdrawal by Subject|1|||
162622844|NCT02400333|587335344|FG002|Overall Study|Withdrawal by Subject|0|||
162892123|NCT02849626|588303669|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
162892124|NCT02849626|588303670|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
163051590|NCT00705757|588897200|FG001|Overall Study|Lack of Efficacy|1|||
163051591|NCT00705757|588897201|FG002|Overall Study|Lack of Efficacy|3|||
163051592|NCT00705757|588897199|FG000|Overall Study|Lost to Follow-up|7|||
163051593|NCT00705757|588897200|FG001|Overall Study|Lost to Follow-up|6|||
163051594|NCT00705757|588897201|FG002|Overall Study|Lost to Follow-up|6|||
163051595|NCT00705757|588897199|FG000|Overall Study|Withdrawal by Subject|1|||
163051596|NCT00705757|588897200|FG001|Overall Study|Withdrawal by Subject|1|||
163051597|NCT00705757|588897201|FG002|Overall Study|Withdrawal by Subject|2|||
163051598|NCT05696392|588897206|FG000|Overall Study|Lost to Follow-up|3|||
163051599|NCT05696392|588897206|FG000|Overall Study|Protocol Violation|1|||
163051600|NCT05696392|588897206|FG000|Overall Study|Withdrawal by Subject|1|||
163051601|NCT03389620|588897216|FG000|Overall Study|Lost to Follow-up|5|||
162622845|NCT02400333|587335345|FG003|Overall Study|Withdrawal by Subject|1|||
163051602|NCT03389620|588897217|FG001|Overall Study|Lost to Follow-up|1|||
163051603|NCT04782180|588897224|FG000|Overall Study|Withdrawal by Subject|2|||
163051604|NCT04782180|588897224|FG000|Overall Study|Lost to Follow-up|2|||
163051605|NCT05852353|588897225|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
163051606|NCT05852353|588897225|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
163051607|NCT05852353|588897225|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
163051608|NCT05852353|588897225|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
163051609|NCT01005745|588897226|FG000|Overall Study|No TIL growth|1|||
163051610|NCT01005745|588897226|FG000|Overall Study|Disease progressed during TIL growth|3|||
163051611|NCT01005745|588897226|FG000|Overall Study|Death prior to treatment|1|||
163051612|NCT01005745|588897226|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
163051613|NCT06077773|588897227|FG000|Overall Study|Withdrawal by Subject|1|||
163051614|NCT06077773|588897228|FG001|Overall Study|Withdrawal by Subject|0|||
163051615|NCT06077773|588897229|FG002|Overall Study|Withdrawal by Subject|1|||
163051616|NCT06077773|588897227|FG000|Overall Study|Lost to Follow-up|0|||
163051617|NCT06077773|588897228|FG001|Overall Study|Lost to Follow-up|1|||
163051618|NCT06077773|588897229|FG002|Overall Study|Lost to Follow-up|0|||
163051619|NCT06077773|588897227|FG000|Overall Study|Adverse Event|0|||
163051620|NCT06077773|588897228|FG001|Overall Study|Adverse Event|0|||
163051621|NCT06077773|588897229|FG002|Overall Study|Adverse Event|2|||
163051622|NCT03834506|588897230|FG000|Overall Study|Death|336|||
163051623|NCT03834506|588897231|FG001|Overall Study|Death|326|||
163051624|NCT03834506|588897230|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163051625|NCT03834506|588897231|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163051626|NCT03834506|588897230|FG000|Overall Study|Withdrawal by Subject|10|||
163051627|NCT03834506|588897231|FG001|Overall Study|Withdrawal by Subject|8|||
163051628|NCT03834506|588897230|FG000|Overall Study|Sponsor decision|165|||
163051629|NCT03834506|588897231|FG001|Overall Study|Sponsor decision|178|||
163051630|NCT03834506|588897230|FG000|Overall Study|Physician Decision|3|||
163051631|NCT03834506|588897231|FG001|Overall Study|Physician Decision|1|||
163051632|NCT03834506|588897230|FG000|Overall Study|Lost to Follow-up|0|||
163051633|NCT03834506|588897231|FG001|Overall Study|Lost to Follow-up|1|||
163051634|NCT04577794|588897232|FG000|Overall Study|Adverse Event|1|||
163051635|NCT04577794|588897233|FG001|Overall Study|Adverse Event|1|||
163051636|NCT00689338|588897234|FG000|Overall Study|Death|65|||
163051637|NCT00689338|588897234|FG000|Overall Study|Adverse Event|13|||
163051638|NCT00689338|588897234|FG000|Overall Study|Insufficient Clinical Response|1|||
163051639|NCT00689338|588897234|FG000|Overall Study|Lack of Efficacy|6|||
163051640|NCT00689338|588897234|FG000|Overall Study|Other|8|||
163051641|NCT00689338|588897234|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
163051642|NCT00689338|588897234|FG000|Overall Study|Lost to Follow-up|5|||
163051643|NCT00689338|588897234|FG000|Overall Study|Withdrawal by Subject|3|||
163051644|NCT00689338|588897234|FG000|Overall Study|Protocol Violation|15|||
163051645|NCT02104895|588897237|FG000|Overall Study|Withdrawal by Subject|0|||
163051646|NCT02104895|588897238|FG001|Overall Study|Withdrawal by Subject|14|||
163051647|NCT00969228|588897239|FG000|Overall Study|Adverse Event|1|||
163051648|NCT00969228|588897240|FG001|Overall Study|Adverse Event|0|||
163051649|NCT00969228|588897239|FG000|Overall Study|Withdrawal by Subject|4|||
163051650|NCT00969228|588897240|FG001|Overall Study|Withdrawal by Subject|0|||
163051651|NCT00969228|588897239|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
163051652|NCT00969228|588897240|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
163051653|NCT01883895|588897244|FG000|Overall Study|Lost to Follow-up|2|||
163051654|NCT02895295|588897245|FG000|Overall Study|Survey Non-response|71|||
163051655|NCT02895295|588897246|FG001|Overall Study|Survey Non-response|94|||
163051656|NCT02895295|588897247|FG002|Overall Study|Survey Non-response|92|||
163051657|NCT02532283|588897248|FG000|Overall Study|Adverse Event|0|||
163051658|NCT02532283|588897249|FG001|Overall Study|Adverse Event|1|||
163051659|NCT02532283|588897248|FG000|Overall Study|Death|1|||
163051660|NCT02532283|588897249|FG001|Overall Study|Death|0|||
163051661|NCT02532283|588897248|FG000|Overall Study|Lost to Follow-up|0|||
163051662|NCT02532283|588897249|FG001|Overall Study|Lost to Follow-up|1|||
163051663|NCT02532283|588897248|FG000|Overall Study|Withdrawal by Subject|8|||
163051664|NCT02532283|588897249|FG001|Overall Study|Withdrawal by Subject|3|||
163051665|NCT03811821|588897250|FG000|Overall Study|Adverse Event|1|||
163051666|NCT03811821|588897251|FG001|Overall Study|Adverse Event|1|||
163051667|NCT03811821|588897250|FG000|Overall Study|Withdrawal by Subject|5|||
163051668|NCT03811821|588897251|FG001|Overall Study|Withdrawal by Subject|4|||
163051669|NCT03811821|588897250|FG000|Overall Study|Lost to Follow-up|2|||
163051670|NCT03811821|588897251|FG001|Overall Study|Lost to Follow-up|2|||
163051671|NCT03811821|588897250|FG000|Overall Study|Contraindication for treatment|0|||
163051672|NCT03811821|588897251|FG001|Overall Study|Contraindication for treatment|1|||
162622846|NCT02400333|587335342|FG000|Overall Study|Protocol Violation|1|||
163051673|NCT03811821|588897250|FG000|Overall Study|Tolerability|0|||
163051674|NCT03811821|588897251|FG001|Overall Study|Tolerability|3|||
163051675|NCT03811821|588897250|FG000|Overall Study|Comorbidities|0|||
163051676|NCT03811821|588897251|FG001|Overall Study|Comorbidities|2|||
162622847|NCT02400333|587335343|FG001|Overall Study|Protocol Violation|0|||
162622848|NCT02400333|587335344|FG002|Overall Study|Protocol Violation|2|||
162622849|NCT02400333|587335345|FG003|Overall Study|Protocol Violation|1|||
162622850|NCT02468674|587335346|FG000|Overall Study|Adverse Event|0|||
162622851|NCT02468674|587335347|FG001|Overall Study|Adverse Event|0|||
162622852|NCT02468674|587335348|FG002|Overall Study|Adverse Event|0|||
162622853|NCT02468674|587335349|FG003|Overall Study|Adverse Event|1|||
163051677|NCT03433898|588897252|FG000|Overall Study|Progressive disease|6|||
163051678|NCT03433898|588897253|FG001|Overall Study|Progressive disease|3|||
163051679|NCT03433898|588897254|FG002|Overall Study|Progressive disease|3|||
163051680|NCT03433898|588897255|FG003|Overall Study|Progressive disease|2|||
163051681|NCT03433898|588897256|FG004|Overall Study|Progressive disease|30|||
163051682|NCT03433898|588897257|FG005|Overall Study|Progressive disease|29|||
163051683|NCT03433898|588897258|FG006|Overall Study|Progressive disease|17|||
163051684|NCT03433898|588897259|FG007|Overall Study|Progressive disease|30|||
163051685|NCT03433898|588897252|FG000|Overall Study|Not treated|1|||
163051686|NCT03433898|588897253|FG001|Overall Study|Not treated|0|||
163051687|NCT03433898|588897254|FG002|Overall Study|Not treated|0|||
163051688|NCT03433898|588897255|FG003|Overall Study|Not treated|0|||
163051689|NCT03433898|588897256|FG004|Overall Study|Not treated|1|||
163051690|NCT03433898|588897257|FG005|Overall Study|Not treated|0|||
163051691|NCT03433898|588897258|FG006|Overall Study|Not treated|0|||
163051692|NCT03433898|588897259|FG007|Overall Study|Not treated|0|||
163051693|NCT03433898|588897252|FG000|Overall Study|Death|0|||
163051694|NCT03433898|588897253|FG001|Overall Study|Death|0|||
163051695|NCT03433898|588897254|FG002|Overall Study|Death|0|||
163051696|NCT03433898|588897255|FG003|Overall Study|Death|0|||
163051697|NCT03433898|588897256|FG004|Overall Study|Death|0|||
163051698|NCT03433898|588897257|FG005|Overall Study|Death|0|||
163051699|NCT03433898|588897258|FG006|Overall Study|Death|1|||
163051700|NCT03433898|588897259|FG007|Overall Study|Death|1|||
163051701|NCT03433898|588897252|FG000|Overall Study|Withdrawal by Subject|0|||
163051702|NCT03433898|588897253|FG001|Overall Study|Withdrawal by Subject|0|||
163051703|NCT03433898|588897254|FG002|Overall Study|Withdrawal by Subject|0|||
163051704|NCT03433898|588897255|FG003|Overall Study|Withdrawal by Subject|0|||
163051705|NCT03433898|588897256|FG004|Overall Study|Withdrawal by Subject|2|||
163051706|NCT03433898|588897257|FG005|Overall Study|Withdrawal by Subject|0|||
163051707|NCT03433898|588897258|FG006|Overall Study|Withdrawal by Subject|0|||
163051708|NCT03433898|588897259|FG007|Overall Study|Withdrawal by Subject|0|||
163051709|NCT03433898|588897252|FG000|Overall Study|Adverse Event|0|||
163051710|NCT03433898|588897253|FG001|Overall Study|Adverse Event|0|||
163051711|NCT03433898|588897254|FG002|Overall Study|Adverse Event|0|||
163051712|NCT03433898|588897255|FG003|Overall Study|Adverse Event|0|||
163051713|NCT03433898|588897256|FG004|Overall Study|Adverse Event|0|||
163051714|NCT03433898|588897257|FG005|Overall Study|Adverse Event|5|||
162892125|NCT02849626|588303667|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
162892126|NCT02849626|588303668|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
162892127|NCT02849626|588303669|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
163051715|NCT03433898|588897258|FG006|Overall Study|Adverse Event|2|||
163051716|NCT03433898|588897259|FG007|Overall Study|Adverse Event|2|||
163051717|NCT03433898|588897252|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051718|NCT03433898|588897253|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051719|NCT03433898|588897254|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051720|NCT03433898|588897255|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051721|NCT03433898|588897256|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
163051722|NCT03433898|588897257|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051723|NCT03433898|588897258|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
162892128|NCT02849626|588303670|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
162892129|NCT02849626|588303667|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
162892130|NCT02849626|588303668|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
162892131|NCT02849626|588303669|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
162892132|NCT02849626|588303670|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
162892133|NCT02849626|588303667|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
162892134|NCT02849626|588303668|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
162892135|NCT02849626|588303669|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
162892136|NCT02849626|588303670|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
163051724|NCT03433898|588897259|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
163051725|NCT05069259|588897263|FG000|Overall Study|Withdrawal by Subject|1|||
163051726|NCT05069259|588897263|FG000|Overall Study|Sponsor decision|1|||
163051727|NCT01496976|588898691|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
163051728|NCT00922636|588898692|FG000|Overall Study|Adverse Event|3|||
163051729|NCT00922636|588898693|FG001|Overall Study|Adverse Event|3|||
163051730|NCT00922636|588898694|FG002|Overall Study|Adverse Event|2|||
163051731|NCT00922636|588898695|FG003|Overall Study|Adverse Event|3|||
162622854|NCT02468674|587335350|FG004|Overall Study|Adverse Event|0|||
162622855|NCT02468674|587335351|FG005|Overall Study|Adverse Event|1|||
162622856|NCT02468674|587335352|FG006|Overall Study|Adverse Event|0|||
163051732|NCT00922636|588898696|FG004|Overall Study|Adverse Event|2|||
163051733|NCT00922636|588898692|FG000|Overall Study|Lack of Efficacy|1|||
163051734|NCT00922636|588898693|FG001|Overall Study|Lack of Efficacy|7|||
163051735|NCT00922636|588898694|FG002|Overall Study|Lack of Efficacy|3|||
163051736|NCT00922636|588898695|FG003|Overall Study|Lack of Efficacy|2|||
163051737|NCT00922636|588898696|FG004|Overall Study|Lack of Efficacy|4|||
163051738|NCT00922636|588898692|FG000|Overall Study|Sponsor Decision|0|||
163051739|NCT00922636|588898693|FG001|Overall Study|Sponsor Decision|0|||
163051740|NCT00922636|588898694|FG002|Overall Study|Sponsor Decision|2|||
163051741|NCT00922636|588898695|FG003|Overall Study|Sponsor Decision|0|||
163051742|NCT00922636|588898696|FG004|Overall Study|Sponsor Decision|0|||
163051743|NCT00922636|588898692|FG000|Overall Study|Withdrawal by Subject|0|||
163051744|NCT00922636|588898693|FG001|Overall Study|Withdrawal by Subject|0|||
163051745|NCT00922636|588898694|FG002|Overall Study|Withdrawal by Subject|5|||
163051746|NCT00922636|588898695|FG003|Overall Study|Withdrawal by Subject|2|||
163051747|NCT00922636|588898696|FG004|Overall Study|Withdrawal by Subject|4|||
163051748|NCT00922636|588898692|FG000|Overall Study|Protocol Violation|0|||
163051749|NCT00922636|588898693|FG001|Overall Study|Protocol Violation|0|||
163051750|NCT00922636|588898694|FG002|Overall Study|Protocol Violation|2|||
163051751|NCT00922636|588898695|FG003|Overall Study|Protocol Violation|2|||
163051752|NCT00922636|588898696|FG004|Overall Study|Protocol Violation|0|||
163051753|NCT00922636|588898692|FG000|Overall Study|Entry Criteria Not Met|0|||
163051754|NCT00922636|588898693|FG001|Overall Study|Entry Criteria Not Met|0|||
163051755|NCT00922636|588898694|FG002|Overall Study|Entry Criteria Not Met|1|||
163051756|NCT00922636|588898695|FG003|Overall Study|Entry Criteria Not Met|1|||
163051757|NCT00922636|588898696|FG004|Overall Study|Entry Criteria Not Met|0|||
163051758|NCT00922636|588898692|FG000|Overall Study|Parent/Caregiver Decision|2|||
163051759|NCT00922636|588898693|FG001|Overall Study|Parent/Caregiver Decision|4|||
163051760|NCT00922636|588898694|FG002|Overall Study|Parent/Caregiver Decision|3|||
163051761|NCT00922636|588898695|FG003|Overall Study|Parent/Caregiver Decision|5|||
163051762|NCT00922636|588898696|FG004|Overall Study|Parent/Caregiver Decision|2|||
163051763|NCT00922636|588898692|FG000|Overall Study|Lost to Follow-up|1|||
163051764|NCT00922636|588898693|FG001|Overall Study|Lost to Follow-up|2|||
163051765|NCT00922636|588898694|FG002|Overall Study|Lost to Follow-up|2|||
163051766|NCT00922636|588898695|FG003|Overall Study|Lost to Follow-up|2|||
163051767|NCT00922636|588898696|FG004|Overall Study|Lost to Follow-up|4|||
163051768|NCT00870727|588898697|FG000|Overall Study|Lost to Follow-up|0|||
163051769|NCT00870727|588898698|FG001|Overall Study|Lost to Follow-up|1|||
163051770|NCT00870727|588898697|FG000|Overall Study|Lack of Efficacy|1|||
163051771|NCT00870727|588898698|FG001|Overall Study|Lack of Efficacy|3|||
163051772|NCT00870727|588898697|FG000|Overall Study|Adverse Event|0|||
163051773|NCT00870727|588898698|FG001|Overall Study|Adverse Event|1|||
163051774|NCT01117870|588898706|FG000|Overall Study|Inability to place needle|1|||
163051775|NCT01117870|588898707|FG001|Overall Study|Inability to place needle|0|||
163051776|NCT01309386|588898708|FG000|Overall Study|Other|2|||
163051777|NCT01309386|588898709|FG001|Overall Study|Other|0|||
163051778|NCT01309386|588898708|FG000|Overall Study|Withdrawal by Subject|2|||
163051779|NCT01309386|588898709|FG001|Overall Study|Withdrawal by Subject|0|||
163051780|NCT01309386|588898708|FG000|Overall Study|Progressive disease|9|||
163051781|NCT01309386|588898709|FG001|Overall Study|Progressive disease|11|||
163051782|NCT01309386|588898708|FG000|Overall Study|Physician Decision|1|||
163051783|NCT01309386|588898709|FG001|Overall Study|Physician Decision|1|||
163051784|NCT01309386|588898708|FG000|Overall Study|Lack of Efficacy|3|||
163051785|NCT01309386|588898709|FG001|Overall Study|Lack of Efficacy|1|||
163051786|NCT01309386|588898708|FG000|Overall Study|Adverse Event|5|||
163051787|NCT01309386|588898709|FG001|Overall Study|Adverse Event|8|||
163051788|NCT01774981|588898714|FG000|Overall Study|Adverse Event|0|||
163051789|NCT01774981|588898715|FG001|Overall Study|Adverse Event|0|||
163051790|NCT01774981|588898716|FG002|Overall Study|Adverse Event|0|||
163051791|NCT01774981|588898717|FG003|Overall Study|Adverse Event|0|||
163051792|NCT01774981|588898718|FG004|Overall Study|Adverse Event|0|||
163051793|NCT01774981|588898719|FG005|Overall Study|Adverse Event|1|||
163051794|NCT01774981|588898720|FG006|Overall Study|Adverse Event|0|||
163051795|NCT01774981|588898721|FG007|Overall Study|Adverse Event|0|||
163051796|NCT01774981|588898714|FG000|Overall Study|Withdrawal by Subject|0|||
163051797|NCT01774981|588898715|FG001|Overall Study|Withdrawal by Subject|0|||
163051798|NCT01774981|588898716|FG002|Overall Study|Withdrawal by Subject|0|||
163051799|NCT01774981|588898717|FG003|Overall Study|Withdrawal by Subject|0|||
163051800|NCT01774981|588898718|FG004|Overall Study|Withdrawal by Subject|0|||
163051801|NCT01774981|588898719|FG005|Overall Study|Withdrawal by Subject|0|||
162622857|NCT02468674|587335353|FG007|Overall Study|Adverse Event|0|||
162622858|NCT02468674|587335354|FG008|Overall Study|Adverse Event|0|||
162892137|NCT02849626|588303667|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
163051802|NCT01774981|588898720|FG006|Overall Study|Withdrawal by Subject|0|||
163051803|NCT01774981|588898721|FG007|Overall Study|Withdrawal by Subject|1|||
163051804|NCT01774981|588898714|FG000|Overall Study|Death|0|||
163051805|NCT01774981|588898715|FG001|Overall Study|Death|0|||
163051806|NCT01774981|588898716|FG002|Overall Study|Death|0|||
163051807|NCT01774981|588898717|FG003|Overall Study|Death|0|||
163051808|NCT01774981|588898718|FG004|Overall Study|Death|1|||
162892138|NCT02849626|588303668|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
162892139|NCT02849626|588303669|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
162892140|NCT02849626|588303670|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
162892141|NCT02849626|588303667|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
163051809|NCT01774981|588898719|FG005|Overall Study|Death|0|||
163051810|NCT01774981|588898720|FG006|Overall Study|Death|0|||
163051811|NCT01774981|588898721|FG007|Overall Study|Death|0|||
163051812|NCT02915835|588898724|FG000|Overall Study|Physician Decision|1|||
163051813|NCT02915835|588898725|FG001|Overall Study|Physician Decision|0|||
163051814|NCT02915835|588898724|FG000|Overall Study|Withdrawal by Subject|0|||
163051815|NCT02915835|588898725|FG001|Overall Study|Withdrawal by Subject|1|||
163051816|NCT02456727|588898726|FG000|Overall Study|Lost to Follow-up|63|||
162892142|NCT02849626|588303668|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
162892143|NCT02849626|588303669|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
162892144|NCT02849626|588303670|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
162892145|NCT02849626|588303667|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
162892146|NCT02849626|588303668|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
162892147|NCT02849626|588303669|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
162892148|NCT02849626|588303670|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
162892149|NCT02849626|588303667|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
162892150|NCT02849626|588303668|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
162892151|NCT02849626|588303669|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
162892152|NCT02849626|588303670|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
162892153|NCT02849626|588303667|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
162892154|NCT02849626|588303668|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
162892155|NCT02849626|588303669|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
162892156|NCT02849626|588303670|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
162892157|NCT04176445|588303675|FG000|Overall Study|Adverse Event|0|||
162892158|NCT04176445|588303676|FG001|Overall Study|Adverse Event|1|||
162892159|NCT04176445|588303675|FG000|Overall Study|change plans weaning after first intervention|0|||
162892160|NCT04176445|588303676|FG001|Overall Study|change plans weaning after first intervention|1|||
162892161|NCT00187889|588303677|FG000|Overall Study|Withdrawal by Subject|6|||
162892162|NCT00187889|588303678|FG001|Overall Study|Withdrawal by Subject|4|||
162892163|NCT04046341|588303679|FG000|Overall Study|Lost to Follow-up|2|||
162892164|NCT04046341|588303679|FG000|Overall Study|Withdrawal by Subject|1|||
162892165|NCT04377672|588303680|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
162892166|NCT03954444|588303681|FG000|Overall Study|Withdrawal by Subject|5|||
162892167|NCT03954444|588303682|FG001|Overall Study|Withdrawal by Subject|5|||
162892168|NCT03954444|588303683|FG002|Overall Study|Withdrawal by Subject|5|||
162892169|NCT03954444|588303681|FG000|Overall Study|Adverse Event|1|||
162892170|NCT03954444|588303682|FG001|Overall Study|Adverse Event|3|||
162892171|NCT03954444|588303683|FG002|Overall Study|Adverse Event|2|||
162892172|NCT03954444|588303681|FG000|Overall Study|Protocol Violation|0|||
162892173|NCT03954444|588303682|FG001|Overall Study|Protocol Violation|3|||
162892174|NCT03954444|588303683|FG002|Overall Study|Protocol Violation|5|||
162892175|NCT03954444|588303681|FG000|Overall Study|Use of prohibited therapy|1|||
162892176|NCT03954444|588303682|FG001|Overall Study|Use of prohibited therapy|1|||
162892177|NCT03954444|588303683|FG002|Overall Study|Use of prohibited therapy|2|||
162892178|NCT03954444|588303681|FG000|Overall Study|Lost to Follow-up|1|||
162892179|NCT03954444|588303682|FG001|Overall Study|Lost to Follow-up|0|||
162892180|NCT03954444|588303683|FG002|Overall Study|Lost to Follow-up|1|||
162892181|NCT03954444|588303681|FG000|Overall Study|Non-compliant with study drug application|2|||
162892182|NCT03954444|588303682|FG001|Overall Study|Non-compliant with study drug application|2|||
162892183|NCT03954444|588303683|FG002|Overall Study|Non-compliant with study drug application|0|||
162892184|NCT03954444|588303681|FG000|Overall Study|Administrative reasons|0|||
162892185|NCT03954444|588303682|FG001|Overall Study|Administrative reasons|0|||
162892186|NCT03954444|588303683|FG002|Overall Study|Administrative reasons|1|||
162892187|NCT03954444|588303681|FG000|Overall Study|Miscellaneous|3|||
163051817|NCT02456727|588898727|FG001|Overall Study|Lost to Follow-up|65|||
163051818|NCT02456727|588898726|FG000|Overall Study|Death|2|||
162892188|NCT03954444|588303682|FG001|Overall Study|Miscellaneous|2|||
162892189|NCT03954444|588303683|FG002|Overall Study|Miscellaneous|1|||
162892190|NCT02447458|588303684|FG000|Overall Study|Other|0|||
162892191|NCT02447458|588303685|FG001|Overall Study|Other|0|||
162892192|NCT02447458|588303686|FG002|Overall Study|Other|1|||
163051819|NCT02456727|588898727|FG001|Overall Study|Death|1|||
162892193|NCT02447458|588303687|FG003|Overall Study|Other|0|||
162892194|NCT02447458|588303688|FG004|Overall Study|Other|0|||
162892195|NCT02447458|588303689|FG005|Overall Study|Other|0|||
162892196|NCT00405652|588303690|FG000|Overall Study|Adverse Event|4|||
162892197|NCT03505749|588303692|FG000|Overall Study|Lost to Follow-up|7|||
162892198|NCT03505749|588303693|FG001|Overall Study|Lost to Follow-up|11|||
162892199|NCT03505749|588303692|FG000|Overall Study|Withdrawal by Subject|6|||
162892200|NCT03505749|588303693|FG001|Overall Study|Withdrawal by Subject|0|||
162892201|NCT03505749|588303692|FG000|Overall Study|Discharged from treatment|3|||
162892202|NCT03505749|588303693|FG001|Overall Study|Discharged from treatment|6|||
162892203|NCT00435994|588303695|FG000|Overall Study|Lost to Follow-up|7|||
162892204|NCT00435994|588303696|FG001|Overall Study|Lost to Follow-up|0|||
162892205|NCT00435994|588303697|FG002|Overall Study|Lost to Follow-up|0|||
162892206|NCT03846219|588303699|FG000|Overall Study|Withdrawal by Subject|3|||
162892207|NCT03846219|588303700|FG001|Overall Study|Withdrawal by Subject|2|||
162892208|NCT03846219|588303701|FG002|Overall Study|Withdrawal by Subject|2|||
162892209|NCT03846219|588303699|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
162892210|NCT03846219|588303700|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
162892211|NCT03846219|588303701|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
162892212|NCT03846219|588303699|FG000|Overall Study|Physician Decision|0|||
162892213|NCT03846219|588303700|FG001|Overall Study|Physician Decision|0|||
162892214|NCT03846219|588303701|FG002|Overall Study|Physician Decision|2|||
162892215|NCT05109702|588303702|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
162892216|NCT05109702|588303703|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
162892217|NCT05109702|588303704|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
162892218|NCT05109702|588303702|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
162892219|NCT05109702|588303703|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
162892220|NCT05109702|588303704|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
162892221|NCT05109702|588303702|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
162892222|NCT05109702|588303703|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
162892223|NCT05109702|588303704|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
162892224|NCT05109702|588303702|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
162892225|NCT05109702|588303703|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
162892226|NCT05109702|588303704|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
162892227|NCT05109702|588303702|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
162892228|NCT05109702|588303703|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
162892229|NCT05109702|588303704|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
162892230|NCT03094832|588303705|FG000|Overall Study|Lost to Follow-up|0|||
162892231|NCT03094832|588303706|FG001|Overall Study|Lost to Follow-up|0|||
162892232|NCT03094832|588303707|FG002|Overall Study|Lost to Follow-up|0|||
162892233|NCT03094832|588303708|FG003|Overall Study|Lost to Follow-up|1|||
162892234|NCT03094832|588303709|FG004|Overall Study|Lost to Follow-up|1|||
162892235|NCT03094832|588303705|FG000|Overall Study|Death|1|||
162892236|NCT03094832|588303706|FG001|Overall Study|Death|0|||
162892237|NCT03094832|588303707|FG002|Overall Study|Death|0|||
162892238|NCT03094832|588303708|FG003|Overall Study|Death|0|||
162892239|NCT03094832|588303709|FG004|Overall Study|Death|0|||
162892240|NCT03094832|588303705|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162892241|NCT03094832|588303706|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162892242|NCT03094832|588303707|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162892243|NCT03094832|588303708|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162892244|NCT03094832|588303709|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162892245|NCT03094832|588303705|FG000|Overall Study|Other|13|||
162892246|NCT03094832|588303706|FG001|Overall Study|Other|20|||
162892247|NCT03094832|588303707|FG002|Overall Study|Other|1|||
162892248|NCT03094832|588303708|FG003|Overall Study|Other|7|||
162622859|NCT02468674|587335346|FG000|Overall Study|Lost to Follow-up|1|||
162622860|NCT02468674|587335347|FG001|Overall Study|Lost to Follow-up|0|||
162622861|NCT02468674|587335348|FG002|Overall Study|Lost to Follow-up|0|||
162622862|NCT02468674|587335349|FG003|Overall Study|Lost to Follow-up|0|||
162622863|NCT02468674|587335350|FG004|Overall Study|Lost to Follow-up|0|||
162622864|NCT02468674|587335351|FG005|Overall Study|Lost to Follow-up|0|||
162622865|NCT02468674|587335352|FG006|Overall Study|Lost to Follow-up|0|||
162622866|NCT02468674|587335353|FG007|Overall Study|Lost to Follow-up|1|||
162622867|NCT02468674|587335354|FG008|Overall Study|Lost to Follow-up|1|||
162622868|NCT02468674|587335346|FG000|Overall Study|Physician Decision|0|||
162622869|NCT02468674|587335347|FG001|Overall Study|Physician Decision|0|||
162892249|NCT03094832|588303709|FG004|Overall Study|Other|1|||
162892250|NCT01392378|588303716|FG000|Infant Series|Adverse Event|0|||
162892251|NCT01392378|588303717|FG001|Infant Series|Adverse Event|0|||
162622870|NCT02468674|587335348|FG002|Overall Study|Physician Decision|0|||
162622871|NCT02468674|587335349|FG003|Overall Study|Physician Decision|0|||
162622872|NCT02468674|587335350|FG004|Overall Study|Physician Decision|0|||
162622873|NCT02468674|587335351|FG005|Overall Study|Physician Decision|0|||
162892252|NCT01392378|588303718|FG002|Infant Series|Adverse Event|0|||
162892253|NCT01392378|588303719|FG003|Infant Series|Adverse Event|1|||
162892254|NCT01392378|588303720|FG004|Infant Series|Adverse Event|0|||
162892255|NCT01392378|588303716|FG000|Infant Series|Lost to Follow-up|0|||
162622874|NCT02468674|587335352|FG006|Overall Study|Physician Decision|1|||
162892256|NCT01392378|588303717|FG001|Infant Series|Lost to Follow-up|0|||
162892257|NCT01392378|588303718|FG002|Infant Series|Lost to Follow-up|0|||
162892258|NCT01392378|588303719|FG003|Infant Series|Lost to Follow-up|1|||
162892259|NCT01392378|588303720|FG004|Infant Series|Lost to Follow-up|0|||
162892260|NCT01392378|588303716|FG000|Infant Series|Protocol Violation|0|||
162892261|NCT01392378|588303717|FG001|Infant Series|Protocol Violation|1|||
162892262|NCT01392378|588303718|FG002|Infant Series|Protocol Violation|0|||
162892263|NCT01392378|588303719|FG003|Infant Series|Protocol Violation|0|||
162892264|NCT01392378|588303720|FG004|Infant Series|Protocol Violation|0|||
162892265|NCT01392378|588303716|FG000|Infant Series|Withdrawal by Parent|4|||
162892266|NCT01392378|588303717|FG001|Infant Series|Withdrawal by Parent|1|||
162892267|NCT01392378|588303718|FG002|Infant Series|Withdrawal by Parent|0|||
162892268|NCT01392378|588303719|FG003|Infant Series|Withdrawal by Parent|0|||
162892269|NCT01392378|588303720|FG004|Infant Series|Withdrawal by Parent|0|||
162892270|NCT01392378|588303716|FG000|After Infant Series|Lost to Follow-up|0|||
162892271|NCT01392378|588303717|FG001|After Infant Series|Lost to Follow-up|0|||
162892272|NCT01392378|588303718|FG002|After Infant Series|Lost to Follow-up|1|||
162892273|NCT01392378|588303719|FG003|After Infant Series|Lost to Follow-up|0|||
162892274|NCT01392378|588303720|FG004|After Infant Series|Lost to Follow-up|0|||
162892275|NCT01392378|588303716|FG000|After Infant Series|Withdrawal by Parent|0|||
162892276|NCT01392378|588303717|FG001|After Infant Series|Withdrawal by Parent|1|||
162892277|NCT01392378|588303718|FG002|After Infant Series|Withdrawal by Parent|1|||
162892278|NCT01392378|588303719|FG003|After Infant Series|Withdrawal by Parent|0|||
162892279|NCT01392378|588303720|FG004|After Infant Series|Withdrawal by Parent|1|||
162892280|NCT01392378|588303716|FG000|Toddler Dose|Lost to Follow-up|0|||
162892281|NCT01392378|588303717|FG001|Toddler Dose|Lost to Follow-up|0|||
162892282|NCT01392378|588303718|FG002|Toddler Dose|Lost to Follow-up|0|||
162892283|NCT01392378|588303719|FG003|Toddler Dose|Lost to Follow-up|1|||
162892284|NCT01392378|588303720|FG004|Toddler Dose|Lost to Follow-up|0|||
162892285|NCT01392378|588303716|FG000|Toddler Dose|Withdrawal by Parent|0|||
162892286|NCT01392378|588303717|FG001|Toddler Dose|Withdrawal by Parent|1|||
162892287|NCT01392378|588303718|FG002|Toddler Dose|Withdrawal by Parent|0|||
162892288|NCT01392378|588303719|FG003|Toddler Dose|Withdrawal by Parent|1|||
162892289|NCT01392378|588303720|FG004|Toddler Dose|Withdrawal by Parent|1|||
162892290|NCT02322411|588303723|FG000|Overall Study|Lost to Follow-up|4|||
162892291|NCT02322411|588303724|FG001|Overall Study|Lost to Follow-up|7|||
162892292|NCT02322411|588303723|FG000|Overall Study|Withdrawal by Subject|1|||
162892293|NCT02322411|588303724|FG001|Overall Study|Withdrawal by Subject|0|||
162892294|NCT00788697|588303725|FG000|Overall Study|No study drug administered|12|||
162892295|NCT00788697|588303725|FG000|Overall Study|Training Patients|74|||
162892296|NCT00788697|588303725|FG000|Overall Study|no truth standard procedure available|5|||
162892297|NCT00788697|588303725|FG000|Overall Study|Technically inadequate truth standard|1|||
162892298|NCT00788697|588303725|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
162892299|NCT01998880|588303727|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
162892300|NCT01998880|588303728|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
162892301|NCT01998880|588303727|FG000|Overall Study|Disease Progression|1|||
162892302|NCT01998880|588303728|FG001|Overall Study|Disease Progression|8|||
162892303|NCT01998880|588303727|FG000|Overall Study|Withdrew Consent|2|||
162892304|NCT01998880|588303728|FG001|Overall Study|Withdrew Consent|1|||
162892305|NCT01998880|588303727|FG000|Overall Study|Death|3|||
162892306|NCT01998880|588303728|FG001|Overall Study|Death|6|||
162892307|NCT01998880|588303727|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162892308|NCT01998880|588303728|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162892309|NCT01998880|588303727|FG000|Overall Study|Administrative/Other|1|||
162892310|NCT01998880|588303728|FG001|Overall Study|Administrative/Other|1|||
162892311|NCT01998880|588303727|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
162892312|NCT01998880|588303728|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162892313|NCT01998880|588303727|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162892314|NCT01998880|588303728|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162892315|NCT01998880|588303727|FG000|Overall Study|Did Not Receive Treatment|3|||
162892316|NCT01998880|588303728|FG001|Overall Study|Did Not Receive Treatment|2|||
162892317|NCT02248857|588303729|FG000|3 Month|Withdrawal by Subject|9|||
162892318|NCT02248857|588303730|FG001|3 Month|Withdrawal by Subject|3|||
162892319|NCT02248857|588303731|FG002|3 Month|Withdrawal by Subject|4|||
162892320|NCT02248857|588303729|FG000|3 Month|Unable to reach for 3 month|35|||
162892321|NCT02248857|588303730|FG001|3 Month|Unable to reach for 3 month|29|||
162622875|NCT02468674|587335353|FG007|Overall Study|Physician Decision|0|||
162622876|NCT02468674|587335354|FG008|Overall Study|Physician Decision|0|||
162622877|NCT02468674|587335346|FG000|Overall Study|Patient/Guardian Decision|0|||
162622878|NCT02468674|587335347|FG001|Overall Study|Patient/Guardian Decision|0|||
162622879|NCT02468674|587335348|FG002|Overall Study|Patient/Guardian Decision|0|||
162622880|NCT02468674|587335349|FG003|Overall Study|Patient/Guardian Decision|0|||
162892322|NCT02248857|588303731|FG002|3 Month|Unable to reach for 3 month|26|||
162892323|NCT02248857|588303729|FG000|3 Month|Partially completed, unable to finish|2|||
162892324|NCT02248857|588303730|FG001|3 Month|Partially completed, unable to finish|2|||
162892325|NCT02248857|588303731|FG002|3 Month|Partially completed, unable to finish|1|||
162892326|NCT02248857|588303729|FG000|6 Month|Lost to Follow-up|27|||
162892327|NCT02248857|588303730|FG001|6 Month|Lost to Follow-up|26|||
162892328|NCT02248857|588303731|FG002|6 Month|Lost to Follow-up|15|||
162892329|NCT02248857|588303729|FG000|6 Month|Partially completed, unable to finish|0|||
162892330|NCT02248857|588303730|FG001|6 Month|Partially completed, unable to finish|1|||
162892331|NCT02248857|588303731|FG002|6 Month|Partially completed, unable to finish|0|||
162892332|NCT02248857|588303729|FG000|6 Month|Withdrawal by Subject|0|||
162892333|NCT02248857|588303730|FG001|6 Month|Withdrawal by Subject|2|||
162892334|NCT02248857|588303731|FG002|6 Month|Withdrawal by Subject|2|||
162892335|NCT02248857|588303729|FG000|6 Month|Death|1|||
162892336|NCT02248857|588303730|FG001|6 Month|Death|0|||
162892337|NCT02248857|588303731|FG002|6 Month|Death|0|||
162892338|NCT02671461|588303732|FG000|Treatment|Adverse Event|0|||
162892339|NCT02671461|588303733|FG001|Treatment|Adverse Event|0|||
162892340|NCT02671461|588303734|FG002|Treatment|Adverse Event|1|||
162892341|NCT02671461|588303732|FG000|Treatment|Administrative Reason by Sponsor|1|||
162892342|NCT02671461|588303733|FG001|Treatment|Administrative Reason by Sponsor|3|||
162892343|NCT02671461|588303734|FG002|Treatment|Administrative Reason by Sponsor|4|||
162892344|NCT02671461|588303732|FG000|Treatment|Randomized, not treated|1|||
162892345|NCT02671461|588303733|FG001|Treatment|Randomized, not treated|0|||
162892346|NCT02671461|588303734|FG002|Treatment|Randomized, not treated|0|||
162892347|NCT02671461|588303732|FG000|Follow-up|Withdrawal by Subject|1|||
162892348|NCT02671461|588303733|FG001|Follow-up|Withdrawal by Subject|0|||
162892349|NCT02671461|588303734|FG002|Follow-up|Withdrawal by Subject|0|||
162892350|NCT02671461|588303732|FG000|Follow-up|Lost to Follow-up|0|||
162892351|NCT02671461|588303733|FG001|Follow-up|Lost to Follow-up|0|||
162892352|NCT02671461|588303734|FG002|Follow-up|Lost to Follow-up|1|||
162892353|NCT02671461|588303732|FG000|Follow-up|Administrative Reason by Sponsor|0|||
162892354|NCT02671461|588303733|FG001|Follow-up|Administrative Reason by Sponsor|1|||
162892355|NCT02671461|588303734|FG002|Follow-up|Administrative Reason by Sponsor|0|||
162892356|NCT00367432|588303736|FG000|First Period (16 Weeks)|Adverse Event|6|||
162892357|NCT00367432|588303737|FG001|First Period (16 Weeks)|Adverse Event|0|||
162892358|NCT00367432|588303736|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
162892359|NCT00367432|588303737|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
162892360|NCT00367432|588303736|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
162892361|NCT00367432|588303737|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
162892362|NCT00367432|588303736|FG000|First Period (16 Weeks)|Other Reason|2|||
162892363|NCT00367432|588303737|FG001|First Period (16 Weeks)|Other Reason|0|||
162892364|NCT00367432|588303736|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
162892365|NCT00367432|588303737|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
162892366|NCT00367432|588303736|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
162892367|NCT00367432|588303737|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
162892368|NCT00367432|588303736|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
162892369|NCT00367432|588303737|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
162892370|NCT00367432|588303736|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
162892371|NCT00367432|588303737|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
162892372|NCT00367432|588303736|FG000|Second Period (up to 54 Months)|Other Reason|6|||
162892373|NCT00367432|588303737|FG001|Second Period (up to 54 Months)|Other Reason|2|||
162892374|NCT00903370|588303738|FG000|Overall Study|Death|13|||
162892375|NCT00903370|588303739|FG001|Overall Study|Death|10|||
162892376|NCT00903370|588303738|FG000|Overall Study|Withdrawal by Subject|9|||
162892377|NCT00903370|588303739|FG001|Overall Study|Withdrawal by Subject|6|||
162892378|NCT00903370|588303738|FG000|Overall Study|Lost to Follow-up|6|||
162892379|NCT00903370|588303739|FG001|Overall Study|Lost to Follow-up|8|||
162892380|NCT00014911|588303740|FG000|Overall Study|Adverse Event|1|||
162892381|NCT00014911|588303740|FG000|Overall Study|Lost to Follow-up|1|||
162892382|NCT00014911|588303740|FG000|Overall Study|Withdrawal by Subject|6|||
162892383|NCT00014911|588303740|FG000|Overall Study|Unknown Reasons|2|||
162892384|NCT00014911|588303740|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
162892385|NCT03170258|588305608|FG000|Overall Study|Physician Decision|4|||
162892386|NCT03170258|588305609|FG001|Overall Study|Physician Decision|0|||
162892387|NCT03170258|588305608|FG000|Overall Study|Equipment issues|1|||
162892388|NCT03170258|588305609|FG001|Overall Study|Equipment issues|0|||
162892389|NCT03170258|588305608|FG000|Overall Study|Medication|1|||
162892390|NCT03170258|588305609|FG001|Overall Study|Medication|0|||
162892391|NCT03170258|588305608|FG000|Overall Study|Sleep issues|1|||
162892392|NCT03170258|588305609|FG001|Overall Study|Sleep issues|0|||
162892393|NCT04209530|588305610|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
162892394|NCT04209530|588305611|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
162892395|NCT04209530|588305610|FG000|Overall Study|Withdrawal by Subject|0|||
162892396|NCT04209530|588305611|FG001|Overall Study|Withdrawal by Subject|1|||
162892397|NCT04839393|588305612|FG000|Overall Study|Adverse Event|0|||
162892398|NCT04839393|588305613|FG001|Overall Study|Adverse Event|0|||
162892399|NCT04839393|588305614|FG002|Overall Study|Adverse Event|2|||
162892400|NCT04839393|588305612|FG000|Overall Study|Withdrawal by participant|0|||
162622881|NCT02468674|587335350|FG004|Overall Study|Patient/Guardian Decision|1|||
162622882|NCT02468674|587335351|FG005|Overall Study|Patient/Guardian Decision|0|||
162622883|NCT02468674|587335352|FG006|Overall Study|Patient/Guardian Decision|0|||
162622884|NCT02468674|587335353|FG007|Overall Study|Patient/Guardian Decision|2|||
162892401|NCT04839393|588305613|FG001|Overall Study|Withdrawal by participant|0|||
162892402|NCT04839393|588305614|FG002|Overall Study|Withdrawal by participant|1|||
162892403|NCT05091918|588305617|FG000|Overall Study|Adverse Event|1|||
162892404|NCT05091918|588305617|FG000|Overall Study|Withdrawal by Subject|81|||
162892405|NCT01100658|588305619|FG000|Overall Study|Withdrawal by Subject|1|||
162892406|NCT01094808|588305622|FG000|Overall Study|Withdrawal by Subject|1|||
162892407|NCT01094808|588305623|FG001|Overall Study|Withdrawal by Subject|1|||
162892408|NCT01094808|588305624|FG002|Overall Study|Withdrawal by Subject|0|||
162892409|NCT00369278|588305625|FG000|Overall Study|Adverse Event|14|||
162892410|NCT00369278|588305626|FG001|Overall Study|Adverse Event|11|||
162892411|NCT00369278|588305625|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162892412|NCT00369278|588305626|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
162892413|NCT00369278|588305625|FG000|Overall Study|Protocol Violation|2|||
162892414|NCT00369278|588305626|FG001|Overall Study|Protocol Violation|1|||
162892415|NCT00369278|588305625|FG000|Overall Study|Withdrawal by Subject|2|||
162892416|NCT00369278|588305626|FG001|Overall Study|Withdrawal by Subject|2|||
162892417|NCT00369278|588305625|FG000|Overall Study|Lost to Follow-up|1|||
162892418|NCT00369278|588305626|FG001|Overall Study|Lost to Follow-up|0|||
162892419|NCT00369278|588305625|FG000|Overall Study|Graft loss|1|||
162892420|NCT00369278|588305626|FG001|Overall Study|Graft loss|2|||
162892421|NCT02044822|588305627|FG000|Overall Study|Study Terminated by Sponsor|77|||
162892422|NCT02044822|588305627|FG000|Overall Study|Investigator's Discretion|10|||
162892423|NCT02044822|588305627|FG000|Overall Study|Withdrew Consent|3|||
162892424|NCT02044822|588305627|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
162892425|NCT02044822|588305627|FG000|Overall Study|Lost to Follow-up|1|||
162892426|NCT02025530|588305630|FG000|Overall Study|No longer met elligibility criteria|5|||
162892427|NCT02025530|588305631|FG001|Overall Study|No longer met elligibility criteria|1|||
162892428|NCT03551626|588305636|FG000|Overall Study|Adverse Event|88|||
162892429|NCT03551626|588305636|FG000|Overall Study|Disease relapse|18|||
162892430|NCT03551626|588305636|FG000|Overall Study|Withdrawal of informed consent|6|||
162892431|NCT03551626|588305636|FG000|Overall Study|Patient decision|5|||
162892432|NCT03551626|588305636|FG000|Overall Study|Physician Decision|4|||
162892433|NCT03551626|588305636|FG000|Overall Study|Lost to Follow-up|3|||
162892434|NCT03551626|588305636|FG000|Overall Study|Pregnancy|1|||
162892435|NCT03551626|588305636|FG000|Overall Study|Protocol deviation|1|||
162892436|NCT03551626|588305636|FG000|Overall Study|Technical problems|1|||
162892437|NCT00653328|588305637|FG000|Overall Study|Withdrawal by Subject|1|||
162892438|NCT00653328|588305637|FG000|Overall Study|Adverse Event|2|||
162892439|NCT00653328|588305637|FG000|Overall Study|Disease progression|10|||
162892440|NCT00653328|588305637|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
162892441|NCT03051217|588305648|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
162892442|NCT03051217|588305649|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162892443|NCT03051217|588305650|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
162892444|NCT03051217|588305651|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162892445|NCT03051217|588305652|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162892446|NCT03051217|588305653|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162892447|NCT03051217|588305654|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162892448|NCT03051217|588305648|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892449|NCT03051217|588305649|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
162892450|NCT03051217|588305650|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892451|NCT03051217|588305651|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892452|NCT03051217|588305652|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892453|NCT03051217|588305653|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892454|NCT03051217|588305654|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
162892455|NCT03051217|588305648|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
162892456|NCT03051217|588305649|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
162892457|NCT03051217|588305650|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
162892458|NCT03051217|588305651|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162892459|NCT03051217|588305652|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162892460|NCT03051217|588305653|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162892461|NCT03051217|588305654|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162622885|NCT02468674|587335354|FG008|Overall Study|Patient/Guardian Decision|1|||
162892462|NCT03051217|588305648|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
162892463|NCT03051217|588305649|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
162892464|NCT03051217|588305650|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
162892465|NCT03051217|588305651|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
162892466|NCT03051217|588305652|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
162892467|NCT03051217|588305653|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
162892468|NCT03051217|588305654|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
162892469|NCT03051217|588305648|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892470|NCT03051217|588305649|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892471|NCT03051217|588305650|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892472|NCT03051217|588305651|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
162892473|NCT03051217|588305652|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892474|NCT03051217|588305653|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892475|NCT03051217|588305654|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
162892476|NCT03051217|588305648|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892477|NCT03051217|588305649|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892478|NCT03051217|588305650|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892479|NCT03051217|588305651|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
162892480|NCT03051217|588305652|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892481|NCT03051217|588305653|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892482|NCT03051217|588305654|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
162892483|NCT03051217|588305648|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892484|NCT03051217|588305649|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892485|NCT03051217|588305650|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892486|NCT03051217|588305651|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892487|NCT03051217|588305652|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
162892488|NCT03051217|588305653|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892489|NCT03051217|588305654|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
162892490|NCT03051217|588305648|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892491|NCT03051217|588305649|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892492|NCT03051217|588305650|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892493|NCT03051217|588305651|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892494|NCT03051217|588305652|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892495|NCT03051217|588305653|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
162892496|NCT03051217|588305654|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
162892497|NCT01989754|588305655|FG000|Overall Study|Withdrawal by Subject|10|||
162892498|NCT01989754|588305656|FG001|Overall Study|Withdrawal by Subject|14|||
162892499|NCT01989754|588305655|FG000|Overall Study|Lost to Follow-up|28|||
162892500|NCT01989754|588305656|FG001|Overall Study|Lost to Follow-up|20|||
162892501|NCT01989754|588305655|FG000|Overall Study|Closed Site|1|||
162892502|NCT01989754|588305656|FG001|Overall Study|Closed Site|1|||
162892503|NCT00391807|588305658|FG000|Overall Study|Did not receive study medication|23|||
162892504|NCT00391807|588305658|FG000|Overall Study|Adverse Event|177|||
162892505|NCT00391807|588305658|FG000|Overall Study|Pregnancy|25|||
162892506|NCT00391807|588305658|FG000|Overall Study|Lost to Follow-up|227|||
162892507|NCT00391807|588305658|FG000|Overall Study|Withdrawal by Subject|147|||
162892508|NCT00391807|588305658|FG000|Overall Study|Protocol Violation|20|||
162892509|NCT00391807|588305658|FG000|Overall Study|Various|96|||
162892510|NCT01369225|588305663|FG000|Overall Study|Withdrawal by Subject|1|||
162622886|NCT02468674|587335346|FG000|Overall Study|Protocol Deviation|0|||
162892511|NCT01369225|588305664|FG001|Overall Study|Withdrawal by Subject|0|||
162892512|NCT01369225|588305665|FG002|Overall Study|Withdrawal by Subject|2|||
162892513|NCT01369225|588305666|FG003|Overall Study|Withdrawal by Subject|1|||
162892514|NCT01369225|588305667|FG004|Overall Study|Withdrawal by Subject|0|||
162892515|NCT01369225|588305668|FG005|Overall Study|Withdrawal by Subject|0|||
162892516|NCT01369225|588305663|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
162892517|NCT01369225|588305664|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
162892518|NCT01369225|588305665|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
162892519|NCT01369225|588305666|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
162892520|NCT01369225|588305667|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
162892521|NCT01369225|588305668|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
162892522|NCT01369225|588305663|FG000|Overall Study|Other|1|||
162892523|NCT01369225|588305664|FG001|Overall Study|Other|0|||
162892524|NCT01369225|588305665|FG002|Overall Study|Other|0|||
162892525|NCT01369225|588305666|FG003|Overall Study|Other|0|||
162892526|NCT01369225|588305667|FG004|Overall Study|Other|1|||
162892527|NCT01369225|588305668|FG005|Overall Study|Other|0|||
162892528|NCT01369225|588305663|FG000|Overall Study|Adverse Event|0|||
162892529|NCT01369225|588305664|FG001|Overall Study|Adverse Event|0|||
162892530|NCT01369225|588305665|FG002|Overall Study|Adverse Event|0|||
162892531|NCT01369225|588305666|FG003|Overall Study|Adverse Event|1|||
162622887|NCT02468674|587335347|FG001|Overall Study|Protocol Deviation|0|||
162892532|NCT01369225|588305667|FG004|Overall Study|Adverse Event|1|||
162892533|NCT01369225|588305668|FG005|Overall Study|Adverse Event|0|||
162892534|NCT04539262|588305670|FG000|Overall Study|Adverse Event|0|||
162892535|NCT04539262|588305671|FG001|Overall Study|Adverse Event|0|||
162892536|NCT04539262|588305672|FG002|Overall Study|Adverse Event|1|||
162892537|NCT04539262|588305673|FG003|Overall Study|Adverse Event|0|||
162892538|NCT04539262|588305674|FG004|Overall Study|Adverse Event|0|||
162892539|NCT04539262|588305675|FG005|Overall Study|Adverse Event|0|||
162892540|NCT04539262|588305676|FG006|Overall Study|Adverse Event|0|||
162892541|NCT04539262|588305677|FG007|Overall Study|Adverse Event|0|||
162892542|NCT04539262|588305670|FG000|Overall Study|Withdrew Consent|0|||
162892543|NCT04539262|588305671|FG001|Overall Study|Withdrew Consent|0|||
162892544|NCT04539262|588305672|FG002|Overall Study|Withdrew Consent|0|||
162892545|NCT04539262|588305673|FG003|Overall Study|Withdrew Consent|1|||
162892546|NCT04539262|588305674|FG004|Overall Study|Withdrew Consent|0|||
162892547|NCT04539262|588305675|FG005|Overall Study|Withdrew Consent|0|||
162892548|NCT04539262|588305676|FG006|Overall Study|Withdrew Consent|0|||
162892549|NCT04539262|588305677|FG007|Overall Study|Withdrew Consent|0|||
162892550|NCT04539262|588305670|FG000|Overall Study|Randomized, Not treated|0|||
162892551|NCT04539262|588305671|FG001|Overall Study|Randomized, Not treated|1|||
162892552|NCT04539262|588305672|FG002|Overall Study|Randomized, Not treated|0|||
162892553|NCT04539262|588305673|FG003|Overall Study|Randomized, Not treated|0|||
162892554|NCT04539262|588305674|FG004|Overall Study|Randomized, Not treated|0|||
162892555|NCT04539262|588305675|FG005|Overall Study|Randomized, Not treated|0|||
162892556|NCT04539262|588305676|FG006|Overall Study|Randomized, Not treated|1|||
162892557|NCT04539262|588305677|FG007|Overall Study|Randomized, Not treated|0|||
162892558|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
162892559|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
162892560|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
162892561|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
162892562|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
162892563|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
162892564|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
162892565|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
162892566|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
162892567|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
162892568|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
162892569|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
162892570|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
162892571|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
162892572|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
162892573|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
162892574|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
162892575|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
162892576|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
162892577|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
162892578|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
162892579|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
162892580|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
162892581|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
162892582|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
162892583|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Other|1|||
162892584|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Other|0|||
162892585|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Other|0|||
162892586|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Other|0|||
162892587|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Other|1|||
162892588|NCT02980692|588305680|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
162892589|NCT02980692|588305681|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
162892590|NCT02980692|588305682|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
162892591|NCT02980692|588305683|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
162892592|NCT02980692|588305684|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
162892593|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Adverse Event|0|||
162892594|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Adverse Event|0|||
162892595|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Adverse Event|0|||
162892596|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Adverse Event|1|||
162892597|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Adverse Event|1|||
162892598|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
162892599|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
162892600|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
162892601|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
162892602|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
162892603|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
162892604|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
162892605|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
162892606|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
162892607|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
162892608|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Pregnancy|0|||
162892609|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Pregnancy|0|||
162892610|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Pregnancy|1|||
162892611|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Pregnancy|1|||
162892612|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Pregnancy|0|||
162892613|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
162892614|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
162892615|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
162892616|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
162892617|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
162892618|NCT02980692|588305680|FG000|Double-blind Follow-up Period|Other|0|||
162892619|NCT02980692|588305681|FG001|Double-blind Follow-up Period|Other|0|||
162892620|NCT02980692|588305682|FG002|Double-blind Follow-up Period|Other|1|||
162892621|NCT02980692|588305683|FG003|Double-blind Follow-up Period|Other|1|||
162892622|NCT02980692|588305684|FG004|Double-blind Follow-up Period|Other|3|||
162892623|NCT00792701|588305685|FG000|Overall Study|Adverse Event|0|||
162892624|NCT00792701|588305686|FG001|Overall Study|Adverse Event|22|||
162892625|NCT00792701|588305685|FG000|Overall Study|Ineligible|1|||
163051820|NCT02456727|588898726|FG000|Overall Study|Withdrawal by Subject|1|||
163051821|NCT02456727|588898727|FG001|Overall Study|Withdrawal by Subject|10|||
163051822|NCT02456727|588898726|FG000|Overall Study|Never Initiated Treatment|43|||
163051823|NCT02456727|588898727|FG001|Overall Study|Never Initiated Treatment|30|||
163051824|NCT01319565|588898728|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
163051825|NCT01319565|588898729|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
163051826|NCT01319565|588898730|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
163051827|NCT00113607|588898731|FG000|Overall Study|Adverse Event|40|||
163051828|NCT00113607|588898732|FG001|Overall Study|Adverse Event|71|||
163051829|NCT00113607|588898731|FG000|Overall Study|Death|8|||
163051830|NCT00113607|588898732|FG001|Overall Study|Death|8|||
163051831|NCT00113607|588898731|FG000|Overall Study|Withdrawal by Subject|50|||
163051832|NCT00113607|588898732|FG001|Overall Study|Withdrawal by Subject|58|||
163051833|NCT00113607|588898731|FG000|Overall Study|Lost to Follow-up|0|||
163051834|NCT00113607|588898732|FG001|Overall Study|Lost to Follow-up|2|||
163051835|NCT00113607|588898731|FG000|Overall Study|Disease Progression|180|||
163051836|NCT00113607|588898732|FG001|Overall Study|Disease Progression|142|||
163051837|NCT00113607|588898731|FG000|Overall Study|Complete Response (Confirmed)|14|||
163051838|NCT00113607|588898732|FG001|Overall Study|Complete Response (Confirmed)|24|||
163051839|NCT00113607|588898731|FG000|Overall Study|Other|43|||
163051840|NCT00113607|588898732|FG001|Overall Study|Other|32|||
163051841|NCT00909844|588898733|FG000|Overall Study|Adverse Event|1|||
163051842|NCT00909844|588898733|FG000|Overall Study|Withdrawal by Subject|1|||
163051843|NCT00909844|588898733|FG000|Overall Study|Lost to Follow-up|2|||
163051844|NCT02974868|588898734|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
163051845|NCT02974868|588898735|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
163051846|NCT02974868|588898736|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
162892626|NCT00792701|588305686|FG001|Overall Study|Ineligible|3|||
162892627|NCT00792701|588305685|FG000|Overall Study|Withdrawal by Subject|1|||
162892628|NCT00792701|588305686|FG001|Overall Study|Withdrawal by Subject|19|||
162892629|NCT00792701|588305685|FG000|Overall Study|Not protocol specified|17|||
162892630|NCT00792701|588305686|FG001|Overall Study|Not protocol specified|0|||
162892631|NCT05507580|588305689|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162892632|NCT05507580|588305690|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162892633|NCT05507580|588305691|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
162892634|NCT05507580|588305692|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
162892635|NCT05507580|588305693|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
162892636|NCT05507580|588305694|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
162892637|NCT05507580|588305689|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
162892638|NCT05507580|588305690|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162892639|NCT05507580|588305691|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162892640|NCT05507580|588305692|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162892641|NCT05507580|588305693|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162892642|NCT05507580|588305694|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162892643|NCT05507580|588305689|FG000|Double-Blind Treatment Period|Other, not specified|5|||
162892644|NCT05507580|588305690|FG001|Double-Blind Treatment Period|Other, not specified|4|||
162892645|NCT05507580|588305691|FG002|Double-Blind Treatment Period|Other, not specified|0|||
162892646|NCT05507580|588305692|FG003|Double-Blind Treatment Period|Other, not specified|0|||
162892647|NCT05507580|588305693|FG004|Double-Blind Treatment Period|Other, not specified|0|||
162892648|NCT05507580|588305694|FG005|Double-Blind Treatment Period|Other, not specified|0|||
162892649|NCT05507580|588305689|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
162892650|NCT05507580|588305690|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
162892651|NCT05507580|588305691|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
162892652|NCT05507580|588305692|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
162892653|NCT05507580|588305693|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
162892654|NCT05507580|588305694|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
162892655|NCT05507580|588305689|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
162892656|NCT05507580|588305690|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
162892657|NCT05507580|588305691|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
162892658|NCT05507580|588305692|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
162892659|NCT05507580|588305693|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
162892660|NCT05507580|588305694|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
162892661|NCT05507580|588305689|FG000|Single-Blind Treatment Period|Other, not specified|0|||
162892662|NCT05507580|588305690|FG001|Single-Blind Treatment Period|Other, not specified|0|||
162892663|NCT05507580|588305691|FG002|Single-Blind Treatment Period|Other, not specified|2|||
162892664|NCT05507580|588305692|FG003|Single-Blind Treatment Period|Other, not specified|7|||
162892665|NCT05507580|588305693|FG004|Single-Blind Treatment Period|Other, not specified|3|||
162892666|NCT05507580|588305694|FG005|Single-Blind Treatment Period|Other, not specified|5|||
162892667|NCT04702984|588305695|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
162892668|NCT03673956|588305701|FG000|Overall Study|Lost to Follow-up|1|||
162892669|NCT03673956|588305702|FG001|Overall Study|Lost to Follow-up|0|||
162892670|NCT03673956|588305703|FG002|Overall Study|Lost to Follow-up|0|||
162892671|NCT03673956|588305704|FG003|Overall Study|Lost to Follow-up|0|||
162892672|NCT03673956|588305701|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
162892673|NCT03673956|588305702|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
162892674|NCT03673956|588305703|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
162892675|NCT03673956|588305704|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
162892676|NCT01057862|588305705|FG000|Overall Study|Withdrawal by Subject|1|||
162892677|NCT01057862|588305706|FG001|Overall Study|Withdrawal by Subject|2|||
162892678|NCT00802867|588305707|FG000|Overall Study|Lost to Follow-up|6|||
162892679|NCT00802867|588305707|FG000|Overall Study|Protocol Violation|6|||
162892680|NCT00802867|588305707|FG000|Overall Study|Withdrawal by Subject|1|||
162892681|NCT03363165|588305708|FG000|3-month Follow-up|Death|0|||
162892682|NCT03363165|588305709|FG001|3-month Follow-up|Death|1|||
162892683|NCT03363165|588305708|FG000|6-month Follow-up|Death|0|||
162892684|NCT03363165|588305709|FG001|6-month Follow-up|Death|1|||
162892685|NCT03363165|588305708|FG000|6-month Follow-up|Withdrawal by Subject|1|||
162892686|NCT03363165|588305709|FG001|6-month Follow-up|Withdrawal by Subject|1|||
162892687|NCT03363165|588305708|FG000|12-month Follow-up|Death|1|||
162892688|NCT03363165|588305709|FG001|12-month Follow-up|Death|1|||
162892689|NCT03363165|588305708|FG000|12-month Follow-up|Withdrawal by Subject|1|||
162892690|NCT03363165|588305709|FG001|12-month Follow-up|Withdrawal by Subject|1|||
162892691|NCT00618813|588305710|FG000|Overall Study|Lack of Efficacy|1|||
162892692|NCT00618813|588305710|FG000|Overall Study|Physician Decision|2|||
162892693|NCT00618813|588305710|FG000|Overall Study|Withdrawal by Subject|1|||
162892694|NCT01809197|588305711|FG000|Overall Study|Lost to Follow-up|4|||
162892695|NCT01809197|588305712|FG001|Overall Study|Lost to Follow-up|2|||
162892696|NCT01809197|588305711|FG000|Overall Study|Adverse Event|2|||
162892697|NCT01809197|588305712|FG001|Overall Study|Adverse Event|3|||
162892698|NCT01809197|588305711|FG000|Overall Study|Failed slit lamp exam|1|||
162892699|NCT01809197|588305712|FG001|Overall Study|Failed slit lamp exam|0|||
162892700|NCT01809197|588305711|FG000|Overall Study|Non-Compliance|1|||
162892701|NCT01809197|588305712|FG001|Overall Study|Non-Compliance|1|||
162892702|NCT01809197|588305711|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
162892703|NCT01809197|588305712|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
162892704|NCT01809197|588305711|FG000|Overall Study|Withdrawal by Subject|1|||
162892705|NCT01809197|588305712|FG001|Overall Study|Withdrawal by Subject|1|||
162892706|NCT01809197|588305711|FG000|Overall Study|Product not available|0|||
162892707|NCT01809197|588305712|FG001|Overall Study|Product not available|1|||
162708724|NCT04833855|587642881|FG001|Overall Study|Withdrawal by Subject|1|||
162892708|NCT01855945|588305713|FG000|Overall Study|Adverse Event|0|||
162892709|NCT01855945|588305714|FG001|Overall Study|Adverse Event|0|||
162892710|NCT01855945|588305715|FG002|Overall Study|Adverse Event|0|||
162892711|NCT01855945|588305716|FG003|Overall Study|Adverse Event|0|||
162892712|NCT01855945|588305717|FG004|Overall Study|Adverse Event|0|||
162892713|NCT01855945|588305718|FG005|Overall Study|Adverse Event|0|||
162892714|NCT01855945|588305719|FG006|Overall Study|Adverse Event|1|||
162892715|NCT01855945|588305720|FG007|Overall Study|Adverse Event|0|||
162892716|NCT01855945|588305721|FG008|Overall Study|Adverse Event|0|||
162892717|NCT01855945|588305722|FG009|Overall Study|Adverse Event|0|||
162892718|NCT01855945|588305723|FG010|Overall Study|Adverse Event|0|||
162892719|NCT01855945|588305724|FG011|Overall Study|Adverse Event|0|||
162892720|NCT01855945|588305713|FG000|Overall Study|Death|0|||
162892721|NCT01855945|588305714|FG001|Overall Study|Death|0|||
162892722|NCT01855945|588305715|FG002|Overall Study|Death|0|||
162892723|NCT01855945|588305716|FG003|Overall Study|Death|0|||
162892724|NCT01855945|588305717|FG004|Overall Study|Death|0|||
162892725|NCT01855945|588305718|FG005|Overall Study|Death|0|||
162892726|NCT01855945|588305719|FG006|Overall Study|Death|2|||
162892727|NCT01855945|588305720|FG007|Overall Study|Death|0|||
162892728|NCT01855945|588305721|FG008|Overall Study|Death|0|||
162892729|NCT01855945|588305722|FG009|Overall Study|Death|0|||
162892730|NCT01855945|588305723|FG010|Overall Study|Death|0|||
162892731|NCT01855945|588305724|FG011|Overall Study|Death|0|||
162892732|NCT01855945|588305713|FG000|Overall Study|Lost to Follow-up|11|||
162892733|NCT01855945|588305714|FG001|Overall Study|Lost to Follow-up|10|||
162892734|NCT01855945|588305715|FG002|Overall Study|Lost to Follow-up|7|||
162892735|NCT01855945|588305716|FG003|Overall Study|Lost to Follow-up|3|||
162892736|NCT01855945|588305717|FG004|Overall Study|Lost to Follow-up|0|||
162892737|NCT01855945|588305718|FG005|Overall Study|Lost to Follow-up|3|||
162892738|NCT01855945|588305719|FG006|Overall Study|Lost to Follow-up|4|||
162892739|NCT01855945|588305720|FG007|Overall Study|Lost to Follow-up|7|||
162892740|NCT01855945|588305721|FG008|Overall Study|Lost to Follow-up|2|||
162892741|NCT01855945|588305722|FG009|Overall Study|Lost to Follow-up|0|||
162892742|NCT01855945|588305723|FG010|Overall Study|Lost to Follow-up|0|||
162892743|NCT01855945|588305724|FG011|Overall Study|Lost to Follow-up|2|||
162892744|NCT01855945|588305713|FG000|Overall Study|Other - Unclassified|1|||
162892745|NCT01855945|588305714|FG001|Overall Study|Other - Unclassified|1|||
162892746|NCT01855945|588305715|FG002|Overall Study|Other - Unclassified|1|||
162892747|NCT01855945|588305716|FG003|Overall Study|Other - Unclassified|0|||
162892748|NCT01855945|588305717|FG004|Overall Study|Other - Unclassified|0|||
162892749|NCT01855945|588305718|FG005|Overall Study|Other - Unclassified|0|||
162892750|NCT01855945|588305719|FG006|Overall Study|Other - Unclassified|2|||
162892751|NCT01855945|588305720|FG007|Overall Study|Other - Unclassified|1|||
162892752|NCT01855945|588305721|FG008|Overall Study|Other - Unclassified|0|||
162892753|NCT01855945|588305722|FG009|Overall Study|Other - Unclassified|0|||
162892754|NCT01855945|588305723|FG010|Overall Study|Other - Unclassified|1|||
162892755|NCT01855945|588305724|FG011|Overall Study|Other - Unclassified|0|||
162892756|NCT01855945|588305713|FG000|Overall Study|Withdrawal by Subject|4|||
162892757|NCT01855945|588305714|FG001|Overall Study|Withdrawal by Subject|0|||
162892758|NCT01855945|588305715|FG002|Overall Study|Withdrawal by Subject|4|||
162892759|NCT01855945|588305716|FG003|Overall Study|Withdrawal by Subject|1|||
162892760|NCT01855945|588305717|FG004|Overall Study|Withdrawal by Subject|1|||
162892761|NCT01855945|588305718|FG005|Overall Study|Withdrawal by Subject|0|||
162892762|NCT01855945|588305719|FG006|Overall Study|Withdrawal by Subject|1|||
162892763|NCT01855945|588305720|FG007|Overall Study|Withdrawal by Subject|0|||
162892764|NCT01855945|588305721|FG008|Overall Study|Withdrawal by Subject|0|||
162892765|NCT01855945|588305722|FG009|Overall Study|Withdrawal by Subject|2|||
162892766|NCT01855945|588305723|FG010|Overall Study|Withdrawal by Subject|4|||
162892767|NCT01855945|588305724|FG011|Overall Study|Withdrawal by Subject|1|||
162892768|NCT02156804|588305729|FG000|Overall Study|Withdrawal by Subject|1|||
162892769|NCT03000686|588305730|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
162892770|NCT03000686|588305731|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
162892771|NCT03000686|588305732|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
162892772|NCT03000686|588305733|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
162892773|NCT00770224|588305738|FG000|Step 1: Induction|Adverse Event|3|||
162892774|NCT00770224|588305739|FG001|Step 1: Induction|Adverse Event|0|||
162892775|NCT00770224|588305738|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
162892776|NCT00770224|588305739|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
162892777|NCT00770224|588305738|FG000|Step 1: Induction|Other reason not protocol specified|2|||
162892778|NCT00770224|588305739|FG001|Step 1: Induction|Other reason not protocol specified|0|||
162892779|NCT00770224|588305738|FG000|Step 1: Induction|Ineligible|2|||
162892780|NCT00770224|588305739|FG001|Step 1: Induction|Ineligible|0|||
162892781|NCT00770224|588305738|FG000|Step 1: Induction|No protocol treatment given|1|||
162892782|NCT00770224|588305739|FG001|Step 1: Induction|No protocol treatment given|0|||
162892783|NCT00770224|588305738|FG000|Step 2: Maintenance|Adverse Event|0|||
162892784|NCT00770224|588305739|FG001|Step 2: Maintenance|Adverse Event|10|||
162892785|NCT00770224|588305738|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
162892786|NCT00770224|588305739|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
162892787|NCT00770224|588305738|FG000|Step 2: Maintenance|Progression/relapse|0|||
162892788|NCT00770224|588305739|FG001|Step 2: Maintenance|Progression/relapse|1|||
162892789|NCT00770224|588305738|FG000|Step 2: Maintenance|Death|0|||
162892790|NCT00770224|588305739|FG001|Step 2: Maintenance|Death|2|||
162892791|NCT00770224|588305738|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
162892792|NCT00770224|588305739|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
162892793|NCT00770224|588305738|FG000|Step 2: Maintenance|Ineligible|0|||
162892794|NCT00770224|588305739|FG001|Step 2: Maintenance|Ineligible|2|||
162892795|NCT01112982|588305740|FG000|Overall Study|Withdrawal by Subject|1|||
162892796|NCT01112982|588305740|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
162892797|NCT01851863|588305741|FG000|Overall Study|Did not receive study medication|2|||
162892798|NCT01851863|588305742|FG001|Overall Study|Did not receive study medication|5|||
162892799|NCT01851863|588305743|FG002|Overall Study|Did not receive study medication|3|||
162892800|NCT01851863|588305744|FG003|Overall Study|Did not receive study medication|0|||
162892801|NCT01851863|588305741|FG000|Overall Study|Lost to Follow-up|3|||
162892802|NCT01851863|588305742|FG001|Overall Study|Lost to Follow-up|4|||
162892803|NCT01851863|588305743|FG002|Overall Study|Lost to Follow-up|2|||
162892804|NCT01851863|588305744|FG003|Overall Study|Lost to Follow-up|3|||
162892805|NCT00753623|588305745|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
162892806|NCT00753623|588305746|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
162892807|NCT00753623|588305745|FG000|Phase I (14 Days)|Physician Decision|1|||
162892808|NCT00753623|588305746|FG001|Phase I (14 Days)|Physician Decision|2|||
162892809|NCT00753623|588305745|FG000|Phase I (14 Days)|Adverse Event|0|||
162892810|NCT00753623|588305746|FG001|Phase I (14 Days)|Adverse Event|1|||
162892811|NCT00753623|588305745|FG000|Washout (7 Days)|Physician Decision|1|||
162892812|NCT00753623|588305746|FG001|Washout (7 Days)|Physician Decision|0|||
162892813|NCT00753623|588305745|FG000|Phase II (14 Days)|Physician Decision|0|||
162892814|NCT00753623|588305746|FG001|Phase II (14 Days)|Physician Decision|1|||
162892815|NCT03332303|588305747|FG000|Overall Study|Participant did not dose|1|||
162892816|NCT03332303|588305748|FG001|Overall Study|Participant did not dose|2|||
162892817|NCT03332303|588305749|FG002|Overall Study|Participant did not dose|0|||
162892818|NCT03332303|588305747|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
162892819|NCT03332303|588305748|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
162892820|NCT03332303|588305749|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
162892821|NCT03332303|588305747|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
162892822|NCT03332303|588305748|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
162892823|NCT03332303|588305749|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
162892824|NCT03332303|588305747|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
162892825|NCT03332303|588305748|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
162892826|NCT03332303|588305749|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
162892827|NCT03332303|588305747|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
162892828|NCT03332303|588305748|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
162892829|NCT03332303|588305749|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
162892830|NCT03332303|588305747|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
162892831|NCT03332303|588305748|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
162892832|NCT03332303|588305749|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
162892833|NCT03332303|588305747|FG000|Overall Study|Participant had a significant protocol deviation|0|||
162892834|NCT03332303|588305748|FG001|Overall Study|Participant had a significant protocol deviation|1|||
162892835|NCT03332303|588305749|FG002|Overall Study|Participant had a significant protocol deviation|0|||
162892836|NCT05425719|588305750|FG000|Overall Study|Lost to Follow-up|4|||
162892837|NCT05425719|588305751|FG001|Overall Study|Lost to Follow-up|0|||
162892838|NCT05425719|588305750|FG000|Overall Study|Withdrew consent|1|||
162892839|NCT05425719|588305751|FG001|Overall Study|Withdrew consent|1|||
162892840|NCT00889681|588305752|FG000|Overall Study|Not meeting qualification Criteria|2|||
162892841|NCT00889681|588305752|FG000|Overall Study|Insurance disapproval|1|||
162892842|NCT01185704|588305753|FG000|Overall Study|Randomized but not treated|3|||
162892843|NCT01185704|588305754|FG001|Overall Study|Randomized but not treated|3|||
162892844|NCT01185704|588305753|FG000|Overall Study|Lack of ovarian response|5|||
162892845|NCT01185704|588305754|FG001|Overall Study|Lack of ovarian response|1|||
162892846|NCT01185704|588305753|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
162892847|NCT01185704|588305754|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
162892848|NCT01185704|588305753|FG000|Overall Study|Ectopic pregnancy|0|||
162964714|NCT01968031|588569862|FG001|Overall Study|Prohibited concomitant medication|0|||
162964715|NCT01968031|588569863|FG002|Overall Study|Prohibited concomitant medication|0|||
162964716|NCT00840879|588569864|FG000|Second Intervention|Withdrawal by Subject|1|||
162964717|NCT00840879|588569865|FG001|Second Intervention|Withdrawal by Subject|0|||
162892849|NCT01185704|588305754|FG001|Overall Study|Ectopic pregnancy|1|||
162892850|NCT00871572|588305755|FG000|Overall Study|Adverse Event|0|||
162892851|NCT00871572|588305756|FG001|Overall Study|Adverse Event|2|||
162892852|NCT00871572|588305757|FG002|Overall Study|Adverse Event|0|||
162892853|NCT00871572|588305758|FG003|Overall Study|Adverse Event|3|||
162892854|NCT00871572|588305755|FG000|Overall Study|Investigator Decision|0|||
162892855|NCT00871572|588305756|FG001|Overall Study|Investigator Decision|1|||
162892856|NCT00871572|588305757|FG002|Overall Study|Investigator Decision|0|||
162964718|NCT00477594|588569866|FG000|Year 1 and Year 2|Adverse Event|4|||
162964719|NCT00477594|588569867|FG001|Year 1 and Year 2|Adverse Event|2|||
162964720|NCT00477594|588569866|FG000|Year 1 and Year 2|Physician Decision|2|||
162622888|NCT02468674|587335348|FG002|Overall Study|Protocol Deviation|0|||
162622889|NCT02468674|587335349|FG003|Overall Study|Protocol Deviation|0|||
162622890|NCT02468674|587335350|FG004|Overall Study|Protocol Deviation|0|||
162622891|NCT02468674|587335351|FG005|Overall Study|Protocol Deviation|0|||
162622892|NCT02468674|587335352|FG006|Overall Study|Protocol Deviation|0|||
162892857|NCT00871572|588305758|FG003|Overall Study|Investigator Decision|1|||
162892858|NCT00871572|588305755|FG000|Overall Study|Lost to Follow-up|0|||
162892859|NCT00871572|588305756|FG001|Overall Study|Lost to Follow-up|1|||
162892860|NCT00871572|588305757|FG002|Overall Study|Lost to Follow-up|0|||
162892861|NCT00871572|588305758|FG003|Overall Study|Lost to Follow-up|1|||
162892862|NCT00871572|588305755|FG000|Overall Study|Protocol Violation|0|||
162892863|NCT00871572|588305756|FG001|Overall Study|Protocol Violation|0|||
162892864|NCT00871572|588305757|FG002|Overall Study|Protocol Violation|1|||
162892865|NCT00871572|588305758|FG003|Overall Study|Protocol Violation|1|||
162892866|NCT00871572|588305755|FG000|Overall Study|Sponsor Decision|1|||
162892867|NCT00871572|588305756|FG001|Overall Study|Sponsor Decision|0|||
162892868|NCT00871572|588305757|FG002|Overall Study|Sponsor Decision|0|||
162892869|NCT00871572|588305758|FG003|Overall Study|Sponsor Decision|0|||
162892870|NCT00871572|588305755|FG000|Overall Study|Withdrawal by Subject|1|||
162892871|NCT00871572|588305756|FG001|Overall Study|Withdrawal by Subject|2|||
162892872|NCT00871572|588305757|FG002|Overall Study|Withdrawal by Subject|3|||
162892873|NCT00871572|588305758|FG003|Overall Study|Withdrawal by Subject|1|||
162892874|NCT00345540|588305759|FG000|Overall Study|Withdrawal by Subject|1|||
162892875|NCT04179786|588305760|FG000|Overall Study|Withdrawal by Subject|8|||
162892876|NCT01938001|588305761|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
162892877|NCT01938001|588305762|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
162892878|NCT01938001|588305761|FG000|Pre-Treatment|Death|1|||
162892879|NCT01938001|588305762|FG001|Pre-Treatment|Death|0|||
162892880|NCT01938001|588305761|FG000|Treatment|Death|2|||
162892881|NCT01938001|588305762|FG001|Treatment|Death|0|||
162892882|NCT01938001|588305761|FG000|Treatment|Adverse Event|14|||
162892883|NCT01938001|588305762|FG001|Treatment|Adverse Event|8|||
162892884|NCT01938001|588305761|FG000|Treatment|Progressive Disease|21|||
162892885|NCT01938001|588305762|FG001|Treatment|Progressive Disease|54|||
162892886|NCT01938001|588305761|FG000|Treatment|Withdrawal by Subject|13|||
162892887|NCT01938001|588305762|FG001|Treatment|Withdrawal by Subject|7|||
162892888|NCT01938001|588305761|FG000|Treatment|Other reasons|2|||
162892889|NCT01938001|588305762|FG001|Treatment|Other reasons|1|||
162892890|NCT03310580|588305763|FG000|Overall Study|Adverse Event|0|||
162892891|NCT03310580|588305764|FG001|Overall Study|Adverse Event|1|||
162892892|NCT03310580|588305765|FG002|Overall Study|Adverse Event|0|||
162892893|NCT03205982|588305766|FG000|Overall Study|Lost to Follow-up|20|||
162892894|NCT03205982|588305767|FG001|Overall Study|Lost to Follow-up|19|||
162892895|NCT03205982|588305766|FG000|Overall Study|Withdrawal by Subject|4|||
162892896|NCT03205982|588305767|FG001|Overall Study|Withdrawal by Subject|3|||
162892897|NCT03205982|588305766|FG000|Overall Study|Withdrawal by PI|0|||
162892898|NCT03205982|588305767|FG001|Overall Study|Withdrawal by PI|1|||
162892899|NCT01468701|588305770|FG000|Overall Study|Not eligible|91|||
162892900|NCT01468701|588305771|FG001|Overall Study|Not eligible|140|||
162892901|NCT01468701|588305772|FG002|Overall Study|Not eligible|29|||
162892902|NCT01468701|588305773|FG003|Overall Study|Not eligible|12|||
162892903|NCT01468701|588305774|FG004|Overall Study|Not eligible|22|||
162892904|NCT01468701|588305775|FG005|Overall Study|Not eligible|2|||
162892905|NCT01468701|588305776|FG006|Overall Study|Not eligible|39|||
162892906|NCT01468701|588305777|FG007|Overall Study|Not eligible|1|||
162892907|NCT01468701|588305778|FG008|Overall Study|Not eligible|40|||
162892908|NCT01468701|588305779|FG009|Overall Study|Not eligible|126|||
162892909|NCT01468701|588305780|FG010|Overall Study|Not eligible|39|||
162892910|NCT01468701|588305781|FG011|Overall Study|Not eligible|33|||
162892911|NCT01468701|588305782|FG012|Overall Study|Not eligible|1|||
162892912|NCT01468701|588305783|FG013|Overall Study|Not eligible|19|||
162892913|NCT01468701|588305784|FG014|Overall Study|Not eligible|1|||
162892914|NCT01468701|588305785|FG015|Overall Study|Not eligible|32|||
162622893|NCT02468674|587335353|FG007|Overall Study|Protocol Deviation|1|||
162622894|NCT02468674|587335354|FG008|Overall Study|Protocol Deviation|1|||
162622895|NCT01687998|587335362|FG000|Overall Study|Withdrawal by Subject|49|||
162622896|NCT01687998|587335363|FG001|Overall Study|Withdrawal by Subject|51|||
162892915|NCT01468701|588305786|FG016|Overall Study|Not eligible|0|||
162892916|NCT01468701|588305770|FG000|Overall Study|Lost to Follow-up|306|||
162892917|NCT01468701|588305771|FG001|Overall Study|Lost to Follow-up|0|||
162892918|NCT01468701|588305772|FG002|Overall Study|Lost to Follow-up|0|||
162892919|NCT01468701|588305773|FG003|Overall Study|Lost to Follow-up|0|||
162892920|NCT01468701|588305774|FG004|Overall Study|Lost to Follow-up|0|||
162892921|NCT01468701|588305775|FG005|Overall Study|Lost to Follow-up|0|||
162892922|NCT01468701|588305776|FG006|Overall Study|Lost to Follow-up|0|||
162892923|NCT01468701|588305777|FG007|Overall Study|Lost to Follow-up|0|||
162892924|NCT01468701|588305778|FG008|Overall Study|Lost to Follow-up|215|||
162892925|NCT01468701|588305779|FG009|Overall Study|Lost to Follow-up|309|||
162892926|NCT01468701|588305780|FG010|Overall Study|Lost to Follow-up|224|||
162892927|NCT01468701|588305781|FG011|Overall Study|Lost to Follow-up|212|||
162892928|NCT01468701|588305782|FG012|Overall Study|Lost to Follow-up|11|||
162708725|NCT04833855|587642882|FG002|Overall Study|Withdrawal by Subject|3|||
162708726|NCT04833855|587642883|FG003|Overall Study|Withdrawal by Subject|1|||
162892929|NCT01468701|588305783|FG013|Overall Study|Lost to Follow-up|164|||
162892930|NCT01468701|588305784|FG014|Overall Study|Lost to Follow-up|17|||
162892931|NCT01468701|588305785|FG015|Overall Study|Lost to Follow-up|127|||
162892932|NCT01468701|588305786|FG016|Overall Study|Lost to Follow-up|1|||
162892933|NCT01468701|588305770|FG000|Overall Study|Withdrawal by Subject|165|||
162892934|NCT01468701|588305771|FG001|Overall Study|Withdrawal by Subject|0|||
162892935|NCT01468701|588305772|FG002|Overall Study|Withdrawal by Subject|0|||
162892936|NCT01468701|588305773|FG003|Overall Study|Withdrawal by Subject|0|||
162892937|NCT01468701|588305774|FG004|Overall Study|Withdrawal by Subject|0|||
162892938|NCT01468701|588305775|FG005|Overall Study|Withdrawal by Subject|0|||
162892939|NCT01468701|588305776|FG006|Overall Study|Withdrawal by Subject|0|||
162892940|NCT01468701|588305777|FG007|Overall Study|Withdrawal by Subject|0|||
162892941|NCT01468701|588305778|FG008|Overall Study|Withdrawal by Subject|83|||
162892942|NCT01468701|588305779|FG009|Overall Study|Withdrawal by Subject|88|||
162892943|NCT01468701|588305780|FG010|Overall Study|Withdrawal by Subject|100|||
162892944|NCT01468701|588305781|FG011|Overall Study|Withdrawal by Subject|114|||
162892945|NCT01468701|588305782|FG012|Overall Study|Withdrawal by Subject|9|||
162892946|NCT01468701|588305783|FG013|Overall Study|Withdrawal by Subject|47|||
162892947|NCT01468701|588305784|FG014|Overall Study|Withdrawal by Subject|6|||
162892948|NCT01468701|588305785|FG015|Overall Study|Withdrawal by Subject|31|||
162892949|NCT01468701|588305786|FG016|Overall Study|Withdrawal by Subject|0|||
162892950|NCT01468701|588305770|FG000|Overall Study|Other reasons than listed|437|||
162892951|NCT01468701|588305771|FG001|Overall Study|Other reasons than listed|0|||
162892952|NCT01468701|588305772|FG002|Overall Study|Other reasons than listed|0|||
162892953|NCT01468701|588305773|FG003|Overall Study|Other reasons than listed|0|||
162892954|NCT01468701|588305774|FG004|Overall Study|Other reasons than listed|0|||
162892955|NCT01468701|588305775|FG005|Overall Study|Other reasons than listed|0|||
162892956|NCT01468701|588305776|FG006|Overall Study|Other reasons than listed|0|||
162892957|NCT01468701|588305777|FG007|Overall Study|Other reasons than listed|0|||
162892958|NCT01468701|588305778|FG008|Overall Study|Other reasons than listed|318|||
162892959|NCT01468701|588305779|FG009|Overall Study|Other reasons than listed|658|||
162892960|NCT01468701|588305780|FG010|Overall Study|Other reasons than listed|433|||
162892961|NCT01468701|588305781|FG011|Overall Study|Other reasons than listed|504|||
162892962|NCT01468701|588305782|FG012|Overall Study|Other reasons than listed|28|||
162892963|NCT01468701|588305783|FG013|Overall Study|Other reasons than listed|239|||
162892964|NCT01468701|588305784|FG014|Overall Study|Other reasons than listed|39|||
162892965|NCT01468701|588305785|FG015|Overall Study|Other reasons than listed|172|||
162892966|NCT01468701|588305786|FG016|Overall Study|Other reasons than listed|0|||
162892967|NCT01468701|588305770|FG000|Overall Study|No end of study case report form|0|||
162892968|NCT01468701|588305771|FG001|Overall Study|No end of study case report form|0|||
162892969|NCT01468701|588305772|FG002|Overall Study|No end of study case report form|0|||
162892970|NCT01468701|588305773|FG003|Overall Study|No end of study case report form|0|||
162892971|NCT01468701|588305774|FG004|Overall Study|No end of study case report form|0|||
162892972|NCT01468701|588305775|FG005|Overall Study|No end of study case report form|0|||
162892973|NCT01468701|588305776|FG006|Overall Study|No end of study case report form|0|||
162892974|NCT01468701|588305777|FG007|Overall Study|No end of study case report form|0|||
162892975|NCT01468701|588305778|FG008|Overall Study|No end of study case report form|4|||
162892976|NCT01468701|588305779|FG009|Overall Study|No end of study case report form|1|||
162892977|NCT01468701|588305780|FG010|Overall Study|No end of study case report form|2|||
162892978|NCT01468701|588305781|FG011|Overall Study|No end of study case report form|3|||
162892979|NCT01468701|588305782|FG012|Overall Study|No end of study case report form|0|||
162892980|NCT01468701|588305783|FG013|Overall Study|No end of study case report form|1|||
162892981|NCT01468701|588305784|FG014|Overall Study|No end of study case report form|0|||
162892982|NCT01468701|588305785|FG015|Overall Study|No end of study case report form|0|||
162708727|NCT04833855|587642880|FG000|Overall Study|Lost to Follow-up|1|||
162892983|NCT01468701|588305786|FG016|Overall Study|No end of study case report form|0|||
162892984|NCT01468701|588305770|FG000|Overall Study|Not being followed up|0|||
162708728|NCT04833855|587642881|FG001|Overall Study|Lost to Follow-up|0|||
162708729|NCT04833855|587642882|FG002|Overall Study|Lost to Follow-up|2|||
162892985|NCT01468701|588305771|FG001|Overall Study|Not being followed up|4963|||
162892986|NCT01468701|588305772|FG002|Overall Study|Not being followed up|1755|||
162892987|NCT01468701|588305773|FG003|Overall Study|Not being followed up|703|||
162708730|NCT04833855|587642883|FG003|Overall Study|Lost to Follow-up|2|||
162892988|NCT01468701|588305774|FG004|Overall Study|Not being followed up|1714|||
162892989|NCT01468701|588305775|FG005|Overall Study|Not being followed up|126|||
162892990|NCT01468701|588305776|FG006|Overall Study|Not being followed up|1170|||
162708731|NCT04833855|587642880|FG000|Overall Study|Protocol specified criteria|0|||
162892991|NCT01468701|588305777|FG007|Overall Study|Not being followed up|4|||
162892992|NCT01468701|588305778|FG008|Overall Study|Not being followed up|0|||
162964721|NCT00477594|588569867|FG001|Year 1 and Year 2|Physician Decision|1|||
162708732|NCT04833855|587642881|FG001|Overall Study|Protocol specified criteria|0|||
162964722|NCT00477594|588569866|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
162892993|NCT01468701|588305779|FG009|Overall Study|Not being followed up|0|||
162892994|NCT01468701|588305780|FG010|Overall Study|Not being followed up|0|||
162892995|NCT01468701|588305781|FG011|Overall Study|Not being followed up|0|||
162892996|NCT01468701|588305782|FG012|Overall Study|Not being followed up|0|||
162892997|NCT01468701|588305783|FG013|Overall Study|Not being followed up|0|||
162892998|NCT01468701|588305784|FG014|Overall Study|Not being followed up|0|||
162892999|NCT01468701|588305785|FG015|Overall Study|Not being followed up|0|||
162893000|NCT01468701|588305786|FG016|Overall Study|Not being followed up|0|||
162893001|NCT01079195|588305794|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
162893002|NCT01079195|588305794|FG000|Overall Study|No Documentation Available|437|||
162893003|NCT01079195|588305794|FG000|Overall Study|Adverse Event|157|||
162893004|NCT01079195|588305794|FG000|Overall Study|Reason Unknown|39|||
162893005|NCT01079195|588305794|FG000|Overall Study|Withdrawal by Subject|18|||
162893006|NCT01079195|588305794|FG000|Overall Study|Financial Reasons|15|||
162893007|NCT01079195|588305794|FG000|Overall Study|Lack of Effectiveness|12|||
162893008|NCT01079195|588305794|FG000|Overall Study|Physician Decision|4|||
162893009|NCT01079195|588305794|FG000|Overall Study|Improved Status of Participant|4|||
162893010|NCT01079195|588305794|FG000|Overall Study|No Follow-up Documentation Available|4|||
162893011|NCT01079195|588305794|FG000|Overall Study|Non-compliance|2|||
162893012|NCT01999946|588305795|FG000|Overall Study|Participant not released from jail|2|||
162893013|NCT01999946|588305796|FG001|Overall Study|Participant not released from jail|2|||
162893014|NCT01999946|588305797|FG002|Overall Study|Participant not released from jail|0|||
162893015|NCT01999946|588305795|FG000|Overall Study|Not included in primary outcome analysis|0|||
162893016|NCT01999946|588305796|FG001|Overall Study|Not included in primary outcome analysis|0|||
162893017|NCT01999946|588305797|FG002|Overall Study|Not included in primary outcome analysis|79|||
162893018|NCT01105936|588307241|FG000|Period 1|Adverse Event|0|||
162893019|NCT01105936|588307242|FG001|Period 1|Adverse Event|0|||
162893020|NCT01105936|588307243|FG002|Period 1|Adverse Event|0|||
162893021|NCT01105936|588307244|FG003|Period 1|Adverse Event|1|||
162893022|NCT01105936|588307241|FG000|Period 2|Adverse Event|1|||
162893023|NCT01105936|588307242|FG001|Period 2|Adverse Event|0|||
162893024|NCT01105936|588307243|FG002|Period 2|Adverse Event|0|||
162893025|NCT01105936|588307244|FG003|Period 2|Adverse Event|0|||
162893026|NCT01105936|588307241|FG000|Period 3|Protocol Violation|0|||
162893027|NCT01105936|588307242|FG001|Period 3|Protocol Violation|2|||
162893028|NCT01105936|588307243|FG002|Period 3|Protocol Violation|0|||
162893029|NCT01105936|588307244|FG003|Period 3|Protocol Violation|0|||
162893030|NCT03907969|588307246|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
162893031|NCT03907969|588307247|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
162893032|NCT03907969|588307248|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
162893033|NCT03907969|588307249|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
162893034|NCT03907969|588307250|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
162893035|NCT03907969|588307251|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
162893036|NCT03907969|588307252|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
162893037|NCT03907969|588307253|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
162893038|NCT03907969|588307254|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
162893039|NCT03907969|588307255|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
162893040|NCT03907969|588307256|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
162893041|NCT03907969|588307246|FG000|Monotherapy Part A|Progressive Disease|0|||
162893042|NCT03907969|588307247|FG001|Monotherapy Part A|Progressive Disease|1|||
162893043|NCT03907969|588307248|FG002|Monotherapy Part A|Progressive Disease|0|||
162893044|NCT03907969|588307249|FG003|Monotherapy Part A|Progressive Disease|0|||
162893045|NCT03907969|588307250|FG004|Monotherapy Part A|Progressive Disease|0|||
162893046|NCT03907969|588307251|FG005|Monotherapy Part A|Progressive Disease|1|||
162893047|NCT03907969|588307252|FG006|Monotherapy Part A|Progressive Disease|2|||
162893048|NCT03907969|588307253|FG007|Monotherapy Part A|Progressive Disease|0|||
162893049|NCT03907969|588307254|FG008|Monotherapy Part A|Progressive Disease|0|||
162893050|NCT03907969|588307255|FG009|Monotherapy Part A|Progressive Disease|0|||
162893051|NCT03907969|588307256|FG010|Monotherapy Part A|Progressive Disease|0|||
162893052|NCT03907969|588307246|FG000|Monotherapy Part A|Death|0|||
162893053|NCT03907969|588307247|FG001|Monotherapy Part A|Death|0|||
162893054|NCT03907969|588307248|FG002|Monotherapy Part A|Death|1|||
162893055|NCT03907969|588307249|FG003|Monotherapy Part A|Death|1|||
162893056|NCT03907969|588307250|FG004|Monotherapy Part A|Death|0|||
162893057|NCT03907969|588307251|FG005|Monotherapy Part A|Death|1|||
162893058|NCT03907969|588307252|FG006|Monotherapy Part A|Death|0|||
162893059|NCT03907969|588307253|FG007|Monotherapy Part A|Death|0|||
162893060|NCT03907969|588307254|FG008|Monotherapy Part A|Death|0|||
162893061|NCT03907969|588307255|FG009|Monotherapy Part A|Death|0|||
162893062|NCT03907969|588307256|FG010|Monotherapy Part A|Death|0|||
162893063|NCT03907969|588307246|FG000|Combination Therapy Part A|Adverse Event|0|||
162893064|NCT03907969|588307247|FG001|Combination Therapy Part A|Adverse Event|0|||
162893065|NCT03907969|588307248|FG002|Combination Therapy Part A|Adverse Event|0|||
162893066|NCT03907969|588307249|FG003|Combination Therapy Part A|Adverse Event|0|||
162893067|NCT03907969|588307250|FG004|Combination Therapy Part A|Adverse Event|0|||
162893068|NCT03907969|588307251|FG005|Combination Therapy Part A|Adverse Event|0|||
162893069|NCT03907969|588307252|FG006|Combination Therapy Part A|Adverse Event|0|||
162893070|NCT03907969|588307253|FG007|Combination Therapy Part A|Adverse Event|0|||
162893071|NCT03907969|588307254|FG008|Combination Therapy Part A|Adverse Event|0|||
162893072|NCT03907969|588307255|FG009|Combination Therapy Part A|Adverse Event|1|||
162893073|NCT03907969|588307256|FG010|Combination Therapy Part A|Adverse Event|1|||
162893074|NCT03907969|588307246|FG000|Combination Therapy Part A|Progressive disease|0|||
162893075|NCT03907969|588307247|FG001|Combination Therapy Part A|Progressive disease|0|||
162893076|NCT03907969|588307248|FG002|Combination Therapy Part A|Progressive disease|0|||
162893077|NCT03907969|588307249|FG003|Combination Therapy Part A|Progressive disease|0|||
162893078|NCT03907969|588307250|FG004|Combination Therapy Part A|Progressive disease|0|||
162893079|NCT03907969|588307251|FG005|Combination Therapy Part A|Progressive disease|0|||
162893080|NCT03907969|588307252|FG006|Combination Therapy Part A|Progressive disease|0|||
162893081|NCT03907969|588307253|FG007|Combination Therapy Part A|Progressive disease|1|||
162893082|NCT03907969|588307254|FG008|Combination Therapy Part A|Progressive disease|0|||
162893083|NCT03907969|588307255|FG009|Combination Therapy Part A|Progressive disease|2|||
162893084|NCT03907969|588307256|FG010|Combination Therapy Part A|Progressive disease|3|||
162893085|NCT03907969|588307246|FG000|Combination Therapy Part A|Death|0|||
162893086|NCT03907969|588307247|FG001|Combination Therapy Part A|Death|0|||
162893087|NCT03907969|588307248|FG002|Combination Therapy Part A|Death|0|||
162893088|NCT03907969|588307249|FG003|Combination Therapy Part A|Death|0|||
162893089|NCT03907969|588307250|FG004|Combination Therapy Part A|Death|0|||
162893090|NCT03907969|588307251|FG005|Combination Therapy Part A|Death|0|||
162893091|NCT03907969|588307252|FG006|Combination Therapy Part A|Death|0|||
162893092|NCT03907969|588307253|FG007|Combination Therapy Part A|Death|0|||
162893093|NCT03907969|588307254|FG008|Combination Therapy Part A|Death|1|||
162893094|NCT03907969|588307255|FG009|Combination Therapy Part A|Death|0|||
162893095|NCT03907969|588307256|FG010|Combination Therapy Part A|Death|1|||
162893096|NCT03907969|588307246|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
162893097|NCT03907969|588307247|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
162893098|NCT03907969|588307248|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
162893099|NCT03907969|588307249|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
162893100|NCT03907969|588307250|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
162893101|NCT03907969|588307251|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
162893102|NCT03907969|588307252|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
162893103|NCT03907969|588307253|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
162893104|NCT03907969|588307254|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
162893105|NCT03907969|588307255|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
162893106|NCT03907969|588307256|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
162893107|NCT03907969|588307246|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
162893108|NCT03907969|588307247|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
162893109|NCT03907969|588307248|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
162893110|NCT03907969|588307249|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
162893111|NCT03907969|588307250|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
162893112|NCT03907969|588307251|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
162893113|NCT03907969|588307252|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
162893114|NCT03907969|588307253|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
162893115|NCT03907969|588307254|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
162893116|NCT03907969|588307255|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
162893117|NCT03907969|588307256|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
162893118|NCT03907969|588307246|FG000|Combination Therapy Part A|Physician Decision|0|||
162893119|NCT03907969|588307247|FG001|Combination Therapy Part A|Physician Decision|0|||
162893120|NCT03907969|588307248|FG002|Combination Therapy Part A|Physician Decision|0|||
162893121|NCT03907969|588307249|FG003|Combination Therapy Part A|Physician Decision|0|||
162893122|NCT03907969|588307250|FG004|Combination Therapy Part A|Physician Decision|0|||
162893123|NCT03907969|588307251|FG005|Combination Therapy Part A|Physician Decision|0|||
162893124|NCT03907969|588307252|FG006|Combination Therapy Part A|Physician Decision|0|||
162893125|NCT03907969|588307253|FG007|Combination Therapy Part A|Physician Decision|1|||
162893126|NCT03907969|588307254|FG008|Combination Therapy Part A|Physician Decision|0|||
162893127|NCT03907969|588307255|FG009|Combination Therapy Part A|Physician Decision|0|||
162893128|NCT03907969|588307256|FG010|Combination Therapy Part A|Physician Decision|1|||
162893129|NCT00666536|588307257|FG000|Overall Study|Adverse Event|9|||
162893130|NCT00666536|588307258|FG001|Overall Study|Adverse Event|19|||
162893131|NCT00666536|588307257|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162893132|NCT00666536|588307258|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162893133|NCT00666536|588307257|FG000|Overall Study|Protocol deviation(s)|8|||
162893134|NCT00666536|588307258|FG001|Overall Study|Protocol deviation(s)|6|||
162893135|NCT00666536|588307257|FG000|Overall Study|Withdrawal by Subject|10|||
162893136|NCT00666536|588307258|FG001|Overall Study|Withdrawal by Subject|9|||
162893137|NCT00666536|588307257|FG000|Overall Study|Lost to Follow-up|4|||
162893138|NCT00666536|588307258|FG001|Overall Study|Lost to Follow-up|3|||
162893139|NCT02853123|588307262|FG000|Treatment Period 1|Adverse Event|0|||
162893140|NCT02853123|588307263|FG001|Treatment Period 1|Adverse Event|3|||
162893141|NCT02853123|588307262|FG000|Washout Period|Worsening of COPD|0|||
162893142|NCT02853123|588307263|FG001|Washout Period|Worsening of COPD|3|||
162893143|NCT02853123|588307262|FG000|Washout Period|Adverse Event|1|||
162893144|NCT02853123|588307263|FG001|Washout Period|Adverse Event|0|||
162893145|NCT01419015|588307276|FG000|Overall Study|Death|2|||
162893146|NCT01510028|588307277|FG000|Overall Study|Lack of Efficacy|1|||
162893147|NCT01510028|588307278|FG001|Overall Study|Lack of Efficacy|0|||
162893148|NCT01510028|588307279|FG002|Overall Study|Lack of Efficacy|0|||
162893149|NCT01510028|588307280|FG003|Overall Study|Lack of Efficacy|0|||
162893150|NCT00633893|588307281|FG000|Overall Study|Death|1|||
162893151|NCT00633893|588307282|FG001|Overall Study|Death|3|||
162893152|NCT00633893|588307283|FG002|Overall Study|Death|9|||
162893153|NCT00633893|588307281|FG000|Overall Study|Adverse Event|65|||
162893154|NCT00633893|588307282|FG001|Overall Study|Adverse Event|58|||
162893155|NCT00633893|588307283|FG002|Overall Study|Adverse Event|126|||
162893156|NCT00633893|588307281|FG000|Overall Study|Withdrawal by Subject|7|||
162893157|NCT00633893|588307282|FG001|Overall Study|Withdrawal by Subject|12|||
162893158|NCT00633893|588307283|FG002|Overall Study|Withdrawal by Subject|6|||
162893159|NCT00633893|588307281|FG000|Overall Study|Lost to Follow-up|2|||
162893160|NCT00633893|588307282|FG001|Overall Study|Lost to Follow-up|4|||
162893161|NCT00633893|588307283|FG002|Overall Study|Lost to Follow-up|8|||
162893162|NCT00633893|588307281|FG000|Overall Study|Poor/non-compliance|5|||
162893163|NCT00633893|588307282|FG001|Overall Study|Poor/non-compliance|12|||
162893164|NCT00633893|588307283|FG002|Overall Study|Poor/non-compliance|3|||
162893165|NCT00633893|588307281|FG000|Overall Study|Pregnancy|2|||
162893166|NCT00633893|588307282|FG001|Overall Study|Pregnancy|1|||
162893167|NCT00633893|588307283|FG002|Overall Study|Pregnancy|1|||
162893168|NCT00633893|588307281|FG000|Overall Study|Not meet/no longer meets criteria|4|||
162893169|NCT00633893|588307282|FG001|Overall Study|Not meet/no longer meets criteria|6|||
162893170|NCT00633893|588307283|FG002|Overall Study|Not meet/no longer meets criteria|4|||
162893171|NCT00633893|588307281|FG000|Overall Study|Other|28|||
162893172|NCT00633893|588307282|FG001|Overall Study|Other|33|||
162893173|NCT00633893|588307283|FG002|Overall Study|Other|31|||
162893174|NCT02741310|588307284|FG000|Overall Study|Sponsor Decision|2|||
162893175|NCT02741310|588307285|FG001|Overall Study|Sponsor Decision|2|||
162893176|NCT01784211|588307286|FG000|Part A (Days 1-15)|Adverse Event|1|||
162893177|NCT01784211|588307287|FG001|Part A (Days 1-15)|Adverse Event|1|||
162893178|NCT01784211|588307288|FG002|Part A (Days 1-15)|Adverse Event|0|||
162893179|NCT01784211|588307289|FG003|Part A (Days 1-15)|Adverse Event|0|||
162893180|NCT01784211|588307290|FG004|Part A (Days 1-15)|Adverse Event|0|||
162893181|NCT01784211|588307291|FG005|Part A (Days 1-15)|Adverse Event|0|||
162893182|NCT01784211|588307286|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
162893183|NCT01784211|588307287|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
162893184|NCT01784211|588307288|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
162893185|NCT01784211|588307289|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
162893186|NCT01784211|588307290|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
162893187|NCT01784211|588307291|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
162893188|NCT01017549|588307292|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
162893189|NCT01017549|588307292|FG000|One-year Follow-up|Lost to Follow-up|2|||
162893190|NCT01017549|588307292|FG000|One-year Follow-up|Withdrawal by Subject|5|||
162893191|NCT01017549|588307292|FG000|5 Year Follow-up|Lost to Follow-up|9|||
162893192|NCT01017549|588307292|FG000|5 Year Follow-up|Mastectomy|3|||
162893193|NCT03725293|588307301|FG000|Overall Study|Physician Decision|9|||
162893194|NCT03725293|588307302|FG001|Overall Study|Physician Decision|6|||
162893195|NCT03725293|588307301|FG000|Overall Study|alternative vascular access needs|1|||
162893196|NCT03725293|588307302|FG001|Overall Study|alternative vascular access needs|2|||
162893197|NCT03725293|588307301|FG000|Overall Study|venous anatomy screen failures|2|||
162893198|NCT03725293|588307302|FG001|Overall Study|venous anatomy screen failures|1|||
162893199|NCT02143141|588307303|FG000|Overall Study|pain scores at 24 hours not collected|1|||
162893200|NCT02143141|588307304|FG001|Overall Study|pain scores at 24 hours not collected|0|||
162893201|NCT02255760|588307305|FG000|Overall Study|Lost to Follow-up|0|||
162893202|NCT02255760|588307306|FG001|Overall Study|Lost to Follow-up|1|||
162893203|NCT02255760|588307307|FG002|Overall Study|Lost to Follow-up|0|||
162893204|NCT02255760|588307308|FG003|Overall Study|Lost to Follow-up|0|||
162893205|NCT02255760|588307309|FG004|Overall Study|Lost to Follow-up|0|||
162893206|NCT00003838|588307310|FG000|Overall Study|Death|0|||
162893207|NCT00003838|588307311|FG001|Overall Study|Death|12|||
162893208|NCT00003838|588307312|FG002|Overall Study|Death|7|||
162893209|NCT00003838|588307310|FG000|Overall Study|Lost to Follow-up|0|||
162893210|NCT00003838|588307311|FG001|Overall Study|Lost to Follow-up|1|||
162893211|NCT00003838|588307312|FG002|Overall Study|Lost to Follow-up|1|||
162893212|NCT00003838|588307310|FG000|Overall Study|Disease Progression|0|||
162893213|NCT00003838|588307311|FG001|Overall Study|Disease Progression|12|||
162893214|NCT00003838|588307312|FG002|Overall Study|Disease Progression|0|||
162893215|NCT03228394|588307313|FG000|Overall Study|Lost to Follow-up|0|||
162893216|NCT03228394|588307314|FG001|Overall Study|Lost to Follow-up|0|||
162893217|NCT03228394|588307315|FG002|Overall Study|Lost to Follow-up|1|||
162893218|NCT03228394|588307316|FG003|Overall Study|Lost to Follow-up|1|||
162893219|NCT03228394|588307317|FG004|Overall Study|Lost to Follow-up|0|||
162893220|NCT03228394|588307318|FG005|Overall Study|Lost to Follow-up|0|||
162893221|NCT03228394|588307319|FG006|Overall Study|Lost to Follow-up|2|||
162893222|NCT03228394|588307320|FG007|Overall Study|Lost to Follow-up|0|||
162893223|NCT03228394|588307313|FG000|Overall Study|Withdrawal by Subject|0|||
162893224|NCT03228394|588307314|FG001|Overall Study|Withdrawal by Subject|0|||
162893225|NCT03228394|588307315|FG002|Overall Study|Withdrawal by Subject|1|||
162893226|NCT03228394|588307316|FG003|Overall Study|Withdrawal by Subject|0|||
162893227|NCT03228394|588307317|FG004|Overall Study|Withdrawal by Subject|0|||
162893228|NCT03228394|588307318|FG005|Overall Study|Withdrawal by Subject|0|||
162893229|NCT03228394|588307319|FG006|Overall Study|Withdrawal by Subject|1|||
162893230|NCT03228394|588307320|FG007|Overall Study|Withdrawal by Subject|3|||
162893231|NCT03228394|588307313|FG000|Overall Study|Protocol Violation|0|||
162893232|NCT03228394|588307314|FG001|Overall Study|Protocol Violation|0|||
162893233|NCT03228394|588307315|FG002|Overall Study|Protocol Violation|0|||
162893234|NCT03228394|588307316|FG003|Overall Study|Protocol Violation|1|||
162893235|NCT03228394|588307317|FG004|Overall Study|Protocol Violation|0|||
162893236|NCT03228394|588307318|FG005|Overall Study|Protocol Violation|0|||
162893237|NCT03228394|588307319|FG006|Overall Study|Protocol Violation|0|||
162893238|NCT03228394|588307320|FG007|Overall Study|Protocol Violation|0|||
162893239|NCT03228394|588307313|FG000|Overall Study|Physician Decision|0|||
162893240|NCT03228394|588307314|FG001|Overall Study|Physician Decision|0|||
162893241|NCT03228394|588307315|FG002|Overall Study|Physician Decision|0|||
162893242|NCT03228394|588307316|FG003|Overall Study|Physician Decision|0|||
162893243|NCT03228394|588307317|FG004|Overall Study|Physician Decision|0|||
162893244|NCT03228394|588307318|FG005|Overall Study|Physician Decision|0|||
162893245|NCT03228394|588307319|FG006|Overall Study|Physician Decision|1|||
162893246|NCT03228394|588307320|FG007|Overall Study|Physician Decision|0|||
162893247|NCT03228394|588307313|FG000|Overall Study|Noncompliance|0|||
162893248|NCT03228394|588307314|FG001|Overall Study|Noncompliance|0|||
162893249|NCT03228394|588307315|FG002|Overall Study|Noncompliance|0|||
162893250|NCT03228394|588307316|FG003|Overall Study|Noncompliance|0|||
162893251|NCT03228394|588307317|FG004|Overall Study|Noncompliance|0|||
162893252|NCT03228394|588307318|FG005|Overall Study|Noncompliance|0|||
162893253|NCT03228394|588307319|FG006|Overall Study|Noncompliance|1|||
162893254|NCT03228394|588307320|FG007|Overall Study|Noncompliance|0|||
162893255|NCT00291187|588307321|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
162893256|NCT00291187|588307322|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
162893257|NCT00291187|588307323|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
162893258|NCT00291187|588307324|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
162893259|NCT02023268|588307325|FG000|Overall Study|Lack of Efficacy|0|||
162893260|NCT02023268|588307326|FG001|Overall Study|Lack of Efficacy|1|||
162893261|NCT02023268|588307325|FG000|Overall Study|Adverse Event|0|||
162893262|NCT02023268|588307326|FG001|Overall Study|Adverse Event|2|||
162893263|NCT02023268|588307325|FG000|Overall Study|Withdrawal by Subject|0|||
162893264|NCT02023268|588307326|FG001|Overall Study|Withdrawal by Subject|1|||
162893265|NCT00126672|588307328|FG000|Overall Study|Adverse Event|4|||
162893266|NCT00126672|588307328|FG000|Overall Study|Lost to Follow-up|4|||
162893267|NCT01296698|588307333|FG000|Overall Study|Adverse Event|1|||
162893268|NCT01296698|588307334|FG001|Overall Study|Adverse Event|0|||
162893269|NCT01296698|588307333|FG000|Overall Study|Death|1|||
162893270|NCT01296698|588307334|FG001|Overall Study|Death|0|||
162893271|NCT01296698|588307333|FG000|Overall Study|Lost to Follow-up|19|||
162893272|NCT01296698|588307334|FG001|Overall Study|Lost to Follow-up|1|||
162893273|NCT01296698|588307333|FG000|Overall Study|Withdrawal by Subject|12|||
162893274|NCT01296698|588307334|FG001|Overall Study|Withdrawal by Subject|0|||
163051847|NCT02974868|588898737|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
163051848|NCT02974868|588898734|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
162622897|NCT01687998|587335362|FG000|Overall Study|Known to be Alive at Study End|54|||
162622898|NCT01687998|587335363|FG001|Overall Study|Known to be Alive at Study End|62|||
162622899|NCT01687998|587335362|FG000|Overall Study|Lost to Follow-up|9|||
162622900|NCT01687998|587335363|FG001|Overall Study|Lost to Follow-up|7|||
162622901|NCT00443261|587335366|FG000|Overall Study|Death|1|||
162622902|NCT01663532|587335367|FG000|Overall Study|Lost to Follow-up|9|||
162622903|NCT01663532|587335368|FG001|Overall Study|Lost to Follow-up|10|||
162622904|NCT01663532|587335367|FG000|Overall Study|Adverse Event|7|||
162893275|NCT01296698|588307333|FG000|Overall Study|Difficulty Contacting Subject|2|||
162893276|NCT01296698|588307334|FG001|Overall Study|Difficulty Contacting Subject|0|||
162893277|NCT01296698|588307333|FG000|Overall Study|Study Terminated by Sponsor|209|||
162893278|NCT01296698|588307334|FG001|Overall Study|Study Terminated by Sponsor|12|||
162893279|NCT03495817|588307338|FG000|26 Week Open Label|Adverse Event|3|||
162893280|NCT03495817|588307338|FG000|26 Week Open Label|Withdrawal by Subject|4|||
162893281|NCT03495817|588307338|FG000|26 Week Open Label|Lost to Follow-up|1|||
162893282|NCT03495817|588307338|FG000|26 Week Extension|Lost to Follow-up|2|||
162893283|NCT01957787|588307339|FG000|Overall Study|Death|18|||
162893284|NCT01957787|588307339|FG000|Overall Study|Lost to Follow-up|3|||
162893285|NCT01957787|588307339|FG000|Overall Study|Withdrawal by Subject|3|||
162893286|NCT01957787|588307339|FG000|Overall Study|Entered Hospice or Similar Program|2|||
162893287|NCT01957787|588307339|FG000|Overall Study|Index Tumor(s) Resected|2|||
162893288|NCT01957787|588307339|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
162893289|NCT01957787|588307339|FG000|Overall Study|Local therapy, not cryoablation|6|||
162893290|NCT01686958|588307340|FG000|Overall Study|Withdrawal by Subject|1|||
162893291|NCT04294095|588307349|FG000|Overall Study|Adverse Event|1|||
162893292|NCT04294095|588307350|FG001|Overall Study|Adverse Event|0|||
162893293|NCT02224638|588307353|FG000|Overall Study|Adverse Event|1|||
162893294|NCT02224638|588307354|FG001|Overall Study|Adverse Event|1|||
162893295|NCT00659126|588307359|FG000|Overall Study|Adverse Event|2|||
162893296|NCT00659126|588307360|FG001|Overall Study|Adverse Event|2|||
162893297|NCT00659126|588307359|FG000|Overall Study|Screen failure|1|||
162893298|NCT00659126|588307360|FG001|Overall Study|Screen failure|1|||
162893299|NCT00659126|588307359|FG000|Overall Study|Technical problems with MRI|0|||
162893300|NCT00659126|588307360|FG001|Overall Study|Technical problems with MRI|1|||
162893301|NCT00260429|588307361|FG000|Overall Study|failure to follow appointments|1|||
162893302|NCT00260429|588307362|FG001|Overall Study|failure to follow appointments|0|||
162893303|NCT00260429|588307361|FG000|Overall Study|scheduled hand surgery|1|||
162893304|NCT00260429|588307362|FG001|Overall Study|scheduled hand surgery|0|||
162893305|NCT01400139|588307371|FG000|HYD Core Study|Adverse Event|210|||
162893306|NCT01400139|588307371|FG000|HYD Core Study|Lack of Efficacy|59|||
162893307|NCT01400139|588307371|FG000|HYD Core Study|Withdrawal by Subject|114|||
162893308|NCT01400139|588307371|FG000|HYD Core Study|Lost to Follow-up|39|||
162893309|NCT01400139|588307371|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
162893310|NCT01400139|588307371|FG000|HYD Core Study|Administrative|56|||
162893311|NCT01400139|588307371|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
162893312|NCT01400139|588307371|FG000|HYD Extension Period|Adverse Event|8|||
162893313|NCT01400139|588307371|FG000|HYD Extension Period|Withdrawal by Subject|5|||
162893314|NCT01400139|588307371|FG000|HYD Extension Period|Administrative|10|||
162893315|NCT00418717|588307372|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
162893316|NCT00418717|588307372|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
162893317|NCT02762708|588307375|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
162893318|NCT02762708|588307376|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
162893319|NCT02762708|588307377|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
162893320|NCT02762708|588307378|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
162893321|NCT00631540|588307379|FG000|Overall Study|Withdrawal by Subject|5|||
162893322|NCT00631540|588307379|FG000|Overall Study|Death|4|||
162893323|NCT00631540|588307379|FG000|Overall Study|Lost to Follow-up|2|||
162893324|NCT00631540|588307379|FG000|Overall Study|Core Lab Data Unavailable|3|||
162893325|NCT00795509|588307380|FG000|Overall Study|Protocol Violation|31|||
162893326|NCT00970268|588307381|FG000|Overall Study|Withdrawal by Subject|12|||
162893327|NCT00970268|588307382|FG001|Overall Study|Withdrawal by Subject|19|||
162893328|NCT00970268|588307381|FG000|Overall Study|Adverse Event|15|||
162893329|NCT00970268|588307382|FG001|Overall Study|Adverse Event|12|||
162893330|NCT00970268|588307381|FG000|Overall Study|Lack of Efficacy|3|||
162893331|NCT00970268|588307382|FG001|Overall Study|Lack of Efficacy|6|||
162893332|NCT00970268|588307381|FG000|Overall Study|Protocol Violation|4|||
162893333|NCT00970268|588307382|FG001|Overall Study|Protocol Violation|7|||
162893334|NCT00970268|588307381|FG000|Overall Study|Other Reason|3|||
162893335|NCT00970268|588307382|FG001|Overall Study|Other Reason|1|||
162893336|NCT00970268|588307381|FG000|Overall Study|COPD Exacerbation|4|||
162893337|NCT00970268|588307382|FG001|Overall Study|COPD Exacerbation|2|||
162893338|NCT00970268|588307381|FG000|Overall Study|Lost to Follow-up|1|||
162893339|NCT00970268|588307382|FG001|Overall Study|Lost to Follow-up|2|||
162893340|NCT00970268|588307381|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
162893341|NCT00970268|588307382|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
162893342|NCT00719953|588307383|FG000|Overall Study|Adverse Event|4|||
162893343|NCT03726333|588307389|FG000|Overall Study|Progressive Disease|0|||
162893344|NCT03726333|588307390|FG001|Overall Study|Progressive Disease|0|||
162893345|NCT03726333|588307391|FG002|Overall Study|Progressive Disease|1|||
162893346|NCT03726333|588307392|FG003|Overall Study|Progressive Disease|0|||
162893347|NCT03726333|588307393|FG004|Overall Study|Progressive Disease|0|||
162893348|NCT02947022|588307394|FG000|Overall Study|Study Stopped|1|||
162893349|NCT01230749|588307395|FG000|Overall Study|Adverse Event|0|||
162893350|NCT01230749|588307396|FG001|Overall Study|Adverse Event|0|||
162893351|NCT01230749|588307397|FG002|Overall Study|Adverse Event|0|||
163051849|NCT02974868|588898735|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
163051850|NCT02974868|588898736|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
162893352|NCT01230749|588307398|FG003|Overall Study|Adverse Event|1|||
162893353|NCT01230749|588307395|FG000|Overall Study|Physician Decision|0|||
162893354|NCT01230749|588307396|FG001|Overall Study|Physician Decision|0|||
162893355|NCT01230749|588307397|FG002|Overall Study|Physician Decision|1|||
162893356|NCT01230749|588307398|FG003|Overall Study|Physician Decision|0|||
162893357|NCT01230749|588307395|FG000|Overall Study|Withdrawal by Subject|0|||
162893358|NCT01230749|588307396|FG001|Overall Study|Withdrawal by Subject|1|||
162893359|NCT01230749|588307397|FG002|Overall Study|Withdrawal by Subject|0|||
162893360|NCT01230749|588307398|FG003|Overall Study|Withdrawal by Subject|0|||
162893361|NCT01230749|588307395|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
162622905|NCT01663532|587335368|FG001|Overall Study|Adverse Event|13|||
162622906|NCT01663532|587335367|FG000|Overall Study|Met Withdrawal Criteria|7|||
162622907|NCT01663532|587335368|FG001|Overall Study|Met Withdrawal Criteria|6|||
162622908|NCT01663532|587335367|FG000|Overall Study|Physician Decision|1|||
162622909|NCT01663532|587335368|FG001|Overall Study|Physician Decision|1|||
162893362|NCT01230749|588307396|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
162893363|NCT01230749|588307397|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
162893364|NCT01230749|588307398|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
162893365|NCT03906136|588309746|FG000|Overall Study|Adverse Event|1|||
162893366|NCT03906136|588309747|FG001|Overall Study|Adverse Event|0|||
162893367|NCT03906136|588309746|FG000|Overall Study|Lost to Follow-up|7|||
162893368|NCT03906136|588309747|FG001|Overall Study|Lost to Follow-up|4|||
162893369|NCT03906136|588309746|FG000|Overall Study|Physician Decision|1|||
162893370|NCT03906136|588309747|FG001|Overall Study|Physician Decision|0|||
162893371|NCT03906136|588309746|FG000|Overall Study|Withdrawal by Subject|3|||
162893372|NCT03906136|588309747|FG001|Overall Study|Withdrawal by Subject|7|||
162893373|NCT01696396|588309752|FG000|Overall Study|Withdrawal by Subject|19|||
162893374|NCT01696396|588309753|FG001|Overall Study|Withdrawal by Subject|5|||
162893375|NCT01696396|588309754|FG002|Overall Study|Withdrawal by Subject|19|||
162893376|NCT01696396|588309755|FG003|Overall Study|Withdrawal by Subject|11|||
162893377|NCT01696396|588309752|FG000|Overall Study|Decision by Sponsor|3|||
162893378|NCT01696396|588309753|FG001|Overall Study|Decision by Sponsor|1|||
162893379|NCT01696396|588309754|FG002|Overall Study|Decision by Sponsor|2|||
162893380|NCT01696396|588309755|FG003|Overall Study|Decision by Sponsor|2|||
162893381|NCT01696396|588309752|FG000|Overall Study|Lost to Follow-up|9|||
162893382|NCT01696396|588309753|FG001|Overall Study|Lost to Follow-up|1|||
162893383|NCT01696396|588309754|FG002|Overall Study|Lost to Follow-up|4|||
162893384|NCT01696396|588309755|FG003|Overall Study|Lost to Follow-up|1|||
162893385|NCT01696396|588309752|FG000|Overall Study|Death|0|||
162893386|NCT01696396|588309753|FG001|Overall Study|Death|0|||
162893387|NCT01696396|588309754|FG002|Overall Study|Death|1|||
162893388|NCT01696396|588309755|FG003|Overall Study|Death|0|||
162893389|NCT02371980|588309761|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
162893390|NCT02371980|588309762|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
162893391|NCT02371980|588309763|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
162893392|NCT02371980|588309764|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
162893393|NCT02371980|588309765|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
162893394|NCT02371980|588309761|FG000|Open-label Period|Significant Protocol Deviation|19|||
162893395|NCT02371980|588309762|FG001|Open-label Period|Significant Protocol Deviation|0|||
162893396|NCT02371980|588309763|FG002|Open-label Period|Significant Protocol Deviation|0|||
162893397|NCT02371980|588309764|FG003|Open-label Period|Significant Protocol Deviation|0|||
162893398|NCT02371980|588309765|FG004|Open-label Period|Significant Protocol Deviation|0|||
162893399|NCT02371980|588309761|FG000|Open-label Period|Noncompliance with Study Drug|10|||
162893400|NCT02371980|588309762|FG001|Open-label Period|Noncompliance with Study Drug|0|||
162893401|NCT02371980|588309763|FG002|Open-label Period|Noncompliance with Study Drug|0|||
162893402|NCT02371980|588309764|FG003|Open-label Period|Noncompliance with Study Drug|0|||
162893403|NCT02371980|588309765|FG004|Open-label Period|Noncompliance with Study Drug|0|||
162893404|NCT02371980|588309761|FG000|Open-label Period|Lost to Follow-up|55|||
162893405|NCT02371980|588309762|FG001|Open-label Period|Lost to Follow-up|0|||
162893406|NCT02371980|588309763|FG002|Open-label Period|Lost to Follow-up|0|||
162893407|NCT02371980|588309764|FG003|Open-label Period|Lost to Follow-up|0|||
162893408|NCT02371980|588309765|FG004|Open-label Period|Lost to Follow-up|0|||
162893409|NCT02371980|588309761|FG000|Open-label Period|Voluntary Withdrawal|91|||
162893410|NCT02371980|588309762|FG001|Open-label Period|Voluntary Withdrawal|0|||
162893411|NCT02371980|588309763|FG002|Open-label Period|Voluntary Withdrawal|0|||
162893412|NCT02371980|588309764|FG003|Open-label Period|Voluntary Withdrawal|0|||
162893413|NCT02371980|588309765|FG004|Open-label Period|Voluntary Withdrawal|0|||
162893414|NCT02371980|588309761|FG000|Open-label Period|Pregnancy|1|||
162893415|NCT02371980|588309762|FG001|Open-label Period|Pregnancy|0|||
162893416|NCT02371980|588309763|FG002|Open-label Period|Pregnancy|0|||
162964723|NCT00477594|588569867|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
162964724|NCT00477594|588569866|FG000|Year 1 and Year 2|Other|1|||
162964725|NCT00477594|588569867|FG001|Year 1 and Year 2|Other|0|||
162964726|NCT00477594|588569866|FG000|Year 3|Adverse Event|1|||
162964727|NCT00477594|588569867|FG001|Year 3|Adverse Event|0|||
162964728|NCT00477594|588569866|FG000|Year 3|Withdrawal by Subject|1|||
162622910|NCT01663532|587335367|FG000|Overall Study|Withdrawal by Subject|35|||
162622911|NCT01663532|587335368|FG001|Overall Study|Withdrawal by Subject|17|||
162893417|NCT02371980|588309764|FG003|Open-label Period|Pregnancy|0|||
162893418|NCT02371980|588309765|FG004|Open-label Period|Pregnancy|0|||
162893419|NCT02371980|588309761|FG000|Open-label Period|Lack of Efficacy|116|||
162893420|NCT02371980|588309762|FG001|Open-label Period|Lack of Efficacy|0|||
162893421|NCT02371980|588309763|FG002|Open-label Period|Lack of Efficacy|0|||
162964729|NCT00477594|588569867|FG001|Year 3|Withdrawal by Subject|0|||
162964730|NCT00477594|588569866|FG000|Follow-up Period|Withdrawal by Subject|2|||
162964731|NCT00477594|588569867|FG001|Follow-up Period|Withdrawal by Subject|1|||
162964732|NCT00477594|588569866|FG000|Follow-up Period|Other|1|||
162893422|NCT02371980|588309764|FG003|Open-label Period|Lack of Efficacy|0|||
162893423|NCT02371980|588309765|FG004|Open-label Period|Lack of Efficacy|0|||
162893424|NCT02371980|588309761|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
162893425|NCT02371980|588309762|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
162893426|NCT02371980|588309763|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
162893427|NCT02371980|588309764|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
162893428|NCT02371980|588309765|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
162893429|NCT02371980|588309761|FG000|Open-label Period|Reason not Specified|9|||
162893430|NCT02371980|588309762|FG001|Open-label Period|Reason not Specified|0|||
162893431|NCT02371980|588309763|FG002|Open-label Period|Reason not Specified|0|||
162893432|NCT02371980|588309764|FG003|Open-label Period|Reason not Specified|0|||
162893433|NCT02371980|588309765|FG004|Open-label Period|Reason not Specified|0|||
162893434|NCT02371980|588309761|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
162893435|NCT02371980|588309762|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
162893436|NCT02371980|588309763|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
162893437|NCT02371980|588309764|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
162893438|NCT02371980|588309765|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
162893439|NCT02371980|588309761|FG000|Double-blind Period|Significant Protocol Deviation|0|||
162893440|NCT02371980|588309762|FG001|Double-blind Period|Significant Protocol Deviation|2|||
162893441|NCT02371980|588309763|FG002|Double-blind Period|Significant Protocol Deviation|7|||
162893442|NCT02371980|588309764|FG003|Double-blind Period|Significant Protocol Deviation|3|||
162893443|NCT02371980|588309765|FG004|Double-blind Period|Significant Protocol Deviation|3|||
162893444|NCT02371980|588309761|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
162893445|NCT02371980|588309762|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
162893446|NCT02371980|588309763|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
162893447|NCT02371980|588309764|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
162893448|NCT02371980|588309765|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
162893449|NCT02371980|588309761|FG000|Double-blind Period|Lost to Follow-up|0|||
162893450|NCT02371980|588309762|FG001|Double-blind Period|Lost to Follow-up|8|||
162893451|NCT02371980|588309763|FG002|Double-blind Period|Lost to Follow-up|8|||
162893452|NCT02371980|588309764|FG003|Double-blind Period|Lost to Follow-up|6|||
162893453|NCT02371980|588309765|FG004|Double-blind Period|Lost to Follow-up|5|||
162893454|NCT02371980|588309761|FG000|Double-blind Period|Voluntary Withdrawal|0|||
162893455|NCT02371980|588309762|FG001|Double-blind Period|Voluntary Withdrawal|12|||
162893456|NCT02371980|588309763|FG002|Double-blind Period|Voluntary Withdrawal|8|||
162893457|NCT02371980|588309764|FG003|Double-blind Period|Voluntary Withdrawal|9|||
162893458|NCT02371980|588309765|FG004|Double-blind Period|Voluntary Withdrawal|11|||
162893459|NCT02371980|588309761|FG000|Double-blind Period|Relapse|0|||
162893460|NCT02371980|588309762|FG001|Double-blind Period|Relapse|50|||
162893461|NCT02371980|588309763|FG002|Double-blind Period|Relapse|25|||
162893462|NCT02371980|588309764|FG003|Double-blind Period|Relapse|25|||
162893463|NCT02371980|588309765|FG004|Double-blind Period|Relapse|26|||
162893464|NCT02371980|588309761|FG000|Double-blind Period|Reason not Specified|0|||
162893465|NCT02371980|588309762|FG001|Double-blind Period|Reason not Specified|3|||
162893466|NCT02371980|588309763|FG002|Double-blind Period|Reason not Specified|3|||
162893467|NCT02371980|588309764|FG003|Double-blind Period|Reason not Specified|2|||
162893468|NCT02371980|588309765|FG004|Double-blind Period|Reason not Specified|1|||
162893469|NCT02371980|588309761|FG000|Double-blind Period|Missing|0|||
162893470|NCT02371980|588309762|FG001|Double-blind Period|Missing|1|||
162893471|NCT02371980|588309763|FG002|Double-blind Period|Missing|0|||
162893472|NCT02371980|588309764|FG003|Double-blind Period|Missing|0|||
162893473|NCT02371980|588309765|FG004|Double-blind Period|Missing|0|||
162893474|NCT01280812|588309767|FG000|Overall Study|Withdrawal by Subject|2|||
162893475|NCT01280812|588309768|FG001|Overall Study|Withdrawal by Subject|1|||
162893476|NCT01280812|588309769|FG002|Overall Study|Withdrawal by Subject|0|||
162893477|NCT01280812|588309767|FG000|Overall Study|Lost to Follow-up|1|||
162893478|NCT01280812|588309768|FG001|Overall Study|Lost to Follow-up|1|||
162893479|NCT01280812|588309769|FG002|Overall Study|Lost to Follow-up|1|||
162893480|NCT01594749|588309775|FG000|Overall Study|Adverse Event|2|||
162893481|NCT01594749|588309776|FG001|Overall Study|Adverse Event|1|||
162893482|NCT01594749|588309775|FG000|Overall Study|Withdrawal by Subject|2|||
162893483|NCT01594749|588309776|FG001|Overall Study|Withdrawal by Subject|2|||
162893484|NCT01594749|588309775|FG000|Overall Study|Protocol Violation|2|||
163051851|NCT02974868|588898737|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
163051852|NCT02974868|588898734|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
162893485|NCT01594749|588309776|FG001|Overall Study|Protocol Violation|0|||
162893486|NCT01594749|588309775|FG000|Overall Study|Physician Decision|1|||
162893487|NCT01594749|588309776|FG001|Overall Study|Physician Decision|1|||
162893488|NCT01594749|588309775|FG000|Overall Study|Non-compliance with Protocol|0|||
162893489|NCT01594749|588309776|FG001|Overall Study|Non-compliance with Protocol|1|||
162893490|NCT01594749|588309775|FG000|Overall Study|Lost to Follow-up|1|||
162893491|NCT01594749|588309776|FG001|Overall Study|Lost to Follow-up|0|||
162893492|NCT01594749|588309775|FG000|Overall Study|Death|9|||
162893493|NCT01594749|588309776|FG001|Overall Study|Death|3|||
162893494|NCT01594749|588309775|FG000|Overall Study|Not Treated|4|||
162893495|NCT01594749|588309776|FG001|Overall Study|Not Treated|10|||
162893496|NCT01594749|588309775|FG000|Overall Study|Lost Source Documentation|1|||
162893497|NCT01594749|588309776|FG001|Overall Study|Lost Source Documentation|0|||
162893498|NCT00959894|588309777|FG000|Overall Study|Lost to Follow-up|10|||
162893499|NCT00959894|588309777|FG000|Overall Study|Adverse Event|3|||
162893500|NCT00959894|588309777|FG000|Overall Study|Withdrawal by Subject|1|||
162893501|NCT00959894|588309777|FG000|Overall Study|Need for contraindicated medication|1|||
162893502|NCT00959894|588309777|FG000|Overall Study|Subject moved out of town|1|||
162893503|NCT00922974|588309778|FG000|Phase II Component|Protocol Violation|2|||
162893504|NCT00922974|588309779|FG001|Phase II Component|Protocol Violation|0|||
162893505|NCT00922974|588309778|FG000|Phase II Component|Not evaluable for treatment review|5|||
162893506|NCT00922974|588309779|FG001|Phase II Component|Not evaluable for treatment review|0|||
162893507|NCT00922974|588309778|FG000|Phase III Component|Protocol Violation|8|||
162893508|NCT00922974|588309779|FG001|Phase III Component|Protocol Violation|6|||
162893509|NCT03682055|588309780|FG000|Overall Study|Lack of Efficacy|1|||
162893510|NCT03682055|588309781|FG001|Overall Study|Lack of Efficacy|2|||
162893511|NCT03682055|588309782|FG002|Overall Study|Lack of Efficacy|1|||
162893512|NCT03682055|588309783|FG003|Overall Study|Lack of Efficacy|2|||
162893513|NCT03682055|588309784|FG004|Overall Study|Lack of Efficacy|1|||
162893514|NCT03682055|588309785|FG005|Overall Study|Lack of Efficacy|3|||
162893515|NCT03682055|588309780|FG000|Overall Study|Withdrawal by Subject|0|||
162893516|NCT03682055|588309781|FG001|Overall Study|Withdrawal by Subject|0|||
162893517|NCT03682055|588309782|FG002|Overall Study|Withdrawal by Subject|0|||
162893518|NCT03682055|588309783|FG003|Overall Study|Withdrawal by Subject|0|||
162893519|NCT03682055|588309784|FG004|Overall Study|Withdrawal by Subject|0|||
162893520|NCT03682055|588309785|FG005|Overall Study|Withdrawal by Subject|1|||
162893521|NCT03682055|588309780|FG000|Overall Study|Termination of Study by Sponsor|0|||
162893522|NCT03682055|588309781|FG001|Overall Study|Termination of Study by Sponsor|0|||
162893523|NCT03682055|588309782|FG002|Overall Study|Termination of Study by Sponsor|0|||
162893524|NCT03682055|588309783|FG003|Overall Study|Termination of Study by Sponsor|0|||
162893525|NCT03682055|588309784|FG004|Overall Study|Termination of Study by Sponsor|0|||
162893526|NCT03682055|588309785|FG005|Overall Study|Termination of Study by Sponsor|3|||
162893527|NCT00191386|588309786|FG000|Overall Study|Adverse Event|16|||
162893528|NCT00191386|588309786|FG000|Overall Study|Lost to Follow-up|1|||
162893529|NCT00191386|588309786|FG000|Overall Study|Entry Criteria Exclusion|3|||
162893530|NCT00191386|588309786|FG000|Overall Study|Protocol Violation|18|||
162893531|NCT00191386|588309786|FG000|Overall Study|Withdrawal by Subject|96|||
162893532|NCT00191386|588309786|FG000|Overall Study|Physician Decision|11|||
162893533|NCT00191386|588309786|FG000|Overall Study|Lack of Efficacy|15|||
162893534|NCT03077243|588309788|FG000|Overall Study|Death|1|||
162893535|NCT03077243|588309789|FG001|Overall Study|Death|2|||
162893536|NCT03077243|588309790|FG002|Overall Study|Death|0|||
162893537|NCT03077243|588309791|FG003|Overall Study|Death|0|||
162893538|NCT03077243|588309788|FG000|Overall Study|Withdrawal by Subject|1|||
162893539|NCT03077243|588309789|FG001|Overall Study|Withdrawal by Subject|3|||
162893540|NCT03077243|588309790|FG002|Overall Study|Withdrawal by Subject|0|||
162893541|NCT03077243|588309791|FG003|Overall Study|Withdrawal by Subject|0|||
162893542|NCT03077243|588309788|FG000|Overall Study|Physician Decision|1|||
162893543|NCT03077243|588309789|FG001|Overall Study|Physician Decision|0|||
162893544|NCT03077243|588309790|FG002|Overall Study|Physician Decision|0|||
162893545|NCT03077243|588309791|FG003|Overall Study|Physician Decision|0|||
162893546|NCT03077243|588309788|FG000|Overall Study|Research at two study sites terminated early|0|||
162893547|NCT03077243|588309789|FG001|Overall Study|Research at two study sites terminated early|0|||
162893548|NCT03077243|588309790|FG002|Overall Study|Research at two study sites terminated early|0|||
162893549|NCT03077243|588309791|FG003|Overall Study|Research at two study sites terminated early|69|||
162893550|NCT01544478|588309792|FG000|Overall Study|Adverse Event|1|||
162893551|NCT01544478|588309792|FG000|Overall Study|Death|1|||
162893552|NCT01544478|588309792|FG000|Overall Study|Lost to Follow-up|48|||
162893553|NCT01544478|588309792|FG000|Overall Study|Physician Decision|15|||
162893554|NCT01544478|588309792|FG000|Overall Study|Pregnancy|1|||
162964733|NCT00477594|588569867|FG001|Follow-up Period|Other|0|||
162964734|NCT01894230|588571930|FG000|Overall Study|Lost to Follow-up|2|||
162893555|NCT01544478|588309792|FG000|Overall Study|Withdrawal by Subject|52|||
162893556|NCT00212758|588309793|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
162893557|NCT00212758|588309794|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
162893558|NCT00212758|588309793|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
162893559|NCT00212758|588309794|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
162893560|NCT02574481|588309795|FG000|Overall Study|Withdrawal by Subject|29|||
162893561|NCT02574481|588309796|FG001|Overall Study|Withdrawal by Subject|15|||
162893562|NCT02574481|588309797|FG002|Overall Study|Withdrawal by Subject|4|||
162893563|NCT02574481|588309798|FG003|Overall Study|Withdrawal by Subject|1|||
162893564|NCT02574481|588309795|FG000|Overall Study|Adverse Event|5|||
162893565|NCT02574481|588309796|FG001|Overall Study|Adverse Event|1|||
162893566|NCT02574481|588309797|FG002|Overall Study|Adverse Event|1|||
162893567|NCT02574481|588309798|FG003|Overall Study|Adverse Event|0|||
162893568|NCT02574481|588309795|FG000|Overall Study|Visit Missed|15|||
162893569|NCT02574481|588309796|FG001|Overall Study|Visit Missed|7|||
162893570|NCT02574481|588309797|FG002|Overall Study|Visit Missed|5|||
162893571|NCT02574481|588309798|FG003|Overall Study|Visit Missed|0|||
162893572|NCT02574481|588309795|FG000|Overall Study|Other|7|||
162893573|NCT02574481|588309796|FG001|Overall Study|Other|2|||
162893574|NCT02574481|588309797|FG002|Overall Study|Other|0|||
162893575|NCT02574481|588309798|FG003|Overall Study|Other|0|||
162893576|NCT02574481|588309795|FG000|Overall Study|Death|48|||
162893577|NCT02574481|588309796|FG001|Overall Study|Death|26|||
162893578|NCT02574481|588309797|FG002|Overall Study|Death|12|||
162893579|NCT02574481|588309798|FG003|Overall Study|Death|4|||
162893580|NCT02574481|588309795|FG000|Overall Study|Physician Decision|5|||
162893581|NCT02574481|588309796|FG001|Overall Study|Physician Decision|2|||
162893582|NCT02574481|588309797|FG002|Overall Study|Physician Decision|0|||
162893583|NCT02574481|588309798|FG003|Overall Study|Physician Decision|0|||
162893584|NCT02574481|588309795|FG000|Overall Study|Lost to Follow-up|5|||
162893585|NCT02574481|588309796|FG001|Overall Study|Lost to Follow-up|1|||
162893586|NCT02574481|588309797|FG002|Overall Study|Lost to Follow-up|3|||
162893587|NCT02574481|588309798|FG003|Overall Study|Lost to Follow-up|0|||
162893588|NCT00446641|588309802|FG000|Overall Study|Withdrawal by Subject|8|||
162893589|NCT00446641|588309803|FG001|Overall Study|Withdrawal by Subject|3|||
162893590|NCT00446641|588309802|FG000|Overall Study|poor compliance|8|||
162893591|NCT00446641|588309803|FG001|Overall Study|poor compliance|6|||
162893592|NCT00446641|588309802|FG000|Overall Study|Lost to Follow-up|1|||
162893593|NCT00446641|588309803|FG001|Overall Study|Lost to Follow-up|1|||
162893594|NCT01826448|588309805|FG000|Overall Study|Adverse Event|1|||
162893595|NCT01826448|588309806|FG001|Overall Study|Adverse Event|3|||
162893596|NCT01826448|588309805|FG000|Overall Study|Disease progression|2|||
162893597|NCT01826448|588309806|FG001|Overall Study|Disease progression|4|||
162893598|NCT01826448|588309805|FG000|Overall Study|Withdrawal by Subject|1|||
162893599|NCT01826448|588309806|FG001|Overall Study|Withdrawal by Subject|0|||
162893600|NCT01826448|588309805|FG000|Overall Study|Physician Decision|0|||
162893601|NCT01826448|588309806|FG001|Overall Study|Physician Decision|1|||
162893602|NCT01826448|588309805|FG000|Overall Study|2 active cancers|0|||
162893603|NCT01826448|588309806|FG001|Overall Study|2 active cancers|1|||
162893604|NCT02578992|588309808|FG000|Overall Study|equipment not available or malfunction|3|||
162893605|NCT02578992|588309809|FG001|Overall Study|equipment not available or malfunction|3|||
162893606|NCT00086385|588309812|FG000|Overall Study|Death|2|||
162893607|NCT00086385|588309813|FG001|Overall Study|Death|2|||
162893608|NCT00086385|588309814|FG002|Overall Study|Death|1|||
162893609|NCT00086385|588309815|FG003|Overall Study|Death|1|||
162893610|NCT00880100|588309816|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
162893611|NCT00880100|588309816|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
162893612|NCT00880100|588309816|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
162893613|NCT02038790|588309819|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
162893614|NCT02038790|588309820|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
162893615|NCT02431702|588309822|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
162893616|NCT02431702|588309823|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162893617|NCT02431702|588309824|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162708733|NCT04833855|587642882|FG002|Overall Study|Protocol specified criteria|2|||
162708734|NCT04833855|587642883|FG003|Overall Study|Protocol specified criteria|1|||
162893618|NCT02431702|588309825|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162893619|NCT02431702|588309826|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162893620|NCT02431702|588309827|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162893621|NCT02431702|588309828|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
162893622|NCT02431702|588309822|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
162893623|NCT02431702|588309823|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
162893624|NCT02431702|588309824|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
162893625|NCT02431702|588309825|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
162893626|NCT02431702|588309826|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
162893627|NCT02431702|588309827|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
162893628|NCT02431702|588309828|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
162893629|NCT02431702|588309822|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
162893630|NCT02431702|588309823|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
162893631|NCT02431702|588309824|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
162893632|NCT02431702|588309825|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
162893633|NCT02431702|588309826|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
162893634|NCT02431702|588309827|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
162893635|NCT02431702|588309828|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
162893636|NCT02431702|588309822|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
162893637|NCT02431702|588309823|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
162893638|NCT02431702|588309824|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
162893639|NCT02431702|588309825|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
162893640|NCT02431702|588309826|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
162893641|NCT02431702|588309827|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
162893642|NCT02431702|588309828|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
162893643|NCT02431702|588309822|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
162893644|NCT02431702|588309823|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893645|NCT02431702|588309824|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893646|NCT02431702|588309825|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893647|NCT02431702|588309826|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893648|NCT02431702|588309827|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893649|NCT02431702|588309828|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
162893650|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
162893651|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
162893652|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
162893653|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
162893654|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
162893655|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
162893656|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
162893657|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
162893658|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
162893659|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
162893660|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
162893661|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
162893662|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
162893663|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
162893664|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
162893665|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
162893666|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
162893667|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
162893668|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
162893669|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
162893670|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
162893671|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893672|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
162893673|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893674|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893675|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893676|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893677|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
162893678|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
162893679|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
162893680|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
162893681|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
162893682|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
162893683|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
162893684|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
162893685|NCT02431702|588309822|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893686|NCT02431702|588309823|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893687|NCT02431702|588309824|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
162893688|NCT02431702|588309825|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893689|NCT02431702|588309826|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893690|NCT02431702|588309827|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893691|NCT02431702|588309828|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
162893692|NCT02431702|588309822|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
162893693|NCT02431702|588309823|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
162893694|NCT02431702|588309824|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
162893695|NCT02431702|588309825|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
162893696|NCT02431702|588309826|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
162893697|NCT02431702|588309827|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
162893698|NCT02431702|588309828|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
162893699|NCT02431702|588309822|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
162893700|NCT02431702|588309823|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
162893701|NCT02431702|588309824|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
162893702|NCT02431702|588309825|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
162893703|NCT02431702|588309826|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
162893704|NCT02431702|588309827|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
162893705|NCT02431702|588309828|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
162893706|NCT02431702|588309822|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
162893707|NCT02431702|588309823|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
162893708|NCT02431702|588309824|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
162893709|NCT02431702|588309825|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
162893710|NCT02431702|588309826|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
162893711|NCT02431702|588309827|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
162893712|NCT02431702|588309828|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
162893713|NCT02431702|588309822|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
162893714|NCT02431702|588309823|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
162893715|NCT02431702|588309824|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
162893716|NCT02431702|588309825|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
162893717|NCT02431702|588309826|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
162893718|NCT02431702|588309827|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
162893719|NCT02431702|588309828|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
162893720|NCT01376388|588309838|FG000|Overall Study|Adverse Event|13|||
162893721|NCT01376388|588309838|FG000|Overall Study|Lack of Efficacy|2|||
162893722|NCT01376388|588309838|FG000|Overall Study|Withdrawal by Subject|3|||
162893723|NCT02009930|588309839|FG000|Overall Study|withdrawn|5|||
162893724|NCT00425113|588309851|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
162893725|NCT00425113|588309852|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
162893726|NCT00425113|588309851|FG000|Overall Study|diagnosis of abdominal TB|0|||
162893727|NCT00425113|588309852|FG001|Overall Study|diagnosis of abdominal TB|1|||
162893728|NCT00425113|588309851|FG000|Overall Study|missing study drug more than 14 days|0|||
162893729|NCT00425113|588309852|FG001|Overall Study|missing study drug more than 14 days|1|||
162893730|NCT00425113|588309851|FG000|Overall Study|Withdrawal by Subject|1|||
162893731|NCT00425113|588309852|FG001|Overall Study|Withdrawal by Subject|0|||
162893732|NCT00879437|588309853|FG000|Overall Study|Protocol Violation|0|||
162893733|NCT00879437|588309854|FG001|Overall Study|Protocol Violation|1|||
162893734|NCT00879437|588309853|FG000|Overall Study|Death|1|||
162893735|NCT00879437|588309854|FG001|Overall Study|Death|0|||
162893736|NCT02920450|588309855|FG000|Overall Study|Death|1|||
162893737|NCT02920450|588309856|FG001|Overall Study|Death|0|||
162893738|NCT02920450|588309857|FG002|Overall Study|Death|0|||
162893739|NCT02920450|588309858|FG003|Overall Study|Death|0|||
162893740|NCT02920450|588309855|FG000|Overall Study|Withdrawal by Subject|1|||
162893741|NCT02920450|588309856|FG001|Overall Study|Withdrawal by Subject|0|||
162893742|NCT02920450|588309857|FG002|Overall Study|Withdrawal by Subject|0|||
162893743|NCT02920450|588309858|FG003|Overall Study|Withdrawal by Subject|0|||
162893744|NCT01001234|588309859|FG000|Overall Study|Withdrawal by Subject|2|||
162893745|NCT01001234|588309860|FG001|Overall Study|Withdrawal by Subject|0|||
162893746|NCT01001234|588309861|FG002|Overall Study|Withdrawal by Subject|3|||
162893747|NCT01001234|588309862|FG003|Overall Study|Withdrawal by Subject|0|||
162893748|NCT01001234|588309863|FG004|Overall Study|Withdrawal by Subject|0|||
162893749|NCT01001234|588309859|FG000|Overall Study|Protocol Violation|34|||
162893750|NCT01001234|588309860|FG001|Overall Study|Protocol Violation|3|||
162893751|NCT01001234|588309861|FG002|Overall Study|Protocol Violation|19|||
162893752|NCT01001234|588309862|FG003|Overall Study|Protocol Violation|18|||
162893753|NCT01001234|588309863|FG004|Overall Study|Protocol Violation|0|||
162893754|NCT01001234|588309859|FG000|Overall Study|Lost to Follow-up|0|||
162893755|NCT01001234|588309860|FG001|Overall Study|Lost to Follow-up|0|||
162964735|NCT01894230|588571931|FG001|Overall Study|Lost to Follow-up|2|||
162964736|NCT01894230|588571930|FG000|Overall Study|Withdrawal by Subject|4|||
162964737|NCT01894230|588571931|FG001|Overall Study|Withdrawal by Subject|4|||
162964738|NCT01894230|588571930|FG000|Overall Study|Non-adherent|0|||
162893756|NCT01001234|588309861|FG002|Overall Study|Lost to Follow-up|1|||
162893757|NCT01001234|588309862|FG003|Overall Study|Lost to Follow-up|2|||
162893758|NCT01001234|588309863|FG004|Overall Study|Lost to Follow-up|0|||
162893759|NCT01001234|588309859|FG000|Overall Study|Physician Decision|1|||
162893760|NCT01001234|588309860|FG001|Overall Study|Physician Decision|0|||
162893761|NCT01001234|588309861|FG002|Overall Study|Physician Decision|0|||
162893762|NCT01001234|588309862|FG003|Overall Study|Physician Decision|0|||
162893763|NCT01001234|588309863|FG004|Overall Study|Physician Decision|0|||
162893764|NCT01001234|588309859|FG000|Overall Study|Not Treated: Adverse Event|1|||
162893765|NCT01001234|588309860|FG001|Overall Study|Not Treated: Adverse Event|0|||
162893766|NCT01001234|588309861|FG002|Overall Study|Not Treated: Adverse Event|0|||
162893767|NCT01001234|588309862|FG003|Overall Study|Not Treated: Adverse Event|0|||
162964739|NCT01894230|588571931|FG001|Overall Study|Non-adherent|1|||
162893768|NCT01001234|588309863|FG004|Overall Study|Not Treated: Adverse Event|0|||
162893769|NCT01001234|588309859|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
162893770|NCT01001234|588309860|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
162893771|NCT01001234|588309861|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
162893772|NCT01001234|588309862|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
162893773|NCT01001234|588309863|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
162893774|NCT01001234|588309859|FG000|Overall Study|Not Treated: Protocol Violation|3|||
162893775|NCT01001234|588309860|FG001|Overall Study|Not Treated: Protocol Violation|0|||
162893776|NCT01001234|588309861|FG002|Overall Study|Not Treated: Protocol Violation|0|||
162893777|NCT01001234|588309862|FG003|Overall Study|Not Treated: Protocol Violation|0|||
162893778|NCT01001234|588309863|FG004|Overall Study|Not Treated: Protocol Violation|0|||
162893779|NCT01001234|588309859|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
162893780|NCT01001234|588309860|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
162893781|NCT01001234|588309861|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
162893782|NCT01001234|588309862|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
162893783|NCT01001234|588309863|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
162893784|NCT01001234|588309859|FG000|Overall Study|Not Treated: Pregnancy|3|||
162893785|NCT01001234|588309860|FG001|Overall Study|Not Treated: Pregnancy|0|||
162893786|NCT01001234|588309861|FG002|Overall Study|Not Treated: Pregnancy|0|||
162893787|NCT01001234|588309862|FG003|Overall Study|Not Treated: Pregnancy|0|||
162893788|NCT01001234|588309863|FG004|Overall Study|Not Treated: Pregnancy|0|||
162893789|NCT01001234|588309859|FG000|Overall Study|Not Treated: Physician Decision|37|||
162893790|NCT01001234|588309860|FG001|Overall Study|Not Treated: Physician Decision|4|||
162893791|NCT01001234|588309861|FG002|Overall Study|Not Treated: Physician Decision|0|||
162893792|NCT01001234|588309862|FG003|Overall Study|Not Treated: Physician Decision|0|||
162893793|NCT01001234|588309863|FG004|Overall Study|Not Treated: Physician Decision|0|||
162893794|NCT01001234|588309859|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
162893795|NCT01001234|588309860|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
162893796|NCT01001234|588309861|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
162893797|NCT01001234|588309862|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
162893798|NCT01001234|588309863|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
162893799|NCT03379376|588309866|FG000|Overall Study|Lost to Follow-up|2|||
162893800|NCT03379376|588309866|FG000|Overall Study|Did not wish to complete follow up|1|||
162893801|NCT03379376|588309866|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
162893802|NCT03379376|588309866|FG000|Overall Study|Death|1|||
162893803|NCT02475629|588309867|FG000|Overall Study|Adverse Event|1|||
162893804|NCT02475629|588309867|FG000|Overall Study|Death|4|||
162893805|NCT02475629|588309867|FG000|Overall Study|Physician Decision|1|||
162893806|NCT02475629|588309867|FG000|Overall Study|Withdrawal by Subject|1|||
162893807|NCT02475629|588309867|FG000|Overall Study|Lost to Follow-up|1|||
162893808|NCT02475629|588309867|FG000|Overall Study|Subject non-compliance|1|||
162893809|NCT01611298|588309868|FG000|Overall Study|Relapsed|2|||
162893810|NCT03238352|588309869|FG000|Overall Study|Lost to Follow-up|0|||
162893811|NCT03238352|588309870|FG001|Overall Study|Lost to Follow-up|2|||
162893812|NCT03238352|588309871|FG002|Overall Study|Lost to Follow-up|1|||
162893813|NCT03238352|588309869|FG000|Overall Study|Withdrawal by Subject|0|||
162893814|NCT03238352|588309870|FG001|Overall Study|Withdrawal by Subject|1|||
162893815|NCT03238352|588309871|FG002|Overall Study|Withdrawal by Subject|0|||
162893816|NCT00928512|588309872|FG000|Overall Study|Adverse Event|4|||
162893817|NCT00928512|588309873|FG001|Overall Study|Adverse Event|3|||
162893818|NCT00928512|588309874|FG002|Overall Study|Adverse Event|2|||
162893819|NCT00928512|588309875|FG003|Overall Study|Adverse Event|8|||
162893820|NCT00928512|588309876|FG004|Overall Study|Adverse Event|6|||
162893821|NCT00928512|588309872|FG000|Overall Study|Lack of Efficacy|2|||
162893822|NCT00928512|588309873|FG001|Overall Study|Lack of Efficacy|0|||
162893823|NCT00928512|588309874|FG002|Overall Study|Lack of Efficacy|4|||
162893824|NCT00928512|588309875|FG003|Overall Study|Lack of Efficacy|7|||
162893825|NCT00928512|588309876|FG004|Overall Study|Lack of Efficacy|3|||
162893826|NCT00928512|588309872|FG000|Overall Study|Protocol Violation|0|||
162893827|NCT00928512|588309873|FG001|Overall Study|Protocol Violation|1|||
162893828|NCT00928512|588309874|FG002|Overall Study|Protocol Violation|0|||
162964740|NCT01894230|588571930|FG000|Overall Study|Death|1|||
162893829|NCT00928512|588309875|FG003|Overall Study|Protocol Violation|1|||
162964741|NCT01894230|588571931|FG001|Overall Study|Death|0|||
162893830|NCT00928512|588309876|FG004|Overall Study|Protocol Violation|3|||
162893831|NCT00928512|588309872|FG000|Overall Study|Withdrawal by Subject|3|||
162964742|NCT02219009|588571932|FG000|Overall Study|Withdrawal by Subject|5|||
162893832|NCT00928512|588309873|FG001|Overall Study|Withdrawal by Subject|0|||
162893833|NCT00928512|588309874|FG002|Overall Study|Withdrawal by Subject|3|||
162893834|NCT00928512|588309875|FG003|Overall Study|Withdrawal by Subject|4|||
162964743|NCT02219009|588571933|FG001|Overall Study|Withdrawal by Subject|1|||
162893835|NCT00928512|588309876|FG004|Overall Study|Withdrawal by Subject|0|||
162893836|NCT00928512|588309872|FG000|Overall Study|Lost to Follow-up|1|||
162893837|NCT00928512|588309873|FG001|Overall Study|Lost to Follow-up|1|||
162964744|NCT02219009|588571932|FG000|Overall Study|Adverse Event|2|||
162893838|NCT00928512|588309874|FG002|Overall Study|Lost to Follow-up|2|||
162893839|NCT00928512|588309875|FG003|Overall Study|Lost to Follow-up|1|||
162893840|NCT00928512|588309876|FG004|Overall Study|Lost to Follow-up|3|||
162893841|NCT00928512|588309872|FG000|Overall Study|Administrative Problems|0|||
162893842|NCT00928512|588309873|FG001|Overall Study|Administrative Problems|1|||
162893843|NCT00928512|588309874|FG002|Overall Study|Administrative Problems|0|||
162893844|NCT00928512|588309875|FG003|Overall Study|Administrative Problems|0|||
162893845|NCT00928512|588309876|FG004|Overall Study|Administrative Problems|0|||
162893846|NCT04153929|588309877|FG000|Overall Study|Other than listed|2|||
162893847|NCT04153929|588309878|FG001|Overall Study|Other than listed|2|||
162893848|NCT04153929|588309879|FG002|Overall Study|Other than listed|0|||
162893849|NCT04153929|588309880|FG003|Overall Study|Other than listed|1|||
162893850|NCT04153929|588309881|FG004|Overall Study|Other than listed|0|||
162893851|NCT04153929|588309882|FG005|Overall Study|Other than listed|2|||
162893852|NCT04153929|588309883|FG006|Overall Study|Other than listed|2|||
162893853|NCT04153929|588309884|FG007|Overall Study|Other than listed|1|||
162893854|NCT04153929|588309877|FG000|Overall Study|Lost to Follow-up|2|||
162893855|NCT04153929|588309878|FG001|Overall Study|Lost to Follow-up|1|||
162893856|NCT04153929|588309879|FG002|Overall Study|Lost to Follow-up|0|||
162893857|NCT04153929|588309880|FG003|Overall Study|Lost to Follow-up|1|||
162893858|NCT04153929|588309881|FG004|Overall Study|Lost to Follow-up|1|||
162893859|NCT04153929|588309882|FG005|Overall Study|Lost to Follow-up|0|||
162893860|NCT04153929|588309883|FG006|Overall Study|Lost to Follow-up|0|||
162893861|NCT04153929|588309884|FG007|Overall Study|Lost to Follow-up|0|||
162893862|NCT04153929|588309877|FG000|Overall Study|Withdrawal by Subject|3|||
162893863|NCT04153929|588309878|FG001|Overall Study|Withdrawal by Subject|1|||
162893864|NCT04153929|588309879|FG002|Overall Study|Withdrawal by Subject|0|||
162893865|NCT04153929|588309880|FG003|Overall Study|Withdrawal by Subject|3|||
162893866|NCT04153929|588309881|FG004|Overall Study|Withdrawal by Subject|1|||
162893867|NCT04153929|588309882|FG005|Overall Study|Withdrawal by Subject|0|||
162893868|NCT04153929|588309883|FG006|Overall Study|Withdrawal by Subject|1|||
162893869|NCT04153929|588309884|FG007|Overall Study|Withdrawal by Subject|0|||
162893870|NCT04153929|588309877|FG000|Overall Study|Protocol Violation|0|||
162893871|NCT04153929|588309878|FG001|Overall Study|Protocol Violation|0|||
162893872|NCT04153929|588309879|FG002|Overall Study|Protocol Violation|0|||
162893873|NCT04153929|588309880|FG003|Overall Study|Protocol Violation|0|||
162893874|NCT04153929|588309881|FG004|Overall Study|Protocol Violation|0|||
162893875|NCT04153929|588309882|FG005|Overall Study|Protocol Violation|0|||
162893876|NCT04153929|588309883|FG006|Overall Study|Protocol Violation|1|||
162893877|NCT04153929|588309884|FG007|Overall Study|Protocol Violation|2|||
162893878|NCT04153929|588309877|FG000|Overall Study|Adverse Event|3|||
162893879|NCT04153929|588309878|FG001|Overall Study|Adverse Event|5|||
162893880|NCT04153929|588309879|FG002|Overall Study|Adverse Event|5|||
162893881|NCT04153929|588309880|FG003|Overall Study|Adverse Event|11|||
162893882|NCT04153929|588309881|FG004|Overall Study|Adverse Event|15|||
162893883|NCT04153929|588309882|FG005|Overall Study|Adverse Event|4|||
162893884|NCT04153929|588309883|FG006|Overall Study|Adverse Event|8|||
162893885|NCT04153929|588309884|FG007|Overall Study|Adverse Event|2|||
162893886|NCT04153929|588309877|FG000|Overall Study|Not treated|1|||
162893887|NCT04153929|588309878|FG001|Overall Study|Not treated|0|||
162893888|NCT04153929|588309879|FG002|Overall Study|Not treated|0|||
162893889|NCT04153929|588309880|FG003|Overall Study|Not treated|0|||
162893890|NCT04153929|588309881|FG004|Overall Study|Not treated|0|||
162893891|NCT04153929|588309882|FG005|Overall Study|Not treated|0|||
162893892|NCT04153929|588309883|FG006|Overall Study|Not treated|1|||
162893893|NCT04153929|588309884|FG007|Overall Study|Not treated|0|||
162893894|NCT03383614|588309885|FG000|Overall Study|Withdrawal by Subject|0|||
162893895|NCT03383614|588309886|FG001|Overall Study|Withdrawal by Subject|1|||
162893896|NCT03383614|588309887|FG002|Overall Study|Withdrawal by Subject|0|||
162893897|NCT03383614|588309888|FG003|Overall Study|Withdrawal by Subject|0|||
162893898|NCT03199638|588309889|FG000|Overall Study|inability to drink glutamine during regularly|0|||
162893899|NCT03199638|588309890|FG001|Overall Study|inability to drink glutamine during regularly|2|||
162893900|NCT02807844|588309893|FG000|Overall Study|Physician Decision|0|||
162893901|NCT02807844|588309894|FG001|Overall Study|Physician Decision|0|||
162893902|NCT02807844|588309895|FG002|Overall Study|Physician Decision|0|||
162893903|NCT02807844|588309896|FG003|Overall Study|Physician Decision|0|||
162893904|NCT02807844|588309897|FG004|Overall Study|Physician Decision|0|||
162893905|NCT02807844|588309898|FG005|Overall Study|Physician Decision|0|||
162893906|NCT02807844|588309899|FG006|Overall Study|Physician Decision|3|||
162893907|NCT02807844|588309900|FG007|Overall Study|Physician Decision|0|||
162893908|NCT02807844|588309901|FG008|Overall Study|Physician Decision|1|||
162893909|NCT02807844|588309902|FG009|Overall Study|Physician Decision|2|||
162893910|NCT02807844|588309893|FG000|Overall Study|Death|0|||
162893911|NCT02807844|588309894|FG001|Overall Study|Death|0|||
162893912|NCT02807844|588309895|FG002|Overall Study|Death|2|||
162893913|NCT02807844|588309896|FG003|Overall Study|Death|4|||
162893914|NCT02807844|588309897|FG004|Overall Study|Death|1|||
162893915|NCT02807844|588309898|FG005|Overall Study|Death|2|||
162893916|NCT02807844|588309899|FG006|Overall Study|Death|1|||
162893917|NCT02807844|588309900|FG007|Overall Study|Death|2|||
162893918|NCT02807844|588309901|FG008|Overall Study|Death|0|||
162893919|NCT02807844|588309902|FG009|Overall Study|Death|1|||
162893920|NCT02807844|588309893|FG000|Overall Study|Withdrawal by Subject|0|||
162893921|NCT02807844|588309894|FG001|Overall Study|Withdrawal by Subject|0|||
162893922|NCT02807844|588309895|FG002|Overall Study|Withdrawal by Subject|2|||
162893923|NCT02807844|588309896|FG003|Overall Study|Withdrawal by Subject|1|||
162893924|NCT02807844|588309897|FG004|Overall Study|Withdrawal by Subject|1|||
162893925|NCT02807844|588309898|FG005|Overall Study|Withdrawal by Subject|0|||
162893926|NCT02807844|588309899|FG006|Overall Study|Withdrawal by Subject|1|||
162893927|NCT02807844|588309900|FG007|Overall Study|Withdrawal by Subject|0|||
162893928|NCT02807844|588309901|FG008|Overall Study|Withdrawal by Subject|0|||
162893929|NCT02807844|588309902|FG009|Overall Study|Withdrawal by Subject|0|||
162893930|NCT02807844|588309893|FG000|Overall Study|Progressive disease|5|||
162893931|NCT02807844|588309894|FG001|Overall Study|Progressive disease|12|||
162893932|NCT02807844|588309895|FG002|Overall Study|Progressive disease|8|||
162893933|NCT02807844|588309896|FG003|Overall Study|Progressive disease|8|||
162893934|NCT02807844|588309897|FG004|Overall Study|Progressive disease|3|||
162893935|NCT02807844|588309898|FG005|Overall Study|Progressive disease|8|||
162893936|NCT02807844|588309899|FG006|Overall Study|Progressive disease|14|||
162893937|NCT02807844|588309900|FG007|Overall Study|Progressive disease|17|||
162893938|NCT02807844|588309901|FG008|Overall Study|Progressive disease|19|||
162893939|NCT02807844|588309902|FG009|Overall Study|Progressive disease|15|||
162893940|NCT02807844|588309893|FG000|Overall Study|Adverse Event|1|||
162893941|NCT02807844|588309894|FG001|Overall Study|Adverse Event|0|||
162893942|NCT02807844|588309895|FG002|Overall Study|Adverse Event|0|||
162893943|NCT02807844|588309896|FG003|Overall Study|Adverse Event|0|||
162893944|NCT02807844|588309897|FG004|Overall Study|Adverse Event|1|||
162893945|NCT02807844|588309898|FG005|Overall Study|Adverse Event|1|||
162893946|NCT02807844|588309899|FG006|Overall Study|Adverse Event|1|||
162893947|NCT02807844|588309900|FG007|Overall Study|Adverse Event|1|||
162893948|NCT02807844|588309901|FG008|Overall Study|Adverse Event|1|||
162893949|NCT02807844|588309902|FG009|Overall Study|Adverse Event|2|||
162893950|NCT00108953|588309909|FG000|Follow-up|Death|18|||
162893951|NCT00108953|588309910|FG001|Follow-up|Death|26|||
162893952|NCT00108953|588309909|FG000|Follow-up|Lost to Follow-up|1|||
162893953|NCT00108953|588309910|FG001|Follow-up|Lost to Follow-up|1|||
162893954|NCT00108953|588309909|FG000|Follow-up|Study terminated by sponsor|10|||
162893955|NCT00108953|588309910|FG001|Follow-up|Study terminated by sponsor|6|||
162893956|NCT00293241|588309912|FG000|Overall Study|Lost to Follow-up|9|||
162893957|NCT00293241|588309913|FG001|Overall Study|Lost to Follow-up|16|||
162893958|NCT00293241|588309912|FG000|Overall Study|Physician Decision|23|||
162893959|NCT00293241|588309913|FG001|Overall Study|Physician Decision|17|||
162893960|NCT00293241|588309912|FG000|Overall Study|Withdrawal by Subject|4|||
162893961|NCT00293241|588309913|FG001|Overall Study|Withdrawal by Subject|8|||
162893962|NCT03595384|588309914|FG000|Overall Study|Other time commitments|8|||
162893963|NCT03595384|588309914|FG000|Overall Study|Changes to session time|7|||
162893964|NCT03595384|588309914|FG000|Overall Study|Relocation out of country|1|||
162893965|NCT03803202|588309915|FG000|Overall Study|Other|0|||
162893966|NCT03803202|588309916|FG001|Overall Study|Other|1|||
162893967|NCT03803202|588309917|FG002|Overall Study|Other|0|||
162893968|NCT03803202|588309918|FG003|Overall Study|Other|0|||
162893969|NCT03803202|588309919|FG004|Overall Study|Other|0|||
162893970|NCT03803202|588309920|FG005|Overall Study|Other|0|||
162893971|NCT03803202|588309921|FG006|Overall Study|Other|0|||
162893972|NCT03803202|588309922|FG007|Overall Study|Other|0|||
162893973|NCT03803202|588309923|FG008|Overall Study|Other|0|||
162893974|NCT03803202|588309915|FG000|Overall Study|Death|0|||
162964745|NCT02219009|588571933|FG001|Overall Study|Adverse Event|4|||
162964746|NCT02219009|588571932|FG000|Overall Study|Lost to Follow-up|2|||
162964747|NCT02219009|588571933|FG001|Overall Study|Lost to Follow-up|2|||
162964748|NCT02219009|588571932|FG000|Overall Study|Protocol deviation|1|||
162964749|NCT02219009|588571933|FG001|Overall Study|Protocol deviation|0|||
162964750|NCT02219009|588571932|FG000|Overall Study|Physician Decision|0|||
162964751|NCT02219009|588571933|FG001|Overall Study|Physician Decision|1|||
162893975|NCT03803202|588309916|FG001|Overall Study|Death|0|||
162893976|NCT03803202|588309917|FG002|Overall Study|Death|0|||
162893977|NCT03803202|588309918|FG003|Overall Study|Death|0|||
162893978|NCT03803202|588309919|FG004|Overall Study|Death|0|||
162893979|NCT03803202|588309920|FG005|Overall Study|Death|1|||
162893980|NCT03803202|588309921|FG006|Overall Study|Death|0|||
162893981|NCT03803202|588309922|FG007|Overall Study|Death|0|||
162964752|NCT02259348|588571934|FG000|Overall Study|Donors|6|||
162964753|NCT02259348|588571934|FG000|Overall Study|Death|4|||
162893982|NCT03803202|588309923|FG008|Overall Study|Death|0|||
162893983|NCT03803202|588309915|FG000|Overall Study|Withdrawal by Subject|0|||
162893984|NCT03803202|588309916|FG001|Overall Study|Withdrawal by Subject|0|||
162893985|NCT03803202|588309917|FG002|Overall Study|Withdrawal by Subject|1|||
162893986|NCT03803202|588309918|FG003|Overall Study|Withdrawal by Subject|0|||
162893987|NCT03803202|588309919|FG004|Overall Study|Withdrawal by Subject|0|||
162964754|NCT01622660|588571935|FG000|Overall Study|Adverse Event|1|||
162964755|NCT00642993|588571936|FG000|Overall Study|Adverse Event|85|||
162964756|NCT00642993|588571937|FG001|Overall Study|Adverse Event|4|||
162893988|NCT03803202|588309920|FG005|Overall Study|Withdrawal by Subject|0|||
162893989|NCT03803202|588309921|FG006|Overall Study|Withdrawal by Subject|0|||
162893990|NCT03803202|588309922|FG007|Overall Study|Withdrawal by Subject|1|||
162893991|NCT03803202|588309923|FG008|Overall Study|Withdrawal by Subject|0|||
162893992|NCT03803202|588309915|FG000|Overall Study|Lost to Follow-up|0|||
162893993|NCT03803202|588309916|FG001|Overall Study|Lost to Follow-up|0|||
162893994|NCT03803202|588309917|FG002|Overall Study|Lost to Follow-up|0|||
162893995|NCT03803202|588309918|FG003|Overall Study|Lost to Follow-up|1|||
162893996|NCT03803202|588309919|FG004|Overall Study|Lost to Follow-up|1|||
162893997|NCT03803202|588309920|FG005|Overall Study|Lost to Follow-up|0|||
162893998|NCT03803202|588309921|FG006|Overall Study|Lost to Follow-up|1|||
162893999|NCT03803202|588309922|FG007|Overall Study|Lost to Follow-up|0|||
162894000|NCT03803202|588309923|FG008|Overall Study|Lost to Follow-up|0|||
162894001|NCT01125293|588309924|FG000|Overall Study|Disease Progression|1|||
162894002|NCT01125293|588309925|FG001|Overall Study|Disease Progression|3|||
162894003|NCT01125293|588309926|FG002|Overall Study|Disease Progression|4|||
162894004|NCT01125293|588309927|FG003|Overall Study|Disease Progression|3|||
162894005|NCT01125293|588309928|FG004|Overall Study|Disease Progression|5|||
162894006|NCT01125293|588309929|FG005|Overall Study|Disease Progression|12|||
162894007|NCT01125293|588309924|FG000|Overall Study|Adverse Event|1|||
162894008|NCT01125293|588309925|FG001|Overall Study|Adverse Event|0|||
162894009|NCT01125293|588309926|FG002|Overall Study|Adverse Event|0|||
162894010|NCT01125293|588309927|FG003|Overall Study|Adverse Event|0|||
162894011|NCT01125293|588309928|FG004|Overall Study|Adverse Event|2|||
162894012|NCT01125293|588309929|FG005|Overall Study|Adverse Event|8|||
162894013|NCT01125293|588309924|FG000|Overall Study|Symptomatic Deterioration|1|||
162894014|NCT01125293|588309925|FG001|Overall Study|Symptomatic Deterioration|0|||
162894015|NCT01125293|588309926|FG002|Overall Study|Symptomatic Deterioration|0|||
162894016|NCT01125293|588309927|FG003|Overall Study|Symptomatic Deterioration|0|||
162894017|NCT01125293|588309928|FG004|Overall Study|Symptomatic Deterioration|0|||
162894018|NCT01125293|588309929|FG005|Overall Study|Symptomatic Deterioration|0|||
162894019|NCT01125293|588309924|FG000|Overall Study|Death|0|||
162894020|NCT01125293|588309925|FG001|Overall Study|Death|0|||
162894021|NCT01125293|588309926|FG002|Overall Study|Death|0|||
162894022|NCT01125293|588309927|FG003|Overall Study|Death|0|||
162894023|NCT01125293|588309928|FG004|Overall Study|Death|1|||
162894024|NCT01125293|588309929|FG005|Overall Study|Death|0|||
162894025|NCT01125293|588309924|FG000|Overall Study|Withdrawal by Subject|0|||
162894026|NCT01125293|588309925|FG001|Overall Study|Withdrawal by Subject|0|||
162894027|NCT01125293|588309926|FG002|Overall Study|Withdrawal by Subject|0|||
162894028|NCT01125293|588309927|FG003|Overall Study|Withdrawal by Subject|0|||
162894029|NCT01125293|588309928|FG004|Overall Study|Withdrawal by Subject|2|||
162894030|NCT01125293|588309929|FG005|Overall Study|Withdrawal by Subject|1|||
162894031|NCT01125293|588309924|FG000|Overall Study|Physician Decision|0|||
162894032|NCT01125293|588309925|FG001|Overall Study|Physician Decision|0|||
162894033|NCT01125293|588309926|FG002|Overall Study|Physician Decision|0|||
162894034|NCT01125293|588309927|FG003|Overall Study|Physician Decision|0|||
162894035|NCT01125293|588309928|FG004|Overall Study|Physician Decision|0|||
162894036|NCT01125293|588309929|FG005|Overall Study|Physician Decision|2|||
162894037|NCT01270958|588309930|FG000|Overall Study|Lost to Follow-up|2|||
162894038|NCT01270958|588309930|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
162894039|NCT01406652|588309931|FG000|Overall Study|Lost-to-follow-up|3|||
162894040|NCT01406652|588309932|FG001|Overall Study|Lost-to-follow-up|4|||
162894041|NCT01406652|588309931|FG000|Overall Study|Withdrawal by Subject|2|||
162894042|NCT01406652|588309932|FG001|Overall Study|Withdrawal by Subject|2|||
162894043|NCT01406652|588309931|FG000|Overall Study|Insufficient follow-up|5|||
162894044|NCT01406652|588309932|FG001|Overall Study|Insufficient follow-up|4|||
162894045|NCT01406652|588309931|FG000|Overall Study|Infection not sure|10|||
162894046|NCT01406652|588309932|FG001|Overall Study|Infection not sure|10|||
162964757|NCT00642993|588571936|FG000|Overall Study|Lost to Follow-up|8|||
162964758|NCT00642993|588571937|FG001|Overall Study|Lost to Follow-up|4|||
162964759|NCT00642993|588571936|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
162964760|NCT00642993|588571937|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
162894047|NCT02228564|588309933|FG000|Overall Study|Withdrawal by Subject|10|||
162964761|NCT00642993|588571936|FG000|Overall Study|Protocol Violation|1|||
162964762|NCT00642993|588571937|FG001|Overall Study|Protocol Violation|4|||
162894048|NCT02228564|588309933|FG000|Overall Study|Death|11|||
162894049|NCT02228564|588309933|FG000|Overall Study|Physician Decision|5|||
162894050|NCT02228564|588309933|FG000|Overall Study|Lost to Follow-up|17|||
162894051|NCT02228564|588309933|FG000|Overall Study|Other|6|||
162894052|NCT02633046|588309935|FG000|Overall Study|Adverse Event|8|||
162894053|NCT02633046|588309935|FG000|Overall Study|Physician Decision|7|||
162894054|NCT02633046|588309935|FG000|Overall Study|Withdrawal by Subject|8|||
162894055|NCT02633046|588309935|FG000|Overall Study|Increased proteinuria|2|||
162622912|NCT01663532|587335367|FG000|Overall Study|Lack of Efficacy|15|||
162894056|NCT02633046|588309935|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
162894057|NCT02633046|588309935|FG000|Overall Study|Mutual decision patient and physician|1|||
162964763|NCT00642993|588571936|FG000|Overall Study|Did not meet protocol eligibility|0|||
162622913|NCT01663532|587335368|FG001|Overall Study|Lack of Efficacy|60|||
162894058|NCT02142504|588309936|FG000|Overall Study|Protocol Violation|2|||
162894059|NCT02142504|588309937|FG001|Overall Study|Protocol Violation|1|||
162894060|NCT02142504|588309938|FG002|Overall Study|Protocol Violation|2|||
162894061|NCT02142504|588309936|FG000|Overall Study|Adverse Event|2|||
162894062|NCT02142504|588309937|FG001|Overall Study|Adverse Event|3|||
162894063|NCT02142504|588309938|FG002|Overall Study|Adverse Event|4|||
162894064|NCT02142504|588309936|FG000|Overall Study|Lost to Follow-up|12|||
162894065|NCT02142504|588309937|FG001|Overall Study|Lost to Follow-up|19|||
162894066|NCT02142504|588309938|FG002|Overall Study|Lost to Follow-up|17|||
162894067|NCT02142504|588309936|FG000|Overall Study|Withdrawal by Subject|7|||
162894068|NCT02142504|588309937|FG001|Overall Study|Withdrawal by Subject|9|||
162894069|NCT02142504|588309938|FG002|Overall Study|Withdrawal by Subject|11|||
162894070|NCT02142504|588309936|FG000|Overall Study|Pregnancy|4|||
162894071|NCT02142504|588309937|FG001|Overall Study|Pregnancy|4|||
162894072|NCT02142504|588309938|FG002|Overall Study|Pregnancy|2|||
162894073|NCT02142504|588309936|FG000|Overall Study|Physician Decision|0|||
162894074|NCT02142504|588309937|FG001|Overall Study|Physician Decision|1|||
162894075|NCT02142504|588309938|FG002|Overall Study|Physician Decision|3|||
162894076|NCT02142504|588309936|FG000|Overall Study|Reason Not Specified|4|||
162894077|NCT02142504|588309937|FG001|Overall Study|Reason Not Specified|5|||
162894078|NCT02142504|588309938|FG002|Overall Study|Reason Not Specified|4|||
162894079|NCT02925312|588309939|FG000|Overall Study|Lost to Follow-up|25|||
162894080|NCT02925312|588309940|FG001|Overall Study|Lost to Follow-up|0|||
162894081|NCT02925312|588309939|FG000|Overall Study|Adverse Event|2|||
162894082|NCT02925312|588309940|FG001|Overall Study|Adverse Event|0|||
162894083|NCT04114539|588309949|FG000|Overall Study|Adverse Event|14|||
162894084|NCT04114539|588309949|FG000|Overall Study|Lost to Follow-up|2|||
162894085|NCT04114539|588309949|FG000|Overall Study|Non-compliance with Protocol|2|||
162894086|NCT04114539|588309949|FG000|Overall Study|Non-compliance with Study Drug|1|||
162894087|NCT04114539|588309949|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
162894088|NCT04114539|588309949|FG000|Overall Study|Withdrew consent|10|||
162894089|NCT04114539|588309949|FG000|Overall Study|Others not specified|5|||
162894090|NCT04114539|588309949|FG000|Overall Study|Investigator Decision|2|||
162894091|NCT03136367|588309958|FG000|T1 Consultation|discontinued mistakenly included|2|||
162894092|NCT03136367|588309959|FG001|T1 Consultation|discontinued mistakenly included|6|||
162894093|NCT03136367|588309960|FG002|T1 Consultation|discontinued mistakenly included|1|||
162894094|NCT03136367|588309958|FG000|T1 Consultation|Discontinued other|0|||
162894095|NCT03136367|588309959|FG001|T1 Consultation|Discontinued other|1|||
162964764|NCT00642993|588571937|FG001|Overall Study|Did not meet protocol eligibility|1|||
162964765|NCT00642993|588571936|FG000|Overall Study|Administrative|1|||
162964766|NCT00642993|588571937|FG001|Overall Study|Administrative|0|||
162964767|NCT02664415|588571938|FG000|Overall Study|Adverse Event|1|||
162964768|NCT02664415|588571939|FG001|Overall Study|Adverse Event|0|||
162964769|NCT02034513|588571940|FG000|Overall Study|Adverse Event|11|||
162964770|NCT02034513|588571941|FG001|Overall Study|Adverse Event|10|||
162964771|NCT02034513|588571940|FG000|Overall Study|Lack of Efficacy|0|||
162964772|NCT02034513|588571941|FG001|Overall Study|Lack of Efficacy|1|||
162964773|NCT02034513|588571940|FG000|Overall Study|Lost to Follow-up|6|||
162964774|NCT02034513|588571941|FG001|Overall Study|Lost to Follow-up|7|||
162964775|NCT02034513|588571940|FG000|Overall Study|Pregnancy|0|||
162964776|NCT02034513|588571941|FG001|Overall Study|Pregnancy|3|||
162964777|NCT02034513|588571940|FG000|Overall Study|Protocol Violation|7|||
162964778|NCT02034513|588571941|FG001|Overall Study|Protocol Violation|10|||
162964779|NCT02034513|588571940|FG000|Overall Study|Withdrawal by Subject|25|||
162964780|NCT02034513|588571941|FG001|Overall Study|Withdrawal by Subject|25|||
162964781|NCT02034513|588571940|FG000|Overall Study|Unclassified|0|||
162964782|NCT02034513|588571941|FG001|Overall Study|Unclassified|1|||
163051853|NCT02974868|588898735|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
162622914|NCT01871532|587335374|FG000|Overall Study|Withdrawal by Subject|1|||
162622915|NCT01871532|587335375|FG001|Overall Study|Withdrawal by Subject|2|||
162622916|NCT00283400|587335376|FG000|Overall Study|Withdrawal by Subject|1|||
162622917|NCT00283400|587335377|FG001|Overall Study|Withdrawal by Subject|1|||
162622918|NCT00283400|587335378|FG002|Overall Study|Withdrawal by Subject|0|||
162622919|NCT00283400|587335379|FG003|Overall Study|Withdrawal by Subject|0|||
162622920|NCT00283400|587335376|FG000|Overall Study|Death|1|||
162622921|NCT00283400|587335377|FG001|Overall Study|Death|0|||
162622922|NCT00283400|587335378|FG002|Overall Study|Death|1|||
162622923|NCT00283400|587335379|FG003|Overall Study|Death|0|||
162622924|NCT00934089|587335383|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
162622925|NCT00934089|587335384|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
162622926|NCT00934089|587335383|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
162894096|NCT03136367|588309960|FG002|T1 Consultation|Discontinued other|0|||
162894097|NCT03136367|588309958|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
162964783|NCT00960154|588571942|FG000|Overall Study|Study termination|25|||
162964784|NCT00960154|588571943|FG001|Overall Study|Study termination|25|||
162964785|NCT00757705|588571944|FG000|Overall Study|Adverse Event|19|||
162964786|NCT00757705|588571944|FG000|Overall Study|Lost to Follow-up|16|||
162894098|NCT03136367|588309959|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
162894099|NCT03136367|588309960|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
162894100|NCT03136367|588309958|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
162894101|NCT03136367|588309959|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
162894102|NCT03136367|588309960|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
162894103|NCT03136367|588309958|FG000|T2 Post-consultation|Discontinued other|0|||
162894104|NCT03136367|588309959|FG001|T2 Post-consultation|Discontinued other|2|||
162894105|NCT03136367|588309960|FG002|T2 Post-consultation|Discontinued other|6|||
162894106|NCT03136367|588309958|FG000|T2 Post-consultation|Discontinued transferred care|0|||
162894107|NCT03136367|588309959|FG001|T2 Post-consultation|Discontinued transferred care|0|||
162894108|NCT03136367|588309960|FG002|T2 Post-consultation|Discontinued transferred care|3|||
162894109|NCT03136367|588309958|FG000|T2 Post-consultation|Discontinued lost contact|0|||
162894110|NCT03136367|588309959|FG001|T2 Post-consultation|Discontinued lost contact|1|||
162894111|NCT03136367|588309960|FG002|T2 Post-consultation|Discontinued lost contact|0|||
162894112|NCT03136367|588309958|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
162894113|NCT03136367|588309959|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
162894114|NCT03136367|588309960|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
162894115|NCT03136367|588309958|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
162894116|NCT03136367|588309959|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
162894117|NCT03136367|588309960|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
162894118|NCT03136367|588309958|FG000|T3 1 Week After Surgery|other discontinued|2|||
162894119|NCT03136367|588309959|FG001|T3 1 Week After Surgery|other discontinued|4|||
162894120|NCT03136367|588309960|FG002|T3 1 Week After Surgery|other discontinued|3|||
162894121|NCT03136367|588309958|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
162894122|NCT03136367|588309959|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
162894123|NCT03136367|588309960|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
162894124|NCT03136367|588309958|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
162894125|NCT03136367|588309959|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
162894126|NCT03136367|588309960|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
162894127|NCT03136367|588309958|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
162894128|NCT03136367|588309959|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
162894129|NCT03136367|588309960|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
162894130|NCT03136367|588309958|FG000|T4 12 Weeks After Surgery|Death|0|||
162894131|NCT03136367|588309959|FG001|T4 12 Weeks After Surgery|Death|1|||
162894132|NCT03136367|588309960|FG002|T4 12 Weeks After Surgery|Death|3|||
162894133|NCT03136367|588309958|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
162894134|NCT03136367|588309959|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
162894135|NCT03136367|588309960|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
162894136|NCT03136367|588309958|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
162894137|NCT03136367|588309959|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
162894138|NCT03136367|588309960|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
162894139|NCT03136367|588309958|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
162894140|NCT03136367|588309959|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
162894141|NCT03136367|588309960|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
162894142|NCT03136367|588309958|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
162894143|NCT03136367|588309959|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
162894144|NCT03136367|588309960|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
162622927|NCT00934089|587335384|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
162622928|NCT01020981|587335385|FG000|Overall Study|Did not return mailed survey|74|||
162622929|NCT01020981|587335386|FG001|Overall Study|Did not return mailed survey|58|||
162622930|NCT01020981|587335385|FG000|Overall Study|Survey returned undeliverable|8|||
162622931|NCT01020981|587335386|FG001|Overall Study|Survey returned undeliverable|32|||
162622932|NCT01020981|587335385|FG000|Overall Study|Participant declined to complete survey|2|||
162622933|NCT01020981|587335386|FG001|Overall Study|Participant declined to complete survey|0|||
162622934|NCT00680017|587335389|FG000|Overall Study|Adverse Event|13|||
162622935|NCT00680017|587335390|FG001|Overall Study|Adverse Event|7|||
162622936|NCT00680017|587335389|FG000|Overall Study|Withdrawal by Subject|2|||
162622937|NCT00680017|587335390|FG001|Overall Study|Withdrawal by Subject|5|||
162622938|NCT00680017|587335389|FG000|Overall Study|Lost to Follow-up|2|||
162622939|NCT00680017|587335390|FG001|Overall Study|Lost to Follow-up|0|||
162622940|NCT01434667|587335391|FG000|Overall Study|Lost to Follow-up|5|||
162622941|NCT01434667|587335392|FG001|Overall Study|Lost to Follow-up|10|||
162622942|NCT02034110|587335395|FG000|Overall Study|Physician Decision|0|||
162894145|NCT03136367|588309958|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
162894146|NCT03136367|588309959|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
162894147|NCT03136367|588309960|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
162894148|NCT03136367|588309958|FG000|T5 1 Year After Surgery|Death|0|||
162894149|NCT03136367|588309959|FG001|T5 1 Year After Surgery|Death|0|||
162622943|NCT02034110|587335396|FG001|Overall Study|Physician Decision|0|||
162622944|NCT02034110|587335397|FG002|Overall Study|Physician Decision|0|||
162622945|NCT02034110|587335398|FG003|Overall Study|Physician Decision|0|||
162622946|NCT02034110|587335399|FG004|Overall Study|Physician Decision|2|||
162622947|NCT02034110|587335400|FG005|Overall Study|Physician Decision|0|||
162894150|NCT03136367|588309960|FG002|T5 1 Year After Surgery|Death|1|||
162894151|NCT03136367|588309958|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
162894152|NCT03136367|588309959|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
162894153|NCT03136367|588309960|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
162894154|NCT03136367|588309958|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
162894155|NCT03136367|588309959|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
162894156|NCT03136367|588309960|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
162894157|NCT03136367|588309958|FG000|T5 1 Year After Surgery|study ended before due|31|||
162894158|NCT03136367|588309959|FG001|T5 1 Year After Surgery|study ended before due|103|||
162894159|NCT03136367|588309960|FG002|T5 1 Year After Surgery|study ended before due|110|||
162894160|NCT03136367|588309958|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
162894161|NCT03136367|588309959|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
162894162|NCT03136367|588309960|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
162894163|NCT04038385|588312159|FG000|Overall Study|Completed baseline assessment only|7|||
162894164|NCT04038385|588312160|FG001|Overall Study|Completed baseline assessment only|4|||
162894165|NCT04038385|588312159|FG000|Overall Study|Moved out of area|4|||
162894166|NCT04038385|588312160|FG001|Overall Study|Moved out of area|2|||
162894167|NCT04038385|588312159|FG000|Overall Study|Discontinued study involvement|6|||
162894168|NCT04038385|588312160|FG001|Overall Study|Discontinued study involvement|1|||
162894169|NCT03424044|588312161|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894170|NCT03424044|588312162|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894171|NCT03424044|588312163|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
162894172|NCT03424044|588312164|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894173|NCT03424044|588312165|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894174|NCT03424044|588312166|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894175|NCT03424044|588312167|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894176|NCT03424044|588312168|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894177|NCT03424044|588312169|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
162894178|NCT03424044|588312161|FG000|First Intervention (76 Hours)|Adverse Event|0|||
162894179|NCT03424044|588312162|FG001|First Intervention (76 Hours)|Adverse Event|0|||
162894180|NCT03424044|588312163|FG002|First Intervention (76 Hours)|Adverse Event|0|||
162894181|NCT03424044|588312164|FG003|First Intervention (76 Hours)|Adverse Event|0|||
162894182|NCT03424044|588312165|FG004|First Intervention (76 Hours)|Adverse Event|1|||
162894183|NCT03424044|588312166|FG005|First Intervention (76 Hours)|Adverse Event|0|||
162894184|NCT03424044|588312167|FG006|First Intervention (76 Hours)|Adverse Event|0|||
162894185|NCT03424044|588312168|FG007|First Intervention (76 Hours)|Adverse Event|0|||
162894186|NCT03424044|588312169|FG008|First Intervention (76 Hours)|Adverse Event|0|||
162894187|NCT03424044|588312161|FG000|First Intervention (76 Hours)|device issues|0|||
162894188|NCT03424044|588312162|FG001|First Intervention (76 Hours)|device issues|0|||
162894189|NCT03424044|588312163|FG002|First Intervention (76 Hours)|device issues|0|||
162894190|NCT03424044|588312164|FG003|First Intervention (76 Hours)|device issues|0|||
162894191|NCT03424044|588312165|FG004|First Intervention (76 Hours)|device issues|0|||
162894192|NCT03424044|588312166|FG005|First Intervention (76 Hours)|device issues|0|||
162894193|NCT03424044|588312167|FG006|First Intervention (76 Hours)|device issues|1|||
162894194|NCT03424044|588312168|FG007|First Intervention (76 Hours)|device issues|1|||
162894195|NCT03424044|588312169|FG008|First Intervention (76 Hours)|device issues|1|||
162894196|NCT03424044|588312161|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
162894197|NCT03424044|588312162|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
162894198|NCT03424044|588312163|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
162894199|NCT03424044|588312164|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
162894200|NCT03424044|588312165|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
162622948|NCT02034110|587335401|FG006|Overall Study|Physician Decision|1|||
162622949|NCT02034110|587335402|FG007|Overall Study|Physician Decision|0|||
162622950|NCT02034110|587335395|FG000|Overall Study|Lost to Follow-up|1|||
162622951|NCT02034110|587335396|FG001|Overall Study|Lost to Follow-up|0|||
162894201|NCT03424044|588312166|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
162894202|NCT03424044|588312167|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
162894203|NCT03424044|588312168|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
162894204|NCT03424044|588312169|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
162894205|NCT03424044|588312161|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894206|NCT03424044|588312162|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894207|NCT03424044|588312163|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894208|NCT03424044|588312164|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
162894209|NCT03424044|588312165|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894210|NCT03424044|588312166|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162622952|NCT02034110|587335397|FG002|Overall Study|Lost to Follow-up|0|||
162622953|NCT02034110|587335398|FG003|Overall Study|Lost to Follow-up|0|||
162894211|NCT03424044|588312167|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894212|NCT03424044|588312168|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894213|NCT03424044|588312169|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
162894214|NCT00402285|588312176|FG000|Overall Study|insufficient RNA quality|7|||
162894215|NCT00402285|588312177|FG001|Overall Study|insufficient RNA quality|6|||
162894216|NCT00402285|588312178|FG002|Overall Study|insufficient RNA quality|2|||
162894217|NCT00784459|588312181|FG000|Overall Study|Adverse Event|0|||
162894218|NCT00784459|588312182|FG001|Overall Study|Adverse Event|2|||
162894219|NCT00405275|588312183|FG000|Overall Study|Death|1|||
162894220|NCT00405275|588312184|FG001|Overall Study|Death|0|||
162894221|NCT00405275|588312183|FG000|Overall Study|Lost to Follow-up|5|||
162894222|NCT00405275|588312184|FG001|Overall Study|Lost to Follow-up|1|||
162894223|NCT00405275|588312183|FG000|Overall Study|Withdrawal by Subject|7|||
162894224|NCT00405275|588312184|FG001|Overall Study|Withdrawal by Subject|9|||
162894225|NCT00405275|588312183|FG000|Overall Study|Unwilling to continue|10|||
162894226|NCT00405275|588312184|FG001|Overall Study|Unwilling to continue|9|||
162894227|NCT00088595|588312185|FG000|Overall Study|Adverse Event|11|||
162894228|NCT00088595|588312185|FG000|Overall Study|Withdrawal by Subject|8|||
162894229|NCT00088595|588312185|FG000|Overall Study|Ongoing (After Core)|7|||
162894230|NCT00088595|588312185|FG000|Overall Study|New Cancer Therapy|2|||
162894231|NCT02959970|588312200|FG000|Overall Study|Adverse Event|1|||
162894232|NCT02959970|588312201|FG001|Overall Study|Adverse Event|0|||
162894233|NCT02959970|588312200|FG000|Overall Study|Withdrawal by Subject|0|||
162894234|NCT02959970|588312201|FG001|Overall Study|Withdrawal by Subject|2|||
162894235|NCT02959970|588312200|FG000|Overall Study|Lost to Follow-up|1|||
162894236|NCT02959970|588312201|FG001|Overall Study|Lost to Follow-up|5|||
162894237|NCT01473355|588312204|FG000|Overall Study|Protocol Violation|2|||
162894238|NCT01473355|588312204|FG000|Overall Study|Adverse Event|2|||
162894239|NCT01473355|588312204|FG000|Overall Study|Lost to Follow-up|2|||
162894240|NCT00606177|588312207|FG000|Overall Study|Adverse Event|9|||
162894241|NCT00606177|588312208|FG001|Overall Study|Adverse Event|5|||
162894242|NCT00606177|588312207|FG000|Overall Study|Lack of Efficacy|3|||
162894243|NCT00606177|588312208|FG001|Overall Study|Lack of Efficacy|7|||
162894244|NCT00606177|588312207|FG000|Overall Study|Physician Decision|1|||
162894245|NCT00606177|588312208|FG001|Overall Study|Physician Decision|0|||
162894246|NCT00606177|588312207|FG000|Overall Study|Protocol Violation|1|||
162894247|NCT00606177|588312208|FG001|Overall Study|Protocol Violation|4|||
162894248|NCT00606177|588312207|FG000|Overall Study|Withdrawal by Subject|5|||
162894249|NCT00606177|588312208|FG001|Overall Study|Withdrawal by Subject|6|||
162894250|NCT00606177|588312207|FG000|Overall Study|Progression to depressive phase|6|||
162894251|NCT00606177|588312208|FG001|Overall Study|Progression to depressive phase|1|||
162894252|NCT00606177|588312207|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
162894253|NCT00606177|588312208|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
162894254|NCT00606177|588312207|FG000|Overall Study|Change of residence or other commitments|1|||
162894255|NCT00606177|588312208|FG001|Overall Study|Change of residence or other commitments|1|||
162894256|NCT02603172|588312213|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894257|NCT02603172|588312214|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894258|NCT02603172|588312215|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
162894259|NCT02603172|588312216|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894260|NCT02603172|588312217|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894261|NCT02603172|588312218|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894262|NCT02603172|588312219|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894263|NCT02603172|588312220|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
162894264|NCT00863317|588312221|FG000|Overall Study|Lost to Follow-up|8|||
162894265|NCT00863317|588312222|FG001|Overall Study|Lost to Follow-up|9|||
162894266|NCT00441727|588312223|FG000|Overall Study|Protocol Violation|19|||
162894267|NCT00441727|588312224|FG001|Overall Study|Protocol Violation|28|||
162894268|NCT00441727|588312225|FG002|Overall Study|Protocol Violation|32|||
162894269|NCT00441727|588312223|FG000|Overall Study|Adverse Event|26|||
162894270|NCT00441727|588312224|FG001|Overall Study|Adverse Event|33|||
162894271|NCT00441727|588312225|FG002|Overall Study|Adverse Event|28|||
162894272|NCT00441727|588312223|FG000|Overall Study|Lack of Efficacy|7|||
162894273|NCT00441727|588312224|FG001|Overall Study|Lack of Efficacy|8|||
162894274|NCT00441727|588312225|FG002|Overall Study|Lack of Efficacy|48|||
162894275|NCT00441727|588312223|FG000|Overall Study|Withdrawal by Subject|40|||
162894276|NCT00441727|588312224|FG001|Overall Study|Withdrawal by Subject|34|||
162894277|NCT00441727|588312225|FG002|Overall Study|Withdrawal by Subject|47|||
162894278|NCT00441727|588312223|FG000|Overall Study|Lost to Follow-up|5|||
162894279|NCT00441727|588312224|FG001|Overall Study|Lost to Follow-up|6|||
162894280|NCT00441727|588312225|FG002|Overall Study|Lost to Follow-up|5|||
162894281|NCT00441727|588312223|FG000|Overall Study|Safety Reasons|3|||
162894282|NCT00441727|588312224|FG001|Overall Study|Safety Reasons|1|||
162894283|NCT00441727|588312225|FG002|Overall Study|Safety Reasons|3|||
162894284|NCT00441727|588312223|FG000|Overall Study|Various reason specified|6|||
162894285|NCT00441727|588312224|FG001|Overall Study|Various reason specified|8|||
162894286|NCT00441727|588312225|FG002|Overall Study|Various reason specified|5|||
162894287|NCT03417505|588312228|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
162894288|NCT03417505|588312229|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
162894289|NCT02133001|588312230|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
162894290|NCT02133001|588312231|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
162894291|NCT02133001|588312230|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
162894292|NCT02133001|588312231|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
162894293|NCT02133001|588312230|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
162894294|NCT02133001|588312231|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
162894295|NCT02133001|588312230|FG000|Double Blind (Day 1-25)|Other|2|||
162894296|NCT02133001|588312231|FG001|Double Blind (Day 1-25)|Other|2|||
162894297|NCT02133001|588312230|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
162894298|NCT02133001|588312231|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
162894299|NCT02133001|588312230|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
162894300|NCT02133001|588312231|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
162894301|NCT02133001|588312230|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
162894302|NCT02133001|588312231|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
162894303|NCT02133001|588312230|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
162894304|NCT02133001|588312231|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
162894305|NCT04211961|588312232|FG000|Overall Study|Death|0|||
162894306|NCT04211961|588312233|FG001|Overall Study|Death|1|||
162894307|NCT04211961|588312232|FG000|Overall Study|Lost to Follow-up|0|||
162894308|NCT04211961|588312233|FG001|Overall Study|Lost to Follow-up|1|||
162894309|NCT04211961|588312232|FG000|Overall Study|Withdrawal by Subject|0|||
162894310|NCT04211961|588312233|FG001|Overall Study|Withdrawal by Subject|1|||
162894311|NCT03235726|588312234|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894312|NCT03235726|588312235|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894313|NCT03235726|588312236|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894314|NCT03235726|588312237|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894315|NCT03235726|588312238|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
162894316|NCT03235726|588312239|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894317|NCT03235726|588312240|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894318|NCT03235726|588312241|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894319|NCT03235726|588312242|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894320|NCT03235726|588312243|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
162894321|NCT03235726|588312234|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894322|NCT03235726|588312235|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894323|NCT03235726|588312236|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894324|NCT03235726|588312237|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894325|NCT03235726|588312238|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
162894326|NCT03235726|588312239|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894327|NCT03235726|588312240|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894328|NCT03235726|588312241|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894329|NCT03235726|588312242|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894330|NCT03235726|588312243|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
162894331|NCT00268463|588312244|FG000|Overall Study|study terminated due to low accrual|10|||
162894332|NCT00268463|588312245|FG001|Overall Study|study terminated due to low accrual|12|||
162894333|NCT04685538|588312246|FG000|Overall Study|Adverse Event|0|||
162894334|NCT04685538|588312247|FG001|Overall Study|Adverse Event|1|||
162894335|NCT04685538|588312246|FG000|Overall Study|Lost to Follow-up|0|||
162894336|NCT04685538|588312247|FG001|Overall Study|Lost to Follow-up|2|||
162894337|NCT01040845|588312248|FG000|Overall Study|Withdrawal by Subject|1|||
162894338|NCT01040845|588312249|FG001|Overall Study|Withdrawal by Subject|1|||
162894339|NCT01040845|588312248|FG000|Overall Study|Physician Decision|1|||
162894340|NCT01040845|588312249|FG001|Overall Study|Physician Decision|0|||
162894341|NCT04362813|588312250|FG000|Overall Study|Death|12|||
163051854|NCT02974868|588898736|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
162894342|NCT04362813|588312251|FG001|Overall Study|Death|16|||
162894343|NCT04362813|588312250|FG000|Overall Study|Withdrawal by Subject|3|||
162894344|NCT04362813|588312251|FG001|Overall Study|Withdrawal by Subject|1|||
162894345|NCT04362813|588312250|FG000|Overall Study|Protocol Violation|0|||
162894346|NCT04362813|588312251|FG001|Overall Study|Protocol Violation|3|||
162894347|NCT04362813|588312250|FG000|Overall Study|Lost to Follow-up|1|||
162894348|NCT04362813|588312251|FG001|Overall Study|Lost to Follow-up|1|||
162894349|NCT04362813|588312250|FG000|Overall Study|Enrolled but did not receive treatment|2|||
162894350|NCT04362813|588312251|FG001|Overall Study|Enrolled but did not receive treatment|4|||
162894351|NCT01732107|588312256|FG000|Overall Study|Adverse Event|2|||
162894352|NCT01732107|588312256|FG000|Overall Study|Disease Progression|8|||
162894353|NCT01732107|588312256|FG000|Overall Study|Physician Decision|1|||
162894354|NCT01732107|588312256|FG000|Overall Study|Withdrawal by Subject|2|||
162894355|NCT04445688|588312257|FG000|Washout (One Week)|Adverse Event|2|||
162894356|NCT04445688|588312257|FG000|Washout (One Week)|Withdrawal by Subject|1|||
162894357|NCT00918346|588312259|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
162894358|NCT00918346|588312260|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
162894359|NCT01963780|588312261|FG000|Overall Study|Death|7|||
162894360|NCT04083794|588312262|FG000|Overall Study|Lost to Follow-up|9|||
162894361|NCT01749800|588312265|FG000|Overall Study|not meeting inclusion criteria|3|||
162894362|NCT01749800|588312266|FG001|Overall Study|not meeting inclusion criteria|0|||
162894363|NCT01749800|588312267|FG002|Overall Study|not meeting inclusion criteria|0|||
162894364|NCT01749800|588312265|FG000|Overall Study|Withdrawal by Subject|0|||
162894365|NCT01749800|588312266|FG001|Overall Study|Withdrawal by Subject|1|||
162894366|NCT01749800|588312267|FG002|Overall Study|Withdrawal by Subject|0|||
162894367|NCT00224003|588312272|FG000|Overall Study|Adverse Event|1|||
162894368|NCT00224003|588312272|FG000|Overall Study|Protocol Violation|2|||
162894369|NCT00224003|588312272|FG000|Overall Study|Withdrawal by Subject|1|||
162894370|NCT00224003|588312272|FG000|Overall Study|unk|3|||
162894371|NCT03549429|588312273|FG000|Overall Study|Protocol Violation|5|||
162894372|NCT03549429|588312274|FG001|Overall Study|Protocol Violation|3|||
162894373|NCT00729326|588312282|FG000|Overall Study|Lost to Follow-up|2|||
162894374|NCT00729326|588312283|FG001|Overall Study|Lost to Follow-up|0|||
162894375|NCT00729326|588312282|FG000|Overall Study|Physician Decision|0|||
162894376|NCT00729326|588312283|FG001|Overall Study|Physician Decision|1|||
162894377|NCT00729326|588312282|FG000|Overall Study|Protocol Violation|3|||
162894378|NCT00729326|588312283|FG001|Overall Study|Protocol Violation|2|||
162894379|NCT00729326|588312282|FG000|Overall Study|Subject Decision|4|||
162894380|NCT00729326|588312283|FG001|Overall Study|Subject Decision|4|||
162894381|NCT00729326|588312282|FG000|Overall Study|Sponsor Decision|1|||
162894382|NCT00729326|588312283|FG001|Overall Study|Sponsor Decision|2|||
162894383|NCT01235728|588312286|FG000|Overall Study|Protocol Violation|0|||
162894384|NCT01235728|588312287|FG001|Overall Study|Protocol Violation|0|||
162894385|NCT01235728|588312288|FG002|Overall Study|Protocol Violation|0|||
162894386|NCT01235728|588312289|FG003|Overall Study|Protocol Violation|1|||
162894387|NCT01235728|588312290|FG004|Overall Study|Protocol Violation|0|||
162894388|NCT01235728|588312291|FG005|Overall Study|Protocol Violation|0|||
162894389|NCT01235728|588312292|FG006|Overall Study|Protocol Violation|0|||
162894390|NCT01235728|588312293|FG007|Overall Study|Protocol Violation|0|||
162894391|NCT01000025|588312294|FG000|Overall Study|Adverse Event|43|||
162894392|NCT01000025|588312295|FG001|Overall Study|Adverse Event|2|||
162894393|NCT01000025|588312294|FG000|Overall Study|Withdrawal by Subject|13|||
162894394|NCT01000025|588312295|FG001|Overall Study|Withdrawal by Subject|8|||
162894395|NCT01000025|588312294|FG000|Overall Study|Death|23|||
162894396|NCT01000025|588312295|FG001|Overall Study|Death|13|||
162894397|NCT01000025|588312294|FG000|Overall Study|Lack of Efficacy|363|||
162894398|NCT01000025|588312295|FG001|Overall Study|Lack of Efficacy|208|||
162894399|NCT01000025|588312294|FG000|Overall Study|Intercurrent Illness|26|||
162894400|NCT01000025|588312295|FG001|Overall Study|Intercurrent Illness|7|||
162894401|NCT04423757|588312296|FG000|Overall Study|Adverse Event|2|||
162894402|NCT04423757|588312297|FG001|Overall Study|Adverse Event|0|||
162894403|NCT04423757|588312296|FG000|Overall Study|Not treated|1|||
162894404|NCT04423757|588312297|FG001|Overall Study|Not treated|1|||
162894405|NCT01202760|588312298|FG000|Overall Study|Entry Criteria Not Met|0|||
162894406|NCT01202760|588312299|FG001|Overall Study|Entry Criteria Not Met|3|||
162894407|NCT01202760|588312300|FG002|Overall Study|Entry Criteria Not Met|1|||
162894408|NCT01202760|588312298|FG000|Overall Study|Adverse Event|11|||
162894409|NCT01202760|588312299|FG001|Overall Study|Adverse Event|9|||
162894410|NCT01202760|588312300|FG002|Overall Study|Adverse Event|10|||
162964787|NCT00757705|588571944|FG000|Overall Study|Withdrawal by Subject|25|||
162964788|NCT00757705|588571944|FG000|Overall Study|Insufficient Response|26|||
162622954|NCT02034110|587335399|FG004|Overall Study|Lost to Follow-up|1|||
162622955|NCT02034110|587335400|FG005|Overall Study|Lost to Follow-up|0|||
162964789|NCT00757705|588571944|FG000|Overall Study|Ineligible to continue|8|||
162964790|NCT00757705|588571944|FG000|Overall Study|Non-compliant|9|||
162894411|NCT01202760|588312298|FG000|Overall Study|Death|2|||
162894412|NCT01202760|588312299|FG001|Overall Study|Death|1|||
162894413|NCT01202760|588312300|FG002|Overall Study|Death|0|||
162894414|NCT01202760|588312298|FG000|Overall Study|Lack of Efficacy|6|||
162894415|NCT01202760|588312299|FG001|Overall Study|Lack of Efficacy|8|||
162894416|NCT01202760|588312300|FG002|Overall Study|Lack of Efficacy|7|||
162894417|NCT01202760|588312298|FG000|Overall Study|Lost to Follow-up|0|||
162894418|NCT01202760|588312299|FG001|Overall Study|Lost to Follow-up|2|||
162894419|NCT01202760|588312300|FG002|Overall Study|Lost to Follow-up|1|||
162894420|NCT01202760|588312298|FG000|Overall Study|Parent / Caregiver Decision|0|||
162894421|NCT01202760|588312299|FG001|Overall Study|Parent / Caregiver Decision|1|||
162894422|NCT01202760|588312300|FG002|Overall Study|Parent / Caregiver Decision|0|||
162894423|NCT01202760|588312298|FG000|Overall Study|Withdrawal by Subject|17|||
162894424|NCT01202760|588312299|FG001|Overall Study|Withdrawal by Subject|18|||
162894425|NCT01202760|588312300|FG002|Overall Study|Withdrawal by Subject|14|||
162894426|NCT01202760|588312298|FG000|Overall Study|Physician Decision|0|||
162894427|NCT01202760|588312299|FG001|Overall Study|Physician Decision|1|||
162964791|NCT00757705|588571944|FG000|Overall Study|Other|18|||
162894428|NCT01202760|588312300|FG002|Overall Study|Physician Decision|0|||
162894429|NCT01202760|588312298|FG000|Overall Study|Protocol Violation|7|||
162894430|NCT01202760|588312299|FG001|Overall Study|Protocol Violation|5|||
162894431|NCT01202760|588312300|FG002|Overall Study|Protocol Violation|2|||
162894432|NCT01202760|588312298|FG000|Overall Study|Sponsor Decision|4|||
162894433|NCT01202760|588312299|FG001|Overall Study|Sponsor Decision|4|||
162894434|NCT01202760|588312300|FG002|Overall Study|Sponsor Decision|0|||
162894435|NCT01654523|588312301|FG000|Overall Study|Withdrawal by Subject|1|||
162894436|NCT02810951|588312302|FG000|Overall Study|Adverse Event|1|||
162894437|NCT01575899|588312303|FG000|Overall Study|Lost to Follow-up|3|||
162894438|NCT01575899|588312304|FG001|Overall Study|Lost to Follow-up|4|||
162894439|NCT01575899|588312305|FG002|Overall Study|Lost to Follow-up|2|||
162894440|NCT01575899|588312303|FG000|Overall Study|Protocol Violation|2|||
162894441|NCT01575899|588312304|FG001|Overall Study|Protocol Violation|1|||
162894442|NCT01575899|588312305|FG002|Overall Study|Protocol Violation|0|||
162894443|NCT03097029|588312306|FG000|Overall Study|Withdrawal by Subject|1|||
162894444|NCT00709124|588312307|FG000|Overall Study|Death|3|||
162894445|NCT00709124|588312308|FG001|Overall Study|Death|1|||
162894446|NCT00709124|588312307|FG000|Overall Study|encephalopathy; can't do assessment|1|||
162894447|NCT00709124|588312308|FG001|Overall Study|encephalopathy; can't do assessment|0|||
162894448|NCT00373490|588312309|FG000|Overall Study|Adverse Event|0|||
162894449|NCT00373490|588312310|FG001|Overall Study|Adverse Event|1|||
162894450|NCT00373490|588312309|FG000|Overall Study|Lack of Efficacy|9|||
162894451|NCT00373490|588312310|FG001|Overall Study|Lack of Efficacy|4|||
162894452|NCT00373490|588312309|FG000|Overall Study|Withdrawal by Subject|0|||
162894453|NCT00373490|588312310|FG001|Overall Study|Withdrawal by Subject|1|||
162894454|NCT01250756|588312311|FG000|Infant Series|Withdrawal by Subject|4|||
162894455|NCT01250756|588312312|FG001|Infant Series|Withdrawal by Subject|5|||
162894456|NCT01250756|588312311|FG000|Infant Series|Randomized, Not Vaccinated|2|||
162894457|NCT01250756|588312312|FG001|Infant Series|Randomized, Not Vaccinated|2|||
162894458|NCT01250756|588312311|FG000|Infant Series|Other|22|||
162894459|NCT01250756|588312312|FG001|Infant Series|Other|0|||
162894460|NCT01250756|588312311|FG000|After Infant Series|Adverse Event|5|||
162894461|NCT01250756|588312312|FG001|After Infant Series|Adverse Event|2|||
162894462|NCT01250756|588312311|FG000|After Infant Series|Withdrawal by Subject|4|||
162894463|NCT01250756|588312312|FG001|After Infant Series|Withdrawal by Subject|1|||
162894464|NCT01250756|588312311|FG000|After Infant Series|Other|2|||
162894465|NCT01250756|588312312|FG001|After Infant Series|Other|1|||
162894466|NCT01250756|588312311|FG000|Toddler Dose|Adverse Event|0|||
162894467|NCT01250756|588312312|FG001|Toddler Dose|Adverse Event|1|||
162894468|NCT01250756|588312311|FG000|After Toddler Dose|Adverse Event|0|||
162894469|NCT01250756|588312312|FG001|After Toddler Dose|Adverse Event|1|||
162894470|NCT00753688|588312313|FG000|Overall Study|Death|102|||
162894471|NCT00753688|588312314|FG001|Overall Study|Death|203|||
162894472|NCT00753688|588312313|FG000|Overall Study|Missing|4|||
162894473|NCT00753688|588312314|FG001|Overall Study|Missing|9|||
162894474|NCT00753688|588312313|FG000|Overall Study|Participant Withdrew Consent|2|||
162894475|NCT00753688|588312314|FG001|Overall Study|Participant Withdrew Consent|2|||
162894476|NCT00753688|588312313|FG000|Overall Study|Ongoing - in Follow-up|15|||
162894477|NCT00753688|588312314|FG001|Overall Study|Ongoing - in Follow-up|31|||
162894478|NCT00753688|588312313|FG000|Overall Study|Adverse Event|0|||
162894479|NCT00753688|588312314|FG001|Overall Study|Adverse Event|1|||
162894480|NCT02999100|588312317|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
162894481|NCT02999100|588312318|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
162894482|NCT02999100|588312319|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
162894483|NCT02999100|588312320|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
162894484|NCT02999100|588312321|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
162894485|NCT02999100|588312322|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
162894486|NCT02999100|588312317|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
162894487|NCT02999100|588312318|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
162894488|NCT02999100|588312319|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
162894489|NCT02999100|588312320|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
162894490|NCT02999100|588312321|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
162894491|NCT02999100|588312322|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
162894492|NCT02999100|588312317|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
162894493|NCT02999100|588312318|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
162894494|NCT02999100|588312319|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
162894495|NCT02999100|588312320|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
162894496|NCT02999100|588312321|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
162894497|NCT02999100|588312322|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
162894498|NCT01455415|588312325|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
162894499|NCT01455415|588312326|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
162894500|NCT01455415|588312325|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
162622956|NCT02034110|587335401|FG006|Overall Study|Lost to Follow-up|1|||
162622957|NCT02034110|587335402|FG007|Overall Study|Lost to Follow-up|0|||
162622958|NCT02034110|587335395|FG000|Overall Study|Withdrawal by Subject|5|||
162622959|NCT02034110|587335396|FG001|Overall Study|Withdrawal by Subject|7|||
162622960|NCT02034110|587335397|FG002|Overall Study|Withdrawal by Subject|0|||
162622961|NCT02034110|587335398|FG003|Overall Study|Withdrawal by Subject|3|||
162622962|NCT02034110|587335399|FG004|Overall Study|Withdrawal by Subject|7|||
162622963|NCT02034110|587335400|FG005|Overall Study|Withdrawal by Subject|0|||
162622964|NCT02034110|587335401|FG006|Overall Study|Withdrawal by Subject|3|||
162622965|NCT02034110|587335402|FG007|Overall Study|Withdrawal by Subject|1|||
162622966|NCT02034110|587335395|FG000|Overall Study|Study closed by sponsor|6|||
162622967|NCT02034110|587335396|FG001|Overall Study|Study closed by sponsor|2|||
162622968|NCT02034110|587335397|FG002|Overall Study|Study closed by sponsor|0|||
162622969|NCT02034110|587335398|FG003|Overall Study|Study closed by sponsor|6|||
162622970|NCT02034110|587335399|FG004|Overall Study|Study closed by sponsor|7|||
162622971|NCT02034110|587335400|FG005|Overall Study|Study closed by sponsor|0|||
162622972|NCT02034110|587335401|FG006|Overall Study|Study closed by sponsor|42|||
162622973|NCT02034110|587335402|FG007|Overall Study|Study closed by sponsor|0|||
162622974|NCT00064337|587335403|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
162622975|NCT00064337|587335403|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
162622976|NCT00064337|587335403|FG000|PBSCC or Induction/PBSCC|Progression|3|||
162622977|NCT00064337|587335403|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
162622978|NCT00064337|587335403|FG000|PBSCC or Induction/PBSCC|Death|2|||
162622979|NCT00064337|587335403|FG000|Transplant|Adverse Event|9|||
162894501|NCT01455415|588312326|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
162894502|NCT01455415|588312325|FG000|Period 1|Drug Error not Associated to AE|0|||
162894503|NCT01455415|588312326|FG001|Period 1|Drug Error not Associated to AE|1|||
162894504|NCT01455415|588312325|FG000|Period 1|AE Not Related to Study Drug|2|||
162894505|NCT01455415|588312326|FG001|Period 1|AE Not Related to Study Drug|6|||
162894506|NCT01455415|588312325|FG000|Period 1|Withdrawal by Subject|4|||
162894507|NCT01455415|588312326|FG001|Period 1|Withdrawal by Subject|5|||
162894508|NCT01455415|588312325|FG000|Period 1|Unspecified Reason|1|||
162894509|NCT01455415|588312326|FG001|Period 1|Unspecified Reason|1|||
162894510|NCT01455415|588312325|FG000|Period 1|Protocol Violation|0|||
162894511|NCT01455415|588312326|FG001|Period 1|Protocol Violation|2|||
162894512|NCT01455415|588312325|FG000|Washout|AE Related to Study Drug|2|||
162894513|NCT01455415|588312326|FG001|Washout|AE Related to Study Drug|0|||
162894514|NCT01455415|588312325|FG000|Washout|Lost to Follow-up|1|||
162894515|NCT01455415|588312326|FG001|Washout|Lost to Follow-up|0|||
162894516|NCT01455415|588312325|FG000|Washout|Drug Error not Associated to AE|2|||
162894517|NCT01455415|588312326|FG001|Washout|Drug Error not Associated to AE|1|||
162894518|NCT01455415|588312325|FG000|Washout|AE Not Related to Study Drug|2|||
162894519|NCT01455415|588312326|FG001|Washout|AE Not Related to Study Drug|3|||
162894520|NCT01455415|588312325|FG000|Washout|Unspecified Reason|1|||
162894521|NCT01455415|588312326|FG001|Washout|Unspecified Reason|2|||
162894522|NCT01455415|588312325|FG000|Washout|Protocol Violation|0|||
162894523|NCT01455415|588312326|FG001|Washout|Protocol Violation|1|||
162894524|NCT01455415|588312325|FG000|Period 2|AE Related to Study Drug|1|||
162894525|NCT01455415|588312326|FG001|Period 2|AE Related to Study Drug|2|||
162894526|NCT01455415|588312325|FG000|Period 2|Lost to Follow-up|2|||
162894527|NCT01455415|588312326|FG001|Period 2|Lost to Follow-up|1|||
162894528|NCT01455415|588312325|FG000|Period 2|AE Not Related to Study Drug|2|||
162894529|NCT01455415|588312326|FG001|Period 2|AE Not Related to Study Drug|1|||
162894530|NCT01455415|588312325|FG000|Period 2|Lack of Efficacy|2|||
162622980|NCT00064337|587335403|FG000|Transplant|Not protocol-specified|5|||
162622981|NCT00064337|587335403|FG000|Transplant|Death|3|||
162622982|NCT00064337|587335403|FG000|Transplant|Patient Refusal|2|||
162622983|NCT00064337|587335403|FG000|Transplant|Progression|2|||
162622984|NCT00064337|587335403|FG000|Maintenance|Adverse Event|3|||
162622985|NCT00064337|587335403|FG000|Maintenance|Progression|2|||
162622986|NCT00064337|587335403|FG000|Maintenance|On treatment at time of analysis|2|||
162894531|NCT01455415|588312326|FG001|Period 2|Lack of Efficacy|0|||
162894532|NCT01455415|588312325|FG000|Period 2|Withdrawal by Subject|2|||
162894533|NCT01455415|588312326|FG001|Period 2|Withdrawal by Subject|3|||
162894534|NCT01455415|588312325|FG000|Period 2|Unspecified Reason|2|||
162894535|NCT01455415|588312326|FG001|Period 2|Unspecified Reason|3|||
162894536|NCT01455415|588312325|FG000|Period 2|Protocol Violation|2|||
162894537|NCT01455415|588312326|FG001|Period 2|Protocol Violation|0|||
162894538|NCT01455415|588312325|FG000|Follow-up|AE Related to Study Drug|0|||
162622987|NCT00064337|587335403|FG000|Maintenance|Not protocol-specified|2|||
162622988|NCT00064337|587335403|FG000|Maintenance|Death|1|||
162622989|NCT02279420|587335404|FG000|Overall Study|Lost to Follow-up|23|||
162622990|NCT03535844|587335407|FG000|Overall Study|Withdrawal by Subject|0|||
162622991|NCT03535844|587335408|FG001|Overall Study|Withdrawal by Subject|1|||
162894539|NCT01455415|588312326|FG001|Follow-up|AE Related to Study Drug|1|||
162894540|NCT01455415|588312325|FG000|Follow-up|Lack of Efficacy|0|||
162894541|NCT01455415|588312326|FG001|Follow-up|Lack of Efficacy|1|||
162894542|NCT01455415|588312325|FG000|Follow-up|Withdrawal by Subject|2|||
162894543|NCT01455415|588312326|FG001|Follow-up|Withdrawal by Subject|0|||
162894544|NCT01455415|588312325|FG000|Follow-up|Unspecified Reason|1|||
162894545|NCT01455415|588312326|FG001|Follow-up|Unspecified Reason|0|||
162894546|NCT00587301|588312327|FG000|Overall Study|Screen Failure|9|||
162894547|NCT00587301|588312327|FG000|Overall Study|Lost to Follow-up|22|||
162894548|NCT00587301|588312327|FG000|Overall Study|Withdrawal by Subject|7|||
162894549|NCT00587301|588312327|FG000|Overall Study|Protocol Violation|7|||
162894550|NCT02460978|588312329|FG000|Overall Study|Adverse Event|17|||
162894551|NCT02460978|588312330|FG001|Overall Study|Adverse Event|11|||
162894552|NCT02460978|588312331|FG002|Overall Study|Adverse Event|11|||
162894553|NCT02460978|588312329|FG000|Overall Study|Withdrawal by Subject|5|||
162894554|NCT02460978|588312330|FG001|Overall Study|Withdrawal by Subject|5|||
162894555|NCT02460978|588312331|FG002|Overall Study|Withdrawal by Subject|14|||
162894556|NCT02460978|588312329|FG000|Overall Study|Lost to Follow-up|2|||
162894557|NCT02460978|588312330|FG001|Overall Study|Lost to Follow-up|3|||
162894558|NCT02460978|588312331|FG002|Overall Study|Lost to Follow-up|1|||
162894559|NCT02460978|588312329|FG000|Overall Study|Protocol Violation|1|||
162894560|NCT02460978|588312330|FG001|Overall Study|Protocol Violation|1|||
162894561|NCT02460978|588312331|FG002|Overall Study|Protocol Violation|1|||
162894562|NCT02460978|588312329|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
162894563|NCT02460978|588312330|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
162894564|NCT02460978|588312331|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
162894565|NCT02460978|588312329|FG000|Overall Study|Pregnancy|0|||
162894566|NCT02460978|588312330|FG001|Overall Study|Pregnancy|0|||
162894567|NCT02460978|588312331|FG002|Overall Study|Pregnancy|2|||
162894568|NCT00719537|588312332|FG000|Overall Study|Withdrawal by Subject|1|||
162894569|NCT00719537|588312333|FG001|Overall Study|Withdrawal by Subject|0|||
162894570|NCT00719537|588312332|FG000|Overall Study|Lost to Follow-up|0|||
162894571|NCT00719537|588312333|FG001|Overall Study|Lost to Follow-up|1|||
162894572|NCT01142193|588312334|FG000|Overall Study|Adverse Event|12|||
162894573|NCT01142193|588312335|FG001|Overall Study|Adverse Event|4|||
162894574|NCT01142193|588312334|FG000|Overall Study|Lack of Efficacy|2|||
162894575|NCT01142193|588312335|FG001|Overall Study|Lack of Efficacy|1|||
162894576|NCT01142193|588312334|FG000|Overall Study|Physician Decision|1|||
162894577|NCT01142193|588312335|FG001|Overall Study|Physician Decision|1|||
162894578|NCT01142193|588312334|FG000|Overall Study|Withdrawal by Subject|4|||
162894579|NCT01142193|588312335|FG001|Overall Study|Withdrawal by Subject|3|||
162894580|NCT01142193|588312334|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
162894581|NCT01142193|588312335|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
162894582|NCT01142193|588312334|FG000|Overall Study|Other|1|||
162894583|NCT01142193|588312335|FG001|Overall Study|Other|2|||
162894584|NCT00994162|588312336|FG000|Overall Study|Withdrawal by Subject|1|||
162894585|NCT00994162|588312336|FG000|Overall Study|Lost to Follow-up|2|||
162894586|NCT00994162|588312336|FG000|Overall Study|Product Complaint|1|||
162894587|NCT00994162|588312336|FG000|Overall Study|Poor Compliance|5|||
162894588|NCT00994162|588312336|FG000|Overall Study|Lack of Response|3|||
162894589|NCT00994162|588312336|FG000|Overall Study|Discharged from Hospital|4|||
162894590|NCT00994162|588312336|FG000|Overall Study|Death|2|||
162894591|NCT00994162|588312336|FG000|Overall Study|Care Transferred to Another Physician|2|||
162894592|NCT00994162|588312336|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
162894593|NCT00994162|588312336|FG000|Overall Study|Physician Decision|2|||
162622992|NCT00612040|587335409|FG000|Overall Study|Adverse Event|0|||
162622993|NCT00612040|587335410|FG001|Overall Study|Adverse Event|2|||
162622994|NCT00612040|587335411|FG002|Overall Study|Adverse Event|1|||
162622995|NCT00612040|587335409|FG000|Overall Study|Protocol Violation|1|||
162622996|NCT00612040|587335410|FG001|Overall Study|Protocol Violation|2|||
162622997|NCT00612040|587335411|FG002|Overall Study|Protocol Violation|1|||
162622998|NCT00612040|587335409|FG000|Overall Study|Lack of Efficacy|2|||
162622999|NCT00612040|587335410|FG001|Overall Study|Lack of Efficacy|1|||
162623000|NCT00612040|587335411|FG002|Overall Study|Lack of Efficacy|0|||
162623001|NCT00612040|587335409|FG000|Overall Study|Unclassified|2|||
162623002|NCT00612040|587335410|FG001|Overall Study|Unclassified|2|||
162623003|NCT00612040|587335411|FG002|Overall Study|Unclassified|5|||
162623004|NCT00297830|587335412|FG000|6 Month Visit|Death|1|||
162623005|NCT00297830|587335413|FG001|6 Month Visit|Death|0|||
162623006|NCT00297830|587335414|FG002|6 Month Visit|Death|2|||
162708735|NCT03682536|587642884|FG000|Randomization|Withdrawal by Subject|0|||
162708736|NCT03682536|587642885|FG001|Randomization|Withdrawal by Subject|2|||
162894594|NCT00994162|588312336|FG000|Overall Study|Surrounding Wound Erythematous|1|||
162894595|NCT00994162|588312336|FG000|Overall Study|Machine Losing Vaccum|1|||
162894596|NCT00994162|588312336|FG000|Overall Study|Patient Lived Too Far Away|1|||
162894597|NCT00994162|588312336|FG000|Overall Study|Above Knee Amputation|1|||
162894598|NCT00994162|588312336|FG000|Overall Study|Reason Not Reported By Site|1|||
162894599|NCT00910728|588312339|FG000|Overall Study|Lack of Efficacy|2|||
162894600|NCT00910728|588312340|FG001|Overall Study|Lack of Efficacy|3|||
162894601|NCT00910728|588312341|FG002|Overall Study|Lack of Efficacy|1|||
162894602|NCT00910728|588312342|FG003|Overall Study|Lack of Efficacy|2|||
162894603|NCT00910728|588312343|FG004|Overall Study|Lack of Efficacy|1|||
162894604|NCT00910728|588312344|FG005|Overall Study|Lack of Efficacy|0|||
162894605|NCT00910728|588312345|FG006|Overall Study|Lack of Efficacy|2|||
162894606|NCT00910728|588312346|FG007|Overall Study|Lack of Efficacy|2|||
162894607|NCT00910728|588312347|FG008|Overall Study|Lack of Efficacy|2|||
162894608|NCT00910728|588312339|FG000|Overall Study|Withdrawal by Subject|0|||
162894609|NCT00910728|588312340|FG001|Overall Study|Withdrawal by Subject|0|||
162894610|NCT00910728|588312341|FG002|Overall Study|Withdrawal by Subject|0|||
162894611|NCT00910728|588312342|FG003|Overall Study|Withdrawal by Subject|0|||
162894612|NCT00910728|588312343|FG004|Overall Study|Withdrawal by Subject|3|||
162894613|NCT00910728|588312344|FG005|Overall Study|Withdrawal by Subject|1|||
162894614|NCT00910728|588312345|FG006|Overall Study|Withdrawal by Subject|2|||
162894615|NCT00910728|588312346|FG007|Overall Study|Withdrawal by Subject|0|||
162894616|NCT00910728|588312347|FG008|Overall Study|Withdrawal by Subject|0|||
162894617|NCT00910728|588312339|FG000|Overall Study|(not specified)|2|||
162894618|NCT00910728|588312340|FG001|Overall Study|(not specified)|0|||
162894619|NCT00910728|588312341|FG002|Overall Study|(not specified)|1|||
162894620|NCT00910728|588312342|FG003|Overall Study|(not specified)|0|||
162894621|NCT00910728|588312343|FG004|Overall Study|(not specified)|1|||
162894622|NCT00910728|588312344|FG005|Overall Study|(not specified)|0|||
162894623|NCT00910728|588312345|FG006|Overall Study|(not specified)|0|||
162894624|NCT00910728|588312346|FG007|Overall Study|(not specified)|0|||
162894625|NCT00910728|588312347|FG008|Overall Study|(not specified)|0|||
162894626|NCT00910728|588312339|FG000|Overall Study|Adverse Event|2|||
162894627|NCT00910728|588312340|FG001|Overall Study|Adverse Event|0|||
162894628|NCT00910728|588312341|FG002|Overall Study|Adverse Event|1|||
162894629|NCT00910728|588312342|FG003|Overall Study|Adverse Event|1|||
162894630|NCT00910728|588312343|FG004|Overall Study|Adverse Event|0|||
162894631|NCT00910728|588312344|FG005|Overall Study|Adverse Event|0|||
162894632|NCT00910728|588312345|FG006|Overall Study|Adverse Event|2|||
162894633|NCT00910728|588312346|FG007|Overall Study|Adverse Event|1|||
162708737|NCT03682536|587642884|FG000|Treatment|Other Reasons|8|||
162708738|NCT03682536|587642885|FG001|Treatment|Other Reasons|7|||
162894634|NCT00910728|588312347|FG008|Overall Study|Adverse Event|1|||
162894635|NCT01225172|588312349|FG000|Overall Study|Subject decision to stop|1|||
162894636|NCT01225172|588312350|FG001|Overall Study|Subject decision to stop|0|||
162894637|NCT01225172|588312349|FG000|Overall Study|Subject request to discontinue treatment|3|||
162894638|NCT01225172|588312350|FG001|Overall Study|Subject request to discontinue treatment|1|||
162894639|NCT01225172|588312349|FG000|Overall Study|Subject no longer meets study criteria|1|||
162894640|NCT01225172|588312350|FG001|Overall Study|Subject no longer meets study criteria|0|||
162894641|NCT01225172|588312349|FG000|Overall Study|Withdrawal by Subject|1|||
162894642|NCT01225172|588312350|FG001|Overall Study|Withdrawal by Subject|0|||
162894643|NCT03175562|588312355|FG000|Overall Study|Adverse Event|1|||
162894644|NCT03175562|588312355|FG000|Overall Study|Lost to Follow-up|3|||
162894645|NCT03175562|588312355|FG000|Overall Study|Withdrawal by Subject|7|||
162894646|NCT03175562|588312355|FG000|Overall Study|Other (Not Specified)|5|||
162623007|NCT00297830|587335412|FG000|6 Month Visit|Withdrawal by Subject|2|||
162623008|NCT00297830|587335413|FG001|6 Month Visit|Withdrawal by Subject|1|||
162623009|NCT00297830|587335414|FG002|6 Month Visit|Withdrawal by Subject|1|||
162708739|NCT03682536|587642884|FG000|Treatment|Physician Decision|5|||
162894647|NCT01946412|588312356|FG000|Overall Study|Adverse Event|1|||
162894648|NCT01946412|588312356|FG000|Overall Study|Non-Compliance|1|||
162623010|NCT00297830|587335412|FG000|6 Month Visit|Adverse Event|0|||
162623011|NCT00297830|587335413|FG001|6 Month Visit|Adverse Event|1|||
162623012|NCT00297830|587335414|FG002|6 Month Visit|Adverse Event|0|||
162623013|NCT00297830|587335412|FG000|12 Month Visit|Lost to Follow-up|1|||
162623014|NCT00297830|587335413|FG001|12 Month Visit|Lost to Follow-up|0|||
162623015|NCT00297830|587335414|FG002|12 Month Visit|Lost to Follow-up|0|||
162623016|NCT00297830|587335412|FG000|12 Month Visit|Adverse Event|0|||
162623017|NCT00297830|587335413|FG001|12 Month Visit|Adverse Event|3|||
162623018|NCT00297830|587335414|FG002|12 Month Visit|Adverse Event|0|||
162623019|NCT00297830|587335412|FG000|12 Month Visit|Withdrawal by Subject|0|||
162623020|NCT00297830|587335413|FG001|12 Month Visit|Withdrawal by Subject|3|||
162623021|NCT00297830|587335414|FG002|12 Month Visit|Withdrawal by Subject|0|||
162623022|NCT02835820|587335415|FG000|Overall Study|Baseline Screen Failure|0|||
162623023|NCT02835820|587335416|FG001|Overall Study|Baseline Screen Failure|3|||
162623024|NCT00827502|587335417|FG000|Overall Study|randomized but not treated|11|||
162623025|NCT00827502|587335417|FG000|Overall Study|Adverse Event|1|||
162623026|NCT00827502|587335417|FG000|Overall Study|Lost to Follow-up|4|||
162623027|NCT00827502|587335417|FG000|Overall Study|Withdrawal by Subject|5|||
162623028|NCT05096221|587335418|FG000|Part 2|Physician Decision|0|||
162623029|NCT05096221|587335419|FG001|Part 2|Physician Decision|1|||
162623030|NCT03417219|587335426|FG000|Overall Study|Lost to Follow-up|0|||
162623031|NCT03417219|587335427|FG001|Overall Study|Lost to Follow-up|3|||
162623032|NCT02264639|587335432|FG000|Overall Study|Death (after completing single-dose phase)|1|||
162894649|NCT01946412|588312356|FG000|Overall Study|Continued with commercial Kalydeco|2|||
162894650|NCT01946412|588312356|FG000|Overall Study|Difficulty in swallowing|1|||
162894651|NCT01731990|588313885|FG000|Overall Study|Adverse Event|1|||
162894652|NCT01731990|588313886|FG001|Overall Study|Adverse Event|5|||
162894653|NCT01731990|588313885|FG000|Overall Study|Withdrawal by Subject|1|||
162894654|NCT01731990|588313886|FG001|Overall Study|Withdrawal by Subject|1|||
162894655|NCT01731990|588313885|FG000|Overall Study|Protocol deviation|1|||
162894656|NCT01731990|588313886|FG001|Overall Study|Protocol deviation|2|||
162894657|NCT01731990|588313885|FG000|Overall Study|Death|1|||
162894658|NCT01731990|588313886|FG001|Overall Study|Death|0|||
162894659|NCT01183104|588313889|FG000|Overall Study|Adverse Event|8|||
162894660|NCT01183104|588313890|FG001|Overall Study|Adverse Event|6|||
162894661|NCT01183104|588313889|FG000|Overall Study|Death|0|||
162894662|NCT01183104|588313890|FG001|Overall Study|Death|1|||
162623033|NCT02264639|587335433|FG001|Overall Study|Death (after completing single-dose phase)|0|||
162623034|NCT02264639|587335434|FG002|Overall Study|Death (after completing single-dose phase)|0|||
162623035|NCT02264639|587335435|FG003|Overall Study|Death (after completing single-dose phase)|0|||
162894663|NCT01183104|588313889|FG000|Overall Study|Lost to Follow-up|14|||
162894664|NCT01183104|588313890|FG001|Overall Study|Lost to Follow-up|7|||
162894665|NCT01183104|588313889|FG000|Overall Study|Physician Decision|5|||
162894666|NCT01183104|588313890|FG001|Overall Study|Physician Decision|8|||
162894667|NCT01183104|588313889|FG000|Overall Study|Withdrawal by Subject|6|||
162894668|NCT01183104|588313890|FG001|Overall Study|Withdrawal by Subject|11|||
162894669|NCT01183104|588313889|FG000|Overall Study|Nonparticipation in Extension Study|39|||
162894670|NCT01183104|588313890|FG001|Overall Study|Nonparticipation in Extension Study|50|||
162894671|NCT01183104|588313889|FG000|Overall Study|Did not receive study drug|5|||
162894672|NCT01183104|588313890|FG001|Overall Study|Did not receive study drug|9|||
162894673|NCT00323310|588313891|FG000|Overall Study|Withdrawal by Subject|1|||
162894674|NCT00323310|588313891|FG000|Overall Study|a parent refused blood draw|1|||
162894675|NCT00323310|588313891|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
162894676|NCT03565991|588313892|FG000|Overall Study|Other|11|||
162894677|NCT03565991|588313893|FG001|Overall Study|Other|0|||
162894678|NCT03565991|588313892|FG000|Overall Study|Global deterioration of health status|14|||
162894679|NCT03565991|588313893|FG001|Overall Study|Global deterioration of health status|4|||
162894680|NCT03565991|588313892|FG000|Overall Study|Withdrawal by Subject|2|||
162894681|NCT03565991|588313893|FG001|Overall Study|Withdrawal by Subject|6|||
162894682|NCT03565991|588313892|FG000|Overall Study|Progressive disease|121|||
162708740|NCT03682536|587642885|FG001|Treatment|Physician Decision|5|||
162894683|NCT03565991|588313893|FG001|Overall Study|Progressive disease|29|||
162894684|NCT03565991|588313892|FG000|Overall Study|Death|3|||
162964792|NCT04408924|588571948|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
162964793|NCT04408924|588571948|FG000|Overall Study|Lost to Follow-up|3|||
162964794|NCT04408924|588571948|FG000|Overall Study|Withdrawal by Subject|5|||
162964795|NCT04408924|588571948|FG000|Overall Study|Sponsor Decision|2|||
162964796|NCT00486434|588571949|FG000|Overall Study|Withdrawal by Subject|34|||
162964797|NCT00486434|588571950|FG001|Overall Study|Withdrawal by Subject|39|||
162964798|NCT00486434|588571949|FG000|Overall Study|Adverse Event|118|||
162964799|NCT00486434|588571950|FG001|Overall Study|Adverse Event|44|||
162964800|NCT00486434|588571949|FG000|Overall Study|Protocol Violation|22|||
162964801|NCT00486434|588571950|FG001|Overall Study|Protocol Violation|21|||
162964802|NCT00486434|588571949|FG000|Overall Study|Lack of Efficacy|12|||
162964803|NCT00486434|588571950|FG001|Overall Study|Lack of Efficacy|19|||
162623036|NCT02264639|587335436|FG004|Overall Study|Death (after completing single-dose phase)|0|||
162623037|NCT02264639|587335432|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
162623038|NCT02264639|587335433|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162623039|NCT02264639|587335434|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162623040|NCT02264639|587335435|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162623041|NCT02264639|587335436|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162623042|NCT02264639|587335432|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162894685|NCT03565991|588313893|FG001|Overall Study|Death|0|||
162894686|NCT03565991|588313892|FG000|Overall Study|Adverse Event|7|||
162894687|NCT03565991|588313893|FG001|Overall Study|Adverse Event|2|||
162894688|NCT02944513|588313894|FG000|Overall Study|Withdrawal by Subject|4|||
162894689|NCT02944513|588313895|FG001|Overall Study|Withdrawal by Subject|1|||
162894690|NCT00937326|588313896|FG000|Overall Study|Adverse Event|0|||
162894691|NCT00937326|588313897|FG001|Overall Study|Adverse Event|3|||
162894692|NCT00937326|588313898|FG002|Overall Study|Adverse Event|1|||
162894693|NCT00937326|588313899|FG003|Overall Study|Adverse Event|1|||
162894694|NCT00937326|588313900|FG004|Overall Study|Adverse Event|2|||
162894695|NCT00937326|588313896|FG000|Overall Study|Death|0|||
162894696|NCT00937326|588313897|FG001|Overall Study|Death|0|||
162894697|NCT00937326|588313898|FG002|Overall Study|Death|1|||
162894698|NCT00937326|588313899|FG003|Overall Study|Death|0|||
162894699|NCT00937326|588313900|FG004|Overall Study|Death|0|||
162894700|NCT00937326|588313896|FG000|Overall Study|Withdrawal by Subject|3|||
162894701|NCT00937326|588313897|FG001|Overall Study|Withdrawal by Subject|4|||
162894702|NCT00937326|588313898|FG002|Overall Study|Withdrawal by Subject|1|||
162894703|NCT00937326|588313899|FG003|Overall Study|Withdrawal by Subject|4|||
162894704|NCT00937326|588313900|FG004|Overall Study|Withdrawal by Subject|3|||
162894705|NCT00937326|588313896|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
162894706|NCT00937326|588313897|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
162894707|NCT00937326|588313898|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
162894708|NCT00937326|588313899|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
162894709|NCT00937326|588313900|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
162894710|NCT00790218|588313901|FG000|Overall Study|Death|1|||
162894711|NCT00790218|588313902|FG001|Overall Study|Death|0|||
162894712|NCT00790218|588313903|FG002|Overall Study|Death|0|||
162894713|NCT04402385|588313909|FG000|Overall Study|Withdrawal by Subject|4|||
162894714|NCT04402385|588313910|FG001|Overall Study|Withdrawal by Subject|4|||
162894715|NCT04402385|588313909|FG000|Overall Study|Lost to Follow-up|1|||
162894716|NCT04402385|588313910|FG001|Overall Study|Lost to Follow-up|1|||
162894717|NCT04402385|588313909|FG000|Overall Study|Physician Decision|0|||
162894718|NCT04402385|588313910|FG001|Overall Study|Physician Decision|1|||
162894719|NCT00731666|588313911|FG000|Overall Study|Adverse Event|2|||
162894720|NCT00731666|588313911|FG000|Overall Study|Lost to Follow-up|8|||
162894721|NCT00731666|588313911|FG000|Overall Study|Withdrawal by Subject|2|||
162894722|NCT01308853|588313912|FG000|Overall Study|Adverse Event|1|||
162894723|NCT01308853|588313912|FG000|Overall Study|Lost to Follow-up|2|||
162894724|NCT01308853|588313912|FG000|Overall Study|Insertion of permanent implants|1|||
162964804|NCT00486434|588571949|FG000|Overall Study|Lost to Follow-up|2|||
162708741|NCT03682536|587642884|FG000|Treatment|Protocol Violation|1|||
162894725|NCT03250624|588313916|FG000|Overall Study|Lack of Efficacy|1|||
162894726|NCT03250624|588313917|FG001|Overall Study|Lack of Efficacy|4|||
162894727|NCT03250624|588313916|FG000|Overall Study|Adverse Event|0|||
162964805|NCT00486434|588571950|FG001|Overall Study|Lost to Follow-up|3|||
162894728|NCT03250624|588313917|FG001|Overall Study|Adverse Event|1|||
162894729|NCT03250624|588313916|FG000|Overall Study|Other|1|||
162894730|NCT03250624|588313917|FG001|Overall Study|Other|2|||
162894731|NCT00106249|588313918|FG000|Overall Study|Lost to Follow-up|3|||
162894732|NCT00106249|588313919|FG001|Overall Study|Lost to Follow-up|2|||
162894733|NCT01843205|588313920|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
162894734|NCT01843205|588313921|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
162894735|NCT00136357|588313922|FG000|Overall Study|Withdrawal by Subject|3|||
162894736|NCT00136357|588313923|FG001|Overall Study|Withdrawal by Subject|2|||
162894737|NCT01518309|588313924|FG000|Overall Study|Adverse Event|6|||
162964806|NCT00486434|588571949|FG000|Overall Study|Death|1|||
162964807|NCT00486434|588571950|FG001|Overall Study|Death|2|||
162623043|NCT02264639|587335433|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162623044|NCT02264639|587335434|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
162623045|NCT02264639|587335435|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162623046|NCT02264639|587335436|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162623047|NCT02264639|587335432|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162623048|NCT02264639|587335433|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162623049|NCT02264639|587335434|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162894738|NCT01518309|588313924|FG000|Overall Study|Death|6|||
162894739|NCT01518309|588313924|FG000|Overall Study|Lack of Efficacy|7|||
162894740|NCT01518309|588313924|FG000|Overall Study|Withdrawal by Subject|6|||
162894741|NCT01518309|588313924|FG000|Overall Study|Physician Decision|3|||
162623050|NCT02264639|587335435|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162623051|NCT02264639|587335436|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
162623052|NCT00369824|587335440|FG000|Overall Study|Adverse Event|0|||
162623053|NCT00369824|587335441|FG001|Overall Study|Adverse Event|2|||
162623054|NCT00369824|587335442|FG002|Overall Study|Adverse Event|0|||
162623055|NCT00369824|587335443|FG003|Overall Study|Adverse Event|0|||
162623056|NCT00369824|587335444|FG004|Overall Study|Adverse Event|1|||
162623057|NCT00369824|587335445|FG005|Overall Study|Adverse Event|0|||
162623058|NCT00369824|587335440|FG000|Overall Study|Protocol Violation|0|||
162623059|NCT00369824|587335441|FG001|Overall Study|Protocol Violation|1|||
162623060|NCT00369824|587335442|FG002|Overall Study|Protocol Violation|0|||
162623061|NCT00369824|587335443|FG003|Overall Study|Protocol Violation|1|||
162623062|NCT00369824|587335444|FG004|Overall Study|Protocol Violation|1|||
162623063|NCT00369824|587335445|FG005|Overall Study|Protocol Violation|0|||
162623064|NCT00369824|587335440|FG000|Overall Study|Withdrawal by Subject|9|||
162623065|NCT00369824|587335441|FG001|Overall Study|Withdrawal by Subject|5|||
162623066|NCT00369824|587335442|FG002|Overall Study|Withdrawal by Subject|5|||
162623067|NCT00369824|587335443|FG003|Overall Study|Withdrawal by Subject|4|||
162623068|NCT00369824|587335444|FG004|Overall Study|Withdrawal by Subject|6|||
162623069|NCT00369824|587335445|FG005|Overall Study|Withdrawal by Subject|2|||
162623070|NCT00369824|587335440|FG000|Overall Study|Lost to Follow-up|6|||
162623071|NCT00369824|587335441|FG001|Overall Study|Lost to Follow-up|11|||
162623072|NCT00369824|587335442|FG002|Overall Study|Lost to Follow-up|7|||
162623073|NCT00369824|587335443|FG003|Overall Study|Lost to Follow-up|8|||
162623074|NCT00369824|587335444|FG004|Overall Study|Lost to Follow-up|9|||
162623075|NCT00369824|587335445|FG005|Overall Study|Lost to Follow-up|6|||
162623076|NCT00369824|587335440|FG000|Overall Study|Other|0|||
162623077|NCT00369824|587335441|FG001|Overall Study|Other|0|||
162623078|NCT00369824|587335442|FG002|Overall Study|Other|0|||
162623079|NCT00369824|587335443|FG003|Overall Study|Other|2|||
162623080|NCT00369824|587335444|FG004|Overall Study|Other|1|||
162623081|NCT00369824|587335445|FG005|Overall Study|Other|3|||
162623082|NCT01443078|587335446|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
162623083|NCT01443078|587335446|FG000|Overall Study|Withdrawal by Subject|1|||
162623084|NCT01443078|587335446|FG000|Overall Study|Patient had brain mets|1|||
162623085|NCT01390649|587335447|FG000|Overall Study|Physician Decision|1|||
162623086|NCT00415168|587335448|FG000|Overall Study|Death|26|||
162623087|NCT00415168|587335448|FG000|Overall Study|Lost to Follow-up|3|||
162623088|NCT00415168|587335448|FG000|Overall Study|Physician Decision|13|||
162623089|NCT00415168|587335448|FG000|Overall Study|Sponsor Decision|4|||
162623090|NCT00415168|587335448|FG000|Overall Study|Withdrawal by Subject|6|||
162623091|NCT01612858|587335450|FG000|Overall Study|Withdrawal by Subject|5|||
162623092|NCT01612858|587335451|FG001|Overall Study|Withdrawal by Subject|1|||
162623093|NCT00003487|587335452|FG000|Overall Study|Not evaluable|2|||
162623094|NCT00005044|587335455|FG000|Overall Study|Protocol Violation|37|||
162623095|NCT00005044|587335456|FG001|Overall Study|Protocol Violation|46|||
162623096|NCT00005044|587335455|FG000|Overall Study|Withdrawal by Subject|1|||
162623097|NCT00005044|587335456|FG001|Overall Study|Withdrawal by Subject|5|||
162623098|NCT00005044|587335455|FG000|Overall Study|No protocol treatment|0|||
162894742|NCT01518309|588313924|FG000|Overall Study|Sponsor Decision|2|||
162894743|NCT01518309|588313924|FG000|Overall Study|Not in Predefined Categories|9|||
162894744|NCT00038142|588313927|FG000|Overall Study|Ineligible|1|||
162894745|NCT00038142|588313928|FG001|Overall Study|Ineligible|0|||
162894746|NCT00038142|588313927|FG000|Overall Study|Progressive Disease|11|||
162623099|NCT00005044|587335456|FG001|Overall Study|No protocol treatment|1|||
162894747|NCT00038142|588313928|FG001|Overall Study|Progressive Disease|7|||
162894748|NCT00038142|588313927|FG000|Overall Study|Death|1|||
162623100|NCT00843856|587335457|FG000|Overall Study|Lost to Follow-up|1|||
162623101|NCT00843856|587335458|FG001|Overall Study|Lost to Follow-up|2|||
162623102|NCT02993757|587335463|FG000|Overall Study|Non compliance with the protocol|155|||
162623103|NCT02993757|587335464|FG001|Overall Study|Non compliance with the protocol|170|||
162623104|NCT02993757|587335463|FG000|Overall Study|Lost to Follow-up|1|||
162623105|NCT02993757|587335464|FG001|Overall Study|Lost to Follow-up|0|||
162894749|NCT00038142|588313928|FG001|Overall Study|Death|0|||
162894750|NCT00038142|588313927|FG000|Overall Study|Adverse Event|1|||
162894751|NCT00038142|588313928|FG001|Overall Study|Adverse Event|0|||
162623106|NCT02993757|587335463|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
162894752|NCT00038142|588313927|FG000|Overall Study|Unknown Reason|8|||
162894753|NCT00038142|588313928|FG001|Overall Study|Unknown Reason|0|||
162894754|NCT01831804|588313933|FG000|Overall Study|Adverse Event|0|||
162894755|NCT01831804|588313934|FG001|Overall Study|Adverse Event|0|||
162894756|NCT01831804|588313935|FG002|Overall Study|Adverse Event|0|||
162623107|NCT02993757|587335464|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
162623108|NCT00087607|587335473|FG000|Overall Study|Adverse Event|14|||
162623109|NCT00087607|587335474|FG001|Overall Study|Adverse Event|24|||
162623110|NCT00087607|587335473|FG000|Overall Study|Death|0|||
162623111|NCT00087607|587335474|FG001|Overall Study|Death|1|||
162623112|NCT00087607|587335473|FG000|Overall Study|Insufficient Therapeutic Response|53|||
162623113|NCT00087607|587335474|FG001|Overall Study|Insufficient Therapeutic Response|42|||
162623114|NCT00087607|587335473|FG000|Overall Study|Failure to return|21|||
162623115|NCT00087607|587335474|FG001|Overall Study|Failure to return|17|||
162623116|NCT00087607|587335473|FG000|Overall Study|Withdrew Consent|12|||
162623117|NCT00087607|587335474|FG001|Overall Study|Withdrew Consent|16|||
162623118|NCT00087607|587335473|FG000|Overall Study|Administrative|12|||
162623119|NCT00087607|587335474|FG001|Overall Study|Administrative|12|||
162623120|NCT00087607|587335473|FG000|Overall Study|Refused Treatment|5|||
162623121|NCT00087607|587335474|FG001|Overall Study|Refused Treatment|7|||
162623122|NCT00087607|587335473|FG000|Overall Study|Other Protocol Violation|5|||
162623123|NCT00087607|587335474|FG001|Overall Study|Other Protocol Violation|2|||
162623124|NCT00087607|587335473|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162623125|NCT00087607|587335474|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162623126|NCT00190671|587335475|FG000|Overall Study|Satisfactory Response|4|||
162623127|NCT00190671|587335476|FG001|Overall Study|Satisfactory Response|7|||
162623128|NCT00190671|587335475|FG000|Overall Study|Lack of Efficacy|19|||
162623129|NCT00190671|587335476|FG001|Overall Study|Lack of Efficacy|24|||
162623130|NCT00190671|587335475|FG000|Overall Study|Death from Study Disease|1|||
162623131|NCT00190671|587335476|FG001|Overall Study|Death from Study Disease|1|||
162623132|NCT00190671|587335475|FG000|Overall Study|Adverse Event|3|||
162623133|NCT00190671|587335476|FG001|Overall Study|Adverse Event|2|||
162623134|NCT00190671|587335475|FG000|Overall Study|Clinical Relapse|0|||
162623135|NCT00190671|587335476|FG001|Overall Study|Clinical Relapse|1|||
162623136|NCT00190671|587335475|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
162623137|NCT00190671|587335476|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
162623138|NCT00190671|587335475|FG000|Overall Study|Death from Other Causes|0|||
162623139|NCT00190671|587335476|FG001|Overall Study|Death from Other Causes|2|||
162623140|NCT00190671|587335475|FG000|Overall Study|Protocol Violation|0|||
162623141|NCT00190671|587335476|FG001|Overall Study|Protocol Violation|1|||
162623142|NCT00190671|587335475|FG000|Overall Study|Withdrawal by Subject|0|||
162623143|NCT00190671|587335476|FG001|Overall Study|Withdrawal by Subject|2|||
162623144|NCT02699593|587335477|FG000|Period 1|Unsatisfactory Visual Response|0|||
162623145|NCT02699593|587335478|FG001|Period 1|Unsatisfactory Visual Response|1|||
162623146|NCT02699593|587335477|FG000|Period 1|Torn Contact Len|4|||
162623147|NCT02699593|587335478|FG001|Period 1|Torn Contact Len|3|||
162623148|NCT02699593|587335477|FG000|Period 1|Protocol Violation|0|||
162623149|NCT02699593|587335478|FG001|Period 1|Protocol Violation|1|||
162623150|NCT02699593|587335477|FG000|Period 1|Withdrawal by Subject|0|||
162623151|NCT02699593|587335478|FG001|Period 1|Withdrawal by Subject|1|||
162623152|NCT02699593|587335477|FG000|Period 1|Adverse Event|1|||
162623153|NCT02699593|587335478|FG001|Period 1|Adverse Event|1|||
162623154|NCT02699593|587335477|FG000|Period 2|Adverse Event|1|||
162623155|NCT02699593|587335478|FG001|Period 2|Adverse Event|1|||
162623156|NCT02699593|587335477|FG000|Period 2|Lost Contact Lens|0|||
162623157|NCT02699593|587335478|FG001|Period 2|Lost Contact Lens|1|||
162623158|NCT02699593|587335477|FG000|Period 2|Torn Contact Lens|1|||
162623159|NCT02699593|587335478|FG001|Period 2|Torn Contact Lens|0|||
162623160|NCT02015754|587335479|FG000|Overall Study|Disease progression|5|||
162623161|NCT02015754|587335479|FG000|Overall Study|Change in treatment modality|5|||
162623162|NCT02015754|587335479|FG000|Overall Study|Lost to Follow-up|1|||
162623163|NCT02229383|587335482|FG000|Overall Study|Adverse Event|7|||
162623164|NCT02229383|587335483|FG001|Overall Study|Adverse Event|4|||
162623165|NCT02229383|587335482|FG000|Overall Study|Death|0|||
162623166|NCT02229383|587335483|FG001|Overall Study|Death|1|||
162623167|NCT02229383|587335482|FG000|Overall Study|Lost to Follow-up|5|||
162623168|NCT02229383|587335483|FG001|Overall Study|Lost to Follow-up|3|||
162623169|NCT02229383|587335482|FG000|Overall Study|Withdrawal by Subject|4|||
162623170|NCT02229383|587335483|FG001|Overall Study|Withdrawal by Subject|6|||
162623171|NCT02229383|587335482|FG000|Overall Study|Did not receive treatment|1|||
162623172|NCT02229383|587335483|FG001|Overall Study|Did not receive treatment|0|||
162623173|NCT02229383|587335482|FG000|Overall Study|Other|3|||
162623174|NCT02229383|587335483|FG001|Overall Study|Other|8|||
162623175|NCT00873015|587335487|FG000|Overall Study|Withdrawal by Subject|0|||
162623176|NCT00873015|587335488|FG001|Overall Study|Withdrawal by Subject|1|||
162623177|NCT00873015|587335489|FG002|Overall Study|Withdrawal by Subject|0|||
162894757|NCT01831804|588313936|FG003|Overall Study|Adverse Event|0|||
162894758|NCT01831804|588313937|FG004|Overall Study|Adverse Event|0|||
162623178|NCT00873015|587335490|FG003|Overall Study|Withdrawal by Subject|0|||
162623179|NCT06934993|587335497|FG000|Overall Study|Withdrawal by Subject|29|||
162623180|NCT06934993|587335497|FG000|Overall Study|elevated postoperative creatinine level|11|||
162623181|NCT06934993|587335497|FG000|Overall Study|Death|3|||
162623182|NCT01218113|587337549|FG000|Overall Study|Withdrawal by Subject|1|||
162623183|NCT01218113|587337550|FG001|Overall Study|Withdrawal by Subject|0|||
162623184|NCT01218113|587337551|FG002|Overall Study|Withdrawal by Subject|1|||
162623185|NCT01218113|587337549|FG000|Overall Study|Lost to Follow-up|4|||
162623186|NCT01218113|587337550|FG001|Overall Study|Lost to Follow-up|1|||
162623187|NCT01218113|587337551|FG002|Overall Study|Lost to Follow-up|4|||
162623188|NCT01218113|587337549|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
162623189|NCT01218113|587337550|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
162623190|NCT01218113|587337551|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
162623191|NCT01385566|587337555|FG000|Overall Study|Lost to Follow-up|1|||
162623192|NCT01385566|587337556|FG001|Overall Study|Lost to Follow-up|0|||
162623193|NCT01385566|587337557|FG002|Overall Study|Lost to Follow-up|0|||
162623194|NCT01385566|587337558|FG003|Overall Study|Lost to Follow-up|0|||
162623195|NCT01385566|587337559|FG004|Overall Study|Lost to Follow-up|0|||
162623196|NCT01385566|587337560|FG005|Overall Study|Lost to Follow-up|0|||
162623197|NCT01385566|587337555|FG000|Overall Study|Withdrawal by Subject|0|||
162623198|NCT01385566|587337556|FG001|Overall Study|Withdrawal by Subject|0|||
162623199|NCT01385566|587337557|FG002|Overall Study|Withdrawal by Subject|0|||
162623200|NCT01385566|587337558|FG003|Overall Study|Withdrawal by Subject|1|||
162623201|NCT01385566|587337559|FG004|Overall Study|Withdrawal by Subject|0|||
162623202|NCT01385566|587337560|FG005|Overall Study|Withdrawal by Subject|0|||
162623203|NCT00967668|587337561|FG000|Overall Study|Withdrawal by Subject|13|||
162623204|NCT00967668|587337562|FG001|Overall Study|Withdrawal by Subject|8|||
162623205|NCT00967668|587337563|FG002|Overall Study|Withdrawal by Subject|8|||
162623206|NCT00967668|587337561|FG000|Overall Study|Death|0|||
162623207|NCT00967668|587337562|FG001|Overall Study|Death|2|||
162623208|NCT00967668|587337563|FG002|Overall Study|Death|4|||
162623209|NCT00967668|587337561|FG000|Overall Study|Removed due to behavior|1|||
162623210|NCT00967668|587337562|FG001|Overall Study|Removed due to behavior|1|||
162623211|NCT00967668|587337563|FG002|Overall Study|Removed due to behavior|2|||
162623212|NCT00967668|587337561|FG000|Overall Study|Refused Year 2|11|||
162623213|NCT00967668|587337562|FG001|Overall Study|Refused Year 2|6|||
162623214|NCT00967668|587337563|FG002|Overall Study|Refused Year 2|4|||
162623215|NCT00967668|587337561|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
162623216|NCT00967668|587337562|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
162623217|NCT00967668|587337563|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
162623218|NCT00967668|587337561|FG000|Overall Study|Lost to Follow-up|15|||
162623219|NCT00967668|587337562|FG001|Overall Study|Lost to Follow-up|9|||
162623220|NCT00967668|587337563|FG002|Overall Study|Lost to Follow-up|16|||
162623221|NCT00967668|587337561|FG000|Overall Study|Refused 12-mo assessment|3|||
162623222|NCT00967668|587337562|FG001|Overall Study|Refused 12-mo assessment|1|||
162623223|NCT00967668|587337563|FG002|Overall Study|Refused 12-mo assessment|9|||
162623224|NCT00967668|587337561|FG000|Overall Study|Pregnancy|1|||
162623225|NCT00967668|587337562|FG001|Overall Study|Pregnancy|0|||
162623226|NCT00967668|587337563|FG002|Overall Study|Pregnancy|0|||
162623227|NCT00825682|587337564|FG000|Overall Study|personal reasons/ inconvenience|13|||
162623228|NCT00825682|587337565|FG001|Overall Study|personal reasons/ inconvenience|5|||
162623229|NCT03281577|587337566|FG000|Overall Study|Adverse Event|0|||
162623230|NCT03281577|587337567|FG001|Overall Study|Adverse Event|0|||
162623231|NCT03281577|587337568|FG002|Overall Study|Adverse Event|0|||
162623232|NCT03281577|587337569|FG003|Overall Study|Adverse Event|1|||
162623233|NCT03281577|587337566|FG000|Overall Study|Withdrawal by Subject|1|||
162623234|NCT03281577|587337567|FG001|Overall Study|Withdrawal by Subject|0|||
162623235|NCT03281577|587337568|FG002|Overall Study|Withdrawal by Subject|0|||
162623236|NCT03281577|587337569|FG003|Overall Study|Withdrawal by Subject|0|||
162623237|NCT01644565|587337570|FG000|Overall Study|Undisclosed Medical History|1|||
162623238|NCT01644565|587337571|FG001|Overall Study|Undisclosed Medical History|0|||
162623239|NCT01644565|587337572|FG002|Overall Study|Undisclosed Medical History|0|||
162623240|NCT01644565|587337573|FG003|Overall Study|Undisclosed Medical History|0|||
162623241|NCT01644565|587337574|FG004|Overall Study|Undisclosed Medical History|0|||
162623242|NCT01644565|587337575|FG005|Overall Study|Undisclosed Medical History|0|||
162623243|NCT01644565|587337576|FG006|Overall Study|Undisclosed Medical History|0|||
162623244|NCT01644565|587337577|FG007|Overall Study|Undisclosed Medical History|0|||
162623245|NCT01644565|587337578|FG008|Overall Study|Undisclosed Medical History|0|||
162623246|NCT01644565|587337570|FG000|Overall Study|Lost to Follow-up|0|||
162623247|NCT01644565|587337571|FG001|Overall Study|Lost to Follow-up|0|||
162623248|NCT01644565|587337572|FG002|Overall Study|Lost to Follow-up|0|||
162623249|NCT01644565|587337573|FG003|Overall Study|Lost to Follow-up|1|||
162623250|NCT01644565|587337574|FG004|Overall Study|Lost to Follow-up|0|||
162623251|NCT01644565|587337575|FG005|Overall Study|Lost to Follow-up|0|||
162623252|NCT01644565|587337576|FG006|Overall Study|Lost to Follow-up|0|||
162623253|NCT01644565|587337577|FG007|Overall Study|Lost to Follow-up|2|||
162623254|NCT01644565|587337578|FG008|Overall Study|Lost to Follow-up|0|||
162623255|NCT01644565|587337570|FG000|Overall Study|Family emergency|0|||
162623256|NCT01644565|587337571|FG001|Overall Study|Family emergency|0|||
162623257|NCT01644565|587337572|FG002|Overall Study|Family emergency|0|||
162623258|NCT01644565|587337573|FG003|Overall Study|Family emergency|0|||
162623259|NCT01644565|587337574|FG004|Overall Study|Family emergency|1|||
162623260|NCT01644565|587337575|FG005|Overall Study|Family emergency|0|||
162623261|NCT01644565|587337576|FG006|Overall Study|Family emergency|0|||
162623262|NCT01644565|587337577|FG007|Overall Study|Family emergency|0|||
162623263|NCT01644565|587337578|FG008|Overall Study|Family emergency|0|||
162623264|NCT01644565|587337570|FG000|Overall Study|Relocation|0|||
162623265|NCT01644565|587337571|FG001|Overall Study|Relocation|0|||
162623266|NCT01644565|587337572|FG002|Overall Study|Relocation|0|||
162623267|NCT01644565|587337573|FG003|Overall Study|Relocation|0|||
162623268|NCT01644565|587337574|FG004|Overall Study|Relocation|0|||
162623269|NCT01644565|587337575|FG005|Overall Study|Relocation|0|||
162623270|NCT01644565|587337576|FG006|Overall Study|Relocation|0|||
162623271|NCT01644565|587337577|FG007|Overall Study|Relocation|0|||
162623272|NCT01644565|587337578|FG008|Overall Study|Relocation|1|||
162623273|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
162623274|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
162623275|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
162623276|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
162623277|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
162623278|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
162623279|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
162623280|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
162623281|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
162623282|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
162623283|NCT00787891|587337579|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
162623284|NCT00787891|587337580|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
162623285|NCT00787891|587337579|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
162623286|NCT00787891|587337580|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
162623287|NCT00787891|587337579|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
162623288|NCT00787891|587337580|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
162623289|NCT00787891|587337579|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
162623290|NCT00787891|587337580|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
162623291|NCT00787891|587337579|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
162623292|NCT00787891|587337580|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
162623293|NCT01594281|587337581|FG000|Interventional Core Phase|Protocol Deviation|1|||
162623294|NCT01594281|587337582|FG001|Interventional Core Phase|Protocol Deviation|0|||
162623295|NCT01594281|587337583|FG002|Interventional Core Phase|Protocol Deviation|0|||
162623296|NCT01594281|587337581|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
162623297|NCT01594281|587337582|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
162623298|NCT01594281|587337583|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
162623299|NCT01594281|587337581|FG000|Interventional Core Phase|Death|1|||
162623300|NCT01594281|587337582|FG001|Interventional Core Phase|Death|1|||
162623301|NCT01594281|587337583|FG002|Interventional Core Phase|Death|2|||
162623302|NCT01594281|587337581|FG000|Interventional Core Phase|Lost to Follow-up|1|||
162623303|NCT01594281|587337582|FG001|Interventional Core Phase|Lost to Follow-up|4|||
162623304|NCT01594281|587337583|FG002|Interventional Core Phase|Lost to Follow-up|1|||
162623305|NCT01594281|587337581|FG000|Interventional Core Phase|Adverse Event|4|||
162623306|NCT01594281|587337582|FG001|Interventional Core Phase|Adverse Event|4|||
162623307|NCT01594281|587337583|FG002|Interventional Core Phase|Adverse Event|4|||
162623308|NCT01594281|587337581|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
162623309|NCT01594281|587337582|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
162623310|NCT01594281|587337583|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
162623311|NCT01594281|587337581|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
162623312|NCT01594281|587337582|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
162623313|NCT01594281|587337583|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
162623314|NCT01594281|587337581|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
162623315|NCT01594281|587337582|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
162623316|NCT01594281|587337583|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
162623317|NCT01193530|587337587|FG000|Overall Study|Withdrawal by Subject|2|||
162623318|NCT01193530|587337588|FG001|Overall Study|Withdrawal by Subject|2|||
162623319|NCT01193530|587337587|FG000|Overall Study|Began Contraindicated Therapy|1|||
162623320|NCT01193530|587337588|FG001|Overall Study|Began Contraindicated Therapy|0|||
162623321|NCT01193530|587337587|FG000|Overall Study|Lost Light Box|0|||
162623322|NCT01193530|587337588|FG001|Overall Study|Lost Light Box|1|||
162623323|NCT01193530|587337587|FG000|Overall Study|Returned home - out of state|0|||
162623324|NCT01193530|587337588|FG001|Overall Study|Returned home - out of state|1|||
162623325|NCT01193530|587337587|FG000|Overall Study|Non-Compliance|0|||
162623326|NCT01193530|587337588|FG001|Overall Study|Non-Compliance|1|||
162623327|NCT01890473|587337589|FG000|Overall Study|Lost to Follow-up|1|||
162623328|NCT01890473|587337590|FG001|Overall Study|Lost to Follow-up|0|||
162623329|NCT01890473|587337589|FG000|Overall Study|Poor/non-compliance|1|||
162623330|NCT01890473|587337590|FG001|Overall Study|Poor/non-compliance|0|||
162623331|NCT01945281|587337591|FG000|Overall Study|Adverse Event|1|||
162623332|NCT01945281|587337592|FG001|Overall Study|Adverse Event|0|||
162623333|NCT01945281|587337591|FG000|Overall Study|Death|3|||
162623334|NCT01945281|587337592|FG001|Overall Study|Death|3|||
162623335|NCT01945281|587337591|FG000|Overall Study|Physician Decision|1|||
162623336|NCT01945281|587337592|FG001|Overall Study|Physician Decision|1|||
162623337|NCT01945281|587337591|FG000|Overall Study|Technical Problems|1|||
162623338|NCT01945281|587337592|FG001|Overall Study|Technical Problems|0|||
162623339|NCT05074667|587337595|FG000|Overall Study|Death|1|||
162623340|NCT05074667|587337595|FG000|Overall Study|Withdrawal by Subject|4|||
162623341|NCT05074667|587337595|FG000|Overall Study|Lost to Follow-up|10|||
162623342|NCT02478632|587337597|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
162623343|NCT02478632|587337598|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
162623344|NCT02478632|587337597|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
162623345|NCT02478632|587337598|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
162623346|NCT02478632|587337597|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
162623347|NCT02478632|587337598|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
162623348|NCT01867424|587337599|FG000|Overall Study|Patient noncompliance|2|||
162623349|NCT01867424|587337600|FG001|Overall Study|Patient noncompliance|1|||
162623350|NCT04645953|587337601|FG000|Overall Study|Lost to Follow-up|2|||
162623351|NCT04645953|587337602|FG001|Overall Study|Lost to Follow-up|1|||
162623352|NCT04645953|587337603|FG002|Overall Study|Lost to Follow-up|1|||
162623353|NCT04645953|587337601|FG000|Overall Study|Withdrawal by Subject|0|||
162623354|NCT04645953|587337602|FG001|Overall Study|Withdrawal by Subject|1|||
162623355|NCT04645953|587337603|FG002|Overall Study|Withdrawal by Subject|0|||
162623356|NCT04645953|587337601|FG000|Overall Study|Physician Decision|0|||
162623357|NCT04645953|587337602|FG001|Overall Study|Physician Decision|1|||
162623358|NCT04645953|587337603|FG002|Overall Study|Physician Decision|0|||
162623359|NCT04645953|587337601|FG000|Overall Study|Discontinued Prior to Dosing|0|||
162623360|NCT04645953|587337602|FG001|Overall Study|Discontinued Prior to Dosing|0|||
162623361|NCT04645953|587337603|FG002|Overall Study|Discontinued Prior to Dosing|2|||
162623362|NCT04613375|587337604|FG000|Overall Study|Death|198|||
162623363|NCT04613375|587337604|FG000|Overall Study|Withdrawal by Subject|3|||
162623364|NCT00434954|587337608|FG000|Overall Study|Adverse Event|17|||
162623365|NCT00434954|587337609|FG001|Overall Study|Adverse Event|2|||
162623366|NCT00434954|587337608|FG000|Overall Study|Entry criteria not met|14|||
162623367|NCT00434954|587337609|FG001|Overall Study|Entry criteria not met|16|||
162623368|NCT00434954|587337608|FG000|Overall Study|Lost to Follow-up|0|||
162623369|NCT00434954|587337609|FG001|Overall Study|Lost to Follow-up|1|||
162623370|NCT00434954|587337608|FG000|Overall Study|Physician Decision|6|||
162623371|NCT00434954|587337609|FG001|Overall Study|Physician Decision|3|||
162623372|NCT00434954|587337608|FG000|Overall Study|Protocol Violation|36|||
162623373|NCT00434954|587337609|FG001|Overall Study|Protocol Violation|27|||
162623374|NCT00434954|587337608|FG000|Overall Study|Sponsor decision|1|||
162623375|NCT00434954|587337609|FG001|Overall Study|Sponsor decision|0|||
162623376|NCT00434954|587337608|FG000|Overall Study|Subject decision|8|||
162623377|NCT00434954|587337609|FG001|Overall Study|Subject decision|22|||
162623378|NCT00002651|587337610|FG000|Induction|Adverse Event|44|||
162623379|NCT00002651|587337611|FG001|Induction|Adverse Event|0|||
162623380|NCT00002651|587337612|FG002|Induction|Adverse Event|0|||
162623381|NCT00002651|587337610|FG000|Induction|Refusal unrelated to adverse event|50|||
162623382|NCT00002651|587337611|FG001|Induction|Refusal unrelated to adverse event|0|||
162623383|NCT00002651|587337612|FG002|Induction|Refusal unrelated to adverse event|0|||
162623384|NCT00002651|587337610|FG000|Induction|Progression/relapse|274|||
162623385|NCT00002651|587337611|FG001|Induction|Progression/relapse|0|||
162623386|NCT00002651|587337612|FG002|Induction|Progression/relapse|0|||
162623387|NCT00002651|587337610|FG000|Induction|Death|62|||
162623388|NCT00002651|587337611|FG001|Induction|Death|0|||
162623389|NCT00002651|587337612|FG002|Induction|Death|0|||
162623390|NCT00002651|587337610|FG000|Induction|Other|823|||
162623391|NCT00002651|587337611|FG001|Induction|Other|0|||
162623392|NCT00002651|587337612|FG002|Induction|Other|0|||
162623393|NCT00002651|587337610|FG000|Induction|not eligible|90|||
162623394|NCT00002651|587337611|FG001|Induction|not eligible|0|||
162623395|NCT00002651|587337612|FG002|Induction|not eligible|0|||
162623396|NCT00002651|587337610|FG000|Consolidation and Randomization|Adverse Event|0|||
162623397|NCT00002651|587337611|FG001|Consolidation and Randomization|Adverse Event|36|||
162623398|NCT00002651|587337612|FG002|Consolidation and Randomization|Adverse Event|14|||
162623399|NCT00002651|587337610|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
162623400|NCT00002651|587337611|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
162623401|NCT00002651|587337612|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
162623402|NCT00002651|587337610|FG000|Consolidation and Randomization|Progression/relapse|0|||
162623403|NCT00002651|587337611|FG001|Consolidation and Randomization|Progression/relapse|295|||
162623404|NCT00002651|587337612|FG002|Consolidation and Randomization|Progression/relapse|298|||
162623405|NCT00002651|587337610|FG000|Consolidation and Randomization|Death|0|||
162623406|NCT00002651|587337611|FG001|Consolidation and Randomization|Death|38|||
162623407|NCT00002651|587337612|FG002|Consolidation and Randomization|Death|48|||
162623408|NCT00002651|587337610|FG000|Consolidation and Randomization|Other|0|||
162623409|NCT00002651|587337611|FG001|Consolidation and Randomization|Other|314|||
162623410|NCT00002651|587337612|FG002|Consolidation and Randomization|Other|313|||
162623411|NCT00002651|587337610|FG000|Consolidation and Randomization|not eligible|0|||
162623412|NCT00002651|587337611|FG001|Consolidation and Randomization|not eligible|102|||
162623413|NCT00002651|587337612|FG002|Consolidation and Randomization|not eligible|112|||
162623414|NCT01705730|587337613|FG000|Overall Study|Lack of Efficacy|1|||
162623415|NCT01705730|587337613|FG000|Overall Study|Adverse Event|3|||
162623416|NCT01705730|587337613|FG000|Overall Study|Lost to Follow-up|1|||
162623417|NCT01705730|587337613|FG000|Overall Study|Reason not Specified|4|||
162623418|NCT04891978|587337617|FG000|Baseline|Protocol Violation|2|||
162623419|NCT04891978|587337618|FG001|Baseline|Protocol Violation|1|||
162623420|NCT04891978|587337619|FG002|Baseline|Protocol Violation|0|||
162623421|NCT04891978|587337617|FG000|Baseline|Missing AIRQ|1|||
162623422|NCT04891978|587337618|FG001|Baseline|Missing AIRQ|0|||
162623423|NCT04891978|587337619|FG002|Baseline|Missing AIRQ|0|||
162623424|NCT04891978|587337617|FG000|Baseline|Did not attend a baseline visit|0|||
162623425|NCT04891978|587337618|FG001|Baseline|Did not attend a baseline visit|0|||
162708742|NCT03682536|587642885|FG001|Treatment|Protocol Violation|0|||
162894759|NCT01831804|588313938|FG005|Overall Study|Adverse Event|0|||
162964808|NCT00486434|588571949|FG000|Overall Study|Personal reasons|5|||
162964809|NCT00486434|588571950|FG001|Overall Study|Personal reasons|6|||
162964810|NCT02218541|588571951|FG000|Overall Study|Lost to Follow-up|2|||
162964811|NCT02218541|588571952|FG001|Overall Study|Lost to Follow-up|1|||
162964812|NCT02218541|588571951|FG000|Overall Study|Implant Failure|4|||
162964813|NCT02218541|588571952|FG001|Overall Study|Implant Failure|1|||
162964814|NCT00856349|588571953|FG000|Overall Study|Death|418|||
162964815|NCT00856349|588571953|FG000|Overall Study|Withdrawal by Subject|116|||
162964816|NCT00856349|588571953|FG000|Overall Study|Lost to Follow-up|91|||
162964817|NCT00856349|588571953|FG000|Overall Study|Protocol Violation|38|||
162964818|NCT00856349|588571953|FG000|Overall Study|Physician Decision|13|||
162623426|NCT04891978|587337619|FG002|Baseline|Did not attend a baseline visit|9|||
162623427|NCT01776840|587337620|FG000|Overall Study|Lost to Follow-up|12|||
162623428|NCT01776840|587337621|FG001|Overall Study|Lost to Follow-up|7|||
162894760|NCT01831804|588313939|FG006|Overall Study|Adverse Event|1|||
162894761|NCT01831804|588313940|FG007|Overall Study|Adverse Event|0|||
162894762|NCT01831804|588313941|FG008|Overall Study|Adverse Event|1|||
162894763|NCT01831804|588313933|FG000|Overall Study|Protocol Violation|0|||
162894764|NCT01831804|588313934|FG001|Overall Study|Protocol Violation|0|||
162894765|NCT01831804|588313935|FG002|Overall Study|Protocol Violation|2|||
162894766|NCT01831804|588313936|FG003|Overall Study|Protocol Violation|0|||
162894767|NCT01831804|588313937|FG004|Overall Study|Protocol Violation|0|||
162894768|NCT01831804|588313938|FG005|Overall Study|Protocol Violation|0|||
162894769|NCT01831804|588313939|FG006|Overall Study|Protocol Violation|0|||
162894770|NCT01831804|588313940|FG007|Overall Study|Protocol Violation|0|||
162894771|NCT01831804|588313941|FG008|Overall Study|Protocol Violation|0|||
162623429|NCT01776840|587337620|FG000|Overall Study|Withdrawal by Subject|32|||
162623430|NCT01776840|587337621|FG001|Overall Study|Withdrawal by Subject|48|||
162894772|NCT01831804|588313933|FG000|Overall Study|Protocol defined stopping criteria|1|||
162894773|NCT01831804|588313934|FG001|Overall Study|Protocol defined stopping criteria|1|||
162964819|NCT00856349|588571953|FG000|Overall Study|Subject relocation|104|||
162964820|NCT00856349|588571953|FG000|Overall Study|Device explant|33|||
162964821|NCT00856349|588571953|FG000|Overall Study|Site closure|78|||
163051855|NCT02974868|588898737|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
163051856|NCT02974868|588898734|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
163051857|NCT02974868|588898735|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
163051858|NCT02974868|588898736|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
163051859|NCT02974868|588898737|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
163051860|NCT00749398|588898738|FG000|Overall Study|Lack of Efficacy|7|||
163051861|NCT00749398|588898738|FG000|Overall Study|Adverse Event|4|||
163051862|NCT00749398|588898738|FG000|Overall Study|Serious adverse event|11|||
163051863|NCT00749398|588898738|FG000|Overall Study|Withdrawal by Subject|17|||
163051864|NCT00749398|588898738|FG000|Overall Study|Lost to Follow-up|11|||
163051865|NCT00749398|588898738|FG000|Overall Study|Reason not specified|2|||
163051866|NCT00749398|588898738|FG000|Overall Study|Unknown reason|1|||
163051867|NCT01663402|588898739|FG000|Overall Study|Randomized but not treated|19|||
163051868|NCT01663402|588898740|FG001|Overall Study|Randomized but not treated|11|||
163051869|NCT01663402|588898739|FG000|Overall Study|Adverse Event|347|||
163051870|NCT01663402|588898740|FG001|Overall Study|Adverse Event|362|||
163051871|NCT01663402|588898739|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
163051872|NCT01663402|588898740|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
163051873|NCT01663402|588898739|FG000|Overall Study|Poor compliance to protocol|529|||
162623431|NCT01776840|587337620|FG000|Overall Study|Sponsor decision|89|||
162623432|NCT01776840|587337621|FG001|Overall Study|Sponsor decision|87|||
162623433|NCT05338216|587337622|FG000|Overall Study|Withdrawal by Subject|1|||
162623434|NCT05338216|587337623|FG001|Overall Study|Withdrawal by Subject|1|||
162623435|NCT02589405|587337627|FG000|Overall Study|Adverse Event|3|||
162623436|NCT02589405|587337627|FG000|Overall Study|Withdrawal by Subject|1|||
162623437|NCT02693119|587337630|FG000|Open-Label Period|Withdrawal by Subject|0|||
162623438|NCT02693119|587337631|FG001|Open-Label Period|Withdrawal by Subject|1|||
162623439|NCT01719783|587337632|FG000|Dose 2|Physician Decision|1|||
162623440|NCT01719783|587337633|FG001|Dose 2|Physician Decision|0|||
162623441|NCT01350492|587337634|FG000|Intervention|Lost to Follow-up|2|||
162894774|NCT01831804|588313935|FG002|Overall Study|Protocol defined stopping criteria|3|||
162894775|NCT01831804|588313936|FG003|Overall Study|Protocol defined stopping criteria|0|||
162894776|NCT01831804|588313937|FG004|Overall Study|Protocol defined stopping criteria|1|||
162894777|NCT01831804|588313938|FG005|Overall Study|Protocol defined stopping criteria|0|||
162894778|NCT01831804|588313939|FG006|Overall Study|Protocol defined stopping criteria|0|||
162894779|NCT01831804|588313940|FG007|Overall Study|Protocol defined stopping criteria|0|||
162894780|NCT01831804|588313941|FG008|Overall Study|Protocol defined stopping criteria|0|||
162894781|NCT01831804|588313933|FG000|Overall Study|Lost to Follow-up|0|||
162894782|NCT01831804|588313934|FG001|Overall Study|Lost to Follow-up|0|||
162894783|NCT01831804|588313935|FG002|Overall Study|Lost to Follow-up|1|||
162894784|NCT01831804|588313936|FG003|Overall Study|Lost to Follow-up|0|||
162894785|NCT01831804|588313937|FG004|Overall Study|Lost to Follow-up|0|||
162894786|NCT01831804|588313938|FG005|Overall Study|Lost to Follow-up|0|||
162894787|NCT01831804|588313939|FG006|Overall Study|Lost to Follow-up|0|||
162894788|NCT01831804|588313940|FG007|Overall Study|Lost to Follow-up|0|||
162894789|NCT01831804|588313941|FG008|Overall Study|Lost to Follow-up|1|||
162894790|NCT01831804|588313933|FG000|Overall Study|Investigator discretion|0|||
162894791|NCT01831804|588313934|FG001|Overall Study|Investigator discretion|0|||
162894792|NCT01831804|588313935|FG002|Overall Study|Investigator discretion|0|||
162894793|NCT01831804|588313936|FG003|Overall Study|Investigator discretion|0|||
162894794|NCT01831804|588313937|FG004|Overall Study|Investigator discretion|1|||
162894795|NCT01831804|588313938|FG005|Overall Study|Investigator discretion|0|||
162894796|NCT01831804|588313939|FG006|Overall Study|Investigator discretion|0|||
162894797|NCT01831804|588313940|FG007|Overall Study|Investigator discretion|1|||
162894798|NCT01831804|588313941|FG008|Overall Study|Investigator discretion|0|||
162894799|NCT01831804|588313933|FG000|Overall Study|Withdrew Consent|0|||
162894800|NCT01831804|588313934|FG001|Overall Study|Withdrew Consent|1|||
162894801|NCT01831804|588313935|FG002|Overall Study|Withdrew Consent|0|||
162894802|NCT01831804|588313936|FG003|Overall Study|Withdrew Consent|0|||
162894803|NCT01831804|588313937|FG004|Overall Study|Withdrew Consent|0|||
162894804|NCT01831804|588313938|FG005|Overall Study|Withdrew Consent|0|||
162894805|NCT01831804|588313939|FG006|Overall Study|Withdrew Consent|0|||
162894806|NCT01831804|588313940|FG007|Overall Study|Withdrew Consent|2|||
162894807|NCT01831804|588313941|FG008|Overall Study|Withdrew Consent|0|||
162894808|NCT01819506|588313942|FG000|Overall Study|Physician Decision|5|||
162894809|NCT01819506|588313943|FG001|Overall Study|Physician Decision|2|||
162894810|NCT01819506|588313942|FG000|Overall Study|Withdrawal by Subject|3|||
162894811|NCT01819506|588313943|FG001|Overall Study|Withdrawal by Subject|3|||
162894812|NCT01505114|588313946|FG000|Overall Study|Withdrawal by Subject|5|||
162894813|NCT01505114|588313947|FG001|Overall Study|Withdrawal by Subject|4|||
162894814|NCT01505114|588313948|FG002|Overall Study|Withdrawal by Subject|4|||
162894815|NCT01505114|588313949|FG003|Overall Study|Withdrawal by Subject|7|||
162894816|NCT01505114|588313946|FG000|Overall Study|Death|1|||
162894817|NCT01505114|588313947|FG001|Overall Study|Death|0|||
162894818|NCT01505114|588313948|FG002|Overall Study|Death|0|||
162894819|NCT01505114|588313949|FG003|Overall Study|Death|1|||
162894820|NCT01505114|588313946|FG000|Overall Study|unable to adhere to visit schedule|3|||
162623442|NCT01350492|587337635|FG001|Intervention|Lost to Follow-up|5|||
162623443|NCT01350492|587337634|FG000|Intervention|Withdrawal by Subject|3|||
162623444|NCT01350492|587337635|FG001|Intervention|Withdrawal by Subject|1|||
162623445|NCT01350492|587337634|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
162623446|NCT01350492|587337635|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
162623447|NCT01350492|587337634|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
162623448|NCT01350492|587337635|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
162623449|NCT00753766|587337636|FG000|Overall Study|Physician Decision|1|||
162623450|NCT00753766|587337637|FG001|Overall Study|Physician Decision|0|||
162623451|NCT03800173|587337640|FG000|Overall Study|Lost to Follow-up|0|||
162623452|NCT03800173|587337641|FG001|Overall Study|Lost to Follow-up|0|||
162623453|NCT03800173|587337642|FG002|Overall Study|Lost to Follow-up|0|||
162623454|NCT03800173|587337643|FG003|Overall Study|Lost to Follow-up|0|||
162623455|NCT03800173|587337644|FG004|Overall Study|Lost to Follow-up|1|||
162623456|NCT00932126|587337647|FG000|Overall Study|Adverse Event|0|||
162623457|NCT00932126|587337648|FG001|Overall Study|Adverse Event|0|||
162623458|NCT00932126|587337649|FG002|Overall Study|Adverse Event|0|||
162623459|NCT00932126|587337650|FG003|Overall Study|Adverse Event|0|||
162623460|NCT00932126|587337651|FG004|Overall Study|Adverse Event|0|||
162623461|NCT00932126|587337652|FG005|Overall Study|Adverse Event|0|||
162623462|NCT00932126|587337653|FG006|Overall Study|Adverse Event|1|||
162623463|NCT00932126|587337654|FG007|Overall Study|Adverse Event|2|||
162623464|NCT00932126|587337647|FG000|Overall Study|Protocol Violation|0|||
162623465|NCT00932126|587337648|FG001|Overall Study|Protocol Violation|0|||
162623466|NCT00932126|587337649|FG002|Overall Study|Protocol Violation|0|||
162623467|NCT00932126|587337650|FG003|Overall Study|Protocol Violation|0|||
162623468|NCT00932126|587337651|FG004|Overall Study|Protocol Violation|1|||
162623469|NCT00932126|587337652|FG005|Overall Study|Protocol Violation|0|||
162623470|NCT00932126|587337653|FG006|Overall Study|Protocol Violation|0|||
162894821|NCT01505114|588313947|FG001|Overall Study|unable to adhere to visit schedule|2|||
162894822|NCT01505114|588313948|FG002|Overall Study|unable to adhere to visit schedule|3|||
162894823|NCT01505114|588313949|FG003|Overall Study|unable to adhere to visit schedule|3|||
162894824|NCT01505114|588313946|FG000|Overall Study|Lost to Follow-up|11|||
162894825|NCT01505114|588313947|FG001|Overall Study|Lost to Follow-up|5|||
162894826|NCT01505114|588313948|FG002|Overall Study|Lost to Follow-up|8|||
162894827|NCT01505114|588313949|FG003|Overall Study|Lost to Follow-up|7|||
162894828|NCT01505114|588313946|FG000|Overall Study|relocated|4|||
162894829|NCT01505114|588313947|FG001|Overall Study|relocated|2|||
162894830|NCT01505114|588313948|FG002|Overall Study|relocated|2|||
162894831|NCT01505114|588313949|FG003|Overall Study|relocated|3|||
162894832|NCT01505114|588313946|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
162894833|NCT01505114|588313947|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
162894834|NCT01505114|588313948|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
162894835|NCT01505114|588313949|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
162894836|NCT01505114|588313946|FG000|Overall Study|staff safety concerns|0|||
162894837|NCT01505114|588313947|FG001|Overall Study|staff safety concerns|0|||
162708743|NCT03682536|587642884|FG000|Treatment|Study Terminated by Sponsor|1|||
162708744|NCT03682536|587642885|FG001|Treatment|Study Terminated by Sponsor|2|||
162708745|NCT03682536|587642884|FG000|Treatment|Lost to Follow-up|0|||
162894838|NCT01505114|588313948|FG002|Overall Study|staff safety concerns|0|||
162894839|NCT01505114|588313949|FG003|Overall Study|staff safety concerns|1|||
162894840|NCT01505114|588313946|FG000|Overall Study|investigator decision|1|||
162894841|NCT01505114|588313947|FG001|Overall Study|investigator decision|0|||
162894842|NCT01505114|588313948|FG002|Overall Study|investigator decision|1|||
162894843|NCT01505114|588313949|FG003|Overall Study|investigator decision|0|||
162894844|NCT00615459|588313950|FG000|Period I|Adverse Event|2|||
162894845|NCT00615459|588313951|FG001|Period I|Adverse Event|0|||
162894846|NCT00615459|588313952|FG002|Period I|Adverse Event|1|||
162894847|NCT00615459|588313953|FG003|Period I|Adverse Event|0|||
162894848|NCT00615459|588313950|FG000|Period I|Subject withdrew consent|1|||
162894849|NCT00615459|588313951|FG001|Period I|Subject withdrew consent|0|||
162894850|NCT00615459|588313952|FG002|Period I|Subject withdrew consent|0|||
162894851|NCT00615459|588313953|FG003|Period I|Subject withdrew consent|1|||
162894852|NCT00615459|588313950|FG000|Period I|Abnormal test procedure results|1|||
162894853|NCT00615459|588313951|FG001|Period I|Abnormal test procedure results|1|||
162894854|NCT00615459|588313952|FG002|Period I|Abnormal test procedure results|1|||
162894855|NCT00615459|588313953|FG003|Period I|Abnormal test procedure results|0|||
162894856|NCT00615459|588313950|FG000|Period II|Adverse Event|1|||
162894857|NCT00615459|588313951|FG001|Period II|Adverse Event|0|||
162894858|NCT00615459|588313952|FG002|Period II|Adverse Event|0|||
162894859|NCT00615459|588313953|FG003|Period II|Adverse Event|0|||
162894860|NCT00615459|588313950|FG000|Period II|Lost to Follow-up|0|||
162894861|NCT00615459|588313951|FG001|Period II|Lost to Follow-up|0|||
162894862|NCT00615459|588313952|FG002|Period II|Lost to Follow-up|0|||
163051874|NCT01663402|588898740|FG001|Overall Study|Poor compliance to protocol|454|||
162708746|NCT03682536|587642885|FG001|Treatment|Lost to Follow-up|1|||
162894863|NCT00615459|588313953|FG003|Period II|Lost to Follow-up|1|||
162894864|NCT00615459|588313950|FG000|Period III|Adverse Event|0|||
162894865|NCT00615459|588313951|FG001|Period III|Adverse Event|1|||
162708747|NCT03682536|587642884|FG000|Treatment|Withdrawal by Subject|16|||
162894866|NCT00615459|588313952|FG002|Period III|Adverse Event|0|||
162894867|NCT00615459|588313953|FG003|Period III|Adverse Event|0|||
162894868|NCT00615459|588313950|FG000|Period III|Administrative problems|0|||
162894869|NCT00615459|588313951|FG001|Period III|Administrative problems|1|||
162894870|NCT00615459|588313952|FG002|Period III|Administrative problems|1|||
162894871|NCT00615459|588313953|FG003|Period III|Administrative problems|0|||
162894872|NCT00615459|588313950|FG000|Period III|Unsatisfactory therapeutic effect|0|||
162894873|NCT00615459|588313951|FG001|Period III|Unsatisfactory therapeutic effect|1|||
162894874|NCT00615459|588313952|FG002|Period III|Unsatisfactory therapeutic effect|0|||
162894875|NCT00615459|588313953|FG003|Period III|Unsatisfactory therapeutic effect|0|||
162894876|NCT02017704|588313960|FG000|Overall Study|Withdrawal by Subject|2|||
162894877|NCT02017704|588313961|FG001|Overall Study|Withdrawal by Subject|0|||
162894878|NCT02076334|588313962|FG000|Overall Study|Protocol Violation|1|||
162894879|NCT02076334|588313963|FG001|Overall Study|Protocol Violation|0|||
162894880|NCT02076334|588313964|FG002|Overall Study|Protocol Violation|0|||
162894881|NCT02076334|588313965|FG003|Overall Study|Protocol Violation|0|||
162894882|NCT02076334|588313962|FG000|Overall Study|Lost to Follow-up|0|||
162894883|NCT02076334|588313963|FG001|Overall Study|Lost to Follow-up|1|||
162894884|NCT02076334|588313964|FG002|Overall Study|Lost to Follow-up|1|||
163051875|NCT01663402|588898739|FG000|Overall Study|Physician Decision|77|||
162894885|NCT02076334|588313965|FG003|Overall Study|Lost to Follow-up|0|||
162894886|NCT02076334|588313962|FG000|Overall Study|muscle soreness|0|||
162894887|NCT02076334|588313963|FG001|Overall Study|muscle soreness|0|||
162894888|NCT02076334|588313964|FG002|Overall Study|muscle soreness|0|||
162894889|NCT02076334|588313965|FG003|Overall Study|muscle soreness|1|||
162894890|NCT01975675|588313966|FG000|Overall Study|Death|0|||
162894891|NCT01975675|588313967|FG001|Overall Study|Death|1|||
162894892|NCT01975675|588313968|FG002|Overall Study|Death|0|||
162894893|NCT01975675|588313969|FG003|Overall Study|Death|0|||
162894894|NCT03639987|588313970|FG000|Overall Study|Study terminated by sponsor|26|||
162894895|NCT03639987|588313971|FG001|Overall Study|Study terminated by sponsor|25|||
162894896|NCT03639987|588313970|FG000|Overall Study|Lost to Follow-up|0|||
162964822|NCT00856349|588571953|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
162964823|NCT02998541|588571957|FG000|Overall Study|Adverse Event|4|||
162964824|NCT02998541|588571958|FG001|Overall Study|Adverse Event|5|||
162964825|NCT02998541|588571959|FG002|Overall Study|Adverse Event|1|||
162894897|NCT03639987|588313971|FG001|Overall Study|Lost to Follow-up|1|||
162894898|NCT04354155|588313972|FG000|Overall Study|Withdrawal by Subject|1|||
162894899|NCT04354155|588313972|FG000|Overall Study|Did not meet criteria for study intervention|1|||
162894900|NCT01015820|588313975|FG000|Overall Study|Suboptimal measurements|1|||
162894901|NCT01015820|588313976|FG001|Overall Study|Suboptimal measurements|0|||
162894902|NCT01998399|588313977|FG000|Overall Study|Lost to Follow-up|1|||
162964826|NCT02998541|588571957|FG000|Overall Study|Protocol Violation|1|||
162964827|NCT02998541|588571958|FG001|Overall Study|Protocol Violation|0|||
162964828|NCT02998541|588571959|FG002|Overall Study|Protocol Violation|0|||
162964829|NCT02998541|588571957|FG000|Overall Study|Withdrawal by Subject|3|||
162964830|NCT02998541|588571958|FG001|Overall Study|Withdrawal by Subject|1|||
162964831|NCT02998541|588571959|FG002|Overall Study|Withdrawal by Subject|0|||
162964832|NCT02998541|588571957|FG000|Overall Study|Lost to Follow-up|0|||
162964833|NCT02998541|588571958|FG001|Overall Study|Lost to Follow-up|3|||
162964834|NCT02998541|588571959|FG002|Overall Study|Lost to Follow-up|1|||
162964835|NCT02998541|588571957|FG000|Overall Study|Physician Decision|0|||
162964836|NCT02998541|588571958|FG001|Overall Study|Physician Decision|0|||
162964837|NCT02998541|588571959|FG002|Overall Study|Physician Decision|3|||
162964838|NCT02998541|588571957|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163051876|NCT01663402|588898740|FG001|Overall Study|Physician Decision|62|||
162894903|NCT01998399|588313978|FG001|Overall Study|Lost to Follow-up|3|||
162894904|NCT01998399|588313977|FG000|Overall Study|Death|4|||
162894905|NCT01998399|588313978|FG001|Overall Study|Death|2|||
162964839|NCT02998541|588571958|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162964840|NCT02998541|588571959|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
162964841|NCT03540160|588571960|FG000|Overall Study|Protocol Violation|1|||
162964842|NCT03540160|588571960|FG000|Overall Study|Physician Decision|8|||
162964843|NCT03540160|588571960|FG000|Overall Study|Lack of Efficacy|60|||
162964844|NCT03540160|588571960|FG000|Overall Study|Pregnancy|1|||
162623471|NCT00932126|587337654|FG007|Overall Study|Protocol Violation|0|||
162623472|NCT00932126|587337647|FG000|Overall Study|Withdrawal by Subject|0|||
162894906|NCT01998399|588313977|FG000|Overall Study|Study stopped before dosing completed|3|||
162894907|NCT01998399|588313978|FG001|Overall Study|Study stopped before dosing completed|3|||
162894908|NCT01998399|588313977|FG000|Overall Study|Withdrawal by Subject|0|||
162894909|NCT01998399|588313978|FG001|Overall Study|Withdrawal by Subject|1|||
162894910|NCT00376246|588313979|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
162894911|NCT00376246|588313980|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
162894912|NCT00376246|588313979|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162894913|NCT00376246|588313980|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
162894914|NCT00376246|588313979|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
162894915|NCT00376246|588313980|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162894916|NCT00351819|588313983|FG000|Overall Study|Lost to Follow-up|4|||
162894917|NCT00351819|588313984|FG001|Overall Study|Lost to Follow-up|4|||
162894918|NCT00351819|588313983|FG000|Overall Study|Withdrawal by Subject|0|||
162894919|NCT00351819|588313984|FG001|Overall Study|Withdrawal by Subject|4|||
162894920|NCT00351819|588313983|FG000|Overall Study|Elevated PSA|1|||
162894921|NCT00351819|588313984|FG001|Overall Study|Elevated PSA|1|||
162894922|NCT00351819|588313983|FG000|Overall Study|Traumatic ankle fracture|1|||
162894923|NCT00351819|588313984|FG001|Overall Study|Traumatic ankle fracture|0|||
162894924|NCT00351819|588313983|FG000|Overall Study|Unprofessional behavior|1|||
162894925|NCT00351819|588313984|FG001|Overall Study|Unprofessional behavior|0|||
162894926|NCT00351819|588313983|FG000|Overall Study|Non-compliance|0|||
162894927|NCT00351819|588313984|FG001|Overall Study|Non-compliance|1|||
162894928|NCT00351819|588313983|FG000|Overall Study|Incarcerated|0|||
162894929|NCT00351819|588313984|FG001|Overall Study|Incarcerated|1|||
162894930|NCT00351819|588313983|FG000|Overall Study|Enrolled in another trial|0|||
162894931|NCT00351819|588313984|FG001|Overall Study|Enrolled in another trial|1|||
162894932|NCT01459068|588313986|FG000|Overall Study|Withdrawal by Subject|8|||
162894933|NCT01459068|588313987|FG001|Overall Study|Withdrawal by Subject|18|||
162894934|NCT01459068|588313986|FG000|Overall Study|Lost to Follow-up|31|||
162894935|NCT01459068|588313987|FG001|Overall Study|Lost to Follow-up|15|||
162894936|NCT01459068|588313986|FG000|Overall Study|Death|0|||
162894937|NCT01459068|588313987|FG001|Overall Study|Death|1|||
162894938|NCT02023112|588313990|FG000|Overall Study|Withdrawal by Subject|2|||
162894939|NCT02023112|588313991|FG001|Overall Study|Withdrawal by Subject|1|||
162894940|NCT01425749|588313992|FG000|Overall Study|progression of melanoma|0|||
162894941|NCT01425749|588313993|FG001|Overall Study|progression of melanoma|1|||
162894942|NCT02910219|588313994|FG000|Overall Study|Withdrawal by Subject|1|||
162894943|NCT02910219|588313995|FG001|Overall Study|Withdrawal by Subject|1|||
162894944|NCT02096042|588313998|FG000|Overall Study|Disease Progression|1|||
162894945|NCT02096042|588313999|FG001|Overall Study|Disease Progression|0|||
162894946|NCT02096042|588314000|FG002|Overall Study|Disease Progression|0|||
162894947|NCT00701441|588314003|FG000|Overall Study|failure in cpap compliance|0|||
162894948|NCT00701441|588314004|FG001|Overall Study|failure in cpap compliance|4|||
162894949|NCT01313078|588314005|FG000|Overall Study|Death|1|||
162894950|NCT01313078|588314005|FG000|Overall Study|Discontinued study drug|1|||
162894951|NCT01313078|588314005|FG000|Overall Study|Withdrawal by Subject|1|||
162894952|NCT01068717|588314009|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
162623473|NCT00932126|587337648|FG001|Overall Study|Withdrawal by Subject|0|||
162623474|NCT00932126|587337649|FG002|Overall Study|Withdrawal by Subject|1|||
162623475|NCT00932126|587337650|FG003|Overall Study|Withdrawal by Subject|0|||
162623476|NCT00932126|587337651|FG004|Overall Study|Withdrawal by Subject|0|||
162623477|NCT00932126|587337652|FG005|Overall Study|Withdrawal by Subject|0|||
162623478|NCT00932126|587337653|FG006|Overall Study|Withdrawal by Subject|0|||
162623479|NCT00932126|587337654|FG007|Overall Study|Withdrawal by Subject|1|||
162623480|NCT00932126|587337647|FG000|Overall Study|Objective progression or relapse|3|||
162623481|NCT00932126|587337648|FG001|Overall Study|Objective progression or relapse|3|||
162623482|NCT00932126|587337649|FG002|Overall Study|Objective progression or relapse|2|||
162623483|NCT00932126|587337650|FG003|Overall Study|Objective progression or relapse|3|||
162708748|NCT03682536|587642885|FG001|Treatment|Withdrawal by Subject|18|||
162708749|NCT03682536|587642884|FG000|Treatment|Lack of Efficacy|41|||
162894953|NCT01068717|588314010|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
162894954|NCT01068717|588314011|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
162894955|NCT01068717|588314012|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
162894956|NCT01822223|588314013|FG000|Overall Study|Death|0|||
162894957|NCT01822223|588314014|FG001|Overall Study|Death|1|||
162623484|NCT00932126|587337651|FG004|Overall Study|Objective progression or relapse|3|||
162623485|NCT00932126|587337652|FG005|Overall Study|Objective progression or relapse|3|||
162623486|NCT00932126|587337653|FG006|Overall Study|Objective progression or relapse|3|||
162623487|NCT00932126|587337654|FG007|Overall Study|Objective progression or relapse|5|||
162894958|NCT01449955|588314020|FG000|Overall Study|Withdrawal by Subject|1|||
162894959|NCT01449955|588314021|FG001|Overall Study|Withdrawal by Subject|2|||
162894960|NCT03404518|588314027|FG000|Overall Study|Lost to Follow-up|28|||
162964845|NCT03540160|588571960|FG000|Overall Study|Adverse Event|20|||
162964846|NCT03540160|588571960|FG000|Overall Study|Withdrawal by Subject|68|||
162964847|NCT03540160|588571960|FG000|Overall Study|COVID-19|2|||
162964848|NCT03540160|588571960|FG000|Overall Study|Study Closure|10|||
162964849|NCT03540160|588571960|FG000|Overall Study|Lost to Follow-up|18|||
162964850|NCT03540160|588571960|FG000|Overall Study|Sponsor decision|191|||
162964851|NCT01944722|588571961|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
162964852|NCT01944722|588571961|FG000|Overall Study|Specimen Shipping Issues|34|||
162964853|NCT01944722|588571961|FG000|Overall Study|Improper Storage/Transport|5|||
162964854|NCT01944722|588571961|FG000|Overall Study|Insufficient Volume for Test|1|||
162964855|NCT01944722|588571961|FG000|Overall Study|Missing Specimens|3|||
162964856|NCT01944722|588571961|FG000|Overall Study|Specimens Mislabeled|2|||
162964857|NCT01944722|588571961|FG000|Overall Study|Withdrawal by Subject|8|||
162964858|NCT01944722|588571961|FG000|Overall Study|NILM Subjects <30 years old|8106|||
162964859|NCT01944722|588571961|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
162964860|NCT01944722|588571961|FG000|Overall Study|>ASCUS Cytology|1122|||
162964861|NCT01923740|588571962|FG000|Overall Study|Lost to Follow-up|4|||
162964862|NCT01923740|588571963|FG001|Overall Study|Lost to Follow-up|9|||
162964863|NCT01923740|588571962|FG000|Overall Study|Withdrawal by Subject|2|||
162964864|NCT01923740|588571963|FG001|Overall Study|Withdrawal by Subject|0|||
162964865|NCT03345420|588571965|FG000|Overall Study|Withdrawal by Subject|1|||
162964866|NCT02933060|588571997|FG000|Overall Study|Withdrawal by Subject|0|||
162964867|NCT02933060|588571998|FG001|Overall Study|Withdrawal by Subject|1|||
162964868|NCT01945580|588571999|FG000|Overall Study|Withdrawal by Subject|13|||
162964869|NCT01945580|588572000|FG001|Overall Study|Withdrawal by Subject|35|||
162964870|NCT01945580|588571999|FG000|Overall Study|Physician Decision|3|||
162964871|NCT01945580|588572000|FG001|Overall Study|Physician Decision|2|||
162964872|NCT01945580|588571999|FG000|Overall Study|Lost to Follow-up|26|||
162964873|NCT01945580|588572000|FG001|Overall Study|Lost to Follow-up|39|||
162964874|NCT01945580|588571999|FG000|Overall Study|Death|7|||
162964875|NCT01945580|588572000|FG001|Overall Study|Death|2|||
162964876|NCT01945580|588571999|FG000|Overall Study|Patient moved out of state|0|||
162964877|NCT01945580|588572000|FG001|Overall Study|Patient moved out of state|1|||
162964878|NCT01945580|588571999|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
162964879|NCT01945580|588572000|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
162964880|NCT01945580|588571999|FG000|Overall Study|Family illness - unable to return|0|||
162964881|NCT01945580|588572000|FG001|Overall Study|Family illness - unable to return|1|||
162964882|NCT01945580|588571999|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
162964883|NCT01945580|588572000|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
162964884|NCT01945580|588571999|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
162964885|NCT01945580|588572000|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
162964886|NCT01945580|588571999|FG000|Overall Study|Noncompliance with 36 month visit|1|||
162964887|NCT01945580|588572000|FG001|Overall Study|Noncompliance with 36 month visit|0|||
162964888|NCT01945580|588571999|FG000|Overall Study|The patient moved.|1|||
162964889|NCT01945580|588572000|FG001|Overall Study|The patient moved.|0|||
162964890|NCT01945580|588571999|FG000|Overall Study|No data available|0|||
162964891|NCT01945580|588572000|FG001|Overall Study|No data available|2|||
162964892|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
162964893|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
162964894|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
162964895|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
162964896|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
162964897|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
162964898|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
162964899|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
162964900|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
162964901|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
162964902|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
162964903|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
162964904|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
162964905|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
162964906|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
162964907|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
162964908|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
162964909|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
162623488|NCT00932126|587337647|FG000|Overall Study|Other|0|||
162623489|NCT00932126|587337648|FG001|Overall Study|Other|0|||
162623490|NCT00932126|587337649|FG002|Overall Study|Other|0|||
162623491|NCT00932126|587337650|FG003|Overall Study|Other|0|||
162623492|NCT00932126|587337651|FG004|Overall Study|Other|1|||
162623493|NCT00932126|587337652|FG005|Overall Study|Other|0|||
162623494|NCT00932126|587337653|FG006|Overall Study|Other|1|||
162623495|NCT00932126|587337654|FG007|Overall Study|Other|2|||
162623496|NCT02121522|587337662|FG000|Overall Study|Adverse Event|1|||
162623497|NCT01235689|587337663|FG000|Overall Study|Adverse Event|12|||
162623498|NCT01235689|587337664|FG001|Overall Study|Adverse Event|16|||
162623499|NCT01235689|587337663|FG000|Overall Study|Lack of Efficacy|12|||
162623500|NCT01235689|587337664|FG001|Overall Study|Lack of Efficacy|5|||
162623501|NCT01235689|587337663|FG000|Overall Study|Withdrawal by Subject|3|||
162623502|NCT01235689|587337664|FG001|Overall Study|Withdrawal by Subject|4|||
162623503|NCT01235689|587337663|FG000|Overall Study|Lost to Follow-up|1|||
162623504|NCT01235689|587337664|FG001|Overall Study|Lost to Follow-up|2|||
162623505|NCT01235689|587337663|FG000|Overall Study|Miscellaneous|1|||
162623506|NCT01235689|587337664|FG001|Overall Study|Miscellaneous|5|||
162623507|NCT00806351|587337665|FG000|Overall Study|Death|5|||
162623508|NCT00806351|587337666|FG001|Overall Study|Death|4|||
162623509|NCT00672646|587337670|FG000|Overall Study|Lost to Follow-up|0|||
162623510|NCT00672646|587337671|FG001|Overall Study|Lost to Follow-up|1|||
162623511|NCT00672646|587337672|FG002|Overall Study|Lost to Follow-up|2|||
162623512|NCT00672646|587337670|FG000|Overall Study|Withdrawal by Subject|0|||
162623513|NCT00672646|587337671|FG001|Overall Study|Withdrawal by Subject|0|||
162623514|NCT00672646|587337672|FG002|Overall Study|Withdrawal by Subject|1|||
162623515|NCT00289783|587337673|FG000|Primary Phase|Adverse Event|10|||
162623516|NCT00289783|587337674|FG001|Primary Phase|Adverse Event|1|||
162623517|NCT00289783|587337673|FG000|Primary Phase|Protocol Violation|27|||
162623518|NCT00289783|587337674|FG001|Primary Phase|Protocol Violation|6|||
162623519|NCT00289783|587337673|FG000|Primary Phase|Withdrawal by Subject|93|||
162623520|NCT00289783|587337674|FG001|Primary Phase|Withdrawal by Subject|40|||
162623521|NCT00289783|587337673|FG000|Primary Phase|Lost to Follow-up|60|||
162623522|NCT00289783|587337674|FG001|Primary Phase|Lost to Follow-up|14|||
162623523|NCT00289783|587337673|FG000|Primary Phase|Migration from the study area|26|||
162623524|NCT00289783|587337674|FG001|Primary Phase|Migration from the study area|10|||
162894961|NCT03404518|588314028|FG001|Overall Study|Lost to Follow-up|30|||
162894962|NCT03404518|588314027|FG000|Overall Study|Protocol Violation|13|||
162894963|NCT03404518|588314028|FG001|Overall Study|Protocol Violation|6|||
162894964|NCT03693404|588314031|FG000|Overall Study|Withdrawal by Subject|1|||
162894965|NCT03693404|588314032|FG001|Overall Study|Withdrawal by Subject|0|||
162894966|NCT03693404|588314031|FG000|Overall Study|Lost to Follow-up|0|||
162894967|NCT03693404|588314032|FG001|Overall Study|Lost to Follow-up|5|||
162894968|NCT03693404|588314031|FG000|Overall Study|Excluded from Analysis|0|||
162894969|NCT03693404|588314032|FG001|Overall Study|Excluded from Analysis|1|||
162894970|NCT01176240|588314033|FG000|Study 306A|Lack of Efficacy|2|||
162894971|NCT01176240|588314034|FG001|Study 306A|Lack of Efficacy|1|||
162894972|NCT01176240|588314033|FG000|Study 306A|Protocol Violation|0|||
162894973|NCT01176240|588314034|FG001|Study 306A|Protocol Violation|1|||
162894974|NCT01176240|588314033|FG000|Study 306A|Withdrawal by Subject|0|||
162894975|NCT01176240|588314034|FG001|Study 306A|Withdrawal by Subject|1|||
162894976|NCT01176240|588314033|FG000|Study 306A|Stop due to diverse problems|1|||
162894977|NCT01176240|588314034|FG001|Study 306A|Stop due to diverse problems|0|||
162894978|NCT01176240|588314033|FG000|Study 306B|Lack of Efficacy|5|||
162894979|NCT01176240|588314034|FG001|Study 306B|Lack of Efficacy|3|||
162894980|NCT01176240|588314033|FG000|Study 306B|Adverse Event|10|||
162894981|NCT01176240|588314034|FG001|Study 306B|Adverse Event|5|||
162894982|NCT01176240|588314033|FG000|Study 306B|Protocol Violation|2|||
162623525|NCT00289783|587337673|FG000|Primary Phase|Other|32|||
162623526|NCT00289783|587337674|FG001|Primary Phase|Other|12|||
162623527|NCT00289783|587337673|FG000|Fourth Dose Phase|Adverse Event|1|||
162623528|NCT00289783|587337674|FG001|Fourth Dose Phase|Adverse Event|0|||
162623529|NCT00289783|587337673|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
162623530|NCT00289783|587337674|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
162708750|NCT03682536|587642885|FG001|Treatment|Lack of Efficacy|68|||
162623531|NCT00289783|587337673|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
162623532|NCT00289783|587337674|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
162623533|NCT00289783|587337673|FG000|Fourth Dose Phase|Migration from the study area|1|||
162623534|NCT00289783|587337674|FG001|Fourth Dose Phase|Migration from the study area|1|||
162623535|NCT00289783|587337673|FG000|Fourth Dose Phase|Other|22|||
162623536|NCT00289783|587337674|FG001|Fourth Dose Phase|Other|10|||
162623537|NCT05248867|587337675|FG000|Double-blind Period|Lost to Follow-up|0|||
162708751|NCT03682536|587642884|FG000|Treatment|Disease Progression|9|||
162894983|NCT01176240|588314034|FG001|Study 306B|Protocol Violation|3|||
162894984|NCT01176240|588314033|FG000|Study 306B|Withdrawal by Subject|4|||
162894985|NCT01176240|588314034|FG001|Study 306B|Withdrawal by Subject|1|||
162894986|NCT01176240|588314033|FG000|Study 306B|Physician Decision|2|||
162894987|NCT01176240|588314034|FG001|Study 306B|Physician Decision|1|||
162894988|NCT01176240|588314033|FG000|Study 306B|Supine Hypertension|1|||
162894989|NCT01176240|588314034|FG001|Study 306B|Supine Hypertension|2|||
162894990|NCT01176240|588314033|FG000|Study 306B|Lost to Follow-up|0|||
162894991|NCT01176240|588314034|FG001|Study 306B|Lost to Follow-up|1|||
162894992|NCT01176240|588314033|FG000|Study 306B|withdrew prior to dosing|2|||
162894993|NCT01176240|588314034|FG001|Study 306B|withdrew prior to dosing|1|||
162894994|NCT05200455|588314035|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
162894995|NCT00807014|588314038|FG000|Overall Study|Participant Considered Disease Cured|13|||
162894996|NCT00807014|588314039|FG001|Overall Study|Participant Considered Disease Cured|2|||
162894997|NCT00807014|588314038|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
162894998|NCT00807014|588314039|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
162894999|NCT00807014|588314038|FG000|Overall Study|Protocol Violation|2|||
162895000|NCT00807014|588314039|FG001|Overall Study|Protocol Violation|8|||
162895001|NCT00807014|588314038|FG000|Overall Study|Adverse Event|0|||
162895002|NCT00807014|588314039|FG001|Overall Study|Adverse Event|2|||
162895003|NCT00807014|588314038|FG000|Overall Study|Lost to Follow-up|9|||
162895004|NCT00807014|588314039|FG001|Overall Study|Lost to Follow-up|7|||
162895005|NCT00807014|588314038|FG000|Overall Study|Recovery|1|||
162895006|NCT00807014|588314039|FG001|Overall Study|Recovery|0|||
162895007|NCT00807014|588314038|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
162895008|NCT00807014|588314039|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
162895009|NCT00651313|588314040|FG000|Overall Study|Adverse Event|0|||
162895010|NCT00651313|588314041|FG001|Overall Study|Adverse Event|1|||
162895011|NCT00651313|588314040|FG000|Overall Study|Withdrawal by Subject|3|||
162895012|NCT00651313|588314041|FG001|Overall Study|Withdrawal by Subject|1|||
162895013|NCT00651313|588314040|FG000|Overall Study|Lost to Follow-up|1|||
162895014|NCT00651313|588314041|FG001|Overall Study|Lost to Follow-up|1|||
162895015|NCT00651313|588314040|FG000|Overall Study|Adminstrative Discontinuation|2|||
162895016|NCT00651313|588314041|FG001|Overall Study|Adminstrative Discontinuation|3|||
162895017|NCT02146833|588314042|FG000|Overall Study|Death|10|||
162895018|NCT02146833|588314042|FG000|Overall Study|No longer consented to study treatment|1|||
162895019|NCT00948428|588315983|FG000|Overall Study|Withdrawal by Subject|6|||
162895020|NCT00948428|588315984|FG001|Overall Study|Withdrawal by Subject|12|||
162895021|NCT00948428|588315985|FG002|Overall Study|Withdrawal by Subject|7|||
162895022|NCT00948428|588315983|FG000|Overall Study|Adverse Event|6|||
162895023|NCT00948428|588315984|FG001|Overall Study|Adverse Event|3|||
162623538|NCT05248867|587337676|FG001|Double-blind Period|Lost to Follow-up|3|||
162623539|NCT05248867|587337677|FG002|Double-blind Period|Lost to Follow-up|0|||
162895024|NCT00948428|588315985|FG002|Overall Study|Adverse Event|0|||
162895025|NCT00948428|588315983|FG000|Overall Study|Lost to Follow-up|2|||
162895026|NCT00948428|588315984|FG001|Overall Study|Lost to Follow-up|1|||
162895027|NCT00948428|588315985|FG002|Overall Study|Lost to Follow-up|1|||
162895028|NCT00948428|588315983|FG000|Overall Study|Death|2|||
162895029|NCT00948428|588315984|FG001|Overall Study|Death|0|||
162895030|NCT00948428|588315985|FG002|Overall Study|Death|0|||
162895031|NCT00948428|588315983|FG000|Overall Study|Intercurrent Illness|1|||
162895032|NCT00948428|588315984|FG001|Overall Study|Intercurrent Illness|0|||
162895033|NCT00948428|588315985|FG002|Overall Study|Intercurrent Illness|0|||
162895034|NCT00948428|588315983|FG000|Overall Study|Non-compliance|1|||
162895035|NCT00948428|588315984|FG001|Overall Study|Non-compliance|2|||
162895036|NCT00948428|588315985|FG002|Overall Study|Non-compliance|0|||
162895037|NCT01495689|588315989|FG000|Overall Study|Death|0|||
162895038|NCT01495689|588315990|FG001|Overall Study|Death|1|||
162895039|NCT01495689|588315989|FG000|Overall Study|Withdrawal by Subject|3|||
162895040|NCT01495689|588315990|FG001|Overall Study|Withdrawal by Subject|0|||
162895041|NCT01495689|588315989|FG000|Overall Study|Lost to Follow-up|7|||
162895042|NCT01495689|588315990|FG001|Overall Study|Lost to Follow-up|6|||
162895043|NCT05516134|588315997|FG000|Overall Study|Lost to Follow-up|1|||
162895044|NCT05516134|588315998|FG001|Overall Study|Lost to Follow-up|0|||
162895045|NCT05516134|588315999|FG002|Overall Study|Lost to Follow-up|0|||
162895046|NCT01119963|588316006|FG000|Overall Study|Lost to Follow-up|1|||
162895047|NCT01119963|588316007|FG001|Overall Study|Lost to Follow-up|1|||
162895048|NCT01355497|588316012|FG000|Overall Study|Death|19|||
162895049|NCT01355497|588316013|FG001|Overall Study|Death|18|||
162895050|NCT01355497|588316012|FG000|Overall Study|Lost to Follow-up|3|||
162895051|NCT01355497|588316013|FG001|Overall Study|Lost to Follow-up|0|||
162895052|NCT01355497|588316012|FG000|Overall Study|Protocol Violation|0|||
162895053|NCT01355497|588316013|FG001|Overall Study|Protocol Violation|1|||
162895054|NCT01355497|588316012|FG000|Overall Study|other-not provided|9|||
162895055|NCT01355497|588316013|FG001|Overall Study|other-not provided|4|||
162895056|NCT01355497|588316012|FG000|Overall Study|Withdrawal by Subject|12|||
162895057|NCT01355497|588316013|FG001|Overall Study|Withdrawal by Subject|20|||
162895058|NCT01355497|588316012|FG000|Overall Study|noncompliance|1|||
162895059|NCT01355497|588316013|FG001|Overall Study|noncompliance|2|||
162895060|NCT01355497|588316012|FG000|Overall Study|progressive disease|11|||
162895061|NCT01355497|588316013|FG001|Overall Study|progressive disease|8|||
162895062|NCT01355497|588316012|FG000|Overall Study|Adverse Event|11|||
162895063|NCT01355497|588316013|FG001|Overall Study|Adverse Event|10|||
162895064|NCT00420342|588316016|FG000|Overall Study|Lost to Follow-up|1|||
162895065|NCT00420342|588316017|FG001|Overall Study|Lost to Follow-up|0|||
162895066|NCT00420342|588316018|FG002|Overall Study|Lost to Follow-up|1|||
162895067|NCT00420342|588316016|FG000|Overall Study|Withdrawal by Subject|0|||
162895068|NCT00420342|588316017|FG001|Overall Study|Withdrawal by Subject|2|||
162895069|NCT00420342|588316018|FG002|Overall Study|Withdrawal by Subject|0|||
162895070|NCT00839436|588316021|FG000|Overall Study|Developed exclusionary condition|1|||
162895071|NCT00839436|588316022|FG001|Overall Study|Developed exclusionary condition|0|||
162895072|NCT00839436|588316023|FG002|Overall Study|Developed exclusionary condition|0|||
162895073|NCT00839436|588316021|FG000|Overall Study|Withdrawal by Subject|0|||
162895074|NCT00839436|588316022|FG001|Overall Study|Withdrawal by Subject|1|||
162895075|NCT00839436|588316023|FG002|Overall Study|Withdrawal by Subject|0|||
162895076|NCT00839436|588316021|FG000|Overall Study|Study drug no longer available|0|||
162895077|NCT00839436|588316022|FG001|Overall Study|Study drug no longer available|0|||
162895078|NCT00839436|588316023|FG002|Overall Study|Study drug no longer available|1|||
162895079|NCT01440972|588316024|FG000|Overall Study|Withdrawal by Subject|3|||
162895080|NCT01440972|588316025|FG001|Overall Study|Withdrawal by Subject|2|||
162895081|NCT03933215|588316026|FG000|Overall Study|Other|6|||
162895082|NCT03933215|588316026|FG000|Overall Study|Sponsor decision|5|||
162895083|NCT03933215|588316026|FG000|Overall Study|Protocol Violation|5|||
162895084|NCT03933215|588316026|FG000|Overall Study|Withdrawal by Subject|6|||
162895085|NCT03933215|588316026|FG000|Overall Study|Lost to Follow-up|6|||
162895086|NCT03933215|588316026|FG000|Overall Study|Enrolled but not treated|38|||
162895087|NCT04072575|588316029|FG000|Overall Study|Physician Decision|1|||
162895088|NCT04072575|588316029|FG000|Overall Study|Adverse Event|7|||
162895089|NCT04072575|588316029|FG000|Overall Study|Withdrawal by Subject|14|||
162895090|NCT04072575|588316029|FG000|Overall Study|Other|2|||
162895091|NCT05784129|588316030|FG000|Overall Study|Study terminated by sponsor|2|||
162895092|NCT05784129|588316031|FG001|Overall Study|Study terminated by sponsor|2|||
162895093|NCT00407550|588316032|FG000|Overall Study|Adverse Event|0|||
162895094|NCT00407550|588316033|FG001|Overall Study|Adverse Event|1|||
162895095|NCT00407550|588316032|FG000|Overall Study|Withdrawal by Subject|0|||
162895096|NCT00407550|588316033|FG001|Overall Study|Withdrawal by Subject|2|||
162895097|NCT00407550|588316032|FG000|Overall Study|Death|1|||
162895098|NCT00407550|588316033|FG001|Overall Study|Death|0|||
162895099|NCT00407550|588316032|FG000|Overall Study|Insurance or Other medical condition|2|||
162895100|NCT00407550|588316033|FG001|Overall Study|Insurance or Other medical condition|1|||
162895101|NCT01444898|588316034|FG000|Overall Study|Withdrawal by Subject|1|||
162895102|NCT01599806|588316036|FG000|Overall Study|Lost to Follow-up|20|||
162895103|NCT01599806|588316037|FG001|Overall Study|Lost to Follow-up|20|||
162895104|NCT01599806|588316036|FG000|Overall Study|Withdrawal by Subject|12|||
162895105|NCT01599806|588316037|FG001|Overall Study|Withdrawal by Subject|12|||
162895106|NCT01599806|588316036|FG000|Overall Study|Other Eligibility criteria|11|||
162895107|NCT01599806|588316037|FG001|Overall Study|Other Eligibility criteria|9|||
162895108|NCT02873208|588316038|FG000|Overall Study|Withdrawal by Subject|36|||
162895109|NCT02873208|588316038|FG000|Overall Study|Lost to Follow-up|22|||
162895110|NCT02873208|588316038|FG000|Overall Study|Adverse Event|15|||
162895111|NCT02873208|588316038|FG000|Overall Study|Non-compliance with study drug|12|||
162895112|NCT02873208|588316038|FG000|Overall Study|Protocol Violation|8|||
162623540|NCT05248867|587337678|FG003|Double-blind Period|Lost to Follow-up|0|||
162623541|NCT05248867|587337679|FG004|Double-blind Period|Lost to Follow-up|0|||
162623542|NCT05248867|587337680|FG005|Double-blind Period|Lost to Follow-up|0|||
162623543|NCT05248867|587337675|FG000|Double-blind Period|Withdrawal by Subject|5|||
162623544|NCT05248867|587337676|FG001|Double-blind Period|Withdrawal by Subject|14|||
162623545|NCT05248867|587337677|FG002|Double-blind Period|Withdrawal by Subject|0|||
162623546|NCT05248867|587337678|FG003|Double-blind Period|Withdrawal by Subject|0|||
162623547|NCT05248867|587337679|FG004|Double-blind Period|Withdrawal by Subject|0|||
162623548|NCT05248867|587337680|FG005|Double-blind Period|Withdrawal by Subject|0|||
162623549|NCT05248867|587337675|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162623550|NCT05248867|587337676|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
162623551|NCT05248867|587337677|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162623552|NCT05248867|587337678|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162623553|NCT05248867|587337679|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162623554|NCT05248867|587337680|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162623555|NCT05248867|587337675|FG000|Double-blind Period|Other, not specified|3|||
162623556|NCT05248867|587337676|FG001|Double-blind Period|Other, not specified|8|||
162623557|NCT05248867|587337677|FG002|Double-blind Period|Other, not specified|0|||
162623558|NCT05248867|587337678|FG003|Double-blind Period|Other, not specified|0|||
162623559|NCT05248867|587337679|FG004|Double-blind Period|Other, not specified|0|||
162623560|NCT05248867|587337680|FG005|Double-blind Period|Other, not specified|0|||
162623561|NCT05248867|587337675|FG000|Open-label Period|Withdrawal by Subject|0|||
162623562|NCT05248867|587337676|FG001|Open-label Period|Withdrawal by Subject|0|||
162623563|NCT05248867|587337677|FG002|Open-label Period|Withdrawal by Subject|3|||
162623564|NCT05248867|587337678|FG003|Open-label Period|Withdrawal by Subject|1|||
162623565|NCT05248867|587337679|FG004|Open-label Period|Withdrawal by Subject|7|||
162623566|NCT05248867|587337680|FG005|Open-label Period|Withdrawal by Subject|9|||
162623567|NCT05248867|587337675|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162623568|NCT05248867|587337676|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162623569|NCT05248867|587337677|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162623570|NCT05248867|587337678|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
162623571|NCT05248867|587337679|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162623572|NCT05248867|587337680|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162623573|NCT05248867|587337675|FG000|Open-label Period|Lost to Follow-up|0|||
162623574|NCT05248867|587337676|FG001|Open-label Period|Lost to Follow-up|0|||
162623575|NCT05248867|587337677|FG002|Open-label Period|Lost to Follow-up|0|||
162623576|NCT05248867|587337678|FG003|Open-label Period|Lost to Follow-up|0|||
162623577|NCT05248867|587337679|FG004|Open-label Period|Lost to Follow-up|5|||
162623578|NCT05248867|587337680|FG005|Open-label Period|Lost to Follow-up|2|||
162623579|NCT05248867|587337675|FG000|Open-label Period|COVID-19 Infection|0|||
162623580|NCT05248867|587337676|FG001|Open-label Period|COVID-19 Infection|0|||
162623581|NCT05248867|587337677|FG002|Open-label Period|COVID-19 Infection|0|||
162623582|NCT05248867|587337678|FG003|Open-label Period|COVID-19 Infection|0|||
162623583|NCT05248867|587337679|FG004|Open-label Period|COVID-19 Infection|1|||
162623584|NCT05248867|587337680|FG005|Open-label Period|COVID-19 Infection|0|||
162623585|NCT05248867|587337675|FG000|Open-label Period|Other, not specified|0|||
162623586|NCT05248867|587337676|FG001|Open-label Period|Other, not specified|0|||
162623587|NCT05248867|587337677|FG002|Open-label Period|Other, not specified|0|||
162623588|NCT05248867|587337678|FG003|Open-label Period|Other, not specified|0|||
162623589|NCT05248867|587337679|FG004|Open-label Period|Other, not specified|4|||
162623590|NCT05248867|587337680|FG005|Open-label Period|Other, not specified|0|||
162895113|NCT02873208|588316038|FG000|Overall Study|Pregnancy|2|||
162964910|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
162964911|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
162623591|NCT03128411|587337682|FG000|Treatment Phase|Adverse Event|21|||
162623592|NCT03128411|587337682|FG000|Treatment Phase|Physician Decision|1|||
162623593|NCT03128411|587337682|FG000|Treatment Phase|Other|2|||
162623594|NCT03128411|587337682|FG000|Long Term Follow-up Phase|Death|2|||
162895114|NCT02873208|588316038|FG000|Overall Study|Incarceration|1|||
162895115|NCT02873208|588316038|FG000|Overall Study|Lack of Efficacy|1|||
162979002|NCT03545191|588623546|FG000|Overall Study|Withdrawal by Subject|13|||
162623595|NCT00345839|587337683|FG000|Overall Study|Withdrawal by Subject|91|||
162623596|NCT00345839|587337684|FG001|Overall Study|Withdrawal by Subject|98|||
162623597|NCT00345839|587337683|FG000|Overall Study|Lost to Follow-up|58|||
162623598|NCT00345839|587337684|FG001|Overall Study|Lost to Follow-up|61|||
162623599|NCT03298867|587337702|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
162623600|NCT03298867|587337703|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
162623601|NCT03298867|587337702|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
162623602|NCT03298867|587337703|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
162623603|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
162623604|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
162623605|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
162623606|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
162623607|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
162895116|NCT02873208|588316038|FG000|Overall Study|Physician Decision|1|||
162895117|NCT00415584|588316039|FG000|Overall Study|Withdrawal by Subject|1|||
162623608|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
162623609|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
162623610|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
162623611|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
162623612|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
162623613|NCT03298867|587337702|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
162623614|NCT03298867|587337703|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
162623615|NCT03298867|587337702|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
162623616|NCT03298867|587337703|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
162623617|NCT03749447|587339575|FG000|Overall Study|Adverse Event|11|||
162623618|NCT03749447|587339576|FG001|Overall Study|Adverse Event|3|||
162623619|NCT03749447|587339575|FG000|Overall Study|Death|1|||
162623620|NCT03749447|587339576|FG001|Overall Study|Death|1|||
162623621|NCT03749447|587339575|FG000|Overall Study|Lost to Follow-up|2|||
162623622|NCT03749447|587339576|FG001|Overall Study|Lost to Follow-up|2|||
162623623|NCT03749447|587339575|FG000|Overall Study|Reason Not Specified|0|||
162895118|NCT00563368|588316040|FG000|Overall Study|Lost to Follow-up|14|||
162895119|NCT00563368|588316041|FG001|Overall Study|Lost to Follow-up|14|||
162895120|NCT00563368|588316042|FG002|Overall Study|Lost to Follow-up|12|||
162895121|NCT00563368|588316043|FG003|Overall Study|Lost to Follow-up|6|||
162895122|NCT00563368|588316044|FG004|Overall Study|Lost to Follow-up|9|||
162895123|NCT00563368|588316045|FG005|Overall Study|Lost to Follow-up|8|||
162895124|NCT00563368|588316046|FG006|Overall Study|Lost to Follow-up|9|||
162895125|NCT00563368|588316040|FG000|Overall Study|Adverse Event|3|||
162895126|NCT00563368|588316041|FG001|Overall Study|Adverse Event|4|||
162895127|NCT00563368|588316042|FG002|Overall Study|Adverse Event|5|||
162895128|NCT00563368|588316043|FG003|Overall Study|Adverse Event|9|||
162895129|NCT00563368|588316044|FG004|Overall Study|Adverse Event|6|||
162895130|NCT00563368|588316045|FG005|Overall Study|Adverse Event|10|||
162895131|NCT00563368|588316046|FG006|Overall Study|Adverse Event|17|||
162895132|NCT00563368|588316040|FG000|Overall Study|Withdrawal by Subject|11|||
162895133|NCT00563368|588316041|FG001|Overall Study|Withdrawal by Subject|6|||
162895134|NCT00563368|588316042|FG002|Overall Study|Withdrawal by Subject|5|||
162895135|NCT00563368|588316043|FG003|Overall Study|Withdrawal by Subject|7|||
162623624|NCT03749447|587339576|FG001|Overall Study|Reason Not Specified|3|||
162623625|NCT03749447|587339575|FG000|Overall Study|Physician Decision|4|||
162895136|NCT00563368|588316044|FG004|Overall Study|Withdrawal by Subject|8|||
162895137|NCT00563368|588316045|FG005|Overall Study|Withdrawal by Subject|5|||
162895138|NCT00563368|588316046|FG006|Overall Study|Withdrawal by Subject|4|||
162895139|NCT00563368|588316040|FG000|Overall Study|protocol non-compliance|1|||
162895140|NCT00563368|588316041|FG001|Overall Study|protocol non-compliance|1|||
162895141|NCT00563368|588316042|FG002|Overall Study|protocol non-compliance|2|||
162895142|NCT00563368|588316043|FG003|Overall Study|protocol non-compliance|1|||
162964912|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
162964913|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
162964914|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
162964915|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
162623626|NCT03749447|587339576|FG001|Overall Study|Physician Decision|3|||
162623627|NCT03749447|587339575|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
162623628|NCT03749447|587339576|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
162895143|NCT00563368|588316044|FG004|Overall Study|protocol non-compliance|0|||
162895144|NCT00563368|588316045|FG005|Overall Study|protocol non-compliance|1|||
162895145|NCT00563368|588316046|FG006|Overall Study|protocol non-compliance|3|||
162895146|NCT00563368|588316040|FG000|Overall Study|Pregnancy|1|||
162895147|NCT00563368|588316041|FG001|Overall Study|Pregnancy|0|||
162895148|NCT00563368|588316042|FG002|Overall Study|Pregnancy|1|||
162895149|NCT00563368|588316043|FG003|Overall Study|Pregnancy|2|||
162895150|NCT00563368|588316044|FG004|Overall Study|Pregnancy|1|||
162895151|NCT00563368|588316045|FG005|Overall Study|Pregnancy|2|||
162895152|NCT00563368|588316046|FG006|Overall Study|Pregnancy|0|||
162895153|NCT00563368|588316040|FG000|Overall Study|requirement for restricted medication|0|||
162895154|NCT00563368|588316041|FG001|Overall Study|requirement for restricted medication|0|||
162895155|NCT00563368|588316042|FG002|Overall Study|requirement for restricted medication|2|||
162895156|NCT00563368|588316043|FG003|Overall Study|requirement for restricted medication|0|||
162895157|NCT00563368|588316044|FG004|Overall Study|requirement for restricted medication|0|||
162895158|NCT00563368|588316045|FG005|Overall Study|requirement for restricted medication|0|||
162895159|NCT00563368|588316046|FG006|Overall Study|requirement for restricted medication|0|||
162895160|NCT00563368|588316040|FG000|Overall Study|Other|5|||
162895161|NCT00563368|588316041|FG001|Overall Study|Other|5|||
162895162|NCT00563368|588316042|FG002|Overall Study|Other|3|||
162895163|NCT00563368|588316043|FG003|Overall Study|Other|4|||
162895164|NCT00563368|588316044|FG004|Overall Study|Other|4|||
162895165|NCT00563368|588316045|FG005|Overall Study|Other|4|||
162895166|NCT00563368|588316046|FG006|Overall Study|Other|0|||
162895167|NCT01061567|588316047|FG000|Overall Study|Adverse Event|32|||
162895168|NCT01061567|588316047|FG000|Overall Study|Death|2|||
162895169|NCT01061567|588316047|FG000|Overall Study|Lack of Efficacy|3|||
162895170|NCT01061567|588316047|FG000|Overall Study|Lost to Follow-up|24|||
162895171|NCT01061567|588316047|FG000|Overall Study|Protocol Violation|1|||
162895172|NCT01061567|588316047|FG000|Overall Study|Withdrawal by Subject|11|||
162895173|NCT01061567|588316047|FG000|Overall Study|Other reason than stated above|3|||
162895174|NCT00114218|588316059|FG000|Overall Study|Wrong Cell Type|2|||
162895175|NCT00114218|588316059|FG000|Overall Study|Wrong Primary|1|||
162895176|NCT00114218|588316059|FG000|Overall Study|Never Treated|1|||
162895177|NCT03168555|588316060|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
162895178|NCT03168555|588316060|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
162895179|NCT03168555|588316060|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
162964916|NCT00073307|588572007|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
162964917|NCT00073307|588572008|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
162964918|NCT00073307|588572009|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
162964919|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
162895180|NCT03168555|588316060|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
162895181|NCT02959190|588316062|FG000|Open Label|Adverse Event|5|||
162895182|NCT02959190|588316063|FG001|Open Label|Adverse Event|7|||
162895183|NCT02959190|588316064|FG002|Open Label|Adverse Event|3|||
162895184|NCT02959190|588316065|FG003|Open Label|Adverse Event|4|||
162895185|NCT02959190|588316062|FG000|Open Label|Pregnancy|0|||
162895186|NCT02959190|588316063|FG001|Open Label|Pregnancy|1|||
162895187|NCT02959190|588316064|FG002|Open Label|Pregnancy|0|||
162895188|NCT02959190|588316065|FG003|Open Label|Pregnancy|0|||
162895189|NCT02959190|588316062|FG000|Open Label|Withdrawal by Subject|2|||
162895190|NCT02959190|588316063|FG001|Open Label|Withdrawal by Subject|8|||
162895191|NCT02959190|588316064|FG002|Open Label|Withdrawal by Subject|0|||
162895192|NCT02959190|588316065|FG003|Open Label|Withdrawal by Subject|0|||
162895193|NCT02959190|588316062|FG000|Open Label|Physician Decision|0|||
162964920|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
162964921|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
162964922|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
162964923|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
162964924|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
162964925|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
162964926|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
162964927|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
162964928|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
162708752|NCT03682536|587642885|FG001|Treatment|Disease Progression|7|||
162708753|NCT03682536|587642884|FG000|Treatment|Adverse Event|9|||
162964929|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
162964930|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
162964931|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
162964932|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
162964933|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
162708754|NCT03682536|587642885|FG001|Treatment|Adverse Event|5|||
162708755|NCT03682536|587642884|FG000|Treatment|Death|14|||
162708756|NCT03682536|587642885|FG001|Treatment|Death|13|||
162895194|NCT02959190|588316063|FG001|Open Label|Physician Decision|0|||
162895195|NCT02959190|588316064|FG002|Open Label|Physician Decision|1|||
162895196|NCT02959190|588316065|FG003|Open Label|Physician Decision|0|||
162895197|NCT02959190|588316062|FG000|Open Label|Protocol Violation|0|||
162895198|NCT02959190|588316063|FG001|Open Label|Protocol Violation|0|||
162895199|NCT02959190|588316064|FG002|Open Label|Protocol Violation|0|||
162895200|NCT02959190|588316065|FG003|Open Label|Protocol Violation|2|||
162895201|NCT02959190|588316062|FG000|Post Treatment Follow Up|Adverse Event|1|||
162895202|NCT02959190|588316063|FG001|Post Treatment Follow Up|Adverse Event|1|||
162895203|NCT02959190|588316064|FG002|Post Treatment Follow Up|Adverse Event|0|||
162895204|NCT02959190|588316065|FG003|Post Treatment Follow Up|Adverse Event|0|||
162895205|NCT02959190|588316062|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
162895206|NCT02959190|588316063|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
162895207|NCT02959190|588316064|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
162895208|NCT02959190|588316065|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
162895209|NCT01235507|588316067|FG000|Overall Study|Adverse Event|1|||
162895210|NCT01235507|588316067|FG000|Overall Study|Withdrawal by Subject|1|||
162895211|NCT02738580|588316070|FG000|Overall Study|Adverse Event|1|||
162895212|NCT02738580|588316071|FG001|Overall Study|Adverse Event|0|||
162895213|NCT02738580|588316070|FG000|Overall Study|Lack of Efficacy|3|||
162895214|NCT02738580|588316071|FG001|Overall Study|Lack of Efficacy|2|||
162895215|NCT02738580|588316070|FG000|Overall Study|Withdrawal by Subject|0|||
162895216|NCT02738580|588316071|FG001|Overall Study|Withdrawal by Subject|1|||
162895217|NCT02738580|588316070|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
162895218|NCT02738580|588316071|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
162895219|NCT00617591|588316075|FG000|Overall Study|Withdrew consent during Induction|4|||
162895220|NCT00617591|588316075|FG000|Overall Study|Withdrew consent during Maintenance|6|||
162895221|NCT00588523|588316078|FG000|Overall Study|Not treated|3|||
162895222|NCT03034057|588316080|FG000|Overall Study|Withdrawal by Subject|10|||
162895223|NCT03034057|588316080|FG000|Overall Study|Protocol Violation|1|||
162895224|NCT03034057|588316080|FG000|Overall Study|Not defined|2|||
162895225|NCT03034057|588316080|FG000|Overall Study|Lost to Follow-up|19|||
162895226|NCT03034057|588316080|FG000|Overall Study|Adverse Event|22|||
162895227|NCT03034057|588316080|FG000|Overall Study|Medication error without associated AE|1|||
162895228|NCT03339401|588316082|FG000|Overall Study|Death|2|||
162895229|NCT03339401|588316083|FG001|Overall Study|Death|1|||
162895230|NCT03339401|588316082|FG000|Overall Study|Withdrawal by Subject|2|||
162895231|NCT03339401|588316083|FG001|Overall Study|Withdrawal by Subject|0|||
162895232|NCT03339401|588316082|FG000|Overall Study|Study terminated|4|||
162895233|NCT03339401|588316083|FG001|Overall Study|Study terminated|3|||
162895234|NCT03339401|588316082|FG000|Overall Study|Investigator Decision|1|||
162895235|NCT03339401|588316083|FG001|Overall Study|Investigator Decision|0|||
162895236|NCT00718523|588316084|FG000|Overall Study|Withdrawal by Subject|5|||
163051877|NCT01663402|588898739|FG000|Overall Study|Site terminated by sponsor|1|||
163051878|NCT01663402|588898740|FG001|Overall Study|Site terminated by sponsor|3|||
163051879|NCT01663402|588898739|FG000|Overall Study|Participant moved|139|||
163051880|NCT01663402|588898740|FG001|Overall Study|Participant moved|104|||
163051881|NCT01663402|588898739|FG000|Overall Study|Withdrawal by Subject|118|||
163051882|NCT01663402|588898740|FG001|Overall Study|Withdrawal by Subject|91|||
163051883|NCT01663402|588898739|FG000|Overall Study|Related to study drug administration|96|||
163051884|NCT01663402|588898740|FG001|Overall Study|Related to study drug administration|105|||
163051885|NCT01663402|588898739|FG000|Overall Study|Lost to Follow-up|17|||
163051886|NCT01663402|588898740|FG001|Overall Study|Lost to Follow-up|15|||
163051887|NCT01663402|588898739|FG000|Overall Study|Other than specified above|172|||
163051888|NCT01663402|588898740|FG001|Overall Study|Other than specified above|147|||
163051889|NCT05953363|588898743|FG000|Overall Study|Screen Failure|2|||
163051890|NCT05953363|588898743|FG000|Overall Study|Withdrawal by Subject|3|||
163051891|NCT05953363|588898743|FG000|Overall Study|Surgery cancelled|2|||
163051892|NCT05953363|588898743|FG000|Overall Study|Adverse Event|1|||
163051893|NCT01701674|588898744|FG000|Overall Study|Unable to safely complete treatment|1|||
163051894|NCT04464707|588898749|FG000|Overall Study|Adverse Event|1|||
163051895|NCT04464707|588898750|FG001|Overall Study|Adverse Event|0|||
162895237|NCT00718523|588316085|FG001|Overall Study|Withdrawal by Subject|7|||
162895238|NCT00718523|588316084|FG000|Overall Study|Death|13|||
162895239|NCT00718523|588316085|FG001|Overall Study|Death|17|||
162895240|NCT02679781|588316086|FG000|Overall Study|Lost to Follow-up|1|||
163051896|NCT04464707|588898751|FG002|Overall Study|Adverse Event|0|||
162708757|NCT02338609|587642886|FG000|Overall Study|Physician Decision|1|||
162895241|NCT02679781|588316087|FG001|Overall Study|Lost to Follow-up|2|||
162895242|NCT02679781|588316086|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
162895243|NCT02679781|588316087|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
162895244|NCT04209400|588316090|FG000|Overall Study|Withdrawal by Subject|0|||
162895245|NCT04209400|588316091|FG001|Overall Study|Withdrawal by Subject|1|||
162895246|NCT01496274|588316092|FG000|Overall Study|Protocol Violation|0|||
163051897|NCT04464707|588898749|FG000|Overall Study|Withdrawal by Subject|0|||
163051898|NCT04464707|588898750|FG001|Overall Study|Withdrawal by Subject|0|||
162895247|NCT01496274|588316093|FG001|Overall Study|Protocol Violation|1|||
162895248|NCT01496274|588316092|FG000|Overall Study|Adverse Event|1|||
162895249|NCT01496274|588316093|FG001|Overall Study|Adverse Event|1|||
162895250|NCT01496274|588316092|FG000|Overall Study|Withdrawal by Subject|2|||
162895251|NCT01496274|588316093|FG001|Overall Study|Withdrawal by Subject|0|||
162895252|NCT01496274|588316092|FG000|Overall Study|Lost to Follow-up|0|||
162895253|NCT01496274|588316093|FG001|Overall Study|Lost to Follow-up|3|||
162895254|NCT05041062|588316095|FG000|Overall Study|Adverse Event|2|||
162895255|NCT04968353|588316099|FG000|Overall Study|Non-compliance|1|||
162895256|NCT04968353|588316100|FG001|Overall Study|Non-compliance|0|||
162895257|NCT04968353|588316101|FG002|Overall Study|Non-compliance|2|||
162895258|NCT04968353|588316102|FG003|Overall Study|Non-compliance|0|||
162895259|NCT00318370|588316103|FG000|Period 1|Lack of Efficacy|5|||
162895260|NCT00318370|588316104|FG001|Period 1|Lack of Efficacy|0|||
162895261|NCT00318370|588316105|FG002|Period 1|Lack of Efficacy|0|||
162895262|NCT00318370|588316103|FG000|Period 1|Physician Decision|1|||
162895263|NCT00318370|588316104|FG001|Period 1|Physician Decision|0|||
162895264|NCT00318370|588316105|FG002|Period 1|Physician Decision|0|||
162895265|NCT00318370|588316103|FG000|Period 1|Withdrawal by Subject|1|||
162895266|NCT00318370|588316104|FG001|Period 1|Withdrawal by Subject|0|||
162895267|NCT00318370|588316105|FG002|Period 1|Withdrawal by Subject|0|||
162895268|NCT00318370|588316103|FG000|Period 2|Adverse Event|0|||
162895269|NCT00318370|588316104|FG001|Period 2|Adverse Event|3|||
162895270|NCT00318370|588316105|FG002|Period 2|Adverse Event|0|||
162895271|NCT00318370|588316103|FG000|Period 2|Lack of Efficacy|0|||
162895272|NCT00318370|588316104|FG001|Period 2|Lack of Efficacy|5|||
162895273|NCT00318370|588316105|FG002|Period 2|Lack of Efficacy|0|||
162895274|NCT00318370|588316103|FG000|Period 2|Physician Decision|0|||
162964934|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
162964935|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
162964936|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
162895275|NCT00318370|588316104|FG001|Period 2|Physician Decision|1|||
162895276|NCT00318370|588316105|FG002|Period 2|Physician Decision|0|||
162895277|NCT00318370|588316103|FG000|Period 2|Withdrawal by Subject|0|||
162895278|NCT00318370|588316104|FG001|Period 2|Withdrawal by Subject|1|||
162895279|NCT00318370|588316105|FG002|Period 2|Withdrawal by Subject|0|||
162895280|NCT00318370|588316103|FG000|Period 2|Other|0|||
162895281|NCT00318370|588316104|FG001|Period 2|Other|1|||
162895282|NCT00318370|588316105|FG002|Period 2|Other|0|||
162895283|NCT00318370|588316103|FG000|Period 3|Adverse Event|0|||
162895284|NCT00318370|588316104|FG001|Period 3|Adverse Event|0|||
162895285|NCT00318370|588316105|FG002|Period 3|Adverse Event|1|||
162895286|NCT00318370|588316103|FG000|Period 3|Lack of Efficacy|0|||
162895287|NCT00318370|588316104|FG001|Period 3|Lack of Efficacy|0|||
162895288|NCT00318370|588316105|FG002|Period 3|Lack of Efficacy|24|||
162895289|NCT00318370|588316103|FG000|Period 3|Death|0|||
162623629|NCT03749447|587339575|FG000|Overall Study|Study Terminated By Sponsor|112|||
162623630|NCT03749447|587339576|FG001|Overall Study|Study Terminated By Sponsor|105|||
162623631|NCT03749447|587339575|FG000|Overall Study|Withdrawal by Subject|12|||
162623632|NCT03749447|587339576|FG001|Overall Study|Withdrawal by Subject|6|||
162623633|NCT03749447|587339575|FG000|Overall Study|Non-compliance With Study Drug|0|||
162623634|NCT03749447|587339576|FG001|Overall Study|Non-compliance With Study Drug|1|||
162623635|NCT01673867|587339578|FG000|Randomization|Adverse event unrelated to study drug|1|||
162623636|NCT01673867|587339579|FG001|Randomization|Adverse event unrelated to study drug|0|||
162623637|NCT01673867|587339578|FG000|Randomization|Participant request to discontinue study treatment|0|||
162623638|NCT01673867|587339579|FG001|Randomization|Participant request to discontinue study treatment|4|||
162623639|NCT01673867|587339578|FG000|Randomization|Withdrawal by participant|0|||
162623640|NCT01673867|587339579|FG001|Randomization|Withdrawal by participant|12|||
162623641|NCT01673867|587339578|FG000|Randomization|Lost to Follow-up|0|||
162623642|NCT01673867|587339579|FG001|Randomization|Lost to Follow-up|1|||
162623643|NCT01673867|587339578|FG000|Randomization|Participant no longer meets study criteria|4|||
162623644|NCT01673867|587339579|FG001|Randomization|Participant no longer meets study criteria|5|||
162623645|NCT01673867|587339578|FG000|Treatment|Disease Progression|208|||
162623646|NCT01673867|587339579|FG001|Treatment|Disease Progression|178|||
162623647|NCT01673867|587339578|FG000|Treatment|Study Drug Toxicity|23|||
162623648|NCT01673867|587339579|FG001|Treatment|Study Drug Toxicity|43|||
162623649|NCT01673867|587339578|FG000|Treatment|Death|2|||
162623650|NCT01673867|587339579|FG001|Treatment|Death|3|||
162623651|NCT01673867|587339578|FG000|Treatment|Adverse event unrelated to study drug|23|||
162623652|NCT01673867|587339579|FG001|Treatment|Adverse event unrelated to study drug|10|||
162623653|NCT01673867|587339578|FG000|Treatment|Participant request to discontinue study treatment|7|||
162623654|NCT01673867|587339579|FG001|Treatment|Participant request to discontinue study treatment|17|||
162895290|NCT00318370|588316104|FG001|Period 3|Death|0|||
162895291|NCT00318370|588316105|FG002|Period 3|Death|1|||
162895292|NCT00318370|588316103|FG000|Period 3|Physician Decision|0|||
162895293|NCT00318370|588316104|FG001|Period 3|Physician Decision|0|||
162895294|NCT00318370|588316105|FG002|Period 3|Physician Decision|1|||
162895295|NCT00318370|588316103|FG000|Period 3|Withdrawal by Subject|0|||
162895296|NCT00318370|588316104|FG001|Period 3|Withdrawal by Subject|0|||
162895297|NCT00318370|588316105|FG002|Period 3|Withdrawal by Subject|3|||
162895298|NCT00318370|588316103|FG000|Period 3|Other|0|||
162895299|NCT00318370|588316104|FG001|Period 3|Other|0|||
162895300|NCT00318370|588316105|FG002|Period 3|Other|3|||
162895301|NCT00892957|588316111|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
162895302|NCT00892957|588316112|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
162895303|NCT00892957|588316111|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
162895304|NCT00892957|588316112|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
162895305|NCT03307629|588316118|FG000|Overall Study|Withdrawal by Subject|0|||
162895306|NCT03307629|588316119|FG001|Overall Study|Withdrawal by Subject|0|||
162895307|NCT03307629|588316120|FG002|Overall Study|Withdrawal by Subject|0|||
162895308|NCT03307629|588316121|FG003|Overall Study|Withdrawal by Subject|2|||
162895309|NCT03307629|588316118|FG000|Overall Study|Disease Progression|0|||
162895310|NCT03307629|588316119|FG001|Overall Study|Disease Progression|0|||
162895311|NCT03307629|588316120|FG002|Overall Study|Disease Progression|0|||
162895312|NCT03307629|588316121|FG003|Overall Study|Disease Progression|3|||
162895313|NCT03307629|588316118|FG000|Overall Study|Death|0|||
162895314|NCT03307629|588316119|FG001|Overall Study|Death|3|||
162895315|NCT03307629|588316120|FG002|Overall Study|Death|0|||
162895316|NCT03307629|588316121|FG003|Overall Study|Death|1|||
162895317|NCT02853032|588316126|FG000|Overall Study|Adverse Event|4|||
162895318|NCT02853032|588316127|FG001|Overall Study|Adverse Event|0|||
162964937|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
162964938|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
162964939|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
162964940|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
162964941|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
162964942|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
162964943|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
162964944|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
162895319|NCT02853032|588316126|FG000|Overall Study|Withdrawal by Subject|3|||
162623655|NCT01673867|587339578|FG000|Treatment|Withdrawal by participant|5|||
162623656|NCT01673867|587339579|FG001|Treatment|Withdrawal by participant|5|||
162623657|NCT01673867|587339578|FG000|Treatment|Maximum clinical benefit|1|||
162623658|NCT01673867|587339579|FG001|Treatment|Maximum clinical benefit|10|||
162623659|NCT01673867|587339578|FG000|Treatment|Participant no longer meets study criteria|2|||
162623660|NCT01673867|587339579|FG001|Treatment|Participant no longer meets study criteria|0|||
162623661|NCT01673867|587339578|FG000|Treatment|Administrative reason by sponsor|3|||
162895320|NCT02853032|588316127|FG001|Overall Study|Withdrawal by Subject|1|||
162895321|NCT02853032|588316126|FG000|Overall Study|Requested to withdraw from all treatment|2|||
162895322|NCT02853032|588316127|FG001|Overall Study|Requested to withdraw from all treatment|2|||
162623662|NCT01673867|587339579|FG001|Treatment|Administrative reason by sponsor|0|||
162623663|NCT01673867|587339578|FG000|Treatment|Other reason|11|||
162623664|NCT01673867|587339579|FG001|Treatment|Other reason|2|||
162623665|NCT02550106|587339580|FG000|Overall Study|Adverse Event|1|||
162623666|NCT02550106|587339580|FG000|Overall Study|Lack of Efficacy|3|||
162623667|NCT02550106|587339580|FG000|Overall Study|Protocol Violation|6|||
162623668|NCT02550106|587339580|FG000|Overall Study|Withdrawal by Subject|2|||
162623669|NCT01709513|587339581|FG000|Overall Study|Randomized but not treated|0|||
162623670|NCT01709513|587339582|FG001|Overall Study|Randomized but not treated|1|||
162623671|NCT01709513|587339583|FG002|Overall Study|Randomized but not treated|0|||
162623672|NCT01709513|587339581|FG000|Overall Study|Adverse Event|16|||
162708758|NCT02338609|587642886|FG000|Overall Study|Death|1|||
162708759|NCT02084082|587642887|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
162623673|NCT01709513|587339582|FG001|Overall Study|Adverse Event|31|||
162708760|NCT02084082|587642888|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
162623674|NCT01709513|587339583|FG002|Overall Study|Adverse Event|23|||
162895323|NCT00676208|588316132|FG000|Overall Study|Lost to Follow-up|0|||
162895324|NCT00676208|588316133|FG001|Overall Study|Lost to Follow-up|2|||
162895325|NCT00676208|588316132|FG000|Overall Study|Incomplete data|2|||
162895326|NCT00676208|588316133|FG001|Overall Study|Incomplete data|4|||
162895327|NCT00669032|588316134|FG000|Overall Study|Lost to Follow-up|6|||
162895328|NCT00669032|588316135|FG001|Overall Study|Lost to Follow-up|5|||
162895329|NCT00669032|588316134|FG000|Overall Study|Lack of Efficacy|8|||
162895330|NCT00669032|588316135|FG001|Overall Study|Lack of Efficacy|19|||
162895331|NCT00669032|588316134|FG000|Overall Study|Withdrawal by Subject|12|||
162895332|NCT00669032|588316135|FG001|Overall Study|Withdrawal by Subject|13|||
162895333|NCT00669032|588316134|FG000|Overall Study|Adverse Event|12|||
162895334|NCT00669032|588316135|FG001|Overall Study|Adverse Event|16|||
162895335|NCT00669032|588316134|FG000|Overall Study|Physician Decision|1|||
162895336|NCT00669032|588316135|FG001|Overall Study|Physician Decision|1|||
162623675|NCT01709513|587339581|FG000|Overall Study|Poor compliance to protocol|2|||
162623676|NCT01709513|587339582|FG001|Overall Study|Poor compliance to protocol|0|||
162623677|NCT01709513|587339583|FG002|Overall Study|Poor compliance to protocol|0|||
162623678|NCT01709513|587339581|FG000|Overall Study|Other|3|||
162623679|NCT01709513|587339582|FG001|Overall Study|Other|11|||
162623680|NCT01709513|587339583|FG002|Overall Study|Other|7|||
162623681|NCT04218695|587339584|FG000|Overall Study|Adverse Event|1|||
162623682|NCT04218695|587339585|FG001|Overall Study|Adverse Event|0|||
162623683|NCT03166735|587339586|FG000|Overall Study|Not Treated|1|||
162623684|NCT03166735|587339587|FG001|Overall Study|Not Treated|0|||
162623685|NCT03166735|587339588|FG002|Overall Study|Not Treated|0|||
162623686|NCT03166735|587339589|FG003|Overall Study|Not Treated|0|||
162623687|NCT03166735|587339590|FG004|Overall Study|Not Treated|0|||
162623688|NCT03166735|587339586|FG000|Overall Study|follow-up not completed as planned|0|||
162623689|NCT03166735|587339587|FG001|Overall Study|follow-up not completed as planned|1|||
162623690|NCT03166735|587339588|FG002|Overall Study|follow-up not completed as planned|1|||
162623691|NCT03166735|587339589|FG003|Overall Study|follow-up not completed as planned|0|||
162623692|NCT03166735|587339590|FG004|Overall Study|follow-up not completed as planned|1|||
162623693|NCT03166735|587339586|FG000|Overall Study|Withdrawal by Subject|0|||
162623694|NCT03166735|587339587|FG001|Overall Study|Withdrawal by Subject|0|||
162623695|NCT03166735|587339588|FG002|Overall Study|Withdrawal by Subject|1|||
162623696|NCT03166735|587339589|FG003|Overall Study|Withdrawal by Subject|1|||
162623697|NCT03166735|587339590|FG004|Overall Study|Withdrawal by Subject|2|||
162623698|NCT03166735|587339586|FG000|Overall Study|Lost to Follow-up|0|||
162623699|NCT03166735|587339587|FG001|Overall Study|Lost to Follow-up|2|||
162623700|NCT03166735|587339588|FG002|Overall Study|Lost to Follow-up|1|||
162623701|NCT03166735|587339589|FG003|Overall Study|Lost to Follow-up|0|||
162623702|NCT03166735|587339590|FG004|Overall Study|Lost to Follow-up|1|||
162623703|NCT01543958|587339591|FG000|Overall Study|Loss to follow-up|3|||
162623704|NCT01543958|587339591|FG000|Overall Study|ART initiation|1|||
162623705|NCT00926328|587339592|FG000|Overall Study|Lost to Follow-up|12|||
162623706|NCT00926328|587339593|FG001|Overall Study|Lost to Follow-up|14|||
162623707|NCT00726986|587339594|FG000|Induction Phase|Adverse Event|4|||
162623708|NCT00726986|587339594|FG000|Induction Phase|Withdrawal by Subject|2|||
162623709|NCT00726986|587339594|FG000|Induction Phase|Death|2|||
162623710|NCT00726986|587339594|FG000|Induction Phase|Lack of Efficacy|5|||
162623711|NCT00726986|587339594|FG000|Induction Phase|Secondary Disease|2|||
162623712|NCT00726986|587339594|FG000|Maintenance Phase|Adverse Event|1|||
162623713|NCT00726986|587339594|FG000|Maintenance Phase|Lack of Efficacy|2|||
162623714|NCT01819831|587339597|FG000|Overall Study|Withdrawal by Subject|1|||
162623715|NCT01513343|587339598|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
162623716|NCT01513343|587339599|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
162623717|NCT01513343|587339598|FG000|Post Data Collection|Dropped/withdrew from study|7|||
162623718|NCT01513343|587339599|FG001|Post Data Collection|Dropped/withdrew from study|1|||
162623719|NCT01513343|587339598|FG000|Post Data Collection|Lost to Follow-up|10|||
162623720|NCT01513343|587339599|FG001|Post Data Collection|Lost to Follow-up|23|||
162623721|NCT01513343|587339598|FG000|6-month Follow-up|Lost to Follow-up|28|||
162623722|NCT01513343|587339599|FG001|6-month Follow-up|Lost to Follow-up|17|||
162623723|NCT01513343|587339598|FG000|12-month Follow-up|Lost to Follow-up|10|||
162623724|NCT01513343|587339599|FG001|12-month Follow-up|Lost to Follow-up|3|||
162623725|NCT00599924|587339600|FG000|Overall Study|Lack of Efficacy|3|||
162623726|NCT00599924|587339601|FG001|Overall Study|Lack of Efficacy|5|||
162623727|NCT00599924|587339602|FG002|Overall Study|Lack of Efficacy|1|||
162623728|NCT00599924|587339603|FG003|Overall Study|Lack of Efficacy|2|||
162623729|NCT00599924|587339604|FG004|Overall Study|Lack of Efficacy|3|||
162623730|NCT00599924|587339605|FG005|Overall Study|Lack of Efficacy|2|||
162623731|NCT00599924|587339606|FG006|Overall Study|Lack of Efficacy|0|||
162623732|NCT00599924|587339600|FG000|Overall Study|Adverse Event|0|||
163051899|NCT04464707|588898751|FG002|Overall Study|Withdrawal by Subject|2|||
163051900|NCT04464707|588898749|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163051901|NCT04464707|588898750|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163051902|NCT04464707|588898751|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163051903|NCT04464707|588898749|FG000|Overall Study|Protocol Deviation|1|||
162623733|NCT00599924|587339601|FG001|Overall Study|Adverse Event|0|||
162623734|NCT00599924|587339602|FG002|Overall Study|Adverse Event|0|||
162623735|NCT00599924|587339603|FG003|Overall Study|Adverse Event|2|||
162623736|NCT00599924|587339604|FG004|Overall Study|Adverse Event|0|||
162623737|NCT00599924|587339605|FG005|Overall Study|Adverse Event|0|||
163051904|NCT04464707|588898750|FG001|Overall Study|Protocol Deviation|0|||
162623738|NCT00599924|587339606|FG006|Overall Study|Adverse Event|2|||
162623739|NCT00599924|587339600|FG000|Overall Study|Death|0|||
162623740|NCT00599924|587339601|FG001|Overall Study|Death|0|||
162623741|NCT00599924|587339602|FG002|Overall Study|Death|0|||
162623742|NCT00599924|587339603|FG003|Overall Study|Death|2|||
162623743|NCT00599924|587339604|FG004|Overall Study|Death|0|||
162623744|NCT00599924|587339605|FG005|Overall Study|Death|2|||
162623745|NCT00599924|587339606|FG006|Overall Study|Death|1|||
162623746|NCT00599924|587339600|FG000|Overall Study|Protocol Violation|0|||
162623747|NCT00599924|587339601|FG001|Overall Study|Protocol Violation|0|||
162623748|NCT00599924|587339602|FG002|Overall Study|Protocol Violation|0|||
162623749|NCT00599924|587339603|FG003|Overall Study|Protocol Violation|1|||
162895337|NCT00669032|588316134|FG000|Overall Study|No fulfilment of the selection criteria|5|||
162895338|NCT00669032|588316135|FG001|Overall Study|No fulfilment of the selection criteria|5|||
162895339|NCT03700736|588316138|FG000|Overall Study|Pregnancy|1|||
162895340|NCT03700736|588316139|FG001|Overall Study|Pregnancy|1|||
162895341|NCT03700736|588316138|FG000|Overall Study|Withdrawal by Subject|2|||
162895342|NCT03700736|588316139|FG001|Overall Study|Withdrawal by Subject|6|||
162895343|NCT00642018|588316140|FG000|Overall Study|Adverse Event|11|||
162895344|NCT00642018|588316141|FG001|Overall Study|Adverse Event|36|||
162895345|NCT00642018|588316140|FG000|Overall Study|Withdrawal by Subject|4|||
162895346|NCT00642018|588316141|FG001|Overall Study|Withdrawal by Subject|10|||
162895347|NCT00642018|588316140|FG000|Overall Study|Progressive Disease|13|||
162895348|NCT00642018|588316141|FG001|Overall Study|Progressive Disease|18|||
162895349|NCT00642018|588316140|FG000|Overall Study|Physician Decision|0|||
162895350|NCT00642018|588316141|FG001|Overall Study|Physician Decision|10|||
162895351|NCT00642018|588316140|FG000|Overall Study|Protocol Violation|0|||
162895352|NCT00642018|588316141|FG001|Overall Study|Protocol Violation|1|||
162895353|NCT00642018|588316140|FG000|Overall Study|Death|0|||
162895354|NCT00642018|588316141|FG001|Overall Study|Death|3|||
162895355|NCT00642018|588316140|FG000|Overall Study|Entry Criteria Not Met|0|||
162895356|NCT00642018|588316141|FG001|Overall Study|Entry Criteria Not Met|1|||
162895357|NCT01410799|588316142|FG000|Overall Study|PI decision|13|||
162895358|NCT04126031|588316144|FG000|Part A|Withdrawal by Subject|0|||
162895359|NCT04126031|588316145|FG001|Part A|Withdrawal by Subject|0|||
162895360|NCT04126031|588316146|FG002|Part A|Withdrawal by Subject|1|||
162895361|NCT04126031|588316147|FG003|Part A|Withdrawal by Subject|0|||
162895362|NCT04126031|588316148|FG004|Part A|Withdrawal by Subject|0|||
162895363|NCT04126031|588316149|FG005|Part A|Withdrawal by Subject|0|||
162895364|NCT04126031|588316144|FG000|Part A|Other|1|||
162895365|NCT04126031|588316145|FG001|Part A|Other|0|||
162895366|NCT04126031|588316146|FG002|Part A|Other|0|||
162895367|NCT04126031|588316147|FG003|Part A|Other|0|||
162895368|NCT04126031|588316148|FG004|Part A|Other|0|||
162895369|NCT04126031|588316149|FG005|Part A|Other|0|||
162895370|NCT04126031|588316144|FG000|Part B|Adverse Event|0|||
162964945|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
162623750|NCT00599924|587339604|FG004|Overall Study|Protocol Violation|0|||
162895371|NCT04126031|588316145|FG001|Part B|Adverse Event|0|||
162895372|NCT04126031|588316146|FG002|Part B|Adverse Event|0|||
162895373|NCT04126031|588316147|FG003|Part B|Adverse Event|0|||
162895374|NCT04126031|588316148|FG004|Part B|Adverse Event|0|||
162895375|NCT04126031|588316149|FG005|Part B|Adverse Event|2|||
162895376|NCT04126031|588316144|FG000|Part B|Pre-existing hypertransaminasemia|0|||
162623751|NCT00599924|587339605|FG005|Overall Study|Protocol Violation|0|||
162623752|NCT00599924|587339606|FG006|Overall Study|Protocol Violation|0|||
162623753|NCT00599924|587339600|FG000|Overall Study|Withdrawal by Subject|0|||
162623754|NCT00599924|587339601|FG001|Overall Study|Withdrawal by Subject|0|||
162623755|NCT00599924|587339602|FG002|Overall Study|Withdrawal by Subject|1|||
162623756|NCT00599924|587339603|FG003|Overall Study|Withdrawal by Subject|0|||
162623757|NCT00599924|587339604|FG004|Overall Study|Withdrawal by Subject|1|||
162623758|NCT00599924|587339605|FG005|Overall Study|Withdrawal by Subject|0|||
162623759|NCT00599924|587339606|FG006|Overall Study|Withdrawal by Subject|0|||
162623760|NCT00599924|587339600|FG000|Overall Study|Other|0|||
162623761|NCT00599924|587339601|FG001|Overall Study|Other|0|||
162623762|NCT00599924|587339602|FG002|Overall Study|Other|0|||
162623763|NCT00599924|587339603|FG003|Overall Study|Other|1|||
162623764|NCT00599924|587339604|FG004|Overall Study|Other|2|||
162623765|NCT00599924|587339605|FG005|Overall Study|Other|0|||
162623766|NCT00599924|587339606|FG006|Overall Study|Other|2|||
162623767|NCT02587234|587339607|FG000|Overall Study|Withdrawal by Subject|1|||
162623768|NCT02587234|587339608|FG001|Overall Study|Withdrawal by Subject|1|||
162623769|NCT02587234|587339607|FG000|Overall Study|Lost to Follow-up|0|||
162623770|NCT02587234|587339608|FG001|Overall Study|Lost to Follow-up|2|||
162623771|NCT02165215|587339609|FG000|Induction Phase|Adverse Event|1|||
162623772|NCT02165215|587339610|FG001|Induction Phase|Adverse Event|0|||
162623773|NCT02165215|587339611|FG002|Induction Phase|Adverse Event|0|||
162623774|NCT02165215|587339609|FG000|Induction Phase|Withdrawal by Subject|10|||
162708761|NCT02084082|587642889|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
162895377|NCT04126031|588316145|FG001|Part B|Pre-existing hypertransaminasemia|0|||
162623775|NCT02165215|587339610|FG001|Induction Phase|Withdrawal by Subject|0|||
162623776|NCT02165215|587339611|FG002|Induction Phase|Withdrawal by Subject|0|||
162623777|NCT02165215|587339609|FG000|Induction Phase|Protocol Violation|1|||
162895378|NCT04126031|588316146|FG002|Part B|Pre-existing hypertransaminasemia|0|||
162895379|NCT04126031|588316147|FG003|Part B|Pre-existing hypertransaminasemia|0|||
162623778|NCT02165215|587339610|FG001|Induction Phase|Protocol Violation|0|||
162623779|NCT02165215|587339611|FG002|Induction Phase|Protocol Violation|0|||
162623780|NCT02165215|587339609|FG000|Induction Phase|Physician Decision|1|||
162623781|NCT02165215|587339610|FG001|Induction Phase|Physician Decision|0|||
162623782|NCT02165215|587339611|FG002|Induction Phase|Physician Decision|0|||
162623783|NCT02165215|587339609|FG000|Induction Phase|Lack of Efficacy|2|||
162623784|NCT02165215|587339610|FG001|Induction Phase|Lack of Efficacy|0|||
162623785|NCT02165215|587339611|FG002|Induction Phase|Lack of Efficacy|0|||
162623786|NCT02165215|587339609|FG000|Induction Phase|Non-Compliance|2|||
162623787|NCT02165215|587339610|FG001|Induction Phase|Non-Compliance|0|||
162623788|NCT02165215|587339611|FG002|Induction Phase|Non-Compliance|0|||
162623789|NCT02165215|587339609|FG000|Induction Phase|Lost to Follow-up|6|||
162623790|NCT02165215|587339610|FG001|Induction Phase|Lost to Follow-up|0|||
162623791|NCT02165215|587339611|FG002|Induction Phase|Lost to Follow-up|0|||
162623792|NCT02165215|587339609|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162623793|NCT02165215|587339610|FG001|Maintenance Phase|Withdrawal by Subject|7|||
162623794|NCT02165215|587339611|FG002|Maintenance Phase|Withdrawal by Subject|3|||
162895380|NCT04126031|588316148|FG004|Part B|Pre-existing hypertransaminasemia|1|||
162895381|NCT04126031|588316149|FG005|Part B|Pre-existing hypertransaminasemia|0|||
162895382|NCT00131664|588316150|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
162895383|NCT00131664|588316151|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
162895384|NCT00131664|588316152|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
162623795|NCT02165215|587339609|FG000|Maintenance Phase|Multiple reasons|0|||
162623796|NCT02165215|587339610|FG001|Maintenance Phase|Multiple reasons|2|||
162623797|NCT02165215|587339611|FG002|Maintenance Phase|Multiple reasons|1|||
162623798|NCT02165215|587339609|FG000|Maintenance Phase|Lost to Follow-up|0|||
162623799|NCT02165215|587339610|FG001|Maintenance Phase|Lost to Follow-up|2|||
162623800|NCT02165215|587339611|FG002|Maintenance Phase|Lost to Follow-up|0|||
162623801|NCT02165215|587339609|FG000|Maintenance Phase|Adverse Event|0|||
162623802|NCT02165215|587339610|FG001|Maintenance Phase|Adverse Event|1|||
162623803|NCT02165215|587339611|FG002|Maintenance Phase|Adverse Event|1|||
162623804|NCT01877265|587339612|FG000|Treatment Period 1|Sponsor Decision|0|||
162623805|NCT01877265|587339613|FG001|Treatment Period 1|Sponsor Decision|0|||
162623806|NCT01877265|587339614|FG002|Treatment Period 1|Sponsor Decision|1|||
162964946|NCT00073307|588572007|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
162964947|NCT00073307|588572008|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
162979003|NCT03545191|588623547|FG001|Overall Study|Withdrawal by Subject|10|||
162895385|NCT00131664|588316153|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
162895386|NCT00131664|588316154|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
162895387|NCT00131664|588316155|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
162895388|NCT00131664|588316150|FG000|First Period (First 6 Months)|Death|0|||
162895389|NCT00131664|588316151|FG001|First Period (First 6 Months)|Death|1|||
162895390|NCT00131664|588316152|FG002|First Period (First 6 Months)|Death|0|||
162895391|NCT00131664|588316153|FG003|First Period (First 6 Months)|Death|0|||
162895392|NCT00131664|588316154|FG004|First Period (First 6 Months)|Death|0|||
162895393|NCT00131664|588316155|FG005|First Period (First 6 Months)|Death|0|||
162895394|NCT00131664|588316150|FG000|First Period (First 6 Months)|Protocol Violation|2|||
162895395|NCT00131664|588316151|FG001|First Period (First 6 Months)|Protocol Violation|2|||
162895396|NCT00131664|588316152|FG002|First Period (First 6 Months)|Protocol Violation|1|||
162895397|NCT00131664|588316153|FG003|First Period (First 6 Months)|Protocol Violation|0|||
162895398|NCT00131664|588316154|FG004|First Period (First 6 Months)|Protocol Violation|0|||
162895399|NCT00131664|588316155|FG005|First Period (First 6 Months)|Protocol Violation|0|||
162895400|NCT00131664|588316150|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
162895401|NCT00131664|588316151|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
162895402|NCT00131664|588316152|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
162895403|NCT00131664|588316153|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
162895404|NCT00131664|588316154|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
162895405|NCT00131664|588316155|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
162895406|NCT00131664|588316150|FG000|First Period (First 6 Months)|Adverse Event|9|||
162895407|NCT00131664|588316151|FG001|First Period (First 6 Months)|Adverse Event|4|||
162895408|NCT00131664|588316152|FG002|First Period (First 6 Months)|Adverse Event|5|||
162895409|NCT00131664|588316153|FG003|First Period (First 6 Months)|Adverse Event|0|||
162895410|NCT00131664|588316154|FG004|First Period (First 6 Months)|Adverse Event|0|||
162895411|NCT00131664|588316155|FG005|First Period (First 6 Months)|Adverse Event|0|||
162895412|NCT00131664|588316150|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
162895413|NCT00131664|588316151|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
162895414|NCT00131664|588316152|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
162895415|NCT00131664|588316153|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
162895416|NCT00131664|588316154|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
162895417|NCT00131664|588316155|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
162895418|NCT00131664|588316150|FG000|First Period (First 6 Months)|Administrative reasons|2|||
162895419|NCT00131664|588316151|FG001|First Period (First 6 Months)|Administrative reasons|0|||
162895420|NCT00131664|588316152|FG002|First Period (First 6 Months)|Administrative reasons|5|||
162895421|NCT00131664|588316153|FG003|First Period (First 6 Months)|Administrative reasons|0|||
162895422|NCT00131664|588316154|FG004|First Period (First 6 Months)|Administrative reasons|0|||
162895423|NCT00131664|588316155|FG005|First Period (First 6 Months)|Administrative reasons|0|||
162895424|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
162895425|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
162895426|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
162895427|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
162895428|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
162895429|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
162895430|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
162895431|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
162895432|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
162895433|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
162895434|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
162895435|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
162895436|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
162895437|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
162895438|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
162895439|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
162895440|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
162895441|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
162895442|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
162895443|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
162895444|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
162895445|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
162895446|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
162895447|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
162895448|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
162895449|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
162895450|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
162895451|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
162895452|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
162895453|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
162895454|NCT00131664|588316150|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
162895455|NCT00131664|588316151|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
162895456|NCT00131664|588316152|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
162895457|NCT00131664|588316153|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
162895458|NCT00131664|588316154|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
162895459|NCT00131664|588316155|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
162895460|NCT00617656|588316156|FG000|Overall Study|Inclusion error|4|||
162895461|NCT00617656|588316157|FG001|Overall Study|Inclusion error|4|||
162895462|NCT00617656|588316158|FG002|Overall Study|Inclusion error|0|||
162895463|NCT00617656|588316159|FG003|Overall Study|Inclusion error|0|||
162895464|NCT00617656|588316156|FG000|Overall Study|Missing data|44|||
162895465|NCT00617656|588316157|FG001|Overall Study|Missing data|30|||
162895466|NCT00617656|588316158|FG002|Overall Study|Missing data|13|||
162895467|NCT00617656|588316159|FG003|Overall Study|Missing data|6|||
162895468|NCT00617656|588316156|FG000|Overall Study|Withdrawal by Subject|0|||
162895469|NCT00617656|588316157|FG001|Overall Study|Withdrawal by Subject|2|||
162895470|NCT00617656|588316158|FG002|Overall Study|Withdrawal by Subject|0|||
162895471|NCT00617656|588316159|FG003|Overall Study|Withdrawal by Subject|0|||
162895472|NCT00254163|588317761|FG000|Overall Study|Adverse Event|29|||
162895473|NCT00254163|588317762|FG001|Overall Study|Adverse Event|26|||
162895474|NCT00254163|588317761|FG000|Overall Study|Patient request/withdrew consent|6|||
162895475|NCT00254163|588317762|FG001|Overall Study|Patient request/withdrew consent|4|||
162895476|NCT00254163|588317761|FG000|Overall Study|Investigator request|1|||
162895477|NCT00254163|588317762|FG001|Overall Study|Investigator request|3|||
162895478|NCT00254163|588317761|FG000|Overall Study|Failed entry|1|||
162895479|NCT00254163|588317762|FG001|Overall Study|Failed entry|3|||
162895480|NCT00254163|588317761|FG000|Overall Study|Progressive disease|0|||
162895481|NCT00254163|588317762|FG001|Overall Study|Progressive disease|1|||
162895482|NCT00254163|588317761|FG000|Overall Study|Death|0|||
162895483|NCT00254163|588317762|FG001|Overall Study|Death|1|||
162895484|NCT00254163|588317761|FG000|Overall Study|Other|8|||
162895485|NCT00254163|588317762|FG001|Overall Study|Other|8|||
162895486|NCT02579863|588317764|FG000|Overall Study|Final Disposition Unknown|2|||
162895487|NCT02579863|588317765|FG001|Overall Study|Final Disposition Unknown|1|||
162895488|NCT02579863|588317764|FG000|Overall Study|Adverse Event|18|||
162895489|NCT02579863|588317765|FG001|Overall Study|Adverse Event|11|||
162895490|NCT02579863|588317764|FG000|Overall Study|Death|31|||
162895491|NCT02579863|588317765|FG001|Overall Study|Death|29|||
162895492|NCT02579863|588317764|FG000|Overall Study|Lost to Follow-up|2|||
162895493|NCT02579863|588317765|FG001|Overall Study|Lost to Follow-up|1|||
162895494|NCT02579863|588317764|FG000|Overall Study|Physician Decision|1|||
162895495|NCT02579863|588317765|FG001|Overall Study|Physician Decision|2|||
162895496|NCT02579863|588317764|FG000|Overall Study|Screen Failure|0|||
162623807|NCT01877265|587339615|FG003|Treatment Period 1|Sponsor Decision|0|||
162623808|NCT01877265|587339616|FG004|Treatment Period 1|Sponsor Decision|0|||
162623809|NCT01877265|587339617|FG005|Treatment Period 1|Sponsor Decision|0|||
162623810|NCT01877265|587339612|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162623811|NCT01877265|587339613|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162623812|NCT01877265|587339614|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162623813|NCT01877265|587339615|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162623814|NCT01877265|587339616|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162623815|NCT01877265|587339617|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
162623816|NCT01877265|587339612|FG000|Treatment Period 3|Lost to Follow-up|1|||
162623817|NCT01877265|587339613|FG001|Treatment Period 3|Lost to Follow-up|0|||
162623818|NCT01877265|587339614|FG002|Treatment Period 3|Lost to Follow-up|0|||
162623819|NCT01877265|587339615|FG003|Treatment Period 3|Lost to Follow-up|0|||
162623820|NCT01877265|587339616|FG004|Treatment Period 3|Lost to Follow-up|0|||
162623821|NCT01877265|587339617|FG005|Treatment Period 3|Lost to Follow-up|0|||
162623822|NCT01947582|587339618|FG000|Overall Study|Withdrawal by Subject|1|||
162623823|NCT00592384|587339619|FG000|Overall Study|Withdrawal by Subject|5|||
162623824|NCT00592384|587339620|FG001|Overall Study|Withdrawal by Subject|6|||
162623825|NCT01153347|587339624|FG000|Overall Study|Withdrawal by Subject|7|||
162623826|NCT01153347|587339625|FG001|Overall Study|Withdrawal by Subject|7|||
162623827|NCT01153347|587339626|FG002|Overall Study|Withdrawal by Subject|7|||
162623828|NCT01153347|587339627|FG003|Overall Study|Withdrawal by Subject|7|||
162623829|NCT01153347|587339624|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162623830|NCT01153347|587339625|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162623831|NCT01153347|587339626|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
162623832|NCT01153347|587339627|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162623833|NCT01153347|587339624|FG000|Overall Study|Adverse Event|3|||
162623834|NCT01153347|587339625|FG001|Overall Study|Adverse Event|9|||
162623835|NCT01153347|587339626|FG002|Overall Study|Adverse Event|21|||
162623836|NCT01153347|587339627|FG003|Overall Study|Adverse Event|7|||
162623837|NCT01153347|587339624|FG000|Overall Study|Severe non-compliance to protocol|6|||
162623838|NCT01153347|587339625|FG001|Overall Study|Severe non-compliance to protocol|7|||
162623839|NCT01153347|587339626|FG002|Overall Study|Severe non-compliance to protocol|4|||
162623840|NCT01153347|587339627|FG003|Overall Study|Severe non-compliance to protocol|3|||
162623841|NCT01153347|587339624|FG000|Overall Study|Condition under investigation worsened|1|||
162623842|NCT01153347|587339625|FG001|Overall Study|Condition under investigation worsened|1|||
162623843|NCT01153347|587339626|FG002|Overall Study|Condition under investigation worsened|0|||
162623844|NCT01153347|587339627|FG003|Overall Study|Condition under investigation worsened|0|||
162623845|NCT01153347|587339624|FG000|Overall Study|Lack of Efficacy|2|||
162623846|NCT01153347|587339625|FG001|Overall Study|Lack of Efficacy|2|||
162623847|NCT01153347|587339626|FG002|Overall Study|Lack of Efficacy|0|||
162623848|NCT01153347|587339627|FG003|Overall Study|Lack of Efficacy|4|||
162623849|NCT01153347|587339624|FG000|Overall Study|Study-specific withdrawal criteria|4|||
162623850|NCT01153347|587339625|FG001|Overall Study|Study-specific withdrawal criteria|3|||
162623851|NCT01153347|587339626|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162623852|NCT01153347|587339627|FG003|Overall Study|Study-specific withdrawal criteria|2|||
162623853|NCT01153347|587339624|FG000|Overall Study|Lost to Follow-up|4|||
162623854|NCT01153347|587339625|FG001|Overall Study|Lost to Follow-up|9|||
162623855|NCT01153347|587339626|FG002|Overall Study|Lost to Follow-up|11|||
162623856|NCT01153347|587339627|FG003|Overall Study|Lost to Follow-up|8|||
162623857|NCT01153347|587339624|FG000|Overall Study|Other|5|||
162623858|NCT01153347|587339625|FG001|Overall Study|Other|5|||
162623859|NCT01153347|587339626|FG002|Overall Study|Other|4|||
162623860|NCT01153347|587339627|FG003|Overall Study|Other|0|||
162623861|NCT01153347|587339624|FG000|Overall Study|Death|1|||
162623862|NCT01153347|587339625|FG001|Overall Study|Death|0|||
162623863|NCT01153347|587339626|FG002|Overall Study|Death|0|||
162895497|NCT02579863|588317765|FG001|Overall Study|Screen Failure|2|||
162895498|NCT02579863|588317764|FG000|Overall Study|Study Terminated at Selected Sites|82|||
162895499|NCT02579863|588317765|FG001|Overall Study|Study Terminated at Selected Sites|88|||
162895500|NCT02579863|588317764|FG000|Overall Study|Withdrawal by Subject|20|||
162895501|NCT02579863|588317765|FG001|Overall Study|Withdrawal by Subject|20|||
162895502|NCT00809614|588317770|FG000|Overall Study|Lack of Efficacy|2|||
162895503|NCT00809614|588317771|FG001|Overall Study|Lack of Efficacy|3|||
162895504|NCT00809614|588317770|FG000|Overall Study|Withdrawal by Subject|1|||
162895505|NCT00809614|588317771|FG001|Overall Study|Withdrawal by Subject|1|||
162623864|NCT01153347|587339627|FG003|Overall Study|Death|0|||
162623865|NCT04401423|587339630|FG000|Overall Study|Withdrawal by Subject|3|||
162623866|NCT04401423|587339631|FG001|Overall Study|Withdrawal by Subject|1|||
162623867|NCT04401423|587339630|FG000|Overall Study|Physician Decision|2|||
162623868|NCT04401423|587339631|FG001|Overall Study|Physician Decision|1|||
162623869|NCT00003473|587339632|FG000|Overall Study|Three patients were not evaluable.|3|||
162623870|NCT04678661|587339633|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
162895506|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Death|3|||
162895507|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Death|0|||
162895508|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Death|0|||
162895509|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Death|0|||
162895510|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Death|0|||
162895511|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
162895512|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
162895513|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
162895514|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
162895515|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
162895516|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
162895517|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
162895518|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
162895519|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
162895520|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
162895521|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Other|0|||
162895522|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Other|0|||
162895523|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Other|1|||
162895524|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Other|0|||
162895525|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Other|0|||
162895526|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
162895527|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
162895528|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
162895529|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
162895530|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
162895531|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
162895532|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
162895533|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
162895534|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
162895535|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
162895536|NCT01224106|588317772|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
162895537|NCT01224106|588317773|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162895538|NCT01224106|588317774|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
162895539|NCT01224106|588317775|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162895540|NCT01224106|588317776|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162895541|NCT01224106|588317772|FG000|Open-Label Extension (OLE) Phase|Death|0|||
162895542|NCT01224106|588317773|FG001|Open-Label Extension (OLE) Phase|Death|0|||
162895543|NCT01224106|588317774|FG002|Open-Label Extension (OLE) Phase|Death|0|||
162895544|NCT01224106|588317775|FG003|Open-Label Extension (OLE) Phase|Death|1|||
162895545|NCT01224106|588317776|FG004|Open-Label Extension (OLE) Phase|Death|3|||
162895546|NCT01224106|588317772|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
162895547|NCT01224106|588317773|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
162895548|NCT01224106|588317774|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
162895549|NCT01224106|588317775|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
162895550|NCT01224106|588317776|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
162895551|NCT01224106|588317772|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
162895552|NCT01224106|588317773|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
162895553|NCT01224106|588317774|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
162895554|NCT01224106|588317775|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
162895555|NCT01224106|588317776|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
162895556|NCT01224106|588317772|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
162895557|NCT01224106|588317773|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
162895558|NCT01224106|588317774|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
162895559|NCT01224106|588317775|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
162964948|NCT00073307|588572009|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
162623871|NCT04678661|587339634|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
162623872|NCT04678661|587339633|FG000|Overall Study|Protocol Violation|2|||
162623873|NCT04678661|587339634|FG001|Overall Study|Protocol Violation|0|||
162623874|NCT04678661|587339633|FG000|Overall Study|Withdrawal by Subject|1|||
162623875|NCT04678661|587339634|FG001|Overall Study|Withdrawal by Subject|0|||
162623876|NCT04678661|587339633|FG000|Overall Study|Lost to Follow-up|2|||
162623877|NCT04678661|587339634|FG001|Overall Study|Lost to Follow-up|0|||
162895560|NCT01224106|588317776|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
162895561|NCT01224106|588317772|FG000|Open-Label Extension (OLE) Phase|Other|0|||
162895562|NCT01224106|588317773|FG001|Open-Label Extension (OLE) Phase|Other|0|||
162895563|NCT01224106|588317774|FG002|Open-Label Extension (OLE) Phase|Other|0|||
162895564|NCT01224106|588317775|FG003|Open-Label Extension (OLE) Phase|Other|5|||
162895565|NCT01224106|588317776|FG004|Open-Label Extension (OLE) Phase|Other|3|||
162895566|NCT00446797|588317777|FG000|Overall Study|Lack of Efficacy|0|||
162895567|NCT00446797|588317778|FG001|Overall Study|Lack of Efficacy|2|||
162895568|NCT00446797|588317777|FG000|Overall Study|Lost to Follow-up|5|||
162895569|NCT00446797|588317778|FG001|Overall Study|Lost to Follow-up|3|||
162895570|NCT00446797|588317777|FG000|Overall Study|Withdrawal by Subject|2|||
162895571|NCT00446797|588317778|FG001|Overall Study|Withdrawal by Subject|2|||
162623878|NCT04678661|587339633|FG000|Overall Study|Death|2|||
162895572|NCT00446797|588317777|FG000|Overall Study|Protocol Violation|1|||
162895573|NCT00446797|588317778|FG001|Overall Study|Protocol Violation|3|||
162895574|NCT00446797|588317777|FG000|Overall Study|subject entered at another site|0|||
162895575|NCT00446797|588317778|FG001|Overall Study|subject entered at another site|1|||
162623879|NCT04678661|587339634|FG001|Overall Study|Death|0|||
162623880|NCT03039283|587339637|FG000|Overall Study|Protocol Violation|2|||
162895576|NCT00446797|588317777|FG000|Overall Study|did not meet entrance criteria|0|||
162895577|NCT00446797|588317778|FG001|Overall Study|did not meet entrance criteria|1|||
162895578|NCT00364832|588317779|FG000|Core Period|Early Withdrawals|2|||
162895579|NCT00364832|588317780|FG001|Core Period|Early Withdrawals|2|||
162895580|NCT00364832|588317781|FG002|Core Period|Early Withdrawals|1|||
162895581|NCT00364832|588317782|FG003|Core Period|Early Withdrawals|1|||
162895582|NCT00364832|588317783|FG004|Core Period|Early Withdrawals|0|||
162895583|NCT00364832|588317784|FG005|Core Period|Early Withdrawals|0|||
162895584|NCT00364832|588317785|FG006|Core Period|Early Withdrawals|4|||
162895585|NCT00364832|588317786|FG007|Core Period|Early Withdrawals|1|||
162895586|NCT00364832|588317787|FG008|Core Period|Early Withdrawals|0|||
162895587|NCT00364832|588317788|FG009|Core Period|Early Withdrawals|0|||
162895588|NCT00364832|588317789|FG010|Core Period|Early Withdrawals|0|||
162895589|NCT00364832|588317790|FG011|Core Period|Early Withdrawals|0|||
162895590|NCT00364832|588317779|FG000|Extension Year 1|Early Withdrawals|0|||
162895591|NCT00364832|588317780|FG001|Extension Year 1|Early Withdrawals|0|||
162895592|NCT00364832|588317781|FG002|Extension Year 1|Early Withdrawals|0|||
162895593|NCT00364832|588317782|FG003|Extension Year 1|Early Withdrawals|0|||
162895594|NCT00364832|588317783|FG004|Extension Year 1|Early Withdrawals|0|||
162895595|NCT00364832|588317784|FG005|Extension Year 1|Early Withdrawals|0|||
162895596|NCT00364832|588317785|FG006|Extension Year 1|Early Withdrawals|0|||
162895597|NCT00364832|588317786|FG007|Extension Year 1|Early Withdrawals|0|||
162895598|NCT00364832|588317787|FG008|Extension Year 1|Early Withdrawals|0|||
162895599|NCT00364832|588317788|FG009|Extension Year 1|Early Withdrawals|4|||
162895600|NCT00364832|588317789|FG010|Extension Year 1|Early Withdrawals|2|||
162895601|NCT00364832|588317790|FG011|Extension Year 1|Early Withdrawals|10|||
162895602|NCT00364832|588317779|FG000|Extension Year 2|Early Withdrawals|0|||
162895603|NCT00364832|588317780|FG001|Extension Year 2|Early Withdrawals|0|||
162895604|NCT00364832|588317781|FG002|Extension Year 2|Early Withdrawals|0|||
162895605|NCT00364832|588317782|FG003|Extension Year 2|Early Withdrawals|0|||
162895606|NCT00364832|588317783|FG004|Extension Year 2|Early Withdrawals|0|||
162895607|NCT00364832|588317784|FG005|Extension Year 2|Early Withdrawals|0|||
162895608|NCT00364832|588317785|FG006|Extension Year 2|Early Withdrawals|0|||
162895609|NCT00364832|588317786|FG007|Extension Year 2|Early Withdrawals|0|||
162895610|NCT00364832|588317787|FG008|Extension Year 2|Early Withdrawals|0|||
162895611|NCT00364832|588317788|FG009|Extension Year 2|Early Withdrawals|5|||
162895612|NCT00364832|588317789|FG010|Extension Year 2|Early Withdrawals|5|||
162895613|NCT00364832|588317790|FG011|Extension Year 2|Early Withdrawals|3|||
162895614|NCT03210220|588317791|FG000|Overall Study|Physician Decision|1|||
162895615|NCT03210220|588317792|FG001|Overall Study|Physician Decision|0|||
162895616|NCT02580591|588317793|FG000|Overall Study|Adverse Event|0|||
162895617|NCT02580591|588317794|FG001|Overall Study|Adverse Event|1|||
162895618|NCT02580591|588317795|FG002|Overall Study|Adverse Event|2|||
162895619|NCT02580591|588317796|FG003|Overall Study|Adverse Event|5|||
162895620|NCT02580591|588317793|FG000|Overall Study|Protocol Violation|3|||
162895621|NCT02580591|588317794|FG001|Overall Study|Protocol Violation|2|||
162895622|NCT02580591|588317795|FG002|Overall Study|Protocol Violation|1|||
162895623|NCT02580591|588317796|FG003|Overall Study|Protocol Violation|1|||
162895624|NCT02580591|588317793|FG000|Overall Study|Lost to Follow-up|5|||
162895625|NCT02580591|588317794|FG001|Overall Study|Lost to Follow-up|3|||
162895626|NCT02580591|588317795|FG002|Overall Study|Lost to Follow-up|3|||
162895627|NCT02580591|588317796|FG003|Overall Study|Lost to Follow-up|1|||
162895628|NCT02580591|588317793|FG000|Overall Study|Withdrawal by Subject|6|||
162895629|NCT02580591|588317794|FG001|Overall Study|Withdrawal by Subject|1|||
162895630|NCT02580591|588317795|FG002|Overall Study|Withdrawal by Subject|2|||
162895631|NCT02580591|588317796|FG003|Overall Study|Withdrawal by Subject|3|||
162895632|NCT02580591|588317793|FG000|Overall Study|Not treated|1|||
162895633|NCT02580591|588317794|FG001|Overall Study|Not treated|1|||
162895634|NCT02580591|588317795|FG002|Overall Study|Not treated|0|||
162895635|NCT02580591|588317796|FG003|Overall Study|Not treated|0|||
162895636|NCT02580591|588317793|FG000|Overall Study|Other than specified|3|||
162895637|NCT02580591|588317794|FG001|Overall Study|Other than specified|2|||
162895638|NCT02580591|588317795|FG002|Overall Study|Other than specified|5|||
162895639|NCT02580591|588317796|FG003|Overall Study|Other than specified|2|||
162895640|NCT01366534|588317801|FG000|Overall Study|Lost to Follow-up|1|||
162895641|NCT01366534|588317802|FG001|Overall Study|Lost to Follow-up|0|||
162895642|NCT01366534|588317803|FG002|Overall Study|Lost to Follow-up|0|||
162623881|NCT01086033|587339638|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
162623882|NCT01086033|587339638|FG000|Overall Study|Lost to Follow-up|86|||
162623883|NCT01086033|587339638|FG000|Overall Study|Adverse Event|42|||
162623884|NCT01086033|587339638|FG000|Overall Study|Withdrawal by Subject|41|||
162623885|NCT01086033|587339638|FG000|Overall Study|Other|14|||
162623886|NCT01086033|587339638|FG000|Overall Study|Other|13|||
162623887|NCT01086033|587339638|FG000|Overall Study|AE and Withdrew Consent|5|||
162623888|NCT01086033|587339638|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
162623889|NCT01086033|587339638|FG000|Overall Study|Withdrew consent and Other Reason|4|||
162623890|NCT01086033|587339638|FG000|Overall Study|AE and Lack of Efficacy|4|||
162623891|NCT01086033|587339638|FG000|Overall Study|Death|1|||
162623892|NCT01086033|587339638|FG000|Overall Study|AE and Lost to Follow-up|1|||
162623893|NCT01086033|587339638|FG000|Overall Study|AE and Other Reason|1|||
162623894|NCT01086033|587339638|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
162623895|NCT02193867|587339639|FG000|Overall Study|Death|2|||
162623896|NCT02193867|587339639|FG000|Overall Study|Sponsor Study Termination|2|||
162623897|NCT03639935|587339640|FG000|Overall Study|Death|3|||
162895643|NCT01366534|588317801|FG000|Overall Study|Migrated|1|||
162895644|NCT01366534|588317802|FG001|Overall Study|Migrated|1|||
162895645|NCT01366534|588317803|FG002|Overall Study|Migrated|0|||
162895646|NCT01366534|588317801|FG000|Overall Study|Declined challenged|0|||
162895647|NCT01366534|588317802|FG001|Overall Study|Declined challenged|1|||
162895648|NCT01366534|588317803|FG002|Overall Study|Declined challenged|0|||
162895649|NCT03006926|588317804|FG000|Overall Study|Adverse Event|0|||
162895650|NCT03006926|588317805|FG001|Overall Study|Adverse Event|27|||
162895651|NCT03006926|588317804|FG000|Overall Study|Withdrawal by Subject|0|||
162895652|NCT03006926|588317805|FG001|Overall Study|Withdrawal by Subject|1|||
162895653|NCT03006926|588317804|FG000|Overall Study|Radiological Disease Progression|0|||
162623898|NCT03639935|587339640|FG000|Overall Study|Adverse Event|1|||
162623899|NCT02924571|587339641|FG000|Overall Study|Lost to Follow-up|1|||
162623900|NCT02924571|587339642|FG001|Overall Study|Lost to Follow-up|1|||
162623901|NCT02924571|587339643|FG002|Overall Study|Lost to Follow-up|0|||
162623902|NCT00864721|587339644|FG000|Overall Study|Patient request|11|||
162623903|NCT00864721|587339644|FG000|Overall Study|Hospitalized|1|||
162623904|NCT00864721|587339644|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
162623905|NCT00864721|587339644|FG000|Overall Study|Adverse Event|21|||
162623906|NCT01921387|587339647|FG000|Overall Study|Adverse Event|1|||
162623907|NCT01773733|587339648|FG000|Overall Study|Adverse Event|3286|||
162623908|NCT01773733|587339649|FG001|Overall Study|Adverse Event|540|||
162623909|NCT01773733|587339648|FG000|Overall Study|Pregnancy|28|||
162623910|NCT01773733|587339649|FG001|Overall Study|Pregnancy|0|||
162623911|NCT01773733|587339648|FG000|Overall Study|Other different categories of not compl|55415|||
162623912|NCT01773733|587339649|FG001|Overall Study|Other different categories of not compl|7781|||
162623913|NCT00261807|587339652|FG000|Overall Study|Lost to Follow-up|2|||
162623914|NCT00261807|587339652|FG000|Overall Study|Adverse Event|2|||
162623915|NCT00261807|587339652|FG000|Overall Study|Death|1|||
162623916|NCT00261807|587339652|FG000|Overall Study|Protocol Violation|2|||
162623917|NCT00762229|587339656|FG000|Overall Study|Lost to Follow-up|1|||
162623918|NCT00762229|587339657|FG001|Overall Study|Lost to Follow-up|1|||
162623919|NCT00762229|587339656|FG000|Overall Study|did not recveive intervention|0|||
162623920|NCT00762229|587339657|FG001|Overall Study|did not recveive intervention|1|||
162623921|NCT01081678|587339659|FG000|Overall Study|Ineligibility Determined|0|||
162623922|NCT01081678|587339660|FG001|Overall Study|Ineligibility Determined|0|||
162623923|NCT01081678|587339661|FG002|Overall Study|Ineligibility Determined|1|||
162623924|NCT01081678|587339662|FG003|Overall Study|Ineligibility Determined|1|||
162623925|NCT01081678|587339659|FG000|Overall Study|Noncompliance|3|||
162623926|NCT01081678|587339660|FG001|Overall Study|Noncompliance|4|||
162623927|NCT01081678|587339661|FG002|Overall Study|Noncompliance|5|||
162623928|NCT01081678|587339662|FG003|Overall Study|Noncompliance|2|||
162895654|NCT03006926|588317805|FG001|Overall Study|Radiological Disease Progression|52|||
162895655|NCT03006926|588317804|FG000|Overall Study|Clinical Disease Progression|0|||
162895656|NCT03006926|588317805|FG001|Overall Study|Clinical Disease Progression|10|||
162895657|NCT03006926|588317804|FG000|Overall Study|Other|0|||
162623929|NCT01081678|587339659|FG000|Overall Study|Adverse Event|2|||
162623930|NCT01081678|587339660|FG001|Overall Study|Adverse Event|1|||
162623931|NCT01081678|587339661|FG002|Overall Study|Adverse Event|2|||
162623932|NCT01081678|587339662|FG003|Overall Study|Adverse Event|2|||
162623933|NCT01081678|587339659|FG000|Overall Study|Withdrawal by Subject|15|||
162623934|NCT01081678|587339660|FG001|Overall Study|Withdrawal by Subject|7|||
162895658|NCT03006926|588317805|FG001|Overall Study|Other|8|||
162895659|NCT01838213|588317806|FG000|Overall Study|Ineligible|166|||
162895660|NCT01838213|588317807|FG001|Overall Study|Ineligible|191|||
162623935|NCT01081678|587339661|FG002|Overall Study|Withdrawal by Subject|17|||
162623936|NCT01081678|587339662|FG003|Overall Study|Withdrawal by Subject|14|||
162623937|NCT01081678|587339659|FG000|Overall Study|Administrative Decision|1|||
162623938|NCT01081678|587339660|FG001|Overall Study|Administrative Decision|0|||
162623939|NCT01081678|587339661|FG002|Overall Study|Administrative Decision|0|||
162623940|NCT01081678|587339662|FG003|Overall Study|Administrative Decision|1|||
162623941|NCT01081678|587339659|FG000|Overall Study|Lost to Follow-up|4|||
162623942|NCT01081678|587339660|FG001|Overall Study|Lost to Follow-up|1|||
162623943|NCT01081678|587339661|FG002|Overall Study|Lost to Follow-up|4|||
162623944|NCT01081678|587339662|FG003|Overall Study|Lost to Follow-up|3|||
162623945|NCT01081678|587339659|FG000|Overall Study|Death|2|||
162623946|NCT01081678|587339660|FG001|Overall Study|Death|2|||
162623947|NCT01081678|587339661|FG002|Overall Study|Death|2|||
162623948|NCT01081678|587339662|FG003|Overall Study|Death|6|||
162623949|NCT01081678|587339659|FG000|Overall Study|Other|0|||
162623950|NCT01081678|587339660|FG001|Overall Study|Other|1|||
162623951|NCT01081678|587339661|FG002|Overall Study|Other|0|||
162623952|NCT01081678|587339662|FG003|Overall Study|Other|0|||
162623953|NCT01619423|587339667|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
162895661|NCT04882072|588317812|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
162895662|NCT04882072|588317813|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
162895663|NCT04882072|588317812|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
162895664|NCT04882072|588317813|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
162895665|NCT04882072|588317812|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
162895666|NCT04882072|588317813|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
162895667|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
162895668|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
162623954|NCT01619423|587339668|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
162623955|NCT01619423|587339669|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
162623956|NCT01619423|587339670|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
162623957|NCT01281865|587339677|FG000|Overall Study|Adverse Event|1|||
162623958|NCT01281865|587339678|FG001|Overall Study|Adverse Event|1|||
162623959|NCT01281865|587339677|FG000|Overall Study|Withdrawal by Subject|1|||
162623960|NCT01281865|587339678|FG001|Overall Study|Withdrawal by Subject|0|||
162623961|NCT01281865|587339677|FG000|Overall Study|Lack of Efficacy|1|||
162623962|NCT01281865|587339678|FG001|Overall Study|Lack of Efficacy|0|||
162623963|NCT03478657|587339679|FG000|Overall Study|Withdrawal by Subject|0|||
162623964|NCT03478657|587339680|FG001|Overall Study|Withdrawal by Subject|1|||
162623965|NCT02590003|587339681|FG000|Overall Study|Death|1|||
162623966|NCT02590003|587339682|FG001|Overall Study|Death|2|||
162623967|NCT03733470|587339683|FG000|Overall Study|PI Decision|1|||
162623968|NCT03733470|587339684|FG001|Overall Study|PI Decision|1|||
162895669|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
162895670|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
162623969|NCT04457336|587339687|FG000|Period 2: Part A|Withdrawal by Subject|0|||
162623970|NCT04457336|587339688|FG001|Period 2: Part A|Withdrawal by Subject|1|||
162623971|NCT04457336|587339689|FG002|Period 2: Part A|Withdrawal by Subject|1|||
162623972|NCT04457336|587339690|FG003|Period 2: Part A|Withdrawal by Subject|1|||
162623973|NCT04457336|587339691|FG004|Period 2: Part A|Withdrawal by Subject|0|||
162623974|NCT04457336|587339692|FG005|Period 2: Part A|Withdrawal by Subject|0|||
162623975|NCT04457336|587339693|FG006|Period 2: Part A|Withdrawal by Subject|0|||
162623976|NCT04457336|587339694|FG007|Period 2: Part A|Withdrawal by Subject|0|||
162623977|NCT04457336|587339687|FG000|Period 2: Part A|Adverse Event|0|||
162623978|NCT04457336|587339688|FG001|Period 2: Part A|Adverse Event|0|||
162623979|NCT04457336|587339689|FG002|Period 2: Part A|Adverse Event|1|||
162623980|NCT04457336|587339690|FG003|Period 2: Part A|Adverse Event|1|||
162623981|NCT04457336|587339691|FG004|Period 2: Part A|Adverse Event|0|||
162623982|NCT04457336|587339692|FG005|Period 2: Part A|Adverse Event|0|||
162895671|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
162895672|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
162895673|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
162623983|NCT04457336|587339693|FG006|Period 2: Part A|Adverse Event|0|||
162623984|NCT04457336|587339694|FG007|Period 2: Part A|Adverse Event|0|||
162623985|NCT04457336|587339687|FG000|Period 2: Part A|Study Terminated|0|||
162623986|NCT04457336|587339688|FG001|Period 2: Part A|Study Terminated|0|||
162895674|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
162895675|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
162623987|NCT04457336|587339689|FG002|Period 2: Part A|Study Terminated|1|||
162623988|NCT04457336|587339690|FG003|Period 2: Part A|Study Terminated|0|||
162623989|NCT04457336|587339691|FG004|Period 2: Part A|Study Terminated|0|||
162623990|NCT04457336|587339692|FG005|Period 2: Part A|Study Terminated|0|||
162623991|NCT04457336|587339693|FG006|Period 2: Part A|Study Terminated|0|||
162623992|NCT04457336|587339694|FG007|Period 2: Part A|Study Terminated|0|||
162623993|NCT04457336|587339687|FG000|Period 2: Part A|Protocol Violation|0|||
162623994|NCT04457336|587339688|FG001|Period 2: Part A|Protocol Violation|1|||
162623995|NCT04457336|587339689|FG002|Period 2: Part A|Protocol Violation|0|||
162623996|NCT04457336|587339690|FG003|Period 2: Part A|Protocol Violation|0|||
162623997|NCT04457336|587339691|FG004|Period 2: Part A|Protocol Violation|0|||
162623998|NCT04457336|587339692|FG005|Period 2: Part A|Protocol Violation|0|||
162623999|NCT04457336|587339693|FG006|Period 2: Part A|Protocol Violation|0|||
162624000|NCT04457336|587339694|FG007|Period 2: Part A|Protocol Violation|0|||
162624001|NCT04457336|587339687|FG000|Period 2: Part A|Lost to Follow-up|0|||
162895676|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
162895677|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
162895678|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
162895679|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
162895680|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
162895681|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
162895682|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
162895683|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
162895684|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
162895685|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
162895686|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
162895687|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
162895688|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
162895689|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
162895690|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
162895691|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
162895692|NCT02918318|588317814|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
162895693|NCT02918318|588317815|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
162895694|NCT02918318|588317816|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
162895695|NCT02918318|588317817|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
162895696|NCT02918318|588317818|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
162895697|NCT02918318|588317814|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
162895698|NCT02918318|588317815|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
162895699|NCT02918318|588317816|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
162895700|NCT02918318|588317817|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
162895701|NCT02918318|588317818|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
162895702|NCT02918318|588317814|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
162895703|NCT02918318|588317815|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
162895704|NCT02918318|588317816|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
162895705|NCT02918318|588317817|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
162895706|NCT02918318|588317818|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
162964949|NCT00858780|588572010|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
162964950|NCT00858780|588572011|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964951|NCT00858780|588572012|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964952|NCT00858780|588572013|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964953|NCT00858780|588572014|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
162964954|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964955|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964956|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
162964957|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964958|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
162964959|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
162964960|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
162964961|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
162964962|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
162964963|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
162964964|NCT00858780|588572010|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964965|NCT00858780|588572011|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
162964966|NCT00858780|588572012|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964967|NCT00858780|588572013|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964968|NCT00858780|588572014|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
162964969|NCT00858780|588572010|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964970|NCT00858780|588572011|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964971|NCT00858780|588572012|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964972|NCT00858780|588572013|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
162964973|NCT00858780|588572014|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
162964974|NCT00858780|588572010|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964975|NCT00858780|588572011|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964976|NCT00858780|588572012|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964977|NCT00858780|588572013|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
162964978|NCT00858780|588572014|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
162964979|NCT01024855|588572017|FG000|Overall Study|Inclusion/exclusion criteria|1|||
162964980|NCT03306277|588572021|FG000|Overall Study|Death|1|||
162964981|NCT03306277|588572021|FG000|Overall Study|Adverse Event|1|||
162964982|NCT03306277|588572021|FG000|Overall Study|Withdrawal by Subject|1|||
162964983|NCT01926119|588572025|FG000|Overall Study|Withdrawal by Subject|1|||
162964984|NCT00645853|588572026|FG000|Overall Study|Adverse Event|18|||
162964985|NCT00645853|588572027|FG001|Overall Study|Adverse Event|7|||
162964986|NCT00645853|588572026|FG000|Overall Study|AZ study closure in Hungary|60|||
162964987|NCT00645853|588572027|FG001|Overall Study|AZ study closure in Hungary|40|||
162964988|NCT00645853|588572026|FG000|Overall Study|Withdrawal by Subject|5|||
162964989|NCT00645853|588572027|FG001|Overall Study|Withdrawal by Subject|2|||
162964990|NCT00645853|588572026|FG000|Overall Study|Protocol Violation|0|||
162964991|NCT00645853|588572027|FG001|Overall Study|Protocol Violation|2|||
162964992|NCT00645853|588572026|FG000|Overall Study|Discontinuation criteria|2|||
162964993|NCT00645853|588572027|FG001|Overall Study|Discontinuation criteria|2|||
162964994|NCT00645853|588572026|FG000|Overall Study|recall of ICF, planned operation, death|7|||
162964995|NCT00645853|588572027|FG001|Overall Study|recall of ICF, planned operation, death|4|||
162964996|NCT00406393|588572028|FG000|Overall Study|Did not undergo transplantation|2|||
162964997|NCT00406393|588572029|FG001|Overall Study|Did not undergo transplantation|1|||
162964998|NCT03885934|588572030|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
162964999|NCT03885934|588572031|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
162965000|NCT03885934|588572032|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
162965001|NCT03885934|588572033|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
162965002|NCT03885934|588572034|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
162965003|NCT03885934|588572035|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
162965004|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
162965005|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
162965006|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
162965007|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
162965008|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
162965009|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
162965010|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
162624002|NCT04457336|587339688|FG001|Period 2: Part A|Lost to Follow-up|1|||
162624003|NCT04457336|587339689|FG002|Period 2: Part A|Lost to Follow-up|0|||
162624004|NCT04457336|587339690|FG003|Period 2: Part A|Lost to Follow-up|0|||
162624005|NCT04457336|587339691|FG004|Period 2: Part A|Lost to Follow-up|0|||
162624006|NCT04457336|587339692|FG005|Period 2: Part A|Lost to Follow-up|0|||
162624007|NCT04457336|587339693|FG006|Period 2: Part A|Lost to Follow-up|0|||
162624008|NCT04457336|587339694|FG007|Period 2: Part A|Lost to Follow-up|0|||
162624009|NCT04457336|587339687|FG000|Period 2: Part A|Other|0|||
162624010|NCT04457336|587339688|FG001|Period 2: Part A|Other|1|||
162624011|NCT04457336|587339689|FG002|Period 2: Part A|Other|0|||
162624012|NCT04457336|587339690|FG003|Period 2: Part A|Other|0|||
162965011|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
162965012|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
162965013|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
162965014|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
162965015|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
162965016|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
162965017|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
162965018|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
162965019|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
162965020|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
162965021|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
162965022|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
162965023|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
162965024|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
162965025|NCT02227238|588572036|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
162965026|NCT02227238|588572037|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
162965027|NCT02227238|588572038|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
162965028|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
162965029|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
162965030|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
162965031|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
162965032|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
162965033|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
162965034|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
162965035|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
162965036|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
162965037|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
162965038|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
162965039|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
162965040|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
162965041|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
162965042|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
162965043|NCT02227238|588572036|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
162965044|NCT02227238|588572037|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
162965045|NCT02227238|588572038|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
162965046|NCT00380588|588572039|FG000|Overall Study|Unequivocal Disease Progression|25|||
162965047|NCT00380588|588572040|FG001|Overall Study|Unequivocal Disease Progression|34|||
162965048|NCT00380588|588572039|FG000|Overall Study|Next Cycle Not Started|4|||
162965049|NCT00380588|588572040|FG001|Overall Study|Next Cycle Not Started|0|||
162965050|NCT00380588|588572039|FG000|Overall Study|Adverse Event|7|||
162965051|NCT00380588|588572040|FG001|Overall Study|Adverse Event|3|||
162965052|NCT00380588|588572039|FG000|Overall Study|Withdrawal by Subject|1|||
162965053|NCT00380588|588572040|FG001|Overall Study|Withdrawal by Subject|3|||
162965054|NCT00380588|588572039|FG000|Overall Study|Physician Decision|2|||
162895707|NCT02918318|588317814|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
162895708|NCT02918318|588317815|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
162895709|NCT02918318|588317816|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
162895710|NCT02918318|588317817|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
162895711|NCT02918318|588317818|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
162895712|NCT02918318|588317814|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
162895713|NCT02918318|588317815|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
162895714|NCT02918318|588317816|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
162895715|NCT02918318|588317817|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
162895716|NCT02918318|588317818|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
162895717|NCT02918318|588317814|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
162895718|NCT02918318|588317815|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
162895719|NCT02918318|588317816|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
162895720|NCT02918318|588317817|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
162895721|NCT02918318|588317818|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
162895722|NCT02918318|588317814|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
162895723|NCT02918318|588317815|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
162895724|NCT02918318|588317816|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
162895725|NCT02918318|588317817|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
162895726|NCT02918318|588317818|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
162895727|NCT00990249|588317819|FG000|Overall Study|Disease Progression|8|||
162895728|NCT00990249|588317819|FG000|Overall Study|Non-Compliance|1|||
162895729|NCT00990249|588317819|FG000|Overall Study|Death|2|||
162895730|NCT00990249|588317819|FG000|Overall Study|Not treated|2|||
162895731|NCT01548417|588317820|FG000|Overall Study|Withdrawal by Subject|0|||
162965055|NCT00380588|588572040|FG001|Overall Study|Physician Decision|0|||
162965056|NCT02096705|588572041|FG000|Treatment|Adverse Event|6|||
162965057|NCT02096705|588572042|FG001|Treatment|Adverse Event|3|||
162965058|NCT02096705|588572041|FG000|Treatment|Subject request to discontinue treatment|1|||
162965059|NCT02096705|588572042|FG001|Treatment|Subject request to discontinue treatment|1|||
162895732|NCT01548417|588317821|FG001|Overall Study|Withdrawal by Subject|2|||
162895733|NCT04583969|588317824|FG000|Overall Study|Death|31|||
162895734|NCT04583969|588317825|FG001|Overall Study|Death|38|||
162895735|NCT04583969|588317824|FG000|Overall Study|Lost to Follow-up|16|||
162895736|NCT04583969|588317825|FG001|Overall Study|Lost to Follow-up|13|||
162895737|NCT04583969|588317824|FG000|Overall Study|Protocol Violation|1|||
162895738|NCT04583969|588317825|FG001|Overall Study|Protocol Violation|0|||
162895739|NCT04583969|588317824|FG000|Overall Study|Withdrawal by Subject|3|||
162895740|NCT04583969|588317825|FG001|Overall Study|Withdrawal by Subject|3|||
162895741|NCT04583969|588317824|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
162895742|NCT04583969|588317825|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
162895743|NCT04583969|588317824|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
162895744|NCT04583969|588317825|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
162895745|NCT04583969|588317824|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
162895746|NCT04583969|588317825|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
162895747|NCT04583969|588317824|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
162895748|NCT04583969|588317825|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
162895749|NCT04583969|588317824|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
162895750|NCT04583969|588317825|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
162895751|NCT04080752|588317826|FG000|Overall Study|Adverse Event|2|||
162895752|NCT04080752|588317827|FG001|Overall Study|Adverse Event|3|||
162895753|NCT04080752|588317826|FG000|Overall Study|Lack of Efficacy|1|||
162895754|NCT04080752|588317827|FG001|Overall Study|Lack of Efficacy|0|||
162895755|NCT04080752|588317826|FG000|Overall Study|Lost to Follow-up|1|||
162895756|NCT04080752|588317827|FG001|Overall Study|Lost to Follow-up|0|||
162895757|NCT04080752|588317826|FG000|Overall Study|Pregnancy|0|||
162895758|NCT04080752|588317827|FG001|Overall Study|Pregnancy|1|||
162895759|NCT04080752|588317826|FG000|Overall Study|Withdrawal by Subject|7|||
162895760|NCT04080752|588317827|FG001|Overall Study|Withdrawal by Subject|0|||
162895761|NCT04080752|588317826|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162895762|NCT04080752|588317827|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162895763|NCT04080752|588317826|FG000|Overall Study|Other|2|||
162895764|NCT04080752|588317827|FG001|Overall Study|Other|1|||
162895765|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
162895766|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
162895767|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
162895768|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
162708762|NCT02084082|587642890|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
162708763|NCT02084082|587642887|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162895769|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
162895770|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
162895771|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
162624013|NCT04457336|587339691|FG004|Period 2: Part A|Other|0|||
162624014|NCT04457336|587339692|FG005|Period 2: Part A|Other|0|||
162624015|NCT04457336|587339693|FG006|Period 2: Part A|Other|0|||
162624016|NCT04457336|587339694|FG007|Period 2: Part A|Other|0|||
162624017|NCT04457336|587339687|FG000|Period 2: Part A|Physician Decision|0|||
162624018|NCT04457336|587339688|FG001|Period 2: Part A|Physician Decision|0|||
162624019|NCT04457336|587339689|FG002|Period 2: Part A|Physician Decision|0|||
162624020|NCT04457336|587339690|FG003|Period 2: Part A|Physician Decision|1|||
162624021|NCT04457336|587339691|FG004|Period 2: Part A|Physician Decision|0|||
162624022|NCT04457336|587339692|FG005|Period 2: Part A|Physician Decision|0|||
162624023|NCT04457336|587339693|FG006|Period 2: Part A|Physician Decision|0|||
162624024|NCT04457336|587339694|FG007|Period 2: Part A|Physician Decision|0|||
162624025|NCT04457336|587339687|FG000|Period 3: Part B|Study Terminated|0|||
162624026|NCT04457336|587339688|FG001|Period 3: Part B|Study Terminated|0|||
162624027|NCT04457336|587339689|FG002|Period 3: Part B|Study Terminated|0|||
162624028|NCT04457336|587339690|FG003|Period 3: Part B|Study Terminated|0|||
162624029|NCT04457336|587339691|FG004|Period 3: Part B|Study Terminated|1|||
162624030|NCT04457336|587339692|FG005|Period 3: Part B|Study Terminated|10|||
162624031|NCT04457336|587339693|FG006|Period 3: Part B|Study Terminated|13|||
162895772|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
162895773|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
162895774|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
162895775|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
162895776|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
162895777|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
162895778|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
162895779|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
162895780|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
162895781|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
162895782|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
162895783|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
162624032|NCT04457336|587339694|FG007|Period 3: Part B|Study Terminated|0|||
162624033|NCT04457336|587339687|FG000|Period 3: Part B|Withdrawal by Subject|0|||
162624034|NCT04457336|587339688|FG001|Period 3: Part B|Withdrawal by Subject|0|||
162624035|NCT04457336|587339689|FG002|Period 3: Part B|Withdrawal by Subject|0|||
162895784|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
162895785|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
162895786|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
162895787|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
162895788|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
162895789|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Other|0|||
162895790|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Other|1|||
162895791|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Other|0|||
162895792|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Other|0|||
162895793|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
162895794|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
162895795|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
162895796|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
162895797|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
162895798|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
162895799|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
162895800|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
162895801|NCT01194414|588317830|FG000|24 Weeks Double Blind Period|Death|0|||
162895802|NCT01194414|588317831|FG001|24 Weeks Double Blind Period|Death|1|||
162895803|NCT01194414|588317832|FG002|24 Weeks Double Blind Period|Death|0|||
162895804|NCT01194414|588317833|FG003|24 Weeks Double Blind Period|Death|0|||
162895805|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
162895806|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
162895807|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
162895808|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
162895809|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
162895810|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
162895811|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
162895812|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
162965060|NCT02096705|588572041|FG000|Treatment|Withdrawal by Subject|1|||
162965061|NCT02096705|588572042|FG001|Treatment|Withdrawal by Subject|0|||
162895813|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
162895814|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
162895815|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
162895816|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
162895817|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
162895818|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
162895819|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
162895820|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
162895821|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
162895822|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
162895823|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
162895824|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
162895825|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
162895826|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
162895827|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
162895828|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
162895829|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Other|2|||
162895830|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Other|1|||
162895831|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Other|0|||
162895832|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Other|0|||
162895833|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
162895834|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
162895835|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
162895836|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
162895837|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
162895838|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
162895839|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
162895840|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
162895841|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
162895842|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
162895843|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
162895844|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
162895845|NCT01194414|588317830|FG000|72 Weeks Open Label Extension|Death|1|||
162895846|NCT01194414|588317831|FG001|72 Weeks Open Label Extension|Death|2|||
162895847|NCT01194414|588317832|FG002|72 Weeks Open Label Extension|Death|0|||
162895848|NCT01194414|588317833|FG003|72 Weeks Open Label Extension|Death|2|||
162895849|NCT01098032|588317835|FG000|Overall Study|Withdrawal by Subject|1|||
162895850|NCT01098032|588317836|FG001|Overall Study|Withdrawal by Subject|1|||
162895851|NCT01421069|588317837|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
162895852|NCT01421069|588317837|FG000|Parent Study|Failed to return|3|||
162895853|NCT01421069|588317837|FG000|Parent Study|Withdrawal by Subject|1|||
162895854|NCT01421069|588317837|FG000|Parent Study|Lost to Follow-up|2|||
162624036|NCT04457336|587339690|FG003|Period 3: Part B|Withdrawal by Subject|0|||
162624037|NCT04457336|587339691|FG004|Period 3: Part B|Withdrawal by Subject|0|||
162624038|NCT04457336|587339692|FG005|Period 3: Part B|Withdrawal by Subject|1|||
162624039|NCT04457336|587339693|FG006|Period 3: Part B|Withdrawal by Subject|2|||
162624040|NCT04457336|587339694|FG007|Period 3: Part B|Withdrawal by Subject|0|||
162624041|NCT04457336|587339687|FG000|Period 4: Part C|Study Terminated|0|||
162624042|NCT04457336|587339688|FG001|Period 4: Part C|Study Terminated|0|||
162624043|NCT04457336|587339689|FG002|Period 4: Part C|Study Terminated|0|||
162624044|NCT04457336|587339690|FG003|Period 4: Part C|Study Terminated|0|||
162624045|NCT04457336|587339691|FG004|Period 4: Part C|Study Terminated|0|||
162624046|NCT04457336|587339692|FG005|Period 4: Part C|Study Terminated|0|||
162624047|NCT04457336|587339693|FG006|Period 4: Part C|Study Terminated|0|||
162624048|NCT04457336|587339694|FG007|Period 4: Part C|Study Terminated|30|||
162624049|NCT04457336|587339687|FG000|Period 4: Part C|Adverse Event|0|||
162624050|NCT04457336|587339688|FG001|Period 4: Part C|Adverse Event|0|||
162624051|NCT04457336|587339689|FG002|Period 4: Part C|Adverse Event|0|||
162624052|NCT04457336|587339690|FG003|Period 4: Part C|Adverse Event|0|||
162624053|NCT04457336|587339691|FG004|Period 4: Part C|Adverse Event|0|||
162624054|NCT04457336|587339692|FG005|Period 4: Part C|Adverse Event|0|||
162624055|NCT04457336|587339693|FG006|Period 4: Part C|Adverse Event|0|||
162895855|NCT01421069|588317837|FG000|Parent Study|Lack of Efficacy|1|||
162895856|NCT01421069|588317837|FG000|Overall Period for Extension Study|Other|2|||
162895857|NCT01421069|588317837|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
162895858|NCT01421069|588317837|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
162895859|NCT01421069|588317837|FG000|Overall Period for Extension Study|Pregnancy|1|||
162895860|NCT01421069|588317837|FG000|Overall Period for Extension Study|Adverse Event|1|||
162624056|NCT04457336|587339694|FG007|Period 4: Part C|Adverse Event|2|||
162624057|NCT04457336|587339687|FG000|Period 4: Part C|Site Terminated|0|||
162624058|NCT04457336|587339688|FG001|Period 4: Part C|Site Terminated|0|||
162624059|NCT04457336|587339689|FG002|Period 4: Part C|Site Terminated|0|||
162624060|NCT04457336|587339690|FG003|Period 4: Part C|Site Terminated|0|||
162624061|NCT04457336|587339691|FG004|Period 4: Part C|Site Terminated|0|||
162624062|NCT04457336|587339692|FG005|Period 4: Part C|Site Terminated|0|||
162624063|NCT04457336|587339693|FG006|Period 4: Part C|Site Terminated|0|||
162624064|NCT04457336|587339694|FG007|Period 4: Part C|Site Terminated|1|||
162624065|NCT04457336|587339687|FG000|Period 4: Part C|Other|0|||
162624066|NCT04457336|587339688|FG001|Period 4: Part C|Other|0|||
162624067|NCT04457336|587339689|FG002|Period 4: Part C|Other|0|||
162624068|NCT04457336|587339690|FG003|Period 4: Part C|Other|0|||
162624069|NCT04457336|587339691|FG004|Period 4: Part C|Other|0|||
162624070|NCT04457336|587339692|FG005|Period 4: Part C|Other|0|||
162624071|NCT04457336|587339693|FG006|Period 4: Part C|Other|0|||
162624072|NCT04457336|587339694|FG007|Period 4: Part C|Other|2|||
162624073|NCT04457336|587339687|FG000|Period 4: Part C|Withdrawal by Subject|0|||
162624074|NCT04457336|587339688|FG001|Period 4: Part C|Withdrawal by Subject|0|||
162624075|NCT04457336|587339689|FG002|Period 4: Part C|Withdrawal by Subject|0|||
162624076|NCT04457336|587339690|FG003|Period 4: Part C|Withdrawal by Subject|0|||
162624077|NCT04457336|587339691|FG004|Period 4: Part C|Withdrawal by Subject|0|||
162624078|NCT04457336|587339692|FG005|Period 4: Part C|Withdrawal by Subject|0|||
162624079|NCT04457336|587339693|FG006|Period 4: Part C|Withdrawal by Subject|0|||
162624080|NCT04457336|587339694|FG007|Period 4: Part C|Withdrawal by Subject|3|||
162624081|NCT01416272|587339704|FG000|Overall Study|Unacceptable distance visual acuity|2|||
162624082|NCT01416272|587339704|FG000|Overall Study|Lost to Follow-up|1|||
162624083|NCT01416272|587339704|FG000|Overall Study|Study related complaints|1|||
162624084|NCT00239590|587339709|FG000|Randomized|Lost to Follow-up|0|||
162624085|NCT00239590|587339710|FG001|Randomized|Lost to Follow-up|1|||
162624086|NCT00239590|587339709|FG000|Randomized|Withdrawal by Subject|0|||
162624087|NCT00239590|587339710|FG001|Randomized|Withdrawal by Subject|1|||
162624088|NCT00239590|587339709|FG000|Completed Study Protocol|Adverse Event|1|||
162624089|NCT00239590|587339710|FG001|Completed Study Protocol|Adverse Event|1|||
162624090|NCT00239590|587339709|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
162624091|NCT00239590|587339710|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
162624092|NCT00892047|587339715|FG000|Overall Study|Adverse Event|2|||
162624093|NCT00892047|587339716|FG001|Overall Study|Adverse Event|2|||
162624094|NCT00892047|587339715|FG000|Overall Study|subject burden|2|||
162624095|NCT00892047|587339716|FG001|Overall Study|subject burden|3|||
162624096|NCT00892047|587339715|FG000|Overall Study|Lack of Efficacy|0|||
162624097|NCT00892047|587339716|FG001|Overall Study|Lack of Efficacy|2|||
162624098|NCT02217878|587339717|FG000|Overall Study|required morphine due to chest pain|1|||
162965062|NCT02096705|588572041|FG000|Treatment|Other|1|||
162624099|NCT02217878|587339718|FG001|Overall Study|required morphine due to chest pain|2|||
162624100|NCT02217878|587339717|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
162624101|NCT02217878|587339718|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
162624102|NCT01201785|587339722|FG000|Overall Study|Lost to Follow-up|16|||
162624103|NCT02151110|587339723|FG000|Overall Study|Withdrawal by Subject|0|||
162624104|NCT02151110|587339724|FG001|Overall Study|Withdrawal by Subject|0|||
162624105|NCT02151110|587339725|FG002|Overall Study|Withdrawal by Subject|0|||
162624106|NCT02151110|587339726|FG003|Overall Study|Withdrawal by Subject|0|||
162624107|NCT02151110|587339727|FG004|Overall Study|Withdrawal by Subject|0|||
162624108|NCT02151110|587339728|FG005|Overall Study|Withdrawal by Subject|0|||
162624109|NCT02151110|587339729|FG006|Overall Study|Withdrawal by Subject|0|||
162624110|NCT02151110|587339730|FG007|Overall Study|Withdrawal by Subject|1|||
162624111|NCT02151110|587339723|FG000|Overall Study|Lost to Follow-up|0|||
162624112|NCT02151110|587339724|FG001|Overall Study|Lost to Follow-up|0|||
162624113|NCT02151110|587339725|FG002|Overall Study|Lost to Follow-up|0|||
162624114|NCT02151110|587339726|FG003|Overall Study|Lost to Follow-up|0|||
162624115|NCT02151110|587339727|FG004|Overall Study|Lost to Follow-up|0|||
162624116|NCT02151110|587339728|FG005|Overall Study|Lost to Follow-up|0|||
162624117|NCT02151110|587339729|FG006|Overall Study|Lost to Follow-up|0|||
162624118|NCT02151110|587339730|FG007|Overall Study|Lost to Follow-up|2|||
162624119|NCT01999179|587339731|FG000|Overall Study|Adverse Event|1|||
162624120|NCT01999179|587339731|FG000|Overall Study|Lost to Follow-up|1|||
162624121|NCT01999179|587339731|FG000|Overall Study|Change in Therapy|3|||
162624122|NCT01999179|587339731|FG000|Overall Study|New catheter|2|||
162624123|NCT01146665|587339732|FG000|Overall Study|Withdrawal by Subject|10|||
162624124|NCT01146665|587339733|FG001|Overall Study|Withdrawal by Subject|16|||
162624125|NCT01064310|587339736|FG000|Period 1|Adverse Event|7|||
162624126|NCT01064310|587339737|FG001|Period 1|Adverse Event|10|||
162624127|NCT01064310|587339738|FG002|Period 1|Adverse Event|0|||
162624128|NCT01064310|587339736|FG000|Period 1|Physician Decision|1|||
162624129|NCT01064310|587339737|FG001|Period 1|Physician Decision|0|||
162624130|NCT01064310|587339738|FG002|Period 1|Physician Decision|0|||
162624131|NCT01064310|587339736|FG000|Period 1|Withdrawal by Subject|2|||
162624132|NCT01064310|587339737|FG001|Period 1|Withdrawal by Subject|2|||
162624133|NCT01064310|587339738|FG002|Period 1|Withdrawal by Subject|0|||
162624134|NCT01064310|587339736|FG000|Period 1|Lack of Efficacy|3|||
162624135|NCT01064310|587339737|FG001|Period 1|Lack of Efficacy|5|||
162624136|NCT01064310|587339738|FG002|Period 1|Lack of Efficacy|0|||
162624137|NCT01064310|587339736|FG000|Period 1|Entered Open-label Period|1|||
162895861|NCT01421069|588317837|FG000|Overall Period for Extension Study|Protocol Violation|1|||
162895862|NCT01421069|588317837|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
162895863|NCT01421069|588317837|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
162895864|NCT01421069|588317837|FG000|Active Treatment Period|Other|1|||
162895865|NCT01421069|588317837|FG000|Active Treatment Period|No longer willing to participate in study|8|||
162895866|NCT01421069|588317837|FG000|Active Treatment Period|Insufficient clinical response|1|||
162895867|NCT01421069|588317837|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
162895868|NCT01421069|588317837|FG000|Active Treatment Period|Pregnancy|1|||
162895869|NCT01421069|588317837|FG000|Active Treatment Period|Adverse Event|1|||
162895870|NCT01421069|588317837|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
162895871|NCT01421069|588317837|FG000|Active Treatment Period|Enrolled in observational period|29|||
162895872|NCT01421069|588317837|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
162895873|NCT01421069|588317837|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
162895874|NCT01421069|588317837|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
162895875|NCT01421069|588317837|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
162895876|NCT01421069|588317837|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
162895877|NCT01421069|588317837|FG000|2b. Retreatment Period|Protocol Violation|1|||
162895878|NCT01421069|588317837|FG000|Observational Period|Other|1|||
162895879|NCT01421069|588317837|FG000|Observational Period|No longer willing to participate in study|4|||
162895880|NCT01421069|588317837|FG000|Observational Period|Lost to Follow-up|3|||
162895881|NCT01641081|588317838|FG000|Period 1|Sponsor request (potential unblinding)|0|||
162895882|NCT01641081|588317839|FG001|Period 1|Sponsor request (potential unblinding)|0|||
162895883|NCT01641081|588317840|FG002|Period 1|Sponsor request (potential unblinding)|0|||
162895884|NCT01641081|588317841|FG003|Period 1|Sponsor request (potential unblinding)|0|||
162895885|NCT01641081|588317842|FG004|Period 1|Sponsor request (potential unblinding)|0|||
162895886|NCT01641081|588317843|FG005|Period 1|Sponsor request (potential unblinding)|0|||
162895887|NCT01641081|588317844|FG006|Period 1|Sponsor request (potential unblinding)|1|||
162895888|NCT01641081|588317845|FG007|Period 1|Sponsor request (potential unblinding)|0|||
162624138|NCT01064310|587339737|FG001|Period 1|Entered Open-label Period|1|||
162624139|NCT01064310|587339738|FG002|Period 1|Entered Open-label Period|0|||
162624140|NCT01064310|587339736|FG000|Period 2|Adverse Event|2|||
162624141|NCT01064310|587339737|FG001|Period 2|Adverse Event|1|||
162624142|NCT01064310|587339738|FG002|Period 2|Adverse Event|0|||
162624143|NCT01064310|587339736|FG000|Period 2|Physician Decision|0|||
162624144|NCT01064310|587339737|FG001|Period 2|Physician Decision|1|||
162624145|NCT01064310|587339738|FG002|Period 2|Physician Decision|0|||
162624146|NCT01064310|587339736|FG000|Period 2|Entered Open-label Period|1|||
162624147|NCT01064310|587339737|FG001|Period 2|Entered Open-label Period|0|||
162624148|NCT01064310|587339738|FG002|Period 2|Entered Open-label Period|0|||
162624149|NCT01064310|587339736|FG000|Period 2|Lack of Efficacy|1|||
162624150|NCT01064310|587339737|FG001|Period 2|Lack of Efficacy|4|||
162624151|NCT01064310|587339738|FG002|Period 2|Lack of Efficacy|0|||
162624152|NCT01064310|587339736|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
162624153|NCT01064310|587339737|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
162624154|NCT01064310|587339738|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
162624155|NCT01064310|587339736|FG000|Open Label Pazopinib|Adverse Event|0|||
162624156|NCT01064310|587339737|FG001|Open Label Pazopinib|Adverse Event|0|||
162624157|NCT01064310|587339738|FG002|Open Label Pazopinib|Adverse Event|12|||
162624158|NCT01064310|587339736|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
162624159|NCT01064310|587339737|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
162624160|NCT01064310|587339738|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
162624161|NCT01064310|587339736|FG000|Open Label Pazopinib|Physician Decision|0|||
162624162|NCT01064310|587339737|FG001|Open Label Pazopinib|Physician Decision|0|||
162624163|NCT01064310|587339738|FG002|Open Label Pazopinib|Physician Decision|20|||
162624164|NCT00001880|587339739|FG000|Overall Study|Death|14|||
162624165|NCT02639065|587339740|FG000|Study Treatment|Disease Progression|13|||
162624166|NCT02639065|587339740|FG000|Study Treatment|Adverse Event|9|||
162624167|NCT02639065|587339740|FG000|Study Treatment|Withdrawal by Subject|1|||
162624168|NCT02639065|587339740|FG000|Follow up|Subject refused to follow up|1|||
162624169|NCT02639065|587339740|FG000|Follow up|Symptomatic Deterioration|2|||
162624170|NCT02639065|587339740|FG000|Follow up|Death|2|||
162624171|NCT02639065|587339740|FG000|Follow up|Study Terminated|1|||
162624172|NCT02639065|587339740|FG000|Follow up|Disease Progression|3|||
162624173|NCT00660699|587339741|FG000|Overall Study|Withdrawal by Subject|2|||
162624174|NCT05147428|587339742|FG000|Overall Study|Removed prior to mailing|289|||
162624175|NCT05147428|587339743|FG001|Overall Study|Removed prior to mailing|306|||
162624176|NCT05147428|587339744|FG002|Overall Study|Removed prior to mailing|270|||
162624177|NCT05147428|587339742|FG000|Overall Study|Died or disenrolled during blackout period|239|||
162624178|NCT05147428|587339743|FG001|Overall Study|Died or disenrolled during blackout period|278|||
162624179|NCT05147428|587339744|FG002|Overall Study|Died or disenrolled during blackout period|273|||
162624180|NCT03128047|587339745|FG000|Overall Study|Withdrawal by Subject|1|||
162624181|NCT01713686|587341255|FG000|Overall Study|Lost to Follow-up|9|||
162624182|NCT01713686|587341255|FG000|Overall Study|Withdrawal by Subject|6|||
162624183|NCT02385045|587341256|FG000|Overall Study|Endoscopy could not be completed|4|||
162624184|NCT00381485|587341258|FG000|Open-Label Run-In Period|Adverse Event|9|||
162624185|NCT00381485|587341259|FG001|Open-Label Run-In Period|Adverse Event|0|||
162624186|NCT00381485|587341260|FG002|Open-Label Run-In Period|Adverse Event|0|||
162624187|NCT00381485|587341261|FG003|Open-Label Run-In Period|Adverse Event|0|||
162895889|NCT01641081|588317846|FG008|Period 1|Sponsor request (potential unblinding)|0|||
162895890|NCT01641081|588317847|FG009|Period 1|Sponsor request (potential unblinding)|0|||
162895891|NCT01641081|588317838|FG000|Period 1|Protocol Violation|0|||
162895892|NCT01641081|588317839|FG001|Period 1|Protocol Violation|0|||
162895893|NCT01641081|588317840|FG002|Period 1|Protocol Violation|0|||
162895894|NCT01641081|588317841|FG003|Period 1|Protocol Violation|0|||
162895895|NCT01641081|588317842|FG004|Period 1|Protocol Violation|1|||
162895896|NCT01641081|588317843|FG005|Period 1|Protocol Violation|0|||
162895897|NCT01641081|588317844|FG006|Period 1|Protocol Violation|0|||
162895898|NCT01641081|588317845|FG007|Period 1|Protocol Violation|1|||
162895899|NCT01641081|588317846|FG008|Period 1|Protocol Violation|0|||
162895900|NCT01641081|588317847|FG009|Period 1|Protocol Violation|0|||
162895901|NCT01641081|588317838|FG000|Period 1|Adverse Event|1|||
162895902|NCT01641081|588317839|FG001|Period 1|Adverse Event|0|||
162624188|NCT00381485|587341258|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
162624189|NCT00381485|587341259|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162624190|NCT00381485|587341260|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162624191|NCT00381485|587341261|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162624192|NCT00381485|587341258|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
162624193|NCT00381485|587341259|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162624194|NCT00381485|587341260|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162624195|NCT00381485|587341261|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162624196|NCT00381485|587341258|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
162624197|NCT00381485|587341259|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162624198|NCT00381485|587341260|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162624199|NCT00381485|587341261|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162624200|NCT00381485|587341258|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
162624201|NCT00381485|587341259|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
162895903|NCT01641081|588317840|FG002|Period 1|Adverse Event|0|||
162895904|NCT01641081|588317841|FG003|Period 1|Adverse Event|0|||
162895905|NCT01641081|588317842|FG004|Period 1|Adverse Event|0|||
162895906|NCT01641081|588317843|FG005|Period 1|Adverse Event|0|||
162624202|NCT00381485|587341260|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
162624203|NCT00381485|587341261|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
162624204|NCT00381485|587341258|FG000|Open-Label Run-In Period|Treatment failure|1|||
162624205|NCT00381485|587341259|FG001|Open-Label Run-In Period|Treatment failure|0|||
162624206|NCT00381485|587341260|FG002|Open-Label Run-In Period|Treatment failure|0|||
162624207|NCT00381485|587341261|FG003|Open-Label Run-In Period|Treatment failure|0|||
162624208|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162624209|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162624210|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Adverse Event|2|||
162624211|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Adverse Event|5|||
162624212|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
162624213|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
162624214|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
162624215|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
162624216|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162624217|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
162624218|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
162624219|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162624220|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
162624221|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
162624222|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
162624223|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
162624224|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
162624225|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162624226|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
162624227|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162624228|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
162624229|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
162624230|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
162624231|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
162624232|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162624233|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162624234|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162624235|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
162624236|NCT00381485|587341258|FG000|Double-Blind Treatment Period|Administrative|0|||
162624237|NCT00381485|587341259|FG001|Double-Blind Treatment Period|Administrative|1|||
162624238|NCT00381485|587341260|FG002|Double-Blind Treatment Period|Administrative|0|||
162624239|NCT00381485|587341261|FG003|Double-Blind Treatment Period|Administrative|1|||
162624240|NCT01235351|587341262|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
162624241|NCT01235351|587341263|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
162624242|NCT00745823|587341264|FG000|Overall Study|Adverse Event|5|||
162624243|NCT00745823|587341265|FG001|Overall Study|Adverse Event|3|||
162624244|NCT00745823|587341264|FG000|Overall Study|Lack of Efficacy|20|||
162624245|NCT00745823|587341265|FG001|Overall Study|Lack of Efficacy|6|||
162624246|NCT00745823|587341264|FG000|Overall Study|Lost to Follow-up|10|||
162624247|NCT00745823|587341265|FG001|Overall Study|Lost to Follow-up|11|||
162624248|NCT00745823|587341264|FG000|Overall Study|Physician Decision|10|||
162624249|NCT00745823|587341265|FG001|Overall Study|Physician Decision|5|||
162624250|NCT00745823|587341264|FG000|Overall Study|Pregnancy|0|||
162624251|NCT00745823|587341265|FG001|Overall Study|Pregnancy|4|||
162624252|NCT00745823|587341264|FG000|Overall Study|Withdrawal by Subject|14|||
162624253|NCT00745823|587341265|FG001|Overall Study|Withdrawal by Subject|8|||
162624254|NCT00745823|587341264|FG000|Overall Study|Study Terminated by Sponsor|326|||
162624255|NCT00745823|587341265|FG001|Overall Study|Study Terminated by Sponsor|349|||
163051905|NCT04464707|588898751|FG002|Overall Study|Protocol Deviation|0|||
163051906|NCT04464707|588898749|FG000|Overall Study|Lost to Follow-up|2|||
163051907|NCT04464707|588898750|FG001|Overall Study|Lost to Follow-up|0|||
163051908|NCT04464707|588898751|FG002|Overall Study|Lost to Follow-up|1|||
163051909|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
163051910|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
162624256|NCT02980601|587341277|FG000|Overall Study|Lost to Follow-up|2|||
162624257|NCT02980601|587341278|FG001|Overall Study|Lost to Follow-up|2|||
162624258|NCT02980601|587341277|FG000|Overall Study|Death|0|||
162624259|NCT02980601|587341278|FG001|Overall Study|Death|1|||
162624260|NCT02980601|587341277|FG000|Overall Study|Graft loss|1|||
162624261|NCT02980601|587341278|FG001|Overall Study|Graft loss|0|||
162624262|NCT02980601|587341277|FG000|Overall Study|Failed to sign consent|2|||
162708764|NCT02084082|587642888|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162624263|NCT02980601|587341278|FG001|Overall Study|Failed to sign consent|0|||
163051911|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
163051912|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Adverse Event|2|||
162624264|NCT01575769|587341279|FG000|Overall Study|Adverse Event|1|||
162624265|NCT01575769|587341279|FG000|Overall Study|Study terminated by sponsor|40|||
162624266|NCT00290888|587341280|FG000|Overall Study|Physician Decision|3|||
162624267|NCT00290888|587341281|FG001|Overall Study|Physician Decision|1|||
162624268|NCT01473836|587341282|FG000|Overall Study|Adverse Event|4|||
162624269|NCT01473836|587341282|FG000|Overall Study|Lack of Efficacy|1|||
162624270|NCT01473836|587341282|FG000|Overall Study|Does not meet entrance criteria|1|||
162624271|NCT01034631|587341283|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
162624272|NCT01034631|587341284|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
162624273|NCT01034631|587341285|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
162624274|NCT01034631|587341283|FG000|Phase II|Not Evaluable per protocol|0|||
162624275|NCT01034631|587341284|FG001|Phase II|Not Evaluable per protocol|0|||
162624276|NCT01034631|587341285|FG002|Phase II|Not Evaluable per protocol|2|||
162624277|NCT01034631|587341283|FG000|Phase II|Determined Ineligible per protocol|0|||
162624278|NCT01034631|587341284|FG001|Phase II|Determined Ineligible per protocol|1|||
162624279|NCT01034631|587341285|FG002|Phase II|Determined Ineligible per protocol|0|||
162624280|NCT00799383|587341286|FG000|Overall Study|Protocol Violation|1|||
162624281|NCT00799383|587341287|FG001|Overall Study|Protocol Violation|1|||
162624282|NCT00799383|587341286|FG000|Overall Study|Adverse Event|0|||
162624283|NCT00799383|587341287|FG001|Overall Study|Adverse Event|1|||
162624284|NCT00799383|587341286|FG000|Overall Study|Lost to Follow-up|1|||
162624285|NCT00799383|587341287|FG001|Overall Study|Lost to Follow-up|2|||
162624286|NCT00799383|587341286|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
162624287|NCT00799383|587341287|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
162895907|NCT01641081|588317844|FG006|Period 1|Adverse Event|0|||
162895908|NCT01641081|588317845|FG007|Period 1|Adverse Event|2|||
162624288|NCT00799383|587341286|FG000|Overall Study|Withdrawal by Subject|0|||
162624289|NCT00799383|587341287|FG001|Overall Study|Withdrawal by Subject|1|||
162624290|NCT03486223|587341297|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
162624291|NCT03486223|587341298|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
162624292|NCT03068130|587341311|FG000|Overall Study|Adverse Event|19|||
162624293|NCT03068130|587341311|FG000|Overall Study|Death|14|||
162624294|NCT03068130|587341311|FG000|Overall Study|Lost to Follow-up|4|||
162624295|NCT03068130|587341311|FG000|Overall Study|Withdrawal by Subject|26|||
162624296|NCT03068130|587341311|FG000|Overall Study|Administrative Reasons|3|||
162624297|NCT03068130|587341311|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
162895909|NCT01641081|588317846|FG008|Period 1|Adverse Event|0|||
162895910|NCT01641081|588317847|FG009|Period 1|Adverse Event|0|||
162895911|NCT01641081|588317838|FG000|Period 2|Adverse Event|0|||
162624298|NCT03068130|587341311|FG000|Overall Study|Study terminated by sponsor|194|||
162624299|NCT00590720|587341312|FG000|Overall Study|Lost to Follow-up|1|||
162624300|NCT00590720|587341313|FG001|Overall Study|Lost to Follow-up|0|||
162624301|NCT00590720|587341312|FG000|Overall Study|Withdrawal by Subject|0|||
162624302|NCT00590720|587341313|FG001|Overall Study|Withdrawal by Subject|1|||
162624303|NCT03741062|587341318|FG000|Overall Study|Protocol Violation|1|||
162624304|NCT03741062|587341319|FG001|Overall Study|Protocol Violation|0|||
162624305|NCT02527161|587341320|FG000|Overall Study|Failed MRI|52|||
162624306|NCT02527161|587341320|FG000|Overall Study|Withdrawal by Subject|19|||
162624307|NCT02527161|587341320|FG000|Overall Study|Delay in or unfit for surgery|16|||
162624308|NCT02527161|587341320|FG000|Overall Study|MRI contraindication|6|||
162624309|NCT02527161|587341320|FG000|Overall Study|Consent violation|4|||
162624310|NCT02527161|587341320|FG000|Overall Study|Only Recruited to Part A|27|||
162624311|NCT02527161|587341320|FG000|Overall Study|Physician Decision|1|||
162624312|NCT02527161|587341320|FG000|Overall Study|Adverse Event|1|||
162624313|NCT02527161|587341320|FG000|Overall Study|Lost to Follow-up|6|||
162624314|NCT02609828|587341321|FG000|Overall Study|Adverse Event|8|||
162624315|NCT02609828|587341322|FG001|Overall Study|Adverse Event|1|||
162624316|NCT02609828|587341323|FG002|Overall Study|Adverse Event|0|||
162624317|NCT02609828|587341324|FG003|Overall Study|Adverse Event|6|||
162624318|NCT02609828|587341321|FG000|Overall Study|Death|15|||
162624319|NCT02609828|587341322|FG001|Overall Study|Death|1|||
162624320|NCT02609828|587341323|FG002|Overall Study|Death|1|||
162895912|NCT01641081|588317839|FG001|Period 2|Adverse Event|0|||
162895913|NCT01641081|588317840|FG002|Period 2|Adverse Event|0|||
162965063|NCT02096705|588572042|FG001|Treatment|Other|1|||
162624321|NCT02609828|587341324|FG003|Overall Study|Death|19|||
162624322|NCT02609828|587341321|FG000|Overall Study|Insufficient clinical response|2|||
162624323|NCT02609828|587341322|FG001|Overall Study|Insufficient clinical response|1|||
162624324|NCT02609828|587341323|FG002|Overall Study|Insufficient clinical response|0|||
162624325|NCT02609828|587341324|FG003|Overall Study|Insufficient clinical response|0|||
162624326|NCT02609828|587341321|FG000|Overall Study|Lost to Follow-up|0|||
162624327|NCT02609828|587341322|FG001|Overall Study|Lost to Follow-up|0|||
162624328|NCT02609828|587341323|FG002|Overall Study|Lost to Follow-up|0|||
162624329|NCT02609828|587341324|FG003|Overall Study|Lost to Follow-up|1|||
162624330|NCT02609828|587341321|FG000|Overall Study|Protocol Violation|2|||
162895914|NCT01641081|588317841|FG003|Period 2|Adverse Event|0|||
162895915|NCT01641081|588317842|FG004|Period 2|Adverse Event|0|||
162965064|NCT02096705|588572041|FG000|Follow-up|Withdrawal by Subject|1|||
162708765|NCT02084082|587642889|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162708766|NCT02084082|587642890|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
162708767|NCT01822821|587642893|FG000|Overall Study|Eligible surgery cancelled|1|||
162624331|NCT02609828|587341322|FG001|Overall Study|Protocol Violation|0|||
162624332|NCT02609828|587341323|FG002|Overall Study|Protocol Violation|0|||
162624333|NCT02609828|587341324|FG003|Overall Study|Protocol Violation|1|||
162624334|NCT02609828|587341321|FG000|Overall Study|Withdrawal by Subject|12|||
162624335|NCT02609828|587341322|FG001|Overall Study|Withdrawal by Subject|1|||
162624336|NCT02609828|587341323|FG002|Overall Study|Withdrawal by Subject|0|||
162624337|NCT02609828|587341324|FG003|Overall Study|Withdrawal by Subject|10|||
162624338|NCT02609828|587341321|FG000|Overall Study|Other|3|||
162624339|NCT02609828|587341322|FG001|Overall Study|Other|0|||
162624340|NCT02609828|587341323|FG002|Overall Study|Other|0|||
162624341|NCT02609828|587341324|FG003|Overall Study|Other|6|||
162624342|NCT02609828|587341321|FG000|Overall Study|Randomized but not treated|1|||
162624343|NCT02609828|587341322|FG001|Overall Study|Randomized but not treated|0|||
162624344|NCT02609828|587341323|FG002|Overall Study|Randomized but not treated|0|||
162624345|NCT02609828|587341324|FG003|Overall Study|Randomized but not treated|0|||
162624346|NCT01786668|587341327|FG000|Overall Study|Adverse Event|0|||
162624347|NCT01786668|587341328|FG001|Overall Study|Adverse Event|1|||
162624348|NCT01786668|587341329|FG002|Overall Study|Adverse Event|1|||
162624349|NCT01786668|587341330|FG003|Overall Study|Adverse Event|2|||
162624350|NCT01786668|587341327|FG000|Overall Study|Withdrawal by Subject|0|||
162624351|NCT01786668|587341328|FG001|Overall Study|Withdrawal by Subject|0|||
162624352|NCT01786668|587341329|FG002|Overall Study|Withdrawal by Subject|3|||
162624353|NCT01786668|587341330|FG003|Overall Study|Withdrawal by Subject|1|||
162624354|NCT01786668|587341327|FG000|Overall Study|Pregnancy|0|||
162624355|NCT01786668|587341328|FG001|Overall Study|Pregnancy|0|||
162624356|NCT01786668|587341329|FG002|Overall Study|Pregnancy|0|||
162624357|NCT01786668|587341330|FG003|Overall Study|Pregnancy|1|||
162624358|NCT01786668|587341327|FG000|Overall Study|Lost to Follow-up|1|||
162624359|NCT01786668|587341328|FG001|Overall Study|Lost to Follow-up|0|||
162624360|NCT01786668|587341329|FG002|Overall Study|Lost to Follow-up|1|||
162624361|NCT01786668|587341330|FG003|Overall Study|Lost to Follow-up|0|||
162624362|NCT03068455|587341335|FG000|Pre-treatment Period|Disease progression|0|||
162624363|NCT03068455|587341336|FG001|Pre-treatment Period|Disease progression|1|||
162624364|NCT03068455|587341335|FG000|Pre-treatment Period|Participant withdrew consent|1|||
162624365|NCT03068455|587341336|FG001|Pre-treatment Period|Participant withdrew consent|1|||
162624366|NCT03068455|587341335|FG000|Pre-treatment Period|Poor/non-compliance|0|||
162624367|NCT03068455|587341336|FG001|Pre-treatment Period|Poor/non-compliance|1|||
162624368|NCT03068455|587341335|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
162624369|NCT03068455|587341336|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
162624370|NCT03068455|587341335|FG000|Pre-treatment Period|Not reported|2|||
162624371|NCT03068455|587341336|FG001|Pre-treatment Period|Not reported|1|||
162624372|NCT03068455|587341335|FG000|Treatment Period|Disease progression|166|||
162624373|NCT03068455|587341336|FG001|Treatment Period|Disease progression|208|||
162624374|NCT03068455|587341335|FG000|Treatment Period|Study drug toxicity|317|||
162624375|NCT03068455|587341336|FG001|Treatment Period|Study drug toxicity|104|||
162624376|NCT03068455|587341335|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
162708768|NCT01822821|587642894|FG001|Overall Study|Eligible surgery cancelled|1|||
162708769|NCT01822821|587642893|FG000|Overall Study|Other reasons|1|||
162708770|NCT01822821|587642894|FG001|Overall Study|Other reasons|0|||
162708771|NCT02322775|587642895|FG000|Overall Study|Adverse Event|1|||
162708772|NCT02322775|587642896|FG001|Overall Study|Adverse Event|0|||
162708773|NCT02322775|587642895|FG000|Overall Study|Lost to Follow-up|0|||
162708774|NCT02322775|587642896|FG001|Overall Study|Lost to Follow-up|1|||
162708775|NCT02322775|587642895|FG000|Overall Study|Protocol Violation|1|||
162708776|NCT02322775|587642896|FG001|Overall Study|Protocol Violation|0|||
162708777|NCT02322775|587642895|FG000|Overall Study|Withdrawal by Subject|3|||
162708778|NCT02322775|587642896|FG001|Overall Study|Withdrawal by Subject|4|||
162624377|NCT03068455|587341336|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
162624378|NCT03068455|587341335|FG000|Treatment Period|Participant request to stop therapy|33|||
162624379|NCT03068455|587341336|FG001|Treatment Period|Participant request to stop therapy|20|||
162624380|NCT03068455|587341335|FG000|Treatment Period|Participant withdrew consent|5|||
162624381|NCT03068455|587341336|FG001|Treatment Period|Participant withdrew consent|10|||
162624382|NCT03068455|587341335|FG000|Treatment Period|Poor/non-compliance|3|||
162624383|NCT03068455|587341336|FG001|Treatment Period|Poor/non-compliance|0|||
162624384|NCT03068455|587341335|FG000|Treatment Period|Participant no longer meets study criteria|1|||
162624385|NCT03068455|587341336|FG001|Treatment Period|Participant no longer meets study criteria|3|||
162624386|NCT03068455|587341335|FG000|Treatment Period|Other reasons|12|||
162624387|NCT03068455|587341336|FG001|Treatment Period|Other reasons|4|||
162624388|NCT05379231|587341337|FG000|Home Visit|Withdrawal by Subject|2|||
162624389|NCT05379231|587341337|FG000|In-lab Visit|Withdrawal by Subject|2|||
162624390|NCT00446251|587341341|FG000|Overall Study|On-study Transplants|2|||
162624391|NCT00446251|587341341|FG000|Overall Study|Rituximab Infusion Reaction|2|||
162624392|NCT00446251|587341341|FG000|Overall Study|Lost to Follow-up|1|||
162624393|NCT00702689|587341342|FG000|Overall Study|Withdrawal by Subject|4|||
162624394|NCT00702689|587341342|FG000|Overall Study|Recurrent malignancy|1|||
162624395|NCT00702689|587341342|FG000|Overall Study|Adverse Event|1|||
162624396|NCT01986907|587341343|FG000|Overall Study|Adverse Event|11|||
162624397|NCT01986907|587341343|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
162624398|NCT01986907|587341343|FG000|Overall Study|Protocol Violation|4|||
162624399|NCT01986907|587341343|FG000|Overall Study|Withdrawal by Subject|76|||
162624400|NCT01986907|587341343|FG000|Overall Study|Lost to Follow-up|38|||
162624401|NCT01986907|587341343|FG000|Overall Study|Death|9|||
162624402|NCT02805972|587341344|FG000|Washout Period|Lost to Follow-up|3|||
162624403|NCT02805972|587341345|FG001|Washout Period|Lost to Follow-up|0|||
162624404|NCT00939640|587341347|FG000|Overall Study|Physician Decision|1|||
162624405|NCT00389597|587341352|FG000|Overall Study|Lost to Follow-up|8|||
162895916|NCT01641081|588317843|FG005|Period 2|Adverse Event|1|||
162895917|NCT01641081|588317844|FG006|Period 2|Adverse Event|0|||
162895918|NCT01641081|588317845|FG007|Period 2|Adverse Event|0|||
162895919|NCT01641081|588317846|FG008|Period 2|Adverse Event|0|||
162895920|NCT01641081|588317847|FG009|Period 2|Adverse Event|0|||
162895921|NCT01641081|588317838|FG000|Period 2|Withdrawal by Subject|0|||
162895922|NCT01641081|588317839|FG001|Period 2|Withdrawal by Subject|0|||
162965065|NCT02096705|588572042|FG001|Follow-up|Withdrawal by Subject|0|||
162624406|NCT00389597|587341353|FG001|Overall Study|Lost to Follow-up|6|||
162624407|NCT00389597|587341354|FG002|Overall Study|Lost to Follow-up|4|||
162624408|NCT00389597|587341355|FG003|Overall Study|Lost to Follow-up|6|||
162624409|NCT00306189|587341358|FG000|Overall Study|Physician Decision|0|||
162624410|NCT00306189|587341359|FG001|Overall Study|Physician Decision|0|||
162624411|NCT00306189|587341360|FG002|Overall Study|Physician Decision|0|||
162624412|NCT00306189|587341361|FG003|Overall Study|Physician Decision|1|||
162624413|NCT00306189|587341358|FG000|Overall Study|Adverse Event|3|||
162624414|NCT00306189|587341359|FG001|Overall Study|Adverse Event|3|||
162624415|NCT00306189|587341360|FG002|Overall Study|Adverse Event|2|||
162624416|NCT00306189|587341361|FG003|Overall Study|Adverse Event|2|||
162624417|NCT00306189|587341358|FG000|Overall Study|Withdrawal by Subject|4|||
162624418|NCT00306189|587341359|FG001|Overall Study|Withdrawal by Subject|2|||
162624419|NCT00306189|587341360|FG002|Overall Study|Withdrawal by Subject|8|||
162624420|NCT00306189|587341361|FG003|Overall Study|Withdrawal by Subject|1|||
162624421|NCT00306189|587341358|FG000|Overall Study|Ineligibility determined|1|||
162624422|NCT00306189|587341359|FG001|Overall Study|Ineligibility determined|1|||
162624423|NCT00306189|587341360|FG002|Overall Study|Ineligibility determined|1|||
162624424|NCT00306189|587341361|FG003|Overall Study|Ineligibility determined|1|||
162624425|NCT00306189|587341358|FG000|Overall Study|Other|1|||
162624426|NCT00306189|587341359|FG001|Overall Study|Other|0|||
162624427|NCT00306189|587341360|FG002|Overall Study|Other|0|||
162624428|NCT00306189|587341361|FG003|Overall Study|Other|0|||
162624429|NCT00259610|587341362|FG000|Overall Study|Withdrawal by Subject|33|||
162624430|NCT00259610|587341363|FG001|Overall Study|Withdrawal by Subject|25|||
162624431|NCT00259610|587341364|FG002|Overall Study|Withdrawal by Subject|29|||
162624432|NCT00259610|587341365|FG003|Overall Study|Withdrawal by Subject|19|||
162624433|NCT00259610|587341362|FG000|Overall Study|Lost to Follow-up|19|||
162624434|NCT00259610|587341363|FG001|Overall Study|Lost to Follow-up|8|||
162624435|NCT00259610|587341364|FG002|Overall Study|Lost to Follow-up|18|||
162624436|NCT00259610|587341365|FG003|Overall Study|Lost to Follow-up|15|||
162624437|NCT00259610|587341362|FG000|Overall Study|Physician Decision|6|||
162624438|NCT00259610|587341363|FG001|Overall Study|Physician Decision|4|||
162624439|NCT00259610|587341364|FG002|Overall Study|Physician Decision|7|||
162624440|NCT00259610|587341365|FG003|Overall Study|Physician Decision|2|||
162624441|NCT00259610|587341362|FG000|Overall Study|Death|1|||
162624442|NCT00259610|587341363|FG001|Overall Study|Death|1|||
162624443|NCT00259610|587341364|FG002|Overall Study|Death|2|||
162624444|NCT00259610|587341365|FG003|Overall Study|Death|0|||
162624445|NCT00259610|587341362|FG000|Overall Study|non medical reason|6|||
162624446|NCT00259610|587341363|FG001|Overall Study|non medical reason|2|||
162624447|NCT00259610|587341364|FG002|Overall Study|non medical reason|10|||
162624448|NCT00259610|587341365|FG003|Overall Study|non medical reason|3|||
162624449|NCT00259610|587341362|FG000|Overall Study|Adverse Event|3|||
162624450|NCT00259610|587341363|FG001|Overall Study|Adverse Event|4|||
162624451|NCT00259610|587341364|FG002|Overall Study|Adverse Event|5|||
162624452|NCT00259610|587341365|FG003|Overall Study|Adverse Event|2|||
162624453|NCT00259610|587341362|FG000|Overall Study|Serious Adverse Event|8|||
162624454|NCT00259610|587341363|FG001|Overall Study|Serious Adverse Event|2|||
162624455|NCT00259610|587341364|FG002|Overall Study|Serious Adverse Event|2|||
162965066|NCT02096705|588572041|FG000|Follow-up|Adverse Event|2|||
162624456|NCT00259610|587341365|FG003|Overall Study|Serious Adverse Event|2|||
162624457|NCT00282984|587341368|FG000|Overall Study|Death|2|||
162895923|NCT01641081|588317840|FG002|Period 2|Withdrawal by Subject|0|||
162895924|NCT01641081|588317841|FG003|Period 2|Withdrawal by Subject|1|||
162895925|NCT01641081|588317842|FG004|Period 2|Withdrawal by Subject|0|||
162624458|NCT00282984|587341369|FG001|Overall Study|Death|5|||
162624459|NCT00282984|587341368|FG000|Overall Study|Adverse Event|8|||
162624460|NCT00282984|587341369|FG001|Overall Study|Adverse Event|5|||
162895926|NCT01641081|588317843|FG005|Period 2|Withdrawal by Subject|0|||
162624461|NCT00282984|587341368|FG000|Overall Study|Lack of Efficacy|0|||
162624462|NCT00282984|587341369|FG001|Overall Study|Lack of Efficacy|2|||
162624463|NCT00282984|587341368|FG000|Overall Study|Lost to Follow-up|14|||
162624464|NCT00282984|587341369|FG001|Overall Study|Lost to Follow-up|10|||
162624465|NCT00282984|587341368|FG000|Overall Study|Withdrawal by Participant|22|||
162624466|NCT00282984|587341369|FG001|Overall Study|Withdrawal by Participant|34|||
162624467|NCT00282984|587341368|FG000|Overall Study|Participant stopped study medication|2|||
162624468|NCT00282984|587341369|FG001|Overall Study|Participant stopped study medication|2|||
162624469|NCT00282984|587341368|FG000|Overall Study|Participant only allowed phone follow-up|0|||
162624470|NCT00282984|587341369|FG001|Overall Study|Participant only allowed phone follow-up|1|||
162624471|NCT00282984|587341368|FG000|Overall Study|Participant used antipsychosis meds|0|||
162624472|NCT00282984|587341369|FG001|Overall Study|Participant used antipsychosis meds|1|||
162624473|NCT00282984|587341368|FG000|Overall Study|lack of motivation|1|||
162624474|NCT00282984|587341369|FG001|Overall Study|lack of motivation|0|||
162624475|NCT00282984|587341368|FG000|Overall Study|in prison|0|||
162624476|NCT00282984|587341369|FG001|Overall Study|in prison|1|||
162624477|NCT00282984|587341368|FG000|Overall Study|Protocol Violation|2|||
162624478|NCT00282984|587341369|FG001|Overall Study|Protocol Violation|0|||
162624479|NCT00674362|587341370|FG000|Double Blind|Adverse Event|6|||
162624480|NCT00674362|587341371|FG001|Double Blind|Adverse Event|6|||
162624481|NCT00674362|587341370|FG000|Double Blind|Lack of Efficacy|2|||
162624482|NCT00674362|587341371|FG001|Double Blind|Lack of Efficacy|6|||
162624483|NCT00674362|587341370|FG000|Double Blind|Loss of efficacy|0|||
162624484|NCT00674362|587341371|FG001|Double Blind|Loss of efficacy|1|||
162624485|NCT00674362|587341370|FG000|Double Blind|Withdrawal by Subject|4|||
162624486|NCT00674362|587341371|FG001|Double Blind|Withdrawal by Subject|3|||
162624487|NCT00674362|587341370|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
162624488|NCT00674362|587341371|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
162624489|NCT00674362|587341370|FG000|Double Blind|Other: Surgery|0|||
162624490|NCT00674362|587341371|FG001|Double Blind|Other: Surgery|1|||
162624491|NCT00674362|587341370|FG000|Open Label|Adverse Event|1|||
162624492|NCT00674362|587341371|FG001|Open Label|Adverse Event|0|||
162624493|NCT00674362|587341370|FG000|Open Label|Other: Subject moved to extension study|1|||
162624494|NCT00674362|587341371|FG001|Open Label|Other: Subject moved to extension study|0|||
162624495|NCT00939770|587341374|FG000|Overall Study|Adverse Event|1|||
162624496|NCT00939770|587341375|FG001|Overall Study|Adverse Event|1|||
162624497|NCT00939770|587341376|FG002|Overall Study|Adverse Event|0|||
162624498|NCT00939770|587341377|FG003|Overall Study|Adverse Event|0|||
162624499|NCT00939770|587341378|FG004|Overall Study|Adverse Event|6|||
162624500|NCT00939770|587341379|FG005|Overall Study|Adverse Event|2|||
162624501|NCT00939770|587341380|FG006|Overall Study|Adverse Event|1|||
162624502|NCT00939770|587341381|FG007|Overall Study|Adverse Event|1|||
162895927|NCT01641081|588317844|FG006|Period 2|Withdrawal by Subject|2|||
162895928|NCT01641081|588317845|FG007|Period 2|Withdrawal by Subject|0|||
162895929|NCT01641081|588317846|FG008|Period 2|Withdrawal by Subject|0|||
162895930|NCT01641081|588317847|FG009|Period 2|Withdrawal by Subject|0|||
162895931|NCT01641081|588317838|FG000|Period 2|Protocol Violation|1|||
162895932|NCT01641081|588317839|FG001|Period 2|Protocol Violation|0|||
162895933|NCT01641081|588317840|FG002|Period 2|Protocol Violation|0|||
162895934|NCT01641081|588317841|FG003|Period 2|Protocol Violation|0|||
162895935|NCT01641081|588317842|FG004|Period 2|Protocol Violation|0|||
162895936|NCT01641081|588317843|FG005|Period 2|Protocol Violation|0|||
162895937|NCT01641081|588317844|FG006|Period 2|Protocol Violation|0|||
162895938|NCT01641081|588317845|FG007|Period 2|Protocol Violation|0|||
162895939|NCT01641081|588317846|FG008|Period 2|Protocol Violation|0|||
162895940|NCT01641081|588317847|FG009|Period 2|Protocol Violation|0|||
162895941|NCT01641081|588317838|FG000|Period 3|Adverse Event|0|||
162895942|NCT01641081|588317839|FG001|Period 3|Adverse Event|0|||
162895943|NCT01641081|588317840|FG002|Period 3|Adverse Event|1|||
162895944|NCT01641081|588317841|FG003|Period 3|Adverse Event|0|||
162895945|NCT01641081|588317842|FG004|Period 3|Adverse Event|0|||
162965067|NCT02096705|588572042|FG001|Follow-up|Adverse Event|2|||
162895946|NCT01641081|588317843|FG005|Period 3|Adverse Event|0|||
162895947|NCT01641081|588317844|FG006|Period 3|Adverse Event|0|||
162965068|NCT02096705|588572041|FG000|Follow-up|Subjects not reporting status|1|||
162624503|NCT00939770|587341374|FG000|Overall Study|Lack of Efficacy|4|||
162624504|NCT00939770|587341375|FG001|Overall Study|Lack of Efficacy|6|||
162624505|NCT00939770|587341376|FG002|Overall Study|Lack of Efficacy|13|||
162624506|NCT00939770|587341377|FG003|Overall Study|Lack of Efficacy|9|||
162624507|NCT00939770|587341378|FG004|Overall Study|Lack of Efficacy|16|||
162895948|NCT01641081|588317845|FG007|Period 3|Adverse Event|0|||
162895949|NCT01641081|588317846|FG008|Period 3|Adverse Event|0|||
162895950|NCT01641081|588317847|FG009|Period 3|Adverse Event|0|||
162624508|NCT00939770|587341379|FG005|Overall Study|Lack of Efficacy|8|||
162624509|NCT00939770|587341380|FG006|Overall Study|Lack of Efficacy|11|||
162624510|NCT00939770|587341381|FG007|Overall Study|Lack of Efficacy|1|||
162895951|NCT01641081|588317838|FG000|Period 3|Withdrawal by Subject|0|||
162895952|NCT01641081|588317839|FG001|Period 3|Withdrawal by Subject|0|||
162895953|NCT01641081|588317840|FG002|Period 3|Withdrawal by Subject|0|||
162895954|NCT01641081|588317841|FG003|Period 3|Withdrawal by Subject|0|||
162624511|NCT00939770|587341374|FG000|Overall Study|Lost to Follow-up|0|||
162624512|NCT00939770|587341375|FG001|Overall Study|Lost to Follow-up|0|||
162624513|NCT00939770|587341376|FG002|Overall Study|Lost to Follow-up|0|||
162624514|NCT00939770|587341377|FG003|Overall Study|Lost to Follow-up|0|||
162624515|NCT00939770|587341378|FG004|Overall Study|Lost to Follow-up|1|||
162624516|NCT00939770|587341379|FG005|Overall Study|Lost to Follow-up|0|||
162624517|NCT00939770|587341380|FG006|Overall Study|Lost to Follow-up|0|||
162624518|NCT00939770|587341381|FG007|Overall Study|Lost to Follow-up|0|||
162624519|NCT00939770|587341374|FG000|Overall Study|Physician Decision|0|||
162624520|NCT00939770|587341375|FG001|Overall Study|Physician Decision|0|||
162624521|NCT00939770|587341376|FG002|Overall Study|Physician Decision|2|||
162624522|NCT00939770|587341377|FG003|Overall Study|Physician Decision|0|||
162624523|NCT00939770|587341378|FG004|Overall Study|Physician Decision|7|||
162624524|NCT00939770|587341379|FG005|Overall Study|Physician Decision|1|||
162624525|NCT00939770|587341380|FG006|Overall Study|Physician Decision|0|||
162624526|NCT00939770|587341381|FG007|Overall Study|Physician Decision|6|||
162624527|NCT00939770|587341374|FG000|Overall Study|Protocol Violation|0|||
162624528|NCT00939770|587341375|FG001|Overall Study|Protocol Violation|0|||
162624529|NCT00939770|587341376|FG002|Overall Study|Protocol Violation|0|||
162624530|NCT00939770|587341377|FG003|Overall Study|Protocol Violation|0|||
162624531|NCT00939770|587341378|FG004|Overall Study|Protocol Violation|1|||
162624532|NCT00939770|587341379|FG005|Overall Study|Protocol Violation|0|||
162624533|NCT00939770|587341380|FG006|Overall Study|Protocol Violation|0|||
162624534|NCT00939770|587341381|FG007|Overall Study|Protocol Violation|0|||
162624535|NCT00939770|587341374|FG000|Overall Study|Withdrawal by Subject|0|||
162624536|NCT00939770|587341375|FG001|Overall Study|Withdrawal by Subject|1|||
162624537|NCT00939770|587341376|FG002|Overall Study|Withdrawal by Subject|5|||
162624538|NCT00939770|587341377|FG003|Overall Study|Withdrawal by Subject|2|||
162624539|NCT00939770|587341378|FG004|Overall Study|Withdrawal by Subject|6|||
162624540|NCT00939770|587341379|FG005|Overall Study|Withdrawal by Subject|0|||
162624541|NCT00939770|587341380|FG006|Overall Study|Withdrawal by Subject|2|||
162624542|NCT00939770|587341381|FG007|Overall Study|Withdrawal by Subject|2|||
162624543|NCT04665856|587341382|FG000|Overall Study|Site Terminated by Sponsor|1|||
162624544|NCT04665856|587341383|FG001|Overall Study|Site Terminated by Sponsor|0|||
162624545|NCT04665856|587341382|FG000|Overall Study|Withdrawal by Subject|2|||
162624546|NCT04665856|587341383|FG001|Overall Study|Withdrawal by Subject|0|||
162624547|NCT04665856|587341382|FG000|Overall Study|Lost to Follow-up|3|||
162624548|NCT04665856|587341383|FG001|Overall Study|Lost to Follow-up|2|||
162624549|NCT04665856|587341382|FG000|Overall Study|Death|39|||
162624550|NCT04665856|587341383|FG001|Overall Study|Death|44|||
162624551|NCT04665856|587341382|FG000|Overall Study|Ongoing in study|17|||
162624552|NCT04665856|587341383|FG001|Overall Study|Ongoing in study|15|||
162624553|NCT03386448|587341384|FG000|Overall Study|Adverse Event|0|||
162624554|NCT03386448|587341385|FG001|Overall Study|Adverse Event|2|||
162624555|NCT02564796|587341386|FG000|Overall Study|Physician Decision|2|||
162624556|NCT02564796|587341387|FG001|Overall Study|Physician Decision|2|||
162624557|NCT00114530|587341388|FG000|Overall Study|Death|3|||
162624558|NCT00114530|587341389|FG001|Overall Study|Death|11|||
162624559|NCT00114530|587341388|FG000|Overall Study|Lost to Follow-up|1|||
162624560|NCT00114530|587341389|FG001|Overall Study|Lost to Follow-up|1|||
162624561|NCT00114530|587341388|FG000|Overall Study|Physician Decision|1|||
162624562|NCT00114530|587341389|FG001|Overall Study|Physician Decision|1|||
162624563|NCT00114530|587341388|FG000|Overall Study|Withdrawal by Subject|2|||
162624564|NCT00114530|587341389|FG001|Overall Study|Withdrawal by Subject|6|||
162624565|NCT00114530|587341388|FG000|Overall Study|Breast Cancer|1|||
162624566|NCT00114530|587341389|FG001|Overall Study|Breast Cancer|0|||
162624567|NCT00114530|587341388|FG000|Overall Study|Subject decision after endpoint failure|0|||
162624568|NCT00114530|587341389|FG001|Overall Study|Subject decision after endpoint failure|1|||
162624569|NCT00114530|587341388|FG000|Overall Study|Ineligible|1|||
162624570|NCT00114530|587341389|FG001|Overall Study|Ineligible|0|||
162624571|NCT02538029|587341392|FG000|Overall Study|unable to complete cognitive assessments|1|||
162624572|NCT02538029|587341393|FG001|Overall Study|unable to complete cognitive assessments|0|||
162624573|NCT02538029|587341394|FG002|Overall Study|unable to complete cognitive assessments|1|||
162624574|NCT01466153|587341395|FG000|Overall Study|Disease Progression|2|||
162624575|NCT01466153|587341396|FG001|Overall Study|Disease Progression|2|||
162624576|NCT01466153|587341397|FG002|Overall Study|Disease Progression|0|||
162708779|NCT02322775|587642895|FG000|Overall Study|Not willing to perform all FU visits|0|||
162624577|NCT01466153|587341395|FG000|Overall Study|Adverse Event|14|||
162624578|NCT01466153|587341396|FG001|Overall Study|Adverse Event|13|||
162624579|NCT01466153|587341397|FG002|Overall Study|Adverse Event|17|||
162624580|NCT01466153|587341395|FG000|Overall Study|Withdrawal of Consent|2|||
162624581|NCT01466153|587341396|FG001|Overall Study|Withdrawal of Consent|0|||
162624582|NCT01466153|587341397|FG002|Overall Study|Withdrawal of Consent|0|||
162624583|NCT01466153|587341395|FG000|Overall Study|Investigator Discretion|3|||
162624584|NCT01466153|587341396|FG001|Overall Study|Investigator Discretion|2|||
162624585|NCT01466153|587341397|FG002|Overall Study|Investigator Discretion|2|||
162624586|NCT01466153|587341395|FG000|Overall Study|Randomized-Not Treated|2|||
162624587|NCT01466153|587341396|FG001|Overall Study|Randomized-Not Treated|3|||
162624588|NCT01466153|587341397|FG002|Overall Study|Randomized-Not Treated|4|||
162624589|NCT01466153|587341395|FG000|Overall Study|Other-Unspecified|6|||
162624590|NCT01466153|587341396|FG001|Overall Study|Other-Unspecified|4|||
162624591|NCT01466153|587341397|FG002|Overall Study|Other-Unspecified|2|||
162624592|NCT01088997|587341400|FG000|Overall Study|Physician Decision|1|||
162624593|NCT01088997|587341401|FG001|Overall Study|Physician Decision|1|||
162624594|NCT01088997|587341400|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
162624595|NCT01088997|587341401|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
162624596|NCT01088997|587341400|FG000|Overall Study|Excluded prior to receiving drug|1|||
162624597|NCT01088997|587341401|FG001|Overall Study|Excluded prior to receiving drug|1|||
162624598|NCT00688753|587342984|FG000|Overall Study|Disease progression|55|||
162624599|NCT00688753|587342984|FG000|Overall Study|Missing|1|||
162624600|NCT00688753|587342984|FG000|Overall Study|Death|9|||
162624601|NCT00688753|587342984|FG000|Overall Study|Withdrawal by Subject|3|||
162624602|NCT00688753|587342984|FG000|Overall Study|Adverse Event|20|||
162624603|NCT00688753|587342984|FG000|Overall Study|Protocol Violation|1|||
162624604|NCT00688753|587342984|FG000|Overall Study|Lost to Follow-up|3|||
162624605|NCT05996718|587342990|FG000|Overall Study|Lost to Follow-up|3|||
162624606|NCT04840615|587342992|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
162624607|NCT04840615|587342993|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
162624608|NCT04840615|587342994|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
162624609|NCT00115739|587342995|FG000|Overall Study|Lost to Follow-up|3|||
162624610|NCT00259649|587342998|FG000|Overall Study|Lost to Follow-up|7|||
162624611|NCT00259649|587342998|FG000|Overall Study|irregular menses|3|||
162624612|NCT02200211|587342999|FG000|Overall Study|Lost to Follow-up|7|||
162624613|NCT02200211|587343000|FG001|Overall Study|Lost to Follow-up|7|||
162624614|NCT02200211|587343001|FG002|Overall Study|Lost to Follow-up|1|||
162624615|NCT02200211|587343002|FG003|Overall Study|Lost to Follow-up|2|||
162624616|NCT02200211|587342999|FG000|Overall Study|Withdrawal by Subject|1|||
162624617|NCT02200211|587343000|FG001|Overall Study|Withdrawal by Subject|0|||
162624618|NCT02200211|587343001|FG002|Overall Study|Withdrawal by Subject|0|||
162624619|NCT02200211|587343002|FG003|Overall Study|Withdrawal by Subject|0|||
162624620|NCT02501473|587343003|FG000|Overall Study|Study Terminated|2|||
162624621|NCT02501473|587343004|FG001|Overall Study|Study Terminated|3|||
162624622|NCT02501473|587343005|FG002|Overall Study|Study Terminated|7|||
162624623|NCT02501473|587343006|FG003|Overall Study|Study Terminated|9|||
162624624|NCT02501473|587343007|FG004|Overall Study|Study Terminated|2|||
162624625|NCT02501473|587343008|FG005|Overall Study|Study Terminated|10|||
162624626|NCT02501473|587343009|FG006|Overall Study|Study Terminated|1|||
162624627|NCT02501473|587343010|FG007|Overall Study|Study Terminated|0|||
162624628|NCT02501473|587343003|FG000|Overall Study|Withdrawal by Subject|0|||
162624629|NCT02501473|587343004|FG001|Overall Study|Withdrawal by Subject|0|||
162624630|NCT02501473|587343005|FG002|Overall Study|Withdrawal by Subject|3|||
162624631|NCT02501473|587343006|FG003|Overall Study|Withdrawal by Subject|3|||
162624632|NCT02501473|587343007|FG004|Overall Study|Withdrawal by Subject|2|||
162624633|NCT02501473|587343008|FG005|Overall Study|Withdrawal by Subject|2|||
162624634|NCT02501473|587343009|FG006|Overall Study|Withdrawal by Subject|0|||
162624635|NCT02501473|587343010|FG007|Overall Study|Withdrawal by Subject|0|||
162624636|NCT02501473|587343003|FG000|Overall Study|Death|0|||
162624637|NCT02501473|587343004|FG001|Overall Study|Death|0|||
162624638|NCT02501473|587343005|FG002|Overall Study|Death|1|||
162624639|NCT02501473|587343006|FG003|Overall Study|Death|1|||
162624640|NCT02501473|587343007|FG004|Overall Study|Death|0|||
162624641|NCT02501473|587343008|FG005|Overall Study|Death|1|||
162624642|NCT02501473|587343009|FG006|Overall Study|Death|0|||
162624643|NCT02501473|587343010|FG007|Overall Study|Death|0|||
162624644|NCT02501473|587343003|FG000|Overall Study|Lost to Follow-up|1|||
162624645|NCT02501473|587343004|FG001|Overall Study|Lost to Follow-up|0|||
162624646|NCT02501473|587343005|FG002|Overall Study|Lost to Follow-up|1|||
162624647|NCT02501473|587343006|FG003|Overall Study|Lost to Follow-up|0|||
162624648|NCT02501473|587343007|FG004|Overall Study|Lost to Follow-up|0|||
162624649|NCT02501473|587343008|FG005|Overall Study|Lost to Follow-up|1|||
162624650|NCT02501473|587343009|FG006|Overall Study|Lost to Follow-up|0|||
162624651|NCT02501473|587343010|FG007|Overall Study|Lost to Follow-up|0|||
162624652|NCT02501473|587343003|FG000|Overall Study|Reason not specified|0|||
162624653|NCT02501473|587343004|FG001|Overall Study|Reason not specified|0|||
162624654|NCT02501473|587343005|FG002|Overall Study|Reason not specified|1|||
162624655|NCT02501473|587343006|FG003|Overall Study|Reason not specified|1|||
162624656|NCT02501473|587343007|FG004|Overall Study|Reason not specified|0|||
162624657|NCT02501473|587343008|FG005|Overall Study|Reason not specified|0|||
162624658|NCT02501473|587343009|FG006|Overall Study|Reason not specified|0|||
162624659|NCT02501473|587343010|FG007|Overall Study|Reason not specified|0|||
162624660|NCT02954237|587343011|FG000|Overall Study|Withdrawal by Subject|25|||
162624661|NCT02954237|587343011|FG000|Overall Study|Missed visit|16|||
162624662|NCT02954237|587343011|FG000|Overall Study|Death|2|||
162624663|NCT00621985|587343018|FG000|Dexamethasone Admission|Adverse Event|1|||
162624664|NCT01806298|587343019|FG000|Overall Study|Adverse Event|3|||
162624665|NCT01806298|587343019|FG000|Overall Study|Protocol Non-compliance|1|||
162895955|NCT01641081|588317842|FG004|Period 3|Withdrawal by Subject|0|||
162895956|NCT01641081|588317843|FG005|Period 3|Withdrawal by Subject|0|||
162895957|NCT01641081|588317844|FG006|Period 3|Withdrawal by Subject|0|||
162895958|NCT01641081|588317845|FG007|Period 3|Withdrawal by Subject|0|||
162895959|NCT01641081|588317846|FG008|Period 3|Withdrawal by Subject|1|||
162895960|NCT01641081|588317847|FG009|Period 3|Withdrawal by Subject|0|||
162895961|NCT01641081|588317838|FG000|Period 4|Adverse Event|0|||
162895962|NCT01641081|588317839|FG001|Period 4|Adverse Event|1|||
162895963|NCT01641081|588317840|FG002|Period 4|Adverse Event|0|||
162895964|NCT01641081|588317841|FG003|Period 4|Adverse Event|1|||
162895965|NCT01641081|588317842|FG004|Period 4|Adverse Event|0|||
162895966|NCT01641081|588317843|FG005|Period 4|Adverse Event|0|||
162895967|NCT01641081|588317844|FG006|Period 4|Adverse Event|0|||
162895968|NCT01641081|588317845|FG007|Period 4|Adverse Event|0|||
162895969|NCT01641081|588317846|FG008|Period 4|Adverse Event|0|||
162895970|NCT01641081|588317847|FG009|Period 4|Adverse Event|0|||
162895971|NCT01641081|588317838|FG000|Period 5|Adverse Event|0|||
162895972|NCT01641081|588317839|FG001|Period 5|Adverse Event|0|||
162895973|NCT01641081|588317840|FG002|Period 5|Adverse Event|2|||
162895974|NCT01641081|588317841|FG003|Period 5|Adverse Event|0|||
162895975|NCT01641081|588317842|FG004|Period 5|Adverse Event|0|||
162895976|NCT01641081|588317843|FG005|Period 5|Adverse Event|0|||
162895977|NCT01641081|588317844|FG006|Period 5|Adverse Event|0|||
162895978|NCT01641081|588317845|FG007|Period 5|Adverse Event|0|||
162895979|NCT01641081|588317846|FG008|Period 5|Adverse Event|0|||
162895980|NCT01641081|588317847|FG009|Period 5|Adverse Event|0|||
162895981|NCT01095666|588317848|FG000|Overall Study|Lack of Efficacy|0|||
163051913|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Adverse Event|0|||
163051914|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Adverse Event|1|||
163051915|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
163051916|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
163051917|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
162624666|NCT01806298|587343019|FG000|Overall Study|Withdrawal by Subject|1|||
162624667|NCT01806298|587343019|FG000|Overall Study|Other|5|||
162895982|NCT01095666|588317849|FG001|Overall Study|Lack of Efficacy|0|||
162895983|NCT01095666|588317850|FG002|Overall Study|Lack of Efficacy|1|||
162895984|NCT01095666|588317848|FG000|Overall Study|Adverse Event|2|||
162895985|NCT01095666|588317849|FG001|Overall Study|Adverse Event|1|||
162895986|NCT01095666|588317850|FG002|Overall Study|Adverse Event|3|||
162895987|NCT01095666|588317848|FG000|Overall Study|Lost to Follow-up|2|||
162895988|NCT01095666|588317849|FG001|Overall Study|Lost to Follow-up|2|||
162895989|NCT01095666|588317850|FG002|Overall Study|Lost to Follow-up|0|||
162895990|NCT01095666|588317848|FG000|Overall Study|Withdrawal by Subject|6|||
162895991|NCT01095666|588317849|FG001|Overall Study|Withdrawal by Subject|6|||
162895992|NCT01095666|588317850|FG002|Overall Study|Withdrawal by Subject|1|||
162895993|NCT01095666|588317848|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
162895994|NCT01095666|588317849|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
162895995|NCT01095666|588317850|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
162895996|NCT00841672|588317855|FG000|Overall Study|Adverse Event|7|||
162895997|NCT00841672|588317856|FG001|Overall Study|Adverse Event|16|||
162895998|NCT00841672|588317855|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162895999|NCT00841672|588317856|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162896000|NCT00841672|588317855|FG000|Overall Study|Subject withdrew consent|2|||
162896001|NCT00841672|588317856|FG001|Overall Study|Subject withdrew consent|4|||
162896002|NCT00841672|588317855|FG000|Overall Study|Lost to Follow-up|1|||
162896003|NCT00841672|588317856|FG001|Overall Study|Lost to Follow-up|1|||
162896004|NCT00841672|588317855|FG000|Overall Study|Administrative problems|9|||
162896005|NCT00841672|588317856|FG001|Overall Study|Administrative problems|9|||
162896006|NCT00841672|588317855|FG000|Overall Study|Misrandomized|1|||
162896007|NCT00841672|588317856|FG001|Overall Study|Misrandomized|0|||
162896008|NCT00841672|588317855|FG000|Overall Study|Protocol Deviation|0|||
162896009|NCT00841672|588317856|FG001|Overall Study|Protocol Deviation|1|||
162896010|NCT00166517|588317857|FG000|Overall Study|Lost to Follow-up|1|||
162896011|NCT00166517|588317858|FG001|Overall Study|Lost to Follow-up|0|||
162624668|NCT01001377|587343022|FG000|Overall Study|Ineligibility determined|2|||
162624669|NCT01001377|587343023|FG001|Overall Study|Ineligibility determined|0|||
162624670|NCT01001377|587343022|FG000|Overall Study|Withdrawal by Subject|19|||
162624671|NCT01001377|587343023|FG001|Overall Study|Withdrawal by Subject|20|||
162896012|NCT00166517|588317857|FG000|Overall Study|Protocol Violation|4|||
162896013|NCT00166517|588317858|FG001|Overall Study|Protocol Violation|1|||
162896014|NCT00166517|588317857|FG000|Overall Study|Withdrawal by Subject|0|||
162896015|NCT00166517|588317858|FG001|Overall Study|Withdrawal by Subject|1|||
162896016|NCT03094611|588317862|FG000|Overall Study|Lack of Efficacy|1|||
162896017|NCT03094611|588317862|FG000|Overall Study|Stem Cell Transplant|1|||
162896018|NCT04285853|588317863|FG000|Overall Study|Withdrawal by Subject|1|||
162896019|NCT04285853|588317864|FG001|Overall Study|Withdrawal by Subject|0|||
162896020|NCT04285853|588317863|FG000|Overall Study|Lost to Follow-up|9|||
162896021|NCT04285853|588317864|FG001|Overall Study|Lost to Follow-up|5|||
162896022|NCT02758613|588317867|FG000|Treatment|Physician and Sponsor Decision|1|||
162896023|NCT02758613|588317868|FG001|Treatment|Physician and Sponsor Decision|0|||
162896024|NCT02758613|588317869|FG002|Treatment|Physician and Sponsor Decision|0|||
162896025|NCT02758613|588317870|FG003|Treatment|Physician and Sponsor Decision|0|||
162896026|NCT02758613|588317867|FG000|Treatment|Withdrawal by Subject|1|||
162896027|NCT02758613|588317868|FG001|Treatment|Withdrawal by Subject|0|||
162896028|NCT02758613|588317869|FG002|Treatment|Withdrawal by Subject|1|||
162896029|NCT02758613|588317870|FG003|Treatment|Withdrawal by Subject|0|||
162896030|NCT00196196|588317876|FG000|Overall Study|Withdrawal by Subject|2|||
162896031|NCT00196196|588317876|FG000|Overall Study|Did not have required condition (hydroce|5|||
162896032|NCT02343952|588317877|FG000|Study Treatment|Disease Progression|23|||
162896033|NCT02343952|588317877|FG000|Study Treatment|Death|3|||
162624672|NCT01001377|587343022|FG000|Overall Study|Lost to Follow-up|14|||
162896034|NCT02343952|588317877|FG000|Study Treatment|Adverse Event|19|||
162896035|NCT02343952|588317877|FG000|Study Treatment|Withdrawal by Subject|7|||
162965069|NCT02096705|588572042|FG001|Follow-up|Subjects not reporting status|2|||
162624673|NCT01001377|587343023|FG001|Overall Study|Lost to Follow-up|17|||
162624674|NCT01001377|587343022|FG000|Overall Study|Death|391|||
162624675|NCT01001377|587343023|FG001|Overall Study|Death|384|||
162624676|NCT04343261|587343024|FG000|Overall Study|Adverse Event|1|||
162624677|NCT04343261|587343024|FG000|Overall Study|received inadequate amount of antibodies|7|||
162624678|NCT02849678|587343025|FG000|Overall Study|Protocol Violation|3|||
162624679|NCT02849678|587343026|FG001|Overall Study|Protocol Violation|6|||
162624680|NCT00289991|587343027|FG000|Overall Study|Death|35|||
162965070|NCT02905435|588572043|FG000|Overall Study|Death|2|||
162965071|NCT02905435|588572043|FG000|Overall Study|Physician Decision|1|||
162965072|NCT02905435|588572043|FG000|Overall Study|Lost to Follow-up|4|||
162624681|NCT00289991|587343028|FG001|Overall Study|Death|38|||
162624682|NCT00289991|587343027|FG000|Overall Study|Adverse Event|15|||
162896036|NCT02343952|588317877|FG000|Study Treatment|other complicating Diseases|1|||
162896037|NCT02343952|588317877|FG000|Follow up|Withdrawal by Subject|3|||
162896038|NCT02343952|588317877|FG000|Follow up|Death|33|||
162896039|NCT02343952|588317877|FG000|Follow up|Patient does not meet eligibility for study.|1|||
162624683|NCT00289991|587343028|FG001|Overall Study|Adverse Event|13|||
162896040|NCT02343952|588317877|FG000|Follow up|Research department closed by the practice.|5|||
162896041|NCT02343952|588317877|FG000|Follow up|Patient went home to Russia|1|||
162896042|NCT02343952|588317877|FG000|Follow up|Disease Progression|1|||
162896043|NCT02343952|588317877|FG000|Follow up|study terminated|1|||
162624684|NCT00289991|587343027|FG000|Overall Study|Failure of prophylaxis|1|||
162624685|NCT00289991|587343028|FG001|Overall Study|Failure of prophylaxis|1|||
162896044|NCT04018612|588317878|FG000|Overall Study|Withdrawal by Subject|1|||
162896045|NCT04018612|588317879|FG001|Overall Study|Withdrawal by Subject|0|||
162896046|NCT04018612|588317880|FG002|Overall Study|Withdrawal by Subject|1|||
162896047|NCT00361218|588317881|FG000|Overall Study|Lost to Follow-up|11|||
162896048|NCT00361218|588317881|FG000|Overall Study|Personal Reasons|7|||
162896049|NCT00361218|588317881|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
162896050|NCT02671760|588317882|FG000|Overall Study|Lost to Follow-up|0|||
162896051|NCT02671760|588317883|FG001|Overall Study|Lost to Follow-up|1|||
162896052|NCT02671760|588317884|FG002|Overall Study|Lost to Follow-up|0|||
163051918|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
163051919|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
163051920|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
163051921|NCT04613518|588898752|FG000|Double-Blind Treatment Period|Other Reasons|2|||
163051922|NCT04613518|588898753|FG001|Double-Blind Treatment Period|Other Reasons|0|||
163051923|NCT04613518|588898754|FG002|Double-Blind Treatment Period|Other Reasons|0|||
163051924|NCT04613518|588898752|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
163051925|NCT04613518|588898753|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
163051926|NCT04613518|588898754|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163051927|NCT04613518|588898752|FG000|Open-Label Treatment Period|Adverse Event|1|||
163051928|NCT04613518|588898753|FG001|Open-Label Treatment Period|Adverse Event|0|||
163051929|NCT04613518|588898754|FG002|Open-Label Treatment Period|Adverse Event|3|||
162896053|NCT01041404|588317891|FG000|Overall Study|Adverse Event|45|||
162896054|NCT01041404|588317892|FG001|Overall Study|Adverse Event|35|||
162896055|NCT01041404|588317891|FG000|Overall Study|Lack of Efficacy|200|||
162896056|NCT01041404|588317892|FG001|Overall Study|Lack of Efficacy|210|||
162896057|NCT01041404|588317891|FG000|Overall Study|Violation of Selection Criteria|0|||
162896058|NCT01041404|588317892|FG001|Overall Study|Violation of Selection Criteria|1|||
162896059|NCT01041404|588317891|FG000|Overall Study|Protocol Violation|4|||
162896060|NCT01041404|588317892|FG001|Overall Study|Protocol Violation|0|||
162896061|NCT01041404|588317891|FG000|Overall Study|Withdrawal by Subject|29|||
162896062|NCT01041404|588317892|FG001|Overall Study|Withdrawal by Subject|23|||
162896063|NCT01041404|588317891|FG000|Overall Study|Failure to Return|1|||
162896064|NCT01041404|588317892|FG001|Overall Study|Failure to Return|2|||
162896065|NCT01041404|588317891|FG000|Overall Study|Other|11|||
162896066|NCT01041404|588317892|FG001|Overall Study|Other|23|||
162896067|NCT01750840|588317893|FG000|Overall Study|Lost to Follow-up|4|||
162896068|NCT02091921|588317894|FG000|Overall Study|Adverse Event|3|||
162896069|NCT02483078|588317895|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
162896070|NCT02483078|588317896|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
162896071|NCT02483078|588317895|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
162896072|NCT02483078|588317896|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
162896073|NCT02483078|588317895|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162896074|NCT02483078|588317896|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
162624686|NCT00289991|587343027|FG000|Overall Study|Fungal breakthrough infection|0|||
162624687|NCT00289991|587343028|FG001|Overall Study|Fungal breakthrough infection|1|||
162624688|NCT00289991|587343027|FG000|Overall Study|Lost to Follow-up|0|||
162624689|NCT00289991|587343028|FG001|Overall Study|Lost to Follow-up|1|||
162624690|NCT00289991|587343027|FG000|Overall Study|Withdrawal by Subject|2|||
162624691|NCT00289991|587343028|FG001|Overall Study|Withdrawal by Subject|12|||
162624692|NCT00289991|587343027|FG000|Overall Study|Other|5|||
162624693|NCT00289991|587343028|FG001|Overall Study|Other|14|||
162624694|NCT01496807|587343029|FG000|Overall Study|Progressive Disease|21|||
162896075|NCT02483078|588317895|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
162896076|NCT02483078|588317896|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
162896077|NCT02483078|588317895|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
162896078|NCT02483078|588317896|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
162896079|NCT02483078|588317895|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
162896080|NCT02483078|588317896|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
162896081|NCT04876599|588317897|FG000|Overall Study|Missed|2|||
162896082|NCT04876599|588317898|FG001|Overall Study|Missed|0|||
162896083|NCT04876599|588317897|FG000|Overall Study|Declined|2|||
162896084|NCT04876599|588317898|FG001|Overall Study|Declined|3|||
162896085|NCT01607073|588317901|FG000|Overall Study|Adverse Event|1|||
162896086|NCT01432756|588319555|FG000|Overall Study|Lost to Follow-up|1|||
162896087|NCT01432756|588319556|FG001|Overall Study|Lost to Follow-up|0|||
162896088|NCT01432756|588319557|FG002|Overall Study|Lost to Follow-up|2|||
162896089|NCT01432756|588319558|FG003|Overall Study|Lost to Follow-up|1|||
162896090|NCT02712008|588319559|FG000|Baseline (Day 1) up to Week 12|Death|3|||
162896091|NCT02712008|588319560|FG001|Baseline (Day 1) up to Week 12|Death|0|||
162896092|NCT02712008|588319561|FG002|Baseline (Day 1) up to Week 12|Death|0|||
162896093|NCT02712008|588319562|FG003|Baseline (Day 1) up to Week 12|Death|0|||
162896094|NCT02712008|588319563|FG004|Baseline (Day 1) up to Week 12|Death|0|||
162896095|NCT02712008|588319564|FG005|Baseline (Day 1) up to Week 12|Death|0|||
162624695|NCT01496807|587343029|FG000|Overall Study|Participant preference/toxicity|8|||
162624696|NCT01496807|587343029|FG000|Overall Study|Change in diagnosis|1|||
162624697|NCT03330288|587343032|FG000|Overall Study|Other reason|1|||
162624698|NCT03330288|587343033|FG001|Overall Study|Other reason|1|||
162624699|NCT03330288|587343032|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
162624700|NCT03330288|587343033|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
162624701|NCT03330288|587343032|FG000|Overall Study|Adverse Event|1|||
162624702|NCT03330288|587343033|FG001|Overall Study|Adverse Event|0|||
162624703|NCT03330288|587343032|FG000|Overall Study|Withdrawal by Subject|1|||
162624704|NCT03330288|587343033|FG001|Overall Study|Withdrawal by Subject|0|||
162624705|NCT03330288|587343032|FG000|Overall Study|Lost to Follow-up|26|||
162624706|NCT03330288|587343033|FG001|Overall Study|Lost to Follow-up|7|||
162624707|NCT04447794|587343034|FG000|Overall Study|Lost to Follow-up|2|||
162624708|NCT04447794|587343035|FG001|Overall Study|Lost to Follow-up|3|||
162624709|NCT04447794|587343036|FG002|Overall Study|Lost to Follow-up|8|||
162624710|NCT04447794|587343034|FG000|Overall Study|Withdrawal by Subject|1|||
162624711|NCT04447794|587343035|FG001|Overall Study|Withdrawal by Subject|1|||
162624712|NCT04447794|587343036|FG002|Overall Study|Withdrawal by Subject|0|||
162896096|NCT02712008|588319565|FG006|Baseline (Day 1) up to Week 12|Death|0|||
162896097|NCT02712008|588319566|FG007|Baseline (Day 1) up to Week 12|Death|0|||
162896098|NCT02712008|588319559|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162896099|NCT02712008|588319560|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
162896100|NCT02712008|588319561|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
162896101|NCT02712008|588319562|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162896102|NCT02712008|588319563|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162624713|NCT00205881|587343041|FG000|Overall Study|Withdrawal by Subject|16|||
162624714|NCT04203498|587343044|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
162624715|NCT04203498|587343045|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
162896103|NCT02712008|588319564|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162896104|NCT02712008|588319565|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162896105|NCT02712008|588319566|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162896106|NCT02712008|588319559|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
162896107|NCT02712008|588319560|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896108|NCT02712008|588319561|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
162896109|NCT02712008|588319562|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896110|NCT02712008|588319563|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896111|NCT02712008|588319564|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896112|NCT02712008|588319565|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896113|NCT02712008|588319566|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162896114|NCT02712008|588319559|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896115|NCT02712008|588319560|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896116|NCT02712008|588319561|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
162896117|NCT02712008|588319562|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162624716|NCT04203498|587343044|FG000|Overall Study|Withdrawal of patient consent|7|||
162624717|NCT04203498|587343045|FG001|Overall Study|Withdrawal of patient consent|2|||
162624718|NCT04203498|587343044|FG000|Overall Study|Adverse Event|4|||
162624719|NCT04203498|587343045|FG001|Overall Study|Adverse Event|1|||
162624720|NCT04203498|587343044|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
162624721|NCT04203498|587343045|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
162896118|NCT02712008|588319563|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896119|NCT02712008|588319564|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896120|NCT02712008|588319565|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896121|NCT02712008|588319566|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
162896122|NCT02712008|588319559|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162624722|NCT04203498|587343044|FG000|Overall Study|Did not receive IMP|2|||
162624723|NCT04203498|587343045|FG001|Overall Study|Did not receive IMP|0|||
162624724|NCT00334958|587343047|FG000|Overall Study|Medication Noncompliance|0|||
162624725|NCT00334958|587343048|FG001|Overall Study|Medication Noncompliance|3|||
162624726|NCT00334958|587343047|FG000|Overall Study|Protocol Violation|2|||
162624727|NCT00334958|587343048|FG001|Overall Study|Protocol Violation|2|||
162624728|NCT00334958|587343047|FG000|Overall Study|Request of the investigator or sponsor|0|||
162624729|NCT00334958|587343048|FG001|Overall Study|Request of the investigator or sponsor|1|||
162624730|NCT00334958|587343047|FG000|Overall Study|Withdrawal by Subject|7|||
162624731|NCT00334958|587343048|FG001|Overall Study|Withdrawal by Subject|4|||
162624732|NCT00334958|587343047|FG000|Overall Study|Adverse Event|27|||
162624733|NCT00334958|587343048|FG001|Overall Study|Adverse Event|12|||
162624734|NCT00334958|587343047|FG000|Overall Study|Other|1|||
162624735|NCT00334958|587343048|FG001|Overall Study|Other|2|||
162624736|NCT01548287|587343049|FG000|Screening|No reason provided|0|||
162624737|NCT01548287|587343050|FG001|Screening|No reason provided|0|||
162624738|NCT01548287|587343051|FG002|Screening|No reason provided|0|||
162624739|NCT01548287|587343052|FG003|Screening|No reason provided|0|||
162624740|NCT01548287|587343053|FG004|Screening|No reason provided|9|||
162624741|NCT01548287|587343049|FG000|Screening|Did not meet eligibility criteria|0|||
162624742|NCT01548287|587343050|FG001|Screening|Did not meet eligibility criteria|0|||
162624743|NCT01548287|587343051|FG002|Screening|Did not meet eligibility criteria|0|||
162624744|NCT01548287|587343052|FG003|Screening|Did not meet eligibility criteria|0|||
162624745|NCT01548287|587343053|FG004|Screening|Did not meet eligibility criteria|74|||
162624746|NCT01548287|587343049|FG000|Randomized Period|Did not meet inclusion criteria|0|||
162624747|NCT01548287|587343050|FG001|Randomized Period|Did not meet inclusion criteria|0|||
162624748|NCT01548287|587343051|FG002|Randomized Period|Did not meet inclusion criteria|2|||
162624749|NCT01548287|587343052|FG003|Randomized Period|Did not meet inclusion criteria|0|||
162624750|NCT01548287|587343053|FG004|Randomized Period|Did not meet inclusion criteria|0|||
162624751|NCT01548287|587343049|FG000|Randomized Period|Adverse Event|0|||
162624752|NCT01548287|587343050|FG001|Randomized Period|Adverse Event|2|||
162624753|NCT01548287|587343051|FG002|Randomized Period|Adverse Event|5|||
162624754|NCT01548287|587343052|FG003|Randomized Period|Adverse Event|0|||
162624755|NCT01548287|587343053|FG004|Randomized Period|Adverse Event|0|||
162624756|NCT02762578|587343058|FG000|Overall Study|Adverse Event|1|||
162624757|NCT02762578|587343059|FG001|Overall Study|Adverse Event|6|||
162624758|NCT02762578|587343058|FG000|Overall Study|Protocol Violation|4|||
162624759|NCT02762578|587343059|FG001|Overall Study|Protocol Violation|2|||
162624760|NCT02762578|587343058|FG000|Overall Study|Withdrawal by Subject|4|||
162896123|NCT02712008|588319560|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
162896124|NCT02712008|588319561|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162896125|NCT02712008|588319562|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162896126|NCT02712008|588319563|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162624761|NCT02762578|587343059|FG001|Overall Study|Withdrawal by Subject|2|||
162624762|NCT02762578|587343058|FG000|Overall Study|Unclassified|6|||
162624763|NCT02762578|587343059|FG001|Overall Study|Unclassified|0|||
162624764|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162624765|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162896127|NCT02712008|588319564|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162896128|NCT02712008|588319565|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162896129|NCT02712008|588319566|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
162896130|NCT02712008|588319559|FG000|From Week 12 up to Week 36|Adverse Event|0|||
162896131|NCT02712008|588319560|FG001|From Week 12 up to Week 36|Adverse Event|0|||
162896132|NCT02712008|588319561|FG002|From Week 12 up to Week 36|Adverse Event|0|||
162896133|NCT02712008|588319562|FG003|From Week 12 up to Week 36|Adverse Event|0|||
162896134|NCT02712008|588319563|FG004|From Week 12 up to Week 36|Adverse Event|1|||
162896135|NCT02712008|588319564|FG005|From Week 12 up to Week 36|Adverse Event|0|||
162896136|NCT02712008|588319565|FG006|From Week 12 up to Week 36|Adverse Event|0|||
162896137|NCT02712008|588319566|FG007|From Week 12 up to Week 36|Adverse Event|2|||
162896138|NCT02712008|588319559|FG000|From Week 12 up to Week 36|Death|1|||
162896139|NCT02712008|588319560|FG001|From Week 12 up to Week 36|Death|0|||
162896140|NCT02712008|588319561|FG002|From Week 12 up to Week 36|Death|0|||
162896141|NCT02712008|588319562|FG003|From Week 12 up to Week 36|Death|0|||
162896142|NCT02712008|588319563|FG004|From Week 12 up to Week 36|Death|0|||
162896143|NCT02712008|588319564|FG005|From Week 12 up to Week 36|Death|0|||
162896144|NCT02712008|588319565|FG006|From Week 12 up to Week 36|Death|1|||
162896145|NCT02712008|588319566|FG007|From Week 12 up to Week 36|Death|0|||
162896146|NCT02712008|588319559|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896147|NCT02712008|588319560|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896148|NCT02712008|588319561|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896149|NCT02712008|588319562|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
162896150|NCT02712008|588319563|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896151|NCT02712008|588319564|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896152|NCT02712008|588319565|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
162896153|NCT02712008|588319566|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
162896154|NCT02712008|588319559|FG000|From Week 12 up to Week 36|Physician Decision|0|||
162896155|NCT02712008|588319560|FG001|From Week 12 up to Week 36|Physician Decision|0|||
162896156|NCT02712008|588319561|FG002|From Week 12 up to Week 36|Physician Decision|0|||
162896157|NCT02712008|588319562|FG003|From Week 12 up to Week 36|Physician Decision|1|||
162896158|NCT02712008|588319563|FG004|From Week 12 up to Week 36|Physician Decision|1|||
162896159|NCT02712008|588319564|FG005|From Week 12 up to Week 36|Physician Decision|0|||
162896160|NCT02712008|588319565|FG006|From Week 12 up to Week 36|Physician Decision|0|||
162896161|NCT02712008|588319566|FG007|From Week 12 up to Week 36|Physician Decision|0|||
162896162|NCT02712008|588319559|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896163|NCT02712008|588319560|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896164|NCT02712008|588319561|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896165|NCT02712008|588319562|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896166|NCT02712008|588319563|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896167|NCT02712008|588319564|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
162896168|NCT02712008|588319565|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
162896169|NCT02712008|588319566|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
162896170|NCT00364351|588319567|FG000|Overall Study|Adverse Event|90|||
162896171|NCT00364351|588319568|FG001|Overall Study|Adverse Event|44|||
162896172|NCT00364351|588319567|FG000|Overall Study|Condition under investigation worsened|469|||
162896173|NCT00364351|588319568|FG001|Overall Study|Condition under investigation worsened|497|||
162896174|NCT00364351|588319567|FG000|Overall Study|Prohibited concomitant medication|0|||
162896175|NCT00364351|588319568|FG001|Overall Study|Prohibited concomitant medication|2|||
162896176|NCT00364351|588319567|FG000|Overall Study|Lost to Follow-up|1|||
162896177|NCT00364351|588319568|FG001|Overall Study|Lost to Follow-up|1|||
162896178|NCT00364351|588319567|FG000|Overall Study|Withdrawal by Subject|30|||
162896179|NCT00364351|588319568|FG001|Overall Study|Withdrawal by Subject|29|||
163058601|NCT00042289|588924241|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
162624766|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162624767|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
162624768|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162624769|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162624770|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162624771|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162624772|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162624773|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
162624774|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162624775|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162896180|NCT00364351|588319567|FG000|Overall Study|Incorrect enrollment|1|||
162896181|NCT00364351|588319568|FG001|Overall Study|Incorrect enrollment|1|||
162896182|NCT00364351|588319567|FG000|Overall Study|Sponsor decision|1|||
162896183|NCT00364351|588319568|FG001|Overall Study|Sponsor decision|0|||
162896184|NCT00364351|588319567|FG000|Overall Study|Poor treatment compliance|0|||
162896185|NCT00364351|588319568|FG001|Overall Study|Poor treatment compliance|3|||
162896186|NCT00364351|588319567|FG000|Overall Study|Investigator error|0|||
162896187|NCT00364351|588319568|FG001|Overall Study|Investigator error|2|||
162896188|NCT00364351|588319567|FG000|Overall Study|Patient could not travel to site|0|||
162896189|NCT00364351|588319568|FG001|Overall Study|Patient could not travel to site|1|||
162896190|NCT00364351|588319567|FG000|Overall Study|Randomised treatment not started|0|||
162896191|NCT00364351|588319568|FG001|Overall Study|Randomised treatment not started|3|||
162896192|NCT00509028|588319572|FG000|Overall Study|Adverse Event|2|||
162896193|NCT00509028|588319573|FG001|Overall Study|Adverse Event|0|||
162896194|NCT00509028|588319572|FG000|Overall Study|Withdrawal by Subject|4|||
162896195|NCT00509028|588319573|FG001|Overall Study|Withdrawal by Subject|3|||
162896196|NCT00509028|588319572|FG000|Overall Study|Lost to Follow-up|0|||
162896197|NCT00509028|588319573|FG001|Overall Study|Lost to Follow-up|1|||
162896198|NCT00509028|588319572|FG000|Overall Study|Protocol Violation|4|||
162896199|NCT00509028|588319573|FG001|Overall Study|Protocol Violation|2|||
162896200|NCT00509028|588319572|FG000|Overall Study|Non-compliance|2|||
162896201|NCT00509028|588319573|FG001|Overall Study|Non-compliance|1|||
162896202|NCT02996110|588319574|FG000|Pre-Treatment|Other Reasons|0|||
162896203|NCT02996110|588319575|FG001|Pre-Treatment|Other Reasons|1|||
162896204|NCT02996110|588319576|FG002|Pre-Treatment|Other Reasons|0|||
162896205|NCT02996110|588319577|FG003|Pre-Treatment|Other Reasons|0|||
162896206|NCT02996110|588319578|FG004|Pre-Treatment|Other Reasons|1|||
162896207|NCT02996110|588319574|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
162896208|NCT02996110|588319575|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
162896209|NCT02996110|588319576|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
162896210|NCT02996110|588319577|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
162896211|NCT02996110|588319578|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
162896212|NCT02996110|588319574|FG000|Track 1|Disease Progression|15|||
162896213|NCT02996110|588319575|FG001|Track 1|Disease Progression|17|||
162896214|NCT02996110|588319576|FG002|Track 1|Disease Progression|0|||
162896215|NCT02996110|588319577|FG003|Track 1|Disease Progression|0|||
162896216|NCT02996110|588319578|FG004|Track 1|Disease Progression|0|||
162896217|NCT02996110|588319574|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
162896218|NCT02996110|588319575|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
162896219|NCT02996110|588319576|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
162896220|NCT02996110|588319577|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
162896221|NCT02996110|588319578|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
162896222|NCT02996110|588319574|FG000|Track 1|Study Drug Toxicity|5|||
162896223|NCT02996110|588319575|FG001|Track 1|Study Drug Toxicity|3|||
162896224|NCT02996110|588319576|FG002|Track 1|Study Drug Toxicity|0|||
162896225|NCT02996110|588319577|FG003|Track 1|Study Drug Toxicity|0|||
162896226|NCT02996110|588319578|FG004|Track 1|Study Drug Toxicity|0|||
162896227|NCT02996110|588319574|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
162896228|NCT02996110|588319575|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
162896229|NCT02996110|588319576|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
162896230|NCT02996110|588319577|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
162896231|NCT02996110|588319578|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
162896232|NCT02996110|588319574|FG000|Track 1|Administrative Reason by Sponsor|0|||
162896233|NCT02996110|588319575|FG001|Track 1|Administrative Reason by Sponsor|1|||
162896234|NCT02996110|588319576|FG002|Track 1|Administrative Reason by Sponsor|0|||
162896235|NCT02996110|588319577|FG003|Track 1|Administrative Reason by Sponsor|0|||
162896236|NCT02996110|588319578|FG004|Track 1|Administrative Reason by Sponsor|0|||
162896237|NCT02996110|588319574|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
162896238|NCT02996110|588319575|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
162896239|NCT02996110|588319576|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
162896240|NCT02996110|588319577|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
162896241|NCT02996110|588319578|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
162896242|NCT02996110|588319574|FG000|Track 2|Disease Progression|33|||
162896243|NCT02996110|588319575|FG001|Track 2|Disease Progression|26|||
162896244|NCT02996110|588319576|FG002|Track 2|Disease Progression|19|||
162896245|NCT02996110|588319577|FG003|Track 2|Disease Progression|16|||
162896246|NCT02996110|588319578|FG004|Track 2|Disease Progression|15|||
162896247|NCT02996110|588319574|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
162896248|NCT02996110|588319575|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
162896249|NCT02996110|588319576|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
162896250|NCT02996110|588319577|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
162896251|NCT02996110|588319578|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
162965073|NCT02377349|588572047|FG000|Overall Study|Serious Adverse Event|1|||
162965074|NCT02377349|588572048|FG001|Overall Study|Serious Adverse Event|0|||
162896252|NCT02996110|588319574|FG000|Track 2|Death|0|||
162965075|NCT02377349|588572047|FG000|Overall Study|Protocol Violation|3|||
162896253|NCT02996110|588319575|FG001|Track 2|Death|0|||
162896254|NCT02996110|588319576|FG002|Track 2|Death|1|||
162896255|NCT02996110|588319577|FG003|Track 2|Death|0|||
162896256|NCT02996110|588319578|FG004|Track 2|Death|1|||
162896257|NCT02996110|588319574|FG000|Track 2|Study Drug Toxicity|4|||
162896258|NCT02996110|588319575|FG001|Track 2|Study Drug Toxicity|1|||
162896259|NCT02996110|588319576|FG002|Track 2|Study Drug Toxicity|4|||
162896260|NCT02996110|588319577|FG003|Track 2|Study Drug Toxicity|1|||
162624776|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162624777|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162896261|NCT02996110|588319578|FG004|Track 2|Study Drug Toxicity|0|||
162896262|NCT02996110|588319574|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
162896263|NCT02996110|588319575|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
162896264|NCT02996110|588319576|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
162896265|NCT02996110|588319577|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
162896266|NCT02996110|588319578|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
162896267|NCT02996110|588319574|FG000|Track 2|Participant Withdrew Consent|1|||
162896268|NCT02996110|588319575|FG001|Track 2|Participant Withdrew Consent|2|||
162896269|NCT02996110|588319576|FG002|Track 2|Participant Withdrew Consent|3|||
162896270|NCT02996110|588319577|FG003|Track 2|Participant Withdrew Consent|1|||
162896271|NCT02996110|588319578|FG004|Track 2|Participant Withdrew Consent|1|||
162896272|NCT02996110|588319574|FG000|Track 2|Other Reasons|0|||
162896273|NCT02996110|588319575|FG001|Track 2|Other Reasons|0|||
162896274|NCT02996110|588319576|FG002|Track 2|Other Reasons|1|||
162896275|NCT02996110|588319577|FG003|Track 2|Other Reasons|0|||
162896276|NCT02996110|588319578|FG004|Track 2|Other Reasons|1|||
162896277|NCT02436915|588319579|FG000|Overall Study|Withdrawal by Subject|0|||
162896278|NCT02436915|588319580|FG001|Overall Study|Withdrawal by Subject|1|||
162896279|NCT03805971|588319581|FG000|Overall Study|Withdrawal by Subject|1|||
162896280|NCT03805971|588319581|FG000|Overall Study|Protocol Violation|2|||
162896281|NCT02939976|588319589|FG000|Overall Study|Lost to Follow-up|7|||
162896282|NCT02939976|588319590|FG001|Overall Study|Lost to Follow-up|1|||
162896283|NCT02939976|588319591|FG002|Overall Study|Lost to Follow-up|1|||
162896284|NCT02939976|588319592|FG003|Overall Study|Lost to Follow-up|2|||
162896285|NCT02939976|588319589|FG000|Overall Study|Withdrawal by Subject|4|||
162896286|NCT02939976|588319590|FG001|Overall Study|Withdrawal by Subject|0|||
162896287|NCT02939976|588319591|FG002|Overall Study|Withdrawal by Subject|2|||
162896288|NCT02939976|588319592|FG003|Overall Study|Withdrawal by Subject|4|||
162896289|NCT02939976|588319589|FG000|Overall Study|Due to early study closure|4|||
162896290|NCT02939976|588319590|FG001|Overall Study|Due to early study closure|3|||
162896291|NCT02939976|588319591|FG002|Overall Study|Due to early study closure|2|||
162896292|NCT02939976|588319592|FG003|Overall Study|Due to early study closure|3|||
162896293|NCT01585168|588319597|FG000|Overall Study|Lost to Follow-up|3|||
162896294|NCT01585168|588319598|FG001|Overall Study|Lost to Follow-up|1|||
162896295|NCT01585168|588319599|FG002|Overall Study|Lost to Follow-up|1|||
162896296|NCT01585168|588319600|FG003|Overall Study|Lost to Follow-up|1|||
162896297|NCT01192100|588319601|FG000|Overall Study|Withdrawal by Subject|0|||
162896298|NCT01192100|588319602|FG001|Overall Study|Withdrawal by Subject|0|||
162896299|NCT01192100|588319603|FG002|Overall Study|Withdrawal by Subject|0|||
162896300|NCT01192100|588319604|FG003|Overall Study|Withdrawal by Subject|0|||
162896301|NCT01192100|588319605|FG004|Overall Study|Withdrawal by Subject|1|||
162896302|NCT01192100|588319606|FG005|Overall Study|Withdrawal by Subject|0|||
162896303|NCT01192100|588319601|FG000|Overall Study|Protocol Violation|0|||
162896304|NCT01192100|588319602|FG001|Overall Study|Protocol Violation|0|||
162896305|NCT01192100|588319603|FG002|Overall Study|Protocol Violation|0|||
162896306|NCT01192100|588319604|FG003|Overall Study|Protocol Violation|1|||
162896307|NCT01192100|588319605|FG004|Overall Study|Protocol Violation|0|||
162896308|NCT01192100|588319606|FG005|Overall Study|Protocol Violation|0|||
162896309|NCT02057068|588319607|FG000|Overall Study|Withdrawal by Subject|2|||
162896310|NCT02057068|588319608|FG001|Overall Study|Withdrawal by Subject|2|||
162896311|NCT02057068|588319607|FG000|Overall Study|Caregiver (CG) Health|0|||
162896312|NCT02057068|588319608|FG001|Overall Study|Caregiver (CG) Health|2|||
162896313|NCT02057068|588319607|FG000|Overall Study|Carepartner (CP) Health|4|||
162896314|NCT02057068|588319608|FG001|Overall Study|Carepartner (CP) Health|2|||
162896315|NCT02057068|588319607|FG000|Overall Study|Lost to Follow-up|2|||
162896316|NCT02057068|588319608|FG001|Overall Study|Lost to Follow-up|2|||
162896317|NCT00329784|588319612|FG000|Overall Study|Lost to Follow-up|0|||
162896318|NCT00329784|588319613|FG001|Overall Study|Lost to Follow-up|1|||
162896319|NCT00329784|588319614|FG002|Overall Study|Lost to Follow-up|0|||
162896320|NCT00329784|588319615|FG003|Overall Study|Lost to Follow-up|0|||
162896321|NCT00329784|588319612|FG000|Overall Study|Withdrawal by Subject|4|||
162624778|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162624779|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
162624780|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624781|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162896322|NCT00329784|588319613|FG001|Overall Study|Withdrawal by Subject|2|||
162896323|NCT00329784|588319614|FG002|Overall Study|Withdrawal by Subject|0|||
162896324|NCT00329784|588319615|FG003|Overall Study|Withdrawal by Subject|0|||
162896325|NCT00329784|588319612|FG000|Overall Study|Other|1|||
162896326|NCT00329784|588319613|FG001|Overall Study|Other|2|||
162896327|NCT00329784|588319614|FG002|Overall Study|Other|0|||
162896328|NCT00329784|588319615|FG003|Overall Study|Other|0|||
162896329|NCT01928082|588319622|FG000|Overall Study|Study terminated.|1|||
162896330|NCT05563714|588319623|FG000|Overall Study|Death|2|||
162896331|NCT05563714|588319624|FG001|Overall Study|Death|2|||
162896332|NCT05563714|588319625|FG002|Overall Study|Death|0|||
162896333|NCT05563714|588319626|FG003|Overall Study|Death|0|||
162896334|NCT05563714|588319623|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
162896335|NCT05563714|588319624|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
162896336|NCT05563714|588319625|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
162896337|NCT05563714|588319626|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
162896338|NCT05563714|588319623|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
162896339|NCT05563714|588319624|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
162896340|NCT05563714|588319625|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
162624782|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
162624783|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624784|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624785|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624786|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624787|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624788|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Other|0|||
162624789|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Other|0|||
162624790|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Other|1|||
162896341|NCT05563714|588319626|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
162924467|NCT03539952|588423898|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
162924468|NCT03539952|588423897|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
162924469|NCT03539952|588423898|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
162924470|NCT03539952|588423897|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
162924471|NCT03539952|588423898|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
162924472|NCT02184988|588423899|FG000|Overall Study|Pregnancy|2|||
162924473|NCT02184988|588423899|FG000|Overall Study|Adverse Event|2|||
162924474|NCT02184988|588423899|FG000|Overall Study|moving away/travelling/unable to complet|6|||
162924475|NCT02184988|588423899|FG000|Overall Study|work scheduling issues|4|||
162924476|NCT02184988|588423899|FG000|Overall Study|various other reasons|9|||
162924477|NCT02184988|588423899|FG000|Overall Study|Lost to Follow-up|32|||
162924478|NCT01371006|588426025|FG000|Overall Study|Adverse Event|1|||
162924479|NCT01371006|588426026|FG001|Overall Study|Adverse Event|0|||
162924480|NCT03256526|588426027|FG000|Overall Study|Adverse Event|1|||
162924481|NCT03256526|588426028|FG001|Overall Study|Adverse Event|0|||
162924482|NCT03256526|588426029|FG002|Overall Study|Adverse Event|1|||
162924483|NCT03256526|588426027|FG000|Overall Study|Lost to Follow-up|1|||
162924484|NCT03256526|588426028|FG001|Overall Study|Lost to Follow-up|0|||
162924485|NCT03256526|588426029|FG002|Overall Study|Lost to Follow-up|2|||
162924486|NCT00891527|588426030|FG000|Overall Study|Withdrawal by Subject|2|||
162924487|NCT01186744|588426031|FG000|Overall Study|Lack of Efficacy|156|||
162924488|NCT01186744|588426032|FG001|Overall Study|Lack of Efficacy|99|||
162924489|NCT01186744|588426033|FG002|Overall Study|Lack of Efficacy|0|||
162924490|NCT01186744|588426034|FG003|Overall Study|Lack of Efficacy|2|||
162924491|NCT01186744|588426035|FG004|Overall Study|Lack of Efficacy|2|||
162924492|NCT01186744|588426036|FG005|Overall Study|Lack of Efficacy|5|||
162924493|NCT01186744|588426031|FG000|Overall Study|Protocol Violation|1|||
162924494|NCT01186744|588426032|FG001|Overall Study|Protocol Violation|2|||
162924495|NCT01186744|588426033|FG002|Overall Study|Protocol Violation|0|||
162924496|NCT01186744|588426034|FG003|Overall Study|Protocol Violation|1|||
162924497|NCT01186744|588426035|FG004|Overall Study|Protocol Violation|1|||
162924498|NCT01186744|588426036|FG005|Overall Study|Protocol Violation|2|||
162896342|NCT05563714|588319623|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
162896343|NCT05563714|588319624|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
162896344|NCT05563714|588319625|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
162896345|NCT05563714|588319626|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
162896346|NCT05563714|588319623|FG000|Overall Study|Lost to Follow-up|22|||
162896347|NCT05563714|588319624|FG001|Overall Study|Lost to Follow-up|19|||
162896348|NCT05563714|588319625|FG002|Overall Study|Lost to Follow-up|0|||
162896349|NCT05563714|588319626|FG003|Overall Study|Lost to Follow-up|0|||
162896350|NCT02427100|588319629|FG000|Overall Study|Lost to Follow-up|0|||
162896351|NCT02427100|588319630|FG001|Overall Study|Lost to Follow-up|2|||
162896352|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
162896353|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
162896354|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
162896355|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
162896356|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
162896357|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
162896358|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
162896359|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
162896360|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896361|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896362|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896363|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896364|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896365|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
162896366|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
162896367|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
162896368|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
162896369|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
162896370|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
162896371|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
162896372|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
162896373|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
162896374|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896375|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896376|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896377|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896378|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896379|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
162896380|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
162896381|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896382|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896383|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896384|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896385|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896386|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
162896387|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
162896388|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896389|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896390|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896391|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896392|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896393|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
162896394|NCT02120352|588319633|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
162896395|NCT02120352|588319634|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
162896396|NCT02120352|588319635|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
162896397|NCT02120352|588319636|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
162896398|NCT02120352|588319637|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
162896399|NCT02120352|588319638|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
162624791|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Other|1|||
162624792|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Other|2|||
162624793|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Other|0|||
162624794|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Other|0|||
162624795|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Other|0|||
162624796|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
162896400|NCT02120352|588319639|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
162896401|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
162896402|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
162896403|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
162624797|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
162896404|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
162896405|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
162896406|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
162896407|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
162896408|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
162896409|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
162896410|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
162896411|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
162896412|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
162896413|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
162896414|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
162896415|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
162896416|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
162896417|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
162896418|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
162896419|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
162896420|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
162896421|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
162896422|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
162896423|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
162896424|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
162896425|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
162896426|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
162896427|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
162896428|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
162896429|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896430|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896431|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896432|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
162896433|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896434|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896435|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
162896436|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
162896437|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
162896438|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
162896439|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
162896440|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
162896441|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
162896442|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
162896443|NCT02120352|588319633|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896444|NCT02120352|588319634|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
162896445|NCT02120352|588319635|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896446|NCT02120352|588319636|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896447|NCT02120352|588319637|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896448|NCT02120352|588319638|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896449|NCT02120352|588319639|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
162896450|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
162896451|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
162896452|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
162896453|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
162896454|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
162896455|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
162896456|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
162896457|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896458|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896459|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896460|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896461|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
162896462|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896463|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
162896464|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
162896465|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
162896466|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
162896467|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
162896468|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
162896469|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
162896470|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
162896471|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
162896472|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
162896473|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
162896474|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
162896475|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
162896476|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
162896477|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
162896478|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
162896479|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
162896480|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
162896481|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
162896482|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
162896483|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
162896484|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
162896485|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
162896486|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
162896487|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
162896488|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
162896489|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
162896490|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
162896491|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
162896492|NCT02120352|588319633|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
162896493|NCT02120352|588319634|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
162896494|NCT02120352|588319635|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
162896495|NCT02120352|588319636|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
162896496|NCT02120352|588319637|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
162896497|NCT02120352|588319638|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
162896498|NCT02120352|588319639|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
163051930|NCT04613518|588898752|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
163051931|NCT04613518|588898753|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
163051932|NCT04613518|588898754|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
163051933|NCT04613518|588898752|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
163051934|NCT04613518|588898753|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
163051935|NCT04613518|588898754|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
163051936|NCT04613518|588898752|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
162896499|NCT02120352|588319633|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896500|NCT02120352|588319634|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896501|NCT02120352|588319635|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896502|NCT02120352|588319636|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896503|NCT02120352|588319637|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896504|NCT02120352|588319638|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
162896505|NCT02120352|588319639|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
162896506|NCT02186561|588319641|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
162896507|NCT02186561|588319641|FG000|Enrollment|Enrollment Cap Reached|5|||
162896508|NCT02186561|588319641|FG000|Enrollment|Insurance Denial|2|||
162896509|NCT02186561|588319641|FG000|Enrollment|Withdrawal by Subject|2|||
162896510|NCT02186561|588319641|FG000|Enrollment|Investigator Withdrew Consent|1|||
162896511|NCT02186561|588319641|FG000|30-Day Post Index Procedure Visit|Death|1|||
162896512|NCT02186561|588319641|FG000|1- Year Post Index Procedure Visit|Death|1|||
162896513|NCT02186561|588319641|FG000|1- Year Post Index Procedure Visit|Missed|1|||
162896514|NCT00842361|588319642|FG000|Overall Study|Protocol Violation|1|||
162896515|NCT00842361|588319643|FG001|Overall Study|Protocol Violation|0|||
162896516|NCT00842361|588319642|FG000|Overall Study|Unclassified|0|||
162896517|NCT00842361|588319643|FG001|Overall Study|Unclassified|2|||
162896518|NCT01072448|588319646|FG000|Overall Study|Adverse Event|9|||
162896519|NCT01072448|588319647|FG001|Overall Study|Adverse Event|10|||
162896520|NCT01072448|588319646|FG000|Overall Study|Subject withdrew consent|4|||
162896521|NCT01072448|588319647|FG001|Overall Study|Subject withdrew consent|9|||
162896522|NCT01072448|588319646|FG000|Overall Study|Protocol deviation|3|||
162896523|NCT01072448|588319647|FG001|Overall Study|Protocol deviation|4|||
162896524|NCT01072448|588319646|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162896525|NCT01072448|588319647|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162896526|NCT01072448|588319646|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162896527|NCT01072448|588319647|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162896528|NCT01072448|588319646|FG000|Overall Study|Lost to Follow-up|1|||
162896529|NCT01072448|588319647|FG001|Overall Study|Lost to Follow-up|1|||
162896530|NCT01072448|588319646|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162896531|NCT01072448|588319647|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162896532|NCT01072448|588319646|FG000|Overall Study|Death|0|||
162896533|NCT01072448|588319647|FG001|Overall Study|Death|2|||
162896534|NCT00249795|588319648|FG000|Overall Study|Not treated|16|||
162896535|NCT00249795|588319649|FG001|Overall Study|Not treated|14|||
162896536|NCT00249795|588319648|FG000|Overall Study|Symptomatic hypotension|127|||
162896537|NCT00249795|588319649|FG001|Overall Study|Symptomatic hypotension|64|||
162896538|NCT00249795|588319648|FG000|Overall Study|Other Serious Adverse Event|84|||
162896539|NCT00249795|588319649|FG001|Overall Study|Other Serious Adverse Event|93|||
162896540|NCT00249795|588319648|FG000|Overall Study|Qualifying condition not present|26|||
162896541|NCT00249795|588319649|FG001|Overall Study|Qualifying condition not present|29|||
162896542|NCT00249795|588319648|FG000|Overall Study|Withdrawal by Subject|678|||
162896543|NCT00249795|588319649|FG001|Overall Study|Withdrawal by Subject|742|||
162896544|NCT00249795|588319648|FG000|Overall Study|Thromboembolic / outcome event|39|||
162896545|NCT00249795|588319649|FG001|Overall Study|Thromboembolic / outcome event|45|||
162896546|NCT00249795|588319648|FG000|Overall Study|Oral anticoagulant required|2|||
162896547|NCT00249795|588319649|FG001|Overall Study|Oral anticoagulant required|0|||
162896548|NCT00249795|588319648|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
162896549|NCT00249795|588319649|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
162896550|NCT00249795|588319648|FG000|Overall Study|Non-compliance|71|||
162896551|NCT00249795|588319649|FG001|Overall Study|Non-compliance|69|||
162896552|NCT00249795|588319648|FG000|Overall Study|Study drug intolerance|3|||
162896553|NCT00249795|588319649|FG001|Overall Study|Study drug intolerance|3|||
162896554|NCT00249795|588319648|FG000|Overall Study|Other adverse events (non-serious)|188|||
162896555|NCT00249795|588319649|FG001|Overall Study|Other adverse events (non-serious)|159|||
162896556|NCT00249795|588319648|FG000|Overall Study|Physician withdrew consent|71|||
162896557|NCT00249795|588319649|FG001|Overall Study|Physician withdrew consent|63|||
162896558|NCT00249795|588319648|FG000|Overall Study|Surgery / procedure|4|||
162896559|NCT00249795|588319649|FG001|Overall Study|Surgery / procedure|5|||
162896560|NCT00249795|588319648|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
162896561|NCT00249795|588319649|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
162896562|NCT00249795|588319648|FG000|Overall Study|Lightheadedness / dizziness|15|||
162896563|NCT00249795|588319649|FG001|Overall Study|Lightheadedness / dizziness|11|||
162896564|NCT00249795|588319648|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
162896565|NCT00249795|588319649|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
162896566|NCT00249795|588319648|FG000|Overall Study|Other contraindicated medication|1|||
162896567|NCT00249795|588319649|FG001|Overall Study|Other contraindicated medication|1|||
162896568|NCT00249795|588319648|FG000|Overall Study|Event related to cardiac condition|17|||
162896569|NCT00249795|588319649|FG001|Overall Study|Event related to cardiac condition|16|||
162896570|NCT00249795|588319648|FG000|Overall Study|Patient not wish to continue after May08|4|||
162896571|NCT00249795|588319649|FG001|Overall Study|Patient not wish to continue after May08|6|||
162896572|NCT00249795|588319648|FG000|Overall Study|Site not agree to continue after May08|1|||
162896573|NCT00249795|588319649|FG001|Overall Study|Site not agree to continue after May08|1|||
162896574|NCT00249795|588319648|FG000|Overall Study|Lost to Follow-up|0|||
162896575|NCT00249795|588319649|FG001|Overall Study|Lost to Follow-up|2|||
162896576|NCT00249795|588319648|FG000|Overall Study|Missing|0|||
162896577|NCT00249795|588319649|FG001|Overall Study|Missing|1|||
162896578|NCT01814826|588319654|FG000|Overall Study|Other|3|||
162896579|NCT01814826|588319655|FG001|Overall Study|Other|5|||
162896580|NCT01814826|588319656|FG002|Overall Study|Other|0|||
162896581|NCT01814826|588319654|FG000|Overall Study|Death|29|||
162896582|NCT01814826|588319655|FG001|Overall Study|Death|24|||
162896583|NCT01814826|588319656|FG002|Overall Study|Death|3|||
162896584|NCT02917629|588319657|FG000|Overall Study|Withdrawal by Subject|0|||
162896585|NCT02917629|588319658|FG001|Overall Study|Withdrawal by Subject|1|||
162896586|NCT03271307|588319659|FG000|Overall Study|Lost to Follow-up|0|||
162896587|NCT03271307|588319660|FG001|Overall Study|Lost to Follow-up|0|||
162896588|NCT03271307|588319661|FG002|Overall Study|Lost to Follow-up|0|||
162896589|NCT03271307|588319662|FG003|Overall Study|Lost to Follow-up|28|||
162896590|NCT03271307|588319663|FG004|Overall Study|Lost to Follow-up|91|||
162896591|NCT01042938|588319664|FG000|Overall Study|Withdrawal by Subject|1|||
162896592|NCT01042938|588319665|FG001|Overall Study|Withdrawal by Subject|1|||
162896593|NCT01042938|588319664|FG000|Overall Study|Protocol Violation|1|||
162896594|NCT01042938|588319665|FG001|Overall Study|Protocol Violation|1|||
162896595|NCT01042938|588319664|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
162896596|NCT01042938|588319665|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
162896597|NCT03136484|588319666|FG000|Overall Study|Withdrawal by Subject|19|||
162896598|NCT03136484|588319667|FG001|Overall Study|Withdrawal by Subject|14|||
162896599|NCT03136484|588319666|FG000|Overall Study|Lost to Follow-up|7|||
162896600|NCT03136484|588319667|FG001|Overall Study|Lost to Follow-up|8|||
162896601|NCT03136484|588319666|FG000|Overall Study|Death|1|||
162896602|NCT03136484|588319667|FG001|Overall Study|Death|0|||
162896603|NCT01601470|588319670|FG000|Period 2 - LCZ696|Physician Decision|1|||
162896604|NCT03032510|588319671|FG000|Overall Study|Adverse Event|5|||
162896605|NCT03032510|588319672|FG001|Overall Study|Adverse Event|2|||
162965076|NCT02377349|588572048|FG001|Overall Study|Protocol Violation|2|||
162965077|NCT02377349|588572047|FG000|Overall Study|Withdrawal by Subject|5|||
162965078|NCT02377349|588572048|FG001|Overall Study|Withdrawal by Subject|3|||
162965079|NCT02377349|588572047|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
162965080|NCT02377349|588572048|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
162965081|NCT02377349|588572047|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
162965082|NCT02377349|588572048|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
162965083|NCT02377349|588572047|FG000|Overall Study|Other|0|||
162965084|NCT02377349|588572048|FG001|Overall Study|Other|1|||
162965085|NCT01507662|588572057|FG000|Overall Study|Death|26|||
162965086|NCT01507662|588572058|FG001|Overall Study|Death|18|||
162965087|NCT01507662|588572057|FG000|Overall Study|Withdrawal by Subject|290|||
162965088|NCT01507662|588572058|FG001|Overall Study|Withdrawal by Subject|287|||
162965089|NCT01507662|588572057|FG000|Overall Study|Lost to Follow-up|498|||
162965090|NCT01507662|588572058|FG001|Overall Study|Lost to Follow-up|523|||
162965091|NCT01507662|588572057|FG000|Overall Study|Proxy interview done|2|||
162965092|NCT01507662|588572058|FG001|Overall Study|Proxy interview done|3|||
162965093|NCT01395017|588572063|FG000|Overall Study|Lost to Follow-up|1|||
162965094|NCT01395017|588572064|FG001|Overall Study|Lost to Follow-up|0|||
162965095|NCT01395017|588572063|FG000|Overall Study|Adverse Event|26|||
162965096|NCT01395017|588572064|FG001|Overall Study|Adverse Event|12|||
162965097|NCT01395017|588572063|FG000|Overall Study|Physician Decision|11|||
162965098|NCT01395017|588572064|FG001|Overall Study|Physician Decision|15|||
162965099|NCT01395017|588572063|FG000|Overall Study|Withdrawal by Subject|14|||
162965100|NCT01395017|588572064|FG001|Overall Study|Withdrawal by Subject|8|||
162965101|NCT01395017|588572063|FG000|Overall Study|Protocol deviation|1|||
162965102|NCT01395017|588572064|FG001|Overall Study|Protocol deviation|2|||
162965103|NCT01395017|588572063|FG000|Overall Study|Death|4|||
162965104|NCT01395017|588572064|FG001|Overall Study|Death|3|||
162896606|NCT03032510|588319671|FG000|Overall Study|Lost to Follow-up|8|||
162896607|NCT03032510|588319672|FG001|Overall Study|Lost to Follow-up|7|||
162896608|NCT03032510|588319671|FG000|Overall Study|Withdrawal by Subject|8|||
162965105|NCT01395017|588572063|FG000|Overall Study|Disease progression|42|||
162965106|NCT01395017|588572064|FG001|Overall Study|Disease progression|58|||
162965107|NCT01395017|588572063|FG000|Overall Study|Sponsor discontinued study|1|||
162965108|NCT01395017|588572064|FG001|Overall Study|Sponsor discontinued study|4|||
162965109|NCT00999687|588572068|FG000|First Intervention|Withdrawal by Subject|1|||
162965110|NCT00999687|588572068|FG000|Second Intervention|Withdrawal by Subject|2|||
162965111|NCT00999687|588572068|FG000|Second Intervention|Lack of Efficacy|1|||
162896609|NCT03032510|588319672|FG001|Overall Study|Withdrawal by Subject|7|||
162896610|NCT03032510|588319671|FG000|Overall Study|Subject noncompliance|4|||
162896611|NCT03032510|588319672|FG001|Overall Study|Subject noncompliance|2|||
162896612|NCT03032510|588319671|FG000|Overall Study|Physician Decision|2|||
162896613|NCT03032510|588319672|FG001|Overall Study|Physician Decision|0|||
162896614|NCT01203787|588319673|FG000|Overall Study|Death|12|||
162896615|NCT01203787|588319674|FG001|Overall Study|Death|10|||
162896616|NCT01203787|588319673|FG000|Overall Study|Withdrawal by Subject|6|||
162896617|NCT01203787|588319674|FG001|Overall Study|Withdrawal by Subject|2|||
162896618|NCT01203787|588319673|FG000|Overall Study|Lost to Follow-up|2|||
162896619|NCT01203787|588319674|FG001|Overall Study|Lost to Follow-up|0|||
162896620|NCT01203787|588319673|FG000|Overall Study|Adverse Event|11|||
162896621|NCT01203787|588319674|FG001|Overall Study|Adverse Event|15|||
162896622|NCT00431496|588319677|FG000|Overall Study|Adverse Event|3|||
162896623|NCT00431496|588319677|FG000|Overall Study|Lost to Follow-up|1|||
163051937|NCT04613518|588898753|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
163051938|NCT04613518|588898754|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
163051939|NCT04613518|588898752|FG000|Open-Label Treatment Period|Other reasons|1|||
163051940|NCT04613518|588898753|FG001|Open-Label Treatment Period|Other reasons|0|||
163051941|NCT04613518|588898754|FG002|Open-Label Treatment Period|Other reasons|0|||
163051942|NCT04831138|588898755|FG000|Overall Study|Lost to Follow-up|2|||
163051943|NCT04831138|588898756|FG001|Overall Study|Lost to Follow-up|0|||
163051944|NCT04202497|588898759|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
163051945|NCT04202497|588898760|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051946|NCT04202497|588898761|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051947|NCT04202497|588898762|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
163051948|NCT05590377|588898763|FG000|Overall Study|Death|1|||
163051949|NCT05590377|588898764|FG001|Overall Study|Death|1|||
163051950|NCT05590377|588898765|FG002|Overall Study|Death|2|||
163051951|NCT05590377|588898766|FG003|Overall Study|Death|0|||
163051952|NCT05590377|588898767|FG004|Overall Study|Death|0|||
163051953|NCT05590377|588898763|FG000|Overall Study|Study Terminated by Sponsor|1|||
163051954|NCT05590377|588898764|FG001|Overall Study|Study Terminated by Sponsor|5|||
163051955|NCT05590377|588898765|FG002|Overall Study|Study Terminated by Sponsor|4|||
163051956|NCT05590377|588898766|FG003|Overall Study|Study Terminated by Sponsor|0|||
163051957|NCT05590377|588898767|FG004|Overall Study|Study Terminated by Sponsor|0|||
163051958|NCT05590377|588898763|FG000|Overall Study|Withdrawal by Subject|1|||
163051959|NCT05590377|588898764|FG001|Overall Study|Withdrawal by Subject|0|||
163051960|NCT05590377|588898765|FG002|Overall Study|Withdrawal by Subject|0|||
163051961|NCT05590377|588898766|FG003|Overall Study|Withdrawal by Subject|0|||
163051962|NCT05590377|588898767|FG004|Overall Study|Withdrawal by Subject|0|||
163051963|NCT02499146|588898768|FG000|Overall Study|Global deterioration of health status|1|||
163051964|NCT02499146|588898768|FG000|Overall Study|Objective progression or relapse|20|||
162708780|NCT02322775|587642896|FG001|Overall Study|Not willing to perform all FU visits|1|||
162896624|NCT00431496|588319677|FG000|Overall Study|Withdrawal by Subject|2|||
162896625|NCT00431496|588319677|FG000|Overall Study|Protocol-specified criteria|5|||
162896626|NCT02999191|588319678|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
162896627|NCT02999191|588319679|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
162896628|NCT02999191|588319680|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
162896629|NCT02079519|588319686|FG000|Overall Study|Disease Progression|9|||
162896630|NCT02079519|588319686|FG000|Overall Study|Adverse Event|1|||
162896631|NCT01802515|588319687|FG000|Overall Study|Withdrawal by Subject|3|||
163051965|NCT02499146|588898768|FG000|Overall Study|Other|2|||
163051966|NCT02499146|588898768|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
163051967|NCT04325828|588898769|FG000|Overall Study|Ongoing|26|||
163051968|NCT05115630|588898770|FG000|Overall Study|Due to COVID19|1|||
163051969|NCT05115630|588898770|FG000|Overall Study|Due to Bacteremia|1|||
163051970|NCT05115630|588898770|FG000|Overall Study|Due to viral infection|1|||
162896632|NCT01802515|588319688|FG001|Overall Study|Withdrawal by Subject|0|||
163051971|NCT02287038|588898773|FG000|Overall Study|Stopped attending appointments|3|||
163051972|NCT02287038|588898774|FG001|Overall Study|Stopped attending appointments|2|||
162896633|NCT01802515|588319689|FG002|Overall Study|Withdrawal by Subject|0|||
162896634|NCT02566109|588319690|FG000|Overall Study|Withdrawal by Subject|1|||
162896635|NCT01993667|588319693|FG000|Overall Study|Insufficient data to analyze|16|||
162896636|NCT01993667|588319694|FG001|Overall Study|Insufficient data to analyze|16|||
162896637|NCT01993667|588319693|FG000|Overall Study|Insufficient altitude reached|3|||
162896638|NCT01993667|588319694|FG001|Overall Study|Insufficient altitude reached|1|||
162896639|NCT01993667|588319693|FG000|Overall Study|Lost to Follow-up|2|||
162896640|NCT01993667|588319694|FG001|Overall Study|Lost to Follow-up|2|||
162896641|NCT01931150|588319695|FG000|Overall Study|Withdrawal by Subject|1|||
162896642|NCT01931150|588319696|FG001|Overall Study|Withdrawal by Subject|2|||
162896643|NCT00845845|588319697|FG000|Overall Study|Lost to Follow-up|0|||
162896644|NCT00845845|588319698|FG001|Overall Study|Lost to Follow-up|4|||
162896645|NCT01685203|588319699|FG000|Overall Study|Lost to Follow-up|3|||
162896646|NCT01685203|588319700|FG001|Overall Study|Lost to Follow-up|3|||
162896647|NCT01685203|588319701|FG002|Overall Study|Lost to Follow-up|0|||
162896648|NCT01685203|588319702|FG003|Overall Study|Lost to Follow-up|1|||
162896649|NCT01685203|588319703|FG004|Overall Study|Lost to Follow-up|0|||
162896650|NCT01685203|588319704|FG005|Overall Study|Lost to Follow-up|0|||
162896651|NCT01685203|588319705|FG006|Overall Study|Lost to Follow-up|0|||
162896652|NCT01685203|588319699|FG000|Overall Study|Adverse Event|0|||
162896653|NCT01685203|588319700|FG001|Overall Study|Adverse Event|0|||
162896654|NCT01685203|588319701|FG002|Overall Study|Adverse Event|0|||
162896655|NCT01685203|588319702|FG003|Overall Study|Adverse Event|0|||
162896656|NCT01685203|588319703|FG004|Overall Study|Adverse Event|0|||
162896657|NCT01685203|588319704|FG005|Overall Study|Adverse Event|2|||
162896658|NCT01685203|588319705|FG006|Overall Study|Adverse Event|0|||
162896659|NCT01685203|588319699|FG000|Overall Study|Adverse event and withdrew consent|1|||
162896660|NCT01685203|588319700|FG001|Overall Study|Adverse event and withdrew consent|0|||
162896661|NCT01685203|588319701|FG002|Overall Study|Adverse event and withdrew consent|0|||
162896662|NCT01685203|588319702|FG003|Overall Study|Adverse event and withdrew consent|0|||
162896663|NCT01685203|588319703|FG004|Overall Study|Adverse event and withdrew consent|0|||
162896664|NCT01685203|588319704|FG005|Overall Study|Adverse event and withdrew consent|0|||
162896665|NCT01685203|588319705|FG006|Overall Study|Adverse event and withdrew consent|0|||
162896666|NCT01685203|588319699|FG000|Overall Study|Patient's decision|0|||
162896667|NCT01685203|588319700|FG001|Overall Study|Patient's decision|0|||
162896668|NCT01685203|588319701|FG002|Overall Study|Patient's decision|0|||
162896669|NCT01685203|588319702|FG003|Overall Study|Patient's decision|0|||
162896670|NCT01685203|588319703|FG004|Overall Study|Patient's decision|0|||
162896671|NCT01685203|588319704|FG005|Overall Study|Patient's decision|1|||
162965112|NCT03614728|588572071|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
162965113|NCT03614728|588572072|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965114|NCT03614728|588572073|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965115|NCT03614728|588572074|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162965116|NCT03614728|588572071|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162896672|NCT01685203|588319705|FG006|Overall Study|Patient's decision|0|||
162896673|NCT01570309|588319706|FG000|Overall Study|Withdrawal by Subject|3|||
162965117|NCT03614728|588572072|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
162965118|NCT03614728|588572073|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162965119|NCT03614728|588572074|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
162965120|NCT01401062|588572082|FG000|Overall Study|Death|9|||
162965121|NCT01401062|588572083|FG001|Overall Study|Death|7|||
162965122|NCT01401062|588572082|FG000|Overall Study|Physician Decision|1|||
162965123|NCT01401062|588572083|FG001|Overall Study|Physician Decision|0|||
162965124|NCT01401062|588572082|FG000|Overall Study|Withdrawal by Subject|1|||
162965125|NCT01401062|588572083|FG001|Overall Study|Withdrawal by Subject|1|||
162965126|NCT04203823|588572086|FG000|Overall Study|Withdrawal by Subject|2|||
162965127|NCT04203823|588572087|FG001|Overall Study|Withdrawal by Subject|2|||
162896674|NCT01570309|588319707|FG001|Overall Study|Withdrawal by Subject|3|||
162896675|NCT04095793|588319708|FG000|Overall Study|Adverse Event|3|||
162896676|NCT04095793|588319708|FG000|Overall Study|Study Terminated by Sponsor|103|||
162896677|NCT04095793|588319708|FG000|Overall Study|Withdrawal by Subject|4|||
162896678|NCT03619837|588319709|FG000|Screening|received organs from HCV-negative donors|47|||
162896679|NCT03619837|588319709|FG000|Screening|died on the wait-list|2|||
162896680|NCT03619837|588319709|FG000|Screening|remained on the wait list|40|||
162896681|NCT03619837|588319709|FG000|Screening|didn't meet eligibility criteria|3|||
162896682|NCT03619837|588319709|FG000|Screening|withdrew consent|2|||
162896683|NCT03619837|588319709|FG000|Screening|never listed for HCV-viremic donor|1|||
162896684|NCT03619837|588319709|FG000|Screening|developed exclusion criteria|2|||
162965128|NCT04203823|588572086|FG000|Overall Study|Adverse Event|1|||
162965129|NCT04203823|588572087|FG001|Overall Study|Adverse Event|1|||
162965130|NCT04203823|588572086|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162965131|NCT04203823|588572087|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
162965132|NCT03684928|588572088|FG000|First Intervention|Lost to Follow-up|0|||
162965133|NCT03684928|588572089|FG001|First Intervention|Lost to Follow-up|1|||
162965134|NCT03684928|588572088|FG000|First Intervention|Withdrawal by Subject|0|||
163051973|NCT02287038|588898773|FG000|Overall Study|Anxiety after starting medication|0|||
163051974|NCT02287038|588898774|FG001|Overall Study|Anxiety after starting medication|1|||
163051975|NCT02287038|588898773|FG000|Overall Study|Nausea after starting medication|1|||
163051976|NCT02287038|588898774|FG001|Overall Study|Nausea after starting medication|0|||
163051977|NCT02287038|588898773|FG000|Overall Study|Abnormal ECG after starting medication|1|||
163051978|NCT02287038|588898774|FG001|Overall Study|Abnormal ECG after starting medication|0|||
163051979|NCT02667301|588898782|FG000|Overall Study|Adverse Event|1|||
162896685|NCT03619837|588319709|FG000|Screening|excluded by the investigator due to non-compliance|1|||
162896686|NCT01602549|588319710|FG000|Overall Study|Protocol Violation|0|||
162896687|NCT01602549|588319711|FG001|Overall Study|Protocol Violation|1|||
162896688|NCT01602549|588319710|FG000|Overall Study|Withdrawal by Subject|1|||
162896689|NCT01602549|588319711|FG001|Overall Study|Withdrawal by Subject|0|||
162896690|NCT03627494|588319714|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
162896691|NCT03627494|588319715|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896692|NCT03627494|588319716|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
162896693|NCT03627494|588319717|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
163051980|NCT02667301|588898782|FG000|Overall Study|Lack of Efficacy|1|||
163051981|NCT00846586|588898784|FG000|Overall Study|Adverse Event|20|||
163051982|NCT00846586|588898785|FG001|Overall Study|Adverse Event|10|||
163051983|NCT00846586|588898784|FG000|Overall Study|Subject withdrew consent|8|||
163051984|NCT00846586|588898785|FG001|Overall Study|Subject withdrew consent|10|||
163051985|NCT00846586|588898784|FG000|Overall Study|Administrative problems|5|||
163051986|NCT00846586|588898785|FG001|Overall Study|Administrative problems|4|||
163051987|NCT00846586|588898784|FG000|Overall Study|Death|2|||
163051988|NCT00846586|588898785|FG001|Overall Study|Death|0|||
163051989|NCT00846586|588898784|FG000|Overall Study|Protocol deviation|2|||
163051990|NCT00846586|588898785|FG001|Overall Study|Protocol deviation|6|||
163051991|NCT00846586|588898784|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163051992|NCT00846586|588898785|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163051993|NCT00846586|588898784|FG000|Overall Study|Lost to Follow-up|1|||
163051994|NCT00846586|588898785|FG001|Overall Study|Lost to Follow-up|4|||
162896694|NCT03627494|588319718|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896695|NCT03627494|588319719|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896696|NCT03627494|588319720|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896697|NCT03627494|588319721|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896698|NCT03627494|588319722|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896699|NCT03627494|588319723|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896700|NCT03627494|588319724|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896701|NCT03627494|588319725|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
162896702|NCT03627494|588319714|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896703|NCT03627494|588319715|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896704|NCT03627494|588319716|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896705|NCT03627494|588319717|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896706|NCT03627494|588319718|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896707|NCT03627494|588319719|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896708|NCT03627494|588319720|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896709|NCT03627494|588319721|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896710|NCT03627494|588319722|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
162896711|NCT03627494|588319723|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896712|NCT03627494|588319724|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896713|NCT03627494|588319725|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
162896714|NCT03627494|588319714|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896715|NCT03627494|588319715|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896716|NCT03627494|588319716|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896717|NCT03627494|588319717|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896718|NCT03627494|588319718|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896719|NCT03627494|588319719|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896720|NCT03627494|588319720|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896721|NCT03627494|588319721|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896722|NCT03627494|588319722|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896723|NCT03627494|588319723|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
162896724|NCT03627494|588319724|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
162896725|NCT03627494|588319725|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
162896726|NCT04483544|588321233|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
162896727|NCT04483544|588321233|FG000|Post-Treatment|Admitted to hospice|2|||
162896728|NCT04483544|588321233|FG000|Post-Treatment|Study terminated|3|||
162896729|NCT01131078|588321234|FG000|Overall Study|Adverse Event|22|||
162896730|NCT01131078|588321235|FG001|Overall Study|Adverse Event|12|||
162896731|NCT01131078|588321236|FG002|Overall Study|Adverse Event|17|||
162896732|NCT01131078|588321234|FG000|Overall Study|Progressive Disease|58|||
162896733|NCT01131078|588321235|FG001|Overall Study|Progressive Disease|77|||
162896734|NCT01131078|588321236|FG002|Overall Study|Progressive Disease|71|||
162896735|NCT01131078|588321234|FG000|Overall Study|Protocol Violation|1|||
162896736|NCT01131078|588321235|FG001|Overall Study|Protocol Violation|0|||
162896737|NCT01131078|588321236|FG002|Overall Study|Protocol Violation|0|||
162896738|NCT01131078|588321234|FG000|Overall Study|Lost to Follow-up|1|||
162896739|NCT01131078|588321235|FG001|Overall Study|Lost to Follow-up|1|||
162896740|NCT01131078|588321236|FG002|Overall Study|Lost to Follow-up|1|||
162896741|NCT01131078|588321234|FG000|Overall Study|Withdrawal by Subject|2|||
162896742|NCT01131078|588321235|FG001|Overall Study|Withdrawal by Subject|4|||
162896743|NCT01131078|588321236|FG002|Overall Study|Withdrawal by Subject|3|||
162896744|NCT01131078|588321234|FG000|Overall Study|Non-compliance|3|||
162896745|NCT01131078|588321235|FG001|Overall Study|Non-compliance|0|||
162896746|NCT01131078|588321236|FG002|Overall Study|Non-compliance|0|||
162896747|NCT01131078|588321234|FG000|Overall Study|Physician Decision|10|||
162896748|NCT01131078|588321235|FG001|Overall Study|Physician Decision|6|||
162896749|NCT01131078|588321236|FG002|Overall Study|Physician Decision|8|||
162896750|NCT01131078|588321234|FG000|Overall Study|Death|4|||
162896751|NCT01131078|588321235|FG001|Overall Study|Death|0|||
162896752|NCT01131078|588321236|FG002|Overall Study|Death|2|||
162896753|NCT01131078|588321234|FG000|Overall Study|Other|0|||
162896754|NCT01131078|588321235|FG001|Overall Study|Other|1|||
162896755|NCT01131078|588321236|FG002|Overall Study|Other|0|||
162896756|NCT02177786|588321237|FG000|Overall Study|Withdrew Consent|2|||
162896757|NCT02177786|588321238|FG001|Overall Study|Withdrew Consent|6|||
162896758|NCT02177786|588321239|FG002|Overall Study|Withdrew Consent|9|||
162896759|NCT02177786|588321240|FG003|Overall Study|Withdrew Consent|5|||
162896760|NCT02177786|588321237|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
162896761|NCT02177786|588321238|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
162896762|NCT02177786|588321239|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
162896763|NCT02177786|588321240|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
162896764|NCT02177786|588321237|FG000|Overall Study|Adverse Event|1|||
162896765|NCT02177786|588321238|FG001|Overall Study|Adverse Event|1|||
162896766|NCT02177786|588321239|FG002|Overall Study|Adverse Event|2|||
162896767|NCT02177786|588321240|FG003|Overall Study|Adverse Event|3|||
162896768|NCT02177786|588321237|FG000|Overall Study|Death|1|||
162896769|NCT02177786|588321238|FG001|Overall Study|Death|1|||
162896770|NCT02177786|588321239|FG002|Overall Study|Death|1|||
162896771|NCT02177786|588321240|FG003|Overall Study|Death|1|||
162896772|NCT02177786|588321237|FG000|Overall Study|Lost to Follow-up|0|||
162896773|NCT02177786|588321238|FG001|Overall Study|Lost to Follow-up|0|||
162896774|NCT02177786|588321239|FG002|Overall Study|Lost to Follow-up|2|||
162896775|NCT02177786|588321240|FG003|Overall Study|Lost to Follow-up|2|||
162896776|NCT02177786|588321237|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162896777|NCT02177786|588321238|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162896778|NCT02177786|588321239|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162896779|NCT02177786|588321240|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162896780|NCT02177786|588321237|FG000|Overall Study|Protocol Violation|0|||
162896781|NCT02177786|588321238|FG001|Overall Study|Protocol Violation|0|||
162896782|NCT02177786|588321239|FG002|Overall Study|Protocol Violation|2|||
162896783|NCT02177786|588321240|FG003|Overall Study|Protocol Violation|0|||
162896784|NCT02177786|588321237|FG000|Overall Study|Progressive Disease|0|||
162896785|NCT02177786|588321238|FG001|Overall Study|Progressive Disease|1|||
162896786|NCT02177786|588321239|FG002|Overall Study|Progressive Disease|0|||
162896787|NCT02177786|588321240|FG003|Overall Study|Progressive Disease|0|||
162896788|NCT02177786|588321237|FG000|Overall Study|Missing study completion status|0|||
162896789|NCT02177786|588321238|FG001|Overall Study|Missing study completion status|1|||
162896790|NCT02177786|588321239|FG002|Overall Study|Missing study completion status|0|||
162896791|NCT02177786|588321240|FG003|Overall Study|Missing study completion status|0|||
162896792|NCT01305941|588321241|FG000|Overall Study|Adverse Event|6|||
162896793|NCT01305941|588321241|FG000|Overall Study|Clinical decline|2|||
162896794|NCT01305941|588321241|FG000|Overall Study|Withdrawal by Subject|1|||
162896795|NCT01305941|588321241|FG000|Overall Study|Death|1|||
162896796|NCT00430027|588321243|FG000|Overall Study|Study terminated|8|||
162896797|NCT01957215|588321244|FG000|Overall Study|Adverse Event|2|||
162896798|NCT01957215|588321245|FG001|Overall Study|Adverse Event|2|||
162896799|NCT01957215|588321244|FG000|Overall Study|Lost to Follow-up|3|||
162896800|NCT01957215|588321245|FG001|Overall Study|Lost to Follow-up|3|||
162896801|NCT01957215|588321244|FG000|Overall Study|Protocol Violation|1|||
162896802|NCT01957215|588321245|FG001|Overall Study|Protocol Violation|2|||
162896803|NCT01957215|588321244|FG000|Overall Study|Withdrawal by Subject|7|||
162896804|NCT01957215|588321245|FG001|Overall Study|Withdrawal by Subject|5|||
162896805|NCT01977040|588321248|FG000|Overall Study|Vasa previa not confirmed|2|||
162896806|NCT03597503|588321252|FG000|Overall Study|Withdrawal by Subject|0|||
162896807|NCT03597503|588321253|FG001|Overall Study|Withdrawal by Subject|2|||
162896808|NCT03597503|588321252|FG000|Overall Study|Lost to Follow-up|1|||
162896809|NCT03597503|588321253|FG001|Overall Study|Lost to Follow-up|2|||
162896810|NCT03597503|588321252|FG000|Overall Study|Protocol Violation|1|||
162896811|NCT03597503|588321253|FG001|Overall Study|Protocol Violation|0|||
162896812|NCT02667236|588321256|FG000|Overall Study|Adverse Event|1|||
162896813|NCT02667236|588321257|FG001|Overall Study|Adverse Event|1|||
162896814|NCT02667236|588321256|FG000|Overall Study|Withdrawal by Subject|2|||
162896815|NCT02667236|588321257|FG001|Overall Study|Withdrawal by Subject|0|||
162896816|NCT00634751|588321258|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
162896817|NCT00634751|588321259|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
162896818|NCT00634751|588321260|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
162896819|NCT00634751|588321261|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
162896820|NCT00634751|588321258|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
162896821|NCT00634751|588321259|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
162896822|NCT00634751|588321260|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
162896823|NCT00634751|588321261|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
162896824|NCT00634751|588321258|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
162896825|NCT00634751|588321259|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
162896826|NCT00634751|588321260|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
162896827|NCT00634751|588321261|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
162896828|NCT00608894|588321262|FG000|Overall Study|Withdrawal by Subject|0|||
162896829|NCT00608894|588321263|FG001|Overall Study|Withdrawal by Subject|2|||
162896830|NCT03654560|588321270|FG000|Overall Study|Death|3|||
162896831|NCT03654560|588321271|FG001|Overall Study|Death|1|||
162896832|NCT03654560|588321270|FG000|Overall Study|Lost to Follow-up|1|||
162896833|NCT03654560|588321271|FG001|Overall Study|Lost to Follow-up|0|||
162896834|NCT00209092|588321272|FG000|Overall Study|Progression of disease|7|||
162896835|NCT00209092|588321273|FG001|Overall Study|Progression of disease|1|||
162896836|NCT00209092|588321272|FG000|Overall Study|Adverse Event|0|||
162896837|NCT00209092|588321273|FG001|Overall Study|Adverse Event|1|||
162896838|NCT00209092|588321272|FG000|Overall Study|Withdrawal by Subject|1|||
162896839|NCT00209092|588321273|FG001|Overall Study|Withdrawal by Subject|0|||
162896840|NCT00693420|588321274|FG000|Overall Study|Adverse Event|4|||
162896841|NCT00693420|588321275|FG001|Overall Study|Adverse Event|4|||
162896842|NCT00693420|588321274|FG000|Overall Study|Lost to Follow-up|0|||
162896843|NCT00693420|588321275|FG001|Overall Study|Lost to Follow-up|3|||
162896844|NCT00693420|588321274|FG000|Overall Study|Withdrawal by Subject|1|||
162896845|NCT00693420|588321275|FG001|Overall Study|Withdrawal by Subject|0|||
162896846|NCT00693420|588321274|FG000|Overall Study|Protocol Violation|0|||
162896847|NCT00693420|588321275|FG001|Overall Study|Protocol Violation|2|||
162896848|NCT00693420|588321274|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
162896849|NCT00693420|588321275|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
162896850|NCT00693420|588321274|FG000|Overall Study|Personal Reasons|1|||
162896851|NCT00693420|588321275|FG001|Overall Study|Personal Reasons|4|||
162896852|NCT01235338|588321277|FG000|Overall Study|Adverse Event|3|||
162896853|NCT01235338|588321278|FG001|Overall Study|Adverse Event|2|||
162896854|NCT01235338|588321277|FG000|Overall Study|Protocol Violation|1|||
162896855|NCT01235338|588321278|FG001|Overall Study|Protocol Violation|1|||
162896856|NCT01235338|588321277|FG000|Overall Study|Withdrawal by Subject|5|||
162896857|NCT01235338|588321278|FG001|Overall Study|Withdrawal by Subject|0|||
162896858|NCT01235338|588321277|FG000|Overall Study|Exclusion criteria violations|1|||
162896859|NCT01235338|588321278|FG001|Overall Study|Exclusion criteria violations|1|||
162896860|NCT01235338|588321277|FG000|Overall Study|Positive drug screen|0|||
162896861|NCT01235338|588321278|FG001|Overall Study|Positive drug screen|1|||
162896862|NCT01235338|588321277|FG000|Overall Study|Prohibited meds|1|||
162896863|NCT01235338|588321278|FG001|Overall Study|Prohibited meds|0|||
162896864|NCT05283499|588321280|FG000|Overall Study|Did not receive intervention|1|||
162896865|NCT05283499|588321281|FG001|Overall Study|Did not receive intervention|2|||
162896866|NCT02828644|588321282|FG000|Overall Study|Lost to Follow-up|23|||
162896867|NCT02828644|588321283|FG001|Overall Study|Lost to Follow-up|22|||
162896868|NCT02408484|588321284|FG000|Overall Study|Withdrawal by Subject|3|||
162896869|NCT02408484|588321284|FG000|Overall Study|Not treated during study period|1|||
162896870|NCT01117181|588321288|FG000|Overall Study|Lost to Follow-up|1|||
162896871|NCT01117181|588321289|FG001|Overall Study|Lost to Follow-up|0|||
162896872|NCT01117181|588321288|FG000|Overall Study|Withdrawal by Subject|0|||
162896873|NCT01117181|588321289|FG001|Overall Study|Withdrawal by Subject|2|||
162896874|NCT00524043|588321295|FG000|Overall Study|Lack of Efficacy|15|||
162896875|NCT00524043|588321296|FG001|Overall Study|Lack of Efficacy|13|||
162896876|NCT00524043|588321297|FG002|Overall Study|Lack of Efficacy|14|||
162896877|NCT00524043|588321295|FG000|Overall Study|Withdrawal by Subject|5|||
162896878|NCT00524043|588321296|FG001|Overall Study|Withdrawal by Subject|7|||
162896879|NCT00524043|588321297|FG002|Overall Study|Withdrawal by Subject|7|||
162896880|NCT00524043|588321295|FG000|Overall Study|Adverse Event|5|||
162896881|NCT00524043|588321296|FG001|Overall Study|Adverse Event|2|||
162896882|NCT00524043|588321297|FG002|Overall Study|Adverse Event|7|||
162896883|NCT00524043|588321295|FG000|Overall Study|Lost to Follow-up|3|||
162896884|NCT00524043|588321296|FG001|Overall Study|Lost to Follow-up|5|||
162896885|NCT00524043|588321297|FG002|Overall Study|Lost to Follow-up|3|||
162896886|NCT00524043|588321295|FG000|Overall Study|Various (eg, incarceration)|2|||
162896887|NCT00524043|588321296|FG001|Overall Study|Various (eg, incarceration)|1|||
162896888|NCT00524043|588321297|FG002|Overall Study|Various (eg, incarceration)|0|||
162896889|NCT00517413|588321299|FG000|Overall Study|Adverse Event|7|||
162896890|NCT00517413|588321299|FG000|Overall Study|Death|13|||
162896891|NCT00517413|588321299|FG000|Overall Study|Protocol Violation|15|||
162896892|NCT00517413|588321299|FG000|Overall Study|Withdrawal by Subject|2|||
162896893|NCT00517413|588321299|FG000|Overall Study|Failure to return|1|||
162896894|NCT00517413|588321299|FG000|Overall Study|Other-Reasons|23|||
162896895|NCT03938636|588321300|FG000|Overall Study|Protocol Violation|0|||
162896896|NCT03938636|588321301|FG001|Overall Study|Protocol Violation|1|||
162896897|NCT03938636|588321302|FG002|Overall Study|Protocol Violation|1|||
162896898|NCT03938636|588321300|FG000|Overall Study|Subject withdrew due to death in family|0|||
162896899|NCT03938636|588321301|FG001|Overall Study|Subject withdrew due to death in family|1|||
162896900|NCT03938636|588321302|FG002|Overall Study|Subject withdrew due to death in family|0|||
162896901|NCT03938636|588321300|FG000|Overall Study|Missed visit|0|||
162896902|NCT03938636|588321301|FG001|Overall Study|Missed visit|1|||
162624798|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
162624799|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
162624800|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
162624801|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
162624802|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
162624803|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
162896903|NCT03938636|588321302|FG002|Overall Study|Missed visit|0|||
162896904|NCT03938636|588321300|FG000|Overall Study|Adverse Event|0|||
162896905|NCT03938636|588321301|FG001|Overall Study|Adverse Event|0|||
162896906|NCT03938636|588321302|FG002|Overall Study|Adverse Event|1|||
162896907|NCT03938636|588321300|FG000|Overall Study|Lost to Follow-up|0|||
162896908|NCT03938636|588321301|FG001|Overall Study|Lost to Follow-up|0|||
162896909|NCT03938636|588321302|FG002|Overall Study|Lost to Follow-up|1|||
162896910|NCT00216086|588321303|FG000|Overall Study|Protocol Violation|1|||
162896911|NCT00216086|588321303|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
162896912|NCT00216086|588321303|FG000|Overall Study|Social Reasons|2|||
162896913|NCT01080625|588321310|FG000|Overall Study|Physician Decision|0|||
162896914|NCT01080625|588321311|FG001|Overall Study|Physician Decision|2|||
162896915|NCT01080625|588321312|FG002|Overall Study|Physician Decision|1|||
162896916|NCT00735072|588321317|FG000|Overall Study|interrupted study med during ARV change|1|||
162896917|NCT00735072|588321318|FG001|Overall Study|interrupted study med during ARV change|0|||
162896918|NCT00735072|588321317|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
162896919|NCT00735072|588321318|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
162896920|NCT00911144|588321319|FG000|Overall Study|Withdrawal by Subject|16|||
162896921|NCT00911144|588321320|FG001|Overall Study|Withdrawal by Subject|5|||
162896922|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
162896923|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
162896924|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
162896925|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
162896926|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
162896927|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
162896928|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
162896929|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
162896930|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
162896931|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
162624804|NCT01090492|587343060|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
162896932|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
162896933|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
162896934|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
162896935|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
162896936|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
162896937|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
162896938|NCT01291511|588321321|FG000|Cross-Titration and Stabilization Phase|Death|1|||
162896939|NCT01291511|588321322|FG001|Cross-Titration and Stabilization Phase|Death|0|||
162896940|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
162896941|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
162896942|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
162896943|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
162896944|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
162896945|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
162896946|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
162896947|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
162896948|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
162896949|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
162896950|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
162896951|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
162896952|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
162896953|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
162896954|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
162896955|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
162896956|NCT01291511|588321321|FG000|Double-blind Relapse Prevention Phase|Death|1|||
162896957|NCT01291511|588321322|FG001|Double-blind Relapse Prevention Phase|Death|0|||
162896958|NCT02640755|588321333|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
162896959|NCT02640755|588321334|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
162896960|NCT02640755|588321333|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
162896961|NCT02640755|588321334|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
162624805|NCT01090492|587343061|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
162896962|NCT02640755|588321333|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
162896963|NCT02640755|588321334|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
162896964|NCT00865046|588321335|FG000|Overall Study|Lost to Follow-up|1|||
162896965|NCT00865046|588321336|FG001|Overall Study|Lost to Follow-up|4|||
162896966|NCT00865046|588321337|FG002|Overall Study|Lost to Follow-up|0|||
162896967|NCT00865046|588321335|FG000|Overall Study|Death|0|||
162624806|NCT01090492|587343062|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
162624807|NCT01090492|587343063|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
162624808|NCT01090492|587343064|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
162624809|NCT01090492|587343065|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
162624810|NCT01090492|587343066|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
162624811|NCT01090492|587343067|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
162624812|NCT01090492|587343060|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162624813|NCT01090492|587343061|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162624814|NCT01090492|587343062|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162624815|NCT01090492|587343063|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162624816|NCT01090492|587343064|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162624817|NCT01090492|587343065|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162624818|NCT01090492|587343066|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162624819|NCT01090492|587343067|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162624820|NCT01090492|587343060|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624821|NCT01090492|587343061|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
162624822|NCT01090492|587343062|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624823|NCT01090492|587343063|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624824|NCT01090492|587343064|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624825|NCT01090492|587343065|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162708781|NCT04739423|587642897|FG000|Overall Study|Protocol Violation|0|||
162708782|NCT04739423|587642898|FG001|Overall Study|Protocol Violation|1|||
162896968|NCT00865046|588321336|FG001|Overall Study|Death|1|||
162896969|NCT00865046|588321337|FG002|Overall Study|Death|1|||
162896970|NCT00865046|588321335|FG000|Overall Study|Withdrawal by Subject|5|||
162896971|NCT00865046|588321336|FG001|Overall Study|Withdrawal by Subject|0|||
162896972|NCT00865046|588321337|FG002|Overall Study|Withdrawal by Subject|0|||
162896973|NCT00654420|588321340|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
162896974|NCT00654420|588321341|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
162896975|NCT00654420|588321342|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
162896976|NCT00654420|588321343|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
162896977|NCT00654420|588321340|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
162896978|NCT00654420|588321341|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
162896979|NCT00654420|588321342|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
162896980|NCT00654420|588321343|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
162896981|NCT00654420|588321340|FG000|Phase II|Adverse Event|0|||
162896982|NCT00654420|588321341|FG001|Phase II|Adverse Event|0|||
162896983|NCT00654420|588321342|FG002|Phase II|Adverse Event|3|||
162896984|NCT00654420|588321343|FG003|Phase II|Adverse Event|3|||
162896985|NCT00654420|588321340|FG000|Phase II|Lost to Follow-up|0|||
162896986|NCT00654420|588321341|FG001|Phase II|Lost to Follow-up|0|||
162896987|NCT00654420|588321342|FG002|Phase II|Lost to Follow-up|0|||
162896988|NCT00654420|588321343|FG003|Phase II|Lost to Follow-up|1|||
162896989|NCT00654420|588321340|FG000|Phase II|Physician Decision|0|||
162896990|NCT00654420|588321341|FG001|Phase II|Physician Decision|0|||
162896991|NCT00654420|588321342|FG002|Phase II|Physician Decision|0|||
162896992|NCT00654420|588321343|FG003|Phase II|Physician Decision|4|||
162896993|NCT00654420|588321340|FG000|Phase II|Progressive Disease|0|||
162896994|NCT00654420|588321341|FG001|Phase II|Progressive Disease|0|||
162896995|NCT00654420|588321342|FG002|Phase II|Progressive Disease|29|||
162896996|NCT00654420|588321343|FG003|Phase II|Progressive Disease|29|||
162896997|NCT00654420|588321340|FG000|Phase II|Withdrawal by Subject|0|||
162896998|NCT00654420|588321341|FG001|Phase II|Withdrawal by Subject|0|||
162896999|NCT00654420|588321342|FG002|Phase II|Withdrawal by Subject|4|||
162897000|NCT00654420|588321343|FG003|Phase II|Withdrawal by Subject|1|||
162897001|NCT00654420|588321340|FG000|Phase II|Missing Disposition Record|0|||
162897002|NCT00654420|588321341|FG001|Phase II|Missing Disposition Record|0|||
162897003|NCT00654420|588321342|FG002|Phase II|Missing Disposition Record|1|||
162897004|NCT00654420|588321343|FG003|Phase II|Missing Disposition Record|0|||
162897005|NCT01587274|588321348|FG000|Overall Study|Lost to Follow-up|4|||
162897006|NCT01587274|588321349|FG001|Overall Study|Lost to Follow-up|5|||
162897007|NCT01587274|588321350|FG002|Overall Study|Lost to Follow-up|3|||
162624826|NCT01090492|587343066|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624827|NCT01090492|587343067|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162624828|NCT01090492|587343060|FG000|Second Intervention Period (4 Weeks)|Other|0|||
162624829|NCT01090492|587343061|FG001|Second Intervention Period (4 Weeks)|Other|1|||
162897008|NCT03236506|588321358|FG000|Overall Study|Death|1|||
162897009|NCT03236506|588321359|FG001|Overall Study|Death|1|||
162897010|NCT03236506|588321360|FG002|Overall Study|Death|1|||
162897011|NCT03236506|588321358|FG000|Overall Study|Withdrawal by Subject|3|||
162897012|NCT03236506|588321359|FG001|Overall Study|Withdrawal by Subject|3|||
162897013|NCT03236506|588321360|FG002|Overall Study|Withdrawal by Subject|4|||
162897014|NCT03236506|588321358|FG000|Overall Study|Did not initiate treatment|2|||
162897015|NCT03236506|588321359|FG001|Overall Study|Did not initiate treatment|1|||
162897016|NCT03236506|588321360|FG002|Overall Study|Did not initiate treatment|2|||
162897017|NCT00422669|588321371|FG000|Overall Study|The study was terminated early.|98|||
162897018|NCT00422669|588321372|FG001|Overall Study|The study was terminated early.|100|||
162897019|NCT00422669|588321373|FG002|Overall Study|The study was terminated early.|7|||
162897020|NCT02709109|588321374|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
162897021|NCT02709109|588321375|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
162897022|NCT02709109|588321376|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
162897023|NCT02709109|588321377|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
162897024|NCT02709109|588321374|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
162897025|NCT02709109|588321375|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
162897026|NCT02709109|588321376|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
162897027|NCT02709109|588321377|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
162897028|NCT02709109|588321374|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
162897029|NCT02709109|588321375|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
162897030|NCT02709109|588321376|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
162897031|NCT02709109|588321377|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
162897032|NCT02709109|588321374|FG000|Washout Period (28 Days)|Other|2|||
162897033|NCT02709109|588321375|FG001|Washout Period (28 Days)|Other|2|||
162897034|NCT02709109|588321376|FG002|Washout Period (28 Days)|Other|3|||
162897035|NCT02709109|588321377|FG003|Washout Period (28 Days)|Other|0|||
162624830|NCT01090492|587343062|FG002|Second Intervention Period (4 Weeks)|Other|1|||
162897036|NCT02709109|588321374|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
162897037|NCT02709109|588321375|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
162897038|NCT02709109|588321376|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
163051995|NCT00846586|588898784|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162624831|NCT01090492|587343063|FG003|Second Intervention Period (4 Weeks)|Other|0|||
162624832|NCT01090492|587343064|FG004|Second Intervention Period (4 Weeks)|Other|0|||
162624833|NCT01090492|587343065|FG005|Second Intervention Period (4 Weeks)|Other|0|||
162624834|NCT01090492|587343066|FG006|Second Intervention Period (4 Weeks)|Other|0|||
162624835|NCT01090492|587343067|FG007|Second Intervention Period (4 Weeks)|Other|0|||
162624836|NCT01090492|587343060|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162624837|NCT01090492|587343061|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162624838|NCT01090492|587343062|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162624839|NCT01090492|587343063|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162897039|NCT02709109|588321377|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
162897040|NCT02709109|588321374|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
162897041|NCT02709109|588321375|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
162897042|NCT02709109|588321376|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
162897043|NCT02709109|588321377|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
162897044|NCT02709109|588321374|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
162897045|NCT02709109|588321375|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
162897046|NCT02709109|588321376|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
162897047|NCT02709109|588321377|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
162897048|NCT02709109|588321374|FG000|Treatment Period 2 (28 Days)|Other|0|||
162624840|NCT01090492|587343064|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162624841|NCT01090492|587343065|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162897049|NCT02709109|588321375|FG001|Treatment Period 2 (28 Days)|Other|0|||
162897050|NCT02709109|588321376|FG002|Treatment Period 2 (28 Days)|Other|1|||
162897051|NCT02709109|588321377|FG003|Treatment Period 2 (28 Days)|Other|0|||
162897052|NCT00741260|588321379|FG000|Overall Study|Disease Progression|3|||
162897053|NCT00741260|588321380|FG001|Overall Study|Disease Progression|5|||
162897054|NCT00741260|588321381|FG002|Overall Study|Disease Progression|3|||
162897055|NCT00741260|588321382|FG003|Overall Study|Disease Progression|3|||
162897056|NCT00741260|588321383|FG004|Overall Study|Disease Progression|5|||
162897057|NCT00741260|588321384|FG005|Overall Study|Disease Progression|37|||
162897058|NCT00741260|588321385|FG006|Overall Study|Disease Progression|4|||
162897059|NCT00741260|588321379|FG000|Overall Study|Death|0|||
162897060|NCT00741260|588321380|FG001|Overall Study|Death|1|||
162897061|NCT00741260|588321381|FG002|Overall Study|Death|0|||
162897062|NCT00741260|588321382|FG003|Overall Study|Death|1|||
162897063|NCT00741260|588321383|FG004|Overall Study|Death|2|||
162897064|NCT00741260|588321384|FG005|Overall Study|Death|2|||
162897065|NCT00741260|588321385|FG006|Overall Study|Death|1|||
162897066|NCT00741260|588321379|FG000|Overall Study|Withdrawal by Subject|0|||
162897067|NCT00741260|588321380|FG001|Overall Study|Withdrawal by Subject|0|||
162897068|NCT00741260|588321381|FG002|Overall Study|Withdrawal by Subject|0|||
162897069|NCT00741260|588321382|FG003|Overall Study|Withdrawal by Subject|0|||
162897070|NCT00741260|588321383|FG004|Overall Study|Withdrawal by Subject|1|||
162897071|NCT00741260|588321384|FG005|Overall Study|Withdrawal by Subject|3|||
162897072|NCT00741260|588321385|FG006|Overall Study|Withdrawal by Subject|1|||
162897073|NCT00741260|588321379|FG000|Overall Study|Physician Decision|1|||
162897074|NCT00741260|588321380|FG001|Overall Study|Physician Decision|1|||
162624842|NCT01090492|587343066|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
162624843|NCT01090492|587343067|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162624844|NCT01090492|587343060|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162897075|NCT00741260|588321381|FG002|Overall Study|Physician Decision|0|||
162897076|NCT00741260|588321382|FG003|Overall Study|Physician Decision|0|||
162897077|NCT00741260|588321383|FG004|Overall Study|Physician Decision|0|||
162897078|NCT00741260|588321384|FG005|Overall Study|Physician Decision|0|||
162897079|NCT00741260|588321385|FG006|Overall Study|Physician Decision|0|||
162897080|NCT00741260|588321379|FG000|Overall Study|Other|2|||
162897081|NCT00741260|588321380|FG001|Overall Study|Other|1|||
162897082|NCT00741260|588321381|FG002|Overall Study|Other|1|||
162965135|NCT03684928|588572089|FG001|First Intervention|Withdrawal by Subject|2|||
162897083|NCT00741260|588321382|FG003|Overall Study|Other|2|||
162897084|NCT00741260|588321383|FG004|Overall Study|Other|1|||
162897085|NCT00741260|588321384|FG005|Overall Study|Other|3|||
162897086|NCT00741260|588321385|FG006|Overall Study|Other|1|||
162897087|NCT02565615|588321386|FG000|Overall Study|Death|0|||
162897088|NCT02565615|588321387|FG001|Overall Study|Death|1|||
162897089|NCT02565615|588321388|FG002|Overall Study|Death|0|||
162624845|NCT01090492|587343061|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624846|NCT01090492|587343062|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162708783|NCT04739423|587642899|FG002|Overall Study|Protocol Violation|0|||
162897090|NCT02565615|588321389|FG003|Overall Study|Death|0|||
162897091|NCT02565615|588321390|FG004|Overall Study|Death|4|||
162897092|NCT02565615|588321386|FG000|Overall Study|Not willing to participate in study|2|||
162897093|NCT02565615|588321387|FG001|Overall Study|Not willing to participate in study|21|||
162897094|NCT02565615|588321388|FG002|Overall Study|Not willing to participate in study|0|||
162897095|NCT02565615|588321389|FG003|Overall Study|Not willing to participate in study|1|||
162897096|NCT02565615|588321390|FG004|Overall Study|Not willing to participate in study|169|||
162965136|NCT03684928|588572088|FG000|Second Intervention|Soft Tissue Injury|1|||
162897097|NCT02565615|588321386|FG000|Overall Study|Lost to Follow-up|0|||
162897098|NCT02565615|588321387|FG001|Overall Study|Lost to Follow-up|4|||
162897099|NCT02565615|588321388|FG002|Overall Study|Lost to Follow-up|0|||
162897100|NCT02565615|588321389|FG003|Overall Study|Lost to Follow-up|1|||
162897101|NCT02565615|588321390|FG004|Overall Study|Lost to Follow-up|765|||
162897102|NCT02565615|588321386|FG000|Overall Study|Not meeting eligibility criteria|0|||
162897103|NCT02565615|588321387|FG001|Overall Study|Not meeting eligibility criteria|7|||
162897104|NCT02565615|588321388|FG002|Overall Study|Not meeting eligibility criteria|0|||
162897105|NCT02565615|588321389|FG003|Overall Study|Not meeting eligibility criteria|0|||
162897106|NCT02565615|588321390|FG004|Overall Study|Not meeting eligibility criteria|25|||
162897107|NCT02565615|588321386|FG000|Overall Study|Reason not defined|0|||
162897108|NCT02565615|588321387|FG001|Overall Study|Reason not defined|2|||
162897109|NCT02565615|588321388|FG002|Overall Study|Reason not defined|0|||
162897110|NCT02565615|588321389|FG003|Overall Study|Reason not defined|1|||
162897111|NCT02565615|588321390|FG004|Overall Study|Reason not defined|62|||
162897112|NCT02565615|588321386|FG000|Overall Study|Adverse Event|1|||
162897113|NCT02565615|588321387|FG001|Overall Study|Adverse Event|1|||
162897114|NCT02565615|588321388|FG002|Overall Study|Adverse Event|0|||
162897115|NCT02565615|588321389|FG003|Overall Study|Adverse Event|0|||
162897116|NCT02565615|588321390|FG004|Overall Study|Adverse Event|9|||
162897117|NCT02565615|588321386|FG000|Overall Study|Untreated|0|||
162897118|NCT02565615|588321387|FG001|Overall Study|Untreated|0|||
162897119|NCT02565615|588321388|FG002|Overall Study|Untreated|0|||
162897120|NCT02565615|588321389|FG003|Overall Study|Untreated|0|||
162897121|NCT02565615|588321390|FG004|Overall Study|Untreated|567|||
162897122|NCT01815580|588321397|FG000|Overall Study|Lost to Follow-up|4|||
162897123|NCT01815580|588321398|FG001|Overall Study|Lost to Follow-up|7|||
162897124|NCT01815580|588321397|FG000|Overall Study|Withdrawal by Subject|3|||
162897125|NCT01815580|588321398|FG001|Overall Study|Withdrawal by Subject|4|||
162897126|NCT01815580|588321397|FG000|Overall Study|Excluded from analysis|5|||
162897127|NCT01815580|588321398|FG001|Overall Study|Excluded from analysis|4|||
162708784|NCT04739423|587642900|FG003|Overall Study|Protocol Violation|0|||
162897128|NCT01610206|588321404|FG000|Overall Study|Adverse Event|10|||
162897129|NCT01610206|588321405|FG001|Overall Study|Adverse Event|30|||
162897130|NCT00023712|588321406|FG000|Overall Study|Not platinum sensitive|1|||
162897131|NCT00023712|588321407|FG001|Overall Study|Not platinum sensitive|0|||
162897132|NCT00023712|588321406|FG000|Overall Study|Never treated|1|||
162897133|NCT00023712|588321407|FG001|Overall Study|Never treated|1|||
162897134|NCT03695471|588324073|FG000|Overall Study|Cancellation|1|||
162897135|NCT02859558|588324074|FG000|Step 1|Not Eligible|0|||
162897136|NCT02859558|588324075|FG001|Step 1|Not Eligible|0|||
162897137|NCT02859558|588324076|FG002|Step 1|Not Eligible|0|||
162897138|NCT02859558|588324077|FG003|Step 1|Not Eligible|0|||
162897139|NCT02859558|588324078|FG004|Step 1|Not Eligible|3|||
162897140|NCT02859558|588324074|FG000|Step 1|Lost to Follow-up|1|||
162897141|NCT02859558|588324075|FG001|Step 1|Lost to Follow-up|3|||
162897142|NCT02859558|588324076|FG002|Step 1|Lost to Follow-up|3|||
162897143|NCT02859558|588324077|FG003|Step 1|Lost to Follow-up|0|||
162897144|NCT02859558|588324078|FG004|Step 1|Lost to Follow-up|0|||
162897145|NCT02859558|588324074|FG000|Step 1|Did Not Return to Clinic|2|||
162897146|NCT02859558|588324075|FG001|Step 1|Did Not Return to Clinic|3|||
162897147|NCT02859558|588324076|FG002|Step 1|Did Not Return to Clinic|4|||
162897148|NCT02859558|588324077|FG003|Step 1|Did Not Return to Clinic|0|||
162897149|NCT02859558|588324078|FG004|Step 1|Did Not Return to Clinic|0|||
162897150|NCT02859558|588324074|FG000|Step 1|Moved|0|||
162897151|NCT02859558|588324075|FG001|Step 1|Moved|1|||
162897152|NCT02859558|588324076|FG002|Step 1|Moved|1|||
162897153|NCT02859558|588324077|FG003|Step 1|Moved|0|||
162897154|NCT02859558|588324078|FG004|Step 1|Moved|0|||
162897155|NCT02859558|588324074|FG000|Step 1|Withdrawal By Participant|1|||
162897156|NCT02859558|588324075|FG001|Step 1|Withdrawal By Participant|2|||
162897157|NCT02859558|588324076|FG002|Step 1|Withdrawal By Participant|1|||
162897158|NCT02859558|588324077|FG003|Step 1|Withdrawal By Participant|0|||
162897159|NCT02859558|588324078|FG004|Step 1|Withdrawal By Participant|0|||
162897160|NCT02859558|588324074|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
162897161|NCT02859558|588324075|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
162897162|NCT02859558|588324076|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
162897163|NCT02859558|588324077|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
162897164|NCT02859558|588324078|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
162897165|NCT02859558|588324074|FG000|Step 1|Incarceration|0|||
162897166|NCT02859558|588324075|FG001|Step 1|Incarceration|1|||
162897167|NCT02859558|588324076|FG002|Step 1|Incarceration|0|||
162897168|NCT02859558|588324077|FG003|Step 1|Incarceration|0|||
162897169|NCT02859558|588324078|FG004|Step 1|Incarceration|0|||
162897170|NCT02859558|588324074|FG000|Step 1|Non-Adherence to Study Drug|2|||
162897171|NCT02859558|588324075|FG001|Step 1|Non-Adherence to Study Drug|0|||
162897172|NCT02859558|588324076|FG002|Step 1|Non-Adherence to Study Drug|1|||
162897173|NCT02859558|588324077|FG003|Step 1|Non-Adherence to Study Drug|0|||
162897174|NCT02859558|588324078|FG004|Step 1|Non-Adherence to Study Drug|0|||
162897175|NCT02859558|588324074|FG000|Step 1|Non-Adherence to Study Requirements|3|||
162897176|NCT02859558|588324075|FG001|Step 1|Non-Adherence to Study Requirements|1|||
162897177|NCT02859558|588324076|FG002|Step 1|Non-Adherence to Study Requirements|0|||
162897178|NCT02859558|588324077|FG003|Step 1|Non-Adherence to Study Requirements|0|||
162897179|NCT02859558|588324078|FG004|Step 1|Non-Adherence to Study Requirements|0|||
162897180|NCT02859558|588324074|FG000|Step 1|Virologic Failure|2|||
162897181|NCT02859558|588324075|FG001|Step 1|Virologic Failure|1|||
162897182|NCT02859558|588324076|FG002|Step 1|Virologic Failure|1|||
162897183|NCT02859558|588324077|FG003|Step 1|Virologic Failure|0|||
162897184|NCT02859558|588324078|FG004|Step 1|Virologic Failure|0|||
162897185|NCT02859558|588324074|FG000|Step 2|Lost to Follow-up|3|||
162897186|NCT02859558|588324075|FG001|Step 2|Lost to Follow-up|3|||
162897187|NCT02859558|588324076|FG002|Step 2|Lost to Follow-up|1|||
162897188|NCT02859558|588324077|FG003|Step 2|Lost to Follow-up|0|||
162897189|NCT02859558|588324078|FG004|Step 2|Lost to Follow-up|0|||
162897190|NCT02859558|588324074|FG000|Step 2|Withdrawal by Subject|0|||
162897191|NCT02859558|588324075|FG001|Step 2|Withdrawal by Subject|1|||
162897192|NCT02859558|588324076|FG002|Step 2|Withdrawal by Subject|1|||
162897193|NCT02859558|588324077|FG003|Step 2|Withdrawal by Subject|0|||
162897194|NCT02859558|588324078|FG004|Step 2|Withdrawal by Subject|0|||
162897195|NCT02859558|588324074|FG000|Step 2|Unexpected Closure of Site|0|||
162897196|NCT02859558|588324075|FG001|Step 2|Unexpected Closure of Site|1|||
162897197|NCT02859558|588324076|FG002|Step 2|Unexpected Closure of Site|1|||
162897198|NCT02859558|588324077|FG003|Step 2|Unexpected Closure of Site|0|||
162897199|NCT02859558|588324078|FG004|Step 2|Unexpected Closure of Site|0|||
162897200|NCT02859558|588324074|FG000|Step 2|Death|1|||
162897201|NCT02859558|588324075|FG001|Step 2|Death|0|||
163051996|NCT00846586|588898785|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163051997|NCT01619878|588898786|FG000|6 Week Follow-up Phase|Adverse Event|1|||
163051998|NCT01619878|588898786|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
163051999|NCT01619878|588898786|FG000|Follow-up at 12 Months of Age|Death|2|||
163052000|NCT04414787|588898787|FG000|Overall Study|Patient Death|18|||
163052001|NCT04414787|588898788|FG001|Overall Study|Patient Death|18|||
163052002|NCT04414787|588898789|FG002|Overall Study|Patient Death|15|||
163052003|NCT04414787|588898790|FG003|Overall Study|Patient Death|15|||
163052004|NCT04414787|588898787|FG000|Overall Study|Patient Hospitalization|1|||
163052005|NCT04414787|588898788|FG001|Overall Study|Patient Hospitalization|1|||
163052006|NCT04414787|588898789|FG002|Overall Study|Patient Hospitalization|2|||
163052007|NCT04414787|588898790|FG003|Overall Study|Patient Hospitalization|2|||
163052008|NCT04414787|588898787|FG000|Overall Study|Lost to Follow-up|7|||
163052009|NCT04414787|588898788|FG001|Overall Study|Lost to Follow-up|7|||
163052010|NCT04414787|588898789|FG002|Overall Study|Lost to Follow-up|5|||
163052011|NCT04414787|588898790|FG003|Overall Study|Lost to Follow-up|5|||
163052012|NCT04414787|588898787|FG000|Overall Study|Residence in post-acute care facility|3|||
163052013|NCT04414787|588898788|FG001|Overall Study|Residence in post-acute care facility|3|||
163052014|NCT04414787|588898789|FG002|Overall Study|Residence in post-acute care facility|5|||
163052015|NCT04414787|588898790|FG003|Overall Study|Residence in post-acute care facility|5|||
163052016|NCT05093933|588898791|FG000|Overall Study|Death|372|||
163052017|NCT05093933|588898792|FG001|Overall Study|Death|434|||
163052018|NCT05093933|588898791|FG000|Overall Study|Lost to Follow-up|13|||
163052019|NCT05093933|588898792|FG001|Overall Study|Lost to Follow-up|16|||
163052020|NCT05093933|588898791|FG000|Overall Study|Physician Decision|0|||
163052021|NCT05093933|588898792|FG001|Overall Study|Physician Decision|2|||
163052022|NCT05093933|588898791|FG000|Overall Study|Sponsor Decision|1|||
163052023|NCT05093933|588898792|FG001|Overall Study|Sponsor Decision|3|||
163052024|NCT05093933|588898791|FG000|Overall Study|Withdrawal by Guardian|1|||
163052025|NCT05093933|588898792|FG001|Overall Study|Withdrawal by Guardian|1|||
162708785|NCT04739423|587642901|FG004|Overall Study|Protocol Violation|0|||
163052026|NCT05093933|588898791|FG000|Overall Study|Withdrawal by Subject|18|||
163052027|NCT05093933|588898792|FG001|Overall Study|Withdrawal by Subject|25|||
163052028|NCT05027815|588898795|FG000|Overall Study|Death|2|||
163052029|NCT05027815|588898796|FG001|Overall Study|Death|1|||
163052030|NCT04802161|588898798|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
163052031|NCT04802161|588898799|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
163052032|NCT04802161|588898800|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
162897202|NCT02859558|588324076|FG002|Step 2|Death|0|||
162897203|NCT02859558|588324077|FG003|Step 2|Death|0|||
162897204|NCT02859558|588324078|FG004|Step 2|Death|0|||
162897205|NCT02859558|588324074|FG000|Step 2|Incarceration|0|||
162897206|NCT02859558|588324075|FG001|Step 2|Incarceration|0|||
162897207|NCT02859558|588324076|FG002|Step 2|Incarceration|1|||
162897208|NCT02859558|588324077|FG003|Step 2|Incarceration|0|||
162897209|NCT02859558|588324078|FG004|Step 2|Incarceration|0|||
162897210|NCT04507360|588324079|FG000|Week 1|Lost to Follow-up|0|||
162897211|NCT04507360|588324080|FG001|Week 1|Lost to Follow-up|0|||
162897212|NCT04507360|588324081|FG002|Week 1|Lost to Follow-up|0|||
163052033|NCT04802161|588898801|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
163052034|NCT04802161|588898798|FG000|Overall Study|Clinical Instability|0|||
163052035|NCT04802161|588898799|FG001|Overall Study|Clinical Instability|0|||
163052036|NCT04802161|588898800|FG002|Overall Study|Clinical Instability|1|||
162897213|NCT04507360|588324082|FG003|Week 1|Lost to Follow-up|0|||
162897214|NCT04507360|588324083|FG004|Week 1|Lost to Follow-up|0|||
162897215|NCT04507360|588324084|FG005|Week 1|Lost to Follow-up|0|||
162897216|NCT04507360|588324085|FG006|Week 1|Lost to Follow-up|0|||
162897217|NCT04507360|588324086|FG007|Week 1|Lost to Follow-up|0|||
162897218|NCT04507360|588324087|FG008|Week 1|Lost to Follow-up|72|||
162897219|NCT04507360|588324088|FG009|Week 1|Lost to Follow-up|22|||
162897220|NCT04507360|588324089|FG010|Week 1|Lost to Follow-up|10|||
162897221|NCT04507360|588324079|FG000|Week 2|Lost to Follow-up|0|||
162897222|NCT04507360|588324080|FG001|Week 2|Lost to Follow-up|0|||
162897223|NCT04507360|588324081|FG002|Week 2|Lost to Follow-up|0|||
162897224|NCT04507360|588324082|FG003|Week 2|Lost to Follow-up|0|||
162897225|NCT04507360|588324083|FG004|Week 2|Lost to Follow-up|0|||
162897226|NCT04507360|588324084|FG005|Week 2|Lost to Follow-up|0|||
162897227|NCT04507360|588324085|FG006|Week 2|Lost to Follow-up|0|||
162897228|NCT04507360|588324086|FG007|Week 2|Lost to Follow-up|0|||
162897229|NCT04507360|588324087|FG008|Week 2|Lost to Follow-up|121|||
162897230|NCT04507360|588324088|FG009|Week 2|Lost to Follow-up|85|||
162897231|NCT04507360|588324089|FG010|Week 2|Lost to Follow-up|82|||
162897232|NCT04507360|588324079|FG000|Week 3|Lost to Follow-up|0|||
162897233|NCT04507360|588324080|FG001|Week 3|Lost to Follow-up|0|||
162897234|NCT04507360|588324081|FG002|Week 3|Lost to Follow-up|0|||
162897235|NCT04507360|588324082|FG003|Week 3|Lost to Follow-up|0|||
162897236|NCT04507360|588324083|FG004|Week 3|Lost to Follow-up|0|||
162897237|NCT04507360|588324084|FG005|Week 3|Lost to Follow-up|0|||
162897238|NCT04507360|588324085|FG006|Week 3|Lost to Follow-up|0|||
162897239|NCT04507360|588324086|FG007|Week 3|Lost to Follow-up|0|||
162897240|NCT04507360|588324087|FG008|Week 3|Lost to Follow-up|123|||
162897241|NCT04507360|588324088|FG009|Week 3|Lost to Follow-up|92|||
162897242|NCT04507360|588324089|FG010|Week 3|Lost to Follow-up|84|||
162897243|NCT04507360|588324079|FG000|Week 4|Lost to Follow-up|0|||
162897244|NCT04507360|588324080|FG001|Week 4|Lost to Follow-up|0|||
162897245|NCT04507360|588324081|FG002|Week 4|Lost to Follow-up|0|||
162897246|NCT04507360|588324082|FG003|Week 4|Lost to Follow-up|0|||
162897247|NCT04507360|588324083|FG004|Week 4|Lost to Follow-up|0|||
162897248|NCT04507360|588324084|FG005|Week 4|Lost to Follow-up|0|||
162897249|NCT04507360|588324085|FG006|Week 4|Lost to Follow-up|0|||
162897250|NCT04507360|588324086|FG007|Week 4|Lost to Follow-up|0|||
162897251|NCT04507360|588324087|FG008|Week 4|Lost to Follow-up|131|||
162897252|NCT04507360|588324088|FG009|Week 4|Lost to Follow-up|115|||
162897253|NCT04507360|588324089|FG010|Week 4|Lost to Follow-up|102|||
162897254|NCT04507360|588324079|FG000|Week 5|Lost to Follow-up|0|||
162897255|NCT04507360|588324080|FG001|Week 5|Lost to Follow-up|0|||
162897256|NCT04507360|588324081|FG002|Week 5|Lost to Follow-up|0|||
162897257|NCT04507360|588324082|FG003|Week 5|Lost to Follow-up|0|||
162897258|NCT04507360|588324083|FG004|Week 5|Lost to Follow-up|0|||
162897259|NCT04507360|588324084|FG005|Week 5|Lost to Follow-up|0|||
162897260|NCT04507360|588324085|FG006|Week 5|Lost to Follow-up|0|||
162897261|NCT04507360|588324086|FG007|Week 5|Lost to Follow-up|0|||
162897262|NCT04507360|588324087|FG008|Week 5|Lost to Follow-up|103|||
162897263|NCT04507360|588324088|FG009|Week 5|Lost to Follow-up|135|||
162897264|NCT04507360|588324089|FG010|Week 5|Lost to Follow-up|143|||
162897265|NCT04507360|588324079|FG000|Week 8|Lost to Follow-up|0|||
162897266|NCT04507360|588324080|FG001|Week 8|Lost to Follow-up|0|||
162897267|NCT04507360|588324081|FG002|Week 8|Lost to Follow-up|0|||
162897268|NCT04507360|588324082|FG003|Week 8|Lost to Follow-up|0|||
162965137|NCT03684928|588572089|FG001|Second Intervention|Soft Tissue Injury|0|||
162897269|NCT04507360|588324083|FG004|Week 8|Lost to Follow-up|0|||
162965138|NCT03193021|588572090|FG000|Overall Study|Lost to Follow-up|1|||
162897270|NCT04507360|588324084|FG005|Week 8|Lost to Follow-up|0|||
162897271|NCT04507360|588324085|FG006|Week 8|Lost to Follow-up|0|||
162897272|NCT04507360|588324086|FG007|Week 8|Lost to Follow-up|0|||
162897273|NCT04507360|588324087|FG008|Week 8|Lost to Follow-up|139|||
162897274|NCT04507360|588324088|FG009|Week 8|Lost to Follow-up|145|||
162897275|NCT04507360|588324089|FG010|Week 8|Lost to Follow-up|152|||
162897276|NCT00400946|588324090|FG000|Overall Study|Ineligible|0|||
162897277|NCT00400946|588324091|FG001|Overall Study|Ineligible|0|||
162897278|NCT00400946|588324092|FG002|Overall Study|Ineligible|0|||
162897279|NCT00400946|588324093|FG003|Overall Study|Ineligible|5|||
162897280|NCT00400946|588324094|FG004|Overall Study|Ineligible|1|||
162897281|NCT00400946|588324090|FG000|Overall Study|Induction Failure|0|||
162897282|NCT00400946|588324091|FG001|Overall Study|Induction Failure|0|||
162897283|NCT00400946|588324092|FG002|Overall Study|Induction Failure|0|||
162965139|NCT03193021|588572091|FG001|Overall Study|Lost to Follow-up|1|||
163052037|NCT04802161|588898801|FG003|Overall Study|Clinical Instability|0|||
163052038|NCT04802161|588898798|FG000|Overall Study|Adverse Event|0|||
162897284|NCT00400946|588324093|FG003|Overall Study|Induction Failure|11|||
163052039|NCT04802161|588898799|FG001|Overall Study|Adverse Event|0|||
163052040|NCT04802161|588898800|FG002|Overall Study|Adverse Event|1|||
162708786|NCT04739423|587642902|FG005|Overall Study|Protocol Violation|0|||
162897285|NCT00400946|588324094|FG004|Overall Study|Induction Failure|8|||
162897286|NCT00400946|588324090|FG000|Overall Study|Induction Death|0|||
162897287|NCT00400946|588324091|FG001|Overall Study|Induction Death|0|||
162897288|NCT00400946|588324092|FG002|Overall Study|Induction Death|0|||
162897289|NCT00400946|588324093|FG003|Overall Study|Induction Death|13|||
162897290|NCT00400946|588324094|FG004|Overall Study|Induction Death|3|||
162897291|NCT00400946|588324090|FG000|Overall Study|Lost to Follow-up|1|||
162897292|NCT00400946|588324091|FG001|Overall Study|Lost to Follow-up|1|||
162897293|NCT00400946|588324092|FG002|Overall Study|Lost to Follow-up|0|||
162897294|NCT00400946|588324093|FG003|Overall Study|Lost to Follow-up|0|||
162897295|NCT00400946|588324094|FG004|Overall Study|Lost to Follow-up|1|||
162897296|NCT00400946|588324090|FG000|Overall Study|Remission Death|1|||
162897297|NCT00400946|588324091|FG001|Overall Study|Remission Death|1|||
162897298|NCT00400946|588324092|FG002|Overall Study|Remission Death|0|||
162897299|NCT00400946|588324093|FG003|Overall Study|Remission Death|0|||
162897300|NCT00400946|588324094|FG004|Overall Study|Remission Death|1|||
162897301|NCT00400946|588324090|FG000|Overall Study|Relapse|9|||
162897302|NCT00400946|588324091|FG001|Overall Study|Relapse|2|||
162897303|NCT00400946|588324092|FG002|Overall Study|Relapse|1|||
162897304|NCT00400946|588324093|FG003|Overall Study|Relapse|1|||
162897305|NCT00400946|588324094|FG004|Overall Study|Relapse|5|||
162897306|NCT00400946|588324090|FG000|Overall Study|Transplant in CR1|0|||
162897307|NCT00400946|588324091|FG001|Overall Study|Transplant in CR1|0|||
162897308|NCT00400946|588324092|FG002|Overall Study|Transplant in CR1|0|||
162897309|NCT00400946|588324093|FG003|Overall Study|Transplant in CR1|10|||
162897310|NCT00400946|588324094|FG004|Overall Study|Transplant in CR1|1|||
162897311|NCT00400946|588324090|FG000|Overall Study|Withdrawal by Subject|2|||
162897312|NCT00400946|588324091|FG001|Overall Study|Withdrawal by Subject|5|||
162897313|NCT00400946|588324092|FG002|Overall Study|Withdrawal by Subject|1|||
162897314|NCT00400946|588324093|FG003|Overall Study|Withdrawal by Subject|5|||
162897315|NCT00400946|588324094|FG004|Overall Study|Withdrawal by Subject|8|||
162897316|NCT00400946|588324090|FG000|Overall Study|Clinical|1|||
162897317|NCT00400946|588324091|FG001|Overall Study|Clinical|2|||
162897318|NCT00400946|588324092|FG002|Overall Study|Clinical|0|||
162897319|NCT00400946|588324093|FG003|Overall Study|Clinical|2|||
162897320|NCT00400946|588324094|FG004|Overall Study|Clinical|9|||
162897321|NCT00400946|588324090|FG000|Overall Study|Other|0|||
162897322|NCT00400946|588324091|FG001|Overall Study|Other|0|||
162897323|NCT00400946|588324092|FG002|Overall Study|Other|0|||
162897324|NCT00400946|588324093|FG003|Overall Study|Other|0|||
162897325|NCT00400946|588324094|FG004|Overall Study|Other|1|||
162897326|NCT03950440|588324097|FG000|Overall Study|Death|8|||
162897327|NCT03950440|588324098|FG001|Overall Study|Death|2|||
162897328|NCT03950440|588324099|FG002|Overall Study|Death|1|||
162897329|NCT02892734|588324100|FG000|Treatment on Study|Progressive Disease|2|||
162897330|NCT02892734|588324100|FG000|Follow up for 2 Years|Death|2|||
162897331|NCT02892734|588324100|FG000|Follow up for 2 Years|Study closed early|1|||
162897332|NCT00439309|588324101|FG000|Follow-Up|Death|1|||
162897333|NCT00439309|588324102|FG001|Follow-Up|Death|0|||
162897334|NCT00439309|588324101|FG000|Follow-Up|Lost to Follow-up|2|||
162897335|NCT00439309|588324102|FG001|Follow-Up|Lost to Follow-up|0|||
162897336|NCT00439309|588324101|FG000|Follow-Up|Withdrawal by Subject|0|||
162897337|NCT00439309|588324102|FG001|Follow-Up|Withdrawal by Subject|1|||
162897338|NCT00439309|588324101|FG000|Follow-Up|Late response by subject|0|||
162897339|NCT00439309|588324102|FG001|Follow-Up|Late response by subject|1|||
162897340|NCT02043509|588324103|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
162897341|NCT02043509|588324104|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
162897342|NCT02043509|588324103|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
162897343|NCT02043509|588324104|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
162897344|NCT02043509|588324103|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
163052041|NCT04802161|588898801|FG003|Overall Study|Adverse Event|0|||
162897345|NCT02043509|588324104|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
162897346|NCT02043509|588324103|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
162897347|NCT02043509|588324104|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
162897348|NCT00608244|588324109|FG000|Overall Study|Adverse Event|1|||
162897349|NCT00608244|588324109|FG000|Overall Study|Low trough levels|1|||
162897350|NCT01685060|588324112|FG000|Overall Study|Rollover patients|16|||
162897351|NCT01685060|588324112|FG000|Overall Study|Adverse Event|12|||
162897352|NCT01685060|588324112|FG000|Overall Study|Progressive disease|69|||
162897353|NCT01685060|588324112|FG000|Overall Study|Physician Decision|14|||
162897354|NCT01685060|588324112|FG000|Overall Study|Subject/guardian decision|20|||
162897355|NCT01685060|588324112|FG000|Overall Study|Lost to Follow-up|1|||
162897356|NCT01685060|588324112|FG000|Overall Study|Death|8|||
162897357|NCT02443155|588324115|FG000|Overall Study|Adverse Event|3|||
162897358|NCT02443155|588324116|FG001|Overall Study|Adverse Event|4|||
162897359|NCT02443155|588324117|FG002|Overall Study|Adverse Event|1|||
162897360|NCT02443155|588324118|FG003|Overall Study|Adverse Event|2|||
162897361|NCT02443155|588324115|FG000|Overall Study|Unclassified|0|||
162897362|NCT02443155|588324116|FG001|Overall Study|Unclassified|0|||
162965140|NCT02286466|588572092|FG000|Overall Study|Death|1|||
162965141|NCT02286466|588572093|FG001|Overall Study|Death|3|||
162965142|NCT02286466|588572092|FG000|Overall Study|Withdrawal by Subject|5|||
162965143|NCT02286466|588572093|FG001|Overall Study|Withdrawal by Subject|2|||
162965144|NCT02286466|588572092|FG000|Overall Study|Lost to Follow-up|1|||
162965145|NCT02286466|588572093|FG001|Overall Study|Lost to Follow-up|4|||
162965146|NCT02286466|588572092|FG000|Overall Study|Declined Clinician Assessment|0|||
162965147|NCT02286466|588572093|FG001|Overall Study|Declined Clinician Assessment|1|||
162965148|NCT00835081|588572094|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162965149|NCT00835081|588572095|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162965150|NCT00874276|588572096|FG000|Overall Study|Withdrawal by Subject|1|||
162965151|NCT00874276|588572097|FG001|Overall Study|Withdrawal by Subject|1|||
162965152|NCT04573309|588573214|FG000|Overall Study|Protocol Violation|1|||
162965153|NCT04573309|588573215|FG001|Overall Study|Protocol Violation|0|||
162965154|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
162965155|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
162965156|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
162965157|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
162965158|NCT02300987|588573216|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
162965159|NCT02300987|588573217|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
162965160|NCT02300987|588573216|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
162965161|NCT02300987|588573217|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
162965162|NCT02300987|588573216|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
162965163|NCT02300987|588573217|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
162965164|NCT04211766|588573218|FG000|Overall Study|Withdrawal by Subject|5|||
162965165|NCT04211766|588573219|FG001|Overall Study|Withdrawal by Subject|1|||
162965166|NCT05330975|588573220|FG000|Primary|Lost to Follow-up|12|||
162965167|NCT05330975|588573221|FG001|Primary|Lost to Follow-up|21|||
162965168|NCT05330975|588573222|FG002|Primary|Lost to Follow-up|38|||
162965169|NCT05330975|588573223|FG003|Primary|Lost to Follow-up|30|||
162965170|NCT05330975|588573224|FG004|Primary|Lost to Follow-up|25|||
162965171|NCT05330975|588573225|FG005|Primary|Lost to Follow-up|28|||
162965172|NCT05330975|588573226|FG006|Primary|Lost to Follow-up|0|||
162965173|NCT05330975|588573220|FG000|Primary|Withdrawal by Subject|4|||
162965174|NCT05330975|588573221|FG001|Primary|Withdrawal by Subject|11|||
162965175|NCT05330975|588573222|FG002|Primary|Withdrawal by Subject|8|||
162965176|NCT05330975|588573223|FG003|Primary|Withdrawal by Subject|23|||
162965177|NCT05330975|588573224|FG004|Primary|Withdrawal by Subject|20|||
162965178|NCT05330975|588573225|FG005|Primary|Withdrawal by Subject|19|||
162965179|NCT05330975|588573226|FG006|Primary|Withdrawal by Subject|0|||
162965180|NCT05330975|588573220|FG000|Primary|Protocol Violation|0|||
162965181|NCT05330975|588573221|FG001|Primary|Protocol Violation|2|||
162965182|NCT05330975|588573222|FG002|Primary|Protocol Violation|0|||
162965183|NCT05330975|588573223|FG003|Primary|Protocol Violation|4|||
162965184|NCT05330975|588573224|FG004|Primary|Protocol Violation|0|||
162965185|NCT05330975|588573225|FG005|Primary|Protocol Violation|3|||
162965186|NCT05330975|588573226|FG006|Primary|Protocol Violation|0|||
162965187|NCT05330975|588573220|FG000|Primary|Death|0|||
162897363|NCT02443155|588324117|FG002|Overall Study|Unclassified|2|||
162965188|NCT05330975|588573221|FG001|Primary|Death|3|||
162897364|NCT02443155|588324118|FG003|Overall Study|Unclassified|1|||
162897365|NCT02443155|588324115|FG000|Overall Study|Withdrawal by Subject|4|||
162897366|NCT02443155|588324116|FG001|Overall Study|Withdrawal by Subject|7|||
162897367|NCT02443155|588324117|FG002|Overall Study|Withdrawal by Subject|3|||
162897368|NCT02443155|588324118|FG003|Overall Study|Withdrawal by Subject|9|||
162897369|NCT02443155|588324115|FG000|Overall Study|Pregnancy|3|||
162965189|NCT05330975|588573222|FG002|Primary|Death|1|||
162965190|NCT05330975|588573223|FG003|Primary|Death|1|||
162965191|NCT05330975|588573224|FG004|Primary|Death|0|||
162965192|NCT05330975|588573225|FG005|Primary|Death|0|||
162897370|NCT02443155|588324116|FG001|Overall Study|Pregnancy|1|||
162965193|NCT05330975|588573226|FG006|Primary|Death|0|||
162897371|NCT02443155|588324117|FG002|Overall Study|Pregnancy|1|||
162897372|NCT02443155|588324118|FG003|Overall Study|Pregnancy|2|||
162965194|NCT05330975|588573220|FG000|Primary|Other Than Specified|0|||
162965195|NCT05330975|588573221|FG001|Primary|Other Than Specified|1|||
162897373|NCT02443155|588324115|FG000|Overall Study|Lost to Follow-up|1|||
162897374|NCT02443155|588324116|FG001|Overall Study|Lost to Follow-up|2|||
162897375|NCT02443155|588324117|FG002|Overall Study|Lost to Follow-up|0|||
162897376|NCT02443155|588324118|FG003|Overall Study|Lost to Follow-up|1|||
162897377|NCT02443155|588324115|FG000|Overall Study|Protocol Violation|1|||
162897378|NCT02443155|588324116|FG001|Overall Study|Protocol Violation|0|||
162897379|NCT02443155|588324117|FG002|Overall Study|Protocol Violation|1|||
162897380|NCT02443155|588324118|FG003|Overall Study|Protocol Violation|1|||
162897381|NCT02443155|588324115|FG000|Overall Study|Death|0|||
162897382|NCT02443155|588324116|FG001|Overall Study|Death|0|||
162897383|NCT02443155|588324117|FG002|Overall Study|Death|1|||
162897384|NCT02443155|588324118|FG003|Overall Study|Death|0|||
162897385|NCT00688623|588324119|FG000|Overall Study|Adverse Event|22|||
162897386|NCT00688623|588324119|FG000|Overall Study|abnormal lab value|1|||
162897387|NCT00688623|588324119|FG000|Overall Study|Withdrawal by Subject|4|||
162897388|NCT00688623|588324119|FG000|Overall Study|Death|3|||
162897389|NCT00688623|588324119|FG000|Overall Study|disease progression|23|||
162897390|NCT00688623|588324119|FG000|Overall Study|Protocol Violation|2|||
162897391|NCT02000219|588324120|FG000|14-Week Study Period|Physician Decision|1|||
162897392|NCT02000219|588324120|FG000|14-Week Study Period|Adverse Event|1|||
162897393|NCT02000219|588324120|FG000|14-Week Study Period|Underwent transplantation|1|||
162897394|NCT02000219|588324120|FG000|Continuation Period|Withdrawal by Subject|1|||
162897395|NCT02000219|588324120|FG000|Continuation Period|Had liver transplant|2|||
162897396|NCT02000219|588324120|FG000|Continuation Period|Non-compliance with study drug|2|||
162897397|NCT00464620|588324121|FG000|Overall Study|Physician Decision|1|||
162897398|NCT00464620|588324122|FG001|Overall Study|Physician Decision|0|||
162897399|NCT00464620|588324123|FG002|Overall Study|Physician Decision|0|||
162897400|NCT00464620|588324121|FG000|Overall Study|Withdrawal by Subject|1|||
162897401|NCT00464620|588324122|FG001|Overall Study|Withdrawal by Subject|0|||
162897402|NCT00464620|588324123|FG002|Overall Study|Withdrawal by Subject|3|||
162897403|NCT00464620|588324121|FG000|Overall Study|Ineligible sarcoma subtype|0|||
162897404|NCT00464620|588324122|FG001|Overall Study|Ineligible sarcoma subtype|2|||
162897405|NCT00464620|588324123|FG002|Overall Study|Ineligible sarcoma subtype|2|||
162897406|NCT00464620|588324121|FG000|Overall Study|Use of prohibited concomitant medication|0|||
162897407|NCT00464620|588324122|FG001|Overall Study|Use of prohibited concomitant medication|0|||
162897408|NCT00464620|588324123|FG002|Overall Study|Use of prohibited concomitant medication|2|||
162897409|NCT01998906|588324124|FG000|Overall Study|Participants ongoing in follow-up|77|||
162897410|NCT01998906|588324125|FG001|Overall Study|Participants ongoing in follow-up|60|||
162897411|NCT01998906|588324126|FG002|Overall Study|Participants ongoing in follow-up|58|||
162897412|NCT01998906|588324124|FG000|Overall Study|Death|21|||
162897413|NCT01998906|588324125|FG001|Overall Study|Death|30|||
162897414|NCT01998906|588324126|FG002|Overall Study|Death|17|||
162897415|NCT01998906|588324124|FG000|Overall Study|Lack of Efficacy|10|||
162624847|NCT01090492|587343063|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162897416|NCT01998906|588324125|FG001|Overall Study|Lack of Efficacy|9|||
162897417|NCT01998906|588324126|FG002|Overall Study|Lack of Efficacy|8|||
162897418|NCT01998906|588324124|FG000|Overall Study|Failure to return|0|||
162897419|NCT01998906|588324125|FG001|Overall Study|Failure to return|2|||
162897420|NCT01998906|588324126|FG002|Overall Study|Failure to return|4|||
162897421|NCT01998906|588324124|FG000|Overall Study|Violation of Selection Criteria|0|||
162897422|NCT01998906|588324125|FG001|Overall Study|Violation of Selection Criteria|0|||
162897423|NCT01998906|588324126|FG002|Overall Study|Violation of Selection Criteria|1|||
162897424|NCT01998906|588324124|FG000|Overall Study|Withdrawal by Subject|1|||
162897425|NCT01998906|588324125|FG001|Overall Study|Withdrawal by Subject|4|||
162897426|NCT01998906|588324126|FG002|Overall Study|Withdrawal by Subject|3|||
162897427|NCT01998906|588324124|FG000|Overall Study|Administrative/Other|2|||
162897428|NCT01998906|588324125|FG001|Overall Study|Administrative/Other|1|||
162897429|NCT01998906|588324126|FG002|Overall Study|Administrative/Other|3|||
162897430|NCT01998906|588324124|FG000|Overall Study|Other|3|||
162897431|NCT01998906|588324125|FG001|Overall Study|Other|8|||
162897432|NCT01998906|588324126|FG002|Overall Study|Other|4|||
162897433|NCT01572844|588324127|FG000|Overall Study|Physician Decision|1|||
162897434|NCT01572844|588324128|FG001|Overall Study|Physician Decision|1|||
162897435|NCT02809118|588324131|FG000|Overall Study|Withdrawal by Subject|0|||
162897436|NCT02809118|588324132|FG001|Overall Study|Withdrawal by Subject|1|||
162897437|NCT02809118|588324133|FG002|Overall Study|Withdrawal by Subject|1|||
162897438|NCT06048809|588324142|FG000|Overall Study|Adverse Event|2|||
162897439|NCT06048809|588324143|FG001|Overall Study|Adverse Event|0|||
162924499|NCT01186744|588426031|FG000|Overall Study|Lost to Follow-up|15|||
162624848|NCT01090492|587343064|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624849|NCT01090492|587343065|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624850|NCT01090492|587343066|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
162624851|NCT01090492|587343067|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162624852|NCT02083965|587343068|FG000|Treatment Period|Other|1|||
162624853|NCT02083965|587343069|FG001|Treatment Period|Other|0|||
162624854|NCT00868608|587343072|FG000|Overall Study|Withdrawal by Subject|3|||
162624855|NCT00868608|587343073|FG001|Overall Study|Withdrawal by Subject|1|||
162624856|NCT00868608|587343074|FG002|Overall Study|Withdrawal by Subject|0|||
162624857|NCT00868608|587343072|FG000|Overall Study|Lost to Follow-up|3|||
162624858|NCT00868608|587343073|FG001|Overall Study|Lost to Follow-up|0|||
162624859|NCT00868608|587343074|FG002|Overall Study|Lost to Follow-up|1|||
162624860|NCT00868608|587343072|FG000|Overall Study|Death|16|||
162624861|NCT00868608|587343073|FG001|Overall Study|Death|2|||
162624862|NCT00868608|587343074|FG002|Overall Study|Death|4|||
162624863|NCT00868608|587343072|FG000|Overall Study|Other - Unspecified|1|||
162624864|NCT00868608|587343073|FG001|Overall Study|Other - Unspecified|0|||
162897440|NCT06048809|588324142|FG000|Overall Study|Withdrawal by Subject|1|||
162897441|NCT06048809|588324143|FG001|Overall Study|Withdrawal by Subject|1|||
162897442|NCT02158728|588324144|FG000|Overall Study|no procedure according to CIP done|3|||
162897443|NCT02158728|588324144|FG000|Overall Study|no qualified dataset|24|||
162897444|NCT02658149|588324148|FG000|Overall Study|Physician Decision|1|||
162897445|NCT02658149|588324149|FG001|Overall Study|Physician Decision|0|||
162897446|NCT01680991|588324152|FG000|Overall Study|Adverse Event|1|||
162897447|NCT01680991|588324153|FG001|Overall Study|Adverse Event|0|||
162897448|NCT01680991|588324154|FG002|Overall Study|Adverse Event|0|||
162897449|NCT01680991|588324152|FG000|Overall Study|Death|1|||
162897450|NCT01680991|588324153|FG001|Overall Study|Death|0|||
162897451|NCT01680991|588324154|FG002|Overall Study|Death|1|||
162897452|NCT01680991|588324152|FG000|Overall Study|Protocol Violation|0|||
162897453|NCT01680991|588324153|FG001|Overall Study|Protocol Violation|1|||
162897454|NCT01680991|588324154|FG002|Overall Study|Protocol Violation|0|||
162897455|NCT01680991|588324152|FG000|Overall Study|Withdrawal by Subject|5|||
162897456|NCT01680991|588324153|FG001|Overall Study|Withdrawal by Subject|1|||
162897457|NCT01680991|588324154|FG002|Overall Study|Withdrawal by Subject|0|||
162897458|NCT01680991|588324152|FG000|Overall Study|Progressive disease (PD)|0|||
162897459|NCT01680991|588324153|FG001|Overall Study|Progressive disease (PD)|10|||
162897460|NCT01680991|588324154|FG002|Overall Study|Progressive disease (PD)|0|||
162897461|NCT01680991|588324152|FG000|Overall Study|Physician Decision|0|||
162897462|NCT01680991|588324153|FG001|Overall Study|Physician Decision|7|||
162897463|NCT01680991|588324154|FG002|Overall Study|Physician Decision|2|||
162897464|NCT01680991|588324152|FG000|Overall Study|Bad physical condition|0|||
162897465|NCT01680991|588324153|FG001|Overall Study|Bad physical condition|0|||
162897466|NCT01680991|588324154|FG002|Overall Study|Bad physical condition|1|||
162897467|NCT01680991|588324152|FG000|Overall Study|PD confirmed in other hospital|1|||
162897468|NCT01680991|588324153|FG001|Overall Study|PD confirmed in other hospital|0|||
162897469|NCT01680991|588324154|FG002|Overall Study|PD confirmed in other hospital|0|||
162897470|NCT01156363|588324155|FG000|Overall Study|Adverse Event|6|||
162897471|NCT01156363|588324155|FG000|Overall Study|Insufficient Therapeutic Response|5|||
162897472|NCT01156363|588324155|FG000|Overall Study|Failure to Return|1|||
162897473|NCT01156363|588324155|FG000|Overall Study|Refused Treatment|4|||
162897474|NCT01156363|588324155|FG000|Overall Study|Other|6|||
162897475|NCT03135262|588324156|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
162897476|NCT03135262|588324157|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
162897477|NCT03135262|588324158|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
162897478|NCT03135262|588324159|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
162897479|NCT03135262|588324160|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
162897480|NCT03135262|588324156|FG000|Overall Study|Progression of disease|0|||
162897481|NCT03135262|588324157|FG001|Overall Study|Progression of disease|0|||
162897482|NCT03135262|588324158|FG002|Overall Study|Progression of disease|0|||
162897483|NCT03135262|588324159|FG003|Overall Study|Progression of disease|1|||
162897484|NCT03135262|588324160|FG004|Overall Study|Progression of disease|0|||
162897485|NCT03135262|588324156|FG000|Overall Study|Death|6|||
162897486|NCT03135262|588324157|FG001|Overall Study|Death|2|||
162897487|NCT03135262|588324158|FG002|Overall Study|Death|2|||
162897488|NCT03135262|588324159|FG003|Overall Study|Death|2|||
162897489|NCT03135262|588324160|FG004|Overall Study|Death|0|||
162897490|NCT03135262|588324156|FG000|Overall Study|Withdrawal by Subject|0|||
162897491|NCT03135262|588324157|FG001|Overall Study|Withdrawal by Subject|0|||
162897492|NCT03135262|588324158|FG002|Overall Study|Withdrawal by Subject|1|||
162897493|NCT03135262|588324159|FG003|Overall Study|Withdrawal by Subject|0|||
162624865|NCT00868608|587343074|FG002|Overall Study|Other - Unspecified|0|||
162624866|NCT00911547|587343075|FG000|Overall Study|Adverse Event|8|||
162624867|NCT00911547|587343076|FG001|Overall Study|Adverse Event|27|||
162624868|NCT00911547|587343077|FG002|Overall Study|Adverse Event|11|||
162708787|NCT04739423|587642897|FG000|Overall Study|Adverse Event|0|||
162624869|NCT00911547|587343078|FG003|Overall Study|Adverse Event|6|||
162624870|NCT00911547|587343075|FG000|Overall Study|Lost to Follow-up|0|||
162624871|NCT00911547|587343076|FG001|Overall Study|Lost to Follow-up|0|||
162624872|NCT00911547|587343077|FG002|Overall Study|Lost to Follow-up|2|||
162624873|NCT00911547|587343078|FG003|Overall Study|Lost to Follow-up|1|||
162624874|NCT00911547|587343075|FG000|Overall Study|Protocol Violation|0|||
162624875|NCT00911547|587343076|FG001|Overall Study|Protocol Violation|5|||
162624876|NCT00911547|587343077|FG002|Overall Study|Protocol Violation|5|||
162624877|NCT00911547|587343078|FG003|Overall Study|Protocol Violation|1|||
162624878|NCT00911547|587343075|FG000|Overall Study|Withdrawal by Subject|3|||
162624879|NCT00911547|587343076|FG001|Overall Study|Withdrawal by Subject|10|||
162624880|NCT00911547|587343077|FG002|Overall Study|Withdrawal by Subject|4|||
162624881|NCT00911547|587343078|FG003|Overall Study|Withdrawal by Subject|8|||
162624882|NCT00457301|587343079|FG000|Overall Study|Withdrawal by Subject|3|||
162624883|NCT00457301|587343080|FG001|Overall Study|Withdrawal by Subject|3|||
162624884|NCT00457301|587343079|FG000|Overall Study|Censored out of the study|15|||
162624885|NCT00457301|587343080|FG001|Overall Study|Censored out of the study|14|||
162624886|NCT00457301|587343079|FG000|Overall Study|Death|5|||
162624887|NCT00457301|587343080|FG001|Overall Study|Death|7|||
162624888|NCT00191269|587343081|FG000|Overall Study|Protocol Violation|0|||
162624889|NCT00191269|587343082|FG001|Overall Study|Protocol Violation|2|||
162624890|NCT00191269|587343081|FG000|Overall Study|Adverse Event|1|||
162624891|NCT00191269|587343082|FG001|Overall Study|Adverse Event|4|||
162624892|NCT00191269|587343081|FG000|Overall Study|Progression of Disease|4|||
162624893|NCT00191269|587343082|FG001|Overall Study|Progression of Disease|42|||
162624894|NCT00191269|587343081|FG000|Overall Study|Lack of Efficacy|1|||
162624895|NCT00191269|587343082|FG001|Overall Study|Lack of Efficacy|5|||
162624896|NCT00191269|587343081|FG000|Overall Study|Withdrawal by Subject|0|||
162624897|NCT00191269|587343082|FG001|Overall Study|Withdrawal by Subject|1|||
162624898|NCT00191269|587343081|FG000|Overall Study|Pathologic Aggrevation|0|||
162624899|NCT00191269|587343082|FG001|Overall Study|Pathologic Aggrevation|1|||
162624900|NCT00191269|587343081|FG000|Overall Study|Physician Decision|0|||
162624901|NCT00191269|587343082|FG001|Overall Study|Physician Decision|3|||
162624902|NCT03583697|587343085|FG000|Overall Study|Withdrawal by Subject|0|||
162624903|NCT03583697|587343086|FG001|Overall Study|Withdrawal by Subject|0|||
162624904|NCT03583697|587343087|FG002|Overall Study|Withdrawal by Subject|1|||
162624905|NCT03583697|587343085|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
162624906|NCT03583697|587343086|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
162624907|NCT03583697|587343087|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
162624908|NCT00365508|587343088|FG000|Overall Study|Lost to Follow-up|139|||
162624909|NCT00365508|587343089|FG001|Overall Study|Lost to Follow-up|154|||
162624910|NCT00404235|587343092|FG000|Overall Study|Withdrawal by Subject|1|||
162624911|NCT00404235|587343093|FG001|Overall Study|Withdrawal by Subject|2|||
162624912|NCT00679432|587343094|FG000|Overall Study|Adverse Event|5|||
162624913|NCT00679432|587343095|FG001|Overall Study|Adverse Event|6|||
162624914|NCT00679432|587343096|FG002|Overall Study|Adverse Event|10|||
162624915|NCT00679432|587343097|FG003|Overall Study|Adverse Event|7|||
162624916|NCT00679432|587343094|FG000|Overall Study|Protocol Violation|1|||
162624917|NCT00679432|587343095|FG001|Overall Study|Protocol Violation|1|||
162624918|NCT00679432|587343096|FG002|Overall Study|Protocol Violation|2|||
162624919|NCT00679432|587343097|FG003|Overall Study|Protocol Violation|1|||
162624920|NCT00679432|587343094|FG000|Overall Study|Withdrawal by Subject|8|||
162624921|NCT00679432|587343095|FG001|Overall Study|Withdrawal by Subject|11|||
162624922|NCT00679432|587343096|FG002|Overall Study|Withdrawal by Subject|10|||
162624923|NCT00679432|587343097|FG003|Overall Study|Withdrawal by Subject|9|||
162624924|NCT00679432|587343094|FG000|Overall Study|Lost to Follow-up|1|||
162624925|NCT00679432|587343095|FG001|Overall Study|Lost to Follow-up|5|||
162624926|NCT00679432|587343096|FG002|Overall Study|Lost to Follow-up|4|||
162624927|NCT00679432|587343097|FG003|Overall Study|Lost to Follow-up|2|||
162624928|NCT00679432|587343094|FG000|Overall Study|Physician Decision|3|||
162965196|NCT05330975|588573222|FG002|Primary|Other Than Specified|2|||
162965197|NCT05330975|588573223|FG003|Primary|Other Than Specified|1|||
162965198|NCT05330975|588573224|FG004|Primary|Other Than Specified|2|||
162965199|NCT05330975|588573225|FG005|Primary|Other Than Specified|2|||
162624929|NCT00679432|587343095|FG001|Overall Study|Physician Decision|2|||
162624930|NCT00679432|587343096|FG002|Overall Study|Physician Decision|2|||
162624931|NCT00679432|587343097|FG003|Overall Study|Physician Decision|2|||
162624932|NCT00679432|587343094|FG000|Overall Study|Sponsor decision|1|||
162624933|NCT00679432|587343095|FG001|Overall Study|Sponsor decision|0|||
162624934|NCT00679432|587343096|FG002|Overall Study|Sponsor decision|0|||
162965200|NCT05330975|588573226|FG006|Primary|Other Than Specified|0|||
162624935|NCT00679432|587343097|FG003|Overall Study|Sponsor decision|0|||
162624936|NCT00679432|587343094|FG000|Overall Study|Lack of Efficacy|13|||
162624937|NCT00679432|587343095|FG001|Overall Study|Lack of Efficacy|9|||
162624938|NCT00679432|587343096|FG002|Overall Study|Lack of Efficacy|14|||
162624939|NCT00679432|587343097|FG003|Overall Study|Lack of Efficacy|8|||
162624940|NCT00679432|587343094|FG000|Overall Study|Infectious colitis, normal histology|5|||
162965201|NCT05330975|588573220|FG000|Primary|Adverse Event|0|||
162624941|NCT00679432|587343095|FG001|Overall Study|Infectious colitis, normal histology|4|||
162624942|NCT00679432|587343096|FG002|Overall Study|Infectious colitis, normal histology|8|||
162624943|NCT00679432|587343097|FG003|Overall Study|Infectious colitis, normal histology|3|||
162624944|NCT00679432|587343094|FG000|Overall Study|Randomization error, return to prior Rx|0|||
162624945|NCT00679432|587343095|FG001|Overall Study|Randomization error, return to prior Rx|0|||
162624946|NCT00679432|587343096|FG002|Overall Study|Randomization error, return to prior Rx|3|||
162624947|NCT00679432|587343097|FG003|Overall Study|Randomization error, return to prior Rx|0|||
162624948|NCT00824720|587343098|FG000|Overall Study|failed plug insertion|3|||
162624949|NCT00824720|587343099|FG001|Overall Study|failed plug insertion|1|||
162624950|NCT00824720|587343100|FG002|Overall Study|failed plug insertion|0|||
162624951|NCT00824720|587343098|FG000|Overall Study|Protocol Violation|0|||
162624952|NCT00824720|587343099|FG001|Overall Study|Protocol Violation|0|||
162624953|NCT00824720|587343100|FG002|Overall Study|Protocol Violation|1|||
162624954|NCT01558271|587343103|FG000|Overall Study|Adverse Event|6|||
162624955|NCT01558271|587343104|FG001|Overall Study|Adverse Event|3|||
162624956|NCT01558271|587343105|FG002|Overall Study|Adverse Event|4|||
162624957|NCT01558271|587343103|FG000|Overall Study|Lost to Follow-up|1|||
162624958|NCT01558271|587343104|FG001|Overall Study|Lost to Follow-up|0|||
162624959|NCT01558271|587343105|FG002|Overall Study|Lost to Follow-up|0|||
162624960|NCT01558271|587343103|FG000|Overall Study|Protocol Violation|1|||
162624961|NCT01558271|587343104|FG001|Overall Study|Protocol Violation|0|||
162624962|NCT01558271|587343105|FG002|Overall Study|Protocol Violation|0|||
162624963|NCT01558271|587343103|FG000|Overall Study|Withdrawal by Subject|10|||
162624964|NCT01558271|587343104|FG001|Overall Study|Withdrawal by Subject|6|||
162624965|NCT01558271|587343105|FG002|Overall Study|Withdrawal by Subject|12|||
162624966|NCT01558271|587343103|FG000|Overall Study|Physician Decision|0|||
162624967|NCT01558271|587343104|FG001|Overall Study|Physician Decision|2|||
162624968|NCT01558271|587343105|FG002|Overall Study|Physician Decision|1|||
162624969|NCT02610725|587343106|FG000|Overall Study|Lost to Follow-up|197|||
162624970|NCT02610725|587343106|FG000|Overall Study|self-reported contraindication|9|||
162624971|NCT04094883|587343107|FG000|Overall Study|Withdrawal by Subject|1|||
162624972|NCT00743483|587343108|FG000|Baseline Period|Physician Decision|1|||
162624973|NCT00743483|587343108|FG000|Treatment Period|Adverse Event|1|||
162624974|NCT01084083|587343109|FG000|Overall Study|Adverse Event|5|||
162624975|NCT01084083|587343109|FG000|Overall Study|Death|1|||
162624976|NCT01084083|587343109|FG000|Overall Study|Withdrawal by Subject|2|||
162624977|NCT01084083|587343109|FG000|Overall Study|Complicating disease|1|||
162624978|NCT01084083|587343109|FG000|Overall Study|Other|2|||
162897494|NCT03135262|588324160|FG004|Overall Study|Withdrawal by Subject|1|||
162897495|NCT03135262|588324156|FG000|Overall Study|Study terminated by sponsor|2|||
162897496|NCT03135262|588324157|FG001|Overall Study|Study terminated by sponsor|4|||
162897497|NCT03135262|588324158|FG002|Overall Study|Study terminated by sponsor|4|||
162897498|NCT03135262|588324159|FG003|Overall Study|Study terminated by sponsor|3|||
162897499|NCT03135262|588324160|FG004|Overall Study|Study terminated by sponsor|0|||
162897500|NCT03745989|588324162|FG000|Overall Study|Death|3|||
162897501|NCT03745989|588324163|FG001|Overall Study|Death|7|||
162897502|NCT03745989|588324164|FG002|Overall Study|Death|4|||
162897503|NCT03745989|588324162|FG000|Overall Study|Lost to Follow-up|0|||
162897504|NCT03745989|588324163|FG001|Overall Study|Lost to Follow-up|2|||
162897505|NCT03745989|588324164|FG002|Overall Study|Lost to Follow-up|0|||
162897506|NCT03745989|588324162|FG000|Overall Study|Sponsor Decision|0|||
162897507|NCT03745989|588324163|FG001|Overall Study|Sponsor Decision|2|||
162897508|NCT03745989|588324164|FG002|Overall Study|Sponsor Decision|8|||
162897509|NCT03745989|588324162|FG000|Overall Study|Withdrawal by Subject|0|||
162897510|NCT03745989|588324163|FG001|Overall Study|Withdrawal by Subject|1|||
162897511|NCT03745989|588324164|FG002|Overall Study|Withdrawal by Subject|3|||
162897512|NCT02728206|588324166|FG000|Overall Study|Death|1|||
162897513|NCT00047008|588324170|FG000|Overall Study|Withdrawn consent|2|||
162897514|NCT00047008|588324171|FG001|Overall Study|Withdrawn consent|3|||
162897515|NCT00047008|588324170|FG000|Overall Study|Ineligible|9|||
162897516|NCT00047008|588324171|FG001|Overall Study|Ineligible|8|||
162897517|NCT00429572|588324172|FG000|Overall Study|Disease progression|1|||
162897518|NCT02773368|588324175|FG000|Overall Study|Lost to Follow-up|4|||
162897519|NCT02773368|588324176|FG001|Overall Study|Lost to Follow-up|1|||
162897520|NCT02773368|588324175|FG000|Overall Study|Withdrawal by Subject|5|||
162897521|NCT02773368|588324176|FG001|Overall Study|Withdrawal by Subject|1|||
162897522|NCT02773368|588324175|FG000|Overall Study|Unclassified|1|||
162897523|NCT02773368|588324176|FG001|Overall Study|Unclassified|1|||
162897524|NCT02773368|588324175|FG000|Overall Study|Missing|0|||
162897525|NCT02773368|588324176|FG001|Overall Study|Missing|1|||
162897526|NCT01929018|588324179|FG000|Overall Study|Lost to Follow-up|1|||
162624979|NCT01084083|587343109|FG000|Overall Study|Never started assigned therapy|1|||
162624980|NCT00873912|587343111|FG000|Overall Study|Withdrawal by Subject|1|||
162624981|NCT00873912|587343112|FG001|Overall Study|Withdrawal by Subject|0|||
162624982|NCT00873912|587343111|FG000|Overall Study|Lost to Follow-up|2|||
162624983|NCT00873912|587343112|FG001|Overall Study|Lost to Follow-up|0|||
162897527|NCT01929018|588324180|FG001|Overall Study|Lost to Follow-up|0|||
162897528|NCT01929018|588324179|FG000|Overall Study|Hospitalization|0|||
162624984|NCT05570500|587343115|FG000|Overall Study|Lost to Follow-up|7|||
162624985|NCT05570500|587343116|FG001|Overall Study|Lost to Follow-up|5|||
162624986|NCT01095731|587343117|FG000|Overall Study|Protocol Violation|1|||
162624987|NCT01095731|587343118|FG001|Overall Study|Protocol Violation|1|||
162624988|NCT01095731|587343117|FG000|Overall Study|Withdrawal by Subject|0|||
162624989|NCT01095731|587343118|FG001|Overall Study|Withdrawal by Subject|1|||
162624990|NCT02302807|587343121|FG000|Overall Study|Withdrawal by Subject|28|||
162624991|NCT02302807|587343122|FG001|Overall Study|Withdrawal by Subject|11|||
162624992|NCT02302807|587343121|FG000|Overall Study|Lost to Follow-up|4|||
162624993|NCT02302807|587343122|FG001|Overall Study|Lost to Follow-up|6|||
162624994|NCT02302807|587343121|FG000|Overall Study|Death|397|||
162624995|NCT02302807|587343122|FG001|Overall Study|Death|385|||
162624996|NCT02302807|587343121|FG000|Overall Study|Study Terminated By Sponsor|35|||
162624997|NCT02302807|587343122|FG001|Overall Study|Study Terminated By Sponsor|64|||
162624998|NCT02302807|587343121|FG000|Overall Study|Physician Decision|0|||
162624999|NCT02302807|587343122|FG001|Overall Study|Physician Decision|1|||
162625000|NCT01980940|587343124|FG000|Overall Study|Protocol Violation|0|||
162625001|NCT01980940|587343125|FG001|Overall Study|Protocol Violation|0|||
162625002|NCT01980940|587343126|FG002|Overall Study|Protocol Violation|0|||
162625003|NCT01980940|587343127|FG003|Overall Study|Protocol Violation|0|||
162625004|NCT01980940|587343128|FG004|Overall Study|Protocol Violation|0|||
162625005|NCT01980940|587343129|FG005|Overall Study|Protocol Violation|2|||
162625006|NCT01980940|587343130|FG006|Overall Study|Protocol Violation|0|||
162625007|NCT01980940|587343131|FG007|Overall Study|Protocol Violation|0|||
162897529|NCT01929018|588324180|FG001|Overall Study|Hospitalization|1|||
162897530|NCT01047436|588324184|FG000|Overall Study|Protocol Violation|1|||
162897531|NCT01047436|588324185|FG001|Overall Study|Protocol Violation|0|||
162897532|NCT02635867|588324188|FG000|Overall Study|Lost to Follow-up|4|||
162897533|NCT02635867|588324189|FG001|Overall Study|Lost to Follow-up|3|||
162897534|NCT02635867|588324190|FG002|Overall Study|Lost to Follow-up|3|||
162897535|NCT02635867|588324191|FG003|Overall Study|Lost to Follow-up|4|||
162897536|NCT02635867|588324192|FG004|Overall Study|Lost to Follow-up|1|||
162897537|NCT02565576|588324195|FG000|Overall Study|abnormal lab value|2|||
162897538|NCT02565576|588324196|FG001|Overall Study|abnormal lab value|0|||
162897539|NCT02565576|588324195|FG000|Overall Study|subject / guardian decision|1|||
162897540|NCT02565576|588324196|FG001|Overall Study|subject / guardian decision|3|||
162897541|NCT02565576|588324195|FG000|Overall Study|Lost to Follow-up|1|||
162897542|NCT02565576|588324196|FG001|Overall Study|Lost to Follow-up|0|||
163052042|NCT04802161|588898798|FG000|Overall Study|Death|0|||
163052043|NCT04802161|588898799|FG001|Overall Study|Death|0|||
163052044|NCT04802161|588898800|FG002|Overall Study|Death|1|||
163052045|NCT04802161|588898801|FG003|Overall Study|Death|0|||
163052046|NCT02997163|588900884|FG000|Overall Study|Adverse Event|1|||
163052047|NCT02997163|588900885|FG001|Overall Study|Adverse Event|0|||
163052048|NCT02997163|588900886|FG002|Overall Study|Adverse Event|0|||
163052049|NCT02997163|588900887|FG003|Overall Study|Adverse Event|1|||
163052050|NCT00557466|588900890|FG000|Overall Study|Adverse Event|3|||
163052051|NCT00557466|588900891|FG001|Overall Study|Adverse Event|1|||
163052052|NCT00557466|588900892|FG002|Overall Study|Adverse Event|4|||
163052053|NCT00557466|588900893|FG003|Overall Study|Adverse Event|1|||
163052054|NCT00557466|588900894|FG004|Overall Study|Adverse Event|2|||
163052055|NCT00557466|588900895|FG005|Overall Study|Adverse Event|4|||
163052056|NCT00557466|588900890|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163052057|NCT00557466|588900891|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163052058|NCT00557466|588900892|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163052059|NCT00557466|588900893|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163052060|NCT00557466|588900894|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163052061|NCT00557466|588900895|FG005|Overall Study|Abnormal laboratory value(s)|0|||
163052062|NCT00557466|588900890|FG000|Overall Study|Protocol deviation|0|||
163052063|NCT00557466|588900891|FG001|Overall Study|Protocol deviation|1|||
162897543|NCT02565576|588324195|FG000|Overall Study|Death|0|||
162897544|NCT02565576|588324196|FG001|Overall Study|Death|2|||
163052064|NCT00557466|588900892|FG002|Overall Study|Protocol deviation|0|||
163052065|NCT00557466|588900893|FG003|Overall Study|Protocol deviation|2|||
163052066|NCT00557466|588900894|FG004|Overall Study|Protocol deviation|0|||
163052067|NCT00557466|588900895|FG005|Overall Study|Protocol deviation|0|||
163052068|NCT00557466|588900890|FG000|Overall Study|Subject withdrew consent|0|||
163052069|NCT00557466|588900891|FG001|Overall Study|Subject withdrew consent|0|||
163052070|NCT00557466|588900892|FG002|Overall Study|Subject withdrew consent|0|||
163052071|NCT00557466|588900893|FG003|Overall Study|Subject withdrew consent|0|||
162625008|NCT04731363|587343135|FG000|Overall Study|Could not obtain samples|0|||
162625009|NCT04731363|587343136|FG001|Overall Study|Could not obtain samples|1|||
162625010|NCT04731363|587343137|FG002|Overall Study|Could not obtain samples|0|||
162625011|NCT04731363|587343138|FG003|Overall Study|Could not obtain samples|0|||
162625012|NCT04731363|587343135|FG000|Overall Study|Physician Decision|0|||
162625013|NCT04731363|587343136|FG001|Overall Study|Physician Decision|1|||
162625014|NCT04731363|587343137|FG002|Overall Study|Physician Decision|0|||
162625015|NCT04731363|587343138|FG003|Overall Study|Physician Decision|0|||
162897545|NCT02565576|588324195|FG000|Overall Study|Adverse Event|1|||
162625016|NCT03192462|587344772|FG000|Overall Study|Death|13|||
162625017|NCT03192462|587344773|FG001|Overall Study|Death|11|||
162625018|NCT03192462|587344774|FG002|Overall Study|Death|10|||
162625019|NCT03192462|587344772|FG000|Overall Study|Lost to Follow-up|0|||
162625020|NCT03192462|587344773|FG001|Overall Study|Lost to Follow-up|1|||
162625021|NCT03192462|587344774|FG002|Overall Study|Lost to Follow-up|0|||
162625022|NCT03187197|587344775|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
162625023|NCT03187197|587344776|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
162625024|NCT03187197|587344777|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
162625025|NCT03187197|587344775|FG000|Overall Study|Withdrawal by Subject|8|||
162625026|NCT03187197|587344776|FG001|Overall Study|Withdrawal by Subject|63|||
162625027|NCT03187197|587344777|FG002|Overall Study|Withdrawal by Subject|4|||
162625028|NCT03187197|587344775|FG000|Overall Study|Lost to Follow-up|1|||
162625029|NCT03187197|587344776|FG001|Overall Study|Lost to Follow-up|60|||
162625030|NCT03187197|587344777|FG002|Overall Study|Lost to Follow-up|7|||
162625031|NCT03187197|587344775|FG000|Overall Study|Adverse Event|6|||
162625032|NCT03187197|587344776|FG001|Overall Study|Adverse Event|29|||
162625033|NCT03187197|587344777|FG002|Overall Study|Adverse Event|0|||
162625034|NCT03187197|587344775|FG000|Overall Study|Death|0|||
162625035|NCT03187197|587344776|FG001|Overall Study|Death|11|||
162625036|NCT03187197|587344777|FG002|Overall Study|Death|0|||
162625037|NCT03187197|587344775|FG000|Overall Study|Administrative problem|1|||
162625038|NCT03187197|587344776|FG001|Overall Study|Administrative problem|1|||
162625039|NCT03187197|587344777|FG002|Overall Study|Administrative problem|0|||
162625040|NCT03187197|587344775|FG000|Overall Study|Reason not listed|2|||
162625041|NCT03187197|587344776|FG001|Overall Study|Reason not listed|54|||
162625042|NCT03187197|587344777|FG002|Overall Study|Reason not listed|1|||
162625043|NCT03187197|587344775|FG000|Overall Study|Missing|1|||
162625044|NCT03187197|587344776|FG001|Overall Study|Missing|32|||
162625045|NCT03187197|587344777|FG002|Overall Study|Missing|3|||
162897546|NCT02565576|588324196|FG001|Overall Study|Adverse Event|0|||
162897547|NCT00282568|588324197|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
162897548|NCT00282568|588324197|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
162897549|NCT00282568|588324197|FG000|Extended Treatment Period|Adverse Event|17|||
162897550|NCT00282568|588324197|FG000|Extended Treatment Period|Non-compliance|4|||
162897551|NCT00282568|588324197|FG000|Extended Treatment Period|Physician Decision|1|||
162897552|NCT00282568|588324197|FG000|Extended Treatment Period|Lost to Follow-up|2|||
162897553|NCT01266070|588324198|FG000|Overall Study|Adverse Event|3|||
162897554|NCT01266070|588324198|FG000|Overall Study|Protocol Violation|1|||
162897555|NCT00939341|588324199|FG000|Overall Study|Adverse Event|15|||
162897556|NCT00939341|588324199|FG000|Overall Study|Pregnancy|1|||
162897557|NCT00939341|588324199|FG000|Overall Study|Lost to Follow-up|23|||
162897558|NCT00939341|588324199|FG000|Overall Study|Withdrawal by Subject|13|||
162897559|NCT00939341|588324199|FG000|Overall Study|Protocol Violation|6|||
162897560|NCT00939341|588324199|FG000|Overall Study|Incorrect enrolment|8|||
162897561|NCT01408732|588324200|FG000|Overall Study|Withdrawal by Subject|2|||
162897562|NCT01408732|588324201|FG001|Overall Study|Withdrawal by Subject|2|||
162897563|NCT00764322|588324203|FG000|Overall Study|Withdrawal by Subject|11|||
162897564|NCT00764322|588324203|FG000|Overall Study|No CYP2D6 genotyping|9|||
162897565|NCT00796003|588324204|FG000|Overall Study|Disease Progression|2|||
162897566|NCT00796003|588324205|FG001|Overall Study|Disease Progression|13|||
162897567|NCT00796003|588324204|FG000|Overall Study|Adverse Event|1|||
162897568|NCT00796003|588324205|FG001|Overall Study|Adverse Event|7|||
162625046|NCT03187197|587344775|FG000|Overall Study|Status missing|2|||
162625047|NCT03187197|587344776|FG001|Overall Study|Status missing|33|||
162625048|NCT03187197|587344777|FG002|Overall Study|Status missing|3|||
162625049|NCT03187197|587344775|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
162625050|NCT03187197|587344776|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
162625051|NCT03187197|587344777|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
162625052|NCT00982137|587344778|FG000|Overall Study|Lost to Follow-up|0|||
162625053|NCT00982137|587344779|FG001|Overall Study|Lost to Follow-up|0|||
162897569|NCT00796003|588324204|FG000|Overall Study|Specified organ function not met|0|||
162897570|NCT00796003|588324205|FG001|Overall Study|Specified organ function not met|1|||
162897571|NCT00796003|588324204|FG000|Overall Study|Physician Decision|0|||
162897572|NCT00796003|588324205|FG001|Overall Study|Physician Decision|4|||
162625054|NCT00982137|587344780|FG002|Overall Study|Lost to Follow-up|0|||
162625055|NCT00982137|587344781|FG003|Overall Study|Lost to Follow-up|1|||
162625056|NCT00982137|587344778|FG000|Overall Study|Withdrawal by Subject|0|||
162625057|NCT00982137|587344779|FG001|Overall Study|Withdrawal by Subject|1|||
162625058|NCT00982137|587344780|FG002|Overall Study|Withdrawal by Subject|0|||
162625059|NCT00982137|587344781|FG003|Overall Study|Withdrawal by Subject|0|||
162625060|NCT00126191|587344782|FG000|Overall Study|Physician Decision|0|||
162625061|NCT00126191|587344783|FG001|Overall Study|Physician Decision|1|||
162625062|NCT00126191|587344782|FG000|Overall Study|Death|0|||
162625063|NCT00126191|587344783|FG001|Overall Study|Death|1|||
162625064|NCT00674700|587344795|FG000|Year 1|Adverse Event|17|||
162897573|NCT00796003|588324204|FG000|Overall Study|Withdrawal by Subject|0|||
162897574|NCT00796003|588324205|FG001|Overall Study|Withdrawal by Subject|1|||
162625065|NCT00674700|587344796|FG001|Year 1|Adverse Event|20|||
162965202|NCT05330975|588573221|FG001|Primary|Adverse Event|0|||
162965203|NCT05330975|588573222|FG002|Primary|Adverse Event|0|||
162965204|NCT05330975|588573223|FG003|Primary|Adverse Event|1|||
162965205|NCT05330975|588573224|FG004|Primary|Adverse Event|0|||
162965206|NCT05330975|588573225|FG005|Primary|Adverse Event|0|||
162965207|NCT05330975|588573226|FG006|Primary|Adverse Event|0|||
162965208|NCT05330975|588573220|FG000|Primary|Physician Decision|0|||
162965209|NCT05330975|588573221|FG001|Primary|Physician Decision|0|||
162965210|NCT05330975|588573222|FG002|Primary|Physician Decision|0|||
162965211|NCT05330975|588573223|FG003|Primary|Physician Decision|0|||
162965212|NCT05330975|588573224|FG004|Primary|Physician Decision|1|||
162965213|NCT05330975|588573225|FG005|Primary|Physician Decision|0|||
162965214|NCT05330975|588573226|FG006|Primary|Physician Decision|0|||
162965215|NCT05330975|588573220|FG000|Revaccination|Adverse Event|0|||
162897575|NCT00796003|588324204|FG000|Overall Study|Other|0|||
162897576|NCT00796003|588324205|FG001|Overall Study|Other|1|||
162897577|NCT00796003|588324204|FG000|Overall Study|Participants Not treated|0|||
162897578|NCT00796003|588324205|FG001|Overall Study|Participants Not treated|2|||
162897579|NCT03185819|588324210|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
162897580|NCT03185819|588324211|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
162897581|NCT03185819|588324212|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
162897582|NCT03185819|588324213|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
162897583|NCT03185819|588324210|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
162897584|NCT03185819|588324211|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
162897585|NCT03185819|588324212|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
162897586|NCT03185819|588324213|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
162897587|NCT03185819|588324210|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
162897588|NCT03185819|588324211|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
162897589|NCT03185819|588324212|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
162897590|NCT03185819|588324213|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
162897591|NCT03185819|588324210|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
162897592|NCT03185819|588324211|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
162897593|NCT03185819|588324212|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
162897594|NCT03185819|588324213|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
162897595|NCT03185819|588324210|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
162897596|NCT03185819|588324211|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
162897597|NCT03185819|588324212|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
162897598|NCT03185819|588324213|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
162897599|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
162897600|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
162897601|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
162965216|NCT05330975|588573221|FG001|Revaccination|Adverse Event|0|||
162965217|NCT05330975|588573222|FG002|Revaccination|Adverse Event|0|||
162965218|NCT05330975|588573223|FG003|Revaccination|Adverse Event|0|||
162965219|NCT05330975|588573224|FG004|Revaccination|Adverse Event|0|||
162965220|NCT05330975|588573225|FG005|Revaccination|Adverse Event|0|||
162965221|NCT05330975|588573226|FG006|Revaccination|Adverse Event|3|||
162965222|NCT05330975|588573220|FG000|Revaccination|Lost to Follow-up|0|||
162965223|NCT05330975|588573221|FG001|Revaccination|Lost to Follow-up|0|||
162965224|NCT05330975|588573222|FG002|Revaccination|Lost to Follow-up|0|||
162965225|NCT05330975|588573223|FG003|Revaccination|Lost to Follow-up|0|||
162965226|NCT05330975|588573224|FG004|Revaccination|Lost to Follow-up|0|||
162965227|NCT05330975|588573225|FG005|Revaccination|Lost to Follow-up|0|||
162965228|NCT05330975|588573226|FG006|Revaccination|Lost to Follow-up|10|||
162965229|NCT05330975|588573220|FG000|Revaccination|Withdrawal by Subject|0|||
162965230|NCT05330975|588573221|FG001|Revaccination|Withdrawal by Subject|0|||
162965231|NCT05330975|588573222|FG002|Revaccination|Withdrawal by Subject|0|||
162965232|NCT05330975|588573223|FG003|Revaccination|Withdrawal by Subject|0|||
163052072|NCT00557466|588900894|FG004|Overall Study|Subject withdrew consent|1|||
162897602|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
162897603|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
163052073|NCT00557466|588900895|FG005|Overall Study|Subject withdrew consent|2|||
162897604|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
162897605|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
162897606|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
162965233|NCT05330975|588573224|FG004|Revaccination|Withdrawal by Subject|0|||
162965234|NCT05330975|588573225|FG005|Revaccination|Withdrawal by Subject|0|||
162965235|NCT05330975|588573226|FG006|Revaccination|Withdrawal by Subject|2|||
163052074|NCT00557466|588900890|FG000|Overall Study|Administrative problems|0|||
163052075|NCT00557466|588900891|FG001|Overall Study|Administrative problems|1|||
163052076|NCT00557466|588900892|FG002|Overall Study|Administrative problems|1|||
163052077|NCT00557466|588900893|FG003|Overall Study|Administrative problems|0|||
162965236|NCT05330975|588573220|FG000|Revaccination|Death|0|||
163052078|NCT00557466|588900894|FG004|Overall Study|Administrative problems|0|||
163052079|NCT00557466|588900895|FG005|Overall Study|Administrative problems|0|||
163052080|NCT00557466|588900890|FG000|Overall Study|Abnormal test procedure results|0|||
163052081|NCT00557466|588900891|FG001|Overall Study|Abnormal test procedure results|0|||
163052082|NCT00557466|588900892|FG002|Overall Study|Abnormal test procedure results|1|||
163052083|NCT00557466|588900893|FG003|Overall Study|Abnormal test procedure results|0|||
163052084|NCT00557466|588900894|FG004|Overall Study|Abnormal test procedure results|0|||
163052085|NCT00557466|588900895|FG005|Overall Study|Abnormal test procedure results|0|||
163052086|NCT00557466|588900890|FG000|Overall Study|Lost to Follow-up|0|||
163052087|NCT00557466|588900891|FG001|Overall Study|Lost to Follow-up|0|||
162897607|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
162897608|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
162897609|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
162897610|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
162897611|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
162897612|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
162897613|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
162897614|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
162897615|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
162897616|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
162897617|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
162897618|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
162897619|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
162897620|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
162897621|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
162897622|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
162897623|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
162897624|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
162897625|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
162897626|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
162897627|NCT03185819|588324210|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
162897628|NCT03185819|588324211|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
162897629|NCT03185819|588324212|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
162897630|NCT03185819|588324213|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
162897631|NCT00732641|588324214|FG000|Overall Study|Relapse or Progressive Disease|65|||
162897632|NCT00732641|588324215|FG001|Overall Study|Relapse or Progressive Disease|101|||
162897633|NCT00732641|588324214|FG000|Overall Study|Serious Adverse Events|12|||
162897634|NCT00732641|588324215|FG001|Overall Study|Serious Adverse Events|3|||
162897635|NCT00732641|588324214|FG000|Overall Study|Physician Decision|6|||
162897636|NCT00732641|588324215|FG001|Overall Study|Physician Decision|0|||
162897637|NCT00732641|588324214|FG000|Overall Study|Withdrawal by Subject|4|||
162897638|NCT00732641|588324215|FG001|Overall Study|Withdrawal by Subject|2|||
162897639|NCT00732641|588324214|FG000|Overall Study|Unable to Complete|1|||
162897640|NCT00732641|588324215|FG001|Overall Study|Unable to Complete|1|||
162897641|NCT00732641|588324214|FG000|Overall Study|Other|18|||
162897642|NCT00732641|588324215|FG001|Overall Study|Other|5|||
162897643|NCT02910089|588324216|FG000|Overall Study|Lost insurance eligibility|22|||
162897644|NCT02910089|588324217|FG001|Overall Study|Lost insurance eligibility|16|||
162897645|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
162897646|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
162897647|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
162897648|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
162897649|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
162897650|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
163052088|NCT00557466|588900892|FG002|Overall Study|Lost to Follow-up|0|||
163052089|NCT00557466|588900893|FG003|Overall Study|Lost to Follow-up|1|||
163052090|NCT00557466|588900894|FG004|Overall Study|Lost to Follow-up|0|||
163052091|NCT00557466|588900895|FG005|Overall Study|Lost to Follow-up|0|||
163052092|NCT01712516|588900896|FG000|Overall Study|Technical problems|0|||
163052093|NCT01712516|588900897|FG001|Overall Study|Technical problems|0|||
163052094|NCT01712516|588900898|FG002|Overall Study|Technical problems|0|||
163052095|NCT01712516|588900899|FG003|Overall Study|Technical problems|2|||
163052096|NCT01712516|588900896|FG000|Overall Study|Lost to Follow-up|0|||
163052097|NCT01712516|588900897|FG001|Overall Study|Lost to Follow-up|0|||
163052098|NCT01712516|588900898|FG002|Overall Study|Lost to Follow-up|2|||
163052099|NCT01712516|588900899|FG003|Overall Study|Lost to Follow-up|1|||
163052100|NCT01712516|588900896|FG000|Overall Study|Death|0|||
163052101|NCT01712516|588900897|FG001|Overall Study|Death|1|||
162897651|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
162897652|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
162897653|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
162897654|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
162897655|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
162897656|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
162897657|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
162897658|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
162897659|NCT03434041|588324220|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
162897660|NCT03434041|588324221|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
162897661|NCT03434041|588324220|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
162897662|NCT03434041|588324221|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
162897663|NCT03434041|588324220|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
162897664|NCT03434041|588324221|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
162897665|NCT03434041|588324220|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
162897666|NCT03434041|588324221|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
162897667|NCT03447821|588324223|FG000|Overall Study|Withdrawal by Subject|1|||
162897668|NCT03447821|588324224|FG001|Overall Study|Withdrawal by Subject|1|||
162897669|NCT03447821|588324225|FG002|Overall Study|Withdrawal by Subject|0|||
162897670|NCT03447821|588324223|FG000|Overall Study|Lost to Follow-up|0|||
162897671|NCT03447821|588324224|FG001|Overall Study|Lost to Follow-up|0|||
162897672|NCT03447821|588324225|FG002|Overall Study|Lost to Follow-up|1|||
162897673|NCT02977507|588324226|FG000|Overall Study|Protocol Deviation|1|||
162897674|NCT02977507|588324227|FG001|Overall Study|Protocol Deviation|0|||
162897675|NCT02977507|588324226|FG000|Overall Study|Lost to Follow-up|1|||
162897676|NCT02977507|588324227|FG001|Overall Study|Lost to Follow-up|0|||
162897677|NCT00437203|588324228|FG000|Overall Study|Death|0|||
162897678|NCT00437203|588324229|FG001|Overall Study|Death|0|||
162897679|NCT00437203|588324230|FG002|Overall Study|Death|1|||
162897680|NCT00437203|588324231|FG003|Overall Study|Death|0|||
162897681|NCT00437203|588324232|FG004|Overall Study|Death|0|||
162897682|NCT00437203|588324233|FG005|Overall Study|Death|0|||
162897683|NCT00437203|588324234|FG006|Overall Study|Death|0|||
162897684|NCT00437203|588324235|FG007|Overall Study|Death|1|||
162897685|NCT00437203|588324236|FG008|Overall Study|Death|0|||
162897686|NCT00437203|588324237|FG009|Overall Study|Death|1|||
162897687|NCT00437203|588324228|FG000|Overall Study|Adverse Event|1|||
162897688|NCT00437203|588324229|FG001|Overall Study|Adverse Event|1|||
162625066|NCT00674700|587344797|FG002|Year 1|Adverse Event|5|||
162625067|NCT00674700|587344795|FG000|Year 1|Withdrawal by Subject|7|||
162897689|NCT00437203|588324230|FG002|Overall Study|Adverse Event|0|||
162897690|NCT00437203|588324231|FG003|Overall Study|Adverse Event|0|||
162897691|NCT00437203|588324232|FG004|Overall Study|Adverse Event|0|||
162897692|NCT00437203|588324233|FG005|Overall Study|Adverse Event|0|||
162897693|NCT00437203|588324234|FG006|Overall Study|Adverse Event|0|||
162897694|NCT00437203|588324235|FG007|Overall Study|Adverse Event|1|||
162897695|NCT00437203|588324236|FG008|Overall Study|Adverse Event|0|||
162897696|NCT00437203|588324237|FG009|Overall Study|Adverse Event|1|||
162897697|NCT00437203|588324228|FG000|Overall Study|Study terminated by sponsor|0|||
162897698|NCT00437203|588324229|FG001|Overall Study|Study terminated by sponsor|0|||
162897699|NCT00437203|588324230|FG002|Overall Study|Study terminated by sponsor|0|||
162897700|NCT00437203|588324231|FG003|Overall Study|Study terminated by sponsor|0|||
162897701|NCT00437203|588324232|FG004|Overall Study|Study terminated by sponsor|0|||
162897702|NCT00437203|588324233|FG005|Overall Study|Study terminated by sponsor|0|||
162897703|NCT00437203|588324234|FG006|Overall Study|Study terminated by sponsor|0|||
162897704|NCT00437203|588324235|FG007|Overall Study|Study terminated by sponsor|0|||
162897705|NCT00437203|588324236|FG008|Overall Study|Study terminated by sponsor|1|||
162897706|NCT00437203|588324237|FG009|Overall Study|Study terminated by sponsor|0|||
162625068|NCT00674700|587344796|FG001|Year 1|Withdrawal by Subject|7|||
162625069|NCT00674700|587344797|FG002|Year 1|Withdrawal by Subject|6|||
162625070|NCT00674700|587344795|FG000|Year 1|Any other reason not above-mentioned|7|||
162625071|NCT00674700|587344796|FG001|Year 1|Any other reason not above-mentioned|7|||
162625072|NCT00674700|587344797|FG002|Year 1|Any other reason not above-mentioned|6|||
162625073|NCT00674700|587344795|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
162625074|NCT00674700|587344796|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
162897707|NCT00437203|588324228|FG000|Overall Study|Objective progression or relapse|5|||
162897708|NCT00437203|588324229|FG001|Overall Study|Objective progression or relapse|6|||
162897709|NCT00437203|588324230|FG002|Overall Study|Objective progression or relapse|2|||
162897710|NCT00437203|588324231|FG003|Overall Study|Objective progression or relapse|3|||
162897711|NCT00437203|588324232|FG004|Overall Study|Objective progression or relapse|3|||
162897712|NCT00437203|588324233|FG005|Overall Study|Objective progression or relapse|3|||
162897713|NCT00437203|588324234|FG006|Overall Study|Objective progression or relapse|6|||
162897714|NCT00437203|588324235|FG007|Overall Study|Objective progression or relapse|1|||
162897715|NCT00437203|588324236|FG008|Overall Study|Objective progression or relapse|2|||
162897716|NCT00437203|588324237|FG009|Overall Study|Objective progression or relapse|2|||
162897717|NCT00437203|588324228|FG000|Overall Study|Other|0|||
162897718|NCT00437203|588324229|FG001|Overall Study|Other|1|||
162897719|NCT00437203|588324230|FG002|Overall Study|Other|0|||
162897720|NCT00437203|588324231|FG003|Overall Study|Other|0|||
162897721|NCT00437203|588324232|FG004|Overall Study|Other|0|||
162897722|NCT00437203|588324233|FG005|Overall Study|Other|0|||
162897723|NCT00437203|588324234|FG006|Overall Study|Other|1|||
162897724|NCT00437203|588324235|FG007|Overall Study|Other|0|||
162897725|NCT00437203|588324236|FG008|Overall Study|Other|0|||
162897726|NCT00437203|588324237|FG009|Overall Study|Other|0|||
162897727|NCT03997760|588324238|FG000|Overall Study|Protocol Deviation|0|||
162897728|NCT03997760|588324239|FG001|Overall Study|Protocol Deviation|1|||
162897729|NCT03997760|588324240|FG002|Overall Study|Protocol Deviation|0|||
162897730|NCT03997760|588324241|FG003|Overall Study|Protocol Deviation|0|||
162897731|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
162897732|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
162897733|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
162897734|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
162897735|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
162897736|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
162897737|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
162897738|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
162897739|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
162897740|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
162897741|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
162897742|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
162897743|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
162897744|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
162897745|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
162897746|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
162897747|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
162897748|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
162897749|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
162897750|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
162897751|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
162897752|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
162897753|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
162897754|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
162897755|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
162897756|NCT00856986|588324242|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
162897757|NCT00856986|588324243|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
162897758|NCT00856986|588324244|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
162897759|NCT00856986|588324245|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
162897760|NCT00856986|588324246|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
162897761|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
162897762|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
162897763|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
162897764|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
162897765|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
162897766|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
162897767|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
162897768|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
162897769|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
162625075|NCT00674700|587344797|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
162625076|NCT00674700|587344795|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
162625077|NCT00674700|587344796|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
162625078|NCT00674700|587344797|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
162625079|NCT00674700|587344795|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
162625080|NCT00674700|587344796|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
162625081|NCT00674700|587344797|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
162625082|NCT02732119|587344802|FG000|Phase I|Adverse Event|1|||
162625083|NCT02732119|587344803|FG001|Phase I|Adverse Event|3|||
162625084|NCT02732119|587344804|FG002|Phase I|Adverse Event|1|||
162897770|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
162625085|NCT02732119|587344805|FG003|Phase I|Adverse Event|0|||
162625086|NCT02732119|587344806|FG004|Phase I|Adverse Event|0|||
162897771|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
162897772|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
162897773|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
162897774|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
162897775|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
162897776|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
162897777|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
162897778|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
162897779|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
162897780|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
162897781|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
162897782|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
162897783|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
162897784|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
162897785|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
162897786|NCT00856986|588324242|FG000|Main Period, Weeks 0-26|Unclassified|7|||
162625087|NCT02732119|587344802|FG000|Phase I|Progressive disease|7|||
162897787|NCT00856986|588324243|FG001|Main Period, Weeks 0-26|Unclassified|6|||
162897788|NCT00856986|588324244|FG002|Main Period, Weeks 0-26|Unclassified|7|||
162897789|NCT00856986|588324245|FG003|Main Period, Weeks 0-26|Unclassified|0|||
162897790|NCT00856986|588324246|FG004|Main Period, Weeks 0-26|Unclassified|0|||
162897791|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
162897792|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
162897793|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
162897794|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
162897795|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
162897796|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
162897797|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
162965237|NCT05330975|588573221|FG001|Revaccination|Death|0|||
162965238|NCT05330975|588573222|FG002|Revaccination|Death|0|||
162965239|NCT05330975|588573223|FG003|Revaccination|Death|0|||
162965240|NCT05330975|588573224|FG004|Revaccination|Death|0|||
162965241|NCT05330975|588573225|FG005|Revaccination|Death|0|||
162965242|NCT05330975|588573226|FG006|Revaccination|Death|3|||
162965243|NCT05267106|588573230|FG000|Overall Study|Death|50|||
162965244|NCT05267106|588573231|FG001|Overall Study|Death|2|||
162965245|NCT05267106|588573230|FG000|Overall Study|Study terminated by Sponsor|24|||
162965246|NCT05267106|588573231|FG001|Overall Study|Study terminated by Sponsor|6|||
162965247|NCT05267106|588573230|FG000|Overall Study|Withdrawal by Subject|0|||
162965248|NCT05267106|588573231|FG001|Overall Study|Withdrawal by Subject|1|||
162965249|NCT04165824|588573232|FG000|Overall Study|Adverse Event|23|||
162965250|NCT04165824|588573232|FG000|Overall Study|Physician Decision|1|||
162965251|NCT04165824|588573232|FG000|Overall Study|Withdrawal by Subject|17|||
162965252|NCT04165824|588573232|FG000|Overall Study|Other|5|||
162965253|NCT00834444|588573238|FG000|First Intervention|Adverse Event|1|||
162965254|NCT00834444|588573239|FG001|First Intervention|Adverse Event|0|||
162965255|NCT00834444|588573238|FG000|First Intervention|Intolerance to Venopuncture|0|||
162965256|NCT00834444|588573239|FG001|First Intervention|Intolerance to Venopuncture|1|||
162965257|NCT00834444|588573238|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
162965258|NCT00834444|588573239|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
162965259|NCT00834444|588573238|FG000|Second Intervention|Adverse Event|1|||
162965260|NCT00834444|588573239|FG001|Second Intervention|Adverse Event|0|||
162965261|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965262|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
162965263|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965264|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965265|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965266|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965267|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965268|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
162965269|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965270|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965271|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965272|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965273|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965274|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162965275|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
162965276|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
162625088|NCT02732119|587344803|FG001|Phase I|Progressive disease|3|||
162625089|NCT02732119|587344804|FG002|Phase I|Progressive disease|2|||
162625090|NCT02732119|587344805|FG003|Phase I|Progressive disease|0|||
162625091|NCT02732119|587344806|FG004|Phase I|Progressive disease|0|||
162965277|NCT02890992|588573240|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965278|NCT02890992|588573241|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
162897798|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
162897799|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
162965279|NCT02890992|588573242|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
163052102|NCT01712516|588900898|FG002|Overall Study|Death|0|||
162897800|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
162897801|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
162897802|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
162897803|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
162897804|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
162897805|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
162897806|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
162897807|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
162897808|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
162897809|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
162897810|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
162897811|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
162897812|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
162897813|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
162897814|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
162897815|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
162897816|NCT00856986|588324242|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
162897817|NCT00856986|588324243|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
162897818|NCT00856986|588324244|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
162897819|NCT00856986|588324245|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
162897820|NCT00856986|588324246|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
162897821|NCT01906476|588324248|FG000|Overall Study|Lost to Follow-up|17|||
162897822|NCT01906476|588324249|FG001|Overall Study|Lost to Follow-up|16|||
162897823|NCT00479167|588324253|FG000|Overall Study|Withdrawal by Subject|1|||
162897824|NCT02384993|588324257|FG000|Overall Study|Adverse Event|0|||
162897825|NCT02384993|588324258|FG001|Overall Study|Adverse Event|1|||
162897826|NCT01576406|588324259|FG000|Overall Study|Lost to Follow-up|1|||
162897827|NCT01576406|588324260|FG001|Overall Study|Lost to Follow-up|2|||
162897828|NCT01576406|588324261|FG002|Overall Study|Lost to Follow-up|0|||
162897829|NCT01576406|588324262|FG003|Overall Study|Lost to Follow-up|0|||
162897830|NCT01576406|588324263|FG004|Overall Study|Lost to Follow-up|0|||
162897831|NCT01576406|588324264|FG005|Overall Study|Lost to Follow-up|0|||
162897832|NCT01576406|588324259|FG000|Overall Study|Death|3|||
162897833|NCT01576406|588324260|FG001|Overall Study|Death|4|||
162897834|NCT01576406|588324261|FG002|Overall Study|Death|8|||
162897835|NCT01576406|588324262|FG003|Overall Study|Death|5|||
162897836|NCT01576406|588324263|FG004|Overall Study|Death|7|||
162897837|NCT01576406|588324264|FG005|Overall Study|Death|9|||
162897838|NCT01576406|588324259|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
162897839|NCT01576406|588324260|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
162897840|NCT01576406|588324261|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
162897841|NCT01576406|588324262|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
162897842|NCT01576406|588324263|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
162897843|NCT01576406|588324264|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
162897844|NCT01576406|588324259|FG000|Overall Study|Withdrawal the consent|2|||
162897845|NCT01576406|588324260|FG001|Overall Study|Withdrawal the consent|2|||
162897846|NCT01576406|588324261|FG002|Overall Study|Withdrawal the consent|5|||
162897847|NCT01576406|588324262|FG003|Overall Study|Withdrawal the consent|1|||
162965280|NCT02890992|588573243|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965281|NCT02890992|588573244|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965282|NCT02890992|588573245|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965283|NCT02890992|588573246|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965284|NCT02890992|588573247|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
162965285|NCT01496118|588573248|FG000|Overall Study|Disease progression|3|||
162965286|NCT01496118|588573249|FG001|Overall Study|Disease progression|2|||
162965287|NCT01496118|588573250|FG002|Overall Study|Disease progression|3|||
162897848|NCT01576406|588324263|FG004|Overall Study|Withdrawal the consent|1|||
162897849|NCT01576406|588324264|FG005|Overall Study|Withdrawal the consent|3|||
162897850|NCT01576406|588324259|FG000|Overall Study|Other|0|||
162897851|NCT01576406|588324260|FG001|Overall Study|Other|0|||
162897852|NCT01576406|588324261|FG002|Overall Study|Other|2|||
162897853|NCT01576406|588324262|FG003|Overall Study|Other|2|||
162897854|NCT01576406|588324263|FG004|Overall Study|Other|0|||
162897855|NCT01576406|588324264|FG005|Overall Study|Other|0|||
162897856|NCT01627782|588324265|FG000|Overall Study|Adverse Event|1|||
162897857|NCT01627782|588324266|FG001|Overall Study|Adverse Event|2|||
162897858|NCT01627782|588324267|FG002|Overall Study|Adverse Event|0|||
162625092|NCT02732119|587344802|FG000|Phase I|Protocol deviation|0|||
162625093|NCT02732119|587344803|FG001|Phase I|Protocol deviation|1|||
162625094|NCT02732119|587344804|FG002|Phase I|Protocol deviation|0|||
162897859|NCT01627782|588324268|FG003|Overall Study|Adverse Event|1|||
162897860|NCT01627782|588324265|FG000|Overall Study|Lack of Efficacy|11|||
162897861|NCT01627782|588324266|FG001|Overall Study|Lack of Efficacy|1|||
162897862|NCT01627782|588324267|FG002|Overall Study|Lack of Efficacy|15|||
162897863|NCT01627782|588324268|FG003|Overall Study|Lack of Efficacy|2|||
162897864|NCT01627782|588324265|FG000|Overall Study|Protocol Violation|1|||
162897865|NCT01627782|588324266|FG001|Overall Study|Protocol Violation|0|||
162897866|NCT01627782|588324267|FG002|Overall Study|Protocol Violation|0|||
162897867|NCT01627782|588324268|FG003|Overall Study|Protocol Violation|0|||
162897868|NCT01627782|588324265|FG000|Overall Study|Withdrawal by Subject|2|||
162897869|NCT01627782|588324266|FG001|Overall Study|Withdrawal by Subject|1|||
162897870|NCT01627782|588324267|FG002|Overall Study|Withdrawal by Subject|0|||
162897871|NCT01627782|588324268|FG003|Overall Study|Withdrawal by Subject|0|||
162625095|NCT02732119|587344805|FG003|Phase I|Protocol deviation|0|||
162897872|NCT01627782|588324265|FG000|Overall Study|Other|0|||
162897873|NCT01627782|588324266|FG001|Overall Study|Other|2|||
162897874|NCT01627782|588324267|FG002|Overall Study|Other|0|||
162897875|NCT01627782|588324268|FG003|Overall Study|Other|3|||
162897876|NCT01627782|588324265|FG000|Overall Study|Randomized But Not Treated|1|||
162897877|NCT01627782|588324266|FG001|Overall Study|Randomized But Not Treated|0|||
162924500|NCT01186744|588426032|FG001|Overall Study|Lost to Follow-up|16|||
162924501|NCT01186744|588426033|FG002|Overall Study|Lost to Follow-up|2|||
162924502|NCT01186744|588426034|FG003|Overall Study|Lost to Follow-up|1|||
162924503|NCT01186744|588426035|FG004|Overall Study|Lost to Follow-up|1|||
162924504|NCT01186744|588426036|FG005|Overall Study|Lost to Follow-up|4|||
162924505|NCT01186744|588426031|FG000|Overall Study|Screen failure|1|||
162924506|NCT01186744|588426032|FG001|Overall Study|Screen failure|1|||
162924507|NCT01186744|588426033|FG002|Overall Study|Screen failure|0|||
162924508|NCT01186744|588426034|FG003|Overall Study|Screen failure|1|||
162924509|NCT01186744|588426035|FG004|Overall Study|Screen failure|0|||
162924510|NCT01186744|588426036|FG005|Overall Study|Screen failure|0|||
162924511|NCT01186744|588426031|FG000|Overall Study|Withdrawal by Subject|14|||
162924512|NCT01186744|588426032|FG001|Overall Study|Withdrawal by Subject|10|||
162924513|NCT01186744|588426033|FG002|Overall Study|Withdrawal by Subject|2|||
162924514|NCT01186744|588426034|FG003|Overall Study|Withdrawal by Subject|5|||
162924515|NCT01186744|588426035|FG004|Overall Study|Withdrawal by Subject|0|||
162924516|NCT01186744|588426036|FG005|Overall Study|Withdrawal by Subject|6|||
162924517|NCT01186744|588426031|FG000|Overall Study|Study terminated by Sponsor|1|||
162924518|NCT01186744|588426032|FG001|Overall Study|Study terminated by Sponsor|0|||
162924519|NCT01186744|588426033|FG002|Overall Study|Study terminated by Sponsor|0|||
162924520|NCT01186744|588426034|FG003|Overall Study|Study terminated by Sponsor|0|||
162924521|NCT01186744|588426035|FG004|Overall Study|Study terminated by Sponsor|0|||
162924522|NCT01186744|588426036|FG005|Overall Study|Study terminated by Sponsor|0|||
162924523|NCT01186744|588426031|FG000|Overall Study|Other|9|||
162924524|NCT01186744|588426032|FG001|Overall Study|Other|10|||
162924525|NCT01186744|588426033|FG002|Overall Study|Other|1|||
162924526|NCT01186744|588426034|FG003|Overall Study|Other|2|||
162924527|NCT01186744|588426035|FG004|Overall Study|Other|1|||
162924528|NCT01186744|588426036|FG005|Overall Study|Other|5|||
162924529|NCT01186744|588426031|FG000|Overall Study|Adverse Event|10|||
162924530|NCT01186744|588426032|FG001|Overall Study|Adverse Event|14|||
162924531|NCT01186744|588426033|FG002|Overall Study|Adverse Event|1|||
162924532|NCT01186744|588426034|FG003|Overall Study|Adverse Event|0|||
162924533|NCT01186744|588426035|FG004|Overall Study|Adverse Event|1|||
162924534|NCT01186744|588426036|FG005|Overall Study|Adverse Event|4|||
162924535|NCT01186744|588426031|FG000|Overall Study|Death|1|||
162924536|NCT01186744|588426032|FG001|Overall Study|Death|0|||
162924537|NCT01186744|588426033|FG002|Overall Study|Death|0|||
162924538|NCT01186744|588426034|FG003|Overall Study|Death|0|||
162924539|NCT01186744|588426035|FG004|Overall Study|Death|0|||
162924540|NCT01186744|588426036|FG005|Overall Study|Death|0|||
162924541|NCT03515837|588426040|FG000|Overall Study|Death|219|||
162924542|NCT03515837|588426041|FG001|Overall Study|Death|227|||
162924543|NCT03515837|588426040|FG000|Overall Study|Lost to Follow-up|0|||
162924544|NCT03515837|588426041|FG001|Overall Study|Lost to Follow-up|1|||
162924545|NCT03515837|588426040|FG000|Overall Study|Withdrawal by Subject|0|||
162924546|NCT03515837|588426041|FG001|Overall Study|Withdrawal by Subject|4|||
162924547|NCT03515837|588426040|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
162924548|NCT03515837|588426041|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
162924549|NCT02325401|588426042|FG000|Overall Study|Withdrawal by Subject|0|||
162924550|NCT02325401|588426043|FG001|Overall Study|Withdrawal by Subject|1|||
162924551|NCT02325401|588426044|FG002|Overall Study|Withdrawal by Subject|1|||
162924552|NCT01856686|588426045|FG000|Overall Study|Lost to Follow-up|5|||
162924553|NCT01856686|588426046|FG001|Overall Study|Lost to Follow-up|11|||
162924554|NCT02406742|588426049|FG000|Overall Study|Progression of Disease|5|||
162625096|NCT02732119|587344806|FG004|Phase I|Protocol deviation|0|||
162625097|NCT02732119|587344802|FG000|Phase I|Physician Decision|0|||
162625098|NCT02732119|587344803|FG001|Phase I|Physician Decision|3|||
162625099|NCT02732119|587344804|FG002|Phase I|Physician Decision|4|||
162625100|NCT02732119|587344805|FG003|Phase I|Physician Decision|0|||
162625101|NCT02732119|587344806|FG004|Phase I|Physician Decision|0|||
162625102|NCT02732119|587344802|FG000|Phase II|Adverse Event|0|||
162625103|NCT02732119|587344803|FG001|Phase II|Adverse Event|0|||
162625104|NCT02732119|587344804|FG002|Phase II|Adverse Event|0|||
162625105|NCT02732119|587344805|FG003|Phase II|Adverse Event|3|||
162625106|NCT02732119|587344806|FG004|Phase II|Adverse Event|3|||
162625107|NCT02732119|587344802|FG000|Phase II|Death|0|||
162625108|NCT02732119|587344803|FG001|Phase II|Death|0|||
162625109|NCT02732119|587344804|FG002|Phase II|Death|0|||
162625110|NCT02732119|587344805|FG003|Phase II|Death|1|||
162625111|NCT02732119|587344806|FG004|Phase II|Death|0|||
162625112|NCT02732119|587344802|FG000|Phase II|Progressive dissease|0|||
162625113|NCT02732119|587344803|FG001|Phase II|Progressive dissease|0|||
162625114|NCT02732119|587344804|FG002|Phase II|Progressive dissease|0|||
162625115|NCT02732119|587344805|FG003|Phase II|Progressive dissease|30|||
162625116|NCT02732119|587344806|FG004|Phase II|Progressive dissease|23|||
162625117|NCT02732119|587344802|FG000|Phase II|Study terminated by sponsor|0|||
162625118|NCT02732119|587344803|FG001|Phase II|Study terminated by sponsor|0|||
162897878|NCT01627782|588324267|FG002|Overall Study|Randomized But Not Treated|0|||
162897879|NCT01627782|588324268|FG003|Overall Study|Randomized But Not Treated|0|||
162897880|NCT01004159|588326490|FG000|Overall Study|Adverse Event|2|||
162897881|NCT01004159|588326490|FG000|Overall Study|Disease Progression|18|||
162897882|NCT01199198|588326496|FG000|Overall Study|Adverse Event|3|||
162897883|NCT01199198|588326497|FG001|Overall Study|Adverse Event|0|||
162897884|NCT01199198|588326496|FG000|Overall Study|Lost to Follow-up|1|||
162897885|NCT01199198|588326497|FG001|Overall Study|Lost to Follow-up|5|||
162897886|NCT01199198|588326496|FG000|Overall Study|Withdrawal by Subject|1|||
162897887|NCT01199198|588326497|FG001|Overall Study|Withdrawal by Subject|2|||
162897888|NCT01199198|588326496|FG000|Overall Study|ICU Transfer|1|||
162965288|NCT01496118|588573251|FG003|Overall Study|Disease progression|1|||
162965289|NCT01496118|588573252|FG004|Overall Study|Disease progression|2|||
162965290|NCT01496118|588573253|FG005|Overall Study|Disease progression|2|||
163052103|NCT01712516|588900899|FG003|Overall Study|Death|0|||
163052104|NCT01712516|588900896|FG000|Overall Study|Protocol deviation|1|||
163052105|NCT01712516|588900897|FG001|Overall Study|Protocol deviation|0|||
163052106|NCT01712516|588900898|FG002|Overall Study|Protocol deviation|1|||
163052107|NCT01712516|588900899|FG003|Overall Study|Protocol deviation|0|||
163052108|NCT01712516|588900896|FG000|Overall Study|Physician Decision|2|||
163052109|NCT01712516|588900897|FG001|Overall Study|Physician Decision|0|||
163052110|NCT01712516|588900898|FG002|Overall Study|Physician Decision|0|||
163052111|NCT01712516|588900899|FG003|Overall Study|Physician Decision|1|||
163052112|NCT01712516|588900896|FG000|Overall Study|Withdrawal by Subject|3|||
163052113|NCT01712516|588900897|FG001|Overall Study|Withdrawal by Subject|9|||
163052114|NCT01712516|588900898|FG002|Overall Study|Withdrawal by Subject|3|||
163052115|NCT01712516|588900899|FG003|Overall Study|Withdrawal by Subject|9|||
163052116|NCT01251952|588900900|FG000|Overall Study|Adverse Event|1|||
163052117|NCT00496769|588900901|FG000|Double Blind|>=1 reason assigned per patient|558|||
163052118|NCT00496769|588900902|FG001|Double Blind|>=1 reason assigned per patient|649|||
162625119|NCT02732119|587344804|FG002|Phase II|Study terminated by sponsor|0|||
162625120|NCT02732119|587344805|FG003|Phase II|Study terminated by sponsor|2|||
162625121|NCT02732119|587344806|FG004|Phase II|Study terminated by sponsor|2|||
162625122|NCT02732119|587344802|FG000|Phase II|Other|0|||
162625123|NCT02732119|587344803|FG001|Phase II|Other|0|||
162625124|NCT02732119|587344804|FG002|Phase II|Other|0|||
162965291|NCT01496118|588573254|FG006|Overall Study|Disease progression|14|||
162965292|NCT01496118|588573255|FG007|Overall Study|Disease progression|10|||
162965293|NCT01496118|588573248|FG000|Overall Study|Physician Decision|0|||
162965294|NCT01496118|588573249|FG001|Overall Study|Physician Decision|0|||
162965295|NCT01496118|588573250|FG002|Overall Study|Physician Decision|0|||
162965296|NCT01496118|588573251|FG003|Overall Study|Physician Decision|0|||
162965297|NCT01496118|588573252|FG004|Overall Study|Physician Decision|1|||
162625125|NCT02732119|587344805|FG003|Phase II|Other|2|||
162625126|NCT02732119|587344806|FG004|Phase II|Other|0|||
163052119|NCT00496769|588900903|FG002|Double Blind|>=1 reason assigned per patient|0|||
162625127|NCT02732119|587344802|FG000|Phase II|Physician Decision|0|||
162625128|NCT02732119|587344803|FG001|Phase II|Physician Decision|0|||
162625129|NCT02732119|587344804|FG002|Phase II|Physician Decision|0|||
162625130|NCT02732119|587344805|FG003|Phase II|Physician Decision|8|||
162625131|NCT02732119|587344806|FG004|Phase II|Physician Decision|5|||
162625132|NCT00964860|587344807|FG000|Overall Study|Withdrawal by Subject|0|||
162965298|NCT01496118|588573253|FG005|Overall Study|Physician Decision|0|||
162965299|NCT01496118|588573254|FG006|Overall Study|Physician Decision|3|||
162625133|NCT00964860|587344808|FG001|Overall Study|Withdrawal by Subject|1|||
162625134|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Physician Decision|0|||
162897889|NCT01199198|588326497|FG001|Overall Study|ICU Transfer|2|||
162965300|NCT01496118|588573255|FG007|Overall Study|Physician Decision|6|||
162625135|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Physician Decision|1|||
162625136|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Physician Decision|0|||
162965301|NCT01496118|588573248|FG000|Overall Study|Adverse Event|1|||
162965302|NCT01496118|588573249|FG001|Overall Study|Adverse Event|1|||
162965303|NCT01496118|588573250|FG002|Overall Study|Adverse Event|0|||
162965304|NCT01496118|588573251|FG003|Overall Study|Adverse Event|0|||
162965305|NCT01496118|588573252|FG004|Overall Study|Adverse Event|0|||
162965306|NCT01496118|588573253|FG005|Overall Study|Adverse Event|0|||
162965307|NCT01496118|588573254|FG006|Overall Study|Adverse Event|6|||
162965308|NCT01496118|588573255|FG007|Overall Study|Adverse Event|10|||
162965309|NCT01496118|588573248|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965310|NCT01496118|588573249|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965311|NCT01496118|588573250|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
163052120|NCT00496769|588900901|FG000|Open Label|>=1 reason assigned per patient|0|||
163052121|NCT00496769|588900902|FG001|Open Label|>=1 reason assigned per patient|0|||
162897890|NCT01199198|588326496|FG000|Overall Study|Hospice-care transfer|1|||
162897891|NCT01199198|588326497|FG001|Overall Study|Hospice-care transfer|2|||
162897892|NCT04315298|588326498|FG000|Overall Study|Withdrawal by Subject|0|||
162897893|NCT04315298|588326499|FG001|Overall Study|Withdrawal by Subject|0|||
162897894|NCT04315298|588326500|FG002|Overall Study|Withdrawal by Subject|0|||
162897895|NCT04315298|588326501|FG003|Overall Study|Withdrawal by Subject|2|||
162897896|NCT04315298|588326502|FG004|Overall Study|Withdrawal by Subject|2|||
162897897|NCT04315298|588326503|FG005|Overall Study|Withdrawal by Subject|2|||
162897898|NCT04315298|588326504|FG006|Overall Study|Withdrawal by Subject|0|||
162897899|NCT04315298|588326505|FG007|Overall Study|Withdrawal by Subject|1|||
162897900|NCT04315298|588326506|FG008|Overall Study|Withdrawal by Subject|1|||
162897901|NCT04315298|588326507|FG009|Overall Study|Withdrawal by Subject|1|||
162897902|NCT04315298|588326508|FG010|Overall Study|Withdrawal by Subject|0|||
162897903|NCT04315298|588326509|FG011|Overall Study|Withdrawal by Subject|0|||
162897904|NCT04315298|588326510|FG012|Overall Study|Withdrawal by Subject|0|||
162897905|NCT04315298|588326511|FG013|Overall Study|Withdrawal by Subject|0|||
162897906|NCT04315298|588326512|FG014|Overall Study|Withdrawal by Subject|0|||
162897907|NCT04315298|588326513|FG015|Overall Study|Withdrawal by Subject|0|||
162897908|NCT04315298|588326514|FG016|Overall Study|Withdrawal by Subject|0|||
162897909|NCT04315298|588326515|FG017|Overall Study|Withdrawal by Subject|0|||
162897910|NCT04315298|588326516|FG018|Overall Study|Withdrawal by Subject|0|||
162897911|NCT04315298|588326498|FG000|Overall Study|Physician Decision|0|||
162897912|NCT04315298|588326499|FG001|Overall Study|Physician Decision|0|||
162897913|NCT04315298|588326500|FG002|Overall Study|Physician Decision|0|||
163052122|NCT00496769|588900903|FG002|Open Label|>=1 reason assigned per patient|1011|||
163052123|NCT02308046|588900904|FG000|Overall Study|Negative yeast culture at Baseline|32|||
163052124|NCT02308046|588900905|FG001|Overall Study|Negative yeast culture at Baseline|33|||
163052125|NCT02308046|588900904|FG000|Overall Study|Positive for STD at Baseline|1|||
163052126|NCT02308046|588900905|FG001|Overall Study|Positive for STD at Baseline|2|||
163052127|NCT02308046|588900904|FG000|Overall Study|Lost to Follow-up|1|||
163052128|NCT02308046|588900905|FG001|Overall Study|Lost to Follow-up|3|||
163052129|NCT02224625|588900911|FG000|Irritation|Adverse Event|6|||
163052130|NCT02224625|588900911|FG000|Sensitization|Adverse Event|55|||
163052131|NCT01181167|588900912|FG000|Overall Study|Adverse Event|11|||
163052132|NCT01181167|588900913|FG001|Overall Study|Adverse Event|21|||
163052133|NCT01181167|588900912|FG000|Overall Study|Lost to Follow-up|1|||
163052134|NCT01181167|588900913|FG001|Overall Study|Lost to Follow-up|0|||
163052135|NCT01181167|588900912|FG000|Overall Study|Physician Decision|2|||
163052136|NCT01181167|588900913|FG001|Overall Study|Physician Decision|3|||
163052137|NCT01181167|588900912|FG000|Overall Study|Protocol Violation|3|||
163052138|NCT01181167|588900913|FG001|Overall Study|Protocol Violation|0|||
163052139|NCT01181167|588900912|FG000|Overall Study|Withdrawal by Subject|6|||
163052140|NCT01181167|588900913|FG001|Overall Study|Withdrawal by Subject|8|||
163052141|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
163052142|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
163052143|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
163052144|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
163052145|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
163052146|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
163052147|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
163052148|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
163052149|NCT01573000|588900914|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
163052150|NCT01573000|588900915|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
162897914|NCT04315298|588326501|FG003|Overall Study|Physician Decision|0|||
162897915|NCT04315298|588326502|FG004|Overall Study|Physician Decision|1|||
162897916|NCT04315298|588326503|FG005|Overall Study|Physician Decision|0|||
162897917|NCT04315298|588326504|FG006|Overall Study|Physician Decision|0|||
162897918|NCT04315298|588326505|FG007|Overall Study|Physician Decision|0|||
162897919|NCT04315298|588326506|FG008|Overall Study|Physician Decision|0|||
162897920|NCT04315298|588326507|FG009|Overall Study|Physician Decision|0|||
162897921|NCT04315298|588326508|FG010|Overall Study|Physician Decision|0|||
162897922|NCT04315298|588326509|FG011|Overall Study|Physician Decision|0|||
162897923|NCT04315298|588326510|FG012|Overall Study|Physician Decision|0|||
162897924|NCT04315298|588326511|FG013|Overall Study|Physician Decision|0|||
162897925|NCT04315298|588326512|FG014|Overall Study|Physician Decision|0|||
162897926|NCT04315298|588326513|FG015|Overall Study|Physician Decision|0|||
162897927|NCT04315298|588326514|FG016|Overall Study|Physician Decision|0|||
162897928|NCT04315298|588326515|FG017|Overall Study|Physician Decision|0|||
162897929|NCT04315298|588326516|FG018|Overall Study|Physician Decision|0|||
162897930|NCT04315298|588326498|FG000|Overall Study|Lost to Follow-up|5|||
162897931|NCT04315298|588326499|FG001|Overall Study|Lost to Follow-up|10|||
162897932|NCT04315298|588326500|FG002|Overall Study|Lost to Follow-up|6|||
162897933|NCT04315298|588326501|FG003|Overall Study|Lost to Follow-up|8|||
162625137|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
162625138|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
162625139|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
162625140|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
162897934|NCT04315298|588326502|FG004|Overall Study|Lost to Follow-up|12|||
162897935|NCT04315298|588326503|FG005|Overall Study|Lost to Follow-up|13|||
162897936|NCT04315298|588326504|FG006|Overall Study|Lost to Follow-up|9|||
162897937|NCT04315298|588326505|FG007|Overall Study|Lost to Follow-up|16|||
162897938|NCT04315298|588326506|FG008|Overall Study|Lost to Follow-up|14|||
162625141|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
162625142|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
162625143|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Other|4|||
162625144|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Other|4|||
162625145|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Other|0|||
162625146|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
162625147|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
162625148|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
162625149|NCT02585960|587344809|FG000|PK/Safety Assessment Period|Screen Failure|0|||
162625150|NCT02585960|587344810|FG001|PK/Safety Assessment Period|Screen Failure|0|||
162625151|NCT02585960|587344811|FG002|PK/Safety Assessment Period|Screen Failure|1|||
162625152|NCT02585960|587344809|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
162708788|NCT04739423|587642898|FG001|Overall Study|Adverse Event|0|||
162708789|NCT04739423|587642899|FG002|Overall Study|Adverse Event|1|||
162897939|NCT04315298|588326507|FG009|Overall Study|Lost to Follow-up|0|||
162897940|NCT04315298|588326508|FG010|Overall Study|Lost to Follow-up|2|||
162897941|NCT04315298|588326509|FG011|Overall Study|Lost to Follow-up|1|||
162897942|NCT04315298|588326510|FG012|Overall Study|Lost to Follow-up|0|||
162897943|NCT04315298|588326511|FG013|Overall Study|Lost to Follow-up|0|||
162897944|NCT04315298|588326512|FG014|Overall Study|Lost to Follow-up|0|||
162897945|NCT04315298|588326513|FG015|Overall Study|Lost to Follow-up|2|||
162897946|NCT04315298|588326514|FG016|Overall Study|Lost to Follow-up|0|||
162897947|NCT04315298|588326515|FG017|Overall Study|Lost to Follow-up|0|||
162897948|NCT04315298|588326516|FG018|Overall Study|Lost to Follow-up|0|||
162897949|NCT04315298|588326498|FG000|Overall Study|Death|24|||
162897950|NCT04315298|588326499|FG001|Overall Study|Death|60|||
162897951|NCT04315298|588326500|FG002|Overall Study|Death|49|||
162897952|NCT04315298|588326501|FG003|Overall Study|Death|59|||
162897953|NCT04315298|588326502|FG004|Overall Study|Death|70|||
162897954|NCT04315298|588326503|FG005|Overall Study|Death|114|||
162897955|NCT04315298|588326504|FG006|Overall Study|Death|9|||
162897956|NCT04315298|588326505|FG007|Overall Study|Death|12|||
162897957|NCT04315298|588326506|FG008|Overall Study|Death|21|||
162897958|NCT04315298|588326507|FG009|Overall Study|Death|16|||
162897959|NCT04315298|588326508|FG010|Overall Study|Death|40|||
162897960|NCT04315298|588326509|FG011|Overall Study|Death|40|||
162897961|NCT04315298|588326510|FG012|Overall Study|Death|3|||
162897962|NCT04315298|588326511|FG013|Overall Study|Death|4|||
162897963|NCT04315298|588326512|FG014|Overall Study|Death|6|||
162897964|NCT04315298|588326513|FG015|Overall Study|Death|4|||
162897965|NCT04315298|588326514|FG016|Overall Study|Death|3|||
162897966|NCT04315298|588326515|FG017|Overall Study|Death|1|||
162897967|NCT04315298|588326516|FG018|Overall Study|Death|0|||
162897968|NCT00736385|588326517|FG000|Overall Study|Withdrawal by Subject|2|||
162897969|NCT00736385|588326518|FG001|Overall Study|Withdrawal by Subject|2|||
162897970|NCT00736385|588326517|FG000|Overall Study|Adverse Event|0|||
162897971|NCT00736385|588326518|FG001|Overall Study|Adverse Event|1|||
162897972|NCT00098865|588326519|FG000|Overall Study|Progressive Disease|6|||
162897973|NCT00098865|588326519|FG000|Overall Study|Adverse Event|2|||
162897974|NCT00098865|588326519|FG000|Overall Study|Alternative Therapy|1|||
162965312|NCT01496118|588573251|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965313|NCT01496118|588573252|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965314|NCT01496118|588573253|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
163052151|NCT01573000|588900914|FG000|Crossover Phase|Lack of Efficacy|0|||
162625153|NCT02585960|587344810|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
162708790|NCT04739423|587642900|FG003|Overall Study|Adverse Event|0|||
162708791|NCT04739423|587642901|FG004|Overall Study|Adverse Event|1|||
162897975|NCT03267511|588326520|FG000|Overall Study|Lost to Follow-up|0|||
162897976|NCT03267511|588326521|FG001|Overall Study|Lost to Follow-up|0|||
162897977|NCT03267511|588326522|FG002|Overall Study|Lost to Follow-up|0|||
162897978|NCT03267511|588326523|FG003|Overall Study|Lost to Follow-up|1|||
162897979|NCT03050307|588326526|FG000|Overall Study|Adverse Event|4|||
162897980|NCT03050307|588326527|FG001|Overall Study|Adverse Event|2|||
162897981|NCT03050307|588326526|FG000|Overall Study|Significant Protocol Deviation|0|||
162897982|NCT03050307|588326527|FG001|Overall Study|Significant Protocol Deviation|1|||
162897983|NCT03050307|588326526|FG000|Overall Study|Lost to Follow-up|0|||
162897984|NCT03050307|588326527|FG001|Overall Study|Lost to Follow-up|1|||
162897985|NCT03050307|588326526|FG000|Overall Study|Voluntary Withdrawal|3|||
162897986|NCT03050307|588326527|FG001|Overall Study|Voluntary Withdrawal|4|||
162625154|NCT02585960|587344811|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
162625155|NCT02585960|587344809|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
162625156|NCT02585960|587344810|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
162625157|NCT02585960|587344811|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
162625158|NCT06333613|587344813|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
162625159|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
162625160|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
162625161|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
162625162|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
162625163|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625164|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625165|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625166|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625167|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625168|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625169|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162625170|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
162625171|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
162625172|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
162625173|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
162625174|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625175|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625176|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625177|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162897987|NCT03050307|588326526|FG000|Overall Study|Reason not Specified|1|||
162897988|NCT03050307|588326527|FG001|Overall Study|Reason not Specified|1|||
162897989|NCT00653068|588326528|FG000|Overall Study|Death|9|||
162625178|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625179|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625180|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162625181|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
162625182|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
162625183|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
162625184|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
162625185|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625186|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625187|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625188|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625189|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625190|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625191|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162625192|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162897990|NCT00653068|588326528|FG000|Overall Study|Lack of Efficacy|34|||
162897991|NCT00653068|588326528|FG000|Overall Study|Physician Decision|4|||
162897992|NCT00653068|588326528|FG000|Overall Study|Withdrawal by Subject|1|||
162897993|NCT00653068|588326528|FG000|Overall Study|Ineligible|2|||
162897994|NCT01536418|588326547|FG000|Overall Study|Protocol Violation|2|||
162897995|NCT01536418|588326548|FG001|Overall Study|Protocol Violation|3|||
162897996|NCT01536418|588326547|FG000|Overall Study|Physician Decision|1|||
162897997|NCT01536418|588326548|FG001|Overall Study|Physician Decision|3|||
162897998|NCT01536418|588326547|FG000|Overall Study|Study closed/terminated|41|||
162897999|NCT01536418|588326548|FG001|Overall Study|Study closed/terminated|37|||
162898000|NCT01536418|588326547|FG000|Overall Study|Lack of Efficacy|10|||
162708792|NCT04739423|587642902|FG005|Overall Study|Adverse Event|0|||
162898001|NCT01536418|588326548|FG001|Overall Study|Lack of Efficacy|16|||
162898002|NCT01536418|588326547|FG000|Overall Study|Adverse Event|9|||
162898003|NCT01536418|588326548|FG001|Overall Study|Adverse Event|4|||
162898004|NCT01536418|588326547|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
162898005|NCT01536418|588326548|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
162898006|NCT01536418|588326547|FG000|Overall Study|Withdrawal by Subject|5|||
162898007|NCT01536418|588326548|FG001|Overall Study|Withdrawal by Subject|3|||
162898008|NCT00711412|588326550|FG000|Induction Treatment|Death|2|||
162898009|NCT00711412|588326550|FG000|Induction Treatment|Adverse Event|1|||
162898010|NCT00711412|588326550|FG000|Induction Treatment|Other|1|||
162965315|NCT01496118|588573254|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
162965316|NCT01496118|588573255|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
162965317|NCT01496118|588573248|FG000|Overall Study|Death|0|||
162898011|NCT00711412|588326550|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
162708793|NCT04739423|587642897|FG000|Overall Study|Withdrawal by Subject|0|||
162708794|NCT04739423|587642898|FG001|Overall Study|Withdrawal by Subject|0|||
162898012|NCT00711412|588326550|FG000|Evaluated for Combination Treatment|Death|1|||
162898013|NCT00711412|588326550|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
162898014|NCT00711412|588326550|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
162898015|NCT00711412|588326550|FG000|Combination Treatment|Progressive Disease|1|||
162898016|NCT00711412|588326550|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
162898017|NCT00711412|588326550|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
162898018|NCT00711412|588326550|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
162898019|NCT00711412|588326550|FG000|Evaluation for Response and Surgery|Death|1|||
162898020|NCT00711412|588326550|FG000|Survival Follow up Until Death|Other|12|||
162898021|NCT04097028|588326554|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
162898022|NCT04097028|588326554|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
162898023|NCT04097028|588326554|FG000|Overall Study|Disease Progression prior to Surgery|2|||
162898024|NCT04097028|588326554|FG000|Overall Study|Adverse Event prior to Surgery|1|||
162898025|NCT02498392|588326555|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
162898026|NCT02498392|588326556|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
162898027|NCT02498392|588326555|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
162898028|NCT02498392|588326556|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
162898029|NCT02498392|588326555|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
162898030|NCT02498392|588326556|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
162898031|NCT02498392|588326555|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
162898032|NCT02498392|588326556|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
162898033|NCT02498392|588326555|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
162898034|NCT02498392|588326556|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
162898035|NCT02498392|588326555|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
162898036|NCT02498392|588326556|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
162898037|NCT02473289|588326557|FG000|Overall Study|Adverse Event|2|||
162965318|NCT01496118|588573249|FG001|Overall Study|Death|0|||
162965319|NCT01496118|588573250|FG002|Overall Study|Death|0|||
162965320|NCT01496118|588573251|FG003|Overall Study|Death|0|||
162965321|NCT01496118|588573252|FG004|Overall Study|Death|0|||
162965322|NCT01496118|588573253|FG005|Overall Study|Death|0|||
162965323|NCT01496118|588573254|FG006|Overall Study|Death|1|||
162965324|NCT01496118|588573255|FG007|Overall Study|Death|1|||
162965325|NCT01496118|588573248|FG000|Overall Study|Withdrawal by Subject|0|||
162965326|NCT01496118|588573249|FG001|Overall Study|Withdrawal by Subject|0|||
162965327|NCT01496118|588573250|FG002|Overall Study|Withdrawal by Subject|0|||
162965328|NCT01496118|588573251|FG003|Overall Study|Withdrawal by Subject|2|||
162965329|NCT01496118|588573252|FG004|Overall Study|Withdrawal by Subject|0|||
162965330|NCT01496118|588573253|FG005|Overall Study|Withdrawal by Subject|1|||
162965331|NCT01496118|588573254|FG006|Overall Study|Withdrawal by Subject|6|||
162965332|NCT01496118|588573255|FG007|Overall Study|Withdrawal by Subject|3|||
162965333|NCT00841659|588573256|FG000|Washout: 2 Weeks|Protocol Violation|1|||
162965334|NCT00841659|588573257|FG001|Washout: 2 Weeks|Protocol Violation|0|||
162965335|NCT03499873|588573261|FG000|Overall Study|Withdrawal by Subject|4|||
162965336|NCT03499873|588573262|FG001|Overall Study|Withdrawal by Subject|6|||
162965337|NCT03499873|588573263|FG002|Overall Study|Withdrawal by Subject|1|||
162965338|NCT03499873|588573261|FG000|Overall Study|Subjects condition worsened|0|||
162965339|NCT03499873|588573262|FG001|Overall Study|Subjects condition worsened|3|||
162965340|NCT03499873|588573263|FG002|Overall Study|Subjects condition worsened|11|||
162965341|NCT03499873|588573261|FG000|Overall Study|Adverse Event|8|||
162965342|NCT03499873|588573262|FG001|Overall Study|Adverse Event|3|||
162965343|NCT03499873|588573263|FG002|Overall Study|Adverse Event|6|||
162965344|NCT03499873|588573261|FG000|Overall Study|Physician Decision|1|||
162965345|NCT03499873|588573262|FG001|Overall Study|Physician Decision|0|||
162965346|NCT03499873|588573263|FG002|Overall Study|Physician Decision|0|||
163052152|NCT01573000|588900915|FG001|Crossover Phase|Lack of Efficacy|13|||
162898038|NCT02473289|588326558|FG001|Overall Study|Adverse Event|3|||
162898039|NCT02473289|588326557|FG000|Overall Study|Lost to Follow-up|1|||
162898040|NCT02473289|588326558|FG001|Overall Study|Lost to Follow-up|1|||
162898041|NCT02473289|588326557|FG000|Overall Study|Protocol Violation|0|||
162898042|NCT02473289|588326558|FG001|Overall Study|Protocol Violation|1|||
162898043|NCT02473289|588326557|FG000|Overall Study|Withdrawal of consent|6|||
162898044|NCT02473289|588326558|FG001|Overall Study|Withdrawal of consent|7|||
162898045|NCT02473289|588326557|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
162898046|NCT02473289|588326558|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
162898047|NCT02473289|588326557|FG000|Overall Study|Other|2|||
162898048|NCT02473289|588326558|FG001|Overall Study|Other|0|||
162898049|NCT06073054|588326559|FG000|Overall Study|Withdrawal by Subject|2|||
162898050|NCT02244619|588326560|FG000|Overall Study|Did not receive study intervention|8|||
162898051|NCT02244619|588326561|FG001|Overall Study|Did not receive study intervention|21|||
162898052|NCT03285490|588326562|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
162898053|NCT03285490|588326563|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
162898054|NCT03285490|588326562|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
162898055|NCT03285490|588326563|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
162898056|NCT00068822|588326564|FG000|First Randomized Intervention|Lost to Follow-up|1|||
162898057|NCT00068822|588326565|FG001|First Randomized Intervention|Lost to Follow-up|2|||
162898058|NCT00424099|588326566|FG000|Overall Study|Adverse Event|0|||
162898059|NCT00424099|588326567|FG001|Overall Study|Adverse Event|1|||
162898060|NCT00424099|588326568|FG002|Overall Study|Adverse Event|1|||
162898061|NCT00424099|588326569|FG003|Overall Study|Adverse Event|0|||
162898062|NCT00424099|588326566|FG000|Overall Study|Death|0|||
162898063|NCT00424099|588326567|FG001|Overall Study|Death|1|||
162898064|NCT00424099|588326568|FG002|Overall Study|Death|0|||
162898065|NCT00424099|588326569|FG003|Overall Study|Death|0|||
162898066|NCT00424099|588326566|FG000|Overall Study|Illness|2|||
162898067|NCT00424099|588326567|FG001|Overall Study|Illness|0|||
162898068|NCT00424099|588326568|FG002|Overall Study|Illness|1|||
162898069|NCT00424099|588326569|FG003|Overall Study|Illness|4|||
162898070|NCT00424099|588326566|FG000|Overall Study|Lost to Follow-up|0|||
162898071|NCT00424099|588326567|FG001|Overall Study|Lost to Follow-up|0|||
162898072|NCT00424099|588326568|FG002|Overall Study|Lost to Follow-up|3|||
162898073|NCT00424099|588326569|FG003|Overall Study|Lost to Follow-up|0|||
162898074|NCT00424099|588326566|FG000|Overall Study|Hospitalized|1|||
162898075|NCT00424099|588326567|FG001|Overall Study|Hospitalized|2|||
162898076|NCT00424099|588326568|FG002|Overall Study|Hospitalized|1|||
162898077|NCT00424099|588326569|FG003|Overall Study|Hospitalized|3|||
162898078|NCT00424099|588326566|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
162898079|NCT00424099|588326567|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
162898080|NCT00424099|588326568|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
162898081|NCT00424099|588326569|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
162898082|NCT00424099|588326566|FG000|Overall Study|Withdrawal by Subject|1|||
162898083|NCT00424099|588326567|FG001|Overall Study|Withdrawal by Subject|9|||
162898084|NCT00424099|588326568|FG002|Overall Study|Withdrawal by Subject|4|||
162898085|NCT00424099|588326569|FG003|Overall Study|Withdrawal by Subject|6|||
162898086|NCT00424099|588326566|FG000|Overall Study|Physician Decision|0|||
162898087|NCT00424099|588326567|FG001|Overall Study|Physician Decision|0|||
162898088|NCT00424099|588326568|FG002|Overall Study|Physician Decision|1|||
162898089|NCT00424099|588326569|FG003|Overall Study|Physician Decision|0|||
162898090|NCT00424099|588326566|FG000|Overall Study|Missing|0|||
162898091|NCT00424099|588326567|FG001|Overall Study|Missing|0|||
162898092|NCT00424099|588326568|FG002|Overall Study|Missing|1|||
162898093|NCT00424099|588326569|FG003|Overall Study|Missing|0|||
162898094|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
162898095|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
162898096|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
162898097|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
162708795|NCT04739423|587642899|FG002|Overall Study|Withdrawal by Subject|0|||
162898098|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
162898099|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
162898100|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
162898101|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
162898102|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
162898103|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
162898104|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
162898105|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
162898106|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
162898107|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
162898108|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
162898109|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
162898110|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
162898111|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
162898112|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
162625193|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625194|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625195|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
162625196|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625197|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625198|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625199|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625200|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625201|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625202|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162625203|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
162625204|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
162625205|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
162625206|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
162625207|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625208|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625209|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625210|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625211|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625212|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625213|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162625214|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
162625215|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
162898113|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
162898114|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
162898115|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
162898116|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
162898117|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
162898118|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
162898119|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
162898120|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
162898121|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
162898122|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
162898123|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
162898124|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
162898125|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
162898126|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
162898127|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
162898128|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
162898129|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
162898130|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
162898131|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
162898132|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
162898133|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
162898134|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
162898135|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
162898136|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
162898137|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
162898138|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
162898139|NCT03689972|588326570|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
162898140|NCT03689972|588326571|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
162898141|NCT03689972|588326572|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
162898142|NCT03689972|588326573|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
162898143|NCT03689972|588326574|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
162898144|NCT03689972|588326570|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
162898145|NCT03689972|588326571|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163052153|NCT01573000|588900914|FG000|Crossover Phase|Lost to Follow-up|0|||
163052154|NCT01573000|588900915|FG001|Crossover Phase|Lost to Follow-up|2|||
162898146|NCT03689972|588326572|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
162898147|NCT03689972|588326573|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
162898148|NCT03689972|588326574|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
163052155|NCT01573000|588900914|FG000|Crossover Phase|Death|0|||
163052156|NCT01573000|588900915|FG001|Crossover Phase|Death|3|||
163052157|NCT01573000|588900914|FG000|Long-Term Follow-Up|Death|3|||
163052158|NCT01573000|588900915|FG001|Long-Term Follow-Up|Death|0|||
163052159|NCT01573000|588900914|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
163052160|NCT01573000|588900915|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
163052161|NCT03342001|588900921|FG000|Overall Study|Adverse Event|1|||
163052162|NCT03342001|588900921|FG000|Overall Study|Lost to Follow-up|1|||
163052163|NCT01384877|588900922|FG000|Treatment 2|Lost to Follow-up|2|||
163052164|NCT01384877|588900923|FG001|Treatment 2|Lost to Follow-up|2|||
163052165|NCT01930539|588900932|FG000|Overall Study|Withdrawal by Subject|2|||
163052166|NCT01930539|588900933|FG001|Overall Study|Withdrawal by Subject|2|||
163052167|NCT01548404|588900934|FG000|Overall Study|Adverse Event|3|||
163052168|NCT01548404|588900935|FG001|Overall Study|Adverse Event|1|||
163052169|NCT01548404|588900934|FG000|Overall Study|Physician Decision|2|||
163052170|NCT01548404|588900935|FG001|Overall Study|Physician Decision|1|||
163052171|NCT01548404|588900934|FG000|Overall Study|Inadequate response to study treatment|23|||
163052172|NCT01548404|588900935|FG001|Overall Study|Inadequate response to study treatment|7|||
163052173|NCT01548404|588900934|FG000|Overall Study|Lost to Follow-up|2|||
163052174|NCT01548404|588900935|FG001|Overall Study|Lost to Follow-up|0|||
163052175|NCT01548404|588900934|FG000|Overall Study|Withdrawal by Subject|0|||
163052176|NCT01548404|588900935|FG001|Overall Study|Withdrawal by Subject|3|||
163052177|NCT01548404|588900934|FG000|Overall Study|Other than specified above|0|||
163052178|NCT01548404|588900935|FG001|Overall Study|Other than specified above|2|||
163052179|NCT04040439|588900936|FG000|Overall Study|Invalid registration|11|||
163052180|NCT04040439|588900936|FG000|Overall Study|No IC* on publication of study results|2|||
163052181|NCT00426270|588900937|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
163052182|NCT00426270|588900937|FG000|Overall Study|Adverse Event|5|||
163052183|NCT01450813|588900938|FG000|Overall Study|Physician Decision|1|||
163052184|NCT01450813|588900939|FG001|Overall Study|Physician Decision|1|||
163052185|NCT01450813|588900940|FG002|Overall Study|Physician Decision|0|||
163052186|NCT01450813|588900941|FG003|Overall Study|Physician Decision|3|||
163052187|NCT02062437|588900944|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
163052188|NCT02062437|588900944|FG000|Overall Study|Patient not available for the 2y visit|18|||
163052189|NCT02062437|588900944|FG000|Overall Study|Death|2|||
163052190|NCT02062437|588900944|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
162625216|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
162625217|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
162898149|NCT03689972|588326570|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
162898150|NCT03689972|588326571|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
162898151|NCT03689972|588326572|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
162898152|NCT03689972|588326573|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
162898153|NCT03689972|588326574|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
162898154|NCT03689972|588326570|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
162898155|NCT03689972|588326571|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
162898156|NCT03689972|588326572|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
162898157|NCT03689972|588326573|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
162898158|NCT03689972|588326574|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
162898159|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
162898160|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
162898161|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
162898162|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
162898163|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
162898164|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
162898165|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
162898166|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
162898167|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
162898168|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
162898169|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
162898170|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
162898171|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
162898172|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
162898173|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
162898174|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
162898175|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
162898176|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
162898177|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
162898178|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
162898179|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
162898180|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
162898181|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
162898182|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
162898183|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
162898184|NCT03689972|588326570|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
162898185|NCT03689972|588326571|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
162898186|NCT03689972|588326572|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
162898187|NCT03689972|588326573|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
162625218|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162625219|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162625220|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162625221|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162898188|NCT03689972|588326574|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
162898189|NCT01131130|588326578|FG000|Period 1 - Baseline|Pregnancy|1|||
162898190|NCT01131130|588326578|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
162898191|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
162898192|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
162898193|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
162898194|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
162898195|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
162898196|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
162898197|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
162965347|NCT03499873|588573261|FG000|Overall Study|Administrative reasons|0|||
162965348|NCT03499873|588573262|FG001|Overall Study|Administrative reasons|1|||
162965349|NCT03499873|588573263|FG002|Overall Study|Administrative reasons|0|||
162965350|NCT03499873|588573261|FG000|Overall Study|Concomitant therapy|5|||
162965351|NCT03499873|588573262|FG001|Overall Study|Concomitant therapy|4|||
162965352|NCT03499873|588573263|FG002|Overall Study|Concomitant therapy|7|||
162965353|NCT03499873|588573261|FG000|Overall Study|Miscellaneous|1|||
162965354|NCT03499873|588573262|FG001|Overall Study|Miscellaneous|2|||
162965355|NCT03499873|588573263|FG002|Overall Study|Miscellaneous|2|||
162965356|NCT03499873|588573261|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
162625222|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162898198|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
162898199|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
162898200|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
162898201|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
162898202|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
162898203|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
162898204|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
162898205|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
162898206|NCT02417064|588326579|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
162898207|NCT02417064|588326580|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
162898208|NCT02417064|588326581|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
162898209|NCT02417064|588326579|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
162898210|NCT02417064|588326580|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
162898211|NCT02417064|588326581|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
162898212|NCT02417064|588326579|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
162898213|NCT02417064|588326580|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
162898214|NCT02417064|588326581|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
162898215|NCT02417064|588326579|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
162898216|NCT02417064|588326580|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
162898217|NCT02417064|588326581|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
162898218|NCT02417064|588326579|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
162898219|NCT02417064|588326580|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
162898220|NCT02417064|588326581|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
162898221|NCT02417064|588326579|FG000|Follow-up Phase (24 Weeks)|Other|2|||
162898222|NCT02417064|588326580|FG001|Follow-up Phase (24 Weeks)|Other|2|||
162898223|NCT02417064|588326581|FG002|Follow-up Phase (24 Weeks)|Other|3|||
162898224|NCT02437162|588326582|FG000|Overall Study|Protocol Violation|0|||
162965357|NCT03499873|588573262|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
162965358|NCT03499873|588573263|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
162965359|NCT04608448|588573264|FG000|Overall Study|Withdrawal by Subject|1|||
162965360|NCT04608448|588573264|FG000|Overall Study|Adverse Event|1|||
162965361|NCT01297504|588573265|FG000|Overall Study|Invalid Consent|1|||
162965362|NCT01297504|588573265|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
162965363|NCT01297504|588573265|FG000|Overall Study|No Study Visits|4|||
162965364|NCT01297504|588573265|FG000|Overall Study|Death|3|||
162965365|NCT01297504|588573265|FG000|Overall Study|Lost to Follow-up|43|||
162965366|NCT01297504|588573265|FG000|Overall Study|Withdrawal by Subject|9|||
162965367|NCT01297504|588573265|FG000|Overall Study|Site Closure|3|||
162965368|NCT01297504|588573265|FG000|Overall Study|Protocol Violation|3|||
162965369|NCT00654186|588573266|FG000|Overall Study|Withdrawal by Subject|5|||
162965370|NCT00577655|588573267|FG000|Overall Study|Patient Request|0|||
162965371|NCT00577655|588573268|FG001|Overall Study|Patient Request|2|||
162965372|NCT00577655|588573267|FG000|Overall Study|Protocol Violation|0|||
162965373|NCT00577655|588573268|FG001|Overall Study|Protocol Violation|1|||
162965374|NCT00577655|588573267|FG000|Overall Study|Lost to Follow-up|1|||
162965375|NCT00577655|588573268|FG001|Overall Study|Lost to Follow-up|1|||
162965376|NCT01370863|588573269|FG000|Overall Study|Adverse Event|1|||
162965377|NCT01370863|588573270|FG001|Overall Study|Adverse Event|1|||
162965378|NCT01370863|588573269|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
162965379|NCT01370863|588573270|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
162965380|NCT01370863|588573269|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
162965381|NCT01370863|588573270|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
162965382|NCT00881751|588573271|FG000|Overall Study|Physician Decision|0|||
162965383|NCT00881751|588573272|FG001|Overall Study|Physician Decision|1|||
162965384|NCT00881751|588573271|FG000|Overall Study|Adverse Event|0|||
162965385|NCT00881751|588573272|FG001|Overall Study|Adverse Event|2|||
162965386|NCT00881751|588573271|FG000|Overall Study|Withdrawal by Subject|0|||
162965387|NCT00881751|588573272|FG001|Overall Study|Withdrawal by Subject|2|||
162965388|NCT05004649|588573275|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
162965389|NCT05004649|588573275|FG000|Overall Study|Lost to Follow-up|1|||
162898225|NCT02437162|588326583|FG001|Overall Study|Protocol Violation|1|||
163052191|NCT00752089|588900945|FG000|Overall Study|Adverse Event|1|||
163052192|NCT00752089|588900945|FG000|Overall Study|Protocol Deviation|2|||
163052193|NCT00752089|588900945|FG000|Overall Study|Could not attend visit 9|1|||
163052194|NCT00752089|588900945|FG000|Overall Study|Not capable of wearing partial denture|1|||
163052195|NCT00752089|588900945|FG000|Overall Study|Cannot continue the study|1|||
163052196|NCT01324102|588900946|FG000|Overall Study|illness|1|||
163052197|NCT01324102|588900947|FG001|Overall Study|illness|6|||
163052198|NCT00728494|588900950|FG000|Overall Study|Adverse Event|7|||
163052199|NCT00728494|588900951|FG001|Overall Study|Adverse Event|0|||
163052200|NCT00728494|588900950|FG000|Overall Study|Withdrawal by Subject|0|||
163052201|NCT00728494|588900951|FG001|Overall Study|Withdrawal by Subject|2|||
163052202|NCT00728494|588900950|FG000|Overall Study|Lack of Efficacy|2|||
163052203|NCT00728494|588900951|FG001|Overall Study|Lack of Efficacy|4|||
163052204|NCT00728494|588900950|FG000|Overall Study|No data available|0|||
163052205|NCT00728494|588900951|FG001|Overall Study|No data available|1|||
163052206|NCT00975416|588900952|FG000|Overall Study|early discharge from tx|3|||
163052207|NCT00975416|588900953|FG001|Overall Study|early discharge from tx|5|||
163052208|NCT03426345|588900954|FG000|Overall Study|Adverse Event|4|||
163052209|NCT03426345|588900955|FG001|Overall Study|Adverse Event|4|||
163052210|NCT03426345|588900954|FG000|Overall Study|Lack of Efficacy|1|||
163052211|NCT03426345|588900955|FG001|Overall Study|Lack of Efficacy|0|||
162898226|NCT02437162|588326584|FG002|Overall Study|Protocol Violation|0|||
162898227|NCT02437162|588326582|FG000|Overall Study|Randomized but not treated|0|||
162898228|NCT02437162|588326583|FG001|Overall Study|Randomized but not treated|0|||
162898229|NCT02437162|588326584|FG002|Overall Study|Randomized but not treated|1|||
162898230|NCT02437162|588326582|FG000|Overall Study|Study discontinued by Sponsor|93|||
162898231|NCT02437162|588326583|FG001|Overall Study|Study discontinued by Sponsor|98|||
162898232|NCT02437162|588326584|FG002|Overall Study|Study discontinued by Sponsor|97|||
162898233|NCT02437162|588326582|FG000|Overall Study|Withdrawal by Subject|13|||
162898234|NCT02437162|588326583|FG001|Overall Study|Withdrawal by Subject|7|||
162898235|NCT02437162|588326584|FG002|Overall Study|Withdrawal by Subject|9|||
162898236|NCT02437162|588326582|FG000|Overall Study|Adverse Event|0|||
162898237|NCT02437162|588326583|FG001|Overall Study|Adverse Event|1|||
162898238|NCT02437162|588326584|FG002|Overall Study|Adverse Event|0|||
162898239|NCT02437162|588326582|FG000|Overall Study|Lost to Follow-up|1|||
162898240|NCT02437162|588326583|FG001|Overall Study|Lost to Follow-up|0|||
162898241|NCT02437162|588326584|FG002|Overall Study|Lost to Follow-up|1|||
162898242|NCT02437162|588326582|FG000|Overall Study|Death|0|||
162898243|NCT02437162|588326583|FG001|Overall Study|Death|1|||
162898244|NCT02437162|588326584|FG002|Overall Study|Death|0|||
162898245|NCT02437162|588326582|FG000|Overall Study|Other|0|||
162898246|NCT02437162|588326583|FG001|Overall Study|Other|0|||
162898247|NCT02437162|588326584|FG002|Overall Study|Other|1|||
162898248|NCT03981744|588326585|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
162898249|NCT03981744|588326586|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
162898250|NCT03981744|588326587|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
162898251|NCT03981744|588326588|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
162898252|NCT03981744|588326585|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
162898253|NCT03981744|588326586|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
162898254|NCT03981744|588326587|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
162898255|NCT03981744|588326588|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
163052212|NCT03426345|588900954|FG000|Overall Study|Withdrawal by Subject|5|||
163052213|NCT03426345|588900955|FG001|Overall Study|Withdrawal by Subject|6|||
163052214|NCT03426345|588900954|FG000|Overall Study|Lost to Follow-up|3|||
162708796|NCT04739423|587642900|FG003|Overall Study|Withdrawal by Subject|0|||
162898256|NCT03981744|588326585|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
162898257|NCT03981744|588326586|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
162898258|NCT03981744|588326587|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
162898259|NCT03981744|588326588|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
162898260|NCT02782104|588326589|FG000|Overall Study|Other|215|||
162898261|NCT02782104|588326589|FG000|Overall Study|Induction Day 28 Non Responder|9|||
162898262|NCT02782104|588326589|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162898263|NCT02782104|588326589|FG000|Overall Study|Death|8|||
163052215|NCT03426345|588900955|FG001|Overall Study|Lost to Follow-up|1|||
162898264|NCT02782104|588326589|FG000|Overall Study|Pregnancy|6|||
162898265|NCT02782104|588326589|FG000|Overall Study|Withdrawal by Subject|63|||
162898266|NCT02782104|588326589|FG000|Overall Study|Protocol Violation|7|||
162898267|NCT02782104|588326589|FG000|Overall Study|Lack of Efficacy|61|||
163052216|NCT03426345|588900954|FG000|Overall Study|Protocol Deviation|3|||
163052217|NCT03426345|588900955|FG001|Overall Study|Protocol Deviation|4|||
163052218|NCT03426345|588900954|FG000|Overall Study|Reason Not Specified|1|||
163052219|NCT03426345|588900955|FG001|Overall Study|Reason Not Specified|2|||
163052220|NCT03426345|588900954|FG000|Overall Study|Missing Completion Status|1|||
162898268|NCT02782104|588326589|FG000|Overall Study|Lost to Follow-up|23|||
163052221|NCT03426345|588900955|FG001|Overall Study|Missing Completion Status|0|||
163052222|NCT00192114|588900962|FG000|Overall Study|Objective Tumor Progression|19|||
162898269|NCT02782104|588326589|FG000|Overall Study|Adverse Event|74|||
162898270|NCT04338321|588326590|FG000|Overall Study|Adverse Event|4|||
162625223|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162625224|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162625225|NCT01847274|587344814|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
162625226|NCT01847274|587344815|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
162625227|NCT01847274|587344816|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
162625228|NCT01847274|587344817|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
162625229|NCT01847274|587344818|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162625230|NCT01847274|587344819|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162898271|NCT04338321|588326591|FG001|Overall Study|Adverse Event|10|||
162898272|NCT04338321|588326590|FG000|Overall Study|Death|1|||
162898273|NCT04338321|588326591|FG001|Overall Study|Death|1|||
162898274|NCT04338321|588326590|FG000|Overall Study|Lost to Follow-up|4|||
162898275|NCT04338321|588326591|FG001|Overall Study|Lost to Follow-up|9|||
162898276|NCT04338321|588326590|FG000|Overall Study|Withdrawal by Subject|45|||
162898277|NCT04338321|588326591|FG001|Overall Study|Withdrawal by Subject|69|||
162898278|NCT04338321|588326590|FG000|Overall Study|Physician Decision|5|||
162898279|NCT04338321|588326591|FG001|Overall Study|Physician Decision|9|||
162898280|NCT04338321|588326590|FG000|Overall Study|Other|3|||
162898281|NCT04338321|588326591|FG001|Overall Study|Other|10|||
162898282|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
162898283|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
162898284|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
162898285|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
162898286|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
162898287|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
162898288|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
162898289|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
162898290|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
162898291|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
162898292|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
162898293|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
162898294|NCT03321526|588326592|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
162898295|NCT03321526|588326593|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
162898296|NCT03321526|588326592|FG000|Follow-up Phase (2 Weeks)|Other|24|||
162898297|NCT03321526|588326593|FG001|Follow-up Phase (2 Weeks)|Other|24|||
162625231|NCT01847274|587344820|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162625232|NCT01847274|587344821|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162898298|NCT03097133|588326594|FG000|Overall Study|Lost to Follow-up|3|||
162898299|NCT03097133|588326595|FG001|Overall Study|Lost to Follow-up|2|||
162898300|NCT03097133|588326594|FG000|Overall Study|Withdrawal by Subject|2|||
162898301|NCT03097133|588326595|FG001|Overall Study|Withdrawal by Subject|5|||
162898302|NCT03097133|588326594|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
162898303|NCT03097133|588326595|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
162898304|NCT03097133|588326594|FG000|Overall Study|Other|3|||
162898305|NCT03097133|588326595|FG001|Overall Study|Other|2|||
162898306|NCT03097133|588326594|FG000|Overall Study|Adverse Event|1|||
162898307|NCT03097133|588326595|FG001|Overall Study|Adverse Event|0|||
162898308|NCT01989572|588326598|FG000|Overall Study|Lack of Efficacy|35|||
162898309|NCT01989572|588326599|FG001|Overall Study|Lack of Efficacy|48|||
162898310|NCT01989572|588326600|FG002|Overall Study|Lack of Efficacy|48|||
162898311|NCT01989572|588326601|FG003|Overall Study|Lack of Efficacy|43|||
162898312|NCT01989572|588326602|FG004|Overall Study|Lack of Efficacy|71|||
162898313|NCT01989572|588326603|FG005|Overall Study|Lack of Efficacy|79|||
162898314|NCT01989572|588326598|FG000|Overall Study|Adverse Event|2|||
162625233|NCT01847274|587344822|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162898315|NCT01989572|588326599|FG001|Overall Study|Adverse Event|1|||
162898316|NCT01989572|588326600|FG002|Overall Study|Adverse Event|3|||
162898317|NCT01989572|588326601|FG003|Overall Study|Adverse Event|0|||
162898318|NCT01989572|588326602|FG004|Overall Study|Adverse Event|3|||
162898319|NCT01989572|588326603|FG005|Overall Study|Adverse Event|0|||
162898320|NCT01989572|588326598|FG000|Overall Study|Death|0|||
162898321|NCT01989572|588326599|FG001|Overall Study|Death|0|||
162898322|NCT01989572|588326600|FG002|Overall Study|Death|0|||
162898323|NCT01989572|588326601|FG003|Overall Study|Death|0|||
162898324|NCT01989572|588326602|FG004|Overall Study|Death|1|||
162898325|NCT01989572|588326603|FG005|Overall Study|Death|0|||
162898326|NCT01989572|588326598|FG000|Overall Study|Withdrawal by Subject|4|||
162898327|NCT01989572|588326599|FG001|Overall Study|Withdrawal by Subject|1|||
162898328|NCT01989572|588326600|FG002|Overall Study|Withdrawal by Subject|5|||
162898329|NCT01989572|588326601|FG003|Overall Study|Withdrawal by Subject|1|||
162898330|NCT01989572|588326602|FG004|Overall Study|Withdrawal by Subject|12|||
162898331|NCT01989572|588326603|FG005|Overall Study|Withdrawal by Subject|4|||
162898332|NCT01989572|588326598|FG000|Overall Study|complicating disease|1|||
162898333|NCT01989572|588326599|FG001|Overall Study|complicating disease|1|||
162898334|NCT01989572|588326600|FG002|Overall Study|complicating disease|2|||
162898335|NCT01989572|588326601|FG003|Overall Study|complicating disease|0|||
162898336|NCT01989572|588326602|FG004|Overall Study|complicating disease|1|||
162898337|NCT01989572|588326603|FG005|Overall Study|complicating disease|0|||
162898338|NCT01989572|588326598|FG000|Overall Study|error|2|||
162898339|NCT01989572|588326599|FG001|Overall Study|error|1|||
162898340|NCT01989572|588326600|FG002|Overall Study|error|1|||
162898341|NCT01989572|588326601|FG003|Overall Study|error|1|||
162898342|NCT01989572|588326602|FG004|Overall Study|error|1|||
162898343|NCT01989572|588326603|FG005|Overall Study|error|1|||
162898344|NCT01989572|588326598|FG000|Overall Study|maximum dose reached|0|||
162898345|NCT01989572|588326599|FG001|Overall Study|maximum dose reached|1|||
162898346|NCT01989572|588326600|FG002|Overall Study|maximum dose reached|0|||
162898347|NCT01989572|588326601|FG003|Overall Study|maximum dose reached|0|||
162898348|NCT01989572|588326602|FG004|Overall Study|maximum dose reached|1|||
162898349|NCT01989572|588326603|FG005|Overall Study|maximum dose reached|0|||
162898350|NCT01989572|588326598|FG000|Overall Study|unknown/not specify|3|||
162898351|NCT01989572|588326599|FG001|Overall Study|unknown/not specify|4|||
162898352|NCT01989572|588326600|FG002|Overall Study|unknown/not specify|1|||
162898353|NCT01989572|588326601|FG003|Overall Study|unknown/not specify|3|||
162898354|NCT01989572|588326602|FG004|Overall Study|unknown/not specify|3|||
162898355|NCT01989572|588326603|FG005|Overall Study|unknown/not specify|5|||
162898356|NCT01989572|588326598|FG000|Overall Study|not start protocol therapy|5|||
162898357|NCT01989572|588326599|FG001|Overall Study|not start protocol therapy|1|||
162898358|NCT01989572|588326600|FG002|Overall Study|not start protocol therapy|2|||
162898359|NCT01989572|588326601|FG003|Overall Study|not start protocol therapy|3|||
162898360|NCT01989572|588326602|FG004|Overall Study|not start protocol therapy|4|||
162898361|NCT01989572|588326603|FG005|Overall Study|not start protocol therapy|18|||
162898362|NCT01989572|588326598|FG000|Overall Study|alternative therapy|3|||
162898363|NCT01989572|588326599|FG001|Overall Study|alternative therapy|0|||
162898364|NCT01989572|588326600|FG002|Overall Study|alternative therapy|0|||
162898365|NCT01989572|588326601|FG003|Overall Study|alternative therapy|0|||
162898366|NCT01989572|588326602|FG004|Overall Study|alternative therapy|1|||
162898367|NCT01989572|588326603|FG005|Overall Study|alternative therapy|3|||
162898368|NCT00732238|588326608|FG000|Overall Study|Bacteremia|4|||
162898369|NCT00732238|588326609|FG001|Overall Study|Bacteremia|1|||
162898370|NCT00732238|588326608|FG000|Overall Study|Asymptomatic bacteriuria|1|||
162898371|NCT00732238|588326609|FG001|Overall Study|Asymptomatic bacteriuria|0|||
162898372|NCT04159701|588326610|FG000|Period 1: Treatment Period|Pregnancy|1|||
162898373|NCT04159701|588326611|FG001|Period 1: Treatment Period|Pregnancy|0|||
162898374|NCT04159701|588326610|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
162898375|NCT04159701|588326611|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
162898376|NCT04159701|588326610|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
162898377|NCT04159701|588326611|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
162898378|NCT04159701|588326610|FG000|Washout Period|site terminated by sponsor|0|||
162898379|NCT04159701|588326611|FG001|Washout Period|site terminated by sponsor|1|||
162898380|NCT04159701|588326610|FG000|Washout Period|study terminated by sponsor|10|||
162898381|NCT04159701|588326611|FG001|Washout Period|study terminated by sponsor|3|||
162898382|NCT04159701|588326610|FG000|Washout Period|Withdrawal by Subject|1|||
162898383|NCT04159701|588326611|FG001|Washout Period|Withdrawal by Subject|0|||
162898384|NCT04159701|588326610|FG000|Washout Period|Inadvertent Enrollment|1|||
162898385|NCT04159701|588326611|FG001|Washout Period|Inadvertent Enrollment|0|||
162898386|NCT04159701|588326610|FG000|Washout Period|Miscellaneous|1|||
162898387|NCT04159701|588326611|FG001|Washout Period|Miscellaneous|0|||
162898388|NCT04159701|588326610|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
162898389|NCT04159701|588326611|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
163052223|NCT00192114|588900962|FG000|Overall Study|Adverse Event|2|||
162898390|NCT04159701|588326610|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
162898391|NCT04159701|588326611|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
162898392|NCT04159701|588326610|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
162898393|NCT04159701|588326611|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
162898394|NCT04159701|588326610|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
162898395|NCT04159701|588326611|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
162898396|NCT04159701|588326610|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
162898397|NCT04159701|588326611|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
162898398|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
162898399|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
162898400|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
162898401|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
162898402|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
162898403|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
162898404|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
162898405|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
162898406|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
162898407|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
162898408|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
162898409|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
162898410|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
162898411|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
162898412|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
162898413|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
162898414|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
162898415|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
162898416|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
162898417|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
162898418|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
162898419|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
162898420|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
162898421|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
162898422|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
162898423|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
162898424|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
162898425|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
162898426|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
162898427|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
162898428|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
162898429|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
162898430|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
162898431|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
162898432|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
162898433|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
162898434|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
162898435|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
162898436|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
162898437|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
162898438|NCT03605836|588326612|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
162898439|NCT03605836|588326613|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
162898440|NCT03605836|588326614|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
162898441|NCT03605836|588326615|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
162898442|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
162898443|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
162898444|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
162898445|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
162898446|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
162898447|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
162898448|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
162898449|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
162898450|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
162898451|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
162898452|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
162898453|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
162898454|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
162898455|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
162625234|NCT01847274|587344823|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162625235|NCT01847274|587344824|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162625236|NCT01847274|587344814|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625237|NCT01847274|587344815|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625238|NCT01847274|587344816|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625239|NCT01847274|587344817|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625240|NCT01847274|587344818|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625241|NCT01847274|587344819|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
162625242|NCT01847274|587344820|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625243|NCT01847274|587344821|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162898456|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
162898457|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
162898458|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
162898459|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
162898460|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
162898461|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
162898462|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
162898463|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
162898464|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
162898465|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
162898466|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
162898467|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
162898468|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
162898469|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
162898470|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
162898471|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
162898472|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
162898473|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
162898474|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
162898475|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
162898476|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
162898477|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
162898478|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
162898479|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
162898480|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
162898481|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
162898482|NCT03605836|588326612|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
162625244|NCT01847274|587344822|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625245|NCT01847274|587344823|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625246|NCT01847274|587344824|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162625247|NCT01847274|587344814|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625248|NCT01847274|587344815|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625249|NCT01847274|587344816|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625250|NCT01847274|587344817|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625251|NCT01847274|587344818|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
162625252|NCT01847274|587344819|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625253|NCT01847274|587344820|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625254|NCT01847274|587344821|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625255|NCT01847274|587344822|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625256|NCT01847274|587344823|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162625257|NCT01847274|587344824|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162898483|NCT03605836|588326613|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
162898484|NCT03605836|588326614|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
162898485|NCT03605836|588326615|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
162898486|NCT01782885|588326620|FG000|Overall Study|Lost to Follow-up|4|||
162898487|NCT01782885|588326621|FG001|Overall Study|Lost to Follow-up|6|||
162898488|NCT00633360|588326622|FG000|Overall Study|Lost to Follow-up|1|||
162625258|NCT01847274|587344814|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625259|NCT01847274|587344815|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162898489|NCT00633360|588326623|FG001|Overall Study|Lost to Follow-up|1|||
162898490|NCT00633360|588326622|FG000|Overall Study|Adverse Event|3|||
162898491|NCT00633360|588326623|FG001|Overall Study|Adverse Event|1|||
163052224|NCT00192114|588900962|FG000|Overall Study|Clinical Progression|2|||
163052225|NCT00192114|588900962|FG000|Overall Study|Death|1|||
163052226|NCT00492297|588900963|FG000|Treatment|Death|2|||
162898492|NCT00633360|588326622|FG000|Overall Study|Protocol Violation|0|||
162898493|NCT00633360|588326623|FG001|Overall Study|Protocol Violation|1|||
162898494|NCT00610207|588326624|FG000|Overall Study|Lost to Follow-up|3|||
162898495|NCT02348840|588326630|FG000|Overall Study|Withdrawal by Subject|2|||
162898496|NCT02348840|588326631|FG001|Overall Study|Withdrawal by Subject|1|||
162898497|NCT02348840|588326632|FG002|Overall Study|Withdrawal by Subject|0|||
162898498|NCT02348840|588326633|FG003|Overall Study|Withdrawal by Subject|0|||
162898499|NCT01025232|588326634|FG000|Overall Study|Study drug no longer available|3|||
162898500|NCT01025232|588326635|FG001|Overall Study|Study drug no longer available|6|||
162898501|NCT00373880|588326638|FG000|Overall Study|Physician Decision|3|||
162898502|NCT00373880|588326638|FG000|Overall Study|Arrested|1|||
162898503|NCT00373880|588326638|FG000|Overall Study|Protocol Violation|14|||
162898504|NCT03748420|588326639|FG000|Overall Study|No 12 month medication adherence data available|0|||
162898505|NCT03748420|588326640|FG001|Overall Study|No 12 month medication adherence data available|1|||
162898506|NCT03748420|588326639|FG000|Overall Study|Death|24|||
162898507|NCT03748420|588326640|FG001|Overall Study|Death|28|||
162898508|NCT03748420|588326639|FG000|Overall Study|Lost to Follow-up|231|||
162898509|NCT03748420|588326640|FG001|Overall Study|Lost to Follow-up|230|||
162898510|NCT01347073|588326642|FG000|Overall Study|Adverse Event|1|||
162898511|NCT01347073|588326642|FG000|Overall Study|Liver Transplant|1|||
162898512|NCT00621244|588326643|FG000|Overall Study|Withdrawal by Subject|7|||
162898513|NCT00621244|588326644|FG001|Overall Study|Withdrawal by Subject|3|||
162898514|NCT00621244|588326645|FG002|Overall Study|Withdrawal by Subject|3|||
162898515|NCT00621244|588326646|FG003|Overall Study|Withdrawal by Subject|3|||
162898516|NCT00621244|588326643|FG000|Overall Study|Disease progression|44|||
162898517|NCT00621244|588326644|FG001|Overall Study|Disease progression|20|||
162898518|NCT00621244|588326645|FG002|Overall Study|Disease progression|20|||
162898519|NCT00621244|588326646|FG003|Overall Study|Disease progression|15|||
162898520|NCT00621244|588326643|FG000|Overall Study|Death|3|||
162898521|NCT00621244|588326644|FG001|Overall Study|Death|3|||
162898522|NCT00621244|588326645|FG002|Overall Study|Death|1|||
162898523|NCT00621244|588326646|FG003|Overall Study|Death|1|||
162898524|NCT00621244|588326643|FG000|Overall Study|Adverse Event|27|||
162898525|NCT00621244|588326644|FG001|Overall Study|Adverse Event|7|||
162898526|NCT00621244|588326645|FG002|Overall Study|Adverse Event|9|||
162898527|NCT00621244|588326646|FG003|Overall Study|Adverse Event|2|||
162898528|NCT00621244|588326643|FG000|Overall Study|Administrative problems|5|||
162898529|NCT00621244|588326644|FG001|Overall Study|Administrative problems|1|||
162898530|NCT00621244|588326645|FG002|Overall Study|Administrative problems|0|||
162898531|NCT00621244|588326646|FG003|Overall Study|Administrative problems|2|||
162898532|NCT01690988|588326647|FG000|Overall Study|Withdrawal by Subject|2|||
162898533|NCT01690988|588326648|FG001|Overall Study|Withdrawal by Subject|2|||
162898534|NCT01690988|588326649|FG002|Overall Study|Withdrawal by Subject|3|||
162898535|NCT01690988|588326647|FG000|Overall Study|Physician Decision|0|||
162898536|NCT01690988|588326648|FG001|Overall Study|Physician Decision|0|||
162898537|NCT01690988|588326649|FG002|Overall Study|Physician Decision|1|||
162898538|NCT01690988|588326647|FG000|Overall Study|Operation Cancelled|1|||
162898539|NCT01690988|588326648|FG001|Overall Study|Operation Cancelled|1|||
162898540|NCT01690988|588326649|FG002|Overall Study|Operation Cancelled|0|||
162898541|NCT01690988|588326647|FG000|Overall Study|Determined ineligible|1|||
162898542|NCT01690988|588326648|FG001|Overall Study|Determined ineligible|0|||
162898543|NCT01690988|588326649|FG002|Overall Study|Determined ineligible|0|||
162898544|NCT01690988|588326647|FG000|Overall Study|Death|1|||
162898545|NCT01690988|588326648|FG001|Overall Study|Death|1|||
162898546|NCT01690988|588326649|FG002|Overall Study|Death|1|||
162898547|NCT01690988|588326647|FG000|Overall Study|Sedated|1|||
162898548|NCT01690988|588326648|FG001|Overall Study|Sedated|1|||
162898549|NCT01690988|588326649|FG002|Overall Study|Sedated|2|||
162898550|NCT00312728|588326654|FG000|Overall Study|Progressive disease|53|||
162898551|NCT00312728|588326654|FG000|Overall Study|Adverse Event|32|||
162898552|NCT00312728|588326654|FG000|Overall Study|Withdrawal by Subject|10|||
162898553|NCT00312728|588326654|FG000|Overall Study|Required non-protocol cancer treatment|2|||
162898554|NCT00312728|588326654|FG000|Overall Study|Protocol Violation|2|||
162898555|NCT00312728|588326654|FG000|Overall Study|Other|10|||
162898556|NCT00312728|588326654|FG000|Overall Study|Other|1|||
162898557|NCT03696576|588326655|FG000|Overall Study|Soreness of throat after therapy|1|||
162898558|NCT03696576|588326656|FG001|Overall Study|Soreness of throat after therapy|1|||
162898559|NCT03696576|588326655|FG000|Overall Study|Lost to Follow-up|2|||
162898560|NCT03696576|588326656|FG001|Overall Study|Lost to Follow-up|4|||
162898561|NCT01634100|588326657|FG000|Overall Study|Withdrawal by Subject|1|||
162898562|NCT01634100|588326658|FG001|Overall Study|Withdrawal by Subject|0|||
162898563|NCT01634100|588326659|FG002|Overall Study|Withdrawal by Subject|1|||
162898564|NCT01634100|588326660|FG003|Overall Study|Withdrawal by Subject|0|||
162898565|NCT01634100|588326661|FG004|Overall Study|Withdrawal by Subject|0|||
162898566|NCT01634100|588326662|FG005|Overall Study|Withdrawal by Subject|0|||
162898567|NCT00338806|588326663|FG000|Acute Phase|Withdrawal by Subject|0|||
162898568|NCT00338806|588326664|FG001|Acute Phase|Withdrawal by Subject|1|||
162898569|NCT00338806|588326663|FG000|Follow-up|Lost to Follow-up|1|||
162898570|NCT00338806|588326664|FG001|Follow-up|Lost to Follow-up|3|||
162898571|NCT00744991|588326665|FG000|Overall Study|Progressive Disease|11|||
162898572|NCT00744991|588326665|FG000|Overall Study|Withdrawal by Subject|8|||
162898573|NCT00744991|588326665|FG000|Overall Study|Physician Decision|3|||
162898574|NCT00744991|588326665|FG000|Overall Study|Adverse Event|2|||
162898575|NCT00744991|588326665|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
162965390|NCT05004649|588573275|FG000|Overall Study|Withdrawal by Subject|2|||
162965391|NCT05004649|588573275|FG000|Overall Study|COVID-19|1|||
162965392|NCT00301964|588573276|FG000|Overall Study|Second primary|2|||
162965393|NCT00301964|588573276|FG000|Overall Study|Wrong primary|1|||
162965394|NCT00301964|588573276|FG000|Overall Study|Inadequate pathology|1|||
162965395|NCT02385708|588573278|FG000|Overall Study|Withdrawal by Subject|0|||
162965396|NCT02385708|588573279|FG001|Overall Study|Withdrawal by Subject|2|||
162965397|NCT02385708|588573278|FG000|Overall Study|Withdrawn - surgery canceled|2|||
162965398|NCT02385708|588573279|FG001|Overall Study|Withdrawn - surgery canceled|5|||
162965399|NCT02385708|588573278|FG000|Overall Study|Investigator decision|5|||
162965400|NCT02385708|588573279|FG001|Overall Study|Investigator decision|7|||
162965401|NCT02385708|588573278|FG000|Overall Study|Protocol Violation|1|||
162965402|NCT02385708|588573279|FG001|Overall Study|Protocol Violation|1|||
162965403|NCT02436200|588573280|FG000|Overall Study|Significant outlier|1|||
162965404|NCT02761915|588573281|FG000|Overall Study|Death|3|||
162965405|NCT02761915|588573282|FG001|Overall Study|Death|1|||
162965406|NCT02761915|588573283|FG002|Overall Study|Death|1|||
162965407|NCT02761915|588573284|FG003|Overall Study|Death|1|||
162965408|NCT02761915|588573285|FG004|Overall Study|Death|0|||
162965409|NCT02761915|588573286|FG005|Overall Study|Death|1|||
162965410|NCT02761915|588573281|FG000|Overall Study|Withdrawal by Subject|1|||
162965411|NCT02761915|588573282|FG001|Overall Study|Withdrawal by Subject|0|||
162965412|NCT02761915|588573283|FG002|Overall Study|Withdrawal by Subject|0|||
162965413|NCT02761915|588573284|FG003|Overall Study|Withdrawal by Subject|0|||
162965414|NCT02761915|588573285|FG004|Overall Study|Withdrawal by Subject|1|||
162965415|NCT02761915|588573286|FG005|Overall Study|Withdrawal by Subject|2|||
162965416|NCT02761915|588573281|FG000|Overall Study|Disease Progression|0|||
162965417|NCT02761915|588573282|FG001|Overall Study|Disease Progression|0|||
162965418|NCT02761915|588573283|FG002|Overall Study|Disease Progression|0|||
162965419|NCT02761915|588573284|FG003|Overall Study|Disease Progression|2|||
162965420|NCT02761915|588573285|FG004|Overall Study|Disease Progression|2|||
162965421|NCT02761915|588573286|FG005|Overall Study|Disease Progression|2|||
162965422|NCT02654145|588573293|FG000|Overall Study|Lack of Efficacy|1|||
162965423|NCT02654145|588573293|FG000|Overall Study|Protocol Violation|1|||
162898576|NCT01662986|588326666|FG000|Overall Study|Adverse Event|5|||
162898577|NCT01662986|588326667|FG001|Overall Study|Adverse Event|4|||
162898578|NCT01662986|588326666|FG000|Overall Study|Protocol Violation|2|||
162898579|NCT01662986|588326667|FG001|Overall Study|Protocol Violation|3|||
162898580|NCT01662986|588326666|FG000|Overall Study|Lost to Follow-up|5|||
162898581|NCT01662986|588326667|FG001|Overall Study|Lost to Follow-up|4|||
162898582|NCT01662986|588326666|FG000|Overall Study|Withdrawal by Subject|2|||
162898583|NCT01662986|588326667|FG001|Overall Study|Withdrawal by Subject|2|||
162898584|NCT01662986|588326666|FG000|Overall Study|Not Treated|1|||
162898585|NCT01662986|588326667|FG001|Overall Study|Not Treated|0|||
162898586|NCT01662986|588326666|FG000|Overall Study|Other than stated above|3|||
162898587|NCT01662986|588326667|FG001|Overall Study|Other than stated above|0|||
162898588|NCT01594411|588326670|FG000|Overall Study|Lost to Follow-up|2|||
162965424|NCT02654145|588573293|FG000|Overall Study|Withdrawal by Subject|5|||
162965425|NCT00354835|588573294|FG000|Overall Study|Death|1|||
162965426|NCT00354835|588573295|FG001|Overall Study|Death|1|||
162965427|NCT00354835|588573294|FG000|Overall Study|Physician Decision|8|||
163052227|NCT00492297|588900963|FG000|Treatment|Study terminated by sponsor|3|||
162898589|NCT00924729|588326671|FG000|Overall Study|insufficient volume for analysis|1|||
162898590|NCT00924729|588326672|FG001|Overall Study|insufficient volume for analysis|0|||
162898591|NCT00924729|588326671|FG000|Overall Study|Protocol Violation|1|||
162898592|NCT00924729|588326672|FG001|Overall Study|Protocol Violation|0|||
162965428|NCT00354835|588573295|FG001|Overall Study|Physician Decision|13|||
162965429|NCT00354835|588573294|FG000|Overall Study|Withdrawal by Subject|2|||
162965430|NCT00354835|588573295|FG001|Overall Study|Withdrawal by Subject|1|||
162965431|NCT00354835|588573294|FG000|Overall Study|Ineligible|17|||
162965432|NCT00354835|588573295|FG001|Overall Study|Ineligible|16|||
163052228|NCT00492297|588900963|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
162625260|NCT01847274|587344816|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625261|NCT01847274|587344817|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625262|NCT01847274|587344818|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625263|NCT01847274|587344819|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625264|NCT01847274|587344820|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
162625265|NCT01847274|587344821|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625266|NCT01847274|587344822|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625267|NCT01847274|587344823|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162898593|NCT01929707|588326673|FG000|Intervention Period 1|Lost to Follow-up|0|||
162898594|NCT01929707|588326674|FG001|Intervention Period 1|Lost to Follow-up|0|||
162898595|NCT01929707|588326675|FG002|Intervention Period 1|Lost to Follow-up|0|||
162898596|NCT01929707|588326676|FG003|Intervention Period 1|Lost to Follow-up|1|||
162898597|NCT01929707|588326677|FG004|Intervention Period 1|Lost to Follow-up|0|||
162898598|NCT01929707|588326678|FG005|Intervention Period 1|Lost to Follow-up|0|||
162898599|NCT01929707|588326679|FG006|Intervention Period 1|Lost to Follow-up|0|||
162898600|NCT01929707|588326680|FG007|Intervention Period 1|Lost to Follow-up|0|||
162898601|NCT01929707|588326673|FG000|Intervention Period 1|Withdrawal by Subject|0|||
162898602|NCT01929707|588326674|FG001|Intervention Period 1|Withdrawal by Subject|0|||
162898603|NCT01929707|588326675|FG002|Intervention Period 1|Withdrawal by Subject|0|||
162898604|NCT01929707|588326676|FG003|Intervention Period 1|Withdrawal by Subject|2|||
162898605|NCT01929707|588326677|FG004|Intervention Period 1|Withdrawal by Subject|0|||
162898606|NCT01929707|588326678|FG005|Intervention Period 1|Withdrawal by Subject|0|||
162898607|NCT01929707|588326679|FG006|Intervention Period 1|Withdrawal by Subject|0|||
162898608|NCT01929707|588326680|FG007|Intervention Period 1|Withdrawal by Subject|0|||
162898609|NCT01929707|588326673|FG000|Intervention Period 2|Withdrawal by Subject|0|||
162898610|NCT01929707|588326674|FG001|Intervention Period 2|Withdrawal by Subject|0|||
162898611|NCT01929707|588326675|FG002|Intervention Period 2|Withdrawal by Subject|0|||
162898612|NCT01929707|588326676|FG003|Intervention Period 2|Withdrawal by Subject|0|||
162898613|NCT01929707|588326677|FG004|Intervention Period 2|Withdrawal by Subject|0|||
162898614|NCT01929707|588326678|FG005|Intervention Period 2|Withdrawal by Subject|2|||
162898615|NCT01929707|588326679|FG006|Intervention Period 2|Withdrawal by Subject|0|||
162898616|NCT01929707|588326680|FG007|Intervention Period 2|Withdrawal by Subject|0|||
162898617|NCT03209362|588326687|FG000|Overall Study|Adverse Event|0|||
162898618|NCT03209362|588326688|FG001|Overall Study|Adverse Event|1|||
162898619|NCT03209362|588326687|FG000|Overall Study|Lost to Follow-up|0|||
162898620|NCT03209362|588326688|FG001|Overall Study|Lost to Follow-up|1|||
162898621|NCT03209362|588326687|FG000|Overall Study|Withdrawal by Subject|2|||
162898622|NCT03209362|588326688|FG001|Overall Study|Withdrawal by Subject|0|||
162625268|NCT01847274|587344824|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162625269|NCT01847274|587344814|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625270|NCT01847274|587344815|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162898623|NCT03209362|588326687|FG000|Overall Study|Other|0|||
162898624|NCT03209362|588326688|FG001|Overall Study|Other|1|||
162898625|NCT00643448|588326693|FG000|Overall Study|Lack of Efficacy|2|||
162898626|NCT00643448|588326694|FG001|Overall Study|Lack of Efficacy|0|||
162898627|NCT00643448|588326695|FG002|Overall Study|Lack of Efficacy|4|||
162898628|NCT00643448|588326693|FG000|Overall Study|Adverse Event|2|||
162898629|NCT00643448|588326694|FG001|Overall Study|Adverse Event|2|||
162898630|NCT00643448|588326695|FG002|Overall Study|Adverse Event|2|||
162898631|NCT00643448|588326693|FG000|Overall Study|QTcF>550 ms|0|||
162898632|NCT00643448|588326694|FG001|Overall Study|QTcF>550 ms|3|||
162898633|NCT00643448|588326695|FG002|Overall Study|QTcF>550 ms|0|||
162898634|NCT00981682|588326696|FG000|Overall Study|Adverse Event|48|||
162898635|NCT00981682|588326696|FG000|Overall Study|Withdrawal by Subject|52|||
162898636|NCT00981682|588326696|FG000|Overall Study|Lost to Follow-up|14|||
162898637|NCT00981682|588326696|FG000|Overall Study|Lack of Efficacy|13|||
162898638|NCT00981682|588326696|FG000|Overall Study|Protocol Violation|6|||
162898639|NCT00981682|588326696|FG000|Overall Study|administrative|9|||
162924555|NCT02406742|588426050|FG001|Overall Study|Progression of Disease|1|||
162924556|NCT02406742|588426051|FG002|Overall Study|Progression of Disease|6|||
162924557|NCT02406742|588426049|FG000|Overall Study|Adverse Event|3|||
162924558|NCT02406742|588426050|FG001|Overall Study|Adverse Event|0|||
162924559|NCT02406742|588426051|FG002|Overall Study|Adverse Event|2|||
162924560|NCT02406742|588426049|FG000|Overall Study|Death|1|||
162924561|NCT02406742|588426050|FG001|Overall Study|Death|0|||
162924562|NCT02406742|588426051|FG002|Overall Study|Death|0|||
162924563|NCT02406742|588426049|FG000|Overall Study|Lack of Efficacy|0|||
162924564|NCT02406742|588426050|FG001|Overall Study|Lack of Efficacy|0|||
162924565|NCT02406742|588426051|FG002|Overall Study|Lack of Efficacy|1|||
162924566|NCT02406742|588426049|FG000|Overall Study|Withdrawal by Participant|1|||
162924567|NCT02406742|588426050|FG001|Overall Study|Withdrawal by Participant|2|||
162924568|NCT02406742|588426051|FG002|Overall Study|Withdrawal by Participant|0|||
162924569|NCT02406742|588426049|FG000|Overall Study|Physician Decision|1|||
162924570|NCT02406742|588426050|FG001|Overall Study|Physician Decision|2|||
162924571|NCT02406742|588426051|FG002|Overall Study|Physician Decision|1|||
162625271|NCT01847274|587344816|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625272|NCT01847274|587344817|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625273|NCT01847274|587344818|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625274|NCT01847274|587344819|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625275|NCT01847274|587344820|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
162625276|NCT01847274|587344821|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625277|NCT01847274|587344822|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625278|NCT01847274|587344823|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625279|NCT01847274|587344824|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162625280|NCT01847274|587344814|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625281|NCT01847274|587344815|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625282|NCT01847274|587344816|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625283|NCT01847274|587344817|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625284|NCT01847274|587344818|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625285|NCT01847274|587344819|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625286|NCT01847274|587344820|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
162625287|NCT01847274|587344821|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625288|NCT01847274|587344822|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625289|NCT01847274|587344823|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625290|NCT01847274|587344824|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162625291|NCT01847274|587344814|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625292|NCT01847274|587344815|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625293|NCT01847274|587344816|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625294|NCT01847274|587344817|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625295|NCT01847274|587344818|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625296|NCT01847274|587344819|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625297|NCT01847274|587344820|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162625298|NCT01847274|587344821|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
162625299|NCT01847274|587344822|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
162625300|NCT01847274|587344823|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
162625301|NCT01847274|587344824|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
162625302|NCT01847274|587344814|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625303|NCT01847274|587344815|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625304|NCT01847274|587344816|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625305|NCT01847274|587344817|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625306|NCT01847274|587344818|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625307|NCT01847274|587344819|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625308|NCT01847274|587344820|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625309|NCT01847274|587344821|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
162625310|NCT01847274|587344822|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625311|NCT01847274|587344823|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
162625312|NCT01847274|587344824|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162625313|NCT01847274|587344814|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625314|NCT01847274|587344815|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625315|NCT01847274|587344816|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625316|NCT01847274|587344817|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162898640|NCT02358863|588328666|FG000|Overall Study|Physician Decision|3|||
162898641|NCT05426460|588328671|FG000|Overall Study|Protocol Violation|1|||
162898642|NCT05426460|588328672|FG001|Overall Study|Protocol Violation|1|||
162898643|NCT05426460|588328673|FG002|Overall Study|Protocol Violation|1|||
162898644|NCT05426460|588328674|FG003|Overall Study|Protocol Violation|0|||
162898645|NCT02204410|588328675|FG000|Overall Study|Lost to Follow-up|5|||
162898646|NCT02204410|588328675|FG000|Overall Study|Physician Decision|2|||
162898647|NCT02204410|588328675|FG000|Overall Study|Protocol Violation|1|||
162898648|NCT02204410|588328675|FG000|Overall Study|Withdrawal by Subject|3|||
162898649|NCT01405027|588328678|FG000|Overall Study|Withdrawn consent|3|||
162898650|NCT01405027|588328679|FG001|Overall Study|Withdrawn consent|0|||
162898651|NCT01405027|588328678|FG000|Overall Study|Lost to Follow-up|16|||
162625317|NCT01847274|587344818|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625318|NCT01847274|587344819|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625319|NCT01847274|587344820|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625320|NCT01847274|587344821|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
162898652|NCT01405027|588328679|FG001|Overall Study|Lost to Follow-up|24|||
162898653|NCT01405027|588328678|FG000|Overall Study|Investigator judgement|0|||
162898654|NCT01405027|588328679|FG001|Overall Study|Investigator judgement|2|||
162898655|NCT01405027|588328678|FG000|Overall Study|Death|1|||
162625321|NCT01847274|587344822|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162625322|NCT01847274|587344823|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
162898656|NCT01405027|588328679|FG001|Overall Study|Death|0|||
162625323|NCT01847274|587344824|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
162625324|NCT01847274|587344814|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625325|NCT01847274|587344815|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625326|NCT01847274|587344816|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625327|NCT01847274|587344817|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625328|NCT01847274|587344818|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625329|NCT01847274|587344819|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625330|NCT01847274|587344820|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625331|NCT01847274|587344821|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625332|NCT01847274|587344822|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625333|NCT01847274|587344823|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
162625334|NCT01847274|587344824|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162625335|NCT02059395|587344826|FG000|Overall Study|Lost to Follow-up|2|||
162625336|NCT02059395|587344827|FG001|Overall Study|Lost to Follow-up|4|||
162625337|NCT00134082|587344828|FG000|Overall Study|Adverse Event|2|||
162625338|NCT00134082|587344828|FG000|Overall Study|Death|1|||
162625339|NCT00724932|587344831|FG000|Overall Study|Lost to Follow-up|1|||
162625340|NCT00724932|587344832|FG001|Overall Study|Lost to Follow-up|0|||
162625341|NCT00724932|587344831|FG000|Overall Study|Not treated|4|||
162625342|NCT00724932|587344832|FG001|Overall Study|Not treated|3|||
162898657|NCT01405027|588328678|FG000|Overall Study|Other or Unknown|12|||
162898658|NCT01405027|588328679|FG001|Overall Study|Other or Unknown|25|||
162898659|NCT02234050|588328690|FG000|Overall Study|Lack of Efficacy|38|||
162898660|NCT02234050|588328691|FG001|Overall Study|Lack of Efficacy|22|||
162898661|NCT02234050|588328690|FG000|Overall Study|Adverse Event|13|||
162898662|NCT02234050|588328691|FG001|Overall Study|Adverse Event|1|||
162898663|NCT02234050|588328690|FG000|Overall Study|Withdrawal by Subject|4|||
162898664|NCT02234050|588328691|FG001|Overall Study|Withdrawal by Subject|2|||
162898665|NCT02234050|588328690|FG000|Overall Study|Sponsor's decision|6|||
162898666|NCT02234050|588328691|FG001|Overall Study|Sponsor's decision|0|||
162898667|NCT00981292|588328695|FG000|Day 1|Protocol Violation|1|||
162898668|NCT00981292|588328696|FG001|Day 1|Protocol Violation|0|||
162898669|NCT00981292|588328697|FG002|Day 1|Protocol Violation|0|||
162898670|NCT00981292|588328698|FG003|Day 1|Protocol Violation|0|||
162898671|NCT00981292|588328699|FG004|Day 1|Protocol Violation|0|||
162898672|NCT00981292|588328700|FG005|Day 1|Protocol Violation|2|||
162898673|NCT00981292|588328695|FG000|Day 2|Protocol Violation|2|||
162898674|NCT00981292|588328696|FG001|Day 2|Protocol Violation|0|||
162898675|NCT00981292|588328697|FG002|Day 2|Protocol Violation|0|||
162898676|NCT00981292|588328698|FG003|Day 2|Protocol Violation|0|||
162898677|NCT00981292|588328699|FG004|Day 2|Protocol Violation|0|||
162898678|NCT00981292|588328700|FG005|Day 2|Protocol Violation|0|||
162898679|NCT00981292|588328695|FG000|Day 3|Protocol Violation|0|||
162898680|NCT00981292|588328696|FG001|Day 3|Protocol Violation|0|||
162898681|NCT00981292|588328697|FG002|Day 3|Protocol Violation|0|||
162898682|NCT00981292|588328698|FG003|Day 3|Protocol Violation|0|||
162898683|NCT00981292|588328699|FG004|Day 3|Protocol Violation|0|||
162898684|NCT00981292|588328700|FG005|Day 3|Protocol Violation|1|||
162898685|NCT02438787|588328701|FG000|Overall Study|Adverse Event|1|||
162898686|NCT02438787|588328702|FG001|Overall Study|Adverse Event|0|||
162898687|NCT02438787|588328703|FG002|Overall Study|Adverse Event|2|||
162625343|NCT02021331|587344833|FG000|Overall Study|Adverse Event|0|||
162625344|NCT02021331|587344834|FG001|Overall Study|Adverse Event|2|||
162625345|NCT01488370|587344835|FG000|Overall Study|Protocol Violation|0|||
162898688|NCT02438787|588328701|FG000|Overall Study|Lack of Efficacy|1|||
162898689|NCT02438787|588328702|FG001|Overall Study|Lack of Efficacy|2|||
162898690|NCT02438787|588328703|FG002|Overall Study|Lack of Efficacy|0|||
162898691|NCT02438787|588328701|FG000|Overall Study|Lost to Follow-up|0|||
162898692|NCT02438787|588328702|FG001|Overall Study|Lost to Follow-up|1|||
162898693|NCT02438787|588328703|FG002|Overall Study|Lost to Follow-up|0|||
162898694|NCT02438787|588328701|FG000|Overall Study|Protocol Violation|0|||
162898695|NCT02438787|588328702|FG001|Overall Study|Protocol Violation|0|||
162898696|NCT02438787|588328703|FG002|Overall Study|Protocol Violation|1|||
162898697|NCT02438787|588328701|FG000|Overall Study|Withdrawal by Subject|15|||
162898698|NCT02438787|588328702|FG001|Overall Study|Withdrawal by Subject|7|||
162898699|NCT02438787|588328703|FG002|Overall Study|Withdrawal by Subject|10|||
162898700|NCT02438787|588328701|FG000|Overall Study|Study discontinued by sponsor|64|||
162898701|NCT02438787|588328702|FG001|Overall Study|Study discontinued by sponsor|72|||
162898702|NCT02438787|588328703|FG002|Overall Study|Study discontinued by sponsor|69|||
162898703|NCT02438787|588328701|FG000|Overall Study|Other|0|||
162898704|NCT02438787|588328702|FG001|Overall Study|Other|1|||
162898705|NCT02438787|588328703|FG002|Overall Study|Other|0|||
162898706|NCT02438787|588328701|FG000|Overall Study|Site terminated by sponsor|0|||
162898707|NCT02438787|588328702|FG001|Overall Study|Site terminated by sponsor|0|||
162898708|NCT02438787|588328703|FG002|Overall Study|Site terminated by sponsor|1|||
162898709|NCT03412565|588328704|FG000|Overall Study|Lost to Follow-up|0|||
162898710|NCT03412565|588328705|FG001|Overall Study|Lost to Follow-up|0|||
162898711|NCT03412565|588328706|FG002|Overall Study|Lost to Follow-up|1|||
162898712|NCT03412565|588328707|FG003|Overall Study|Lost to Follow-up|0|||
162898713|NCT03412565|588328704|FG000|Overall Study|Physician Decision|0|||
162898714|NCT03412565|588328705|FG001|Overall Study|Physician Decision|0|||
162898715|NCT03412565|588328706|FG002|Overall Study|Physician Decision|0|||
162898716|NCT03412565|588328707|FG003|Overall Study|Physician Decision|1|||
162898717|NCT03412565|588328704|FG000|Overall Study|Withdrawal by Subject|0|||
162898718|NCT03412565|588328705|FG001|Overall Study|Withdrawal by Subject|4|||
162898719|NCT03412565|588328706|FG002|Overall Study|Withdrawal by Subject|5|||
162898720|NCT03412565|588328707|FG003|Overall Study|Withdrawal by Subject|5|||
162898721|NCT03412565|588328704|FG000|Overall Study|Death|1|||
162898722|NCT03412565|588328705|FG001|Overall Study|Death|3|||
162898723|NCT03412565|588328706|FG002|Overall Study|Death|4|||
162898724|NCT03412565|588328707|FG003|Overall Study|Death|5|||
162898725|NCT03412565|588328704|FG000|Overall Study|Data collection ended|0|||
162898726|NCT03412565|588328705|FG001|Overall Study|Data collection ended|41|||
162898727|NCT03412565|588328706|FG002|Overall Study|Data collection ended|41|||
162898728|NCT03412565|588328707|FG003|Overall Study|Data collection ended|40|||
162898729|NCT02280096|588328708|FG000|Overall Study|Pregnancy|1|||
162898730|NCT02280096|588328709|FG001|Overall Study|Pregnancy|0|||
162898731|NCT02280096|588328708|FG000|Overall Study|Functional neurological disorder|1|||
162898732|NCT02280096|588328709|FG001|Overall Study|Functional neurological disorder|0|||
162898733|NCT02280096|588328708|FG000|Overall Study|Lack of attachment|0|||
162898734|NCT02280096|588328709|FG001|Overall Study|Lack of attachment|1|||
162898735|NCT00246376|588328714|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
162898736|NCT00246376|588328715|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
162898737|NCT00246376|588328716|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
162898738|NCT00246376|588328717|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
162898739|NCT00246376|588328718|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
162898740|NCT00246376|588328714|FG000|Overall Study|Adverse Event|2|||
162898741|NCT00246376|588328715|FG001|Overall Study|Adverse Event|3|||
162898742|NCT00246376|588328716|FG002|Overall Study|Adverse Event|1|||
162898743|NCT00246376|588328717|FG003|Overall Study|Adverse Event|3|||
162898744|NCT00246376|588328718|FG004|Overall Study|Adverse Event|1|||
162625346|NCT01488370|587344836|FG001|Overall Study|Protocol Violation|1|||
162625347|NCT01488370|587344837|FG002|Overall Study|Protocol Violation|1|||
162625348|NCT00288054|587344843|FG000|Overall Study|Protocol Violation|2|||
162625349|NCT00288054|587344843|FG000|Overall Study|Lack of Efficacy|16|||
162625350|NCT00288054|587344843|FG000|Overall Study|Adverse Event|3|||
162625351|NCT00288054|587344843|FG000|Overall Study|Withdrawal by Subject|1|||
162625352|NCT00288054|587344843|FG000|Overall Study|Not protocol specified|2|||
162625353|NCT02340975|587344857|FG000|Overall Study|Death|6|||
162625354|NCT02340975|587344858|FG001|Overall Study|Death|23|||
162625355|NCT02340975|587344859|FG002|Overall Study|Death|21|||
162625356|NCT02340975|587344860|FG003|Overall Study|Death|7|||
162625357|NCT02340975|587344861|FG004|Overall Study|Death|21|||
162625358|NCT02340975|587344862|FG005|Overall Study|Death|13|||
162625359|NCT02340975|587344857|FG000|Overall Study|Lost to Follow-up|0|||
162898745|NCT00246376|588328714|FG000|Overall Study|Lost to Follow-up|2|||
162898746|NCT00246376|588328715|FG001|Overall Study|Lost to Follow-up|11|||
162898747|NCT00246376|588328716|FG002|Overall Study|Lost to Follow-up|11|||
162898748|NCT00246376|588328717|FG003|Overall Study|Lost to Follow-up|16|||
162898749|NCT00246376|588328718|FG004|Overall Study|Lost to Follow-up|13|||
162898750|NCT01872897|588328723|FG000|Overall Study|Withdrawal by Subject|1|||
162898751|NCT01872897|588328724|FG001|Overall Study|Withdrawal by Subject|0|||
162898752|NCT01849562|588328732|FG000|Overall Study|Lost to Follow-up|1|||
162898753|NCT01849562|588328733|FG001|Overall Study|Lost to Follow-up|0|||
162898754|NCT01849562|588328734|FG002|Overall Study|Lost to Follow-up|0|||
162898755|NCT01849562|588328732|FG000|Overall Study|Non-compliance with Study Drug|1|||
162898756|NCT01849562|588328733|FG001|Overall Study|Non-compliance with Study Drug|0|||
162898757|NCT01849562|588328734|FG002|Overall Study|Non-compliance with Study Drug|0|||
162898758|NCT00693693|588328738|FG000|Overall Study|Lost to Follow-up|1|||
162898759|NCT00693693|588328739|FG001|Overall Study|Lost to Follow-up|1|||
162898760|NCT00693693|588328740|FG002|Overall Study|Lost to Follow-up|2|||
162625360|NCT02340975|587344858|FG001|Overall Study|Lost to Follow-up|0|||
162898761|NCT04599972|588328741|FG000|Overall Study|Withdrawal by Subject|6|||
162625361|NCT02340975|587344859|FG002|Overall Study|Lost to Follow-up|0|||
162625362|NCT02340975|587344860|FG003|Overall Study|Lost to Follow-up|0|||
162898762|NCT04599972|588328742|FG001|Overall Study|Withdrawal by Subject|1|||
162898763|NCT04599972|588328741|FG000|Overall Study|Adverse Event|1|||
162625363|NCT02340975|587344861|FG004|Overall Study|Lost to Follow-up|2|||
162898764|NCT04599972|588328742|FG001|Overall Study|Adverse Event|1|||
162898765|NCT04599972|588328741|FG000|Overall Study|Lost to Follow-up|1|||
162898766|NCT04599972|588328742|FG001|Overall Study|Lost to Follow-up|6|||
162898767|NCT04599972|588328741|FG000|Overall Study|Protocol Violation|1|||
162625364|NCT02340975|587344862|FG005|Overall Study|Lost to Follow-up|0|||
162625365|NCT02340975|587344857|FG000|Overall Study|Withdrawal by Subject|0|||
162898768|NCT04599972|588328742|FG001|Overall Study|Protocol Violation|0|||
162898769|NCT04599972|588328741|FG000|Overall Study|Other reason|1|||
162898770|NCT04599972|588328742|FG001|Overall Study|Other reason|0|||
162898771|NCT01975376|588328752|FG000|Overall Study|Adverse Event|5|||
162898772|NCT01975376|588328753|FG001|Overall Study|Adverse Event|5|||
162898773|NCT01975376|588328752|FG000|Overall Study|Death|65|||
162898774|NCT01975376|588328753|FG001|Overall Study|Death|72|||
162898775|NCT01975376|588328752|FG000|Overall Study|Lost to Follow-up|70|||
162898776|NCT01975376|588328753|FG001|Overall Study|Lost to Follow-up|66|||
162898777|NCT01975376|588328752|FG000|Overall Study|Withdrew consent|68|||
162898778|NCT01975376|588328753|FG001|Overall Study|Withdrew consent|62|||
162898779|NCT01975376|588328752|FG000|Overall Study|Other|2|||
162898780|NCT01975376|588328753|FG001|Overall Study|Other|4|||
162898781|NCT01975376|588328752|FG000|Overall Study|Randomized, Not Treated|16|||
162898782|NCT01975376|588328753|FG001|Overall Study|Randomized, Not Treated|8|||
162898783|NCT01451398|588328757|FG000|Overall Study|Adverse Event|7|||
162898784|NCT01451398|588328758|FG001|Overall Study|Adverse Event|9|||
162898785|NCT01451398|588328757|FG000|Overall Study|Protocol Violation|1|||
162898786|NCT01451398|588328758|FG001|Overall Study|Protocol Violation|2|||
162898787|NCT01451398|588328757|FG000|Overall Study|Physician Decision|1|||
162898788|NCT01451398|588328758|FG001|Overall Study|Physician Decision|1|||
162898789|NCT01451398|588328757|FG000|Overall Study|Withdrawal by Subject|10|||
162898790|NCT01451398|588328758|FG001|Overall Study|Withdrawal by Subject|14|||
162898791|NCT01451398|588328757|FG000|Overall Study|Lost to Follow-up|6|||
162898792|NCT01451398|588328758|FG001|Overall Study|Lost to Follow-up|4|||
162898793|NCT01451398|588328757|FG000|Overall Study|Non-compliance with study drug|1|||
162898794|NCT01451398|588328758|FG001|Overall Study|Non-compliance with study drug|3|||
162898795|NCT01451398|588328757|FG000|Overall Study|Non-compliance with protocol|1|||
162898796|NCT01451398|588328758|FG001|Overall Study|Non-compliance with protocol|1|||
162898797|NCT01451398|588328757|FG000|Overall Study|Moved out of country|0|||
162898798|NCT01451398|588328758|FG001|Overall Study|Moved out of country|1|||
162898799|NCT01451398|588328757|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
162625366|NCT02340975|587344858|FG001|Overall Study|Withdrawal by Subject|0|||
162625367|NCT02340975|587344859|FG002|Overall Study|Withdrawal by Subject|3|||
162625368|NCT02340975|587344860|FG003|Overall Study|Withdrawal by Subject|3|||
162625369|NCT02340975|587344861|FG004|Overall Study|Withdrawal by Subject|2|||
162898800|NCT01451398|588328758|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
162898801|NCT01451398|588328757|FG000|Overall Study|Lack of Efficacy|0|||
162625370|NCT02340975|587344862|FG005|Overall Study|Withdrawal by Subject|0|||
162625371|NCT02340975|587344857|FG000|Overall Study|Other|0|||
162898802|NCT01451398|588328758|FG001|Overall Study|Lack of Efficacy|1|||
162898803|NCT04449276|588328759|FG000|Overall Study|Adverse Event|1|||
162898804|NCT04449276|588328760|FG001|Overall Study|Adverse Event|2|||
162898805|NCT04449276|588328761|FG002|Overall Study|Adverse Event|0|||
162898806|NCT04449276|588328762|FG003|Overall Study|Adverse Event|0|||
162898807|NCT04449276|588328763|FG004|Overall Study|Adverse Event|2|||
162898808|NCT04449276|588328764|FG005|Overall Study|Adverse Event|0|||
162898809|NCT04449276|588328765|FG006|Overall Study|Adverse Event|0|||
162898810|NCT04449276|588328766|FG007|Overall Study|Adverse Event|1|||
162898811|NCT04449276|588328759|FG000|Overall Study|Withdrawal by Subject|2|||
162898812|NCT04449276|588328760|FG001|Overall Study|Withdrawal by Subject|0|||
162898813|NCT04449276|588328761|FG002|Overall Study|Withdrawal by Subject|0|||
162898814|NCT04449276|588328762|FG003|Overall Study|Withdrawal by Subject|1|||
162898815|NCT04449276|588328763|FG004|Overall Study|Withdrawal by Subject|0|||
162898816|NCT04449276|588328764|FG005|Overall Study|Withdrawal by Subject|0|||
162898817|NCT04449276|588328765|FG006|Overall Study|Withdrawal by Subject|0|||
162898818|NCT04449276|588328766|FG007|Overall Study|Withdrawal by Subject|0|||
162625372|NCT02340975|587344858|FG001|Overall Study|Other|4|||
162625373|NCT02340975|587344859|FG002|Overall Study|Other|0|||
162898819|NCT04449276|588328759|FG000|Overall Study|Other|0|||
162898820|NCT04449276|588328760|FG001|Overall Study|Other|2|||
162898821|NCT04449276|588328761|FG002|Overall Study|Other|3|||
162898822|NCT04449276|588328762|FG003|Overall Study|Other|2|||
162898823|NCT04449276|588328763|FG004|Overall Study|Other|0|||
162898824|NCT04449276|588328764|FG005|Overall Study|Other|0|||
162898825|NCT04449276|588328765|FG006|Overall Study|Other|0|||
162898826|NCT04449276|588328766|FG007|Overall Study|Other|1|||
162898827|NCT01614795|588328767|FG000|Overall Study|Adverse Event|0|||
162898828|NCT01614795|588328768|FG001|Overall Study|Adverse Event|0|||
162898829|NCT01614795|588328769|FG002|Overall Study|Adverse Event|1|||
162898830|NCT01614795|588328770|FG003|Overall Study|Adverse Event|1|||
162898831|NCT01614795|588328767|FG000|Overall Study|Lack of Efficacy|10|||
162898832|NCT01614795|588328768|FG001|Overall Study|Lack of Efficacy|10|||
162898833|NCT01614795|588328769|FG002|Overall Study|Lack of Efficacy|9|||
162898834|NCT01614795|588328770|FG003|Overall Study|Lack of Efficacy|8|||
162625374|NCT02340975|587344860|FG003|Overall Study|Other|2|||
162898835|NCT01614795|588328767|FG000|Overall Study|Physician Decision|1|||
162898836|NCT01614795|588328768|FG001|Overall Study|Physician Decision|0|||
162898837|NCT01614795|588328769|FG002|Overall Study|Physician Decision|1|||
162898838|NCT01614795|588328770|FG003|Overall Study|Physician Decision|1|||
162625375|NCT02340975|587344861|FG004|Overall Study|Other|0|||
162625376|NCT02340975|587344862|FG005|Overall Study|Other|6|||
162625377|NCT01007812|587344865|FG000|Period 1, One Week|Lost to Follow-up|0|||
162625378|NCT01007812|587344866|FG001|Period 1, One Week|Lost to Follow-up|1|||
162625379|NCT01007812|587344865|FG000|Period 1, One Week|Discomfort|1|||
162625380|NCT01007812|587344866|FG001|Period 1, One Week|Discomfort|0|||
163052229|NCT00492297|588900963|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
163052230|NCT00492297|588900963|FG000|Survival Only Follow-up|Death|46|||
163052231|NCT00492297|588900963|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
163052232|NCT00492297|588900963|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
163052233|NCT03885908|588900964|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
163052234|NCT03885908|588900965|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
163052235|NCT03885908|588900964|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
163052236|NCT03885908|588900965|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
163052237|NCT03885908|588900964|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
162625381|NCT01091974|587344867|FG000|Overall Study|Did not start intervention|3|||
162625382|NCT01091974|587344868|FG001|Overall Study|Did not start intervention|1|||
162625383|NCT01091974|587344869|FG002|Overall Study|Did not start intervention|3|||
162625384|NCT01091974|587344870|FG003|Overall Study|Did not start intervention|1|||
162625385|NCT01091974|587344867|FG000|Overall Study|resumed sleep medication|0|||
162625386|NCT01091974|587344868|FG001|Overall Study|resumed sleep medication|0|||
162625387|NCT01091974|587344869|FG002|Overall Study|resumed sleep medication|1|||
162625388|NCT01091974|587344870|FG003|Overall Study|resumed sleep medication|2|||
162898839|NCT01614795|588328767|FG000|Overall Study|Withdrawal by Subject|0|||
162898840|NCT01614795|588328768|FG001|Overall Study|Withdrawal by Subject|1|||
162898841|NCT01614795|588328769|FG002|Overall Study|Withdrawal by Subject|0|||
162898842|NCT01614795|588328770|FG003|Overall Study|Withdrawal by Subject|2|||
162898843|NCT01614795|588328767|FG000|Overall Study|Ineligible|0|||
162898844|NCT01614795|588328768|FG001|Overall Study|Ineligible|1|||
162898845|NCT01614795|588328769|FG002|Overall Study|Ineligible|0|||
162898846|NCT01614795|588328770|FG003|Overall Study|Ineligible|0|||
162898847|NCT00701103|588328771|FG000|Overall Study|Adverse Event|0|||
162898848|NCT00701103|588328772|FG001|Overall Study|Adverse Event|0|||
162898849|NCT00701103|588328773|FG002|Overall Study|Adverse Event|1|||
163052238|NCT03885908|588900965|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
163052239|NCT03885908|588900964|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
163052240|NCT03885908|588900965|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
163052241|NCT01900444|588900975|FG000|Overall Study|Protocol Violation|2|||
163052242|NCT01900444|588900975|FG000|Overall Study|Lost to Follow-up|1|||
162625389|NCT01091974|587344867|FG000|Overall Study|Withdrawal by Subject|1|||
162625390|NCT01091974|587344868|FG001|Overall Study|Withdrawal by Subject|3|||
162625391|NCT01091974|587344869|FG002|Overall Study|Withdrawal by Subject|2|||
162625392|NCT01091974|587344870|FG003|Overall Study|Withdrawal by Subject|2|||
162625393|NCT01091974|587344867|FG000|Overall Study|side-effects|1|||
162625394|NCT01091974|587344868|FG001|Overall Study|side-effects|1|||
162625395|NCT01091974|587344869|FG002|Overall Study|side-effects|0|||
162625396|NCT01091974|587344870|FG003|Overall Study|side-effects|2|||
163052243|NCT00072384|588900976|FG000|Overall Study|Physician Decision|1|||
163052244|NCT00072384|588900976|FG000|Overall Study|Ineligible|8|||
162625397|NCT03948581|587344871|FG000|Overall Study|Lost to Follow-up|0|||
162625398|NCT03948581|587344872|FG001|Overall Study|Lost to Follow-up|1|||
162625399|NCT03173313|587344873|FG000|Overall Study|Lost to Follow-up|2|||
162625400|NCT03173313|587344874|FG001|Overall Study|Lost to Follow-up|3|||
162625401|NCT03173313|587344873|FG000|Overall Study|Withdrawal by Subject|0|||
162625402|NCT03173313|587344874|FG001|Overall Study|Withdrawal by Subject|1|||
162625403|NCT03173313|587344873|FG000|Overall Study|Death|5|||
162625404|NCT03173313|587344874|FG001|Overall Study|Death|0|||
162625405|NCT03173313|587344873|FG000|Overall Study|Physician Decision|1|||
162625406|NCT03173313|587344874|FG001|Overall Study|Physician Decision|0|||
162898850|NCT00701103|588328774|FG003|Overall Study|Adverse Event|1|||
162625407|NCT03173313|587344873|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
162625408|NCT03173313|587344874|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
162625409|NCT03173313|587344873|FG000|Overall Study|Bone Fracture|1|||
162625410|NCT03173313|587344874|FG001|Overall Study|Bone Fracture|0|||
162898851|NCT00701103|588328775|FG004|Overall Study|Adverse Event|0|||
162898852|NCT00701103|588328776|FG005|Overall Study|Adverse Event|1|||
162898853|NCT00701103|588328777|FG006|Overall Study|Adverse Event|1|||
162898854|NCT00701103|588328778|FG007|Overall Study|Adverse Event|0|||
162625411|NCT01876420|587344875|FG000|Overall Study|Missed 30 day visit|1|||
162625412|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
162625413|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
162708797|NCT04739423|587642901|FG004|Overall Study|Withdrawal by Subject|0|||
162898855|NCT00701103|588328779|FG008|Overall Study|Adverse Event|0|||
162898856|NCT00701103|588328780|FG009|Overall Study|Adverse Event|2|||
162898857|NCT00701103|588328781|FG010|Overall Study|Adverse Event|0|||
162898858|NCT00701103|588328771|FG000|Overall Study|Progressive Disease|5|||
162898859|NCT00701103|588328772|FG001|Overall Study|Progressive Disease|2|||
162898860|NCT00701103|588328773|FG002|Overall Study|Progressive Disease|6|||
162898861|NCT00701103|588328774|FG003|Overall Study|Progressive Disease|5|||
162898862|NCT00701103|588328775|FG004|Overall Study|Progressive Disease|6|||
162898863|NCT00701103|588328776|FG005|Overall Study|Progressive Disease|5|||
162898864|NCT00701103|588328777|FG006|Overall Study|Progressive Disease|7|||
162898865|NCT00701103|588328778|FG007|Overall Study|Progressive Disease|7|||
162898866|NCT00701103|588328779|FG008|Overall Study|Progressive Disease|8|||
162898867|NCT00701103|588328780|FG009|Overall Study|Progressive Disease|8|||
162898868|NCT00701103|588328781|FG010|Overall Study|Progressive Disease|11|||
162898869|NCT00701103|588328771|FG000|Overall Study|Withdrawal by Subject|0|||
162898870|NCT00701103|588328772|FG001|Overall Study|Withdrawal by Subject|1|||
162898871|NCT00701103|588328773|FG002|Overall Study|Withdrawal by Subject|1|||
162898872|NCT00701103|588328774|FG003|Overall Study|Withdrawal by Subject|0|||
162898873|NCT00701103|588328775|FG004|Overall Study|Withdrawal by Subject|0|||
162898874|NCT00701103|588328776|FG005|Overall Study|Withdrawal by Subject|0|||
162898875|NCT00701103|588328777|FG006|Overall Study|Withdrawal by Subject|0|||
162898876|NCT00701103|588328778|FG007|Overall Study|Withdrawal by Subject|0|||
162898877|NCT00701103|588328779|FG008|Overall Study|Withdrawal by Subject|0|||
162898878|NCT00701103|588328780|FG009|Overall Study|Withdrawal by Subject|0|||
162898879|NCT00701103|588328781|FG010|Overall Study|Withdrawal by Subject|0|||
162898880|NCT00701103|588328771|FG000|Overall Study|Other|0|||
162898881|NCT00701103|588328772|FG001|Overall Study|Other|0|||
162898882|NCT00701103|588328773|FG002|Overall Study|Other|0|||
162898883|NCT00701103|588328774|FG003|Overall Study|Other|0|||
162898884|NCT00701103|588328775|FG004|Overall Study|Other|0|||
162898885|NCT00701103|588328776|FG005|Overall Study|Other|0|||
162898886|NCT00701103|588328777|FG006|Overall Study|Other|0|||
162898887|NCT00701103|588328778|FG007|Overall Study|Other|0|||
162898888|NCT00701103|588328779|FG008|Overall Study|Other|1|||
162898889|NCT00701103|588328780|FG009|Overall Study|Other|1|||
162898890|NCT00701103|588328781|FG010|Overall Study|Other|0|||
162898891|NCT00179517|588328782|FG000|Overall Study|Withdrawal by Subject|2|||
162898892|NCT00179517|588328783|FG001|Overall Study|Withdrawal by Subject|1|||
162898893|NCT01915095|588328784|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
162898894|NCT01915095|588328785|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
162898895|NCT01915095|588328786|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
162898896|NCT01915095|588328787|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
162898897|NCT01915095|588328788|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
162898898|NCT02067533|588328789|FG000|Overall Study|Lost to Follow-up|4|||
162898899|NCT02067533|588328790|FG001|Overall Study|Lost to Follow-up|2|||
162898900|NCT00565812|588328791|FG000|Overall Study|Death|2|||
162898901|NCT00565812|588328792|FG001|Overall Study|Death|1|||
162898902|NCT00565812|588328793|FG002|Overall Study|Death|3|||
162898903|NCT00565812|588328791|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
162898904|NCT00565812|588328792|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
162898905|NCT00565812|588328793|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
162898906|NCT00565812|588328791|FG000|Overall Study|Lost to Follow-up|10|||
162898907|NCT00565812|588328792|FG001|Overall Study|Lost to Follow-up|8|||
162898908|NCT00565812|588328793|FG002|Overall Study|Lost to Follow-up|8|||
162898909|NCT00565812|588328791|FG000|Overall Study|Withdrawal by Subject|58|||
162898910|NCT00565812|588328792|FG001|Overall Study|Withdrawal by Subject|47|||
162898911|NCT00565812|588328793|FG002|Overall Study|Withdrawal by Subject|48|||
162898912|NCT00565812|588328791|FG000|Overall Study|Work Schedule|5|||
162898913|NCT00565812|588328792|FG001|Overall Study|Work Schedule|3|||
162898914|NCT00565812|588328793|FG002|Overall Study|Work Schedule|1|||
162898915|NCT00565812|588328791|FG000|Overall Study|Protocol Violation|2|||
162898916|NCT00565812|588328792|FG001|Overall Study|Protocol Violation|6|||
162898917|NCT00565812|588328793|FG002|Overall Study|Protocol Violation|4|||
162898918|NCT00565812|588328791|FG000|Overall Study|Adverse Event|41|||
162898919|NCT00565812|588328792|FG001|Overall Study|Adverse Event|54|||
162898920|NCT00565812|588328793|FG002|Overall Study|Adverse Event|40|||
162898921|NCT00565812|588328791|FG000|Overall Study|Jury Duty|1|||
162898922|NCT00565812|588328792|FG001|Overall Study|Jury Duty|0|||
162965433|NCT00354835|588573294|FG000|Overall Study|Disease progression or relapse|15|||
162898923|NCT00565812|588328793|FG002|Overall Study|Jury Duty|0|||
162898924|NCT00565812|588328791|FG000|Overall Study|Relocated Out of Area|5|||
162898925|NCT00565812|588328792|FG001|Overall Study|Relocated Out of Area|8|||
162898926|NCT00565812|588328793|FG002|Overall Study|Relocated Out of Area|9|||
162898927|NCT00565812|588328791|FG000|Overall Study|Sponsor Decision|1|||
162898928|NCT00565812|588328792|FG001|Overall Study|Sponsor Decision|5|||
162625414|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
162625415|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
162625416|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
162625417|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162625418|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
162898929|NCT00565812|588328793|FG002|Overall Study|Sponsor Decision|1|||
162898930|NCT00565812|588328791|FG000|Overall Study|Domestic Reasons|7|||
162898931|NCT00565812|588328792|FG001|Overall Study|Domestic Reasons|1|||
162898932|NCT00565812|588328793|FG002|Overall Study|Domestic Reasons|3|||
162898933|NCT00565812|588328791|FG000|Overall Study|Research Site Closure|6|||
162898934|NCT00565812|588328792|FG001|Overall Study|Research Site Closure|1|||
162898935|NCT00565812|588328793|FG002|Overall Study|Research Site Closure|8|||
162898936|NCT00565812|588328791|FG000|Overall Study|Surgical Intervention|0|||
162898937|NCT00565812|588328792|FG001|Overall Study|Surgical Intervention|1|||
162898938|NCT00565812|588328793|FG002|Overall Study|Surgical Intervention|2|||
162898939|NCT00565812|588328791|FG000|Overall Study|Low Compliance|1|||
162898940|NCT00565812|588328792|FG001|Overall Study|Low Compliance|0|||
162898941|NCT00565812|588328793|FG002|Overall Study|Low Compliance|1|||
162898942|NCT00565812|588328791|FG000|Overall Study|Follow-up Visit Not Completed|2|||
162898943|NCT00565812|588328792|FG001|Overall Study|Follow-up Visit Not Completed|0|||
162898944|NCT00565812|588328793|FG002|Overall Study|Follow-up Visit Not Completed|1|||
162898945|NCT00565812|588328791|FG000|Overall Study|Physician Decision|2|||
162898946|NCT00565812|588328792|FG001|Overall Study|Physician Decision|0|||
162898947|NCT00565812|588328793|FG002|Overall Study|Physician Decision|0|||
162898948|NCT02896192|588328801|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
162898949|NCT02896192|588328801|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
162898950|NCT02896192|588328801|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
162898951|NCT03215667|588328806|FG000|Overall Study|Physician Decision|4|||
162898952|NCT01997281|588328807|FG000|Overall Study|Withdrawal by Subject|1|||
162898953|NCT01997281|588328808|FG001|Overall Study|Withdrawal by Subject|0|||
162898954|NCT00333970|588328810|FG000|Overall Study|Withdrawal by Subject|13|||
162898955|NCT00333970|588328811|FG001|Overall Study|Withdrawal by Subject|7|||
162898956|NCT00614991|588328812|FG000|Overall Study|Adverse Event|3|||
162898957|NCT00614991|588328813|FG001|Overall Study|Adverse Event|3|||
162898958|NCT00614991|588328814|FG002|Overall Study|Adverse Event|0|||
162898959|NCT00614991|588328815|FG003|Overall Study|Adverse Event|0|||
162898960|NCT00614991|588328816|FG004|Overall Study|Adverse Event|1|||
162898961|NCT00614991|588328817|FG005|Overall Study|Adverse Event|0|||
162898962|NCT04857892|588328818|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
162898963|NCT04857892|588328819|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
162898964|NCT04857892|588328820|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
162898965|NCT04857892|588328821|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
162898966|NCT04857892|588328822|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
162898967|NCT04857892|588328818|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
162898968|NCT04857892|588328819|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
162898969|NCT04857892|588328820|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
162898970|NCT04857892|588328821|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
162898971|NCT04857892|588328822|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
162898972|NCT04857892|588328818|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
162898973|NCT04857892|588328819|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
162898974|NCT04857892|588328820|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
162625419|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
162625420|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162625421|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162625422|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
162625423|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
162625424|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
162625425|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
162898975|NCT04857892|588328821|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
162898976|NCT04857892|588328822|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
162898977|NCT00899678|588328823|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
162898978|NCT00899678|588328824|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
162898979|NCT00899678|588328825|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
162898980|NCT00899678|588328823|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
162898981|NCT00899678|588328824|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
162898982|NCT00899678|588328825|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
162898983|NCT00899678|588328823|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
162898984|NCT00899678|588328824|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
162898985|NCT00899678|588328825|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
162898986|NCT00899678|588328823|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
162898987|NCT00899678|588328824|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
162898988|NCT00899678|588328825|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
162898989|NCT00899678|588328823|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
162898990|NCT00899678|588328824|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
162898991|NCT00899678|588328825|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
162898992|NCT00899678|588328823|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
162898993|NCT00899678|588328824|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
162898994|NCT00899678|588328825|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
162898995|NCT00899678|588328823|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
162898996|NCT00899678|588328824|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
162898997|NCT00899678|588328825|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
162898998|NCT00899678|588328823|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
162898999|NCT00899678|588328824|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
162899000|NCT00899678|588328825|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
162899001|NCT00899678|588328823|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
162899002|NCT00899678|588328824|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
162899003|NCT00899678|588328825|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
162899004|NCT00368472|588328829|FG000|Overall Study|Adverse Event|22|||
162899005|NCT00368472|588328829|FG000|Overall Study|Medication non-compliance|4|||
162899006|NCT00368472|588328829|FG000|Overall Study|Protocol Violation|2|||
162899007|NCT00368472|588328829|FG000|Overall Study|Request of Investigator or Sponsor|3|||
162899008|NCT00368472|588328829|FG000|Overall Study|Withdrawal by Subject|40|||
162899009|NCT00368472|588328829|FG000|Overall Study|Diary non-compliance|1|||
162899010|NCT00368472|588328829|FG000|Overall Study|Other|32|||
162899011|NCT00368472|588328829|FG000|Overall Study|Missing Final Disposition Date|1|||
162899012|NCT02650895|588328831|FG000|Overall Study|Withdrawal by Subject|0|||
162899013|NCT02650895|588328832|FG001|Overall Study|Withdrawal by Subject|1|||
162899014|NCT02650895|588328833|FG002|Overall Study|Withdrawal by Subject|0|||
162899015|NCT02650895|588328834|FG003|Overall Study|Withdrawal by Subject|0|||
162899016|NCT02650895|588328835|FG004|Overall Study|Withdrawal by Subject|0|||
162899017|NCT02650895|588328836|FG005|Overall Study|Withdrawal by Subject|0|||
162899018|NCT02632344|588330443|FG000|Overall Study|Adverse Event|3|||
162899019|NCT02632344|588330443|FG000|Overall Study|Lack of Efficacy|3|||
162899020|NCT02632344|588330443|FG000|Overall Study|Withdrawal by Subject|2|||
162899021|NCT00777257|588330444|FG000|Overall Study|Adverse Event|3|||
162899022|NCT00777257|588330445|FG001|Overall Study|Adverse Event|1|||
162899023|NCT00777257|588330446|FG002|Overall Study|Adverse Event|0|||
162899024|NCT00777257|588330444|FG000|Overall Study|Lost to Follow-up|3|||
162899025|NCT00777257|588330445|FG001|Overall Study|Lost to Follow-up|3|||
162899026|NCT00777257|588330446|FG002|Overall Study|Lost to Follow-up|2|||
162899027|NCT00777257|588330444|FG000|Overall Study|Protocol Violation|2|||
162899028|NCT00777257|588330445|FG001|Overall Study|Protocol Violation|2|||
162899029|NCT00777257|588330446|FG002|Overall Study|Protocol Violation|2|||
162899030|NCT00777257|588330444|FG000|Overall Study|Withdrawal by Subject|3|||
162899031|NCT00777257|588330445|FG001|Overall Study|Withdrawal by Subject|6|||
162899032|NCT00777257|588330446|FG002|Overall Study|Withdrawal by Subject|5|||
162899033|NCT01370499|588330447|FG000|Overall Study|Adverse Event|38|||
162899034|NCT01370499|588330448|FG001|Overall Study|Adverse Event|12|||
162899035|NCT01370499|588330447|FG000|Overall Study|Lack of Efficacy|4|||
162899036|NCT01370499|588330448|FG001|Overall Study|Lack of Efficacy|2|||
162899037|NCT01370499|588330447|FG000|Overall Study|Lost to Follow-up|2|||
162899038|NCT01370499|588330448|FG001|Overall Study|Lost to Follow-up|1|||
162899039|NCT01370499|588330447|FG000|Overall Study|Physician Decision|3|||
162899040|NCT01370499|588330448|FG001|Overall Study|Physician Decision|3|||
162899041|NCT01370499|588330447|FG000|Overall Study|Protocol Violation|5|||
162899042|NCT01370499|588330448|FG001|Overall Study|Protocol Violation|4|||
162899043|NCT01370499|588330447|FG000|Overall Study|Withdrawal by Subject|18|||
162899044|NCT01370499|588330448|FG001|Overall Study|Withdrawal by Subject|7|||
162899045|NCT01370499|588330447|FG000|Overall Study|Sponsor Decision|41|||
162899046|NCT01370499|588330448|FG001|Overall Study|Sponsor Decision|15|||
162899047|NCT04984876|588330449|FG000|Overall Study|Subject decision|2|||
162899048|NCT04984876|588330450|FG001|Overall Study|Subject decision|10|||
162899049|NCT04984876|588330451|FG002|Overall Study|Subject decision|3|||
162899050|NCT04984876|588330452|FG003|Overall Study|Subject decision|3|||
162899051|NCT04984876|588330453|FG004|Overall Study|Subject decision|3|||
162899052|NCT04984876|588330454|FG005|Overall Study|Subject decision|0|||
162899053|NCT04984876|588330449|FG000|Overall Study|Guardian decision|0|||
162899054|NCT04984876|588330450|FG001|Overall Study|Guardian decision|1|||
162899055|NCT04984876|588330451|FG002|Overall Study|Guardian decision|0|||
162899056|NCT04984876|588330452|FG003|Overall Study|Guardian decision|2|||
162899057|NCT04984876|588330453|FG004|Overall Study|Guardian decision|0|||
162899058|NCT04984876|588330454|FG005|Overall Study|Guardian decision|1|||
162899059|NCT04984876|588330449|FG000|Overall Study|Lost to Follow-up|0|||
162899060|NCT04984876|588330450|FG001|Overall Study|Lost to Follow-up|0|||
162899061|NCT04984876|588330451|FG002|Overall Study|Lost to Follow-up|1|||
162899062|NCT04984876|588330452|FG003|Overall Study|Lost to Follow-up|1|||
162899063|NCT04984876|588330453|FG004|Overall Study|Lost to Follow-up|0|||
162899064|NCT04984876|588330454|FG005|Overall Study|Lost to Follow-up|0|||
162899065|NCT04984876|588330449|FG000|Overall Study|Physician Decision|1|||
162899066|NCT04984876|588330450|FG001|Overall Study|Physician Decision|0|||
162899067|NCT04984876|588330451|FG002|Overall Study|Physician Decision|0|||
162899068|NCT04984876|588330452|FG003|Overall Study|Physician Decision|1|||
162899069|NCT04984876|588330453|FG004|Overall Study|Physician Decision|0|||
162899070|NCT04984876|588330454|FG005|Overall Study|Physician Decision|0|||
162899071|NCT04984876|588330449|FG000|Overall Study|Adverse Event|0|||
162899072|NCT04984876|588330450|FG001|Overall Study|Adverse Event|0|||
162899073|NCT04984876|588330451|FG002|Overall Study|Adverse Event|1|||
162899074|NCT04984876|588330452|FG003|Overall Study|Adverse Event|0|||
162899075|NCT04984876|588330453|FG004|Overall Study|Adverse Event|0|||
162899076|NCT04984876|588330454|FG005|Overall Study|Adverse Event|0|||
162899077|NCT01077193|588330457|FG000|Overall Study|Lost to Follow-up|1|||
162899078|NCT01077193|588330457|FG000|Overall Study|Withdrawal by Subject|2|||
162899079|NCT01077193|588330457|FG000|Overall Study|Lack of Efficacy|1|||
162899080|NCT01077193|588330457|FG000|Overall Study|Study Terminated by Sponsor|40|||
162899081|NCT04960202|588330458|FG000|Overall Study|Other|5|||
162899082|NCT04960202|588330459|FG001|Overall Study|Other|0|||
162899083|NCT04960202|588330458|FG000|Overall Study|Withdrawal by Subject|37|||
162899084|NCT04960202|588330459|FG001|Overall Study|Withdrawal by Subject|43|||
162899085|NCT04960202|588330458|FG000|Overall Study|Lost to Follow-up|20|||
162625426|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
162899086|NCT04960202|588330459|FG001|Overall Study|Lost to Follow-up|16|||
162899087|NCT04960202|588330458|FG000|Overall Study|Death|0|||
162899088|NCT04960202|588330459|FG001|Overall Study|Death|15|||
162899089|NCT03687827|588330463|FG000|Treatment Period 1|Death|0|||
162899090|NCT03687827|588330464|FG001|Treatment Period 1|Death|1|||
162899091|NCT03687827|588330463|FG000|Treatment Period 1|Lost to Follow-up|2|||
162899092|NCT03687827|588330464|FG001|Treatment Period 1|Lost to Follow-up|2|||
162899093|NCT03687827|588330463|FG000|Treatment Period 1|Physician Decision|5|||
162899094|NCT03687827|588330464|FG001|Treatment Period 1|Physician Decision|2|||
162899095|NCT03687827|588330463|FG000|Treatment Period 1|Withdrawal by Subject|7|||
162899096|NCT03687827|588330464|FG001|Treatment Period 1|Withdrawal by Subject|3|||
162899097|NCT03687827|588330463|FG000|Treatment Period 2|Physician Decision|4|||
162899098|NCT03687827|588330464|FG001|Treatment Period 2|Physician Decision|1|||
162899099|NCT03687827|588330463|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162899100|NCT03687827|588330464|FG001|Treatment Period 2|Withdrawal by Subject|2|||
162899101|NCT03377452|588330467|FG000|Overall Study|Refused assessment|0|||
162899102|NCT03377452|588330468|FG001|Overall Study|Refused assessment|2|||
162899103|NCT03377452|588330467|FG000|Overall Study|Lost to Follow-up|5|||
162899104|NCT03377452|588330468|FG001|Overall Study|Lost to Follow-up|4|||
162899105|NCT03464136|588330469|FG000|Overall Study|Lost to Follow-up|5|||
162899106|NCT03464136|588330470|FG001|Overall Study|Lost to Follow-up|8|||
162899107|NCT03464136|588330469|FG000|Overall Study|Withdrawal by Subject|16|||
162899108|NCT03464136|588330470|FG001|Overall Study|Withdrawal by Subject|13|||
162899109|NCT03464136|588330469|FG000|Overall Study|Death|1|||
162899110|NCT03464136|588330470|FG001|Overall Study|Death|0|||
162899111|NCT03464136|588330469|FG000|Overall Study|Other|8|||
162899112|NCT03464136|588330470|FG001|Overall Study|Other|4|||
162899113|NCT03146403|588330471|FG000|Overall Study|Withdrawal by Subject|0|||
162899114|NCT03146403|588330472|FG001|Overall Study|Withdrawal by Subject|3|||
162899115|NCT03146403|588330471|FG000|Overall Study|Lost to Follow-up|2|||
162899116|NCT03146403|588330472|FG001|Overall Study|Lost to Follow-up|0|||
162899117|NCT00481988|588330473|FG000|Overall Study|Withdrawal by Subject|1|||
162899118|NCT00481988|588330474|FG001|Overall Study|Withdrawal by Subject|1|||
162899119|NCT02182999|588330475|FG000|Overall Study|Adverse Event|4|||
162899120|NCT02182999|588330476|FG001|Overall Study|Adverse Event|3|||
162899121|NCT02182999|588330475|FG000|Overall Study|Physician Decision|1|||
162899122|NCT02182999|588330476|FG001|Overall Study|Physician Decision|0|||
162899123|NCT02252588|588330478|FG000|Overall Study|Withdrawal by Subject|4|||
162899124|NCT02252588|588330479|FG001|Overall Study|Withdrawal by Subject|0|||
162899125|NCT00638690|588330484|FG000|Overall Study|Death|655|||
162899126|NCT00638690|588330485|FG001|Overall Study|Death|335|||
162899127|NCT00638690|588330484|FG000|Overall Study|Withdrawal by Subject|22|||
162899128|NCT00638690|588330485|FG001|Overall Study|Withdrawal by Subject|5|||
162899129|NCT00638690|588330484|FG000|Overall Study|Lost to Follow-up|4|||
162899130|NCT00638690|588330485|FG001|Overall Study|Lost to Follow-up|2|||
162899131|NCT02203916|588330488|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162899132|NCT02203916|588330489|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
162899133|NCT02203916|588330490|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
162899134|NCT02203916|588330488|FG000|Overall Study|Major Protocol Deviation|1|||
162899135|NCT02203916|588330489|FG001|Overall Study|Major Protocol Deviation|1|||
162899136|NCT02203916|588330490|FG002|Overall Study|Major Protocol Deviation|0|||
162899137|NCT02203916|588330488|FG000|Overall Study|Lost to Follow-up|0|||
162899138|NCT02203916|588330489|FG001|Overall Study|Lost to Follow-up|1|||
162899139|NCT02203916|588330490|FG002|Overall Study|Lost to Follow-up|0|||
162899140|NCT02203916|588330488|FG000|Overall Study|Voluntary Withdrawal|3|||
162899141|NCT02203916|588330489|FG001|Overall Study|Voluntary Withdrawal|3|||
162899142|NCT02203916|588330490|FG002|Overall Study|Voluntary Withdrawal|8|||
162899143|NCT02203916|588330488|FG000|Overall Study|Lack of Efficacy|3|||
162899144|NCT02203916|588330489|FG001|Overall Study|Lack of Efficacy|0|||
162899145|NCT02203916|588330490|FG002|Overall Study|Lack of Efficacy|0|||
162899146|NCT02203916|588330488|FG000|Overall Study|Reason Not Specified|0|||
162899147|NCT02203916|588330489|FG001|Overall Study|Reason Not Specified|2|||
162899148|NCT02203916|588330490|FG002|Overall Study|Reason Not Specified|1|||
162899149|NCT03152110|588330501|FG000|Overall Study|Withdrawal by Subject|3|||
162899150|NCT00552344|588330511|FG000|Overall Study|Lack of Efficacy|55|||
162899151|NCT00552344|588330511|FG000|Overall Study|Loss of efficacy|75|||
162899152|NCT00552344|588330511|FG000|Overall Study|Lost to Follow-up|8|||
162899153|NCT00552344|588330511|FG000|Overall Study|Withdrawal by Subject|48|||
162899154|NCT00552344|588330511|FG000|Overall Study|SAE, non-fatal|6|||
162899155|NCT00552344|588330511|FG000|Overall Study|AE, non-serious non-fatal|38|||
162899156|NCT00552344|588330511|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
162899157|NCT00552344|588330511|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
162899158|NCT00552344|588330511|FG000|Overall Study|Other Reason|22|||
162899159|NCT04247828|588330514|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
162899160|NCT00045630|588330517|FG000|Overall Study|Adverse Event|1|||
162899161|NCT00045630|588330517|FG000|Overall Study|Refusal unrelated to adverse event|1|||
162899162|NCT00045630|588330517|FG000|Overall Study|Progression/relapse|1|||
162899163|NCT00045630|588330517|FG000|Overall Study|Death|1|||
162899164|NCT00045630|588330517|FG000|Overall Study|Ineligible|2|||
162899165|NCT01448707|588330524|FG000|Overall Study|Adverse Event|3|||
162899166|NCT01448707|588330525|FG001|Overall Study|Adverse Event|1|||
162899167|NCT01448707|588330524|FG000|Overall Study|Lost to Follow-up|2|||
162899168|NCT01448707|588330525|FG001|Overall Study|Lost to Follow-up|6|||
162899169|NCT01448707|588330524|FG000|Overall Study|Withdrawal by Subject|6|||
162899170|NCT01448707|588330525|FG001|Overall Study|Withdrawal by Subject|7|||
162899171|NCT01448707|588330524|FG000|Overall Study|Other|7|||
162899172|NCT01448707|588330525|FG001|Overall Study|Other|4|||
162899173|NCT00383708|588330529|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
162899174|NCT00383708|588330529|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
162899175|NCT00383708|588330529|FG000|Run-in Period|Protocol Violation|4|||
162899176|NCT00383708|588330529|FG000|Run-in Period|Adverse Event|2|||
162899177|NCT00383708|588330529|FG000|Run-in Period|Claustrophobia|1|||
162899178|NCT00383708|588330529|FG000|Co-administration Period|Adverse Event|5|||
162899179|NCT02033850|588330530|FG000|Overall Study|Death|1|||
162899180|NCT02033850|588330531|FG001|Overall Study|Death|0|||
162899181|NCT02033850|588330530|FG000|Overall Study|unrelated medical reason|1|||
162899182|NCT02033850|588330531|FG001|Overall Study|unrelated medical reason|1|||
162899183|NCT02820038|588330532|FG000|Overall Study|Lost to Follow-up|7|||
162899184|NCT02820038|588330533|FG001|Overall Study|Lost to Follow-up|11|||
162899185|NCT02820038|588330534|FG002|Overall Study|Lost to Follow-up|2|||
162899186|NCT02820038|588330535|FG003|Overall Study|Lost to Follow-up|9|||
162899187|NCT02820038|588330532|FG000|Overall Study|Withdrawal by Subject|3|||
162899188|NCT02820038|588330533|FG001|Overall Study|Withdrawal by Subject|14|||
162899189|NCT02820038|588330534|FG002|Overall Study|Withdrawal by Subject|3|||
162899190|NCT02820038|588330535|FG003|Overall Study|Withdrawal by Subject|13|||
162899191|NCT03934203|588330536|FG000|Overall Study|Adverse Event|0|||
162899192|NCT03934203|588330537|FG001|Overall Study|Adverse Event|0|||
162899193|NCT03934203|588330538|FG002|Overall Study|Adverse Event|1|||
162899194|NCT03934203|588330539|FG003|Overall Study|Adverse Event|0|||
162899195|NCT03934203|588330540|FG004|Overall Study|Adverse Event|1|||
162899196|NCT03934203|588330541|FG005|Overall Study|Adverse Event|0|||
162899197|NCT03934203|588330542|FG006|Overall Study|Adverse Event|2|||
162899198|NCT03934203|588330543|FG007|Overall Study|Adverse Event|0|||
162899199|NCT03934203|588330544|FG008|Overall Study|Adverse Event|0|||
162899200|NCT03934203|588330545|FG009|Overall Study|Adverse Event|0|||
162899201|NCT03934203|588330546|FG010|Overall Study|Adverse Event|0|||
162899202|NCT03934203|588330547|FG011|Overall Study|Adverse Event|0|||
162899203|NCT03934203|588330548|FG012|Overall Study|Adverse Event|0|||
162899204|NCT03934203|588330549|FG013|Overall Study|Adverse Event|1|||
162899205|NCT03934203|588330550|FG014|Overall Study|Adverse Event|0|||
162899206|NCT00560794|588330551|FG000|Overall Study|Adverse Event|2|||
162899207|NCT00560794|588330551|FG000|Overall Study|Patient was not Compliant|1|||
162899208|NCT00560794|588330551|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
162899209|NCT00560794|588330551|FG000|Overall Study|Hematological Relapse|1|||
162899210|NCT00560794|588330551|FG000|Overall Study|Received Bone Marrow Transplant|6|||
162899211|NCT00441480|588330552|FG000|Overall Study|Protocol Violation|1|||
162899212|NCT00441480|588330553|FG001|Overall Study|Protocol Violation|1|||
162965434|NCT00354835|588573295|FG001|Overall Study|Disease progression or relapse|22|||
162965435|NCT00354835|588573294|FG000|Overall Study|Adverse Event|6|||
162965436|NCT00354835|588573295|FG001|Overall Study|Adverse Event|0|||
162965437|NCT00354835|588573294|FG000|Overall Study|Refusal of further therapy|3|||
162965438|NCT00354835|588573295|FG001|Overall Study|Refusal of further therapy|8|||
162965439|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
162965440|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
162965441|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
162965442|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
162965443|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
162965444|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
162965445|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
162965446|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
163052245|NCT06058390|588900978|FG000|Overall Study|Lost to Follow-up|0|||
163052246|NCT06058390|588900979|FG001|Overall Study|Lost to Follow-up|0|||
163052247|NCT06058390|588900980|FG002|Overall Study|Lost to Follow-up|2|||
163052248|NCT06058390|588900981|FG003|Overall Study|Lost to Follow-up|1|||
163052249|NCT06058390|588900978|FG000|Overall Study|Physician Decision|0|||
163052250|NCT06058390|588900979|FG001|Overall Study|Physician Decision|0|||
163052251|NCT06058390|588900980|FG002|Overall Study|Physician Decision|0|||
163052252|NCT06058390|588900981|FG003|Overall Study|Physician Decision|1|||
163052253|NCT06058390|588900978|FG000|Overall Study|Participants did not receive any study intervention|0|||
163052254|NCT06058390|588900979|FG001|Overall Study|Participants did not receive any study intervention|0|||
163052255|NCT06058390|588900980|FG002|Overall Study|Participants did not receive any study intervention|0|||
163052256|NCT06058390|588900981|FG003|Overall Study|Participants did not receive any study intervention|1|||
163052257|NCT03292016|588900982|FG000|Second Washout|Adverse Event|0|||
163052258|NCT03292016|588900983|FG001|Second Washout|Adverse Event|1|||
163052259|NCT03292016|588900984|FG002|Second Washout|Adverse Event|0|||
163052260|NCT03292016|588900985|FG003|Second Washout|Adverse Event|0|||
163052261|NCT03292016|588900986|FG004|Second Washout|Adverse Event|0|||
163052262|NCT03292016|588900987|FG005|Second Washout|Adverse Event|0|||
163052263|NCT01172873|588900988|FG000|Overall Study|Withdrawal by Subject|3|||
163052264|NCT01172873|588900989|FG001|Overall Study|Withdrawal by Subject|2|||
163052265|NCT05518539|588900990|FG000|Overall Study|Lost to Follow-up|6|||
163052266|NCT03589807|588900992|FG000|Overall Study|Lost to Follow-up|0|||
163052267|NCT03589807|588900993|FG001|Overall Study|Lost to Follow-up|2|||
163052268|NCT03589807|588900994|FG002|Overall Study|Lost to Follow-up|2|||
163052269|NCT03589807|588900995|FG003|Overall Study|Lost to Follow-up|3|||
163052270|NCT03589807|588900996|FG004|Overall Study|Lost to Follow-up|1|||
163052271|NCT03589807|588900997|FG005|Overall Study|Lost to Follow-up|1|||
163052272|NCT03589807|588900992|FG000|Overall Study|Withdrawal by Subject|0|||
163052273|NCT03589807|588900993|FG001|Overall Study|Withdrawal by Subject|5|||
163052274|NCT03589807|588900994|FG002|Overall Study|Withdrawal by Subject|0|||
163052275|NCT03589807|588900995|FG003|Overall Study|Withdrawal by Subject|0|||
163052276|NCT03589807|588900996|FG004|Overall Study|Withdrawal by Subject|0|||
163052277|NCT03589807|588900997|FG005|Overall Study|Withdrawal by Subject|0|||
163052278|NCT03589807|588900992|FG000|Overall Study|Protocol Violation|0|||
163052279|NCT03589807|588900993|FG001|Overall Study|Protocol Violation|0|||
163052280|NCT03589807|588900994|FG002|Overall Study|Protocol Violation|0|||
163052281|NCT03589807|588900995|FG003|Overall Study|Protocol Violation|1|||
163052282|NCT03589807|588900996|FG004|Overall Study|Protocol Violation|0|||
163052283|NCT03589807|588900997|FG005|Overall Study|Protocol Violation|0|||
163052284|NCT03589807|588900992|FG000|Overall Study|Enrolled but treatment not administered|0|||
163052285|NCT03589807|588900993|FG001|Overall Study|Enrolled but treatment not administered|0|||
163052286|NCT03589807|588900994|FG002|Overall Study|Enrolled but treatment not administered|0|||
163052287|NCT03589807|588900995|FG003|Overall Study|Enrolled but treatment not administered|0|||
163052288|NCT03589807|588900996|FG004|Overall Study|Enrolled but treatment not administered|1|||
162965447|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
162965448|NCT01968551|588573296|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
163052289|NCT03589807|588900997|FG005|Overall Study|Enrolled but treatment not administered|0|||
163052290|NCT01211145|588900998|FG000|Overall Study|Reason not specified|3|||
163052291|NCT01211145|588900999|FG001|Overall Study|Reason not specified|2|||
163052292|NCT01211145|588901000|FG002|Overall Study|Reason not specified|2|||
163052293|NCT01211145|588901001|FG003|Overall Study|Reason not specified|1|||
163052294|NCT01211145|588900998|FG000|Overall Study|Lost to Follow-up|3|||
163052295|NCT01211145|588900999|FG001|Overall Study|Lost to Follow-up|2|||
163052296|NCT01211145|588901000|FG002|Overall Study|Lost to Follow-up|1|||
163052297|NCT01211145|588901001|FG003|Overall Study|Lost to Follow-up|2|||
163052298|NCT01211145|588900998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
162965449|NCT01968551|588573297|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
162965450|NCT01968551|588573298|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
162899213|NCT00441480|588330552|FG000|Overall Study|Withdrawal by Subject|2|||
162899214|NCT00441480|588330553|FG001|Overall Study|Withdrawal by Subject|3|||
162899215|NCT01922739|588330561|FG000|Titration/Adjustment Period|Adverse Event|3|||
162899216|NCT01922739|588330561|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
162899217|NCT01922739|588330561|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
162899218|NCT01922739|588330561|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
162899219|NCT01922739|588330561|FG000|Open-label Treatment Period|Adverse Event|6|||
162899220|NCT01922739|588330561|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
162899221|NCT01922739|588330561|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
162899222|NCT01922739|588330561|FG000|Open-label Treatment Period|Protocol Violation|5|||
162899223|NCT01922739|588330561|FG000|Open-label Treatment Period|Pregnancy|1|||
162899224|NCT01922739|588330561|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
162899225|NCT01922739|588330561|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
162899226|NCT01922739|588330561|FG000|Open-label Treatment Period|Physician Decision|1|||
162899227|NCT01922739|588330561|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
162899228|NCT00044213|588330562|FG000|Overall Study|Withdrawal by Subject|50|||
162899229|NCT00044213|588330563|FG001|Overall Study|Withdrawal by Subject|65|||
162899230|NCT00044213|588330564|FG002|Overall Study|Withdrawal by Subject|91|||
162899231|NCT00044213|588330565|FG003|Overall Study|Withdrawal by Subject|83|||
162899232|NCT00044213|588330562|FG000|Overall Study|Death|42|||
162899233|NCT00044213|588330563|FG001|Overall Study|Death|42|||
162899234|NCT00044213|588330564|FG002|Overall Study|Death|42|||
162899235|NCT00044213|588330565|FG003|Overall Study|Death|49|||
162899236|NCT00044213|588330562|FG000|Overall Study|Lost to Follow-up|8|||
162899237|NCT00044213|588330563|FG001|Overall Study|Lost to Follow-up|5|||
162899238|NCT00044213|588330564|FG002|Overall Study|Lost to Follow-up|5|||
162899239|NCT00044213|588330565|FG003|Overall Study|Lost to Follow-up|4|||
162899240|NCT00422240|588330566|FG000|Overall Study|Lack of Efficacy|1|||
162899241|NCT00422240|588330567|FG001|Overall Study|Lack of Efficacy|2|||
162899242|NCT00422240|588330568|FG002|Overall Study|Lack of Efficacy|0|||
162899243|NCT00422240|588330569|FG003|Overall Study|Lack of Efficacy|1|||
162899244|NCT00422240|588330566|FG000|Overall Study|Adverse Event|11|||
162899245|NCT00422240|588330567|FG001|Overall Study|Adverse Event|4|||
162899246|NCT00422240|588330568|FG002|Overall Study|Adverse Event|5|||
162899247|NCT00422240|588330569|FG003|Overall Study|Adverse Event|2|||
162899248|NCT00422240|588330566|FG000|Overall Study|Subject request|21|||
162899249|NCT00422240|588330567|FG001|Overall Study|Subject request|17|||
162899250|NCT00422240|588330568|FG002|Overall Study|Subject request|18|||
162899251|NCT00422240|588330569|FG003|Overall Study|Subject request|30|||
162899252|NCT00422240|588330566|FG000|Overall Study|Protocol Violation|0|||
162899253|NCT00422240|588330567|FG001|Overall Study|Protocol Violation|1|||
162899254|NCT00422240|588330568|FG002|Overall Study|Protocol Violation|0|||
162899255|NCT00422240|588330569|FG003|Overall Study|Protocol Violation|1|||
162899256|NCT00422240|588330566|FG000|Overall Study|Lost to Follow-up|31|||
162899257|NCT00422240|588330567|FG001|Overall Study|Lost to Follow-up|32|||
162899258|NCT00422240|588330568|FG002|Overall Study|Lost to Follow-up|19|||
162899259|NCT00422240|588330569|FG003|Overall Study|Lost to Follow-up|34|||
162899260|NCT00422240|588330566|FG000|Overall Study|Other|1|||
162899261|NCT00422240|588330567|FG001|Overall Study|Other|0|||
162899262|NCT00422240|588330568|FG002|Overall Study|Other|0|||
162899263|NCT00422240|588330569|FG003|Overall Study|Other|1|||
162899264|NCT00422240|588330566|FG000|Overall Study|Pregnancy|3|||
162965451|NCT01968551|588573296|FG000|Extension Phase|Adverse Event|0|||
162965452|NCT01968551|588573297|FG001|Extension Phase|Adverse Event|0|||
162965453|NCT01968551|588573298|FG002|Extension Phase|Adverse Event|2|||
162965454|NCT01968551|588573296|FG000|Extension Phase|Death|0|||
162965455|NCT01968551|588573297|FG001|Extension Phase|Death|1|||
162965456|NCT01968551|588573298|FG002|Extension Phase|Death|0|||
162965457|NCT01968551|588573296|FG000|Extension Phase|Withdrew Consent|0|||
162965458|NCT01968551|588573297|FG001|Extension Phase|Withdrew Consent|0|||
162965459|NCT01968551|588573298|FG002|Extension Phase|Withdrew Consent|1|||
162899265|NCT00422240|588330567|FG001|Overall Study|Pregnancy|1|||
162899266|NCT00422240|588330568|FG002|Overall Study|Pregnancy|1|||
162899267|NCT00422240|588330569|FG003|Overall Study|Pregnancy|2|||
162965460|NCT01968551|588573296|FG000|Extension Phase|Lost to Follow-up|1|||
162965461|NCT01968551|588573297|FG001|Extension Phase|Lost to Follow-up|0|||
162965462|NCT01968551|588573298|FG002|Extension Phase|Lost to Follow-up|1|||
162899268|NCT00880607|588330570|FG000|Overall Study|Physician Decision|2|||
162899269|NCT00880607|588330571|FG001|Overall Study|Physician Decision|2|||
162899270|NCT00880607|588330570|FG000|Overall Study|Protocol Violation|2|||
162899271|NCT00880607|588330571|FG001|Overall Study|Protocol Violation|1|||
162899272|NCT00880607|588330570|FG000|Overall Study|surgery did not extend past L1 level|3|||
162899273|NCT00880607|588330571|FG001|Overall Study|surgery did not extend past L1 level|0|||
162899274|NCT05104749|588330572|FG000|Overall Study|Lost to Follow-up|2|||
162899275|NCT05104749|588330573|FG001|Overall Study|Lost to Follow-up|3|||
162899276|NCT02963766|588330574|FG000|Double-Blind Period|Adverse Event|1|||
162965463|NCT06475729|588573299|FG000|Overall Study|Withdrawal by Subject|2|||
162965464|NCT06475729|588573300|FG001|Overall Study|Withdrawal by Subject|1|||
162965465|NCT06475729|588573299|FG000|Overall Study|Randomized but did not receive any dose|3|||
162625427|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
162625428|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
162625429|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
162625430|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
162625431|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
162625432|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
162625433|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
162625434|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
162625435|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
162625436|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
162625437|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162625438|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162625439|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
162625440|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162625441|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162625442|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
162625443|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162625444|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162625445|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162625446|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162625447|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162625448|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
162625449|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162625450|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162625451|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162625452|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162625453|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
162625454|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162625455|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162625456|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
162625457|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162899277|NCT02963766|588330575|FG001|Double-Blind Period|Adverse Event|0|||
162899278|NCT02963766|588330576|FG002|Double-Blind Period|Adverse Event|1|||
162899279|NCT02963766|588330574|FG000|Double-Blind Period|Physician Decision|1|||
162899280|NCT02963766|588330575|FG001|Double-Blind Period|Physician Decision|0|||
162899281|NCT02963766|588330576|FG002|Double-Blind Period|Physician Decision|0|||
162899282|NCT02963766|588330574|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162899283|NCT02963766|588330575|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162899284|NCT02963766|588330576|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162899285|NCT02963766|588330574|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
162899286|NCT02963766|588330575|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
162899287|NCT02963766|588330576|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
162899288|NCT02963766|588330574|FG000|Double-Blind Period|Protocol Violation|1|||
162899289|NCT02963766|588330575|FG001|Double-Blind Period|Protocol Violation|0|||
162899290|NCT02963766|588330576|FG002|Double-Blind Period|Protocol Violation|0|||
162899291|NCT02963766|588330574|FG000|Double-Blind Period|Lost to Follow-up|0|||
162899292|NCT02963766|588330575|FG001|Double-Blind Period|Lost to Follow-up|1|||
162899293|NCT02963766|588330576|FG002|Double-Blind Period|Lost to Follow-up|0|||
162899294|NCT02963766|588330574|FG000|Open Label Extension (OLE)|Physician Decision|1|||
162899295|NCT02963766|588330575|FG001|Open Label Extension (OLE)|Physician Decision|2|||
162899296|NCT02963766|588330576|FG002|Open Label Extension (OLE)|Physician Decision|2|||
162899297|NCT02963766|588330574|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
162899298|NCT02963766|588330575|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
162899299|NCT02963766|588330576|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
162899300|NCT00901394|588330577|FG000|Overall Study|Physician Decision|1|||
162899301|NCT00901394|588330578|FG001|Overall Study|Physician Decision|1|||
162899302|NCT00901394|588330579|FG002|Overall Study|Physician Decision|2|||
162899303|NCT04964557|588330583|FG000|Overall Study|Withdrawal by Subject|3|||
162899304|NCT04964557|588330584|FG001|Overall Study|Withdrawal by Subject|2|||
162899305|NCT04964557|588330583|FG000|Overall Study|Lost to Follow-up|1|||
162899306|NCT04964557|588330584|FG001|Overall Study|Lost to Follow-up|2|||
162899307|NCT04964557|588330583|FG000|Overall Study|Physician Decision|2|||
162899308|NCT04964557|588330584|FG001|Overall Study|Physician Decision|0|||
162899309|NCT04964557|588330583|FG000|Overall Study|Death|3|||
162899310|NCT04964557|588330584|FG001|Overall Study|Death|0|||
162899311|NCT04964557|588330583|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
162899312|NCT04964557|588330584|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
162899313|NCT00251589|588330585|FG000|Overall Study|Adverse Event|5|||
162899314|NCT00251589|588330586|FG001|Overall Study|Adverse Event|1|||
162899315|NCT00251589|588330587|FG002|Overall Study|Adverse Event|2|||
162899316|NCT00251589|588330588|FG003|Overall Study|Adverse Event|1|||
162899317|NCT00251589|588330585|FG000|Overall Study|Withdrawal by Subject|1|||
162899318|NCT00251589|588330586|FG001|Overall Study|Withdrawal by Subject|1|||
162899319|NCT00251589|588330587|FG002|Overall Study|Withdrawal by Subject|0|||
162899320|NCT00251589|588330588|FG003|Overall Study|Withdrawal by Subject|0|||
162899321|NCT00251589|588330585|FG000|Overall Study|Discontinued due to progressive disease|9|||
162899322|NCT00251589|588330586|FG001|Overall Study|Discontinued due to progressive disease|1|||
162899323|NCT00251589|588330587|FG002|Overall Study|Discontinued due to progressive disease|0|||
162899324|NCT00251589|588330588|FG003|Overall Study|Discontinued due to progressive disease|1|||
162899325|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Adverse Event|22|||
162899326|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Adverse Event|0|||
162899327|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
162899328|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
162899329|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
162899330|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
162899331|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
162899332|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
162899333|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
162899334|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
162899335|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
162899336|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
162899337|NCT02493868|588330591|FG000|Induction Phase: DE Participants|Other|8|||
162899338|NCT02493868|588330592|FG001|Induction Phase: DE Participants|Other|0|||
162899339|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
162899340|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
162899341|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
162899342|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
162899343|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
162899344|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
162899345|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
162899346|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
162899347|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
162899348|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
162899349|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
162899350|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
162899351|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
162899352|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
162899353|NCT02493868|588330591|FG000|Optimization Phase: DE+TE Participants|Other|10|||
162899354|NCT02493868|588330592|FG001|Optimization Phase: DE+TE Participants|Other|2|||
162899355|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
162899356|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
162899357|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
162899358|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
162899359|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
162899360|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
162899361|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
162899362|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
162899363|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
162899364|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
162899365|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
162899366|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
162899367|NCT02493868|588330591|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
162899368|NCT02493868|588330592|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
162899369|NCT02493868|588330591|FG000|Follow-up Phase|Lost to Follow-up|1|||
162899370|NCT02493868|588330592|FG001|Follow-up Phase|Lost to Follow-up|0|||
162899371|NCT02493868|588330591|FG000|Follow-up Phase|Withdrawal by Subject|3|||
162899372|NCT02493868|588330592|FG001|Follow-up Phase|Withdrawal by Subject|0|||
162965466|NCT06475729|588573300|FG001|Overall Study|Randomized but did not receive any dose|2|||
162965467|NCT06475729|588573299|FG000|Overall Study|Lost to Follow-up|1|||
162965468|NCT06475729|588573300|FG001|Overall Study|Lost to Follow-up|2|||
162899373|NCT02493868|588330591|FG000|Follow-up Phase|Investigator Decision|5|||
162899374|NCT02493868|588330592|FG001|Follow-up Phase|Investigator Decision|1|||
162965469|NCT06475729|588573299|FG000|Overall Study|Physician Decision|5|||
162965470|NCT06475729|588573300|FG001|Overall Study|Physician Decision|2|||
162965471|NCT06475729|588573299|FG000|Overall Study|Adverse Event|1|||
162965472|NCT06475729|588573300|FG001|Overall Study|Adverse Event|1|||
162899375|NCT02493868|588330591|FG000|Follow-up Phase|Other|2|||
162899376|NCT02493868|588330592|FG001|Follow-up Phase|Other|1|||
162899377|NCT03039569|588330595|FG000|Overall Study|Lost to Follow-up|5|||
162899378|NCT03039569|588330596|FG001|Overall Study|Lost to Follow-up|4|||
162899379|NCT01167153|588330597|FG000|Overall Study|Non-effective therapy|1|||
162899380|NCT01167153|588330598|FG001|Overall Study|Non-effective therapy|4|||
162899381|NCT01167153|588330597|FG000|Overall Study|AE including clinical laboratory AE|2|||
162899382|NCT01167153|588330598|FG001|Overall Study|AE including clinical laboratory AE|8|||
162899383|NCT01167153|588330597|FG000|Overall Study|Hypotension|1|||
162899384|NCT01167153|588330598|FG001|Overall Study|Hypotension|0|||
162899385|NCT01167153|588330597|FG000|Overall Study|Lost to Follow-up|7|||
162899386|NCT01167153|588330598|FG001|Overall Study|Lost to Follow-up|9|||
162899387|NCT01167153|588330597|FG000|Overall Study|Non-compliance to concomitant medication|0|||
162899388|NCT01167153|588330598|FG001|Overall Study|Non-compliance to concomitant medication|2|||
162899389|NCT01167153|588330597|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
162899390|NCT01167153|588330598|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
162899391|NCT01167153|588330597|FG000|Overall Study|Withdrawal consent|1|||
162899392|NCT01167153|588330598|FG001|Overall Study|Withdrawal consent|1|||
162899393|NCT01167153|588330597|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
162899394|NCT01167153|588330598|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
162899395|NCT04888507|588332960|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
162899396|NCT00636155|588332961|FG000|Overall Study|Adverse Event|8|||
162899397|NCT00636155|588332961|FG000|Overall Study|Lack of Efficacy|1|||
162899398|NCT00636155|588332961|FG000|Overall Study|Withdrawal by Subject|3|||
162899399|NCT00636155|588332961|FG000|Overall Study|Stem cell transplant|1|||
162899400|NCT00636155|588332961|FG000|Overall Study|Physician Decision|5|||
162899401|NCT00766142|588332962|FG000|Overall Study|Protocol Violation|4|||
162899402|NCT05643170|588332968|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
162899403|NCT05643170|588332968|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
162899404|NCT02973997|588332975|FG000|Overall Study|Withdrawal by Subject|4|||
162899405|NCT02973997|588332976|FG001|Overall Study|Withdrawal by Subject|0|||
162899406|NCT02973997|588332975|FG000|Overall Study|Adverse Event|4|||
162899407|NCT02973997|588332976|FG001|Overall Study|Adverse Event|1|||
162899408|NCT02973997|588332975|FG000|Overall Study|Disease Progression|11|||
162899409|NCT02973997|588332976|FG001|Overall Study|Disease Progression|20|||
162899410|NCT02973997|588332975|FG000|Overall Study|Alternative Therapy|3|||
162899411|NCT02973997|588332976|FG001|Overall Study|Alternative Therapy|0|||
162899412|NCT02973997|588332975|FG000|Overall Study|Other complicating disease|0|||
163052299|NCT01211145|588900999|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163052300|NCT01211145|588901000|FG002|Overall Study|Study-specific withdrawal criteria|0|||
163052301|NCT01211145|588901001|FG003|Overall Study|Study-specific withdrawal criteria|0|||
163052302|NCT01211145|588900998|FG000|Overall Study|Severe noncompliance to protocol|1|||
163052303|NCT01211145|588900999|FG001|Overall Study|Severe noncompliance to protocol|0|||
163052304|NCT01211145|588901000|FG002|Overall Study|Severe noncompliance to protocol|0|||
163052305|NCT01211145|588901001|FG003|Overall Study|Severe noncompliance to protocol|0|||
163052306|NCT01211145|588900998|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
163052307|NCT01211145|588900999|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
162625458|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162625459|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
162625460|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162899413|NCT02973997|588332976|FG001|Overall Study|Other complicating disease|1|||
162899414|NCT02973997|588332975|FG000|Overall Study|Death|0|||
162899415|NCT02973997|588332976|FG001|Overall Study|Death|1|||
162899416|NCT01431521|588332977|FG000|Overall Study|Withdrawal by Subject|0|||
162899417|NCT01431521|588332978|FG001|Overall Study|Withdrawal by Subject|0|||
162899418|NCT01431521|588332979|FG002|Overall Study|Withdrawal by Subject|1|||
162899419|NCT01431521|588332980|FG003|Overall Study|Withdrawal by Subject|0|||
162899420|NCT00444951|588332981|FG000|Overall Study|Lost to Follow-up|1|||
162899421|NCT00444951|588332982|FG001|Overall Study|Lost to Follow-up|1|||
162899422|NCT00444951|588332983|FG002|Overall Study|Lost to Follow-up|0|||
162899423|NCT00444951|588332981|FG000|Overall Study|Withdrawal by Subject|4|||
162899424|NCT00444951|588332982|FG001|Overall Study|Withdrawal by Subject|5|||
162899425|NCT00444951|588332983|FG002|Overall Study|Withdrawal by Subject|3|||
162899426|NCT02710422|588332984|FG000|Overall Study|Termination of study|9|||
163052308|NCT01211145|588901000|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
162899427|NCT02710422|588332985|FG001|Overall Study|Termination of study|9|||
162899428|NCT00887822|588332986|FG000|Overall Study|Insufficient therapeutic response|53|||
162899429|NCT00887822|588332987|FG001|Overall Study|Insufficient therapeutic response|55|||
162899430|NCT00887822|588332986|FG000|Overall Study|Adverse Event|14|||
162899431|NCT00887822|588332987|FG001|Overall Study|Adverse Event|17|||
162899432|NCT00887822|588332986|FG000|Overall Study|Failure to return|11|||
162899433|NCT00887822|588332987|FG001|Overall Study|Failure to return|11|||
162899434|NCT00887822|588332986|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
162899435|NCT00887822|588332987|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
162899436|NCT00887822|588332986|FG000|Overall Study|Administrative/Other than specified|5|||
162899437|NCT00887822|588332987|FG001|Overall Study|Administrative/Other than specified|4|||
162899438|NCT00887822|588332986|FG000|Overall Study|Death|2|||
162899439|NCT00887822|588332987|FG001|Overall Study|Death|3|||
162899440|NCT00887822|588332986|FG000|Overall Study|Protocol Violation|0|||
162899441|NCT00887822|588332987|FG001|Overall Study|Protocol Violation|1|||
162899442|NCT00887822|588332986|FG000|Overall Study|Randomized but not treated|0|||
162899443|NCT00887822|588332987|FG001|Overall Study|Randomized but not treated|1|||
162899444|NCT02000622|588332988|FG000|Overall Study|Withdrawal by Subject|5|||
162899445|NCT02000622|588332989|FG001|Overall Study|Withdrawal by Subject|7|||
162899446|NCT02000622|588332988|FG000|Overall Study|Lost to Follow-up|4|||
162899447|NCT02000622|588332989|FG001|Overall Study|Lost to Follow-up|0|||
162899448|NCT02000622|588332988|FG000|Overall Study|Death|159|||
162899449|NCT02000622|588332989|FG001|Overall Study|Death|73|||
162899450|NCT02000622|588332988|FG000|Overall Study|Withdrawn due to site closure|1|||
162899451|NCT02000622|588332989|FG001|Overall Study|Withdrawn due to site closure|0|||
162899452|NCT01462045|588332993|FG000|Overall Study|Family matter|0|||
162899453|NCT01462045|588332994|FG001|Overall Study|Family matter|1|||
162899454|NCT01462045|588332995|FG002|Overall Study|Family matter|0|||
162899455|NCT02045979|588332996|FG000|Overall Study|Informed Consent Withdrawn|2|||
162965473|NCT03922750|588573307|FG000|Overall Study|Unclassified|0|||
162965474|NCT03922750|588573308|FG001|Overall Study|Unclassified|0|||
162965475|NCT03922750|588573309|FG002|Overall Study|Unclassified|1|||
162965476|NCT03922750|588573307|FG000|Overall Study|Adverse Event|0|||
162965477|NCT03922750|588573308|FG001|Overall Study|Adverse Event|1|||
162965478|NCT03922750|588573309|FG002|Overall Study|Adverse Event|0|||
162965479|NCT03366428|588573310|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
162965480|NCT03366428|588573310|FG000|Overall Study|Adverse Event|12|||
162965481|NCT03366428|588573310|FG000|Overall Study|Clinical progression|2|||
162965482|NCT03366428|588573310|FG000|Overall Study|Withdrawal by Subject|4|||
162965483|NCT01046084|588573314|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
162965484|NCT01046084|588573315|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
162965485|NCT02166606|588573316|FG000|Overall Study|Adverse Event|3|||
162965486|NCT02166606|588573316|FG000|Overall Study|Death|31|||
162965487|NCT02166606|588573316|FG000|Overall Study|Protocol Violation|7|||
162965488|NCT02166606|588573316|FG000|Overall Study|Lost to Follow-up|30|||
162965489|NCT02166606|588573316|FG000|Overall Study|Withdrawal by Subject|1|||
162965490|NCT02166606|588573316|FG000|Overall Study|Physician Decision|1|||
162965491|NCT02166606|588573316|FG000|Overall Study|Device upgrade|1|||
162965492|NCT02166606|588573316|FG000|Overall Study|Enrolled after End of Enrollment|4|||
162965493|NCT01958476|588573317|FG000|Overall Study|Parent requested exclusion from analysis|1|||
162965494|NCT01958476|588573318|FG001|Overall Study|Parent requested exclusion from analysis|0|||
162965495|NCT01971645|588573319|FG000|Overall Study|Adverse Event|1|||
162965496|NCT01971645|588573320|FG001|Overall Study|Adverse Event|0|||
162899456|NCT02045979|588332997|FG001|Overall Study|Informed Consent Withdrawn|0|||
162899457|NCT02045979|588332998|FG002|Overall Study|Informed Consent Withdrawn|1|||
162899458|NCT02045979|588332996|FG000|Overall Study|not specified above|0|||
162899459|NCT02045979|588332997|FG001|Overall Study|not specified above|1|||
162899460|NCT02045979|588332998|FG002|Overall Study|not specified above|0|||
162899461|NCT01938391|588333001|FG000|6 Month Follow up|Withdrawal by Subject|1|||
162899462|NCT01938391|588333001|FG000|12 Month Follow up|Physician Decision|1|||
162965497|NCT01971645|588573321|FG002|Overall Study|Adverse Event|0|||
162965498|NCT01971645|588573319|FG000|Overall Study|Lost to Follow-up|1|||
162965499|NCT01971645|588573320|FG001|Overall Study|Lost to Follow-up|0|||
162965500|NCT01971645|588573321|FG002|Overall Study|Lost to Follow-up|1|||
162965501|NCT01971645|588573319|FG000|Overall Study|Protocol Violation|0|||
162965502|NCT01971645|588573320|FG001|Overall Study|Protocol Violation|0|||
162965503|NCT01971645|588573321|FG002|Overall Study|Protocol Violation|1|||
162965504|NCT02943096|588573324|FG000|Overall Study|Lack of Efficacy|0|||
162899463|NCT01938391|588333001|FG000|12 Month Follow up|Withdrawal by Subject|1|||
162899464|NCT04924114|588333005|FG000|Overall Study|Withdrawal by Subject|0|||
162899465|NCT04924114|588333006|FG001|Overall Study|Withdrawal by Subject|2|||
162899466|NCT04924114|588333007|FG002|Overall Study|Withdrawal by Subject|2|||
162899467|NCT04924114|588333008|FG003|Overall Study|Withdrawal by Subject|0|||
162899468|NCT04924114|588333009|FG004|Overall Study|Withdrawal by Subject|2|||
162899469|NCT03558828|588333013|FG000|Overall Study|Lost to Follow-up|4|||
162899470|NCT03558828|588333014|FG001|Overall Study|Lost to Follow-up|3|||
162899471|NCT03558828|588333015|FG002|Overall Study|Lost to Follow-up|3|||
162965505|NCT02943096|588573325|FG001|Overall Study|Lack of Efficacy|1|||
162625461|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162625462|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
162625463|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
162625464|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
162625465|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
162625466|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
162625467|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
162625468|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
162625469|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
162625470|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
162625471|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
162625472|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162625473|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162625474|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162625475|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
162625476|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162625477|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162625478|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162625479|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
162625480|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162625481|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162625482|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Change of location|0|||
162625483|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Change of location|0|||
162625484|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Change of location|0|||
162625485|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Change of location|1|||
162625486|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Change of location|0|||
162625487|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
162625488|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
162625489|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
162625490|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
162625491|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
162625492|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162625493|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162625494|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162625495|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162625496|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
162625497|NCT00730405|587344881|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
162899472|NCT03558828|588333016|FG003|Overall Study|Lost to Follow-up|5|||
162899473|NCT03558828|588333017|FG004|Overall Study|Lost to Follow-up|2|||
162899474|NCT03558828|588333018|FG005|Overall Study|Lost to Follow-up|3|||
162899475|NCT03558828|588333013|FG000|Overall Study|dropped before the intervention|1|||
162899476|NCT03558828|588333014|FG001|Overall Study|dropped before the intervention|1|||
162899477|NCT03558828|588333015|FG002|Overall Study|dropped before the intervention|0|||
162899478|NCT03558828|588333016|FG003|Overall Study|dropped before the intervention|0|||
162899479|NCT03558828|588333017|FG004|Overall Study|dropped before the intervention|0|||
162899480|NCT03558828|588333018|FG005|Overall Study|dropped before the intervention|0|||
162899481|NCT00378534|588333019|FG000|Overall Study|Participants did not receive transplant|3|||
162899482|NCT00378534|588333020|FG001|Overall Study|Participants did not receive transplant|0|||
162899483|NCT03671148|588333024|FG000|Overall Study|Adverse Event|3|||
162899484|NCT03671148|588333025|FG001|Overall Study|Adverse Event|2|||
162899485|NCT03671148|588333024|FG000|Overall Study|Withdrawal by Subject|8|||
162899486|NCT03671148|588333025|FG001|Overall Study|Withdrawal by Subject|2|||
162899487|NCT03671148|588333024|FG000|Overall Study|Lost to Follow-up|1|||
162899488|NCT03671148|588333025|FG001|Overall Study|Lost to Follow-up|2|||
162899489|NCT03671148|588333024|FG000|Overall Study|Lack of Efficacy|7|||
162899490|NCT03671148|588333025|FG001|Overall Study|Lack of Efficacy|2|||
162899491|NCT03671148|588333024|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
162899492|NCT03671148|588333025|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
162899493|NCT03671148|588333024|FG000|Overall Study|Other|1|||
162899494|NCT03671148|588333025|FG001|Overall Study|Other|0|||
162899495|NCT03671148|588333024|FG000|Overall Study|Incomplete Randomization Visit|1|||
162899496|NCT03671148|588333025|FG001|Overall Study|Incomplete Randomization Visit|0|||
162899497|NCT00425945|588333026|FG000|Overall Study|Concern about Supplement|2|||
162899498|NCT00425945|588333027|FG001|Overall Study|Concern about Supplement|0|||
162899499|NCT00425945|588333026|FG000|Overall Study|Inconvenience|0|||
162899500|NCT00425945|588333027|FG001|Overall Study|Inconvenience|2|||
162899501|NCT00425945|588333026|FG000|Overall Study|Lost to Follow-up|0|||
162899502|NCT00425945|588333027|FG001|Overall Study|Lost to Follow-up|2|||
162899503|NCT00425945|588333026|FG000|Overall Study|Began hypertension medication|1|||
162899504|NCT00425945|588333027|FG001|Overall Study|Began hypertension medication|0|||
162899505|NCT00425945|588333026|FG000|Overall Study|Began cancer treatments|1|||
162899506|NCT00425945|588333027|FG001|Overall Study|Began cancer treatments|0|||
162899507|NCT00425945|588333026|FG000|Overall Study|Moved from area|0|||
162899508|NCT00425945|588333027|FG001|Overall Study|Moved from area|1|||
162899509|NCT03878160|588333031|FG000|Overall Study|Lost to Follow-up|1|||
162899510|NCT03878160|588333032|FG001|Overall Study|Lost to Follow-up|1|||
162899511|NCT03878160|588333033|FG002|Overall Study|Lost to Follow-up|1|||
162899512|NCT03878160|588333031|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
162899513|NCT03878160|588333032|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
162899514|NCT03878160|588333033|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
162899515|NCT00673816|588333034|FG000|Overall Study|Adverse Event|1|||
162899516|NCT00673816|588333034|FG000|Overall Study|Withdrawal by Subject|1|||
162899517|NCT05618808|588333035|FG000|Overall Study|Withdrawal by Subject|3|||
162899518|NCT05618808|588333036|FG001|Overall Study|Withdrawal by Subject|1|||
162899519|NCT05618808|588333037|FG002|Overall Study|Withdrawal by Subject|3|||
162899520|NCT01804842|588333041|FG000|Overall Study|Adverse Event|1|||
162899521|NCT01804842|588333042|FG001|Overall Study|Adverse Event|1|||
162899522|NCT01804842|588333043|FG002|Overall Study|Adverse Event|0|||
162899523|NCT01804842|588333041|FG000|Overall Study|Lost to Follow-up|1|||
162899524|NCT01804842|588333042|FG001|Overall Study|Lost to Follow-up|0|||
162899525|NCT01804842|588333043|FG002|Overall Study|Lost to Follow-up|0|||
162899526|NCT01804842|588333041|FG000|Overall Study|Non-Compliance|1|||
162899527|NCT01804842|588333042|FG001|Overall Study|Non-Compliance|1|||
162899528|NCT01804842|588333043|FG002|Overall Study|Non-Compliance|0|||
162899529|NCT01804842|588333041|FG000|Overall Study|Personal Reason|0|||
162899530|NCT01804842|588333042|FG001|Overall Study|Personal Reason|0|||
162899531|NCT01804842|588333043|FG002|Overall Study|Personal Reason|1|||
162899532|NCT02365506|588333046|FG000|Overall Study|Investigator's Discretion|0|||
162899533|NCT02365506|588333047|FG001|Overall Study|Investigator's Discretion|0|||
162899534|NCT02365506|588333048|FG002|Overall Study|Investigator's Discretion|1|||
162899535|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
162899536|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
162899537|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
162899538|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
162899539|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
162899540|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
162899541|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
162899542|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
162899543|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
162899544|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
162899545|NCT03774875|588333049|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
162899546|NCT03774875|588333050|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
162899547|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
162899548|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
162899549|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
162899550|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
162899551|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
162899552|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
162899553|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
162899554|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
162899555|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
162899556|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
162899557|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
162899558|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
162899559|NCT03774875|588333049|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
162625498|NCT00730405|587344882|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162625499|NCT00730405|587344883|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162625500|NCT00730405|587344884|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162625501|NCT00730405|587344885|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162625502|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
162965506|NCT03868631|588573326|FG000|Baseline to Week 6|Adverse Event|0|||
162965507|NCT03868631|588573327|FG001|Baseline to Week 6|Adverse Event|3|||
162965508|NCT03868631|588573326|FG000|Baseline to Week 6|Protocol Violation|1|||
162965509|NCT03868631|588573327|FG001|Baseline to Week 6|Protocol Violation|1|||
162965510|NCT03868631|588573326|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
162965511|NCT03868631|588573327|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
162965512|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
162965513|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
162965514|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
162965515|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
162965516|NCT03868631|588573326|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
162965517|NCT03868631|588573327|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
162965518|NCT03867760|588573328|FG000|Overall Study|Lost to Follow-up|2|||
162965519|NCT03867760|588573329|FG001|Overall Study|Lost to Follow-up|3|||
162965520|NCT03867760|588573328|FG000|Overall Study|Withdrawal by Subject|1|||
162965521|NCT03867760|588573329|FG001|Overall Study|Withdrawal by Subject|2|||
162965522|NCT03867760|588573328|FG000|Overall Study|subject could not meet study logistics|3|||
162965523|NCT03867760|588573329|FG001|Overall Study|subject could not meet study logistics|3|||
162965524|NCT01717040|588573331|FG000|Overall Study|Lost to Follow-up|2|||
162965525|NCT01717040|588573332|FG001|Overall Study|Lost to Follow-up|3|||
162965526|NCT01717040|588573331|FG000|Overall Study|Lack of Efficacy|1|||
162965527|NCT01717040|588573332|FG001|Overall Study|Lack of Efficacy|1|||
162965528|NCT01717040|588573331|FG000|Overall Study|Adverse Event|1|||
162965529|NCT01717040|588573332|FG001|Overall Study|Adverse Event|0|||
162965530|NCT01717040|588573331|FG000|Overall Study|Required Medication Change|0|||
162965531|NCT01717040|588573332|FG001|Overall Study|Required Medication Change|1|||
162965532|NCT01717040|588573331|FG000|Overall Study|New Substance Use Disorder|1|||
162965533|NCT01717040|588573332|FG001|Overall Study|New Substance Use Disorder|0|||
162965534|NCT04236596|588573333|FG000|Overall Study|Withdrawal by Subject|1|||
162965535|NCT04236596|588573333|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
162965536|NCT04236596|588573333|FG000|Overall Study|Participants did not receive implant at all|4|||
162965537|NCT02588339|588573335|FG000|Overall Study|Withdrawal by Subject|1|||
162965538|NCT02588339|588573335|FG000|Overall Study|GVHD Progression prior to treatment|2|||
162965539|NCT02966340|588574552|FG000|Overall Study|Adverse Event|0|||
162965540|NCT02966340|588574553|FG001|Overall Study|Adverse Event|1|||
162965541|NCT02966340|588574552|FG000|Overall Study|Lost to Follow-up|0|||
162965542|NCT02966340|588574553|FG001|Overall Study|Lost to Follow-up|1|||
162965543|NCT02966340|588574552|FG000|Overall Study|Withdrawal by Subject|1|||
162965544|NCT02966340|588574553|FG001|Overall Study|Withdrawal by Subject|0|||
162965545|NCT02966340|588574552|FG000|Overall Study|data acquisition error|1|||
162965546|NCT02966340|588574553|FG001|Overall Study|data acquisition error|0|||
162965547|NCT02966340|588574552|FG000|Overall Study|startle non-responder|1|||
162965548|NCT02966340|588574553|FG001|Overall Study|startle non-responder|1|||
162965549|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965550|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965551|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965552|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
162965553|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965554|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
162965555|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965556|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965557|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
162965558|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
162965559|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162899560|NCT03774875|588333050|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
162899561|NCT02352090|588333051|FG000|Overall Study|general malaise|1|||
162899562|NCT02352090|588333052|FG001|Overall Study|general malaise|0|||
162899563|NCT02352090|588333053|FG002|Overall Study|general malaise|0|||
162899564|NCT02352090|588333051|FG000|Overall Study|non-specified mild side-effects|0|||
162899565|NCT02352090|588333052|FG001|Overall Study|non-specified mild side-effects|0|||
162625503|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
162625504|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
162625505|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
162625506|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
162625507|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
162625508|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
162625509|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
162625510|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
162625511|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
162625512|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
162625513|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
162625514|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
162625515|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
162625516|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
162625517|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Death|0|||
162625518|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Death|1|||
162625519|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Death|0|||
162625520|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Death|1|||
162625521|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Death|0|||
162625522|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Change of location|1|||
162625523|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Change of location|1|||
162625524|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Change of location|0|||
162625525|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Change of location|1|||
162625526|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Change of location|0|||
162625527|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
162625528|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
162625529|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
162625530|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
162625531|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
162625532|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162625533|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162625534|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
162625535|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162625536|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162625537|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162625538|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162625539|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
162625540|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162625541|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162625542|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162625543|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162625544|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162625545|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162899566|NCT02352090|588333053|FG002|Overall Study|non-specified mild side-effects|2|||
162899567|NCT06048367|588333056|FG000|Overall Study|Withdrawal by Subject|0|||
162899568|NCT06048367|588333057|FG001|Overall Study|Withdrawal by Subject|1|||
162899569|NCT06048367|588333058|FG002|Overall Study|Withdrawal by Subject|0|||
162899570|NCT06048367|588333059|FG003|Overall Study|Withdrawal by Subject|0|||
162899571|NCT06048367|588333060|FG004|Overall Study|Withdrawal by Subject|0|||
162899572|NCT06048367|588333056|FG000|Overall Study|Withdrawal by Subject|0|||
162899573|NCT06048367|588333057|FG001|Overall Study|Withdrawal by Subject|0|||
162899574|NCT06048367|588333058|FG002|Overall Study|Withdrawal by Subject|1|||
162899575|NCT06048367|588333059|FG003|Overall Study|Withdrawal by Subject|0|||
162899576|NCT06048367|588333060|FG004|Overall Study|Withdrawal by Subject|0|||
162899577|NCT06048367|588333056|FG000|Overall Study|Withdrawal by Subject|0|||
162899578|NCT06048367|588333057|FG001|Overall Study|Withdrawal by Subject|0|||
162899579|NCT06048367|588333058|FG002|Overall Study|Withdrawal by Subject|0|||
162899580|NCT06048367|588333059|FG003|Overall Study|Withdrawal by Subject|1|||
162899581|NCT06048367|588333060|FG004|Overall Study|Withdrawal by Subject|0|||
162899582|NCT06048367|588333056|FG000|Overall Study|Withdrawal by Subject|0|||
162899583|NCT06048367|588333057|FG001|Overall Study|Withdrawal by Subject|0|||
162899584|NCT06048367|588333058|FG002|Overall Study|Withdrawal by Subject|0|||
162899585|NCT06048367|588333059|FG003|Overall Study|Withdrawal by Subject|1|||
162899586|NCT06048367|588333060|FG004|Overall Study|Withdrawal by Subject|0|||
162899587|NCT00413777|588333062|FG000|Fixed-dose Period|Lost to Follow-up|1|||
162899588|NCT00413777|588333063|FG001|Fixed-dose Period|Lost to Follow-up|1|||
162899589|NCT00413777|588333062|FG000|Fixed-dose Period|Adverse Event|2|||
162899590|NCT00413777|588333063|FG001|Fixed-dose Period|Adverse Event|1|||
163052309|NCT01211145|588901001|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
162899591|NCT00413777|588333062|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
162899592|NCT00413777|588333063|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
162899593|NCT00413777|588333062|FG000|Fixed-dose Period|Withdrew Consent|0|||
162899594|NCT00413777|588333063|FG001|Fixed-dose Period|Withdrew Consent|1|||
162899595|NCT01678313|588333064|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
162899596|NCT01678313|588333065|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
162899597|NCT01678313|588333064|FG000|Completed the 3-month Therapy|Physician Decision|3|||
162899598|NCT01678313|588333065|FG001|Completed the 3-month Therapy|Physician Decision|4|||
162899599|NCT01678313|588333064|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
162899600|NCT01678313|588333065|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
162899601|NCT01678313|588333064|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
162899602|NCT01678313|588333065|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
162899603|NCT05179057|588333066|FG000|Overall Study|Adverse Event|3|||
162899604|NCT05179057|588333067|FG001|Overall Study|Adverse Event|2|||
162899605|NCT05179057|588333066|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
162899606|NCT05179057|588333067|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
162899607|NCT05179057|588333066|FG000|Overall Study|Study terminated|13|||
162899608|NCT05179057|588333067|FG001|Overall Study|Study terminated|7|||
162965560|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
162965561|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965562|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965563|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
162965564|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965565|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965566|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
162965567|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965568|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965569|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
162965570|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
162965571|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965572|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
162965573|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965574|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965575|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
162965576|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
162965577|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965578|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
162965579|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
162965580|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
162965581|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
162965582|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
162965583|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
162965584|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
162965585|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
162965586|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
162965587|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
162965588|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
162965589|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
162965590|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
162965591|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162899609|NCT05179057|588333066|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
162899610|NCT05179057|588333067|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
162899611|NCT05179057|588333066|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
162899612|NCT05179057|588333067|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
162899613|NCT03345342|588333068|FG000|Open-Label Phase|Adverse Event|30|||
162899614|NCT03345342|588333069|FG001|Open-Label Phase|Adverse Event|0|||
162899615|NCT03345342|588333070|FG002|Open-Label Phase|Adverse Event|0|||
162899616|NCT03345342|588333071|FG003|Open-Label Phase|Adverse Event|0|||
162899617|NCT03345342|588333072|FG004|Open-Label Phase|Adverse Event|0|||
162899618|NCT03345342|588333068|FG000|Open-Label Phase|Death|1|||
162899619|NCT03345342|588333069|FG001|Open-Label Phase|Death|0|||
162899620|NCT03345342|588333070|FG002|Open-Label Phase|Death|0|||
162899621|NCT03345342|588333071|FG003|Open-Label Phase|Death|0|||
162899622|NCT03345342|588333072|FG004|Open-Label Phase|Death|0|||
162899623|NCT03345342|588333068|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
162899624|NCT03345342|588333069|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
162899625|NCT03345342|588333070|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
162899626|NCT03345342|588333071|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
162899627|NCT03345342|588333072|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
162899628|NCT03345342|588333068|FG000|Open-Label Phase|Lack of Efficacy|6|||
162899629|NCT03345342|588333069|FG001|Open-Label Phase|Lack of Efficacy|0|||
162899630|NCT03345342|588333070|FG002|Open-Label Phase|Lack of Efficacy|0|||
162899631|NCT03345342|588333071|FG003|Open-Label Phase|Lack of Efficacy|0|||
162899632|NCT03345342|588333072|FG004|Open-Label Phase|Lack of Efficacy|0|||
162899633|NCT03345342|588333068|FG000|Open-Label Phase|Lost to Follow-up|9|||
162899634|NCT03345342|588333069|FG001|Open-Label Phase|Lost to Follow-up|0|||
162899635|NCT03345342|588333070|FG002|Open-Label Phase|Lost to Follow-up|0|||
162899636|NCT03345342|588333071|FG003|Open-Label Phase|Lost to Follow-up|0|||
162899637|NCT03345342|588333072|FG004|Open-Label Phase|Lost to Follow-up|0|||
162899638|NCT03345342|588333068|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
162899639|NCT03345342|588333069|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
162899640|NCT03345342|588333070|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
162899641|NCT03345342|588333071|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
162899642|NCT03345342|588333072|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
162899643|NCT03345342|588333068|FG000|Open-Label Phase|Physician Decision|4|||
162899644|NCT03345342|588333069|FG001|Open-Label Phase|Physician Decision|0|||
162899645|NCT03345342|588333070|FG002|Open-Label Phase|Physician Decision|0|||
162899646|NCT03345342|588333071|FG003|Open-Label Phase|Physician Decision|0|||
162899647|NCT03345342|588333072|FG004|Open-Label Phase|Physician Decision|0|||
162899648|NCT03345342|588333068|FG000|Open-Label Phase|Protocol Violation|8|||
162899649|NCT03345342|588333069|FG001|Open-Label Phase|Protocol Violation|0|||
162899650|NCT03345342|588333070|FG002|Open-Label Phase|Protocol Violation|0|||
162899651|NCT03345342|588333071|FG003|Open-Label Phase|Protocol Violation|0|||
162899652|NCT03345342|588333072|FG004|Open-Label Phase|Protocol Violation|0|||
162899653|NCT03345342|588333068|FG000|Open-Label Phase|Withdrawal by Subject|57|||
162899654|NCT03345342|588333069|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162899655|NCT03345342|588333070|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162899656|NCT03345342|588333071|FG003|Open-Label Phase|Withdrawal by Subject|0|||
162899657|NCT03345342|588333072|FG004|Open-Label Phase|Withdrawal by Subject|0|||
162899658|NCT03345342|588333068|FG000|Open-Label Phase|Other|15|||
162899659|NCT03345342|588333069|FG001|Open-Label Phase|Other|0|||
162899660|NCT03345342|588333070|FG002|Open-Label Phase|Other|0|||
162899661|NCT03345342|588333071|FG003|Open-Label Phase|Other|0|||
162899662|NCT03345342|588333072|FG004|Open-Label Phase|Other|0|||
162899663|NCT03345342|588333068|FG000|Double-Blind Phase|Adverse Event|0|||
162899664|NCT03345342|588333069|FG001|Double-Blind Phase|Adverse Event|1|||
162899665|NCT03345342|588333070|FG002|Double-Blind Phase|Adverse Event|6|||
162899666|NCT03345342|588333071|FG003|Double-Blind Phase|Adverse Event|0|||
162899667|NCT03345342|588333072|FG004|Double-Blind Phase|Adverse Event|0|||
162899668|NCT03345342|588333068|FG000|Double-Blind Phase|Death|0|||
162899669|NCT03345342|588333069|FG001|Double-Blind Phase|Death|2|||
162899670|NCT03345342|588333070|FG002|Double-Blind Phase|Death|1|||
162899671|NCT03345342|588333071|FG003|Double-Blind Phase|Death|0|||
162899672|NCT03345342|588333072|FG004|Double-Blind Phase|Death|0|||
162899673|NCT03345342|588333068|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
162899674|NCT03345342|588333069|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
162899675|NCT03345342|588333070|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
162899676|NCT03345342|588333071|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
162899677|NCT03345342|588333072|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
162899678|NCT03345342|588333068|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162899679|NCT03345342|588333069|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162899680|NCT03345342|588333070|FG002|Double-Blind Phase|Lost to Follow-up|7|||
162899681|NCT03345342|588333071|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162899682|NCT03345342|588333072|FG004|Double-Blind Phase|Lost to Follow-up|0|||
162899683|NCT03345342|588333068|FG000|Double-Blind Phase|Physician Decision|0|||
162899684|NCT03345342|588333069|FG001|Double-Blind Phase|Physician Decision|1|||
162899685|NCT03345342|588333070|FG002|Double-Blind Phase|Physician Decision|4|||
162899686|NCT03345342|588333071|FG003|Double-Blind Phase|Physician Decision|0|||
162899687|NCT03345342|588333072|FG004|Double-Blind Phase|Physician Decision|0|||
162899688|NCT03345342|588333068|FG000|Double-Blind Phase|Protocol Violation|0|||
162899689|NCT03345342|588333069|FG001|Double-Blind Phase|Protocol Violation|0|||
162899690|NCT03345342|588333070|FG002|Double-Blind Phase|Protocol Violation|1|||
162899691|NCT03345342|588333071|FG003|Double-Blind Phase|Protocol Violation|0|||
162899692|NCT03345342|588333072|FG004|Double-Blind Phase|Protocol Violation|0|||
162899693|NCT03345342|588333068|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162899694|NCT03345342|588333069|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
162899695|NCT03345342|588333070|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
163052310|NCT01211145|588900998|FG000|Overall Study|Patient decision|2|||
163052311|NCT01211145|588900999|FG001|Overall Study|Patient decision|1|||
163052312|NCT01211145|588901000|FG002|Overall Study|Patient decision|0|||
163052313|NCT01211145|588901001|FG003|Overall Study|Patient decision|2|||
163052314|NCT00249834|588901004|FG000|Overall Study|Ovarian stimulation failed|1|||
163052315|NCT00249834|588901005|FG001|Overall Study|Ovarian stimulation failed|0|||
163052316|NCT00249834|588901006|FG002|Overall Study|Ovarian stimulation failed|0|||
163052317|NCT00249834|588901007|FG003|Overall Study|Ovarian stimulation failed|0|||
163052318|NCT00249834|588901008|FG004|Overall Study|Ovarian stimulation failed|0|||
163052319|NCT00249834|588901009|FG005|Overall Study|Ovarian stimulation failed|0|||
163052320|NCT00249834|588901010|FG006|Overall Study|Ovarian stimulation failed|0|||
162899696|NCT03345342|588333071|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162899697|NCT03345342|588333072|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
162899698|NCT03345342|588333068|FG000|Double-Blind Phase|Other|0|||
162899699|NCT03345342|588333069|FG001|Double-Blind Phase|Other|1|||
162899700|NCT03345342|588333070|FG002|Double-Blind Phase|Other|3|||
162899701|NCT03345342|588333071|FG003|Double-Blind Phase|Other|0|||
162899702|NCT03345342|588333072|FG004|Double-Blind Phase|Other|0|||
162899703|NCT03345342|588333068|FG000|Follow-Up Phase|Adverse Event|0|||
162899704|NCT03345342|588333069|FG001|Follow-Up Phase|Adverse Event|0|||
162899705|NCT03345342|588333070|FG002|Follow-Up Phase|Adverse Event|0|||
162899706|NCT03345342|588333071|FG003|Follow-Up Phase|Adverse Event|0|||
162899707|NCT03345342|588333072|FG004|Follow-Up Phase|Adverse Event|4|||
162899708|NCT03345342|588333068|FG000|Follow-Up Phase|Lost to Follow-up|0|||
162899709|NCT03345342|588333069|FG001|Follow-Up Phase|Lost to Follow-up|0|||
162899710|NCT03345342|588333070|FG002|Follow-Up Phase|Lost to Follow-up|0|||
162899711|NCT03345342|588333071|FG003|Follow-Up Phase|Lost to Follow-up|0|||
162899712|NCT03345342|588333072|FG004|Follow-Up Phase|Lost to Follow-up|6|||
162899713|NCT03345342|588333068|FG000|Follow-Up Phase|Physician Decision|0|||
162899714|NCT03345342|588333069|FG001|Follow-Up Phase|Physician Decision|0|||
162899715|NCT03345342|588333070|FG002|Follow-Up Phase|Physician Decision|0|||
163052321|NCT00249834|588901011|FG007|Overall Study|Ovarian stimulation failed|0|||
163052322|NCT00249834|588901004|FG000|Overall Study|Failure of down-regulation|0|||
163052323|NCT00249834|588901005|FG001|Overall Study|Failure of down-regulation|0|||
163052324|NCT00249834|588901006|FG002|Overall Study|Failure of down-regulation|0|||
163052325|NCT00249834|588901007|FG003|Overall Study|Failure of down-regulation|0|||
163052326|NCT00249834|588901008|FG004|Overall Study|Failure of down-regulation|0|||
163052327|NCT00249834|588901009|FG005|Overall Study|Failure of down-regulation|0|||
163052328|NCT00249834|588901010|FG006|Overall Study|Failure of down-regulation|1|||
163052329|NCT00249834|588901011|FG007|Overall Study|Failure of down-regulation|0|||
163052330|NCT00249834|588901004|FG000|Overall Study|Protocol Violation|0|||
163052331|NCT00249834|588901005|FG001|Overall Study|Protocol Violation|19|||
163052332|NCT00249834|588901006|FG002|Overall Study|Protocol Violation|14|||
163052333|NCT00249834|588901007|FG003|Overall Study|Protocol Violation|8|||
163052334|NCT00249834|588901008|FG004|Overall Study|Protocol Violation|5|||
163052335|NCT00249834|588901009|FG005|Overall Study|Protocol Violation|2|||
163052336|NCT00249834|588901010|FG006|Overall Study|Protocol Violation|0|||
163052337|NCT00249834|588901011|FG007|Overall Study|Protocol Violation|0|||
163052338|NCT02688933|588901014|FG000|Overall Study|Adverse Event|3|||
163052339|NCT02688933|588901015|FG001|Overall Study|Adverse Event|1|||
163052340|NCT02688933|588901014|FG000|Overall Study|Lack of Efficacy|2|||
163052341|NCT02688933|588901015|FG001|Overall Study|Lack of Efficacy|2|||
163052342|NCT02688933|588901014|FG000|Overall Study|Poor compliance to protocol|7|||
163052343|NCT02688933|588901015|FG001|Overall Study|Poor compliance to protocol|4|||
163052344|NCT02688933|588901014|FG000|Overall Study|Hypoglycemia|2|||
163052345|NCT02688933|588901015|FG001|Overall Study|Hypoglycemia|0|||
163052346|NCT02688933|588901014|FG000|Overall Study|Other than Specified|14|||
163052347|NCT02688933|588901015|FG001|Overall Study|Other than Specified|25|||
163052348|NCT02688933|588901014|FG000|Overall Study|Lost to Follow-up|1|||
163052349|NCT02688933|588901015|FG001|Overall Study|Lost to Follow-up|5|||
163052350|NCT03509467|588901018|FG000|Overall Study|Withdrawal by Subject|5|||
163052351|NCT03509467|588901019|FG001|Overall Study|Withdrawal by Subject|1|||
163052352|NCT03509467|588901020|FG002|Overall Study|Withdrawal by Subject|6|||
163052353|NCT03509467|588901021|FG003|Overall Study|Withdrawal by Subject|7|||
163052354|NCT03509467|588901022|FG004|Overall Study|Withdrawal by Subject|10|||
163052355|NCT03509467|588901023|FG005|Overall Study|Withdrawal by Subject|10|||
163052356|NCT03509467|588901024|FG006|Overall Study|Withdrawal by Subject|10|||
163052357|NCT03509467|588901025|FG007|Overall Study|Withdrawal by Subject|10|||
163052358|NCT03509467|588901018|FG000|Overall Study|Death|0|||
162625546|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
162625547|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
162625548|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162625549|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162625550|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162625551|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162625552|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162625553|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162625554|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162625555|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
162625556|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162625557|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162625558|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
162625559|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
162625560|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162625561|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162625562|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
162625563|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
162625564|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162899716|NCT03345342|588333071|FG003|Follow-Up Phase|Physician Decision|0|||
162899717|NCT03345342|588333072|FG004|Follow-Up Phase|Physician Decision|5|||
162899718|NCT03345342|588333068|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
162899719|NCT03345342|588333069|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
162899720|NCT03345342|588333070|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
162899721|NCT03345342|588333071|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
162625565|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162899722|NCT03345342|588333072|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
162625566|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162625567|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
162899723|NCT03345342|588333068|FG000|Follow-Up Phase|Other|0|||
162899724|NCT03345342|588333069|FG001|Follow-Up Phase|Other|0|||
162899725|NCT03345342|588333070|FG002|Follow-Up Phase|Other|0|||
163052359|NCT03509467|588901019|FG001|Overall Study|Death|0|||
163052360|NCT03509467|588901020|FG002|Overall Study|Death|2|||
163052361|NCT03509467|588901021|FG003|Overall Study|Death|2|||
163052362|NCT03509467|588901022|FG004|Overall Study|Death|1|||
162899726|NCT03345342|588333071|FG003|Follow-Up Phase|Other|3|||
162899727|NCT03345342|588333072|FG004|Follow-Up Phase|Other|1|||
162899728|NCT03375203|588333073|FG000|Overall Study|Protocol Violation|0|||
162899729|NCT03375203|588333074|FG001|Overall Study|Protocol Violation|0|||
162899730|NCT03375203|588333075|FG002|Overall Study|Protocol Violation|1|||
162899731|NCT03375203|588333076|FG003|Overall Study|Protocol Violation|0|||
162899732|NCT03375203|588333077|FG004|Overall Study|Protocol Violation|0|||
162899733|NCT03375203|588333073|FG000|Overall Study|Adverse Event|2|||
162899734|NCT03375203|588333074|FG001|Overall Study|Adverse Event|3|||
162899735|NCT03375203|588333075|FG002|Overall Study|Adverse Event|0|||
162899736|NCT03375203|588333076|FG003|Overall Study|Adverse Event|2|||
162899737|NCT03375203|588333077|FG004|Overall Study|Adverse Event|2|||
162899738|NCT03375203|588333073|FG000|Overall Study|Withdrawal by Subject|3|||
162899739|NCT03375203|588333074|FG001|Overall Study|Withdrawal by Subject|0|||
162899740|NCT03375203|588333075|FG002|Overall Study|Withdrawal by Subject|1|||
162899741|NCT03375203|588333076|FG003|Overall Study|Withdrawal by Subject|0|||
162899742|NCT03375203|588333077|FG004|Overall Study|Withdrawal by Subject|2|||
162899743|NCT03375203|588333073|FG000|Overall Study|Non-compliance with study drug|1|||
162899744|NCT03375203|588333074|FG001|Overall Study|Non-compliance with study drug|0|||
162899745|NCT03375203|588333075|FG002|Overall Study|Non-compliance with study drug|0|||
162899746|NCT03375203|588333076|FG003|Overall Study|Non-compliance with study drug|0|||
162899747|NCT03375203|588333077|FG004|Overall Study|Non-compliance with study drug|0|||
162899748|NCT03375203|588333073|FG000|Overall Study|Randomized, not treated.|0|||
162899749|NCT03375203|588333074|FG001|Overall Study|Randomized, not treated.|1|||
162899750|NCT03375203|588333075|FG002|Overall Study|Randomized, not treated.|0|||
162899751|NCT03375203|588333076|FG003|Overall Study|Randomized, not treated.|0|||
162899752|NCT03375203|588333077|FG004|Overall Study|Randomized, not treated.|0|||
162899753|NCT03107793|588333078|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
162899754|NCT03107793|588333079|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
162899755|NCT03107793|588333080|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
162899756|NCT03107793|588333081|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
162899757|NCT03107793|588333082|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
162899758|NCT03107793|588333078|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
162899759|NCT03107793|588333079|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
162899760|NCT03107793|588333080|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
162899761|NCT03107793|588333081|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
162899762|NCT03107793|588333082|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
162899763|NCT03107793|588333078|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
162899764|NCT03107793|588333079|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
162899765|NCT03107793|588333080|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
162899766|NCT03107793|588333081|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
162899767|NCT03107793|588333082|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
162899768|NCT03107793|588333078|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
162899769|NCT03107793|588333079|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162899770|NCT03107793|588333080|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162899771|NCT03107793|588333081|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162899772|NCT03107793|588333082|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162899773|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
162899774|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
162899775|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
162899776|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
162899777|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
162899778|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
162899779|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
162899780|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
162899781|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
162899782|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
162899783|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
162899784|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
162899785|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
162899786|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
162899787|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
162899788|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
162899789|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
162899790|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
162899791|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163052363|NCT03509467|588901023|FG005|Overall Study|Death|0|||
162899792|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
162899793|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
162899794|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
162899795|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
162899796|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
162899797|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
162899798|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
162899799|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
162899800|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
162899801|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
162899802|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
162899803|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
162899804|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
162899805|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
162899806|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
162899807|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
162899808|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
162899809|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
162899810|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
162899811|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
162899812|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
162899813|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
162899814|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
162899815|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
162899816|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
162899817|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
162899818|NCT03107793|588333078|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
162899819|NCT03107793|588333079|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
162899820|NCT03107793|588333080|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
162899821|NCT03107793|588333081|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
162899822|NCT03107793|588333082|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
162899823|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
162899824|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
162899825|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
162899826|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
162899827|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
162899828|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
162899829|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
162899830|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
162899831|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
162899832|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
162899833|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
162899834|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
162899835|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
162899836|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
162899837|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
162899838|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Death|0|||
162899839|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Death|0|||
162899840|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Death|0|||
162899841|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Death|0|||
162899842|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Death|1|||
162899843|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
162899844|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
162899845|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
162899846|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
162899847|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
162899848|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
162899849|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
162899850|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
162899851|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
162899852|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
162899853|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
162899854|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
162899855|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
162899856|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
163052364|NCT03509467|588901024|FG006|Overall Study|Death|1|||
162899857|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
162899858|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
162899859|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
162899860|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
162899861|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
162899862|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
162899863|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
162899864|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
162899865|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
162899866|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
162899867|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
162899868|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Other|0|||
162899869|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Other|0|||
162899870|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Other|0|||
162899871|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Other|1|||
162899872|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Other|3|||
162899873|NCT03107793|588333078|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
162899874|NCT03107793|588333079|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
162899875|NCT03107793|588333080|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
162899876|NCT03107793|588333081|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
162899877|NCT03107793|588333082|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
162899878|NCT03277105|588333083|FG000|Overall Study|Death|129|||
162899879|NCT03277105|588333084|FG001|Overall Study|Death|124|||
162899880|NCT03277105|588333083|FG000|Overall Study|Lost to Follow-up|2|||
162899881|NCT03277105|588333084|FG001|Overall Study|Lost to Follow-up|4|||
162899882|NCT03277105|588333083|FG000|Overall Study|Withdrawal by Subject|10|||
162899883|NCT03277105|588333084|FG001|Overall Study|Withdrawal by Subject|10|||
162899884|NCT03277105|588333083|FG000|Overall Study|Other|118|||
162899885|NCT03277105|588333084|FG001|Overall Study|Other|125|||
162899886|NCT05180721|588333088|FG000|Overall Study|Lost to Follow-up|4|||
162899887|NCT02040857|588333092|FG000|Overall Study|Adverse Event|14|||
162899888|NCT02040857|588333092|FG000|Overall Study|Physician Decision|5|||
162899889|NCT02040857|588333092|FG000|Overall Study|Withdrawal by Subject|31|||
162899890|NCT02040857|588333092|FG000|Overall Study|patient non-compliance|3|||
162899891|NCT02040857|588333092|FG000|Overall Study|Lost to Follow-up|2|||
162899892|NCT02040857|588333092|FG000|Overall Study|recurrence|4|||
162625568|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
162625569|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
162625570|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
162899893|NCT02040857|588333092|FG000|Overall Study|ineligible|1|||
162899894|NCT00976963|588333093|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
162899895|NCT00976963|588333094|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
162899896|NCT00976963|588333093|FG000|Overall Study|administrative error|1|||
162899897|NCT00976963|588333094|FG001|Overall Study|administrative error|0|||
162625571|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
162625572|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
162625573|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
162899898|NCT00976963|588333093|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
162899899|NCT00976963|588333094|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
162899900|NCT00608842|588333095|FG000|Overall Study|Participant's Request|0|||
162899901|NCT00608842|588333096|FG001|Overall Study|Participant's Request|1|||
162899902|NCT00608842|588333097|FG002|Overall Study|Participant's Request|2|||
162899903|NCT00608842|588333098|FG003|Overall Study|Participant's Request|1|||
162899904|NCT00608842|588333095|FG000|Overall Study|Lost to Follow-up|1|||
162899905|NCT00608842|588333096|FG001|Overall Study|Lost to Follow-up|0|||
162899906|NCT00608842|588333097|FG002|Overall Study|Lost to Follow-up|0|||
162899907|NCT00608842|588333098|FG003|Overall Study|Lost to Follow-up|0|||
162899908|NCT01024920|588333099|FG000|Overall Study|Progressive disease|47|||
162899909|NCT01024920|588333100|FG001|Overall Study|Progressive disease|25|||
162899910|NCT01024920|588333099|FG000|Overall Study|Adverse Event|8|||
162965592|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
162965593|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
162965594|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
162965595|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162965596|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162965597|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
162965598|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965599|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
162965600|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
162965601|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965602|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
162965603|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
162965604|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
162965605|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
162965606|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
162965607|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
162965608|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
162965609|NCT03395197|588574554|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
162965610|NCT03395197|588574555|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965611|NCT03395197|588574556|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
162965612|NCT03395197|588574557|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
162965613|NCT03395197|588574558|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965614|NCT03395197|588574559|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
162965615|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Death|0|||
162965616|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Death|0|||
162965617|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Death|0|||
162965618|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Death|0|||
162965619|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Death|1|||
162965620|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Death|4|||
162965621|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965622|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965623|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965624|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
162965625|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
162965626|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
162965627|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965628|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965629|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965630|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965631|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
162965632|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
162965633|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965634|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965635|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965636|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
162965637|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
162965638|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
163052365|NCT03509467|588901025|FG007|Overall Study|Death|0|||
162899911|NCT01024920|588333100|FG001|Overall Study|Adverse Event|4|||
162899912|NCT01024920|588333099|FG000|Overall Study|Lost to Follow-up|0|||
162899913|NCT01024920|588333100|FG001|Overall Study|Lost to Follow-up|1|||
162899914|NCT01024920|588333099|FG000|Overall Study|Patient refusal to continue|4|||
162899915|NCT01024920|588333100|FG001|Overall Study|Patient refusal to continue|0|||
162899916|NCT01024920|588333099|FG000|Overall Study|Other than listed|5|||
162899917|NCT01024920|588333100|FG001|Overall Study|Other than listed|1|||
162899918|NCT01024920|588333099|FG000|Overall Study|Not treated|3|||
162899919|NCT01024920|588333100|FG001|Overall Study|Not treated|0|||
162899920|NCT01024920|588333099|FG000|Overall Study|Protocol Violation|0|||
162899921|NCT01024920|588333100|FG001|Overall Study|Protocol Violation|1|||
162899922|NCT03039790|588333102|FG000|Overall Study|Lost to Follow-up|2|||
162899923|NCT03039790|588333103|FG001|Overall Study|Lost to Follow-up|0|||
162899924|NCT03039790|588333104|FG002|Overall Study|Lost to Follow-up|1|||
162899925|NCT03039790|588333105|FG003|Overall Study|Lost to Follow-up|1|||
162899926|NCT03039790|588333106|FG004|Overall Study|Lost to Follow-up|0|||
162899927|NCT03039790|588333107|FG005|Overall Study|Lost to Follow-up|1|||
162899928|NCT03039790|588333108|FG006|Overall Study|Lost to Follow-up|1|||
162899929|NCT03039790|588333109|FG007|Overall Study|Lost to Follow-up|1|||
162899930|NCT03039790|588333110|FG008|Overall Study|Lost to Follow-up|0|||
162965639|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965640|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965641|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965642|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
162965643|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
162965644|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
162965645|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965646|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965647|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965648|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
162965649|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
162965650|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
162965651|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965652|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965653|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965654|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
162965655|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
162965656|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
162965657|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Other|0|||
162965658|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Other|0|||
162965659|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Other|0|||
162965660|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Other|0|||
162965661|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Other|3|||
162965662|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Other|3|||
162965663|NCT03395197|588574554|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965664|NCT03395197|588574555|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965665|NCT03395197|588574556|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965666|NCT03395197|588574557|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
162965667|NCT03395197|588574558|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
162965668|NCT03395197|588574559|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
162965669|NCT02308241|588574565|FG000|Overall Study|Withdrawal by Subject|3|||
162965670|NCT03609944|588574566|FG000|Overall Study|Lost to Follow-up|1|||
162965671|NCT03609944|588574567|FG001|Overall Study|Lost to Follow-up|5|||
162965672|NCT03609944|588574566|FG000|Overall Study|Withdrawal by Subject|1|||
162965673|NCT03609944|588574567|FG001|Overall Study|Withdrawal by Subject|1|||
162965674|NCT00659815|588574568|FG000|Overall Study|Study related symptoms and complaints|2|||
162899931|NCT03039790|588333111|FG009|Overall Study|Lost to Follow-up|1|||
162899932|NCT03039790|588333112|FG010|Overall Study|Lost to Follow-up|1|||
162899933|NCT03039790|588333113|FG011|Overall Study|Lost to Follow-up|0|||
162899934|NCT03039790|588333114|FG012|Overall Study|Lost to Follow-up|1|||
162899935|NCT03039790|588333115|FG013|Overall Study|Lost to Follow-up|0|||
162899936|NCT03039790|588333116|FG014|Overall Study|Lost to Follow-up|3|||
162899937|NCT03039790|588333117|FG015|Overall Study|Lost to Follow-up|1|||
162899938|NCT03039790|588333118|FG016|Overall Study|Lost to Follow-up|2|||
162965675|NCT00659815|588574569|FG001|Overall Study|Study related symptoms and complaints|1|||
162965676|NCT00659815|588574568|FG000|Overall Study|Inability to maintain wearing schedule|1|||
162899939|NCT03039790|588333119|FG017|Overall Study|Lost to Follow-up|2|||
162899940|NCT03039790|588333120|FG018|Overall Study|Lost to Follow-up|1|||
162899941|NCT03039790|588333121|FG019|Overall Study|Lost to Follow-up|3|||
162899942|NCT03039790|588333102|FG000|Overall Study|Withdrawal of Consent|1|||
162899943|NCT03039790|588333103|FG001|Overall Study|Withdrawal of Consent|0|||
162899944|NCT03039790|588333104|FG002|Overall Study|Withdrawal of Consent|0|||
162899945|NCT03039790|588333105|FG003|Overall Study|Withdrawal of Consent|1|||
162899946|NCT03039790|588333106|FG004|Overall Study|Withdrawal of Consent|0|||
162899947|NCT03039790|588333107|FG005|Overall Study|Withdrawal of Consent|0|||
162899948|NCT03039790|588333108|FG006|Overall Study|Withdrawal of Consent|0|||
162899949|NCT03039790|588333109|FG007|Overall Study|Withdrawal of Consent|0|||
162899950|NCT03039790|588333110|FG008|Overall Study|Withdrawal of Consent|0|||
162899951|NCT03039790|588333111|FG009|Overall Study|Withdrawal of Consent|1|||
162899952|NCT03039790|588333112|FG010|Overall Study|Withdrawal of Consent|0|||
162899953|NCT03039790|588333113|FG011|Overall Study|Withdrawal of Consent|0|||
162899954|NCT03039790|588333114|FG012|Overall Study|Withdrawal of Consent|2|||
162899955|NCT03039790|588333115|FG013|Overall Study|Withdrawal of Consent|0|||
162899956|NCT03039790|588333116|FG014|Overall Study|Withdrawal of Consent|1|||
162899957|NCT03039790|588333117|FG015|Overall Study|Withdrawal of Consent|5|||
162899958|NCT03039790|588333118|FG016|Overall Study|Withdrawal of Consent|3|||
162899959|NCT03039790|588333119|FG017|Overall Study|Withdrawal of Consent|0|||
162899960|NCT03039790|588333120|FG018|Overall Study|Withdrawal of Consent|2|||
162899961|NCT03039790|588333121|FG019|Overall Study|Withdrawal of Consent|5|||
162899962|NCT03039790|588333102|FG000|Overall Study|Death|0|||
162899963|NCT03039790|588333103|FG001|Overall Study|Death|0|||
162899964|NCT03039790|588333104|FG002|Overall Study|Death|0|||
162899965|NCT03039790|588333105|FG003|Overall Study|Death|0|||
162899966|NCT03039790|588333106|FG004|Overall Study|Death|0|||
162899967|NCT03039790|588333107|FG005|Overall Study|Death|0|||
162899968|NCT03039790|588333108|FG006|Overall Study|Death|0|||
162899969|NCT03039790|588333109|FG007|Overall Study|Death|0|||
162899970|NCT03039790|588333110|FG008|Overall Study|Death|0|||
162899971|NCT03039790|588333111|FG009|Overall Study|Death|0|||
162899972|NCT03039790|588333112|FG010|Overall Study|Death|0|||
162899973|NCT03039790|588333113|FG011|Overall Study|Death|0|||
162899974|NCT03039790|588333114|FG012|Overall Study|Death|0|||
162899975|NCT03039790|588333115|FG013|Overall Study|Death|0|||
162899976|NCT03039790|588333116|FG014|Overall Study|Death|0|||
162899977|NCT03039790|588333117|FG015|Overall Study|Death|1|||
162899978|NCT03039790|588333118|FG016|Overall Study|Death|3|||
162899979|NCT03039790|588333119|FG017|Overall Study|Death|0|||
162899980|NCT03039790|588333120|FG018|Overall Study|Death|2|||
162899981|NCT03039790|588333121|FG019|Overall Study|Death|0|||
162899982|NCT03039790|588333102|FG000|Overall Study|Reason, not Specified|1|||
162899983|NCT03039790|588333103|FG001|Overall Study|Reason, not Specified|0|||
162899984|NCT03039790|588333104|FG002|Overall Study|Reason, not Specified|0|||
162899985|NCT03039790|588333105|FG003|Overall Study|Reason, not Specified|0|||
162899986|NCT03039790|588333106|FG004|Overall Study|Reason, not Specified|0|||
162899987|NCT03039790|588333107|FG005|Overall Study|Reason, not Specified|0|||
162899988|NCT03039790|588333108|FG006|Overall Study|Reason, not Specified|0|||
162899989|NCT03039790|588333109|FG007|Overall Study|Reason, not Specified|0|||
162899990|NCT03039790|588333110|FG008|Overall Study|Reason, not Specified|0|||
162899991|NCT03039790|588333111|FG009|Overall Study|Reason, not Specified|0|||
162899992|NCT03039790|588333112|FG010|Overall Study|Reason, not Specified|0|||
162899993|NCT03039790|588333113|FG011|Overall Study|Reason, not Specified|0|||
162899994|NCT03039790|588333114|FG012|Overall Study|Reason, not Specified|0|||
162899995|NCT03039790|588333115|FG013|Overall Study|Reason, not Specified|0|||
162899996|NCT03039790|588333116|FG014|Overall Study|Reason, not Specified|0|||
162899997|NCT03039790|588333117|FG015|Overall Study|Reason, not Specified|0|||
162899998|NCT03039790|588333118|FG016|Overall Study|Reason, not Specified|2|||
162899999|NCT03039790|588333119|FG017|Overall Study|Reason, not Specified|0|||
162900000|NCT03039790|588333120|FG018|Overall Study|Reason, not Specified|1|||
162900001|NCT03039790|588333121|FG019|Overall Study|Reason, not Specified|0|||
162900002|NCT02736929|588333126|FG000|Main Study|Lost to Follow-up|7|||
162900003|NCT02736929|588333127|FG001|Main Study|Lost to Follow-up|1|||
162900004|NCT02736929|588333128|FG002|Main Study|Lost to Follow-up|0|||
162625574|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
162625575|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
162900005|NCT02736929|588333126|FG000|Main Study|Withdrawal by Subject|1|||
162900006|NCT02736929|588333127|FG001|Main Study|Withdrawal by Subject|1|||
162900007|NCT02736929|588333128|FG002|Main Study|Withdrawal by Subject|0|||
162900008|NCT02736929|588333126|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
162900009|NCT02736929|588333127|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
162900010|NCT02736929|588333128|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
162900011|NCT00285649|588333129|FG000|Overall Study|Lost to Follow-up|6|||
162900012|NCT00285649|588333130|FG001|Overall Study|Lost to Follow-up|4|||
162900013|NCT00285649|588333131|FG002|Overall Study|Lost to Follow-up|4|||
162900014|NCT00285649|588333129|FG000|Overall Study|Withdrawal by Subject|3|||
162900015|NCT00285649|588333130|FG001|Overall Study|Withdrawal by Subject|2|||
162900016|NCT00285649|588333131|FG002|Overall Study|Withdrawal by Subject|2|||
162900017|NCT02972593|588333132|FG000|Overall Study|Lost to Follow-up|19|||
162900018|NCT02972593|588333133|FG001|Overall Study|Lost to Follow-up|15|||
162625576|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
162625577|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Missing|0|||
162900019|NCT02972593|588333132|FG000|Overall Study|Protocol Violation|1|||
162900020|NCT02972593|588333133|FG001|Overall Study|Protocol Violation|0|||
162900021|NCT03077711|588333136|FG000|Overall Study|Lost to Follow-up|2|||
162900022|NCT03077711|588333137|FG001|Overall Study|Lost to Follow-up|2|||
162900023|NCT03077711|588333136|FG000|Overall Study|noncompliant taking medication|2|||
162900024|NCT03077711|588333137|FG001|Overall Study|noncompliant taking medication|0|||
162900025|NCT01819194|588333138|FG000|Overall Study|Loss of study articles|2|||
162900026|NCT01927068|588333142|FG000|Overall Study|Death|37|||
162900027|NCT01927068|588333143|FG001|Overall Study|Death|3|||
162900028|NCT01927068|588333142|FG000|Overall Study|Withdrawal by Subject|50|||
162900029|NCT01927068|588333143|FG001|Overall Study|Withdrawal by Subject|3|||
162625578|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Missing|0|||
162625579|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Missing|2|||
162900030|NCT01927068|588333142|FG000|Overall Study|Lost to Follow-up|10|||
162900031|NCT01927068|588333143|FG001|Overall Study|Lost to Follow-up|2|||
162900032|NCT01927068|588333142|FG000|Overall Study|Physician Decision|9|||
162900033|NCT01927068|588333143|FG001|Overall Study|Physician Decision|0|||
162625580|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Missing|0|||
162625581|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Missing|0|||
162625582|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162625583|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162625584|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162625585|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162625586|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
162625587|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162625588|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162625589|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
162625590|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162625591|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162625592|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
162625593|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
162625594|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
162625595|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
162625596|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
162625597|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
162900034|NCT01927068|588333142|FG000|Overall Study|Missed last follow-up visit|2|||
162900035|NCT01927068|588333143|FG001|Overall Study|Missed last follow-up visit|0|||
162900036|NCT01624467|588333144|FG000|Overall Study|Withdrawal by Subject|2|||
162900037|NCT01624467|588333144|FG000|Overall Study|Lost to Follow-up|1|||
162900038|NCT01624467|588333144|FG000|Overall Study|Adverse Event|7|||
162900039|NCT01624467|588333144|FG000|Overall Study|Progressive Disease|19|||
162900040|NCT01624467|588333144|FG000|Overall Study|Per Sponsor Requirement|1|||
162900041|NCT01624467|588333144|FG000|Overall Study|Subject Withdrew from Treatment|1|||
162900042|NCT02290340|588333146|FG000|Overall Study|Lost to Follow-up|0|||
162900043|NCT02290340|588333147|FG001|Overall Study|Lost to Follow-up|0|||
162900044|NCT02290340|588333148|FG002|Overall Study|Lost to Follow-up|0|||
162900045|NCT02290340|588333149|FG003|Overall Study|Lost to Follow-up|1|||
162900046|NCT02290340|588333146|FG000|Overall Study|Withdrawal by Subject|1|||
162900047|NCT02290340|588333147|FG001|Overall Study|Withdrawal by Subject|0|||
162900048|NCT02290340|588333148|FG002|Overall Study|Withdrawal by Subject|0|||
162900049|NCT02290340|588333149|FG003|Overall Study|Withdrawal by Subject|0|||
162900050|NCT02290340|588333146|FG000|Overall Study|Other|1|||
162900051|NCT02290340|588333147|FG001|Overall Study|Other|0|||
162900052|NCT02290340|588333148|FG002|Overall Study|Other|0|||
162900053|NCT02290340|588333149|FG003|Overall Study|Other|1|||
162900054|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
162900055|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
162900056|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
162900057|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
162900058|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
162900059|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
162900060|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
162900061|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
162900062|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
162900063|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
162900064|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
162900065|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
162900066|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
162900067|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Death|0|||
162900068|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Death|0|||
162900069|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Death|1|||
162900070|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Death|0|||
162625598|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
162900071|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Death|0|||
162900072|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Death|0|||
162900073|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Death|0|||
162900074|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Death|0|||
162900075|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Death|0|||
162900076|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Death|0|||
162900077|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Death|0|||
162900078|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Death|0|||
162900079|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Death|0|||
162900080|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
162900081|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
162900082|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
162900083|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900084|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900085|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900086|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900087|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900088|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900089|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900090|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900091|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900092|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
162900093|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900094|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900095|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
162900096|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900097|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900098|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900099|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900100|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900101|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900102|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900103|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900104|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900105|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
162900106|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
162900107|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
162900108|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
162900109|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
162900110|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
162965677|NCT00659815|588574569|FG001|Overall Study|Inability to maintain wearing schedule|2|||
162965678|NCT00659815|588574568|FG000|Overall Study|Withdrawal by Subject|1|||
162965679|NCT00659815|588574569|FG001|Overall Study|Withdrawal by Subject|1|||
162965680|NCT02578641|588574570|FG000|Overall Study|Adverse Event|5|||
162965681|NCT02578641|588574571|FG001|Overall Study|Adverse Event|15|||
162965682|NCT02578641|588574570|FG000|Overall Study|Death|16|||
162965683|NCT02578641|588574571|FG001|Overall Study|Death|8|||
162965684|NCT02578641|588574570|FG000|Overall Study|Lost to Follow-up|0|||
162900111|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
162900112|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
162625599|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
162625600|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
162625601|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
162625602|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162625603|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162625604|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162625605|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
162625606|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162625607|NCT00730405|587344881|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
162625608|NCT00730405|587344882|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162625609|NCT00730405|587344883|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162625610|NCT00730405|587344884|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162625611|NCT00730405|587344885|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162625612|NCT00963937|587344886|FG000|Overall Study|Protocol Violation|1|||
162625613|NCT00963937|587344887|FG001|Overall Study|Protocol Violation|1|||
162625614|NCT00963937|587344888|FG002|Overall Study|Protocol Violation|0|||
162625615|NCT00963937|587344886|FG000|Overall Study|Physician Decision|18|||
162625616|NCT00963937|587344887|FG001|Overall Study|Physician Decision|10|||
162625617|NCT00963937|587344888|FG002|Overall Study|Physician Decision|4|||
162625618|NCT02106975|587344889|FG000|Overall Study|Death|25|||
162625619|NCT02106975|587344890|FG001|Overall Study|Death|39|||
162625620|NCT00622401|587344891|FG000|Overall Study|Disease progression prior to treatment|3|||
162625621|NCT00622401|587344892|FG001|Overall Study|Disease progression prior to treatment|2|||
162625622|NCT00622401|587344893|FG002|Overall Study|Disease progression prior to treatment|0|||
162625623|NCT03546062|587344894|FG000|Overall Study|Adverse Event|6|||
162625624|NCT03546062|587344895|FG001|Overall Study|Adverse Event|5|||
162625625|NCT03546062|587344896|FG002|Overall Study|Adverse Event|8|||
162625626|NCT00181155|587344897|FG000|Overall Study|Physician Decision|1|||
162625627|NCT00181155|587344898|FG001|Overall Study|Physician Decision|0|||
162625628|NCT00181155|587344897|FG000|Overall Study|Withdrawal by Subject|1|||
162625629|NCT00181155|587344898|FG001|Overall Study|Withdrawal by Subject|0|||
162625630|NCT02572401|587344899|FG000|Overall Study|Lost to Follow-up|5|||
162625631|NCT02572401|587344900|FG001|Overall Study|Lost to Follow-up|8|||
162625632|NCT02572401|587344901|FG002|Overall Study|Lost to Follow-up|9|||
162625633|NCT02572401|587344902|FG003|Overall Study|Lost to Follow-up|9|||
162625634|NCT02572401|587344899|FG000|Overall Study|Death|0|||
162625635|NCT02572401|587344900|FG001|Overall Study|Death|0|||
162625636|NCT02572401|587344901|FG002|Overall Study|Death|0|||
162625637|NCT02572401|587344902|FG003|Overall Study|Death|1|||
162625638|NCT01768286|587344908|FG000|Overall Study|Randomized But Not Treated|0|||
163052366|NCT03509467|588901018|FG000|Overall Study|Proxy Withdrawal|0|||
163052367|NCT03509467|588901019|FG001|Overall Study|Proxy Withdrawal|0|||
163052368|NCT03509467|588901020|FG002|Overall Study|Proxy Withdrawal|0|||
163052369|NCT03509467|588901021|FG003|Overall Study|Proxy Withdrawal|0|||
163052370|NCT03509467|588901022|FG004|Overall Study|Proxy Withdrawal|0|||
163052371|NCT03509467|588901023|FG005|Overall Study|Proxy Withdrawal|0|||
163052372|NCT03509467|588901024|FG006|Overall Study|Proxy Withdrawal|0|||
163052373|NCT03509467|588901025|FG007|Overall Study|Proxy Withdrawal|1|||
163052374|NCT04275973|588901028|FG000|Overall Study|Withdrawal by Subject|2|||
163052375|NCT04275973|588901029|FG001|Overall Study|Withdrawal by Subject|1|||
163052376|NCT06110754|588901030|FG000|Overall Study|Withdrawal by Subject|0|||
163052377|NCT06110754|588901031|FG001|Overall Study|Withdrawal by Subject|0|||
163052378|NCT06110754|588901032|FG002|Overall Study|Withdrawal by Subject|1|||
163052379|NCT06110754|588901033|FG003|Overall Study|Withdrawal by Subject|0|||
163052380|NCT05502302|588901038|FG000|Overall Study|Lost to Follow-up|6|||
163052381|NCT05502302|588901038|FG000|Overall Study|Death|2|||
163052382|NCT04037358|588901045|FG000|Overall Study|Patient withdrew before intervention|1|||
163052383|NCT04037358|588901046|FG001|Overall Study|Patient withdrew before intervention|0|||
163052384|NCT01949142|588901047|FG000|Overall Study|Withdrawal of consent|1|||
163052385|NCT01949142|588901048|FG001|Overall Study|Withdrawal of consent|0|||
163052386|NCT01949142|588901047|FG000|Overall Study|Lost to Follow-up|1|||
163052387|NCT01949142|588901048|FG001|Overall Study|Lost to Follow-up|1|||
163052388|NCT01949142|588901047|FG000|Overall Study|Parent changed their mind|1|||
163052389|NCT01949142|588901048|FG001|Overall Study|Parent changed their mind|0|||
163052390|NCT00447902|588901054|FG000|Overall Study|Adverse Event|0|||
163052391|NCT00447902|588901055|FG001|Overall Study|Adverse Event|3|||
163052392|NCT00447902|588901054|FG000|Overall Study|Protocol Violation|1|||
163052393|NCT00447902|588901055|FG001|Overall Study|Protocol Violation|0|||
163052394|NCT00447902|588901054|FG000|Overall Study|Withdrawal by Subject|0|||
163052395|NCT00447902|588901055|FG001|Overall Study|Withdrawal by Subject|1|||
163052396|NCT00447902|588901054|FG000|Overall Study|included patients who discontinued|1|||
163052397|NCT00447902|588901055|FG001|Overall Study|included patients who discontinued|1|||
163052398|NCT00447902|588901054|FG000|Overall Study|Lack of Efficacy|2|||
163052399|NCT00447902|588901055|FG001|Overall Study|Lack of Efficacy|1|||
163052400|NCT02873689|588903016|FG000|Overall Study|Lack of Efficacy|1|||
163052401|NCT02873689|588903017|FG001|Overall Study|Lack of Efficacy|0|||
163052402|NCT02873689|588903016|FG000|Overall Study|Withdrawal by Subject|2|||
163052403|NCT02873689|588903017|FG001|Overall Study|Withdrawal by Subject|2|||
163052404|NCT02873689|588903016|FG000|Overall Study|Protocol Violation|1|||
163052405|NCT02873689|588903017|FG001|Overall Study|Protocol Violation|0|||
163052406|NCT02873689|588903016|FG000|Overall Study|Adverse Event|2|||
163052407|NCT02873689|588903017|FG001|Overall Study|Adverse Event|2|||
162900113|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
162900114|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
162900115|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
162900116|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
162900117|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
162900118|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
162900119|NCT02407236|588333151|FG000|Induction Study (8 Weeks)|Other|2|||
162900120|NCT02407236|588333152|FG001|Induction Study (8 Weeks)|Other|1|||
162900121|NCT02407236|588333153|FG002|Induction Study (8 Weeks)|Other|5|||
162900122|NCT02407236|588333154|FG003|Induction Study (8 Weeks)|Other|0|||
162900123|NCT02407236|588333155|FG004|Induction Study (8 Weeks)|Other|0|||
162900124|NCT02407236|588333156|FG005|Induction Study (8 Weeks)|Other|0|||
162900125|NCT02407236|588333157|FG006|Induction Study (8 Weeks)|Other|0|||
163052408|NCT02873689|588903016|FG000|Overall Study|Randomized but not Treated|1|||
162900126|NCT02407236|588333158|FG007|Induction Study (8 Weeks)|Other|0|||
162900127|NCT02407236|588333159|FG008|Induction Study (8 Weeks)|Other|0|||
162900128|NCT02407236|588333160|FG009|Induction Study (8 Weeks)|Other|0|||
162900129|NCT02407236|588333161|FG010|Induction Study (8 Weeks)|Other|0|||
162900130|NCT02407236|588333162|FG011|Induction Study (8 Weeks)|Other|0|||
162900131|NCT02407236|588333163|FG012|Induction Study (8 Weeks)|Other|0|||
162900132|NCT02407236|588333151|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900133|NCT02407236|588333152|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900134|NCT02407236|588333153|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900135|NCT02407236|588333154|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
162900136|NCT02407236|588333155|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
162900137|NCT02407236|588333156|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
162900138|NCT02407236|588333157|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
162900139|NCT02407236|588333158|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
162900140|NCT02407236|588333159|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900141|NCT02407236|588333160|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900142|NCT02407236|588333161|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900143|NCT02407236|588333162|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900144|NCT02407236|588333163|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
162900145|NCT02407236|588333151|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900146|NCT02407236|588333152|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900147|NCT02407236|588333153|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900148|NCT02407236|588333154|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
162900149|NCT02407236|588333155|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
162900150|NCT02407236|588333156|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
162900151|NCT02407236|588333157|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
162900152|NCT02407236|588333158|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
162900153|NCT02407236|588333159|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
163052409|NCT02873689|588903017|FG001|Overall Study|Randomized but not Treated|1|||
162625639|NCT01768286|587344909|FG001|Overall Study|Randomized But Not Treated|0|||
162625640|NCT01768286|587344910|FG002|Overall Study|Randomized But Not Treated|1|||
162625641|NCT01768286|587344911|FG003|Overall Study|Randomized But Not Treated|0|||
162625642|NCT01768286|587344908|FG000|Overall Study|Lack of Efficacy|7|||
162625643|NCT01768286|587344909|FG001|Overall Study|Lack of Efficacy|4|||
162625644|NCT01768286|587344910|FG002|Overall Study|Lack of Efficacy|0|||
162625645|NCT01768286|587344911|FG003|Overall Study|Lack of Efficacy|1|||
162625646|NCT01768286|587344908|FG000|Overall Study|Withdrew Consent|0|||
162625647|NCT01768286|587344909|FG001|Overall Study|Withdrew Consent|0|||
162625648|NCT01768286|587344910|FG002|Overall Study|Withdrew Consent|1|||
162625649|NCT01768286|587344911|FG003|Overall Study|Withdrew Consent|0|||
162625650|NCT02243696|587344912|FG000|Overall Study|Death|282|||
162625651|NCT02243696|587344912|FG000|Overall Study|Withdrawal by Subject|79|||
162625652|NCT02243696|587344912|FG000|Overall Study|Lost to Follow-up|57|||
162625653|NCT02243696|587344912|FG000|Overall Study|Subject No Longer has Study System|42|||
162625654|NCT02243696|587344912|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
162625655|NCT02243696|587344912|FG000|Overall Study|Study Terminated for EP PASSION|961|||
162625656|NCT00622284|587344913|FG000|Overall Study|Lack of Efficacy|45|||
162625657|NCT00622284|587344914|FG001|Overall Study|Lack of Efficacy|15|||
162625658|NCT00622284|587344913|FG000|Overall Study|Adverse Event|61|||
162625659|NCT00622284|587344914|FG001|Overall Study|Adverse Event|90|||
162625660|NCT00622284|587344913|FG000|Overall Study|Protocol Violation|12|||
162625661|NCT00622284|587344914|FG001|Overall Study|Protocol Violation|5|||
162625662|NCT00622284|587344913|FG000|Overall Study|Lost to Follow-up|11|||
162625663|NCT00622284|587344914|FG001|Overall Study|Lost to Follow-up|13|||
162625664|NCT00622284|587344913|FG000|Overall Study|Withdrawal by Subject|27|||
162625665|NCT00622284|587344914|FG001|Overall Study|Withdrawal by Subject|24|||
162625666|NCT00622284|587344913|FG000|Overall Study|Other reason (not specified)|33|||
162625667|NCT00622284|587344914|FG001|Overall Study|Other reason (not specified)|24|||
162900154|NCT02407236|588333160|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900155|NCT02407236|588333161|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900156|NCT02407236|588333162|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900157|NCT02407236|588333163|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
162900158|NCT02407236|588333151|FG000|Maintenance Study (44 Weeks)|Other|0|||
162900159|NCT02407236|588333152|FG001|Maintenance Study (44 Weeks)|Other|0|||
162900160|NCT02407236|588333153|FG002|Maintenance Study (44 Weeks)|Other|0|||
162900161|NCT02407236|588333154|FG003|Maintenance Study (44 Weeks)|Other|5|||
162900162|NCT02407236|588333155|FG004|Maintenance Study (44 Weeks)|Other|7|||
162900163|NCT02407236|588333156|FG005|Maintenance Study (44 Weeks)|Other|8|||
162900164|NCT02407236|588333157|FG006|Maintenance Study (44 Weeks)|Other|4|||
162900165|NCT02407236|588333158|FG007|Maintenance Study (44 Weeks)|Other|6|||
162900166|NCT02407236|588333159|FG008|Maintenance Study (44 Weeks)|Other|0|||
162900167|NCT02407236|588333160|FG009|Maintenance Study (44 Weeks)|Other|0|||
162900168|NCT02407236|588333161|FG010|Maintenance Study (44 Weeks)|Other|0|||
162900169|NCT02407236|588333162|FG011|Maintenance Study (44 Weeks)|Other|0|||
162900170|NCT02407236|588333163|FG012|Maintenance Study (44 Weeks)|Other|0|||
162900171|NCT02407236|588333151|FG000|Maintenance Study (44 Weeks)|Death|0|||
162900172|NCT02407236|588333152|FG001|Maintenance Study (44 Weeks)|Death|0|||
162900173|NCT02407236|588333153|FG002|Maintenance Study (44 Weeks)|Death|0|||
162900174|NCT02407236|588333154|FG003|Maintenance Study (44 Weeks)|Death|0|||
162900175|NCT02407236|588333155|FG004|Maintenance Study (44 Weeks)|Death|0|||
162900176|NCT02407236|588333156|FG005|Maintenance Study (44 Weeks)|Death|0|||
162900177|NCT02407236|588333157|FG006|Maintenance Study (44 Weeks)|Death|0|||
162900178|NCT02407236|588333158|FG007|Maintenance Study (44 Weeks)|Death|1|||
162965685|NCT02578641|588574571|FG001|Overall Study|Lost to Follow-up|1|||
162625668|NCT02935842|587344915|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
162625669|NCT02935842|587344916|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162900179|NCT02407236|588333159|FG008|Maintenance Study (44 Weeks)|Death|0|||
162900180|NCT02407236|588333160|FG009|Maintenance Study (44 Weeks)|Death|0|||
162900181|NCT02407236|588333161|FG010|Maintenance Study (44 Weeks)|Death|0|||
162900182|NCT02407236|588333162|FG011|Maintenance Study (44 Weeks)|Death|0|||
162900183|NCT02407236|588333163|FG012|Maintenance Study (44 Weeks)|Death|0|||
162900184|NCT02407236|588333151|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162965686|NCT02578641|588574570|FG000|Overall Study|Withdrawal by Subject|14|||
162900185|NCT02407236|588333152|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162965687|NCT02578641|588574571|FG001|Overall Study|Withdrawal by Subject|7|||
162965688|NCT02578641|588574570|FG000|Overall Study|Progressive Disease|69|||
162625670|NCT02935842|587344917|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162625671|NCT02935842|587344918|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162625672|NCT02935842|587344915|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
162625673|NCT02935842|587344916|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
162625674|NCT02935842|587344917|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
162625675|NCT02935842|587344918|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
162625676|NCT02935842|587344915|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
162900186|NCT02407236|588333153|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900187|NCT02407236|588333154|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900188|NCT02407236|588333155|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900189|NCT02407236|588333156|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900190|NCT02407236|588333157|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900191|NCT02407236|588333158|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
162900192|NCT02407236|588333159|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
162900193|NCT02407236|588333160|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
162900194|NCT02407236|588333161|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
162900195|NCT02407236|588333162|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
162900196|NCT02407236|588333163|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
162900197|NCT02407236|588333151|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900198|NCT02407236|588333152|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900199|NCT02407236|588333153|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900200|NCT02407236|588333154|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900201|NCT02407236|588333155|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900202|NCT02407236|588333156|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900203|NCT02407236|588333157|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900204|NCT02407236|588333158|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900205|NCT02407236|588333159|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900206|NCT02407236|588333160|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900207|NCT02407236|588333161|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
162900208|NCT02407236|588333162|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900209|NCT02407236|588333163|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
162900210|NCT02407236|588333151|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900211|NCT02407236|588333152|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900212|NCT02407236|588333153|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900213|NCT02407236|588333154|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900214|NCT02407236|588333155|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900215|NCT02407236|588333156|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900216|NCT02407236|588333157|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900217|NCT02407236|588333158|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
162900218|NCT02407236|588333159|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
162900219|NCT02407236|588333160|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
162900220|NCT02407236|588333161|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
162900221|NCT02407236|588333162|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
162900222|NCT02407236|588333163|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
162900223|NCT02407236|588333151|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
162900224|NCT02407236|588333152|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
162900225|NCT02407236|588333153|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
162900226|NCT02407236|588333154|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
162900227|NCT02407236|588333155|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
162900228|NCT02407236|588333156|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
162900229|NCT02407236|588333157|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
162900230|NCT02407236|588333158|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
162900231|NCT02407236|588333159|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
162900232|NCT02407236|588333160|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
162900233|NCT02407236|588333161|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
162900234|NCT02407236|588333162|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
162900235|NCT02407236|588333163|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
162900236|NCT03287830|588335559|FG000|Overall Study|Withdrawal by Subject|1|||
162900237|NCT03287830|588335560|FG001|Overall Study|Withdrawal by Subject|1|||
162900238|NCT03287830|588335559|FG000|Overall Study|not meeting inclusion criteria|5|||
162900239|NCT03287830|588335560|FG001|Overall Study|not meeting inclusion criteria|12|||
162900240|NCT03598140|588335563|FG000|Overall Study|enrolled but didn't start|1|||
162900241|NCT03598140|588335564|FG001|Overall Study|enrolled but didn't start|0|||
162900242|NCT02155712|588335568|FG000|Overall Study|Death|12|||
162900243|NCT02155712|588335569|FG001|Overall Study|Death|0|||
162900244|NCT02155712|588335568|FG000|Overall Study|Lost to Follow-up|37|||
162900245|NCT02155712|588335569|FG001|Overall Study|Lost to Follow-up|22|||
162900246|NCT02155712|588335568|FG000|Overall Study|Revision of device|4|||
162900247|NCT02155712|588335569|FG001|Overall Study|Revision of device|3|||
162900248|NCT02155712|588335568|FG000|Overall Study|Withdrawal by Subject|39|||
162900249|NCT02155712|588335569|FG001|Overall Study|Withdrawal by Subject|21|||
162900250|NCT02155712|588335568|FG000|Overall Study|Site termination|77|||
162900251|NCT02155712|588335569|FG001|Overall Study|Site termination|19|||
162900252|NCT02155712|588335568|FG000|Overall Study|Sponsor terminated study early|150|||
162900253|NCT02155712|588335569|FG001|Overall Study|Sponsor terminated study early|0|||
162900254|NCT02155712|588335568|FG000|Overall Study|Missed final 5-year protocol visit|0|||
162625677|NCT02935842|587344916|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
162625678|NCT02935842|587344917|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
162625679|NCT02935842|587344918|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
162625680|NCT02935842|587344915|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
162625681|NCT02935842|587344916|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
162625682|NCT02935842|587344917|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
162625683|NCT02935842|587344918|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
162625684|NCT02935842|587344915|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162625685|NCT02935842|587344916|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162625686|NCT02935842|587344917|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
162625687|NCT02935842|587344918|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162625688|NCT01201850|587344921|FG000|Overall Study|Tumor progression|4|||
162625689|NCT04066023|587344922|FG000|Overall Study|Adverse Event|0|||
162625690|NCT04066023|587344923|FG001|Overall Study|Adverse Event|0|||
162625691|NCT04066023|587344924|FG002|Overall Study|Adverse Event|1|||
162625692|NCT04066023|587344922|FG000|Overall Study|Sponsor decision|3|||
162625693|NCT04066023|587344923|FG001|Overall Study|Sponsor decision|6|||
162625694|NCT04066023|587344924|FG002|Overall Study|Sponsor decision|2|||
162625695|NCT04066023|587344922|FG000|Overall Study|Physician Decision|0|||
162625696|NCT04066023|587344923|FG001|Overall Study|Physician Decision|0|||
162625697|NCT04066023|587344924|FG002|Overall Study|Physician Decision|1|||
162625698|NCT04066023|587344922|FG000|Overall Study|Lost to Follow-up|0|||
162625699|NCT04066023|587344923|FG001|Overall Study|Lost to Follow-up|1|||
162625700|NCT04066023|587344924|FG002|Overall Study|Lost to Follow-up|1|||
162625701|NCT04066023|587344922|FG000|Overall Study|Noncompliance|0|||
162625702|NCT04066023|587344923|FG001|Overall Study|Noncompliance|1|||
162625703|NCT04066023|587344924|FG002|Overall Study|Noncompliance|1|||
162625704|NCT01552694|587344925|FG000|Overall Study|Lost to Follow-up|0|||
162625705|NCT01552694|587344926|FG001|Overall Study|Lost to Follow-up|1|||
162625706|NCT01552694|587344925|FG000|Overall Study|Protocol Violation|0|||
162625707|NCT01552694|587344926|FG001|Overall Study|Protocol Violation|1|||
162625708|NCT03338010|587344927|FG000|Overall Study|Withdrawal by Subject|14|||
162625709|NCT03338010|587344928|FG001|Overall Study|Withdrawal by Subject|8|||
162625710|NCT03338010|587344927|FG000|Overall Study|Lost to Follow-up|4|||
162625711|NCT03338010|587344928|FG001|Overall Study|Lost to Follow-up|2|||
162625712|NCT03338010|587344927|FG000|Overall Study|Adverse Event|3|||
162625713|NCT03338010|587344928|FG001|Overall Study|Adverse Event|2|||
162625714|NCT03338010|587344927|FG000|Overall Study|Physician Decision|2|||
162625715|NCT03338010|587344928|FG001|Overall Study|Physician Decision|2|||
162625716|NCT03338010|587344927|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162900255|NCT02155712|588335569|FG001|Overall Study|Missed final 5-year protocol visit|32|||
162900256|NCT02155712|588335568|FG000|Overall Study|Censored because surgery cancelled|6|||
162900257|NCT02155712|588335569|FG001|Overall Study|Censored because surgery cancelled|10|||
162900258|NCT02155712|588335568|FG000|Overall Study|Censored because study device was not implanted|61|||
162900259|NCT02155712|588335569|FG001|Overall Study|Censored because study device was not implanted|66|||
162900260|NCT02155712|588335568|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
162900261|NCT02155712|588335569|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
162900262|NCT02060903|588335570|FG000|Overall Study|Lost to Follow-up|4|||
162900263|NCT02060903|588335571|FG001|Overall Study|Lost to Follow-up|0|||
162900264|NCT02060903|588335570|FG000|Overall Study|Withdrawal by Subject|0|||
162900265|NCT02060903|588335571|FG001|Overall Study|Withdrawal by Subject|7|||
162900266|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
162900267|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
162900268|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
162900269|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
162900270|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
162900271|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
162900272|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
162900273|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
162900274|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
162900275|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
162900276|NCT02418585|588335572|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
162625717|NCT03338010|587344928|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162625718|NCT03338010|587344927|FG000|Overall Study|Protocol Violation|0|||
162625719|NCT03338010|587344928|FG001|Overall Study|Protocol Violation|1|||
162625720|NCT00293033|587344933|FG000|Open-label Titration Period|Adverse Event|10|||
162625721|NCT00293033|587344933|FG000|Open-label Titration Period|Death|3|||
162625722|NCT00293033|587344933|FG000|Open-label Titration Period|Lack of Efficacy|5|||
162625723|NCT00293033|587344933|FG000|Open-label Titration Period|Protocol Violation|2|||
162625724|NCT00293033|587344933|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
162625725|NCT00293033|587344933|FG000|Open-label Titration Period|Noncompliance and other|27|||
162625726|NCT00293033|587344933|FG000|Double-blind Treatment Period|Adverse Event|3|||
162900277|NCT02418585|588335573|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
162625727|NCT00293033|587344933|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
162625728|NCT00293033|587344933|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
162625729|NCT00293033|587344933|FG000|Double-blind Treatment Period|Noncompliance|4|||
162625730|NCT00837811|587344934|FG000|Overall Study|Adverse Event|4|||
162625731|NCT00837811|587344935|FG001|Overall Study|Adverse Event|6|||
162625732|NCT00837811|587344936|FG002|Overall Study|Adverse Event|0|||
162625733|NCT00837811|587344934|FG000|Overall Study|Death|1|||
162625734|NCT00837811|587344935|FG001|Overall Study|Death|1|||
162625735|NCT00837811|587344936|FG002|Overall Study|Death|0|||
162625736|NCT00837811|587344934|FG000|Overall Study|Lack of Efficacy|0|||
162625737|NCT00837811|587344935|FG001|Overall Study|Lack of Efficacy|11|||
162625738|NCT00837811|587344936|FG002|Overall Study|Lack of Efficacy|0|||
162625739|NCT00837811|587344934|FG000|Overall Study|Lost to Follow-up|1|||
162625740|NCT00837811|587344935|FG001|Overall Study|Lost to Follow-up|3|||
162625741|NCT00837811|587344936|FG002|Overall Study|Lost to Follow-up|0|||
162625742|NCT00837811|587344934|FG000|Overall Study|Physician Decision|0|||
162625743|NCT00837811|587344935|FG001|Overall Study|Physician Decision|2|||
162625744|NCT00837811|587344936|FG002|Overall Study|Physician Decision|1|||
162625745|NCT00837811|587344934|FG000|Overall Study|Withdrawal by Subject|1|||
162625746|NCT00837811|587344935|FG001|Overall Study|Withdrawal by Subject|9|||
162625747|NCT00837811|587344936|FG002|Overall Study|Withdrawal by Subject|0|||
162625748|NCT00837811|587344934|FG000|Overall Study|Sponsor Decision|0|||
162625749|NCT00837811|587344935|FG001|Overall Study|Sponsor Decision|2|||
162625750|NCT00837811|587344936|FG002|Overall Study|Sponsor Decision|0|||
162625751|NCT00717197|587346893|FG000|Overall Study|Unable to purchase study drug|5|||
162625752|NCT00717197|587346893|FG000|Overall Study|Tumor Progression|1|||
162625753|NCT00717197|587346893|FG000|Overall Study|Physician Decision|1|||
162625754|NCT01898806|587346896|FG000|Overall Study|Withdrawal by Subject|2|||
162625755|NCT01898806|587346896|FG000|Overall Study|Physician Decision|1|||
162625756|NCT03003390|587346897|FG000|Overall Study|Physician Decision|2|||
162625757|NCT03003390|587346898|FG001|Overall Study|Physician Decision|0|||
162625758|NCT03003390|587346897|FG000|Overall Study|Parent refused intervention|2|||
162625759|NCT03003390|587346898|FG001|Overall Study|Parent refused intervention|0|||
162625760|NCT01648101|587346899|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
162625761|NCT01648101|587346900|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
162625762|NCT01648101|587346901|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
162625763|NCT01648101|587346899|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
162625764|NCT01648101|587346900|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
162625765|NCT01648101|587346901|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
162625766|NCT01648101|587346899|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
162625767|NCT01648101|587346900|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
162625768|NCT01648101|587346901|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
162625769|NCT01648101|587346899|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
162625770|NCT01648101|587346900|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
162625771|NCT01648101|587346901|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
162625772|NCT01648101|587346899|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
162625773|NCT01648101|587346900|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
162625774|NCT01648101|587346901|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
162625775|NCT01648101|587346899|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
162625776|NCT01648101|587346900|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
162625777|NCT01648101|587346901|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
162625778|NCT01648101|587346899|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
162625779|NCT01648101|587346900|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
162625780|NCT01648101|587346901|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
163052410|NCT00434252|588903018|FG000|Overall Study|Lack of Efficacy|50|||
163052411|NCT00434252|588903019|FG001|Overall Study|Lack of Efficacy|100|||
163052412|NCT00434252|588903018|FG000|Overall Study|Adverse Event|6|||
163052413|NCT00434252|588903019|FG001|Overall Study|Adverse Event|13|||
162900278|NCT02418585|588335572|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
162900279|NCT02418585|588335573|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
162900280|NCT02418585|588335572|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
162900281|NCT02418585|588335573|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
162900282|NCT02418585|588335572|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
162900283|NCT02418585|588335573|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
162900284|NCT02418585|588335572|FG000|Follow-up Phase (24 Weeks)|Other|3|||
163052414|NCT00434252|588903018|FG000|Overall Study|Death|1|||
163052415|NCT00434252|588903019|FG001|Overall Study|Death|2|||
163052416|NCT00434252|588903018|FG000|Overall Study|Lost to Follow-up|0|||
163052417|NCT00434252|588903019|FG001|Overall Study|Lost to Follow-up|1|||
163052418|NCT00434252|588903018|FG000|Overall Study|Physician Decision|4|||
163052419|NCT00434252|588903019|FG001|Overall Study|Physician Decision|8|||
163052420|NCT00434252|588903018|FG000|Overall Study|Withdrawal by Subject|3|||
163052421|NCT00434252|588903019|FG001|Overall Study|Withdrawal by Subject|7|||
163052422|NCT00352118|588903022|FG000|Overall Study|Physician Decision|4|||
163052423|NCT02337764|588903023|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
163052424|NCT02337764|588903023|FG000|Overall Study|Voluntary Withdrawal|12|||
163052425|NCT02337764|588903023|FG000|Overall Study|Lack of Efficacy|2|||
163052426|NCT02990000|588903024|FG000|Overall Study|Failed to provide data beyond baseline|36|||
163052427|NCT02990000|588903025|FG001|Overall Study|Failed to provide data beyond baseline|34|||
163052428|NCT02810418|588903037|FG000|Arm A Dose Escalation|Adverse Event|2|||
163052429|NCT02810418|588903038|FG001|Arm A Dose Escalation|Adverse Event|1|||
163052430|NCT02810418|588903039|FG002|Arm A Dose Escalation|Adverse Event|0|||
163052431|NCT02810418|588903040|FG003|Arm A Dose Escalation|Adverse Event|0|||
163052432|NCT02810418|588903041|FG004|Arm A Dose Escalation|Adverse Event|0|||
163052433|NCT02810418|588903042|FG005|Arm A Dose Escalation|Adverse Event|0|||
163052434|NCT02810418|588903043|FG006|Arm A Dose Escalation|Adverse Event|0|||
163052435|NCT02810418|588903037|FG000|Dose Expansion|Adverse Event|0|||
163052436|NCT02810418|588903038|FG001|Dose Expansion|Adverse Event|1|||
163052437|NCT02810418|588903039|FG002|Dose Expansion|Adverse Event|1|||
162625781|NCT01648101|587346899|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
162625782|NCT01648101|587346900|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
162625783|NCT01648101|587346901|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
162625784|NCT01648101|587346899|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
163052438|NCT02810418|588903040|FG003|Dose Expansion|Adverse Event|0|||
163052439|NCT02810418|588903041|FG004|Dose Expansion|Adverse Event|0|||
163052440|NCT02810418|588903042|FG005|Dose Expansion|Adverse Event|0|||
163052441|NCT02810418|588903043|FG006|Dose Expansion|Adverse Event|0|||
163052442|NCT02810418|588903037|FG000|Dose Expansion|Physician Decision|0|||
163052443|NCT02810418|588903038|FG001|Dose Expansion|Physician Decision|0|||
163052444|NCT02810418|588903039|FG002|Dose Expansion|Physician Decision|2|||
163052445|NCT02810418|588903040|FG003|Dose Expansion|Physician Decision|0|||
163052446|NCT02810418|588903041|FG004|Dose Expansion|Physician Decision|0|||
163052447|NCT02810418|588903042|FG005|Dose Expansion|Physician Decision|0|||
163052448|NCT02810418|588903043|FG006|Dose Expansion|Physician Decision|0|||
163052449|NCT02810418|588903037|FG000|Arm B Dose Escalation|Adverse Event|0|||
163052450|NCT02810418|588903038|FG001|Arm B Dose Escalation|Adverse Event|0|||
163052451|NCT02810418|588903039|FG002|Arm B Dose Escalation|Adverse Event|0|||
163052452|NCT02810418|588903040|FG003|Arm B Dose Escalation|Adverse Event|0|||
163052453|NCT02810418|588903041|FG004|Arm B Dose Escalation|Adverse Event|1|||
163052454|NCT02810418|588903042|FG005|Arm B Dose Escalation|Adverse Event|2|||
163052455|NCT02810418|588903043|FG006|Arm B Dose Escalation|Adverse Event|0|||
163052456|NCT03103503|588903044|FG000|Overall Study|Death|64|||
163052457|NCT03103503|588903044|FG000|Overall Study|Physician Decision|57|||
163052458|NCT03103503|588903044|FG000|Overall Study|Withdrawal by Subject|10|||
163052459|NCT03103503|588903044|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
162625785|NCT01648101|587346900|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
162625786|NCT01648101|587346901|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
162625787|NCT01648101|587346899|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
162625788|NCT01648101|587346900|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
162625789|NCT01648101|587346901|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
162625790|NCT01648101|587346899|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
162625791|NCT01648101|587346900|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
162625792|NCT01648101|587346901|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
162900285|NCT02418585|588335573|FG001|Follow-up Phase (24 Weeks)|Other|2|||
162900286|NCT01688999|588335576|FG000|Overall Study|Withdrawal by Subject|5|||
162900287|NCT01688999|588335577|FG001|Overall Study|Withdrawal by Subject|1|||
162900288|NCT01688999|588335578|FG002|Overall Study|Withdrawal by Subject|1|||
162900289|NCT01688999|588335576|FG000|Overall Study|Adverse Event|2|||
162625793|NCT02469298|587346914|FG000|Overall Study|Protocol Violation|0|||
162625794|NCT02469298|587346915|FG001|Overall Study|Protocol Violation|1|||
162900290|NCT01688999|588335577|FG001|Overall Study|Adverse Event|0|||
163052460|NCT03103503|588903044|FG000|Overall Study|Lost to Follow-up|3|||
162900291|NCT01688999|588335578|FG002|Overall Study|Adverse Event|2|||
162900292|NCT01688999|588335576|FG000|Overall Study|Ineligible/Not treated|1|||
162900293|NCT01688999|588335577|FG001|Overall Study|Ineligible/Not treated|0|||
162900294|NCT01688999|588335578|FG002|Overall Study|Ineligible/Not treated|0|||
162900295|NCT02768103|588335579|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
162900296|NCT00498368|588335607|FG000|Overall Study|Withdrawal by Subject|3|||
163052461|NCT03103503|588903044|FG000|Overall Study|Study Closure|757|||
163052462|NCT01433159|588903049|FG000|Overall Study|Adverse Event|1|||
163052463|NCT01433159|588903050|FG001|Overall Study|Adverse Event|0|||
163052464|NCT01433159|588903049|FG000|Overall Study|Physician Decision|1|||
163052465|NCT01433159|588903050|FG001|Overall Study|Physician Decision|0|||
163052466|NCT01433159|588903049|FG000|Overall Study|Protocol Violation|0|||
163052467|NCT01433159|588903050|FG001|Overall Study|Protocol Violation|1|||
163052468|NCT01100853|588903051|FG000|Overall Study|Lost to Follow-up|11|||
163052469|NCT01100853|588903052|FG001|Overall Study|Lost to Follow-up|6|||
163052470|NCT01100853|588903051|FG000|Overall Study|Received <4 study injections|10|||
163052471|NCT01100853|588903052|FG001|Overall Study|Received <4 study injections|13|||
163052472|NCT01100853|588903051|FG000|Overall Study|Withdrawal by Subject|6|||
163052473|NCT01100853|588903052|FG001|Overall Study|Withdrawal by Subject|4|||
163052474|NCT04161391|588903055|FG000|Overall Study|Adverse Event|0|||
163052475|NCT04161391|588903056|FG001|Overall Study|Adverse Event|1|||
163052476|NCT04161391|588903057|FG002|Overall Study|Adverse Event|0|||
163052477|NCT04161391|588903058|FG003|Overall Study|Adverse Event|1|||
163052478|NCT04161391|588903059|FG004|Overall Study|Adverse Event|0|||
163052479|NCT04161391|588903060|FG005|Overall Study|Adverse Event|0|||
163052480|NCT04161391|588903061|FG006|Overall Study|Adverse Event|0|||
163052481|NCT04161391|588903062|FG007|Overall Study|Adverse Event|3|||
163052482|NCT04161391|588903063|FG008|Overall Study|Adverse Event|0|||
163052483|NCT04161391|588903055|FG000|Overall Study|Death|0|||
162900297|NCT00498368|588335608|FG001|Overall Study|Withdrawal by Subject|2|||
162900298|NCT01855425|588335616|FG000|Overall Study|Physician Decision|20|||
162900299|NCT02148952|588335623|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
162900300|NCT02148952|588335624|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
162900301|NCT02148952|588335623|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
162900302|NCT02148952|588335624|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
162900303|NCT02148952|588335623|FG000|Follow-Up|Lost to Follow-up|219|||
162900304|NCT02148952|588335624|FG001|Follow-Up|Lost to Follow-up|231|||
162900305|NCT02148952|588335623|FG000|Follow-Up|Withdrawal by Subject|46|||
162900306|NCT02148952|588335624|FG001|Follow-Up|Withdrawal by Subject|48|||
162900307|NCT01600105|588335625|FG000|Total Participants|Withdrawal by Subject|1|||
162900308|NCT01600105|588335626|FG001|Total Participants|Withdrawal by Subject|0|||
162900309|NCT01600105|588335625|FG000|Total Participants|No images in PACS|10|||
162900310|NCT01600105|588335626|FG001|Total Participants|No images in PACS|0|||
162965689|NCT02578641|588574571|FG001|Overall Study|Progressive Disease|21|||
162965690|NCT02578641|588574570|FG000|Overall Study|No Study Drug|2|||
162965691|NCT02578641|588574571|FG001|Overall Study|No Study Drug|0|||
162965692|NCT02578641|588574570|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
162965693|NCT02578641|588574571|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
162965694|NCT02578641|588574570|FG000|Overall Study|Non-compliance with Study Schedule|1|||
162965695|NCT02578641|588574571|FG001|Overall Study|Non-compliance with Study Schedule|0|||
162965696|NCT02578641|588574570|FG000|Overall Study|Other|1|||
162965697|NCT02578641|588574571|FG001|Overall Study|Other|10|||
162965698|NCT02578641|588574570|FG000|Overall Study|Not treated|1|||
162965699|NCT02578641|588574571|FG001|Overall Study|Not treated|4|||
162965700|NCT02655224|588574574|FG000|Overall Study|Adverse Event|1|||
162965701|NCT02655224|588574575|FG001|Overall Study|Adverse Event|1|||
162965702|NCT03036930|588574576|FG000|Overall Study|Lost to Follow-up|7|||
162965703|NCT03036930|588574576|FG000|Overall Study|Withdrawal by Subject|3|||
162965704|NCT03036930|588574576|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
162965705|NCT04227899|588574583|FG000|Overall Study|Withdrawal by Subject|6|||
162965706|NCT04227899|588574584|FG001|Overall Study|Withdrawal by Subject|3|||
162965707|NCT04227899|588574583|FG000|Overall Study|Death|12|||
162965708|NCT04227899|588574584|FG001|Overall Study|Death|6|||
162965709|NCT04227899|588574583|FG000|Overall Study|Lost to Follow-up|2|||
162965710|NCT04227899|588574584|FG001|Overall Study|Lost to Follow-up|1|||
162965711|NCT05151471|588574585|FG000|Overall Study|Adverse Event|21|||
162965712|NCT05151471|588574586|FG001|Overall Study|Adverse Event|16|||
162965713|NCT05151471|588574585|FG000|Overall Study|Death|1|||
162965714|NCT05151471|588574586|FG001|Overall Study|Death|0|||
162965715|NCT05151471|588574585|FG000|Overall Study|Lost to Follow-up|0|||
162965716|NCT05151471|588574586|FG001|Overall Study|Lost to Follow-up|1|||
162965717|NCT05151471|588574585|FG000|Overall Study|Withdrawal by Subject|7|||
162965718|NCT05151471|588574586|FG001|Overall Study|Withdrawal by Subject|9|||
162965719|NCT05151471|588574585|FG000|Overall Study|Study terminated by sponsor|49|||
162965720|NCT05151471|588574586|FG001|Overall Study|Study terminated by sponsor|47|||
162965721|NCT05151471|588574585|FG000|Overall Study|Other|2|||
162965722|NCT05151471|588574586|FG001|Overall Study|Other|1|||
163052484|NCT04161391|588903056|FG001|Overall Study|Death|0|||
162900311|NCT01600105|588335625|FG000|Total Participants|Insufficient image quality|30|||
163052485|NCT04161391|588903057|FG002|Overall Study|Death|0|||
163052486|NCT04161391|588903058|FG003|Overall Study|Death|0|||
162900312|NCT01600105|588335626|FG001|Total Participants|Insufficient image quality|10|||
162900313|NCT01600105|588335625|FG000|Sub Study I|Insufficient image quality|0|||
162965723|NCT03292458|588574594|FG000|Period 1|Adverse Event|2|||
162965724|NCT03292458|588574595|FG001|Period 1|Adverse Event|0|||
162965725|NCT01513239|588574596|FG000|Period 1: Main Phase|Adverse Event|1|||
163052487|NCT04161391|588903059|FG004|Overall Study|Death|0|||
163052488|NCT04161391|588903060|FG005|Overall Study|Death|0|||
162900314|NCT01600105|588335626|FG001|Sub Study I|Insufficient image quality|10|||
162900315|NCT01600105|588335625|FG000|Sub Study II|Withdrawal by Subject|1|||
162965726|NCT01513239|588574597|FG001|Period 1: Main Phase|Adverse Event|1|||
162965727|NCT01513239|588574598|FG002|Period 1: Main Phase|Adverse Event|2|||
163052489|NCT04161391|588903061|FG006|Overall Study|Death|0|||
162965728|NCT01513239|588574599|FG003|Period 1: Main Phase|Adverse Event|0|||
162965729|NCT01513239|588574600|FG004|Period 1: Main Phase|Adverse Event|0|||
162965730|NCT01513239|588574601|FG005|Period 1: Main Phase|Adverse Event|0|||
163052490|NCT04161391|588903062|FG007|Overall Study|Death|1|||
163052491|NCT04161391|588903063|FG008|Overall Study|Death|0|||
162900316|NCT01600105|588335626|FG001|Sub Study II|Withdrawal by Subject|0|||
162900317|NCT01600105|588335625|FG000|Sub Study II|No images in PACS|1|||
162900318|NCT01600105|588335626|FG001|Sub Study II|No images in PACS|0|||
162900319|NCT01600105|588335625|FG000|Sub Study II|Insufficient image quality|3|||
162900320|NCT01600105|588335626|FG001|Sub Study II|Insufficient image quality|0|||
162900321|NCT01600105|588335625|FG000|Sub Study III|Insufficient image quality|5|||
162900322|NCT01600105|588335626|FG001|Sub Study III|Insufficient image quality|0|||
162900323|NCT01600105|588335625|FG000|Sub Study V|Poor Image Quality|2|||
162900324|NCT01600105|588335626|FG001|Sub Study V|Poor Image Quality|0|||
162900325|NCT01263444|588335627|FG000|Overall Study|Adverse Event|8|||
162900326|NCT01263444|588335627|FG000|Overall Study|Withdrawal by Subject|1|||
162900327|NCT01263444|588335627|FG000|Overall Study|Protocol Violation|1|||
162900328|NCT01764022|588335628|FG000|Overall Study|Death|3|||
162900329|NCT01764022|588335629|FG001|Overall Study|Death|5|||
162900330|NCT01764022|588335628|FG000|Overall Study|Withdrawal by Subject|2|||
162965731|NCT01513239|588574596|FG000|Period 1: Main Phase|Death|29|||
162965732|NCT01513239|588574597|FG001|Period 1: Main Phase|Death|22|||
162965733|NCT01513239|588574598|FG002|Period 1: Main Phase|Death|32|||
162965734|NCT01513239|588574599|FG003|Period 1: Main Phase|Death|0|||
162965735|NCT01513239|588574600|FG004|Period 1: Main Phase|Death|0|||
162965736|NCT01513239|588574601|FG005|Period 1: Main Phase|Death|0|||
162965737|NCT01513239|588574596|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
162965738|NCT01513239|588574597|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
162965739|NCT01513239|588574598|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
162965740|NCT01513239|588574599|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
162965741|NCT01513239|588574600|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
162965742|NCT01513239|588574601|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
162965743|NCT01513239|588574596|FG000|Period 1: Main Phase|Physician Decision|4|||
162965744|NCT01513239|588574597|FG001|Period 1: Main Phase|Physician Decision|4|||
162965745|NCT01513239|588574598|FG002|Period 1: Main Phase|Physician Decision|4|||
162965746|NCT01513239|588574599|FG003|Period 1: Main Phase|Physician Decision|0|||
162965747|NCT01513239|588574600|FG004|Period 1: Main Phase|Physician Decision|0|||
162965748|NCT01513239|588574601|FG005|Period 1: Main Phase|Physician Decision|0|||
162965749|NCT01513239|588574596|FG000|Period 1: Main Phase|Protocol Violation|2|||
162965750|NCT01513239|588574597|FG001|Period 1: Main Phase|Protocol Violation|2|||
162965751|NCT01513239|588574598|FG002|Period 1: Main Phase|Protocol Violation|2|||
162965752|NCT01513239|588574599|FG003|Period 1: Main Phase|Protocol Violation|0|||
162965753|NCT01513239|588574600|FG004|Period 1: Main Phase|Protocol Violation|0|||
162965754|NCT01513239|588574601|FG005|Period 1: Main Phase|Protocol Violation|0|||
162965755|NCT01513239|588574596|FG000|Period 1: Main Phase|Technical Problems|1|||
162965756|NCT01513239|588574597|FG001|Period 1: Main Phase|Technical Problems|2|||
162965757|NCT01513239|588574598|FG002|Period 1: Main Phase|Technical Problems|0|||
162965758|NCT01513239|588574599|FG003|Period 1: Main Phase|Technical Problems|0|||
162965759|NCT01513239|588574600|FG004|Period 1: Main Phase|Technical Problems|0|||
162965760|NCT01513239|588574601|FG005|Period 1: Main Phase|Technical Problems|0|||
162965761|NCT01513239|588574596|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
162965762|NCT01513239|588574597|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
162965763|NCT01513239|588574598|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
162965764|NCT01513239|588574599|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
162965765|NCT01513239|588574600|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
162965766|NCT01513239|588574601|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
162965767|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965768|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965769|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
162965770|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
162965771|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
162965772|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
162965773|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Death|0|||
163052492|NCT04161391|588903055|FG000|Overall Study|Physician Decision|0|||
162965774|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Death|0|||
162965775|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Death|0|||
162965776|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Death|2|||
162965777|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Death|5|||
163052493|NCT04161391|588903056|FG001|Overall Study|Physician Decision|0|||
162625795|NCT02469298|587346916|FG002|Overall Study|Protocol Violation|1|||
163052494|NCT04161391|588903057|FG002|Overall Study|Physician Decision|1|||
162708798|NCT04739423|587642902|FG005|Overall Study|Withdrawal by Subject|1|||
162708799|NCT02698436|587642906|FG000|Overall Study|Adverse Event|1|||
162708800|NCT02698436|587642907|FG001|Overall Study|Adverse Event|0|||
162900331|NCT01764022|588335629|FG001|Overall Study|Withdrawal by Subject|6|||
162900332|NCT01764022|588335628|FG000|Overall Study|Lack of Efficacy|0|||
162900333|NCT01764022|588335629|FG001|Overall Study|Lack of Efficacy|1|||
162900334|NCT01764022|588335628|FG000|Overall Study|Physician Decision|0|||
162900335|NCT01764022|588335629|FG001|Overall Study|Physician Decision|2|||
162900336|NCT01764022|588335628|FG000|Overall Study|Lost to Follow-up|2|||
162900337|NCT01764022|588335629|FG001|Overall Study|Lost to Follow-up|0|||
162900338|NCT01764022|588335628|FG000|Overall Study|Protocol Violation|1|||
162900339|NCT01764022|588335629|FG001|Overall Study|Protocol Violation|0|||
162900340|NCT01899768|588335630|FG000|Part A|Adverse Event|2|||
162900341|NCT01899768|588335630|FG000|Part A|Withdrawal by Subject|1|||
162900342|NCT01899768|588335630|FG000|Part B|Adverse Event|1|||
162900343|NCT01899768|588335630|FG000|Part B|Withdrawal by Subject|1|||
162900344|NCT04043416|588335632|FG000|Washout|Change in health condition|0|||
162900345|NCT04043416|588335633|FG001|Washout|Change in health condition|1|||
162900346|NCT00414973|588335634|FG000|Overall Study|Withdrawal by Subject|14|||
162900347|NCT00414973|588335635|FG001|Overall Study|Withdrawal by Subject|4|||
162900348|NCT00414973|588335636|FG002|Overall Study|Withdrawal by Subject|1|||
162900349|NCT00414973|588335637|FG003|Overall Study|Withdrawal by Subject|0|||
162900350|NCT00414973|588335634|FG000|Overall Study|Adverse Event|10|||
162900351|NCT00414973|588335635|FG001|Overall Study|Adverse Event|0|||
162900352|NCT00414973|588335636|FG002|Overall Study|Adverse Event|1|||
162900353|NCT00414973|588335637|FG003|Overall Study|Adverse Event|0|||
162900354|NCT00414973|588335634|FG000|Overall Study|Protocol Violation|3|||
162900355|NCT00414973|588335635|FG001|Overall Study|Protocol Violation|4|||
162900356|NCT00414973|588335636|FG002|Overall Study|Protocol Violation|0|||
162900357|NCT00414973|588335637|FG003|Overall Study|Protocol Violation|0|||
162900358|NCT00414973|588335634|FG000|Overall Study|Lost to Follow-up|0|||
162900359|NCT00414973|588335635|FG001|Overall Study|Lost to Follow-up|2|||
162900360|NCT00414973|588335636|FG002|Overall Study|Lost to Follow-up|0|||
162900361|NCT00414973|588335637|FG003|Overall Study|Lost to Follow-up|0|||
162900362|NCT00414973|588335634|FG000|Overall Study|Sponsor Decision|1|||
162900363|NCT00414973|588335635|FG001|Overall Study|Sponsor Decision|0|||
162900364|NCT00414973|588335636|FG002|Overall Study|Sponsor Decision|0|||
162900365|NCT00414973|588335637|FG003|Overall Study|Sponsor Decision|0|||
162900366|NCT00414973|588335634|FG000|Overall Study|Death|0|||
162900367|NCT00414973|588335635|FG001|Overall Study|Death|0|||
162900368|NCT00414973|588335636|FG002|Overall Study|Death|1|||
162900369|NCT00414973|588335637|FG003|Overall Study|Death|0|||
162900370|NCT01466062|588335638|FG000|Overall Study|Adverse Event|1|||
162900371|NCT01466062|588335638|FG000|Overall Study|Withdrawal by Subject|1|||
162900372|NCT00118040|588335639|FG000|Overall Study|Adverse Event|0|||
162900373|NCT00118040|588335640|FG001|Overall Study|Adverse Event|1|||
162900374|NCT00118040|588335641|FG002|Overall Study|Adverse Event|0|||
162900375|NCT00118040|588335639|FG000|Overall Study|Withdrawal by Subject|0|||
162900376|NCT00118040|588335640|FG001|Overall Study|Withdrawal by Subject|0|||
162900377|NCT00118040|588335641|FG002|Overall Study|Withdrawal by Subject|2|||
162900378|NCT00118040|588335639|FG000|Overall Study|Medical Contraindication|0|||
162900379|NCT00118040|588335640|FG001|Overall Study|Medical Contraindication|0|||
162900380|NCT00118040|588335641|FG002|Overall Study|Medical Contraindication|1|||
163052495|NCT04161391|588903058|FG003|Overall Study|Physician Decision|2|||
163052496|NCT04161391|588903059|FG004|Overall Study|Physician Decision|0|||
163052497|NCT04161391|588903060|FG005|Overall Study|Physician Decision|0|||
163052498|NCT04161391|588903061|FG006|Overall Study|Physician Decision|2|||
162708801|NCT02698436|587642906|FG000|Overall Study|Withdrawal by Subject|3|||
162900381|NCT00118040|588335639|FG000|Overall Study|Non-Compliant Participant|1|||
162900382|NCT00118040|588335640|FG001|Overall Study|Non-Compliant Participant|1|||
162900383|NCT00118040|588335641|FG002|Overall Study|Non-Compliant Participant|2|||
162900384|NCT00118040|588335639|FG000|Overall Study|Other|0|||
162900385|NCT00118040|588335640|FG001|Overall Study|Other|0|||
162900386|NCT00118040|588335641|FG002|Overall Study|Other|1|||
162900387|NCT02865928|588335642|FG000|Overall Study|Withdrawal by Subject|1|||
162900388|NCT02865928|588335643|FG001|Overall Study|Withdrawal by Subject|0|||
162900389|NCT02865928|588335642|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
162900390|NCT02865928|588335643|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
162900391|NCT02865928|588335642|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
162900392|NCT02865928|588335643|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
162900393|NCT01925014|588335644|FG000|Overall Study|Inappropriate enrollment|4|||
163052499|NCT04161391|588903062|FG007|Overall Study|Physician Decision|0|||
163052500|NCT04161391|588903063|FG008|Overall Study|Physician Decision|0|||
163052501|NCT04161391|588903055|FG000|Overall Study|Progressive Disease|4|||
163052502|NCT04161391|588903056|FG001|Overall Study|Progressive Disease|3|||
162965778|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Death|2|||
162965779|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965780|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965781|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965782|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
162965783|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
162965784|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
162965785|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965786|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965787|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965788|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
162965789|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965790|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162965791|NCT01513239|588574596|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965792|NCT01513239|588574597|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162900394|NCT01925014|588335645|FG001|Overall Study|Inappropriate enrollment|6|||
162900395|NCT01925014|588335644|FG000|Overall Study|Withdrawal by Subject|5|||
162900396|NCT01925014|588335645|FG001|Overall Study|Withdrawal by Subject|13|||
162900397|NCT01196091|588335649|FG000|Overall Study|Adverse Event|22|||
162900398|NCT01196091|588335650|FG001|Overall Study|Adverse Event|27|||
162900399|NCT01196091|588335651|FG002|Overall Study|Adverse Event|26|||
162900400|NCT01196091|588335649|FG000|Overall Study|Death|3|||
162900401|NCT01196091|588335650|FG001|Overall Study|Death|2|||
162900402|NCT01196091|588335651|FG002|Overall Study|Death|2|||
162900403|NCT01196091|588335649|FG000|Overall Study|Entry Criteria Not Met|11|||
162900404|NCT01196091|588335650|FG001|Overall Study|Entry Criteria Not Met|11|||
162900405|NCT01196091|588335651|FG002|Overall Study|Entry Criteria Not Met|10|||
162900406|NCT01196091|588335649|FG000|Overall Study|Lack of Efficacy|15|||
162900407|NCT01196091|588335650|FG001|Overall Study|Lack of Efficacy|12|||
162900408|NCT01196091|588335651|FG002|Overall Study|Lack of Efficacy|17|||
162900409|NCT01196091|588335649|FG000|Overall Study|Lost to Follow-up|5|||
162900410|NCT01196091|588335650|FG001|Overall Study|Lost to Follow-up|5|||
162900411|NCT01196091|588335651|FG002|Overall Study|Lost to Follow-up|6|||
162900412|NCT01196091|588335649|FG000|Overall Study|Parent/Caregiver Decision|0|||
162900413|NCT01196091|588335650|FG001|Overall Study|Parent/Caregiver Decision|0|||
162900414|NCT01196091|588335651|FG002|Overall Study|Parent/Caregiver Decision|1|||
162900415|NCT01196091|588335649|FG000|Overall Study|Withdrawal by Subject|16|||
162900416|NCT01196091|588335650|FG001|Overall Study|Withdrawal by Subject|19|||
162900417|NCT01196091|588335651|FG002|Overall Study|Withdrawal by Subject|22|||
163052503|NCT04161391|588903057|FG002|Overall Study|Progressive Disease|3|||
162900418|NCT01196091|588335649|FG000|Overall Study|Physician Decision|3|||
163052504|NCT04161391|588903058|FG003|Overall Study|Progressive Disease|5|||
163052505|NCT04161391|588903059|FG004|Overall Study|Progressive Disease|3|||
163052506|NCT04161391|588903060|FG005|Overall Study|Progressive Disease|3|||
163052507|NCT04161391|588903061|FG006|Overall Study|Progressive Disease|5|||
163052508|NCT04161391|588903062|FG007|Overall Study|Progressive Disease|2|||
163052509|NCT04161391|588903063|FG008|Overall Study|Progressive Disease|2|||
162625796|NCT02469298|587346917|FG003|Overall Study|Protocol Violation|0|||
162625797|NCT02469298|587346914|FG000|Overall Study|Lost to Follow-up|1|||
162625798|NCT02469298|587346915|FG001|Overall Study|Lost to Follow-up|0|||
162625799|NCT02469298|587346916|FG002|Overall Study|Lost to Follow-up|1|||
162625800|NCT02469298|587346917|FG003|Overall Study|Lost to Follow-up|0|||
162625801|NCT02469298|587346914|FG000|Overall Study|Physician Decision|0|||
162625802|NCT02469298|587346915|FG001|Overall Study|Physician Decision|0|||
162625803|NCT02469298|587346916|FG002|Overall Study|Physician Decision|0|||
162625804|NCT02469298|587346917|FG003|Overall Study|Physician Decision|1|||
162625805|NCT02469298|587346914|FG000|Overall Study|Withdrawal by Subject|0|||
163052510|NCT01739335|588903070|FG000|Overall Study|Lost to Follow-up|7|||
163052511|NCT01739335|588903071|FG001|Overall Study|Lost to Follow-up|4|||
163052512|NCT01739335|588903070|FG000|Overall Study|Ineligible patient randomized|0|||
163052513|NCT01739335|588903071|FG001|Overall Study|Ineligible patient randomized|1|||
163052514|NCT01863771|588903073|FG000|Induction Phase|Adverse Event|9|||
163052515|NCT01863771|588903074|FG001|Induction Phase|Adverse Event|0|||
162900419|NCT01196091|588335650|FG001|Overall Study|Physician Decision|3|||
162900420|NCT01196091|588335651|FG002|Overall Study|Physician Decision|4|||
162900421|NCT01196091|588335649|FG000|Overall Study|Protocol Violation|1|||
163052516|NCT01863771|588903075|FG002|Induction Phase|Adverse Event|0|||
163052517|NCT01863771|588903076|FG003|Induction Phase|Adverse Event|0|||
163052518|NCT01863771|588903073|FG000|Induction Phase|Lack of Efficacy|10|||
163052519|NCT01863771|588903074|FG001|Induction Phase|Lack of Efficacy|0|||
163052520|NCT01863771|588903075|FG002|Induction Phase|Lack of Efficacy|0|||
163052521|NCT01863771|588903076|FG003|Induction Phase|Lack of Efficacy|0|||
163052522|NCT01863771|588903073|FG000|Induction Phase|Withdrawal by Subject|2|||
162900422|NCT01196091|588335650|FG001|Overall Study|Protocol Violation|3|||
162900423|NCT01196091|588335651|FG002|Overall Study|Protocol Violation|3|||
162900424|NCT01196091|588335649|FG000|Overall Study|Sponsor Decision|6|||
162900425|NCT01196091|588335650|FG001|Overall Study|Sponsor Decision|5|||
162900426|NCT01196091|588335651|FG002|Overall Study|Sponsor Decision|4|||
162900427|NCT01196091|588335649|FG000|Overall Study|Excluded Site|5|||
162900428|NCT01196091|588335650|FG001|Overall Study|Excluded Site|11|||
162900429|NCT01196091|588335651|FG002|Overall Study|Excluded Site|8|||
162900430|NCT01196091|588335649|FG000|Overall Study|Randomized, No Study Drug Received|1|||
162900431|NCT01196091|588335650|FG001|Overall Study|Randomized, No Study Drug Received|0|||
162900432|NCT01196091|588335651|FG002|Overall Study|Randomized, No Study Drug Received|1|||
162900433|NCT03733249|588335652|FG000|Overall Study|Death|7|||
162900434|NCT03733249|588335652|FG000|Overall Study|Disease relapse|16|||
162900435|NCT03733249|588335652|FG000|Overall Study|Lost to Follow-up|4|||
162900436|NCT03733249|588335652|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
162900437|NCT03733249|588335652|FG000|Overall Study|Withdrawal by Subject|1|||
162900438|NCT04476108|588335653|FG000|Overall Study|Adverse Event|4|||
162900439|NCT04476108|588335654|FG001|Overall Study|Adverse Event|1|||
162900440|NCT04476108|588335653|FG000|Overall Study|Lost to Follow-up|1|||
162900441|NCT04476108|588335654|FG001|Overall Study|Lost to Follow-up|0|||
162900442|NCT04476108|588335653|FG000|Overall Study|Inadvertent Enrollment|1|||
162900443|NCT04476108|588335654|FG001|Overall Study|Inadvertent Enrollment|0|||
162900444|NCT04476108|588335653|FG000|Overall Study|Protocol Violation|1|||
162900445|NCT04476108|588335654|FG001|Overall Study|Protocol Violation|1|||
162900446|NCT04476108|588335653|FG000|Overall Study|Withdrawal by Subject|1|||
162900447|NCT04476108|588335654|FG001|Overall Study|Withdrawal by Subject|1|||
162900448|NCT00471276|588335655|FG000|Overall Study|Death|2|||
162900449|NCT00471276|588335655|FG000|Overall Study|Adverse Event|16|||
162900450|NCT00471276|588335655|FG000|Overall Study|Protocol Violation|1|||
162900451|NCT00471276|588335655|FG000|Overall Study|Objective progression or relapse|54|||
162900452|NCT00471276|588335655|FG000|Overall Study|Global deterioration of health status|1|||
162900453|NCT00471276|588335655|FG000|Overall Study|Other|3|||
162900454|NCT00471276|588335655|FG000|Overall Study|Refused treatment|6|||
163052523|NCT01863771|588903074|FG001|Induction Phase|Withdrawal by Subject|0|||
163052524|NCT01863771|588903075|FG002|Induction Phase|Withdrawal by Subject|0|||
163052525|NCT01863771|588903076|FG003|Induction Phase|Withdrawal by Subject|0|||
162900455|NCT01487863|588335659|FG000|Overall Study|Death|19|||
162900456|NCT01487863|588335660|FG001|Overall Study|Death|19|||
162900457|NCT02324049|588335664|FG000|Part C|Study terminated|11|||
162900458|NCT02159365|588335665|FG000|Overall Study|Disease Progression|23|||
163052526|NCT01863771|588903073|FG000|Maintenance Phase|Adverse Event|0|||
162625806|NCT02469298|587346915|FG001|Overall Study|Withdrawal by Subject|0|||
162625807|NCT02469298|587346916|FG002|Overall Study|Withdrawal by Subject|0|||
162900459|NCT02159365|588335665|FG000|Overall Study|Other reasons|11|||
163052527|NCT01863771|588903074|FG001|Maintenance Phase|Adverse Event|0|||
163052528|NCT01863771|588903075|FG002|Maintenance Phase|Adverse Event|1|||
163052529|NCT01863771|588903076|FG003|Maintenance Phase|Adverse Event|1|||
163052530|NCT01863771|588903073|FG000|Maintenance Phase|Lack of Efficacy|0|||
163052531|NCT01863771|588903074|FG001|Maintenance Phase|Lack of Efficacy|3|||
163052532|NCT01863771|588903075|FG002|Maintenance Phase|Lack of Efficacy|7|||
163052533|NCT01863771|588903076|FG003|Maintenance Phase|Lack of Efficacy|38|||
163052534|NCT01863771|588903073|FG000|Maintenance Phase|Physician Decision|0|||
163052535|NCT01863771|588903074|FG001|Maintenance Phase|Physician Decision|0|||
163052536|NCT01863771|588903075|FG002|Maintenance Phase|Physician Decision|2|||
163052537|NCT01863771|588903076|FG003|Maintenance Phase|Physician Decision|1|||
163052538|NCT01863771|588903073|FG000|Maintenance Phase|Pregnancy|0|||
163052539|NCT01863771|588903074|FG001|Maintenance Phase|Pregnancy|1|||
163052540|NCT01863771|588903075|FG002|Maintenance Phase|Pregnancy|0|||
163052541|NCT01863771|588903076|FG003|Maintenance Phase|Pregnancy|0|||
163052542|NCT01863771|588903073|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163052543|NCT01863771|588903074|FG001|Maintenance Phase|Withdrawal by Subject|1|||
163052544|NCT01863771|588903075|FG002|Maintenance Phase|Withdrawal by Subject|2|||
163052545|NCT01863771|588903076|FG003|Maintenance Phase|Withdrawal by Subject|3|||
163052546|NCT00883181|588903077|FG000|Overall Study|Hematological Adverse Event|26|||
163052547|NCT00883181|588903077|FG000|Overall Study|Non-hematological Adverse Event|55|||
163052548|NCT00883181|588903077|FG000|Overall Study|Disease Progression|94|||
163052549|NCT00883181|588903077|FG000|Overall Study|Administrative Reason|24|||
163052550|NCT00883181|588903077|FG000|Overall Study|Withdrawal by Subject|4|||
162900460|NCT02159365|588335665|FG000|Overall Study|Administrative reason by Sponsor|9|||
162900461|NCT02159365|588335665|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
162900462|NCT02159365|588335665|FG000|Overall Study|Study drug toxicity|7|||
162900463|NCT02159365|588335665|FG000|Overall Study|Maximum clinical benefit|3|||
162900464|NCT02159365|588335665|FG000|Overall Study|Subject request to discontinue treatment|3|||
162900465|NCT02159365|588335665|FG000|Overall Study|Subject withdrew consent|3|||
162900466|NCT02159365|588335665|FG000|Overall Study|Death|1|||
162900467|NCT02159365|588335665|FG000|Overall Study|Lost to Follow-up|1|||
162900468|NCT01437267|588335669|FG000|Overall Study|Withdrawal by Subject|0|||
162900469|NCT01437267|588335670|FG001|Overall Study|Withdrawal by Subject|0|||
162900470|NCT01437267|588335671|FG002|Overall Study|Withdrawal by Subject|0|||
162900471|NCT01437267|588335672|FG003|Overall Study|Withdrawal by Subject|1|||
162900472|NCT01437267|588335673|FG004|Overall Study|Withdrawal by Subject|0|||
162900473|NCT01437267|588335674|FG005|Overall Study|Withdrawal by Subject|0|||
162900474|NCT01437267|588335669|FG000|Overall Study|Protocol Violation|0|||
162900475|NCT01437267|588335670|FG001|Overall Study|Protocol Violation|1|||
162900476|NCT01437267|588335671|FG002|Overall Study|Protocol Violation|0|||
162900477|NCT01437267|588335672|FG003|Overall Study|Protocol Violation|0|||
162900478|NCT01437267|588335673|FG004|Overall Study|Protocol Violation|0|||
162900479|NCT01437267|588335674|FG005|Overall Study|Protocol Violation|0|||
162900480|NCT01810380|588335677|FG000|Overall Study|Randomised not treated|2|||
162900481|NCT01810380|588335678|FG001|Overall Study|Randomised not treated|1|||
162900482|NCT01810380|588335679|FG002|Overall Study|Randomised not treated|1|||
162900483|NCT01810380|588335677|FG000|Overall Study|Adverse Event|11|||
162900484|NCT01810380|588335678|FG001|Overall Study|Adverse Event|14|||
162900485|NCT01810380|588335679|FG002|Overall Study|Adverse Event|4|||
162900486|NCT01810380|588335677|FG000|Overall Study|Lack of Efficacy|24|||
162900487|NCT01810380|588335678|FG001|Overall Study|Lack of Efficacy|10|||
162900488|NCT01810380|588335679|FG002|Overall Study|Lack of Efficacy|11|||
162900489|NCT01810380|588335677|FG000|Overall Study|Protocol Violation|1|||
162900490|NCT01810380|588335678|FG001|Overall Study|Protocol Violation|0|||
162900491|NCT01810380|588335679|FG002|Overall Study|Protocol Violation|1|||
162900492|NCT01810380|588335677|FG000|Overall Study|Withdrawal by Subject|6|||
162900493|NCT01810380|588335678|FG001|Overall Study|Withdrawal by Subject|0|||
162900494|NCT01810380|588335679|FG002|Overall Study|Withdrawal by Subject|6|||
162900495|NCT01810380|588335677|FG000|Overall Study|Administrative or other reasons|11|||
162900496|NCT01810380|588335678|FG001|Overall Study|Administrative or other reasons|13|||
162900497|NCT01810380|588335679|FG002|Overall Study|Administrative or other reasons|9|||
162900498|NCT00033371|588335680|FG000|Overall Study|Adverse Event|1|||
162900499|NCT00033371|588335681|FG001|Overall Study|Adverse Event|5|||
162900500|NCT00033371|588335680|FG000|Overall Study|Lost to Follow-up|2|||
162900501|NCT00033371|588335681|FG001|Overall Study|Lost to Follow-up|1|||
162900502|NCT00033371|588335680|FG000|Overall Study|Withdrawal by Subject|3|||
162900503|NCT00033371|588335681|FG001|Overall Study|Withdrawal by Subject|3|||
162900504|NCT00033371|588335680|FG000|Overall Study|Disease Progression|0|||
162900505|NCT00033371|588335681|FG001|Overall Study|Disease Progression|1|||
162900506|NCT02699125|588335682|FG000|Placebo|Lost to Follow-up|2|||
162900507|NCT02699125|588335683|FG001|Placebo|Lost to Follow-up|0|||
162900508|NCT02699125|588335682|FG000|Placebo|Protocol Violation|1|||
162900509|NCT02699125|588335683|FG001|Placebo|Protocol Violation|0|||
162900510|NCT02699125|588335682|FG000|Placebo|Withdrawal by Subject|0|||
162900511|NCT02699125|588335683|FG001|Placebo|Withdrawal by Subject|4|||
162900512|NCT02699125|588335682|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
163052551|NCT00883181|588903077|FG000|Overall Study|Death|31|||
163052552|NCT00883181|588903077|FG000|Overall Study|Other|38|||
163052553|NCT00883181|588903077|FG000|Overall Study|Protocol Deviation|3|||
163052554|NCT00883181|588903077|FG000|Overall Study|Noncompliance|3|||
163052555|NCT00386334|588903080|FG000|Double Blind Period|Adverse Event|9|||
163052556|NCT00386334|588903081|FG001|Double Blind Period|Adverse Event|14|||
163052557|NCT00386334|588903080|FG000|Double Blind Period|Protocol Violation|1|||
163052558|NCT00386334|588903081|FG001|Double Blind Period|Protocol Violation|1|||
163052559|NCT00386334|588903080|FG000|Double Blind Period|Withdrawal by Subject|9|||
163052560|NCT00386334|588903081|FG001|Double Blind Period|Withdrawal by Subject|13|||
163052561|NCT00386334|588903080|FG000|Double Blind Period|Lack of Efficacy|20|||
163052562|NCT00386334|588903081|FG001|Double Blind Period|Lack of Efficacy|11|||
163052563|NCT00386334|588903080|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
163052564|NCT00386334|588903081|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
163052565|NCT00386334|588903080|FG000|Double Blind Period|Other|3|||
162708802|NCT02698436|587642907|FG001|Overall Study|Withdrawal by Subject|3|||
162900513|NCT02699125|588335683|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
162900514|NCT01390038|588335686|FG000|Overall Study|Death|1|||
162900515|NCT01390038|588335686|FG000|Overall Study|Lost to Follow-up|1|||
162900516|NCT01390038|588335686|FG000|Overall Study|Withdrawal by Subject|4|||
162900517|NCT01390038|588335686|FG000|Overall Study|Simpliciti System Removal|2|||
162900518|NCT03799627|588335687|FG000|Overall Study|Adverse Event|1|||
162900519|NCT03799627|588335688|FG001|Overall Study|Adverse Event|2|||
162900520|NCT03799627|588335689|FG002|Overall Study|Adverse Event|0|||
162900521|NCT03799627|588335690|FG003|Overall Study|Adverse Event|0|||
162900522|NCT03799627|588335691|FG004|Overall Study|Adverse Event|2|||
162900523|NCT03799627|588335692|FG005|Overall Study|Adverse Event|5|||
162900524|NCT03799627|588335693|FG006|Overall Study|Adverse Event|0|||
162900525|NCT03799627|588335694|FG007|Overall Study|Adverse Event|2|||
162900526|NCT03799627|588335695|FG008|Overall Study|Adverse Event|0|||
162900527|NCT03799627|588335687|FG000|Overall Study|Physician Decision|2|||
162900528|NCT03799627|588335688|FG001|Overall Study|Physician Decision|2|||
162900529|NCT03799627|588335689|FG002|Overall Study|Physician Decision|0|||
162900530|NCT03799627|588335690|FG003|Overall Study|Physician Decision|0|||
162900531|NCT03799627|588335691|FG004|Overall Study|Physician Decision|2|||
162900532|NCT03799627|588335692|FG005|Overall Study|Physician Decision|2|||
162900533|NCT03799627|588335693|FG006|Overall Study|Physician Decision|0|||
162900534|NCT03799627|588335694|FG007|Overall Study|Physician Decision|0|||
162900535|NCT03799627|588335695|FG008|Overall Study|Physician Decision|0|||
162900536|NCT03799627|588335687|FG000|Overall Study|Withdrawal by Subject|1|||
162900537|NCT03799627|588335688|FG001|Overall Study|Withdrawal by Subject|1|||
162900538|NCT03799627|588335689|FG002|Overall Study|Withdrawal by Subject|0|||
162900539|NCT03799627|588335690|FG003|Overall Study|Withdrawal by Subject|2|||
162900540|NCT03799627|588335691|FG004|Overall Study|Withdrawal by Subject|0|||
162900541|NCT03799627|588335692|FG005|Overall Study|Withdrawal by Subject|3|||
162900542|NCT03799627|588335693|FG006|Overall Study|Withdrawal by Subject|0|||
162900543|NCT03799627|588335694|FG007|Overall Study|Withdrawal by Subject|0|||
162900544|NCT03799627|588335695|FG008|Overall Study|Withdrawal by Subject|0|||
162900545|NCT03799627|588335687|FG000|Overall Study|Lack of Efficacy|0|||
162900546|NCT03799627|588335688|FG001|Overall Study|Lack of Efficacy|0|||
162900547|NCT03799627|588335689|FG002|Overall Study|Lack of Efficacy|0|||
162900548|NCT03799627|588335690|FG003|Overall Study|Lack of Efficacy|1|||
162900549|NCT03799627|588335691|FG004|Overall Study|Lack of Efficacy|0|||
162900550|NCT03799627|588335692|FG005|Overall Study|Lack of Efficacy|0|||
162900551|NCT03799627|588335693|FG006|Overall Study|Lack of Efficacy|0|||
162900552|NCT03799627|588335694|FG007|Overall Study|Lack of Efficacy|0|||
162900553|NCT03799627|588335695|FG008|Overall Study|Lack of Efficacy|0|||
162900554|NCT03799627|588335687|FG000|Overall Study|Lost to Follow-up|0|||
162900555|NCT03799627|588335688|FG001|Overall Study|Lost to Follow-up|0|||
162900556|NCT03799627|588335689|FG002|Overall Study|Lost to Follow-up|0|||
162900557|NCT03799627|588335690|FG003|Overall Study|Lost to Follow-up|0|||
162900558|NCT03799627|588335691|FG004|Overall Study|Lost to Follow-up|0|||
162900559|NCT03799627|588335692|FG005|Overall Study|Lost to Follow-up|0|||
162900560|NCT03799627|588335693|FG006|Overall Study|Lost to Follow-up|1|||
162900561|NCT03799627|588335694|FG007|Overall Study|Lost to Follow-up|0|||
162900562|NCT03799627|588335695|FG008|Overall Study|Lost to Follow-up|1|||
162900563|NCT03799627|588335687|FG000|Overall Study|Death|0|||
162900564|NCT03799627|588335688|FG001|Overall Study|Death|0|||
162900565|NCT03799627|588335689|FG002|Overall Study|Death|0|||
162900566|NCT03799627|588335690|FG003|Overall Study|Death|1|||
162900567|NCT03799627|588335691|FG004|Overall Study|Death|0|||
162900568|NCT03799627|588335692|FG005|Overall Study|Death|0|||
162900569|NCT03799627|588335693|FG006|Overall Study|Death|0|||
163052566|NCT00386334|588903081|FG001|Double Blind Period|Other|3|||
163052567|NCT00386334|588903080|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
162900570|NCT03799627|588335694|FG007|Overall Study|Death|0|||
162900571|NCT03799627|588335695|FG008|Overall Study|Death|0|||
162900572|NCT03799627|588335687|FG000|Overall Study|Study Drug Put on Hold|1|||
162900573|NCT03799627|588335688|FG001|Overall Study|Study Drug Put on Hold|0|||
162900574|NCT03799627|588335689|FG002|Overall Study|Study Drug Put on Hold|0|||
162900575|NCT03799627|588335690|FG003|Overall Study|Study Drug Put on Hold|0|||
163052568|NCT00386334|588903081|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
163052569|NCT03238417|588903082|FG000|Overall|non-response|955|||
163052570|NCT03238417|588903083|FG001|Overall|non-response|1920|||
163052571|NCT03238417|588903082|FG000|Overall|partial completion|48|||
163052572|NCT03238417|588903083|FG001|Overall|partial completion|68|||
163052573|NCT03238417|588903082|FG000|Baseline|Partial completion|17|||
163052574|NCT03238417|588903083|FG001|Baseline|Partial completion|48|||
163052575|NCT03238417|588903082|FG000|Baseline|non-response|372|||
163052576|NCT03238417|588903083|FG001|Baseline|non-response|669|||
163052577|NCT03238417|588903082|FG000|12-month|non-response|296|||
163052578|NCT03238417|588903083|FG001|12-month|non-response|669|||
163052579|NCT03238417|588903082|FG000|12-month|partial completion|23|||
163052580|NCT03238417|588903083|FG001|12-month|partial completion|37|||
163052581|NCT03238417|588903082|FG000|24-month|non-response|287|||
163052582|NCT03238417|588903083|FG001|24-month|non-response|594|||
163052583|NCT03238417|588903082|FG000|24-month|partial completion|8|||
163052584|NCT03238417|588903083|FG001|24-month|partial completion|31|||
163052585|NCT02089347|588903084|FG000|Overall Study|Protocol Violation|1|||
163052586|NCT02089347|588903085|FG001|Overall Study|Protocol Violation|0|||
163052587|NCT02914834|588903086|FG000|Overall Study|Study halted due to COVID|1|||
163052588|NCT02914834|588903087|FG001|Overall Study|Study halted due to COVID|1|||
162900576|NCT03799627|588335691|FG004|Overall Study|Study Drug Put on Hold|0|||
162900577|NCT03799627|588335692|FG005|Overall Study|Study Drug Put on Hold|0|||
162900578|NCT03799627|588335693|FG006|Overall Study|Study Drug Put on Hold|0|||
162900579|NCT03799627|588335694|FG007|Overall Study|Study Drug Put on Hold|0|||
162900580|NCT03799627|588335695|FG008|Overall Study|Study Drug Put on Hold|0|||
162900581|NCT03799627|588335687|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
162900582|NCT03799627|588335688|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
163052589|NCT02914834|588903086|FG000|Overall Study|1 subject withdrew|0|||
163052590|NCT02914834|588903087|FG001|Overall Study|1 subject withdrew|1|||
163052591|NCT01249131|588903090|FG000|Washout Period of 10 Days|Adverse Event|0|||
162625808|NCT02469298|587346917|FG003|Overall Study|Withdrawal by Subject|1|||
162625809|NCT00307294|587346918|FG000|Overall Study|Withdrawal by Subject|1|||
162625810|NCT03311724|587346919|FG000|Overall Study|Physician Decision|0|||
162625811|NCT03311724|587346920|FG001|Overall Study|Physician Decision|0|||
162625812|NCT03311724|587346921|FG002|Overall Study|Physician Decision|0|||
162625813|NCT03311724|587346922|FG003|Overall Study|Physician Decision|1|||
162625814|NCT03311724|587346919|FG000|Overall Study|Protocol Violation|1|||
162625815|NCT03311724|587346920|FG001|Overall Study|Protocol Violation|0|||
162965793|NCT01513239|588574598|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965794|NCT01513239|588574599|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162965795|NCT01513239|588574600|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
162965796|NCT01513239|588574601|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
162965797|NCT00396162|588574602|FG000|Overall Study|Withdrawal by Subject|2|||
162625816|NCT03311724|587346921|FG002|Overall Study|Protocol Violation|1|||
162965798|NCT00396162|588574603|FG001|Overall Study|Withdrawal by Subject|3|||
162965799|NCT02694536|588574604|FG000|Overall Study|Progressive Disease|40|||
162965800|NCT02694536|588574604|FG000|Overall Study|Lost to Follow-up|1|||
162965801|NCT02694536|588574604|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
162965802|NCT02694536|588574604|FG000|Overall Study|Withdrawal by Subject|8|||
162965803|NCT02694536|588574604|FG000|Overall Study|Death|8|||
162965804|NCT02694536|588574604|FG000|Overall Study|Other|22|||
162965805|NCT01741545|588574605|FG000|Treatment Period|Lack of Efficacy|0|||
162965806|NCT01741545|588574606|FG001|Treatment Period|Lack of Efficacy|1|||
162965807|NCT01741545|588574605|FG000|Treatment Period|Adverse event, non-fatal|1|||
162965808|NCT01741545|588574606|FG001|Treatment Period|Adverse event, non-fatal|3|||
162708803|NCT02698436|587642906|FG000|Overall Study|Lost to Follow-up|2|||
162965809|NCT01741545|588574605|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
162965810|NCT01741545|588574606|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
162965811|NCT01741545|588574605|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162965812|NCT01741545|588574606|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162965813|NCT01911429|588574607|FG000|Overall Study|Adverse Event|5|||
162965814|NCT01911429|588574608|FG001|Overall Study|Adverse Event|3|||
162965815|NCT01911429|588574609|FG002|Overall Study|Adverse Event|9|||
162965816|NCT01911429|588574607|FG000|Overall Study|Lack of Efficacy|1|||
162965817|NCT01911429|588574608|FG001|Overall Study|Lack of Efficacy|2|||
162965818|NCT01911429|588574609|FG002|Overall Study|Lack of Efficacy|4|||
162965819|NCT01911429|588574607|FG000|Overall Study|Lost to Follow-up|0|||
162965820|NCT01911429|588574608|FG001|Overall Study|Lost to Follow-up|0|||
162965821|NCT01911429|588574609|FG002|Overall Study|Lost to Follow-up|1|||
162965822|NCT01911429|588574607|FG000|Overall Study|Protocol Violation|0|||
162965823|NCT01911429|588574608|FG001|Overall Study|Protocol Violation|0|||
162965824|NCT01911429|588574609|FG002|Overall Study|Protocol Violation|1|||
162965825|NCT01911429|588574607|FG000|Overall Study|Withdrawal by Subject|5|||
162965826|NCT01911429|588574608|FG001|Overall Study|Withdrawal by Subject|5|||
162965827|NCT01911429|588574609|FG002|Overall Study|Withdrawal by Subject|4|||
162965828|NCT01911429|588574607|FG000|Overall Study|Accidental randomization|0|||
162965829|NCT01911429|588574608|FG001|Overall Study|Accidental randomization|0|||
162965830|NCT01911429|588574609|FG002|Overall Study|Accidental randomization|1|||
162965831|NCT01911429|588574607|FG000|Overall Study|subject left study|1|||
162965832|NCT01911429|588574608|FG001|Overall Study|subject left study|0|||
162965833|NCT01911429|588574609|FG002|Overall Study|subject left study|0|||
162965834|NCT01664039|588574613|FG000|Overall Study|Adverse Event|3|||
162965835|NCT01664039|588574614|FG001|Overall Study|Adverse Event|4|||
162965836|NCT01664039|588574613|FG000|Overall Study|Lost to Follow-up|1|||
162965837|NCT01664039|588574614|FG001|Overall Study|Lost to Follow-up|1|||
162965838|NCT01664039|588574613|FG000|Overall Study|Withdrawal by Subject|1|||
162965839|NCT01664039|588574614|FG001|Overall Study|Withdrawal by Subject|3|||
162965840|NCT01664039|588574613|FG000|Overall Study|Noncompliance|1|||
162965841|NCT01664039|588574614|FG001|Overall Study|Noncompliance|1|||
162965842|NCT01853176|588574615|FG000|Overall Study|Study terminated|4|||
162965843|NCT01853176|588574616|FG001|Overall Study|Study terminated|0|||
162965844|NCT02276885|588574617|FG000|Overall Study|Withdrawal by Subject|2|||
162965845|NCT02276885|588574618|FG001|Overall Study|Withdrawal by Subject|0|||
162965846|NCT02276885|588574617|FG000|Overall Study|Lost to Follow-up|5|||
162965847|NCT02276885|588574618|FG001|Overall Study|Lost to Follow-up|2|||
162965848|NCT04569032|588574619|FG000|Overall Study|Death|10|||
162965849|NCT04569032|588574620|FG001|Overall Study|Death|13|||
162965850|NCT04569032|588574619|FG000|Overall Study|Withdrawal by Subject|2|||
162965851|NCT04569032|588574620|FG001|Overall Study|Withdrawal by Subject|0|||
162965852|NCT04569032|588574619|FG000|Overall Study|Lost to Follow-up|0|||
162965853|NCT04569032|588574620|FG001|Overall Study|Lost to Follow-up|1|||
162965854|NCT04569032|588574619|FG000|Overall Study|In long term follow up|22|||
162965855|NCT04569032|588574620|FG001|Overall Study|In long term follow up|34|||
162965856|NCT03837626|588574626|FG000|Overall Study|Adverse Event|3|||
162965857|NCT03837626|588574627|FG001|Overall Study|Adverse Event|3|||
162965858|NCT03837626|588574626|FG000|Overall Study|Withdrawal by Subject|2|||
162965859|NCT03837626|588574627|FG001|Overall Study|Withdrawal by Subject|4|||
162965860|NCT03837626|588574626|FG000|Overall Study|Physician Decision|2|||
162965861|NCT03837626|588574627|FG001|Overall Study|Physician Decision|3|||
162965862|NCT03837626|588574626|FG000|Overall Study|Lost to Follow-up|3|||
162965863|NCT03837626|588574627|FG001|Overall Study|Lost to Follow-up|1|||
162965864|NCT03599362|588574628|FG000|Overall Study|Screen Failure|3|||
162965865|NCT03707587|588574629|FG000|Overall Study|Death|0|||
162965866|NCT03707587|588574630|FG001|Overall Study|Death|1|||
162965867|NCT00958724|588574640|FG000|Overall Study|Disease Progression|6|||
162965868|NCT04442503|588574641|FG000|Overall Study|Adverse Event|1|||
162965869|NCT04442503|588574642|FG001|Overall Study|Adverse Event|1|||
162965870|NCT04442503|588574641|FG000|Overall Study|Lost to Follow-up|8|||
162965871|NCT04442503|588574642|FG001|Overall Study|Lost to Follow-up|6|||
162965872|NCT04442503|588574641|FG000|Overall Study|Physician Decision|0|||
163052592|NCT01249131|588903091|FG001|Washout Period of 10 Days|Adverse Event|0|||
163052593|NCT01249131|588903092|FG002|Washout Period of 10 Days|Adverse Event|0|||
163052594|NCT01249131|588903093|FG003|Washout Period of 10 Days|Adverse Event|0|||
163052595|NCT01249131|588903094|FG004|Washout Period of 10 Days|Adverse Event|1|||
163052596|NCT01249131|588903095|FG005|Washout Period of 10 Days|Adverse Event|0|||
163052597|NCT01225549|588903096|FG000|Period 4 - Washout|Disallowed medication|0|||
163052598|NCT01225549|588903097|FG001|Period 4 - Washout|Disallowed medication|1|||
163052599|NCT01225549|588903098|FG002|Period 4 - Washout|Disallowed medication|0|||
163052600|NCT01225549|588903099|FG003|Period 4 - Washout|Disallowed medication|0|||
163052601|NCT01225549|588903100|FG004|Period 4 - Washout|Disallowed medication|0|||
163052602|NCT01225549|588903101|FG005|Period 4 - Washout|Disallowed medication|0|||
163052603|NCT01225549|588903102|FG006|Period 4 - Washout|Disallowed medication|0|||
163052604|NCT01225549|588903103|FG007|Period 4 - Washout|Disallowed medication|0|||
163052605|NCT01225549|588903104|FG008|Period 4 - Washout|Disallowed medication|0|||
163052606|NCT01225549|588903105|FG009|Period 4 - Washout|Disallowed medication|0|||
163052607|NCT01225549|588903096|FG000|Period 6 - Washout|Disallowed medication|0|||
163052608|NCT01225549|588903097|FG001|Period 6 - Washout|Disallowed medication|0|||
163052609|NCT01225549|588903098|FG002|Period 6 - Washout|Disallowed medication|0|||
163052610|NCT01225549|588903099|FG003|Period 6 - Washout|Disallowed medication|1|||
163052611|NCT01225549|588903100|FG004|Period 6 - Washout|Disallowed medication|0|||
163052612|NCT01225549|588903101|FG005|Period 6 - Washout|Disallowed medication|0|||
163052613|NCT01225549|588903102|FG006|Period 6 - Washout|Disallowed medication|0|||
163052614|NCT01225549|588903103|FG007|Period 6 - Washout|Disallowed medication|0|||
163052615|NCT01225549|588903104|FG008|Period 6 - Washout|Disallowed medication|0|||
163052616|NCT01225549|588903105|FG009|Period 6 - Washout|Disallowed medication|0|||
163052617|NCT00473083|588903108|FG000|Overall Study|Adverse Event|1|||
163052618|NCT00473083|588903109|FG001|Overall Study|Adverse Event|0|||
163052619|NCT00473083|588903110|FG002|Overall Study|Adverse Event|0|||
163052620|NCT01184872|588903111|FG000|Overall Study|Adverse Event|3|||
163052621|NCT01184872|588903112|FG001|Overall Study|Adverse Event|4|||
163052622|NCT01184872|588903111|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163052623|NCT01184872|588903112|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163052624|NCT01184872|588903111|FG000|Overall Study|Withdrawal by Subject|2|||
163052625|NCT01184872|588903112|FG001|Overall Study|Withdrawal by Subject|0|||
162625817|NCT03311724|587346922|FG003|Overall Study|Protocol Violation|0|||
162625818|NCT03311724|587346919|FG000|Overall Study|Withdrawal by Subject|1|||
162625819|NCT03311724|587346920|FG001|Overall Study|Withdrawal by Subject|1|||
162625820|NCT03311724|587346921|FG002|Overall Study|Withdrawal by Subject|0|||
162900583|NCT03799627|588335689|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
162900584|NCT03799627|588335690|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
162900585|NCT03799627|588335691|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
162900586|NCT03799627|588335692|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
162900587|NCT03799627|588335693|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
162900588|NCT03799627|588335694|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
162900589|NCT03799627|588335695|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
162900590|NCT03799627|588335687|FG000|Overall Study|Kidney Transplantation|1|||
162900591|NCT03799627|588335688|FG001|Overall Study|Kidney Transplantation|0|||
162900592|NCT03799627|588335689|FG002|Overall Study|Kidney Transplantation|0|||
162900593|NCT03799627|588335690|FG003|Overall Study|Kidney Transplantation|1|||
162900594|NCT03799627|588335691|FG004|Overall Study|Kidney Transplantation|1|||
162900595|NCT03799627|588335692|FG005|Overall Study|Kidney Transplantation|0|||
163052626|NCT01184872|588903111|FG000|Overall Study|Lost to Follow-up|0|||
163052627|NCT01184872|588903112|FG001|Overall Study|Lost to Follow-up|1|||
163052628|NCT01184872|588903111|FG000|Overall Study|Administrative problems|1|||
163052629|NCT01184872|588903112|FG001|Overall Study|Administrative problems|1|||
163052630|NCT01184872|588903111|FG000|Overall Study|Protocol deviation|1|||
163052631|NCT01184872|588903112|FG001|Overall Study|Protocol deviation|0|||
163052632|NCT02446691|588903113|FG000|Overall Study|Withdrawal by Subject|2|||
163052633|NCT02446691|588903113|FG000|Overall Study|Lost to Follow-up|8|||
163052634|NCT02446691|588903113|FG000|Overall Study|Protocol Violation|1|||
163052635|NCT03903172|588903116|FG000|Overall Study|screen fail|4|||
162625821|NCT03311724|587346922|FG003|Overall Study|Withdrawal by Subject|0|||
162625822|NCT03311724|587346919|FG000|Overall Study|Lost to Follow-up|1|||
162965873|NCT04442503|588574642|FG001|Overall Study|Physician Decision|2|||
162965874|NCT04442503|588574641|FG000|Overall Study|Withdrawal by Subject|3|||
162965875|NCT04442503|588574642|FG001|Overall Study|Withdrawal by Subject|4|||
162965876|NCT04442503|588574641|FG000|Overall Study|Reason not Specified|0|||
162965877|NCT04442503|588574642|FG001|Overall Study|Reason not Specified|1|||
162965878|NCT04442503|588574641|FG000|Overall Study|Randomized but not Treated|3|||
162965879|NCT04442503|588574642|FG001|Overall Study|Randomized but not Treated|1|||
162965880|NCT05034874|588574649|FG000|Overall Study|Withdrawal by Subject|6|||
162625823|NCT03311724|587346920|FG001|Overall Study|Lost to Follow-up|0|||
162625824|NCT03311724|587346921|FG002|Overall Study|Lost to Follow-up|0|||
163052636|NCT03903172|588903117|FG001|Overall Study|screen fail|1|||
163052637|NCT01545388|588903118|FG000|Overall Study|Adverse Event|2|||
163052638|NCT01545388|588903119|FG001|Overall Study|Adverse Event|4|||
162965881|NCT05034874|588574650|FG001|Overall Study|Withdrawal by Subject|6|||
162965882|NCT05034874|588574649|FG000|Overall Study|Lost to Follow-up|18|||
162965883|NCT05034874|588574650|FG001|Overall Study|Lost to Follow-up|8|||
162965884|NCT05034874|588574649|FG000|Overall Study|Physician Decision|0|||
162965885|NCT05034874|588574650|FG001|Overall Study|Physician Decision|1|||
162965886|NCT05034874|588574649|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
162965887|NCT05034874|588574650|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
162965888|NCT01867658|588574651|FG000|Overall Study|Withdrawal by Subject|6|||
162965889|NCT01867658|588574651|FG000|Overall Study|Death|2|||
162965890|NCT01867658|588574651|FG000|Overall Study|Subject could not be contacted|1|||
162965891|NCT05278858|588574652|FG000|Overall Study|Withdrawal by Subject|1|||
162965892|NCT00474058|588574653|FG000|Overall Study|Adverse Event|11|||
162965893|NCT00474058|588574654|FG001|Overall Study|Adverse Event|6|||
162965894|NCT00474058|588574653|FG000|Overall Study|Lack of Efficacy|0|||
162965895|NCT00474058|588574654|FG001|Overall Study|Lack of Efficacy|4|||
162965896|NCT00474058|588574653|FG000|Overall Study|Withdrawal by Subject|11|||
162965897|NCT00474058|588574654|FG001|Overall Study|Withdrawal by Subject|7|||
162965898|NCT00474058|588574653|FG000|Overall Study|Other|2|||
162965899|NCT00474058|588574654|FG001|Overall Study|Other|0|||
162965900|NCT03101358|588574655|FG000|Overall Study|Non-compliance with study schedule|1|||
162965901|NCT03101358|588574656|FG001|Overall Study|Non-compliance with study schedule|0|||
162965902|NCT03101358|588574657|FG002|Overall Study|Non-compliance with study schedule|0|||
162965903|NCT03101358|588574658|FG003|Overall Study|Non-compliance with study schedule|1|||
162965904|NCT03101358|588574655|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965905|NCT03101358|588574656|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965906|NCT03101358|588574657|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
162965907|NCT03101358|588574658|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
162965908|NCT03101358|588574655|FG000|Overall Study|Physician Decision|1|||
162965909|NCT03101358|588574656|FG001|Overall Study|Physician Decision|0|||
162965910|NCT03101358|588574657|FG002|Overall Study|Physician Decision|0|||
162965911|NCT03101358|588574658|FG003|Overall Study|Physician Decision|3|||
162965912|NCT03101358|588574655|FG000|Overall Study|Adverse Event|0|||
162965913|NCT03101358|588574656|FG001|Overall Study|Adverse Event|0|||
162965914|NCT03101358|588574657|FG002|Overall Study|Adverse Event|1|||
162965915|NCT03101358|588574658|FG003|Overall Study|Adverse Event|0|||
162965916|NCT03101358|588574655|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965917|NCT03101358|588574656|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965918|NCT03101358|588574657|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
162965919|NCT03101358|588574658|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
162965920|NCT03101358|588574655|FG000|Overall Study|Lost to Follow-up|1|||
162965921|NCT03101358|588574656|FG001|Overall Study|Lost to Follow-up|0|||
162965922|NCT03101358|588574657|FG002|Overall Study|Lost to Follow-up|0|||
162965923|NCT03101358|588574658|FG003|Overall Study|Lost to Follow-up|1|||
162965924|NCT02640235|588574659|FG000|Overall Study|Withdrawal by Subject|7|||
162965925|NCT02640235|588574660|FG001|Overall Study|Withdrawal by Subject|6|||
162965926|NCT02640235|588574659|FG000|Overall Study|Lost to Follow-up|4|||
162965927|NCT02640235|588574660|FG001|Overall Study|Lost to Follow-up|3|||
162965928|NCT02640235|588574659|FG000|Overall Study|Death|2|||
162965929|NCT02640235|588574660|FG001|Overall Study|Death|3|||
162965930|NCT02640235|588574659|FG000|Overall Study|Other|1|||
162965931|NCT02640235|588574660|FG001|Overall Study|Other|2|||
162965932|NCT02426918|588574661|FG000|Overall Study|Adverse Event|2|||
162965933|NCT02426918|588574662|FG001|Overall Study|Adverse Event|2|||
162965934|NCT02426918|588574663|FG002|Overall Study|Adverse Event|0|||
162965935|NCT02426918|588574661|FG000|Overall Study|Physician Decision|1|||
162965936|NCT02426918|588574662|FG001|Overall Study|Physician Decision|1|||
162965937|NCT02426918|588574663|FG002|Overall Study|Physician Decision|1|||
162965938|NCT02426918|588574661|FG000|Overall Study|Withdrawal by Subject|5|||
162965939|NCT02426918|588574662|FG001|Overall Study|Withdrawal by Subject|5|||
162965940|NCT02426918|588574663|FG002|Overall Study|Withdrawal by Subject|4|||
162965941|NCT02426918|588574661|FG000|Overall Study|Other|9|||
162965942|NCT02426918|588574662|FG001|Overall Study|Other|11|||
162965943|NCT02426918|588574663|FG002|Overall Study|Other|9|||
162965944|NCT02420353|588574666|FG000|Overall Study|Withdrawal by Subject|0|||
162965945|NCT02420353|588574667|FG001|Overall Study|Withdrawal by Subject|1|||
162965946|NCT00503867|588574668|FG000|Overall Study|Lost to Follow-up|1|||
162965947|NCT00503867|588574668|FG000|Overall Study|Adverse Event|1|||
163052639|NCT01545388|588903120|FG002|Overall Study|Adverse Event|1|||
162965948|NCT01149057|588574669|FG000|Overall Study|Lack of Efficacy|16|||
162965949|NCT01149057|588574669|FG000|Overall Study|Adverse Event|13|||
162965950|NCT01149057|588574669|FG000|Overall Study|Withdrawal by Subject|9|||
162965951|NCT01149057|588574669|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
162965952|NCT01149057|588574669|FG000|Overall Study|B Cell Depletion|4|||
162965953|NCT01149057|588574669|FG000|Overall Study|Participant Non-Compliance|2|||
162965954|NCT01149057|588574669|FG000|Overall Study|Lost to Follow-up|1|||
162900596|NCT03799627|588335693|FG006|Overall Study|Kidney Transplantation|0|||
162900597|NCT03799627|588335694|FG007|Overall Study|Kidney Transplantation|0|||
162900598|NCT03799627|588335695|FG008|Overall Study|Kidney Transplantation|0|||
162900599|NCT03799627|588335687|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
162900600|NCT03799627|588335688|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
162900601|NCT03799627|588335689|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
162900602|NCT03799627|588335690|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
162900603|NCT03799627|588335691|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
162900604|NCT03799627|588335692|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
162900605|NCT03799627|588335693|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
163052640|NCT01545388|588903118|FG000|Overall Study|Lack of Efficacy|3|||
163052641|NCT01545388|588903119|FG001|Overall Study|Lack of Efficacy|2|||
163052642|NCT01545388|588903120|FG002|Overall Study|Lack of Efficacy|5|||
163052643|NCT01545388|588903118|FG000|Overall Study|Participant moved or relocated|1|||
163052644|NCT01545388|588903119|FG001|Overall Study|Participant moved or relocated|0|||
163052645|NCT01545388|588903120|FG002|Overall Study|Participant moved or relocated|0|||
163052646|NCT01545388|588903118|FG000|Overall Study|Withdrawal by Subject|1|||
163052647|NCT01545388|588903119|FG001|Overall Study|Withdrawal by Subject|4|||
163052648|NCT01545388|588903120|FG002|Overall Study|Withdrawal by Subject|2|||
163052649|NCT01545388|588903118|FG000|Overall Study|Other|1|||
163052650|NCT01545388|588903119|FG001|Overall Study|Other|1|||
163052651|NCT01545388|588903120|FG002|Overall Study|Other|0|||
163052652|NCT01825200|588903123|FG000|Overall Study|Lost to Follow-up|5|||
163052653|NCT01825200|588903124|FG001|Overall Study|Lost to Follow-up|6|||
163052654|NCT01825200|588903123|FG000|Overall Study|Withdrawal by Subject|0|||
163052655|NCT01825200|588903124|FG001|Overall Study|Withdrawal by Subject|1|||
163052656|NCT01474486|588903125|FG000|Overall Study|Death|2|||
163052657|NCT01474486|588903125|FG000|Overall Study|Withdrawal by Subject|4|||
163052658|NCT01474486|588903125|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
163052659|NCT01255163|588903126|FG000|Overall Study|Withdrawal by Subject|1|||
163052660|NCT01255163|588903127|FG001|Overall Study|Withdrawal by Subject|0|||
163052661|NCT01255163|588903126|FG000|Overall Study|Lost to Follow-up|2|||
163052662|NCT01255163|588903127|FG001|Overall Study|Lost to Follow-up|0|||
163052663|NCT01255163|588903126|FG000|Overall Study|Adverse Event|0|||
163052664|NCT01255163|588903127|FG001|Overall Study|Adverse Event|2|||
163052665|NCT01255163|588903126|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
163052666|NCT01255163|588903127|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
163052667|NCT04219189|588903128|FG000|Overall Study|Withdrawal by Subject|1|||
163052668|NCT04219189|588903129|FG001|Overall Study|Withdrawal by Subject|2|||
163052669|NCT04219189|588903128|FG000|Overall Study|Protocol Violation|0|||
163052670|NCT04219189|588903129|FG001|Overall Study|Protocol Violation|1|||
163052671|NCT04219189|588903128|FG000|Overall Study|Lost to Follow-up|0|||
163052672|NCT04219189|588903129|FG001|Overall Study|Lost to Follow-up|1|||
163052673|NCT04219189|588903128|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
163052674|NCT04219189|588903129|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
163052675|NCT02495389|588903130|FG000|Overall Study|Withdrawal by Subject|40|||
163052676|NCT01924533|588903131|FG000|Overall Study|Death|181|||
163052677|NCT01924533|588903132|FG001|Overall Study|Death|200|||
163052678|NCT01924533|588903131|FG000|Overall Study|Lost to Follow-up|0|||
163052679|NCT01924533|588903132|FG001|Overall Study|Lost to Follow-up|1|||
163052680|NCT01924533|588903131|FG000|Overall Study|Withdrawal by Subject|7|||
163052681|NCT01924533|588903132|FG001|Overall Study|Withdrawal by Subject|3|||
163052682|NCT01924533|588903131|FG000|Overall Study|Other Eligibility criteria|1|||
163052683|NCT01924533|588903132|FG001|Overall Study|Other Eligibility criteria|1|||
163052684|NCT05817669|588903133|FG000|Overall Study|Prohibited medication used|1|||
163052685|NCT05817669|588903134|FG001|Overall Study|Prohibited medication used|2|||
162900606|NCT03799627|588335694|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
162900607|NCT03799627|588335695|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
162900608|NCT03799627|588335687|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900609|NCT03799627|588335688|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
162900610|NCT03799627|588335689|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900611|NCT03799627|588335690|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900612|NCT03799627|588335691|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
163052686|NCT05817669|588903133|FG000|Overall Study|Adverse Event|1|||
163052687|NCT05817669|588903134|FG001|Overall Study|Adverse Event|0|||
163052688|NCT05817669|588903133|FG000|Overall Study|Withdrawal by Subject|1|||
162625825|NCT03311724|587346922|FG003|Overall Study|Lost to Follow-up|0|||
162708804|NCT02698436|587642907|FG001|Overall Study|Lost to Follow-up|4|||
162708805|NCT02698436|587642906|FG000|Overall Study|Non-compliance with study regimen|1|||
162708806|NCT02698436|587642907|FG001|Overall Study|Non-compliance with study regimen|0|||
162900613|NCT03799627|588335692|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900614|NCT03799627|588335693|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900615|NCT03799627|588335694|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900616|NCT03799627|588335695|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
162900617|NCT03799627|588335687|FG000|Overall Study|Met Exclusion Criteria|0|||
162900618|NCT03799627|588335688|FG001|Overall Study|Met Exclusion Criteria|0|||
162900619|NCT03799627|588335689|FG002|Overall Study|Met Exclusion Criteria|0|||
162900620|NCT03799627|588335690|FG003|Overall Study|Met Exclusion Criteria|1|||
162900621|NCT03799627|588335691|FG004|Overall Study|Met Exclusion Criteria|0|||
162900622|NCT03799627|588335692|FG005|Overall Study|Met Exclusion Criteria|0|||
162900623|NCT03799627|588335693|FG006|Overall Study|Met Exclusion Criteria|0|||
162900624|NCT03799627|588335694|FG007|Overall Study|Met Exclusion Criteria|0|||
162900625|NCT03799627|588335695|FG008|Overall Study|Met Exclusion Criteria|0|||
162900626|NCT03799627|588335687|FG000|Overall Study|Investigational Product Noncompliance|0|||
162900627|NCT03799627|588335688|FG001|Overall Study|Investigational Product Noncompliance|0|||
162900628|NCT03799627|588335689|FG002|Overall Study|Investigational Product Noncompliance|0|||
162900629|NCT03799627|588335690|FG003|Overall Study|Investigational Product Noncompliance|1|||
162900630|NCT03799627|588335691|FG004|Overall Study|Investigational Product Noncompliance|0|||
162900631|NCT03799627|588335692|FG005|Overall Study|Investigational Product Noncompliance|0|||
162900632|NCT03799627|588335693|FG006|Overall Study|Investigational Product Noncompliance|0|||
162900633|NCT03799627|588335694|FG007|Overall Study|Investigational Product Noncompliance|0|||
162900634|NCT03799627|588335695|FG008|Overall Study|Investigational Product Noncompliance|0|||
162625826|NCT03311724|587346919|FG000|Overall Study|Sponsor Decision|0|||
162625827|NCT03311724|587346920|FG001|Overall Study|Sponsor Decision|0|||
162900635|NCT03799627|588335687|FG000|Overall Study|Participant Relocation|0|||
162900636|NCT03799627|588335688|FG001|Overall Study|Participant Relocation|0|||
162900637|NCT03799627|588335689|FG002|Overall Study|Participant Relocation|0|||
162900638|NCT03799627|588335690|FG003|Overall Study|Participant Relocation|1|||
162900639|NCT03799627|588335691|FG004|Overall Study|Participant Relocation|0|||
162900640|NCT03799627|588335692|FG005|Overall Study|Participant Relocation|1|||
162900641|NCT03799627|588335693|FG006|Overall Study|Participant Relocation|0|||
162900642|NCT03799627|588335694|FG007|Overall Study|Participant Relocation|0|||
162900643|NCT03799627|588335695|FG008|Overall Study|Participant Relocation|0|||
162900644|NCT03799627|588335687|FG000|Overall Study|Eurofin Issue|0|||
162900645|NCT03799627|588335688|FG001|Overall Study|Eurofin Issue|0|||
162900646|NCT03799627|588335689|FG002|Overall Study|Eurofin Issue|0|||
162900647|NCT03799627|588335690|FG003|Overall Study|Eurofin Issue|0|||
162900648|NCT03799627|588335691|FG004|Overall Study|Eurofin Issue|1|||
162900649|NCT03799627|588335692|FG005|Overall Study|Eurofin Issue|0|||
162900650|NCT03799627|588335693|FG006|Overall Study|Eurofin Issue|0|||
162900651|NCT03799627|588335694|FG007|Overall Study|Eurofin Issue|0|||
162900652|NCT03799627|588335695|FG008|Overall Study|Eurofin Issue|0|||
162900653|NCT03799627|588335687|FG000|Overall Study|Noncompliance with Site Instructions|0|||
162900654|NCT03799627|588335688|FG001|Overall Study|Noncompliance with Site Instructions|0|||
162900655|NCT03799627|588335689|FG002|Overall Study|Noncompliance with Site Instructions|0|||
162900656|NCT03799627|588335690|FG003|Overall Study|Noncompliance with Site Instructions|0|||
162900657|NCT03799627|588335691|FG004|Overall Study|Noncompliance with Site Instructions|1|||
162900658|NCT03799627|588335692|FG005|Overall Study|Noncompliance with Site Instructions|0|||
162900659|NCT03799627|588335693|FG006|Overall Study|Noncompliance with Site Instructions|0|||
162900660|NCT03799627|588335694|FG007|Overall Study|Noncompliance with Site Instructions|0|||
162900661|NCT03799627|588335695|FG008|Overall Study|Noncompliance with Site Instructions|0|||
162900662|NCT03799627|588335687|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900663|NCT03799627|588335688|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900664|NCT03799627|588335689|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900665|NCT03799627|588335690|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900666|NCT03799627|588335691|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
162900667|NCT03799627|588335692|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900668|NCT03799627|588335693|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900669|NCT03799627|588335694|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900670|NCT03799627|588335695|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
162900671|NCT03799627|588335687|FG000|Overall Study|Changes In Hemoglobin Values|1|||
162900672|NCT03799627|588335688|FG001|Overall Study|Changes In Hemoglobin Values|2|||
162900673|NCT03799627|588335689|FG002|Overall Study|Changes In Hemoglobin Values|1|||
162900674|NCT03799627|588335690|FG003|Overall Study|Changes In Hemoglobin Values|0|||
162900675|NCT03799627|588335691|FG004|Overall Study|Changes In Hemoglobin Values|0|||
162900676|NCT03799627|588335692|FG005|Overall Study|Changes In Hemoglobin Values|2|||
162900677|NCT03799627|588335693|FG006|Overall Study|Changes In Hemoglobin Values|1|||
162900678|NCT03799627|588335694|FG007|Overall Study|Changes In Hemoglobin Values|0|||
162900679|NCT03799627|588335695|FG008|Overall Study|Changes In Hemoglobin Values|1|||
162900680|NCT03964493|588335705|FG000|Overall Study|Withdrawal by Subject|4|||
162900681|NCT03964493|588335706|FG001|Overall Study|Withdrawal by Subject|1|||
162900682|NCT03964493|588335705|FG000|Overall Study|Lost to Follow-up|13|||
162900683|NCT03964493|588335706|FG001|Overall Study|Lost to Follow-up|4|||
162900684|NCT00398138|588335707|FG000|Overall Study|Adverse Event|2|||
162900685|NCT02092324|588335708|FG000|Overall Study|Adverse Event|1|||
162900686|NCT02092324|588335708|FG000|Overall Study|Lack of Efficacy|6|||
162900687|NCT02092324|588335708|FG000|Overall Study|Proceed to Transplant|3|||
162900688|NCT02092324|588335708|FG000|Overall Study|Physician Decision|7|||
162900689|NCT02092324|588335708|FG000|Overall Study|Misdiagnosis|2|||
162965955|NCT01149057|588574669|FG000|Overall Study|High Parathyroid Hormone Value|1|||
162965956|NCT01149057|588574669|FG000|Overall Study|Other|6|||
162965957|NCT05616728|588574670|FG000|Overall Study|Lost to Follow-up|0|||
162965958|NCT05616728|588574671|FG001|Overall Study|Lost to Follow-up|0|||
162965959|NCT05616728|588574672|FG002|Overall Study|Lost to Follow-up|1|||
162965960|NCT05616728|588574670|FG000|Overall Study|Withdrawal by Subject|1|||
162965961|NCT05616728|588574671|FG001|Overall Study|Withdrawal by Subject|1|||
162965962|NCT05616728|588574672|FG002|Overall Study|Withdrawal by Subject|0|||
162965963|NCT05616728|588574670|FG000|Overall Study|Physician Decision|1|||
162965964|NCT05616728|588574671|FG001|Overall Study|Physician Decision|1|||
162965965|NCT05616728|588574672|FG002|Overall Study|Physician Decision|1|||
162965966|NCT05616728|588574670|FG000|Overall Study|Other|0|||
162965967|NCT05616728|588574671|FG001|Overall Study|Other|2|||
162965968|NCT05616728|588574672|FG002|Overall Study|Other|0|||
162965969|NCT05468320|588574682|FG000|Overall Study|Other|1|||
162965970|NCT05468320|588574682|FG000|Overall Study|Adverse Event|1|||
162965971|NCT03921554|588574683|FG000|Overall Study|Adverse Event|2|||
162900690|NCT02224274|588335712|FG000|Overall Study|Death|1|||
162900691|NCT02224274|588335713|FG001|Overall Study|Death|0|||
162900692|NCT00887068|588335714|FG000|Overall Study|Withdrawal by Subject|2|||
162900693|NCT00887068|588335715|FG001|Overall Study|Withdrawal by Subject|0|||
162900694|NCT00887068|588335714|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
162900695|NCT00887068|588335715|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
162900696|NCT00499460|588335716|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
162900697|NCT00499460|588335717|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
162900698|NCT00499460|588335716|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
162900699|NCT00499460|588335717|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
162900700|NCT00499460|588335716|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
162900701|NCT00499460|588335717|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
162900702|NCT03418376|588335723|FG000|Overall Study|Musculoskeletal injury|1|||
162900703|NCT03418376|588335724|FG001|Overall Study|Musculoskeletal injury|2|||
162900704|NCT03418376|588335725|FG002|Overall Study|Musculoskeletal injury|1|||
162900705|NCT03418376|588335726|FG003|Overall Study|Musculoskeletal injury|0|||
162900706|NCT03418376|588335723|FG000|Overall Study|Personal reasons|0|||
162900707|NCT03418376|588335724|FG001|Overall Study|Personal reasons|2|||
162900708|NCT03418376|588335725|FG002|Overall Study|Personal reasons|2|||
162900709|NCT03418376|588335726|FG003|Overall Study|Personal reasons|1|||
162900710|NCT03418376|588335723|FG000|Overall Study|Exacerbation|0|||
162900711|NCT03418376|588335724|FG001|Overall Study|Exacerbation|1|||
162900712|NCT03418376|588335725|FG002|Overall Study|Exacerbation|0|||
162900713|NCT03418376|588335726|FG003|Overall Study|Exacerbation|0|||
162900714|NCT00814307|588335727|FG000|Overall Study|Randomized but not treated|1|||
162900715|NCT00814307|588335728|FG001|Overall Study|Randomized but not treated|0|||
162900716|NCT00814307|588335729|FG002|Overall Study|Randomized but not treated|0|||
162900717|NCT00814307|588335730|FG003|Overall Study|Randomized but not treated|0|||
162900718|NCT00814307|588335727|FG000|Overall Study|Adverse Event|3|||
162900719|NCT00814307|588335728|FG001|Overall Study|Adverse Event|9|||
162900720|NCT00814307|588335729|FG002|Overall Study|Adverse Event|3|||
162900721|NCT00814307|588335730|FG003|Overall Study|Adverse Event|2|||
162900722|NCT00814307|588335727|FG000|Overall Study|Lack of Efficacy|1|||
162900723|NCT00814307|588335728|FG001|Overall Study|Lack of Efficacy|1|||
162900724|NCT00814307|588335729|FG002|Overall Study|Lack of Efficacy|3|||
162900725|NCT00814307|588335730|FG003|Overall Study|Lack of Efficacy|4|||
162900726|NCT00814307|588335727|FG000|Overall Study|Other|1|||
162900727|NCT00814307|588335728|FG001|Overall Study|Other|2|||
162900728|NCT00814307|588335729|FG002|Overall Study|Other|0|||
162900729|NCT00814307|588335730|FG003|Overall Study|Other|1|||
162900730|NCT00814307|588335727|FG000|Overall Study|Protocol Violation|2|||
162900731|NCT00814307|588335728|FG001|Overall Study|Protocol Violation|8|||
162900732|NCT00814307|588335729|FG002|Overall Study|Protocol Violation|1|||
162900733|NCT00814307|588335730|FG003|Overall Study|Protocol Violation|1|||
162900734|NCT00814307|588335727|FG000|Overall Study|Withdrawal by Subject|4|||
162900735|NCT00814307|588335728|FG001|Overall Study|Withdrawal by Subject|6|||
162900736|NCT00814307|588335729|FG002|Overall Study|Withdrawal by Subject|0|||
162900737|NCT00814307|588335730|FG003|Overall Study|Withdrawal by Subject|2|||
162900738|NCT00814307|588335727|FG000|Overall Study|Death|0|||
162900739|NCT00814307|588335728|FG001|Overall Study|Death|1|||
162900740|NCT00814307|588335729|FG002|Overall Study|Death|0|||
162900741|NCT00814307|588335730|FG003|Overall Study|Death|0|||
162900742|NCT03073200|588335739|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162900743|NCT03073200|588335740|FG001|Double Blind Treatment Period|Protocol Violation|0|||
162900744|NCT03073200|588335741|FG002|Double Blind Treatment Period|Protocol Violation|0|||
162900745|NCT03073200|588335742|FG003|Double Blind Treatment Period|Protocol Violation|0|||
162900746|NCT03073200|588335743|FG004|Double Blind Treatment Period|Protocol Violation|0|||
162900747|NCT03073200|588335744|FG005|Double Blind Treatment Period|Protocol Violation|0|||
162900748|NCT03073200|588335745|FG006|Double Blind Treatment Period|Protocol Violation|0|||
162900749|NCT03073200|588335746|FG007|Double Blind Treatment Period|Protocol Violation|0|||
162900750|NCT03073200|588335747|FG008|Double Blind Treatment Period|Protocol Violation|0|||
162900751|NCT03073200|588335748|FG009|Double Blind Treatment Period|Protocol Violation|0|||
162900752|NCT03073200|588335749|FG010|Double Blind Treatment Period|Protocol Violation|0|||
162900753|NCT03073200|588335750|FG011|Double Blind Treatment Period|Protocol Violation|0|||
162900754|NCT03073200|588335751|FG012|Double Blind Treatment Period|Protocol Violation|0|||
162900755|NCT03073200|588335752|FG013|Double Blind Treatment Period|Protocol Violation|0|||
162900756|NCT03073200|588335753|FG014|Double Blind Treatment Period|Protocol Violation|0|||
162900757|NCT03073200|588335739|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162965972|NCT03921554|588574683|FG000|Overall Study|Withdrawal by Subject|1|||
162965973|NCT03921554|588574683|FG000|Overall Study|Death|3|||
162965974|NCT04440592|588574684|FG000|Overall Study|Adverse Event|8|||
162965975|NCT04440592|588574685|FG001|Overall Study|Adverse Event|0|||
162965976|NCT04440592|588574684|FG000|Overall Study|Lost to Follow-up|1|||
162965977|NCT04440592|588574685|FG001|Overall Study|Lost to Follow-up|0|||
162965978|NCT04440592|588574684|FG000|Overall Study|Withdrawal by Subject|1|||
162965979|NCT04440592|588574685|FG001|Overall Study|Withdrawal by Subject|1|||
162965980|NCT04440592|588574684|FG000|Overall Study|Other therapy needed|0|||
162965981|NCT04440592|588574685|FG001|Overall Study|Other therapy needed|1|||
162965982|NCT02957331|588574688|FG000|Overall Study|Protocol Violation|1|||
162965983|NCT02957331|588574689|FG001|Overall Study|Protocol Violation|0|||
162965984|NCT05568615|588576366|FG000|Overall Study|Death|1|||
162965985|NCT05568615|588576366|FG000|Overall Study|Physician Decision|1|||
162965986|NCT00565851|588576367|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
162965987|NCT00565851|588576368|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
162965988|NCT00565851|588576369|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
162965989|NCT00565851|588576370|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
162965990|NCT00565851|588576371|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
162965991|NCT00565851|588576372|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
162965992|NCT00565851|588576373|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
162965993|NCT00565851|588576374|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
162965994|NCT00565851|588576367|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965995|NCT00565851|588576368|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
162965996|NCT00565851|588576369|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965997|NCT00565851|588576370|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
162965998|NCT00565851|588576371|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
162965999|NCT00565851|588576372|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
162966000|NCT00565851|588576373|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
162966001|NCT00565851|588576374|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
162966002|NCT03291067|588576375|FG000|Overall Study|Adverse Event|0|||
162966003|NCT03291067|588576376|FG001|Overall Study|Adverse Event|2|||
162966004|NCT03291067|588576377|FG002|Overall Study|Adverse Event|17|||
162966005|NCT03291067|588576378|FG003|Overall Study|Adverse Event|3|||
162966006|NCT03291067|588576375|FG000|Overall Study|Lost to Follow-up|2|||
162966007|NCT03291067|588576376|FG001|Overall Study|Lost to Follow-up|1|||
162966008|NCT03291067|588576377|FG002|Overall Study|Lost to Follow-up|0|||
162966009|NCT03291067|588576378|FG003|Overall Study|Lost to Follow-up|1|||
162966010|NCT03291067|588576375|FG000|Overall Study|Physician Decision|0|||
162966011|NCT03291067|588576376|FG001|Overall Study|Physician Decision|0|||
162966012|NCT03291067|588576377|FG002|Overall Study|Physician Decision|1|||
162966013|NCT03291067|588576378|FG003|Overall Study|Physician Decision|0|||
162966014|NCT03291067|588576375|FG000|Overall Study|Protocol Violation|5|||
162966015|NCT03291067|588576376|FG001|Overall Study|Protocol Violation|3|||
162900758|NCT03073200|588335740|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
162900759|NCT03073200|588335741|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900760|NCT03073200|588335742|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900761|NCT03073200|588335743|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900762|NCT03073200|588335744|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900763|NCT03073200|588335745|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162708807|NCT00665561|587642908|FG000|Overall Study|Death recorded on subject summary pages|75|||
162900764|NCT03073200|588335746|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900765|NCT03073200|588335747|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900766|NCT03073200|588335748|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900767|NCT03073200|588335749|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900768|NCT03073200|588335750|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900769|NCT03073200|588335751|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900770|NCT03073200|588335752|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900771|NCT03073200|588335753|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
162900772|NCT03073200|588335739|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
162900773|NCT03073200|588335740|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900774|NCT03073200|588335741|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
162966016|NCT03291067|588576377|FG002|Overall Study|Protocol Violation|4|||
162966017|NCT03291067|588576378|FG003|Overall Study|Protocol Violation|2|||
162966018|NCT03291067|588576375|FG000|Overall Study|Withdrawal by Subject|3|||
162966019|NCT03291067|588576376|FG001|Overall Study|Withdrawal by Subject|4|||
162966020|NCT03291067|588576377|FG002|Overall Study|Withdrawal by Subject|7|||
162708808|NCT00665561|587642909|FG001|Overall Study|Death recorded on subject summary pages|75|||
162900775|NCT03073200|588335742|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900776|NCT03073200|588335743|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900777|NCT03073200|588335744|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900778|NCT03073200|588335745|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900779|NCT03073200|588335746|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900780|NCT03073200|588335747|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900781|NCT03073200|588335748|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900782|NCT03073200|588335749|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900783|NCT03073200|588335750|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900784|NCT03073200|588335751|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900785|NCT03073200|588335752|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900786|NCT03073200|588335753|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
162900787|NCT03073200|588335739|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900788|NCT03073200|588335740|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900789|NCT03073200|588335741|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900790|NCT03073200|588335742|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
162900791|NCT03073200|588335743|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
162900792|NCT03073200|588335744|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900793|NCT03073200|588335745|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900794|NCT03073200|588335746|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900795|NCT03073200|588335747|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900796|NCT03073200|588335748|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900797|NCT03073200|588335749|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900798|NCT03073200|588335750|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900799|NCT03073200|588335751|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900800|NCT03073200|588335752|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900801|NCT03073200|588335753|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
162900802|NCT03073200|588335739|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
162900803|NCT03073200|588335740|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
162900804|NCT03073200|588335741|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
162900805|NCT03073200|588335742|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
162900806|NCT03073200|588335743|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
162900807|NCT03073200|588335744|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
162900808|NCT03073200|588335745|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
162900809|NCT03073200|588335746|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
162900810|NCT03073200|588335747|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
162900811|NCT03073200|588335748|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
162900812|NCT03073200|588335749|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
162900813|NCT03073200|588335750|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
162900814|NCT03073200|588335751|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
162900815|NCT03073200|588335752|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
163052689|NCT05817669|588903134|FG001|Overall Study|Withdrawal by Subject|2|||
163052690|NCT04233879|588903135|FG000|Overall Study|Death|2|||
163052691|NCT04233879|588903136|FG001|Overall Study|Death|0|||
163052692|NCT04233879|588903135|FG000|Overall Study|Lost to Follow-up|3|||
163052693|NCT04233879|588903136|FG001|Overall Study|Lost to Follow-up|8|||
163052694|NCT04233879|588903135|FG000|Overall Study|Physician Decision|4|||
163052695|NCT04233879|588903136|FG001|Overall Study|Physician Decision|4|||
162900816|NCT03073200|588335753|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
162900817|NCT03073200|588335739|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900818|NCT03073200|588335740|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900819|NCT03073200|588335741|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900820|NCT03073200|588335742|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900821|NCT03073200|588335743|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
162900822|NCT03073200|588335744|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
162966021|NCT03291067|588576378|FG003|Overall Study|Withdrawal by Subject|5|||
162966022|NCT03291067|588576375|FG000|Overall Study|Other|0|||
162966023|NCT03291067|588576376|FG001|Overall Study|Other|4|||
163052696|NCT04233879|588903135|FG000|Overall Study|Withdrawal by Subject|7|||
163052697|NCT04233879|588903136|FG001|Overall Study|Withdrawal by Subject|10|||
163052698|NCT04233879|588903135|FG000|Overall Study|Other|281|||
163052699|NCT04233879|588903136|FG001|Overall Study|Other|279|||
163052700|NCT03585270|588903139|FG000|Overall Study|Withdrawal by Subject|2|||
163052701|NCT03585270|588903140|FG001|Overall Study|Withdrawal by Subject|6|||
163052702|NCT03585270|588903139|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
163052703|NCT03585270|588903140|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
163052704|NCT03585270|588903139|FG000|Overall Study|Adverse Event|5|||
163052705|NCT03585270|588903140|FG001|Overall Study|Adverse Event|2|||
163052706|NCT03585270|588903139|FG000|Overall Study|Lost to Follow-up|1|||
163052707|NCT03585270|588903140|FG001|Overall Study|Lost to Follow-up|4|||
163052708|NCT03585270|588903139|FG000|Overall Study|Death|5|||
163052709|NCT03585270|588903140|FG001|Overall Study|Death|3|||
163052710|NCT03585270|588903139|FG000|Overall Study|Other reasons|2|||
163052711|NCT03585270|588903140|FG001|Overall Study|Other reasons|2|||
163052712|NCT01802385|588903142|FG000|Overall Study|Death|106|||
163052713|NCT01802385|588903143|FG001|Overall Study|Death|120|||
163052714|NCT00323063|588903145|FG000|Overall Study|Adverse Event|1|||
163052715|NCT00323063|588903146|FG001|Overall Study|Adverse Event|0|||
163052716|NCT00323063|588903145|FG000|Overall Study|brain mets discovered prior to treatment|1|||
163052717|NCT00323063|588903146|FG001|Overall Study|brain mets discovered prior to treatment|0|||
163052718|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052719|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052720|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
163052721|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
162900823|NCT03073200|588335745|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
162966024|NCT03291067|588576377|FG002|Overall Study|Other|4|||
162966025|NCT03291067|588576378|FG003|Overall Study|Other|6|||
162966026|NCT01520987|588576386|FG000|Overall Study|Withdrawal by Subject|1|||
162966027|NCT01520987|588576387|FG001|Overall Study|Withdrawal by Subject|0|||
162966028|NCT01520987|588576388|FG002|Overall Study|Withdrawal by Subject|0|||
162966029|NCT01520987|588576389|FG003|Overall Study|Withdrawal by Subject|0|||
162966030|NCT01520987|588576390|FG004|Overall Study|Withdrawal by Subject|0|||
162966031|NCT01520987|588576391|FG005|Overall Study|Withdrawal by Subject|1|||
162966032|NCT01520987|588576392|FG006|Overall Study|Withdrawal by Subject|0|||
162966033|NCT01520987|588576393|FG007|Overall Study|Withdrawal by Subject|0|||
163052722|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052723|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163052724|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052725|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052726|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
163052727|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162966034|NCT02005562|588576394|FG000|Overall Study|Death|2|||
162966035|NCT02005562|588576395|FG001|Overall Study|Death|2|||
162966036|NCT02005562|588576394|FG000|Overall Study|Graft loss|7|||
162966037|NCT02005562|588576395|FG001|Overall Study|Graft loss|6|||
162966038|NCT02005562|588576394|FG000|Overall Study|Withdrawal by Subject|2|||
163052728|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
162966039|NCT02005562|588576395|FG001|Overall Study|Withdrawal by Subject|2|||
163052729|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163052730|NCT03904693|588903147|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052731|NCT03904693|588903148|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
163052732|NCT03904693|588903149|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
162900824|NCT03073200|588335746|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
162966040|NCT02005562|588576394|FG000|Overall Study|No transplant|1|||
162966041|NCT02005562|588576395|FG001|Overall Study|No transplant|4|||
162966042|NCT02005562|588576394|FG000|Overall Study|Physician Decision|0|||
163052733|NCT03904693|588903150|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052734|NCT03904693|588903151|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052735|NCT03904693|588903152|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163052736|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163052737|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163052738|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
162900825|NCT03073200|588335747|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900826|NCT03073200|588335748|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900827|NCT03073200|588335749|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900828|NCT03073200|588335750|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900829|NCT03073200|588335751|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900830|NCT03073200|588335752|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900831|NCT03073200|588335753|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
162900832|NCT03073200|588335739|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900833|NCT03073200|588335740|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900834|NCT03073200|588335741|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900835|NCT03073200|588335742|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
162900836|NCT03073200|588335743|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
162900837|NCT03073200|588335744|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900838|NCT03073200|588335745|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900839|NCT03073200|588335746|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
163052739|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
163052740|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
163052741|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
163052742|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052743|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052744|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052745|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052746|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
163052747|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
163052748|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
162900840|NCT03073200|588335747|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900841|NCT03073200|588335748|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900842|NCT03073200|588335749|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900843|NCT03073200|588335750|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900844|NCT03073200|588335751|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900845|NCT03073200|588335752|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900846|NCT03073200|588335753|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
162900847|NCT03073200|588335739|FG000|Extension Period|Lost to Follow-up|0|||
162900848|NCT03073200|588335740|FG001|Extension Period|Lost to Follow-up|0|||
162900849|NCT03073200|588335741|FG002|Extension Period|Lost to Follow-up|0|||
162900850|NCT03073200|588335742|FG003|Extension Period|Lost to Follow-up|0|||
162900851|NCT03073200|588335743|FG004|Extension Period|Lost to Follow-up|0|||
162900852|NCT03073200|588335744|FG005|Extension Period|Lost to Follow-up|0|||
162900853|NCT03073200|588335745|FG006|Extension Period|Lost to Follow-up|1|||
162900854|NCT03073200|588335746|FG007|Extension Period|Lost to Follow-up|1|||
162900855|NCT03073200|588335747|FG008|Extension Period|Lost to Follow-up|0|||
162900856|NCT03073200|588335748|FG009|Extension Period|Lost to Follow-up|0|||
162900857|NCT03073200|588335749|FG010|Extension Period|Lost to Follow-up|0|||
162900858|NCT03073200|588335750|FG011|Extension Period|Lost to Follow-up|0|||
162900859|NCT03073200|588335751|FG012|Extension Period|Lost to Follow-up|0|||
162900860|NCT03073200|588335752|FG013|Extension Period|Lost to Follow-up|0|||
162900861|NCT03073200|588335753|FG014|Extension Period|Lost to Follow-up|0|||
162900862|NCT03073200|588335739|FG000|Extension Period|Sponsor Decision|0|||
162900863|NCT03073200|588335740|FG001|Extension Period|Sponsor Decision|0|||
162900864|NCT03073200|588335741|FG002|Extension Period|Sponsor Decision|0|||
162900865|NCT03073200|588335742|FG003|Extension Period|Sponsor Decision|0|||
163052749|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052750|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052751|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
163052752|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
163052753|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
162708809|NCT00665561|587642908|FG000|Overall Study|Does not meet entrance criteria|19|||
163052754|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
162708810|NCT00665561|587642909|FG001|Overall Study|Does not meet entrance criteria|21|||
162900866|NCT03073200|588335743|FG004|Extension Period|Sponsor Decision|0|||
162900867|NCT03073200|588335744|FG005|Extension Period|Sponsor Decision|0|||
162900868|NCT03073200|588335745|FG006|Extension Period|Sponsor Decision|0|||
163052755|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
162900869|NCT03073200|588335746|FG007|Extension Period|Sponsor Decision|0|||
162900870|NCT03073200|588335747|FG008|Extension Period|Sponsor Decision|1|||
162900871|NCT03073200|588335748|FG009|Extension Period|Sponsor Decision|0|||
162900872|NCT03073200|588335749|FG010|Extension Period|Sponsor Decision|0|||
162900873|NCT03073200|588335750|FG011|Extension Period|Sponsor Decision|0|||
162900874|NCT03073200|588335751|FG012|Extension Period|Sponsor Decision|0|||
162625828|NCT03311724|587346921|FG002|Overall Study|Sponsor Decision|1|||
162625829|NCT03311724|587346922|FG003|Overall Study|Sponsor Decision|0|||
162625830|NCT01433991|587346923|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
162625831|NCT01433991|587346924|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162625832|NCT01433991|587346925|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162625833|NCT01433991|587346926|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162625834|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
162625835|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
162625836|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
162625837|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
162625838|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162625839|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162625840|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162625841|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
162625842|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
163052756|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052757|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
163052758|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052759|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
163052760|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052761|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052762|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052763|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052764|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
163052765|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
163052766|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052767|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052768|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052769|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052770|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
163052771|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
163052772|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052773|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052774|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052775|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052776|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
163052777|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
163052778|NCT03904693|588903147|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052779|NCT03904693|588903148|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052780|NCT03904693|588903149|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052781|NCT03904693|588903150|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052782|NCT03904693|588903151|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
163052783|NCT03904693|588903152|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
163052784|NCT05002972|588903154|FG000|Overall Study|Withdrawal by Subject|2|||
163052785|NCT01664091|588903155|FG000|Overall Study|Death|1|||
162625843|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
162625844|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
162625845|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
162625846|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
162625847|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
162625848|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
163052786|NCT01664091|588903155|FG000|Overall Study|Disease Progression|2|||
162625849|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
162625850|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
162625851|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
162625852|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
162900875|NCT03073200|588335752|FG013|Extension Period|Sponsor Decision|0|||
162900876|NCT03073200|588335753|FG014|Extension Period|Sponsor Decision|0|||
162900877|NCT03073200|588335739|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
162708811|NCT00665561|587642908|FG000|Overall Study|Lost to Follow-up|203|||
162900878|NCT03073200|588335740|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
162900879|NCT03073200|588335741|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
162900880|NCT03073200|588335742|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
162900881|NCT03073200|588335743|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
162900882|NCT03073200|588335744|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
162900883|NCT03073200|588335745|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
162900884|NCT03073200|588335746|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
162966043|NCT02005562|588576395|FG001|Overall Study|Physician Decision|1|||
162966044|NCT04768296|588576396|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
162966045|NCT04768296|588576397|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
162966046|NCT00255346|588576404|FG000|Overall Study|Adverse Event|1|||
162966047|NCT00255346|588576405|FG001|Overall Study|Adverse Event|0|||
162966048|NCT00255346|588576406|FG002|Overall Study|Adverse Event|0|||
162966049|NCT00255346|588576407|FG003|Overall Study|Adverse Event|0|||
162966050|NCT00255346|588576408|FG004|Overall Study|Adverse Event|0|||
162966051|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966052|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
162966053|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966054|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966055|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
162966056|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
162966057|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966058|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966059|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966060|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162966061|NCT04402489|588576414|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
162966062|NCT04402489|588576415|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
162966063|NCT04402489|588576416|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
162966064|NCT04402489|588576417|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
162966065|NCT04402489|588576418|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
162966066|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966067|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966068|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
162966069|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966070|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162966071|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966072|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966073|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966074|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
162966075|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
162966076|NCT04402489|588576414|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966077|NCT04402489|588576415|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
162966078|NCT04402489|588576416|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
162966079|NCT04402489|588576417|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966080|NCT04402489|588576418|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
162966081|NCT03192891|588576419|FG000|Overall Study|Lost to Follow-up|55|||
162900885|NCT03073200|588335747|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
162900886|NCT03073200|588335748|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
162900887|NCT03073200|588335749|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
162900888|NCT03073200|588335750|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
162900889|NCT03073200|588335751|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
162900890|NCT03073200|588335752|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
162900891|NCT03073200|588335753|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
162900892|NCT03073200|588335739|FG000|Extension Period|Withdrawal by Subject|0|||
162900893|NCT03073200|588335740|FG001|Extension Period|Withdrawal by Subject|0|||
162900894|NCT03073200|588335741|FG002|Extension Period|Withdrawal by Subject|0|||
162900895|NCT03073200|588335742|FG003|Extension Period|Withdrawal by Subject|0|||
162900896|NCT03073200|588335743|FG004|Extension Period|Withdrawal by Subject|0|||
162900897|NCT03073200|588335744|FG005|Extension Period|Withdrawal by Subject|0|||
162900898|NCT03073200|588335745|FG006|Extension Period|Withdrawal by Subject|1|||
162900899|NCT03073200|588335746|FG007|Extension Period|Withdrawal by Subject|2|||
162900900|NCT03073200|588335747|FG008|Extension Period|Withdrawal by Subject|0|||
162900901|NCT03073200|588335748|FG009|Extension Period|Withdrawal by Subject|0|||
162900902|NCT03073200|588335749|FG010|Extension Period|Withdrawal by Subject|0|||
162900903|NCT03073200|588335750|FG011|Extension Period|Withdrawal by Subject|0|||
162900904|NCT03073200|588335751|FG012|Extension Period|Withdrawal by Subject|0|||
162900905|NCT03073200|588335752|FG013|Extension Period|Withdrawal by Subject|0|||
162900906|NCT03073200|588335753|FG014|Extension Period|Withdrawal by Subject|0|||
162900907|NCT03073200|588335739|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900908|NCT03073200|588335740|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900909|NCT03073200|588335741|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900910|NCT03073200|588335742|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900911|NCT03073200|588335743|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900912|NCT03073200|588335744|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
162966082|NCT05223868|588576420|FG000|Overall Study|Lost to Follow-up|1|||
163052787|NCT01664091|588903155|FG000|Overall Study|Lost to Follow-up|2|||
163052788|NCT01664091|588903155|FG000|Overall Study|Withdrawal by Subject|1|||
163052789|NCT02053493|588903158|FG000|Overall Study|Withdrawal by Subject|1|||
163052790|NCT02053493|588903159|FG001|Overall Study|Withdrawal by Subject|1|||
163052791|NCT01076543|588903162|FG000|Overall Study|Withdrawal by Subject|2|||
163052792|NCT01076543|588903163|FG001|Overall Study|Withdrawal by Subject|0|||
162966083|NCT05223868|588576421|FG001|Overall Study|Lost to Follow-up|3|||
162966084|NCT05223868|588576422|FG002|Overall Study|Lost to Follow-up|0|||
162966085|NCT05223868|588576423|FG003|Overall Study|Lost to Follow-up|0|||
162966086|NCT05223868|588576424|FG004|Overall Study|Lost to Follow-up|0|||
162966087|NCT05223868|588576425|FG005|Overall Study|Lost to Follow-up|1|||
162966088|NCT05223868|588576420|FG000|Overall Study|Withdrawal by Subject|6|||
162966089|NCT05223868|588576421|FG001|Overall Study|Withdrawal by Subject|2|||
162966090|NCT05223868|588576422|FG002|Overall Study|Withdrawal by Subject|3|||
162966091|NCT05223868|588576423|FG003|Overall Study|Withdrawal by Subject|1|||
162966092|NCT05223868|588576424|FG004|Overall Study|Withdrawal by Subject|1|||
162966093|NCT05223868|588576425|FG005|Overall Study|Withdrawal by Subject|2|||
162966094|NCT05223868|588576420|FG000|Overall Study|Other|0|||
162966095|NCT05223868|588576421|FG001|Overall Study|Other|2|||
162966096|NCT05223868|588576422|FG002|Overall Study|Other|0|||
162966097|NCT05223868|588576423|FG003|Overall Study|Other|0|||
162966098|NCT05223868|588576424|FG004|Overall Study|Other|1|||
162966099|NCT05223868|588576425|FG005|Overall Study|Other|1|||
162966100|NCT05029687|588576426|FG000|Overall Study|Withdrawal by Subject|4|||
162966101|NCT05029687|588576427|FG001|Overall Study|Withdrawal by Subject|0|||
162966102|NCT05029687|588576428|FG002|Overall Study|Withdrawal by Subject|2|||
162966103|NCT05029687|588576426|FG000|Overall Study|Lost to Follow-up|4|||
162966104|NCT05029687|588576427|FG001|Overall Study|Lost to Follow-up|0|||
162966105|NCT05029687|588576428|FG002|Overall Study|Lost to Follow-up|2|||
162966106|NCT05740371|588576431|FG000|Overall Study|Death|1|||
162966107|NCT00874822|588576435|FG000|Overall Study|excluded by criteria|8|||
162708812|NCT00665561|587642909|FG001|Overall Study|Lost to Follow-up|264|||
162900913|NCT03073200|588335745|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900914|NCT03073200|588335746|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900915|NCT03073200|588335747|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900916|NCT03073200|588335748|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900917|NCT03073200|588335749|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
162966108|NCT02854800|588576436|FG000|Overall Study|Protocol Violation|16|||
162966109|NCT02854800|588576437|FG001|Overall Study|Protocol Violation|11|||
162966110|NCT02854800|588576438|FG002|Overall Study|Protocol Violation|3|||
162966111|NCT02854800|588576436|FG000|Overall Study|Withdrawal by Subject|4|||
162966112|NCT02854800|588576437|FG001|Overall Study|Withdrawal by Subject|2|||
162966113|NCT02854800|588576438|FG002|Overall Study|Withdrawal by Subject|3|||
162966114|NCT01634139|588576440|FG000|Overall Study|Non compliant with protocol|1|||
162966115|NCT01634139|588576441|FG001|Overall Study|Non compliant with protocol|0|||
163052793|NCT01076543|588903164|FG002|Overall Study|Withdrawal by Subject|0|||
162900918|NCT03073200|588335750|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
162900919|NCT03073200|588335751|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900920|NCT03073200|588335752|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900921|NCT03073200|588335753|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
162900922|NCT03073200|588335739|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900923|NCT03073200|588335740|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900924|NCT03073200|588335741|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900925|NCT03073200|588335742|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162708813|NCT00665561|587642908|FG000|Overall Study|Withdrawal by Subject|74|||
162708814|NCT00665561|587642909|FG001|Overall Study|Withdrawal by Subject|65|||
162708815|NCT00665561|587642908|FG000|Overall Study|Other|123|||
162900926|NCT03073200|588335743|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900927|NCT03073200|588335744|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900928|NCT03073200|588335745|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900929|NCT03073200|588335746|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900930|NCT03073200|588335747|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900931|NCT03073200|588335748|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900932|NCT03073200|588335749|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900933|NCT03073200|588335750|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
162900934|NCT03073200|588335751|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900935|NCT03073200|588335752|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900936|NCT03073200|588335753|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
162900937|NCT03073200|588335739|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900938|NCT03073200|588335740|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900939|NCT03073200|588335741|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900940|NCT03073200|588335742|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900941|NCT03073200|588335743|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900942|NCT03073200|588335744|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900943|NCT03073200|588335745|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162966116|NCT01634139|588576442|FG002|Overall Study|Non compliant with protocol|0|||
162900944|NCT03073200|588335746|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900945|NCT03073200|588335747|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900946|NCT03073200|588335748|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900947|NCT03073200|588335749|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
162966117|NCT01634139|588576440|FG000|Overall Study|Consent withdrawn not due to AE|4|||
163052794|NCT01076543|588903165|FG003|Overall Study|Withdrawal by Subject|0|||
163052795|NCT01076543|588903166|FG004|Overall Study|Withdrawal by Subject|0|||
163052796|NCT01076543|588903167|FG005|Overall Study|Withdrawal by Subject|0|||
163052797|NCT00338741|588903168|FG000|Overall Study|Lost to Follow-up|2|||
163052798|NCT00338741|588903169|FG001|Overall Study|Lost to Follow-up|0|||
162900948|NCT03073200|588335750|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
162900949|NCT03073200|588335751|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900950|NCT03073200|588335752|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900951|NCT03073200|588335753|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162900952|NCT03073200|588335739|FG000|Randomized Withdrawal Period|Adverse Event|0|||
162900953|NCT03073200|588335740|FG001|Randomized Withdrawal Period|Adverse Event|0|||
162900954|NCT03073200|588335741|FG002|Randomized Withdrawal Period|Adverse Event|0|||
162900955|NCT03073200|588335742|FG003|Randomized Withdrawal Period|Adverse Event|0|||
162900956|NCT03073200|588335743|FG004|Randomized Withdrawal Period|Adverse Event|0|||
162900957|NCT03073200|588335744|FG005|Randomized Withdrawal Period|Adverse Event|0|||
162900958|NCT03073200|588335745|FG006|Randomized Withdrawal Period|Adverse Event|0|||
162900959|NCT03073200|588335746|FG007|Randomized Withdrawal Period|Adverse Event|0|||
162900960|NCT03073200|588335747|FG008|Randomized Withdrawal Period|Adverse Event|0|||
162900961|NCT03073200|588335748|FG009|Randomized Withdrawal Period|Adverse Event|0|||
162900962|NCT03073200|588335749|FG010|Randomized Withdrawal Period|Adverse Event|1|||
162900963|NCT03073200|588335750|FG011|Randomized Withdrawal Period|Adverse Event|0|||
162900964|NCT03073200|588335751|FG012|Randomized Withdrawal Period|Adverse Event|0|||
162900965|NCT03073200|588335752|FG013|Randomized Withdrawal Period|Adverse Event|0|||
162900966|NCT03073200|588335753|FG014|Randomized Withdrawal Period|Adverse Event|0|||
162900967|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900968|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900969|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900970|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900971|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900972|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900973|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900974|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
163052799|NCT01534273|588903170|FG000|Period 1|Physician Decision|0|||
163052800|NCT01534273|588903171|FG001|Period 1|Physician Decision|0|||
162900975|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900976|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
163052801|NCT01534273|588903172|FG002|Period 1|Physician Decision|0|||
163052802|NCT01534273|588903173|FG003|Period 1|Physician Decision|1|||
163052803|NCT01534273|588903174|FG004|Period 1|Physician Decision|0|||
163052804|NCT01534273|588903175|FG005|Period 1|Physician Decision|0|||
163052805|NCT01534273|588903176|FG006|Period 1|Physician Decision|0|||
163052806|NCT01619865|588903177|FG000|Overall Study|Adverse Event|1|||
163052807|NCT01619865|588903177|FG000|Overall Study|Death|2|||
163052808|NCT01619865|588903177|FG000|Overall Study|subject not able to comply|1|||
163052809|NCT03586050|588903178|FG000|Overall Study|Death|3|||
163052810|NCT03586050|588903178|FG000|Overall Study|Withdrawal by Subject|2|||
163052811|NCT01494818|588903179|FG000|Overall Study|Relocation|1|||
163052812|NCT01494818|588903180|FG001|Overall Study|Relocation|2|||
163052813|NCT01494818|588903179|FG000|Overall Study|Lost to Follow-up|1|||
163052814|NCT01494818|588903180|FG001|Overall Study|Lost to Follow-up|0|||
163052815|NCT00791999|588903181|FG000|Overall Study|Protocol planed withdrawal|14|||
162900977|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900978|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900979|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900980|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
162900981|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
162900982|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900983|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900984|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900985|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900986|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900987|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900988|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900989|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900990|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900991|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900992|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900993|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900994|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
162900995|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162900996|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163052816|NCT00791999|588903182|FG001|Overall Study|Protocol planed withdrawal|11|||
162900997|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162900998|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162900999|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901000|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901001|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901002|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901003|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901004|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901005|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901006|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901007|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901008|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901009|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901010|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
162901011|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
162901012|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901013|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901014|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901015|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901016|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901017|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901018|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901019|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901020|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
163052817|NCT00791999|588903183|FG002|Overall Study|Protocol planed withdrawal|11|||
163052818|NCT00791999|588903184|FG003|Overall Study|Protocol planed withdrawal|45|||
163052819|NCT00791999|588903181|FG000|Overall Study|Withdrawal by Subject|0|||
162966118|NCT01634139|588576441|FG001|Overall Study|Consent withdrawn not due to AE|3|||
162966119|NCT01634139|588576442|FG002|Overall Study|Consent withdrawn not due to AE|2|||
162966120|NCT01634139|588576440|FG000|Overall Study|Other|4|||
162966121|NCT01634139|588576441|FG001|Overall Study|Other|0|||
162966122|NCT01634139|588576442|FG002|Overall Study|Other|3|||
162966123|NCT01634139|588576440|FG000|Overall Study|Lost to Follow-up|0|||
162966124|NCT01634139|588576441|FG001|Overall Study|Lost to Follow-up|2|||
162966125|NCT01634139|588576442|FG002|Overall Study|Lost to Follow-up|0|||
162966126|NCT01634139|588576440|FG000|Overall Study|Not treated|1|||
162966127|NCT01634139|588576441|FG001|Overall Study|Not treated|1|||
162966128|NCT01634139|588576442|FG002|Overall Study|Not treated|0|||
162966129|NCT02627963|588576448|FG000|Overall Study|Randomized but not treated|2|||
162966130|NCT02627963|588576449|FG001|Overall Study|Randomized but not treated|6|||
162966131|NCT01168856|588576450|FG000|Overall Study|Lost to Follow-up|4|||
162966132|NCT01168856|588576451|FG001|Overall Study|Lost to Follow-up|34|||
162966133|NCT01168856|588576450|FG000|Overall Study|Withdrawal by Subject|6|||
162966134|NCT01168856|588576451|FG001|Overall Study|Withdrawal by Subject|8|||
162966135|NCT01168856|588576450|FG000|Overall Study|Physician Decision|2|||
162966136|NCT01168856|588576451|FG001|Overall Study|Physician Decision|1|||
162966137|NCT01168856|588576450|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
162966138|NCT01168856|588576451|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
162966139|NCT01168856|588576450|FG000|Overall Study|Participant received anti-HCV treatment|1|||
162966140|NCT01168856|588576451|FG001|Overall Study|Participant received anti-HCV treatment|0|||
162966141|NCT01168856|588576450|FG000|Overall Study|Death|0|||
162966142|NCT01168856|588576451|FG001|Overall Study|Death|2|||
162966143|NCT01168856|588576450|FG000|Overall Study|Other|1|||
162966144|NCT01168856|588576451|FG001|Overall Study|Other|291|||
162966145|NCT01168856|588576450|FG000|Overall Study|Protocol Violation|4|||
162966146|NCT01168856|588576451|FG001|Overall Study|Protocol Violation|6|||
162966147|NCT05562011|588576452|FG000|Overall Study|Withdrawal by Subject|3|||
162966148|NCT05562011|588576452|FG000|Overall Study|Lost to Follow-up|1|||
162966149|NCT05562011|588576452|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
162966150|NCT05562011|588576452|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
162966151|NCT05562011|588576452|FG000|Overall Study|Device malfunction|13|||
162966152|NCT00387153|588576453|FG000|Overall Study|Adverse Event|1|||
162966153|NCT00387153|588576453|FG000|Overall Study|Disease Progression|3|||
162966154|NCT00387153|588576453|FG000|Overall Study|Lack of Response|4|||
162966155|NCT03073798|588576454|FG000|Overall Study|Adverse Event|1|||
162966156|NCT03073798|588576454|FG000|Overall Study|Withdrawal by Subject|1|||
162966157|NCT04411680|588576459|FG000|Treatment Period|Adverse Event|3|||
162966158|NCT04411680|588576460|FG001|Treatment Period|Adverse Event|0|||
162966159|NCT04411680|588576459|FG000|Treatment Period|Discharged from hospital|18|||
162966160|NCT04411680|588576460|FG001|Treatment Period|Discharged from hospital|7|||
162966161|NCT04411680|588576459|FG000|Treatment Period|Missed 1 or more doses|8|||
162966162|NCT04411680|588576460|FG001|Treatment Period|Missed 1 or more doses|0|||
162966163|NCT04411680|588576459|FG000|Treatment Period|Transferred to another hospital|0|||
162966164|NCT04411680|588576460|FG001|Treatment Period|Transferred to another hospital|1|||
162966165|NCT04411680|588576459|FG000|Follow up Period|Withdrawal by Subject|2|||
162966166|NCT04411680|588576460|FG001|Follow up Period|Withdrawal by Subject|0|||
162966167|NCT04411680|588576459|FG000|Follow up Period|Lost to Follow-up|5|||
162966168|NCT04411680|588576460|FG001|Follow up Period|Lost to Follow-up|6|||
162966169|NCT04411680|588576459|FG000|Follow up Period|Death|11|||
162966170|NCT04411680|588576460|FG001|Follow up Period|Death|8|||
162966171|NCT00840658|588576461|FG000|Overall Study|Death|2|||
162966172|NCT00840658|588576462|FG001|Overall Study|Death|2|||
162966173|NCT00840658|588576463|FG002|Overall Study|Death|3|||
162966174|NCT00840658|588576464|FG003|Overall Study|Death|3|||
162966175|NCT00840658|588576461|FG000|Overall Study|Lost to Follow-up|3|||
162966176|NCT00840658|588576462|FG001|Overall Study|Lost to Follow-up|1|||
162966177|NCT00840658|588576463|FG002|Overall Study|Lost to Follow-up|2|||
162966178|NCT00840658|588576464|FG003|Overall Study|Lost to Follow-up|1|||
162966179|NCT02372006|588576469|FG000|Overall Study|Progressive disease|8|||
162966180|NCT02372006|588576470|FG001|Overall Study|Progressive disease|7|||
162966181|NCT02372006|588576471|FG002|Overall Study|Progressive disease|34|||
162966182|NCT02372006|588576469|FG000|Overall Study|Dose limiting toxicity|0|||
162966183|NCT02372006|588576470|FG001|Overall Study|Dose limiting toxicity|1|||
162966184|NCT02372006|588576471|FG002|Overall Study|Dose limiting toxicity|0|||
162966185|NCT02372006|588576469|FG000|Overall Study|Adverse Event|0|||
162966186|NCT02372006|588576470|FG001|Overall Study|Adverse Event|0|||
162966187|NCT02372006|588576471|FG002|Overall Study|Adverse Event|3|||
162966188|NCT02372006|588576469|FG000|Overall Study|Withdrawal by Subject|0|||
162966189|NCT02372006|588576470|FG001|Overall Study|Withdrawal by Subject|1|||
162966190|NCT02372006|588576471|FG002|Overall Study|Withdrawal by Subject|1|||
162966191|NCT02372006|588576469|FG000|Overall Study|Other reason for not completing|0|||
162966192|NCT02372006|588576470|FG001|Overall Study|Other reason for not completing|0|||
162966193|NCT02372006|588576471|FG002|Overall Study|Other reason for not completing|1|||
162966194|NCT03504085|588576472|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
162901021|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901022|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901023|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901024|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901025|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
162901026|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
162901027|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901028|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901029|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901030|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901031|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901032|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901033|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901034|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901035|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901036|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901037|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901038|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901039|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901040|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
162901041|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
162901042|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901043|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901044|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901045|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901046|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901047|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901048|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901049|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901050|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901051|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901052|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901053|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901054|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901055|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
162901056|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
162901057|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901058|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901059|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901060|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901061|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901062|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901063|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901064|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901065|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901066|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901067|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162966195|NCT03504085|588576473|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
162901068|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901069|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901070|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
162901071|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162901072|NCT03073200|588335739|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901073|NCT03073200|588335740|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901074|NCT03073200|588335741|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901075|NCT03073200|588335742|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901076|NCT03073200|588335743|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901077|NCT03073200|588335744|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901078|NCT03073200|588335745|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901079|NCT03073200|588335746|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901080|NCT03073200|588335747|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901081|NCT03073200|588335748|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901082|NCT03073200|588335749|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901083|NCT03073200|588335750|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901084|NCT03073200|588335751|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901085|NCT03073200|588335752|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
162901086|NCT03073200|588335753|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
162901087|NCT01474889|588335754|FG000|Overall Study|Physician Decision|1|||
162901088|NCT01474889|588335755|FG001|Overall Study|Physician Decision|0|||
162901089|NCT01474889|588335756|FG002|Overall Study|Physician Decision|0|||
162901090|NCT01474889|588335754|FG000|Overall Study|Did not meet inclusion|1|||
162901091|NCT01474889|588335755|FG001|Overall Study|Did not meet inclusion|0|||
162901092|NCT01474889|588335756|FG002|Overall Study|Did not meet inclusion|0|||
162901093|NCT01474889|588335754|FG000|Overall Study|Withdrawal by Subject|0|||
162901094|NCT01474889|588335755|FG001|Overall Study|Withdrawal by Subject|1|||
162901095|NCT01474889|588335756|FG002|Overall Study|Withdrawal by Subject|0|||
162901096|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
162901097|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
162901098|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
162901099|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
162901100|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
162901101|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
162901102|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
162901103|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
162901104|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
162901105|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
162901106|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
162901107|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
162901108|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
162901109|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162901110|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162901111|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162901112|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
162901113|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
162901114|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
162901115|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
162901116|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
162901117|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
162901118|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
162901119|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
162901120|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
162901121|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
162901122|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
162901123|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
162901124|NCT03227224|588335757|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
162901125|NCT03227224|588335758|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
162901126|NCT03227224|588335759|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
162901127|NCT03227224|588335760|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
162901128|NCT03227224|588335757|FG000|Follow-up Phase (2 Weeks)|Other|4|||
162901129|NCT03227224|588335758|FG001|Follow-up Phase (2 Weeks)|Other|4|||
162901130|NCT03227224|588335759|FG002|Follow-up Phase (2 Weeks)|Other|6|||
162901131|NCT03227224|588335760|FG003|Follow-up Phase (2 Weeks)|Other|3|||
162901132|NCT03782376|588335763|FG000|Overall Study|Lost to Follow-up|2|||
162901133|NCT03782376|588335764|FG001|Overall Study|Lost to Follow-up|2|||
162901134|NCT03782376|588335763|FG000|Overall Study|Withdrawal by Subject|7|||
162901135|NCT03782376|588335764|FG001|Overall Study|Withdrawal by Subject|11|||
162901136|NCT03782376|588335763|FG000|Overall Study|Death|1|||
162901137|NCT03782376|588335764|FG001|Overall Study|Death|0|||
162901138|NCT03782376|588335763|FG000|Overall Study|Other|16|||
162901139|NCT03782376|588335764|FG001|Overall Study|Other|17|||
162901140|NCT02659098|588335765|FG000|Overall Study|Withdrawal by Subject|7|||
162901141|NCT03039192|588335766|FG000|Overall Study|Lost to Follow-up|4|||
162901142|NCT03039192|588335767|FG001|Overall Study|Lost to Follow-up|4|||
162901143|NCT03039192|588335766|FG000|Overall Study|Adverse event, serious fatal|0|||
162901144|NCT03039192|588335767|FG001|Overall Study|Adverse event, serious fatal|1|||
162901145|NCT03039192|588335766|FG000|Overall Study|Adverse event, non-fatal|0|||
162901146|NCT03039192|588335767|FG001|Overall Study|Adverse event, non-fatal|2|||
162901147|NCT03039192|588335766|FG000|Overall Study|Withdrawal by Subject|6|||
162901148|NCT03039192|588335767|FG001|Overall Study|Withdrawal by Subject|9|||
162901149|NCT03039192|588335766|FG000|Overall Study|Discontinued from treatment phase|19|||
162901150|NCT03039192|588335767|FG001|Overall Study|Discontinued from treatment phase|12|||
162901151|NCT03039192|588335766|FG000|Overall Study|Other|3|||
162901152|NCT03039192|588335767|FG001|Overall Study|Other|2|||
162901153|NCT03277794|588335770|FG000|Overall Study|Lost to Follow-up|2|||
162901154|NCT03277794|588335771|FG001|Overall Study|Lost to Follow-up|4|||
162901155|NCT03277794|588335770|FG000|Overall Study|Withdrew due to high acuity|1|||
162901156|NCT03277794|588335771|FG001|Overall Study|Withdrew due to high acuity|0|||
162901157|NCT02254304|588335775|FG000|Overall Study|Adverse Event|2|||
162901158|NCT02254304|588335776|FG001|Overall Study|Adverse Event|1|||
162901159|NCT02254304|588335775|FG000|Overall Study|Lost to Follow-up|2|||
162901160|NCT02254304|588335776|FG001|Overall Study|Lost to Follow-up|2|||
162901161|NCT02254304|588335775|FG000|Overall Study|Protocol Violation|1|||
162901162|NCT02254304|588335776|FG001|Overall Study|Protocol Violation|0|||
162901163|NCT02254304|588335775|FG000|Overall Study|Withdrawal by Subject|3|||
162901164|NCT02254304|588335776|FG001|Overall Study|Withdrawal by Subject|0|||
162901165|NCT02254304|588335775|FG000|Overall Study|Injection site pain and Injection fear|1|||
162901166|NCT02254304|588335776|FG001|Overall Study|Injection site pain and Injection fear|0|||
162901167|NCT02254304|588335775|FG000|Overall Study|Personal causes|4|||
162901168|NCT02254304|588335776|FG001|Overall Study|Personal causes|1|||
162901169|NCT02254304|588335775|FG000|Overall Study|Personal decision|1|||
162901170|NCT02254304|588335776|FG001|Overall Study|Personal decision|0|||
162901171|NCT00952419|588335777|FG000|Overall Study|Adverse Event|2|||
162901172|NCT00952419|588335778|FG001|Overall Study|Adverse Event|0|||
162901173|NCT00952419|588335779|FG002|Overall Study|Adverse Event|0|||
162901174|NCT00952419|588335777|FG000|Overall Study|Protocol Violation|3|||
162901175|NCT00952419|588335778|FG001|Overall Study|Protocol Violation|7|||
162901176|NCT00952419|588335779|FG002|Overall Study|Protocol Violation|0|||
162901177|NCT00952419|588335777|FG000|Overall Study|Withdrawal by Subject|1|||
162901178|NCT00952419|588335778|FG001|Overall Study|Withdrawal by Subject|3|||
162901179|NCT00952419|588335779|FG002|Overall Study|Withdrawal by Subject|0|||
162901180|NCT02266004|588337501|FG000|Overall Study|unrelated adverse event|1|||
162901181|NCT02266004|588337501|FG000|Overall Study|Physician Decision|1|||
162901182|NCT00537771|588337502|FG000|Overall Study|Withdrawal by Subject|6|||
162901183|NCT00537771|588337503|FG001|Overall Study|Withdrawal by Subject|23|||
162901184|NCT00537771|588337502|FG000|Overall Study|Adverse Event|8|||
162901185|NCT00537771|588337503|FG001|Overall Study|Adverse Event|15|||
162901186|NCT00537771|588337502|FG000|Overall Study|Lost to Follow-up|9|||
162901187|NCT00537771|588337503|FG001|Overall Study|Lost to Follow-up|15|||
162901188|NCT00537771|588337502|FG000|Overall Study|Protocol Violation|2|||
162901189|NCT00537771|588337503|FG001|Overall Study|Protocol Violation|6|||
162901190|NCT00537771|588337502|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
162901191|NCT00537771|588337503|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
162901192|NCT02465489|588337506|FG000|Overall Study|Adverse Event|5|||
162901193|NCT00850135|588337507|FG000|Overall Study|Physician Decision|1|||
162901194|NCT02253992|588337508|FG000|Overall Study|Study drug toxicity|1|||
162901195|NCT02253992|588337509|FG001|Overall Study|Study drug toxicity|0|||
162901196|NCT02253992|588337510|FG002|Overall Study|Study drug toxicity|10|||
162901197|NCT02253992|588337508|FG000|Overall Study|Disease progression|4|||
162901198|NCT02253992|588337509|FG001|Overall Study|Disease progression|3|||
162901199|NCT02253992|588337510|FG002|Overall Study|Disease progression|98|||
162901200|NCT02253992|588337508|FG000|Overall Study|Withdrawal by Subject|0|||
162901201|NCT02253992|588337509|FG001|Overall Study|Withdrawal by Subject|0|||
162901202|NCT02253992|588337510|FG002|Overall Study|Withdrawal by Subject|3|||
162901203|NCT02253992|588337508|FG000|Overall Study|Adverse Event|0|||
162901204|NCT02253992|588337509|FG001|Overall Study|Adverse Event|0|||
162901205|NCT02253992|588337510|FG002|Overall Study|Adverse Event|8|||
162901206|NCT02253992|588337508|FG000|Overall Study|Death|0|||
162901207|NCT02253992|588337509|FG001|Overall Study|Death|0|||
162901208|NCT02253992|588337510|FG002|Overall Study|Death|1|||
162901209|NCT02253992|588337508|FG000|Overall Study|Subject discontinued study drug|1|||
162901210|NCT02253992|588337509|FG001|Overall Study|Subject discontinued study drug|0|||
162901211|NCT02253992|588337510|FG002|Overall Study|Subject discontinued study drug|1|||
162901212|NCT02253992|588337508|FG000|Overall Study|Completed treatment as per protocol|0|||
162901213|NCT02253992|588337509|FG001|Overall Study|Completed treatment as per protocol|1|||
162901214|NCT02253992|588337510|FG002|Overall Study|Completed treatment as per protocol|22|||
162901215|NCT02253992|588337508|FG000|Overall Study|Other|0|||
162901216|NCT02253992|588337509|FG001|Overall Study|Other|0|||
162901217|NCT02253992|588337510|FG002|Overall Study|Other|1|||
162901218|NCT03198728|588337511|FG000|Overall Study|Adverse Event|10|||
162901219|NCT03198728|588337512|FG001|Overall Study|Adverse Event|5|||
162901220|NCT03198728|588337511|FG000|Overall Study|Lost to Follow-up|21|||
162901221|NCT03198728|588337512|FG001|Overall Study|Lost to Follow-up|7|||
162901222|NCT03198728|588337511|FG000|Overall Study|Physician Decision|7|||
162901223|NCT03198728|588337512|FG001|Overall Study|Physician Decision|2|||
162901224|NCT03198728|588337511|FG000|Overall Study|Withdrawal by Subject|14|||
162901225|NCT03198728|588337512|FG001|Overall Study|Withdrawal by Subject|10|||
162901226|NCT04051944|588337513|FG000|Overall Study|Study ending|1|||
162901227|NCT04051944|588337514|FG001|Overall Study|Study ending|1|||
162901228|NCT04051944|588337513|FG000|Overall Study|Early study termination by participant|1|||
162901229|NCT04051944|588337514|FG001|Overall Study|Early study termination by participant|0|||
162901230|NCT04051944|588337513|FG000|Overall Study|Withdrawal by Subject|2|||
162901231|NCT04051944|588337514|FG001|Overall Study|Withdrawal by Subject|2|||
162901232|NCT04051944|588337513|FG000|Overall Study|Lack of Efficacy|3|||
162901233|NCT04051944|588337514|FG001|Overall Study|Lack of Efficacy|0|||
162901234|NCT04051944|588337513|FG000|Overall Study|Adverse event, non- fatal|1|||
162901235|NCT04051944|588337514|FG001|Overall Study|Adverse event, non- fatal|1|||
162901236|NCT03083470|588337515|FG000|Overall Study|Lost to Follow-up|0|||
162901237|NCT03083470|588337516|FG001|Overall Study|Lost to Follow-up|0|||
162901238|NCT03083470|588337517|FG002|Overall Study|Lost to Follow-up|0|||
162901239|NCT03083470|588337518|FG003|Overall Study|Lost to Follow-up|0|||
162901240|NCT03083470|588337519|FG004|Overall Study|Lost to Follow-up|1|||
162901241|NCT03083470|588337515|FG000|Overall Study|Withdrawal by Subject|0|||
162901242|NCT03083470|588337516|FG001|Overall Study|Withdrawal by Subject|0|||
162901243|NCT03083470|588337517|FG002|Overall Study|Withdrawal by Subject|0|||
162901244|NCT03083470|588337518|FG003|Overall Study|Withdrawal by Subject|0|||
162901245|NCT03083470|588337519|FG004|Overall Study|Withdrawal by Subject|1|||
162901246|NCT01512693|588337520|FG000|Overall Study|Withdrawal by Subject|0|||
162901247|NCT01512693|588337521|FG001|Overall Study|Withdrawal by Subject|1|||
162901248|NCT02139280|588337522|FG000|Overall Study|No longer eligible|2|||
162901249|NCT02139280|588337523|FG001|Overall Study|No longer eligible|0|||
162901250|NCT00736450|588337530|FG000|Overall Study|Not ABC gene eligible|19|||
162901251|NCT00736450|588337530|FG000|Overall Study|Withdrawal by Subject|5|||
162901252|NCT00736450|588337530|FG000|Overall Study|Physician Decision|1|||
162901253|NCT04157751|588337534|FG000|Overall Study|Withdrawal by Subject|12|||
162901254|NCT04157751|588337535|FG001|Overall Study|Withdrawal by Subject|17|||
162901255|NCT04157751|588337534|FG000|Overall Study|Lost to Follow-up|6|||
162901256|NCT04157751|588337535|FG001|Overall Study|Lost to Follow-up|2|||
162901257|NCT04157751|588337534|FG000|Overall Study|Adverse Event|34|||
162901258|NCT04157751|588337535|FG001|Overall Study|Adverse Event|23|||
162901259|NCT04157751|588337534|FG000|Overall Study|Not treated|1|||
162966196|NCT03504085|588576472|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
162966197|NCT03504085|588576473|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
162966198|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Death|1|||
162966199|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Death|0|||
162966200|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Death|0|||
162966201|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Death|0|||
162966202|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
162901260|NCT04157751|588337535|FG001|Overall Study|Not treated|5|||
162901261|NCT04157751|588337534|FG000|Overall Study|Other reason not stated above|10|||
162901262|NCT04157751|588337535|FG001|Overall Study|Other reason not stated above|10|||
162901263|NCT04731922|588337536|FG000|Overall Study|Adverse Event|0|||
162901264|NCT04731922|588337537|FG001|Overall Study|Adverse Event|0|||
163052820|NCT00791999|588903182|FG001|Overall Study|Withdrawal by Subject|1|||
162901265|NCT04731922|588337538|FG002|Overall Study|Adverse Event|0|||
162901266|NCT04731922|588337539|FG003|Overall Study|Adverse Event|0|||
162901267|NCT04731922|588337540|FG004|Overall Study|Adverse Event|0|||
163052821|NCT00791999|588903183|FG002|Overall Study|Withdrawal by Subject|0|||
162901268|NCT04731922|588337541|FG005|Overall Study|Adverse Event|0|||
162901269|NCT04731922|588337542|FG006|Overall Study|Adverse Event|0|||
162901270|NCT04731922|588337543|FG007|Overall Study|Adverse Event|0|||
162901271|NCT04731922|588337544|FG008|Overall Study|Adverse Event|0|||
162901272|NCT04731922|588337545|FG009|Overall Study|Adverse Event|0|||
162625853|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
162901273|NCT04731922|588337546|FG010|Overall Study|Adverse Event|1|||
162901274|NCT04731922|588337547|FG011|Overall Study|Adverse Event|0|||
162901275|NCT04731922|588337548|FG012|Overall Study|Adverse Event|0|||
162901276|NCT04731922|588337549|FG013|Overall Study|Adverse Event|0|||
162901277|NCT04731922|588337550|FG014|Overall Study|Adverse Event|0|||
162901278|NCT04731922|588337551|FG015|Overall Study|Adverse Event|0|||
162901279|NCT04731922|588337552|FG016|Overall Study|Adverse Event|0|||
162901280|NCT04731922|588337536|FG000|Overall Study|Lost to Follow-up|0|||
162901281|NCT04731922|588337537|FG001|Overall Study|Lost to Follow-up|0|||
162901282|NCT04731922|588337538|FG002|Overall Study|Lost to Follow-up|0|||
162901283|NCT04731922|588337539|FG003|Overall Study|Lost to Follow-up|1|||
162901284|NCT04731922|588337540|FG004|Overall Study|Lost to Follow-up|0|||
162901285|NCT04731922|588337541|FG005|Overall Study|Lost to Follow-up|1|||
162625854|NCT01433991|587346923|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162625855|NCT01433991|587346924|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162625856|NCT01433991|587346925|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
162625857|NCT01433991|587346926|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162625858|NCT02955602|587346927|FG000|Overall Study|Adverse Event|0|||
162625859|NCT02955602|587346928|FG001|Overall Study|Adverse Event|3|||
162625860|NCT02955602|587346929|FG002|Overall Study|Adverse Event|0|||
162625861|NCT02955602|587346927|FG000|Overall Study|Withdrawal of informed consent|1|||
162625862|NCT02955602|587346928|FG001|Overall Study|Withdrawal of informed consent|3|||
162625863|NCT02955602|587346929|FG002|Overall Study|Withdrawal of informed consent|2|||
163052822|NCT00791999|588903184|FG003|Overall Study|Withdrawal by Subject|2|||
163052823|NCT00791999|588903181|FG000|Overall Study|Protocol Violation|3|||
163052824|NCT00791999|588903182|FG001|Overall Study|Protocol Violation|0|||
163052825|NCT00791999|588903183|FG002|Overall Study|Protocol Violation|1|||
163052826|NCT00791999|588903184|FG003|Overall Study|Protocol Violation|0|||
163052827|NCT00791999|588903181|FG000|Overall Study|Adverse Event|3|||
163052828|NCT00791999|588903182|FG001|Overall Study|Adverse Event|3|||
163052829|NCT00791999|588903183|FG002|Overall Study|Adverse Event|7|||
163052830|NCT00791999|588903184|FG003|Overall Study|Adverse Event|3|||
163052831|NCT00791999|588903181|FG000|Overall Study|Lack of Efficacy|0|||
163052832|NCT00791999|588903182|FG001|Overall Study|Lack of Efficacy|1|||
163052833|NCT00791999|588903183|FG002|Overall Study|Lack of Efficacy|0|||
163052834|NCT00791999|588903184|FG003|Overall Study|Lack of Efficacy|2|||
163052835|NCT00791999|588903181|FG000|Overall Study|Reason other than those above|1|||
163052836|NCT00791999|588903182|FG001|Overall Study|Reason other than those above|0|||
163052837|NCT00791999|588903183|FG002|Overall Study|Reason other than those above|1|||
162901286|NCT04731922|588337542|FG006|Overall Study|Lost to Follow-up|0|||
162901287|NCT04731922|588337543|FG007|Overall Study|Lost to Follow-up|0|||
162901288|NCT04731922|588337544|FG008|Overall Study|Lost to Follow-up|0|||
162901289|NCT04731922|588337545|FG009|Overall Study|Lost to Follow-up|0|||
162901290|NCT04731922|588337546|FG010|Overall Study|Lost to Follow-up|0|||
163052838|NCT00791999|588903184|FG003|Overall Study|Reason other than those above|0|||
163052839|NCT02998151|588903187|FG000|Overall Study|Withdrawal by Subject|3|||
163052840|NCT02998151|588903187|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
163052841|NCT02998151|588903187|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
163052842|NCT00350545|588904727|FG000|Overall Study|Withdrawal by Subject|2|||
163052843|NCT01655901|588904731|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052844|NCT01655901|588904732|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052845|NCT01655901|588904733|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
162901291|NCT04731922|588337547|FG011|Overall Study|Lost to Follow-up|0|||
162901292|NCT04731922|588337548|FG012|Overall Study|Lost to Follow-up|0|||
162901293|NCT04731922|588337549|FG013|Overall Study|Lost to Follow-up|0|||
162901294|NCT04731922|588337550|FG014|Overall Study|Lost to Follow-up|0|||
163052846|NCT01655901|588904734|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
163052847|NCT01655901|588904735|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
163052848|NCT01655901|588904736|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
163052849|NCT02579629|588904740|FG000|Overall Study|Withdrawal by Subject|0|||
163052850|NCT02579629|588904741|FG001|Overall Study|Withdrawal by Subject|1|||
163052851|NCT02579629|588904742|FG002|Overall Study|Withdrawal by Subject|0|||
163052852|NCT02579629|588904740|FG000|Overall Study|Screen Failure|2|||
163052853|NCT02579629|588904741|FG001|Overall Study|Screen Failure|0|||
163052854|NCT02579629|588904742|FG002|Overall Study|Screen Failure|2|||
163052855|NCT01190891|588904743|FG000|Overall Study|Protocol Violation|1|||
163052856|NCT01190891|588904744|FG001|Overall Study|Protocol Violation|0|||
163052857|NCT01190891|588904743|FG000|Overall Study|Withdrawal by Subject|5|||
163052858|NCT01190891|588904744|FG001|Overall Study|Withdrawal by Subject|0|||
163052859|NCT00737048|588904745|FG000|Overall Study|Physician Decision|0|||
163052860|NCT00737048|588904746|FG001|Overall Study|Physician Decision|0|||
163052861|NCT00737048|588904747|FG002|Overall Study|Physician Decision|1|||
163052862|NCT00737048|588904745|FG000|Overall Study|Adverse Event|0|||
163052863|NCT00737048|588904746|FG001|Overall Study|Adverse Event|1|||
163052864|NCT00737048|588904747|FG002|Overall Study|Adverse Event|0|||
163052865|NCT00737048|588904745|FG000|Overall Study|Worsening of the symptoms|3|||
163052866|NCT00737048|588904746|FG001|Overall Study|Worsening of the symptoms|5|||
163052867|NCT00737048|588904747|FG002|Overall Study|Worsening of the symptoms|3|||
163052868|NCT00301834|588904748|FG000|Overall Study|Death|1|||
163052869|NCT02737358|588904749|FG000|Overall Study|Withdrawal by Subject|7|||
163052870|NCT02737358|588904750|FG001|Overall Study|Withdrawal by Subject|12|||
163052871|NCT02737358|588904749|FG000|Overall Study|Lost to Follow-up|2|||
163052872|NCT02737358|588904750|FG001|Overall Study|Lost to Follow-up|3|||
163052873|NCT00744939|588904751|FG000|Overall Study|Withdrawal by Subject|9|||
163052874|NCT00744939|588904751|FG000|Overall Study|Protocol Violation|13|||
163052875|NCT00744939|588904751|FG000|Overall Study|Death|24|||
163052876|NCT00744939|588904751|FG000|Overall Study|distance|4|||
163052877|NCT00744939|588904751|FG000|Overall Study|Lost to Follow-up|12|||
163052878|NCT00744939|588904751|FG000|Overall Study|Medical history exclusionary|1|||
163052879|NCT00744939|588904751|FG000|Overall Study|Did not receive Magnevist|7|||
163052880|NCT00744939|588904751|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
163052881|NCT00744939|588904751|FG000|Overall Study|coma|1|||
163052882|NCT00744939|588904751|FG000|Overall Study|incorrect race|1|||
163052883|NCT00183430|588904752|FG000|Overall Study|Adverse Event|1|||
163052884|NCT00183430|588904753|FG001|Overall Study|Adverse Event|0|||
163052885|NCT00183430|588904752|FG000|Overall Study|Lost to Follow-up|3|||
163052886|NCT00183430|588904753|FG001|Overall Study|Lost to Follow-up|0|||
163052887|NCT00183430|588904752|FG000|Overall Study|did not meet inclusion criteria|1|||
163052888|NCT00183430|588904753|FG001|Overall Study|did not meet inclusion criteria|0|||
163052889|NCT00183430|588904752|FG000|Overall Study|Withdrawal by Subject|1|||
163052890|NCT00183430|588904753|FG001|Overall Study|Withdrawal by Subject|0|||
163052891|NCT03636256|588904758|FG000|Overall Study|Lost to Follow-up|3|||
163052892|NCT03636256|588904759|FG001|Overall Study|Lost to Follow-up|0|||
163052893|NCT03636256|588904760|FG002|Overall Study|Lost to Follow-up|2|||
162708816|NCT00665561|587642909|FG001|Overall Study|Other|108|||
163052894|NCT03636256|588904761|FG003|Overall Study|Lost to Follow-up|1|||
163052895|NCT03636256|588904762|FG004|Overall Study|Lost to Follow-up|0|||
162708817|NCT00665561|587642908|FG000|Overall Study|Site closed|8|||
162901295|NCT04731922|588337551|FG015|Overall Study|Lost to Follow-up|0|||
162901296|NCT04731922|588337552|FG016|Overall Study|Lost to Follow-up|0|||
162901297|NCT04731922|588337536|FG000|Overall Study|Withdrawal by Subject|1|||
162901298|NCT04731922|588337537|FG001|Overall Study|Withdrawal by Subject|0|||
162901299|NCT04731922|588337538|FG002|Overall Study|Withdrawal by Subject|0|||
162901300|NCT04731922|588337539|FG003|Overall Study|Withdrawal by Subject|0|||
162901301|NCT04731922|588337540|FG004|Overall Study|Withdrawal by Subject|1|||
162901302|NCT04731922|588337541|FG005|Overall Study|Withdrawal by Subject|0|||
162901303|NCT04731922|588337542|FG006|Overall Study|Withdrawal by Subject|1|||
162901304|NCT04731922|588337543|FG007|Overall Study|Withdrawal by Subject|0|||
162901305|NCT04731922|588337544|FG008|Overall Study|Withdrawal by Subject|0|||
162901306|NCT04731922|588337545|FG009|Overall Study|Withdrawal by Subject|0|||
162901307|NCT04731922|588337546|FG010|Overall Study|Withdrawal by Subject|0|||
162901308|NCT04731922|588337547|FG011|Overall Study|Withdrawal by Subject|0|||
162901309|NCT04731922|588337548|FG012|Overall Study|Withdrawal by Subject|0|||
162901310|NCT04731922|588337549|FG013|Overall Study|Withdrawal by Subject|1|||
162901311|NCT04731922|588337550|FG014|Overall Study|Withdrawal by Subject|0|||
162901312|NCT04731922|588337551|FG015|Overall Study|Withdrawal by Subject|0|||
162901313|NCT04731922|588337552|FG016|Overall Study|Withdrawal by Subject|0|||
162901314|NCT04731922|588337536|FG000|Overall Study|Other|0|||
162901315|NCT04731922|588337537|FG001|Overall Study|Other|0|||
162901316|NCT04731922|588337538|FG002|Overall Study|Other|0|||
162901317|NCT04731922|588337539|FG003|Overall Study|Other|0|||
162901318|NCT04731922|588337540|FG004|Overall Study|Other|0|||
162901319|NCT04731922|588337541|FG005|Overall Study|Other|0|||
162901320|NCT04731922|588337542|FG006|Overall Study|Other|1|||
162966203|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
162966204|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
162966205|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
162966206|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
162966207|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
162966208|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
162966209|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
162966210|NCT04133311|588576475|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966211|NCT04133311|588576476|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
162966212|NCT04133311|588576477|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966213|NCT04133311|588576478|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162966214|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966215|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966216|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
162966217|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
162966218|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162966219|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162966220|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
162966221|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
162966222|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966223|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966224|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
162966225|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
162966226|NCT04133311|588576475|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
162966227|NCT04133311|588576476|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
162966228|NCT04133311|588576477|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
162966229|NCT04133311|588576478|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
162966230|NCT00728754|588576481|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
162966231|NCT00728754|588576482|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
162966232|NCT00728754|588576481|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
162966233|NCT00728754|588576482|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
162966234|NCT00728754|588576481|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
162966235|NCT00728754|588576482|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
162966236|NCT01859598|588576483|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
162966237|NCT00672984|588576484|FG000|First Intervention|Adverse Event|5|||
162966238|NCT00672984|588576485|FG001|First Intervention|Adverse Event|0|||
162966239|NCT00672984|588576486|FG002|First Intervention|Adverse Event|0|||
162966240|NCT00672984|588576484|FG000|First Intervention|Withdrawal by Subject|1|||
162901321|NCT04731922|588337543|FG007|Overall Study|Other|0|||
162901322|NCT04731922|588337544|FG008|Overall Study|Other|0|||
162901323|NCT04731922|588337545|FG009|Overall Study|Other|0|||
162901324|NCT04731922|588337546|FG010|Overall Study|Other|0|||
162901325|NCT04731922|588337547|FG011|Overall Study|Other|0|||
162901326|NCT04731922|588337548|FG012|Overall Study|Other|0|||
162901327|NCT04731922|588337549|FG013|Overall Study|Other|0|||
162901328|NCT04731922|588337550|FG014|Overall Study|Other|0|||
163052896|NCT03636256|588904763|FG005|Overall Study|Lost to Follow-up|4|||
162625864|NCT02955602|587346927|FG000|Overall Study|Lost to Follow-up|0|||
162625865|NCT02955602|587346928|FG001|Overall Study|Lost to Follow-up|0|||
162901329|NCT04731922|588337551|FG015|Overall Study|Other|0|||
162901330|NCT04731922|588337552|FG016|Overall Study|Other|0|||
162901331|NCT00981747|588337559|FG000|Losartan|Withdrawal by Subject|1|||
162901332|NCT00981747|588337559|FG000|Losartan|Death|1|||
162901333|NCT00981747|588337559|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
162901334|NCT03148795|588337567|FG000|Overall Study|Progressive Disease|1|||
162901335|NCT00441012|588337568|FG000|Overall Study|Adverse Event|0|||
162901336|NCT00441012|588337569|FG001|Overall Study|Adverse Event|1|||
162901337|NCT00441012|588337568|FG000|Overall Study|Lost to Follow-up|3|||
162901338|NCT00441012|588337569|FG001|Overall Study|Lost to Follow-up|3|||
162901339|NCT00441012|588337568|FG000|Overall Study|Protocol Violation|10|||
162901340|NCT00441012|588337569|FG001|Overall Study|Protocol Violation|9|||
162901341|NCT00441012|588337568|FG000|Overall Study|Withdrawal by Subject|4|||
162901342|NCT00441012|588337569|FG001|Overall Study|Withdrawal by Subject|0|||
162901343|NCT00441012|588337568|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
162901344|NCT00441012|588337569|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
162901345|NCT04489940|588337570|FG000|Overall Study|Other|2|||
162901346|NCT04489940|588337570|FG000|Overall Study|Withdrawal by Subject|2|||
162901347|NCT04489940|588337570|FG000|Overall Study|Death|5|||
162901348|NCT04489940|588337570|FG000|Overall Study|Lost to Follow-up|1|||
162901349|NCT04498468|588337571|FG000|Overall Study|Lost to Follow-up|3|||
162901350|NCT00090766|588337574|FG000|Overall Study|Nephrectomy Planned|0|||
162901351|NCT00090766|588337575|FG001|Overall Study|Nephrectomy Planned|0|||
162901352|NCT00090766|588337576|FG002|Overall Study|Nephrectomy Planned|1|||
162901353|NCT00090766|588337574|FG000|Overall Study|Death|1|||
162901354|NCT00090766|588337575|FG001|Overall Study|Death|0|||
162901355|NCT00090766|588337576|FG002|Overall Study|Death|0|||
162901356|NCT00090766|588337574|FG000|Overall Study|Admin|0|||
162901357|NCT00090766|588337575|FG001|Overall Study|Admin|2|||
162901358|NCT00090766|588337576|FG002|Overall Study|Admin|0|||
162966241|NCT00672984|588576485|FG001|First Intervention|Withdrawal by Subject|2|||
162966242|NCT00672984|588576486|FG002|First Intervention|Withdrawal by Subject|2|||
162966243|NCT00672984|588576484|FG000|First Intervention|Sponsor decision|3|||
162966244|NCT00672984|588576485|FG001|First Intervention|Sponsor decision|0|||
162966245|NCT00672984|588576486|FG002|First Intervention|Sponsor decision|0|||
162966246|NCT00672984|588576484|FG000|Second Intervention|Non-compliance with facility policies|0|||
162966247|NCT00672984|588576485|FG001|Second Intervention|Non-compliance with facility policies|2|||
162966248|NCT00672984|588576486|FG002|Second Intervention|Non-compliance with facility policies|0|||
162966249|NCT00672984|588576484|FG000|Second Intervention|Withdrawal by Subject|0|||
162966250|NCT00672984|588576485|FG001|Second Intervention|Withdrawal by Subject|3|||
162966251|NCT00672984|588576486|FG002|Second Intervention|Withdrawal by Subject|0|||
162966252|NCT00672984|588576484|FG000|Second Intervention|Protocol Violation|0|||
162966253|NCT00672984|588576485|FG001|Second Intervention|Protocol Violation|1|||
162966254|NCT00672984|588576486|FG002|Second Intervention|Protocol Violation|1|||
162966255|NCT00672984|588576484|FG000|Third Intervention|Adverse Event|1|||
162966256|NCT00672984|588576485|FG001|Third Intervention|Adverse Event|0|||
162966257|NCT00672984|588576486|FG002|Third Intervention|Adverse Event|1|||
162966258|NCT00009945|588576487|FG000|Overall Study|no follow up data|7|||
162966259|NCT00009945|588576488|FG001|Overall Study|no follow up data|5|||
162966260|NCT00573313|588576493|FG000|Overall Study|Protocol Violation|5|||
162966261|NCT00573313|588576494|FG001|Overall Study|Protocol Violation|0|||
162966262|NCT00573313|588576495|FG002|Overall Study|Protocol Violation|6|||
162966263|NCT00573313|588576496|FG003|Overall Study|Protocol Violation|0|||
162966264|NCT00295490|588576499|FG000|Overall Study|Protocol Violation|0|||
162966265|NCT00295490|588576500|FG001|Overall Study|Protocol Violation|0|||
162966266|NCT00295490|588576501|FG002|Overall Study|Protocol Violation|3|||
162966267|NCT00295490|588576502|FG003|Overall Study|Protocol Violation|3|||
162966268|NCT00295490|588576499|FG000|Overall Study|Withdrawal by Subject|0|||
162966269|NCT00295490|588576500|FG001|Overall Study|Withdrawal by Subject|2|||
162966270|NCT00295490|588576501|FG002|Overall Study|Withdrawal by Subject|0|||
162966271|NCT00295490|588576502|FG003|Overall Study|Withdrawal by Subject|1|||
162966272|NCT00295490|588576499|FG000|Overall Study|Lost to Follow-up|0|||
163052897|NCT03636256|588904764|FG006|Overall Study|Lost to Follow-up|2|||
162625866|NCT02955602|587346929|FG002|Overall Study|Lost to Follow-up|1|||
162625867|NCT02955602|587346927|FG000|Overall Study|Other|0|||
162901359|NCT00090766|588337574|FG000|Overall Study|Lost to Follow-up|2|||
162901360|NCT00090766|588337575|FG001|Overall Study|Lost to Follow-up|0|||
162901361|NCT00090766|588337576|FG002|Overall Study|Lost to Follow-up|2|||
162901362|NCT00804986|588337577|FG000|Overall Study|Adverse Event|0|||
162901363|NCT00804986|588337578|FG001|Overall Study|Adverse Event|1|||
162901364|NCT00804986|588337579|FG002|Overall Study|Adverse Event|2|||
162901365|NCT00804986|588337580|FG003|Overall Study|Adverse Event|1|||
162901366|NCT00804986|588337581|FG004|Overall Study|Adverse Event|3|||
162901367|NCT00804986|588337582|FG005|Overall Study|Adverse Event|0|||
162901368|NCT00804986|588337577|FG000|Overall Study|Lack of Efficacy|0|||
162966273|NCT00295490|588576500|FG001|Overall Study|Lost to Follow-up|0|||
163052898|NCT03636256|588904765|FG007|Overall Study|Lost to Follow-up|0|||
162901369|NCT00804986|588337578|FG001|Overall Study|Lack of Efficacy|0|||
162901370|NCT00804986|588337579|FG002|Overall Study|Lack of Efficacy|0|||
162901371|NCT00804986|588337580|FG003|Overall Study|Lack of Efficacy|1|||
162901372|NCT00804986|588337581|FG004|Overall Study|Lack of Efficacy|0|||
162901373|NCT00804986|588337582|FG005|Overall Study|Lack of Efficacy|3|||
162901374|NCT00804986|588337577|FG000|Overall Study|Lost to Follow-up|0|||
162901375|NCT00804986|588337578|FG001|Overall Study|Lost to Follow-up|0|||
162901376|NCT00804986|588337579|FG002|Overall Study|Lost to Follow-up|0|||
162901377|NCT00804986|588337580|FG003|Overall Study|Lost to Follow-up|1|||
162901378|NCT00804986|588337581|FG004|Overall Study|Lost to Follow-up|1|||
162901379|NCT00804986|588337582|FG005|Overall Study|Lost to Follow-up|3|||
162901380|NCT00804986|588337577|FG000|Overall Study|Protocol Violation|0|||
162901381|NCT00804986|588337578|FG001|Overall Study|Protocol Violation|1|||
162901382|NCT00804986|588337579|FG002|Overall Study|Protocol Violation|0|||
162901383|NCT00804986|588337580|FG003|Overall Study|Protocol Violation|1|||
162901384|NCT00804986|588337581|FG004|Overall Study|Protocol Violation|0|||
162901385|NCT00804986|588337582|FG005|Overall Study|Protocol Violation|0|||
162901386|NCT00804986|588337577|FG000|Overall Study|Withdrawal by Subject|0|||
162901387|NCT00804986|588337578|FG001|Overall Study|Withdrawal by Subject|3|||
162901388|NCT00804986|588337579|FG002|Overall Study|Withdrawal by Subject|0|||
162901389|NCT00804986|588337580|FG003|Overall Study|Withdrawal by Subject|3|||
162901390|NCT00804986|588337581|FG004|Overall Study|Withdrawal by Subject|5|||
162966274|NCT00295490|588576501|FG002|Overall Study|Lost to Follow-up|1|||
162966275|NCT00295490|588576502|FG003|Overall Study|Lost to Follow-up|0|||
162901391|NCT00804986|588337582|FG005|Overall Study|Withdrawal by Subject|3|||
162901392|NCT00804986|588337577|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
162901393|NCT00804986|588337578|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
162901394|NCT00804986|588337579|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
162901395|NCT00804986|588337580|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
162901396|NCT00804986|588337581|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
162901397|NCT00804986|588337582|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
162901398|NCT00804986|588337577|FG000|Overall Study|Sponsor Decision|0|||
162901399|NCT00804986|588337578|FG001|Overall Study|Sponsor Decision|1|||
162901400|NCT00804986|588337579|FG002|Overall Study|Sponsor Decision|0|||
162901401|NCT00804986|588337580|FG003|Overall Study|Sponsor Decision|0|||
162901402|NCT00804986|588337581|FG004|Overall Study|Sponsor Decision|0|||
162901403|NCT00804986|588337582|FG005|Overall Study|Sponsor Decision|0|||
162901404|NCT00804986|588337577|FG000|Overall Study|Physician Decision|1|||
162901405|NCT00804986|588337578|FG001|Overall Study|Physician Decision|0|||
162901406|NCT00804986|588337579|FG002|Overall Study|Physician Decision|0|||
162901407|NCT00804986|588337580|FG003|Overall Study|Physician Decision|0|||
162901408|NCT00804986|588337581|FG004|Overall Study|Physician Decision|0|||
162901409|NCT00804986|588337582|FG005|Overall Study|Physician Decision|0|||
162901410|NCT02774291|588337584|FG000|Overall Study|Lost to Follow-up|1|||
162901411|NCT00149890|588337588|FG000|Overall Study|Adverse Event|1|||
162901412|NCT00149890|588337589|FG001|Overall Study|Adverse Event|8|||
162901413|NCT00149890|588337588|FG000|Overall Study|Lack of Efficacy|8|||
162901414|NCT00149890|588337589|FG001|Overall Study|Lack of Efficacy|9|||
162901415|NCT00149890|588337588|FG000|Overall Study|Protocol Violation|1|||
162901416|NCT00149890|588337589|FG001|Overall Study|Protocol Violation|0|||
162901417|NCT00149890|588337588|FG000|Overall Study|Lost to Follow-up|1|||
162901418|NCT00149890|588337589|FG001|Overall Study|Lost to Follow-up|0|||
162901419|NCT00149890|588337588|FG000|Overall Study|Graft Loss|2|||
162901420|NCT00149890|588337589|FG001|Overall Study|Graft Loss|1|||
162901421|NCT01387594|588337590|FG000|Overall Study|Withdrawal by Subject|0|||
162901422|NCT01387594|588337591|FG001|Overall Study|Withdrawal by Subject|2|||
162901423|NCT01387594|588337590|FG000|Overall Study|Lost to Follow-up|0|||
162901424|NCT01387594|588337591|FG001|Overall Study|Lost to Follow-up|1|||
162901425|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
162901426|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
162901427|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
162901428|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
162901429|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
162901430|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
162901431|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
162901432|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
162901433|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
162901434|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
162901435|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
162966276|NCT00295490|588576499|FG000|Overall Study|Adverse Event|1|||
162966277|NCT00295490|588576500|FG001|Overall Study|Adverse Event|0|||
162966278|NCT00295490|588576501|FG002|Overall Study|Adverse Event|0|||
162966279|NCT00295490|588576502|FG003|Overall Study|Adverse Event|0|||
162966280|NCT00295490|588576499|FG000|Overall Study|Other|0|||
162901436|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
162901437|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
162901438|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
162901439|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
162901440|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
162901441|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
162901442|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
162901443|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
162901444|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
162901445|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
162901446|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
162901447|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
162901448|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
162901449|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
162901450|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
162901451|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
162901452|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
162901453|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
162901454|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
162901455|NCT04757376|588337592|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
162901456|NCT04757376|588337593|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
162901457|NCT04757376|588337594|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
162901458|NCT04757376|588337595|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
162901459|NCT04757376|588337596|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
162901460|NCT04757376|588337592|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
162901461|NCT04757376|588337593|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
162901462|NCT04757376|588337594|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
162901463|NCT04757376|588337595|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
162901464|NCT04757376|588337596|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
162901465|NCT01307046|588337597|FG000|Overall Study|Adverse Event|3|||
162901466|NCT01307046|588337598|FG001|Overall Study|Adverse Event|3|||
162901467|NCT01307046|588337597|FG000|Overall Study|Lack of Efficacy|0|||
162901468|NCT01307046|588337598|FG001|Overall Study|Lack of Efficacy|2|||
162901469|NCT01307046|588337597|FG000|Overall Study|Physician Decision|2|||
162901470|NCT01307046|588337598|FG001|Overall Study|Physician Decision|0|||
162901471|NCT01307046|588337597|FG000|Overall Study|Withdrawal by Subject|1|||
162901472|NCT01307046|588337598|FG001|Overall Study|Withdrawal by Subject|1|||
162901473|NCT01307046|588337597|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
162901474|NCT01307046|588337598|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
162901475|NCT01307046|588337597|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
162901476|NCT01307046|588337598|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
162901477|NCT03898323|588337599|FG000|Overall Study|Physician Decision|1|||
162901478|NCT00397891|588337608|FG000|Overall Study|Withdrawal by Subject|1|||
162901479|NCT00397891|588337609|FG001|Overall Study|Withdrawal by Subject|0|||
162901480|NCT00397891|588337610|FG002|Overall Study|Withdrawal by Subject|0|||
162901481|NCT00397891|588337611|FG003|Overall Study|Withdrawal by Subject|0|||
162901482|NCT00397891|588337612|FG004|Overall Study|Withdrawal by Subject|1|||
162901483|NCT00796224|588337615|FG000|Overall Study|Adverse Event|1|||
162901484|NCT00796224|588337616|FG001|Overall Study|Adverse Event|0|||
162901485|NCT00796224|588337615|FG000|Overall Study|Protocol Violation|0|||
162901486|NCT00796224|588337616|FG001|Overall Study|Protocol Violation|1|||
162901487|NCT02569398|588337621|FG000|Overall Study|Adverse Event|0|||
162901488|NCT02569398|588337622|FG001|Overall Study|Adverse Event|1|||
162901489|NCT02569398|588337623|FG002|Overall Study|Adverse Event|6|||
162901490|NCT02569398|588337621|FG000|Overall Study|Withdrawal by Subject|43|||
162901491|NCT02569398|588337622|FG001|Overall Study|Withdrawal by Subject|43|||
162901492|NCT02569398|588337623|FG002|Overall Study|Withdrawal by Subject|30|||
162901493|NCT02569398|588337621|FG000|Overall Study|Study terminated by sponsor|130|||
162901494|NCT02569398|588337622|FG001|Overall Study|Study terminated by sponsor|131|||
162901495|NCT02569398|588337623|FG002|Overall Study|Study terminated by sponsor|134|||
162901496|NCT02569398|588337621|FG000|Overall Study|Other|12|||
162901497|NCT02569398|588337622|FG001|Overall Study|Other|14|||
162901498|NCT02569398|588337623|FG002|Overall Study|Other|13|||
162901499|NCT02116361|588337624|FG000|Overall Study|Pregnancy|0|||
162625868|NCT02955602|587346928|FG001|Overall Study|Other|1|||
162901500|NCT02116361|588337625|FG001|Overall Study|Pregnancy|0|||
162901501|NCT02116361|588337626|FG002|Overall Study|Pregnancy|0|||
162901502|NCT02116361|588337627|FG003|Overall Study|Pregnancy|1|||
162901503|NCT02116361|588337624|FG000|Overall Study|Protocol Violation|1|||
162901504|NCT02116361|588337625|FG001|Overall Study|Protocol Violation|0|||
162901505|NCT02116361|588337626|FG002|Overall Study|Protocol Violation|0|||
162901506|NCT02116361|588337627|FG003|Overall Study|Protocol Violation|2|||
162901507|NCT02116361|588337624|FG000|Overall Study|Physician Decision|2|||
162901508|NCT02116361|588337625|FG001|Overall Study|Physician Decision|3|||
162901509|NCT02116361|588337626|FG002|Overall Study|Physician Decision|0|||
162901510|NCT02116361|588337627|FG003|Overall Study|Physician Decision|0|||
162901511|NCT02116361|588337624|FG000|Overall Study|Adverse Event|1|||
162901512|NCT02116361|588337625|FG001|Overall Study|Adverse Event|0|||
162901513|NCT02116361|588337626|FG002|Overall Study|Adverse Event|0|||
162901514|NCT02116361|588337627|FG003|Overall Study|Adverse Event|3|||
162901515|NCT02116361|588337624|FG000|Overall Study|Other Reasons|3|||
162901516|NCT02116361|588337625|FG001|Overall Study|Other Reasons|3|||
162901517|NCT02116361|588337626|FG002|Overall Study|Other Reasons|3|||
162901518|NCT02116361|588337627|FG003|Overall Study|Other Reasons|3|||
162901519|NCT02116361|588337624|FG000|Overall Study|Lack of Efficacy|5|||
162901520|NCT02116361|588337625|FG001|Overall Study|Lack of Efficacy|7|||
162901521|NCT02116361|588337626|FG002|Overall Study|Lack of Efficacy|4|||
162901522|NCT02116361|588337627|FG003|Overall Study|Lack of Efficacy|3|||
162901523|NCT02116361|588337624|FG000|Overall Study|Lost to Follow-up|4|||
162901524|NCT02116361|588337625|FG001|Overall Study|Lost to Follow-up|5|||
162901525|NCT02116361|588337626|FG002|Overall Study|Lost to Follow-up|7|||
162901526|NCT02116361|588337627|FG003|Overall Study|Lost to Follow-up|5|||
162901527|NCT02116361|588337624|FG000|Overall Study|Personal Reasons|6|||
162901528|NCT02116361|588337625|FG001|Overall Study|Personal Reasons|6|||
162901529|NCT02116361|588337626|FG002|Overall Study|Personal Reasons|4|||
162901530|NCT02116361|588337627|FG003|Overall Study|Personal Reasons|9|||
162901531|NCT02116361|588337624|FG000|Overall Study|Investigator Decision - Relapse|9|||
162901532|NCT02116361|588337625|FG001|Overall Study|Investigator Decision - Relapse|7|||
162901533|NCT02116361|588337626|FG002|Overall Study|Investigator Decision - Relapse|8|||
162901534|NCT02116361|588337627|FG003|Overall Study|Investigator Decision - Relapse|5|||
162901535|NCT02571972|588337630|FG000|Overall Study|Protocol Violation|2|||
162901536|NCT02571972|588337630|FG000|Overall Study|Withdrawal by Subject|2|||
162901537|NCT04195750|588337631|FG000|Overall Study|Death|245|||
162901538|NCT04195750|588337632|FG001|Overall Study|Death|253|||
162625869|NCT02955602|587346929|FG002|Overall Study|Other|3|||
162625870|NCT01581931|587346932|FG000|Washout|Adverse Event|0|||
162625871|NCT01581931|587346933|FG001|Washout|Adverse Event|1|||
162625872|NCT00395304|587346940|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162625873|NCT00395304|587346941|FG001|Treatment Period 1|Withdrawal by Subject|3|||
162625874|NCT00395304|587346942|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162625875|NCT00395304|587346943|FG003|Treatment Period 1|Withdrawal by Subject|2|||
162625876|NCT00395304|587346944|FG004|Treatment Period 1|Withdrawal by Subject|1|||
163052899|NCT03636256|588904766|FG008|Overall Study|Lost to Follow-up|4|||
162901539|NCT04195750|588337633|FG002|Overall Study|Death|5|||
162901540|NCT04195750|588337631|FG000|Overall Study|Physician Decision|0|||
162901541|NCT04195750|588337632|FG001|Overall Study|Physician Decision|1|||
162901542|NCT04195750|588337633|FG002|Overall Study|Physician Decision|0|||
162901543|NCT04195750|588337631|FG000|Overall Study|Withdrawal by Subject|9|||
162901544|NCT04195750|588337632|FG001|Overall Study|Withdrawal by Subject|8|||
162625877|NCT00395304|587346945|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162625878|NCT00395304|587346940|FG000|Treatment Period 1|Lost to Follow-up|1|||
162901545|NCT04195750|588337633|FG002|Overall Study|Withdrawal by Subject|0|||
162901546|NCT04195750|588337631|FG000|Overall Study|Ongoing|120|||
162901547|NCT04195750|588337632|FG001|Overall Study|Ongoing|110|||
163052900|NCT03636256|588904758|FG000|Overall Study|Withdrawal by Subject|0|||
163052901|NCT03636256|588904759|FG001|Overall Study|Withdrawal by Subject|0|||
163052902|NCT03636256|588904760|FG002|Overall Study|Withdrawal by Subject|0|||
163052903|NCT03636256|588904761|FG003|Overall Study|Withdrawal by Subject|0|||
163052904|NCT03636256|588904762|FG004|Overall Study|Withdrawal by Subject|0|||
163052905|NCT03636256|588904763|FG005|Overall Study|Withdrawal by Subject|0|||
163052906|NCT03636256|588904764|FG006|Overall Study|Withdrawal by Subject|0|||
163052907|NCT03636256|588904765|FG007|Overall Study|Withdrawal by Subject|0|||
162625879|NCT00395304|587346941|FG001|Treatment Period 1|Lost to Follow-up|0|||
162625880|NCT00395304|587346942|FG002|Treatment Period 1|Lost to Follow-up|0|||
162625881|NCT00395304|587346943|FG003|Treatment Period 1|Lost to Follow-up|1|||
162625882|NCT00395304|587346944|FG004|Treatment Period 1|Lost to Follow-up|0|||
162625883|NCT00395304|587346945|FG005|Treatment Period 1|Lost to Follow-up|1|||
162625884|NCT00395304|587346940|FG000|Treatment Period 1|Physician Decision|0|||
162625885|NCT00395304|587346941|FG001|Treatment Period 1|Physician Decision|1|||
162625886|NCT00395304|587346942|FG002|Treatment Period 1|Physician Decision|0|||
162625887|NCT00395304|587346943|FG003|Treatment Period 1|Physician Decision|0|||
162625888|NCT00395304|587346944|FG004|Treatment Period 1|Physician Decision|0|||
162625889|NCT00395304|587346945|FG005|Treatment Period 1|Physician Decision|0|||
162625890|NCT00395304|587346940|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162625891|NCT00395304|587346941|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162625892|NCT00395304|587346942|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162625893|NCT00395304|587346943|FG003|Treatment Period 2|Withdrawal by Subject|1|||
162625894|NCT00395304|587346944|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162625895|NCT00395304|587346945|FG005|Treatment Period 2|Withdrawal by Subject|2|||
162625896|NCT00395304|587346940|FG000|Treatment Period 2|Lost to Follow-up|0|||
162625897|NCT00395304|587346941|FG001|Treatment Period 2|Lost to Follow-up|3|||
162625898|NCT00395304|587346942|FG002|Treatment Period 2|Lost to Follow-up|0|||
162625899|NCT00395304|587346943|FG003|Treatment Period 2|Lost to Follow-up|0|||
162625900|NCT00395304|587346944|FG004|Treatment Period 2|Lost to Follow-up|0|||
162625901|NCT00395304|587346945|FG005|Treatment Period 2|Lost to Follow-up|0|||
162625902|NCT00395304|587346940|FG000|Treatment Period 2|Physician Decision|0|||
162625903|NCT00395304|587346941|FG001|Treatment Period 2|Physician Decision|0|||
162625904|NCT00395304|587346942|FG002|Treatment Period 2|Physician Decision|1|||
163052908|NCT03636256|588904766|FG008|Overall Study|Withdrawal by Subject|1|||
163052909|NCT01218308|588904767|FG000|Overall Study|Adverse Event|1|||
163052910|NCT01218308|588904768|FG001|Overall Study|Adverse Event|2|||
163052911|NCT01218308|588904767|FG000|Overall Study|Protocol Violation|0|||
163052912|NCT01218308|588904768|FG001|Overall Study|Protocol Violation|2|||
163052913|NCT01218308|588904767|FG000|Overall Study|Withdrawal by Subject|61|||
163052914|NCT01218308|588904768|FG001|Overall Study|Withdrawal by Subject|64|||
163052915|NCT01218308|588904767|FG000|Overall Study|Lost to Follow-up|27|||
163052916|NCT01218308|588904768|FG001|Overall Study|Lost to Follow-up|31|||
163052917|NCT01218308|588904767|FG000|Overall Study|Other|14|||
163052918|NCT01218308|588904768|FG001|Overall Study|Other|21|||
163052919|NCT00960193|588904773|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
163052920|NCT01245101|588904781|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
163052921|NCT01245101|588904782|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
163052922|NCT01245101|588904781|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
163052923|NCT01245101|588904782|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
162625905|NCT00395304|587346943|FG003|Treatment Period 2|Physician Decision|0|||
162625906|NCT00395304|587346944|FG004|Treatment Period 2|Physician Decision|0|||
162625907|NCT00395304|587346945|FG005|Treatment Period 2|Physician Decision|0|||
162625908|NCT00395304|587346940|FG000|Treatment Period 2|Other|0|||
162625909|NCT00395304|587346941|FG001|Treatment Period 2|Other|1|||
162625910|NCT00395304|587346942|FG002|Treatment Period 2|Other|0|||
162625911|NCT00395304|587346943|FG003|Treatment Period 2|Other|0|||
162625912|NCT00395304|587346944|FG004|Treatment Period 2|Other|0|||
162625913|NCT00395304|587346945|FG005|Treatment Period 2|Other|0|||
162625914|NCT00395304|587346940|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163052924|NCT01245101|588904781|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
162625915|NCT00395304|587346941|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162625916|NCT00395304|587346942|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162625917|NCT00395304|587346943|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163052925|NCT01245101|588904782|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
163052926|NCT02666222|588904786|FG000|Overall Study|Death|2|||
162625918|NCT00395304|587346944|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162901548|NCT04195750|588337633|FG002|Overall Study|Ongoing|4|||
162625919|NCT00395304|587346945|FG005|Treatment Period 3|Withdrawal by Subject|1|||
162625920|NCT00395304|587346940|FG000|Treatment Period 3|Lost to Follow-up|1|||
162625921|NCT00395304|587346941|FG001|Treatment Period 3|Lost to Follow-up|1|||
162901549|NCT02406027|588337634|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
163052927|NCT03504917|588904790|FG000|Blinded Treatment Period|Protocol Violation|1|||
162625922|NCT00395304|587346942|FG002|Treatment Period 3|Lost to Follow-up|0|||
162625923|NCT00395304|587346943|FG003|Treatment Period 3|Lost to Follow-up|0|||
163052928|NCT03504917|588904791|FG001|Blinded Treatment Period|Protocol Violation|0|||
162625924|NCT00395304|587346944|FG004|Treatment Period 3|Lost to Follow-up|0|||
162625925|NCT00395304|587346945|FG005|Treatment Period 3|Lost to Follow-up|0|||
162625926|NCT00395304|587346940|FG000|Treatment Period 3|Physician Decision|0|||
162625927|NCT00395304|587346941|FG001|Treatment Period 3|Physician Decision|1|||
162625928|NCT00395304|587346942|FG002|Treatment Period 3|Physician Decision|0|||
162625929|NCT00395304|587346943|FG003|Treatment Period 3|Physician Decision|0|||
162625930|NCT00395304|587346944|FG004|Treatment Period 3|Physician Decision|0|||
162625931|NCT00395304|587346945|FG005|Treatment Period 3|Physician Decision|0|||
162625932|NCT00395304|587346940|FG000|Treatment Period 3|Other|0|||
162625933|NCT00395304|587346941|FG001|Treatment Period 3|Other|0|||
162625934|NCT00395304|587346942|FG002|Treatment Period 3|Other|0|||
162625935|NCT00395304|587346943|FG003|Treatment Period 3|Other|1|||
162625936|NCT00395304|587346944|FG004|Treatment Period 3|Other|0|||
162625937|NCT00395304|587346945|FG005|Treatment Period 3|Other|0|||
162901550|NCT02406027|588337635|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
162901551|NCT02406027|588337636|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
162901552|NCT02406027|588337637|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
162625938|NCT00980057|587346950|FG000|Overall Study|Death|13|||
162625939|NCT00980057|587346951|FG001|Overall Study|Death|3|||
162625940|NCT00980057|587346950|FG000|Overall Study|Adverse Event|0|||
162625941|NCT00980057|587346951|FG001|Overall Study|Adverse Event|1|||
162901553|NCT02406027|588337638|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
162901554|NCT02406027|588337639|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
162901555|NCT02406027|588337640|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
162625942|NCT00980057|587346950|FG000|Overall Study|Physician Decision|4|||
162901556|NCT02406027|588337634|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
163052929|NCT03504917|588904790|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
163052930|NCT03504917|588904791|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
163052931|NCT03504917|588904790|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
163052932|NCT03504917|588904791|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
163052933|NCT03504917|588904790|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
163052934|NCT03504917|588904791|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
163052935|NCT03504917|588904790|FG000|Blinded Treatment Period|Adverse Event|4|||
163052936|NCT03504917|588904791|FG001|Blinded Treatment Period|Adverse Event|4|||
163052937|NCT03504917|588904790|FG000|Blinded Treatment Period|Physician Decision|1|||
163052938|NCT03504917|588904791|FG001|Blinded Treatment Period|Physician Decision|0|||
163052939|NCT03504917|588904790|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
163052940|NCT03504917|588904791|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
163052941|NCT03504917|588904790|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
163052942|NCT03504917|588904791|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
163052943|NCT03504917|588904790|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
163052944|NCT03504917|588904791|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
162901557|NCT02406027|588337635|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
162901558|NCT02406027|588337636|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
162901559|NCT02406027|588337637|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
162901560|NCT02406027|588337638|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
162901561|NCT02406027|588337639|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
162901562|NCT02406027|588337640|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
162901563|NCT02406027|588337634|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
162901564|NCT02406027|588337635|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
162901565|NCT02406027|588337636|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
162901566|NCT02406027|588337637|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
162901567|NCT02406027|588337638|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
162901568|NCT02406027|588337639|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
162901569|NCT02406027|588337640|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
162901570|NCT02406027|588337634|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
162901571|NCT02406027|588337635|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
162901572|NCT02406027|588337636|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
162901573|NCT02406027|588337637|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
162901574|NCT02406027|588337638|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
162901575|NCT02406027|588337639|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
163052945|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
163052946|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
163052947|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
163052948|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
163052949|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
163052950|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
162901576|NCT02406027|588337640|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
162901577|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
162901578|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
162901579|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
162901580|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
162901581|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
162901582|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
162901583|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
162901584|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
162901585|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
162901586|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
162901587|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
162901588|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
162901589|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
162966281|NCT00295490|588576500|FG001|Overall Study|Other|2|||
162966282|NCT00295490|588576501|FG002|Overall Study|Other|0|||
162966283|NCT00295490|588576502|FG003|Overall Study|Other|1|||
162966284|NCT03255980|588576503|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
162966285|NCT03255980|588576504|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
162966286|NCT03255980|588576505|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
162966287|NCT03255980|588576506|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
162966288|NCT03255980|588576503|FG000|Overall Study|Adverse Event|1|||
162966289|NCT03255980|588576504|FG001|Overall Study|Adverse Event|1|||
162966290|NCT03255980|588576505|FG002|Overall Study|Adverse Event|0|||
162966291|NCT03255980|588576506|FG003|Overall Study|Adverse Event|1|||
162966292|NCT03255980|588576503|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
162966293|NCT03255980|588576504|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
162966294|NCT03255980|588576505|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
162966295|NCT03255980|588576506|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
162966296|NCT03255980|588576503|FG000|Overall Study|Lost to Follow-up|1|||
162966297|NCT03255980|588576504|FG001|Overall Study|Lost to Follow-up|1|||
162966298|NCT03255980|588576505|FG002|Overall Study|Lost to Follow-up|0|||
162966299|NCT03255980|588576506|FG003|Overall Study|Lost to Follow-up|3|||
162966300|NCT03255980|588576503|FG000|Overall Study|Withdrawal by Subject|0|||
162966301|NCT03255980|588576504|FG001|Overall Study|Withdrawal by Subject|1|||
162966302|NCT03255980|588576505|FG002|Overall Study|Withdrawal by Subject|0|||
162966303|NCT03255980|588576506|FG003|Overall Study|Withdrawal by Subject|3|||
162966304|NCT01597791|588576507|FG000|Overall Study|Physician Decision|2|||
162966305|NCT01597791|588576508|FG001|Overall Study|Physician Decision|1|||
162966306|NCT01597791|588576507|FG000|Overall Study|Cesarean Section|6|||
162966307|NCT01597791|588576508|FG001|Overall Study|Cesarean Section|7|||
162966308|NCT01597791|588576507|FG000|Overall Study|Subject withdrawal|0|||
162966309|NCT01597791|588576508|FG001|Overall Study|Subject withdrawal|1|||
162966310|NCT01597791|588576507|FG000|Overall Study|Protocol Violation|0|||
162966311|NCT01597791|588576508|FG001|Overall Study|Protocol Violation|1|||
162966312|NCT02611362|588576509|FG000|Overall Study|Withdrawal by Subject|7|||
162966313|NCT02611362|588576510|FG001|Overall Study|Withdrawal by Subject|2|||
162966314|NCT02611362|588576509|FG000|Overall Study|Lost to Follow-up|2|||
162966315|NCT02611362|588576510|FG001|Overall Study|Lost to Follow-up|4|||
162966316|NCT00354159|588576511|FG000|Randomized Study Period|Withdrawal by Subject|5|||
162966317|NCT00354159|588576512|FG001|Randomized Study Period|Withdrawal by Subject|3|||
162966318|NCT00354159|588576511|FG000|Randomized Study Period|Physician Decision|6|||
162966319|NCT00354159|588576512|FG001|Randomized Study Period|Physician Decision|10|||
162966320|NCT00354159|588576511|FG000|Randomized Study Period|Lost to Follow-up|4|||
162966321|NCT00354159|588576512|FG001|Randomized Study Period|Lost to Follow-up|0|||
162966322|NCT00354159|588576511|FG000|Randomized Study Period|Death|7|||
162966323|NCT00354159|588576512|FG001|Randomized Study Period|Death|9|||
162966324|NCT00354159|588576511|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
162966325|NCT00354159|588576512|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
162966326|NCT00354159|588576511|FG000|Long-term Follow-up|Physician Decision|127|||
162966327|NCT00354159|588576512|FG001|Long-term Follow-up|Physician Decision|122|||
162966328|NCT00354159|588576511|FG000|Long-term Follow-up|Lost to Follow-up|1|||
162966329|NCT00354159|588576512|FG001|Long-term Follow-up|Lost to Follow-up|0|||
162966330|NCT00354159|588576511|FG000|Long-term Follow-up|Death|14|||
162966331|NCT00354159|588576512|FG001|Long-term Follow-up|Death|11|||
162966332|NCT00354159|588576511|FG000|Long-term Follow-up|Study Closed|29|||
162966333|NCT00354159|588576512|FG001|Long-term Follow-up|Study Closed|34|||
162901590|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
162901591|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
162901592|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
162901593|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
162901594|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
162901595|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
162901596|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
162901597|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
162901598|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
162901599|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
162901600|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
162901601|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
162901602|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
162901603|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
162901604|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
162901605|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901606|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901607|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901608|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901609|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901610|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
162901611|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
162901612|NCT02406027|588337634|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901613|NCT02406027|588337635|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901614|NCT02406027|588337636|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901615|NCT02406027|588337637|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901616|NCT02406027|588337638|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
162901617|NCT02406027|588337639|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901618|NCT02406027|588337640|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
162901619|NCT04363944|588337641|FG000|Overall Study|Withdrawal by Subject|2|||
162901620|NCT04363944|588337642|FG001|Overall Study|Withdrawal by Subject|0|||
162901621|NCT03559192|588337643|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
162901622|NCT03559192|588337644|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
162901623|NCT03559192|588337645|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
162901624|NCT03559192|588337643|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
162901625|NCT03559192|588337644|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
162901626|NCT03559192|588337645|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
162901627|NCT03559192|588337643|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
162901628|NCT03559192|588337644|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
162901629|NCT03559192|588337645|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
162901630|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
162901631|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
162901632|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
162901633|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
162901634|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
162901635|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
162901636|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
162901637|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
162901638|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
162901639|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
162901640|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
162901641|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
162901642|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
162901643|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
162901644|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
162901645|NCT03559192|588337643|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
162901646|NCT03559192|588337644|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
162966334|NCT02229084|588576514|FG000|Overall Study|Adverse Event|1|||
162966335|NCT02229084|588576515|FG001|Overall Study|Adverse Event|0|||
162966336|NCT02229084|588576516|FG002|Overall Study|Adverse Event|0|||
162966337|NCT02229084|588576517|FG003|Overall Study|Adverse Event|0|||
162966338|NCT02229084|588576518|FG004|Overall Study|Adverse Event|0|||
162966339|NCT02229084|588576519|FG005|Overall Study|Adverse Event|0|||
162966340|NCT02229084|588576520|FG006|Overall Study|Adverse Event|0|||
162966341|NCT02229084|588576514|FG000|Overall Study|Lost to Follow-up|0|||
162966342|NCT02229084|588576515|FG001|Overall Study|Lost to Follow-up|0|||
162966343|NCT02229084|588576516|FG002|Overall Study|Lost to Follow-up|1|||
163052951|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
162625943|NCT00980057|587346951|FG001|Overall Study|Physician Decision|0|||
162625944|NCT00980057|587346950|FG000|Overall Study|Lost to Follow-up|1|||
162625945|NCT00980057|587346951|FG001|Overall Study|Lost to Follow-up|0|||
162625946|NCT00980057|587346950|FG000|Overall Study|Withdrawal by Subject|1|||
162625947|NCT00980057|587346951|FG001|Overall Study|Withdrawal by Subject|1|||
162625948|NCT00691015|587346955|FG000|Overall Study|Refused further treatment|1|||
162625949|NCT01397084|587346956|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
162625950|NCT01397084|587346956|FG000|Overall Study|Protocol Violation|2|||
162625951|NCT01397084|587346956|FG000|Overall Study|Adverse Event|2|||
162625952|NCT01397084|587346956|FG000|Overall Study|Withdrawal by Subject|1|||
162625953|NCT01397084|587346956|FG000|Overall Study|Lost to Follow-up|1|||
162625954|NCT01397084|587346956|FG000|Overall Study|Used other proton pump inhibitor|1|||
162625955|NCT04160195|587346959|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
162625956|NCT04160195|587346960|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
162625957|NCT03766581|587346963|FG000|Randomization|Other reasons|2|||
162625958|NCT03766581|587346964|FG001|Randomization|Other reasons|1|||
162625959|NCT03766581|587346965|FG002|Randomization|Other reasons|0|||
162625960|NCT03766581|587346966|FG003|Randomization|Other reasons|1|||
162625961|NCT03766581|587346967|FG004|Randomization|Other reasons|0|||
162625962|NCT03766581|587346968|FG005|Randomization|Other reasons|0|||
162625963|NCT03766581|587346969|FG006|Randomization|Other reasons|0|||
162625964|NCT03766581|587346970|FG007|Randomization|Other reasons|0|||
162625965|NCT03766581|587346963|FG000|Randomization|Participant no longer meets study criteria|5|||
162625966|NCT03766581|587346964|FG001|Randomization|Participant no longer meets study criteria|3|||
162625967|NCT03766581|587346965|FG002|Randomization|Participant no longer meets study criteria|4|||
162625968|NCT03766581|587346966|FG003|Randomization|Participant no longer meets study criteria|0|||
162625969|NCT03766581|587346967|FG004|Randomization|Participant no longer meets study criteria|2|||
162708818|NCT00665561|587642909|FG001|Overall Study|Site closed|0|||
162708819|NCT00665561|587642908|FG000|Overall Study|Withdrawn due to pregnancy|0|||
162708820|NCT00665561|587642909|FG001|Overall Study|Withdrawn due to pregnancy|1|||
163052952|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
163052953|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
163052954|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
163052955|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
163052956|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
163052957|NCT03504917|588904790|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
163052958|NCT03504917|588904791|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
163052959|NCT03863353|588904792|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
163052960|NCT03863353|588904793|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
163052961|NCT04079790|588904797|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
163052962|NCT04079790|588904798|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052963|NCT04079790|588904799|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052964|NCT04079790|588904800|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
163052965|NCT04079790|588904797|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052966|NCT04079790|588904798|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052967|NCT04079790|588904799|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
163052968|NCT04079790|588904800|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
163052969|NCT04079790|588904797|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052970|NCT04079790|588904798|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052971|NCT04079790|588904799|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
163052972|NCT04079790|588904800|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
163052973|NCT03810183|588904802|FG000|Overall Study|Study terminated by Sponsor|2|||
163052974|NCT03810183|588904803|FG001|Overall Study|Study terminated by Sponsor|1|||
163052975|NCT04275336|588904806|FG000|Overall Study|First venipuncture failed|4|||
163052976|NCT04275336|588904807|FG001|Overall Study|First venipuncture failed|6|||
163052977|NCT04275336|588904808|FG002|Overall Study|First venipuncture failed|5|||
163052978|NCT04275336|588904806|FG000|Overall Study|Unscheduled venipuncture|9|||
163052979|NCT04275336|588904807|FG001|Overall Study|Unscheduled venipuncture|13|||
163052980|NCT04275336|588904808|FG002|Overall Study|Unscheduled venipuncture|7|||
163052981|NCT04275336|588904806|FG000|Overall Study|Failed specimen of saliva|4|||
163052982|NCT04275336|588904807|FG001|Overall Study|Failed specimen of saliva|3|||
163052983|NCT04275336|588904808|FG002|Overall Study|Failed specimen of saliva|4|||
163052984|NCT03055936|588904809|FG000|Overall Study|Adverse Event|0|||
163052985|NCT03055936|588904810|FG001|Overall Study|Adverse Event|1|||
163052986|NCT03055936|588904811|FG002|Overall Study|Adverse Event|1|||
163052987|NCT03055936|588904812|FG003|Overall Study|Adverse Event|1|||
163052988|NCT03055936|588904809|FG000|Overall Study|Personal reason|2|||
163052989|NCT03055936|588904810|FG001|Overall Study|Personal reason|0|||
163052990|NCT03055936|588904811|FG002|Overall Study|Personal reason|1|||
163052991|NCT03055936|588904812|FG003|Overall Study|Personal reason|0|||
162901647|NCT03559192|588337645|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
162901648|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
162901649|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
162901650|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Death|0|||
162901651|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Death|4|||
162901652|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
162901653|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
162901654|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
162901655|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
162901656|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
162901657|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
162901658|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
162901659|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
162901660|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
162901661|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
162901662|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Other|4|||
162901663|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Other|3|||
162901664|NCT03517722|588337646|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
162901665|NCT03517722|588337647|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
162901666|NCT03517722|588337646|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
162901667|NCT03517722|588337647|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
162901668|NCT03517722|588337646|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
162901669|NCT03517722|588337647|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
162901670|NCT03517722|588337646|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
162901671|NCT03517722|588337647|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
162901672|NCT03517722|588337646|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
162901673|NCT03517722|588337647|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
162901674|NCT02177812|588337650|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162901675|NCT02177812|588337651|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162901676|NCT02177812|588337652|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162901677|NCT02177812|588337653|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162901678|NCT02177812|588337654|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162901679|NCT02177812|588337655|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
162966344|NCT02229084|588576517|FG003|Overall Study|Lost to Follow-up|1|||
162966345|NCT02229084|588576518|FG004|Overall Study|Lost to Follow-up|0|||
162901680|NCT02177812|588337656|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
162901681|NCT02177812|588337657|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
162966346|NCT02229084|588576519|FG005|Overall Study|Lost to Follow-up|0|||
162966347|NCT02229084|588576520|FG006|Overall Study|Lost to Follow-up|1|||
162966348|NCT02229084|588576514|FG000|Overall Study|Physician Decision|0|||
162966349|NCT02229084|588576515|FG001|Overall Study|Physician Decision|0|||
162966350|NCT02229084|588576516|FG002|Overall Study|Physician Decision|0|||
162966351|NCT02229084|588576517|FG003|Overall Study|Physician Decision|1|||
162966352|NCT02229084|588576518|FG004|Overall Study|Physician Decision|3|||
162966353|NCT02229084|588576519|FG005|Overall Study|Physician Decision|0|||
162966354|NCT02229084|588576520|FG006|Overall Study|Physician Decision|1|||
162966355|NCT02229084|588576514|FG000|Overall Study|Withdrawal by Subject|0|||
162966356|NCT02229084|588576515|FG001|Overall Study|Withdrawal by Subject|0|||
162966357|NCT02229084|588576516|FG002|Overall Study|Withdrawal by Subject|1|||
162966358|NCT02229084|588576517|FG003|Overall Study|Withdrawal by Subject|0|||
162966359|NCT02229084|588576518|FG004|Overall Study|Withdrawal by Subject|1|||
162966360|NCT02229084|588576519|FG005|Overall Study|Withdrawal by Subject|1|||
162966361|NCT02229084|588576520|FG006|Overall Study|Withdrawal by Subject|1|||
162966362|NCT02229084|588576514|FG000|Overall Study|Death|0|||
162966363|NCT02229084|588576515|FG001|Overall Study|Death|0|||
162966364|NCT02229084|588576516|FG002|Overall Study|Death|0|||
162966365|NCT02229084|588576517|FG003|Overall Study|Death|0|||
162966366|NCT02229084|588576518|FG004|Overall Study|Death|0|||
162966367|NCT02229084|588576519|FG005|Overall Study|Death|0|||
162966368|NCT02229084|588576520|FG006|Overall Study|Death|1|||
162966369|NCT01728116|588576523|FG000|Overall Study|Sponsor Terminated Study|106|||
162966370|NCT01728116|588576524|FG001|Overall Study|Sponsor Terminated Study|35|||
162966371|NCT01728116|588576523|FG000|Overall Study|Withdrawal by Subject|16|||
162966372|NCT01728116|588576524|FG001|Overall Study|Withdrawal by Subject|9|||
162901682|NCT02177812|588337658|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
162966373|NCT01728116|588576523|FG000|Overall Study|Adverse Event|13|||
162966374|NCT01728116|588576524|FG001|Overall Study|Adverse Event|0|||
162966375|NCT01728116|588576523|FG000|Overall Study|Procedure/device failure|7|||
162966376|NCT01728116|588576524|FG001|Overall Study|Procedure/device failure|0|||
162966377|NCT01728116|588576523|FG000|Overall Study|Lost to Follow-up|9|||
162966378|NCT01728116|588576524|FG001|Overall Study|Lost to Follow-up|2|||
162966379|NCT01728116|588576523|FG000|Overall Study|Physician Decision|2|||
162966380|NCT01728116|588576524|FG001|Overall Study|Physician Decision|0|||
162901683|NCT02177812|588337650|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901684|NCT02177812|588337651|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901685|NCT02177812|588337652|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901686|NCT02177812|588337653|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901687|NCT02177812|588337654|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901688|NCT02177812|588337655|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
162901689|NCT02177812|588337656|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
162901690|NCT02177812|588337657|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901691|NCT02177812|588337658|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
162901692|NCT02177812|588337650|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
162901693|NCT02177812|588337651|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
162901694|NCT02177812|588337652|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
162901695|NCT02177812|588337653|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
162901696|NCT02177812|588337654|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
162901697|NCT02177812|588337655|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
162901698|NCT02177812|588337656|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
162901699|NCT02177812|588337657|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
162901700|NCT02177812|588337658|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
162901701|NCT00089999|588337659|FG000|Overall Study|Adverse Event|4|||
162901702|NCT00089999|588337660|FG001|Overall Study|Adverse Event|7|||
162901703|NCT00089999|588337659|FG000|Overall Study|Withdrawal by Subject|0|||
162901704|NCT00089999|588337660|FG001|Overall Study|Withdrawal by Subject|4|||
162901705|NCT00089999|588337659|FG000|Overall Study|Lost to Follow-up|2|||
162901706|NCT00089999|588337660|FG001|Overall Study|Lost to Follow-up|1|||
162901707|NCT00089999|588337659|FG000|Overall Study|Radiological Progression of Cancer|52|||
162901708|NCT00089999|588337660|FG001|Overall Study|Radiological Progression of Cancer|44|||
162901709|NCT00089999|588337659|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
162901710|NCT00089999|588337660|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
162901711|NCT00089999|588337659|FG000|Overall Study|Death|3|||
162901712|NCT00089999|588337660|FG001|Overall Study|Death|3|||
162901713|NCT00089999|588337659|FG000|Overall Study|Poor General Condition|1|||
162901714|NCT00089999|588337660|FG001|Overall Study|Poor General Condition|0|||
162901715|NCT00089999|588337659|FG000|Overall Study|Clinical Progression|1|||
162901716|NCT00089999|588337660|FG001|Overall Study|Clinical Progression|2|||
162901717|NCT00089999|588337659|FG000|Overall Study|Physician Decision|2|||
162901718|NCT00089999|588337660|FG001|Overall Study|Physician Decision|2|||
162901719|NCT00089999|588337659|FG000|Overall Study|Patient Underwent Surgery|2|||
162901720|NCT00089999|588337660|FG001|Overall Study|Patient Underwent Surgery|0|||
162901721|NCT00089999|588337659|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
162901722|NCT00089999|588337660|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
162901723|NCT03573804|588337664|FG000|Overall Study|claustrophobia or MRI table problems|10|||
162901724|NCT05166603|588337668|FG000|Overall Study|Withdrawal by Subject|68|||
162901725|NCT05166603|588337669|FG001|Overall Study|Withdrawal by Subject|0|||
162901726|NCT04418427|588339324|FG000|Overall Study|Death|0|||
162901727|NCT04418427|588339325|FG001|Overall Study|Death|1|||
162901728|NCT04418427|588339326|FG002|Overall Study|Death|0|||
162901729|NCT04418427|588339324|FG000|Overall Study|Lost to Follow-up|0|||
162901730|NCT04418427|588339325|FG001|Overall Study|Lost to Follow-up|2|||
162901731|NCT04418427|588339326|FG002|Overall Study|Lost to Follow-up|2|||
162901732|NCT04418427|588339324|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
162901733|NCT04418427|588339325|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
162901734|NCT04418427|588339326|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
162901735|NCT04418427|588339324|FG000|Overall Study|Pre-existing medical condition|0|||
162901736|NCT04418427|588339325|FG001|Overall Study|Pre-existing medical condition|1|||
162901737|NCT04418427|588339326|FG002|Overall Study|Pre-existing medical condition|0|||
162901738|NCT01673373|588339329|FG000|Overall Study|Death|2|||
162901739|NCT01654224|588339330|FG000|Overall Study|Lost to Follow-up|2|||
162901740|NCT01654224|588339331|FG001|Overall Study|Lost to Follow-up|2|||
162901741|NCT01654224|588339330|FG000|Overall Study|Did not receive allocation|1|||
162901742|NCT01654224|588339331|FG001|Overall Study|Did not receive allocation|8|||
162901743|NCT01654224|588339330|FG000|Overall Study|Insufficient blood sample|3|||
162901744|NCT01654224|588339331|FG001|Overall Study|Insufficient blood sample|2|||
162901745|NCT00166504|588339333|FG000|Overall Study|Adverse Event|3|||
162901746|NCT00166504|588339334|FG001|Overall Study|Adverse Event|3|||
162966381|NCT01728116|588576523|FG000|Overall Study|Subject Non-Compliance|2|||
162966382|NCT01728116|588576524|FG001|Overall Study|Subject Non-Compliance|0|||
162966383|NCT01728116|588576523|FG000|Overall Study|Inter-current finding at procedure|1|||
162966384|NCT01728116|588576524|FG001|Overall Study|Inter-current finding at procedure|0|||
162901747|NCT00166504|588339333|FG000|Overall Study|Lost to Follow-up|1|||
162901748|NCT00166504|588339334|FG001|Overall Study|Lost to Follow-up|1|||
162966385|NCT01728116|588576523|FG000|Overall Study|Incorrectly enrolled in Study|0|||
162966386|NCT01728116|588576524|FG001|Overall Study|Incorrectly enrolled in Study|1|||
162966387|NCT01728116|588576523|FG000|Overall Study|various not noted previously|5|||
162966388|NCT01728116|588576524|FG001|Overall Study|various not noted previously|0|||
162966389|NCT01868243|588576527|FG000|Overall Study|Death|0|||
163052992|NCT01909804|588904819|FG000|Overall Study|Randomized but Never Treated|0|||
163052993|NCT01909804|588904820|FG001|Overall Study|Randomized but Never Treated|0|||
163052994|NCT01909804|588904821|FG002|Overall Study|Randomized but Never Treated|0|||
163052995|NCT01909804|588904822|FG003|Overall Study|Randomized but Never Treated|0|||
163052996|NCT01909804|588904823|FG004|Overall Study|Randomized but Never Treated|0|||
163052997|NCT01909804|588904824|FG005|Overall Study|Randomized but Never Treated|0|||
163052998|NCT01909804|588904825|FG006|Overall Study|Randomized but Never Treated|1|||
163052999|NCT01909804|588904826|FG007|Overall Study|Randomized but Never Treated|0|||
163053000|NCT01909804|588904827|FG008|Overall Study|Randomized but Never Treated|0|||
163053001|NCT01909804|588904828|FG009|Overall Study|Randomized but Never Treated|0|||
163053002|NCT01909804|588904829|FG010|Overall Study|Randomized but Never Treated|0|||
163053003|NCT01909804|588904830|FG011|Overall Study|Randomized but Never Treated|1|||
163053004|NCT01909804|588904819|FG000|Overall Study|Death|0|||
163053005|NCT01909804|588904820|FG001|Overall Study|Death|0|||
163053006|NCT01909804|588904821|FG002|Overall Study|Death|0|||
163053007|NCT01909804|588904822|FG003|Overall Study|Death|0|||
163053008|NCT01909804|588904823|FG004|Overall Study|Death|0|||
163053009|NCT01909804|588904824|FG005|Overall Study|Death|0|||
163053010|NCT01909804|588904825|FG006|Overall Study|Death|0|||
163053011|NCT01909804|588904826|FG007|Overall Study|Death|0|||
163053012|NCT01909804|588904827|FG008|Overall Study|Death|0|||
163053013|NCT01909804|588904828|FG009|Overall Study|Death|0|||
163053014|NCT01909804|588904829|FG010|Overall Study|Death|1|||
163053015|NCT01909804|588904830|FG011|Overall Study|Death|0|||
163053016|NCT01909804|588904819|FG000|Overall Study|Lack of Efficacy|4|||
163053017|NCT01909804|588904820|FG001|Overall Study|Lack of Efficacy|1|||
163053018|NCT01909804|588904821|FG002|Overall Study|Lack of Efficacy|0|||
163053019|NCT01909804|588904822|FG003|Overall Study|Lack of Efficacy|0|||
163053020|NCT01909804|588904823|FG004|Overall Study|Lack of Efficacy|7|||
163053021|NCT01909804|588904824|FG005|Overall Study|Lack of Efficacy|3|||
163053022|NCT01909804|588904825|FG006|Overall Study|Lack of Efficacy|1|||
163053023|NCT01909804|588904826|FG007|Overall Study|Lack of Efficacy|1|||
163053024|NCT01909804|588904827|FG008|Overall Study|Lack of Efficacy|0|||
163053025|NCT01909804|588904828|FG009|Overall Study|Lack of Efficacy|1|||
163053026|NCT01909804|588904829|FG010|Overall Study|Lack of Efficacy|0|||
163053027|NCT01909804|588904830|FG011|Overall Study|Lack of Efficacy|1|||
162901749|NCT00166504|588339333|FG000|Overall Study|Withdrawal by Subject|1|||
162901750|NCT00166504|588339334|FG001|Overall Study|Withdrawal by Subject|0|||
162901751|NCT03261037|588339337|FG000|Overall Study|Withdrawal by Subject|2|||
162901752|NCT03261037|588339338|FG001|Overall Study|Withdrawal by Subject|13|||
162901753|NCT03261037|588339339|FG002|Overall Study|Withdrawal by Subject|0|||
162901754|NCT03261037|588339340|FG003|Overall Study|Withdrawal by Subject|18|||
162901755|NCT03261037|588339337|FG000|Overall Study|Non-compliance with study procedures|0|||
162901756|NCT03261037|588339338|FG001|Overall Study|Non-compliance with study procedures|2|||
162901757|NCT03261037|588339339|FG002|Overall Study|Non-compliance with study procedures|0|||
162901758|NCT03261037|588339340|FG003|Overall Study|Non-compliance with study procedures|6|||
162901759|NCT03261037|588339337|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
162901760|NCT03261037|588339338|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
162901761|NCT03261037|588339339|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
162901762|NCT03261037|588339340|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
162901763|NCT03261037|588339337|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
162901764|NCT03261037|588339338|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
162901765|NCT03261037|588339339|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
162901766|NCT03261037|588339340|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
162901767|NCT03261037|588339337|FG000|Overall Study|Diagnosed but protocol deviation|1|||
162901768|NCT03261037|588339338|FG001|Overall Study|Diagnosed but protocol deviation|0|||
162901769|NCT03261037|588339339|FG002|Overall Study|Diagnosed but protocol deviation|0|||
163053028|NCT01909804|588904819|FG000|Overall Study|Withdrew Consent|0|||
163053029|NCT01909804|588904820|FG001|Overall Study|Withdrew Consent|0|||
163053030|NCT01909804|588904821|FG002|Overall Study|Withdrew Consent|0|||
163053031|NCT01909804|588904822|FG003|Overall Study|Withdrew Consent|0|||
162625970|NCT03766581|587346968|FG005|Randomization|Participant no longer meets study criteria|3|||
162625971|NCT03766581|587346969|FG006|Randomization|Participant no longer meets study criteria|0|||
162901770|NCT03261037|588339340|FG003|Overall Study|Diagnosed but protocol deviation|0|||
162901771|NCT03261037|588339337|FG000|Overall Study|Participant did not want to continue the study|0|||
162901772|NCT03261037|588339338|FG001|Overall Study|Participant did not want to continue the study|1|||
162901773|NCT03261037|588339339|FG002|Overall Study|Participant did not want to continue the study|0|||
162625972|NCT03766581|587346970|FG007|Randomization|Participant no longer meets study criteria|1|||
162901774|NCT03261037|588339340|FG003|Overall Study|Participant did not want to continue the study|0|||
162901775|NCT03261037|588339337|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
163053032|NCT01909804|588904823|FG004|Overall Study|Withdrew Consent|1|||
163053033|NCT01909804|588904824|FG005|Overall Study|Withdrew Consent|1|||
162901776|NCT03261037|588339338|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
162901777|NCT03261037|588339339|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
162901778|NCT03261037|588339340|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
162901779|NCT03261037|588339337|FG000|Overall Study|Participant presented clinical improvement|0|||
162901780|NCT03261037|588339338|FG001|Overall Study|Participant presented clinical improvement|2|||
162901781|NCT03261037|588339339|FG002|Overall Study|Participant presented clinical improvement|0|||
162901782|NCT03261037|588339340|FG003|Overall Study|Participant presented clinical improvement|0|||
162901783|NCT03261037|588339337|FG000|Overall Study|Technical difficulties|0|||
162901784|NCT03261037|588339338|FG001|Overall Study|Technical difficulties|0|||
162901785|NCT03261037|588339339|FG002|Overall Study|Technical difficulties|0|||
162901786|NCT03261037|588339340|FG003|Overall Study|Technical difficulties|1|||
162901787|NCT03261037|588339337|FG000|Overall Study|Equipment failed to work|0|||
162901788|NCT03261037|588339338|FG001|Overall Study|Equipment failed to work|0|||
162901789|NCT03261037|588339339|FG002|Overall Study|Equipment failed to work|0|||
162901790|NCT03261037|588339340|FG003|Overall Study|Equipment failed to work|1|||
162901791|NCT03261037|588339337|FG000|Overall Study|End of study for participant and no follow up|0|||
162901792|NCT03261037|588339338|FG001|Overall Study|End of study for participant and no follow up|0|||
162901793|NCT03261037|588339339|FG002|Overall Study|End of study for participant and no follow up|0|||
162901794|NCT03261037|588339340|FG003|Overall Study|End of study for participant and no follow up|1|||
162901795|NCT03261037|588339337|FG000|Overall Study|Participant was too weak to continue in study|1|||
162901796|NCT03261037|588339338|FG001|Overall Study|Participant was too weak to continue in study|0|||
162901797|NCT03261037|588339339|FG002|Overall Study|Participant was too weak to continue in study|0|||
162901798|NCT03261037|588339340|FG003|Overall Study|Participant was too weak to continue in study|0|||
162901799|NCT04423718|588339341|FG000|Main Study|Adverse Event|9|||
162901800|NCT04423718|588339342|FG001|Main Study|Adverse Event|5|||
162901801|NCT04423718|588339343|FG002|Main Study|Adverse Event|8|||
162901802|NCT04423718|588339341|FG000|Main Study|Physician Decision|3|||
162901803|NCT04423718|588339342|FG001|Main Study|Physician Decision|3|||
162901804|NCT04423718|588339343|FG002|Main Study|Physician Decision|2|||
162901805|NCT04423718|588339341|FG000|Main Study|Protocol Violation|0|||
162901806|NCT04423718|588339342|FG001|Main Study|Protocol Violation|0|||
162901807|NCT04423718|588339343|FG002|Main Study|Protocol Violation|1|||
162901808|NCT04423718|588339341|FG000|Main Study|Lost to Follow-up|3|||
162901809|NCT04423718|588339342|FG001|Main Study|Lost to Follow-up|3|||
162901810|NCT04423718|588339343|FG002|Main Study|Lost to Follow-up|4|||
162901811|NCT04423718|588339341|FG000|Main Study|Lack of Efficacy|2|||
162901812|NCT04423718|588339342|FG001|Main Study|Lack of Efficacy|1|||
162901813|NCT04423718|588339343|FG002|Main Study|Lack of Efficacy|0|||
162901814|NCT04423718|588339341|FG000|Main Study|Withdrawal by Subject|14|||
162901815|NCT04423718|588339342|FG001|Main Study|Withdrawal by Subject|20|||
162901816|NCT04423718|588339343|FG002|Main Study|Withdrawal by Subject|20|||
162901817|NCT04423718|588339341|FG000|Main Study|Death|10|||
162901818|NCT04423718|588339342|FG001|Main Study|Death|7|||
162901819|NCT04423718|588339343|FG002|Main Study|Death|7|||
162901820|NCT04423718|588339341|FG000|Main Study|COVID-19 pandemic|2|||
162901821|NCT04423718|588339342|FG001|Main Study|COVID-19 pandemic|2|||
162901822|NCT04423718|588339343|FG002|Main Study|COVID-19 pandemic|2|||
162901823|NCT04423718|588339341|FG000|Main Study|Other|7|||
162901824|NCT04423718|588339342|FG001|Main Study|Other|3|||
162901825|NCT04423718|588339343|FG002|Main Study|Other|2|||
162901826|NCT04423718|588339341|FG000|Extension Phase|Other|1|||
162901827|NCT04423718|588339342|FG001|Extension Phase|Other|0|||
162901828|NCT04423718|588339343|FG002|Extension Phase|Other|0|||
162901829|NCT04423718|588339341|FG000|Extension Phase|Logistical problems|0|||
162901830|NCT04423718|588339342|FG001|Extension Phase|Logistical problems|1|||
162901831|NCT04423718|588339343|FG002|Extension Phase|Logistical problems|1|||
162901832|NCT04423718|588339341|FG000|Extension Phase|Physician Decision|1|||
162901833|NCT04423718|588339342|FG001|Extension Phase|Physician Decision|0|||
162901834|NCT04423718|588339343|FG002|Extension Phase|Physician Decision|1|||
162901835|NCT04423718|588339341|FG000|Extension Phase|Lack of Efficacy|2|||
162901836|NCT04423718|588339342|FG001|Extension Phase|Lack of Efficacy|0|||
162901837|NCT04423718|588339343|FG002|Extension Phase|Lack of Efficacy|1|||
162901838|NCT04423718|588339341|FG000|Extension Phase|Lost to Follow-up|0|||
162901839|NCT04423718|588339342|FG001|Extension Phase|Lost to Follow-up|2|||
162901840|NCT04423718|588339343|FG002|Extension Phase|Lost to Follow-up|3|||
162901841|NCT04423718|588339341|FG000|Extension Phase|Adverse Event|2|||
162901842|NCT04423718|588339342|FG001|Extension Phase|Adverse Event|3|||
162901843|NCT04423718|588339343|FG002|Extension Phase|Adverse Event|1|||
162901844|NCT04423718|588339341|FG000|Extension Phase|Death|4|||
162901845|NCT04423718|588339342|FG001|Extension Phase|Death|7|||
162901846|NCT04423718|588339343|FG002|Extension Phase|Death|2|||
162901847|NCT04423718|588339341|FG000|Extension Phase|Withdrawal by Subject|11|||
162901848|NCT04423718|588339342|FG001|Extension Phase|Withdrawal by Subject|11|||
162901849|NCT04423718|588339343|FG002|Extension Phase|Withdrawal by Subject|7|||
162901850|NCT00589602|588339347|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
162901851|NCT05298774|588339351|FG000|Overall Study|Physician Decision|3|||
162901852|NCT05298774|588339351|FG000|Overall Study|Withdrawal by Subject|2|||
162901853|NCT05298774|588339351|FG000|Overall Study|Lost to Follow-up|3|||
162901854|NCT05298774|588339351|FG000|Overall Study|Screen failure|1|||
162901855|NCT04992507|588339352|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
162901856|NCT04992507|588339353|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
162901857|NCT04992507|588339352|FG000|Overall Study|Death|0|||
162901858|NCT04992507|588339353|FG001|Overall Study|Death|1|||
162901859|NCT03887052|588339354|FG000|Overall Study|Adverse Event|2|||
162901860|NCT03887052|588339354|FG000|Overall Study|Physician Decision|2|||
162901861|NCT03887052|588339354|FG000|Overall Study|Withdrawal by Subject|3|||
162901862|NCT03887052|588339354|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
162901863|NCT03887052|588339354|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
162901864|NCT04517253|588339357|FG000|Primary Treatment Period|Adverse Event|1|||
162901865|NCT04517253|588339358|FG001|Primary Treatment Period|Adverse Event|0|||
162901866|NCT04517253|588339359|FG002|Primary Treatment Period|Adverse Event|0|||
162901867|NCT04517253|588339357|FG000|Primary Treatment Period|Death|0|||
162901868|NCT04517253|588339358|FG001|Primary Treatment Period|Death|1|||
162901869|NCT04517253|588339359|FG002|Primary Treatment Period|Death|0|||
162901870|NCT04517253|588339357|FG000|Maintenance Period|Withdrawal by Subject|1|||
162901871|NCT04517253|588339358|FG001|Maintenance Period|Withdrawal by Subject|0|||
162901872|NCT04517253|588339359|FG002|Maintenance Period|Withdrawal by Subject|0|||
162901873|NCT04517253|588339357|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
162901874|NCT04517253|588339358|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
162901875|NCT04517253|588339359|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
162901876|NCT01023516|588339360|FG000|Overall Study|Voluntary discontinuation|7|||
162901877|NCT01023516|588339361|FG001|Overall Study|Voluntary discontinuation|5|||
162901878|NCT01023516|588339360|FG000|Overall Study|Adverse Event|9|||
162901879|NCT01023516|588339361|FG001|Overall Study|Adverse Event|6|||
162901880|NCT01023516|588339360|FG000|Overall Study|Safety reason|0|||
162901881|NCT01023516|588339361|FG001|Overall Study|Safety reason|3|||
162901882|NCT01023516|588339360|FG000|Overall Study|Study-specific criteria|4|||
162901883|NCT01023516|588339361|FG001|Overall Study|Study-specific criteria|2|||
162901884|NCT01023516|588339360|FG000|Overall Study|Incorrect enrolment|4|||
162901885|NCT01023516|588339361|FG001|Overall Study|Incorrect enrolment|2|||
162901886|NCT01266876|588339362|FG000|Overall Study|Adverse Event|0|||
162901887|NCT01266876|588339363|FG001|Overall Study|Adverse Event|0|||
162901888|NCT01266876|588339364|FG002|Overall Study|Adverse Event|0|||
162901889|NCT01266876|588339365|FG003|Overall Study|Adverse Event|1|||
162901890|NCT01266876|588339366|FG004|Overall Study|Adverse Event|0|||
162901891|NCT01058395|588339367|FG000|Overall Study|Death|2|||
162901892|NCT01058395|588339368|FG001|Overall Study|Death|1|||
162901893|NCT01058395|588339367|FG000|Overall Study|Lost to Follow-up|1|||
162901894|NCT01058395|588339368|FG001|Overall Study|Lost to Follow-up|0|||
162901895|NCT05016037|588339370|FG000|Overall Study|Lost to Follow-up|2|||
162901896|NCT00557323|588339371|FG000|Overall Study|Death|3|||
162901897|NCT00557323|588339371|FG000|Overall Study|Withdrawal by Subject|2|||
162901898|NCT00557323|588339371|FG000|Overall Study|Administrative change|2|||
162901899|NCT04007367|588339373|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
162901900|NCT04007367|588339374|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
162901901|NCT04007367|588339375|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
162901902|NCT04007367|588339373|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
162901903|NCT04007367|588339374|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
162901904|NCT04007367|588339375|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
162901905|NCT04007367|588339373|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
162901906|NCT04007367|588339374|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
162901907|NCT04007367|588339375|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
162901908|NCT04007367|588339373|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
162901909|NCT04007367|588339374|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
162901910|NCT04007367|588339375|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
162901911|NCT04007367|588339373|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
162901912|NCT04007367|588339374|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
162901913|NCT04007367|588339375|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
162901914|NCT02010567|588339377|FG000|Overall Study|Adverse Event|0|||
163053034|NCT01909804|588904825|FG006|Overall Study|Withdrew Consent|0|||
163053035|NCT01909804|588904826|FG007|Overall Study|Withdrew Consent|0|||
162901915|NCT02010567|588339378|FG001|Overall Study|Adverse Event|0|||
162901916|NCT02010567|588339379|FG002|Overall Study|Adverse Event|1|||
162901917|NCT02010567|588339380|FG003|Overall Study|Adverse Event|0|||
163053036|NCT01909804|588904827|FG008|Overall Study|Withdrew Consent|0|||
163053037|NCT01909804|588904828|FG009|Overall Study|Withdrew Consent|0|||
162901918|NCT02010567|588339381|FG004|Overall Study|Adverse Event|1|||
162901919|NCT00606229|588339385|FG000|Overall Study|Adverse Event|11|||
162901920|NCT00606229|588339385|FG000|Overall Study|Lack of Efficacy|1|||
162901921|NCT00606229|588339385|FG000|Overall Study|Withdrawal by Subject|4|||
163053038|NCT01909804|588904829|FG010|Overall Study|Withdrew Consent|0|||
162901922|NCT00606229|588339385|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
162901923|NCT00606229|588339385|FG000|Overall Study|change of residence or other commitments|2|||
162901924|NCT03523715|588339386|FG000|Overall Study|Lost to Follow-up|11|||
162901925|NCT03523715|588339387|FG001|Overall Study|Lost to Follow-up|14|||
162901926|NCT03523715|588339386|FG000|Overall Study|Did not meet inclusion criteria|1|||
162901927|NCT03523715|588339387|FG001|Overall Study|Did not meet inclusion criteria|0|||
162901928|NCT03523715|588339386|FG000|Overall Study|Internally inconsistent reporting|0|||
162901929|NCT03523715|588339387|FG001|Overall Study|Internally inconsistent reporting|2|||
162901930|NCT01526928|588339388|FG000|Overall Study|Progressive Disease|35|||
162901931|NCT01526928|588339389|FG001|Overall Study|Progressive Disease|17|||
162901932|NCT01526928|588339390|FG002|Overall Study|Progressive Disease|150|||
162901933|NCT01526928|588339391|FG003|Overall Study|Progressive Disease|182|||
162901934|NCT01526928|588339392|FG004|Overall Study|Progressive Disease|76|||
162901935|NCT01526928|588339393|FG005|Overall Study|Progressive Disease|4|||
162901936|NCT01526928|588339388|FG000|Overall Study|Adverse Event|2|||
162901937|NCT01526928|588339389|FG001|Overall Study|Adverse Event|1|||
162901938|NCT01526928|588339390|FG002|Overall Study|Adverse Event|29|||
162901939|NCT01526928|588339391|FG003|Overall Study|Adverse Event|40|||
162901940|NCT01526928|588339392|FG004|Overall Study|Adverse Event|13|||
162901941|NCT01526928|588339393|FG005|Overall Study|Adverse Event|2|||
162901942|NCT01526928|588339388|FG000|Overall Study|Death|0|||
162901943|NCT01526928|588339389|FG001|Overall Study|Death|0|||
162901944|NCT01526928|588339390|FG002|Overall Study|Death|3|||
162901945|NCT01526928|588339391|FG003|Overall Study|Death|0|||
162901946|NCT01526928|588339392|FG004|Overall Study|Death|0|||
162901947|NCT01526928|588339393|FG005|Overall Study|Death|0|||
162901948|NCT01526928|588339388|FG000|Overall Study|Withdrawal by Subject|1|||
162901949|NCT01526928|588339389|FG001|Overall Study|Withdrawal by Subject|0|||
162901950|NCT01526928|588339390|FG002|Overall Study|Withdrawal by Subject|13|||
162901951|NCT01526928|588339391|FG003|Overall Study|Withdrawal by Subject|11|||
162901952|NCT01526928|588339392|FG004|Overall Study|Withdrawal by Subject|3|||
162901953|NCT01526928|588339393|FG005|Overall Study|Withdrawal by Subject|0|||
162901954|NCT01526928|588339388|FG000|Overall Study|Physician Decision|0|||
162901955|NCT01526928|588339389|FG001|Overall Study|Physician Decision|0|||
162901956|NCT01526928|588339390|FG002|Overall Study|Physician Decision|2|||
162901957|NCT01526928|588339391|FG003|Overall Study|Physician Decision|5|||
162901958|NCT01526928|588339392|FG004|Overall Study|Physician Decision|0|||
162901959|NCT01526928|588339393|FG005|Overall Study|Physician Decision|0|||
162901960|NCT01526928|588339388|FG000|Overall Study|Other Reason|0|||
162901961|NCT01526928|588339389|FG001|Overall Study|Other Reason|1|||
162901962|NCT01526928|588339390|FG002|Overall Study|Other Reason|11|||
162901963|NCT01526928|588339391|FG003|Overall Study|Other Reason|4|||
162901964|NCT01526928|588339392|FG004|Overall Study|Other Reason|1|||
162901965|NCT01526928|588339393|FG005|Overall Study|Other Reason|0|||
162901966|NCT01526928|588339388|FG000|Overall Study|Lost to Follow-up|0|||
162901967|NCT01526928|588339389|FG001|Overall Study|Lost to Follow-up|0|||
162901968|NCT01526928|588339390|FG002|Overall Study|Lost to Follow-up|0|||
162901969|NCT01526928|588339391|FG003|Overall Study|Lost to Follow-up|1|||
162901970|NCT01526928|588339392|FG004|Overall Study|Lost to Follow-up|0|||
162901971|NCT01526928|588339393|FG005|Overall Study|Lost to Follow-up|0|||
162901972|NCT01526928|588339388|FG000|Overall Study|Protocol Deviation|0|||
162901973|NCT01526928|588339389|FG001|Overall Study|Protocol Deviation|0|||
162901974|NCT01526928|588339390|FG002|Overall Study|Protocol Deviation|0|||
162901975|NCT01526928|588339391|FG003|Overall Study|Protocol Deviation|2|||
162901976|NCT01526928|588339392|FG004|Overall Study|Protocol Deviation|0|||
162901977|NCT01526928|588339393|FG005|Overall Study|Protocol Deviation|0|||
162901978|NCT01526928|588339388|FG000|Overall Study|Missing|0|||
162901979|NCT01526928|588339389|FG001|Overall Study|Missing|0|||
162901980|NCT01526928|588339390|FG002|Overall Study|Missing|1|||
162901981|NCT01526928|588339391|FG003|Overall Study|Missing|0|||
162901982|NCT01526928|588339392|FG004|Overall Study|Missing|2|||
162901983|NCT01526928|588339393|FG005|Overall Study|Missing|0|||
162901984|NCT00942422|588339394|FG000|Overall Study|Withdrawal by Subject|1|||
162966390|NCT01868243|588576528|FG001|Overall Study|Death|1|||
162966391|NCT01745094|588576529|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
162966392|NCT01745094|588576530|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
162901985|NCT00942422|588339394|FG000|Overall Study|Death|1|||
162901986|NCT00942422|588339394|FG000|Overall Study|Progressive diease|1|||
162901987|NCT05559203|588339402|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
162901988|NCT00422903|588339407|FG000|Overall Study|Disease Progression|3|||
162901989|NCT00422903|588339408|FG001|Overall Study|Disease Progression|1|||
162901990|NCT00422903|588339407|FG000|Overall Study|Adverse Event|0|||
162901991|NCT00422903|588339408|FG001|Overall Study|Adverse Event|2|||
162901992|NCT00422903|588339407|FG000|Overall Study|Informed Consent Withdrawn|1|||
162901993|NCT00422903|588339408|FG001|Overall Study|Informed Consent Withdrawn|2|||
163053039|NCT01909804|588904830|FG011|Overall Study|Withdrew Consent|0|||
163053040|NCT01909804|588904819|FG000|Overall Study|Protocol Violation|0|||
163053041|NCT01909804|588904820|FG001|Overall Study|Protocol Violation|0|||
162901994|NCT01947894|588339409|FG000|Overall Study|Other|3|||
162901995|NCT01947894|588339410|FG001|Overall Study|Other|4|||
162901996|NCT01947894|588339411|FG002|Overall Study|Other|3|||
162901997|NCT01947894|588339409|FG000|Overall Study|Withdrawal by Subject|12|||
162901998|NCT01947894|588339410|FG001|Overall Study|Withdrawal by Subject|4|||
162901999|NCT01947894|588339411|FG002|Overall Study|Withdrawal by Subject|1|||
163053042|NCT01909804|588904821|FG002|Overall Study|Protocol Violation|0|||
162625973|NCT03766581|587346963|FG000|Randomization|Participant request to discontinue study treatment|1|||
162625974|NCT03766581|587346964|FG001|Randomization|Participant request to discontinue study treatment|0|||
162625975|NCT03766581|587346965|FG002|Randomization|Participant request to discontinue study treatment|0|||
162625976|NCT03766581|587346966|FG003|Randomization|Participant request to discontinue study treatment|0|||
162625977|NCT03766581|587346967|FG004|Randomization|Participant request to discontinue study treatment|1|||
162625978|NCT03766581|587346968|FG005|Randomization|Participant request to discontinue study treatment|2|||
162625979|NCT03766581|587346969|FG006|Randomization|Participant request to discontinue study treatment|0|||
162625980|NCT03766581|587346970|FG007|Randomization|Participant request to discontinue study treatment|0|||
162625981|NCT03766581|587346963|FG000|Randomization|Participant withdrew consent|1|||
162625982|NCT03766581|587346964|FG001|Randomization|Participant withdrew consent|0|||
162625983|NCT03766581|587346965|FG002|Randomization|Participant withdrew consent|1|||
162902000|NCT01947894|588339409|FG000|Overall Study|Death|12|||
163053043|NCT01909804|588904822|FG003|Overall Study|Protocol Violation|0|||
163053044|NCT01909804|588904823|FG004|Overall Study|Protocol Violation|0|||
163053045|NCT01909804|588904824|FG005|Overall Study|Protocol Violation|0|||
163053046|NCT01909804|588904825|FG006|Overall Study|Protocol Violation|0|||
163053047|NCT01909804|588904826|FG007|Overall Study|Protocol Violation|0|||
163053048|NCT01909804|588904827|FG008|Overall Study|Protocol Violation|0|||
163053049|NCT01909804|588904828|FG009|Overall Study|Protocol Violation|0|||
163053050|NCT01909804|588904829|FG010|Overall Study|Protocol Violation|0|||
163053051|NCT01909804|588904830|FG011|Overall Study|Protocol Violation|1|||
163053052|NCT05401565|588904832|FG000|Overall Study|Lost to Follow-up|1|||
163053053|NCT05401565|588904833|FG001|Overall Study|Lost to Follow-up|0|||
163053054|NCT05401565|588904832|FG000|Overall Study|Adverse Event|2|||
163053055|NCT05401565|588904833|FG001|Overall Study|Adverse Event|0|||
163053056|NCT00617357|588904834|FG000|Overall Study|Lost to Follow-up|7|||
163053057|NCT00617357|588904834|FG000|Overall Study|Death|5|||
163053058|NCT00617357|588904834|FG000|Overall Study|insurance concerns|2|||
163053059|NCT00617357|588904834|FG000|Overall Study|Withdrawal by Subject|1|||
163053060|NCT00617357|588904834|FG000|Overall Study|Physician Decision|1|||
163053061|NCT02153918|588904839|FG000|Overall Study|Refused further treatment|1|||
163053062|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053063|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053064|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053065|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053066|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053067|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
163053068|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Refused|0|||
163053069|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Refused|0|||
163053070|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Refused|0|||
163053071|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Refused|0|||
163053072|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Refused|1|||
163053073|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Refused|0|||
163053074|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053075|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
163053076|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053077|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053078|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
162902001|NCT01947894|588339410|FG001|Overall Study|Death|1|||
162902002|NCT01947894|588339411|FG002|Overall Study|Death|0|||
162902003|NCT01947894|588339409|FG000|Overall Study|Physician Decision|2|||
163053079|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
163053080|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|Death|0|||
163053081|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|Death|0|||
163053082|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|Death|0|||
163053083|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|Death|0|||
162902004|NCT01947894|588339410|FG001|Overall Study|Physician Decision|0|||
162902005|NCT01947894|588339411|FG002|Overall Study|Physician Decision|0|||
163053084|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|Death|1|||
163053085|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|Death|0|||
163058602|NCT00042289|588924242|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
162902006|NCT01947894|588339409|FG000|Overall Study|Adverse Event|5|||
162902007|NCT01947894|588339410|FG001|Overall Study|Adverse Event|1|||
162902008|NCT01947894|588339411|FG002|Overall Study|Adverse Event|0|||
162902009|NCT01947894|588339409|FG000|Overall Study|Switched to other growth hormone brand|53|||
162902010|NCT01947894|588339410|FG001|Overall Study|Switched to other growth hormone brand|8|||
163053086|NCT03327324|588904840|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053087|NCT03327324|588904841|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053088|NCT03327324|588904842|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053089|NCT03327324|588904843|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053090|NCT03327324|588904844|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053091|NCT03327324|588904845|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
163053092|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053093|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053094|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
162625984|NCT03766581|587346966|FG003|Randomization|Participant withdrew consent|2|||
162625985|NCT03766581|587346967|FG004|Randomization|Participant withdrew consent|1|||
162625986|NCT03766581|587346968|FG005|Randomization|Participant withdrew consent|1|||
162625987|NCT03766581|587346969|FG006|Randomization|Participant withdrew consent|0|||
163053095|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053096|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053097|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053098|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
163053099|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053100|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053101|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
163053102|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
163053103|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
163053104|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
163053105|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053106|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053107|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053108|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053109|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
163053110|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|Death|1|||
163053111|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|Death|0|||
163053112|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|Death|1|||
163053113|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|Death|1|||
163053114|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|Death|1|||
163053115|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|Death|0|||
163053116|NCT03327324|588904840|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
162625988|NCT03766581|587346970|FG007|Randomization|Participant withdrew consent|0|||
162625989|NCT03766581|587346963|FG000|Treatment|Adverse Event|82|||
162625990|NCT03766581|587346964|FG001|Treatment|Adverse Event|44|||
162625991|NCT03766581|587346965|FG002|Treatment|Adverse Event|47|||
162625992|NCT03766581|587346966|FG003|Treatment|Adverse Event|46|||
162625993|NCT03766581|587346967|FG004|Treatment|Adverse Event|50|||
162625994|NCT03766581|587346968|FG005|Treatment|Adverse Event|77|||
162625995|NCT03766581|587346969|FG006|Treatment|Adverse Event|5|||
162625996|NCT03766581|587346970|FG007|Treatment|Adverse Event|2|||
162625997|NCT03766581|587346963|FG000|Treatment|Participant request to discontinue treatment|34|||
162625998|NCT03766581|587346964|FG001|Treatment|Participant request to discontinue treatment|6|||
162708821|NCT04949399|587642910|FG000|Overall Study|Lost to Follow-up|11|||
163053117|NCT03327324|588904841|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053118|NCT03327324|588904842|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053119|NCT03327324|588904843|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
162902011|NCT01947894|588339411|FG002|Overall Study|Switched to other growth hormone brand|23|||
162902012|NCT01302691|588339412|FG000|Overall Study|Adverse Event|2|||
162902013|NCT01302691|588339413|FG001|Overall Study|Adverse Event|0|||
162902014|NCT01302691|588339412|FG000|Overall Study|Death|0|||
162902015|NCT01302691|588339413|FG001|Overall Study|Death|1|||
162902016|NCT01302691|588339412|FG000|Overall Study|Lost to Follow-up|1|||
162902017|NCT01302691|588339413|FG001|Overall Study|Lost to Follow-up|0|||
162902018|NCT01302691|588339412|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
162902019|NCT01302691|588339413|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
162902020|NCT01302691|588339412|FG000|Overall Study|Physician Decision|0|||
162902021|NCT01302691|588339413|FG001|Overall Study|Physician Decision|1|||
162902022|NCT01302691|588339412|FG000|Overall Study|Protocol Violation|1|||
162902023|NCT01302691|588339413|FG001|Overall Study|Protocol Violation|0|||
162902024|NCT02829775|588339418|FG000|Overall Study|Death|1|||
162902025|NCT02829775|588339418|FG000|Overall Study|Withdrawal by Subject|3|||
162902026|NCT02829775|588339418|FG000|Overall Study|Disease remission|1|||
162902027|NCT01678560|588339429|FG000|Overall Study|Physician Decision|4|||
162902028|NCT01678560|588339430|FG001|Overall Study|Physician Decision|4|||
162902029|NCT01678560|588339429|FG000|Overall Study|Death|0|||
162902030|NCT01678560|588339430|FG001|Overall Study|Death|1|||
162902031|NCT01678560|588339429|FG000|Overall Study|Withdrawal by Subject|0|||
162902032|NCT01678560|588339430|FG001|Overall Study|Withdrawal by Subject|1|||
162902033|NCT02725268|588339431|FG000|Overall Study|Death|58|||
162902034|NCT02725268|588339432|FG001|Overall Study|Death|59|||
162902035|NCT02725268|588339433|FG002|Overall Study|Death|30|||
162902036|NCT02725268|588339434|FG003|Overall Study|Death|16|||
162902037|NCT02725268|588339431|FG000|Overall Study|Lost to Follow-up|4|||
162902038|NCT02725268|588339432|FG001|Overall Study|Lost to Follow-up|3|||
162902039|NCT02725268|588339433|FG002|Overall Study|Lost to Follow-up|0|||
163053120|NCT03327324|588904844|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053121|NCT03327324|588904845|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
163053122|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
163053123|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053124|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053125|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053126|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053127|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
163053128|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
163053129|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
163053130|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053131|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053132|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053133|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
163053134|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053135|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053136|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
163053137|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053138|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053139|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
163053140|NCT03327324|588904840|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053141|NCT03327324|588904841|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053142|NCT03327324|588904842|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
162902040|NCT02725268|588339434|FG003|Overall Study|Lost to Follow-up|1|||
162902041|NCT02725268|588339431|FG000|Overall Study|Site Terminated by Sponsor|0|||
162902042|NCT02725268|588339432|FG001|Overall Study|Site Terminated by Sponsor|1|||
162902043|NCT02725268|588339433|FG002|Overall Study|Site Terminated by Sponsor|0|||
162902044|NCT02725268|588339434|FG003|Overall Study|Site Terminated by Sponsor|0|||
162902045|NCT02725268|588339431|FG000|Overall Study|Withdrawal by Subject|8|||
162902046|NCT02725268|588339432|FG001|Overall Study|Withdrawal by Subject|6|||
162902047|NCT02725268|588339433|FG002|Overall Study|Withdrawal by Subject|8|||
162902048|NCT02725268|588339434|FG003|Overall Study|Withdrawal by Subject|1|||
162902049|NCT02725268|588339431|FG000|Overall Study|Reason not Specified|2|||
162902050|NCT02725268|588339432|FG001|Overall Study|Reason not Specified|1|||
162902051|NCT02725268|588339433|FG002|Overall Study|Reason not Specified|0|||
162902052|NCT02725268|588339434|FG003|Overall Study|Reason not Specified|0|||
162902053|NCT00262314|588339440|FG000|Overall Study|Changing physicians|38|||
162902054|NCT00262314|588339440|FG000|Overall Study|Death|12|||
162902055|NCT00262314|588339440|FG000|Overall Study|Patient's decision|92|||
162902056|NCT00262314|588339440|FG000|Overall Study|Other|95|||
162902057|NCT00262314|588339440|FG000|Overall Study|Lost to Follow-up|70|||
162902058|NCT00262314|588339440|FG000|Overall Study|Administrative withdrawal|30|||
162902059|NCT00117572|588339445|FG000|Overall Study|Site withdrew before starting treatment|2|||
162902060|NCT00117572|588339446|FG001|Overall Study|Site withdrew before starting treatment|3|||
162902061|NCT00117572|588339445|FG000|Overall Study|Withdrawal by Subject|3|||
162902062|NCT00117572|588339446|FG001|Overall Study|Withdrawal by Subject|3|||
162902063|NCT00117572|588339445|FG000|Overall Study|Protocol Violation|1|||
162902064|NCT00117572|588339446|FG001|Overall Study|Protocol Violation|0|||
162902065|NCT04973085|588339451|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
163053143|NCT03327324|588904843|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
163053144|NCT03327324|588904844|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
163053145|NCT03327324|588904845|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
163053146|NCT03327324|588904840|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
163053147|NCT03327324|588904841|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053148|NCT03327324|588904842|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053149|NCT03327324|588904843|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053150|NCT03327324|588904844|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053151|NCT03327324|588904845|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
163053152|NCT03327324|588904840|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
163053153|NCT03327324|588904841|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053154|NCT03327324|588904842|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053155|NCT03327324|588904843|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053156|NCT03327324|588904844|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053157|NCT03327324|588904845|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
163053158|NCT01791985|588904846|FG000|Overall Study|Adverse Event|7|||
163053159|NCT01791985|588904846|FG000|Overall Study|Withdrawal by Subject|1|||
163053160|NCT01103323|588904847|FG000|Without/Before Drug Switch|Adverse Event|50|||
163053161|NCT01103323|588904848|FG001|Without/Before Drug Switch|Adverse Event|7|||
163053162|NCT01103323|588904847|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
163053163|NCT01103323|588904848|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
163053164|NCT01103323|588904847|FG000|Without/Before Drug Switch|Protocol Violation|2|||
163053165|NCT01103323|588904848|FG001|Without/Before Drug Switch|Protocol Violation|0|||
163053166|NCT01103323|588904847|FG000|Without/Before Drug Switch|Physician Decision|2|||
163053167|NCT01103323|588904848|FG001|Without/Before Drug Switch|Physician Decision|0|||
163053168|NCT01103323|588904847|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
163053169|NCT01103323|588904848|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
163053170|NCT01103323|588904847|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
163053171|NCT01103323|588904848|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
163053172|NCT01103323|588904847|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
163053173|NCT01103323|588904848|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
163053174|NCT01946204|588904854|FG000|Overall Study|Death|38|||
163053175|NCT01946204|588904855|FG001|Overall Study|Death|59|||
163053176|NCT01946204|588904854|FG000|Overall Study|Withdrawal by Subject|37|||
163053177|NCT01946204|588904855|FG001|Overall Study|Withdrawal by Subject|50|||
163053178|NCT01946204|588904854|FG000|Overall Study|Lost to Follow-up|3|||
163053179|NCT01946204|588904855|FG001|Overall Study|Lost to Follow-up|7|||
163053180|NCT01946204|588904854|FG000|Overall Study|Ongoing|316|||
163053181|NCT01946204|588904855|FG001|Overall Study|Ongoing|687|||
163053182|NCT01946204|588904854|FG000|Overall Study|Other|7|||
163053183|NCT01946204|588904855|FG001|Overall Study|Other|3|||
163053184|NCT03797898|588904856|FG000|Overall Study|Lost to Follow-up|60|||
163053185|NCT03797898|588904857|FG001|Overall Study|Lost to Follow-up|69|||
163053186|NCT03797898|588904856|FG000|Overall Study|Withdrawal by Subject|9|||
163053187|NCT03797898|588904857|FG001|Overall Study|Withdrawal by Subject|7|||
163053188|NCT03797898|588904856|FG000|Overall Study|Became ineligible|5|||
163053189|NCT03797898|588904857|FG001|Overall Study|Became ineligible|2|||
163053190|NCT00485069|588904858|FG000|Overall Study|Adverse Event|10|||
163053191|NCT00485069|588904859|FG001|Overall Study|Adverse Event|4|||
163053192|NCT00485069|588904858|FG000|Overall Study|Lack of Efficacy|2|||
163053193|NCT00485069|588904859|FG001|Overall Study|Lack of Efficacy|1|||
163053194|NCT00485069|588904858|FG000|Overall Study|Protocol Violation|0|||
163053195|NCT00485069|588904859|FG001|Overall Study|Protocol Violation|1|||
163053196|NCT00485069|588904858|FG000|Overall Study|Withdrawal by Subject|6|||
163053197|NCT00485069|588904859|FG001|Overall Study|Withdrawal by Subject|6|||
163053198|NCT03217591|588904860|FG000|Overall Study|Adverse Event|1|||
163053199|NCT03217591|588904861|FG001|Overall Study|Adverse Event|2|||
163053200|NCT03217591|588904862|FG002|Overall Study|Adverse Event|6|||
162902066|NCT04973085|588339452|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
163053201|NCT03217591|588904860|FG000|Overall Study|Withdrawal by Subject|0|||
163053202|NCT03217591|588904861|FG001|Overall Study|Withdrawal by Subject|1|||
163053203|NCT03217591|588904862|FG002|Overall Study|Withdrawal by Subject|3|||
163053204|NCT03217591|588904860|FG000|Overall Study|Lost to Follow-up|1|||
163053205|NCT03217591|588904861|FG001|Overall Study|Lost to Follow-up|0|||
163053206|NCT03217591|588904862|FG002|Overall Study|Lost to Follow-up|0|||
163053207|NCT03217591|588904860|FG000|Overall Study|Protocol Violation|1|||
163053208|NCT03217591|588904861|FG001|Overall Study|Protocol Violation|0|||
163053209|NCT03217591|588904862|FG002|Overall Study|Protocol Violation|1|||
163053210|NCT00086190|588904863|FG000|Overall Study|Adverse Event|6|||
163053211|NCT00086190|588904864|FG001|Overall Study|Adverse Event|2|||
163053212|NCT00086190|588904865|FG002|Overall Study|Adverse Event|2|||
163053213|NCT00086190|588904863|FG000|Overall Study|Withdrawal by Subject|0|||
163053214|NCT00086190|588904864|FG001|Overall Study|Withdrawal by Subject|2|||
163053215|NCT00086190|588904865|FG002|Overall Study|Withdrawal by Subject|2|||
163053216|NCT00086190|588904863|FG000|Overall Study|Protocol Violation|1|||
163053217|NCT00086190|588904864|FG001|Overall Study|Protocol Violation|0|||
163053218|NCT00086190|588904865|FG002|Overall Study|Protocol Violation|0|||
163053219|NCT00086190|588904863|FG000|Overall Study|Moved|1|||
163053220|NCT00086190|588904864|FG001|Overall Study|Moved|0|||
163053221|NCT00086190|588904865|FG002|Overall Study|Moved|0|||
163053222|NCT00086190|588904863|FG000|Overall Study|Worsening depression|0|||
163053223|NCT00086190|588904864|FG001|Overall Study|Worsening depression|0|||
163053224|NCT00086190|588904865|FG002|Overall Study|Worsening depression|2|||
163053225|NCT03528551|588904871|FG000|Overall Study|Lost to Follow-up|0|||
163053226|NCT03528551|588904872|FG001|Overall Study|Lost to Follow-up|1|||
163053227|NCT03528551|588904873|FG002|Overall Study|Lost to Follow-up|0|||
163053228|NCT03528551|588904871|FG000|Overall Study|Transferred to other arm/group|2|||
163053229|NCT03528551|588904872|FG001|Overall Study|Transferred to other arm/group|3|||
163053230|NCT03528551|588904873|FG002|Overall Study|Transferred to other arm/group|0|||
163053231|NCT03528551|588904871|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163053232|NCT03528551|588904872|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163053233|NCT03528551|588904873|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163053234|NCT03528551|588904871|FG000|Overall Study|Protocol Violation|0|||
163053235|NCT03528551|588904872|FG001|Overall Study|Protocol Violation|3|||
163053236|NCT03528551|588904873|FG002|Overall Study|Protocol Violation|0|||
163053237|NCT03528551|588904871|FG000|Overall Study|Withdrawal by Subject|0|||
163053238|NCT03528551|588904872|FG001|Overall Study|Withdrawal by Subject|7|||
163053239|NCT03528551|588904873|FG002|Overall Study|Withdrawal by Subject|0|||
163053240|NCT01789047|588904874|FG000|Overall Study|Adverse Event|3|||
162902067|NCT01188811|588339453|FG000|Overall Study|Withdrawal by Subject|0|||
162902068|NCT01188811|588339454|FG001|Overall Study|Withdrawal by Subject|2|||
162902069|NCT01188811|588339453|FG000|Overall Study|Adverse Event|6|||
162902070|NCT01188811|588339454|FG001|Overall Study|Adverse Event|0|||
162902071|NCT00654368|588339455|FG000|Overall Study|Ineligibility determined|6|||
162902072|NCT00654368|588339456|FG001|Overall Study|Ineligibility determined|0|||
162902073|NCT00654368|588339457|FG002|Overall Study|Ineligibility determined|0|||
162902074|NCT00654368|588339455|FG000|Overall Study|Protocol deviation|3|||
162902075|NCT00654368|588339456|FG001|Overall Study|Protocol deviation|2|||
162902076|NCT00654368|588339457|FG002|Overall Study|Protocol deviation|1|||
162902077|NCT00654368|588339455|FG000|Overall Study|Non-compliance|2|||
162902078|NCT00654368|588339456|FG001|Overall Study|Non-compliance|1|||
162902079|NCT00654368|588339457|FG002|Overall Study|Non-compliance|2|||
162902080|NCT00654368|588339455|FG000|Overall Study|Withdrawal by Subject|5|||
162902081|NCT00654368|588339456|FG001|Overall Study|Withdrawal by Subject|2|||
162902082|NCT00654368|588339457|FG002|Overall Study|Withdrawal by Subject|2|||
162902083|NCT00654368|588339455|FG000|Overall Study|Disease progression|21|||
162902084|NCT00654368|588339456|FG001|Overall Study|Disease progression|31|||
162902085|NCT00654368|588339457|FG002|Overall Study|Disease progression|13|||
162902086|NCT00654368|588339455|FG000|Overall Study|Requirement for alternative therapy|1|||
162902087|NCT00654368|588339456|FG001|Overall Study|Requirement for alternative therapy|1|||
162902088|NCT00654368|588339457|FG002|Overall Study|Requirement for alternative therapy|1|||
162902089|NCT00654368|588339455|FG000|Overall Study|Physician Decision|0|||
162902090|NCT00654368|588339456|FG001|Overall Study|Physician Decision|0|||
163053241|NCT01789047|588904875|FG001|Overall Study|Adverse Event|2|||
163053242|NCT01789047|588904874|FG000|Overall Study|Withdrawal by Subject|1|||
163053243|NCT01789047|588904875|FG001|Overall Study|Withdrawal by Subject|2|||
163053244|NCT02700048|588904876|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
163053245|NCT02700048|588904877|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
163053246|NCT01204671|588904878|FG000|Overall Study|Adverse Event|4|||
163053247|NCT01204671|588904879|FG001|Overall Study|Adverse Event|3|||
162902091|NCT00654368|588339457|FG002|Overall Study|Physician Decision|2|||
162902092|NCT00654368|588339455|FG000|Overall Study|Death|1|||
162902093|NCT00654368|588339456|FG001|Overall Study|Death|0|||
162902094|NCT00654368|588339457|FG002|Overall Study|Death|0|||
162902095|NCT00654368|588339455|FG000|Overall Study|Pregnancy|0|||
162902096|NCT00654368|588339456|FG001|Overall Study|Pregnancy|0|||
162902097|NCT00654368|588339457|FG002|Overall Study|Pregnancy|2|||
162902098|NCT00654368|588339455|FG000|Overall Study|Other|0|||
162902099|NCT00654368|588339456|FG001|Overall Study|Other|2|||
163053248|NCT01204671|588904880|FG002|Overall Study|Adverse Event|3|||
163053249|NCT01204671|588904881|FG003|Overall Study|Adverse Event|3|||
163053250|NCT01204671|588904882|FG004|Overall Study|Adverse Event|1|||
163053251|NCT01204671|588904878|FG000|Overall Study|Withdrawal by Subject|2|||
163053252|NCT01204671|588904879|FG001|Overall Study|Withdrawal by Subject|3|||
163053253|NCT01204671|588904880|FG002|Overall Study|Withdrawal by Subject|4|||
163053254|NCT01204671|588904881|FG003|Overall Study|Withdrawal by Subject|5|||
162902100|NCT00654368|588339457|FG002|Overall Study|Other|3|||
162902101|NCT00654368|588339455|FG000|Overall Study|Adverse Event|14|||
162902102|NCT00654368|588339456|FG001|Overall Study|Adverse Event|9|||
162902103|NCT00654368|588339457|FG002|Overall Study|Adverse Event|6|||
162902104|NCT04228445|588339461|FG000|Overall Study|Lost to Follow-up|1|||
162902105|NCT04228445|588339462|FG001|Overall Study|Lost to Follow-up|1|||
162902106|NCT04228445|588339461|FG000|Overall Study|Physician Decision|1|||
162902107|NCT04228445|588339462|FG001|Overall Study|Physician Decision|2|||
162902108|NCT04228445|588339461|FG000|Overall Study|Withdrawal by Subject|0|||
162902109|NCT04228445|588339462|FG001|Overall Study|Withdrawal by Subject|1|||
162902110|NCT04228445|588339461|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
162902111|NCT04228445|588339462|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
162902112|NCT03954704|588339471|FG000|Overall Study|Death|1|||
162902113|NCT03954704|588339472|FG001|Overall Study|Death|1|||
162902114|NCT03954704|588339473|FG002|Overall Study|Death|1|||
162902115|NCT03954704|588339474|FG003|Overall Study|Death|3|||
162902116|NCT03954704|588339475|FG004|Overall Study|Death|2|||
162902117|NCT03954704|588339476|FG005|Overall Study|Death|2|||
162902118|NCT03954704|588339477|FG006|Overall Study|Death|0|||
162902119|NCT03954704|588339471|FG000|Overall Study|Withdrew Consent|0|||
162902120|NCT03954704|588339472|FG001|Overall Study|Withdrew Consent|0|||
162902121|NCT03954704|588339473|FG002|Overall Study|Withdrew Consent|1|||
162902122|NCT03954704|588339474|FG003|Overall Study|Withdrew Consent|0|||
162902123|NCT03954704|588339475|FG004|Overall Study|Withdrew Consent|0|||
162902124|NCT03954704|588339476|FG005|Overall Study|Withdrew Consent|1|||
162902125|NCT03954704|588339477|FG006|Overall Study|Withdrew Consent|0|||
162902126|NCT03954704|588339471|FG000|Overall Study|Lost to Follow-up|0|||
162902127|NCT03954704|588339472|FG001|Overall Study|Lost to Follow-up|0|||
162902128|NCT03954704|588339473|FG002|Overall Study|Lost to Follow-up|0|||
162902129|NCT03954704|588339474|FG003|Overall Study|Lost to Follow-up|0|||
162902130|NCT03954704|588339475|FG004|Overall Study|Lost to Follow-up|0|||
162902131|NCT03954704|588339476|FG005|Overall Study|Lost to Follow-up|0|||
162902132|NCT03954704|588339477|FG006|Overall Study|Lost to Follow-up|1|||
162902133|NCT03954704|588339471|FG000|Overall Study|Study Terminated by Sponsor|0|||
162902134|NCT03954704|588339472|FG001|Overall Study|Study Terminated by Sponsor|0|||
162902135|NCT03954704|588339473|FG002|Overall Study|Study Terminated by Sponsor|1|||
162902136|NCT03954704|588339474|FG003|Overall Study|Study Terminated by Sponsor|0|||
162902137|NCT03954704|588339475|FG004|Overall Study|Study Terminated by Sponsor|1|||
162902138|NCT03954704|588339476|FG005|Overall Study|Study Terminated by Sponsor|4|||
162902139|NCT03954704|588339477|FG006|Overall Study|Study Terminated by Sponsor|2|||
162902140|NCT03954704|588339471|FG000|Overall Study|Enrolled but not Treated|0|||
162902141|NCT03954704|588339472|FG001|Overall Study|Enrolled but not Treated|0|||
162902142|NCT03954704|588339473|FG002|Overall Study|Enrolled but not Treated|0|||
162902143|NCT03954704|588339474|FG003|Overall Study|Enrolled but not Treated|0|||
163053255|NCT01204671|588904882|FG004|Overall Study|Withdrawal by Subject|3|||
163053256|NCT01204671|588904878|FG000|Overall Study|Lost to Follow-up|7|||
162902144|NCT03954704|588339475|FG004|Overall Study|Enrolled but not Treated|0|||
162902145|NCT03954704|588339476|FG005|Overall Study|Enrolled but not Treated|1|||
162902146|NCT03954704|588339477|FG006|Overall Study|Enrolled but not Treated|0|||
162902147|NCT04035473|588339480|FG000|Screening/Baseline|Death|0|||
162902148|NCT04035473|588339481|FG001|Screening/Baseline|Death|1|||
162902149|NCT04035473|588339480|FG000|Screening/Baseline|Adverse Event|0|||
162902150|NCT04035473|588339481|FG001|Screening/Baseline|Adverse Event|1|||
162902151|NCT04035473|588339480|FG000|Follow-up Period|Adverse Event|2|||
162902152|NCT04035473|588339481|FG001|Follow-up Period|Adverse Event|0|||
162902153|NCT00366444|588341405|FG000|Overall Study|Withdrawal by Subject|1|||
162902154|NCT00366444|588341406|FG001|Overall Study|Withdrawal by Subject|1|||
162902155|NCT00366444|588341405|FG000|Overall Study|Lack of Efficacy|0|||
162902156|NCT00366444|588341406|FG001|Overall Study|Lack of Efficacy|1|||
162902157|NCT03763942|588341411|FG000|Overall Study|Lost to Follow-up|114|||
162902158|NCT03763942|588341412|FG001|Overall Study|Lost to Follow-up|54|||
162902159|NCT03763942|588341411|FG000|Overall Study|Protocol Violation|1|||
162902160|NCT03763942|588341412|FG001|Overall Study|Protocol Violation|0|||
162902161|NCT03763942|588341411|FG000|Overall Study|Withdrawal by Subject|2|||
162902162|NCT03763942|588341412|FG001|Overall Study|Withdrawal by Subject|0|||
163053257|NCT01204671|588904879|FG001|Overall Study|Lost to Follow-up|8|||
162902163|NCT03763942|588341411|FG000|Overall Study|Other|2|||
162902164|NCT03763942|588341412|FG001|Overall Study|Other|3|||
162902165|NCT02200510|588341413|FG000|Overall Study|Death|1|||
162902166|NCT02200510|588341414|FG001|Overall Study|Death|1|||
162902167|NCT02200510|588341413|FG000|Overall Study|Protocol Violation|0|||
162902168|NCT02200510|588341414|FG001|Overall Study|Protocol Violation|1|||
162902169|NCT02200510|588341413|FG000|Overall Study|Lost to Follow-up|7|||
163053258|NCT01204671|588904880|FG002|Overall Study|Lost to Follow-up|6|||
162902170|NCT02200510|588341414|FG001|Overall Study|Lost to Follow-up|1|||
162902171|NCT02200510|588341413|FG000|Overall Study|potential COI - joined study team|1|||
162902172|NCT02200510|588341414|FG001|Overall Study|potential COI - joined study team|0|||
162902173|NCT04969900|588341417|FG000|Overall Study|Physician Decision|1|||
162902174|NCT04969900|588341418|FG001|Overall Study|Physician Decision|1|||
162902175|NCT04969900|588341417|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
162902176|NCT04969900|588341418|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
162902177|NCT02881151|588341419|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
162902178|NCT04284787|588341423|FG000|Overall Study|Disease Progression|9|||
162902179|NCT04284787|588341424|FG001|Overall Study|Disease Progression|12|||
162902180|NCT04284787|588341423|FG000|Overall Study|Physician Decision|12|||
162902181|NCT04284787|588341424|FG001|Overall Study|Physician Decision|7|||
162902182|NCT04284787|588341423|FG000|Overall Study|Transplant|5|||
162902183|NCT04284787|588341424|FG001|Overall Study|Transplant|4|||
162902184|NCT04284787|588341423|FG000|Overall Study|Death|1|||
162902185|NCT04284787|588341424|FG001|Overall Study|Death|2|||
162902186|NCT04284787|588341423|FG000|Overall Study|Adverse Event|0|||
162902187|NCT04284787|588341424|FG001|Overall Study|Adverse Event|4|||
162902188|NCT04284787|588341423|FG000|Overall Study|Non-adherence|2|||
162902189|NCT04284787|588341424|FG001|Overall Study|Non-adherence|0|||
162902190|NCT04284787|588341423|FG000|Overall Study|Lack of Efficacy|2|||
162902191|NCT04284787|588341424|FG001|Overall Study|Lack of Efficacy|0|||
162902192|NCT01874353|588341425|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
162902193|NCT01874353|588341426|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
162902194|NCT01874353|588341427|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
162902195|NCT01874353|588341428|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
162902196|NCT01874353|588341425|FG000|Overall Study|Lost to Follow-up|2|||
162902197|NCT01874353|588341426|FG001|Overall Study|Lost to Follow-up|2|||
162902198|NCT01874353|588341427|FG002|Overall Study|Lost to Follow-up|2|||
162902199|NCT01874353|588341428|FG003|Overall Study|Lost to Follow-up|0|||
162902200|NCT01874353|588341425|FG000|Overall Study|Death|110|||
162902201|NCT01874353|588341426|FG001|Overall Study|Death|60|||
162902202|NCT01874353|588341427|FG002|Overall Study|Death|13|||
162902203|NCT01874353|588341428|FG003|Overall Study|Death|7|||
162902204|NCT01874353|588341425|FG000|Overall Study|Withdrawal by Subject|13|||
162902205|NCT01874353|588341426|FG001|Overall Study|Withdrawal by Subject|11|||
162902206|NCT01874353|588341427|FG002|Overall Study|Withdrawal by Subject|0|||
162902207|NCT01874353|588341428|FG003|Overall Study|Withdrawal by Subject|0|||
162902208|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
162902209|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
162902210|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Death|1|||
162902211|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Death|1|||
162902212|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
162902213|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
162902214|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
162902215|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
162902216|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
162902217|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
162902218|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
162902219|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
162902220|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
162902221|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
162902222|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
162902223|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
162902224|NCT03728881|588341429|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
162902225|NCT03728881|588341430|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
162902226|NCT03728881|588341429|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
162902227|NCT03728881|588341430|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
162902228|NCT03728881|588341429|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
162902229|NCT03728881|588341430|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
162902230|NCT04651777|588341431|FG000|Overall Study|Adverse Event|1|||
162902231|NCT04651777|588341431|FG000|Overall Study|Withdrawal by Subject|2|||
162902232|NCT05505734|588341432|FG000|Overall Study|Withdrawal by Subject|51|||
162966393|NCT01745094|588576531|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
162966394|NCT01745094|588576532|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
162966395|NCT01745094|588576529|FG000|Overall Study|Adverse Event|0|||
162966396|NCT01745094|588576530|FG001|Overall Study|Adverse Event|0|||
162966397|NCT01745094|588576531|FG002|Overall Study|Adverse Event|3|||
162966398|NCT01745094|588576532|FG003|Overall Study|Adverse Event|0|||
162966399|NCT01745094|588576529|FG000|Overall Study|Withdrawal by Subject|2|||
162966400|NCT01745094|588576530|FG001|Overall Study|Withdrawal by Subject|0|||
162966401|NCT01745094|588576531|FG002|Overall Study|Withdrawal by Subject|1|||
162966402|NCT01745094|588576532|FG003|Overall Study|Withdrawal by Subject|2|||
162966403|NCT01745094|588576529|FG000|Overall Study|Protocol Violation|1|||
162966404|NCT01745094|588576530|FG001|Overall Study|Protocol Violation|0|||
162966405|NCT01745094|588576531|FG002|Overall Study|Protocol Violation|3|||
162966406|NCT01745094|588576532|FG003|Overall Study|Protocol Violation|1|||
162966407|NCT01745094|588576529|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966408|NCT01745094|588576530|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966409|NCT01745094|588576531|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
162966410|NCT01745094|588576532|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
162966411|NCT01745094|588576529|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
162966412|NCT01745094|588576530|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
162966413|NCT01745094|588576531|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
162966414|NCT01745094|588576532|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
162966415|NCT01745094|588576529|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
162966416|NCT01745094|588576530|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966417|NCT01745094|588576531|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966418|NCT01745094|588576532|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162966419|NCT01451541|588576534|FG000|Overall Study|Adverse Event|4|||
162966420|NCT01451541|588576535|FG001|Overall Study|Adverse Event|3|||
162966421|NCT01451541|588576536|FG002|Overall Study|Adverse Event|6|||
162966422|NCT01451541|588576534|FG000|Overall Study|Lack of Efficacy|2|||
162966423|NCT01451541|588576535|FG001|Overall Study|Lack of Efficacy|0|||
162966424|NCT01451541|588576536|FG002|Overall Study|Lack of Efficacy|0|||
162966425|NCT01451541|588576534|FG000|Overall Study|Lost to Follow-up|4|||
162966426|NCT01451541|588576535|FG001|Overall Study|Lost to Follow-up|4|||
162966427|NCT01451541|588576536|FG002|Overall Study|Lost to Follow-up|7|||
162966428|NCT01451541|588576534|FG000|Overall Study|Withdrawal by Subject|15|||
162966429|NCT01451541|588576535|FG001|Overall Study|Withdrawal by Subject|8|||
162966430|NCT01451541|588576536|FG002|Overall Study|Withdrawal by Subject|6|||
162966431|NCT01451541|588576534|FG000|Overall Study|randomization error, noncompliance|11|||
162966432|NCT01451541|588576535|FG001|Overall Study|randomization error, noncompliance|10|||
162966433|NCT01451541|588576536|FG002|Overall Study|randomization error, noncompliance|8|||
162966434|NCT05665387|588576539|FG000|Overall Study|Withdrawal by Subject|1|||
162966435|NCT05665387|588576540|FG001|Overall Study|Withdrawal by Subject|0|||
162966436|NCT05665387|588576541|FG002|Overall Study|Withdrawal by Subject|1|||
162966437|NCT01824498|588576542|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
162966438|NCT01824498|588576543|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
162966439|NCT01824498|588576544|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
162966440|NCT01824498|588576545|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
162966441|NCT01824498|588576546|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
162966442|NCT01824498|588576547|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
162966443|NCT00006436|588576548|FG000|Overall Study|Refused further treatment|2|||
162966444|NCT00006436|588576548|FG000|Overall Study|Declined to participate (before treatment started)|1|||
162966445|NCT00939523|588576549|FG000|Overall Study|Lack of Efficacy|1|||
162966446|NCT00939523|588576549|FG000|Overall Study|Physician Decision|2|||
162966447|NCT00757172|588576550|FG000|Overall Study|Withdrawal by Subject|4|||
162966448|NCT00757172|588576550|FG000|Overall Study|Physician Decision|3|||
162966449|NCT00757172|588576550|FG000|Overall Study|Progression|4|||
162966450|NCT00660387|588577931|FG000|Overall Study|Adverse Event|1|||
162966451|NCT00660387|588577932|FG001|Overall Study|Adverse Event|2|||
162966452|NCT00660387|588577931|FG000|Overall Study|Lack of Efficacy|0|||
162966453|NCT00660387|588577932|FG001|Overall Study|Lack of Efficacy|1|||
162966454|NCT00660387|588577931|FG000|Overall Study|Protocol Violation|1|||
162966455|NCT00660387|588577932|FG001|Overall Study|Protocol Violation|0|||
162966456|NCT03086135|588577933|FG000|Overall Study|Adverse Event|1|||
162966457|NCT03086135|588577933|FG000|Overall Study|Lost to Follow-up|2|||
162966458|NCT01023061|588577934|FG000|Overall Study|Withdrawal prior to treatment|2|||
162966459|NCT02710214|588577936|FG000|Overall Study|Lost to Follow-up|1|||
162966460|NCT02710214|588577937|FG001|Overall Study|Lost to Follow-up|0|||
162966461|NCT02710214|588577936|FG000|Overall Study|Lack of Efficacy|0|||
162966462|NCT02710214|588577937|FG001|Overall Study|Lack of Efficacy|1|||
162966463|NCT02710214|588577936|FG000|Overall Study|Death|0|||
162966464|NCT02710214|588577937|FG001|Overall Study|Death|1|||
162966465|NCT02832167|588577938|FG000|Treatment Period 1|Disease progression|90|||
162966466|NCT02832167|588577938|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
162966467|NCT02832167|588577938|FG000|Treatment Period 1|Death|2|||
162966468|NCT02832167|588577938|FG000|Treatment Period 1|Study Drug Toxicity|6|||
162902233|NCT05505734|588341433|FG001|Overall Study|Withdrawal by Subject|64|||
163053259|NCT01204671|588904881|FG003|Overall Study|Lost to Follow-up|4|||
163053260|NCT01204671|588904882|FG004|Overall Study|Lost to Follow-up|0|||
163053261|NCT01204671|588904878|FG000|Overall Study|Unknown Completion Status|1|||
163053262|NCT01204671|588904879|FG001|Overall Study|Unknown Completion Status|1|||
162902234|NCT05505734|588341432|FG000|Overall Study|Adverse Event|6|||
162902235|NCT05505734|588341433|FG001|Overall Study|Adverse Event|20|||
162902236|NCT05505734|588341432|FG000|Overall Study|Protocol Violation|8|||
162902237|NCT05505734|588341433|FG001|Overall Study|Protocol Violation|15|||
163053263|NCT01204671|588904880|FG002|Overall Study|Unknown Completion Status|0|||
163053264|NCT01204671|588904881|FG003|Overall Study|Unknown Completion Status|0|||
163053265|NCT01204671|588904882|FG004|Overall Study|Unknown Completion Status|0|||
163053266|NCT01204671|588904878|FG000|Overall Study|Physician Decision|0|||
163053267|NCT01204671|588904879|FG001|Overall Study|Physician Decision|0|||
163053268|NCT01204671|588904880|FG002|Overall Study|Physician Decision|0|||
163053269|NCT01204671|588904881|FG003|Overall Study|Physician Decision|1|||
163053270|NCT01204671|588904882|FG004|Overall Study|Physician Decision|0|||
163053271|NCT02340000|588904883|FG000|Time Period 1|Withdrawal by Subject|6|||
163053272|NCT02340000|588904884|FG001|Time Period 1|Withdrawal by Subject|8|||
163053273|NCT02340000|588904883|FG000|Time Period 1|Lost to Follow-up|6|||
163053274|NCT02340000|588904884|FG001|Time Period 1|Lost to Follow-up|7|||
163053275|NCT02340000|588904883|FG000|Time Period 2|Withdrawal by Subject|9|||
163053276|NCT02340000|588904884|FG001|Time Period 2|Withdrawal by Subject|7|||
163053277|NCT02340000|588904883|FG000|Time Period 2|Lost to Follow-up|10|||
163053278|NCT02340000|588904884|FG001|Time Period 2|Lost to Follow-up|8|||
163053279|NCT02668640|588904885|FG000|Overall Study|Lost to Follow-up|13|||
163053280|NCT02668640|588904885|FG000|Overall Study|Other, not specified|1|||
163053281|NCT00919633|588904895|FG000|Overall Study|Adverse Event|1|||
163053282|NCT00919633|588904896|FG001|Overall Study|Adverse Event|9|||
163053283|NCT00919633|588904897|FG002|Overall Study|Adverse Event|12|||
163053284|NCT00919633|588904898|FG003|Overall Study|Adverse Event|10|||
163053285|NCT00919633|588904895|FG000|Overall Study|Death|0|||
163053286|NCT00919633|588904896|FG001|Overall Study|Death|0|||
163053287|NCT00919633|588904897|FG002|Overall Study|Death|2|||
163053288|NCT00919633|588904898|FG003|Overall Study|Death|0|||
163053289|NCT00919633|588904895|FG000|Overall Study|Lack of Efficacy|17|||
163053290|NCT00919633|588904896|FG001|Overall Study|Lack of Efficacy|3|||
162902238|NCT05505734|588341432|FG000|Overall Study|Lack of therapeutic response|0|||
162902239|NCT05505734|588341433|FG001|Overall Study|Lack of therapeutic response|1|||
162902240|NCT05505734|588341432|FG000|Overall Study|Lost to Follow-up|247|||
162902241|NCT05505734|588341433|FG001|Overall Study|Lost to Follow-up|237|||
162902242|NCT05505734|588341432|FG000|Overall Study|Physician Decision|22|||
162902243|NCT05505734|588341433|FG001|Overall Study|Physician Decision|13|||
162902244|NCT05505734|588341432|FG000|Overall Study|Death|2|||
162902245|NCT05505734|588341433|FG001|Overall Study|Death|1|||
162902246|NCT05505734|588341432|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162902247|NCT05505734|588341433|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162902248|NCT05505734|588341432|FG000|Overall Study|Pregnancy|1|||
162902249|NCT05505734|588341433|FG001|Overall Study|Pregnancy|0|||
162966469|NCT02832167|588577938|FG000|Treatment Period 1|Participant request to discontinue|9|||
162902250|NCT05505734|588341432|FG000|Overall Study|Other|17|||
162902251|NCT05505734|588341433|FG001|Overall Study|Other|13|||
162902252|NCT00732472|588341434|FG000|Overall Study|Adverse Event|0|||
162902253|NCT00732472|588341435|FG001|Overall Study|Adverse Event|1|||
162902254|NCT00732472|588341436|FG002|Overall Study|Adverse Event|1|||
162966470|NCT02832167|588577938|FG000|Treatment Period 1|No longer meet study criteria|1|||
162966471|NCT02832167|588577938|FG000|Treatment Period 1|Participant withdrew consent|3|||
162966472|NCT02832167|588577938|FG000|Treatment Period 1|Other reasons|6|||
162966473|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
162966474|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
162966475|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Death|2|||
162902255|NCT00732472|588341437|FG003|Overall Study|Adverse Event|1|||
162966476|NCT02832167|588577938|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
163053291|NCT00919633|588904897|FG002|Overall Study|Lack of Efficacy|2|||
163053292|NCT00919633|588904898|FG003|Overall Study|Lack of Efficacy|3|||
163053293|NCT00919633|588904895|FG000|Overall Study|Withdrawal by Subject|1|||
163053294|NCT00919633|588904896|FG001|Overall Study|Withdrawal by Subject|2|||
163053295|NCT00919633|588904897|FG002|Overall Study|Withdrawal by Subject|4|||
163053296|NCT00919633|588904898|FG003|Overall Study|Withdrawal by Subject|3|||
163053297|NCT00919633|588904895|FG000|Overall Study|Lost to Follow-up|3|||
163053298|NCT00919633|588904896|FG001|Overall Study|Lost to Follow-up|1|||
163053299|NCT00919633|588904897|FG002|Overall Study|Lost to Follow-up|0|||
163053300|NCT00919633|588904898|FG003|Overall Study|Lost to Follow-up|2|||
163053301|NCT00919633|588904895|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
162902256|NCT00732472|588341434|FG000|Overall Study|Protocol Violation|0|||
162902257|NCT00732472|588341435|FG001|Overall Study|Protocol Violation|0|||
163053302|NCT00919633|588904896|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
163053303|NCT00919633|588904897|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
163053304|NCT00919633|588904898|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
163053305|NCT00919633|588904895|FG000|Overall Study|Protocol Violation|0|||
163053306|NCT00919633|588904896|FG001|Overall Study|Protocol Violation|0|||
163053307|NCT00919633|588904897|FG002|Overall Study|Protocol Violation|0|||
163053308|NCT00919633|588904898|FG003|Overall Study|Protocol Violation|1|||
163053309|NCT00919633|588904895|FG000|Overall Study|Physician Decision|0|||
163053310|NCT00919633|588904896|FG001|Overall Study|Physician Decision|0|||
163053311|NCT00919633|588904897|FG002|Overall Study|Physician Decision|0|||
163053312|NCT00919633|588904898|FG003|Overall Study|Physician Decision|1|||
163053313|NCT00919633|588904895|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
163053314|NCT00919633|588904896|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
163053315|NCT00919633|588904897|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
163053316|NCT00919633|588904898|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
163053317|NCT00919633|588904895|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
163053318|NCT00919633|588904896|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
163053319|NCT00919633|588904897|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
163053320|NCT00919633|588904898|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
163053321|NCT01526785|588904899|FG000|Overall Study|Study Terminated by Sponsor|8|||
163053322|NCT01526785|588904899|FG000|Overall Study|Death|2|||
163053323|NCT01526785|588904899|FG000|Overall Study|Physician Decision|1|||
163053324|NCT01526785|588904899|FG000|Overall Study|Withdrawal by Subject|2|||
163053325|NCT01121263|588904902|FG000|Overall Study|Death|3|||
163053326|NCT01121263|588904903|FG001|Overall Study|Death|2|||
163053327|NCT01121263|588904902|FG000|Overall Study|Lost to Follow-up|22|||
163053328|NCT01121263|588904903|FG001|Overall Study|Lost to Follow-up|12|||
163053329|NCT01121263|588904902|FG000|Overall Study|Withdrawal by Subject|0|||
163053330|NCT01121263|588904903|FG001|Overall Study|Withdrawal by Subject|1|||
163053331|NCT02337491|588906392|FG000|Overall Study|Death|1|||
163053332|NCT02337491|588906393|FG001|Overall Study|Death|1|||
163053333|NCT02337491|588906392|FG000|Overall Study|Adverse Event|0|||
163053334|NCT02337491|588906393|FG001|Overall Study|Adverse Event|1|||
163053335|NCT02337491|588906392|FG000|Overall Study|Withdrawal by Subject|3|||
163053336|NCT02337491|588906393|FG001|Overall Study|Withdrawal by Subject|0|||
163053337|NCT02337491|588906392|FG000|Overall Study|Progressive Disease|44|||
163053338|NCT02337491|588906393|FG001|Overall Study|Progressive Disease|28|||
163053339|NCT02337491|588906392|FG000|Overall Study|On Treatment|2|||
163053340|NCT02337491|588906393|FG001|Overall Study|On Treatment|0|||
163053341|NCT00723229|588906394|FG000|First Intervention|Lost to Follow-up|7|||
163053342|NCT00723229|588906395|FG001|First Intervention|Lost to Follow-up|3|||
163053343|NCT01432951|588906396|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
163053344|NCT02900352|588906397|FG000|Overall Study|Lost to Follow-up|28|||
163053345|NCT02900352|588906398|FG001|Overall Study|Lost to Follow-up|17|||
162902258|NCT00732472|588341436|FG002|Overall Study|Protocol Violation|0|||
162902259|NCT00732472|588341437|FG003|Overall Study|Protocol Violation|1|||
162902260|NCT00732472|588341434|FG000|Overall Study|Withdrawal by Subject|0|||
162902261|NCT00732472|588341435|FG001|Overall Study|Withdrawal by Subject|2|||
162902262|NCT00732472|588341436|FG002|Overall Study|Withdrawal by Subject|0|||
162902263|NCT00732472|588341437|FG003|Overall Study|Withdrawal by Subject|1|||
162902264|NCT03575351|588341440|FG000|Overall Study|Adverse Event|1|||
162902265|NCT03575351|588341441|FG001|Overall Study|Adverse Event|0|||
162902266|NCT03575351|588341440|FG000|Overall Study|Death|2|||
162902267|NCT03575351|588341441|FG001|Overall Study|Death|2|||
162902268|NCT03575351|588341440|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
162902269|NCT03575351|588341441|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
162902270|NCT03575351|588341440|FG000|Overall Study|Lack of Efficacy|28|||
162902271|NCT03575351|588341441|FG001|Overall Study|Lack of Efficacy|0|||
162902272|NCT03575351|588341440|FG000|Overall Study|Withdrawal by Subject|1|||
162902273|NCT03575351|588341441|FG001|Overall Study|Withdrawal by Subject|1|||
162902274|NCT03575351|588341440|FG000|Overall Study|Physician Decision|3|||
163053346|NCT00785356|588906400|FG000|Overall Study|Study prematurely terminated|8|||
162902275|NCT03575351|588341441|FG001|Overall Study|Physician Decision|0|||
162902276|NCT03575351|588341440|FG000|Overall Study|Disease relapse|15|||
163053347|NCT03712280|588906406|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
163053348|NCT03712280|588906407|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
163053349|NCT03712280|588906408|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
163053350|NCT03712280|588906409|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
163053351|NCT03712280|588906406|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
163053352|NCT03712280|588906407|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053353|NCT03712280|588906408|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053354|NCT03712280|588906409|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
163053355|NCT03712280|588906406|FG000|Overall Study|Adverse Event|0|||
163053356|NCT03712280|588906407|FG001|Overall Study|Adverse Event|0|||
163053357|NCT03712280|588906408|FG002|Overall Study|Adverse Event|1|||
163053358|NCT03712280|588906409|FG003|Overall Study|Adverse Event|0|||
163053359|NCT00106002|588906410|FG000|Overall Study|Did not take any study drug|1|||
162902277|NCT03575351|588341441|FG001|Overall Study|Disease relapse|6|||
162902278|NCT03575351|588341440|FG000|Overall Study|Study drug manufacturing failure|0|||
162902279|NCT03575351|588341441|FG001|Overall Study|Study drug manufacturing failure|1|||
162902280|NCT03575351|588341440|FG000|Overall Study|other reasons|5|||
162902281|NCT03575351|588341441|FG001|Overall Study|other reasons|0|||
162902282|NCT03715205|588341442|FG000|Overall Study|Death|13|||
162902283|NCT03715205|588341442|FG000|Overall Study|Lost to Follow-up|2|||
162902284|NCT03715205|588341442|FG000|Overall Study|Physician Decision|93|||
162902285|NCT03715205|588341442|FG000|Overall Study|Withdrawal by Subject|26|||
162902286|NCT02623699|588341443|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902287|NCT02623699|588341444|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
162902288|NCT02623699|588341445|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902289|NCT02623699|588341446|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902290|NCT02623699|588341447|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902291|NCT02623699|588341448|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902292|NCT02623699|588341449|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902293|NCT02623699|588341450|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902294|NCT02623699|588341451|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902295|NCT02623699|588341452|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902296|NCT02623699|588341453|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902297|NCT02623699|588341454|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
162902298|NCT02623699|588341443|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902299|NCT02623699|588341444|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902300|NCT02623699|588341445|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902301|NCT02623699|588341446|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902302|NCT02623699|588341447|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902303|NCT02623699|588341448|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902304|NCT02623699|588341449|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
162902305|NCT02623699|588341450|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902306|NCT02623699|588341451|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902307|NCT02623699|588341452|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902308|NCT02623699|588341453|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902309|NCT02623699|588341454|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
162902310|NCT02623699|588341443|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902311|NCT02623699|588341444|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902312|NCT02623699|588341445|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902313|NCT02623699|588341446|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902314|NCT02623699|588341447|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902315|NCT02623699|588341448|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
162902316|NCT02623699|588341449|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902317|NCT02623699|588341450|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902318|NCT02623699|588341451|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902319|NCT02623699|588341452|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902320|NCT02623699|588341453|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902321|NCT02623699|588341454|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
162902322|NCT02623699|588341443|FG000|Part B (Up to 289 Days)|Death|0|||
162902323|NCT02623699|588341444|FG001|Part B (Up to 289 Days)|Death|0|||
162902324|NCT02623699|588341445|FG002|Part B (Up to 289 Days)|Death|0|||
162902325|NCT02623699|588341446|FG003|Part B (Up to 289 Days)|Death|0|||
162902326|NCT02623699|588341447|FG004|Part B (Up to 289 Days)|Death|0|||
162902327|NCT02623699|588341448|FG005|Part B (Up to 289 Days)|Death|1|||
162902328|NCT02623699|588341449|FG006|Part B (Up to 289 Days)|Death|1|||
162902329|NCT02623699|588341450|FG007|Part B (Up to 289 Days)|Death|0|||
162902330|NCT02623699|588341451|FG008|Part B (Up to 289 Days)|Death|1|||
162902331|NCT02623699|588341452|FG009|Part B (Up to 289 Days)|Death|0|||
162902332|NCT02623699|588341453|FG010|Part B (Up to 289 Days)|Death|0|||
162902333|NCT02623699|588341454|FG011|Part B (Up to 289 Days)|Death|0|||
162902334|NCT02623699|588341443|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
162902335|NCT02623699|588341444|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
163053360|NCT00106002|588906410|FG000|Overall Study|Ineligible after Registration|1|||
162902336|NCT02623699|588341445|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
162902337|NCT02623699|588341446|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
162902338|NCT02623699|588341447|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
162902339|NCT02623699|588341448|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
162902340|NCT02623699|588341449|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
162902341|NCT02623699|588341450|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
162902342|NCT02623699|588341451|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
162902343|NCT02623699|588341452|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
162902344|NCT02623699|588341453|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
162902345|NCT02623699|588341454|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
162902346|NCT02623699|588341443|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902347|NCT02623699|588341444|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902348|NCT02623699|588341445|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902349|NCT02623699|588341446|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902350|NCT02623699|588341447|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902351|NCT02623699|588341448|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902352|NCT02623699|588341449|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902353|NCT02623699|588341450|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902354|NCT02623699|588341451|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902355|NCT02623699|588341452|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
162902356|NCT02623699|588341453|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
162902357|NCT02623699|588341454|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
162902358|NCT02623699|588341443|FG000|Part C (Up to 236 Days)|Death|0|||
162902359|NCT02623699|588341444|FG001|Part C (Up to 236 Days)|Death|0|||
162902360|NCT02623699|588341445|FG002|Part C (Up to 236 Days)|Death|0|||
162902361|NCT02623699|588341446|FG003|Part C (Up to 236 Days)|Death|0|||
162902362|NCT02623699|588341447|FG004|Part C (Up to 236 Days)|Death|0|||
162902363|NCT02623699|588341448|FG005|Part C (Up to 236 Days)|Death|0|||
162902364|NCT02623699|588341449|FG006|Part C (Up to 236 Days)|Death|0|||
162902365|NCT02623699|588341450|FG007|Part C (Up to 236 Days)|Death|0|||
162902366|NCT02623699|588341451|FG008|Part C (Up to 236 Days)|Death|0|||
162902367|NCT02623699|588341452|FG009|Part C (Up to 236 Days)|Death|0|||
162902368|NCT02623699|588341453|FG010|Part C (Up to 236 Days)|Death|0|||
162902369|NCT02623699|588341454|FG011|Part C (Up to 236 Days)|Death|1|||
162902370|NCT02623699|588341443|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
162902371|NCT02623699|588341444|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
162902372|NCT02623699|588341445|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
162902373|NCT02623699|588341446|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
162902374|NCT02623699|588341447|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
162902375|NCT02623699|588341448|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
162902376|NCT02623699|588341449|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
162902377|NCT02623699|588341450|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
162902378|NCT02623699|588341451|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
162902379|NCT02623699|588341452|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
162902380|NCT02623699|588341453|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
162902381|NCT02623699|588341454|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
162902382|NCT01426009|588341455|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
162902383|NCT01426009|588341455|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
162902384|NCT01426009|588341455|FG000|Washout 1|Withdrawal by Subject|1|||
162902385|NCT01426009|588341455|FG000|Washout 1|Personal Reasons|1|||
162902386|NCT01426009|588341455|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
162966477|NCT02832167|588577938|FG000|Treatment Period 2|Disease progression|69|||
162966478|NCT02832167|588577938|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
162966479|NCT02832167|588577938|FG000|Treatment Period 2|Maximum clinical benefit|1|||
162966480|NCT02832167|588577938|FG000|Treatment Period 2|Study Drug Toxicity|5|||
162966481|NCT02832167|588577938|FG000|Treatment Period 2|Participant request to discontinue|2|||
162966482|NCT02832167|588577938|FG000|Treatment Period 2|Participant withdrew consent|3|||
162966483|NCT02832167|588577938|FG000|Treatment Period 2|Other reasons|3|||
163053361|NCT01122173|588906415|FG000|Overall Study|Lost to Follow-up|3|||
163053362|NCT01122173|588906415|FG000|Overall Study|Withdrawal by Subject|3|||
163053363|NCT01122173|588906415|FG000|Overall Study|Left study for other reasons|3|||
163053364|NCT04076917|588906417|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
163053365|NCT04076917|588906417|FG000|Overall Study|Study closure|13|||
162966484|NCT01754376|588577939|FG000|Overall Study|Adverse Event|1|||
162966485|NCT01754376|588577939|FG000|Overall Study|Lack of Efficacy|2|||
162966486|NCT04590781|588577940|FG000|Overall Study|Death|0|||
162966487|NCT04590781|588577941|FG001|Overall Study|Death|2|||
163053366|NCT04076917|588906417|FG000|Overall Study|Physician Decision|3|||
163053367|NCT04076917|588906417|FG000|Overall Study|Death|1|||
163053368|NCT04076917|588906417|FG000|Overall Study|Lost to Follow-up|1|||
163053369|NCT04076917|588906417|FG000|Overall Study|Withdrawal by Subject|1|||
163053370|NCT04076917|588906417|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
163053371|NCT04210986|588906418|FG000|Overall Study|Lost to Follow-up|5|||
162966488|NCT04590781|588577940|FG000|Overall Study|Withdrawal by Subject|2|||
162966489|NCT04590781|588577941|FG001|Overall Study|Withdrawal by Subject|0|||
162902387|NCT01426009|588341455|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
162902388|NCT01426009|588341455|FG000|Washout 2|electrive surgery|1|||
162902389|NCT01426009|588341455|FG000|Washout 3|personal reasons|1|||
162902390|NCT01426009|588341455|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
162902391|NCT01426009|588341455|FG000|Washout 4|Lost to Follow-up|1|||
162902392|NCT00515099|588341461|FG000|Overall Study|Lost to Follow-up|0|||
162902393|NCT00515099|588341462|FG001|Overall Study|Lost to Follow-up|4|||
162902394|NCT00515099|588341461|FG000|Overall Study|Withdrawal by Subject|2|||
162902395|NCT00515099|588341462|FG001|Overall Study|Withdrawal by Subject|0|||
162902396|NCT00515099|588341461|FG000|Overall Study|IRB Recommendation|1|||
162902397|NCT00515099|588341462|FG001|Overall Study|IRB Recommendation|0|||
162966490|NCT00820599|588577943|FG000|Overall Study|Death|129|||
162966491|NCT00820599|588577943|FG000|Overall Study|Withdrawal by Subject|2|||
162966492|NCT03686215|588577944|FG000|Overall Study|Adverse Event|0|||
163053372|NCT04210986|588906419|FG001|Overall Study|Lost to Follow-up|2|||
163053373|NCT04210986|588906418|FG000|Overall Study|Withdrawal by Subject|3|||
163053374|NCT04210986|588906419|FG001|Overall Study|Withdrawal by Subject|1|||
163053375|NCT04210986|588906418|FG000|Overall Study|Protocol Violation|1|||
163053376|NCT04210986|588906419|FG001|Overall Study|Protocol Violation|1|||
163053377|NCT04210986|588906418|FG000|Overall Study|Physician Decision|0|||
163053378|NCT04210986|588906419|FG001|Overall Study|Physician Decision|1|||
163053379|NCT01774591|588906420|FG000|Overall Study|Physician Decision|1|||
163053380|NCT01774591|588906421|FG001|Overall Study|Physician Decision|1|||
163053381|NCT01774591|588906420|FG000|Overall Study|Withdrawal by Subject|0|||
163053382|NCT01774591|588906421|FG001|Overall Study|Withdrawal by Subject|1|||
163053383|NCT01774591|588906420|FG000|Overall Study|Adverse Event|0|||
163053384|NCT01774591|588906421|FG001|Overall Study|Adverse Event|2|||
163053385|NCT05222880|588906422|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
162902398|NCT03342404|588341463|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
162902399|NCT03342404|588341464|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
163053386|NCT05222880|588906422|FG000|Overall Study|Withdrew Consent during Study|1|||
163053387|NCT05222880|588906422|FG000|Overall Study|COVID-19 Related|1|||
163053388|NCT01077323|588906425|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
163053389|NCT01077323|588906426|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
163053390|NCT01077323|588906427|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
163053391|NCT01077323|588906425|FG000|Overall Study|Dispensing of drug in baseline period|0|||
163053392|NCT01077323|588906426|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
163053393|NCT01077323|588906427|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
163053394|NCT01077323|588906425|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
163053395|NCT01077323|588906426|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
163053396|NCT01077323|588906427|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
163053397|NCT02984982|588906428|FG000|Overall Study|Adverse Event|2|||
163053398|NCT02984982|588906429|FG001|Overall Study|Adverse Event|5|||
163053399|NCT02984982|588906428|FG000|Overall Study|Poor Compliance to Protocol|4|||
162902400|NCT03342404|588341463|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
162902401|NCT03342404|588341464|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
162902402|NCT03342404|588341463|FG000|Blinded Treatment Phase|Adverse Event|5|||
162902403|NCT03342404|588341464|FG001|Blinded Treatment Phase|Adverse Event|4|||
162902404|NCT03342404|588341463|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
162902405|NCT03342404|588341464|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
162902406|NCT03342404|588341463|FG000|Blinded Treatment Phase|Other reasons|1|||
162902407|NCT03342404|588341464|FG001|Blinded Treatment Phase|Other reasons|0|||
162902408|NCT03342404|588341463|FG000|Blinded Treatment Phase|Physician Decision|1|||
162902409|NCT03342404|588341464|FG001|Blinded Treatment Phase|Physician Decision|0|||
162902410|NCT03342404|588341463|FG000|Blinded Treatment Phase|Death|1|||
162902411|NCT03342404|588341464|FG001|Blinded Treatment Phase|Death|0|||
162902412|NCT03342404|588341463|FG000|Open-Label Phase|Lost to Follow-up|0|||
163053400|NCT02984982|588906429|FG001|Overall Study|Poor Compliance to Protocol|4|||
163053401|NCT02984982|588906428|FG000|Overall Study|Withdrawal by Subject|2|||
163053402|NCT02984982|588906429|FG001|Overall Study|Withdrawal by Subject|0|||
163053403|NCT02984982|588906428|FG000|Overall Study|Randomized but not treated|0|||
163053404|NCT02984982|588906429|FG001|Overall Study|Randomized but not treated|1|||
163053405|NCT02144701|588906430|FG000|Overall Study|development of relapse, GVHD or death|9|||
163053406|NCT02144701|588906431|FG001|Overall Study|development of relapse, GVHD or death|3|||
162902413|NCT03342404|588341464|FG001|Open-Label Phase|Lost to Follow-up|1|||
162902414|NCT03342404|588341463|FG000|Open-Label Phase|Other reasons|0|||
162902415|NCT03342404|588341464|FG001|Open-Label Phase|Other reasons|1|||
162902416|NCT03342404|588341463|FG000|Open-Label Phase|Adverse Event|0|||
162902417|NCT03342404|588341464|FG001|Open-Label Phase|Adverse Event|3|||
162902418|NCT03342404|588341463|FG000|Open-Label Phase|Withdrawal by Subject|0|||
162902419|NCT03342404|588341464|FG001|Open-Label Phase|Withdrawal by Subject|6|||
162902420|NCT00372489|588341470|FG000|Overall Study|Adverse Event|18|||
163053407|NCT03902613|588906442|FG000|Overall Study|Physician Decision|1|||
163053408|NCT04622969|588906447|FG000|Overall Study|Withdrawal by Subject|2|||
163053409|NCT04622969|588906448|FG001|Overall Study|Withdrawal by Subject|3|||
163053410|NCT04249427|588906451|FG000|Overall Study|Adverse Event|3|||
163053411|NCT04249427|588906452|FG001|Overall Study|Adverse Event|1|||
163053412|NCT04249427|588906451|FG000|Overall Study|Lack of Efficacy|0|||
163053413|NCT04249427|588906452|FG001|Overall Study|Lack of Efficacy|1|||
163053414|NCT04249427|588906451|FG000|Overall Study|Withdrawal by Subject|1|||
163053415|NCT04249427|588906452|FG001|Overall Study|Withdrawal by Subject|2|||
163053416|NCT01676012|588906457|FG000|Overall Study|Adverse Event|2|||
163053417|NCT01676012|588906457|FG000|Overall Study|incomplete set of videos|1|||
163053418|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
163053419|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
162902421|NCT00372489|588341470|FG000|Overall Study|Lack of Efficacy|1|||
162902422|NCT00372489|588341470|FG000|Overall Study|Lost to Follow-up|3|||
162902423|NCT00372489|588341470|FG000|Overall Study|Physician Decision|3|||
162902424|NCT00372489|588341470|FG000|Overall Study|Withdrawal by Subject|5|||
162902425|NCT00372489|588341470|FG000|Overall Study|Patient Relocation|2|||
162902426|NCT00372489|588341470|FG000|Overall Study|Renal transplant|6|||
162902427|NCT00372489|588341470|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
162902428|NCT00772889|588341471|FG000|Overall Study|Adverse Event|7|||
162902429|NCT00772889|588341472|FG001|Overall Study|Adverse Event|4|||
162902430|NCT00772889|588341473|FG002|Overall Study|Adverse Event|0|||
162902431|NCT00772889|588341471|FG000|Overall Study|Withdrawal by Subject|9|||
162966493|NCT03686215|588577945|FG001|Overall Study|Adverse Event|0|||
162966494|NCT03686215|588577946|FG002|Overall Study|Adverse Event|7|||
162966495|NCT03686215|588577944|FG000|Overall Study|Physician Decision|0|||
162966496|NCT03686215|588577945|FG001|Overall Study|Physician Decision|0|||
162966497|NCT03686215|588577946|FG002|Overall Study|Physician Decision|1|||
162902432|NCT00772889|588341472|FG001|Overall Study|Withdrawal by Subject|8|||
162902433|NCT00772889|588341473|FG002|Overall Study|Withdrawal by Subject|9|||
162902434|NCT00772889|588341471|FG000|Overall Study|Lost to Follow-up|6|||
162902435|NCT00772889|588341472|FG001|Overall Study|Lost to Follow-up|6|||
162902436|NCT00772889|588341473|FG002|Overall Study|Lost to Follow-up|7|||
162902437|NCT03323086|588341474|FG000|Overall Study|Lost to Follow-up|3|||
162902438|NCT03323086|588341475|FG001|Overall Study|Lost to Follow-up|2|||
162902439|NCT00355615|588341481|FG000|Randomized Double Blind Period|Adverse Event|1|||
162902440|NCT00355615|588341482|FG001|Randomized Double Blind Period|Adverse Event|0|||
162902441|NCT00355615|588341483|FG002|Randomized Double Blind Period|Adverse Event|0|||
162902442|NCT00355615|588341484|FG003|Randomized Double Blind Period|Adverse Event|0|||
162902443|NCT00355615|588341485|FG004|Randomized Double Blind Period|Adverse Event|0|||
162902444|NCT00355615|588341481|FG000|Randomized Double Blind Period|Protocol Violation|0|||
162902445|NCT00355615|588341482|FG001|Randomized Double Blind Period|Protocol Violation|0|||
162902446|NCT00355615|588341483|FG002|Randomized Double Blind Period|Protocol Violation|1|||
162902447|NCT00355615|588341484|FG003|Randomized Double Blind Period|Protocol Violation|1|||
162902448|NCT00355615|588341485|FG004|Randomized Double Blind Period|Protocol Violation|0|||
162902449|NCT00355615|588341481|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
162902450|NCT00355615|588341482|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
162902451|NCT00355615|588341483|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
162902452|NCT00355615|588341484|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
162902453|NCT00355615|588341485|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
162902454|NCT00355615|588341481|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
162902455|NCT00355615|588341482|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
162902456|NCT00355615|588341483|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
162902457|NCT00355615|588341484|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
162902458|NCT00355615|588341485|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
162902459|NCT00355615|588341481|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
162902460|NCT00355615|588341482|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
162902461|NCT00355615|588341483|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
162902462|NCT00355615|588341484|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
162902463|NCT00355615|588341485|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
162902464|NCT00355615|588341481|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
162902465|NCT00355615|588341482|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
162902466|NCT00355615|588341483|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
162902467|NCT00355615|588341484|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
162902468|NCT00355615|588341485|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
162902469|NCT04259346|588341486|FG000|Overall Study|Lost to Follow-up|1|||
162902470|NCT04259346|588341487|FG001|Overall Study|Lost to Follow-up|3|||
162902471|NCT04259346|588341486|FG000|Overall Study|Protocol Violation|1|||
162902472|NCT04259346|588341487|FG001|Overall Study|Protocol Violation|0|||
162902473|NCT04259346|588341486|FG000|Overall Study|Withdrawal by Subject|1|||
162902474|NCT04259346|588341487|FG001|Overall Study|Withdrawal by Subject|0|||
162902475|NCT04259346|588341486|FG000|Overall Study|Adverse Event|1|||
162902476|NCT04259346|588341487|FG001|Overall Study|Adverse Event|1|||
162966498|NCT03686215|588577944|FG000|Overall Study|Protocol Violation|0|||
162966499|NCT03686215|588577945|FG001|Overall Study|Protocol Violation|0|||
162966500|NCT03686215|588577946|FG002|Overall Study|Protocol Violation|4|||
162966501|NCT03686215|588577944|FG000|Overall Study|Device issue|1|||
162966502|NCT03686215|588577945|FG001|Overall Study|Device issue|0|||
162966503|NCT03686215|588577946|FG002|Overall Study|Device issue|2|||
162966504|NCT00202839|588577947|FG000|Overall Study|Adverse Event|1|||
162966505|NCT00202839|588577948|FG001|Overall Study|Adverse Event|5|||
162902477|NCT00085644|588341490|FG000|Double-Blind Period|Adverse Event|5|||
162902478|NCT00085644|588341491|FG001|Double-Blind Period|Adverse Event|2|||
162902479|NCT00085644|588341492|FG002|Double-Blind Period|Adverse Event|0|||
162966506|NCT00202839|588577947|FG000|Overall Study|Physician Decision|12|||
162966507|NCT00202839|588577948|FG001|Overall Study|Physician Decision|0|||
162966508|NCT00202839|588577947|FG000|Overall Study|Withdrawal by Subject|6|||
162966509|NCT00202839|588577948|FG001|Overall Study|Withdrawal by Subject|2|||
162902480|NCT00085644|588341490|FG000|Double-Blind Period|Withdrawal by Subject|3|||
162902481|NCT00085644|588341491|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162902482|NCT00085644|588341492|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162902483|NCT00085644|588341490|FG000|Double-Blind Period|Lost to Follow-up|2|||
162902484|NCT00085644|588341491|FG001|Double-Blind Period|Lost to Follow-up|1|||
162902485|NCT00085644|588341492|FG002|Double-Blind Period|Lost to Follow-up|0|||
162902486|NCT00085644|588341490|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
162902487|NCT00085644|588341491|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
162902488|NCT00085644|588341492|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
162902489|NCT00085644|588341490|FG000|Double-Blind Period|Contemplating pregnancy|1|||
163053420|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
162902490|NCT00085644|588341491|FG001|Double-Blind Period|Contemplating pregnancy|0|||
162902491|NCT00085644|588341492|FG002|Double-Blind Period|Contemplating pregnancy|0|||
162902492|NCT00085644|588341490|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
162902493|NCT00085644|588341491|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
162902494|NCT00085644|588341492|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
162902495|NCT00085644|588341490|FG000|Open-Label Period|Adverse Event|0|||
162902496|NCT00085644|588341491|FG001|Open-Label Period|Adverse Event|0|||
162902497|NCT00085644|588341492|FG002|Open-Label Period|Adverse Event|38|||
162902498|NCT00085644|588341490|FG000|Open-Label Period|Withdrawal by Subject|0|||
162902499|NCT00085644|588341491|FG001|Open-Label Period|Withdrawal by Subject|0|||
162902500|NCT00085644|588341492|FG002|Open-Label Period|Withdrawal by Subject|29|||
162902501|NCT00085644|588341490|FG000|Open-Label Period|Lost to Follow-up|0|||
162902502|NCT00085644|588341491|FG001|Open-Label Period|Lost to Follow-up|0|||
162902503|NCT00085644|588341492|FG002|Open-Label Period|Lost to Follow-up|13|||
162902504|NCT00085644|588341490|FG000|Open-Label Period|Lack of Efficacy|0|||
162902505|NCT00085644|588341491|FG001|Open-Label Period|Lack of Efficacy|0|||
162902506|NCT00085644|588341492|FG002|Open-Label Period|Lack of Efficacy|15|||
162902507|NCT00085644|588341490|FG000|Open-Label Period|Pregnancy|0|||
162902508|NCT00085644|588341491|FG001|Open-Label Period|Pregnancy|0|||
162902509|NCT00085644|588341492|FG002|Open-Label Period|Pregnancy|3|||
162902510|NCT00085644|588341490|FG000|Open-Label Period|Contemplating pregnancy|0|||
162902511|NCT00085644|588341491|FG001|Open-Label Period|Contemplating pregnancy|0|||
162902512|NCT00085644|588341492|FG002|Open-Label Period|Contemplating pregnancy|3|||
162902513|NCT00085644|588341490|FG000|Open-Label Period|Protocol Violation|0|||
162902514|NCT00085644|588341491|FG001|Open-Label Period|Protocol Violation|0|||
162902515|NCT00085644|588341492|FG002|Open-Label Period|Protocol Violation|4|||
162902516|NCT00085644|588341490|FG000|Open-Label Period|Personal reason|0|||
162902517|NCT00085644|588341491|FG001|Open-Label Period|Personal reason|0|||
162902518|NCT00085644|588341492|FG002|Open-Label Period|Personal reason|4|||
162902519|NCT03330106|588341500|FG000|Part A|Withdrawal by Subject|1|||
162902520|NCT03330106|588341501|FG001|Part A|Withdrawal by Subject|1|||
162902521|NCT03330106|588341502|FG002|Part A|Withdrawal by Subject|0|||
162902522|NCT03330106|588341503|FG003|Part A|Withdrawal by Subject|0|||
162902523|NCT03330106|588341500|FG000|Part A|Death|2|||
162902524|NCT03330106|588341501|FG001|Part A|Death|1|||
162902525|NCT03330106|588341502|FG002|Part A|Death|0|||
162902526|NCT03330106|588341503|FG003|Part A|Death|0|||
162902527|NCT03330106|588341500|FG000|Part A|Adverse Event|0|||
162902528|NCT03330106|588341501|FG001|Part A|Adverse Event|1|||
162902529|NCT03330106|588341502|FG002|Part A|Adverse Event|0|||
162902530|NCT03330106|588341503|FG003|Part A|Adverse Event|0|||
162902531|NCT03330106|588341500|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
162902532|NCT03330106|588341501|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
162902533|NCT03330106|588341502|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
162902534|NCT03330106|588341503|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
162902535|NCT03330106|588341500|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
162902536|NCT03330106|588341501|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
163053421|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
163053422|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
162902537|NCT03330106|588341502|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
163053423|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
163053424|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
163053425|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
162902538|NCT03330106|588341503|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
162902539|NCT03330106|588341500|FG000|Part A|Progressive Disease|0|||
162902540|NCT03330106|588341501|FG001|Part A|Progressive Disease|1|||
162902541|NCT03330106|588341502|FG002|Part A|Progressive Disease|0|||
162902542|NCT03330106|588341503|FG003|Part A|Progressive Disease|0|||
162902543|NCT03330106|588341500|FG000|Part B|Lost to Follow-up|0|||
162902544|NCT03330106|588341501|FG001|Part B|Lost to Follow-up|0|||
162902545|NCT03330106|588341502|FG002|Part B|Lost to Follow-up|0|||
162902546|NCT03330106|588341503|FG003|Part B|Lost to Follow-up|1|||
162902547|NCT03330106|588341500|FG000|Part B|Withdrawal by Subject|0|||
163053426|NCT02849080|588906458|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
162902548|NCT03330106|588341501|FG001|Part B|Withdrawal by Subject|0|||
162902549|NCT03330106|588341502|FG002|Part B|Withdrawal by Subject|4|||
162902550|NCT03330106|588341503|FG003|Part B|Withdrawal by Subject|0|||
162902551|NCT03330106|588341500|FG000|Part B|Death|0|||
162902552|NCT03330106|588341501|FG001|Part B|Death|0|||
162902553|NCT03330106|588341502|FG002|Part B|Death|2|||
162902554|NCT03330106|588341503|FG003|Part B|Death|0|||
162902555|NCT03330106|588341500|FG000|Part B|Clinical Progression|0|||
162902556|NCT03330106|588341501|FG001|Part B|Clinical Progression|0|||
162902557|NCT03330106|588341502|FG002|Part B|Clinical Progression|1|||
162902558|NCT03330106|588341503|FG003|Part B|Clinical Progression|1|||
162902559|NCT03330106|588341500|FG000|Part B|Symptomatic Deterioration|0|||
162902560|NCT03330106|588341501|FG001|Part B|Symptomatic Deterioration|0|||
162902561|NCT03330106|588341502|FG002|Part B|Symptomatic Deterioration|0|||
162902562|NCT03330106|588341503|FG003|Part B|Symptomatic Deterioration|1|||
162902563|NCT03330106|588341500|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
162902564|NCT03330106|588341501|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
162902565|NCT03330106|588341502|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
162902566|NCT03330106|588341503|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
162902567|NCT03330106|588341500|FG000|Part B|Progressive Disease|0|||
162902568|NCT03330106|588341501|FG001|Part B|Progressive Disease|0|||
162902569|NCT03330106|588341502|FG002|Part B|Progressive Disease|11|||
162902570|NCT03330106|588341503|FG003|Part B|Progressive Disease|4|||
162902571|NCT00623766|588341505|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
162902572|NCT00623766|588341506|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
162902573|NCT00623766|588341505|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
162902574|NCT00623766|588341506|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
163053427|NCT02849080|588906459|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
163053428|NCT02849080|588906460|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
162902575|NCT00623766|588341505|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
162902576|NCT00623766|588341506|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
162902577|NCT00623766|588341505|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
162902578|NCT00623766|588341506|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
162902579|NCT00623766|588341505|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
163053429|NCT02849080|588906461|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
163053430|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
163053431|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053432|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053433|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
163053434|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
163053435|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
163053436|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
163053437|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
163053438|NCT02849080|588906458|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
163053439|NCT02849080|588906459|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053440|NCT02849080|588906460|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053441|NCT02849080|588906461|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
163053442|NCT01819727|588906466|FG000|Overall Study|Adverse Event|8|||
163053443|NCT01819727|588906467|FG001|Overall Study|Adverse Event|9|||
163053444|NCT01819727|588906466|FG000|Overall Study|Death|1|||
163053445|NCT01819727|588906467|FG001|Overall Study|Death|0|||
163053446|NCT01819727|588906466|FG000|Overall Study|Lost to Follow-up|1|||
163053447|NCT01819727|588906467|FG001|Overall Study|Lost to Follow-up|1|||
163053448|NCT01819727|588906466|FG000|Overall Study|Physician Decision|3|||
163053449|NCT01819727|588906467|FG001|Overall Study|Physician Decision|2|||
163053450|NCT01819727|588906466|FG000|Overall Study|Pregnancy|1|||
163053451|NCT01819727|588906467|FG001|Overall Study|Pregnancy|0|||
163053452|NCT01819727|588906466|FG000|Overall Study|Protocol Violation|0|||
163053453|NCT01819727|588906467|FG001|Overall Study|Protocol Violation|2|||
163053454|NCT01819727|588906466|FG000|Overall Study|Study Terminated by Sponsor|0|||
163053455|NCT01819727|588906467|FG001|Overall Study|Study Terminated by Sponsor|1|||
163053456|NCT01819727|588906466|FG000|Overall Study|Withdrawal by Subject|6|||
163053457|NCT01819727|588906467|FG001|Overall Study|Withdrawal by Subject|11|||
163053458|NCT01819727|588906466|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
163053459|NCT01819727|588906467|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
163053460|NCT01819727|588906466|FG000|Overall Study|Quit due to lack of health benifits|0|||
162902580|NCT00623766|588341506|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
162902581|NCT00486889|588341508|FG000|Overall Study|Death|3|||
162902582|NCT00486889|588341508|FG000|Overall Study|Non-compliant|2|||
162902583|NCT00486889|588341508|FG000|Overall Study|Withdrawal by Subject|6|||
163053461|NCT01819727|588906467|FG001|Overall Study|Quit due to lack of health benifits|1|||
163053462|NCT02155985|588906474|FG000|Overall Study|Withdrawal by Subject|0|||
163053463|NCT02155985|588906475|FG001|Overall Study|Withdrawal by Subject|0|||
163053464|NCT02155985|588906476|FG002|Overall Study|Withdrawal by Subject|1|||
163053465|NCT02155985|588906474|FG000|Overall Study|Lost to Follow-up|1|||
163053466|NCT02155985|588906475|FG001|Overall Study|Lost to Follow-up|0|||
163053467|NCT02155985|588906476|FG002|Overall Study|Lost to Follow-up|0|||
163053468|NCT00402727|588906477|FG000|Overall Study|Adverse Event|10|||
163053469|NCT00402727|588906478|FG001|Overall Study|Adverse Event|6|||
163053470|NCT00402727|588906477|FG000|Overall Study|Death|1|||
163053471|NCT00402727|588906478|FG001|Overall Study|Death|0|||
163053472|NCT00402727|588906477|FG000|Overall Study|Lack of Efficacy|1|||
163053473|NCT00402727|588906478|FG001|Overall Study|Lack of Efficacy|3|||
163053474|NCT00402727|588906477|FG000|Overall Study|Lost to Follow-up|24|||
163053475|NCT00402727|588906478|FG001|Overall Study|Lost to Follow-up|11|||
163053476|NCT00402727|588906477|FG000|Overall Study|Physician Decision|1|||
163053477|NCT00402727|588906478|FG001|Overall Study|Physician Decision|1|||
163053478|NCT00402727|588906477|FG000|Overall Study|Protocol Violation|0|||
163053479|NCT00402727|588906478|FG001|Overall Study|Protocol Violation|4|||
163053480|NCT00402727|588906477|FG000|Overall Study|Withdrawal by Subject|3|||
163053481|NCT00402727|588906478|FG001|Overall Study|Withdrawal by Subject|7|||
163053482|NCT00402727|588906477|FG000|Overall Study|supply problems|2|||
163053483|NCT00402727|588906478|FG001|Overall Study|supply problems|1|||
163053484|NCT00402727|588906477|FG000|Overall Study|non-compliance|0|||
163053485|NCT00402727|588906478|FG001|Overall Study|non-compliance|1|||
163053486|NCT00732069|588906479|FG000|Washout After First Study Drug|Adverse Event|1|||
163053487|NCT00732069|588906480|FG001|Washout After First Study Drug|Adverse Event|0|||
163053488|NCT00732069|588906481|FG002|Washout After First Study Drug|Adverse Event|0|||
163053489|NCT00732069|588906482|FG003|Washout After First Study Drug|Adverse Event|0|||
163053490|NCT00732069|588906483|FG004|Washout After First Study Drug|Adverse Event|0|||
163053491|NCT00732069|588906484|FG005|Washout After First Study Drug|Adverse Event|0|||
163053492|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Early discharge|5|||
163053493|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Early discharge|5|||
163053494|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
163053495|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
163053496|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
163053497|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
163053498|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
163053499|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
163053500|NCT04460326|588906485|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
163053501|NCT04460326|588906486|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
163053502|NCT04460326|588906485|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
163053503|NCT04460326|588906486|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
163053504|NCT00577317|588906487|FG000|Overall Study|Study Terminated|0|||
163053505|NCT00577317|588906488|FG001|Overall Study|Study Terminated|2|||
163053506|NCT03372798|588906489|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
163053507|NCT03372798|588906490|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
163053508|NCT03372798|588906489|FG000|Overall Study|Failure of imaging probe|0|||
163053509|NCT03372798|588906490|FG001|Overall Study|Failure of imaging probe|1|||
163053510|NCT04794751|588906492|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
163053511|NCT04794751|588906493|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
163053512|NCT04794751|588906492|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
163053513|NCT04794751|588906493|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
163053514|NCT04794751|588906492|FG000|Period 1|Protocol Violation|0|||
163053515|NCT04794751|588906493|FG001|Period 1|Protocol Violation|2|||
163053516|NCT04794751|588906492|FG000|Period 1|Withdrawal by Subject|0|||
163053517|NCT04794751|588906493|FG001|Period 1|Withdrawal by Subject|1|||
163053518|NCT04794751|588906492|FG000|Period 2|Withdrawal by Subject|0|||
163053519|NCT04794751|588906493|FG001|Period 2|Withdrawal by Subject|1|||
163053520|NCT04794751|588906492|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
163053521|NCT04794751|588906493|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
163053522|NCT04794751|588906492|FG000|Period 2|Protocol Violation|1|||
163053523|NCT04794751|588906493|FG001|Period 2|Protocol Violation|0|||
163053524|NCT01405898|588906496|FG000|Overall Study|Withdrawal by Subject|2|||
163053525|NCT01405898|588906497|FG001|Overall Study|Withdrawal by Subject|2|||
163053526|NCT02283658|588906498|FG000|Overall Study|Withdrawal by Subject|1|||
163053527|NCT01687218|588906499|FG000|Overall Study|Withdrawal by Subject|2|||
163053528|NCT01687218|588906500|FG001|Overall Study|Withdrawal by Subject|3|||
163053529|NCT01687218|588906501|FG002|Overall Study|Withdrawal by Subject|0|||
163053530|NCT01687218|588906502|FG003|Overall Study|Withdrawal by Subject|1|||
163053531|NCT01687218|588906503|FG004|Overall Study|Withdrawal by Subject|1|||
163053532|NCT01687218|588906504|FG005|Overall Study|Withdrawal by Subject|0|||
163053533|NCT01687218|588906499|FG000|Overall Study|Relocated, no follow-up planned|1|||
163053534|NCT01687218|588906500|FG001|Overall Study|Relocated, no follow-up planned|0|||
163053535|NCT01687218|588906501|FG002|Overall Study|Relocated, no follow-up planned|1|||
163053536|NCT01687218|588906502|FG003|Overall Study|Relocated, no follow-up planned|1|||
163053537|NCT01687218|588906503|FG004|Overall Study|Relocated, no follow-up planned|0|||
163053538|NCT01687218|588906504|FG005|Overall Study|Relocated, no follow-up planned|0|||
163053539|NCT03608826|588906506|FG000|Overall Study|Death|3|||
162902584|NCT02750501|588341509|FG000|Overall Study|Adverse Event|4|||
162902585|NCT02750501|588341509|FG000|Overall Study|Physician Decision|1|||
162902586|NCT02750501|588341509|FG000|Overall Study|Protocol Violation|1|||
162902587|NCT02750501|588341509|FG000|Overall Study|G-tube came out|1|||
162902588|NCT02750501|588341509|FG000|Overall Study|Non-compliant use of PERT|1|||
162902589|NCT00893763|588341510|FG000|Overall Study|extubated|110|||
162902590|NCT00893763|588341511|FG001|Overall Study|extubated|110|||
162902591|NCT01738594|588341512|FG000|Registration and Treatment Start|Adverse Event|0|||
162902592|NCT01738594|588341513|FG001|Registration and Treatment Start|Adverse Event|1|||
162902593|NCT01738594|588341514|FG002|Registration and Treatment Start|Adverse Event|0|||
162902594|NCT01738594|588341515|FG003|Registration and Treatment Start|Adverse Event|0|||
162902595|NCT01738594|588341516|FG004|Registration and Treatment Start|Adverse Event|0|||
162902596|NCT01738594|588341517|FG005|Registration and Treatment Start|Adverse Event|0|||
162902597|NCT01738594|588341518|FG006|Registration and Treatment Start|Adverse Event|0|||
162902598|NCT01738594|588341519|FG007|Registration and Treatment Start|Adverse Event|0|||
162902599|NCT01738594|588341512|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902600|NCT01738594|588341513|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902601|NCT01738594|588341514|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902602|NCT01738594|588341515|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902603|NCT01738594|588341516|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902604|NCT01738594|588341517|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
162902605|NCT01738594|588341518|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902606|NCT01738594|588341519|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
162902607|NCT01738594|588341512|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902608|NCT01738594|588341513|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
162902609|NCT01738594|588341514|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902610|NCT01738594|588341515|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902611|NCT01738594|588341516|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902612|NCT01738594|588341517|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902613|NCT01738594|588341518|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902614|NCT01738594|588341519|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
162902615|NCT01738594|588341512|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902616|NCT01738594|588341513|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902617|NCT01738594|588341514|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902618|NCT01738594|588341515|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902619|NCT01738594|588341516|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902620|NCT01738594|588341517|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
162902621|NCT01738594|588341518|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902622|NCT01738594|588341519|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
162902623|NCT01738594|588341512|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902624|NCT01738594|588341513|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902625|NCT01738594|588341514|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902626|NCT01738594|588341515|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902627|NCT01738594|588341516|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902628|NCT01738594|588341517|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
162902629|NCT01738594|588341518|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902630|NCT01738594|588341519|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
162902631|NCT01738594|588341512|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902632|NCT01738594|588341513|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902633|NCT01738594|588341514|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902634|NCT01738594|588341515|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902635|NCT01738594|588341516|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
162902636|NCT01738594|588341517|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902637|NCT01738594|588341518|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902638|NCT01738594|588341519|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
162902639|NCT01738594|588341512|FG000|Follow up for 1 Year|Death|0|||
162902640|NCT01738594|588341513|FG001|Follow up for 1 Year|Death|0|||
162902641|NCT01738594|588341514|FG002|Follow up for 1 Year|Death|0|||
162625999|NCT03766581|587346965|FG002|Treatment|Participant request to discontinue treatment|10|||
162626000|NCT03766581|587346966|FG003|Treatment|Participant request to discontinue treatment|10|||
162626001|NCT03766581|587346967|FG004|Treatment|Participant request to discontinue treatment|14|||
162626002|NCT03766581|587346968|FG005|Treatment|Participant request to discontinue treatment|15|||
162626003|NCT03766581|587346969|FG006|Treatment|Participant request to discontinue treatment|0|||
162626004|NCT03766581|587346970|FG007|Treatment|Participant request to discontinue treatment|1|||
162626005|NCT03766581|587346963|FG000|Treatment|Participant withdrew consent|11|||
162626006|NCT03766581|587346964|FG001|Treatment|Participant withdrew consent|4|||
162626007|NCT03766581|587346965|FG002|Treatment|Participant withdrew consent|5|||
162902642|NCT01738594|588341515|FG003|Follow up for 1 Year|Death|0|||
162902643|NCT01738594|588341516|FG004|Follow up for 1 Year|Death|0|||
162902644|NCT01738594|588341517|FG005|Follow up for 1 Year|Death|1|||
162902645|NCT01738594|588341518|FG006|Follow up for 1 Year|Death|0|||
162626008|NCT03766581|587346966|FG003|Treatment|Participant withdrew consent|5|||
162626009|NCT03766581|587346967|FG004|Treatment|Participant withdrew consent|4|||
162626010|NCT03766581|587346968|FG005|Treatment|Participant withdrew consent|4|||
162626011|NCT03766581|587346969|FG006|Treatment|Participant withdrew consent|0|||
162626012|NCT03766581|587346970|FG007|Treatment|Participant withdrew consent|0|||
162626013|NCT03766581|587346963|FG000|Treatment|Death|1|||
162626014|NCT03766581|587346964|FG001|Treatment|Death|0|||
162626015|NCT03766581|587346965|FG002|Treatment|Death|0|||
162626016|NCT03766581|587346966|FG003|Treatment|Death|0|||
162902646|NCT01738594|588341519|FG007|Follow up for 1 Year|Death|0|||
162902647|NCT01738594|588341512|FG000|Follow up for 1 Year|Other|0|||
162902648|NCT01738594|588341513|FG001|Follow up for 1 Year|Other|0|||
162902649|NCT01738594|588341514|FG002|Follow up for 1 Year|Other|0|||
162902650|NCT01738594|588341515|FG003|Follow up for 1 Year|Other|0|||
162902651|NCT01738594|588341516|FG004|Follow up for 1 Year|Other|0|||
162902652|NCT01738594|588341517|FG005|Follow up for 1 Year|Other|2|||
162902653|NCT01738594|588341518|FG006|Follow up for 1 Year|Other|0|||
162902654|NCT01738594|588341519|FG007|Follow up for 1 Year|Other|0|||
162902655|NCT00796549|588341520|FG000|Overall Study|Adverse Event|11|||
162902656|NCT00796549|588341520|FG000|Overall Study|not entered|149|||
162902657|NCT00796549|588341520|FG000|Overall Study|Other|2|||
162902658|NCT00796549|588341520|FG000|Overall Study|Progressive disease|56|||
162902659|NCT04430036|588341522|FG000|Safety Run in Phase|Progression of disease|2|||
162902660|NCT04107935|588341523|FG000|Overall Study|Death|1|||
162902661|NCT04107935|588341524|FG001|Overall Study|Death|0|||
162902662|NCT01842334|588341525|FG000|Overall Study|Withdrawal by Subject|3|||
162902663|NCT01842334|588341526|FG001|Overall Study|Withdrawal by Subject|3|||
162902664|NCT01842334|588341525|FG000|Overall Study|Moved away mid-study|0|||
162902665|NCT01842334|588341526|FG001|Overall Study|Moved away mid-study|1|||
162902666|NCT00376675|588341527|FG000|Overall Study|Withdrawal by Subject|9|||
162902667|NCT00376675|588341528|FG001|Overall Study|Withdrawal by Subject|2|||
162902668|NCT00376675|588341527|FG000|Overall Study|Adverse Event|10|||
162902669|NCT00376675|588341528|FG001|Overall Study|Adverse Event|5|||
162902670|NCT00376675|588341527|FG000|Overall Study|Other Reason|1|||
162902671|NCT00376675|588341528|FG001|Overall Study|Other Reason|7|||
162902672|NCT02201472|588341532|FG000|Overall Study|Lack of Efficacy|2|||
162902673|NCT01300767|588341533|FG000|Overall Study|Discomfort|2|||
162902674|NCT01300767|588341533|FG000|Overall Study|Biomicroscopy|1|||
162902675|NCT01300767|588341533|FG000|Overall Study|Unacceptable fit|1|||
162902676|NCT00959699|588341534|FG000|Treatment Period|Adverse Event|3|||
162902677|NCT00959699|588341535|FG001|Treatment Period|Adverse Event|13|||
162902678|NCT00959699|588341534|FG000|Treatment Period|Lack of Efficacy|15|||
162902679|NCT00959699|588341535|FG001|Treatment Period|Lack of Efficacy|6|||
162902680|NCT00959699|588341534|FG000|Treatment Period|Lost to Follow-up|0|||
162902681|NCT00959699|588341535|FG001|Treatment Period|Lost to Follow-up|1|||
162902682|NCT00959699|588341534|FG000|Treatment Period|Withdrawal by Subject|1|||
162966510|NCT00202839|588577947|FG000|Overall Study|Protocol Violation|2|||
162966511|NCT00202839|588577948|FG001|Overall Study|Protocol Violation|1|||
162966512|NCT00202839|588577947|FG000|Overall Study|Lost to Follow-up|3|||
162966513|NCT00202839|588577948|FG001|Overall Study|Lost to Follow-up|2|||
162966514|NCT01662024|588577951|FG000|Overall Study|Pregnancy|2|||
162966515|NCT01662024|588577951|FG000|Overall Study|Withdrawal by Subject|3|||
162966516|NCT01490190|588577955|FG000|Overall Study|Withdrawal by Subject|9|||
162966517|NCT01490190|588577955|FG000|Overall Study|Adverse Event|17|||
162966518|NCT01490190|588577955|FG000|Overall Study|Protocol Violation|5|||
162966519|NCT01490190|588577955|FG000|Overall Study|Lost to Follow-up|13|||
162966520|NCT01490190|588577955|FG000|Overall Study|Relocation|1|||
162966521|NCT01490190|588577955|FG000|Overall Study|Inconvenience|1|||
162966522|NCT01490190|588577955|FG000|Overall Study|Ring expulsion|2|||
162966523|NCT00063258|588577958|FG000|Overall Study|Physician Decision|2|||
162966524|NCT00063258|588577959|FG001|Overall Study|Physician Decision|0|||
162966525|NCT00063258|588577958|FG000|Overall Study|Lack of Efficacy|2|||
162966526|NCT00063258|588577959|FG001|Overall Study|Lack of Efficacy|0|||
162966527|NCT03988608|588577960|FG000|Overall Study|Adverse Event|1|||
162966528|NCT03988608|588577960|FG000|Overall Study|Lost to Follow-up|1|||
162966529|NCT03988608|588577960|FG000|Overall Study|Withdrawal by Subject|3|||
162902683|NCT00959699|588341535|FG001|Treatment Period|Withdrawal by Subject|3|||
162902684|NCT00959699|588341534|FG000|Treatment Period|Non-Compliance with Protocol|0|||
162902685|NCT00959699|588341535|FG001|Treatment Period|Non-Compliance with Protocol|1|||
162902686|NCT00959699|588341534|FG000|Treatment Period|Did not receive treatment|0|||
162902687|NCT00959699|588341535|FG001|Treatment Period|Did not receive treatment|1|||
162902688|NCT00959699|588341534|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
162902689|NCT00959699|588341535|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
162902690|NCT00959699|588341534|FG000|Follow-up Period|Lost to Follow-up|3|||
162902691|NCT00959699|588341535|FG001|Follow-up Period|Lost to Follow-up|2|||
162902692|NCT00959699|588341534|FG000|Follow-up Period|Withdrawal by Subject|3|||
162902693|NCT00959699|588341535|FG001|Follow-up Period|Withdrawal by Subject|4|||
162902694|NCT03924427|588341536|FG000|Overall Study|Adverse Event|4|||
162902695|NCT03924427|588341536|FG000|Overall Study|Lack of Efficacy|1|||
162902696|NCT03924427|588341536|FG000|Overall Study|Withdrawal by Subject|1|||
162902697|NCT00609167|588341539|FG000|Overall Study|Withdrawal by Subject|1|||
162902698|NCT00609167|588341540|FG001|Overall Study|Withdrawal by Subject|0|||
162902699|NCT00609167|588341539|FG000|Overall Study|Lack of Efficacy|1|||
162902700|NCT00609167|588341540|FG001|Overall Study|Lack of Efficacy|0|||
162902701|NCT00609167|588341539|FG000|Overall Study|Adverse Event|5|||
162902702|NCT00609167|588341540|FG001|Overall Study|Adverse Event|1|||
162902703|NCT00609167|588341539|FG000|Overall Study|Disease Progression|1|||
162902704|NCT00609167|588341540|FG001|Overall Study|Disease Progression|0|||
162902705|NCT00609167|588341539|FG000|Overall Study|Stem Cell Transplant|0|||
162902706|NCT00609167|588341540|FG001|Overall Study|Stem Cell Transplant|6|||
162902707|NCT00712270|588341541|FG000|Overall Study|Withdrawal by Subject|11|||
162902708|NCT00712270|588341541|FG000|Overall Study|Screen Failure|3|||
162902709|NCT04412668|588341542|FG000|Overall Study|Death - multiple comorbidities|2|||
162902710|NCT04412668|588341543|FG001|Overall Study|Death - multiple comorbidities|0|||
162902711|NCT04412668|588341544|FG002|Overall Study|Death - multiple comorbidities|0|||
162902712|NCT04412668|588341542|FG000|Overall Study|Withdrawal by Subject|3|||
162902713|NCT04412668|588341543|FG001|Overall Study|Withdrawal by Subject|0|||
162902714|NCT04412668|588341544|FG002|Overall Study|Withdrawal by Subject|0|||
162902715|NCT04412668|588341542|FG000|Overall Study|Other than Specified|2|||
162902716|NCT04412668|588341543|FG001|Overall Study|Other than Specified|0|||
162902717|NCT04412668|588341544|FG002|Overall Study|Other than Specified|0|||
162902718|NCT03864627|588341545|FG000|Overall Study|Adverse Event|0|||
162902719|NCT03864627|588341546|FG001|Overall Study|Adverse Event|1|||
162902720|NCT03864627|588341545|FG000|Overall Study|Lack of Efficacy|0|||
162902721|NCT03864627|588341546|FG001|Overall Study|Lack of Efficacy|1|||
162902722|NCT03864627|588341545|FG000|Overall Study|Lost to Follow-up|0|||
162902723|NCT03864627|588341546|FG001|Overall Study|Lost to Follow-up|1|||
162902724|NCT03864627|588341545|FG000|Overall Study|Withdrawal by Subject|4|||
162902725|NCT03864627|588341546|FG001|Overall Study|Withdrawal by Subject|8|||
162902726|NCT03864627|588341545|FG000|Overall Study|Study terminated by sponsor|0|||
162902727|NCT03864627|588341546|FG001|Overall Study|Study terminated by sponsor|1|||
162902728|NCT01388491|588341547|FG000|Overall Study|Adverse Event|10|||
162902729|NCT01388491|588341548|FG001|Overall Study|Adverse Event|9|||
162902730|NCT01388491|588341547|FG000|Overall Study|Sponsor Request|9|||
162902731|NCT01388491|588341548|FG001|Overall Study|Sponsor Request|7|||
162902732|NCT01388491|588341547|FG000|Overall Study|Withdrawal by Subject|6|||
162902733|NCT01388491|588341548|FG001|Overall Study|Withdrawal by Subject|10|||
162902734|NCT01388491|588341547|FG000|Overall Study|Lost to Follow-up|4|||
162902735|NCT01388491|588341548|FG001|Overall Study|Lost to Follow-up|3|||
162902736|NCT01388491|588341547|FG000|Overall Study|Protocol Violation|2|||
162902737|NCT01388491|588341548|FG001|Overall Study|Protocol Violation|0|||
162902738|NCT01388491|588341547|FG000|Overall Study|Noncompliance|2|||
162902739|NCT01388491|588341548|FG001|Overall Study|Noncompliance|0|||
162902740|NCT01388491|588341547|FG000|Overall Study|Pregnancy|1|||
162902741|NCT01388491|588341548|FG001|Overall Study|Pregnancy|0|||
162902742|NCT00112840|588341549|FG000|Overall Study|Physician Decision|1|||
162902743|NCT00112840|588341550|FG001|Overall Study|Physician Decision|0|||
162902744|NCT00112840|588341551|FG002|Overall Study|Physician Decision|0|||
162902745|NCT00112840|588341549|FG000|Overall Study|Withdrawal by Subject|1|||
162902746|NCT00112840|588341550|FG001|Overall Study|Withdrawal by Subject|0|||
162966530|NCT03988608|588577960|FG000|Overall Study|Death|1|||
162966531|NCT01456962|588577970|FG000|Overall Study|Lost to Follow-up|2|||
162902747|NCT00112840|588341551|FG002|Overall Study|Withdrawal by Subject|1|||
162902748|NCT00112840|588341549|FG000|Overall Study|Protocol Violation|0|||
162902749|NCT00112840|588341550|FG001|Overall Study|Protocol Violation|0|||
162902750|NCT00112840|588341551|FG002|Overall Study|Protocol Violation|5|||
162902751|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
162902752|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
162902753|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
162902754|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
162902755|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Other|13|||
162966532|NCT01456962|588577971|FG001|Overall Study|Lost to Follow-up|1|||
162966533|NCT02483416|588577972|FG000|Overall Study|Other reason|0|||
163053540|NCT03608826|588906506|FG000|Overall Study|Heart Transplant|3|||
163053541|NCT03608826|588906506|FG000|Overall Study|Physician Decision|4|||
163053542|NCT00875810|588906521|FG000|Overall Study|Withdrawal by Subject|1|||
163053543|NCT00875810|588906521|FG000|Overall Study|Physician Decision|3|||
163053544|NCT00875810|588906521|FG000|Overall Study|Lost to Follow-up|39|||
163053545|NCT00875810|588906521|FG000|Overall Study|Patient enroled but not implanted|2|||
163053546|NCT00875810|588906521|FG000|Overall Study|Device explanted|1|||
163053547|NCT03644017|588906525|FG000|Overall Study|Access Abandonment|5|||
163053548|NCT03644017|588906525|FG000|Overall Study|Kidney Transplant|2|||
163053549|NCT02175225|588906526|FG000|Overall Study|Withdrawal by Subject|1|||
163053550|NCT02175225|588906527|FG001|Overall Study|Withdrawal by Subject|2|||
163053551|NCT02175225|588906526|FG000|Overall Study|Lost to Follow-up|6|||
163053552|NCT02175225|588906527|FG001|Overall Study|Lost to Follow-up|7|||
163053553|NCT02175225|588906526|FG000|Overall Study|Study drug not administered|1|||
163053554|NCT02175225|588906527|FG001|Overall Study|Study drug not administered|2|||
163053555|NCT03106077|588906528|FG000|Overall Study|Screen Failure|94|||
163053556|NCT03106077|588906529|FG001|Overall Study|Screen Failure|0|||
163053557|NCT02008526|588906530|FG000|Overall Study|Death|0|||
163053558|NCT02008526|588906531|FG001|Overall Study|Death|2|||
163053559|NCT02008526|588906532|FG002|Overall Study|Death|1|||
163053560|NCT02008526|588906530|FG000|Overall Study|Withdrawal by Subject|3|||
163053561|NCT02008526|588906531|FG001|Overall Study|Withdrawal by Subject|3|||
163053562|NCT02008526|588906532|FG002|Overall Study|Withdrawal by Subject|2|||
163053563|NCT02008526|588906530|FG000|Overall Study|Lost to Follow-up|5|||
163053564|NCT02008526|588906531|FG001|Overall Study|Lost to Follow-up|9|||
163053565|NCT02008526|588906532|FG002|Overall Study|Lost to Follow-up|6|||
163053566|NCT01305564|588906535|FG000|Overall Study|Death|21|||
163053567|NCT01305564|588906535|FG000|Overall Study|Lost to Follow-up|12|||
163053568|NCT01305564|588906535|FG000|Overall Study|Withdrawal by Subject|1|||
163053569|NCT01305564|588906535|FG000|Overall Study|Physician Decision|3|||
163053570|NCT01190813|588906536|FG000|Overall Study|Lost to Follow-up|1|||
163053571|NCT01190813|588906537|FG001|Overall Study|Lost to Follow-up|2|||
163053572|NCT01190813|588906536|FG000|Overall Study|Withdrawal by Subject|2|||
163053573|NCT01190813|588906537|FG001|Overall Study|Withdrawal by Subject|1|||
163053574|NCT01190813|588906536|FG000|Overall Study|Refused study treatment after randomized|1|||
163053575|NCT01190813|588906537|FG001|Overall Study|Refused study treatment after randomized|0|||
163053576|NCT01190813|588906536|FG000|Overall Study|Adverse Event|0|||
163053577|NCT01190813|588906537|FG001|Overall Study|Adverse Event|1|||
163053578|NCT03810456|588906538|FG000|Treatment|Urgent Family Matters|3|||
163053579|NCT03810456|588906539|FG001|Treatment|Urgent Family Matters|0|||
163053580|NCT03810456|588906540|FG002|Treatment|Urgent Family Matters|0|||
163053581|NCT03810456|588906538|FG000|Treatment|Scheduling Conflicts|0|||
162626017|NCT03766581|587346967|FG004|Treatment|Death|0|||
162626018|NCT03766581|587346968|FG005|Treatment|Death|0|||
162626019|NCT03766581|587346969|FG006|Treatment|Death|0|||
162626020|NCT03766581|587346970|FG007|Treatment|Death|0|||
162626021|NCT03766581|587346963|FG000|Treatment|Lost to Follow-up|1|||
162902756|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
162902757|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
162902758|NCT02497287|588341552|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
162902759|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
162902760|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
162902761|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
162902762|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
162626022|NCT03766581|587346964|FG001|Treatment|Lost to Follow-up|0|||
162626023|NCT03766581|587346965|FG002|Treatment|Lost to Follow-up|0|||
162902763|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
162902764|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
162902765|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
162902766|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
162902767|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
162902768|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
162902769|NCT02497287|588341552|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
162902770|NCT02497287|588341552|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
162902771|NCT02497287|588341552|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
162902772|NCT02497287|588341552|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
162902773|NCT02497287|588341552|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
162902774|NCT02497287|588341552|FG000|Follow-up Phase (4 Week)|Other|1|||
162902775|NCT03128307|588341556|FG000|Overall Study|Lost to Follow-up|29|||
162902776|NCT03128307|588341556|FG000|Overall Study|Withdrawal by Subject|5|||
162626024|NCT03766581|587346966|FG003|Treatment|Lost to Follow-up|1|||
162626025|NCT03766581|587346967|FG004|Treatment|Lost to Follow-up|0|||
162626026|NCT03766581|587346968|FG005|Treatment|Lost to Follow-up|0|||
162626027|NCT03766581|587346969|FG006|Treatment|Lost to Follow-up|0|||
162902777|NCT01592773|588342871|FG000|Overall Study|Study Terminated by Sponsor|582|||
163053582|NCT03810456|588906539|FG001|Treatment|Scheduling Conflicts|11|||
162626028|NCT03766581|587346970|FG007|Treatment|Lost to Follow-up|0|||
162626029|NCT03766581|587346963|FG000|Treatment|Poor/Non compliance|2|||
162626030|NCT03766581|587346964|FG001|Treatment|Poor/Non compliance|2|||
162626031|NCT03766581|587346965|FG002|Treatment|Poor/Non compliance|1|||
162626032|NCT03766581|587346966|FG003|Treatment|Poor/Non compliance|1|||
162626033|NCT03766581|587346967|FG004|Treatment|Poor/Non compliance|1|||
162626034|NCT03766581|587346968|FG005|Treatment|Poor/Non compliance|1|||
162626035|NCT03766581|587346969|FG006|Treatment|Poor/Non compliance|0|||
162902778|NCT01592773|588342871|FG000|Overall Study|Withdrawal by Subject|35|||
162902779|NCT01592773|588342871|FG000|Overall Study|Lost to Follow-up|19|||
162902780|NCT01592773|588342871|FG000|Overall Study|Adverse Event|17|||
162902781|NCT01592773|588342871|FG000|Overall Study|Lack of Efficacy|9|||
162902782|NCT01592773|588342871|FG000|Overall Study|Protocol Violation|2|||
162902783|NCT01592773|588342871|FG000|Overall Study|Inclusion/exclusion not meet|1|||
162902784|NCT01592773|588342871|FG000|Overall Study|Other Reason|1|||
162902785|NCT00121485|588342872|FG000|Overall Study|Not implanted|1|||
162902786|NCT00121485|588342873|FG001|Overall Study|Not implanted|5|||
162902787|NCT00121485|588342872|FG000|Overall Study|Crossover|0|||
162902788|NCT00121485|588342873|FG001|Overall Study|Crossover|2|||
162902789|NCT04124952|588342875|FG000|Overall Study|Lost to Follow-up|1|||
162902790|NCT02145429|588342876|FG000|Overall Study|Death|4|||
162902791|NCT02145429|588342877|FG001|Overall Study|Death|5|||
162902792|NCT02145429|588342876|FG000|Overall Study|Lost to Follow-up|4|||
162902793|NCT02145429|588342877|FG001|Overall Study|Lost to Follow-up|3|||
162902794|NCT02145429|588342876|FG000|Overall Study|Withdrawal by Subject|8|||
162902795|NCT02145429|588342877|FG001|Overall Study|Withdrawal by Subject|3|||
162966534|NCT02483416|588577973|FG001|Overall Study|Other reason|1|||
162966535|NCT02483416|588577972|FG000|Overall Study|Treatment stop|3|||
162966536|NCT02483416|588577973|FG001|Overall Study|Treatment stop|0|||
162966537|NCT03387462|588577975|FG000|Overall Study|Lost to Follow-up|1|||
162966538|NCT01460628|588577976|FG000|Overall Study|Adverse Event|3|||
162966539|NCT01460628|588577976|FG000|Overall Study|Withdrawal by Subject|2|||
162966540|NCT00210639|588577978|FG000|Overall Study|Lost to Follow-up|37|||
163053583|NCT03810456|588906540|FG002|Treatment|Scheduling Conflicts|0|||
163053584|NCT03810456|588906538|FG000|Treatment|No Longer Interested|0|||
163053585|NCT03810456|588906539|FG001|Treatment|No Longer Interested|12|||
163053586|NCT03810456|588906540|FG002|Treatment|No Longer Interested|0|||
163053587|NCT03810456|588906538|FG000|Treatment|Transportation Issues|0|||
163053588|NCT03810456|588906539|FG001|Treatment|Transportation Issues|1|||
163053589|NCT03810456|588906540|FG002|Treatment|Transportation Issues|0|||
163053590|NCT03810456|588906538|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
163053591|NCT03810456|588906539|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
163053592|NCT03810456|588906540|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
163053593|NCT03810456|588906538|FG000|1 Month Follow-Up|Relocated to Different State|1|||
163053594|NCT03810456|588906539|FG001|1 Month Follow-Up|Relocated to Different State|0|||
163053595|NCT03810456|588906540|FG002|1 Month Follow-Up|Relocated to Different State|1|||
163053596|NCT03810456|588906538|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
163053597|NCT03810456|588906539|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
163053598|NCT03810456|588906540|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
163053599|NCT03810456|588906538|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
163053600|NCT03810456|588906539|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
163053601|NCT03810456|588906540|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
163053602|NCT03810456|588906538|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
162626036|NCT03766581|587346970|FG007|Treatment|Poor/Non compliance|0|||
162966541|NCT00210639|588577979|FG001|Overall Study|Lost to Follow-up|29|||
162966542|NCT00210639|588577978|FG000|Overall Study|Withdrawal by Subject|8|||
162966543|NCT00210639|588577979|FG001|Overall Study|Withdrawal by Subject|1|||
162966544|NCT00210639|588577978|FG000|Overall Study|Other|18|||
162966545|NCT00210639|588577979|FG001|Overall Study|Other|12|||
162966546|NCT01559116|588578003|FG000|Overall Study|Adverse Event|10|||
162966547|NCT01559116|588578003|FG000|Overall Study|Lack of Efficacy|1|||
162966548|NCT01559116|588578003|FG000|Overall Study|Lost to Follow-up|1|||
163053603|NCT03810456|588906539|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
163053604|NCT03810456|588906540|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
163053605|NCT03810456|588906538|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
163053606|NCT03810456|588906539|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
163053607|NCT03810456|588906540|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
162902796|NCT00081263|588342878|FG000|Overall Study|clerical error|1|||
162902797|NCT00081263|588342879|FG001|Overall Study|clerical error|0|||
162902798|NCT00081263|588342878|FG000|Overall Study|wrong cell type|7|||
162902799|NCT00081263|588342879|FG001|Overall Study|wrong cell type|5|||
162902800|NCT00081263|588342878|FG000|Overall Study|improper pre-protocol therapy|0|||
162966549|NCT01559116|588578003|FG000|Overall Study|Protocol Violation|1|||
162966550|NCT01559116|588578003|FG000|Overall Study|Withdrawal by Subject|4|||
162966551|NCT01559116|588578003|FG000|Overall Study|other than stated above|9|||
162966552|NCT04610580|588578005|FG000|Two-way Crossover Period|Adverse Event|1|||
162966553|NCT04610580|588578006|FG001|Two-way Crossover Period|Adverse Event|0|||
162626037|NCT03766581|587346963|FG000|Treatment|Participant no longer meets study criteria|9|||
162902801|NCT00081263|588342879|FG001|Overall Study|improper pre-protocol therapy|1|||
162902802|NCT00081263|588342878|FG000|Overall Study|Inadequate pathology|0|||
162902803|NCT00081263|588342879|FG001|Overall Study|Inadequate pathology|1|||
162902804|NCT00081263|588342878|FG000|Overall Study|Never treated|4|||
162902805|NCT00081263|588342879|FG001|Overall Study|Never treated|5|||
162902806|NCT00081263|588342878|FG000|Overall Study|Inadequate data|5|||
162902807|NCT00081263|588342879|FG001|Overall Study|Inadequate data|10|||
162902808|NCT01267955|588342886|FG000|Stage 1 (6 Months)|Death|3|||
162902809|NCT01267955|588342886|FG000|Stage 2 (6 Months)|Death|5|||
162966554|NCT04610580|588578007|FG002|Two-way Crossover Period|Adverse Event|0|||
162966555|NCT04610580|588578008|FG003|Two-way Crossover Period|Adverse Event|0|||
162966556|NCT04610580|588578009|FG004|Two-way Crossover Period|Adverse Event|0|||
162966557|NCT04610580|588578010|FG005|Two-way Crossover Period|Adverse Event|0|||
162966558|NCT04610580|588578005|FG000|Two-way Crossover Period|Physician Decision|1|||
162966559|NCT04610580|588578006|FG001|Two-way Crossover Period|Physician Decision|0|||
162966560|NCT04610580|588578007|FG002|Two-way Crossover Period|Physician Decision|0|||
162966561|NCT04610580|588578008|FG003|Two-way Crossover Period|Physician Decision|0|||
162966562|NCT04610580|588578009|FG004|Two-way Crossover Period|Physician Decision|0|||
162966563|NCT04610580|588578010|FG005|Two-way Crossover Period|Physician Decision|0|||
162966564|NCT04610580|588578005|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
162966565|NCT04610580|588578006|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
162966566|NCT04610580|588578007|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
162966567|NCT04610580|588578008|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
162966568|NCT04610580|588578009|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
162966569|NCT04610580|588578010|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
162966570|NCT04610580|588578005|FG000|Two-way Crossover Period|Other than specified|0|||
162966571|NCT04610580|588578006|FG001|Two-way Crossover Period|Other than specified|1|||
162966572|NCT04610580|588578007|FG002|Two-way Crossover Period|Other than specified|0|||
162966573|NCT04610580|588578008|FG003|Two-way Crossover Period|Other than specified|0|||
162966574|NCT04610580|588578009|FG004|Two-way Crossover Period|Other than specified|0|||
162966575|NCT04610580|588578010|FG005|Two-way Crossover Period|Other than specified|0|||
162966576|NCT04610580|588578005|FG000|Washout Before Extension Period|Other than specified|0|||
162966577|NCT04610580|588578006|FG001|Washout Before Extension Period|Other than specified|1|||
162966578|NCT04610580|588578007|FG002|Washout Before Extension Period|Other than specified|0|||
162966579|NCT04610580|588578008|FG003|Washout Before Extension Period|Other than specified|0|||
162966580|NCT04610580|588578009|FG004|Washout Before Extension Period|Other than specified|0|||
162966581|NCT04610580|588578010|FG005|Washout Before Extension Period|Other than specified|0|||
162966582|NCT04610580|588578005|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
162966583|NCT04610580|588578006|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
162966584|NCT04610580|588578007|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
162966585|NCT04610580|588578008|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
162966586|NCT04610580|588578009|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
162966587|NCT04610580|588578010|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
162966588|NCT04610580|588578005|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966589|NCT04610580|588578006|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966590|NCT04610580|588578007|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966591|NCT04610580|588578008|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966592|NCT04610580|588578009|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
162966593|NCT04610580|588578010|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
162966594|NCT01528735|588578015|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
162966595|NCT01528735|588578016|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
162966596|NCT01528735|588578015|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
162966597|NCT01528735|588578016|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
162966598|NCT01942135|588578019|FG000|Overall Study|Adverse Event|21|||
162966599|NCT01942135|588578020|FG001|Overall Study|Adverse Event|7|||
162966600|NCT01942135|588578019|FG000|Overall Study|Global Deterioration of Health Status|9|||
162966601|NCT01942135|588578020|FG001|Overall Study|Global Deterioration of Health Status|6|||
162966602|NCT01942135|588578019|FG000|Overall Study|Randomized Not Treated|2|||
162966603|NCT01942135|588578020|FG001|Overall Study|Randomized Not Treated|2|||
162966604|NCT01942135|588578019|FG000|Overall Study|Death|2|||
163053608|NCT03810456|588906538|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
163053609|NCT03810456|588906539|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
162966605|NCT01942135|588578020|FG001|Overall Study|Death|1|||
163053610|NCT03810456|588906540|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
162902810|NCT01267955|588342886|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
162902811|NCT00610714|588342888|FG000|Overall Study|Adverse Event|3|||
162902812|NCT00610714|588342889|FG001|Overall Study|Adverse Event|1|||
162902813|NCT00610714|588342888|FG000|Overall Study|Death|12|||
162966606|NCT01942135|588578019|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
162966607|NCT01942135|588578020|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
162966608|NCT01942135|588578019|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
162626038|NCT03766581|587346964|FG001|Treatment|Participant no longer meets study criteria|1|||
162626039|NCT03766581|587346965|FG002|Treatment|Participant no longer meets study criteria|5|||
162626040|NCT03766581|587346966|FG003|Treatment|Participant no longer meets study criteria|4|||
162626041|NCT03766581|587346967|FG004|Treatment|Participant no longer meets study criteria|4|||
162902814|NCT00610714|588342889|FG001|Overall Study|Death|18|||
162902815|NCT00610714|588342888|FG000|Overall Study|Withdrawal by Subject|9|||
162902816|NCT00610714|588342889|FG001|Overall Study|Withdrawal by Subject|3|||
162902817|NCT00610714|588342888|FG000|Overall Study|Study completion at 120 PFS events|2|||
162626042|NCT03766581|587346968|FG005|Treatment|Participant no longer meets study criteria|4|||
162626043|NCT03766581|587346969|FG006|Treatment|Participant no longer meets study criteria|2|||
162626044|NCT03766581|587346970|FG007|Treatment|Participant no longer meets study criteria|0|||
162626045|NCT03766581|587346963|FG000|Treatment|Other reasons|13|||
162626046|NCT03766581|587346964|FG001|Treatment|Other reasons|8|||
162626047|NCT03766581|587346965|FG002|Treatment|Other reasons|3|||
162626048|NCT03766581|587346966|FG003|Treatment|Other reasons|7|||
162626049|NCT03766581|587346967|FG004|Treatment|Other reasons|3|||
162626050|NCT03766581|587346968|FG005|Treatment|Other reasons|3|||
162626051|NCT03766581|587346969|FG006|Treatment|Other reasons|0|||
162626052|NCT03766581|587346970|FG007|Treatment|Other reasons|0|||
162626053|NCT03716024|587346971|FG000|Overall Study|Randomized, not Treated|7|||
162626054|NCT03716024|587346972|FG001|Overall Study|Randomized, not Treated|8|||
162626055|NCT03716024|587346971|FG000|Overall Study|Adverse Event|1|||
162626056|NCT03716024|587346972|FG001|Overall Study|Adverse Event|2|||
162626057|NCT03716024|587346971|FG000|Overall Study|Treatment Failure|1|||
162626058|NCT03716024|587346972|FG001|Overall Study|Treatment Failure|0|||
163053611|NCT03408899|588908369|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
163053612|NCT04745351|588908373|FG000|Overall Study|Death|51|||
163053613|NCT04745351|588908374|FG001|Overall Study|Death|25|||
163053614|NCT04745351|588908373|FG000|Overall Study|Lost to Follow-up|9|||
163053615|NCT04745351|588908374|FG001|Overall Study|Lost to Follow-up|3|||
163053616|NCT04745351|588908373|FG000|Overall Study|Randomized but Never Treated|3|||
163053617|NCT04745351|588908374|FG001|Overall Study|Randomized but Never Treated|3|||
163053618|NCT04745351|588908373|FG000|Overall Study|Adverse Event|4|||
163053619|NCT04745351|588908374|FG001|Overall Study|Adverse Event|0|||
163053620|NCT04745351|588908373|FG000|Overall Study|Withdrew Consent|1|||
163053621|NCT04745351|588908374|FG001|Overall Study|Withdrew Consent|2|||
163053622|NCT04745351|588908373|FG000|Overall Study|Investigator's Discretion|2|||
163053623|NCT04745351|588908374|FG001|Overall Study|Investigator's Discretion|0|||
163053624|NCT04745351|588908373|FG000|Overall Study|Protocol Violation|1|||
163053625|NCT04745351|588908374|FG001|Overall Study|Protocol Violation|0|||
163053626|NCT02014272|588908375|FG000|Intervention Period 1|Withdrawal by Subject|1|||
163053627|NCT02014272|588908376|FG001|Intervention Period 1|Withdrawal by Subject|0|||
163053628|NCT02014272|588908375|FG000|Intervention Period 1|Adverse Event|0|||
163053629|NCT02014272|588908376|FG001|Intervention Period 1|Adverse Event|1|||
163053630|NCT03499795|588908377|FG000|Overall Study|Adverse Event|1|||
163053631|NCT03499795|588908377|FG000|Overall Study|Lost to Follow-up|1|||
163053632|NCT02265510|588908378|FG000|Overall Study|Withdrawal by Subject|1|||
163053633|NCT02265510|588908379|FG001|Overall Study|Withdrawal by Subject|1|||
163053634|NCT02265510|588908380|FG002|Overall Study|Withdrawal by Subject|2|||
162626059|NCT03716024|587346971|FG000|Overall Study|Lost to Follow-up|2|||
162626060|NCT03716024|587346972|FG001|Overall Study|Lost to Follow-up|6|||
162626061|NCT03716024|587346971|FG000|Overall Study|Withdrawal by Subject|0|||
162626062|NCT03716024|587346972|FG001|Overall Study|Withdrawal by Subject|1|||
162626063|NCT03716024|587346971|FG000|Overall Study|Missing Reason|0|||
162626064|NCT03716024|587346972|FG001|Overall Study|Missing Reason|1|||
162626065|NCT00867568|587346973|FG000|Overall Study|Lack of Efficacy|10|||
162902818|NCT00610714|588342889|FG001|Overall Study|Study completion at 120 PFS events|2|||
162626066|NCT00867568|587346973|FG000|Overall Study|Adverse Event|4|||
162626067|NCT00867568|587346973|FG000|Overall Study|Withdrawal by Subject|1|||
162626068|NCT01056653|587346974|FG000|Overall Study|Lost to Follow-up|0|||
162626069|NCT01056653|587346975|FG001|Overall Study|Lost to Follow-up|0|||
162626070|NCT01056653|587346976|FG002|Overall Study|Lost to Follow-up|2|||
162626071|NCT05275400|587346977|FG000|Treatment Period|Adverse Event|7|||
163053635|NCT02265510|588908381|FG003|Overall Study|Withdrawal by Subject|1|||
163053636|NCT02265510|588908382|FG004|Overall Study|Withdrawal by Subject|0|||
163053637|NCT02265510|588908383|FG005|Overall Study|Withdrawal by Subject|2|||
163053638|NCT02265510|588908384|FG006|Overall Study|Withdrawal by Subject|0|||
163053639|NCT02265510|588908385|FG007|Overall Study|Withdrawal by Subject|2|||
163053640|NCT02265510|588908386|FG008|Overall Study|Withdrawal by Subject|0|||
163053641|NCT02265510|588908387|FG009|Overall Study|Withdrawal by Subject|0|||
163053642|NCT02265510|588908388|FG010|Overall Study|Withdrawal by Subject|0|||
163053643|NCT02265510|588908389|FG011|Overall Study|Withdrawal by Subject|0|||
163053644|NCT02265510|588908390|FG012|Overall Study|Withdrawal by Subject|1|||
162626072|NCT05275400|587346978|FG001|Treatment Period|Adverse Event|1|||
163053645|NCT02265510|588908391|FG013|Overall Study|Withdrawal by Subject|0|||
163053646|NCT02265510|588908378|FG000|Overall Study|Disease Progression|0|||
162708822|NCT04949399|587642911|FG001|Overall Study|Lost to Follow-up|6|||
163053647|NCT02265510|588908379|FG001|Overall Study|Disease Progression|1|||
163053648|NCT02265510|588908380|FG002|Overall Study|Disease Progression|2|||
163053649|NCT02265510|588908381|FG003|Overall Study|Disease Progression|1|||
163053650|NCT02265510|588908382|FG004|Overall Study|Disease Progression|1|||
163053651|NCT02265510|588908383|FG005|Overall Study|Disease Progression|0|||
163053652|NCT02265510|588908384|FG006|Overall Study|Disease Progression|0|||
163053653|NCT02265510|588908385|FG007|Overall Study|Disease Progression|0|||
163053654|NCT02265510|588908386|FG008|Overall Study|Disease Progression|0|||
163053655|NCT02265510|588908387|FG009|Overall Study|Disease Progression|0|||
163053656|NCT02265510|588908388|FG010|Overall Study|Disease Progression|0|||
163053657|NCT02265510|588908389|FG011|Overall Study|Disease Progression|0|||
163053658|NCT02265510|588908390|FG012|Overall Study|Disease Progression|0|||
163053659|NCT02265510|588908391|FG013|Overall Study|Disease Progression|0|||
163053660|NCT02265510|588908378|FG000|Overall Study|Death|2|||
162626073|NCT05275400|587346977|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
162626074|NCT05275400|587346978|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
162626075|NCT05275400|587346977|FG000|Treatment Period|Death|5|||
162626076|NCT05275400|587346978|FG001|Treatment Period|Death|2|||
162626077|NCT05275400|587346977|FG000|Treatment Period|Protocol Violation|1|||
162626078|NCT05275400|587346978|FG001|Treatment Period|Protocol Violation|0|||
162626079|NCT05275400|587346977|FG000|Treatment Period|Physician Decision|5|||
162626080|NCT05275400|587346978|FG001|Treatment Period|Physician Decision|4|||
162626081|NCT05275400|587346977|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
162626082|NCT05275400|587346978|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
162626083|NCT05275400|587346977|FG000|Treatment Period|Withdrawal by Subject|30|||
162626084|NCT05275400|587346978|FG001|Treatment Period|Withdrawal by Subject|12|||
162902819|NCT01108263|588342890|FG000|Overall Study|Adverse Event|0|||
162902820|NCT01108263|588342891|FG001|Overall Study|Adverse Event|1|||
162902821|NCT02974621|588342893|FG000|Overall Study|Didn't receive study treatment|1|||
162902822|NCT02974621|588342894|FG001|Overall Study|Didn't receive study treatment|10|||
162902823|NCT02559115|588342895|FG000|Overall Study|Withdrawal by Subject|3|||
162902824|NCT04288089|588342896|FG000|Overall Study|Ongoing Treatment|2|||
162902825|NCT04288089|588342897|FG001|Overall Study|Ongoing Treatment|1|||
162902826|NCT04288089|588342898|FG002|Overall Study|Ongoing Treatment|1|||
162902827|NCT04288089|588342899|FG003|Overall Study|Ongoing Treatment|4|||
162902828|NCT02354690|588342900|FG000|Overall Study|Physician Decision|1|||
162902829|NCT04556175|588342904|FG000|Overall Study|Study terminated due to COVID-19|8|||
162902830|NCT04556175|588342905|FG001|Overall Study|Study terminated due to COVID-19|8|||
162902831|NCT05549505|588342906|FG000|Overall Study|Lost to Follow-up|2|||
162902832|NCT05549505|588342907|FG001|Overall Study|Lost to Follow-up|0|||
162902833|NCT05549505|588342906|FG000|Overall Study|Withdrawal by Subject|3|||
162902834|NCT05549505|588342907|FG001|Overall Study|Withdrawal by Subject|3|||
162902835|NCT05549505|588342906|FG000|Overall Study|Other: Miscellaneous|3|||
162902836|NCT05549505|588342907|FG001|Overall Study|Other: Miscellaneous|6|||
162902837|NCT00592072|588342910|FG000|Wash Out Period|Lost to Follow-up|1|||
162902838|NCT00592072|588342911|FG001|Wash Out Period|Lost to Follow-up|1|||
162902839|NCT05333289|588342912|FG000|Overall Study|Other|1|||
162902840|NCT05333289|588342913|FG001|Overall Study|Other|0|||
162902841|NCT05333289|588342914|FG002|Overall Study|Other|0|||
162902842|NCT05333289|588342915|FG003|Overall Study|Other|1|||
162902843|NCT05333289|588342916|FG004|Overall Study|Other|1|||
162902844|NCT05333289|588342917|FG005|Overall Study|Other|2|||
162902845|NCT05333289|588342918|FG006|Overall Study|Other|2|||
162902846|NCT05333289|588342919|FG007|Overall Study|Other|0|||
162902847|NCT05333289|588342912|FG000|Overall Study|Withdrawal by Subject|1|||
162902848|NCT05333289|588342913|FG001|Overall Study|Withdrawal by Subject|2|||
162902849|NCT05333289|588342914|FG002|Overall Study|Withdrawal by Subject|2|||
162902850|NCT05333289|588342915|FG003|Overall Study|Withdrawal by Subject|1|||
162902851|NCT05333289|588342916|FG004|Overall Study|Withdrawal by Subject|1|||
162902852|NCT05333289|588342917|FG005|Overall Study|Withdrawal by Subject|2|||
162902853|NCT05333289|588342918|FG006|Overall Study|Withdrawal by Subject|1|||
162902854|NCT05333289|588342919|FG007|Overall Study|Withdrawal by Subject|3|||
163053661|NCT02265510|588908379|FG001|Overall Study|Death|0|||
163053662|NCT02265510|588908380|FG002|Overall Study|Death|2|||
163053663|NCT02265510|588908381|FG003|Overall Study|Death|2|||
163053664|NCT02265510|588908382|FG004|Overall Study|Death|1|||
163053665|NCT02265510|588908383|FG005|Overall Study|Death|3|||
162902855|NCT05333289|588342912|FG000|Overall Study|Protocol Violation|1|||
162626085|NCT05275400|587346977|FG000|Treatment Period|Lost to Follow-up|1|||
162626086|NCT05275400|587346978|FG001|Treatment Period|Lost to Follow-up|5|||
162902856|NCT05333289|588342913|FG001|Overall Study|Protocol Violation|0|||
163053666|NCT02265510|588908384|FG006|Overall Study|Death|2|||
162902857|NCT05333289|588342914|FG002|Overall Study|Protocol Violation|0|||
162902858|NCT05333289|588342915|FG003|Overall Study|Protocol Violation|0|||
163053667|NCT02265510|588908385|FG007|Overall Study|Death|1|||
163053668|NCT02265510|588908386|FG008|Overall Study|Death|3|||
163053669|NCT02265510|588908387|FG009|Overall Study|Death|3|||
163053670|NCT02265510|588908388|FG010|Overall Study|Death|4|||
162902859|NCT05333289|588342916|FG004|Overall Study|Protocol Violation|0|||
163053671|NCT02265510|588908389|FG011|Overall Study|Death|12|||
162902860|NCT05333289|588342917|FG005|Overall Study|Protocol Violation|0|||
162902861|NCT05333289|588342918|FG006|Overall Study|Protocol Violation|0|||
162902862|NCT05333289|588342919|FG007|Overall Study|Protocol Violation|0|||
162902863|NCT05333289|588342912|FG000|Overall Study|Physician Decision|0|||
162902864|NCT05333289|588342913|FG001|Overall Study|Physician Decision|0|||
162902865|NCT05333289|588342914|FG002|Overall Study|Physician Decision|1|||
162902866|NCT05333289|588342915|FG003|Overall Study|Physician Decision|0|||
162902867|NCT05333289|588342916|FG004|Overall Study|Physician Decision|0|||
162902868|NCT05333289|588342917|FG005|Overall Study|Physician Decision|2|||
162902869|NCT05333289|588342918|FG006|Overall Study|Physician Decision|0|||
162902870|NCT05333289|588342919|FG007|Overall Study|Physician Decision|0|||
162902871|NCT05333289|588342912|FG000|Overall Study|Lost to Follow-up|6|||
162902872|NCT05333289|588342913|FG001|Overall Study|Lost to Follow-up|0|||
162902873|NCT05333289|588342914|FG002|Overall Study|Lost to Follow-up|1|||
162902874|NCT05333289|588342915|FG003|Overall Study|Lost to Follow-up|6|||
162902875|NCT05333289|588342916|FG004|Overall Study|Lost to Follow-up|3|||
162902876|NCT05333289|588342917|FG005|Overall Study|Lost to Follow-up|3|||
162902877|NCT05333289|588342918|FG006|Overall Study|Lost to Follow-up|2|||
162902878|NCT05333289|588342919|FG007|Overall Study|Lost to Follow-up|1|||
162902879|NCT05333289|588342912|FG000|Overall Study|Death|1|||
162902880|NCT05333289|588342913|FG001|Overall Study|Death|0|||
162902881|NCT05333289|588342914|FG002|Overall Study|Death|0|||
162902882|NCT05333289|588342915|FG003|Overall Study|Death|0|||
162902883|NCT05333289|588342916|FG004|Overall Study|Death|0|||
162902884|NCT05333289|588342917|FG005|Overall Study|Death|0|||
162902885|NCT05333289|588342918|FG006|Overall Study|Death|0|||
162902886|NCT05333289|588342919|FG007|Overall Study|Death|0|||
162902887|NCT00403390|588342921|FG000|Overall Study|Withdrawal by Subject|1|||
162902888|NCT00403390|588342922|FG001|Overall Study|Withdrawal by Subject|0|||
162902889|NCT00403390|588342921|FG000|Overall Study|samples lost|1|||
162902890|NCT00403390|588342922|FG001|Overall Study|samples lost|0|||
162902891|NCT00403390|588342921|FG000|Overall Study|non-compliant|1|||
162902892|NCT00403390|588342922|FG001|Overall Study|non-compliant|0|||
162902893|NCT01878175|588342923|FG000|Overall Study|Developed contraindicated health problem|2|||
162902894|NCT01796106|588342924|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
162902895|NCT01796106|588342925|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
162902896|NCT01332851|588342928|FG000|Overall Study|Withdrawal by Subject|4|||
162902897|NCT01332851|588342929|FG001|Overall Study|Withdrawal by Subject|2|||
162902898|NCT01332851|588342928|FG000|Overall Study|Lost to Follow-up|7|||
162966609|NCT01942135|588578020|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
162966610|NCT01942135|588578019|FG000|Overall Study|Withdrawal by Subject|4|||
162966611|NCT01942135|588578020|FG001|Overall Study|Withdrawal by Subject|3|||
162966612|NCT01942135|588578019|FG000|Overall Study|Protocol Violation|1|||
162966613|NCT01942135|588578020|FG001|Overall Study|Protocol Violation|0|||
162966614|NCT01942135|588578019|FG000|Overall Study|Other|19|||
162966615|NCT01942135|588578020|FG001|Overall Study|Other|4|||
162966616|NCT01499043|588578021|FG000|Overall Study|Progressive disease (radiographic)|2|||
162966617|NCT01499043|588578021|FG000|Overall Study|Progressive disease (clinical)|1|||
162966618|NCT01499043|588578021|FG000|Overall Study|Withdrawal by Subject|2|||
162966619|NCT01499043|588578021|FG000|Overall Study|Adverse Event|1|||
162966620|NCT01596127|588578024|FG000|Overall Study|Patient Ineligible|1|||
162966621|NCT01566435|588578025|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
162966622|NCT00438633|588578026|FG000|Overall Study|Withdrawal by Subject|1|||
162966623|NCT00438633|588578027|FG001|Overall Study|Withdrawal by Subject|0|||
162966624|NCT00438633|588578026|FG000|Overall Study|Lost to Follow-up|15|||
162966625|NCT00438633|588578027|FG001|Overall Study|Lost to Follow-up|17|||
162966626|NCT04569084|588578028|FG000|Overall Study|Adverse Event|10|||
162966627|NCT04569084|588578029|FG001|Overall Study|Adverse Event|14|||
162966628|NCT04569084|588578028|FG000|Overall Study|Death|2|||
162966629|NCT04569084|588578029|FG001|Overall Study|Death|3|||
162966630|NCT04569084|588578028|FG000|Overall Study|Lost to Follow-up|1|||
162966631|NCT04569084|588578029|FG001|Overall Study|Lost to Follow-up|1|||
162966632|NCT04569084|588578028|FG000|Overall Study|Physician Decision|3|||
162966633|NCT04569084|588578029|FG001|Overall Study|Physician Decision|3|||
162902899|NCT01332851|588342929|FG001|Overall Study|Lost to Follow-up|11|||
162966634|NCT04569084|588578028|FG000|Overall Study|Protocol Violation|2|||
162966635|NCT04569084|588578029|FG001|Overall Study|Protocol Violation|1|||
162626087|NCT05275400|587346977|FG000|Treatment Period|Lack of Efficacy|1|||
162902900|NCT03446612|588342930|FG000|Overall Study|Protocol defined stopping criteria|0|||
162902901|NCT03446612|588342931|FG001|Overall Study|Protocol defined stopping criteria|1|||
162902902|NCT01249157|588342932|FG000|Overall Study|Withdrawal by Subject|1|||
162902903|NCT03796195|588342933|FG000|Overall Study|Study closed early|1|||
162902904|NCT04445051|588342934|FG000|Overall Study|Adverse Event|0|||
162902905|NCT04445051|588342935|FG001|Overall Study|Adverse Event|0|||
162966636|NCT04569084|588578028|FG000|Overall Study|Withdrawal by Subject|20|||
162966637|NCT04569084|588578029|FG001|Overall Study|Withdrawal by Subject|21|||
162966638|NCT04569084|588578028|FG000|Overall Study|Study terminated by sponsor|26|||
162966639|NCT04569084|588578029|FG001|Overall Study|Study terminated by sponsor|23|||
162902906|NCT04445051|588342936|FG002|Overall Study|Adverse Event|1|||
162902907|NCT04445051|588342937|FG003|Overall Study|Adverse Event|0|||
162902908|NCT04445051|588342938|FG004|Overall Study|Adverse Event|0|||
162902909|NCT04445051|588342939|FG005|Overall Study|Adverse Event|0|||
162902910|NCT02392468|588342942|FG000|Overall Study|Adverse Event|0|||
162902911|NCT02392468|588342943|FG001|Overall Study|Adverse Event|1|||
162902912|NCT02392468|588342944|FG002|Overall Study|Adverse Event|0|||
162902913|NCT02392468|588342945|FG003|Overall Study|Adverse Event|0|||
162902914|NCT02392468|588342946|FG004|Overall Study|Adverse Event|0|||
162902915|NCT02392468|588342947|FG005|Overall Study|Adverse Event|1|||
162902916|NCT01039428|588342948|FG000|Overall Study|Protocol Violation|1|||
162902917|NCT01039428|588342949|FG001|Overall Study|Protocol Violation|0|||
162902918|NCT01039428|588342948|FG000|Overall Study|Withdrawal by Subject|1|||
162902919|NCT01039428|588342949|FG001|Overall Study|Withdrawal by Subject|0|||
162902920|NCT01313039|588342950|FG000|Overall Study|Physician Decision|1|||
162902921|NCT01313039|588342950|FG000|Overall Study|Adverse Event|1|||
162902922|NCT03630016|588342951|FG000|Overall Study|Poor Sensor Placement|1|||
162902923|NCT05083949|588342952|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
162902924|NCT05083949|588342953|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
162902925|NCT05083949|588342952|FG000|Period 1|Adverse Event|1|||
162902926|NCT05083949|588342953|FG001|Period 1|Adverse Event|1|||
162902927|NCT05083949|588342952|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
162902928|NCT05083949|588342953|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
162902929|NCT05083949|588342952|FG000|Period 2|Adverse Event|0|||
162902930|NCT05083949|588342953|FG001|Period 2|Adverse Event|2|||
162902931|NCT02470429|588342954|FG000|Overall Study|Adverse Event|1|||
162902932|NCT02470429|588342955|FG001|Overall Study|Adverse Event|0|||
162902933|NCT02470429|588342954|FG000|Overall Study|Withdrawal by Subject|1|||
162902934|NCT02470429|588342955|FG001|Overall Study|Withdrawal by Subject|0|||
162902935|NCT01602744|588342956|FG000|Overall Study|Death|17|||
162902936|NCT01602744|588342957|FG001|Overall Study|Death|15|||
162902937|NCT01602744|588342956|FG000|Overall Study|Lost to Follow-up|13|||
162902938|NCT01602744|588342957|FG001|Overall Study|Lost to Follow-up|8|||
162902939|NCT00606294|588342958|FG000|Overall Study|Withdrawal by Subject|36|||
162902940|NCT00606294|588342959|FG001|Overall Study|Withdrawal by Subject|0|||
162902941|NCT01976624|588342960|FG000|Overall Study|Participants contraindicated|2|||
162902942|NCT01976624|588342960|FG000|Overall Study|Participants age less than 19 years|12|||
162902943|NCT01885104|588342961|FG000|Overall Study|Withdrawal of Consent|1|||
162902944|NCT01885104|588342962|FG001|Overall Study|Withdrawal of Consent|0|||
162902945|NCT01885104|588342961|FG000|Overall Study|Lost to Follow-up|0|||
162902946|NCT01885104|588342962|FG001|Overall Study|Lost to Follow-up|1|||
162902947|NCT01885104|588342961|FG000|Overall Study|Physician Decision|1|||
162902948|NCT01885104|588342962|FG001|Overall Study|Physician Decision|0|||
162902949|NCT00126425|588342964|FG000|Overall Study|Withdrawal by Subject|17|||
162902950|NCT00126425|588342965|FG001|Overall Study|Withdrawal by Subject|1|||
162902951|NCT00126425|588342964|FG000|Overall Study|Lost to Follow-up|8|||
162902952|NCT00126425|588342965|FG001|Overall Study|Lost to Follow-up|4|||
162902953|NCT00126425|588342964|FG000|Overall Study|Protocol Violation|9|||
162902954|NCT00126425|588342965|FG001|Overall Study|Protocol Violation|6|||
162902955|NCT00126425|588342964|FG000|Overall Study|Adverse Event|1|||
162902956|NCT00126425|588342965|FG001|Overall Study|Adverse Event|0|||
162902957|NCT00126425|588342964|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
162902958|NCT00126425|588342965|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
162902959|NCT00126425|588342964|FG000|Overall Study|Other|5|||
162902960|NCT00126425|588342965|FG001|Overall Study|Other|0|||
162902961|NCT01316380|588342966|FG000|Overall Study|Adverse Event|0|||
162902962|NCT01316380|588342967|FG001|Overall Study|Adverse Event|2|||
162902963|NCT01316380|588342968|FG002|Overall Study|Adverse Event|1|||
162902964|NCT01316380|588342966|FG000|Overall Study|Protocol Violation|0|||
162902965|NCT01316380|588342967|FG001|Overall Study|Protocol Violation|0|||
162902966|NCT01316380|588342968|FG002|Overall Study|Protocol Violation|1|||
162966640|NCT04569084|588578028|FG000|Overall Study|Other|3|||
162966641|NCT04569084|588578029|FG001|Overall Study|Other|5|||
162966642|NCT03196284|588578030|FG000|Main Part|Withdrawal by Subject|0|||
162966643|NCT03196284|588578031|FG001|Main Part|Withdrawal by Subject|1|||
162966644|NCT03196284|588578032|FG002|Main Part|Withdrawal by Subject|0|||
162966645|NCT03196284|588578030|FG000|Extension Part|Lack of Efficacy|0|||
162966646|NCT03196284|588578031|FG001|Extension Part|Lack of Efficacy|0|||
162966647|NCT03196284|588578032|FG002|Extension Part|Lack of Efficacy|1|||
162966648|NCT03196284|588578030|FG000|Extension Part|Withdrawal by Subject|0|||
162966649|NCT03196284|588578031|FG001|Extension Part|Withdrawal by Subject|0|||
162966650|NCT03196284|588578032|FG002|Extension Part|Withdrawal by Subject|1|||
162966651|NCT03196284|588578030|FG000|Extension Part|Physician Decision|0|||
162966652|NCT03196284|588578031|FG001|Extension Part|Physician Decision|0|||
162966653|NCT03196284|588578032|FG002|Extension Part|Physician Decision|1|||
162966654|NCT00685334|588578038|FG000|Overall Study|Withdrawal by Subject|5|||
162966655|NCT00685334|588578039|FG001|Overall Study|Withdrawal by Subject|6|||
162966656|NCT00685334|588578038|FG000|Overall Study|Lost to Follow-up|4|||
162902967|NCT01316380|588342966|FG000|Overall Study|Withdrawal by Subject|1|||
162902968|NCT01316380|588342967|FG001|Overall Study|Withdrawal by Subject|2|||
162902969|NCT01316380|588342968|FG002|Overall Study|Withdrawal by Subject|0|||
162902970|NCT01316380|588342966|FG000|Overall Study|Other|0|||
162902971|NCT01316380|588342967|FG001|Overall Study|Other|1|||
162902972|NCT01316380|588342968|FG002|Overall Study|Other|1|||
162902973|NCT01316380|588342966|FG000|Overall Study|Not treated|1|||
162902974|NCT01316380|588342967|FG001|Overall Study|Not treated|0|||
162902975|NCT01316380|588342968|FG002|Overall Study|Not treated|0|||
162902976|NCT01894776|588342969|FG000|Overall Study|Withdrawal by Subject|1|||
162902977|NCT00471315|588342971|FG000|Overall Study|Adverse Event|7|||
162902978|NCT00471315|588342971|FG000|Overall Study|Withdrawal by Subject|1|||
162902979|NCT02574520|588342975|FG000|Overall Study|Not dosed|2|||
162902980|NCT02574520|588342976|FG001|Overall Study|Not dosed|0|||
162902981|NCT02574520|588342977|FG002|Overall Study|Not dosed|5|||
162902982|NCT02574520|588342978|FG003|Overall Study|Not dosed|4|||
162902983|NCT02574520|588342975|FG000|Overall Study|Adverse Event|0|||
162902984|NCT02574520|588342976|FG001|Overall Study|Adverse Event|0|||
162902985|NCT02574520|588342977|FG002|Overall Study|Adverse Event|0|||
162902986|NCT02574520|588342978|FG003|Overall Study|Adverse Event|1|||
162902987|NCT02574520|588342975|FG000|Overall Study|Withdrawal by Subject|0|||
162902988|NCT02574520|588342976|FG001|Overall Study|Withdrawal by Subject|0|||
162902989|NCT02574520|588342977|FG002|Overall Study|Withdrawal by Subject|0|||
162902990|NCT02574520|588342978|FG003|Overall Study|Withdrawal by Subject|1|||
162902991|NCT02574520|588342975|FG000|Overall Study|Other|0|||
162902992|NCT02574520|588342976|FG001|Overall Study|Other|0|||
162902993|NCT02574520|588342977|FG002|Overall Study|Other|0|||
162902994|NCT02574520|588342978|FG003|Overall Study|Other|2|||
162902995|NCT01365091|588342981|FG000|Period 1|Adverse Event|1|||
162902996|NCT01365091|588342982|FG001|Period 1|Adverse Event|0|||
162902997|NCT01365091|588342983|FG002|Period 1|Adverse Event|2|||
162902998|NCT01365091|588342984|FG003|Period 1|Adverse Event|3|||
162902999|NCT01365091|588342981|FG000|Period 1|Positive test result for drugs of abuse|1|||
162903000|NCT01365091|588342982|FG001|Period 1|Positive test result for drugs of abuse|0|||
162903001|NCT01365091|588342983|FG002|Period 1|Positive test result for drugs of abuse|0|||
162903002|NCT01365091|588342984|FG003|Period 1|Positive test result for drugs of abuse|0|||
162903003|NCT01365091|588342981|FG000|Period 1|No longer met study criteria|0|||
162903004|NCT01365091|588342982|FG001|Period 1|No longer met study criteria|1|||
162903005|NCT01365091|588342983|FG002|Period 1|No longer met study criteria|0|||
162903006|NCT01365091|588342984|FG003|Period 1|No longer met study criteria|0|||
162903007|NCT01365091|588342981|FG000|Period 1|Withdrawal by Subject|0|||
162903008|NCT01365091|588342982|FG001|Period 1|Withdrawal by Subject|1|||
162903009|NCT01365091|588342983|FG002|Period 1|Withdrawal by Subject|0|||
162903010|NCT01365091|588342984|FG003|Period 1|Withdrawal by Subject|0|||
162903011|NCT01365091|588342981|FG000|Period 1|Personal reasons|0|||
162903012|NCT01365091|588342982|FG001|Period 1|Personal reasons|0|||
162903013|NCT01365091|588342983|FG002|Period 1|Personal reasons|1|||
162903014|NCT01365091|588342984|FG003|Period 1|Personal reasons|0|||
162903015|NCT01365091|588342981|FG000|Period 2|Withdrawal by Subject|1|||
162903016|NCT01365091|588342982|FG001|Period 2|Withdrawal by Subject|0|||
162903017|NCT01365091|588342983|FG002|Period 2|Withdrawal by Subject|0|||
162903018|NCT01365091|588342984|FG003|Period 2|Withdrawal by Subject|0|||
162903019|NCT01365091|588342981|FG000|Period 2|Adverse Event|0|||
162903020|NCT01365091|588342982|FG001|Period 2|Adverse Event|0|||
162903021|NCT01365091|588342983|FG002|Period 2|Adverse Event|1|||
162903022|NCT01365091|588342984|FG003|Period 2|Adverse Event|0|||
163053672|NCT02265510|588908390|FG012|Overall Study|Death|7|||
163053673|NCT02265510|588908391|FG013|Overall Study|Death|6|||
163053674|NCT02265510|588908378|FG000|Overall Study|Lost to Follow-up|0|||
163053675|NCT02265510|588908379|FG001|Overall Study|Lost to Follow-up|0|||
163053676|NCT02265510|588908380|FG002|Overall Study|Lost to Follow-up|0|||
163053677|NCT02265510|588908381|FG003|Overall Study|Lost to Follow-up|0|||
163053678|NCT02265510|588908382|FG004|Overall Study|Lost to Follow-up|1|||
163053679|NCT02265510|588908383|FG005|Overall Study|Lost to Follow-up|0|||
163053680|NCT02265510|588908384|FG006|Overall Study|Lost to Follow-up|0|||
162903023|NCT05307523|588342986|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
162903024|NCT05307523|588342987|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
162903025|NCT05307523|588342986|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
162903026|NCT05307523|588342987|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
162903027|NCT05116683|588342989|FG000|Overall Study|Physician Decision|4|||
162903028|NCT03935594|588342993|FG000|Overall Study|Physician Decision|3|||
162903029|NCT01435122|588342994|FG000|Overall Study|Early withdrawal due to toxicity|8|||
162903030|NCT00683774|588342995|FG000|Overall Study|Withdrawal by Subject|0|||
162903031|NCT00683774|588342996|FG001|Overall Study|Withdrawal by Subject|1|||
162903032|NCT00683774|588342995|FG000|Overall Study|Physician Decision|3|||
162903033|NCT00683774|588342996|FG001|Overall Study|Physician Decision|0|||
162903034|NCT02875366|588342997|FG000|Overall Study|Adverse Event|0|||
162903035|NCT02875366|588342998|FG001|Overall Study|Adverse Event|2|||
162903036|NCT02875366|588342997|FG000|Overall Study|Noncompliance|0|||
162903037|NCT02875366|588342998|FG001|Overall Study|Noncompliance|1|||
163053681|NCT02265510|588908385|FG007|Overall Study|Lost to Follow-up|0|||
162903038|NCT03595176|588342999|FG000|Overall Study|Death|0|||
162903039|NCT03595176|588343000|FG001|Overall Study|Death|2|||
162903040|NCT03595176|588342999|FG000|Overall Study|Lost to Follow-up|0|||
162903041|NCT03595176|588343000|FG001|Overall Study|Lost to Follow-up|1|||
162903042|NCT02735044|588343002|FG000|Overall Study|Adverse Event|3|||
162903043|NCT02735044|588343003|FG001|Overall Study|Adverse Event|3|||
162903044|NCT02735044|588343002|FG000|Overall Study|Lack of Efficacy|1|||
162903045|NCT02735044|588343003|FG001|Overall Study|Lack of Efficacy|0|||
162903046|NCT02735044|588343002|FG000|Overall Study|Poor compliance to protocol|7|||
162903047|NCT02735044|588343003|FG001|Overall Study|Poor compliance to protocol|7|||
162903048|NCT02735044|588343002|FG000|Overall Study|Randomized and not treated|0|||
162903049|NCT02735044|588343003|FG001|Overall Study|Randomized and not treated|2|||
162903050|NCT02735044|588343002|FG000|Overall Study|Other, not specified above|5|||
162903051|NCT02735044|588343003|FG001|Overall Study|Other, not specified above|11|||
162903052|NCT00412113|588343005|FG000|Overall Study|Adverse Event|11|||
162903053|NCT00412113|588343006|FG001|Overall Study|Adverse Event|15|||
162903054|NCT00412113|588343005|FG000|Overall Study|did not receive treatment|1|||
162903055|NCT00412113|588343006|FG001|Overall Study|did not receive treatment|0|||
162903056|NCT01201967|588343007|FG000|Overall Study|Lost to Follow-up|6|||
162903057|NCT01201967|588343008|FG001|Overall Study|Lost to Follow-up|5|||
162903058|NCT01226472|588343009|FG000|Overall Study|Progressive Disease|1|||
162903059|NCT00740116|588344864|FG000|Overall Study|Withdrawal by Subject|1|||
162903060|NCT00740116|588344865|FG001|Overall Study|Withdrawal by Subject|1|||
162903061|NCT00740116|588344864|FG000|Overall Study|Protocol Violation|1|||
162903062|NCT00740116|588344865|FG001|Overall Study|Protocol Violation|4|||
162903063|NCT00621764|588344866|FG000|Overall Study|Protocol Violation|0|||
162903064|NCT00621764|588344867|FG001|Overall Study|Protocol Violation|0|||
162903065|NCT00621764|588344868|FG002|Overall Study|Protocol Violation|0|||
162903066|NCT00621764|588344869|FG003|Overall Study|Protocol Violation|1|||
162903067|NCT02499172|588344870|FG000|Overall Study|Financial reason|0|||
162903068|NCT02499172|588344871|FG001|Overall Study|Financial reason|0|||
162903069|NCT02499172|588344872|FG002|Overall Study|Financial reason|523|||
162903070|NCT02499172|588344873|FG003|Overall Study|Financial reason|436|||
162903071|NCT02499172|588344870|FG000|Overall Study|Lost to Follow-up|65|||
162903072|NCT02499172|588344871|FG001|Overall Study|Lost to Follow-up|64|||
162903073|NCT02499172|588344872|FG002|Overall Study|Lost to Follow-up|0|||
162903074|NCT02499172|588344873|FG003|Overall Study|Lost to Follow-up|0|||
162903075|NCT01293123|588344874|FG000|Overall Study|Lost to Follow-up|0|||
162903076|NCT01293123|588344875|FG001|Overall Study|Lost to Follow-up|1|||
162903077|NCT01888965|588344885|FG000|Overall Study|Adverse Event|5|||
162903078|NCT01888965|588344885|FG000|Overall Study|Lack of Efficacy|4|||
162903079|NCT04076579|588344886|FG000|Overall Study|Adverse Event|2|||
162903080|NCT04076579|588344887|FG001|Overall Study|Adverse Event|0|||
162903081|NCT04076579|588344886|FG000|Overall Study|discontinued due to toxicity|1|||
162903082|NCT04076579|588344887|FG001|Overall Study|discontinued due to toxicity|0|||
162903083|NCT04076579|588344886|FG000|Overall Study|Physician Decision|1|||
162903084|NCT04076579|588344887|FG001|Overall Study|Physician Decision|0|||
162903085|NCT04076579|588344886|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
162903086|NCT04076579|588344887|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
162903087|NCT04076579|588344886|FG000|Overall Study|Noncompliance|0|||
162903088|NCT04076579|588344887|FG001|Overall Study|Noncompliance|1|||
162966657|NCT00685334|588578039|FG001|Overall Study|Lost to Follow-up|0|||
162966658|NCT00685334|588578038|FG000|Overall Study|Chose to enter hospital|1|||
162966659|NCT00685334|588578039|FG001|Overall Study|Chose to enter hospital|1|||
162966660|NCT04577404|588578040|FG000|Overall Study|Adverse Event|31|||
162966661|NCT04577404|588578040|FG000|Overall Study|Death|1|||
162966662|NCT04577404|588578040|FG000|Overall Study|Lack of Efficacy|3|||
162966663|NCT04577404|588578040|FG000|Overall Study|Physician Decision|7|||
162966664|NCT04577404|588578040|FG000|Overall Study|Withdrawal by Subject|21|||
162966665|NCT04577404|588578040|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
162966666|NCT04729101|588579493|FG000|Overall Study|Adverse Event|1|||
162966667|NCT04729101|588579494|FG001|Overall Study|Adverse Event|0|||
162966668|NCT04729101|588579493|FG000|Overall Study|Physician Decision|1|||
162903089|NCT04076579|588344886|FG000|Overall Study|Withdrawal by Subject|0|||
162903090|NCT04076579|588344887|FG001|Overall Study|Withdrawal by Subject|2|||
162966669|NCT04729101|588579494|FG001|Overall Study|Physician Decision|0|||
162966670|NCT04729101|588579493|FG000|Overall Study|Withdrawal by Subject|1|||
162966671|NCT04729101|588579494|FG001|Overall Study|Withdrawal by Subject|0|||
162903091|NCT00186121|588344888|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
162903092|NCT00186121|588344888|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
162903093|NCT00186121|588344888|FG000|Overall Study|Not eligible (no treatment)|1|||
162903094|NCT03650387|588344889|FG000|Overall Study|Withdrawal by Subject|13|||
162903095|NCT03650387|588344889|FG000|Overall Study|Lost to Follow-up|12|||
162903096|NCT03650387|588344889|FG000|Overall Study|Adverse Event (Not related)|1|||
162903097|NCT03650387|588344889|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
162903098|NCT00417248|588344890|FG000|Overall Study|Study Terminated|6|||
162903099|NCT00417248|588344890|FG000|Overall Study|Death|1|||
162966672|NCT00762411|588579495|FG000|Initial Treatment|Death|7|||
162903100|NCT00417248|588344890|FG000|Overall Study|Lack of Efficacy|1|||
162903101|NCT05815758|588344891|FG000|Overall Study|Adverse Event|6|||
162903102|NCT05815758|588344892|FG001|Overall Study|Adverse Event|2|||
162903103|NCT05815758|588344891|FG000|Overall Study|Lost to Follow-up|14|||
162903104|NCT05815758|588344892|FG001|Overall Study|Lost to Follow-up|1|||
162903105|NCT05815758|588344891|FG000|Overall Study|Withdrawal by Subject|6|||
162903106|NCT05815758|588344892|FG001|Overall Study|Withdrawal by Subject|6|||
162903107|NCT05815758|588344891|FG000|Overall Study|Protocol Violation|1|||
162903108|NCT05815758|588344892|FG001|Overall Study|Protocol Violation|1|||
162903109|NCT05815758|588344891|FG000|Overall Study|Discontinued|4|||
162903110|NCT05815758|588344892|FG001|Overall Study|Discontinued|4|||
162903111|NCT03661983|588344893|FG000|Open Label Stabilization Phase|Adverse Event|5|||
162903112|NCT03661983|588344894|FG001|Open Label Stabilization Phase|Adverse Event|0|||
162903113|NCT03661983|588344895|FG002|Open Label Stabilization Phase|Adverse Event|0|||
162903114|NCT03661983|588344896|FG003|Open Label Stabilization Phase|Adverse Event|0|||
162903115|NCT03661983|588344893|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
162903116|NCT03661983|588344894|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
162903117|NCT03661983|588344895|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
162903118|NCT03661983|588344896|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
162903119|NCT03661983|588344893|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
162903120|NCT03661983|588344894|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
162903121|NCT03661983|588344895|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
162903122|NCT03661983|588344896|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
162903123|NCT03661983|588344893|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
162903124|NCT03661983|588344894|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
162903125|NCT03661983|588344895|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
162903126|NCT03661983|588344896|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
162903127|NCT03661983|588344893|FG000|Double-blind Randomized Phase|Adverse Event|0|||
162903128|NCT03661983|588344894|FG001|Double-blind Randomized Phase|Adverse Event|1|||
162903129|NCT03661983|588344895|FG002|Double-blind Randomized Phase|Adverse Event|0|||
162903130|NCT03661983|588344896|FG003|Double-blind Randomized Phase|Adverse Event|0|||
162903131|NCT03661983|588344893|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
162903132|NCT03661983|588344894|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
162903133|NCT03661983|588344895|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
162903134|NCT03661983|588344896|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
162903135|NCT03661983|588344893|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
162903136|NCT03661983|588344894|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
162903137|NCT03661983|588344895|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
162903138|NCT03661983|588344896|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
162903139|NCT03661983|588344893|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
162903140|NCT03661983|588344894|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
162903141|NCT03661983|588344895|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
162903142|NCT03661983|588344896|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
162903143|NCT02903966|588344897|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
162903144|NCT02903966|588344898|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
162903145|NCT02903966|588344897|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
162903146|NCT02903966|588344898|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
162903147|NCT02903966|588344897|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
162903148|NCT02903966|588344898|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
162903149|NCT00934791|588344899|FG000|Overall Study|Withdrawal by Subject|1|||
162903150|NCT00934791|588344900|FG001|Overall Study|Withdrawal by Subject|0|||
162903151|NCT01320033|588344902|FG000|Overall Study|Lack of Efficacy|0|||
162903152|NCT01320033|588344903|FG001|Overall Study|Lack of Efficacy|0|||
162903153|NCT01320033|588344904|FG002|Overall Study|Lack of Efficacy|1|||
162903154|NCT01320033|588344902|FG000|Overall Study|Adverse Event|9|||
162903155|NCT01320033|588344903|FG001|Overall Study|Adverse Event|7|||
162903156|NCT01320033|588344904|FG002|Overall Study|Adverse Event|8|||
162903157|NCT01320033|588344902|FG000|Overall Study|Withdrawal by Subject|22|||
162903158|NCT01320033|588344903|FG001|Overall Study|Withdrawal by Subject|23|||
162903159|NCT01320033|588344904|FG002|Overall Study|Withdrawal by Subject|23|||
162903160|NCT01320033|588344902|FG000|Overall Study|Protocol Violation|3|||
162903161|NCT01320033|588344903|FG001|Overall Study|Protocol Violation|5|||
162903162|NCT01320033|588344904|FG002|Overall Study|Protocol Violation|3|||
162903163|NCT01320033|588344902|FG000|Overall Study|Lost to Follow-up|22|||
162903164|NCT01320033|588344903|FG001|Overall Study|Lost to Follow-up|26|||
162903165|NCT01320033|588344904|FG002|Overall Study|Lost to Follow-up|17|||
162903166|NCT01320033|588344902|FG000|Overall Study|Other|2|||
162903167|NCT01320033|588344903|FG001|Overall Study|Other|3|||
162903168|NCT01320033|588344904|FG002|Overall Study|Other|1|||
163053682|NCT02265510|588908386|FG008|Overall Study|Lost to Follow-up|0|||
162903169|NCT02425891|588344905|FG000|Overall Study|Death|333|||
162903170|NCT02425891|588344906|FG001|Overall Study|Death|314|||
162903171|NCT02425891|588344905|FG000|Overall Study|Lost to Follow-up|4|||
162903172|NCT02425891|588344906|FG001|Overall Study|Lost to Follow-up|6|||
162903173|NCT02425891|588344905|FG000|Overall Study|Non-Compliance|1|||
162903174|NCT02425891|588344906|FG001|Overall Study|Non-Compliance|1|||
162903175|NCT02425891|588344905|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
162903176|NCT02425891|588344906|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
162903177|NCT02425891|588344905|FG000|Overall Study|Physician Decision|0|||
162903178|NCT02425891|588344906|FG001|Overall Study|Physician Decision|1|||
162903179|NCT02425891|588344905|FG000|Overall Study|Protocol Violation|1|||
162903180|NCT02425891|588344906|FG001|Overall Study|Protocol Violation|1|||
162903181|NCT02425891|588344905|FG000|Overall Study|Study Terminated By Sponsor|85|||
162966673|NCT00762411|588579496|FG001|Initial Treatment|Death|6|||
162966674|NCT00762411|588579495|FG000|Initial Treatment|Adverse Event|132|||
162966675|NCT00762411|588579496|FG001|Initial Treatment|Adverse Event|40|||
162966676|NCT00762411|588579495|FG000|Initial Treatment|Protocol Violation|4|||
162966677|NCT00762411|588579496|FG001|Initial Treatment|Protocol Violation|1|||
162966678|NCT00762411|588579495|FG000|Initial Treatment|Withdrawal by Subject|65|||
162966679|NCT00762411|588579496|FG001|Initial Treatment|Withdrawal by Subject|52|||
162966680|NCT00762411|588579495|FG000|Initial Treatment|Physician Decision|1|||
162966681|NCT00762411|588579496|FG001|Initial Treatment|Physician Decision|0|||
162966682|NCT00762411|588579495|FG000|Initial Treatment|Sponsor Decision|293|||
162966683|NCT00762411|588579496|FG001|Initial Treatment|Sponsor Decision|401|||
162966684|NCT00762411|588579495|FG000|Initial Treatment|Lost to Follow-up|5|||
162966685|NCT00762411|588579496|FG001|Initial Treatment|Lost to Follow-up|0|||
162966686|NCT00762411|588579495|FG000|Initial Treatment|Caregiver Decision|21|||
162966687|NCT00762411|588579496|FG001|Initial Treatment|Caregiver Decision|16|||
162966688|NCT00762411|588579495|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
162966689|NCT00762411|588579496|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
162966690|NCT00762411|588579495|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
162966691|NCT00762411|588579496|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
162966692|NCT00762411|588579495|FG000|Delayed Start|Adverse Event|0|||
162966693|NCT00762411|588579496|FG001|Delayed Start|Adverse Event|4|||
162966694|NCT00762411|588579495|FG000|Delayed Start|Protocol Violation|0|||
162966695|NCT00762411|588579496|FG001|Delayed Start|Protocol Violation|1|||
162966696|NCT00762411|588579495|FG000|Delayed Start|Sponsor Decision|16|||
162966697|NCT00762411|588579496|FG001|Delayed Start|Sponsor Decision|20|||
162966698|NCT00762411|588579495|FG000|Delayed Start|Caregiver Decision|1|||
162966699|NCT00762411|588579496|FG001|Delayed Start|Caregiver Decision|1|||
162966700|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
162966701|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
162966702|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
162966703|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
162966704|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
162966705|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
162966706|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
162966707|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
162966708|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
162966709|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
162966710|NCT00762411|588579495|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
162966711|NCT00762411|588579496|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
162966712|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
162966713|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162966714|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162966715|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966716|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966717|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966718|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966719|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162966720|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
162966721|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966722|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966723|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966724|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966725|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966726|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966727|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162966728|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162966729|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966730|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162966731|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966732|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966733|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966734|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163053683|NCT02265510|588908387|FG009|Overall Study|Lost to Follow-up|2|||
163053684|NCT02265510|588908388|FG010|Overall Study|Lost to Follow-up|0|||
163053685|NCT02265510|588908389|FG011|Overall Study|Lost to Follow-up|0|||
163053686|NCT02265510|588908390|FG012|Overall Study|Lost to Follow-up|0|||
163053687|NCT02265510|588908391|FG013|Overall Study|Lost to Follow-up|2|||
162903182|NCT02425891|588344906|FG001|Overall Study|Study Terminated By Sponsor|95|||
162903183|NCT02425891|588344905|FG000|Overall Study|Withdrawal by Subject|27|||
162903184|NCT02425891|588344906|FG001|Overall Study|Withdrawal by Subject|32|||
162903185|NCT00963469|588344907|FG000|Overall Study|Adverse Event|15|||
162903186|NCT00963469|588344908|FG001|Overall Study|Adverse Event|11|||
162903187|NCT00963469|588344909|FG002|Overall Study|Adverse Event|1|||
162903188|NCT00963469|588344907|FG000|Overall Study|Lack of Efficacy|10|||
162903189|NCT00963469|588344908|FG001|Overall Study|Lack of Efficacy|7|||
162903190|NCT00963469|588344909|FG002|Overall Study|Lack of Efficacy|2|||
162903191|NCT00963469|588344907|FG000|Overall Study|Lost to Follow-up|1|||
162903192|NCT00963469|588344908|FG001|Overall Study|Lost to Follow-up|1|||
162903193|NCT00963469|588344909|FG002|Overall Study|Lost to Follow-up|0|||
162903194|NCT00963469|588344907|FG000|Overall Study|Protocol Violation|5|||
162903195|NCT00963469|588344908|FG001|Overall Study|Protocol Violation|5|||
162903196|NCT00963469|588344909|FG002|Overall Study|Protocol Violation|3|||
162903197|NCT00963469|588344907|FG000|Overall Study|Withdrawal by Subject|4|||
162903198|NCT00963469|588344908|FG001|Overall Study|Withdrawal by Subject|1|||
162903199|NCT00963469|588344909|FG002|Overall Study|Withdrawal by Subject|1|||
162903200|NCT00963469|588344907|FG000|Overall Study|Pre-randomization Adverse Event|1|||
162903201|NCT00963469|588344908|FG001|Overall Study|Pre-randomization Adverse Event|2|||
162903202|NCT00963469|588344909|FG002|Overall Study|Pre-randomization Adverse Event|0|||
162903203|NCT00963469|588344907|FG000|Overall Study|Moved|1|||
162903204|NCT00963469|588344908|FG001|Overall Study|Moved|0|||
162903205|NCT00963469|588344909|FG002|Overall Study|Moved|0|||
162903206|NCT00963469|588344907|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
162903207|NCT00963469|588344908|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
162903208|NCT00963469|588344909|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
162903209|NCT02943577|588344911|FG000|Overall Study|Protocol Violation|0|||
162903210|NCT02943577|588344912|FG001|Overall Study|Protocol Violation|1|||
162903211|NCT02943577|588344911|FG000|Overall Study|Adverse Event|3|||
162903212|NCT02943577|588344912|FG001|Overall Study|Adverse Event|2|||
162903213|NCT02943577|588344911|FG000|Overall Study|Lost to Follow-up|0|||
162903214|NCT02943577|588344912|FG001|Overall Study|Lost to Follow-up|1|||
162903215|NCT02943577|588344911|FG000|Overall Study|Withdrawal by Subject|1|||
162903216|NCT02943577|588344912|FG001|Overall Study|Withdrawal by Subject|1|||
162903217|NCT02943577|588344911|FG000|Overall Study|Pregnancy|1|||
162903218|NCT02943577|588344912|FG001|Overall Study|Pregnancy|0|||
162903219|NCT03991936|588344917|FG000|Overall Study|Lost to Follow-up|1|||
162903220|NCT03991936|588344918|FG001|Overall Study|Lost to Follow-up|1|||
162903221|NCT03991936|588344919|FG002|Overall Study|Lost to Follow-up|1|||
162903222|NCT03991936|588344920|FG003|Overall Study|Lost to Follow-up|1|||
162903223|NCT03991936|588344921|FG004|Overall Study|Lost to Follow-up|1|||
162903224|NCT00939055|588344922|FG000|Overall Study|Discontinuation prior to procedure|4|||
162903225|NCT00939055|588344923|FG001|Overall Study|Discontinuation prior to procedure|0|||
162903226|NCT00584987|588344926|FG000|Overall Study|Protocol Violation|1|||
162903227|NCT00584987|588344927|FG001|Overall Study|Protocol Violation|1|||
162903228|NCT00584987|588344928|FG002|Overall Study|Protocol Violation|1|||
162903229|NCT00584987|588344929|FG003|Overall Study|Protocol Violation|0|||
162903230|NCT00584987|588344926|FG000|Overall Study|Adverse Event|0|||
162903231|NCT00584987|588344927|FG001|Overall Study|Adverse Event|0|||
162903232|NCT00584987|588344928|FG002|Overall Study|Adverse Event|0|||
162903233|NCT00584987|588344929|FG003|Overall Study|Adverse Event|1|||
162903234|NCT01944462|588344933|FG000|PPPP Educational Program|Lost to Follow-up|60|||
162903235|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
162903236|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
162903237|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
162903238|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
162903239|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Other|1|||
162903240|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Other|0|||
162903241|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Other|2|||
162903242|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Other|4|||
162903243|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
162903244|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
162903245|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
162903246|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
162903247|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Adverse Event|0|||
162903248|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Adverse Event|0|||
162903249|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Adverse Event|1|||
162903250|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Adverse Event|2|||
162903251|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
162903252|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
162903253|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
162903254|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
162903255|NCT00808028|588344934|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
162903256|NCT00808028|588344935|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
162903257|NCT00808028|588344936|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
162903258|NCT00808028|588344937|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
162903259|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
162903260|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
162903261|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
162903262|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
162903263|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
162903264|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
162903265|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
162903266|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
162903267|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
162903268|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
162903269|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
162903270|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
162903271|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
162903272|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
162903273|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
162903274|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
162903275|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
162903276|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
162903277|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
162903278|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
162903279|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
162903280|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
162903281|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
162903282|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
162903283|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
162903284|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
162903285|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
162903286|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
162903287|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
162903288|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
162903289|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
162903290|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
162903291|NCT00808028|588344934|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
162966735|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162966736|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
162966737|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966738|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966739|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966740|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966741|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966742|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163053688|NCT02265510|588908378|FG000|Overall Study|Other|0|||
162903292|NCT00808028|588344935|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
162903293|NCT00808028|588344936|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
162903294|NCT00808028|588344937|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
162903295|NCT01599585|588344939|FG000|Overall Study|Withdrawal by Subject|16|||
162903296|NCT01599585|588344940|FG001|Overall Study|Withdrawal by Subject|9|||
162903297|NCT01599585|588344939|FG000|Overall Study|Lost to Follow-up|3|||
162903298|NCT01599585|588344940|FG001|Overall Study|Lost to Follow-up|5|||
162903299|NCT01599585|588344939|FG000|Overall Study|randomized did not start treatment|3|||
162903300|NCT01599585|588344940|FG001|Overall Study|randomized did not start treatment|3|||
162903301|NCT01852591|588344948|FG000|Overall Study|Withdrawal by Subject|2|||
162903302|NCT01852591|588344948|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
162903303|NCT01263470|588344949|FG000|Overall Study|Adverse Event|2|||
162903304|NCT01263470|588344950|FG001|Overall Study|Adverse Event|2|||
162903305|NCT01263470|588344951|FG002|Overall Study|Adverse Event|1|||
162903306|NCT01263470|588344952|FG003|Overall Study|Adverse Event|1|||
162903307|NCT01263470|588344953|FG004|Overall Study|Adverse Event|2|||
162903308|NCT01263470|588344954|FG005|Overall Study|Adverse Event|2|||
162903309|NCT01263470|588344949|FG000|Overall Study|Protocol Violation|0|||
162903310|NCT01263470|588344950|FG001|Overall Study|Protocol Violation|1|||
162903311|NCT01263470|588344951|FG002|Overall Study|Protocol Violation|0|||
162903312|NCT01263470|588344952|FG003|Overall Study|Protocol Violation|0|||
162903313|NCT01263470|588344953|FG004|Overall Study|Protocol Violation|0|||
162903314|NCT01263470|588344954|FG005|Overall Study|Protocol Violation|1|||
162903315|NCT01263470|588344949|FG000|Overall Study|Withdrawal by Subject|0|||
162903316|NCT01263470|588344950|FG001|Overall Study|Withdrawal by Subject|1|||
162903317|NCT01263470|588344951|FG002|Overall Study|Withdrawal by Subject|1|||
162903318|NCT01263470|588344952|FG003|Overall Study|Withdrawal by Subject|2|||
162903319|NCT01263470|588344953|FG004|Overall Study|Withdrawal by Subject|0|||
162903320|NCT01263470|588344954|FG005|Overall Study|Withdrawal by Subject|2|||
162903321|NCT01263470|588344949|FG000|Overall Study|Lack of Efficacy|0|||
162903322|NCT01263470|588344950|FG001|Overall Study|Lack of Efficacy|0|||
162903323|NCT01263470|588344951|FG002|Overall Study|Lack of Efficacy|2|||
162903324|NCT01263470|588344952|FG003|Overall Study|Lack of Efficacy|0|||
162903325|NCT01263470|588344953|FG004|Overall Study|Lack of Efficacy|0|||
162903326|NCT01263470|588344954|FG005|Overall Study|Lack of Efficacy|0|||
162903327|NCT01263470|588344949|FG000|Overall Study|Participant Unavailability|0|||
162903328|NCT01263470|588344950|FG001|Overall Study|Participant Unavailability|1|||
162903329|NCT01263470|588344951|FG002|Overall Study|Participant Unavailability|0|||
162903330|NCT01263470|588344952|FG003|Overall Study|Participant Unavailability|0|||
162903331|NCT01263470|588344953|FG004|Overall Study|Participant Unavailability|0|||
162903332|NCT01263470|588344954|FG005|Overall Study|Participant Unavailability|0|||
162903333|NCT01263470|588344949|FG000|Overall Study|Study Drug Non-compliance|0|||
162903334|NCT01263470|588344950|FG001|Overall Study|Study Drug Non-compliance|0|||
162903335|NCT01263470|588344951|FG002|Overall Study|Study Drug Non-compliance|0|||
162903336|NCT01263470|588344952|FG003|Overall Study|Study Drug Non-compliance|0|||
162903337|NCT01263470|588344953|FG004|Overall Study|Study Drug Non-compliance|1|||
162903338|NCT01263470|588344954|FG005|Overall Study|Study Drug Non-compliance|0|||
162903339|NCT01327573|588344955|FG000|Overall Study|Physician Decision|3|||
162903340|NCT01327573|588344956|FG001|Overall Study|Physician Decision|1|||
162903341|NCT03070119|588344957|FG000|Overall Study|Adverse Event|0|||
162903342|NCT03070119|588344958|FG001|Overall Study|Adverse Event|0|||
162903343|NCT03070119|588344959|FG002|Overall Study|Adverse Event|1|||
162903344|NCT03070119|588344957|FG000|Overall Study|Lost to Follow-up|0|||
162903345|NCT03070119|588344958|FG001|Overall Study|Lost to Follow-up|1|||
162903346|NCT03070119|588344959|FG002|Overall Study|Lost to Follow-up|0|||
162903347|NCT03070119|588344957|FG000|Overall Study|Consent Withdrawn|6|||
162903348|NCT03070119|588344958|FG001|Overall Study|Consent Withdrawn|5|||
162903349|NCT03070119|588344959|FG002|Overall Study|Consent Withdrawn|3|||
162903350|NCT03070119|588344957|FG000|Overall Study|Investigator Decision|0|||
162903351|NCT03070119|588344958|FG001|Overall Study|Investigator Decision|0|||
162903352|NCT03070119|588344959|FG002|Overall Study|Investigator Decision|1|||
162903353|NCT03070119|588344957|FG000|Overall Study|Death|7|||
162903354|NCT03070119|588344958|FG001|Overall Study|Death|14|||
162903355|NCT03070119|588344959|FG002|Overall Study|Death|5|||
162903356|NCT03070119|588344957|FG000|Overall Study|Disease Progression|5|||
162903357|NCT03070119|588344958|FG001|Overall Study|Disease Progression|7|||
162903358|NCT03070119|588344959|FG002|Overall Study|Disease Progression|7|||
162903359|NCT03070119|588344957|FG000|Overall Study|Reason not Specified|2|||
162903360|NCT03070119|588344958|FG001|Overall Study|Reason not Specified|2|||
162903361|NCT03070119|588344959|FG002|Overall Study|Reason not Specified|1|||
162903362|NCT01996865|588344960|FG000|Induction Period|Protocol Violation|1|||
162903363|NCT01996865|588344961|FG001|Induction Period|Protocol Violation|0|||
162903364|NCT01996865|588344962|FG002|Induction Period|Protocol Violation|0|||
162903365|NCT01996865|588344960|FG000|Induction Period|Progressive Disease|4|||
162903366|NCT01996865|588344961|FG001|Induction Period|Progressive Disease|0|||
162903367|NCT01996865|588344962|FG002|Induction Period|Progressive Disease|0|||
162903368|NCT01996865|588344960|FG000|Induction Period|Lost to Follow-up|10|||
162903369|NCT01996865|588344961|FG001|Induction Period|Lost to Follow-up|0|||
162903370|NCT01996865|588344962|FG002|Induction Period|Lost to Follow-up|0|||
162903371|NCT01996865|588344960|FG000|Induction Period|Other Reasons|13|||
162903372|NCT01996865|588344961|FG001|Induction Period|Other Reasons|0|||
162903373|NCT01996865|588344962|FG002|Induction Period|Other Reasons|0|||
162903374|NCT01996865|588344960|FG000|Induction Period|Adverse Event|20|||
162903375|NCT01996865|588344961|FG001|Induction Period|Adverse Event|0|||
162903376|NCT01996865|588344962|FG002|Induction Period|Adverse Event|0|||
162903377|NCT01996865|588344960|FG000|Induction Period|Withdrawal by Subject|60|||
162903378|NCT01996865|588344961|FG001|Induction Period|Withdrawal by Subject|0|||
162903379|NCT01996865|588344962|FG002|Induction Period|Withdrawal by Subject|0|||
162903380|NCT01996865|588344960|FG000|Induction Period|Death|111|||
162903381|NCT01996865|588344961|FG001|Induction Period|Death|0|||
162903382|NCT01996865|588344962|FG002|Induction Period|Death|0|||
162903383|NCT01996865|588344960|FG000|Maintenance Period|Protocol Violation|0|||
162903384|NCT01996865|588344961|FG001|Maintenance Period|Protocol Violation|1|||
162903385|NCT01996865|588344962|FG002|Maintenance Period|Protocol Violation|1|||
162903386|NCT01996865|588344960|FG000|Maintenance Period|Other reasons|0|||
162903387|NCT01996865|588344961|FG001|Maintenance Period|Other reasons|8|||
162903388|NCT01996865|588344962|FG002|Maintenance Period|Other reasons|5|||
162966743|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162966744|NCT04556734|588579500|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966745|NCT04556734|588579501|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966746|NCT04556734|588579502|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
162966747|NCT04556734|588579503|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966748|NCT04556734|588579504|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966749|NCT04556734|588579505|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966750|NCT04556734|588579506|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966751|NCT04556734|588579507|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
162966752|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Not reported|0|||
162966753|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Not reported|0|||
162966754|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Not reported|0|||
162966755|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Not reported|0|||
162966756|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Not reported|0|||
162966757|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Not reported|1|||
162966758|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Not reported|0|||
162966759|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Not reported|0|||
162966760|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966761|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966762|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966763|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966764|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162966765|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162903389|NCT01996865|588344960|FG000|Maintenance Period|Progressive Disease|0|||
162903390|NCT01996865|588344961|FG001|Maintenance Period|Progressive Disease|6|||
162903391|NCT01996865|588344962|FG002|Maintenance Period|Progressive Disease|23|||
162903392|NCT01996865|588344960|FG000|Maintenance Period|Withdrawal by Subject|0|||
162903393|NCT01996865|588344961|FG001|Maintenance Period|Withdrawal by Subject|18|||
162903394|NCT01996865|588344962|FG002|Maintenance Period|Withdrawal by Subject|4|||
162966766|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
162903395|NCT01996865|588344960|FG000|Maintenance Period|Adverse Event|0|||
162903396|NCT01996865|588344961|FG001|Maintenance Period|Adverse Event|7|||
162903397|NCT01996865|588344962|FG002|Maintenance Period|Adverse Event|7|||
162903398|NCT01996865|588344960|FG000|Maintenance Period|Death|0|||
162903399|NCT01996865|588344961|FG001|Maintenance Period|Death|15|||
162903400|NCT01996865|588344962|FG002|Maintenance Period|Death|3|||
162966767|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
162966768|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
162966769|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
162903401|NCT01996865|588344960|FG000|Maintenance Period|Lost to Follow-up|0|||
162966770|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
162966771|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
162966772|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
162966773|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
162966774|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
162966775|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
162966776|NCT04556734|588579500|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966777|NCT04556734|588579501|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966778|NCT04556734|588579502|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966779|NCT04556734|588579503|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162966780|NCT04556734|588579504|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
162966781|NCT04556734|588579505|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
162966782|NCT04556734|588579506|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162966783|NCT04556734|588579507|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
162966784|NCT01813435|588579510|FG000|Overall Study|did not finish experimental regimen|1902|||
162966785|NCT01813435|588579511|FG001|Overall Study|did not finish experimental regimen|770|||
162966786|NCT01813435|588579510|FG000|Overall Study|Lost to Follow-up|268|||
162966787|NCT01813435|588579511|FG001|Overall Study|Lost to Follow-up|237|||
162966788|NCT01765751|588579518|FG000|Overall Study|Lost to Follow-up|0|||
162966789|NCT01765751|588579519|FG001|Overall Study|Lost to Follow-up|2|||
162966790|NCT01765751|588579520|FG002|Overall Study|Lost to Follow-up|1|||
162966791|NCT01120899|588579521|FG000|Overall Study|Withdrawal by Subject|3|||
162966792|NCT00452348|588579522|FG000|Overall Study|Adverse Event|6|||
162966793|NCT00452348|588579523|FG001|Overall Study|Adverse Event|9|||
162966794|NCT00452348|588579522|FG000|Overall Study|Lack of Efficacy|10|||
162966795|NCT00452348|588579523|FG001|Overall Study|Lack of Efficacy|9|||
162966796|NCT00452348|588579522|FG000|Overall Study|Lost to Follow-up|14|||
162966797|NCT00452348|588579523|FG001|Overall Study|Lost to Follow-up|8|||
162966798|NCT00452348|588579522|FG000|Overall Study|Protocol Violation|22|||
162966799|NCT00452348|588579523|FG001|Overall Study|Protocol Violation|28|||
162966800|NCT00452348|588579522|FG000|Overall Study|Withdrawal by Subject|18|||
162966801|NCT00452348|588579523|FG001|Overall Study|Withdrawal by Subject|21|||
163053689|NCT02265510|588908379|FG001|Overall Study|Other|1|||
163053690|NCT02265510|588908380|FG002|Overall Study|Other|0|||
163053691|NCT02265510|588908381|FG003|Overall Study|Other|0|||
162966802|NCT00452348|588579522|FG000|Overall Study|Other|9|||
162966803|NCT00452348|588579523|FG001|Overall Study|Other|9|||
162966804|NCT00544167|588579527|FG000|Overall Study|Adverse Event|21|||
162966805|NCT00544167|588579527|FG000|Overall Study|Physician Decision|8|||
162966806|NCT00874549|588579528|FG000|Overall Study|Adverse Event|0|||
162966807|NCT00874549|588579529|FG001|Overall Study|Adverse Event|0|||
162966808|NCT00874549|588579530|FG002|Overall Study|Adverse Event|1|||
163053692|NCT02265510|588908382|FG004|Overall Study|Other|0|||
162903402|NCT01996865|588344961|FG001|Maintenance Period|Lost to Follow-up|2|||
162903403|NCT01996865|588344962|FG002|Maintenance Period|Lost to Follow-up|0|||
162903404|NCT05304611|588344965|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903405|NCT05304611|588344966|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903406|NCT05304611|588344967|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903407|NCT05304611|588344968|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903408|NCT05304611|588344969|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903409|NCT05304611|588344970|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903410|NCT05304611|588344971|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
162903411|NCT05304611|588344972|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903412|NCT05304611|588344973|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
162903413|NCT05304611|588344974|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903414|NCT05304611|588344975|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903415|NCT05304611|588344976|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
162903416|NCT05304611|588344965|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
162903417|NCT05304611|588344966|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
162903418|NCT05304611|588344967|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
162903419|NCT05304611|588344968|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
162903420|NCT05304611|588344969|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
162903421|NCT05304611|588344970|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
162903422|NCT05304611|588344971|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
162966809|NCT00874549|588579531|FG003|Overall Study|Adverse Event|0|||
162966810|NCT00874549|588579528|FG000|Overall Study|Protocol Violation|1|||
162966811|NCT00874549|588579529|FG001|Overall Study|Protocol Violation|0|||
162966812|NCT00874549|588579530|FG002|Overall Study|Protocol Violation|2|||
162966813|NCT00874549|588579531|FG003|Overall Study|Protocol Violation|1|||
162966814|NCT00874549|588579528|FG000|Overall Study|Lost to Follow-up|0|||
162966815|NCT00874549|588579529|FG001|Overall Study|Lost to Follow-up|0|||
162966816|NCT00874549|588579530|FG002|Overall Study|Lost to Follow-up|1|||
162903423|NCT05304611|588344972|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
162903424|NCT05304611|588344973|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
162903425|NCT05304611|588344974|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
162903426|NCT05304611|588344975|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
162903427|NCT05304611|588344976|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
162903428|NCT05304611|588344965|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
162903429|NCT05304611|588344966|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
162903430|NCT05304611|588344967|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
162903431|NCT05304611|588344968|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
162903432|NCT05304611|588344969|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
162903433|NCT05304611|588344970|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
162903434|NCT05304611|588344971|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
162903435|NCT05304611|588344972|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
162903436|NCT05304611|588344973|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
162903437|NCT05304611|588344974|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
162903438|NCT05304611|588344975|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
162903439|NCT05304611|588344976|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
162903440|NCT00963820|588344981|FG000|Dose Escalation Phase|Progressive Disease|3|||
162903441|NCT00963820|588344982|FG001|Dose Escalation Phase|Progressive Disease|3|||
162903442|NCT00963820|588344983|FG002|Dose Escalation Phase|Progressive Disease|3|||
162903443|NCT00963820|588344984|FG003|Dose Escalation Phase|Progressive Disease|3|||
162903444|NCT00963820|588344985|FG004|Dose Escalation Phase|Progressive Disease|4|||
162903445|NCT00963820|588344986|FG005|Dose Escalation Phase|Progressive Disease|3|||
162903446|NCT00963820|588344987|FG006|Dose Escalation Phase|Progressive Disease|3|||
162903447|NCT00963820|588344988|FG007|Dose Escalation Phase|Progressive Disease|2|||
162903448|NCT00963820|588344989|FG008|Dose Escalation Phase|Progressive Disease|0|||
162903449|NCT00963820|588344990|FG009|Dose Escalation Phase|Progressive Disease|0|||
162903450|NCT00963820|588344991|FG010|Dose Escalation Phase|Progressive Disease|0|||
162903451|NCT00963820|588344992|FG011|Dose Escalation Phase|Progressive Disease|0|||
162903452|NCT00963820|588344981|FG000|Dose Escalation Phase|Adverse Event|0|||
162903453|NCT00963820|588344982|FG001|Dose Escalation Phase|Adverse Event|0|||
162903454|NCT00963820|588344983|FG002|Dose Escalation Phase|Adverse Event|0|||
162903455|NCT00963820|588344984|FG003|Dose Escalation Phase|Adverse Event|0|||
162903456|NCT00963820|588344985|FG004|Dose Escalation Phase|Adverse Event|0|||
162903457|NCT00963820|588344986|FG005|Dose Escalation Phase|Adverse Event|0|||
162903458|NCT00963820|588344987|FG006|Dose Escalation Phase|Adverse Event|3|||
162903459|NCT00963820|588344988|FG007|Dose Escalation Phase|Adverse Event|1|||
162903460|NCT00963820|588344989|FG008|Dose Escalation Phase|Adverse Event|0|||
162903461|NCT00963820|588344990|FG009|Dose Escalation Phase|Adverse Event|0|||
162903462|NCT00963820|588344991|FG010|Dose Escalation Phase|Adverse Event|0|||
162903463|NCT00963820|588344992|FG011|Dose Escalation Phase|Adverse Event|0|||
162903464|NCT00963820|588344981|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
162903465|NCT00963820|588344982|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162903466|NCT00963820|588344983|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162903467|NCT00963820|588344984|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162903468|NCT00963820|588344985|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
162903469|NCT00963820|588344986|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
162903470|NCT00963820|588344987|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
162903471|NCT00963820|588344988|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
163053693|NCT02265510|588908383|FG005|Overall Study|Other|0|||
163053694|NCT02265510|588908384|FG006|Overall Study|Other|0|||
162903472|NCT00963820|588344989|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
162903473|NCT00963820|588344990|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
162903474|NCT00963820|588344991|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
162903475|NCT00963820|588344992|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
162903476|NCT00963820|588344981|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903477|NCT00963820|588344982|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903478|NCT00963820|588344983|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903479|NCT00963820|588344984|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903480|NCT00963820|588344985|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903481|NCT00963820|588344986|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903482|NCT00963820|588344987|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
162903483|NCT00963820|588344988|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903484|NCT00963820|588344989|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903485|NCT00963820|588344990|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903486|NCT00963820|588344991|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
162903487|NCT00963820|588344992|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163053695|NCT02265510|588908385|FG007|Overall Study|Other|0|||
162903488|NCT00963820|588344981|FG000|Expansion Phase|Progressive Disease|0|||
162903489|NCT00963820|588344982|FG001|Expansion Phase|Progressive Disease|0|||
162903490|NCT00963820|588344983|FG002|Expansion Phase|Progressive Disease|0|||
162903491|NCT00963820|588344984|FG003|Expansion Phase|Progressive Disease|0|||
162903492|NCT00963820|588344985|FG004|Expansion Phase|Progressive Disease|0|||
162903493|NCT00963820|588344986|FG005|Expansion Phase|Progressive Disease|0|||
162903494|NCT00963820|588344987|FG006|Expansion Phase|Progressive Disease|0|||
162903495|NCT00963820|588344988|FG007|Expansion Phase|Progressive Disease|0|||
162903496|NCT00963820|588344989|FG008|Expansion Phase|Progressive Disease|8|||
162903497|NCT00963820|588344990|FG009|Expansion Phase|Progressive Disease|6|||
162903498|NCT00963820|588344991|FG010|Expansion Phase|Progressive Disease|4|||
162903499|NCT00963820|588344992|FG011|Expansion Phase|Progressive Disease|2|||
162903500|NCT00963820|588344981|FG000|Expansion Phase|Adverse Event|0|||
162903501|NCT00963820|588344982|FG001|Expansion Phase|Adverse Event|0|||
162903502|NCT00963820|588344983|FG002|Expansion Phase|Adverse Event|0|||
162903503|NCT00963820|588344984|FG003|Expansion Phase|Adverse Event|0|||
162903504|NCT00963820|588344985|FG004|Expansion Phase|Adverse Event|0|||
162903505|NCT00963820|588344986|FG005|Expansion Phase|Adverse Event|0|||
162903506|NCT00963820|588344987|FG006|Expansion Phase|Adverse Event|0|||
162903507|NCT00963820|588344988|FG007|Expansion Phase|Adverse Event|0|||
162903508|NCT00963820|588344989|FG008|Expansion Phase|Adverse Event|1|||
162903509|NCT00963820|588344990|FG009|Expansion Phase|Adverse Event|3|||
162903510|NCT00963820|588344991|FG010|Expansion Phase|Adverse Event|0|||
162903511|NCT00963820|588344992|FG011|Expansion Phase|Adverse Event|0|||
162903512|NCT00963820|588344981|FG000|Expansion Phase|Withdrawal by Subject|0|||
162903513|NCT00963820|588344982|FG001|Expansion Phase|Withdrawal by Subject|0|||
162903514|NCT00963820|588344983|FG002|Expansion Phase|Withdrawal by Subject|0|||
162903515|NCT00963820|588344984|FG003|Expansion Phase|Withdrawal by Subject|0|||
162903516|NCT00963820|588344985|FG004|Expansion Phase|Withdrawal by Subject|0|||
162903517|NCT00963820|588344986|FG005|Expansion Phase|Withdrawal by Subject|0|||
162903518|NCT00963820|588344987|FG006|Expansion Phase|Withdrawal by Subject|0|||
162903519|NCT00963820|588344988|FG007|Expansion Phase|Withdrawal by Subject|0|||
162903520|NCT00963820|588344989|FG008|Expansion Phase|Withdrawal by Subject|1|||
162903521|NCT00963820|588344990|FG009|Expansion Phase|Withdrawal by Subject|0|||
162903522|NCT00963820|588344991|FG010|Expansion Phase|Withdrawal by Subject|1|||
162903523|NCT00963820|588344992|FG011|Expansion Phase|Withdrawal by Subject|1|||
162903524|NCT00963820|588344981|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903525|NCT00963820|588344982|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903526|NCT00963820|588344983|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903527|NCT00963820|588344984|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903528|NCT00963820|588344985|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903529|NCT00963820|588344986|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903530|NCT00963820|588344987|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903531|NCT00963820|588344988|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903532|NCT00963820|588344989|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903533|NCT00963820|588344990|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903534|NCT00963820|588344991|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
162903535|NCT00963820|588344992|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
162903536|NCT02756845|588344998|FG000|Overall Study|Death|12|||
162903537|NCT02756845|588344999|FG001|Overall Study|Death|2|||
162903538|NCT02756845|588344998|FG000|Overall Study|Withdrawal by Subject|1|||
162903539|NCT02756845|588344999|FG001|Overall Study|Withdrawal by Subject|0|||
162903540|NCT02005211|588345004|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903541|NCT02005211|588345005|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903542|NCT02005211|588345006|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903543|NCT02005211|588345007|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903544|NCT02005211|588345008|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
162903545|NCT02005211|588345009|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903546|NCT02005211|588345010|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
162903547|NCT00397631|588345013|FG000|Overall Study|Adverse Event|5|||
162903548|NCT00397631|588345014|FG001|Overall Study|Adverse Event|6|||
162903549|NCT00397631|588345013|FG000|Overall Study|Lack of Efficacy|7|||
162903550|NCT00397631|588345014|FG001|Overall Study|Lack of Efficacy|10|||
162903551|NCT00397631|588345013|FG000|Overall Study|Lost to Follow-up|8|||
162903552|NCT00397631|588345014|FG001|Overall Study|Lost to Follow-up|9|||
162903553|NCT00397631|588345013|FG000|Overall Study|Physician Decision|2|||
162903554|NCT00397631|588345014|FG001|Overall Study|Physician Decision|0|||
162903555|NCT00397631|588345013|FG000|Overall Study|Protocol Violation|0|||
162903556|NCT00397631|588345014|FG001|Overall Study|Protocol Violation|1|||
162903557|NCT00397631|588345013|FG000|Overall Study|Withdrawal by Subject|7|||
162903558|NCT00397631|588345014|FG001|Overall Study|Withdrawal by Subject|14|||
162903559|NCT00397631|588345013|FG000|Overall Study|protocol discontinuation criteria|1|||
162903560|NCT00397631|588345014|FG001|Overall Study|protocol discontinuation criteria|4|||
162903561|NCT02202161|588345015|FG000|Overall Study|Adverse Event|1|||
162903562|NCT02202161|588345016|FG001|Overall Study|Adverse Event|1|||
162903563|NCT02202161|588345017|FG002|Overall Study|Adverse Event|0|||
162903564|NCT02202161|588345018|FG003|Overall Study|Adverse Event|0|||
162903565|NCT02202161|588345019|FG004|Overall Study|Adverse Event|0|||
162903566|NCT02202161|588345020|FG005|Overall Study|Adverse Event|1|||
162903567|NCT02202161|588345021|FG006|Overall Study|Adverse Event|0|||
162903568|NCT02202161|588345022|FG007|Overall Study|Adverse Event|0|||
162903569|NCT02202161|588345015|FG000|Overall Study|Did not meet continuation criteria|0|||
162903570|NCT02202161|588345016|FG001|Overall Study|Did not meet continuation criteria|0|||
162903571|NCT02202161|588345017|FG002|Overall Study|Did not meet continuation criteria|0|||
162903572|NCT02202161|588345018|FG003|Overall Study|Did not meet continuation criteria|0|||
162903573|NCT02202161|588345019|FG004|Overall Study|Did not meet continuation criteria|0|||
162903574|NCT02202161|588345020|FG005|Overall Study|Did not meet continuation criteria|0|||
162903575|NCT02202161|588345021|FG006|Overall Study|Did not meet continuation criteria|0|||
162903576|NCT02202161|588345022|FG007|Overall Study|Did not meet continuation criteria|3|||
162903577|NCT02202161|588345015|FG000|Overall Study|Physician Decision|0|||
162903578|NCT02202161|588345016|FG001|Overall Study|Physician Decision|0|||
162903579|NCT02202161|588345017|FG002|Overall Study|Physician Decision|0|||
162903580|NCT02202161|588345018|FG003|Overall Study|Physician Decision|0|||
162903581|NCT02202161|588345019|FG004|Overall Study|Physician Decision|0|||
162903582|NCT02202161|588345020|FG005|Overall Study|Physician Decision|0|||
162903583|NCT02202161|588345021|FG006|Overall Study|Physician Decision|0|||
162903584|NCT02202161|588345022|FG007|Overall Study|Physician Decision|3|||
162903585|NCT02202161|588345015|FG000|Overall Study|Withdrawal by Subject|0|||
162903586|NCT02202161|588345016|FG001|Overall Study|Withdrawal by Subject|0|||
162903587|NCT02202161|588345017|FG002|Overall Study|Withdrawal by Subject|0|||
162903588|NCT02202161|588345018|FG003|Overall Study|Withdrawal by Subject|0|||
162903589|NCT02202161|588345019|FG004|Overall Study|Withdrawal by Subject|1|||
162903590|NCT02202161|588345020|FG005|Overall Study|Withdrawal by Subject|0|||
162903591|NCT02202161|588345021|FG006|Overall Study|Withdrawal by Subject|0|||
162903592|NCT02202161|588345022|FG007|Overall Study|Withdrawal by Subject|0|||
162903593|NCT03685643|588345025|FG000|Overall Study|Lost to Follow-up|14|||
162903594|NCT03685643|588345026|FG001|Overall Study|Lost to Follow-up|22|||
162903595|NCT03797144|588345027|FG000|Enrollment|Protocol Violation|4|||
162903596|NCT03797144|588345028|FG001|Enrollment|Protocol Violation|1|||
162903597|NCT03797144|588345027|FG000|Surgery|Protocol Violation|1|||
162903598|NCT03797144|588345028|FG001|Surgery|Protocol Violation|0|||
162903599|NCT03797144|588345027|FG000|3 Month|Early termination cut-off date|2|||
162903600|NCT03797144|588345028|FG001|3 Month|Early termination cut-off date|0|||
162903601|NCT03797144|588345027|FG000|12 Month|Early termination cut-off date|8|||
162903602|NCT03797144|588345028|FG001|12 Month|Early termination cut-off date|9|||
162903603|NCT03797144|588345027|FG000|24 Month|Early termination cut-off date|1|||
162903604|NCT03797144|588345028|FG001|24 Month|Early termination cut-off date|1|||
162903605|NCT03299166|588345031|FG000|Overall Study|Adverse Event|9|||
162903606|NCT03299166|588345032|FG001|Overall Study|Adverse Event|4|||
162903607|NCT03299166|588345031|FG000|Overall Study|Withdrawal by Subject|6|||
162903608|NCT03299166|588345032|FG001|Overall Study|Withdrawal by Subject|5|||
162903609|NCT03299166|588345031|FG000|Overall Study|Physician Decision|1|||
162903610|NCT03299166|588345032|FG001|Overall Study|Physician Decision|1|||
162903611|NCT03299166|588345031|FG000|Overall Study|Sponsor Decision|3|||
162903612|NCT03299166|588345032|FG001|Overall Study|Sponsor Decision|0|||
162903613|NCT03299166|588345031|FG000|Overall Study|Lost to Follow-up|2|||
162903614|NCT03299166|588345032|FG001|Overall Study|Lost to Follow-up|4|||
162903615|NCT03299166|588345031|FG000|Overall Study|Randomization Error|0|||
162903616|NCT03299166|588345032|FG001|Overall Study|Randomization Error|1|||
162903617|NCT03299166|588345031|FG000|Overall Study|Subject unable to return due to COVID|1|||
162903618|NCT03299166|588345032|FG001|Overall Study|Subject unable to return due to COVID|0|||
162903619|NCT03299166|588345031|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
162903620|NCT03299166|588345032|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
162903621|NCT00707486|588345037|FG000|Overall Study|Withdrawal by Subject|1|||
162903622|NCT01682759|588345051|FG000|Overall Study|Death|2|||
162903623|NCT01682759|588345052|FG001|Overall Study|Death|1|||
162903624|NCT01682759|588345051|FG000|Overall Study|Lost to Follow-up|10|||
162903625|NCT01682759|588345052|FG001|Overall Study|Lost to Follow-up|13|||
162903626|NCT01682759|588345051|FG000|Overall Study|Physician Decision|1|||
162903627|NCT01682759|588345052|FG001|Overall Study|Physician Decision|1|||
162966817|NCT00874549|588579531|FG003|Overall Study|Lost to Follow-up|0|||
162966818|NCT00874549|588579528|FG000|Overall Study|Withdrawal by Subject|0|||
162966819|NCT00874549|588579529|FG001|Overall Study|Withdrawal by Subject|1|||
162903628|NCT01682759|588345051|FG000|Overall Study|Withdrawal by Subject|56|||
162903629|NCT01682759|588345052|FG001|Overall Study|Withdrawal by Subject|55|||
162903630|NCT02972658|588347094|FG000|Overall Study|Adverse Event|0|||
162903631|NCT02972658|588347095|FG001|Overall Study|Adverse Event|3|||
162903632|NCT02972658|588347096|FG002|Overall Study|Adverse Event|0|||
162903633|NCT02972658|588347097|FG003|Overall Study|Adverse Event|2|||
162903634|NCT02972658|588347094|FG000|Overall Study|Other-determined by Investigator|1|||
162903635|NCT02972658|588347095|FG001|Overall Study|Other-determined by Investigator|1|||
162903636|NCT02972658|588347096|FG002|Overall Study|Other-determined by Investigator|0|||
162903637|NCT02972658|588347097|FG003|Overall Study|Other-determined by Investigator|0|||
162903638|NCT02972658|588347094|FG000|Overall Study|Death|0|||
162903639|NCT02972658|588347095|FG001|Overall Study|Death|0|||
162903640|NCT02972658|588347096|FG002|Overall Study|Death|0|||
162903641|NCT02972658|588347097|FG003|Overall Study|Death|1|||
162903642|NCT02972658|588347094|FG000|Overall Study|Lost to Follow-up|0|||
162903643|NCT02972658|588347095|FG001|Overall Study|Lost to Follow-up|1|||
163053696|NCT02265510|588908386|FG008|Overall Study|Other|0|||
163053697|NCT02265510|588908387|FG009|Overall Study|Other|0|||
163053698|NCT02265510|588908388|FG010|Overall Study|Other|0|||
163053699|NCT02265510|588908389|FG011|Overall Study|Other|0|||
162903644|NCT02972658|588347096|FG002|Overall Study|Lost to Follow-up|1|||
162903645|NCT02972658|588347097|FG003|Overall Study|Lost to Follow-up|2|||
162903646|NCT02972658|588347094|FG000|Overall Study|Progressive Disease|0|||
162903647|NCT02972658|588347095|FG001|Overall Study|Progressive Disease|1|||
162903648|NCT02972658|588347096|FG002|Overall Study|Progressive Disease|0|||
162903649|NCT02972658|588347097|FG003|Overall Study|Progressive Disease|1|||
162903650|NCT02972658|588347094|FG000|Overall Study|Withdrawal by Subject|4|||
162903651|NCT02972658|588347095|FG001|Overall Study|Withdrawal by Subject|4|||
162903652|NCT02972658|588347096|FG002|Overall Study|Withdrawal by Subject|1|||
162903653|NCT02972658|588347097|FG003|Overall Study|Withdrawal by Subject|6|||
162903654|NCT02972658|588347094|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
162903655|NCT02972658|588347095|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
162903656|NCT02972658|588347096|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
162903657|NCT02972658|588347097|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
162903658|NCT02972658|588347094|FG000|Overall Study|Sponsor Decision|70|||
162903659|NCT02972658|588347095|FG001|Overall Study|Sponsor Decision|127|||
162903660|NCT02972658|588347096|FG002|Overall Study|Sponsor Decision|72|||
162903661|NCT02972658|588347097|FG003|Overall Study|Sponsor Decision|119|||
162903662|NCT03958149|588347102|FG000|Overall Study|Withdrawal by Subject|0|||
162903663|NCT03958149|588347103|FG001|Overall Study|Withdrawal by Subject|1|||
162903664|NCT02785588|588347104|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
162903665|NCT02785588|588347104|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
162903666|NCT03037489|588347105|FG000|Overall Study|Adverse Event|4|||
162903667|NCT03037489|588347106|FG001|Overall Study|Adverse Event|0|||
162903668|NCT03037489|588347105|FG000|Overall Study|Withdrawal by Subject|3|||
162903669|NCT03037489|588347106|FG001|Overall Study|Withdrawal by Subject|0|||
162903670|NCT00724243|588347108|FG000|Overall Study|Lack of Efficacy|10|||
162903671|NCT00724243|588347108|FG000|Overall Study|Adverse Event|5|||
162903672|NCT03031327|588347109|FG000|Overall Study|Withdrawal by Subject|0|||
162903673|NCT03031327|588347110|FG001|Overall Study|Withdrawal by Subject|1|||
162903674|NCT03031327|588347111|FG002|Overall Study|Withdrawal by Subject|1|||
162903675|NCT00669240|588347112|FG000|Overall Study|Lack of Efficacy|33|||
162903676|NCT00669240|588347112|FG000|Overall Study|Withdrawal by Subject|42|||
162903677|NCT00669240|588347112|FG000|Overall Study|Lost to Follow-up|34|||
162903678|NCT00669240|588347112|FG000|Overall Study|Adverse Event|21|||
162903679|NCT00669240|588347112|FG000|Overall Study|Other|19|||
162903680|NCT00669240|588347112|FG000|Overall Study|Enrolled but not treated|15|||
162903681|NCT00669240|588347112|FG000|Overall Study|Enrolled but no dosing record|1|||
162903682|NCT03793010|588347113|FG000|Overall Study|Withdrawal by Subject|5|||
162903683|NCT03793010|588347114|FG001|Overall Study|Withdrawal by Subject|7|||
162903684|NCT03793010|588347113|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
162903685|NCT03793010|588347114|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
162903686|NCT03793010|588347113|FG000|Overall Study|Lost to Follow-up|1|||
162903687|NCT03793010|588347114|FG001|Overall Study|Lost to Follow-up|2|||
162903688|NCT03793010|588347113|FG000|Overall Study|Patient couldn't sit still for injection|1|||
162903689|NCT03793010|588347114|FG001|Overall Study|Patient couldn't sit still for injection|0|||
162903690|NCT03793010|588347113|FG000|Overall Study|Withdrew to pursue other treatment|1|||
162903691|NCT03793010|588347114|FG001|Overall Study|Withdrew to pursue other treatment|0|||
162903692|NCT03793010|588347113|FG000|Overall Study|Did not meet eligibility criteria|1|||
162903693|NCT03793010|588347114|FG001|Overall Study|Did not meet eligibility criteria|0|||
162903694|NCT01997892|588347119|FG000|Overall Study|Physician Decision|2|||
162903695|NCT01997892|588347119|FG000|Overall Study|Lost to Follow-up|6|||
162903696|NCT01997892|588347119|FG000|Overall Study|Death|14|||
162903697|NCT01997892|588347119|FG000|Overall Study|Renal transplant|8|||
162903698|NCT01997892|588347119|FG000|Overall Study|Other|3|||
162903699|NCT01997892|588347119|FG000|Overall Study|Study completion data not recorded|35|||
162903700|NCT00364611|588347120|FG000|Overall Study|Did not receive study medication|0|||
162903701|NCT00364611|588347121|FG001|Overall Study|Did not receive study medication|1|||
162903702|NCT00364611|588347120|FG000|Overall Study|Adverse Event|7|||
162903703|NCT00364611|588347121|FG001|Overall Study|Adverse Event|4|||
162903704|NCT00364611|588347120|FG000|Overall Study|Participant's Request|3|||
162903705|NCT00364611|588347121|FG001|Overall Study|Participant's Request|4|||
162903706|NCT00364611|588347120|FG000|Overall Study|Disease Progression|38|||
163053700|NCT02265510|588908390|FG012|Overall Study|Other|0|||
163053701|NCT02265510|588908391|FG013|Overall Study|Other|0|||
162903707|NCT00364611|588347121|FG001|Overall Study|Disease Progression|8|||
162903708|NCT00364611|588347120|FG000|Overall Study|Investigator decision|2|||
162903709|NCT00364611|588347121|FG001|Overall Study|Investigator decision|2|||
162903710|NCT00364611|588347120|FG000|Overall Study|Found Ineligible|1|||
162903711|NCT00364611|588347121|FG001|Overall Study|Found Ineligible|0|||
162903712|NCT00364611|588347120|FG000|Overall Study|Presumed CR on Study|0|||
162903713|NCT00364611|588347121|FG001|Overall Study|Presumed CR on Study|1|||
162903714|NCT00364611|588347120|FG000|Overall Study|Receiving Liver Ablation|0|||
162903715|NCT00364611|588347121|FG001|Overall Study|Receiving Liver Ablation|1|||
162903716|NCT02531633|588347122|FG000|Part A (52 Weeks)|Sponsor request|24|||
162903717|NCT02531633|588347123|FG001|Part A (52 Weeks)|Sponsor request|24|||
162903718|NCT02531633|588347124|FG002|Part A (52 Weeks)|Sponsor request|18|||
162903719|NCT02531633|588347125|FG003|Part A (52 Weeks)|Sponsor request|18|||
162903720|NCT02531633|588347126|FG004|Part A (52 Weeks)|Sponsor request|19|||
162903721|NCT02531633|588347127|FG005|Part A (52 Weeks)|Sponsor request|0|||
162903722|NCT02531633|588347128|FG006|Part A (52 Weeks)|Sponsor request|0|||
162903723|NCT02531633|588347129|FG007|Part A (52 Weeks)|Sponsor request|0|||
162903724|NCT02531633|588347130|FG008|Part A (52 Weeks)|Sponsor request|0|||
162903725|NCT02531633|588347131|FG009|Part A (52 Weeks)|Sponsor request|0|||
162903726|NCT02531633|588347122|FG000|Part A (52 Weeks)|Protocol Violation|1|||
162903727|NCT02531633|588347123|FG001|Part A (52 Weeks)|Protocol Violation|0|||
162903728|NCT02531633|588347124|FG002|Part A (52 Weeks)|Protocol Violation|0|||
162903729|NCT02531633|588347125|FG003|Part A (52 Weeks)|Protocol Violation|0|||
162903730|NCT02531633|588347126|FG004|Part A (52 Weeks)|Protocol Violation|0|||
162903731|NCT02531633|588347127|FG005|Part A (52 Weeks)|Protocol Violation|0|||
162903732|NCT02531633|588347128|FG006|Part A (52 Weeks)|Protocol Violation|0|||
162903733|NCT02531633|588347129|FG007|Part A (52 Weeks)|Protocol Violation|0|||
162903734|NCT02531633|588347130|FG008|Part A (52 Weeks)|Protocol Violation|0|||
162903735|NCT02531633|588347131|FG009|Part A (52 Weeks)|Protocol Violation|0|||
162903736|NCT02531633|588347122|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
162903737|NCT02531633|588347123|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
162903738|NCT02531633|588347124|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
162903739|NCT02531633|588347125|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
162903740|NCT02531633|588347126|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
162903741|NCT02531633|588347127|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
162903742|NCT02531633|588347128|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
162903743|NCT02531633|588347129|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
162903744|NCT02531633|588347130|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
162903745|NCT02531633|588347131|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
162903746|NCT02531633|588347122|FG000|Part A (52 Weeks)|Physician Decision|1|||
162903747|NCT02531633|588347123|FG001|Part A (52 Weeks)|Physician Decision|4|||
162903748|NCT02531633|588347124|FG002|Part A (52 Weeks)|Physician Decision|3|||
162903749|NCT02531633|588347125|FG003|Part A (52 Weeks)|Physician Decision|1|||
162903750|NCT02531633|588347126|FG004|Part A (52 Weeks)|Physician Decision|0|||
162903751|NCT02531633|588347127|FG005|Part A (52 Weeks)|Physician Decision|0|||
162903752|NCT02531633|588347128|FG006|Part A (52 Weeks)|Physician Decision|0|||
162903753|NCT02531633|588347129|FG007|Part A (52 Weeks)|Physician Decision|0|||
162903754|NCT02531633|588347130|FG008|Part A (52 Weeks)|Physician Decision|0|||
162903755|NCT02531633|588347131|FG009|Part A (52 Weeks)|Physician Decision|0|||
162903756|NCT02531633|588347122|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
162903757|NCT02531633|588347123|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
162903758|NCT02531633|588347124|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
162903759|NCT02531633|588347125|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
162903760|NCT02531633|588347126|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
162903761|NCT02531633|588347127|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
162903762|NCT02531633|588347128|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
162903763|NCT02531633|588347129|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
162903764|NCT02531633|588347130|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
162903765|NCT02531633|588347131|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
162903766|NCT02531633|588347122|FG000|Part A (52 Weeks)|Other|2|||
162903767|NCT02531633|588347123|FG001|Part A (52 Weeks)|Other|0|||
162903768|NCT02531633|588347124|FG002|Part A (52 Weeks)|Other|0|||
162903769|NCT02531633|588347125|FG003|Part A (52 Weeks)|Other|0|||
162903770|NCT02531633|588347126|FG004|Part A (52 Weeks)|Other|0|||
162708823|NCT04949399|587642910|FG000|Overall Study|Withdrawal by Subject|2|||
162708824|NCT04949399|587642911|FG001|Overall Study|Withdrawal by Subject|3|||
162708825|NCT01515319|587642912|FG000|Overall Study|Withdrawal by Subject|0|||
162708826|NCT01515319|587642913|FG001|Overall Study|Withdrawal by Subject|0|||
162708827|NCT01515319|587642914|FG002|Overall Study|Withdrawal by Subject|0|||
162903771|NCT02531633|588347127|FG005|Part A (52 Weeks)|Other|0|||
162903772|NCT02531633|588347128|FG006|Part A (52 Weeks)|Other|0|||
162903773|NCT02531633|588347129|FG007|Part A (52 Weeks)|Other|0|||
162903774|NCT02531633|588347130|FG008|Part A (52 Weeks)|Other|0|||
162903775|NCT02531633|588347131|FG009|Part A (52 Weeks)|Other|0|||
162903776|NCT02531633|588347122|FG000|Part B (104 Weeks)|Sponsor request|0|||
162903777|NCT02531633|588347123|FG001|Part B (104 Weeks)|Sponsor request|0|||
162903778|NCT02531633|588347124|FG002|Part B (104 Weeks)|Sponsor request|0|||
162903779|NCT02531633|588347125|FG003|Part B (104 Weeks)|Sponsor request|0|||
162708828|NCT01515319|587642915|FG003|Overall Study|Withdrawal by Subject|0|||
162903780|NCT02531633|588347126|FG004|Part B (104 Weeks)|Sponsor request|0|||
162903781|NCT02531633|588347127|FG005|Part B (104 Weeks)|Sponsor request|8|||
162903782|NCT02531633|588347128|FG006|Part B (104 Weeks)|Sponsor request|5|||
162903783|NCT02531633|588347129|FG007|Part B (104 Weeks)|Sponsor request|3|||
162903784|NCT02531633|588347130|FG008|Part B (104 Weeks)|Sponsor request|5|||
162903785|NCT02531633|588347131|FG009|Part B (104 Weeks)|Sponsor request|4|||
162903786|NCT02531633|588347122|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
162903787|NCT02531633|588347123|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
162903788|NCT02531633|588347124|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
162903789|NCT02531633|588347125|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
162903790|NCT02531633|588347126|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
162903791|NCT02531633|588347127|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
162903792|NCT02531633|588347128|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
162903793|NCT02531633|588347129|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
162903794|NCT02531633|588347130|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
162903795|NCT02531633|588347131|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
162903796|NCT04097925|588347138|FG000|Overall Study|Withdrawal by Subject|1|||
162903797|NCT02608099|588347139|FG000|Overall Study|Ablation procedure not initiated|3|||
162903798|NCT02608099|588347140|FG001|Overall Study|Ablation procedure not initiated|2|||
162903799|NCT00087594|588347145|FG000|Overall Study|Adverse Event|2|||
162903800|NCT00087594|588347146|FG001|Overall Study|Adverse Event|3|||
162903801|NCT00087594|588347145|FG000|Overall Study|Lost to Follow-up|0|||
162903802|NCT00087594|588347146|FG001|Overall Study|Lost to Follow-up|2|||
162903803|NCT00087594|588347145|FG000|Overall Study|Withdrawal by Subject|4|||
162903804|NCT00087594|588347146|FG001|Overall Study|Withdrawal by Subject|2|||
162903805|NCT00087594|588347145|FG000|Overall Study|Lack of Efficacy|2|||
162903806|NCT00087594|588347146|FG001|Overall Study|Lack of Efficacy|5|||
162903807|NCT01952041|588347150|FG000|Overall Study|Lost to Follow-up|9|||
162903808|NCT01952041|588347151|FG001|Overall Study|Lost to Follow-up|16|||
162903809|NCT01952041|588347150|FG000|Overall Study|Withdrawal by Subject|7|||
162903810|NCT01952041|588347151|FG001|Overall Study|Withdrawal by Subject|5|||
162903811|NCT01952041|588347150|FG000|Overall Study|Death|1|||
162903812|NCT01952041|588347151|FG001|Overall Study|Death|0|||
162903813|NCT01736176|588347152|FG000|Overall Study|Adverse Event|3|||
162903814|NCT01736176|588347152|FG000|Overall Study|Withdrawal by Subject|4|||
162903815|NCT01736176|588347152|FG000|Overall Study|Lack of Efficacy|3|||
162903816|NCT01736176|588347152|FG000|Overall Study|Unable to Complete PEG Placement|1|||
162903817|NCT01569568|588347153|FG000|Overall Study|Physician Decision|0|||
162903818|NCT01569568|588347154|FG001|Overall Study|Physician Decision|2|||
162903819|NCT00290355|588347159|FG000|Overall Study|Serious adverse event|7|||
162903820|NCT00290355|588347160|FG001|Overall Study|Serious adverse event|4|||
162903821|NCT00290355|588347159|FG000|Overall Study|Study product reactogenicity|1|||
162903822|NCT00290355|588347160|FG001|Overall Study|Study product reactogenicity|0|||
162903823|NCT00290355|588347159|FG000|Overall Study|Protocol Violation|1|||
162903824|NCT00290355|588347160|FG001|Overall Study|Protocol Violation|0|||
162903825|NCT00290355|588347159|FG000|Overall Study|Withdrawal by Subject|2|||
162903826|NCT00290355|588347160|FG001|Overall Study|Withdrawal by Subject|0|||
162903827|NCT00290355|588347159|FG000|Overall Study|Migrated / moved from the study area|1|||
162903828|NCT00290355|588347160|FG001|Overall Study|Migrated / moved from the study area|0|||
162903829|NCT00290355|588347159|FG000|Overall Study|Lost to Follow-up|3|||
162708829|NCT01515319|587642916|FG004|Overall Study|Withdrawal by Subject|0|||
162903830|NCT00290355|588347160|FG001|Overall Study|Lost to Follow-up|1|||
162903831|NCT00290355|588347159|FG000|Overall Study|Other|2|||
162903832|NCT00290355|588347160|FG001|Overall Study|Other|0|||
162903833|NCT03345849|588347161|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
162903834|NCT03345849|588347162|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
162903835|NCT03345849|588347163|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
162903836|NCT03345849|588347164|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
162903837|NCT03345849|588347161|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
162903838|NCT03345849|588347162|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
162903839|NCT03345849|588347163|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
162903840|NCT03345849|588347164|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
162903841|NCT03345849|588347161|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
162903842|NCT03345849|588347162|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
162903843|NCT03345849|588347163|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
162903844|NCT03345849|588347164|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
162903845|NCT03345849|588347161|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
162903846|NCT03345849|588347162|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
162903847|NCT03345849|588347163|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
162903848|NCT03345849|588347164|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
162903849|NCT03345849|588347161|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
162903850|NCT03345849|588347162|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
162903851|NCT03345849|588347163|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
162903852|NCT03345849|588347164|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
162903853|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
162903854|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
162903855|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
162903856|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
162966820|NCT00874549|588579530|FG002|Overall Study|Withdrawal by Subject|0|||
162966821|NCT00874549|588579531|FG003|Overall Study|Withdrawal by Subject|1|||
162966822|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
162966823|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
162966824|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
162966825|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
162966826|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
162966827|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
162966828|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
163053702|NCT02265510|588908378|FG000|Overall Study|Study Terminated by Sponsor|0|||
163053703|NCT02265510|588908379|FG001|Overall Study|Study Terminated by Sponsor|0|||
163053704|NCT02265510|588908380|FG002|Overall Study|Study Terminated by Sponsor|0|||
163053705|NCT02265510|588908381|FG003|Overall Study|Study Terminated by Sponsor|0|||
163053706|NCT02265510|588908382|FG004|Overall Study|Study Terminated by Sponsor|0|||
163053707|NCT02265510|588908383|FG005|Overall Study|Study Terminated by Sponsor|1|||
163053708|NCT02265510|588908384|FG006|Overall Study|Study Terminated by Sponsor|1|||
163053709|NCT02265510|588908385|FG007|Overall Study|Study Terminated by Sponsor|1|||
163053710|NCT02265510|588908386|FG008|Overall Study|Study Terminated by Sponsor|1|||
163053711|NCT02265510|588908387|FG009|Overall Study|Study Terminated by Sponsor|2|||
163053712|NCT02265510|588908388|FG010|Overall Study|Study Terminated by Sponsor|1|||
163053713|NCT02265510|588908389|FG011|Overall Study|Study Terminated by Sponsor|4|||
163053714|NCT02265510|588908390|FG012|Overall Study|Study Terminated by Sponsor|1|||
163053715|NCT02265510|588908391|FG013|Overall Study|Study Terminated by Sponsor|2|||
163053716|NCT02530385|588908392|FG000|Overall Study|Withdrawal by Subject|0|||
163053717|NCT02530385|588908393|FG001|Overall Study|Withdrawal by Subject|1|||
162903857|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
162903858|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
162903859|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
162903860|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
162903861|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
162903862|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
162903863|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
162903864|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
162903865|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
162903866|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
162903867|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
162903868|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
162903869|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
162903870|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
162903871|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
162903872|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
162903873|NCT03345849|588347161|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
162903874|NCT03345849|588347162|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
162903875|NCT03345849|588347163|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
162903876|NCT03345849|588347164|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
162903877|NCT00723489|588347167|FG000|Overall Study|Physician Decision|0|||
162903878|NCT00723489|588347168|FG001|Overall Study|Physician Decision|1|||
162903879|NCT00723489|588347169|FG002|Overall Study|Physician Decision|0|||
162903880|NCT00723489|588347170|FG003|Overall Study|Physician Decision|0|||
162903881|NCT00723489|588347167|FG000|Overall Study|Pregnancy|0|||
162903882|NCT00723489|588347168|FG001|Overall Study|Pregnancy|0|||
162903883|NCT00723489|588347169|FG002|Overall Study|Pregnancy|0|||
162966829|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
162966830|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
162966831|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
162966832|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
162708830|NCT01515319|587642917|FG005|Overall Study|Withdrawal by Subject|0|||
162708831|NCT01515319|587642918|FG006|Overall Study|Withdrawal by Subject|1|||
162903884|NCT00723489|588347170|FG003|Overall Study|Pregnancy|1|||
163053718|NCT00116142|588908394|FG000|Overall Study|Adverse Event|8|||
163053719|NCT00116142|588908395|FG001|Overall Study|Adverse Event|7|||
163053720|NCT00116142|588908394|FG000|Overall Study|Protocol Violation|2|||
162903885|NCT00723489|588347167|FG000|Overall Study|Withdrawal by Subject|0|||
162903886|NCT00723489|588347168|FG001|Overall Study|Withdrawal by Subject|0|||
162903887|NCT00723489|588347169|FG002|Overall Study|Withdrawal by Subject|0|||
162903888|NCT00723489|588347170|FG003|Overall Study|Withdrawal by Subject|1|||
162903889|NCT00723489|588347167|FG000|Overall Study|Seropositive at baseline|1|||
162903890|NCT00723489|588347168|FG001|Overall Study|Seropositive at baseline|0|||
162903891|NCT00723489|588347169|FG002|Overall Study|Seropositive at baseline|0|||
162903892|NCT00723489|588347170|FG003|Overall Study|Seropositive at baseline|0|||
162966833|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
162966834|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
162966835|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
162966836|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
162966837|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
162966838|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
162903893|NCT00723489|588347167|FG000|Overall Study|Prohibited Medication|0|||
162903894|NCT00723489|588347168|FG001|Overall Study|Prohibited Medication|0|||
162903895|NCT00723489|588347169|FG002|Overall Study|Prohibited Medication|0|||
162903896|NCT00723489|588347170|FG003|Overall Study|Prohibited Medication|1|||
162903897|NCT00723489|588347167|FG000|Overall Study|Samples Collected Out of Window|0|||
162903898|NCT00723489|588347168|FG001|Overall Study|Samples Collected Out of Window|3|||
162903899|NCT00723489|588347169|FG002|Overall Study|Samples Collected Out of Window|0|||
162966839|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
162966840|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
162966841|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
162966842|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
162966843|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
162966844|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
162966845|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
162966846|NCT01710358|588579534|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
162966847|NCT01710358|588579535|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
162966848|NCT01710358|588579536|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
162966849|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
163053721|NCT00116142|588908395|FG001|Overall Study|Protocol Violation|1|||
163053722|NCT00116142|588908394|FG000|Overall Study|Withdrawal by Subject|5|||
163053723|NCT00116142|588908395|FG001|Overall Study|Withdrawal by Subject|5|||
163053724|NCT00116142|588908394|FG000|Overall Study|Physician Decision|3|||
163053725|NCT00116142|588908395|FG001|Overall Study|Physician Decision|1|||
163053726|NCT00116142|588908394|FG000|Overall Study|Delayed Radiation Therapy|1|||
163053727|NCT00116142|588908395|FG001|Overall Study|Delayed Radiation Therapy|0|||
163053728|NCT00116142|588908394|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
163053729|NCT00116142|588908395|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
163053730|NCT00116142|588908394|FG000|Overall Study|Patient stopped due to depression|0|||
163053731|NCT00116142|588908395|FG001|Overall Study|Patient stopped due to depression|1|||
163053732|NCT00116142|588908394|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
163053733|NCT00116142|588908395|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
163053734|NCT00116142|588908394|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
163053735|NCT00116142|588908395|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
163053736|NCT00116142|588908394|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
163053737|NCT00116142|588908395|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
163053738|NCT03093181|588908396|FG000|Overall Study|Withdrawal by Subject|2|||
163053739|NCT03093181|588908397|FG001|Overall Study|Withdrawal by Subject|1|||
163053740|NCT03093181|588908398|FG002|Overall Study|Withdrawal by Subject|2|||
163053741|NCT03093181|588908396|FG000|Overall Study|Other (Not specified)|1|||
163053742|NCT03093181|588908397|FG001|Overall Study|Other (Not specified)|0|||
163053743|NCT03093181|588908398|FG002|Overall Study|Other (Not specified)|0|||
163053744|NCT03093181|588908396|FG000|Overall Study|Adverse Event|0|||
162903900|NCT00723489|588347170|FG003|Overall Study|Samples Collected Out of Window|0|||
162903901|NCT03657576|588347171|FG000|Overall Study|Death|0|||
162903902|NCT03657576|588347172|FG001|Overall Study|Death|1|||
162966850|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
162966851|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
162966852|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
162966853|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
162966854|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
163053745|NCT03093181|588908397|FG001|Overall Study|Adverse Event|1|||
162903903|NCT03657576|588347173|FG002|Overall Study|Death|1|||
162903904|NCT03657576|588347174|FG003|Overall Study|Death|0|||
162903905|NCT03657576|588347175|FG004|Overall Study|Death|0|||
162966855|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
162966856|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
162903906|NCT03657576|588347176|FG005|Overall Study|Death|0|||
162903907|NCT03657576|588347171|FG000|Overall Study|Withdrawal by Subject|0|||
162903908|NCT03657576|588347172|FG001|Overall Study|Withdrawal by Subject|0|||
162903909|NCT03657576|588347173|FG002|Overall Study|Withdrawal by Subject|0|||
162903910|NCT03657576|588347174|FG003|Overall Study|Withdrawal by Subject|1|||
162903911|NCT03657576|588347175|FG004|Overall Study|Withdrawal by Subject|0|||
162903912|NCT03657576|588347176|FG005|Overall Study|Withdrawal by Subject|0|||
162903913|NCT03657576|588347171|FG000|Overall Study|Screen Fail|0|||
162903914|NCT03657576|588347172|FG001|Overall Study|Screen Fail|0|||
162903915|NCT03657576|588347173|FG002|Overall Study|Screen Fail|0|||
162903916|NCT03657576|588347174|FG003|Overall Study|Screen Fail|0|||
162903917|NCT03657576|588347175|FG004|Overall Study|Screen Fail|0|||
162903918|NCT03657576|588347176|FG005|Overall Study|Screen Fail|5|||
162903919|NCT03657576|588347171|FG000|Overall Study|Disease Progression|1|||
162903920|NCT03657576|588347172|FG001|Overall Study|Disease Progression|1|||
162903921|NCT03657576|588347173|FG002|Overall Study|Disease Progression|0|||
162903922|NCT03657576|588347174|FG003|Overall Study|Disease Progression|5|||
162903923|NCT03657576|588347175|FG004|Overall Study|Disease Progression|0|||
162903924|NCT03657576|588347176|FG005|Overall Study|Disease Progression|0|||
162903925|NCT03657576|588347171|FG000|Overall Study|Insurance Coverage|0|||
162903926|NCT03657576|588347172|FG001|Overall Study|Insurance Coverage|0|||
162903927|NCT03657576|588347173|FG002|Overall Study|Insurance Coverage|0|||
162903928|NCT03657576|588347174|FG003|Overall Study|Insurance Coverage|1|||
162903929|NCT03657576|588347175|FG004|Overall Study|Insurance Coverage|0|||
162903930|NCT03657576|588347176|FG005|Overall Study|Insurance Coverage|0|||
162903931|NCT04437511|588347177|FG000|Overall Study|Adverse Event|50|||
162903932|NCT04437511|588347178|FG001|Overall Study|Adverse Event|21|||
162903933|NCT04437511|588347177|FG000|Overall Study|Death|15|||
162903934|NCT04437511|588347178|FG001|Overall Study|Death|10|||
162903935|NCT04437511|588347177|FG000|Overall Study|Lost to Follow-up|11|||
162903936|NCT04437511|588347178|FG001|Overall Study|Lost to Follow-up|11|||
162903937|NCT04437511|588347177|FG000|Overall Study|Physician Decision|19|||
162903938|NCT04437511|588347178|FG001|Overall Study|Physician Decision|10|||
162903939|NCT04437511|588347177|FG000|Overall Study|Progressive Disease|4|||
162903940|NCT04437511|588347178|FG001|Overall Study|Progressive Disease|7|||
162903941|NCT04437511|588347177|FG000|Overall Study|Withdrawal by Subject|111|||
162903942|NCT04437511|588347178|FG001|Overall Study|Withdrawal by Subject|94|||
162903943|NCT04437511|588347177|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
162903944|NCT04437511|588347178|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
162903945|NCT04437511|588347177|FG000|Overall Study|Continuing Study|7|||
162903946|NCT04437511|588347178|FG001|Overall Study|Continuing Study|5|||
162903947|NCT03093350|588347185|FG000|Overall Study|Death|1|||
162903948|NCT03093350|588347185|FG000|Overall Study|Signed consent, never began treartment|1|||
162903949|NCT00777036|588347186|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
162903950|NCT00777036|588347187|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
162903951|NCT00777036|588347188|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
162903952|NCT00777036|588347189|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
162903953|NCT00777036|588347186|FG000|On Treatment|Administrative Reason By Sponsor|1|||
162903954|NCT00777036|588347187|FG001|On Treatment|Administrative Reason By Sponsor|0|||
162903955|NCT00777036|588347188|FG002|On Treatment|Administrative Reason By Sponsor|9|||
162903956|NCT00777036|588347189|FG003|On Treatment|Administrative Reason By Sponsor|0|||
162903957|NCT00777036|588347186|FG000|On Treatment|Failure to Meet Study Criteria|0|||
162903958|NCT00777036|588347187|FG001|On Treatment|Failure to Meet Study Criteria|1|||
162903959|NCT00777036|588347188|FG002|On Treatment|Failure to Meet Study Criteria|4|||
162903960|NCT00777036|588347189|FG003|On Treatment|Failure to Meet Study Criteria|0|||
162903961|NCT00777036|588347186|FG000|On Treatment|Pregnancy|1|||
162903962|NCT00777036|588347187|FG001|On Treatment|Pregnancy|0|||
162903963|NCT00777036|588347188|FG002|On Treatment|Pregnancy|1|||
162903964|NCT00777036|588347189|FG003|On Treatment|Pregnancy|0|||
162903965|NCT00777036|588347186|FG000|On Treatment|Non-compliance with Study Drug|1|||
162903966|NCT00777036|588347187|FG001|On Treatment|Non-compliance with Study Drug|0|||
162903967|NCT00777036|588347188|FG002|On Treatment|Non-compliance with Study Drug|1|||
162903968|NCT00777036|588347189|FG003|On Treatment|Non-compliance with Study Drug|0|||
162903969|NCT00777036|588347186|FG000|On Treatment|Maximum Clinical Benefit|2|||
162903970|NCT00777036|588347187|FG001|On Treatment|Maximum Clinical Benefit|0|||
162708832|NCT01515319|587642919|FG007|Overall Study|Withdrawal by Subject|0|||
162708833|NCT01515319|587642920|FG008|Overall Study|Withdrawal by Subject|0|||
162903971|NCT00777036|588347188|FG002|On Treatment|Maximum Clinical Benefit|5|||
162903972|NCT00777036|588347189|FG003|On Treatment|Maximum Clinical Benefit|0|||
162903973|NCT00777036|588347186|FG000|On Treatment|Withdrawal by Subject|0|||
162903974|NCT00777036|588347187|FG001|On Treatment|Withdrawal by Subject|2|||
162903975|NCT00777036|588347188|FG002|On Treatment|Withdrawal by Subject|2|||
162903976|NCT00777036|588347189|FG003|On Treatment|Withdrawal by Subject|0|||
162903977|NCT00777036|588347186|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
162903978|NCT00777036|588347187|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
162903979|NCT00777036|588347188|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
162903980|NCT00777036|588347189|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
162903981|NCT00777036|588347186|FG000|On Treatment|Death|0|||
162903982|NCT00777036|588347187|FG001|On Treatment|Death|2|||
162903983|NCT00777036|588347188|FG002|On Treatment|Death|0|||
162903984|NCT00777036|588347189|FG003|On Treatment|Death|0|||
162903985|NCT00777036|588347186|FG000|On Treatment|Study Drug Toxicity|1|||
162903986|NCT00777036|588347187|FG001|On Treatment|Study Drug Toxicity|0|||
162903987|NCT00777036|588347188|FG002|On Treatment|Study Drug Toxicity|4|||
162903988|NCT00777036|588347189|FG003|On Treatment|Study Drug Toxicity|0|||
162903989|NCT00777036|588347186|FG000|On Treatment|Progressive Disease|6|||
162903990|NCT00777036|588347187|FG001|On Treatment|Progressive Disease|4|||
162903991|NCT00777036|588347188|FG002|On Treatment|Progressive Disease|7|||
162903992|NCT00777036|588347189|FG003|On Treatment|Progressive Disease|0|||
162903993|NCT00777036|588347186|FG000|On Treatment|Not Reported|0|||
162903994|NCT00777036|588347187|FG001|On Treatment|Not Reported|0|||
162903995|NCT00777036|588347188|FG002|On Treatment|Not Reported|2|||
162903996|NCT00777036|588347189|FG003|On Treatment|Not Reported|0|||
162903997|NCT00777036|588347186|FG000|On Treatment|Site Closed|0|||
162903998|NCT00777036|588347187|FG001|On Treatment|Site Closed|1|||
162903999|NCT00777036|588347188|FG002|On Treatment|Site Closed|1|||
162904000|NCT00777036|588347189|FG003|On Treatment|Site Closed|0|||
162904001|NCT00777036|588347186|FG000|Follow-Up|Withdrawal by Subject|0|||
162904002|NCT00777036|588347187|FG001|Follow-Up|Withdrawal by Subject|0|||
162904003|NCT00777036|588347188|FG002|Follow-Up|Withdrawal by Subject|5|||
162904004|NCT00777036|588347189|FG003|Follow-Up|Withdrawal by Subject|0|||
162904005|NCT00777036|588347186|FG000|Follow-Up|Death|1|||
162904006|NCT00777036|588347187|FG001|Follow-Up|Death|9|||
162904007|NCT00777036|588347188|FG002|Follow-Up|Death|0|||
162904008|NCT00777036|588347189|FG003|Follow-Up|Death|0|||
162904009|NCT00777036|588347186|FG000|Follow-Up|Lost to Follow-up|3|||
162904010|NCT00777036|588347187|FG001|Follow-Up|Lost to Follow-up|0|||
162904011|NCT00777036|588347188|FG002|Follow-Up|Lost to Follow-up|0|||
162904012|NCT00777036|588347189|FG003|Follow-Up|Lost to Follow-up|0|||
162904013|NCT00777036|588347186|FG000|Follow-Up|Reason Not Specified|4|||
162904014|NCT00777036|588347187|FG001|Follow-Up|Reason Not Specified|0|||
162904015|NCT00777036|588347188|FG002|Follow-Up|Reason Not Specified|13|||
162904016|NCT00777036|588347189|FG003|Follow-Up|Reason Not Specified|0|||
162904017|NCT00777036|588347186|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
162904018|NCT00777036|588347187|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
162904019|NCT00777036|588347188|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
162904020|NCT00777036|588347189|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
162904021|NCT05564039|588347192|FG000|Overall Study|Adverse Event|1|||
162904022|NCT05564039|588347193|FG001|Overall Study|Adverse Event|0|||
162904023|NCT05564039|588347192|FG000|Overall Study|Death|1|||
162904024|NCT05564039|588347193|FG001|Overall Study|Death|1|||
162904025|NCT05564039|588347192|FG000|Overall Study|Lost to Follow-up|3|||
162904026|NCT05564039|588347193|FG001|Overall Study|Lost to Follow-up|2|||
162904027|NCT05564039|588347192|FG000|Overall Study|Withdrawal by Subject|2|||
162904028|NCT05564039|588347193|FG001|Overall Study|Withdrawal by Subject|0|||
162904029|NCT05564039|588347192|FG000|Overall Study|Inadvertent enrollment|3|||
162904030|NCT05564039|588347193|FG001|Overall Study|Inadvertent enrollment|6|||
162904031|NCT00729560|588347194|FG000|Overall Study|Withdrawal by Subject|3|||
162904032|NCT03233308|588347195|FG000|Overall Study|Adverse Event|1|||
162904033|NCT03233308|588347195|FG000|Overall Study|Protocol Violation|1|||
162904034|NCT03662789|588347196|FG000|Overall Study|Lost to Follow-up|1|||
162904035|NCT03662789|588347197|FG001|Overall Study|Lost to Follow-up|2|||
162904036|NCT03662789|588347196|FG000|Overall Study|Could not perform treadmill test|4|||
162904037|NCT03662789|588347197|FG001|Overall Study|Could not perform treadmill test|4|||
162904038|NCT03662789|588347196|FG000|Overall Study|Death|0|||
162904039|NCT03662789|588347197|FG001|Overall Study|Death|1|||
162904040|NCT02136134|588347198|FG000|Overall Study|Death|170|||
162904041|NCT02136134|588347199|FG001|Overall Study|Death|148|||
162904042|NCT02136134|588347198|FG000|Overall Study|Withdrawal by Subject|19|||
162904043|NCT02136134|588347199|FG001|Overall Study|Withdrawal by Subject|10|||
162904044|NCT02136134|588347198|FG000|Overall Study|Lost to Follow-up|3|||
162904045|NCT02136134|588347199|FG001|Overall Study|Lost to Follow-up|3|||
162904046|NCT02136134|588347198|FG000|Overall Study|Uspecified|55|||
162904047|NCT02136134|588347199|FG001|Overall Study|Uspecified|90|||
162904048|NCT00638989|588347200|FG000|Overall Study|Lost to Follow-up|0|||
162904049|NCT00638989|588347201|FG001|Overall Study|Lost to Follow-up|0|||
162626088|NCT05275400|587346978|FG001|Treatment Period|Lack of Efficacy|0|||
162626089|NCT05275400|587346977|FG000|Treatment Period|Sponsor Decision|1|||
162626090|NCT05275400|587346978|FG001|Treatment Period|Sponsor Decision|0|||
162626091|NCT05275400|587346977|FG000|Follow-Up Period|Death|2|||
162626092|NCT05275400|587346978|FG001|Follow-Up Period|Death|0|||
162626093|NCT05275400|587346977|FG000|Follow-Up Period|Protocol Violation|1|||
162626094|NCT05275400|587346978|FG001|Follow-Up Period|Protocol Violation|0|||
162626095|NCT05275400|587346977|FG000|Follow-Up Period|Withdrawal by Subject|3|||
162626096|NCT05275400|587346978|FG001|Follow-Up Period|Withdrawal by Subject|0|||
162626097|NCT01651039|587346980|FG000|Overall Study|Non-evaluables|5|||
162626098|NCT01651039|587346980|FG000|Overall Study|Physician Decision|2|||
162626099|NCT01651039|587346980|FG000|Overall Study|Withdrawal by Subject|1|||
162626100|NCT01651039|587346980|FG000|Overall Study|Progressive Disease|22|||
162626101|NCT03727230|587346981|FG000|Overall Study|Lost to Follow-up|12|||
162626102|NCT03600818|587346982|FG000|Overall Study|Adverse Event|4|||
162904050|NCT00638989|588347202|FG002|Overall Study|Lost to Follow-up|1|||
162904051|NCT05245071|588347203|FG000|Overall Study|Progressive disease|18|||
162904052|NCT05245071|588347203|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
162904053|NCT05245071|588347203|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
162904054|NCT01602822|588347206|FG000|Overall Study|Adverse Event|11|||
162904055|NCT00853112|588347210|FG000|Overall Study|Randomized but not treated|0|||
162904056|NCT00853112|588347211|FG001|Overall Study|Randomized but not treated|1|||
162904057|NCT00853112|588347212|FG002|Overall Study|Randomized but not treated|0|||
162904058|NCT00853112|588347213|FG003|Overall Study|Randomized but not treated|2|||
162904059|NCT00853112|588347214|FG004|Overall Study|Randomized but not treated|0|||
162904060|NCT00853112|588347215|FG005|Overall Study|Randomized but not treated|0|||
162904061|NCT00853112|588347216|FG006|Overall Study|Randomized but not treated|1|||
162904062|NCT01553591|588347217|FG000|Overall Study|Voluntarily withdrew|94|||
162904063|NCT01553591|588347218|FG001|Overall Study|Voluntarily withdrew|79|||
162904064|NCT01553591|588347219|FG002|Overall Study|Voluntarily withdrew|96|||
162904065|NCT01553591|588347217|FG000|Overall Study|Adverse Event|36|||
162904066|NCT01553591|588347218|FG001|Overall Study|Adverse Event|45|||
162904067|NCT01553591|588347219|FG002|Overall Study|Adverse Event|16|||
162904068|NCT01553591|588347217|FG000|Overall Study|Lost to Follow-up|25|||
162904069|NCT01553591|588347218|FG001|Overall Study|Lost to Follow-up|23|||
162904070|NCT01553591|588347219|FG002|Overall Study|Lost to Follow-up|16|||
162904071|NCT01553591|588347217|FG000|Overall Study|Physician decision: other|11|||
162904072|NCT01553591|588347218|FG001|Overall Study|Physician decision: other|14|||
162904073|NCT01553591|588347219|FG002|Overall Study|Physician decision: other|16|||
162904074|NCT01553591|588347217|FG000|Overall Study|Physician decision: lack of efficacy|2|||
162904075|NCT01553591|588347218|FG001|Overall Study|Physician decision: lack of efficacy|3|||
162904076|NCT01553591|588347219|FG002|Overall Study|Physician decision: lack of efficacy|7|||
162904077|NCT01553591|588347217|FG000|Overall Study|Protocol Violation|3|||
162904078|NCT01553591|588347218|FG001|Overall Study|Protocol Violation|4|||
162904079|NCT01553591|588347219|FG002|Overall Study|Protocol Violation|4|||
162904080|NCT01553591|588347217|FG000|Overall Study|Sponsor decision|1|||
162904081|NCT01553591|588347218|FG001|Overall Study|Sponsor decision|0|||
162904082|NCT01553591|588347219|FG002|Overall Study|Sponsor decision|3|||
162904083|NCT01553591|588347217|FG000|Overall Study|Randomized and never dispensed drug|0|||
162904084|NCT01553591|588347218|FG001|Overall Study|Randomized and never dispensed drug|1|||
162904085|NCT01553591|588347219|FG002|Overall Study|Randomized and never dispensed drug|0|||
162904086|NCT02477800|588347220|FG000|Placebo-Controlled Period|Adverse Event|16|||
162904087|NCT02477800|588347221|FG001|Placebo-Controlled Period|Adverse Event|25|||
162966857|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
162966858|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
162966859|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
162966860|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
162966861|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
162966862|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
162966863|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
162966864|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
162966865|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
162966866|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
162966867|NCT01710358|588579534|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
162966868|NCT01710358|588579535|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
162966869|NCT01710358|588579536|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
162966870|NCT01710358|588579534|FG000|Rescue Period|Adverse Event|0|||
162966871|NCT01710358|588579535|FG001|Rescue Period|Adverse Event|15|||
162966872|NCT01710358|588579536|FG002|Rescue Period|Adverse Event|0|||
162966873|NCT01710358|588579534|FG000|Rescue Period|Death|0|||
162966874|NCT01710358|588579535|FG001|Rescue Period|Death|1|||
162966875|NCT01710358|588579536|FG002|Rescue Period|Death|0|||
162966876|NCT01710358|588579534|FG000|Rescue Period|Lack of Efficacy|0|||
162904088|NCT02477800|588347222|FG002|Placebo-Controlled Period|Adverse Event|28|||
162904089|NCT02477800|588347223|FG003|Placebo-Controlled Period|Adverse Event|0|||
162904090|NCT02477800|588347224|FG004|Placebo-Controlled Period|Adverse Event|0|||
162904091|NCT02477800|588347225|FG005|Placebo-Controlled Period|Adverse Event|0|||
162904092|NCT02477800|588347226|FG006|Placebo-Controlled Period|Adverse Event|0|||
162904093|NCT02477800|588347220|FG000|Placebo-Controlled Period|Change of Treatment|1|||
162904094|NCT02477800|588347221|FG001|Placebo-Controlled Period|Change of Treatment|2|||
162904095|NCT02477800|588347222|FG002|Placebo-Controlled Period|Change of Treatment|1|||
162904096|NCT02477800|588347223|FG003|Placebo-Controlled Period|Change of Treatment|0|||
162904097|NCT02477800|588347224|FG004|Placebo-Controlled Period|Change of Treatment|0|||
162904098|NCT02477800|588347225|FG005|Placebo-Controlled Period|Change of Treatment|0|||
162904099|NCT02477800|588347226|FG006|Placebo-Controlled Period|Change of Treatment|0|||
162904100|NCT02477800|588347220|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
162904101|NCT02477800|588347221|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
162904102|NCT02477800|588347222|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
162904103|NCT02477800|588347223|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
162904104|NCT02477800|588347224|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
162904105|NCT02477800|588347225|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
162904106|NCT02477800|588347226|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
162904107|NCT02477800|588347220|FG000|Placebo-Controlled Period|Death|0|||
162904108|NCT02477800|588347221|FG001|Placebo-Controlled Period|Death|3|||
162904109|NCT02477800|588347222|FG002|Placebo-Controlled Period|Death|2|||
162904110|NCT02477800|588347223|FG003|Placebo-Controlled Period|Death|0|||
162904111|NCT02477800|588347224|FG004|Placebo-Controlled Period|Death|0|||
162904112|NCT02477800|588347225|FG005|Placebo-Controlled Period|Death|0|||
162904113|NCT02477800|588347226|FG006|Placebo-Controlled Period|Death|0|||
162904114|NCT02477800|588347220|FG000|Placebo-Controlled Period|Disease Progression|1|||
162904115|NCT02477800|588347221|FG001|Placebo-Controlled Period|Disease Progression|0|||
162904116|NCT02477800|588347222|FG002|Placebo-Controlled Period|Disease Progression|1|||
162904117|NCT02477800|588347223|FG003|Placebo-Controlled Period|Disease Progression|0|||
162904118|NCT02477800|588347224|FG004|Placebo-Controlled Period|Disease Progression|0|||
162904119|NCT02477800|588347225|FG005|Placebo-Controlled Period|Disease Progression|0|||
162904120|NCT02477800|588347226|FG006|Placebo-Controlled Period|Disease Progression|0|||
162904121|NCT02477800|588347220|FG000|Placebo-Controlled Period|Investigator Decision|3|||
162904122|NCT02477800|588347221|FG001|Placebo-Controlled Period|Investigator Decision|2|||
162904123|NCT02477800|588347222|FG002|Placebo-Controlled Period|Investigator Decision|1|||
162904124|NCT02477800|588347223|FG003|Placebo-Controlled Period|Investigator Decision|0|||
162904125|NCT02477800|588347224|FG004|Placebo-Controlled Period|Investigator Decision|0|||
162904126|NCT02477800|588347225|FG005|Placebo-Controlled Period|Investigator Decision|0|||
162904127|NCT02477800|588347226|FG006|Placebo-Controlled Period|Investigator Decision|0|||
162904128|NCT02477800|588347220|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
162904129|NCT02477800|588347221|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
162904130|NCT02477800|588347222|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
162904131|NCT02477800|588347223|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
162904132|NCT02477800|588347224|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
162904133|NCT02477800|588347225|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
162904134|NCT02477800|588347226|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
162904135|NCT02477800|588347220|FG000|Placebo-Controlled Period|Relocation|2|||
162904136|NCT02477800|588347221|FG001|Placebo-Controlled Period|Relocation|0|||
162904137|NCT02477800|588347222|FG002|Placebo-Controlled Period|Relocation|0|||
162904138|NCT02477800|588347223|FG003|Placebo-Controlled Period|Relocation|0|||
162904139|NCT02477800|588347224|FG004|Placebo-Controlled Period|Relocation|0|||
162904140|NCT02477800|588347225|FG005|Placebo-Controlled Period|Relocation|0|||
162904141|NCT02477800|588347226|FG006|Placebo-Controlled Period|Relocation|0|||
162904142|NCT02477800|588347220|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
162904143|NCT02477800|588347221|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
162904144|NCT02477800|588347222|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
162904145|NCT02477800|588347223|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
162904146|NCT02477800|588347224|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
162904147|NCT02477800|588347225|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
162904148|NCT02477800|588347226|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
162904149|NCT02477800|588347220|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
162904150|NCT02477800|588347221|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
163053746|NCT03093181|588908398|FG002|Overall Study|Adverse Event|0|||
162904151|NCT02477800|588347222|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
162904152|NCT02477800|588347223|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
162904153|NCT02477800|588347224|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
162904154|NCT02477800|588347225|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
162904155|NCT02477800|588347226|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
162904156|NCT02477800|588347220|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
163053747|NCT03093181|588908396|FG000|Overall Study|Other (Protocol violation)|0|||
162904157|NCT02477800|588347221|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
162904158|NCT02477800|588347222|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
162904159|NCT02477800|588347223|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
162904160|NCT02477800|588347224|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
162904161|NCT02477800|588347225|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
162904162|NCT02477800|588347226|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
162904163|NCT02477800|588347220|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162904164|NCT02477800|588347221|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
162904165|NCT02477800|588347222|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
162904166|NCT02477800|588347223|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162904167|NCT02477800|588347224|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162904168|NCT02477800|588347225|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162904169|NCT02477800|588347226|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162904170|NCT02477800|588347220|FG000|Placebo-Controlled Period|Reason not Specified|161|||
162904171|NCT02477800|588347221|FG001|Placebo-Controlled Period|Reason not Specified|161|||
162904172|NCT02477800|588347222|FG002|Placebo-Controlled Period|Reason not Specified|189|||
162904173|NCT02477800|588347223|FG003|Placebo-Controlled Period|Reason not Specified|0|||
162904174|NCT02477800|588347224|FG004|Placebo-Controlled Period|Reason not Specified|0|||
162904175|NCT02477800|588347225|FG005|Placebo-Controlled Period|Reason not Specified|0|||
162904176|NCT02477800|588347226|FG006|Placebo-Controlled Period|Reason not Specified|0|||
162904177|NCT02477800|588347220|FG000|Long Term Extension Period|Adverse Event|0|||
162904178|NCT02477800|588347221|FG001|Long Term Extension Period|Adverse Event|0|||
162904179|NCT02477800|588347222|FG002|Long Term Extension Period|Adverse Event|0|||
162904180|NCT02477800|588347223|FG003|Long Term Extension Period|Adverse Event|6|||
162904181|NCT02477800|588347224|FG004|Long Term Extension Period|Adverse Event|2|||
162904182|NCT02477800|588347225|FG005|Long Term Extension Period|Adverse Event|4|||
162904183|NCT02477800|588347226|FG006|Long Term Extension Period|Adverse Event|3|||
162904184|NCT02477800|588347220|FG000|Long Term Extension Period|Death|0|||
162904185|NCT02477800|588347221|FG001|Long Term Extension Period|Death|0|||
162904186|NCT02477800|588347222|FG002|Long Term Extension Period|Death|0|||
162904187|NCT02477800|588347223|FG003|Long Term Extension Period|Death|1|||
162904188|NCT02477800|588347224|FG004|Long Term Extension Period|Death|1|||
162904189|NCT02477800|588347225|FG005|Long Term Extension Period|Death|1|||
162904190|NCT02477800|588347226|FG006|Long Term Extension Period|Death|2|||
162904191|NCT02477800|588347220|FG000|Long Term Extension Period|Consent Withdrawn|0|||
162904192|NCT02477800|588347221|FG001|Long Term Extension Period|Consent Withdrawn|0|||
162904193|NCT02477800|588347222|FG002|Long Term Extension Period|Consent Withdrawn|0|||
162904194|NCT02477800|588347223|FG003|Long Term Extension Period|Consent Withdrawn|10|||
162904195|NCT02477800|588347224|FG004|Long Term Extension Period|Consent Withdrawn|4|||
162904196|NCT02477800|588347225|FG005|Long Term Extension Period|Consent Withdrawn|13|||
162904197|NCT02477800|588347226|FG006|Long Term Extension Period|Consent Withdrawn|16|||
162904198|NCT02477800|588347220|FG000|Long Term Extension Period|Disease Progression|0|||
162904199|NCT02477800|588347221|FG001|Long Term Extension Period|Disease Progression|0|||
162904200|NCT02477800|588347222|FG002|Long Term Extension Period|Disease Progression|0|||
162904201|NCT02477800|588347223|FG003|Long Term Extension Period|Disease Progression|3|||
162904202|NCT02477800|588347224|FG004|Long Term Extension Period|Disease Progression|1|||
162904203|NCT02477800|588347225|FG005|Long Term Extension Period|Disease Progression|1|||
162904204|NCT02477800|588347226|FG006|Long Term Extension Period|Disease Progression|0|||
162904205|NCT02477800|588347220|FG000|Long Term Extension Period|Investigator Decision|0|||
162904206|NCT02477800|588347221|FG001|Long Term Extension Period|Investigator Decision|0|||
162904207|NCT02477800|588347222|FG002|Long Term Extension Period|Investigator Decision|0|||
162904208|NCT02477800|588347223|FG003|Long Term Extension Period|Investigator Decision|0|||
163053748|NCT03093181|588908397|FG001|Overall Study|Other (Protocol violation)|0|||
163053749|NCT03093181|588908398|FG002|Overall Study|Other (Protocol violation)|1|||
162904209|NCT02477800|588347224|FG004|Long Term Extension Period|Investigator Decision|0|||
162904210|NCT02477800|588347225|FG005|Long Term Extension Period|Investigator Decision|0|||
162904211|NCT02477800|588347226|FG006|Long Term Extension Period|Investigator Decision|2|||
162904212|NCT02477800|588347220|FG000|Long Term Extension Period|Lost to Follow-up|0|||
162904213|NCT02477800|588347221|FG001|Long Term Extension Period|Lost to Follow-up|0|||
162904214|NCT02477800|588347222|FG002|Long Term Extension Period|Lost to Follow-up|0|||
162904215|NCT02477800|588347223|FG003|Long Term Extension Period|Lost to Follow-up|0|||
162904216|NCT02477800|588347224|FG004|Long Term Extension Period|Lost to Follow-up|1|||
162904217|NCT02477800|588347225|FG005|Long Term Extension Period|Lost to Follow-up|3|||
162904218|NCT02477800|588347226|FG006|Long Term Extension Period|Lost to Follow-up|0|||
163053750|NCT02378662|588908399|FG000|Overall Study|Early Discontinuation|2|||
163053751|NCT02378662|588908400|FG001|Overall Study|Early Discontinuation|0|||
163053752|NCT01159574|588908401|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
163053753|NCT01159574|588908401|FG000|Treatment Phase|Adverse Event|3|||
162904219|NCT02477800|588347220|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
162904220|NCT02477800|588347221|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
162904221|NCT02477800|588347222|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
162966877|NCT01710358|588579535|FG001|Rescue Period|Lack of Efficacy|7|||
162966878|NCT01710358|588579536|FG002|Rescue Period|Lack of Efficacy|0|||
162904222|NCT02477800|588347223|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
162904223|NCT02477800|588347224|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
162904224|NCT02477800|588347225|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
162904225|NCT02477800|588347226|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
162966879|NCT01710358|588579534|FG000|Rescue Period|Withdrawal by Subject|0|||
162966880|NCT01710358|588579535|FG001|Rescue Period|Withdrawal by Subject|8|||
162966881|NCT01710358|588579536|FG002|Rescue Period|Withdrawal by Subject|0|||
162966882|NCT00880334|588579537|FG000|Randomized Phase|Physician Decision|1|||
162966883|NCT00880334|588579538|FG001|Randomized Phase|Physician Decision|0|||
162966884|NCT00880334|588579537|FG000|Randomized Phase|Withdrawal by Subject|2|||
162966885|NCT00880334|588579538|FG001|Randomized Phase|Withdrawal by Subject|1|||
162966886|NCT00880334|588579537|FG000|Randomized Phase|Inadequate Labs|1|||
162966887|NCT00880334|588579538|FG001|Randomized Phase|Inadequate Labs|1|||
162966888|NCT00880334|588579537|FG000|Randomized Phase|Brain Metastasis|0|||
162966889|NCT00880334|588579538|FG001|Randomized Phase|Brain Metastasis|1|||
162966890|NCT00880334|588579537|FG000|Randomized Phase|Crossover Participants|0|||
162966891|NCT00880334|588579538|FG001|Randomized Phase|Crossover Participants|37|||
162966892|NCT00084864|588579543|FG000|Overall Study|Adverse Event|1|||
162966893|NCT00084864|588579544|FG001|Overall Study|Adverse Event|0|||
162966894|NCT00084864|588579545|FG002|Overall Study|Adverse Event|0|||
162966895|NCT00084864|588579546|FG003|Overall Study|Adverse Event|0|||
162966896|NCT02460835|588579551|FG000|Overall Study|Disease progression prior to treatment|3|||
162966897|NCT02460835|588579551|FG000|Overall Study|Unable to complete planning scans|2|||
162966898|NCT02460835|588579551|FG000|Overall Study|Decrease in performance status|1|||
162904226|NCT02477800|588347220|FG000|Long Term Extension Period|Study Visit Burden|0|||
162904227|NCT02477800|588347221|FG001|Long Term Extension Period|Study Visit Burden|0|||
162904228|NCT02477800|588347222|FG002|Long Term Extension Period|Study Visit Burden|0|||
162904229|NCT02477800|588347223|FG003|Long Term Extension Period|Study Visit Burden|3|||
162904230|NCT02477800|588347224|FG004|Long Term Extension Period|Study Visit Burden|0|||
162904231|NCT02477800|588347225|FG005|Long Term Extension Period|Study Visit Burden|2|||
162904232|NCT02477800|588347226|FG006|Long Term Extension Period|Study Visit Burden|2|||
162904233|NCT02477800|588347220|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
162904234|NCT02477800|588347221|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
162904235|NCT02477800|588347222|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
162904236|NCT02477800|588347223|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
162904237|NCT02477800|588347224|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
162904238|NCT02477800|588347225|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
162904239|NCT02477800|588347226|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
162904240|NCT02477800|588347220|FG000|Long Term Extension Period|Reason not Specified|0|||
162966899|NCT02460835|588579551|FG000|Overall Study|Withdrawal by Subject|3|||
162966900|NCT02460835|588579551|FG000|Overall Study|Underwent fractionated RT|10|||
162966901|NCT02460835|588579551|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
162966902|NCT00969124|588579566|FG000|Overall Study|Protocol Violation|2|||
162966903|NCT00969124|588579566|FG000|Overall Study|Inadequate bowel preparation|15|||
162966904|NCT00969124|588579566|FG000|Overall Study|Inability to reach cecum|9|||
162966905|NCT00969124|588579566|FG000|Overall Study|Previously unrecognized disease|3|||
162966906|NCT00969124|588579566|FG000|Overall Study|Technical error|1|||
162966907|NCT02786953|588579571|FG000|Overall Study|Withdrawal by Subject|3|||
162966908|NCT02786953|588579572|FG001|Overall Study|Withdrawal by Subject|0|||
162966909|NCT02786953|588579571|FG000|Overall Study|Physician Decision|0|||
162966910|NCT02786953|588579572|FG001|Overall Study|Physician Decision|1|||
162966911|NCT01186458|588579578|FG000|Overall Study|Adverse Event|1|||
162966912|NCT04281472|588579579|FG000|Stage A|Lack of Efficacy|8|||
162966913|NCT04281472|588579580|FG001|Stage A|Lack of Efficacy|0|||
162966914|NCT04281472|588579581|FG002|Stage A|Lack of Efficacy|0|||
162966915|NCT04281472|588579579|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
163053754|NCT01159574|588908401|FG000|Treatment Phase|Death|6|||
163053755|NCT01159574|588908401|FG000|Treatment Phase|Physician Decision|2|||
163053756|NCT01159574|588908401|FG000|Treatment Phase|Withdrawal by Subject|7|||
163053757|NCT01159574|588908401|FG000|Treatment Phase|still on treatment|2|||
163053758|NCT01159574|588908401|FG000|Follow Up Phase|Lost to Follow-up|2|||
163053759|NCT01159574|588908401|FG000|Follow Up Phase|still being followed for overall surviva|18|||
163053760|NCT00324155|588908402|FG000|Enrolled and Randomized|No longer met study criteria|3|||
163053761|NCT00324155|588908403|FG001|Enrolled and Randomized|No longer met study criteria|0|||
162904241|NCT02477800|588347221|FG001|Long Term Extension Period|Reason not Specified|0|||
162904242|NCT02477800|588347222|FG002|Long Term Extension Period|Reason not Specified|0|||
162904243|NCT02477800|588347223|FG003|Long Term Extension Period|Reason not Specified|126|||
162904244|NCT02477800|588347224|FG004|Long Term Extension Period|Reason not Specified|140|||
162966916|NCT04281472|588579580|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
162966917|NCT04281472|588579581|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
162904245|NCT02477800|588347225|FG005|Long Term Extension Period|Reason not Specified|270|||
162904246|NCT02477800|588347226|FG006|Long Term Extension Period|Reason not Specified|224|||
162904247|NCT00423592|588347228|FG000|Overall Study|Adverse Event (through Week 12)|2|||
162904248|NCT00423592|588347228|FG000|Overall Study|Adverse Event (post Week 12)|5|||
162904249|NCT00062647|588347229|FG000|Overall Study|Death|2|||
162904250|NCT00062647|588347230|FG001|Overall Study|Death|2|||
162904251|NCT00062647|588347229|FG000|Overall Study|Adverse Event|1|||
162904252|NCT00062647|588347230|FG001|Overall Study|Adverse Event|1|||
162904253|NCT00062647|588347229|FG000|Overall Study|Withdrawal by Subject|2|||
162904254|NCT00062647|588347230|FG001|Overall Study|Withdrawal by Subject|1|||
162904255|NCT00062647|588347229|FG000|Overall Study|Protocol Violation|1|||
162904256|NCT00062647|588347230|FG001|Overall Study|Protocol Violation|0|||
162904257|NCT00062647|588347229|FG000|Overall Study|Lost to Follow-up|1|||
162904258|NCT00062647|588347230|FG001|Overall Study|Lost to Follow-up|2|||
162904259|NCT00062647|588347229|FG000|Overall Study|Failed continuation criteria|4|||
162904260|NCT00062647|588347230|FG001|Overall Study|Failed continuation criteria|2|||
162904261|NCT00062647|588347229|FG000|Overall Study|Other|4|||
162904262|NCT00062647|588347230|FG001|Overall Study|Other|4|||
162904263|NCT00062647|588347229|FG000|Overall Study|Never received study treatment|1|||
162904264|NCT00062647|588347230|FG001|Overall Study|Never received study treatment|1|||
162904265|NCT00002981|588347233|FG000|Overall Study|Inevaluable|6|||
162904266|NCT00255008|588347234|FG000|Overall Study|Adverse Event|1|||
162904267|NCT00255008|588347235|FG001|Overall Study|Adverse Event|1|||
162904268|NCT00255008|588347236|FG002|Overall Study|Adverse Event|2|||
162904269|NCT00255008|588347237|FG003|Overall Study|Adverse Event|0|||
162904270|NCT00255008|588347234|FG000|Overall Study|Lost to Follow-up|1|||
162904271|NCT00255008|588347235|FG001|Overall Study|Lost to Follow-up|0|||
162904272|NCT00255008|588347236|FG002|Overall Study|Lost to Follow-up|1|||
162904273|NCT00255008|588347237|FG003|Overall Study|Lost to Follow-up|2|||
162904274|NCT00255008|588347234|FG000|Overall Study|Did not meet viral reduction criteria|4|||
162904275|NCT00255008|588347235|FG001|Overall Study|Did not meet viral reduction criteria|5|||
162904276|NCT00255008|588347236|FG002|Overall Study|Did not meet viral reduction criteria|0|||
162904277|NCT00255008|588347237|FG003|Overall Study|Did not meet viral reduction criteria|1|||
162904278|NCT00255008|588347234|FG000|Overall Study|Withdrew consent|0|||
162904279|NCT00255008|588347235|FG001|Overall Study|Withdrew consent|0|||
162904280|NCT00255008|588347236|FG002|Overall Study|Withdrew consent|2|||
162904281|NCT00255008|588347237|FG003|Overall Study|Withdrew consent|0|||
162904282|NCT00255008|588347234|FG000|Overall Study|Sponsor request|18|||
162904283|NCT00255008|588347235|FG001|Overall Study|Sponsor request|3|||
162904284|NCT00255008|588347236|FG002|Overall Study|Sponsor request|8|||
162904285|NCT00255008|588347237|FG003|Overall Study|Sponsor request|17|||
162904286|NCT00255008|588347234|FG000|Overall Study|Adverse lab experience|1|||
162904287|NCT00255008|588347235|FG001|Overall Study|Adverse lab experience|0|||
162904288|NCT00255008|588347236|FG002|Overall Study|Adverse lab experience|0|||
162904289|NCT00255008|588347237|FG003|Overall Study|Adverse lab experience|0|||
162904290|NCT00255008|588347234|FG000|Overall Study|Other|7|||
162904291|NCT00255008|588347235|FG001|Overall Study|Other|0|||
162904292|NCT00255008|588347236|FG002|Overall Study|Other|3|||
162904293|NCT00255008|588347237|FG003|Overall Study|Other|2|||
162904294|NCT00322387|588347242|FG000|Treatment Period|Adverse Event|0|||
162904295|NCT00322387|588347243|FG001|Treatment Period|Adverse Event|1|||
162904296|NCT00322387|588347242|FG000|Follow-up Period|Final assessment not done|1|||
162904297|NCT00322387|588347243|FG001|Follow-up Period|Final assessment not done|3|||
162904298|NCT00322387|588347242|FG000|Follow-up Period|Death|1|||
162904299|NCT00322387|588347243|FG001|Follow-up Period|Death|0|||
162904300|NCT02415595|588347246|FG000|Overall Study|Administrative reason by sponsor|39|||
162904301|NCT02415595|588347247|FG001|Overall Study|Administrative reason by sponsor|40|||
162904302|NCT02415595|588347248|FG002|Overall Study|Administrative reason by sponsor|41|||
163053762|NCT00324155|588908402|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
163053763|NCT00324155|588908403|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
163053764|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
163053765|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
162904303|NCT02415595|588347249|FG003|Overall Study|Administrative reason by sponsor|39|||
162904304|NCT02415595|588347246|FG000|Overall Study|Adverse Event|1|||
162904305|NCT02415595|588347247|FG001|Overall Study|Adverse Event|3|||
162904306|NCT02415595|588347248|FG002|Overall Study|Adverse Event|5|||
162904307|NCT02415595|588347249|FG003|Overall Study|Adverse Event|10|||
162904308|NCT02415595|588347246|FG000|Overall Study|Lack of Efficacy|4|||
162904309|NCT02415595|588347247|FG001|Overall Study|Lack of Efficacy|4|||
162904310|NCT02415595|588347248|FG002|Overall Study|Lack of Efficacy|0|||
162904311|NCT02415595|588347249|FG003|Overall Study|Lack of Efficacy|0|||
162904312|NCT02415595|588347246|FG000|Overall Study|Lost to Follow-up|1|||
162904313|NCT02415595|588347247|FG001|Overall Study|Lost to Follow-up|3|||
162904314|NCT02415595|588347248|FG002|Overall Study|Lost to Follow-up|1|||
162904315|NCT02415595|588347249|FG003|Overall Study|Lost to Follow-up|1|||
162904316|NCT02415595|588347246|FG000|Overall Study|Poor/Non-compliance|1|||
162904317|NCT02415595|588347247|FG001|Overall Study|Poor/Non-compliance|0|||
162904318|NCT02415595|588347248|FG002|Overall Study|Poor/Non-compliance|1|||
162904319|NCT02415595|588347249|FG003|Overall Study|Poor/Non-compliance|0|||
162904320|NCT02415595|588347246|FG000|Overall Study|Reached stopping criteria|0|||
162904321|NCT02415595|588347247|FG001|Overall Study|Reached stopping criteria|1|||
162904322|NCT02415595|588347248|FG002|Overall Study|Reached stopping criteria|1|||
162904323|NCT02415595|588347249|FG003|Overall Study|Reached stopping criteria|0|||
162904324|NCT02415595|588347246|FG000|Overall Study|Withdrawal by Subject|4|||
162904325|NCT02415595|588347247|FG001|Overall Study|Withdrawal by Subject|0|||
162904326|NCT02415595|588347248|FG002|Overall Study|Withdrawal by Subject|1|||
162904327|NCT02415595|588347249|FG003|Overall Study|Withdrawal by Subject|3|||
162904328|NCT02415595|588347246|FG000|Overall Study|Other|0|||
162904329|NCT02415595|588347247|FG001|Overall Study|Other|1|||
162904330|NCT02415595|588347248|FG002|Overall Study|Other|1|||
162904331|NCT02415595|588347249|FG003|Overall Study|Other|0|||
162904332|NCT03074318|588347252|FG000|Overall Study|Adverse Event|0|||
162904333|NCT03074318|588347253|FG001|Overall Study|Adverse Event|1|||
162904334|NCT03074318|588347254|FG002|Overall Study|Adverse Event|1|||
162904335|NCT03074318|588347255|FG003|Overall Study|Adverse Event|1|||
162904336|NCT03074318|588347252|FG000|Overall Study|Death|1|||
162904337|NCT03074318|588347253|FG001|Overall Study|Death|0|||
162904338|NCT03074318|588347254|FG002|Overall Study|Death|0|||
162904339|NCT03074318|588347255|FG003|Overall Study|Death|0|||
162904340|NCT03074318|588347252|FG000|Overall Study|Withdrawal by Subject|1|||
162904341|NCT03074318|588347253|FG001|Overall Study|Withdrawal by Subject|2|||
162904342|NCT03074318|588347254|FG002|Overall Study|Withdrawal by Subject|2|||
162904343|NCT03074318|588347255|FG003|Overall Study|Withdrawal by Subject|4|||
162904344|NCT03074318|588347252|FG000|Overall Study|Trial Closure|2|||
162904345|NCT03074318|588347253|FG001|Overall Study|Trial Closure|2|||
162904346|NCT03074318|588347254|FG002|Overall Study|Trial Closure|3|||
162904347|NCT03074318|588347255|FG003|Overall Study|Trial Closure|11|||
162904348|NCT01855919|588348622|FG000|Overall Study|Adverse Event|16|||
162904349|NCT01855919|588348623|FG001|Overall Study|Adverse Event|8|||
162904350|NCT01855919|588348622|FG000|Overall Study|Lack of Efficacy|1|||
162904351|NCT01855919|588348623|FG001|Overall Study|Lack of Efficacy|3|||
162904352|NCT01855919|588348622|FG000|Overall Study|Withdrawal by Subject|4|||
162904353|NCT01855919|588348623|FG001|Overall Study|Withdrawal by Subject|10|||
162904354|NCT01855919|588348622|FG000|Overall Study|Entry Criteria Not Met|1|||
162904355|NCT01855919|588348623|FG001|Overall Study|Entry Criteria Not Met|1|||
162904356|NCT01855919|588348622|FG000|Overall Study|Protocol Violation|1|||
162904357|NCT01855919|588348623|FG001|Overall Study|Protocol Violation|4|||
162904358|NCT01625897|588348626|FG000|Overall Study|Adverse Event|27|||
162904359|NCT01625897|588348627|FG001|Overall Study|Adverse Event|10|||
162904360|NCT01625897|588348626|FG000|Overall Study|Physician Decision|0|||
162904361|NCT01625897|588348627|FG001|Overall Study|Physician Decision|1|||
162904362|NCT01625897|588348626|FG000|Overall Study|Withdrawal by Subject|25|||
162904363|NCT01625897|588348627|FG001|Overall Study|Withdrawal by Subject|3|||
162904364|NCT03455530|588348628|FG000|Overall Study|Withdrawal by Subject|9|||
162904365|NCT03455530|588348629|FG001|Overall Study|Withdrawal by Subject|1|||
162904366|NCT03455530|588348630|FG002|Overall Study|Withdrawal by Subject|3|||
162904367|NCT03455530|588348631|FG003|Overall Study|Withdrawal by Subject|3|||
162904368|NCT00908895|588348634|FG000|Overall Study|Lost to Follow-up|1|||
162904369|NCT00908895|588348635|FG001|Overall Study|Lost to Follow-up|3|||
162904370|NCT00908895|588348634|FG000|Overall Study|algodystrophy|2|||
162904371|NCT00908895|588348635|FG001|Overall Study|algodystrophy|2|||
162904372|NCT00908895|588348634|FG000|Overall Study|Adverse Event|1|||
162904373|NCT00908895|588348635|FG001|Overall Study|Adverse Event|1|||
162904374|NCT02059174|588348661|FG000|Period 1|Withdrawal by Subject|0|||
162904375|NCT02059174|588348662|FG001|Period 1|Withdrawal by Subject|2|||
162904376|NCT02059174|588348661|FG000|Period 2|Withdrawal by Subject|0|||
162904377|NCT02059174|588348662|FG001|Period 2|Withdrawal by Subject|2|||
162904378|NCT02059174|588348661|FG000|Period 2|Protocol Violation|1|||
162904379|NCT02059174|588348662|FG001|Period 2|Protocol Violation|0|||
162904380|NCT02059174|588348661|FG000|Period 3|Physician Decision|1|||
162904381|NCT02059174|588348662|FG001|Period 3|Physician Decision|0|||
162904382|NCT00768040|588348663|FG000|Overall Study|Adverse Event|3|||
162904383|NCT00768040|588348664|FG001|Overall Study|Adverse Event|2|||
162904384|NCT00768040|588348663|FG000|Overall Study|Abnormal laboratory value|1|||
162904385|NCT00768040|588348664|FG001|Overall Study|Abnormal laboratory value|1|||
162904386|NCT02511106|588348669|FG000|Overall Study|Lost to Follow-up|6|||
162904387|NCT02511106|588348670|FG001|Overall Study|Lost to Follow-up|4|||
162904388|NCT02511106|588348669|FG000|Overall Study|Withdrawal by Subject|24|||
162904389|NCT02511106|588348670|FG001|Overall Study|Withdrawal by Subject|21|||
162904390|NCT02511106|588348669|FG000|Overall Study|Death|42|||
162904391|NCT02511106|588348670|FG001|Overall Study|Death|82|||
162904392|NCT02511106|588348669|FG000|Overall Study|Ongoing study at data cut-off|3|||
162966918|NCT04281472|588579579|FG000|Stage A|Adverse Event|20|||
162904393|NCT02511106|588348670|FG001|Overall Study|Ongoing study at data cut-off|2|||
162904394|NCT02511106|588348669|FG000|Overall Study|Without specified reason|3|||
162904395|NCT02511106|588348670|FG001|Overall Study|Without specified reason|0|||
162904396|NCT01222767|588348671|FG000|Overall Study|Progressive disease|13|||
162904397|NCT01222767|588348671|FG000|Overall Study|Adverse Event|2|||
162904398|NCT01222767|588348671|FG000|Overall Study|Surgical resection|1|||
162904399|NCT01222767|588348671|FG000|Overall Study|Never treated|1|||
162904400|NCT02773849|588348672|FG000|Overall Study|Lost to Follow-up|11|||
162904401|NCT02773849|588348672|FG000|Overall Study|Death|26|||
162904402|NCT02773849|588348672|FG000|Overall Study|Withdrawal by Subject|5|||
162904403|NCT02773849|588348672|FG000|Overall Study|Withdrawal of Consent|9|||
162904404|NCT02773849|588348672|FG000|Overall Study|Other: not due to lack of tolerability|11|||
162904405|NCT02274311|588348679|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
162904406|NCT00508001|588348680|FG000|Overall Study|Adverse Event|2|||
162904407|NCT00508001|588348681|FG001|Overall Study|Adverse Event|0|||
162904408|NCT00508001|588348682|FG002|Overall Study|Adverse Event|4|||
162904409|NCT00508001|588348680|FG000|Overall Study|condition under investigation worsened|13|||
162904410|NCT00508001|588348681|FG001|Overall Study|condition under investigation worsened|7|||
162904411|NCT00508001|588348682|FG002|Overall Study|condition under investigation worsened|1|||
162904412|NCT00508001|588348680|FG000|Overall Study|Death|0|||
162904413|NCT00508001|588348681|FG001|Overall Study|Death|1|||
162904414|NCT00508001|588348682|FG002|Overall Study|Death|1|||
162904415|NCT00508001|588348680|FG000|Overall Study|Withdrawal by Subject|4|||
162904416|NCT00508001|588348681|FG001|Overall Study|Withdrawal by Subject|4|||
162904417|NCT00508001|588348682|FG002|Overall Study|Withdrawal by Subject|1|||
162904418|NCT01685372|588348683|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
162904419|NCT01685372|588348684|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
162904420|NCT01626859|588348685|FG000|Overall Study|Adverse Event|1|||
162904421|NCT01626859|588348686|FG001|Overall Study|Adverse Event|3|||
162904422|NCT01626859|588348687|FG002|Overall Study|Adverse Event|2|||
162904423|NCT01626859|588348685|FG000|Overall Study|Physician Decision|0|||
162904424|NCT01626859|588348686|FG001|Overall Study|Physician Decision|1|||
162904425|NCT01626859|588348687|FG002|Overall Study|Physician Decision|0|||
162904426|NCT01626859|588348685|FG000|Overall Study|Withdrawal by Subject|1|||
162904427|NCT01626859|588348686|FG001|Overall Study|Withdrawal by Subject|4|||
162904428|NCT01626859|588348687|FG002|Overall Study|Withdrawal by Subject|2|||
162904429|NCT01969565|588348696|FG000|Overall Study|Withdrawal by Subject|1|||
162904430|NCT00832091|588348697|FG000|Overall Study|Adverse Event|1|||
162904431|NCT00832091|588348698|FG001|Overall Study|Adverse Event|1|||
162904432|NCT00832091|588348697|FG000|Overall Study|Protocol Violation|1|||
162904433|NCT00832091|588348698|FG001|Overall Study|Protocol Violation|0|||
162904434|NCT00832091|588348697|FG000|Overall Study|Withdrawal by Subject|2|||
162904435|NCT00832091|588348698|FG001|Overall Study|Withdrawal by Subject|1|||
162904436|NCT00832091|588348697|FG000|Overall Study|Prohibited Medication|1|||
162904437|NCT00832091|588348698|FG001|Overall Study|Prohibited Medication|0|||
162904438|NCT02087241|588348700|FG000|Overall Study|Death|2|||
162904439|NCT02087241|588348701|FG001|Overall Study|Death|1|||
162904440|NCT02087241|588348702|FG002|Overall Study|Death|1|||
162904441|NCT02087241|588348703|FG003|Overall Study|Death|1|||
162904442|NCT02087241|588348700|FG000|Overall Study|Withdrawal by Subject|1|||
162904443|NCT02087241|588348701|FG001|Overall Study|Withdrawal by Subject|0|||
162904444|NCT02087241|588348702|FG002|Overall Study|Withdrawal by Subject|0|||
162904445|NCT02087241|588348703|FG003|Overall Study|Withdrawal by Subject|1|||
162904446|NCT02087241|588348700|FG000|Overall Study|Progressive Disease|0|||
162904447|NCT02087241|588348701|FG001|Overall Study|Progressive Disease|0|||
162904448|NCT02087241|588348702|FG002|Overall Study|Progressive Disease|0|||
162904449|NCT02087241|588348703|FG003|Overall Study|Progressive Disease|1|||
162904450|NCT02087241|588348700|FG000|Overall Study|Study Terminated by Sponsor|0|||
162904451|NCT02087241|588348701|FG001|Overall Study|Study Terminated by Sponsor|2|||
162904452|NCT02087241|588348702|FG002|Overall Study|Study Terminated by Sponsor|0|||
162904453|NCT02087241|588348703|FG003|Overall Study|Study Terminated by Sponsor|4|||
162904454|NCT01955005|588348704|FG000|Overall Study|Withdrawal by Subject|3|||
162904455|NCT01955005|588348705|FG001|Overall Study|Withdrawal by Subject|5|||
162904456|NCT00836953|588348706|FG000|Overall Study|Withdrawal by Subject|1|||
162904457|NCT00836953|588348706|FG000|Overall Study|Lost to Follow-up|1|||
162904458|NCT02943668|588348707|FG000|Overall Study|Disease Progression|1|||
162904459|NCT01200758|588348708|FG000|Stage I|Death|0|||
162904460|NCT01200758|588348709|FG001|Stage I|Death|1|||
162904461|NCT01200758|588348710|FG002|Stage I|Death|0|||
162904462|NCT01200758|588348711|FG003|Stage I|Death|0|||
162904463|NCT01200758|588348708|FG000|Stage I|Physician Decision|1|||
162904464|NCT01200758|588348709|FG001|Stage I|Physician Decision|1|||
162904465|NCT01200758|588348710|FG002|Stage I|Physician Decision|0|||
162904466|NCT01200758|588348711|FG003|Stage I|Physician Decision|0|||
162904467|NCT01200758|588348708|FG000|Stage I|Lack of Efficacy|2|||
162904468|NCT01200758|588348709|FG001|Stage I|Lack of Efficacy|1|||
162904469|NCT01200758|588348710|FG002|Stage I|Lack of Efficacy|0|||
162904470|NCT01200758|588348711|FG003|Stage I|Lack of Efficacy|0|||
162904471|NCT01200758|588348708|FG000|Stage I|Adverse Event|5|||
162904472|NCT01200758|588348709|FG001|Stage I|Adverse Event|5|||
162904473|NCT01200758|588348710|FG002|Stage I|Adverse Event|0|||
162904474|NCT01200758|588348711|FG003|Stage I|Adverse Event|0|||
162904475|NCT01200758|588348708|FG000|Stage I|Withdrawal by Subject|1|||
162904476|NCT01200758|588348709|FG001|Stage I|Withdrawal by Subject|2|||
162904477|NCT01200758|588348710|FG002|Stage I|Withdrawal by Subject|0|||
162904478|NCT01200758|588348711|FG003|Stage I|Withdrawal by Subject|0|||
162904479|NCT01200758|588348708|FG000|Stage I|Disease Progression|9|||
162904480|NCT01200758|588348709|FG001|Stage I|Disease Progression|7|||
162904481|NCT01200758|588348710|FG002|Stage I|Disease Progression|0|||
162904482|NCT01200758|588348711|FG003|Stage I|Disease Progression|0|||
162904483|NCT01200758|588348708|FG000|Stage 2|Disease Progression|0|||
162904484|NCT01200758|588348709|FG001|Stage 2|Disease Progression|0|||
162904485|NCT01200758|588348710|FG002|Stage 2|Disease Progression|16|||
162904486|NCT01200758|588348711|FG003|Stage 2|Disease Progression|21|||
162904487|NCT01200758|588348708|FG000|Stage 2|Lack of Efficacy|0|||
162904488|NCT01200758|588348709|FG001|Stage 2|Lack of Efficacy|0|||
162904489|NCT01200758|588348710|FG002|Stage 2|Lack of Efficacy|4|||
162904490|NCT01200758|588348711|FG003|Stage 2|Lack of Efficacy|2|||
162904491|NCT01200758|588348708|FG000|Stage 2|Physician Decision|0|||
162904492|NCT01200758|588348709|FG001|Stage 2|Physician Decision|0|||
162904493|NCT01200758|588348710|FG002|Stage 2|Physician Decision|5|||
162904494|NCT01200758|588348711|FG003|Stage 2|Physician Decision|7|||
162904495|NCT01200758|588348708|FG000|Stage 2|Adverse Event|0|||
162904496|NCT01200758|588348709|FG001|Stage 2|Adverse Event|0|||
162904497|NCT01200758|588348710|FG002|Stage 2|Adverse Event|5|||
162904498|NCT01200758|588348711|FG003|Stage 2|Adverse Event|9|||
162904499|NCT01200758|588348708|FG000|Stage 2|Withdrawal by Subject|0|||
162904500|NCT01200758|588348709|FG001|Stage 2|Withdrawal by Subject|0|||
162904501|NCT01200758|588348710|FG002|Stage 2|Withdrawal by Subject|4|||
162904502|NCT01200758|588348711|FG003|Stage 2|Withdrawal by Subject|1|||
162904503|NCT01200758|588348708|FG000|Stage 2|Lost to Follow-up|0|||
162904504|NCT01200758|588348709|FG001|Stage 2|Lost to Follow-up|0|||
162904505|NCT01200758|588348710|FG002|Stage 2|Lost to Follow-up|3|||
162904506|NCT01200758|588348711|FG003|Stage 2|Lost to Follow-up|1|||
162904507|NCT01200758|588348708|FG000|Stage 2|Protocol Violation|0|||
162904508|NCT01200758|588348709|FG001|Stage 2|Protocol Violation|0|||
162904509|NCT01200758|588348710|FG002|Stage 2|Protocol Violation|1|||
162904510|NCT01200758|588348711|FG003|Stage 2|Protocol Violation|4|||
162904511|NCT01200758|588348708|FG000|Stage 2|Death|0|||
162904512|NCT01200758|588348709|FG001|Stage 2|Death|0|||
162904513|NCT01200758|588348710|FG002|Stage 2|Death|3|||
162904514|NCT01200758|588348711|FG003|Stage 2|Death|5|||
162904515|NCT04048876|588348712|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
162904516|NCT04048876|588348713|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
162904517|NCT04048876|588348714|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
162904518|NCT04048876|588348715|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
162904519|NCT04048876|588348712|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
162904520|NCT04048876|588348713|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
162904521|NCT04048876|588348714|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
162904522|NCT04048876|588348715|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
162904523|NCT04048876|588348712|FG000|Placebo Controlled Phase|Adverse Event|0|||
162904524|NCT04048876|588348713|FG001|Placebo Controlled Phase|Adverse Event|1|||
162904525|NCT04048876|588348714|FG002|Placebo Controlled Phase|Adverse Event|0|||
162904526|NCT04048876|588348715|FG003|Placebo Controlled Phase|Adverse Event|0|||
162904527|NCT04048876|588348712|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
162904528|NCT04048876|588348713|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
162904529|NCT04048876|588348714|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
162904530|NCT04048876|588348715|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
162904531|NCT01828567|588348716|FG000|Overall Study|Lost to Follow-up|27|||
162904532|NCT01828567|588348717|FG001|Overall Study|Lost to Follow-up|9|||
162904533|NCT01828567|588348716|FG000|Overall Study|Excluded - did not meet criteria|4|||
162904534|NCT01828567|588348717|FG001|Overall Study|Excluded - did not meet criteria|1|||
162904535|NCT03325010|588348726|FG000|Overall Study|Adverse Event|3|||
162904536|NCT03325010|588348727|FG001|Overall Study|Adverse Event|8|||
162904537|NCT03325010|588348726|FG000|Overall Study|Protocol Violation|1|||
162708834|NCT01515319|587642921|FG009|Overall Study|Withdrawal by Subject|0|||
162708835|NCT01515319|587642912|FG000|Overall Study|Adverse Event|0|||
162708836|NCT01515319|587642913|FG001|Overall Study|Adverse Event|0|||
162708837|NCT01515319|587642914|FG002|Overall Study|Adverse Event|0|||
162904538|NCT03325010|588348727|FG001|Overall Study|Protocol Violation|8|||
162904539|NCT03325010|588348726|FG000|Overall Study|Withdrawal by Subject|1|||
162904540|NCT03325010|588348727|FG001|Overall Study|Withdrawal by Subject|3|||
162904541|NCT03325010|588348726|FG000|Overall Study|Lost to Follow-up|1|||
162904542|NCT03325010|588348727|FG001|Overall Study|Lost to Follow-up|0|||
162904543|NCT03325010|588348726|FG000|Overall Study|Physician Decision|1|||
162904544|NCT03325010|588348727|FG001|Overall Study|Physician Decision|1|||
162904545|NCT03325010|588348726|FG000|Overall Study|Lack of Efficacy|2|||
162904546|NCT03325010|588348727|FG001|Overall Study|Lack of Efficacy|0|||
162904547|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
162904548|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
162904549|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
162904550|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
162904551|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
162904552|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
162904553|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
162904554|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
162904555|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
162904556|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
162904557|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
162904558|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162904559|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
162904560|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
162904561|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
162904562|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
162904563|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
162904564|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
162904565|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
162904566|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
162904567|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
162904568|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
162904569|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
162904570|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
162904571|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Screen failure|0|||
162904572|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Screen failure|1|||
162904573|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Screen failure|2|||
162904574|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Screen failure|0|||
162904575|NCT02614261|588348728|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
162904576|NCT02614261|588348729|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
162904577|NCT02614261|588348730|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
162904578|NCT02614261|588348731|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
162904579|NCT02614261|588348728|FG000|Open-Label Extension Phase|Adverse Event|23|||
162904580|NCT02614261|588348729|FG001|Open-Label Extension Phase|Adverse Event|12|||
162904581|NCT02614261|588348730|FG002|Open-Label Extension Phase|Adverse Event|11|||
162904582|NCT02614261|588348731|FG003|Open-Label Extension Phase|Adverse Event|0|||
162904583|NCT02614261|588348728|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
162904584|NCT02614261|588348729|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
162904585|NCT02614261|588348730|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
162904586|NCT02614261|588348731|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
162904587|NCT02614261|588348728|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
162904588|NCT02614261|588348729|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
162904589|NCT02614261|588348730|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
162904590|NCT02614261|588348731|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
162904591|NCT02614261|588348728|FG000|Open-Label Extension Phase|Physician Decision|2|||
162904592|NCT02614261|588348729|FG001|Open-Label Extension Phase|Physician Decision|0|||
162904593|NCT02614261|588348730|FG002|Open-Label Extension Phase|Physician Decision|0|||
162904594|NCT02614261|588348731|FG003|Open-Label Extension Phase|Physician Decision|0|||
162904595|NCT02614261|588348728|FG000|Open-Label Extension Phase|Pregnancy|1|||
162966919|NCT04281472|588579580|FG001|Stage A|Adverse Event|0|||
162966920|NCT04281472|588579581|FG002|Stage A|Adverse Event|0|||
162966921|NCT04281472|588579579|FG000|Stage A|Death|1|||
162966922|NCT04281472|588579580|FG001|Stage A|Death|0|||
162966923|NCT04281472|588579581|FG002|Stage A|Death|0|||
162966924|NCT04281472|588579579|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
162966925|NCT04281472|588579580|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
162966926|NCT04281472|588579581|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
162966927|NCT04281472|588579579|FG000|Stage A|Lost to Follow-up|2|||
162966928|NCT04281472|588579580|FG001|Stage A|Lost to Follow-up|0|||
162966929|NCT04281472|588579581|FG002|Stage A|Lost to Follow-up|0|||
162966930|NCT04281472|588579579|FG000|Stage A|Non-compliance with study drug|1|||
162904596|NCT02614261|588348729|FG001|Open-Label Extension Phase|Pregnancy|2|||
162904597|NCT02614261|588348730|FG002|Open-Label Extension Phase|Pregnancy|1|||
162904598|NCT02614261|588348731|FG003|Open-Label Extension Phase|Pregnancy|0|||
162904599|NCT02614261|588348728|FG000|Open-Label Extension Phase|Protocol Violation|3|||
162904600|NCT02614261|588348729|FG001|Open-Label Extension Phase|Protocol Violation|4|||
162904601|NCT02614261|588348730|FG002|Open-Label Extension Phase|Protocol Violation|1|||
163053766|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
163053767|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
163053768|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Death|8|||
163053769|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Death|15|||
163053770|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
163053771|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
163053772|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
163053773|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
163053774|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
163053775|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
163053776|NCT00324155|588908402|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
163053777|NCT00324155|588908403|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
163053778|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
162708838|NCT01515319|587642915|FG003|Overall Study|Adverse Event|0|||
162904602|NCT02614261|588348731|FG003|Open-Label Extension Phase|Protocol Violation|0|||
162904603|NCT02614261|588348728|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
162904604|NCT02614261|588348729|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
162904605|NCT02614261|588348730|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
162904606|NCT02614261|588348731|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
162904607|NCT02614261|588348728|FG000|Follow-up Phase|Adverse Event|2|||
162904608|NCT02614261|588348729|FG001|Follow-up Phase|Adverse Event|0|||
162904609|NCT02614261|588348730|FG002|Follow-up Phase|Adverse Event|1|||
162904610|NCT02614261|588348731|FG003|Follow-up Phase|Adverse Event|0|||
162904611|NCT02614261|588348728|FG000|Follow-up Phase|Lost to Follow-up|12|||
162904612|NCT02614261|588348729|FG001|Follow-up Phase|Lost to Follow-up|5|||
162904613|NCT02614261|588348730|FG002|Follow-up Phase|Lost to Follow-up|2|||
163053779|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
162708839|NCT01515319|587642916|FG004|Overall Study|Adverse Event|0|||
162904614|NCT02614261|588348731|FG003|Follow-up Phase|Lost to Follow-up|0|||
162904615|NCT02614261|588348728|FG000|Follow-up Phase|Physician Decision|5|||
162904616|NCT02614261|588348729|FG001|Follow-up Phase|Physician Decision|1|||
162904617|NCT02614261|588348730|FG002|Follow-up Phase|Physician Decision|0|||
162904618|NCT02614261|588348731|FG003|Follow-up Phase|Physician Decision|0|||
162904619|NCT02614261|588348728|FG000|Follow-up Phase|Pregnancy|0|||
162904620|NCT02614261|588348729|FG001|Follow-up Phase|Pregnancy|1|||
162904621|NCT02614261|588348730|FG002|Follow-up Phase|Pregnancy|0|||
162904622|NCT02614261|588348731|FG003|Follow-up Phase|Pregnancy|0|||
162904623|NCT02614261|588348728|FG000|Follow-up Phase|Protocol Violation|1|||
162904624|NCT02614261|588348729|FG001|Follow-up Phase|Protocol Violation|0|||
162904625|NCT02614261|588348730|FG002|Follow-up Phase|Protocol Violation|0|||
162904626|NCT02614261|588348731|FG003|Follow-up Phase|Protocol Violation|0|||
162904627|NCT02614261|588348728|FG000|Follow-up Phase|Withdrawal by Subject|12|||
162904628|NCT02614261|588348729|FG001|Follow-up Phase|Withdrawal by Subject|4|||
162904629|NCT02614261|588348730|FG002|Follow-up Phase|Withdrawal by Subject|11|||
162904630|NCT02614261|588348731|FG003|Follow-up Phase|Withdrawal by Subject|0|||
162904631|NCT02614261|588348728|FG000|Israel Addendum|Withdrawal by Subject|0|||
162904632|NCT02614261|588348729|FG001|Israel Addendum|Withdrawal by Subject|0|||
162904633|NCT02614261|588348730|FG002|Israel Addendum|Withdrawal by Subject|0|||
162904634|NCT02614261|588348731|FG003|Israel Addendum|Withdrawal by Subject|4|||
162904635|NCT04350372|588348734|FG000|Overall Study|Death|1|||
162904636|NCT03512275|588348736|FG000|Overall Study|Withdrawal by Subject|1|||
162904637|NCT03512275|588348737|FG001|Overall Study|Withdrawal by Subject|3|||
162904638|NCT03512275|588348736|FG000|Overall Study|Physician Decision|0|||
162904639|NCT03512275|588348737|FG001|Overall Study|Physician Decision|1|||
162904640|NCT03512275|588348736|FG000|Overall Study|Lost to Follow-up|0|||
162904641|NCT03512275|588348737|FG001|Overall Study|Lost to Follow-up|3|||
162904642|NCT03512275|588348736|FG000|Overall Study|Other|1|||
162904643|NCT03512275|588348737|FG001|Overall Study|Other|0|||
162904644|NCT00113555|588348738|FG000|Overall Study|Baseline Failure|59|||
162904645|NCT00113555|588348738|FG000|Overall Study|Permanently Explanted|7|||
162904646|NCT00113555|588348738|FG000|Overall Study|Death|1|||
162904647|NCT00113555|588348738|FG000|Overall Study|Missed Followup|4|||
162904648|NCT00113555|588348738|FG000|Overall Study|Lost to Follow-up|8|||
162904649|NCT04474366|588348739|FG000|Overall Study|Lost to Follow-up|2|||
162904650|NCT04474366|588348740|FG001|Overall Study|Lost to Follow-up|5|||
162904651|NCT04063865|588348741|FG000|Overall Study|Physician Decision|1|||
162904652|NCT04063865|588348742|FG001|Overall Study|Physician Decision|3|||
162904653|NCT04063865|588348741|FG000|Overall Study|Study Closed Prior to Completion|4|||
162904654|NCT04063865|588348742|FG001|Overall Study|Study Closed Prior to Completion|4|||
162904655|NCT04063865|588348741|FG000|Overall Study|Withdrawal by Subject|1|||
162904656|NCT04063865|588348742|FG001|Overall Study|Withdrawal by Subject|1|||
162904657|NCT00320190|588348743|FG000|First 12 Months|Completed but did not enter extension|5|||
162904658|NCT00320190|588348744|FG001|First 12 Months|Completed but did not enter extension|3|||
162904659|NCT00320190|588348743|FG000|First 12 Months|Sponsor terminated study|2|||
162904660|NCT00320190|588348744|FG001|First 12 Months|Sponsor terminated study|2|||
162904661|NCT00320190|588348743|FG000|First 12 Months|Lost to Follow-up|0|||
162904662|NCT00320190|588348744|FG001|First 12 Months|Lost to Follow-up|1|||
162904663|NCT00320190|588348743|FG000|First 12 Months|Enrollment failure|0|||
162904664|NCT00320190|588348744|FG001|First 12 Months|Enrollment failure|1|||
162904665|NCT00320190|588348743|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
162904666|NCT00320190|588348744|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
162904667|NCT00320190|588348743|FG000|First 12 Months|Investigator request|0|||
162904668|NCT00320190|588348744|FG001|First 12 Months|Investigator request|1|||
162904669|NCT00320190|588348743|FG000|First 12 Months|Study drug toxicity|0|||
162904670|NCT00320190|588348744|FG001|First 12 Months|Study drug toxicity|1|||
162904671|NCT00320190|588348743|FG000|First 12 Months|Withdrawal by Subject|0|||
162904672|NCT00320190|588348744|FG001|First 12 Months|Withdrawal by Subject|1|||
162904673|NCT00320190|588348743|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
162904674|NCT00320190|588348744|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
162904675|NCT00320190|588348743|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
162904676|NCT00320190|588348744|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
162904677|NCT00320190|588348743|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
162904678|NCT00320190|588348744|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
162904679|NCT01700140|588348745|FG000|Overall Study|Use of rescue drugs|3|||
162904680|NCT01700140|588348746|FG001|Overall Study|Use of rescue drugs|3|||
162904681|NCT01700140|588348747|FG002|Overall Study|Use of rescue drugs|1|||
162904682|NCT01700140|588348745|FG000|Overall Study|Discontinuation of radiotherapy|1|||
162904683|NCT01700140|588348746|FG001|Overall Study|Discontinuation of radiotherapy|0|||
162966931|NCT04281472|588579580|FG001|Stage A|Non-compliance with study drug|0|||
162966932|NCT04281472|588579581|FG002|Stage A|Non-compliance with study drug|0|||
162966933|NCT04281472|588579579|FG000|Stage A|Physician Decision|1|||
162966934|NCT04281472|588579580|FG001|Stage A|Physician Decision|0|||
162966935|NCT04281472|588579581|FG002|Stage A|Physician Decision|0|||
162966936|NCT04281472|588579579|FG000|Stage A|Prohibited medications|2|||
162966937|NCT04281472|588579580|FG001|Stage A|Prohibited medications|0|||
163053780|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
162966938|NCT04281472|588579581|FG002|Stage A|Prohibited medications|0|||
162966939|NCT04281472|588579579|FG000|Stage A|Withdrawal by Subject|11|||
162966940|NCT04281472|588579580|FG001|Stage A|Withdrawal by Subject|0|||
162966941|NCT04281472|588579581|FG002|Stage A|Withdrawal by Subject|0|||
162966942|NCT04281472|588579579|FG000|Stage A|Other|5|||
162966943|NCT04281472|588579580|FG001|Stage A|Other|0|||
162966944|NCT04281472|588579581|FG002|Stage A|Other|0|||
162966945|NCT04281472|588579579|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
162966946|NCT04281472|588579580|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
162966947|NCT04281472|588579581|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
162966948|NCT04281472|588579579|FG000|Stage B|Adverse Event|0|||
162966949|NCT04281472|588579580|FG001|Stage B|Adverse Event|3|||
162966950|NCT04281472|588579581|FG002|Stage B|Adverse Event|0|||
162966951|NCT04281472|588579579|FG000|Stage B|Death|0|||
162966952|NCT04281472|588579580|FG001|Stage B|Death|0|||
162966953|NCT04281472|588579581|FG002|Stage B|Death|1|||
162966954|NCT04281472|588579579|FG000|Stage B|Lack of Efficacy|0|||
162966955|NCT04281472|588579580|FG001|Stage B|Lack of Efficacy|0|||
162966956|NCT04281472|588579581|FG002|Stage B|Lack of Efficacy|1|||
162966957|NCT04281472|588579579|FG000|Stage B|Lost to Follow-up|0|||
162904684|NCT01700140|588348747|FG002|Overall Study|Discontinuation of radiotherapy|0|||
162904685|NCT01700140|588348745|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
162904686|NCT01700140|588348746|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
162904687|NCT01700140|588348747|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
162904688|NCT01700140|588348745|FG000|Overall Study|Aggravation of symptoms|1|||
162904689|NCT01700140|588348746|FG001|Overall Study|Aggravation of symptoms|0|||
162966958|NCT04281472|588579580|FG001|Stage B|Lost to Follow-up|0|||
162966959|NCT04281472|588579581|FG002|Stage B|Lost to Follow-up|2|||
162966960|NCT04281472|588579579|FG000|Stage B|Prohibited medications|0|||
162966961|NCT04281472|588579580|FG001|Stage B|Prohibited medications|2|||
162904690|NCT01700140|588348747|FG002|Overall Study|Aggravation of symptoms|0|||
162904691|NCT01700140|588348745|FG000|Overall Study|Adverse Event|0|||
162904692|NCT01700140|588348746|FG001|Overall Study|Adverse Event|1|||
162904693|NCT01700140|588348747|FG002|Overall Study|Adverse Event|0|||
162966962|NCT04281472|588579581|FG002|Stage B|Prohibited medications|1|||
162966963|NCT04281472|588579579|FG000|Stage B|Protocol Violation|0|||
162966964|NCT04281472|588579580|FG001|Stage B|Protocol Violation|1|||
162904694|NCT01700140|588348745|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
162904695|NCT01700140|588348746|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
162904696|NCT01700140|588348747|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
162904697|NCT01060124|588348748|FG000|Overall Study|Other|16|||
162904698|NCT01060124|588348748|FG000|Overall Study|Adverse Event|14|||
162904699|NCT01060124|588348748|FG000|Overall Study|Withdrawal by Subject|7|||
162904700|NCT00102804|588348751|FG000|Overall Study|Progressive Disease (PD)|307|||
162904701|NCT00102804|588348752|FG001|Overall Study|Progressive Disease (PD)|196|||
162904702|NCT00102804|588348751|FG000|Overall Study|Withdrawal by Subject|46|||
162904703|NCT00102804|588348752|FG001|Overall Study|Withdrawal by Subject|7|||
162904704|NCT00102804|588348751|FG000|Overall Study|Adverse Event|37|||
162904705|NCT00102804|588348752|FG001|Overall Study|Adverse Event|3|||
162904706|NCT00102804|588348751|FG000|Overall Study|Physician Decision|24|||
162904707|NCT00102804|588348752|FG001|Overall Study|Physician Decision|6|||
162904708|NCT00102804|588348751|FG000|Overall Study|Death|5|||
162904709|NCT00102804|588348752|FG001|Overall Study|Death|6|||
162904710|NCT00102804|588348751|FG000|Overall Study|Enrollment Criteria Not Met|6|||
162904711|NCT00102804|588348752|FG001|Overall Study|Enrollment Criteria Not Met|0|||
162904712|NCT00102804|588348751|FG000|Overall Study|Lost to Follow-up|4|||
162904713|NCT00102804|588348752|FG001|Overall Study|Lost to Follow-up|1|||
162904714|NCT00102804|588348751|FG000|Overall Study|Protocol Violation|2|||
162904715|NCT00102804|588348752|FG001|Overall Study|Protocol Violation|1|||
162904716|NCT00102804|588348751|FG000|Overall Study|Satisfactory Response|2|||
162904717|NCT00102804|588348752|FG001|Overall Study|Satisfactory Response|0|||
162904718|NCT00102804|588348751|FG000|Overall Study|Sponsor Decision|1|||
162904719|NCT00102804|588348752|FG001|Overall Study|Sponsor Decision|0|||
162904720|NCT00102804|588348751|FG000|Overall Study|Alive, Receiving Treatment|7|||
162904721|NCT00102804|588348752|FG001|Overall Study|Alive, Receiving Treatment|2|||
162904722|NCT03858686|588348753|FG000|Period 1|Adverse Event|1|||
162904723|NCT03858686|588348754|FG001|Period 1|Adverse Event|1|||
162904724|NCT03858686|588348753|FG000|Period 1|Lack of compliance|0|||
162904725|NCT03858686|588348754|FG001|Period 1|Lack of compliance|1|||
162904726|NCT03858686|588348753|FG000|Period 1|Adverse Event|0|||
162904727|NCT03858686|588348754|FG001|Period 1|Adverse Event|1|||
162904728|NCT03858686|588348753|FG000|Period 2|Adverse Event|0|||
162904729|NCT03858686|588348754|FG001|Period 2|Adverse Event|1|||
162904730|NCT02299206|588348761|FG000|Overall Study|Lost to Follow-up|1|||
162904731|NCT02299206|588348761|FG000|Overall Study|Withdrawal by Subject|1|||
162904732|NCT00691054|588348762|FG000|Overall Study|Withdrawal by Subject|1|||
162904733|NCT00518336|588348763|FG000|Year 7|Lost to Follow-up|2|||
162904734|NCT00518336|588348764|FG001|Year 7|Lost to Follow-up|0|||
162904735|NCT00518336|588348763|FG000|Year 7|Could not attend in time|0|||
162904736|NCT00518336|588348764|FG001|Year 7|Could not attend in time|3|||
162904737|NCT00518336|588348763|FG000|Year 8|Lost to Follow-up|1|||
162904738|NCT00518336|588348764|FG001|Year 8|Lost to Follow-up|1|||
162904739|NCT00518336|588348763|FG000|Year 8|Could not attend in time|0|||
162904740|NCT00518336|588348764|FG001|Year 8|Could not attend in time|1|||
162904741|NCT00518336|588348763|FG000|Year 9|Migrated/moved from study area|1|||
162904742|NCT00518336|588348764|FG001|Year 9|Migrated/moved from study area|1|||
162904743|NCT00518336|588348763|FG000|Year 9|Lost to Follow-up|3|||
162904744|NCT00518336|588348764|FG001|Year 9|Lost to Follow-up|0|||
162904745|NCT00518336|588348763|FG000|Year 9|Personal reasons|1|||
162904746|NCT00518336|588348764|FG001|Year 9|Personal reasons|0|||
162904747|NCT02314637|588349922|FG000|Overall Study|Adverse Event|4|||
162904748|NCT02314637|588349923|FG001|Overall Study|Adverse Event|8|||
162904749|NCT02314637|588349922|FG000|Overall Study|Lack of Efficacy|1|||
163053781|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
163053782|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
163053783|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
163053784|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
163053785|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
163053786|NCT00324155|588908402|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
163053787|NCT00324155|588908403|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
162904750|NCT02314637|588349923|FG001|Overall Study|Lack of Efficacy|0|||
162904751|NCT02314637|588349922|FG000|Overall Study|Physician Decision|5|||
162904752|NCT02314637|588349923|FG001|Overall Study|Physician Decision|2|||
162904753|NCT02314637|588349922|FG000|Overall Study|Withdrawal by Subject|5|||
162904754|NCT02314637|588349923|FG001|Overall Study|Withdrawal by Subject|4|||
162904755|NCT02314637|588349922|FG000|Overall Study|Other Reason|1|||
162904756|NCT02314637|588349923|FG001|Overall Study|Other Reason|0|||
162904757|NCT00686699|588349925|FG000|Treatment Period 1|Adverse Event|0|||
162904758|NCT00686699|588349926|FG001|Treatment Period 1|Adverse Event|2|||
162904759|NCT00033514|588349928|FG000|Overall Study|Lost to Follow-up|1|||
162904760|NCT00033514|588349929|FG001|Overall Study|Lost to Follow-up|1|||
162904761|NCT00033514|588349928|FG000|Overall Study|Withdrawal by Subject|0|||
162904762|NCT00033514|588349929|FG001|Overall Study|Withdrawal by Subject|3|||
162904763|NCT04221945|588349932|FG000|Overall Study|Death|103|||
162904764|NCT04221945|588349933|FG001|Overall Study|Death|140|||
162904765|NCT04221945|588349932|FG000|Overall Study|Lost to Follow-up|5|||
162904766|NCT04221945|588349933|FG001|Overall Study|Lost to Follow-up|8|||
162904767|NCT04221945|588349932|FG000|Overall Study|Withdrawal by Subject|21|||
162904768|NCT04221945|588349933|FG001|Overall Study|Withdrawal by Subject|11|||
162904769|NCT04221945|588349932|FG000|Overall Study|Participants Ongoing|400|||
162904770|NCT04221945|588349933|FG001|Overall Study|Participants Ongoing|372|||
162904771|NCT00974090|588349935|FG000|Period 1: Double Blind Period|Adverse Event|2|||
162904772|NCT00974090|588349936|FG001|Period 1: Double Blind Period|Adverse Event|1|||
162904773|NCT00974090|588349935|FG000|Period 1: Double Blind Period|Physician Decision|1|||
162904774|NCT00974090|588349936|FG001|Period 1: Double Blind Period|Physician Decision|0|||
162904775|NCT00974090|588349935|FG000|Period 2: Open-label Period|Adverse Event|4|||
162904776|NCT00974090|588349936|FG001|Period 2: Open-label Period|Adverse Event|6|||
162904777|NCT00974090|588349935|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
162904778|NCT00974090|588349936|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
162904779|NCT00974090|588349935|FG000|Period 2: Open-label Period|Physician Decision|0|||
162904780|NCT00974090|588349936|FG001|Period 2: Open-label Period|Physician Decision|3|||
162904781|NCT00974090|588349935|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
162904782|NCT00974090|588349936|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
162904783|NCT01626872|588349937|FG000|Overall Study|Physician Decision|13|||
162904784|NCT01626872|588349938|FG001|Overall Study|Physician Decision|9|||
162904785|NCT01626872|588349939|FG002|Overall Study|Physician Decision|6|||
162904786|NCT01626872|588349937|FG000|Overall Study|Withdrawal by Subject|19|||
162904787|NCT01626872|588349938|FG001|Overall Study|Withdrawal by Subject|27|||
162904788|NCT01626872|588349939|FG002|Overall Study|Withdrawal by Subject|8|||
162904789|NCT01626872|588349937|FG000|Overall Study|Adverse Event (including Death)|20|||
162904790|NCT01626872|588349938|FG001|Overall Study|Adverse Event (including Death)|28|||
162904791|NCT01626872|588349939|FG002|Overall Study|Adverse Event (including Death)|8|||
162904792|NCT01626872|588349937|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
162904793|NCT01626872|588349938|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
162904794|NCT01626872|588349939|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
162904795|NCT05626751|588349940|FG000|Overall Study|Lost to Follow-up|1|||
162904796|NCT05626751|588349941|FG001|Overall Study|Lost to Follow-up|2|||
162904797|NCT05626751|588349942|FG002|Overall Study|Lost to Follow-up|1|||
162904798|NCT05626751|588349940|FG000|Overall Study|Trial Terminated by Sponsor|39|||
162904799|NCT05626751|588349941|FG001|Overall Study|Trial Terminated by Sponsor|30|||
162904800|NCT05626751|588349942|FG002|Overall Study|Trial Terminated by Sponsor|37|||
162904801|NCT05626751|588349940|FG000|Overall Study|Withdrawal by Subject|7|||
162904802|NCT05626751|588349941|FG001|Overall Study|Withdrawal by Subject|5|||
162904803|NCT05626751|588349942|FG002|Overall Study|Withdrawal by Subject|5|||
162904804|NCT01625000|588349943|FG000|Overall Study|Physician Decision|15|||
162904805|NCT01625000|588349944|FG001|Overall Study|Physician Decision|7|||
162904806|NCT01625000|588349945|FG002|Overall Study|Physician Decision|7|||
162904807|NCT01625000|588349946|FG003|Overall Study|Physician Decision|2|||
162904808|NCT01625000|588349947|FG004|Overall Study|Physician Decision|15|||
162904809|NCT01625000|588349943|FG000|Overall Study|Protocol Violation|3|||
162904810|NCT01625000|588349944|FG001|Overall Study|Protocol Violation|10|||
162904811|NCT01625000|588349945|FG002|Overall Study|Protocol Violation|4|||
162904812|NCT01625000|588349946|FG003|Overall Study|Protocol Violation|1|||
162904813|NCT01625000|588349947|FG004|Overall Study|Protocol Violation|2|||
162904814|NCT01625000|588349943|FG000|Overall Study|Withdrawal by Subject|19|||
162904815|NCT01625000|588349944|FG001|Overall Study|Withdrawal by Subject|16|||
162904816|NCT01625000|588349945|FG002|Overall Study|Withdrawal by Subject|11|||
162904817|NCT01625000|588349946|FG003|Overall Study|Withdrawal by Subject|9|||
162904818|NCT01625000|588349947|FG004|Overall Study|Withdrawal by Subject|17|||
162904819|NCT01625000|588349943|FG000|Overall Study|Adverse Event (including Death)|15|||
162904820|NCT01625000|588349944|FG001|Overall Study|Adverse Event (including Death)|19|||
162904821|NCT01625000|588349945|FG002|Overall Study|Adverse Event (including Death)|11|||
162904822|NCT01625000|588349946|FG003|Overall Study|Adverse Event (including Death)|7|||
162904823|NCT01625000|588349947|FG004|Overall Study|Adverse Event (including Death)|21|||
162904824|NCT03912064|588349948|FG000|Overall Study|Withdrawal by Subject|2|||
162966965|NCT04281472|588579581|FG002|Stage B|Protocol Violation|1|||
162966966|NCT04281472|588579579|FG000|Stage B|Sponsor decision|0|||
162966967|NCT04281472|588579580|FG001|Stage B|Sponsor decision|0|||
162966968|NCT04281472|588579581|FG002|Stage B|Sponsor decision|1|||
162904825|NCT03912064|588349949|FG001|Overall Study|Withdrawal by Subject|0|||
162904826|NCT03912064|588349950|FG002|Overall Study|Withdrawal by Subject|0|||
162904827|NCT03912064|588349948|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
162904828|NCT03912064|588349949|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
162966969|NCT04281472|588579579|FG000|Stage B|Withdrawal by Subject|0|||
162904829|NCT03912064|588349950|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
162904830|NCT03912064|588349948|FG000|Overall Study|Progression/Relapse|7|||
162904831|NCT03912064|588349949|FG001|Overall Study|Progression/Relapse|3|||
162904832|NCT03912064|588349950|FG002|Overall Study|Progression/Relapse|0|||
162904833|NCT03912064|588349948|FG000|Overall Study|Prolonged treatment delays|3|||
162904834|NCT03912064|588349949|FG001|Overall Study|Prolonged treatment delays|2|||
162966970|NCT04281472|588579580|FG001|Stage B|Withdrawal by Subject|3|||
162966971|NCT04281472|588579581|FG002|Stage B|Withdrawal by Subject|3|||
162966972|NCT04281472|588579579|FG000|Stage B|Other|0|||
162966973|NCT04281472|588579580|FG001|Stage B|Other|3|||
162966974|NCT04281472|588579581|FG002|Stage B|Other|0|||
162966975|NCT04697173|588579590|FG000|Overall Study|Withdrawal by Subject|34|||
162966976|NCT04697173|588579591|FG001|Overall Study|Withdrawal by Subject|38|||
162966977|NCT03277248|588579596|FG000|Overall Study|Adverse Event|3|||
162966978|NCT03277248|588579597|FG001|Overall Study|Adverse Event|1|||
162966979|NCT03277248|588579596|FG000|Overall Study|Subject Withdrawal of Consent|6|||
162904835|NCT03912064|588349950|FG002|Overall Study|Prolonged treatment delays|0|||
162966980|NCT03277248|588579597|FG001|Overall Study|Subject Withdrawal of Consent|23|||
162966981|NCT03277248|588579596|FG000|Overall Study|Investigator/Sponsor Decision|2|||
162966982|NCT03277248|588579597|FG001|Overall Study|Investigator/Sponsor Decision|2|||
162966983|NCT03277248|588579596|FG000|Overall Study|Pregnancy|4|||
162966984|NCT03277248|588579597|FG001|Overall Study|Pregnancy|1|||
162966985|NCT03277248|588579596|FG000|Overall Study|Lost to Follow-up|0|||
162966986|NCT03277248|588579597|FG001|Overall Study|Lost to Follow-up|2|||
162966987|NCT03277248|588579596|FG000|Overall Study|Lack of Efficacy|0|||
162966988|NCT03277248|588579597|FG001|Overall Study|Lack of Efficacy|2|||
162966989|NCT03277248|588579596|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162966990|NCT03277248|588579597|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162966991|NCT01993940|588579598|FG000|Overall Study|Adverse Event|16|||
162966992|NCT01993940|588579599|FG001|Overall Study|Adverse Event|11|||
162966993|NCT01993940|588579598|FG000|Overall Study|Withdrawal by Subject|15|||
162966994|NCT01993940|588579599|FG001|Overall Study|Withdrawal by Subject|19|||
162904836|NCT03912064|588349948|FG000|Overall Study|Prohibited concomitant treatments|3|||
162904837|NCT03912064|588349949|FG001|Overall Study|Prohibited concomitant treatments|1|||
162904838|NCT03912064|588349950|FG002|Overall Study|Prohibited concomitant treatments|0|||
162904839|NCT01026194|588349951|FG000|Period 1：Double Blind Period|Adverse Event|2|||
162904840|NCT01026194|588349952|FG001|Period 1：Double Blind Period|Adverse Event|1|||
162904841|NCT01026194|588349951|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
162904842|NCT01026194|588349952|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
162904843|NCT01026194|588349951|FG000|Period 1：Double Blind Period|Physician Decision|0|||
162904844|NCT01026194|588349952|FG001|Period 1：Double Blind Period|Physician Decision|4|||
162966995|NCT01993940|588579598|FG000|Overall Study|Lost to Follow-up|2|||
162966996|NCT01993940|588579599|FG001|Overall Study|Lost to Follow-up|5|||
162966997|NCT01993940|588579598|FG000|Overall Study|Protocol Violation|5|||
162966998|NCT01993940|588579599|FG001|Overall Study|Protocol Violation|8|||
162966999|NCT01993940|588579598|FG000|Overall Study|Death|1|||
162967000|NCT01993940|588579599|FG001|Overall Study|Death|0|||
162967001|NCT01993940|588579598|FG000|Overall Study|Other - Miscellaneous|1|||
162967002|NCT01993940|588579599|FG001|Overall Study|Other - Miscellaneous|1|||
162967003|NCT01949532|588579600|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
162967004|NCT01949532|588579601|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
162967005|NCT00379353|588579602|FG000|Overall Study|Hospitalization|3|||
162967006|NCT00379353|588579603|FG001|Overall Study|Hospitalization|3|||
162967007|NCT00379353|588579602|FG000|Overall Study|Withdrawal by Subject|5|||
162967008|NCT00379353|588579603|FG001|Overall Study|Withdrawal by Subject|2|||
162967009|NCT00379353|588579602|FG000|Overall Study|Death|1|||
162967010|NCT00379353|588579603|FG001|Overall Study|Death|0|||
162967011|NCT00379353|588579602|FG000|Overall Study|Cardiac Tamponade|1|||
162967012|NCT00379353|588579603|FG001|Overall Study|Cardiac Tamponade|0|||
162967013|NCT00379353|588579602|FG000|Overall Study|Non-compliance|1|||
162967014|NCT00379353|588579603|FG001|Overall Study|Non-compliance|0|||
162967015|NCT00379353|588579602|FG000|Overall Study|Conflicting drug treatment|0|||
162967016|NCT00379353|588579603|FG001|Overall Study|Conflicting drug treatment|1|||
162967017|NCT01211262|588579608|FG000|Overall Study|Progressive Disease|18|||
162967018|NCT01211262|588579609|FG001|Overall Study|Progressive Disease|9|||
162967019|NCT01211262|588579608|FG000|Overall Study|Adverse Event|4|||
162967020|NCT01211262|588579609|FG001|Overall Study|Adverse Event|0|||
162967021|NCT01211262|588579608|FG000|Overall Study|Withdrawal of Consent|1|||
162967022|NCT01211262|588579609|FG001|Overall Study|Withdrawal of Consent|0|||
162967023|NCT01211262|588579608|FG000|Overall Study|Other|0|||
162967024|NCT01211262|588579609|FG001|Overall Study|Other|1|||
162904845|NCT01026194|588349951|FG000|Period 2：Open-label Period|Adverse Event|4|||
162904846|NCT01026194|588349952|FG001|Period 2：Open-label Period|Adverse Event|5|||
162967025|NCT01277510|588579612|FG000|Double-blind Phase|Non-compliance|0|||
162967026|NCT01277510|588579613|FG001|Double-blind Phase|Non-compliance|1|||
162967027|NCT01277510|588579612|FG000|Double-blind Phase|Adverse Event|1|||
162904847|NCT01026194|588349951|FG000|Period 2：Open-label Period|Physician Decision|3|||
162904848|NCT01026194|588349952|FG001|Period 2：Open-label Period|Physician Decision|1|||
162967028|NCT01277510|588579613|FG001|Double-blind Phase|Adverse Event|0|||
162967029|NCT01277510|588579612|FG000|Double-blind Phase|Withdrawal by Subject|2|||
162967030|NCT01277510|588579613|FG001|Double-blind Phase|Withdrawal by Subject|0|||
162967031|NCT01277510|588579612|FG000|Double-blind Phase|Administrative decision|7|||
162967032|NCT01277510|588579613|FG001|Double-blind Phase|Administrative decision|9|||
162904849|NCT01026194|588349951|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
162904850|NCT01026194|588349952|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
162904851|NCT04295759|588349953|FG000|Overall Study|Lack of Efficacy|9|||
162904852|NCT04295759|588349953|FG000|Overall Study|Death|1|||
162904853|NCT04295759|588349953|FG000|Overall Study|Withdrawal by Subject|2|||
162904854|NCT04295759|588349953|FG000|Overall Study|Deemed ineligible|1|||
162904855|NCT05740566|588349954|FG000|Overall Study|Death|151|||
162904856|NCT05740566|588349955|FG001|Overall Study|Death|111|||
162904857|NCT05740566|588349954|FG000|Overall Study|Withdrawal by Subject|2|||
162904858|NCT05740566|588349955|FG001|Overall Study|Withdrawal by Subject|0|||
162904859|NCT05740566|588349954|FG000|Overall Study|Ongoing in study|102|||
162904860|NCT05740566|588349955|FG001|Overall Study|Ongoing in study|143|||
162904861|NCT00829010|588349958|FG000|Overall Study|Adverse Event|1|||
162904862|NCT00829010|588349959|FG001|Overall Study|Adverse Event|0|||
162904863|NCT00829010|588349960|FG002|Overall Study|Adverse Event|0|||
162904864|NCT00829010|588349961|FG003|Overall Study|Adverse Event|0|||
162904865|NCT00829010|588349962|FG004|Overall Study|Adverse Event|0|||
162904866|NCT00829010|588349958|FG000|Overall Study|Withdrawal by Subject|0|||
162904867|NCT00829010|588349959|FG001|Overall Study|Withdrawal by Subject|1|||
162904868|NCT00829010|588349960|FG002|Overall Study|Withdrawal by Subject|1|||
162904869|NCT00829010|588349961|FG003|Overall Study|Withdrawal by Subject|0|||
162904870|NCT00829010|588349962|FG004|Overall Study|Withdrawal by Subject|2|||
162904871|NCT00829010|588349958|FG000|Overall Study|Lost to Follow-up|1|||
162904872|NCT00829010|588349959|FG001|Overall Study|Lost to Follow-up|0|||
162904873|NCT00829010|588349960|FG002|Overall Study|Lost to Follow-up|2|||
162904874|NCT00829010|588349961|FG003|Overall Study|Lost to Follow-up|0|||
162904875|NCT00829010|588349962|FG004|Overall Study|Lost to Follow-up|0|||
162904876|NCT00829010|588349958|FG000|Overall Study|Fatality|5|||
162904877|NCT00829010|588349959|FG001|Overall Study|Fatality|4|||
162904878|NCT00829010|588349960|FG002|Overall Study|Fatality|0|||
162904879|NCT00829010|588349961|FG003|Overall Study|Fatality|3|||
162904880|NCT00829010|588349962|FG004|Overall Study|Fatality|0|||
162904881|NCT00829010|588349958|FG000|Overall Study|Migrated/Moved from study area|3|||
162904882|NCT00829010|588349959|FG001|Overall Study|Migrated/Moved from study area|4|||
162904883|NCT00829010|588349960|FG002|Overall Study|Migrated/Moved from study area|0|||
162904884|NCT00829010|588349961|FG003|Overall Study|Migrated/Moved from study area|5|||
162904885|NCT00829010|588349962|FG004|Overall Study|Migrated/Moved from study area|0|||
162904886|NCT06210035|588349963|FG000|Overall Study|Withdrawal by Subject|3|||
162904887|NCT06210035|588349964|FG001|Overall Study|Withdrawal by Subject|0|||
162904888|NCT06210035|588349965|FG002|Overall Study|Withdrawal by Subject|0|||
162904889|NCT01029691|588349966|FG000|Continued APAP to Delivery|Death|0|||
162904890|NCT01029691|588349967|FG001|Continued APAP to Delivery|Death|0|||
162904891|NCT01029691|588349968|FG002|Continued APAP to Delivery|Death|1|||
162904892|NCT05616221|588349973|FG000|Overall Study|Withdrawal by Subject|0|||
162904893|NCT05616221|588349974|FG001|Overall Study|Withdrawal by Subject|1|||
162904894|NCT05616221|588349975|FG002|Overall Study|Withdrawal by Subject|0|||
162904895|NCT05616221|588349976|FG003|Overall Study|Withdrawal by Subject|0|||
162904896|NCT05616221|588349977|FG004|Overall Study|Withdrawal by Subject|0|||
162904897|NCT05616221|588349978|FG005|Overall Study|Withdrawal by Subject|0|||
162904898|NCT05616221|588349973|FG000|Overall Study|Adverse Event|0|||
162904899|NCT05616221|588349974|FG001|Overall Study|Adverse Event|2|||
162904900|NCT05616221|588349975|FG002|Overall Study|Adverse Event|0|||
162904901|NCT05616221|588349976|FG003|Overall Study|Adverse Event|0|||
162904902|NCT05616221|588349977|FG004|Overall Study|Adverse Event|2|||
162904903|NCT05616221|588349978|FG005|Overall Study|Adverse Event|0|||
162904904|NCT04880733|588349979|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
162904905|NCT04880733|588349980|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
162904906|NCT04880733|588349981|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
162904907|NCT04880733|588349979|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
162904908|NCT04880733|588349980|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
162904909|NCT04880733|588349981|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
162904910|NCT04880733|588349979|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
162904911|NCT04880733|588349980|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
162904912|NCT04880733|588349981|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
162904913|NCT04880733|588349979|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
162904914|NCT04880733|588349980|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
162904915|NCT04880733|588349981|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
162904916|NCT04880733|588349979|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
162904917|NCT04880733|588349980|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
162904918|NCT04880733|588349981|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
162904919|NCT00862992|588349982|FG000|Overall Study|Adverse Event|2|||
162904920|NCT00862992|588349983|FG001|Overall Study|Adverse Event|1|||
162904921|NCT00862992|588349984|FG002|Overall Study|Adverse Event|1|||
162904922|NCT00862992|588349982|FG000|Overall Study|Physician Decision|1|||
163053788|NCT00324155|588908402|FG000|Follow-up Phase|On-going participants still on drug|11|||
162904923|NCT00862992|588349983|FG001|Overall Study|Physician Decision|0|||
162904924|NCT00862992|588349984|FG002|Overall Study|Physician Decision|0|||
162904925|NCT00862992|588349982|FG000|Overall Study|Withdrawal by Subject|0|||
162904926|NCT00862992|588349983|FG001|Overall Study|Withdrawal by Subject|0|||
162904927|NCT00862992|588349984|FG002|Overall Study|Withdrawal by Subject|2|||
162904928|NCT05492877|588349985|FG000|Overall Study|Adverse Event|11|||
162904929|NCT05492877|588349986|FG001|Overall Study|Adverse Event|7|||
162904930|NCT05492877|588349985|FG000|Overall Study|Death|1|||
162904931|NCT05492877|588349986|FG001|Overall Study|Death|0|||
162904932|NCT05492877|588349985|FG000|Overall Study|Lost to Follow-up|1|||
162904933|NCT05492877|588349986|FG001|Overall Study|Lost to Follow-up|1|||
162904934|NCT05492877|588349985|FG000|Overall Study|Physician Decision|1|||
162904935|NCT05492877|588349986|FG001|Overall Study|Physician Decision|2|||
162904936|NCT05492877|588349985|FG000|Overall Study|Protocol Violation|1|||
162904937|NCT05492877|588349986|FG001|Overall Study|Protocol Violation|1|||
162904938|NCT05492877|588349985|FG000|Overall Study|Withdrawal by Subject|3|||
162904939|NCT05492877|588349986|FG001|Overall Study|Withdrawal by Subject|7|||
162904940|NCT05492877|588349985|FG000|Overall Study|Reason not specified|6|||
162904941|NCT05492877|588349986|FG001|Overall Study|Reason not specified|4|||
162904942|NCT02871791|588349987|FG000|Phase 1b|Death|0|||
162904943|NCT02871791|588349988|FG001|Phase 1b|Death|1|||
162904944|NCT02871791|588349987|FG000|Phase 1b|progressive disease|6|||
162904945|NCT02871791|588349988|FG001|Phase 1b|progressive disease|2|||
162904946|NCT02871791|588349987|FG000|Phase 2|Death|1|||
162904947|NCT02871791|588349988|FG001|Phase 2|Death|0|||
162904948|NCT02871791|588349987|FG000|Phase 2|Lost to Follow-up|2|||
162904949|NCT02871791|588349988|FG001|Phase 2|Lost to Follow-up|0|||
162904950|NCT03737318|588350000|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
162904951|NCT03737318|588350001|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
162904952|NCT03737318|588350002|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
162904953|NCT00528840|588350006|FG000|Overall Study|Lost to Follow-up|10|||
162904954|NCT00528840|588350006|FG000|Overall Study|Adverse Event|1|||
162904955|NCT00528840|588350006|FG000|Overall Study|Withdrawal by Subject|17|||
162904956|NCT00528840|588350006|FG000|Overall Study|Death|2|||
162904957|NCT00528840|588350006|FG000|Overall Study|Administrative Reasons|1|||
162904958|NCT00528840|588350006|FG000|Overall Study|Other|2|||
162904959|NCT01603628|588350007|FG000|Overall Study|Personal Reasons|1|||
162904960|NCT01603628|588350008|FG001|Overall Study|Personal Reasons|1|||
162904961|NCT01603628|588350009|FG002|Overall Study|Personal Reasons|2|||
162904962|NCT01603628|588350007|FG000|Overall Study|Protocol Violation|1|||
162904963|NCT01603628|588350008|FG001|Overall Study|Protocol Violation|1|||
162904964|NCT01603628|588350009|FG002|Overall Study|Protocol Violation|0|||
162904965|NCT01603628|588350007|FG000|Overall Study|Lost to Follow-up|0|||
162904966|NCT01603628|588350008|FG001|Overall Study|Lost to Follow-up|1|||
162904967|NCT01603628|588350009|FG002|Overall Study|Lost to Follow-up|0|||
162904968|NCT01603628|588350007|FG000|Overall Study|Other Miscellaneous Reason|1|||
162904969|NCT01603628|588350008|FG001|Overall Study|Other Miscellaneous Reason|0|||
162904970|NCT01603628|588350009|FG002|Overall Study|Other Miscellaneous Reason|0|||
162904971|NCT02711553|588350012|FG000|Overall Study|Withdrawal by Subject|2|||
162904972|NCT02711553|588350013|FG001|Overall Study|Withdrawal by Subject|1|||
162904973|NCT02711553|588350014|FG002|Overall Study|Withdrawal by Subject|1|||
162904974|NCT02711553|588350015|FG003|Overall Study|Withdrawal by Subject|0|||
162904975|NCT02711553|588350012|FG000|Overall Study|Lost to Follow-up|3|||
162904976|NCT02711553|588350013|FG001|Overall Study|Lost to Follow-up|3|||
162904977|NCT02711553|588350014|FG002|Overall Study|Lost to Follow-up|6|||
162904978|NCT02711553|588350015|FG003|Overall Study|Lost to Follow-up|3|||
162904979|NCT02711553|588350012|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
162904980|NCT02711553|588350013|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
162904981|NCT02711553|588350014|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
162904982|NCT02711553|588350015|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
162904983|NCT03457636|588350020|FG000|Overall Study|Lost to Follow-up|2|||
162904984|NCT03399786|588350024|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162904985|NCT03399786|588350025|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162904986|NCT03399786|588350026|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162904987|NCT03399786|588350027|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162904988|NCT03399786|588350024|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
162904989|NCT03399786|588350025|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
162904990|NCT03399786|588350026|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
162904991|NCT03399786|588350027|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
162904992|NCT03399786|588350024|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
162904993|NCT03399786|588350025|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
162904994|NCT03399786|588350026|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
162904995|NCT03399786|588350027|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
162904996|NCT03053180|588351762|FG000|Overall Study|Failure to Return|1|||
162904997|NCT01465958|588351767|FG000|Run-in Phase|Protocol Violation|1|||
162904998|NCT01465958|588351768|FG001|Run-in Phase|Protocol Violation|0|||
162626103|NCT03600818|587346983|FG001|Overall Study|Adverse Event|7|||
162904999|NCT01465958|588351767|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
162905000|NCT01465958|588351768|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
162905001|NCT00211536|588351776|FG000|Overall Study|Withdrawal by Subject|2|||
162905002|NCT00211536|588351777|FG001|Overall Study|Withdrawal by Subject|2|||
162905003|NCT00211536|588351776|FG000|Overall Study|Physician Decision|0|||
162905004|NCT00211536|588351777|FG001|Overall Study|Physician Decision|5|||
162905005|NCT00211536|588351776|FG000|Overall Study|Adverse Event|2|||
162905006|NCT00211536|588351777|FG001|Overall Study|Adverse Event|0|||
162905007|NCT02583399|588351778|FG000|Overall Study|Able to be discharged|3|||
162905008|NCT02583399|588351778|FG000|Overall Study|Wanted to use a restricted medication|3|||
162905009|NCT01004861|588351779|FG000|Overall Study|Disease progression|3|||
162905010|NCT01004861|588351780|FG001|Overall Study|Disease progression|4|||
162905011|NCT01004861|588351781|FG002|Overall Study|Disease progression|5|||
162905012|NCT01004861|588351782|FG003|Overall Study|Disease progression|4|||
162905013|NCT01004861|588351783|FG004|Overall Study|Disease progression|4|||
162905014|NCT01004861|588351784|FG005|Overall Study|Disease progression|4|||
162905015|NCT01004861|588351785|FG006|Overall Study|Disease progression|5|||
162905016|NCT01004861|588351786|FG007|Overall Study|Disease progression|1|||
162905017|NCT01004861|588351787|FG008|Overall Study|Disease progression|4|||
162905018|NCT01004861|588351788|FG009|Overall Study|Disease progression|7|||
162905019|NCT01004861|588351789|FG010|Overall Study|Disease progression|6|||
162905020|NCT01004861|588351790|FG011|Overall Study|Disease progression|3|||
162905021|NCT01004861|588351791|FG012|Overall Study|Disease progression|8|||
162905022|NCT01004861|588351779|FG000|Overall Study|Physician Decision|0|||
162905023|NCT01004861|588351780|FG001|Overall Study|Physician Decision|2|||
162905024|NCT01004861|588351781|FG002|Overall Study|Physician Decision|1|||
162905025|NCT01004861|588351782|FG003|Overall Study|Physician Decision|1|||
162905026|NCT01004861|588351783|FG004|Overall Study|Physician Decision|1|||
162905027|NCT01004861|588351784|FG005|Overall Study|Physician Decision|0|||
162905028|NCT01004861|588351785|FG006|Overall Study|Physician Decision|0|||
162905029|NCT01004861|588351786|FG007|Overall Study|Physician Decision|1|||
162905030|NCT01004861|588351787|FG008|Overall Study|Physician Decision|0|||
162905031|NCT01004861|588351788|FG009|Overall Study|Physician Decision|0|||
162905032|NCT01004861|588351789|FG010|Overall Study|Physician Decision|0|||
162905033|NCT01004861|588351790|FG011|Overall Study|Physician Decision|0|||
162905034|NCT01004861|588351791|FG012|Overall Study|Physician Decision|3|||
162905035|NCT01004861|588351779|FG000|Overall Study|Adverse Event|0|||
162905036|NCT01004861|588351780|FG001|Overall Study|Adverse Event|0|||
162905037|NCT01004861|588351781|FG002|Overall Study|Adverse Event|0|||
162905038|NCT01004861|588351782|FG003|Overall Study|Adverse Event|1|||
162905039|NCT01004861|588351783|FG004|Overall Study|Adverse Event|0|||
162905040|NCT01004861|588351784|FG005|Overall Study|Adverse Event|2|||
162905041|NCT01004861|588351785|FG006|Overall Study|Adverse Event|1|||
162905042|NCT01004861|588351786|FG007|Overall Study|Adverse Event|1|||
162905043|NCT01004861|588351787|FG008|Overall Study|Adverse Event|13|||
162905044|NCT01004861|588351788|FG009|Overall Study|Adverse Event|1|||
162905045|NCT01004861|588351789|FG010|Overall Study|Adverse Event|1|||
162905046|NCT01004861|588351790|FG011|Overall Study|Adverse Event|0|||
162905047|NCT01004861|588351791|FG012|Overall Study|Adverse Event|2|||
162905048|NCT01004861|588351779|FG000|Overall Study|Protocol Violation|0|||
162905049|NCT01004861|588351780|FG001|Overall Study|Protocol Violation|0|||
162905050|NCT01004861|588351781|FG002|Overall Study|Protocol Violation|0|||
162905051|NCT01004861|588351782|FG003|Overall Study|Protocol Violation|0|||
162905052|NCT01004861|588351783|FG004|Overall Study|Protocol Violation|1|||
162905053|NCT01004861|588351784|FG005|Overall Study|Protocol Violation|0|||
162905054|NCT01004861|588351785|FG006|Overall Study|Protocol Violation|0|||
162967033|NCT01277510|588579612|FG000|Double-blind Phase|Death|0|||
162626104|NCT03600818|587346982|FG000|Overall Study|Lack of Efficacy|9|||
162967034|NCT01277510|588579613|FG001|Double-blind Phase|Death|1|||
162967035|NCT01277510|588579612|FG000|Double-blind Phase|Protocol-specified criteria|2|||
162967036|NCT01277510|588579613|FG001|Double-blind Phase|Protocol-specified criteria|6|||
162967037|NCT01277510|588579612|FG000|Double-blind Phase|Other|1|||
162967038|NCT01277510|588579613|FG001|Double-blind Phase|Other|1|||
162626105|NCT03600818|587346983|FG001|Overall Study|Lack of Efficacy|4|||
162626106|NCT03600818|587346982|FG000|Overall Study|Withdrawal by Subject|4|||
162626107|NCT03600818|587346983|FG001|Overall Study|Withdrawal by Subject|3|||
162905055|NCT01004861|588351786|FG007|Overall Study|Protocol Violation|0|||
162905056|NCT01004861|588351787|FG008|Overall Study|Protocol Violation|0|||
162905057|NCT01004861|588351788|FG009|Overall Study|Protocol Violation|0|||
162905058|NCT01004861|588351789|FG010|Overall Study|Protocol Violation|0|||
162905059|NCT01004861|588351790|FG011|Overall Study|Protocol Violation|0|||
162905060|NCT01004861|588351791|FG012|Overall Study|Protocol Violation|0|||
162905061|NCT01004861|588351779|FG000|Overall Study|Lost to Follow-up|0|||
162905062|NCT01004861|588351780|FG001|Overall Study|Lost to Follow-up|0|||
162905063|NCT01004861|588351781|FG002|Overall Study|Lost to Follow-up|0|||
162905064|NCT01004861|588351782|FG003|Overall Study|Lost to Follow-up|0|||
162905065|NCT01004861|588351783|FG004|Overall Study|Lost to Follow-up|0|||
162905066|NCT01004861|588351784|FG005|Overall Study|Lost to Follow-up|0|||
162905067|NCT01004861|588351785|FG006|Overall Study|Lost to Follow-up|0|||
162905068|NCT01004861|588351786|FG007|Overall Study|Lost to Follow-up|1|||
162905069|NCT01004861|588351787|FG008|Overall Study|Lost to Follow-up|3|||
162905070|NCT01004861|588351788|FG009|Overall Study|Lost to Follow-up|0|||
162905071|NCT01004861|588351789|FG010|Overall Study|Lost to Follow-up|0|||
162905072|NCT01004861|588351790|FG011|Overall Study|Lost to Follow-up|1|||
162905073|NCT01004861|588351791|FG012|Overall Study|Lost to Follow-up|0|||
162905074|NCT01004861|588351779|FG000|Overall Study|Non-compliance|0|||
162905075|NCT01004861|588351780|FG001|Overall Study|Non-compliance|0|||
162626108|NCT03600818|587346982|FG000|Overall Study|Other-unspecified|5|||
162626109|NCT03600818|587346983|FG001|Overall Study|Other-unspecified|3|||
162626110|NCT03600818|587346982|FG000|Overall Study|Randomized and not treated|0|||
162626111|NCT03600818|587346983|FG001|Overall Study|Randomized and not treated|1|||
162905076|NCT01004861|588351781|FG002|Overall Study|Non-compliance|0|||
162905077|NCT01004861|588351782|FG003|Overall Study|Non-compliance|0|||
162905078|NCT01004861|588351783|FG004|Overall Study|Non-compliance|0|||
162905079|NCT01004861|588351784|FG005|Overall Study|Non-compliance|0|||
162905080|NCT01004861|588351785|FG006|Overall Study|Non-compliance|0|||
162905081|NCT01004861|588351786|FG007|Overall Study|Non-compliance|0|||
162905082|NCT01004861|588351787|FG008|Overall Study|Non-compliance|5|||
162905083|NCT01004861|588351788|FG009|Overall Study|Non-compliance|0|||
162905084|NCT01004861|588351789|FG010|Overall Study|Non-compliance|0|||
162905085|NCT01004861|588351790|FG011|Overall Study|Non-compliance|0|||
162905086|NCT01004861|588351791|FG012|Overall Study|Non-compliance|1|||
162905087|NCT01004861|588351779|FG000|Overall Study|Other|0|||
162905088|NCT01004861|588351780|FG001|Overall Study|Other|0|||
162905089|NCT01004861|588351781|FG002|Overall Study|Other|0|||
162905090|NCT01004861|588351782|FG003|Overall Study|Other|0|||
162905091|NCT01004861|588351783|FG004|Overall Study|Other|0|||
162905092|NCT01004861|588351784|FG005|Overall Study|Other|0|||
162905093|NCT01004861|588351785|FG006|Overall Study|Other|0|||
162905094|NCT01004861|588351786|FG007|Overall Study|Other|0|||
162905095|NCT01004861|588351787|FG008|Overall Study|Other|0|||
162905096|NCT01004861|588351788|FG009|Overall Study|Other|2|||
162905097|NCT01004861|588351789|FG010|Overall Study|Other|1|||
162905098|NCT01004861|588351790|FG011|Overall Study|Other|2|||
162905099|NCT01004861|588351791|FG012|Overall Study|Other|3|||
162905100|NCT01004861|588351779|FG000|Overall Study|Patient decision|0|||
162905101|NCT01004861|588351780|FG001|Overall Study|Patient decision|0|||
162905102|NCT01004861|588351781|FG002|Overall Study|Patient decision|0|||
162905103|NCT01004861|588351782|FG003|Overall Study|Patient decision|0|||
162905104|NCT01004861|588351783|FG004|Overall Study|Patient decision|1|||
162905105|NCT01004861|588351784|FG005|Overall Study|Patient decision|0|||
162905106|NCT01004861|588351785|FG006|Overall Study|Patient decision|1|||
162905107|NCT01004861|588351786|FG007|Overall Study|Patient decision|0|||
162905108|NCT01004861|588351787|FG008|Overall Study|Patient decision|7|||
162905109|NCT01004861|588351788|FG009|Overall Study|Patient decision|1|||
162905110|NCT01004861|588351789|FG010|Overall Study|Patient decision|1|||
162905111|NCT01004861|588351790|FG011|Overall Study|Patient decision|2|||
162905112|NCT01004861|588351791|FG012|Overall Study|Patient decision|3|||
162905113|NCT01004861|588351779|FG000|Overall Study|Transitioned to Phase 4 study|0|||
162905114|NCT01004861|588351780|FG001|Overall Study|Transitioned to Phase 4 study|0|||
162905115|NCT01004861|588351781|FG002|Overall Study|Transitioned to Phase 4 study|0|||
162626112|NCT01706146|587346984|FG000|Overall Study|Withdrawal by Subject|1|||
162905116|NCT01004861|588351782|FG003|Overall Study|Transitioned to Phase 4 study|0|||
162905117|NCT01004861|588351783|FG004|Overall Study|Transitioned to Phase 4 study|0|||
162905118|NCT01004861|588351784|FG005|Overall Study|Transitioned to Phase 4 study|0|||
162905119|NCT01004861|588351785|FG006|Overall Study|Transitioned to Phase 4 study|0|||
162905120|NCT01004861|588351786|FG007|Overall Study|Transitioned to Phase 4 study|0|||
162905121|NCT01004861|588351787|FG008|Overall Study|Transitioned to Phase 4 study|2|||
162905122|NCT01004861|588351788|FG009|Overall Study|Transitioned to Phase 4 study|0|||
162905123|NCT01004861|588351789|FG010|Overall Study|Transitioned to Phase 4 study|0|||
162905124|NCT01004861|588351790|FG011|Overall Study|Transitioned to Phase 4 study|0|||
162905125|NCT01004861|588351791|FG012|Overall Study|Transitioned to Phase 4 study|0|||
162905126|NCT01004861|588351779|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905127|NCT01004861|588351780|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905128|NCT01004861|588351781|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905129|NCT01004861|588351782|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905130|NCT01004861|588351783|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905131|NCT01004861|588351784|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905132|NCT01004861|588351785|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905133|NCT01004861|588351786|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905134|NCT01004861|588351787|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
162905135|NCT01004861|588351788|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905136|NCT01004861|588351789|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905137|NCT01004861|588351790|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905138|NCT01004861|588351791|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
162905139|NCT01004861|588351779|FG000|Overall Study|Patient withdrew|0|||
162905140|NCT01004861|588351780|FG001|Overall Study|Patient withdrew|0|||
162905141|NCT01004861|588351781|FG002|Overall Study|Patient withdrew|0|||
162905142|NCT01004861|588351782|FG003|Overall Study|Patient withdrew|0|||
162905143|NCT01004861|588351783|FG004|Overall Study|Patient withdrew|0|||
162905144|NCT01004861|588351784|FG005|Overall Study|Patient withdrew|0|||
162905145|NCT01004861|588351785|FG006|Overall Study|Patient withdrew|0|||
162905146|NCT01004861|588351786|FG007|Overall Study|Patient withdrew|0|||
162905147|NCT01004861|588351787|FG008|Overall Study|Patient withdrew|1|||
162905148|NCT01004861|588351788|FG009|Overall Study|Patient withdrew|0|||
162905149|NCT01004861|588351789|FG010|Overall Study|Patient withdrew|0|||
162905150|NCT01004861|588351790|FG011|Overall Study|Patient withdrew|0|||
162905151|NCT01004861|588351791|FG012|Overall Study|Patient withdrew|0|||
162905152|NCT01004861|588351779|FG000|Overall Study|Surgical resection|0|||
162905153|NCT01004861|588351780|FG001|Overall Study|Surgical resection|0|||
162905154|NCT01004861|588351781|FG002|Overall Study|Surgical resection|0|||
162905155|NCT01004861|588351782|FG003|Overall Study|Surgical resection|0|||
162905156|NCT01004861|588351783|FG004|Overall Study|Surgical resection|0|||
162905157|NCT01004861|588351784|FG005|Overall Study|Surgical resection|0|||
162905158|NCT01004861|588351785|FG006|Overall Study|Surgical resection|0|||
162905159|NCT01004861|588351786|FG007|Overall Study|Surgical resection|0|||
162905160|NCT01004861|588351787|FG008|Overall Study|Surgical resection|1|||
162905161|NCT01004861|588351788|FG009|Overall Study|Surgical resection|0|||
162905162|NCT01004861|588351789|FG010|Overall Study|Surgical resection|0|||
162905163|NCT01004861|588351790|FG011|Overall Study|Surgical resection|0|||
162905164|NCT01004861|588351791|FG012|Overall Study|Surgical resection|0|||
162905165|NCT01004861|588351779|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905166|NCT01004861|588351780|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905167|NCT01004861|588351781|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905168|NCT01004861|588351782|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905169|NCT01004861|588351783|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905170|NCT01004861|588351784|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162626113|NCT01706146|587346984|FG000|Overall Study|Adverse Event|3|||
162905171|NCT01004861|588351785|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905172|NCT01004861|588351786|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905173|NCT01004861|588351787|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
162905174|NCT01004861|588351788|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905175|NCT01004861|588351789|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905176|NCT01004861|588351790|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905177|NCT01004861|588351791|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162905178|NCT01004861|588351779|FG000|Overall Study|Study termination by Sponsor|0|||
162905179|NCT01004861|588351780|FG001|Overall Study|Study termination by Sponsor|0|||
162905180|NCT01004861|588351781|FG002|Overall Study|Study termination by Sponsor|0|||
162905181|NCT01004861|588351782|FG003|Overall Study|Study termination by Sponsor|0|||
162905182|NCT01004861|588351783|FG004|Overall Study|Study termination by Sponsor|0|||
162905183|NCT01004861|588351784|FG005|Overall Study|Study termination by Sponsor|0|||
162905184|NCT01004861|588351785|FG006|Overall Study|Study termination by Sponsor|0|||
162905185|NCT01004861|588351786|FG007|Overall Study|Study termination by Sponsor|0|||
162905186|NCT01004861|588351787|FG008|Overall Study|Study termination by Sponsor|1|||
162905187|NCT01004861|588351788|FG009|Overall Study|Study termination by Sponsor|0|||
162905188|NCT01004861|588351789|FG010|Overall Study|Study termination by Sponsor|0|||
162905189|NCT01004861|588351790|FG011|Overall Study|Study termination by Sponsor|0|||
162905190|NCT01004861|588351791|FG012|Overall Study|Study termination by Sponsor|0|||
162905191|NCT04610827|588351793|FG000|Overall Study|Withdrawal by Subject|1|||
162905192|NCT04610827|588351794|FG001|Overall Study|Withdrawal by Subject|1|||
162905193|NCT04610827|588351795|FG002|Overall Study|Withdrawal by Subject|0|||
162905194|NCT01823991|588351796|FG000|Overall Study|Withdrawal by Subject|8|||
162967039|NCT01277510|588579612|FG000|Open-label Phase|Administrative decision|4|||
162905195|NCT01823991|588351797|FG001|Overall Study|Withdrawal by Subject|5|||
162905196|NCT00805194|588351798|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
162905197|NCT00805194|588351799|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
162905198|NCT00805194|588351798|FG000|Overall Study|Worsening or AE of underlying disease|64|||
162905199|NCT00805194|588351799|FG001|Overall Study|Worsening or AE of underlying disease|70|||
162905200|NCT00805194|588351798|FG000|Overall Study|Other AE|84|||
162967040|NCT01277510|588579613|FG001|Open-label Phase|Administrative decision|3|||
162967041|NCT01277510|588579612|FG000|Open-label Phase|Protocol-specified criteria|1|||
162905201|NCT00805194|588351799|FG001|Overall Study|Other AE|73|||
162905202|NCT00805194|588351798|FG000|Overall Study|Protocol Violation|9|||
162905203|NCT00805194|588351799|FG001|Overall Study|Protocol Violation|9|||
162905204|NCT00805194|588351798|FG000|Overall Study|Lost to Follow-up|5|||
162905205|NCT00805194|588351799|FG001|Overall Study|Lost to Follow-up|5|||
162905206|NCT00805194|588351798|FG000|Overall Study|Withdrawal by Subject|60|||
162905207|NCT00805194|588351799|FG001|Overall Study|Withdrawal by Subject|42|||
162905208|NCT00805194|588351798|FG000|Overall Study|Not treated|3|||
162905209|NCT00805194|588351799|FG001|Overall Study|Not treated|4|||
162905210|NCT00805194|588351798|FG000|Overall Study|Reasons other than stated above|20|||
162905211|NCT00805194|588351799|FG001|Overall Study|Reasons other than stated above|16|||
162905212|NCT02185040|588351803|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
162905213|NCT02185040|588351804|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
162905214|NCT02185040|588351805|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
163053789|NCT00324155|588908403|FG001|Follow-up Phase|On-going participants still on drug|6|||
162905215|NCT02185040|588351806|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
162905216|NCT02185040|588351807|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
162905217|NCT02185040|588351808|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
162905218|NCT02185040|588351809|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
162905219|NCT02185040|588351803|FG000|Part 1 Treatment Phase|Adverse Event|1|||
162905220|NCT02185040|588351804|FG001|Part 1 Treatment Phase|Adverse Event|0|||
162905221|NCT02185040|588351805|FG002|Part 1 Treatment Phase|Adverse Event|0|||
162905222|NCT02185040|588351806|FG003|Part 1 Treatment Phase|Adverse Event|2|||
162905223|NCT02185040|588351807|FG004|Part 1 Treatment Phase|Adverse Event|3|||
162905224|NCT02185040|588351808|FG005|Part 1 Treatment Phase|Adverse Event|0|||
162905225|NCT02185040|588351809|FG006|Part 1 Treatment Phase|Adverse Event|0|||
162905226|NCT02185040|588351803|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905227|NCT02185040|588351804|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
162905228|NCT02185040|588351805|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905229|NCT02185040|588351806|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905230|NCT02185040|588351807|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905231|NCT02185040|588351808|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905232|NCT02185040|588351809|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
162905233|NCT02185040|588351803|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905234|NCT02185040|588351804|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
162905235|NCT02185040|588351805|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905236|NCT02185040|588351806|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905237|NCT02185040|588351807|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905238|NCT02185040|588351808|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905239|NCT02185040|588351809|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
162905240|NCT02185040|588351803|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
162905241|NCT02185040|588351804|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
163053790|NCT00390689|588908404|FG000|Overall Study|Adverse Event|2|||
163053791|NCT00390689|588908405|FG001|Overall Study|Adverse Event|5|||
163053792|NCT00390689|588908406|FG002|Overall Study|Adverse Event|2|||
163053793|NCT00390689|588908404|FG000|Overall Study|Lack of Efficacy|0|||
163053794|NCT00390689|588908405|FG001|Overall Study|Lack of Efficacy|0|||
163053795|NCT00390689|588908406|FG002|Overall Study|Lack of Efficacy|1|||
163053796|NCT00390689|588908404|FG000|Overall Study|Protocol Violation|1|||
163053797|NCT00390689|588908405|FG001|Overall Study|Protocol Violation|0|||
163053798|NCT00390689|588908406|FG002|Overall Study|Protocol Violation|0|||
163053799|NCT00390689|588908404|FG000|Overall Study|Investigator's judgement|2|||
163053800|NCT00390689|588908405|FG001|Overall Study|Investigator's judgement|0|||
163053801|NCT00390689|588908406|FG002|Overall Study|Investigator's judgement|0|||
163053802|NCT01253161|588908407|FG000|Overall Study|Adverse Event|1|||
163053803|NCT03101020|588908409|FG000|Overall Study|Lack of time to participate|1|||
163053804|NCT03101020|588908410|FG001|Overall Study|Lack of time to participate|0|||
162905242|NCT02185040|588351805|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
162905243|NCT02185040|588351806|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
163053805|NCT03101020|588908409|FG000|Overall Study|Ran over by a car|0|||
163053806|NCT03101020|588908410|FG001|Overall Study|Ran over by a car|1|||
163053807|NCT03101020|588908409|FG000|Overall Study|Withdrawal by Subject|0|||
163053808|NCT03101020|588908410|FG001|Overall Study|Withdrawal by Subject|2|||
163053809|NCT05412134|588908411|FG000|Overall Study|Lost to Follow-up|2|||
162708840|NCT01515319|587642917|FG005|Overall Study|Adverse Event|0|||
162905244|NCT02185040|588351807|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
163053810|NCT05412134|588908412|FG001|Overall Study|Lost to Follow-up|0|||
162905245|NCT02185040|588351808|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
162905246|NCT02185040|588351809|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
162905247|NCT02185040|588351803|FG000|Active Treatment Extension Phase|Adverse Event|0|||
162905248|NCT02185040|588351804|FG001|Active Treatment Extension Phase|Adverse Event|0|||
162905249|NCT02185040|588351805|FG002|Active Treatment Extension Phase|Adverse Event|0|||
162905250|NCT02185040|588351806|FG003|Active Treatment Extension Phase|Adverse Event|0|||
163053811|NCT03167242|588908414|FG000|Overall Study|Patient/Guardian Decision|0|||
162905251|NCT02185040|588351807|FG004|Active Treatment Extension Phase|Adverse Event|0|||
162905252|NCT02185040|588351808|FG005|Active Treatment Extension Phase|Adverse Event|1|||
162905253|NCT02185040|588351809|FG006|Active Treatment Extension Phase|Adverse Event|4|||
162905254|NCT02185040|588351803|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
162905255|NCT02185040|588351804|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
162905256|NCT02185040|588351805|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
162905257|NCT02185040|588351806|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
162905258|NCT02185040|588351807|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
162905259|NCT02185040|588351808|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
162905260|NCT02185040|588351809|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
162905261|NCT02185040|588351803|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905262|NCT02185040|588351804|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905263|NCT02185040|588351805|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905264|NCT02185040|588351806|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905265|NCT02185040|588351807|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905266|NCT02185040|588351808|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
162905267|NCT02185040|588351809|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
162905268|NCT00718887|588351813|FG000|Overall Study|Withdrawal by Subject|3|||
162905269|NCT00718887|588351814|FG001|Overall Study|Withdrawal by Subject|2|||
162905270|NCT00718887|588351813|FG000|Overall Study|Not identified|2|||
162905271|NCT00718887|588351814|FG001|Overall Study|Not identified|7|||
162905272|NCT03557801|588351817|FG000|Overall Study|Protocol Violation|1|||
162905273|NCT03557801|588351818|FG001|Overall Study|Protocol Violation|0|||
162905274|NCT03557801|588351819|FG002|Overall Study|Protocol Violation|0|||
162905275|NCT03557801|588351817|FG000|Overall Study|Withdrawal by Subject|1|||
162905276|NCT03557801|588351818|FG001|Overall Study|Withdrawal by Subject|0|||
162905277|NCT03557801|588351819|FG002|Overall Study|Withdrawal by Subject|3|||
162905278|NCT03557801|588351817|FG000|Overall Study|Lost to Follow-up|0|||
162905279|NCT03557801|588351818|FG001|Overall Study|Lost to Follow-up|1|||
162905280|NCT03557801|588351819|FG002|Overall Study|Lost to Follow-up|0|||
162905281|NCT00535236|588351820|FG000|Overall Study|Adverse Event|1|||
162905282|NCT00535236|588351821|FG001|Overall Study|Adverse Event|0|||
162905283|NCT00535236|588351822|FG002|Overall Study|Adverse Event|9|||
162905284|NCT00535236|588351823|FG003|Overall Study|Adverse Event|3|||
162905285|NCT00535236|588351824|FG004|Overall Study|Adverse Event|3|||
162905286|NCT00535236|588351825|FG005|Overall Study|Adverse Event|0|||
162905287|NCT00535236|588351826|FG006|Overall Study|Adverse Event|5|||
162905288|NCT00535236|588351827|FG007|Overall Study|Adverse Event|1|||
162905289|NCT00535236|588351828|FG008|Overall Study|Adverse Event|2|||
162905290|NCT00535236|588351829|FG009|Overall Study|Adverse Event|1|||
162905291|NCT00535236|588351820|FG000|Overall Study|Lost to Follow-up|1|||
162905292|NCT00535236|588351821|FG001|Overall Study|Lost to Follow-up|2|||
162905293|NCT00535236|588351822|FG002|Overall Study|Lost to Follow-up|0|||
162905294|NCT00535236|588351823|FG003|Overall Study|Lost to Follow-up|0|||
162905295|NCT00535236|588351824|FG004|Overall Study|Lost to Follow-up|2|||
162905296|NCT00535236|588351825|FG005|Overall Study|Lost to Follow-up|0|||
162905297|NCT00535236|588351826|FG006|Overall Study|Lost to Follow-up|0|||
162905298|NCT00535236|588351827|FG007|Overall Study|Lost to Follow-up|0|||
162905299|NCT00535236|588351828|FG008|Overall Study|Lost to Follow-up|6|||
162905300|NCT00535236|588351829|FG009|Overall Study|Lost to Follow-up|1|||
162905301|NCT00535236|588351820|FG000|Overall Study|Physician Decision|0|||
162905302|NCT00535236|588351821|FG001|Overall Study|Physician Decision|0|||
162905303|NCT00535236|588351822|FG002|Overall Study|Physician Decision|0|||
162905304|NCT00535236|588351823|FG003|Overall Study|Physician Decision|0|||
162905305|NCT00535236|588351824|FG004|Overall Study|Physician Decision|1|||
162905306|NCT00535236|588351825|FG005|Overall Study|Physician Decision|0|||
162905307|NCT00535236|588351826|FG006|Overall Study|Physician Decision|1|||
162905308|NCT00535236|588351827|FG007|Overall Study|Physician Decision|0|||
162905309|NCT00535236|588351828|FG008|Overall Study|Physician Decision|0|||
162905310|NCT00535236|588351829|FG009|Overall Study|Physician Decision|0|||
162905311|NCT00535236|588351820|FG000|Overall Study|Protocol Violation|2|||
162905312|NCT00535236|588351821|FG001|Overall Study|Protocol Violation|0|||
162967042|NCT01277510|588579613|FG001|Open-label Phase|Protocol-specified criteria|0|||
162905313|NCT00535236|588351822|FG002|Overall Study|Protocol Violation|1|||
162905314|NCT00535236|588351823|FG003|Overall Study|Protocol Violation|0|||
162905315|NCT00535236|588351824|FG004|Overall Study|Protocol Violation|0|||
162905316|NCT00535236|588351825|FG005|Overall Study|Protocol Violation|0|||
162905317|NCT00535236|588351826|FG006|Overall Study|Protocol Violation|0|||
162905318|NCT00535236|588351827|FG007|Overall Study|Protocol Violation|0|||
162905319|NCT00535236|588351828|FG008|Overall Study|Protocol Violation|1|||
162905320|NCT00535236|588351829|FG009|Overall Study|Protocol Violation|0|||
163053812|NCT03167242|588908415|FG001|Overall Study|Patient/Guardian Decision|1|||
163053813|NCT03167242|588908416|FG002|Overall Study|Patient/Guardian Decision|2|||
163053814|NCT03167242|588908417|FG003|Overall Study|Patient/Guardian Decision|1|||
163053815|NCT03167242|588908418|FG004|Overall Study|Patient/Guardian Decision|1|||
163053816|NCT03167242|588908419|FG005|Overall Study|Patient/Guardian Decision|1|||
163053817|NCT03167242|588908420|FG006|Overall Study|Patient/Guardian Decision|0|||
163053818|NCT03167242|588908421|FG007|Overall Study|Patient/Guardian Decision|0|||
163053819|NCT03167242|588908422|FG008|Overall Study|Patient/Guardian Decision|0|||
163053820|NCT03167242|588908423|FG009|Overall Study|Patient/Guardian Decision|0|||
163053821|NCT03167242|588908424|FG010|Overall Study|Patient/Guardian Decision|1|||
163053822|NCT03167242|588908425|FG011|Overall Study|Patient/Guardian Decision|0|||
163053823|NCT03167242|588908414|FG000|Overall Study|Lost to Follow-up|0|||
163053824|NCT03167242|588908415|FG001|Overall Study|Lost to Follow-up|0|||
163053825|NCT03167242|588908416|FG002|Overall Study|Lost to Follow-up|1|||
163053826|NCT03167242|588908417|FG003|Overall Study|Lost to Follow-up|0|||
163053827|NCT03167242|588908418|FG004|Overall Study|Lost to Follow-up|0|||
163053828|NCT03167242|588908419|FG005|Overall Study|Lost to Follow-up|1|||
163053829|NCT03167242|588908420|FG006|Overall Study|Lost to Follow-up|2|||
163053830|NCT03167242|588908421|FG007|Overall Study|Lost to Follow-up|1|||
163053831|NCT03167242|588908422|FG008|Overall Study|Lost to Follow-up|0|||
163053832|NCT03167242|588908423|FG009|Overall Study|Lost to Follow-up|0|||
163053833|NCT03167242|588908424|FG010|Overall Study|Lost to Follow-up|1|||
163053834|NCT03167242|588908425|FG011|Overall Study|Lost to Follow-up|1|||
163053835|NCT03167242|588908414|FG000|Overall Study|Reason not provided|0|||
163053836|NCT03167242|588908415|FG001|Overall Study|Reason not provided|0|||
163053837|NCT03167242|588908416|FG002|Overall Study|Reason not provided|0|||
163053838|NCT03167242|588908417|FG003|Overall Study|Reason not provided|0|||
163053839|NCT03167242|588908418|FG004|Overall Study|Reason not provided|0|||
163053840|NCT03167242|588908419|FG005|Overall Study|Reason not provided|0|||
163053841|NCT03167242|588908420|FG006|Overall Study|Reason not provided|0|||
163053842|NCT03167242|588908421|FG007|Overall Study|Reason not provided|0|||
163053843|NCT03167242|588908422|FG008|Overall Study|Reason not provided|1|||
163053844|NCT03167242|588908423|FG009|Overall Study|Reason not provided|0|||
163053845|NCT03167242|588908424|FG010|Overall Study|Reason not provided|0|||
163053846|NCT03167242|588908425|FG011|Overall Study|Reason not provided|0|||
163053847|NCT03444584|588908426|FG000|Overall Study|Withdrawal by Subject|0|||
163053848|NCT03444584|588908427|FG001|Overall Study|Withdrawal by Subject|1|||
163053849|NCT03444584|588908426|FG000|Overall Study|Other|0|||
163053850|NCT03444584|588908427|FG001|Overall Study|Other|1|||
163053851|NCT03786380|588908428|FG000|Overall Study|Adverse Event|1|||
163053852|NCT03786380|588908429|FG001|Overall Study|Adverse Event|0|||
163053853|NCT03786380|588908430|FG002|Overall Study|Adverse Event|0|||
163053854|NCT03786380|588908431|FG003|Overall Study|Adverse Event|3|||
163053855|NCT03786380|588908432|FG004|Overall Study|Adverse Event|1|||
163053856|NCT03786380|588908428|FG000|Overall Study|Lack of Efficacy|0|||
163053857|NCT03786380|588908429|FG001|Overall Study|Lack of Efficacy|0|||
163053858|NCT03786380|588908430|FG002|Overall Study|Lack of Efficacy|0|||
163053859|NCT03786380|588908431|FG003|Overall Study|Lack of Efficacy|0|||
163053860|NCT03786380|588908432|FG004|Overall Study|Lack of Efficacy|1|||
163053861|NCT03786380|588908428|FG000|Overall Study|Withdrawal by Subject|1|||
163053862|NCT03786380|588908429|FG001|Overall Study|Withdrawal by Subject|2|||
162905321|NCT00535236|588351820|FG000|Overall Study|Withdrawal by Subject|3|||
162905322|NCT00535236|588351821|FG001|Overall Study|Withdrawal by Subject|0|||
162905323|NCT00535236|588351822|FG002|Overall Study|Withdrawal by Subject|2|||
162905324|NCT00535236|588351823|FG003|Overall Study|Withdrawal by Subject|1|||
162905325|NCT00535236|588351824|FG004|Overall Study|Withdrawal by Subject|6|||
162905326|NCT00535236|588351825|FG005|Overall Study|Withdrawal by Subject|1|||
162905327|NCT00535236|588351826|FG006|Overall Study|Withdrawal by Subject|5|||
162905328|NCT00535236|588351827|FG007|Overall Study|Withdrawal by Subject|0|||
162905329|NCT00535236|588351828|FG008|Overall Study|Withdrawal by Subject|4|||
162905330|NCT00535236|588351829|FG009|Overall Study|Withdrawal by Subject|2|||
163053863|NCT03786380|588908430|FG002|Overall Study|Withdrawal by Subject|2|||
163053864|NCT03786380|588908431|FG003|Overall Study|Withdrawal by Subject|1|||
163053865|NCT03786380|588908432|FG004|Overall Study|Withdrawal by Subject|2|||
163053866|NCT03786380|588908428|FG000|Overall Study|Lost to Follow-up|3|||
162905331|NCT03558503|588351831|FG000|Overall Study|Adverse Event|1|||
163053867|NCT03786380|588908429|FG001|Overall Study|Lost to Follow-up|0|||
163053868|NCT03786380|588908430|FG002|Overall Study|Lost to Follow-up|1|||
163053869|NCT03786380|588908431|FG003|Overall Study|Lost to Follow-up|2|||
162905332|NCT03558503|588351831|FG000|Overall Study|Death|1|||
162905333|NCT03558503|588351831|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
163053870|NCT03786380|588908432|FG004|Overall Study|Lost to Follow-up|0|||
163053871|NCT03786380|588908428|FG000|Overall Study|Physician Decision|0|||
163053872|NCT03786380|588908429|FG001|Overall Study|Physician Decision|0|||
163053873|NCT03786380|588908430|FG002|Overall Study|Physician Decision|1|||
162905334|NCT00561795|588351832|FG000|Overall Study|Adverse Event|3|||
163053874|NCT03786380|588908431|FG003|Overall Study|Physician Decision|0|||
163053875|NCT03786380|588908432|FG004|Overall Study|Physician Decision|0|||
162905335|NCT00561795|588351833|FG001|Overall Study|Adverse Event|3|||
162905336|NCT00561795|588351834|FG002|Overall Study|Adverse Event|0|||
162905337|NCT00561795|588351835|FG003|Overall Study|Adverse Event|0|||
162905338|NCT00561795|588351832|FG000|Overall Study|Study Closed/Terminated|0|||
162905339|NCT00561795|588351833|FG001|Overall Study|Study Closed/Terminated|3|||
162905340|NCT00561795|588351834|FG002|Overall Study|Study Closed/Terminated|0|||
162905341|NCT00561795|588351835|FG003|Overall Study|Study Closed/Terminated|0|||
162905342|NCT00561795|588351832|FG000|Overall Study|Physician Decision|1|||
162905343|NCT00561795|588351833|FG001|Overall Study|Physician Decision|0|||
162905344|NCT00561795|588351834|FG002|Overall Study|Physician Decision|0|||
162905345|NCT00561795|588351835|FG003|Overall Study|Physician Decision|0|||
162905346|NCT02094612|588351836|FG000|Overall Study|Lost to Follow-up|47|||
162905347|NCT02094612|588351837|FG001|Overall Study|Lost to Follow-up|47|||
162905348|NCT02094612|588351836|FG000|Overall Study|Never started ADHD medication|32|||
162905349|NCT02094612|588351837|FG001|Overall Study|Never started ADHD medication|23|||
162905350|NCT04167514|588351838|FG000|Overall Study|Adverse event, not serious|0|||
162905351|NCT04167514|588351839|FG001|Overall Study|Adverse event, not serious|1|||
162905352|NCT04167514|588351838|FG000|Overall Study|Lost to Follow-up|1|||
162905353|NCT04167514|588351839|FG001|Overall Study|Lost to Follow-up|0|||
162905354|NCT04167514|588351838|FG000|Overall Study|Participant Decision|2|||
162905355|NCT04167514|588351839|FG001|Overall Study|Participant Decision|4|||
162905356|NCT04167514|588351838|FG000|Overall Study|Physician Decision|3|||
162905357|NCT04167514|588351839|FG001|Overall Study|Physician Decision|2|||
162905358|NCT04167514|588351838|FG000|Overall Study|Death|14|||
162905359|NCT04167514|588351839|FG001|Overall Study|Death|18|||
162905360|NCT04167514|588351838|FG000|Overall Study|Enrolled but treatment not administered|2|||
162905361|NCT04167514|588351839|FG001|Overall Study|Enrolled but treatment not administered|0|||
162905362|NCT04167514|588351838|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
162905363|NCT04167514|588351839|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
162905364|NCT04167514|588351838|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
162905365|NCT04167514|588351839|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
162905366|NCT02646891|588351840|FG000|Overall Study|Adverse Event|0|||
162905367|NCT02646891|588351841|FG001|Overall Study|Adverse Event|1|||
162905368|NCT02646891|588351842|FG002|Overall Study|Adverse Event|0|||
162905369|NCT02646891|588351843|FG003|Overall Study|Adverse Event|0|||
162905370|NCT02646891|588351844|FG004|Overall Study|Adverse Event|0|||
162905371|NCT02646891|588351845|FG005|Overall Study|Adverse Event|0|||
162905372|NCT02646891|588351846|FG006|Overall Study|Adverse Event|0|||
162905373|NCT02646891|588351847|FG007|Overall Study|Adverse Event|0|||
162905374|NCT02646891|588351848|FG008|Overall Study|Adverse Event|0|||
162905375|NCT02646891|588351849|FG009|Overall Study|Adverse Event|0|||
162905376|NCT02646891|588351840|FG000|Overall Study|Lost to Follow-up|0|||
162905377|NCT02646891|588351841|FG001|Overall Study|Lost to Follow-up|0|||
162905378|NCT02646891|588351842|FG002|Overall Study|Lost to Follow-up|0|||
162967043|NCT01277510|588579612|FG000|Open-label Phase|Never received investigational product|2|||
162967044|NCT01277510|588579613|FG001|Open-label Phase|Never received investigational product|0|||
162967045|NCT00533507|588579614|FG000|Overall Study|Withdrawal by Subject|1|||
162967046|NCT02119936|588579623|FG000|Overall Study|Lost to Follow-up|10|||
162967047|NCT00570128|588579624|FG000|Overall Study|Adverse Event|1|||
162967048|NCT00570128|588579625|FG001|Overall Study|Adverse Event|0|||
162967049|NCT00570128|588579624|FG000|Overall Study|Lost to Follow-up|1|||
162967050|NCT00570128|588579625|FG001|Overall Study|Lost to Follow-up|0|||
162967051|NCT00570128|588579624|FG000|Overall Study|Withdrawal by Subject|2|||
162967052|NCT00570128|588579625|FG001|Overall Study|Withdrawal by Subject|0|||
162967053|NCT03555695|588579630|FG000|Overall Study|Withdrawal by Subject|1|||
162967054|NCT03555695|588579630|FG000|Overall Study|Lost to Follow-up|1|||
162967055|NCT03555695|588579630|FG000|Overall Study|appendicitis (unrelated)|1|||
162967056|NCT03555695|588579630|FG000|Overall Study|pre-existing sciatica|1|||
162967057|NCT01426854|588579631|FG000|Overall Study|Adverse Event|1|||
162967058|NCT01426854|588579632|FG001|Overall Study|Adverse Event|5|||
162967059|NCT01426854|588579631|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
162967060|NCT01426854|588579632|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
162967061|NCT01426854|588579631|FG000|Overall Study|Lost to Follow-up|3|||
162967062|NCT01426854|588579632|FG001|Overall Study|Lost to Follow-up|0|||
162967063|NCT01426854|588579631|FG000|Overall Study|Noncompliance|0|||
162967064|NCT01426854|588579632|FG001|Overall Study|Noncompliance|1|||
162967065|NCT01426854|588579631|FG000|Overall Study|Treatment Failure|0|||
162967066|NCT01426854|588579632|FG001|Overall Study|Treatment Failure|16|||
162967067|NCT01426854|588579631|FG000|Overall Study|Protocol Deviation|0|||
162967068|NCT01426854|588579632|FG001|Overall Study|Protocol Deviation|1|||
162967069|NCT01426854|588579631|FG000|Overall Study|Other|3|||
162967070|NCT01426854|588579632|FG001|Overall Study|Other|2|||
162967071|NCT03820947|588579634|FG000|Overall Study|Physician Decision|0|||
162967072|NCT03820947|588579635|FG001|Overall Study|Physician Decision|1|||
162967073|NCT03820947|588579636|FG002|Overall Study|Physician Decision|1|||
162967074|NCT03820947|588579637|FG003|Overall Study|Physician Decision|0|||
162905379|NCT02646891|588351843|FG003|Overall Study|Lost to Follow-up|0|||
162905380|NCT02646891|588351844|FG004|Overall Study|Lost to Follow-up|0|||
162905381|NCT02646891|588351845|FG005|Overall Study|Lost to Follow-up|0|||
162905382|NCT02646891|588351846|FG006|Overall Study|Lost to Follow-up|2|||
162905383|NCT02646891|588351847|FG007|Overall Study|Lost to Follow-up|2|||
162905384|NCT02646891|588351848|FG008|Overall Study|Lost to Follow-up|2|||
162905385|NCT02646891|588351849|FG009|Overall Study|Lost to Follow-up|2|||
162905386|NCT02646891|588351840|FG000|Overall Study|Protocol Violation|0|||
162905387|NCT02646891|588351841|FG001|Overall Study|Protocol Violation|0|||
162905388|NCT02646891|588351842|FG002|Overall Study|Protocol Violation|0|||
162905389|NCT02646891|588351843|FG003|Overall Study|Protocol Violation|0|||
162905390|NCT02646891|588351844|FG004|Overall Study|Protocol Violation|0|||
162905391|NCT02646891|588351845|FG005|Overall Study|Protocol Violation|0|||
162905392|NCT02646891|588351846|FG006|Overall Study|Protocol Violation|1|||
162905393|NCT02646891|588351847|FG007|Overall Study|Protocol Violation|1|||
162905394|NCT02646891|588351848|FG008|Overall Study|Protocol Violation|0|||
162905395|NCT02646891|588351849|FG009|Overall Study|Protocol Violation|0|||
162905396|NCT02646891|588351840|FG000|Overall Study|Withdrawal by Subject|2|||
162905397|NCT02646891|588351841|FG001|Overall Study|Withdrawal by Subject|0|||
162905398|NCT02646891|588351842|FG002|Overall Study|Withdrawal by Subject|1|||
162905399|NCT02646891|588351843|FG003|Overall Study|Withdrawal by Subject|0|||
162905400|NCT02646891|588351844|FG004|Overall Study|Withdrawal by Subject|0|||
162905401|NCT02646891|588351845|FG005|Overall Study|Withdrawal by Subject|0|||
162905402|NCT02646891|588351846|FG006|Overall Study|Withdrawal by Subject|5|||
162905403|NCT02646891|588351847|FG007|Overall Study|Withdrawal by Subject|9|||
162905404|NCT02646891|588351848|FG008|Overall Study|Withdrawal by Subject|7|||
162905405|NCT02646891|588351849|FG009|Overall Study|Withdrawal by Subject|3|||
162905406|NCT02646891|588351840|FG000|Overall Study|Death|0|||
162905407|NCT02646891|588351841|FG001|Overall Study|Death|0|||
162905408|NCT02646891|588351842|FG002|Overall Study|Death|0|||
162905409|NCT02646891|588351843|FG003|Overall Study|Death|0|||
162905410|NCT02646891|588351844|FG004|Overall Study|Death|0|||
162905411|NCT02646891|588351845|FG005|Overall Study|Death|0|||
162905412|NCT02646891|588351846|FG006|Overall Study|Death|1|||
162905413|NCT02646891|588351847|FG007|Overall Study|Death|1|||
162905414|NCT02646891|588351848|FG008|Overall Study|Death|1|||
162905415|NCT02646891|588351849|FG009|Overall Study|Death|0|||
162905416|NCT01542632|588351850|FG000|Overall Study|Withdrawal of Consent|0|||
162905417|NCT01542632|588351851|FG001|Overall Study|Withdrawal of Consent|0|||
162905418|NCT01542632|588351852|FG002|Overall Study|Withdrawal of Consent|0|||
162905419|NCT01542632|588351853|FG003|Overall Study|Withdrawal of Consent|2|||
162905420|NCT01542632|588351854|FG004|Overall Study|Withdrawal of Consent|3|||
162905421|NCT01542632|588351855|FG005|Overall Study|Withdrawal of Consent|0|||
162905422|NCT01542632|588351850|FG000|Overall Study|Adverse Event|0|||
162905423|NCT01542632|588351851|FG001|Overall Study|Adverse Event|0|||
162905424|NCT01542632|588351852|FG002|Overall Study|Adverse Event|1|||
162905425|NCT01542632|588351853|FG003|Overall Study|Adverse Event|0|||
162905426|NCT01542632|588351854|FG004|Overall Study|Adverse Event|0|||
162905427|NCT01542632|588351855|FG005|Overall Study|Adverse Event|0|||
162905428|NCT01542632|588351850|FG000|Overall Study|Lost to Follow-up|0|||
162905429|NCT01542632|588351851|FG001|Overall Study|Lost to Follow-up|1|||
162905430|NCT01542632|588351852|FG002|Overall Study|Lost to Follow-up|0|||
162905431|NCT01542632|588351853|FG003|Overall Study|Lost to Follow-up|0|||
162905432|NCT01542632|588351854|FG004|Overall Study|Lost to Follow-up|0|||
162905433|NCT01542632|588351855|FG005|Overall Study|Lost to Follow-up|0|||
162905434|NCT01542632|588351850|FG000|Overall Study|Sponsor/Investigator Decision|0|||
162905435|NCT01542632|588351851|FG001|Overall Study|Sponsor/Investigator Decision|0|||
162905436|NCT01542632|588351852|FG002|Overall Study|Sponsor/Investigator Decision|0|||
162905437|NCT01542632|588351853|FG003|Overall Study|Sponsor/Investigator Decision|0|||
162905438|NCT01542632|588351854|FG004|Overall Study|Sponsor/Investigator Decision|1|||
162905439|NCT01542632|588351855|FG005|Overall Study|Sponsor/Investigator Decision|0|||
162905440|NCT03225833|588351856|FG000|Overall Study|Adverse Event|0|||
162905441|NCT03225833|588351857|FG001|Overall Study|Adverse Event|1|||
162967075|NCT03820947|588579638|FG004|Overall Study|Physician Decision|3|||
162905442|NCT03225833|588351858|FG002|Overall Study|Adverse Event|2|||
162905443|NCT03225833|588351859|FG003|Overall Study|Adverse Event|0|||
162905444|NCT03225833|588351860|FG004|Overall Study|Adverse Event|0|||
162905445|NCT03225833|588351861|FG005|Overall Study|Adverse Event|2|||
162905446|NCT03225833|588351856|FG000|Overall Study|Withdrawal by Subject|1|||
162905447|NCT03225833|588351857|FG001|Overall Study|Withdrawal by Subject|0|||
162905448|NCT03225833|588351858|FG002|Overall Study|Withdrawal by Subject|0|||
162905449|NCT03225833|588351859|FG003|Overall Study|Withdrawal by Subject|0|||
162967076|NCT03820947|588579634|FG000|Overall Study|Withdrawal by Subject|6|||
162967077|NCT03820947|588579635|FG001|Overall Study|Withdrawal by Subject|10|||
162967078|NCT03820947|588579636|FG002|Overall Study|Withdrawal by Subject|3|||
162967079|NCT03820947|588579637|FG003|Overall Study|Withdrawal by Subject|8|||
162967080|NCT03820947|588579638|FG004|Overall Study|Withdrawal by Subject|5|||
162967081|NCT03820947|588579634|FG000|Overall Study|Procedure Not Attempted|0|||
162967082|NCT03820947|588579635|FG001|Overall Study|Procedure Not Attempted|2|||
162967083|NCT03820947|588579636|FG002|Overall Study|Procedure Not Attempted|1|||
162967084|NCT03820947|588579637|FG003|Overall Study|Procedure Not Attempted|0|||
162967085|NCT03820947|588579638|FG004|Overall Study|Procedure Not Attempted|0|||
162967086|NCT03820947|588579634|FG000|Overall Study|Other Exit|1|||
162967087|NCT03820947|588579635|FG001|Overall Study|Other Exit|3|||
162967088|NCT03820947|588579636|FG002|Overall Study|Other Exit|3|||
162967089|NCT03820947|588579637|FG003|Overall Study|Other Exit|3|||
162967090|NCT03820947|588579638|FG004|Overall Study|Other Exit|0|||
162967091|NCT03820947|588579634|FG000|Overall Study|Follow-up Not Done|10|||
162967092|NCT03820947|588579635|FG001|Overall Study|Follow-up Not Done|13|||
162967093|NCT03820947|588579636|FG002|Overall Study|Follow-up Not Done|2|||
162967094|NCT03820947|588579637|FG003|Overall Study|Follow-up Not Done|3|||
162967095|NCT03820947|588579638|FG004|Overall Study|Follow-up Not Done|12|||
162967096|NCT03820947|588579634|FG000|Overall Study|Death|0|||
162967097|NCT03820947|588579635|FG001|Overall Study|Death|0|||
162967098|NCT03820947|588579636|FG002|Overall Study|Death|0|||
162967099|NCT03820947|588579637|FG003|Overall Study|Death|0|||
162967100|NCT03820947|588579638|FG004|Overall Study|Death|9|||
162967101|NCT03820947|588579634|FG000|Overall Study|Lost to Follow-up|4|||
162967102|NCT03820947|588579635|FG001|Overall Study|Lost to Follow-up|6|||
162967103|NCT03820947|588579636|FG002|Overall Study|Lost to Follow-up|0|||
162967104|NCT03820947|588579637|FG003|Overall Study|Lost to Follow-up|0|||
162967105|NCT03820947|588579638|FG004|Overall Study|Lost to Follow-up|9|||
162967106|NCT02940522|588581223|FG000|Overall Study|Lost to Follow-up|1|||
162967107|NCT02940522|588581224|FG001|Overall Study|Lost to Follow-up|2|||
162967108|NCT02940522|588581223|FG000|Overall Study|Withdrawal by Subject|1|||
162967109|NCT02940522|588581224|FG001|Overall Study|Withdrawal by Subject|0|||
162967110|NCT00274625|588581225|FG000|Overall Study|Lost to Follow-up|46|||
162967111|NCT00274625|588581226|FG001|Overall Study|Lost to Follow-up|54|||
162967112|NCT00274625|588581225|FG000|Overall Study|Excluded from analysis|14|||
162967113|NCT00274625|588581226|FG001|Overall Study|Excluded from analysis|8|||
162967114|NCT05135273|588581229|FG000|Overall Study|Recruited into the army|0|||
162967115|NCT05135273|588581230|FG001|Overall Study|Recruited into the army|0|||
162967116|NCT05135273|588581231|FG002|Overall Study|Recruited into the army|0|||
162967117|NCT05135273|588581232|FG003|Overall Study|Recruited into the army|0|||
162967118|NCT05135273|588581233|FG004|Overall Study|Recruited into the army|1|||
162967119|NCT05135273|588581234|FG005|Overall Study|Recruited into the army|0|||
162967120|NCT05135273|588581235|FG006|Overall Study|Recruited into the army|0|||
162967121|NCT05135273|588581236|FG007|Overall Study|Recruited into the army|0|||
162967122|NCT05135273|588581229|FG000|Overall Study|Moved away from study site|0|||
162967123|NCT05135273|588581230|FG001|Overall Study|Moved away from study site|0|||
162967124|NCT05135273|588581231|FG002|Overall Study|Moved away from study site|0|||
162967125|NCT05135273|588581232|FG003|Overall Study|Moved away from study site|0|||
162967126|NCT05135273|588581233|FG004|Overall Study|Moved away from study site|0|||
162967127|NCT05135273|588581234|FG005|Overall Study|Moved away from study site|1|||
162967128|NCT05135273|588581235|FG006|Overall Study|Moved away from study site|1|||
162967129|NCT05135273|588581236|FG007|Overall Study|Moved away from study site|0|||
162967130|NCT05135273|588581229|FG000|Overall Study|Travel|0|||
162967131|NCT05135273|588581230|FG001|Overall Study|Travel|0|||
162967132|NCT05135273|588581231|FG002|Overall Study|Travel|0|||
162967133|NCT05135273|588581232|FG003|Overall Study|Travel|0|||
162967134|NCT05135273|588581233|FG004|Overall Study|Travel|0|||
162967135|NCT05135273|588581234|FG005|Overall Study|Travel|0|||
162967136|NCT05135273|588581235|FG006|Overall Study|Travel|0|||
162967137|NCT05135273|588581236|FG007|Overall Study|Travel|1|||
162967138|NCT04264819|588581242|FG000|Overall Study|Physician Decision|19|||
162967139|NCT04264819|588581242|FG000|Overall Study|Adverse Event|12|||
162967140|NCT04264819|588581242|FG000|Overall Study|Withdrawal by Subject|11|||
162967141|NCT04264819|588581242|FG000|Overall Study|Lost to Follow-up|2|||
162967142|NCT04264819|588581242|FG000|Overall Study|Death|2|||
162967143|NCT01680016|588581244|FG000|Overall Study|Adverse Event|0|||
162967144|NCT01680016|588581245|FG001|Overall Study|Adverse Event|0|||
162967145|NCT01680016|588581246|FG002|Overall Study|Adverse Event|1|||
162967146|NCT01680016|588581247|FG003|Overall Study|Adverse Event|4|||
162967147|NCT01680016|588581244|FG000|Overall Study|The Subject went out of The Trial|1|||
162967148|NCT01680016|588581245|FG001|Overall Study|The Subject went out of The Trial|0|||
162967149|NCT01680016|588581246|FG002|Overall Study|The Subject went out of The Trial|3|||
162967150|NCT01680016|588581247|FG003|Overall Study|The Subject went out of The Trial|0|||
162967151|NCT01680016|588581244|FG000|Overall Study|Protocol Violation|0|||
162967152|NCT01680016|588581245|FG001|Overall Study|Protocol Violation|1|||
162967153|NCT01680016|588581246|FG002|Overall Study|Protocol Violation|0|||
162967154|NCT01680016|588581247|FG003|Overall Study|Protocol Violation|0|||
162708841|NCT01515319|587642918|FG006|Overall Study|Adverse Event|0|||
162967155|NCT01680016|588581244|FG000|Overall Study|Withdrawal by Subject|5|||
162967156|NCT01680016|588581245|FG001|Overall Study|Withdrawal by Subject|7|||
162967157|NCT01680016|588581246|FG002|Overall Study|Withdrawal by Subject|1|||
162967158|NCT01680016|588581247|FG003|Overall Study|Withdrawal by Subject|1|||
162967159|NCT01958060|588581251|FG000|Overall Study|Not treated|2|||
162967160|NCT01958060|588581252|FG001|Overall Study|Not treated|0|||
162967161|NCT01958060|588581253|FG002|Overall Study|Not treated|0|||
162905450|NCT03225833|588351860|FG004|Overall Study|Withdrawal by Subject|1|||
162905451|NCT03225833|588351861|FG005|Overall Study|Withdrawal by Subject|0|||
162905452|NCT03225833|588351856|FG000|Overall Study|Termination of Study by Sponsor|4|||
162905453|NCT03225833|588351857|FG001|Overall Study|Termination of Study by Sponsor|0|||
162905454|NCT03225833|588351858|FG002|Overall Study|Termination of Study by Sponsor|0|||
162905455|NCT03225833|588351859|FG003|Overall Study|Termination of Study by Sponsor|0|||
162905456|NCT03225833|588351860|FG004|Overall Study|Termination of Study by Sponsor|0|||
162905457|NCT03225833|588351861|FG005|Overall Study|Termination of Study by Sponsor|7|||
162905458|NCT03225833|588351856|FG000|Overall Study|Sponsor Decision|0|||
162905459|NCT03225833|588351857|FG001|Overall Study|Sponsor Decision|0|||
162905460|NCT03225833|588351858|FG002|Overall Study|Sponsor Decision|0|||
162905461|NCT03225833|588351859|FG003|Overall Study|Sponsor Decision|0|||
162905462|NCT03225833|588351860|FG004|Overall Study|Sponsor Decision|0|||
162905463|NCT03225833|588351861|FG005|Overall Study|Sponsor Decision|1|||
162905464|NCT06029127|588351863|FG000|Overall Study|Withdrawal by Subject|2|||
162905465|NCT06029127|588351864|FG001|Overall Study|Withdrawal by Subject|0|||
162905466|NCT06029127|588351863|FG000|Overall Study|Lost to Follow-up|1|||
162905467|NCT06029127|588351864|FG001|Overall Study|Lost to Follow-up|0|||
162905468|NCT06029127|588351863|FG000|Overall Study|Study Closed by Sponsor|6|||
162905469|NCT06029127|588351864|FG001|Overall Study|Study Closed by Sponsor|6|||
162905470|NCT06029127|588351863|FG000|Overall Study|Death|12|||
162905471|NCT06029127|588351864|FG001|Overall Study|Death|7|||
162905472|NCT06029127|588351863|FG000|Overall Study|Declined Follow-Up Contact|0|||
162905473|NCT06029127|588351864|FG001|Overall Study|Declined Follow-Up Contact|1|||
162905474|NCT04785144|588351865|FG000|Overall Study|Withdrawal by Subject|4|||
162905475|NCT04785144|588351866|FG001|Overall Study|Withdrawal by Subject|1|||
162905476|NCT04785144|588351867|FG002|Overall Study|Withdrawal by Subject|0|||
162905477|NCT04785144|588351868|FG003|Overall Study|Withdrawal by Subject|0|||
162905478|NCT04785144|588351869|FG004|Overall Study|Withdrawal by Subject|0|||
162905479|NCT04785144|588351870|FG005|Overall Study|Withdrawal by Subject|2|||
162905480|NCT04785144|588351871|FG006|Overall Study|Withdrawal by Subject|2|||
162905481|NCT04785144|588351872|FG007|Overall Study|Withdrawal by Subject|0|||
162905482|NCT04785144|588351873|FG008|Overall Study|Withdrawal by Subject|1|||
162905483|NCT04785144|588351874|FG009|Overall Study|Withdrawal by Subject|0|||
162905484|NCT04785144|588351865|FG000|Overall Study|Lost to Follow-up|1|||
162905485|NCT04785144|588351866|FG001|Overall Study|Lost to Follow-up|0|||
162905486|NCT04785144|588351867|FG002|Overall Study|Lost to Follow-up|0|||
162905487|NCT04785144|588351868|FG003|Overall Study|Lost to Follow-up|0|||
162905488|NCT04785144|588351869|FG004|Overall Study|Lost to Follow-up|1|||
162905489|NCT04785144|588351870|FG005|Overall Study|Lost to Follow-up|2|||
162905490|NCT04785144|588351871|FG006|Overall Study|Lost to Follow-up|1|||
162905491|NCT04785144|588351872|FG007|Overall Study|Lost to Follow-up|2|||
162905492|NCT04785144|588351873|FG008|Overall Study|Lost to Follow-up|4|||
162905493|NCT04785144|588351874|FG009|Overall Study|Lost to Follow-up|1|||
162905494|NCT04785144|588351865|FG000|Overall Study|Protocol Violation|0|||
162905495|NCT04785144|588351866|FG001|Overall Study|Protocol Violation|0|||
162905496|NCT04785144|588351867|FG002|Overall Study|Protocol Violation|0|||
162905497|NCT04785144|588351868|FG003|Overall Study|Protocol Violation|0|||
162905498|NCT04785144|588351869|FG004|Overall Study|Protocol Violation|0|||
162905499|NCT04785144|588351870|FG005|Overall Study|Protocol Violation|0|||
162905500|NCT04785144|588351871|FG006|Overall Study|Protocol Violation|1|||
162905501|NCT04785144|588351872|FG007|Overall Study|Protocol Violation|0|||
162905502|NCT04785144|588351873|FG008|Overall Study|Protocol Violation|0|||
162905503|NCT04785144|588351874|FG009|Overall Study|Protocol Violation|0|||
162905504|NCT04785144|588351865|FG000|Overall Study|Physician Decision|0|||
162905505|NCT04785144|588351866|FG001|Overall Study|Physician Decision|0|||
162967162|NCT01958060|588581254|FG003|Overall Study|Not treated|0|||
162905506|NCT04785144|588351867|FG002|Overall Study|Physician Decision|0|||
162905507|NCT04785144|588351868|FG003|Overall Study|Physician Decision|0|||
162905508|NCT04785144|588351869|FG004|Overall Study|Physician Decision|0|||
162905509|NCT04785144|588351870|FG005|Overall Study|Physician Decision|0|||
162905510|NCT04785144|588351871|FG006|Overall Study|Physician Decision|0|||
162905511|NCT04785144|588351872|FG007|Overall Study|Physician Decision|0|||
162967163|NCT01958060|588581255|FG004|Overall Study|Not treated|1|||
162967164|NCT01958060|588581256|FG005|Overall Study|Not treated|0|||
162905512|NCT04785144|588351873|FG008|Overall Study|Physician Decision|0|||
162905513|NCT04785144|588351874|FG009|Overall Study|Physician Decision|1|||
162967165|NCT02846883|588581262|FG000|Overall Study|Death|0|||
162905514|NCT04785144|588351865|FG000|Overall Study|Unable to continue due to work schedule|0|||
162905515|NCT04785144|588351866|FG001|Overall Study|Unable to continue due to work schedule|0|||
162905516|NCT04785144|588351867|FG002|Overall Study|Unable to continue due to work schedule|0|||
162905517|NCT04785144|588351868|FG003|Overall Study|Unable to continue due to work schedule|0|||
162905518|NCT04785144|588351869|FG004|Overall Study|Unable to continue due to work schedule|0|||
162905519|NCT04785144|588351870|FG005|Overall Study|Unable to continue due to work schedule|0|||
162905520|NCT04785144|588351871|FG006|Overall Study|Unable to continue due to work schedule|0|||
162905521|NCT04785144|588351872|FG007|Overall Study|Unable to continue due to work schedule|0|||
162905522|NCT04785144|588351873|FG008|Overall Study|Unable to continue due to work schedule|0|||
162905523|NCT04785144|588351874|FG009|Overall Study|Unable to continue due to work schedule|1|||
162905524|NCT00129376|588351875|FG000|Overall Study|Adverse Event|1|||
162905525|NCT00129376|588351875|FG000|Overall Study|Lack of Efficacy|1|||
162905526|NCT01766401|588351876|FG000|Overall Study|Adverse Event|7|||
162905527|NCT01766401|588351877|FG001|Overall Study|Adverse Event|22|||
162905528|NCT01766401|588351876|FG000|Overall Study|Lack of Efficacy|1|||
162905529|NCT01766401|588351877|FG001|Overall Study|Lack of Efficacy|2|||
162905530|NCT01766401|588351876|FG000|Overall Study|Protocol Violation|3|||
162905531|NCT01766401|588351877|FG001|Overall Study|Protocol Violation|8|||
162905532|NCT01766401|588351876|FG000|Overall Study|Withdrawal by Subject|15|||
162905533|NCT01766401|588351877|FG001|Overall Study|Withdrawal by Subject|12|||
162905534|NCT01766401|588351876|FG000|Overall Study|Lost to Follow-up|10|||
162905535|NCT01766401|588351877|FG001|Overall Study|Lost to Follow-up|11|||
162905536|NCT01766401|588351876|FG000|Overall Study|Pregnancy|1|||
162905537|NCT01766401|588351877|FG001|Overall Study|Pregnancy|1|||
162905538|NCT00886587|588351878|FG000|Overall Study|Adverse Event|2|||
162905539|NCT00886587|588351879|FG001|Overall Study|Adverse Event|1|||
162905540|NCT00886587|588351878|FG000|Overall Study|Protocol Violation|2|||
162905541|NCT00886587|588351879|FG001|Overall Study|Protocol Violation|0|||
162905542|NCT00886587|588351878|FG000|Overall Study|Withdrawal by Subject|0|||
162905543|NCT00886587|588351879|FG001|Overall Study|Withdrawal by Subject|1|||
162905544|NCT01108068|588351883|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
162905545|NCT01108068|588351884|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
162905546|NCT00398086|588351885|FG000|Overall Study|Unacceptable Toxicity|2|||
162905547|NCT00398086|588351886|FG001|Overall Study|Unacceptable Toxicity|8|||
162905548|NCT00398086|588351887|FG002|Overall Study|Unacceptable Toxicity|2|||
162905549|NCT00398086|588351885|FG000|Overall Study|Adverse Event|1|||
162905550|NCT00398086|588351886|FG001|Overall Study|Adverse Event|4|||
162905551|NCT00398086|588351887|FG002|Overall Study|Adverse Event|0|||
162905552|NCT00398086|588351885|FG000|Overall Study|Physician Decision|1|||
162905553|NCT00398086|588351886|FG001|Overall Study|Physician Decision|4|||
162905554|NCT00398086|588351887|FG002|Overall Study|Physician Decision|0|||
162905555|NCT00398086|588351885|FG000|Overall Study|Withdrawal by Subject|5|||
162905556|NCT00398086|588351886|FG001|Overall Study|Withdrawal by Subject|7|||
162905557|NCT00398086|588351887|FG002|Overall Study|Withdrawal by Subject|0|||
162905558|NCT00696774|588351888|FG000|Period II|Adverse Event|0|||
162905559|NCT00696774|588351889|FG001|Period II|Adverse Event|0|||
162905560|NCT00696774|588351890|FG002|Period II|Adverse Event|15|||
162905561|NCT00696774|588351888|FG000|Period II|Lost to Follow-up|0|||
162905562|NCT00696774|588351889|FG001|Period II|Lost to Follow-up|0|||
162905563|NCT00696774|588351890|FG002|Period II|Lost to Follow-up|4|||
163053876|NCT03786380|588908428|FG000|Overall Study|Study Terminated by the Sponsor|30|||
163053877|NCT03786380|588908429|FG001|Overall Study|Study Terminated by the Sponsor|20|||
163053878|NCT03786380|588908430|FG002|Overall Study|Study Terminated by the Sponsor|50|||
163053879|NCT03786380|588908431|FG003|Overall Study|Study Terminated by the Sponsor|57|||
163053880|NCT03786380|588908432|FG004|Overall Study|Study Terminated by the Sponsor|23|||
163053881|NCT03786380|588908428|FG000|Overall Study|Reason Not Specified|0|||
163053882|NCT03786380|588908429|FG001|Overall Study|Reason Not Specified|0|||
163053883|NCT03786380|588908430|FG002|Overall Study|Reason Not Specified|0|||
162905564|NCT00696774|588351888|FG000|Period II|Protocol Violation|0|||
162905565|NCT00696774|588351889|FG001|Period II|Protocol Violation|0|||
163053884|NCT03786380|588908431|FG003|Overall Study|Reason Not Specified|0|||
163053885|NCT03786380|588908432|FG004|Overall Study|Reason Not Specified|1|||
162905566|NCT00696774|588351890|FG002|Period II|Protocol Violation|11|||
162905567|NCT00696774|588351888|FG000|Period II|Withdrawal by Subject|0|||
162905568|NCT00696774|588351889|FG001|Period II|Withdrawal by Subject|0|||
162905569|NCT00696774|588351890|FG002|Period II|Withdrawal by Subject|4|||
162905570|NCT00696774|588351888|FG000|Period II|Sponsor Decision|0|||
162905571|NCT00696774|588351889|FG001|Period II|Sponsor Decision|0|||
162905572|NCT00696774|588351890|FG002|Period II|Sponsor Decision|0|||
162905573|NCT00696774|588351888|FG000|Period II|Lack of Efficacy|0|||
162905574|NCT00696774|588351889|FG001|Period II|Lack of Efficacy|0|||
162905575|NCT00696774|588351890|FG002|Period II|Lack of Efficacy|2|||
162905576|NCT00696774|588351888|FG000|Period III|Adverse Event|1|||
162905577|NCT00696774|588351889|FG001|Period III|Adverse Event|1|||
162905578|NCT00696774|588351890|FG002|Period III|Adverse Event|0|||
162905579|NCT00696774|588351888|FG000|Period III|Lost to Follow-up|2|||
162905580|NCT00696774|588351889|FG001|Period III|Lost to Follow-up|1|||
162905581|NCT00696774|588351890|FG002|Period III|Lost to Follow-up|0|||
162905582|NCT00696774|588351888|FG000|Period III|Protocol Violation|1|||
162905583|NCT00696774|588351889|FG001|Period III|Protocol Violation|1|||
162905584|NCT00696774|588351890|FG002|Period III|Protocol Violation|0|||
162905585|NCT00696774|588351888|FG000|Period III|Withdrawal by Subject|1|||
162905586|NCT00696774|588351889|FG001|Period III|Withdrawal by Subject|2|||
162905587|NCT00696774|588351890|FG002|Period III|Withdrawal by Subject|0|||
162905588|NCT00696774|588351888|FG000|Period III|Sponsor Decision|2|||
162905589|NCT00696774|588351889|FG001|Period III|Sponsor Decision|0|||
162905590|NCT00696774|588351890|FG002|Period III|Sponsor Decision|0|||
162905591|NCT00696774|588351888|FG000|Period III|Lack of Efficacy|0|||
162905592|NCT00696774|588351889|FG001|Period III|Lack of Efficacy|2|||
162905593|NCT00696774|588351890|FG002|Period III|Lack of Efficacy|0|||
162905594|NCT00033293|588351897|FG000|Overall Study|Death|0|||
162905595|NCT00033293|588351898|FG001|Overall Study|Death|1|||
162905596|NCT00033293|588351897|FG000|Overall Study|Lack of Efficacy|5|||
162905597|NCT00033293|588351898|FG001|Overall Study|Lack of Efficacy|8|||
162905598|NCT00033293|588351897|FG000|Overall Study|Lost to Follow-up|0|||
162905599|NCT00033293|588351898|FG001|Overall Study|Lost to Follow-up|1|||
162905600|NCT00033293|588351897|FG000|Overall Study|Physician Decision|3|||
162905601|NCT00033293|588351898|FG001|Overall Study|Physician Decision|1|||
162905602|NCT00033293|588351897|FG000|Overall Study|Withdrawal by Subject|1|||
162905603|NCT00033293|588351898|FG001|Overall Study|Withdrawal by Subject|0|||
162905604|NCT00033293|588351897|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
162905605|NCT00033293|588351898|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
162905606|NCT00033293|588351897|FG000|Overall Study|Treatment refused|0|||
162905607|NCT00033293|588351898|FG001|Overall Study|Treatment refused|6|||
162905608|NCT00935701|588351899|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
162905609|NCT02201251|588351900|FG000|Overall Study|Adverse Event|1|||
162905610|NCT02201251|588351901|FG001|Overall Study|Adverse Event|1|||
162905611|NCT02201251|588351900|FG000|Overall Study|Protocol Violation|1|||
162905612|NCT02201251|588351901|FG001|Overall Study|Protocol Violation|0|||
162905613|NCT02201251|588351900|FG000|Overall Study|Noncompliance with Study Drug|0|||
162905614|NCT02201251|588351901|FG001|Overall Study|Noncompliance with Study Drug|1|||
162905615|NCT02201251|588351900|FG000|Overall Study|Withdrawal by Subject|2|||
162905616|NCT02201251|588351901|FG001|Overall Study|Withdrawal by Subject|1|||
162905617|NCT01197794|588351904|FG000|Overall Study|Adverse Event|3|||
162905618|NCT01197794|588351905|FG001|Overall Study|Adverse Event|2|||
162905619|NCT01197794|588351906|FG002|Overall Study|Adverse Event|4|||
162905620|NCT01197794|588351907|FG003|Overall Study|Adverse Event|4|||
162905621|NCT01197794|588351908|FG004|Overall Study|Adverse Event|4|||
162905622|NCT01197794|588351909|FG005|Overall Study|Adverse Event|2|||
162905623|NCT01197794|588351910|FG006|Overall Study|Adverse Event|3|||
162905624|NCT01197794|588351904|FG000|Overall Study|Protocol Violation|0|||
162708842|NCT01515319|587642919|FG007|Overall Study|Adverse Event|0|||
162708843|NCT01515319|587642920|FG008|Overall Study|Adverse Event|3|||
162708844|NCT01515319|587642921|FG009|Overall Study|Adverse Event|0|||
162905625|NCT01197794|588351905|FG001|Overall Study|Protocol Violation|0|||
162905626|NCT01197794|588351906|FG002|Overall Study|Protocol Violation|0|||
162905627|NCT01197794|588351907|FG003|Overall Study|Protocol Violation|0|||
162905628|NCT01197794|588351908|FG004|Overall Study|Protocol Violation|2|||
162905629|NCT01197794|588351909|FG005|Overall Study|Protocol Violation|0|||
162905630|NCT01197794|588351910|FG006|Overall Study|Protocol Violation|1|||
162905631|NCT01197794|588351904|FG000|Overall Study|Development of study withdrawal criteria|3|||
162905632|NCT01197794|588351905|FG001|Overall Study|Development of study withdrawal criteria|0|||
162905633|NCT01197794|588351906|FG002|Overall Study|Development of study withdrawal criteria|0|||
162905634|NCT01197794|588351907|FG003|Overall Study|Development of study withdrawal criteria|1|||
162905635|NCT01197794|588351908|FG004|Overall Study|Development of study withdrawal criteria|0|||
162905636|NCT01197794|588351909|FG005|Overall Study|Development of study withdrawal criteria|0|||
162905637|NCT01197794|588351910|FG006|Overall Study|Development of study withdrawal criteria|1|||
162905638|NCT01197794|588351904|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
162905639|NCT01197794|588351905|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
162905640|NCT01197794|588351906|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
162905641|NCT01197794|588351907|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
162905642|NCT01197794|588351908|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
162905643|NCT01197794|588351909|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
162905644|NCT01197794|588351910|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
162905645|NCT01197794|588351904|FG000|Overall Study|Withdrawal by Subject|3|||
162905646|NCT01197794|588351905|FG001|Overall Study|Withdrawal by Subject|3|||
162905647|NCT01197794|588351906|FG002|Overall Study|Withdrawal by Subject|4|||
162905648|NCT01197794|588351907|FG003|Overall Study|Withdrawal by Subject|1|||
162905649|NCT01197794|588351908|FG004|Overall Study|Withdrawal by Subject|1|||
162905650|NCT01197794|588351909|FG005|Overall Study|Withdrawal by Subject|5|||
162905651|NCT01197794|588351910|FG006|Overall Study|Withdrawal by Subject|6|||
162905652|NCT01197794|588351904|FG000|Overall Study|Lost to Follow-up|1|||
162905653|NCT01197794|588351905|FG001|Overall Study|Lost to Follow-up|1|||
162905654|NCT01197794|588351906|FG002|Overall Study|Lost to Follow-up|0|||
162905655|NCT01197794|588351907|FG003|Overall Study|Lost to Follow-up|1|||
162905656|NCT01197794|588351908|FG004|Overall Study|Lost to Follow-up|0|||
162905657|NCT01197794|588351909|FG005|Overall Study|Lost to Follow-up|1|||
162905658|NCT01197794|588351910|FG006|Overall Study|Lost to Follow-up|0|||
162905659|NCT01197794|588351904|FG000|Overall Study|Other|1|||
162905660|NCT01197794|588351905|FG001|Overall Study|Other|1|||
162905661|NCT01197794|588351906|FG002|Overall Study|Other|3|||
162905662|NCT01197794|588351907|FG003|Overall Study|Other|0|||
162905663|NCT01197794|588351908|FG004|Overall Study|Other|2|||
162905664|NCT01197794|588351909|FG005|Overall Study|Other|2|||
162905665|NCT01197794|588351910|FG006|Overall Study|Other|4|||
162905666|NCT04055844|588351911|FG000|Overall Study|Adverse Event|12|||
162905667|NCT04055844|588351911|FG000|Overall Study|Poor Performance|1|||
162905668|NCT04055844|588351911|FG000|Overall Study|Death|1|||
162905669|NCT00572728|588351912|FG000|Overall Study|Withdrawal by Subject|10|||
162905670|NCT00572728|588351912|FG000|Overall Study|Ineligible|3|||
162905671|NCT00572728|588351912|FG000|Overall Study|Enrolled under Amendment 4|5|||
162905672|NCT00572728|588351912|FG000|Overall Study|Offstudy due to complicating disease|1|||
162905673|NCT00572728|588351912|FG000|Overall Study|FLT1 not completed|4|||
162905674|NCT00572728|588351912|FG000|Overall Study|First Chemotherapy not initiated|2|||
162905675|NCT00572728|588351912|FG000|Overall Study|FLT2 not completed|5|||
162905676|NCT00572728|588351912|FG000|Overall Study|Second chemotherapy not initiated|1|||
162905677|NCT00572728|588351912|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
162905678|NCT00572728|588351912|FG000|Overall Study|Pathology missing|1|||
162905679|NCT03231228|588351921|FG000|Overall Study|Lost to Follow-up|2|||
162905680|NCT03231228|588351922|FG001|Overall Study|Lost to Follow-up|0|||
162905681|NCT03231228|588351921|FG000|Overall Study|Physician Decision|1|||
162905682|NCT03231228|588351922|FG001|Overall Study|Physician Decision|0|||
162905683|NCT03049852|588351932|FG000|Overall Study|Lost to Follow-up|0|||
162905684|NCT03049852|588351933|FG001|Overall Study|Lost to Follow-up|1|||
162905685|NCT03049852|588351934|FG002|Overall Study|Lost to Follow-up|0|||
162905686|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
162905687|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162905688|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162905689|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162905690|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162905691|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162905692|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
162905693|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162905694|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162905695|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162905696|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162905697|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162905698|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
162905699|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162905700|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162905701|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162905702|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162905703|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162905704|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Other|14|||
162905705|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Other|0|||
162905706|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Other|0|||
162905707|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Other|0|||
162967166|NCT02846883|588581263|FG001|Overall Study|Death|1|||
162967167|NCT02846883|588581264|FG002|Overall Study|Death|1|||
162905708|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Other|0|||
162905709|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Other|0|||
162905710|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
162905711|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
162905712|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
162905713|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
162905714|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
162905715|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
162905716|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
162905717|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162905718|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162905719|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162967168|NCT02846883|588581262|FG000|Overall Study|Lost to Follow-up|0|||
162905720|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162905721|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162905722|NCT02141854|588351935|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
162905723|NCT02141854|588351936|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162905724|NCT02141854|588351937|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162905725|NCT02141854|588351938|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162905726|NCT02141854|588351939|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162905727|NCT02141854|588351940|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162905728|NCT02141854|588351935|FG000|Treatment Period|Protocol Violation|0|||
162905729|NCT02141854|588351936|FG001|Treatment Period|Protocol Violation|1|||
162905730|NCT02141854|588351937|FG002|Treatment Period|Protocol Violation|0|||
162905731|NCT02141854|588351938|FG003|Treatment Period|Protocol Violation|2|||
162905732|NCT02141854|588351939|FG004|Treatment Period|Protocol Violation|2|||
162905733|NCT02141854|588351940|FG005|Treatment Period|Protocol Violation|1|||
162905734|NCT02141854|588351935|FG000|Treatment Period|Noncompliance|0|||
162905735|NCT02141854|588351936|FG001|Treatment Period|Noncompliance|0|||
162905736|NCT02141854|588351937|FG002|Treatment Period|Noncompliance|0|||
162905737|NCT02141854|588351938|FG003|Treatment Period|Noncompliance|1|||
162905738|NCT02141854|588351939|FG004|Treatment Period|Noncompliance|0|||
162905739|NCT02141854|588351940|FG005|Treatment Period|Noncompliance|0|||
162905740|NCT02141854|588351935|FG000|Treatment Period|Lack of Efficacy|0|||
162905741|NCT02141854|588351936|FG001|Treatment Period|Lack of Efficacy|0|||
162905742|NCT02141854|588351937|FG002|Treatment Period|Lack of Efficacy|0|||
162905743|NCT02141854|588351938|FG003|Treatment Period|Lack of Efficacy|1|||
162905744|NCT02141854|588351939|FG004|Treatment Period|Lack of Efficacy|1|||
162905745|NCT02141854|588351940|FG005|Treatment Period|Lack of Efficacy|7|||
162905746|NCT02141854|588351935|FG000|Treatment Period|Pregnancy|0|||
162905747|NCT02141854|588351936|FG001|Treatment Period|Pregnancy|1|||
162905748|NCT02141854|588351937|FG002|Treatment Period|Pregnancy|0|||
162905749|NCT02141854|588351938|FG003|Treatment Period|Pregnancy|0|||
162905750|NCT02141854|588351939|FG004|Treatment Period|Pregnancy|0|||
162905751|NCT02141854|588351940|FG005|Treatment Period|Pregnancy|0|||
162905752|NCT02141854|588351935|FG000|Treatment Period|Other|0|||
162905753|NCT02141854|588351936|FG001|Treatment Period|Other|1|||
162905754|NCT02141854|588351937|FG002|Treatment Period|Other|2|||
162905755|NCT02141854|588351938|FG003|Treatment Period|Other|0|||
162905756|NCT02141854|588351939|FG004|Treatment Period|Other|1|||
162905757|NCT02141854|588351940|FG005|Treatment Period|Other|2|||
162905758|NCT02141854|588351935|FG000|Treatment Period|Adverse Event|0|||
162905759|NCT02141854|588351936|FG001|Treatment Period|Adverse Event|2|||
162905760|NCT02141854|588351937|FG002|Treatment Period|Adverse Event|2|||
162905761|NCT02141854|588351938|FG003|Treatment Period|Adverse Event|0|||
162905762|NCT02141854|588351939|FG004|Treatment Period|Adverse Event|2|||
162905763|NCT02141854|588351940|FG005|Treatment Period|Adverse Event|2|||
162905764|NCT02141854|588351935|FG000|Treatment Period|Withdrawal by Subject|0|||
162905765|NCT02141854|588351936|FG001|Treatment Period|Withdrawal by Subject|2|||
162905766|NCT02141854|588351937|FG002|Treatment Period|Withdrawal by Subject|3|||
162905767|NCT02141854|588351938|FG003|Treatment Period|Withdrawal by Subject|3|||
162905768|NCT02141854|588351939|FG004|Treatment Period|Withdrawal by Subject|4|||
162905769|NCT02141854|588351940|FG005|Treatment Period|Withdrawal by Subject|7|||
162905770|NCT02141854|588351935|FG000|Treatment Period|Disease progression|0|||
162905771|NCT02141854|588351936|FG001|Treatment Period|Disease progression|2|||
162905772|NCT02141854|588351937|FG002|Treatment Period|Disease progression|1|||
162905773|NCT02141854|588351938|FG003|Treatment Period|Disease progression|3|||
162905774|NCT02141854|588351939|FG004|Treatment Period|Disease progression|0|||
162905775|NCT02141854|588351940|FG005|Treatment Period|Disease progression|18|||
162905776|NCT02141854|588351935|FG000|Treatment Period|Lost to Follow-up|0|||
162905777|NCT02141854|588351936|FG001|Treatment Period|Lost to Follow-up|1|||
162905778|NCT02141854|588351937|FG002|Treatment Period|Lost to Follow-up|1|||
162905779|NCT02141854|588351938|FG003|Treatment Period|Lost to Follow-up|1|||
162905780|NCT02141854|588351939|FG004|Treatment Period|Lost to Follow-up|0|||
162905781|NCT02141854|588351940|FG005|Treatment Period|Lost to Follow-up|1|||
162905782|NCT01868594|588351941|FG000|Overall Study|Do not meet inclusion criteria|4|||
162905783|NCT01868594|588351942|FG001|Overall Study|Do not meet inclusion criteria|3|||
163053886|NCT00467519|588908435|FG000|Overall Study|Protocol Violation|8|||
163053887|NCT00467519|588908436|FG001|Overall Study|Protocol Violation|4|||
162905784|NCT04490057|588351943|FG000|Stage 1|Death|1|||
162905785|NCT04490057|588351944|FG001|Stage 1|Death|2|||
162905786|NCT04490057|588351945|FG002|Stage 1|Death|0|||
162905787|NCT04490057|588351946|FG003|Stage 1|Death|0|||
162905788|NCT04490057|588351947|FG004|Stage 1|Death|0|||
162905789|NCT04490057|588351948|FG005|Stage 1|Death|0|||
162905790|NCT04490057|588351949|FG006|Stage 1|Death|0|||
162905791|NCT04490057|588351950|FG007|Stage 1|Death|0|||
162905792|NCT04490057|588351943|FG000|Stage 1|Withdrawal by Subject|2|||
162905793|NCT04490057|588351944|FG001|Stage 1|Withdrawal by Subject|0|||
162905794|NCT04490057|588351945|FG002|Stage 1|Withdrawal by Subject|0|||
162905795|NCT04490057|588351946|FG003|Stage 1|Withdrawal by Subject|0|||
162905796|NCT04490057|588351947|FG004|Stage 1|Withdrawal by Subject|0|||
162905797|NCT04490057|588351948|FG005|Stage 1|Withdrawal by Subject|0|||
162905798|NCT04490057|588351949|FG006|Stage 1|Withdrawal by Subject|0|||
162905799|NCT04490057|588351950|FG007|Stage 1|Withdrawal by Subject|0|||
162905800|NCT04490057|588351943|FG000|Stage 2|Death|0|||
162905801|NCT04490057|588351944|FG001|Stage 2|Death|0|||
162905802|NCT04490057|588351945|FG002|Stage 2|Death|0|||
162905803|NCT04490057|588351946|FG003|Stage 2|Death|0|||
162905804|NCT04490057|588351947|FG004|Stage 2|Death|1|||
162905805|NCT04490057|588351948|FG005|Stage 2|Death|0|||
162905806|NCT04490057|588351949|FG006|Stage 2|Death|0|||
162905807|NCT04490057|588351950|FG007|Stage 2|Death|0|||
162905808|NCT04490057|588351943|FG000|Stage 2|Lost to Follow-up|0|||
162905809|NCT04490057|588351944|FG001|Stage 2|Lost to Follow-up|0|||
162905810|NCT04490057|588351945|FG002|Stage 2|Lost to Follow-up|0|||
162905811|NCT04490057|588351946|FG003|Stage 2|Lost to Follow-up|11|||
162905812|NCT04490057|588351947|FG004|Stage 2|Lost to Follow-up|17|||
162905813|NCT04490057|588351948|FG005|Stage 2|Lost to Follow-up|4|||
162905814|NCT04490057|588351949|FG006|Stage 2|Lost to Follow-up|21|||
162905815|NCT04490057|588351950|FG007|Stage 2|Lost to Follow-up|14|||
162905816|NCT02598661|588351953|FG000|Overall Study|Death|27|||
162905817|NCT02598661|588351954|FG001|Overall Study|Death|34|||
162905818|NCT02598661|588351955|FG002|Overall Study|Death|14|||
162905819|NCT02598661|588351956|FG003|Overall Study|Death|1|||
162905820|NCT02598661|588351957|FG004|Overall Study|Death|0|||
162905821|NCT02598661|588351953|FG000|Overall Study|Lost to Follow-up|2|||
162905822|NCT02598661|588351954|FG001|Overall Study|Lost to Follow-up|3|||
162905823|NCT02598661|588351955|FG002|Overall Study|Lost to Follow-up|2|||
162905824|NCT02598661|588351956|FG003|Overall Study|Lost to Follow-up|0|||
162905825|NCT02598661|588351957|FG004|Overall Study|Lost to Follow-up|0|||
162905826|NCT02598661|588351953|FG000|Overall Study|Withdrawal by Subject|13|||
162905827|NCT02598661|588351954|FG001|Overall Study|Withdrawal by Subject|24|||
162905828|NCT02598661|588351955|FG002|Overall Study|Withdrawal by Subject|14|||
162905829|NCT02598661|588351956|FG003|Overall Study|Withdrawal by Subject|1|||
162905830|NCT02598661|588351957|FG004|Overall Study|Withdrawal by Subject|1|||
162905831|NCT02598661|588351953|FG000|Overall Study|Adverse Event|0|||
162905832|NCT02598661|588351954|FG001|Overall Study|Adverse Event|0|||
162905833|NCT02598661|588351955|FG002|Overall Study|Adverse Event|1|||
162905834|NCT02598661|588351956|FG003|Overall Study|Adverse Event|0|||
162905835|NCT02598661|588351957|FG004|Overall Study|Adverse Event|0|||
162905836|NCT02598661|588351953|FG000|Overall Study|Randomized, Never Treated|0|||
162905837|NCT02598661|588351954|FG001|Overall Study|Randomized, Never Treated|0|||
162905838|NCT02598661|588351955|FG002|Overall Study|Randomized, Never Treated|0|||
162905839|NCT02598661|588351956|FG003|Overall Study|Randomized, Never Treated|0|||
162905840|NCT02598661|588351957|FG004|Overall Study|Randomized, Never Treated|1|||
162905841|NCT04564027|588353607|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
162905842|NCT04564027|588353608|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
162905843|NCT04564027|588353609|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
162905844|NCT04564027|588353610|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
162905845|NCT05827978|588353611|FG000|Overall Study|Adverse Event|1|||
162905846|NCT05827978|588353612|FG001|Overall Study|Adverse Event|0|||
162905847|NCT05827978|588353613|FG002|Overall Study|Adverse Event|0|||
162905848|NCT05827978|588353614|FG003|Overall Study|Adverse Event|1|||
162905849|NCT05827978|588353615|FG004|Overall Study|Adverse Event|0|||
162905850|NCT05827978|588353616|FG005|Overall Study|Adverse Event|0|||
162905851|NCT05827978|588353611|FG000|Overall Study|Death|1|||
162905852|NCT05827978|588353612|FG001|Overall Study|Death|5|||
162905853|NCT05827978|588353613|FG002|Overall Study|Death|2|||
162905854|NCT05827978|588353614|FG003|Overall Study|Death|3|||
162905855|NCT05827978|588353615|FG004|Overall Study|Death|1|||
162905856|NCT05827978|588353616|FG005|Overall Study|Death|3|||
162905857|NCT05827978|588353611|FG000|Overall Study|Lost to Follow-up|57|||
162905858|NCT05827978|588353612|FG001|Overall Study|Lost to Follow-up|88|||
162905859|NCT05827978|588353613|FG002|Overall Study|Lost to Follow-up|54|||
162905860|NCT05827978|588353614|FG003|Overall Study|Lost to Follow-up|47|||
162905861|NCT05827978|588353615|FG004|Overall Study|Lost to Follow-up|25|||
162905862|NCT05827978|588353616|FG005|Overall Study|Lost to Follow-up|10|||
162905863|NCT05827978|588353611|FG000|Overall Study|Noncompliance with Study Procedures|0|||
162905864|NCT05827978|588353612|FG001|Overall Study|Noncompliance with Study Procedures|1|||
162905865|NCT05827978|588353613|FG002|Overall Study|Noncompliance with Study Procedures|1|||
162905866|NCT05827978|588353614|FG003|Overall Study|Noncompliance with Study Procedures|1|||
162905867|NCT05827978|588353615|FG004|Overall Study|Noncompliance with Study Procedures|1|||
162967169|NCT02846883|588581263|FG001|Overall Study|Lost to Follow-up|0|||
162905868|NCT05827978|588353616|FG005|Overall Study|Noncompliance with Study Procedures|0|||
162905869|NCT05827978|588353611|FG000|Overall Study|Physician Decision|2|||
162905870|NCT05827978|588353612|FG001|Overall Study|Physician Decision|0|||
162905871|NCT05827978|588353613|FG002|Overall Study|Physician Decision|1|||
162905872|NCT05827978|588353614|FG003|Overall Study|Physician Decision|2|||
162905873|NCT05827978|588353615|FG004|Overall Study|Physician Decision|1|||
162905874|NCT05827978|588353616|FG005|Overall Study|Physician Decision|1|||
162967170|NCT02846883|588581264|FG002|Overall Study|Lost to Follow-up|1|||
162967171|NCT02846883|588581262|FG000|Overall Study|Withdrawal by Subject|1|||
162967172|NCT02846883|588581263|FG001|Overall Study|Withdrawal by Subject|0|||
162967173|NCT02846883|588581264|FG002|Overall Study|Withdrawal by Subject|0|||
162967174|NCT02846883|588581262|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
162967175|NCT02846883|588581263|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
162967176|NCT02846883|588581264|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
162967177|NCT02846883|588581262|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
162967178|NCT02846883|588581263|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
162967179|NCT02846883|588581264|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
162967180|NCT00927251|588581265|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
162967181|NCT00442351|588581269|FG000|Overall Study|Administrative|6|||
162967182|NCT00442351|588581270|FG001|Overall Study|Administrative|5|||
162967183|NCT00442351|588581269|FG000|Overall Study|Did not meet protocol eligibility|1|||
162967184|NCT00442351|588581270|FG001|Overall Study|Did not meet protocol eligibility|0|||
162967185|NCT00442351|588581269|FG000|Overall Study|Other|0|||
162967186|NCT00442351|588581270|FG001|Overall Study|Other|1|||
162967187|NCT00500318|588581271|FG000|Overall Study|Adverse Event|3|||
162967188|NCT00500318|588581272|FG001|Overall Study|Adverse Event|8|||
162967189|NCT00500318|588581271|FG000|Overall Study|Protocol Violation|1|||
162967190|NCT00500318|588581272|FG001|Overall Study|Protocol Violation|3|||
162967191|NCT00500318|588581271|FG000|Overall Study|Withdrawal by Subject|1|||
162967192|NCT00500318|588581272|FG001|Overall Study|Withdrawal by Subject|2|||
162967193|NCT00500318|588581271|FG000|Overall Study|Lack of Efficacy|0|||
162967194|NCT00500318|588581272|FG001|Overall Study|Lack of Efficacy|3|||
162967195|NCT00500318|588581271|FG000|Overall Study|Other Reason|0|||
162967196|NCT00500318|588581272|FG001|Overall Study|Other Reason|1|||
162967197|NCT01011335|588581275|FG000|Overall Study|Lost to Follow-up|0|||
162967198|NCT01011335|588581276|FG001|Overall Study|Lost to Follow-up|0|||
162967199|NCT01011335|588581277|FG002|Overall Study|Lost to Follow-up|1|||
162967200|NCT01011335|588581278|FG003|Overall Study|Lost to Follow-up|1|||
162967201|NCT01011335|588581279|FG004|Overall Study|Lost to Follow-up|1|||
162967202|NCT01011335|588581280|FG005|Overall Study|Lost to Follow-up|1|||
162967203|NCT01011335|588581281|FG006|Overall Study|Lost to Follow-up|2|||
162967204|NCT01011335|588581282|FG007|Overall Study|Lost to Follow-up|2|||
162967205|NCT01011335|588581283|FG008|Overall Study|Lost to Follow-up|1|||
162967206|NCT01011335|588581284|FG009|Overall Study|Lost to Follow-up|0|||
162967207|NCT01011335|588581285|FG010|Overall Study|Lost to Follow-up|0|||
162967208|NCT01011335|588581286|FG011|Overall Study|Lost to Follow-up|1|||
162967209|NCT01011335|588581287|FG012|Overall Study|Lost to Follow-up|2|||
162967210|NCT01011335|588581275|FG000|Overall Study|Protocol Violation|0|||
162967211|NCT01011335|588581276|FG001|Overall Study|Protocol Violation|1|||
162967212|NCT01011335|588581277|FG002|Overall Study|Protocol Violation|0|||
162967213|NCT01011335|588581278|FG003|Overall Study|Protocol Violation|0|||
162967214|NCT01011335|588581279|FG004|Overall Study|Protocol Violation|0|||
162967215|NCT01011335|588581280|FG005|Overall Study|Protocol Violation|0|||
163053888|NCT00467519|588908435|FG000|Overall Study|Lost to Follow-up|2|||
163053889|NCT00467519|588908436|FG001|Overall Study|Lost to Follow-up|9|||
163053890|NCT00467519|588908435|FG000|Overall Study|Withdrawal by Subject|4|||
163053891|NCT00467519|588908436|FG001|Overall Study|Withdrawal by Subject|10|||
162905875|NCT05827978|588353611|FG000|Overall Study|Protocol Violation|5|||
162905876|NCT05827978|588353612|FG001|Overall Study|Protocol Violation|2|||
162905877|NCT05827978|588353613|FG002|Overall Study|Protocol Violation|0|||
162905878|NCT05827978|588353614|FG003|Overall Study|Protocol Violation|0|||
162905879|NCT05827978|588353615|FG004|Overall Study|Protocol Violation|0|||
162905880|NCT05827978|588353616|FG005|Overall Study|Protocol Violation|0|||
162905881|NCT05827978|588353611|FG000|Overall Study|Withdrawal by Subject|17|||
162905882|NCT05827978|588353612|FG001|Overall Study|Withdrawal by Subject|16|||
162905883|NCT05827978|588353613|FG002|Overall Study|Withdrawal by Subject|10|||
162905884|NCT05827978|588353614|FG003|Overall Study|Withdrawal by Subject|12|||
162905885|NCT05827978|588353615|FG004|Overall Study|Withdrawal by Subject|10|||
162905886|NCT05827978|588353616|FG005|Overall Study|Withdrawal by Subject|9|||
162905887|NCT05827978|588353611|FG000|Overall Study|Other Than Specified|0|||
162905888|NCT05827978|588353612|FG001|Overall Study|Other Than Specified|0|||
162905889|NCT05827978|588353613|FG002|Overall Study|Other Than Specified|1|||
162905890|NCT05827978|588353614|FG003|Overall Study|Other Than Specified|0|||
162905891|NCT05827978|588353615|FG004|Overall Study|Other Than Specified|2|||
162905892|NCT05827978|588353616|FG005|Overall Study|Other Than Specified|0|||
162905893|NCT04566445|588353617|FG000|Overall Study|Death|4|||
162905894|NCT04566445|588353618|FG001|Overall Study|Death|1|||
162905895|NCT04566445|588353619|FG002|Overall Study|Death|1|||
162905896|NCT04566445|588353617|FG000|Overall Study|Lost to Follow-up|3|||
162905897|NCT04566445|588353618|FG001|Overall Study|Lost to Follow-up|1|||
162905898|NCT04566445|588353619|FG002|Overall Study|Lost to Follow-up|1|||
162905899|NCT04566445|588353617|FG000|Overall Study|Study terminated by sponsor|11|||
162905900|NCT04566445|588353618|FG001|Overall Study|Study terminated by sponsor|17|||
162905901|NCT04566445|588353619|FG002|Overall Study|Study terminated by sponsor|32|||
162905902|NCT04566445|588353617|FG000|Overall Study|Withdrawal by Subject|12|||
162905903|NCT04566445|588353618|FG001|Overall Study|Withdrawal by Subject|14|||
162905904|NCT04566445|588353619|FG002|Overall Study|Withdrawal by Subject|13|||
162905905|NCT04566445|588353617|FG000|Overall Study|Randomized but not treated due to AE|2|||
162905906|NCT04566445|588353618|FG001|Overall Study|Randomized but not treated due to AE|1|||
162905907|NCT04566445|588353619|FG002|Overall Study|Randomized but not treated due to AE|0|||
162905908|NCT04566445|588353617|FG000|Overall Study|Adverse Event|1|||
162905909|NCT04566445|588353618|FG001|Overall Study|Adverse Event|1|||
163053892|NCT00372424|588908437|FG000|Overall Study|Adverse Event|2|||
163053893|NCT00372424|588908437|FG000|Overall Study|Withdrawal by Subject|1|||
163053894|NCT00372424|588908437|FG000|Overall Study|Death|1|||
163053895|NCT00372424|588908437|FG000|Overall Study|Objective Progression or Relapse|14|||
162905910|NCT04566445|588353619|FG002|Overall Study|Adverse Event|0|||
162905911|NCT00137267|588353622|FG000|Overall Study|Lost to Follow-up|15|||
162905912|NCT00137267|588353623|FG001|Overall Study|Lost to Follow-up|21|||
162905913|NCT02061540|588353628|FG000|Overall Study|Adverse Event|2|||
163053896|NCT00372424|588908437|FG000|Overall Study|Other|7|||
162905914|NCT02061540|588353628|FG000|Overall Study|Withdrawal by Subject|2|||
162905915|NCT04005755|588353630|FG000|Overall Study|Adverse Event|6|||
163053897|NCT00372424|588908437|FG000|Overall Study|Enrolled, Not Treated|1|||
163053898|NCT02314728|588908448|FG000|Overall Study|Protocol Violation|1|||
163053899|NCT02314728|588908449|FG001|Overall Study|Protocol Violation|0|||
163053900|NCT02314728|588908448|FG000|Overall Study|Lost to Follow-up|0|||
163053901|NCT02314728|588908449|FG001|Overall Study|Lost to Follow-up|1|||
163053902|NCT03118934|588908451|FG000|Overall Study|Adverse Event|0|||
163053903|NCT03118934|588908452|FG001|Overall Study|Adverse Event|0|||
163053904|NCT03118934|588908453|FG002|Overall Study|Adverse Event|0|||
163053905|NCT03118934|588908454|FG003|Overall Study|Adverse Event|0|||
163053906|NCT03118934|588908455|FG004|Overall Study|Adverse Event|0|||
163053907|NCT03118934|588908456|FG005|Overall Study|Adverse Event|1|||
163053908|NCT03118934|588908451|FG000|Overall Study|Physician Decision|0|||
163053909|NCT03118934|588908452|FG001|Overall Study|Physician Decision|0|||
163053910|NCT03118934|588908453|FG002|Overall Study|Physician Decision|0|||
163053911|NCT03118934|588908454|FG003|Overall Study|Physician Decision|0|||
163053912|NCT03118934|588908455|FG004|Overall Study|Physician Decision|0|||
163053913|NCT03118934|588908456|FG005|Overall Study|Physician Decision|1|||
163053914|NCT03118934|588908451|FG000|Overall Study|Discontinued prior to exposure|0|||
163053915|NCT03118934|588908452|FG001|Overall Study|Discontinued prior to exposure|1|||
163053916|NCT03118934|588908453|FG002|Overall Study|Discontinued prior to exposure|1|||
163053917|NCT03118934|588908454|FG003|Overall Study|Discontinued prior to exposure|1|||
163053918|NCT03118934|588908455|FG004|Overall Study|Discontinued prior to exposure|2|||
163053919|NCT03118934|588908456|FG005|Overall Study|Discontinued prior to exposure|0|||
163053920|NCT00069264|588908459|FG000|Overall Study|Adverse Event|3|||
163053921|NCT00069264|588908459|FG000|Overall Study|Progressive Disease|23|||
163053922|NCT00069264|588908459|FG000|Overall Study|Withdrawal by Subject|3|||
162708845|NCT01515319|587642912|FG000|Overall Study|Protocol Violation|0|||
162708846|NCT01515319|587642913|FG001|Overall Study|Protocol Violation|0|||
162905916|NCT04005755|588353630|FG000|Overall Study|Physician Decision|3|||
162905917|NCT04005755|588353630|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
162905918|NCT04005755|588353630|FG000|Overall Study|Withdrawal by Subject|3|||
162905919|NCT04005755|588353630|FG000|Overall Study|Lost to Follow-up|1|||
162905920|NCT02289833|588353632|FG000|Overall Study|Study discontinuation|0|||
162905921|NCT02289833|588353633|FG001|Overall Study|Study discontinuation|1|||
162905922|NCT02289833|588353632|FG000|Overall Study|Lost to Follow-up|4|||
162905923|NCT02289833|588353633|FG001|Overall Study|Lost to Follow-up|0|||
162905924|NCT02289833|588353632|FG000|Overall Study|Death|23|||
162905925|NCT02289833|588353633|FG001|Overall Study|Death|16|||
162905926|NCT02561273|588353640|FG000|Overall Study|Protocol Violation|1|||
162905927|NCT02561273|588353641|FG001|Overall Study|Protocol Violation|0|||
162905928|NCT00958191|588353642|FG000|Overall Study|Death|4|||
162905929|NCT00958191|588353642|FG000|Overall Study|Lost to Follow-up|5|||
162905930|NCT00958191|588353642|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
162905931|NCT00958191|588353642|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
162905932|NCT00958191|588353642|FG000|Overall Study|Revision of study device|4|||
163053923|NCT00069264|588908459|FG000|Overall Study|Discon Therapy|3|||
163053924|NCT04467515|588908460|FG000|Overall Study|Lost to Follow-up|1|||
163053925|NCT04467515|588908461|FG001|Overall Study|Lost to Follow-up|0|||
163053926|NCT04467515|588908462|FG002|Overall Study|Lost to Follow-up|0|||
163053927|NCT04467515|588908460|FG000|Overall Study|Withdrawal by Subject|1|||
163053928|NCT04467515|588908461|FG001|Overall Study|Withdrawal by Subject|0|||
163053929|NCT04467515|588908462|FG002|Overall Study|Withdrawal by Subject|1|||
163053930|NCT04467515|588908460|FG000|Overall Study|Progressive Disease|0|||
163053931|NCT04467515|588908461|FG001|Overall Study|Progressive Disease|1|||
162905933|NCT00958191|588353642|FG000|Overall Study|Site termination|11|||
162905934|NCT00958191|588353642|FG000|Overall Study|No 5 yr x-rays|56|||
162905935|NCT01642004|588353643|FG000|Randomization|Adverse Event unrelated to study drug|1|||
162905936|NCT01642004|588353644|FG001|Randomization|Adverse Event unrelated to study drug|0|||
162905937|NCT01642004|588353643|FG000|Randomization|Participant withdrew consent|1|||
162905938|NCT01642004|588353644|FG001|Randomization|Participant withdrew consent|6|||
162905939|NCT01642004|588353643|FG000|Randomization|No longer meets study criteria|2|||
162905940|NCT01642004|588353644|FG001|Randomization|No longer meets study criteria|2|||
162905941|NCT01642004|588353643|FG000|Treatment|Disease progression|95|||
162905942|NCT01642004|588353644|FG001|Treatment|Disease progression|79|||
162905943|NCT01642004|588353643|FG000|Treatment|Study drug toxicity|10|||
162905944|NCT01642004|588353644|FG001|Treatment|Study drug toxicity|13|||
162905945|NCT01642004|588353643|FG000|Treatment|Death|1|||
162905946|NCT01642004|588353644|FG001|Treatment|Death|1|||
163053932|NCT04467515|588908462|FG002|Overall Study|Progressive Disease|3|||
163053933|NCT04467515|588908460|FG000|Overall Study|Death|0|||
163053934|NCT04467515|588908461|FG001|Overall Study|Death|1|||
163053935|NCT04467515|588908462|FG002|Overall Study|Death|0|||
163053936|NCT03886272|588908463|FG000|Period 1|Withdrawal by Subject|0|||
163053937|NCT03886272|588908464|FG001|Period 1|Withdrawal by Subject|0|||
163053938|NCT03886272|588908465|FG002|Period 1|Withdrawal by Subject|0|||
163053939|NCT03886272|588908466|FG003|Period 1|Withdrawal by Subject|0|||
163053940|NCT03886272|588908467|FG004|Period 1|Withdrawal by Subject|0|||
163053941|NCT03886272|588908468|FG005|Period 1|Withdrawal by Subject|1|||
163053942|NCT03886272|588908469|FG006|Period 1|Withdrawal by Subject|0|||
163053943|NCT03014206|588908470|FG000|Overall Study|Registration Violation|12|||
163053944|NCT01091246|588908471|FG000|Overall Study|Lost to Follow-up|23|||
163053945|NCT01091246|588908472|FG001|Overall Study|Lost to Follow-up|11|||
163053946|NCT01091246|588908473|FG002|Overall Study|Lost to Follow-up|7|||
162905947|NCT01642004|588353643|FG000|Treatment|Adverse event unrelated to study drug|9|||
162905948|NCT01642004|588353644|FG001|Treatment|Adverse event unrelated to study drug|13|||
162905949|NCT01642004|588353643|FG000|Treatment|Maximum clinical benefit|1|||
162905950|NCT01642004|588353644|FG001|Treatment|Maximum clinical benefit|9|||
162905951|NCT01642004|588353643|FG000|Treatment|Poor/non-compliance|1|||
162905952|NCT01642004|588353644|FG001|Treatment|Poor/non-compliance|0|||
162905953|NCT01642004|588353643|FG000|Treatment|No longer meets study criteria|1|||
162905954|NCT01642004|588353644|FG001|Treatment|No longer meets study criteria|2|||
162905955|NCT01642004|588353643|FG000|Treatment|Other reasons|2|||
162905956|NCT01642004|588353644|FG001|Treatment|Other reasons|0|||
162905957|NCT01642004|588353643|FG000|Treatment|Not reported|0|||
162905958|NCT01642004|588353644|FG001|Treatment|Not reported|3|||
162905959|NCT01642004|588353643|FG000|Treatment|Participant request to discontinue study treatment|6|||
162905960|NCT01642004|588353644|FG001|Treatment|Participant request to discontinue study treatment|4|||
162905961|NCT01642004|588353643|FG000|Treatment|Participant withdrew consent|5|||
162905962|NCT01642004|588353644|FG001|Treatment|Participant withdrew consent|5|||
162905963|NCT01818765|588353647|FG000|Overall Study|Death|2|||
162905964|NCT01562327|588353648|FG000|Overall Study|Adverse Event|2|||
162905965|NCT01562327|588353648|FG000|Overall Study|Lack of Efficacy|1|||
163053947|NCT01091246|588908471|FG000|Overall Study|Adverse Event|1|||
163053948|NCT01091246|588908472|FG001|Overall Study|Adverse Event|0|||
163053949|NCT01091246|588908473|FG002|Overall Study|Adverse Event|1|||
163053950|NCT01091246|588908471|FG000|Overall Study|Withdrawal by Subject|9|||
163053951|NCT01091246|588908472|FG001|Overall Study|Withdrawal by Subject|5|||
163053952|NCT01091246|588908473|FG002|Overall Study|Withdrawal by Subject|4|||
162905966|NCT01562327|588353648|FG000|Overall Study|Participant drop-out|1|||
162905967|NCT01562327|588353648|FG000|Overall Study|Infusion not received at 6 month window|4|||
162905968|NCT04554394|588353657|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
162905969|NCT04554394|588353658|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
162905970|NCT04554394|588353657|FG000|Overall Study|Withdrawal by Subject|2|||
162905971|NCT04554394|588353658|FG001|Overall Study|Withdrawal by Subject|2|||
162905972|NCT04554394|588353657|FG000|Overall Study|Lost to Follow-up|2|||
162905973|NCT04554394|588353658|FG001|Overall Study|Lost to Follow-up|2|||
162708847|NCT01515319|587642914|FG002|Overall Study|Protocol Violation|0|||
162905974|NCT04554394|588353657|FG000|Overall Study|Physician Decision|1|||
162905975|NCT04554394|588353658|FG001|Overall Study|Physician Decision|1|||
162905976|NCT02795182|588353659|FG000|Overall Study|Death|5|||
162905977|NCT02795182|588353660|FG001|Overall Study|Death|4|||
162905978|NCT02795182|588353661|FG002|Overall Study|Death|4|||
163053953|NCT01091246|588908471|FG000|Overall Study|Subject not dosed|2|||
163053954|NCT01091246|588908472|FG001|Overall Study|Subject not dosed|0|||
163053955|NCT01091246|588908473|FG002|Overall Study|Subject not dosed|1|||
163053956|NCT01673178|588908474|FG000|Overall Study|Lost to Follow-up|0|||
162905979|NCT02795182|588353662|FG003|Overall Study|Death|18|||
163053957|NCT01673178|588908475|FG001|Overall Study|Lost to Follow-up|1|||
162905980|NCT02795182|588353659|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
162905981|NCT02795182|588353660|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
162905982|NCT02795182|588353661|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
162905983|NCT02795182|588353662|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
162905984|NCT02795182|588353659|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
162905985|NCT02795182|588353660|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
162905986|NCT02795182|588353661|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
162905987|NCT02795182|588353662|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
162905988|NCT02795182|588353659|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
162905989|NCT02795182|588353660|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
162905990|NCT02795182|588353661|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
162905991|NCT02795182|588353662|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
162905992|NCT02795182|588353659|FG000|Overall Study|Withdrawal by Subject|4|||
162905993|NCT02795182|588353660|FG001|Overall Study|Withdrawal by Subject|0|||
162905994|NCT02795182|588353661|FG002|Overall Study|Withdrawal by Subject|0|||
162905995|NCT02795182|588353662|FG003|Overall Study|Withdrawal by Subject|3|||
162905996|NCT02795182|588353659|FG000|Overall Study|Lost to Follow-up|0|||
162905997|NCT02795182|588353660|FG001|Overall Study|Lost to Follow-up|0|||
162905998|NCT02795182|588353661|FG002|Overall Study|Lost to Follow-up|1|||
162905999|NCT02795182|588353662|FG003|Overall Study|Lost to Follow-up|1|||
162906000|NCT02795182|588353659|FG000|Overall Study|Roll Over to Long Term Extension|3|||
162906001|NCT02795182|588353660|FG001|Overall Study|Roll Over to Long Term Extension|3|||
162906002|NCT02795182|588353661|FG002|Overall Study|Roll Over to Long Term Extension|2|||
162906003|NCT02795182|588353662|FG003|Overall Study|Roll Over to Long Term Extension|5|||
162906004|NCT02795182|588353659|FG000|Overall Study|Progressive Disease|0|||
162906005|NCT02795182|588353660|FG001|Overall Study|Progressive Disease|1|||
163053958|NCT01673178|588908476|FG002|Overall Study|Lost to Follow-up|0|||
163053959|NCT01673178|588908477|FG003|Overall Study|Lost to Follow-up|0|||
163053960|NCT01673178|588908478|FG004|Overall Study|Lost to Follow-up|0|||
163053961|NCT01673178|588908474|FG000|Overall Study|Withdrawal by Subject|0|||
163053962|NCT01673178|588908475|FG001|Overall Study|Withdrawal by Subject|0|||
163053963|NCT01673178|588908476|FG002|Overall Study|Withdrawal by Subject|1|||
163053964|NCT01673178|588908477|FG003|Overall Study|Withdrawal by Subject|4|||
162906006|NCT02795182|588353661|FG002|Overall Study|Progressive Disease|0|||
162906007|NCT02795182|588353662|FG003|Overall Study|Progressive Disease|4|||
162906008|NCT02795182|588353659|FG000|Overall Study|Physician Decision|0|||
162967216|NCT01011335|588581281|FG006|Overall Study|Protocol Violation|0|||
162967217|NCT01011335|588581282|FG007|Overall Study|Protocol Violation|0|||
162967218|NCT01011335|588581283|FG008|Overall Study|Protocol Violation|0|||
162967219|NCT01011335|588581284|FG009|Overall Study|Protocol Violation|0|||
162967220|NCT01011335|588581285|FG010|Overall Study|Protocol Violation|0|||
162967221|NCT01011335|588581286|FG011|Overall Study|Protocol Violation|0|||
162967222|NCT01011335|588581287|FG012|Overall Study|Protocol Violation|0|||
162967223|NCT01011335|588581275|FG000|Overall Study|Moved/deployed or no booster|1|||
162967224|NCT01011335|588581276|FG001|Overall Study|Moved/deployed or no booster|0|||
162967225|NCT01011335|588581277|FG002|Overall Study|Moved/deployed or no booster|0|||
162967226|NCT01011335|588581278|FG003|Overall Study|Moved/deployed or no booster|1|||
162967227|NCT01011335|588581279|FG004|Overall Study|Moved/deployed or no booster|0|||
162967228|NCT01011335|588581280|FG005|Overall Study|Moved/deployed or no booster|0|||
162967229|NCT01011335|588581281|FG006|Overall Study|Moved/deployed or no booster|1|||
162967230|NCT01011335|588581282|FG007|Overall Study|Moved/deployed or no booster|0|||
162967231|NCT01011335|588581283|FG008|Overall Study|Moved/deployed or no booster|1|||
162967232|NCT01011335|588581284|FG009|Overall Study|Moved/deployed or no booster|0|||
162967233|NCT01011335|588581285|FG010|Overall Study|Moved/deployed or no booster|2|||
162967234|NCT01011335|588581286|FG011|Overall Study|Moved/deployed or no booster|0|||
162967235|NCT01011335|588581287|FG012|Overall Study|Moved/deployed or no booster|0|||
163053965|NCT01673178|588908478|FG004|Overall Study|Withdrawal by Subject|2|||
163053966|NCT01673178|588908474|FG000|Overall Study|Protocol Violation|1|||
163053967|NCT01673178|588908475|FG001|Overall Study|Protocol Violation|1|||
163053968|NCT01673178|588908476|FG002|Overall Study|Protocol Violation|0|||
163053969|NCT01673178|588908477|FG003|Overall Study|Protocol Violation|1|||
162906009|NCT02795182|588353660|FG001|Overall Study|Physician Decision|0|||
162906010|NCT02795182|588353661|FG002|Overall Study|Physician Decision|0|||
162906011|NCT02795182|588353662|FG003|Overall Study|Physician Decision|1|||
162906012|NCT01021553|588353663|FG000|Overall Study|Adverse Event|1|||
162906013|NCT01021553|588353664|FG001|Overall Study|Adverse Event|0|||
162906014|NCT01021553|588353665|FG002|Overall Study|Adverse Event|0|||
163053970|NCT01673178|588908478|FG004|Overall Study|Protocol Violation|0|||
163053971|NCT01673178|588908474|FG000|Overall Study|Adverse Event|1|||
163053972|NCT01673178|588908475|FG001|Overall Study|Adverse Event|0|||
162906015|NCT01021553|588353663|FG000|Overall Study|Lack of Efficacy|2|||
162906016|NCT01021553|588353664|FG001|Overall Study|Lack of Efficacy|2|||
162906017|NCT01021553|588353665|FG002|Overall Study|Lack of Efficacy|0|||
162906018|NCT01021553|588353663|FG000|Overall Study|Protocol Violation|0|||
162906019|NCT01021553|588353664|FG001|Overall Study|Protocol Violation|2|||
162906020|NCT01021553|588353665|FG002|Overall Study|Protocol Violation|2|||
162906021|NCT01021553|588353663|FG000|Overall Study|Lost to Follow-up|0|||
162906022|NCT01021553|588353664|FG001|Overall Study|Lost to Follow-up|0|||
162906023|NCT01021553|588353665|FG002|Overall Study|Lost to Follow-up|1|||
162906024|NCT01021553|588353663|FG000|Overall Study|Withdrawal by Subject|1|||
162906025|NCT01021553|588353664|FG001|Overall Study|Withdrawal by Subject|1|||
162906026|NCT01021553|588353665|FG002|Overall Study|Withdrawal by Subject|0|||
162906027|NCT01950364|588353666|FG000|Overall Study|Adverse Event|3|||
162906028|NCT01950364|588353667|FG001|Overall Study|Adverse Event|0|||
162906029|NCT01950364|588353666|FG000|Overall Study|Stem Cell Transplant|2|||
162906030|NCT01950364|588353667|FG001|Overall Study|Stem Cell Transplant|6|||
162906031|NCT01950364|588353666|FG000|Overall Study|Disease Progression|5|||
162906032|NCT01950364|588353667|FG001|Overall Study|Disease Progression|2|||
162906033|NCT01950364|588353666|FG000|Overall Study|Withdrawal by Subject|0|||
162906034|NCT01950364|588353667|FG001|Overall Study|Withdrawal by Subject|1|||
162906035|NCT01950364|588353666|FG000|Overall Study|Protocol Violation|0|||
162906036|NCT01950364|588353667|FG001|Overall Study|Protocol Violation|1|||
162906037|NCT01055457|588353670|FG000|Overall Study|Lost to Follow-up|0|||
162906038|NCT01055457|588353671|FG001|Overall Study|Lost to Follow-up|1|||
162906039|NCT01055457|588353672|FG002|Overall Study|Lost to Follow-up|0|||
162906040|NCT01055457|588353673|FG003|Overall Study|Lost to Follow-up|0|||
162906041|NCT01055457|588353674|FG004|Overall Study|Lost to Follow-up|0|||
162906042|NCT01055457|588353675|FG005|Overall Study|Lost to Follow-up|1|||
162906043|NCT01055457|588353676|FG006|Overall Study|Lost to Follow-up|0|||
162906044|NCT01055457|588353677|FG007|Overall Study|Lost to Follow-up|0|||
162906045|NCT01055457|588353678|FG008|Overall Study|Lost to Follow-up|0|||
162906046|NCT01055457|588353679|FG009|Overall Study|Lost to Follow-up|0|||
162906047|NCT01055457|588353670|FG000|Overall Study|Protocol Violation|0|||
162906048|NCT01055457|588353671|FG001|Overall Study|Protocol Violation|0|||
162906049|NCT01055457|588353672|FG002|Overall Study|Protocol Violation|1|||
162906050|NCT01055457|588353673|FG003|Overall Study|Protocol Violation|1|||
162906051|NCT01055457|588353674|FG004|Overall Study|Protocol Violation|1|||
162906052|NCT01055457|588353675|FG005|Overall Study|Protocol Violation|2|||
162906053|NCT01055457|588353676|FG006|Overall Study|Protocol Violation|1|||
162906054|NCT01055457|588353677|FG007|Overall Study|Protocol Violation|0|||
162906055|NCT01055457|588353678|FG008|Overall Study|Protocol Violation|0|||
162906056|NCT01055457|588353679|FG009|Overall Study|Protocol Violation|1|||
162906057|NCT01055457|588353670|FG000|Overall Study|Subject Disinterest|0|||
162906058|NCT01055457|588353671|FG001|Overall Study|Subject Disinterest|0|||
162906059|NCT01055457|588353672|FG002|Overall Study|Subject Disinterest|0|||
162906060|NCT01055457|588353673|FG003|Overall Study|Subject Disinterest|0|||
162906061|NCT01055457|588353674|FG004|Overall Study|Subject Disinterest|0|||
162906062|NCT01055457|588353675|FG005|Overall Study|Subject Disinterest|0|||
162906063|NCT01055457|588353676|FG006|Overall Study|Subject Disinterest|0|||
162906064|NCT01055457|588353677|FG007|Overall Study|Subject Disinterest|1|||
163053973|NCT01673178|588908476|FG002|Overall Study|Adverse Event|0|||
163053974|NCT01673178|588908477|FG003|Overall Study|Adverse Event|2|||
163053975|NCT01673178|588908478|FG004|Overall Study|Adverse Event|0|||
163053976|NCT01673178|588908474|FG000|Overall Study|Other|1|||
162906065|NCT01055457|588353678|FG008|Overall Study|Subject Disinterest|0|||
162906066|NCT01055457|588353679|FG009|Overall Study|Subject Disinterest|0|||
162906067|NCT01055457|588353670|FG000|Overall Study|Subject Ineligible|1|||
162906068|NCT01055457|588353671|FG001|Overall Study|Subject Ineligible|0|||
162906069|NCT01055457|588353672|FG002|Overall Study|Subject Ineligible|1|||
162906070|NCT01055457|588353673|FG003|Overall Study|Subject Ineligible|0|||
162906071|NCT01055457|588353674|FG004|Overall Study|Subject Ineligible|1|||
162906072|NCT01055457|588353675|FG005|Overall Study|Subject Ineligible|0|||
162906073|NCT01055457|588353676|FG006|Overall Study|Subject Ineligible|0|||
162906074|NCT01055457|588353677|FG007|Overall Study|Subject Ineligible|0|||
162906075|NCT01055457|588353678|FG008|Overall Study|Subject Ineligible|0|||
162906076|NCT01055457|588353679|FG009|Overall Study|Subject Ineligible|0|||
162906077|NCT01055457|588353670|FG000|Overall Study|Discomfort|0|||
163053977|NCT01673178|588908475|FG001|Overall Study|Other|0|||
163053978|NCT01673178|588908476|FG002|Overall Study|Other|2|||
162906078|NCT01055457|588353671|FG001|Overall Study|Discomfort|0|||
162906079|NCT01055457|588353672|FG002|Overall Study|Discomfort|0|||
162906080|NCT01055457|588353673|FG003|Overall Study|Discomfort|0|||
162906081|NCT01055457|588353674|FG004|Overall Study|Discomfort|1|||
162906082|NCT01055457|588353675|FG005|Overall Study|Discomfort|0|||
162906083|NCT01055457|588353676|FG006|Overall Study|Discomfort|0|||
162906084|NCT01055457|588353677|FG007|Overall Study|Discomfort|0|||
162906085|NCT01055457|588353678|FG008|Overall Study|Discomfort|0|||
162906086|NCT01055457|588353679|FG009|Overall Study|Discomfort|0|||
162906087|NCT01055457|588353670|FG000|Overall Study|Pregnancy|0|||
162906088|NCT01055457|588353671|FG001|Overall Study|Pregnancy|0|||
162906089|NCT01055457|588353672|FG002|Overall Study|Pregnancy|0|||
162906090|NCT01055457|588353673|FG003|Overall Study|Pregnancy|1|||
162906091|NCT01055457|588353674|FG004|Overall Study|Pregnancy|0|||
162906092|NCT01055457|588353675|FG005|Overall Study|Pregnancy|0|||
162906093|NCT01055457|588353676|FG006|Overall Study|Pregnancy|0|||
162906094|NCT01055457|588353677|FG007|Overall Study|Pregnancy|0|||
162906095|NCT01055457|588353678|FG008|Overall Study|Pregnancy|0|||
162906096|NCT01055457|588353679|FG009|Overall Study|Pregnancy|0|||
162906097|NCT01055457|588353670|FG000|Overall Study|Adverse Event|0|||
162906098|NCT01055457|588353671|FG001|Overall Study|Adverse Event|0|||
162906099|NCT01055457|588353672|FG002|Overall Study|Adverse Event|0|||
162906100|NCT01055457|588353673|FG003|Overall Study|Adverse Event|1|||
162906101|NCT01055457|588353674|FG004|Overall Study|Adverse Event|0|||
162906102|NCT01055457|588353675|FG005|Overall Study|Adverse Event|0|||
162906103|NCT01055457|588353676|FG006|Overall Study|Adverse Event|0|||
162906104|NCT01055457|588353677|FG007|Overall Study|Adverse Event|0|||
162906105|NCT01055457|588353678|FG008|Overall Study|Adverse Event|0|||
162906106|NCT01055457|588353679|FG009|Overall Study|Adverse Event|0|||
162906107|NCT01833806|588353682|FG000|Overall Study|Alternative treatment|2|||
162906108|NCT01833806|588353682|FG000|Overall Study|Death|5|||
162906109|NCT01833806|588353682|FG000|Overall Study|Physician Decision|1|||
162906110|NCT01833806|588353682|FG000|Overall Study|Lost to Follow-up|1|||
162906111|NCT02724111|588353683|FG000|Overall Study|Protocol Violation|2|||
162906112|NCT02724111|588353684|FG001|Overall Study|Protocol Violation|5|||
162906113|NCT02996500|588353685|FG000|Overall Study|Adverse Event|1|||
162906114|NCT02996500|588353686|FG001|Overall Study|Adverse Event|1|||
162906115|NCT02996500|588353687|FG002|Overall Study|Adverse Event|4|||
162906116|NCT02996500|588353688|FG003|Overall Study|Adverse Event|3|||
162906117|NCT02996500|588353689|FG004|Overall Study|Adverse Event|1|||
162906118|NCT02996500|588353690|FG005|Overall Study|Adverse Event|2|||
162906119|NCT02996500|588353685|FG000|Overall Study|Lack of Efficacy|0|||
162906120|NCT02996500|588353686|FG001|Overall Study|Lack of Efficacy|0|||
162906121|NCT02996500|588353687|FG002|Overall Study|Lack of Efficacy|0|||
162906122|NCT02996500|588353688|FG003|Overall Study|Lack of Efficacy|0|||
162906123|NCT02996500|588353689|FG004|Overall Study|Lack of Efficacy|2|||
162906124|NCT02996500|588353690|FG005|Overall Study|Lack of Efficacy|0|||
162906125|NCT02996500|588353685|FG000|Overall Study|Lost to Follow-up|1|||
162906126|NCT02996500|588353686|FG001|Overall Study|Lost to Follow-up|0|||
162906127|NCT02996500|588353687|FG002|Overall Study|Lost to Follow-up|0|||
162906128|NCT02996500|588353688|FG003|Overall Study|Lost to Follow-up|0|||
162906129|NCT02996500|588353689|FG004|Overall Study|Lost to Follow-up|0|||
162906130|NCT02996500|588353690|FG005|Overall Study|Lost to Follow-up|1|||
162906131|NCT02996500|588353685|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162906132|NCT02996500|588353686|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162906133|NCT02996500|588353687|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
162906134|NCT02996500|588353688|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
162906135|NCT02996500|588353689|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
162906136|NCT02996500|588353690|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
162906137|NCT02996500|588353685|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162906138|NCT02996500|588353686|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162906139|NCT02996500|588353687|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162906140|NCT02996500|588353688|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162906141|NCT02996500|588353689|FG004|Overall Study|Non-Compliance With Study Drug|0|||
162906142|NCT02996500|588353690|FG005|Overall Study|Non-Compliance With Study Drug|1|||
162906143|NCT02996500|588353685|FG000|Overall Study|Progressive Disease|1|||
162906144|NCT02996500|588353686|FG001|Overall Study|Progressive Disease|0|||
162906145|NCT02996500|588353687|FG002|Overall Study|Progressive Disease|0|||
162906146|NCT02996500|588353688|FG003|Overall Study|Progressive Disease|0|||
162906147|NCT02996500|588353689|FG004|Overall Study|Progressive Disease|0|||
162906148|NCT02996500|588353690|FG005|Overall Study|Progressive Disease|0|||
162906149|NCT02996500|588353685|FG000|Overall Study|Other|2|||
162906150|NCT02996500|588353686|FG001|Overall Study|Other|0|||
162906151|NCT02996500|588353687|FG002|Overall Study|Other|2|||
162906152|NCT02996500|588353688|FG003|Overall Study|Other|0|||
162906153|NCT02996500|588353689|FG004|Overall Study|Other|0|||
162906154|NCT02996500|588353690|FG005|Overall Study|Other|0|||
162906155|NCT02996500|588353685|FG000|Overall Study|Protocol Violation|0|||
162906156|NCT02996500|588353686|FG001|Overall Study|Protocol Violation|0|||
163053979|NCT01673178|588908477|FG003|Overall Study|Other|1|||
162906157|NCT02996500|588353687|FG002|Overall Study|Protocol Violation|0|||
162906158|NCT02996500|588353688|FG003|Overall Study|Protocol Violation|1|||
162906159|NCT02996500|588353689|FG004|Overall Study|Protocol Violation|0|||
162906160|NCT02996500|588353690|FG005|Overall Study|Protocol Violation|0|||
162906161|NCT02996500|588353685|FG000|Overall Study|Withdrawal by Subject|3|||
162906162|NCT02996500|588353686|FG001|Overall Study|Withdrawal by Subject|0|||
163053980|NCT01673178|588908478|FG004|Overall Study|Other|0|||
163053981|NCT03177148|588908479|FG000|Overall Study|Lost to Follow-up|50|||
163053982|NCT03177148|588908480|FG001|Overall Study|Lost to Follow-up|1|||
163053983|NCT03177148|588908479|FG000|Overall Study|Death|1|||
163053984|NCT03177148|588908480|FG001|Overall Study|Death|0|||
163053985|NCT02848664|588908484|FG000|Overall Study|Withdrawal by Subject|2|||
163053986|NCT02848664|588908484|FG000|Overall Study|Adverse Event|1|||
163053987|NCT02848664|588908484|FG000|Overall Study|no assistance for device training|1|||
163053988|NCT03139552|588908491|FG000|Overall Study|unable to attend tasting due to schedule|3|||
163053989|NCT00780975|588908498|FG000|Overall Study|Progressive disease|3|||
163053990|NCT00780975|588908498|FG000|Overall Study|Toxicity|5|||
163053991|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
163053992|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
163053993|NCT00887484|588908499|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
163053994|NCT01061606|588908500|FG000|Overall Study|Adverse Event|1|||
163053995|NCT01061606|588908500|FG000|Overall Study|Death|1|||
163053996|NCT01061606|588908500|FG000|Overall Study|Disease Progression|4|||
163053997|NCT01061606|588908500|FG000|Overall Study|alternative therapy|2|||
163053998|NCT03044314|588908501|FG000|Overall Study|Physician Decision|2|||
163053999|NCT03044314|588908501|FG000|Overall Study|Withdrawal by Subject|1|||
163054000|NCT03044314|588908501|FG000|Overall Study|Connector tubing not available|1|||
163054001|NCT03122171|588908502|FG000|Overall Study|Withdrawal by Subject|1|||
163054002|NCT01316224|588908503|FG000|Overall Study|Protocol Violation|3|||
163054003|NCT01316224|588908503|FG000|Overall Study|Adverse Event|3|||
163054004|NCT01316224|588908503|FG000|Overall Study|Lack of Efficacy|1|||
163054005|NCT01316224|588908503|FG000|Overall Study|Withdrawal by Subject|1|||
163054006|NCT01316224|588908503|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
163054007|NCT01316224|588908503|FG000|Overall Study|Other|1|||
163054008|NCT00264147|588908504|FG000|Treatment I Period|Adverse Event|3|||
163054009|NCT00264147|588908505|FG001|Treatment I Period|Adverse Event|6|||
162626114|NCT01706146|587346984|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
162626115|NCT02582983|587346988|FG000|Overall Study|Death|3|||
162626116|NCT02582983|587346988|FG000|Overall Study|Withdrawal by Subject|2|||
162626117|NCT02582983|587346988|FG000|Overall Study|Adverse Event|1|||
162626118|NCT04377620|587346989|FG000|Overall Study|Death|42|||
162626119|NCT04377620|587346990|FG001|Overall Study|Death|48|||
162626120|NCT04377620|587346991|FG002|Overall Study|Death|36|||
162626121|NCT04377620|587346989|FG000|Overall Study|Withdrawal by Subject|0|||
162967236|NCT01011335|588581275|FG000|Overall Study|Adverse Event|0|||
162967237|NCT01011335|588581276|FG001|Overall Study|Adverse Event|0|||
162967238|NCT01011335|588581277|FG002|Overall Study|Adverse Event|0|||
162967239|NCT01011335|588581278|FG003|Overall Study|Adverse Event|0|||
162967240|NCT01011335|588581279|FG004|Overall Study|Adverse Event|0|||
162967241|NCT01011335|588581280|FG005|Overall Study|Adverse Event|0|||
162967242|NCT01011335|588581281|FG006|Overall Study|Adverse Event|0|||
162967243|NCT01011335|588581282|FG007|Overall Study|Adverse Event|0|||
162967244|NCT01011335|588581283|FG008|Overall Study|Adverse Event|0|||
162967245|NCT01011335|588581284|FG009|Overall Study|Adverse Event|0|||
162967246|NCT01011335|588581285|FG010|Overall Study|Adverse Event|4|||
162967247|NCT01011335|588581286|FG011|Overall Study|Adverse Event|0|||
162626122|NCT04377620|587346990|FG001|Overall Study|Withdrawal by Subject|2|||
162626123|NCT04377620|587346991|FG002|Overall Study|Withdrawal by Subject|0|||
162967248|NCT01011335|588581287|FG012|Overall Study|Adverse Event|1|||
162626124|NCT04930965|587346992|FG000|Overall Study|Lost to Follow-up|7|||
162626125|NCT04930965|587346993|FG001|Overall Study|Lost to Follow-up|5|||
162967249|NCT02435433|588581288|FG000|Overall Study|Withdrawal by Subject|2|||
163054010|NCT00264147|588908506|FG002|Treatment I Period|Adverse Event|3|||
163054011|NCT00264147|588908507|FG003|Treatment I Period|Adverse Event|5|||
162626126|NCT05209360|587346994|FG000|Overall Study|Withdrawal by Subject|0|||
162967250|NCT02435433|588581289|FG001|Overall Study|Withdrawal by Subject|3|||
163054012|NCT00264147|588908508|FG004|Treatment I Period|Adverse Event|7|||
162967251|NCT02435433|588581290|FG002|Overall Study|Withdrawal by Subject|1|||
162967252|NCT02435433|588581291|FG003|Overall Study|Withdrawal by Subject|0|||
162967253|NCT02435433|588581292|FG004|Overall Study|Withdrawal by Subject|0|||
162967254|NCT02435433|588581288|FG000|Overall Study|Lost to Follow-up|2|||
162967255|NCT02435433|588581289|FG001|Overall Study|Lost to Follow-up|2|||
162708848|NCT01515319|587642915|FG003|Overall Study|Protocol Violation|0|||
162708849|NCT01515319|587642916|FG004|Overall Study|Protocol Violation|0|||
162708850|NCT01515319|587642917|FG005|Overall Study|Protocol Violation|0|||
162708851|NCT01515319|587642918|FG006|Overall Study|Protocol Violation|0|||
162708852|NCT01515319|587642919|FG007|Overall Study|Protocol Violation|0|||
162708853|NCT01515319|587642920|FG008|Overall Study|Protocol Violation|2|||
162708854|NCT01515319|587642921|FG009|Overall Study|Protocol Violation|0|||
162708855|NCT01354106|587642922|FG000|Overall Study|Withdrawal by Subject|2|||
162708856|NCT01871285|587642923|FG000|First Intervention (1 Day)|Adverse Event|1|||
162708857|NCT01871285|587642924|FG001|First Intervention (1 Day)|Adverse Event|0|||
162708858|NCT01871285|587642925|FG002|First Intervention (1 Day)|Adverse Event|0|||
162708859|NCT01871285|587642926|FG003|First Intervention (1 Day)|Adverse Event|0|||
162708860|NCT01871285|587642923|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
162708861|NCT01871285|587642924|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
162708862|NCT01871285|587642925|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
162708863|NCT01871285|587642926|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
162708864|NCT05397470|587642927|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
162708865|NCT05397470|587642928|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
162708866|NCT05397470|587642929|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
162708867|NCT05397470|587642927|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
162708868|NCT05397470|587642928|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
162967256|NCT02435433|588581290|FG002|Overall Study|Lost to Follow-up|4|||
162967257|NCT02435433|588581291|FG003|Overall Study|Lost to Follow-up|1|||
162967258|NCT02435433|588581292|FG004|Overall Study|Lost to Follow-up|0|||
162967259|NCT01243151|588581293|FG000|Overall Study|Adverse Event|0|||
162967260|NCT01243151|588581294|FG001|Overall Study|Adverse Event|1|||
162967261|NCT01243151|588581295|FG002|Overall Study|Adverse Event|0|||
162967262|NCT01243151|588581296|FG003|Overall Study|Adverse Event|0|||
162967263|NCT01243151|588581297|FG004|Overall Study|Adverse Event|0|||
162967264|NCT01243151|588581293|FG000|Overall Study|Protocol Violation|0|||
162967265|NCT01243151|588581294|FG001|Overall Study|Protocol Violation|0|||
162967266|NCT01243151|588581295|FG002|Overall Study|Protocol Violation|1|||
162967267|NCT01243151|588581296|FG003|Overall Study|Protocol Violation|0|||
162967268|NCT01243151|588581297|FG004|Overall Study|Protocol Violation|0|||
162967269|NCT01243151|588581293|FG000|Overall Study|Other|0|||
162967270|NCT01243151|588581294|FG001|Overall Study|Other|0|||
162967271|NCT01243151|588581295|FG002|Overall Study|Other|0|||
162967272|NCT01243151|588581296|FG003|Overall Study|Other|1|||
162967273|NCT01243151|588581297|FG004|Overall Study|Other|0|||
162967274|NCT01243151|588581293|FG000|Overall Study|Randomized but not treated|0|||
162967275|NCT01243151|588581294|FG001|Overall Study|Randomized but not treated|0|||
162967276|NCT01243151|588581295|FG002|Overall Study|Randomized but not treated|0|||
162967277|NCT01243151|588581296|FG003|Overall Study|Randomized but not treated|1|||
162967278|NCT01243151|588581297|FG004|Overall Study|Randomized but not treated|0|||
162967279|NCT03119662|588581298|FG000|Overall Study|Withdrawal by Subject|0|||
162967280|NCT03119662|588581299|FG001|Overall Study|Withdrawal by Subject|1|||
162708869|NCT05397470|587642929|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
162967281|NCT02817828|588581300|FG000|Overall Study|Lost to Follow-up|41|||
162967282|NCT02817828|588581300|FG000|Overall Study|Adverse event not related to bleeding|104|||
162967283|NCT02817828|588581300|FG000|Overall Study|Adverse event related to bleeding|53|||
162906163|NCT02996500|588353687|FG002|Overall Study|Withdrawal by Subject|3|||
162906164|NCT02996500|588353688|FG003|Overall Study|Withdrawal by Subject|0|||
162906165|NCT02996500|588353689|FG004|Overall Study|Withdrawal by Subject|2|||
162906166|NCT02996500|588353690|FG005|Overall Study|Withdrawal by Subject|0|||
162626127|NCT05209360|587346995|FG001|Overall Study|Withdrawal by Subject|0|||
162906167|NCT02187224|588353691|FG000|Overall Study|Did not show up for test day|1|||
162906168|NCT02187224|588353692|FG001|Overall Study|Did not show up for test day|0|||
162906169|NCT01010776|588353697|FG000|Main Phase|Withdrawal by Subject|14|||
162626128|NCT05209360|587346996|FG002|Overall Study|Withdrawal by Subject|1|||
162906170|NCT01010776|588353697|FG000|Main Phase|Lack of Efficacy|8|||
162906171|NCT01010776|588353697|FG000|Main Phase|Adverse Event|7|||
163054013|NCT00264147|588908509|FG005|Treatment I Period|Adverse Event|0|||
163054014|NCT00264147|588908504|FG000|Treatment I Period|Laboratory Adverse Event|0|||
163054015|NCT00264147|588908505|FG001|Treatment I Period|Laboratory Adverse Event|0|||
163054016|NCT00264147|588908506|FG002|Treatment I Period|Laboratory Adverse Event|0|||
163054017|NCT00264147|588908507|FG003|Treatment I Period|Laboratory Adverse Event|1|||
163054018|NCT00264147|588908508|FG004|Treatment I Period|Laboratory Adverse Event|0|||
163054019|NCT00264147|588908509|FG005|Treatment I Period|Laboratory Adverse Event|0|||
163054020|NCT00264147|588908504|FG000|Treatment I Period|Lack of Efficacy|6|||
163054021|NCT00264147|588908505|FG001|Treatment I Period|Lack of Efficacy|2|||
163054022|NCT00264147|588908506|FG002|Treatment I Period|Lack of Efficacy|8|||
163054023|NCT00264147|588908507|FG003|Treatment I Period|Lack of Efficacy|0|||
163054024|NCT00264147|588908508|FG004|Treatment I Period|Lack of Efficacy|1|||
163054025|NCT00264147|588908509|FG005|Treatment I Period|Lack of Efficacy|0|||
163054026|NCT00264147|588908504|FG000|Treatment I Period|Lost to Follow-up|1|||
163054027|NCT00264147|588908505|FG001|Treatment I Period|Lost to Follow-up|0|||
162626129|NCT05209360|587346997|FG003|Overall Study|Withdrawal by Subject|0|||
162626130|NCT05209360|587346998|FG004|Overall Study|Withdrawal by Subject|0|||
162626131|NCT05209360|587346999|FG005|Overall Study|Withdrawal by Subject|0|||
162626132|NCT04189081|587347001|FG000|Overall Study|Lost to Follow-up|1|||
162626133|NCT04189081|587347002|FG001|Overall Study|Lost to Follow-up|0|||
162626134|NCT04189081|587347003|FG002|Overall Study|Lost to Follow-up|0|||
162626135|NCT04189081|587347001|FG000|Overall Study|Withdrawal by Subject|0|||
162626136|NCT04189081|587347002|FG001|Overall Study|Withdrawal by Subject|0|||
162626137|NCT04189081|587347003|FG002|Overall Study|Withdrawal by Subject|1|||
162626138|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
162626139|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
162906172|NCT01010776|588353697|FG000|Main Phase|Lost to Follow-up|6|||
163054028|NCT00264147|588908506|FG002|Treatment I Period|Lost to Follow-up|0|||
163054029|NCT00264147|588908507|FG003|Treatment I Period|Lost to Follow-up|1|||
163054030|NCT00264147|588908508|FG004|Treatment I Period|Lost to Follow-up|1|||
163054031|NCT00264147|588908509|FG005|Treatment I Period|Lost to Follow-up|0|||
163054032|NCT00264147|588908504|FG000|Treatment I Period|Protocol Violation|2|||
163054033|NCT00264147|588908505|FG001|Treatment I Period|Protocol Violation|2|||
163054034|NCT00264147|588908506|FG002|Treatment I Period|Protocol Violation|0|||
163054035|NCT00264147|588908507|FG003|Treatment I Period|Protocol Violation|0|||
163054036|NCT00264147|588908508|FG004|Treatment I Period|Protocol Violation|0|||
163054037|NCT00264147|588908509|FG005|Treatment I Period|Protocol Violation|0|||
163054038|NCT00264147|588908504|FG000|Treatment I Period|Withdrawal by Subject|2|||
163054039|NCT00264147|588908505|FG001|Treatment I Period|Withdrawal by Subject|0|||
163054040|NCT00264147|588908506|FG002|Treatment I Period|Withdrawal by Subject|0|||
163054041|NCT00264147|588908507|FG003|Treatment I Period|Withdrawal by Subject|2|||
163054042|NCT00264147|588908508|FG004|Treatment I Period|Withdrawal by Subject|2|||
163054043|NCT00264147|588908509|FG005|Treatment I Period|Withdrawal by Subject|0|||
163054044|NCT00264147|588908504|FG000|Treatment I Period|Patient out of town for an extended time|0|||
163054045|NCT00264147|588908505|FG001|Treatment I Period|Patient out of town for an extended time|1|||
163054046|NCT00264147|588908506|FG002|Treatment I Period|Patient out of town for an extended time|0|||
163054047|NCT00264147|588908507|FG003|Treatment I Period|Patient out of town for an extended time|0|||
163054048|NCT00264147|588908508|FG004|Treatment I Period|Patient out of town for an extended time|0|||
163054049|NCT00264147|588908509|FG005|Treatment I Period|Patient out of town for an extended time|0|||
163054050|NCT00264147|588908504|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054051|NCT00264147|588908505|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054052|NCT00264147|588908506|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
163054053|NCT00264147|588908507|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054054|NCT00264147|588908508|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054055|NCT00264147|588908509|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
163054056|NCT00264147|588908504|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
163054057|NCT00264147|588908505|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
163054058|NCT00264147|588908506|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
163054059|NCT00264147|588908507|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
163054060|NCT00264147|588908508|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
163054061|NCT00264147|588908509|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
162708870|NCT05397470|587642927|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
162708871|NCT05397470|587642928|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
162708872|NCT05397470|587642929|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
162708873|NCT05397470|587642927|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
162708874|NCT05397470|587642928|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
162708875|NCT05397470|587642929|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
162708876|NCT05397470|587642927|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
162708877|NCT05397470|587642928|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
162708878|NCT05397470|587642929|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
162708879|NCT05397470|587642927|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
162708880|NCT05397470|587642928|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
162708881|NCT05397470|587642929|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
162708882|NCT05397470|587642927|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
162708883|NCT05397470|587642928|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
162708884|NCT05397470|587642929|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
162708885|NCT01919619|587642930|FG000|Overall Study|Physician Decision|1|||
162708886|NCT01919619|587642931|FG001|Overall Study|Physician Decision|1|||
162708887|NCT01257503|587644785|FG000|Overall Study|Lost to Follow-up|7|||
162708888|NCT01257503|587644786|FG001|Overall Study|Lost to Follow-up|10|||
162708889|NCT01257503|587644785|FG000|Overall Study|Over 5 years old at enrollment|0|||
162708890|NCT01257503|587644786|FG001|Overall Study|Over 5 years old at enrollment|1|||
162708891|NCT01257503|587644785|FG000|Overall Study|strep culture positive at enrollment|1|||
162708892|NCT01257503|587644786|FG001|Overall Study|strep culture positive at enrollment|0|||
162708893|NCT02333630|587644787|FG000|Overall Study|Lost to Follow-up|5|||
162708894|NCT02333630|587644788|FG001|Overall Study|Lost to Follow-up|2|||
162708895|NCT00315055|587644789|FG000|Overall Study|Protocol Violation|2|||
162708896|NCT00315055|587644790|FG001|Overall Study|Protocol Violation|4|||
162708897|NCT00315055|587644789|FG000|Overall Study|Lost to Follow-up|1|||
162708898|NCT00315055|587644790|FG001|Overall Study|Lost to Follow-up|1|||
162708899|NCT02359435|587644791|FG000|Overall Study|Lost to Follow-up|4|||
162708900|NCT02359435|587644792|FG001|Overall Study|Lost to Follow-up|4|||
162708901|NCT02347943|587644794|FG000|Overall Study|Study was cancelled|140|||
162708902|NCT02347943|587644795|FG001|Overall Study|Study was cancelled|67|||
162708903|NCT02347943|587644796|FG002|Overall Study|Study was cancelled|45|||
162708904|NCT00711646|587644801|FG000|Overall Study|Adverse Event|6|||
162708905|NCT00711646|587644802|FG001|Overall Study|Adverse Event|1|||
162708906|NCT00711646|587644801|FG000|Overall Study|Withdrawal by Subject|4|||
162708907|NCT00711646|587644802|FG001|Overall Study|Withdrawal by Subject|0|||
162708908|NCT00711646|587644801|FG000|Overall Study|Protocol Violation|0|||
162708909|NCT00711646|587644802|FG001|Overall Study|Protocol Violation|1|||
162708910|NCT00711646|587644801|FG000|Overall Study|Lost to Follow-up|1|||
162708911|NCT00711646|587644802|FG001|Overall Study|Lost to Follow-up|0|||
162708912|NCT00711646|587644801|FG000|Overall Study|administrative decision|0|||
162708913|NCT00711646|587644802|FG001|Overall Study|administrative decision|1|||
162708914|NCT00711646|587644801|FG000|Overall Study|patient non-compliance|1|||
162708915|NCT00711646|587644802|FG001|Overall Study|patient non-compliance|0|||
162708916|NCT03441360|587644803|FG000|Overall Study|Radiological disease progression|5|||
162708917|NCT03441360|587644804|FG001|Overall Study|Radiological disease progression|6|||
162906173|NCT01010776|588353697|FG000|Main Phase|Non-compliance to study medication|5|||
162906174|NCT01010776|588353697|FG000|Main Phase|Selection failure|2|||
162906175|NCT01010776|588353697|FG000|Main Phase|Inform consent withdrawal|1|||
162906176|NCT01010776|588353697|FG000|Main Phase|Other|1|||
162906177|NCT01010776|588353697|FG000|Main Phase|Did not received study medication|5|||
162906178|NCT01010776|588353697|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
162906179|NCT01010776|588353697|FG000|Extension Phase|Other|3|||
162906180|NCT02332876|588353698|FG000|Overall Study|Lost to Follow-up|1|||
162906181|NCT02332876|588353699|FG001|Overall Study|Lost to Follow-up|1|||
162967284|NCT02817828|588581300|FG000|Overall Study|Protocol Violation|11|||
162967285|NCT02817828|588581300|FG000|Overall Study|Pregnancy|7|||
162967286|NCT02817828|588581300|FG000|Overall Study|Pregnancy wish|15|||
163054062|NCT00264147|588908504|FG000|Treatment II Period|Adverse Event|0|||
163054063|NCT00264147|588908505|FG001|Treatment II Period|Adverse Event|0|||
163054064|NCT00264147|588908506|FG002|Treatment II Period|Adverse Event|0|||
162708918|NCT03441360|587644805|FG002|Overall Study|Radiological disease progression|4|||
162708919|NCT03441360|587644803|FG000|Overall Study|Clinical disease progression|2|||
162708920|NCT03441360|587644804|FG001|Overall Study|Clinical disease progression|2|||
162708921|NCT03441360|587644805|FG002|Overall Study|Clinical disease progression|0|||
162708922|NCT03441360|587644803|FG000|Overall Study|Adverse Event|1|||
162708923|NCT03441360|587644804|FG001|Overall Study|Adverse Event|0|||
162708924|NCT03441360|587644805|FG002|Overall Study|Adverse Event|1|||
162708925|NCT01360840|587644806|FG000|Overall Study|Ongoing at data cut-off|10|||
162708926|NCT01360840|587644807|FG001|Overall Study|Ongoing at data cut-off|10|||
162708927|NCT01360840|587644808|FG002|Overall Study|Ongoing at data cut-off|9|||
162708928|NCT00688688|587644809|FG000|Overall Study|Eligibility criterion not met|7|||
162708929|NCT00688688|587644810|FG001|Overall Study|Eligibility criterion not met|7|||
162708930|NCT00688688|587644811|FG002|Overall Study|Eligibility criterion not met|10|||
162708931|NCT00688688|587644809|FG000|Overall Study|Adverse Event|52|||
162708932|NCT00688688|587644810|FG001|Overall Study|Adverse Event|51|||
162708933|NCT00688688|587644811|FG002|Overall Study|Adverse Event|50|||
162708934|NCT00688688|587644809|FG000|Overall Study|Lack of Efficacy|34|||
162708935|NCT00688688|587644810|FG001|Overall Study|Lack of Efficacy|25|||
162708936|NCT00688688|587644811|FG002|Overall Study|Lack of Efficacy|45|||
162708937|NCT00688688|587644809|FG000|Overall Study|Withdrawal by Subject|66|||
162708938|NCT00688688|587644810|FG001|Overall Study|Withdrawal by Subject|75|||
162708939|NCT00688688|587644811|FG002|Overall Study|Withdrawal by Subject|65|||
162708940|NCT00688688|587644809|FG000|Overall Study|Lost to Follow-up|14|||
162708941|NCT00688688|587644810|FG001|Overall Study|Lost to Follow-up|7|||
162708942|NCT00688688|587644811|FG002|Overall Study|Lost to Follow-up|7|||
162708943|NCT00688688|587644809|FG000|Overall Study|Protocol Violation|6|||
162708944|NCT00688688|587644810|FG001|Overall Study|Protocol Violation|9|||
162708945|NCT00688688|587644811|FG002|Overall Study|Protocol Violation|11|||
163054065|NCT00264147|588908507|FG003|Treatment II Period|Adverse Event|0|||
163054066|NCT00264147|588908508|FG004|Treatment II Period|Adverse Event|9|||
163054067|NCT00264147|588908509|FG005|Treatment II Period|Adverse Event|9|||
163054068|NCT00264147|588908504|FG000|Treatment II Period|Laboratory Adverse Event|0|||
163054069|NCT00264147|588908505|FG001|Treatment II Period|Laboratory Adverse Event|0|||
163054070|NCT00264147|588908506|FG002|Treatment II Period|Laboratory Adverse Event|0|||
163054071|NCT00264147|588908507|FG003|Treatment II Period|Laboratory Adverse Event|0|||
163054072|NCT00264147|588908508|FG004|Treatment II Period|Laboratory Adverse Event|0|||
163054073|NCT00264147|588908509|FG005|Treatment II Period|Laboratory Adverse Event|1|||
162708946|NCT00688688|587644809|FG000|Overall Study|Randomized but never received study drug|1|||
162708947|NCT00688688|587644810|FG001|Overall Study|Randomized but never received study drug|0|||
162708948|NCT00688688|587644811|FG002|Overall Study|Randomized but never received study drug|0|||
162708949|NCT00688688|587644809|FG000|Overall Study|Non-compliance with study procedures|5|||
162708950|NCT00688688|587644810|FG001|Overall Study|Non-compliance with study procedures|3|||
162708951|NCT00688688|587644811|FG002|Overall Study|Non-compliance with study procedures|4|||
162708952|NCT00688688|587644809|FG000|Overall Study|Taking exclusionary medications|1|||
163054074|NCT00264147|588908504|FG000|Treatment II Period|Lack of Efficacy|0|||
163054075|NCT00264147|588908505|FG001|Treatment II Period|Lack of Efficacy|0|||
163054076|NCT00264147|588908506|FG002|Treatment II Period|Lack of Efficacy|0|||
163054077|NCT00264147|588908507|FG003|Treatment II Period|Lack of Efficacy|0|||
162708953|NCT00688688|587644810|FG001|Overall Study|Taking exclusionary medications|0|||
162708954|NCT00688688|587644811|FG002|Overall Study|Taking exclusionary medications|0|||
162708955|NCT00688688|587644809|FG000|Overall Study|Site closure|0|||
162708956|NCT00688688|587644810|FG001|Overall Study|Site closure|1|||
162708957|NCT00688688|587644811|FG002|Overall Study|Site closure|0|||
162708958|NCT00688688|587644809|FG000|Overall Study|Violation of exclusion criterion|0|||
162708959|NCT00688688|587644810|FG001|Overall Study|Violation of exclusion criterion|1|||
162708960|NCT00688688|587644811|FG002|Overall Study|Violation of exclusion criterion|0|||
162708961|NCT01237678|587644814|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
162708962|NCT01237678|587644815|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
162708963|NCT01237678|587644816|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
162708964|NCT01237678|587644814|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
163054078|NCT00264147|588908508|FG004|Treatment II Period|Lack of Efficacy|20|||
162708965|NCT01237678|587644815|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
162708966|NCT01237678|587644816|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
162708967|NCT01237678|587644814|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
162708968|NCT01237678|587644815|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
163054079|NCT00264147|588908509|FG005|Treatment II Period|Lack of Efficacy|19|||
163054080|NCT00264147|588908504|FG000|Treatment II Period|Lost to Follow-up|0|||
163054081|NCT00264147|588908505|FG001|Treatment II Period|Lost to Follow-up|0|||
163054082|NCT00264147|588908506|FG002|Treatment II Period|Lost to Follow-up|0|||
163054083|NCT00264147|588908507|FG003|Treatment II Period|Lost to Follow-up|0|||
163054084|NCT00264147|588908508|FG004|Treatment II Period|Lost to Follow-up|1|||
163054085|NCT00264147|588908509|FG005|Treatment II Period|Lost to Follow-up|1|||
163054086|NCT00264147|588908504|FG000|Treatment II Period|Withdrawal by Subject|0|||
163054087|NCT00264147|588908505|FG001|Treatment II Period|Withdrawal by Subject|0|||
163054088|NCT00264147|588908506|FG002|Treatment II Period|Withdrawal by Subject|0|||
163054089|NCT00264147|588908507|FG003|Treatment II Period|Withdrawal by Subject|0|||
162708969|NCT01237678|587644816|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
162708970|NCT01237678|587644814|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
162708971|NCT01237678|587644815|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
162708972|NCT01237678|587644816|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
162708973|NCT01237678|587644814|FG000|Phase II|Adverse Event|0|||
162708974|NCT01237678|587644815|FG001|Phase II|Adverse Event|39|||
162708975|NCT01237678|587644816|FG002|Phase II|Adverse Event|9|||
162708976|NCT01237678|587644814|FG000|Phase II|Death|0|||
162708977|NCT01237678|587644815|FG001|Phase II|Death|0|||
163054090|NCT00264147|588908508|FG004|Treatment II Period|Withdrawal by Subject|3|||
162708978|NCT01237678|587644816|FG002|Phase II|Death|2|||
162708979|NCT01237678|587644814|FG000|Phase II|Lack of Efficacy|0|||
162708980|NCT01237678|587644815|FG001|Phase II|Lack of Efficacy|25|||
162708981|NCT01237678|587644816|FG002|Phase II|Lack of Efficacy|3|||
162708982|NCT01237678|587644814|FG000|Phase II|Withdrawal by Subject|0|||
162708983|NCT01237678|587644815|FG001|Phase II|Withdrawal by Subject|1|||
162708984|NCT01237678|587644816|FG002|Phase II|Withdrawal by Subject|5|||
162708985|NCT01237678|587644814|FG000|Phase II|Completed Cycles 4-6|0|||
162708986|NCT01237678|587644815|FG001|Phase II|Completed Cycles 4-6|11|||
162708987|NCT01237678|587644816|FG002|Phase II|Completed Cycles 4-6|21|||
162708988|NCT01237678|587644814|FG000|Phase II|Sponsor Decision/Study Closed|0|||
162708989|NCT01237678|587644815|FG001|Phase II|Sponsor Decision/Study Closed|18|||
162708990|NCT01237678|587644816|FG002|Phase II|Sponsor Decision/Study Closed|7|||
162708991|NCT01237678|587644814|FG000|Phase II|Randomized but were not treated|0|||
162708992|NCT01237678|587644815|FG001|Phase II|Randomized but were not treated|4|||
162708993|NCT01237678|587644816|FG002|Phase II|Randomized but were not treated|3|||
162708994|NCT01982760|587644819|FG000|Overall Study|Physician Decision|1|||
162708995|NCT01982760|587644820|FG001|Overall Study|Physician Decision|0|||
162708996|NCT00530777|587644821|FG000|Overall Study|Lost to Follow-up|0|||
162708997|NCT00530777|587644822|FG001|Overall Study|Lost to Follow-up|1|||
162708998|NCT00530777|587644821|FG000|Overall Study|Death|1|||
162708999|NCT00530777|587644822|FG001|Overall Study|Death|2|||
162709000|NCT00530777|587644821|FG000|Overall Study|Physician Decision|1|||
162709001|NCT00530777|587644822|FG001|Overall Study|Physician Decision|0|||
162709002|NCT00530777|587644821|FG000|Overall Study|Withdrawal by Subject|0|||
162709003|NCT00530777|587644822|FG001|Overall Study|Withdrawal by Subject|1|||
162709004|NCT00530777|587644821|FG000|Overall Study|Unable to adhere to visit schedule|5|||
162709005|NCT00530777|587644822|FG001|Overall Study|Unable to adhere to visit schedule|1|||
162709006|NCT02954055|587644824|FG000|Overall Study|Did not initiate therapy|6|||
162967287|NCT02817828|588581300|FG000|Overall Study|Withdrawal by Subject|78|||
162967288|NCT02817828|588581300|FG000|Overall Study|Other|26|||
162967289|NCT00522041|588581302|FG000|Overall Study|Adverse Event|9|||
162967290|NCT00522041|588581303|FG001|Overall Study|Adverse Event|3|||
162967291|NCT00522041|588581302|FG000|Overall Study|Protocol Violation|2|||
162967292|NCT00522041|588581303|FG001|Overall Study|Protocol Violation|0|||
162967293|NCT00522041|588581302|FG000|Overall Study|Lost to Follow-up|1|||
162967294|NCT00522041|588581303|FG001|Overall Study|Lost to Follow-up|4|||
162967295|NCT00522041|588581302|FG000|Overall Study|Voluntary withdrawal|5|||
162967296|NCT00522041|588581303|FG001|Overall Study|Voluntary withdrawal|4|||
162967297|NCT00522041|588581302|FG000|Overall Study|Did not receive treatment|0|||
162967298|NCT00522041|588581303|FG001|Overall Study|Did not receive treatment|1|||
162967299|NCT01579006|588581304|FG000|Overall Study|Lack of Efficacy|10|||
162967300|NCT01579006|588581304|FG000|Overall Study|Adverse Event|13|||
162967301|NCT01579006|588581304|FG000|Overall Study|Withdrawal by Subject|5|||
162967302|NCT01579006|588581304|FG000|Overall Study|Non-compliance|3|||
162967303|NCT01579006|588581304|FG000|Overall Study|Due to participant's health fund|1|||
162967304|NCT01579006|588581304|FG000|Overall Study|Scheduled surgery|1|||
162967305|NCT00799708|588581308|FG000|Overall Study|non-compliance|1|||
162967306|NCT00799708|588581309|FG001|Overall Study|non-compliance|0|||
162967307|NCT00799708|588581310|FG002|Overall Study|non-compliance|0|||
162967308|NCT03343639|588581311|FG000|Overall Study|Withdrawal by Subject|10|||
162967309|NCT03343639|588581312|FG001|Overall Study|Withdrawal by Subject|6|||
162967310|NCT03343639|588581311|FG000|Overall Study|Lost to Follow-up|4|||
162967311|NCT03343639|588581312|FG001|Overall Study|Lost to Follow-up|5|||
162967312|NCT03343639|588581311|FG000|Overall Study|Protocol Violation|0|||
162967313|NCT03343639|588581312|FG001|Overall Study|Protocol Violation|1|||
162709007|NCT02954055|587644825|FG001|Overall Study|Did not initiate therapy|1|||
162967314|NCT00735696|588581315|FG000|Overall Study|Withdrawal by Subject|1|||
162967315|NCT00735696|588581315|FG000|Overall Study|Enrolled but never Treated|1|||
162967316|NCT01192776|588581316|FG000|Overall Study|Death|8|||
162967317|NCT01192776|588581317|FG001|Overall Study|Death|15|||
162967318|NCT01192776|588581318|FG002|Overall Study|Death|18|||
163054091|NCT00264147|588908509|FG005|Treatment II Period|Withdrawal by Subject|2|||
163054092|NCT00264147|588908504|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054093|NCT00264147|588908505|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054094|NCT00264147|588908506|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054095|NCT00264147|588908507|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054096|NCT00264147|588908508|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
163054097|NCT00264147|588908509|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
163054098|NCT03234465|588908510|FG000|Overall Study|Adverse Event|4|||
163054099|NCT03234465|588908511|FG001|Overall Study|Adverse Event|2|||
163054100|NCT03234465|588908510|FG000|Overall Study|Death|0|||
163054101|NCT03234465|588908511|FG001|Overall Study|Death|1|||
163054102|NCT03234465|588908510|FG000|Overall Study|Lost to Follow-up|1|||
163054103|NCT03234465|588908511|FG001|Overall Study|Lost to Follow-up|1|||
163054104|NCT03234465|588908510|FG000|Overall Study|Withdrawal by Subject|12|||
163054105|NCT03234465|588908511|FG001|Overall Study|Withdrawal by Subject|27|||
163054106|NCT03234465|588908510|FG000|Overall Study|Symptomatic deterioration|0|||
163054107|NCT03234465|588908511|FG001|Overall Study|Symptomatic deterioration|1|||
163054108|NCT03234465|588908510|FG000|Overall Study|Non-compliance|2|||
163054109|NCT03234465|588908511|FG001|Overall Study|Non-compliance|0|||
163054110|NCT03234465|588908510|FG000|Overall Study|Other|14|||
163054111|NCT03234465|588908511|FG001|Overall Study|Other|8|||
163054112|NCT01274533|588908516|FG000|Overall Study|Withdrawal by Subject|1|||
163054113|NCT01274533|588908516|FG000|Overall Study|Non-compliance|1|||
163054114|NCT01274533|588908516|FG000|Overall Study|Disease progression|2|||
163054115|NCT02563899|588908517|FG000|Overall Study|Protocol Violation|1|||
162626140|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
162626141|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
162626142|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
162626143|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
162626144|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
162626145|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
162626146|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
162626147|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
162626148|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
162626149|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
162626150|NCT00044083|587347004|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
162626151|NCT00044083|587347005|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
162626152|NCT00044083|587347004|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
162626153|NCT00044083|587347005|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
162626154|NCT00044083|587347004|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
162626155|NCT00044083|587347005|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
162626156|NCT00044083|587347004|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
162626157|NCT00044083|587347005|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
162626158|NCT00444912|587347006|FG000|Overall Study|Death|1|||
162626159|NCT00444912|587347007|FG001|Overall Study|Death|2|||
162626160|NCT00444912|587347006|FG000|Overall Study|Lost to Follow-up|1|||
162626161|NCT00444912|587347007|FG001|Overall Study|Lost to Follow-up|0|||
163054116|NCT02563899|588908518|FG001|Overall Study|Protocol Violation|0|||
163054117|NCT02563899|588908519|FG002|Overall Study|Protocol Violation|0|||
163054118|NCT02563899|588908520|FG003|Overall Study|Protocol Violation|0|||
163054119|NCT02563899|588908517|FG000|Overall Study|Withdrawal by Subject|0|||
163054120|NCT02563899|588908518|FG001|Overall Study|Withdrawal by Subject|0|||
163054121|NCT02563899|588908519|FG002|Overall Study|Withdrawal by Subject|1|||
163054122|NCT02563899|588908520|FG003|Overall Study|Withdrawal by Subject|0|||
163054123|NCT00369343|588908533|FG000|Double-blind Phase|Adverse Event|19|||
163054124|NCT00369343|588908534|FG001|Double-blind Phase|Adverse Event|4|||
163054125|NCT00369343|588908533|FG000|Double-blind Phase|Failed to return|2|||
163054126|NCT00369343|588908534|FG001|Double-blind Phase|Failed to return|0|||
163054127|NCT00369343|588908533|FG000|Double-blind Phase|Lost to Follow-up|9|||
163054128|NCT00369343|588908534|FG001|Double-blind Phase|Lost to Follow-up|2|||
163054129|NCT00369343|588908533|FG000|Double-blind Phase|Protocol Violation|2|||
163054130|NCT00369343|588908534|FG001|Double-blind Phase|Protocol Violation|0|||
163054131|NCT00369343|588908533|FG000|Double-blind Phase|Withdrawal by Subject|8|||
163054132|NCT00369343|588908534|FG001|Double-blind Phase|Withdrawal by Subject|6|||
162626162|NCT00444912|587347006|FG000|Overall Study|Participant Failed Mobilization|1|||
162626163|NCT00444912|587347007|FG001|Overall Study|Participant Failed Mobilization|0|||
162626164|NCT03758066|587347008|FG000|Overall Study|Lost to Follow-up|14|||
162626165|NCT03706079|587347014|FG000|Predecessor Study|Death|0|||
162626166|NCT03706079|587347015|FG001|Predecessor Study|Death|2|||
162626167|NCT03706079|587347016|FG002|Predecessor Study|Death|0|||
162626168|NCT03706079|587347017|FG003|Predecessor Study|Death|1|||
162626169|NCT03706079|587347018|FG004|Predecessor Study|Death|0|||
162626170|NCT03706079|587347019|FG005|Predecessor Study|Death|0|||
163054133|NCT00369343|588908533|FG000|Double-blind Phase|Lack of Efficacy|0|||
162709008|NCT01008748|587644826|FG000|Overall Study|Lost to Follow-up|80|||
162709009|NCT01008748|587644826|FG000|Overall Study|Other|1|||
162709010|NCT03251378|587644827|FG000|Overall Study|Death|3|||
162709011|NCT03251378|587644828|FG001|Overall Study|Death|2|||
162709012|NCT03251378|587644829|FG002|Overall Study|Death|3|||
162709013|NCT03251378|587644830|FG003|Overall Study|Death|30|||
162709014|NCT03251378|587644831|FG004|Overall Study|Death|24|||
162709015|NCT03251378|587644832|FG005|Overall Study|Death|12|||
162709016|NCT03251378|587644833|FG006|Overall Study|Death|12|||
162709017|NCT03251378|587644827|FG000|Overall Study|Lost to Follow-up|0|||
162709018|NCT03251378|587644828|FG001|Overall Study|Lost to Follow-up|0|||
162709019|NCT03251378|587644829|FG002|Overall Study|Lost to Follow-up|1|||
162626171|NCT03706079|587347014|FG000|Predecessor Study|Lost to Follow-up|5|||
162626172|NCT03706079|587347015|FG001|Predecessor Study|Lost to Follow-up|2|||
162626173|NCT03706079|587347016|FG002|Predecessor Study|Lost to Follow-up|0|||
162626174|NCT03706079|587347017|FG003|Predecessor Study|Lost to Follow-up|0|||
162709020|NCT03251378|587644830|FG003|Overall Study|Lost to Follow-up|3|||
162709021|NCT03251378|587644831|FG004|Overall Study|Lost to Follow-up|0|||
162709022|NCT03251378|587644832|FG005|Overall Study|Lost to Follow-up|0|||
162709023|NCT03251378|587644833|FG006|Overall Study|Lost to Follow-up|0|||
162709024|NCT03251378|587644827|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162709025|NCT03251378|587644828|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162709026|NCT03251378|587644829|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162709027|NCT03251378|587644830|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
162709028|NCT03251378|587644831|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
162709029|NCT03251378|587644832|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
162709030|NCT03251378|587644833|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
162709031|NCT03251378|587644827|FG000|Overall Study|Progressive disease|2|||
162626175|NCT03706079|587347018|FG004|Predecessor Study|Lost to Follow-up|1|||
162626176|NCT03706079|587347019|FG005|Predecessor Study|Lost to Follow-up|0|||
162626177|NCT03706079|587347014|FG000|Predecessor Study|Withdrawal by Subject|8|||
162626178|NCT03706079|587347015|FG001|Predecessor Study|Withdrawal by Subject|15|||
162709032|NCT03251378|587644828|FG001|Overall Study|Progressive disease|0|||
162709033|NCT03251378|587644829|FG002|Overall Study|Progressive disease|0|||
162709034|NCT03251378|587644830|FG003|Overall Study|Progressive disease|1|||
162709035|NCT03251378|587644831|FG004|Overall Study|Progressive disease|0|||
162709036|NCT03251378|587644832|FG005|Overall Study|Progressive disease|0|||
162709037|NCT03251378|587644833|FG006|Overall Study|Progressive disease|0|||
162709038|NCT03251378|587644827|FG000|Overall Study|Physician Decision|0|||
162709039|NCT03251378|587644828|FG001|Overall Study|Physician Decision|2|||
162709040|NCT03251378|587644829|FG002|Overall Study|Physician Decision|0|||
162709041|NCT03251378|587644830|FG003|Overall Study|Physician Decision|0|||
162709042|NCT03251378|587644831|FG004|Overall Study|Physician Decision|0|||
162709043|NCT03251378|587644832|FG005|Overall Study|Physician Decision|0|||
162709044|NCT03251378|587644833|FG006|Overall Study|Physician Decision|0|||
162709045|NCT03251378|587644827|FG000|Overall Study|Other|2|||
162709046|NCT03251378|587644828|FG001|Overall Study|Other|3|||
162709047|NCT03251378|587644829|FG002|Overall Study|Other|2|||
162709048|NCT03251378|587644830|FG003|Overall Study|Other|0|||
162709049|NCT03251378|587644831|FG004|Overall Study|Other|1|||
162709050|NCT03251378|587644832|FG005|Overall Study|Other|1|||
162709051|NCT03251378|587644833|FG006|Overall Study|Other|1|||
162709052|NCT03251378|587644827|FG000|Overall Study|Other|0|||
162709053|NCT03251378|587644828|FG001|Overall Study|Other|0|||
162709054|NCT03251378|587644829|FG002|Overall Study|Other|0|||
162709055|NCT03251378|587644830|FG003|Overall Study|Other|4|||
162709056|NCT03251378|587644831|FG004|Overall Study|Other|13|||
162709057|NCT03251378|587644832|FG005|Overall Study|Other|0|||
162709058|NCT03251378|587644833|FG006|Overall Study|Other|0|||
162709059|NCT05780047|587644834|FG000|Overall Study|Did not submit baseline urine test kit|226|||
162709060|NCT05780047|587644834|FG000|Overall Study|Lost to Follow-up|34|||
162709061|NCT05780047|587644834|FG000|Overall Study|Did not submit second urine test kit|124|||
162709062|NCT00764868|587644844|FG000|Overall Study|Adverse Event|18|||
162709063|NCT00764868|587644844|FG000|Overall Study|Withdrawal by Subject|31|||
162709064|NCT00764868|587644844|FG000|Overall Study|Non-compliance|16|||
162709065|NCT00764868|587644844|FG000|Overall Study|Lost to Follow-up|25|||
162709066|NCT00764868|587644844|FG000|Overall Study|Lack of Efficacy|5|||
162709067|NCT00764868|587644844|FG000|Overall Study|Subject moved|7|||
162709068|NCT00764868|587644844|FG000|Overall Study|Pregnancy|3|||
162709069|NCT00764868|587644844|FG000|Overall Study|Prohibited medication|1|||
162709070|NCT00764868|587644844|FG000|Overall Study|Out of town|1|||
162709071|NCT00764868|587644844|FG000|Overall Study|Misuse and compliance of study drug|1|||
162709072|NCT00764868|587644844|FG000|Overall Study|Subject sent to boarding school|1|||
162709073|NCT00764868|587644844|FG000|Overall Study|Met an exclusion criteria|1|||
162709074|NCT00764868|587644844|FG000|Overall Study|Positive drug screen|2|||
162709075|NCT00764868|587644844|FG000|Overall Study|Sponsor requested withdrawal|1|||
162709076|NCT00783692|587644845|FG000|Induction Phase|Adverse Event|7|||
162709077|NCT00783692|587644846|FG001|Induction Phase|Adverse Event|9|||
162709078|NCT00783692|587644847|FG002|Induction Phase|Adverse Event|24|||
162709079|NCT00783692|587644848|FG003|Induction Phase|Adverse Event|0|||
162709080|NCT00783692|587644849|FG004|Induction Phase|Adverse Event|0|||
162709081|NCT00783692|587644850|FG005|Induction Phase|Adverse Event|0|||
162709082|NCT00783692|587644851|FG006|Induction Phase|Adverse Event|0|||
162709083|NCT00783692|587644845|FG000|Induction Phase|Protocol Violation|0|||
162709084|NCT00783692|587644846|FG001|Induction Phase|Protocol Violation|0|||
162709085|NCT00783692|587644847|FG002|Induction Phase|Protocol Violation|1|||
162709086|NCT00783692|587644848|FG003|Induction Phase|Protocol Violation|0|||
162709087|NCT00783692|587644849|FG004|Induction Phase|Protocol Violation|0|||
162709088|NCT00783692|587644850|FG005|Induction Phase|Protocol Violation|0|||
162906182|NCT00415623|588353703|FG000|Overall Study|Adverse Event|3|||
162906183|NCT00415623|588353704|FG001|Overall Study|Adverse Event|4|||
162906184|NCT00415623|588353703|FG000|Overall Study|Death|1|||
162906185|NCT00415623|588353704|FG001|Overall Study|Death|0|||
162906186|NCT00415623|588353703|FG000|Overall Study|Withdrawal by Subject|1|||
162906187|NCT00415623|588353704|FG001|Overall Study|Withdrawal by Subject|1|||
162906188|NCT01369069|588353705|FG000|Overall Study|Lost to Follow-up|8|||
162906189|NCT01369069|588353706|FG001|Overall Study|Lost to Follow-up|9|||
162906190|NCT01369069|588353705|FG000|Overall Study|Withdrawal by Subject|9|||
162626179|NCT03706079|587347016|FG002|Predecessor Study|Withdrawal by Subject|0|||
162906191|NCT01369069|588353706|FG001|Overall Study|Withdrawal by Subject|7|||
162626180|NCT03706079|587347017|FG003|Predecessor Study|Withdrawal by Subject|5|||
162626181|NCT03706079|587347018|FG004|Predecessor Study|Withdrawal by Subject|2|||
162626182|NCT03706079|587347019|FG005|Predecessor Study|Withdrawal by Subject|0|||
162626183|NCT03706079|587347014|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
162626184|NCT03706079|587347015|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
162626185|NCT03706079|587347016|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162626186|NCT03706079|587347017|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162626187|NCT03706079|587347018|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162626188|NCT03706079|587347019|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162626189|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162626190|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162626191|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162626192|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162626193|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162626194|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
162626195|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
162626196|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162626197|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
162906192|NCT02573012|588353707|FG000|Overall Study|Adverse Event|5|||
162906193|NCT02573012|588353708|FG001|Overall Study|Adverse Event|5|||
163054134|NCT00369343|588908534|FG001|Double-blind Phase|Lack of Efficacy|4|||
163054135|NCT00369343|588908533|FG000|Double-blind Phase|Protocol deviation|4|||
163054136|NCT00369343|588908534|FG001|Double-blind Phase|Protocol deviation|0|||
163054137|NCT00369343|588908533|FG000|Open-label Phase|Adverse Event|19|||
163054138|NCT00369343|588908534|FG001|Open-label Phase|Adverse Event|7|||
163054139|NCT00369343|588908533|FG000|Open-label Phase|Failed to return|4|||
163054140|NCT00369343|588908534|FG001|Open-label Phase|Failed to return|0|||
163054141|NCT00369343|588908533|FG000|Open-label Phase|Physician Decision|2|||
163054142|NCT00369343|588908534|FG001|Open-label Phase|Physician Decision|0|||
163054143|NCT00369343|588908533|FG000|Open-label Phase|Lost to Follow-up|5|||
163054144|NCT00369343|588908534|FG001|Open-label Phase|Lost to Follow-up|3|||
163054145|NCT00369343|588908533|FG000|Open-label Phase|inadvertently reported study completers|3|||
163054146|NCT00369343|588908534|FG001|Open-label Phase|inadvertently reported study completers|2|||
163054147|NCT00369343|588908533|FG000|Open-label Phase|Protocol Violation|1|||
163054148|NCT00369343|588908534|FG001|Open-label Phase|Protocol Violation|3|||
163054149|NCT00369343|588908533|FG000|Open-label Phase|Withdrawal by Subject|15|||
163054150|NCT00369343|588908534|FG001|Open-label Phase|Withdrawal by Subject|6|||
163054151|NCT00369343|588908533|FG000|Open-label Phase|Lack of Efficacy|4|||
163054152|NCT00369343|588908534|FG001|Open-label Phase|Lack of Efficacy|3|||
163054153|NCT00369343|588908533|FG000|Open-label Phase|Lack of continuance tolerability|3|||
163054154|NCT00369343|588908534|FG001|Open-label Phase|Lack of continuance tolerability|4|||
163054155|NCT00369343|588908533|FG000|Open-label Phase|did not take study drug|1|||
163054156|NCT00369343|588908534|FG001|Open-label Phase|did not take study drug|2|||
163054157|NCT02322749|588908535|FG000|Period 2|Adverse Event|0|||
163054158|NCT02322749|588908536|FG001|Period 2|Adverse Event|0|||
163054159|NCT02322749|588908537|FG002|Period 2|Adverse Event|0|||
163054160|NCT02322749|588908538|FG003|Period 2|Adverse Event|1|||
163054161|NCT02322749|588908539|FG004|Period 2|Adverse Event|0|||
163054162|NCT02322749|588908540|FG005|Period 2|Adverse Event|0|||
163054163|NCT02322749|588908535|FG000|Period 2|Withdrawal by Subject|0|||
163054164|NCT02322749|588908536|FG001|Period 2|Withdrawal by Subject|0|||
163054165|NCT02322749|588908537|FG002|Period 2|Withdrawal by Subject|0|||
163054166|NCT02322749|588908538|FG003|Period 2|Withdrawal by Subject|1|||
163054167|NCT02322749|588908539|FG004|Period 2|Withdrawal by Subject|0|||
163054168|NCT02322749|588908540|FG005|Period 2|Withdrawal by Subject|0|||
163054169|NCT02322749|588908535|FG000|Period 3|Withdrawal by Subject|0|||
163054170|NCT02322749|588908536|FG001|Period 3|Withdrawal by Subject|0|||
163054171|NCT02322749|588908537|FG002|Period 3|Withdrawal by Subject|1|||
163054172|NCT02322749|588908538|FG003|Period 3|Withdrawal by Subject|0|||
163054173|NCT02322749|588908539|FG004|Period 3|Withdrawal by Subject|0|||
162709089|NCT00783692|587644851|FG006|Induction Phase|Protocol Violation|0|||
162709090|NCT00783692|587644845|FG000|Induction Phase|Lack of Efficacy|1|||
162709091|NCT00783692|587644846|FG001|Induction Phase|Lack of Efficacy|3|||
162709092|NCT00783692|587644847|FG002|Induction Phase|Lack of Efficacy|28|||
162709093|NCT00783692|587644848|FG003|Induction Phase|Lack of Efficacy|0|||
162709094|NCT00783692|587644849|FG004|Induction Phase|Lack of Efficacy|0|||
162709095|NCT00783692|587644850|FG005|Induction Phase|Lack of Efficacy|0|||
162709096|NCT00783692|587644851|FG006|Induction Phase|Lack of Efficacy|0|||
162709097|NCT00783692|587644845|FG000|Induction Phase|Withdrawal by Subject|3|||
162709098|NCT00783692|587644846|FG001|Induction Phase|Withdrawal by Subject|9|||
162709099|NCT00783692|587644847|FG002|Induction Phase|Withdrawal by Subject|16|||
162709100|NCT00783692|587644848|FG003|Induction Phase|Withdrawal by Subject|0|||
162709101|NCT00783692|587644849|FG004|Induction Phase|Withdrawal by Subject|0|||
162709102|NCT00783692|587644850|FG005|Induction Phase|Withdrawal by Subject|0|||
162709103|NCT00783692|587644851|FG006|Induction Phase|Withdrawal by Subject|0|||
162709104|NCT00783692|587644845|FG000|Induction Phase|Lost to Follow-up|0|||
162709105|NCT00783692|587644846|FG001|Induction Phase|Lost to Follow-up|0|||
163054174|NCT02322749|588908540|FG005|Period 3|Withdrawal by Subject|0|||
162709106|NCT00783692|587644847|FG002|Induction Phase|Lost to Follow-up|3|||
162709107|NCT00783692|587644848|FG003|Induction Phase|Lost to Follow-up|0|||
162709108|NCT00783692|587644849|FG004|Induction Phase|Lost to Follow-up|0|||
162709109|NCT00783692|587644850|FG005|Induction Phase|Lost to Follow-up|0|||
162709110|NCT00783692|587644851|FG006|Induction Phase|Lost to Follow-up|0|||
162709111|NCT00783692|587644845|FG000|Induction Phase|Other|0|||
162709112|NCT00783692|587644846|FG001|Induction Phase|Other|0|||
162709113|NCT00783692|587644847|FG002|Induction Phase|Other|2|||
162709114|NCT00783692|587644848|FG003|Induction Phase|Other|0|||
162709115|NCT00783692|587644849|FG004|Induction Phase|Other|0|||
162709116|NCT00783692|587644850|FG005|Induction Phase|Other|0|||
162709117|NCT00783692|587644851|FG006|Induction Phase|Other|0|||
162709118|NCT00783692|587644845|FG000|Maintenance Phase|Adverse Event|7|||
162709119|NCT00783692|587644846|FG001|Maintenance Phase|Adverse Event|0|||
162709120|NCT00783692|587644847|FG002|Maintenance Phase|Adverse Event|0|||
162709121|NCT00783692|587644848|FG003|Maintenance Phase|Adverse Event|15|||
162709122|NCT00783692|587644849|FG004|Maintenance Phase|Adverse Event|12|||
162709123|NCT00783692|587644850|FG005|Maintenance Phase|Adverse Event|9|||
162709124|NCT00783692|587644851|FG006|Maintenance Phase|Adverse Event|38|||
162709125|NCT00783692|587644845|FG000|Maintenance Phase|Protocol Violation|0|||
162709126|NCT00783692|587644846|FG001|Maintenance Phase|Protocol Violation|0|||
162906194|NCT02573012|588353707|FG000|Overall Study|Lack of Efficacy|5|||
162906195|NCT02573012|588353708|FG001|Overall Study|Lack of Efficacy|4|||
162906196|NCT02573012|588353707|FG000|Overall Study|Non-compliance|1|||
162906197|NCT02573012|588353708|FG001|Overall Study|Non-compliance|2|||
162906198|NCT02573012|588353707|FG000|Overall Study|Withdrawal by Subject|2|||
162906199|NCT02573012|588353708|FG001|Overall Study|Withdrawal by Subject|2|||
162906200|NCT02573012|588353707|FG000|Overall Study|Study Ended per Protocol|1|||
162906201|NCT02573012|588353708|FG001|Overall Study|Study Ended per Protocol|0|||
162709127|NCT00783692|587644847|FG002|Maintenance Phase|Protocol Violation|0|||
162709128|NCT00783692|587644848|FG003|Maintenance Phase|Protocol Violation|1|||
162709129|NCT00783692|587644849|FG004|Maintenance Phase|Protocol Violation|2|||
162709130|NCT00783692|587644850|FG005|Maintenance Phase|Protocol Violation|3|||
162709131|NCT00783692|587644851|FG006|Maintenance Phase|Protocol Violation|4|||
162709132|NCT00783692|587644845|FG000|Maintenance Phase|Lack of Efficacy|79|||
162709133|NCT00783692|587644846|FG001|Maintenance Phase|Lack of Efficacy|0|||
162709134|NCT00783692|587644847|FG002|Maintenance Phase|Lack of Efficacy|0|||
162709135|NCT00783692|587644848|FG003|Maintenance Phase|Lack of Efficacy|64|||
162709136|NCT00783692|587644849|FG004|Maintenance Phase|Lack of Efficacy|58|||
162709137|NCT00783692|587644850|FG005|Maintenance Phase|Lack of Efficacy|48|||
162709138|NCT00783692|587644851|FG006|Maintenance Phase|Lack of Efficacy|177|||
162709139|NCT00783692|587644845|FG000|Maintenance Phase|Withdrawal by Subject|7|||
162709140|NCT00783692|587644846|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162709141|NCT00783692|587644847|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162709142|NCT00783692|587644848|FG003|Maintenance Phase|Withdrawal by Subject|7|||
162709143|NCT00783692|587644849|FG004|Maintenance Phase|Withdrawal by Subject|6|||
162709144|NCT00783692|587644850|FG005|Maintenance Phase|Withdrawal by Subject|9|||
162709145|NCT00783692|587644851|FG006|Maintenance Phase|Withdrawal by Subject|24|||
162709146|NCT00783692|587644845|FG000|Maintenance Phase|Lost to Follow-up|2|||
162709147|NCT00783692|587644846|FG001|Maintenance Phase|Lost to Follow-up|0|||
162709148|NCT00783692|587644847|FG002|Maintenance Phase|Lost to Follow-up|0|||
162709149|NCT00783692|587644848|FG003|Maintenance Phase|Lost to Follow-up|1|||
162709150|NCT00783692|587644849|FG004|Maintenance Phase|Lost to Follow-up|3|||
162709151|NCT00783692|587644850|FG005|Maintenance Phase|Lost to Follow-up|2|||
163054175|NCT02033759|588908543|FG000|Overall Study|Withdrawal by Subject|2|||
163054176|NCT02033759|588908544|FG001|Overall Study|Withdrawal by Subject|1|||
163054177|NCT02033759|588908543|FG000|Overall Study|Protocol Violation|1|||
163054178|NCT02033759|588908544|FG001|Overall Study|Protocol Violation|1|||
163054179|NCT04265261|588908553|FG000|Overall Study|Adverse Event|2|||
163054180|NCT04265261|588908554|FG001|Overall Study|Adverse Event|0|||
163054181|NCT04265261|588908555|FG002|Overall Study|Adverse Event|0|||
163054182|NCT04265261|588908553|FG000|Overall Study|Death|1|||
163054183|NCT04265261|588908554|FG001|Overall Study|Death|0|||
163054184|NCT04265261|588908555|FG002|Overall Study|Death|0|||
163054185|NCT04265261|588908553|FG000|Overall Study|Lost to Follow-up|4|||
163054186|NCT04265261|588908554|FG001|Overall Study|Lost to Follow-up|1|||
163054187|NCT04265261|588908555|FG002|Overall Study|Lost to Follow-up|3|||
163054188|NCT04265261|588908553|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163054189|NCT04265261|588908554|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163054190|NCT04265261|588908555|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163054191|NCT04265261|588908553|FG000|Overall Study|Physician Decision|0|||
163054192|NCT04265261|588908554|FG001|Overall Study|Physician Decision|0|||
163054193|NCT04265261|588908555|FG002|Overall Study|Physician Decision|1|||
163054194|NCT04265261|588908553|FG000|Overall Study|Protocol Deviation|0|||
163054195|NCT04265261|588908554|FG001|Overall Study|Protocol Deviation|2|||
163054196|NCT04265261|588908555|FG002|Overall Study|Protocol Deviation|0|||
162967319|NCT01192776|588581319|FG003|Overall Study|Death|15|||
162967320|NCT01192776|588581316|FG000|Overall Study|Lost to Follow-up|3|||
162967321|NCT01192776|588581317|FG001|Overall Study|Lost to Follow-up|6|||
162967322|NCT01192776|588581318|FG002|Overall Study|Lost to Follow-up|3|||
162967323|NCT01192776|588581319|FG003|Overall Study|Lost to Follow-up|5|||
162967324|NCT02587143|588581320|FG000|Overall Study|Adverse Event|1|||
162967325|NCT02587143|588581321|FG001|Overall Study|Adverse Event|0|||
162967326|NCT00611884|588581322|FG000|Overall Study|Adverse Event|1|||
162967327|NCT00611884|588581323|FG001|Overall Study|Adverse Event|0|||
162967328|NCT00611884|588581324|FG002|Overall Study|Adverse Event|0|||
162967329|NCT00611884|588581325|FG003|Overall Study|Adverse Event|1|||
162967330|NCT00611884|588581322|FG000|Overall Study|Non-Compliance|1|||
162967331|NCT00611884|588581323|FG001|Overall Study|Non-Compliance|4|||
162967332|NCT00611884|588581324|FG002|Overall Study|Non-Compliance|2|||
162967333|NCT00611884|588581325|FG003|Overall Study|Non-Compliance|2|||
162967334|NCT00611884|588581322|FG000|Overall Study|Lack of Efficacy|0|||
162967335|NCT00611884|588581323|FG001|Overall Study|Lack of Efficacy|1|||
162967336|NCT00611884|588581324|FG002|Overall Study|Lack of Efficacy|0|||
162967337|NCT00611884|588581325|FG003|Overall Study|Lack of Efficacy|0|||
162967338|NCT00611884|588581322|FG000|Overall Study|Unclassified|7|||
162967339|NCT00611884|588581323|FG001|Overall Study|Unclassified|4|||
162967340|NCT00611884|588581324|FG002|Overall Study|Unclassified|2|||
162967341|NCT00611884|588581325|FG003|Overall Study|Unclassified|3|||
162967342|NCT00981799|588581326|FG000|Overall Study|Adverse Event|1|||
162967343|NCT00981799|588581327|FG001|Overall Study|Adverse Event|1|||
162967344|NCT00981799|588581328|FG002|Overall Study|Adverse Event|0|||
162967345|NCT00981799|588581329|FG003|Overall Study|Adverse Event|0|||
163054197|NCT04265261|588908553|FG000|Overall Study|Withdrawal by Subject|2|||
163054198|NCT04265261|588908554|FG001|Overall Study|Withdrawal by Subject|1|||
163054199|NCT04265261|588908555|FG002|Overall Study|Withdrawal by Subject|4|||
163054200|NCT00499122|588910183|FG000|Overall Study|Withdrawal by Subject|2|||
163054201|NCT02466399|588910187|FG000|Overall Study|Adverse Event|1|||
163054202|NCT02466399|588910188|FG001|Overall Study|Adverse Event|0|||
163054203|NCT02466399|588910187|FG000|Overall Study|Early exit due to family emergency|1|||
163054204|NCT02466399|588910188|FG001|Overall Study|Early exit due to family emergency|0|||
163054205|NCT02669849|588910189|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163054206|NCT02669849|588910190|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163054207|NCT02669849|588910191|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
162626198|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162626199|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162626200|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162967346|NCT01055834|588581336|FG000|Treatment Period I|Adverse Event|1|||
162626201|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
162626202|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
162626203|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
162626204|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
162967347|NCT01055834|588581337|FG001|Treatment Period I|Adverse Event|0|||
162967348|NCT01943435|588581338|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
162967349|NCT01943435|588581339|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
162967350|NCT01943435|588581340|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
162967351|NCT01943435|588581338|FG000|Intervention Period|Withdrawal by Subject|3|||
162967352|NCT01943435|588581339|FG001|Intervention Period|Withdrawal by Subject|3|||
163054208|NCT02669849|588910189|FG000|Overall Study|Lost to Follow-up|1|||
163054209|NCT02669849|588910190|FG001|Overall Study|Lost to Follow-up|0|||
162709152|NCT00783692|587644851|FG006|Maintenance Phase|Lost to Follow-up|5|||
162709153|NCT00783692|587644845|FG000|Maintenance Phase|Other|0|||
162709154|NCT00783692|587644846|FG001|Maintenance Phase|Other|0|||
162709155|NCT00783692|587644847|FG002|Maintenance Phase|Other|0|||
162709156|NCT00783692|587644848|FG003|Maintenance Phase|Other|1|||
162709157|NCT00783692|587644849|FG004|Maintenance Phase|Other|0|||
162709158|NCT00783692|587644850|FG005|Maintenance Phase|Other|1|||
162709159|NCT00783692|587644851|FG006|Maintenance Phase|Other|1|||
162709160|NCT04438785|587644859|FG000|Overall Study|change of weight, give up intervention|2|||
162626205|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
162626206|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
162626207|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162626208|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162626209|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162709161|NCT04438785|587644860|FG001|Overall Study|change of weight, give up intervention|10|||
162709162|NCT04831775|587644861|FG000|Overall Study|Lost to Follow-up|11|||
162709163|NCT04831775|587644862|FG001|Overall Study|Lost to Follow-up|13|||
162709164|NCT02027935|587644863|FG000|Overall Study|Death|1|||
162709165|NCT02027935|587644863|FG000|Overall Study|Lack of Efficacy|5|||
162709166|NCT02027935|587644863|FG000|Overall Study|Study Closure|1|||
162709167|NCT03115346|587644864|FG000|Overall Study|Did not have AAA surgery|28|||
162906202|NCT02573012|588353707|FG000|Overall Study|Physician Decision|1|||
162906203|NCT02573012|588353708|FG001|Overall Study|Physician Decision|2|||
162906204|NCT00882362|588353709|FG000|Overall Study|Adverse Event|13|||
162906205|NCT00882362|588353710|FG001|Overall Study|Adverse Event|10|||
162906206|NCT00882362|588353709|FG000|Overall Study|Withdrawal by Subject|13|||
162906207|NCT00882362|588353710|FG001|Overall Study|Withdrawal by Subject|10|||
162906208|NCT00882362|588353709|FG000|Overall Study|Lack of Efficacy|3|||
162906209|NCT00882362|588353710|FG001|Overall Study|Lack of Efficacy|0|||
162906210|NCT00882362|588353709|FG000|Overall Study|Protocol Violation|7|||
162906211|NCT00882362|588353710|FG001|Overall Study|Protocol Violation|2|||
162626210|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
162626211|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162626212|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
162626213|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
162626214|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162626215|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162709168|NCT03115346|587644865|FG001|Overall Study|Did not have AAA surgery|15|||
162709169|NCT03115346|587644864|FG000|Overall Study|Death|3|||
162709170|NCT03115346|587644865|FG001|Overall Study|Death|1|||
162709171|NCT03115346|587644864|FG000|Overall Study|Withdrawal by Subject|0|||
162709172|NCT03115346|587644865|FG001|Overall Study|Withdrawal by Subject|3|||
162709173|NCT03115346|587644864|FG000|Overall Study|Lost to Follow-up|0|||
162709174|NCT03115346|587644865|FG001|Overall Study|Lost to Follow-up|3|||
162906212|NCT00882362|588353709|FG000|Overall Study|Pregnancy|1|||
162906213|NCT00882362|588353710|FG001|Overall Study|Pregnancy|0|||
162906214|NCT00882362|588353709|FG000|Overall Study|Physician Decision|5|||
162906215|NCT00882362|588353710|FG001|Overall Study|Physician Decision|1|||
162906216|NCT00882362|588353709|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
162906217|NCT00882362|588353710|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
162906218|NCT00882362|588353709|FG000|Overall Study|change of residence or other commitments|5|||
162906219|NCT00882362|588353710|FG001|Overall Study|change of residence or other commitments|0|||
162906220|NCT01268514|588353711|FG000|Overall Study|Adverse Event|20|||
162906221|NCT01268514|588353711|FG000|Overall Study|Death|8|||
162906222|NCT01268514|588353711|FG000|Overall Study|Lost to Follow-up|5|||
162906223|NCT01268514|588353711|FG000|Overall Study|Withdrawal by Subject|3|||
162626216|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
162626217|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162626218|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
162626219|NCT03706079|587347014|FG000|Long Term Extension (DESTINATION)|Death|8|||
162626220|NCT03706079|587347015|FG001|Long Term Extension (DESTINATION)|Death|2|||
162626221|NCT03706079|587347016|FG002|Long Term Extension (DESTINATION)|Death|2|||
162626222|NCT03706079|587347017|FG003|Long Term Extension (DESTINATION)|Death|1|||
162906224|NCT01268514|588353711|FG000|Overall Study|Withdrawal by Surgeon|5|||
162906225|NCT02382276|588353714|FG000|Overall Study|Withdrawal by Subject|4|||
162709175|NCT00689104|587644866|FG000|Overall Study|Eligibility criterion not met|5|||
162709176|NCT00689104|587644867|FG001|Overall Study|Eligibility criterion not met|8|||
162709177|NCT00689104|587644868|FG002|Overall Study|Eligibility criterion not met|0|||
162709178|NCT00689104|587644869|FG003|Overall Study|Eligibility criterion not met|4|||
162626223|NCT03706079|587347018|FG004|Long Term Extension (DESTINATION)|Death|0|||
162626224|NCT03706079|587347019|FG005|Long Term Extension (DESTINATION)|Death|0|||
162626225|NCT00329238|587347020|FG000|Overall Study|Adverse Event|147|||
162626226|NCT00329238|587347021|FG001|Overall Study|Adverse Event|129|||
162626227|NCT00329238|587347020|FG000|Overall Study|Protocol Violation|23|||
162626228|NCT00329238|587347021|FG001|Overall Study|Protocol Violation|34|||
162626229|NCT00329238|587347020|FG000|Overall Study|Lost to Follow-up|2|||
162626230|NCT00329238|587347021|FG001|Overall Study|Lost to Follow-up|6|||
162626231|NCT00329238|587347020|FG000|Overall Study|Withdrawal by Subject|64|||
162626232|NCT00329238|587347021|FG001|Overall Study|Withdrawal by Subject|58|||
162626233|NCT00329238|587347020|FG000|Overall Study|Other reason (not specified)|40|||
162626234|NCT00329238|587347021|FG001|Overall Study|Other reason (not specified)|54|||
162709179|NCT00689104|587644866|FG000|Overall Study|Adverse Event|13|||
162709180|NCT00689104|587644867|FG001|Overall Study|Adverse Event|25|||
162709181|NCT00689104|587644868|FG002|Overall Study|Adverse Event|16|||
162709182|NCT00689104|587644869|FG003|Overall Study|Adverse Event|24|||
162709183|NCT00689104|587644866|FG000|Overall Study|Lack of Efficacy|5|||
162709184|NCT00689104|587644867|FG001|Overall Study|Lack of Efficacy|6|||
162709185|NCT00689104|587644868|FG002|Overall Study|Lack of Efficacy|2|||
162709186|NCT00689104|587644869|FG003|Overall Study|Lack of Efficacy|3|||
162709187|NCT00689104|587644866|FG000|Overall Study|Withdrawal by Subject|12|||
162626235|NCT01306942|587347032|FG000|Phase I|Adverse Event|2|||
162626236|NCT01306942|587347033|FG001|Phase I|Adverse Event|2|||
162626237|NCT01306942|587347034|FG002|Phase I|Adverse Event|0|||
162626238|NCT01306942|587347035|FG003|Phase I|Adverse Event|0|||
162709188|NCT00689104|587644867|FG001|Overall Study|Withdrawal by Subject|11|||
162709189|NCT00689104|587644868|FG002|Overall Study|Withdrawal by Subject|18|||
162709190|NCT00689104|587644869|FG003|Overall Study|Withdrawal by Subject|11|||
162709191|NCT00689104|587644866|FG000|Overall Study|Lost to Follow-up|4|||
162709192|NCT00689104|587644867|FG001|Overall Study|Lost to Follow-up|3|||
162709193|NCT00689104|587644868|FG002|Overall Study|Lost to Follow-up|2|||
162709194|NCT00689104|587644869|FG003|Overall Study|Lost to Follow-up|5|||
162709195|NCT00689104|587644866|FG000|Overall Study|Protocol Violation|2|||
162709196|NCT00689104|587644867|FG001|Overall Study|Protocol Violation|3|||
162709197|NCT00689104|587644868|FG002|Overall Study|Protocol Violation|5|||
162709198|NCT00689104|587644869|FG003|Overall Study|Protocol Violation|3|||
162709199|NCT00689104|587644866|FG000|Overall Study|Randomized but never received study drug|2|||
162709200|NCT00689104|587644867|FG001|Overall Study|Randomized but never received study drug|1|||
162709201|NCT00689104|587644868|FG002|Overall Study|Randomized but never received study drug|1|||
162906226|NCT02382276|588353715|FG001|Overall Study|Withdrawal by Subject|8|||
162626239|NCT01306942|587347032|FG000|Phase I|Physician Decision|3|||
162626240|NCT01306942|587347033|FG001|Phase I|Physician Decision|1|||
162626241|NCT01306942|587347034|FG002|Phase I|Physician Decision|0|||
162626242|NCT01306942|587347035|FG003|Phase I|Physician Decision|0|||
162709202|NCT00689104|587644869|FG003|Overall Study|Randomized but never received study drug|0|||
162709203|NCT00689104|587644866|FG000|Overall Study|Physician Decision|1|||
162709204|NCT00689104|587644867|FG001|Overall Study|Physician Decision|0|||
162709205|NCT00689104|587644868|FG002|Overall Study|Physician Decision|0|||
162906227|NCT02382276|588353716|FG002|Overall Study|Withdrawal by Subject|5|||
162906228|NCT02382276|588353714|FG000|Overall Study|Adverse Event|7|||
162906229|NCT02382276|588353715|FG001|Overall Study|Adverse Event|2|||
162906230|NCT02382276|588353716|FG002|Overall Study|Adverse Event|32|||
162906231|NCT02382276|588353714|FG000|Overall Study|Physician Decision|0|||
162906232|NCT02382276|588353715|FG001|Overall Study|Physician Decision|0|||
162906233|NCT02382276|588353716|FG002|Overall Study|Physician Decision|2|||
162906234|NCT01222416|588353717|FG000|Overall Study|ineligible;metastasis|3|||
162906235|NCT01222416|588353718|FG001|Overall Study|ineligible;metastasis|0|||
162906236|NCT01222416|588353717|FG000|Overall Study|Adverse Event|4|||
162906237|NCT01222416|588353718|FG001|Overall Study|Adverse Event|0|||
162906238|NCT01222416|588353717|FG000|Overall Study|Withdrawal by Subject|5|||
162626243|NCT01306942|587347032|FG000|Phase II|Adverse Event|0|||
162626244|NCT01306942|587347033|FG001|Phase II|Adverse Event|0|||
162906239|NCT01222416|588353718|FG001|Overall Study|Withdrawal by Subject|0|||
162906240|NCT01222416|588353717|FG000|Overall Study|scheduling|6|||
162906241|NCT01222416|588353718|FG001|Overall Study|scheduling|0|||
162709206|NCT00689104|587644869|FG003|Overall Study|Physician Decision|0|||
162709207|NCT00689104|587644866|FG000|Overall Study|Non-compliance with study procedures|0|||
162709208|NCT00689104|587644867|FG001|Overall Study|Non-compliance with study procedures|0|||
162709209|NCT00689104|587644868|FG002|Overall Study|Non-compliance with study procedures|1|||
162709210|NCT00689104|587644869|FG003|Overall Study|Non-compliance with study procedures|0|||
162709211|NCT01737268|587644870|FG000|Overall Study|Adverse Event|6|||
162709212|NCT01737268|587644870|FG000|Overall Study|Worsening of Target Disease|2|||
162709213|NCT01737268|587644870|FG000|Overall Study|In consideration of the patient's safety|1|||
162709214|NCT04873817|587644871|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
162709215|NCT04873817|587644871|FG000|Overall Study|Lost to Follow-up|4|||
162709216|NCT04873817|587644871|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
162709217|NCT04873817|587644871|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
162709218|NCT04873817|587644871|FG000|Overall Study|Other Reasons|3|||
162709219|NCT02696226|587644879|FG000|Overall Study|Study terminated - lack of enrollment|1|||
162709220|NCT02696226|587644880|FG001|Overall Study|Study terminated - lack of enrollment|0|||
162709221|NCT02696226|587644881|FG002|Overall Study|Study terminated - lack of enrollment|2|||
162709222|NCT02696226|587644882|FG003|Overall Study|Study terminated - lack of enrollment|0|||
162709223|NCT00097370|587644883|FG000|Stage 1|Adverse Event|3|||
162709224|NCT00097370|587644883|FG000|Stage 1|Withdrawal by Subject|1|||
162709225|NCT00097370|587644883|FG000|Stage 1|Lack of Efficacy|2|||
162709226|NCT00097370|587644883|FG000|Stage 2|Adverse Event|5|||
162709227|NCT00097370|587644883|FG000|Stage 2|Withdrawal by Subject|1|||
162709228|NCT00097370|587644883|FG000|Stage 2|Lack of Efficacy|3|||
162709229|NCT00097370|587644883|FG000|Stage 2|Pregnancy|1|||
162709230|NCT00097370|587644883|FG000|Stage 2|Sponsor Terminated Study|2|||
162709231|NCT00097370|587644883|FG000|Stage 2|Lost to Follow-up|1|||
162709232|NCT00097370|587644883|FG000|Stage 3|Adverse Event|2|||
162709233|NCT00097370|587644883|FG000|Stage 3|Withdrawal by Subject|3|||
162709234|NCT00097370|587644883|FG000|Stage 3|Lack of Efficacy|1|||
162709235|NCT00097370|587644883|FG000|Stage 3|Sponsor Terminated Study|52|||
162709236|NCT00097370|587644883|FG000|Stage 3|Lost to Follow-up|1|||
162709237|NCT01394991|587644886|FG000|Overall Study|Adverse Event|0|||
162709238|NCT01394991|587644887|FG001|Overall Study|Adverse Event|4|||
162709239|NCT01394991|587644886|FG000|Overall Study|Lack of Efficacy|5|||
162709240|NCT01394991|587644887|FG001|Overall Study|Lack of Efficacy|7|||
162709241|NCT01394991|587644886|FG000|Overall Study|Lost to Follow-up|6|||
162709242|NCT01394991|587644887|FG001|Overall Study|Lost to Follow-up|8|||
162709243|NCT01394991|587644886|FG000|Overall Study|Physician Decision|1|||
162709244|NCT01394991|587644887|FG001|Overall Study|Physician Decision|3|||
162906242|NCT01222416|588353717|FG000|Overall Study|missed view/scan|1|||
162626245|NCT01306942|587347034|FG002|Phase II|Adverse Event|0|||
162626246|NCT01306942|587347035|FG003|Phase II|Adverse Event|6|||
162626247|NCT01306942|587347032|FG000|Phase II|Physician Decision|2|||
162626248|NCT01306942|587347033|FG001|Phase II|Physician Decision|0|||
162626249|NCT01306942|587347034|FG002|Phase II|Physician Decision|0|||
162626250|NCT01306942|587347035|FG003|Phase II|Physician Decision|5|||
162626251|NCT01306942|587347032|FG000|Phase II|Withdrawal by Subject|0|||
162626252|NCT01306942|587347033|FG001|Phase II|Withdrawal by Subject|0|||
162626253|NCT01306942|587347034|FG002|Phase II|Withdrawal by Subject|0|||
162626254|NCT01306942|587347035|FG003|Phase II|Withdrawal by Subject|2|||
162626255|NCT01306942|587347032|FG000|Phase II|Death|0|||
162626256|NCT01306942|587347033|FG001|Phase II|Death|0|||
162626257|NCT01306942|587347034|FG002|Phase II|Death|0|||
162626258|NCT01306942|587347035|FG003|Phase II|Death|1|||
162626259|NCT01306942|587347032|FG000|Phase II|Not finished treatment|0|||
162626260|NCT01306942|587347033|FG001|Phase II|Not finished treatment|0|||
162626261|NCT01306942|587347034|FG002|Phase II|Not finished treatment|0|||
162626262|NCT01306942|587347035|FG003|Phase II|Not finished treatment|1|||
162626263|NCT01306942|587347032|FG000|Phase II|Protocol Violation|0|||
162626264|NCT01306942|587347033|FG001|Phase II|Protocol Violation|0|||
162906243|NCT01222416|588353718|FG001|Overall Study|missed view/scan|0|||
162906244|NCT01222416|588353717|FG000|Overall Study|Death|1|||
162906245|NCT01222416|588353718|FG001|Overall Study|Death|0|||
162906246|NCT03258762|588353725|FG000|Overall Study|Lost to Follow-up|0|||
162906247|NCT03258762|588353726|FG001|Overall Study|Lost to Follow-up|1|||
162906248|NCT02545049|588353733|FG000|Overall Study|Withdrawal by Subject|1|||
162906249|NCT02545049|588353734|FG001|Overall Study|Withdrawal by Subject|7|||
162906250|NCT02545049|588353733|FG000|Overall Study|Lost to Follow-up|4|||
162906251|NCT02545049|588353734|FG001|Overall Study|Lost to Follow-up|6|||
162626265|NCT01306942|587347034|FG002|Phase II|Protocol Violation|0|||
162626266|NCT01306942|587347035|FG003|Phase II|Protocol Violation|1|||
162626267|NCT03988088|587347036|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162626268|NCT03988088|587347037|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
162709245|NCT01394991|587644886|FG000|Overall Study|Protocol Violation|1|||
162906252|NCT02545049|588353733|FG000|Overall Study|GCP violations|37|||
162906253|NCT02545049|588353734|FG001|Overall Study|GCP violations|48|||
162626269|NCT03988088|587347038|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162906254|NCT04191096|588353736|FG000|Overall Study|Death|102|||
162906255|NCT04191096|588353737|FG001|Overall Study|Death|89|||
162906256|NCT04191096|588353736|FG000|Overall Study|Lost to Follow-up|1|||
162906257|NCT04191096|588353737|FG001|Overall Study|Lost to Follow-up|1|||
162906258|NCT04191096|588353736|FG000|Overall Study|Withdrawal by Subject|5|||
162906259|NCT04191096|588353737|FG001|Overall Study|Withdrawal by Subject|5|||
162906260|NCT04191096|588353736|FG000|Overall Study|Participants Ongoing|518|||
162626270|NCT03988088|587347039|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162626271|NCT03988088|587347036|FG000|Open-Label Addendum|Lost to Follow-up|0|||
162626272|NCT03988088|587347037|FG001|Open-Label Addendum|Lost to Follow-up|0|||
162626273|NCT03988088|587347038|FG002|Open-Label Addendum|Lost to Follow-up|1|||
162626274|NCT03988088|587347039|FG003|Open-Label Addendum|Lost to Follow-up|0|||
162626275|NCT03344796|587347040|FG000|Overall Study|Lost to Follow-up|0|||
162626276|NCT03344796|587347041|FG001|Overall Study|Lost to Follow-up|0|||
162626277|NCT03344796|587347042|FG002|Overall Study|Lost to Follow-up|0|||
162626278|NCT03344796|587347043|FG003|Overall Study|Lost to Follow-up|0|||
162626279|NCT03344796|587347044|FG004|Overall Study|Lost to Follow-up|0|||
162626280|NCT03344796|587347045|FG005|Overall Study|Lost to Follow-up|2|||
162626281|NCT00915278|587347046|FG000|Overall Study|Death|1|||
162626282|NCT00915278|587347047|FG001|Overall Study|Death|0|||
162626283|NCT00915278|587347048|FG002|Overall Study|Death|0|||
162626284|NCT00915278|587347049|FG003|Overall Study|Death|0|||
162626285|NCT00915278|587347050|FG004|Overall Study|Death|0|||
162626286|NCT00915278|587347051|FG005|Overall Study|Death|0|||
162626287|NCT00915278|587347046|FG000|Overall Study|Lost to Follow-up|0|||
162626288|NCT00915278|587347047|FG001|Overall Study|Lost to Follow-up|1|||
162626289|NCT00915278|587347048|FG002|Overall Study|Lost to Follow-up|0|||
162626290|NCT00915278|587347049|FG003|Overall Study|Lost to Follow-up|0|||
162626291|NCT00915278|587347050|FG004|Overall Study|Lost to Follow-up|0|||
162626292|NCT00915278|587347051|FG005|Overall Study|Lost to Follow-up|0|||
162626293|NCT00915278|587347046|FG000|Overall Study|Withdrawal by Subject|0|||
162626294|NCT00915278|587347047|FG001|Overall Study|Withdrawal by Subject|1|||
162626295|NCT00915278|587347048|FG002|Overall Study|Withdrawal by Subject|0|||
162626296|NCT00915278|587347049|FG003|Overall Study|Withdrawal by Subject|0|||
162626297|NCT00915278|587347050|FG004|Overall Study|Withdrawal by Subject|1|||
162626298|NCT00915278|587347051|FG005|Overall Study|Withdrawal by Subject|4|||
162626299|NCT00915278|587347046|FG000|Overall Study|Adverse Event|4|||
162626300|NCT00915278|587347047|FG001|Overall Study|Adverse Event|1|||
162626301|NCT00915278|587347048|FG002|Overall Study|Adverse Event|0|||
162626302|NCT00915278|587347049|FG003|Overall Study|Adverse Event|0|||
162626303|NCT00915278|587347050|FG004|Overall Study|Adverse Event|0|||
162626304|NCT00915278|587347051|FG005|Overall Study|Adverse Event|0|||
162626305|NCT00915278|587347046|FG000|Overall Study|Progressive disease/clinical progression|0|||
162626306|NCT00915278|587347047|FG001|Overall Study|Progressive disease/clinical progression|0|||
162626307|NCT00915278|587347048|FG002|Overall Study|Progressive disease/clinical progression|0|||
162626308|NCT00915278|587347049|FG003|Overall Study|Progressive disease/clinical progression|3|||
162626309|NCT00915278|587347050|FG004|Overall Study|Progressive disease/clinical progression|1|||
162626310|NCT00915278|587347051|FG005|Overall Study|Progressive disease/clinical progression|2|||
162626311|NCT00915278|587347046|FG000|Overall Study|Infusion related AEs|0|||
162626312|NCT00915278|587347047|FG001|Overall Study|Infusion related AEs|0|||
162626313|NCT00915278|587347048|FG002|Overall Study|Infusion related AEs|0|||
162626314|NCT00915278|587347049|FG003|Overall Study|Infusion related AEs|0|||
162626315|NCT00915278|587347050|FG004|Overall Study|Infusion related AEs|0|||
162626316|NCT00915278|587347051|FG005|Overall Study|Infusion related AEs|2|||
162626317|NCT00915278|587347046|FG000|Overall Study|Admission to hospice|0|||
162626318|NCT00915278|587347047|FG001|Overall Study|Admission to hospice|0|||
162626319|NCT00915278|587347048|FG002|Overall Study|Admission to hospice|1|||
162626320|NCT00915278|587347049|FG003|Overall Study|Admission to hospice|0|||
162626321|NCT00915278|587347050|FG004|Overall Study|Admission to hospice|0|||
162626322|NCT00915278|587347051|FG005|Overall Study|Admission to hospice|0|||
162626323|NCT02412618|587347052|FG000|Overall Study|Withdrawal by Subject|1|||
162626324|NCT02412618|587347053|FG001|Overall Study|Withdrawal by Subject|1|||
162626325|NCT02412618|587347052|FG000|Overall Study|Expulsion|1|||
162626326|NCT02412618|587347053|FG001|Overall Study|Expulsion|1|||
162626327|NCT00923156|587347055|FG000|Overall Study|Adverse Event|0|||
162626328|NCT00923156|587347056|FG001|Overall Study|Adverse Event|2|||
162626329|NCT00923156|587347057|FG002|Overall Study|Adverse Event|1|||
162626330|NCT00923156|587347055|FG000|Overall Study|Abnormal laboratory values|0|||
162626331|NCT00923156|587347056|FG001|Overall Study|Abnormal laboratory values|0|||
162626332|NCT00923156|587347057|FG002|Overall Study|Abnormal laboratory values|1|||
162626333|NCT00923156|587347055|FG000|Overall Study|Withdrawal by Subject|0|||
162626334|NCT00923156|587347056|FG001|Overall Study|Withdrawal by Subject|1|||
162626335|NCT00923156|587347057|FG002|Overall Study|Withdrawal by Subject|0|||
162626336|NCT00923156|587347055|FG000|Overall Study|Death|0|||
162626337|NCT00923156|587347056|FG001|Overall Study|Death|1|||
162906261|NCT04191096|588353737|FG001|Overall Study|Participants Ongoing|530|||
162906262|NCT00027027|588355588|FG000|Overall Study|Adverse Event|0|||
162626338|NCT00923156|587347057|FG002|Overall Study|Death|0|||
162626339|NCT00923156|587347055|FG000|Overall Study|Lack of Efficacy|0|||
162626340|NCT00923156|587347056|FG001|Overall Study|Lack of Efficacy|0|||
162626341|NCT00923156|587347057|FG002|Overall Study|Lack of Efficacy|1|||
162626342|NCT03137537|587347058|FG000|Overall Study|Adverse Event|0|||
162626343|NCT03137537|587347059|FG001|Overall Study|Adverse Event|1|||
162626344|NCT02465515|587347063|FG000|Overall Study|Investigator site closed|4|||
162626345|NCT02465515|587347064|FG001|Overall Study|Investigator site closed|5|||
162626346|NCT02465515|587347063|FG000|Overall Study|Withdrawal by Subject|74|||
162626347|NCT02465515|587347064|FG001|Overall Study|Withdrawal by Subject|43|||
162626348|NCT02465515|587347063|FG000|Overall Study|Physician Decision|8|||
162626349|NCT02465515|587347064|FG001|Overall Study|Physician Decision|12|||
162626350|NCT02465515|587347063|FG000|Overall Study|Lost to Follow-up|68|||
162626351|NCT02465515|587347064|FG001|Overall Study|Lost to Follow-up|51|||
162626352|NCT00629707|587347065|FG000|Overall Study|Withdrawal by Subject|0|||
162626353|NCT00629707|587347066|FG001|Overall Study|Withdrawal by Subject|1|||
162626354|NCT00629707|587347065|FG000|Overall Study|Physician Decision|0|||
162626355|NCT00629707|587347066|FG001|Overall Study|Physician Decision|1|||
162626356|NCT00453063|587347067|FG000|Overall Study|Adverse Event|1|||
162626357|NCT00453063|587347068|FG001|Overall Study|Adverse Event|2|||
162626358|NCT00453063|587347067|FG000|Overall Study|Withdrawal by Subject|1|||
162626359|NCT00453063|587347068|FG001|Overall Study|Withdrawal by Subject|1|||
162626360|NCT00453063|587347067|FG000|Overall Study|Protocol Violation|1|||
162626361|NCT00453063|587347068|FG001|Overall Study|Protocol Violation|0|||
162626362|NCT01918774|587348695|FG000|Overall Study|Lost prior to first CBTw session|4|||
162626363|NCT01918774|587348695|FG000|Overall Study|Lost to Follow-up|1|||
162626364|NCT03000439|587348698|FG000|Open Label Part 1|Adverse Event|6|||
162626365|NCT03000439|587348699|FG001|Open Label Part 1|Adverse Event|0|||
162626366|NCT03000439|587348700|FG002|Open Label Part 1|Adverse Event|0|||
162626367|NCT03000439|587348701|FG003|Open Label Part 1|Adverse Event|0|||
162626368|NCT03000439|587348698|FG000|Open Label Part 1|Other|2|||
162626369|NCT03000439|587348699|FG001|Open Label Part 1|Other|0|||
162626370|NCT03000439|587348700|FG002|Open Label Part 1|Other|0|||
162626371|NCT03000439|587348701|FG003|Open Label Part 1|Other|0|||
162626372|NCT03000439|587348698|FG000|Open Label Part 1|Insufficient clinical response|16|||
162626373|NCT03000439|587348699|FG001|Open Label Part 1|Insufficient clinical response|0|||
162626374|NCT03000439|587348700|FG002|Open Label Part 1|Insufficient clinical response|0|||
162626375|NCT03000439|587348701|FG003|Open Label Part 1|Insufficient clinical response|0|||
162626376|NCT03000439|587348698|FG000|Open Label Part 2|Other|0|||
162626377|NCT03000439|587348699|FG001|Open Label Part 2|Other|5|||
162626378|NCT03000439|587348700|FG002|Open Label Part 2|Other|0|||
162626379|NCT03000439|587348701|FG003|Open Label Part 2|Other|0|||
162626380|NCT03000439|587348698|FG000|Open Label Part 2|Insufficient clinical response|0|||
162626381|NCT03000439|587348699|FG001|Open Label Part 2|Insufficient clinical response|12|||
162626382|NCT03000439|587348700|FG002|Open Label Part 2|Insufficient clinical response|0|||
162626383|NCT03000439|587348701|FG003|Open Label Part 2|Insufficient clinical response|0|||
163054210|NCT02669849|588910191|FG002|Overall Study|Lost to Follow-up|3|||
163054211|NCT02669849|588910189|FG000|Overall Study|Death|1|||
163054212|NCT02669849|588910190|FG001|Overall Study|Death|1|||
163054213|NCT02669849|588910191|FG002|Overall Study|Death|2|||
163054214|NCT02669849|588910189|FG000|Overall Study|Study terminated by sponsor|16|||
163054215|NCT02669849|588910190|FG001|Overall Study|Study terminated by sponsor|1|||
163054216|NCT02669849|588910191|FG002|Overall Study|Study terminated by sponsor|14|||
163054217|NCT02669849|588910189|FG000|Overall Study|Other|0|||
163054218|NCT02669849|588910190|FG001|Overall Study|Other|0|||
163054219|NCT02669849|588910191|FG002|Overall Study|Other|2|||
163054220|NCT00606008|588910192|FG000|Overall Study|Adverse Event|1|||
163054221|NCT00606008|588910192|FG000|Overall Study|Withdrawal by Subject|4|||
163054222|NCT03736967|588910193|FG000|Overall Study|Withdrawal by Subject|26|||
163054223|NCT03736967|588910194|FG001|Overall Study|Withdrawal by Subject|25|||
163054224|NCT03736967|588910195|FG002|Overall Study|Withdrawal by Subject|23|||
162626384|NCT03000439|587348698|FG000|Double Blind Phase|Adverse Event|0|||
162626385|NCT03000439|587348699|FG001|Double Blind Phase|Adverse Event|0|||
162626386|NCT03000439|587348700|FG002|Double Blind Phase|Adverse Event|2|||
162626387|NCT03000439|587348701|FG003|Double Blind Phase|Adverse Event|1|||
163054225|NCT03736967|588910196|FG003|Overall Study|Withdrawal by Subject|26|||
163054226|NCT03736967|588910193|FG000|Overall Study|Lost to Follow-up|3|||
163054227|NCT03736967|588910194|FG001|Overall Study|Lost to Follow-up|2|||
162626388|NCT03000439|587348698|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
162626389|NCT03000439|587348699|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
163054228|NCT03736967|588910195|FG002|Overall Study|Lost to Follow-up|1|||
163054229|NCT03736967|588910196|FG003|Overall Study|Lost to Follow-up|1|||
162626390|NCT03000439|587348700|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
162709246|NCT01394991|587644887|FG001|Overall Study|Protocol Violation|1|||
162709247|NCT01394991|587644886|FG000|Overall Study|Withdrawal by Subject|20|||
162709248|NCT01394991|587644887|FG001|Overall Study|Withdrawal by Subject|17|||
162709249|NCT01394991|587644886|FG000|Overall Study|Chemotherapy Termination|10|||
162709250|NCT01394991|587644887|FG001|Overall Study|Chemotherapy Termination|15|||
162709251|NCT01394991|587644886|FG000|Overall Study|Disease Progression|7|||
162709252|NCT01394991|587644887|FG001|Overall Study|Disease Progression|7|||
162709253|NCT01394991|587644886|FG000|Overall Study|Prematurely Termination of Trial|9|||
162709254|NCT01394991|587644887|FG001|Overall Study|Prematurely Termination of Trial|10|||
162709255|NCT02337361|587644889|FG000|3-month Follow-up|Lost to Follow-up|19|||
162709256|NCT02337361|587644890|FG001|3-month Follow-up|Lost to Follow-up|14|||
162709257|NCT02337361|587644889|FG000|6-month Follow-up|Lost to Follow-up|2|||
162709258|NCT02337361|587644890|FG001|6-month Follow-up|Lost to Follow-up|4|||
162709259|NCT03073005|587644891|FG000|Overall Study|Death|6|||
162709260|NCT03073005|587644892|FG001|Overall Study|Death|0|||
162709261|NCT03073005|587644893|FG002|Overall Study|Death|7|||
162709262|NCT03073005|587644894|FG003|Overall Study|Death|0|||
162709263|NCT03073005|587644891|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
162709264|NCT03073005|587644892|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
162709265|NCT03073005|587644893|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
162906263|NCT00027027|588355589|FG001|Overall Study|Adverse Event|0|||
162709266|NCT03073005|587644894|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
162709267|NCT03073005|587644891|FG000|Overall Study|Lost to Follow-up|2|||
162709268|NCT03073005|587644892|FG001|Overall Study|Lost to Follow-up|2|||
162709269|NCT03073005|587644893|FG002|Overall Study|Lost to Follow-up|1|||
162709270|NCT03073005|587644894|FG003|Overall Study|Lost to Follow-up|2|||
162709271|NCT03073005|587644891|FG000|Overall Study|Withdrawal by Subject|0|||
162709272|NCT03073005|587644892|FG001|Overall Study|Withdrawal by Subject|4|||
162709273|NCT03073005|587644893|FG002|Overall Study|Withdrawal by Subject|4|||
162709274|NCT03073005|587644894|FG003|Overall Study|Withdrawal by Subject|4|||
162709275|NCT02427646|587644902|FG000|Overall Study|Lack of Efficacy|2|||
162709276|NCT02427646|587644903|FG001|Overall Study|Lack of Efficacy|3|||
162709277|NCT02427646|587644902|FG000|Overall Study|Physician Decision|1|||
162709278|NCT02427646|587644903|FG001|Overall Study|Physician Decision|4|||
162906264|NCT00027027|588355590|FG002|Overall Study|Adverse Event|1|||
162906265|NCT00027027|588355591|FG003|Overall Study|Adverse Event|0|||
162906266|NCT00027027|588355592|FG004|Overall Study|Adverse Event|1|||
162906267|NCT00027027|588355588|FG000|Overall Study|Admitted for Signs of PD|0|||
162906268|NCT00027027|588355589|FG001|Overall Study|Admitted for Signs of PD|0|||
162906269|NCT00027027|588355590|FG002|Overall Study|Admitted for Signs of PD|0|||
162906270|NCT00027027|588355591|FG003|Overall Study|Admitted for Signs of PD|0|||
162906271|NCT00027027|588355592|FG004|Overall Study|Admitted for Signs of PD|1|||
162906272|NCT00027027|588355588|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
162906273|NCT00027027|588355589|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
162906274|NCT00027027|588355590|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
162906275|NCT00027027|588355591|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
162906276|NCT00027027|588355592|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
162906277|NCT00027027|588355588|FG000|Overall Study|PD Requiring Surgery|0|||
162906278|NCT00027027|588355589|FG001|Overall Study|PD Requiring Surgery|0|||
162906279|NCT00027027|588355590|FG002|Overall Study|PD Requiring Surgery|1|||
162906280|NCT00027027|588355591|FG003|Overall Study|PD Requiring Surgery|0|||
162906281|NCT00027027|588355592|FG004|Overall Study|PD Requiring Surgery|0|||
162906282|NCT00027027|588355588|FG000|Overall Study|Physician Decision Due To PD|2|||
162709279|NCT02427646|587644902|FG000|Overall Study|Protocol Violation|3|||
162709280|NCT02427646|587644903|FG001|Overall Study|Protocol Violation|3|||
162709281|NCT02427646|587644902|FG000|Overall Study|Bothersome hand weakness|2|||
162709282|NCT02427646|587644903|FG001|Overall Study|Bothersome hand weakness|4|||
162709283|NCT00062868|587644904|FG000|Dose Level 1|Death|2|||
162709284|NCT00062868|587644905|FG001|Dose Level 1|Death|0|||
162709285|NCT00062868|587644906|FG002|Dose Level 1|Death|0|||
162709286|NCT00062868|587644907|FG003|Dose Level 1|Death|2|||
162709287|NCT00062868|587644908|FG004|Dose Level 1|Death|0|||
162709288|NCT00062868|587644909|FG005|Dose Level 1|Death|0|||
162709289|NCT00062868|587644910|FG006|Dose Level 1|Death|3|||
162709290|NCT00062868|587644911|FG007|Dose Level 1|Death|0|||
162709291|NCT00062868|587644912|FG008|Dose Level 1|Death|0|||
162709292|NCT00062868|587644913|FG009|Dose Level 1|Death|0|||
162709293|NCT00062868|587644914|FG010|Dose Level 1|Death|0|||
162709294|NCT00062868|587644915|FG011|Dose Level 1|Death|0|||
162906283|NCT00027027|588355589|FG001|Overall Study|Physician Decision Due To PD|3|||
162906284|NCT00027027|588355590|FG002|Overall Study|Physician Decision Due To PD|2|||
162906285|NCT00027027|588355591|FG003|Overall Study|Physician Decision Due To PD|3|||
162906286|NCT00027027|588355592|FG004|Overall Study|Physician Decision Due To PD|5|||
162906287|NCT00027027|588355588|FG000|Overall Study|Withdrawal by Subject|0|||
162906288|NCT00027027|588355589|FG001|Overall Study|Withdrawal by Subject|0|||
162906289|NCT00027027|588355590|FG002|Overall Study|Withdrawal by Subject|0|||
162906290|NCT00027027|588355591|FG003|Overall Study|Withdrawal by Subject|0|||
162906291|NCT00027027|588355592|FG004|Overall Study|Withdrawal by Subject|1|||
162906292|NCT00003389|588355596|FG000|Overall Study|Disease progression|6|||
162906293|NCT00003389|588355597|FG001|Overall Study|Disease progression|1|||
162906294|NCT00003389|588355596|FG000|Overall Study|Adverse Event|13|||
162906295|NCT00003389|588355597|FG001|Overall Study|Adverse Event|2|||
162906296|NCT00003389|588355596|FG000|Overall Study|Death|0|||
162906297|NCT00003389|588355597|FG001|Overall Study|Death|3|||
162906298|NCT00003389|588355596|FG000|Overall Study|Withdrawal by Subject|12|||
162906299|NCT00003389|588355597|FG001|Overall Study|Withdrawal by Subject|5|||
162906300|NCT00003389|588355596|FG000|Overall Study|Alternative therapy|2|||
162709295|NCT00062868|587644916|FG012|Dose Level 1|Death|0|||
162709296|NCT00062868|587644917|FG013|Dose Level 1|Death|0|||
162709297|NCT00062868|587644918|FG014|Dose Level 1|Death|0|||
162709298|NCT00062868|587644919|FG015|Dose Level 1|Death|0|||
162709299|NCT00062868|587644920|FG016|Dose Level 1|Death|0|||
162906301|NCT00003389|588355597|FG001|Overall Study|Alternative therapy|1|||
162906302|NCT00003389|588355596|FG000|Overall Study|Complicating disease|1|||
162906303|NCT00003389|588355597|FG001|Overall Study|Complicating disease|0|||
162906304|NCT00003389|588355596|FG000|Overall Study|Off-treatment reason missing|31|||
162906305|NCT00003389|588355597|FG001|Overall Study|Off-treatment reason missing|21|||
162906306|NCT00003389|588355596|FG000|Overall Study|Ineligible|33|||
162906307|NCT00003389|588355597|FG001|Overall Study|Ineligible|27|||
162906308|NCT04397757|588355599|FG000|Overall Study|Death|3|||
162906309|NCT04397757|588355600|FG001|Overall Study|Death|11|||
162906310|NCT04397757|588355599|FG000|Overall Study|Withdrawal by Subject|2|||
162906311|NCT04397757|588355600|FG001|Overall Study|Withdrawal by Subject|0|||
162906312|NCT04397757|588355599|FG000|Overall Study|Lost to Follow-up|4|||
162906313|NCT04397757|588355600|FG001|Overall Study|Lost to Follow-up|3|||
162906314|NCT02306148|588355601|FG000|Overall Study|Adverse Event|12|||
162906315|NCT02306148|588355602|FG001|Overall Study|Adverse Event|6|||
162906316|NCT02306148|588355601|FG000|Overall Study|Lost to Follow-up|1|||
162906317|NCT02306148|588355602|FG001|Overall Study|Lost to Follow-up|4|||
162906318|NCT04657003|588355609|FG000|Overall Study|Adverse Event|5|||
162906319|NCT04657003|588355610|FG001|Overall Study|Adverse Event|1|||
162906320|NCT04657003|588355611|FG002|Overall Study|Adverse Event|5|||
162906321|NCT04657003|588355609|FG000|Overall Study|Death|0|||
162906322|NCT04657003|588355610|FG001|Overall Study|Death|2|||
162906323|NCT04657003|588355611|FG002|Overall Study|Death|0|||
162906324|NCT04657003|588355609|FG000|Overall Study|Lost to Follow-up|8|||
162906325|NCT04657003|588355610|FG001|Overall Study|Lost to Follow-up|4|||
162906326|NCT04657003|588355611|FG002|Overall Study|Lost to Follow-up|10|||
162906327|NCT04657003|588355609|FG000|Overall Study|Other - As Reported by Investigator|3|||
162906328|NCT04657003|588355610|FG001|Overall Study|Other - As Reported by Investigator|2|||
162906329|NCT04657003|588355611|FG002|Overall Study|Other - As Reported by Investigator|2|||
162906330|NCT04657003|588355609|FG000|Overall Study|Pregnancy|2|||
162906331|NCT04657003|588355610|FG001|Overall Study|Pregnancy|0|||
162906332|NCT04657003|588355611|FG002|Overall Study|Pregnancy|2|||
162906333|NCT04657003|588355609|FG000|Overall Study|Withdrawal by Subject|16|||
162906334|NCT04657003|588355610|FG001|Overall Study|Withdrawal by Subject|7|||
162906335|NCT04657003|588355611|FG002|Overall Study|Withdrawal by Subject|10|||
162906336|NCT05158244|588355614|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
162906337|NCT05158244|588355615|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
162906338|NCT05158244|588355616|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
162906339|NCT05158244|588355617|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
162906340|NCT05158244|588355618|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
162709300|NCT00062868|587644921|FG017|Dose Level 1|Death|0|||
162709301|NCT00062868|587644922|FG018|Dose Level 1|Death|7|||
162906341|NCT05158244|588355614|FG000|Overall Study|Withdrawal by Subject|0|||
162906342|NCT05158244|588355615|FG001|Overall Study|Withdrawal by Subject|0|||
162709302|NCT00062868|587644923|FG019|Dose Level 1|Death|0|||
162709303|NCT00062868|587644924|FG020|Dose Level 1|Death|1|||
162709304|NCT00062868|587644904|FG000|Dose Level 1|Lost to Follow-up|0|||
162709305|NCT00062868|587644905|FG001|Dose Level 1|Lost to Follow-up|0|||
162709306|NCT00062868|587644906|FG002|Dose Level 1|Lost to Follow-up|0|||
162709307|NCT00062868|587644907|FG003|Dose Level 1|Lost to Follow-up|0|||
162906343|NCT05158244|588355616|FG002|Overall Study|Withdrawal by Subject|1|||
162906344|NCT05158244|588355617|FG003|Overall Study|Withdrawal by Subject|0|||
162906345|NCT05158244|588355618|FG004|Overall Study|Withdrawal by Subject|0|||
162906346|NCT02408016|588355620|FG000|Overall Study|Death|6|||
162906347|NCT02408016|588355621|FG001|Overall Study|Death|1|||
162906348|NCT02408016|588355622|FG002|Overall Study|Death|0|||
162906349|NCT02408016|588355620|FG000|Overall Study|Physician Decision|0|||
162709308|NCT00062868|587644908|FG004|Dose Level 1|Lost to Follow-up|0|||
162709309|NCT00062868|587644909|FG005|Dose Level 1|Lost to Follow-up|0|||
162709310|NCT00062868|587644910|FG006|Dose Level 1|Lost to Follow-up|0|||
162709311|NCT00062868|587644911|FG007|Dose Level 1|Lost to Follow-up|0|||
162709312|NCT00062868|587644912|FG008|Dose Level 1|Lost to Follow-up|0|||
162709313|NCT00062868|587644913|FG009|Dose Level 1|Lost to Follow-up|0|||
162709314|NCT00062868|587644914|FG010|Dose Level 1|Lost to Follow-up|0|||
162709315|NCT00062868|587644915|FG011|Dose Level 1|Lost to Follow-up|0|||
162709316|NCT00062868|587644916|FG012|Dose Level 1|Lost to Follow-up|1|||
162709317|NCT00062868|587644917|FG013|Dose Level 1|Lost to Follow-up|0|||
162709318|NCT00062868|587644918|FG014|Dose Level 1|Lost to Follow-up|0|||
162709319|NCT00062868|587644919|FG015|Dose Level 1|Lost to Follow-up|0|||
162709320|NCT00062868|587644920|FG016|Dose Level 1|Lost to Follow-up|0|||
162709321|NCT00062868|587644921|FG017|Dose Level 1|Lost to Follow-up|0|||
162709322|NCT00062868|587644922|FG018|Dose Level 1|Lost to Follow-up|2|||
162709323|NCT00062868|587644923|FG019|Dose Level 1|Lost to Follow-up|0|||
162709324|NCT00062868|587644924|FG020|Dose Level 1|Lost to Follow-up|1|||
162709325|NCT00062868|587644904|FG000|Dose Level 2|Death|0|||
162709326|NCT00062868|587644905|FG001|Dose Level 2|Death|3|||
162709327|NCT00062868|587644906|FG002|Dose Level 2|Death|0|||
162709328|NCT00062868|587644907|FG003|Dose Level 2|Death|0|||
162709329|NCT00062868|587644908|FG004|Dose Level 2|Death|2|||
162709330|NCT00062868|587644909|FG005|Dose Level 2|Death|0|||
162709331|NCT00062868|587644910|FG006|Dose Level 2|Death|0|||
162709332|NCT00062868|587644911|FG007|Dose Level 2|Death|0|||
162709333|NCT00062868|587644912|FG008|Dose Level 2|Death|0|||
162709334|NCT00062868|587644913|FG009|Dose Level 2|Death|0|||
162709335|NCT00062868|587644914|FG010|Dose Level 2|Death|1|||
162709336|NCT00062868|587644915|FG011|Dose Level 2|Death|0|||
162709337|NCT00062868|587644916|FG012|Dose Level 2|Death|0|||
162709338|NCT00062868|587644917|FG013|Dose Level 2|Death|0|||
162709339|NCT00062868|587644918|FG014|Dose Level 2|Death|0|||
162709340|NCT00062868|587644919|FG015|Dose Level 2|Death|0|||
162906350|NCT02408016|588355621|FG001|Overall Study|Physician Decision|2|||
162906351|NCT02408016|588355622|FG002|Overall Study|Physician Decision|0|||
162709341|NCT00062868|587644920|FG016|Dose Level 2|Death|2|||
162709342|NCT00062868|587644921|FG017|Dose Level 2|Death|0|||
162709343|NCT00062868|587644922|FG018|Dose Level 2|Death|0|||
162709344|NCT00062868|587644923|FG019|Dose Level 2|Death|0|||
162709345|NCT00062868|587644924|FG020|Dose Level 2|Death|0|||
162709346|NCT00062868|587644904|FG000|Dose Level 2|Lost to Follow-up|0|||
163054230|NCT03736967|588910193|FG000|Overall Study|Physician Decision|1|||
163054231|NCT03736967|588910194|FG001|Overall Study|Physician Decision|0|||
162709347|NCT00062868|587644905|FG001|Dose Level 2|Lost to Follow-up|0|||
162709348|NCT00062868|587644906|FG002|Dose Level 2|Lost to Follow-up|0|||
162709349|NCT00062868|587644907|FG003|Dose Level 2|Lost to Follow-up|0|||
162709350|NCT00062868|587644908|FG004|Dose Level 2|Lost to Follow-up|0|||
162709351|NCT00062868|587644909|FG005|Dose Level 2|Lost to Follow-up|0|||
163054232|NCT03736967|588910195|FG002|Overall Study|Physician Decision|0|||
163054233|NCT03736967|588910196|FG003|Overall Study|Physician Decision|1|||
162709352|NCT00062868|587644910|FG006|Dose Level 2|Lost to Follow-up|0|||
162709353|NCT00062868|587644911|FG007|Dose Level 2|Lost to Follow-up|0|||
162709354|NCT00062868|587644912|FG008|Dose Level 2|Lost to Follow-up|0|||
162709355|NCT00062868|587644913|FG009|Dose Level 2|Lost to Follow-up|0|||
162709356|NCT00062868|587644914|FG010|Dose Level 2|Lost to Follow-up|0|||
163054234|NCT03736967|588910193|FG000|Overall Study|Adverse Event|0|||
163054235|NCT03736967|588910194|FG001|Overall Study|Adverse Event|1|||
162709357|NCT00062868|587644915|FG011|Dose Level 2|Lost to Follow-up|0|||
163054236|NCT03736967|588910195|FG002|Overall Study|Adverse Event|0|||
162709358|NCT00062868|587644916|FG012|Dose Level 2|Lost to Follow-up|0|||
163054237|NCT03736967|588910196|FG003|Overall Study|Adverse Event|1|||
162709359|NCT00062868|587644917|FG013|Dose Level 2|Lost to Follow-up|1|||
162709360|NCT00062868|587644918|FG014|Dose Level 2|Lost to Follow-up|0|||
162709361|NCT00062868|587644919|FG015|Dose Level 2|Lost to Follow-up|0|||
162709362|NCT00062868|587644920|FG016|Dose Level 2|Lost to Follow-up|1|||
162709363|NCT00062868|587644921|FG017|Dose Level 2|Lost to Follow-up|0|||
162709364|NCT00062868|587644922|FG018|Dose Level 2|Lost to Follow-up|0|||
162709365|NCT00062868|587644923|FG019|Dose Level 2|Lost to Follow-up|0|||
162709366|NCT00062868|587644924|FG020|Dose Level 2|Lost to Follow-up|0|||
162709367|NCT00062868|587644904|FG000|Dose Level 3|Death|0|||
162709368|NCT00062868|587644905|FG001|Dose Level 3|Death|0|||
162709369|NCT00062868|587644906|FG002|Dose Level 3|Death|0|||
162709370|NCT00062868|587644907|FG003|Dose Level 3|Death|0|||
162709371|NCT00062868|587644908|FG004|Dose Level 3|Death|0|||
162709372|NCT00062868|587644909|FG005|Dose Level 3|Death|0|||
162709373|NCT00062868|587644910|FG006|Dose Level 3|Death|0|||
162709374|NCT00062868|587644911|FG007|Dose Level 3|Death|0|||
162709375|NCT00062868|587644912|FG008|Dose Level 3|Death|0|||
162709376|NCT00062868|587644913|FG009|Dose Level 3|Death|0|||
162709377|NCT00062868|587644914|FG010|Dose Level 3|Death|0|||
162709378|NCT00062868|587644915|FG011|Dose Level 3|Death|1|||
162709379|NCT00062868|587644916|FG012|Dose Level 3|Death|0|||
162709380|NCT00062868|587644917|FG013|Dose Level 3|Death|0|||
162709381|NCT00062868|587644918|FG014|Dose Level 3|Death|0|||
162709382|NCT00062868|587644919|FG015|Dose Level 3|Death|0|||
162709383|NCT00062868|587644920|FG016|Dose Level 3|Death|0|||
162709384|NCT00062868|587644921|FG017|Dose Level 3|Death|1|||
162709385|NCT00062868|587644922|FG018|Dose Level 3|Death|0|||
162709386|NCT00062868|587644923|FG019|Dose Level 3|Death|0|||
162709387|NCT00062868|587644924|FG020|Dose Level 3|Death|0|||
162709388|NCT00062868|587644904|FG000|Dose Level 3|Lost to Follow-up|0|||
162709389|NCT00062868|587644905|FG001|Dose Level 3|Lost to Follow-up|0|||
162709390|NCT00062868|587644906|FG002|Dose Level 3|Lost to Follow-up|0|||
162709391|NCT00062868|587644907|FG003|Dose Level 3|Lost to Follow-up|0|||
162709392|NCT00062868|587644908|FG004|Dose Level 3|Lost to Follow-up|0|||
162709393|NCT00062868|587644909|FG005|Dose Level 3|Lost to Follow-up|0|||
162709394|NCT00062868|587644910|FG006|Dose Level 3|Lost to Follow-up|0|||
162709395|NCT00062868|587644911|FG007|Dose Level 3|Lost to Follow-up|0|||
162709396|NCT00062868|587644912|FG008|Dose Level 3|Lost to Follow-up|0|||
162709397|NCT00062868|587644913|FG009|Dose Level 3|Lost to Follow-up|0|||
162709398|NCT00062868|587644914|FG010|Dose Level 3|Lost to Follow-up|0|||
162709399|NCT00062868|587644915|FG011|Dose Level 3|Lost to Follow-up|0|||
162709400|NCT00062868|587644916|FG012|Dose Level 3|Lost to Follow-up|0|||
162709401|NCT00062868|587644917|FG013|Dose Level 3|Lost to Follow-up|0|||
162709402|NCT00062868|587644918|FG014|Dose Level 3|Lost to Follow-up|1|||
162709403|NCT00062868|587644919|FG015|Dose Level 3|Lost to Follow-up|0|||
162709404|NCT00062868|587644920|FG016|Dose Level 3|Lost to Follow-up|0|||
162709405|NCT00062868|587644921|FG017|Dose Level 3|Lost to Follow-up|0|||
162709406|NCT00062868|587644922|FG018|Dose Level 3|Lost to Follow-up|0|||
162709407|NCT00062868|587644923|FG019|Dose Level 3|Lost to Follow-up|0|||
162709408|NCT00062868|587644924|FG020|Dose Level 3|Lost to Follow-up|0|||
162709409|NCT00062868|587644904|FG000|Dose Level 3|Withdrew|0|||
162709410|NCT00062868|587644905|FG001|Dose Level 3|Withdrew|0|||
162709411|NCT00062868|587644906|FG002|Dose Level 3|Withdrew|2|||
162709412|NCT00062868|587644907|FG003|Dose Level 3|Withdrew|0|||
162626391|NCT03000439|587348701|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
162626392|NCT03000439|587348698|FG000|Double Blind Phase|Other|0|||
162626393|NCT03000439|587348699|FG001|Double Blind Phase|Other|0|||
162626394|NCT03000439|587348700|FG002|Double Blind Phase|Other|10|||
162626395|NCT03000439|587348701|FG003|Double Blind Phase|Other|11|||
162626396|NCT03000439|587348698|FG000|Double Blind Phase|Insufficient clinical response|0|||
162626397|NCT03000439|587348699|FG001|Double Blind Phase|Insufficient clinical response|0|||
162626398|NCT03000439|587348700|FG002|Double Blind Phase|Insufficient clinical response|0|||
162626399|NCT03000439|587348701|FG003|Double Blind Phase|Insufficient clinical response|2|||
162626400|NCT01389817|587348704|FG000|Overall Study|Physician Decision|1|||
162626401|NCT01389817|587348705|FG001|Overall Study|Physician Decision|0|||
162626402|NCT01389817|587348704|FG000|Overall Study|Lost to Follow-up|1|||
162626403|NCT01389817|587348705|FG001|Overall Study|Lost to Follow-up|0|||
162626404|NCT01389817|587348704|FG000|Overall Study|Withdrawal by Subject|2|||
162626405|NCT01389817|587348705|FG001|Overall Study|Withdrawal by Subject|0|||
162626406|NCT01749137|587348706|FG000|Overall Study|Adverse Event|4|||
162626407|NCT01749137|587348707|FG001|Overall Study|Adverse Event|4|||
162626408|NCT01749137|587348706|FG000|Overall Study|Lost to Follow-up|2|||
162626409|NCT01749137|587348707|FG001|Overall Study|Lost to Follow-up|3|||
162626410|NCT01749137|587348706|FG000|Overall Study|Physician Decision|1|||
162626411|NCT01749137|587348707|FG001|Overall Study|Physician Decision|0|||
162626412|NCT01749137|587348706|FG000|Overall Study|Withdrawal by Subject|8|||
162626413|NCT01749137|587348707|FG001|Overall Study|Withdrawal by Subject|4|||
162626414|NCT04980040|587348709|FG000|Overall Study|Violated the Inclusion Criteria|260|||
162626415|NCT04980040|587348709|FG000|Overall Study|Violated the Administration & Dosage|225|||
162626416|NCT04980040|587348709|FG000|Overall Study|Lost to Safety-Follow-up|4|||
162626417|NCT04980040|587348709|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
162626418|NCT03130257|587348710|FG000|Overall Study|Withdrawal by Subject|1|||
162626419|NCT03130257|587348711|FG001|Overall Study|Withdrawal by Subject|0|||
162626420|NCT03130257|587348712|FG002|Overall Study|Withdrawal by Subject|2|||
162626421|NCT01508650|587348713|FG000|Overall Study|Lost to Follow-up|0|||
162626422|NCT01508650|587348714|FG001|Overall Study|Lost to Follow-up|3|||
162626423|NCT02064894|587348715|FG000|Overall Study|Withdrawal by Subject|43|||
162626424|NCT02064894|587348716|FG001|Overall Study|Withdrawal by Subject|102|||
162626425|NCT02064894|587348717|FG002|Overall Study|Withdrawal by Subject|115|||
162626426|NCT01976338|587348718|FG000|Overall Study|Physician Decision|0|||
162626427|NCT01976338|587348719|FG001|Overall Study|Physician Decision|1|||
162626428|NCT01976338|587348718|FG000|Overall Study|Lost to Follow-up|3|||
162626429|NCT01976338|587348719|FG001|Overall Study|Lost to Follow-up|0|||
162626430|NCT01976338|587348718|FG000|Overall Study|Withdrawal by Subject|5|||
162626431|NCT01976338|587348719|FG001|Overall Study|Withdrawal by Subject|2|||
162626432|NCT01976338|587348718|FG000|Overall Study|Adverse Event|5|||
162626433|NCT01976338|587348719|FG001|Overall Study|Adverse Event|1|||
162626434|NCT00705484|587348723|FG000|Overall Study|Adverse Event|28|||
162626435|NCT00705484|587348724|FG001|Overall Study|Adverse Event|27|||
162626436|NCT00705484|587348723|FG000|Overall Study|Lost to Follow-up|169|||
162626437|NCT00705484|587348724|FG001|Overall Study|Lost to Follow-up|250|||
162626438|NCT00705484|587348723|FG000|Overall Study|Withdrawal by Subject|96|||
162626439|NCT00705484|587348724|FG001|Overall Study|Withdrawal by Subject|72|||
162626440|NCT00705484|587348723|FG000|Overall Study|Administrative|89|||
162626441|NCT00705484|587348724|FG001|Overall Study|Administrative|59|||
162626442|NCT02197247|587348725|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
162626443|NCT02197247|587348725|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
162626444|NCT02197247|587348725|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
162626445|NCT02197247|587348725|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
162626446|NCT02197247|587348725|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
162626447|NCT02197247|587348725|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
162626448|NCT02197247|587348725|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
162626449|NCT02197247|587348725|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
162626450|NCT01606007|587348726|FG000|Overall Study|Reason 'Other' in the protocol|0|||
162626451|NCT01606007|587348727|FG001|Overall Study|Reason 'Other' in the protocol|1|||
162626452|NCT01606007|587348728|FG002|Overall Study|Reason 'Other' in the protocol|1|||
162626453|NCT01606007|587348726|FG000|Overall Study|Pregnancy|0|||
162626454|NCT01606007|587348727|FG001|Overall Study|Pregnancy|1|||
162626455|NCT01606007|587348728|FG002|Overall Study|Pregnancy|1|||
162626456|NCT01606007|587348726|FG000|Overall Study|Withdrawal by Subject|8|||
162626457|NCT01606007|587348727|FG001|Overall Study|Withdrawal by Subject|6|||
162626458|NCT01606007|587348728|FG002|Overall Study|Withdrawal by Subject|1|||
162626459|NCT01606007|587348726|FG000|Overall Study|Adverse Event|0|||
162626460|NCT01606007|587348727|FG001|Overall Study|Adverse Event|1|||
162626461|NCT01606007|587348728|FG002|Overall Study|Adverse Event|1|||
162626462|NCT01606007|587348726|FG000|Overall Study|discontinue study treatment|0|||
162626463|NCT01606007|587348727|FG001|Overall Study|discontinue study treatment|2|||
162626464|NCT01606007|587348728|FG002|Overall Study|discontinue study treatment|1|||
162626465|NCT01606007|587348726|FG000|Overall Study|Lost to Follow-up|6|||
162709413|NCT00062868|587644908|FG004|Dose Level 3|Withdrew|0|||
162709414|NCT00062868|587644909|FG005|Dose Level 3|Withdrew|0|||
162709415|NCT00062868|587644910|FG006|Dose Level 3|Withdrew|0|||
162709416|NCT00062868|587644911|FG007|Dose Level 3|Withdrew|0|||
162709417|NCT00062868|587644912|FG008|Dose Level 3|Withdrew|0|||
162709418|NCT00062868|587644913|FG009|Dose Level 3|Withdrew|0|||
162709419|NCT00062868|587644914|FG010|Dose Level 3|Withdrew|0|||
162709420|NCT00062868|587644915|FG011|Dose Level 3|Withdrew|0|||
162709421|NCT00062868|587644916|FG012|Dose Level 3|Withdrew|0|||
162709422|NCT00062868|587644917|FG013|Dose Level 3|Withdrew|0|||
162709423|NCT00062868|587644918|FG014|Dose Level 3|Withdrew|0|||
162709424|NCT00062868|587644919|FG015|Dose Level 3|Withdrew|0|||
162709425|NCT00062868|587644920|FG016|Dose Level 3|Withdrew|0|||
162709426|NCT00062868|587644921|FG017|Dose Level 3|Withdrew|0|||
162709427|NCT00062868|587644922|FG018|Dose Level 3|Withdrew|0|||
162709428|NCT00062868|587644923|FG019|Dose Level 3|Withdrew|0|||
162709429|NCT00062868|587644924|FG020|Dose Level 3|Withdrew|0|||
162709430|NCT01734811|587644925|FG000|Overall Study|Lost to Follow-up|2|||
162709431|NCT01734811|587644926|FG001|Overall Study|Lost to Follow-up|3|||
162709432|NCT01734811|587644925|FG000|Overall Study|Withdrawal by Subject|2|||
162709433|NCT01734811|587644926|FG001|Overall Study|Withdrawal by Subject|0|||
162709434|NCT03824236|587644927|FG000|Overall Study|Lost to Follow-up|0|||
162709435|NCT03824236|587644928|FG001|Overall Study|Lost to Follow-up|0|||
162709436|NCT03824236|587644929|FG002|Overall Study|Lost to Follow-up|1|||
162709437|NCT01641861|587644930|FG000|Overall Study|Lost to Follow-up|21|||
162709438|NCT01641861|587644931|FG001|Overall Study|Lost to Follow-up|16|||
162709439|NCT01641861|587644930|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
162709440|NCT01641861|587644931|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
162709441|NCT01641861|587644930|FG000|Overall Study|Died due to drowning|0|||
162709442|NCT01641861|587644931|FG001|Overall Study|Died due to drowning|1|||
162709443|NCT01101542|587644934|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
162709444|NCT01101542|587644934|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
162709445|NCT01101542|587644934|FG000|Year 4 Surveillance Period|Other|287|||
162709446|NCT01101542|587644934|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
162709447|NCT01101542|587644934|FG000|Year 5 Surveillance Period|Pregnancy|1|||
162709448|NCT01101542|587644934|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
162709449|NCT01101542|587644934|FG000|Year 6 Surveillance Period|Pregnancy|1|||
162709450|NCT01101542|587644934|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
162709451|NCT00701311|587644935|FG000|Overall Study|Lack of Efficacy|3|||
162709452|NCT00701311|587644935|FG000|Overall Study|Adverse Event|3|||
162709453|NCT00701311|587644935|FG000|Overall Study|Withdrawal by Subject|2|||
162709454|NCT04580407|587644936|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
162709455|NCT00814489|587644964|FG000|Overall Study|Other|2|||
162709456|NCT00814489|587644965|FG001|Overall Study|Other|0|||
162709457|NCT00814489|587644966|FG002|Overall Study|Other|1|||
162709458|NCT01712685|587644967|FG000|Overall Study|pt declined to participate before trmt|1|||
162709459|NCT04880161|587644968|FG000|Overall Study|Withdrawal by Subject|1|||
162709460|NCT04880161|587644969|FG001|Overall Study|Withdrawal by Subject|0|||
162709461|NCT04880161|587644968|FG000|Overall Study|Lack of Compliance|1|||
162709462|NCT04880161|587644969|FG001|Overall Study|Lack of Compliance|1|||
162709463|NCT04880161|587644968|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
162709464|NCT04880161|587644969|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
162709465|NCT04880161|587644968|FG000|Overall Study|Screen Failure|0|||
162709466|NCT04880161|587644969|FG001|Overall Study|Screen Failure|1|||
162709467|NCT00901485|587644970|FG000|Overall Study|Lack of Efficacy|0|||
162967353|NCT01943435|588581340|FG002|Intervention Period|Withdrawal by Subject|4|||
162967354|NCT01943435|588581338|FG000|2 Month Follow up|Lost to Follow-up|2|||
162709468|NCT00901485|587644971|FG001|Overall Study|Lack of Efficacy|2|||
162709469|NCT00901485|587644970|FG000|Overall Study|Withdrawal by Subject|1|||
162709470|NCT00901485|587644971|FG001|Overall Study|Withdrawal by Subject|2|||
162709471|NCT02738840|587646280|FG000|Overall Study|MRI Scan not Performed|5|||
162709472|NCT02738840|587646280|FG000|Overall Study|Lost to Follow-up|1|||
162709473|NCT02738840|587646280|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
162709474|NCT02738840|587646280|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
162709475|NCT02268396|587646283|FG000|Overall Study|Adverse Event|3|||
162709476|NCT02268396|587646283|FG000|Overall Study|Administrative|2|||
162709477|NCT02268396|587646283|FG000|Overall Study|Withdrawal by Subject|1|||
162709478|NCT02268396|587646283|FG000|Overall Study|Lost to Follow-up|2|||
162709479|NCT02268396|587646283|FG000|Overall Study|Protocol-Specified Criteria|2|||
162709480|NCT02268396|587646283|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
162709481|NCT01311648|587646284|FG000|Main Study|Protocol Violation|0|||
162709482|NCT01311648|587646285|FG001|Main Study|Protocol Violation|1|||
162709483|NCT01311648|587646284|FG000|Main Study|Adverse Event|0|||
162709484|NCT01311648|587646285|FG001|Main Study|Adverse Event|1|||
162709485|NCT01311648|587646284|FG000|Main Study|Inhibitor management|0|||
162709486|NCT01311648|587646285|FG001|Main Study|Inhibitor management|17|||
162967355|NCT01943435|588581339|FG001|2 Month Follow up|Lost to Follow-up|3|||
162709487|NCT01311648|587646284|FG000|Main Study|Withdrawal by Subject|0|||
163054238|NCT03736967|588910193|FG000|Overall Study|Death|0|||
163054239|NCT03736967|588910194|FG001|Overall Study|Death|0|||
163054240|NCT03736967|588910195|FG002|Overall Study|Death|0|||
163054241|NCT03736967|588910196|FG003|Overall Study|Death|1|||
163054242|NCT03736967|588910193|FG000|Overall Study|Randomized but never treated|1|||
163054243|NCT03736967|588910194|FG001|Overall Study|Randomized but never treated|0|||
163054244|NCT03736967|588910195|FG002|Overall Study|Randomized but never treated|0|||
163054245|NCT03736967|588910196|FG003|Overall Study|Randomized but never treated|0|||
163054246|NCT02369653|588910197|FG000|Overall Study|Lost to Follow-up|0|||
163054247|NCT02369653|588910198|FG001|Overall Study|Lost to Follow-up|1|||
163054248|NCT02369653|588910197|FG000|Overall Study|Administrative reason by sponsor|0|||
163054249|NCT02369653|588910198|FG001|Overall Study|Administrative reason by sponsor|1|||
163054250|NCT02369653|588910197|FG000|Overall Study|Death|1|||
163054251|NCT02369653|588910198|FG001|Overall Study|Death|2|||
162626466|NCT01606007|587348727|FG001|Overall Study|Lost to Follow-up|8|||
162626467|NCT01606007|587348728|FG002|Overall Study|Lost to Follow-up|5|||
162626468|NCT01606007|587348726|FG000|Overall Study|Poor/Non-compliance|1|||
162626469|NCT01606007|587348727|FG001|Overall Study|Poor/Non-compliance|0|||
162626470|NCT01606007|587348728|FG002|Overall Study|Poor/Non-compliance|0|||
162626471|NCT00851747|587348730|FG000|Overall Study|Physician Decision|6|||
162626472|NCT00851747|587348731|FG001|Overall Study|Physician Decision|6|||
162626473|NCT00851747|587348732|FG002|Overall Study|Physician Decision|6|||
162626474|NCT02499783|587348735|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
162626475|NCT02499783|587348736|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
162626476|NCT02499783|587348737|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
162626477|NCT02499783|587348735|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
162626478|NCT02499783|587348736|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
162626479|NCT02499783|587348737|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
162626480|NCT02499783|587348735|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
162626481|NCT02499783|587348736|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
162626482|NCT02499783|587348737|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
162626483|NCT02499783|587348735|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
162626484|NCT02499783|587348736|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
162626485|NCT02499783|587348737|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
162626486|NCT02499783|587348735|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
162626487|NCT02499783|587348736|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
162626488|NCT02499783|587348737|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
162626489|NCT02499783|587348735|FG000|DB Period: Weeks 0-8|Other|1|||
162626490|NCT02499783|587348736|FG001|DB Period: Weeks 0-8|Other|1|||
162626491|NCT02499783|587348737|FG002|DB Period: Weeks 0-8|Other|0|||
162626492|NCT02499783|587348735|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
162626493|NCT02499783|587348736|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
162626494|NCT02499783|587348737|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
162626495|NCT02499783|587348735|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
162626496|NCT02499783|587348736|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
162626497|NCT02499783|587348737|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
162626498|NCT02499783|587348735|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
162626499|NCT02499783|587348736|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
162626500|NCT02499783|587348737|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
162626501|NCT02499783|587348735|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
162626502|NCT02499783|587348736|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
162626503|NCT02499783|587348737|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
162626504|NCT02228460|587348738|FG000|Overall Study|Adverse Event|1|||
162626505|NCT02228460|587348738|FG000|Overall Study|Lost to Follow-up|1|||
162626506|NCT01243892|587348739|FG000|Overall Study|Did not meet eligibility criteria|2|||
162626507|NCT01243892|587348740|FG001|Overall Study|Did not meet eligibility criteria|0|||
162626508|NCT00119106|587348745|FG000|Overall Study|HIV infected at baseline|179|||
162626509|NCT00119106|587348746|FG001|Overall Study|HIV infected at baseline|178|||
162626510|NCT01866293|587348747|FG000|Overall Study|Adverse Event|2|||
162626511|NCT01010061|587348748|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
162626512|NCT01010061|587348749|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
162626513|NCT01010061|587348748|FG000|Overall Study|Disease Progression|2|||
162626514|NCT01010061|587348749|FG001|Overall Study|Disease Progression|8|||
162626515|NCT01010061|587348748|FG000|Overall Study|Withdrew Consent|5|||
162626516|NCT01010061|587348749|FG001|Overall Study|Withdrew Consent|1|||
162626517|NCT01010061|587348748|FG000|Overall Study|Death|3|||
162626518|NCT01010061|587348749|FG001|Overall Study|Death|6|||
162626519|NCT01010061|587348748|FG000|Overall Study|Administrative/Other|0|||
162626520|NCT01010061|587348749|FG001|Overall Study|Administrative/Other|1|||
162626521|NCT01010061|587348748|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
162626522|NCT01010061|587348749|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162626523|NCT01010061|587348748|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162626524|NCT01010061|587348749|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162626525|NCT01010061|587348748|FG000|Overall Study|Violation of Selection Criteria|0|||
162709488|NCT01311648|587646285|FG001|Main Study|Withdrawal by Subject|2|||
162709489|NCT01311648|587646284|FG000|Extension Study|Physician Decision|0|||
162709490|NCT01311648|587646285|FG001|Extension Study|Physician Decision|1|||
162709491|NCT01311648|587646284|FG000|Extension Study|ITI therapy with marketed product|0|||
162709492|NCT01311648|587646285|FG001|Extension Study|ITI therapy with marketed product|1|||
162709493|NCT01311648|587646284|FG000|Extension Study|Incorrect visit planning|0|||
162709494|NCT01311648|587646285|FG001|Extension Study|Incorrect visit planning|1|||
162709495|NCT01311648|587646284|FG000|Extension Study|Family's decision|0|||
162709496|NCT01311648|587646285|FG001|Extension Study|Family's decision|1|||
162709497|NCT01311648|587646284|FG000|Extension Study|Failure of ITI therapy|0|||
162709498|NCT01311648|587646285|FG001|Extension Study|Failure of ITI therapy|3|||
162709499|NCT01311648|587646284|FG000|Extension Study|Long travel|0|||
162709500|NCT01311648|587646285|FG001|Extension Study|Long travel|1|||
162709501|NCT01311648|587646284|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
162709502|NCT01311648|587646285|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
162709503|NCT01311648|587646284|FG000|Extension Study|Withdrawal by Subject|0|||
162709504|NCT01311648|587646285|FG001|Extension Study|Withdrawal by Subject|1|||
162709505|NCT01311648|587646284|FG000|Extension Study|Inhibitor management|0|||
162709506|NCT01311648|587646285|FG001|Extension Study|Inhibitor management|2|||
162709507|NCT01645111|587646286|FG000|Overall Study|Did not require Clevidipine|15|||
162709508|NCT01304706|587646292|FG000|Overall Study|Adverse Event|2|||
162709509|NCT01304706|587646292|FG000|Overall Study|Lack of Efficacy|1|||
162709510|NCT01304706|587646292|FG000|Overall Study|Death|3|||
162709511|NCT01304706|587646292|FG000|Overall Study|Withdrawal by Subject|3|||
162709512|NCT01304706|587646292|FG000|Overall Study|Lost to Follow-up|7|||
162709513|NCT01304706|587646292|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
162709514|NCT05526911|587646295|FG000|Overall Study|Adverse Event|2|||
162709515|NCT05025449|587646296|FG000|Overall Study|Withdrawal by Subject|1|||
162709516|NCT05025449|587646296|FG000|Overall Study|Patient emergently taken to operating room|1|||
162709517|NCT00256308|587646297|FG000|Overall Study|Death|2|||
162709518|NCT01419717|587646298|FG000|Overall Study|Protocol-specified Criteria|62|||
162709519|NCT01419717|587646298|FG000|Overall Study|Adverse Event|19|||
162709520|NCT01419717|587646298|FG000|Overall Study|Death|17|||
162709521|NCT01419717|587646298|FG000|Overall Study|Withdrawal by Subject|10|||
162709522|NCT01419717|587646298|FG000|Overall Study|Disease Progression|9|||
162709523|NCT01419717|587646298|FG000|Overall Study|Other|4|||
162709524|NCT01419717|587646298|FG000|Overall Study|Lost to Follow-up|2|||
162709525|NCT01419717|587646298|FG000|Overall Study|Administrative Decision|1|||
162709526|NCT01419717|587646298|FG000|Overall Study|Noncompliance|1|||
162709527|NCT01240356|587646300|FG000|Overall Study|Withdrawal by Subject|2|||
162709528|NCT01240356|587646301|FG001|Overall Study|Withdrawal by Subject|0|||
162709529|NCT01240356|587646300|FG000|Overall Study|MRI contraindication|1|||
162709530|NCT01240356|587646301|FG001|Overall Study|MRI contraindication|0|||
162709531|NCT04048135|587646304|FG000|Overall Study|Withdrawal by Subject|1|||
162709532|NCT04048135|587646305|FG001|Overall Study|Withdrawal by Subject|1|||
162709533|NCT04048135|587646306|FG002|Overall Study|Withdrawal by Subject|1|||
162709534|NCT04048135|587646307|FG003|Overall Study|Withdrawal by Subject|2|||
162709535|NCT04048135|587646308|FG004|Overall Study|Withdrawal by Subject|0|||
162709536|NCT04048135|587646309|FG005|Overall Study|Withdrawal by Subject|0|||
162709537|NCT04048135|587646310|FG006|Overall Study|Withdrawal by Subject|1|||
162709538|NCT04048135|587646311|FG007|Overall Study|Withdrawal by Subject|1|||
162709539|NCT04048135|587646304|FG000|Overall Study|Adverse Event|0|||
162709540|NCT04048135|587646305|FG001|Overall Study|Adverse Event|0|||
162709541|NCT04048135|587646306|FG002|Overall Study|Adverse Event|0|||
162709542|NCT04048135|587646307|FG003|Overall Study|Adverse Event|1|||
162709543|NCT04048135|587646308|FG004|Overall Study|Adverse Event|1|||
162709544|NCT04048135|587646309|FG005|Overall Study|Adverse Event|0|||
162709545|NCT04048135|587646310|FG006|Overall Study|Adverse Event|0|||
162709546|NCT04048135|587646311|FG007|Overall Study|Adverse Event|0|||
162709547|NCT04048135|587646304|FG000|Overall Study|Protocol Violation|0|||
162709548|NCT04048135|587646305|FG001|Overall Study|Protocol Violation|0|||
162709549|NCT04048135|587646306|FG002|Overall Study|Protocol Violation|0|||
162709550|NCT04048135|587646307|FG003|Overall Study|Protocol Violation|0|||
162709551|NCT04048135|587646308|FG004|Overall Study|Protocol Violation|0|||
162709552|NCT04048135|587646309|FG005|Overall Study|Protocol Violation|1|||
162709553|NCT04048135|587646310|FG006|Overall Study|Protocol Violation|0|||
162709554|NCT04048135|587646311|FG007|Overall Study|Protocol Violation|0|||
162709555|NCT00448864|587646312|FG000|Overall Study|Death|1|||
162709556|NCT00448864|587646313|FG001|Overall Study|Death|0|||
162709557|NCT00448864|587646314|FG002|Overall Study|Death|0|||
162709558|NCT00448864|587646312|FG000|Overall Study|Lost to Follow-up|3|||
162709559|NCT00448864|587646313|FG001|Overall Study|Lost to Follow-up|1|||
162709560|NCT00448864|587646314|FG002|Overall Study|Lost to Follow-up|0|||
162709561|NCT00448864|587646312|FG000|Overall Study|Physician Decision|1|||
162709562|NCT00448864|587646313|FG001|Overall Study|Physician Decision|0|||
162709563|NCT00448864|587646314|FG002|Overall Study|Physician Decision|1|||
162709564|NCT00448864|587646312|FG000|Overall Study|Withdrawal by Subject|0|||
162709565|NCT00448864|587646313|FG001|Overall Study|Withdrawal by Subject|2|||
162906352|NCT00775138|588355623|FG000|Overall Study|Withdrawal by Subject|0|||
162906353|NCT00775138|588355624|FG001|Overall Study|Withdrawal by Subject|0|||
162906354|NCT00775138|588355625|FG002|Overall Study|Withdrawal by Subject|2|||
162906355|NCT00775138|588355626|FG003|Overall Study|Withdrawal by Subject|2|||
162906356|NCT00775138|588355623|FG000|Overall Study|Adverse Event|0|||
162906357|NCT00775138|588355624|FG001|Overall Study|Adverse Event|0|||
162906358|NCT00775138|588355625|FG002|Overall Study|Adverse Event|1|||
162906359|NCT00775138|588355626|FG003|Overall Study|Adverse Event|0|||
162906360|NCT00712712|588355629|FG000|Overall Study|Protocol Violation|11|||
162906361|NCT00712712|588355629|FG000|Overall Study|Radiofrequency not done|3|||
162906362|NCT00712712|588355629|FG000|Overall Study|Death|8|||
162906363|NCT00712712|588355629|FG000|Overall Study|Withdrawal by Subject|1|||
162906364|NCT02723019|588355630|FG000|Overall Study|Death|17|||
162906365|NCT02723019|588355631|FG001|Overall Study|Death|13|||
162906366|NCT02723019|588355630|FG000|Overall Study|Withdrawal by Subject|11|||
162906367|NCT02723019|588355631|FG001|Overall Study|Withdrawal by Subject|7|||
162906368|NCT02723019|588355630|FG000|Overall Study|Lost to Follow-up|57|||
162906369|NCT02723019|588355631|FG001|Overall Study|Lost to Follow-up|70|||
162626526|NCT01010061|587348749|FG001|Overall Study|Violation of Selection Criteria|1|||
162906370|NCT00611767|588355633|FG000|Overall Study|Withdrawal by Subject|4|||
162906371|NCT00611767|588355634|FG001|Overall Study|Withdrawal by Subject|1|||
162906372|NCT00611767|588355633|FG000|Overall Study|Thiopental not available|3|||
162906373|NCT00611767|588355634|FG001|Overall Study|Thiopental not available|0|||
162906374|NCT00611767|588355633|FG000|Overall Study|didn't like the medication|1|||
162906375|NCT00611767|588355634|FG001|Overall Study|didn't like the medication|1|||
162906376|NCT00611767|588355633|FG000|Overall Study|Physician Decision|1|||
162626527|NCT01010061|587348748|FG000|Overall Study|Did Not Receive Treatment|2|||
162626528|NCT01010061|587348749|FG001|Overall Study|Did Not Receive Treatment|2|||
162626529|NCT03066804|587348750|FG000|Overall Study|Physician Decision|0|||
162626530|NCT03066804|587348751|FG001|Overall Study|Physician Decision|4|||
162626531|NCT03066804|587348750|FG000|Overall Study|Death|23|||
162626532|NCT03066804|587348751|FG001|Overall Study|Death|17|||
162626533|NCT03066804|587348750|FG000|Overall Study|Withdrawal by Subject|19|||
162626534|NCT03066804|587348751|FG001|Overall Study|Withdrawal by Subject|25|||
162626535|NCT03066804|587348750|FG000|Overall Study|Lost to Follow-up|2|||
162626536|NCT03066804|587348751|FG001|Overall Study|Lost to Follow-up|0|||
162626537|NCT03066804|587348750|FG000|Overall Study|Adverse Event|2|||
162626538|NCT03066804|587348751|FG001|Overall Study|Adverse Event|3|||
162626539|NCT03066804|587348750|FG000|Overall Study|Technical problems|5|||
162626540|NCT03066804|587348751|FG001|Overall Study|Technical problems|1|||
162626541|NCT03982368|587348756|FG000|Overall Study|Adverse Event|6|||
162626542|NCT03982368|587348757|FG001|Overall Study|Adverse Event|4|||
162626543|NCT03982368|587348758|FG002|Overall Study|Adverse Event|3|||
162626544|NCT03982368|587348756|FG000|Overall Study|Lost to Follow-up|2|||
162626545|NCT03982368|587348757|FG001|Overall Study|Lost to Follow-up|1|||
162626546|NCT03982368|587348758|FG002|Overall Study|Lost to Follow-up|0|||
162626547|NCT03982368|587348756|FG000|Overall Study|Withdrawal by Subject|1|||
162626548|NCT03982368|587348757|FG001|Overall Study|Withdrawal by Subject|2|||
162626549|NCT03982368|587348758|FG002|Overall Study|Withdrawal by Subject|0|||
162626550|NCT03982368|587348756|FG000|Overall Study|unknow|4|||
162626551|NCT03982368|587348757|FG001|Overall Study|unknow|0|||
162906377|NCT00611767|588355634|FG001|Overall Study|Physician Decision|0|||
162906378|NCT02718625|588355635|FG000|Overall Study|Adverse Event|0|||
162906379|NCT02718625|588355636|FG001|Overall Study|Adverse Event|1|||
162906380|NCT02718625|588355635|FG000|Overall Study|Termination of Study by Sponsor|0|||
162906381|NCT02718625|588355636|FG001|Overall Study|Termination of Study by Sponsor|1|||
162906382|NCT00811395|588355637|FG000|Extension Treatment|Adverse Event|1|||
162906383|NCT00811395|588355638|FG001|Extension Treatment|Adverse Event|2|||
162906384|NCT00811395|588355639|FG002|Extension Treatment|Adverse Event|2|||
162906385|NCT00811395|588355640|FG003|Extension Treatment|Adverse Event|2|||
162906386|NCT00811395|588355641|FG004|Extension Treatment|Adverse Event|0|||
162906387|NCT00811395|588355642|FG005|Extension Treatment|Adverse Event|1|||
162906388|NCT00811395|588355637|FG000|Extension Treatment|Progressive disease|1|||
162906389|NCT00811395|588355638|FG001|Extension Treatment|Progressive disease|1|||
162906390|NCT00811395|588355639|FG002|Extension Treatment|Progressive disease|0|||
162906391|NCT00811395|588355640|FG003|Extension Treatment|Progressive disease|0|||
162906392|NCT00811395|588355641|FG004|Extension Treatment|Progressive disease|0|||
162626552|NCT03982368|587348758|FG002|Overall Study|unknow|2|||
162626553|NCT03570697|587348759|FG000|Overall Study|Lost to Follow-up|0|||
162626554|NCT03570697|587348760|FG001|Overall Study|Lost to Follow-up|1|||
162626555|NCT03570697|587348759|FG000|Overall Study|Death|2|||
162626556|NCT03570697|587348760|FG001|Overall Study|Death|0|||
162626557|NCT03570697|587348759|FG000|Overall Study|Withdrawal by Subject|4|||
162626558|NCT03570697|587348760|FG001|Overall Study|Withdrawal by Subject|2|||
162626559|NCT00518284|587348761|FG000|Overall Study|Adverse Event|0|||
162626560|NCT00518284|587348762|FG001|Overall Study|Adverse Event|1|||
162626561|NCT00518284|587348763|FG002|Overall Study|Adverse Event|0|||
162626562|NCT00518284|587348764|FG003|Overall Study|Adverse Event|0|||
162626563|NCT00518284|587348761|FG000|Overall Study|Study Termination|0|||
162626564|NCT00518284|587348762|FG001|Overall Study|Study Termination|2|||
162626565|NCT00518284|587348763|FG002|Overall Study|Study Termination|1|||
162626566|NCT00518284|587348764|FG003|Overall Study|Study Termination|2|||
162626567|NCT01849783|587348765|FG000|Overall Study|Adverse Event|5|||
162709566|NCT00448864|587646314|FG002|Overall Study|Withdrawal by Subject|0|||
162709567|NCT00448864|587646312|FG000|Overall Study|Protocol Violation|0|||
162709568|NCT00448864|587646313|FG001|Overall Study|Protocol Violation|2|||
162709569|NCT00448864|587646314|FG002|Overall Study|Protocol Violation|0|||
162709570|NCT01474538|587646316|FG000|Treatment Period 1|Death|1|||
162709571|NCT01474538|587646317|FG001|Treatment Period 1|Death|0|||
162709572|NCT01474538|587646316|FG000|Treatment Period 1|Physician Decision|1|||
162709573|NCT01474538|587646317|FG001|Treatment Period 1|Physician Decision|0|||
162709574|NCT01474538|587646316|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162709575|NCT01474538|587646317|FG001|Treatment Period 1|Withdrawal by Subject|3|||
162709576|NCT01474538|587646316|FG000|Treatment Period 1|Protocol Violation|0|||
162709577|NCT01474538|587646317|FG001|Treatment Period 1|Protocol Violation|1|||
162709578|NCT01474538|587646316|FG000|Treatment Period 2|Death|1|||
162709579|NCT01474538|587646317|FG001|Treatment Period 2|Death|0|||
162709580|NCT01474538|587646316|FG000|Treatment Period 2|Adverse Event|1|||
162709581|NCT01474538|587646317|FG001|Treatment Period 2|Adverse Event|1|||
162709582|NCT01474538|587646316|FG000|Treatment Period 2|Withdrawal by Subject|2|||
162709583|NCT01474538|587646317|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162709584|NCT01474538|587646316|FG000|Treatment Period 2|Sponsor decision|1|||
162709585|NCT01474538|587646317|FG001|Treatment Period 2|Sponsor decision|0|||
162709586|NCT01474538|587646316|FG000|Treatment Period 2|Physician Decision|0|||
162709587|NCT01474538|587646317|FG001|Treatment Period 2|Physician Decision|1|||
162709588|NCT01474538|587646316|FG000|Treatment Period 2|Protocol Violation|1|||
162709589|NCT01474538|587646317|FG001|Treatment Period 2|Protocol Violation|0|||
162709590|NCT00367237|587646318|FG000|Overall Study|Adverse Event|7|||
162709591|NCT00367237|587646319|FG001|Overall Study|Adverse Event|2|||
162709592|NCT00367237|587646318|FG000|Overall Study|Lost to Follow-up|1|||
162709593|NCT00367237|587646319|FG001|Overall Study|Lost to Follow-up|0|||
162709594|NCT00367237|587646318|FG000|Overall Study|Withdrawal by Subject|0|||
162709595|NCT00367237|587646319|FG001|Overall Study|Withdrawal by Subject|4|||
162709596|NCT00367237|587646318|FG000|Overall Study|Protocol Violation|2|||
162709597|NCT00367237|587646319|FG001|Overall Study|Protocol Violation|5|||
162709598|NCT02501629|587646320|FG000|Overall Study|Death|0|||
162709599|NCT02501629|587646321|FG001|Overall Study|Death|1|||
162709600|NCT02501629|587646320|FG000|Overall Study|Withdrawn from study by sponsor|1|||
162709601|NCT02501629|587646321|FG001|Overall Study|Withdrawn from study by sponsor|0|||
162709602|NCT02501629|587646320|FG000|Overall Study|Early termination by sponsor|1|||
162709603|NCT02501629|587646321|FG001|Overall Study|Early termination by sponsor|0|||
162709604|NCT02501629|587646320|FG000|Overall Study|Withdrawal by Subject|3|||
162709605|NCT02501629|587646321|FG001|Overall Study|Withdrawal by Subject|5|||
162709606|NCT02501629|587646320|FG000|Overall Study|Subject did not return to site|0|||
162709607|NCT02501629|587646321|FG001|Overall Study|Subject did not return to site|1|||
162709608|NCT00868231|587646322|FG000|Treatment Period 1|Adverse Event|0|||
162709609|NCT00868231|587646323|FG001|Treatment Period 1|Adverse Event|0|||
162709610|NCT00868231|587646324|FG002|Treatment Period 1|Adverse Event|0|||
162709611|NCT00868231|587646325|FG003|Treatment Period 1|Adverse Event|0|||
162709612|NCT00868231|587646326|FG004|Treatment Period 1|Adverse Event|1|||
162709613|NCT00868231|587646327|FG005|Treatment Period 1|Adverse Event|0|||
162906393|NCT00811395|588355642|FG005|Extension Treatment|Progressive disease|0|||
162906394|NCT00811395|588355637|FG000|Extension Treatment|Participant did not wish to continue|0|||
162709614|NCT00868231|587646322|FG000|Treatment Period 2|Adverse Event|1|||
162709615|NCT00868231|587646323|FG001|Treatment Period 2|Adverse Event|0|||
162709616|NCT00868231|587646324|FG002|Treatment Period 2|Adverse Event|0|||
162709617|NCT00868231|587646325|FG003|Treatment Period 2|Adverse Event|0|||
162709618|NCT00868231|587646326|FG004|Treatment Period 2|Adverse Event|0|||
162709619|NCT00868231|587646327|FG005|Treatment Period 2|Adverse Event|0|||
162709620|NCT00868231|587646322|FG000|Treatment Period 3|Adverse Event|0|||
162906395|NCT00811395|588355638|FG001|Extension Treatment|Participant did not wish to continue|3|||
162709621|NCT00868231|587646323|FG001|Treatment Period 3|Adverse Event|0|||
162709622|NCT00868231|587646324|FG002|Treatment Period 3|Adverse Event|1|||
162709623|NCT00868231|587646325|FG003|Treatment Period 3|Adverse Event|0|||
162709624|NCT00868231|587646326|FG004|Treatment Period 3|Adverse Event|0|||
162709625|NCT00868231|587646327|FG005|Treatment Period 3|Adverse Event|0|||
162709626|NCT03120676|587646328|FG000|Overall Study|Not treated|1|||
162906396|NCT00811395|588355639|FG002|Extension Treatment|Participant did not wish to continue|0|||
162906397|NCT00811395|588355640|FG003|Extension Treatment|Participant did not wish to continue|1|||
162906398|NCT00811395|588355641|FG004|Extension Treatment|Participant did not wish to continue|0|||
162906399|NCT00811395|588355642|FG005|Extension Treatment|Participant did not wish to continue|1|||
162906400|NCT00811395|588355637|FG000|Extension Treatment|Other than above|0|||
162906401|NCT00811395|588355638|FG001|Extension Treatment|Other than above|0|||
162906402|NCT00811395|588355639|FG002|Extension Treatment|Other than above|1|||
162906403|NCT00811395|588355640|FG003|Extension Treatment|Other than above|0|||
162709627|NCT00886613|587646333|FG000|Overall Study|Protocol deviation (Part B)|1|||
162709628|NCT00886613|587646334|FG001|Overall Study|Protocol deviation (Part B)|0|||
162709629|NCT00886613|587646335|FG002|Overall Study|Protocol deviation (Part B)|0|||
162709630|NCT00886613|587646333|FG000|Overall Study|Lost to follow-up (Part B)|1|||
162709631|NCT00886613|587646334|FG001|Overall Study|Lost to follow-up (Part B)|0|||
162709632|NCT00886613|587646335|FG002|Overall Study|Lost to follow-up (Part B)|1|||
162709633|NCT00886613|587646333|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
162709634|NCT00886613|587646334|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
162709635|NCT00886613|587646335|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
162709636|NCT01124162|587646336|FG000|First Intervention|Adverse Event|2|||
162709637|NCT01124162|587646337|FG001|First Intervention|Adverse Event|0|||
162709638|NCT01124162|587646336|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162709639|NCT01124162|587646337|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162709640|NCT03681691|587646338|FG000|Overall Study|COVID|1|||
162709641|NCT03681691|587646339|FG001|Overall Study|COVID|0|||
162709642|NCT03681691|587646338|FG000|Overall Study|prolonged bleeding|1|||
162709643|NCT03681691|587646339|FG001|Overall Study|prolonged bleeding|0|||
162709644|NCT03681691|587646338|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
162709645|NCT03681691|587646339|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
162709646|NCT00465985|587646340|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
162709647|NCT00465985|587646341|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
162709648|NCT00465985|587646340|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
162709649|NCT00465985|587646341|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
162709650|NCT00465985|587646340|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
162709651|NCT00465985|587646341|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
162709652|NCT00465985|587646340|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
162709653|NCT00465985|587646341|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
162709654|NCT02534896|587646342|FG000|Overall Study|Adverse Event|2|||
162709655|NCT02534896|587646343|FG001|Overall Study|Adverse Event|1|||
162709656|NCT02534896|587646344|FG002|Overall Study|Adverse Event|1|||
163054252|NCT02369653|588910197|FG000|Overall Study|Participant withdrew consent|13|||
162709657|NCT02534896|587646342|FG000|Overall Study|Insufficient therapeutic response|2|||
162709658|NCT02534896|587646343|FG001|Overall Study|Insufficient therapeutic response|0|||
162709659|NCT02534896|587646344|FG002|Overall Study|Insufficient therapeutic response|0|||
162709660|NCT00269399|587646345|FG000|Overall Study|Lack of Efficacy|27|||
162709661|NCT00269399|587646346|FG001|Overall Study|Lack of Efficacy|10|||
163054253|NCT02369653|588910198|FG001|Overall Study|Participant withdrew consent|3|||
162709662|NCT00269399|587646345|FG000|Overall Study|Adverse Event|10|||
162709663|NCT00269399|587646346|FG001|Overall Study|Adverse Event|4|||
162709664|NCT00269399|587646345|FG000|Overall Study|Withdrawal by Subject|2|||
162626568|NCT01849783|587348765|FG000|Overall Study|Death|2|||
162626569|NCT01849783|587348765|FG000|Overall Study|Physician Decision|1|||
162626570|NCT01849783|587348765|FG000|Overall Study|Withdrawal by Subject|1|||
162626571|NCT01849783|587348765|FG000|Overall Study|Unable to comply|2|||
162626572|NCT01849783|587348765|FG000|Overall Study|Disease progression|11|||
162626573|NCT02571777|587348766|FG000|Overall Study|Subject/guardian decision|34|||
162626574|NCT02571777|587348767|FG001|Overall Study|Subject/guardian decision|26|||
162626575|NCT02571777|587348768|FG002|Overall Study|Subject/guardian decision|26|||
162626576|NCT02571777|587348769|FG003|Overall Study|Subject/guardian decision|25|||
162626577|NCT02571777|587348770|FG004|Overall Study|Subject/guardian decision|27|||
162626578|NCT02571777|587348766|FG000|Overall Study|Protocol Deviation|2|||
162626579|NCT02571777|587348767|FG001|Overall Study|Protocol Deviation|3|||
162626580|NCT02571777|587348768|FG002|Overall Study|Protocol Deviation|4|||
162626581|NCT02571777|587348769|FG003|Overall Study|Protocol Deviation|8|||
162626582|NCT02571777|587348770|FG004|Overall Study|Protocol Deviation|4|||
162626583|NCT02571777|587348766|FG000|Overall Study|Death|1|||
162626584|NCT02571777|587348767|FG001|Overall Study|Death|1|||
162626585|NCT02571777|587348768|FG002|Overall Study|Death|4|||
162626586|NCT02571777|587348769|FG003|Overall Study|Death|0|||
162626587|NCT02571777|587348770|FG004|Overall Study|Death|0|||
162626588|NCT02571777|587348766|FG000|Overall Study|Lost to Follow-up|1|||
162626589|NCT02571777|587348767|FG001|Overall Study|Lost to Follow-up|1|||
162626590|NCT02571777|587348768|FG002|Overall Study|Lost to Follow-up|2|||
162626591|NCT02571777|587348769|FG003|Overall Study|Lost to Follow-up|0|||
162626592|NCT02571777|587348770|FG004|Overall Study|Lost to Follow-up|1|||
162626593|NCT02571777|587348766|FG000|Overall Study|Physician Decision|1|||
162626594|NCT02571777|587348767|FG001|Overall Study|Physician Decision|7|||
162626595|NCT02571777|587348768|FG002|Overall Study|Physician Decision|5|||
162626596|NCT02571777|587348769|FG003|Overall Study|Physician Decision|2|||
162626597|NCT02571777|587348770|FG004|Overall Study|Physician Decision|4|||
162626598|NCT02571777|587348766|FG000|Overall Study|Pregnancy|0|||
162626599|NCT02571777|587348767|FG001|Overall Study|Pregnancy|0|||
162626600|NCT02571777|587348768|FG002|Overall Study|Pregnancy|0|||
162626601|NCT02571777|587348769|FG003|Overall Study|Pregnancy|2|||
162626602|NCT02571777|587348770|FG004|Overall Study|Pregnancy|0|||
162626603|NCT05393895|587348774|FG000|Overall Study|Adverse Event|2|||
162626604|NCT05393895|587348775|FG001|Overall Study|Adverse Event|3|||
162626605|NCT05393895|587348774|FG000|Overall Study|Lost to Follow-up|4|||
162626606|NCT05393895|587348775|FG001|Overall Study|Lost to Follow-up|3|||
162626607|NCT05393895|587348774|FG000|Overall Study|Protocol Violation|1|||
162626608|NCT05393895|587348775|FG001|Overall Study|Protocol Violation|0|||
162626609|NCT05393895|587348774|FG000|Overall Study|Withdrawal by Subject|1|||
162626610|NCT05393895|587348775|FG001|Overall Study|Withdrawal by Subject|4|||
162626611|NCT03190915|587348776|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
162626612|NCT03190915|587348776|FG000|Overall Study|Progressive Disease|3|||
162626613|NCT01546883|587348790|FG000|Overall Study|Withdrawal by Subject|3|||
162626614|NCT01546883|587348790|FG000|Overall Study|Adverse Event|4|||
162626615|NCT01546883|587348790|FG000|Overall Study|Lost to Follow-up|2|||
162626616|NCT01546883|587348790|FG000|Overall Study|early closure of study|2|||
162626617|NCT01546883|587348790|FG000|Overall Study|other unrelated illness|1|||
162626618|NCT02021773|587348791|FG000|Overall Study|Adverse Event|1|||
162626619|NCT02021773|587348792|FG001|Overall Study|Adverse Event|4|||
162626620|NCT02021773|587348793|FG002|Overall Study|Adverse Event|3|||
162626621|NCT02021773|587348791|FG000|Overall Study|Lack of Efficacy|2|||
162626622|NCT02021773|587348792|FG001|Overall Study|Lack of Efficacy|2|||
162626623|NCT02021773|587348793|FG002|Overall Study|Lack of Efficacy|2|||
162626624|NCT02021773|587348791|FG000|Overall Study|Protocol Violation|2|||
162626625|NCT02021773|587348792|FG001|Overall Study|Protocol Violation|3|||
162626626|NCT02021773|587348793|FG002|Overall Study|Protocol Violation|1|||
162626627|NCT02021773|587348791|FG000|Overall Study|Withdrawal by Subject|3|||
162626628|NCT02021773|587348792|FG001|Overall Study|Withdrawal by Subject|4|||
162626629|NCT02021773|587348793|FG002|Overall Study|Withdrawal by Subject|5|||
162626630|NCT02021773|587348791|FG000|Overall Study|Lost to Follow-up|1|||
162626631|NCT02021773|587348792|FG001|Overall Study|Lost to Follow-up|3|||
162626632|NCT02021773|587348793|FG002|Overall Study|Lost to Follow-up|0|||
162709665|NCT00269399|587646346|FG001|Overall Study|Withdrawal by Subject|5|||
162709666|NCT00269399|587646345|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
162709667|NCT00269399|587646346|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
162709668|NCT00269399|587646345|FG000|Overall Study|Other|0|||
162709669|NCT00269399|587646346|FG001|Overall Study|Other|4|||
162709670|NCT00269399|587646345|FG000|Overall Study|Development of exclusion criteria|0|||
162709671|NCT00269399|587646346|FG001|Overall Study|Development of exclusion criteria|1|||
162709672|NCT03439124|587646347|FG000|Overall Study|Adverse Event|2|||
162709673|NCT03439124|587646348|FG001|Overall Study|Adverse Event|0|||
162709674|NCT03439124|587646347|FG000|Overall Study|Lost to Follow-up|1|||
162709675|NCT03439124|587646348|FG001|Overall Study|Lost to Follow-up|0|||
162709676|NCT03439124|587646347|FG000|Overall Study|Other reasons|1|||
162709677|NCT03439124|587646348|FG001|Overall Study|Other reasons|0|||
162709678|NCT04353037|587646349|FG000|Overall Study|Lost to Follow-up|0|||
162709679|NCT04353037|587646350|FG001|Overall Study|Lost to Follow-up|1|||
162709680|NCT04353037|587646351|FG002|Overall Study|Lost to Follow-up|2|||
162709681|NCT04353037|587646352|FG003|Overall Study|Lost to Follow-up|3|||
162709682|NCT04353037|587646349|FG000|Overall Study|Withdrawal by Subject|0|||
162709683|NCT04353037|587646350|FG001|Overall Study|Withdrawal by Subject|2|||
162709684|NCT04353037|587646351|FG002|Overall Study|Withdrawal by Subject|3|||
162709685|NCT04353037|587646352|FG003|Overall Study|Withdrawal by Subject|5|||
162709686|NCT04353037|587646349|FG000|Overall Study|Adverse Event|0|||
162709687|NCT04353037|587646350|FG001|Overall Study|Adverse Event|0|||
162709688|NCT04353037|587646351|FG002|Overall Study|Adverse Event|2|||
162709689|NCT04353037|587646352|FG003|Overall Study|Adverse Event|0|||
162906404|NCT00811395|588355641|FG004|Extension Treatment|Other than above|0|||
162906405|NCT00811395|588355642|FG005|Extension Treatment|Other than above|0|||
162906406|NCT01947127|588355647|FG000|Overall Study|Protocol Violation|18|||
162906407|NCT01947127|588355648|FG001|Overall Study|Protocol Violation|38|||
162906408|NCT01947127|588355647|FG000|Overall Study|Withdrawal by Subject|1|||
162906409|NCT01947127|588355648|FG001|Overall Study|Withdrawal by Subject|1|||
162906410|NCT01947127|588355647|FG000|Overall Study|Data loss|4|||
162906411|NCT01947127|588355648|FG001|Overall Study|Data loss|4|||
162906412|NCT00170846|588355649|FG000|Overall Study|Subject withdrew Informed Consent|5|||
162906413|NCT00170846|588355650|FG001|Overall Study|Subject withdrew Informed Consent|12|||
162906414|NCT00170846|588355651|FG002|Overall Study|Subject withdrew Informed Consent|8|||
162906415|NCT00170846|588355649|FG000|Overall Study|Lost to Follow-up|6|||
162906416|NCT00170846|588355650|FG001|Overall Study|Lost to Follow-up|3|||
162906417|NCT00170846|588355651|FG002|Overall Study|Lost to Follow-up|2|||
162906418|NCT00170846|588355649|FG000|Overall Study|Death|0|||
162906419|NCT00170846|588355650|FG001|Overall Study|Death|3|||
162906420|NCT00170846|588355651|FG002|Overall Study|Death|3|||
162906421|NCT00170846|588355649|FG000|Overall Study|Reason Missing|0|||
162906422|NCT00170846|588355650|FG001|Overall Study|Reason Missing|1|||
162906423|NCT00170846|588355651|FG002|Overall Study|Reason Missing|0|||
162906424|NCT00952588|588355652|FG000|Overall Study|Death|28|||
162906425|NCT00952588|588355653|FG001|Overall Study|Death|13|||
162906426|NCT00952588|588355652|FG000|Overall Study|Withdrawal by Subject|2|||
162906427|NCT00952588|588355653|FG001|Overall Study|Withdrawal by Subject|5|||
162906428|NCT00952588|588355652|FG000|Overall Study|Adverse Event|2|||
162906429|NCT00952588|588355653|FG001|Overall Study|Adverse Event|3|||
162906430|NCT00952588|588355652|FG000|Overall Study|Lost to Follow-up|2|||
162709690|NCT04353037|587646349|FG000|Overall Study|Exposure Change|0|||
162709691|NCT04353037|587646350|FG001|Overall Study|Exposure Change|0|||
162709692|NCT04353037|587646351|FG002|Overall Study|Exposure Change|0|||
162709693|NCT04353037|587646352|FG003|Overall Study|Exposure Change|2|||
162709694|NCT00463151|587646354|FG000|Overall Study|Adverse Event|0|||
162709695|NCT00463151|587646355|FG001|Overall Study|Adverse Event|0|||
162709696|NCT00463151|587646356|FG002|Overall Study|Adverse Event|1|||
162709697|NCT00463151|587646357|FG003|Overall Study|Adverse Event|0|||
162709698|NCT00463151|587646354|FG000|Overall Study|Lack of Efficacy|2|||
162709699|NCT00463151|587646355|FG001|Overall Study|Lack of Efficacy|5|||
162709700|NCT00463151|587646356|FG002|Overall Study|Lack of Efficacy|2|||
162709701|NCT00463151|587646357|FG003|Overall Study|Lack of Efficacy|5|||
162709702|NCT00463151|587646354|FG000|Overall Study|Protocol Violation|0|||
162709703|NCT00463151|587646355|FG001|Overall Study|Protocol Violation|0|||
162709704|NCT00463151|587646356|FG002|Overall Study|Protocol Violation|0|||
162709705|NCT00463151|587646357|FG003|Overall Study|Protocol Violation|1|||
162709706|NCT00463151|587646354|FG000|Overall Study|Withdrawal by Subject|0|||
162709707|NCT00463151|587646355|FG001|Overall Study|Withdrawal by Subject|0|||
162709708|NCT00463151|587646356|FG002|Overall Study|Withdrawal by Subject|0|||
162709709|NCT00463151|587646357|FG003|Overall Study|Withdrawal by Subject|1|||
162709710|NCT05349084|587646358|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
162709711|NCT01579578|587646359|FG000|Overall Study|Death|4|||
162709712|NCT01579578|587646360|FG001|Overall Study|Death|1|||
162709713|NCT01579578|587646359|FG000|Overall Study|Lost to Follow-up|1|||
162906431|NCT00952588|588355653|FG001|Overall Study|Lost to Follow-up|0|||
162709714|NCT01579578|587646360|FG001|Overall Study|Lost to Follow-up|1|||
162906432|NCT00952588|588355652|FG000|Overall Study|Physician Decision|0|||
162709715|NCT01579578|587646359|FG000|Overall Study|Withdrawal by Subject|2|||
162709716|NCT01579578|587646360|FG001|Overall Study|Withdrawal by Subject|1|||
162709717|NCT01579578|587646359|FG000|Overall Study|Eligibility criteria|3|||
162709718|NCT01579578|587646360|FG001|Overall Study|Eligibility criteria|9|||
162709719|NCT01579578|587646359|FG000|Overall Study|Ongoing|3|||
162709720|NCT01579578|587646360|FG001|Overall Study|Ongoing|0|||
162709721|NCT01004263|587646363|FG000|Overall Study|Adverse Event|15|||
162709722|NCT01004263|587646363|FG000|Overall Study|Withdrawal by Subject|58|||
162709723|NCT01004263|587646363|FG000|Overall Study|Protocol Violation|10|||
162709724|NCT01004263|587646363|FG000|Overall Study|Lost to Follow-up|64|||
162709725|NCT01004263|587646363|FG000|Overall Study|Lack of Efficacy|13|||
162709726|NCT01004263|587646363|FG000|Overall Study|Pregnancy|2|||
162709727|NCT01004263|587646363|FG000|Overall Study|Physician Decision|15|||
162709728|NCT01004263|587646363|FG000|Overall Study|Lack of Qualifying Event|2|||
162709729|NCT03398356|587646367|FG000|Before Treatment|Lost to Follow-up|1|||
162709730|NCT03398356|587646368|FG001|Before Treatment|Lost to Follow-up|2|||
162709731|NCT03398356|587646369|FG002|Before Treatment|Lost to Follow-up|0|||
162709732|NCT03398356|587646367|FG000|Before Treatment|drug intolerance|2|||
162709733|NCT03398356|587646368|FG001|Before Treatment|drug intolerance|1|||
162709734|NCT03398356|587646369|FG002|Before Treatment|drug intolerance|0|||
162709735|NCT03398356|587646367|FG000|Before Treatment|Withdrawal by Subject|0|||
162709736|NCT03398356|587646368|FG001|Before Treatment|Withdrawal by Subject|5|||
162709737|NCT03398356|587646369|FG002|Before Treatment|Withdrawal by Subject|0|||
162709738|NCT03398356|587646367|FG000|Before Treatment|Physician Decision|0|||
162709739|NCT03398356|587646368|FG001|Before Treatment|Physician Decision|0|||
162709740|NCT03398356|587646369|FG002|Before Treatment|Physician Decision|11|||
162709741|NCT03398356|587646367|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
162709742|NCT03398356|587646368|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
162709743|NCT03398356|587646369|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
162709744|NCT00821236|587646372|FG000|Overall Study|Lost to Follow-up|3|||
162709745|NCT01582243|587646373|FG000|Overall Study|Withdrawal by Subject|1|||
162709746|NCT01582243|587646373|FG000|Overall Study|Adverse Event|1|||
162709747|NCT01582243|587646373|FG000|Overall Study|Lost to Follow-up|1|||
162709748|NCT02096003|587646375|FG000|Overall Study|Protocol Violation|0|||
162709749|NCT02096003|587646376|FG001|Overall Study|Protocol Violation|2|||
162709750|NCT02096003|587646375|FG000|Overall Study|additional surgery|2|||
162709751|NCT02096003|587646376|FG001|Overall Study|additional surgery|1|||
162709752|NCT01763047|587646377|FG000|Period 1|Test Article Not Available|4|||
162709753|NCT01763047|587646378|FG001|Period 1|Test Article Not Available|1|||
162709754|NCT01763047|587646377|FG000|Period 1|Protocol Violation|4|||
162709755|NCT01763047|587646378|FG001|Period 1|Protocol Violation|4|||
162709756|NCT01763047|587646377|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
162709757|NCT01763047|587646378|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
162709758|NCT01763047|587646377|FG000|Period 1|Adverse Event|0|||
162709759|NCT01763047|587646378|FG001|Period 1|Adverse Event|1|||
162709760|NCT01763047|587646377|FG000|Period 1|Unsatisfactory Visual Response|0|||
162709761|NCT01763047|587646378|FG001|Period 1|Unsatisfactory Visual Response|3|||
162709762|NCT01763047|587646377|FG000|Period 1|Lens Power Not Available|0|||
162709763|NCT01763047|587646378|FG001|Period 1|Lens Power Not Available|1|||
162709764|NCT01763047|587646377|FG000|Period 1|Study Site office Closed|0|||
162709765|NCT01763047|587646378|FG001|Period 1|Study Site office Closed|1|||
162709766|NCT01763047|587646377|FG000|Period 2|Lens Discomfort|1|||
162709767|NCT01763047|587646378|FG001|Period 2|Lens Discomfort|0|||
162709768|NCT01763047|587646377|FG000|Period 2|No longer meets Eligibility Criteria|1|||
162709769|NCT01763047|587646378|FG001|Period 2|No longer meets Eligibility Criteria|0|||
162709770|NCT01763047|587646377|FG000|Period 2|Study Site office Closed|1|||
162709771|NCT01763047|587646378|FG001|Period 2|Study Site office Closed|1|||
162709772|NCT01763047|587646377|FG000|Period 2|Unsatisfactory Visual Response|1|||
162709773|NCT01763047|587646378|FG001|Period 2|Unsatisfactory Visual Response|1|||
162709774|NCT01763047|587646377|FG000|Period 2|Protocol Violation|0|||
162709775|NCT01763047|587646378|FG001|Period 2|Protocol Violation|2|||
162709776|NCT01763047|587646377|FG000|Period 2|Unsatisfactory lens Fitting|0|||
162709777|NCT01763047|587646378|FG001|Period 2|Unsatisfactory lens Fitting|1|||
162709778|NCT01941316|587646386|FG000|Overall Study|Adverse Event|0|||
162709779|NCT01941316|587646387|FG001|Overall Study|Adverse Event|1|||
162709780|NCT01941316|587646388|FG002|Overall Study|Adverse Event|0|||
162709781|NCT01941316|587646389|FG003|Overall Study|Adverse Event|7|||
162709782|NCT01941316|587646386|FG000|Overall Study|Progressive Disease|3|||
162709783|NCT01941316|587646387|FG001|Overall Study|Progressive Disease|6|||
162709784|NCT01941316|587646388|FG002|Overall Study|Progressive Disease|2|||
162709785|NCT01941316|587646389|FG003|Overall Study|Progressive Disease|29|||
162709786|NCT01941316|587646386|FG000|Overall Study|Withdrawal by Subject|0|||
162709787|NCT01941316|587646387|FG001|Overall Study|Withdrawal by Subject|2|||
162709788|NCT01941316|587646388|FG002|Overall Study|Withdrawal by Subject|1|||
162709789|NCT01941316|587646389|FG003|Overall Study|Withdrawal by Subject|8|||
162709790|NCT01941316|587646386|FG000|Overall Study|Death|0|||
162709791|NCT01941316|587646387|FG001|Overall Study|Death|0|||
162709792|NCT01941316|587646388|FG002|Overall Study|Death|0|||
162709793|NCT01941316|587646389|FG003|Overall Study|Death|3|||
162626633|NCT02021773|587348791|FG000|Overall Study|Reason not specified|3|||
162626634|NCT02021773|587348792|FG001|Overall Study|Reason not specified|0|||
162626635|NCT02021773|587348793|FG002|Overall Study|Reason not specified|0|||
162626636|NCT01253408|587348797|FG000|Overall Study|Adverse Event|0|||
162626637|NCT01253408|587348798|FG001|Overall Study|Adverse Event|1|||
162626638|NCT01253408|587348799|FG002|Overall Study|Adverse Event|0|||
162626639|NCT03408483|587348800|FG000|Overall Study|Physician Decision|3|||
162626640|NCT03408483|587348801|FG001|Overall Study|Physician Decision|3|||
162626641|NCT03408483|587348800|FG000|Overall Study|Lost to Follow-up|3|||
162626642|NCT03408483|587348801|FG001|Overall Study|Lost to Follow-up|0|||
162626643|NCT00478231|587348802|FG000|Overall Study|Death|7|||
162626644|NCT00478231|587348802|FG000|Overall Study|Lack of Efficacy|47|||
162626645|NCT00478231|587348802|FG000|Overall Study|Lost to Follow-up|7|||
162626646|NCT00478231|587348802|FG000|Overall Study|Withdrawal by Subject|6|||
162626647|NCT00478231|587348802|FG000|Overall Study|Other|9|||
162626648|NCT00478231|587348802|FG000|Overall Study|Adverse Event|5|||
162626649|NCT00478231|587348802|FG000|Overall Study|Randomized, not treated|3|||
162626650|NCT00191139|587348807|FG000|Overall Study|Adverse Event|2|||
162626651|NCT00191139|587348808|FG001|Overall Study|Adverse Event|6|||
162626652|NCT00191139|587348807|FG000|Overall Study|Death|2|||
162626653|NCT00191139|587348808|FG001|Overall Study|Death|0|||
162626654|NCT00191139|587348807|FG000|Overall Study|Withdrawal by Subject|0|||
162626655|NCT00191139|587348808|FG001|Overall Study|Withdrawal by Subject|3|||
162626656|NCT00191139|587348807|FG000|Overall Study|Disease Progression|0|||
162626657|NCT00191139|587348808|FG001|Overall Study|Disease Progression|1|||
162626658|NCT00191139|587348807|FG000|Overall Study|Other|1|||
162626659|NCT00191139|587348808|FG001|Overall Study|Other|2|||
162626660|NCT00816595|587348809|FG000|Overall Study|Withdrawal by Subject|2|||
162626661|NCT00816595|587348810|FG001|Overall Study|Withdrawal by Subject|0|||
162626662|NCT01817530|587348811|FG000|Overall Study|Exclusionary Medication Received|0|||
162626663|NCT01817530|587348812|FG001|Overall Study|Exclusionary Medication Received|0|||
162626664|NCT01817530|587348813|FG002|Overall Study|Exclusionary Medication Received|0|||
162626665|NCT01817530|587348814|FG003|Overall Study|Exclusionary Medication Received|0|||
162626666|NCT01817530|587348815|FG004|Overall Study|Exclusionary Medication Received|1|||
162626667|NCT01817530|587348816|FG005|Overall Study|Exclusionary Medication Received|0|||
162626668|NCT01817530|587348817|FG006|Overall Study|Exclusionary Medication Received|0|||
162626669|NCT01817530|587348818|FG007|Overall Study|Exclusionary Medication Received|0|||
162626670|NCT01817530|587348811|FG000|Overall Study|Adverse Event|6|||
162626671|NCT01817530|587348812|FG001|Overall Study|Adverse Event|3|||
162626672|NCT01817530|587348813|FG002|Overall Study|Adverse Event|2|||
162626673|NCT01817530|587348814|FG003|Overall Study|Adverse Event|5|||
162626674|NCT01817530|587348815|FG004|Overall Study|Adverse Event|0|||
162626675|NCT01817530|587348816|FG005|Overall Study|Adverse Event|10|||
162626676|NCT01817530|587348817|FG006|Overall Study|Adverse Event|5|||
162626677|NCT01817530|587348818|FG007|Overall Study|Adverse Event|8|||
162626678|NCT01817530|587348811|FG000|Overall Study|Subject Noncompliant|3|||
162626679|NCT01817530|587348812|FG001|Overall Study|Subject Noncompliant|1|||
162626680|NCT01817530|587348813|FG002|Overall Study|Subject Noncompliant|0|||
162626681|NCT01817530|587348814|FG003|Overall Study|Subject Noncompliant|4|||
162626682|NCT01817530|587348815|FG004|Overall Study|Subject Noncompliant|0|||
162626683|NCT01817530|587348816|FG005|Overall Study|Subject Noncompliant|1|||
162626684|NCT01817530|587348817|FG006|Overall Study|Subject Noncompliant|1|||
162626685|NCT01817530|587348818|FG007|Overall Study|Subject Noncompliant|1|||
162626686|NCT01817530|587348811|FG000|Overall Study|Lack of Efficacy|1|||
162626687|NCT01817530|587348812|FG001|Overall Study|Lack of Efficacy|0|||
162626688|NCT01817530|587348813|FG002|Overall Study|Lack of Efficacy|0|||
162626689|NCT01817530|587348814|FG003|Overall Study|Lack of Efficacy|0|||
162626690|NCT01817530|587348815|FG004|Overall Study|Lack of Efficacy|0|||
162626691|NCT01817530|587348816|FG005|Overall Study|Lack of Efficacy|1|||
162626692|NCT01817530|587348817|FG006|Overall Study|Lack of Efficacy|0|||
162626693|NCT01817530|587348818|FG007|Overall Study|Lack of Efficacy|1|||
162626694|NCT01817530|587348811|FG000|Overall Study|Pregnancy|0|||
162709794|NCT01941316|587646386|FG000|Overall Study|Physician Decision|0|||
162709795|NCT01941316|587646387|FG001|Overall Study|Physician Decision|0|||
162709796|NCT01941316|587646388|FG002|Overall Study|Physician Decision|0|||
162709797|NCT01941316|587646389|FG003|Overall Study|Physician Decision|3|||
162709798|NCT01941316|587646386|FG000|Overall Study|Protocol Violation|0|||
162709799|NCT01941316|587646387|FG001|Overall Study|Protocol Violation|0|||
162709800|NCT01941316|587646388|FG002|Overall Study|Protocol Violation|0|||
162709801|NCT01941316|587646389|FG003|Overall Study|Protocol Violation|3|||
162709802|NCT01941316|587646386|FG000|Overall Study|Intercurrent illness|0|||
162709803|NCT01941316|587646387|FG001|Overall Study|Intercurrent illness|0|||
162709804|NCT01941316|587646388|FG002|Overall Study|Intercurrent illness|0|||
162709805|NCT01941316|587646389|FG003|Overall Study|Intercurrent illness|1|||
162709806|NCT01941316|587646386|FG000|Overall Study|Other, not specified|0|||
162709807|NCT01941316|587646387|FG001|Overall Study|Other, not specified|0|||
162709808|NCT01941316|587646388|FG002|Overall Study|Other, not specified|0|||
162709809|NCT01941316|587646389|FG003|Overall Study|Other, not specified|1|||
162709810|NCT02775435|587646390|FG000|Overall Study|Adverse Event|32|||
162709811|NCT02775435|587646391|FG001|Overall Study|Adverse Event|27|||
162709812|NCT02775435|587646390|FG000|Overall Study|Lost to Follow-up|2|||
162709813|NCT02775435|587646391|FG001|Overall Study|Lost to Follow-up|2|||
162709814|NCT02775435|587646390|FG000|Overall Study|Sponsor decision|44|||
162709815|NCT02775435|587646391|FG001|Overall Study|Sponsor decision|19|||
162626695|NCT01817530|587348812|FG001|Overall Study|Pregnancy|0|||
162626696|NCT01817530|587348813|FG002|Overall Study|Pregnancy|0|||
162626697|NCT01817530|587348814|FG003|Overall Study|Pregnancy|0|||
162626698|NCT01817530|587348815|FG004|Overall Study|Pregnancy|0|||
162626699|NCT01817530|587348816|FG005|Overall Study|Pregnancy|1|||
162626700|NCT01817530|587348817|FG006|Overall Study|Pregnancy|0|||
162626701|NCT01817530|587348818|FG007|Overall Study|Pregnancy|0|||
162626702|NCT01817530|587348811|FG000|Overall Study|Other|0|||
162626703|NCT01817530|587348812|FG001|Overall Study|Other|1|||
162626704|NCT01817530|587348813|FG002|Overall Study|Other|0|||
162626705|NCT01817530|587348814|FG003|Overall Study|Other|0|||
162626706|NCT01817530|587348815|FG004|Overall Study|Other|1|||
162626707|NCT01817530|587348816|FG005|Overall Study|Other|0|||
162626708|NCT01817530|587348817|FG006|Overall Study|Other|5|||
162626709|NCT01817530|587348818|FG007|Overall Study|Other|0|||
162626710|NCT01817530|587348811|FG000|Overall Study|Surgery or Invasive Intervention|1|||
162626711|NCT01817530|587348812|FG001|Overall Study|Surgery or Invasive Intervention|0|||
162626712|NCT01817530|587348813|FG002|Overall Study|Surgery or Invasive Intervention|0|||
162626713|NCT01817530|587348814|FG003|Overall Study|Surgery or Invasive Intervention|0|||
162709816|NCT02775435|587646390|FG000|Overall Study|Withdrawal by Subject|4|||
162709817|NCT02775435|587646391|FG001|Overall Study|Withdrawal by Subject|9|||
162967356|NCT01943435|588581340|FG002|2 Month Follow up|Lost to Follow-up|0|||
162967357|NCT01943435|588581338|FG000|6 Month Follow up|Lost to Follow-up|12|||
162967358|NCT01943435|588581339|FG001|6 Month Follow up|Lost to Follow-up|7|||
162967359|NCT01943435|588581340|FG002|6 Month Follow up|Lost to Follow-up|15|||
162967360|NCT04535986|588581343|FG000|Overall Study|Death|4|||
162967361|NCT04535986|588581344|FG001|Overall Study|Death|5|||
162967362|NCT04535986|588581343|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
162967363|NCT04535986|588581344|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
162967364|NCT04535986|588581343|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
162967365|NCT04535986|588581344|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
162967366|NCT04535986|588581343|FG000|Overall Study|Adverse Event|10|||
162967367|NCT04535986|588581344|FG001|Overall Study|Adverse Event|1|||
162967368|NCT04535986|588581343|FG000|Overall Study|Lack of Efficacy|3|||
162967369|NCT04535986|588581344|FG001|Overall Study|Lack of Efficacy|2|||
162967370|NCT04535986|588581343|FG000|Overall Study|Investigator discretion|3|||
162967371|NCT04535986|588581344|FG001|Overall Study|Investigator discretion|0|||
162967372|NCT04535986|588581343|FG000|Overall Study|Withdrawal by Subject|32|||
162967373|NCT04535986|588581344|FG001|Overall Study|Withdrawal by Subject|14|||
162967374|NCT04535986|588581343|FG000|Overall Study|Lost to Follow-up|5|||
162967375|NCT04535986|588581344|FG001|Overall Study|Lost to Follow-up|3|||
162967376|NCT04535986|588581343|FG000|Overall Study|Other|7|||
162967377|NCT04535986|588581344|FG001|Overall Study|Other|3|||
163054254|NCT01587885|588910199|FG000|Treatment Period 1|Failure to Return|0|||
163054255|NCT01587885|588910200|FG001|Treatment Period 1|Failure to Return|1|||
162709818|NCT02775435|587646390|FG000|Overall Study|Death|196|||
162967378|NCT01632306|588581345|FG000|Overall Study|Protocol Violation|1|||
162967379|NCT01632306|588581346|FG001|Overall Study|Protocol Violation|0|||
162967380|NCT01632306|588581347|FG002|Overall Study|Protocol Violation|0|||
162967381|NCT00467597|588581348|FG000|Overall Study|Withdrawal by Subject|2|||
162967382|NCT00467597|588581349|FG001|Overall Study|Withdrawal by Subject|0|||
162967383|NCT03141151|588581354|FG000|Overall Study|Lost to Follow-up|3|||
162967384|NCT03141151|588581355|FG001|Overall Study|Lost to Follow-up|2|||
162626714|NCT01817530|587348815|FG004|Overall Study|Surgery or Invasive Intervention|1|||
162626715|NCT01817530|587348816|FG005|Overall Study|Surgery or Invasive Intervention|1|||
162709819|NCT02775435|587646391|FG001|Overall Study|Death|224|||
162709820|NCT00320489|587646392|FG000|Overall Study|Adverse Event|26|||
162626716|NCT01817530|587348817|FG006|Overall Study|Surgery or Invasive Intervention|1|||
162626717|NCT01817530|587348818|FG007|Overall Study|Surgery or Invasive Intervention|0|||
162626718|NCT01817530|587348811|FG000|Overall Study|Consent Withdrawn by Subject|3|||
162626719|NCT01817530|587348812|FG001|Overall Study|Consent Withdrawn by Subject|4|||
162626720|NCT01817530|587348813|FG002|Overall Study|Consent Withdrawn by Subject|7|||
162626721|NCT01817530|587348814|FG003|Overall Study|Consent Withdrawn by Subject|3|||
162626722|NCT01817530|587348815|FG004|Overall Study|Consent Withdrawn by Subject|5|||
162626723|NCT01817530|587348816|FG005|Overall Study|Consent Withdrawn by Subject|3|||
162626724|NCT01817530|587348817|FG006|Overall Study|Consent Withdrawn by Subject|3|||
162709821|NCT00320489|587646393|FG001|Overall Study|Adverse Event|25|||
162967385|NCT03141151|588581354|FG000|Overall Study|Withdrawal by Subject|3|||
162967386|NCT03141151|588581355|FG001|Overall Study|Withdrawal by Subject|2|||
162967387|NCT04561115|588581362|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
162967388|NCT04561115|588581363|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
162967389|NCT04561115|588581362|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
162967390|NCT04561115|588581363|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
162979004|NCT03545191|588623548|FG002|Overall Study|Withdrawal by Subject|12|||
162709822|NCT00320489|587646392|FG000|Overall Study|Clinical Relapse|26|||
162709823|NCT00320489|587646393|FG001|Overall Study|Clinical Relapse|20|||
162709824|NCT00320489|587646392|FG000|Overall Study|Death|0|||
162709825|NCT00320489|587646393|FG001|Overall Study|Death|2|||
162709826|NCT00320489|587646392|FG000|Overall Study|Entry Criteria Exclusion|2|||
162709827|NCT00320489|587646393|FG001|Overall Study|Entry Criteria Exclusion|4|||
162709828|NCT00320489|587646392|FG000|Overall Study|Lack of Efficacy|16|||
162709829|NCT00320489|587646393|FG001|Overall Study|Lack of Efficacy|7|||
162709830|NCT00320489|587646392|FG000|Overall Study|Lost to Follow-up|21|||
162709831|NCT00320489|587646393|FG001|Overall Study|Lost to Follow-up|22|||
162709832|NCT00320489|587646392|FG000|Overall Study|Physician Decision|8|||
162709833|NCT00320489|587646393|FG001|Overall Study|Physician Decision|8|||
162709834|NCT00320489|587646392|FG000|Overall Study|Protocol Violation|4|||
162709835|NCT00320489|587646393|FG001|Overall Study|Protocol Violation|4|||
162709836|NCT00320489|587646392|FG000|Overall Study|Sponsor Decision|3|||
162709837|NCT00320489|587646393|FG001|Overall Study|Sponsor Decision|3|||
162709838|NCT00320489|587646392|FG000|Overall Study|Withdrawal by Subject|39|||
162709839|NCT00320489|587646393|FG001|Overall Study|Withdrawal by Subject|41|||
162709840|NCT02282527|587646394|FG000|Overall Study|Lost to Follow-up|0|||
162709841|NCT02282527|587646395|FG001|Overall Study|Lost to Follow-up|1|||
162709842|NCT02282527|587646394|FG000|Overall Study|Lack of home health aid|1|||
162709843|NCT02282527|587646395|FG001|Overall Study|Lack of home health aid|0|||
162709844|NCT00941031|587646396|FG000|Induction Period|Lack of Efficacy|2|||
162709845|NCT00941031|587646397|FG001|Induction Period|Lack of Efficacy|1|||
162709846|NCT00941031|587646398|FG002|Induction Period|Lack of Efficacy|0|||
162709847|NCT00941031|587646399|FG003|Induction Period|Lack of Efficacy|5|||
162709848|NCT00941031|587646400|FG004|Induction Period|Lack of Efficacy|0|||
162709849|NCT00941031|587646401|FG005|Induction Period|Lack of Efficacy|0|||
162709850|NCT00941031|587646402|FG006|Induction Period|Lack of Efficacy|0|||
162709851|NCT00941031|587646396|FG000|Induction Period|Withdrawal by Subject|1|||
162709852|NCT00941031|587646397|FG001|Induction Period|Withdrawal by Subject|2|||
162709853|NCT00941031|587646398|FG002|Induction Period|Withdrawal by Subject|2|||
162709854|NCT00941031|587646399|FG003|Induction Period|Withdrawal by Subject|2|||
162709855|NCT00941031|587646400|FG004|Induction Period|Withdrawal by Subject|0|||
162709856|NCT00941031|587646401|FG005|Induction Period|Withdrawal by Subject|0|||
162709857|NCT00941031|587646402|FG006|Induction Period|Withdrawal by Subject|0|||
162709858|NCT00941031|587646396|FG000|Induction Period|Adminstative Problems|1|||
162709859|NCT00941031|587646397|FG001|Induction Period|Adminstative Problems|1|||
162709860|NCT00941031|587646398|FG002|Induction Period|Adminstative Problems|1|||
162709861|NCT00941031|587646399|FG003|Induction Period|Adminstative Problems|0|||
162709862|NCT00941031|587646400|FG004|Induction Period|Adminstative Problems|0|||
162709863|NCT00941031|587646401|FG005|Induction Period|Adminstative Problems|0|||
162709864|NCT00941031|587646402|FG006|Induction Period|Adminstative Problems|0|||
162709865|NCT00941031|587646396|FG000|Induction Period|Adverse Event|1|||
162709866|NCT00941031|587646397|FG001|Induction Period|Adverse Event|0|||
162709867|NCT00941031|587646398|FG002|Induction Period|Adverse Event|3|||
162709868|NCT00941031|587646399|FG003|Induction Period|Adverse Event|2|||
162709869|NCT00941031|587646400|FG004|Induction Period|Adverse Event|0|||
162709870|NCT00941031|587646401|FG005|Induction Period|Adverse Event|0|||
162709871|NCT00941031|587646402|FG006|Induction Period|Adverse Event|0|||
162709872|NCT00941031|587646396|FG000|Maintenance Period|Withdrawal by Subject|0|||
162709873|NCT00941031|587646397|FG001|Maintenance Period|Withdrawal by Subject|0|||
162709874|NCT00941031|587646398|FG002|Maintenance Period|Withdrawal by Subject|0|||
162709875|NCT00941031|587646399|FG003|Maintenance Period|Withdrawal by Subject|0|||
162709876|NCT00941031|587646400|FG004|Maintenance Period|Withdrawal by Subject|6|||
162709877|NCT00941031|587646401|FG005|Maintenance Period|Withdrawal by Subject|2|||
162709878|NCT00941031|587646402|FG006|Maintenance Period|Withdrawal by Subject|13|||
162709879|NCT00941031|587646396|FG000|Maintenance Period|Administrative Problems|0|||
162709880|NCT00941031|587646397|FG001|Maintenance Period|Administrative Problems|0|||
162709881|NCT00941031|587646398|FG002|Maintenance Period|Administrative Problems|0|||
162709882|NCT00941031|587646399|FG003|Maintenance Period|Administrative Problems|0|||
162709883|NCT00941031|587646400|FG004|Maintenance Period|Administrative Problems|1|||
162709884|NCT00941031|587646401|FG005|Maintenance Period|Administrative Problems|0|||
162709885|NCT00941031|587646402|FG006|Maintenance Period|Administrative Problems|1|||
162709886|NCT00941031|587646396|FG000|Maintenance Period|Protocol Violation|0|||
162709887|NCT00941031|587646397|FG001|Maintenance Period|Protocol Violation|0|||
162709888|NCT00941031|587646398|FG002|Maintenance Period|Protocol Violation|0|||
163054256|NCT01587885|588910199|FG000|Treatment Period 1|Protocol Violation|0|||
162709889|NCT00941031|587646399|FG003|Maintenance Period|Protocol Violation|0|||
162709890|NCT00941031|587646400|FG004|Maintenance Period|Protocol Violation|0|||
162709891|NCT00941031|587646401|FG005|Maintenance Period|Protocol Violation|0|||
162709892|NCT00941031|587646402|FG006|Maintenance Period|Protocol Violation|1|||
162709893|NCT00941031|587646396|FG000|Maintenance Period|Adverse Event|0|||
162709894|NCT00941031|587646397|FG001|Maintenance Period|Adverse Event|0|||
162709895|NCT00941031|587646398|FG002|Maintenance Period|Adverse Event|0|||
162709896|NCT00941031|587646399|FG003|Maintenance Period|Adverse Event|0|||
162709897|NCT00941031|587646400|FG004|Maintenance Period|Adverse Event|0|||
162709898|NCT00941031|587646401|FG005|Maintenance Period|Adverse Event|2|||
162709899|NCT00941031|587646402|FG006|Maintenance Period|Adverse Event|8|||
162709900|NCT00941031|587646396|FG000|Maintenance Period|Lost to Follow-up|0|||
162709901|NCT00941031|587646397|FG001|Maintenance Period|Lost to Follow-up|0|||
162709902|NCT00941031|587646398|FG002|Maintenance Period|Lost to Follow-up|0|||
162709903|NCT00941031|587646399|FG003|Maintenance Period|Lost to Follow-up|0|||
162709904|NCT00941031|587646400|FG004|Maintenance Period|Lost to Follow-up|2|||
162709905|NCT00941031|587646401|FG005|Maintenance Period|Lost to Follow-up|2|||
162709906|NCT00941031|587646402|FG006|Maintenance Period|Lost to Follow-up|7|||
162709907|NCT00941031|587646396|FG000|Maintenance Period|Lack of Efficacy|0|||
162709908|NCT00941031|587646397|FG001|Maintenance Period|Lack of Efficacy|0|||
162709909|NCT00941031|587646398|FG002|Maintenance Period|Lack of Efficacy|0|||
162709910|NCT00941031|587646399|FG003|Maintenance Period|Lack of Efficacy|0|||
162709911|NCT00941031|587646400|FG004|Maintenance Period|Lack of Efficacy|0|||
162709912|NCT00941031|587646401|FG005|Maintenance Period|Lack of Efficacy|0|||
162709913|NCT00941031|587646402|FG006|Maintenance Period|Lack of Efficacy|13|||
162709914|NCT01872611|587646403|FG000|Overall Study|Adverse Event|3|||
162709915|NCT01872611|587646404|FG001|Overall Study|Adverse Event|1|||
162709916|NCT01872611|587646403|FG000|Overall Study|Adverse Event, prior to treatment|0|||
162709917|NCT01872611|587646404|FG001|Overall Study|Adverse Event, prior to treatment|1|||
162709918|NCT01872611|587646403|FG000|Overall Study|Death|0|||
162709919|NCT01872611|587646404|FG001|Overall Study|Death|1|||
162709920|NCT01872611|587646403|FG000|Overall Study|Death, prior to treatment|0|||
162709921|NCT01872611|587646404|FG001|Overall Study|Death, prior to treatment|1|||
162709922|NCT01872611|587646403|FG000|Overall Study|Lost to Follow-up|8|||
162709923|NCT01872611|587646404|FG001|Overall Study|Lost to Follow-up|1|||
162709924|NCT01872611|587646403|FG000|Overall Study|Physician Decision|1|||
162709925|NCT01872611|587646404|FG001|Overall Study|Physician Decision|0|||
162709926|NCT01872611|587646403|FG000|Overall Study|Withdrawal by Subject|6|||
162709927|NCT01872611|587646404|FG001|Overall Study|Withdrawal by Subject|1|||
162709928|NCT01872611|587646403|FG000|Overall Study|Reason not provided|6|||
162709929|NCT01872611|587646404|FG001|Overall Study|Reason not provided|6|||
162709930|NCT04555044|587646407|FG000|Overall Study|Adverse Event|0|||
162709931|NCT04555044|587646408|FG001|Overall Study|Adverse Event|1|||
162709932|NCT04088188|587646411|FG000|Overall Study|Withdrawal by Subject|2|||
162709933|NCT04088188|587646412|FG001|Overall Study|Withdrawal by Subject|0|||
162709934|NCT04088188|587646411|FG000|Overall Study|Adverse Event|2|||
162709935|NCT04088188|587646412|FG001|Overall Study|Adverse Event|0|||
162709936|NCT03686384|587646413|FG000|Overall Study|Lack of Efficacy|4|||
162709937|NCT03686384|587646414|FG001|Overall Study|Lack of Efficacy|13|||
162709938|NCT03686384|587646413|FG000|Overall Study|Lost to Follow-up|3|||
162709939|NCT03686384|587646414|FG001|Overall Study|Lost to Follow-up|0|||
162709940|NCT03686384|587646413|FG000|Overall Study|Physician Decision|0|||
162709941|NCT03686384|587646414|FG001|Overall Study|Physician Decision|1|||
162709942|NCT03686384|587646413|FG000|Overall Study|Took prohibited medication|0|||
162709943|NCT03686384|587646414|FG001|Overall Study|Took prohibited medication|1|||
162709944|NCT01767909|587646417|FG000|Overall Study|Withdrawal by Subject|4|||
162709945|NCT01767909|587646418|FG001|Overall Study|Withdrawal by Subject|7|||
162709946|NCT01767909|587646417|FG000|Overall Study|Adverse Event|3|||
162709947|NCT01767909|587646418|FG001|Overall Study|Adverse Event|1|||
162709948|NCT01767909|587646417|FG000|Overall Study|Withdrawal by Study Partner|3|||
162709949|NCT01767909|587646418|FG001|Overall Study|Withdrawal by Study Partner|1|||
162709950|NCT01767909|587646417|FG000|Overall Study|Non-Compliance|2|||
162709951|NCT01767909|587646418|FG001|Overall Study|Non-Compliance|0|||
162709952|NCT01767909|587646417|FG000|Overall Study|Perceived Lack of Efficacy|1|||
162709953|NCT01767909|587646418|FG001|Overall Study|Perceived Lack of Efficacy|0|||
162709954|NCT01767909|587646417|FG000|Overall Study|Investigator Recommendation|0|||
162709955|NCT01767909|587646418|FG001|Overall Study|Investigator Recommendation|1|||
162709956|NCT01767909|587646417|FG000|Overall Study|Lost to Follow-up|0|||
162709957|NCT01767909|587646418|FG001|Overall Study|Lost to Follow-up|1|||
162709958|NCT01767909|587646417|FG000|Overall Study|LP uncessessful|0|||
162709959|NCT01767909|587646418|FG001|Overall Study|LP uncessessful|1|||
162709960|NCT02466516|587648892|FG000|Overall Study|Adverse Event|1|||
162709961|NCT02466516|587648893|FG001|Overall Study|Adverse Event|1|||
162709962|NCT02466516|587648894|FG002|Overall Study|Adverse Event|0|||
162709963|NCT02466516|587648895|FG003|Overall Study|Adverse Event|0|||
162709964|NCT02466516|587648896|FG004|Overall Study|Adverse Event|0|||
162709965|NCT02466516|587648892|FG000|Overall Study|Withdrew Consent|1|||
162709966|NCT02466516|587648893|FG001|Overall Study|Withdrew Consent|0|||
162709967|NCT02466516|587648894|FG002|Overall Study|Withdrew Consent|0|||
162709968|NCT02466516|587648895|FG003|Overall Study|Withdrew Consent|0|||
162709969|NCT02466516|587648896|FG004|Overall Study|Withdrew Consent|0|||
162709970|NCT02466516|587648892|FG000|Overall Study|Lost to Follow-up|2|||
162709971|NCT02466516|587648893|FG001|Overall Study|Lost to Follow-up|0|||
162709972|NCT02466516|587648894|FG002|Overall Study|Lost to Follow-up|1|||
162709973|NCT02466516|587648895|FG003|Overall Study|Lost to Follow-up|0|||
162709974|NCT02466516|587648896|FG004|Overall Study|Lost to Follow-up|0|||
162709975|NCT04358549|587648897|FG000|Overall Study|Adverse Event|0|||
162709976|NCT04358549|587648898|FG001|Overall Study|Adverse Event|1|||
162709977|NCT04358549|587648897|FG000|Overall Study|Death|1|||
162709978|NCT04358549|587648898|FG001|Overall Study|Death|0|||
162709979|NCT04358549|587648897|FG000|Overall Study|Lost to Follow-up|2|||
162709980|NCT04358549|587648898|FG001|Overall Study|Lost to Follow-up|1|||
162709981|NCT04358549|587648897|FG000|Overall Study|Withdrawal by Subject|6|||
162709982|NCT04358549|587648898|FG001|Overall Study|Withdrawal by Subject|6|||
162709983|NCT04358549|587648897|FG000|Overall Study|Start remdesivir|1|||
162709984|NCT04358549|587648898|FG001|Overall Study|Start remdesivir|0|||
162709985|NCT03712930|587648899|FG000|Overall Study|Death|7|||
162709986|NCT03712930|587648899|FG000|Overall Study|Physician Decision|1|||
162709987|NCT03712930|587648899|FG000|Overall Study|Study Terminated by Sponsor|3|||
162709988|NCT03712930|587648899|FG000|Overall Study|Progressive Disease|2|||
162709989|NCT03837028|587648902|FG000|Overall Study|Lost to Follow-up|4|||
162709990|NCT03837028|587648903|FG001|Overall Study|Lost to Follow-up|0|||
162709991|NCT03837028|587648904|FG002|Overall Study|Lost to Follow-up|2|||
162709992|NCT03837028|587648905|FG003|Overall Study|Lost to Follow-up|0|||
162709993|NCT03837028|587648902|FG000|Overall Study|Withdrawal by Subject|12|||
162709994|NCT03837028|587648903|FG001|Overall Study|Withdrawal by Subject|11|||
162709995|NCT03837028|587648904|FG002|Overall Study|Withdrawal by Subject|11|||
162709996|NCT03837028|587648905|FG003|Overall Study|Withdrawal by Subject|7|||
162709997|NCT03784963|587648906|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
162709998|NCT03784963|587648907|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
162709999|NCT03784963|587648908|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
162710000|NCT03784963|587648909|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
162710001|NCT04867902|587648910|FG000|Overall Study|Lost to Follow-up|1|||
162710002|NCT04867902|587648910|FG000|Overall Study|Withdrawal by Subject|2|||
162710003|NCT04867902|587648910|FG000|Overall Study|Protocol Violation|1|||
162710004|NCT00672256|587648919|FG000|Overall Study|PI dropped, bad data|44|||
162710005|NCT03255018|587648922|FG000|Overall Study|Death on study|0|||
162710006|NCT03255018|587648923|FG001|Overall Study|Death on study|5|||
162710007|NCT03255018|587648922|FG000|Overall Study|Withdrawal by Subject|0|||
162710008|NCT03255018|587648923|FG001|Overall Study|Withdrawal by Subject|2|||
162710009|NCT01688973|587648924|FG000|Overall Study|Ineligible|2|||
162710010|NCT01688973|587648925|FG001|Overall Study|Ineligible|3|||
162710011|NCT03710564|587648929|FG000|Overall Study|Study Terminated by Sponsor|104|||
162710012|NCT03710564|587648930|FG001|Overall Study|Study Terminated by Sponsor|55|||
162710013|NCT03710564|587648929|FG000|Overall Study|Withdrawal by Subject|57|||
162710014|NCT03710564|587648930|FG001|Overall Study|Withdrawal by Subject|25|||
162710015|NCT03710564|587648929|FG000|Overall Study|Death|10|||
162710016|NCT03710564|587648930|FG001|Overall Study|Death|4|||
162710017|NCT03710564|587648929|FG000|Overall Study|Lost to Follow-up|5|||
162710018|NCT03710564|587648930|FG001|Overall Study|Lost to Follow-up|4|||
162710019|NCT03710564|587648929|FG000|Overall Study|Protocol Violation|3|||
162710020|NCT03710564|587648930|FG001|Overall Study|Protocol Violation|2|||
162710021|NCT03710564|587648929|FG000|Overall Study|Adverse Event|3|||
162710022|NCT03710564|587648930|FG001|Overall Study|Adverse Event|0|||
162710023|NCT03710564|587648929|FG000|Overall Study|Physician Decision|2|||
162710024|NCT03710564|587648930|FG001|Overall Study|Physician Decision|3|||
162710025|NCT00293462|587648931|FG000|Overall Study|Withdrawal by Subject|4|||
162710026|NCT00293462|587648932|FG001|Overall Study|Withdrawal by Subject|3|||
162710027|NCT00293462|587648933|FG002|Overall Study|Withdrawal by Subject|8|||
162710028|NCT00293462|587648931|FG000|Overall Study|Death|1|||
162710029|NCT00293462|587648932|FG001|Overall Study|Death|0|||
162710030|NCT00293462|587648933|FG002|Overall Study|Death|0|||
162710031|NCT00293462|587648931|FG000|Overall Study|Lost to Follow-up|0|||
162710032|NCT00293462|587648932|FG001|Overall Study|Lost to Follow-up|1|||
162710033|NCT00293462|587648933|FG002|Overall Study|Lost to Follow-up|0|||
162710034|NCT00293462|587648931|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
162710035|NCT00293462|587648932|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
162710036|NCT00293462|587648933|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
162710037|NCT00293462|587648931|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
162710038|NCT00293462|587648932|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
162710039|NCT00293462|587648933|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
162710040|NCT00293462|587648931|FG000|Overall Study|Refuse Radiation Treatment|1|||
162710041|NCT00293462|587648932|FG001|Overall Study|Refuse Radiation Treatment|0|||
162710042|NCT00293462|587648933|FG002|Overall Study|Refuse Radiation Treatment|0|||
162967391|NCT04561115|588581362|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
162979005|NCT03545191|588623546|FG000|Overall Study|Lost to Follow-up|1|||
162710043|NCT00293462|587648931|FG000|Overall Study|No Show|0|||
162710044|NCT00293462|587648932|FG001|Overall Study|No Show|0|||
162710045|NCT00293462|587648933|FG002|Overall Study|No Show|1|||
162710046|NCT00293462|587648931|FG000|Overall Study|Went back to his home country|0|||
162710047|NCT00293462|587648932|FG001|Overall Study|Went back to his home country|0|||
162710048|NCT00293462|587648933|FG002|Overall Study|Went back to his home country|1|||
162710049|NCT00293462|587648931|FG000|Overall Study|Blood clot after chemotherapy|0|||
162710050|NCT00293462|587648932|FG001|Overall Study|Blood clot after chemotherapy|0|||
162710051|NCT00293462|587648933|FG002|Overall Study|Blood clot after chemotherapy|1|||
162710052|NCT00293462|587648931|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
162710053|NCT00293462|587648932|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
162710054|NCT00293462|587648933|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
162710055|NCT00293462|587648931|FG000|Overall Study|Possible Tracheostomy leakage|0|||
162710056|NCT00293462|587648932|FG001|Overall Study|Possible Tracheostomy leakage|1|||
162710057|NCT00293462|587648933|FG002|Overall Study|Possible Tracheostomy leakage|0|||
162710058|NCT00293462|587648931|FG000|Overall Study|Low radiation dose in oral cavity|0|||
162710059|NCT00293462|587648932|FG001|Overall Study|Low radiation dose in oral cavity|1|||
162710060|NCT00293462|587648933|FG002|Overall Study|Low radiation dose in oral cavity|0|||
162710061|NCT00293462|587648931|FG000|Overall Study|Physician Decision|0|||
162710062|NCT00293462|587648932|FG001|Overall Study|Physician Decision|1|||
162710063|NCT00293462|587648933|FG002|Overall Study|Physician Decision|0|||
162710064|NCT00372060|587648934|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
162710065|NCT00372060|587648935|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
162710066|NCT00372060|587648934|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
162710067|NCT00372060|587648935|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
162710068|NCT00372060|587648934|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
162710069|NCT00372060|587648935|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
162710070|NCT00372060|587648934|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
162710071|NCT00372060|587648935|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
162710072|NCT00372060|587648934|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
162710073|NCT00372060|587648935|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
162710074|NCT00372060|587648934|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
162710075|NCT00372060|587648935|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
162710076|NCT00647348|587648936|FG000|Overall Study|Lost to Follow-up|3|||
162710077|NCT00647348|587648937|FG001|Overall Study|Lost to Follow-up|6|||
162710078|NCT03382821|587648941|FG000|Overall Study|Did not receive allocated intervention.|0|||
162710079|NCT03382821|587648942|FG001|Overall Study|Did not receive allocated intervention.|3|||
162710080|NCT00282438|587648943|FG000|Overall Study|Lack of Efficacy|1|||
162710081|NCT00282438|587648944|FG001|Overall Study|Lack of Efficacy|0|||
162710082|NCT00282438|587648943|FG000|Overall Study|Death|0|||
162710083|NCT00282438|587648944|FG001|Overall Study|Death|1|||
162710084|NCT01119703|587648953|FG000|Overall Study|Adverse Event|0|||
162710085|NCT01119703|587648954|FG001|Overall Study|Adverse Event|1|||
162710086|NCT01511250|587648955|FG000|Overall Study|Withdrawal of Consent|1|||
162710087|NCT01511250|587648956|FG001|Overall Study|Withdrawal of Consent|0|||
162710088|NCT01511250|587648957|FG002|Overall Study|Withdrawal of Consent|0|||
162710089|NCT01511250|587648958|FG003|Overall Study|Withdrawal of Consent|0|||
162710090|NCT01511250|587648959|FG004|Overall Study|Withdrawal of Consent|0|||
162710091|NCT01511250|587648960|FG005|Overall Study|Withdrawal of Consent|0|||
162710092|NCT01511250|587648961|FG006|Overall Study|Withdrawal of Consent|0|||
162710093|NCT01511250|587648962|FG007|Overall Study|Withdrawal of Consent|1|||
162710094|NCT01511250|587648963|FG008|Overall Study|Withdrawal of Consent|1|||
162710095|NCT01511250|587648964|FG009|Overall Study|Withdrawal of Consent|0|||
162710096|NCT01511250|587648955|FG000|Overall Study|Sponsor/Investigator Decision|1|||
162710097|NCT01511250|587648956|FG001|Overall Study|Sponsor/Investigator Decision|0|||
162710098|NCT01511250|587648957|FG002|Overall Study|Sponsor/Investigator Decision|0|||
162710099|NCT01511250|587648958|FG003|Overall Study|Sponsor/Investigator Decision|0|||
162710100|NCT01511250|587648959|FG004|Overall Study|Sponsor/Investigator Decision|0|||
162710101|NCT01511250|587648960|FG005|Overall Study|Sponsor/Investigator Decision|0|||
162710102|NCT01511250|587648961|FG006|Overall Study|Sponsor/Investigator Decision|0|||
162710103|NCT01511250|587648962|FG007|Overall Study|Sponsor/Investigator Decision|0|||
162710104|NCT01511250|587648963|FG008|Overall Study|Sponsor/Investigator Decision|0|||
162710105|NCT01511250|587648964|FG009|Overall Study|Sponsor/Investigator Decision|0|||
162710106|NCT01511250|587648955|FG000|Overall Study|Lost to Follow-up|7|||
162710107|NCT01511250|587648956|FG001|Overall Study|Lost to Follow-up|3|||
162710108|NCT01511250|587648957|FG002|Overall Study|Lost to Follow-up|3|||
162906433|NCT00952588|588355653|FG001|Overall Study|Physician Decision|1|||
162906434|NCT00952588|588355652|FG000|Overall Study|Lack of Efficacy|2|||
162906435|NCT00952588|588355653|FG001|Overall Study|Lack of Efficacy|2|||
162906436|NCT00887913|588355656|FG000|Overall Study|Withdrawal by Subject|6|||
162906437|NCT01469637|588355657|FG000|First Intervention|Unacceptable behavior|0|||
162906438|NCT01469637|588355658|FG001|First Intervention|Unacceptable behavior|1|||
162906439|NCT01469637|588355657|FG000|Second Intervention|Incarcerated|1|||
162906440|NCT01469637|588355658|FG001|Second Intervention|Incarcerated|0|||
162906441|NCT01708915|588355672|FG000|Overall Study|Adverse Event|1|||
162906442|NCT01708915|588355673|FG001|Overall Study|Adverse Event|0|||
162906443|NCT01708915|588355674|FG002|Overall Study|Adverse Event|9|||
162906444|NCT01708915|588355675|FG003|Overall Study|Adverse Event|13|||
162906445|NCT01708915|588355672|FG000|Overall Study|Lack of Efficacy|84|||
162710109|NCT01511250|587648958|FG003|Overall Study|Lost to Follow-up|3|||
162710110|NCT01511250|587648959|FG004|Overall Study|Lost to Follow-up|0|||
162710111|NCT01511250|587648960|FG005|Overall Study|Lost to Follow-up|0|||
162710112|NCT01511250|587648961|FG006|Overall Study|Lost to Follow-up|2|||
162710113|NCT01511250|587648962|FG007|Overall Study|Lost to Follow-up|3|||
162710114|NCT01511250|587648963|FG008|Overall Study|Lost to Follow-up|13|||
162710115|NCT01511250|587648964|FG009|Overall Study|Lost to Follow-up|5|||
162710116|NCT01511250|587648955|FG000|Overall Study|Protocol Violation|0|||
162710117|NCT01511250|587648956|FG001|Overall Study|Protocol Violation|2|||
162710118|NCT01511250|587648957|FG002|Overall Study|Protocol Violation|1|||
162710119|NCT01511250|587648958|FG003|Overall Study|Protocol Violation|0|||
162710120|NCT01511250|587648959|FG004|Overall Study|Protocol Violation|0|||
162710121|NCT01511250|587648960|FG005|Overall Study|Protocol Violation|0|||
162710122|NCT01511250|587648961|FG006|Overall Study|Protocol Violation|0|||
162710123|NCT01511250|587648962|FG007|Overall Study|Protocol Violation|0|||
162710124|NCT01511250|587648963|FG008|Overall Study|Protocol Violation|0|||
162710125|NCT01511250|587648964|FG009|Overall Study|Protocol Violation|0|||
162710126|NCT04668144|587648965|FG000|Overall Study|Protocol Violation|0|||
162710127|NCT04668144|587648966|FG001|Overall Study|Protocol Violation|1|||
162906446|NCT01708915|588355673|FG001|Overall Study|Lack of Efficacy|60|||
162906447|NCT01708915|588355674|FG002|Overall Study|Lack of Efficacy|35|||
162906448|NCT01708915|588355675|FG003|Overall Study|Lack of Efficacy|15|||
162710128|NCT04668144|587648967|FG002|Overall Study|Protocol Violation|2|||
162710129|NCT02095158|587648968|FG000|Overall Study|Adverse Event|14|||
162710130|NCT02095158|587648968|FG000|Overall Study|Lack of Efficacy|3|||
162710131|NCT02095158|587648968|FG000|Overall Study|Pregnancy|1|||
162710132|NCT02095158|587648968|FG000|Overall Study|Lost to Follow-up|20|||
162710133|NCT02095158|587648968|FG000|Overall Study|Personal Reasons|35|||
162710134|NCT02095158|587648968|FG000|Overall Study|Protocol Violation|1|||
162710135|NCT02095158|587648968|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162710136|NCT03441984|587648969|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710137|NCT03441984|587648970|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710138|NCT03441984|587648971|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
162710139|NCT03441984|587648972|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710140|NCT03441984|587648973|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710141|NCT03441984|587648974|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710142|NCT03441984|587648975|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710143|NCT03441984|587648976|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710144|NCT03441984|587648977|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710145|NCT03441984|587648978|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710146|NCT03441984|587648979|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710147|NCT03441984|587648980|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162710148|NCT00631917|587648981|FG000|Overall Study|Adverse Event|34|||
162710149|NCT00631917|587648982|FG001|Overall Study|Adverse Event|45|||
162710150|NCT00631917|587648981|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162710151|NCT00631917|587648982|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162710152|NCT00631917|587648981|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162906449|NCT01708915|588355672|FG000|Overall Study|Protocol Violation|0|||
162906450|NCT01708915|588355673|FG001|Overall Study|Protocol Violation|0|||
162906451|NCT01708915|588355674|FG002|Overall Study|Protocol Violation|0|||
162906452|NCT01708915|588355675|FG003|Overall Study|Protocol Violation|1|||
162906453|NCT01708915|588355672|FG000|Overall Study|Withdrawal by Subject|0|||
162906454|NCT01708915|588355673|FG001|Overall Study|Withdrawal by Subject|1|||
162906455|NCT01708915|588355674|FG002|Overall Study|Withdrawal by Subject|2|||
162906456|NCT01708915|588355675|FG003|Overall Study|Withdrawal by Subject|2|||
162906457|NCT01708915|588355672|FG000|Overall Study|Other reasons than stated above|1|||
162906458|NCT01708915|588355673|FG001|Overall Study|Other reasons than stated above|1|||
162906459|NCT01708915|588355674|FG002|Overall Study|Other reasons than stated above|0|||
162906460|NCT01708915|588355675|FG003|Overall Study|Other reasons than stated above|2|||
162906461|NCT03267576|588355676|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
162906462|NCT03267576|588355677|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
162906463|NCT03267576|588355676|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
162906464|NCT03267576|588355677|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
162906465|NCT02168816|588355683|FG000|Overall Study|Lost to Follow-up|2|||
162906466|NCT02168816|588355684|FG001|Overall Study|Lost to Follow-up|2|||
162710153|NCT00631917|587648982|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162710154|NCT00631917|587648981|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
162710155|NCT00631917|587648982|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
162710156|NCT00631917|587648981|FG000|Overall Study|No longer required study drug|0|||
162710157|NCT00631917|587648982|FG001|Overall Study|No longer required study drug|1|||
162710158|NCT00631917|587648981|FG000|Overall Study|Protocol deviation|6|||
162906467|NCT01984294|588355685|FG000|Overall Study|Randomized but Never Treated|0|||
162906468|NCT01984294|588355686|FG001|Overall Study|Randomized but Never Treated|0|||
162626725|NCT01817530|587348818|FG007|Overall Study|Consent Withdrawn by Subject|10|||
162906469|NCT01984294|588355687|FG002|Overall Study|Randomized but Never Treated|1|||
162906470|NCT01984294|588355685|FG000|Overall Study|Lack of Efficacy|4|||
162906471|NCT01984294|588355686|FG001|Overall Study|Lack of Efficacy|2|||
162906472|NCT01984294|588355687|FG002|Overall Study|Lack of Efficacy|6|||
162906473|NCT01984294|588355685|FG000|Overall Study|Adverse Event|0|||
162906474|NCT01984294|588355686|FG001|Overall Study|Adverse Event|1|||
162906475|NCT01984294|588355687|FG002|Overall Study|Adverse Event|0|||
162906476|NCT01987609|588355690|FG000|Overall Study|Adverse Event|1|||
162906477|NCT02709889|588355695|FG000|Overall Study|Withdrawal by Subject|11|||
162906478|NCT02709889|588355696|FG001|Overall Study|Withdrawal by Subject|10|||
162906479|NCT02709889|588355697|FG002|Overall Study|Withdrawal by Subject|2|||
162906480|NCT02709889|588355698|FG003|Overall Study|Withdrawal by Subject|12|||
162906481|NCT02709889|588355695|FG000|Overall Study|Death|25|||
162906482|NCT02709889|588355696|FG001|Overall Study|Death|38|||
162906483|NCT02709889|588355697|FG002|Overall Study|Death|4|||
162906484|NCT02709889|588355698|FG003|Overall Study|Death|44|||
162906485|NCT02709889|588355695|FG000|Overall Study|Physician Decision|1|||
162906486|NCT02709889|588355696|FG001|Overall Study|Physician Decision|2|||
162906487|NCT02709889|588355697|FG002|Overall Study|Physician Decision|3|||
162906488|NCT02709889|588355698|FG003|Overall Study|Physician Decision|5|||
162906489|NCT02709889|588355695|FG000|Overall Study|Lost to Follow-up|2|||
162906490|NCT02709889|588355696|FG001|Overall Study|Lost to Follow-up|0|||
162906491|NCT02709889|588355697|FG002|Overall Study|Lost to Follow-up|0|||
162906492|NCT02709889|588355698|FG003|Overall Study|Lost to Follow-up|4|||
162906493|NCT02709889|588355695|FG000|Overall Study|Study Terminated by Sponsor|4|||
162906494|NCT02709889|588355696|FG001|Overall Study|Study Terminated by Sponsor|6|||
162906495|NCT02709889|588355697|FG002|Overall Study|Study Terminated by Sponsor|2|||
162906496|NCT02709889|588355698|FG003|Overall Study|Study Terminated by Sponsor|17|||
162906497|NCT02709889|588355695|FG000|Overall Study|Other, Not Specified|0|||
162626726|NCT01817530|587348811|FG000|Overall Study|Lost to Follow-up|1|||
162626727|NCT01817530|587348812|FG001|Overall Study|Lost to Follow-up|4|||
162626728|NCT01817530|587348813|FG002|Overall Study|Lost to Follow-up|2|||
162626729|NCT01817530|587348814|FG003|Overall Study|Lost to Follow-up|1|||
162626730|NCT01817530|587348815|FG004|Overall Study|Lost to Follow-up|3|||
162626731|NCT01817530|587348816|FG005|Overall Study|Lost to Follow-up|2|||
162626732|NCT01817530|587348817|FG006|Overall Study|Lost to Follow-up|8|||
162626733|NCT01817530|587348818|FG007|Overall Study|Lost to Follow-up|4|||
162626734|NCT00566995|587348820|FG000|Overall Study|Toxicity|4|||
162626735|NCT00566995|587348820|FG000|Overall Study|Withdrew consent|3|||
162626736|NCT02657369|587348821|FG000|Overall Study|Death|27|||
162626737|NCT02657369|587348821|FG000|Overall Study|Study terminated by sponsor|7|||
162626738|NCT00481078|587348822|FG000|Overall Study|Progression of disease|11|||
162626739|NCT00481078|587348823|FG001|Overall Study|Progression of disease|11|||
162626740|NCT00481078|587348822|FG000|Overall Study|Adverse Event|15|||
162626741|NCT00481078|587348823|FG001|Overall Study|Adverse Event|3|||
162626742|NCT00481078|587348822|FG000|Overall Study|Death|5|||
162626743|NCT00481078|587348823|FG001|Overall Study|Death|3|||
162626744|NCT00481078|587348822|FG000|Overall Study|Intercurrent illness|1|||
162626745|NCT00481078|587348823|FG001|Overall Study|Intercurrent illness|0|||
162626746|NCT00481078|587348822|FG000|Overall Study|Withdrawal by Subject|7|||
162626747|NCT00481078|587348823|FG001|Overall Study|Withdrawal by Subject|1|||
162626748|NCT00481078|587348822|FG000|Overall Study|Information not available|1|||
162626749|NCT00481078|587348823|FG001|Overall Study|Information not available|0|||
162626750|NCT00481078|587348822|FG000|Overall Study|Received other treatment|2|||
162626751|NCT00481078|587348823|FG001|Overall Study|Received other treatment|1|||
162626752|NCT00481078|587348822|FG000|Overall Study|Brain metastasis|0|||
162626753|NCT00481078|587348823|FG001|Overall Study|Brain metastasis|1|||
162626754|NCT00074152|587348824|FG000|Overall Study|Death|21|||
162626755|NCT00074152|587348825|FG001|Overall Study|Death|9|||
162626756|NCT00074152|587348824|FG000|Overall Study|Lack of Efficacy|34|||
162626757|NCT00074152|587348825|FG001|Overall Study|Lack of Efficacy|24|||
162626758|NCT00228384|587348826|FG000|Overall Study|Death|9|||
162626759|NCT00228384|587348827|FG001|Overall Study|Death|3|||
162626760|NCT00228384|587348826|FG000|Overall Study|Lost to Follow-up|6|||
162626761|NCT00228384|587348827|FG001|Overall Study|Lost to Follow-up|10|||
162626762|NCT00228384|587348826|FG000|Overall Study|Surgical Intervention (bypass)|5|||
162626763|NCT00228384|587348827|FG001|Overall Study|Surgical Intervention (bypass)|5|||
162626764|NCT00228384|587348826|FG000|Overall Study|Withdrawal by Subject|9|||
162626765|NCT00228384|587348827|FG001|Overall Study|Withdrawal by Subject|10|||
162626766|NCT00228384|587348826|FG000|Overall Study|Physician Decision|0|||
162626767|NCT00228384|587348827|FG001|Overall Study|Physician Decision|1|||
162626768|NCT01785069|587348828|FG000|Overall Study|Implanted with nonstudy device|1|||
162906498|NCT02709889|588355696|FG001|Overall Study|Other, Not Specified|1|||
162906499|NCT02709889|588355697|FG002|Overall Study|Other, Not Specified|1|||
162906500|NCT02709889|588355698|FG003|Overall Study|Other, Not Specified|6|||
162906501|NCT00537810|588355699|FG000|Overall Study|Withdrawal by Subject|4|||
162906502|NCT00537810|588355700|FG001|Overall Study|Withdrawal by Subject|11|||
162906503|NCT00537810|588355701|FG002|Overall Study|Withdrawal by Subject|4|||
162906504|NCT00537810|588355702|FG003|Overall Study|Withdrawal by Subject|3|||
162626769|NCT01785069|587348829|FG001|Overall Study|Implanted with nonstudy device|2|||
162626770|NCT01785069|587348830|FG002|Overall Study|Implanted with nonstudy device|1|||
162626771|NCT01785069|587348831|FG003|Overall Study|Implanted with nonstudy device|0|||
162626772|NCT01785069|587348828|FG000|Overall Study|Death|0|||
162626773|NCT01785069|587348829|FG001|Overall Study|Death|0|||
162626774|NCT01785069|587348830|FG002|Overall Study|Death|2|||
162626775|NCT01785069|587348831|FG003|Overall Study|Death|0|||
162626776|NCT01785069|587348828|FG000|Overall Study|Subject choice|2|||
162626777|NCT01785069|587348829|FG001|Overall Study|Subject choice|2|||
162626778|NCT01785069|587348830|FG002|Overall Study|Subject choice|0|||
162626779|NCT01785069|587348831|FG003|Overall Study|Subject choice|1|||
162626780|NCT01785069|587348828|FG000|Overall Study|Lost to Follow-up|1|||
162626781|NCT01785069|587348829|FG001|Overall Study|Lost to Follow-up|2|||
162626782|NCT01785069|587348830|FG002|Overall Study|Lost to Follow-up|4|||
162906505|NCT00537810|588355699|FG000|Overall Study|Medically withdrawn|2|||
162906506|NCT00537810|588355700|FG001|Overall Study|Medically withdrawn|2|||
162906507|NCT00537810|588355701|FG002|Overall Study|Medically withdrawn|0|||
162906508|NCT00537810|588355702|FG003|Overall Study|Medically withdrawn|1|||
162906509|NCT01066546|588355703|FG000|Overall Study|Study terminated by sponsor|5|||
162906510|NCT03452397|588355708|FG000|Overall Study|Adverse Event|1|||
162906511|NCT03452397|588355709|FG001|Overall Study|Adverse Event|0|||
162906512|NCT03452397|588355710|FG002|Overall Study|Adverse Event|0|||
162906513|NCT03452397|588355711|FG003|Overall Study|Adverse Event|0|||
162906514|NCT03452397|588355708|FG000|Overall Study|Administrative reason|0|||
162626783|NCT01785069|587348831|FG003|Overall Study|Lost to Follow-up|1|||
162626784|NCT01785069|587348828|FG000|Overall Study|Reason not Specified|1|||
162626785|NCT01785069|587348829|FG001|Overall Study|Reason not Specified|2|||
162626786|NCT01785069|587348830|FG002|Overall Study|Reason not Specified|1|||
162626787|NCT01785069|587348831|FG003|Overall Study|Reason not Specified|4|||
162626788|NCT01785069|587348828|FG000|Overall Study|Not evaluable|7|||
162626789|NCT01785069|587348829|FG001|Overall Study|Not evaluable|4|||
162626790|NCT01785069|587348830|FG002|Overall Study|Not evaluable|5|||
162626791|NCT01785069|587348831|FG003|Overall Study|Not evaluable|8|||
162626792|NCT03288129|587348832|FG000|Overall Study|Adverse Event|10|||
162626793|NCT03288129|587348832|FG000|Overall Study|Lost to Follow-up|3|||
162626794|NCT03288129|587348832|FG000|Overall Study|Withdrawal by Subject|3|||
162626795|NCT03288129|587348832|FG000|Overall Study|Withdrawal of consent/assent|1|||
162626796|NCT03288129|587348832|FG000|Overall Study|Other|5|||
162626797|NCT01744197|587348835|FG000|Overall Study|Received 1 patch|2|||
162906515|NCT03452397|588355709|FG001|Overall Study|Administrative reason|0|||
162906516|NCT03452397|588355710|FG002|Overall Study|Administrative reason|1|||
162906517|NCT03452397|588355711|FG003|Overall Study|Administrative reason|1|||
162906518|NCT03452397|588355708|FG000|Overall Study|Withdrawal by Subject|0|||
162906519|NCT03452397|588355709|FG001|Overall Study|Withdrawal by Subject|0|||
162906520|NCT03452397|588355710|FG002|Overall Study|Withdrawal by Subject|1|||
162906521|NCT03452397|588355711|FG003|Overall Study|Withdrawal by Subject|0|||
162906522|NCT00125268|588355712|FG000|Overall Study|Withdrawal by Subject|1|||
162906523|NCT00125268|588355713|FG001|Overall Study|Withdrawal by Subject|1|||
162906524|NCT00925522|588355714|FG000|Overall Study|study closed -- business decision|20|||
162906525|NCT02561572|588355715|FG000|Overall Study|Inadequate time before surgery|2|||
162906526|NCT02561572|588355716|FG001|Overall Study|Inadequate time before surgery|1|||
162906527|NCT02561572|588355715|FG000|Overall Study|Protocol Violation|0|||
162906528|NCT02561572|588355716|FG001|Overall Study|Protocol Violation|1|||
162906529|NCT02691468|588355717|FG000|Overall Study|Bronchial blocker use|2|||
162906530|NCT02691468|588355718|FG001|Overall Study|Bronchial blocker use|1|||
162906531|NCT02691468|588355717|FG000|Overall Study|Lost to Follow-up|2|||
162906532|NCT02691468|588355718|FG001|Overall Study|Lost to Follow-up|1|||
162906533|NCT02691468|588355717|FG000|Overall Study|Failure to advance FOB|2|||
162906534|NCT02691468|588355718|FG001|Overall Study|Failure to advance FOB|0|||
162906535|NCT01190020|588355721|FG000|Overall Study|Adverse Event|2|||
162906536|NCT01190020|588355722|FG001|Overall Study|Adverse Event|0|||
162906537|NCT01190020|588355721|FG000|Overall Study|Lost to Follow-up|2|||
162906538|NCT01190020|588355722|FG001|Overall Study|Lost to Follow-up|0|||
162906539|NCT01190020|588355721|FG000|Overall Study|Withdrawal by Subject|3|||
162906540|NCT01190020|588355722|FG001|Overall Study|Withdrawal by Subject|0|||
162906541|NCT00656799|588355725|FG000|Overall Study|Death|2|||
162906542|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
162906543|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
162906544|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
162626798|NCT01744197|587348836|FG001|Overall Study|Received 1 patch|1|||
162626799|NCT01744197|587348835|FG000|Overall Study|No patch received|2|||
162626800|NCT01744197|587348836|FG001|Overall Study|No patch received|2|||
162626801|NCT02777333|587348837|FG000|Overall Study|Withdrawal by Subject|0|||
162906545|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
162906546|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
162906547|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
162906548|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
162906549|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
162906550|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
162906551|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
162906552|NCT02422186|588355726|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
162906553|NCT02422186|588355727|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
162906554|NCT02422186|588355726|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
162906555|NCT02422186|588355727|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
162906556|NCT02422186|588355726|FG000|Follow-up Phase (2 Weeks)|Other|3|||
162906557|NCT02422186|588355727|FG001|Follow-up Phase (2 Weeks)|Other|0|||
162906558|NCT05281094|588355728|FG000|Overall Study|Adverse Event|1|||
162906559|NCT05281094|588355729|FG001|Overall Study|Adverse Event|0|||
162906560|NCT05281094|588355728|FG000|Overall Study|Lost to Follow-up|29|||
162906561|NCT05281094|588355729|FG001|Overall Study|Lost to Follow-up|22|||
162906562|NCT05281094|588355728|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
162906563|NCT05281094|588355729|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
162906564|NCT05281094|588355728|FG000|Overall Study|Death|1|||
162906565|NCT05281094|588355729|FG001|Overall Study|Death|2|||
162906566|NCT05281094|588355728|FG000|Overall Study|Not pre-specified reason|8|||
162906567|NCT05281094|588355729|FG001|Overall Study|Not pre-specified reason|5|||
162906568|NCT02683668|588355740|FG000|Period 2|Withdrawal by Subject|0|||
162906569|NCT02683668|588355741|FG001|Period 2|Withdrawal by Subject|1|||
162906570|NCT02683668|588355742|FG002|Period 2|Withdrawal by Subject|0|||
162906571|NCT04223778|588355743|FG000|Overall Study|Death|1|||
162906572|NCT04223778|588355744|FG001|Overall Study|Death|1|||
162906573|NCT04223778|588355743|FG000|Overall Study|Lost to Follow-up|4|||
162906574|NCT04223778|588355744|FG001|Overall Study|Lost to Follow-up|5|||
162906575|NCT04223778|588355743|FG000|Overall Study|Physician Decision|10|||
162906576|NCT04223778|588355744|FG001|Overall Study|Physician Decision|6|||
162906577|NCT04223778|588355743|FG000|Overall Study|Withdrawal by Subject|35|||
162906578|NCT04223778|588355744|FG001|Overall Study|Withdrawal by Subject|17|||
162906579|NCT04223778|588355743|FG000|Overall Study|Not Reported|7|||
162906580|NCT04223778|588355744|FG001|Overall Study|Not Reported|8|||
162906581|NCT03893630|588355747|FG000|Overall Study|Lost to Follow-up|5|||
162906582|NCT03893630|588355748|FG001|Overall Study|Lost to Follow-up|4|||
162906583|NCT03893630|588355749|FG002|Overall Study|Lost to Follow-up|2|||
162906584|NCT03893630|588355747|FG000|Overall Study|Withdrawal by Subject|3|||
162906585|NCT03893630|588355748|FG001|Overall Study|Withdrawal by Subject|6|||
162906586|NCT03893630|588355749|FG002|Overall Study|Withdrawal by Subject|3|||
162906587|NCT03893630|588355747|FG000|Overall Study|Discontinued Intervention|0|||
162906588|NCT03893630|588355748|FG001|Overall Study|Discontinued Intervention|4|||
162906589|NCT03893630|588355749|FG002|Overall Study|Discontinued Intervention|2|||
162906590|NCT02390167|588357725|FG000|Overall Study|Lost to Follow-up|1|||
162906591|NCT01265719|588357727|FG000|Overall Study|Does not meet entrance criteria|0|||
162906592|NCT01265719|588357728|FG001|Overall Study|Does not meet entrance criteria|3|||
162906593|NCT01265719|588357727|FG000|Overall Study|Other reasons|2|||
162906594|NCT01265719|588357728|FG001|Overall Study|Other reasons|0|||
162906595|NCT01265719|588357727|FG000|Overall Study|Withdrawal by Subject|8|||
162906596|NCT01265719|588357728|FG001|Overall Study|Withdrawal by Subject|3|||
162906597|NCT01265719|588357727|FG000|Overall Study|Lost to Follow-up|2|||
162906598|NCT01265719|588357728|FG001|Overall Study|Lost to Follow-up|7|||
162906599|NCT01265719|588357727|FG000|Overall Study|Adverse Event|2|||
162626802|NCT02777333|587348838|FG001|Overall Study|Withdrawal by Subject|1|||
162906600|NCT01265719|588357728|FG001|Overall Study|Adverse Event|0|||
162906601|NCT00303602|588357729|FG000|Overall Study|Adverse Event|2|||
162906602|NCT00303602|588357730|FG001|Overall Study|Adverse Event|2|||
162906603|NCT00303602|588357729|FG000|Overall Study|Withdrawal by Subject|5|||
162626803|NCT02777333|587348837|FG000|Overall Study|Lost to Follow-up|0|||
162626804|NCT02777333|587348838|FG001|Overall Study|Lost to Follow-up|1|||
162626805|NCT03305575|587350828|FG000|Overall Study|Physician Decision|1|||
162626806|NCT03305575|587350829|FG001|Overall Study|Physician Decision|0|||
162626807|NCT02871297|587350837|FG000|Overall Study|Adverse Event|34|||
162626808|NCT02871297|587350837|FG000|Overall Study|Lack of Efficacy|10|||
162626809|NCT02871297|587350837|FG000|Overall Study|Non-compliance with study drug|15|||
162626810|NCT02871297|587350837|FG000|Overall Study|Protocol Violation|3|||
162626811|NCT02871297|587350837|FG000|Overall Study|Withdrawal by Subject|20|||
162626812|NCT02871297|587350837|FG000|Overall Study|Lost to Follow-up|13|||
162626813|NCT02871297|587350837|FG000|Overall Study|Rolled over to 13546A|2|||
162626814|NCT02871297|587350837|FG000|Overall Study|Other than specified|39|||
162626815|NCT02966028|587350838|FG000|Overall Study|Adverse Event|7|||
162626816|NCT02966028|587350839|FG001|Overall Study|Adverse Event|13|||
162626817|NCT02966028|587350840|FG002|Overall Study|Adverse Event|10|||
162626818|NCT02966028|587350838|FG000|Overall Study|Physician Decision|1|||
162626819|NCT02966028|587350839|FG001|Overall Study|Physician Decision|0|||
162626820|NCT02966028|587350840|FG002|Overall Study|Physician Decision|2|||
162626821|NCT02966028|587350838|FG000|Overall Study|Withdrawal by Subject|7|||
162626822|NCT02966028|587350839|FG001|Overall Study|Withdrawal by Subject|5|||
162626823|NCT02966028|587350840|FG002|Overall Study|Withdrawal by Subject|5|||
162626824|NCT02966028|587350838|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
162626825|NCT02966028|587350839|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
162626826|NCT02966028|587350840|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
162626827|NCT04115839|587350841|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
162626828|NCT04115839|587350842|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
162626829|NCT04115839|587350843|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
162626830|NCT04115839|587350844|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162626831|NCT04115839|587350845|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162626832|NCT04115839|587350846|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162626833|NCT04115839|587350847|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162626834|NCT04115839|587350841|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
162626835|NCT04115839|587350842|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
162626836|NCT04115839|587350843|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
162626837|NCT04115839|587350844|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162626838|NCT04115839|587350845|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162626839|NCT04115839|587350846|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162626840|NCT04115839|587350847|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162626841|NCT04115839|587350841|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
162626842|NCT04115839|587350842|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626843|NCT04115839|587350843|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626844|NCT04115839|587350844|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626845|NCT04115839|587350845|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626846|NCT04115839|587350846|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626847|NCT04115839|587350847|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162626848|NCT04115839|587350841|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162626849|NCT04115839|587350842|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162626850|NCT04115839|587350843|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
162626851|NCT04115839|587350844|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162626852|NCT04115839|587350845|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162626853|NCT04115839|587350846|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162626854|NCT04115839|587350847|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162906604|NCT00303602|588357730|FG001|Overall Study|Withdrawal by Subject|6|||
162906605|NCT00303602|588357729|FG000|Overall Study|Lost to Follow-up|5|||
162906606|NCT00303602|588357730|FG001|Overall Study|Lost to Follow-up|2|||
162906607|NCT00303602|588357729|FG000|Overall Study|Protocol entry criteria not met|2|||
162906608|NCT00303602|588357730|FG001|Overall Study|Protocol entry criteria not met|2|||
162906609|NCT00303602|588357729|FG000|Overall Study|Physician Decision|2|||
162626855|NCT04115839|587350841|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162626856|NCT04115839|587350842|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162626857|NCT04115839|587350843|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162626858|NCT04115839|587350844|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
162626859|NCT04115839|587350845|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
162626860|NCT04115839|587350846|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
162710159|NCT00631917|587648982|FG001|Overall Study|Protocol deviation|5|||
162906610|NCT00303602|588357730|FG001|Overall Study|Physician Decision|1|||
162906611|NCT00303602|588357729|FG000|Overall Study|Noncompliance|2|||
162906612|NCT00303602|588357730|FG001|Overall Study|Noncompliance|2|||
162906613|NCT00303602|588357729|FG000|Overall Study|Protocol Violation|1|||
162906614|NCT00303602|588357730|FG001|Overall Study|Protocol Violation|0|||
162906615|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
162906616|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
162906617|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
162906618|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
162906619|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
162906620|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
162626861|NCT04115839|587350847|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
162626862|NCT04115839|587350841|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162626863|NCT04115839|587350842|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162626864|NCT04115839|587350843|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162626865|NCT04115839|587350844|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
162626866|NCT04115839|587350845|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
162626867|NCT04115839|587350846|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162626868|NCT04115839|587350847|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162626869|NCT01408485|587350848|FG000|Overall Study|Withdrawal by Subject|21|||
162626870|NCT02151591|587350849|FG000|Overall Study|Lost to Follow-up|6|||
162626871|NCT02151591|587350850|FG001|Overall Study|Lost to Follow-up|3|||
162626872|NCT01342796|587350851|FG000|Overall Study|Withdrawal by Subject|2|||
162626873|NCT01342796|587350852|FG001|Overall Study|Withdrawal by Subject|0|||
162626874|NCT01342796|587350851|FG000|Overall Study|Lost to Follow-up|0|||
162626875|NCT01342796|587350852|FG001|Overall Study|Lost to Follow-up|3|||
162626876|NCT01342796|587350851|FG000|Overall Study|Inappropriate enrollment|1|||
162626877|NCT01342796|587350852|FG001|Overall Study|Inappropriate enrollment|0|||
162626878|NCT01751867|587350853|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
162626879|NCT01751867|587350854|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
162626880|NCT01751867|587350853|FG000|Overall Study|Diease Progression|4|||
162626881|NCT01751867|587350854|FG001|Overall Study|Diease Progression|18|||
162906621|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
162906622|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
162906623|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Death|0|||
162906624|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Death|0|||
162906625|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Death|0|||
162906626|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Death|1|||
162906627|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Death|1|||
162626882|NCT01751867|587350853|FG000|Overall Study|Adverse Event|8|||
162626883|NCT01751867|587350854|FG001|Overall Study|Adverse Event|15|||
162626884|NCT01751867|587350853|FG000|Overall Study|Poor Compliance|0|||
162626885|NCT01751867|587350854|FG001|Overall Study|Poor Compliance|5|||
162906628|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Death|0|||
162906629|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Death|2|||
162906630|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Death|0|||
162906631|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906632|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906633|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906634|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
162906635|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906636|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906637|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906638|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
162906639|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906640|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906641|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906642|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
162906643|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906644|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906645|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906646|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
162906647|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
162906648|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
162906649|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
162906650|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
162906651|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
162906652|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
162906653|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
162906654|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
162906655|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
162906656|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
162906657|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
162906658|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
162906659|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
162906660|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
162906661|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
162906662|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
162906663|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
162906664|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
162906665|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
162906666|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
162906667|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
162906668|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
162906669|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
162906670|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
162906671|NCT02442765|588357731|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906672|NCT02442765|588357732|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906673|NCT02442765|588357733|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906674|NCT02442765|588357734|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906675|NCT02442765|588357735|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
162906676|NCT02442765|588357736|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906677|NCT02442765|588357737|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
162906678|NCT02442765|588357738|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
162906679|NCT02554721|588357739|FG000|Overall Study|Adverse Event|1|||
162906680|NCT02554721|588357740|FG001|Overall Study|Adverse Event|0|||
162906681|NCT02554721|588357741|FG002|Overall Study|Adverse Event|0|||
163054257|NCT01587885|588910200|FG001|Treatment Period 1|Protocol Violation|2|||
163054258|NCT01458587|588910201|FG000|Overall Study|Withdrawal by Subject|1|||
163054259|NCT01458587|588910202|FG001|Overall Study|Withdrawal by Subject|0|||
163054260|NCT01603602|588910203|FG000|Overall Study|Adverse Event|1|||
163054261|NCT01603602|588910204|FG001|Overall Study|Adverse Event|0|||
163054262|NCT01603602|588910205|FG002|Overall Study|Adverse Event|0|||
163054263|NCT01603602|588910203|FG000|Overall Study|Personal Reasons|1|||
163054264|NCT01603602|588910204|FG001|Overall Study|Personal Reasons|0|||
163054265|NCT01603602|588910205|FG002|Overall Study|Personal Reasons|1|||
162906682|NCT02554721|588357742|FG003|Overall Study|Adverse Event|0|||
162906683|NCT02554721|588357743|FG004|Overall Study|Adverse Event|1|||
162626886|NCT01751867|587350853|FG000|Overall Study|Withdrawal by Subject|3|||
162906684|NCT02554721|588357739|FG000|Overall Study|Noncompliance|0|||
163054266|NCT04748718|588910209|FG000|Overall Study|Lost to Follow-up|50|||
163054267|NCT00316004|588910210|FG000|Overall Study|Subject was not given study fluid.|14|||
163054268|NCT00316004|588910211|FG001|Overall Study|Subject was not given study fluid.|14|||
162626887|NCT01751867|587350854|FG001|Overall Study|Withdrawal by Subject|1|||
162626888|NCT01751867|587350853|FG000|Overall Study|Physician Decision|4|||
162626889|NCT01751867|587350854|FG001|Overall Study|Physician Decision|7|||
162906685|NCT02554721|588357740|FG001|Overall Study|Noncompliance|0|||
162906686|NCT02554721|588357741|FG002|Overall Study|Noncompliance|0|||
162906687|NCT02554721|588357742|FG003|Overall Study|Noncompliance|0|||
162906688|NCT02554721|588357743|FG004|Overall Study|Noncompliance|1|||
162906689|NCT01693562|588357746|FG000|Escalation Phase|Withdrawal by Subject|0|||
162906690|NCT01693562|588357747|FG001|Escalation Phase|Withdrawal by Subject|1|||
162906691|NCT01693562|588357748|FG002|Escalation Phase|Withdrawal by Subject|0|||
162906692|NCT01693562|588357749|FG003|Escalation Phase|Withdrawal by Subject|0|||
162906693|NCT01693562|588357750|FG004|Escalation Phase|Withdrawal by Subject|0|||
162906694|NCT01693562|588357751|FG005|Escalation Phase|Withdrawal by Subject|2|||
162906695|NCT01693562|588357752|FG006|Escalation Phase|Withdrawal by Subject|0|||
162906696|NCT01693562|588357753|FG007|Escalation Phase|Withdrawal by Subject|0|||
162906697|NCT01693562|588357754|FG008|Escalation Phase|Withdrawal by Subject|0|||
162906698|NCT01693562|588357755|FG009|Escalation Phase|Withdrawal by Subject|0|||
162906699|NCT01693562|588357756|FG010|Escalation Phase|Withdrawal by Subject|0|||
162906700|NCT01693562|588357757|FG011|Escalation Phase|Withdrawal by Subject|0|||
162906701|NCT01693562|588357758|FG012|Escalation Phase|Withdrawal by Subject|0|||
162906702|NCT01693562|588357759|FG013|Escalation Phase|Withdrawal by Subject|0|||
162906703|NCT01693562|588357760|FG014|Escalation Phase|Withdrawal by Subject|0|||
162906704|NCT01693562|588357761|FG015|Escalation Phase|Withdrawal by Subject|0|||
162906705|NCT01693562|588357762|FG016|Escalation Phase|Withdrawal by Subject|0|||
162906706|NCT01693562|588357763|FG017|Escalation Phase|Withdrawal by Subject|0|||
162906707|NCT01693562|588357764|FG018|Escalation Phase|Withdrawal by Subject|0|||
162906708|NCT01693562|588357765|FG019|Escalation Phase|Withdrawal by Subject|0|||
162906709|NCT01693562|588357766|FG020|Escalation Phase|Withdrawal by Subject|0|||
162906710|NCT01693562|588357767|FG021|Escalation Phase|Withdrawal by Subject|0|||
162906711|NCT01693562|588357768|FG022|Escalation Phase|Withdrawal by Subject|0|||
162626890|NCT01751867|587350853|FG000|Overall Study|Protocol Violation|0|||
162906712|NCT01693562|588357746|FG000|Escalation Phase|Death|4|||
162906713|NCT01693562|588357747|FG001|Escalation Phase|Death|2|||
162906714|NCT01693562|588357748|FG002|Escalation Phase|Death|0|||
162906715|NCT01693562|588357749|FG003|Escalation Phase|Death|3|||
162906716|NCT01693562|588357750|FG004|Escalation Phase|Death|6|||
162906717|NCT01693562|588357751|FG005|Escalation Phase|Death|4|||
162906718|NCT01693562|588357752|FG006|Escalation Phase|Death|0|||
162906719|NCT01693562|588357753|FG007|Escalation Phase|Death|0|||
162906720|NCT01693562|588357754|FG008|Escalation Phase|Death|0|||
162906721|NCT01693562|588357755|FG009|Escalation Phase|Death|0|||
162906722|NCT01693562|588357756|FG010|Escalation Phase|Death|0|||
162906723|NCT01693562|588357757|FG011|Escalation Phase|Death|0|||
162906724|NCT01693562|588357758|FG012|Escalation Phase|Death|0|||
162906725|NCT01693562|588357759|FG013|Escalation Phase|Death|0|||
162906726|NCT01693562|588357760|FG014|Escalation Phase|Death|0|||
162906727|NCT01693562|588357761|FG015|Escalation Phase|Death|0|||
162906728|NCT01693562|588357762|FG016|Escalation Phase|Death|0|||
162906729|NCT01693562|588357763|FG017|Escalation Phase|Death|0|||
162906730|NCT01693562|588357764|FG018|Escalation Phase|Death|0|||
162906731|NCT01693562|588357765|FG019|Escalation Phase|Death|0|||
162906732|NCT01693562|588357766|FG020|Escalation Phase|Death|0|||
162906733|NCT01693562|588357767|FG021|Escalation Phase|Death|0|||
162906734|NCT01693562|588357768|FG022|Escalation Phase|Death|0|||
162906735|NCT01693562|588357746|FG000|Escalation Phase|Lost to Follow-up|0|||
162906736|NCT01693562|588357747|FG001|Escalation Phase|Lost to Follow-up|1|||
162906737|NCT01693562|588357748|FG002|Escalation Phase|Lost to Follow-up|1|||
162906738|NCT01693562|588357749|FG003|Escalation Phase|Lost to Follow-up|0|||
162906739|NCT01693562|588357750|FG004|Escalation Phase|Lost to Follow-up|0|||
162906740|NCT01693562|588357751|FG005|Escalation Phase|Lost to Follow-up|0|||
162906741|NCT01693562|588357752|FG006|Escalation Phase|Lost to Follow-up|0|||
162906742|NCT01693562|588357753|FG007|Escalation Phase|Lost to Follow-up|0|||
162906743|NCT01693562|588357754|FG008|Escalation Phase|Lost to Follow-up|0|||
162626891|NCT01751867|587350854|FG001|Overall Study|Protocol Violation|2|||
162906744|NCT01693562|588357755|FG009|Escalation Phase|Lost to Follow-up|0|||
162906745|NCT01693562|588357756|FG010|Escalation Phase|Lost to Follow-up|0|||
162906746|NCT01693562|588357757|FG011|Escalation Phase|Lost to Follow-up|0|||
162906747|NCT01693562|588357758|FG012|Escalation Phase|Lost to Follow-up|0|||
162906748|NCT01693562|588357759|FG013|Escalation Phase|Lost to Follow-up|0|||
162906749|NCT01693562|588357760|FG014|Escalation Phase|Lost to Follow-up|0|||
162906750|NCT01693562|588357761|FG015|Escalation Phase|Lost to Follow-up|0|||
162906751|NCT01693562|588357762|FG016|Escalation Phase|Lost to Follow-up|0|||
162906752|NCT01693562|588357763|FG017|Escalation Phase|Lost to Follow-up|0|||
162906753|NCT01693562|588357764|FG018|Escalation Phase|Lost to Follow-up|0|||
162906754|NCT01693562|588357765|FG019|Escalation Phase|Lost to Follow-up|0|||
162906755|NCT01693562|588357766|FG020|Escalation Phase|Lost to Follow-up|0|||
162906756|NCT01693562|588357767|FG021|Escalation Phase|Lost to Follow-up|0|||
162906757|NCT01693562|588357768|FG022|Escalation Phase|Lost to Follow-up|0|||
162906758|NCT01693562|588357746|FG000|Escalation Phase|Other|0|||
162906759|NCT01693562|588357747|FG001|Escalation Phase|Other|0|||
162626892|NCT01751867|587350853|FG000|Overall Study|Death|0|||
162906760|NCT01693562|588357748|FG002|Escalation Phase|Other|2|||
162906761|NCT01693562|588357749|FG003|Escalation Phase|Other|0|||
162906762|NCT01693562|588357750|FG004|Escalation Phase|Other|0|||
162906763|NCT01693562|588357751|FG005|Escalation Phase|Other|1|||
162906764|NCT01693562|588357752|FG006|Escalation Phase|Other|0|||
162906765|NCT01693562|588357753|FG007|Escalation Phase|Other|0|||
162906766|NCT01693562|588357754|FG008|Escalation Phase|Other|0|||
162906767|NCT01693562|588357755|FG009|Escalation Phase|Other|0|||
162626893|NCT01751867|587350854|FG001|Overall Study|Death|5|||
162626894|NCT01751867|587350853|FG000|Overall Study|Other|11|||
162626895|NCT01751867|587350854|FG001|Overall Study|Other|37|||
162626896|NCT01751867|587350853|FG000|Overall Study|Randomized but not treated.|2|||
162626897|NCT01751867|587350854|FG001|Overall Study|Randomized but not treated.|1|||
162906768|NCT01693562|588357756|FG010|Escalation Phase|Other|0|||
162906769|NCT01693562|588357757|FG011|Escalation Phase|Other|0|||
162906770|NCT01693562|588357758|FG012|Escalation Phase|Other|0|||
162906771|NCT01693562|588357759|FG013|Escalation Phase|Other|0|||
162906772|NCT01693562|588357760|FG014|Escalation Phase|Other|0|||
162906773|NCT01693562|588357761|FG015|Escalation Phase|Other|0|||
162906774|NCT01693562|588357762|FG016|Escalation Phase|Other|0|||
162906775|NCT01693562|588357763|FG017|Escalation Phase|Other|0|||
162906776|NCT01693562|588357764|FG018|Escalation Phase|Other|0|||
162906777|NCT01693562|588357765|FG019|Escalation Phase|Other|0|||
162906778|NCT01693562|588357766|FG020|Escalation Phase|Other|0|||
162906779|NCT01693562|588357767|FG021|Escalation Phase|Other|0|||
162906780|NCT01693562|588357768|FG022|Escalation Phase|Other|0|||
162906781|NCT01693562|588357746|FG000|Exploration Phase|Withdrawal by Subject|0|||
162906782|NCT01693562|588357747|FG001|Exploration Phase|Withdrawal by Subject|0|||
162906783|NCT01693562|588357748|FG002|Exploration Phase|Withdrawal by Subject|0|||
162906784|NCT01693562|588357749|FG003|Exploration Phase|Withdrawal by Subject|0|||
162906785|NCT01693562|588357750|FG004|Exploration Phase|Withdrawal by Subject|0|||
162906786|NCT01693562|588357751|FG005|Exploration Phase|Withdrawal by Subject|0|||
162906787|NCT01693562|588357752|FG006|Exploration Phase|Withdrawal by Subject|2|||
162906788|NCT01693562|588357753|FG007|Exploration Phase|Withdrawal by Subject|0|||
162906789|NCT01693562|588357754|FG008|Exploration Phase|Withdrawal by Subject|0|||
162906790|NCT01693562|588357755|FG009|Exploration Phase|Withdrawal by Subject|0|||
162906791|NCT01693562|588357756|FG010|Exploration Phase|Withdrawal by Subject|0|||
162906792|NCT01693562|588357757|FG011|Exploration Phase|Withdrawal by Subject|0|||
162906793|NCT01693562|588357758|FG012|Exploration Phase|Withdrawal by Subject|0|||
162906794|NCT01693562|588357759|FG013|Exploration Phase|Withdrawal by Subject|0|||
162906795|NCT01693562|588357760|FG014|Exploration Phase|Withdrawal by Subject|0|||
162906796|NCT01693562|588357761|FG015|Exploration Phase|Withdrawal by Subject|0|||
162906797|NCT01693562|588357762|FG016|Exploration Phase|Withdrawal by Subject|0|||
162906798|NCT01693562|588357763|FG017|Exploration Phase|Withdrawal by Subject|0|||
162906799|NCT01693562|588357764|FG018|Exploration Phase|Withdrawal by Subject|0|||
162906800|NCT01693562|588357765|FG019|Exploration Phase|Withdrawal by Subject|0|||
162906801|NCT01693562|588357766|FG020|Exploration Phase|Withdrawal by Subject|0|||
162906802|NCT01693562|588357767|FG021|Exploration Phase|Withdrawal by Subject|0|||
162906803|NCT01693562|588357768|FG022|Exploration Phase|Withdrawal by Subject|0|||
162906804|NCT01693562|588357746|FG000|Exploration Phase|Death|0|||
162906805|NCT01693562|588357747|FG001|Exploration Phase|Death|0|||
162906806|NCT01693562|588357748|FG002|Exploration Phase|Death|0|||
162906807|NCT01693562|588357749|FG003|Exploration Phase|Death|0|||
162906808|NCT01693562|588357750|FG004|Exploration Phase|Death|0|||
162906809|NCT01693562|588357751|FG005|Exploration Phase|Death|0|||
162906810|NCT01693562|588357752|FG006|Exploration Phase|Death|17|||
162906811|NCT01693562|588357753|FG007|Exploration Phase|Death|0|||
162906812|NCT01693562|588357754|FG008|Exploration Phase|Death|0|||
162906813|NCT01693562|588357755|FG009|Exploration Phase|Death|0|||
162906814|NCT01693562|588357756|FG010|Exploration Phase|Death|0|||
162626898|NCT01396148|587350855|FG000|Overall Study|Patient Decision|1|||
162626899|NCT00224042|587350864|FG000|Overall Study|Adverse Event|2|||
162626900|NCT00224042|587350865|FG001|Overall Study|Adverse Event|1|||
162626901|NCT00224042|587350864|FG000|Overall Study|Protocol Violation|0|||
162626902|NCT00224042|587350865|FG001|Overall Study|Protocol Violation|1|||
162626903|NCT00224042|587350864|FG000|Overall Study|Physician Decision|0|||
162906815|NCT01693562|588357757|FG011|Exploration Phase|Death|0|||
162906816|NCT01693562|588357758|FG012|Exploration Phase|Death|0|||
162906817|NCT01693562|588357759|FG013|Exploration Phase|Death|0|||
162906818|NCT01693562|588357760|FG014|Exploration Phase|Death|0|||
162906819|NCT01693562|588357761|FG015|Exploration Phase|Death|0|||
162906820|NCT01693562|588357762|FG016|Exploration Phase|Death|0|||
162906821|NCT01693562|588357763|FG017|Exploration Phase|Death|0|||
162906822|NCT01693562|588357764|FG018|Exploration Phase|Death|0|||
162979006|NCT03545191|588623547|FG001|Overall Study|Lost to Follow-up|2|||
162626904|NCT00224042|587350865|FG001|Overall Study|Physician Decision|1|||
162906823|NCT01693562|588357765|FG019|Exploration Phase|Death|0|||
162906824|NCT01693562|588357766|FG020|Exploration Phase|Death|0|||
162906825|NCT01693562|588357767|FG021|Exploration Phase|Death|0|||
162906826|NCT01693562|588357768|FG022|Exploration Phase|Death|0|||
162906827|NCT01693562|588357746|FG000|Exploration Phase|Other|0|||
162906828|NCT01693562|588357747|FG001|Exploration Phase|Other|0|||
162626905|NCT00224042|587350864|FG000|Overall Study|Did not meet lab incusion criteria|2|||
162906829|NCT01693562|588357748|FG002|Exploration Phase|Other|0|||
162906830|NCT01693562|588357749|FG003|Exploration Phase|Other|0|||
162967392|NCT04561115|588581363|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
162967393|NCT00743145|588581364|FG000|Overall Study|Withdrawal by Subject|1|||
162967394|NCT00743145|588581364|FG000|Overall Study|Adverse Event|2|||
162967395|NCT00743145|588581364|FG000|Overall Study|Pregnancy|1|||
162967396|NCT02179190|588581365|FG000|Enrollment|Exit Prior to Device Attempt|11|||
162967397|NCT02179190|588581365|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
162967398|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
162967399|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
162967400|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
162967401|NCT02179190|588581365|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
162967402|NCT01670097|588581366|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
162967403|NCT01670097|588581367|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
162967404|NCT01670097|588581366|FG000|Overall Study|Study burden|1|||
163054269|NCT00316004|588910212|FG002|Overall Study|Subject was not given study fluid.|21|||
163054270|NCT01118299|588910214|FG000|Overall Study|Death|7|||
163054271|NCT01118299|588910215|FG001|Overall Study|Death|5|||
163054272|NCT01118299|588910214|FG000|Overall Study|Withdrawal by Subject|8|||
163054273|NCT01118299|588910215|FG001|Overall Study|Withdrawal by Subject|8|||
163054274|NCT01118299|588910214|FG000|Overall Study|Lost to Follow-up|2|||
163054275|NCT01118299|588910215|FG001|Overall Study|Lost to Follow-up|1|||
163054276|NCT01118299|588910214|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
163054277|NCT01118299|588910215|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
163054278|NCT01935089|588910216|FG000|Overall Study|Adverse Event|2|||
163054279|NCT01935089|588910216|FG000|Overall Study|Withdrawal by Subject|1|||
163054280|NCT02932943|588910217|FG000|Overall Study|Lost to Follow-up|0|||
163054281|NCT02932943|588910218|FG001|Overall Study|Lost to Follow-up|2|||
163054282|NCT02932943|588910217|FG000|Overall Study|Adverse Event|2|||
163054283|NCT02932943|588910218|FG001|Overall Study|Adverse Event|2|||
163054284|NCT02932943|588910217|FG000|Overall Study|Withdrawal by Subject|3|||
163054285|NCT02932943|588910218|FG001|Overall Study|Withdrawal by Subject|3|||
163054286|NCT02665117|588910221|FG000|Overall Study|Physician Decision|1|||
163054287|NCT02665117|588910222|FG001|Overall Study|Physician Decision|0|||
163054288|NCT00977197|588910223|FG000|Overall Study|Withdrawal by Subject|3|||
163054289|NCT00977197|588910224|FG001|Overall Study|Withdrawal by Subject|4|||
162626906|NCT00224042|587350865|FG001|Overall Study|Did not meet lab incusion criteria|3|||
162626907|NCT00224042|587350864|FG000|Overall Study|Other|2|||
162626908|NCT00224042|587350865|FG001|Overall Study|Other|0|||
162626909|NCT00840450|587350866|FG000|Overall Study|Adverse Event|1|||
162626910|NCT00840450|587350866|FG000|Overall Study|Lack of Efficacy|2|||
162906831|NCT01693562|588357750|FG004|Exploration Phase|Other|0|||
162906832|NCT01693562|588357751|FG005|Exploration Phase|Other|0|||
162906833|NCT01693562|588357752|FG006|Exploration Phase|Other|2|||
162906834|NCT01693562|588357753|FG007|Exploration Phase|Other|0|||
162906835|NCT01693562|588357754|FG008|Exploration Phase|Other|0|||
162906836|NCT01693562|588357755|FG009|Exploration Phase|Other|0|||
162967405|NCT01670097|588581367|FG001|Overall Study|Study burden|0|||
162967406|NCT01670097|588581366|FG000|Overall Study|COPD exacerbation|0|||
162967407|NCT01670097|588581367|FG001|Overall Study|COPD exacerbation|1|||
163054290|NCT00977197|588910223|FG000|Overall Study|Adverse Event|3|||
162906837|NCT01693562|588357756|FG010|Exploration Phase|Other|0|||
162906838|NCT01693562|588357757|FG011|Exploration Phase|Other|0|||
162906839|NCT01693562|588357758|FG012|Exploration Phase|Other|0|||
162906840|NCT01693562|588357759|FG013|Exploration Phase|Other|0|||
162906841|NCT01693562|588357760|FG014|Exploration Phase|Other|0|||
162906842|NCT01693562|588357761|FG015|Exploration Phase|Other|0|||
162906843|NCT01693562|588357762|FG016|Exploration Phase|Other|0|||
162906844|NCT01693562|588357763|FG017|Exploration Phase|Other|0|||
162906845|NCT01693562|588357764|FG018|Exploration Phase|Other|0|||
162906846|NCT01693562|588357765|FG019|Exploration Phase|Other|0|||
162906847|NCT01693562|588357766|FG020|Exploration Phase|Other|0|||
162906848|NCT01693562|588357767|FG021|Exploration Phase|Other|0|||
162967408|NCT01670097|588581366|FG000|Overall Study|Neutropenia|0|||
162967409|NCT01670097|588581367|FG001|Overall Study|Neutropenia|1|||
163054291|NCT00977197|588910224|FG001|Overall Study|Adverse Event|1|||
163054292|NCT00977197|588910223|FG000|Overall Study|Lack of Efficacy|1|||
163054293|NCT00977197|588910224|FG001|Overall Study|Lack of Efficacy|0|||
163054294|NCT00977197|588910223|FG000|Overall Study|Lost to Follow-up|1|||
162626911|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
163054295|NCT00977197|588910224|FG001|Overall Study|Lost to Follow-up|3|||
162626912|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
162626913|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162626914|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162626915|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162906849|NCT01693562|588357768|FG022|Exploration Phase|Other|0|||
162967410|NCT01670097|588581366|FG000|Overall Study|Clinical deterioration|0|||
162906850|NCT01693562|588357746|FG000|Expansion Phase|Withdrawal by Subject|0|||
162906851|NCT01693562|588357747|FG001|Expansion Phase|Withdrawal by Subject|0|||
163054296|NCT00977197|588910223|FG000|Overall Study|Nonadherence|1|||
162626916|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162626917|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162626918|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162626919|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
162626920|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
162626921|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162626922|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162906852|NCT01693562|588357748|FG002|Expansion Phase|Withdrawal by Subject|0|||
162906853|NCT01693562|588357749|FG003|Expansion Phase|Withdrawal by Subject|0|||
162906854|NCT01693562|588357750|FG004|Expansion Phase|Withdrawal by Subject|0|||
162906855|NCT01693562|588357751|FG005|Expansion Phase|Withdrawal by Subject|0|||
162906856|NCT01693562|588357752|FG006|Expansion Phase|Withdrawal by Subject|0|||
162906857|NCT01693562|588357753|FG007|Expansion Phase|Withdrawal by Subject|16|||
162906858|NCT01693562|588357754|FG008|Expansion Phase|Withdrawal by Subject|2|||
162906859|NCT01693562|588357755|FG009|Expansion Phase|Withdrawal by Subject|54|||
162906860|NCT01693562|588357756|FG010|Expansion Phase|Withdrawal by Subject|2|||
162906861|NCT01693562|588357757|FG011|Expansion Phase|Withdrawal by Subject|2|||
162906862|NCT01693562|588357758|FG012|Expansion Phase|Withdrawal by Subject|3|||
162906863|NCT01693562|588357759|FG013|Expansion Phase|Withdrawal by Subject|5|||
162906864|NCT01693562|588357760|FG014|Expansion Phase|Withdrawal by Subject|16|||
162906865|NCT01693562|588357761|FG015|Expansion Phase|Withdrawal by Subject|7|||
162906866|NCT01693562|588357762|FG016|Expansion Phase|Withdrawal by Subject|40|||
162906867|NCT01693562|588357763|FG017|Expansion Phase|Withdrawal by Subject|4|||
162906868|NCT01693562|588357764|FG018|Expansion Phase|Withdrawal by Subject|8|||
162906869|NCT01693562|588357765|FG019|Expansion Phase|Withdrawal by Subject|3|||
162906870|NCT01693562|588357766|FG020|Expansion Phase|Withdrawal by Subject|1|||
162906871|NCT01693562|588357767|FG021|Expansion Phase|Withdrawal by Subject|8|||
162906872|NCT01693562|588357768|FG022|Expansion Phase|Withdrawal by Subject|1|||
162906873|NCT01693562|588357746|FG000|Expansion Phase|Death|0|||
162906874|NCT01693562|588357747|FG001|Expansion Phase|Death|0|||
162626923|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162626924|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162626925|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162626926|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162626927|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
162626928|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
162626929|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626930|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626931|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626932|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626933|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626934|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162626935|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626936|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
162626937|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626938|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626939|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626940|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626941|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626942|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162626943|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
162626944|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
162906875|NCT01693562|588357748|FG002|Expansion Phase|Death|0|||
162906876|NCT01693562|588357749|FG003|Expansion Phase|Death|0|||
162906877|NCT01693562|588357750|FG004|Expansion Phase|Death|0|||
162906878|NCT01693562|588357751|FG005|Expansion Phase|Death|0|||
162906879|NCT01693562|588357752|FG006|Expansion Phase|Death|0|||
162906880|NCT01693562|588357753|FG007|Expansion Phase|Death|42|||
162906881|NCT01693562|588357754|FG008|Expansion Phase|Death|17|||
162906882|NCT01693562|588357755|FG009|Expansion Phase|Death|208|||
162906883|NCT01693562|588357756|FG010|Expansion Phase|Death|30|||
162906884|NCT01693562|588357757|FG011|Expansion Phase|Death|8|||
162626945|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162906885|NCT01693562|588357758|FG012|Expansion Phase|Death|19|||
162906886|NCT01693562|588357759|FG013|Expansion Phase|Death|42|||
162906887|NCT01693562|588357760|FG014|Expansion Phase|Death|23|||
162626946|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162906888|NCT01693562|588357761|FG015|Expansion Phase|Death|23|||
162906889|NCT01693562|588357762|FG016|Expansion Phase|Death|128|||
162906890|NCT01693562|588357763|FG017|Expansion Phase|Death|16|||
162906891|NCT01693562|588357764|FG018|Expansion Phase|Death|36|||
162906892|NCT01693562|588357765|FG019|Expansion Phase|Death|16|||
162906893|NCT01693562|588357766|FG020|Expansion Phase|Death|17|||
162906894|NCT01693562|588357767|FG021|Expansion Phase|Death|35|||
162906895|NCT01693562|588357768|FG022|Expansion Phase|Death|7|||
162626947|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162626948|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162626949|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162626950|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162626951|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
162626952|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626953|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626954|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626955|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626956|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626957|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626958|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162626959|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
162626960|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
162626961|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626962|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626963|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626964|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626965|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626966|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162626967|NCT03095066|587350867|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
162626968|NCT03095066|587350868|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
162626969|NCT03095066|587350869|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626970|NCT03095066|587350870|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626971|NCT03095066|587350871|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626972|NCT03095066|587350872|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626973|NCT03095066|587350873|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626974|NCT03095066|587350874|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162626975|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626976|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626977|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
162626978|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626979|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626980|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626981|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162626982|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
162626983|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626984|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626985|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
162626986|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626987|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626988|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626989|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162626990|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
162626991|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626992|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626993|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
162626994|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626995|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626996|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626997|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162626998|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
162626999|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162627000|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162906896|NCT01693562|588357746|FG000|Expansion Phase|Lost to Follow-up|0|||
162906897|NCT01693562|588357747|FG001|Expansion Phase|Lost to Follow-up|0|||
162906898|NCT01693562|588357748|FG002|Expansion Phase|Lost to Follow-up|0|||
162906899|NCT01693562|588357749|FG003|Expansion Phase|Lost to Follow-up|0|||
162906900|NCT01693562|588357750|FG004|Expansion Phase|Lost to Follow-up|0|||
162906901|NCT01693562|588357751|FG005|Expansion Phase|Lost to Follow-up|0|||
162906902|NCT01693562|588357752|FG006|Expansion Phase|Lost to Follow-up|0|||
162906903|NCT01693562|588357753|FG007|Expansion Phase|Lost to Follow-up|1|||
162627001|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
162906904|NCT01693562|588357754|FG008|Expansion Phase|Lost to Follow-up|2|||
162906905|NCT01693562|588357755|FG009|Expansion Phase|Lost to Follow-up|10|||
162906906|NCT01693562|588357756|FG010|Expansion Phase|Lost to Follow-up|4|||
162627002|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162906907|NCT01693562|588357757|FG011|Expansion Phase|Lost to Follow-up|4|||
162906908|NCT01693562|588357758|FG012|Expansion Phase|Lost to Follow-up|1|||
162906909|NCT01693562|588357759|FG013|Expansion Phase|Lost to Follow-up|3|||
162906910|NCT01693562|588357760|FG014|Expansion Phase|Lost to Follow-up|0|||
162906911|NCT01693562|588357761|FG015|Expansion Phase|Lost to Follow-up|1|||
162906912|NCT01693562|588357762|FG016|Expansion Phase|Lost to Follow-up|1|||
162906913|NCT01693562|588357763|FG017|Expansion Phase|Lost to Follow-up|0|||
162627003|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162627004|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162627005|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162627006|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
162627007|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627008|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627009|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
162627010|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627011|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627012|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627013|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627014|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162627015|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627016|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627017|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
162627018|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627019|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627020|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627021|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162627022|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
162627023|NCT03095066|587350867|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627024|NCT03095066|587350868|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627025|NCT03095066|587350869|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627026|NCT03095066|587350870|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627027|NCT03095066|587350871|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627028|NCT03095066|587350872|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162627029|NCT03095066|587350873|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162906914|NCT01693562|588357764|FG018|Expansion Phase|Lost to Follow-up|2|||
162906915|NCT01693562|588357765|FG019|Expansion Phase|Lost to Follow-up|1|||
162906916|NCT01693562|588357766|FG020|Expansion Phase|Lost to Follow-up|2|||
162906917|NCT01693562|588357767|FG021|Expansion Phase|Lost to Follow-up|2|||
162906918|NCT01693562|588357768|FG022|Expansion Phase|Lost to Follow-up|1|||
162906919|NCT01693562|588357746|FG000|Expansion Phase|Other|0|||
162906920|NCT01693562|588357747|FG001|Expansion Phase|Other|0|||
162906921|NCT01693562|588357748|FG002|Expansion Phase|Other|0|||
162906922|NCT01693562|588357749|FG003|Expansion Phase|Other|0|||
162627030|NCT03095066|587350874|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
162906923|NCT01693562|588357750|FG004|Expansion Phase|Other|0|||
162906924|NCT01693562|588357751|FG005|Expansion Phase|Other|0|||
162906925|NCT01693562|588357752|FG006|Expansion Phase|Other|0|||
162906926|NCT01693562|588357753|FG007|Expansion Phase|Other|3|||
162906927|NCT01693562|588357754|FG008|Expansion Phase|Other|1|||
162906928|NCT01693562|588357755|FG009|Expansion Phase|Other|28|||
162906929|NCT01693562|588357756|FG010|Expansion Phase|Other|4|||
162710160|NCT00631917|587648981|FG000|Overall Study|Subject withdrew consent|25|||
162710161|NCT00631917|587648982|FG001|Overall Study|Subject withdrew consent|33|||
162710162|NCT00631917|587648981|FG000|Overall Study|Lost to Follow-up|7|||
162710163|NCT00631917|587648982|FG001|Overall Study|Lost to Follow-up|7|||
162710164|NCT00631917|587648981|FG000|Overall Study|Administrative problems|2|||
162710165|NCT00631917|587648982|FG001|Overall Study|Administrative problems|0|||
162710166|NCT00631917|587648981|FG000|Overall Study|Death|1|||
162710167|NCT00631917|587648982|FG001|Overall Study|Death|0|||
162710168|NCT02696785|587648986|FG000|Blinded Treatment Period|Adverse Event|0|||
162710169|NCT02696785|587648987|FG001|Blinded Treatment Period|Adverse Event|1|||
162710170|NCT02696785|587648988|FG002|Blinded Treatment Period|Adverse Event|3|||
162710171|NCT02696785|587648989|FG003|Blinded Treatment Period|Adverse Event|0|||
162710172|NCT02696785|587648986|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
162710173|NCT02696785|587648987|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
162710174|NCT02696785|587648988|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
162710175|NCT02696785|587648989|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
162710176|NCT02696785|587648986|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
162627031|NCT03095066|587350867|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627032|NCT03095066|587350868|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627033|NCT03095066|587350869|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627034|NCT03095066|587350870|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627035|NCT03095066|587350871|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627036|NCT03095066|587350872|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
162627037|NCT03095066|587350873|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627038|NCT03095066|587350874|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162627039|NCT03095066|587350867|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627040|NCT03095066|587350868|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627041|NCT03095066|587350869|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627042|NCT03095066|587350870|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627043|NCT03095066|587350871|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
162627044|NCT03095066|587350872|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627045|NCT03095066|587350873|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
162627046|NCT03095066|587350874|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162627047|NCT03095066|587350867|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162627048|NCT03095066|587350868|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162627049|NCT03095066|587350869|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162710177|NCT02696785|587648987|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
162710178|NCT02696785|587648988|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
162710179|NCT02696785|587648989|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
162710180|NCT02696785|587648986|FG000|Blinded Treatment Period|Screen Failure|1|||
162710181|NCT02696785|587648987|FG001|Blinded Treatment Period|Screen Failure|0|||
162710182|NCT02696785|587648988|FG002|Blinded Treatment Period|Screen Failure|0|||
162710183|NCT02696785|587648989|FG003|Blinded Treatment Period|Screen Failure|0|||
162710184|NCT02696785|587648986|FG000|Washout Period|Withdrawal by Subject|0|||
162710185|NCT02696785|587648987|FG001|Washout Period|Withdrawal by Subject|1|||
162710186|NCT02696785|587648988|FG002|Washout Period|Withdrawal by Subject|0|||
162710187|NCT02696785|587648989|FG003|Washout Period|Withdrawal by Subject|0|||
162710188|NCT02696785|587648986|FG000|Washout Period|Lack of Efficacy|0|||
162710189|NCT02696785|587648987|FG001|Washout Period|Lack of Efficacy|1|||
162710190|NCT02696785|587648988|FG002|Washout Period|Lack of Efficacy|0|||
162710191|NCT02696785|587648989|FG003|Washout Period|Lack of Efficacy|0|||
162710192|NCT02696785|587648986|FG000|Extended Treatment Period|Adverse Event|2|||
162710193|NCT02696785|587648987|FG001|Extended Treatment Period|Adverse Event|3|||
162627050|NCT03095066|587350870|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162627051|NCT03095066|587350871|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
162627052|NCT03095066|587350872|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162627053|NCT03095066|587350873|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162627054|NCT03095066|587350874|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
162627055|NCT03095066|587350867|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162627056|NCT03095066|587350868|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162627057|NCT03095066|587350869|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162627058|NCT03095066|587350870|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162627059|NCT03095066|587350871|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
162627060|NCT03095066|587350872|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162627061|NCT03095066|587350873|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162710194|NCT02696785|587648988|FG002|Extended Treatment Period|Adverse Event|2|||
162710195|NCT02696785|587648989|FG003|Extended Treatment Period|Adverse Event|1|||
162710196|NCT02696785|587648986|FG000|Extended Treatment Period|Lack of Efficacy|0|||
162710197|NCT02696785|587648987|FG001|Extended Treatment Period|Lack of Efficacy|1|||
162710198|NCT02696785|587648988|FG002|Extended Treatment Period|Lack of Efficacy|0|||
162710199|NCT02696785|587648989|FG003|Extended Treatment Period|Lack of Efficacy|0|||
162710200|NCT02696785|587648986|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
162710201|NCT02696785|587648987|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
162710202|NCT02696785|587648988|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
162710203|NCT02696785|587648989|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
162710204|NCT02696785|587648986|FG000|Follow-up Period|Adverse Event|0|||
162710205|NCT02696785|587648987|FG001|Follow-up Period|Adverse Event|0|||
162710206|NCT02696785|587648988|FG002|Follow-up Period|Adverse Event|8|||
162710207|NCT02696785|587648989|FG003|Follow-up Period|Adverse Event|2|||
162710208|NCT02696785|587648986|FG000|Follow-up Period|Lost to Follow-up|0|||
162710209|NCT02696785|587648987|FG001|Follow-up Period|Lost to Follow-up|0|||
162710210|NCT02696785|587648988|FG002|Follow-up Period|Lost to Follow-up|0|||
162710211|NCT02696785|587648989|FG003|Follow-up Period|Lost to Follow-up|1|||
162710212|NCT02696785|587648986|FG000|Follow-up Period|Lack of Efficacy|0|||
162710213|NCT02696785|587648987|FG001|Follow-up Period|Lack of Efficacy|0|||
162710214|NCT02696785|587648988|FG002|Follow-up Period|Lack of Efficacy|0|||
162710215|NCT02696785|587648989|FG003|Follow-up Period|Lack of Efficacy|1|||
162710216|NCT02696785|587648986|FG000|Follow-up Period|Withdrawal by Subject|1|||
162710217|NCT02696785|587648987|FG001|Follow-up Period|Withdrawal by Subject|0|||
162710218|NCT02696785|587648988|FG002|Follow-up Period|Withdrawal by Subject|5|||
162710219|NCT02696785|587648989|FG003|Follow-up Period|Withdrawal by Subject|4|||
162710220|NCT04863898|587648993|FG000|Overall Study|Away from study clinic during intervention training period|2|||
162710221|NCT04863898|587648993|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
162710222|NCT04863898|587648993|FG000|Overall Study|Lost to Follow-up|3|||
162710223|NCT04863898|587648993|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
162710224|NCT04863898|587648993|FG000|Overall Study|No longer employed at clinic|3|||
162710225|NCT00614744|587648994|FG000|Overall Study|Lost to Follow-up|5|||
162710226|NCT00614744|587648995|FG001|Overall Study|Lost to Follow-up|4|||
162710227|NCT00614744|587648994|FG000|Overall Study|Incomplete for Behavior Issues|0|||
162710228|NCT00614744|587648995|FG001|Overall Study|Incomplete for Behavior Issues|2|||
162710229|NCT00877851|587648996|FG000|Overall Study|Lost to Follow-up|5|||
162710230|NCT00877851|587648997|FG001|Overall Study|Lost to Follow-up|5|||
162710231|NCT00877851|587648996|FG000|Overall Study|computer problem|3|||
162710232|NCT00877851|587648997|FG001|Overall Study|computer problem|0|||
162710233|NCT00877851|587648996|FG000|Overall Study|no longer interested in participating|1|||
162627062|NCT03095066|587350874|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
162627063|NCT03095066|587350867|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162710234|NCT00877851|587648997|FG001|Overall Study|no longer interested in participating|0|||
162710235|NCT03285711|587648998|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
162710236|NCT03285711|587648999|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
162710237|NCT03285711|587649000|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
162627064|NCT03095066|587350868|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162906930|NCT01693562|588357757|FG011|Expansion Phase|Other|7|||
162906931|NCT01693562|588357758|FG012|Expansion Phase|Other|0|||
162906932|NCT01693562|588357759|FG013|Expansion Phase|Other|1|||
162906933|NCT01693562|588357760|FG014|Expansion Phase|Other|1|||
162906934|NCT01693562|588357761|FG015|Expansion Phase|Other|0|||
162906935|NCT01693562|588357762|FG016|Expansion Phase|Other|28|||
162906936|NCT01693562|588357763|FG017|Expansion Phase|Other|0|||
162906937|NCT01693562|588357764|FG018|Expansion Phase|Other|1|||
162906938|NCT01693562|588357765|FG019|Expansion Phase|Other|0|||
162906939|NCT01693562|588357766|FG020|Expansion Phase|Other|1|||
162627065|NCT03095066|587350869|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162627066|NCT03095066|587350870|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
162627067|NCT03095066|587350871|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162906940|NCT01693562|588357767|FG021|Expansion Phase|Other|17|||
162906941|NCT01693562|588357768|FG022|Expansion Phase|Other|1|||
162627068|NCT03095066|587350872|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
162906942|NCT05466240|588357770|FG000|Overall Study|Adverse Event|1|||
162906943|NCT05466240|588357771|FG001|Overall Study|Adverse Event|0|||
162906944|NCT05466240|588357770|FG000|Overall Study|Withdrawal by Subject|1|||
162710238|NCT03285711|587649001|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
162710239|NCT03285711|587648998|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
162710240|NCT03285711|587648999|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162906945|NCT05466240|588357771|FG001|Overall Study|Withdrawal by Subject|0|||
162906946|NCT02759939|588357772|FG000|Overall Study|Missing data on first outcome assessed|11|||
162906947|NCT02759939|588357773|FG001|Overall Study|Missing data on first outcome assessed|2|||
162906948|NCT02759939|588357774|FG002|Overall Study|Missing data on first outcome assessed|5|||
162906949|NCT02759939|588357775|FG003|Overall Study|Missing data on first outcome assessed|2|||
162906950|NCT02759939|588357772|FG000|Overall Study|Ineligible for T2 and T3|310|||
162906951|NCT02759939|588357773|FG001|Overall Study|Ineligible for T2 and T3|179|||
162906952|NCT02759939|588357774|FG002|Overall Study|Ineligible for T2 and T3|366|||
162906953|NCT02759939|588357775|FG003|Overall Study|Ineligible for T2 and T3|391|||
162906954|NCT02759939|588357772|FG000|Overall Study|Lost to Follow-up|735|||
162906955|NCT02759939|588357773|FG001|Overall Study|Lost to Follow-up|791|||
162906956|NCT02759939|588357774|FG002|Overall Study|Lost to Follow-up|783|||
162906957|NCT02759939|588357775|FG003|Overall Study|Lost to Follow-up|650|||
162906958|NCT04735432|588357776|FG000|Overall Study|Other - due to personal reason|1|||
162906959|NCT04735432|588357777|FG001|Overall Study|Other - due to personal reason|0|||
162906960|NCT04735432|588357776|FG000|Overall Study|Adverse Event|2|||
162906961|NCT04735432|588357777|FG001|Overall Study|Adverse Event|0|||
162906962|NCT00626327|588357778|FG000|Overall Study|Withdrawal by Subject|21|||
162906963|NCT00626327|588357779|FG001|Overall Study|Withdrawal by Subject|29|||
162906964|NCT00626327|588357780|FG002|Overall Study|Withdrawal by Subject|30|||
162906965|NCT00626327|588357778|FG000|Overall Study|Adverse Event|1|||
162906966|NCT00626327|588357779|FG001|Overall Study|Adverse Event|0|||
162906967|NCT00626327|588357780|FG002|Overall Study|Adverse Event|0|||
162906968|NCT00626327|588357778|FG000|Overall Study|Lost to Follow-up|24|||
162906969|NCT00626327|588357779|FG001|Overall Study|Lost to Follow-up|21|||
162906970|NCT00626327|588357780|FG002|Overall Study|Lost to Follow-up|23|||
162906971|NCT00626327|588357778|FG000|Overall Study|Inappropriate enrollment|4|||
162906972|NCT00626327|588357779|FG001|Overall Study|Inappropriate enrollment|5|||
162906973|NCT00626327|588357780|FG002|Overall Study|Inappropriate enrollment|3|||
162906974|NCT00626327|588357778|FG000|Overall Study|Administrative Reason|2|||
162906975|NCT00626327|588357779|FG001|Overall Study|Administrative Reason|0|||
162906976|NCT00626327|588357780|FG002|Overall Study|Administrative Reason|6|||
162906977|NCT00626327|588357778|FG000|Overall Study|Protocol Violation|26|||
162906978|NCT00626327|588357779|FG001|Overall Study|Protocol Violation|4|||
162906979|NCT00626327|588357780|FG002|Overall Study|Protocol Violation|26|||
162906980|NCT03347279|588357783|FG000|Overall Study|Withdrawal by Subject|8|||
162906981|NCT03347279|588357784|FG001|Overall Study|Withdrawal by Subject|15|||
162906982|NCT03347279|588357783|FG000|Overall Study|Death|0|||
162906983|NCT03347279|588357784|FG001|Overall Study|Death|2|||
162906984|NCT03347279|588357783|FG000|Overall Study|Lost to Follow-up|5|||
162906985|NCT03347279|588357784|FG001|Overall Study|Lost to Follow-up|2|||
162906986|NCT03347279|588357783|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
162906987|NCT03347279|588357784|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
162906988|NCT03818399|588357785|FG000|Overall Study|Lost to Follow-up|11|||
162906989|NCT03818399|588357785|FG000|Overall Study|Withdrawal by Subject|1|||
162906990|NCT03818399|588357785|FG000|Overall Study|Protocol Violation|2|||
162906991|NCT04880642|588357786|FG000|Randomization|Withdrawal by Subject|2|||
162906992|NCT04880642|588357787|FG001|Randomization|Withdrawal by Subject|3|||
162906993|NCT04880642|588357786|FG000|Treatment Period|Adverse Event|0|||
162906994|NCT04880642|588357787|FG001|Treatment Period|Adverse Event|1|||
162906995|NCT04880642|588357786|FG000|Treatment Period|Death|6|||
162906996|NCT04880642|588357787|FG001|Treatment Period|Death|6|||
162906997|NCT04880642|588357786|FG000|Treatment Period|Lost to Follow-up|1|||
162906998|NCT04880642|588357787|FG001|Treatment Period|Lost to Follow-up|0|||
162979007|NCT03545191|588623548|FG002|Overall Study|Lost to Follow-up|3|||
162627069|NCT03095066|587350873|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162627070|NCT03095066|587350874|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162627071|NCT05988619|587350876|FG000|Overall Study|Lost to Follow-up|1|||
162627072|NCT05988619|587350877|FG001|Overall Study|Lost to Follow-up|4|||
162627073|NCT05988619|587350876|FG000|Overall Study|Withdrawal by Subject|2|||
162627074|NCT05988619|587350877|FG001|Overall Study|Withdrawal by Subject|9|||
162627075|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Death|0|||
162627076|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Death|0|||
162627077|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Death|0|||
162627078|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Death|0|||
162627079|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Death|1|||
162627080|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Death|0|||
162627081|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Death|0|||
162627082|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Death|0|||
162627083|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
162627084|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
162627085|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
162627086|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
162627087|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
162627088|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
162627089|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
162627090|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
162627091|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
162627092|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162627093|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162627094|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
162627095|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162627096|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
162627097|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162627098|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162627099|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
162627100|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
162627101|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
162627102|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
162627103|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
162627104|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
162627105|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
162627106|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
162627107|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
162627108|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162627109|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162627110|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
162627111|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
162627112|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162627113|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
162627114|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
162627115|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
162627116|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162627117|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162627118|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
162627119|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
162627120|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
162627121|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162627122|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162627123|NCT00726232|587350880|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
162627124|NCT00726232|587350881|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
162627125|NCT00726232|587350882|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
162627126|NCT00726232|587350883|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
162627127|NCT00726232|587350884|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
162627128|NCT00726232|587350885|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
162967411|NCT01670097|588581367|FG001|Overall Study|Clinical deterioration|1|||
162967412|NCT01670097|588581366|FG000|Overall Study|Disease progression|0|||
162967413|NCT01670097|588581367|FG001|Overall Study|Disease progression|1|||
162967414|NCT02311894|588581368|FG000|Overall Study|Discontinued in error|1|||
162967415|NCT02311894|588581368|FG000|Overall Study|Lost to Follow-up|1|||
162967416|NCT02311894|588581368|FG000|Overall Study|Adverse Event|1|||
162627129|NCT00726232|587350886|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
162627130|NCT00726232|587350887|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
162967417|NCT02311894|588581368|FG000|Overall Study|Withdrawal by Subject|1|||
162627131|NCT00726232|587350880|FG000|Expansion Phase|Death|0|||
162627132|NCT00726232|587350881|FG001|Expansion Phase|Death|0|||
162627133|NCT00726232|587350882|FG002|Expansion Phase|Death|0|||
162627134|NCT00726232|587350883|FG003|Expansion Phase|Death|0|||
162627135|NCT00726232|587350884|FG004|Expansion Phase|Death|0|||
162627136|NCT00726232|587350885|FG005|Expansion Phase|Death|0|||
162627137|NCT00726232|587350886|FG006|Expansion Phase|Death|0|||
162627138|NCT00726232|587350887|FG007|Expansion Phase|Death|1|||
162627139|NCT00726232|587350880|FG000|Expansion Phase|Adverse Event|0|||
162627140|NCT00726232|587350881|FG001|Expansion Phase|Adverse Event|0|||
162627141|NCT00726232|587350882|FG002|Expansion Phase|Adverse Event|0|||
162627142|NCT00726232|587350883|FG003|Expansion Phase|Adverse Event|0|||
162627143|NCT00726232|587350884|FG004|Expansion Phase|Adverse Event|0|||
162627144|NCT00726232|587350885|FG005|Expansion Phase|Adverse Event|0|||
162627145|NCT00726232|587350886|FG006|Expansion Phase|Adverse Event|6|||
162627146|NCT00726232|587350887|FG007|Expansion Phase|Adverse Event|11|||
162627147|NCT00726232|587350880|FG000|Expansion Phase|Withdrawal by Subject|0|||
162627148|NCT00726232|587350881|FG001|Expansion Phase|Withdrawal by Subject|0|||
162627149|NCT00726232|587350882|FG002|Expansion Phase|Withdrawal by Subject|0|||
162627150|NCT00726232|587350883|FG003|Expansion Phase|Withdrawal by Subject|0|||
162627151|NCT00726232|587350884|FG004|Expansion Phase|Withdrawal by Subject|0|||
162627152|NCT00726232|587350885|FG005|Expansion Phase|Withdrawal by Subject|0|||
162627153|NCT00726232|587350886|FG006|Expansion Phase|Withdrawal by Subject|2|||
162627154|NCT00726232|587350887|FG007|Expansion Phase|Withdrawal by Subject|3|||
162627155|NCT00726232|587350880|FG000|Expansion Phase|Disease progression|0|||
162627156|NCT00726232|587350881|FG001|Expansion Phase|Disease progression|0|||
162627157|NCT00726232|587350882|FG002|Expansion Phase|Disease progression|0|||
162627158|NCT00726232|587350883|FG003|Expansion Phase|Disease progression|0|||
162627159|NCT00726232|587350884|FG004|Expansion Phase|Disease progression|0|||
162627160|NCT00726232|587350885|FG005|Expansion Phase|Disease progression|0|||
162627161|NCT00726232|587350886|FG006|Expansion Phase|Disease progression|4|||
162627162|NCT00726232|587350887|FG007|Expansion Phase|Disease progression|0|||
162627163|NCT00726232|587350880|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
162627164|NCT00726232|587350881|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
162627165|NCT00726232|587350882|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
162627166|NCT00726232|587350883|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
162627167|NCT00726232|587350884|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
162906999|NCT04880642|588357786|FG000|Treatment Period|Protocol Violation|0|||
162907000|NCT04880642|588357787|FG001|Treatment Period|Protocol Violation|1|||
162907001|NCT04880642|588357786|FG000|Treatment Period|Withdrawal by Subject|5|||
162907002|NCT04880642|588357787|FG001|Treatment Period|Withdrawal by Subject|3|||
162907003|NCT04880642|588357786|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
162907004|NCT04880642|588357787|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
162907005|NCT04880642|588357786|FG000|Follow-up|Death|4|||
162907006|NCT04880642|588357787|FG001|Follow-up|Death|3|||
162907007|NCT04880642|588357786|FG000|Follow-up|Withdrawal by Subject|1|||
162907008|NCT04880642|588357787|FG001|Follow-up|Withdrawal by Subject|0|||
162907009|NCT00141297|588357789|FG000|Overall Study|Adverse Event|0|||
162907010|NCT00141297|588357790|FG001|Overall Study|Adverse Event|0|||
162907011|NCT00141297|588357791|FG002|Overall Study|Adverse Event|1|||
162907012|NCT00141297|588357792|FG003|Overall Study|Adverse Event|0|||
162907013|NCT00141297|588357793|FG004|Overall Study|Adverse Event|1|||
162907014|NCT00141297|588357794|FG005|Overall Study|Adverse Event|1|||
162907015|NCT00141297|588357795|FG006|Overall Study|Adverse Event|0|||
162907016|NCT00141297|588357796|FG007|Overall Study|Adverse Event|1|||
162907017|NCT00141297|588357797|FG008|Overall Study|Adverse Event|1|||
162907018|NCT00141297|588357798|FG009|Overall Study|Adverse Event|0|||
162907019|NCT00141297|588357789|FG000|Overall Study|Death|1|||
162907020|NCT00141297|588357790|FG001|Overall Study|Death|0|||
162907021|NCT00141297|588357791|FG002|Overall Study|Death|0|||
162907022|NCT00141297|588357792|FG003|Overall Study|Death|0|||
162907023|NCT00141297|588357793|FG004|Overall Study|Death|0|||
162907024|NCT00141297|588357794|FG005|Overall Study|Death|0|||
162907025|NCT00141297|588357795|FG006|Overall Study|Death|0|||
162907026|NCT00141297|588357796|FG007|Overall Study|Death|0|||
162627168|NCT00726232|587350885|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
162907027|NCT00141297|588357797|FG008|Overall Study|Death|1|||
162627169|NCT00726232|587350886|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
162627170|NCT00726232|587350887|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
162907028|NCT00141297|588357798|FG009|Overall Study|Death|0|||
162907029|NCT00141297|588357789|FG000|Overall Study|Withdrawal by Subject|0|||
162907030|NCT00141297|588357790|FG001|Overall Study|Withdrawal by Subject|0|||
162907031|NCT00141297|588357791|FG002|Overall Study|Withdrawal by Subject|0|||
162627171|NCT00726232|587350880|FG000|Expansion Phase|Per Investigator: lack of response|0|||
162627172|NCT00726232|587350881|FG001|Expansion Phase|Per Investigator: lack of response|0|||
162627173|NCT00726232|587350882|FG002|Expansion Phase|Per Investigator: lack of response|0|||
162907032|NCT00141297|588357792|FG003|Overall Study|Withdrawal by Subject|0|||
162907033|NCT00141297|588357793|FG004|Overall Study|Withdrawal by Subject|0|||
162710241|NCT03285711|587649000|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162710242|NCT03285711|587649001|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162710243|NCT03285711|587648998|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
162710244|NCT03285711|587648999|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
162710245|NCT03285711|587649000|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
162710246|NCT03285711|587649001|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
162710247|NCT03285711|587648998|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162710248|NCT03285711|587648999|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
162710249|NCT03285711|587649000|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162710250|NCT03285711|587649001|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162710251|NCT02431533|587649002|FG000|Overall Study|Withdrawal by Subject|1|||
162710252|NCT02431533|587649003|FG001|Overall Study|Withdrawal by Subject|3|||
162907034|NCT00141297|588357794|FG005|Overall Study|Withdrawal by Subject|0|||
162907035|NCT00141297|588357795|FG006|Overall Study|Withdrawal by Subject|0|||
162907036|NCT00141297|588357796|FG007|Overall Study|Withdrawal by Subject|0|||
162907037|NCT00141297|588357797|FG008|Overall Study|Withdrawal by Subject|1|||
162907038|NCT00141297|588357798|FG009|Overall Study|Withdrawal by Subject|0|||
162907039|NCT00141297|588357789|FG000|Overall Study|Other|0|||
162907040|NCT00141297|588357790|FG001|Overall Study|Other|0|||
162907041|NCT00141297|588357791|FG002|Overall Study|Other|0|||
162907042|NCT00141297|588357792|FG003|Overall Study|Other|1|||
162907043|NCT00141297|588357793|FG004|Overall Study|Other|5|||
162907044|NCT00141297|588357794|FG005|Overall Study|Other|0|||
162907045|NCT00141297|588357795|FG006|Overall Study|Other|0|||
162907046|NCT00141297|588357796|FG007|Overall Study|Other|0|||
162907047|NCT00141297|588357797|FG008|Overall Study|Other|2|||
162907048|NCT00141297|588357798|FG009|Overall Study|Other|0|||
162907049|NCT00141297|588357789|FG000|Overall Study|Progressive Disease|2|||
162907050|NCT00141297|588357790|FG001|Overall Study|Progressive Disease|3|||
162907051|NCT00141297|588357791|FG002|Overall Study|Progressive Disease|6|||
162907052|NCT00141297|588357792|FG003|Overall Study|Progressive Disease|2|||
162907053|NCT00141297|588357793|FG004|Overall Study|Progressive Disease|15|||
162907054|NCT00141297|588357794|FG005|Overall Study|Progressive Disease|2|||
162907055|NCT00141297|588357795|FG006|Overall Study|Progressive Disease|3|||
162907056|NCT00141297|588357796|FG007|Overall Study|Progressive Disease|3|||
162907057|NCT00141297|588357797|FG008|Overall Study|Progressive Disease|15|||
162907058|NCT00141297|588357798|FG009|Overall Study|Progressive Disease|6|||
162907059|NCT00141297|588357789|FG000|Overall Study|Transitioned|0|||
162907060|NCT00141297|588357790|FG001|Overall Study|Transitioned|0|||
162907061|NCT00141297|588357791|FG002|Overall Study|Transitioned|0|||
162907062|NCT00141297|588357792|FG003|Overall Study|Transitioned|0|||
162907063|NCT00141297|588357793|FG004|Overall Study|Transitioned|1|||
162907064|NCT00141297|588357794|FG005|Overall Study|Transitioned|0|||
162907065|NCT00141297|588357795|FG006|Overall Study|Transitioned|0|||
162907066|NCT00141297|588357796|FG007|Overall Study|Transitioned|0|||
162907067|NCT00141297|588357797|FG008|Overall Study|Transitioned|0|||
162907068|NCT00141297|588357798|FG009|Overall Study|Transitioned|0|||
162907069|NCT02987205|588357799|FG000|Overall Study|Adverse Event|1|||
162907070|NCT02987205|588357799|FG000|Overall Study|Withdrawal by Subject|3|||
162907071|NCT02807376|588357801|FG000|Overall Study|Intra-operative exclusion criteria|3|||
162907072|NCT02807376|588357802|FG001|Overall Study|Intra-operative exclusion criteria|0|||
162907073|NCT02807376|588357801|FG000|Overall Study|Lost to Follow-up|0|||
162907074|NCT02807376|588357802|FG001|Overall Study|Lost to Follow-up|1|||
162907075|NCT03228836|588357805|FG000|Overall Study|Adverse Event|3|||
162907076|NCT03228836|588357805|FG000|Overall Study|Withdrawal by Subject|1|||
162907077|NCT03228836|588357805|FG000|Overall Study|Death|1|||
162907078|NCT03228836|588357805|FG000|Overall Study|Physician Decision|1|||
162907079|NCT03228836|588357805|FG000|Overall Study|Disease Progression|7|||
162907080|NCT03228836|588357805|FG000|Overall Study|Other|4|||
162907081|NCT00948389|588357806|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
162907082|NCT00948389|588357807|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
162907083|NCT00948389|588357808|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
163054297|NCT00977197|588910224|FG001|Overall Study|Nonadherence|1|||
163054298|NCT05379920|588910225|FG000|Overall Study|Lost to Follow-up|0|||
162710253|NCT02431533|587649002|FG000|Overall Study|Developed Exclusionary criteria|1|||
162710254|NCT02431533|587649003|FG001|Overall Study|Developed Exclusionary criteria|0|||
162907084|NCT00948389|588357809|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
162907085|NCT00948389|588357810|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
162907086|NCT00948389|588357806|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
163054299|NCT05379920|588910226|FG001|Overall Study|Lost to Follow-up|5|||
162907087|NCT00948389|588357807|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
162907088|NCT00948389|588357808|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
162907089|NCT00948389|588357809|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
162907090|NCT00948389|588357810|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
162907091|NCT00948389|588357806|FG000|Overall Study|Both Progression and Toxicity|1|||
162907092|NCT00948389|588357807|FG001|Overall Study|Both Progression and Toxicity|0|||
162907093|NCT00948389|588357808|FG002|Overall Study|Both Progression and Toxicity|0|||
162627174|NCT00726232|587350883|FG003|Expansion Phase|Per Investigator: lack of response|0|||
162627175|NCT00726232|587350884|FG004|Expansion Phase|Per Investigator: lack of response|0|||
162627176|NCT00726232|587350885|FG005|Expansion Phase|Per Investigator: lack of response|0|||
162627177|NCT00726232|587350886|FG006|Expansion Phase|Per Investigator: lack of response|1|||
162627178|NCT00726232|587350887|FG007|Expansion Phase|Per Investigator: lack of response|7|||
162627179|NCT00726232|587350880|FG000|Expansion Phase|Unspecified reason|0|||
162627180|NCT00726232|587350881|FG001|Expansion Phase|Unspecified reason|0|||
162627181|NCT00726232|587350882|FG002|Expansion Phase|Unspecified reason|0|||
162627182|NCT00726232|587350883|FG003|Expansion Phase|Unspecified reason|0|||
162627183|NCT00726232|587350884|FG004|Expansion Phase|Unspecified reason|0|||
162627184|NCT00726232|587350885|FG005|Expansion Phase|Unspecified reason|0|||
162627185|NCT00726232|587350886|FG006|Expansion Phase|Unspecified reason|1|||
162627186|NCT00726232|587350887|FG007|Expansion Phase|Unspecified reason|0|||
162627187|NCT01471171|587350888|FG000|Treatment Period 1|Adverse Event|4|||
162627188|NCT01471171|587350889|FG001|Treatment Period 1|Adverse Event|1|||
162627189|NCT01471171|587350888|FG000|Treatment Period 2|Adverse Event|1|||
162627190|NCT01471171|587350889|FG001|Treatment Period 2|Adverse Event|0|||
162627191|NCT02864498|587350890|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
162627192|NCT02864498|587350891|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
162627193|NCT02864498|587350892|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
162627194|NCT02864498|587350890|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
162627195|NCT02864498|587350891|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
162627196|NCT02864498|587350892|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
162627197|NCT02864498|587350890|FG000|Overall Study|Investigator Discretion|0|||
162627198|NCT02864498|587350891|FG001|Overall Study|Investigator Discretion|2|||
162627199|NCT02864498|587350892|FG002|Overall Study|Investigator Discretion|1|||
162627200|NCT02864498|587350890|FG000|Overall Study|Lost to Follow-up|8|||
162627201|NCT02864498|587350891|FG001|Overall Study|Lost to Follow-up|6|||
162627202|NCT02864498|587350892|FG002|Overall Study|Lost to Follow-up|3|||
162627203|NCT02864498|587350890|FG000|Overall Study|Lack of Efficacy|5|||
162627204|NCT02864498|587350891|FG001|Overall Study|Lack of Efficacy|3|||
162627205|NCT02864498|587350892|FG002|Overall Study|Lack of Efficacy|3|||
162627206|NCT02864498|587350890|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
162627207|NCT02864498|587350891|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
162627208|NCT02864498|587350892|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
162627209|NCT02864498|587350890|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
162627210|NCT02864498|587350891|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
162627211|NCT02864498|587350892|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
162627212|NCT02864498|587350890|FG000|Overall Study|Subject moved out of the country.|0|||
162627213|NCT02864498|587350891|FG001|Overall Study|Subject moved out of the country.|0|||
162627214|NCT02864498|587350892|FG002|Overall Study|Subject moved out of the country.|1|||
162627215|NCT00730132|587350895|FG000|Overall Study|Protocol Violation|154|||
162627216|NCT00730132|587350895|FG000|Overall Study|Death|1|||
162627217|NCT00370032|587350896|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
162627218|NCT00370032|587350897|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
162627219|NCT00370032|587350896|FG000|Washout Period|Withdrawal by Subject|0|||
162627220|NCT00370032|587350897|FG001|Washout Period|Withdrawal by Subject|1|||
162627221|NCT00370032|587350896|FG000|Washout Period|Lost to Follow-up|0|||
162627222|NCT00370032|587350897|FG001|Washout Period|Lost to Follow-up|1|||
162627223|NCT00370032|587350896|FG000|Washout Period|Adverse Event|1|||
162627224|NCT00370032|587350897|FG001|Washout Period|Adverse Event|0|||
162627225|NCT00370032|587350896|FG000|Follow-up Period|Withdrawal by Subject|1|||
162627226|NCT00370032|587350897|FG001|Follow-up Period|Withdrawal by Subject|0|||
162627227|NCT00801632|587350898|FG000|Overall Study|Re-transplant|1|||
162627228|NCT01203098|587350905|FG000|Overall Study|Adverse Event|3|||
162627229|NCT01203098|587350906|FG001|Overall Study|Adverse Event|1|||
162627230|NCT01203098|587350907|FG002|Overall Study|Adverse Event|7|||
162627231|NCT01203098|587350905|FG000|Overall Study|Lost to Follow-up|0|||
162627232|NCT01203098|587350906|FG001|Overall Study|Lost to Follow-up|0|||
162627233|NCT01203098|587350907|FG002|Overall Study|Lost to Follow-up|1|||
162627234|NCT01203098|587350905|FG000|Overall Study|Physician Decision|2|||
162627235|NCT01203098|587350906|FG001|Overall Study|Physician Decision|2|||
162627236|NCT01203098|587350907|FG002|Overall Study|Physician Decision|0|||
162627237|NCT01203098|587350905|FG000|Overall Study|Withdrawal by Subject|1|||
162907094|NCT00948389|588357809|FG003|Overall Study|Both Progression and Toxicity|0|||
162907095|NCT00948389|588357810|FG004|Overall Study|Both Progression and Toxicity|0|||
162907096|NCT00750867|588357829|FG000|Overall Study|Adverse Event|2|||
162627238|NCT01203098|587350906|FG001|Overall Study|Withdrawal by Subject|1|||
162627239|NCT01203098|587350907|FG002|Overall Study|Withdrawal by Subject|3|||
162627240|NCT03851705|587350915|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
162627241|NCT03851705|587350916|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162627242|NCT03851705|587350917|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162710255|NCT00770211|587649006|FG000|Overall Study|Lost to Follow-up|1|||
162710256|NCT00770211|587649007|FG001|Overall Study|Lost to Follow-up|0|||
162710257|NCT00770211|587649006|FG000|Overall Study|Withdrawal by Subject|0|||
162710258|NCT00770211|587649007|FG001|Overall Study|Withdrawal by Subject|2|||
162710259|NCT00318656|587649008|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
162710260|NCT00318656|587649009|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
162710261|NCT00318656|587649008|FG000|Overall Study|Did not receive any treatment|0|||
162710262|NCT00318656|587649009|FG001|Overall Study|Did not receive any treatment|1|||
162710263|NCT01446003|587649011|FG000|Period 1|Protocol Violation|2|||
162710264|NCT01446003|587649012|FG001|Period 1|Protocol Violation|0|||
162710265|NCT01446003|587649011|FG000|Period 2|Adverse Event|1|||
162710266|NCT01446003|587649012|FG001|Period 2|Adverse Event|0|||
162710267|NCT01740557|587649013|FG000|Overall Study|Ineligible|1|||
162710268|NCT01740557|587649013|FG000|Overall Study|Screen failure|1|||
162710269|NCT00490555|587649014|FG000|Overall Study|noncompliant with drug administration|0|||
162710270|NCT00490555|587649015|FG001|Overall Study|noncompliant with drug administration|0|||
162710271|NCT00490555|587649016|FG002|Overall Study|noncompliant with drug administration|2|||
162710272|NCT00490555|587649017|FG003|Overall Study|noncompliant with drug administration|0|||
162710273|NCT01007149|587649018|FG000|Overall Study|Administrative problems|0|||
162710274|NCT01007149|587649019|FG001|Overall Study|Administrative problems|1|||
162710275|NCT02320253|587649020|FG000|Overall Study|Withdrawal by Subject|3|||
162627243|NCT03851705|587350918|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162627244|NCT03851705|587350915|FG000|Part 1: Double-Blind Period|Other reason|1|||
162627245|NCT03851705|587350916|FG001|Part 1: Double-Blind Period|Other reason|0|||
162627246|NCT03851705|587350917|FG002|Part 1: Double-Blind Period|Other reason|0|||
162627247|NCT03851705|587350918|FG003|Part 1: Double-Blind Period|Other reason|0|||
162627248|NCT03851705|587350915|FG000|Part 2: Open-Label Period|Other reason|0|||
162627249|NCT03851705|587350916|FG001|Part 2: Open-Label Period|Other reason|0|||
162627250|NCT03851705|587350917|FG002|Part 2: Open-Label Period|Other reason|0|||
162627251|NCT03851705|587350918|FG003|Part 2: Open-Label Period|Other reason|1|||
162627252|NCT03851705|587350915|FG000|Part 2: Open-Label Period|Death|0|||
162627253|NCT03851705|587350916|FG001|Part 2: Open-Label Period|Death|0|||
162627254|NCT03851705|587350917|FG002|Part 2: Open-Label Period|Death|3|||
162627255|NCT03851705|587350918|FG003|Part 2: Open-Label Period|Death|0|||
162627256|NCT03851705|587350915|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162627257|NCT03851705|587350916|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162627258|NCT03851705|587350917|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
162627259|NCT03851705|587350918|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162627260|NCT03095612|587350919|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627261|NCT03095612|587350920|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
162627262|NCT03095612|587350921|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627263|NCT03095612|587350922|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627264|NCT03095612|587350923|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627265|NCT03095612|587350924|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627266|NCT03095612|587350925|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162627267|NCT00621582|587350926|FG000|Overall Study|Adverse Event|7|||
162627268|NCT00621582|587350926|FG000|Overall Study|Protocol Violation|57|||
162627269|NCT00621582|587350926|FG000|Overall Study|Lost to Follow-up|24|||
162627270|NCT00621582|587350926|FG000|Overall Study|issues not identified by investigators|18|||
162627271|NCT01042678|587350927|FG000|Overall Study|Physician Decision|1|||
162627272|NCT01042678|587350928|FG001|Overall Study|Physician Decision|0|||
162627273|NCT01042678|587350929|FG002|Overall Study|Physician Decision|0|||
162627274|NCT01042678|587350930|FG003|Overall Study|Physician Decision|0|||
162627275|NCT01042678|587350931|FG004|Overall Study|Physician Decision|0|||
162627276|NCT01042678|587350932|FG005|Overall Study|Physician Decision|0|||
162627277|NCT03617185|587350933|FG000|Baseline|Lost to Follow-up|0|||
162627278|NCT03617185|587350934|FG001|Baseline|Lost to Follow-up|2|||
162627279|NCT03617185|587350935|FG002|Baseline|Lost to Follow-up|1|||
162627280|NCT03617185|587350936|FG003|Baseline|Lost to Follow-up|1|||
162627281|NCT03617185|587350933|FG000|Baseline|Withdrawal by Subject|0|||
162627282|NCT03617185|587350934|FG001|Baseline|Withdrawal by Subject|1|||
162627283|NCT03617185|587350935|FG002|Baseline|Withdrawal by Subject|0|||
162627284|NCT03617185|587350936|FG003|Baseline|Withdrawal by Subject|1|||
162710276|NCT02320253|587649021|FG001|Overall Study|Withdrawal by Subject|0|||
162710277|NCT02320253|587649022|FG002|Overall Study|Withdrawal by Subject|0|||
162710278|NCT02320253|587649020|FG000|Overall Study|Lost to Follow-up|2|||
162710279|NCT02320253|587649021|FG001|Overall Study|Lost to Follow-up|2|||
162627285|NCT03617185|587350933|FG000|Baseline|Driving Distance/Travel|0|||
162710280|NCT02320253|587649022|FG002|Overall Study|Lost to Follow-up|1|||
162710281|NCT02320253|587649020|FG000|Overall Study|Death|1|||
162710282|NCT02320253|587649021|FG001|Overall Study|Death|0|||
162627286|NCT03617185|587350934|FG001|Baseline|Driving Distance/Travel|0|||
162627287|NCT03617185|587350935|FG002|Baseline|Driving Distance/Travel|2|||
162710283|NCT02320253|587649022|FG002|Overall Study|Death|1|||
162627288|NCT03617185|587350936|FG003|Baseline|Driving Distance/Travel|0|||
162627289|NCT03617185|587350933|FG000|Baseline|Family Obligations|0|||
162627290|NCT03617185|587350934|FG001|Baseline|Family Obligations|0|||
162627291|NCT03617185|587350935|FG002|Baseline|Family Obligations|0|||
162627292|NCT03617185|587350936|FG003|Baseline|Family Obligations|1|||
162627293|NCT03617185|587350933|FG000|3 Months|Lost to Follow-up|4|||
162627294|NCT03617185|587350934|FG001|3 Months|Lost to Follow-up|1|||
162627295|NCT03617185|587350935|FG002|3 Months|Lost to Follow-up|0|||
162627296|NCT03617185|587350936|FG003|3 Months|Lost to Follow-up|2|||
162627297|NCT03617185|587350933|FG000|3 Months|Withdrawal by Subject|1|||
162627298|NCT03617185|587350934|FG001|3 Months|Withdrawal by Subject|3|||
162627299|NCT03617185|587350935|FG002|3 Months|Withdrawal by Subject|0|||
162627300|NCT03617185|587350936|FG003|3 Months|Withdrawal by Subject|0|||
162627301|NCT03617185|587350933|FG000|3 Months|Driving Distance/Travel|1|||
162627302|NCT03617185|587350934|FG001|3 Months|Driving Distance/Travel|0|||
162627303|NCT03617185|587350935|FG002|3 Months|Driving Distance/Travel|0|||
162627304|NCT03617185|587350936|FG003|3 Months|Driving Distance/Travel|0|||
162627305|NCT03617185|587350933|FG000|3 Months|Family Obligations|0|||
162627306|NCT03617185|587350934|FG001|3 Months|Family Obligations|0|||
162627307|NCT03617185|587350935|FG002|3 Months|Family Obligations|0|||
162627308|NCT03617185|587350936|FG003|3 Months|Family Obligations|1|||
162627309|NCT03617185|587350933|FG000|12 Months|Lost to Follow-up|3|||
162627310|NCT03617185|587350934|FG001|12 Months|Lost to Follow-up|1|||
162627311|NCT03617185|587350935|FG002|12 Months|Lost to Follow-up|3|||
162627312|NCT03617185|587350936|FG003|12 Months|Lost to Follow-up|0|||
162627313|NCT03617185|587350933|FG000|12 Months|Withdrawal by Subject|0|||
162627314|NCT03617185|587350934|FG001|12 Months|Withdrawal by Subject|0|||
162627315|NCT03617185|587350935|FG002|12 Months|Withdrawal by Subject|0|||
162627316|NCT03617185|587350936|FG003|12 Months|Withdrawal by Subject|1|||
162627317|NCT03617185|587350933|FG000|12 Months|Driving Distance/Travel|0|||
162627318|NCT03617185|587350934|FG001|12 Months|Driving Distance/Travel|0|||
162627319|NCT03617185|587350935|FG002|12 Months|Driving Distance/Travel|1|||
162627320|NCT03617185|587350936|FG003|12 Months|Driving Distance/Travel|0|||
162627321|NCT01387932|587350938|FG000|Randomized and Treated|Physician Decision|3|||
162627322|NCT01387932|587350939|FG001|Randomized and Treated|Physician Decision|2|||
162627323|NCT01387932|587350938|FG000|Randomized and Treated|Withdrawal by Subject|4|||
162627324|NCT01387932|587350939|FG001|Randomized and Treated|Withdrawal by Subject|2|||
162627325|NCT01387932|587350938|FG000|Survival Follow-up|Liver Transplant|24|||
162627326|NCT01387932|587350939|FG001|Survival Follow-up|Liver Transplant|28|||
162627327|NCT01387932|587350938|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
162627328|NCT01387932|587350939|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
162627329|NCT01387932|587350938|FG000|Survival Follow-up|Withdrawal by Subject|2|||
162627330|NCT01387932|587350939|FG001|Survival Follow-up|Withdrawal by Subject|4|||
162627331|NCT01387932|587350938|FG000|Survival Follow-up|Lost to Follow-up|6|||
162627332|NCT01387932|587350939|FG001|Survival Follow-up|Lost to Follow-up|5|||
162627333|NCT01964430|587350940|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
162627334|NCT01964430|587350941|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
162627335|NCT01964430|587350940|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
162627336|NCT01964430|587350941|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
162907097|NCT03018340|588357830|FG000|Overall Study|Adverse Event|1|||
162907098|NCT03018340|588357831|FG001|Overall Study|Adverse Event|2|||
162907099|NCT03018340|588357830|FG000|Overall Study|Withdrawal by Subject|0|||
162627337|NCT01964430|587350940|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
162907100|NCT03018340|588357831|FG001|Overall Study|Withdrawal by Subject|8|||
162907101|NCT03018340|588357830|FG000|Overall Study|Lack of Efficacy|0|||
162907102|NCT03018340|588357831|FG001|Overall Study|Lack of Efficacy|1|||
162907103|NCT03018340|588357830|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
162907104|NCT03018340|588357831|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
162907105|NCT03018340|588357830|FG000|Overall Study|Lost to Follow-up|1|||
162907106|NCT03018340|588357831|FG001|Overall Study|Lost to Follow-up|7|||
162907107|NCT03018340|588357830|FG000|Overall Study|Protocol Violation|3|||
162907108|NCT03018340|588357831|FG001|Overall Study|Protocol Violation|7|||
162907109|NCT03018340|588357830|FG000|Overall Study|Not further specified|0|||
162907110|NCT03018340|588357831|FG001|Overall Study|Not further specified|1|||
162907111|NCT04652102|588357832|FG000|Overall Study|Adverse Event|14|||
162907112|NCT04652102|588357833|FG001|Overall Study|Adverse Event|13|||
162907113|NCT04652102|588357832|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
162627338|NCT01964430|587350941|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
162907114|NCT04652102|588357833|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
162627339|NCT01964430|587350940|FG000|Treatment Period|Adverse Event|71|||
162627340|NCT01964430|587350941|FG001|Treatment Period|Adverse Event|37|||
162627341|NCT01964430|587350940|FG000|Treatment Period|Withdrawal by Subject|36|||
162627342|NCT01964430|587350941|FG001|Treatment Period|Withdrawal by Subject|27|||
162627343|NCT01964430|587350940|FG000|Treatment Period|Death|1|||
162627344|NCT01964430|587350941|FG001|Treatment Period|Death|3|||
162627345|NCT01964430|587350940|FG000|Treatment Period|Protocol Deviation|0|||
162627346|NCT01964430|587350941|FG001|Treatment Period|Protocol Deviation|1|||
162627347|NCT01964430|587350940|FG000|Treatment Period|Physician Decision|5|||
162627348|NCT01964430|587350941|FG001|Treatment Period|Physician Decision|4|||
162627349|NCT01964430|587350940|FG000|Treatment Period|Disease Relapse|28|||
162627350|NCT01964430|587350941|FG001|Treatment Period|Disease Relapse|38|||
162627351|NCT01964430|587350940|FG000|Treatment Period|Other reasons|1|||
162627352|NCT01964430|587350941|FG001|Treatment Period|Other reasons|3|||
162627353|NCT02591290|587350942|FG000|Overall Study|Withdrawal by Subject|2|||
162627354|NCT02571075|587350945|FG000|Overall Study|Lost to Follow-up|20|||
162627355|NCT02571075|587350946|FG001|Overall Study|Lost to Follow-up|24|||
162627356|NCT02197520|587350949|FG000|Period 1|Withdrawal by Subject|1|||
162627357|NCT02197520|587350950|FG001|Period 1|Withdrawal by Subject|0|||
162627358|NCT02197520|587350949|FG000|Period 2|Adverse Event|0|||
162627359|NCT02197520|587350950|FG001|Period 2|Adverse Event|2|||
162627360|NCT02197520|587350949|FG000|Period 2|Withdrawal by Subject|1|||
162627361|NCT02197520|587350950|FG001|Period 2|Withdrawal by Subject|0|||
162627362|NCT00913497|587350951|FG000|Overall Study|Adverse Event|1|||
162627363|NCT00913497|587350951|FG000|Overall Study|Withdrawal by Subject|2|||
162627364|NCT03208244|587350952|FG000|Overall Study|Death|1|||
162627365|NCT04431453|587350957|FG000|Overall Study|Withdrew Consent|0|||
162627366|NCT04431453|587350958|FG001|Overall Study|Withdrew Consent|1|||
162627367|NCT04431453|587350959|FG002|Overall Study|Withdrew Consent|0|||
162627368|NCT04431453|587350960|FG003|Overall Study|Withdrew Consent|2|||
162627369|NCT04431453|587350961|FG004|Overall Study|Withdrew Consent|0|||
162627370|NCT04431453|587350962|FG005|Overall Study|Withdrew Consent|0|||
162627371|NCT04431453|587350963|FG006|Overall Study|Withdrew Consent|0|||
162627372|NCT04431453|587350964|FG007|Overall Study|Withdrew Consent|0|||
162627373|NCT04431453|587350957|FG000|Overall Study|Death|1|||
162627374|NCT04431453|587350958|FG001|Overall Study|Death|0|||
162627375|NCT04431453|587350959|FG002|Overall Study|Death|0|||
162627376|NCT04431453|587350960|FG003|Overall Study|Death|0|||
162627377|NCT04431453|587350961|FG004|Overall Study|Death|0|||
162627378|NCT04431453|587350962|FG005|Overall Study|Death|0|||
162627379|NCT04431453|587350963|FG006|Overall Study|Death|0|||
162627380|NCT04431453|587350964|FG007|Overall Study|Death|1|||
162627381|NCT04431453|587350957|FG000|Overall Study|Lost to Follow-up|0|||
162627382|NCT04431453|587350958|FG001|Overall Study|Lost to Follow-up|0|||
162627383|NCT04431453|587350959|FG002|Overall Study|Lost to Follow-up|1|||
162627384|NCT04431453|587350960|FG003|Overall Study|Lost to Follow-up|1|||
162627385|NCT04431453|587350961|FG004|Overall Study|Lost to Follow-up|0|||
162627386|NCT04431453|587350962|FG005|Overall Study|Lost to Follow-up|0|||
162627387|NCT04431453|587350963|FG006|Overall Study|Lost to Follow-up|0|||
162627388|NCT04431453|587350964|FG007|Overall Study|Lost to Follow-up|0|||
162627389|NCT04431453|587350957|FG000|Overall Study|Enrolled but Never Treated|0|||
162627390|NCT04431453|587350958|FG001|Overall Study|Enrolled but Never Treated|0|||
162627391|NCT04431453|587350959|FG002|Overall Study|Enrolled but Never Treated|0|||
162627392|NCT04431453|587350960|FG003|Overall Study|Enrolled but Never Treated|0|||
162627393|NCT04431453|587350961|FG004|Overall Study|Enrolled but Never Treated|1|||
162627394|NCT04431453|587350962|FG005|Overall Study|Enrolled but Never Treated|0|||
162627395|NCT04431453|587350963|FG006|Overall Study|Enrolled but Never Treated|0|||
162627396|NCT04431453|587350964|FG007|Overall Study|Enrolled but Never Treated|0|||
162627397|NCT03385564|587350965|FG000|Overall Study|Adverse Event|0|||
162627398|NCT03385564|587350966|FG001|Overall Study|Adverse Event|0|||
162627399|NCT03385564|587350967|FG002|Overall Study|Adverse Event|3|||
162627400|NCT03385564|587350968|FG003|Overall Study|Adverse Event|3|||
162627401|NCT03385564|587350965|FG000|Overall Study|Other than listed|0|||
162627402|NCT03385564|587350966|FG001|Overall Study|Other than listed|0|||
162627403|NCT03385564|587350967|FG002|Overall Study|Other than listed|0|||
162627404|NCT03385564|587350968|FG003|Overall Study|Other than listed|5|||
162627405|NCT03385564|587350965|FG000|Overall Study|Withdrawal by Subject|0|||
162627406|NCT03385564|587350966|FG001|Overall Study|Withdrawal by Subject|1|||
162907115|NCT04652102|588357832|FG000|Overall Study|Physician Decision|78|||
162627407|NCT03385564|587350967|FG002|Overall Study|Withdrawal by Subject|1|||
162627408|NCT03385564|587350968|FG003|Overall Study|Withdrawal by Subject|0|||
162627409|NCT03385564|587350965|FG000|Overall Study|Lack of Efficacy|0|||
162627410|NCT03385564|587350966|FG001|Overall Study|Lack of Efficacy|0|||
162627411|NCT03385564|587350967|FG002|Overall Study|Lack of Efficacy|0|||
162627412|NCT03385564|587350968|FG003|Overall Study|Lack of Efficacy|1|||
162627413|NCT03385564|587350965|FG000|Overall Study|Death|0|||
162627414|NCT03385564|587350966|FG001|Overall Study|Death|0|||
162907116|NCT04652102|588357833|FG001|Overall Study|Physician Decision|40|||
162627415|NCT03385564|587350967|FG002|Overall Study|Death|1|||
162627416|NCT03385564|587350968|FG003|Overall Study|Death|0|||
162627417|NCT01702961|587350975|FG000|Overall Study|Additional treatment|3|||
162627418|NCT01702961|587350975|FG000|Overall Study|Progressive disease|5|||
162627419|NCT01702961|587350975|FG000|Overall Study|Relapse|20|||
162627420|NCT01702961|587350975|FG000|Overall Study|Death|6|||
162627421|NCT01702961|587350975|FG000|Overall Study|Lost to Follow-up|2|||
162627422|NCT01702961|587350975|FG000|Overall Study|Ongoing|11|||
162627423|NCT03724032|587350978|FG000|Overall Study|Physician Decision|1|||
162627424|NCT03724032|587350979|FG001|Overall Study|Physician Decision|0|||
162627425|NCT03724032|587350980|FG002|Overall Study|Physician Decision|0|||
162627426|NCT03724032|587350978|FG000|Overall Study|Protocol Violation|2|||
162627427|NCT03724032|587350979|FG001|Overall Study|Protocol Violation|2|||
162627428|NCT03724032|587350980|FG002|Overall Study|Protocol Violation|1|||
162627429|NCT00751933|587350981|FG000|Overall Study|Withdrawal by Subject|0|||
162627430|NCT00751933|587350982|FG001|Overall Study|Withdrawal by Subject|1|||
162627431|NCT00751933|587350983|FG002|Overall Study|Withdrawal by Subject|0|||
162627432|NCT00751933|587350984|FG003|Overall Study|Withdrawal by Subject|0|||
162627433|NCT00751933|587350981|FG000|Overall Study|Physician Decision|0|||
162627434|NCT00751933|587350982|FG001|Overall Study|Physician Decision|0|||
162627435|NCT00751933|587350983|FG002|Overall Study|Physician Decision|1|||
162627436|NCT00751933|587350984|FG003|Overall Study|Physician Decision|1|||
162627437|NCT00361569|587350986|FG000|Overall Study|Protocol Violation|3|||
162627438|NCT00361569|587350987|FG001|Overall Study|Protocol Violation|2|||
162627439|NCT00361569|587350988|FG002|Overall Study|Protocol Violation|4|||
162627440|NCT00361569|587350989|FG003|Overall Study|Protocol Violation|2|||
162627441|NCT00361569|587350986|FG000|Overall Study|Withdrawal by Subject|2|||
162627442|NCT00361569|587350987|FG001|Overall Study|Withdrawal by Subject|1|||
162627443|NCT00361569|587350988|FG002|Overall Study|Withdrawal by Subject|9|||
162627444|NCT00361569|587350989|FG003|Overall Study|Withdrawal by Subject|14|||
162627445|NCT00361569|587350986|FG000|Overall Study|Adverse Event|3|||
162627446|NCT00361569|587350987|FG001|Overall Study|Adverse Event|5|||
162627447|NCT00361569|587350988|FG002|Overall Study|Adverse Event|2|||
162627448|NCT00361569|587350989|FG003|Overall Study|Adverse Event|2|||
162907117|NCT04652102|588357832|FG000|Overall Study|Study Ended by Sponsor|64|||
162907118|NCT04652102|588357833|FG001|Overall Study|Study Ended by Sponsor|17|||
162907119|NCT04652102|588357832|FG000|Overall Study|Withdrawal by Subject|4625|||
162907120|NCT04652102|588357833|FG001|Overall Study|Withdrawal by Subject|5594|||
162627449|NCT00361569|587350986|FG000|Overall Study|Lost to Follow-up|2|||
162627450|NCT00361569|587350987|FG001|Overall Study|Lost to Follow-up|3|||
162627451|NCT00361569|587350988|FG002|Overall Study|Lost to Follow-up|3|||
162627452|NCT00361569|587350989|FG003|Overall Study|Lost to Follow-up|2|||
162627453|NCT00361569|587350986|FG000|Overall Study|Not specified by investigator|2|||
162627454|NCT00361569|587350987|FG001|Overall Study|Not specified by investigator|0|||
162907121|NCT04652102|588357832|FG000|Overall Study|Lost to Follow-up|2019|||
162907122|NCT04652102|588357833|FG001|Overall Study|Lost to Follow-up|1082|||
162907123|NCT04652102|588357832|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
162907124|NCT04652102|588357833|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
162907125|NCT04652102|588357832|FG000|Overall Study|Miscellaneous|80|||
162907126|NCT04652102|588357833|FG001|Overall Study|Miscellaneous|64|||
162907127|NCT02192190|588357836|FG000|Overall Study|Adverse Event|1|||
162907128|NCT02192190|588357837|FG001|Overall Study|Adverse Event|1|||
162907129|NCT02192190|588357838|FG002|Overall Study|Adverse Event|0|||
162907130|NCT02192190|588357839|FG003|Overall Study|Adverse Event|0|||
162907131|NCT02192190|588357840|FG004|Overall Study|Adverse Event|0|||
162907132|NCT02192190|588357841|FG005|Overall Study|Adverse Event|0|||
162907133|NCT02192190|588357836|FG000|Overall Study|Lost to Follow-up|3|||
162907134|NCT02192190|588357837|FG001|Overall Study|Lost to Follow-up|3|||
162907135|NCT02192190|588357838|FG002|Overall Study|Lost to Follow-up|2|||
162907136|NCT02192190|588357839|FG003|Overall Study|Lost to Follow-up|1|||
162907137|NCT02192190|588357840|FG004|Overall Study|Lost to Follow-up|4|||
162907138|NCT02192190|588357841|FG005|Overall Study|Lost to Follow-up|3|||
162907139|NCT02192190|588357836|FG000|Overall Study|Physician Decision|2|||
162907140|NCT02192190|588357837|FG001|Overall Study|Physician Decision|0|||
162907141|NCT02192190|588357838|FG002|Overall Study|Physician Decision|0|||
162907142|NCT02192190|588357839|FG003|Overall Study|Physician Decision|0|||
162907143|NCT02192190|588357840|FG004|Overall Study|Physician Decision|0|||
162907144|NCT02192190|588357841|FG005|Overall Study|Physician Decision|0|||
162907145|NCT02192190|588357836|FG000|Overall Study|Terminated by Sponsor|43|||
162907146|NCT02192190|588357837|FG001|Overall Study|Terminated by Sponsor|23|||
162907147|NCT02192190|588357838|FG002|Overall Study|Terminated by Sponsor|20|||
162907148|NCT02192190|588357839|FG003|Overall Study|Terminated by Sponsor|23|||
162907149|NCT02192190|588357840|FG004|Overall Study|Terminated by Sponsor|21|||
162907150|NCT02192190|588357841|FG005|Overall Study|Terminated by Sponsor|23|||
162907151|NCT02192190|588357836|FG000|Overall Study|Withdrawal by Subject|4|||
162627455|NCT00361569|587350988|FG002|Overall Study|Not specified by investigator|0|||
162627456|NCT00361569|587350989|FG003|Overall Study|Not specified by investigator|1|||
162907152|NCT02192190|588357837|FG001|Overall Study|Withdrawal by Subject|1|||
162907153|NCT02192190|588357838|FG002|Overall Study|Withdrawal by Subject|2|||
162627457|NCT02605824|587350990|FG000|Overall Study|Physician Decision|1|||
162627458|NCT02605824|587350991|FG001|Overall Study|Physician Decision|0|||
162627459|NCT04875195|587350992|FG000|Overall Study|Death|9|||
162907154|NCT02192190|588357839|FG003|Overall Study|Withdrawal by Subject|1|||
162907155|NCT02192190|588357840|FG004|Overall Study|Withdrawal by Subject|5|||
162907156|NCT02192190|588357841|FG005|Overall Study|Withdrawal by Subject|3|||
162907157|NCT02192190|588357836|FG000|Overall Study|Could not Keep Visit Schedule|1|||
162907158|NCT02192190|588357837|FG001|Overall Study|Could not Keep Visit Schedule|0|||
162907159|NCT02192190|588357838|FG002|Overall Study|Could not Keep Visit Schedule|0|||
162710284|NCT01516892|587649024|FG000|Overall Study|Adverse Event|25|||
162710285|NCT01516892|587649024|FG000|Overall Study|Lack of Efficacy|35|||
162710286|NCT01516892|587649024|FG000|Overall Study|Pregnancy|5|||
162710287|NCT01516892|587649024|FG000|Overall Study|Lost to Follow-up|82|||
162710288|NCT01516892|587649024|FG000|Overall Study|Subject Withdrew Consent|92|||
162710289|NCT01516892|587649024|FG000|Overall Study|Protocol Violation|60|||
162710290|NCT01516892|587649024|FG000|Overall Study|Other Miscellaneous Reasons|43|||
162710291|NCT01516892|587649024|FG000|Overall Study|Missing|1|||
162907160|NCT02192190|588357839|FG003|Overall Study|Could not Keep Visit Schedule|0|||
162907161|NCT02192190|588357840|FG004|Overall Study|Could not Keep Visit Schedule|0|||
162907162|NCT02192190|588357841|FG005|Overall Study|Could not Keep Visit Schedule|0|||
162907163|NCT02192190|588357836|FG000|Overall Study|Positive Drug Screen|0|||
162907164|NCT02192190|588357837|FG001|Overall Study|Positive Drug Screen|0|||
162907165|NCT02192190|588357838|FG002|Overall Study|Positive Drug Screen|0|||
162907166|NCT02192190|588357839|FG003|Overall Study|Positive Drug Screen|1|||
162907167|NCT02192190|588357840|FG004|Overall Study|Positive Drug Screen|0|||
162907168|NCT02192190|588357841|FG005|Overall Study|Positive Drug Screen|0|||
162907169|NCT02192190|588357836|FG000|Overall Study|Inadequate Pain Relief|0|||
162907170|NCT02192190|588357837|FG001|Overall Study|Inadequate Pain Relief|1|||
162907171|NCT02192190|588357838|FG002|Overall Study|Inadequate Pain Relief|1|||
162907172|NCT02192190|588357839|FG003|Overall Study|Inadequate Pain Relief|0|||
162907173|NCT02192190|588357840|FG004|Overall Study|Inadequate Pain Relief|0|||
162907174|NCT02192190|588357841|FG005|Overall Study|Inadequate Pain Relief|0|||
162907175|NCT01756833|588357842|FG000|Overall Study|Withdrawal by Subject|4|||
162907176|NCT01756833|588357843|FG001|Overall Study|Withdrawal by Subject|3|||
162907177|NCT00808132|588357844|FG000|Overall Study|Adverse Event|34|||
162907178|NCT00808132|588357845|FG001|Overall Study|Adverse Event|33|||
162907179|NCT00808132|588357846|FG002|Overall Study|Adverse Event|16|||
162907180|NCT00808132|588357847|FG003|Overall Study|Adverse Event|31|||
162710292|NCT02956967|587649025|FG000|Overall Study|Adverse Event|3|||
162710293|NCT02956967|587649025|FG000|Overall Study|Reason non-related to neutropenia|10|||
162907181|NCT00808132|588357848|FG004|Overall Study|Adverse Event|33|||
162907182|NCT00808132|588357844|FG000|Overall Study|Death|0|||
162907183|NCT00808132|588357845|FG001|Overall Study|Death|0|||
162907184|NCT00808132|588357846|FG002|Overall Study|Death|0|||
162907185|NCT00808132|588357847|FG003|Overall Study|Death|0|||
162710294|NCT02956967|587649025|FG000|Overall Study|Lost to Follow-up|5|||
162907186|NCT00808132|588357848|FG004|Overall Study|Death|1|||
162907187|NCT00808132|588357844|FG000|Overall Study|Physician Decision|0|||
162907188|NCT00808132|588357845|FG001|Overall Study|Physician Decision|1|||
162907189|NCT00808132|588357846|FG002|Overall Study|Physician Decision|0|||
162907190|NCT00808132|588357847|FG003|Overall Study|Physician Decision|0|||
162907191|NCT00808132|588357848|FG004|Overall Study|Physician Decision|0|||
162907192|NCT00808132|588357844|FG000|Overall Study|Lost to Follow-up|8|||
162907193|NCT00808132|588357845|FG001|Overall Study|Lost to Follow-up|10|||
162907194|NCT00808132|588357846|FG002|Overall Study|Lost to Follow-up|11|||
162907195|NCT00808132|588357847|FG003|Overall Study|Lost to Follow-up|8|||
162907196|NCT00808132|588357848|FG004|Overall Study|Lost to Follow-up|9|||
162907197|NCT00808132|588357844|FG000|Overall Study|Protocol Violation|8|||
162907198|NCT00808132|588357845|FG001|Overall Study|Protocol Violation|9|||
162907199|NCT00808132|588357846|FG002|Overall Study|Protocol Violation|4|||
162907200|NCT00808132|588357847|FG003|Overall Study|Protocol Violation|9|||
162907201|NCT00808132|588357848|FG004|Overall Study|Protocol Violation|5|||
162907202|NCT00808132|588357844|FG000|Overall Study|Withdrawal by Subject|27|||
162907203|NCT00808132|588357845|FG001|Overall Study|Withdrawal by Subject|18|||
162907204|NCT00808132|588357846|FG002|Overall Study|Withdrawal by Subject|2|||
162907205|NCT00808132|588357847|FG003|Overall Study|Withdrawal by Subject|7|||
162907206|NCT00808132|588357848|FG004|Overall Study|Withdrawal by Subject|16|||
162907207|NCT00808132|588357844|FG000|Overall Study|Other|6|||
162907208|NCT00808132|588357845|FG001|Overall Study|Other|4|||
162907209|NCT00808132|588357846|FG002|Overall Study|Other|6|||
162907210|NCT00808132|588357847|FG003|Overall Study|Other|2|||
162907211|NCT00808132|588357848|FG004|Overall Study|Other|15|||
162907212|NCT00808132|588357844|FG000|Overall Study|Randomized, but not treated|10|||
162907213|NCT00808132|588357845|FG001|Overall Study|Randomized, but not treated|7|||
162907214|NCT00808132|588357846|FG002|Overall Study|Randomized, but not treated|9|||
162907215|NCT00808132|588357847|FG003|Overall Study|Randomized, but not treated|8|||
162907216|NCT00808132|588357848|FG004|Overall Study|Randomized, but not treated|9|||
162907217|NCT00808132|588357844|FG000|Overall Study|Unsatisfactory response|5|||
162907218|NCT00808132|588357845|FG001|Overall Study|Unsatisfactory response|6|||
162907219|NCT00808132|588357846|FG002|Overall Study|Unsatisfactory response|6|||
162907220|NCT00808132|588357847|FG003|Overall Study|Unsatisfactory response|4|||
162907221|NCT00808132|588357848|FG004|Overall Study|Unsatisfactory response|12|||
162907222|NCT00890201|588357849|FG000|Overall Study|Protocol Violation|5|||
162907223|NCT00890201|588357850|FG001|Overall Study|Protocol Violation|56|||
162907224|NCT01371721|588357851|FG000|Overall Study|Adverse Event|5|||
162907225|NCT01371721|588357852|FG001|Overall Study|Adverse Event|4|||
162907226|NCT01371721|588357853|FG002|Overall Study|Adverse Event|5|||
162907227|NCT01371721|588357851|FG000|Overall Study|Protocol Violation|6|||
162907228|NCT01371721|588357852|FG001|Overall Study|Protocol Violation|4|||
162907229|NCT01371721|588357853|FG002|Overall Study|Protocol Violation|5|||
162967418|NCT00884390|588581369|FG000|Overall Study|Adverse Event|0|||
162967419|NCT00884390|588581370|FG001|Overall Study|Adverse Event|1|||
162967420|NCT00884390|588581369|FG000|Overall Study|Lost to Follow-up|0|||
162627460|NCT04875195|587350993|FG001|Overall Study|Death|3|||
162627461|NCT04875195|587350992|FG000|Overall Study|Withdrawal by Subject|2|||
162627462|NCT04875195|587350993|FG001|Overall Study|Withdrawal by Subject|1|||
162627463|NCT04875195|587350992|FG000|Overall Study|Ongoing in study|49|||
162627464|NCT04875195|587350993|FG001|Overall Study|Ongoing in study|2|||
162627465|NCT02339584|587350994|FG000|Overall Study|Adverse Event|11|||
162627466|NCT02339584|587350995|FG001|Overall Study|Adverse Event|7|||
162627467|NCT02339584|587350994|FG000|Overall Study|Lack of Efficacy|0|||
162627468|NCT02339584|587350995|FG001|Overall Study|Lack of Efficacy|1|||
162627469|NCT02339584|587350994|FG000|Overall Study|Physician Decision|1|||
162627470|NCT02339584|587350995|FG001|Overall Study|Physician Decision|2|||
162627471|NCT02339584|587350994|FG000|Overall Study|Protocol Violation|1|||
162627472|NCT02339584|587350995|FG001|Overall Study|Protocol Violation|1|||
162627473|NCT02339584|587350994|FG000|Overall Study|Withdrawal by Subject|2|||
162627474|NCT02339584|587350995|FG001|Overall Study|Withdrawal by Subject|4|||
162627475|NCT00826943|587350996|FG000|Overall Study|Withdrawal by Subject|0|||
162627476|NCT00826943|587350997|FG001|Overall Study|Withdrawal by Subject|0|||
162627477|NCT00826943|587350998|FG002|Overall Study|Withdrawal by Subject|0|||
162627478|NCT00826943|587350999|FG003|Overall Study|Withdrawal by Subject|0|||
162627479|NCT00826943|587351000|FG004|Overall Study|Withdrawal by Subject|1|||
162627480|NCT00826943|587351001|FG005|Overall Study|Withdrawal by Subject|0|||
162627481|NCT03715530|587351002|FG000|Overall Study|Lost to Follow-up|3|||
162627482|NCT03715530|587351003|FG001|Overall Study|Lost to Follow-up|1|||
162627483|NCT03715530|587351004|FG002|Overall Study|Lost to Follow-up|2|||
162627484|NCT01594762|587351005|FG000|Overall Study|Withdrawal by Subject|1|||
162627485|NCT01594762|587351006|FG001|Overall Study|Withdrawal by Subject|0|||
162627486|NCT01594762|587351005|FG000|Overall Study|Lost to Follow-up|10|||
162627487|NCT01594762|587351006|FG001|Overall Study|Lost to Follow-up|10|||
162627488|NCT03338998|587351010|FG000|Treatment Period|Withdrawal by Subject|1|||
162627489|NCT03338998|587351011|FG001|Treatment Period|Withdrawal by Subject|1|||
162907230|NCT01371721|588357851|FG000|Overall Study|Lost to Follow-up|8|||
162907231|NCT01371721|588357852|FG001|Overall Study|Lost to Follow-up|2|||
162907232|NCT01371721|588357853|FG002|Overall Study|Lost to Follow-up|6|||
162907233|NCT01371721|588357851|FG000|Overall Study|Withdrawal by Subject|5|||
162907234|NCT01371721|588357852|FG001|Overall Study|Withdrawal by Subject|7|||
162907235|NCT01371721|588357853|FG002|Overall Study|Withdrawal by Subject|11|||
163054300|NCT05379920|588910227|FG002|Overall Study|Lost to Follow-up|0|||
163054301|NCT05379920|588910228|FG003|Overall Study|Lost to Follow-up|0|||
163054302|NCT03530293|588910231|FG000|Pre-randomization|Adverse Event|12|||
163054303|NCT03530293|588910232|FG001|Pre-randomization|Adverse Event|0|||
163054304|NCT03530293|588910233|FG002|Pre-randomization|Adverse Event|0|||
163054305|NCT03530293|588910231|FG000|Pre-randomization|Protocol Violation|2|||
163054306|NCT03530293|588910232|FG001|Pre-randomization|Protocol Violation|0|||
163054307|NCT03530293|588910233|FG002|Pre-randomization|Protocol Violation|0|||
163054308|NCT03530293|588910231|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
163054309|NCT03530293|588910232|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
163054310|NCT03530293|588910233|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
163054311|NCT03530293|588910231|FG000|Pre-randomization|Withdrawal by Subject|5|||
162627490|NCT03338998|587351010|FG000|Treatment Period|Adverse Event|0|||
162627491|NCT03338998|587351011|FG001|Treatment Period|Adverse Event|2|||
162627492|NCT03338998|587351010|FG000|Treatment Period|Protocol deviation|1|||
162627493|NCT03338998|587351011|FG001|Treatment Period|Protocol deviation|0|||
162627494|NCT03338998|587351010|FG000|Treatment Period|Physician Decision|2|||
162627495|NCT03338998|587351011|FG001|Treatment Period|Physician Decision|0|||
162627496|NCT03338998|587351010|FG000|Treatment Period|Subject failed swallow test|4|||
162627497|NCT03338998|587351011|FG001|Treatment Period|Subject failed swallow test|0|||
162627498|NCT03338998|587351010|FG000|Safety Follow-Up Period|Adverse Event|0|||
162627499|NCT03338998|587351011|FG001|Safety Follow-Up Period|Adverse Event|1|||
162627500|NCT03338998|587351010|FG000|Safety Follow-Up Period|Protocol deviation|1|||
162627501|NCT03338998|587351011|FG001|Safety Follow-Up Period|Protocol deviation|0|||
162627502|NCT03338998|587351010|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
162627503|NCT03338998|587351011|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
162627504|NCT04706091|587351014|FG000|Treatment 2|Withdrawal by Subject|1|||
162627505|NCT04706091|587351015|FG001|Treatment 2|Withdrawal by Subject|0|||
162627506|NCT03329573|587351016|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162627507|NCT03329573|587351017|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
162627508|NCT03329573|587351018|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162627509|NCT03329573|587351019|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162627510|NCT03329573|587351016|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162627511|NCT03329573|587351017|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
162627512|NCT03329573|587351018|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162627513|NCT03329573|587351019|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162627514|NCT03329573|587351016|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
162627515|NCT03329573|587351017|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162627516|NCT03329573|587351018|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162627517|NCT03329573|587351019|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162627518|NCT03329573|587351016|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162627519|NCT03329573|587351017|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
162627520|NCT03329573|587351018|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162627521|NCT03329573|587351019|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162627522|NCT05695209|587351029|FG000|3-months|Withdrawal by Subject|2|||
162627523|NCT05695209|587351030|FG001|3-months|Withdrawal by Subject|0|||
162907236|NCT01371721|588357851|FG000|Overall Study|Other|2|||
163054312|NCT03530293|588910232|FG001|Pre-randomization|Withdrawal by Subject|0|||
163054313|NCT03530293|588910233|FG002|Pre-randomization|Withdrawal by Subject|0|||
162627524|NCT05695209|587351029|FG000|3-months|Unable to contact for 3-month data collection|0|||
162627525|NCT05695209|587351030|FG001|3-months|Unable to contact for 3-month data collection|1|||
162907237|NCT01371721|588357852|FG001|Overall Study|Other|3|||
162907238|NCT01371721|588357853|FG002|Overall Study|Other|0|||
162907239|NCT01371721|588357851|FG000|Overall Study|Lack of Efficacy|2|||
162907240|NCT01371721|588357852|FG001|Overall Study|Lack of Efficacy|4|||
162907241|NCT01371721|588357853|FG002|Overall Study|Lack of Efficacy|3|||
162907242|NCT01371721|588357851|FG000|Overall Study|Randomized but not treated|1|||
162907243|NCT01371721|588357852|FG001|Overall Study|Randomized but not treated|0|||
162907244|NCT01371721|588357853|FG002|Overall Study|Randomized but not treated|0|||
162907245|NCT01347840|588357854|FG000|Overall Study|Withdrawal by Subject|1|||
162907246|NCT01846208|588357857|FG000|Overall Study|Withdrew prior to treatment|1|||
162907247|NCT01846208|588357858|FG001|Overall Study|Withdrew prior to treatment|1|||
162627526|NCT05695209|587351029|FG000|6-months|Lost to Follow-up|1|||
162627527|NCT05695209|587351030|FG001|6-months|Lost to Follow-up|1|||
162627528|NCT03069378|587351031|FG000|Overall Study|Withdrawal by Subject|1|||
162627529|NCT01397708|587351032|FG000|Overall Study|Withdrawal by Subject|0|||
162627530|NCT01397708|587351033|FG001|Overall Study|Withdrawal by Subject|0|||
162627531|NCT01397708|587351034|FG002|Overall Study|Withdrawal by Subject|1|||
162627532|NCT01397708|587351035|FG003|Overall Study|Withdrawal by Subject|0|||
162627533|NCT01397708|587351036|FG004|Overall Study|Withdrawal by Subject|0|||
162627534|NCT01397708|587351037|FG005|Overall Study|Withdrawal by Subject|0|||
162627535|NCT01397708|587351038|FG006|Overall Study|Withdrawal by Subject|0|||
162627536|NCT01397708|587351039|FG007|Overall Study|Withdrawal by Subject|1|||
162627537|NCT01397708|587351032|FG000|Overall Study|Death|0|||
162627538|NCT01397708|587351033|FG001|Overall Study|Death|0|||
162627539|NCT01397708|587351034|FG002|Overall Study|Death|1|||
162627540|NCT01397708|587351035|FG003|Overall Study|Death|1|||
162627541|NCT01397708|587351036|FG004|Overall Study|Death|0|||
162627542|NCT01397708|587351037|FG005|Overall Study|Death|0|||
162627543|NCT01397708|587351038|FG006|Overall Study|Death|0|||
162627544|NCT01397708|587351039|FG007|Overall Study|Death|0|||
162627545|NCT01397708|587351032|FG000|Overall Study|Lost to Follow-up|0|||
162627546|NCT01397708|587351033|FG001|Overall Study|Lost to Follow-up|0|||
162627547|NCT01397708|587351034|FG002|Overall Study|Lost to Follow-up|0|||
162627548|NCT01397708|587351035|FG003|Overall Study|Lost to Follow-up|0|||
162907248|NCT01846208|588357859|FG002|Overall Study|Withdrew prior to treatment|1|||
162907249|NCT01846208|588357857|FG000|Overall Study|Dosing Symptoms|1|||
162907250|NCT01846208|588357858|FG001|Overall Study|Dosing Symptoms|2|||
162907251|NCT01846208|588357859|FG002|Overall Study|Dosing Symptoms|6|||
162907252|NCT01846208|588357857|FG000|Overall Study|Withdrawal by Subject|5|||
162907253|NCT01846208|588357858|FG001|Overall Study|Withdrawal by Subject|0|||
162907254|NCT01846208|588357859|FG002|Overall Study|Withdrawal by Subject|0|||
162907255|NCT01846208|588357857|FG000|Overall Study|Non-compliance|1|||
162907256|NCT01846208|588357858|FG001|Overall Study|Non-compliance|1|||
162907257|NCT01846208|588357859|FG002|Overall Study|Non-compliance|0|||
162907258|NCT01846208|588357857|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
162907259|NCT01846208|588357858|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
162907260|NCT01846208|588357859|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
162907261|NCT01846208|588357857|FG000|Overall Study|Refused SU OFC|0|||
162907262|NCT01846208|588357858|FG001|Overall Study|Refused SU OFC|0|||
162907263|NCT01846208|588357859|FG002|Overall Study|Refused SU OFC|1|||
162907264|NCT01432938|588357860|FG000|First Intervention|Protocol Violation|1|||
162907265|NCT01432938|588357861|FG001|First Intervention|Protocol Violation|0|||
162907266|NCT01432938|588357860|FG000|First Intervention|Physician Decision|1|||
162907267|NCT01432938|588357861|FG001|First Intervention|Physician Decision|0|||
162907268|NCT01432938|588357860|FG000|Second Intervention|Adverse Event|1|||
162907269|NCT01432938|588357861|FG001|Second Intervention|Adverse Event|0|||
162907270|NCT01875874|588357865|FG000|Overall Study|Death|3|||
162907271|NCT00374127|588357866|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
162907272|NCT00374127|588357866|FG000|Overall Study|Blood could not be drawn.|2|||
162907273|NCT00374127|588357866|FG000|Overall Study|Protocol Violation|5|||
162967421|NCT00884390|588581370|FG001|Overall Study|Lost to Follow-up|1|||
162627549|NCT01397708|587351036|FG004|Overall Study|Lost to Follow-up|1|||
162627550|NCT01397708|587351037|FG005|Overall Study|Lost to Follow-up|0|||
162627551|NCT01397708|587351038|FG006|Overall Study|Lost to Follow-up|0|||
162907274|NCT00374127|588357866|FG000|Overall Study|Pregnancy|1|||
162907275|NCT00281528|588357870|FG000|Overall Study|Progressive Disease|28|||
162907276|NCT00281528|588357871|FG001|Overall Study|Progressive Disease|18|||
162907277|NCT00281528|588357872|FG002|Overall Study|Progressive Disease|27|||
162907278|NCT00281528|588357870|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
162907279|NCT00281528|588357871|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
162907280|NCT00281528|588357872|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
162907281|NCT00281528|588357870|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
162627552|NCT01397708|587351039|FG007|Overall Study|Lost to Follow-up|0|||
162627553|NCT01397708|587351032|FG000|Overall Study|Other|0|||
162627554|NCT01397708|587351033|FG001|Overall Study|Other|0|||
162907282|NCT00281528|588357871|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
162907283|NCT00281528|588357872|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
162907284|NCT00281528|588357870|FG000|Overall Study|Physician Decision|11|||
162907285|NCT00281528|588357871|FG001|Overall Study|Physician Decision|4|||
162907286|NCT00281528|588357872|FG002|Overall Study|Physician Decision|5|||
162907287|NCT00281528|588357870|FG000|Overall Study|Protocol Violation|1|||
162907288|NCT00281528|588357871|FG001|Overall Study|Protocol Violation|0|||
162907289|NCT00281528|588357872|FG002|Overall Study|Protocol Violation|1|||
162907290|NCT00281528|588357870|FG000|Overall Study|Withdrawal by Subject|5|||
162907291|NCT00281528|588357871|FG001|Overall Study|Withdrawal by Subject|5|||
162907292|NCT00281528|588357872|FG002|Overall Study|Withdrawal by Subject|7|||
162907293|NCT00281528|588357870|FG000|Overall Study|Other|6|||
162907294|NCT00281528|588357871|FG001|Overall Study|Other|3|||
162907295|NCT00281528|588357872|FG002|Overall Study|Other|5|||
162907296|NCT02520141|588357875|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
162907297|NCT00703781|588357876|FG000|Overall Study|Withdrawal by Subject|1|||
162907298|NCT00703781|588357877|FG001|Overall Study|Withdrawal by Subject|2|||
162907299|NCT00703781|588357876|FG000|Overall Study|Cancelled surgery|1|||
162907300|NCT00703781|588357877|FG001|Overall Study|Cancelled surgery|0|||
162907301|NCT01225211|588357878|FG000|Overall Study|Adverse Event|0|||
162907302|NCT01225211|588357879|FG001|Overall Study|Adverse Event|0|||
162627555|NCT01397708|587351034|FG002|Overall Study|Other|0|||
162627556|NCT01397708|587351035|FG003|Overall Study|Other|0|||
162627557|NCT01397708|587351036|FG004|Overall Study|Other|0|||
162627558|NCT01397708|587351037|FG005|Overall Study|Other|0|||
162627559|NCT01397708|587351038|FG006|Overall Study|Other|1|||
162627560|NCT01397708|587351039|FG007|Overall Study|Other|0|||
162627561|NCT04997304|587351040|FG000|Overall Study|Lost to Follow-up|11|||
162907303|NCT01225211|588357880|FG002|Overall Study|Adverse Event|1|||
162907304|NCT01225211|588357881|FG003|Overall Study|Adverse Event|0|||
162907305|NCT01225211|588357882|FG004|Overall Study|Adverse Event|0|||
162907306|NCT01225211|588357883|FG005|Overall Study|Adverse Event|0|||
162907307|NCT01225211|588357884|FG006|Overall Study|Adverse Event|0|||
162907308|NCT01225211|588357885|FG007|Overall Study|Adverse Event|0|||
162907309|NCT01225211|588357886|FG008|Overall Study|Adverse Event|0|||
162907310|NCT01225211|588357887|FG009|Overall Study|Adverse Event|1|||
162907311|NCT01225211|588357878|FG000|Overall Study|Withdrawal by Subject|0|||
162907312|NCT01225211|588357879|FG001|Overall Study|Withdrawal by Subject|0|||
162907313|NCT01225211|588357880|FG002|Overall Study|Withdrawal by Subject|0|||
162907314|NCT01225211|588357881|FG003|Overall Study|Withdrawal by Subject|0|||
162907315|NCT01225211|588357882|FG004|Overall Study|Withdrawal by Subject|0|||
162907316|NCT01225211|588357883|FG005|Overall Study|Withdrawal by Subject|0|||
162907317|NCT01225211|588357884|FG006|Overall Study|Withdrawal by Subject|1|||
162907318|NCT01225211|588357885|FG007|Overall Study|Withdrawal by Subject|0|||
162907319|NCT01225211|588357886|FG008|Overall Study|Withdrawal by Subject|1|||
162907320|NCT01225211|588357887|FG009|Overall Study|Withdrawal by Subject|3|||
162907321|NCT01225211|588357878|FG000|Overall Study|Other|0|||
162907322|NCT01225211|588357879|FG001|Overall Study|Other|0|||
162907323|NCT01225211|588357880|FG002|Overall Study|Other|0|||
162907324|NCT01225211|588357881|FG003|Overall Study|Other|0|||
162907325|NCT01225211|588357882|FG004|Overall Study|Other|0|||
162907326|NCT01225211|588357883|FG005|Overall Study|Other|0|||
162907327|NCT01225211|588357884|FG006|Overall Study|Other|0|||
162907328|NCT01225211|588357885|FG007|Overall Study|Other|0|||
162907329|NCT01225211|588357886|FG008|Overall Study|Other|0|||
162907330|NCT01225211|588357887|FG009|Overall Study|Other|1|||
162907331|NCT00410514|588357892|FG000|Overall Study|Adverse Event|2|||
162627562|NCT04997304|587351040|FG000|Overall Study|Death|1|||
162627563|NCT04997304|587351040|FG000|Overall Study|Withdrawal by Subject|14|||
162627564|NCT01606800|587352646|FG000|Overall Study|Adverse Event|3|||
162627565|NCT01606800|587352647|FG001|Overall Study|Adverse Event|1|||
162627566|NCT01606800|587352646|FG000|Overall Study|Participant withdrew consent|0|||
162627567|NCT01606800|587352647|FG001|Overall Study|Participant withdrew consent|1|||
162907332|NCT00410514|588357893|FG001|Overall Study|Adverse Event|2|||
162907333|NCT00410514|588357894|FG002|Overall Study|Adverse Event|2|||
162907334|NCT00410514|588357892|FG000|Overall Study|Protocol Violation|0|||
162907335|NCT00410514|588357893|FG001|Overall Study|Protocol Violation|1|||
162907336|NCT00410514|588357894|FG002|Overall Study|Protocol Violation|1|||
162907337|NCT00410514|588357892|FG000|Overall Study|Lost to Follow-up|0|||
162907338|NCT00410514|588357893|FG001|Overall Study|Lost to Follow-up|0|||
162907339|NCT00410514|588357894|FG002|Overall Study|Lost to Follow-up|2|||
162907340|NCT00410514|588357892|FG000|Overall Study|Non-compliant with study procedures|0|||
162907341|NCT00410514|588357893|FG001|Overall Study|Non-compliant with study procedures|0|||
162907342|NCT00410514|588357894|FG002|Overall Study|Non-compliant with study procedures|2|||
162627568|NCT01606800|587352646|FG000|Overall Study|Missing completion status|2|||
162627569|NCT01606800|587352647|FG001|Overall Study|Missing completion status|0|||
162627570|NCT00612690|587352653|FG000|Overall Study|Lost to Follow-up|72|||
162907343|NCT02449915|588357896|FG000|Overall Study|Exclusion criteria - drug use|1|||
162907344|NCT02449915|588357897|FG001|Overall Study|Exclusion criteria - drug use|0|||
162907345|NCT02449915|588357896|FG000|Overall Study|Withdrawal by Subject|0|||
162907346|NCT02449915|588357897|FG001|Overall Study|Withdrawal by Subject|2|||
162710295|NCT02956967|587649025|FG000|Overall Study|Missing|1|||
162710296|NCT02956967|587649025|FG000|Overall Study|Termination of Nivestim administration|29|||
162710297|NCT00819234|587649028|FG000|Overall Study|Withdrawal by Subject|8|||
162710298|NCT00819234|587649029|FG001|Overall Study|Withdrawal by Subject|13|||
162710299|NCT00819234|587649030|FG002|Overall Study|Withdrawal by Subject|6|||
162710300|NCT00819234|587649031|FG003|Overall Study|Withdrawal by Subject|3|||
162710301|NCT00819234|587649032|FG004|Overall Study|Withdrawal by Subject|0|||
162710302|NCT00819234|587649033|FG005|Overall Study|Withdrawal by Subject|4|||
162710303|NCT00819234|587649034|FG006|Overall Study|Withdrawal by Subject|4|||
162710304|NCT00819234|587649035|FG007|Overall Study|Withdrawal by Subject|8|||
162710305|NCT00819234|587649036|FG008|Overall Study|Withdrawal by Subject|5|||
162710306|NCT00819234|587649037|FG009|Overall Study|Withdrawal by Subject|3|||
162907347|NCT02449915|588357896|FG000|Overall Study|Intraoperative surgical findings|1|||
162907348|NCT02449915|588357897|FG001|Overall Study|Intraoperative surgical findings|1|||
162907349|NCT02449915|588357896|FG000|Overall Study|Abnormal preop lab|0|||
162907350|NCT02449915|588357897|FG001|Overall Study|Abnormal preop lab|1|||
162907351|NCT01436357|588357898|FG000|Overall Study|Death|5|||
162907352|NCT01436357|588357899|FG001|Overall Study|Death|1|||
162907353|NCT01436357|588357898|FG000|Overall Study|Enrolled but not vaccinated|1|||
162907354|NCT01436357|588357899|FG001|Overall Study|Enrolled but not vaccinated|1|||
162907355|NCT01436357|588357898|FG000|Overall Study|Incarceration|18|||
162907356|NCT01436357|588357899|FG001|Overall Study|Incarceration|20|||
162907357|NCT01436357|588357898|FG000|Overall Study|Lost to Follow-up|67|||
162907358|NCT01436357|588357899|FG001|Overall Study|Lost to Follow-up|61|||
162907359|NCT01436357|588357898|FG000|Overall Study|Protocol Violation|1|||
162907360|NCT01436357|588357899|FG001|Overall Study|Protocol Violation|0|||
162907361|NCT01436357|588357898|FG000|Overall Study|Withdrawal by Subject|26|||
162907362|NCT01436357|588357899|FG001|Overall Study|Withdrawal by Subject|38|||
162907363|NCT01436357|588357898|FG000|Overall Study|Physician Decision|3|||
162907364|NCT01436357|588357899|FG001|Overall Study|Physician Decision|4|||
162907365|NCT01436357|588357898|FG000|Overall Study|Moved out of area|1|||
162907366|NCT01436357|588357899|FG001|Overall Study|Moved out of area|2|||
162907367|NCT01436357|588357898|FG000|Overall Study|Subject in rehab|0|||
162907368|NCT01436357|588357899|FG001|Overall Study|Subject in rehab|1|||
162907369|NCT01021293|588357904|FG000|Overall Study|Serious Adverse Event|2|||
162907370|NCT01021293|588357905|FG001|Overall Study|Serious Adverse Event|1|||
162710307|NCT00819234|587649028|FG000|Overall Study|Adverse Event|0|||
162710308|NCT00819234|587649029|FG001|Overall Study|Adverse Event|0|||
162710309|NCT00819234|587649030|FG002|Overall Study|Adverse Event|1|||
162907371|NCT01021293|588357904|FG000|Overall Study|Adverse Event|2|||
162907372|NCT01021293|588357905|FG001|Overall Study|Adverse Event|1|||
162907373|NCT01021293|588357904|FG000|Overall Study|Withdrawal by Subject|1|||
162907374|NCT01021293|588357905|FG001|Overall Study|Withdrawal by Subject|3|||
162907375|NCT01021293|588357904|FG000|Overall Study|Migrated/moved from study area|6|||
162627571|NCT00612690|587352654|FG001|Overall Study|Lost to Follow-up|98|||
162627572|NCT00612690|587352653|FG000|Overall Study|Withdrawal by Subject|32|||
162627573|NCT00612690|587352654|FG001|Overall Study|Withdrawal by Subject|20|||
162627574|NCT00612690|587352653|FG000|Overall Study|Withdrawal by Site|11|||
162627575|NCT00612690|587352654|FG001|Overall Study|Withdrawal by Site|0|||
162627576|NCT02370160|587352657|FG000|Overall Study|Death|3|||
162627577|NCT02370160|587352658|FG001|Overall Study|Death|4|||
162627578|NCT02370160|587352659|FG002|Overall Study|Death|1|||
162627579|NCT04487730|587352660|FG000|Overall Study|Withdrawal by Subject|3|||
162627580|NCT04487730|587352661|FG001|Overall Study|Withdrawal by Subject|1|||
162627581|NCT04487730|587352660|FG000|Overall Study|Lost to Follow-up|0|||
162627582|NCT04487730|587352661|FG001|Overall Study|Lost to Follow-up|1|||
162627583|NCT04487730|587352660|FG000|Overall Study|Physician Decision|0|||
162627584|NCT04487730|587352661|FG001|Overall Study|Physician Decision|1|||
162627585|NCT00907777|587352662|FG000|Overall Study|Withdrawal by Subject|0|||
162627586|NCT00907777|587352663|FG001|Overall Study|Withdrawal by Subject|1|||
162627587|NCT03291808|587352664|FG000|Overall Study|Lost to Follow-up|6|||
162627588|NCT03291808|587352664|FG000|Overall Study|Research burden|4|||
162627589|NCT00638378|587352665|FG000|Overall Study|Death|2|||
162627590|NCT00638378|587352665|FG000|Overall Study|Adverse Event|1|||
162627591|NCT00638378|587352665|FG000|Overall Study|Disease progression|15|||
162627592|NCT00638378|587352665|FG000|Overall Study|Physician Decision|4|||
162627593|NCT03364023|587352668|FG000|Overall Study|Lost to Follow-up|3|||
162627594|NCT03364023|587352668|FG000|Overall Study|Death|14|||
162627595|NCT02891850|587352669|FG000|Overall Study|Adverse Event|3|||
162627596|NCT02891850|587352670|FG001|Overall Study|Adverse Event|0|||
162627597|NCT02891850|587352669|FG000|Overall Study|Death|0|||
162627598|NCT02891850|587352670|FG001|Overall Study|Death|4|||
162627599|NCT02891850|587352669|FG000|Overall Study|Physician Decision|1|||
162627600|NCT02891850|587352670|FG001|Overall Study|Physician Decision|0|||
162627601|NCT02891850|587352669|FG000|Overall Study|Pregnancy|1|||
162627602|NCT02891850|587352670|FG001|Overall Study|Pregnancy|0|||
162627603|NCT02891850|587352669|FG000|Overall Study|Withdrawal by Subject|2|||
162627604|NCT02891850|587352670|FG001|Overall Study|Withdrawal by Subject|3|||
162627605|NCT03797014|587352673|FG000|Overall Study|Withdrawal by Subject|1|||
162710310|NCT00819234|587649031|FG003|Overall Study|Adverse Event|0|||
162710311|NCT00819234|587649032|FG004|Overall Study|Adverse Event|0|||
162710312|NCT00819234|587649033|FG005|Overall Study|Adverse Event|2|||
162710313|NCT00819234|587649034|FG006|Overall Study|Adverse Event|0|||
162710314|NCT00819234|587649035|FG007|Overall Study|Adverse Event|0|||
162710315|NCT00819234|587649036|FG008|Overall Study|Adverse Event|0|||
162710316|NCT00819234|587649037|FG009|Overall Study|Adverse Event|0|||
162710317|NCT00819234|587649028|FG000|Overall Study|Physician Decision|0|||
162710318|NCT00819234|587649029|FG001|Overall Study|Physician Decision|0|||
162710319|NCT00819234|587649030|FG002|Overall Study|Physician Decision|0|||
162710320|NCT00819234|587649031|FG003|Overall Study|Physician Decision|1|||
162710321|NCT00819234|587649032|FG004|Overall Study|Physician Decision|0|||
162907376|NCT01021293|588357905|FG001|Overall Study|Migrated/moved from study area|18|||
162907377|NCT01021293|588357904|FG000|Overall Study|Lost to Follow-up|1|||
162907378|NCT01021293|588357905|FG001|Overall Study|Lost to Follow-up|1|||
162907379|NCT04335929|588359494|FG000|Overall Study|Lost to Follow-up|10|||
162907380|NCT02491463|588359496|FG000|Overall Study|Withdrawal by Subject|1|||
162907381|NCT02491463|588359497|FG001|Overall Study|Withdrawal by Subject|2|||
162627606|NCT03797014|587352673|FG000|Overall Study|Lost to Follow-up|1|||
162627607|NCT03797014|587352673|FG000|Overall Study|Protocol Violation|1|||
162627608|NCT01970397|587352674|FG000|Overall Study|Adverse Event|0|||
162627609|NCT01970397|587352675|FG001|Overall Study|Adverse Event|1|||
162627610|NCT01970397|587352674|FG000|Overall Study|Lost to Follow-up|0|||
162627611|NCT01970397|587352675|FG001|Overall Study|Lost to Follow-up|1|||
162627612|NCT01970397|587352674|FG000|Overall Study|Personal Reasons|1|||
162627613|NCT01970397|587352675|FG001|Overall Study|Personal Reasons|2|||
162627614|NCT01970397|587352674|FG000|Overall Study|Protocol Violation|1|||
162627615|NCT01970397|587352675|FG001|Overall Study|Protocol Violation|1|||
162627616|NCT00105469|587352680|FG000|Overall Study|Adverse Event|9|||
162627617|NCT00105469|587352681|FG001|Overall Study|Adverse Event|8|||
162627618|NCT00105469|587352680|FG000|Overall Study|Protocol Violation|4|||
162627619|NCT00105469|587352681|FG001|Overall Study|Protocol Violation|0|||
162627620|NCT00105469|587352680|FG000|Overall Study|Withdrawal by Subject|2|||
162627621|NCT00105469|587352681|FG001|Overall Study|Withdrawal by Subject|3|||
162627622|NCT00105469|587352680|FG000|Overall Study|Lost to Follow-up|1|||
162627623|NCT00105469|587352681|FG001|Overall Study|Lost to Follow-up|0|||
162627624|NCT00105469|587352680|FG000|Overall Study|Lack of Efficacy|2|||
162627625|NCT00105469|587352681|FG001|Overall Study|Lack of Efficacy|0|||
162627626|NCT00105469|587352680|FG000|Overall Study|Other Reason|4|||
162627627|NCT00105469|587352681|FG001|Overall Study|Other Reason|0|||
162627628|NCT02820753|587352686|FG000|2 Month|Withdrawal by Subject|3|||
162627629|NCT02820753|587352687|FG001|2 Month|Withdrawal by Subject|3|||
162627630|NCT02820753|587352686|FG000|2 Month|Lost to Follow-up|24|||
162627631|NCT02820753|587352687|FG001|2 Month|Lost to Follow-up|26|||
162627632|NCT02820753|587352686|FG000|2 Month|Stopped per NIH Hold|51|||
162627633|NCT02820753|587352687|FG001|2 Month|Stopped per NIH Hold|13|||
162627634|NCT02820753|587352686|FG000|6 Month|Withdrawal by Subject|2|||
162627635|NCT02820753|587352687|FG001|6 Month|Withdrawal by Subject|2|||
162627636|NCT02820753|587352686|FG000|6 Month|Lost to Follow-up|20|||
162627637|NCT02820753|587352687|FG001|6 Month|Lost to Follow-up|27|||
162627638|NCT02820753|587352686|FG000|6 Month|Stopped per NIH Hold|81|||
162627639|NCT02820753|587352687|FG001|6 Month|Stopped per NIH Hold|81|||
162627640|NCT02820753|587352686|FG000|6 Month|Death|0|||
162627641|NCT02820753|587352687|FG001|6 Month|Death|1|||
162627642|NCT01652703|587352688|FG000|Overall Study|Withdrawal by Subject|0|||
162710322|NCT00819234|587649033|FG005|Overall Study|Physician Decision|0|||
162710323|NCT00819234|587649034|FG006|Overall Study|Physician Decision|0|||
162710324|NCT00819234|587649035|FG007|Overall Study|Physician Decision|0|||
162710325|NCT00819234|587649036|FG008|Overall Study|Physician Decision|0|||
162710326|NCT00819234|587649037|FG009|Overall Study|Physician Decision|2|||
162907382|NCT02491463|588359498|FG002|Overall Study|Withdrawal by Subject|0|||
162907383|NCT02491463|588359499|FG003|Overall Study|Withdrawal by Subject|0|||
162627643|NCT01652703|587352689|FG001|Overall Study|Withdrawal by Subject|1|||
162627644|NCT01652703|587352690|FG002|Overall Study|Withdrawal by Subject|3|||
162627645|NCT01652703|587352691|FG003|Overall Study|Withdrawal by Subject|1|||
162627646|NCT01652703|587352692|FG004|Overall Study|Withdrawal by Subject|0|||
162627647|NCT01652703|587352693|FG005|Overall Study|Withdrawal by Subject|1|||
162710327|NCT00819234|587649028|FG000|Overall Study|Protocol Violation|0|||
162710328|NCT00819234|587649029|FG001|Overall Study|Protocol Violation|0|||
162710329|NCT00819234|587649030|FG002|Overall Study|Protocol Violation|1|||
162710330|NCT00819234|587649031|FG003|Overall Study|Protocol Violation|0|||
162710331|NCT00819234|587649032|FG004|Overall Study|Protocol Violation|0|||
162907384|NCT02491463|588359496|FG000|Overall Study|Migrated/moved from study area|1|||
162907385|NCT02491463|588359497|FG001|Overall Study|Migrated/moved from study area|5|||
162710332|NCT00819234|587649033|FG005|Overall Study|Protocol Violation|0|||
162710333|NCT00819234|587649034|FG006|Overall Study|Protocol Violation|0|||
162907386|NCT02491463|588359498|FG002|Overall Study|Migrated/moved from study area|1|||
162907387|NCT02491463|588359499|FG003|Overall Study|Migrated/moved from study area|1|||
162907388|NCT02491463|588359496|FG000|Overall Study|Lost to Follow-up|0|||
162907389|NCT02491463|588359497|FG001|Overall Study|Lost to Follow-up|3|||
162907390|NCT02491463|588359498|FG002|Overall Study|Lost to Follow-up|3|||
162907391|NCT02491463|588359499|FG003|Overall Study|Lost to Follow-up|0|||
162710334|NCT00819234|587649035|FG007|Overall Study|Protocol Violation|0|||
162710335|NCT00819234|587649036|FG008|Overall Study|Protocol Violation|0|||
162710336|NCT00819234|587649037|FG009|Overall Study|Protocol Violation|0|||
162710337|NCT00819234|587649028|FG000|Overall Study|Lost to Follow-up|2|||
162710338|NCT00819234|587649029|FG001|Overall Study|Lost to Follow-up|2|||
162710339|NCT00819234|587649030|FG002|Overall Study|Lost to Follow-up|0|||
162710340|NCT00819234|587649031|FG003|Overall Study|Lost to Follow-up|2|||
162710341|NCT00819234|587649032|FG004|Overall Study|Lost to Follow-up|1|||
162710342|NCT00819234|587649033|FG005|Overall Study|Lost to Follow-up|1|||
162710343|NCT00819234|587649034|FG006|Overall Study|Lost to Follow-up|1|||
162710344|NCT00819234|587649035|FG007|Overall Study|Lost to Follow-up|1|||
162907392|NCT01491802|588359500|FG000|Overall Study|Adverse Event|1|||
162907393|NCT01491802|588359501|FG001|Overall Study|Adverse Event|1|||
162710345|NCT00819234|587649036|FG008|Overall Study|Lost to Follow-up|1|||
162710346|NCT00819234|587649037|FG009|Overall Study|Lost to Follow-up|2|||
162710347|NCT01096056|587649038|FG000|Overall Study|Lost to Follow-up|0|||
162710348|NCT01096056|587649039|FG001|Overall Study|Lost to Follow-up|1|||
162710349|NCT03568162|587649040|FG000|Overall Study|Adverse Event|0|||
162710350|NCT03568162|587649041|FG001|Overall Study|Adverse Event|1|||
162710351|NCT03568162|587649042|FG002|Overall Study|Adverse Event|2|||
162710352|NCT03568162|587649043|FG003|Overall Study|Adverse Event|0|||
162710353|NCT03568162|587649044|FG004|Overall Study|Adverse Event|0|||
162710354|NCT03568162|587649045|FG005|Overall Study|Adverse Event|1|||
162710355|NCT03568162|587649040|FG000|Overall Study|Death|0|||
162710356|NCT03568162|587649041|FG001|Overall Study|Death|0|||
162907394|NCT01491802|588359500|FG000|Overall Study|Withdrawal by Subject|0|||
162907395|NCT01491802|588359501|FG001|Overall Study|Withdrawal by Subject|1|||
162907396|NCT01864746|588359504|FG000|Overall Study|Disease recurrence|25|||
162907397|NCT01864746|588359505|FG001|Overall Study|Disease recurrence|40|||
162907398|NCT01864746|588359504|FG000|Overall Study|Second primary invasive nonbreast|2|||
162907399|NCT01864746|588359505|FG001|Overall Study|Second primary invasive nonbreast|3|||
162907400|NCT01864746|588359504|FG000|Overall Study|Death|2|||
162907401|NCT01864746|588359505|FG001|Overall Study|Death|1|||
162907402|NCT01864746|588359504|FG000|Overall Study|Adverse Event|33|||
162907403|NCT01864746|588359505|FG001|Overall Study|Adverse Event|5|||
162907404|NCT01864746|588359504|FG000|Overall Study|Withdrawal by Subject|56|||
162907405|NCT01864746|588359505|FG001|Overall Study|Withdrawal by Subject|41|||
162907406|NCT01864746|588359504|FG000|Overall Study|Physician Decision|5|||
162907407|NCT01864746|588359505|FG001|Overall Study|Physician Decision|6|||
162907408|NCT01005966|588359506|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
162907409|NCT01005966|588359507|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
162907410|NCT01005966|588359508|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
162907411|NCT01005966|588359509|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
162907412|NCT01005966|588359510|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
162907413|NCT01005966|588359506|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
162907414|NCT01005966|588359507|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
162907415|NCT01005966|588359508|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
162710357|NCT03568162|587649042|FG002|Overall Study|Death|0|||
162907416|NCT01005966|588359509|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
162907417|NCT01005966|588359510|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
162907418|NCT01005966|588359506|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
162907419|NCT01005966|588359507|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
162907420|NCT01005966|588359508|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
162907421|NCT01005966|588359509|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
162967422|NCT00884390|588581369|FG000|Overall Study|Physician Decision|2|||
162710358|NCT03568162|587649043|FG003|Overall Study|Death|0|||
162710359|NCT03568162|587649044|FG004|Overall Study|Death|1|||
162710360|NCT03568162|587649045|FG005|Overall Study|Death|0|||
162710361|NCT03568162|587649040|FG000|Overall Study|Lost to Follow-up|3|||
162710362|NCT03568162|587649041|FG001|Overall Study|Lost to Follow-up|2|||
162710363|NCT03568162|587649042|FG002|Overall Study|Lost to Follow-up|4|||
162710364|NCT03568162|587649043|FG003|Overall Study|Lost to Follow-up|2|||
162907422|NCT01005966|588359510|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
162710365|NCT03568162|587649044|FG004|Overall Study|Lost to Follow-up|3|||
162710366|NCT03568162|587649045|FG005|Overall Study|Lost to Follow-up|2|||
162627648|NCT01652703|587352688|FG000|Overall Study|Other|0|||
162627649|NCT01652703|587352689|FG001|Overall Study|Other|0|||
162627650|NCT01652703|587352690|FG002|Overall Study|Other|0|||
162907423|NCT01005966|588359506|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
162907424|NCT01005966|588359507|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
162907425|NCT01005966|588359508|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
162907426|NCT01005966|588359509|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
162907427|NCT01005966|588359510|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
162907428|NCT01005966|588359506|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
162907429|NCT01005966|588359507|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
162907430|NCT01005966|588359508|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
162907431|NCT01005966|588359509|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
162907432|NCT01005966|588359510|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
162907433|NCT01005966|588359506|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162907434|NCT01005966|588359507|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162907435|NCT01005966|588359508|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162907436|NCT01005966|588359509|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162907437|NCT01005966|588359510|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162907438|NCT01005966|588359506|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
162907439|NCT01005966|588359507|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
162907440|NCT01005966|588359508|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
162907441|NCT01005966|588359509|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
162907442|NCT01005966|588359510|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
162907443|NCT01005966|588359506|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
162907444|NCT01005966|588359507|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
162907445|NCT01005966|588359508|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
162907446|NCT01005966|588359509|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
162907447|NCT01005966|588359510|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
162907448|NCT01005966|588359506|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
162907449|NCT01005966|588359507|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
162907450|NCT01005966|588359508|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
162907451|NCT01005966|588359509|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
162907452|NCT01005966|588359510|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
162907453|NCT01347931|588359511|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
162907454|NCT03890731|588359512|FG000|Overall Study|Progressive disease|1|||
162907455|NCT03890731|588359512|FG000|Overall Study|Patient's decision|1|||
162907456|NCT03890731|588359512|FG000|Overall Study|Adverse Event|4|||
162627651|NCT01652703|587352691|FG003|Overall Study|Other|1|||
162627652|NCT01652703|587352692|FG004|Overall Study|Other|1|||
162907457|NCT00945945|588359515|FG000|Overall Study|Adverse Event|15|||
162907458|NCT00945945|588359516|FG001|Overall Study|Adverse Event|35|||
162907459|NCT00945945|588359515|FG000|Overall Study|Withdrawal by Subject|7|||
162907460|NCT00945945|588359516|FG001|Overall Study|Withdrawal by Subject|10|||
162907461|NCT00945945|588359515|FG000|Overall Study|Lost to Follow-up|4|||
162907462|NCT00945945|588359516|FG001|Overall Study|Lost to Follow-up|5|||
162907463|NCT00945945|588359515|FG000|Overall Study|Lack of Efficacy|6|||
162907464|NCT00945945|588359516|FG001|Overall Study|Lack of Efficacy|2|||
162907465|NCT00945945|588359515|FG000|Overall Study|Protocol Violation|4|||
162907466|NCT00945945|588359516|FG001|Overall Study|Protocol Violation|2|||
162907467|NCT00945945|588359515|FG000|Overall Study|Entry Criteria Not Met|0|||
162907468|NCT00945945|588359516|FG001|Overall Study|Entry Criteria Not Met|1|||
162907469|NCT00394654|588359517|FG000|Overall Study|Lost to Follow-up|1|||
162907470|NCT00394654|588359518|FG001|Overall Study|Lost to Follow-up|0|||
162907471|NCT00394654|588359517|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
162907472|NCT00394654|588359518|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
162907473|NCT03442595|588359519|FG000|Overall Study|Lost to Follow-up|94|||
162907474|NCT03442595|588359520|FG001|Overall Study|Lost to Follow-up|0|||
162907475|NCT01060150|588359523|FG000|Overall Study|Adverse Event|6|||
162907476|NCT01060150|588359523|FG000|Overall Study|Lost to Follow-up|1|||
162907477|NCT01060150|588359523|FG000|Overall Study|Protocol Violation|6|||
162907478|NCT01060150|588359523|FG000|Overall Study|Withdrawal by Subject|8|||
162907479|NCT01060150|588359523|FG000|Overall Study|Enrolled, but not treated|2|||
162907480|NCT01836549|588359524|FG000|Overall Study|Did not receive study drug|0|||
162907481|NCT01836549|588359525|FG001|Overall Study|Did not receive study drug|0|||
162907482|NCT01836549|588359526|FG002|Overall Study|Did not receive study drug|1|||
162907483|NCT01836549|588359527|FG003|Overall Study|Did not receive study drug|0|||
162907484|NCT01836549|588359528|FG004|Overall Study|Did not receive study drug|0|||
162907485|NCT01836549|588359529|FG005|Overall Study|Did not receive study drug|0|||
162907486|NCT01836549|588359530|FG006|Overall Study|Did not receive study drug|0|||
162627653|NCT01652703|587352693|FG005|Overall Study|Other|1|||
162907487|NCT01836549|588359524|FG000|Overall Study|Patient declared ineligible|0|||
162907488|NCT01836549|588359525|FG001|Overall Study|Patient declared ineligible|0|||
162907489|NCT01836549|588359526|FG002|Overall Study|Patient declared ineligible|0|||
162907490|NCT01836549|588359527|FG003|Overall Study|Patient declared ineligible|1|||
162907491|NCT01836549|588359528|FG004|Overall Study|Patient declared ineligible|0|||
162907492|NCT01836549|588359529|FG005|Overall Study|Patient declared ineligible|0|||
162907493|NCT01836549|588359530|FG006|Overall Study|Patient declared ineligible|0|||
162907494|NCT01836549|588359524|FG000|Overall Study|Patient inevaluable to start therapy|0|||
162907495|NCT01836549|588359525|FG001|Overall Study|Patient inevaluable to start therapy|0|||
162907496|NCT01836549|588359526|FG002|Overall Study|Patient inevaluable to start therapy|0|||
162907497|NCT01836549|588359527|FG003|Overall Study|Patient inevaluable to start therapy|0|||
162907498|NCT01836549|588359528|FG004|Overall Study|Patient inevaluable to start therapy|0|||
162907499|NCT01836549|588359529|FG005|Overall Study|Patient inevaluable to start therapy|0|||
162907500|NCT01836549|588359530|FG006|Overall Study|Patient inevaluable to start therapy|1|||
162907501|NCT00381706|588359531|FG000|Overall Study|Never treated|7|||
162907502|NCT00381706|588359532|FG001|Overall Study|Never treated|2|||
162907503|NCT00381706|588359533|FG002|Overall Study|Never treated|1|||
162907504|NCT02364999|588359534|FG000|Overall Study|Death|136|||
162907505|NCT02364999|588359535|FG001|Overall Study|Death|138|||
162907506|NCT02364999|588359534|FG000|Overall Study|Lost to Follow-up|10|||
162907507|NCT02364999|588359535|FG001|Overall Study|Lost to Follow-up|15|||
162907508|NCT02364999|588359534|FG000|Overall Study|Protocol Violation|3|||
162907509|NCT02364999|588359535|FG001|Overall Study|Protocol Violation|2|||
162907510|NCT02364999|588359534|FG000|Overall Study|Withdrawal by Subject|14|||
162907511|NCT02364999|588359535|FG001|Overall Study|Withdrawal by Subject|14|||
162907512|NCT02364999|588359534|FG000|Overall Study|Other|0|||
162907513|NCT02364999|588359535|FG001|Overall Study|Other|1|||
162907514|NCT02364999|588359534|FG000|Overall Study|Randomized but did not receive treatment|2|||
162907515|NCT02364999|588359535|FG001|Overall Study|Randomized but did not receive treatment|3|||
162907516|NCT00550615|588359536|FG000|Overall Study|Withdrawal by Subject|0|||
162907517|NCT00550615|588359537|FG001|Overall Study|Withdrawal by Subject|0|||
162907518|NCT00550615|588359538|FG002|Overall Study|Withdrawal by Subject|2|||
162907519|NCT00550615|588359539|FG003|Overall Study|Withdrawal by Subject|3|||
162907520|NCT00550615|588359536|FG000|Overall Study|Not evaluable|0|||
162907521|NCT00550615|588359537|FG001|Overall Study|Not evaluable|0|||
162907522|NCT00550615|588359538|FG002|Overall Study|Not evaluable|2|||
162907523|NCT00550615|588359539|FG003|Overall Study|Not evaluable|7|||
162907524|NCT01234337|588359540|FG000|Overall Study|Adverse Event|58|||
162907525|NCT01234337|588359541|FG001|Overall Study|Adverse Event|21|||
162907526|NCT01234337|588359540|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
162907527|NCT01234337|588359541|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
162907528|NCT01234337|588359540|FG000|Overall Study|Investi. decision not protocol driven|5|||
162907529|NCT01234337|588359541|FG001|Overall Study|Investi. decision not protocol driven|6|||
162907530|NCT01234337|588359540|FG000|Overall Study|Non-compliant with study medication|3|||
162907531|NCT01234337|588359541|FG001|Overall Study|Non-compliant with study medication|2|||
162907532|NCT01234337|588359540|FG000|Overall Study|Randomized but not treated|6|||
162907533|NCT01234337|588359541|FG001|Overall Study|Randomized but not treated|4|||
162907534|NCT01234337|588359540|FG000|Overall Study|Lost to Follow-up|0|||
162907535|NCT01234337|588359541|FG001|Overall Study|Lost to Follow-up|1|||
162907536|NCT01234337|588359540|FG000|Overall Study|Protocol Violation|2|||
162907537|NCT01234337|588359541|FG001|Overall Study|Protocol Violation|3|||
162907538|NCT01234337|588359540|FG000|Overall Study|Withdrawal by Subject|11|||
162907539|NCT01234337|588359541|FG001|Overall Study|Withdrawal by Subject|9|||
162907540|NCT01234337|588359540|FG000|Overall Study|Death|0|||
162907541|NCT01234337|588359541|FG001|Overall Study|Death|1|||
162907542|NCT01234337|588359540|FG000|Overall Study|Switch to commercial drug|0|||
162907543|NCT01234337|588359541|FG001|Overall Study|Switch to commercial drug|1|||
162907544|NCT02181504|588359545|FG000|Overall Study|Adverse Event|1|||
162907545|NCT02181504|588359546|FG001|Overall Study|Adverse Event|1|||
162907546|NCT02181504|588359547|FG002|Overall Study|Adverse Event|1|||
162907547|NCT02555722|588359548|FG000|Week 2|Adverse Event|0|||
162907548|NCT02555722|588359549|FG001|Week 2|Adverse Event|1|||
162907549|NCT02555722|588359548|FG000|Week 2|Withdrawal by Subject|1|||
162907550|NCT02555722|588359549|FG001|Week 2|Withdrawal by Subject|0|||
162907551|NCT02555722|588359548|FG000|Month 1|Lens Discomfort|1|||
162907552|NCT02555722|588359549|FG001|Month 1|Lens Discomfort|0|||
162907553|NCT02555722|588359548|FG000|Month 2|Withdrawal by Subject|3|||
162907554|NCT02555722|588359549|FG001|Month 2|Withdrawal by Subject|0|||
162907555|NCT02555722|588359548|FG000|Month 2|Lost to Follow-up|1|||
162907556|NCT02555722|588359549|FG001|Month 2|Lost to Follow-up|0|||
162907557|NCT00598585|588359556|FG000|Overall Study|Lost to Follow-up|1|||
162907558|NCT00598585|588359557|FG001|Overall Study|Lost to Follow-up|0|||
162907559|NCT00545584|588359558|FG000|Overall Study|Only one reason for discontinuation|62|||
162907560|NCT00545584|588359559|FG001|Overall Study|Only one reason for discontinuation|61|||
162907561|NCT00545584|588359560|FG002|Overall Study|Only one reason for discontinuation|48|||
162907562|NCT00545584|588359558|FG000|Overall Study|Two or more reasons for discontinuation|17|||
162907563|NCT00545584|588359559|FG001|Overall Study|Two or more reasons for discontinuation|19|||
162907564|NCT00545584|588359560|FG002|Overall Study|Two or more reasons for discontinuation|8|||
162907565|NCT00135694|588359566|FG000|Overall Study|Adverse Event|17|||
162907566|NCT00135694|588359567|FG001|Overall Study|Adverse Event|4|||
162907567|NCT00135694|588359568|FG002|Overall Study|Adverse Event|0|||
162907568|NCT00135694|588359566|FG000|Overall Study|Death|14|||
162907569|NCT00135694|588359567|FG001|Overall Study|Death|1|||
162907570|NCT00135694|588359568|FG002|Overall Study|Death|2|||
162907571|NCT00135694|588359566|FG000|Overall Study|Lost to Follow-up|8|||
162710367|NCT03568162|587649040|FG000|Overall Study|Physician Decision|0|||
162710368|NCT03568162|587649041|FG001|Overall Study|Physician Decision|1|||
162710369|NCT03568162|587649042|FG002|Overall Study|Physician Decision|1|||
162710370|NCT03568162|587649043|FG003|Overall Study|Physician Decision|0|||
162710371|NCT03568162|587649044|FG004|Overall Study|Physician Decision|1|||
162710372|NCT03568162|587649045|FG005|Overall Study|Physician Decision|0|||
162710373|NCT03568162|587649040|FG000|Overall Study|Pregnancy|0|||
162710374|NCT03568162|587649041|FG001|Overall Study|Pregnancy|0|||
162710375|NCT03568162|587649042|FG002|Overall Study|Pregnancy|0|||
162710376|NCT03568162|587649043|FG003|Overall Study|Pregnancy|1|||
162710377|NCT03568162|587649044|FG004|Overall Study|Pregnancy|0|||
162710378|NCT03568162|587649045|FG005|Overall Study|Pregnancy|0|||
162710379|NCT03568162|587649040|FG000|Overall Study|Protocol Violation|1|||
162907572|NCT00135694|588359567|FG001|Overall Study|Lost to Follow-up|7|||
162907573|NCT00135694|588359568|FG002|Overall Study|Lost to Follow-up|1|||
162907574|NCT00135694|588359566|FG000|Overall Study|Withdrawal by Subject|41|||
162907575|NCT00135694|588359567|FG001|Overall Study|Withdrawal by Subject|7|||
162907576|NCT00135694|588359568|FG002|Overall Study|Withdrawal by Subject|4|||
162907577|NCT00135694|588359566|FG000|Overall Study|Protocol Violation|19|||
162907578|NCT00135694|588359567|FG001|Overall Study|Protocol Violation|1|||
162907579|NCT00135694|588359568|FG002|Overall Study|Protocol Violation|0|||
162907580|NCT00135694|588359566|FG000|Overall Study|Hepatitis C related reasons|39|||
162907581|NCT00135694|588359567|FG001|Overall Study|Hepatitis C related reasons|1|||
162907582|NCT00135694|588359568|FG002|Overall Study|Hepatitis C related reasons|0|||
162907583|NCT00135694|588359566|FG000|Overall Study|Ineligible for Random assignment|42|||
162907584|NCT00135694|588359567|FG001|Overall Study|Ineligible for Random assignment|0|||
162907585|NCT00135694|588359568|FG002|Overall Study|Ineligible for Random assignment|0|||
162907586|NCT02584660|588359569|FG000|Overall Study|Adverse Event|4|||
162907587|NCT02584660|588359570|FG001|Overall Study|Adverse Event|0|||
162907588|NCT02584660|588359569|FG000|Overall Study|Lost to Follow-up|3|||
162907589|NCT02584660|588359570|FG001|Overall Study|Lost to Follow-up|4|||
162627654|NCT03555591|587352694|FG000|Overall Study|Protocol Violation|77|||
162627655|NCT02380677|587352702|FG000|Overall Study|Adverse Event|0|||
162627656|NCT02380677|587352703|FG001|Overall Study|Adverse Event|0|||
162627657|NCT02380677|587352704|FG002|Overall Study|Adverse Event|0|||
162627658|NCT02380677|587352705|FG003|Overall Study|Adverse Event|1|||
162627659|NCT02380677|587352706|FG004|Overall Study|Adverse Event|1|||
162627660|NCT02380677|587352707|FG005|Overall Study|Adverse Event|4|||
162627661|NCT02380677|587352708|FG006|Overall Study|Adverse Event|2|||
162627662|NCT02380677|587352709|FG007|Overall Study|Adverse Event|2|||
162627663|NCT02380677|587352710|FG008|Overall Study|Adverse Event|2|||
162627664|NCT02380677|587352711|FG009|Overall Study|Adverse Event|1|||
162627665|NCT02380677|587352712|FG010|Overall Study|Adverse Event|2|||
162627666|NCT02380677|587352713|FG011|Overall Study|Adverse Event|1|||
162627667|NCT02380677|587352702|FG000|Overall Study|Physician Decision|1|||
162627668|NCT02380677|587352703|FG001|Overall Study|Physician Decision|0|||
162627669|NCT02380677|587352704|FG002|Overall Study|Physician Decision|1|||
162627670|NCT02380677|587352705|FG003|Overall Study|Physician Decision|1|||
162627671|NCT02380677|587352706|FG004|Overall Study|Physician Decision|0|||
162627672|NCT02380677|587352707|FG005|Overall Study|Physician Decision|0|||
162627673|NCT02380677|587352708|FG006|Overall Study|Physician Decision|0|||
162627674|NCT02380677|587352709|FG007|Overall Study|Physician Decision|0|||
162627675|NCT02380677|587352710|FG008|Overall Study|Physician Decision|0|||
162627676|NCT02380677|587352711|FG009|Overall Study|Physician Decision|0|||
162627677|NCT02380677|587352712|FG010|Overall Study|Physician Decision|0|||
162627678|NCT02380677|587352713|FG011|Overall Study|Physician Decision|0|||
162627679|NCT02380677|587352702|FG000|Overall Study|Lack of Efficacy|0|||
162627680|NCT02380677|587352703|FG001|Overall Study|Lack of Efficacy|1|||
162627681|NCT02380677|587352704|FG002|Overall Study|Lack of Efficacy|2|||
162627682|NCT02380677|587352705|FG003|Overall Study|Lack of Efficacy|0|||
162627683|NCT02380677|587352706|FG004|Overall Study|Lack of Efficacy|4|||
162627684|NCT02380677|587352707|FG005|Overall Study|Lack of Efficacy|1|||
162627685|NCT02380677|587352708|FG006|Overall Study|Lack of Efficacy|1|||
162627686|NCT02380677|587352709|FG007|Overall Study|Lack of Efficacy|2|||
162627687|NCT02380677|587352710|FG008|Overall Study|Lack of Efficacy|2|||
162627688|NCT02380677|587352711|FG009|Overall Study|Lack of Efficacy|0|||
162627689|NCT02380677|587352712|FG010|Overall Study|Lack of Efficacy|2|||
162627690|NCT02380677|587352713|FG011|Overall Study|Lack of Efficacy|1|||
162627691|NCT02380677|587352702|FG000|Overall Study|Withdrawal by Subject|0|||
162627692|NCT02380677|587352703|FG001|Overall Study|Withdrawal by Subject|0|||
162627693|NCT02380677|587352704|FG002|Overall Study|Withdrawal by Subject|0|||
162627694|NCT02380677|587352705|FG003|Overall Study|Withdrawal by Subject|0|||
162627695|NCT02380677|587352706|FG004|Overall Study|Withdrawal by Subject|0|||
162627696|NCT02380677|587352707|FG005|Overall Study|Withdrawal by Subject|0|||
162627697|NCT02380677|587352708|FG006|Overall Study|Withdrawal by Subject|0|||
162627698|NCT02380677|587352709|FG007|Overall Study|Withdrawal by Subject|0|||
162627699|NCT02380677|587352710|FG008|Overall Study|Withdrawal by Subject|0|||
162627700|NCT02380677|587352711|FG009|Overall Study|Withdrawal by Subject|1|||
162627701|NCT02380677|587352712|FG010|Overall Study|Withdrawal by Subject|0|||
162627702|NCT02380677|587352713|FG011|Overall Study|Withdrawal by Subject|3|||
162627703|NCT02380677|587352702|FG000|Overall Study|Other|0|||
162627704|NCT02380677|587352703|FG001|Overall Study|Other|0|||
162627705|NCT02380677|587352704|FG002|Overall Study|Other|0|||
162627706|NCT02380677|587352705|FG003|Overall Study|Other|1|||
162627707|NCT02380677|587352706|FG004|Overall Study|Other|1|||
162627708|NCT02380677|587352707|FG005|Overall Study|Other|1|||
162627709|NCT02380677|587352708|FG006|Overall Study|Other|0|||
162627710|NCT02380677|587352709|FG007|Overall Study|Other|0|||
162627711|NCT02380677|587352710|FG008|Overall Study|Other|0|||
162627712|NCT02380677|587352711|FG009|Overall Study|Other|0|||
162627713|NCT02380677|587352712|FG010|Overall Study|Other|0|||
162627714|NCT02380677|587352713|FG011|Overall Study|Other|0|||
162627715|NCT05035550|587352714|FG000|Overall Study|Withdrawal by Subject|3|||
162627716|NCT05035550|587352715|FG001|Overall Study|Withdrawal by Subject|0|||
162627717|NCT00160693|587352718|FG000|Overall Study|Adverse Event|97|||
162967423|NCT00884390|588581370|FG001|Overall Study|Physician Decision|1|||
162967424|NCT00884390|588581369|FG000|Overall Study|Protocol Violation|4|||
162967425|NCT00884390|588581370|FG001|Overall Study|Protocol Violation|1|||
162967426|NCT00884390|588581369|FG000|Overall Study|Withdrawal by Subject|4|||
162967427|NCT00884390|588581370|FG001|Overall Study|Withdrawal by Subject|1|||
162967428|NCT00884390|588581369|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
162967429|NCT00884390|588581370|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
162967430|NCT00884390|588581369|FG000|Overall Study|Other|11|||
162967431|NCT00884390|588581370|FG001|Overall Study|Other|1|||
162967432|NCT01691612|588581371|FG000|Overall Study|deemed ineligible after 1st visit|6|||
162967433|NCT01691612|588581371|FG000|Overall Study|Adverse Event|1|||
162967434|NCT04049097|588581375|FG000|Overall Study|Adverse Event|18|||
162967435|NCT04049097|588581375|FG000|Overall Study|Death|2|||
162967436|NCT04049097|588581375|FG000|Overall Study|Lost to Follow-up|1|||
162967437|NCT04049097|588581375|FG000|Overall Study|Physician Decision|2|||
162967438|NCT04049097|588581375|FG000|Overall Study|Withdrawal by Subject|9|||
162967439|NCT04049097|588581375|FG000|Overall Study|Protocol Violation|2|||
162967440|NCT04049097|588581375|FG000|Overall Study|Other|1|||
162967441|NCT04049097|588581375|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
162967442|NCT01874535|588581379|FG000|Overall Study|Lost to Follow-up|10|||
162967443|NCT01874535|588581380|FG001|Overall Study|Lost to Follow-up|9|||
162967444|NCT01874535|588581379|FG000|Overall Study|incomplete symptom resolution|45|||
162967445|NCT01874535|588581380|FG001|Overall Study|incomplete symptom resolution|35|||
162967446|NCT02616380|588581382|FG000|Overall Study|Lost to Follow-up|1|||
162967447|NCT02616380|588581382|FG000|Overall Study|Other|2|||
162967448|NCT05065619|588581383|FG000|Up to Day 42|Lost to Follow-up|1|||
162967449|NCT05065619|588581384|FG001|Up to Day 42|Lost to Follow-up|0|||
162967450|NCT05065619|588581383|FG000|Up to Day 42|Withdrawal by Subject|1|||
162627718|NCT00160693|587352718|FG000|Overall Study|Lack of Efficacy|30|||
162627719|NCT00160693|587352718|FG000|Overall Study|Protocol Violation|24|||
162627720|NCT00160693|587352718|FG000|Overall Study|Lost to Follow-up|15|||
162627721|NCT00160693|587352718|FG000|Overall Study|Withdrawal by Subject|54|||
162627722|NCT00160693|587352718|FG000|Overall Study|Study terminated by sponsor|15|||
162627723|NCT00617123|587352719|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
162627724|NCT00617123|587352720|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
162627725|NCT00617123|587352719|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
162627726|NCT00617123|587352720|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
162627727|NCT00617123|587352719|FG000|Referral Screening Period|Adverse Event|0|||
162627728|NCT00617123|587352720|FG001|Referral Screening Period|Adverse Event|1|||
162907590|NCT02584660|588359569|FG000|Overall Study|Protocol Violation|0|||
162907591|NCT02584660|588359570|FG001|Overall Study|Protocol Violation|1|||
162907592|NCT02584660|588359569|FG000|Overall Study|Withdrawal by Subject|0|||
162907593|NCT02584660|588359570|FG001|Overall Study|Withdrawal by Subject|2|||
162907594|NCT02584660|588359569|FG000|Overall Study|Other|0|||
162907595|NCT02584660|588359570|FG001|Overall Study|Other|1|||
162627729|NCT00617123|587352719|FG000|Study Treatment Period|Withdrawal by Subject|8|||
162627730|NCT00617123|587352720|FG001|Study Treatment Period|Withdrawal by Subject|12|||
162627731|NCT00617123|587352719|FG000|Study Treatment Period|Adverse Event|7|||
162627732|NCT00617123|587352720|FG001|Study Treatment Period|Adverse Event|3|||
162627733|NCT00617123|587352719|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
162627734|NCT00617123|587352720|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
162627735|NCT00617123|587352719|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
162627736|NCT00617123|587352720|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
162627737|NCT03052725|587352721|FG000|Overall Study|Adverse Event|2|||
162627738|NCT03052725|587352722|FG001|Overall Study|Adverse Event|0|||
162627739|NCT03052725|587352721|FG000|Overall Study|Withdrawal by Subject|3|||
162627740|NCT03052725|587352722|FG001|Overall Study|Withdrawal by Subject|4|||
162627741|NCT03052725|587352721|FG000|Overall Study|Pregnancy|0|||
162627742|NCT03052725|587352722|FG001|Overall Study|Pregnancy|1|||
162627743|NCT03052725|587352721|FG000|Overall Study|Site closure|0|||
162627744|NCT03052725|587352722|FG001|Overall Study|Site closure|1|||
162627745|NCT03052725|587352721|FG000|Overall Study|Study terminated by sponsor|143|||
162627746|NCT03052725|587352722|FG001|Overall Study|Study terminated by sponsor|144|||
162627747|NCT00777608|587352724|FG000|Overall Study|Lost to Follow-up|1|||
162627748|NCT00777608|587352725|FG001|Overall Study|Lost to Follow-up|1|||
162627749|NCT00777608|587352724|FG000|Overall Study|Withdrawal by Subject|1|||
162627750|NCT00777608|587352725|FG001|Overall Study|Withdrawal by Subject|3|||
162627751|NCT00777608|587352724|FG000|Overall Study|Protocol Violation|1|||
162627752|NCT00777608|587352725|FG001|Overall Study|Protocol Violation|0|||
162627753|NCT00777608|587352724|FG000|Overall Study|Investigator Decision|1|||
162627754|NCT00777608|587352725|FG001|Overall Study|Investigator Decision|2|||
162627755|NCT04213079|587352726|FG000|Overall Study|Lost to Follow-up|0|||
162627756|NCT04213079|587352727|FG001|Overall Study|Lost to Follow-up|2|||
162627757|NCT00520936|587352728|FG000|Overall Study|Physician Decision|0|||
162627758|NCT00520936|587352729|FG001|Overall Study|Physician Decision|2|||
162627759|NCT00520936|587352730|FG002|Overall Study|Physician Decision|1|||
162627760|NCT00520936|587352731|FG003|Overall Study|Physician Decision|0|||
162627761|NCT00520936|587352732|FG004|Overall Study|Physician Decision|0|||
162627762|NCT00520936|587352733|FG005|Overall Study|Physician Decision|0|||
162627763|NCT00520936|587352734|FG006|Overall Study|Physician Decision|0|||
162627764|NCT00520936|587352735|FG007|Overall Study|Physician Decision|0|||
162627765|NCT00520936|587352728|FG000|Overall Study|Withdrawal by Subject|0|||
162627766|NCT00520936|587352729|FG001|Overall Study|Withdrawal by Subject|0|||
162627767|NCT00520936|587352730|FG002|Overall Study|Withdrawal by Subject|0|||
162627768|NCT00520936|587352731|FG003|Overall Study|Withdrawal by Subject|0|||
162627769|NCT00520936|587352732|FG004|Overall Study|Withdrawal by Subject|0|||
162627770|NCT00520936|587352733|FG005|Overall Study|Withdrawal by Subject|0|||
162627771|NCT00520936|587352734|FG006|Overall Study|Withdrawal by Subject|0|||
162627772|NCT00520936|587352735|FG007|Overall Study|Withdrawal by Subject|1|||
162627773|NCT00520936|587352728|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
162627774|NCT00520936|587352729|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
162627775|NCT00520936|587352730|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
162627776|NCT00520936|587352731|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
162627777|NCT00520936|587352732|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
162627778|NCT00520936|587352733|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
162907596|NCT00461552|588359571|FG000|Overall Study|Drug Dispensing error|0|||
162907597|NCT00461552|588359572|FG001|Overall Study|Drug Dispensing error|2|||
162907598|NCT00660816|588359573|FG000|Overall Study|Adverse Event|1|||
162907599|NCT00660816|588359574|FG001|Overall Study|Adverse Event|2|||
162627779|NCT00520936|587352734|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
162627780|NCT00520936|587352735|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
162907600|NCT00660816|588359573|FG000|Overall Study|Withdrawal by Subject|1|||
162907601|NCT00660816|588359574|FG001|Overall Study|Withdrawal by Subject|0|||
162627781|NCT00520936|587352728|FG000|Overall Study|Death|0|||
162627782|NCT00520936|587352729|FG001|Overall Study|Death|0|||
162710380|NCT03568162|587649041|FG001|Overall Study|Protocol Violation|0|||
162907602|NCT00660816|588359573|FG000|Overall Study|Death|0|||
162627783|NCT00520936|587352730|FG002|Overall Study|Death|0|||
162907603|NCT00660816|588359574|FG001|Overall Study|Death|2|||
162907604|NCT00660816|588359573|FG000|Overall Study|Lack of Efficacy|1|||
162907605|NCT00660816|588359574|FG001|Overall Study|Lack of Efficacy|0|||
162907606|NCT00660816|588359573|FG000|Overall Study|Physician Decision|0|||
162907607|NCT00660816|588359574|FG001|Overall Study|Physician Decision|2|||
162907608|NCT00660816|588359573|FG000|Overall Study|Protocol Violation|1|||
162907609|NCT00660816|588359574|FG001|Overall Study|Protocol Violation|0|||
162907610|NCT00660816|588359573|FG000|Overall Study|Disease Progression|16|||
162907611|NCT00660816|588359574|FG001|Overall Study|Disease Progression|12|||
162907612|NCT00660816|588359573|FG000|Overall Study|Complicating Disease|0|||
162907613|NCT00660816|588359574|FG001|Overall Study|Complicating Disease|1|||
162907614|NCT00374452|588359575|FG000|Overall Study|Left clinic before intervention started|4|||
162907615|NCT00374452|588359576|FG001|Overall Study|Left clinic before intervention started|1|||
162907616|NCT00374452|588359575|FG000|Overall Study|Change in job role before intervention|0|||
162907617|NCT00374452|588359576|FG001|Overall Study|Change in job role before intervention|1|||
162907618|NCT00374452|588359575|FG000|Overall Study|Left clinic after intervention started|1|||
162907619|NCT00374452|588359576|FG001|Overall Study|Left clinic after intervention started|1|||
162907620|NCT00374452|588359575|FG000|Overall Study|Withdrawal by Subject|0|||
162907621|NCT00374452|588359576|FG001|Overall Study|Withdrawal by Subject|2|||
162907622|NCT02877134|588359577|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907623|NCT02877134|588359578|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
162907624|NCT02877134|588359579|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907625|NCT02877134|588359580|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907626|NCT02877134|588359581|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907627|NCT02877134|588359582|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
162907628|NCT02877134|588359583|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907629|NCT02877134|588359584|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907630|NCT02877134|588359585|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
162627784|NCT00520936|587352731|FG003|Overall Study|Death|0|||
162627785|NCT00520936|587352732|FG004|Overall Study|Death|0|||
162627786|NCT00520936|587352733|FG005|Overall Study|Death|0|||
162627787|NCT00520936|587352734|FG006|Overall Study|Death|1|||
162627788|NCT00520936|587352735|FG007|Overall Study|Death|0|||
162627789|NCT00520936|587352728|FG000|Overall Study|Protocol Violation|0|||
162627790|NCT00520936|587352729|FG001|Overall Study|Protocol Violation|1|||
162627791|NCT00520936|587352730|FG002|Overall Study|Protocol Violation|1|||
162627792|NCT00520936|587352731|FG003|Overall Study|Protocol Violation|0|||
162627793|NCT00520936|587352732|FG004|Overall Study|Protocol Violation|1|||
162627794|NCT00520936|587352733|FG005|Overall Study|Protocol Violation|0|||
162627795|NCT00520936|587352734|FG006|Overall Study|Protocol Violation|1|||
162627796|NCT00520936|587352735|FG007|Overall Study|Protocol Violation|0|||
162627797|NCT00587054|587352739|FG000|Overall Study|Patient not treated|9|||
162627798|NCT03858309|587352740|FG000|Overall Study|Withdrawal by Subject|2|||
162627799|NCT03858309|587352741|FG001|Overall Study|Withdrawal by Subject|3|||
162627800|NCT01812174|587352742|FG000|Overall Study|Death|1|||
162627801|NCT01812174|587352743|FG001|Overall Study|Death|0|||
162627802|NCT01812174|587352742|FG000|Overall Study|Protocol Violation|2|||
162627803|NCT01812174|587352743|FG001|Overall Study|Protocol Violation|0|||
162627804|NCT01051323|587352746|FG000|Overall Study|Discontinuation of treatment|103|||
162627805|NCT01051323|587352746|FG000|Overall Study|Transplantation|28|||
162627806|NCT01051323|587352746|FG000|Overall Study|Dialysis dependency|22|||
162627807|NCT01051323|587352746|FG000|Overall Study|Withdrawal by Subject|13|||
162907631|NCT02877134|588359586|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907632|NCT02877134|588359587|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907633|NCT02877134|588359588|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
162907634|NCT02877134|588359577|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907635|NCT02877134|588359578|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
162907636|NCT02877134|588359579|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907637|NCT02877134|588359580|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
162907638|NCT02877134|588359581|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907639|NCT02877134|588359582|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907640|NCT02877134|588359583|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
162907641|NCT02877134|588359584|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907642|NCT02877134|588359585|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907643|NCT02877134|588359586|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907644|NCT02877134|588359587|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162627808|NCT01051323|587352746|FG000|Overall Study|Lost to Follow-up|31|||
162627809|NCT01051323|587352746|FG000|Overall Study|Death|129|||
162627810|NCT01051323|587352746|FG000|Overall Study|Hospitalization|28|||
162627811|NCT01051323|587352746|FG000|Overall Study|Other|148|||
162627812|NCT01051323|587352746|FG000|Overall Study|Missing|37|||
162627813|NCT05469178|587352747|FG000|Overall Study|Death|1|||
162627814|NCT05469178|587352748|FG001|Overall Study|Death|1|||
162627815|NCT05469178|587352749|FG002|Overall Study|Death|3|||
162627816|NCT05469178|587352750|FG003|Overall Study|Death|6|||
162710381|NCT03568162|587649042|FG002|Overall Study|Protocol Violation|1|||
162710382|NCT03568162|587649043|FG003|Overall Study|Protocol Violation|1|||
162710383|NCT03568162|587649044|FG004|Overall Study|Protocol Violation|1|||
162710384|NCT03568162|587649045|FG005|Overall Study|Protocol Violation|1|||
162710385|NCT03568162|587649040|FG000|Overall Study|Withdrawal by Subject|15|||
162710386|NCT03568162|587649041|FG001|Overall Study|Withdrawal by Subject|15|||
162710387|NCT03568162|587649042|FG002|Overall Study|Withdrawal by Subject|26|||
162710388|NCT03568162|587649043|FG003|Overall Study|Withdrawal by Subject|22|||
162710389|NCT03568162|587649044|FG004|Overall Study|Withdrawal by Subject|6|||
162710390|NCT03568162|587649045|FG005|Overall Study|Withdrawal by Subject|9|||
162710391|NCT03568162|587649040|FG000|Overall Study|Others|3|||
162710392|NCT03568162|587649041|FG001|Overall Study|Others|4|||
162710393|NCT03568162|587649042|FG002|Overall Study|Others|1|||
162710394|NCT03568162|587649043|FG003|Overall Study|Others|4|||
162710395|NCT03568162|587649044|FG004|Overall Study|Others|2|||
162710396|NCT03568162|587649045|FG005|Overall Study|Others|1|||
162710397|NCT00337818|587649046|FG000|Overall Study|Lost to Follow-up|289|||
162710398|NCT00337818|587649047|FG001|Overall Study|Lost to Follow-up|91|||
162710399|NCT00337818|587649048|FG002|Overall Study|Lost to Follow-up|107|||
162710400|NCT00938340|587649050|FG000|Overall Study|Withdrawal by Subject|3|||
162710401|NCT00938340|587649050|FG000|Overall Study|Protocol Violation|1|||
162710402|NCT00938340|587649050|FG000|Overall Study|Adverse Event|1|||
162710403|NCT05174065|587649052|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
162710404|NCT05174065|587649053|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
162907645|NCT02877134|588359588|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
162907646|NCT02877134|588359577|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
162907647|NCT02877134|588359578|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
162907648|NCT02877134|588359579|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
162907649|NCT02877134|588359580|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
162907650|NCT02877134|588359581|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
162907651|NCT02877134|588359582|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
162907652|NCT02877134|588359583|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
162907653|NCT02877134|588359584|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
162907654|NCT02877134|588359585|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
162907655|NCT02877134|588359586|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
162907656|NCT02877134|588359587|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
162907657|NCT02877134|588359588|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
162907658|NCT02877134|588359577|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
162710405|NCT05174065|587649054|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
162710406|NCT05174065|587649052|FG000|Placebo-controlled Period|Other|0|||
162710407|NCT05174065|587649053|FG001|Placebo-controlled Period|Other|1|||
162710408|NCT05174065|587649054|FG002|Placebo-controlled Period|Other|0|||
162710409|NCT05174065|587649052|FG000|Placebo-controlled Period|Adverse Event|1|||
162710410|NCT05174065|587649053|FG001|Placebo-controlled Period|Adverse Event|1|||
162710411|NCT05174065|587649054|FG002|Placebo-controlled Period|Adverse Event|0|||
162710412|NCT05174065|587649052|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
162710413|NCT05174065|587649053|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
162710414|NCT05174065|587649054|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
162710415|NCT05174065|587649052|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
162710416|NCT05174065|587649053|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
162710417|NCT05174065|587649054|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
162710418|NCT05174065|587649052|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
162907659|NCT02877134|588359578|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
162907660|NCT02877134|588359579|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
162967451|NCT05065619|588581384|FG001|Up to Day 42|Withdrawal by Subject|0|||
162967452|NCT05065619|588581383|FG000|After Day 43|Lost to Follow-up|1|||
162967453|NCT05065619|588581384|FG001|After Day 43|Lost to Follow-up|0|||
162967454|NCT05065619|588581383|FG000|After Day 43|Physician Decision|3|||
162710419|NCT05174065|587649053|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
162967455|NCT05065619|588581384|FG001|After Day 43|Physician Decision|0|||
162967456|NCT05065619|588581383|FG000|After Day 43|Withdrawal by Subject|1|||
162967457|NCT05065619|588581384|FG001|After Day 43|Withdrawal by Subject|2|||
162967458|NCT05065619|588581383|FG000|After Day 43|Public vaccination|6|||
162967459|NCT05065619|588581384|FG001|After Day 43|Public vaccination|8|||
162967460|NCT05065619|588581383|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
162967461|NCT05065619|588581384|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
162967462|NCT05065619|588581383|FG000|After Day 43|Study Terminated by Sponsor|88|||
162967463|NCT05065619|588581384|FG001|After Day 43|Study Terminated by Sponsor|16|||
162710420|NCT05174065|587649054|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
162710421|NCT00924560|587649057|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
162710422|NCT00924560|587649058|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
162710423|NCT00924560|587649059|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
162907661|NCT02877134|588359580|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
162907662|NCT02877134|588359581|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
162907663|NCT02877134|588359582|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
162907664|NCT02877134|588359583|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
162907665|NCT02877134|588359584|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
162627817|NCT05469178|587352747|FG000|Overall Study|Lack of Efficacy|2|||
162627818|NCT05469178|587352748|FG001|Overall Study|Lack of Efficacy|2|||
162627819|NCT05469178|587352749|FG002|Overall Study|Lack of Efficacy|1|||
162627820|NCT05469178|587352750|FG003|Overall Study|Lack of Efficacy|10|||
162627821|NCT00968513|587352751|FG000|Overall Study|Death|4|||
162627822|NCT00968513|587352752|FG001|Overall Study|Death|10|||
162627823|NCT00968513|587352753|FG002|Overall Study|Death|15|||
162907666|NCT02877134|588359585|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
162907667|NCT02877134|588359586|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
162907668|NCT02877134|588359587|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
162907669|NCT02877134|588359588|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
162907670|NCT02877134|588359577|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907671|NCT02877134|588359578|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907672|NCT02877134|588359579|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907673|NCT02877134|588359580|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907674|NCT02877134|588359581|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907675|NCT02877134|588359582|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907676|NCT02877134|588359583|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907677|NCT02877134|588359584|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907678|NCT02877134|588359585|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
162907679|NCT02877134|588359586|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907680|NCT02877134|588359587|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907681|NCT02877134|588359588|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
162907682|NCT02877134|588359577|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907683|NCT02877134|588359578|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907684|NCT02877134|588359579|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907685|NCT02877134|588359580|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907686|NCT02877134|588359581|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907687|NCT02877134|588359582|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907688|NCT02877134|588359583|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
162907689|NCT02877134|588359584|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
162907690|NCT02877134|588359585|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
162907691|NCT02877134|588359586|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
162907692|NCT02877134|588359587|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
162627824|NCT05466682|587352756|FG000|Overall Study|Withdrawal by Subject|0|||
162627825|NCT05466682|587352757|FG001|Overall Study|Withdrawal by Subject|2|||
162627826|NCT05466682|587352756|FG000|Overall Study|Lost to Follow-up|2|||
162627827|NCT05466682|587352757|FG001|Overall Study|Lost to Follow-up|1|||
162627828|NCT02801396|587352758|FG000|Period 1|Withdrawal by Subject|0|||
162627829|NCT02801396|587352759|FG001|Period 1|Withdrawal by Subject|0|||
162627830|NCT02801396|587352760|FG002|Period 1|Withdrawal by Subject|0|||
162627831|NCT02801396|587352761|FG003|Period 1|Withdrawal by Subject|0|||
162627832|NCT02801396|587352762|FG004|Period 1|Withdrawal by Subject|1|||
162627833|NCT02801396|587352763|FG005|Period 1|Withdrawal by Subject|0|||
162627834|NCT03087643|587352770|FG000|Overall Study|Withdrawal by Subject|2|||
162627835|NCT03087643|587352771|FG001|Overall Study|Withdrawal by Subject|4|||
162627836|NCT03087643|587352770|FG000|Overall Study|Death|2|||
162627837|NCT03087643|587352771|FG001|Overall Study|Death|2|||
162627838|NCT02083783|587352772|FG000|Overall Study|Withdrawal by Subject|1|||
162627839|NCT02083783|587352773|FG001|Overall Study|Withdrawal by Subject|0|||
162627840|NCT04528732|587352774|FG000|Overall Study|Death|1|||
162627841|NCT04528732|587352775|FG001|Overall Study|Death|0|||
162907693|NCT02877134|588359588|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
162907694|NCT02877134|588359577|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907695|NCT02877134|588359578|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907696|NCT02877134|588359579|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907697|NCT02877134|588359580|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162967464|NCT01929681|588581385|FG000|Overall Study|Withdrawal by Subject|1|||
162967465|NCT01929681|588581386|FG001|Overall Study|Withdrawal by Subject|0|||
162627842|NCT04528732|587352776|FG002|Overall Study|Death|1|||
162627843|NCT04528732|587352774|FG000|Overall Study|Lost to Follow-up|0|||
162627844|NCT04528732|587352775|FG001|Overall Study|Lost to Follow-up|1|||
162627845|NCT04528732|587352776|FG002|Overall Study|Lost to Follow-up|2|||
162627846|NCT02405780|587352788|FG000|Period I|Adverse Event|8|||
162627847|NCT02405780|587352789|FG001|Period I|Adverse Event|0|||
162710424|NCT00924560|587649057|FG000|Overall Study|Non Compliance with the Protocol|20|||
162627848|NCT02405780|587352790|FG002|Period I|Adverse Event|3|||
162627849|NCT02405780|587352791|FG003|Period I|Adverse Event|7|||
163054314|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
163054315|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
163054316|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
162907698|NCT02877134|588359581|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907699|NCT02877134|588359582|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907700|NCT02877134|588359583|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907701|NCT02877134|588359584|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
162907702|NCT02877134|588359585|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
162907703|NCT02877134|588359586|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
162907704|NCT02877134|588359587|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907705|NCT02877134|588359588|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
162907706|NCT02877134|588359577|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
162907707|NCT02877134|588359578|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
162907708|NCT02877134|588359579|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
162907709|NCT02877134|588359580|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
162907710|NCT02877134|588359581|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
162907711|NCT02877134|588359582|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
162907712|NCT02877134|588359583|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
162907713|NCT02877134|588359584|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
162907714|NCT02877134|588359585|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
162907715|NCT02877134|588359586|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
162907716|NCT02877134|588359587|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
162907717|NCT02877134|588359588|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
162907718|NCT00523744|588359589|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
162907719|NCT00523744|588359589|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
162907720|NCT00523744|588359589|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
162907721|NCT00523744|588359589|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
162907722|NCT00523744|588359589|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
162907723|NCT00523744|588359589|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
162907724|NCT01289028|588359590|FG000|Overall Study|Progressive Disease|49|||
162907725|NCT01289028|588359590|FG000|Overall Study|Adverse Event|14|||
162907726|NCT01289028|588359590|FG000|Overall Study|Withdrawal by Subject|6|||
162907727|NCT01289028|588359590|FG000|Overall Study|Death|4|||
162907728|NCT01289028|588359590|FG000|Overall Study|Lack of Efficacy|2|||
162907729|NCT01289028|588359590|FG000|Overall Study|No longer required|2|||
162907730|NCT01289028|588359590|FG000|Overall Study|Lost to Follow-up|2|||
162907731|NCT01289028|588359590|FG000|Overall Study|New Cancer Therapy|2|||
162907732|NCT01289028|588359590|FG000|Overall Study|Abnormal Lab Value|1|||
162907733|NCT01289028|588359590|FG000|Overall Study|Missing reason for discon|1|||
162907734|NCT00998985|588359597|FG000|Overall Study|Withdrawal by Subject|0|||
162907735|NCT00998985|588359598|FG001|Overall Study|Withdrawal by Subject|0|||
162907736|NCT00998985|588359599|FG002|Overall Study|Withdrawal by Subject|0|||
162907737|NCT00998985|588359600|FG003|Overall Study|Withdrawal by Subject|0|||
162907738|NCT00998985|588359601|FG004|Overall Study|Withdrawal by Subject|0|||
162907739|NCT00998985|588359602|FG005|Overall Study|Withdrawal by Subject|0|||
162907740|NCT00998985|588359603|FG006|Overall Study|Withdrawal by Subject|0|||
162907741|NCT00998985|588359604|FG007|Overall Study|Withdrawal by Subject|0|||
162907742|NCT00998985|588359605|FG008|Overall Study|Withdrawal by Subject|1|||
162907743|NCT00998985|588359606|FG009|Overall Study|Withdrawal by Subject|0|||
163054317|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
162627850|NCT02405780|587352788|FG000|Period I|Medical reasons|1|||
162627851|NCT02405780|587352789|FG001|Period I|Medical reasons|1|||
162627852|NCT02405780|587352790|FG002|Period I|Medical reasons|0|||
162627853|NCT02405780|587352791|FG003|Period I|Medical reasons|1|||
162627854|NCT02405780|587352788|FG000|Period I|Screening Failure|1|||
162627855|NCT02405780|587352789|FG001|Period I|Screening Failure|0|||
162627856|NCT02405780|587352790|FG002|Period I|Screening Failure|1|||
162710425|NCT00924560|587649058|FG001|Overall Study|Non Compliance with the Protocol|15|||
162710426|NCT00924560|587649059|FG002|Overall Study|Non Compliance with the Protocol|4|||
162710427|NCT00924560|587649057|FG000|Overall Study|Physician Decision|2|||
162710428|NCT00924560|587649058|FG001|Overall Study|Physician Decision|3|||
162710429|NCT00924560|587649059|FG002|Overall Study|Physician Decision|4|||
162710430|NCT00924560|587649057|FG000|Overall Study|Withdrawal by Subject|50|||
162710431|NCT00924560|587649058|FG001|Overall Study|Withdrawal by Subject|44|||
162710432|NCT00924560|587649059|FG002|Overall Study|Withdrawal by Subject|18|||
162710433|NCT00924560|587649057|FG000|Overall Study|Adverse Event|39|||
162907744|NCT00998985|588359607|FG010|Overall Study|Withdrawal by Subject|0|||
162907745|NCT00998985|588359608|FG011|Overall Study|Withdrawal by Subject|0|||
162907746|NCT00998985|588359609|FG012|Overall Study|Withdrawal by Subject|0|||
162907747|NCT00998985|588359610|FG013|Overall Study|Withdrawal by Subject|0|||
162907748|NCT00998985|588359597|FG000|Overall Study|Protocol Violation|0|||
162907749|NCT00998985|588359598|FG001|Overall Study|Protocol Violation|0|||
162907750|NCT00998985|588359599|FG002|Overall Study|Protocol Violation|0|||
162907751|NCT00998985|588359600|FG003|Overall Study|Protocol Violation|0|||
162907752|NCT00998985|588359601|FG004|Overall Study|Protocol Violation|0|||
162907753|NCT00998985|588359602|FG005|Overall Study|Protocol Violation|1|||
162907754|NCT00998985|588359603|FG006|Overall Study|Protocol Violation|0|||
162907755|NCT00998985|588359604|FG007|Overall Study|Protocol Violation|0|||
162627857|NCT02405780|587352791|FG003|Period I|Screening Failure|0|||
162627858|NCT02405780|587352788|FG000|Period I|Withdrawal by Subject|9|||
162627859|NCT02405780|587352789|FG001|Period I|Withdrawal by Subject|1|||
162627860|NCT02405780|587352790|FG002|Period I|Withdrawal by Subject|3|||
162627861|NCT02405780|587352791|FG003|Period I|Withdrawal by Subject|4|||
162627862|NCT02405780|587352788|FG000|Period I|Non-compliance with study procedures|8|||
162627863|NCT02405780|587352789|FG001|Period I|Non-compliance with study procedures|6|||
162710434|NCT00924560|587649058|FG001|Overall Study|Adverse Event|33|||
162907756|NCT00998985|588359605|FG008|Overall Study|Protocol Violation|0|||
162907757|NCT00998985|588359606|FG009|Overall Study|Protocol Violation|0|||
162907758|NCT00998985|588359607|FG010|Overall Study|Protocol Violation|0|||
162907759|NCT00998985|588359608|FG011|Overall Study|Protocol Violation|0|||
162907760|NCT00998985|588359609|FG012|Overall Study|Protocol Violation|0|||
162907761|NCT00998985|588359610|FG013|Overall Study|Protocol Violation|0|||
162907762|NCT01040728|588359612|FG000|Overall Study|Adverse Event|4|||
162907763|NCT01040728|588359613|FG001|Overall Study|Adverse Event|8|||
162907764|NCT01040728|588359614|FG002|Overall Study|Adverse Event|0|||
162907765|NCT01040728|588359615|FG003|Overall Study|Adverse Event|4|||
162907766|NCT01040728|588359612|FG000|Overall Study|Withdrawal by Subject|0|||
162907767|NCT01040728|588359613|FG001|Overall Study|Withdrawal by Subject|1|||
162907768|NCT01040728|588359614|FG002|Overall Study|Withdrawal by Subject|1|||
162907769|NCT01040728|588359615|FG003|Overall Study|Withdrawal by Subject|0|||
162907770|NCT01040728|588359612|FG000|Overall Study|Protocol Violation|0|||
162907771|NCT01040728|588359613|FG001|Overall Study|Protocol Violation|0|||
162907772|NCT01040728|588359614|FG002|Overall Study|Protocol Violation|0|||
162907773|NCT01040728|588359615|FG003|Overall Study|Protocol Violation|1|||
162907774|NCT01040728|588359612|FG000|Overall Study|Lack of Efficacy|0|||
162907775|NCT01040728|588359613|FG001|Overall Study|Lack of Efficacy|1|||
162967466|NCT01929681|588581385|FG000|Overall Study|Physician Decision|1|||
162967467|NCT01929681|588581386|FG001|Overall Study|Physician Decision|1|||
162967468|NCT05315713|588581387|FG000|Overall Study|Death|5|||
162967469|NCT05315713|588581387|FG000|Overall Study|Progressive disease|1|||
162967470|NCT05315713|588581387|FG000|Overall Study|Withdrawal by Subject|1|||
162967471|NCT05315713|588581387|FG000|Overall Study|Study terminated by sponsor|1|||
162967472|NCT00421304|588581388|FG000|Overall Study|Lost to Follow-up|5|||
162967473|NCT00421304|588581389|FG001|Overall Study|Lost to Follow-up|2|||
162967474|NCT00421304|588581390|FG002|Overall Study|Lost to Follow-up|5|||
162967475|NCT00421304|588581388|FG000|Overall Study|Withdrawal by Subject|2|||
162967476|NCT00421304|588581389|FG001|Overall Study|Withdrawal by Subject|2|||
162967477|NCT00421304|588581390|FG002|Overall Study|Withdrawal by Subject|2|||
162967478|NCT00421304|588581388|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
162967479|NCT00421304|588581389|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
162967480|NCT00421304|588581390|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
162967481|NCT00421304|588581388|FG000|Overall Study|Did not attend Day 360 visit|0|||
162967482|NCT00421304|588581389|FG001|Overall Study|Did not attend Day 360 visit|0|||
162627864|NCT02405780|587352790|FG002|Period I|Non-compliance with study procedures|8|||
162627865|NCT02405780|587352791|FG003|Period I|Non-compliance with study procedures|11|||
162627866|NCT02405780|587352788|FG000|Period II|Adverse Event|3|||
162710435|NCT00924560|587649059|FG002|Overall Study|Adverse Event|0|||
162710436|NCT00924560|587649057|FG000|Overall Study|Pregnancy|5|||
162967483|NCT00421304|588581390|FG002|Overall Study|Did not attend Day 360 visit|1|||
162967484|NCT00903877|588581391|FG000|Overall Study|Did not meet study criteria|33|||
162967485|NCT00903877|588581391|FG000|Overall Study|Withdrawal by Subject|3|||
162967486|NCT00903877|588581391|FG000|Overall Study|Adverse Event|2|||
162967487|NCT00903877|588581391|FG000|Overall Study|Lost to Follow-up|1|||
162967488|NCT00903877|588581391|FG000|Overall Study|Participation put on hold|4|||
162967489|NCT00919711|588581392|FG000|Overall Study|Withdrawal by Subject|15|||
162967490|NCT00919711|588581393|FG001|Overall Study|Withdrawal by Subject|7|||
162967491|NCT00919711|588581392|FG000|Overall Study|Adverse Event|13|||
162967492|NCT00919711|588581393|FG001|Overall Study|Adverse Event|3|||
162967493|NCT00919711|588581392|FG000|Overall Study|Other|1|||
162967494|NCT00919711|588581393|FG001|Overall Study|Other|2|||
162967495|NCT00919711|588581392|FG000|Overall Study|Administrative Decision|0|||
162967496|NCT00919711|588581393|FG001|Overall Study|Administrative Decision|1|||
162967497|NCT00919711|588581392|FG000|Overall Study|Lost to Follow-up|2|||
162967498|NCT00919711|588581393|FG001|Overall Study|Lost to Follow-up|0|||
162967499|NCT00919711|588581392|FG000|Overall Study|Death|1|||
162967500|NCT00919711|588581393|FG001|Overall Study|Death|0|||
162967501|NCT00919711|588581392|FG000|Overall Study|Noncompliance|1|||
162967502|NCT00919711|588581393|FG001|Overall Study|Noncompliance|0|||
162627867|NCT02405780|587352789|FG001|Period II|Adverse Event|5|||
162627868|NCT02405780|587352790|FG002|Period II|Adverse Event|4|||
162627869|NCT02405780|587352791|FG003|Period II|Adverse Event|11|||
162627870|NCT02405780|587352788|FG000|Period II|Medical reason|0|||
162627871|NCT02405780|587352789|FG001|Period II|Medical reason|1|||
162627872|NCT02405780|587352790|FG002|Period II|Medical reason|0|||
162627873|NCT02405780|587352791|FG003|Period II|Medical reason|0|||
162627874|NCT02405780|587352788|FG000|Period II|Pregnancy|0|||
162627875|NCT02405780|587352789|FG001|Period II|Pregnancy|0|||
162627876|NCT02405780|587352790|FG002|Period II|Pregnancy|1|||
162627877|NCT02405780|587352791|FG003|Period II|Pregnancy|0|||
162627878|NCT02405780|587352788|FG000|Period II|Withdrawal by Subject|7|||
162627879|NCT02405780|587352789|FG001|Period II|Withdrawal by Subject|4|||
162627880|NCT02405780|587352790|FG002|Period II|Withdrawal by Subject|0|||
162627881|NCT02405780|587352791|FG003|Period II|Withdrawal by Subject|3|||
162627882|NCT02405780|587352788|FG000|Period II|Non-compliance with study procedures|5|||
162627883|NCT02405780|587352789|FG001|Period II|Non-compliance with study procedures|2|||
162627884|NCT02405780|587352790|FG002|Period II|Non-compliance with study procedures|7|||
162627885|NCT02405780|587352791|FG003|Period II|Non-compliance with study procedures|4|||
162627886|NCT01654536|587352792|FG000|Overall Study|Lost to Follow-up|5|||
162627887|NCT01654536|587352793|FG001|Overall Study|Lost to Follow-up|5|||
162627888|NCT01654536|587352792|FG000|Overall Study|Physician Decision|12|||
162627889|NCT01654536|587352793|FG001|Overall Study|Physician Decision|8|||
162627890|NCT01654536|587352792|FG000|Overall Study|Withdrawal by Subject|27|||
162627891|NCT01654536|587352793|FG001|Overall Study|Withdrawal by Subject|25|||
162627892|NCT00668707|587352794|FG000|Overall Study|Cancer Recurrence|58|||
162627893|NCT00668707|587352795|FG001|Overall Study|Cancer Recurrence|58|||
162627894|NCT00668707|587352794|FG000|Overall Study|Withdrawal by Subject|117|||
162627895|NCT00668707|587352795|FG001|Overall Study|Withdrawal by Subject|100|||
162627896|NCT00668707|587352794|FG000|Overall Study|Lost to Follow-up|3|||
162627897|NCT00668707|587352795|FG001|Overall Study|Lost to Follow-up|6|||
162627898|NCT00668707|587352794|FG000|Overall Study|Protocol Violation|10|||
162627899|NCT00668707|587352795|FG001|Overall Study|Protocol Violation|12|||
162627900|NCT00668707|587352794|FG000|Overall Study|Death|11|||
162627901|NCT00668707|587352795|FG001|Overall Study|Death|4|||
162627902|NCT03846804|587352800|FG000|Overall Study|Refused blood draw|1|||
162627903|NCT03846804|587352800|FG000|Overall Study|Protocol Violation|1|||
162710437|NCT00924560|587649058|FG001|Overall Study|Pregnancy|7|||
162627904|NCT04698187|587352803|FG000|Overall Study|Withdrawal by Subject|7|||
162627905|NCT04698187|587352803|FG000|Overall Study|Death|21|||
162627906|NCT04698187|587352803|FG000|Overall Study|Sponsor Decision|15|||
162627907|NCT04698187|587352803|FG000|Overall Study|In-transit Disease|1|||
162627908|NCT02993146|587352804|FG000|Overall Study|Withdrawal by Subject|0|||
162627909|NCT02993146|587352805|FG001|Overall Study|Withdrawal by Subject|0|||
162627910|NCT02993146|587352806|FG002|Overall Study|Withdrawal by Subject|1|||
162710438|NCT00924560|587649059|FG002|Overall Study|Pregnancy|1|||
162967503|NCT03694197|588581394|FG000|Overall Study|Adverse Event|9|||
162967504|NCT03694197|588581394|FG000|Overall Study|Protocol became inconvenient to participate|1|||
162967505|NCT03694197|588581394|FG000|Overall Study|Physician Decision|4|||
162967506|NCT03694197|588581394|FG000|Overall Study|Study terminated by sponsor|1350|||
162967507|NCT03694197|588581394|FG000|Overall Study|Participant moved|5|||
162967508|NCT03694197|588581394|FG000|Overall Study|Participant withdrew consent|10|||
162627911|NCT02993146|587352807|FG003|Overall Study|Withdrawal by Subject|1|||
162627912|NCT04362072|587352808|FG000|Treatment|Adverse Event|1|||
162627913|NCT04362072|587352808|FG000|Treatment|Death|9|||
162627914|NCT04362072|587352808|FG000|Treatment|Physician Decision|2|||
162627915|NCT04362072|587352808|FG000|Treatment|Progressive disease|27|||
162627916|NCT04362072|587352808|FG000|Treatment|Withdrawal by Subject|4|||
162627917|NCT04362072|587352808|FG000|Treatment|Global deterioration of health status|1|||
162627918|NCT04362072|587352808|FG000|Treatment|Switched to commercial Lorlatinib|13|||
162627919|NCT04362072|587352808|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
162627920|NCT04362072|587352808|FG000|Treatment|Other|3|||
162627921|NCT04362072|587352808|FG000|Follow up|Death|2|||
162627922|NCT04362072|587352808|FG000|Follow up|Other|2|||
162627923|NCT04524689|587352809|FG000|Overall Study|Withdrawal by Subject|1|||
162627924|NCT04524689|587352810|FG001|Overall Study|Withdrawal by Subject|1|||
162627925|NCT04524689|587352811|FG002|Overall Study|Withdrawal by Subject|0|||
162627926|NCT04524689|587352812|FG003|Overall Study|Withdrawal by Subject|0|||
162627927|NCT04524689|587352813|FG004|Overall Study|Withdrawal by Subject|2|||
162627928|NCT04524689|587352814|FG005|Overall Study|Withdrawal by Subject|0|||
162627929|NCT04524689|587352809|FG000|Overall Study|Study terminated by Sponsor|6|||
162627930|NCT04524689|587352810|FG001|Overall Study|Study terminated by Sponsor|0|||
162627931|NCT04524689|587352811|FG002|Overall Study|Study terminated by Sponsor|1|||
162627932|NCT04524689|587352812|FG003|Overall Study|Study terminated by Sponsor|0|||
162627933|NCT04524689|587352813|FG004|Overall Study|Study terminated by Sponsor|4|||
163054318|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
163054319|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
163054320|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
163054321|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
163054322|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
163054323|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
163054324|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
163054325|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
163054326|NCT03530293|588910231|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
163054327|NCT03530293|588910232|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
163054328|NCT03530293|588910233|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
163054329|NCT03482024|588910235|FG000|Overall Study|Physician Decision|1|||
163054330|NCT03482024|588910236|FG001|Overall Study|Physician Decision|0|||
163054331|NCT03482024|588910237|FG002|Overall Study|Physician Decision|0|||
163054332|NCT03482024|588910238|FG003|Overall Study|Physician Decision|0|||
163054333|NCT03482024|588910239|FG004|Overall Study|Physician Decision|0|||
163054334|NCT00630916|588910240|FG000|Overall Study|Death|110|||
162627934|NCT04524689|587352814|FG005|Overall Study|Study terminated by Sponsor|0|||
162627935|NCT04524689|587352809|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
162627936|NCT04524689|587352810|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
162627937|NCT04524689|587352811|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
162627938|NCT04524689|587352812|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
162627939|NCT04524689|587352813|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
162627940|NCT04524689|587352814|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
162627941|NCT01133522|587352815|FG000|Overall Study|Withdrawal by Subject|0|||
162627942|NCT01133522|587352816|FG001|Overall Study|Withdrawal by Subject|1|||
162627943|NCT01133522|587352817|FG002|Overall Study|Withdrawal by Subject|0|||
162627944|NCT01133522|587352818|FG003|Overall Study|Withdrawal by Subject|1|||
162627945|NCT01133522|587352819|FG004|Overall Study|Withdrawal by Subject|0|||
162627946|NCT01133522|587352820|FG005|Overall Study|Withdrawal by Subject|0|||
162627947|NCT01133522|587352821|FG006|Overall Study|Withdrawal by Subject|0|||
162627948|NCT01133522|587352822|FG007|Overall Study|Withdrawal by Subject|0|||
162627949|NCT01133522|587352823|FG008|Overall Study|Withdrawal by Subject|0|||
162627950|NCT01133522|587352824|FG009|Overall Study|Withdrawal by Subject|0|||
162627951|NCT01133522|587352815|FG000|Overall Study|Physician Decision|0|||
162627952|NCT01133522|587352816|FG001|Overall Study|Physician Decision|0|||
162627953|NCT01133522|587352817|FG002|Overall Study|Physician Decision|0|||
162627954|NCT01133522|587352818|FG003|Overall Study|Physician Decision|0|||
162627955|NCT01133522|587352819|FG004|Overall Study|Physician Decision|1|||
162627956|NCT01133522|587352820|FG005|Overall Study|Physician Decision|0|||
162627957|NCT01133522|587352821|FG006|Overall Study|Physician Decision|0|||
162627958|NCT01133522|587352822|FG007|Overall Study|Physician Decision|0|||
162627959|NCT01133522|587352823|FG008|Overall Study|Physician Decision|0|||
162907776|NCT01040728|588359614|FG002|Overall Study|Lack of Efficacy|0|||
162907777|NCT01040728|588359615|FG003|Overall Study|Lack of Efficacy|1|||
162907778|NCT01040728|588359612|FG000|Overall Study|Other reasons not listed above|0|||
162907779|NCT01040728|588359613|FG001|Overall Study|Other reasons not listed above|1|||
162907780|NCT01040728|588359614|FG002|Overall Study|Other reasons not listed above|0|||
162627960|NCT01133522|587352824|FG009|Overall Study|Physician Decision|0|||
162627961|NCT01664533|587354706|FG000|Overall Study|Death|42|||
162627962|NCT01664533|587354706|FG000|Overall Study|Lost to Follow-up|3|||
162627963|NCT01664533|587354706|FG000|Overall Study|Study termination|9|||
162627964|NCT01664533|587354706|FG000|Overall Study|Protocol Violation|3|||
162907781|NCT01040728|588359615|FG003|Overall Study|Other reasons not listed above|0|||
162907782|NCT00542425|588359622|FG000|Initial 24 Weeks|Administrative reasons|0|||
163054335|NCT00630916|588910240|FG000|Overall Study|Explant|8|||
163054336|NCT00630916|588910240|FG000|Overall Study|Lost to Follow-up|5|||
163054337|NCT00630916|588910240|FG000|Overall Study|Withdrawal by Subject|30|||
163054338|NCT00630916|588910240|FG000|Overall Study|Protocol Violation|7|||
162627965|NCT00844831|587354708|FG000|Overall Study|Withdrawal by Subject|4|||
162627966|NCT00844831|587354708|FG000|Overall Study|Adverse Event|1|||
162627967|NCT00844831|587354708|FG000|Overall Study|Physician Decision|1|||
162627968|NCT05255068|587354709|FG000|Overall Study|Lost to Follow-up|0|||
162627969|NCT05255068|587354710|FG001|Overall Study|Lost to Follow-up|1|||
162627970|NCT03156543|587354712|FG000|Overall Study|Withdrawal by Subject|1|||
162627971|NCT03156543|587354713|FG001|Overall Study|Withdrawal by Subject|0|||
162627972|NCT02397278|587354714|FG000|Overall Study|Withdrawal by Subject|0|||
162627973|NCT02397278|587354715|FG001|Overall Study|Withdrawal by Subject|2|||
162627974|NCT02397278|587354714|FG000|Overall Study|Deemed ineligible following surgery|1|||
162627975|NCT02397278|587354715|FG001|Overall Study|Deemed ineligible following surgery|1|||
162627976|NCT02601469|587354717|FG000|Overall Study|Enrolled in Error|1|||
162627977|NCT02601469|587354718|FG001|Overall Study|Enrolled in Error|0|||
162627978|NCT00056316|587354719|FG000|Overall Study|Withdrawal by Subject|2|||
162907783|NCT00542425|588359623|FG001|Initial 24 Weeks|Administrative reasons|0|||
162907784|NCT00542425|588359624|FG002|Initial 24 Weeks|Administrative reasons|1|||
162907785|NCT00542425|588359625|FG003|Initial 24 Weeks|Administrative reasons|1|||
162907786|NCT00542425|588359626|FG004|Initial 24 Weeks|Administrative reasons|0|||
162907787|NCT00542425|588359622|FG000|Initial 24 Weeks|Adverse Event|0|||
162907788|NCT00542425|588359623|FG001|Initial 24 Weeks|Adverse Event|1|||
162907789|NCT00542425|588359624|FG002|Initial 24 Weeks|Adverse Event|1|||
162907790|NCT00542425|588359625|FG003|Initial 24 Weeks|Adverse Event|3|||
162907791|NCT00542425|588359626|FG004|Initial 24 Weeks|Adverse Event|2|||
162907792|NCT00542425|588359622|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
162907793|NCT00542425|588359623|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
162907794|NCT00542425|588359624|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
162907795|NCT00542425|588359625|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
163054339|NCT00630916|588910240|FG000|Overall Study|Physician Decision|47|||
162627979|NCT00056316|587354720|FG001|Overall Study|Withdrawal by Subject|2|||
162627980|NCT00056316|587354719|FG000|Overall Study|Death/NH placement of pt|1|||
162627981|NCT00056316|587354720|FG001|Overall Study|Death/NH placement of pt|1|||
162627982|NCT01315678|587354725|FG000|Overall Study|Withdrawal by Subject|7|||
162627983|NCT01315678|587354726|FG001|Overall Study|Withdrawal by Subject|3|||
162627984|NCT01315678|587354725|FG000|Overall Study|Adverse Event|3|||
162627985|NCT01315678|587354726|FG001|Overall Study|Adverse Event|1|||
162627986|NCT01315678|587354725|FG000|Overall Study|Lost to Follow-up|1|||
162627987|NCT01315678|587354726|FG001|Overall Study|Lost to Follow-up|0|||
162627988|NCT01315678|587354725|FG000|Overall Study|similar reason to those listed above|3|||
162627989|NCT01315678|587354726|FG001|Overall Study|similar reason to those listed above|2|||
162627990|NCT00790023|587354730|FG000|Overall Study|Adverse Event|2|||
162627991|NCT00790023|587354731|FG001|Overall Study|Adverse Event|1|||
162627992|NCT00790023|587354732|FG002|Overall Study|Adverse Event|4|||
162627993|NCT00790023|587354730|FG000|Overall Study|Protocol Violation|2|||
162627994|NCT00790023|587354731|FG001|Overall Study|Protocol Violation|4|||
162627995|NCT00790023|587354732|FG002|Overall Study|Protocol Violation|2|||
162627996|NCT00790023|587354730|FG000|Overall Study|Withdrawal by Subject|2|||
162627997|NCT00790023|587354731|FG001|Overall Study|Withdrawal by Subject|0|||
162627998|NCT00790023|587354732|FG002|Overall Study|Withdrawal by Subject|6|||
162627999|NCT00790023|587354730|FG000|Overall Study|Lost to Follow-up|0|||
162628000|NCT00790023|587354731|FG001|Overall Study|Lost to Follow-up|0|||
162628001|NCT00790023|587354732|FG002|Overall Study|Lost to Follow-up|1|||
162628002|NCT00790023|587354730|FG000|Overall Study|Other|5|||
162628003|NCT00790023|587354731|FG001|Overall Study|Other|5|||
162628004|NCT00790023|587354732|FG002|Overall Study|Other|8|||
162628005|NCT00573469|587354733|FG000|Overall Study|Adverse Event|1|||
162628006|NCT00573469|587354734|FG001|Overall Study|Adverse Event|1|||
162628007|NCT00573469|587354735|FG002|Overall Study|Adverse Event|1|||
162907796|NCT00542425|588359626|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
162710439|NCT00924560|587649057|FG000|Overall Study|Lost to Follow-up|78|||
162907797|NCT00542425|588359622|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
162907798|NCT00542425|588359623|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
162907799|NCT00542425|588359624|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
162907800|NCT00542425|588359625|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
162907801|NCT00542425|588359626|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
162907802|NCT00542425|588359622|FG000|Initial 24 Weeks|Non-compliance|0|||
162907803|NCT00542425|588359623|FG001|Initial 24 Weeks|Non-compliance|0|||
162907804|NCT00542425|588359624|FG002|Initial 24 Weeks|Non-compliance|0|||
162907805|NCT00542425|588359625|FG003|Initial 24 Weeks|Non-compliance|1|||
162907806|NCT00542425|588359626|FG004|Initial 24 Weeks|Non-compliance|1|||
162907807|NCT00542425|588359622|FG000|Initial 24 Weeks|Protocol Violation|0|||
162907808|NCT00542425|588359623|FG001|Initial 24 Weeks|Protocol Violation|0|||
162907809|NCT00542425|588359624|FG002|Initial 24 Weeks|Protocol Violation|0|||
162907810|NCT00542425|588359625|FG003|Initial 24 Weeks|Protocol Violation|1|||
162907811|NCT00542425|588359626|FG004|Initial 24 Weeks|Protocol Violation|0|||
162907812|NCT00542425|588359622|FG000|Initial 24 Weeks|Refusal of treatment|2|||
162967509|NCT03694197|588581394|FG000|Overall Study|Related to IMP administration|1|||
162967510|NCT03694197|588581394|FG000|Overall Study|Not disclosed|5|||
162967511|NCT01188226|588582914|FG000|Overall Study|Withdrawal by Subject|4|||
162967512|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
162967513|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
162967514|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
162967515|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
162967516|NCT04980456|588582915|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
162967517|NCT04980456|588582916|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
162967518|NCT04980456|588582915|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
162967519|NCT04980456|588582916|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
162967520|NCT01350934|588582945|FG000|Base Study|Adverse Event|6|||
162967521|NCT01350934|588582946|FG001|Base Study|Adverse Event|0|||
162967522|NCT01350934|588582945|FG000|Base Study|Lost to Follow-up|1|||
162967523|NCT01350934|588582946|FG001|Base Study|Lost to Follow-up|0|||
162967524|NCT01350934|588582945|FG000|Base Study|Protocol Violation|1|||
162967525|NCT01350934|588582946|FG001|Base Study|Protocol Violation|1|||
162967526|NCT01350934|588582945|FG000|Base Study|Withdrawal by Subject|1|||
162907813|NCT00542425|588359623|FG001|Initial 24 Weeks|Refusal of treatment|2|||
162907814|NCT00542425|588359624|FG002|Initial 24 Weeks|Refusal of treatment|1|||
162907815|NCT00542425|588359625|FG003|Initial 24 Weeks|Refusal of treatment|4|||
162907816|NCT00542425|588359626|FG004|Initial 24 Weeks|Refusal of treatment|1|||
162907817|NCT00542425|588359622|FG000|Initial 24 Weeks|Other|0|||
162907818|NCT00542425|588359623|FG001|Initial 24 Weeks|Other|2|||
162907819|NCT00542425|588359624|FG002|Initial 24 Weeks|Other|1|||
162907820|NCT00542425|588359625|FG003|Initial 24 Weeks|Other|0|||
162907821|NCT00542425|588359626|FG004|Initial 24 Weeks|Other|0|||
162907822|NCT00542425|588359622|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
162907823|NCT00542425|588359623|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
162907824|NCT00542425|588359624|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
162907825|NCT00542425|588359625|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
162907826|NCT00542425|588359626|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
162907827|NCT00542425|588359622|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
162907828|NCT00542425|588359623|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
162907829|NCT00542425|588359624|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
162907830|NCT00542425|588359625|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
162907831|NCT00542425|588359626|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
162907832|NCT00542425|588359622|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
162907833|NCT00542425|588359623|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
162907834|NCT00542425|588359624|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
162907835|NCT00542425|588359625|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
162907836|NCT00542425|588359626|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
162907837|NCT00542425|588359622|FG000|Extended 24 Weeks of Treatment|Other|1|||
162907838|NCT00542425|588359623|FG001|Extended 24 Weeks of Treatment|Other|1|||
162907839|NCT00542425|588359624|FG002|Extended 24 Weeks of Treatment|Other|0|||
162907840|NCT00542425|588359625|FG003|Extended 24 Weeks of Treatment|Other|0|||
162907841|NCT00542425|588359626|FG004|Extended 24 Weeks of Treatment|Other|1|||
162907842|NCT01424306|588359627|FG000|Overall Study|Protocol Violation|0|||
162907843|NCT01424306|588359628|FG001|Overall Study|Protocol Violation|0|||
162907844|NCT01424306|588359629|FG002|Overall Study|Protocol Violation|0|||
162907845|NCT01424306|588359630|FG003|Overall Study|Protocol Violation|0|||
162907846|NCT01424306|588359631|FG004|Overall Study|Protocol Violation|1|||
162907847|NCT01424306|588359632|FG005|Overall Study|Protocol Violation|0|||
162907848|NCT01601873|588359635|FG000|Overall Study|Lost to Follow-up|2|||
162907849|NCT01601873|588359636|FG001|Overall Study|Lost to Follow-up|3|||
162907850|NCT02096471|588359637|FG000|Overall Study|Adverse Event|1|||
162907851|NCT02096471|588359637|FG000|Overall Study|Lack of Efficacy|7|||
162967527|NCT01350934|588582946|FG001|Base Study|Withdrawal by Subject|2|||
162967528|NCT01350934|588582945|FG000|Base Study|Non-Compliance With Study Drug|2|||
162967529|NCT01350934|588582946|FG001|Base Study|Non-Compliance With Study Drug|0|||
162628008|NCT00573469|587354733|FG000|Overall Study|Withdrawal by Subject|0|||
162628009|NCT00573469|587354734|FG001|Overall Study|Withdrawal by Subject|2|||
162628010|NCT00573469|587354735|FG002|Overall Study|Withdrawal by Subject|0|||
162628011|NCT00573469|587354733|FG000|Overall Study|Other|5|||
162628012|NCT00573469|587354734|FG001|Overall Study|Other|1|||
162628013|NCT00573469|587354735|FG002|Overall Study|Other|3|||
162628014|NCT02468414|587354736|FG000|Overall Study|Early Study Termination by Sponsor|1|||
162628015|NCT02468414|587354737|FG001|Overall Study|Early Study Termination by Sponsor|0|||
162628016|NCT02468414|587354736|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
162628017|NCT02468414|587354737|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
162628018|NCT02468414|587354736|FG000|Overall Study|Screen Failure|1|||
162628019|NCT02468414|587354737|FG001|Overall Study|Screen Failure|0|||
162628020|NCT01338792|587354738|FG000|Overall Study|Adverse Event|2|||
162628021|NCT01338792|587354738|FG000|Overall Study|Death|1|||
162628022|NCT01338792|587354738|FG000|Overall Study|Withdrawal by Subject|1|||
162628023|NCT00004978|587354739|FG000|Overall Study|Death|107|||
162628024|NCT00004978|587354740|FG001|Overall Study|Death|116|||
162628025|NCT00004978|587354739|FG000|Overall Study|Lost to Follow-up|101|||
162628026|NCT00004978|587354740|FG001|Overall Study|Lost to Follow-up|108|||
162628027|NCT00004978|587354739|FG000|Overall Study|Withdrawal by Subject|17|||
162628028|NCT00004978|587354740|FG001|Overall Study|Withdrawal by Subject|26|||
162628029|NCT00004978|587354739|FG000|Overall Study|site closure - not in analysis cohort|19|||
162628030|NCT00004978|587354740|FG001|Overall Study|site closure - not in analysis cohort|20|||
162628031|NCT00062374|587354745|FG000|Overall Study|Not treated|12|||
162628032|NCT02155608|587354748|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
162628033|NCT02155608|587354749|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
162628034|NCT02155608|587354748|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
162628035|NCT02155608|587354749|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
162628036|NCT01532414|587354750|FG000|Overall Study|Lost to Follow-up|3|||
162628037|NCT01532414|587354751|FG001|Overall Study|Lost to Follow-up|0|||
162628038|NCT01532414|587354752|FG002|Overall Study|Lost to Follow-up|1|||
162628039|NCT01532414|587354750|FG000|Overall Study|Withdrawal by Subject|3|||
162628040|NCT01532414|587354751|FG001|Overall Study|Withdrawal by Subject|0|||
162628041|NCT01532414|587354752|FG002|Overall Study|Withdrawal by Subject|0|||
162628042|NCT01532414|587354750|FG000|Overall Study|No V6 semen sample|0|||
162628043|NCT01532414|587354751|FG001|Overall Study|No V6 semen sample|1|||
162628044|NCT01532414|587354752|FG002|Overall Study|No V6 semen sample|0|||
162628045|NCT01532414|587354750|FG000|Overall Study|Adverse Event|0|||
162628046|NCT01532414|587354751|FG001|Overall Study|Adverse Event|1|||
162628047|NCT01532414|587354752|FG002|Overall Study|Adverse Event|1|||
162628048|NCT01532414|587354750|FG000|Overall Study|Unable to complete 24 hour PK|0|||
162628049|NCT01532414|587354751|FG001|Overall Study|Unable to complete 24 hour PK|0|||
162710440|NCT00924560|587649058|FG001|Overall Study|Lost to Follow-up|94|||
162907852|NCT02096471|588359637|FG000|Overall Study|Withdrawal by Subject|3|||
162907853|NCT02096471|588359637|FG000|Overall Study|Non-Compliant|2|||
162907854|NCT03196973|588359638|FG000|Overall Study|Adverse Event|1|||
162907855|NCT03196973|588359639|FG001|Overall Study|Adverse Event|1|||
162907856|NCT03196973|588359640|FG002|Overall Study|Adverse Event|2|||
162907857|NCT03196973|588359638|FG000|Overall Study|Lack of Efficacy|2|||
162907858|NCT03196973|588359639|FG001|Overall Study|Lack of Efficacy|6|||
162907859|NCT03196973|588359640|FG002|Overall Study|Lack of Efficacy|1|||
162907860|NCT03196973|588359638|FG000|Overall Study|Lost to Follow-up|4|||
162907861|NCT03196973|588359639|FG001|Overall Study|Lost to Follow-up|3|||
162907862|NCT03196973|588359640|FG002|Overall Study|Lost to Follow-up|2|||
162907863|NCT03196973|588359638|FG000|Overall Study|Consent withdrawn|2|||
162907864|NCT03196973|588359639|FG001|Overall Study|Consent withdrawn|1|||
162907865|NCT03196973|588359640|FG002|Overall Study|Consent withdrawn|0|||
162907866|NCT03196973|588359638|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
162907867|NCT03196973|588359639|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
162907868|NCT03196973|588359640|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
162907869|NCT03344562|588359641|FG000|Overall Study|Withdrawal by Subject|2|||
162907870|NCT03344562|588359642|FG001|Overall Study|Withdrawal by Subject|0|||
162907871|NCT02736474|588359643|FG000|Overall Study|Lost to Follow-up|0|||
162907872|NCT02736474|588359644|FG001|Overall Study|Lost to Follow-up|1|||
162907873|NCT02463331|588359645|FG000|Overall Study|Adverse Event|4|||
162907874|NCT02463331|588359646|FG001|Overall Study|Adverse Event|2|||
162907875|NCT02463331|588359645|FG000|Overall Study|Lost to Follow-up|1|||
162907876|NCT02463331|588359646|FG001|Overall Study|Lost to Follow-up|1|||
162907877|NCT02463331|588359645|FG000|Overall Study|Pregnancy|2|||
162907878|NCT02463331|588359646|FG001|Overall Study|Pregnancy|3|||
162907879|NCT02463331|588359645|FG000|Overall Study|Lack of Efficacy|6|||
162907880|NCT02463331|588359646|FG001|Overall Study|Lack of Efficacy|0|||
162907881|NCT02463331|588359645|FG000|Overall Study|Physician Decision|3|||
162907882|NCT02463331|588359646|FG001|Overall Study|Physician Decision|0|||
162628050|NCT01532414|587354752|FG002|Overall Study|Unable to complete 24 hour PK|1|||
162628051|NCT01532414|587354750|FG000|Overall Study|Withdrawn by sponsor|1|||
162628052|NCT01532414|587354751|FG001|Overall Study|Withdrawn by sponsor|0|||
162628053|NCT01532414|587354752|FG002|Overall Study|Withdrawn by sponsor|0|||
162628054|NCT02599129|587354757|FG000|Overall Study|Lack of Efficacy|2|||
162628055|NCT02599129|587354758|FG001|Overall Study|Lack of Efficacy|2|||
162628056|NCT02599129|587354757|FG000|Overall Study|Lost to Follow-up|1|||
162628057|NCT02599129|587354758|FG001|Overall Study|Lost to Follow-up|0|||
162628058|NCT02599129|587354757|FG000|Overall Study|Withdrawal by Subject|2|||
162628059|NCT02599129|587354758|FG001|Overall Study|Withdrawal by Subject|1|||
162628060|NCT00617773|587354759|FG000|Overall Study|Physician Decision|1|||
162628061|NCT00617773|587354759|FG000|Overall Study|Lack of compliance with the protocol|1|||
162628062|NCT00617773|587354759|FG000|Overall Study|Withdrawal by Subject|1|||
162628063|NCT00617773|587354759|FG000|Overall Study|Death|1|||
162628064|NCT00617773|587354759|FG000|Overall Study|Progressive disease|19|||
162628065|NCT00617773|587354759|FG000|Overall Study|Protocol Violation|1|||
162628066|NCT01029795|587354760|FG000|Overall Study|Entry Criteria Not Met|2|||
162628067|NCT01029795|587354761|FG001|Overall Study|Entry Criteria Not Met|1|||
162628068|NCT01029795|587354760|FG000|Overall Study|Physician Decision|2|||
162628069|NCT01029795|587354761|FG001|Overall Study|Physician Decision|1|||
162628070|NCT01029795|587354760|FG000|Overall Study|Sponsor Decision|11|||
162710441|NCT00924560|587649059|FG002|Overall Study|Lost to Follow-up|45|||
162907883|NCT02483611|588359647|FG000|Overall Study|Protocol Violation|0|||
162628071|NCT01029795|587354761|FG001|Overall Study|Sponsor Decision|17|||
162628072|NCT01029795|587354760|FG000|Overall Study|Withdrawal by Subject|1|||
162628073|NCT01029795|587354761|FG001|Overall Study|Withdrawal by Subject|3|||
162628074|NCT01061177|587354772|FG000|Overall Study|Adverse Event|117|||
162628075|NCT01061177|587354772|FG000|Overall Study|Withdrawal by Subject|27|||
162907884|NCT02483611|588359648|FG001|Overall Study|Protocol Violation|0|||
162907885|NCT02483611|588359649|FG002|Overall Study|Protocol Violation|1|||
162628076|NCT01061177|587354772|FG000|Overall Study|Disease progression|17|||
162907886|NCT02590406|588359650|FG000|Overall Study|Adverse Event|1|||
162907887|NCT02590406|588359651|FG001|Overall Study|Adverse Event|0|||
162907888|NCT02590406|588359650|FG000|Overall Study|Saturometer malfunction|0|||
162907889|NCT02590406|588359651|FG001|Overall Study|Saturometer malfunction|1|||
162907890|NCT00631969|588359652|FG000|Overall Study|Adverse Event|3|||
162907891|NCT00631969|588359653|FG001|Overall Study|Adverse Event|1|||
162628077|NCT01061177|587354772|FG000|Overall Study|Protocol Violation|11|||
162907892|NCT00631969|588359652|FG000|Overall Study|Lack of Efficacy|2|||
162628078|NCT01061177|587354772|FG000|Overall Study|Lost to Follow-up|9|||
162628079|NCT01061177|587354772|FG000|Overall Study|New cancer therapy|9|||
162628080|NCT01061177|587354772|FG000|Overall Study|Abnormal laboratory values|6|||
162628081|NCT01061177|587354772|FG000|Overall Study|Abnormal test procedure results|4|||
162628082|NCT01061177|587354772|FG000|Overall Study|Administratie problems|4|||
162628083|NCT01061177|587354772|FG000|Overall Study|Death|4|||
162907893|NCT00631969|588359653|FG001|Overall Study|Lack of Efficacy|8|||
162907894|NCT00631969|588359652|FG000|Overall Study|Lost to Follow-up|2|||
162907895|NCT00631969|588359653|FG001|Overall Study|Lost to Follow-up|1|||
162907896|NCT00631969|588359652|FG000|Overall Study|Protocol Violation|1|||
162907897|NCT00631969|588359653|FG001|Overall Study|Protocol Violation|1|||
162907898|NCT00631969|588359652|FG000|Overall Study|Consent Withdrawn|5|||
162907899|NCT00631969|588359653|FG001|Overall Study|Consent Withdrawn|7|||
162907900|NCT00631969|588359652|FG000|Overall Study|Noncompliant With Study Medication|0|||
162907901|NCT00631969|588359653|FG001|Overall Study|Noncompliant With Study Medication|1|||
162907902|NCT00631969|588359652|FG000|Overall Study|No Drug Exposure|2|||
162907903|NCT00631969|588359653|FG001|Overall Study|No Drug Exposure|2|||
162907904|NCT01084096|588361284|FG000|Overall Study|Lost to Follow-up|1501|||
162907905|NCT01084096|588361285|FG001|Overall Study|Lost to Follow-up|1833|||
162907906|NCT01084096|588361284|FG000|Overall Study|Withdrawal by Subject|3|||
162907907|NCT01084096|588361285|FG001|Overall Study|Withdrawal by Subject|0|||
162907908|NCT01084096|588361284|FG000|Overall Study|Woman had a miscarriage|21|||
162907909|NCT01084096|588361285|FG001|Overall Study|Woman had a miscarriage|17|||
162907910|NCT00027846|588361286|FG000|Overall Study|Lost to Follow-up|0|||
162907911|NCT00027846|588361287|FG001|Overall Study|Lost to Follow-up|41|||
162907912|NCT00027846|588361288|FG002|Overall Study|Lost to Follow-up|9|||
162907913|NCT00027846|588361286|FG000|Overall Study|Withdrawal by Subject|0|||
162907914|NCT00027846|588361287|FG001|Overall Study|Withdrawal by Subject|14|||
162907915|NCT00027846|588361288|FG002|Overall Study|Withdrawal by Subject|7|||
162628084|NCT03616600|587354773|FG000|Overall Study|Withdrawal by Subject|1|||
162628085|NCT03616600|587354774|FG001|Overall Study|Withdrawal by Subject|0|||
162628086|NCT03984994|587354775|FG000|Overall Study|Withdrawal by Subject|2|||
162628087|NCT03984994|587354776|FG001|Overall Study|Withdrawal by Subject|1|||
162628088|NCT03010176|587354778|FG000|Overall Study|Death|21|||
162628089|NCT03010176|587354779|FG001|Overall Study|Death|35|||
162628090|NCT03010176|587354780|FG002|Overall Study|Death|19|||
162628091|NCT03010176|587354781|FG003|Overall Study|Death|19|||
162628092|NCT03010176|587354782|FG004|Overall Study|Death|14|||
162907916|NCT00027846|588361286|FG000|Overall Study|Ineligible for study|2|||
162628093|NCT03010176|587354783|FG005|Overall Study|Death|0|||
162628094|NCT03010176|587354778|FG000|Overall Study|Lost to Follow-up|0|||
162628095|NCT03010176|587354779|FG001|Overall Study|Lost to Follow-up|0|||
162628096|NCT03010176|587354780|FG002|Overall Study|Lost to Follow-up|0|||
162628097|NCT03010176|587354781|FG003|Overall Study|Lost to Follow-up|0|||
162628098|NCT03010176|587354782|FG004|Overall Study|Lost to Follow-up|1|||
162628099|NCT03010176|587354783|FG005|Overall Study|Lost to Follow-up|0|||
162628100|NCT03010176|587354778|FG000|Overall Study|Physician Decision|0|||
162628101|NCT03010176|587354779|FG001|Overall Study|Physician Decision|4|||
162628102|NCT03010176|587354780|FG002|Overall Study|Physician Decision|0|||
162628103|NCT03010176|587354781|FG003|Overall Study|Physician Decision|1|||
162628104|NCT03010176|587354782|FG004|Overall Study|Physician Decision|0|||
162628105|NCT03010176|587354783|FG005|Overall Study|Physician Decision|0|||
162628106|NCT03010176|587354778|FG000|Overall Study|Sponsor Decision|0|||
162628107|NCT03010176|587354779|FG001|Overall Study|Sponsor Decision|4|||
162628108|NCT03010176|587354780|FG002|Overall Study|Sponsor Decision|4|||
162628109|NCT03010176|587354781|FG003|Overall Study|Sponsor Decision|1|||
162628110|NCT03010176|587354782|FG004|Overall Study|Sponsor Decision|6|||
162628111|NCT03010176|587354783|FG005|Overall Study|Sponsor Decision|0|||
162628112|NCT03010176|587354778|FG000|Overall Study|Withdrawal by Subject|11|||
162628113|NCT03010176|587354779|FG001|Overall Study|Withdrawal by Subject|9|||
162710442|NCT00924560|587649057|FG000|Overall Study|Miscellaneous Reasons|13|||
162710443|NCT00924560|587649058|FG001|Overall Study|Miscellaneous Reasons|10|||
162710444|NCT00924560|587649059|FG002|Overall Study|Miscellaneous Reasons|10|||
162710445|NCT00209274|587649060|FG000|Overall Study|Missed visit|3|||
162710446|NCT00209274|587649061|FG001|Overall Study|Missed visit|2|||
162628114|NCT03010176|587354780|FG002|Overall Study|Withdrawal by Subject|3|||
162907917|NCT00027846|588361287|FG001|Overall Study|Ineligible for study|6|||
162907918|NCT00027846|588361288|FG002|Overall Study|Ineligible for study|14|||
162907919|NCT00027846|588361286|FG000|Overall Study|Entry into another COG therapeutic study|0|||
162907920|NCT00027846|588361287|FG001|Overall Study|Entry into another COG therapeutic study|5|||
162907921|NCT00027846|588361288|FG002|Overall Study|Entry into another COG therapeutic study|2|||
162967530|NCT01350934|588582945|FG000|Extension Study|Adverse Event|2|||
162967531|NCT01350934|588582946|FG001|Extension Study|Adverse Event|1|||
162967532|NCT01350934|588582945|FG000|Extension Study|Lost to Follow-up|2|||
162967533|NCT01350934|588582946|FG001|Extension Study|Lost to Follow-up|0|||
162967534|NCT01350934|588582945|FG000|Extension Study|Protocol Violation|1|||
162967535|NCT01350934|588582946|FG001|Extension Study|Protocol Violation|1|||
162967536|NCT01350934|588582945|FG000|Extension Study|Lack of Efficacy|0|||
162967537|NCT01350934|588582946|FG001|Extension Study|Lack of Efficacy|1|||
162628115|NCT03010176|587354781|FG003|Overall Study|Withdrawal by Subject|0|||
162628116|NCT03010176|587354782|FG004|Overall Study|Withdrawal by Subject|4|||
162628117|NCT03010176|587354783|FG005|Overall Study|Withdrawal by Subject|0|||
162628118|NCT04220866|587354784|FG000|Overall Study|Death|4|||
162967538|NCT01350934|588582945|FG000|Extension Study|Withdrawal by Subject|0|||
162628119|NCT04220866|587354785|FG001|Overall Study|Death|5|||
162628120|NCT04220866|587354784|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
162710447|NCT00209274|587649060|FG000|Overall Study|Death|32|||
162907922|NCT00027846|588361286|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
162907923|NCT00027846|588361287|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
162907924|NCT00027846|588361288|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
162907925|NCT02033369|588361289|FG000|Overall Study|Physician Decision|1|||
162907926|NCT02033369|588361290|FG001|Overall Study|Physician Decision|2|||
162907927|NCT02033369|588361289|FG000|Overall Study|Not a good demographic match|0|||
162907928|NCT02033369|588361290|FG001|Overall Study|Not a good demographic match|2|||
162907929|NCT02033369|588361289|FG000|Overall Study|Withdrawal by Subject|1|||
162907930|NCT02033369|588361290|FG001|Overall Study|Withdrawal by Subject|1|||
162907931|NCT02033369|588361289|FG000|Overall Study|Lost to Follow-up|1|||
162907932|NCT02033369|588361290|FG001|Overall Study|Lost to Follow-up|0|||
162907933|NCT02033369|588361289|FG000|Overall Study|Protocol Violation|2|||
162907934|NCT02033369|588361290|FG001|Overall Study|Protocol Violation|0|||
162907935|NCT00663208|588361293|FG000|Treatment Period|Lost to Follow-up|0|||
162907936|NCT00663208|588361294|FG001|Treatment Period|Lost to Follow-up|1|||
162907937|NCT00663208|588361295|FG002|Treatment Period|Lost to Follow-up|0|||
162907938|NCT00663208|588361296|FG003|Treatment Period|Lost to Follow-up|0|||
162907939|NCT00663208|588361297|FG004|Treatment Period|Lost to Follow-up|0|||
162907940|NCT00663208|588361298|FG005|Treatment Period|Lost to Follow-up|0|||
162907941|NCT00663208|588361299|FG006|Treatment Period|Lost to Follow-up|0|||
162907942|NCT00663208|588361293|FG000|Follow-up Period|Lost to Follow-up|2|||
162907943|NCT00663208|588361294|FG001|Follow-up Period|Lost to Follow-up|0|||
162907944|NCT00663208|588361295|FG002|Follow-up Period|Lost to Follow-up|3|||
162907945|NCT00663208|588361296|FG003|Follow-up Period|Lost to Follow-up|2|||
162907946|NCT00663208|588361297|FG004|Follow-up Period|Lost to Follow-up|0|||
162907947|NCT00663208|588361298|FG005|Follow-up Period|Lost to Follow-up|0|||
162907948|NCT00663208|588361299|FG006|Follow-up Period|Lost to Follow-up|0|||
162907949|NCT00663208|588361293|FG000|Follow-up Period|Other reason|1|||
162907950|NCT00663208|588361294|FG001|Follow-up Period|Other reason|0|||
162907951|NCT00663208|588361295|FG002|Follow-up Period|Other reason|0|||
162907952|NCT00663208|588361296|FG003|Follow-up Period|Other reason|0|||
162907953|NCT00663208|588361297|FG004|Follow-up Period|Other reason|0|||
162907954|NCT00663208|588361298|FG005|Follow-up Period|Other reason|0|||
162907955|NCT00663208|588361299|FG006|Follow-up Period|Other reason|1|||
162628121|NCT04220866|587354785|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
162628122|NCT04220866|587354784|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
162628123|NCT04220866|587354785|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
162628124|NCT04220866|587354784|FG000|Overall Study|Withdrawal by Subject|0|||
162628125|NCT04220866|587354785|FG001|Overall Study|Withdrawal by Subject|1|||
162628126|NCT00709761|587354790|FG000|Overall Study|Withdrawal by Subject|8|||
162628127|NCT00709761|587354790|FG000|Overall Study|study closed/terminated|17|||
162628128|NCT00709761|587354790|FG000|Overall Study|Lost to Follow-up|2|||
162628129|NCT03478930|587354791|FG000|Overall Study|Adverse Event|0|||
162628130|NCT03478930|587354792|FG001|Overall Study|Adverse Event|1|||
162628131|NCT03478930|587354791|FG000|Overall Study|Lack of Efficacy|3|||
162628132|NCT03478930|587354792|FG001|Overall Study|Lack of Efficacy|3|||
162628133|NCT03478930|587354791|FG000|Overall Study|Withdrawal by Subject|6|||
162628134|NCT03478930|587354792|FG001|Overall Study|Withdrawal by Subject|5|||
162628135|NCT00553644|587354795|FG000|Overall Study|Adverse Event|17|||
162628136|NCT00553644|587354795|FG000|Overall Study|Withdrawal by Subject|4|||
162628137|NCT00553644|587354795|FG000|Overall Study|Physician Decision|1|||
162628138|NCT00553644|587354795|FG000|Overall Study|Alternative therapy|6|||
162628139|NCT01336764|587354796|FG000|Overall Study|Withdrawal by Subject|5|||
162628140|NCT01336764|587354797|FG001|Overall Study|Withdrawal by Subject|5|||
162628141|NCT00555971|587354798|FG000|Overall Study|Adverse Event|1|||
162628142|NCT00555971|587354799|FG001|Overall Study|Adverse Event|1|||
162628143|NCT01626391|587354800|FG000|Overall Study|Physician Decision|1|||
162628144|NCT01626391|587354801|FG001|Overall Study|Physician Decision|0|||
162628145|NCT01626391|587354800|FG000|Overall Study|Withdrawal by Subject|1|||
162628146|NCT01626391|587354801|FG001|Overall Study|Withdrawal by Subject|0|||
162628147|NCT02573311|587354802|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
162628148|NCT02573311|587354803|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
162628149|NCT02573311|587354802|FG000|Disposition for Part 2|Physician Decision|25|||
162628150|NCT02573311|587354803|FG001|Disposition for Part 2|Physician Decision|7|||
162628151|NCT02573311|587354802|FG000|Disposition for Part 2|Adverse Event|36|||
162628152|NCT02573311|587354803|FG001|Disposition for Part 2|Adverse Event|5|||
162628153|NCT02573311|587354802|FG000|Disposition for Part 2|Lost to Follow-up|76|||
162628154|NCT02573311|587354803|FG001|Disposition for Part 2|Lost to Follow-up|7|||
162628155|NCT02573311|587354802|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
162710448|NCT00209274|587649061|FG001|Overall Study|Death|15|||
162710449|NCT00209274|587649060|FG000|Overall Study|Withdrawal by Subject|30|||
162710450|NCT00209274|587649061|FG001|Overall Study|Withdrawal by Subject|15|||
162907956|NCT01451203|588361300|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
162907957|NCT01451203|588361301|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
162907958|NCT01451203|588361300|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
162907959|NCT01451203|588361301|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
162907960|NCT01451203|588361300|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
162907961|NCT01451203|588361301|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
162907962|NCT01451203|588361300|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
162907963|NCT01451203|588361301|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
162907964|NCT01451203|588361300|FG000|Double-blind Treatment Period|Adverse Event|6|||
162907965|NCT01451203|588361301|FG001|Double-blind Treatment Period|Adverse Event|9|||
162907966|NCT01451203|588361300|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
162907967|NCT01451203|588361301|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
162907968|NCT01451203|588361300|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
162907969|NCT01451203|588361301|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
162907970|NCT01451203|588361300|FG000|Double-blind Treatment Period|Investigator decision|2|||
162907971|NCT01451203|588361301|FG001|Double-blind Treatment Period|Investigator decision|0|||
162907972|NCT01451203|588361300|FG000|Post-treatment Period|Consent withdrawn|2|||
162907973|NCT01451203|588361301|FG001|Post-treatment Period|Consent withdrawn|4|||
162907974|NCT01451203|588361300|FG000|Post-treatment Period|Lack of Efficacy|12|||
162907975|NCT01451203|588361301|FG001|Post-treatment Period|Lack of Efficacy|28|||
162628156|NCT02573311|587354803|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
162628157|NCT02573311|587354802|FG000|Disposition for Part 2|Investigator decision|0|||
162628158|NCT02573311|587354803|FG001|Disposition for Part 2|Investigator decision|1|||
162628159|NCT02573311|587354802|FG000|Disposition for Part 2|Other than specified above|13|||
162628160|NCT02573311|587354803|FG001|Disposition for Part 2|Other than specified above|3|||
162628161|NCT05683249|587354804|FG000|Overall Study|Adverse Event|3|||
162907976|NCT01451203|588361300|FG000|Post-treatment Period|Adverse Event|0|||
162907977|NCT01451203|588361301|FG001|Post-treatment Period|Adverse Event|1|||
162907978|NCT01451203|588361300|FG000|Post-treatment Period|Investigator decision|0|||
162907979|NCT01451203|588361301|FG001|Post-treatment Period|Investigator decision|1|||
162907980|NCT00039377|588361302|FG000|Initial Registration|Adverse Event|2|||
162907981|NCT00039377|588361303|FG001|Initial Registration|Adverse Event|0|||
162907982|NCT00039377|588361304|FG002|Initial Registration|Adverse Event|0|||
162907983|NCT00039377|588361305|FG003|Initial Registration|Adverse Event|0|||
162907984|NCT00039377|588361302|FG000|Initial Registration|Relapsed|6|||
162907985|NCT00039377|588361303|FG001|Initial Registration|Relapsed|0|||
162907986|NCT00039377|588361304|FG002|Initial Registration|Relapsed|0|||
162907987|NCT00039377|588361305|FG003|Initial Registration|Relapsed|0|||
162907988|NCT00039377|588361302|FG000|Initial Registration|Received non-protocol therapy|11|||
162907989|NCT00039377|588361303|FG001|Initial Registration|Received non-protocol therapy|0|||
162907990|NCT00039377|588361304|FG002|Initial Registration|Received non-protocol therapy|0|||
162907991|NCT00039377|588361305|FG003|Initial Registration|Received non-protocol therapy|0|||
162907992|NCT00039377|588361302|FG000|Initial Registration|Withdrawal by Subject|3|||
162907993|NCT00039377|588361303|FG001|Initial Registration|Withdrawal by Subject|0|||
162907994|NCT00039377|588361304|FG002|Initial Registration|Withdrawal by Subject|0|||
162907995|NCT00039377|588361305|FG003|Initial Registration|Withdrawal by Subject|0|||
162907996|NCT01249404|588361306|FG000|Overall Study|Study treatment not received|0|||
162907997|NCT01249404|588361307|FG001|Overall Study|Study treatment not received|1|||
162907998|NCT01249404|588361308|FG002|Overall Study|Study treatment not received|2|||
162907999|NCT01249404|588361306|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
162908000|NCT01249404|588361307|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
162908001|NCT01249404|588361308|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
162908002|NCT01249404|588361306|FG000|Overall Study|Adverse Event|2|||
162908003|NCT01249404|588361307|FG001|Overall Study|Adverse Event|2|||
162908004|NCT01249404|588361308|FG002|Overall Study|Adverse Event|2|||
162908005|NCT01249404|588361306|FG000|Overall Study|Withdrawal by Subject|2|||
162908006|NCT01249404|588361307|FG001|Overall Study|Withdrawal by Subject|2|||
162908007|NCT01249404|588361308|FG002|Overall Study|Withdrawal by Subject|0|||
162908008|NCT01249404|588361306|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
162908009|NCT01249404|588361307|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
162908010|NCT01249404|588361308|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
162908011|NCT01249404|588361306|FG000|Overall Study|Non compliance to visit schedule|0|||
162908012|NCT01249404|588361307|FG001|Overall Study|Non compliance to visit schedule|1|||
162908013|NCT01249404|588361308|FG002|Overall Study|Non compliance to visit schedule|0|||
162908014|NCT03758612|588361309|FG000|Washout Period|Withdrawal by Subject|0|||
162908015|NCT03758612|588361310|FG001|Washout Period|Withdrawal by Subject|0|||
162908016|NCT03758612|588361311|FG002|Washout Period|Withdrawal by Subject|2|||
162908017|NCT03758612|588361312|FG003|Washout Period|Withdrawal by Subject|0|||
162908018|NCT03758612|588361313|FG004|Washout Period|Withdrawal by Subject|0|||
162908019|NCT03758612|588361314|FG005|Washout Period|Withdrawal by Subject|0|||
162908020|NCT03758612|588361315|FG006|Washout Period|Withdrawal by Subject|0|||
162908021|NCT03758612|588361316|FG007|Washout Period|Withdrawal by Subject|0|||
162908022|NCT03758612|588361317|FG008|Washout Period|Withdrawal by Subject|0|||
162908023|NCT03758612|588361318|FG009|Washout Period|Withdrawal by Subject|0|||
162908024|NCT03758612|588361319|FG010|Washout Period|Withdrawal by Subject|0|||
162908025|NCT03758612|588361320|FG011|Washout Period|Withdrawal by Subject|0|||
162908026|NCT03758612|588361309|FG000|Period 2|Protocol Violation|0|||
162908027|NCT03758612|588361310|FG001|Period 2|Protocol Violation|0|||
162908028|NCT03758612|588361311|FG002|Period 2|Protocol Violation|0|||
162908029|NCT03758612|588361312|FG003|Period 2|Protocol Violation|0|||
162908030|NCT03758612|588361313|FG004|Period 2|Protocol Violation|1|||
162908031|NCT03758612|588361314|FG005|Period 2|Protocol Violation|0|||
162908032|NCT03758612|588361315|FG006|Period 2|Protocol Violation|0|||
162908033|NCT03758612|588361316|FG007|Period 2|Protocol Violation|0|||
162908034|NCT03758612|588361317|FG008|Period 2|Protocol Violation|0|||
162908035|NCT03758612|588361318|FG009|Period 2|Protocol Violation|0|||
162908036|NCT03758612|588361319|FG010|Period 2|Protocol Violation|0|||
162908037|NCT03758612|588361320|FG011|Period 2|Protocol Violation|0|||
162908038|NCT02500901|588361321|FG000|Overall Study|Disease ProgressionDD|2|||
162908039|NCT01191190|588361322|FG000|Overall Study|Withdrawal by Subject|1|||
162908040|NCT01716585|588361325|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
162908041|NCT01716585|588361326|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
162628162|NCT05683249|587354805|FG001|Overall Study|Adverse Event|1|||
162908042|NCT01716585|588361325|FG000|Double-blind Treatment|Adverse Event|2|||
162908043|NCT01716585|588361326|FG001|Double-blind Treatment|Adverse Event|1|||
162908044|NCT01716585|588361325|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
162908045|NCT01716585|588361326|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
162908046|NCT01716585|588361325|FG000|Double-blind Treatment|Lost to Follow-up|2|||
162908047|NCT01716585|588361326|FG001|Double-blind Treatment|Lost to Follow-up|0|||
162908048|NCT01716585|588361325|FG000|Double-blind Treatment|Subject Noncompliant|1|||
162908049|NCT01716585|588361326|FG001|Double-blind Treatment|Subject Noncompliant|0|||
162908050|NCT01716585|588361325|FG000|Double-blind Treatment|Other|1|||
162908051|NCT01716585|588361326|FG001|Double-blind Treatment|Other|0|||
162908052|NCT01716585|588361325|FG000|Open-label Treatment|Adverse Event|0|||
162908053|NCT01716585|588361326|FG001|Open-label Treatment|Adverse Event|2|||
162908054|NCT01716585|588361325|FG000|Open-label Treatment|Virologic Failure|0|||
162908055|NCT01716585|588361326|FG001|Open-label Treatment|Virologic Failure|2|||
162908056|NCT01716585|588361325|FG000|Open-label Treatment|Withdrawal by Subject|0|||
162908057|NCT01716585|588361326|FG001|Open-label Treatment|Withdrawal by Subject|3|||
162908058|NCT04235959|588361327|FG000|Overall Study|Protocol Violation|0|||
162908059|NCT04235959|588361328|FG001|Overall Study|Protocol Violation|1|||
162908060|NCT04235959|588361329|FG002|Overall Study|Protocol Violation|0|||
162908061|NCT04235959|588361327|FG000|Overall Study|Adverse Event|1|||
162908062|NCT04235959|588361328|FG001|Overall Study|Adverse Event|0|||
162908063|NCT04235959|588361329|FG002|Overall Study|Adverse Event|0|||
162908064|NCT00125138|588361330|FG000|Overall Study|Adverse Event|1|||
162908065|NCT00125138|588361331|FG001|Overall Study|Adverse Event|0|||
162908066|NCT00125138|588361332|FG002|Overall Study|Adverse Event|3|||
162908067|NCT00125138|588361333|FG003|Overall Study|Adverse Event|2|||
162908068|NCT00125138|588361330|FG000|Overall Study|Withdrawal by Subject|2|||
162908069|NCT00125138|588361331|FG001|Overall Study|Withdrawal by Subject|3|||
162908070|NCT00125138|588361332|FG002|Overall Study|Withdrawal by Subject|1|||
162908071|NCT00125138|588361333|FG003|Overall Study|Withdrawal by Subject|1|||
162908072|NCT00125138|588361330|FG000|Overall Study|Lack of Efficacy|0|||
162908073|NCT00125138|588361331|FG001|Overall Study|Lack of Efficacy|0|||
162908074|NCT00125138|588361332|FG002|Overall Study|Lack of Efficacy|0|||
162908075|NCT00125138|588361333|FG003|Overall Study|Lack of Efficacy|1|||
162908076|NCT00125138|588361330|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
162908077|NCT00125138|588361331|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
162908078|NCT00125138|588361332|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
162908079|NCT00125138|588361333|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
162908080|NCT00348686|588361338|FG000|Overall Study|Withdrawal by Subject|45|||
162908081|NCT00348686|588361338|FG000|Overall Study|Adverse Event|5|||
162908082|NCT00348686|588361338|FG000|Overall Study|Protocol Violation|6|||
162908083|NCT00348686|588361338|FG000|Overall Study|Lost to Follow-up|2|||
162908084|NCT00348686|588361338|FG000|Overall Study|Multiple Reasons|8|||
162908085|NCT01258738|588361341|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
162908086|NCT01258738|588361342|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
162908087|NCT01258738|588361341|FG000|Double-blind Period|Withdrawal by Subject|2|||
162908088|NCT01258738|588361342|FG001|Double-blind Period|Withdrawal by Subject|2|||
162908089|NCT01258738|588361341|FG000|Double-blind Period|Protocol Violation|1|||
162908090|NCT01258738|588361342|FG001|Double-blind Period|Protocol Violation|1|||
162908091|NCT01258738|588361341|FG000|Double-blind Period|Adverse Event|3|||
162908092|NCT01258738|588361342|FG001|Double-blind Period|Adverse Event|1|||
162908093|NCT01258738|588361341|FG000|Open-label Period|Did not meet inclusion criteria|0|||
162908094|NCT01258738|588361342|FG001|Open-label Period|Did not meet inclusion criteria|1|||
162908095|NCT01258738|588361341|FG000|Open-label Period|Insufficient clinical response|5|||
162908096|NCT01258738|588361342|FG001|Open-label Period|Insufficient clinical response|3|||
162908097|NCT01258738|588361341|FG000|Open-label Period|Lost to Follow-up|0|||
162908098|NCT01258738|588361342|FG001|Open-label Period|Lost to Follow-up|2|||
162908099|NCT01258738|588361341|FG000|Open-label Period|Withdrawal by Subject|5|||
162908100|NCT01258738|588361342|FG001|Open-label Period|Withdrawal by Subject|6|||
162908101|NCT01258738|588361341|FG000|Open-label Period|Protocol Violation|2|||
162908102|NCT01258738|588361342|FG001|Open-label Period|Protocol Violation|2|||
162908103|NCT01258738|588361341|FG000|Open-label Period|Adverse Event|4|||
162908104|NCT01258738|588361342|FG001|Open-label Period|Adverse Event|5|||
162908105|NCT01258738|588361341|FG000|Open-label Period|Other Reasons|0|||
162908106|NCT01258738|588361342|FG001|Open-label Period|Other Reasons|1|||
162908107|NCT01258738|588361341|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
162908108|NCT01258738|588361342|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
162908109|NCT02870348|588361343|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
162908110|NCT02381795|588361344|FG000|Overall Study|Withdrawal by Subject|1|||
162908111|NCT02381795|588361344|FG000|Overall Study|Study Terminated|2|||
162908112|NCT01488994|588361349|FG000|Overall Study|Withdrawal by Subject|0|||
162908113|NCT01488994|588361350|FG001|Overall Study|Withdrawal by Subject|1|||
162908114|NCT02908841|588361351|FG000|Overall Study|Physician Decision|4|||
162908115|NCT02908841|588361352|FG001|Overall Study|Physician Decision|0|||
162908116|NCT03798366|588361353|FG000|Overall Study|Lost to Follow-up|0|||
162908117|NCT03798366|588361354|FG001|Overall Study|Lost to Follow-up|1|||
162908118|NCT00474539|588361355|FG000|Infant Series|Withdrawal by Subject|3|||
162908119|NCT00474539|588361356|FG001|Infant Series|Withdrawal by Subject|4|||
162908120|NCT00474539|588361355|FG000|Infant Series|Randomization error|5|||
162908121|NCT00474539|588361356|FG001|Infant Series|Randomization error|0|||
162908122|NCT00474539|588361355|FG000|Infant Series|Lost to Follow-up|2|||
162908123|NCT00474539|588361356|FG001|Infant Series|Lost to Follow-up|1|||
162908124|NCT00474539|588361355|FG000|Infant Series|Protocol Violation|0|||
162908125|NCT00474539|588361356|FG001|Infant Series|Protocol Violation|1|||
162908126|NCT00474539|588361355|FG000|After Infant Series|Lost to Follow-up|3|||
162908127|NCT00474539|588361356|FG001|After Infant Series|Lost to Follow-up|0|||
162908128|NCT00474539|588361355|FG000|After Infant Series|Withdrawal by Subject|1|||
162908129|NCT00474539|588361356|FG001|After Infant Series|Withdrawal by Subject|0|||
162908130|NCT00474539|588361355|FG000|Toddler Dose|Protocol Violation|1|||
162908131|NCT00474539|588361356|FG001|Toddler Dose|Protocol Violation|0|||
162908132|NCT01117428|588361357|FG000|Overall Study|Lack of Efficacy|1|||
162908133|NCT01117428|588361358|FG001|Overall Study|Lack of Efficacy|0|||
162908134|NCT01117428|588361359|FG002|Overall Study|Lack of Efficacy|0|||
162908135|NCT01117428|588361360|FG003|Overall Study|Lack of Efficacy|0|||
162908136|NCT01117428|588361361|FG004|Overall Study|Lack of Efficacy|0|||
162908137|NCT01117428|588361362|FG005|Overall Study|Lack of Efficacy|0|||
162908138|NCT01117428|588361357|FG000|Overall Study|Adverse Event|4|||
162908139|NCT01117428|588361358|FG001|Overall Study|Adverse Event|0|||
162908140|NCT01117428|588361359|FG002|Overall Study|Adverse Event|0|||
162908141|NCT01117428|588361360|FG003|Overall Study|Adverse Event|0|||
162908142|NCT01117428|588361361|FG004|Overall Study|Adverse Event|1|||
162908143|NCT01117428|588361362|FG005|Overall Study|Adverse Event|2|||
162908144|NCT01117428|588361357|FG000|Overall Study|Death|0|||
162908145|NCT01117428|588361358|FG001|Overall Study|Death|1|||
162908146|NCT01117428|588361359|FG002|Overall Study|Death|2|||
162908147|NCT01117428|588361360|FG003|Overall Study|Death|0|||
162908148|NCT01117428|588361361|FG004|Overall Study|Death|0|||
162908149|NCT01117428|588361362|FG005|Overall Study|Death|1|||
162908150|NCT01117428|588361357|FG000|Overall Study|Physician Decision|0|||
162908151|NCT01117428|588361358|FG001|Overall Study|Physician Decision|1|||
162908152|NCT01117428|588361359|FG002|Overall Study|Physician Decision|0|||
162908153|NCT01117428|588361360|FG003|Overall Study|Physician Decision|0|||
162908154|NCT01117428|588361361|FG004|Overall Study|Physician Decision|0|||
162908155|NCT01117428|588361362|FG005|Overall Study|Physician Decision|0|||
162908156|NCT01117428|588361357|FG000|Overall Study|Withdrawal by Subject|0|||
162908157|NCT01117428|588361358|FG001|Overall Study|Withdrawal by Subject|0|||
162908158|NCT01117428|588361359|FG002|Overall Study|Withdrawal by Subject|1|||
162908159|NCT01117428|588361360|FG003|Overall Study|Withdrawal by Subject|0|||
162908160|NCT01117428|588361361|FG004|Overall Study|Withdrawal by Subject|0|||
162908161|NCT01117428|588361362|FG005|Overall Study|Withdrawal by Subject|0|||
162908162|NCT01117428|588361357|FG000|Overall Study|Progressive disease|15|||
162908163|NCT01117428|588361358|FG001|Overall Study|Progressive disease|27|||
162908164|NCT01117428|588361359|FG002|Overall Study|Progressive disease|10|||
162908165|NCT01117428|588361360|FG003|Overall Study|Progressive disease|12|||
162908166|NCT01117428|588361361|FG004|Overall Study|Progressive disease|16|||
162908167|NCT01117428|588361362|FG005|Overall Study|Progressive disease|17|||
162908168|NCT02195531|588361363|FG000|Overall Study|Withdrawal by Subject|1|||
162908169|NCT02195531|588361364|FG001|Overall Study|Withdrawal by Subject|1|||
162908170|NCT02195531|588361365|FG002|Overall Study|Withdrawal by Subject|1|||
162908171|NCT01657253|588361372|FG000|Overall Study|Lost to Follow-up|6|||
162908172|NCT01657253|588361373|FG001|Overall Study|Lost to Follow-up|5|||
162908173|NCT01657253|588361372|FG000|Overall Study|Withdrawal by Subject|11|||
162908174|NCT01657253|588361373|FG001|Overall Study|Withdrawal by Subject|12|||
162908175|NCT01657253|588361372|FG000|Overall Study|Adverse Event|0|||
162908176|NCT01657253|588361373|FG001|Overall Study|Adverse Event|1|||
162908177|NCT01970540|588361374|FG000|Overall Study|Non-treatment-related AE|0|||
162908178|NCT01970540|588361375|FG001|Overall Study|Non-treatment-related AE|0|||
162908179|NCT01970540|588361376|FG002|Overall Study|Non-treatment-related AE|1|||
162908180|NCT01970540|588361374|FG000|Overall Study|Progressive disease|55|||
162908181|NCT01970540|588361375|FG001|Overall Study|Progressive disease|23|||
162908182|NCT01970540|588361376|FG002|Overall Study|Progressive disease|10|||
162628163|NCT05683249|587354804|FG000|Overall Study|Lack of Efficacy|0|||
162628164|NCT05683249|587354805|FG001|Overall Study|Lack of Efficacy|2|||
162628165|NCT05683249|587354804|FG000|Overall Study|Lost to Follow-up|6|||
162628166|NCT05683249|587354805|FG001|Overall Study|Lost to Follow-up|5|||
162908183|NCT01970540|588361374|FG000|Overall Study|Treatment delay over protocol|0|||
162908184|NCT01970540|588361375|FG001|Overall Study|Treatment delay over protocol|0|||
162628167|NCT05683249|587354804|FG000|Overall Study|Non-compliance with Study Drug|2|||
162628168|NCT05683249|587354805|FG001|Overall Study|Non-compliance with Study Drug|0|||
162628169|NCT05683249|587354804|FG000|Overall Study|Protocol Violation|6|||
162908185|NCT01970540|588361376|FG002|Overall Study|Treatment delay over protocol|1|||
162908186|NCT01970540|588361374|FG000|Overall Study|Physician Decision|7|||
162908187|NCT01970540|588361375|FG001|Overall Study|Physician Decision|2|||
162908188|NCT01970540|588361376|FG002|Overall Study|Physician Decision|0|||
162628170|NCT05683249|587354805|FG001|Overall Study|Protocol Violation|3|||
162908189|NCT01970540|588361374|FG000|Overall Study|Clinical progression|0|||
162908190|NCT01970540|588361375|FG001|Overall Study|Clinical progression|1|||
162908191|NCT01970540|588361376|FG002|Overall Study|Clinical progression|1|||
162908192|NCT01970540|588361374|FG000|Overall Study|End of study|2|||
162908193|NCT01970540|588361375|FG001|Overall Study|End of study|0|||
162908194|NCT01970540|588361376|FG002|Overall Study|End of study|2|||
162908195|NCT01970540|588361374|FG000|Overall Study|Adverse Event|0|||
162908196|NCT01970540|588361375|FG001|Overall Study|Adverse Event|2|||
162908197|NCT01970540|588361376|FG002|Overall Study|Adverse Event|1|||
162908198|NCT01970540|588361374|FG000|Overall Study|Treatment-related AE|4|||
162908199|NCT01970540|588361375|FG001|Overall Study|Treatment-related AE|0|||
162908200|NCT01970540|588361376|FG002|Overall Study|Treatment-related AE|2|||
162908201|NCT01970540|588361374|FG000|Overall Study|Withdrawal by Subject|4|||
162908202|NCT01970540|588361375|FG001|Overall Study|Withdrawal by Subject|0|||
162908203|NCT01970540|588361376|FG002|Overall Study|Withdrawal by Subject|1|||
162908204|NCT01970540|588361374|FG000|Overall Study|Clinical deterioration|1|||
162908205|NCT01970540|588361375|FG001|Overall Study|Clinical deterioration|0|||
162908206|NCT01970540|588361376|FG002|Overall Study|Clinical deterioration|0|||
162908207|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Adverse Event|30|||
162908208|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Adverse Event|25|||
162908209|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Adverse Event|23|||
162908210|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Adverse Event|14|||
162908211|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Death|0|||
162908212|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Death|0|||
162908213|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Death|1|||
162908214|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Death|0|||
162908215|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Physician Decision|0|||
162908216|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Physician Decision|1|||
162908217|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Physician Decision|0|||
162908218|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Physician Decision|1|||
162908219|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
162908220|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
162908221|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
162908222|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
162908223|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Other|6|||
162908224|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Other|1|||
162908225|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Other|0|||
162908226|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Other|2|||
162908227|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
162908228|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
162908229|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
162908230|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
162908231|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
162908232|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
162908233|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
162908234|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
162908235|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
162908236|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
162908237|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
162908238|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
162908239|NCT00242710|588361378|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
162908240|NCT00242710|588361379|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
162908241|NCT00242710|588361380|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
162908242|NCT00242710|588361381|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
162908243|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Adverse Event|2|||
162908244|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Adverse Event|3|||
162908245|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Adverse Event|5|||
162908246|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Adverse Event|2|||
162908247|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Physician Decision|1|||
162908248|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Physician Decision|1|||
162908249|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Physician Decision|0|||
162908250|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Physician Decision|0|||
162908251|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Other|24|||
162908252|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Other|24|||
162908253|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Other|9|||
162908254|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Other|11|||
162908255|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Extension not Available|17|||
162908256|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Extension not Available|21|||
162908257|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Extension not Available|8|||
162908258|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Extension not Available|7|||
162908259|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
162908260|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
162908261|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
162908262|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
162908263|NCT00242710|588361378|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
162908264|NCT00242710|588361379|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
162908265|NCT00242710|588361380|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
162908266|NCT00242710|588361381|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
162908267|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
162908268|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
162908269|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
162908270|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
162908271|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Death|0|||
162908272|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Death|0|||
162908273|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Death|0|||
162908274|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Death|1|||
162908275|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
162908276|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
162908277|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
162908278|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
162908279|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Other|3|||
162908280|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Other|5|||
162908281|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Other|4|||
162908282|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Other|3|||
162908283|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
162908284|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
162908285|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
162908286|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
162908287|NCT00242710|588361378|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
162908288|NCT00242710|588361379|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
162908289|NCT00242710|588361380|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
162908290|NCT00242710|588361381|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
162908291|NCT01057394|588361382|FG000|Overall Study|Not eligible|0|||
162908292|NCT01057394|588361383|FG001|Overall Study|Not eligible|2|||
162908293|NCT00579527|588361384|FG000|Overall Study|Death|4|||
162908294|NCT00203294|588361385|FG000|Overall Study|Withdrawal by Subject|8|||
162908295|NCT00203294|588361386|FG001|Overall Study|Withdrawal by Subject|13|||
162908296|NCT02177942|588361396|FG000|Overall Study|Adverse Event|1|||
162908297|NCT02177942|588361397|FG001|Overall Study|Adverse Event|0|||
162908298|NCT02177942|588361396|FG000|Overall Study|Lost to Follow-up|1|||
162908299|NCT02177942|588361397|FG001|Overall Study|Lost to Follow-up|1|||
162908300|NCT02177942|588361396|FG000|Overall Study|Protocol Violation|4|||
162908301|NCT02177942|588361397|FG001|Overall Study|Protocol Violation|6|||
162908302|NCT02177942|588361396|FG000|Overall Study|Withdrawal by Subject|71|||
162908303|NCT02177942|588361397|FG001|Overall Study|Withdrawal by Subject|81|||
162908304|NCT01948791|588361401|FG000|Overall Study|Adverse Event|12|||
162908305|NCT01948791|588361401|FG000|Overall Study|Lack of Efficacy|3|||
162908306|NCT01948791|588361401|FG000|Overall Study|Protocol Violation|2|||
162908307|NCT01948791|588361401|FG000|Overall Study|Withdrawal by Subject|5|||
162908308|NCT01948791|588361401|FG000|Overall Study|Lost to Follow-up|6|||
162908309|NCT01948791|588361401|FG000|Overall Study|Management issues|1|||
162908310|NCT01948791|588361401|FG000|Overall Study|Others|7|||
162908311|NCT01948791|588361401|FG000|Overall Study|Screening failure|35|||
162908312|NCT00702949|588361409|FG000|Overall Study|Refusal|3|||
162908313|NCT00702949|588361410|FG001|Overall Study|Refusal|2|||
162908314|NCT00702949|588361411|FG002|Overall Study|Refusal|2|||
162908315|NCT00702949|588361409|FG000|Overall Study|Adverse Event|1|||
162908316|NCT00702949|588361410|FG001|Overall Study|Adverse Event|6|||
162908317|NCT00702949|588361411|FG002|Overall Study|Adverse Event|3|||
162908318|NCT00702949|588361409|FG000|Overall Study|Other Medical Reason/unknown|1|||
162908319|NCT00702949|588361410|FG001|Overall Study|Other Medical Reason/unknown|1|||
162908320|NCT00702949|588361411|FG002|Overall Study|Other Medical Reason/unknown|3|||
162908321|NCT01610414|588361414|FG000|Study Start - Month 13|Serious Adverse Event|65|||
162908322|NCT01610414|588361415|FG001|Study Start - Month 13|Serious Adverse Event|67|||
162908323|NCT01610414|588361414|FG000|Study Start - Month 13|Adverse Event|14|||
162908324|NCT01610414|588361415|FG001|Study Start - Month 13|Adverse Event|14|||
162908325|NCT01610414|588361414|FG000|Study Start - Month 13|Protocol Violation|3|||
162908326|NCT01610414|588361415|FG001|Study Start - Month 13|Protocol Violation|1|||
162908327|NCT01610414|588361414|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
162908328|NCT01610414|588361415|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
162908329|NCT01610414|588361414|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
162908330|NCT01610414|588361415|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
162908331|NCT01610414|588361414|FG000|Study Start - Month 13|Lost to Follow-up|4|||
162908332|NCT01610414|588361415|FG001|Study Start - Month 13|Lost to Follow-up|6|||
162908333|NCT01610414|588361414|FG000|Study Start - Month 13|Suspected HZ episode|1|||
162908334|NCT01610414|588361415|FG001|Study Start - Month 13|Suspected HZ episode|3|||
162908335|NCT01610414|588361414|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
162908336|NCT01610414|588361415|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
162908337|NCT01610414|588361414|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
162908338|NCT01610414|588361415|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
162908339|NCT01610414|588361414|FG000|Month 13 - Month 25|Adverse Event|8|||
162908340|NCT01610414|588361415|FG001|Month 13 - Month 25|Adverse Event|4|||
162710451|NCT00209274|587649060|FG000|Overall Study|Randomized not treated (RNT)|6|||
162710452|NCT00209274|587649061|FG001|Overall Study|Randomized not treated (RNT)|15|||
162710453|NCT02753530|587649064|FG000|Overall Study|Adverse Event|7|||
162710454|NCT02753530|587649065|FG001|Overall Study|Adverse Event|1|||
162710455|NCT02753530|587649064|FG000|Overall Study|Death|0|||
162710456|NCT02753530|587649065|FG001|Overall Study|Death|1|||
162908341|NCT01610414|588361414|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
162908342|NCT01610414|588361415|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
162908343|NCT01610414|588361414|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
162908344|NCT01610414|588361415|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
162908345|NCT01610414|588361414|FG000|Month 13 - Month 25|Protocol Violation|0|||
162908346|NCT01610414|588361415|FG001|Month 13 - Month 25|Protocol Violation|2|||
162908347|NCT01610414|588361414|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
162908348|NCT01610414|588361415|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
162908349|NCT01610414|588361414|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
162908350|NCT01610414|588361415|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
162908351|NCT01610414|588361414|FG000|After Month 25|Study end not reached|48|||
162908352|NCT01610414|588361415|FG001|After Month 25|Study end not reached|53|||
162908353|NCT00472043|588361417|FG000|Overall Study|Withdrawal by Subject|1|||
162908354|NCT00472043|588361418|FG001|Overall Study|Withdrawal by Subject|0|||
162908355|NCT00472043|588361417|FG000|Overall Study|Death|1|||
162908356|NCT00472043|588361418|FG001|Overall Study|Death|0|||
162908359|NCT04009824|588361422|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
162908360|NCT04009824|588361423|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
162908361|NCT04009824|588361424|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
162908362|NCT04009824|588361425|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
162908363|NCT04009824|588361426|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
162908364|NCT03147495|588361427|FG000|Overall Study|Physician Decision|0|||
162908365|NCT03147495|588361428|FG001|Overall Study|Physician Decision|6|||
162908366|NCT01024946|588361429|FG000|Overall Study|Screen Failure|3|||
162908367|NCT01024946|588361429|FG000|Overall Study|Withdrawal by Subject|1|||
162908368|NCT01024946|588361429|FG000|Overall Study|Adverse Event|1|||
162908369|NCT02608892|588361430|FG000|Overall Study|Lost to Follow-up|1|||
162908370|NCT02608892|588361431|FG001|Overall Study|Lost to Follow-up|0|||
162908371|NCT03032523|588361432|FG000|Overall Study|Withdrawal by Subject|2|||
162908372|NCT03032523|588361433|FG001|Overall Study|Withdrawal by Subject|2|||
162908373|NCT03032523|588361432|FG000|Overall Study|Physician Decision|1|||
162908374|NCT03032523|588361433|FG001|Overall Study|Physician Decision|0|||
162710457|NCT02753530|587649064|FG000|Overall Study|Physician Decision|0|||
162710458|NCT02753530|587649065|FG001|Overall Study|Physician Decision|1|||
162710459|NCT02753530|587649064|FG000|Overall Study|Protocol Violation|1|||
162908375|NCT00957723|588361434|FG000|Overall Study|Death|3|||
162908376|NCT00957723|588361434|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
162908377|NCT00957723|588361434|FG000|Overall Study|Lost to Follow-up|8|||
162908378|NCT00957723|588361434|FG000|Overall Study|Withdrawal by Subject|24|||
162908379|NCT00957723|588361434|FG000|Overall Study|Investigative Site Terminated|61|||
162908380|NCT00957723|588361434|FG000|Overall Study|Intercurrent Illness|2|||
162908381|NCT00957723|588361434|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
162908382|NCT05375838|588361435|FG000|Overall Study|Other|0|||
162710460|NCT02753530|587649065|FG001|Overall Study|Protocol Violation|0|||
162908383|NCT05375838|588361436|FG001|Overall Study|Other|0|||
162908384|NCT05375838|588361437|FG002|Overall Study|Other|0|||
162908385|NCT05375838|588361438|FG003|Overall Study|Other|1|||
162908386|NCT05375838|588361439|FG004|Overall Study|Other|1|||
162908387|NCT05375838|588361440|FG005|Overall Study|Other|0|||
162908388|NCT05375838|588361435|FG000|Overall Study|Withdrawal by Subject|2|||
162908389|NCT05375838|588361436|FG001|Overall Study|Withdrawal by Subject|1|||
162908390|NCT05375838|588361437|FG002|Overall Study|Withdrawal by Subject|3|||
162908391|NCT05375838|588361438|FG003|Overall Study|Withdrawal by Subject|2|||
162908392|NCT05375838|588361439|FG004|Overall Study|Withdrawal by Subject|2|||
162908393|NCT05375838|588361440|FG005|Overall Study|Withdrawal by Subject|0|||
162908394|NCT05375838|588361435|FG000|Overall Study|Protocol Violation|0|||
162908395|NCT05375838|588361436|FG001|Overall Study|Protocol Violation|0|||
162908396|NCT05375838|588361437|FG002|Overall Study|Protocol Violation|0|||
162908397|NCT05375838|588361438|FG003|Overall Study|Protocol Violation|0|||
162908398|NCT05375838|588361439|FG004|Overall Study|Protocol Violation|1|||
162908399|NCT05375838|588361440|FG005|Overall Study|Protocol Violation|0|||
162908400|NCT05375838|588361435|FG000|Overall Study|Physician Decision|0|||
162908401|NCT05375838|588361436|FG001|Overall Study|Physician Decision|1|||
162908402|NCT05375838|588361437|FG002|Overall Study|Physician Decision|0|||
162908403|NCT05375838|588361438|FG003|Overall Study|Physician Decision|0|||
162908404|NCT05375838|588361439|FG004|Overall Study|Physician Decision|0|||
162908405|NCT05375838|588361440|FG005|Overall Study|Physician Decision|1|||
162908406|NCT05375838|588361435|FG000|Overall Study|Lost to Follow-up|2|||
162908407|NCT05375838|588361436|FG001|Overall Study|Lost to Follow-up|7|||
162908408|NCT05375838|588361437|FG002|Overall Study|Lost to Follow-up|0|||
162908409|NCT05375838|588361438|FG003|Overall Study|Lost to Follow-up|4|||
162908410|NCT05375838|588361439|FG004|Overall Study|Lost to Follow-up|2|||
162908411|NCT05375838|588361440|FG005|Overall Study|Lost to Follow-up|3|||
162908412|NCT00877890|588361441|FG000|Overall Study|Adverse Event|6|||
162908413|NCT00877890|588361442|FG001|Overall Study|Adverse Event|6|||
162908414|NCT00877890|588361441|FG000|Overall Study|Lost to Follow-up|5|||
162908415|NCT00877890|588361442|FG001|Overall Study|Lost to Follow-up|5|||
162908416|NCT00877890|588361441|FG000|Overall Study|Protocol Violation|0|||
162908417|NCT00877890|588361442|FG001|Overall Study|Protocol Violation|1|||
162908418|NCT00877890|588361441|FG000|Overall Study|Withdrawal of Consent|6|||
162908419|NCT00877890|588361442|FG001|Overall Study|Withdrawal of Consent|12|||
162908420|NCT00877890|588361441|FG000|Overall Study|Investigator Decision|0|||
162908421|NCT00877890|588361442|FG001|Overall Study|Investigator Decision|2|||
162908422|NCT00877890|588361441|FG000|Overall Study|Loss of Glucose Control|3|||
162908423|NCT00877890|588361442|FG001|Overall Study|Loss of Glucose Control|4|||
162908424|NCT00984009|588361443|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
162908425|NCT02036476|588361450|FG000|Overall Study|Withdrawal by Subject|2|||
162908426|NCT02036476|588361450|FG000|Overall Study|Progressive Disease|4|||
162908427|NCT02036476|588361450|FG000|Overall Study|Unacceptable Toxicity|2|||
162908428|NCT02698176|588361451|FG000|Overall Study|Progressive disease|4|||
162908429|NCT02698176|588361452|FG001|Overall Study|Progressive disease|3|||
162908430|NCT02698176|588361453|FG002|Overall Study|Progressive disease|1|||
162908431|NCT02698176|588361454|FG003|Overall Study|Progressive disease|0|||
162908432|NCT02698176|588361451|FG000|Overall Study|Adverse Event|2|||
162908433|NCT02698176|588361452|FG001|Overall Study|Adverse Event|0|||
162908434|NCT02698176|588361453|FG002|Overall Study|Adverse Event|0|||
162908435|NCT02698176|588361454|FG003|Overall Study|Adverse Event|0|||
162908436|NCT02698176|588361451|FG000|Overall Study|Clinical progression|3|||
162908437|NCT02698176|588361452|FG001|Overall Study|Clinical progression|0|||
162908438|NCT02698176|588361453|FG002|Overall Study|Clinical progression|0|||
162908439|NCT02698176|588361454|FG003|Overall Study|Clinical progression|0|||
162908440|NCT02985684|588361456|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
162908441|NCT02985684|588361456|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
162908442|NCT02985684|588361456|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
162908443|NCT01640353|588363024|FG000|Overall Study|Withdrew prior to treatment|10|||
162908444|NCT01640353|588363024|FG000|Overall Study|Withdrawn from analysis at term site|12|||
162908445|NCT01640353|588363024|FG000|Overall Study|Withdrawal by Subject|5|||
162908446|NCT01640353|588363024|FG000|Overall Study|Death|2|||
162908447|NCT01640353|588363024|FG000|Overall Study|Early site termination|3|||
162908448|NCT01640353|588363024|FG000|Overall Study|Lost to Follow-up|12|||
162908449|NCT01640353|588363024|FG000|Overall Study|Physician Decision|1|||
162908450|NCT01967134|588363025|FG000|Overall Study|Lost to Follow-up|0|||
162908451|NCT01967134|588363026|FG001|Overall Study|Lost to Follow-up|1|||
162908452|NCT01967134|588363027|FG002|Overall Study|Lost to Follow-up|0|||
162908453|NCT00443534|588363028|FG000|Overall Study|Lack of Efficacy|67|||
162908454|NCT00443534|588363028|FG000|Overall Study|Adverse Event|16|||
162908455|NCT00443534|588363028|FG000|Overall Study|Death|9|||
162908456|NCT00443534|588363028|FG000|Overall Study|Withdrawal by Subject|8|||
163054340|NCT00630916|588910240|FG000|Overall Study|Lack of Efficacy|3|||
162908457|NCT00443534|588363028|FG000|Overall Study|Study Terminated by Sponsor|12|||
162908458|NCT00443534|588363028|FG000|Overall Study|Other|10|||
162908459|NCT00443534|588363028|FG000|Overall Study|Enrolled, Not Treated|1|||
162908460|NCT02679222|588363030|FG000|Overall Study|No time for project|1|||
162908461|NCT03419741|588363031|FG000|Overall Study|Adverse Event|1|||
162908462|NCT03419741|588363032|FG001|Overall Study|Adverse Event|0|||
162908463|NCT03419741|588363031|FG000|Overall Study|Withdrawal by Subject|1|||
162908464|NCT03419741|588363032|FG001|Overall Study|Withdrawal by Subject|2|||
162908465|NCT02719028|588363040|FG000|Overall Study|Adverse Event|2|||
162908466|NCT02719028|588363041|FG001|Overall Study|Adverse Event|1|||
162908467|NCT02719028|588363042|FG002|Overall Study|Adverse Event|4|||
162908468|NCT02719028|588363043|FG003|Overall Study|Adverse Event|8|||
162908469|NCT02719028|588363040|FG000|Overall Study|Physician Decision|0|||
162908470|NCT02719028|588363041|FG001|Overall Study|Physician Decision|1|||
162908471|NCT02719028|588363042|FG002|Overall Study|Physician Decision|1|||
162908472|NCT02719028|588363043|FG003|Overall Study|Physician Decision|1|||
162908473|NCT02719028|588363040|FG000|Overall Study|Use of prohibited medication|0|||
162908474|NCT02719028|588363041|FG001|Overall Study|Use of prohibited medication|0|||
162908475|NCT02719028|588363042|FG002|Overall Study|Use of prohibited medication|1|||
162908476|NCT02719028|588363043|FG003|Overall Study|Use of prohibited medication|0|||
162908477|NCT02719028|588363040|FG000|Overall Study|Protocol Violation|0|||
162908478|NCT02719028|588363041|FG001|Overall Study|Protocol Violation|0|||
162908479|NCT02719028|588363042|FG002|Overall Study|Protocol Violation|0|||
162908480|NCT02719028|588363043|FG003|Overall Study|Protocol Violation|1|||
162908481|NCT00298766|588363044|FG000|Overall Study|Adverse Event|18|||
162908482|NCT00298766|588363044|FG000|Overall Study|Death|2|||
162908483|NCT00298766|588363044|FG000|Overall Study|Withdrawal by Subject|9|||
162908484|NCT00298766|588363044|FG000|Overall Study|Treatment ongoing|4|||
162908485|NCT00298766|588363044|FG000|Overall Study|Progression of amyloid markers|4|||
162908486|NCT00298766|588363044|FG000|Overall Study|Deterioration in KPS and organ function|1|||
162908487|NCT00298766|588363044|FG000|Overall Study|Subjects overall condition deterioration|4|||
162908488|NCT00298766|588363044|FG000|Overall Study|Other|4|||
162908489|NCT00303719|588363045|FG000|Overall Study|Not evaluable, prior therapies|0|||
162908490|NCT00303719|588363046|FG001|Overall Study|Not evaluable, prior therapies|30|||
162908491|NCT00303719|588363045|FG000|Overall Study|Lost to Follow-up|0|||
162908492|NCT00303719|588363046|FG001|Overall Study|Lost to Follow-up|7|||
162908493|NCT03633461|588363053|FG000|Overall Study|Lost to Follow-up|0|||
162908494|NCT03633461|588363054|FG001|Overall Study|Lost to Follow-up|1|||
162908495|NCT00689611|588363058|FG000|Overall Study|Death|6|||
162908496|NCT00689611|588363059|FG001|Overall Study|Death|9|||
162908497|NCT00689611|588363058|FG000|Overall Study|Withdrawal by Subject|8|||
162908498|NCT00689611|588363059|FG001|Overall Study|Withdrawal by Subject|9|||
162908499|NCT00689611|588363058|FG000|Overall Study|Lost to Follow-up|27|||
162908500|NCT00689611|588363059|FG001|Overall Study|Lost to Follow-up|28|||
162908501|NCT00568399|588363061|FG000|Overall Study|Death|2|||
162908502|NCT00568399|588363061|FG000|Overall Study|Adverse Event|5|||
162908503|NCT00568399|588363061|FG000|Overall Study|Withdrawal by Subject|8|||
163054341|NCT02295644|588910241|FG000|Overall Study|Did not meet inclusion criterion|0|||
163054342|NCT02295644|588910242|FG001|Overall Study|Did not meet inclusion criterion|0|||
163054343|NCT02295644|588910243|FG002|Overall Study|Did not meet inclusion criterion|1|||
163054344|NCT02295644|588910244|FG003|Overall Study|Did not meet inclusion criterion|2|||
162908504|NCT02967562|588363066|FG000|Overall Study|Consent not obtained|1|||
162908505|NCT02967562|588363067|FG001|Overall Study|Consent not obtained|0|||
162908506|NCT02967562|588363066|FG000|Overall Study|High leak precluding analysis|1|||
162908507|NCT02967562|588363067|FG001|Overall Study|High leak precluding analysis|1|||
162908508|NCT00405756|588363068|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
162908509|NCT00405756|588363069|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
162908510|NCT00405756|588363070|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
162908511|NCT00405756|588363068|FG000|Double-blind Treatment|Adverse Event|31|||
162908512|NCT00405756|588363069|FG001|Double-blind Treatment|Adverse Event|27|||
162908513|NCT00405756|588363070|FG002|Double-blind Treatment|Adverse Event|12|||
162908514|NCT00405756|588363068|FG000|Double-blind Treatment|Disease Progression|47|||
162908515|NCT00405756|588363069|FG001|Double-blind Treatment|Disease Progression|81|||
162628171|NCT05683249|587354804|FG000|Overall Study|Withdrawal by Subject|9|||
162628172|NCT05683249|587354805|FG001|Overall Study|Withdrawal by Subject|8|||
162628173|NCT05683249|587354804|FG000|Overall Study|Other|0|||
162908516|NCT00405756|588363070|FG002|Double-blind Treatment|Disease Progression|102|||
162908517|NCT00405756|588363068|FG000|Double-blind Treatment|Lack of Efficacy|1|||
162908518|NCT00405756|588363069|FG001|Double-blind Treatment|Lack of Efficacy|4|||
162908519|NCT00405756|588363070|FG002|Double-blind Treatment|Lack of Efficacy|2|||
162908520|NCT00405756|588363068|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
162908521|NCT00405756|588363069|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
162908522|NCT00405756|588363070|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
162908523|NCT00405756|588363068|FG000|Double-blind Treatment|Lost to Follow-up|1|||
162908524|NCT00405756|588363069|FG001|Double-blind Treatment|Lost to Follow-up|0|||
162908525|NCT00405756|588363070|FG002|Double-blind Treatment|Lost to Follow-up|0|||
162908526|NCT00405756|588363068|FG000|Double-blind Treatment|Death|4|||
162908527|NCT00405756|588363069|FG001|Double-blind Treatment|Death|4|||
162908528|NCT00405756|588363070|FG002|Double-blind Treatment|Death|4|||
163054345|NCT02147626|588910245|FG000|Overall Study|Lost to Follow-up|4|||
162908529|NCT00405756|588363068|FG000|Double-blind Treatment|Protocol Violation|1|||
162908530|NCT00405756|588363069|FG001|Double-blind Treatment|Protocol Violation|0|||
162908531|NCT00405756|588363070|FG002|Double-blind Treatment|Protocol Violation|2|||
162908532|NCT00405756|588363068|FG000|Double-blind Treatment|Other|7|||
162908533|NCT00405756|588363069|FG001|Double-blind Treatment|Other|4|||
162908534|NCT00405756|588363070|FG002|Double-blind Treatment|Other|4|||
162908535|NCT00405756|588363068|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
162908536|NCT00405756|588363069|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
162908537|NCT00405756|588363070|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
162908538|NCT00405756|588363068|FG000|Open-label Extension|Adverse Event|1|||
162908539|NCT00405756|588363069|FG001|Open-label Extension|Adverse Event|3|||
162908540|NCT00405756|588363070|FG002|Open-label Extension|Adverse Event|7|||
162908541|NCT00405756|588363068|FG000|Open-label Extension|Disease Progression|8|||
162908542|NCT00405756|588363069|FG001|Open-label Extension|Disease Progression|23|||
162908543|NCT00405756|588363070|FG002|Open-label Extension|Disease Progression|26|||
162908544|NCT00405756|588363068|FG000|Open-label Extension|Withdrawal by Subject|2|||
162908545|NCT00405756|588363069|FG001|Open-label Extension|Withdrawal by Subject|3|||
162908546|NCT00405756|588363070|FG002|Open-label Extension|Withdrawal by Subject|3|||
162908547|NCT00405756|588363068|FG000|Open-label Extension|Death|1|||
162908548|NCT00405756|588363069|FG001|Open-label Extension|Death|2|||
162908549|NCT00405756|588363070|FG002|Open-label Extension|Death|4|||
162908550|NCT00405756|588363068|FG000|Open-label Extension|Other|0|||
162908551|NCT00405756|588363069|FG001|Open-label Extension|Other|1|||
162908552|NCT00405756|588363070|FG002|Open-label Extension|Other|7|||
162908553|NCT00405756|588363068|FG000|Follow-up|Ongoing in Follow-up Period|52|||
162908554|NCT00405756|588363069|FG001|Follow-up|Ongoing in Follow-up Period|51|||
162908555|NCT00405756|588363070|FG002|Follow-up|Ongoing in Follow-up Period|60|||
162908556|NCT00405756|588363068|FG000|Follow-up|Death|21|||
162908557|NCT00405756|588363069|FG001|Follow-up|Death|31|||
162908558|NCT00405756|588363070|FG002|Follow-up|Death|24|||
162908559|NCT00405756|588363068|FG000|Follow-up|Lost to Follow-up|2|||
162908560|NCT00405756|588363069|FG001|Follow-up|Lost to Follow-up|8|||
162908561|NCT00405756|588363070|FG002|Follow-up|Lost to Follow-up|4|||
162908562|NCT00286156|588363073|FG000|Overall Study|Missed 12 month visit|0|||
162908563|NCT00286156|588363074|FG001|Overall Study|Missed 12 month visit|0|||
162908564|NCT00286156|588363075|FG002|Overall Study|Missed 12 month visit|1|||
162908565|NCT00286156|588363073|FG000|Overall Study|AE: pulmonary embolus|0|||
162908566|NCT00286156|588363074|FG001|Overall Study|AE: pulmonary embolus|1|||
162628174|NCT05683249|587354805|FG001|Overall Study|Other|2|||
162628175|NCT01328431|587354806|FG000|Baseline|Protocol Violation|0|||
162908567|NCT00286156|588363075|FG002|Overall Study|AE: pulmonary embolus|0|||
162908568|NCT00286156|588363073|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
162908569|NCT00286156|588363074|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
162908570|NCT00286156|588363075|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
162908571|NCT00286156|588363073|FG000|Overall Study|AE: pneumonia|1|||
162908572|NCT00286156|588363074|FG001|Overall Study|AE: pneumonia|0|||
162908573|NCT00286156|588363075|FG002|Overall Study|AE: pneumonia|0|||
162908574|NCT00672139|588363080|FG000|Overall Study|Death|14|||
162908575|NCT00672139|588363081|FG001|Overall Study|Death|23|||
162908576|NCT00672139|588363080|FG000|Overall Study|Withdrawal by Subject|2|||
162908577|NCT00672139|588363081|FG001|Overall Study|Withdrawal by Subject|11|||
162908578|NCT00672139|588363080|FG000|Overall Study|Adverse Event|4|||
162908579|NCT00672139|588363081|FG001|Overall Study|Adverse Event|7|||
162908580|NCT00672139|588363080|FG000|Overall Study|Physician Decision|2|||
162908581|NCT00672139|588363081|FG001|Overall Study|Physician Decision|0|||
162908582|NCT00672139|588363080|FG000|Overall Study|Lack of Efficacy|4|||
162908583|NCT00672139|588363081|FG001|Overall Study|Lack of Efficacy|1|||
162908584|NCT00672139|588363080|FG000|Overall Study|Protocol Violation|1|||
162908585|NCT00672139|588363081|FG001|Overall Study|Protocol Violation|1|||
162908586|NCT00672139|588363080|FG000|Overall Study|hospice discharge, caregiver requests|3|||
162908587|NCT00672139|588363081|FG001|Overall Study|hospice discharge, caregiver requests|2|||
162908588|NCT01051856|588363082|FG000|Overall Study|Withdrawal by Subject|1|||
162908589|NCT01051856|588363083|FG001|Overall Study|Withdrawal by Subject|0|||
162908590|NCT02176226|588363084|FG000|Overall Study|Lost to Follow-up|3|||
162908591|NCT02176226|588363084|FG000|Overall Study|Withdrew prior to treatment|6|||
162908592|NCT01072500|588363087|FG000|Overall Study|Death|2|||
162908593|NCT01072500|588363088|FG001|Overall Study|Death|2|||
162908594|NCT01072500|588363087|FG000|Overall Study|Lost to Follow-up|5|||
162908595|NCT01072500|588363088|FG001|Overall Study|Lost to Follow-up|2|||
162908596|NCT01072500|588363087|FG000|Overall Study|Withdrawal by Subject|17|||
162908597|NCT01072500|588363088|FG001|Overall Study|Withdrawal by Subject|10|||
162908598|NCT00103207|588363089|FG000|Overall Study|Adverse Event|3|||
162908599|NCT00103207|588363089|FG000|Overall Study|Death|1|||
162908600|NCT00103207|588363089|FG000|Overall Study|Withdrawal by Subject|2|||
162908601|NCT00103207|588363089|FG000|Overall Study|Other complicating disease|1|||
162908602|NCT00103207|588363089|FG000|Overall Study|Ineligible|4|||
162908603|NCT00103207|588363089|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
162908604|NCT01611558|588363090|FG000|Induction Phase|Study drug toxicity|15|||
162908605|NCT01611558|588363090|FG000|Induction Phase|Disease progression|18|||
162908606|NCT01611558|588363090|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
162908607|NCT01611558|588363090|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
162908608|NCT01611558|588363090|FG000|Induction Phase|Death|1|||
162908609|NCT01611558|588363090|FG000|Maintenance Phase|Withdrawal by Subject|1|||
162908610|NCT01611558|588363090|FG000|Maintenance Phase|Elevated Uric acid|1|||
162908611|NCT01412333|588363105|FG000|Overall Study|Adverse Event|40|||
162908612|NCT01412333|588363106|FG001|Overall Study|Adverse Event|42|||
162908613|NCT01412333|588363105|FG000|Overall Study|Death|5|||
162908614|NCT01412333|588363106|FG001|Overall Study|Death|6|||
162908615|NCT01412333|588363105|FG000|Overall Study|Lack of Efficacy|22|||
162908616|NCT01412333|588363106|FG001|Overall Study|Lack of Efficacy|10|||
162908617|NCT01412333|588363105|FG000|Overall Study|Lost to Follow-up|15|||
162908618|NCT01412333|588363106|FG001|Overall Study|Lost to Follow-up|12|||
162908619|NCT01412333|588363105|FG000|Overall Study|Non-Compliance|3|||
162908620|NCT01412333|588363106|FG001|Overall Study|Non-Compliance|7|||
162908621|NCT01412333|588363105|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162908622|NCT01412333|588363106|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162908623|NCT01412333|588363105|FG000|Overall Study|Other|30|||
162908624|NCT01412333|588363106|FG001|Overall Study|Other|33|||
162908625|NCT01412333|588363105|FG000|Overall Study|Physician Decision|11|||
162908626|NCT01412333|588363106|FG001|Overall Study|Physician Decision|16|||
162908627|NCT01412333|588363105|FG000|Overall Study|Pregnancy|6|||
162908628|NCT01412333|588363106|FG001|Overall Study|Pregnancy|4|||
162908629|NCT01412333|588363105|FG000|Overall Study|Protocol Violation|1|||
162908630|NCT01412333|588363106|FG001|Overall Study|Protocol Violation|2|||
162908631|NCT01412333|588363105|FG000|Overall Study|Study Terminated By Sponsor|3|||
162908632|NCT01412333|588363106|FG001|Overall Study|Study Terminated By Sponsor|2|||
162908633|NCT01412333|588363105|FG000|Overall Study|Withdrawal by Subject|51|||
162908634|NCT01412333|588363106|FG001|Overall Study|Withdrawal by Subject|54|||
162908635|NCT01412333|588363105|FG000|Overall Study|Missing|1|||
162908636|NCT01412333|588363106|FG001|Overall Study|Missing|3|||
162908637|NCT04005885|588363107|FG000|First Intervention|Withdrawal by Subject|1|||
162908638|NCT04005885|588363108|FG001|First Intervention|Withdrawal by Subject|1|||
162908639|NCT04005885|588363107|FG000|Second Intervention|Withdrawal by Subject|0|||
162908640|NCT04005885|588363108|FG001|Second Intervention|Withdrawal by Subject|2|||
162908641|NCT01038635|588363110|FG000|Overall Study|Disease Progression|2|||
162908642|NCT01038635|588363111|FG001|Overall Study|Disease Progression|0|||
162908643|NCT01038635|588363112|FG002|Overall Study|Disease Progression|0|||
162908644|NCT01038635|588363113|FG003|Overall Study|Disease Progression|0|||
162908645|NCT01038635|588363114|FG004|Overall Study|Disease Progression|0|||
162908646|NCT01038635|588363115|FG005|Overall Study|Disease Progression|0|||
162908647|NCT01038635|588363116|FG006|Overall Study|Disease Progression|1|||
162908648|NCT01038635|588363117|FG007|Overall Study|Disease Progression|4|||
162908649|NCT01038635|588363118|FG008|Overall Study|Disease Progression|0|||
162908650|NCT01038635|588363110|FG000|Overall Study|Death|0|||
162908651|NCT01038635|588363111|FG001|Overall Study|Death|0|||
162908652|NCT01038635|588363112|FG002|Overall Study|Death|0|||
162908653|NCT01038635|588363113|FG003|Overall Study|Death|0|||
162908654|NCT01038635|588363114|FG004|Overall Study|Death|1|||
162908655|NCT01038635|588363115|FG005|Overall Study|Death|0|||
162908656|NCT01038635|588363116|FG006|Overall Study|Death|1|||
162908657|NCT01038635|588363117|FG007|Overall Study|Death|1|||
162908658|NCT01038635|588363118|FG008|Overall Study|Death|2|||
162967539|NCT01350934|588582946|FG001|Extension Study|Withdrawal by Subject|1|||
162908659|NCT01227252|588363119|FG000|Overall Study|Sponsor Decision|0|||
162908660|NCT01227252|588363120|FG001|Overall Study|Sponsor Decision|1|||
162908661|NCT01227252|588363121|FG002|Overall Study|Sponsor Decision|0|||
162908662|NCT01227252|588363122|FG003|Overall Study|Sponsor Decision|0|||
162908663|NCT01227252|588363119|FG000|Overall Study|Lost to Follow-up|0|||
162908664|NCT01227252|588363120|FG001|Overall Study|Lost to Follow-up|1|||
162908665|NCT01227252|588363121|FG002|Overall Study|Lost to Follow-up|0|||
162908666|NCT01227252|588363122|FG003|Overall Study|Lost to Follow-up|0|||
162908667|NCT01227252|588363119|FG000|Overall Study|Withdrawal by Subject|0|||
162908668|NCT01227252|588363120|FG001|Overall Study|Withdrawal by Subject|1|||
162908669|NCT01227252|588363121|FG002|Overall Study|Withdrawal by Subject|0|||
162908670|NCT01227252|588363122|FG003|Overall Study|Withdrawal by Subject|0|||
162908671|NCT01034709|588363124|FG000|Overall Study|Protocol Violation|9|||
162908672|NCT01034709|588363125|FG001|Overall Study|Protocol Violation|16|||
162908673|NCT03227692|588363126|FG000|Overall Study|Protocol Violation|1|||
162908674|NCT03227692|588363127|FG001|Overall Study|Protocol Violation|1|||
162908675|NCT03227692|588363126|FG000|Overall Study|Lost to Follow-up|4|||
162908676|NCT03227692|588363127|FG001|Overall Study|Lost to Follow-up|2|||
162908677|NCT03227692|588363126|FG000|Overall Study|Adverse Event|0|||
162908678|NCT03227692|588363127|FG001|Overall Study|Adverse Event|2|||
162908679|NCT02447952|588363128|FG000|Overall Study|Adverse Event|2|||
162908680|NCT02447952|588363128|FG000|Overall Study|Physician Decision|1|||
162908681|NCT02447952|588363128|FG000|Overall Study|Withdrawal by Subject|4|||
162908682|NCT01683058|588363129|FG000|Overall Study|Lost to Follow-up|9|||
162908683|NCT01683058|588363129|FG000|Overall Study|Adverse Event|6|||
162628176|NCT01328431|587354807|FG001|Baseline|Protocol Violation|2|||
162628177|NCT01328431|587354806|FG000|1 Month (1M)|Lost to Follow-up|55|||
162628178|NCT01328431|587354807|FG001|1 Month (1M)|Lost to Follow-up|58|||
162628179|NCT01328431|587354806|FG000|3 Month (3M)|Death|2|||
162628180|NCT01328431|587354807|FG001|3 Month (3M)|Death|2|||
162908684|NCT01683058|588363129|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
162908685|NCT01683058|588363129|FG000|Overall Study|Withdrawal by Subject|7|||
162908686|NCT01683058|588363129|FG000|Overall Study|Lack of Efficacy|2|||
162908687|NCT01195636|588363130|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
162908688|NCT01195636|588363131|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
162908689|NCT01195636|588363130|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
162908690|NCT01195636|588363131|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
162908691|NCT01195636|588363130|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162908692|NCT01195636|588363131|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
162908693|NCT01195636|588363130|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
162908694|NCT01195636|588363131|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
162908695|NCT01195636|588363130|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
162908696|NCT01195636|588363131|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
162908697|NCT01195636|588363130|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
162908698|NCT01195636|588363131|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
162908699|NCT01195636|588363130|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
162908700|NCT01195636|588363131|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
162908701|NCT01195636|588363130|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
162908702|NCT01195636|588363131|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
162908703|NCT01566981|588363132|FG000|Overall Study|Lost to Follow-up|5|||
162908704|NCT01566981|588363133|FG001|Overall Study|Lost to Follow-up|8|||
162628181|NCT01328431|587354806|FG000|3 Month (3M)|Lost to Follow-up|75|||
162628182|NCT01328431|587354807|FG001|3 Month (3M)|Lost to Follow-up|70|||
162967540|NCT02415387|588582947|FG000|Overall Study|Withdrawal by Subject|6|||
162967541|NCT02415387|588582948|FG001|Overall Study|Withdrawal by Subject|1|||
162967542|NCT02415387|588582947|FG000|Overall Study|blood draw problem|0|||
162967543|NCT02415387|588582948|FG001|Overall Study|blood draw problem|1|||
162967544|NCT02415387|588582947|FG000|Overall Study|Protocol Violation|1|||
162967545|NCT02415387|588582948|FG001|Overall Study|Protocol Violation|0|||
162967546|NCT02733627|588582950|FG000|Overall Study|Adverse Event|0|||
162967547|NCT02733627|588582951|FG001|Overall Study|Adverse Event|1|||
162967548|NCT02733627|588582952|FG002|Overall Study|Adverse Event|1|||
162967549|NCT02733627|588582953|FG003|Overall Study|Adverse Event|0|||
162967550|NCT02733627|588582950|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967551|NCT02733627|588582951|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967552|NCT02733627|588582952|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
162967553|NCT02733627|588582953|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
162967554|NCT02246764|588582954|FG000|Overall Study|Adverse Event|15|||
162967555|NCT02246764|588582955|FG001|Overall Study|Adverse Event|29|||
162967556|NCT02246764|588582956|FG002|Overall Study|Adverse Event|1|||
162967557|NCT02246764|588582954|FG000|Overall Study|Withdrawal by Subject|0|||
162967558|NCT02246764|588582955|FG001|Overall Study|Withdrawal by Subject|0|||
162967559|NCT02246764|588582956|FG002|Overall Study|Withdrawal by Subject|1|||
162967560|NCT02246764|588582954|FG000|Overall Study|Disallowed Concomitant Medication|1|||
162967561|NCT02246764|588582955|FG001|Overall Study|Disallowed Concomitant Medication|0|||
162967562|NCT02246764|588582956|FG002|Overall Study|Disallowed Concomitant Medication|0|||
162967563|NCT02246764|588582954|FG000|Overall Study|Physician Decision|0|||
162967564|NCT02246764|588582955|FG001|Overall Study|Physician Decision|2|||
162967565|NCT02246764|588582956|FG002|Overall Study|Physician Decision|1|||
162967566|NCT02246764|588582954|FG000|Overall Study|Protocol Violation|2|||
162967567|NCT02246764|588582955|FG001|Overall Study|Protocol Violation|1|||
162967568|NCT02246764|588582956|FG002|Overall Study|Protocol Violation|1|||
162967569|NCT05393271|588582957|FG000|Overall Study|Physician Decision|0|||
162967570|NCT05393271|588582958|FG001|Overall Study|Physician Decision|0|||
162967571|NCT05393271|588582959|FG002|Overall Study|Physician Decision|0|||
162967572|NCT05393271|588582960|FG003|Overall Study|Physician Decision|0|||
162967573|NCT05393271|588582961|FG004|Overall Study|Physician Decision|0|||
162967574|NCT05393271|588582962|FG005|Overall Study|Physician Decision|0|||
162628183|NCT01328431|587354806|FG000|12 Month (12M)|Death|2|||
162908705|NCT02405091|588363134|FG000|Overall Study|Adverse Event|16|||
162967575|NCT05393271|588582963|FG006|Overall Study|Physician Decision|1|||
162967576|NCT05393271|588582964|FG007|Overall Study|Physician Decision|0|||
162967577|NCT05393271|588582965|FG008|Overall Study|Physician Decision|0|||
162967578|NCT05393271|588582966|FG009|Overall Study|Physician Decision|0|||
162967579|NCT05393271|588582967|FG010|Overall Study|Physician Decision|0|||
162967580|NCT02048813|588582968|FG000|Overall Study|Still on treatment|279|||
162908706|NCT02405091|588363135|FG001|Overall Study|Adverse Event|10|||
162908707|NCT02405091|588363136|FG002|Overall Study|Adverse Event|0|||
162967581|NCT02048813|588582969|FG001|Overall Study|Still on treatment|0|||
162628184|NCT01328431|587354807|FG001|12 Month (12M)|Death|6|||
162908708|NCT02405091|588363134|FG000|Overall Study|Protocol Violation|1|||
162908709|NCT02405091|588363135|FG001|Overall Study|Protocol Violation|0|||
162908710|NCT02405091|588363136|FG002|Overall Study|Protocol Violation|0|||
162908711|NCT02405091|588363134|FG000|Overall Study|Noncompliance|1|||
162908712|NCT02405091|588363135|FG001|Overall Study|Noncompliance|6|||
162908713|NCT02405091|588363136|FG002|Overall Study|Noncompliance|2|||
162908714|NCT02405091|588363134|FG000|Overall Study|Withdrawal by Subject|4|||
162908715|NCT02405091|588363135|FG001|Overall Study|Withdrawal by Subject|8|||
162908716|NCT02405091|588363136|FG002|Overall Study|Withdrawal by Subject|0|||
162908717|NCT02405091|588363134|FG000|Overall Study|Death|0|||
162908718|NCT02405091|588363135|FG001|Overall Study|Death|1|||
162908719|NCT02405091|588363136|FG002|Overall Study|Death|0|||
162908720|NCT02405091|588363134|FG000|Overall Study|Lost to Follow-up|5|||
162908721|NCT02405091|588363135|FG001|Overall Study|Lost to Follow-up|6|||
162908722|NCT02405091|588363136|FG002|Overall Study|Lost to Follow-up|0|||
162908723|NCT02405091|588363134|FG000|Overall Study|Physician Decision|2|||
162908724|NCT02405091|588363135|FG001|Overall Study|Physician Decision|2|||
162908725|NCT02405091|588363136|FG002|Overall Study|Physician Decision|0|||
162908726|NCT01012037|588363146|FG000|Overall Study|Adverse Event|0|||
162908727|NCT01012037|588363147|FG001|Overall Study|Adverse Event|8|||
162908728|NCT01012037|588363148|FG002|Overall Study|Adverse Event|3|||
162908729|NCT01012037|588363146|FG000|Overall Study|Protocol Violation|0|||
162908730|NCT01012037|588363147|FG001|Overall Study|Protocol Violation|3|||
162908731|NCT01012037|588363148|FG002|Overall Study|Protocol Violation|5|||
162908732|NCT01012037|588363146|FG000|Overall Study|Withdrawal by Subject|0|||
162908733|NCT01012037|588363147|FG001|Overall Study|Withdrawal by Subject|4|||
162908734|NCT01012037|588363148|FG002|Overall Study|Withdrawal by Subject|1|||
162908735|NCT01012037|588363146|FG000|Overall Study|Other reason (not specified)|1|||
162908736|NCT01012037|588363147|FG001|Overall Study|Other reason (not specified)|1|||
162908737|NCT01012037|588363148|FG002|Overall Study|Other reason (not specified)|1|||
162908738|NCT00590031|588363152|FG000|Overall Study|Adverse Event|3|||
162908739|NCT00590031|588363152|FG000|Overall Study|Withdrawal by Subject|1|||
162908740|NCT00590031|588363152|FG000|Overall Study|Metastatic Disease|1|||
162908741|NCT00590031|588363152|FG000|Overall Study|Admin Hold|1|||
162908742|NCT01809327|588363153|FG000|Overall Study|Lost to Follow-up|5|||
162908743|NCT01809327|588363154|FG001|Overall Study|Lost to Follow-up|2|||
162908744|NCT01809327|588363155|FG002|Overall Study|Lost to Follow-up|4|||
162908745|NCT01809327|588363156|FG003|Overall Study|Lost to Follow-up|2|||
162908746|NCT01809327|588363157|FG004|Overall Study|Lost to Follow-up|3|||
162908747|NCT01809327|588363153|FG000|Overall Study|Withdrawal by Subject|6|||
162908748|NCT01809327|588363154|FG001|Overall Study|Withdrawal by Subject|4|||
162908749|NCT01809327|588363155|FG002|Overall Study|Withdrawal by Subject|4|||
162908750|NCT01809327|588363156|FG003|Overall Study|Withdrawal by Subject|2|||
162908751|NCT01809327|588363157|FG004|Overall Study|Withdrawal by Subject|5|||
162908752|NCT01809327|588363153|FG000|Overall Study|Adverse Event|4|||
162908753|NCT01809327|588363154|FG001|Overall Study|Adverse Event|3|||
162908754|NCT01809327|588363155|FG002|Overall Study|Adverse Event|7|||
162908755|NCT01809327|588363156|FG003|Overall Study|Adverse Event|4|||
162908756|NCT01809327|588363157|FG004|Overall Study|Adverse Event|8|||
162908757|NCT01809327|588363153|FG000|Overall Study|Death|1|||
162908758|NCT01809327|588363154|FG001|Overall Study|Death|0|||
162908759|NCT01809327|588363155|FG002|Overall Study|Death|0|||
162908760|NCT01809327|588363156|FG003|Overall Study|Death|0|||
162908761|NCT01809327|588363157|FG004|Overall Study|Death|0|||
162908762|NCT01809327|588363153|FG000|Overall Study|Protocol Violation|0|||
162908763|NCT01809327|588363154|FG001|Overall Study|Protocol Violation|1|||
162908764|NCT01809327|588363155|FG002|Overall Study|Protocol Violation|0|||
162908765|NCT01809327|588363156|FG003|Overall Study|Protocol Violation|0|||
162908766|NCT01809327|588363157|FG004|Overall Study|Protocol Violation|0|||
162908767|NCT01809327|588363153|FG000|Overall Study|Physician Decision|1|||
162908768|NCT01809327|588363154|FG001|Overall Study|Physician Decision|1|||
162908769|NCT01809327|588363155|FG002|Overall Study|Physician Decision|0|||
162628185|NCT01328431|587354806|FG000|12 Month (12M)|Lost to Follow-up|82|||
162908770|NCT01809327|588363156|FG003|Overall Study|Physician Decision|0|||
162908771|NCT01809327|588363157|FG004|Overall Study|Physician Decision|0|||
162908772|NCT01809327|588363153|FG000|Overall Study|Pregnancy|1|||
162908773|NCT01809327|588363154|FG001|Overall Study|Pregnancy|0|||
162908774|NCT01809327|588363155|FG002|Overall Study|Pregnancy|0|||
162908775|NCT01809327|588363156|FG003|Overall Study|Pregnancy|0|||
162908776|NCT01809327|588363157|FG004|Overall Study|Pregnancy|0|||
162908777|NCT01809327|588363153|FG000|Overall Study|Other|14|||
162908778|NCT01809327|588363154|FG001|Overall Study|Other|15|||
162908779|NCT01809327|588363155|FG002|Overall Study|Other|7|||
162908780|NCT01809327|588363156|FG003|Overall Study|Other|4|||
162908781|NCT01809327|588363157|FG004|Overall Study|Other|9|||
162908782|NCT01166386|588363159|FG000|Overall Study|Withdrawal by Subject|3|||
162908783|NCT01166386|588363160|FG001|Overall Study|Withdrawal by Subject|5|||
162908784|NCT02802735|588363161|FG000|Overall Study|Withdrawal by Subject|0|||
162908785|NCT02802735|588363162|FG001|Overall Study|Withdrawal by Subject|1|||
162908786|NCT02802735|588363163|FG002|Overall Study|Withdrawal by Subject|0|||
162908787|NCT02802735|588363164|FG003|Overall Study|Withdrawal by Subject|0|||
163054346|NCT02147626|588910246|FG001|Overall Study|Lost to Follow-up|4|||
163054347|NCT02147626|588910245|FG000|Overall Study|Pregnancy|1|||
163054348|NCT02147626|588910246|FG001|Overall Study|Pregnancy|2|||
163054349|NCT02147626|588910245|FG000|Overall Study|Withdrawal by Subject|0|||
162628186|NCT01328431|587354807|FG001|12 Month (12M)|Lost to Follow-up|91|||
162908788|NCT02802735|588363165|FG004|Overall Study|Withdrawal by Subject|0|||
162628187|NCT02256631|587354810|FG000|Overall Study|Lost to Follow-up|1|||
162628188|NCT02256631|587354811|FG001|Overall Study|Lost to Follow-up|1|||
162628189|NCT02256631|587354812|FG002|Overall Study|Lost to Follow-up|0|||
162628190|NCT02256631|587354813|FG003|Overall Study|Lost to Follow-up|2|||
162628191|NCT02256631|587354814|FG004|Overall Study|Lost to Follow-up|0|||
162628192|NCT02256631|587354815|FG005|Overall Study|Lost to Follow-up|4|||
162628193|NCT02256631|587354816|FG006|Overall Study|Lost to Follow-up|1|||
162908789|NCT03922711|588363168|FG000|Overall Study|Adverse Event|3|||
162908790|NCT03922711|588363169|FG001|Overall Study|Adverse Event|2|||
162908791|NCT03922711|588363170|FG002|Overall Study|Adverse Event|2|||
162908792|NCT03922711|588363168|FG000|Overall Study|Protocol Violation|1|||
162908793|NCT03922711|588363169|FG001|Overall Study|Protocol Violation|0|||
162908794|NCT03922711|588363170|FG002|Overall Study|Protocol Violation|0|||
162908795|NCT03922711|588363168|FG000|Overall Study|Withdrawal by Subject|0|||
162908796|NCT03922711|588363169|FG001|Overall Study|Withdrawal by Subject|3|||
162908797|NCT03922711|588363170|FG002|Overall Study|Withdrawal by Subject|1|||
162908798|NCT03922711|588363168|FG000|Overall Study|Not further specified|0|||
162908799|NCT03922711|588363169|FG001|Overall Study|Not further specified|0|||
162628194|NCT02256631|587354810|FG000|Overall Study|Withdrawal by Subject|0|||
162628195|NCT02256631|587354811|FG001|Overall Study|Withdrawal by Subject|0|||
162628196|NCT02256631|587354812|FG002|Overall Study|Withdrawal by Subject|0|||
162628197|NCT02256631|587354813|FG003|Overall Study|Withdrawal by Subject|1|||
162628198|NCT02256631|587354814|FG004|Overall Study|Withdrawal by Subject|1|||
162628199|NCT02256631|587354815|FG005|Overall Study|Withdrawal by Subject|0|||
162628200|NCT02256631|587354816|FG006|Overall Study|Withdrawal by Subject|1|||
162628201|NCT02256631|587354810|FG000|Overall Study|Unable to get to clinic|0|||
162628202|NCT02256631|587354811|FG001|Overall Study|Unable to get to clinic|2|||
162628203|NCT02256631|587354812|FG002|Overall Study|Unable to get to clinic|0|||
162628204|NCT02256631|587354813|FG003|Overall Study|Unable to get to clinic|1|||
162628205|NCT02256631|587354814|FG004|Overall Study|Unable to get to clinic|0|||
162628206|NCT02256631|587354815|FG005|Overall Study|Unable to get to clinic|1|||
162628207|NCT02256631|587354816|FG006|Overall Study|Unable to get to clinic|2|||
162628208|NCT01427972|587354817|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628209|NCT01427972|587354818|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628210|NCT01427972|587354819|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628211|NCT01427972|587354820|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628212|NCT01427972|587354821|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628213|NCT01427972|587354822|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628214|NCT01427972|587354823|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628215|NCT01427972|587354824|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
162628216|NCT01427972|587354825|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628217|NCT01427972|587354826|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628218|NCT01427972|587354827|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628219|NCT01427972|587354828|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162628220|NCT01427972|587354817|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628221|NCT01427972|587354818|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628222|NCT01427972|587354819|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628223|NCT01427972|587354820|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628224|NCT01427972|587354821|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628225|NCT01427972|587354822|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
162628226|NCT01427972|587354823|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162710461|NCT02753530|587649064|FG000|Overall Study|Withdrawal by Subject|4|||
162908800|NCT03922711|588363170|FG002|Overall Study|Not further specified|1|||
162908801|NCT00420212|588363173|FG000|Overall Study|Adverse Event|22|||
162908802|NCT00420212|588363174|FG001|Overall Study|Adverse Event|40|||
162908803|NCT00420212|588363175|FG002|Overall Study|Adverse Event|36|||
162908804|NCT00420212|588363173|FG000|Overall Study|Lost to Follow-up|9|||
162908805|NCT00420212|588363174|FG001|Overall Study|Lost to Follow-up|11|||
162908806|NCT00420212|588363175|FG002|Overall Study|Lost to Follow-up|11|||
162908807|NCT00420212|588363173|FG000|Overall Study|Withdrawal by Subject|31|||
163054350|NCT02147626|588910246|FG001|Overall Study|Withdrawal by Subject|1|||
162908808|NCT00420212|588363174|FG001|Overall Study|Withdrawal by Subject|22|||
163054351|NCT00423046|588910248|FG000|Overall Study|Other|340|||
162628227|NCT01427972|587354824|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162710462|NCT02753530|587649065|FG001|Overall Study|Withdrawal by Subject|3|||
162908809|NCT00420212|588363175|FG002|Overall Study|Withdrawal by Subject|19|||
162908810|NCT00420212|588363173|FG000|Overall Study|Physician Decision|4|||
162908811|NCT00420212|588363174|FG001|Overall Study|Physician Decision|4|||
162908812|NCT00420212|588363175|FG002|Overall Study|Physician Decision|3|||
163054352|NCT00423046|588910249|FG001|Overall Study|Other|345|||
162628228|NCT01427972|587354825|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628229|NCT01427972|587354826|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628230|NCT01427972|587354827|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162628231|NCT01427972|587354828|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162908813|NCT00420212|588363173|FG000|Overall Study|Protocol Violation|4|||
162908814|NCT00420212|588363174|FG001|Overall Study|Protocol Violation|4|||
162908815|NCT00420212|588363175|FG002|Overall Study|Protocol Violation|8|||
162908816|NCT00420212|588363173|FG000|Overall Study|Death|0|||
162908817|NCT00420212|588363174|FG001|Overall Study|Death|0|||
162908818|NCT00420212|588363175|FG002|Overall Study|Death|1|||
162908819|NCT00420212|588363173|FG000|Overall Study|Other-Unspecified|21|||
162908820|NCT00420212|588363174|FG001|Overall Study|Other-Unspecified|14|||
162908821|NCT00420212|588363175|FG002|Overall Study|Other-Unspecified|18|||
162908822|NCT02390362|588363176|FG000|Overall Study|Withdrawal by Subject|0|||
162908823|NCT02390362|588363177|FG001|Overall Study|Withdrawal by Subject|1|||
162908824|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
162908825|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
162908826|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
162908827|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
162908828|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
162908829|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
162908830|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
162908831|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
162908832|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
162908833|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
162908834|NCT02178592|588363178|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
162908835|NCT02178592|588363179|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
162908836|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
162908837|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
162908838|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
162908839|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
162628232|NCT01427972|587354817|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162908840|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
162628233|NCT01427972|587354818|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
162628234|NCT01427972|587354819|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628235|NCT01427972|587354820|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628236|NCT01427972|587354821|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162710463|NCT03590743|587649067|FG000|Overall Study|Withdrawal by Subject|0|||
162710464|NCT03590743|587649068|FG001|Overall Study|Withdrawal by Subject|1|||
162908841|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
162908842|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
162908843|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
162908844|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
162908845|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
162908846|NCT02178592|588363178|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
162908847|NCT02178592|588363179|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
162908848|NCT02067104|588363184|FG000|Overall Study|Study termination due to low accrual|4|||
162908849|NCT02067104|588363185|FG001|Overall Study|Study termination due to low accrual|5|||
162908850|NCT02610231|588363186|FG000|Overall Study|Withdrawal by Subject|27|||
162908851|NCT02610231|588363186|FG000|Overall Study|Adverse Event|20|||
162908852|NCT02610231|588363186|FG000|Overall Study|Death|5|||
162908853|NCT02610231|588363186|FG000|Overall Study|Surgery|2|||
162908854|NCT02610231|588363186|FG000|Overall Study|Physician Decision|1|||
162908855|NCT02610231|588363186|FG000|Overall Study|Non Compliance|2|||
162908856|NCT02610231|588363186|FG000|Overall Study|Other|3|||
162908857|NCT01279954|588363189|FG000|Overall Study|Lack of Efficacy|3|||
162908858|NCT01279954|588363190|FG001|Overall Study|Lack of Efficacy|4|||
162908859|NCT02140762|588363191|FG000|Overall Study|Adverse Event|1|||
162908860|NCT02140762|588363192|FG001|Overall Study|Adverse Event|1|||
162908861|NCT02140762|588363191|FG000|Overall Study|Lost to Follow-up|9|||
162908862|NCT02140762|588363192|FG001|Overall Study|Lost to Follow-up|5|||
162908863|NCT02140762|588363191|FG000|Overall Study|Protocol Violation|1|||
162908864|NCT02140762|588363192|FG001|Overall Study|Protocol Violation|1|||
162908865|NCT02140762|588363191|FG000|Overall Study|Withdrawal by Subject|6|||
162908866|NCT02140762|588363192|FG001|Overall Study|Withdrawal by Subject|4|||
162908867|NCT02140762|588363191|FG000|Overall Study|Other|0|||
162908868|NCT02140762|588363192|FG001|Overall Study|Other|1|||
162908869|NCT01711359|588363194|FG000|Treatment Period|Withdrawal by Subject|18|||
162908870|NCT01711359|588363195|FG001|Treatment Period|Withdrawal by Subject|7|||
162908871|NCT01711359|588363196|FG002|Treatment Period|Withdrawal by Subject|13|||
162908872|NCT01711359|588363194|FG000|Treatment Period|Lack of Efficacy|13|||
162908873|NCT01711359|588363195|FG001|Treatment Period|Lack of Efficacy|2|||
162908874|NCT01711359|588363196|FG002|Treatment Period|Lack of Efficacy|2|||
162908875|NCT01711359|588363194|FG000|Treatment Period|Adverse Event|8|||
162908876|NCT01711359|588363195|FG001|Treatment Period|Adverse Event|10|||
162908877|NCT01711359|588363196|FG002|Treatment Period|Adverse Event|24|||
162908878|NCT01711359|588363194|FG000|Treatment Period|Physician Decision|4|||
162908879|NCT01711359|588363195|FG001|Treatment Period|Physician Decision|3|||
162908880|NCT01711359|588363196|FG002|Treatment Period|Physician Decision|2|||
162908881|NCT01711359|588363194|FG000|Treatment Period|Death|3|||
162908882|NCT01711359|588363195|FG001|Treatment Period|Death|0|||
162908883|NCT01711359|588363196|FG002|Treatment Period|Death|0|||
162908884|NCT01711359|588363194|FG000|Treatment Period|Entry Criteria Not Met|1|||
162908885|NCT01711359|588363195|FG001|Treatment Period|Entry Criteria Not Met|0|||
162908886|NCT01711359|588363196|FG002|Treatment Period|Entry Criteria Not Met|0|||
162908887|NCT01711359|588363194|FG000|Treatment Period|Sponsor Decision|1|||
162908888|NCT01711359|588363195|FG001|Treatment Period|Sponsor Decision|0|||
162908889|NCT01711359|588363196|FG002|Treatment Period|Sponsor Decision|0|||
162908890|NCT01711359|588363194|FG000|Treatment Period|Lost to Follow-up|1|||
162908891|NCT01711359|588363195|FG001|Treatment Period|Lost to Follow-up|1|||
162908892|NCT01711359|588363196|FG002|Treatment Period|Lost to Follow-up|1|||
163054353|NCT01038687|588910250|FG000|Overall Study|Adverse Event|0|||
163054354|NCT01038687|588910251|FG001|Overall Study|Adverse Event|2|||
163054355|NCT01038687|588910252|FG002|Overall Study|Adverse Event|1|||
163054356|NCT02783911|588910253|FG000|Overall Study|Lost to Follow-up|3|||
163054357|NCT02783911|588910254|FG001|Overall Study|Lost to Follow-up|32|||
163054358|NCT02616783|588910255|FG000|Overall Study|Randomized but Not Treated|1|||
163054359|NCT02616783|588910256|FG001|Overall Study|Randomized but Not Treated|0|||
163054360|NCT02616783|588910255|FG000|Overall Study|Adverse Event|1|||
163054361|NCT02616783|588910256|FG001|Overall Study|Adverse Event|0|||
163054362|NCT02616783|588910255|FG000|Overall Study|Death|1|||
162908893|NCT01711359|588363194|FG000|Treatment Period|Randomized, Not Treated|3|||
162908894|NCT01711359|588363195|FG001|Treatment Period|Randomized, Not Treated|1|||
162908895|NCT01711359|588363196|FG002|Treatment Period|Randomized, Not Treated|0|||
162908896|NCT01385098|588363197|FG000|Overall Study|Adverse Event|10|||
162908897|NCT01385098|588363197|FG000|Overall Study|Lost to Follow-up|4|||
162908898|NCT00795717|588363198|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
162908899|NCT00795717|588363199|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
162908900|NCT00795717|588363198|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
162908901|NCT00795717|588363199|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
162908902|NCT00795717|588363198|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
162908903|NCT00795717|588363199|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
162908904|NCT00795717|588363198|FG000|Phase II|too busy|0|||
162908905|NCT00795717|588363199|FG001|Phase II|too busy|1|||
162908906|NCT02551874|588364658|FG000|Overall Study|Lost to Follow-up|0|||
162908907|NCT02551874|588364659|FG001|Overall Study|Lost to Follow-up|2|||
162908908|NCT02551874|588364658|FG000|Overall Study|Pregnancy|0|||
162908909|NCT02551874|588364659|FG001|Overall Study|Pregnancy|1|||
162908910|NCT02551874|588364658|FG000|Overall Study|Reason not reported|10|||
162908911|NCT02551874|588364659|FG001|Overall Study|Reason not reported|4|||
162908912|NCT02551874|588364658|FG000|Overall Study|Did not receive randomized treatment|0|||
162908913|NCT02551874|588364659|FG001|Overall Study|Did not receive randomized treatment|7|||
162908914|NCT02551874|588364658|FG000|Overall Study|Did not enter long-term study|18|||
162908915|NCT02551874|588364659|FG001|Overall Study|Did not enter long-term study|25|||
162908916|NCT04067310|588364661|FG000|Overall Study|Physician Decision|2|||
162908917|NCT04067310|588364662|FG001|Overall Study|Physician Decision|6|||
162908918|NCT04067310|588364661|FG000|Overall Study|Lost to Follow-up|0|||
162908919|NCT04067310|588364662|FG001|Overall Study|Lost to Follow-up|1|||
162908920|NCT04067310|588364661|FG000|Overall Study|Withdrawal by Subject|3|||
162908921|NCT04067310|588364662|FG001|Overall Study|Withdrawal by Subject|0|||
162908922|NCT01041027|588364663|FG000|Overall Study|Withdrawal by Subject|2|||
162908923|NCT01041027|588364663|FG000|Overall Study|Protocol Violation|1|||
162908924|NCT01041027|588364663|FG000|Overall Study|Delayed Radiation Therapy|1|||
162908925|NCT01041027|588364663|FG000|Overall Study|Adverse Event|4|||
162908926|NCT02493712|588364664|FG000|Overall Study|Withdrawal by Subject|1|||
162908927|NCT02493712|588364665|FG001|Overall Study|Withdrawal by Subject|0|||
162908928|NCT02493712|588364666|FG002|Overall Study|Withdrawal by Subject|2|||
162908929|NCT02493712|588364664|FG000|Overall Study|Protocol Violation|0|||
162908930|NCT02493712|588364665|FG001|Overall Study|Protocol Violation|0|||
162908931|NCT02493712|588364666|FG002|Overall Study|Protocol Violation|1|||
162908932|NCT02493712|588364664|FG000|Overall Study|Lost to Follow-up|1|||
162908933|NCT02493712|588364665|FG001|Overall Study|Lost to Follow-up|0|||
162908934|NCT02493712|588364666|FG002|Overall Study|Lost to Follow-up|0|||
162908935|NCT02493712|588364664|FG000|Overall Study|Physician Decision|0|||
162908936|NCT02493712|588364665|FG001|Overall Study|Physician Decision|1|||
162908937|NCT02493712|588364666|FG002|Overall Study|Physician Decision|0|||
162908938|NCT02493712|588364664|FG000|Overall Study|Lack of Efficacy|0|||
162908939|NCT02493712|588364665|FG001|Overall Study|Lack of Efficacy|5|||
162908940|NCT02493712|588364666|FG002|Overall Study|Lack of Efficacy|3|||
162908941|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
162908942|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
162908943|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
162908944|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
162908945|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
162908946|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
162908947|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
162628237|NCT01427972|587354822|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628238|NCT01427972|587354823|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628239|NCT01427972|587354824|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628240|NCT01427972|587354825|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628241|NCT01427972|587354826|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628242|NCT01427972|587354827|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628243|NCT01427972|587354828|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162628244|NCT02094677|587354829|FG000|Overall Study|Screening|3|||
162628245|NCT02094677|587354830|FG001|Overall Study|Screening|1|||
162628246|NCT04967443|587354834|FG000|Open Label Treatment|Death|1|||
162628247|NCT04967443|587354835|FG001|Open Label Treatment|Death|0|||
162628248|NCT04967443|587354836|FG002|Open Label Treatment|Death|0|||
162628249|NCT04967443|587354837|FG003|Open Label Treatment|Death|0|||
162628250|NCT04967443|587354838|FG004|Open Label Treatment|Death|0|||
162628251|NCT04967443|587354839|FG005|Open Label Treatment|Death|0|||
162628252|NCT04967443|587354840|FG006|Open Label Treatment|Death|0|||
162628253|NCT04967443|587354841|FG007|Open Label Treatment|Death|0|||
162628254|NCT04967443|587354834|FG000|Open Label Treatment|Lost to Follow-up|0|||
162628255|NCT04967443|587354835|FG001|Open Label Treatment|Lost to Follow-up|0|||
162628256|NCT04967443|587354836|FG002|Open Label Treatment|Lost to Follow-up|1|||
162908948|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
162908949|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
162908950|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
162908951|NCT02528643|588364667|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
162908952|NCT02528643|588364668|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
162908953|NCT02528643|588364667|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
162908954|NCT02528643|588364668|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
162908955|NCT02058940|588364669|FG000|Overall Study|Discharged from Critical Care Unit|1|||
162908956|NCT04144140|588364670|FG000|Overall Study|Other|0|||
162908957|NCT04144140|588364671|FG001|Overall Study|Other|0|||
162908958|NCT04144140|588364672|FG002|Overall Study|Other|0|||
162908959|NCT04144140|588364673|FG003|Overall Study|Other|0|||
162908960|NCT04144140|588364674|FG004|Overall Study|Other|0|||
162908961|NCT04144140|588364675|FG005|Overall Study|Other|1|||
162908962|NCT04144140|588364676|FG006|Overall Study|Other|0|||
162908963|NCT02146274|588364677|FG000|Overall Study|Protocol Violation|73|||
162908964|NCT00305773|588364682|FG000|Overall Study|Death|3|||
162908965|NCT00305773|588364683|FG001|Overall Study|Death|2|||
162908966|NCT00305773|588364682|FG000|Overall Study|Adverse Event|1|||
162908967|NCT00305773|588364683|FG001|Overall Study|Adverse Event|2|||
162908968|NCT00305773|588364682|FG000|Overall Study|Alternative Treatment|4|||
162908969|NCT00305773|588364683|FG001|Overall Study|Alternative Treatment|4|||
162908970|NCT00305773|588364682|FG000|Overall Study|Physician Decision|1|||
162908971|NCT00305773|588364683|FG001|Overall Study|Physician Decision|1|||
162908972|NCT00305773|588364682|FG000|Overall Study|Withdrawal by Subject|1|||
162908973|NCT00305773|588364683|FG001|Overall Study|Withdrawal by Subject|4|||
162908974|NCT00305773|588364682|FG000|Overall Study|Disease Progression|1|||
162908975|NCT00305773|588364683|FG001|Overall Study|Disease Progression|3|||
162908976|NCT00305773|588364682|FG000|Overall Study|All other reasons|3|||
162908977|NCT00305773|588364683|FG001|Overall Study|All other reasons|2|||
162908978|NCT03384316|588364684|FG000|Overall Study|Screen failure|0|||
162908979|NCT03384316|588364685|FG001|Overall Study|Screen failure|1|||
162908980|NCT00413231|588364686|FG000|0 to 30-day Post Treatment|Death|5|||
162908981|NCT00413231|588364686|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
162908982|NCT00413231|588364686|FG000|30-day to 365-day Post Treatment|Death|13|||
162908983|NCT00413231|588364686|FG000|365-day to 60-month Post Treatment|Death|36|||
162908984|NCT00413231|588364686|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
162908985|NCT00413231|588364686|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
162908986|NCT00413231|588364686|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
162908987|NCT01539720|588364689|FG000|Overall Study|Screen Fail|15|||
162967582|NCT02048813|588582968|FG000|Overall Study|Adverse Event|40|||
162967583|NCT02048813|588582969|FG001|Overall Study|Adverse Event|38|||
162967584|NCT02048813|588582968|FG000|Overall Study|Disease progression|13|||
162967585|NCT02048813|588582969|FG001|Overall Study|Disease progression|3|||
162967586|NCT02048813|588582968|FG000|Overall Study|Withdrawal by Subject|7|||
162967587|NCT02048813|588582969|FG001|Overall Study|Withdrawal by Subject|8|||
162967588|NCT02048813|588582968|FG000|Overall Study|Death|2|||
162908988|NCT01539720|588364690|FG001|Overall Study|Screen Fail|3|||
162908989|NCT01539720|588364689|FG000|Overall Study|Lost to Follow-up|14|||
162908990|NCT01539720|588364690|FG001|Overall Study|Lost to Follow-up|7|||
162908991|NCT03287960|588364697|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
162908992|NCT03287960|588364697|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
162908993|NCT01641952|588364698|FG000|Overall Study|Lost to Follow-up|28|||
162908994|NCT01641952|588364698|FG000|Overall Study|Adverse Event|6|||
162908995|NCT00656136|588364699|FG000|Overall Study|Progressive disease|177|||
162908996|NCT00656136|588364700|FG001|Overall Study|Progressive disease|322|||
162908997|NCT00656136|588364699|FG000|Overall Study|Other Adverse Event|5|||
162908998|NCT00656136|588364700|FG001|Overall Study|Other Adverse Event|51|||
162908999|NCT00656136|588364699|FG000|Overall Study|Protocol Violation|2|||
162909000|NCT00656136|588364700|FG001|Overall Study|Protocol Violation|3|||
162909001|NCT00656136|588364699|FG000|Overall Study|Patient refused to take study medication|7|||
162909002|NCT00656136|588364700|FG001|Overall Study|Patient refused to take study medication|10|||
162909003|NCT00656136|588364699|FG000|Overall Study|Unknown and others|4|||
162909004|NCT00656136|588364700|FG001|Overall Study|Unknown and others|4|||
162909005|NCT02516306|588364707|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
162909006|NCT02516306|588364708|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
162967589|NCT02048813|588582969|FG001|Overall Study|Death|1|||
162967590|NCT02048813|588582968|FG000|Overall Study|Complication|2|||
162967591|NCT02048813|588582969|FG001|Overall Study|Complication|2|||
162967592|NCT02048813|588582968|FG000|Overall Study|Non-protocol therapy|0|||
162909007|NCT02607865|588364711|FG000|Overall Study|Lost to Follow-up|9|||
162909008|NCT02607865|588364712|FG001|Overall Study|Lost to Follow-up|7|||
162909009|NCT02607865|588364713|FG002|Overall Study|Lost to Follow-up|7|||
162909010|NCT02607865|588364714|FG003|Overall Study|Lost to Follow-up|5|||
162909011|NCT02607865|588364711|FG000|Overall Study|Withdrawal by Subject|18|||
162909012|NCT02607865|588364712|FG001|Overall Study|Withdrawal by Subject|18|||
162909013|NCT02607865|588364713|FG002|Overall Study|Withdrawal by Subject|17|||
162909014|NCT02607865|588364714|FG003|Overall Study|Withdrawal by Subject|8|||
162909015|NCT02607865|588364711|FG000|Overall Study|Death|5|||
162909016|NCT02607865|588364712|FG001|Overall Study|Death|4|||
162909017|NCT02607865|588364713|FG002|Overall Study|Death|1|||
162628257|NCT04967443|587354837|FG003|Open Label Treatment|Lost to Follow-up|0|||
162628258|NCT04967443|587354838|FG004|Open Label Treatment|Lost to Follow-up|0|||
162909018|NCT02607865|588364714|FG003|Overall Study|Death|3|||
162909019|NCT02607865|588364711|FG000|Overall Study|Unclassified|1|||
162909020|NCT02607865|588364712|FG001|Overall Study|Unclassified|1|||
162909021|NCT02607865|588364713|FG002|Overall Study|Unclassified|2|||
162909022|NCT02607865|588364714|FG003|Overall Study|Unclassified|0|||
162909023|NCT01351415|588364718|FG000|Overall Study|Withdrawal by Subject|15|||
162909024|NCT01351415|588364719|FG001|Overall Study|Withdrawal by Subject|17|||
162909025|NCT01351415|588364718|FG000|Overall Study|Trial termination by the Sponsor|28|||
162909026|NCT01351415|588364719|FG001|Overall Study|Trial termination by the Sponsor|19|||
162909027|NCT01351415|588364718|FG000|Overall Study|Lost to Follow-up|5|||
162909028|NCT01351415|588364719|FG001|Overall Study|Lost to Follow-up|7|||
162909029|NCT01351415|588364718|FG000|Overall Study|Death|190|||
162909030|NCT01351415|588364719|FG001|Overall Study|Death|187|||
162909031|NCT01351415|588364718|FG000|Overall Study|Physician Decision|2|||
162909032|NCT01351415|588364719|FG001|Overall Study|Physician Decision|3|||
162909033|NCT01351415|588364718|FG000|Overall Study|Reason unknown|0|||
162909034|NCT01351415|588364719|FG001|Overall Study|Reason unknown|2|||
162909035|NCT01351415|588364718|FG000|Overall Study|Never Started|5|||
162909036|NCT01351415|588364719|FG001|Overall Study|Never Started|5|||
162909037|NCT00247962|588364720|FG000|Overall Study|Adverse Event|15|||
162909038|NCT00247962|588364721|FG001|Overall Study|Adverse Event|12|||
162909039|NCT00247962|588364720|FG000|Overall Study|Lost to Follow-up|3|||
162909040|NCT00247962|588364721|FG001|Overall Study|Lost to Follow-up|1|||
162909041|NCT00247962|588364720|FG000|Overall Study|Physician Decision|0|||
162909042|NCT00247962|588364721|FG001|Overall Study|Physician Decision|1|||
162909043|NCT00247962|588364720|FG000|Overall Study|Protocol Violation|1|||
162909044|NCT00247962|588364721|FG001|Overall Study|Protocol Violation|1|||
162909045|NCT00247962|588364720|FG000|Overall Study|Withdrawal by Subject|3|||
162909046|NCT00247962|588364721|FG001|Overall Study|Withdrawal by Subject|2|||
162909047|NCT00247962|588364720|FG000|Overall Study|Lack of Efficacy|4|||
162909048|NCT00247962|588364721|FG001|Overall Study|Lack of Efficacy|2|||
162628259|NCT04967443|587354839|FG005|Open Label Treatment|Lost to Follow-up|0|||
162628260|NCT04967443|587354840|FG006|Open Label Treatment|Lost to Follow-up|0|||
162628261|NCT04967443|587354841|FG007|Open Label Treatment|Lost to Follow-up|0|||
162628262|NCT04967443|587354834|FG000|Open Label Treatment|Withdrawal by Subject|0|||
162628263|NCT04967443|587354835|FG001|Open Label Treatment|Withdrawal by Subject|1|||
162628264|NCT04967443|587354836|FG002|Open Label Treatment|Withdrawal by Subject|0|||
162628265|NCT04967443|587354837|FG003|Open Label Treatment|Withdrawal by Subject|1|||
162628266|NCT04967443|587354838|FG004|Open Label Treatment|Withdrawal by Subject|0|||
162909049|NCT03525613|588364723|FG000|Overall Study|Adverse Event|11|||
162909050|NCT03525613|588364724|FG001|Overall Study|Adverse Event|8|||
162909051|NCT03525613|588364725|FG002|Overall Study|Adverse Event|3|||
162909052|NCT03525613|588364726|FG003|Overall Study|Adverse Event|3|||
162909053|NCT03525613|588364723|FG000|Overall Study|Lost to Follow-up|4|||
162909054|NCT03525613|588364724|FG001|Overall Study|Lost to Follow-up|5|||
162909055|NCT03525613|588364725|FG002|Overall Study|Lost to Follow-up|3|||
162909056|NCT03525613|588364726|FG003|Overall Study|Lost to Follow-up|2|||
162909057|NCT03525613|588364723|FG000|Overall Study|Physician Decision|0|||
162909058|NCT03525613|588364724|FG001|Overall Study|Physician Decision|1|||
162909059|NCT03525613|588364725|FG002|Overall Study|Physician Decision|0|||
162909060|NCT03525613|588364726|FG003|Overall Study|Physician Decision|1|||
162909061|NCT03525613|588364723|FG000|Overall Study|Consent Withdrawal|25|||
162909062|NCT03525613|588364724|FG001|Overall Study|Consent Withdrawal|16|||
162909063|NCT03525613|588364725|FG002|Overall Study|Consent Withdrawal|12|||
162909064|NCT03525613|588364726|FG003|Overall Study|Consent Withdrawal|9|||
162909065|NCT03525613|588364723|FG000|Overall Study|Death|20|||
162628267|NCT04967443|587354839|FG005|Open Label Treatment|Withdrawal by Subject|1|||
162628268|NCT04967443|587354840|FG006|Open Label Treatment|Withdrawal by Subject|2|||
162628269|NCT04967443|587354841|FG007|Open Label Treatment|Withdrawal by Subject|3|||
162909066|NCT03525613|588364724|FG001|Overall Study|Death|9|||
162909067|NCT03525613|588364725|FG002|Overall Study|Death|7|||
162909068|NCT03525613|588364726|FG003|Overall Study|Death|1|||
162909069|NCT03525613|588364723|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
162909070|NCT03525613|588364724|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
162909071|NCT03525613|588364725|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
162909072|NCT03525613|588364726|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
162909073|NCT03480360|588364727|FG000|Overall Study|Death|2|||
162909074|NCT03117309|588364734|FG000|Overall Study|Not meeting inclusion criteria|0|||
162909075|NCT03117309|588364735|FG001|Overall Study|Not meeting inclusion criteria|1|||
162909076|NCT02120469|588364736|FG000|Overall Study|HER-2/neu-amplified|1|||
162909077|NCT02120469|588364737|FG001|Overall Study|HER-2/neu-amplified|0|||
162909078|NCT02120469|588364738|FG002|Overall Study|HER-2/neu-amplified|1|||
162909079|NCT02583711|588364739|FG000|Overall Study|Withdrawal by Subject|0|||
162909080|NCT02583711|588364740|FG001|Overall Study|Withdrawal by Subject|10|||
162909081|NCT02583711|588364741|FG002|Overall Study|Withdrawal by Subject|0|||
162909082|NCT01142791|588364752|FG000|Overall Study|Alternative Treatment|1|||
162909083|NCT01142791|588364753|FG001|Overall Study|Alternative Treatment|0|||
162909084|NCT01142791|588364752|FG000|Overall Study|Lost to Follow-up|1|||
162909085|NCT01142791|588364753|FG001|Overall Study|Lost to Follow-up|0|||
162909086|NCT01142791|588364752|FG000|Overall Study|Withdrawal by Subject|5|||
162909087|NCT01142791|588364753|FG001|Overall Study|Withdrawal by Subject|0|||
162909088|NCT01142791|588364752|FG000|Overall Study|Received only 1 sonication|0|||
162909089|NCT01142791|588364753|FG001|Overall Study|Received only 1 sonication|6|||
162909090|NCT02975206|588364756|FG000|Overall Study|Withdrawal by Subject|14|||
162909091|NCT02975206|588364757|FG001|Overall Study|Withdrawal by Subject|11|||
162909092|NCT02975206|588364758|FG002|Overall Study|Withdrawal by Subject|11|||
162909093|NCT02975206|588364756|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
162909094|NCT02975206|588364757|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
162909095|NCT02975206|588364758|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
162909096|NCT01981096|588364759|FG000|Overall Study|Parent illness|1|||
162909097|NCT01981096|588364760|FG001|Overall Study|Parent illness|0|||
162909098|NCT01981096|588364759|FG000|Overall Study|Withdrawal by Subject|0|||
162909099|NCT01981096|588364760|FG001|Overall Study|Withdrawal by Subject|1|||
162909100|NCT01981096|588364759|FG000|Overall Study|Lost to Follow-up|2|||
162909101|NCT01981096|588364760|FG001|Overall Study|Lost to Follow-up|0|||
162909102|NCT04129242|588364763|FG000|Overall Study|Physician Decision|1|||
162909103|NCT04129242|588364764|FG001|Overall Study|Physician Decision|1|||
162909104|NCT04129242|588364763|FG000|Overall Study|Protocol Violation|0|||
162909105|NCT04129242|588364764|FG001|Overall Study|Protocol Violation|1|||
162909106|NCT00392210|588364768|FG000|First Voiding Trial|Physician Decision|2|||
162909107|NCT00392210|588364769|FG001|First Voiding Trial|Physician Decision|2|||
162909108|NCT01899729|588364775|FG000|Overall Study|Adverse Event|1|||
162909109|NCT01899729|588364776|FG001|Overall Study|Adverse Event|0|||
162909110|NCT01899729|588364777|FG002|Overall Study|Adverse Event|0|||
162909111|NCT01899729|588364778|FG003|Overall Study|Adverse Event|0|||
162909112|NCT01899729|588364779|FG004|Overall Study|Adverse Event|1|||
162909113|NCT01899729|588364775|FG000|Overall Study|Withdrawal by Subject|1|||
162909114|NCT01899729|588364776|FG001|Overall Study|Withdrawal by Subject|2|||
162909115|NCT01899729|588364777|FG002|Overall Study|Withdrawal by Subject|0|||
162909116|NCT01899729|588364778|FG003|Overall Study|Withdrawal by Subject|0|||
162909117|NCT01899729|588364779|FG004|Overall Study|Withdrawal by Subject|0|||
162909118|NCT01899729|588364775|FG000|Overall Study|Lack of Efficacy|0|||
162909119|NCT01899729|588364776|FG001|Overall Study|Lack of Efficacy|0|||
162909120|NCT01899729|588364777|FG002|Overall Study|Lack of Efficacy|2|||
162909121|NCT01899729|588364778|FG003|Overall Study|Lack of Efficacy|0|||
162909122|NCT01899729|588364779|FG004|Overall Study|Lack of Efficacy|1|||
162909123|NCT01454531|588364780|FG000|Overall Study|Adverse Event|14|||
162909124|NCT01454531|588364780|FG000|Overall Study|Withdrawal by Subject|5|||
162909125|NCT01454531|588364780|FG000|Overall Study|Lost to Follow-up|1|||
162909126|NCT01454531|588364780|FG000|Overall Study|Physician Decision|1|||
162909127|NCT01454531|588364780|FG000|Overall Study|Delay in IMP administration|1|||
162909128|NCT01454531|588364780|FG000|Overall Study|Other|1|||
162909129|NCT01021423|588364783|FG000|Overall Study|Study terminated|4|||
162909130|NCT01021423|588364784|FG001|Overall Study|Study terminated|5|||
162909131|NCT00122317|588364785|FG000|Overall Study|Death|3|||
162909132|NCT00122317|588364785|FG000|Overall Study|Adverse Event|4|||
162909133|NCT00122317|588364785|FG000|Overall Study|Physician Decision|2|||
162909134|NCT00122317|588364785|FG000|Overall Study|patient non-compliance|1|||
162909135|NCT00122317|588364785|FG000|Overall Study|Withdrawal by Subject|1|||
162909136|NCT03756285|588364786|FG000|Overall Study|Lost to Follow-up|0|||
162909137|NCT03756285|588364787|FG001|Overall Study|Lost to Follow-up|1|||
162909138|NCT03756285|588364786|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
162909139|NCT03756285|588364787|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
162909140|NCT03756285|588364786|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
162909141|NCT03756285|588364787|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
162909142|NCT06334055|588364788|FG000|Overall Study|Adverse Event|4|||
162909143|NCT06334055|588364788|FG000|Overall Study|Disqualified|72|||
162909144|NCT04728815|588364789|FG000|Overall Study|Lost to Follow-up|3|||
162909145|NCT04728815|588364790|FG001|Overall Study|Lost to Follow-up|0|||
162628270|NCT04967443|587354834|FG000|Follow-Up|Death|1|||
162628271|NCT04967443|587354835|FG001|Follow-Up|Death|0|||
162628272|NCT04967443|587354836|FG002|Follow-Up|Death|0|||
162628273|NCT04967443|587354837|FG003|Follow-Up|Death|0|||
162909146|NCT04728815|588364791|FG002|Overall Study|Lost to Follow-up|0|||
162909147|NCT04728815|588364792|FG003|Overall Study|Lost to Follow-up|1|||
162909148|NCT04728815|588364793|FG004|Overall Study|Lost to Follow-up|1|||
162909149|NCT04728815|588364794|FG005|Overall Study|Lost to Follow-up|0|||
162909150|NCT04728815|588364795|FG006|Overall Study|Lost to Follow-up|2|||
162909151|NCT04728815|588364796|FG007|Overall Study|Lost to Follow-up|0|||
162909152|NCT04728815|588364789|FG000|Overall Study|Physician Decision|0|||
162909153|NCT04728815|588364790|FG001|Overall Study|Physician Decision|0|||
162909154|NCT04728815|588364791|FG002|Overall Study|Physician Decision|1|||
162909155|NCT04728815|588364792|FG003|Overall Study|Physician Decision|0|||
162710465|NCT01190176|587649069|FG000|Overall Study|Withdrawal by Subject|1|||
162628274|NCT04967443|587354838|FG004|Follow-Up|Death|0|||
162628275|NCT04967443|587354839|FG005|Follow-Up|Death|0|||
162710466|NCT01190176|587649069|FG000|Overall Study|Lost to Follow-up|1|||
162909156|NCT04728815|588364793|FG004|Overall Study|Physician Decision|0|||
162628276|NCT04967443|587354840|FG006|Follow-Up|Death|0|||
162710467|NCT02909101|587649070|FG000|Overall Study|Lost to Follow-up|1|||
162710468|NCT02909101|587649071|FG001|Overall Study|Lost to Follow-up|1|||
162710469|NCT01221181|587649072|FG000|Overall Study|Lost to Follow-up|1|||
162710470|NCT01290094|587649073|FG000|Overall Study|Withdrawal by Subject|1|||
162710471|NCT01290094|587649073|FG000|Overall Study|Lost to Follow-up|5|||
162710472|NCT01959880|587649074|FG000|Overall Study|Withdrawal by Subject|11|||
162710473|NCT01959880|587649075|FG001|Overall Study|Withdrawal by Subject|13|||
162710474|NCT01959880|587649076|FG002|Overall Study|Withdrawal by Subject|8|||
162710475|NCT01959880|587649077|FG003|Overall Study|Withdrawal by Subject|7|||
162710476|NCT01959880|587649074|FG000|Overall Study|Death|1|||
162710477|NCT01959880|587649075|FG001|Overall Study|Death|10|||
162710478|NCT01959880|587649076|FG002|Overall Study|Death|1|||
162710479|NCT01959880|587649077|FG003|Overall Study|Death|2|||
162710480|NCT01959880|587649074|FG000|Overall Study|Lost to Follow-up|95|||
162710481|NCT01959880|587649075|FG001|Overall Study|Lost to Follow-up|18|||
162710482|NCT01959880|587649076|FG002|Overall Study|Lost to Follow-up|15|||
162710483|NCT01959880|587649077|FG003|Overall Study|Lost to Follow-up|8|||
162710484|NCT01959880|587649074|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
162710485|NCT01959880|587649075|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
162710486|NCT01959880|587649076|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
162710487|NCT01959880|587649077|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
162710488|NCT01959880|587649074|FG000|Overall Study|Study completed early-FDA approved|1003|||
162710489|NCT01959880|587649075|FG001|Overall Study|Study completed early-FDA approved|311|||
162710490|NCT01959880|587649076|FG002|Overall Study|Study completed early-FDA approved|179|||
162710491|NCT01959880|587649077|FG003|Overall Study|Study completed early-FDA approved|152|||
162710492|NCT01062126|587650942|FG000|Overall Study|Death|209|||
162710493|NCT01062126|587650942|FG000|Overall Study|All Withdrawals|324|||
162710494|NCT00646451|587650943|FG000|Overall Study|Adverse Event|3|||
162710495|NCT00646451|587650944|FG001|Overall Study|Adverse Event|0|||
162710496|NCT00646451|587650943|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
162710497|NCT00646451|587650944|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
162710498|NCT00157014|587650945|FG000|Overall Study|Death|4|||
162710499|NCT00157014|587650946|FG001|Overall Study|Death|2|||
162710500|NCT00157014|587650947|FG002|Overall Study|Death|1|||
162710501|NCT00157014|587650948|FG003|Overall Study|Death|1|||
162710502|NCT00157014|587650945|FG000|Overall Study|Physician Decision|0|||
162710503|NCT00157014|587650946|FG001|Overall Study|Physician Decision|1|||
162710504|NCT00157014|587650947|FG002|Overall Study|Physician Decision|0|||
162628277|NCT04967443|587354841|FG007|Follow-Up|Death|0|||
162628278|NCT04967443|587354834|FG000|Follow-Up|Lost to Follow-up|0|||
162628279|NCT04967443|587354835|FG001|Follow-Up|Lost to Follow-up|0|||
162628280|NCT04967443|587354836|FG002|Follow-Up|Lost to Follow-up|1|||
162628281|NCT04967443|587354837|FG003|Follow-Up|Lost to Follow-up|1|||
162710505|NCT00157014|587650948|FG003|Overall Study|Physician Decision|0|||
162710506|NCT00157014|587650945|FG000|Overall Study|Medications withdrawn on family request|0|||
162710507|NCT00157014|587650946|FG001|Overall Study|Medications withdrawn on family request|1|||
162710508|NCT00157014|587650947|FG002|Overall Study|Medications withdrawn on family request|0|||
162710509|NCT00157014|587650948|FG003|Overall Study|Medications withdrawn on family request|0|||
162710510|NCT00157014|587650945|FG000|Overall Study|Patient withdrawn by investigator|1|||
162909157|NCT04728815|588364794|FG005|Overall Study|Physician Decision|0|||
162628282|NCT04967443|587354838|FG004|Follow-Up|Lost to Follow-up|0|||
162628283|NCT04967443|587354839|FG005|Follow-Up|Lost to Follow-up|0|||
162628284|NCT04967443|587354840|FG006|Follow-Up|Lost to Follow-up|0|||
162628285|NCT04967443|587354841|FG007|Follow-Up|Lost to Follow-up|0|||
162710511|NCT00157014|587650946|FG001|Overall Study|Patient withdrawn by investigator|0|||
162710512|NCT00157014|587650947|FG002|Overall Study|Patient withdrawn by investigator|0|||
162909158|NCT04728815|588364795|FG006|Overall Study|Physician Decision|0|||
162909159|NCT04728815|588364796|FG007|Overall Study|Physician Decision|0|||
162909160|NCT04728815|588364789|FG000|Overall Study|Treatment drop|0|||
162909161|NCT04728815|588364790|FG001|Overall Study|Treatment drop|2|||
162909162|NCT04728815|588364791|FG002|Overall Study|Treatment drop|1|||
162909163|NCT04728815|588364792|FG003|Overall Study|Treatment drop|0|||
162909164|NCT04728815|588364793|FG004|Overall Study|Treatment drop|3|||
162909165|NCT04728815|588364794|FG005|Overall Study|Treatment drop|1|||
162909166|NCT04728815|588364795|FG006|Overall Study|Treatment drop|3|||
162909167|NCT04728815|588364796|FG007|Overall Study|Treatment drop|0|||
162909168|NCT04728815|588364789|FG000|Overall Study|Study drop|0|||
162909169|NCT04728815|588364790|FG001|Overall Study|Study drop|3|||
162909170|NCT04728815|588364791|FG002|Overall Study|Study drop|3|||
162909171|NCT04728815|588364792|FG003|Overall Study|Study drop|0|||
162909172|NCT04728815|588364793|FG004|Overall Study|Study drop|0|||
162909173|NCT04728815|588364794|FG005|Overall Study|Study drop|0|||
162909174|NCT04728815|588364795|FG006|Overall Study|Study drop|7|||
162909175|NCT04728815|588364796|FG007|Overall Study|Study drop|0|||
162909176|NCT00957034|588364797|FG000|Overall Study|Adverse Event|0|||
162909177|NCT00957034|588364798|FG001|Overall Study|Adverse Event|1|||
162909178|NCT00957034|588364799|FG002|Overall Study|Adverse Event|1|||
162909179|NCT00957034|588364797|FG000|Overall Study|Sponsor Terminated Study|6|||
162909180|NCT00957034|588364798|FG001|Overall Study|Sponsor Terminated Study|1|||
162909181|NCT00957034|588364799|FG002|Overall Study|Sponsor Terminated Study|5|||
162909182|NCT00957034|588364797|FG000|Overall Study|Withdrawal by Subject|0|||
162909183|NCT00957034|588364798|FG001|Overall Study|Withdrawal by Subject|2|||
162909184|NCT00957034|588364799|FG002|Overall Study|Withdrawal by Subject|0|||
162909185|NCT05315297|588364800|FG000|Overall Study|Lost to Follow-up|6|||
162710513|NCT00157014|587650948|FG003|Overall Study|Patient withdrawn by investigator|0|||
162710514|NCT00157014|587650945|FG000|Overall Study|Patient unable to return in nursing home|1|||
162710515|NCT00157014|587650946|FG001|Overall Study|Patient unable to return in nursing home|0|||
162710516|NCT00157014|587650947|FG002|Overall Study|Patient unable to return in nursing home|0|||
162710517|NCT00157014|587650948|FG003|Overall Study|Patient unable to return in nursing home|0|||
162710518|NCT00157014|587650945|FG000|Overall Study|Patient would not receive transplant|0|||
162710519|NCT00157014|587650946|FG001|Overall Study|Patient would not receive transplant|1|||
162710520|NCT00157014|587650947|FG002|Overall Study|Patient would not receive transplant|0|||
162710521|NCT00157014|587650948|FG003|Overall Study|Patient would not receive transplant|0|||
162710522|NCT00157014|587650945|FG000|Overall Study|Withdrawal by Subject|1|||
162710523|NCT00157014|587650946|FG001|Overall Study|Withdrawal by Subject|0|||
162710524|NCT00157014|587650947|FG002|Overall Study|Withdrawal by Subject|0|||
162710525|NCT00157014|587650948|FG003|Overall Study|Withdrawal by Subject|0|||
162710526|NCT01362491|587650949|FG000|Overall Study|Ineligible|1|||
162710527|NCT01362491|587650950|FG001|Overall Study|Ineligible|0|||
162710528|NCT01362491|587650951|FG002|Overall Study|Ineligible|0|||
162710529|NCT05355116|587650952|FG000|Overall Study|Withdrawal by Subject|2|||
162909186|NCT05315297|588364801|FG001|Overall Study|Lost to Follow-up|4|||
162909187|NCT05315297|588364800|FG000|Overall Study|Withdrawal by Subject|0|||
162909188|NCT05315297|588364801|FG001|Overall Study|Withdrawal by Subject|1|||
162710530|NCT01390857|587650953|FG000|Overall Study|Protocol Violation|2|||
162710531|NCT01390857|587650953|FG000|Overall Study|Lost to Follow-up|1|||
162710532|NCT01390857|587650953|FG000|Overall Study|No Visit after the First Visit|7|||
162710533|NCT00349908|587650954|FG000|Overall Study|Withdrawal by Subject|0|||
162909189|NCT01503229|588367745|FG000|Overall Study|Withdrew consent|1|||
162909190|NCT01354964|588367746|FG000|Overall Study|Lost to Follow-up|2|||
162909191|NCT01354964|588367747|FG001|Overall Study|Lost to Follow-up|0|||
162909192|NCT01354964|588367746|FG000|Overall Study|IV access issues|1|||
162909193|NCT01354964|588367747|FG001|Overall Study|IV access issues|1|||
162909194|NCT01354964|588367746|FG000|Overall Study|Physician Decision|1|||
162909195|NCT01354964|588367747|FG001|Overall Study|Physician Decision|0|||
162909196|NCT00711009|588367748|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
162909197|NCT00711009|588367749|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
162909198|NCT00711009|588367748|FG000|Overall Study|Withdrawal by Subject|4|||
162909199|NCT00711009|588367749|FG001|Overall Study|Withdrawal by Subject|2|||
162909200|NCT00711009|588367748|FG000|Overall Study|Lost to Follow-up|3|||
162909201|NCT00711009|588367749|FG001|Overall Study|Lost to Follow-up|9|||
162909202|NCT00711009|588367748|FG000|Overall Study|Participant Noncompliant|0|||
162909203|NCT00711009|588367749|FG001|Overall Study|Participant Noncompliant|1|||
162909204|NCT00711009|588367748|FG000|Overall Study|Virologic Failure|2|||
162909205|NCT00711009|588367749|FG001|Overall Study|Virologic Failure|1|||
162909206|NCT00711009|588367748|FG000|Overall Study|Pregnancy|1|||
162909207|NCT00711009|588367749|FG001|Overall Study|Pregnancy|0|||
162909208|NCT00711009|588367748|FG000|Overall Study|Site closing|0|||
162909209|NCT00711009|588367749|FG001|Overall Study|Site closing|1|||
162909210|NCT00711009|588367748|FG000|Overall Study|Dose adjustment|1|||
162909211|NCT00711009|588367749|FG001|Overall Study|Dose adjustment|0|||
162909212|NCT02534324|588367750|FG000|Overall Study|Protocol Violation|4|||
162909213|NCT02534324|588367751|FG001|Overall Study|Protocol Violation|1|||
162909214|NCT02534324|588367750|FG000|Overall Study|Lost to Follow-up|20|||
162909215|NCT02534324|588367751|FG001|Overall Study|Lost to Follow-up|7|||
162909216|NCT02534324|588367750|FG000|Overall Study|Adverse Event|1|||
162909217|NCT02534324|588367751|FG001|Overall Study|Adverse Event|0|||
162909218|NCT01459016|588367752|FG000|Overall Study|Withdrawal by Subject|11|||
162909219|NCT01459016|588367752|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
162909220|NCT02889861|588367753|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
162909221|NCT02039687|588367754|FG000|Overall Study|Adverse Event|0|||
162909222|NCT02039687|588367755|FG001|Overall Study|Adverse Event|0|||
162909223|NCT02039687|588367756|FG002|Overall Study|Adverse Event|1|||
162909224|NCT02039687|588367757|FG003|Overall Study|Adverse Event|0|||
162909225|NCT02039687|588367754|FG000|Overall Study|Withdrawal by Subject|0|||
162909226|NCT02039687|588367755|FG001|Overall Study|Withdrawal by Subject|1|||
162909227|NCT02039687|588367756|FG002|Overall Study|Withdrawal by Subject|0|||
162909228|NCT02039687|588367757|FG003|Overall Study|Withdrawal by Subject|0|||
162909229|NCT02039687|588367754|FG000|Overall Study|treatment assignment could not be confir|0|||
162710534|NCT00349908|587650955|FG001|Overall Study|Withdrawal by Subject|4|||
162710535|NCT01289119|587650959|FG000|Overall Study|Adverse Event|2|||
162710536|NCT01289119|587650960|FG001|Overall Study|Adverse Event|1|||
162710537|NCT01289119|587650961|FG002|Overall Study|Adverse Event|0|||
162710538|NCT01289119|587650962|FG003|Overall Study|Adverse Event|2|||
162710539|NCT01289119|587650963|FG004|Overall Study|Adverse Event|1|||
162710540|NCT01289119|587650964|FG005|Overall Study|Adverse Event|0|||
162710541|NCT01289119|587650959|FG000|Overall Study|Major Protocol Deviation|2|||
162710542|NCT01289119|587650960|FG001|Overall Study|Major Protocol Deviation|1|||
162710543|NCT01289119|587650961|FG002|Overall Study|Major Protocol Deviation|3|||
162710544|NCT01289119|587650962|FG003|Overall Study|Major Protocol Deviation|0|||
162710545|NCT01289119|587650963|FG004|Overall Study|Major Protocol Deviation|2|||
162710546|NCT01289119|587650964|FG005|Overall Study|Major Protocol Deviation|1|||
162710547|NCT01289119|587650959|FG000|Overall Study|Lost to Follow-up|0|||
162710548|NCT01289119|587650960|FG001|Overall Study|Lost to Follow-up|3|||
162710549|NCT01289119|587650961|FG002|Overall Study|Lost to Follow-up|0|||
162710550|NCT01289119|587650962|FG003|Overall Study|Lost to Follow-up|0|||
162710551|NCT01289119|587650963|FG004|Overall Study|Lost to Follow-up|0|||
162710552|NCT01289119|587650964|FG005|Overall Study|Lost to Follow-up|1|||
162710553|NCT01289119|587650959|FG000|Overall Study|Withdrawal by Subject|4|||
162710554|NCT01289119|587650960|FG001|Overall Study|Withdrawal by Subject|2|||
162710555|NCT01289119|587650961|FG002|Overall Study|Withdrawal by Subject|4|||
162710556|NCT01289119|587650962|FG003|Overall Study|Withdrawal by Subject|3|||
162710557|NCT01289119|587650963|FG004|Overall Study|Withdrawal by Subject|1|||
162710558|NCT01289119|587650964|FG005|Overall Study|Withdrawal by Subject|1|||
162710559|NCT01289119|587650959|FG000|Overall Study|Pregnancy|0|||
162710560|NCT01289119|587650960|FG001|Overall Study|Pregnancy|1|||
162710561|NCT01289119|587650961|FG002|Overall Study|Pregnancy|0|||
162710562|NCT01289119|587650962|FG003|Overall Study|Pregnancy|0|||
162710563|NCT01289119|587650963|FG004|Overall Study|Pregnancy|0|||
162710564|NCT01289119|587650964|FG005|Overall Study|Pregnancy|0|||
162710565|NCT01289119|587650959|FG000|Overall Study|Lack of Efficacy|0|||
162710566|NCT01289119|587650960|FG001|Overall Study|Lack of Efficacy|1|||
162710567|NCT01289119|587650961|FG002|Overall Study|Lack of Efficacy|1|||
162710568|NCT01289119|587650962|FG003|Overall Study|Lack of Efficacy|1|||
162710569|NCT01289119|587650963|FG004|Overall Study|Lack of Efficacy|1|||
162710570|NCT01289119|587650964|FG005|Overall Study|Lack of Efficacy|1|||
162710571|NCT01289119|587650959|FG000|Overall Study|Other|1|||
162710572|NCT01289119|587650960|FG001|Overall Study|Other|0|||
162710573|NCT01289119|587650961|FG002|Overall Study|Other|1|||
162710574|NCT01289119|587650962|FG003|Overall Study|Other|0|||
162710575|NCT01289119|587650963|FG004|Overall Study|Other|0|||
162710576|NCT01289119|587650964|FG005|Overall Study|Other|0|||
162710577|NCT01704846|587650965|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162710578|NCT01704846|587650966|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162710579|NCT04577183|587650970|FG000|Overall Study|Death|1|||
162710580|NCT04577183|587650970|FG000|Overall Study|Withdrawal by Subject|3|||
162710581|NCT04577183|587650970|FG000|Overall Study|Early termination|2|||
162710582|NCT01168401|587650975|FG000|Overall Study|Lost to Follow-up|1|||
162710583|NCT01168401|587650976|FG001|Overall Study|Lost to Follow-up|1|||
162710584|NCT01168401|587650977|FG002|Overall Study|Lost to Follow-up|2|||
162710585|NCT01168401|587650978|FG003|Overall Study|Lost to Follow-up|1|||
162710586|NCT01168401|587650979|FG004|Overall Study|Lost to Follow-up|0|||
162909230|NCT02039687|588367755|FG001|Overall Study|treatment assignment could not be confir|0|||
162710587|NCT01168401|587650980|FG005|Overall Study|Lost to Follow-up|0|||
162710588|NCT01168401|587650981|FG006|Overall Study|Lost to Follow-up|0|||
162710589|NCT01168401|587650982|FG007|Overall Study|Lost to Follow-up|0|||
162710590|NCT01168401|587650983|FG008|Overall Study|Lost to Follow-up|0|||
162710591|NCT01168401|587650984|FG009|Overall Study|Lost to Follow-up|0|||
162710592|NCT01168401|587650985|FG010|Overall Study|Lost to Follow-up|0|||
162710593|NCT01168401|587650975|FG000|Overall Study|Withdrawal by Subject|0|||
162710594|NCT01168401|587650976|FG001|Overall Study|Withdrawal by Subject|0|||
162710595|NCT01168401|587650977|FG002|Overall Study|Withdrawal by Subject|0|||
162710596|NCT01168401|587650978|FG003|Overall Study|Withdrawal by Subject|1|||
162710597|NCT01168401|587650979|FG004|Overall Study|Withdrawal by Subject|0|||
162909231|NCT02039687|588367756|FG002|Overall Study|treatment assignment could not be confir|2|||
162909232|NCT02039687|588367757|FG003|Overall Study|treatment assignment could not be confir|0|||
162909233|NCT00959192|588367773|FG000|Overall Study|Adverse Event|1|||
162909234|NCT00959192|588367774|FG001|Overall Study|Adverse Event|1|||
162909235|NCT00959192|588367775|FG002|Overall Study|Adverse Event|1|||
162909236|NCT00959192|588367776|FG003|Overall Study|Adverse Event|0|||
162909237|NCT00959192|588367773|FG000|Overall Study|Investigator Request|1|||
162909238|NCT00959192|588367774|FG001|Overall Study|Investigator Request|0|||
162909239|NCT00959192|588367775|FG002|Overall Study|Investigator Request|0|||
162909240|NCT00959192|588367776|FG003|Overall Study|Investigator Request|0|||
162909241|NCT00959192|588367773|FG000|Overall Study|Caregiver Request|0|||
162909242|NCT00959192|588367774|FG001|Overall Study|Caregiver Request|0|||
162909243|NCT00959192|588367775|FG002|Overall Study|Caregiver Request|2|||
162909244|NCT00959192|588367776|FG003|Overall Study|Caregiver Request|1|||
162909245|NCT04354870|588367777|FG000|Overall Study|Lost to Follow-up|32|||
162909246|NCT04354870|588367778|FG001|Overall Study|Lost to Follow-up|12|||
162909247|NCT04354870|588367777|FG000|Overall Study|Withdrawal by Subject|10|||
162909248|NCT04354870|588367778|FG001|Overall Study|Withdrawal by Subject|16|||
162909249|NCT04354870|588367777|FG000|Overall Study|Did not complete all study visits|6|||
162909250|NCT04354870|588367778|FG001|Overall Study|Did not complete all study visits|5|||
162909251|NCT04450394|588367779|FG000|Overall Study|Adverse Event|2|||
162909252|NCT04450394|588367780|FG001|Overall Study|Adverse Event|0|||
162909253|NCT04450394|588367781|FG002|Overall Study|Adverse Event|0|||
162909254|NCT04450394|588367779|FG000|Overall Study|Death|0|||
162909255|NCT04450394|588367780|FG001|Overall Study|Death|1|||
162909256|NCT04450394|588367781|FG002|Overall Study|Death|0|||
162909257|NCT04450394|588367779|FG000|Overall Study|Lost to Follow-up|0|||
162909258|NCT04450394|588367780|FG001|Overall Study|Lost to Follow-up|3|||
162909259|NCT04450394|588367781|FG002|Overall Study|Lost to Follow-up|0|||
162909260|NCT04450394|588367779|FG000|Overall Study|Physician Decision|0|||
162967593|NCT02048813|588582969|FG001|Overall Study|Non-protocol therapy|1|||
162967594|NCT02048813|588582968|FG000|Overall Study|Second primary cancer|2|||
162628286|NCT04967443|587354834|FG000|Follow-Up|Withdrawal by Subject|0|||
162628287|NCT04967443|587354835|FG001|Follow-Up|Withdrawal by Subject|1|||
162628288|NCT04967443|587354836|FG002|Follow-Up|Withdrawal by Subject|0|||
162628289|NCT04967443|587354837|FG003|Follow-Up|Withdrawal by Subject|1|||
162628290|NCT04967443|587354838|FG004|Follow-Up|Withdrawal by Subject|0|||
162628291|NCT04967443|587354839|FG005|Follow-Up|Withdrawal by Subject|1|||
162628292|NCT04967443|587354840|FG006|Follow-Up|Withdrawal by Subject|2|||
162628293|NCT04967443|587354841|FG007|Follow-Up|Withdrawal by Subject|3|||
162628294|NCT04502693|587354842|FG000|Overall Study|Adverse Event|7|||
162628295|NCT04502693|587354843|FG001|Overall Study|Adverse Event|6|||
162628296|NCT04502693|587354844|FG002|Overall Study|Adverse Event|11|||
162628297|NCT04502693|587354845|FG003|Overall Study|Adverse Event|1|||
162628298|NCT04502693|587354842|FG000|Overall Study|Lost to Follow-up|32|||
162628299|NCT04502693|587354843|FG001|Overall Study|Lost to Follow-up|36|||
162628300|NCT04502693|587354844|FG002|Overall Study|Lost to Follow-up|69|||
162628301|NCT04502693|587354845|FG003|Overall Study|Lost to Follow-up|4|||
162628302|NCT04502693|587354842|FG000|Overall Study|Protocol Violation|8|||
162628303|NCT04502693|587354843|FG001|Overall Study|Protocol Violation|8|||
162628304|NCT04502693|587354844|FG002|Overall Study|Protocol Violation|16|||
162628305|NCT04502693|587354845|FG003|Overall Study|Protocol Violation|1|||
162628306|NCT04502693|587354842|FG000|Overall Study|Withdrawal by Subject|46|||
162628307|NCT04502693|587354843|FG001|Overall Study|Withdrawal by Subject|38|||
162628308|NCT04502693|587354844|FG002|Overall Study|Withdrawal by Subject|54|||
162628309|NCT04502693|587354845|FG003|Overall Study|Withdrawal by Subject|7|||
162967595|NCT02048813|588582969|FG001|Overall Study|Second primary cancer|0|||
162967596|NCT02048813|588582968|FG000|Overall Study|Insurance|2|||
162967597|NCT02048813|588582969|FG001|Overall Study|Insurance|0|||
162967598|NCT02048813|588582968|FG000|Overall Study|Wound infection/healing|2|||
162967599|NCT02048813|588582969|FG001|Overall Study|Wound infection/healing|0|||
162967600|NCT02048813|588582968|FG000|Overall Study|Missed appointment|3|||
162967601|NCT02048813|588582969|FG001|Overall Study|Missed appointment|0|||
162967602|NCT02048813|588582968|FG000|Overall Study|Never started treatment|2|||
162967603|NCT02048813|588582969|FG001|Overall Study|Never started treatment|17|||
162967604|NCT01708954|588582970|FG000|Step 1|Disease progression|26|||
162967605|NCT01708954|588582971|FG001|Step 1|Disease progression|17|||
162628310|NCT04502693|587354842|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
162628311|NCT04502693|587354843|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
162628312|NCT04502693|587354844|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
162628313|NCT04502693|587354845|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162628314|NCT04502693|587354842|FG000|Overall Study|Other|1|||
162628315|NCT04502693|587354843|FG001|Overall Study|Other|0|||
162909261|NCT04450394|588367780|FG001|Overall Study|Physician Decision|1|||
162909262|NCT04450394|588367781|FG002|Overall Study|Physician Decision|0|||
162909263|NCT04450394|588367779|FG000|Overall Study|Protocol Violation|2|||
162909264|NCT04450394|588367780|FG001|Overall Study|Protocol Violation|0|||
162909265|NCT04450394|588367781|FG002|Overall Study|Protocol Violation|0|||
162909266|NCT04450394|588367779|FG000|Overall Study|Withdrawal by Subject|6|||
162909267|NCT04450394|588367780|FG001|Overall Study|Withdrawal by Subject|9|||
162909268|NCT04450394|588367781|FG002|Overall Study|Withdrawal by Subject|0|||
162909269|NCT02194699|588367782|FG000|Randomised|Did not receive treatment|1|||
162909270|NCT02194699|588367783|FG001|Randomised|Did not receive treatment|5|||
162909271|NCT02194699|588367782|FG000|Randomised|Without potential for 52 weeks of IP|5|||
162909272|NCT02194699|588367783|FG001|Randomised|Without potential for 52 weeks of IP|5|||
162909273|NCT02194699|588367782|FG000|Randomised|Duplicate patient|2|||
162909274|NCT02194699|588367783|FG001|Randomised|Duplicate patient|1|||
162909275|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
162909276|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
162628316|NCT04502693|587354844|FG002|Overall Study|Other|1|||
162628317|NCT04502693|587354845|FG003|Overall Study|Other|1|||
162628318|NCT02784431|587354846|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
162628319|NCT02784431|587354846|FG000|Overall Study|Early Study Termination|19|||
162628320|NCT00279305|587354847|FG000|Overall Study|Pregnancy|1|||
162628321|NCT00279305|587354848|FG001|Overall Study|Pregnancy|0|||
162628322|NCT00279305|587354847|FG000|Overall Study|Withdrawal by Subject|2|||
162628323|NCT00279305|587354848|FG001|Overall Study|Withdrawal by Subject|0|||
162628324|NCT00279305|587354847|FG000|Overall Study|Dificulting establishing IV|1|||
162628325|NCT00279305|587354848|FG001|Overall Study|Dificulting establishing IV|0|||
162628326|NCT00279305|587354847|FG000|Overall Study|FDA Safety Alert|4|||
162628327|NCT00279305|587354848|FG001|Overall Study|FDA Safety Alert|1|||
162628328|NCT04404361|587354849|FG000|Overall Study|Death|12|||
162628329|NCT04404361|587354850|FG001|Overall Study|Death|12|||
162628330|NCT04404361|587354849|FG000|Overall Study|Withdrawal by Subject|13|||
162628331|NCT04404361|587354850|FG001|Overall Study|Withdrawal by Subject|5|||
162628332|NCT04404361|587354849|FG000|Overall Study|Lost to Follow-up|6|||
162628333|NCT04404361|587354850|FG001|Overall Study|Lost to Follow-up|3|||
162628334|NCT04404361|587354849|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
162628335|NCT04404361|587354850|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
162628336|NCT01063868|587354855|FG000|Overall Study|Adverse Event|9|||
162628337|NCT01063868|587354856|FG001|Overall Study|Adverse Event|7|||
162628338|NCT01063868|587354855|FG000|Overall Study|Withdrawal by Subject|3|||
162628339|NCT01063868|587354856|FG001|Overall Study|Withdrawal by Subject|1|||
162628340|NCT01063868|587354855|FG000|Overall Study|Study Terminated By Sponsor|23|||
162628341|NCT01063868|587354856|FG001|Overall Study|Study Terminated By Sponsor|4|||
162628342|NCT01949506|587354857|FG000|Overall Study|Physician Decision|1|||
162628343|NCT01446289|587354858|FG000|Overall Study|Withdrawal by Subject|1|||
162628344|NCT01446289|587354859|FG001|Overall Study|Withdrawal by Subject|0|||
162628345|NCT01446289|587354860|FG002|Overall Study|Withdrawal by Subject|1|||
162628346|NCT01446289|587354861|FG003|Overall Study|Withdrawal by Subject|0|||
162628347|NCT03307967|587354862|FG000|Overall Study|Lost to Follow-up|4|||
162628348|NCT02915016|587354863|FG000|Overall Study|Lost to Follow-up|4|||
162628349|NCT02915016|587354864|FG001|Overall Study|Lost to Follow-up|2|||
162628350|NCT02915016|587354865|FG002|Overall Study|Lost to Follow-up|5|||
162628351|NCT02915016|587354866|FG003|Overall Study|Lost to Follow-up|3|||
162628352|NCT02915016|587354867|FG004|Overall Study|Lost to Follow-up|5|||
162628353|NCT02915016|587354868|FG005|Overall Study|Lost to Follow-up|2|||
162628354|NCT02915016|587354869|FG006|Overall Study|Lost to Follow-up|8|||
162628355|NCT02915016|587354870|FG007|Overall Study|Lost to Follow-up|2|||
162628356|NCT02915016|587354863|FG000|Overall Study|Physician Decision|0|||
162628357|NCT02915016|587354864|FG001|Overall Study|Physician Decision|0|||
162628358|NCT02915016|587354865|FG002|Overall Study|Physician Decision|1|||
162628359|NCT02915016|587354866|FG003|Overall Study|Physician Decision|0|||
162628360|NCT02915016|587354867|FG004|Overall Study|Physician Decision|0|||
162628361|NCT02915016|587354868|FG005|Overall Study|Physician Decision|1|||
162628362|NCT02915016|587354869|FG006|Overall Study|Physician Decision|2|||
162628363|NCT02915016|587354870|FG007|Overall Study|Physician Decision|0|||
162628364|NCT02915016|587354863|FG000|Overall Study|Withdrawal by Subject|2|||
162628365|NCT02915016|587354864|FG001|Overall Study|Withdrawal by Subject|0|||
162628366|NCT02915016|587354865|FG002|Overall Study|Withdrawal by Subject|1|||
162628367|NCT02915016|587354866|FG003|Overall Study|Withdrawal by Subject|0|||
162628368|NCT02915016|587354867|FG004|Overall Study|Withdrawal by Subject|1|||
162628369|NCT02915016|587354868|FG005|Overall Study|Withdrawal by Subject|3|||
162628370|NCT02915016|587354869|FG006|Overall Study|Withdrawal by Subject|1|||
162628371|NCT02915016|587354870|FG007|Overall Study|Withdrawal by Subject|1|||
162628372|NCT02915016|587354863|FG000|Overall Study|Elected not to continue|0|||
162628373|NCT02915016|587354864|FG001|Overall Study|Elected not to continue|0|||
162628374|NCT02915016|587354865|FG002|Overall Study|Elected not to continue|0|||
162628375|NCT02915016|587354866|FG003|Overall Study|Elected not to continue|1|||
162628376|NCT02915016|587354867|FG004|Overall Study|Elected not to continue|0|||
162628377|NCT02915016|587354868|FG005|Overall Study|Elected not to continue|0|||
162628378|NCT02915016|587354869|FG006|Overall Study|Elected not to continue|1|||
162628379|NCT02915016|587354870|FG007|Overall Study|Elected not to continue|0|||
162909277|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
162628380|NCT02915016|587354863|FG000|Overall Study|HIV infection|1|||
162628381|NCT02915016|587354864|FG001|Overall Study|HIV infection|1|||
162909278|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
162909279|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
162909280|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
162909281|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
162909282|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
162909283|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
162909284|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
162909285|NCT02194699|588367782|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
162909286|NCT02194699|588367783|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
162909287|NCT01066819|588367784|FG000|Overall Study|Adverse Event|18|||
162909288|NCT01066819|588367785|FG001|Overall Study|Adverse Event|1|||
162909289|NCT01066819|588367786|FG002|Overall Study|Adverse Event|6|||
162909290|NCT01066819|588367787|FG003|Overall Study|Adverse Event|0|||
162909291|NCT01066819|588367788|FG004|Overall Study|Adverse Event|0|||
162909292|NCT01066819|588367789|FG005|Overall Study|Adverse Event|0|||
162909293|NCT01066819|588367784|FG000|Overall Study|Death|5|||
162909294|NCT01066819|588367785|FG001|Overall Study|Death|0|||
162909295|NCT01066819|588367786|FG002|Overall Study|Death|1|||
162909296|NCT01066819|588367787|FG003|Overall Study|Death|0|||
162909297|NCT01066819|588367788|FG004|Overall Study|Death|0|||
162909298|NCT01066819|588367789|FG005|Overall Study|Death|0|||
162909299|NCT01066819|588367784|FG000|Overall Study|Lack of Efficacy|22|||
162909300|NCT01066819|588367785|FG001|Overall Study|Lack of Efficacy|1|||
162909301|NCT01066819|588367786|FG002|Overall Study|Lack of Efficacy|2|||
162909302|NCT01066819|588367787|FG003|Overall Study|Lack of Efficacy|1|||
162909303|NCT01066819|588367788|FG004|Overall Study|Lack of Efficacy|0|||
162909304|NCT01066819|588367789|FG005|Overall Study|Lack of Efficacy|0|||
162909305|NCT01066819|588367784|FG000|Overall Study|Physician Decision|6|||
162909306|NCT01066819|588367785|FG001|Overall Study|Physician Decision|2|||
162909307|NCT01066819|588367786|FG002|Overall Study|Physician Decision|3|||
162909308|NCT01066819|588367787|FG003|Overall Study|Physician Decision|0|||
162909309|NCT01066819|588367788|FG004|Overall Study|Physician Decision|0|||
162909310|NCT01066819|588367789|FG005|Overall Study|Physician Decision|0|||
162909311|NCT01066819|588367784|FG000|Overall Study|Protocol Violation|12|||
162909312|NCT01066819|588367785|FG001|Overall Study|Protocol Violation|6|||
162909313|NCT01066819|588367786|FG002|Overall Study|Protocol Violation|0|||
162909314|NCT01066819|588367787|FG003|Overall Study|Protocol Violation|0|||
162909315|NCT01066819|588367788|FG004|Overall Study|Protocol Violation|0|||
162909316|NCT01066819|588367789|FG005|Overall Study|Protocol Violation|0|||
162909317|NCT01066819|588367784|FG000|Overall Study|Withdrawal by Subject|29|||
162909318|NCT01066819|588367785|FG001|Overall Study|Withdrawal by Subject|11|||
162909319|NCT01066819|588367786|FG002|Overall Study|Withdrawal by Subject|6|||
162909320|NCT01066819|588367787|FG003|Overall Study|Withdrawal by Subject|0|||
162909321|NCT01066819|588367788|FG004|Overall Study|Withdrawal by Subject|0|||
162909322|NCT01066819|588367789|FG005|Overall Study|Withdrawal by Subject|0|||
162909323|NCT01066819|588367784|FG000|Overall Study|Administrative|6|||
162909324|NCT01066819|588367785|FG001|Overall Study|Administrative|4|||
162909325|NCT01066819|588367786|FG002|Overall Study|Administrative|2|||
162909326|NCT01066819|588367787|FG003|Overall Study|Administrative|0|||
162909327|NCT01066819|588367788|FG004|Overall Study|Administrative|0|||
162909328|NCT01066819|588367789|FG005|Overall Study|Administrative|0|||
162909329|NCT01066819|588367784|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
162909330|NCT01066819|588367785|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
162909331|NCT01066819|588367786|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
162909332|NCT01066819|588367787|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
162909333|NCT01066819|588367788|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
162909334|NCT01066819|588367789|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
162909335|NCT01066819|588367784|FG000|Overall Study|Early termination|2|||
162909336|NCT01066819|588367785|FG001|Overall Study|Early termination|0|||
162628382|NCT02915016|587354865|FG002|Overall Study|HIV infection|1|||
162909337|NCT01066819|588367786|FG002|Overall Study|Early termination|0|||
162909338|NCT01066819|588367787|FG003|Overall Study|Early termination|0|||
162909339|NCT01066819|588367788|FG004|Overall Study|Early termination|0|||
162909340|NCT01066819|588367789|FG005|Overall Study|Early termination|0|||
162909341|NCT01066819|588367784|FG000|Overall Study|Failed to return|298|||
162909342|NCT01066819|588367785|FG001|Overall Study|Failed to return|107|||
162909343|NCT01066819|588367786|FG002|Overall Study|Failed to return|68|||
162909344|NCT01066819|588367787|FG003|Overall Study|Failed to return|7|||
162909345|NCT01066819|588367788|FG004|Overall Study|Failed to return|2|||
162909346|NCT01066819|588367789|FG005|Overall Study|Failed to return|3|||
162909347|NCT01066819|588367784|FG000|Overall Study|Lab test not done|9|||
162909348|NCT01066819|588367785|FG001|Overall Study|Lab test not done|0|||
162909349|NCT01066819|588367786|FG002|Overall Study|Lab test not done|2|||
162909350|NCT01066819|588367787|FG003|Overall Study|Lab test not done|1|||
162909351|NCT01066819|588367788|FG004|Overall Study|Lab test not done|0|||
162909352|NCT01066819|588367789|FG005|Overall Study|Lab test not done|0|||
162909353|NCT01066819|588367784|FG000|Overall Study|Miscellaneous|28|||
162909354|NCT01066819|588367785|FG001|Overall Study|Miscellaneous|10|||
162909355|NCT01066819|588367786|FG002|Overall Study|Miscellaneous|18|||
162909356|NCT01066819|588367787|FG003|Overall Study|Miscellaneous|1|||
162628383|NCT02915016|587354866|FG003|Overall Study|HIV infection|0|||
162628384|NCT02915016|587354867|FG004|Overall Study|HIV infection|1|||
162628385|NCT02915016|587354868|FG005|Overall Study|HIV infection|0|||
162628386|NCT02915016|587354869|FG006|Overall Study|HIV infection|0|||
162628387|NCT02915016|587354870|FG007|Overall Study|HIV infection|0|||
162628388|NCT02915016|587354863|FG000|Overall Study|Participant unable to adhere|0|||
162628389|NCT02915016|587354864|FG001|Overall Study|Participant unable to adhere|0|||
162628390|NCT02915016|587354865|FG002|Overall Study|Participant unable to adhere|0|||
162628391|NCT02915016|587354866|FG003|Overall Study|Participant unable to adhere|0|||
162628392|NCT02915016|587354867|FG004|Overall Study|Participant unable to adhere|0|||
162628393|NCT02915016|587354868|FG005|Overall Study|Participant unable to adhere|0|||
162628394|NCT02915016|587354869|FG006|Overall Study|Participant unable to adhere|0|||
162628395|NCT02915016|587354870|FG007|Overall Study|Participant unable to adhere|1|||
162628396|NCT02578316|587354871|FG000|Extension Phase|Progression of disease|6|||
162628397|NCT02166905|587354872|FG000|Overall Study|Withdrawal by Subject|1|||
162628398|NCT02166905|587354873|FG001|Overall Study|Withdrawal by Subject|0|||
162628399|NCT02166905|587354874|FG002|Overall Study|Withdrawal by Subject|0|||
162628400|NCT02166905|587354875|FG003|Overall Study|Withdrawal by Subject|0|||
162628401|NCT02617628|587354876|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
162628402|NCT02617628|587354877|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
162628403|NCT03278873|587354882|FG000|Overall Study|Withdrawal by Subject|0|||
162628404|NCT03278873|587354883|FG001|Overall Study|Withdrawal by Subject|1|||
162628405|NCT03278873|587354884|FG002|Overall Study|Withdrawal by Subject|0|||
162628406|NCT03278873|587354885|FG003|Overall Study|Withdrawal by Subject|0|||
162628407|NCT03278873|587354882|FG000|Overall Study|Sponsor's decision|0|||
162909357|NCT01066819|588367788|FG004|Overall Study|Miscellaneous|0|||
162909358|NCT01066819|588367789|FG005|Overall Study|Miscellaneous|0|||
162909359|NCT01066819|588367784|FG000|Overall Study|Non responders|123|||
162909360|NCT01066819|588367785|FG001|Overall Study|Non responders|2|||
162909361|NCT01066819|588367786|FG002|Overall Study|Non responders|7|||
162909362|NCT01066819|588367787|FG003|Overall Study|Non responders|2|||
162909363|NCT01066819|588367788|FG004|Overall Study|Non responders|0|||
162909364|NCT01066819|588367789|FG005|Overall Study|Non responders|1|||
162909365|NCT01066819|588367784|FG000|Overall Study|Not categorised|9|||
162909366|NCT01066819|588367785|FG001|Overall Study|Not categorised|2|||
162909367|NCT01066819|588367786|FG002|Overall Study|Not categorised|6|||
162909368|NCT01066819|588367787|FG003|Overall Study|Not categorised|1|||
162909369|NCT01066819|588367788|FG004|Overall Study|Not categorised|0|||
162909370|NCT01066819|588367789|FG005|Overall Study|Not categorised|0|||
162909371|NCT01066819|588367784|FG000|Overall Study|Relapse|16|||
162909372|NCT01066819|588367785|FG001|Overall Study|Relapse|4|||
162909373|NCT01066819|588367786|FG002|Overall Study|Relapse|3|||
162909374|NCT01066819|588367787|FG003|Overall Study|Relapse|0|||
162909375|NCT01066819|588367788|FG004|Overall Study|Relapse|0|||
162909376|NCT01066819|588367789|FG005|Overall Study|Relapse|0|||
162909377|NCT01066819|588367784|FG000|Overall Study|Results not available|1|||
162909378|NCT01066819|588367785|FG001|Overall Study|Results not available|0|||
162909379|NCT01066819|588367786|FG002|Overall Study|Results not available|0|||
162909380|NCT01066819|588367787|FG003|Overall Study|Results not available|0|||
162909381|NCT01066819|588367788|FG004|Overall Study|Results not available|0|||
162909382|NCT01066819|588367789|FG005|Overall Study|Results not available|0|||
162909383|NCT01066819|588367784|FG000|Overall Study|Screen failure|1|||
162628408|NCT03278873|587354883|FG001|Overall Study|Sponsor's decision|1|||
162628409|NCT03278873|587354884|FG002|Overall Study|Sponsor's decision|0|||
162628410|NCT03278873|587354885|FG003|Overall Study|Sponsor's decision|0|||
162628411|NCT03278873|587354882|FG000|Overall Study|Early Termination|2|||
162628412|NCT03278873|587354883|FG001|Overall Study|Early Termination|6|||
162628413|NCT03278873|587354884|FG002|Overall Study|Early Termination|0|||
162628414|NCT03278873|587354885|FG003|Overall Study|Early Termination|4|||
162909384|NCT01066819|588367785|FG001|Overall Study|Screen failure|0|||
162909385|NCT01066819|588367786|FG002|Overall Study|Screen failure|0|||
162909386|NCT01066819|588367787|FG003|Overall Study|Screen failure|0|||
162909387|NCT01066819|588367788|FG004|Overall Study|Screen failure|0|||
162909388|NCT01066819|588367789|FG005|Overall Study|Screen failure|0|||
162909389|NCT01066819|588367784|FG000|Overall Study|Spontaneous cure|1|||
162909390|NCT01066819|588367785|FG001|Overall Study|Spontaneous cure|0|||
162909391|NCT01066819|588367786|FG002|Overall Study|Spontaneous cure|0|||
162909392|NCT01066819|588367787|FG003|Overall Study|Spontaneous cure|0|||
162909393|NCT01066819|588367788|FG004|Overall Study|Spontaneous cure|0|||
162909394|NCT01066819|588367789|FG005|Overall Study|Spontaneous cure|0|||
162909395|NCT01066819|588367784|FG000|Overall Study|Treatment never started|85|||
162909396|NCT01066819|588367785|FG001|Overall Study|Treatment never started|19|||
162909397|NCT01066819|588367786|FG002|Overall Study|Treatment never started|19|||
162909398|NCT01066819|588367787|FG003|Overall Study|Treatment never started|3|||
162909399|NCT01066819|588367788|FG004|Overall Study|Treatment never started|2|||
162909400|NCT01066819|588367789|FG005|Overall Study|Treatment never started|2|||
162909401|NCT01066819|588367784|FG000|Overall Study|Treatment stopped|12|||
162909402|NCT01066819|588367785|FG001|Overall Study|Treatment stopped|1|||
162909403|NCT01066819|588367786|FG002|Overall Study|Treatment stopped|2|||
162909404|NCT01066819|588367787|FG003|Overall Study|Treatment stopped|1|||
162909405|NCT01066819|588367788|FG004|Overall Study|Treatment stopped|0|||
162909406|NCT01066819|588367789|FG005|Overall Study|Treatment stopped|0|||
162909407|NCT01066819|588367784|FG000|Overall Study|Other|5|||
162909408|NCT01066819|588367785|FG001|Overall Study|Other|1|||
162909409|NCT01066819|588367786|FG002|Overall Study|Other|1|||
162909410|NCT01066819|588367787|FG003|Overall Study|Other|0|||
162909411|NCT01066819|588367788|FG004|Overall Study|Other|0|||
162909412|NCT01066819|588367789|FG005|Overall Study|Other|0|||
162909413|NCT03812224|588367791|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
162909414|NCT03812224|588367792|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162909415|NCT03812224|588367791|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
162909416|NCT03812224|588367792|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
162909417|NCT03812224|588367791|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
162909418|NCT03812224|588367792|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
162909419|NCT03812224|588367791|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
162909420|NCT03812224|588367792|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
162909421|NCT01667731|588367798|FG000|Overall Study|Enrolled but not treated|0|||
162909422|NCT01667731|588367799|FG001|Overall Study|Enrolled but not treated|0|||
162909423|NCT01667731|588367800|FG002|Overall Study|Enrolled but not treated|0|||
162909424|NCT01667731|588367801|FG003|Overall Study|Enrolled but not treated|0|||
162909425|NCT01667731|588367802|FG004|Overall Study|Enrolled but not treated|1|||
162909426|NCT01667731|588367798|FG000|Overall Study|Efficacy Failure|1|||
162909427|NCT01667731|588367799|FG001|Overall Study|Efficacy Failure|12|||
162909428|NCT01667731|588367800|FG002|Overall Study|Efficacy Failure|0|||
162909429|NCT01667731|588367801|FG003|Overall Study|Efficacy Failure|1|||
162909430|NCT01667731|588367802|FG004|Overall Study|Efficacy Failure|24|||
162909431|NCT01667731|588367798|FG000|Overall Study|Lost to Follow-up|2|||
162909432|NCT01667731|588367799|FG001|Overall Study|Lost to Follow-up|3|||
162909433|NCT01667731|588367800|FG002|Overall Study|Lost to Follow-up|1|||
162909434|NCT01667731|588367801|FG003|Overall Study|Lost to Follow-up|1|||
162909435|NCT01667731|588367802|FG004|Overall Study|Lost to Follow-up|2|||
162909436|NCT01667731|588367798|FG000|Overall Study|Subject Withdrew Consent|2|||
162909437|NCT01667731|588367799|FG001|Overall Study|Subject Withdrew Consent|0|||
162909438|NCT01667731|588367800|FG002|Overall Study|Subject Withdrew Consent|1|||
162909439|NCT01667731|588367801|FG003|Overall Study|Subject Withdrew Consent|0|||
162909440|NCT01667731|588367802|FG004|Overall Study|Subject Withdrew Consent|1|||
162909441|NCT01667731|588367798|FG000|Overall Study|Death|0|||
162909442|NCT01667731|588367799|FG001|Overall Study|Death|1|||
162909443|NCT01667731|588367800|FG002|Overall Study|Death|0|||
162909444|NCT01667731|588367801|FG003|Overall Study|Death|0|||
162909445|NCT01667731|588367802|FG004|Overall Study|Death|0|||
162909446|NCT02516605|588367811|FG000|Overall Study|Protocol Violation|0|||
162909447|NCT02516605|588367812|FG001|Overall Study|Protocol Violation|0|||
162909448|NCT02516605|588367813|FG002|Overall Study|Protocol Violation|0|||
162909449|NCT02516605|588367814|FG003|Overall Study|Protocol Violation|0|||
162909450|NCT02516605|588367815|FG004|Overall Study|Protocol Violation|1|||
162909451|NCT02516605|588367811|FG000|Overall Study|Withdrawal by Subject|0|||
162628415|NCT03278873|587354882|FG000|Overall Study|Lost to Follow-up|0|||
162628416|NCT03278873|587354883|FG001|Overall Study|Lost to Follow-up|0|||
162628417|NCT03278873|587354884|FG002|Overall Study|Lost to Follow-up|2|||
162628418|NCT03278873|587354885|FG003|Overall Study|Lost to Follow-up|0|||
162628419|NCT03278873|587354882|FG000|Overall Study|The patient decided to withdraw via email|1|||
162628420|NCT03278873|587354883|FG001|Overall Study|The patient decided to withdraw via email|0|||
162628421|NCT03278873|587354884|FG002|Overall Study|The patient decided to withdraw via email|0|||
162909452|NCT02516605|588367812|FG001|Overall Study|Withdrawal by Subject|0|||
162628422|NCT03278873|587354885|FG003|Overall Study|The patient decided to withdraw via email|0|||
162909453|NCT02516605|588367813|FG002|Overall Study|Withdrawal by Subject|0|||
162909454|NCT02516605|588367814|FG003|Overall Study|Withdrawal by Subject|1|||
162909455|NCT02516605|588367815|FG004|Overall Study|Withdrawal by Subject|0|||
162909456|NCT02643420|588367816|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
162909457|NCT02643420|588367817|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
162909458|NCT02643420|588367816|FG000|Overall Study|Withdrawal by Subject|25|||
162909459|NCT02643420|588367817|FG001|Overall Study|Withdrawal by Subject|19|||
162909460|NCT02643420|588367816|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
162909461|NCT02643420|588367817|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
162909462|NCT02643420|588367816|FG000|Overall Study|Lost to Follow-up|6|||
162909463|NCT02643420|588367817|FG001|Overall Study|Lost to Follow-up|10|||
162909464|NCT02643420|588367816|FG000|Overall Study|Investigator Decision|2|||
162909465|NCT02643420|588367817|FG001|Overall Study|Investigator Decision|4|||
162909466|NCT02643420|588367816|FG000|Overall Study|Sponsor decision|1|||
162909467|NCT02643420|588367817|FG001|Overall Study|Sponsor decision|1|||
162909468|NCT02643420|588367816|FG000|Overall Study|Death|0|||
162909469|NCT02643420|588367817|FG001|Overall Study|Death|2|||
162909470|NCT02643420|588367816|FG000|Overall Study|Reason not Specified|8|||
162909471|NCT02643420|588367817|FG001|Overall Study|Reason not Specified|7|||
162909472|NCT02127970|588367818|FG000|Overall Study|Adverse Event|2|||
162909473|NCT02127970|588367819|FG001|Overall Study|Adverse Event|1|||
162909474|NCT02127970|588367818|FG000|Overall Study|Death|1|||
162909475|NCT02127970|588367819|FG001|Overall Study|Death|1|||
162909476|NCT02127970|588367818|FG000|Overall Study|Lost to Follow-up|14|||
162909477|NCT02127970|588367819|FG001|Overall Study|Lost to Follow-up|14|||
162909478|NCT02127970|588367818|FG000|Overall Study|Reason not Specified|4|||
162909479|NCT02127970|588367819|FG001|Overall Study|Reason not Specified|7|||
162909480|NCT02127970|588367818|FG000|Overall Study|Pregnancy|0|||
162909481|NCT02127970|588367819|FG001|Overall Study|Pregnancy|1|||
162909482|NCT02127970|588367818|FG000|Overall Study|Subject Withdrew Consent|5|||
162909483|NCT02127970|588367819|FG001|Overall Study|Subject Withdrew Consent|3|||
162909484|NCT01710709|588367820|FG000|Overall Study|Lost to Follow-up|29|||
162909485|NCT01710709|588367820|FG000|Overall Study|Adverse Event|48|||
162909486|NCT01710709|588367820|FG000|Overall Study|Participant met withdrawal criteria|33|||
162909487|NCT01710709|588367820|FG000|Overall Study|Participant withdrawn by investigator|2|||
162909488|NCT01710709|588367820|FG000|Overall Study|Withdrawal by Subject|53|||
162909489|NCT01710709|588367820|FG000|Overall Study|Protocol Violation|5|||
162909490|NCT01710709|588367820|FG000|Overall Study|Lack of Efficacy|3|||
162909491|NCT01398176|588367822|FG000|Overall Study|Lost to Follow-up|1|||
162909492|NCT01398176|588367823|FG001|Overall Study|Lost to Follow-up|3|||
162909493|NCT01398176|588367822|FG000|Overall Study|Physician Decision|2|||
162909494|NCT01398176|588367823|FG001|Overall Study|Physician Decision|3|||
162909495|NCT01871870|588367827|FG000|Overall Study|Hardware issues|7|||
162909496|NCT01871870|588367827|FG000|Overall Study|hyperglycemia|2|||
162909497|NCT00253747|588367833|FG000|Overall Study|Lost to Follow-up|13|||
162909498|NCT00253747|588367834|FG001|Overall Study|Lost to Follow-up|14|||
162909499|NCT00253747|588367833|FG000|Overall Study|Withdrawal by Subject|10|||
162909500|NCT00253747|588367834|FG001|Overall Study|Withdrawal by Subject|11|||
162909501|NCT00253747|588367833|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
162909502|NCT00253747|588367834|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
162909503|NCT02275052|588367837|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162909504|NCT02275052|588367838|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162909505|NCT02275052|588367839|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162909506|NCT02275052|588367840|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162909507|NCT02275052|588367837|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
162909508|NCT02275052|588367838|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
162909509|NCT02275052|588367839|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
162909510|NCT02275052|588367840|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
162909511|NCT02275052|588367837|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
162909512|NCT02275052|588367838|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
162909513|NCT02275052|588367839|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162909514|NCT02275052|588367840|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162909515|NCT02275052|588367837|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
162909516|NCT02275052|588367838|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
162909517|NCT02275052|588367839|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
162909518|NCT02275052|588367840|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
162909519|NCT02275052|588367837|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
162909520|NCT02275052|588367838|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
162909521|NCT02275052|588367839|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
162710598|NCT01168401|587650980|FG005|Overall Study|Withdrawal by Subject|0|||
162909522|NCT02275052|588367840|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
162909523|NCT02275052|588367837|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
162909524|NCT02275052|588367838|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
162909525|NCT02275052|588367839|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
162909526|NCT02275052|588367840|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
162909527|NCT02275052|588367837|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
162909528|NCT02275052|588367838|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
162909529|NCT02275052|588367839|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
162909530|NCT02275052|588367840|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
162909531|NCT02275052|588367837|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162909532|NCT02275052|588367838|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162909533|NCT02275052|588367839|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
162909534|NCT02275052|588367840|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
162909535|NCT02275052|588367837|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162909536|NCT02275052|588367838|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162909537|NCT02275052|588367839|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162909538|NCT02275052|588367840|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
162909539|NCT02275052|588367837|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
162909540|NCT02275052|588367838|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
162909541|NCT02275052|588367839|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162909542|NCT02275052|588367840|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
162909543|NCT02275052|588367837|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162909544|NCT02275052|588367838|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162909545|NCT02275052|588367839|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162909546|NCT02275052|588367840|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
162909547|NCT05102734|588367841|FG000|Overall Study|Did not require vasopressors|1|||
162909548|NCT05102734|588367842|FG001|Overall Study|Did not require vasopressors|0|||
162909549|NCT05102734|588367841|FG000|Overall Study|Did not have functioning PA catheter|1|||
162909550|NCT05102734|588367842|FG001|Overall Study|Did not have functioning PA catheter|0|||
162909551|NCT05102734|588367841|FG000|Overall Study|Inadequate video quality|2|||
162909552|NCT05102734|588367842|FG001|Overall Study|Inadequate video quality|0|||
162909553|NCT03055806|588367848|FG000|Overall Study|Adverse Event|0|||
162909554|NCT03055806|588367849|FG001|Overall Study|Adverse Event|0|||
162909555|NCT03055806|588367850|FG002|Overall Study|Adverse Event|1|||
162909556|NCT03055806|588367851|FG003|Overall Study|Adverse Event|1|||
162909557|NCT03055806|588367848|FG000|Overall Study|Lost to Follow-up|0|||
162909558|NCT03055806|588367849|FG001|Overall Study|Lost to Follow-up|3|||
162909559|NCT03055806|588367850|FG002|Overall Study|Lost to Follow-up|6|||
162909560|NCT03055806|588367851|FG003|Overall Study|Lost to Follow-up|7|||
162909561|NCT03055806|588367848|FG000|Overall Study|Physician Decision|1|||
162909562|NCT03055806|588367849|FG001|Overall Study|Physician Decision|0|||
162909563|NCT03055806|588367850|FG002|Overall Study|Physician Decision|0|||
162909564|NCT03055806|588367851|FG003|Overall Study|Physician Decision|1|||
162909565|NCT03055806|588367848|FG000|Overall Study|Protocol Violation|1|||
162909566|NCT03055806|588367849|FG001|Overall Study|Protocol Violation|0|||
162909567|NCT03055806|588367850|FG002|Overall Study|Protocol Violation|0|||
162909568|NCT03055806|588367851|FG003|Overall Study|Protocol Violation|0|||
162909569|NCT03055806|588367848|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
162909570|NCT03055806|588367849|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
162909571|NCT03055806|588367850|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
162909572|NCT03055806|588367851|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
162909573|NCT03055806|588367848|FG000|Overall Study|Withdrawal of consent to continue study|2|||
162909574|NCT03055806|588367849|FG001|Overall Study|Withdrawal of consent to continue study|3|||
162909575|NCT03055806|588367850|FG002|Overall Study|Withdrawal of consent to continue study|4|||
162909576|NCT03055806|588367851|FG003|Overall Study|Withdrawal of consent to continue study|6|||
162909577|NCT03055806|588367848|FG000|Overall Study|Partner not willing to try intercourse|1|||
162909578|NCT03055806|588367849|FG001|Overall Study|Partner not willing to try intercourse|0|||
162909579|NCT03055806|588367850|FG002|Overall Study|Partner not willing to try intercourse|0|||
162909580|NCT03055806|588367851|FG003|Overall Study|Partner not willing to try intercourse|0|||
162909581|NCT04601194|588367852|FG000|Overall Study|Lost to Follow-up|7|||
162909582|NCT02630459|588367853|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909583|NCT02630459|588367854|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
162909584|NCT02630459|588367855|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909585|NCT02630459|588367856|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
162909586|NCT02630459|588367857|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909587|NCT02630459|588367858|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909588|NCT02630459|588367859|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909589|NCT02630459|588367860|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
162909590|NCT02630459|588367853|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909591|NCT02630459|588367854|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909592|NCT02630459|588367855|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
162710599|NCT01168401|587650981|FG006|Overall Study|Withdrawal by Subject|0|||
162710600|NCT01168401|587650982|FG007|Overall Study|Withdrawal by Subject|0|||
162710601|NCT01168401|587650983|FG008|Overall Study|Withdrawal by Subject|0|||
162710602|NCT01168401|587650984|FG009|Overall Study|Withdrawal by Subject|0|||
162710603|NCT01168401|587650985|FG010|Overall Study|Withdrawal by Subject|0|||
162710604|NCT02072226|587650988|FG000|Overall Study|Lost to Follow-up|11|||
162710605|NCT02072226|587650989|FG001|Overall Study|Lost to Follow-up|7|||
162710606|NCT02072226|587650988|FG000|Overall Study|Patient Non-compliance|2|||
162909593|NCT02630459|588367856|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162710607|NCT02072226|587650989|FG001|Overall Study|Patient Non-compliance|3|||
162710608|NCT02072226|587650988|FG000|Overall Study|Death|1|||
162710609|NCT02072226|587650989|FG001|Overall Study|Death|0|||
162710610|NCT02072226|587650988|FG000|Overall Study|Patient Withdrawal of Consent|1|||
162710611|NCT02072226|587650989|FG001|Overall Study|Patient Withdrawal of Consent|0|||
162710612|NCT01720043|587650992|FG000|Overall Study|Withdrawal by Subject|1|||
162710613|NCT00972543|587650996|FG000|Overall Study|Adverse Event|1|||
162710614|NCT00972543|587650997|FG001|Overall Study|Adverse Event|0|||
162710615|NCT00972543|587650996|FG000|Overall Study|Early study termination by sponsor|4|||
162710616|NCT00972543|587650997|FG001|Overall Study|Early study termination by sponsor|1|||
162710617|NCT03101592|587650998|FG000|Overall Study|participant files could not be located|111|||
162710618|NCT03101592|587650999|FG001|Overall Study|participant files could not be located|170|||
162710619|NCT03101592|587651000|FG002|Overall Study|participant files could not be located|118|||
162710620|NCT02397889|587651003|FG000|Overall Study|Physician Decision|1|||
162710621|NCT02397889|587651004|FG001|Overall Study|Physician Decision|0|||
162710622|NCT01352507|587651005|FG000|Treatment Period 1|Adverse Event|3|||
162710623|NCT01352507|587651006|FG001|Treatment Period 1|Adverse Event|0|||
162710624|NCT01352507|587651005|FG000|Treatment Period 1|Lost to Follow-up|3|||
162909594|NCT02630459|588367857|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909595|NCT02630459|588367858|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909596|NCT02630459|588367859|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909597|NCT02630459|588367860|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
162909598|NCT02630459|588367853|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
162909599|NCT02630459|588367854|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
162909600|NCT02630459|588367855|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
162909601|NCT02630459|588367856|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
162909602|NCT02630459|588367857|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
162909603|NCT02630459|588367858|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
162909604|NCT02630459|588367859|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
162909605|NCT02630459|588367860|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
162909606|NCT02630459|588367853|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
162909607|NCT02630459|588367854|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909608|NCT02630459|588367855|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909609|NCT02630459|588367856|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909610|NCT02630459|588367857|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909611|NCT02630459|588367858|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909612|NCT02630459|588367859|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909613|NCT02630459|588367860|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162909614|NCT02630459|588367853|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909615|NCT02630459|588367854|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909616|NCT02630459|588367855|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909617|NCT02630459|588367856|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909618|NCT02630459|588367857|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
162909619|NCT02630459|588367858|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
162909620|NCT02630459|588367859|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909621|NCT02630459|588367860|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
162909622|NCT02630459|588367853|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162909623|NCT02630459|588367854|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162909624|NCT02630459|588367855|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162909625|NCT02630459|588367856|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162909626|NCT02630459|588367857|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
162909627|NCT02630459|588367858|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
162909628|NCT02630459|588367859|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162909629|NCT02630459|588367860|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
162967606|NCT01708954|588582972|FG002|Step 1|Disease progression|14|||
162967607|NCT01708954|588582970|FG000|Step 1|Adverse Event|3|||
162967608|NCT01708954|588582971|FG001|Step 1|Adverse Event|11|||
162967609|NCT01708954|588582972|FG002|Step 1|Adverse Event|13|||
162967610|NCT01708954|588582970|FG000|Step 1|Death|3|||
162967611|NCT01708954|588582971|FG001|Step 1|Death|2|||
162967612|NCT01708954|588582972|FG002|Step 1|Death|3|||
162710625|NCT01352507|587651006|FG001|Treatment Period 1|Lost to Follow-up|4|||
162967613|NCT01708954|588582970|FG000|Step 1|Withdrawal by Subject|2|||
162967614|NCT01708954|588582971|FG001|Step 1|Withdrawal by Subject|5|||
162967615|NCT01708954|588582972|FG002|Step 1|Withdrawal by Subject|3|||
162967616|NCT01708954|588582970|FG000|Step 1|Other complicating disease|0|||
162710626|NCT01352507|587651005|FG000|Treatment Period 1|Withdrawal by Subject|7|||
162710627|NCT01352507|587651006|FG001|Treatment Period 1|Withdrawal by Subject|5|||
162710628|NCT01352507|587651005|FG000|Treatment Period 1|Physician Decision|1|||
162710629|NCT01352507|587651006|FG001|Treatment Period 1|Physician Decision|0|||
162909630|NCT02630459|588367853|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909631|NCT02630459|588367854|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909632|NCT02630459|588367855|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909633|NCT02630459|588367856|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909634|NCT02630459|588367857|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
162909635|NCT02630459|588367858|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909636|NCT02630459|588367859|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909637|NCT02630459|588367860|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
162909638|NCT00846027|588367861|FG000|Overall Study|Death|3|||
162909639|NCT00846027|588367861|FG000|Overall Study|Disease Progression|30|||
162909640|NCT00846027|588367861|FG000|Overall Study|Toxicity|12|||
162909641|NCT00846027|588367861|FG000|Overall Study|Patient Decision|7|||
162909642|NCT00846027|588367861|FG000|Overall Study|Investigator Discretion|29|||
162909643|NCT00846027|588367861|FG000|Overall Study|Protocol Violation|2|||
162909644|NCT00846027|588367861|FG000|Overall Study|Subject Not Treated|7|||
162909645|NCT04905563|588367864|FG000|Overall Study|Withdrawal by Subject|1|||
162909646|NCT04905563|588367865|FG001|Overall Study|Withdrawal by Subject|0|||
162909647|NCT04905563|588367864|FG000|Overall Study|Standard of care orders entered by resident|1|||
162909648|NCT04905563|588367865|FG001|Overall Study|Standard of care orders entered by resident|0|||
162909649|NCT04905563|588367864|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
162909650|NCT04905563|588367865|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
162909651|NCT04905563|588367864|FG000|Overall Study|Withdrawal by Subject|0|||
162909652|NCT04905563|588367865|FG001|Overall Study|Withdrawal by Subject|1|||
162909653|NCT01797302|588367866|FG000|Overall Study|Lost to Follow-up|16|||
162909654|NCT01797302|588367867|FG001|Overall Study|Lost to Follow-up|23|||
162909655|NCT01797302|588367868|FG002|Overall Study|Lost to Follow-up|22|||
162909656|NCT01797302|588367866|FG000|Overall Study|Withdrawal by Subject|1|||
162909657|NCT01797302|588367867|FG001|Overall Study|Withdrawal by Subject|3|||
162909658|NCT01797302|588367868|FG002|Overall Study|Withdrawal by Subject|4|||
162909659|NCT02418000|588367869|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
162909660|NCT02418000|588367870|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909661|NCT02418000|588367871|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909662|NCT02418000|588367872|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909663|NCT02418000|588367873|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909664|NCT02418000|588367869|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
162909665|NCT02418000|588367870|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
162909666|NCT02418000|588367871|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
162909667|NCT02418000|588367872|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
162909668|NCT02418000|588367873|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
162909669|NCT02418000|588367869|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
162909670|NCT02418000|588367870|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
162909671|NCT02418000|588367871|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
162909672|NCT02418000|588367872|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
162909673|NCT02418000|588367873|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
162909674|NCT02418000|588367869|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909675|NCT02418000|588367870|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
162909676|NCT02418000|588367871|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909677|NCT02418000|588367872|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909678|NCT02418000|588367873|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
162909679|NCT02418000|588367869|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
162909680|NCT02418000|588367870|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
162909681|NCT02418000|588367871|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
162909682|NCT02418000|588367872|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
162909683|NCT02418000|588367873|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
162909684|NCT02418000|588367869|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909685|NCT02418000|588367870|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909686|NCT02418000|588367871|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
162909687|NCT02418000|588367872|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909688|NCT02418000|588367873|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909689|NCT02418000|588367869|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909690|NCT02418000|588367870|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909691|NCT02418000|588367871|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909692|NCT02418000|588367872|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
162909693|NCT02418000|588367873|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909694|NCT02418000|588367869|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
162909695|NCT02418000|588367870|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
162909696|NCT02418000|588367871|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
162909697|NCT02418000|588367872|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
162909698|NCT02418000|588367873|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
162909699|NCT02418000|588367869|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162628423|NCT03278873|587354882|FG000|Overall Study|The patient was unresponsive to contact|0|||
162628424|NCT03278873|587354883|FG001|Overall Study|The patient was unresponsive to contact|0|||
162628425|NCT03278873|587354884|FG002|Overall Study|The patient was unresponsive to contact|0|||
162628426|NCT03278873|587354885|FG003|Overall Study|The patient was unresponsive to contact|4|||
162909700|NCT02418000|588367870|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909701|NCT02418000|588367871|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909702|NCT02418000|588367872|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
162909703|NCT02418000|588367873|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
162909704|NCT00490815|588367874|FG000|Overall Study|Adverse Event|2|||
162909705|NCT00490815|588367875|FG001|Overall Study|Adverse Event|3|||
162909706|NCT00490815|588367874|FG000|Overall Study|Withdrawal by Subject|4|||
162909707|NCT00490815|588367875|FG001|Overall Study|Withdrawal by Subject|0|||
162909708|NCT00490815|588367874|FG000|Overall Study|Lost to Follow-up|1|||
162909709|NCT00490815|588367875|FG001|Overall Study|Lost to Follow-up|3|||
162909710|NCT00490815|588367874|FG000|Overall Study|Death|1|||
162909711|NCT00490815|588367875|FG001|Overall Study|Death|3|||
162909712|NCT01904760|588367876|FG000|Overall Study|Protocol Violation|1|||
162909713|NCT01904760|588367877|FG001|Overall Study|Protocol Violation|0|||
162909714|NCT04249076|588367879|FG000|Overall Study|Adverse Event|1|||
162909715|NCT04249076|588367880|FG001|Overall Study|Adverse Event|1|||
162909716|NCT04249076|588367879|FG000|Overall Study|Protocol Violation|1|||
162909717|NCT04249076|588367880|FG001|Overall Study|Protocol Violation|2|||
162909718|NCT04249076|588367879|FG000|Overall Study|Lack of Efficacy|0|||
162909719|NCT04249076|588367880|FG001|Overall Study|Lack of Efficacy|1|||
162909720|NCT04249076|588367879|FG000|Overall Study|Withdrawal by Subject|0|||
162909721|NCT04249076|588367880|FG001|Overall Study|Withdrawal by Subject|1|||
162909722|NCT00732199|588367885|FG000|Overall Study|Withdrawal by Subject|25|||
162909723|NCT00732199|588367886|FG001|Overall Study|Withdrawal by Subject|18|||
162909724|NCT00732199|588367885|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
162909725|NCT00732199|588367886|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
163054363|NCT02616783|588910256|FG001|Overall Study|Death|0|||
162628427|NCT03278873|587354882|FG000|Overall Study|The patient wished to participate no longer|0|||
162628428|NCT03278873|587354883|FG001|Overall Study|The patient wished to participate no longer|1|||
162628429|NCT03278873|587354884|FG002|Overall Study|The patient wished to participate no longer|0|||
162628430|NCT03278873|587354885|FG003|Overall Study|The patient wished to participate no longer|0|||
162909726|NCT01284127|588367901|FG000|Overall Study|Adverse Event|2|||
162909727|NCT01284127|588367901|FG000|Overall Study|Withdrawal by Subject|4|||
162909728|NCT01284127|588367901|FG000|Overall Study|Physician Decision|1|||
162909729|NCT00994890|588367903|FG000|Overall Study|Adverse Event|13|||
162909730|NCT00994890|588367904|FG001|Overall Study|Adverse Event|9|||
163054364|NCT02616783|588910255|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163054365|NCT02616783|588910256|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163054366|NCT02616783|588910255|FG000|Overall Study|Protocol Violation|1|||
163054367|NCT02616783|588910256|FG001|Overall Study|Protocol Violation|1|||
163054368|NCT02616783|588910255|FG000|Overall Study|Withdrew Consent|1|||
163054369|NCT02616783|588910256|FG001|Overall Study|Withdrew Consent|1|||
163054370|NCT05214118|588910257|FG000|Overall Study|Lost to Follow-up|0|||
162628431|NCT03278873|587354882|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162628432|NCT03278873|587354883|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162628433|NCT03278873|587354884|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
162628434|NCT03278873|587354885|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162628435|NCT05243641|587354886|FG000|Overall Study|Adverse Event|3|||
162909731|NCT00994890|588367905|FG002|Overall Study|Adverse Event|11|||
162909732|NCT00994890|588367903|FG000|Overall Study|Lack of Efficacy|0|||
162909733|NCT00994890|588367904|FG001|Overall Study|Lack of Efficacy|0|||
162909734|NCT00994890|588367905|FG002|Overall Study|Lack of Efficacy|1|||
162909735|NCT00994890|588367903|FG000|Overall Study|Lost to Follow-up|6|||
162909736|NCT00994890|588367904|FG001|Overall Study|Lost to Follow-up|1|||
163054371|NCT05214118|588910258|FG001|Overall Study|Lost to Follow-up|2|||
162909737|NCT00994890|588367905|FG002|Overall Study|Lost to Follow-up|3|||
162909738|NCT00994890|588367903|FG000|Overall Study|No longer willing to participate|8|||
162909739|NCT00994890|588367904|FG001|Overall Study|No longer willing to participate|5|||
162909740|NCT00994890|588367905|FG002|Overall Study|No longer willing to participate|13|||
162909741|NCT00994890|588367903|FG000|Overall Study|Protocol Violation|2|||
162909742|NCT00994890|588367904|FG001|Overall Study|Protocol Violation|4|||
162909743|NCT00994890|588367905|FG002|Overall Study|Protocol Violation|0|||
162909744|NCT00994890|588367903|FG000|Overall Study|Study terminated by sponsor|199|||
162909745|NCT00994890|588367904|FG001|Overall Study|Study terminated by sponsor|201|||
162909746|NCT00994890|588367905|FG002|Overall Study|Study terminated by sponsor|197|||
162909747|NCT00994890|588367903|FG000|Overall Study|Randomized, but not treated|1|||
162909748|NCT00994890|588367904|FG001|Overall Study|Randomized, but not treated|0|||
162909749|NCT00994890|588367905|FG002|Overall Study|Randomized, but not treated|0|||
162909750|NCT00994890|588367903|FG000|Overall Study|Other|2|||
162909751|NCT00994890|588367904|FG001|Overall Study|Other|2|||
162909752|NCT00994890|588367905|FG002|Overall Study|Other|1|||
162909753|NCT00699582|588367906|FG000|Overall Study|Adverse Event|4|||
162909754|NCT00699582|588367907|FG001|Overall Study|Adverse Event|11|||
162909755|NCT00699582|588367908|FG002|Overall Study|Adverse Event|23|||
162909756|NCT00699582|588367906|FG000|Overall Study|Withdrawal by Subject|6|||
162710630|NCT01352507|587651005|FG000|Washout Period|Withdrawal by Subject|0|||
162909757|NCT00699582|588367907|FG001|Overall Study|Withdrawal by Subject|7|||
162909758|NCT00699582|588367908|FG002|Overall Study|Withdrawal by Subject|4|||
162909759|NCT00699582|588367906|FG000|Overall Study|Lack of Efficacy|1|||
162909760|NCT00699582|588367907|FG001|Overall Study|Lack of Efficacy|0|||
162909761|NCT00699582|588367908|FG002|Overall Study|Lack of Efficacy|1|||
162909762|NCT00699582|588367906|FG000|Overall Study|Progressive Disease|1|||
162909763|NCT00699582|588367907|FG001|Overall Study|Progressive Disease|0|||
162909764|NCT00699582|588367908|FG002|Overall Study|Progressive Disease|0|||
162967617|NCT01708954|588582971|FG001|Step 1|Other complicating disease|2|||
162967618|NCT01708954|588582972|FG002|Step 1|Other complicating disease|0|||
162967619|NCT01708954|588582970|FG000|Step 1|Crossed over to Step 2|2|||
162967620|NCT01708954|588582971|FG001|Step 1|Crossed over to Step 2|0|||
162967621|NCT01708954|588582972|FG002|Step 1|Crossed over to Step 2|0|||
162967622|NCT01708954|588582970|FG000|Step 1|Symptomatic deterioration|1|||
162967623|NCT01708954|588582971|FG001|Step 1|Symptomatic deterioration|0|||
162967624|NCT01708954|588582972|FG002|Step 1|Symptomatic deterioration|1|||
162967625|NCT01708954|588582970|FG000|Step 1|Off-treatment reason not submitted|1|||
162967626|NCT01708954|588582971|FG001|Step 1|Off-treatment reason not submitted|1|||
162967627|NCT01708954|588582972|FG002|Step 1|Off-treatment reason not submitted|1|||
162967628|NCT01708954|588582970|FG000|Step 1|Ineligible or never received treatment|4|||
162967629|NCT01708954|588582971|FG001|Step 1|Ineligible or never received treatment|2|||
162967630|NCT01708954|588582972|FG002|Step 1|Ineligible or never received treatment|8|||
162967631|NCT01708954|588582970|FG000|Step 2|Disease progression|9|||
162967632|NCT01708954|588582971|FG001|Step 2|Disease progression|4|||
162967633|NCT01708954|588582972|FG002|Step 2|Disease progression|0|||
162967634|NCT01708954|588582970|FG000|Step 2|Adverse Event|3|||
162967635|NCT01708954|588582971|FG001|Step 2|Adverse Event|2|||
162967636|NCT01708954|588582972|FG002|Step 2|Adverse Event|0|||
162967637|NCT01708954|588582970|FG000|Step 2|Withdrawal by Subject|1|||
162967638|NCT01708954|588582971|FG001|Step 2|Withdrawal by Subject|1|||
162967639|NCT01708954|588582972|FG002|Step 2|Withdrawal by Subject|0|||
162967640|NCT03314857|588582976|FG000|Overall Study|Death|4|||
162967641|NCT03314857|588582976|FG000|Overall Study|Physician Decision|1|||
162967642|NCT01119625|588582977|FG000|Overall Study|Lost to Follow-up|1|||
162967643|NCT01119625|588582978|FG001|Overall Study|Lost to Follow-up|2|||
162967644|NCT01119625|588582977|FG000|Overall Study|Withdrawal by Subject|2|||
162967645|NCT01119625|588582978|FG001|Overall Study|Withdrawal by Subject|1|||
162967646|NCT01119625|588582977|FG000|Overall Study|Other|0|||
162967647|NCT01119625|588582978|FG001|Overall Study|Other|1|||
162967648|NCT01721772|588582983|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
162967649|NCT01721772|588582984|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
162967650|NCT01721772|588582983|FG000|Pre-Treatment|Poor/non-compliance|0|||
162967651|NCT01721772|588582984|FG001|Pre-Treatment|Poor/non-compliance|1|||
162967652|NCT01721772|588582983|FG000|Pre-Treatment|Participant withdrew consent|0|||
162967653|NCT01721772|588582984|FG001|Pre-Treatment|Participant withdrew consent|1|||
162967654|NCT01721772|588582983|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
162967655|NCT01721772|588582984|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
162967656|NCT01721772|588582983|FG000|Treatment|Disease progression|119|||
162967657|NCT01721772|588582984|FG001|Treatment|Disease progression|168|||
162710631|NCT01352507|587651006|FG001|Washout Period|Withdrawal by Subject|1|||
162909765|NCT00699582|588367906|FG000|Overall Study|Administrative/Other|4|||
162909766|NCT00699582|588367907|FG001|Overall Study|Administrative/Other|3|||
162909767|NCT00699582|588367908|FG002|Overall Study|Administrative/Other|0|||
162967658|NCT01721772|588582983|FG000|Treatment|Study drug toxicity|19|||
162967659|NCT01721772|588582984|FG001|Treatment|Study drug toxicity|10|||
162967660|NCT01721772|588582983|FG000|Treatment|Adverse event unrelated to study drug|7|||
162967661|NCT01721772|588582984|FG001|Treatment|Adverse event unrelated to study drug|7|||
162909768|NCT00699582|588367906|FG000|Overall Study|Randomized, Not Treated|2|||
162909769|NCT00699582|588367907|FG001|Overall Study|Randomized, Not Treated|1|||
162909770|NCT00699582|588367908|FG002|Overall Study|Randomized, Not Treated|0|||
162909771|NCT01849289|588367909|FG000|Overall Study|Adverse Event|3|||
162909772|NCT01849289|588367910|FG001|Overall Study|Adverse Event|3|||
162909773|NCT01849289|588367909|FG000|Overall Study|Protocol Violation|3|||
162909774|NCT01849289|588367910|FG001|Overall Study|Protocol Violation|3|||
162909775|NCT01849289|588367909|FG000|Overall Study|Withdrawal criteria|1|||
162909776|NCT01849289|588367910|FG001|Overall Study|Withdrawal criteria|0|||
162909777|NCT01849289|588367909|FG000|Overall Study|Unclassified|25|||
162909778|NCT01849289|588367910|FG001|Overall Study|Unclassified|18|||
162909779|NCT02692560|588367914|FG000|Overall Study|Withdrawal by Subject|0|||
162909780|NCT02692560|588367915|FG001|Overall Study|Withdrawal by Subject|6|||
162909781|NCT00715949|588367919|FG000|Overall Study|could not finish first test|4|||
162909782|NCT01326910|588367920|FG000|Overall Study|Withdrawal by Subject|3|||
162909783|NCT01326910|588367921|FG001|Overall Study|Withdrawal by Subject|2|||
162909784|NCT01326910|588367920|FG000|Overall Study|Protocol Violation|1|||
162909785|NCT01326910|588367921|FG001|Overall Study|Protocol Violation|1|||
162909786|NCT02274766|588367924|FG000|Overall Study|Withdrawal by Subject|3|||
162909787|NCT02274766|588367925|FG001|Overall Study|Withdrawal by Subject|6|||
162909788|NCT02274766|588367924|FG000|Overall Study|Did Not Receive Study Drug|1|||
162909789|NCT02274766|588367925|FG001|Overall Study|Did Not Receive Study Drug|1|||
162909790|NCT02274766|588367924|FG000|Overall Study|Subject Unwilling to Proceed|0|||
162909791|NCT02274766|588367925|FG001|Overall Study|Subject Unwilling to Proceed|1|||
162909792|NCT02274766|588367924|FG000|Overall Study|Adverse Event|0|||
162909793|NCT02274766|588367925|FG001|Overall Study|Adverse Event|1|||
162909794|NCT00806494|588367936|FG000|Overall Study|Adverse Event|29|||
162909795|NCT00806494|588367936|FG000|Overall Study|Lack of Efficacy|6|||
162909796|NCT00806494|588367936|FG000|Overall Study|Lost to Follow-up|10|||
162909797|NCT00806494|588367936|FG000|Overall Study|Other|30|||
162909798|NCT00806494|588367936|FG000|Overall Study|Withdrawal by Subject|5|||
162909799|NCT02417935|588367937|FG000|Treatment Period|Adverse Event|12|||
162909800|NCT02417935|588367938|FG001|Treatment Period|Adverse Event|10|||
162909801|NCT02417935|588367937|FG000|Treatment Period|Lost to Follow-up|1|||
162909802|NCT02417935|588367938|FG001|Treatment Period|Lost to Follow-up|0|||
162909803|NCT02417935|588367937|FG000|Treatment Period|Entry Criteria not met|0|||
162909804|NCT02417935|588367938|FG001|Treatment Period|Entry Criteria not met|1|||
162909805|NCT02417935|588367937|FG000|Treatment Period|Protocol Violation|2|||
162909806|NCT02417935|588367938|FG001|Treatment Period|Protocol Violation|1|||
162909807|NCT02417935|588367937|FG000|Treatment Period|Withdrawal by Subject|3|||
162628436|NCT05243641|587354887|FG001|Overall Study|Adverse Event|0|||
162628437|NCT05243641|587354888|FG002|Overall Study|Adverse Event|0|||
162628438|NCT05243641|587354889|FG003|Overall Study|Adverse Event|1|||
162628439|NCT05243641|587354890|FG004|Overall Study|Adverse Event|0|||
162628440|NCT05243641|587354891|FG005|Overall Study|Adverse Event|0|||
162628441|NCT05243641|587354886|FG000|Overall Study|Disease progression|4|||
162628442|NCT05243641|587354887|FG001|Overall Study|Disease progression|0|||
162628443|NCT05243641|587354888|FG002|Overall Study|Disease progression|0|||
162628444|NCT05243641|587354889|FG003|Overall Study|Disease progression|2|||
162628445|NCT05243641|587354890|FG004|Overall Study|Disease progression|0|||
162909808|NCT02417935|588367938|FG001|Treatment Period|Withdrawal by Subject|3|||
162909809|NCT02417935|588367937|FG000|Treatment Period|Physician Decision|3|||
162909810|NCT02417935|588367938|FG001|Treatment Period|Physician Decision|1|||
162909811|NCT00962780|588367942|FG000|Overall Study|Death|0|||
162909812|NCT00962780|588367943|FG001|Overall Study|Death|1|||
162909813|NCT00962780|588367942|FG000|Overall Study|Protocol Violation|9|||
162909814|NCT00962780|588367943|FG001|Overall Study|Protocol Violation|4|||
162909815|NCT00962780|588367942|FG000|Overall Study|Withdrawal by Subject|1|||
162909816|NCT00962780|588367943|FG001|Overall Study|Withdrawal by Subject|8|||
162909817|NCT00962780|588367942|FG000|Overall Study|Other|0|||
162909818|NCT00962780|588367943|FG001|Overall Study|Other|1|||
162909819|NCT02363322|588367944|FG000|Overall Study|Lost to Follow-up|1|||
162909820|NCT02363322|588367945|FG001|Overall Study|Lost to Follow-up|0|||
162909821|NCT01775995|588367946|FG000|Overall Study|Lost to Follow-up|1|||
162909822|NCT01775995|588367947|FG001|Overall Study|Lost to Follow-up|1|||
162909823|NCT02909504|588367948|FG000|Overall Study|Adverse Event|2|||
162909824|NCT02909504|588367948|FG000|Overall Study|Lack of Efficacy|3|||
162909825|NCT02909504|588367948|FG000|Overall Study|Withdrawal by Subject|4|||
162909826|NCT02909504|588367948|FG000|Overall Study|Pregnancy|1|||
162909827|NCT02909504|588367948|FG000|Overall Study|Subject moved|1|||
162909828|NCT02909504|588367948|FG000|Overall Study|Lost to Follow-up|1|||
162909829|NCT02055976|588367949|FG000|Overall Study|Other|0|||
162909830|NCT02055976|588367950|FG001|Overall Study|Other|0|||
162909831|NCT02055976|588367951|FG002|Overall Study|Other|1|||
162909832|NCT02055976|588367952|FG003|Overall Study|Other|0|||
162909833|NCT02055976|588367953|FG004|Overall Study|Other|0|||
162909834|NCT02055976|588367954|FG005|Overall Study|Other|0|||
162909835|NCT02055976|588367955|FG006|Overall Study|Other|0|||
162909836|NCT02055976|588367956|FG007|Overall Study|Other|0|||
162909837|NCT02055976|588367957|FG008|Overall Study|Other|0|||
162909838|NCT02055976|588367949|FG000|Overall Study|Adverse Event|0|||
162909839|NCT02055976|588367950|FG001|Overall Study|Adverse Event|0|||
162909840|NCT02055976|588367951|FG002|Overall Study|Adverse Event|0|||
162909841|NCT02055976|588367952|FG003|Overall Study|Adverse Event|0|||
162909842|NCT02055976|588367953|FG004|Overall Study|Adverse Event|0|||
162909843|NCT02055976|588367954|FG005|Overall Study|Adverse Event|1|||
162909844|NCT02055976|588367955|FG006|Overall Study|Adverse Event|1|||
162909845|NCT02055976|588367956|FG007|Overall Study|Adverse Event|0|||
162909846|NCT02055976|588367957|FG008|Overall Study|Adverse Event|0|||
162909847|NCT02055976|588367949|FG000|Overall Study|Does not meet entrance criteria|0|||
162909848|NCT02055976|588367950|FG001|Overall Study|Does not meet entrance criteria|0|||
162909849|NCT02055976|588367951|FG002|Overall Study|Does not meet entrance criteria|0|||
162909850|NCT02055976|588367952|FG003|Overall Study|Does not meet entrance criteria|0|||
162909851|NCT02055976|588367953|FG004|Overall Study|Does not meet entrance criteria|0|||
162909852|NCT02055976|588367954|FG005|Overall Study|Does not meet entrance criteria|0|||
162909853|NCT02055976|588367955|FG006|Overall Study|Does not meet entrance criteria|1|||
162909854|NCT02055976|588367956|FG007|Overall Study|Does not meet entrance criteria|0|||
162909855|NCT02055976|588367957|FG008|Overall Study|Does not meet entrance criteria|0|||
162909856|NCT02055976|588367949|FG000|Overall Study|Lost to Follow-up|0|||
162909857|NCT02055976|588367950|FG001|Overall Study|Lost to Follow-up|0|||
162909858|NCT02055976|588367951|FG002|Overall Study|Lost to Follow-up|0|||
162909859|NCT02055976|588367952|FG003|Overall Study|Lost to Follow-up|1|||
162909860|NCT02055976|588367953|FG004|Overall Study|Lost to Follow-up|0|||
162909861|NCT02055976|588367954|FG005|Overall Study|Lost to Follow-up|0|||
162909862|NCT02055976|588367955|FG006|Overall Study|Lost to Follow-up|0|||
162909863|NCT02055976|588367956|FG007|Overall Study|Lost to Follow-up|0|||
162909864|NCT02055976|588367957|FG008|Overall Study|Lost to Follow-up|0|||
162909865|NCT02504424|588367960|FG000|Overall Study|Withdrawal by Subject|2|||
162909866|NCT05604781|588369511|FG000|Overall Study|Lost to Follow-up|3|||
162909867|NCT05604781|588369511|FG000|Overall Study|Adverse Event|1|||
162909868|NCT03922945|588369525|FG000|Overall Study|Adverse Event|1|||
162909869|NCT03922945|588369526|FG001|Overall Study|Adverse Event|1|||
162909870|NCT03922945|588369527|FG002|Overall Study|Adverse Event|2|||
162909871|NCT03922945|588369525|FG000|Overall Study|Lost to Follow-up|13|||
162909872|NCT03922945|588369526|FG001|Overall Study|Lost to Follow-up|9|||
162909873|NCT03922945|588369527|FG002|Overall Study|Lost to Follow-up|20|||
162909874|NCT03922945|588369525|FG000|Overall Study|Lack of Efficacy|2|||
162909875|NCT03922945|588369526|FG001|Overall Study|Lack of Efficacy|0|||
162909876|NCT03922945|588369527|FG002|Overall Study|Lack of Efficacy|1|||
162909877|NCT03922945|588369525|FG000|Overall Study|Protocol Non-Compliance|0|||
162710632|NCT01352507|587651005|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
162710633|NCT01352507|587651006|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
162710634|NCT01352507|587651005|FG000|Treatment Period 2|Withdrawal by Subject|4|||
162710635|NCT01352507|587651006|FG001|Treatment Period 2|Withdrawal by Subject|3|||
162710636|NCT01352507|587651005|FG000|Treatment Period 2|Lack of Efficacy|1|||
162710637|NCT01352507|587651006|FG001|Treatment Period 2|Lack of Efficacy|0|||
162710638|NCT03178201|587651007|FG000|Overall Study|Off study|5|||
162710639|NCT04639947|587651012|FG000|Overall Study|Screen fail|1|||
162710640|NCT01018511|587651013|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
162710641|NCT01018511|587651014|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
162710642|NCT01018511|587651015|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
162710643|NCT01018511|587651016|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
163054372|NCT05214118|588910257|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
163054373|NCT05214118|588910258|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
162710644|NCT01018511|587651013|FG000|Overall Study|Adverse Event|5|||
162909878|NCT03922945|588369526|FG001|Overall Study|Protocol Non-Compliance|0|||
162909879|NCT03922945|588369527|FG002|Overall Study|Protocol Non-Compliance|1|||
162909880|NCT03922945|588369525|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
162909881|NCT03922945|588369526|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
162909882|NCT03922945|588369527|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
162909883|NCT03922945|588369525|FG000|Overall Study|All Other Personal Reasons|1|||
162909884|NCT03922945|588369526|FG001|Overall Study|All Other Personal Reasons|1|||
162909885|NCT03922945|588369527|FG002|Overall Study|All Other Personal Reasons|2|||
162909886|NCT00313716|588369528|FG000|Overall Study|Death|3|||
162909887|NCT00313716|588369529|FG001|Overall Study|Death|2|||
162909888|NCT00313716|588369530|FG002|Overall Study|Death|9|||
162909889|NCT00313716|588369531|FG003|Overall Study|Death|3|||
162909890|NCT00313716|588369532|FG004|Overall Study|Death|5|||
162909891|NCT00313716|588369533|FG005|Overall Study|Death|9|||
162909892|NCT00313716|588369528|FG000|Overall Study|Lost to Follow-up|2|||
162909893|NCT00313716|588369529|FG001|Overall Study|Lost to Follow-up|5|||
162909894|NCT00313716|588369530|FG002|Overall Study|Lost to Follow-up|2|||
162909895|NCT00313716|588369531|FG003|Overall Study|Lost to Follow-up|1|||
162909896|NCT00313716|588369532|FG004|Overall Study|Lost to Follow-up|0|||
162909897|NCT00313716|588369533|FG005|Overall Study|Lost to Follow-up|4|||
162909898|NCT00313716|588369528|FG000|Overall Study|Withdrawal by Subject|0|||
162909899|NCT00313716|588369529|FG001|Overall Study|Withdrawal by Subject|1|||
162909900|NCT00313716|588369530|FG002|Overall Study|Withdrawal by Subject|1|||
162909901|NCT00313716|588369531|FG003|Overall Study|Withdrawal by Subject|0|||
162909902|NCT00313716|588369532|FG004|Overall Study|Withdrawal by Subject|1|||
162909903|NCT00313716|588369533|FG005|Overall Study|Withdrawal by Subject|0|||
162909904|NCT02927990|588369542|FG000|Overall Study|Protocol Violation|4|||
162909905|NCT02927990|588369542|FG000|Overall Study|Physician Decision|9|||
163054374|NCT05214118|588910257|FG000|Overall Study|moved|1|||
162710645|NCT01018511|587651014|FG001|Overall Study|Adverse Event|9|||
162710646|NCT01018511|587651015|FG002|Overall Study|Adverse Event|13|||
162909906|NCT02927990|588369542|FG000|Overall Study|Room switched and therefore no study device available|15|||
162909907|NCT02927990|588369542|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
162909908|NCT00960323|588369543|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
162909909|NCT01524900|588369553|FG000|Overall Study|Lost to Follow-up|3|||
162909910|NCT01524900|588369554|FG001|Overall Study|Lost to Follow-up|12|||
163054375|NCT05214118|588910258|FG001|Overall Study|moved|0|||
162710647|NCT01018511|587651016|FG003|Overall Study|Adverse Event|10|||
162710648|NCT01018511|587651013|FG000|Overall Study|Lack of Efficacy|4|||
162909911|NCT01524900|588369555|FG002|Overall Study|Lost to Follow-up|1|||
162909912|NCT01524900|588369556|FG003|Overall Study|Lost to Follow-up|0|||
162909913|NCT01524900|588369557|FG004|Overall Study|Lost to Follow-up|0|||
162909914|NCT01524900|588369553|FG000|Overall Study|Other reason than stated above|1|||
162710649|NCT01018511|587651014|FG001|Overall Study|Lack of Efficacy|1|||
162710650|NCT01018511|587651015|FG002|Overall Study|Lack of Efficacy|1|||
162909915|NCT01524900|588369554|FG001|Overall Study|Other reason than stated above|1|||
162909916|NCT01524900|588369555|FG002|Overall Study|Other reason than stated above|0|||
162909917|NCT01524900|588369556|FG003|Overall Study|Other reason than stated above|0|||
162909918|NCT01524900|588369557|FG004|Overall Study|Other reason than stated above|0|||
162909919|NCT01524900|588369553|FG000|Overall Study|No reason documented|2|||
162909920|NCT01524900|588369554|FG001|Overall Study|No reason documented|1|||
162909921|NCT01524900|588369555|FG002|Overall Study|No reason documented|0|||
162909922|NCT01524900|588369556|FG003|Overall Study|No reason documented|1|||
162909923|NCT01524900|588369557|FG004|Overall Study|No reason documented|0|||
162909924|NCT00772031|588369558|FG000|Overall Study|Early termination of trial|12|||
162909925|NCT00772031|588369559|FG001|Overall Study|Early termination of trial|10|||
162909926|NCT00772031|588369558|FG000|Overall Study|Lost to Follow-up|20|||
162909927|NCT00772031|588369559|FG001|Overall Study|Lost to Follow-up|33|||
162909928|NCT00532441|588369560|FG000|Overall Study|Death|1|||
162909929|NCT00532441|588369561|FG001|Overall Study|Death|0|||
162909930|NCT01603615|588369562|FG000|Overall Study|Did not Receive Treatment|7|||
162909931|NCT01603615|588369562|FG000|Overall Study|Lost to Follow-up|9|||
162909932|NCT01603615|588369562|FG000|Overall Study|Personal Reasons|17|||
162909933|NCT01603615|588369562|FG000|Overall Study|Other Miscellaneous|1|||
162909934|NCT00303329|588369563|FG000|Overall Study|Adverse Event|7|||
162909935|NCT00303329|588369564|FG001|Overall Study|Adverse Event|14|||
162909936|NCT00303329|588369563|FG000|Overall Study|Abnormal Laboratory Values|0|||
162909937|NCT00303329|588369564|FG001|Overall Study|Abnormal Laboratory Values|1|||
162909938|NCT00303329|588369563|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
162909939|NCT00303329|588369564|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162909940|NCT00303329|588369563|FG000|Overall Study|Condition no longer requires study drug|0|||
162909941|NCT00303329|588369564|FG001|Overall Study|Condition no longer requires study drug|8|||
162909942|NCT00303329|588369563|FG000|Overall Study|Protocol Violation|3|||
162909943|NCT00303329|588369564|FG001|Overall Study|Protocol Violation|0|||
162909944|NCT00303329|588369563|FG000|Overall Study|Withdrawal by Subject|9|||
162909945|NCT00303329|588369564|FG001|Overall Study|Withdrawal by Subject|15|||
162909946|NCT00303329|588369563|FG000|Overall Study|Lost to Follow-up|0|||
163054376|NCT03080935|588910259|FG000|Overall Study|Death|34|||
163054377|NCT03080935|588910260|FG001|Overall Study|Death|50|||
163054378|NCT03080935|588910259|FG000|Overall Study|Lost to Follow-up|5|||
163054379|NCT03080935|588910260|FG001|Overall Study|Lost to Follow-up|4|||
163054380|NCT03080935|588910259|FG000|Overall Study|Withdrawal by Subject|11|||
163054381|NCT03080935|588910260|FG001|Overall Study|Withdrawal by Subject|15|||
163054382|NCT01614470|588910261|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
163054383|NCT01614470|588910262|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163054384|NCT01614470|588910263|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163054385|NCT01614470|588910261|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
163054386|NCT01614470|588910262|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
163054387|NCT01614470|588910263|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
163054388|NCT02895347|588910266|FG000|Overall Study|Withdrawal by Subject|3|||
163054389|NCT02895347|588910267|FG001|Overall Study|Withdrawal by Subject|1|||
163054390|NCT00449163|588910271|FG000|Overall Study|Physician Decision|3|||
163054391|NCT00606307|588910274|FG000|Overall Study|Adverse Event|2|||
163054392|NCT00606307|588910274|FG000|Overall Study|Withdrawal by Subject|2|||
163054393|NCT00606307|588910274|FG000|Overall Study|Disease progression|6|||
163054394|NCT00606307|588910274|FG000|Overall Study|QTc prolongation|1|||
163054395|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
163054396|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
163054397|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
163054398|NCT03368807|588910275|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
163054399|NCT03669588|588910289|FG000|Overall Study|Adverse Event|1|||
163054400|NCT03669588|588910290|FG001|Overall Study|Adverse Event|0|||
163054401|NCT03669588|588910289|FG000|Overall Study|Physician Decision|0|||
163054402|NCT03669588|588910290|FG001|Overall Study|Physician Decision|1|||
163054403|NCT03669588|588910289|FG000|Overall Study|Protocol Violation|1|||
163054404|NCT03669588|588910290|FG001|Overall Study|Protocol Violation|0|||
163054405|NCT03669588|588910289|FG000|Overall Study|Sponsor Decision|1|||
163054406|NCT03669588|588910290|FG001|Overall Study|Sponsor Decision|1|||
163054407|NCT03669588|588910289|FG000|Overall Study|Withdrawal by Subject|1|||
163054408|NCT03669588|588910290|FG001|Overall Study|Withdrawal by Subject|4|||
162909947|NCT00303329|588369564|FG001|Overall Study|Lost to Follow-up|1|||
162909948|NCT00303329|588369563|FG000|Overall Study|Administrative problems|1|||
163054409|NCT03669588|588910289|FG000|Overall Study|Rescue Therapy Needed|0|||
163054410|NCT03669588|588910290|FG001|Overall Study|Rescue Therapy Needed|1|||
163054411|NCT02949947|588910293|FG000|Overall Study|Non Compliance|0|||
162909949|NCT00303329|588369564|FG001|Overall Study|Administrative problems|0|||
163054412|NCT02949947|588910294|FG001|Overall Study|Non Compliance|1|||
163054413|NCT02949947|588910293|FG000|Overall Study|Insurance change|1|||
162909950|NCT00303329|588369563|FG000|Overall Study|Death|2|||
162909951|NCT00303329|588369564|FG001|Overall Study|Death|12|||
162909952|NCT00303329|588369563|FG000|Overall Study|Stopped at end of core|3|||
162710651|NCT01018511|587651016|FG003|Overall Study|Lack of Efficacy|2|||
162710652|NCT01018511|587651013|FG000|Overall Study|Withdrawal by Subject|6|||
162710653|NCT01018511|587651014|FG001|Overall Study|Withdrawal by Subject|5|||
162710654|NCT01018511|587651015|FG002|Overall Study|Withdrawal by Subject|11|||
162710655|NCT01018511|587651016|FG003|Overall Study|Withdrawal by Subject|9|||
162710656|NCT01018511|587651013|FG000|Overall Study|Lost to Follow-up|0|||
162710657|NCT01018511|587651014|FG001|Overall Study|Lost to Follow-up|0|||
162710658|NCT01018511|587651015|FG002|Overall Study|Lost to Follow-up|1|||
162710659|NCT01018511|587651016|FG003|Overall Study|Lost to Follow-up|0|||
162710660|NCT01018511|587651013|FG000|Overall Study|Protocol Violation|5|||
162710661|NCT01018511|587651014|FG001|Overall Study|Protocol Violation|8|||
162710662|NCT01018511|587651015|FG002|Overall Study|Protocol Violation|7|||
162710663|NCT01018511|587651016|FG003|Overall Study|Protocol Violation|9|||
162710664|NCT01018511|587651013|FG000|Overall Study|Miscellaneous|0|||
162710665|NCT01018511|587651014|FG001|Overall Study|Miscellaneous|2|||
162710666|NCT01018511|587651015|FG002|Overall Study|Miscellaneous|0|||
162628446|NCT05243641|587354891|FG005|Overall Study|Disease progression|0|||
162628447|NCT05372419|587354903|FG000|Overall Study|Protocol Deviation|1|||
162628448|NCT05372419|587354903|FG000|Overall Study|Withdrawal by Subject|5|||
162628449|NCT05372419|587354903|FG000|Overall Study|Lost to Follow-up|7|||
162628450|NCT02801331|587354904|FG000|Overall Study|Transferred to another hospital|8|||
162628451|NCT02801331|587354905|FG001|Overall Study|Transferred to another hospital|7|||
162628452|NCT02801331|587354904|FG000|Overall Study|Withdrawal by Subject|0|||
162628453|NCT02801331|587354905|FG001|Overall Study|Withdrawal by Subject|4|||
162628454|NCT02801331|587354904|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
162628455|NCT02801331|587354905|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
162628456|NCT02443987|587354906|FG000|Overall Study|Bladder injury|1|||
162628457|NCT02443987|587354907|FG001|Overall Study|Bladder injury|1|||
162628458|NCT02443987|587354906|FG000|Overall Study|Other|0|||
162628459|NCT02443987|587354907|FG001|Overall Study|Other|1|||
162628460|NCT02513394|587354909|FG000|Overall Study|Withdrawal by Subject|11|||
162628461|NCT02513394|587354910|FG001|Overall Study|Withdrawal by Subject|23|||
162628462|NCT02513394|587354909|FG000|Overall Study|Ineligible|1|||
162628463|NCT02513394|587354910|FG001|Overall Study|Ineligible|0|||
162628464|NCT02161731|587356608|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
162628465|NCT02161731|587356609|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
162628466|NCT02161731|587356608|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
162628467|NCT02161731|587356609|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
162628468|NCT03633695|587356610|FG000|Overall Study|Lost to Follow-up|4|||
162628469|NCT03633695|587356611|FG001|Overall Study|Lost to Follow-up|5|||
162628470|NCT03633695|587356610|FG000|Overall Study|Discontinued|8|||
162628471|NCT03633695|587356611|FG001|Overall Study|Discontinued|4|||
162628472|NCT00684593|587356612|FG000|Overall Study|Adverse Event|0|||
162628473|NCT00684593|587356613|FG001|Overall Study|Adverse Event|2|||
162628474|NCT03217175|587356617|FG000|Overall Study|Physician Decision|4|||
162628475|NCT03217175|587356618|FG001|Overall Study|Physician Decision|1|||
162628476|NCT00429273|587356619|FG000|Overall Study|Lost to Follow-up|1|||
162628477|NCT00429273|587356620|FG001|Overall Study|Lost to Follow-up|2|||
162628478|NCT00429273|587356621|FG002|Overall Study|Lost to Follow-up|2|||
162628479|NCT00429273|587356619|FG000|Overall Study|Physician Decision|6|||
162628480|NCT00429273|587356620|FG001|Overall Study|Physician Decision|5|||
162628481|NCT00429273|587356621|FG002|Overall Study|Physician Decision|5|||
162628482|NCT00429273|587356619|FG000|Overall Study|Adverse Event|1|||
162628483|NCT00429273|587356620|FG001|Overall Study|Adverse Event|1|||
162628484|NCT00429273|587356621|FG002|Overall Study|Adverse Event|2|||
162628485|NCT01218204|587356626|FG000|Part B Washout|Adverse Event|0|||
162628486|NCT01218204|587356627|FG001|Part B Washout|Adverse Event|1|||
162628487|NCT01218204|587356628|FG002|Part B Washout|Adverse Event|0|||
162628488|NCT01218204|587356629|FG003|Part B Washout|Adverse Event|0|||
162628489|NCT01218204|587356626|FG000|Part B Washout|Lost to Follow-up|0|||
162628490|NCT01218204|587356627|FG001|Part B Washout|Lost to Follow-up|2|||
162628491|NCT01218204|587356628|FG002|Part B Washout|Lost to Follow-up|0|||
162628492|NCT01218204|587356629|FG003|Part B Washout|Lost to Follow-up|0|||
162628493|NCT01218204|587356626|FG000|Part B Washout|Physician Decision|0|||
162628494|NCT01218204|587356627|FG001|Part B Washout|Physician Decision|14|||
162710667|NCT01018511|587651016|FG003|Overall Study|Miscellaneous|0|||
162710668|NCT03424239|587651024|FG000|Overall Study|Withdrawal by Subject|2|||
162710669|NCT00604786|587651025|FG000|Overall Study|Lost to Follow-up|2|||
162710670|NCT00604786|587651026|FG001|Overall Study|Lost to Follow-up|0|||
162710671|NCT03697460|587651027|FG000|Overall Study|Withdrawal by Subject|3|||
162909953|NCT00303329|588369564|FG001|Overall Study|Stopped at end of core|9|||
162628495|NCT01218204|587356628|FG002|Part B Washout|Physician Decision|0|||
162628496|NCT01218204|587356629|FG003|Part B Washout|Physician Decision|0|||
162909954|NCT00303329|588369563|FG000|Overall Study|Stopped at end of extension 1|1|||
162909955|NCT00303329|588369564|FG001|Overall Study|Stopped at end of extension 1|0|||
162909956|NCT01101321|588369571|FG000|Period 1|Withdrawal by Subject|1|||
162909957|NCT01101321|588369572|FG001|Period 1|Withdrawal by Subject|1|||
162909958|NCT01101321|588369571|FG000|Period 1|Adverse Event|3|||
162909959|NCT01101321|588369572|FG001|Period 1|Adverse Event|3|||
162909960|NCT00542321|588369573|FG000|Overall Study|Death|0|||
162909961|NCT00542321|588369574|FG001|Overall Study|Death|1|||
162909962|NCT03339999|588369575|FG000|Overall Study|Adverse Event|1|||
162909963|NCT03339999|588369576|FG001|Overall Study|Adverse Event|2|||
162909964|NCT03339999|588369577|FG002|Overall Study|Adverse Event|2|||
162909965|NCT03339999|588369578|FG003|Overall Study|Adverse Event|1|||
162909966|NCT03339999|588369575|FG000|Overall Study|Lack of Efficacy|0|||
162909967|NCT03339999|588369576|FG001|Overall Study|Lack of Efficacy|1|||
162909968|NCT03339999|588369577|FG002|Overall Study|Lack of Efficacy|0|||
162909969|NCT03339999|588369578|FG003|Overall Study|Lack of Efficacy|0|||
162909970|NCT03339999|588369575|FG000|Overall Study|Lost to Follow-up|0|||
162909971|NCT03339999|588369576|FG001|Overall Study|Lost to Follow-up|0|||
162909972|NCT03339999|588369577|FG002|Overall Study|Lost to Follow-up|0|||
162909973|NCT03339999|588369578|FG003|Overall Study|Lost to Follow-up|1|||
162909974|NCT03339999|588369575|FG000|Overall Study|Study Terminated by Sponsor|6|||
162628497|NCT01218204|587356626|FG000|Part B Washout|Withdrawal by Subject|0|||
162628498|NCT01218204|587356627|FG001|Part B Washout|Withdrawal by Subject|14|||
162628499|NCT01218204|587356628|FG002|Part B Washout|Withdrawal by Subject|0|||
162628500|NCT01218204|587356629|FG003|Part B Washout|Withdrawal by Subject|0|||
162628501|NCT01218204|587356626|FG000|Part B Washout|Reached defined stopping criteria|0|||
162628502|NCT01218204|587356627|FG001|Part B Washout|Reached defined stopping criteria|2|||
162628503|NCT01218204|587356628|FG002|Part B Washout|Reached defined stopping criteria|0|||
162628504|NCT01218204|587356629|FG003|Part B Washout|Reached defined stopping criteria|0|||
162628505|NCT01218204|587356626|FG000|Part B Washout|Did not meet continuation criteria|0|||
162628506|NCT01218204|587356627|FG001|Part B Washout|Did not meet continuation criteria|112|||
162628507|NCT01218204|587356628|FG002|Part B Washout|Did not meet continuation criteria|0|||
162628508|NCT01218204|587356629|FG003|Part B Washout|Did not meet continuation criteria|0|||
162628509|NCT01218204|587356626|FG000|Part B Run-in|Adverse Event|0|||
162628510|NCT01218204|587356627|FG001|Part B Run-in|Adverse Event|0|||
162628511|NCT01218204|587356628|FG002|Part B Run-in|Adverse Event|1|||
162628512|NCT01218204|587356629|FG003|Part B Run-in|Adverse Event|0|||
162628513|NCT01218204|587356626|FG000|Part B Run-in|Protocol Violation|0|||
162628514|NCT01218204|587356627|FG001|Part B Run-in|Protocol Violation|0|||
162628515|NCT01218204|587356628|FG002|Part B Run-in|Protocol Violation|2|||
162628516|NCT01218204|587356629|FG003|Part B Run-in|Protocol Violation|0|||
162628517|NCT01218204|587356626|FG000|Part B Run-in|Withdrawal by Subject|0|||
162909975|NCT03339999|588369576|FG001|Overall Study|Study Terminated by Sponsor|3|||
162909976|NCT03339999|588369577|FG002|Overall Study|Study Terminated by Sponsor|4|||
162909977|NCT03339999|588369578|FG003|Overall Study|Study Terminated by Sponsor|3|||
162909978|NCT00525499|588369579|FG000|Overall Study|Lost to Follow-up|2|||
162909979|NCT00525499|588369580|FG001|Overall Study|Lost to Follow-up|4|||
162909980|NCT00525499|588369581|FG002|Overall Study|Lost to Follow-up|1|||
162909981|NCT00525499|588369582|FG003|Overall Study|Lost to Follow-up|4|||
162967662|NCT01721772|588582983|FG000|Treatment|Maximum clinical benefit|16|||
162967663|NCT01721772|588582984|FG001|Treatment|Maximum clinical benefit|4|||
162967664|NCT01721772|588582983|FG000|Treatment|Other|19|||
162967665|NCT01721772|588582984|FG001|Treatment|Other|2|||
162628518|NCT01218204|587356627|FG001|Part B Run-in|Withdrawal by Subject|0|||
162628519|NCT01218204|587356628|FG002|Part B Run-in|Withdrawal by Subject|3|||
162628520|NCT01218204|587356629|FG003|Part B Run-in|Withdrawal by Subject|0|||
162909982|NCT00525499|588369579|FG000|Overall Study|Adverse Event|0|||
162967666|NCT01721772|588582983|FG000|Treatment|Participant withdrew consent|2|||
162909983|NCT00525499|588369580|FG001|Overall Study|Adverse Event|1|||
162909984|NCT00525499|588369581|FG002|Overall Study|Adverse Event|0|||
162909985|NCT00525499|588369582|FG003|Overall Study|Adverse Event|1|||
162909986|NCT00525499|588369579|FG000|Overall Study|Withdrawal by Subject|5|||
162909987|NCT00525499|588369580|FG001|Overall Study|Withdrawal by Subject|1|||
162909988|NCT00525499|588369581|FG002|Overall Study|Withdrawal by Subject|5|||
162909989|NCT00525499|588369582|FG003|Overall Study|Withdrawal by Subject|2|||
162909990|NCT00525499|588369579|FG000|Overall Study|Protocol Violation|0|||
162909991|NCT00525499|588369580|FG001|Overall Study|Protocol Violation|1|||
162909992|NCT00525499|588369581|FG002|Overall Study|Protocol Violation|1|||
162909993|NCT00525499|588369582|FG003|Overall Study|Protocol Violation|0|||
162909994|NCT01856920|588369585|FG000|Overall Study|Disease Progression On Study|3|||
162909995|NCT01856920|588369586|FG001|Overall Study|Disease Progression On Study|4|||
162909996|NCT01856920|588369585|FG000|Overall Study|Disease Progression before Treatment|1|||
162909997|NCT01856920|588369586|FG001|Overall Study|Disease Progression before Treatment|0|||
162909998|NCT01856920|588369585|FG000|Overall Study|Ineligible|0|||
162909999|NCT01856920|588369586|FG001|Overall Study|Ineligible|1|||
162910000|NCT01856920|588369585|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
162910001|NCT01856920|588369586|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
162910002|NCT01856920|588369585|FG000|Overall Study|Refused further Treatment|5|||
162910003|NCT01856920|588369586|FG001|Overall Study|Refused further Treatment|1|||
162910004|NCT01856920|588369585|FG000|Overall Study|Other Reasons|0|||
162910005|NCT01856920|588369586|FG001|Overall Study|Other Reasons|1|||
162910006|NCT01856920|588369585|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
162910007|NCT01856920|588369586|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
162910008|NCT03287089|588369592|FG000|Overall Study|Lost to Follow-up|0|||
162910009|NCT03287089|588369593|FG001|Overall Study|Lost to Follow-up|2|||
162910010|NCT03287089|588369592|FG000|Overall Study|Physician Decision|0|||
162910011|NCT03287089|588369593|FG001|Overall Study|Physician Decision|2|||
162910012|NCT03287089|588369592|FG000|Overall Study|Withdrawal by Subject|0|||
162910013|NCT03287089|588369593|FG001|Overall Study|Withdrawal by Subject|2|||
162910014|NCT00783263|588369594|FG000|Overall Study|Adverse Event|3|||
162910015|NCT00783263|588369595|FG001|Overall Study|Adverse Event|0|||
162910016|NCT00783263|588369596|FG002|Overall Study|Adverse Event|2|||
162910017|NCT00783263|588369597|FG003|Overall Study|Adverse Event|1|||
162910018|NCT00783263|588369594|FG000|Overall Study|Lost to Follow-up|1|||
162910019|NCT00783263|588369595|FG001|Overall Study|Lost to Follow-up|1|||
162910020|NCT00783263|588369596|FG002|Overall Study|Lost to Follow-up|0|||
162910021|NCT00783263|588369597|FG003|Overall Study|Lost to Follow-up|0|||
162910022|NCT00783263|588369594|FG000|Overall Study|Withdrawal by Subject|0|||
162910023|NCT00783263|588369595|FG001|Overall Study|Withdrawal by Subject|1|||
162910024|NCT00783263|588369596|FG002|Overall Study|Withdrawal by Subject|1|||
162910025|NCT00783263|588369597|FG003|Overall Study|Withdrawal by Subject|2|||
162910026|NCT00106626|588369598|FG000|Overall Study|Adverse Event|5|||
162910027|NCT00106626|588369599|FG001|Overall Study|Adverse Event|4|||
162910028|NCT00106626|588369600|FG002|Overall Study|Adverse Event|3|||
162910029|NCT00106626|588369601|FG003|Overall Study|Adverse Event|3|||
162910030|NCT00106626|588369598|FG000|Overall Study|Progressive Disease|4|||
162910031|NCT00106626|588369599|FG001|Overall Study|Progressive Disease|1|||
162910032|NCT00106626|588369600|FG002|Overall Study|Progressive Disease|9|||
162910033|NCT00106626|588369601|FG003|Overall Study|Progressive Disease|10|||
162910034|NCT00106626|588369598|FG000|Overall Study|Received radiation on new therapy|1|||
162910035|NCT00106626|588369599|FG001|Overall Study|Received radiation on new therapy|0|||
162910036|NCT00106626|588369600|FG002|Overall Study|Received radiation on new therapy|0|||
162910037|NCT00106626|588369601|FG003|Overall Study|Received radiation on new therapy|0|||
162910038|NCT00106626|588369598|FG000|Overall Study|> 14 day delay in therapy start|0|||
162910039|NCT00106626|588369599|FG001|Overall Study|> 14 day delay in therapy start|1|||
162910040|NCT00106626|588369600|FG002|Overall Study|> 14 day delay in therapy start|0|||
162910041|NCT00106626|588369601|FG003|Overall Study|> 14 day delay in therapy start|0|||
162910042|NCT03018028|588369602|FG000|Overall Study|Withdrawal by Subject|3|||
162910043|NCT03018028|588369603|FG001|Overall Study|Withdrawal by Subject|0|||
162910044|NCT03018028|588369604|FG002|Overall Study|Withdrawal by Subject|1|||
162910045|NCT03018028|588369605|FG003|Overall Study|Withdrawal by Subject|2|||
162910046|NCT03018028|588369606|FG004|Overall Study|Withdrawal by Subject|0|||
162910047|NCT02519777|588369607|FG000|Overall Study|Death|1|||
162910048|NCT02519777|588369608|FG001|Overall Study|Death|0|||
162910049|NCT02519777|588369609|FG002|Overall Study|Death|0|||
162910050|NCT02519777|588369607|FG000|Overall Study|Lost to Follow-up|0|||
162910051|NCT02519777|588369608|FG001|Overall Study|Lost to Follow-up|4|||
162910052|NCT02519777|588369609|FG002|Overall Study|Lost to Follow-up|2|||
162910053|NCT02519777|588369607|FG000|Overall Study|Withdrawal by Subject|3|||
162910054|NCT02519777|588369608|FG001|Overall Study|Withdrawal by Subject|1|||
162910055|NCT02519777|588369609|FG002|Overall Study|Withdrawal by Subject|0|||
162910056|NCT02519777|588369607|FG000|Overall Study|Severe Debilitation|1|||
162910057|NCT02519777|588369608|FG001|Overall Study|Severe Debilitation|1|||
162910058|NCT02519777|588369609|FG002|Overall Study|Severe Debilitation|1|||
162910059|NCT02519777|588369607|FG000|Overall Study|Not able to get to clinic|1|||
162910060|NCT02519777|588369608|FG001|Overall Study|Not able to get to clinic|2|||
162910061|NCT02519777|588369609|FG002|Overall Study|Not able to get to clinic|1|||
162910062|NCT00256204|588369613|FG000|Overall Study|Adverse Event|10|||
162910063|NCT00256204|588369614|FG001|Overall Study|Adverse Event|14|||
162910064|NCT00256204|588369615|FG002|Overall Study|Adverse Event|16|||
162910065|NCT00256204|588369616|FG003|Overall Study|Adverse Event|14|||
162910066|NCT00256204|588369613|FG000|Overall Study|Death|0|||
162910067|NCT00256204|588369614|FG001|Overall Study|Death|1|||
162910068|NCT00256204|588369615|FG002|Overall Study|Death|0|||
162910069|NCT00256204|588369616|FG003|Overall Study|Death|0|||
162910070|NCT00256204|588369613|FG000|Overall Study|Lost to Follow-up|1|||
162910071|NCT00256204|588369614|FG001|Overall Study|Lost to Follow-up|1|||
162910072|NCT00256204|588369615|FG002|Overall Study|Lost to Follow-up|1|||
162910073|NCT00256204|588369616|FG003|Overall Study|Lost to Follow-up|2|||
162910074|NCT00256204|588369613|FG000|Overall Study|Protocol Violation|1|||
162910075|NCT00256204|588369614|FG001|Overall Study|Protocol Violation|0|||
162910076|NCT00256204|588369615|FG002|Overall Study|Protocol Violation|2|||
162910077|NCT00256204|588369616|FG003|Overall Study|Protocol Violation|1|||
162910078|NCT00256204|588369613|FG000|Overall Study|Physician Decision|0|||
162910079|NCT00256204|588369614|FG001|Overall Study|Physician Decision|0|||
162910080|NCT00256204|588369615|FG002|Overall Study|Physician Decision|1|||
162910081|NCT00256204|588369616|FG003|Overall Study|Physician Decision|2|||
162910082|NCT00256204|588369613|FG000|Overall Study|Withdrawal by Subject|17|||
162910083|NCT00256204|588369614|FG001|Overall Study|Withdrawal by Subject|6|||
162628521|NCT01218204|587356626|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
162628522|NCT01218204|587356627|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
162628523|NCT01218204|587356628|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
162628524|NCT01218204|587356629|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
162628525|NCT01218204|587356626|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
162628526|NCT01218204|587356627|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
162628527|NCT01218204|587356628|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
162910084|NCT00256204|588369615|FG002|Overall Study|Withdrawal by Subject|7|||
162910085|NCT00256204|588369616|FG003|Overall Study|Withdrawal by Subject|5|||
162910086|NCT00256204|588369613|FG000|Overall Study|Need for additional prohibited treatment|38|||
162910087|NCT00256204|588369614|FG001|Overall Study|Need for additional prohibited treatment|28|||
162628528|NCT01218204|587356629|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
162628529|NCT00407797|587356637|FG000|Overall Study|Lost to Follow-up|2|||
162910088|NCT00256204|588369615|FG002|Overall Study|Need for additional prohibited treatment|27|||
162910089|NCT00256204|588369616|FG003|Overall Study|Need for additional prohibited treatment|25|||
162628530|NCT00407797|587356637|FG000|Overall Study|Adverse Event|6|||
162628531|NCT00407797|587356637|FG000|Overall Study|Other|7|||
162628532|NCT00407797|587356637|FG000|Overall Study|Withdrawal by Subject|3|||
162628533|NCT01402492|587356641|FG000|Overall Study|Withdrawal by Subject|17|||
162628534|NCT01402492|587356642|FG001|Overall Study|Withdrawal by Subject|11|||
162910090|NCT03490734|588369629|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
162910091|NCT03490734|588369630|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
162910092|NCT03490734|588369631|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
162910093|NCT03490734|588369632|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
162910094|NCT03490734|588369629|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
162910095|NCT03490734|588369630|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
162910096|NCT03490734|588369631|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
162910097|NCT03490734|588369632|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
162910098|NCT03490734|588369629|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
162910099|NCT03490734|588369630|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
162910100|NCT03490734|588369631|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
162910101|NCT03490734|588369632|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
162910102|NCT03490734|588369629|FG000|Post-intervention Scan Visit|Adverse Event|2|||
162910103|NCT03490734|588369630|FG001|Post-intervention Scan Visit|Adverse Event|0|||
162910104|NCT03490734|588369631|FG002|Post-intervention Scan Visit|Adverse Event|0|||
162910105|NCT03490734|588369632|FG003|Post-intervention Scan Visit|Adverse Event|0|||
162910106|NCT03490734|588369629|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
162910107|NCT03490734|588369630|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
162910108|NCT03490734|588369631|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
162910109|NCT03490734|588369632|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
162910110|NCT03490734|588369629|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
162910111|NCT03490734|588369630|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
162910112|NCT03490734|588369631|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
162910113|NCT03490734|588369632|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
162910114|NCT04491591|588369638|FG000|Overall Study|Accidently randomized|3|||
162910115|NCT04491591|588369639|FG001|Overall Study|Accidently randomized|1|||
162910116|NCT04491591|588369640|FG002|Overall Study|Accidently randomized|0|||
162910117|NCT04491591|588369638|FG000|Overall Study|Did not complete survey|28|||
162910118|NCT04491591|588369639|FG001|Overall Study|Did not complete survey|20|||
162910119|NCT04491591|588369640|FG002|Overall Study|Did not complete survey|3|||
162910120|NCT04212221|588369643|FG000|Overall Study|Remained on Treatment|0|||
162910121|NCT04212221|588369644|FG001|Overall Study|Remained on Treatment|0|||
162910122|NCT04212221|588369645|FG002|Overall Study|Remained on Treatment|0|||
162910123|NCT04212221|588369646|FG003|Overall Study|Remained on Treatment|1|||
162910124|NCT04212221|588369647|FG004|Overall Study|Remained on Treatment|0|||
162910125|NCT04212221|588369648|FG005|Overall Study|Remained on Treatment|0|||
162910126|NCT04212221|588369649|FG006|Overall Study|Remained on Treatment|3|||
162910127|NCT04212221|588369650|FG007|Overall Study|Remained on Treatment|9|||
162910128|NCT04212221|588369643|FG000|Overall Study|Adverse Event|0|||
162910129|NCT04212221|588369644|FG001|Overall Study|Adverse Event|0|||
162910130|NCT04212221|588369645|FG002|Overall Study|Adverse Event|0|||
162910131|NCT04212221|588369646|FG003|Overall Study|Adverse Event|0|||
162910132|NCT04212221|588369647|FG004|Overall Study|Adverse Event|0|||
162910133|NCT04212221|588369648|FG005|Overall Study|Adverse Event|0|||
162910134|NCT04212221|588369649|FG006|Overall Study|Adverse Event|2|||
162910135|NCT04212221|588369650|FG007|Overall Study|Adverse Event|3|||
162910136|NCT04212221|588369643|FG000|Overall Study|Death|0|||
162910137|NCT04212221|588369644|FG001|Overall Study|Death|0|||
162910138|NCT04212221|588369645|FG002|Overall Study|Death|0|||
162910139|NCT04212221|588369646|FG003|Overall Study|Death|0|||
162910140|NCT04212221|588369647|FG004|Overall Study|Death|0|||
162910141|NCT04212221|588369648|FG005|Overall Study|Death|0|||
162910142|NCT04212221|588369649|FG006|Overall Study|Death|0|||
162910143|NCT04212221|588369650|FG007|Overall Study|Death|2|||
162910144|NCT04212221|588369643|FG000|Overall Study|Disease progression according to irRECIST|1|||
162910145|NCT04212221|588369644|FG001|Overall Study|Disease progression according to irRECIST|2|||
162910146|NCT04212221|588369645|FG002|Overall Study|Disease progression according to irRECIST|3|||
162910147|NCT04212221|588369646|FG003|Overall Study|Disease progression according to irRECIST|3|||
162910148|NCT04212221|588369647|FG004|Overall Study|Disease progression according to irRECIST|2|||
162910149|NCT04212221|588369648|FG005|Overall Study|Disease progression according to irRECIST|2|||
162910150|NCT04212221|588369649|FG006|Overall Study|Disease progression according to irRECIST|21|||
162910151|NCT04212221|588369650|FG007|Overall Study|Disease progression according to irRECIST|17|||
162910152|NCT04212221|588369643|FG000|Overall Study|Global Deterioration of Health Status|0|||
162910153|NCT04212221|588369644|FG001|Overall Study|Global Deterioration of Health Status|0|||
162910154|NCT04212221|588369645|FG002|Overall Study|Global Deterioration of Health Status|0|||
162910155|NCT04212221|588369646|FG003|Overall Study|Global Deterioration of Health Status|0|||
162628535|NCT01402492|587356643|FG002|Overall Study|Withdrawal by Subject|11|||
162628536|NCT01402492|587356641|FG000|Overall Study|Adverse Event|2|||
162628537|NCT01402492|587356642|FG001|Overall Study|Adverse Event|3|||
162628538|NCT01402492|587356643|FG002|Overall Study|Adverse Event|4|||
162628539|NCT01402492|587356641|FG000|Overall Study|Physician Decision|0|||
162628540|NCT01402492|587356642|FG001|Overall Study|Physician Decision|3|||
162628541|NCT01402492|587356643|FG002|Overall Study|Physician Decision|0|||
162628542|NCT01402492|587356641|FG000|Overall Study|Incarcerated (N=3)|2|||
162910156|NCT04212221|588369647|FG004|Overall Study|Global Deterioration of Health Status|0|||
162910157|NCT04212221|588369648|FG005|Overall Study|Global Deterioration of Health Status|0|||
162910158|NCT04212221|588369649|FG006|Overall Study|Global Deterioration of Health Status|0|||
162910159|NCT04212221|588369650|FG007|Overall Study|Global Deterioration of Health Status|2|||
162910160|NCT04212221|588369643|FG000|Overall Study|Investigator's Decision|0|||
162910161|NCT04212221|588369644|FG001|Overall Study|Investigator's Decision|0|||
162910162|NCT04212221|588369645|FG002|Overall Study|Investigator's Decision|0|||
162910163|NCT04212221|588369646|FG003|Overall Study|Investigator's Decision|1|||
162910164|NCT04212221|588369647|FG004|Overall Study|Investigator's Decision|0|||
162910165|NCT04212221|588369648|FG005|Overall Study|Investigator's Decision|0|||
162910166|NCT04212221|588369649|FG006|Overall Study|Investigator's Decision|3|||
162910167|NCT04212221|588369650|FG007|Overall Study|Investigator's Decision|0|||
162910168|NCT04212221|588369643|FG000|Overall Study|Participant refused to continue treatment|0|||
162910169|NCT04212221|588369644|FG001|Overall Study|Participant refused to continue treatment|1|||
162910170|NCT04212221|588369645|FG002|Overall Study|Participant refused to continue treatment|0|||
162910171|NCT04212221|588369646|FG003|Overall Study|Participant refused to continue treatment|1|||
162910172|NCT04212221|588369647|FG004|Overall Study|Participant refused to continue treatment|1|||
162910173|NCT04212221|588369648|FG005|Overall Study|Participant refused to continue treatment|2|||
162910174|NCT04212221|588369649|FG006|Overall Study|Participant refused to continue treatment|4|||
162910175|NCT04212221|588369650|FG007|Overall Study|Participant refused to continue treatment|2|||
162910176|NCT04212221|588369643|FG000|Overall Study|Protocol Violation|0|||
162910177|NCT04212221|588369644|FG001|Overall Study|Protocol Violation|0|||
162910178|NCT04212221|588369645|FG002|Overall Study|Protocol Violation|0|||
162910179|NCT04212221|588369646|FG003|Overall Study|Protocol Violation|0|||
162910180|NCT04212221|588369647|FG004|Overall Study|Protocol Violation|0|||
162910181|NCT04212221|588369648|FG005|Overall Study|Protocol Violation|0|||
162910182|NCT04212221|588369649|FG006|Overall Study|Protocol Violation|0|||
162910183|NCT04212221|588369650|FG007|Overall Study|Protocol Violation|1|||
162910184|NCT02850276|588369655|FG000|Overall Study|screen failure|43|||
162910185|NCT02850276|588369655|FG000|Overall Study|Withdrawal by Subject|14|||
162910186|NCT02850276|588369655|FG000|Overall Study|Physician Decision|2|||
162910187|NCT02850276|588369655|FG000|Overall Study|Lost to Follow-up|2|||
162910188|NCT04815291|588369656|FG000|Overall Study|Lost to Follow-up|1|||
162910189|NCT04815291|588369656|FG000|Overall Study|Physician Decision|4|||
162910190|NCT04815291|588369656|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
162910191|NCT02646332|588369660|FG000|Overall Study|Lost to Follow-up|0|||
162910192|NCT02646332|588369661|FG001|Overall Study|Lost to Follow-up|3|||
162910193|NCT01277666|588369665|FG000|Overall Study|Adverse Event|26|||
162910194|NCT01277666|588369666|FG001|Overall Study|Adverse Event|25|||
162910195|NCT01277666|588369667|FG002|Overall Study|Adverse Event|20|||
162910196|NCT01277666|588369665|FG000|Overall Study|Lack of Efficacy|8|||
162910197|NCT01277666|588369666|FG001|Overall Study|Lack of Efficacy|20|||
162910198|NCT01277666|588369667|FG002|Overall Study|Lack of Efficacy|12|||
162910199|NCT01277666|588369665|FG000|Overall Study|Protocol Violation|2|||
162910200|NCT01277666|588369666|FG001|Overall Study|Protocol Violation|3|||
162910201|NCT01277666|588369667|FG002|Overall Study|Protocol Violation|2|||
162910202|NCT01277666|588369665|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
162910203|NCT01277666|588369666|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
162910204|NCT01277666|588369667|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
162628543|NCT01402492|587356642|FG001|Overall Study|Incarcerated (N=3)|0|||
162910205|NCT01277666|588369665|FG000|Overall Study|Lost to Follow-up|1|||
162910206|NCT01277666|588369666|FG001|Overall Study|Lost to Follow-up|1|||
162910207|NCT01277666|588369667|FG002|Overall Study|Lost to Follow-up|2|||
162910208|NCT01277666|588369665|FG000|Overall Study|Withdrawal by Subject|7|||
162910209|NCT01277666|588369666|FG001|Overall Study|Withdrawal by Subject|8|||
162910210|NCT01277666|588369667|FG002|Overall Study|Withdrawal by Subject|6|||
162910211|NCT01277666|588369665|FG000|Overall Study|Death|0|||
162910212|NCT01277666|588369666|FG001|Overall Study|Death|0|||
162628544|NCT01402492|587356643|FG002|Overall Study|Incarcerated (N=3)|1|||
162628545|NCT02002091|587356655|FG000|Screening|Lost to Follow-up|10|||
162910213|NCT01277666|588369667|FG002|Overall Study|Death|1|||
162910214|NCT01657903|588369669|FG000|Overall Study|Lost to Follow-up|1|||
162910215|NCT01657903|588369669|FG000|Overall Study|Withdrawal by Subject|1|||
162910216|NCT00554840|588369670|FG000|Overall Study|Physician Decision|0|||
162910217|NCT00554840|588369671|FG001|Overall Study|Physician Decision|1|||
162910218|NCT02312934|588369674|FG000|Overall Study|Lost to Follow-up|1|||
162910219|NCT02312934|588369675|FG001|Overall Study|Lost to Follow-up|0|||
162910220|NCT02312934|588369674|FG000|Overall Study|Physician Decision|1|||
162910221|NCT02312934|588369675|FG001|Overall Study|Physician Decision|0|||
162910222|NCT03395704|588369677|FG000|Overall Study|Adverse Event|2|||
162910223|NCT03395704|588369678|FG001|Overall Study|Adverse Event|1|||
162910224|NCT03395704|588369677|FG000|Overall Study|Withdrawal by Subject|2|||
162910225|NCT03395704|588369678|FG001|Overall Study|Withdrawal by Subject|1|||
162910226|NCT03395704|588369677|FG000|Overall Study|Physician Decision|0|||
162910227|NCT03395704|588369678|FG001|Overall Study|Physician Decision|1|||
162910228|NCT04524663|588371717|FG000|Overall Study|Withdrawal by Subject|0|||
162910229|NCT04524663|588371718|FG001|Overall Study|Withdrawal by Subject|2|||
162910230|NCT00911508|588371719|FG000|Overall Study|Lost to Follow-up|27|||
162910231|NCT00911508|588371720|FG001|Overall Study|Lost to Follow-up|18|||
162910232|NCT00911508|588371719|FG000|Overall Study|Withdrawal by Subject|79|||
162910233|NCT00911508|588371720|FG001|Overall Study|Withdrawal by Subject|112|||
162910234|NCT04308668|588371721|FG000|Overall Study|Lost to Follow-up|32|||
162910235|NCT04308668|588371722|FG001|Overall Study|Lost to Follow-up|38|||
162910236|NCT04308668|588371721|FG000|Overall Study|Withdrawal by Subject|4|||
162910237|NCT04308668|588371722|FG001|Overall Study|Withdrawal by Subject|4|||
162910238|NCT01266967|588371723|FG000|Overall Study|Death|69|||
162910239|NCT01266967|588371724|FG001|Overall Study|Death|61|||
162910240|NCT01266967|588371723|FG000|Overall Study|Study Closed/Terminated|15|||
162910241|NCT01266967|588371724|FG001|Overall Study|Study Closed/Terminated|17|||
162910242|NCT01266967|588371723|FG000|Overall Study|Lost to Follow-up|2|||
162910243|NCT01266967|588371724|FG001|Overall Study|Lost to Follow-up|1|||
162910244|NCT01266967|588371723|FG000|Overall Study|Physician Decision|0|||
162910245|NCT01266967|588371724|FG001|Overall Study|Physician Decision|1|||
162910246|NCT01266967|588371723|FG000|Overall Study|Withdrawal by Subject|3|||
162967667|NCT01721772|588582984|FG001|Treatment|Participant withdrew consent|5|||
162967668|NCT01721772|588582983|FG000|Treatment|Participant request to discontinue study treatment|21|||
162967669|NCT01721772|588582984|FG001|Treatment|Participant request to discontinue study treatment|8|||
162967670|NCT01721772|588582983|FG000|Treatment|Death|1|||
162967671|NCT01721772|588582984|FG001|Treatment|Death|0|||
162967672|NCT01721772|588582983|FG000|Treatment|Not reported|1|||
162967673|NCT01721772|588582984|FG001|Treatment|Not reported|0|||
162967674|NCT01721772|588582983|FG000|Treatment|Poor/non-compliance|1|||
162967675|NCT01721772|588582984|FG001|Treatment|Poor/non-compliance|0|||
162967676|NCT01721772|588582983|FG000|Treatment|Lost to Follow-up|0|||
162967677|NCT01721772|588582984|FG001|Treatment|Lost to Follow-up|1|||
162967678|NCT02754492|588582985|FG000|Overall Study|Protocol Violation|2|||
162967679|NCT02754492|588582986|FG001|Overall Study|Protocol Violation|2|||
162967680|NCT02754492|588582987|FG002|Overall Study|Protocol Violation|0|||
162967681|NCT02754492|588582988|FG003|Overall Study|Protocol Violation|1|||
162967682|NCT02754492|588582985|FG000|Overall Study|Withdrawal by Subject|2|||
162967683|NCT02754492|588582986|FG001|Overall Study|Withdrawal by Subject|0|||
162967684|NCT02754492|588582987|FG002|Overall Study|Withdrawal by Subject|0|||
162967685|NCT02754492|588582988|FG003|Overall Study|Withdrawal by Subject|0|||
162967686|NCT02754492|588582985|FG000|Overall Study|Equipment malfuntion|0|||
162967687|NCT02754492|588582986|FG001|Overall Study|Equipment malfuntion|0|||
162967688|NCT02754492|588582987|FG002|Overall Study|Equipment malfuntion|2|||
162967689|NCT02754492|588582988|FG003|Overall Study|Equipment malfuntion|5|||
162967690|NCT02754492|588582985|FG000|Overall Study|Adverse Event|0|||
162967691|NCT02754492|588582986|FG001|Overall Study|Adverse Event|0|||
162967692|NCT02754492|588582987|FG002|Overall Study|Adverse Event|0|||
162967693|NCT02754492|588582988|FG003|Overall Study|Adverse Event|13|||
162967694|NCT02754492|588582985|FG000|Overall Study|Venous access issues not resulting in AE|0|||
162967695|NCT02754492|588582986|FG001|Overall Study|Venous access issues not resulting in AE|0|||
162967696|NCT02754492|588582987|FG002|Overall Study|Venous access issues not resulting in AE|0|||
162710672|NCT03369951|587651028|FG000|Overall Study|Withdrawal by Subject|3|||
162910247|NCT01266967|588371724|FG001|Overall Study|Withdrawal by Subject|3|||
162910248|NCT01519700|588371725|FG000|Overall Study|Death|1|||
162910249|NCT01519700|588371726|FG001|Overall Study|Death|0|||
162910250|NCT01519700|588371727|FG002|Overall Study|Death|0|||
162910251|NCT01519700|588371728|FG003|Overall Study|Death|0|||
162910252|NCT01519700|588371725|FG000|Overall Study|Lost to Follow-up|0|||
162910253|NCT01519700|588371726|FG001|Overall Study|Lost to Follow-up|0|||
162967697|NCT02754492|588582988|FG003|Overall Study|Venous access issues not resulting in AE|4|||
162967698|NCT01408888|588582989|FG000|First Intervention|Adverse Event|0|||
162967699|NCT01408888|588582990|FG001|First Intervention|Adverse Event|1|||
162967700|NCT01408888|588582989|FG000|First Intervention|Withdrawal by Subject|0|||
162967701|NCT01408888|588582990|FG001|First Intervention|Withdrawal by Subject|2|||
163054414|NCT02949947|588910294|FG001|Overall Study|Insurance change|0|||
162910254|NCT01519700|588371727|FG002|Overall Study|Lost to Follow-up|1|||
162910255|NCT01519700|588371728|FG003|Overall Study|Lost to Follow-up|1|||
162910256|NCT01519700|588371725|FG000|Overall Study|Physician Decision|1|||
162910257|NCT01519700|588371726|FG001|Overall Study|Physician Decision|1|||
162910258|NCT01519700|588371727|FG002|Overall Study|Physician Decision|3|||
162910259|NCT01519700|588371728|FG003|Overall Study|Physician Decision|0|||
162910260|NCT01519700|588371725|FG000|Overall Study|Withdrawal by Subject|5|||
162910261|NCT01519700|588371726|FG001|Overall Study|Withdrawal by Subject|3|||
162910262|NCT01519700|588371727|FG002|Overall Study|Withdrawal by Subject|3|||
162910263|NCT01519700|588371728|FG003|Overall Study|Withdrawal by Subject|2|||
162910264|NCT01519700|588371725|FG000|Overall Study|Other Reason|2|||
162910265|NCT01519700|588371726|FG001|Overall Study|Other Reason|2|||
162910266|NCT01519700|588371727|FG002|Overall Study|Other Reason|0|||
162910267|NCT01519700|588371728|FG003|Overall Study|Other Reason|4|||
162910268|NCT05111548|588371729|FG000|Overall Study|Withdrawal by Subject|2|||
162910269|NCT05111548|588371730|FG001|Overall Study|Withdrawal by Subject|1|||
162910270|NCT05111548|588371729|FG000|Overall Study|Adverse Event|1|||
162910271|NCT05111548|588371730|FG001|Overall Study|Adverse Event|0|||
162910272|NCT00561912|588371737|FG000|Overall Study|ineligible|1|||
162910273|NCT03938857|588371738|FG000|Overall Study|Physician Decision|1|||
162910274|NCT03938857|588371739|FG001|Overall Study|Physician Decision|0|||
162910275|NCT03938857|588371740|FG002|Overall Study|Physician Decision|0|||
162910276|NCT03938857|588371741|FG003|Overall Study|Physician Decision|0|||
162910277|NCT01729559|588371742|FG000|Overall Study|Protocol Violation|31|||
162910278|NCT01729559|588371743|FG001|Overall Study|Protocol Violation|28|||
162910279|NCT02452034|588371748|FG000|Overall Study|Adverse Event|0|||
162910280|NCT02452034|588371749|FG001|Overall Study|Adverse Event|0|||
162910281|NCT02452034|588371750|FG002|Overall Study|Adverse Event|0|||
162910282|NCT02452034|588371751|FG003|Overall Study|Adverse Event|0|||
162910283|NCT02452034|588371752|FG004|Overall Study|Adverse Event|0|||
162910284|NCT02452034|588371753|FG005|Overall Study|Adverse Event|1|||
162910285|NCT02452034|588371748|FG000|Overall Study|Death|0|||
162910286|NCT02452034|588371749|FG001|Overall Study|Death|0|||
162910287|NCT02452034|588371750|FG002|Overall Study|Death|0|||
162910288|NCT02452034|588371751|FG003|Overall Study|Death|0|||
162910289|NCT02452034|588371752|FG004|Overall Study|Death|1|||
162910290|NCT02452034|588371753|FG005|Overall Study|Death|1|||
162910291|NCT02452034|588371748|FG000|Overall Study|Physician Decision|0|||
162910292|NCT02452034|588371749|FG001|Overall Study|Physician Decision|1|||
162910293|NCT02452034|588371750|FG002|Overall Study|Physician Decision|1|||
162910294|NCT02452034|588371751|FG003|Overall Study|Physician Decision|0|||
162910295|NCT02452034|588371752|FG004|Overall Study|Physician Decision|0|||
162910296|NCT02452034|588371753|FG005|Overall Study|Physician Decision|0|||
162910297|NCT02452034|588371748|FG000|Overall Study|Protocol Violation|0|||
162910298|NCT02452034|588371749|FG001|Overall Study|Protocol Violation|0|||
162910299|NCT02452034|588371750|FG002|Overall Study|Protocol Violation|0|||
162910300|NCT02452034|588371751|FG003|Overall Study|Protocol Violation|0|||
162910301|NCT02452034|588371752|FG004|Overall Study|Protocol Violation|0|||
162910302|NCT02452034|588371753|FG005|Overall Study|Protocol Violation|1|||
162910303|NCT02452034|588371748|FG000|Overall Study|Screen Failure|1|||
162910304|NCT02452034|588371749|FG001|Overall Study|Screen Failure|0|||
162910305|NCT02452034|588371750|FG002|Overall Study|Screen Failure|0|||
162910306|NCT02452034|588371751|FG003|Overall Study|Screen Failure|1|||
162910307|NCT02452034|588371752|FG004|Overall Study|Screen Failure|0|||
162910308|NCT02452034|588371753|FG005|Overall Study|Screen Failure|0|||
162910309|NCT02452034|588371748|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
162910310|NCT02452034|588371749|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
162910311|NCT02452034|588371750|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
162910312|NCT02452034|588371751|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
162910313|NCT02452034|588371752|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
162967702|NCT01408888|588582989|FG000|Second Intervention|Withdrawal by Subject|1|||
162967703|NCT01408888|588582990|FG001|Second Intervention|Withdrawal by Subject|0|||
162910314|NCT02452034|588371753|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
162967704|NCT01408888|588582989|FG000|Second Intervention|Adverse Event|1|||
162967705|NCT01408888|588582990|FG001|Second Intervention|Adverse Event|0|||
162967706|NCT04542694|588582991|FG000|Overall Study|The need for prohibited therapy|2|||
162967707|NCT04542694|588582992|FG001|Overall Study|The need for prohibited therapy|0|||
162967708|NCT04542694|588582991|FG000|Overall Study|Adverse Event|1|||
162910315|NCT01453439|588371758|FG000|Treatment Phase|Withdrawal by Subject|13|||
162910316|NCT01453439|588371759|FG001|Treatment Phase|Withdrawal by Subject|10|||
162910317|NCT01453439|588371758|FG000|Treatment Phase|Suicidal Ideation|2|||
162910318|NCT01453439|588371759|FG001|Treatment Phase|Suicidal Ideation|0|||
162910319|NCT01453439|588371758|FG000|Treatment Phase|Need for higher level of care|1|||
162910320|NCT01453439|588371759|FG001|Treatment Phase|Need for higher level of care|1|||
162967709|NCT04542694|588582992|FG001|Overall Study|Adverse Event|0|||
162910321|NCT01453439|588371758|FG000|Treatment Phase|Therapist conflict of interest|1|||
162910322|NCT01453439|588371759|FG001|Treatment Phase|Therapist conflict of interest|0|||
162910323|NCT01453439|588371758|FG000|Follow-up|Withdrawal by Subject|0|||
162967710|NCT04542694|588582991|FG000|Overall Study|Protocol Violation|1|||
162910324|NCT01453439|588371759|FG001|Follow-up|Withdrawal by Subject|1|||
162910325|NCT01453439|588371758|FG000|Follow-up|Lost to Follow-up|5|||
162910326|NCT01453439|588371759|FG001|Follow-up|Lost to Follow-up|10|||
162910327|NCT01014442|588371760|FG000|Overall Study|Adverse Event|0|||
162910328|NCT01014442|588371761|FG001|Overall Study|Adverse Event|8|||
162910329|NCT01014442|588371760|FG000|Overall Study|Withdrawal by Subject|4|||
162910330|NCT01014442|588371761|FG001|Overall Study|Withdrawal by Subject|4|||
162910331|NCT01014442|588371760|FG000|Overall Study|Protocol Violation|2|||
162910332|NCT01014442|588371761|FG001|Overall Study|Protocol Violation|5|||
162910333|NCT01014442|588371760|FG000|Overall Study|Lack of Compliance|0|||
162910334|NCT01014442|588371761|FG001|Overall Study|Lack of Compliance|1|||
162910335|NCT01014442|588371760|FG000|Overall Study|Unspecified Reason|1|||
162910336|NCT01014442|588371761|FG001|Overall Study|Unspecified Reason|1|||
162910337|NCT02074059|588371762|FG000|Overall Study|Death|0|||
162910338|NCT02074059|588371763|FG001|Overall Study|Death|0|||
162910339|NCT02074059|588371764|FG002|Overall Study|Death|0|||
162910340|NCT02074059|588371765|FG003|Overall Study|Death|0|||
162910341|NCT02074059|588371766|FG004|Overall Study|Death|1|||
162910342|NCT02074059|588371767|FG005|Overall Study|Death|1|||
162910343|NCT02242305|588371781|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
162910344|NCT02242305|588371782|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
162910345|NCT02242305|588371781|FG000|Overall Study|Adverse Event|1|||
162910346|NCT02242305|588371782|FG001|Overall Study|Adverse Event|0|||
162910347|NCT02242305|588371781|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
162910348|NCT02242305|588371782|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
162910349|NCT02242305|588371781|FG000|Overall Study|Subject withdraws inform consent|0|||
162910350|NCT02242305|588371782|FG001|Overall Study|Subject withdraws inform consent|4|||
162910351|NCT02242305|588371781|FG000|Overall Study|Lost to Follow-up|2|||
162910352|NCT02242305|588371782|FG001|Overall Study|Lost to Follow-up|0|||
162910353|NCT02543801|588371786|FG000|Overall Study|Protocol Violation|1|||
162910354|NCT02543801|588371787|FG001|Overall Study|Protocol Violation|2|||
162910355|NCT02543801|588371788|FG002|Overall Study|Protocol Violation|0|||
162910356|NCT02543801|588371789|FG003|Overall Study|Protocol Violation|0|||
162910357|NCT01756846|588371790|FG000|Overall Study|Lost to Follow-up|5|||
162910358|NCT01756846|588371791|FG001|Overall Study|Lost to Follow-up|10|||
162910359|NCT01756846|588371790|FG000|Overall Study|Withdrawal by Subject|1|||
162910360|NCT01756846|588371791|FG001|Overall Study|Withdrawal by Subject|2|||
162967711|NCT04542694|588582992|FG001|Overall Study|Protocol Violation|0|||
162967712|NCT04633642|588582995|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
162967713|NCT04633642|588582996|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
162967714|NCT05387408|588582997|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
162967715|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Death|0|||
162967716|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Death|1|||
162967717|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
162967718|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
162967719|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
162967720|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
162967721|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
162967722|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
162967723|NCT01717313|588583001|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
162967724|NCT01717313|588583002|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
162967725|NCT01717313|588583001|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
162967726|NCT01717313|588583002|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
162967727|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
162967728|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
162967729|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
162967730|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
162967731|NCT01717313|588583001|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
162967732|NCT01717313|588583002|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
162967733|NCT01617096|588583007|FG000|Overall Study|Withdrawal by Subject|96|||
162967734|NCT01617096|588583008|FG001|Overall Study|Withdrawal by Subject|81|||
162967735|NCT01617096|588583007|FG000|Overall Study|Lost to Follow-up|37|||
162967736|NCT01617096|588583008|FG001|Overall Study|Lost to Follow-up|32|||
162967737|NCT01617096|588583007|FG000|Overall Study|Physician Decision|10|||
162910361|NCT00352027|588371802|FG000|Overall Study|Progressive disease|3|||
162910362|NCT04118127|588371803|FG000|Overall Study|Trial terminated by sponsor|0|||
162910363|NCT04118127|588371804|FG001|Overall Study|Trial terminated by sponsor|12|||
162910364|NCT04118127|588371803|FG000|Overall Study|Adverse Event|1|||
162910365|NCT04118127|588371804|FG001|Overall Study|Adverse Event|2|||
162910366|NCT04118127|588371803|FG000|Overall Study|Physician Decision|0|||
162910367|NCT04118127|588371804|FG001|Overall Study|Physician Decision|1|||
162910368|NCT04118127|588371803|FG000|Overall Study|Withdrawal by Subject|2|||
162910369|NCT04118127|588371804|FG001|Overall Study|Withdrawal by Subject|1|||
162910370|NCT00636506|588371805|FG000|Overall Study|Lost to Follow-up|8|||
162910371|NCT00636506|588371805|FG000|Overall Study|Explanted|1|||
162910372|NCT00636506|588371805|FG000|Overall Study|Withdrawal by Subject|6|||
162910373|NCT00636506|588371805|FG000|Overall Study|Procedure aborted|1|||
162910374|NCT02607735|588371806|FG000|Primary Study|Randomized but Never Treated|1|||
162910375|NCT02607735|588371807|FG001|Primary Study|Randomized but Never Treated|0|||
162910376|NCT02607735|588371808|FG002|Primary Study|Randomized but Never Treated|0|||
162910377|NCT02607735|588371806|FG000|Primary Study|Lost to Follow-up|4|||
162910378|NCT02607735|588371807|FG001|Primary Study|Lost to Follow-up|0|||
162910379|NCT02607735|588371808|FG002|Primary Study|Lost to Follow-up|0|||
162910380|NCT02607735|588371806|FG000|Primary Study|Withdrew Consent|2|||
162910381|NCT02607735|588371807|FG001|Primary Study|Withdrew Consent|0|||
162910382|NCT02607735|588371808|FG002|Primary Study|Withdrew Consent|0|||
162910383|NCT02607735|588371806|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
162910384|NCT02607735|588371807|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
162910385|NCT02607735|588371808|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
162910386|NCT02607735|588371806|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
162910387|NCT02607735|588371807|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
162910388|NCT02607735|588371808|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
162910389|NCT01376908|588371809|FG000|Overall Study|Protocol Violation|1|||
162910390|NCT01376908|588371810|FG001|Overall Study|Protocol Violation|1|||
162910391|NCT01376908|588371809|FG000|Overall Study|Withdrawal by Subject|1|||
162910392|NCT01376908|588371810|FG001|Overall Study|Withdrawal by Subject|2|||
162910393|NCT01681836|588371817|FG000|Second Intervention|Withdrawal by Subject|0|||
162910394|NCT01681836|588371818|FG001|Second Intervention|Withdrawal by Subject|1|||
162910395|NCT02394028|588371819|FG000|Induction Phase|Adverse Event|2|||
162910396|NCT02394028|588371820|FG001|Induction Phase|Adverse Event|4|||
162967738|NCT01617096|588583008|FG001|Overall Study|Physician Decision|18|||
162967739|NCT01617096|588583007|FG000|Overall Study|Death|4|||
162967740|NCT01617096|588583008|FG001|Overall Study|Death|3|||
162710673|NCT03369951|587651028|FG000|Overall Study|Death|1|||
162710674|NCT03369951|587651028|FG000|Overall Study|Lost to Follow-up|1|||
162710675|NCT03369951|587651028|FG000|Overall Study|Protocol Violation|1|||
162710676|NCT03677375|587651029|FG000|Overall Study|Incomplete procedure|8|||
162710677|NCT03677375|587651029|FG000|Overall Study|Adverse Event|3|||
162710678|NCT03677375|587651029|FG000|Overall Study|Physician Decision|1|||
162710679|NCT00725010|587651035|FG000|Overall Study|Toxicity|9|||
162710680|NCT00725010|587651035|FG000|Overall Study|Tumor Progression|7|||
162710681|NCT00725010|587651035|FG000|Overall Study|Withdrawal by Subject|2|||
162710682|NCT00725010|587651035|FG000|Overall Study|Death|1|||
162710683|NCT00725010|587651035|FG000|Overall Study|Lost to Follow-up|1|||
162710684|NCT00725010|587651035|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
162710685|NCT00725010|587651035|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
162710686|NCT00725010|587651035|FG000|Overall Study|No further documentation|1|||
162710687|NCT00725010|587651035|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
162710688|NCT02414828|587651036|FG000|Overall Study|Lost to Follow-up|0|||
162710689|NCT02414828|587651037|FG001|Overall Study|Lost to Follow-up|1|||
162710690|NCT02414828|587651038|FG002|Overall Study|Lost to Follow-up|1|||
162710691|NCT02414828|587651039|FG003|Overall Study|Lost to Follow-up|2|||
162710692|NCT00630864|587651041|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
162710693|NCT00630864|587651041|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
162967741|NCT01617096|588583007|FG000|Overall Study|Other|1|||
162967742|NCT01617096|588583008|FG001|Overall Study|Other|3|||
162967743|NCT01532908|588583011|FG000|Overall Study|Not Transplanted|1|||
162967744|NCT01532908|588583012|FG001|Overall Study|Not Transplanted|0|||
162967745|NCT01196390|588583013|FG000|Overall Study|Protocol Violation|4|||
162967746|NCT01196390|588583014|FG001|Overall Study|Protocol Violation|5|||
162967747|NCT00252564|588583015|FG000|Overall Study|Adverse Event|17|||
162967748|NCT00252564|588583016|FG001|Overall Study|Adverse Event|13|||
162967749|NCT00252564|588583015|FG000|Overall Study|Unrelated Complication|2|||
162710694|NCT00430677|587651042|FG000|Short-term Period|Death|1|||
162710695|NCT00430677|587651043|FG001|Short-term Period|Death|1|||
162710696|NCT00430677|587651044|FG002|Short-term Period|Death|5|||
162710697|NCT00430677|587651042|FG000|Short-term Period|Adverse Event|15|||
162710698|NCT00430677|587651043|FG001|Short-term Period|Adverse Event|13|||
162710699|NCT00430677|587651044|FG002|Short-term Period|Adverse Event|9|||
162710700|NCT00430677|587651042|FG000|Short-term Period|Lack of Efficacy|5|||
162910397|NCT02394028|588371821|FG002|Induction Phase|Adverse Event|1|||
162910398|NCT02394028|588371822|FG003|Induction Phase|Adverse Event|2|||
162910399|NCT02394028|588371823|FG004|Induction Phase|Adverse Event|5|||
162967750|NCT00252564|588583016|FG001|Overall Study|Unrelated Complication|1|||
162967751|NCT00252564|588583015|FG000|Overall Study|Disease Progression|14|||
162967752|NCT00252564|588583016|FG001|Overall Study|Disease Progression|20|||
162710701|NCT00430677|587651043|FG001|Short-term Period|Lack of Efficacy|6|||
162710702|NCT00430677|587651044|FG002|Short-term Period|Lack of Efficacy|4|||
162710703|NCT00430677|587651042|FG000|Short-term Period|Withdrawal by Subject|1|||
162910400|NCT02394028|588371824|FG005|Induction Phase|Adverse Event|2|||
162910401|NCT02394028|588371825|FG006|Induction Phase|Adverse Event|0|||
162910402|NCT02394028|588371826|FG007|Induction Phase|Adverse Event|0|||
162910403|NCT02394028|588371827|FG008|Induction Phase|Adverse Event|0|||
162910404|NCT02394028|588371828|FG009|Induction Phase|Adverse Event|0|||
162910405|NCT02394028|588371829|FG010|Induction Phase|Adverse Event|0|||
162910406|NCT02394028|588371819|FG000|Induction Phase|Lack of Efficacy|3|||
162910407|NCT02394028|588371820|FG001|Induction Phase|Lack of Efficacy|6|||
162910408|NCT02394028|588371821|FG002|Induction Phase|Lack of Efficacy|2|||
162910409|NCT02394028|588371822|FG003|Induction Phase|Lack of Efficacy|17|||
162910410|NCT02394028|588371823|FG004|Induction Phase|Lack of Efficacy|14|||
162910411|NCT02394028|588371824|FG005|Induction Phase|Lack of Efficacy|8|||
162910412|NCT02394028|588371825|FG006|Induction Phase|Lack of Efficacy|17|||
162910413|NCT02394028|588371826|FG007|Induction Phase|Lack of Efficacy|23|||
162910414|NCT02394028|588371827|FG008|Induction Phase|Lack of Efficacy|0|||
162910415|NCT02394028|588371828|FG009|Induction Phase|Lack of Efficacy|0|||
162910416|NCT02394028|588371829|FG010|Induction Phase|Lack of Efficacy|0|||
162910417|NCT02394028|588371819|FG000|Induction Phase|Lost to Follow-up|1|||
162910418|NCT02394028|588371820|FG001|Induction Phase|Lost to Follow-up|0|||
162910419|NCT02394028|588371821|FG002|Induction Phase|Lost to Follow-up|0|||
162910420|NCT02394028|588371822|FG003|Induction Phase|Lost to Follow-up|1|||
162910421|NCT02394028|588371823|FG004|Induction Phase|Lost to Follow-up|0|||
162910422|NCT02394028|588371824|FG005|Induction Phase|Lost to Follow-up|0|||
162910423|NCT02394028|588371825|FG006|Induction Phase|Lost to Follow-up|1|||
162910424|NCT02394028|588371826|FG007|Induction Phase|Lost to Follow-up|0|||
162910425|NCT02394028|588371827|FG008|Induction Phase|Lost to Follow-up|0|||
162910426|NCT02394028|588371828|FG009|Induction Phase|Lost to Follow-up|0|||
162910427|NCT02394028|588371829|FG010|Induction Phase|Lost to Follow-up|0|||
162910428|NCT02394028|588371819|FG000|Induction Phase|Non-compliance|0|||
162910429|NCT02394028|588371820|FG001|Induction Phase|Non-compliance|1|||
162910430|NCT02394028|588371821|FG002|Induction Phase|Non-compliance|3|||
162910431|NCT02394028|588371822|FG003|Induction Phase|Non-compliance|1|||
162910432|NCT02394028|588371823|FG004|Induction Phase|Non-compliance|3|||
162910433|NCT02394028|588371824|FG005|Induction Phase|Non-compliance|0|||
162910434|NCT02394028|588371825|FG006|Induction Phase|Non-compliance|1|||
162910435|NCT02394028|588371826|FG007|Induction Phase|Non-compliance|1|||
162910436|NCT02394028|588371827|FG008|Induction Phase|Non-compliance|0|||
162967753|NCT00252564|588583015|FG000|Overall Study|Death|0|||
162967754|NCT00252564|588583016|FG001|Overall Study|Death|3|||
162967755|NCT00252564|588583015|FG000|Overall Study|Physician Decision|1|||
162967756|NCT00252564|588583016|FG001|Overall Study|Physician Decision|0|||
162910437|NCT02394028|588371828|FG009|Induction Phase|Non-compliance|0|||
162967757|NCT00252564|588583015|FG000|Overall Study|Lost to Follow-up|1|||
162967758|NCT00252564|588583016|FG001|Overall Study|Lost to Follow-up|0|||
162967759|NCT00252564|588583015|FG000|Overall Study|Patient Request|4|||
162967760|NCT00252564|588583016|FG001|Overall Study|Patient Request|5|||
162967761|NCT00252564|588583015|FG000|Overall Study|Withdrawal by Subject|0|||
162967762|NCT00252564|588583016|FG001|Overall Study|Withdrawal by Subject|2|||
162967763|NCT03480022|588583017|FG000|Overall Study|Pregnancy|2|||
162967764|NCT03480022|588583018|FG001|Overall Study|Pregnancy|0|||
162967765|NCT03480022|588583017|FG000|Overall Study|Adverse Event|6|||
162967766|NCT03480022|588583018|FG001|Overall Study|Adverse Event|0|||
162967767|NCT03480022|588583017|FG000|Overall Study|Lack of Efficacy|0|||
162967768|NCT03480022|588583018|FG001|Overall Study|Lack of Efficacy|2|||
162967769|NCT03480022|588583017|FG000|Overall Study|Physician Decision|0|||
162967770|NCT03480022|588583018|FG001|Overall Study|Physician Decision|1|||
162967771|NCT03480022|588583017|FG000|Overall Study|Withdrawal by Subject|2|||
162910438|NCT02394028|588371829|FG010|Induction Phase|Non-compliance|0|||
162910439|NCT02394028|588371819|FG000|Induction Phase|Physician Decision|0|||
162910440|NCT02394028|588371820|FG001|Induction Phase|Physician Decision|0|||
162910441|NCT02394028|588371821|FG002|Induction Phase|Physician Decision|1|||
162910442|NCT02394028|588371822|FG003|Induction Phase|Physician Decision|4|||
162910443|NCT02394028|588371823|FG004|Induction Phase|Physician Decision|0|||
162910444|NCT02394028|588371824|FG005|Induction Phase|Physician Decision|2|||
162967772|NCT03480022|588583018|FG001|Overall Study|Withdrawal by Subject|0|||
162967773|NCT03480022|588583017|FG000|Overall Study|Medication concerns|1|||
162910445|NCT02394028|588371825|FG006|Induction Phase|Physician Decision|1|||
162910446|NCT02394028|588371826|FG007|Induction Phase|Physician Decision|0|||
162910447|NCT02394028|588371827|FG008|Induction Phase|Physician Decision|0|||
162628546|NCT02002091|587356656|FG001|Screening|Lost to Follow-up|12|||
162910448|NCT02394028|588371828|FG009|Induction Phase|Physician Decision|0|||
162910449|NCT02394028|588371829|FG010|Induction Phase|Physician Decision|0|||
162910450|NCT02394028|588371819|FG000|Induction Phase|Protocol Violation|0|||
162628547|NCT02002091|587356655|FG000|Screening|Death|3|||
162910451|NCT02394028|588371820|FG001|Induction Phase|Protocol Violation|2|||
162910452|NCT02394028|588371821|FG002|Induction Phase|Protocol Violation|0|||
162967774|NCT03480022|588583018|FG001|Overall Study|Medication concerns|0|||
162967775|NCT03480022|588583017|FG000|Overall Study|Family member COVID exposure|0|||
162967776|NCT03480022|588583018|FG001|Overall Study|Family member COVID exposure|1|||
162967777|NCT00881569|588583019|FG000|Overall Study|Disease progression|1|||
162910453|NCT02394028|588371822|FG003|Induction Phase|Protocol Violation|3|||
162910454|NCT02394028|588371823|FG004|Induction Phase|Protocol Violation|0|||
162910455|NCT02394028|588371824|FG005|Induction Phase|Protocol Violation|1|||
162910456|NCT02394028|588371825|FG006|Induction Phase|Protocol Violation|1|||
162910457|NCT02394028|588371826|FG007|Induction Phase|Protocol Violation|0|||
162910458|NCT02394028|588371827|FG008|Induction Phase|Protocol Violation|0|||
162910459|NCT02394028|588371828|FG009|Induction Phase|Protocol Violation|0|||
162910460|NCT02394028|588371829|FG010|Induction Phase|Protocol Violation|0|||
162910461|NCT02394028|588371819|FG000|Induction Phase|Withdrawal by Subject|1|||
162910462|NCT02394028|588371820|FG001|Induction Phase|Withdrawal by Subject|2|||
162910463|NCT02394028|588371821|FG002|Induction Phase|Withdrawal by Subject|4|||
162910464|NCT02394028|588371822|FG003|Induction Phase|Withdrawal by Subject|6|||
162910465|NCT02394028|588371823|FG004|Induction Phase|Withdrawal by Subject|7|||
162910466|NCT02394028|588371824|FG005|Induction Phase|Withdrawal by Subject|4|||
162910467|NCT02394028|588371825|FG006|Induction Phase|Withdrawal by Subject|3|||
162910468|NCT02394028|588371826|FG007|Induction Phase|Withdrawal by Subject|6|||
162910469|NCT02394028|588371827|FG008|Induction Phase|Withdrawal by Subject|0|||
162910470|NCT02394028|588371828|FG009|Induction Phase|Withdrawal by Subject|0|||
162910471|NCT02394028|588371829|FG010|Induction Phase|Withdrawal by Subject|0|||
162910472|NCT02394028|588371819|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910473|NCT02394028|588371820|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910474|NCT02394028|588371821|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910475|NCT02394028|588371822|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910476|NCT02394028|588371823|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910477|NCT02394028|588371824|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910478|NCT02394028|588371825|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
162910479|NCT02394028|588371826|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910480|NCT02394028|588371827|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910481|NCT02394028|588371828|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910482|NCT02394028|588371829|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
162910483|NCT02394028|588371819|FG000|Induction Phase|Sponsor decision|0|||
162910484|NCT02394028|588371820|FG001|Induction Phase|Sponsor decision|1|||
162910485|NCT02394028|588371821|FG002|Induction Phase|Sponsor decision|2|||
162910486|NCT02394028|588371822|FG003|Induction Phase|Sponsor decision|0|||
162910487|NCT02394028|588371823|FG004|Induction Phase|Sponsor decision|0|||
162910488|NCT02394028|588371824|FG005|Induction Phase|Sponsor decision|0|||
162910489|NCT02394028|588371825|FG006|Induction Phase|Sponsor decision|0|||
162910490|NCT02394028|588371826|FG007|Induction Phase|Sponsor decision|0|||
162910491|NCT02394028|588371827|FG008|Induction Phase|Sponsor decision|0|||
162910492|NCT02394028|588371828|FG009|Induction Phase|Sponsor decision|0|||
162910493|NCT02394028|588371829|FG010|Induction Phase|Sponsor decision|0|||
162910494|NCT02394028|588371819|FG000|Induction Phase|Technical reason|0|||
162910495|NCT02394028|588371820|FG001|Induction Phase|Technical reason|0|||
162910496|NCT02394028|588371821|FG002|Induction Phase|Technical reason|0|||
162910497|NCT02394028|588371822|FG003|Induction Phase|Technical reason|1|||
162910498|NCT02394028|588371823|FG004|Induction Phase|Technical reason|0|||
162910499|NCT02394028|588371824|FG005|Induction Phase|Technical reason|0|||
162910500|NCT02394028|588371825|FG006|Induction Phase|Technical reason|0|||
162910501|NCT02394028|588371826|FG007|Induction Phase|Technical reason|0|||
162910502|NCT02394028|588371827|FG008|Induction Phase|Technical reason|0|||
162910503|NCT02394028|588371828|FG009|Induction Phase|Technical reason|0|||
162910504|NCT02394028|588371829|FG010|Induction Phase|Technical reason|0|||
162910505|NCT02394028|588371819|FG000|Induction Phase|:ack of calculation|0|||
162910506|NCT02394028|588371820|FG001|Induction Phase|:ack of calculation|0|||
162910507|NCT02394028|588371821|FG002|Induction Phase|:ack of calculation|0|||
162910508|NCT02394028|588371822|FG003|Induction Phase|:ack of calculation|0|||
162910509|NCT02394028|588371823|FG004|Induction Phase|:ack of calculation|0|||
162910510|NCT02394028|588371824|FG005|Induction Phase|:ack of calculation|0|||
162910511|NCT02394028|588371825|FG006|Induction Phase|:ack of calculation|0|||
162910512|NCT02394028|588371826|FG007|Induction Phase|:ack of calculation|1|||
162910513|NCT02394028|588371827|FG008|Induction Phase|:ack of calculation|0|||
162910514|NCT02394028|588371828|FG009|Induction Phase|:ack of calculation|0|||
162910515|NCT02394028|588371829|FG010|Induction Phase|:ack of calculation|0|||
162910516|NCT02394028|588371819|FG000|Maintenance Phase|Protocol Violation|0|||
162967778|NCT00881569|588583020|FG001|Overall Study|Disease progression|1|||
162967779|NCT02623218|588583025|FG000|Overall Study|Lost to Follow-up|0|||
162967780|NCT02623218|588583026|FG001|Overall Study|Lost to Follow-up|1|||
162967781|NCT02623218|588583027|FG002|Overall Study|Lost to Follow-up|0|||
162910517|NCT02394028|588371820|FG001|Maintenance Phase|Protocol Violation|0|||
162910518|NCT02394028|588371821|FG002|Maintenance Phase|Protocol Violation|0|||
162910519|NCT02394028|588371822|FG003|Maintenance Phase|Protocol Violation|0|||
162910520|NCT02394028|588371823|FG004|Maintenance Phase|Protocol Violation|0|||
162910521|NCT02394028|588371824|FG005|Maintenance Phase|Protocol Violation|0|||
162967782|NCT02623218|588583028|FG003|Overall Study|Lost to Follow-up|0|||
162910522|NCT02394028|588371825|FG006|Maintenance Phase|Protocol Violation|0|||
162910523|NCT02394028|588371826|FG007|Maintenance Phase|Protocol Violation|0|||
162910524|NCT02394028|588371827|FG008|Maintenance Phase|Protocol Violation|0|||
162910525|NCT02394028|588371828|FG009|Maintenance Phase|Protocol Violation|0|||
162910526|NCT02394028|588371829|FG010|Maintenance Phase|Protocol Violation|1|||
162910527|NCT02394028|588371819|FG000|Maintenance Phase|Physician Decision|0|||
162910528|NCT02394028|588371820|FG001|Maintenance Phase|Physician Decision|0|||
162910529|NCT02394028|588371821|FG002|Maintenance Phase|Physician Decision|0|||
162910530|NCT02394028|588371822|FG003|Maintenance Phase|Physician Decision|0|||
162910531|NCT02394028|588371823|FG004|Maintenance Phase|Physician Decision|0|||
162910532|NCT02394028|588371824|FG005|Maintenance Phase|Physician Decision|0|||
162910533|NCT02394028|588371825|FG006|Maintenance Phase|Physician Decision|0|||
162910534|NCT02394028|588371826|FG007|Maintenance Phase|Physician Decision|0|||
162910535|NCT02394028|588371827|FG008|Maintenance Phase|Physician Decision|1|||
162910536|NCT02394028|588371828|FG009|Maintenance Phase|Physician Decision|3|||
162910537|NCT02394028|588371829|FG010|Maintenance Phase|Physician Decision|2|||
162910538|NCT02394028|588371819|FG000|Maintenance Phase|Lack of Efficacy|0|||
162910539|NCT02394028|588371820|FG001|Maintenance Phase|Lack of Efficacy|0|||
162910540|NCT02394028|588371821|FG002|Maintenance Phase|Lack of Efficacy|0|||
162910541|NCT02394028|588371822|FG003|Maintenance Phase|Lack of Efficacy|0|||
162910542|NCT02394028|588371823|FG004|Maintenance Phase|Lack of Efficacy|0|||
162910543|NCT02394028|588371824|FG005|Maintenance Phase|Lack of Efficacy|0|||
162910544|NCT02394028|588371825|FG006|Maintenance Phase|Lack of Efficacy|0|||
162910545|NCT02394028|588371826|FG007|Maintenance Phase|Lack of Efficacy|0|||
162910546|NCT02394028|588371827|FG008|Maintenance Phase|Lack of Efficacy|7|||
162910547|NCT02394028|588371828|FG009|Maintenance Phase|Lack of Efficacy|25|||
162910548|NCT02394028|588371829|FG010|Maintenance Phase|Lack of Efficacy|33|||
162910549|NCT02394028|588371819|FG000|Maintenance Phase|Death|0|||
162910550|NCT02394028|588371820|FG001|Maintenance Phase|Death|0|||
162910551|NCT02394028|588371821|FG002|Maintenance Phase|Death|0|||
162910552|NCT02394028|588371822|FG003|Maintenance Phase|Death|0|||
162910553|NCT02394028|588371823|FG004|Maintenance Phase|Death|0|||
162910554|NCT02394028|588371824|FG005|Maintenance Phase|Death|0|||
162910555|NCT02394028|588371825|FG006|Maintenance Phase|Death|0|||
162910556|NCT02394028|588371826|FG007|Maintenance Phase|Death|0|||
162910557|NCT02394028|588371827|FG008|Maintenance Phase|Death|0|||
162910558|NCT02394028|588371828|FG009|Maintenance Phase|Death|0|||
162910559|NCT02394028|588371829|FG010|Maintenance Phase|Death|1|||
162910560|NCT02394028|588371819|FG000|Maintenance Phase|Adverse Event|0|||
162910561|NCT02394028|588371820|FG001|Maintenance Phase|Adverse Event|0|||
162910562|NCT02394028|588371821|FG002|Maintenance Phase|Adverse Event|0|||
162910563|NCT02394028|588371822|FG003|Maintenance Phase|Adverse Event|0|||
162910564|NCT02394028|588371823|FG004|Maintenance Phase|Adverse Event|0|||
162910565|NCT02394028|588371824|FG005|Maintenance Phase|Adverse Event|0|||
162910566|NCT02394028|588371825|FG006|Maintenance Phase|Adverse Event|0|||
162910567|NCT02394028|588371826|FG007|Maintenance Phase|Adverse Event|0|||
162910568|NCT02394028|588371827|FG008|Maintenance Phase|Adverse Event|1|||
162910569|NCT02394028|588371828|FG009|Maintenance Phase|Adverse Event|1|||
162910570|NCT02394028|588371829|FG010|Maintenance Phase|Adverse Event|3|||
162910571|NCT02394028|588371819|FG000|Maintenance Phase|Site closure|0|||
162910572|NCT02394028|588371820|FG001|Maintenance Phase|Site closure|0|||
162910573|NCT02394028|588371821|FG002|Maintenance Phase|Site closure|0|||
162910574|NCT02394028|588371822|FG003|Maintenance Phase|Site closure|0|||
162910575|NCT02394028|588371823|FG004|Maintenance Phase|Site closure|0|||
162910576|NCT02394028|588371824|FG005|Maintenance Phase|Site closure|0|||
162910577|NCT02394028|588371825|FG006|Maintenance Phase|Site closure|0|||
162910578|NCT02394028|588371826|FG007|Maintenance Phase|Site closure|0|||
162910579|NCT02394028|588371827|FG008|Maintenance Phase|Site closure|0|||
162910580|NCT02394028|588371828|FG009|Maintenance Phase|Site closure|1|||
162910581|NCT02394028|588371829|FG010|Maintenance Phase|Site closure|0|||
162910582|NCT02394028|588371819|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162910583|NCT02394028|588371820|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162910584|NCT02394028|588371821|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162910585|NCT02394028|588371822|FG003|Maintenance Phase|Withdrawal by Subject|0|||
162910586|NCT02394028|588371823|FG004|Maintenance Phase|Withdrawal by Subject|0|||
162910587|NCT02394028|588371824|FG005|Maintenance Phase|Withdrawal by Subject|0|||
162910588|NCT02394028|588371825|FG006|Maintenance Phase|Withdrawal by Subject|0|||
162910589|NCT02394028|588371826|FG007|Maintenance Phase|Withdrawal by Subject|0|||
162910590|NCT02394028|588371827|FG008|Maintenance Phase|Withdrawal by Subject|3|||
162910591|NCT02394028|588371828|FG009|Maintenance Phase|Withdrawal by Subject|12|||
162910592|NCT02394028|588371829|FG010|Maintenance Phase|Withdrawal by Subject|12|||
162910593|NCT00742391|588371830|FG000|Overall Study|Adverse Event|2|||
162910594|NCT00742391|588371831|FG001|Overall Study|Adverse Event|1|||
162910595|NCT00742391|588371830|FG000|Overall Study|Lost to Follow-up|1|||
162910596|NCT00742391|588371831|FG001|Overall Study|Lost to Follow-up|0|||
162910597|NCT00742391|588371830|FG000|Overall Study|Protocol Violation|1|||
162910598|NCT00742391|588371831|FG001|Overall Study|Protocol Violation|0|||
162910599|NCT00866606|588371834|FG000|Overall Study|Lost to Follow-up|3|||
162910600|NCT00866606|588371834|FG000|Overall Study|Adverse Event|1|||
162910601|NCT01058356|588371846|FG000|Overall Study|Adverse Event|5|||
162910602|NCT01058356|588371846|FG000|Overall Study|Administration of contraindicated drugs|12|||
162910603|NCT01058356|588371846|FG000|Overall Study|Withdrawal by Subject|21|||
162910604|NCT01058356|588371846|FG000|Overall Study|Lost to Follow-up|4|||
162910605|NCT02993783|588371847|FG000|Overall Study|Reason not Specified|6|||
162910606|NCT02993783|588371848|FG001|Overall Study|Reason not Specified|9|||
162910607|NCT00606021|588371851|FG000|Induction Phase|Death|73|||
162910608|NCT00606021|588371852|FG001|Induction Phase|Death|0|||
162910609|NCT00606021|588371853|FG002|Induction Phase|Death|0|||
162910610|NCT00606021|588371851|FG000|Induction Phase|Physician Decision|2|||
162910611|NCT00606021|588371852|FG001|Induction Phase|Physician Decision|0|||
162910612|NCT00606021|588371853|FG002|Induction Phase|Physician Decision|0|||
162910613|NCT00606021|588371851|FG000|Induction Phase|Withdrawal by Subject|2|||
162910614|NCT00606021|588371852|FG001|Induction Phase|Withdrawal by Subject|0|||
162910615|NCT00606021|588371853|FG002|Induction Phase|Withdrawal by Subject|0|||
162910616|NCT00606021|588371851|FG000|Induction Phase|Lost to Follow-up|10|||
162910617|NCT00606021|588371852|FG001|Induction Phase|Lost to Follow-up|0|||
162910618|NCT00606021|588371853|FG002|Induction Phase|Lost to Follow-up|0|||
162910619|NCT00606021|588371851|FG000|Maintenance Phase|Death|0|||
162910620|NCT00606021|588371852|FG001|Maintenance Phase|Death|17|||
162910621|NCT00606021|588371853|FG002|Maintenance Phase|Death|15|||
162910622|NCT00606021|588371851|FG000|Maintenance Phase|Physician Decision|0|||
162910623|NCT00606021|588371852|FG001|Maintenance Phase|Physician Decision|1|||
162910624|NCT00606021|588371853|FG002|Maintenance Phase|Physician Decision|0|||
162910625|NCT00606021|588371851|FG000|Maintenance Phase|Lost to Follow-up|0|||
162910626|NCT00606021|588371852|FG001|Maintenance Phase|Lost to Follow-up|5|||
162910627|NCT00606021|588371853|FG002|Maintenance Phase|Lost to Follow-up|2|||
162910628|NCT03480841|588371854|FG000|Overall Study|Lost to Follow-up|2|||
162910629|NCT01362049|588371855|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
162910630|NCT01362049|588371856|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
162910631|NCT01362049|588371857|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
162910632|NCT01362049|588371858|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
162910633|NCT01362049|588371855|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
162910634|NCT01362049|588371856|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
162910635|NCT01362049|588371857|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
162910636|NCT01362049|588371858|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
162910637|NCT00095836|588371863|FG000|Overall Study|Lost to Follow-up|1|||
162910638|NCT00095836|588371863|FG000|Overall Study|Adverse Event|1|||
162910639|NCT00095836|588371863|FG000|Overall Study|Death|2|||
162910640|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
162910641|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
162910642|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
162910643|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
162628548|NCT02002091|587356656|FG001|Screening|Death|2|||
162628549|NCT01233258|587356659|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
162628550|NCT01233258|587356660|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
162910644|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
162910645|NCT00989664|588371864|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
162910646|NCT00989664|588371864|FG000|Long-Term Follow-Up|Death|3|||
162910647|NCT00426842|588371865|FG000|Overall Study|Lost to Follow-up|1|||
162910648|NCT02886338|588371866|FG000|Overall Study|Withdrawal by Subject|1|||
162910649|NCT01156012|588371867|FG000|Overall Study|Adverse Event|3|||
162910650|NCT01156012|588371868|FG001|Overall Study|Adverse Event|1|||
162910651|NCT01156012|588371867|FG000|Overall Study|Lost to Follow-up|1|||
162910652|NCT01156012|588371868|FG001|Overall Study|Lost to Follow-up|0|||
162910653|NCT01156012|588371867|FG000|Overall Study|Withdrawal by Subject|1|||
162910654|NCT01156012|588371868|FG001|Overall Study|Withdrawal by Subject|0|||
162910655|NCT01156012|588371867|FG000|Overall Study|use of commercial drug instead of study|0|||
162910656|NCT01156012|588371868|FG001|Overall Study|use of commercial drug instead of study|1|||
162910657|NCT01156012|588371867|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
162910658|NCT01156012|588371868|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
162910659|NCT03359811|588373545|FG000|Overall Study|Protocol Violation|2|||
162910660|NCT03359811|588373546|FG001|Overall Study|Protocol Violation|0|||
162910661|NCT02528331|588373559|FG000|Overall Study|Withdrawal by Subject|2|||
162910662|NCT00386152|588373560|FG000|Overall Study|Adverse Event|6|||
162910663|NCT00386152|588373561|FG001|Overall Study|Adverse Event|5|||
162910664|NCT00386152|588373562|FG002|Overall Study|Adverse Event|4|||
162910665|NCT00386152|588373560|FG000|Overall Study|Chang from original chemo stratification|4|||
162910666|NCT00386152|588373561|FG001|Overall Study|Chang from original chemo stratification|5|||
162910667|NCT00386152|588373562|FG002|Overall Study|Chang from original chemo stratification|6|||
162910668|NCT00386152|588373560|FG000|Overall Study|Death|3|||
162967783|NCT02623218|588583029|FG004|Overall Study|Lost to Follow-up|0|||
162967784|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
162967785|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
162967786|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
162967787|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
162967788|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Death|3|||
162967789|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Death|1|||
162967790|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
162967791|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
162967792|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
162967793|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
162967794|NCT00537095|588583033|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
162967795|NCT00537095|588583034|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
162967796|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Adverse Event|2|||
162967797|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Adverse Event|11|||
162967798|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
162967799|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
162967800|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Death|2|||
162967801|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Death|2|||
162967802|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
162967803|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
162967804|NCT00537095|588583033|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
162967805|NCT00537095|588583034|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
162967806|NCT01970592|588583035|FG000|Overall Study|Withdrawal by Subject|4|||
162967807|NCT01970592|588583035|FG000|Overall Study|Physician Decision|1|||
162967808|NCT01970592|588583035|FG000|Overall Study|Adverse Event|1|||
162910669|NCT00386152|588373561|FG001|Overall Study|Death|0|||
162910670|NCT00386152|588373562|FG002|Overall Study|Death|1|||
162910671|NCT00386152|588373560|FG000|Overall Study|Disease progression|7|||
162910672|NCT00386152|588373561|FG001|Overall Study|Disease progression|4|||
162910673|NCT00386152|588373562|FG002|Overall Study|Disease progression|5|||
162910674|NCT00386152|588373560|FG000|Overall Study|Physician Decision|13|||
162910675|NCT00386152|588373561|FG001|Overall Study|Physician Decision|10|||
162910676|NCT00386152|588373562|FG002|Overall Study|Physician Decision|4|||
162910677|NCT00386152|588373560|FG000|Overall Study|Lost to Follow-up|1|||
162910678|NCT00386152|588373561|FG001|Overall Study|Lost to Follow-up|0|||
162910679|NCT00386152|588373562|FG002|Overall Study|Lost to Follow-up|0|||
162910680|NCT00386152|588373560|FG000|Overall Study|Completed chemotherapy|4|||
162910681|NCT00386152|588373561|FG001|Overall Study|Completed chemotherapy|5|||
162910682|NCT00386152|588373562|FG002|Overall Study|Completed chemotherapy|1|||
162910683|NCT00386152|588373560|FG000|Overall Study|Protocol Violation|3|||
162910684|NCT00386152|588373561|FG001|Overall Study|Protocol Violation|5|||
162910685|NCT00386152|588373562|FG002|Overall Study|Protocol Violation|2|||
162910686|NCT00386152|588373560|FG000|Overall Study|Withdrawal by Subject|3|||
162910687|NCT00386152|588373561|FG001|Overall Study|Withdrawal by Subject|6|||
162910688|NCT00386152|588373562|FG002|Overall Study|Withdrawal by Subject|10|||
162910689|NCT02577107|588373563|FG000|Overall Study|Protocol deviation|0|||
162910690|NCT02577107|588373564|FG001|Overall Study|Protocol deviation|1|||
162910691|NCT00577382|588373565|FG000|Overall Study|Adverse Event|0|||
162910692|NCT00577382|588373566|FG001|Overall Study|Adverse Event|6|||
162910693|NCT00577382|588373565|FG000|Overall Study|Withdrawal by Subject|0|||
162910694|NCT00577382|588373566|FG001|Overall Study|Withdrawal by Subject|1|||
162910695|NCT00577382|588373565|FG000|Overall Study|Progressive Disease|17|||
162910696|NCT00577382|588373566|FG001|Overall Study|Progressive Disease|19|||
162910697|NCT00577382|588373565|FG000|Overall Study|Intercurrent Illness|1|||
162910698|NCT00577382|588373566|FG001|Overall Study|Intercurrent Illness|2|||
162910699|NCT00577382|588373565|FG000|Overall Study|Death|1|||
162910700|NCT00577382|588373566|FG001|Overall Study|Death|1|||
162910701|NCT00577382|588373565|FG000|Overall Study|Lost to Follow-up|2|||
162910702|NCT00577382|588373566|FG001|Overall Study|Lost to Follow-up|2|||
162910703|NCT01345162|588373567|FG000|Overall Study|Protocol Violation|2|||
162910704|NCT01345162|588373568|FG001|Overall Study|Protocol Violation|4|||
162910705|NCT03007472|588373570|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
162910706|NCT03007472|588373570|FG000|Overall Study|Death|2|||
162910707|NCT03007472|588373570|FG000|Overall Study|Loss to Follow Up|1|||
162910708|NCT02988115|588373571|FG000|Overall Study|Adverse Event|6|||
162910709|NCT02988115|588373572|FG001|Overall Study|Adverse Event|1|||
162910710|NCT02988115|588373571|FG000|Overall Study|Sponsor Decision|5|||
162910711|NCT02988115|588373572|FG001|Overall Study|Sponsor Decision|2|||
162910712|NCT02988115|588373571|FG000|Overall Study|Withdrawal by Subject|1|||
162910713|NCT02988115|588373572|FG001|Overall Study|Withdrawal by Subject|1|||
162910714|NCT02988115|588373571|FG000|Overall Study|Withdrawn by Mistake|1|||
162910715|NCT02988115|588373572|FG001|Overall Study|Withdrawn by Mistake|0|||
162910716|NCT02988115|588373571|FG000|Overall Study|Lost to Follow-up|1|||
162910717|NCT02988115|588373572|FG001|Overall Study|Lost to Follow-up|0|||
162910718|NCT01731951|588373573|FG000|Overall Study|Documented Disease Progression|1|||
162910719|NCT01731951|588373574|FG001|Overall Study|Documented Disease Progression|0|||
162910720|NCT01731951|588373575|FG002|Overall Study|Documented Disease Progression|0|||
162910721|NCT01731951|588373576|FG003|Overall Study|Documented Disease Progression|0|||
162910722|NCT01731951|588373577|FG004|Overall Study|Documented Disease Progression|0|||
162910723|NCT01731951|588373578|FG005|Overall Study|Documented Disease Progression|0|||
162910724|NCT01731951|588373573|FG000|Overall Study|Lost to Follow-up|2|||
162910725|NCT01731951|588373574|FG001|Overall Study|Lost to Follow-up|0|||
162910726|NCT01731951|588373575|FG002|Overall Study|Lost to Follow-up|0|||
162910727|NCT01731951|588373576|FG003|Overall Study|Lost to Follow-up|1|||
162910728|NCT01731951|588373577|FG004|Overall Study|Lost to Follow-up|3|||
162910729|NCT01731951|588373578|FG005|Overall Study|Lost to Follow-up|1|||
162910730|NCT01731951|588373573|FG000|Overall Study|Withdrawal of Consent|1|||
162910731|NCT01731951|588373574|FG001|Overall Study|Withdrawal of Consent|0|||
162910732|NCT01731951|588373575|FG002|Overall Study|Withdrawal of Consent|0|||
162910733|NCT01731951|588373576|FG003|Overall Study|Withdrawal of Consent|0|||
162910734|NCT01731951|588373577|FG004|Overall Study|Withdrawal of Consent|0|||
162910735|NCT01731951|588373578|FG005|Overall Study|Withdrawal of Consent|2|||
162910736|NCT01731951|588373573|FG000|Overall Study|Death|13|||
162910737|NCT01731951|588373574|FG001|Overall Study|Death|15|||
162910738|NCT01731951|588373575|FG002|Overall Study|Death|9|||
162910739|NCT01731951|588373576|FG003|Overall Study|Death|8|||
162910740|NCT01731951|588373577|FG004|Overall Study|Death|9|||
162910741|NCT01731951|588373578|FG005|Overall Study|Death|6|||
162910742|NCT00649220|588373585|FG000|Overall Study|Adverse Event|2|||
162910743|NCT00649220|588373585|FG000|Overall Study|Withdrawal by Subject|1|||
162910744|NCT01977651|588373586|FG000|4 Month Treatment Period|Adverse Event|34|||
162910745|NCT01977651|588373586|FG000|4 Month Treatment Period|Death|3|||
162910746|NCT01977651|588373586|FG000|4 Month Treatment Period|Progressive Disease|43|||
162910747|NCT01977651|588373586|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
162910748|NCT01977651|588373586|FG000|4 Month Treatment Period|Physician Decision|4|||
162910749|NCT01977651|588373586|FG000|1 Year Extension Period|Adverse Event|14|||
162910750|NCT01977651|588373586|FG000|1 Year Extension Period|Death|10|||
162910751|NCT01977651|588373586|FG000|1 Year Extension Period|Lost to Follow-up|2|||
162910752|NCT01977651|588373586|FG000|1 Year Extension Period|Progressive Disease|86|||
162910753|NCT01977651|588373586|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
162910754|NCT01977651|588373586|FG000|1 Year Extension Period|Physician Decision|6|||
162910755|NCT01977651|588373586|FG000|1 Year Extension Period|Miscellaneous|1|||
162910756|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Adverse Event|5|||
162910757|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Death|13|||
162910758|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
162910759|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
162910760|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Physician Decision|4|||
162710704|NCT00430677|587651043|FG001|Short-term Period|Withdrawal by Subject|1|||
162710705|NCT00430677|587651044|FG002|Short-term Period|Withdrawal by Subject|2|||
162710706|NCT00430677|587651042|FG000|Short-term Period|Participant no longer met study criteria|1|||
162710707|NCT00430677|587651043|FG001|Short-term Period|Participant no longer met study criteria|1|||
162710708|NCT00430677|587651044|FG002|Short-term Period|Participant no longer met study criteria|2|||
162710709|NCT00430677|587651042|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
162710710|NCT00430677|587651043|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
162710711|NCT00430677|587651044|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
162710712|NCT00430677|587651042|FG000|Short-term Period|Pregnancy|0|||
162710713|NCT00430677|587651043|FG001|Short-term Period|Pregnancy|2|||
162710714|NCT00430677|587651044|FG002|Short-term Period|Pregnancy|0|||
162710715|NCT00430677|587651042|FG000|Long-term Extension Period|Death|1|||
162710716|NCT00430677|587651043|FG001|Long-term Extension Period|Death|0|||
162710717|NCT00430677|587651044|FG002|Long-term Extension Period|Death|0|||
162710718|NCT00430677|587651042|FG000|Long-term Extension Period|Adverse Event|3|||
162710719|NCT00430677|587651043|FG001|Long-term Extension Period|Adverse Event|2|||
162710720|NCT00430677|587651044|FG002|Long-term Extension Period|Adverse Event|5|||
162710721|NCT00430677|587651042|FG000|Long-term Extension Period|Lack of Efficacy|5|||
162710722|NCT00430677|587651043|FG001|Long-term Extension Period|Lack of Efficacy|3|||
162710723|NCT00430677|587651044|FG002|Long-term Extension Period|Lack of Efficacy|8|||
162710724|NCT00430677|587651042|FG000|Long-term Extension Period|Lost to Follow-up|1|||
162710725|NCT00430677|587651043|FG001|Long-term Extension Period|Lost to Follow-up|1|||
162710726|NCT00430677|587651044|FG002|Long-term Extension Period|Lost to Follow-up|1|||
162710727|NCT00430677|587651042|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
162710728|NCT00430677|587651043|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
162710729|NCT00430677|587651044|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
162710730|NCT00430677|587651042|FG000|Long-term Extension Period|Pregnancy|1|||
162710731|NCT00430677|587651043|FG001|Long-term Extension Period|Pregnancy|1|||
162710732|NCT00430677|587651044|FG002|Long-term Extension Period|Pregnancy|0|||
162710733|NCT00430677|587651042|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
162710734|NCT00430677|587651043|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
162710735|NCT00430677|587651044|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
162710736|NCT00430677|587651042|FG000|Long-term Extension Period|Other|2|||
162710737|NCT00430677|587651043|FG001|Long-term Extension Period|Other|1|||
162710738|NCT00430677|587651044|FG002|Long-term Extension Period|Other|1|||
162710739|NCT00430677|587651042|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
162710740|NCT00430677|587651043|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
162710741|NCT00430677|587651044|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
162710742|NCT01555762|587651045|FG000|Overall Study|No information on Bevacizumab intake|11|||
162710743|NCT01555762|587651045|FG000|Overall Study|Missing start date of infusion|8|||
162710744|NCT01555762|587651045|FG000|Overall Study|75 years old or more ticked No|1|||
162710745|NCT01555762|587651045|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
162710746|NCT01555762|587651045|FG000|Overall Study|Death linked to progression of disease|165|||
162710747|NCT01555762|587651045|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
162710748|NCT01555762|587651045|FG000|Overall Study|Investigator's decision|10|||
162710749|NCT01555762|587651045|FG000|Overall Study|Participant not wishing to continue|5|||
162710750|NCT01555762|587651045|FG000|Overall Study|Missing data|1|||
162910761|NCT01977651|588373586|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
162910762|NCT03380091|588373588|FG000|Overall Study|Withdrawal by Subject|2|||
162910763|NCT03380091|588373589|FG001|Overall Study|Withdrawal by Subject|1|||
162710751|NCT01555762|587651045|FG000|Overall Study|Death linked to an adverse event|14|||
162710752|NCT00299702|587651054|FG000|Overall Study|Death|1|||
162710753|NCT00299702|587651055|FG001|Overall Study|Death|0|||
162710754|NCT00299702|587651054|FG000|Overall Study|Adverse Event|0|||
162910764|NCT04594213|588373595|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
162910765|NCT04594213|588373596|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
162710755|NCT00299702|587651055|FG001|Overall Study|Adverse Event|4|||
162910766|NCT04594213|588373597|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
162910767|NCT04594213|588373598|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162967809|NCT03980522|588583038|FG000|Treatment Period|Adverse Event|1|||
162910768|NCT04594213|588373599|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162910769|NCT04594213|588373600|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162910770|NCT04594213|588373595|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
162910771|NCT04594213|588373596|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
162910772|NCT04594213|588373597|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
162910773|NCT04594213|588373598|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
162910774|NCT04594213|588373599|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
162910775|NCT04594213|588373600|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
162910776|NCT04594213|588373595|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
162910777|NCT04594213|588373596|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162910778|NCT04594213|588373597|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
162910779|NCT04594213|588373598|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162910780|NCT04594213|588373599|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162910781|NCT04594213|588373600|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162910782|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162910783|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162910784|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162910785|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162910786|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
162910787|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162910788|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162910789|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162967810|NCT03980522|588583039|FG001|Treatment Period|Adverse Event|0|||
162967811|NCT03980522|588583040|FG002|Treatment Period|Adverse Event|0|||
162967812|NCT03980522|588583041|FG003|Treatment Period|Adverse Event|0|||
162967813|NCT03980522|588583042|FG004|Treatment Period|Adverse Event|0|||
162967814|NCT01320722|588583043|FG000|Overall Study|Did not Receive Intervention|3|||
162967815|NCT01320722|588583044|FG001|Overall Study|Did not Receive Intervention|2|||
162967816|NCT01320722|588583045|FG002|Overall Study|Did not Receive Intervention|1|||
162967817|NCT01320722|588583046|FG003|Overall Study|Did not Receive Intervention|1|||
162967818|NCT01320722|588583047|FG004|Overall Study|Did not Receive Intervention|2|||
162967819|NCT01320722|588583043|FG000|Overall Study|Lost to Follow-up|0|||
162967820|NCT01320722|588583044|FG001|Overall Study|Lost to Follow-up|1|||
162967821|NCT01320722|588583045|FG002|Overall Study|Lost to Follow-up|0|||
162967822|NCT01320722|588583046|FG003|Overall Study|Lost to Follow-up|1|||
162967823|NCT01320722|588583047|FG004|Overall Study|Lost to Follow-up|3|||
162967824|NCT01320722|588583043|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
162967825|NCT01320722|588583044|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
162967826|NCT01320722|588583045|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
162967827|NCT01320722|588583046|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
162967828|NCT01320722|588583047|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
162967829|NCT01320722|588583043|FG000|Overall Study|Participant Developed a Rash|0|||
162967830|NCT01320722|588583044|FG001|Overall Study|Participant Developed a Rash|0|||
162967831|NCT01320722|588583045|FG002|Overall Study|Participant Developed a Rash|2|||
162967832|NCT01320722|588583046|FG003|Overall Study|Participant Developed a Rash|1|||
162967833|NCT01320722|588583047|FG004|Overall Study|Participant Developed a Rash|1|||
162967834|NCT01320722|588583043|FG000|Overall Study|Non-compliant with Medication|0|||
162967835|NCT01320722|588583044|FG001|Overall Study|Non-compliant with Medication|0|||
162967836|NCT01320722|588583045|FG002|Overall Study|Non-compliant with Medication|1|||
162967837|NCT01320722|588583046|FG003|Overall Study|Non-compliant with Medication|0|||
162967838|NCT01320722|588583047|FG004|Overall Study|Non-compliant with Medication|0|||
162967839|NCT01320722|588583043|FG000|Overall Study|Adverse Event|0|||
162967840|NCT01320722|588583044|FG001|Overall Study|Adverse Event|0|||
162967841|NCT01320722|588583045|FG002|Overall Study|Adverse Event|3|||
162967842|NCT01320722|588583046|FG003|Overall Study|Adverse Event|6|||
162967843|NCT01320722|588583047|FG004|Overall Study|Adverse Event|0|||
162967844|NCT01320722|588583043|FG000|Overall Study|Not Compliant with Study Procedures|0|||
162967845|NCT01320722|588583044|FG001|Overall Study|Not Compliant with Study Procedures|0|||
162967846|NCT01320722|588583045|FG002|Overall Study|Not Compliant with Study Procedures|0|||
162967847|NCT01320722|588583046|FG003|Overall Study|Not Compliant with Study Procedures|4|||
162967848|NCT01320722|588583047|FG004|Overall Study|Not Compliant with Study Procedures|0|||
162910790|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162910791|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
162910792|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
162710756|NCT00299702|587651054|FG000|Overall Study|Lost to Follow-up|18|||
162967849|NCT01320722|588583043|FG000|Overall Study|Pregnancy|0|||
162967850|NCT01320722|588583044|FG001|Overall Study|Pregnancy|0|||
162967851|NCT01320722|588583045|FG002|Overall Study|Pregnancy|0|||
162967852|NCT01320722|588583046|FG003|Overall Study|Pregnancy|1|||
162967853|NCT01320722|588583047|FG004|Overall Study|Pregnancy|0|||
162910793|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
162910794|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162910795|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162910796|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162910797|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162910798|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162910799|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
162910800|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162910801|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162910802|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162910803|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
162910804|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162910805|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162910806|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
162910807|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
162910808|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
162910809|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
162910810|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
162910811|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
162910812|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162910813|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162910814|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162910815|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
162910816|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
162910817|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
162910818|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162910819|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162910820|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162910821|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
162910822|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
162910823|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
162910824|NCT04594213|588373595|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
162910825|NCT04594213|588373596|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
162910826|NCT04594213|588373597|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
162910827|NCT04594213|588373598|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
162910828|NCT04594213|588373599|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
162910829|NCT04594213|588373600|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
162910830|NCT01980056|588373602|FG000|Overall Study|Death|1|||
162910831|NCT01980056|588373603|FG001|Overall Study|Death|1|||
162910832|NCT01980056|588373604|FG002|Overall Study|Death|0|||
162910833|NCT00104299|588373605|FG000|Overall Study|Adverse Event|3|||
162910834|NCT00104299|588373606|FG001|Overall Study|Adverse Event|1|||
162910835|NCT00104299|588373605|FG000|Overall Study|Death|2|||
162910836|NCT00104299|588373606|FG001|Overall Study|Death|2|||
162910837|NCT00104299|588373605|FG000|Overall Study|Withdrawal by Subject|2|||
162910838|NCT00104299|588373606|FG001|Overall Study|Withdrawal by Subject|6|||
162910839|NCT00104299|588373605|FG000|Overall Study|Physician Decision|1|||
162910840|NCT00104299|588373606|FG001|Overall Study|Physician Decision|1|||
162910841|NCT00104299|588373605|FG000|Overall Study|To have renal transplant|1|||
162910842|NCT00104299|588373606|FG001|Overall Study|To have renal transplant|0|||
162910843|NCT02906644|588373607|FG000|First 2 Weeks|Withdrawal by Subject|0|||
162910844|NCT02906644|588373608|FG001|First 2 Weeks|Withdrawal by Subject|2|||
162910845|NCT02906644|588373607|FG000|First 2 Weeks|Physician Decision|1|||
162910846|NCT02906644|588373608|FG001|First 2 Weeks|Physician Decision|1|||
162910847|NCT02906644|588373607|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
162910848|NCT02906644|588373608|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
162910849|NCT02906644|588373607|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
162910850|NCT02906644|588373608|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
162910851|NCT03672006|588373611|FG000|Overall Study|exclusion criteria met|0|||
162910852|NCT03672006|588373612|FG001|Overall Study|exclusion criteria met|1|||
162910853|NCT03288987|588373613|FG000|Overall Study|Protocol Violation|10|||
162910854|NCT03288987|588373614|FG001|Overall Study|Protocol Violation|4|||
162910855|NCT00608426|588373615|FG000|Overall Study|Death|32|||
162910856|NCT00608426|588373616|FG001|Overall Study|Death|36|||
162710757|NCT00299702|587651055|FG001|Overall Study|Lost to Follow-up|10|||
162910857|NCT00608426|588373615|FG000|Overall Study|Lost to Follow-up|485|||
162910858|NCT00608426|588373616|FG001|Overall Study|Lost to Follow-up|521|||
162910859|NCT00608426|588373615|FG000|Overall Study|refused, health issues, wrong address|319|||
163054415|NCT00794664|588910295|FG000|Treatment Period|Withdrawal by Subject|0|||
162910860|NCT00608426|588373616|FG001|Overall Study|refused, health issues, wrong address|348|||
162910861|NCT00761891|588373617|FG000|Overall Study|Withdrawal by Subject|10|||
162910862|NCT00368069|588373618|FG000|Overall Study|Adverse Event|5|||
162910863|NCT00368069|588373619|FG001|Overall Study|Adverse Event|2|||
162910864|NCT00368069|588373618|FG000|Overall Study|Lack of Efficacy|0|||
162910865|NCT00368069|588373619|FG001|Overall Study|Lack of Efficacy|1|||
162910866|NCT00368069|588373618|FG000|Overall Study|Lost to Follow-up|1|||
162910867|NCT00368069|588373619|FG001|Overall Study|Lost to Follow-up|0|||
162910868|NCT00368069|588373618|FG000|Overall Study|Protocol Violation|0|||
162910869|NCT00368069|588373619|FG001|Overall Study|Protocol Violation|2|||
162910870|NCT00368069|588373618|FG000|Overall Study|Withdrawal of Consent|2|||
162910871|NCT00368069|588373619|FG001|Overall Study|Withdrawal of Consent|1|||
162910872|NCT00368069|588373618|FG000|Overall Study|no blood sampling possible|0|||
162910873|NCT00368069|588373619|FG001|Overall Study|no blood sampling possible|1|||
162910874|NCT02764229|588373621|FG000|Overall Study|Withdrawal by Subject|15|||
162910875|NCT02764229|588373621|FG000|Overall Study|Adverse Event|9|||
162910876|NCT02764229|588373621|FG000|Overall Study|Physician Decision|5|||
162910877|NCT02764229|588373621|FG000|Overall Study|Lost to Follow-up|3|||
162910878|NCT02764229|588373621|FG000|Overall Study|Lack of Efficacy|1|||
162910879|NCT02764229|588373621|FG000|Overall Study|Study Stopped by Sponsor|69|||
162910880|NCT00672490|588373622|FG000|Overall Study|Withdrawal by Subject|8|||
162910881|NCT00672490|588373623|FG001|Overall Study|Withdrawal by Subject|8|||
162910882|NCT00672490|588373622|FG000|Overall Study|Lack of Compliance|2|||
162910883|NCT00672490|588373623|FG001|Overall Study|Lack of Compliance|7|||
162910884|NCT00672490|588373622|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
162910885|NCT00672490|588373623|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
162910886|NCT00672490|588373622|FG000|Overall Study|Adverse Event|5|||
162910887|NCT00672490|588373623|FG001|Overall Study|Adverse Event|8|||
162910888|NCT00672490|588373622|FG000|Overall Study|Violation of Concomitant Medicine|1|||
162910889|NCT00672490|588373623|FG001|Overall Study|Violation of Concomitant Medicine|0|||
162910890|NCT00672490|588373622|FG000|Overall Study|Intolerance|0|||
162910891|NCT00672490|588373623|FG001|Overall Study|Intolerance|2|||
162910892|NCT00672490|588373622|FG000|Overall Study|Lost to Follow-up|1|||
162910893|NCT00672490|588373623|FG001|Overall Study|Lost to Follow-up|5|||
162910894|NCT00672490|588373622|FG000|Overall Study|No reason was provided|6|||
162910895|NCT00672490|588373623|FG001|Overall Study|No reason was provided|2|||
162910896|NCT02135848|588373636|FG000|Overall Study|Adverse Event|2|||
162910897|NCT02135848|588373637|FG001|Overall Study|Adverse Event|0|||
162910898|NCT02135848|588373636|FG000|Overall Study|Withdrawal by Subject|1|||
162910899|NCT02135848|588373637|FG001|Overall Study|Withdrawal by Subject|1|||
162910900|NCT02030067|588373638|FG000|Overall Study|Disease Progression|1|||
162910901|NCT02030067|588373639|FG001|Overall Study|Disease Progression|1|||
162910902|NCT02030067|588373640|FG002|Overall Study|Disease Progression|2|||
162910903|NCT02030067|588373641|FG003|Overall Study|Disease Progression|2|||
162910904|NCT02030067|588373642|FG004|Overall Study|Disease Progression|3|||
162910905|NCT02030067|588373643|FG005|Overall Study|Disease Progression|2|||
162910906|NCT02030067|588373644|FG006|Overall Study|Disease Progression|3|||
162910907|NCT02030067|588373645|FG007|Overall Study|Disease Progression|3|||
162910908|NCT02030067|588373646|FG008|Overall Study|Disease Progression|4|||
162910909|NCT02030067|588373647|FG009|Overall Study|Disease Progression|3|||
162910910|NCT02030067|588373648|FG010|Overall Study|Disease Progression|7|||
162910911|NCT02030067|588373649|FG011|Overall Study|Disease Progression|2|||
162910912|NCT02030067|588373650|FG012|Overall Study|Disease Progression|59|||
162910913|NCT02030067|588373638|FG000|Overall Study|Withdrawal by Subject|0|||
162910914|NCT02030067|588373639|FG001|Overall Study|Withdrawal by Subject|0|||
162910915|NCT02030067|588373640|FG002|Overall Study|Withdrawal by Subject|0|||
162910916|NCT02030067|588373641|FG003|Overall Study|Withdrawal by Subject|1|||
162910917|NCT02030067|588373642|FG004|Overall Study|Withdrawal by Subject|0|||
162910918|NCT02030067|588373643|FG005|Overall Study|Withdrawal by Subject|0|||
162910919|NCT02030067|588373644|FG006|Overall Study|Withdrawal by Subject|0|||
162910920|NCT02030067|588373645|FG007|Overall Study|Withdrawal by Subject|1|||
162910921|NCT02030067|588373646|FG008|Overall Study|Withdrawal by Subject|0|||
162910922|NCT02030067|588373647|FG009|Overall Study|Withdrawal by Subject|0|||
162910923|NCT02030067|588373648|FG010|Overall Study|Withdrawal by Subject|3|||
162910924|NCT02030067|588373649|FG011|Overall Study|Withdrawal by Subject|0|||
162910925|NCT02030067|588373650|FG012|Overall Study|Withdrawal by Subject|6|||
162910926|NCT02030067|588373638|FG000|Overall Study|Physician Decision|0|||
162910927|NCT02030067|588373639|FG001|Overall Study|Physician Decision|0|||
162910928|NCT02030067|588373640|FG002|Overall Study|Physician Decision|0|||
162910929|NCT02030067|588373641|FG003|Overall Study|Physician Decision|0|||
162910930|NCT02030067|588373642|FG004|Overall Study|Physician Decision|0|||
162910931|NCT02030067|588373643|FG005|Overall Study|Physician Decision|0|||
162910932|NCT02030067|588373644|FG006|Overall Study|Physician Decision|0|||
162910933|NCT02030067|588373645|FG007|Overall Study|Physician Decision|0|||
162910934|NCT02030067|588373646|FG008|Overall Study|Physician Decision|0|||
162910935|NCT02030067|588373647|FG009|Overall Study|Physician Decision|0|||
162910936|NCT02030067|588373648|FG010|Overall Study|Physician Decision|1|||
162910937|NCT02030067|588373649|FG011|Overall Study|Physician Decision|0|||
162628551|NCT01233258|587356661|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
162628552|NCT01233258|587356662|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
162967854|NCT01320722|588583043|FG000|Overall Study|Started an Exclusionary Medication|0|||
162967855|NCT01320722|588583044|FG001|Overall Study|Started an Exclusionary Medication|0|||
162967856|NCT01320722|588583045|FG002|Overall Study|Started an Exclusionary Medication|0|||
162967857|NCT01320722|588583046|FG003|Overall Study|Started an Exclusionary Medication|0|||
162967858|NCT01320722|588583047|FG004|Overall Study|Started an Exclusionary Medication|1|||
162967859|NCT01320722|588583043|FG000|Overall Study|Withdrew due to Health Condition|0|||
162967860|NCT01320722|588583044|FG001|Overall Study|Withdrew due to Health Condition|0|||
162967861|NCT01320722|588583045|FG002|Overall Study|Withdrew due to Health Condition|0|||
162967862|NCT01320722|588583046|FG003|Overall Study|Withdrew due to Health Condition|0|||
162967863|NCT01320722|588583047|FG004|Overall Study|Withdrew due to Health Condition|1|||
162967864|NCT01091363|588583048|FG000|Overall Study|Withdrawal by Subject|11|||
162967865|NCT01091363|588583049|FG001|Overall Study|Withdrawal by Subject|15|||
162967866|NCT01091363|588583048|FG000|Overall Study|Lost to Follow-up|2|||
162967867|NCT01091363|588583049|FG001|Overall Study|Lost to Follow-up|2|||
162967868|NCT00160524|588583050|FG000|Overall Study|Adverse Event|119|||
162967869|NCT00160524|588583050|FG000|Overall Study|Adverse Event and Other|94|||
162967870|NCT00160524|588583050|FG000|Overall Study|Protocol Violation|16|||
162967871|NCT00160524|588583050|FG000|Overall Study|Protocol Violation and Other|2|||
162967872|NCT00160524|588583050|FG000|Overall Study|Withdrawal by Subject|141|||
162967873|NCT00160524|588583050|FG000|Overall Study|Withdrawal by Subject and Other|17|||
162967874|NCT00160524|588583050|FG000|Overall Study|Physician Decision|27|||
162967875|NCT00160524|588583050|FG000|Overall Study|Physician Decision and Other|6|||
162967876|NCT00160524|588583050|FG000|Overall Study|Lost to Follow-up|13|||
162967877|NCT00160524|588583050|FG000|Overall Study|Lost to Follow-up and Other|1|||
162967878|NCT00160524|588583050|FG000|Overall Study|Lack of Efficacy|21|||
162967879|NCT00160524|588583050|FG000|Overall Study|Lack of Efficacy and Other|1|||
162967880|NCT00160524|588583050|FG000|Overall Study|Other|20|||
162967881|NCT00021541|588583051|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
162967882|NCT00021541|588583052|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
162967883|NCT00021541|588583051|FG000|Period 1-First Treatment|Adverse Event|2|||
162967884|NCT00021541|588583052|FG001|Period 1-First Treatment|Adverse Event|1|||
162967885|NCT00021541|588583051|FG000|Period 1-First Treatment|non-adherence|3|||
162967886|NCT00021541|588583052|FG001|Period 1-First Treatment|non-adherence|0|||
162967887|NCT00021541|588583051|FG000|Period 1-First Treatment|Death|1|||
162967888|NCT00021541|588583052|FG001|Period 1-First Treatment|Death|0|||
162967889|NCT00021541|588583051|FG000|Period 1-First Treatment|Pts that did not progress|2|||
162967890|NCT00021541|588583052|FG001|Period 1-First Treatment|Pts that did not progress|2|||
162967891|NCT00021541|588583051|FG000|Period 1-First Treatment|Ineligible|0|||
162967892|NCT00021541|588583052|FG001|Period 1-First Treatment|Ineligible|2|||
162967893|NCT00021541|588583051|FG000|Period 2-crossover|refused phase B|2|||
162967894|NCT00021541|588583052|FG001|Period 2-crossover|refused phase B|2|||
162967895|NCT00021541|588583051|FG000|Period 2-crossover|Withdrawal by Subject|3|||
162967896|NCT00021541|588583052|FG001|Period 2-crossover|Withdrawal by Subject|4|||
162967897|NCT00021541|588583051|FG000|Period 2-crossover|Adverse Event|2|||
162967898|NCT00021541|588583052|FG001|Period 2-crossover|Adverse Event|2|||
162967899|NCT00021541|588583051|FG000|Period 2-crossover|non-adherence|1|||
162967900|NCT00021541|588583052|FG001|Period 2-crossover|non-adherence|0|||
162967901|NCT00021541|588583051|FG000|Period 2-crossover|Pts that did not progress|2|||
162967902|NCT00021541|588583052|FG001|Period 2-crossover|Pts that did not progress|3|||
162967903|NCT04892147|588583053|FG000|Overall Study|Withdrawal by Subject|2|||
162967904|NCT04892147|588583054|FG001|Overall Study|Withdrawal by Subject|0|||
162967905|NCT01215721|588583056|FG000|Overall Study|Adverse Event|2|||
162967906|NCT00045162|588583057|FG000|Overall Study|Ineligible|12|||
162967907|NCT00045162|588583058|FG001|Overall Study|Ineligible|8|||
162910938|NCT02030067|588373650|FG012|Overall Study|Physician Decision|3|||
162910939|NCT02030067|588373638|FG000|Overall Study|other reasons|0|||
162910940|NCT02030067|588373639|FG001|Overall Study|other reasons|0|||
162910941|NCT02030067|588373640|FG002|Overall Study|other reasons|0|||
162910942|NCT02030067|588373641|FG003|Overall Study|other reasons|0|||
162910943|NCT02030067|588373642|FG004|Overall Study|other reasons|0|||
162910944|NCT02030067|588373643|FG005|Overall Study|other reasons|1|||
162910945|NCT02030067|588373644|FG006|Overall Study|other reasons|0|||
162967908|NCT00045162|588583057|FG000|Overall Study|Not treated|7|||
162910946|NCT02030067|588373645|FG007|Overall Study|other reasons|0|||
162910947|NCT02030067|588373646|FG008|Overall Study|other reasons|2|||
162910948|NCT02030067|588373647|FG009|Overall Study|other reasons|0|||
162910949|NCT02030067|588373648|FG010|Overall Study|other reasons|0|||
162910950|NCT02030067|588373649|FG011|Overall Study|other reasons|0|||
162910951|NCT02030067|588373650|FG012|Overall Study|other reasons|4|||
162910952|NCT02030067|588373638|FG000|Overall Study|Adverse Event|0|||
162910953|NCT02030067|588373639|FG001|Overall Study|Adverse Event|0|||
162910954|NCT02030067|588373640|FG002|Overall Study|Adverse Event|0|||
162910955|NCT02030067|588373641|FG003|Overall Study|Adverse Event|0|||
162910956|NCT02030067|588373642|FG004|Overall Study|Adverse Event|0|||
162910957|NCT02030067|588373643|FG005|Overall Study|Adverse Event|0|||
162910958|NCT02030067|588373644|FG006|Overall Study|Adverse Event|0|||
162910959|NCT02030067|588373645|FG007|Overall Study|Adverse Event|0|||
162910960|NCT02030067|588373646|FG008|Overall Study|Adverse Event|0|||
162910961|NCT02030067|588373647|FG009|Overall Study|Adverse Event|0|||
162910962|NCT02030067|588373648|FG010|Overall Study|Adverse Event|0|||
162910963|NCT02030067|588373649|FG011|Overall Study|Adverse Event|1|||
162910964|NCT02030067|588373650|FG012|Overall Study|Adverse Event|8|||
162910965|NCT00565721|588373651|FG000|Overall Study|Screen Failure|2|||
162910966|NCT00565721|588373651|FG000|Overall Study|Lost to Follow-up|6|||
162910967|NCT00565721|588373651|FG000|Overall Study|Technical Problems|1|||
162910968|NCT00565721|588373651|FG000|Overall Study|Physician Decision|2|||
162910969|NCT00565721|588373651|FG000|Overall Study|Other reasons|6|||
162910970|NCT02813681|588373654|FG000|Overall Study|Physician Decision|5|||
162910971|NCT02813681|588373655|FG001|Overall Study|Physician Decision|5|||
162910972|NCT02813681|588373656|FG002|Overall Study|Physician Decision|0|||
162910973|NCT02813681|588373654|FG000|Overall Study|Lost to Follow-up|0|||
162910974|NCT02813681|588373655|FG001|Overall Study|Lost to Follow-up|1|||
162910975|NCT02813681|588373656|FG002|Overall Study|Lost to Follow-up|0|||
162910976|NCT00529152|588373657|FG000|Overall Study|Adverse Event|2|||
162910977|NCT00529152|588373657|FG000|Overall Study|Withdrawal by Subject|2|||
162910978|NCT00529152|588373657|FG000|Overall Study|Lost to Follow-up|1|||
162910979|NCT04062240|588373661|FG000|Overall Study|equipment malfunction|1|||
162910980|NCT03961529|588373662|FG000|Overall Study|Adverse Event|13|||
163054416|NCT00794664|588910296|FG001|Treatment Period|Withdrawal by Subject|2|||
163054417|NCT00794664|588910295|FG000|Treatment Period|Protocol non-compliance|0|||
163054418|NCT00794664|588910296|FG001|Treatment Period|Protocol non-compliance|1|||
163054419|NCT00794664|588910295|FG000|Treatment Period|Other|0|||
163054420|NCT00794664|588910296|FG001|Treatment Period|Other|1|||
163054421|NCT00794664|588910295|FG000|Treatment Period|Adverse Event|1|||
162910981|NCT03961529|588373663|FG001|Overall Study|Adverse Event|5|||
162910982|NCT03961529|588373664|FG002|Overall Study|Adverse Event|2|||
162910983|NCT03961529|588373662|FG000|Overall Study|Withdrawal by Subject|17|||
162967909|NCT00045162|588583058|FG001|Overall Study|Not treated|2|||
162967910|NCT00045162|588583057|FG000|Overall Study|Adverse Event|55|||
162967911|NCT00045162|588583058|FG001|Overall Study|Adverse Event|50|||
162967912|NCT00045162|588583057|FG000|Overall Study|Lack of Efficacy|32|||
162967913|NCT00045162|588583058|FG001|Overall Study|Lack of Efficacy|29|||
162967914|NCT00045162|588583057|FG000|Overall Study|Death|10|||
162967915|NCT00045162|588583058|FG001|Overall Study|Death|10|||
162967916|NCT00045162|588583057|FG000|Overall Study|Withdrawal by Subject|5|||
162967917|NCT00045162|588583058|FG001|Overall Study|Withdrawal by Subject|3|||
163054422|NCT00794664|588910296|FG001|Treatment Period|Adverse Event|8|||
162910984|NCT03961529|588373663|FG001|Overall Study|Withdrawal by Subject|2|||
162910985|NCT03961529|588373664|FG002|Overall Study|Withdrawal by Subject|1|||
162910986|NCT03961529|588373662|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162910987|NCT03961529|588373663|FG001|Overall Study|Withdrawal by parent/guardian|7|||
163054423|NCT00794664|588910295|FG000|Follow-up Period|Other|1|||
162910988|NCT03961529|588373664|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162910989|NCT03961529|588373662|FG000|Overall Study|Physician Decision|2|||
162910990|NCT03961529|588373663|FG001|Overall Study|Physician Decision|1|||
162910991|NCT03961529|588373664|FG002|Overall Study|Physician Decision|1|||
162910992|NCT03961529|588373662|FG000|Overall Study|Lost to Follow-up|2|||
162910993|NCT03961529|588373663|FG001|Overall Study|Lost to Follow-up|1|||
163054424|NCT00794664|588910296|FG001|Follow-up Period|Other|2|||
162910994|NCT03961529|588373664|FG002|Overall Study|Lost to Follow-up|0|||
162910995|NCT03961529|588373662|FG000|Overall Study|Lack of Efficacy|2|||
162967918|NCT00045162|588583057|FG000|Overall Study|Other|21|||
162967919|NCT00045162|588583058|FG001|Overall Study|Other|16|||
162967920|NCT01044433|588583059|FG000|Overall Study|Lost to Follow-up|3|||
162967921|NCT01044433|588583059|FG000|Overall Study|Withdrawal by Subject|3|||
162910996|NCT03961529|588373663|FG001|Overall Study|Lack of Efficacy|0|||
162910997|NCT03961529|588373664|FG002|Overall Study|Lack of Efficacy|1|||
162910998|NCT03961529|588373662|FG000|Overall Study|Other|6|||
162910999|NCT03961529|588373663|FG001|Overall Study|Other|1|||
162911000|NCT03961529|588373664|FG002|Overall Study|Other|0|||
162911001|NCT03500419|588373665|FG000|Overall Study|Withdrawal by Subject|2|||
162911002|NCT03500419|588373666|FG001|Overall Study|Withdrawal by Subject|25|||
162911003|NCT01497899|588373667|FG000|Double-Blind Phase|Randomized but not Treated|1|||
162911004|NCT01497899|588373668|FG001|Double-Blind Phase|Randomized but not Treated|0|||
162911005|NCT01497899|588373669|FG002|Double-Blind Phase|Randomized but not Treated|0|||
162911006|NCT01497899|588373670|FG003|Double-Blind Phase|Randomized but not Treated|0|||
162911007|NCT01497899|588373667|FG000|Double-Blind Phase|Adverse Event|1|||
162911008|NCT01497899|588373668|FG001|Double-Blind Phase|Adverse Event|0|||
162911009|NCT01497899|588373669|FG002|Double-Blind Phase|Adverse Event|0|||
162911010|NCT01497899|588373670|FG003|Double-Blind Phase|Adverse Event|0|||
162911011|NCT01497899|588373667|FG000|Double-Blind Phase|Lack of Efficacy|0|||
162911012|NCT01497899|588373668|FG001|Double-Blind Phase|Lack of Efficacy|1|||
162911013|NCT01497899|588373669|FG002|Double-Blind Phase|Lack of Efficacy|0|||
162911014|NCT01497899|588373670|FG003|Double-Blind Phase|Lack of Efficacy|0|||
162911015|NCT01497899|588373667|FG000|Double-Blind Phase|Investigator's Discretion|1|||
162911016|NCT01497899|588373668|FG001|Double-Blind Phase|Investigator's Discretion|0|||
162911017|NCT01497899|588373669|FG002|Double-Blind Phase|Investigator's Discretion|0|||
162911018|NCT01497899|588373670|FG003|Double-Blind Phase|Investigator's Discretion|0|||
162911019|NCT01497899|588373667|FG000|Double-Blind Phase|Withdrew Consent|0|||
162911020|NCT01497899|588373668|FG001|Double-Blind Phase|Withdrew Consent|1|||
162911021|NCT01497899|588373669|FG002|Double-Blind Phase|Withdrew Consent|0|||
162911022|NCT01497899|588373670|FG003|Double-Blind Phase|Withdrew Consent|0|||
162911023|NCT01497899|588373667|FG000|Double-Blind Phase|Lost to Follow-up|3|||
162911024|NCT01497899|588373668|FG001|Double-Blind Phase|Lost to Follow-up|2|||
162911025|NCT01497899|588373669|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162911026|NCT01497899|588373670|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162911027|NCT01497899|588373667|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
162911028|NCT01497899|588373668|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
162911029|NCT01497899|588373669|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
162911030|NCT01497899|588373670|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
162911031|NCT01497899|588373667|FG000|Open-Label Extension Phase|Adverse Event|1|||
162911032|NCT01497899|588373668|FG001|Open-Label Extension Phase|Adverse Event|0|||
162911033|NCT01497899|588373669|FG002|Open-Label Extension Phase|Adverse Event|0|||
162911034|NCT01497899|588373670|FG003|Open-Label Extension Phase|Adverse Event|0|||
162911035|NCT01497899|588373667|FG000|Open-Label Extension Phase|Death|1|||
162911036|NCT01497899|588373668|FG001|Open-Label Extension Phase|Death|0|||
162911037|NCT01497899|588373669|FG002|Open-Label Extension Phase|Death|0|||
162911038|NCT01497899|588373670|FG003|Open-Label Extension Phase|Death|0|||
162911039|NCT01497899|588373667|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
162911040|NCT01497899|588373668|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
162911041|NCT01497899|588373669|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
162911042|NCT01497899|588373670|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
162911043|NCT01497899|588373667|FG000|Open-Label Extension Phase|Pregnancy|0|||
162911044|NCT01497899|588373668|FG001|Open-Label Extension Phase|Pregnancy|1|||
162911045|NCT01497899|588373669|FG002|Open-Label Extension Phase|Pregnancy|1|||
162911046|NCT01497899|588373670|FG003|Open-Label Extension Phase|Pregnancy|0|||
162911047|NCT01497899|588373667|FG000|Open-Label Extension Phase|Protocol Violation|0|||
162911048|NCT01497899|588373668|FG001|Open-Label Extension Phase|Protocol Violation|0|||
162911049|NCT01497899|588373669|FG002|Open-Label Extension Phase|Protocol Violation|1|||
162911050|NCT01497899|588373670|FG003|Open-Label Extension Phase|Protocol Violation|0|||
162911051|NCT01497899|588373667|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
162911052|NCT01497899|588373668|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
162911053|NCT01497899|588373669|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
162911054|NCT01497899|588373670|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
162911055|NCT00082628|588373673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
162911056|NCT00082628|588373674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
162911057|NCT00082628|588373675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
162911058|NCT00082628|588373676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
162911059|NCT00082628|588373677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
162911060|NCT00082628|588373673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
162911061|NCT00082628|588373674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
162911062|NCT00082628|588373675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
162911063|NCT00082628|588373676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
162911064|NCT00082628|588373677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
162911065|NCT00082628|588373673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
162911066|NCT00082628|588373674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
162911067|NCT00082628|588373675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
162911068|NCT00082628|588373676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
162911069|NCT00082628|588373677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
162911070|NCT00082628|588373673|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
162911071|NCT00082628|588373674|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
162911072|NCT00082628|588373675|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
162911073|NCT00082628|588373676|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
162911074|NCT00082628|588373677|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
162911075|NCT00082628|588373673|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
162911076|NCT00082628|588373674|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
162911077|NCT00082628|588373675|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
162911078|NCT00082628|588373676|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
162911079|NCT00082628|588373677|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
162911080|NCT00082628|588373673|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
162911081|NCT00082628|588373674|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
162911082|NCT00082628|588373675|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
162911083|NCT00082628|588373676|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
162911084|NCT00082628|588373677|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
162911085|NCT00082628|588373673|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
162911086|NCT00082628|588373674|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
162911087|NCT00082628|588373675|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
162911088|NCT00082628|588373676|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
162911089|NCT00082628|588373677|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
162911090|NCT03481634|588373678|FG000|Overall Study|Withdrawal by Subject|16|||
162911091|NCT03481634|588373679|FG001|Overall Study|Withdrawal by Subject|19|||
162911092|NCT03481634|588373680|FG002|Overall Study|Withdrawal by Subject|14|||
162911093|NCT03481634|588373678|FG000|Overall Study|Protocol Violation|1|||
162911094|NCT03481634|588373679|FG001|Overall Study|Protocol Violation|0|||
162911095|NCT03481634|588373680|FG002|Overall Study|Protocol Violation|1|||
162911096|NCT03481634|588373678|FG000|Overall Study|Progressive disease|0|||
162911097|NCT03481634|588373679|FG001|Overall Study|Progressive disease|1|||
162911098|NCT03481634|588373680|FG002|Overall Study|Progressive disease|0|||
162911099|NCT03481634|588373678|FG000|Overall Study|Physician Decision|3|||
162911100|NCT03481634|588373679|FG001|Overall Study|Physician Decision|0|||
162911101|NCT03481634|588373680|FG002|Overall Study|Physician Decision|1|||
162911102|NCT03481634|588373678|FG000|Overall Study|Lost to Follow-up|3|||
162911103|NCT03481634|588373679|FG001|Overall Study|Lost to Follow-up|4|||
162911104|NCT03481634|588373680|FG002|Overall Study|Lost to Follow-up|4|||
162911105|NCT03481634|588373678|FG000|Overall Study|Death|4|||
162911106|NCT03481634|588373679|FG001|Overall Study|Death|8|||
162911107|NCT03481634|588373680|FG002|Overall Study|Death|7|||
162911108|NCT03481634|588373678|FG000|Overall Study|Adverse Event|6|||
162911109|NCT03481634|588373679|FG001|Overall Study|Adverse Event|3|||
162911110|NCT03481634|588373680|FG002|Overall Study|Adverse Event|7|||
162911111|NCT01874288|588373681|FG000|Overall Study|Withdrawal by Subject|1|||
162911112|NCT01874288|588373682|FG001|Overall Study|Withdrawal by Subject|0|||
162911113|NCT01874288|588373683|FG002|Overall Study|Withdrawal by Subject|2|||
162911114|NCT01874288|588373684|FG003|Overall Study|Withdrawal by Subject|1|||
162911115|NCT01874288|588373685|FG004|Overall Study|Withdrawal by Subject|1|||
162911116|NCT01874288|588373681|FG000|Overall Study|Physician Decision|0|||
162911117|NCT01874288|588373682|FG001|Overall Study|Physician Decision|0|||
162967922|NCT05263505|588583060|FG000|Overall Study|Adverse Event|0|||
162967923|NCT05263505|588583061|FG001|Overall Study|Adverse Event|1|||
162967924|NCT00826241|588583062|FG000|Overall Study|Withdrawal from Follow-up|1|||
162967925|NCT00826241|588583062|FG000|Overall Study|Withdrew consent|2|||
162967926|NCT00826241|588583062|FG000|Overall Study|Death|4|||
162967927|NCT00826241|588583062|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
162967928|NCT00826241|588583062|FG000|Overall Study|Non-compliance|1|||
162967929|NCT00826241|588583062|FG000|Overall Study|Progression of disease|1|||
162967930|NCT00826241|588583062|FG000|Overall Study|Patient refused follow-up|3|||
162911118|NCT01874288|588373683|FG002|Overall Study|Physician Decision|0|||
162911119|NCT01874288|588373684|FG003|Overall Study|Physician Decision|1|||
162911120|NCT01874288|588373685|FG004|Overall Study|Physician Decision|0|||
162911121|NCT01874288|588373681|FG000|Overall Study|Progressive disease|2|||
162911122|NCT01874288|588373682|FG001|Overall Study|Progressive disease|0|||
162911123|NCT01874288|588373683|FG002|Overall Study|Progressive disease|3|||
162911124|NCT01874288|588373684|FG003|Overall Study|Progressive disease|5|||
162911125|NCT01874288|588373685|FG004|Overall Study|Progressive disease|1|||
162911126|NCT03099304|588373686|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
162967931|NCT00826241|588583062|FG000|Overall Study|Lost to Follow-up|9|||
162967932|NCT00826241|588583062|FG000|Overall Study|Could not obtain records|1|||
162967933|NCT00826241|588583062|FG000|Overall Study|Screen failure|2|||
162911127|NCT03099304|588373687|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
162911128|NCT03099304|588373688|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
162911129|NCT03099304|588373689|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
162911130|NCT03099304|588373690|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
162911131|NCT03099304|588373691|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
162911132|NCT03099304|588373686|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
162911133|NCT03099304|588373687|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
162911134|NCT03099304|588373688|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
162911135|NCT03099304|588373689|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
162911136|NCT03099304|588373690|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
162911137|NCT03099304|588373691|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
162911138|NCT03099304|588373686|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
162911139|NCT03099304|588373687|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
162911140|NCT03099304|588373688|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
162911141|NCT03099304|588373689|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
162911142|NCT03099304|588373690|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
162911143|NCT03099304|588373691|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
162911144|NCT03099304|588373686|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
162911145|NCT03099304|588373687|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
162911146|NCT03099304|588373688|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
162911147|NCT03099304|588373689|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
162911148|NCT03099304|588373690|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
162911149|NCT03099304|588373691|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
162911150|NCT03099304|588373686|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
162911151|NCT03099304|588373687|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
162911152|NCT03099304|588373688|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
162911153|NCT03099304|588373689|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
162911154|NCT03099304|588373690|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
162911155|NCT03099304|588373691|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
162911156|NCT03099304|588373686|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
162911157|NCT03099304|588373687|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
162911158|NCT03099304|588373688|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
162911159|NCT03099304|588373689|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
162911160|NCT03099304|588373690|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
162911161|NCT03099304|588373691|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
162911162|NCT03099304|588373686|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
162911163|NCT03099304|588373687|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
162911164|NCT03099304|588373688|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
162911165|NCT03099304|588373689|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
162911166|NCT03099304|588373690|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
162967934|NCT00826241|588583062|FG000|Overall Study|Pt unable to proceed to registration|1|||
162967935|NCT00826241|588583062|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
162967936|NCT01050764|588583063|FG000|Overall Study|Death, before HSCT|1|||
162967937|NCT01050764|588583063|FG000|Overall Study|Donor mobilization failure, death|1|||
162967938|NCT01050764|588583063|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
162967939|NCT00556673|588583069|FG000|Overall Study|Protocol deviation|3|||
162967940|NCT00556673|588583070|FG001|Overall Study|Protocol deviation|2|||
162967941|NCT01971554|588583071|FG000|Overall Study|Lost to Follow-up|1|||
162911167|NCT03099304|588373691|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
162911168|NCT03099304|588373686|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
162911169|NCT03099304|588373687|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
162911170|NCT03099304|588373688|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
162911171|NCT03099304|588373689|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
162911172|NCT03099304|588373690|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
162911173|NCT03099304|588373691|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
162911174|NCT03099304|588373686|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
162911175|NCT03099304|588373687|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
162911176|NCT03099304|588373688|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
162911177|NCT03099304|588373689|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
162911178|NCT03099304|588373690|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
162911179|NCT03099304|588373691|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
162911180|NCT03099304|588373686|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
162967942|NCT01971554|588583072|FG001|Overall Study|Lost to Follow-up|0|||
162911181|NCT03099304|588373687|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
162911182|NCT03099304|588373688|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
162911183|NCT03099304|588373689|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
162911184|NCT03099304|588373690|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
162911185|NCT03099304|588373691|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
162911186|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
162967943|NCT01971554|588583073|FG002|Overall Study|Lost to Follow-up|0|||
162967944|NCT01971554|588583074|FG003|Overall Study|Lost to Follow-up|0|||
162967945|NCT04194151|588583076|FG000|Overall Study|Physician Decision|1|||
162911187|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
162911188|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
162911189|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
162911190|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
162911191|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
162911192|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
162911193|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
162911194|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
162911195|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
162911196|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
162911197|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
162911198|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
162911199|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
162911200|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
162911201|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
162911202|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
162911203|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
162911204|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
162911205|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
162911206|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
162911207|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
162911208|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
162911209|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
162911210|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
162911211|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
162911212|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
162911213|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
162911214|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
162911215|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
162911216|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
162911217|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
162911218|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
162911219|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
162911220|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
162911221|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
162911222|NCT03099304|588373686|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
162911223|NCT03099304|588373687|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
162911224|NCT03099304|588373688|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
162911225|NCT03099304|588373689|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
162911226|NCT03099304|588373690|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
162911227|NCT03099304|588373691|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
162911228|NCT01624974|588373692|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
162911229|NCT01624974|588373693|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
162911230|NCT01624974|588373692|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
162911231|NCT01624974|588373693|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
162911232|NCT01624974|588373692|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
162911233|NCT01624974|588373693|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
162911234|NCT01624974|588373692|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
162911235|NCT01624974|588373693|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
162911236|NCT01624974|588373692|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
162911237|NCT01624974|588373693|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
162911238|NCT01624974|588373692|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
162911239|NCT01624974|588373693|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
162967946|NCT04194151|588583077|FG001|Overall Study|Physician Decision|1|||
162967947|NCT04194151|588583078|FG002|Overall Study|Physician Decision|1|||
162967948|NCT04194151|588583079|FG003|Overall Study|Physician Decision|1|||
162967949|NCT04194151|588583080|FG004|Overall Study|Physician Decision|0|||
162967950|NCT04194151|588583081|FG005|Overall Study|Physician Decision|1|||
162967951|NCT04194151|588583076|FG000|Overall Study|Monitorization problem|0|||
162967952|NCT04194151|588583077|FG001|Overall Study|Monitorization problem|1|||
162967953|NCT04194151|588583078|FG002|Overall Study|Monitorization problem|0|||
162967954|NCT04194151|588583079|FG003|Overall Study|Monitorization problem|0|||
162967955|NCT04194151|588583080|FG004|Overall Study|Monitorization problem|0|||
162967956|NCT04194151|588583081|FG005|Overall Study|Monitorization problem|0|||
162967957|NCT00087529|588583083|FG000|Overall Study|Death|1|||
162967958|NCT00087529|588583084|FG001|Overall Study|Death|0|||
162967959|NCT00087529|588583083|FG000|Overall Study|Adverse Event|0|||
162967960|NCT00087529|588583084|FG001|Overall Study|Adverse Event|8|||
162967961|NCT00087529|588583083|FG000|Overall Study|Pregnancy|0|||
162967962|NCT00087529|588583084|FG001|Overall Study|Pregnancy|1|||
162967963|NCT00087529|588583083|FG000|Overall Study|Lost to Follow-up|2|||
162967964|NCT00087529|588583084|FG001|Overall Study|Lost to Follow-up|3|||
162967965|NCT00087529|588583083|FG000|Overall Study|Participant Decision|14|||
162967966|NCT00087529|588583084|FG001|Overall Study|Participant Decision|37|||
162967967|NCT00087529|588583083|FG000|Overall Study|Physician Decision|4|||
162967968|NCT00087529|588583084|FG001|Overall Study|Physician Decision|8|||
162967969|NCT00087529|588583083|FG000|Overall Study|Initiation of Excluded Therapy|0|||
162967970|NCT00087529|588583084|FG001|Overall Study|Initiation of Excluded Therapy|1|||
162967971|NCT00087529|588583083|FG000|Overall Study|Participant Noncompliance|0|||
162967972|NCT00087529|588583084|FG001|Overall Study|Participant Noncompliance|1|||
162967973|NCT00087529|588583083|FG000|Overall Study|Disease Progression|5|||
162967974|NCT00087529|588583084|FG001|Overall Study|Disease Progression|4|||
162967975|NCT00087529|588583083|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
162967976|NCT00087529|588583084|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
162911240|NCT01624974|588373692|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
162911241|NCT01624974|588373693|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
162911242|NCT01624974|588373692|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
162911243|NCT01624974|588373693|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
162911244|NCT01624974|588373692|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
162911245|NCT01624974|588373693|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
162911246|NCT01624974|588373692|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
162911247|NCT01624974|588373693|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
162911248|NCT01624974|588373692|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
162911249|NCT01624974|588373693|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
162911250|NCT01624974|588373692|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
162911251|NCT01624974|588373693|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
162911252|NCT02142712|588373694|FG000|Overall Study|Lost to Follow-up|1|||
162911253|NCT02142712|588373695|FG001|Overall Study|Lost to Follow-up|1|||
162911254|NCT02142712|588373696|FG002|Overall Study|Lost to Follow-up|1|||
162911255|NCT02142712|588373697|FG003|Overall Study|Lost to Follow-up|0|||
162911256|NCT00266695|588373698|FG000|Overall Study|Adverse Event|1|||
162911257|NCT00266695|588373698|FG000|Overall Study|Death|9|||
162911258|NCT00266695|588373698|FG000|Overall Study|Physician Decision|1|||
162911259|NCT00266695|588373698|FG000|Overall Study|Lost to Follow-up|3|||
162911260|NCT00266695|588373698|FG000|Overall Study|Withdrawal by Subject|15|||
162911261|NCT01854918|588373699|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
162911262|NCT01854918|588373700|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
162911263|NCT01854918|588373699|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
162911264|NCT01854918|588373700|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
162911265|NCT01854918|588373699|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
162911266|NCT01854918|588373700|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
162911267|NCT01854918|588373699|FG000|SOC-controlled Period (Year 1)|Death|5|||
162911268|NCT01854918|588373700|FG001|SOC-controlled Period (Year 1)|Death|5|||
162911269|NCT01854918|588373699|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
162911270|NCT01854918|588373700|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
162911271|NCT01854918|588373699|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
162911272|NCT01854918|588373700|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
162911273|NCT01854918|588373699|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
162911274|NCT01854918|588373700|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
162911275|NCT01854918|588373699|FG000|All-IP Period (Years 2 and 3)|Death|5|||
162911276|NCT01854918|588373700|FG001|All-IP Period (Years 2 and 3)|Death|16|||
162911277|NCT02828982|588373704|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162911278|NCT02828982|588373705|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162911279|NCT02475564|588373706|FG000|Overall Study|Withdrawal by Subject|1|||
162911280|NCT02475564|588373707|FG001|Overall Study|Withdrawal by Subject|0|||
162911281|NCT02475564|588373706|FG000|Overall Study|Lost to Follow-up|2|||
162911282|NCT02475564|588373707|FG001|Overall Study|Lost to Follow-up|1|||
162911283|NCT02475564|588373706|FG000|Overall Study|Intense Menstrual bleeding|1|||
162911284|NCT02475564|588373707|FG001|Overall Study|Intense Menstrual bleeding|0|||
162911285|NCT02705755|588373708|FG000|Part A (6 Days)|Adverse Event|1|||
162911286|NCT02705755|588373709|FG001|Part A (6 Days)|Adverse Event|0|||
162911287|NCT02705755|588373710|FG002|Part A (6 Days)|Adverse Event|0|||
162911288|NCT02705755|588373711|FG003|Part A (6 Days)|Adverse Event|0|||
162911289|NCT02705755|588373708|FG000|Part A (6 Days)|Physician Decision|3|||
162911290|NCT02705755|588373709|FG001|Part A (6 Days)|Physician Decision|0|||
162911291|NCT02705755|588373710|FG002|Part A (6 Days)|Physician Decision|0|||
162911292|NCT02705755|588373711|FG003|Part A (6 Days)|Physician Decision|0|||
162967977|NCT02535923|588583085|FG000|Overall Study|Lost to Follow-up|5|||
162967978|NCT02535923|588583086|FG001|Overall Study|Lost to Follow-up|5|||
162967979|NCT02535923|588583085|FG000|Overall Study|Withdrawal by Subject|4|||
162911293|NCT02705755|588373708|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
162967980|NCT02535923|588583086|FG001|Overall Study|Withdrawal by Subject|3|||
162911294|NCT02705755|588373709|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
162911295|NCT02705755|588373710|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
162911296|NCT02705755|588373711|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
162911297|NCT02705755|588373708|FG000|Part C (20 Weeks)|Physician Decision|0|||
162911298|NCT02705755|588373709|FG001|Part C (20 Weeks)|Physician Decision|0|||
162911299|NCT02705755|588373710|FG002|Part C (20 Weeks)|Physician Decision|0|||
162911300|NCT02705755|588373711|FG003|Part C (20 Weeks)|Physician Decision|2|||
162911301|NCT02705755|588373708|FG000|Part C (20 Weeks)|Adverse Event|0|||
162911302|NCT02705755|588373709|FG001|Part C (20 Weeks)|Adverse Event|0|||
162911303|NCT02705755|588373710|FG002|Part C (20 Weeks)|Adverse Event|0|||
162628553|NCT01233258|587356663|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
162628554|NCT01233258|587356664|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
162911304|NCT02705755|588373711|FG003|Part C (20 Weeks)|Adverse Event|6|||
162911305|NCT02705755|588373708|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
162911306|NCT02705755|588373709|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
162911307|NCT02705755|588373710|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
162911308|NCT02705755|588373711|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
162911309|NCT01906489|588373712|FG000|Overall Study|Adverse Event|10|||
162911310|NCT01906489|588373713|FG001|Overall Study|Adverse Event|3|||
162911311|NCT01906489|588373712|FG000|Overall Study|Worsening of CKD|6|||
162911312|NCT01906489|588373713|FG001|Overall Study|Worsening of CKD|4|||
162628555|NCT01233258|587356659|FG000|First Intervention (6 Months)|Protocol Violation|0|||
162628556|NCT01233258|587356660|FG001|First Intervention (6 Months)|Protocol Violation|0|||
162628557|NCT01233258|587356661|FG002|First Intervention (6 Months)|Protocol Violation|1|||
162628558|NCT01233258|587356662|FG003|First Intervention (6 Months)|Protocol Violation|0|||
162911313|NCT01906489|588373712|FG000|Overall Study|Withdrawal by Subject|5|||
162911314|NCT01906489|588373713|FG001|Overall Study|Withdrawal by Subject|0|||
162911315|NCT01906489|588373712|FG000|Overall Study|Worsening of Anemia|1|||
162911316|NCT01906489|588373713|FG001|Overall Study|Worsening of Anemia|0|||
162911317|NCT01906489|588373712|FG000|Overall Study|Protocol Violation|0|||
162911318|NCT01906489|588373713|FG001|Overall Study|Protocol Violation|1|||
162911319|NCT01906489|588373712|FG000|Overall Study|Non- Compliance|1|||
162911320|NCT01906489|588373713|FG001|Overall Study|Non- Compliance|0|||
162911321|NCT01906489|588373712|FG000|Overall Study|Sponsor Decision|1|||
162911322|NCT01906489|588373713|FG001|Overall Study|Sponsor Decision|0|||
162911323|NCT01906489|588373712|FG000|Overall Study|Lost to Follow-up|1|||
162911324|NCT01906489|588373713|FG001|Overall Study|Lost to Follow-up|1|||
162911325|NCT01906489|588373712|FG000|Overall Study|Other|1|||
162911326|NCT01906489|588373713|FG001|Overall Study|Other|0|||
162911327|NCT03458234|588373714|FG000|Overall Study|Withdrawal by Subject|1|||
162911328|NCT01707667|588376256|FG000|Period 1|expulsion of colonic sensor catheter|1|||
162911329|NCT01707667|588376257|FG001|Period 1|expulsion of colonic sensor catheter|0|||
162911330|NCT03802331|588376258|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
162911331|NCT03802331|588376259|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
162911332|NCT03432819|588376263|FG000|Overall Study|Lost to Follow-up|2|||
162628559|NCT01233258|587356663|FG004|First Intervention (6 Months)|Protocol Violation|0|||
162628560|NCT01233258|587356664|FG005|First Intervention (6 Months)|Protocol Violation|0|||
162628561|NCT01233258|587356659|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
162628562|NCT01233258|587356660|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
162628563|NCT01233258|587356661|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
162628564|NCT01233258|587356662|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
162628565|NCT01233258|587356663|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
162628566|NCT01233258|587356664|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
162628567|NCT00530946|587356668|FG000|Overall Study|Adverse Event|1|||
162628568|NCT00530946|587356669|FG001|Overall Study|Adverse Event|2|||
162628569|NCT00530946|587356670|FG002|Overall Study|Adverse Event|1|||
162628570|NCT00530946|587356671|FG003|Overall Study|Adverse Event|1|||
162628571|NCT00530946|587356668|FG000|Overall Study|Protocol Violation|0|||
162628572|NCT00530946|587356669|FG001|Overall Study|Protocol Violation|0|||
162628573|NCT00530946|587356670|FG002|Overall Study|Protocol Violation|0|||
162628574|NCT00530946|587356671|FG003|Overall Study|Protocol Violation|1|||
162911333|NCT03432819|588376264|FG001|Overall Study|Lost to Follow-up|2|||
162911334|NCT03432819|588376263|FG000|Overall Study|Withdrawal by Subject|5|||
162911335|NCT03432819|588376264|FG001|Overall Study|Withdrawal by Subject|3|||
162911336|NCT00265382|588376265|FG000|Overall Study|Adverse Event|21|||
162911337|NCT00265382|588376265|FG000|Overall Study|Laboratory Abnormality|1|||
162628575|NCT00530946|587356668|FG000|Overall Study|Noncompliance|1|||
162628576|NCT00530946|587356669|FG001|Overall Study|Noncompliance|0|||
162911338|NCT00265382|588376265|FG000|Overall Study|Lost to Follow-up|3|||
162911339|NCT00265382|588376265|FG000|Overall Study|Lack of Efficacy|6|||
162911340|NCT00265382|588376265|FG000|Overall Study|Miscellaneous|6|||
162911341|NCT00265382|588376265|FG000|Overall Study|Withdrawal by Subject|13|||
162911342|NCT00265382|588376265|FG000|Overall Study|Study terminated by sponsor|94|||
162911343|NCT00265382|588376265|FG000|Overall Study|Death|1|||
162911344|NCT01474993|588376270|FG000|Overall Study|Lost to Follow-up|1|||
162628577|NCT00530946|587356670|FG002|Overall Study|Noncompliance|0|||
162628578|NCT00530946|587356671|FG003|Overall Study|Noncompliance|0|||
162628579|NCT03322631|587356676|FG000|Overall Study|Withdrawal by Subject|0|||
162628580|NCT03322631|587356677|FG001|Overall Study|Withdrawal by Subject|1|||
162628581|NCT03322631|587356678|FG002|Overall Study|Withdrawal by Subject|0|||
162628582|NCT03322631|587356679|FG003|Overall Study|Withdrawal by Subject|0|||
162628583|NCT03322631|587356676|FG000|Overall Study|Adverse Event|0|||
162628584|NCT03322631|587356677|FG001|Overall Study|Adverse Event|0|||
162628585|NCT03322631|587356678|FG002|Overall Study|Adverse Event|1|||
162628586|NCT03322631|587356679|FG003|Overall Study|Adverse Event|0|||
162628587|NCT01300650|587356681|FG000|Overall Study|Adverse Event|1|||
162628588|NCT00602797|587356682|FG000|Overall Study|Adverse Event|1|||
162628589|NCT03943147|587356683|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
162628590|NCT03943147|587356684|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
162628591|NCT03943147|587356683|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
162628592|NCT03943147|587356684|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
162628593|NCT03943147|587356683|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
162628594|NCT03943147|587356684|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
162628595|NCT03943147|587356683|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
162628596|NCT03943147|587356684|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
162628597|NCT03943147|587356683|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
162628598|NCT03943147|587356684|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
162628599|NCT03943147|587356683|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
162628600|NCT03943147|587356684|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
162628601|NCT01318993|587356685|FG000|Overall Study|Adverse Event|53|||
162628602|NCT01318993|587356685|FG000|Overall Study|Lack of Efficacy|121|||
162628603|NCT01318993|587356685|FG000|Overall Study|Protocol Violation|3|||
162628604|NCT01318993|587356685|FG000|Overall Study|Protocol based stopping criteria|6|||
162628605|NCT01318993|587356685|FG000|Overall Study|Study closed or terminated|174|||
162628606|NCT01318993|587356685|FG000|Overall Study|Lost to Follow-up|4|||
162628607|NCT01318993|587356685|FG000|Overall Study|Physician Decision|13|||
162628608|NCT01318993|587356685|FG000|Overall Study|Withdrawal by Subject|24|||
162628609|NCT03736447|587356689|FG000|Overall Study|Adverse Event|5|||
162628610|NCT03736447|587356690|FG001|Overall Study|Adverse Event|1|||
162628611|NCT03736447|587356689|FG000|Overall Study|Withdrawal by Subject|5|||
162628612|NCT03736447|587356690|FG001|Overall Study|Withdrawal by Subject|1|||
162628613|NCT03736447|587356689|FG000|Overall Study|Lost to Follow-up|1|||
162911345|NCT01474993|588376271|FG001|Overall Study|Lost to Follow-up|2|||
162911346|NCT01474993|588376270|FG000|Overall Study|Adverse Event|0|||
162911347|NCT01474993|588376271|FG001|Overall Study|Adverse Event|1|||
162911348|NCT00760994|588376272|FG000|Overall Study|Lost to Follow-up|4|||
162911349|NCT00760994|588376273|FG001|Overall Study|Lost to Follow-up|4|||
162911350|NCT00760994|588376274|FG002|Overall Study|Lost to Follow-up|3|||
162911351|NCT03258710|588376277|FG000|Overall Study|Adverse Event|1|||
162911352|NCT03258710|588376277|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162911353|NCT03258710|588376277|FG000|Overall Study|Physician Decision|1|||
162911354|NCT03451630|588376278|FG000|Overall Study|Death|15|||
162911355|NCT03451630|588376279|FG001|Overall Study|Death|16|||
162911356|NCT03451630|588376280|FG002|Overall Study|Death|11|||
162911357|NCT03451630|588376278|FG000|Overall Study|Lost to Follow-up|9|||
162911358|NCT03451630|588376279|FG001|Overall Study|Lost to Follow-up|0|||
162911359|NCT03451630|588376280|FG002|Overall Study|Lost to Follow-up|4|||
162911360|NCT03451630|588376278|FG000|Overall Study|Withdrawal by Subject|0|||
162911361|NCT03451630|588376279|FG001|Overall Study|Withdrawal by Subject|3|||
162911362|NCT03451630|588376280|FG002|Overall Study|Withdrawal by Subject|0|||
162911363|NCT03451630|588376278|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
162967981|NCT04388787|588583087|FG000|Blinded Period|Patient could not follow instructions|1|||
162967982|NCT04388787|588583087|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
162967983|NCT02129062|588584739|FG000|Overall Study|Death|1|||
162967984|NCT02129062|588584739|FG000|Overall Study|Disease Progression|2|||
162967985|NCT04662710|588584740|FG000|Overall Study|Death|14|||
162967986|NCT04662710|588584741|FG001|Overall Study|Death|331|||
162967987|NCT04662710|588584742|FG002|Overall Study|Death|367|||
162628614|NCT03736447|587356690|FG001|Overall Study|Lost to Follow-up|0|||
162628615|NCT03736447|587356689|FG000|Overall Study|Physician Decision|1|||
162628616|NCT03736447|587356690|FG001|Overall Study|Physician Decision|0|||
162710758|NCT00299702|587651054|FG000|Overall Study|Withdrawal by Subject|25|||
162710759|NCT00299702|587651055|FG001|Overall Study|Withdrawal by Subject|23|||
162710760|NCT00299702|587651054|FG000|Overall Study|Pregnancy|0|||
162911364|NCT03451630|588376279|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
162967988|NCT04662710|588584740|FG000|Overall Study|Ongoing|1|||
162967989|NCT04662710|588584741|FG001|Overall Study|Ongoing|109|||
162628617|NCT03736447|587356689|FG000|Overall Study|Continued commitment to study treatment|3|||
162628618|NCT03736447|587356690|FG001|Overall Study|Continued commitment to study treatment|0|||
162911365|NCT03451630|588376280|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
162911366|NCT02041533|588376282|FG000|Pre-Treatment Period|Disease Progression|1|||
162911367|NCT02041533|588376283|FG001|Pre-Treatment Period|Disease Progression|1|||
162911368|NCT02041533|588376282|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
162911369|NCT02041533|588376283|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
162911370|NCT02041533|588376282|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
162911371|NCT02041533|588376283|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
162911372|NCT02041533|588376282|FG000|Treatment Period|Disease progression|189|||
162911373|NCT02041533|588376283|FG001|Treatment Period|Disease progression|146|||
162911374|NCT02041533|588376282|FG000|Treatment Period|Study drug toxicity|30|||
162911375|NCT02041533|588376283|FG001|Treatment Period|Study drug toxicity|34|||
162628619|NCT03736447|587356689|FG000|Overall Study|Taste aversion to study product|0|||
162628620|NCT03736447|587356690|FG001|Overall Study|Taste aversion to study product|1|||
162628621|NCT02619175|587356691|FG000|Overall Study|Withdrawal by Subject|1|||
162628622|NCT02619175|587356692|FG001|Overall Study|Withdrawal by Subject|0|||
162628623|NCT02619175|587356691|FG000|Overall Study|foot pain|1|||
162628624|NCT02619175|587356692|FG001|Overall Study|foot pain|0|||
162628625|NCT02795832|587356696|FG000|Overall Study|Adverse Event|0|||
162628626|NCT02795832|587356697|FG001|Overall Study|Adverse Event|0|||
162628627|NCT02795832|587356698|FG002|Overall Study|Adverse Event|0|||
162628628|NCT02795832|587356699|FG003|Overall Study|Adverse Event|0|||
162911376|NCT02041533|588376282|FG000|Treatment Period|Death|1|||
162911377|NCT02041533|588376283|FG001|Treatment Period|Death|0|||
162911378|NCT02041533|588376282|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
162911379|NCT02041533|588376283|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
162911380|NCT02041533|588376282|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
162911381|NCT02041533|588376283|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
162911382|NCT02041533|588376282|FG000|Treatment Period|Participant withdrew consent|2|||
162911383|NCT02041533|588376283|FG001|Treatment Period|Participant withdrew consent|2|||
162911384|NCT02041533|588376282|FG000|Treatment Period|Maximum clinical benefit|0|||
162628629|NCT02795832|587356700|FG004|Overall Study|Adverse Event|0|||
162628630|NCT02795832|587356701|FG005|Overall Study|Adverse Event|3|||
162628631|NCT02695329|587356704|FG000|Overall Study|Adverse Event|1|||
162628632|NCT02695329|587356705|FG001|Overall Study|Adverse Event|0|||
162628633|NCT02695329|587356704|FG000|Overall Study|Poor X-ray quality for measurement|4|||
162911385|NCT02041533|588376283|FG001|Treatment Period|Maximum clinical benefit|18|||
162911386|NCT02041533|588376282|FG000|Treatment Period|Poor/Non-compliance|1|||
162628634|NCT02695329|587356705|FG001|Overall Study|Poor X-ray quality for measurement|5|||
162628635|NCT01382212|587356706|FG000|Overall Study|Kidney transplant|1|||
162628636|NCT01382212|587356706|FG000|Overall Study|Withdrew consent|1|||
162628637|NCT01273597|587356707|FG000|Overall Study|Adverse Event|5|||
162628638|NCT01273597|587356707|FG000|Overall Study|Underwent Kidney Transplantation|2|||
162628639|NCT01273597|587356707|FG000|Overall Study|Reason Not Reported|1|||
162628640|NCT00393029|587356708|FG000|Overall Study|Not treated|0|||
162628641|NCT00393029|587356709|FG001|Overall Study|Not treated|1|||
162628642|NCT03547583|587356711|FG000|Overall Study|Adverse Event|16|||
162628643|NCT03547583|587356712|FG001|Overall Study|Adverse Event|11|||
162628644|NCT03547583|587356713|FG002|Overall Study|Adverse Event|10|||
162628645|NCT03547583|587356711|FG000|Overall Study|Death|11|||
162628646|NCT03547583|587356712|FG001|Overall Study|Death|7|||
162628647|NCT03547583|587356713|FG002|Overall Study|Death|4|||
162628648|NCT03547583|587356711|FG000|Overall Study|Lost to Follow-up|1|||
162911387|NCT02041533|588376283|FG001|Treatment Period|Poor/Non-compliance|0|||
162911388|NCT02041533|588376282|FG000|Treatment Period|Administrative reason by sponsor|1|||
162911389|NCT02041533|588376283|FG001|Treatment Period|Administrative reason by sponsor|0|||
162911390|NCT02041533|588376282|FG000|Treatment Period|Other reasons|9|||
162911391|NCT02041533|588376283|FG001|Treatment Period|Other reasons|2|||
162911392|NCT02041533|588376282|FG000|Treatment Period|Not Reported|0|||
162911393|NCT02041533|588376283|FG001|Treatment Period|Not Reported|1|||
162911394|NCT00545740|588376284|FG000|Overall Study|Lack of Efficacy|34|||
162911395|NCT00545740|588376285|FG001|Overall Study|Lack of Efficacy|35|||
162628649|NCT03547583|587356712|FG001|Overall Study|Lost to Follow-up|0|||
162628650|NCT03547583|587356713|FG002|Overall Study|Lost to Follow-up|0|||
162628651|NCT03547583|587356711|FG000|Overall Study|Non-compliance with study drug|0|||
162628652|NCT03547583|587356712|FG001|Overall Study|Non-compliance with study drug|0|||
162911396|NCT00545740|588376286|FG002|Overall Study|Lack of Efficacy|47|||
162911397|NCT00545740|588376287|FG003|Overall Study|Lack of Efficacy|36|||
162911398|NCT00545740|588376284|FG000|Overall Study|Withdrawal by Subject|17|||
162911399|NCT00545740|588376285|FG001|Overall Study|Withdrawal by Subject|15|||
162911400|NCT00545740|588376286|FG002|Overall Study|Withdrawal by Subject|16|||
162628653|NCT03547583|587356713|FG002|Overall Study|Non-compliance with study drug|1|||
162628654|NCT03547583|587356711|FG000|Overall Study|Physician Decision|1|||
162628655|NCT03547583|587356712|FG001|Overall Study|Physician Decision|0|||
162628656|NCT03547583|587356713|FG002|Overall Study|Physician Decision|3|||
162628657|NCT03547583|587356711|FG000|Overall Study|Protocol Violation|2|||
162628658|NCT03547583|587356712|FG001|Overall Study|Protocol Violation|1|||
162911401|NCT00545740|588376287|FG003|Overall Study|Withdrawal by Subject|18|||
162911402|NCT00545740|588376284|FG000|Overall Study|Adverse Event|10|||
162911403|NCT00545740|588376285|FG001|Overall Study|Adverse Event|18|||
162911404|NCT00545740|588376286|FG002|Overall Study|Adverse Event|19|||
162911405|NCT00545740|588376287|FG003|Overall Study|Adverse Event|9|||
162911406|NCT00545740|588376284|FG000|Overall Study|Lost to Follow-up|7|||
162911407|NCT00545740|588376285|FG001|Overall Study|Lost to Follow-up|5|||
162911408|NCT00545740|588376286|FG002|Overall Study|Lost to Follow-up|5|||
162911409|NCT00545740|588376287|FG003|Overall Study|Lost to Follow-up|6|||
162911410|NCT00545740|588376284|FG000|Overall Study|Protocol Violation|1|||
162911411|NCT00545740|588376285|FG001|Overall Study|Protocol Violation|3|||
162628659|NCT03547583|587356713|FG002|Overall Study|Protocol Violation|1|||
162628660|NCT03547583|587356711|FG000|Overall Study|Withdrawal by Subject|12|||
162628661|NCT03547583|587356712|FG001|Overall Study|Withdrawal by Subject|19|||
162628662|NCT03547583|587356713|FG002|Overall Study|Withdrawal by Subject|10|||
162911412|NCT00545740|588376286|FG002|Overall Study|Protocol Violation|1|||
162911413|NCT00545740|588376287|FG003|Overall Study|Protocol Violation|0|||
162628663|NCT03547583|587356711|FG000|Overall Study|Other|2|||
162628664|NCT03547583|587356712|FG001|Overall Study|Other|2|||
162628665|NCT03547583|587356713|FG002|Overall Study|Other|3|||
162628666|NCT01846416|587356714|FG000|Treatment Phase|Death|2|||
162967990|NCT04662710|588584742|FG002|Overall Study|Ongoing|56|||
162967991|NCT04662710|588584740|FG000|Overall Study|Withdrawal by Subject|0|||
162967992|NCT04662710|588584741|FG001|Overall Study|Withdrawal by Subject|3|||
162967993|NCT04662710|588584742|FG002|Overall Study|Withdrawal by Subject|14|||
162967994|NCT02722616|588584744|FG000|Overall Study|Sponsor closed study after one month|2|||
162967995|NCT02722616|588584745|FG001|Overall Study|Sponsor closed study after one month|0|||
162967996|NCT02722616|588584746|FG002|Overall Study|Sponsor closed study after one month|0|||
162967997|NCT00224484|588584747|FG000|Overall Study|Serious Adverse Event|1|||
162967998|NCT00224484|588584748|FG001|Overall Study|Serious Adverse Event|1|||
162967999|NCT00224484|588584749|FG002|Overall Study|Serious Adverse Event|0|||
162968000|NCT00224484|588584747|FG000|Overall Study|Non-Serious Adverse Event|5|||
162968001|NCT00224484|588584748|FG001|Overall Study|Non-Serious Adverse Event|7|||
162968002|NCT00224484|588584749|FG002|Overall Study|Non-Serious Adverse Event|3|||
162968003|NCT00224484|588584747|FG000|Overall Study|Protocol Violation|2|||
162968004|NCT00224484|588584748|FG001|Overall Study|Protocol Violation|2|||
162968005|NCT00224484|588584749|FG002|Overall Study|Protocol Violation|0|||
162968006|NCT00224484|588584747|FG000|Overall Study|Withdrawal by Subject|49|||
162968007|NCT00224484|588584748|FG001|Overall Study|Withdrawal by Subject|18|||
162968008|NCT00224484|588584749|FG002|Overall Study|Withdrawal by Subject|16|||
162968009|NCT00224484|588584747|FG000|Overall Study|Migrated/moved from study area|18|||
162968010|NCT00224484|588584748|FG001|Overall Study|Migrated/moved from study area|5|||
162968011|NCT00224484|588584749|FG002|Overall Study|Migrated/moved from study area|5|||
162968012|NCT00224484|588584747|FG000|Overall Study|Lost to Follow-up|66|||
162968013|NCT00224484|588584748|FG001|Overall Study|Lost to Follow-up|28|||
162968014|NCT00224484|588584749|FG002|Overall Study|Lost to Follow-up|36|||
162968015|NCT00224484|588584747|FG000|Overall Study|Reason not specified|5|||
162968016|NCT00224484|588584748|FG001|Overall Study|Reason not specified|4|||
162968017|NCT00224484|588584749|FG002|Overall Study|Reason not specified|2|||
162968018|NCT00108628|588584752|FG000|Overall Study|Withdrawal by Subject|17|||
162968019|NCT00108628|588584753|FG001|Overall Study|Withdrawal by Subject|9|||
162968020|NCT00108628|588584752|FG000|Overall Study|Lack of Efficacy|2|||
162968021|NCT00108628|588584753|FG001|Overall Study|Lack of Efficacy|1|||
162968022|NCT00108628|588584752|FG000|Overall Study|Death|1|||
162968023|NCT00108628|588584753|FG001|Overall Study|Death|0|||
162968024|NCT01453153|588584754|FG000|Overall Study|Physician Decision|0|||
162968025|NCT01453153|588584755|FG001|Overall Study|Physician Decision|0|||
162968026|NCT01453153|588584756|FG002|Overall Study|Physician Decision|1|||
162968027|NCT01453153|588584754|FG000|Overall Study|Progressive Disease|3|||
162968028|NCT01453153|588584755|FG001|Overall Study|Progressive Disease|2|||
162968029|NCT01453153|588584756|FG002|Overall Study|Progressive Disease|16|||
162968030|NCT01453153|588584754|FG000|Overall Study|Withdrawal by Subject|0|||
162968031|NCT01453153|588584755|FG001|Overall Study|Withdrawal by Subject|1|||
162968032|NCT01453153|588584756|FG002|Overall Study|Withdrawal by Subject|2|||
162968033|NCT01453153|588584754|FG000|Overall Study|Adverse Event|1|||
162968034|NCT01453153|588584755|FG001|Overall Study|Adverse Event|1|||
162968035|NCT01453153|588584756|FG002|Overall Study|Adverse Event|1|||
162968036|NCT03547635|588584759|FG000|Overall Study|Adverse Event|5|||
162628667|NCT01846416|587356715|FG001|Treatment Phase|Death|9|||
162968037|NCT03547635|588584760|FG001|Overall Study|Adverse Event|2|||
162968038|NCT03547635|588584761|FG002|Overall Study|Adverse Event|3|||
162968039|NCT03547635|588584759|FG000|Overall Study|Lost to Follow-up|1|||
162911414|NCT00545740|588376284|FG000|Overall Study|Non-compliance|0|||
162968040|NCT03547635|588584760|FG001|Overall Study|Lost to Follow-up|3|||
162911415|NCT00545740|588376285|FG001|Overall Study|Non-compliance|2|||
162968041|NCT03547635|588584761|FG002|Overall Study|Lost to Follow-up|4|||
162628668|NCT01846416|587356716|FG002|Treatment Phase|Death|1|||
162628669|NCT01846416|587356714|FG000|Treatment Phase|Withdrawal by Subject|2|||
162968042|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Subject|1|||
162628670|NCT01846416|587356715|FG001|Treatment Phase|Withdrawal by Subject|4|||
162628671|NCT01846416|587356716|FG002|Treatment Phase|Withdrawal by Subject|2|||
162628672|NCT01846416|587356714|FG000|Treatment Phase|Other|1|||
162628673|NCT01846416|587356715|FG001|Treatment Phase|Other|5|||
162628674|NCT01846416|587356716|FG002|Treatment Phase|Other|1|||
162628675|NCT01846416|587356714|FG000|Treatment Phase|Physician Decision|1|||
162628676|NCT01846416|587356715|FG001|Treatment Phase|Physician Decision|2|||
162628677|NCT01846416|587356716|FG002|Treatment Phase|Physician Decision|0|||
162628678|NCT01846416|587356714|FG000|Treatment Phase|Adverse Event|3|||
162628679|NCT01846416|587356715|FG001|Treatment Phase|Adverse Event|4|||
162628680|NCT01846416|587356716|FG002|Treatment Phase|Adverse Event|0|||
162628681|NCT01846416|587356714|FG000|Treatment Phase|Non-compliance|0|||
162628682|NCT01846416|587356715|FG001|Treatment Phase|Non-compliance|2|||
162628683|NCT01846416|587356716|FG002|Treatment Phase|Non-compliance|0|||
162628684|NCT01846416|587356714|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
162628685|NCT01846416|587356715|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
162628686|NCT01846416|587356716|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
162628687|NCT01846416|587356714|FG000|Treatment Phase|Progressive Disease|21|||
162628688|NCT01846416|587356715|FG001|Treatment Phase|Progressive Disease|63|||
162628689|NCT01846416|587356716|FG002|Treatment Phase|Progressive Disease|9|||
162628690|NCT01846416|587356714|FG000|Survival Follow-up|Death|21|||
162628691|NCT01846416|587356715|FG001|Survival Follow-up|Death|62|||
162628692|NCT01846416|587356716|FG002|Survival Follow-up|Death|9|||
162628693|NCT01846416|587356714|FG000|Survival Follow-up|Lost to Follow-up|0|||
162628694|NCT01846416|587356715|FG001|Survival Follow-up|Lost to Follow-up|2|||
162628695|NCT01846416|587356716|FG002|Survival Follow-up|Lost to Follow-up|2|||
162628696|NCT01846416|587356714|FG000|Survival Follow-up|Withdrawal by Subject|2|||
162628697|NCT01846416|587356715|FG001|Survival Follow-up|Withdrawal by Subject|7|||
162628698|NCT01846416|587356716|FG002|Survival Follow-up|Withdrawal by Subject|0|||
162628699|NCT01846416|587356714|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
162628700|NCT01846416|587356715|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
162628701|NCT01846416|587356716|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
162628702|NCT01846416|587356714|FG000|Survival Follow-up|Other|3|||
162628703|NCT01846416|587356715|FG001|Survival Follow-up|Other|1|||
162628704|NCT01846416|587356716|FG002|Survival Follow-up|Other|1|||
162628705|NCT00382252|587356717|FG000|Overall Study|Death|4|||
162628706|NCT00382252|587356717|FG000|Overall Study|Protocol Violation|8|||
162628707|NCT00382252|587356717|FG000|Overall Study|Not treated by RFA|1|||
162628708|NCT00833794|587356718|FG000|Open-label Phase|Adverse Event|225|||
162628709|NCT00833794|587356719|FG001|Open-label Phase|Adverse Event|0|||
162628710|NCT00833794|587356718|FG000|Open-label Phase|Lack of Efficacy|28|||
162628711|NCT00833794|587356719|FG001|Open-label Phase|Lack of Efficacy|0|||
162628712|NCT00833794|587356718|FG000|Open-label Phase|Withdrawal by Subject|48|||
162628713|NCT00833794|587356719|FG001|Open-label Phase|Withdrawal by Subject|0|||
162628714|NCT00833794|587356718|FG000|Open-label Phase|Physician Decision|20|||
162628715|NCT00833794|587356719|FG001|Open-label Phase|Physician Decision|0|||
162628716|NCT00833794|587356718|FG000|Open-label Phase|Administrative reason|1|||
162628717|NCT00833794|587356719|FG001|Open-label Phase|Administrative reason|0|||
162628718|NCT00833794|587356718|FG000|Open-label Phase|Protocol Violation|47|||
162628719|NCT00833794|587356719|FG001|Open-label Phase|Protocol Violation|0|||
162628720|NCT00833794|587356718|FG000|Open-label Phase|Did not complete wash-out period|12|||
162628721|NCT00833794|587356719|FG001|Open-label Phase|Did not complete wash-out period|0|||
162628722|NCT00833794|587356718|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
162628723|NCT00833794|587356719|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
162628724|NCT00833794|587356718|FG000|Double-blind Phase|Adverse Event|44|||
162628725|NCT00833794|587356719|FG001|Double-blind Phase|Adverse Event|11|||
162628726|NCT00833794|587356718|FG000|Double-blind Phase|Lack of Efficacy|34|||
162628727|NCT00833794|587356719|FG001|Double-blind Phase|Lack of Efficacy|22|||
162628728|NCT00833794|587356718|FG000|Double-blind Phase|Withdrawal by Subject|23|||
162628729|NCT00833794|587356719|FG001|Double-blind Phase|Withdrawal by Subject|6|||
162628730|NCT00833794|587356718|FG000|Double-blind Phase|Physician Decision|4|||
162968043|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Subject|0|||
162968044|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Subject|0|||
162968045|NCT03547635|588584759|FG000|Overall Study|Withdrawal By PI|0|||
162968046|NCT03547635|588584760|FG001|Overall Study|Withdrawal By PI|1|||
162968047|NCT03547635|588584761|FG002|Overall Study|Withdrawal By PI|0|||
162968048|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Sponsor|0|||
162968049|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Sponsor|0|||
162968050|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Sponsor|1|||
162628731|NCT00833794|587356719|FG001|Double-blind Phase|Physician Decision|7|||
162628732|NCT00833794|587356718|FG000|Double-blind Phase|Administrative reason|1|||
162628733|NCT00833794|587356719|FG001|Double-blind Phase|Administrative reason|3|||
162628734|NCT00039130|587356722|FG000|Overall Study|Adverse Event|11|||
162628735|NCT00039130|587356722|FG000|Overall Study|Death|9|||
162628736|NCT00039130|587356722|FG000|Overall Study|Withdrawal by Subject|3|||
162628737|NCT00039130|587356722|FG000|Overall Study|Progression|2|||
162628738|NCT00039130|587356722|FG000|Overall Study|Subsequent treatment|2|||
162628739|NCT00039130|587356722|FG000|Overall Study|Physician Decision|3|||
162628740|NCT01269463|587356723|FG000|First Intervention|Withdrawal by Subject|1|||
162628741|NCT01269463|587356724|FG001|First Intervention|Withdrawal by Subject|0|||
162628742|NCT01269463|587356723|FG000|First Intervention|Adverse Event|1|||
162628743|NCT01269463|587356724|FG001|First Intervention|Adverse Event|0|||
162628744|NCT01269463|587356723|FG000|First Intervention|Lack of Efficacy|0|||
162628745|NCT01269463|587356724|FG001|First Intervention|Lack of Efficacy|1|||
162628746|NCT01269463|587356723|FG000|First Intervention|Physician Decision|0|||
162628747|NCT01269463|587356724|FG001|First Intervention|Physician Decision|1|||
162628748|NCT02612727|587356728|FG000|Overall Study|Parent request|4|||
162628749|NCT02612727|587356729|FG001|Overall Study|Parent request|1|||
162628750|NCT02612727|587356728|FG000|Overall Study|Needed treatment incompatible with PT|1|||
162628751|NCT02612727|587356729|FG001|Overall Study|Needed treatment incompatible with PT|1|||
162628752|NCT02612727|587356728|FG000|Overall Study|Direct hyperbilirubinemia|0|||
162911416|NCT00545740|588376286|FG002|Overall Study|Non-compliance|1|||
162911417|NCT00545740|588376287|FG003|Overall Study|Non-compliance|0|||
162911418|NCT00545740|588376284|FG000|Overall Study|Moved|2|||
162911419|NCT00545740|588376285|FG001|Overall Study|Moved|0|||
162911420|NCT00545740|588376286|FG002|Overall Study|Moved|1|||
162911421|NCT00545740|588376287|FG003|Overall Study|Moved|0|||
162911422|NCT00545740|588376284|FG000|Overall Study|Diverticulitis attack|0|||
162911423|NCT00545740|588376285|FG001|Overall Study|Diverticulitis attack|0|||
162911424|NCT00545740|588376286|FG002|Overall Study|Diverticulitis attack|1|||
162911425|NCT00545740|588376287|FG003|Overall Study|Diverticulitis attack|1|||
162911426|NCT00545740|588376284|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
162911427|NCT00545740|588376285|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
162911428|NCT00545740|588376286|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
162911429|NCT00545740|588376287|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
162911430|NCT00545740|588376284|FG000|Overall Study|Site closure|1|||
162911431|NCT00545740|588376285|FG001|Overall Study|Site closure|0|||
162911432|NCT00545740|588376286|FG002|Overall Study|Site closure|0|||
162911433|NCT00545740|588376287|FG003|Overall Study|Site closure|0|||
162911434|NCT00545740|588376284|FG000|Overall Study|Missed visit|1|||
162911435|NCT00545740|588376285|FG001|Overall Study|Missed visit|0|||
162911436|NCT00545740|588376286|FG002|Overall Study|Missed visit|0|||
162911437|NCT00545740|588376287|FG003|Overall Study|Missed visit|0|||
162911438|NCT00545740|588376284|FG000|Overall Study|Physician Decision|0|||
162628753|NCT02612727|587356729|FG001|Overall Study|Direct hyperbilirubinemia|2|||
162628754|NCT04518306|587356732|FG000|Double-Blind Period|Run in failure|0|||
162628755|NCT04518306|587356733|FG001|Double-Blind Period|Run in failure|0|||
162628756|NCT04518306|587356734|FG002|Double-Blind Period|Run in failure|1|||
162628757|NCT04518306|587356732|FG000|Double-Blind Period|Adverse Event|0|||
162628758|NCT04518306|587356733|FG001|Double-Blind Period|Adverse Event|2|||
162628759|NCT04518306|587356734|FG002|Double-Blind Period|Adverse Event|2|||
162628760|NCT04518306|587356732|FG000|Double-Blind Period|Lost to Follow-up|1|||
162628761|NCT04518306|587356733|FG001|Double-Blind Period|Lost to Follow-up|2|||
162628762|NCT04518306|587356734|FG002|Double-Blind Period|Lost to Follow-up|2|||
162628763|NCT04518306|587356732|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
162628764|NCT04518306|587356733|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
162628765|NCT04518306|587356734|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
162628766|NCT04518306|587356732|FG000|Double-Blind Period|Other|0|||
162628767|NCT04518306|587356733|FG001|Double-Blind Period|Other|2|||
162628768|NCT04518306|587356734|FG002|Double-Blind Period|Other|0|||
162628769|NCT04518306|587356732|FG000|Double-Blind Period|Missing|0|||
162628770|NCT04518306|587356733|FG001|Double-Blind Period|Missing|1|||
162628771|NCT04518306|587356734|FG002|Double-Blind Period|Missing|0|||
162628772|NCT03268954|587356735|FG000|Overall Study|Withdrawal by Subject|27|||
162628773|NCT03268954|587356736|FG001|Overall Study|Withdrawal by Subject|17|||
162628774|NCT03268954|587356735|FG000|Overall Study|Lost to Follow-up|2|||
162628775|NCT03268954|587356736|FG001|Overall Study|Lost to Follow-up|3|||
162628776|NCT03268954|587356735|FG000|Overall Study|Reason Not Specified|3|||
162628777|NCT03268954|587356736|FG001|Overall Study|Reason Not Specified|8|||
162628778|NCT05358444|587356737|FG000|Overall Study|Withdrawal by Subject|0|||
162628779|NCT05358444|587356738|FG001|Overall Study|Withdrawal by Subject|1|||
162628780|NCT05358444|587356737|FG000|Overall Study|Lost to Follow-up|0|||
162628781|NCT05358444|587356738|FG001|Overall Study|Lost to Follow-up|3|||
162628782|NCT03820986|587356742|FG000|Overall Study|Death|201|||
162628783|NCT03820986|587356743|FG001|Overall Study|Death|175|||
162628784|NCT03820986|587356742|FG000|Overall Study|Lost to Follow-up|1|||
162628785|NCT03820986|587356743|FG001|Overall Study|Lost to Follow-up|1|||
162911439|NCT00545740|588376285|FG001|Overall Study|Physician Decision|0|||
162911440|NCT00545740|588376286|FG002|Overall Study|Physician Decision|3|||
162911441|NCT00545740|588376287|FG003|Overall Study|Physician Decision|0|||
162911442|NCT00545740|588376284|FG000|Overall Study|Accepted only monthly telephone calls|1|||
162911443|NCT00545740|588376285|FG001|Overall Study|Accepted only monthly telephone calls|0|||
162911444|NCT00545740|588376286|FG002|Overall Study|Accepted only monthly telephone calls|0|||
162911445|NCT00545740|588376287|FG003|Overall Study|Accepted only monthly telephone calls|0|||
162628786|NCT03820986|587356742|FG000|Overall Study|Physician Decision|1|||
162628787|NCT03820986|587356743|FG001|Overall Study|Physician Decision|0|||
162628788|NCT03820986|587356742|FG000|Overall Study|Sponsor Decision|122|||
162628789|NCT03820986|587356743|FG001|Overall Study|Sponsor Decision|160|||
162628790|NCT03820986|587356742|FG000|Overall Study|Withdrawal by Subject|9|||
162628791|NCT03820986|587356743|FG001|Overall Study|Withdrawal by Subject|4|||
162628792|NCT01638546|587356754|FG000|Overall Study|Adverse Event|1|||
162628793|NCT01638546|587356755|FG001|Overall Study|Adverse Event|3|||
162628794|NCT05766423|587356756|FG000|Overall Study|Withdrawal by Subject|1|||
162628795|NCT05766423|587356757|FG001|Overall Study|Withdrawal by Subject|0|||
162628796|NCT05766423|587356756|FG000|Overall Study|Consented, not scheduled|3|||
162628797|NCT05766423|587356757|FG001|Overall Study|Consented, not scheduled|5|||
162911446|NCT00545740|588376284|FG000|Overall Study|Sponsor decision|0|||
162911447|NCT00545740|588376285|FG001|Overall Study|Sponsor decision|1|||
162911448|NCT00545740|588376286|FG002|Overall Study|Sponsor decision|0|||
162911449|NCT00545740|588376287|FG003|Overall Study|Sponsor decision|0|||
162911450|NCT00545740|588376284|FG000|Overall Study|Lack of time|0|||
162911451|NCT00545740|588376285|FG001|Overall Study|Lack of time|1|||
162911452|NCT00545740|588376286|FG002|Overall Study|Lack of time|0|||
162911453|NCT00545740|588376287|FG003|Overall Study|Lack of time|0|||
162911454|NCT00545740|588376284|FG000|Overall Study|Non-adherence to visits|0|||
162911455|NCT00545740|588376285|FG001|Overall Study|Non-adherence to visits|1|||
162911456|NCT00545740|588376286|FG002|Overall Study|Non-adherence to visits|0|||
162911457|NCT00545740|588376287|FG003|Overall Study|Non-adherence to visits|0|||
162911458|NCT00545740|588376284|FG000|Overall Study|Patient difficulties|0|||
162911459|NCT00545740|588376285|FG001|Overall Study|Patient difficulties|1|||
162911460|NCT00545740|588376286|FG002|Overall Study|Patient difficulties|0|||
162911461|NCT00545740|588376287|FG003|Overall Study|Patient difficulties|0|||
162911462|NCT00545740|588376284|FG000|Overall Study|Husband against study|0|||
162911463|NCT00545740|588376285|FG001|Overall Study|Husband against study|0|||
162911464|NCT00545740|588376286|FG002|Overall Study|Husband against study|1|||
162911465|NCT00545740|588376287|FG003|Overall Study|Husband against study|0|||
162911466|NCT02117024|588376288|FG000|Overall Study|Progressive Disease|26|||
162911467|NCT02117024|588376289|FG001|Overall Study|Progressive Disease|9|||
162911468|NCT02117024|588376288|FG000|Overall Study|Significant Clinical Progression|7|||
162911469|NCT02117024|588376289|FG001|Overall Study|Significant Clinical Progression|4|||
162911470|NCT02117024|588376288|FG000|Overall Study|Death|5|||
162911471|NCT02117024|588376289|FG001|Overall Study|Death|0|||
162911472|NCT02117024|588376288|FG000|Overall Study|Withdrawal by Subject|3|||
162911473|NCT02117024|588376289|FG001|Overall Study|Withdrawal by Subject|1|||
162911474|NCT02117024|588376288|FG000|Overall Study|Protocol Violation|1|||
162911475|NCT02117024|588376289|FG001|Overall Study|Protocol Violation|0|||
162911476|NCT02117024|588376288|FG000|Overall Study|Adverse Event|1|||
162911477|NCT02117024|588376289|FG001|Overall Study|Adverse Event|2|||
162911478|NCT02117024|588376288|FG000|Overall Study|Randomized in Error|1|||
162911479|NCT02117024|588376289|FG001|Overall Study|Randomized in Error|0|||
162911480|NCT02117024|588376288|FG000|Overall Study|Patient returned to primary oncologist|0|||
162911481|NCT02117024|588376289|FG001|Overall Study|Patient returned to primary oncologist|1|||
162911482|NCT02117024|588376288|FG000|Overall Study|Patient took treatment break|0|||
162911483|NCT02117024|588376289|FG001|Overall Study|Patient took treatment break|1|||
162911484|NCT02117024|588376288|FG000|Overall Study|Physician Decision|0|||
162911485|NCT02117024|588376289|FG001|Overall Study|Physician Decision|2|||
162911486|NCT01957111|588376290|FG000|Overall Study|Withdrawal by Subject|1|||
162911487|NCT01957111|588376291|FG001|Overall Study|Withdrawal by Subject|1|||
162911488|NCT01646255|588376292|FG000|Overall Study|Adverse Event|7|||
162911489|NCT01646255|588376293|FG001|Overall Study|Adverse Event|8|||
162911490|NCT01646255|588376292|FG000|Overall Study|Lack of Efficacy|2|||
162911491|NCT01646255|588376293|FG001|Overall Study|Lack of Efficacy|0|||
162911492|NCT01646255|588376292|FG000|Overall Study|Withdrawal by Subject|10|||
162911493|NCT01646255|588376293|FG001|Overall Study|Withdrawal by Subject|6|||
162628798|NCT00540514|587358459|FG000|Overall Study|Still on treatment|3|||
162628799|NCT00540514|587358460|FG001|Overall Study|Still on treatment|0|||
162628800|NCT00540514|587358459|FG000|Overall Study|Unacceptable Toxicity|61|||
162628801|NCT00540514|587358460|FG001|Overall Study|Unacceptable Toxicity|62|||
162628802|NCT00540514|587358459|FG000|Overall Study|Adverse Event|20|||
162911494|NCT01646255|588376292|FG000|Overall Study|Compliance is not well|1|||
162911495|NCT01646255|588376293|FG001|Overall Study|Compliance is not well|0|||
162911496|NCT01646255|588376292|FG000|Overall Study|Inclusion Criteria Deviation|1|||
162911497|NCT01646255|588376293|FG001|Overall Study|Inclusion Criteria Deviation|0|||
162911498|NCT01468844|588376294|FG000|Overall Study|Adverse Event|1|||
162911499|NCT01468844|588376295|FG001|Overall Study|Adverse Event|0|||
162911500|NCT01468844|588376294|FG000|Overall Study|Withdrawal by Subject|1|||
162911501|NCT01468844|588376295|FG001|Overall Study|Withdrawal by Subject|0|||
162628803|NCT00540514|587358460|FG001|Overall Study|Adverse Event|24|||
162911502|NCT01241318|588376302|FG000|Overall Study|Woman: false pregnancies|27|||
162911503|NCT01241318|588376303|FG001|Overall Study|Woman: false pregnancies|15|||
162628804|NCT00540514|587358459|FG000|Overall Study|Physician Decision|86|||
162628805|NCT00540514|587358460|FG001|Overall Study|Physician Decision|99|||
162628806|NCT00540514|587358459|FG000|Overall Study|Protocol Deviation|3|||
162911504|NCT01241318|588376302|FG000|Overall Study|Woman: miscarriage/abortion|46|||
162911505|NCT01241318|588376303|FG001|Overall Study|Woman: miscarriage/abortion|38|||
162628807|NCT00540514|587358460|FG001|Overall Study|Protocol Deviation|4|||
162628808|NCT00540514|587358459|FG000|Overall Study|Lost to Follow-up|1|||
162628809|NCT00540514|587358460|FG001|Overall Study|Lost to Follow-up|1|||
162628810|NCT00540514|587358459|FG000|Overall Study|Withdrawal by Subject|65|||
162628811|NCT00540514|587358460|FG001|Overall Study|Withdrawal by Subject|67|||
162628812|NCT00540514|587358459|FG000|Overall Study|Excluded prior to treatment|7|||
162628813|NCT00540514|587358460|FG001|Overall Study|Excluded prior to treatment|7|||
162628814|NCT00540514|587358459|FG000|Overall Study|Paclitaxel not available|0|||
162628815|NCT00540514|587358460|FG001|Overall Study|Paclitaxel not available|2|||
162628816|NCT01892293|587358471|FG000|Overall Study|Apheresed but not treated|4|||
162628817|NCT03602482|587358472|FG000|Overall Study|Withdrawal by Subject|6|||
162628818|NCT03602482|587358473|FG001|Overall Study|Withdrawal by Subject|7|||
162628819|NCT03602482|587358474|FG002|Overall Study|Withdrawal by Subject|0|||
162628820|NCT03602482|587358475|FG003|Overall Study|Withdrawal by Subject|0|||
162628821|NCT00618072|587358495|FG000|Overall Study|Lost to Follow-up|2|||
162628822|NCT00618072|587358496|FG001|Overall Study|Lost to Follow-up|0|||
162628823|NCT00618072|587358497|FG002|Overall Study|Lost to Follow-up|3|||
162628824|NCT00618072|587358495|FG000|Overall Study|Physician Decision|0|||
162628825|NCT00618072|587358496|FG001|Overall Study|Physician Decision|1|||
162911506|NCT01241318|588376302|FG000|Overall Study|Withdrawal by Subject|175|||
162911507|NCT01241318|588376303|FG001|Overall Study|Withdrawal by Subject|46|||
162911508|NCT01241318|588376302|FG000|Overall Study|Lost to Follow-up|740|||
162628826|NCT00618072|587358497|FG002|Overall Study|Physician Decision|1|||
162628827|NCT00684307|587358498|FG000|Overall Study|Adverse Event|11|||
162628828|NCT00684307|587358499|FG001|Overall Study|Adverse Event|6|||
162911509|NCT01241318|588376303|FG001|Overall Study|Lost to Follow-up|455|||
162628829|NCT00684307|587358500|FG002|Overall Study|Adverse Event|15|||
162911510|NCT01241318|588376302|FG000|Overall Study|Death|2|||
162911511|NCT01241318|588376303|FG001|Overall Study|Death|4|||
162911512|NCT01241318|588376302|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
162911513|NCT01241318|588376303|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
162911514|NCT01241318|588376302|FG000|Overall Study|Woman: Stillborn infant|129|||
162911515|NCT01241318|588376303|FG001|Overall Study|Woman: Stillborn infant|146|||
162911516|NCT02355665|588376304|FG000|Overall Study|Adverse Event|16|||
162911517|NCT02355665|588376305|FG001|Overall Study|Adverse Event|24|||
162911518|NCT02355665|588376304|FG000|Overall Study|Protocol Violation|2|||
162911519|NCT02355665|588376305|FG001|Overall Study|Protocol Violation|0|||
162911520|NCT02355665|588376304|FG000|Overall Study|Withdrawal by Subject|90|||
162911521|NCT02355665|588376305|FG001|Overall Study|Withdrawal by Subject|100|||
162911522|NCT02355665|588376304|FG000|Overall Study|Lost to Follow-up|131|||
162911523|NCT02355665|588376305|FG001|Overall Study|Lost to Follow-up|103|||
162911524|NCT02355665|588376304|FG000|Overall Study|Death|4|||
162911525|NCT02355665|588376305|FG001|Overall Study|Death|2|||
162911526|NCT02355665|588376304|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
162911527|NCT02355665|588376305|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
162911528|NCT02380703|588376308|FG000|Overall Study|Withdrawal by Subject|12|||
162911529|NCT02380703|588376309|FG001|Overall Study|Withdrawal by Subject|9|||
162911530|NCT02380703|588376308|FG000|Overall Study|Lost to Follow-up|12|||
162911531|NCT02380703|588376309|FG001|Overall Study|Lost to Follow-up|12|||
162911532|NCT02380703|588376308|FG000|Overall Study|Caregiver death|1|||
162911533|NCT02380703|588376309|FG001|Overall Study|Caregiver death|0|||
162911534|NCT02380703|588376308|FG000|Overall Study|Person with dementia (PWD) death|7|||
162911535|NCT02380703|588376309|FG001|Overall Study|Person with dementia (PWD) death|8|||
162968051|NCT03547635|588584759|FG000|Overall Study|Errant Randomization before Treatment|0|||
162968052|NCT03547635|588584760|FG001|Overall Study|Errant Randomization before Treatment|1|||
162628830|NCT00684307|587358501|FG003|Overall Study|Adverse Event|16|||
162628831|NCT00684307|587358502|FG004|Overall Study|Adverse Event|8|||
162628832|NCT00684307|587358498|FG000|Overall Study|Development of increasing Liver Function|0|||
162628833|NCT00684307|587358499|FG001|Overall Study|Development of increasing Liver Function|2|||
162628834|NCT00684307|587358500|FG002|Overall Study|Development of increasing Liver Function|0|||
162911536|NCT02380703|588376308|FG000|Overall Study|Entered Long-term Care|4|||
162911537|NCT02380703|588376309|FG001|Overall Study|Entered Long-term Care|7|||
162911538|NCT03607994|588376310|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
162911539|NCT03607994|588376311|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
162911540|NCT02853318|588376318|FG000|Overall Study|Withdrawal by Subject|1|||
162968053|NCT03547635|588584761|FG002|Overall Study|Errant Randomization before Treatment|0|||
162628835|NCT00684307|587358501|FG003|Overall Study|Development of increasing Liver Function|1|||
162628836|NCT00684307|587358502|FG004|Overall Study|Development of increasing Liver Function|0|||
162628837|NCT00684307|587358498|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
162968054|NCT03547635|588584759|FG000|Overall Study|Withdrawal by Subject|1|||
162710761|NCT00299702|587651055|FG001|Overall Study|Pregnancy|1|||
162911541|NCT04490499|588376326|FG000|Overall Study|Withdrawal by Subject|2|||
162911542|NCT01882439|588376327|FG000|Overall Study|Adverse event related to study drug|3|||
162911543|NCT01882439|588376328|FG001|Overall Study|Adverse event related to study drug|8|||
162911544|NCT01882439|588376329|FG002|Overall Study|Adverse event related to study drug|1|||
162911545|NCT01882439|588376330|FG003|Overall Study|Adverse event related to study drug|2|||
162911546|NCT01882439|588376327|FG000|Overall Study|Pregnancy|0|||
162911547|NCT01882439|588376328|FG001|Overall Study|Pregnancy|1|||
162911548|NCT01882439|588376329|FG002|Overall Study|Pregnancy|0|||
162911549|NCT01882439|588376330|FG003|Overall Study|Pregnancy|0|||
162911550|NCT01882439|588376327|FG000|Overall Study|Protocol Violation|2|||
162911551|NCT01882439|588376328|FG001|Overall Study|Protocol Violation|2|||
162911552|NCT01882439|588376329|FG002|Overall Study|Protocol Violation|0|||
162911553|NCT01882439|588376330|FG003|Overall Study|Protocol Violation|1|||
162911554|NCT01882439|588376327|FG000|Overall Study|No longer willing to participate|1|||
162911555|NCT01882439|588376328|FG001|Overall Study|No longer willing to participate|4|||
162911556|NCT01882439|588376329|FG002|Overall Study|No longer willing to participate|2|||
162911557|NCT01882439|588376330|FG003|Overall Study|No longer willing to participate|3|||
162911558|NCT01882439|588376327|FG000|Overall Study|Medication error with no associated AE|0|||
162911559|NCT01882439|588376328|FG001|Overall Study|Medication error with no associated AE|0|||
162911560|NCT01882439|588376329|FG002|Overall Study|Medication error with no associated AE|2|||
162911561|NCT01882439|588376330|FG003|Overall Study|Medication error with no associated AE|0|||
162911562|NCT01882439|588376327|FG000|Overall Study|Insufficient clinical response|1|||
162911563|NCT01882439|588376328|FG001|Overall Study|Insufficient clinical response|4|||
162911564|NCT01882439|588376329|FG002|Overall Study|Insufficient clinical response|4|||
162911565|NCT01882439|588376330|FG003|Overall Study|Insufficient clinical response|2|||
162911566|NCT01882439|588376327|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162911567|NCT01882439|588376328|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162911568|NCT01882439|588376329|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162911569|NCT01882439|588376330|FG003|Overall Study|Adverse event unrelated to study drug|1|||
162911570|NCT03125902|588376335|FG000|Overall Study|Adverse Event|0|||
162911571|NCT03125902|588376336|FG001|Overall Study|Adverse Event|1|||
162911572|NCT03125902|588376335|FG000|Overall Study|Death|119|||
162911573|NCT03125902|588376336|FG001|Overall Study|Death|229|||
162911574|NCT03125902|588376335|FG000|Overall Study|Lost to Follow-up|4|||
162911575|NCT03125902|588376336|FG001|Overall Study|Lost to Follow-up|13|||
162911576|NCT03125902|588376335|FG000|Overall Study|Other|0|||
162911577|NCT03125902|588376336|FG001|Overall Study|Other|4|||
162911578|NCT03125902|588376335|FG000|Overall Study|Physician Decision|2|||
162911579|NCT03125902|588376336|FG001|Overall Study|Physician Decision|1|||
162911580|NCT03125902|588376335|FG000|Overall Study|Progressive Disease|0|||
162911581|NCT03125902|588376336|FG001|Overall Study|Progressive Disease|3|||
162911582|NCT03125902|588376335|FG000|Overall Study|Study Terminated By Sponsor|74|||
162911583|NCT03125902|588376336|FG001|Overall Study|Study Terminated By Sponsor|143|||
162911584|NCT03125902|588376335|FG000|Overall Study|Withdrawal by Subject|21|||
162911585|NCT03125902|588376336|FG001|Overall Study|Withdrawal by Subject|37|||
162911586|NCT01997333|588376337|FG000|Randomization and Treatment|Disease Progression|70|||
162911587|NCT01997333|588376338|FG001|Randomization and Treatment|Disease Progression|159|||
162911588|NCT01997333|588376337|FG000|Randomization and Treatment|Adverse Event|10|||
162911589|NCT01997333|588376338|FG001|Randomization and Treatment|Adverse Event|32|||
162911590|NCT01997333|588376337|FG000|Randomization and Treatment|Physician Decision|0|||
162911591|NCT01997333|588376338|FG001|Randomization and Treatment|Physician Decision|4|||
162911592|NCT01997333|588376337|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
162911593|NCT01997333|588376338|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
162911594|NCT01997333|588376337|FG000|Randomization and Treatment|Did not receive treatment|17|||
162911595|NCT01997333|588376338|FG001|Randomization and Treatment|Did not receive treatment|5|||
162911596|NCT01997333|588376337|FG000|Survival Follow up|Withdrawal by Subject|15|||
162911597|NCT01997333|588376338|FG001|Survival Follow up|Withdrawal by Subject|6|||
162911598|NCT01997333|588376337|FG000|Survival Follow up|Lost to Follow-up|0|||
162628838|NCT00684307|587358499|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
162628839|NCT00684307|587358500|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
162628840|NCT00684307|587358501|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
162628841|NCT00684307|587358502|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
162628842|NCT00684307|587358498|FG000|Overall Study|Incorrect enrolment or randomization|4|||
162628843|NCT00684307|587358499|FG001|Overall Study|Incorrect enrolment or randomization|0|||
162628844|NCT00684307|587358500|FG002|Overall Study|Incorrect enrolment or randomization|0|||
162628845|NCT00684307|587358501|FG003|Overall Study|Incorrect enrolment or randomization|0|||
162628846|NCT00684307|587358502|FG004|Overall Study|Incorrect enrolment or randomization|0|||
162628847|NCT00684307|587358498|FG000|Overall Study|Interupted IP for more than 7 days|0|||
162628848|NCT00684307|587358499|FG001|Overall Study|Interupted IP for more than 7 days|4|||
162628849|NCT00684307|587358500|FG002|Overall Study|Interupted IP for more than 7 days|1|||
162628850|NCT00684307|587358501|FG003|Overall Study|Interupted IP for more than 7 days|3|||
162628851|NCT00684307|587358502|FG004|Overall Study|Interupted IP for more than 7 days|3|||
162628852|NCT00684307|587358498|FG000|Overall Study|Severe non compliance to protocol|1|||
162628853|NCT00684307|587358499|FG001|Overall Study|Severe non compliance to protocol|0|||
162911599|NCT01997333|588376338|FG001|Survival Follow up|Lost to Follow-up|6|||
162911600|NCT01997333|588376337|FG000|Survival Follow up|Various|1|||
162911601|NCT01997333|588376338|FG001|Survival Follow up|Various|2|||
162911602|NCT02269709|588376339|FG000|Time of Enrollment|Withdrawal by Subject|3|||
162911603|NCT02269709|588376339|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
162911604|NCT02269709|588376339|FG000|Six Month Follow-up|Lost to Follow-up|12|||
162911605|NCT04411472|588376342|FG000|Overall Study|Adverse Event|5|||
162911606|NCT04411472|588376343|FG001|Overall Study|Adverse Event|10|||
162911607|NCT04411472|588376344|FG002|Overall Study|Adverse Event|1|||
162911608|NCT04411472|588376345|FG003|Overall Study|Adverse Event|0|||
162911609|NCT04411472|588376346|FG004|Overall Study|Adverse Event|0|||
162911610|NCT04411472|588376347|FG005|Overall Study|Adverse Event|0|||
162911611|NCT04411472|588376342|FG000|Overall Study|Protocol Violation|1|||
162911612|NCT04411472|588376343|FG001|Overall Study|Protocol Violation|0|||
162911613|NCT04411472|588376344|FG002|Overall Study|Protocol Violation|0|||
162911614|NCT04411472|588376345|FG003|Overall Study|Protocol Violation|0|||
162911615|NCT04411472|588376346|FG004|Overall Study|Protocol Violation|0|||
162911616|NCT04411472|588376347|FG005|Overall Study|Protocol Violation|0|||
162911617|NCT04411472|588376342|FG000|Overall Study|Withdrawal by Subject|0|||
162911618|NCT04411472|588376343|FG001|Overall Study|Withdrawal by Subject|1|||
162911619|NCT04411472|588376344|FG002|Overall Study|Withdrawal by Subject|0|||
162911620|NCT04411472|588376345|FG003|Overall Study|Withdrawal by Subject|1|||
162911621|NCT04411472|588376346|FG004|Overall Study|Withdrawal by Subject|0|||
162911622|NCT04411472|588376347|FG005|Overall Study|Withdrawal by Subject|0|||
162911623|NCT04411472|588376342|FG000|Overall Study|Physician Decision|1|||
162911624|NCT04411472|588376343|FG001|Overall Study|Physician Decision|0|||
162911625|NCT04411472|588376344|FG002|Overall Study|Physician Decision|0|||
162911626|NCT04411472|588376345|FG003|Overall Study|Physician Decision|0|||
162911627|NCT04411472|588376346|FG004|Overall Study|Physician Decision|0|||
162911628|NCT04411472|588376347|FG005|Overall Study|Physician Decision|0|||
162911629|NCT04411472|588376342|FG000|Overall Study|Study terminated by sponsor|17|||
162911630|NCT04411472|588376343|FG001|Overall Study|Study terminated by sponsor|20|||
162911631|NCT04411472|588376344|FG002|Overall Study|Study terminated by sponsor|3|||
162911632|NCT04411472|588376345|FG003|Overall Study|Study terminated by sponsor|0|||
162911633|NCT04411472|588376346|FG004|Overall Study|Study terminated by sponsor|0|||
162911634|NCT04411472|588376347|FG005|Overall Study|Study terminated by sponsor|0|||
162628854|NCT00684307|587358500|FG002|Overall Study|Severe non compliance to protocol|0|||
162628855|NCT00684307|587358501|FG003|Overall Study|Severe non compliance to protocol|1|||
162628856|NCT00684307|587358502|FG004|Overall Study|Severe non compliance to protocol|2|||
162628857|NCT00684307|587358498|FG000|Overall Study|Participant not willing to continue|7|||
162628858|NCT00684307|587358499|FG001|Overall Study|Participant not willing to continue|10|||
162628859|NCT00684307|587358500|FG002|Overall Study|Participant not willing to continue|11|||
162628860|NCT00684307|587358501|FG003|Overall Study|Participant not willing to continue|5|||
162628861|NCT00684307|587358502|FG004|Overall Study|Participant not willing to continue|8|||
162628862|NCT00684307|587358498|FG000|Overall Study|Criteria from the CSR|0|||
162628863|NCT00684307|587358499|FG001|Overall Study|Criteria from the CSR|0|||
162628864|NCT00684307|587358500|FG002|Overall Study|Criteria from the CSR|1|||
162628865|NCT00684307|587358501|FG003|Overall Study|Criteria from the CSR|3|||
162628866|NCT00684307|587358502|FG004|Overall Study|Criteria from the CSR|3|||
162628867|NCT02170298|587358505|FG000|Overall Study|Withdrawal by Subject|0|||
162628868|NCT02170298|587358506|FG001|Overall Study|Withdrawal by Subject|1|||
162628869|NCT02170298|587358505|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
162628870|NCT02170298|587358506|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
162628871|NCT05048784|587358509|FG000|Period 1|Adverse Event|3|||
162628872|NCT05048784|587358510|FG001|Period 1|Adverse Event|1|||
162628873|NCT05048784|587358511|FG002|Period 1|Adverse Event|0|||
162628874|NCT05048784|587358512|FG003|Period 1|Adverse Event|0|||
162628875|NCT05048784|587358509|FG000|Period 2|Lost to Follow-up|0|||
162628876|NCT05048784|587358510|FG001|Period 2|Lost to Follow-up|1|||
162628877|NCT05048784|587358511|FG002|Period 2|Lost to Follow-up|0|||
162628878|NCT05048784|587358512|FG003|Period 2|Lost to Follow-up|0|||
162628879|NCT02853604|587358517|FG000|Overall Study|Withdrawal by Subject|12|||
162628880|NCT02853604|587358518|FG001|Overall Study|Withdrawal by Subject|35|||
162628881|NCT02853604|587358517|FG000|Overall Study|Lost to Follow-up|4|||
162628882|NCT02853604|587358518|FG001|Overall Study|Lost to Follow-up|8|||
162628883|NCT02853604|587358517|FG000|Overall Study|Death|1|||
162628884|NCT02853604|587358518|FG001|Overall Study|Death|5|||
162628885|NCT02853604|587358517|FG000|Overall Study|Miscellaneous|11|||
162628886|NCT02853604|587358518|FG001|Overall Study|Miscellaneous|2|||
162628887|NCT02853604|587358517|FG000|Overall Study|Progressive Disease|0|||
162628888|NCT02853604|587358518|FG001|Overall Study|Progressive Disease|2|||
162628889|NCT00727025|587358519|FG000|Overall Study|Physician Decision|23|||
162628890|NCT02269241|587358520|FG000|Overall Study|Lost to Follow-up|269|||
162628891|NCT02269241|587358520|FG000|Overall Study|Withdrawal by Subject|155|||
162628892|NCT02269241|587358520|FG000|Overall Study|Protocol Violation|1|||
162628893|NCT02269241|587358520|FG000|Overall Study|Physician Decision|7|||
162628894|NCT02269241|587358520|FG000|Overall Study|Pregnancy|15|||
162628895|NCT02269241|587358520|FG000|Overall Study|Wish for pregnancy|5|||
162628896|NCT02269241|587358520|FG000|Overall Study|Development of an exclusion criteria|16|||
162628897|NCT02269241|587358520|FG000|Overall Study|Adverse Event|113|||
162628898|NCT02269241|587358520|FG000|Overall Study|At the specific request of the sponsor|20|||
162628899|NCT02269241|587358520|FG000|Overall Study|Several reasons not classified|53|||
162628900|NCT02269241|587358520|FG000|Overall Study|Screening failures|546|||
162628901|NCT03020160|587358521|FG000|Overall Study|Withdrawal by Subject|1|||
162628902|NCT03020160|587358522|FG001|Overall Study|Withdrawal by Subject|0|||
162628903|NCT02270957|587358523|FG000|Overall Study|Lack of Efficacy|2|||
162628904|NCT02270957|587358524|FG001|Overall Study|Lack of Efficacy|4|||
162911635|NCT00440232|588376348|FG000|Overall Study|Lost to Follow-up|1|||
162628905|NCT02270957|587358523|FG000|Overall Study|Adverse Event|2|||
162628906|NCT02270957|587358524|FG001|Overall Study|Adverse Event|0|||
162628907|NCT01539538|587358532|FG000|Overall Study|Adverse Event|13|||
162628908|NCT01539538|587358533|FG001|Overall Study|Adverse Event|18|||
162628909|NCT01539538|587358532|FG000|Overall Study|Lack of Efficacy|13|||
162628910|NCT01539538|587358533|FG001|Overall Study|Lack of Efficacy|16|||
162628911|NCT01539538|587358532|FG000|Overall Study|Withdrawal by Subject|2|||
162628912|NCT01539538|587358533|FG001|Overall Study|Withdrawal by Subject|3|||
162628913|NCT01539538|587358532|FG000|Overall Study|PCA no longer required or PCA problem|3|||
162628914|NCT01539538|587358533|FG001|Overall Study|PCA no longer required or PCA problem|7|||
162911636|NCT00440232|588376349|FG001|Overall Study|Lost to Follow-up|1|||
162911637|NCT00440232|588376348|FG000|Overall Study|Unable to treat within allowed time|0|||
162968055|NCT03547635|588584760|FG001|Overall Study|Withdrawal by Subject|0|||
162628915|NCT03897465|587358534|FG000|Overall Study|Lost to Follow-up|2|||
162911638|NCT00440232|588376349|FG001|Overall Study|Unable to treat within allowed time|1|||
162911639|NCT00440232|588376348|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
162911640|NCT00440232|588376349|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
162911641|NCT00819052|588376350|FG000|Overall Study|Adverse Event|0|||
162911642|NCT00819052|588376351|FG001|Overall Study|Adverse Event|5|||
162911643|NCT00819052|588376350|FG000|Overall Study|Protocol Violation|1|||
162911644|NCT00819052|588376351|FG001|Overall Study|Protocol Violation|2|||
162911645|NCT00819052|588376350|FG000|Overall Study|Lost to Follow-up|1|||
162911646|NCT00819052|588376351|FG001|Overall Study|Lost to Follow-up|2|||
162911647|NCT00819052|588376350|FG000|Overall Study|Withdrawal by Subject|1|||
162911648|NCT00819052|588376351|FG001|Overall Study|Withdrawal by Subject|2|||
162911649|NCT00819052|588376350|FG000|Overall Study|Lack of Efficacy|1|||
162911650|NCT00819052|588376351|FG001|Overall Study|Lack of Efficacy|1|||
162911651|NCT00819052|588376350|FG000|Overall Study|Pregnancy|1|||
162911652|NCT00819052|588376351|FG001|Overall Study|Pregnancy|2|||
162911653|NCT00819052|588376350|FG000|Overall Study|Death or events leading to death|1|||
162911654|NCT00819052|588376351|FG001|Overall Study|Death or events leading to death|0|||
162911655|NCT00362297|588376352|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
162911656|NCT00362297|588376353|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
162911657|NCT01747655|588376356|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
162911658|NCT01747655|588376357|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
162911659|NCT01747655|588376356|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
162911660|NCT01747655|588376357|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
162911661|NCT01747655|588376356|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
162911662|NCT01747655|588376357|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
162911663|NCT00982111|588376360|FG000|Overall Study|Adverse Event|1|||
162911664|NCT00982111|588376361|FG001|Overall Study|Adverse Event|1|||
162911665|NCT00982111|588376360|FG000|Overall Study|Progressive Disease|46|||
162911666|NCT00982111|588376361|FG001|Overall Study|Progressive Disease|39|||
162911667|NCT00982111|588376360|FG000|Overall Study|Lost to Follow-up|9|||
162911668|NCT00982111|588376361|FG001|Overall Study|Lost to Follow-up|6|||
162911669|NCT00982111|588376360|FG000|Overall Study|New Anti-Cancer Therapy|5|||
162911670|NCT00982111|588376361|FG001|Overall Study|New Anti-Cancer Therapy|5|||
162911671|NCT00982111|588376360|FG000|Overall Study|Medical Decision|1|||
162911672|NCT00982111|588376361|FG001|Overall Study|Medical Decision|0|||
162911673|NCT00982111|588376360|FG000|Overall Study|Withdrawal by Subject|17|||
162911674|NCT00982111|588376361|FG001|Overall Study|Withdrawal by Subject|19|||
162911675|NCT00982111|588376360|FG000|Overall Study|Global Study End|0|||
162911676|NCT00982111|588376361|FG001|Overall Study|Global Study End|1|||
162911677|NCT00982111|588376360|FG000|Overall Study|Sponsor's Decision|0|||
162911678|NCT00982111|588376361|FG001|Overall Study|Sponsor's Decision|1|||
162911679|NCT03769753|588376362|FG000|Overall Study|Not Treated|6|||
162911680|NCT03769753|588376362|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
162911681|NCT01070381|588376363|FG000|Period 2, 1 Week of Wear|Handling|0|||
162911682|NCT01070381|588376364|FG001|Period 2, 1 Week of Wear|Handling|1|||
162911683|NCT01070381|588376363|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
162911684|NCT01070381|588376364|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
162911685|NCT00684073|588376365|FG000|Selection|Selection/non-selection criteria|3|||
162911686|NCT00684073|588376365|FG000|Selection|Death|1|||
162911687|NCT00684073|588376365|FG000|Selection|noncompliance|1|||
162911688|NCT00684073|588376365|FG000|Selection|Lost to Follow-up|1|||
162911689|NCT00684073|588376365|FG000|Selection|request of the sponsor|1|||
162911690|NCT00684073|588376365|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
162911691|NCT01259388|588376367|FG000|Overall Study|Adverse Event|3|||
162911692|NCT01259388|588376368|FG001|Overall Study|Adverse Event|0|||
162911693|NCT01259388|588376367|FG000|Overall Study|Withdrawal by Subject|1|||
162911694|NCT01259388|588376368|FG001|Overall Study|Withdrawal by Subject|1|||
162911695|NCT01259388|588376367|FG000|Overall Study|Physician Decision|1|||
162911696|NCT01259388|588376368|FG001|Overall Study|Physician Decision|0|||
162911697|NCT00620815|588376369|FG000|Overall Study|Adverse Event|1|||
162911698|NCT00620815|588376370|FG001|Overall Study|Adverse Event|1|||
162911699|NCT00620815|588376371|FG002|Overall Study|Adverse Event|2|||
162911700|NCT00620815|588376369|FG000|Overall Study|Withdrawal by Subject|1|||
162911701|NCT00620815|588376370|FG001|Overall Study|Withdrawal by Subject|2|||
162911702|NCT00620815|588376371|FG002|Overall Study|Withdrawal by Subject|0|||
162911703|NCT00620815|588376369|FG000|Overall Study|Lost to Follow-up|1|||
162911704|NCT00620815|588376370|FG001|Overall Study|Lost to Follow-up|6|||
162911705|NCT00620815|588376371|FG002|Overall Study|Lost to Follow-up|3|||
162911706|NCT00620815|588376369|FG000|Overall Study|Inappropriate enrolment|0|||
162911707|NCT00620815|588376370|FG001|Overall Study|Inappropriate enrolment|0|||
162911708|NCT00620815|588376371|FG002|Overall Study|Inappropriate enrolment|1|||
162911709|NCT00620815|588376369|FG000|Overall Study|Protocol Violation|1|||
162911710|NCT00620815|588376370|FG001|Overall Study|Protocol Violation|2|||
162911711|NCT00620815|588376371|FG002|Overall Study|Protocol Violation|1|||
162911712|NCT00983827|588376372|FG000|Overall Study|Withdrawal by Subject|1|||
162968056|NCT03547635|588584761|FG002|Overall Study|Withdrawal by Subject|0|||
162911713|NCT01230827|588376373|FG000|Overall Study|Lost to Follow-up|0|||
162911714|NCT01230827|588376374|FG001|Overall Study|Lost to Follow-up|0|||
162911715|NCT01230827|588376375|FG002|Overall Study|Lost to Follow-up|1|||
162911716|NCT01230827|588376376|FG003|Overall Study|Lost to Follow-up|3|||
162911717|NCT01230827|588376373|FG000|Overall Study|Withdrawal by Subject|1|||
162911718|NCT01230827|588376374|FG001|Overall Study|Withdrawal by Subject|0|||
162911719|NCT01230827|588376375|FG002|Overall Study|Withdrawal by Subject|3|||
162911720|NCT01230827|588376376|FG003|Overall Study|Withdrawal by Subject|2|||
162911721|NCT01230827|588376373|FG000|Overall Study|Lack of Efficacy|14|||
162911722|NCT01230827|588376374|FG001|Overall Study|Lack of Efficacy|1|||
162911723|NCT01230827|588376375|FG002|Overall Study|Lack of Efficacy|2|||
162911724|NCT01230827|588376376|FG003|Overall Study|Lack of Efficacy|3|||
162911725|NCT01230827|588376373|FG000|Overall Study|Adverse Event|4|||
162911726|NCT01230827|588376374|FG001|Overall Study|Adverse Event|2|||
162911727|NCT01230827|588376375|FG002|Overall Study|Adverse Event|3|||
162911728|NCT01230827|588376376|FG003|Overall Study|Adverse Event|7|||
162911729|NCT01230827|588376373|FG000|Overall Study|Recovery|0|||
162911730|NCT01230827|588376374|FG001|Overall Study|Recovery|6|||
162911731|NCT01230827|588376375|FG002|Overall Study|Recovery|0|||
162911732|NCT01230827|588376376|FG003|Overall Study|Recovery|0|||
162911733|NCT01230827|588376373|FG000|Overall Study|Study terminated by Sponsor|0|||
162911734|NCT01230827|588376374|FG001|Overall Study|Study terminated by Sponsor|2|||
162911735|NCT01230827|588376375|FG002|Overall Study|Study terminated by Sponsor|56|||
162911736|NCT01230827|588376376|FG003|Overall Study|Study terminated by Sponsor|63|||
162911737|NCT01888367|588376382|FG000|Overall Study|Physician Decision|3|||
162911738|NCT01888367|588376383|FG001|Overall Study|Physician Decision|4|||
162911739|NCT01888367|588376384|FG002|Overall Study|Physician Decision|2|||
162911740|NCT01888367|588376382|FG000|Overall Study|Death|2|||
162911741|NCT01888367|588376383|FG001|Overall Study|Death|0|||
162911742|NCT01888367|588376384|FG002|Overall Study|Death|1|||
162911743|NCT01888367|588376382|FG000|Overall Study|Withdrawal by Subject|1|||
162911744|NCT01888367|588376383|FG001|Overall Study|Withdrawal by Subject|0|||
162911745|NCT01888367|588376384|FG002|Overall Study|Withdrawal by Subject|1|||
162911746|NCT01888367|588376382|FG000|Overall Study|Lost to Follow-up|1|||
162911747|NCT01888367|588376383|FG001|Overall Study|Lost to Follow-up|1|||
162911748|NCT01888367|588376384|FG002|Overall Study|Lost to Follow-up|0|||
162911749|NCT01888367|588376382|FG000|Overall Study|Protocol Violation|0|||
162911750|NCT01888367|588376383|FG001|Overall Study|Protocol Violation|0|||
162911751|NCT01888367|588376384|FG002|Overall Study|Protocol Violation|1|||
162911752|NCT01888367|588376382|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
162911753|NCT01888367|588376383|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
162911754|NCT01888367|588376384|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
162911755|NCT02728804|588376385|FG000|Overall Study|Ineligible|3|||
162911756|NCT02728804|588376385|FG000|Overall Study|Did not complete baseline questionnaire|9|||
162911757|NCT02728804|588376385|FG000|Overall Study|Death|99|||
162911758|NCT00591786|588376386|FG000|Overall Study|Withdrawal of Informed Consent|0|||
162911759|NCT00591786|588376387|FG001|Overall Study|Withdrawal of Informed Consent|0|||
162911760|NCT00591786|588376388|FG002|Overall Study|Withdrawal of Informed Consent|1|||
162911761|NCT00591786|588376389|FG003|Overall Study|Withdrawal of Informed Consent|0|||
162628916|NCT03897465|587358535|FG001|Overall Study|Lost to Follow-up|1|||
162628917|NCT03897465|587358534|FG000|Overall Study|Adverse Event|2|||
162628918|NCT03897465|587358535|FG001|Overall Study|Adverse Event|0|||
162911762|NCT00591786|588376390|FG004|Overall Study|Withdrawal of Informed Consent|0|||
162911763|NCT00591786|588376391|FG005|Overall Study|Withdrawal of Informed Consent|0|||
162911764|NCT00591786|588376392|FG006|Overall Study|Withdrawal of Informed Consent|0|||
162911765|NCT00591786|588376393|FG007|Overall Study|Withdrawal of Informed Consent|0|||
162911766|NCT00591786|588376394|FG008|Overall Study|Withdrawal of Informed Consent|0|||
162911767|NCT00591786|588376395|FG009|Overall Study|Withdrawal of Informed Consent|0|||
162911768|NCT01920061|588376397|FG000|Overall Study|Death|1|||
162911769|NCT01920061|588376398|FG001|Overall Study|Death|1|||
162911770|NCT01920061|588376399|FG002|Overall Study|Death|0|||
162911771|NCT01920061|588376400|FG003|Overall Study|Death|1|||
162911772|NCT01920061|588376401|FG004|Overall Study|Death|1|||
162911773|NCT01920061|588376402|FG005|Overall Study|Death|0|||
162911774|NCT01920061|588376403|FG006|Overall Study|Death|0|||
162911775|NCT01920061|588376404|FG007|Overall Study|Death|1|||
162911776|NCT01920061|588376405|FG008|Overall Study|Death|0|||
162911777|NCT01920061|588376406|FG009|Overall Study|Death|1|||
162911778|NCT01920061|588376407|FG010|Overall Study|Death|0|||
162911779|NCT01920061|588376408|FG011|Overall Study|Death|1|||
162911780|NCT01920061|588376409|FG012|Overall Study|Death|0|||
162911781|NCT01920061|588376410|FG013|Overall Study|Death|2|||
162911782|NCT01920061|588376411|FG014|Overall Study|Death|0|||
162911783|NCT01920061|588376412|FG015|Overall Study|Death|0|||
162911784|NCT01920061|588376413|FG016|Overall Study|Death|0|||
162911785|NCT01920061|588376414|FG017|Overall Study|Death|0|||
162911786|NCT01920061|588376415|FG018|Overall Study|Death|1|||
162911787|NCT01920061|588376416|FG019|Overall Study|Death|0|||
162911788|NCT01920061|588376397|FG000|Overall Study|Lost to Follow-up|0|||
162911789|NCT01920061|588376398|FG001|Overall Study|Lost to Follow-up|2|||
162911790|NCT01920061|588376399|FG002|Overall Study|Lost to Follow-up|0|||
162911791|NCT01920061|588376400|FG003|Overall Study|Lost to Follow-up|0|||
162911792|NCT01920061|588376401|FG004|Overall Study|Lost to Follow-up|0|||
162911793|NCT01920061|588376402|FG005|Overall Study|Lost to Follow-up|0|||
162911794|NCT01920061|588376403|FG006|Overall Study|Lost to Follow-up|1|||
162911795|NCT01920061|588376404|FG007|Overall Study|Lost to Follow-up|0|||
162911796|NCT01920061|588376405|FG008|Overall Study|Lost to Follow-up|0|||
162911797|NCT01920061|588376406|FG009|Overall Study|Lost to Follow-up|0|||
162911798|NCT01920061|588376407|FG010|Overall Study|Lost to Follow-up|3|||
162911799|NCT01920061|588376408|FG011|Overall Study|Lost to Follow-up|0|||
162911800|NCT01920061|588376409|FG012|Overall Study|Lost to Follow-up|0|||
162911801|NCT01920061|588376410|FG013|Overall Study|Lost to Follow-up|0|||
162911802|NCT01920061|588376411|FG014|Overall Study|Lost to Follow-up|0|||
162911803|NCT01920061|588376412|FG015|Overall Study|Lost to Follow-up|0|||
162911804|NCT01920061|588376413|FG016|Overall Study|Lost to Follow-up|0|||
162911805|NCT01920061|588376414|FG017|Overall Study|Lost to Follow-up|1|||
162911806|NCT01920061|588376415|FG018|Overall Study|Lost to Follow-up|4|||
162911807|NCT01920061|588376416|FG019|Overall Study|Lost to Follow-up|3|||
162911808|NCT01920061|588376397|FG000|Overall Study|Other|1|||
162911809|NCT01920061|588376398|FG001|Overall Study|Other|1|||
162911810|NCT01920061|588376399|FG002|Overall Study|Other|2|||
162911811|NCT01920061|588376400|FG003|Overall Study|Other|1|||
162911812|NCT01920061|588376401|FG004|Overall Study|Other|0|||
162911813|NCT01920061|588376402|FG005|Overall Study|Other|1|||
162911814|NCT01920061|588376403|FG006|Overall Study|Other|0|||
162911815|NCT01920061|588376404|FG007|Overall Study|Other|0|||
162911816|NCT01920061|588376405|FG008|Overall Study|Other|0|||
162911817|NCT01920061|588376406|FG009|Overall Study|Other|1|||
162911818|NCT01920061|588376407|FG010|Overall Study|Other|1|||
162911819|NCT01920061|588376408|FG011|Overall Study|Other|2|||
162911820|NCT01920061|588376409|FG012|Overall Study|Other|1|||
162911821|NCT01920061|588376410|FG013|Overall Study|Other|4|||
162911822|NCT01920061|588376411|FG014|Overall Study|Other|0|||
162911823|NCT01920061|588376412|FG015|Overall Study|Other|1|||
162911824|NCT01920061|588376413|FG016|Overall Study|Other|1|||
162911825|NCT01920061|588376414|FG017|Overall Study|Other|0|||
162911826|NCT01920061|588376415|FG018|Overall Study|Other|1|||
162911827|NCT01920061|588376416|FG019|Overall Study|Other|1|||
162911828|NCT01920061|588376397|FG000|Overall Study|Participant refused further follow-up|0|||
162911829|NCT01920061|588376398|FG001|Overall Study|Participant refused further follow-up|0|||
162911830|NCT01920061|588376399|FG002|Overall Study|Participant refused further follow-up|0|||
162911831|NCT01920061|588376400|FG003|Overall Study|Participant refused further follow-up|0|||
162911832|NCT01920061|588376401|FG004|Overall Study|Participant refused further follow-up|1|||
162911833|NCT01920061|588376402|FG005|Overall Study|Participant refused further follow-up|1|||
162911834|NCT01920061|588376403|FG006|Overall Study|Participant refused further follow-up|0|||
162911835|NCT01920061|588376404|FG007|Overall Study|Participant refused further follow-up|0|||
162911836|NCT01920061|588376405|FG008|Overall Study|Participant refused further follow-up|1|||
162911837|NCT01920061|588376406|FG009|Overall Study|Participant refused further follow-up|0|||
162911838|NCT01920061|588376407|FG010|Overall Study|Participant refused further follow-up|1|||
162628919|NCT03897465|587358534|FG000|Overall Study|complete healing by V2|1|||
162628920|NCT03897465|587358535|FG001|Overall Study|complete healing by V2|0|||
162628921|NCT03897465|587358534|FG000|Overall Study|occurence of exclusion criterion|1|||
162911839|NCT01920061|588376408|FG011|Overall Study|Participant refused further follow-up|0|||
162911840|NCT01920061|588376409|FG012|Overall Study|Participant refused further follow-up|1|||
162911841|NCT01920061|588376410|FG013|Overall Study|Participant refused further follow-up|0|||
162911842|NCT01920061|588376411|FG014|Overall Study|Participant refused further follow-up|1|||
162911843|NCT01920061|588376412|FG015|Overall Study|Participant refused further follow-up|2|||
162911844|NCT01920061|588376413|FG016|Overall Study|Participant refused further follow-up|1|||
162911845|NCT01920061|588376414|FG017|Overall Study|Participant refused further follow-up|1|||
162911846|NCT01920061|588376415|FG018|Overall Study|Participant refused further follow-up|0|||
162911847|NCT01920061|588376416|FG019|Overall Study|Participant refused further follow-up|0|||
162911848|NCT03969589|588376420|FG000|Overall Study|Lost to Follow-up|3|||
162911849|NCT03969589|588376421|FG001|Overall Study|Lost to Follow-up|2|||
162911850|NCT03969589|588376420|FG000|Overall Study|Declined Follow-Up|0|||
162911851|NCT03969589|588376421|FG001|Overall Study|Declined Follow-Up|1|||
162911852|NCT00453349|588376422|FG000|Randomized|Adverse Event|12|||
162911853|NCT00453349|588376423|FG001|Randomized|Adverse Event|11|||
162911854|NCT00453349|588376422|FG000|Randomized|Lack of Efficacy|2|||
162911855|NCT00453349|588376423|FG001|Randomized|Lack of Efficacy|1|||
162911856|NCT00453349|588376422|FG000|Randomized|Lost to Follow-up|7|||
162911857|NCT00453349|588376423|FG001|Randomized|Lost to Follow-up|5|||
162911858|NCT00453349|588376422|FG000|Randomized|Protocol Violation|1|||
162911859|NCT00453349|588376423|FG001|Randomized|Protocol Violation|1|||
162911860|NCT00453349|588376422|FG000|Randomized|Withdrawal by Subject|3|||
162911861|NCT00453349|588376423|FG001|Randomized|Withdrawal by Subject|5|||
162911862|NCT00453349|588376422|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
162911863|NCT00453349|588376423|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
162628922|NCT03897465|587358535|FG001|Overall Study|occurence of exclusion criterion|1|||
162628923|NCT03897465|587358534|FG000|Overall Study|Other|1|||
162628924|NCT03897465|587358535|FG001|Overall Study|Other|0|||
162628925|NCT00847379|587358536|FG000|Overall Study|Study terminated by Sponsor|59|||
162628926|NCT00847379|587358537|FG001|Overall Study|Study terminated by Sponsor|57|||
162628927|NCT00847379|587358538|FG002|Overall Study|Study terminated by Sponsor|57|||
162628928|NCT00521014|587358539|FG000|Overall Study|Inevaluable, not treated|1|||
162628929|NCT04390191|587358540|FG000|Overall Study|Withdrawal by Subject|1|||
162628930|NCT04390191|587358541|FG001|Overall Study|Withdrawal by Subject|0|||
162628931|NCT03978832|587358544|FG000|Overall Study|Adverse Event|1|||
162911864|NCT00453349|588376422|FG000|Completed Study|Adverse Event|12|||
162911865|NCT00453349|588376423|FG001|Completed Study|Adverse Event|11|||
162911866|NCT00453349|588376422|FG000|Completed Study|Lack of Efficacy|2|||
162911867|NCT00453349|588376423|FG001|Completed Study|Lack of Efficacy|1|||
162911868|NCT00453349|588376422|FG000|Completed Study|Lost to Follow-up|7|||
162911869|NCT00453349|588376423|FG001|Completed Study|Lost to Follow-up|5|||
162911870|NCT00453349|588376422|FG000|Completed Study|Protocol Violation|1|||
162911871|NCT00453349|588376423|FG001|Completed Study|Protocol Violation|1|||
162911872|NCT00453349|588376422|FG000|Completed Study|Withdrawal by Subject|3|||
162911873|NCT00453349|588376423|FG001|Completed Study|Withdrawal by Subject|5|||
162911874|NCT00453349|588376422|FG000|Completed Study|Lost to follow up after study treatment|2|||
162911875|NCT00453349|588376423|FG001|Completed Study|Lost to follow up after study treatment|11|||
162911876|NCT00805142|588376424|FG000|Titration Period|Adverse Event|3|||
162911877|NCT00805142|588376425|FG001|Titration Period|Adverse Event|3|||
162911878|NCT00805142|588376424|FG000|Titration Period|Lack of Efficacy|1|||
162911879|NCT00805142|588376425|FG001|Titration Period|Lack of Efficacy|1|||
162911880|NCT00805142|588376424|FG000|Titration Period|Lost to Follow-up|0|||
162911881|NCT00805142|588376425|FG001|Titration Period|Lost to Follow-up|1|||
162911882|NCT00805142|588376424|FG000|Titration Period|Disease Progression|2|||
162911883|NCT00805142|588376425|FG001|Titration Period|Disease Progression|1|||
162911884|NCT00805142|588376424|FG000|Titration Period|Withdrawal of consent|0|||
162911885|NCT00805142|588376425|FG001|Titration Period|Withdrawal of consent|1|||
162911886|NCT00805142|588376424|FG000|Titration Period|Other|0|||
162911887|NCT00805142|588376425|FG001|Titration Period|Other|3|||
162911888|NCT00805142|588376424|FG000|Maintenance Period|Adverse Event|0|||
162911889|NCT00805142|588376425|FG001|Maintenance Period|Adverse Event|1|||
162911890|NCT00805142|588376424|FG000|Maintenance Period|Other|0|||
162911891|NCT00805142|588376425|FG001|Maintenance Period|Other|1|||
162911892|NCT01513460|588376430|FG000|Overall Study|Death|0|||
162911893|NCT01513460|588376431|FG001|Overall Study|Death|0|||
162911894|NCT01513460|588376432|FG002|Overall Study|Death|1|||
162911895|NCT01513460|588376430|FG000|Overall Study|Lost to Follow-up|0|||
162911896|NCT01513460|588376431|FG001|Overall Study|Lost to Follow-up|0|||
162911897|NCT01513460|588376432|FG002|Overall Study|Lost to Follow-up|2|||
162911898|NCT01513460|588376430|FG000|Overall Study|Abnormal laboratory value|1|||
162911899|NCT01513460|588376431|FG001|Overall Study|Abnormal laboratory value|0|||
162911900|NCT01513460|588376432|FG002|Overall Study|Abnormal laboratory value|1|||
162911901|NCT01513460|588376430|FG000|Overall Study|Lack of Efficacy|1|||
162911902|NCT01513460|588376431|FG001|Overall Study|Lack of Efficacy|2|||
162911903|NCT01513460|588376432|FG002|Overall Study|Lack of Efficacy|5|||
162911904|NCT01513460|588376430|FG000|Overall Study|Protocol deviations|3|||
162628932|NCT03978832|587358544|FG000|Overall Study|Lost to Follow-up|1|||
162628933|NCT03978832|587358544|FG000|Overall Study|Withdrawal by Subject|6|||
162628934|NCT03978832|587358544|FG000|Overall Study|Physician Decision|2|||
162628935|NCT03978832|587358544|FG000|Overall Study|did not pass screening criteria|44|||
162911905|NCT01513460|588376431|FG001|Overall Study|Protocol deviations|4|||
162911906|NCT01513460|588376432|FG002|Overall Study|Protocol deviations|3|||
162968057|NCT03243396|588584762|FG000|Overall Study|Lost to Follow-up|2|||
162968058|NCT03243396|588584763|FG001|Overall Study|Lost to Follow-up|3|||
162968059|NCT03243396|588584764|FG002|Overall Study|Lost to Follow-up|15|||
162968060|NCT03243396|588584765|FG003|Overall Study|Lost to Follow-up|8|||
162968061|NCT03243396|588584766|FG004|Overall Study|Lost to Follow-up|1|||
162968062|NCT03243396|588584767|FG005|Overall Study|Lost to Follow-up|4|||
162628936|NCT00003499|587358545|FG000|Overall Study|Not evaluable|8|||
162628937|NCT02042183|587358550|FG000|Overall Study|Physician Decision|7|||
162628938|NCT02042183|587358551|FG001|Overall Study|Physician Decision|2|||
162628939|NCT02042183|587358550|FG000|Overall Study|Lack of Efficacy|4|||
162911907|NCT01513460|588376430|FG000|Overall Study|Withdrawal by Subject|7|||
162911908|NCT01513460|588376431|FG001|Overall Study|Withdrawal by Subject|8|||
162911909|NCT01513460|588376432|FG002|Overall Study|Withdrawal by Subject|21|||
162911910|NCT01513460|588376430|FG000|Overall Study|Adverse Event|16|||
162911911|NCT01513460|588376431|FG001|Overall Study|Adverse Event|18|||
162911912|NCT01513460|588376432|FG002|Overall Study|Adverse Event|23|||
162911913|NCT01513460|588376430|FG000|Overall Study|Abnormal test procedure|1|||
162628940|NCT02042183|587358551|FG001|Overall Study|Lack of Efficacy|3|||
162911914|NCT01513460|588376431|FG001|Overall Study|Abnormal test procedure|0|||
162911915|NCT01513460|588376432|FG002|Overall Study|Abnormal test procedure|0|||
162911916|NCT00489216|588376433|FG000|Overall Study|Adverse Event|1|||
162968063|NCT03243396|588584768|FG006|Overall Study|Lost to Follow-up|9|||
162911917|NCT00422942|588376436|FG000|Overall Study|Study terminated by Sponsor|3|||
162911918|NCT01078389|588378194|FG000|Overall Study|Adverse Event|10|||
162911919|NCT01078389|588378195|FG001|Overall Study|Adverse Event|6|||
162628941|NCT02042183|587358550|FG000|Overall Study|Non-compliance with Study Drug|2|||
162628942|NCT02042183|587358551|FG001|Overall Study|Non-compliance with Study Drug|3|||
162911920|NCT01078389|588378194|FG000|Overall Study|Major Protocol Deviation|2|||
162911921|NCT01078389|588378195|FG001|Overall Study|Major Protocol Deviation|0|||
162911922|NCT01078389|588378194|FG000|Overall Study|Lost to Follow-up|23|||
162911923|NCT01078389|588378195|FG001|Overall Study|Lost to Follow-up|23|||
162911924|NCT01078389|588378194|FG000|Overall Study|Voluntary Withdrawal|20|||
162911925|NCT01078389|588378195|FG001|Overall Study|Voluntary Withdrawal|36|||
162911926|NCT01078389|588378194|FG000|Overall Study|Other|9|||
162911927|NCT01078389|588378195|FG001|Overall Study|Other|2|||
162911928|NCT04823494|588378196|FG000|Overall Study|Programming software malfunction.|1|||
162911929|NCT04823494|588378197|FG001|Overall Study|Programming software malfunction.|0|||
162911930|NCT04823494|588378196|FG000|Overall Study|Withdrawal by Subject|1|||
162911931|NCT04823494|588378197|FG001|Overall Study|Withdrawal by Subject|0|||
162911932|NCT04823494|588378196|FG000|Overall Study|Devices lost|0|||
162911933|NCT04823494|588378197|FG001|Overall Study|Devices lost|1|||
162911934|NCT03726320|588378198|FG000|Overall Study|Lost to Follow-up|2|||
162968064|NCT03687242|588584769|FG000|Overall Study|Adverse Event|1|||
162968065|NCT01151280|588584770|FG000|Overall Study|Adverse Event|1|||
162968066|NCT01151280|588584770|FG000|Overall Study|Lack of Efficacy|3|||
162911935|NCT03726320|588378199|FG001|Overall Study|Lost to Follow-up|4|||
162628943|NCT02042183|587358550|FG000|Overall Study|Adverse Event|17|||
162628944|NCT02042183|587358551|FG001|Overall Study|Adverse Event|6|||
162628945|NCT02042183|587358550|FG000|Overall Study|Other|3|||
162628946|NCT02042183|587358551|FG001|Overall Study|Other|3|||
162628947|NCT02042183|587358550|FG000|Overall Study|Withdrawal by Subject|21|||
162628948|NCT02042183|587358551|FG001|Overall Study|Withdrawal by Subject|16|||
162628949|NCT02042183|587358550|FG000|Overall Study|Site Terminated by Sponsor|2|||
162628950|NCT02042183|587358551|FG001|Overall Study|Site Terminated by Sponsor|1|||
162628951|NCT02042183|587358550|FG000|Overall Study|Lost to Follow-up|9|||
162628952|NCT02042183|587358551|FG001|Overall Study|Lost to Follow-up|2|||
162628953|NCT01256008|587358552|FG000|Overall Study|Lost to Follow-up|6|||
162628954|NCT01256008|587358553|FG001|Overall Study|Lost to Follow-up|4|||
162628955|NCT01256008|587358554|FG002|Overall Study|Lost to Follow-up|11|||
162628956|NCT01256008|587358552|FG000|Overall Study|Withdrawal by Subject|2|||
162628957|NCT01256008|587358553|FG001|Overall Study|Withdrawal by Subject|3|||
162628958|NCT01256008|587358554|FG002|Overall Study|Withdrawal by Subject|10|||
162628959|NCT00378378|587358557|FG000|Overall Study|Withdrawal by Subject|0|||
162628960|NCT00378378|587358558|FG001|Overall Study|Withdrawal by Subject|1|||
162628961|NCT00378378|587358559|FG002|Overall Study|Withdrawal by Subject|0|||
162628962|NCT00378378|587358557|FG000|Overall Study|Treatment Failure|0|||
162628963|NCT00378378|587358558|FG001|Overall Study|Treatment Failure|0|||
162968067|NCT02473393|588584771|FG000|Overall Study|Adverse Event|0|||
162968068|NCT02473393|588584772|FG001|Overall Study|Adverse Event|0|||
162968069|NCT02473393|588584773|FG002|Overall Study|Adverse Event|1|||
162968070|NCT02473393|588584774|FG003|Overall Study|Adverse Event|0|||
162968071|NCT02473393|588584771|FG000|Overall Study|Withdrawal by Subject|0|||
162968072|NCT02473393|588584772|FG001|Overall Study|Withdrawal by Subject|0|||
162968073|NCT02473393|588584773|FG002|Overall Study|Withdrawal by Subject|1|||
162968074|NCT02473393|588584774|FG003|Overall Study|Withdrawal by Subject|1|||
162968075|NCT02274558|588584777|FG000|Overall Study|Adverse Event|2|||
162968076|NCT02274558|588584778|FG001|Overall Study|Adverse Event|4|||
162968077|NCT02274558|588584779|FG002|Overall Study|Adverse Event|2|||
162968078|NCT02274558|588584777|FG000|Overall Study|Non-compliance|2|||
162968079|NCT02274558|588584778|FG001|Overall Study|Non-compliance|1|||
162968080|NCT02274558|588584779|FG002|Overall Study|Non-compliance|0|||
162968081|NCT02274558|588584777|FG000|Overall Study|Withdrawal by Subject|1|||
162968082|NCT02274558|588584778|FG001|Overall Study|Withdrawal by Subject|5|||
162968083|NCT02274558|588584779|FG002|Overall Study|Withdrawal by Subject|4|||
162628964|NCT00378378|587358559|FG002|Overall Study|Treatment Failure|1|||
162628965|NCT00378378|587358557|FG000|Overall Study|Non-compliance with protocol|0|||
162628966|NCT00378378|587358558|FG001|Overall Study|Non-compliance with protocol|0|||
162968084|NCT02274558|588584777|FG000|Overall Study|Death|0|||
162968085|NCT02274558|588584778|FG001|Overall Study|Death|0|||
162968086|NCT02274558|588584779|FG002|Overall Study|Death|1|||
162968087|NCT02274558|588584777|FG000|Overall Study|Lost to Follow-up|2|||
162968088|NCT02274558|588584778|FG001|Overall Study|Lost to Follow-up|1|||
162968089|NCT02274558|588584779|FG002|Overall Study|Lost to Follow-up|1|||
162628967|NCT00378378|587358559|FG002|Overall Study|Non-compliance with protocol|1|||
162628968|NCT01854710|587358560|FG000|Overall Study|Withdrawal by Subject|2|||
162628969|NCT01854710|587358561|FG001|Overall Study|Withdrawal by Subject|1|||
162628970|NCT01854710|587358562|FG002|Overall Study|Withdrawal by Subject|0|||
162628971|NCT01854710|587358563|FG003|Overall Study|Withdrawal by Subject|0|||
162911936|NCT03726320|588378200|FG002|Overall Study|Lost to Follow-up|0|||
162968090|NCT02274558|588584777|FG000|Overall Study|Physician Decision|0|||
162628972|NCT01854710|587358564|FG004|Overall Study|Withdrawal by Subject|0|||
162628973|NCT01854710|587358565|FG005|Overall Study|Withdrawal by Subject|0|||
162628974|NCT01854710|587358560|FG000|Overall Study|CRI procedural error|2|||
162628975|NCT01854710|587358561|FG001|Overall Study|CRI procedural error|2|||
162628976|NCT01854710|587358562|FG002|Overall Study|CRI procedural error|2|||
162628977|NCT01854710|587358563|FG003|Overall Study|CRI procedural error|2|||
162628978|NCT01854710|587358564|FG004|Overall Study|CRI procedural error|2|||
162628979|NCT01854710|587358565|FG005|Overall Study|CRI procedural error|2|||
162628980|NCT03132220|587358570|FG000|Overall Study|Lost to Follow-up|17|||
162628981|NCT03132220|587358571|FG001|Overall Study|Lost to Follow-up|8|||
162628982|NCT03132220|587358570|FG000|Overall Study|Withdrawal by Subject|1|||
162628983|NCT03132220|587358571|FG001|Overall Study|Withdrawal by Subject|4|||
162628984|NCT00601458|587358573|FG000|Overall Study|Dosing Error|1|||
162628985|NCT00601458|587358574|FG001|Overall Study|Dosing Error|0|||
162628986|NCT00601458|587358575|FG002|Overall Study|Dosing Error|0|||
162628987|NCT00601458|587358573|FG000|Overall Study|Incomplete Data|0|||
162628988|NCT00601458|587358574|FG001|Overall Study|Incomplete Data|2|||
162628989|NCT00601458|587358575|FG002|Overall Study|Incomplete Data|0|||
162628990|NCT00601458|587358573|FG000|Overall Study|Protocol Violation|3|||
162628991|NCT00601458|587358574|FG001|Overall Study|Protocol Violation|2|||
162628992|NCT00601458|587358575|FG002|Overall Study|Protocol Violation|1|||
162628993|NCT00601458|587358573|FG000|Overall Study|Early Termination|0|||
162628994|NCT00601458|587358574|FG001|Overall Study|Early Termination|1|||
162628995|NCT00601458|587358575|FG002|Overall Study|Early Termination|1|||
162628996|NCT00518986|587358576|FG000|Overall Study|Adverse Event|12|||
162628997|NCT00518986|587358577|FG001|Overall Study|Adverse Event|7|||
162628998|NCT00518986|587358576|FG000|Overall Study|Lack of Efficacy|0|||
162628999|NCT00518986|587358577|FG001|Overall Study|Lack of Efficacy|2|||
162629000|NCT00518986|587358576|FG000|Overall Study|Lost to Follow-up|3|||
162629001|NCT00518986|587358577|FG001|Overall Study|Lost to Follow-up|2|||
162629002|NCT00518986|587358576|FG000|Overall Study|Physician Decision|0|||
162629003|NCT00518986|587358577|FG001|Overall Study|Physician Decision|3|||
162629004|NCT00518986|587358576|FG000|Overall Study|Protocol Violation|5|||
162911937|NCT03726320|588378198|FG000|Overall Study|Time Constraints|4|||
162911938|NCT03726320|588378199|FG001|Overall Study|Time Constraints|1|||
162911939|NCT03726320|588378200|FG002|Overall Study|Time Constraints|0|||
162911940|NCT03726320|588378198|FG000|Overall Study|Ineligible after enrollment|3|||
162911941|NCT03726320|588378199|FG001|Overall Study|Ineligible after enrollment|3|||
162911942|NCT03726320|588378200|FG002|Overall Study|Ineligible after enrollment|0|||
162629005|NCT00518986|587358577|FG001|Overall Study|Protocol Violation|7|||
162629006|NCT00518986|587358576|FG000|Overall Study|Withdrawal by Subject|4|||
162629007|NCT00518986|587358577|FG001|Overall Study|Withdrawal by Subject|4|||
162629008|NCT00518986|587358576|FG000|Overall Study|Non-Specific|2|||
162629009|NCT00518986|587358577|FG001|Overall Study|Non-Specific|1|||
162629010|NCT04862585|587358581|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
162629011|NCT04862585|587358582|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
162629012|NCT04862585|587358581|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
162629013|NCT04862585|587358582|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
162629014|NCT04862585|587358581|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
162629015|NCT04862585|587358582|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
162629016|NCT04862585|587358581|FG000|Overall Study|one withdrew without providing a reason|0|||
162629017|NCT04862585|587358582|FG001|Overall Study|one withdrew without providing a reason|1|||
162629018|NCT05288062|587358583|FG000|Overall Study|Ineligible|0|||
162629019|NCT05288062|587358584|FG001|Overall Study|Ineligible|0|||
162629020|NCT05288062|587358585|FG002|Overall Study|Ineligible|1|||
162629021|NCT05288062|587358586|FG003|Overall Study|Ineligible|0|||
162629022|NCT05288062|587358583|FG000|Overall Study|Withdrawal by Subject|0|||
162629023|NCT05288062|587358584|FG001|Overall Study|Withdrawal by Subject|0|||
162629024|NCT05288062|587358585|FG002|Overall Study|Withdrawal by Subject|1|||
162629025|NCT05288062|587358586|FG003|Overall Study|Withdrawal by Subject|0|||
162629026|NCT02099708|587358588|FG000|Overall Study|Data Not Available|30|||
162911943|NCT03726320|588378198|FG000|Overall Study|Clinic / insurance issue|2|||
162911944|NCT03726320|588378199|FG001|Overall Study|Clinic / insurance issue|0|||
162911945|NCT03726320|588378200|FG002|Overall Study|Clinic / insurance issue|0|||
162911946|NCT03726320|588378198|FG000|Overall Study|Language barrier|1|||
162911947|NCT03726320|588378199|FG001|Overall Study|Language barrier|0|||
162629027|NCT02099708|587358588|FG000|Overall Study|Lost to Follow-up|141|||
162629028|NCT02099708|587358588|FG000|Overall Study|Other|29|||
162629029|NCT05229406|587358589|FG000|Overall Study|Withdrawal by Subject|1|||
162629030|NCT05229406|587358590|FG001|Overall Study|Withdrawal by Subject|2|||
162629031|NCT01930123|587358591|FG000|Overall Study|Adverse Event|1|||
162629032|NCT01930123|587358592|FG001|Overall Study|Adverse Event|0|||
162629033|NCT01930123|587358591|FG000|Overall Study|Physician Decision|21|||
162629034|NCT01930123|587358592|FG001|Overall Study|Physician Decision|8|||
162629035|NCT01930123|587358591|FG000|Overall Study|Withdrawal by Subject|1|||
162911948|NCT03726320|588378200|FG002|Overall Study|Language barrier|0|||
162629036|NCT01930123|587358592|FG001|Overall Study|Withdrawal by Subject|0|||
162629037|NCT00729651|587358595|FG000|Overall Study|Withdrawal by Subject|5|||
162629038|NCT00729651|587358596|FG001|Overall Study|Withdrawal by Subject|6|||
162629039|NCT00729651|587358595|FG000|Overall Study|Lost to Follow-up|5|||
162629040|NCT00729651|587358596|FG001|Overall Study|Lost to Follow-up|4|||
162629041|NCT00729651|587358595|FG000|Overall Study|Protocol Violation|0|||
162629042|NCT00729651|587358596|FG001|Overall Study|Protocol Violation|1|||
162629043|NCT00729651|587358595|FG000|Overall Study|Adverse Event|7|||
162629044|NCT00729651|587358596|FG001|Overall Study|Adverse Event|3|||
162629045|NCT00729651|587358595|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
162629046|NCT00729651|587358596|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
162629047|NCT00729651|587358595|FG000|Overall Study|Subject's private reason|2|||
162629048|NCT00729651|587358596|FG001|Overall Study|Subject's private reason|0|||
162710762|NCT00299702|587651054|FG000|Overall Study|Insufficient Response|4|||
162911949|NCT03726320|588378198|FG000|Overall Study|Provider left the clinic|0|||
162911950|NCT03726320|588378199|FG001|Overall Study|Provider left the clinic|0|||
162911951|NCT03726320|588378200|FG002|Overall Study|Provider left the clinic|1|||
162911952|NCT03691831|588378203|FG000|Overall Study|Lost to Follow-up|16|||
162911953|NCT03691831|588378204|FG001|Overall Study|Lost to Follow-up|12|||
162911954|NCT03691831|588378203|FG000|Overall Study|Withdrawal by Subject|9|||
162911955|NCT03691831|588378204|FG001|Overall Study|Withdrawal by Subject|17|||
162911956|NCT03691831|588378203|FG000|Overall Study|Investigator Decision|2|||
162911957|NCT03691831|588378204|FG001|Overall Study|Investigator Decision|2|||
162911958|NCT02198040|588378205|FG000|Overall Study|Work reasons|0|||
162911959|NCT02198040|588378206|FG001|Overall Study|Work reasons|1|||
162911960|NCT02198040|588378207|FG002|Overall Study|Work reasons|0|||
162911961|NCT02198040|588378205|FG000|Overall Study|Withdrawal by Subject|0|||
162911962|NCT02198040|588378206|FG001|Overall Study|Withdrawal by Subject|0|||
162911963|NCT02198040|588378207|FG002|Overall Study|Withdrawal by Subject|1|||
162911964|NCT00337935|588378208|FG000|Overall Study|Adverse Event|2|||
162911965|NCT00337935|588378209|FG001|Overall Study|Adverse Event|5|||
162911966|NCT00337935|588378208|FG000|Overall Study|Death|2|||
162911967|NCT00337935|588378209|FG001|Overall Study|Death|8|||
162911968|NCT00337935|588378208|FG000|Overall Study|Physician Decision|1|||
162911969|NCT00337935|588378209|FG001|Overall Study|Physician Decision|1|||
162911970|NCT00337935|588378208|FG000|Overall Study|Lost to Follow-up|0|||
162911971|NCT00337935|588378209|FG001|Overall Study|Lost to Follow-up|1|||
162911972|NCT00337935|588378208|FG000|Overall Study|Protocol Violation|4|||
162911973|NCT00337935|588378209|FG001|Overall Study|Protocol Violation|3|||
162911974|NCT00337935|588378208|FG000|Overall Study|Withdrawal by Subject|1|||
162911975|NCT00337935|588378209|FG001|Overall Study|Withdrawal by Subject|7|||
162911976|NCT00337935|588378208|FG000|Overall Study|Other|0|||
162911977|NCT00337935|588378209|FG001|Overall Study|Other|1|||
162911978|NCT00337935|588378208|FG000|Overall Study|Lack of Efficacy|0|||
162911979|NCT00337935|588378209|FG001|Overall Study|Lack of Efficacy|1|||
162911980|NCT01884675|588378210|FG000|Overall Study|Study closed/terminated|3|||
162911981|NCT01884675|588378211|FG001|Overall Study|Study closed/terminated|2|||
162911982|NCT02361307|588378212|FG000|Overall Study|Unstable medical condition.|0|||
162911983|NCT02361307|588378213|FG001|Overall Study|Unstable medical condition.|1|||
162911984|NCT01189201|588378220|FG000|Overall Study|Adverse Event|1|||
162911985|NCT01682876|588378221|FG000|Overall Study|Administrative reason|4|||
162911986|NCT01682876|588378222|FG001|Overall Study|Administrative reason|4|||
162911987|NCT01682876|588378223|FG002|Overall Study|Administrative reason|0|||
162911988|NCT01682876|588378224|FG003|Overall Study|Administrative reason|3|||
162911989|NCT01682876|588378221|FG000|Overall Study|Adverse Event|0|||
162911990|NCT01682876|588378222|FG001|Overall Study|Adverse Event|0|||
162911991|NCT01682876|588378223|FG002|Overall Study|Adverse Event|0|||
162911992|NCT01682876|588378224|FG003|Overall Study|Adverse Event|1|||
162911993|NCT01682876|588378221|FG000|Overall Study|Lost to Follow-up|11|||
162911994|NCT01682876|588378222|FG001|Overall Study|Lost to Follow-up|15|||
162911995|NCT01682876|588378223|FG002|Overall Study|Lost to Follow-up|9|||
162911996|NCT01682876|588378224|FG003|Overall Study|Lost to Follow-up|11|||
162911997|NCT01682876|588378221|FG000|Overall Study|Protocol Violation|1|||
162911998|NCT01682876|588378222|FG001|Overall Study|Protocol Violation|1|||
162911999|NCT01682876|588378223|FG002|Overall Study|Protocol Violation|1|||
162912000|NCT01682876|588378224|FG003|Overall Study|Protocol Violation|1|||
162912001|NCT01682876|588378221|FG000|Overall Study|Withdrawal by Subject|4|||
162912002|NCT01682876|588378222|FG001|Overall Study|Withdrawal by Subject|0|||
162912003|NCT01682876|588378223|FG002|Overall Study|Withdrawal by Subject|0|||
162912004|NCT01682876|588378224|FG003|Overall Study|Withdrawal by Subject|2|||
162710763|NCT00299702|587651055|FG001|Overall Study|Insufficient Response|3|||
162912005|NCT01682876|588378221|FG000|Overall Study|Other|1|||
162912006|NCT01682876|588378222|FG001|Overall Study|Other|0|||
162912007|NCT01682876|588378223|FG002|Overall Study|Other|1|||
162912008|NCT01682876|588378224|FG003|Overall Study|Other|1|||
162912009|NCT01277757|588378225|FG000|Overall Study|Disease Progression|1|||
162629049|NCT03310021|587358597|FG000|Overall Study|Withdrawal by Subject|0|||
162629050|NCT03310021|587358598|FG001|Overall Study|Withdrawal by Subject|0|||
162912010|NCT01277757|588378225|FG000|Overall Study|Withdrawal by Subject|1|||
162912011|NCT00240331|588378231|FG000|Overall Study|Withdrawal by Subject|125|||
162912012|NCT00240331|588378232|FG001|Overall Study|Withdrawal by Subject|132|||
162912013|NCT00240331|588378231|FG000|Overall Study|Option selected by investigator|1|||
162912014|NCT00240331|588378232|FG001|Overall Study|Option selected by investigator|2|||
162912015|NCT01409382|588378233|FG000|Overall Study|Lost to Follow-up|1|||
162912016|NCT01409382|588378234|FG001|Overall Study|Lost to Follow-up|1|||
162912017|NCT01409382|588378233|FG000|Overall Study|Protocol Violation|0|||
162912018|NCT01409382|588378234|FG001|Overall Study|Protocol Violation|3|||
162912019|NCT01409382|588378233|FG000|Overall Study|Multiple pregnancy|2|||
162912020|NCT01409382|588378234|FG001|Overall Study|Multiple pregnancy|4|||
162912021|NCT01409382|588378233|FG000|Overall Study|Still pregnant when study ended|13|||
162912022|NCT01409382|588378234|FG001|Overall Study|Still pregnant when study ended|2|||
162912023|NCT01409382|588378233|FG000|Overall Study|Did not manage to get pregnant|64|||
162912024|NCT01409382|588378234|FG001|Overall Study|Did not manage to get pregnant|70|||
162912025|NCT01409382|588378233|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
162912026|NCT01409382|588378234|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
162912027|NCT01233076|588378235|FG000|Period 2, One Week|Lost to Follow-up|1|||
162912028|NCT01233076|588378236|FG001|Period 2, One Week|Lost to Follow-up|0|||
162912029|NCT04563845|588378237|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912030|NCT04563845|588378238|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912031|NCT04563845|588378239|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912032|NCT04563845|588378240|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912033|NCT04563845|588378241|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912034|NCT04563845|588378242|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912035|NCT04563845|588378243|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912036|NCT04563845|588378244|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
162912037|NCT04563845|588378245|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912038|NCT04563845|588378246|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912039|NCT04563845|588378247|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912040|NCT04563845|588378248|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912041|NCT04563845|588378249|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912042|NCT04563845|588378250|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
162912043|NCT04563845|588378237|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912044|NCT04563845|588378238|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912045|NCT04563845|588378239|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912046|NCT04563845|588378240|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912047|NCT04563845|588378241|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
162912048|NCT04563845|588378242|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912049|NCT04563845|588378243|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912050|NCT04563845|588378244|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912051|NCT04563845|588378245|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912052|NCT04563845|588378246|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912053|NCT04563845|588378247|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912054|NCT04563845|588378248|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912055|NCT04563845|588378249|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912056|NCT04563845|588378250|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
162912057|NCT04120116|588378251|FG000|Overall Study|Lost to Follow-up|0|||
162912058|NCT04120116|588378252|FG001|Overall Study|Lost to Follow-up|1|||
162912059|NCT04120116|588378253|FG002|Overall Study|Lost to Follow-up|0|||
162912060|NCT04120116|588378254|FG003|Overall Study|Lost to Follow-up|2|||
162912061|NCT04120116|588378251|FG000|Overall Study|Withdrawal by Subject|1|||
162912062|NCT04120116|588378252|FG001|Overall Study|Withdrawal by Subject|0|||
162912063|NCT04120116|588378253|FG002|Overall Study|Withdrawal by Subject|1|||
162912064|NCT04120116|588378254|FG003|Overall Study|Withdrawal by Subject|1|||
162912065|NCT04120116|588378251|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
162912066|NCT04120116|588378252|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
162912067|NCT04120116|588378253|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
162912068|NCT04120116|588378254|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
162912069|NCT02210559|588378259|FG000|Overall Study|Progressive Disease|3|||
162912070|NCT02210559|588378260|FG001|Overall Study|Progressive Disease|2|||
162912071|NCT02210559|588378259|FG000|Overall Study|Adverse Event|2|||
162912072|NCT02210559|588378260|FG001|Overall Study|Adverse Event|2|||
162912073|NCT02210559|588378259|FG000|Overall Study|Physician Decision|1|||
162912074|NCT02210559|588378260|FG001|Overall Study|Physician Decision|0|||
162912075|NCT02210559|588378259|FG000|Overall Study|Withdrawal by Subject|0|||
162912076|NCT02210559|588378260|FG001|Overall Study|Withdrawal by Subject|1|||
162912077|NCT02210559|588378259|FG000|Overall Study|Other than specified|0|||
162912078|NCT02210559|588378260|FG001|Overall Study|Other than specified|1|||
162912079|NCT00792467|588378261|FG000|Overall Study|progression of disease|17|||
162912080|NCT00792467|588378261|FG000|Overall Study|Adverse Event|1|||
162912081|NCT00792467|588378261|FG000|Overall Study|patient request|1|||
162912082|NCT00792467|588378261|FG000|Overall Study|Lost to Follow-up|1|||
162912083|NCT00792467|588378261|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
162912084|NCT00792467|588378261|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
162912085|NCT01287403|588378265|FG000|1st Intervention (1 Day)|Adverse Event|1|||
162912086|NCT01098266|588378266|FG000|Overall Study|Physician Decision|1|||
162912087|NCT01098266|588378267|FG001|Overall Study|Physician Decision|0|||
162912088|NCT01098266|588378266|FG000|Overall Study|Death|3|||
162912089|NCT01098266|588378267|FG001|Overall Study|Death|2|||
162912090|NCT01098266|588378266|FG000|Overall Study|Withdrawal by Subject|3|||
162912091|NCT01098266|588378267|FG001|Overall Study|Withdrawal by Subject|5|||
162912092|NCT01733758|588378268|FG000|Overall Study|Adverse Event|5|||
162912093|NCT01733758|588378269|FG001|Overall Study|Adverse Event|7|||
162912094|NCT01733758|588378270|FG002|Overall Study|Adverse Event|8|||
162912095|NCT01733758|588378271|FG003|Overall Study|Adverse Event|1|||
162912096|NCT01733758|588378268|FG000|Overall Study|Withdrawal by Subject|1|||
162912097|NCT01733758|588378269|FG001|Overall Study|Withdrawal by Subject|1|||
162912098|NCT01733758|588378270|FG002|Overall Study|Withdrawal by Subject|5|||
162912099|NCT01733758|588378271|FG003|Overall Study|Withdrawal by Subject|3|||
162912100|NCT01733758|588378268|FG000|Overall Study|Persistent Hyperglycemia|3|||
162912101|NCT01733758|588378269|FG001|Overall Study|Persistent Hyperglycemia|2|||
162912102|NCT01733758|588378270|FG002|Overall Study|Persistent Hyperglycemia|0|||
162912103|NCT01733758|588378271|FG003|Overall Study|Persistent Hyperglycemia|0|||
162912104|NCT01733758|588378268|FG000|Overall Study|Protocol Violation|0|||
162912105|NCT01733758|588378269|FG001|Overall Study|Protocol Violation|1|||
162912106|NCT01733758|588378270|FG002|Overall Study|Protocol Violation|2|||
162912107|NCT01733758|588378271|FG003|Overall Study|Protocol Violation|2|||
162912108|NCT01733758|588378268|FG000|Overall Study|Non-compliance|1|||
162912109|NCT01733758|588378269|FG001|Overall Study|Non-compliance|0|||
162912110|NCT01733758|588378270|FG002|Overall Study|Non-compliance|0|||
162912111|NCT01733758|588378271|FG003|Overall Study|Non-compliance|0|||
162912112|NCT01733758|588378268|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
162912113|NCT01733758|588378269|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
162912114|NCT01733758|588378270|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
162912115|NCT01733758|588378271|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
162912116|NCT01733758|588378268|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
162912117|NCT01733758|588378269|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
162912118|NCT01733758|588378270|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
162912119|NCT01733758|588378271|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
162912120|NCT02545270|588378276|FG000|Overall Study|technical difficulties|0|||
162912121|NCT02545270|588378277|FG001|Overall Study|technical difficulties|1|||
162912122|NCT02545270|588378278|FG002|Overall Study|technical difficulties|0|||
162912123|NCT02545270|588378276|FG000|Overall Study|Videos being too similar to other|0|||
162912124|NCT02545270|588378277|FG001|Overall Study|Videos being too similar to other|0|||
162912125|NCT02545270|588378278|FG002|Overall Study|Videos being too similar to other|2|||
162912126|NCT00727246|588378279|FG000|Overall Study|could not complete MRI|0|||
162912127|NCT00727246|588378280|FG001|Overall Study|could not complete MRI|1|||
162912128|NCT00727246|588378281|FG002|Overall Study|could not complete MRI|0|||
162912129|NCT00727246|588378282|FG003|Overall Study|could not complete MRI|1|||
162912130|NCT00727246|588378279|FG000|Overall Study|incidental finding|0|||
162912131|NCT00727246|588378280|FG001|Overall Study|incidental finding|0|||
162912132|NCT00727246|588378281|FG002|Overall Study|incidental finding|0|||
162912133|NCT00727246|588378282|FG003|Overall Study|incidental finding|1|||
162912134|NCT00727246|588378279|FG000|Overall Study|withdrawn|0|||
162912135|NCT00727246|588378280|FG001|Overall Study|withdrawn|0|||
162912136|NCT00727246|588378281|FG002|Overall Study|withdrawn|1|||
162912137|NCT00727246|588378282|FG003|Overall Study|withdrawn|0|||
162912138|NCT00661362|588378283|FG000|Overall Study|Adverse Event|5|||
162912139|NCT00661362|588378284|FG001|Overall Study|Adverse Event|4|||
162912140|NCT00661362|588378283|FG000|Overall Study|Incorrect enrollment|2|||
162912141|NCT00661362|588378284|FG001|Overall Study|Incorrect enrollment|0|||
162912142|NCT00661362|588378283|FG000|Overall Study|Study specific discontinuation criteria|4|||
162912143|NCT00661362|588378284|FG001|Overall Study|Study specific discontinuation criteria|11|||
162912144|NCT00661362|588378283|FG000|Overall Study|Withdrawal by Subject|13|||
162912145|NCT00661362|588378284|FG001|Overall Study|Withdrawal by Subject|23|||
162912146|NCT00661362|588378283|FG000|Overall Study|Lost to Follow-up|3|||
162912147|NCT00661362|588378284|FG001|Overall Study|Lost to Follow-up|1|||
162912148|NCT00661362|588378283|FG000|Overall Study|Severe non-compliance to protocol|0|||
162912149|NCT00661362|588378284|FG001|Overall Study|Severe non-compliance to protocol|1|||
162912150|NCT00661362|588378283|FG000|Overall Study|Safety reasons|1|||
162912151|NCT00661362|588378284|FG001|Overall Study|Safety reasons|0|||
162968091|NCT02274558|588584778|FG001|Overall Study|Physician Decision|2|||
162968092|NCT02274558|588584779|FG002|Overall Study|Physician Decision|1|||
162968093|NCT00397254|588584780|FG000|Overall Study|Lost to Follow-up|2|||
162912152|NCT00661362|588378283|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
162912153|NCT00661362|588378284|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
162912154|NCT00535262|588378287|FG000|Overall Study|No funding|3|||
162912155|NCT04382066|588378290|FG000|Overall Study|Adverse Event|1|||
162912156|NCT04382066|588378291|FG001|Overall Study|Adverse Event|0|||
162912157|NCT04382066|588378292|FG002|Overall Study|Adverse Event|0|||
162912158|NCT04382066|588378290|FG000|Overall Study|Death|1|||
162912159|NCT04382066|588378291|FG001|Overall Study|Death|0|||
162912160|NCT04382066|588378292|FG002|Overall Study|Death|1|||
162912161|NCT04738123|588378293|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
162912162|NCT04738123|588378294|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
162912163|NCT04738123|588378293|FG000|Overall Study|Progressive Disease|0|||
162912164|NCT04738123|588378294|FG001|Overall Study|Progressive Disease|4|||
162912165|NCT04738123|588378293|FG000|Overall Study|Adverse Event|8|||
162912166|NCT04738123|588378294|FG001|Overall Study|Adverse Event|7|||
162912167|NCT04738123|588378293|FG000|Overall Study|Other Reasons|0|||
162912168|NCT04738123|588378294|FG001|Overall Study|Other Reasons|1|||
162912169|NCT04738123|588378293|FG000|Overall Study|Suicidal or assaultive behavior|0|||
162912170|NCT04738123|588378294|FG001|Overall Study|Suicidal or assaultive behavior|2|||
162912171|NCT04738123|588378293|FG000|Overall Study|Protocol Violation|2|||
162912172|NCT04738123|588378294|FG001|Overall Study|Protocol Violation|2|||
162912173|NCT04738123|588378293|FG000|Overall Study|Consent Withdrawn|35|||
162912174|NCT04738123|588378294|FG001|Overall Study|Consent Withdrawn|22|||
162912175|NCT00787527|588378297|FG000|Overall Study|Toxicity|3|||
162912176|NCT00083616|588378298|FG000|Overall Study|Disease Progression|16|||
162912177|NCT00083616|588378298|FG000|Overall Study|Lost to Follow-up|1|||
162912178|NCT00083616|588378298|FG000|Overall Study|Physician Decision|2|||
162912179|NCT00083616|588378298|FG000|Overall Study|Withdrawal by Subject|3|||
162912180|NCT00083616|588378298|FG000|Overall Study|Ineligibility determined|2|||
162912181|NCT00083616|588378298|FG000|Overall Study|Non-compliance|1|||
162912182|NCT00083616|588378298|FG000|Overall Study|Other|6|||
162912183|NCT01724021|588378299|FG000|Overall Study|Adverse Event|11|||
162912184|NCT01724021|588378300|FG001|Overall Study|Adverse Event|6|||
162912185|NCT01724021|588378299|FG000|Overall Study|Death|46|||
162912186|NCT01724021|588378300|FG001|Overall Study|Death|58|||
162912187|NCT01724021|588378299|FG000|Overall Study|Participant request/ Withdrew consent|18|||
162912188|NCT01724021|588378300|FG001|Overall Study|Participant request/ Withdrew consent|14|||
162912189|NCT01724021|588378299|FG000|Overall Study|Lost to Follow-up|15|||
162912190|NCT01724021|588378300|FG001|Overall Study|Lost to Follow-up|15|||
162912191|NCT01724021|588378299|FG000|Overall Study|Reason Not Specified|36|||
162912192|NCT01724021|588378300|FG001|Overall Study|Reason Not Specified|39|||
162912193|NCT01724021|588378299|FG000|Overall Study|Missing|1|||
162912194|NCT01724021|588378300|FG001|Overall Study|Missing|1|||
162912195|NCT02500706|588378303|FG000|Overall Study|Adverse Event|0|||
162912196|NCT02500706|588378304|FG001|Overall Study|Adverse Event|0|||
162912197|NCT02500706|588378305|FG002|Overall Study|Adverse Event|1|||
162912198|NCT02500706|588378303|FG000|Overall Study|Lost to Follow-up|0|||
162912199|NCT02500706|588378304|FG001|Overall Study|Lost to Follow-up|1|||
162912200|NCT02500706|588378305|FG002|Overall Study|Lost to Follow-up|1|||
162912201|NCT02500706|588378303|FG000|Overall Study|Withdrawal by Subject|4|||
162912202|NCT02500706|588378304|FG001|Overall Study|Withdrawal by Subject|6|||
162912203|NCT02500706|588378305|FG002|Overall Study|Withdrawal by Subject|4|||
162968094|NCT00397254|588584781|FG001|Overall Study|Lost to Follow-up|2|||
162968095|NCT00152451|588584784|FG000|Overall Study|Adverse Event|4|||
162968096|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
162968097|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
162968098|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
162912204|NCT02500706|588378303|FG000|Overall Study|Unclassified|0|||
162912205|NCT02500706|588378304|FG001|Overall Study|Unclassified|0|||
162912206|NCT02500706|588378305|FG002|Overall Study|Unclassified|1|||
162912207|NCT03644173|588378308|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
162912208|NCT03644173|588378308|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
162912209|NCT03644173|588378308|FG000|Participants at the 1-month Follow up|Death|2|||
162968099|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
162968100|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
162710764|NCT00299702|587651054|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
162912210|NCT03644173|588378308|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
162912211|NCT03323385|588378309|FG000|Overall Study|Withdrawal by Subject|1|||
162912212|NCT03323385|588378310|FG001|Overall Study|Withdrawal by Subject|2|||
162912213|NCT03323385|588378309|FG000|Overall Study|Noncompliance|0|||
162912214|NCT03323385|588378310|FG001|Overall Study|Noncompliance|1|||
162912215|NCT01000311|588378315|FG000|Overall Study|Adverse Event|2|||
162912216|NCT01000311|588378316|FG001|Overall Study|Adverse Event|5|||
162912217|NCT01000311|588378315|FG000|Overall Study|Withdrawal by Subject|16|||
162710765|NCT00299702|587651055|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
162912218|NCT01000311|588378316|FG001|Overall Study|Withdrawal by Subject|24|||
162912219|NCT01000311|588378315|FG000|Overall Study|Lost to Follow-up|15|||
162912220|NCT01000311|588378316|FG001|Overall Study|Lost to Follow-up|24|||
162912221|NCT01000311|588378315|FG000|Overall Study|Protocol Violation|1|||
162912222|NCT01000311|588378316|FG001|Overall Study|Protocol Violation|2|||
162912223|NCT01000311|588378315|FG000|Overall Study|Inappropriate enrollment|2|||
162912224|NCT01000311|588378316|FG001|Overall Study|Inappropriate enrollment|0|||
162912225|NCT01000311|588378315|FG000|Overall Study|Administrative reason|9|||
162912226|NCT01000311|588378316|FG001|Overall Study|Administrative reason|15|||
162912227|NCT02146352|588378317|FG000|Overall Study|Death|1|||
162912228|NCT02146352|588378317|FG000|Overall Study|Patient entered hospice care|1|||
162912229|NCT02918006|588378318|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
162912230|NCT02918006|588378319|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
162912231|NCT02918006|588378320|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
162912232|NCT02918006|588378318|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
162912233|NCT02918006|588378319|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
162912234|NCT02918006|588378320|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
162912235|NCT02918006|588378318|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
162912236|NCT02918006|588378319|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
162912237|NCT02918006|588378320|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
162912238|NCT02918006|588378318|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
162912239|NCT02918006|588378319|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
162912240|NCT02918006|588378320|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
162912241|NCT02918006|588378318|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
162912242|NCT02918006|588378319|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
162912243|NCT02918006|588378320|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
162912244|NCT02918006|588378318|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
162912245|NCT02918006|588378319|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
162912246|NCT02918006|588378320|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
162912247|NCT02918006|588378318|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
162912248|NCT02918006|588378319|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
162912249|NCT02918006|588378320|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
162912250|NCT02918006|588378318|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
162912251|NCT02918006|588378319|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
162912252|NCT02918006|588378320|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
162912253|NCT02918006|588378318|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
162912254|NCT02918006|588378319|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
162912255|NCT02918006|588378320|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
162912256|NCT03091920|588378325|FG000|Overall Study|Adverse Event|0|||
162912257|NCT03091920|588378326|FG001|Overall Study|Adverse Event|1|||
162912258|NCT03091920|588378327|FG002|Overall Study|Adverse Event|0|||
162912259|NCT00346775|588380426|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
162912260|NCT00346775|588380427|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
162912261|NCT00346775|588380426|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
162912262|NCT00346775|588380427|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
162912263|NCT00346775|588380426|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
162912264|NCT00346775|588380427|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
162912265|NCT01096017|588380435|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
162912266|NCT01096017|588380436|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
162912267|NCT00965458|588380443|FG000|Overall Study|Adverse Event|1|||
162912268|NCT00965458|588380444|FG001|Overall Study|Adverse Event|0|||
162912269|NCT00965458|588380443|FG000|Overall Study|Lost to Follow-up|1|||
162912270|NCT00965458|588380444|FG001|Overall Study|Lost to Follow-up|3|||
162912271|NCT00965458|588380443|FG000|Overall Study|Withdrawal by Subject|0|||
162912272|NCT00965458|588380444|FG001|Overall Study|Withdrawal by Subject|1|||
162912273|NCT01545375|588380446|FG000|Overall Study|Adverse Event|2|||
162912274|NCT01545375|588380447|FG001|Overall Study|Adverse Event|1|||
162912275|NCT01545375|588380446|FG000|Overall Study|Lost to Follow-up|34|||
162912276|NCT01545375|588380447|FG001|Overall Study|Lost to Follow-up|31|||
162912277|NCT01545375|588380446|FG000|Overall Study|Protocol Violation|3|||
162912278|NCT01545375|588380447|FG001|Overall Study|Protocol Violation|3|||
162912279|NCT01545375|588380446|FG000|Overall Study|Withdrawal by Subject|58|||
162912280|NCT01545375|588380447|FG001|Overall Study|Withdrawal by Subject|55|||
162912281|NCT04177862|588380449|FG000|Overall Study|Protocol Violation|2|||
162912282|NCT04177862|588380450|FG001|Overall Study|Protocol Violation|7|||
162912283|NCT01846039|588380451|FG000|Overall Study|Protocol Violation|1|||
162912284|NCT01846039|588380451|FG000|Overall Study|Subject Withdrew Consent|1|||
162912285|NCT00594958|588380452|FG000|Overall Study|Withdrawal by Subject|1|||
162912286|NCT00594958|588380453|FG001|Overall Study|Withdrawal by Subject|0|||
162912287|NCT00594958|588380454|FG002|Overall Study|Withdrawal by Subject|1|||
162912288|NCT00594958|588380452|FG000|Overall Study|Adverse Event|4|||
162912289|NCT00594958|588380453|FG001|Overall Study|Adverse Event|1|||
162912290|NCT00594958|588380454|FG002|Overall Study|Adverse Event|2|||
162912291|NCT00594958|588380452|FG000|Overall Study|Pregnancy|0|||
162912292|NCT00594958|588380453|FG001|Overall Study|Pregnancy|2|||
162912293|NCT00594958|588380454|FG002|Overall Study|Pregnancy|0|||
162912294|NCT00594958|588380452|FG000|Overall Study|Protocol Violation|1|||
162912295|NCT00594958|588380453|FG001|Overall Study|Protocol Violation|0|||
162912296|NCT00594958|588380454|FG002|Overall Study|Protocol Violation|2|||
162912297|NCT00594958|588380452|FG000|Overall Study|Lost to Follow-up|5|||
162912298|NCT00594958|588380453|FG001|Overall Study|Lost to Follow-up|0|||
162912299|NCT00594958|588380454|FG002|Overall Study|Lost to Follow-up|3|||
162912300|NCT00594958|588380452|FG000|Overall Study|administrative|3|||
162912301|NCT00594958|588380453|FG001|Overall Study|administrative|0|||
162912302|NCT00594958|588380454|FG002|Overall Study|administrative|2|||
162912303|NCT05637515|588380455|FG000|Overall Study|Withdrawal by Subject|17|||
162912304|NCT05637515|588380456|FG001|Overall Study|Withdrawal by Subject|17|||
162912305|NCT03233009|588380457|FG000|Overall Study|Lost to Follow-up|1|||
162912306|NCT04516291|588380459|FG000|Treatment Period (24 Weeks)|Other|1|||
162912307|NCT04516291|588380460|FG001|Treatment Period (24 Weeks)|Other|0|||
162912308|NCT04516291|588380461|FG002|Treatment Period (24 Weeks)|Other|0|||
162912309|NCT04516291|588380462|FG003|Treatment Period (24 Weeks)|Other|2|||
162912310|NCT04516291|588380463|FG004|Treatment Period (24 Weeks)|Other|2|||
162912311|NCT04516291|588380464|FG005|Treatment Period (24 Weeks)|Other|4|||
162912312|NCT04516291|588380465|FG006|Treatment Period (24 Weeks)|Other|2|||
162912313|NCT04516291|588380466|FG007|Treatment Period (24 Weeks)|Other|0|||
162912314|NCT04516291|588380459|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162912315|NCT04516291|588380460|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162912316|NCT04516291|588380461|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162912317|NCT04516291|588380462|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162912318|NCT04516291|588380463|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162912319|NCT04516291|588380464|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162912320|NCT04516291|588380465|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162912321|NCT04516291|588380466|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162912322|NCT04516291|588380459|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912323|NCT04516291|588380460|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912324|NCT04516291|588380461|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912325|NCT04516291|588380462|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
162912326|NCT04516291|588380463|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912327|NCT04516291|588380464|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912328|NCT04516291|588380465|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912329|NCT04516291|588380466|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
162912330|NCT04516291|588380459|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912331|NCT04516291|588380460|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162912332|NCT04516291|588380461|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912333|NCT04516291|588380462|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912334|NCT04516291|588380463|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912335|NCT04516291|588380464|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912336|NCT04516291|588380465|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912337|NCT04516291|588380466|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162912338|NCT04516291|588380459|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
162912339|NCT04516291|588380460|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
162912340|NCT04516291|588380461|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
162912341|NCT04516291|588380462|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
162912342|NCT04516291|588380463|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
162912343|NCT04516291|588380464|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
162912344|NCT04516291|588380465|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
162912345|NCT04516291|588380466|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
162912346|NCT04516291|588380459|FG000|Follow-up Period (12 Weeks)|Other|0|||
162912347|NCT04516291|588380460|FG001|Follow-up Period (12 Weeks)|Other|1|||
162912348|NCT04516291|588380461|FG002|Follow-up Period (12 Weeks)|Other|0|||
162912349|NCT04516291|588380462|FG003|Follow-up Period (12 Weeks)|Other|2|||
162912350|NCT04516291|588380463|FG004|Follow-up Period (12 Weeks)|Other|0|||
162912351|NCT04516291|588380464|FG005|Follow-up Period (12 Weeks)|Other|0|||
162912352|NCT04516291|588380465|FG006|Follow-up Period (12 Weeks)|Other|0|||
162912353|NCT04516291|588380466|FG007|Follow-up Period (12 Weeks)|Other|0|||
162912354|NCT04516291|588380459|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912355|NCT04516291|588380460|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912356|NCT04516291|588380461|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912357|NCT04516291|588380462|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912358|NCT04516291|588380463|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
162912359|NCT04516291|588380464|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912360|NCT04516291|588380465|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912361|NCT04516291|588380466|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162912362|NCT04516291|588380459|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912363|NCT04516291|588380460|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912364|NCT04516291|588380461|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
162912365|NCT04516291|588380462|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912366|NCT04516291|588380463|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
162912367|NCT04516291|588380464|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912368|NCT04516291|588380465|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912369|NCT04516291|588380466|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
162912370|NCT01855607|588380467|FG000|Overall Study|Withdrawal by Subject|1|||
162912371|NCT01855607|588380467|FG000|Overall Study|Study was terminated|11|||
162912372|NCT02181634|588380468|FG000|Overall Study|Lack of Efficacy|33|||
162912373|NCT02181634|588380468|FG000|Overall Study|Adverse Event|17|||
162912374|NCT02181634|588380468|FG000|Overall Study|Physician Decision|8|||
162912375|NCT02181634|588380468|FG000|Overall Study|Withdrawal by Subject|5|||
162912376|NCT02181634|588380468|FG000|Overall Study|Death|2|||
162912377|NCT02181634|588380468|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
162912378|NCT02181634|588380468|FG000|Overall Study|Ineligible|1|||
162912379|NCT02181634|588380468|FG000|Overall Study|Max number of dose reduction|1|||
162912380|NCT02181634|588380468|FG000|Overall Study|Symptomatic progression|1|||
162912381|NCT02181634|588380468|FG000|Overall Study|Patient opted to proceed to surgery|1|||
162912382|NCT03824704|588380474|FG000|Overall Study|Study Terminated by Sponsor|1|||
162912383|NCT02155660|588380482|FG000|Overall Study|Other Reason|8|||
162912384|NCT02155660|588380483|FG001|Overall Study|Other Reason|6|||
162912385|NCT02155660|588380484|FG002|Overall Study|Other Reason|10|||
162912386|NCT02155660|588380485|FG003|Overall Study|Other Reason|10|||
162912387|NCT02155660|588380482|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162912388|NCT02155660|588380483|FG001|Overall Study|Study-specific withdrawal criteria|1|||
162912389|NCT02155660|588380484|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162912390|NCT02155660|588380485|FG003|Overall Study|Study-specific withdrawal criteria|1|||
162912391|NCT02155660|588380482|FG000|Overall Study|Severe non-compliance|0|||
162912392|NCT02155660|588380483|FG001|Overall Study|Severe non-compliance|4|||
162912393|NCT02155660|588380484|FG002|Overall Study|Severe non-compliance|0|||
162912394|NCT02155660|588380485|FG003|Overall Study|Severe non-compliance|1|||
162912395|NCT02155660|588380482|FG000|Overall Study|Adverse Event|2|||
162912396|NCT02155660|588380483|FG001|Overall Study|Adverse Event|6|||
162912397|NCT02155660|588380484|FG002|Overall Study|Adverse Event|3|||
162912398|NCT02155660|588380485|FG003|Overall Study|Adverse Event|1|||
162912399|NCT02155660|588380482|FG000|Overall Study|Lost to Follow-up|3|||
162912400|NCT02155660|588380483|FG001|Overall Study|Lost to Follow-up|6|||
162912401|NCT02155660|588380484|FG002|Overall Study|Lost to Follow-up|5|||
162912402|NCT02155660|588380485|FG003|Overall Study|Lost to Follow-up|8|||
162912403|NCT02155660|588380482|FG000|Overall Study|Death|17|||
162912404|NCT02155660|588380483|FG001|Overall Study|Death|19|||
162912405|NCT02155660|588380484|FG002|Overall Study|Death|17|||
162912406|NCT02155660|588380485|FG003|Overall Study|Death|19|||
162912407|NCT02155660|588380482|FG000|Overall Study|Withdrawal by Subject|28|||
162912408|NCT02155660|588380483|FG001|Overall Study|Withdrawal by Subject|31|||
162912409|NCT02155660|588380484|FG002|Overall Study|Withdrawal by Subject|24|||
162912410|NCT02155660|588380485|FG003|Overall Study|Withdrawal by Subject|21|||
162912411|NCT03730987|588380486|FG000|Overall Study|Lost to Follow-up|2|||
162912412|NCT03730987|588380487|FG001|Overall Study|Lost to Follow-up|0|||
162912413|NCT03730987|588380488|FG002|Overall Study|Lost to Follow-up|2|||
162912414|NCT03730987|588380489|FG003|Overall Study|Lost to Follow-up|0|||
162912415|NCT02087085|588380490|FG000|Overall Study|Adverse Event|10|||
162912416|NCT02087085|588380491|FG001|Overall Study|Adverse Event|14|||
162912417|NCT02087085|588380490|FG000|Overall Study|Lack of Efficacy|4|||
162912418|NCT02087085|588380491|FG001|Overall Study|Lack of Efficacy|3|||
162912419|NCT02087085|588380490|FG000|Overall Study|Lost to Follow-up|6|||
162912420|NCT02087085|588380491|FG001|Overall Study|Lost to Follow-up|4|||
162912421|NCT02087085|588380490|FG000|Overall Study|Withdrawal by Subject|9|||
162912422|NCT02087085|588380491|FG001|Overall Study|Withdrawal by Subject|11|||
162912423|NCT02087085|588380490|FG000|Overall Study|Protocol Violation|1|||
162912424|NCT02087085|588380491|FG001|Overall Study|Protocol Violation|0|||
162912425|NCT02087085|588380490|FG000|Overall Study|Study Terminated by Sponsor|87|||
162912426|NCT02087085|588380491|FG001|Overall Study|Study Terminated by Sponsor|80|||
162912427|NCT02087085|588380490|FG000|Overall Study|Other Miscellaneous Reasons|3|||
162912428|NCT02087085|588380491|FG001|Overall Study|Other Miscellaneous Reasons|4|||
162912429|NCT02505945|588380492|FG000|Overall Study|Withdrawal by Subject|13|||
162912430|NCT02505945|588380493|FG001|Overall Study|Withdrawal by Subject|2|||
162912431|NCT02505945|588380492|FG000|Overall Study|Adverse Event|1|||
162912432|NCT02505945|588380493|FG001|Overall Study|Adverse Event|0|||
162912433|NCT02505945|588380492|FG000|Overall Study|Physician Decision|2|||
162912434|NCT02505945|588380493|FG001|Overall Study|Physician Decision|1|||
162912435|NCT02505945|588380492|FG000|Overall Study|Lost to Follow-up|6|||
162912436|NCT02505945|588380493|FG001|Overall Study|Lost to Follow-up|1|||
162912437|NCT00635804|588380494|FG000|Overall Study|Adverse Event|0|||
162912438|NCT00635804|588380495|FG001|Overall Study|Adverse Event|0|||
162912439|NCT00635804|588380496|FG002|Overall Study|Adverse Event|0|||
162912440|NCT00635804|588380497|FG003|Overall Study|Adverse Event|0|||
162912441|NCT00635804|588380498|FG004|Overall Study|Adverse Event|0|||
162912442|NCT00635804|588380499|FG005|Overall Study|Adverse Event|1|||
162912443|NCT00635804|588380500|FG006|Overall Study|Adverse Event|0|||
162968101|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
162968102|NCT00323258|588584787|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
162968103|NCT00323258|588584788|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
162968104|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
162912444|NCT00635804|588380501|FG007|Overall Study|Adverse Event|0|||
162912445|NCT00635804|588380494|FG000|Overall Study|Withdrawal by Subject|1|||
162912446|NCT00635804|588380495|FG001|Overall Study|Withdrawal by Subject|0|||
162912447|NCT00635804|588380496|FG002|Overall Study|Withdrawal by Subject|0|||
162912448|NCT00635804|588380497|FG003|Overall Study|Withdrawal by Subject|0|||
162912449|NCT00635804|588380498|FG004|Overall Study|Withdrawal by Subject|0|||
162912450|NCT00635804|588380499|FG005|Overall Study|Withdrawal by Subject|0|||
162912451|NCT00635804|588380500|FG006|Overall Study|Withdrawal by Subject|0|||
162912452|NCT00635804|588380501|FG007|Overall Study|Withdrawal by Subject|0|||
162912453|NCT01425268|588380509|FG000|Overall Study|Withdrawal by Subject|2|||
162912454|NCT01425268|588380510|FG001|Overall Study|Withdrawal by Subject|0|||
162912455|NCT01425268|588380509|FG000|Overall Study|Sponsor Decision|5|||
162912456|NCT01425268|588380510|FG001|Overall Study|Sponsor Decision|0|||
162912457|NCT01425268|588380509|FG000|Overall Study|Physician Decision|1|||
162912458|NCT01425268|588380510|FG001|Overall Study|Physician Decision|0|||
162912459|NCT00719706|588380511|FG000|Overall Study|Adverse Event|5|||
162912460|NCT00719706|588380512|FG001|Overall Study|Adverse Event|4|||
162912461|NCT00719706|588380511|FG000|Overall Study|Withdrawal by Subject|1|||
162912462|NCT00719706|588380512|FG001|Overall Study|Withdrawal by Subject|2|||
162912463|NCT00719706|588380511|FG000|Overall Study|Protocol Violation|3|||
162912464|NCT00719706|588380512|FG001|Overall Study|Protocol Violation|0|||
162912465|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
162912466|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
162912467|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
162912468|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
162912469|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
162912470|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
162912471|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
162912472|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
162912473|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
162912474|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
162912475|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
162912476|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
162912477|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
162912478|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
162912479|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
162912480|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|Other|6|||
162912481|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|Other|6|||
162912482|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|Other|7|||
162912483|NCT02681094|588380513|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
162912484|NCT02681094|588380514|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
162912485|NCT02681094|588380515|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
162912486|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Participant decision|7|||
162912487|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Participant decision|10|||
162912488|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Participant decision|9|||
162912489|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
162912490|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
162912491|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
162912492|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
162912493|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
162912494|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
162912495|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
162912496|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
162912497|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
162912498|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
162912499|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
162912500|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
162968105|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
162912501|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|Other|6|||
162912502|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|Other|6|||
162912503|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|Other|7|||
162912504|NCT02681094|588380513|FG000|2 - Enrolled Participants Set|No treatment given|0|||
162912505|NCT02681094|588380514|FG001|2 - Enrolled Participants Set|No treatment given|1|||
162912506|NCT02681094|588380515|FG002|2 - Enrolled Participants Set|No treatment given|1|||
162912507|NCT01072175|588380516|FG000|Part A (Drug-Drug Interaction)|Death|1|||
162912508|NCT01072175|588380517|FG001|Part A (Drug-Drug Interaction)|Death|0|||
162912509|NCT01072175|588380518|FG002|Part A (Drug-Drug Interaction)|Death|0|||
162912510|NCT01072175|588380519|FG003|Part A (Drug-Drug Interaction)|Death|0|||
162912511|NCT01072175|588380520|FG004|Part A (Drug-Drug Interaction)|Death|0|||
162912512|NCT01072175|588380521|FG005|Part A (Drug-Drug Interaction)|Death|0|||
162912513|NCT01072175|588380522|FG006|Part A (Drug-Drug Interaction)|Death|0|||
162912514|NCT01072175|588380523|FG007|Part A (Drug-Drug Interaction)|Death|0|||
162912515|NCT01072175|588380524|FG008|Part A (Drug-Drug Interaction)|Death|0|||
162912516|NCT01072175|588380525|FG009|Part A (Drug-Drug Interaction)|Death|0|||
162912517|NCT01072175|588380526|FG010|Part A (Drug-Drug Interaction)|Death|0|||
162912518|NCT01072175|588380527|FG011|Part A (Drug-Drug Interaction)|Death|0|||
162912519|NCT01072175|588380528|FG012|Part A (Drug-Drug Interaction)|Death|0|||
162912520|NCT01072175|588380516|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
162912521|NCT01072175|588380517|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912522|NCT01072175|588380518|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912523|NCT01072175|588380519|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912524|NCT01072175|588380520|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912525|NCT01072175|588380521|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912526|NCT01072175|588380522|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912527|NCT01072175|588380523|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912528|NCT01072175|588380524|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912529|NCT01072175|588380525|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912530|NCT01072175|588380526|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912531|NCT01072175|588380527|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912532|NCT01072175|588380528|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
162912533|NCT01072175|588380516|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
162912534|NCT01072175|588380517|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912535|NCT01072175|588380518|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912536|NCT01072175|588380519|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912537|NCT01072175|588380520|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912538|NCT01072175|588380521|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912539|NCT01072175|588380522|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912540|NCT01072175|588380523|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912541|NCT01072175|588380524|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912542|NCT01072175|588380525|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912543|NCT01072175|588380526|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912544|NCT01072175|588380527|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912545|NCT01072175|588380528|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
162912546|NCT01072175|588380516|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
162912547|NCT01072175|588380517|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
162912548|NCT01072175|588380518|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
162912549|NCT01072175|588380519|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
162912550|NCT01072175|588380520|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
162912551|NCT01072175|588380521|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
162912552|NCT01072175|588380522|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
162912553|NCT01072175|588380523|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
162912554|NCT01072175|588380524|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
162912555|NCT01072175|588380525|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
162912556|NCT01072175|588380526|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
162912557|NCT01072175|588380527|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
162912558|NCT01072175|588380528|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
162912559|NCT01072175|588380516|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912560|NCT01072175|588380517|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912561|NCT01072175|588380518|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
162912562|NCT01072175|588380519|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912563|NCT01072175|588380520|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
162912564|NCT01072175|588380521|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912565|NCT01072175|588380522|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912566|NCT01072175|588380523|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912567|NCT01072175|588380524|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912568|NCT01072175|588380525|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912569|NCT01072175|588380526|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912570|NCT01072175|588380527|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912571|NCT01072175|588380528|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
162912572|NCT01072175|588380516|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912573|NCT01072175|588380517|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
162912574|NCT01072175|588380518|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912575|NCT01072175|588380519|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
162912576|NCT01072175|588380520|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
162912577|NCT01072175|588380521|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912578|NCT01072175|588380522|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912579|NCT01072175|588380523|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912580|NCT01072175|588380524|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912581|NCT01072175|588380525|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912582|NCT01072175|588380526|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912583|NCT01072175|588380527|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912584|NCT01072175|588380528|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
162912585|NCT01072175|588380516|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912586|NCT01072175|588380517|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912587|NCT01072175|588380518|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
162912588|NCT01072175|588380519|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
162912589|NCT01072175|588380520|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
162912590|NCT01072175|588380521|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912591|NCT01072175|588380522|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912592|NCT01072175|588380523|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912593|NCT01072175|588380524|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912594|NCT01072175|588380525|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912595|NCT01072175|588380526|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912596|NCT01072175|588380527|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912597|NCT01072175|588380528|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
162912598|NCT01072175|588380516|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912599|NCT01072175|588380517|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
162912600|NCT01072175|588380518|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912601|NCT01072175|588380519|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
162912602|NCT01072175|588380520|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
162912603|NCT01072175|588380521|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912604|NCT01072175|588380522|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912605|NCT01072175|588380523|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912606|NCT01072175|588380524|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912607|NCT01072175|588380525|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912608|NCT01072175|588380526|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912609|NCT01072175|588380527|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912610|NCT01072175|588380528|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
162912611|NCT01072175|588380516|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
162912612|NCT01072175|588380517|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
162912613|NCT01072175|588380518|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
162912614|NCT01072175|588380519|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
162912615|NCT01072175|588380520|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
162912616|NCT01072175|588380521|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
162968106|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
162968107|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
162968108|NCT00323258|588584787|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
162968109|NCT00323258|588584788|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
162968110|NCT04473326|588584793|FG000|Overall Study|Death|0|||
162968111|NCT04473326|588584794|FG001|Overall Study|Death|1|||
162968112|NCT04473326|588584793|FG000|Overall Study|Withdrawal by Subject|1|||
162968113|NCT04473326|588584794|FG001|Overall Study|Withdrawal by Subject|2|||
162968114|NCT02046122|588584795|FG000|Overall Study|Physician Decision|8|||
162968115|NCT02046122|588584795|FG000|Overall Study|Withdrawal by Subject|1|||
162968116|NCT01097694|588584800|FG000|Overall Study|Adverse Event|5|||
162968117|NCT01097694|588584801|FG001|Overall Study|Adverse Event|0|||
162912617|NCT01072175|588380522|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
162912618|NCT01072175|588380523|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
162912619|NCT01072175|588380524|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
162912620|NCT01072175|588380525|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
162912621|NCT01072175|588380526|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
162912622|NCT01072175|588380527|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
162912623|NCT01072175|588380528|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
162912624|NCT01072175|588380516|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912625|NCT01072175|588380517|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912626|NCT01072175|588380518|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912627|NCT01072175|588380519|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912628|NCT01072175|588380520|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912629|NCT01072175|588380521|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
162912630|NCT01072175|588380522|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
162912631|NCT01072175|588380523|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
162912632|NCT01072175|588380524|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912633|NCT01072175|588380525|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912634|NCT01072175|588380526|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912635|NCT01072175|588380527|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912636|NCT01072175|588380528|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
162912637|NCT01072175|588380516|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912638|NCT01072175|588380517|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912639|NCT01072175|588380518|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912640|NCT01072175|588380519|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912641|NCT01072175|588380520|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912642|NCT01072175|588380521|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912643|NCT01072175|588380522|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
162912644|NCT01072175|588380523|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
162912645|NCT01072175|588380524|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912646|NCT01072175|588380525|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912647|NCT01072175|588380526|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912648|NCT01072175|588380527|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912649|NCT01072175|588380528|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162912650|NCT01072175|588380516|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912651|NCT01072175|588380517|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912652|NCT01072175|588380518|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912653|NCT01072175|588380519|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912654|NCT01072175|588380520|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912655|NCT01072175|588380521|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
162912656|NCT01072175|588380522|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
162912657|NCT01072175|588380523|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
162912658|NCT01072175|588380524|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912659|NCT01072175|588380525|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912660|NCT01072175|588380526|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912661|NCT01072175|588380527|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912662|NCT01072175|588380528|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
162912663|NCT01072175|588380516|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912664|NCT01072175|588380517|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912665|NCT01072175|588380518|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912666|NCT01072175|588380519|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912667|NCT01072175|588380520|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912668|NCT01072175|588380521|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
162912669|NCT01072175|588380522|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
162912670|NCT01072175|588380523|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912671|NCT01072175|588380524|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912672|NCT01072175|588380525|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912673|NCT01072175|588380526|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912674|NCT01072175|588380527|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912675|NCT01072175|588380528|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
162912676|NCT01072175|588380516|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912677|NCT01072175|588380517|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912678|NCT01072175|588380518|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912679|NCT01072175|588380519|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912680|NCT01072175|588380520|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912681|NCT01072175|588380521|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912682|NCT01072175|588380522|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912683|NCT01072175|588380523|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912684|NCT01072175|588380524|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
162912685|NCT01072175|588380525|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912686|NCT01072175|588380526|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912687|NCT01072175|588380527|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912688|NCT01072175|588380528|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
162912689|NCT01072175|588380516|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912690|NCT01072175|588380517|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912691|NCT01072175|588380518|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912692|NCT01072175|588380519|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912693|NCT01072175|588380520|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912694|NCT01072175|588380521|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912695|NCT01072175|588380522|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912696|NCT01072175|588380523|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912697|NCT01072175|588380524|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
162912698|NCT01072175|588380525|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912699|NCT01072175|588380526|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912700|NCT01072175|588380527|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912701|NCT01072175|588380528|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
162912702|NCT01072175|588380516|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912703|NCT01072175|588380517|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912704|NCT01072175|588380518|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912705|NCT01072175|588380519|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912706|NCT01072175|588380520|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912707|NCT01072175|588380521|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912708|NCT01072175|588380522|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912709|NCT01072175|588380523|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912710|NCT01072175|588380524|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
162912711|NCT01072175|588380525|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912712|NCT01072175|588380526|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912713|NCT01072175|588380527|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912714|NCT01072175|588380528|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
162912715|NCT01072175|588380516|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912716|NCT01072175|588380517|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912717|NCT01072175|588380518|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912718|NCT01072175|588380519|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912719|NCT01072175|588380520|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912720|NCT01072175|588380521|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912721|NCT01072175|588380522|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912722|NCT01072175|588380523|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912723|NCT01072175|588380524|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
162912724|NCT01072175|588380525|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912725|NCT01072175|588380526|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912726|NCT01072175|588380527|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912727|NCT01072175|588380528|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
162912728|NCT01072175|588380516|FG000|Part D (HPMC Capsules)|Death|0|||
162912729|NCT01072175|588380517|FG001|Part D (HPMC Capsules)|Death|0|||
162912730|NCT01072175|588380518|FG002|Part D (HPMC Capsules)|Death|0|||
162912731|NCT01072175|588380519|FG003|Part D (HPMC Capsules)|Death|0|||
162912732|NCT01072175|588380520|FG004|Part D (HPMC Capsules)|Death|0|||
162912733|NCT01072175|588380521|FG005|Part D (HPMC Capsules)|Death|0|||
162912734|NCT01072175|588380522|FG006|Part D (HPMC Capsules)|Death|0|||
162912735|NCT01072175|588380523|FG007|Part D (HPMC Capsules)|Death|0|||
162912736|NCT01072175|588380524|FG008|Part D (HPMC Capsules)|Death|0|||
162912737|NCT01072175|588380525|FG009|Part D (HPMC Capsules)|Death|10|||
162912738|NCT01072175|588380526|FG010|Part D (HPMC Capsules)|Death|12|||
162912739|NCT01072175|588380527|FG011|Part D (HPMC Capsules)|Death|28|||
162912740|NCT01072175|588380528|FG012|Part D (HPMC Capsules)|Death|26|||
162912741|NCT01072175|588380516|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
162912742|NCT01072175|588380517|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
162912743|NCT01072175|588380518|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
162912744|NCT01072175|588380519|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
162968118|NCT01097694|588584800|FG000|Overall Study|Lost to Follow-up|0|||
162968119|NCT01097694|588584801|FG001|Overall Study|Lost to Follow-up|3|||
162968120|NCT01097694|588584800|FG000|Overall Study|Withdrawal by Subject|3|||
162968121|NCT01097694|588584801|FG001|Overall Study|Withdrawal by Subject|1|||
162968122|NCT00668395|588584803|FG000|Overall Study|Withdrawal by Subject|4|||
162968123|NCT00668395|588584804|FG001|Overall Study|Withdrawal by Subject|4|||
162912745|NCT01072175|588380520|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
162912746|NCT01072175|588380521|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
162912747|NCT01072175|588380522|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
162912748|NCT01072175|588380523|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
162912749|NCT01072175|588380524|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
162912750|NCT01072175|588380525|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
162912751|NCT01072175|588380526|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
162912752|NCT01072175|588380527|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
162912753|NCT01072175|588380528|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
162912754|NCT01072175|588380516|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912755|NCT01072175|588380517|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912756|NCT01072175|588380518|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912757|NCT01072175|588380519|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912758|NCT01072175|588380520|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912759|NCT01072175|588380521|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912760|NCT01072175|588380522|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912761|NCT01072175|588380523|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912762|NCT01072175|588380524|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912763|NCT01072175|588380525|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
162912764|NCT01072175|588380526|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
162912765|NCT01072175|588380527|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
162912766|NCT01072175|588380528|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
162912767|NCT01072175|588380516|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912768|NCT01072175|588380517|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912769|NCT01072175|588380518|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912770|NCT01072175|588380519|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912771|NCT01072175|588380520|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912772|NCT01072175|588380521|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912773|NCT01072175|588380522|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912774|NCT01072175|588380523|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912775|NCT01072175|588380524|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
162912776|NCT01072175|588380525|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
162912777|NCT01072175|588380526|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
162912778|NCT01072175|588380527|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
162912779|NCT01072175|588380528|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
162912780|NCT01072175|588380516|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912781|NCT01072175|588380517|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912782|NCT01072175|588380518|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912783|NCT01072175|588380519|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912784|NCT01072175|588380520|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912785|NCT01072175|588380521|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162968124|NCT00668395|588584805|FG002|Overall Study|Withdrawal by Subject|1|||
162968125|NCT00668395|588584803|FG000|Overall Study|Adverse Event|1|||
162968126|NCT00668395|588584804|FG001|Overall Study|Adverse Event|1|||
162968127|NCT00668395|588584805|FG002|Overall Study|Adverse Event|0|||
162968128|NCT00668395|588584803|FG000|Overall Study|Physician Decision|1|||
162968129|NCT00668395|588584804|FG001|Overall Study|Physician Decision|1|||
162968130|NCT00668395|588584805|FG002|Overall Study|Physician Decision|0|||
162968131|NCT04164758|588584806|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
162968132|NCT04164758|588584807|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
162968133|NCT04164758|588584808|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
162968134|NCT04164758|588584806|FG000|Overall Study|Adverse Event|0|||
162968135|NCT04164758|588584807|FG001|Overall Study|Adverse Event|1|||
162968136|NCT04164758|588584808|FG002|Overall Study|Adverse Event|0|||
162968137|NCT00697827|588584809|FG000|Overall Study|enrolled but not treated|2|||
162968138|NCT00697827|588584810|FG001|Overall Study|enrolled but not treated|1|||
162968139|NCT03259165|588584811|FG000|Overall Study|COVID 19 pandemic|1|||
162968140|NCT03259165|588584812|FG001|Overall Study|COVID 19 pandemic|1|||
162968141|NCT03732833|588584813|FG000|Overall Study|Adverse Event|0|||
162968142|NCT03732833|588584814|FG001|Overall Study|Adverse Event|3|||
162968143|NCT03732833|588584815|FG002|Overall Study|Adverse Event|1|||
162968144|NCT03732833|588584813|FG000|Overall Study|Withdrawal by Subject|11|||
162968145|NCT03732833|588584814|FG001|Overall Study|Withdrawal by Subject|13|||
162912786|NCT01072175|588380522|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912787|NCT01072175|588380523|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912788|NCT01072175|588380524|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912789|NCT01072175|588380525|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162968146|NCT03732833|588584815|FG002|Overall Study|Withdrawal by Subject|8|||
162968147|NCT03732833|588584813|FG000|Overall Study|Lost to Follow-up|3|||
162968148|NCT03732833|588584814|FG001|Overall Study|Lost to Follow-up|5|||
162968149|NCT03732833|588584815|FG002|Overall Study|Lost to Follow-up|4|||
162968150|NCT03732833|588584813|FG000|Overall Study|Pregnancy|0|||
162912790|NCT01072175|588380526|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
162912791|NCT01072175|588380527|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
162968151|NCT03732833|588584814|FG001|Overall Study|Pregnancy|2|||
162912792|NCT01072175|588380528|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
162912793|NCT02839330|588380529|FG000|Overall Study|Adverse Event|0|||
162912794|NCT02839330|588380530|FG001|Overall Study|Adverse Event|1|||
162912795|NCT02839330|588380531|FG002|Overall Study|Adverse Event|2|||
162912796|NCT02839330|588380532|FG003|Overall Study|Adverse Event|2|||
162912797|NCT02839330|588380529|FG000|Overall Study|Death|4|||
162912798|NCT02839330|588380530|FG001|Overall Study|Death|6|||
162912799|NCT02839330|588380531|FG002|Overall Study|Death|1|||
162912800|NCT02839330|588380532|FG003|Overall Study|Death|1|||
162912801|NCT02839330|588380529|FG000|Overall Study|Withdrawal by Subject|27|||
162912802|NCT02839330|588380530|FG001|Overall Study|Withdrawal by Subject|19|||
162912803|NCT02839330|588380531|FG002|Overall Study|Withdrawal by Subject|11|||
162912804|NCT02839330|588380532|FG003|Overall Study|Withdrawal by Subject|13|||
162912805|NCT02839330|588380529|FG000|Overall Study|Lost to Follow-up|22|||
162912806|NCT02839330|588380530|FG001|Overall Study|Lost to Follow-up|27|||
162912807|NCT02839330|588380531|FG002|Overall Study|Lost to Follow-up|29|||
162912808|NCT02839330|588380532|FG003|Overall Study|Lost to Follow-up|25|||
162912809|NCT02839330|588380529|FG000|Overall Study|Administrative Reason|0|||
162912810|NCT02839330|588380530|FG001|Overall Study|Administrative Reason|0|||
162912811|NCT02839330|588380531|FG002|Overall Study|Administrative Reason|0|||
162912812|NCT02839330|588380532|FG003|Overall Study|Administrative Reason|1|||
162912813|NCT02839330|588380529|FG000|Overall Study|Protocol Violation|1|||
162912814|NCT02839330|588380530|FG001|Overall Study|Protocol Violation|2|||
162912815|NCT02839330|588380531|FG002|Overall Study|Protocol Violation|2|||
162912816|NCT02839330|588380532|FG003|Overall Study|Protocol Violation|3|||
162912817|NCT02839330|588380529|FG000|Overall Study|Other reason, not specified|4|||
162912818|NCT02839330|588380530|FG001|Overall Study|Other reason, not specified|3|||
162912819|NCT02839330|588380531|FG002|Overall Study|Other reason, not specified|3|||
162912820|NCT02839330|588380532|FG003|Overall Study|Other reason, not specified|6|||
162912821|NCT00682539|588380533|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
162912822|NCT00682539|588380534|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
162912823|NCT00682539|588380535|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
162912824|NCT00682539|588380533|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
162912825|NCT00682539|588380534|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
162912826|NCT00682539|588380535|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
162912827|NCT02477215|588380545|FG000|Dose Escalation Phase|Physician Decision|1|||
162912828|NCT02477215|588380546|FG001|Dose Escalation Phase|Physician Decision|2|||
162912829|NCT02477215|588380547|FG002|Dose Escalation Phase|Physician Decision|0|||
162912830|NCT02477215|588380545|FG000|Fixed Dose Phase|Physician Decision|0|||
162912831|NCT02477215|588380546|FG001|Fixed Dose Phase|Physician Decision|7|||
162912832|NCT02477215|588380547|FG002|Fixed Dose Phase|Physician Decision|0|||
162912833|NCT00508872|588380548|FG000|Overall Study|Lost to Follow-up|1|||
162912834|NCT00508872|588380548|FG000|Overall Study|Physician Decision|1|||
162912835|NCT00883896|588380549|FG000|Overall Study|Lost to Follow-up|0|||
162912836|NCT00883896|588380550|FG001|Overall Study|Lost to Follow-up|0|||
162912837|NCT00883896|588380551|FG002|Overall Study|Lost to Follow-up|0|||
162912838|NCT00883896|588380552|FG003|Overall Study|Lost to Follow-up|2|||
162912839|NCT00883896|588380549|FG000|Overall Study|Withdrawal by Subject|5|||
162912840|NCT00883896|588380550|FG001|Overall Study|Withdrawal by Subject|0|||
162912841|NCT00883896|588380551|FG002|Overall Study|Withdrawal by Subject|1|||
162912842|NCT00883896|588380552|FG003|Overall Study|Withdrawal by Subject|3|||
162912843|NCT00883896|588380549|FG000|Overall Study|Lack of Efficacy|0|||
162968152|NCT03732833|588584815|FG002|Overall Study|Pregnancy|0|||
162968153|NCT03732833|588584813|FG000|Overall Study|Physician Decision|2|||
162968154|NCT03732833|588584814|FG001|Overall Study|Physician Decision|3|||
162968155|NCT03732833|588584815|FG002|Overall Study|Physician Decision|1|||
162968156|NCT03732833|588584813|FG000|Overall Study|Covid-19 related and other reasons|2|||
162968157|NCT03732833|588584814|FG001|Overall Study|Covid-19 related and other reasons|7|||
162968158|NCT03732833|588584815|FG002|Overall Study|Covid-19 related and other reasons|3|||
162968159|NCT01567527|588584818|FG000|Conversion Phase.|Protocol deviation|3|||
162968160|NCT01567527|588584819|FG001|Conversion Phase.|Protocol deviation|0|||
162968161|NCT01567527|588584820|FG002|Conversion Phase.|Protocol deviation|0|||
162968162|NCT01567527|588584821|FG003|Conversion Phase.|Protocol deviation|0|||
162968163|NCT01567527|588584822|FG004|Conversion Phase.|Protocol deviation|0|||
162912844|NCT00883896|588380550|FG001|Overall Study|Lack of Efficacy|0|||
162912845|NCT00883896|588380551|FG002|Overall Study|Lack of Efficacy|0|||
162912846|NCT00883896|588380552|FG003|Overall Study|Lack of Efficacy|2|||
162912847|NCT00883896|588380549|FG000|Overall Study|Other|1|||
162912848|NCT00883896|588380550|FG001|Overall Study|Other|0|||
162912849|NCT00883896|588380551|FG002|Overall Study|Other|0|||
162912850|NCT00883896|588380552|FG003|Overall Study|Other|0|||
162912851|NCT02546193|588380553|FG000|Overall Study|Withdrawal by Subject|2|||
162912852|NCT02546193|588380554|FG001|Overall Study|Withdrawal by Subject|0|||
162912853|NCT02546193|588380555|FG002|Overall Study|Withdrawal by Subject|1|||
162912854|NCT02546193|588380556|FG003|Overall Study|Withdrawal by Subject|0|||
162912855|NCT02546193|588380553|FG000|Overall Study|Not eligible at time of induction|4|||
162912856|NCT02546193|588380554|FG001|Overall Study|Not eligible at time of induction|6|||
162912857|NCT02546193|588380555|FG002|Overall Study|Not eligible at time of induction|1|||
162912858|NCT02546193|588380556|FG003|Overall Study|Not eligible at time of induction|0|||
162912859|NCT00310440|588380557|FG000|Overall Study|Lost to Follow-up|17|||
162912860|NCT00310440|588380558|FG001|Overall Study|Lost to Follow-up|8|||
162912861|NCT00310440|588380557|FG000|Overall Study|Withdrawal by Subject|2|||
162912862|NCT00310440|588380558|FG001|Overall Study|Withdrawal by Subject|1|||
162912863|NCT00310440|588380557|FG000|Overall Study|Missed 12 Month Visit|7|||
162912864|NCT00310440|588380558|FG001|Overall Study|Missed 12 Month Visit|4|||
162912865|NCT00438815|588380566|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
162912866|NCT00438815|588380566|FG000|Overall Study|3-month follow-up no longer required|12|||
162912867|NCT00438815|588380566|FG000|Overall Study|Noncompliance with protocol requirements|9|||
162912868|NCT00438815|588380566|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
162912869|NCT00438815|588380566|FG000|Overall Study|Lost to Follow-up|6|||
162912870|NCT00438815|588380566|FG000|Overall Study|Withdrawal by Subject|6|||
162912871|NCT00438815|588380566|FG000|Overall Study|Death|1|||
162912872|NCT01654666|588380567|FG000|Overall Study|Protocol Violation|7|||
162968164|NCT01567527|588584818|FG000|Conversion Phase.|Met withdrawal criteria|10|||
162968165|NCT01567527|588584819|FG001|Conversion Phase.|Met withdrawal criteria|0|||
162968166|NCT01567527|588584820|FG002|Conversion Phase.|Met withdrawal criteria|0|||
162912873|NCT01654666|588380568|FG001|Overall Study|Protocol Violation|4|||
162912874|NCT01654666|588380569|FG002|Overall Study|Protocol Violation|8|||
162912875|NCT01654666|588380567|FG000|Overall Study|Lost to Follow-up|4|||
162912876|NCT01654666|588380568|FG001|Overall Study|Lost to Follow-up|5|||
162912877|NCT01654666|588380569|FG002|Overall Study|Lost to Follow-up|5|||
162912878|NCT01654666|588380567|FG000|Overall Study|Withdrawal by Subject|4|||
162912879|NCT01654666|588380568|FG001|Overall Study|Withdrawal by Subject|4|||
162912880|NCT01654666|588380569|FG002|Overall Study|Withdrawal by Subject|1|||
162912881|NCT01177943|588380571|FG000|First Intervention|Withdrawal by Subject|2|||
162912882|NCT01177943|588380572|FG001|First Intervention|Withdrawal by Subject|0|||
162912883|NCT04225026|588380578|FG000|Overall Study|Withdrawal by Subject|4|||
162912884|NCT04225026|588380578|FG000|Overall Study|Adverse Event|1|||
162912885|NCT04225026|588380578|FG000|Overall Study|Other|1|||
162912886|NCT04225026|588380578|FG000|Overall Study|Death|11|||
162912887|NCT04225026|588380578|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
162912888|NCT00779506|588380581|FG000|Overall Study|Screening Failed|2|||
162912889|NCT00779506|588380581|FG000|Overall Study|Adverse Event|4|||
162912890|NCT00779506|588380581|FG000|Overall Study|Lack of Efficacy|11|||
162912891|NCT00779506|588380581|FG000|Overall Study|Protocol Violation|5|||
162968167|NCT01567527|588584821|FG003|Conversion Phase.|Met withdrawal criteria|0|||
162968168|NCT01567527|588584822|FG004|Conversion Phase.|Met withdrawal criteria|0|||
162968169|NCT01567527|588584818|FG000|Conversion Phase.|Withdrawal by Subject|32|||
162968170|NCT01567527|588584819|FG001|Conversion Phase.|Withdrawal by Subject|0|||
162968171|NCT01567527|588584820|FG002|Conversion Phase.|Withdrawal by Subject|0|||
162968172|NCT01567527|588584821|FG003|Conversion Phase.|Withdrawal by Subject|0|||
162968173|NCT01567527|588584822|FG004|Conversion Phase.|Withdrawal by Subject|0|||
162968174|NCT01567527|588584818|FG000|Conversion Phase.|Lost to Follow-up|16|||
162968175|NCT01567527|588584819|FG001|Conversion Phase.|Lost to Follow-up|0|||
162968176|NCT01567527|588584820|FG002|Conversion Phase.|Lost to Follow-up|0|||
162968177|NCT01567527|588584821|FG003|Conversion Phase.|Lost to Follow-up|0|||
162968178|NCT01567527|588584822|FG004|Conversion Phase.|Lost to Follow-up|0|||
162968179|NCT01567527|588584818|FG000|Conversion Phase.|Lack of Efficacy|2|||
162968180|NCT01567527|588584819|FG001|Conversion Phase.|Lack of Efficacy|0|||
162968181|NCT01567527|588584820|FG002|Conversion Phase.|Lack of Efficacy|0|||
162968182|NCT01567527|588584821|FG003|Conversion Phase.|Lack of Efficacy|0|||
162968183|NCT01567527|588584822|FG004|Conversion Phase.|Lack of Efficacy|0|||
162968184|NCT01567527|588584818|FG000|Conversion Phase.|Adverse Event|33|||
162968185|NCT01567527|588584819|FG001|Conversion Phase.|Adverse Event|0|||
162968186|NCT01567527|588584820|FG002|Conversion Phase.|Adverse Event|0|||
162968187|NCT01567527|588584821|FG003|Conversion Phase.|Adverse Event|0|||
162912892|NCT00779506|588380581|FG000|Overall Study|Withdrawal by Subject|6|||
162629051|NCT03310021|587358599|FG002|Overall Study|Withdrawal by Subject|0|||
162629052|NCT03310021|587358600|FG003|Overall Study|Withdrawal by Subject|0|||
162629053|NCT03310021|587358601|FG004|Overall Study|Withdrawal by Subject|0|||
162912893|NCT00779506|588380581|FG000|Overall Study|Lost to Follow-up|1|||
162912894|NCT03982069|588380583|FG000|Overall Study|Lost to Follow-up|5|||
162912895|NCT03982069|588380584|FG001|Overall Study|Lost to Follow-up|5|||
162912896|NCT03982069|588380585|FG002|Overall Study|Lost to Follow-up|3|||
162912897|NCT03982069|588380586|FG003|Overall Study|Lost to Follow-up|5|||
162968188|NCT01567527|588584822|FG004|Conversion Phase.|Adverse Event|0|||
162968189|NCT01567527|588584818|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
162968190|NCT01567527|588584819|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
162912898|NCT03982069|588380583|FG000|Overall Study|Physician Decision|0|||
162912899|NCT03982069|588380584|FG001|Overall Study|Physician Decision|1|||
163054425|NCT00794664|588910295|FG000|Follow-up Period|Withdrawal by Subject|0|||
162912900|NCT03982069|588380585|FG002|Overall Study|Physician Decision|0|||
162912901|NCT03982069|588380586|FG003|Overall Study|Physician Decision|0|||
162912902|NCT03982069|588380583|FG000|Overall Study|Withdrawal by Subject|2|||
162629054|NCT03310021|587358602|FG005|Overall Study|Withdrawal by Subject|0|||
162629055|NCT03310021|587358603|FG006|Overall Study|Withdrawal by Subject|1|||
162629056|NCT03310021|587358604|FG007|Overall Study|Withdrawal by Subject|0|||
162629057|NCT03310021|587358605|FG008|Overall Study|Withdrawal by Subject|0|||
162912903|NCT03982069|588380584|FG001|Overall Study|Withdrawal by Subject|1|||
162912904|NCT03982069|588380585|FG002|Overall Study|Withdrawal by Subject|5|||
162912905|NCT03982069|588380586|FG003|Overall Study|Withdrawal by Subject|2|||
162912906|NCT03982069|588380583|FG000|Overall Study|Specimen loss|3|||
162912907|NCT03982069|588380584|FG001|Overall Study|Specimen loss|3|||
162912908|NCT03982069|588380585|FG002|Overall Study|Specimen loss|1|||
162629058|NCT03310021|587358606|FG009|Overall Study|Withdrawal by Subject|0|||
162912909|NCT03982069|588380586|FG003|Overall Study|Specimen loss|1|||
162912910|NCT00914940|588380587|FG000|D0 to D100 Post-transplant|Death|2|||
162912911|NCT00914940|588380587|FG000|D101 to 2 Years Post-transplant|Death|8|||
162912912|NCT00914940|588380587|FG000|2 Years to 5 Years Post-transplant|Death|3|||
162912913|NCT00690612|588382086|FG000|Overall Study|Adverse Event|1|||
162912914|NCT00690612|588382086|FG000|Overall Study|Withdrawal by Subject|2|||
162912915|NCT01858701|588382089|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
162912916|NCT01858701|588382090|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
162912917|NCT01858701|588382089|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
162912918|NCT01858701|588382090|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
162912919|NCT01858701|588382089|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
162912920|NCT01858701|588382090|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
162912921|NCT01858701|588382089|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
162912922|NCT01858701|588382090|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
162912923|NCT01674010|588382091|FG000|Open Treatment Phase 1|Adverse Event|10|||
162912924|NCT01674010|588382092|FG001|Open Treatment Phase 1|Adverse Event|0|||
162912925|NCT01674010|588382093|FG002|Open Treatment Phase 1|Adverse Event|0|||
162912926|NCT01674010|588382091|FG000|Open Treatment Phase 1|Death|1|||
162912927|NCT01674010|588382092|FG001|Open Treatment Phase 1|Death|0|||
162912928|NCT01674010|588382093|FG002|Open Treatment Phase 1|Death|0|||
162912929|NCT01674010|588382091|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
162912930|NCT01674010|588382092|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
162912931|NCT01674010|588382093|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
162912932|NCT01674010|588382091|FG000|Open Treatment Phase 1|Physician Decision|9|||
162912933|NCT01674010|588382092|FG001|Open Treatment Phase 1|Physician Decision|0|||
162912934|NCT01674010|588382093|FG002|Open Treatment Phase 1|Physician Decision|0|||
162912935|NCT01674010|588382091|FG000|Open Treatment Phase 1|Protocol Violation|7|||
162912936|NCT01674010|588382092|FG001|Open Treatment Phase 1|Protocol Violation|0|||
162912937|NCT01674010|588382093|FG002|Open Treatment Phase 1|Protocol Violation|0|||
162912938|NCT01674010|588382091|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
162912939|NCT01674010|588382092|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
162912940|NCT01674010|588382093|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
162912941|NCT01674010|588382091|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
162912942|NCT01674010|588382092|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
162912943|NCT01674010|588382093|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
162912944|NCT01674010|588382091|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
162912945|NCT01674010|588382092|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
162912946|NCT01674010|588382093|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
162912947|NCT01674010|588382091|FG000|Randomization Phase 2|Adverse Event|0|||
162912948|NCT01674010|588382092|FG001|Randomization Phase 2|Adverse Event|1|||
162912949|NCT01674010|588382093|FG002|Randomization Phase 2|Adverse Event|1|||
162912950|NCT01674010|588382091|FG000|Randomization Phase 2|Lost to Follow-up|0|||
162912951|NCT01674010|588382092|FG001|Randomization Phase 2|Lost to Follow-up|1|||
162912952|NCT01674010|588382093|FG002|Randomization Phase 2|Lost to Follow-up|2|||
162912953|NCT01674010|588382091|FG000|Randomization Phase 2|Mood episode recurrence|0|||
162912954|NCT01674010|588382092|FG001|Randomization Phase 2|Mood episode recurrence|8|||
162912955|NCT01674010|588382093|FG002|Randomization Phase 2|Mood episode recurrence|2|||
162912956|NCT01674010|588382091|FG000|Randomization Phase 2|Physician Decision|0|||
162912957|NCT01674010|588382092|FG001|Randomization Phase 2|Physician Decision|0|||
162912958|NCT01674010|588382093|FG002|Randomization Phase 2|Physician Decision|2|||
162912959|NCT01674010|588382091|FG000|Randomization Phase 2|Pregnancy|0|||
162912960|NCT01674010|588382092|FG001|Randomization Phase 2|Pregnancy|1|||
162912961|NCT01674010|588382093|FG002|Randomization Phase 2|Pregnancy|1|||
162912962|NCT01674010|588382091|FG000|Randomization Phase 2|Protocol Violation|0|||
162912963|NCT01674010|588382092|FG001|Randomization Phase 2|Protocol Violation|1|||
162912964|NCT01674010|588382093|FG002|Randomization Phase 2|Protocol Violation|1|||
162912965|NCT01674010|588382091|FG000|Randomization Phase 2|Sponsor Decision|0|||
162912966|NCT01674010|588382092|FG001|Randomization Phase 2|Sponsor Decision|42|||
162912967|NCT01674010|588382093|FG002|Randomization Phase 2|Sponsor Decision|45|||
162912968|NCT01674010|588382091|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
162912969|NCT01674010|588382092|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
162968191|NCT01567527|588584820|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
162912970|NCT01674010|588382093|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
162912971|NCT01020812|588382094|FG000|Overall Study|Physician Decision|1|||
162912972|NCT01020812|588382094|FG000|Overall Study|Withdrawal by Subject|1|||
162912973|NCT01020812|588382094|FG000|Overall Study|Protocol Violation|1|||
162912974|NCT01801475|588382103|FG000|Overall Study|Withdrawal by Subject|0|||
162912975|NCT01801475|588382104|FG001|Overall Study|Withdrawal by Subject|0|||
162912976|NCT01801475|588382105|FG002|Overall Study|Withdrawal by Subject|0|||
162912977|NCT01801475|588382106|FG003|Overall Study|Withdrawal by Subject|0|||
162912978|NCT01801475|588382107|FG004|Overall Study|Withdrawal by Subject|1|||
162912979|NCT01786707|588382110|FG000|Overall Study|Lost to Follow-up|1|||
162912980|NCT01786707|588382111|FG001|Overall Study|Lost to Follow-up|1|||
162912981|NCT00421928|588382112|FG000|Overall Study|Adverse Event|61|||
162912982|NCT00421928|588382113|FG001|Overall Study|Adverse Event|140|||
162912983|NCT00421928|588382114|FG002|Overall Study|Adverse Event|22|||
162912984|NCT00421928|588382112|FG000|Overall Study|Lost to Follow-up|5|||
162912985|NCT00421928|588382113|FG001|Overall Study|Lost to Follow-up|0|||
162912986|NCT00421928|588382114|FG002|Overall Study|Lost to Follow-up|3|||
162912987|NCT00421928|588382112|FG000|Overall Study|Withdrawal by Subject|50|||
162912988|NCT00421928|588382113|FG001|Overall Study|Withdrawal by Subject|48|||
162912989|NCT00421928|588382114|FG002|Overall Study|Withdrawal by Subject|43|||
162912990|NCT00421928|588382112|FG000|Overall Study|Lack of Efficacy|15|||
162912991|NCT00421928|588382113|FG001|Overall Study|Lack of Efficacy|7|||
162912992|NCT00421928|588382114|FG002|Overall Study|Lack of Efficacy|35|||
162912993|NCT00421928|588382112|FG000|Overall Study|Study drug non-compliant|6|||
162912994|NCT00421928|588382113|FG001|Overall Study|Study drug non-compliant|7|||
162912995|NCT00421928|588382114|FG002|Overall Study|Study drug non-compliant|4|||
162912996|NCT00421928|588382112|FG000|Overall Study|All other|26|||
162912997|NCT00421928|588382113|FG001|Overall Study|All other|21|||
162912998|NCT00421928|588382114|FG002|Overall Study|All other|27|||
162912999|NCT00421928|588382112|FG000|Overall Study|Death|0|||
162913000|NCT00421928|588382113|FG001|Overall Study|Death|1|||
162913001|NCT00421928|588382114|FG002|Overall Study|Death|0|||
162913002|NCT02946515|588382121|FG000|Overall Study|Lost to Follow-up|2|||
162913003|NCT02946515|588382122|FG001|Overall Study|Lost to Follow-up|1|||
162913004|NCT03039686|588382125|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
162913005|NCT03039686|588382126|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
162913006|NCT03039686|588382127|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
162913007|NCT03039686|588382125|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
162913008|NCT03039686|588382126|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
162913009|NCT03039686|588382127|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
162913010|NCT03039686|588382125|FG000|Double-blind Period|Withdrawal by Subject|2|||
162913011|NCT03039686|588382126|FG001|Double-blind Period|Withdrawal by Subject|2|||
162913012|NCT03039686|588382127|FG002|Double-blind Period|Withdrawal by Subject|1|||
162913013|NCT03039686|588382125|FG000|Double-blind Period|Death|0|||
162913014|NCT03039686|588382126|FG001|Double-blind Period|Death|0|||
162913015|NCT03039686|588382127|FG002|Double-blind Period|Death|1|||
162913016|NCT03039686|588382125|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
162913017|NCT03039686|588382126|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
162913018|NCT03039686|588382127|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
162913019|NCT03039686|588382125|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
162913020|NCT03039686|588382126|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
162913021|NCT03039686|588382127|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
162913022|NCT03039686|588382125|FG000|Open Label Period|Withdrawal by Subject|0|||
162913023|NCT03039686|588382126|FG001|Open Label Period|Withdrawal by Subject|3|||
162913024|NCT03039686|588382127|FG002|Open Label Period|Withdrawal by Subject|1|||
162913025|NCT02158949|588382128|FG000|Overall Study|Withdrawal by Subject|1|||
162913026|NCT02158949|588382129|FG001|Overall Study|Withdrawal by Subject|0|||
162913027|NCT02158949|588382128|FG000|Overall Study|Lost to Follow-up|5|||
162913028|NCT02158949|588382129|FG001|Overall Study|Lost to Follow-up|11|||
162913029|NCT00475657|588382131|FG000|Overall Study|Death|1|||
162913030|NCT00475657|588382131|FG000|Overall Study|Sponsor's Decision|3|||
162913031|NCT00408408|588382132|FG000|Overall Study|No follow up data|2|||
162913032|NCT00408408|588382133|FG001|Overall Study|No follow up data|3|||
162913033|NCT00408408|588382134|FG002|Overall Study|No follow up data|0|||
162913034|NCT00408408|588382135|FG003|Overall Study|No follow up data|7|||
162913035|NCT00408408|588382136|FG004|Overall Study|No follow up data|5|||
162913036|NCT00408408|588382137|FG005|Overall Study|No follow up data|3|||
162913037|NCT02898662|588382144|FG000|Overall Study|Adverse Event|1|||
162913038|NCT02898662|588382145|FG001|Overall Study|Adverse Event|0|||
162913039|NCT02898662|588382144|FG000|Overall Study|Loss of asthma control|23|||
162913040|NCT02898662|588382145|FG001|Overall Study|Loss of asthma control|24|||
162913041|NCT02898662|588382144|FG000|Overall Study|Withdrawal by Subject|4|||
162913042|NCT02898662|588382145|FG001|Overall Study|Withdrawal by Subject|1|||
162913043|NCT02898662|588382144|FG000|Overall Study|Technical issue|0|||
162913044|NCT02898662|588382145|FG001|Overall Study|Technical issue|1|||
162913045|NCT02898662|588382144|FG000|Overall Study|Randomized in error|0|||
162913046|NCT02898662|588382145|FG001|Overall Study|Randomized in error|1|||
162913047|NCT02898662|588382144|FG000|Overall Study|Subject decision|1|||
162913048|NCT02898662|588382145|FG001|Overall Study|Subject decision|0|||
162913049|NCT02898662|588382144|FG000|Overall Study|Other|0|||
162913050|NCT02898662|588382145|FG001|Overall Study|Other|1|||
162913051|NCT00399542|588382146|FG000|Overall Study|Adverse Event|18|||
162913052|NCT00399542|588382147|FG001|Overall Study|Adverse Event|15|||
162913053|NCT00399542|588382146|FG000|Overall Study|Protocol Violation|13|||
162913054|NCT00399542|588382147|FG001|Overall Study|Protocol Violation|3|||
162913055|NCT00399542|588382146|FG000|Overall Study|Withdrawal by Subject|28|||
162913056|NCT00399542|588382147|FG001|Overall Study|Withdrawal by Subject|10|||
162913057|NCT00399542|588382146|FG000|Overall Study|Lack of Efficacy|18|||
162913058|NCT00399542|588382147|FG001|Overall Study|Lack of Efficacy|8|||
162913059|NCT00399542|588382146|FG000|Overall Study|Lost to Follow-up|6|||
162913060|NCT00399542|588382147|FG001|Overall Study|Lost to Follow-up|6|||
162913061|NCT00399542|588382146|FG000|Overall Study|Other|1|||
162913062|NCT00399542|588382147|FG001|Overall Study|Other|0|||
162913063|NCT00399542|588382146|FG000|Overall Study|Physician Decision|0|||
162913064|NCT00399542|588382147|FG001|Overall Study|Physician Decision|1|||
162913065|NCT00917553|588382148|FG000|Overall Study|Lost to Follow-up|2|||
162913066|NCT00917553|588382149|FG001|Overall Study|Lost to Follow-up|1|||
162913067|NCT01616173|588382150|FG000|Overall Study|Lost to Follow-up|0|||
162913068|NCT01616173|588382151|FG001|Overall Study|Lost to Follow-up|2|||
162913069|NCT01616173|588382152|FG002|Overall Study|Lost to Follow-up|0|||
162913070|NCT03172026|588382156|FG000|Overall Study|Withdrawal by Subject|1|||
162913071|NCT03172026|588382157|FG001|Overall Study|Withdrawal by Subject|0|||
162913072|NCT03172026|588382156|FG000|Overall Study|COVID restrictions|1|||
162913073|NCT03172026|588382157|FG001|Overall Study|COVID restrictions|0|||
162913074|NCT01430559|588382161|FG000|Overall Study|Adverse Event|7|||
162913075|NCT01430559|588382162|FG001|Overall Study|Adverse Event|3|||
162913076|NCT01430559|588382161|FG000|Overall Study|Entry criteria not met|1|||
162913077|NCT01430559|588382162|FG001|Overall Study|Entry criteria not met|1|||
162913078|NCT01430559|588382161|FG000|Overall Study|Lost to Follow-up|1|||
162913079|NCT01430559|588382162|FG001|Overall Study|Lost to Follow-up|0|||
162913080|NCT01430559|588382161|FG000|Overall Study|Medication error|1|||
162913081|NCT01430559|588382162|FG001|Overall Study|Medication error|0|||
162913082|NCT01430559|588382161|FG000|Overall Study|Withdrawal by Subject|3|||
162913083|NCT01430559|588382162|FG001|Overall Study|Withdrawal by Subject|2|||
162913084|NCT01430559|588382161|FG000|Overall Study|Protocol Violation|1|||
162913085|NCT01430559|588382162|FG001|Overall Study|Protocol Violation|0|||
162913086|NCT01430559|588382161|FG000|Overall Study|Other|3|||
162913087|NCT01430559|588382162|FG001|Overall Study|Other|3|||
162913088|NCT01430559|588382161|FG000|Overall Study|Randomized, Not Treated|3|||
162913089|NCT01430559|588382162|FG001|Overall Study|Randomized, Not Treated|3|||
162913090|NCT00504595|588382163|FG000|Overall Study|Lack of Efficacy|1|||
162913091|NCT00504595|588382164|FG001|Overall Study|Lack of Efficacy|0|||
162913092|NCT00504595|588382165|FG002|Overall Study|Lack of Efficacy|0|||
162913093|NCT00504595|588382166|FG003|Overall Study|Lack of Efficacy|0|||
162913094|NCT00504595|588382163|FG000|Overall Study|Other|0|||
162913095|NCT00504595|588382164|FG001|Overall Study|Other|0|||
162913096|NCT00504595|588382165|FG002|Overall Study|Other|2|||
162913097|NCT00504595|588382166|FG003|Overall Study|Other|0|||
162913098|NCT01220024|588382167|FG000|Overall Study|Lost to Follow-up|1|||
162913099|NCT01220024|588382168|FG001|Overall Study|Lost to Follow-up|1|||
162913100|NCT00174460|588382170|FG000|Overall Study|Withdrawal by Subject|0|||
162913101|NCT00174460|588382171|FG001|Overall Study|Withdrawal by Subject|1|||
162913102|NCT00579059|588382172|FG000|Overall Study|Study Canceled at 1 Year|21|||
162710766|NCT02931396|587651056|FG000|Overall Study|Lost to Follow-up|3|||
162913103|NCT00579059|588382173|FG001|Overall Study|Study Canceled at 1 Year|10|||
162913104|NCT00779142|588382174|FG000|Overall Study|Screen Failures|3|||
162913105|NCT04652245|588382175|FG000|Wash-Out Period|Adverse Event|0|||
162913106|NCT04652245|588382176|FG001|Wash-Out Period|Adverse Event|2|||
162913107|NCT04652245|588382175|FG000|Wash-Out Period|Withdrawal by Subject|0|||
162913108|NCT04652245|588382176|FG001|Wash-Out Period|Withdrawal by Subject|2|||
162913109|NCT03137433|588382181|FG000|Overall Study|Withdrawal by Subject|11|||
162913110|NCT03137433|588382182|FG001|Overall Study|Withdrawal by Subject|11|||
162913111|NCT03137433|588382181|FG000|Overall Study|Lost to Follow-up|5|||
162913112|NCT03137433|588382182|FG001|Overall Study|Lost to Follow-up|6|||
162913113|NCT03137433|588382181|FG000|Overall Study|Physician Decision|2|||
162913114|NCT03137433|588382182|FG001|Overall Study|Physician Decision|0|||
162913115|NCT03137433|588382181|FG000|Overall Study|Moved out of study area|1|||
162913116|NCT03137433|588382182|FG001|Overall Study|Moved out of study area|0|||
162913117|NCT03137433|588382181|FG000|Overall Study|Too far out of window due to COVID|0|||
162913118|NCT03137433|588382182|FG001|Overall Study|Too far out of window due to COVID|1|||
162913119|NCT01288911|588382183|FG000|Double-blind Period|Death|11|||
162913120|NCT01288911|588382184|FG001|Double-blind Period|Death|7|||
162913121|NCT01288911|588382183|FG000|Double-blind Period|Lost to Follow-up|0|||
162913122|NCT01288911|588382184|FG001|Double-blind Period|Lost to Follow-up|2|||
162913123|NCT01288911|588382183|FG000|Double-blind Period|Progressive Disease|75|||
162913124|NCT01288911|588382184|FG001|Double-blind Period|Progressive Disease|103|||
162913125|NCT01288911|588382183|FG000|Double-blind Period|Protocol Violation|1|||
162913126|NCT01288911|588382184|FG001|Double-blind Period|Protocol Violation|0|||
162913127|NCT01288911|588382183|FG000|Double-blind Period|Withdrawal by Subject|25|||
162913128|NCT01288911|588382184|FG001|Double-blind Period|Withdrawal by Subject|26|||
162913129|NCT01288911|588382183|FG000|Double-blind Period|Miscellaneous Reason|29|||
162913130|NCT01288911|588382184|FG001|Double-blind Period|Miscellaneous Reason|42|||
162913131|NCT01288911|588382183|FG000|Double-blind Period|Randomized but never received study drug|1|||
162913132|NCT01288911|588382184|FG001|Double-blind Period|Randomized but never received study drug|2|||
162913133|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Death|0|||
162913134|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Death|1|||
162913135|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
162913136|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
162913137|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
162913138|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
162913139|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
162913140|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
162913141|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
162913142|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
162913143|NCT01288911|588382183|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
162913144|NCT01288911|588382184|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
162913145|NCT02543918|588382185|FG000|Overall Study|Never treated|0|||
162913146|NCT02543918|588382186|FG001|Overall Study|Never treated|1|||
162913147|NCT02543918|588382185|FG000|Overall Study|Lost to Follow-up|1|||
162913148|NCT02543918|588382186|FG001|Overall Study|Lost to Follow-up|1|||
162913149|NCT02543918|588382185|FG000|Overall Study|Withdrawal by Subject|1|||
162913150|NCT02543918|588382186|FG001|Overall Study|Withdrawal by Subject|1|||
162913151|NCT02543918|588382185|FG000|Overall Study|Adverse Event|1|||
162913152|NCT02543918|588382186|FG001|Overall Study|Adverse Event|1|||
162913153|NCT00486720|588382189|FG000|Overall Study|Adverse Event|1|||
162913154|NCT00486720|588382190|FG001|Overall Study|Adverse Event|2|||
162913155|NCT00486720|588382189|FG000|Overall Study|Lack of Efficacy|4|||
162913156|NCT00486720|588382190|FG001|Overall Study|Lack of Efficacy|6|||
162913157|NCT00486720|588382189|FG000|Overall Study|Physician Decision|1|||
162913158|NCT00486720|588382190|FG001|Overall Study|Physician Decision|2|||
162913159|NCT00486720|588382189|FG000|Overall Study|Protocol Violation|1|||
162913160|NCT00486720|588382190|FG001|Overall Study|Protocol Violation|0|||
162913161|NCT00486720|588382189|FG000|Overall Study|Withdrawal by Subject|3|||
162913162|NCT00486720|588382190|FG001|Overall Study|Withdrawal by Subject|1|||
162913163|NCT00486720|588382189|FG000|Overall Study|Progressive Disease|0|||
162913164|NCT00486720|588382190|FG001|Overall Study|Progressive Disease|1|||
162913165|NCT02452892|588382193|FG000|Week 1 Initial Randommization|Adverse Event|1|||
162913166|NCT02452892|588382194|FG001|Week 1 Initial Randommization|Adverse Event|0|||
162913167|NCT02452892|588382195|FG002|Week 1 Initial Randommization|Adverse Event|0|||
162913168|NCT02452892|588382196|FG003|Week 1 Initial Randommization|Adverse Event|0|||
162913169|NCT02452892|588382193|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
162913170|NCT02452892|588382194|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
162913171|NCT02452892|588382195|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
162913172|NCT02452892|588382196|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
162913173|NCT02452892|588382193|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
162913174|NCT02452892|588382194|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
162913175|NCT02452892|588382195|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
162913176|NCT02452892|588382196|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
162968192|NCT01567527|588584821|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
162968193|NCT01567527|588584822|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
162968194|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968195|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
162968196|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968197|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968198|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
162968199|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968200|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
162913177|NCT02452892|588382193|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
162913178|NCT02452892|588382194|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
162913179|NCT02452892|588382195|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
162913180|NCT02452892|588382196|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
162913181|NCT02452892|588382193|FG000|Follow-up|Withdrawal by Subject|0|||
162913182|NCT02452892|588382194|FG001|Follow-up|Withdrawal by Subject|0|||
162913183|NCT02452892|588382195|FG002|Follow-up|Withdrawal by Subject|0|||
162913184|NCT02452892|588382196|FG003|Follow-up|Withdrawal by Subject|1|||
162913185|NCT02452892|588382193|FG000|Follow-up|Subject left town on Day 42|1|||
162913186|NCT02452892|588382194|FG001|Follow-up|Subject left town on Day 42|0|||
162913187|NCT02452892|588382195|FG002|Follow-up|Subject left town on Day 42|0|||
162913188|NCT02452892|588382196|FG003|Follow-up|Subject left town on Day 42|0|||
162913189|NCT03742271|588382205|FG000|Overall Study|Unsatisfactory Visual Response|1|||
162913190|NCT03742271|588382205|FG000|Overall Study|Withdrawal by Subject|3|||
162913191|NCT03742271|588382205|FG000|Overall Study|Lost to Follow-up|4|||
162913192|NCT03742271|588382205|FG000|Overall Study|Failed Insertion & removal|3|||
162913193|NCT03742271|588382205|FG000|Overall Study|Protocol Violation|1|||
162913194|NCT01843933|588382206|FG000|Overall Study|Data lost|6|||
162913195|NCT01843933|588382207|FG001|Overall Study|Data lost|4|||
162913196|NCT03137173|588382208|FG000|Overall Study|Withdrawal by Subject|8|||
162913197|NCT03137173|588382209|FG001|Overall Study|Withdrawal by Subject|13|||
162913198|NCT03137173|588382208|FG000|Overall Study|Death|1|||
162913199|NCT03137173|588382209|FG001|Overall Study|Death|3|||
162913200|NCT03137173|588382208|FG000|Overall Study|Physician Decision|1|||
162913201|NCT03137173|588382209|FG001|Overall Study|Physician Decision|0|||
162913202|NCT03137173|588382208|FG000|Overall Study|Lost to Follow-up|13|||
162913203|NCT03137173|588382209|FG001|Overall Study|Lost to Follow-up|18|||
162913204|NCT03137173|588382208|FG000|Overall Study|Other reasons|3|||
162913205|NCT03137173|588382209|FG001|Overall Study|Other reasons|2|||
162913206|NCT01535638|588382210|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
162913207|NCT01535638|588382211|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
162913208|NCT01535638|588382212|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
162913209|NCT01535638|588382213|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
162913210|NCT01535638|588382214|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
162913211|NCT01535638|588382215|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
162913212|NCT01535638|588382210|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
162913213|NCT01535638|588382211|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
162913214|NCT01535638|588382212|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
162913215|NCT01535638|588382213|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
162913216|NCT01535638|588382214|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
162913217|NCT01535638|588382215|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
162913218|NCT05060003|588382216|FG000|Overall Study|ctDNA negative|7|||
162913219|NCT03524664|588382217|FG000|Overall Study|Withdrawal by Subject|1|||
162913220|NCT03524664|588382218|FG001|Overall Study|Withdrawal by Subject|2|||
162913221|NCT03524664|588382217|FG000|Overall Study|Lost to Follow-up|4|||
162913222|NCT03524664|588382218|FG001|Overall Study|Lost to Follow-up|13|||
162913223|NCT02694562|588382219|FG000|Overall Study|Death|8|||
162913224|NCT02694562|588382219|FG000|Overall Study|Protocol Violation|4|||
162913225|NCT02694562|588382219|FG000|Overall Study|Lost to Follow-up|3|||
162913226|NCT02694562|588382219|FG000|Overall Study|Screen Failure|2|||
162913227|NCT02694562|588382219|FG000|Overall Study|Physician Decision|1|||
162913228|NCT00827112|588382220|FG000|Overall Study|Adverse Event|2|||
162913229|NCT00827112|588382221|FG001|Overall Study|Adverse Event|0|||
162913230|NCT00827112|588382220|FG000|Overall Study|Lack of Efficacy|2|||
162913231|NCT00827112|588382221|FG001|Overall Study|Lack of Efficacy|0|||
162913232|NCT00827112|588382220|FG000|Overall Study|Lost to Follow-up|3|||
162913233|NCT00827112|588382221|FG001|Overall Study|Lost to Follow-up|2|||
162913234|NCT00827112|588382220|FG000|Overall Study|Pregnancy|0|||
162913235|NCT00827112|588382221|FG001|Overall Study|Pregnancy|1|||
162913236|NCT00827112|588382220|FG000|Overall Study|Protocol Violation|0|||
162913237|NCT00827112|588382221|FG001|Overall Study|Protocol Violation|2|||
162913238|NCT00827112|588382220|FG000|Overall Study|Withdrawal by Subject|2|||
162913239|NCT00827112|588382221|FG001|Overall Study|Withdrawal by Subject|1|||
162913240|NCT00827112|588382220|FG000|Overall Study|Randomized but not treated|5|||
162913241|NCT00827112|588382221|FG001|Overall Study|Randomized but not treated|3|||
162913242|NCT00827112|588382220|FG000|Overall Study|Other|1|||
162913243|NCT00827112|588382221|FG001|Overall Study|Other|3|||
162913244|NCT03529162|588382226|FG000|Overall Study|Lost to Follow-up|2|||
162913245|NCT03529162|588382227|FG001|Overall Study|Lost to Follow-up|2|||
162913246|NCT00554229|588382232|FG000|Overall Study|Lost to Follow-up|3|||
162913247|NCT00554229|588382233|FG001|Overall Study|Lost to Follow-up|6|||
162913248|NCT00554229|588382232|FG000|Overall Study|Withdrawal by Subject|29|||
162913249|NCT00554229|588382233|FG001|Overall Study|Withdrawal by Subject|37|||
162913250|NCT00554229|588382232|FG000|Overall Study|Adverse Event|71|||
162913251|NCT00554229|588382233|FG001|Overall Study|Adverse Event|39|||
162913252|NCT00554229|588382232|FG000|Overall Study|Protocol Violation|3|||
162913253|NCT00554229|588382233|FG001|Overall Study|Protocol Violation|3|||
162913254|NCT00554229|588382232|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
162913255|NCT00554229|588382233|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
162913256|NCT00554229|588382232|FG000|Overall Study|Randomised but no treatment received|1|||
162913257|NCT00554229|588382233|FG001|Overall Study|Randomised but no treatment received|0|||
162913258|NCT00784836|588382234|FG000|Overall Study|Early Study Termination|3|||
162913259|NCT00517634|588382235|FG000|Second Treatment Period|Withdrawal by Subject|0|||
162913260|NCT00517634|588382236|FG001|Second Treatment Period|Withdrawal by Subject|0|||
162913261|NCT00517634|588382237|FG002|Second Treatment Period|Withdrawal by Subject|0|||
162913262|NCT00517634|588382238|FG003|Second Treatment Period|Withdrawal by Subject|0|||
162913263|NCT00517634|588382239|FG004|Second Treatment Period|Withdrawal by Subject|1|||
162913264|NCT00517634|588382240|FG005|Second Treatment Period|Withdrawal by Subject|0|||
162913265|NCT03143855|588382241|FG000|Overall Study|Withdrawal by Subject|4|||
162913266|NCT03143855|588382242|FG001|Overall Study|Withdrawal by Subject|3|||
162913267|NCT03143855|588382241|FG000|Overall Study|Protocol Violation|1|||
162913268|NCT03143855|588382242|FG001|Overall Study|Protocol Violation|0|||
162913269|NCT03143855|588382241|FG000|Overall Study|Participant experienced withdrawal|0|||
162913270|NCT03143855|588382242|FG001|Overall Study|Participant experienced withdrawal|1|||
162913271|NCT00701064|588382245|FG000|Overall Study|Protocol Violation|1|||
162913272|NCT00701064|588382246|FG001|Overall Study|Protocol Violation|1|||
162913273|NCT00701064|588382245|FG000|Overall Study|Withdrawal by Subject|1|||
162913274|NCT00701064|588382246|FG001|Overall Study|Withdrawal by Subject|1|||
162913275|NCT00701064|588382245|FG000|Overall Study|initiated other PTSD treatment|2|||
162913276|NCT00701064|588382246|FG001|Overall Study|initiated other PTSD treatment|2|||
162913277|NCT02613910|588382247|FG000|Overall Study|Termination of study|1|||
162913278|NCT02098733|588382248|FG000|Overall Study|Data Not Available|5|||
162913279|NCT02098733|588382248|FG000|Overall Study|Lost to Follow-up|5|||
162913280|NCT03077646|588382249|FG000|Overall Study|Lost to Follow-up|29|||
162913281|NCT03077646|588382250|FG001|Overall Study|Lost to Follow-up|30|||
162913282|NCT03077646|588382251|FG002|Overall Study|Lost to Follow-up|31|||
162913283|NCT00765726|588382252|FG000|Overall Study|Withdrawal by Subject|1|||
162913284|NCT00765726|588382252|FG000|Overall Study|Discontinuation of study by sponsor|8|||
162913285|NCT02993731|588382253|FG000|Overall Study|Study Termination|101|||
162913286|NCT02993731|588382254|FG001|Overall Study|Study Termination|105|||
162913287|NCT00939094|588382255|FG000|Overall Study|Adverse Event|9|||
162913288|NCT00939094|588382256|FG001|Overall Study|Adverse Event|0|||
162913289|NCT00939094|588382255|FG000|Overall Study|Withdrawal by Subject|1|||
162913290|NCT00939094|588382256|FG001|Overall Study|Withdrawal by Subject|6|||
162913291|NCT00939094|588382255|FG000|Overall Study|Lost to Follow-up|1|||
162913292|NCT00939094|588382256|FG001|Overall Study|Lost to Follow-up|1|||
162913293|NCT00939094|588382255|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162913294|NCT00939094|588382256|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162913295|NCT00939094|588382255|FG000|Overall Study|Severe non-compliance to protocol|0|||
162913296|NCT00939094|588382256|FG001|Overall Study|Severe non-compliance to protocol|1|||
162913297|NCT00939094|588382255|FG000|Overall Study|Study stopped by sponsor|0|||
162913298|NCT00939094|588382256|FG001|Overall Study|Study stopped by sponsor|2|||
162913299|NCT00939094|588382255|FG000|Overall Study|Abnormal ECG findings|1|||
162913300|NCT00939094|588382256|FG001|Overall Study|Abnormal ECG findings|0|||
162913301|NCT01002573|588383968|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
162913302|NCT01002573|588383969|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
162913303|NCT03808298|588383973|FG000|Overall Study|Adverse Event|3|||
162913304|NCT03808298|588383973|FG000|Overall Study|Physician Decision|1|||
162913305|NCT03808298|588383973|FG000|Overall Study|Withdrawal by Subject|1|||
162913306|NCT03808298|588383973|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
162913307|NCT02713490|588383974|FG000|Overall Study|Withdrawal by Subject|2|||
162913308|NCT02713490|588383975|FG001|Overall Study|Withdrawal by Subject|1|||
162913309|NCT02713490|588383974|FG000|Overall Study|Did not receive study drug|1|||
162913310|NCT02713490|588383975|FG001|Overall Study|Did not receive study drug|0|||
162913311|NCT02713490|588383974|FG000|Overall Study|Met exclusion criteria|0|||
162913312|NCT02713490|588383975|FG001|Overall Study|Met exclusion criteria|1|||
162913313|NCT03868410|588383984|FG000|Overall Study|Physician Decision|0|||
162913314|NCT03868410|588383985|FG001|Overall Study|Physician Decision|1|||
162913315|NCT00134563|588383989|FG000|Overall Study|Not treated due to protocol violation|0|||
162913316|NCT00134563|588383990|FG001|Overall Study|Not treated due to protocol violation|1|||
162913317|NCT00134563|588383991|FG002|Overall Study|Not treated due to protocol violation|1|||
162913318|NCT00134563|588383989|FG000|Overall Study|Adverse Event|29|||
162913319|NCT00134563|588383990|FG001|Overall Study|Adverse Event|37|||
162913320|NCT00134563|588383991|FG002|Overall Study|Adverse Event|38|||
162913321|NCT00134563|588383989|FG000|Overall Study|Lack of Efficacy|24|||
162913322|NCT00134563|588383990|FG001|Overall Study|Lack of Efficacy|14|||
162913323|NCT00134563|588383991|FG002|Overall Study|Lack of Efficacy|17|||
162913324|NCT00134563|588383989|FG000|Overall Study|Protocol Violation|3|||
162913325|NCT00134563|588383990|FG001|Overall Study|Protocol Violation|2|||
162913326|NCT00134563|588383991|FG002|Overall Study|Protocol Violation|5|||
162913327|NCT00134563|588383989|FG000|Overall Study|Lost to Follow-up|4|||
162913328|NCT00134563|588383990|FG001|Overall Study|Lost to Follow-up|0|||
162913329|NCT00134563|588383991|FG002|Overall Study|Lost to Follow-up|2|||
162913330|NCT00134563|588383989|FG000|Overall Study|progressive disease|11|||
162913331|NCT00134563|588383990|FG001|Overall Study|progressive disease|4|||
162913332|NCT00134563|588383991|FG002|Overall Study|progressive disease|2|||
162913333|NCT00134563|588383989|FG000|Overall Study|did not wish to continue|33|||
162913334|NCT00134563|588383990|FG001|Overall Study|did not wish to continue|32|||
162913335|NCT00134563|588383991|FG002|Overall Study|did not wish to continue|26|||
162913336|NCT00134563|588383989|FG000|Overall Study|Reason other than above|0|||
162913337|NCT00134563|588383990|FG001|Overall Study|Reason other than above|2|||
162913338|NCT00134563|588383991|FG002|Overall Study|Reason other than above|5|||
162913339|NCT03382639|588383995|FG000|Overall Study|Adverse Event|2|||
162913340|NCT03382639|588383996|FG001|Overall Study|Adverse Event|0|||
162913341|NCT03382639|588383997|FG002|Overall Study|Adverse Event|1|||
162913342|NCT03382639|588383998|FG003|Overall Study|Adverse Event|1|||
162913343|NCT03382639|588383995|FG000|Overall Study|Lost to Follow-up|1|||
162913344|NCT03382639|588383996|FG001|Overall Study|Lost to Follow-up|0|||
162913345|NCT03382639|588383997|FG002|Overall Study|Lost to Follow-up|0|||
162913346|NCT03382639|588383998|FG003|Overall Study|Lost to Follow-up|0|||
162913347|NCT03382639|588383995|FG000|Overall Study|Withdrawal by Subject|4|||
162913348|NCT03382639|588383996|FG001|Overall Study|Withdrawal by Subject|3|||
162913349|NCT03382639|588383997|FG002|Overall Study|Withdrawal by Subject|2|||
162913350|NCT03382639|588383998|FG003|Overall Study|Withdrawal by Subject|3|||
162913351|NCT03382639|588383995|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
162913352|NCT03382639|588383996|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
162913353|NCT03382639|588383997|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
162913354|NCT03382639|588383998|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
162913355|NCT03382639|588383995|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
162913356|NCT03382639|588383996|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
162913357|NCT03382639|588383997|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
162913358|NCT03382639|588383998|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
162913359|NCT03382639|588383995|FG000|Overall Study|Other|2|||
162913360|NCT03382639|588383996|FG001|Overall Study|Other|0|||
162913361|NCT03382639|588383997|FG002|Overall Study|Other|0|||
162913362|NCT03382639|588383998|FG003|Overall Study|Other|3|||
162913363|NCT02406586|588383999|FG000|Overall Study|Lost to Follow-up|0|||
162913364|NCT02406586|588384000|FG001|Overall Study|Lost to Follow-up|4|||
162913365|NCT02406586|588384001|FG002|Overall Study|Lost to Follow-up|2|||
162913366|NCT02406586|588383999|FG000|Overall Study|Withdrawal by Subject|1|||
162913367|NCT02406586|588384000|FG001|Overall Study|Withdrawal by Subject|0|||
162913368|NCT02406586|588384001|FG002|Overall Study|Withdrawal by Subject|0|||
162913369|NCT02624713|588384004|FG000|Overall Study|Lost to Follow-up|14|||
162913370|NCT02624713|588384005|FG001|Overall Study|Lost to Follow-up|0|||
162913371|NCT00285857|588384006|FG000|Overall Study|Withdrawal by Subject|2|||
162913372|NCT00285857|588384006|FG000|Overall Study|Inadequate initial breast cytology|1|||
162913373|NCT00285857|588384006|FG000|Overall Study|Adverse Event|1|||
162913374|NCT00148109|588384011|FG000|Overall Study|Lack of Efficacy|10|||
162913375|NCT00148109|588384012|FG001|Overall Study|Lack of Efficacy|18|||
162913376|NCT00148109|588384011|FG000|Overall Study|Adverse Event|0|||
162913377|NCT00148109|588384012|FG001|Overall Study|Adverse Event|2|||
162913378|NCT00148109|588384011|FG000|Overall Study|Withdrawal by Subject|2|||
162913379|NCT00148109|588384012|FG001|Overall Study|Withdrawal by Subject|0|||
162913380|NCT06104423|588384013|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
162913381|NCT06104423|588384014|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
162913382|NCT06104423|588384015|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
162913383|NCT06104423|588384013|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
162913384|NCT06104423|588384014|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
162913385|NCT06104423|588384015|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
162913386|NCT00351611|588384020|FG000|Overall Study|Adverse Event|11|||
162913387|NCT00351611|588384021|FG001|Overall Study|Adverse Event|3|||
162913388|NCT00351611|588384020|FG000|Overall Study|Death|1|||
162913389|NCT00351611|588384021|FG001|Overall Study|Death|0|||
162913390|NCT00351611|588384020|FG000|Overall Study|Lost to Follow-up|1|||
162913391|NCT00351611|588384021|FG001|Overall Study|Lost to Follow-up|0|||
162913392|NCT00351611|588384020|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
162913393|NCT00351611|588384021|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
162913394|NCT00351611|588384020|FG000|Overall Study|Other|1|||
162913395|NCT00351611|588384021|FG001|Overall Study|Other|0|||
162913396|NCT00351611|588384020|FG000|Overall Study|Protocol Violation|0|||
162913397|NCT00351611|588384021|FG001|Overall Study|Protocol Violation|2|||
162913398|NCT01589185|588384022|FG000|Overall Study|Death|1|||
162913399|NCT01589185|588384023|FG001|Overall Study|Death|2|||
162913400|NCT01589185|588384024|FG002|Overall Study|Death|2|||
162913401|NCT01589185|588384025|FG003|Overall Study|Death|0|||
162913402|NCT01589185|588384026|FG004|Overall Study|Death|1|||
162913403|NCT01589185|588384022|FG000|Overall Study|Lost to Follow-up|1|||
162913404|NCT01589185|588384023|FG001|Overall Study|Lost to Follow-up|0|||
162913405|NCT01589185|588384024|FG002|Overall Study|Lost to Follow-up|2|||
162913406|NCT01589185|588384025|FG003|Overall Study|Lost to Follow-up|3|||
162913407|NCT01589185|588384026|FG004|Overall Study|Lost to Follow-up|0|||
162913408|NCT02708524|588384027|FG000|Overall Study|Adverse Event|0|||
162913409|NCT02708524|588384028|FG001|Overall Study|Adverse Event|1|||
162913410|NCT02708524|588384029|FG002|Overall Study|Adverse Event|0|||
162913411|NCT02708524|588384030|FG003|Overall Study|Adverse Event|0|||
162913412|NCT02708524|588384027|FG000|Overall Study|Lens Discomfort|1|||
162913413|NCT02708524|588384028|FG001|Overall Study|Lens Discomfort|0|||
162913414|NCT02708524|588384029|FG002|Overall Study|Lens Discomfort|1|||
162913415|NCT02708524|588384030|FG003|Overall Study|Lens Discomfort|0|||
162913416|NCT02708524|588384027|FG000|Overall Study|Lost to Follow-up|1|||
162913417|NCT02708524|588384028|FG001|Overall Study|Lost to Follow-up|1|||
162913418|NCT02708524|588384029|FG002|Overall Study|Lost to Follow-up|1|||
162913419|NCT02708524|588384030|FG003|Overall Study|Lost to Follow-up|0|||
162913420|NCT02708524|588384027|FG000|Overall Study|Protocol Violation|0|||
162913421|NCT02708524|588384028|FG001|Overall Study|Protocol Violation|1|||
162913422|NCT02708524|588384029|FG002|Overall Study|Protocol Violation|0|||
162913423|NCT02708524|588384030|FG003|Overall Study|Protocol Violation|0|||
162913424|NCT02708524|588384027|FG000|Overall Study|Withdrawal by Subject|1|||
162913425|NCT02708524|588384028|FG001|Overall Study|Withdrawal by Subject|1|||
162913426|NCT02708524|588384029|FG002|Overall Study|Withdrawal by Subject|0|||
162913427|NCT02708524|588384030|FG003|Overall Study|Withdrawal by Subject|0|||
162913428|NCT02708524|588384027|FG000|Overall Study|Dispensed incorrect study lens|0|||
162913429|NCT02708524|588384028|FG001|Overall Study|Dispensed incorrect study lens|1|||
162913430|NCT02708524|588384029|FG002|Overall Study|Dispensed incorrect study lens|1|||
162913431|NCT02708524|588384030|FG003|Overall Study|Dispensed incorrect study lens|0|||
162913432|NCT02708524|588384027|FG000|Overall Study|Did not wear lens at final visit|0|||
162913433|NCT02708524|588384028|FG001|Overall Study|Did not wear lens at final visit|1|||
162913434|NCT02708524|588384029|FG002|Overall Study|Did not wear lens at final visit|0|||
162913435|NCT02708524|588384030|FG003|Overall Study|Did not wear lens at final visit|0|||
162913436|NCT02708524|588384027|FG000|Overall Study|Subject lost study lens|1|||
162913437|NCT02708524|588384028|FG001|Overall Study|Subject lost study lens|0|||
162913438|NCT02708524|588384029|FG002|Overall Study|Subject lost study lens|0|||
162913439|NCT02708524|588384030|FG003|Overall Study|Subject lost study lens|0|||
162913440|NCT03781167|588384036|FG000|Overall Study|Adverse Event|23|||
162913441|NCT03781167|588384037|FG001|Overall Study|Adverse Event|25|||
162913442|NCT03781167|588384036|FG000|Overall Study|Withdrew consent|16|||
162913443|NCT03781167|588384037|FG001|Overall Study|Withdrew consent|12|||
162913444|NCT03781167|588384036|FG000|Overall Study|Lost to Follow-up|0|||
162913445|NCT03781167|588384037|FG001|Overall Study|Lost to Follow-up|1|||
162913446|NCT03781167|588384036|FG000|Overall Study|Lack of Efficacy|4|||
162913447|NCT03781167|588384037|FG001|Overall Study|Lack of Efficacy|5|||
162913448|NCT03781167|588384036|FG000|Overall Study|Difficulty with drug delivery system|2|||
162913449|NCT03781167|588384037|FG001|Overall Study|Difficulty with drug delivery system|3|||
162913450|NCT03781167|588384036|FG000|Overall Study|Other, not specified|2|||
162913451|NCT03781167|588384037|FG001|Overall Study|Other, not specified|2|||
162913452|NCT00462501|588384038|FG000|Overall Study|Not treated|3|||
162913453|NCT00462501|588384038|FG000|Overall Study|Adverse Event|2|||
162913454|NCT00679354|588384043|FG000|Overall Study|Death|3|||
162913455|NCT00679354|588384043|FG000|Overall Study|Lack of Efficacy|22|||
162913456|NCT00679354|588384043|FG000|Overall Study|Physician Decision|4|||
162913457|NCT00679354|588384043|FG000|Overall Study|Ineligible|1|||
162913458|NCT01258803|588384053|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
162913459|NCT01258803|588384054|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
162913460|NCT01258803|588384055|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
162913461|NCT01258803|588384056|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
162913462|NCT01258803|588384057|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
162913463|NCT01258803|588384058|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
162913464|NCT01258803|588384053|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
162913465|NCT01258803|588384054|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
162913466|NCT01258803|588384055|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
162913467|NCT01258803|588384056|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
162913468|NCT01258803|588384057|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
162913469|NCT01258803|588384058|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
162913470|NCT01258803|588384053|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
162913471|NCT01258803|588384054|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
162913472|NCT01258803|588384055|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
162913473|NCT01258803|588384056|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
162913474|NCT01258803|588384057|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
162913475|NCT01258803|588384058|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
162913476|NCT01552408|588384059|FG000|Overall Study|Lost to Follow-up|2|||
162913477|NCT01552408|588384060|FG001|Overall Study|Lost to Follow-up|0|||
162913478|NCT01552408|588384059|FG000|Overall Study|Relocation|0|||
162913479|NCT01552408|588384060|FG001|Overall Study|Relocation|1|||
162913480|NCT01552408|588384059|FG000|Overall Study|Withdrawal by Subject|2|||
162710767|NCT02931396|587651057|FG001|Overall Study|Lost to Follow-up|0|||
162913481|NCT01552408|588384060|FG001|Overall Study|Withdrawal by Subject|1|||
162913482|NCT01016912|588384065|FG000|End of Treatment Period|Lack of Efficacy|0|||
162913483|NCT01016912|588384066|FG001|End of Treatment Period|Lack of Efficacy|1|||
162913484|NCT01016912|588384067|FG002|End of Treatment Period|Lack of Efficacy|0|||
162913485|NCT01016912|588384068|FG003|End of Treatment Period|Lack of Efficacy|4|||
162913486|NCT01016912|588384069|FG004|End of Treatment Period|Lack of Efficacy|4|||
162913487|NCT01016912|588384065|FG000|End of Treatment Period|Adverse Event|0|||
162913488|NCT01016912|588384066|FG001|End of Treatment Period|Adverse Event|1|||
162913489|NCT01016912|588384067|FG002|End of Treatment Period|Adverse Event|1|||
162710768|NCT02931396|587651056|FG000|Overall Study|Withdrawal by Subject|2|||
162710769|NCT02931396|587651057|FG001|Overall Study|Withdrawal by Subject|0|||
162710770|NCT00670540|587651058|FG000|Overall Study|ineligible|17|||
162710771|NCT00670540|587651058|FG000|Overall Study|not living in France|348|||
162710772|NCT00670540|587651058|FG000|Overall Study|refused to participate|189|||
162710773|NCT00670540|587651058|FG000|Overall Study|controls randomised for no follow up|2770|||
162710774|NCT00670540|587651058|FG000|Overall Study|missing information inclusion criteria|1|||
162710775|NCT01866917|587651059|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
162710776|NCT01866917|587651060|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
162710777|NCT01562743|587651065|FG000|Overall Study|Adverse Event|29|||
162710778|NCT01562743|587651065|FG000|Overall Study|Lack of Efficacy|3|||
162710779|NCT01562743|587651065|FG000|Overall Study|Withdrawal by Subject|13|||
162710780|NCT01562743|587651065|FG000|Overall Study|Protocol Violation|1|||
162710781|NCT01562743|587651065|FG000|Overall Study|Discontinuation criteria|2|||
162710782|NCT01562743|587651065|FG000|Overall Study|Lost to Follow-up|2|||
162710783|NCT01562743|587651065|FG000|Overall Study|Physician Decision|2|||
162710784|NCT00662909|587651067|FG000|Overall Study|Adverse Event|17|||
162710785|NCT00662909|587651068|FG001|Overall Study|Adverse Event|18|||
162710786|NCT00662909|587651069|FG002|Overall Study|Adverse Event|19|||
162710787|NCT00662909|587651067|FG000|Overall Study|Lack of Efficacy|9|||
162710788|NCT00662909|587651068|FG001|Overall Study|Lack of Efficacy|1|||
162710789|NCT00662909|587651069|FG002|Overall Study|Lack of Efficacy|5|||
162710790|NCT00662909|587651067|FG000|Overall Study|Withdrawal by Subject|29|||
162710791|NCT00662909|587651068|FG001|Overall Study|Withdrawal by Subject|22|||
162710792|NCT00662909|587651069|FG002|Overall Study|Withdrawal by Subject|16|||
162710793|NCT00662909|587651067|FG000|Overall Study|Lost to Follow-up|2|||
162710794|NCT00662909|587651068|FG001|Overall Study|Lost to Follow-up|9|||
162710795|NCT00662909|587651069|FG002|Overall Study|Lost to Follow-up|3|||
162710796|NCT00662909|587651067|FG000|Overall Study|Protocol Violation|7|||
162710797|NCT00662909|587651068|FG001|Overall Study|Protocol Violation|4|||
162710798|NCT00662909|587651069|FG002|Overall Study|Protocol Violation|5|||
162710799|NCT00662909|587651067|FG000|Overall Study|Randomized- never received study drug|1|||
162710800|NCT00662909|587651068|FG001|Overall Study|Randomized- never received study drug|0|||
162710801|NCT00662909|587651069|FG002|Overall Study|Randomized- never received study drug|0|||
162710802|NCT00662909|587651067|FG000|Overall Study|Non-compliance with study procedures|3|||
162710803|NCT00662909|587651068|FG001|Overall Study|Non-compliance with study procedures|3|||
162710804|NCT00662909|587651069|FG002|Overall Study|Non-compliance with study procedures|2|||
162710805|NCT00662909|587651067|FG000|Overall Study|Physician Decision|1|||
162710806|NCT00662909|587651068|FG001|Overall Study|Physician Decision|1|||
162710807|NCT00662909|587651069|FG002|Overall Study|Physician Decision|2|||
162710808|NCT00662909|587651067|FG000|Overall Study|Eligibility criterion not met|0|||
162710809|NCT00662909|587651068|FG001|Overall Study|Eligibility criterion not met|1|||
162710810|NCT00662909|587651069|FG002|Overall Study|Eligibility criterion not met|1|||
162710811|NCT01537133|587652767|FG000|Overall Study|Withdrawal by Subject|2|||
162710812|NCT01537133|587652768|FG001|Overall Study|Withdrawal by Subject|0|||
162710813|NCT01537133|587652769|FG002|Overall Study|Withdrawal by Subject|0|||
162710814|NCT01537133|587652770|FG003|Overall Study|Withdrawal by Subject|0|||
162710815|NCT01537133|587652767|FG000|Overall Study|Lost to Follow-up|1|||
162710816|NCT01537133|587652768|FG001|Overall Study|Lost to Follow-up|0|||
162710817|NCT01537133|587652769|FG002|Overall Study|Lost to Follow-up|0|||
162710818|NCT01537133|587652770|FG003|Overall Study|Lost to Follow-up|0|||
162710819|NCT00530335|587652771|FG000|Overall Study|Adverse Event|3|||
162710820|NCT00530335|587652771|FG000|Overall Study|Protocol Violation|1|||
162710821|NCT00530335|587652771|FG000|Overall Study|Withdrawal by Subject|1|||
162710822|NCT00530335|587652771|FG000|Overall Study|Physician Decision|1|||
162710823|NCT01244984|587652772|FG000|Overall Study|Adverse Event|2|||
162913490|NCT01016912|588384068|FG003|End of Treatment Period|Adverse Event|0|||
162710824|NCT01244984|587652773|FG001|Overall Study|Adverse Event|11|||
162710825|NCT01244984|587652774|FG002|Overall Study|Adverse Event|2|||
162710826|NCT01244984|587652772|FG000|Overall Study|Protocol Violation|1|||
162710827|NCT01244984|587652773|FG001|Overall Study|Protocol Violation|0|||
162710828|NCT01244984|587652774|FG002|Overall Study|Protocol Violation|0|||
162913491|NCT01016912|588384069|FG004|End of Treatment Period|Adverse Event|0|||
162913492|NCT01016912|588384065|FG000|End of Treatment Period|Completed double-blind period only|0|||
162913493|NCT01016912|588384066|FG001|End of Treatment Period|Completed double-blind period only|1|||
162968201|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968202|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162710829|NCT01244984|587652772|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
162710830|NCT01244984|587652773|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
162710831|NCT01244984|587652774|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
162913494|NCT01016912|588384067|FG002|End of Treatment Period|Completed double-blind period only|0|||
162913495|NCT01016912|588384068|FG003|End of Treatment Period|Completed double-blind period only|0|||
162913496|NCT01016912|588384069|FG004|End of Treatment Period|Completed double-blind period only|0|||
162913497|NCT01016912|588384065|FG000|Follow-up Period|Other reason|0|||
162913498|NCT01016912|588384066|FG001|Follow-up Period|Other reason|0|||
162913499|NCT01016912|588384067|FG002|Follow-up Period|Other reason|1|||
162913500|NCT01016912|588384068|FG003|Follow-up Period|Other reason|1|||
162913501|NCT01016912|588384069|FG004|Follow-up Period|Other reason|0|||
162913502|NCT01853397|588384072|FG000|Overall Study|Withdrawal by Subject|0|||
162913503|NCT01853397|588384073|FG001|Overall Study|Withdrawal by Subject|0|||
162913504|NCT01853397|588384074|FG002|Overall Study|Withdrawal by Subject|0|||
162913505|NCT01853397|588384075|FG003|Overall Study|Withdrawal by Subject|1|||
162913506|NCT01853397|588384072|FG000|Overall Study|Subject Noncompliance|0|||
162913507|NCT01853397|588384073|FG001|Overall Study|Subject Noncompliance|0|||
162913508|NCT01853397|588384074|FG002|Overall Study|Subject Noncompliance|0|||
162913509|NCT01853397|588384075|FG003|Overall Study|Subject Noncompliance|1|||
162913510|NCT01632345|588384076|FG000|Treatment: Part I|Adverse Event|1|||
162913511|NCT01632345|588384077|FG001|Treatment: Part I|Adverse Event|4|||
162913512|NCT01632345|588384078|FG002|Treatment: Part I|Adverse Event|2|||
162913513|NCT01632345|588384079|FG003|Treatment: Part I|Adverse Event|1|||
162913514|NCT01632345|588384080|FG004|Treatment: Part I|Adverse Event|3|||
162913515|NCT01632345|588384081|FG005|Treatment: Part I|Adverse Event|0|||
162913516|NCT01632345|588384082|FG006|Treatment: Part I|Adverse Event|0|||
162913517|NCT01632345|588384076|FG000|Treatment: Part I|Lack of Efficacy|0|||
162913518|NCT01632345|588384077|FG001|Treatment: Part I|Lack of Efficacy|1|||
162913519|NCT01632345|588384078|FG002|Treatment: Part I|Lack of Efficacy|0|||
162913520|NCT01632345|588384079|FG003|Treatment: Part I|Lack of Efficacy|1|||
162913521|NCT01632345|588384080|FG004|Treatment: Part I|Lack of Efficacy|1|||
162913522|NCT01632345|588384081|FG005|Treatment: Part I|Lack of Efficacy|0|||
162913523|NCT01632345|588384082|FG006|Treatment: Part I|Lack of Efficacy|0|||
162913524|NCT01632345|588384076|FG000|Treatment: Part I|Lost to Follow-up|3|||
162913525|NCT01632345|588384077|FG001|Treatment: Part I|Lost to Follow-up|2|||
162913526|NCT01632345|588384078|FG002|Treatment: Part I|Lost to Follow-up|1|||
162710832|NCT01244984|587652772|FG000|Overall Study|Withdrawal by Subject|1|||
162710833|NCT01244984|587652773|FG001|Overall Study|Withdrawal by Subject|2|||
162710834|NCT01244984|587652774|FG002|Overall Study|Withdrawal by Subject|2|||
162710835|NCT01801930|587652775|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
162710836|NCT01801930|587652776|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
162710837|NCT01801930|587652777|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
162710838|NCT01801930|587652778|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
162710839|NCT01801930|587652775|FG000|Overall Study|DLT occurs|0|||
162710840|NCT01801930|587652776|FG001|Overall Study|DLT occurs|1|||
162710841|NCT01801930|587652777|FG002|Overall Study|DLT occurs|0|||
162710842|NCT01801930|587652778|FG003|Overall Study|DLT occurs|0|||
162710843|NCT03396835|587652788|FG000|Overall Study|Withdrawn prior to completion|1|||
162710844|NCT03396835|587652788|FG000|Overall Study|Did not meet criteria for data analysis|1|||
162710845|NCT03467724|587652789|FG000|Overall Study|Lost to Follow-up|5|||
162710846|NCT03467724|587652789|FG000|Overall Study|Withdrawal by Subject|1|||
162913527|NCT01632345|588384079|FG003|Treatment: Part I|Lost to Follow-up|3|||
162913528|NCT01632345|588384080|FG004|Treatment: Part I|Lost to Follow-up|4|||
162968203|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
162968204|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968205|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
162968206|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968207|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968208|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
162968209|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968210|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
162968211|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968212|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162710847|NCT03467724|587652789|FG000|Overall Study|Protocol Violation|1|||
162710848|NCT03467724|587652789|FG000|Overall Study|Adverse Event|1|||
162710849|NCT01451814|587652790|FG000|Overall Study|Withdrawal by Subject|1|||
162710850|NCT01451814|587652791|FG001|Overall Study|Withdrawal by Subject|1|||
162913529|NCT01632345|588384081|FG005|Treatment: Part I|Lost to Follow-up|0|||
162913530|NCT01632345|588384082|FG006|Treatment: Part I|Lost to Follow-up|0|||
162913531|NCT01632345|588384076|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
162913532|NCT01632345|588384077|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
162913533|NCT01632345|588384078|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
162913534|NCT01632345|588384079|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
162913535|NCT01632345|588384080|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
162913536|NCT01632345|588384081|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
162913537|NCT01632345|588384082|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
162913538|NCT01632345|588384076|FG000|Treatment: Part I|Physician Decision|2|||
162913539|NCT01632345|588384077|FG001|Treatment: Part I|Physician Decision|1|||
162913540|NCT01632345|588384078|FG002|Treatment: Part I|Physician Decision|0|||
162913541|NCT01632345|588384079|FG003|Treatment: Part I|Physician Decision|0|||
162913542|NCT01632345|588384080|FG004|Treatment: Part I|Physician Decision|1|||
162913543|NCT01632345|588384081|FG005|Treatment: Part I|Physician Decision|0|||
162913544|NCT01632345|588384082|FG006|Treatment: Part I|Physician Decision|0|||
162913545|NCT01632345|588384076|FG000|Treatment: Part I|Pregnancy|0|||
162913546|NCT01632345|588384077|FG001|Treatment: Part I|Pregnancy|1|||
162913547|NCT01632345|588384078|FG002|Treatment: Part I|Pregnancy|0|||
162913548|NCT01632345|588384079|FG003|Treatment: Part I|Pregnancy|0|||
162913549|NCT01632345|588384080|FG004|Treatment: Part I|Pregnancy|0|||
162913550|NCT01632345|588384081|FG005|Treatment: Part I|Pregnancy|0|||
162913551|NCT01632345|588384082|FG006|Treatment: Part I|Pregnancy|0|||
162913552|NCT01632345|588384076|FG000|Treatment: Part I|Protocol Deviation|0|||
162913553|NCT01632345|588384077|FG001|Treatment: Part I|Protocol Deviation|0|||
162913554|NCT01632345|588384078|FG002|Treatment: Part I|Protocol Deviation|1|||
162913555|NCT01632345|588384079|FG003|Treatment: Part I|Protocol Deviation|1|||
162913556|NCT01632345|588384080|FG004|Treatment: Part I|Protocol Deviation|0|||
162913557|NCT01632345|588384081|FG005|Treatment: Part I|Protocol Deviation|0|||
162913558|NCT01632345|588384082|FG006|Treatment: Part I|Protocol Deviation|0|||
162913559|NCT01632345|588384076|FG000|Treatment: Part I|Withdrawal by Subject|3|||
162913560|NCT01632345|588384077|FG001|Treatment: Part I|Withdrawal by Subject|4|||
162913561|NCT01632345|588384078|FG002|Treatment: Part I|Withdrawal by Subject|4|||
162913562|NCT01632345|588384079|FG003|Treatment: Part I|Withdrawal by Subject|1|||
162913563|NCT01632345|588384080|FG004|Treatment: Part I|Withdrawal by Subject|4|||
162913564|NCT01632345|588384081|FG005|Treatment: Part I|Withdrawal by Subject|0|||
162913565|NCT01632345|588384082|FG006|Treatment: Part I|Withdrawal by Subject|0|||
162913566|NCT01632345|588384076|FG000|Treatment: Part II|Adverse Event|0|||
162913567|NCT01632345|588384077|FG001|Treatment: Part II|Adverse Event|0|||
162913568|NCT01632345|588384078|FG002|Treatment: Part II|Adverse Event|0|||
162913569|NCT01632345|588384079|FG003|Treatment: Part II|Adverse Event|0|||
162913570|NCT01632345|588384080|FG004|Treatment: Part II|Adverse Event|0|||
162913571|NCT01632345|588384081|FG005|Treatment: Part II|Adverse Event|3|||
162913572|NCT01632345|588384082|FG006|Treatment: Part II|Adverse Event|8|||
162913573|NCT01632345|588384076|FG000|Treatment: Part II|Lost to Follow-up|0|||
162913574|NCT01632345|588384077|FG001|Treatment: Part II|Lost to Follow-up|0|||
162913575|NCT01632345|588384078|FG002|Treatment: Part II|Lost to Follow-up|0|||
162913576|NCT01632345|588384079|FG003|Treatment: Part II|Lost to Follow-up|0|||
162913577|NCT01632345|588384080|FG004|Treatment: Part II|Lost to Follow-up|0|||
162913578|NCT01632345|588384081|FG005|Treatment: Part II|Lost to Follow-up|3|||
162913579|NCT01632345|588384082|FG006|Treatment: Part II|Lost to Follow-up|1|||
162913580|NCT01632345|588384076|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913581|NCT01632345|588384077|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913582|NCT01632345|588384078|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913583|NCT01632345|588384079|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913584|NCT01632345|588384080|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913585|NCT01632345|588384081|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
162913586|NCT01632345|588384082|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
162913587|NCT01632345|588384076|FG000|Treatment: Part II|Withdrawal by Subject|0|||
162913588|NCT01632345|588384077|FG001|Treatment: Part II|Withdrawal by Subject|0|||
162913589|NCT01632345|588384078|FG002|Treatment: Part II|Withdrawal by Subject|0|||
162913590|NCT01632345|588384079|FG003|Treatment: Part II|Withdrawal by Subject|0|||
162913591|NCT01632345|588384080|FG004|Treatment: Part II|Withdrawal by Subject|0|||
162913592|NCT01632345|588384081|FG005|Treatment: Part II|Withdrawal by Subject|2|||
162913593|NCT01632345|588384082|FG006|Treatment: Part II|Withdrawal by Subject|2|||
162913594|NCT00089505|588384083|FG000|Overall Study|Death|4|||
162913595|NCT00089505|588384084|FG001|Overall Study|Death|1|||
162913596|NCT00089505|588384085|FG002|Overall Study|Death|5|||
162913597|NCT00089505|588384086|FG003|Overall Study|Death|8|||
162913598|NCT00089505|588384083|FG000|Overall Study|Withdrawal by Subject|3|||
162913599|NCT00089505|588384084|FG001|Overall Study|Withdrawal by Subject|0|||
162913600|NCT00089505|588384085|FG002|Overall Study|Withdrawal by Subject|6|||
162913601|NCT00089505|588384086|FG003|Overall Study|Withdrawal by Subject|6|||
162913602|NCT00089505|588384083|FG000|Overall Study|Lost to Follow-up|1|||
162913603|NCT00089505|588384084|FG001|Overall Study|Lost to Follow-up|1|||
162913604|NCT00089505|588384085|FG002|Overall Study|Lost to Follow-up|9|||
162913605|NCT00089505|588384086|FG003|Overall Study|Lost to Follow-up|7|||
162913606|NCT00089505|588384083|FG000|Overall Study|Physician Decision|1|||
162913607|NCT00089505|588384084|FG001|Overall Study|Physician Decision|0|||
162913608|NCT00089505|588384085|FG002|Overall Study|Physician Decision|0|||
162913609|NCT00089505|588384086|FG003|Overall Study|Physician Decision|0|||
162913610|NCT00089505|588384083|FG000|Overall Study|Protocol Violation|0|||
162913611|NCT00089505|588384084|FG001|Overall Study|Protocol Violation|0|||
162913612|NCT00089505|588384085|FG002|Overall Study|Protocol Violation|1|||
162913613|NCT00089505|588384086|FG003|Overall Study|Protocol Violation|0|||
162913614|NCT02431559|588384087|FG000|Overall Study|Adverse Event|0|||
162913615|NCT02431559|588384088|FG001|Overall Study|Adverse Event|1|||
162913616|NCT02431559|588384089|FG002|Overall Study|Adverse Event|0|||
162913617|NCT02431559|588384090|FG003|Overall Study|Adverse Event|4|||
162913618|NCT02431559|588384087|FG000|Overall Study|Progressive disease|2|||
162710851|NCT01451814|587652790|FG000|Overall Study|Lost to Follow-up|5|||
162710852|NCT01451814|587652791|FG001|Overall Study|Lost to Follow-up|4|||
162710853|NCT02049866|587652792|FG000|Overall Study|Withdrawal by Subject|1|||
162710854|NCT01466881|587652794|FG000|Overall Study|Ineligible|5|||
162710855|NCT01466881|587652794|FG000|Overall Study|Adverse Event|6|||
162710856|NCT01466881|587652794|FG000|Overall Study|Progression/relapse|20|||
162710857|NCT01466881|587652794|FG000|Overall Study|Death|4|||
162710858|NCT01466881|587652794|FG000|Overall Study|Other reason not protocol specified|5|||
162710859|NCT02219490|587652798|FG000|Overall Study|Adverse Event|24|||
162913619|NCT02431559|588384088|FG001|Overall Study|Progressive disease|1|||
162913620|NCT02431559|588384089|FG002|Overall Study|Progressive disease|4|||
162913621|NCT02431559|588384090|FG003|Overall Study|Progressive disease|22|||
162913622|NCT02431559|588384087|FG000|Overall Study|Withdrawal by Subject|0|||
162913623|NCT02431559|588384088|FG001|Overall Study|Withdrawal by Subject|1|||
162913624|NCT02431559|588384089|FG002|Overall Study|Withdrawal by Subject|0|||
162913625|NCT02431559|588384090|FG003|Overall Study|Withdrawal by Subject|4|||
162913626|NCT02431559|588384087|FG000|Overall Study|Physician Decision|0|||
162913627|NCT02431559|588384088|FG001|Overall Study|Physician Decision|0|||
162913628|NCT02431559|588384089|FG002|Overall Study|Physician Decision|0|||
162913629|NCT02431559|588384090|FG003|Overall Study|Physician Decision|1|||
162913630|NCT05047601|588384096|FG000|Overall Study|Lost to Follow-up|9|||
162710860|NCT02219490|587652798|FG000|Overall Study|Withdrew consent|96|||
162710861|NCT02219490|587652798|FG000|Overall Study|Lost to Follow-up|126|||
162710862|NCT02219490|587652798|FG000|Overall Study|COVID-19 infection|2|||
162710863|NCT02219490|587652798|FG000|Overall Study|COVID-19 logistical restrictions|33|||
162710864|NCT02219490|587652798|FG000|Overall Study|Other, not specified|57|||
162710865|NCT01928940|587652802|FG000|Overall Study|Adverse Event|0|||
162710866|NCT01928940|587652803|FG001|Overall Study|Adverse Event|1|||
162710867|NCT00197236|587652806|FG000|Overall Study|Adverse Event|1|||
162710868|NCT00197236|587652807|FG001|Overall Study|Adverse Event|0|||
162710869|NCT00197236|587652808|FG002|Overall Study|Adverse Event|1|||
162710870|NCT00197236|587652806|FG000|Overall Study|Lost to Follow-up|5|||
162710871|NCT00197236|587652807|FG001|Overall Study|Lost to Follow-up|14|||
162710872|NCT00197236|587652808|FG002|Overall Study|Lost to Follow-up|6|||
162710873|NCT00197236|587652806|FG000|Overall Study|Protocol Violation|0|||
162710874|NCT00197236|587652807|FG001|Overall Study|Protocol Violation|0|||
162710875|NCT00197236|587652808|FG002|Overall Study|Protocol Violation|1|||
162710876|NCT00197236|587652806|FG000|Overall Study|Withdrawal by Subject|7|||
162710877|NCT00197236|587652807|FG001|Overall Study|Withdrawal by Subject|3|||
162710878|NCT00197236|587652808|FG002|Overall Study|Withdrawal by Subject|11|||
162710879|NCT00197236|587652806|FG000|Overall Study|Study drug/medication expiration|1|||
162710880|NCT00197236|587652807|FG001|Overall Study|Study drug/medication expiration|0|||
162913631|NCT05047601|588384097|FG001|Overall Study|Lost to Follow-up|11|||
162913632|NCT05047601|588384098|FG002|Overall Study|Lost to Follow-up|7|||
162913633|NCT05047601|588384096|FG000|Overall Study|Withdrawal by Subject|25|||
162710881|NCT00197236|587652808|FG002|Overall Study|Study drug/medication expiration|3|||
162710882|NCT00197236|587652806|FG000|Overall Study|Returned out of specified time window|0|||
162913634|NCT05047601|588384097|FG001|Overall Study|Withdrawal by Subject|36|||
162913635|NCT05047601|588384098|FG002|Overall Study|Withdrawal by Subject|23|||
162913636|NCT05047601|588384096|FG000|Overall Study|Other|10|||
162913637|NCT05047601|588384097|FG001|Overall Study|Other|6|||
162913638|NCT05047601|588384098|FG002|Overall Study|Other|5|||
162913639|NCT00286234|588384099|FG000|Overall Study|Protocol Violation|1|||
162913640|NCT00286234|588384100|FG001|Overall Study|Protocol Violation|2|||
162913641|NCT00286234|588384101|FG002|Overall Study|Protocol Violation|0|||
162968213|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
162968214|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968215|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
162968216|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162710883|NCT00197236|587652807|FG001|Overall Study|Returned out of specified time window|0|||
162710884|NCT00197236|587652808|FG002|Overall Study|Returned out of specified time window|1|||
162710885|NCT02524288|587652809|FG000|Overall Study|Adverse Event|115|||
162710886|NCT02524288|587652809|FG000|Overall Study|Lost to Follow-up|216|||
162913642|NCT00286234|588384102|FG003|Overall Study|Protocol Violation|1|||
162913643|NCT00286234|588384099|FG000|Overall Study|Physician Decision|1|||
162710887|NCT02524288|587652809|FG000|Overall Study|Non-Compliance With Protocol|32|||
162710888|NCT02524288|587652809|FG000|Overall Study|Non-Compliance With Study Drug|14|||
162913644|NCT00286234|588384100|FG001|Overall Study|Physician Decision|0|||
162913645|NCT00286234|588384101|FG002|Overall Study|Physician Decision|0|||
162913646|NCT00286234|588384102|FG003|Overall Study|Physician Decision|1|||
162710889|NCT02524288|587652809|FG000|Overall Study|Pregnancy Wish|6|||
162710890|NCT02524288|587652809|FG000|Overall Study|Protocol Violation|6|||
162913647|NCT00286234|588384099|FG000|Overall Study|Adverse Event|0|||
162913648|NCT00286234|588384100|FG001|Overall Study|Adverse Event|0|||
162913649|NCT00286234|588384101|FG002|Overall Study|Adverse Event|0|||
162913650|NCT00286234|588384102|FG003|Overall Study|Adverse Event|1|||
162913651|NCT00286234|588384099|FG000|Overall Study|Adverse Event|0|||
162913652|NCT00286234|588384100|FG001|Overall Study|Adverse Event|0|||
162913653|NCT00286234|588384101|FG002|Overall Study|Adverse Event|0|||
162913654|NCT00286234|588384102|FG003|Overall Study|Adverse Event|1|||
162913655|NCT02924129|588384105|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
162913656|NCT02924129|588384106|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
162913657|NCT02924129|588384105|FG000|Overall Study|Withdrawal by Subject|2|||
162913658|NCT02924129|588384106|FG001|Overall Study|Withdrawal by Subject|2|||
162913659|NCT02924129|588384105|FG000|Overall Study|Physician Decision|1|||
162913660|NCT02924129|588384106|FG001|Overall Study|Physician Decision|0|||
162913661|NCT02924129|588384105|FG000|Overall Study|Missed Visit|0|||
162913662|NCT02924129|588384106|FG001|Overall Study|Missed Visit|1|||
162913663|NCT00302731|588384110|FG000|Overall Study|Lost to Follow-up|1|||
162913664|NCT00302731|588384111|FG001|Overall Study|Lost to Follow-up|2|||
162913665|NCT00302731|588384112|FG002|Overall Study|Lost to Follow-up|0|||
162913666|NCT00302731|588384113|FG003|Overall Study|Lost to Follow-up|0|||
162913667|NCT00302731|588384110|FG000|Overall Study|Adverse Event|0|||
162913668|NCT00302731|588384111|FG001|Overall Study|Adverse Event|2|||
162913669|NCT00302731|588384112|FG002|Overall Study|Adverse Event|2|||
162913670|NCT00302731|588384113|FG003|Overall Study|Adverse Event|0|||
162913671|NCT00302731|588384110|FG000|Overall Study|Withdrawal by Subject|1|||
162913672|NCT00302731|588384111|FG001|Overall Study|Withdrawal by Subject|1|||
162913673|NCT00302731|588384112|FG002|Overall Study|Withdrawal by Subject|0|||
162913674|NCT00302731|588384113|FG003|Overall Study|Withdrawal by Subject|0|||
162913675|NCT00302731|588384110|FG000|Overall Study|Protocol Violation|1|||
162913676|NCT00302731|588384111|FG001|Overall Study|Protocol Violation|0|||
162913677|NCT00302731|588384112|FG002|Overall Study|Protocol Violation|0|||
162913678|NCT00302731|588384113|FG003|Overall Study|Protocol Violation|0|||
162913679|NCT00302731|588384110|FG000|Overall Study|cancer unrelated to study discovered|1|||
162913680|NCT00302731|588384111|FG001|Overall Study|cancer unrelated to study discovered|0|||
162913681|NCT00302731|588384112|FG002|Overall Study|cancer unrelated to study discovered|1|||
162913682|NCT00302731|588384113|FG003|Overall Study|cancer unrelated to study discovered|0|||
162913683|NCT01610752|588384116|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
162913684|NCT01610752|588384117|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
162913685|NCT01610752|588384118|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
162913686|NCT00283062|588384119|FG000|Overall Study|Did not receive any study medication|5|||
162913687|NCT00283062|588384120|FG001|Overall Study|Did not receive any study medication|4|||
162913688|NCT00283062|588384121|FG002|Overall Study|Did not receive any study medication|36|||
162913689|NCT00283062|588384122|FG003|Overall Study|Did not receive any study medication|45|||
162913690|NCT00283062|588384119|FG000|Overall Study|Adverse Event|2|||
162913691|NCT00283062|588384120|FG001|Overall Study|Adverse Event|0|||
162913692|NCT00283062|588384121|FG002|Overall Study|Adverse Event|1|||
162913693|NCT00283062|588384122|FG003|Overall Study|Adverse Event|0|||
162913694|NCT00283062|588384119|FG000|Overall Study|Lost to Follow-up|1|||
162913695|NCT00283062|588384120|FG001|Overall Study|Lost to Follow-up|0|||
162913696|NCT00283062|588384121|FG002|Overall Study|Lost to Follow-up|1|||
162913697|NCT00283062|588384122|FG003|Overall Study|Lost to Follow-up|0|||
162913698|NCT00283062|588384119|FG000|Overall Study|Progressive disease|0|||
162913699|NCT00283062|588384120|FG001|Overall Study|Progressive disease|0|||
162913700|NCT00283062|588384121|FG002|Overall Study|Progressive disease|1|||
162913701|NCT00283062|588384122|FG003|Overall Study|Progressive disease|0|||
162913702|NCT00283062|588384119|FG000|Overall Study|Participant did not wish to continue|3|||
162913703|NCT00283062|588384120|FG001|Overall Study|Participant did not wish to continue|2|||
162913704|NCT00283062|588384121|FG002|Overall Study|Participant did not wish to continue|1|||
162913705|NCT00283062|588384122|FG003|Overall Study|Participant did not wish to continue|0|||
162710891|NCT02524288|587652809|FG000|Overall Study|Screen Failure|2|||
162710892|NCT02524288|587652809|FG000|Overall Study|Site Discontinued Study Participation|1|||
162710893|NCT02524288|587652809|FG000|Overall Study|Study Terminated By Sponsor|1417|||
162913706|NCT00283062|588384119|FG000|Overall Study|Undefined|0|||
162913707|NCT00283062|588384120|FG001|Overall Study|Undefined|1|||
162913708|NCT00283062|588384121|FG002|Overall Study|Undefined|1|||
162913709|NCT00283062|588384122|FG003|Overall Study|Undefined|4|||
162913710|NCT00283062|588384119|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
162913711|NCT00283062|588384120|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
162913712|NCT00283062|588384121|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
162913713|NCT00283062|588384122|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
162913714|NCT00252499|588384125|FG000|Overall Study|Lost to Follow-up|1|||
162913715|NCT00252499|588384126|FG001|Overall Study|Lost to Follow-up|0|||
162913716|NCT00252499|588384127|FG002|Overall Study|Lost to Follow-up|0|||
162913717|NCT01482598|588384128|FG000|Overall Study|Death|7|||
162913718|NCT01482598|588384129|FG001|Overall Study|Death|10|||
162913719|NCT01482598|588384128|FG000|Overall Study|Physician Decision|0|||
162913720|NCT01482598|588384129|FG001|Overall Study|Physician Decision|3|||
162913721|NCT01482598|588384128|FG000|Overall Study|Withdrawal by Subject|4|||
162913722|NCT01482598|588384129|FG001|Overall Study|Withdrawal by Subject|5|||
162913723|NCT01482598|588384128|FG000|Overall Study|Lost to Follow-up|5|||
162913724|NCT01482598|588384129|FG001|Overall Study|Lost to Follow-up|4|||
162913725|NCT01373294|588384130|FG000|Overall Study|Adverse Event|1|||
162913726|NCT01373294|588384131|FG001|Overall Study|Adverse Event|0|||
162913727|NCT00423267|588384132|FG000|Period A|Withdrawal by Subject|0|||
162913728|NCT00423267|588384133|FG001|Period A|Withdrawal by Subject|1|||
162913729|NCT00423267|588384132|FG000|Period A|Non-compliance with protocol|1|||
162913730|NCT00423267|588384133|FG001|Period A|Non-compliance with protocol|0|||
162913731|NCT00423267|588384132|FG000|Period A|Administrative|1|||
162913732|NCT00423267|588384133|FG001|Period A|Administrative|0|||
162913733|NCT03702166|588384134|FG000|Overall Study|Lost to Follow-up|1|||
162913734|NCT03702166|588384134|FG000|Overall Study|Withdrawal by Subject|1|||
162913735|NCT01333865|588384135|FG000|Overall Study|Adverse Event|2|||
162913736|NCT03512028|588384136|FG000|Overall Study|Withdrawal by Subject|2|||
162913737|NCT03512028|588384137|FG001|Overall Study|Withdrawal by Subject|0|||
162913738|NCT03512028|588384136|FG000|Overall Study|Protocol Violation|2|||
162913739|NCT03512028|588384137|FG001|Overall Study|Protocol Violation|0|||
162913740|NCT00660829|588384143|FG000|Overall Study|Adverse Event|3|||
162913741|NCT00660829|588384144|FG001|Overall Study|Adverse Event|4|||
162913742|NCT00660829|588384143|FG000|Overall Study|Lack of Efficacy|2|||
162913743|NCT00660829|588384144|FG001|Overall Study|Lack of Efficacy|3|||
162913744|NCT00660829|588384143|FG000|Overall Study|Non-Compliance|0|||
162913745|NCT00660829|588384144|FG001|Overall Study|Non-Compliance|4|||
162913746|NCT00660829|588384143|FG000|Overall Study|Withdrawal by Subject|1|||
162913747|NCT00660829|588384144|FG001|Overall Study|Withdrawal by Subject|2|||
162913748|NCT00660829|588384143|FG000|Overall Study|Lost to Follow-up|3|||
162913749|NCT00660829|588384144|FG001|Overall Study|Lost to Follow-up|2|||
162913750|NCT00660829|588384143|FG000|Overall Study|Other|9|||
162913751|NCT00660829|588384144|FG001|Overall Study|Other|4|||
162913752|NCT02127931|588384147|FG000|Overall Study|Glitch in Game|1|||
162913753|NCT02028182|588385746|FG000|Overall Study|Protocol Violation|2|||
162913754|NCT01684930|588385747|FG000|Overall Study|Withdrawal by Subject|3|||
162913755|NCT01684930|588385748|FG001|Overall Study|Withdrawal by Subject|1|||
162913756|NCT01945866|588385749|FG000|Overall Study|Eyes did not complete or were dropped|2|||
162913757|NCT01945866|588385750|FG001|Overall Study|Eyes did not complete or were dropped|0|||
162913758|NCT01336647|588385751|FG000|Overall Study|Lost to Follow-up|4|||
162913759|NCT01336647|588385752|FG001|Overall Study|Lost to Follow-up|1|||
162913760|NCT01336647|588385753|FG002|Overall Study|Lost to Follow-up|3|||
162913761|NCT01018680|588385754|FG000|Overall Study|Adverse Event|23|||
162913762|NCT01018680|588385755|FG001|Overall Study|Adverse Event|40|||
162913763|NCT01018680|588385754|FG000|Overall Study|Withdrawal by Subject|10|||
162913764|NCT01018680|588385755|FG001|Overall Study|Withdrawal by Subject|10|||
162913765|NCT01018680|588385754|FG000|Overall Study|Protocol Violation|5|||
162913766|NCT01018680|588385755|FG001|Overall Study|Protocol Violation|8|||
162913767|NCT01018680|588385754|FG000|Overall Study|Sponsor Decision|6|||
162913768|NCT01018680|588385755|FG001|Overall Study|Sponsor Decision|7|||
162913769|NCT01018680|588385754|FG000|Overall Study|Lack of Efficacy|8|||
162913770|NCT01018680|588385755|FG001|Overall Study|Lack of Efficacy|2|||
162913771|NCT01018680|588385754|FG000|Overall Study|Lost to Follow-up|5|||
162913772|NCT01018680|588385755|FG001|Overall Study|Lost to Follow-up|3|||
162913773|NCT01018680|588385754|FG000|Overall Study|Entry Criteria Not Met|1|||
162913774|NCT01018680|588385755|FG001|Overall Study|Entry Criteria Not Met|4|||
162913775|NCT01018680|588385754|FG000|Overall Study|Physician Decision|3|||
162913776|NCT01018680|588385755|FG001|Overall Study|Physician Decision|1|||
162913777|NCT02930889|588385756|FG000|Overall Study|Lost to Follow-up|2|||
162913778|NCT02930889|588385756|FG000|Overall Study|Withdrawal by Subject|6|||
162913779|NCT02930889|588385756|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
162913780|NCT04398030|588385757|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
162968217|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968218|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
162968219|NCT01567527|588584818|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968220|NCT01567527|588584819|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
162968221|NCT01567527|588584820|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968222|NCT01567527|588584821|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968223|NCT01567527|588584822|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
162968224|NCT01567527|588584818|FG000|IM Depot Stabilization.|Protocol deviation|0|||
162968225|NCT01567527|588584819|FG001|IM Depot Stabilization.|Protocol deviation|0|||
162913781|NCT04398030|588385758|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
162913782|NCT04398030|588385757|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
162913783|NCT04398030|588385758|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
162913784|NCT05056311|588385759|FG000|Overall Study|Lost to Follow-up|14|||
162913785|NCT05056311|588385759|FG000|Overall Study|Withdrawal by Subject|1|||
162913786|NCT05056311|588385759|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
162913787|NCT01714726|588385760|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
162913788|NCT01714726|588385761|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
162913789|NCT01714726|588385762|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
162913790|NCT01714726|588385763|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
162913791|NCT01714726|588385760|FG000|Double-Blinded Induction Period|Adverse Event|0|||
162913792|NCT01714726|588385761|FG001|Double-Blinded Induction Period|Adverse Event|1|||
162913793|NCT01714726|588385762|FG002|Double-Blinded Induction Period|Adverse Event|0|||
162913794|NCT01714726|588385763|FG003|Double-Blinded Induction Period|Adverse Event|0|||
162913795|NCT01714726|588385760|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
162913796|NCT01714726|588385761|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
162913797|NCT01714726|588385762|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
162913798|NCT01714726|588385763|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
162913799|NCT01714726|588385760|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
162913800|NCT01714726|588385761|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
162913801|NCT01714726|588385762|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
162913802|NCT01714726|588385763|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
162913803|NCT01714726|588385760|FG000|Open-Label Period|Other|0|||
162913804|NCT01714726|588385761|FG001|Open-Label Period|Other|0|||
162913805|NCT01714726|588385762|FG002|Open-Label Period|Other|1|||
162913806|NCT01714726|588385763|FG003|Open-Label Period|Other|3|||
162913807|NCT01714726|588385760|FG000|Open-Label Period|Adverse Event|0|||
162913808|NCT01714726|588385761|FG001|Open-Label Period|Adverse Event|0|||
162913809|NCT01714726|588385762|FG002|Open-Label Period|Adverse Event|1|||
162913810|NCT01714726|588385763|FG003|Open-Label Period|Adverse Event|0|||
162913811|NCT01714726|588385760|FG000|Open-Label Period|Withdrawal by Subject|0|||
162913812|NCT01714726|588385761|FG001|Open-Label Period|Withdrawal by Subject|0|||
162913813|NCT01714726|588385762|FG002|Open-Label Period|Withdrawal by Subject|9|||
162913814|NCT01714726|588385763|FG003|Open-Label Period|Withdrawal by Subject|19|||
162913815|NCT01714726|588385760|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
162913816|NCT01714726|588385761|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
162913817|NCT01714726|588385762|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
162913818|NCT01714726|588385763|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
162913819|NCT01714726|588385760|FG000|Open-Label Period|Lost to Follow-up|0|||
162913820|NCT01714726|588385761|FG001|Open-Label Period|Lost to Follow-up|0|||
162913821|NCT01714726|588385762|FG002|Open-Label Period|Lost to Follow-up|3|||
162913822|NCT01714726|588385763|FG003|Open-Label Period|Lost to Follow-up|4|||
162913823|NCT00548340|588385765|FG000|Overall Study|Protocol Violation|2|||
162913824|NCT00548340|588385766|FG001|Overall Study|Protocol Violation|3|||
162913825|NCT00548340|588385767|FG002|Overall Study|Protocol Violation|3|||
162913826|NCT00548340|588385765|FG000|Overall Study|Adverse Event|2|||
162913827|NCT00548340|588385766|FG001|Overall Study|Adverse Event|2|||
162913828|NCT00548340|588385767|FG002|Overall Study|Adverse Event|2|||
162913829|NCT00548340|588385765|FG000|Overall Study|Lost to Follow-up|1|||
162913830|NCT00548340|588385766|FG001|Overall Study|Lost to Follow-up|1|||
162913831|NCT00548340|588385767|FG002|Overall Study|Lost to Follow-up|0|||
162913832|NCT00548340|588385765|FG000|Overall Study|Withdrawal by Subject|2|||
162913833|NCT00548340|588385766|FG001|Overall Study|Withdrawal by Subject|4|||
162913834|NCT00548340|588385767|FG002|Overall Study|Withdrawal by Subject|3|||
162913835|NCT00548340|588385765|FG000|Overall Study|Other|1|||
162913836|NCT00548340|588385766|FG001|Overall Study|Other|1|||
162913837|NCT00548340|588385767|FG002|Overall Study|Other|1|||
162913838|NCT02600559|588385768|FG000|Overall Study|Withdrawal by Subject|3|||
162913839|NCT02600559|588385768|FG000|Overall Study|Lost to Follow-up|20|||
162913840|NCT00665366|588385771|FG000|Overall Study|Lack of Efficacy|11|||
162913841|NCT00665366|588385772|FG001|Overall Study|Lack of Efficacy|10|||
162913842|NCT00665366|588385771|FG000|Overall Study|Adverse Event|25|||
162913843|NCT00665366|588385772|FG001|Overall Study|Adverse Event|23|||
162913844|NCT00665366|588385771|FG000|Overall Study|Withdrawal by Subject|11|||
162913845|NCT00665366|588385772|FG001|Overall Study|Withdrawal by Subject|14|||
162913846|NCT00665366|588385771|FG000|Overall Study|Lost to Follow-up|3|||
162913847|NCT00665366|588385772|FG001|Overall Study|Lost to Follow-up|5|||
162710894|NCT02524288|587652809|FG000|Overall Study|Subject Moved|32|||
162913848|NCT00665366|588385771|FG000|Overall Study|Poor compliance/noncompliance|3|||
162913849|NCT00665366|588385772|FG001|Overall Study|Poor compliance/noncompliance|5|||
162913850|NCT00665366|588385771|FG000|Overall Study|Pregnancy|1|||
162913851|NCT00665366|588385772|FG001|Overall Study|Pregnancy|0|||
162913852|NCT00665366|588385771|FG000|Overall Study|No longer meets study criteria|0|||
162913853|NCT00665366|588385772|FG001|Overall Study|No longer meets study criteria|1|||
162913854|NCT00665366|588385771|FG000|Overall Study|Other reasons|4|||
162968226|NCT01567527|588584820|FG002|IM Depot Stabilization.|Protocol deviation|5|||
162968227|NCT01567527|588584821|FG003|IM Depot Stabilization.|Protocol deviation|0|||
162913855|NCT00665366|588385772|FG001|Overall Study|Other reasons|1|||
162913856|NCT03628781|588385773|FG000|Overall Study|Lost to Follow-up|16|||
162913857|NCT03628781|588385774|FG001|Overall Study|Lost to Follow-up|8|||
162913858|NCT03628781|588385773|FG000|Overall Study|Withdrawal by Subject|16|||
162913859|NCT03628781|588385774|FG001|Overall Study|Withdrawal by Subject|1|||
162913860|NCT03778021|588385778|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
162913861|NCT03778021|588385779|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
162913862|NCT00679042|588385780|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
162913863|NCT00679042|588385780|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
162913864|NCT00679042|588385780|FG000|5-Year Follow Up|Death|1|||
162913865|NCT00679042|588385780|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
162913866|NCT00679042|588385780|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
162913867|NCT02392078|588385781|FG000|Overall Study|Did not have procedure|32|||
162913868|NCT02392078|588385782|FG001|Overall Study|Did not have procedure|43|||
162913869|NCT02392078|588385783|FG002|Overall Study|Did not have procedure|20|||
162913870|NCT02392078|588385784|FG003|Overall Study|Did not have procedure|1|||
162913871|NCT02079077|588385786|FG000|Overall Study|Lost to Follow-up|5|||
162913872|NCT02079077|588385787|FG001|Overall Study|Lost to Follow-up|7|||
162913873|NCT02079077|588385786|FG000|Overall Study|Became STIs Positive|1|||
162913874|NCT02079077|588385787|FG001|Overall Study|Became STIs Positive|2|||
162913875|NCT01928758|588385788|FG000|Overall Study|Lost to Follow-up|14|||
162913876|NCT01928758|588385789|FG001|Overall Study|Lost to Follow-up|9|||
162913877|NCT01928758|588385788|FG000|Overall Study|Withdrawal by Subject|5|||
162913878|NCT01928758|588385789|FG001|Overall Study|Withdrawal by Subject|2|||
162913879|NCT01928758|588385788|FG000|Overall Study|Adverse Event|3|||
162913880|NCT01928758|588385789|FG001|Overall Study|Adverse Event|5|||
162913881|NCT01928758|588385788|FG000|Overall Study|Protocol Violation|3|||
162913882|NCT01928758|588385789|FG001|Overall Study|Protocol Violation|4|||
162913883|NCT02718131|588385790|FG000|Overall Study|Withdrawal by Subject|1|||
162913884|NCT02718131|588385791|FG001|Overall Study|Withdrawal by Subject|0|||
162913885|NCT02718131|588385790|FG000|Overall Study|Adverse Event|1|||
162913886|NCT02718131|588385791|FG001|Overall Study|Adverse Event|0|||
162913887|NCT02718131|588385790|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
162913888|NCT02718131|588385791|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
162913889|NCT03198559|588385792|FG000|Overall Study|Adverse Event|2|||
162913890|NCT01005875|588385798|FG000|Overall Study|Death|3|||
162913891|NCT00606931|588385799|FG000|Overall Study|Withdrawal by Subject|3|||
162913892|NCT01348828|588385810|FG000|Overall Study|Death|20|||
162913893|NCT01348828|588385810|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
162913894|NCT01348828|588385810|FG000|Overall Study|Conversion|2|||
162913895|NCT01348828|588385810|FG000|Overall Study|missed visit|1|||
162913896|NCT04246996|588385811|FG000|Overall Study|Physician Decision|1|||
162913897|NCT04246996|588385812|FG001|Overall Study|Physician Decision|1|||
162913898|NCT04246996|588385811|FG000|Overall Study|Did not meet eligibility criteria|1|||
162913899|NCT04246996|588385812|FG001|Overall Study|Did not meet eligibility criteria|4|||
162913900|NCT02442284|588385815|FG000|Overall Study|Adverse Event|1|||
162913901|NCT02442284|588385815|FG000|Overall Study|Withdrew Consent|2|||
162913902|NCT02442284|588385815|FG000|Overall Study|Lost to Follow-up|3|||
162913903|NCT02442284|588385815|FG000|Overall Study|Other|1|||
162913904|NCT01365468|588385819|FG000|Overall Study|Physician Decision|1|||
162913905|NCT01365468|588385820|FG001|Overall Study|Physician Decision|0|||
162913906|NCT01365468|588385819|FG000|Overall Study|Disease progression|1|||
162913907|NCT01365468|588385820|FG001|Overall Study|Disease progression|0|||
162913908|NCT01365468|588385819|FG000|Overall Study|Lost to Follow-up|2|||
162913909|NCT01365468|588385820|FG001|Overall Study|Lost to Follow-up|0|||
162913910|NCT01521494|588385823|FG000|Overall Study|Adverse Event|1|||
162913911|NCT01521494|588385824|FG001|Overall Study|Adverse Event|2|||
162913912|NCT01521494|588385825|FG002|Overall Study|Adverse Event|9|||
162913913|NCT01521494|588385826|FG003|Overall Study|Adverse Event|6|||
162913914|NCT01521494|588385827|FG004|Overall Study|Adverse Event|2|||
162913915|NCT01521494|588385823|FG000|Overall Study|Lack of Efficacy|0|||
162913916|NCT01521494|588385824|FG001|Overall Study|Lack of Efficacy|0|||
162913917|NCT01521494|588385825|FG002|Overall Study|Lack of Efficacy|0|||
162913918|NCT01521494|588385826|FG003|Overall Study|Lack of Efficacy|0|||
162913919|NCT01521494|588385827|FG004|Overall Study|Lack of Efficacy|2|||
162913920|NCT01521494|588385823|FG000|Overall Study|Withdrawal by Subject|1|||
162913921|NCT01521494|588385824|FG001|Overall Study|Withdrawal by Subject|1|||
162913922|NCT01521494|588385825|FG002|Overall Study|Withdrawal by Subject|0|||
162913923|NCT01521494|588385826|FG003|Overall Study|Withdrawal by Subject|2|||
162913924|NCT01521494|588385827|FG004|Overall Study|Withdrawal by Subject|0|||
162913925|NCT01521494|588385823|FG000|Overall Study|Decrease in serum phosphate|0|||
162913926|NCT01521494|588385824|FG001|Overall Study|Decrease in serum phosphate|2|||
162913927|NCT01521494|588385825|FG002|Overall Study|Decrease in serum phosphate|3|||
162913928|NCT01521494|588385826|FG003|Overall Study|Decrease in serum phosphate|12|||
162913929|NCT01521494|588385827|FG004|Overall Study|Decrease in serum phosphate|0|||
162913930|NCT01521494|588385823|FG000|Overall Study|Decrease in serum calcium|0|||
162913931|NCT01521494|588385824|FG001|Overall Study|Decrease in serum calcium|0|||
162913932|NCT01521494|588385825|FG002|Overall Study|Decrease in serum calcium|0|||
162913933|NCT01521494|588385826|FG003|Overall Study|Decrease in serum calcium|1|||
162913934|NCT01521494|588385827|FG004|Overall Study|Decrease in serum calcium|1|||
162913935|NCT01521494|588385823|FG000|Overall Study|Physician Decision|0|||
162913936|NCT01521494|588385824|FG001|Overall Study|Physician Decision|0|||
162913937|NCT01521494|588385825|FG002|Overall Study|Physician Decision|0|||
162913938|NCT01521494|588385826|FG003|Overall Study|Physician Decision|0|||
162913939|NCT01521494|588385827|FG004|Overall Study|Physician Decision|2|||
162913940|NCT00877929|588385828|FG000|Overall Study|Adverse Event|11|||
162913941|NCT00877929|588385829|FG001|Overall Study|Adverse Event|20|||
162913942|NCT00877929|588385828|FG000|Overall Study|Protocol Violation|3|||
162913943|NCT00877929|588385829|FG001|Overall Study|Protocol Violation|3|||
162913944|NCT00877929|588385828|FG000|Overall Study|Lost to Follow-up|0|||
162913945|NCT00877929|588385829|FG001|Overall Study|Lost to Follow-up|1|||
162913946|NCT00877929|588385828|FG000|Overall Study|Withdrawal by Subject|4|||
162913947|NCT00877929|588385829|FG001|Overall Study|Withdrawal by Subject|4|||
162913948|NCT00877929|588385828|FG000|Overall Study|Lack of Efficacy|0|||
162913949|NCT00877929|588385829|FG001|Overall Study|Lack of Efficacy|1|||
162913950|NCT00877929|588385828|FG000|Overall Study|Other reason (not specified)|2|||
162913951|NCT00877929|588385829|FG001|Overall Study|Other reason (not specified)|6|||
162913952|NCT01140646|588385830|FG000|Overall Study|Adverse Event|4|||
162913953|NCT01140646|588385830|FG000|Overall Study|Refused Further Treatment|5|||
162913954|NCT00689728|588385834|FG000|Double-Blind Treatment|Adverse Event|1|||
162913955|NCT00689728|588385835|FG001|Double-Blind Treatment|Adverse Event|0|||
162913956|NCT00689728|588385836|FG002|Double-Blind Treatment|Adverse Event|0|||
162913957|NCT00689728|588385834|FG000|Double-Blind Treatment|Protocol Violation|0|||
162913958|NCT00689728|588385835|FG001|Double-Blind Treatment|Protocol Violation|0|||
162913959|NCT00689728|588385836|FG002|Double-Blind Treatment|Protocol Violation|1|||
162913960|NCT00689728|588385834|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
162913961|NCT00689728|588385835|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
162913962|NCT00689728|588385836|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
162913963|NCT00689728|588385834|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
162913964|NCT00689728|588385835|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
162913965|NCT00689728|588385836|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
162913966|NCT00689728|588385834|FG000|Rescue|Adverse Event|0|||
162913967|NCT00689728|588385835|FG001|Rescue|Adverse Event|1|||
162913968|NCT00689728|588385836|FG002|Rescue|Adverse Event|0|||
162913969|NCT00689728|588385834|FG000|Rescue|Withdrawal by Subject|1|||
162913970|NCT00689728|588385835|FG001|Rescue|Withdrawal by Subject|1|||
162913971|NCT00689728|588385836|FG002|Rescue|Withdrawal by Subject|1|||
162913972|NCT00689728|588385834|FG000|Optional Follow-Up|Adverse Event|1|||
162913973|NCT00689728|588385835|FG001|Optional Follow-Up|Adverse Event|0|||
162913974|NCT00689728|588385836|FG002|Optional Follow-Up|Adverse Event|0|||
162710895|NCT02524288|587652809|FG000|Overall Study|Withdrawal by Subject|76|||
162710896|NCT02524288|587652809|FG000|Overall Study|Pregnancy|22|||
162710897|NCT02524288|587652809|FG000|Overall Study|Physician Decision|2|||
162710898|NCT01835899|587652811|FG000|Overall Study|Adverse Event|0|||
162710899|NCT01835899|587652812|FG001|Overall Study|Adverse Event|0|||
162710900|NCT01835899|587652813|FG002|Overall Study|Adverse Event|1|||
162710901|NCT01835899|587652811|FG000|Overall Study|Other than stated above|0|||
162710902|NCT01835899|587652812|FG001|Overall Study|Other than stated above|1|||
162710903|NCT01835899|587652813|FG002|Overall Study|Other than stated above|0|||
162710904|NCT02616263|587652814|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
162710905|NCT02616263|587652815|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
162710906|NCT02616263|587652814|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
162710907|NCT02616263|587652815|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
162710908|NCT02616263|587652814|FG000|6 Month to 1.5 Year|Death|1|||
162710909|NCT02616263|587652815|FG001|6 Month to 1.5 Year|Death|0|||
162710910|NCT02616263|587652814|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
162710911|NCT02616263|587652815|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
162913975|NCT00689728|588385834|FG000|Optional Follow-Up|Lack of Efficacy|0|||
162913976|NCT00689728|588385835|FG001|Optional Follow-Up|Lack of Efficacy|1|||
162913977|NCT00689728|588385836|FG002|Optional Follow-Up|Lack of Efficacy|1|||
162913978|NCT00689728|588385834|FG000|Optional Follow-Up|Lost to Follow-up|0|||
162913979|NCT00689728|588385835|FG001|Optional Follow-Up|Lost to Follow-up|1|||
162913980|NCT00689728|588385836|FG002|Optional Follow-Up|Lost to Follow-up|1|||
162913981|NCT00689728|588385834|FG000|Optional Follow-Up|Protocol Violation|0|||
162913982|NCT00689728|588385835|FG001|Optional Follow-Up|Protocol Violation|0|||
162913983|NCT00689728|588385836|FG002|Optional Follow-Up|Protocol Violation|1|||
162913984|NCT00689728|588385834|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
162710912|NCT02616263|587652814|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
162710913|NCT02616263|587652815|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
162710914|NCT02616263|587652814|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
162913985|NCT00689728|588385835|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
162913986|NCT00689728|588385836|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
162913987|NCT00842829|588385837|FG000|Dose Titration Period|Adverse Event|11|||
162913988|NCT00842829|588385838|FG001|Dose Titration Period|Adverse Event|10|||
162913989|NCT00842829|588385839|FG002|Dose Titration Period|Adverse Event|0|||
162913990|NCT00842829|588385837|FG000|Dose Titration Period|Lack of Efficacy|4|||
162913991|NCT00842829|588385838|FG001|Dose Titration Period|Lack of Efficacy|1|||
162913992|NCT00842829|588385839|FG002|Dose Titration Period|Lack of Efficacy|0|||
162913993|NCT00842829|588385837|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
162913994|NCT00842829|588385838|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
162913995|NCT00842829|588385839|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
162913996|NCT00842829|588385837|FG000|Dose Titration Period|Withdrawal by Subject|2|||
162913997|NCT00842829|588385838|FG001|Dose Titration Period|Withdrawal by Subject|6|||
162913998|NCT00842829|588385839|FG002|Dose Titration Period|Withdrawal by Subject|0|||
162913999|NCT00842829|588385837|FG000|Dose Titration Period|Other|5|||
162914000|NCT00842829|588385838|FG001|Dose Titration Period|Other|4|||
162914001|NCT00842829|588385839|FG002|Dose Titration Period|Other|0|||
162914002|NCT00842829|588385837|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
162914003|NCT00842829|588385838|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
162914004|NCT00842829|588385839|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
162914005|NCT00842829|588385837|FG000|Dose Titration Period|Non-compliance to study drug|2|||
162914006|NCT00842829|588385838|FG001|Dose Titration Period|Non-compliance to study drug|1|||
162914007|NCT00842829|588385839|FG002|Dose Titration Period|Non-compliance to study drug|0|||
162914008|NCT00842829|588385837|FG000|Treatment Period|Adverse Event|0|||
162914009|NCT00842829|588385838|FG001|Treatment Period|Adverse Event|0|||
162914010|NCT00842829|588385839|FG002|Treatment Period|Adverse Event|15|||
162914011|NCT00842829|588385837|FG000|Treatment Period|Lack of Efficacy|0|||
162914012|NCT00842829|588385838|FG001|Treatment Period|Lack of Efficacy|0|||
162914013|NCT00842829|588385839|FG002|Treatment Period|Lack of Efficacy|6|||
162914014|NCT00842829|588385837|FG000|Treatment Period|Unstable persistent cancer pain|0|||
162914015|NCT00842829|588385838|FG001|Treatment Period|Unstable persistent cancer pain|0|||
162914016|NCT00842829|588385839|FG002|Treatment Period|Unstable persistent cancer pain|5|||
162914017|NCT00842829|588385837|FG000|Treatment Period|Withdrawal by Subject|0|||
162914018|NCT00842829|588385838|FG001|Treatment Period|Withdrawal by Subject|0|||
162914019|NCT00842829|588385839|FG002|Treatment Period|Withdrawal by Subject|11|||
162914020|NCT00842829|588385837|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
162914021|NCT00842829|588385838|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
162914022|NCT00842829|588385839|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
162914023|NCT00842829|588385837|FG000|Treatment Period|Protocol Violation|0|||
162914024|NCT00842829|588385838|FG001|Treatment Period|Protocol Violation|0|||
162914025|NCT00842829|588385839|FG002|Treatment Period|Protocol Violation|2|||
162914026|NCT00842829|588385837|FG000|Treatment Period|Other|0|||
162914027|NCT00842829|588385838|FG001|Treatment Period|Other|0|||
162914028|NCT00842829|588385839|FG002|Treatment Period|Other|18|||
162914029|NCT00842829|588385837|FG000|Treatment Period|Non-compliance to study procedures|0|||
162914030|NCT00842829|588385838|FG001|Treatment Period|Non-compliance to study procedures|0|||
162914031|NCT00842829|588385839|FG002|Treatment Period|Non-compliance to study procedures|4|||
162914032|NCT00842829|588385837|FG000|Treatment Period|Unclear completion status|0|||
162914033|NCT00842829|588385838|FG001|Treatment Period|Unclear completion status|0|||
162914034|NCT00842829|588385839|FG002|Treatment Period|Unclear completion status|1|||
162914035|NCT00842829|588385837|FG000|Continuation Period|Adverse Event|0|||
162914036|NCT00842829|588385838|FG001|Continuation Period|Adverse Event|0|||
162914037|NCT00842829|588385839|FG002|Continuation Period|Adverse Event|32|||
162914038|NCT00842829|588385837|FG000|Continuation Period|Lack of Efficacy|0|||
162914039|NCT00842829|588385838|FG001|Continuation Period|Lack of Efficacy|0|||
162914040|NCT00842829|588385839|FG002|Continuation Period|Lack of Efficacy|6|||
162914041|NCT00842829|588385837|FG000|Continuation Period|Unstable persistent cancer pain|0|||
162914042|NCT00842829|588385838|FG001|Continuation Period|Unstable persistent cancer pain|0|||
162914043|NCT00842829|588385839|FG002|Continuation Period|Unstable persistent cancer pain|3|||
162914044|NCT00842829|588385837|FG000|Continuation Period|Withdrawal by Subject|0|||
162914045|NCT00842829|588385838|FG001|Continuation Period|Withdrawal by Subject|0|||
162914046|NCT00842829|588385839|FG002|Continuation Period|Withdrawal by Subject|10|||
162914047|NCT00842829|588385837|FG000|Continuation Period|Other|0|||
162914048|NCT00842829|588385838|FG001|Continuation Period|Other|0|||
162914049|NCT00842829|588385839|FG002|Continuation Period|Other|7|||
162914050|NCT00842829|588385837|FG000|Continuation Period|Non-compliance to study procedures|0|||
162914051|NCT00842829|588385838|FG001|Continuation Period|Non-compliance to study procedures|0|||
162914052|NCT00842829|588385839|FG002|Continuation Period|Non-compliance to study procedures|2|||
162914053|NCT00842829|588385837|FG000|Continuation Period|Non-compliance to study drug|0|||
162914054|NCT00842829|588385838|FG001|Continuation Period|Non-compliance to study drug|0|||
162914055|NCT00842829|588385839|FG002|Continuation Period|Non-compliance to study drug|1|||
162914056|NCT03417999|588385842|FG000|Overall Study|Withdrawal by Subject|1|||
162914057|NCT03417999|588385843|FG001|Overall Study|Withdrawal by Subject|0|||
162914058|NCT03417999|588385844|FG002|Overall Study|Withdrawal by Subject|0|||
162914059|NCT03417999|588385842|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
162914060|NCT03417999|588385843|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
162914061|NCT03417999|588385844|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
162914062|NCT03417999|588385842|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
162914063|NCT03417999|588385843|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
162914064|NCT03417999|588385844|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
162914065|NCT03417999|588385842|FG000|Overall Study|Inadequate study staff available to process samples|0|||
162914066|NCT03417999|588385843|FG001|Overall Study|Inadequate study staff available to process samples|0|||
162914067|NCT03417999|588385844|FG002|Overall Study|Inadequate study staff available to process samples|1|||
162914068|NCT02612194|588385849|FG000|Overall Study|Death|5|||
162914069|NCT02612194|588385850|FG001|Overall Study|Death|0|||
162914070|NCT02612194|588385851|FG002|Overall Study|Death|2|||
162914071|NCT02612194|588385849|FG000|Overall Study|Early Study Termination|1|||
162914072|NCT02612194|588385850|FG001|Overall Study|Early Study Termination|0|||
162914073|NCT02612194|588385851|FG002|Overall Study|Early Study Termination|0|||
162914074|NCT02539160|588385852|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
162914075|NCT02539160|588385853|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
162914076|NCT02539160|588385854|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
162914077|NCT02539160|588385855|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
162914078|NCT02539160|588385852|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
162914079|NCT02539160|588385853|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
162914080|NCT02539160|588385854|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
162914081|NCT02539160|588385855|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
162914082|NCT02539160|588385852|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
162914083|NCT02539160|588385853|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
162914084|NCT02539160|588385854|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
162914085|NCT02539160|588385855|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
162914086|NCT01681004|588385856|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
162914087|NCT01681004|588385857|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
162914088|NCT01681004|588385856|FG000|Study Completion|Lost to Follow-up|8|||
162914089|NCT01681004|588385857|FG001|Study Completion|Lost to Follow-up|3|||
162914090|NCT01681004|588385856|FG000|Study Completion|Physician Decision|1|||
162914091|NCT01681004|588385857|FG001|Study Completion|Physician Decision|3|||
162914092|NCT01681004|588385856|FG000|Study Completion|Site Termination|2|||
162914093|NCT01681004|588385857|FG001|Study Completion|Site Termination|1|||
162914094|NCT01681004|588385856|FG000|Study Completion|Death|1|||
162914095|NCT01681004|588385857|FG001|Study Completion|Death|1|||
162914096|NCT00372905|588385858|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
162914097|NCT00372905|588385859|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
162914098|NCT00372905|588385860|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
162914099|NCT00372905|588385861|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
162914100|NCT00372905|588385858|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
162914101|NCT00372905|588385859|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
162914102|NCT00372905|588385860|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
162914103|NCT00372905|588385861|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
162914104|NCT00372905|588385858|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
162914105|NCT00372905|588385859|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
162914106|NCT00372905|588385860|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
162914107|NCT00372905|588385861|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
162914108|NCT00372905|588385858|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
162914109|NCT00372905|588385859|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
162914110|NCT00372905|588385860|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
162914111|NCT00372905|588385861|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
162914112|NCT00372905|588385858|FG000|Follow up Until Relapse or Progression|Study closed|0|||
162914113|NCT00372905|588385859|FG001|Follow up Until Relapse or Progression|Study closed|0|||
162914114|NCT00372905|588385860|FG002|Follow up Until Relapse or Progression|Study closed|0|||
162914115|NCT00372905|588385861|FG003|Follow up Until Relapse or Progression|Study closed|3|||
162914116|NCT00372905|588385858|FG000|Follow up Until Relapse or Progression|Other|0|||
162914117|NCT00372905|588385859|FG001|Follow up Until Relapse or Progression|Other|1|||
162914118|NCT00372905|588385860|FG002|Follow up Until Relapse or Progression|Other|0|||
162914119|NCT00372905|588385861|FG003|Follow up Until Relapse or Progression|Other|0|||
162914120|NCT01728454|588385862|FG000|Stage 1 and 2|Pregnancy|1|||
162914121|NCT01728454|588385863|FG001|Stage 1 and 2|Pregnancy|0|||
162914122|NCT01728454|588385864|FG002|Stage 1 and 2|Pregnancy|0|||
162914123|NCT01728454|588385862|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
162914124|NCT01728454|588385863|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
162914125|NCT01728454|588385864|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
162914126|NCT01728454|588385862|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
162914127|NCT01728454|588385863|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
162914128|NCT01728454|588385864|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
162914129|NCT01728454|588385862|FG000|Stage 1 and 2|Lost to Follow-up|1|||
162914130|NCT01728454|588385863|FG001|Stage 1 and 2|Lost to Follow-up|1|||
162914131|NCT01728454|588385864|FG002|Stage 1 and 2|Lost to Follow-up|0|||
162914132|NCT01728454|588385862|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
162914133|NCT01728454|588385863|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
162914134|NCT01728454|588385864|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
162914135|NCT01728454|588385862|FG000|Stage 3|Reason Missing|0|||
162914136|NCT01728454|588385863|FG001|Stage 3|Reason Missing|0|||
162914137|NCT01728454|588385864|FG002|Stage 3|Reason Missing|1|||
162914138|NCT01728454|588385862|FG000|Stage 3|Subject Required Other Treatment|0|||
162914139|NCT01728454|588385863|FG001|Stage 3|Subject Required Other Treatment|1|||
162914140|NCT01728454|588385864|FG002|Stage 3|Subject Required Other Treatment|0|||
162914141|NCT01728454|588385862|FG000|Stage 3|Pregnancy|1|||
162914142|NCT01728454|588385863|FG001|Stage 3|Pregnancy|0|||
162914143|NCT01728454|588385864|FG002|Stage 3|Pregnancy|0|||
162914144|NCT01728454|588385862|FG000|Stage 3|Withdrew Consent|1|||
162914145|NCT01728454|588385863|FG001|Stage 3|Withdrew Consent|0|||
162914146|NCT01728454|588385864|FG002|Stage 3|Withdrew Consent|1|||
162914147|NCT01728454|588385862|FG000|Stage 3|Non-compliance with Protocol|0|||
162914148|NCT01728454|588385863|FG001|Stage 3|Non-compliance with Protocol|0|||
162914149|NCT01728454|588385864|FG002|Stage 3|Non-compliance with Protocol|1|||
162914150|NCT01728454|588385862|FG000|Stage 3|Lost to Follow-up|0|||
162914151|NCT01728454|588385863|FG001|Stage 3|Lost to Follow-up|3|||
162914152|NCT01728454|588385864|FG002|Stage 3|Lost to Follow-up|1|||
162914153|NCT01728454|588385862|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
162914154|NCT01728454|588385863|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
162914155|NCT01728454|588385864|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
162914156|NCT00689299|588385865|FG000|Overall Study|Adverse Event|2|||
162914157|NCT00689299|588385866|FG001|Overall Study|Adverse Event|1|||
162914158|NCT00689299|588385867|FG002|Overall Study|Adverse Event|1|||
162914159|NCT00689299|588385865|FG000|Overall Study|Lost to Follow-up|0|||
162914160|NCT00689299|588385866|FG001|Overall Study|Lost to Follow-up|1|||
162914161|NCT00689299|588385867|FG002|Overall Study|Lost to Follow-up|1|||
162914162|NCT00689299|588385865|FG000|Overall Study|Withdrawal by Subject|4|||
162914163|NCT00689299|588385866|FG001|Overall Study|Withdrawal by Subject|1|||
162914164|NCT00689299|588385867|FG002|Overall Study|Withdrawal by Subject|3|||
162914165|NCT00689299|588385865|FG000|Overall Study|Protocol Violation|1|||
162914166|NCT00689299|588385866|FG001|Overall Study|Protocol Violation|0|||
162914167|NCT00689299|588385867|FG002|Overall Study|Protocol Violation|0|||
162914168|NCT00695318|588385874|FG000|Overall Study|Lost to Follow-up|1|||
162914169|NCT00695318|588385875|FG001|Overall Study|Lost to Follow-up|0|||
162914170|NCT00695318|588385874|FG000|Overall Study|Withdrawal by Subject|2|||
162914171|NCT00695318|588385875|FG001|Overall Study|Withdrawal by Subject|0|||
162914172|NCT00695318|588385874|FG000|Overall Study|Death|1|||
162914173|NCT00695318|588385875|FG001|Overall Study|Death|1|||
162914174|NCT00695318|588385874|FG000|Overall Study|Study Terminated|1|||
162914175|NCT00695318|588385875|FG001|Overall Study|Study Terminated|0|||
162914176|NCT02058966|588385876|FG000|Open-Label Methamphetamine|Adverse Event|1|||
162968228|NCT01567527|588584822|FG004|IM Depot Stabilization.|Protocol deviation|0|||
162968229|NCT01567527|588584818|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968230|NCT01567527|588584819|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968231|NCT01567527|588584820|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
162968232|NCT01567527|588584821|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968233|NCT01567527|588584822|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
162968234|NCT01567527|588584818|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968235|NCT01567527|588584819|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968236|NCT01567527|588584820|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
162968237|NCT01567527|588584821|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968238|NCT01567527|588584822|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
162968239|NCT01567527|588584818|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968240|NCT01567527|588584819|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968241|NCT01567527|588584820|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
162629059|NCT03310021|587358607|FG010|Overall Study|Withdrawal by Subject|0|||
162629060|NCT03310021|587358608|FG011|Overall Study|Withdrawal by Subject|0|||
162629061|NCT03310021|587358609|FG012|Overall Study|Withdrawal by Subject|0|||
162629062|NCT03310021|587358610|FG013|Overall Study|Withdrawal by Subject|0|||
162629063|NCT03310021|587358611|FG014|Overall Study|Withdrawal by Subject|0|||
162629064|NCT03310021|587358612|FG015|Overall Study|Withdrawal by Subject|0|||
162629065|NCT03310021|587358613|FG016|Overall Study|Withdrawal by Subject|0|||
162629066|NCT03310021|587358614|FG017|Overall Study|Withdrawal by Subject|0|||
162629067|NCT03310021|587358615|FG018|Overall Study|Withdrawal by Subject|0|||
162629068|NCT03310021|587358616|FG019|Overall Study|Withdrawal by Subject|0|||
162629069|NCT03310021|587358597|FG000|Overall Study|Lost to Follow-up|0|||
162629070|NCT03310021|587358598|FG001|Overall Study|Lost to Follow-up|0|||
162629071|NCT03310021|587358599|FG002|Overall Study|Lost to Follow-up|0|||
162629072|NCT03310021|587358600|FG003|Overall Study|Lost to Follow-up|0|||
162629073|NCT03310021|587358601|FG004|Overall Study|Lost to Follow-up|0|||
162629074|NCT03310021|587358602|FG005|Overall Study|Lost to Follow-up|0|||
162629075|NCT03310021|587358603|FG006|Overall Study|Lost to Follow-up|0|||
162914177|NCT02058966|588385876|FG000|First Intervention|Withdrawal by Subject|1|||
162914178|NCT01362062|588385880|FG000|Overall Study|Adverse Event|1|||
162914179|NCT01362062|588385881|FG001|Overall Study|Adverse Event|0|||
162914180|NCT01362062|588385880|FG000|Overall Study|Lost to Follow-up|11|||
162914181|NCT01362062|588385881|FG001|Overall Study|Lost to Follow-up|0|||
162914182|NCT01362062|588385880|FG000|Overall Study|Withdrawal by Subject|2|||
162914183|NCT01362062|588385881|FG001|Overall Study|Withdrawal by Subject|0|||
162914184|NCT01362062|588385880|FG000|Overall Study|Non-compliant participant|2|||
162914185|NCT01362062|588385881|FG001|Overall Study|Non-compliant participant|0|||
162914186|NCT01362062|588385880|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
162914187|NCT01362062|588385881|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
162914188|NCT01362062|588385880|FG000|Overall Study|Had significant improvement|9|||
162914189|NCT01362062|588385881|FG001|Overall Study|Had significant improvement|0|||
162914190|NCT02545504|588385884|FG000|Overall Study|Death|174|||
162914191|NCT02545504|588385885|FG001|Overall Study|Death|168|||
162914192|NCT02545504|588385884|FG000|Overall Study|Unknown reason|30|||
162914193|NCT02545504|588385885|FG001|Overall Study|Unknown reason|32|||
162914194|NCT02545504|588385884|FG000|Overall Study|Withdrew consent|9|||
162914195|NCT02545504|588385885|FG001|Overall Study|Withdrew consent|11|||
162914196|NCT02545504|588385884|FG000|Overall Study|Investigator's discretion|3|||
162914197|NCT02545504|588385885|FG001|Overall Study|Investigator's discretion|1|||
162914198|NCT02545504|588385884|FG000|Overall Study|Lost to Follow-up|2|||
162914199|NCT02545504|588385885|FG001|Overall Study|Lost to Follow-up|2|||
162914200|NCT00434876|588385886|FG000|Overall Study|Lost to Follow-up|1|||
162914201|NCT00434876|588385887|FG001|Overall Study|Lost to Follow-up|1|||
162914202|NCT00758394|588385888|FG000|2nd Intervention Order|Lost to Follow-up|0|||
162914203|NCT00758394|588385889|FG001|2nd Intervention Order|Lost to Follow-up|1|||
162914204|NCT00758394|588385890|FG002|2nd Intervention Order|Lost to Follow-up|0|||
162914205|NCT00758394|588385891|FG003|2nd Intervention Order|Lost to Follow-up|0|||
162914206|NCT00758394|588385888|FG000|3rd Intervention|Lost to Follow-up|1|||
162914207|NCT00758394|588385889|FG001|3rd Intervention|Lost to Follow-up|0|||
162914208|NCT00758394|588385890|FG002|3rd Intervention|Lost to Follow-up|0|||
162914209|NCT00758394|588385891|FG003|3rd Intervention|Lost to Follow-up|1|||
162914210|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
162914211|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
162914212|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
162914213|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
162914214|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
162914215|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
162914216|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
162914217|NCT00950755|588385892|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
162914218|NCT00950755|588385892|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
162914219|NCT00950755|588385892|FG000|Long-Term Follow-Up|Death|8|||
162914220|NCT00508820|588385895|FG000|Overall Study|Adverse Event|6|||
162914221|NCT00508820|588385896|FG001|Overall Study|Adverse Event|10|||
162914222|NCT00508820|588385895|FG000|Overall Study|Death|6|||
162914223|NCT00508820|588385896|FG001|Overall Study|Death|8|||
162914224|NCT00508820|588385895|FG000|Overall Study|Lost to Follow-up|1|||
162914225|NCT00508820|588385896|FG001|Overall Study|Lost to Follow-up|1|||
162914226|NCT00508820|588385895|FG000|Overall Study|Physician Decision|8|||
162914227|NCT00508820|588385896|FG001|Overall Study|Physician Decision|2|||
162914228|NCT00508820|588385895|FG000|Overall Study|Pregnancy|0|||
162914229|NCT00508820|588385896|FG001|Overall Study|Pregnancy|2|||
162914230|NCT00508820|588385895|FG000|Overall Study|Protocol Violation|2|||
162914231|NCT00508820|588385896|FG001|Overall Study|Protocol Violation|0|||
162914232|NCT00508820|588385895|FG000|Overall Study|Withdrawal by Subject|10|||
162914233|NCT00508820|588385896|FG001|Overall Study|Withdrawal by Subject|12|||
162914234|NCT00508820|588385895|FG000|Overall Study|Other|11|||
162914235|NCT00508820|588385896|FG001|Overall Study|Other|2|||
162914236|NCT00508820|588385895|FG000|Overall Study|Noncompliance|1|||
162914237|NCT00508820|588385896|FG001|Overall Study|Noncompliance|0|||
162914238|NCT00508820|588385895|FG000|Overall Study|Requirement for alternative therapy|7|||
162914239|NCT00508820|588385896|FG001|Overall Study|Requirement for alternative therapy|15|||
162914240|NCT00508820|588385895|FG000|Overall Study|Protocol-specified Criteria|3|||
162914241|NCT00508820|588385896|FG001|Overall Study|Protocol-specified Criteria|12|||
162914242|NCT02926833|588387601|FG000|Overall Study|Death|1|||
162914243|NCT02926833|588387602|FG001|Overall Study|Death|1|||
162710915|NCT02616263|587652815|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
162710916|NCT02939183|587652821|FG000|Overall Study|Death|0|||
162710917|NCT02939183|587652822|FG001|Overall Study|Death|0|||
162710918|NCT02939183|587652823|FG002|Overall Study|Death|1|||
162914244|NCT02926833|588387603|FG002|Overall Study|Death|2|||
162914245|NCT02926833|588387604|FG003|Overall Study|Death|13|||
162914246|NCT02926833|588387601|FG000|Overall Study|Lost to Follow-up|1|||
162914247|NCT02926833|588387602|FG001|Overall Study|Lost to Follow-up|2|||
162914248|NCT02926833|588387603|FG002|Overall Study|Lost to Follow-up|0|||
162914249|NCT02926833|588387604|FG003|Overall Study|Lost to Follow-up|3|||
162914250|NCT02926833|588387601|FG000|Overall Study|Full Consent Withdrawal|0|||
162914251|NCT02926833|588387602|FG001|Overall Study|Full Consent Withdrawal|0|||
162914252|NCT02926833|588387603|FG002|Overall Study|Full Consent Withdrawal|0|||
162914253|NCT02926833|588387604|FG003|Overall Study|Full Consent Withdrawal|2|||
162914254|NCT02926833|588387601|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
162914255|NCT02926833|588387602|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
162914256|NCT02926833|588387603|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
162914257|NCT02926833|588387604|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
162914258|NCT02926833|588387601|FG000|Overall Study|Investigator Decision|0|||
162914259|NCT02926833|588387602|FG001|Overall Study|Investigator Decision|1|||
162914260|NCT02926833|588387603|FG002|Overall Study|Investigator Decision|0|||
162914261|NCT02926833|588387604|FG003|Overall Study|Investigator Decision|0|||
162914262|NCT02926833|588387601|FG000|Overall Study|Adverse Event|0|||
162914263|NCT02926833|588387602|FG001|Overall Study|Adverse Event|0|||
162914264|NCT02926833|588387603|FG002|Overall Study|Adverse Event|1|||
162914265|NCT02926833|588387604|FG003|Overall Study|Adverse Event|0|||
162914266|NCT02926833|588387601|FG000|Overall Study|Partial Withdrawal of Consent|0|||
162914267|NCT02926833|588387602|FG001|Overall Study|Partial Withdrawal of Consent|0|||
162914268|NCT02926833|588387603|FG002|Overall Study|Partial Withdrawal of Consent|0|||
162914269|NCT02926833|588387604|FG003|Overall Study|Partial Withdrawal of Consent|1|||
162914270|NCT01004822|588387605|FG000|Overall Study|Objective progression or relapse|3|||
162914271|NCT01004822|588387606|FG001|Overall Study|Objective progression or relapse|3|||
162914272|NCT01004822|588387607|FG002|Overall Study|Objective progression or relapse|0|||
162914273|NCT01004822|588387608|FG003|Overall Study|Objective progression or relapse|1|||
162914274|NCT01004822|588387609|FG004|Overall Study|Objective progression or relapse|2|||
162914275|NCT01004822|588387610|FG005|Overall Study|Objective progression or relapse|2|||
162914276|NCT01004822|588387611|FG006|Overall Study|Objective progression or relapse|1|||
162914277|NCT01004822|588387612|FG007|Overall Study|Objective progression or relapse|4|||
162914278|NCT01004822|588387605|FG000|Overall Study|Global deterioration of health status|0|||
162914279|NCT01004822|588387606|FG001|Overall Study|Global deterioration of health status|0|||
162914280|NCT01004822|588387607|FG002|Overall Study|Global deterioration of health status|0|||
162914281|NCT01004822|588387608|FG003|Overall Study|Global deterioration of health status|1|||
162914282|NCT01004822|588387609|FG004|Overall Study|Global deterioration of health status|0|||
162914283|NCT01004822|588387610|FG005|Overall Study|Global deterioration of health status|0|||
162914284|NCT01004822|588387611|FG006|Overall Study|Global deterioration of health status|1|||
162914285|NCT01004822|588387612|FG007|Overall Study|Global deterioration of health status|0|||
162914286|NCT01004822|588387605|FG000|Overall Study|No longer willing to continue|0|||
162914287|NCT01004822|588387606|FG001|Overall Study|No longer willing to continue|0|||
162914288|NCT01004822|588387607|FG002|Overall Study|No longer willing to continue|0|||
162914289|NCT01004822|588387608|FG003|Overall Study|No longer willing to continue|1|||
162914290|NCT01004822|588387609|FG004|Overall Study|No longer willing to continue|2|||
162914291|NCT01004822|588387610|FG005|Overall Study|No longer willing to continue|1|||
162914292|NCT01004822|588387611|FG006|Overall Study|No longer willing to continue|1|||
162914293|NCT01004822|588387612|FG007|Overall Study|No longer willing to continue|0|||
162914294|NCT01004822|588387605|FG000|Overall Study|Adverse Event|0|||
162914295|NCT01004822|588387606|FG001|Overall Study|Adverse Event|0|||
162914296|NCT01004822|588387607|FG002|Overall Study|Adverse Event|0|||
162914297|NCT01004822|588387608|FG003|Overall Study|Adverse Event|0|||
162914298|NCT01004822|588387609|FG004|Overall Study|Adverse Event|0|||
162914299|NCT01004822|588387610|FG005|Overall Study|Adverse Event|0|||
162914300|NCT01004822|588387611|FG006|Overall Study|Adverse Event|1|||
162914301|NCT01004822|588387612|FG007|Overall Study|Adverse Event|1|||
162914302|NCT01004822|588387605|FG000|Overall Study|Other|0|||
162914303|NCT01004822|588387606|FG001|Overall Study|Other|0|||
162914304|NCT01004822|588387607|FG002|Overall Study|Other|4|||
162914305|NCT01004822|588387608|FG003|Overall Study|Other|1|||
162914306|NCT01004822|588387609|FG004|Overall Study|Other|0|||
162914307|NCT01004822|588387610|FG005|Overall Study|Other|1|||
162914308|NCT01004822|588387611|FG006|Overall Study|Other|0|||
162914309|NCT01004822|588387612|FG007|Overall Study|Other|0|||
162914310|NCT03159455|588387615|FG000|Overall Study|Adverse Event|0|||
162914311|NCT03159455|588387616|FG001|Overall Study|Adverse Event|0|||
162914312|NCT03159455|588387617|FG002|Overall Study|Adverse Event|0|||
162914313|NCT03159455|588387618|FG003|Overall Study|Adverse Event|0|||
162914314|NCT03159455|588387619|FG004|Overall Study|Adverse Event|0|||
162914315|NCT03159455|588387620|FG005|Overall Study|Adverse Event|1|||
162914316|NCT03799198|588387626|FG000|Overall Study|Lost to Follow-up|4|||
162914317|NCT03799198|588387627|FG001|Overall Study|Lost to Follow-up|8|||
162914318|NCT03799198|588387626|FG000|Overall Study|Death|0|||
162914319|NCT03799198|588387627|FG001|Overall Study|Death|1|||
162914320|NCT00960869|588387629|FG000|Overall Study|Adverse Event|17|||
162914321|NCT00960869|588387630|FG001|Overall Study|Adverse Event|26|||
162914322|NCT00960869|588387629|FG000|Overall Study|Withdrawal by Subject|16|||
162629076|NCT03310021|587358604|FG007|Overall Study|Lost to Follow-up|0|||
162629077|NCT03310021|587358605|FG008|Overall Study|Lost to Follow-up|0|||
162914323|NCT00960869|588387630|FG001|Overall Study|Withdrawal by Subject|14|||
162914324|NCT00960869|588387629|FG000|Overall Study|Lost to Follow-up|1|||
162914325|NCT00960869|588387630|FG001|Overall Study|Lost to Follow-up|4|||
162914326|NCT00960869|588387629|FG000|Overall Study|Misc|19|||
162914327|NCT00960869|588387630|FG001|Overall Study|Misc|18|||
162914328|NCT02501642|588387631|FG000|Overall Study|Lost to Follow-up|7|||
162629078|NCT03310021|587358606|FG009|Overall Study|Lost to Follow-up|0|||
162914329|NCT02501642|588387632|FG001|Overall Study|Lost to Follow-up|11|||
162914330|NCT03410693|588387636|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
162914331|NCT03410693|588387637|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
162914332|NCT03410693|588387636|FG000|Overall Study|Disc trt: Lost to follow up|0|||
162914333|NCT03410693|588387637|FG001|Overall Study|Disc trt: Lost to follow up|1|||
162914334|NCT03410693|588387636|FG000|Overall Study|Disc trt: radiological progression|58|||
162914335|NCT03410693|588387637|FG001|Overall Study|Disc trt: radiological progression|50|||
162914336|NCT03410693|588387636|FG000|Overall Study|Disc trt: Other|1|||
162914337|NCT03410693|588387637|FG001|Overall Study|Disc trt: Other|0|||
162914338|NCT03410693|588387636|FG000|Overall Study|Study drug never administered|1|||
162914339|NCT03410693|588387637|FG001|Overall Study|Study drug never administered|6|||
162914340|NCT03410693|588387636|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
162914341|NCT03410693|588387637|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
162914342|NCT03410693|588387636|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
162914343|NCT03410693|588387637|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
162914344|NCT03410693|588387636|FG000|Overall Study|Disc trt: Physician decision|0|||
162914345|NCT03410693|588387637|FG001|Overall Study|Disc trt: Physician decision|5|||
162914346|NCT03410693|588387636|FG000|Overall Study|Disc trt: clinical progression|1|||
162914347|NCT03410693|588387637|FG001|Overall Study|Disc trt: clinical progression|5|||
162914348|NCT03410693|588387636|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
162914349|NCT03410693|588387637|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
162914350|NCT00953576|588387638|FG000|Overall Study|Adverse Event|0|||
162914351|NCT00953576|588387639|FG001|Overall Study|Adverse Event|1|||
162914352|NCT00953576|588387638|FG000|Overall Study|Ineligible after Consent|2|||
162914353|NCT00953576|588387639|FG001|Overall Study|Ineligible after Consent|0|||
162914354|NCT00501969|588387640|FG000|Overall Study|Major Protocol Violation|4|||
162914355|NCT00501969|588387640|FG000|Overall Study|Lack of Efficacy|29|||
162914356|NCT00501969|588387640|FG000|Overall Study|Adverse Event|76|||
162914357|NCT00501969|588387640|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
162914358|NCT00501969|588387640|FG000|Overall Study|Subject withdrew consent|51|||
162914359|NCT00501969|588387640|FG000|Overall Study|Lost to Follow-up|4|||
162914360|NCT00501969|588387640|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
162914361|NCT00501969|588387640|FG000|Overall Study|Other: Sponsors Request|10|||
162914362|NCT00501969|588387640|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
162914363|NCT00501969|588387640|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
162914364|NCT00501969|588387640|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
162914365|NCT00501969|588387640|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
162914366|NCT00501969|588387640|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
162914367|NCT00501969|588387640|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
162914368|NCT00501969|588387640|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
162914369|NCT00501969|588387640|FG000|Overall Study|Other: As Required by Local EC|2|||
162914370|NCT00501969|588387640|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
162914371|NCT00501969|588387640|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
162914372|NCT02687815|588387641|FG000|Overall Study|Lost to Follow-up|2|||
162914373|NCT02687815|588387642|FG001|Overall Study|Lost to Follow-up|4|||
162914374|NCT02687815|588387641|FG000|Overall Study|Withdrawal by Subject|2|||
162914375|NCT02687815|588387642|FG001|Overall Study|Withdrawal by Subject|4|||
162914376|NCT00379639|588387643|FG000|Overall Study|Disease Progression|3|||
162914377|NCT00379639|588387644|FG001|Overall Study|Disease Progression|3|||
162914378|NCT00379639|588387645|FG002|Overall Study|Disease Progression|3|||
162914379|NCT00379639|588387646|FG003|Overall Study|Disease Progression|4|||
162914380|NCT00379639|588387647|FG004|Overall Study|Disease Progression|4|||
162914381|NCT00379639|588387643|FG000|Overall Study|Physician Decision|0|||
162914382|NCT00379639|588387644|FG001|Overall Study|Physician Decision|2|||
162914383|NCT00379639|588387645|FG002|Overall Study|Physician Decision|1|||
162914384|NCT00379639|588387646|FG003|Overall Study|Physician Decision|1|||
162914385|NCT00379639|588387647|FG004|Overall Study|Physician Decision|0|||
162914386|NCT00379639|588387643|FG000|Overall Study|Symptomatic Deterioration|0|||
162914387|NCT00379639|588387644|FG001|Overall Study|Symptomatic Deterioration|0|||
162914388|NCT00379639|588387645|FG002|Overall Study|Symptomatic Deterioration|1|||
162914389|NCT00379639|588387646|FG003|Overall Study|Symptomatic Deterioration|0|||
162914390|NCT00379639|588387647|FG004|Overall Study|Symptomatic Deterioration|1|||
162914391|NCT00379639|588387643|FG000|Overall Study|Adverse Event|0|||
162914392|NCT00379639|588387644|FG001|Overall Study|Adverse Event|0|||
162914393|NCT00379639|588387645|FG002|Overall Study|Adverse Event|1|||
162914394|NCT00379639|588387646|FG003|Overall Study|Adverse Event|0|||
162914395|NCT00379639|588387647|FG004|Overall Study|Adverse Event|1|||
162914396|NCT00379639|588387643|FG000|Overall Study|Lost to Follow-up|0|||
162914397|NCT00379639|588387644|FG001|Overall Study|Lost to Follow-up|0|||
162914398|NCT00379639|588387645|FG002|Overall Study|Lost to Follow-up|0|||
162914399|NCT00379639|588387646|FG003|Overall Study|Lost to Follow-up|1|||
162914400|NCT00379639|588387647|FG004|Overall Study|Lost to Follow-up|0|||
162914401|NCT00379639|588387643|FG000|Overall Study|Other|0|||
162914402|NCT00379639|588387644|FG001|Overall Study|Other|0|||
162914403|NCT00379639|588387645|FG002|Overall Study|Other|3|||
162914404|NCT00379639|588387646|FG003|Overall Study|Other|0|||
162914405|NCT00379639|588387647|FG004|Overall Study|Other|0|||
162914406|NCT03053102|588387652|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
162914407|NCT03053102|588387652|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
162914408|NCT01798056|588387653|FG000|Overall Study|Serious Adverse Event|13|||
162914409|NCT01798056|588387654|FG001|Overall Study|Serious Adverse Event|12|||
162914410|NCT01798056|588387653|FG000|Overall Study|Withdrawal by Subject|12|||
162914411|NCT01798056|588387654|FG001|Overall Study|Withdrawal by Subject|9|||
162914412|NCT01798056|588387653|FG000|Overall Study|Migrated/moved from study area|1|||
162914413|NCT01798056|588387654|FG001|Overall Study|Migrated/moved from study area|1|||
162914414|NCT01798056|588387653|FG000|Overall Study|Lost to Follow-up|1|||
162914415|NCT01798056|588387654|FG001|Overall Study|Lost to Follow-up|1|||
162914416|NCT01798056|588387653|FG000|Overall Study|Other|0|||
162914417|NCT01798056|588387654|FG001|Overall Study|Other|2|||
162914418|NCT01269346|588387657|FG000|Treatment Phase|Disease progression|3|||
162914419|NCT01269346|588387657|FG000|Treatment Phase|Adverse Event|3|||
162914420|NCT01269346|588387657|FG000|Treatment Phase|Withdrawal by Subject|1|||
162914421|NCT01269346|588387657|FG000|Treatment Phase|Other|2|||
162914422|NCT01269346|588387657|FG000|Extension Phase|Adverse Event|6|||
162914423|NCT01269346|588387657|FG000|Extension Phase|Withdrawal by Subject|4|||
162914424|NCT01269346|588387657|FG000|Extension Phase|Disease progression|22|||
162914425|NCT01269346|588387657|FG000|Extension Phase|Physician decision or participant choice|9|||
162914426|NCT01269346|588387657|FG000|Extension Phase|Clinical progression|1|||
162914427|NCT01269346|588387657|FG000|Extension Phase|Started a prohibited con med|1|||
162914428|NCT02660489|588387666|FG000|Overall Study|Lost to Follow-up|1|||
162914429|NCT02660489|588387667|FG001|Overall Study|Lost to Follow-up|1|||
162914430|NCT02660489|588387666|FG000|Overall Study|Adverse Event|1|||
162914431|NCT02660489|588387667|FG001|Overall Study|Adverse Event|3|||
162914432|NCT02660489|588387666|FG000|Overall Study|no rhinovirus infection|4|||
162914433|NCT02660489|588387667|FG001|Overall Study|no rhinovirus infection|4|||
162914434|NCT02322866|588387668|FG000|Overall Study|Adverse Event|6|||
162914435|NCT02322866|588387669|FG001|Overall Study|Adverse Event|11|||
162914436|NCT02322866|588387668|FG000|Overall Study|Withdrawal of Consent|16|||
162914437|NCT02322866|588387669|FG001|Overall Study|Withdrawal of Consent|25|||
162914438|NCT02322866|588387668|FG000|Overall Study|Lost to Follow-up|36|||
162914439|NCT02322866|588387669|FG001|Overall Study|Lost to Follow-up|39|||
162914440|NCT02322866|588387668|FG000|Overall Study|Protocol Violation|1|||
162914441|NCT02322866|588387669|FG001|Overall Study|Protocol Violation|0|||
162914442|NCT02322866|588387668|FG000|Overall Study|Noncompliance with Treatment|3|||
162914443|NCT02322866|588387669|FG001|Overall Study|Noncompliance with Treatment|4|||
162914444|NCT02322866|588387668|FG000|Overall Study|Lack of Efficacy|3|||
162914445|NCT02322866|588387669|FG001|Overall Study|Lack of Efficacy|1|||
162914446|NCT02322866|588387668|FG000|Overall Study|Other Miscellaneous Reasons|6|||
162914447|NCT02322866|588387669|FG001|Overall Study|Other Miscellaneous Reasons|6|||
162914448|NCT03735680|588387672|FG000|Overall Study|Withdrawal by Subject|0|||
162914449|NCT03735680|588387673|FG001|Overall Study|Withdrawal by Subject|1|||
162914450|NCT03735680|588387674|FG002|Overall Study|Withdrawal by Subject|0|||
162914451|NCT03735680|588387675|FG003|Overall Study|Withdrawal by Subject|0|||
162914452|NCT03735680|588387676|FG004|Overall Study|Withdrawal by Subject|0|||
162914453|NCT03735680|588387677|FG005|Overall Study|Withdrawal by Subject|1|||
162914454|NCT03735680|588387672|FG000|Overall Study|Patient unable or unwilling to continue|0|||
162914455|NCT03735680|588387673|FG001|Overall Study|Patient unable or unwilling to continue|0|||
162914456|NCT03735680|588387674|FG002|Overall Study|Patient unable or unwilling to continue|1|||
162914457|NCT03735680|588387675|FG003|Overall Study|Patient unable or unwilling to continue|0|||
162914458|NCT03735680|588387676|FG004|Overall Study|Patient unable or unwilling to continue|0|||
162914459|NCT03735680|588387677|FG005|Overall Study|Patient unable or unwilling to continue|0|||
162914460|NCT03472586|588387692|FG000|Overall Study|Physician Decision|6|||
162914461|NCT03472586|588387692|FG000|Overall Study|Death|6|||
162914462|NCT03472586|588387692|FG000|Overall Study|Adverse Event|1|||
162914463|NCT02452320|588387695|FG000|Overall Study|Adverse Event|0|||
162914464|NCT02452320|588387696|FG001|Overall Study|Adverse Event|1|||
162914465|NCT03737812|588387697|FG000|Overall Study|Withdrawal by Subject|1|||
162914466|NCT03737812|588387698|FG001|Overall Study|Withdrawal by Subject|2|||
162914467|NCT03737812|588387699|FG002|Overall Study|Withdrawal by Subject|1|||
162914468|NCT03737812|588387697|FG000|Overall Study|Sponsor Discontinued the Study|4|||
162914469|NCT03737812|588387698|FG001|Overall Study|Sponsor Discontinued the Study|3|||
162914470|NCT03737812|588387699|FG002|Overall Study|Sponsor Discontinued the Study|2|||
162914471|NCT03737812|588387697|FG000|Overall Study|Adverse Event|0|||
162914472|NCT03737812|588387698|FG001|Overall Study|Adverse Event|1|||
162914473|NCT03737812|588387699|FG002|Overall Study|Adverse Event|0|||
162914474|NCT03737812|588387697|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
162914475|NCT03737812|588387698|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
162968242|NCT01567527|588584821|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
162914476|NCT03737812|588387699|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
162914477|NCT01474291|588387703|FG000|Overall Study|Not Evaluable for Efficacy|26|||
162914478|NCT01474291|588387703|FG000|Overall Study|Lack of Treatment Efficacy|88|||
162914479|NCT01474291|588387703|FG000|Overall Study|Adverse Event|53|||
162914480|NCT01474291|588387703|FG000|Overall Study|Lost to Follow-up|29|||
162914481|NCT01474291|588387703|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
162914482|NCT01474291|588387703|FG000|Overall Study|No Reason Reported|10|||
162914483|NCT01474291|588387703|FG000|Overall Study|Death|2|||
162914484|NCT03471507|588387704|FG000|Overall Study|Lost to Follow-up|1|||
162914485|NCT03471507|588387705|FG001|Overall Study|Lost to Follow-up|3|||
162914486|NCT03471507|588387704|FG000|Overall Study|Physician Decision|0|||
162914487|NCT03471507|588387705|FG001|Overall Study|Physician Decision|1|||
162914488|NCT03471507|588387704|FG000|Overall Study|Withdrawal by Subject|2|||
162914489|NCT03471507|588387705|FG001|Overall Study|Withdrawal by Subject|1|||
162914490|NCT02557308|588387707|FG000|Overall Study|Withdrawal by Subject|11|||
162914491|NCT02557308|588387708|FG001|Overall Study|Withdrawal by Subject|3|||
162914492|NCT02557308|588387709|FG002|Overall Study|Withdrawal by Subject|2|||
162914493|NCT02557308|588387710|FG003|Overall Study|Withdrawal by Subject|0|||
162914494|NCT02557308|588387711|FG004|Overall Study|Withdrawal by Subject|1|||
162914495|NCT02557308|588387712|FG005|Overall Study|Withdrawal by Subject|0|||
162914496|NCT02557308|588387713|FG006|Overall Study|Withdrawal by Subject|10|||
162914497|NCT02557308|588387714|FG007|Overall Study|Withdrawal by Subject|1|||
162914498|NCT02557308|588387707|FG000|Overall Study|Disease Progression|0|||
162914499|NCT02557308|588387708|FG001|Overall Study|Disease Progression|1|||
162914500|NCT02557308|588387709|FG002|Overall Study|Disease Progression|0|||
162914501|NCT02557308|588387710|FG003|Overall Study|Disease Progression|0|||
162914502|NCT02557308|588387711|FG004|Overall Study|Disease Progression|0|||
162914503|NCT02557308|588387712|FG005|Overall Study|Disease Progression|0|||
162914504|NCT02557308|588387713|FG006|Overall Study|Disease Progression|0|||
162914505|NCT02557308|588387714|FG007|Overall Study|Disease Progression|0|||
162914506|NCT02557308|588387707|FG000|Overall Study|Lack of Efficacy|3|||
162914507|NCT02557308|588387708|FG001|Overall Study|Lack of Efficacy|0|||
162914508|NCT02557308|588387709|FG002|Overall Study|Lack of Efficacy|0|||
162914509|NCT02557308|588387710|FG003|Overall Study|Lack of Efficacy|0|||
162914510|NCT02557308|588387711|FG004|Overall Study|Lack of Efficacy|0|||
162914511|NCT02557308|588387712|FG005|Overall Study|Lack of Efficacy|0|||
162914512|NCT02557308|588387713|FG006|Overall Study|Lack of Efficacy|1|||
162914513|NCT02557308|588387714|FG007|Overall Study|Lack of Efficacy|0|||
162914514|NCT02557308|588387707|FG000|Overall Study|Adverse Event|4|||
162914515|NCT02557308|588387708|FG001|Overall Study|Adverse Event|1|||
162914516|NCT02557308|588387709|FG002|Overall Study|Adverse Event|2|||
162914517|NCT02557308|588387710|FG003|Overall Study|Adverse Event|0|||
162968243|NCT01567527|588584822|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
162968244|NCT01567527|588584818|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
162968245|NCT01567527|588584819|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
162914518|NCT02557308|588387711|FG004|Overall Study|Adverse Event|0|||
162914519|NCT02557308|588387712|FG005|Overall Study|Adverse Event|0|||
162968246|NCT01567527|588584820|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
162914520|NCT02557308|588387713|FG006|Overall Study|Adverse Event|4|||
162914521|NCT02557308|588387714|FG007|Overall Study|Adverse Event|1|||
162914522|NCT02557308|588387707|FG000|Overall Study|Lost to Follow-up|2|||
162968247|NCT01567527|588584821|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
162968248|NCT01567527|588584822|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
162968249|NCT01567527|588584818|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
162968250|NCT01567527|588584819|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
162968251|NCT01567527|588584820|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
162968252|NCT01567527|588584821|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
162968253|NCT01567527|588584822|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
162968254|NCT01567527|588584818|FG000|IM Depot Stabilization.|Adverse Event|0|||
162968255|NCT01567527|588584819|FG001|IM Depot Stabilization.|Adverse Event|0|||
162968256|NCT01567527|588584820|FG002|IM Depot Stabilization.|Adverse Event|37|||
162968257|NCT01567527|588584821|FG003|IM Depot Stabilization.|Adverse Event|0|||
162968258|NCT01567527|588584822|FG004|IM Depot Stabilization.|Adverse Event|0|||
162968259|NCT01567527|588584818|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968260|NCT01567527|588584819|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
163054426|NCT00794664|588910296|FG001|Follow-up Period|Withdrawal by Subject|2|||
162914523|NCT02557308|588387708|FG001|Overall Study|Lost to Follow-up|0|||
162914524|NCT02557308|588387709|FG002|Overall Study|Lost to Follow-up|1|||
162914525|NCT02557308|588387710|FG003|Overall Study|Lost to Follow-up|0|||
162914526|NCT02557308|588387711|FG004|Overall Study|Lost to Follow-up|0|||
162914527|NCT02557308|588387712|FG005|Overall Study|Lost to Follow-up|0|||
162914528|NCT02557308|588387713|FG006|Overall Study|Lost to Follow-up|2|||
162914529|NCT02557308|588387714|FG007|Overall Study|Lost to Follow-up|0|||
162968261|NCT01567527|588584820|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
162968262|NCT01567527|588584821|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968263|NCT01567527|588584822|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
162968264|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
162914530|NCT02557308|588387707|FG000|Overall Study|Death|1|||
162914531|NCT02557308|588387708|FG001|Overall Study|Death|0|||
162914532|NCT02557308|588387709|FG002|Overall Study|Death|0|||
162914533|NCT02557308|588387710|FG003|Overall Study|Death|0|||
162914534|NCT02557308|588387711|FG004|Overall Study|Death|0|||
162914535|NCT02557308|588387712|FG005|Overall Study|Death|0|||
162914536|NCT02557308|588387713|FG006|Overall Study|Death|0|||
162914537|NCT02557308|588387714|FG007|Overall Study|Death|0|||
162914538|NCT02557308|588387707|FG000|Overall Study|Study Close|98|||
162914539|NCT02557308|588387708|FG001|Overall Study|Study Close|18|||
162914540|NCT02557308|588387709|FG002|Overall Study|Study Close|5|||
162914541|NCT02557308|588387710|FG003|Overall Study|Study Close|3|||
162914542|NCT02557308|588387711|FG004|Overall Study|Study Close|1|||
162914543|NCT02557308|588387712|FG005|Overall Study|Study Close|0|||
162914544|NCT02557308|588387713|FG006|Overall Study|Study Close|123|||
162914545|NCT02557308|588387714|FG007|Overall Study|Study Close|5|||
162914546|NCT02557308|588387707|FG000|Overall Study|Except for study close|5|||
162914547|NCT02557308|588387708|FG001|Overall Study|Except for study close|0|||
162914548|NCT02557308|588387709|FG002|Overall Study|Except for study close|0|||
162914549|NCT02557308|588387710|FG003|Overall Study|Except for study close|0|||
162914550|NCT02557308|588387711|FG004|Overall Study|Except for study close|3|||
162914551|NCT02557308|588387712|FG005|Overall Study|Except for study close|0|||
162914552|NCT02557308|588387713|FG006|Overall Study|Except for study close|6|||
162914553|NCT02557308|588387714|FG007|Overall Study|Except for study close|10|||
162914554|NCT02046993|588387718|FG000|Overall Study|Withdrawal by Subject|2|||
162914555|NCT02046993|588387719|FG001|Overall Study|Withdrawal by Subject|10|||
162914556|NCT02046993|588387718|FG000|Overall Study|Lost to Follow-up|1|||
162914557|NCT02046993|588387719|FG001|Overall Study|Lost to Follow-up|1|||
162914558|NCT01590628|588387727|FG000|Overall Study|Death|2|||
162914559|NCT01590628|588387728|FG001|Overall Study|Death|0|||
162914560|NCT00761735|588387729|FG000|Overall Study|Lost to Follow-up|6|||
162914561|NCT00761735|588387729|FG000|Overall Study|Withdrawal by Subject|6|||
162914562|NCT00761735|588387729|FG000|Overall Study|Non-compliance with protocol|1|||
162914563|NCT00761735|588387729|FG000|Overall Study|Administrative|1|||
162914564|NCT03326323|588387730|FG000|Overall Study|Unable to receive ANH protocol|3|||
162914565|NCT00851721|588387735|FG000|Overall Study|planned surgery|1|||
162914566|NCT00851721|588387736|FG001|Overall Study|planned surgery|0|||
162914567|NCT00851721|588387735|FG000|Overall Study|Death|1|||
162914568|NCT00851721|588387736|FG001|Overall Study|Death|0|||
162914569|NCT00851721|588387735|FG000|Overall Study|Adverse Event|0|||
162914570|NCT00851721|588387736|FG001|Overall Study|Adverse Event|1|||
162914571|NCT04047472|588387737|FG000|Overall Study|Adverse Event|3|||
162914572|NCT04047472|588387738|FG001|Overall Study|Adverse Event|3|||
162914573|NCT04047472|588387737|FG000|Overall Study|Death|0|||
162914574|NCT04047472|588387738|FG001|Overall Study|Death|1|||
162914575|NCT04047472|588387737|FG000|Overall Study|Lost to Follow-up|1|||
162914576|NCT04047472|588387738|FG001|Overall Study|Lost to Follow-up|0|||
162914577|NCT04047472|588387737|FG000|Overall Study|Physician Decision|1|||
162914578|NCT04047472|588387738|FG001|Overall Study|Physician Decision|2|||
162914579|NCT04047472|588387737|FG000|Overall Study|Protocol Violation|1|||
162914580|NCT04047472|588387738|FG001|Overall Study|Protocol Violation|0|||
162914581|NCT04047472|588387737|FG000|Overall Study|Withdrawal by Subject|10|||
162914582|NCT04047472|588387738|FG001|Overall Study|Withdrawal by Subject|10|||
162914583|NCT01218477|588387739|FG000|Overall Study|Disease progression|2|||
162914584|NCT01218477|588387740|FG001|Overall Study|Disease progression|3|||
162914585|NCT01218477|588387741|FG002|Overall Study|Disease progression|6|||
162914586|NCT01218477|588387742|FG003|Overall Study|Disease progression|2|||
162914587|NCT01218477|588387739|FG000|Overall Study|Study drug toxicity|0|||
162914588|NCT01218477|588387740|FG001|Overall Study|Study drug toxicity|2|||
162914589|NCT01218477|588387741|FG002|Overall Study|Study drug toxicity|5|||
162914590|NCT01218477|588387742|FG003|Overall Study|Study drug toxicity|0|||
162914591|NCT01218477|588387739|FG000|Overall Study|No longer meets study criteria|1|||
162914592|NCT01218477|588387740|FG001|Overall Study|No longer meets study criteria|0|||
162914593|NCT01218477|588387741|FG002|Overall Study|No longer meets study criteria|0|||
162914594|NCT01218477|588387742|FG003|Overall Study|No longer meets study criteria|0|||
162914595|NCT01218477|588387739|FG000|Overall Study|Withdrawal by Subject|0|||
162914596|NCT01218477|588387740|FG001|Overall Study|Withdrawal by Subject|0|||
163054427|NCT00794664|588910295|FG000|Follow-up Period|Protocol non-compliance|0|||
163054428|NCT00794664|588910296|FG001|Follow-up Period|Protocol non-compliance|1|||
162914597|NCT01218477|588387741|FG002|Overall Study|Withdrawal by Subject|1|||
162914598|NCT01218477|588387742|FG003|Overall Study|Withdrawal by Subject|0|||
162914599|NCT01218477|588387739|FG000|Overall Study|Prepared for cell transplantation|0|||
162914600|NCT01218477|588387740|FG001|Overall Study|Prepared for cell transplantation|1|||
162914601|NCT01218477|588387741|FG002|Overall Study|Prepared for cell transplantation|1|||
162914602|NCT01218477|588387742|FG003|Overall Study|Prepared for cell transplantation|0|||
162914603|NCT01218477|588387739|FG000|Overall Study|Administrative reason by sponsor|0|||
162914604|NCT01218477|588387740|FG001|Overall Study|Administrative reason by sponsor|0|||
162914605|NCT01218477|588387741|FG002|Overall Study|Administrative reason by sponsor|1|||
162914606|NCT01218477|588387742|FG003|Overall Study|Administrative reason by sponsor|0|||
162914607|NCT01218477|588387739|FG000|Overall Study|Maximum clinical benefit|0|||
162914608|NCT01218477|588387740|FG001|Overall Study|Maximum clinical benefit|2|||
162914609|NCT01218477|588387741|FG002|Overall Study|Maximum clinical benefit|0|||
162914610|NCT01218477|588387742|FG003|Overall Study|Maximum clinical benefit|0|||
162914611|NCT01333501|588387746|FG000|Overall Study|Adverse Event|3|||
162914612|NCT01333501|588387747|FG001|Overall Study|Adverse Event|1|||
162914613|NCT01333501|588387746|FG000|Overall Study|Abnormal laboratory value|2|||
162914614|NCT01333501|588387747|FG001|Overall Study|Abnormal laboratory value|1|||
162914615|NCT01333501|588387746|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162914616|NCT01333501|588387747|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
162914617|NCT01333501|588387746|FG000|Overall Study|Withdrawn consent|3|||
162914618|NCT01333501|588387747|FG001|Overall Study|Withdrawn consent|12|||
162914619|NCT01303159|588387748|FG000|Overall Study|Death|16|||
162914620|NCT01303159|588387748|FG000|Overall Study|Study Termination|7|||
162914621|NCT00496782|588387749|FG000|Overall Study|Protocol Violation|1|||
162914622|NCT00496782|588387750|FG001|Overall Study|Protocol Violation|2|||
162914623|NCT02132312|588387752|FG000|Overall Study|Adverse Event|2|||
162914624|NCT02132312|588387753|FG001|Overall Study|Adverse Event|0|||
162914625|NCT02132312|588387752|FG000|Overall Study|Physician Decision|1|||
162914626|NCT02132312|588387753|FG001|Overall Study|Physician Decision|1|||
162914627|NCT02132312|588387752|FG000|Overall Study|Protocol Violation|0|||
162914628|NCT02132312|588387753|FG001|Overall Study|Protocol Violation|1|||
162914629|NCT02132312|588387752|FG000|Overall Study|Withdrawal by Subject|1|||
162914630|NCT02132312|588387753|FG001|Overall Study|Withdrawal by Subject|0|||
162914631|NCT02132312|588387752|FG000|Overall Study|Lost to Follow-up|2|||
162914632|NCT02132312|588387753|FG001|Overall Study|Lost to Follow-up|1|||
162914633|NCT04034225|588387754|FG000|Overall Study|Death|3|||
162914634|NCT04034225|588387754|FG000|Overall Study|Withdrawal by Subject|2|||
162914635|NCT04034225|588387754|FG000|Overall Study|Study termination by Sponsor|18|||
162914636|NCT04034225|588387754|FG000|Overall Study|Physician Decision|1|||
162914637|NCT04034225|588387754|FG000|Overall Study|Lack of Efficacy|1|||
162914638|NCT00955682|588387755|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
162914639|NCT00955682|588387756|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
162914640|NCT01190839|588387764|FG000|Overall Study|Adverse Event|32|||
162914641|NCT01190839|588387765|FG001|Overall Study|Adverse Event|41|||
162914642|NCT01190839|588387764|FG000|Overall Study|Protocol Violation|2|||
162914643|NCT01190839|588387765|FG001|Overall Study|Protocol Violation|2|||
162914644|NCT01190839|588387764|FG000|Overall Study|Lost to Follow-up|7|||
162914645|NCT01190839|588387765|FG001|Overall Study|Lost to Follow-up|1|||
162914646|NCT01190839|588387764|FG000|Overall Study|Death|1|||
162914647|NCT01190839|588387765|FG001|Overall Study|Death|0|||
162914648|NCT01190839|588387764|FG000|Overall Study|Trial stopped by Sponsor|71|||
162914649|NCT01190839|588387765|FG001|Overall Study|Trial stopped by Sponsor|68|||
162914650|NCT01190839|588387764|FG000|Overall Study|Undefined|35|||
162914651|NCT01190839|588387765|FG001|Overall Study|Undefined|31|||
162914652|NCT01190839|588387764|FG000|Overall Study|Randomized but not treated|2|||
162914653|NCT01190839|588387765|FG001|Overall Study|Randomized but not treated|4|||
162914654|NCT01265511|588387766|FG000|Overall Study|Lack of Efficacy|2|||
162914655|NCT01265511|588387767|FG001|Overall Study|Lack of Efficacy|1|||
162914656|NCT01265511|588387766|FG000|Overall Study|Met stopping rules|0|||
162914657|NCT01265511|588387767|FG001|Overall Study|Met stopping rules|2|||
162914658|NCT01153971|588389505|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
162914659|NCT01153971|588389505|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
162914660|NCT01153971|588389505|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
162914661|NCT01153971|588389505|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
162914662|NCT01153971|588389505|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
162914663|NCT01153971|588389505|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
162914664|NCT01153971|588389505|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
162914665|NCT01789476|588389506|FG000|Overall Study|Lack of Efficacy|6|||
162914666|NCT01789476|588389507|FG001|Overall Study|Lack of Efficacy|2|||
162914667|NCT01789476|588389506|FG000|Overall Study|Adverse Event|1|||
162914668|NCT01789476|588389507|FG001|Overall Study|Adverse Event|0|||
162914669|NCT01789476|588389506|FG000|Overall Study|Unable to get IV access|1|||
162914670|NCT01789476|588389507|FG001|Overall Study|Unable to get IV access|0|||
162914671|NCT01238861|588389508|FG000|Overall Study|Lost to Follow-up|4|||
162914672|NCT01238861|588389509|FG001|Overall Study|Lost to Follow-up|2|||
162914673|NCT01238861|588389510|FG002|Overall Study|Lost to Follow-up|3|||
162914674|NCT01238861|588389511|FG003|Overall Study|Lost to Follow-up|1|||
162914675|NCT01238861|588389512|FG004|Overall Study|Lost to Follow-up|1|||
162914676|NCT01238861|588389513|FG005|Overall Study|Lost to Follow-up|2|||
162914677|NCT01238861|588389508|FG000|Overall Study|Unplanned surgery|1|||
162914678|NCT01238861|588389509|FG001|Overall Study|Unplanned surgery|0|||
162914679|NCT01238861|588389510|FG002|Overall Study|Unplanned surgery|0|||
162914680|NCT01238861|588389511|FG003|Overall Study|Unplanned surgery|0|||
162914681|NCT01238861|588389512|FG004|Overall Study|Unplanned surgery|0|||
162914682|NCT01238861|588389513|FG005|Overall Study|Unplanned surgery|0|||
162914683|NCT01238861|588389508|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
162914684|NCT01238861|588389509|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
162914685|NCT01238861|588389510|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
162914686|NCT01238861|588389511|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
162914687|NCT01238861|588389512|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
162914688|NCT01238861|588389513|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
162914689|NCT01238861|588389508|FG000|Overall Study|Incorrect enrollment/randomization|0|||
162914690|NCT01238861|588389509|FG001|Overall Study|Incorrect enrollment/randomization|0|||
162914691|NCT01238861|588389510|FG002|Overall Study|Incorrect enrollment/randomization|1|||
162914692|NCT01238861|588389511|FG003|Overall Study|Incorrect enrollment/randomization|0|||
162914693|NCT01238861|588389512|FG004|Overall Study|Incorrect enrollment/randomization|1|||
162914694|NCT01238861|588389513|FG005|Overall Study|Incorrect enrollment/randomization|0|||
162914695|NCT01238861|588389508|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
162914696|NCT01238861|588389509|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
162914697|NCT01238861|588389510|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
162914698|NCT01238861|588389511|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
162914699|NCT01238861|588389512|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
162914700|NCT01238861|588389513|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
162914701|NCT01238861|588389508|FG000|Overall Study|Subject moved out of state/area|0|||
162914702|NCT01238861|588389509|FG001|Overall Study|Subject moved out of state/area|0|||
162914703|NCT01238861|588389510|FG002|Overall Study|Subject moved out of state/area|1|||
162914704|NCT01238861|588389511|FG003|Overall Study|Subject moved out of state/area|1|||
162914705|NCT01238861|588389512|FG004|Overall Study|Subject moved out of state/area|0|||
162914706|NCT01238861|588389513|FG005|Overall Study|Subject moved out of state/area|0|||
162914707|NCT01238861|588389508|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
162914708|NCT01238861|588389509|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
162914709|NCT01238861|588389510|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
162914710|NCT01238861|588389511|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
162914711|NCT01238861|588389512|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
162914712|NCT01238861|588389513|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
162914713|NCT01238861|588389508|FG000|Overall Study|Personal problems|0|||
162914714|NCT01238861|588389509|FG001|Overall Study|Personal problems|0|||
162914715|NCT01238861|588389510|FG002|Overall Study|Personal problems|0|||
162914716|NCT01238861|588389511|FG003|Overall Study|Personal problems|1|||
162914717|NCT01238861|588389512|FG004|Overall Study|Personal problems|0|||
162914718|NCT01238861|588389513|FG005|Overall Study|Personal problems|0|||
162914719|NCT01238861|588389508|FG000|Overall Study|Unable to continue visits|0|||
162914720|NCT01238861|588389509|FG001|Overall Study|Unable to continue visits|0|||
162914721|NCT01238861|588389510|FG002|Overall Study|Unable to continue visits|0|||
162914722|NCT01238861|588389511|FG003|Overall Study|Unable to continue visits|1|||
162914723|NCT01238861|588389512|FG004|Overall Study|Unable to continue visits|0|||
162914724|NCT01238861|588389513|FG005|Overall Study|Unable to continue visits|1|||
162914725|NCT01238861|588389508|FG000|Overall Study|Serious adverse event|0|||
162914726|NCT01238861|588389509|FG001|Overall Study|Serious adverse event|0|||
162914727|NCT01238861|588389510|FG002|Overall Study|Serious adverse event|0|||
162914728|NCT01238861|588389511|FG003|Overall Study|Serious adverse event|0|||
162914729|NCT01238861|588389512|FG004|Overall Study|Serious adverse event|0|||
162914730|NCT01238861|588389513|FG005|Overall Study|Serious adverse event|1|||
162914731|NCT01238861|588389508|FG000|Overall Study|Lack of compliance|0|||
162629079|NCT03310021|587358607|FG010|Overall Study|Lost to Follow-up|1|||
162629080|NCT03310021|587358608|FG011|Overall Study|Lost to Follow-up|0|||
162629081|NCT03310021|587358609|FG012|Overall Study|Lost to Follow-up|0|||
162629082|NCT03310021|587358610|FG013|Overall Study|Lost to Follow-up|0|||
162629083|NCT03310021|587358611|FG014|Overall Study|Lost to Follow-up|0|||
162629084|NCT03310021|587358612|FG015|Overall Study|Lost to Follow-up|0|||
162629085|NCT03310021|587358613|FG016|Overall Study|Lost to Follow-up|0|||
162629086|NCT03310021|587358614|FG017|Overall Study|Lost to Follow-up|0|||
162629087|NCT03310021|587358615|FG018|Overall Study|Lost to Follow-up|0|||
162629088|NCT03310021|587358616|FG019|Overall Study|Lost to Follow-up|0|||
162629089|NCT01874054|587358617|FG000|Overall Study|Withdrawal by Subject|3|||
162629090|NCT01874054|587358617|FG000|Overall Study|Study Termination by Sponsor|42|||
162629091|NCT01874054|587358617|FG000|Overall Study|Lost to Follow-up|5|||
162629092|NCT01874054|587358617|FG000|Overall Study|Death|5|||
162629093|NCT00702923|587358618|FG000|Overall Study|Adverse Event|1|||
162629094|NCT03953820|587358619|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
162629095|NCT03953820|587358620|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
162629096|NCT03953820|587358621|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
162629097|NCT03953820|587358619|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
162629098|NCT03953820|587358620|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
162629099|NCT03953820|587358621|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
162629100|NCT01534962|587358622|FG000|Overall Study|Randomized but did not start treatment|2|||
162629101|NCT01534962|587358623|FG001|Overall Study|Randomized but did not start treatment|0|||
162710919|NCT02939183|587652824|FG003|Overall Study|Death|0|||
162914732|NCT01238861|588389509|FG001|Overall Study|Lack of compliance|0|||
162914733|NCT01238861|588389510|FG002|Overall Study|Lack of compliance|0|||
162914734|NCT01238861|588389511|FG003|Overall Study|Lack of compliance|0|||
162914735|NCT01238861|588389512|FG004|Overall Study|Lack of compliance|0|||
162914736|NCT01238861|588389513|FG005|Overall Study|Lack of compliance|1|||
162914737|NCT01238861|588389508|FG000|Overall Study|Adverse Event|0|||
162914738|NCT01238861|588389509|FG001|Overall Study|Adverse Event|1|||
163054429|NCT01973218|588910297|FG000|Overall Study|Adverse Event|1|||
162914739|NCT01238861|588389510|FG002|Overall Study|Adverse Event|0|||
162914740|NCT01238861|588389511|FG003|Overall Study|Adverse Event|0|||
162914741|NCT01238861|588389512|FG004|Overall Study|Adverse Event|0|||
162914742|NCT01238861|588389513|FG005|Overall Study|Adverse Event|0|||
162914743|NCT01238861|588389508|FG000|Overall Study|Withdrawal by Subject|6|||
162914744|NCT01238861|588389509|FG001|Overall Study|Withdrawal by Subject|5|||
162914745|NCT01238861|588389510|FG002|Overall Study|Withdrawal by Subject|4|||
162914746|NCT01238861|588389511|FG003|Overall Study|Withdrawal by Subject|8|||
162914747|NCT01238861|588389512|FG004|Overall Study|Withdrawal by Subject|10|||
162914748|NCT01238861|588389513|FG005|Overall Study|Withdrawal by Subject|9|||
162914749|NCT00247416|588389514|FG000|Overall Study|3 patients were found to be ineligible|1|||
162914750|NCT00247416|588389515|FG001|Overall Study|3 patients were found to be ineligible|2|||
162914751|NCT00278473|588389516|FG000|Overall Study|drop out|4|||
162914752|NCT00278473|588389517|FG001|Overall Study|drop out|3|||
162914753|NCT00761761|588389518|FG000|Overall Study|Lost to Follow-up|3|||
162914754|NCT00761761|588389519|FG001|Overall Study|Lost to Follow-up|1|||
162914755|NCT00761761|588389518|FG000|Overall Study|Withdrawal by Subject|3|||
162914756|NCT00761761|588389519|FG001|Overall Study|Withdrawal by Subject|0|||
162914757|NCT04001790|588389520|FG000|Overall Study|Withdrawal by Subject|1|||
162914758|NCT04001790|588389521|FG001|Overall Study|Withdrawal by Subject|2|||
162914759|NCT01342445|588389522|FG000|Overall Study|Experienced side effects|0|||
162914760|NCT01342445|588389523|FG001|Overall Study|Experienced side effects|2|||
162914761|NCT02652793|588389526|FG000|Overall Study|Adverse Event|1|||
162914762|NCT02652793|588389526|FG000|Overall Study|Lost to Follow-up|2|||
162914763|NCT02652793|588389526|FG000|Overall Study|Withdrawal by Subject|1|||
162914764|NCT04963231|588389527|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
162914765|NCT04963231|588389528|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
162914766|NCT04963231|588389529|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
162914767|NCT04963231|588389527|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
162914768|NCT04963231|588389528|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
162914769|NCT04963231|588389529|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
162914770|NCT04963231|588389527|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
162914771|NCT04963231|588389528|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
162914772|NCT04963231|588389529|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
162914773|NCT04963231|588389527|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
162914774|NCT04963231|588389528|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
162914775|NCT04963231|588389529|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
162914776|NCT04963231|588389527|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
162914777|NCT04963231|588389528|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
162914778|NCT04963231|588389529|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
162914779|NCT04963231|588389527|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
162914780|NCT04963231|588389528|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
162914781|NCT04963231|588389529|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
162914782|NCT04963231|588389527|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
162914783|NCT04963231|588389528|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
162914784|NCT04963231|588389529|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
162914785|NCT01059175|588389530|FG000|Overall Study|Death|17|||
162914786|NCT01059175|588389531|FG001|Overall Study|Death|17|||
162914787|NCT01059175|588389530|FG000|Overall Study|Adverse Event|4|||
162914788|NCT01059175|588389531|FG001|Overall Study|Adverse Event|2|||
162914789|NCT01059175|588389530|FG000|Overall Study|Lost to Follow-up|0|||
162914790|NCT01059175|588389531|FG001|Overall Study|Lost to Follow-up|1|||
162914791|NCT02957149|588389532|FG000|Overall Study|Withdrawal by Subject|5|||
162914792|NCT06045026|588389533|FG000|Overall Study|Lost to Follow-up|60|||
162914793|NCT06045026|588389533|FG000|Overall Study|Adverse Event|12|||
162710920|NCT02939183|587652825|FG004|Overall Study|Death|0|||
162914794|NCT06045026|588389533|FG000|Overall Study|Withdrawal by Subject|3|||
162914795|NCT06045026|588389533|FG000|Overall Study|Enrollment closed|1|||
162914796|NCT01399619|588389542|FG000|Overall Study|Adverse Event|10|||
162914797|NCT01399619|588389543|FG001|Overall Study|Adverse Event|0|||
162914798|NCT01399619|588389544|FG002|Overall Study|Adverse Event|4|||
163054430|NCT01973218|588910298|FG001|Overall Study|Adverse Event|0|||
162710921|NCT02939183|587652826|FG005|Overall Study|Death|2|||
162914799|NCT01399619|588389545|FG003|Overall Study|Adverse Event|10|||
162914800|NCT01399619|588389542|FG000|Overall Study|Lack of Efficacy|9|||
162914801|NCT01399619|588389543|FG001|Overall Study|Lack of Efficacy|0|||
162914802|NCT01399619|588389544|FG002|Overall Study|Lack of Efficacy|5|||
163054431|NCT01973218|588910297|FG000|Overall Study|Withdrawal by Subject|1|||
162914803|NCT01399619|588389545|FG003|Overall Study|Lack of Efficacy|0|||
162914804|NCT01399619|588389542|FG000|Overall Study|Withdrawal by Subject|6|||
162914805|NCT01399619|588389543|FG001|Overall Study|Withdrawal by Subject|0|||
162914806|NCT01399619|588389544|FG002|Overall Study|Withdrawal by Subject|3|||
162914807|NCT01399619|588389545|FG003|Overall Study|Withdrawal by Subject|4|||
162914808|NCT01399619|588389542|FG000|Overall Study|Protocol Violation|0|||
162914809|NCT01399619|588389543|FG001|Overall Study|Protocol Violation|0|||
162914810|NCT01399619|588389544|FG002|Overall Study|Protocol Violation|0|||
162914811|NCT01399619|588389545|FG003|Overall Study|Protocol Violation|1|||
162914812|NCT01399619|588389542|FG000|Overall Study|Not treated|0|||
162914813|NCT01399619|588389543|FG001|Overall Study|Not treated|0|||
162914814|NCT01399619|588389544|FG002|Overall Study|Not treated|0|||
162914815|NCT01399619|588389545|FG003|Overall Study|Not treated|2|||
162914816|NCT03911401|588389548|FG000|Overall Study|Adverse Event|1|||
162914817|NCT03911401|588389549|FG001|Overall Study|Adverse Event|2|||
162914818|NCT03911401|588389550|FG002|Overall Study|Adverse Event|5|||
162914819|NCT03911401|588389548|FG000|Overall Study|Lack of Efficacy|1|||
162914820|NCT03911401|588389549|FG001|Overall Study|Lack of Efficacy|1|||
162914821|NCT03911401|588389550|FG002|Overall Study|Lack of Efficacy|8|||
162914822|NCT03911401|588389548|FG000|Overall Study|Physician Decision|0|||
162914823|NCT03911401|588389549|FG001|Overall Study|Physician Decision|0|||
162914824|NCT03911401|588389550|FG002|Overall Study|Physician Decision|1|||
162968265|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
162968266|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
162968267|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
162968268|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
162968269|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968270|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968271|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
162968272|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
162968273|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
162968274|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
162629102|NCT01534962|587358624|FG002|Overall Study|Randomized but did not start treatment|0|||
162629103|NCT01534962|587358625|FG003|Overall Study|Randomized but did not start treatment|1|||
162629104|NCT01534962|587358622|FG000|Overall Study|Discontinued at AF recurrence|35|||
162968275|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
162968276|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
162968277|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
162968278|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
162968279|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968280|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968281|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
162968282|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
162968283|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
162968284|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968285|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968286|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162968287|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
162968288|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
162968289|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968290|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968291|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
162968292|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
162968293|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
162968294|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
162968295|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
162629105|NCT01534962|587358623|FG001|Overall Study|Discontinued at AF recurrence|26|||
162629106|NCT01534962|587358624|FG002|Overall Study|Discontinued at AF recurrence|24|||
162914825|NCT03911401|588389548|FG000|Overall Study|Withdrawal by Subject|1|||
162914826|NCT03911401|588389549|FG001|Overall Study|Withdrawal by Subject|2|||
162914827|NCT03911401|588389550|FG002|Overall Study|Withdrawal by Subject|0|||
162914828|NCT03911401|588389548|FG000|Overall Study|Withdrawal by parent/guardian|4|||
162914829|NCT03911401|588389549|FG001|Overall Study|Withdrawal by parent/guardian|4|||
162914830|NCT03911401|588389550|FG002|Overall Study|Withdrawal by parent/guardian|11|||
162968296|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
162968297|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
162968298|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
162914831|NCT05602818|588389551|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
162914832|NCT05602818|588389552|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
162914833|NCT05602818|588389553|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
162914834|NCT05602818|588389554|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
162914835|NCT05602818|588389555|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
162914836|NCT05602818|588389556|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
162914837|NCT05602818|588389557|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
162914838|NCT05602818|588389558|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
162914839|NCT05602818|588389559|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
162914840|NCT05602818|588389560|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
162914841|NCT05602818|588389561|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
162914842|NCT05602818|588389562|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
162914843|NCT05602818|588389551|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
162914844|NCT05602818|588389552|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
162914845|NCT05602818|588389553|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914846|NCT05602818|588389554|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914847|NCT05602818|588389555|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914848|NCT05602818|588389556|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914849|NCT05602818|588389557|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914850|NCT05602818|588389558|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914851|NCT05602818|588389559|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914852|NCT05602818|588389560|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914853|NCT05602818|588389561|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914854|NCT05602818|588389562|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
162914855|NCT05602818|588389551|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
162914856|NCT05602818|588389552|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914857|NCT05602818|588389553|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914858|NCT05602818|588389554|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914859|NCT05602818|588389555|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914860|NCT05602818|588389556|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914861|NCT05602818|588389557|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914862|NCT05602818|588389558|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914863|NCT05602818|588389559|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914864|NCT05602818|588389560|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914865|NCT05602818|588389561|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914866|NCT05602818|588389562|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
162914867|NCT05602818|588389551|FG000|Qualification Phase (3 Days)|Other|1|||
162914868|NCT05602818|588389552|FG001|Qualification Phase (3 Days)|Other|0|||
162914869|NCT05602818|588389553|FG002|Qualification Phase (3 Days)|Other|0|||
162914870|NCT05602818|588389554|FG003|Qualification Phase (3 Days)|Other|0|||
162914871|NCT05602818|588389555|FG004|Qualification Phase (3 Days)|Other|0|||
162914872|NCT05602818|588389556|FG005|Qualification Phase (3 Days)|Other|0|||
162914873|NCT05602818|588389557|FG006|Qualification Phase (3 Days)|Other|0|||
162914874|NCT05602818|588389558|FG007|Qualification Phase (3 Days)|Other|0|||
162914875|NCT05602818|588389559|FG008|Qualification Phase (3 Days)|Other|0|||
162710922|NCT02939183|587652827|FG006|Overall Study|Death|1|||
162710923|NCT02939183|587652828|FG007|Overall Study|Death|0|||
162914876|NCT05602818|588389560|FG009|Qualification Phase (3 Days)|Other|0|||
162914877|NCT05602818|588389561|FG010|Qualification Phase (3 Days)|Other|0|||
162914878|NCT05602818|588389562|FG011|Qualification Phase (3 Days)|Other|0|||
162968299|NCT01567527|588584818|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968300|NCT01567527|588584819|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968301|NCT01567527|588584820|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162968302|NCT01567527|588584821|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
162968303|NCT01567527|588584822|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
162914879|NCT05602818|588389551|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914880|NCT05602818|588389552|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
162914881|NCT05602818|588389553|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914882|NCT05602818|588389554|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914883|NCT05602818|588389555|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914884|NCT05602818|588389556|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914885|NCT05602818|588389557|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914886|NCT05602818|588389558|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914887|NCT05602818|588389559|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914888|NCT05602818|588389560|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914889|NCT05602818|588389561|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914890|NCT05602818|588389562|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
162914891|NCT05602818|588389551|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
162914892|NCT05602818|588389552|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
162914893|NCT05602818|588389553|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
162914894|NCT05602818|588389554|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
162914895|NCT05602818|588389555|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
162914896|NCT05602818|588389556|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
162914897|NCT05602818|588389557|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
162914898|NCT05602818|588389558|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
162914899|NCT05602818|588389559|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
162914900|NCT05602818|588389560|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
162914901|NCT05602818|588389561|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
162914902|NCT05602818|588389562|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
162914903|NCT05602818|588389551|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914904|NCT05602818|588389552|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914905|NCT05602818|588389553|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914906|NCT05602818|588389554|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914907|NCT05602818|588389555|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914908|NCT05602818|588389556|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914909|NCT05602818|588389557|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914910|NCT05602818|588389558|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914911|NCT05602818|588389559|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914912|NCT05602818|588389560|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
162914913|NCT05602818|588389561|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
162914914|NCT05602818|588389562|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
162914915|NCT05602818|588389551|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
162914916|NCT05602818|588389552|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
162914917|NCT05602818|588389553|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
162914918|NCT05602818|588389554|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
162914919|NCT05602818|588389555|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
162968304|NCT02004691|588584823|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
162968305|NCT02004691|588584824|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
162968306|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
162968307|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
162968308|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
162968309|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
162968310|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
162968311|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
162968312|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
162968313|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
162968314|NCT02004691|588584823|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
162968315|NCT02004691|588584824|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
162968316|NCT01726803|588584825|FG000|Overall Study|Lost to Follow-up|6|||
162968317|NCT01726803|588584826|FG001|Overall Study|Lost to Follow-up|1|||
162968318|NCT01726803|588584825|FG000|Overall Study|Withdrawal by Subject|1|||
162968319|NCT01726803|588584826|FG001|Overall Study|Withdrawal by Subject|0|||
162968320|NCT03407729|588584828|FG000|Overall Study|Lost to Follow-up|2|||
162968321|NCT03407729|588584829|FG001|Overall Study|Lost to Follow-up|0|||
162968322|NCT03407729|588584828|FG000|Overall Study|Unable to schedule|0|||
162968323|NCT03407729|588584829|FG001|Overall Study|Unable to schedule|3|||
162968324|NCT01849458|588584830|FG000|Overall Study|Lost to Follow-up|4|||
162914920|NCT05602818|588389556|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
162914921|NCT05602818|588389557|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
162914922|NCT05602818|588389558|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
162914923|NCT05602818|588389559|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
162914924|NCT05602818|588389560|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
162914925|NCT05602818|588389561|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
162914926|NCT05602818|588389562|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
162914927|NCT03814499|588389563|FG000|Overall Study|Lost to Follow-up|3|||
162914928|NCT03417245|588389564|FG000|Overall Study|Adverse Event|1|||
162914929|NCT03417245|588389565|FG001|Overall Study|Adverse Event|0|||
162914930|NCT03417245|588389564|FG000|Overall Study|Protocol Violation|1|||
162914931|NCT03417245|588389565|FG001|Overall Study|Protocol Violation|0|||
162914932|NCT03417245|588389564|FG000|Overall Study|Withdrawal by Subject|1|||
162914933|NCT03417245|588389565|FG001|Overall Study|Withdrawal by Subject|1|||
162914934|NCT00598442|588389569|FG000|Overall Study|Adverse Event|3|||
162914935|NCT00598442|588389570|FG001|Overall Study|Adverse Event|0|||
162914936|NCT00598442|588389571|FG002|Overall Study|Adverse Event|0|||
162914937|NCT00598442|588389569|FG000|Overall Study|Death|19|||
162914938|NCT00598442|588389570|FG001|Overall Study|Death|11|||
162914939|NCT00598442|588389571|FG002|Overall Study|Death|11|||
162914940|NCT00598442|588389569|FG000|Overall Study|Lost to Follow-up|4|||
162914941|NCT00598442|588389570|FG001|Overall Study|Lost to Follow-up|3|||
162914942|NCT00598442|588389571|FG002|Overall Study|Lost to Follow-up|3|||
162914943|NCT00598442|588389569|FG000|Overall Study|Physician Decision|2|||
162914944|NCT00598442|588389570|FG001|Overall Study|Physician Decision|1|||
162914945|NCT00598442|588389571|FG002|Overall Study|Physician Decision|1|||
162914946|NCT00598442|588389569|FG000|Overall Study|Withdrawal by Subject|8|||
162914947|NCT00598442|588389570|FG001|Overall Study|Withdrawal by Subject|16|||
162914948|NCT00598442|588389571|FG002|Overall Study|Withdrawal by Subject|6|||
162914949|NCT00598442|588389569|FG000|Overall Study|Noncompliance|0|||
162914950|NCT00598442|588389570|FG001|Overall Study|Noncompliance|2|||
162914951|NCT00598442|588389571|FG002|Overall Study|Noncompliance|1|||
162914952|NCT00598442|588389569|FG000|Overall Study|Relocation|1|||
162914953|NCT00598442|588389570|FG001|Overall Study|Relocation|4|||
162914954|NCT00598442|588389571|FG002|Overall Study|Relocation|0|||
162914955|NCT00598442|588389569|FG000|Overall Study|Renal transplant|0|||
162914956|NCT00598442|588389570|FG001|Overall Study|Renal transplant|0|||
162914957|NCT00598442|588389571|FG002|Overall Study|Renal transplant|1|||
162914958|NCT00598442|588389569|FG000|Overall Study|Site closed by sponsor|5|||
162914959|NCT00598442|588389570|FG001|Overall Study|Site closed by sponsor|2|||
162914960|NCT00598442|588389571|FG002|Overall Study|Site closed by sponsor|1|||
162914961|NCT00598442|588389569|FG000|Overall Study|Started dialysis|1|||
162914962|NCT00598442|588389570|FG001|Overall Study|Started dialysis|0|||
162914963|NCT00598442|588389571|FG002|Overall Study|Started dialysis|0|||
162914964|NCT00229931|588389584|FG000|Overall Study|Death|1|||
162914965|NCT00229931|588389585|FG001|Overall Study|Death|0|||
162914966|NCT00229931|588389584|FG000|Overall Study|Lost to Follow-up|3|||
162914967|NCT00229931|588389585|FG001|Overall Study|Lost to Follow-up|2|||
162914968|NCT02992743|588389586|FG000|Overall Study|Withdrawal by Subject|1|||
162914969|NCT02992743|588389587|FG001|Overall Study|Withdrawal by Subject|1|||
162914970|NCT02992743|588389586|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
162914971|NCT02992743|588389587|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
162914972|NCT02992743|588389586|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
162914973|NCT02992743|588389587|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
162914974|NCT02992743|588389586|FG000|Overall Study|No measurable disease|1|||
162914975|NCT02992743|588389587|FG001|Overall Study|No measurable disease|0|||
162914976|NCT02992743|588389586|FG000|Overall Study|Lost to Follow-up|0|||
162914977|NCT02992743|588389587|FG001|Overall Study|Lost to Follow-up|1|||
162914978|NCT00381680|588389588|FG000|Overall Study|Adverse Event|9|||
162914979|NCT00381680|588389589|FG001|Overall Study|Adverse Event|3|||
162914980|NCT00381680|588389588|FG000|Overall Study|Death|10|||
162914981|NCT00381680|588389589|FG001|Overall Study|Death|7|||
162914982|NCT00381680|588389588|FG000|Overall Study|Lost to Follow-up|3|||
162914983|NCT00381680|588389589|FG001|Overall Study|Lost to Follow-up|2|||
162914984|NCT00381680|588389588|FG000|Overall Study|Physician Decision|25|||
162914985|NCT00381680|588389589|FG001|Overall Study|Physician Decision|6|||
162914986|NCT00381680|588389588|FG000|Overall Study|Withdrawal by Subject|3|||
162914987|NCT00381680|588389589|FG001|Overall Study|Withdrawal by Subject|1|||
162914988|NCT00381680|588389588|FG000|Overall Study|Entry onto another COG Trial|1|||
162914989|NCT00381680|588389589|FG001|Overall Study|Entry onto another COG Trial|2|||
162914990|NCT00381680|588389588|FG000|Overall Study|Alternative Therapy|11|||
162914991|NCT00381680|588389589|FG001|Overall Study|Alternative Therapy|5|||
162914992|NCT00381680|588389588|FG000|Overall Study|Secondary Malignancy|3|||
162914993|NCT00381680|588389589|FG001|Overall Study|Secondary Malignancy|0|||
162914994|NCT00381680|588389588|FG000|Overall Study|Delay initiation|1|||
162914995|NCT00381680|588389589|FG001|Overall Study|Delay initiation|0|||
162914996|NCT00381680|588389588|FG000|Overall Study|Stem Cell Transplant|26|||
162968325|NCT00024258|588584833|FG000|Overall Study|Withdrawal by Subject|1|||
162710924|NCT02939183|587652829|FG008|Overall Study|Death|0|||
162710925|NCT02939183|587652821|FG000|Overall Study|Sponsor decision|0|||
162710926|NCT02939183|587652822|FG001|Overall Study|Sponsor decision|1|||
162710927|NCT02939183|587652823|FG002|Overall Study|Sponsor decision|0|||
162710928|NCT02939183|587652824|FG003|Overall Study|Sponsor decision|1|||
162710929|NCT02939183|587652825|FG004|Overall Study|Sponsor decision|2|||
162710930|NCT02939183|587652826|FG005|Overall Study|Sponsor decision|0|||
162710931|NCT02939183|587652827|FG006|Overall Study|Sponsor decision|3|||
162710932|NCT02939183|587652828|FG007|Overall Study|Sponsor decision|1|||
162710933|NCT02939183|587652829|FG008|Overall Study|Sponsor decision|4|||
162710934|NCT02939183|587652821|FG000|Overall Study|Withdrawal by Subject|0|||
162710935|NCT02939183|587652822|FG001|Overall Study|Withdrawal by Subject|2|||
162710936|NCT02939183|587652823|FG002|Overall Study|Withdrawal by Subject|0|||
162710937|NCT02939183|587652824|FG003|Overall Study|Withdrawal by Subject|1|||
162710938|NCT02939183|587652825|FG004|Overall Study|Withdrawal by Subject|0|||
162710939|NCT02939183|587652826|FG005|Overall Study|Withdrawal by Subject|0|||
162710940|NCT02939183|587652827|FG006|Overall Study|Withdrawal by Subject|2|||
162710941|NCT02939183|587652828|FG007|Overall Study|Withdrawal by Subject|2|||
162710942|NCT02939183|587652829|FG008|Overall Study|Withdrawal by Subject|2|||
162710943|NCT02939183|587652821|FG000|Overall Study|Not treated due to adverse event|0|||
162710944|NCT02939183|587652822|FG001|Overall Study|Not treated due to adverse event|0|||
162710945|NCT02939183|587652823|FG002|Overall Study|Not treated due to adverse event|0|||
162710946|NCT02939183|587652824|FG003|Overall Study|Not treated due to adverse event|1|||
162710947|NCT02939183|587652825|FG004|Overall Study|Not treated due to adverse event|0|||
162710948|NCT02939183|587652826|FG005|Overall Study|Not treated due to adverse event|0|||
162710949|NCT02939183|587652827|FG006|Overall Study|Not treated due to adverse event|1|||
162710950|NCT02939183|587652828|FG007|Overall Study|Not treated due to adverse event|0|||
162710951|NCT02939183|587652829|FG008|Overall Study|Not treated due to adverse event|0|||
162710952|NCT05015478|587652830|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
162710953|NCT05015478|587652831|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
162710954|NCT05015478|587652832|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
162710955|NCT05015478|587652833|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
162710956|NCT04939428|587652834|FG000|Overall Study|Death|0|||
162710957|NCT04939428|587652835|FG001|Overall Study|Death|1|||
162710958|NCT04939428|587652836|FG002|Overall Study|Death|0|||
162710959|NCT04939428|587652834|FG000|Overall Study|Lost to Follow-up|0|||
162710960|NCT04939428|587652835|FG001|Overall Study|Lost to Follow-up|5|||
162710961|NCT04939428|587652836|FG002|Overall Study|Lost to Follow-up|0|||
162710962|NCT04939428|587652834|FG000|Overall Study|Physician Decision|1|||
162710963|NCT04939428|587652835|FG001|Overall Study|Physician Decision|0|||
162710964|NCT04939428|587652836|FG002|Overall Study|Physician Decision|0|||
162710965|NCT04939428|587652834|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162710966|NCT04939428|587652835|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162710967|NCT04939428|587652836|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162710968|NCT04939428|587652834|FG000|Overall Study|Withdrawal by Subject|10|||
162710969|NCT04939428|587652835|FG001|Overall Study|Withdrawal by Subject|11|||
162710970|NCT04939428|587652836|FG002|Overall Study|Withdrawal by Subject|0|||
162710971|NCT04939428|587652834|FG000|Overall Study|Unkown|6|||
162710972|NCT04939428|587652835|FG001|Overall Study|Unkown|3|||
162710973|NCT04939428|587652836|FG002|Overall Study|Unkown|0|||
162710974|NCT04939428|587652834|FG000|Overall Study|Discotinued per protocol|0|||
162710975|NCT04939428|587652835|FG001|Overall Study|Discotinued per protocol|0|||
162914997|NCT00381680|588389589|FG001|Overall Study|Stem Cell Transplant|10|||
162914998|NCT00381680|588389588|FG000|Overall Study|Relapse|18|||
162914999|NCT00381680|588389589|FG001|Overall Study|Relapse|9|||
162915000|NCT00381680|588389588|FG000|Overall Study|Induction Failure|4|||
162915001|NCT00381680|588389589|FG001|Overall Study|Induction Failure|1|||
162915002|NCT00381680|588389588|FG000|Overall Study|Progression|1|||
162915003|NCT00381680|588389589|FG001|Overall Study|Progression|1|||
162915004|NCT00381680|588389588|FG000|Overall Study|Other not otherwise specified|7|||
162915005|NCT00381680|588389589|FG001|Overall Study|Other not otherwise specified|2|||
162915006|NCT00381680|588389588|FG000|Overall Study|Ineligible|3|||
162915007|NCT00381680|588389589|FG001|Overall Study|Ineligible|1|||
162915008|NCT03290131|588389592|FG000|Overall Study|Adverse Event|22|||
162915009|NCT03290131|588389593|FG001|Overall Study|Adverse Event|57|||
162710976|NCT04939428|587652836|FG002|Overall Study|Discotinued per protocol|902|||
162710977|NCT04319094|587652839|FG000|Baseline|Lost to Follow-up|4|||
162710978|NCT04319094|587652840|FG001|Baseline|Lost to Follow-up|5|||
162710979|NCT04319094|587652839|FG000|Baseline|Protocol Violation|0|||
162710980|NCT04319094|587652840|FG001|Baseline|Protocol Violation|3|||
162710981|NCT04319094|587652839|FG000|Baseline|Withdrawal by Subject|2|||
162710982|NCT04319094|587652840|FG001|Baseline|Withdrawal by Subject|1|||
162710983|NCT04319094|587652839|FG000|Post-Intervention|Death|0|||
162710984|NCT04319094|587652840|FG001|Post-Intervention|Death|1|||
162710985|NCT04319094|587652839|FG000|Post-Intervention|Lost to Follow-up|4|||
162710986|NCT04319094|587652840|FG001|Post-Intervention|Lost to Follow-up|4|||
162968326|NCT00024258|588584833|FG000|Overall Study|Disease Progression|8|||
162968327|NCT01863433|588584834|FG000|Overall Study|Protocol Violation|1|||
162968328|NCT03950674|588584835|FG000|Overall Study|Death|16|||
162968329|NCT03950674|588584836|FG001|Overall Study|Death|15|||
162968330|NCT03950674|588584835|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
162968331|NCT03950674|588584836|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
162968332|NCT00830167|588584839|FG000|Overall Study|Lack of Efficacy|26|||
162968333|NCT00830167|588584840|FG001|Overall Study|Lack of Efficacy|10|||
162968334|NCT00830167|588584839|FG000|Overall Study|Adverse Event|8|||
162968335|NCT00830167|588584840|FG001|Overall Study|Adverse Event|24|||
162968336|NCT00830167|588584839|FG000|Overall Study|Not meeting entrance criteria|2|||
162968337|NCT00830167|588584840|FG001|Overall Study|Not meeting entrance criteria|5|||
162968338|NCT00830167|588584839|FG000|Overall Study|Withdrawal by Subject|2|||
162968339|NCT00830167|588584840|FG001|Overall Study|Withdrawal by Subject|0|||
162968340|NCT00830167|588584839|FG000|Overall Study|Lost to Follow-up|0|||
162968341|NCT00830167|588584840|FG001|Overall Study|Lost to Follow-up|1|||
162968342|NCT00830167|588584839|FG000|Overall Study|Protocol Violation|0|||
162968343|NCT00830167|588584840|FG001|Overall Study|Protocol Violation|1|||
162968344|NCT00830167|588584839|FG000|Overall Study|Other|2|||
162968345|NCT00830167|588584840|FG001|Overall Study|Other|2|||
162968346|NCT03428945|588584841|FG000|Overall Study|Lost to Follow-up|5|||
162968347|NCT03428945|588584842|FG001|Overall Study|Lost to Follow-up|3|||
162968348|NCT03428945|588584841|FG000|Overall Study|Withdrawal by Subject|10|||
162968349|NCT03428945|588584842|FG001|Overall Study|Withdrawal by Subject|10|||
162968350|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
162968351|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
162968352|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
162968353|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
162968354|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
162968355|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
162968356|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
162968357|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
162968358|NCT00982228|588584843|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
162968359|NCT00982228|588584844|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
162968360|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
162968361|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
162968362|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
162915010|NCT03290131|588389594|FG002|Overall Study|Adverse Event|11|||
162915011|NCT03290131|588389592|FG000|Overall Study|Withdrawal by Subject|18|||
162915012|NCT03290131|588389593|FG001|Overall Study|Withdrawal by Subject|13|||
162915013|NCT03290131|588389594|FG002|Overall Study|Withdrawal by Subject|8|||
162915014|NCT03290131|588389592|FG000|Overall Study|MS Relapse|2|||
162915015|NCT03290131|588389593|FG001|Overall Study|MS Relapse|1|||
162915016|NCT03290131|588389594|FG002|Overall Study|MS Relapse|0|||
162915017|NCT03290131|588389592|FG000|Overall Study|Unknown reason|0|||
162915018|NCT03290131|588389593|FG001|Overall Study|Unknown reason|1|||
162915019|NCT03290131|588389594|FG002|Overall Study|Unknown reason|0|||
162915020|NCT03099096|588389595|FG000|Overall Study|Adverse Event|1|||
162915021|NCT03099096|588389595|FG000|Overall Study|Physician Decision|1|||
162915022|NCT00361504|588389598|FG000|Overall Study|Withdrawal by Subject|94|||
162915023|NCT00361504|588389599|FG001|Overall Study|Withdrawal by Subject|31|||
162915024|NCT00361504|588389598|FG000|Overall Study|Lost to Follow-up|40|||
162915025|NCT00361504|588389599|FG001|Overall Study|Lost to Follow-up|7|||
162915026|NCT00361504|588389598|FG000|Overall Study|Adverse Event|203|||
162915027|NCT00361504|588389599|FG001|Overall Study|Adverse Event|82|||
162915028|NCT00361504|588389598|FG000|Overall Study|Lack of Efficacy|72|||
162915029|NCT00361504|588389599|FG001|Overall Study|Lack of Efficacy|7|||
162915030|NCT00361504|588389598|FG000|Overall Study|Resolution of Pain|2|||
162915031|NCT00361504|588389599|FG001|Overall Study|Resolution of Pain|0|||
162915032|NCT00361504|588389598|FG000|Overall Study|Study medication non compliant|42|||
162915033|NCT00361504|588389599|FG001|Overall Study|Study medication non compliant|15|||
162915034|NCT00361504|588389598|FG000|Overall Study|All other|28|||
162915035|NCT00361504|588389599|FG001|Overall Study|All other|3|||
162915036|NCT03764813|588389601|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
162915037|NCT03764813|588389602|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
162915038|NCT03764813|588389603|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
162968363|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
162968364|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
162968365|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
162968366|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
162968367|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
162710987|NCT04319094|587652839|FG000|Post-Intervention|Withdrawal by Subject|8|||
162915039|NCT03764813|588389604|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
162915040|NCT00450814|588389613|FG000|Overall Study|Failed to complete the initial therapy|0|||
162915041|NCT00450814|588389614|FG001|Overall Study|Failed to complete the initial therapy|0|||
162915042|NCT00450814|588389615|FG002|Overall Study|Failed to complete the initial therapy|0|||
162915043|NCT00450814|588389616|FG003|Overall Study|Failed to complete the initial therapy|1|||
162915044|NCT00450814|588389617|FG004|Overall Study|Failed to complete the initial therapy|1|||
162915045|NCT00450814|588389618|FG005|Overall Study|Failed to complete the initial therapy|1|||
162915046|NCT00450814|588389619|FG006|Overall Study|Failed to complete the initial therapy|0|||
162915047|NCT00450814|588389620|FG007|Overall Study|Failed to complete the initial therapy|0|||
162915048|NCT00450814|588389621|FG008|Overall Study|Failed to complete the initial therapy|0|||
162915049|NCT00450814|588389622|FG009|Overall Study|Failed to complete the initial therapy|0|||
162915050|NCT00450814|588389623|FG010|Overall Study|Failed to complete the initial therapy|0|||
162915051|NCT00450814|588389613|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
162915052|NCT00450814|588389614|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
162915053|NCT00450814|588389615|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
162915054|NCT00450814|588389616|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
162915055|NCT00450814|588389617|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
162915056|NCT00450814|588389618|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
162915057|NCT00450814|588389619|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
162915058|NCT00450814|588389620|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
162915059|NCT00450814|588389621|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
162915060|NCT00450814|588389622|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
162915061|NCT00450814|588389623|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
162915062|NCT03602976|588389628|FG000|Overall Study|Withdrawal by Subject|1|||
162915063|NCT04837807|588389629|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
162915064|NCT04837807|588389630|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
162915065|NCT00267202|588389631|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
162915066|NCT00267202|588389632|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162968368|NCT00982228|588584843|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
162968369|NCT00982228|588584844|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
162968370|NCT00360490|588584848|FG000|Overall Study|Adverse Event|4|||
162968371|NCT00360490|588584849|FG001|Overall Study|Adverse Event|2|||
162968372|NCT00360490|588584848|FG000|Overall Study|Lost to Follow-up|2|||
162968373|NCT00360490|588584849|FG001|Overall Study|Lost to Follow-up|1|||
162968374|NCT00360490|588584848|FG000|Overall Study|Physician Decision|2|||
162968375|NCT00360490|588584849|FG001|Overall Study|Physician Decision|1|||
162968376|NCT00360490|588584848|FG000|Overall Study|Protocol Violation|0|||
162968377|NCT00360490|588584849|FG001|Overall Study|Protocol Violation|4|||
162968378|NCT00360490|588584848|FG000|Overall Study|Withdrawal by Subject|1|||
162968379|NCT00360490|588584849|FG001|Overall Study|Withdrawal by Subject|3|||
162968380|NCT02289820|588584850|FG000|Overall Study|Withdrawal by Subject|2|||
162968381|NCT02289820|588584851|FG001|Overall Study|Withdrawal by Subject|1|||
162968382|NCT02289820|588584852|FG002|Overall Study|Withdrawal by Subject|2|||
162968383|NCT02289820|588584853|FG003|Overall Study|Withdrawal by Subject|1|||
162968384|NCT02289820|588584854|FG004|Overall Study|Withdrawal by Subject|0|||
162968385|NCT02289820|588584855|FG005|Overall Study|Withdrawal by Subject|0|||
162968386|NCT02289820|588584856|FG006|Overall Study|Withdrawal by Subject|1|||
162968387|NCT02289820|588584850|FG000|Overall Study|Death|0|||
162968388|NCT02289820|588584851|FG001|Overall Study|Death|0|||
162915067|NCT00267202|588389631|FG000|Overall Study|Withdrawal by Subject|12|||
162915068|NCT00267202|588389632|FG001|Overall Study|Withdrawal by Subject|15|||
162915069|NCT00267202|588389631|FG000|Overall Study|Adverse Event|13|||
162915070|NCT00267202|588389632|FG001|Overall Study|Adverse Event|7|||
162915071|NCT00267202|588389631|FG000|Overall Study|Protocol Violation|2|||
162915072|NCT00267202|588389632|FG001|Overall Study|Protocol Violation|3|||
162915073|NCT00267202|588389631|FG000|Overall Study|Administrative problems|2|||
162915074|NCT00267202|588389632|FG001|Overall Study|Administrative problems|1|||
162915075|NCT00267202|588389631|FG000|Overall Study|Lost to Follow-up|3|||
162915076|NCT00267202|588389632|FG001|Overall Study|Lost to Follow-up|0|||
162915077|NCT01757821|588389635|FG000|Overall Study|Adverse Event|1|||
162915078|NCT00334893|588389636|FG000|Overall Study|Not Treated|1|||
162915079|NCT00334893|588389637|FG001|Overall Study|Not Treated|0|||
162915080|NCT00920582|588389638|FG000|Overall Study|Lost to Follow-up|5|||
162915081|NCT00920582|588389639|FG001|Overall Study|Lost to Follow-up|1|||
162915082|NCT00920582|588389640|FG002|Overall Study|Lost to Follow-up|2|||
162915083|NCT00920582|588389641|FG003|Overall Study|Lost to Follow-up|0|||
162915084|NCT00920582|588389638|FG000|Overall Study|Withdrawal by Subject|5|||
162915085|NCT00920582|588389639|FG001|Overall Study|Withdrawal by Subject|4|||
162915086|NCT00920582|588389640|FG002|Overall Study|Withdrawal by Subject|6|||
162915087|NCT00920582|588389641|FG003|Overall Study|Withdrawal by Subject|3|||
162915088|NCT00920582|588389638|FG000|Overall Study|Protocol Violation|1|||
162915089|NCT00920582|588389639|FG001|Overall Study|Protocol Violation|0|||
162915090|NCT00920582|588389640|FG002|Overall Study|Protocol Violation|0|||
162915091|NCT00920582|588389641|FG003|Overall Study|Protocol Violation|0|||
162915092|NCT00920582|588389638|FG000|Overall Study|Other|2|||
162915093|NCT00920582|588389639|FG001|Overall Study|Other|1|||
162915094|NCT00920582|588389640|FG002|Overall Study|Other|3|||
162915095|NCT00920582|588389641|FG003|Overall Study|Other|2|||
162915096|NCT03319160|588389642|FG000|Overall Study|Data not available.|7|||
162915097|NCT03604159|588389643|FG000|Overall Study|Lost to Follow-up|6|||
162915098|NCT03604159|588389644|FG001|Overall Study|Lost to Follow-up|7|||
162915099|NCT00665002|588389645|FG000|Overall Study|Progression/relapse during treatment|11|||
162915100|NCT00665002|588389645|FG000|Overall Study|Cytogenetic resistance|1|||
162915101|NCT04533204|588389646|FG000|Overall Study|Unable to understand training instructions|1|||
162915102|NCT04533204|588389647|FG001|Overall Study|Unable to understand training instructions|1|||
162915103|NCT02260791|588389651|FG000|Overall Study|Lost to Follow-up|4|||
162915104|NCT02260791|588389652|FG001|Overall Study|Lost to Follow-up|4|||
162915105|NCT02260791|588389651|FG000|Overall Study|Lack of Efficacy|2|||
162915106|NCT02260791|588389652|FG001|Overall Study|Lack of Efficacy|1|||
162915107|NCT02260791|588389651|FG000|Overall Study|Adverse Event|13|||
162915108|NCT02260791|588389652|FG001|Overall Study|Adverse Event|9|||
162915109|NCT02260791|588389651|FG000|Overall Study|Death|1|||
162915110|NCT02260791|588389652|FG001|Overall Study|Death|0|||
162915111|NCT02260791|588389651|FG000|Overall Study|Withdrawal by Subject|11|||
162915112|NCT02260791|588389652|FG001|Overall Study|Withdrawal by Subject|16|||
162915113|NCT02260791|588389651|FG000|Overall Study|Screen failure|0|||
162915114|NCT02260791|588389652|FG001|Overall Study|Screen failure|1|||
162915115|NCT02260791|588389651|FG000|Overall Study|Protocol deviation|2|||
162915116|NCT02260791|588389652|FG001|Overall Study|Protocol deviation|3|||
162915117|NCT01411917|588389653|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
162915118|NCT01411917|588389654|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
162915119|NCT02354599|588389657|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162915120|NCT02354599|588389658|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162915121|NCT02354599|588389659|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162915122|NCT02354599|588389660|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
162915123|NCT02354599|588389661|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162915124|NCT02354599|588389662|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
162915125|NCT02354599|588389657|FG000|Overall Study|Withdrawal by Subject|1|||
162915126|NCT02354599|588389658|FG001|Overall Study|Withdrawal by Subject|1|||
162915127|NCT02354599|588389659|FG002|Overall Study|Withdrawal by Subject|0|||
162915128|NCT02354599|588389660|FG003|Overall Study|Withdrawal by Subject|0|||
162915129|NCT02354599|588389661|FG004|Overall Study|Withdrawal by Subject|0|||
162915130|NCT02354599|588389662|FG005|Overall Study|Withdrawal by Subject|0|||
162915131|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Death|2|||
162915132|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Death|0|||
162915133|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Adverse Event|33|||
162915134|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Adverse Event|31|||
162915135|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
162915136|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
162915137|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
162915138|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
162915139|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
162915140|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
162915141|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Other|7|||
162915142|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Other|8|||
162915143|NCT00280059|588389663|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
162915144|NCT00280059|588389664|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
162915145|NCT00495794|588389667|FG000|Overall Study|Pharmacist did not activate patient|522|||
162915146|NCT00495794|588389668|FG001|Overall Study|Pharmacist did not activate patient|0|||
162915147|NCT00323479|588389669|FG000|Overall Study|Adverse Event|2|||
162915148|NCT00323479|588389669|FG000|Overall Study|Withdrawal by Subject|2|||
162915149|NCT00323479|588389669|FG000|Overall Study|Protocol Violation|3|||
162915150|NCT00323479|588389669|FG000|Overall Study|house moving|1|||
162915151|NCT03044730|588389672|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
162915152|NCT03044730|588389672|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
162915153|NCT03044730|588389672|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
162915154|NCT03044730|588389672|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
162915155|NCT03044730|588389672|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
162915156|NCT03044730|588389672|FG000|Cycles 4 and Beyond|Adverse Event|1|||
162915157|NCT03044730|588389672|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
162915158|NCT03044730|588389672|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
162915159|NCT03044730|588389672|FG000|On Follow-up for 2 Years|Death|17|||
162915160|NCT01302366|588391643|FG000|Overall Study|patient choice or noncompliance|5|||
162915161|NCT00198107|588391646|FG000|Double-Blind Period|Adverse Event|1|||
162915162|NCT00198107|588391647|FG001|Double-Blind Period|Adverse Event|1|||
162915163|NCT00198107|588391648|FG002|Double-Blind Period|Adverse Event|0|||
162915164|NCT00198107|588391646|FG000|Double-Blind Period|Lack of Efficacy|2|||
162915165|NCT00198107|588391647|FG001|Double-Blind Period|Lack of Efficacy|0|||
162915166|NCT00198107|588391648|FG002|Double-Blind Period|Lack of Efficacy|0|||
162915167|NCT00198107|588391646|FG000|Double-Blind Period|Lost to Follow-up|2|||
162915168|NCT00198107|588391647|FG001|Double-Blind Period|Lost to Follow-up|1|||
162915169|NCT00198107|588391648|FG002|Double-Blind Period|Lost to Follow-up|0|||
162915170|NCT00198107|588391646|FG000|Double-Blind Period|Physician Decision|1|||
162915171|NCT00198107|588391647|FG001|Double-Blind Period|Physician Decision|0|||
162915172|NCT00198107|588391648|FG002|Double-Blind Period|Physician Decision|0|||
162915173|NCT00198107|588391646|FG000|Double-Blind Period|Withdrawal by Subject|0|||
162915174|NCT00198107|588391647|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162915175|NCT00198107|588391648|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162915176|NCT00198107|588391646|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
162915177|NCT00198107|588391647|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
162915178|NCT00198107|588391648|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
162915179|NCT02513732|588391649|FG000|Overall Study|Lost to Follow-up|11|||
162915180|NCT02513732|588391649|FG000|Overall Study|Death|9|||
162915181|NCT02513732|588391649|FG000|Overall Study|Changing hospital|2|||
162968389|NCT02289820|588584852|FG002|Overall Study|Death|1|||
162968390|NCT02289820|588584853|FG003|Overall Study|Death|0|||
162968391|NCT02289820|588584854|FG004|Overall Study|Death|0|||
162968392|NCT02289820|588584855|FG005|Overall Study|Death|0|||
162968393|NCT02289820|588584856|FG006|Overall Study|Death|0|||
162968394|NCT02289820|588584850|FG000|Overall Study|Lost to Follow-up|0|||
162968395|NCT02289820|588584851|FG001|Overall Study|Lost to Follow-up|0|||
162968396|NCT02289820|588584852|FG002|Overall Study|Lost to Follow-up|3|||
162968397|NCT02289820|588584853|FG003|Overall Study|Lost to Follow-up|1|||
162968398|NCT02289820|588584854|FG004|Overall Study|Lost to Follow-up|0|||
162968399|NCT02289820|588584855|FG005|Overall Study|Lost to Follow-up|1|||
162968400|NCT02289820|588584856|FG006|Overall Study|Lost to Follow-up|1|||
162968401|NCT02289820|588584850|FG000|Overall Study|withdrawal of consent|0|||
162968402|NCT02289820|588584851|FG001|Overall Study|withdrawal of consent|1|||
162968403|NCT02289820|588584852|FG002|Overall Study|withdrawal of consent|0|||
162968404|NCT02289820|588584853|FG003|Overall Study|withdrawal of consent|0|||
162968405|NCT02289820|588584854|FG004|Overall Study|withdrawal of consent|0|||
162968406|NCT02289820|588584855|FG005|Overall Study|withdrawal of consent|0|||
162968407|NCT02289820|588584856|FG006|Overall Study|withdrawal of consent|0|||
162968408|NCT02005276|588584857|FG000|Overall Study|No longer interested|5|||
162968409|NCT02005276|588584858|FG001|Overall Study|No longer interested|2|||
162968410|NCT02005276|588584859|FG002|Overall Study|No longer interested|3|||
162968411|NCT02005276|588584860|FG003|Overall Study|No longer interested|3|||
162968412|NCT01688882|588584867|FG000|Overall Study|Adverse Event|1|||
162968413|NCT01688882|588584868|FG001|Overall Study|Adverse Event|0|||
162968414|NCT01688882|588584867|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162915182|NCT00467051|588391650|FG000|Overall Study|Adverse Event|2|||
162915183|NCT00934661|588391651|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
162915184|NCT00934661|588391652|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
162968415|NCT01688882|588584868|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162968416|NCT01688882|588584867|FG000|Overall Study|Administrative problems|1|||
162968417|NCT01688882|588584868|FG001|Overall Study|Administrative problems|0|||
162968418|NCT00124618|588584869|FG000|Overall Study|Ineligible|1|||
162968419|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
162915185|NCT01846442|588391657|FG000|Overall Study|Adverse Event|2|||
162915186|NCT01846442|588391658|FG001|Overall Study|Adverse Event|4|||
162915187|NCT01846442|588391659|FG002|Overall Study|Adverse Event|2|||
162915188|NCT01846442|588391660|FG003|Overall Study|Adverse Event|1|||
162915189|NCT01846442|588391657|FG000|Overall Study|Lost to Follow-up|0|||
162915190|NCT01846442|588391658|FG001|Overall Study|Lost to Follow-up|0|||
162915191|NCT01846442|588391659|FG002|Overall Study|Lost to Follow-up|1|||
162915192|NCT01846442|588391660|FG003|Overall Study|Lost to Follow-up|0|||
162915193|NCT01846442|588391657|FG000|Overall Study|Withdrawal by Subject|3|||
162915194|NCT01846442|588391658|FG001|Overall Study|Withdrawal by Subject|2|||
162915195|NCT01846442|588391659|FG002|Overall Study|Withdrawal by Subject|0|||
162915196|NCT01846442|588391660|FG003|Overall Study|Withdrawal by Subject|1|||
162915197|NCT01846442|588391657|FG000|Overall Study|Left the city/Lost medication|1|||
162915198|NCT01846442|588391658|FG001|Overall Study|Left the city/Lost medication|0|||
162915199|NCT01846442|588391659|FG002|Overall Study|Left the city/Lost medication|1|||
162915200|NCT01846442|588391660|FG003|Overall Study|Left the city/Lost medication|1|||
162915201|NCT02777554|588391663|FG000|Overall Study|Adverse Event|4|||
162915202|NCT02777554|588391664|FG001|Overall Study|Adverse Event|4|||
162915203|NCT02777554|588391665|FG002|Overall Study|Adverse Event|0|||
162915204|NCT02777554|588391666|FG003|Overall Study|Adverse Event|1|||
162915205|NCT02777554|588391667|FG004|Overall Study|Adverse Event|0|||
162915206|NCT02777554|588391668|FG005|Overall Study|Adverse Event|0|||
162915207|NCT02777554|588391663|FG000|Overall Study|Withdrawal by Subject|3|||
162915208|NCT02777554|588391664|FG001|Overall Study|Withdrawal by Subject|1|||
162915209|NCT02777554|588391665|FG002|Overall Study|Withdrawal by Subject|1|||
162915210|NCT02777554|588391666|FG003|Overall Study|Withdrawal by Subject|0|||
162915211|NCT02777554|588391667|FG004|Overall Study|Withdrawal by Subject|0|||
162915212|NCT02777554|588391668|FG005|Overall Study|Withdrawal by Subject|0|||
162915213|NCT02777554|588391663|FG000|Overall Study|Discharged early due to hurricane|22|||
162915214|NCT02777554|588391664|FG001|Overall Study|Discharged early due to hurricane|20|||
162915215|NCT02777554|588391665|FG002|Overall Study|Discharged early due to hurricane|0|||
162915216|NCT02777554|588391666|FG003|Overall Study|Discharged early due to hurricane|0|||
162915217|NCT02777554|588391667|FG004|Overall Study|Discharged early due to hurricane|0|||
162915218|NCT02777554|588391668|FG005|Overall Study|Discharged early due to hurricane|0|||
162915219|NCT02777554|588391663|FG000|Overall Study|Other - Miscellaneous|1|||
162915220|NCT02777554|588391664|FG001|Overall Study|Other - Miscellaneous|0|||
162915221|NCT02777554|588391665|FG002|Overall Study|Other - Miscellaneous|0|||
162915222|NCT02777554|588391666|FG003|Overall Study|Other - Miscellaneous|0|||
162915223|NCT02777554|588391667|FG004|Overall Study|Other - Miscellaneous|0|||
162915224|NCT02777554|588391668|FG005|Overall Study|Other - Miscellaneous|0|||
162915225|NCT02147132|588391669|FG000|Overall Study|Lost to Follow-up|1|||
162915226|NCT02147132|588391670|FG001|Overall Study|Lost to Follow-up|0|||
162915227|NCT02147132|588391671|FG002|Overall Study|Lost to Follow-up|0|||
162915228|NCT02147132|588391672|FG003|Overall Study|Lost to Follow-up|0|||
162915229|NCT01013207|588391673|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
162915230|NCT01541644|588391678|FG000|Overall Study|Withdrawal by Subject|3|||
162915231|NCT01458535|588391681|FG000|Overall Study|Other|0|||
162915232|NCT01458535|588391682|FG001|Overall Study|Other|0|||
162915233|NCT01458535|588391683|FG002|Overall Study|Other|0|||
162915234|NCT01458535|588391684|FG003|Overall Study|Other|0|||
162915235|NCT01458535|588391685|FG004|Overall Study|Other|1|||
162915236|NCT01458535|588391686|FG005|Overall Study|Other|1|||
162915237|NCT01458535|588391681|FG000|Overall Study|Withdrawal by Subject|0|||
162915238|NCT01458535|588391682|FG001|Overall Study|Withdrawal by Subject|0|||
162915239|NCT01458535|588391683|FG002|Overall Study|Withdrawal by Subject|2|||
162915240|NCT01458535|588391684|FG003|Overall Study|Withdrawal by Subject|0|||
162915241|NCT01458535|588391685|FG004|Overall Study|Withdrawal by Subject|1|||
162915242|NCT01458535|588391686|FG005|Overall Study|Withdrawal by Subject|1|||
162915243|NCT01458535|588391681|FG000|Overall Study|Lost to Follow-up|0|||
162915244|NCT01458535|588391682|FG001|Overall Study|Lost to Follow-up|2|||
162915245|NCT01458535|588391683|FG002|Overall Study|Lost to Follow-up|0|||
162915246|NCT01458535|588391684|FG003|Overall Study|Lost to Follow-up|3|||
162915247|NCT01458535|588391685|FG004|Overall Study|Lost to Follow-up|2|||
162915248|NCT01458535|588391686|FG005|Overall Study|Lost to Follow-up|2|||
162915249|NCT01458535|588391681|FG000|Overall Study|Adverse Event|0|||
162915250|NCT01458535|588391682|FG001|Overall Study|Adverse Event|0|||
162915251|NCT01458535|588391683|FG002|Overall Study|Adverse Event|0|||
162915252|NCT01458535|588391684|FG003|Overall Study|Adverse Event|1|||
162915253|NCT01458535|588391685|FG004|Overall Study|Adverse Event|0|||
162629107|NCT01534962|587358625|FG003|Overall Study|Discontinued at AF recurrence|31|||
162968420|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
162968421|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
162629108|NCT00880009|587358626|FG000|Overall Study|Study terminated by sponsor|14|||
162915254|NCT01458535|588391686|FG005|Overall Study|Adverse Event|0|||
162915255|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
162915256|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
162915257|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162968422|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
162629109|NCT00880009|587358626|FG000|Overall Study|Withdrawal by Subject|1|||
162915258|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915259|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915260|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915261|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915262|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915263|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915264|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915265|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915266|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
162915267|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
162915268|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915269|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915270|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915271|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915272|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915273|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
162915274|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915275|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915276|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915277|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
162915278|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
162915279|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915280|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
162915281|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915282|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915283|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915284|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915285|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915286|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915287|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915288|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915289|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915290|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
162915291|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
162915292|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
162915293|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
162915294|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
162915295|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
162915296|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
162915297|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
162915298|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
162915299|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
162915300|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
162915301|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
162915302|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
162915303|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915304|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915305|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915306|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915307|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915308|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
162915309|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915310|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915311|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915312|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915313|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915314|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
162915315|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915316|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915317|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915318|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915319|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162629110|NCT00880009|587358626|FG000|Overall Study|Protocol Violation|1|||
162629111|NCT01128842|587358629|FG000|Overall Study|Adverse Event|1|||
163054432|NCT01973218|588910298|FG001|Overall Study|Withdrawal by Subject|0|||
163054433|NCT00720499|588910299|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
162629112|NCT01128842|587358629|FG000|Overall Study|Disease Progression|6|||
162915320|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
162915321|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915322|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915323|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915324|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915325|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915326|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
162915327|NCT00151775|588391687|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915328|NCT00151775|588391688|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915329|NCT00151775|588391689|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915330|NCT00151775|588391690|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915331|NCT00151775|588391691|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915332|NCT00151775|588391692|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915333|NCT00151775|588391693|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
162968423|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
162968424|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
162968425|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
162968426|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
162968427|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
162968428|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
162968429|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
162968430|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
162968431|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
162968432|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
162968433|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
162968434|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
162968435|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
162968436|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
162968437|NCT00950300|588584870|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
162968438|NCT00950300|588584871|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
162968439|NCT00950300|588584870|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
162968440|NCT00950300|588584871|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
162968441|NCT00950300|588584870|FG000|TFFU Period|Death|4|||
162968442|NCT00950300|588584871|FG001|TFFU Period|Death|1|||
162968443|NCT00950300|588584870|FG000|TFFU Period|Refused Treatment|10|||
162968444|NCT00950300|588584871|FG001|TFFU Period|Refused Treatment|11|||
162968445|NCT00950300|588584870|FG000|TFFU Period|Failure to Return|16|||
162968446|NCT00950300|588584871|FG001|TFFU Period|Failure to Return|16|||
162968447|NCT00950300|588584870|FG000|TFFU Period|Recurrence of Disease|63|||
162968448|NCT00950300|588584871|FG001|TFFU Period|Recurrence of Disease|72|||
162968449|NCT00950300|588584870|FG000|TFFU Period|Other|4|||
162968450|NCT00950300|588584871|FG001|TFFU Period|Other|3|||
162968451|NCT00950300|588584870|FG000|SFU Period|Death|44|||
162968452|NCT00950300|588584871|FG001|SFU Period|Death|42|||
162968453|NCT00950300|588584870|FG000|SFU Period|Lost to Follow-up|30|||
162968454|NCT00950300|588584871|FG001|SFU Period|Lost to Follow-up|28|||
162968455|NCT00950300|588584870|FG000|SFU Period|Withdrawal by Subject|4|||
162968456|NCT00950300|588584871|FG001|SFU Period|Withdrawal by Subject|8|||
162968457|NCT01912807|588584872|FG000|Overall Study|Did not meet elegibility criteria|6|||
162968458|NCT01912807|588584873|FG001|Overall Study|Did not meet elegibility criteria|4|||
162968459|NCT01912807|588584872|FG000|Overall Study|Lost to Follow-up|36|||
162968460|NCT01912807|588584873|FG001|Overall Study|Lost to Follow-up|37|||
162968461|NCT04750239|588584874|FG000|Overall Study|Withdrawal by Subject|2|||
162968462|NCT04750239|588584874|FG000|Overall Study|Trial terminated by sponsor|1|||
162968463|NCT00834613|588584877|FG000|First Intervention|Protocol Violation|1|||
162968464|NCT00834613|588584878|FG001|First Intervention|Protocol Violation|0|||
162915334|NCT00151775|588391694|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915335|NCT00151775|588391695|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915336|NCT00151775|588391696|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915337|NCT00151775|588391697|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915338|NCT00151775|588391698|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
162915339|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915340|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915341|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915342|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915343|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915344|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
162915345|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915346|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915347|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915348|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915349|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915350|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
162915351|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
162915352|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
162915353|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
162915354|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
162915355|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
162915356|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
162915357|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
162915358|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
162915359|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
162915360|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
162915361|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
162915362|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
162915363|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915364|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915365|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915366|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915367|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915368|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915369|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
162915370|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915371|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915372|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915373|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915374|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
162915375|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915376|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915377|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
162915378|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915379|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915380|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915381|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915382|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915383|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915384|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915385|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915386|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
162915387|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915388|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162710988|NCT04319094|587652840|FG001|Post-Intervention|Withdrawal by Subject|5|||
162710989|NCT04319094|587652839|FG000|Post-Intervention|Incomplete Data Collection|1|||
162710990|NCT04319094|587652840|FG001|Post-Intervention|Incomplete Data Collection|3|||
162710991|NCT04319094|587652839|FG000|3-month|Death|1|||
162710992|NCT04319094|587652840|FG001|3-month|Death|0|||
162710993|NCT04319094|587652839|FG000|3-month|Lost to Follow-up|2|||
162710994|NCT04319094|587652840|FG001|3-month|Lost to Follow-up|2|||
162710995|NCT04319094|587652839|FG000|3-month|Withdrawal by Subject|0|||
162710996|NCT04319094|587652840|FG001|3-month|Withdrawal by Subject|3|||
162710997|NCT04319094|587652839|FG000|3-month|Incomplete data collection|9|||
162710998|NCT04319094|587652840|FG001|3-month|Incomplete data collection|7|||
162710999|NCT04319094|587652839|FG000|6-month|Lost to Follow-up|1|||
162711000|NCT04319094|587652840|FG001|6-month|Lost to Follow-up|1|||
162711001|NCT04319094|587652839|FG000|6-month|Withdrawal by Subject|0|||
162915389|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
162915390|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915391|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915392|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915393|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915394|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915395|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915396|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915397|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915398|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
162915399|NCT00151775|588391687|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915400|NCT00151775|588391688|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915401|NCT00151775|588391689|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915402|NCT00151775|588391690|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915403|NCT00151775|588391691|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915404|NCT00151775|588391692|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915405|NCT00151775|588391693|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915406|NCT00151775|588391694|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915407|NCT00151775|588391695|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915408|NCT00151775|588391696|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915409|NCT00151775|588391697|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
162915410|NCT00151775|588391698|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
162915411|NCT00151775|588391687|FG000|Period 4: Open Label|Increased blood pressure|0|||
162915412|NCT00151775|588391688|FG001|Period 4: Open Label|Increased blood pressure|0|||
162915413|NCT00151775|588391689|FG002|Period 4: Open Label|Increased blood pressure|0|||
162915414|NCT00151775|588391690|FG003|Period 4: Open Label|Increased blood pressure|0|||
162915415|NCT00151775|588391691|FG004|Period 4: Open Label|Increased blood pressure|1|||
162915416|NCT00151775|588391692|FG005|Period 4: Open Label|Increased blood pressure|0|||
162915417|NCT00151775|588391693|FG006|Period 4: Open Label|Increased blood pressure|0|||
162915418|NCT00151775|588391694|FG007|Period 4: Open Label|Increased blood pressure|0|||
162915419|NCT00151775|588391695|FG008|Period 4: Open Label|Increased blood pressure|0|||
162915420|NCT00151775|588391696|FG009|Period 4: Open Label|Increased blood pressure|1|||
162915421|NCT00151775|588391697|FG010|Period 4: Open Label|Increased blood pressure|0|||
162915422|NCT00151775|588391698|FG011|Period 4: Open Label|Increased blood pressure|0|||
162915423|NCT00151775|588391687|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
162915424|NCT00151775|588391688|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
162915425|NCT00151775|588391689|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
162915426|NCT00151775|588391690|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
162915427|NCT00151775|588391691|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
162915428|NCT00151775|588391692|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
162915429|NCT00151775|588391693|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
162915430|NCT00151775|588391694|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
162915431|NCT00151775|588391695|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
162915432|NCT00151775|588391696|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
162915433|NCT00151775|588391697|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
162915434|NCT00151775|588391698|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
162915435|NCT00151775|588391687|FG000|Period 4: Open Label|Adverse Event|0|||
162915436|NCT00151775|588391688|FG001|Period 4: Open Label|Adverse Event|0|||
162915437|NCT00151775|588391689|FG002|Period 4: Open Label|Adverse Event|0|||
162915438|NCT00151775|588391690|FG003|Period 4: Open Label|Adverse Event|0|||
162915439|NCT00151775|588391691|FG004|Period 4: Open Label|Adverse Event|1|||
162915440|NCT00151775|588391692|FG005|Period 4: Open Label|Adverse Event|0|||
162915441|NCT00151775|588391693|FG006|Period 4: Open Label|Adverse Event|0|||
162915442|NCT00151775|588391694|FG007|Period 4: Open Label|Adverse Event|0|||
162915443|NCT00151775|588391695|FG008|Period 4: Open Label|Adverse Event|0|||
162915444|NCT00151775|588391696|FG009|Period 4: Open Label|Adverse Event|2|||
162915445|NCT00151775|588391697|FG010|Period 4: Open Label|Adverse Event|0|||
162915446|NCT00151775|588391698|FG011|Period 4: Open Label|Adverse Event|0|||
162968465|NCT00663234|588584879|FG000|Overall Study|Not willing to adhere to requirements|1|||
162968466|NCT01253564|588584882|FG000|Overall Study|Disease Progression|22|||
162968467|NCT01253564|588584882|FG000|Overall Study|Withdrawal by Subject|1|||
162968468|NCT01253564|588584882|FG000|Overall Study|Serious Adverse Event|1|||
162968469|NCT04584983|588584883|FG000|Overall Study|Parental request for withdraw|2|||
162968470|NCT04584983|588584884|FG001|Overall Study|Parental request for withdraw|0|||
162915447|NCT00151775|588391687|FG000|Period 4: Open Label|Lost to Follow-up|0|||
162915448|NCT00151775|588391688|FG001|Period 4: Open Label|Lost to Follow-up|0|||
162968471|NCT00288704|588586237|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
162915449|NCT00151775|588391689|FG002|Period 4: Open Label|Lost to Follow-up|0|||
162915450|NCT00151775|588391690|FG003|Period 4: Open Label|Lost to Follow-up|0|||
162915451|NCT00151775|588391691|FG004|Period 4: Open Label|Lost to Follow-up|17|||
162915452|NCT00151775|588391692|FG005|Period 4: Open Label|Lost to Follow-up|0|||
162915453|NCT00151775|588391693|FG006|Period 4: Open Label|Lost to Follow-up|0|||
162915454|NCT00151775|588391694|FG007|Period 4: Open Label|Lost to Follow-up|0|||
162915455|NCT00151775|588391695|FG008|Period 4: Open Label|Lost to Follow-up|0|||
162915456|NCT00151775|588391696|FG009|Period 4: Open Label|Lost to Follow-up|7|||
162968472|NCT00288704|588586238|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
162968473|NCT00288704|588586239|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
162968474|NCT00288704|588586237|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
162968475|NCT00288704|588586238|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
162968476|NCT00288704|588586239|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
162968477|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
162968478|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
162968479|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
162968480|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
162968481|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
162968482|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
162968483|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
162968484|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
162968485|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
162968486|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
162968487|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
162968488|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
162968489|NCT00288704|588586237|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
162968490|NCT00288704|588586238|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
162968491|NCT00288704|588586239|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
162968492|NCT00676650|588586240|FG000|Overall Study|Death|45|||
162915457|NCT00151775|588391697|FG010|Period 4: Open Label|Lost to Follow-up|0|||
162915458|NCT00151775|588391698|FG011|Period 4: Open Label|Lost to Follow-up|0|||
162915459|NCT00151775|588391687|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
162915460|NCT00151775|588391688|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
162915461|NCT00151775|588391689|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
162915462|NCT00151775|588391690|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
162915463|NCT00151775|588391691|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
162915464|NCT00151775|588391692|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
162915465|NCT00151775|588391693|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
162915466|NCT00151775|588391694|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
162915467|NCT00151775|588391695|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
162915468|NCT00151775|588391696|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
162915469|NCT00151775|588391697|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
162915470|NCT00151775|588391698|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
162915471|NCT00151775|588391687|FG000|Period 4: Open Label|Other|0|||
162915472|NCT00151775|588391688|FG001|Period 4: Open Label|Other|0|||
162915473|NCT00151775|588391689|FG002|Period 4: Open Label|Other|0|||
162915474|NCT00151775|588391690|FG003|Period 4: Open Label|Other|0|||
162915475|NCT00151775|588391691|FG004|Period 4: Open Label|Other|1|||
162915476|NCT00151775|588391692|FG005|Period 4: Open Label|Other|0|||
162915477|NCT00151775|588391693|FG006|Period 4: Open Label|Other|0|||
162915478|NCT00151775|588391694|FG007|Period 4: Open Label|Other|0|||
162915479|NCT00151775|588391695|FG008|Period 4: Open Label|Other|0|||
162915480|NCT00151775|588391696|FG009|Period 4: Open Label|Other|3|||
162915481|NCT00151775|588391697|FG010|Period 4: Open Label|Other|0|||
162915482|NCT00151775|588391698|FG011|Period 4: Open Label|Other|0|||
162915483|NCT00151775|588391687|FG000|Period 4: Open Label|Physician Decision|0|||
162915484|NCT00151775|588391688|FG001|Period 4: Open Label|Physician Decision|0|||
162915485|NCT00151775|588391689|FG002|Period 4: Open Label|Physician Decision|0|||
162915486|NCT00151775|588391690|FG003|Period 4: Open Label|Physician Decision|0|||
162915487|NCT00151775|588391691|FG004|Period 4: Open Label|Physician Decision|0|||
162968493|NCT00676650|588586241|FG001|Overall Study|Death|14|||
162968494|NCT00676650|588586240|FG000|Overall Study|Adverse Event|159|||
162968495|NCT00676650|588586241|FG001|Overall Study|Adverse Event|21|||
162968496|NCT00676650|588586240|FG000|Overall Study|Global deterioration of health status|66|||
162915488|NCT00151775|588391692|FG005|Period 4: Open Label|Physician Decision|0|||
162915489|NCT00151775|588391693|FG006|Period 4: Open Label|Physician Decision|0|||
162915490|NCT00151775|588391694|FG007|Period 4: Open Label|Physician Decision|0|||
162915491|NCT00151775|588391695|FG008|Period 4: Open Label|Physician Decision|0|||
162915492|NCT00151775|588391696|FG009|Period 4: Open Label|Physician Decision|2|||
162915493|NCT00151775|588391697|FG010|Period 4: Open Label|Physician Decision|0|||
162968497|NCT00676650|588586241|FG001|Overall Study|Global deterioration of health status|31|||
162968498|NCT00676650|588586240|FG000|Overall Study|Lost to Follow-up|0|||
162968499|NCT00676650|588586241|FG001|Overall Study|Lost to Follow-up|1|||
162915494|NCT00151775|588391698|FG011|Period 4: Open Label|Physician Decision|0|||
162915495|NCT00151775|588391687|FG000|Period 4: Open Label|Protocol Violation|0|||
162915496|NCT00151775|588391688|FG001|Period 4: Open Label|Protocol Violation|0|||
162915497|NCT00151775|588391689|FG002|Period 4: Open Label|Protocol Violation|0|||
162915498|NCT00151775|588391690|FG003|Period 4: Open Label|Protocol Violation|0|||
162915499|NCT00151775|588391691|FG004|Period 4: Open Label|Protocol Violation|1|||
162915500|NCT00151775|588391692|FG005|Period 4: Open Label|Protocol Violation|0|||
162915501|NCT00151775|588391693|FG006|Period 4: Open Label|Protocol Violation|0|||
162915502|NCT00151775|588391694|FG007|Period 4: Open Label|Protocol Violation|0|||
162915503|NCT00151775|588391695|FG008|Period 4: Open Label|Protocol Violation|0|||
162915504|NCT00151775|588391696|FG009|Period 4: Open Label|Protocol Violation|0|||
162915505|NCT00151775|588391697|FG010|Period 4: Open Label|Protocol Violation|0|||
162915506|NCT00151775|588391698|FG011|Period 4: Open Label|Protocol Violation|0|||
162915507|NCT00474994|588391699|FG000|Overall Study|Patient Not treated|1|||
162915508|NCT00474994|588391699|FG000|Overall Study|Patient evaluable for toxicity only|3|||
162915509|NCT00474994|588391699|FG000|Overall Study|Patient found to be ineligible|1|||
162915510|NCT05064436|588391703|FG000|Overall Study|Other Reasons|1|||
162915511|NCT05064436|588391704|FG001|Overall Study|Other Reasons|0|||
162915512|NCT01711736|588391705|FG000|Overall Study|Lost to Follow-up|4|||
162915513|NCT01711736|588391706|FG001|Overall Study|Lost to Follow-up|1|||
162915514|NCT01711736|588391705|FG000|Overall Study|Withdrawal by Subject|6|||
162915515|NCT01711736|588391706|FG001|Overall Study|Withdrawal by Subject|6|||
162915516|NCT01711736|588391705|FG000|Overall Study|Migrated/moved from study area|2|||
162915517|NCT01711736|588391706|FG001|Overall Study|Migrated/moved from study area|1|||
162915518|NCT02706327|588391707|FG000|Overall Study|Lost to Follow-up|1|||
162915519|NCT02706327|588391708|FG001|Overall Study|Lost to Follow-up|1|||
162915520|NCT02706327|588391709|FG002|Overall Study|Lost to Follow-up|2|||
162915521|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Adverse Event|4|||
162915522|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Adverse Event|3|||
162915523|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Adverse Event|0|||
162915524|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Adverse Event|0|||
162915525|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Death|24|||
162915526|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Death|9|||
162915527|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Death|0|||
162915528|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Death|0|||
162915529|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
162915530|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
162915531|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
162915532|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
162915533|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Physician Decision|4|||
162915534|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Physician Decision|1|||
162915535|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Physician Decision|0|||
162915536|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Physician Decision|0|||
162915537|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Progressive disease|1|||
162915538|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Progressive disease|0|||
162915539|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Progressive disease|0|||
162915540|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Progressive disease|0|||
162915541|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
162915542|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
162915543|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
162915544|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
162915545|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
162915546|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
162915547|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
162915548|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
162915549|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
162915550|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
162915551|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
162915552|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
162915553|NCT04579666|588391710|FG000|RTP (Up to Week 52)|Other|2|||
162915554|NCT04579666|588391711|FG001|RTP (Up to Week 52)|Other|0|||
162915555|NCT04579666|588391712|FG002|RTP (Up to Week 52)|Other|0|||
162915556|NCT04579666|588391713|FG003|RTP (Up to Week 52)|Other|0|||
162915557|NCT04579666|588391710|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
162915558|NCT04579666|588391711|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
162915559|NCT04579666|588391712|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
162915560|NCT04579666|588391713|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
162915561|NCT04579666|588391710|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
162915562|NCT04579666|588391711|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
162915563|NCT04579666|588391712|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
162915564|NCT04579666|588391713|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
162915565|NCT04579666|588391710|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
162915566|NCT04579666|588391711|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
162915567|NCT04579666|588391712|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
162915568|NCT04579666|588391713|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
162915569|NCT04579666|588391710|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
162915570|NCT04579666|588391711|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
162915571|NCT04579666|588391712|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
162915572|NCT04579666|588391713|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
162915573|NCT04579666|588391710|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
162915574|NCT04579666|588391711|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
162711002|NCT04319094|587652840|FG001|6-month|Withdrawal by Subject|3|||
162915575|NCT04579666|588391712|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
162915576|NCT04579666|588391713|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
162915577|NCT05450198|588391714|FG000|Overall Study|Withdrawal by Subject|1|||
162915578|NCT05450198|588391715|FG001|Overall Study|Withdrawal by Subject|1|||
162915579|NCT05450198|588391716|FG002|Overall Study|Withdrawal by Subject|2|||
162915580|NCT05450198|588391717|FG003|Overall Study|Withdrawal by Subject|0|||
162915581|NCT05450198|588391714|FG000|Overall Study|Lost to Follow-up|1|||
162915582|NCT05450198|588391715|FG001|Overall Study|Lost to Follow-up|0|||
162915583|NCT05450198|588391716|FG002|Overall Study|Lost to Follow-up|2|||
162915584|NCT05450198|588391717|FG003|Overall Study|Lost to Follow-up|1|||
162915585|NCT01982942|588391718|FG000|Overall Study|Adverse Event|10|||
162915586|NCT01982942|588391719|FG001|Overall Study|Adverse Event|5|||
162915587|NCT01982942|588391718|FG000|Overall Study|Lost to Follow-up|4|||
162915588|NCT01982942|588391719|FG001|Overall Study|Lost to Follow-up|3|||
162915589|NCT01982942|588391718|FG000|Overall Study|Multiple sclerosis progression|3|||
162915590|NCT01982942|588391719|FG001|Overall Study|Multiple sclerosis progression|2|||
162915591|NCT01982942|588391718|FG000|Overall Study|Wanted to try therapy not permitted|1|||
162915592|NCT01982942|588391719|FG001|Overall Study|Wanted to try therapy not permitted|0|||
162915593|NCT01982942|588391718|FG000|Overall Study|Subject declined future visits|0|||
162968500|NCT00676650|588586240|FG000|Overall Study|Objective progression or relapse|189|||
162968501|NCT00676650|588586241|FG001|Overall Study|Objective progression or relapse|140|||
162968502|NCT00676650|588586240|FG000|Overall Study|Other|14|||
162968503|NCT00676650|588586241|FG001|Overall Study|Other|10|||
162968504|NCT00676650|588586240|FG000|Overall Study|Protocol Violation|3|||
162968505|NCT00676650|588586241|FG001|Overall Study|Protocol Violation|1|||
162968506|NCT00676650|588586240|FG000|Overall Study|Study terminated by sponsor|57|||
162968507|NCT00676650|588586241|FG001|Overall Study|Study terminated by sponsor|43|||
162968508|NCT00676650|588586240|FG000|Overall Study|Withdrawal by Subject|48|||
162968509|NCT00676650|588586241|FG001|Overall Study|Withdrawal by Subject|24|||
162968510|NCT00676650|588586240|FG000|Overall Study|Randomized but not treated|3|||
162968511|NCT00676650|588586241|FG001|Overall Study|Randomized but not treated|4|||
162968512|NCT02297841|588586245|FG000|Overall Study|Withdrawal by Subject|1|||
162968513|NCT02297841|588586245|FG000|Overall Study|Protocol Violation|7|||
162968514|NCT05061992|588586246|FG000|Overall Study|Excess bowel movements|1|||
162968515|NCT05061992|588586247|FG001|Overall Study|Excess bowel movements|0|||
162968516|NCT05061992|588586246|FG000|Overall Study|Complications of Medical Care|1|||
162968517|NCT05061992|588586247|FG001|Overall Study|Complications of Medical Care|0|||
162968518|NCT05061992|588586246|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
162968519|NCT05061992|588586247|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
162968520|NCT05061992|588586246|FG000|Overall Study|Withdrawal by Subject|0|||
162968521|NCT05061992|588586247|FG001|Overall Study|Withdrawal by Subject|1|||
162915594|NCT01982942|588391719|FG001|Overall Study|Subject declined future visits|1|||
162915595|NCT01982942|588391718|FG000|Overall Study|Left geographical area|2|||
162968522|NCT01257581|588586252|FG000|Overall Study|Early Termination|3|||
162968523|NCT01257581|588586253|FG001|Overall Study|Early Termination|1|||
162915596|NCT01982942|588391719|FG001|Overall Study|Left geographical area|0|||
162968524|NCT01257581|588586254|FG002|Overall Study|Early Termination|2|||
162915597|NCT01982942|588391718|FG000|Overall Study|Too many pills|1|||
162915598|NCT01982942|588391719|FG001|Overall Study|Too many pills|0|||
162915599|NCT01982942|588391718|FG000|Overall Study|MS Relapse|0|||
162915600|NCT01982942|588391719|FG001|Overall Study|MS Relapse|1|||
162915601|NCT01982942|588391718|FG000|Overall Study|Chose to join a stem cell trial|0|||
162915602|NCT01982942|588391719|FG001|Overall Study|Chose to join a stem cell trial|1|||
162915603|NCT01982942|588391718|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
162915604|NCT01982942|588391719|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
162915605|NCT04511533|588391720|FG000|Treatment|Other|2|||
162915606|NCT04511533|588391720|FG000|Treatment|Withdrawal by Subject|11|||
162915607|NCT04511533|588391720|FG000|Treatment|Death|5|||
162915608|NCT04511533|588391720|FG000|Treatment|Physician Decision|1|||
162915609|NCT04511533|588391720|FG000|Treatment|Progressive Disease|61|||
162915610|NCT04511533|588391720|FG000|Follow-Up|Other|7|||
162915611|NCT04511533|588391720|FG000|Follow-Up|Withdrawal by Subject|5|||
162915612|NCT04511533|588391720|FG000|Follow-Up|Lost to Follow-up|2|||
162915613|NCT04511533|588391720|FG000|Follow-Up|Death|4|||
162915614|NCT01224171|588391721|FG000|Overall Study|Adverse Event|8|||
162915615|NCT01224171|588391722|FG001|Overall Study|Adverse Event|4|||
162915616|NCT01224171|588391721|FG000|Overall Study|Protocol Violation|0|||
162915617|NCT01224171|588391722|FG001|Overall Study|Protocol Violation|1|||
162915618|NCT01224171|588391721|FG000|Overall Study|Lack of Efficacy|5|||
162915619|NCT01224171|588391722|FG001|Overall Study|Lack of Efficacy|1|||
162915620|NCT01224171|588391721|FG000|Overall Study|Withdrawal of Consent|2|||
162915621|NCT01224171|588391722|FG001|Overall Study|Withdrawal of Consent|4|||
162915622|NCT01224171|588391721|FG000|Overall Study|Lost to Follow-up|0|||
162915623|NCT01224171|588391722|FG001|Overall Study|Lost to Follow-up|3|||
162915624|NCT01097057|588391723|FG000|Overall Study|Physician Decision|3|||
162915625|NCT01270139|588391726|FG000|Overall Study|Adverse Event|8|||
162915626|NCT01270139|588391727|FG001|Overall Study|Adverse Event|17|||
162915627|NCT01270139|588391728|FG002|Overall Study|Adverse Event|18|||
162915628|NCT01270139|588391726|FG000|Overall Study|Lost to Follow-up|10|||
162915629|NCT01270139|588391727|FG001|Overall Study|Lost to Follow-up|9|||
162915630|NCT01270139|588391728|FG002|Overall Study|Lost to Follow-up|2|||
162915631|NCT01161173|588391734|FG000|Overall Study|Protocol Violation|13|||
162915632|NCT01161173|588391734|FG000|Overall Study|Lost to Follow-up|7|||
162915633|NCT01161173|588391734|FG000|Overall Study|Progressive Disease|82|||
162915634|NCT01161173|588391734|FG000|Overall Study|Withdrawal of Consent|5|||
162915635|NCT01161173|588391734|FG000|Overall Study|Unacceptable Toxicity|21|||
162915636|NCT01161173|588391734|FG000|Overall Study|Death|194|||
162915637|NCT01161173|588391734|FG000|Overall Study|End of Study|2|||
162915638|NCT01161173|588391734|FG000|Overall Study|Reasons Not Specified|23|||
162915639|NCT01911546|588391735|FG000|Overall Study|Lost to Follow-up|1|||
162915640|NCT01911546|588391735|FG000|Overall Study|Everolimus was discontinued|5|||
162915641|NCT02213666|588391737|FG000|Overall Study|Withdrawal by Subject|1|||
162915642|NCT01319422|588391738|FG000|Overall Study|Withdrawal by Subject|1|||
162915643|NCT01319422|588391739|FG001|Overall Study|Withdrawal by Subject|0|||
162915644|NCT02918968|588391740|FG000|1st Line AAT|Progressive disease|9|||
162915645|NCT02918968|588391741|FG001|1st Line AAT|Progressive disease|4|||
162915646|NCT02918968|588391740|FG000|1st Line AAT|Adverse Event|12|||
162915647|NCT02918968|588391741|FG001|1st Line AAT|Adverse Event|3|||
162915648|NCT02918968|588391740|FG000|1st Line AAT|Physician Decision|4|||
162915649|NCT02918968|588391741|FG001|1st Line AAT|Physician Decision|2|||
162915650|NCT02918968|588391740|FG000|1st Line AAT|Withdrawal by Subject|2|||
162915651|NCT02918968|588391741|FG001|1st Line AAT|Withdrawal by Subject|1|||
162915652|NCT02918968|588391740|FG000|1st Line AAT|Lost to Follow-up|0|||
162915653|NCT02918968|588391741|FG001|1st Line AAT|Lost to Follow-up|1|||
162915654|NCT02918968|588391740|FG000|1st Line AAT|Death|1|||
162915655|NCT02918968|588391741|FG001|1st Line AAT|Death|0|||
162915656|NCT02918968|588391740|FG000|1st Line AAT|Miscellaneous|1|||
162915657|NCT02918968|588391741|FG001|1st Line AAT|Miscellaneous|0|||
162915658|NCT02918968|588391740|FG000|2nd Line AAT|Progressive disease|21|||
162915659|NCT02918968|588391741|FG001|2nd Line AAT|Progressive disease|3|||
162915660|NCT02918968|588391740|FG000|2nd Line AAT|Adverse Event|2|||
162915661|NCT02918968|588391741|FG001|2nd Line AAT|Adverse Event|5|||
162915662|NCT02918968|588391740|FG000|2nd Line AAT|Physician Decision|0|||
162915663|NCT02918968|588391741|FG001|2nd Line AAT|Physician Decision|1|||
162915664|NCT02918968|588391740|FG000|2nd Line AAT|Withdrawal by Subject|2|||
162915665|NCT02918968|588391741|FG001|2nd Line AAT|Withdrawal by Subject|2|||
162915666|NCT02918968|588391740|FG000|2nd Line AAT|Death|0|||
162915667|NCT02918968|588391741|FG001|2nd Line AAT|Death|1|||
162915668|NCT00750061|588391742|FG000|Overall Study|Adverse Event|2|||
162915669|NCT00750061|588391743|FG001|Overall Study|Adverse Event|0|||
162915670|NCT00750061|588391742|FG000|Overall Study|Withdrawal by Subject|0|||
162915671|NCT00750061|588391743|FG001|Overall Study|Withdrawal by Subject|1|||
162915672|NCT00750061|588391742|FG000|Overall Study|Physician Decision|0|||
162915673|NCT00750061|588391743|FG001|Overall Study|Physician Decision|1|||
162915674|NCT01243762|588391746|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
162915675|NCT01243762|588391747|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
162711003|NCT04319094|587652839|FG000|6-month|Incomplete data collection|14|||
162711004|NCT04319094|587652840|FG001|6-month|Incomplete data collection|9|||
162711005|NCT04319094|587652839|FG000|9-month|Lost to Follow-up|8|||
162711006|NCT04319094|587652840|FG001|9-month|Lost to Follow-up|4|||
162711007|NCT04319094|587652839|FG000|9-month|Withdrawal by Subject|0|||
162711008|NCT04319094|587652840|FG001|9-month|Withdrawal by Subject|1|||
162711009|NCT04319094|587652839|FG000|9-month|Incomplete data collection|8|||
162711010|NCT04319094|587652840|FG001|9-month|Incomplete data collection|5|||
162711011|NCT04319094|587652839|FG000|12-month|Lost to Follow-up|11|||
162711012|NCT04319094|587652840|FG001|12-month|Lost to Follow-up|8|||
162711013|NCT00654238|587652844|FG000|Overall Study|Screen Failures|4|||
162711014|NCT03905135|587652846|FG000|Dose Escalation|Adverse Event|1|||
162711015|NCT03905135|587652847|FG001|Dose Escalation|Adverse Event|1|||
162711016|NCT03905135|587652846|FG000|Dose Escalation|Progressive disease|3|||
162711017|NCT03905135|587652847|FG001|Dose Escalation|Progressive disease|1|||
162711018|NCT03905135|587652846|FG000|Dose Escalation|Intercurrent illness|1|||
162711019|NCT03905135|587652847|FG001|Dose Escalation|Intercurrent illness|0|||
162915676|NCT01243762|588391748|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
162915677|NCT01243762|588391749|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
162915678|NCT01243762|588391750|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
162915679|NCT01243762|588391751|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
162915680|NCT01243762|588391752|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
162915681|NCT01243762|588391746|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
162915682|NCT01243762|588391747|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
162915683|NCT01243762|588391748|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
162915684|NCT01243762|588391749|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
162915685|NCT01243762|588391750|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
162915686|NCT01243762|588391751|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
162915687|NCT01243762|588391752|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
162915688|NCT01243762|588391746|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
162915689|NCT01243762|588391747|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
162915690|NCT01243762|588391748|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
162915691|NCT01243762|588391749|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
162915692|NCT01243762|588391750|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
162915693|NCT01243762|588391751|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
162915694|NCT01243762|588391752|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
162915695|NCT01243762|588391746|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915696|NCT01243762|588391747|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
162915697|NCT01243762|588391748|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915698|NCT01243762|588391749|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915699|NCT01243762|588391750|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915700|NCT01243762|588391751|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915701|NCT01243762|588391752|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
162915702|NCT01243762|588391746|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
162915703|NCT01243762|588391747|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
162915704|NCT01243762|588391748|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
162915705|NCT01243762|588391749|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
162915706|NCT01243762|588391750|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
162915707|NCT01243762|588391751|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
162915708|NCT01243762|588391752|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
162915709|NCT01243762|588391746|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
162915710|NCT01243762|588391747|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
162915711|NCT01243762|588391748|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
162915712|NCT01243762|588391749|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
162915713|NCT01243762|588391750|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
162915714|NCT01243762|588391751|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
162915715|NCT01243762|588391752|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
162915716|NCT01243762|588391746|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
162915717|NCT01243762|588391747|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
162915718|NCT01243762|588391748|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
162915719|NCT01243762|588391749|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
162915720|NCT01243762|588391750|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
162915721|NCT01243762|588391751|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
162915722|NCT01243762|588391752|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
162915723|NCT01243762|588391746|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
162711020|NCT04523181|587652850|FG000|Overall Study|Withdrawal by Subject|4|||
162711021|NCT04523181|587652851|FG001|Overall Study|Withdrawal by Subject|5|||
162711022|NCT04523181|587652850|FG000|Overall Study|Lost to Follow-up|2|||
162711023|NCT04523181|587652851|FG001|Overall Study|Lost to Follow-up|3|||
162711024|NCT04523181|587652850|FG000|Overall Study|Physician Decision|1|||
162711025|NCT04523181|587652851|FG001|Overall Study|Physician Decision|0|||
162915724|NCT01243762|588391747|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
162915725|NCT01243762|588391748|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
162915726|NCT01243762|588391749|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
162915727|NCT01243762|588391750|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
162915728|NCT01243762|588391751|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
162915729|NCT01243762|588391752|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
162915730|NCT01374516|588391753|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
162915731|NCT01374516|588391754|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
162915732|NCT01374516|588391753|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
162915733|NCT01374516|588391754|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
162915734|NCT01374516|588391753|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
162915735|NCT01374516|588391754|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
162915736|NCT01374516|588391753|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
162915737|NCT01374516|588391754|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
162915738|NCT01374516|588391753|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
162915739|NCT01374516|588391754|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
162915740|NCT01374516|588391753|FG000|Surveillance Expansion Period|Protocol Violation|386|||
162915741|NCT01374516|588391754|FG001|Surveillance Expansion Period|Protocol Violation|217|||
162915742|NCT01374516|588391753|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
162915743|NCT01374516|588391754|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
162915744|NCT01374516|588391753|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
162915745|NCT01374516|588391754|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
162915746|NCT01374516|588391753|FG000|Surveillance Expansion Period|Serious adverse event|20|||
162915747|NCT01374516|588391754|FG001|Surveillance Expansion Period|Serious adverse event|5|||
162915748|NCT04629534|588391755|FG000|Overall Study|Physician Decision|1|||
162915749|NCT04629534|588391756|FG001|Overall Study|Physician Decision|0|||
162915750|NCT04629534|588391755|FG000|Overall Study|Protocol Violation|0|||
162915751|NCT04629534|588391756|FG001|Overall Study|Protocol Violation|2|||
162915752|NCT03732534|588391757|FG000|Overall Study|Study terminated by Sponsor|6|||
162915753|NCT02190604|588391758|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915754|NCT02190604|588391759|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915755|NCT02190604|588391760|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915756|NCT02190604|588391761|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915757|NCT02190604|588391762|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915758|NCT02190604|588391763|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915759|NCT02190604|588391764|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915760|NCT02190604|588391765|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915761|NCT02190604|588391766|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915762|NCT02190604|588391767|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915763|NCT02190604|588391768|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915764|NCT02190604|588391769|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915765|NCT02190604|588391770|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915766|NCT02190604|588391771|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915767|NCT02190604|588391772|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
162915768|NCT02190604|588391773|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915769|NCT02190604|588391774|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915770|NCT02190604|588391775|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915771|NCT02190604|588391776|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
162915772|NCT02190604|588391758|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915773|NCT02190604|588391759|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915774|NCT02190604|588391760|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915775|NCT02190604|588391761|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915776|NCT02190604|588391762|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915777|NCT02190604|588391763|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915778|NCT02190604|588391764|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915779|NCT02190604|588391765|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915780|NCT02190604|588391766|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915781|NCT02190604|588391767|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915782|NCT02190604|588391768|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915783|NCT02190604|588391769|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915784|NCT02190604|588391770|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915785|NCT02190604|588391771|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
162915786|NCT02190604|588391772|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915787|NCT02190604|588391773|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915788|NCT02190604|588391774|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915789|NCT02190604|588391775|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162915790|NCT02190604|588391776|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
162968525|NCT01257581|588586252|FG000|Overall Study|Death|2|||
162915791|NCT02797951|588391777|FG000|Overall Study|Adverse Event|4|||
162915792|NCT02797951|588391777|FG000|Overall Study|Death|1|||
162915793|NCT02797951|588391777|FG000|Overall Study|Lack of Efficacy|19|||
162915794|NCT02797951|588391777|FG000|Overall Study|Lost to Follow-up|4|||
162915795|NCT02797951|588391777|FG000|Overall Study|Physician Decision|6|||
162915796|NCT02797951|588391777|FG000|Overall Study|Withdrawal by Subject|15|||
162915797|NCT01901393|588391778|FG000|Overall Study|Adverse Event|1|||
162915798|NCT01901393|588391779|FG001|Overall Study|Adverse Event|0|||
162915799|NCT04585906|588391780|FG000|Overall Study|Lost to Follow-up|8|||
162915800|NCT04585906|588391781|FG001|Overall Study|Lost to Follow-up|5|||
162915801|NCT03125382|588391782|FG000|Randomization|screening failure|1|||
162915802|NCT03125382|588391783|FG001|Randomization|screening failure|4|||
162915803|NCT03125382|588391784|FG002|Randomization|screening failure|2|||
162915804|NCT03125382|588391785|FG003|Randomization|screening failure|0|||
162915805|NCT03125382|588391782|FG000|Follow-up|Death|1|||
162915806|NCT03125382|588391783|FG001|Follow-up|Death|2|||
162915807|NCT03125382|588391784|FG002|Follow-up|Death|1|||
162915808|NCT03125382|588391785|FG003|Follow-up|Death|2|||
162915809|NCT03125382|588391782|FG000|Follow-up|Lost to Follow-up|1|||
162915810|NCT03125382|588391783|FG001|Follow-up|Lost to Follow-up|4|||
162915811|NCT03125382|588391784|FG002|Follow-up|Lost to Follow-up|3|||
162915812|NCT03125382|588391785|FG003|Follow-up|Lost to Follow-up|1|||
162915813|NCT04626947|588391786|FG000|Overall Study|Study terminated|14|||
162915814|NCT01428882|588391797|FG000|Overall Study|Lack of Efficacy|2|||
162915815|NCT01428882|588391798|FG001|Overall Study|Lack of Efficacy|7|||
162915816|NCT01428882|588391797|FG000|Overall Study|Protocol Violation|4|||
162915817|NCT01428882|588391798|FG001|Overall Study|Protocol Violation|3|||
162915818|NCT03907072|588391803|FG000|Overall Study|Study Terminated by Sponsor|2|||
163054434|NCT00720499|588910300|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163054435|NCT00720499|588910299|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
163054436|NCT00720499|588910300|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
163054437|NCT00720499|588910299|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
163054438|NCT00720499|588910300|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
163054439|NCT02247466|588910301|FG000|Overall Study|Procedure changed to open surgery|0|||
163054440|NCT02247466|588910302|FG001|Overall Study|Procedure changed to open surgery|3|||
163054441|NCT00492726|588910303|FG000|Overall Study|Adverse Event|10|||
163054442|NCT00492726|588910304|FG001|Overall Study|Adverse Event|6|||
163054443|NCT00492726|588910303|FG000|Overall Study|Death|7|||
163054444|NCT00492726|588910304|FG001|Overall Study|Death|2|||
163054445|NCT00492726|588910303|FG000|Overall Study|Lack of Efficacy|0|||
163054446|NCT00492726|588910304|FG001|Overall Study|Lack of Efficacy|2|||
163054447|NCT00492726|588910303|FG000|Overall Study|Lost to Follow-up|27|||
163054448|NCT00492726|588910304|FG001|Overall Study|Lost to Follow-up|19|||
163054449|NCT00492726|588910303|FG000|Overall Study|Physician Decision|0|||
163054450|NCT00492726|588910304|FG001|Overall Study|Physician Decision|1|||
163054451|NCT00492726|588910303|FG000|Overall Study|Withdrawal by Subject|6|||
163054452|NCT00492726|588910304|FG001|Overall Study|Withdrawal by Subject|3|||
163054453|NCT00492726|588910303|FG000|Overall Study|Non compliant with study medication|0|||
163054454|NCT00492726|588910304|FG001|Overall Study|Non compliant with study medication|3|||
163054455|NCT01100502|588910305|FG000|Overall Study|Withdrawal by Subject|18|||
163054456|NCT01100502|588910306|FG001|Overall Study|Withdrawal by Subject|25|||
163054457|NCT01100502|588910305|FG000|Overall Study|Lost to Follow-up|13|||
163054458|NCT01100502|588910306|FG001|Overall Study|Lost to Follow-up|28|||
163054459|NCT01100502|588910305|FG000|Overall Study|Site request to end participation in study|0|||
163054460|NCT01100502|588910306|FG001|Overall Study|Site request to end participation in study|1|||
163054461|NCT01100502|588910305|FG000|Overall Study|Death|45|||
163054462|NCT01100502|588910306|FG001|Overall Study|Death|40|||
163054463|NCT04386902|588910307|FG000|Overall Study|Withdrawal by Subject|5|||
163054464|NCT04386902|588910307|FG000|Overall Study|Technical problems in the recording|5|||
163054465|NCT00073918|588910318|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
163054466|NCT00073918|588910318|FG000|Overall Study|Rapid disease progression|2|||
163054467|NCT00073918|588910318|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
163054468|NCT04356937|588910320|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
163054469|NCT04356937|588910321|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
163054470|NCT00807365|588910322|FG000|Overall Study|Study Terminated|5|||
163054471|NCT04821830|588910325|FG000|Overall Study|Withdrawal by Subject|1|||
163054472|NCT04821830|588910326|FG001|Overall Study|Withdrawal by Subject|0|||
163054473|NCT02557399|588910327|FG000|Overall Study|Adverse Event|6|||
163054474|NCT02557399|588910328|FG001|Overall Study|Adverse Event|5|||
163054475|NCT02557399|588910327|FG000|Overall Study|Protocol Violation|0|||
163054476|NCT02557399|588910328|FG001|Overall Study|Protocol Violation|1|||
163054477|NCT02557399|588910327|FG000|Overall Study|Protocol-defined stopping criteria|0|||
163054478|NCT02557399|588910328|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162915819|NCT03907072|588391804|FG001|Overall Study|Study Terminated by Sponsor|2|||
162915820|NCT03907072|588391805|FG002|Overall Study|Study Terminated by Sponsor|2|||
162915821|NCT00612456|588391806|FG000|Overall Study|Adverse Event|1|||
162915822|NCT00612456|588391807|FG001|Overall Study|Adverse Event|0|||
162915823|NCT00612456|588391808|FG002|Overall Study|Adverse Event|0|||
162915824|NCT00612456|588391806|FG000|Overall Study|Lack of Efficacy|1|||
162915825|NCT00612456|588391807|FG001|Overall Study|Lack of Efficacy|1|||
162915826|NCT00612456|588391808|FG002|Overall Study|Lack of Efficacy|0|||
162915827|NCT00612456|588391806|FG000|Overall Study|Withdrawal by Subject|0|||
162915828|NCT00612456|588391807|FG001|Overall Study|Withdrawal by Subject|1|||
162915829|NCT00612456|588391808|FG002|Overall Study|Withdrawal by Subject|0|||
162915830|NCT00265109|588391809|FG000|Overall Study|Withdrawal by Subject|5|||
162915831|NCT00265109|588391809|FG000|Overall Study|Adverse Event|1|||
162915832|NCT02463097|588391810|FG000|Overall Study|Withdrawal by Subject|1|||
162915833|NCT00808665|588391811|FG000|Overall Study|Withdrawal by Subject|1|||
162915834|NCT00808665|588391812|FG001|Overall Study|Withdrawal by Subject|0|||
162915835|NCT00808665|588391811|FG000|Overall Study|only required minimally invasive surgery|1|||
162915836|NCT00808665|588391812|FG001|Overall Study|only required minimally invasive surgery|0|||
162915837|NCT00808665|588391811|FG000|Overall Study|surgery cancelled|1|||
162915838|NCT00808665|588391812|FG001|Overall Study|surgery cancelled|0|||
162915839|NCT00808665|588391811|FG000|Overall Study|required an additional procedure|0|||
162915840|NCT00808665|588391812|FG001|Overall Study|required an additional procedure|1|||
162915841|NCT00808665|588391811|FG000|Overall Study|Physician Decision|3|||
162915842|NCT00808665|588391812|FG001|Overall Study|Physician Decision|1|||
162915843|NCT00808665|588391811|FG000|Overall Study|Medication stopped by resident|0|||
162915844|NCT00808665|588391812|FG001|Overall Study|Medication stopped by resident|1|||
162915845|NCT03831282|588391813|FG000|Overall Study|Could not place sensor|1|||
162915846|NCT03556202|588391817|FG000|Extension Treatment Period|Adverse Event|18|||
162915847|NCT03556202|588391818|FG001|Extension Treatment Period|Adverse Event|14|||
162915848|NCT03556202|588391819|FG002|Extension Treatment Period|Adverse Event|9|||
162915849|NCT03556202|588391817|FG000|Extension Treatment Period|Death|2|||
162915850|NCT03556202|588391818|FG001|Extension Treatment Period|Death|6|||
162915851|NCT03556202|588391819|FG002|Extension Treatment Period|Death|0|||
162915852|NCT03556202|588391817|FG000|Extension Treatment Period|Lack of Efficacy|5|||
162915853|NCT03556202|588391818|FG001|Extension Treatment Period|Lack of Efficacy|12|||
162915854|NCT03556202|588391819|FG002|Extension Treatment Period|Lack of Efficacy|18|||
162915855|NCT03556202|588391817|FG000|Extension Treatment Period|Lost to Follow-up|9|||
162915856|NCT03556202|588391818|FG001|Extension Treatment Period|Lost to Follow-up|20|||
162915857|NCT03556202|588391819|FG002|Extension Treatment Period|Lost to Follow-up|2|||
162915858|NCT03556202|588391817|FG000|Extension Treatment Period|Pregnancy|2|||
162915859|NCT03556202|588391818|FG001|Extension Treatment Period|Pregnancy|4|||
162915860|NCT03556202|588391819|FG002|Extension Treatment Period|Pregnancy|3|||
162915861|NCT03556202|588391817|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
162915862|NCT03556202|588391818|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
162915863|NCT03556202|588391819|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
162915864|NCT03556202|588391817|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
162915865|NCT03556202|588391818|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
162915866|NCT03556202|588391819|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
162915867|NCT03556202|588391817|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
162915868|NCT03556202|588391818|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
162915869|NCT03556202|588391819|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
162915870|NCT03556202|588391817|FG000|Extension Treatment Period|Physician Decision|0|||
162915871|NCT03556202|588391818|FG001|Extension Treatment Period|Physician Decision|8|||
162915872|NCT03556202|588391819|FG002|Extension Treatment Period|Physician Decision|2|||
162915873|NCT03556202|588391817|FG000|Extension Treatment Period|Protocol Violation|0|||
162915874|NCT03556202|588391818|FG001|Extension Treatment Period|Protocol Violation|1|||
162915875|NCT03556202|588391819|FG002|Extension Treatment Period|Protocol Violation|1|||
162915876|NCT03556202|588391817|FG000|Extension Treatment Period|Sponsor Decision|0|||
162915877|NCT03556202|588391818|FG001|Extension Treatment Period|Sponsor Decision|1|||
162915878|NCT03556202|588391819|FG002|Extension Treatment Period|Sponsor Decision|0|||
162915879|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
162915880|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
162915881|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
162915882|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Death|1|||
162915883|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Death|0|||
162915884|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Death|0|||
162915885|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
162915886|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
162968526|NCT01257581|588586253|FG001|Overall Study|Death|2|||
162968527|NCT01257581|588586254|FG002|Overall Study|Death|4|||
162968528|NCT01157234|588586255|FG000|Overall Study|Withdrawal by Subject|1|||
162968529|NCT01157234|588586256|FG001|Overall Study|Withdrawal by Subject|0|||
162968530|NCT05996198|588586269|FG000|Overall Study|Withdrawal by Subject|1|||
162968531|NCT05996198|588586270|FG001|Overall Study|Withdrawal by Subject|0|||
162968532|NCT00059332|588586274|FG000|Overall Study|Withdrawal by Subject|2|||
162968533|NCT00059332|588586275|FG001|Overall Study|Withdrawal by Subject|1|||
162968534|NCT00059332|588586274|FG000|Overall Study|Lost to Follow-up|1|||
163054479|NCT02557399|588910327|FG000|Overall Study|Withdrawal by Subject|1|||
163054480|NCT02557399|588910328|FG001|Overall Study|Withdrawal by Subject|1|||
163054481|NCT00960804|588910329|FG000|Overall Study|Adverse Event|1|||
163054482|NCT00960804|588910330|FG001|Overall Study|Adverse Event|0|||
163054483|NCT00960804|588910331|FG002|Overall Study|Adverse Event|0|||
163054484|NCT00960804|588910329|FG000|Overall Study|Withdrawal by Subject|1|||
163054485|NCT00960804|588910330|FG001|Overall Study|Withdrawal by Subject|0|||
163054486|NCT00960804|588910331|FG002|Overall Study|Withdrawal by Subject|0|||
163054487|NCT00960804|588910329|FG000|Overall Study|Study terminated by the sponsor|5|||
163054488|NCT00960804|588910330|FG001|Overall Study|Study terminated by the sponsor|4|||
163054489|NCT00960804|588910331|FG002|Overall Study|Study terminated by the sponsor|10|||
163054490|NCT02007720|588910332|FG000|Overall Study|Withdrawal by Subject|9|||
163054491|NCT02007720|588910333|FG001|Overall Study|Withdrawal by Subject|11|||
163054492|NCT02007720|588910332|FG000|Overall Study|study terminated by sponsor|58|||
163054493|NCT02007720|588910333|FG001|Overall Study|study terminated by sponsor|54|||
163054494|NCT02007720|588910332|FG000|Overall Study|technical problem|4|||
163054495|NCT02007720|588910333|FG001|Overall Study|technical problem|2|||
163054496|NCT02007720|588910332|FG000|Overall Study|patient followd less than 165 days|11|||
163054497|NCT02007720|588910333|FG001|Overall Study|patient followd less than 165 days|5|||
163054498|NCT00490919|588910335|FG000|Open-label Run-in Period|Adverse Event|239|||
163054499|NCT00490919|588910336|FG001|Open-label Run-in Period|Adverse Event|0|||
163054500|NCT00490919|588910337|FG002|Open-label Run-in Period|Adverse Event|0|||
163054501|NCT00490919|588910335|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
163054502|NCT00490919|588910336|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
163054503|NCT00490919|588910337|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
163054504|NCT00490919|588910335|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
163054505|NCT00490919|588910336|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
163054506|NCT00490919|588910337|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
163054507|NCT00490919|588910335|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
163054508|NCT00490919|588910336|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
163054509|NCT00490919|588910337|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
163054510|NCT00490919|588910335|FG000|Open-label Run-in Period|Administrative|40|||
163054511|NCT00490919|588910336|FG001|Open-label Run-in Period|Administrative|0|||
163054512|NCT00490919|588910337|FG002|Open-label Run-in Period|Administrative|0|||
163054513|NCT00490919|588910335|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
163054514|NCT00490919|588910336|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
163054515|NCT00490919|588910337|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
163054516|NCT00490919|588910335|FG000|Double-blind Phase|Adverse Event|0|||
163054517|NCT00490919|588910336|FG001|Double-blind Phase|Adverse Event|40|||
163054518|NCT00490919|588910337|FG002|Double-blind Phase|Adverse Event|20|||
163054519|NCT00490919|588910335|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163054520|NCT00490919|588910336|FG001|Double-blind Phase|Withdrawal by Subject|10|||
163054521|NCT00490919|588910337|FG002|Double-blind Phase|Withdrawal by Subject|11|||
163054522|NCT00490919|588910335|FG000|Double-blind Phase|Lost to Follow-up|0|||
163054523|NCT00490919|588910336|FG001|Double-blind Phase|Lost to Follow-up|8|||
163054524|NCT00490919|588910337|FG002|Double-blind Phase|Lost to Follow-up|11|||
162915887|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
162915888|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
162915889|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
162915890|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
162915891|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
162915892|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
162915893|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
162915894|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
162915895|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
162915896|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
163054525|NCT00490919|588910335|FG000|Double-blind Phase|Lack of Efficacy|0|||
163054526|NCT00490919|588910336|FG001|Double-blind Phase|Lack of Efficacy|22|||
163054527|NCT00490919|588910337|FG002|Double-blind Phase|Lack of Efficacy|36|||
163054528|NCT00490919|588910335|FG000|Double-blind Phase|Administrative|0|||
163054529|NCT00490919|588910336|FG001|Double-blind Phase|Administrative|6|||
163054530|NCT00490919|588910337|FG002|Double-blind Phase|Administrative|6|||
163054531|NCT02100124|588910340|FG000|Overall Study|Lost to Follow-up|5|||
163054532|NCT02100124|588910341|FG001|Overall Study|Lost to Follow-up|11|||
163054533|NCT02100124|588910342|FG002|Overall Study|Lost to Follow-up|3|||
163054534|NCT02100124|588910340|FG000|Overall Study|Withdrawal by Subject|1|||
163054535|NCT02100124|588910341|FG001|Overall Study|Withdrawal by Subject|0|||
163054536|NCT02100124|588910342|FG002|Overall Study|Withdrawal by Subject|0|||
163054537|NCT04350827|588910343|FG000|Overall Study|Lost to Follow-up|1|||
163054538|NCT04350827|588910344|FG001|Overall Study|Lost to Follow-up|2|||
163054539|NCT07116759|588910345|FG000|Overall Study|Incompatibility with the RHMC device|2|||
163054540|NCT02034006|588911684|FG000|Overall Study|Withdrawal by Subject|7|||
163054541|NCT02034006|588911684|FG000|Overall Study|Lost to Follow-up|5|||
163054542|NCT02034006|588911684|FG000|Overall Study|Death|1|||
163054543|NCT02034006|588911684|FG000|Overall Study|Pregnancy|1|||
162915897|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
162915898|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
162915899|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
162915900|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
162915901|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
162915902|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
162915903|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
162915904|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
162915905|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
162915906|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
162915907|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
162915908|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
162968535|NCT00059332|588586275|FG001|Overall Study|Lost to Follow-up|1|||
162968536|NCT00487695|588586278|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
162968537|NCT00487695|588586279|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
162968538|NCT00487695|588586278|FG000|First Procedure|active wheezing (did not have procedure)|1|||
162968539|NCT00487695|588586279|FG001|First Procedure|active wheezing (did not have procedure)|0|||
162968540|NCT00487695|588586278|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
162968541|NCT00487695|588586279|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
162968542|NCT00487695|588586278|FG000|Second Procedure|active wheezing|0|||
162968543|NCT00487695|588586279|FG001|Second Procedure|active wheezing|1|||
162968544|NCT00487695|588586278|FG000|Second Procedure|Withdrawal by Subject|1|||
162968545|NCT00487695|588586279|FG001|Second Procedure|Withdrawal by Subject|2|||
162968546|NCT01358877|588586280|FG000|Overall Study|Withdrawal by Subject|475|||
162968547|NCT01358877|588586281|FG001|Overall Study|Withdrawal by Subject|466|||
162968548|NCT01358877|588586280|FG000|Overall Study|Recurrence of disease|181|||
162968549|NCT01358877|588586281|FG001|Overall Study|Recurrence of disease|269|||
162968550|NCT01358877|588586280|FG000|Overall Study|Lost to Follow-up|181|||
162968551|NCT01358877|588586281|FG001|Overall Study|Lost to Follow-up|176|||
162968552|NCT01358877|588586280|FG000|Overall Study|Death|41|||
162968553|NCT01358877|588586281|FG001|Overall Study|Death|46|||
162968554|NCT01358877|588586280|FG000|Overall Study|Adverse Event|39|||
162968555|NCT01358877|588586281|FG001|Overall Study|Adverse Event|42|||
162968556|NCT01358877|588586280|FG000|Overall Study|Physician Decision|43|||
162968557|NCT01358877|588586281|FG001|Overall Study|Physician Decision|32|||
162968558|NCT01358877|588586280|FG000|Overall Study|Contralateral breast cancer|42|||
162968559|NCT01358877|588586281|FG001|Overall Study|Contralateral breast cancer|28|||
162968560|NCT01358877|588586280|FG000|Overall Study|Reason not specified|37|||
162968561|NCT01358877|588586281|FG001|Overall Study|Reason not specified|29|||
162968562|NCT01698554|588586287|FG000|Overall Study|Adverse Event|2|||
162968563|NCT01698554|588586288|FG001|Overall Study|Adverse Event|5|||
162968564|NCT01698554|588586289|FG002|Overall Study|Adverse Event|0|||
162968565|NCT01698554|588586290|FG003|Overall Study|Adverse Event|1|||
162968566|NCT01698554|588586287|FG000|Overall Study|Lost to Follow-up|1|||
162968567|NCT01698554|588586288|FG001|Overall Study|Lost to Follow-up|0|||
162968568|NCT01698554|588586289|FG002|Overall Study|Lost to Follow-up|0|||
162968569|NCT01698554|588586290|FG003|Overall Study|Lost to Follow-up|0|||
162968570|NCT01698554|588586287|FG000|Overall Study|Personal Reasons|0|||
162968571|NCT01698554|588586288|FG001|Overall Study|Personal Reasons|5|||
162968572|NCT01698554|588586289|FG002|Overall Study|Personal Reasons|1|||
162968573|NCT01698554|588586290|FG003|Overall Study|Personal Reasons|1|||
162968574|NCT01698554|588586287|FG000|Overall Study|Protocol Violation|2|||
162968575|NCT01698554|588586288|FG001|Overall Study|Protocol Violation|0|||
162968576|NCT01698554|588586289|FG002|Overall Study|Protocol Violation|1|||
162968577|NCT01698554|588586290|FG003|Overall Study|Protocol Violation|0|||
162968578|NCT01698554|588586287|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162968579|NCT01698554|588586288|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162968580|NCT01698554|588586289|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162968581|NCT01698554|588586290|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162968582|NCT00751023|588586293|FG000|Overall Study|Lost to Follow-up|11|||
162968583|NCT00751023|588586294|FG001|Overall Study|Lost to Follow-up|7|||
162968584|NCT01547728|588586298|FG000|Overall Study|Change in procedure and equipment|1|||
162968585|NCT01547728|588586298|FG000|Overall Study|Drug not ready for subject|1|||
162915909|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
162915910|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
162968586|NCT01547728|588586298|FG000|Overall Study|Screen failure|39|||
162968587|NCT00766493|588586299|FG000|30 Days Post-Procedure|Discontinued|7|||
162968588|NCT00766493|588586299|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
162968589|NCT00766493|588586299|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
162968590|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
162968591|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
162968592|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
162968593|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
163054544|NCT00750269|588911697|FG000|Overall Study|Protocol Violation|0|||
163054545|NCT00750269|588911698|FG001|Overall Study|Protocol Violation|1|||
163054546|NCT00750269|588911699|FG002|Overall Study|Protocol Violation|1|||
163054547|NCT00750269|588911700|FG003|Overall Study|Protocol Violation|2|||
163054548|NCT00750269|588911701|FG004|Overall Study|Protocol Violation|4|||
163054549|NCT00750269|588911697|FG000|Overall Study|Withdrawal by Subject|0|||
163054550|NCT00750269|588911698|FG001|Overall Study|Withdrawal by Subject|0|||
163054551|NCT00750269|588911699|FG002|Overall Study|Withdrawal by Subject|2|||
163054552|NCT00750269|588911700|FG003|Overall Study|Withdrawal by Subject|2|||
163054553|NCT00750269|588911701|FG004|Overall Study|Withdrawal by Subject|2|||
163054554|NCT00750269|588911697|FG000|Overall Study|Physician Decision|0|||
163054555|NCT00750269|588911698|FG001|Overall Study|Physician Decision|0|||
163054556|NCT00750269|588911699|FG002|Overall Study|Physician Decision|0|||
163054557|NCT00750269|588911700|FG003|Overall Study|Physician Decision|0|||
163054558|NCT00750269|588911701|FG004|Overall Study|Physician Decision|2|||
163054559|NCT00750269|588911697|FG000|Overall Study|Patient too large for positioning|0|||
163054560|NCT00750269|588911698|FG001|Overall Study|Patient too large for positioning|0|||
163054561|NCT00750269|588911699|FG002|Overall Study|Patient too large for positioning|1|||
163054562|NCT00750269|588911700|FG003|Overall Study|Patient too large for positioning|0|||
163054563|NCT00750269|588911701|FG004|Overall Study|Patient too large for positioning|0|||
163054564|NCT00750269|588911697|FG000|Overall Study|Site error|0|||
163054565|NCT00750269|588911698|FG001|Overall Study|Site error|0|||
163054566|NCT00750269|588911699|FG002|Overall Study|Site error|0|||
163054567|NCT00750269|588911700|FG003|Overall Study|Site error|1|||
163054568|NCT00750269|588911701|FG004|Overall Study|Site error|0|||
163054569|NCT00750269|588911697|FG000|Overall Study|SBRT plan could not be drawn|0|||
163054570|NCT00750269|588911698|FG001|Overall Study|SBRT plan could not be drawn|0|||
163054571|NCT00750269|588911699|FG002|Overall Study|SBRT plan could not be drawn|0|||
163054572|NCT00750269|588911700|FG003|Overall Study|SBRT plan could not be drawn|0|||
163054573|NCT00750269|588911701|FG004|Overall Study|SBRT plan could not be drawn|1|||
163054574|NCT00750269|588911697|FG000|Overall Study|Fiducials could not be placed|0|||
163054575|NCT00750269|588911698|FG001|Overall Study|Fiducials could not be placed|0|||
163054576|NCT00750269|588911699|FG002|Overall Study|Fiducials could not be placed|0|||
163054577|NCT00750269|588911700|FG003|Overall Study|Fiducials could not be placed|0|||
163054578|NCT00750269|588911701|FG004|Overall Study|Fiducials could not be placed|1|||
163054579|NCT01898078|588911702|FG000|Overall Study|Progressive Disease|1|||
163054580|NCT01898078|588911703|FG001|Overall Study|Progressive Disease|5|||
163054581|NCT01898078|588911702|FG000|Overall Study|Adverse Event|2|||
163054582|NCT01898078|588911703|FG001|Overall Study|Adverse Event|1|||
163054583|NCT01898078|588911702|FG000|Overall Study|Withdrawal by Subject|1|||
163054584|NCT01898078|588911703|FG001|Overall Study|Withdrawal by Subject|1|||
163054585|NCT01898078|588911702|FG000|Overall Study|Symptomatic Deterioration|2|||
163054586|NCT01898078|588911703|FG001|Overall Study|Symptomatic Deterioration|0|||
163054587|NCT01898078|588911702|FG000|Overall Study|Reason not Specified|0|||
163054588|NCT01898078|588911703|FG001|Overall Study|Reason not Specified|1|||
163054589|NCT00161213|588911710|FG000|Overall Study|Withdrawal by Subject|1|||
163054590|NCT00161213|588911710|FG000|Overall Study|Evaluable for toxicity but not response|1|||
163054591|NCT03630393|588911711|FG000|Overall Study|Death|1|||
163054592|NCT03630393|588911712|FG001|Overall Study|Death|0|||
163054593|NCT02351934|588911713|FG000|Allocation|POD weight<pre-op weight|3|||
163054594|NCT02351934|588911714|FG001|Allocation|POD weight<pre-op weight|0|||
163054595|NCT02351934|588911713|FG000|Allocation|Hypotension preventing administration|2|||
163054596|NCT02351934|588911714|FG001|Allocation|Hypotension preventing administration|0|||
163054597|NCT02351934|588911713|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
163054598|NCT02351934|588911714|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
163054599|NCT02351934|588911713|FG000|Follow-Up|POD weight<pre-op weight|3|||
163054600|NCT02351934|588911714|FG001|Follow-Up|POD weight<pre-op weight|0|||
163054601|NCT02351934|588911713|FG000|Follow-Up|Acute Kidney Injury|1|||
163054602|NCT02351934|588911714|FG001|Follow-Up|Acute Kidney Injury|0|||
163054603|NCT02351934|588911713|FG000|Follow-Up|Early dismissal|3|||
163054604|NCT02351934|588911714|FG001|Follow-Up|Early dismissal|0|||
163054605|NCT02351934|588911713|FG000|Follow-Up|Hypotension|3|||
163054606|NCT02351934|588911714|FG001|Follow-Up|Hypotension|0|||
163054607|NCT02351934|588911713|FG000|Follow-Up|No documentation|2|||
163054608|NCT02351934|588911714|FG001|Follow-Up|No documentation|0|||
163054609|NCT02351934|588911713|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
163054610|NCT02351934|588911714|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
163054611|NCT02351934|588911713|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
163054612|NCT02351934|588911714|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
163054613|NCT04635839|588911715|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
163054614|NCT04635839|588911716|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
163054615|NCT02870868|588911717|FG000|Overall Study|Withdrawal by Subject|2|||
163054616|NCT02870868|588911718|FG001|Overall Study|Withdrawal by Subject|1|||
163054617|NCT00288912|588911720|FG000|Overall Study|Developed exclusion criterion|4|||
162968594|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
162968595|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
162968596|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
162968597|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
162968598|NCT03448692|588586304|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
162968599|NCT03448692|588586305|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
162915911|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
162915912|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
162915913|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
162915914|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
162915915|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
162915916|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
162915917|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
162915918|NCT03556202|588391817|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
162915919|NCT03556202|588391818|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
162915920|NCT03556202|588391819|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
162915921|NCT00697255|588391822|FG000|Stage 1a|Insufficient ovarian response|1|||
162915922|NCT00697255|588391823|FG001|Stage 1a|Insufficient ovarian response|0|||
162915923|NCT00697255|588391822|FG000|Stage 1a|Multifollicular growth|1|||
162915924|NCT00697255|588391823|FG001|Stage 1a|Multifollicular growth|0|||
162915925|NCT00697255|588391822|FG000|Stage 1a|Not growing of dominant follicle|1|||
162915926|NCT00697255|588391823|FG001|Stage 1a|Not growing of dominant follicle|0|||
162915927|NCT00697255|588391822|FG000|Stage 1b|Not growing of dominant follicle|0|||
162915928|NCT00697255|588391823|FG001|Stage 1b|Not growing of dominant follicle|1|||
162915929|NCT00697255|588391822|FG000|Stage 1b|Insufficient ovarian response|0|||
162915930|NCT00697255|588391823|FG001|Stage 1b|Insufficient ovarian response|1|||
162915931|NCT05664672|588391824|FG000|Overall Study|Adverse Event|0|||
162915932|NCT05664672|588391825|FG001|Overall Study|Adverse Event|0|||
162915933|NCT05664672|588391826|FG002|Overall Study|Adverse Event|0|||
162915934|NCT05664672|588391827|FG003|Overall Study|Adverse Event|0|||
162915935|NCT05664672|588391828|FG004|Overall Study|Adverse Event|0|||
162915936|NCT05664672|588391829|FG005|Overall Study|Adverse Event|1|||
162915937|NCT05664672|588391824|FG000|Overall Study|Withdrawal by Subject|0|||
162915938|NCT05664672|588391825|FG001|Overall Study|Withdrawal by Subject|1|||
162915939|NCT05664672|588391826|FG002|Overall Study|Withdrawal by Subject|3|||
162915940|NCT05664672|588391827|FG003|Overall Study|Withdrawal by Subject|0|||
162915941|NCT05664672|588391828|FG004|Overall Study|Withdrawal by Subject|5|||
162915942|NCT05664672|588391829|FG005|Overall Study|Withdrawal by Subject|6|||
162915943|NCT05664672|588391824|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
162915944|NCT05664672|588391825|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162915945|NCT05664672|588391826|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
162915946|NCT05664672|588391827|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
162915947|NCT05664672|588391828|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
162915948|NCT05664672|588391829|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
162915949|NCT05664672|588391824|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
162915950|NCT05664672|588391825|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
162915951|NCT05664672|588391826|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
162915952|NCT05664672|588391827|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
162915953|NCT05664672|588391828|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
162915954|NCT05664672|588391829|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
162915955|NCT02815670|588391832|FG000|Overall Study|Prematurely discontinued of the trial|1|||
162915956|NCT01815099|588391835|FG000|Overall Study|Lack of Efficacy|1|||
162915957|NCT01815099|588391835|FG000|Overall Study|unable to attend study visits|1|||
162915958|NCT01475214|588391836|FG000|Overall Study|Lost to Follow-up|1|||
162915959|NCT01475214|588391837|FG001|Overall Study|Lost to Follow-up|0|||
162915960|NCT01475214|588391838|FG002|Overall Study|Lost to Follow-up|1|||
162915961|NCT01475214|588391836|FG000|Overall Study|Physician Decision|2|||
162915962|NCT01475214|588391837|FG001|Overall Study|Physician Decision|0|||
162915963|NCT01475214|588391838|FG002|Overall Study|Physician Decision|0|||
162915964|NCT01475214|588391836|FG000|Overall Study|Withdrawal by Subject|2|||
162915965|NCT01475214|588391837|FG001|Overall Study|Withdrawal by Subject|4|||
162915966|NCT01475214|588391838|FG002|Overall Study|Withdrawal by Subject|1|||
162711026|NCT04523181|587652850|FG000|Overall Study|Transferred to external facility.|1|||
162915967|NCT00643851|588391839|FG000|Overall Study|Death|0|||
162915968|NCT00643851|588391840|FG001|Overall Study|Death|1|||
162915969|NCT00643851|588391841|FG002|Overall Study|Death|0|||
162915970|NCT00643851|588391839|FG000|Overall Study|Lack of Efficacy|0|||
162915971|NCT00643851|588391840|FG001|Overall Study|Lack of Efficacy|1|||
162968600|NCT02786927|588586308|FG000|Overall Study|Adverse Event|1|||
162968601|NCT02786927|588586308|FG000|Overall Study|Protocol Violation|4|||
162915972|NCT00643851|588391841|FG002|Overall Study|Lack of Efficacy|0|||
162915973|NCT00643851|588391839|FG000|Overall Study|Adverse Event|2|||
162915974|NCT00643851|588391840|FG001|Overall Study|Adverse Event|6|||
162915975|NCT00643851|588391841|FG002|Overall Study|Adverse Event|6|||
162915976|NCT00643851|588391839|FG000|Overall Study|Lost to Follow-up|4|||
162915977|NCT00643851|588391840|FG001|Overall Study|Lost to Follow-up|6|||
162915978|NCT00643851|588391841|FG002|Overall Study|Lost to Follow-up|9|||
162915979|NCT00643851|588391839|FG000|Overall Study|Withdrawal by Subject|8|||
162915980|NCT00643851|588391840|FG001|Overall Study|Withdrawal by Subject|15|||
162915981|NCT00643851|588391841|FG002|Overall Study|Withdrawal by Subject|9|||
162915982|NCT00643851|588391839|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
162915983|NCT00643851|588391840|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
162915984|NCT00643851|588391841|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
162915985|NCT01977573|588391842|FG000|Overall Study|Adverse Event|7|||
162915986|NCT01977573|588391843|FG001|Overall Study|Adverse Event|0|||
162915987|NCT01977573|588391844|FG002|Overall Study|Adverse Event|2|||
162915988|NCT01977573|588391845|FG003|Overall Study|Adverse Event|1|||
162915989|NCT01977573|588391842|FG000|Overall Study|Lost to Follow-up|1|||
162915990|NCT01977573|588391843|FG001|Overall Study|Lost to Follow-up|0|||
162915991|NCT01977573|588391844|FG002|Overall Study|Lost to Follow-up|0|||
162915992|NCT01977573|588391845|FG003|Overall Study|Lost to Follow-up|1|||
162915993|NCT01977573|588391842|FG000|Overall Study|Physician Decision|1|||
162915994|NCT01977573|588391843|FG001|Overall Study|Physician Decision|0|||
162915995|NCT01977573|588391844|FG002|Overall Study|Physician Decision|0|||
162915996|NCT01977573|588391845|FG003|Overall Study|Physician Decision|0|||
162915997|NCT01977573|588391842|FG000|Overall Study|Protocol Violation|3|||
162915998|NCT01977573|588391843|FG001|Overall Study|Protocol Violation|1|||
162711027|NCT04523181|587652851|FG001|Overall Study|Transferred to external facility.|1|||
162915999|NCT01977573|588391844|FG002|Overall Study|Protocol Violation|0|||
162916000|NCT01977573|588391845|FG003|Overall Study|Protocol Violation|0|||
162916001|NCT01977573|588391842|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
162916002|NCT01977573|588391843|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
162916003|NCT01977573|588391844|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
162916004|NCT01977573|588391845|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
162916005|NCT01977573|588391842|FG000|Overall Study|Withdrawal by Subject|6|||
162916006|NCT01977573|588391843|FG001|Overall Study|Withdrawal by Subject|1|||
162916007|NCT01977573|588391844|FG002|Overall Study|Withdrawal by Subject|1|||
162916008|NCT01977573|588391845|FG003|Overall Study|Withdrawal by Subject|1|||
162916009|NCT03996694|588393661|FG000|First Washout (7 Days)|positive urine drug screen|0|||
162916010|NCT03996694|588393662|FG001|First Washout (7 Days)|positive urine drug screen|0|||
162916011|NCT03996694|588393663|FG002|First Washout (7 Days)|positive urine drug screen|1|||
162916012|NCT03996694|588393664|FG003|First Washout (7 Days)|positive urine drug screen|0|||
162916013|NCT03996694|588393665|FG004|First Washout (7 Days)|positive urine drug screen|0|||
162916014|NCT03996694|588393666|FG005|First Washout (7 Days)|positive urine drug screen|0|||
162916015|NCT03996694|588393661|FG000|First Washout (7 Days)|Adverse Event|0|||
162916016|NCT03996694|588393662|FG001|First Washout (7 Days)|Adverse Event|1|||
162916017|NCT03996694|588393663|FG002|First Washout (7 Days)|Adverse Event|0|||
162916018|NCT03996694|588393664|FG003|First Washout (7 Days)|Adverse Event|0|||
162916019|NCT03996694|588393665|FG004|First Washout (7 Days)|Adverse Event|0|||
162916020|NCT03996694|588393666|FG005|First Washout (7 Days)|Adverse Event|0|||
162916021|NCT03996694|588393661|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
162916022|NCT03996694|588393662|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
162916023|NCT03996694|588393663|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
162916024|NCT03996694|588393664|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
162916025|NCT03996694|588393665|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
162916026|NCT03996694|588393666|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
162916027|NCT03996694|588393661|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
162916028|NCT03996694|588393662|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
162916029|NCT03996694|588393663|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
162916030|NCT03996694|588393664|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
162916031|NCT03996694|588393665|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
162916032|NCT03996694|588393666|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
162916033|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
162916034|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
162916035|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
162916036|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
162916037|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
162916038|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
162916039|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
162916040|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
162916041|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
162916042|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
162711028|NCT02042443|587652852|FG000|Overall Study|Adverse Event|2|||
163054618|NCT00288912|588911721|FG001|Overall Study|Developed exclusion criterion|6|||
163054619|NCT00288912|588911722|FG002|Overall Study|Developed exclusion criterion|7|||
163054620|NCT00288912|588911720|FG000|Overall Study|Lost to Follow-up|9|||
163054621|NCT00288912|588911721|FG001|Overall Study|Lost to Follow-up|6|||
163054622|NCT00288912|588911722|FG002|Overall Study|Lost to Follow-up|9|||
163054623|NCT00288912|588911720|FG000|Overall Study|Withdrawal by Subject|4|||
163054624|NCT00288912|588911721|FG001|Overall Study|Withdrawal by Subject|5|||
163054625|NCT00288912|588911722|FG002|Overall Study|Withdrawal by Subject|12|||
163054626|NCT03312738|588911723|FG000|Overall Study|Progressive disease|58|||
163054627|NCT03312738|588911724|FG001|Overall Study|Progressive disease|67|||
163054628|NCT03312738|588911723|FG000|Overall Study|Patient/guardian decision|13|||
163054629|NCT03312738|588911724|FG001|Overall Study|Patient/guardian decision|5|||
163054630|NCT03312738|588911723|FG000|Overall Study|Adverse Event|5|||
163054631|NCT03312738|588911724|FG001|Overall Study|Adverse Event|3|||
163054632|NCT03312738|588911723|FG000|Overall Study|Protocol deviation|2|||
163054633|NCT03312738|588911724|FG001|Overall Study|Protocol deviation|0|||
163054634|NCT03312738|588911723|FG000|Overall Study|Technical problems|0|||
163054635|NCT03312738|588911724|FG001|Overall Study|Technical problems|1|||
163054636|NCT03312738|588911723|FG000|Overall Study|Physician Decision|2|||
163054637|NCT03312738|588911724|FG001|Overall Study|Physician Decision|3|||
162916043|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
162916044|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
162916045|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
162916046|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
162916047|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
162916048|NCT01694849|588393675|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
162916049|NCT01694849|588393676|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
162916050|NCT01694849|588393677|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
162916051|NCT01694849|588393675|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
162916052|NCT01694849|588393676|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
162916053|NCT01694849|588393677|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
162916054|NCT01694849|588393675|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
162916055|NCT01694849|588393676|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
162916056|NCT01694849|588393677|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
162916057|NCT01326312|588393679|FG000|Overall Study|Adverse Event|11|||
162916058|NCT01326312|588393680|FG001|Overall Study|Adverse Event|11|||
162916059|NCT01326312|588393681|FG002|Overall Study|Adverse Event|1|||
162968602|NCT01801917|588586309|FG000|Period 1 - Randomized|Adverse Event|1|||
162968603|NCT01801917|588586310|FG001|Period 1 - Randomized|Adverse Event|0|||
162968604|NCT01801917|588586311|FG002|Period 1 - Randomized|Adverse Event|1|||
162968605|NCT01801917|588586312|FG003|Period 1 - Randomized|Adverse Event|0|||
162968606|NCT01924364|588586313|FG000|Overall Study|Physician Decision|3|||
162968607|NCT00265785|588586314|FG000|Overall Study|Adverse Event|4|||
162968608|NCT00265785|588586314|FG000|Overall Study|Withdrawal by Subject|3|||
162968609|NCT00265785|588586314|FG000|Overall Study|Progression/Relapse|15|||
162968610|NCT00265785|588586314|FG000|Overall Study|Not protocol specified|2|||
162968611|NCT00265785|588586314|FG000|Overall Study|Ineligible|1|||
162968612|NCT00265785|588586314|FG000|Overall Study|Did not receive protocol treatment|2|||
162968613|NCT03919695|588586315|FG000|3-month Follow-up|Death|1|||
162968614|NCT03919695|588586316|FG001|3-month Follow-up|Death|1|||
162968615|NCT03919695|588586315|FG000|3-month Follow-up|unable to contact|0|||
162968616|NCT03919695|588586316|FG001|3-month Follow-up|unable to contact|3|||
162968617|NCT03919695|588586315|FG000|3-month Follow-up|in prison|0|||
162968618|NCT03919695|588586316|FG001|3-month Follow-up|in prison|1|||
162968619|NCT03919695|588586315|FG000|6-month Follow-up|Death|0|||
162968620|NCT03919695|588586316|FG001|6-month Follow-up|Death|1|||
162968621|NCT03919695|588586315|FG000|6-month Follow-up|Lost to Follow-up|1|||
162968622|NCT03919695|588586316|FG001|6-month Follow-up|Lost to Follow-up|2|||
162968623|NCT03919695|588586315|FG000|6-month Follow-up|in prison|0|||
162968624|NCT03919695|588586316|FG001|6-month Follow-up|in prison|2|||
162968625|NCT03919695|588586315|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
162968626|NCT03919695|588586316|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
162968627|NCT03919695|588586315|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
162968628|NCT03919695|588586316|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
162711029|NCT02042443|587652853|FG001|Overall Study|Adverse Event|1|||
162916060|NCT01326312|588393679|FG000|Overall Study|Withdrawal by Subject|1|||
162916061|NCT01326312|588393680|FG001|Overall Study|Withdrawal by Subject|2|||
162916062|NCT01326312|588393681|FG002|Overall Study|Withdrawal by Subject|1|||
162968629|NCT02416934|588586318|FG000|Overall Study|given steroids|1|||
162968630|NCT02416934|588586319|FG001|Overall Study|given steroids|2|||
162968631|NCT02416934|588586318|FG000|Overall Study|Lost to Follow-up|0|||
162968632|NCT02416934|588586319|FG001|Overall Study|Lost to Follow-up|2|||
162968633|NCT02416934|588586318|FG000|Overall Study|Withdrawal by Subject|1|||
162968634|NCT02416934|588586319|FG001|Overall Study|Withdrawal by Subject|0|||
163054638|NCT00607893|588911730|FG000|Overall Study|Lost to Follow-up|4|||
163054639|NCT00607893|588911731|FG001|Overall Study|Lost to Follow-up|0|||
162711030|NCT02042443|587652852|FG000|Overall Study|Withdrawal by Subject|0|||
162711031|NCT02042443|587652853|FG001|Overall Study|Withdrawal by Subject|1|||
162968635|NCT02416934|588586318|FG000|Overall Study|recruited during continuing renewal proc|0|||
162968636|NCT02416934|588586319|FG001|Overall Study|recruited during continuing renewal proc|1|||
162968637|NCT02416934|588586318|FG000|Overall Study|Protocol Violation|0|||
162968638|NCT02416934|588586319|FG001|Overall Study|Protocol Violation|1|||
162968639|NCT02416934|588586318|FG000|Overall Study|surgery started late|0|||
162968640|NCT02416934|588586319|FG001|Overall Study|surgery started late|1|||
162968641|NCT02416934|588586318|FG000|Overall Study|re-operation|1|||
162968642|NCT02416934|588586319|FG001|Overall Study|re-operation|0|||
162968643|NCT00494013|588586320|FG000|Overall Study|Adverse Event|0|||
162968644|NCT00494013|588586321|FG001|Overall Study|Adverse Event|1|||
162968645|NCT00494013|588586320|FG000|Overall Study|Entry Criteria Not Met|1|||
162968646|NCT00494013|588586321|FG001|Overall Study|Entry Criteria Not Met|4|||
162968647|NCT00494013|588586320|FG000|Overall Study|Lost to Follow-up|5|||
162968648|NCT00494013|588586321|FG001|Overall Study|Lost to Follow-up|6|||
162968649|NCT00494013|588586320|FG000|Overall Study|Physician Decision|3|||
162968650|NCT00494013|588586321|FG001|Overall Study|Physician Decision|5|||
162968651|NCT00494013|588586320|FG000|Overall Study|Protocol Violation|8|||
162968652|NCT00494013|588586321|FG001|Overall Study|Protocol Violation|5|||
162968653|NCT00494013|588586320|FG000|Overall Study|Withdrawal by Subject|13|||
162968654|NCT00494013|588586321|FG001|Overall Study|Withdrawal by Subject|14|||
162968655|NCT00494013|588586320|FG000|Overall Study|Sponsor Decision|0|||
162968656|NCT00494013|588586321|FG001|Overall Study|Sponsor Decision|1|||
162968657|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Adverse Event|8|||
162968658|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Adverse Event|5|||
162968659|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Adverse Event|9|||
162968660|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Adverse Event|0|||
162968661|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Adverse Event|0|||
162968662|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Adverse Event|0|||
162968663|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
162968664|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
162968665|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
162968666|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968667|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968668|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
162968669|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
162968670|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
162968671|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
162968672|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968673|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968674|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
162968675|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Physician Decision|4|||
162968676|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Physician Decision|0|||
162968677|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Physician Decision|2|||
162968678|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Physician Decision|0|||
162968679|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Physician Decision|0|||
162968680|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Physician Decision|0|||
162968681|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Pregnancy|1|||
162968682|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Pregnancy|2|||
162968683|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Pregnancy|0|||
162968684|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Pregnancy|0|||
162968685|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Pregnancy|0|||
162968686|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Pregnancy|0|||
162968687|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
162968688|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
162968689|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
162968690|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
162968691|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
162968692|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
162968693|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
162968694|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968695|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
162711032|NCT02042443|587652852|FG000|Overall Study|Progression|21|||
162968696|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968697|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968698|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
162968699|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
162968700|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
162968701|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
162968702|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
163054640|NCT00607893|588911730|FG000|Overall Study|withdrew due to loss of interest|0|||
163054641|NCT00607893|588911731|FG001|Overall Study|withdrew due to loss of interest|1|||
163054642|NCT00607893|588911730|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
163054643|NCT00607893|588911731|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
163054644|NCT00607893|588911730|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
163054645|NCT00607893|588911731|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
162916063|NCT01326312|588393679|FG000|Overall Study|Protocol Violation|0|||
162916064|NCT01326312|588393680|FG001|Overall Study|Protocol Violation|1|||
162916065|NCT01326312|588393681|FG002|Overall Study|Protocol Violation|0|||
162916066|NCT01326312|588393679|FG000|Overall Study|Lack of Efficacy|13|||
162916067|NCT01326312|588393680|FG001|Overall Study|Lack of Efficacy|7|||
162916068|NCT01326312|588393681|FG002|Overall Study|Lack of Efficacy|1|||
162916069|NCT01326312|588393679|FG000|Overall Study|Death|1|||
162916070|NCT01326312|588393680|FG001|Overall Study|Death|0|||
162916071|NCT01326312|588393681|FG002|Overall Study|Death|1|||
162916072|NCT01326312|588393679|FG000|Overall Study|progressive disease|0|||
162916073|NCT01326312|588393680|FG001|Overall Study|progressive disease|1|||
162916074|NCT01326312|588393681|FG002|Overall Study|progressive disease|1|||
162916075|NCT01326312|588393679|FG000|Overall Study|Study terminated by Sponsor|8|||
162916076|NCT01326312|588393680|FG001|Overall Study|Study terminated by Sponsor|32|||
162916077|NCT01326312|588393681|FG002|Overall Study|Study terminated by Sponsor|46|||
162916078|NCT01326312|588393679|FG000|Overall Study|Treatment arm terminated|19|||
162916079|NCT01326312|588393680|FG001|Overall Study|Treatment arm terminated|0|||
162916080|NCT01326312|588393681|FG002|Overall Study|Treatment arm terminated|0|||
162916081|NCT01326312|588393679|FG000|Overall Study|QTc > 500|0|||
162916082|NCT01326312|588393680|FG001|Overall Study|QTc > 500|1|||
162916083|NCT01326312|588393681|FG002|Overall Study|QTc > 500|0|||
162916084|NCT00678652|588393686|FG000|Overall Study|Protocol Violation|2|||
162916085|NCT00678652|588393687|FG001|Overall Study|Protocol Violation|0|||
162916086|NCT00678652|588393688|FG002|Overall Study|Protocol Violation|0|||
162916087|NCT00678652|588393689|FG003|Overall Study|Protocol Violation|0|||
162916088|NCT00678652|588393686|FG000|Overall Study|Pregnancy|0|||
162916089|NCT00678652|588393687|FG001|Overall Study|Pregnancy|0|||
162916090|NCT00678652|588393688|FG002|Overall Study|Pregnancy|1|||
162916091|NCT00678652|588393689|FG003|Overall Study|Pregnancy|0|||
162916092|NCT00678652|588393686|FG000|Overall Study|Relocation|1|||
162916093|NCT00678652|588393687|FG001|Overall Study|Relocation|0|||
162916094|NCT00678652|588393688|FG002|Overall Study|Relocation|0|||
162916095|NCT00678652|588393689|FG003|Overall Study|Relocation|0|||
162916096|NCT05146999|588393690|FG000|Overall Study|Withdrew consent|6|||
162916097|NCT05146999|588393691|FG001|Overall Study|Withdrew consent|1|||
162916098|NCT05146999|588393690|FG000|Overall Study|Lost to Follow-up|3|||
162916099|NCT05146999|588393691|FG001|Overall Study|Lost to Follow-up|2|||
162916100|NCT05146999|588393690|FG000|Overall Study|Other|1|||
162916101|NCT05146999|588393691|FG001|Overall Study|Other|3|||
162916102|NCT00383292|588393692|FG000|Overall Study|Adverse Event|4|||
162916103|NCT00383292|588393693|FG001|Overall Study|Adverse Event|1|||
162916104|NCT00383292|588393694|FG002|Overall Study|Adverse Event|2|||
162916105|NCT00383292|588393692|FG000|Overall Study|Death|3|||
162916106|NCT00383292|588393693|FG001|Overall Study|Death|3|||
162916107|NCT00383292|588393694|FG002|Overall Study|Death|3|||
162916108|NCT00383292|588393692|FG000|Overall Study|Physician Decision|4|||
162916109|NCT00383292|588393693|FG001|Overall Study|Physician Decision|0|||
162916110|NCT00383292|588393694|FG002|Overall Study|Physician Decision|1|||
162916111|NCT00383292|588393692|FG000|Overall Study|Withdrawal by Subject|3|||
162916112|NCT00383292|588393693|FG001|Overall Study|Withdrawal by Subject|2|||
162916113|NCT00383292|588393694|FG002|Overall Study|Withdrawal by Subject|2|||
162916114|NCT00383292|588393692|FG000|Overall Study|Other|1|||
162916115|NCT00383292|588393693|FG001|Overall Study|Other|0|||
162916116|NCT00383292|588393694|FG002|Overall Study|Other|0|||
162916117|NCT03457701|588393704|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
163054646|NCT00607893|588911730|FG000|Overall Study|Declined to be treated|1|||
162916118|NCT03457701|588393705|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
163054647|NCT00607893|588911731|FG001|Overall Study|Declined to be treated|0|||
162916119|NCT03457701|588393704|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
162916120|NCT03457701|588393705|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
162916121|NCT03329404|588393706|FG000|Overall Study|The study was suspended.|1|||
162916122|NCT03329404|588393707|FG001|Overall Study|The study was suspended.|4|||
162916123|NCT02243306|588393708|FG000|Overall Study|Adverse Event|0|||
162916124|NCT02243306|588393709|FG001|Overall Study|Adverse Event|1|||
162916125|NCT02243306|588393708|FG000|Overall Study|Other: Reached stopping criteria|0|||
162916126|NCT02243306|588393709|FG001|Overall Study|Other: Reached stopping criteria|1|||
162916127|NCT02243306|588393708|FG000|Overall Study|Physician Decision|0|||
163054648|NCT00607893|588911730|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
162916128|NCT02243306|588393709|FG001|Overall Study|Physician Decision|1|||
162916129|NCT02221882|588393710|FG000|Overall Study|Withdrawal by Subject|0|||
162916130|NCT02221882|588393711|FG001|Overall Study|Withdrawal by Subject|0|||
162916131|NCT02221882|588393712|FG002|Overall Study|Withdrawal by Subject|4|||
162916132|NCT02221882|588393713|FG003|Overall Study|Withdrawal by Subject|2|||
162916133|NCT02221882|588393714|FG004|Overall Study|Withdrawal by Subject|2|||
162916134|NCT02221882|588393715|FG005|Overall Study|Withdrawal by Subject|2|||
162916135|NCT02221882|588393710|FG000|Overall Study|Death|0|||
162916136|NCT02221882|588393711|FG001|Overall Study|Death|1|||
162916137|NCT02221882|588393712|FG002|Overall Study|Death|0|||
162916138|NCT02221882|588393713|FG003|Overall Study|Death|0|||
162916139|NCT02221882|588393714|FG004|Overall Study|Death|0|||
162916140|NCT02221882|588393715|FG005|Overall Study|Death|0|||
162916141|NCT04095039|588393721|FG000|Overall Study|Withdrawal by Subject|2|||
162916142|NCT04095039|588393722|FG001|Overall Study|Withdrawal by Subject|16|||
162968703|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162968704|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162968705|NCT02614196|588586325|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
162968706|NCT02614196|588586326|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
162968707|NCT02614196|588586327|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
162968708|NCT02614196|588586328|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
162968709|NCT02614196|588586329|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
162968710|NCT02614196|588586330|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
162968711|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
162968712|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162968713|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162968714|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
162968715|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
162968716|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
162968717|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
162968718|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
162968719|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
162968720|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
162968721|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
162968722|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
162968723|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968724|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
162968725|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968726|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968727|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
162968728|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
162968729|NCT02614196|588586325|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
162968730|NCT02614196|588586326|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
162968731|NCT02614196|588586327|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
162968732|NCT02614196|588586328|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
162968733|NCT02614196|588586329|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
162968734|NCT02614196|588586330|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
162968735|NCT01539239|588586331|FG000|Overall Study|Death|5|||
162968736|NCT01539239|588586332|FG001|Overall Study|Death|5|||
162968737|NCT01539239|588586331|FG000|Overall Study|Lost to Follow-up|7|||
162968738|NCT01539239|588586332|FG001|Overall Study|Lost to Follow-up|12|||
162968739|NCT01562613|588586333|FG000|Overall Study|Lost to Follow-up|2|||
162968740|NCT01562613|588586333|FG000|Overall Study|Withdrawal by Subject|2|||
162968741|NCT00633022|588586336|FG000|Overall Study|Adverse Event|1|||
162968742|NCT00633022|588586337|FG001|Overall Study|Adverse Event|0|||
162968743|NCT00633022|588586338|FG002|Overall Study|Adverse Event|5|||
162968744|NCT00633022|588586336|FG000|Overall Study|Physician Decision|0|||
162968745|NCT00633022|588586337|FG001|Overall Study|Physician Decision|1|||
162968746|NCT00633022|588586338|FG002|Overall Study|Physician Decision|0|||
162968747|NCT03382041|588586340|FG000|Overall Study|Consent Form Lost|2|||
162968748|NCT03382041|588586341|FG001|Overall Study|Consent Form Lost|1|||
162968749|NCT03382041|588586340|FG000|Overall Study|Withdrawal by Subject|1|||
162968750|NCT03382041|588586341|FG001|Overall Study|Withdrawal by Subject|4|||
162968751|NCT03382041|588586340|FG000|Overall Study|Lost to Follow-up|1|||
162968752|NCT03382041|588586341|FG001|Overall Study|Lost to Follow-up|4|||
162968753|NCT01374451|588586344|FG000|Overall Study|Administrative problems|1|||
162968754|NCT01374451|588586345|FG001|Overall Study|Administrative problems|0|||
162968755|NCT01337596|588586346|FG000|Overall Study|Withdrawal by Subject|0|||
162916143|NCT04095039|588393721|FG000|Overall Study|Transplanted|21|||
162916144|NCT04095039|588393722|FG001|Overall Study|Transplanted|24|||
162916145|NCT04095039|588393721|FG000|Overall Study|Transferred to Non-study Facility|47|||
162916146|NCT04095039|588393722|FG001|Overall Study|Transferred to Non-study Facility|44|||
162968756|NCT01337596|588586347|FG001|Overall Study|Withdrawal by Subject|0|||
162968757|NCT01337596|588586348|FG002|Overall Study|Withdrawal by Subject|0|||
162968758|NCT01337596|588586349|FG003|Overall Study|Withdrawal by Subject|0|||
162968759|NCT01337596|588586350|FG004|Overall Study|Withdrawal by Subject|2|||
162968760|NCT01337596|588586351|FG005|Overall Study|Withdrawal by Subject|0|||
162968761|NCT01337596|588586352|FG006|Overall Study|Withdrawal by Subject|0|||
163054649|NCT00607893|588911731|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
163054650|NCT00547339|588911736|FG000|Overall Study|Physician Decision|0|||
163054651|NCT00547339|588911737|FG001|Overall Study|Physician Decision|0|||
162916147|NCT04095039|588393721|FG000|Overall Study|Withdrawal from internvention target|0|||
162916148|NCT04095039|588393722|FG001|Overall Study|Withdrawal from internvention target|2|||
162916149|NCT04095039|588393721|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
162916150|NCT04095039|588393722|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
162916151|NCT04095039|588393721|FG000|Overall Study|Cacliphylaxis|0|||
162916152|NCT04095039|588393722|FG001|Overall Study|Cacliphylaxis|1|||
162916153|NCT04095039|588393721|FG000|Overall Study|Pregnancy|1|||
162916154|NCT04095039|588393722|FG001|Overall Study|Pregnancy|0|||
162916155|NCT04768881|588393723|FG000|Overall Study|Completed Study Follow-up|0|||
162916156|NCT04768881|588393724|FG001|Overall Study|Completed Study Follow-up|2|||
162916157|NCT04768881|588393723|FG000|Overall Study|Death|3|||
162916158|NCT04768881|588393724|FG001|Overall Study|Death|2|||
162916159|NCT04768881|588393723|FG000|Overall Study|Study Terminated by Sponsor|2|||
162916160|NCT04768881|588393724|FG001|Overall Study|Study Terminated by Sponsor|2|||
162916161|NCT04768881|588393723|FG000|Overall Study|Withdrawal by Subject|2|||
162916162|NCT04768881|588393724|FG001|Overall Study|Withdrawal by Subject|0|||
162916163|NCT04768881|588393723|FG000|Overall Study|Other|2|||
162916164|NCT04768881|588393724|FG001|Overall Study|Other|0|||
162916165|NCT02370173|588393727|FG000|Overall Study|Protocol Violation|1|||
162916166|NCT02370173|588393728|FG001|Overall Study|Protocol Violation|1|||
162916167|NCT02370173|588393727|FG000|Overall Study|Withdrawal by Subject|2|||
162916168|NCT02370173|588393728|FG001|Overall Study|Withdrawal by Subject|2|||
162916169|NCT04236986|588393729|FG000|Overall Study|Withdrawal by Subject|3|||
162916170|NCT04236986|588393730|FG001|Overall Study|Withdrawal by Subject|1|||
162916171|NCT00307736|588393733|FG000|Overall Study|Adverse Event|0|||
162916172|NCT00307736|588393734|FG001|Overall Study|Adverse Event|0|||
162916173|NCT00307736|588393735|FG002|Overall Study|Adverse Event|1|||
162916174|NCT00307736|588393736|FG003|Overall Study|Adverse Event|3|||
162916175|NCT00307736|588393733|FG000|Overall Study|Withdrawal by Subject|0|||
162916176|NCT00307736|588393734|FG001|Overall Study|Withdrawal by Subject|0|||
162916177|NCT00307736|588393735|FG002|Overall Study|Withdrawal by Subject|2|||
162916178|NCT00307736|588393736|FG003|Overall Study|Withdrawal by Subject|0|||
162916179|NCT01365182|588393743|FG000|Overall Study|Withdrawal by Subject|10|||
162916180|NCT01365182|588393744|FG001|Overall Study|Withdrawal by Subject|13|||
162916181|NCT01365182|588393745|FG002|Overall Study|Withdrawal by Subject|12|||
162916182|NCT00736840|588393746|FG000|Overall Study|Lost to Follow-up|13|||
162916183|NCT01728194|588393749|FG000|Overall Study|Lost to Follow-up|4|||
162916184|NCT01728194|588393750|FG001|Overall Study|Lost to Follow-up|3|||
162916185|NCT01728194|588393749|FG000|Overall Study|Physician Decision|4|||
162916186|NCT01728194|588393750|FG001|Overall Study|Physician Decision|0|||
162916187|NCT01728194|588393749|FG000|Overall Study|Withdrawal by Subject|7|||
162916188|NCT01728194|588393750|FG001|Overall Study|Withdrawal by Subject|3|||
162916189|NCT01728194|588393749|FG000|Overall Study|Perceived Medication Side Effects|4|||
162916190|NCT01728194|588393750|FG001|Overall Study|Perceived Medication Side Effects|0|||
162916191|NCT01728194|588393749|FG000|Overall Study|Family Member Request|1|||
162916192|NCT01728194|588393750|FG001|Overall Study|Family Member Request|0|||
162916193|NCT02309372|588393751|FG000|Overall Study|Lost to Follow-up|3|||
162916194|NCT02309372|588393752|FG001|Overall Study|Lost to Follow-up|2|||
162916195|NCT03289676|588393757|FG000|Overall Study|Withdrawal by Subject|2|||
162916196|NCT03289676|588393758|FG001|Overall Study|Withdrawal by Subject|0|||
162916197|NCT03289676|588393757|FG000|Overall Study|Protocol Violation|2|||
162916198|NCT03289676|588393758|FG001|Overall Study|Protocol Violation|0|||
162916199|NCT03289676|588393757|FG000|Overall Study|Lost to Follow-up|0|||
162916200|NCT03289676|588393758|FG001|Overall Study|Lost to Follow-up|1|||
162916201|NCT01314261|588393761|FG000|Overall Study|Adverse Event|1|||
162916202|NCT01314261|588393762|FG001|Overall Study|Adverse Event|0|||
162916203|NCT01314261|588393763|FG002|Overall Study|Adverse Event|0|||
162916204|NCT01314261|588393764|FG003|Overall Study|Adverse Event|0|||
162916205|NCT01314261|588393761|FG000|Overall Study|Withdrawal by Subject|0|||
162916206|NCT01314261|588393762|FG001|Overall Study|Withdrawal by Subject|3|||
162916207|NCT01314261|588393763|FG002|Overall Study|Withdrawal by Subject|1|||
162916208|NCT01314261|588393764|FG003|Overall Study|Withdrawal by Subject|0|||
162916209|NCT01314261|588393761|FG000|Overall Study|Lost to Follow-up|1|||
162916210|NCT01314261|588393762|FG001|Overall Study|Lost to Follow-up|0|||
162916211|NCT01314261|588393763|FG002|Overall Study|Lost to Follow-up|2|||
162916212|NCT01314261|588393764|FG003|Overall Study|Lost to Follow-up|2|||
162916213|NCT01314261|588393761|FG000|Overall Study|Virologic Failure|0|||
162916214|NCT01314261|588393762|FG001|Overall Study|Virologic Failure|1|||
162916215|NCT01314261|588393763|FG002|Overall Study|Virologic Failure|0|||
163054652|NCT00547339|588911738|FG002|Overall Study|Physician Decision|1|||
162916216|NCT01314261|588393764|FG003|Overall Study|Virologic Failure|1|||
162916217|NCT01231620|588393765|FG000|Overall Study|Physician Decision|3|||
162916218|NCT01231620|588393766|FG001|Overall Study|Physician Decision|5|||
162916219|NCT01231620|588393767|FG002|Overall Study|Physician Decision|10|||
162916220|NCT01231620|588393765|FG000|Overall Study|Death|12|||
162916221|NCT01231620|588393766|FG001|Overall Study|Death|14|||
162916222|NCT01231620|588393767|FG002|Overall Study|Death|11|||
162916223|NCT01231620|588393765|FG000|Overall Study|Adverse Event|2|||
162916224|NCT01231620|588393766|FG001|Overall Study|Adverse Event|2|||
162968762|NCT01337596|588586353|FG007|Overall Study|Withdrawal by Subject|0|||
162968763|NCT01337596|588586354|FG008|Overall Study|Withdrawal by Subject|0|||
162968764|NCT04640194|588586355|FG000|Overall Study|Adverse Event|3|||
162968765|NCT04640194|588586356|FG001|Overall Study|Adverse Event|7|||
162968766|NCT04640194|588586357|FG002|Overall Study|Adverse Event|0|||
162968767|NCT04640194|588586358|FG003|Overall Study|Adverse Event|5|||
162968768|NCT04640194|588586359|FG004|Overall Study|Adverse Event|0|||
162968769|NCT04640194|588586360|FG005|Overall Study|Adverse Event|4|||
162968770|NCT04640194|588586361|FG006|Overall Study|Adverse Event|0|||
162968771|NCT04640194|588586355|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
162968772|NCT04640194|588586356|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
162968773|NCT04640194|588586357|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
162968774|NCT04640194|588586358|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
162968775|NCT04640194|588586359|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
162968776|NCT04640194|588586360|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
162968777|NCT04640194|588586361|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
162968778|NCT04640194|588586355|FG000|Overall Study|fibrinogen level too low|0|||
162968779|NCT04640194|588586356|FG001|Overall Study|fibrinogen level too low|0|||
162968780|NCT04640194|588586357|FG002|Overall Study|fibrinogen level too low|0|||
162968781|NCT04640194|588586358|FG003|Overall Study|fibrinogen level too low|1|||
162968782|NCT04640194|588586359|FG004|Overall Study|fibrinogen level too low|0|||
162968783|NCT04640194|588586360|FG005|Overall Study|fibrinogen level too low|0|||
162968784|NCT04640194|588586361|FG006|Overall Study|fibrinogen level too low|0|||
162968785|NCT04640194|588586355|FG000|Overall Study|mild bleeding|0|||
162968786|NCT04640194|588586356|FG001|Overall Study|mild bleeding|0|||
162968787|NCT04640194|588586357|FG002|Overall Study|mild bleeding|0|||
162968788|NCT04640194|588586358|FG003|Overall Study|mild bleeding|1|||
162968789|NCT04640194|588586359|FG004|Overall Study|mild bleeding|0|||
162968790|NCT04640194|588586360|FG005|Overall Study|mild bleeding|0|||
162968791|NCT04640194|588586361|FG006|Overall Study|mild bleeding|0|||
162968792|NCT04640194|588586355|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968793|NCT04640194|588586356|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
162968794|NCT04640194|588586357|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968795|NCT04640194|588586358|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968796|NCT04640194|588586359|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968797|NCT04640194|588586360|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968798|NCT04640194|588586361|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
162968799|NCT03201003|588586365|FG000|Overall Study|Adverse Event|14|||
162968800|NCT03201003|588586366|FG001|Overall Study|Adverse Event|1|||
162968801|NCT03201003|588586365|FG000|Overall Study|Other reasons|5|||
162968802|NCT03201003|588586366|FG001|Overall Study|Other reasons|1|||
162968803|NCT03201003|588586365|FG000|Overall Study|Withdrawal by Subject|4|||
162968804|NCT03201003|588586366|FG001|Overall Study|Withdrawal by Subject|1|||
162968805|NCT03201003|588586365|FG000|Overall Study|Lost to Follow-up|2|||
162968806|NCT03201003|588586366|FG001|Overall Study|Lost to Follow-up|0|||
162968807|NCT03201003|588586365|FG000|Overall Study|Protocol Violation|1|||
162968808|NCT03201003|588586366|FG001|Overall Study|Protocol Violation|0|||
162968809|NCT01709903|588586372|FG000|Overall Study|administrative problems|2|||
162968810|NCT01709903|588586373|FG001|Overall Study|administrative problems|6|||
162968811|NCT01709903|588586372|FG000|Overall Study|Abnormal test procedure results|1|||
162968812|NCT01709903|588586373|FG001|Overall Study|Abnormal test procedure results|0|||
162968813|NCT01709903|588586372|FG000|Overall Study|In ability to use device|1|||
162968814|NCT01709903|588586373|FG001|Overall Study|In ability to use device|1|||
162968815|NCT01709903|588586372|FG000|Overall Study|no longer needed study drug|0|||
162916225|NCT01231620|588393767|FG002|Overall Study|Adverse Event|1|||
162916226|NCT01231620|588393765|FG000|Overall Study|Withdrawal by Subject|6|||
162916227|NCT01231620|588393766|FG001|Overall Study|Withdrawal by Subject|6|||
162968816|NCT01709903|588586373|FG001|Overall Study|no longer needed study drug|1|||
162968817|NCT01709903|588586372|FG000|Overall Study|Lost to Follow-up|0|||
162968818|NCT01709903|588586373|FG001|Overall Study|Lost to Follow-up|2|||
162968819|NCT01709903|588586372|FG000|Overall Study|Death|2|||
162968820|NCT01709903|588586373|FG001|Overall Study|Death|0|||
162968821|NCT01709903|588586372|FG000|Overall Study|Protocol Violation|3|||
163054653|NCT00547339|588911739|FG003|Overall Study|Physician Decision|0|||
163054654|NCT02426684|588911740|FG000|Overall Study|Physician Decision|1|||
163054655|NCT03587636|588911741|FG000|Overall Study|Lost to Follow-up|2|||
163054656|NCT03587636|588911742|FG001|Overall Study|Lost to Follow-up|5|||
162711033|NCT02042443|587652853|FG001|Overall Study|Progression|17|||
163054657|NCT01483118|588911752|FG000|Overall Study|Lost to Follow-up|12|||
163054658|NCT01483118|588911753|FG001|Overall Study|Lost to Follow-up|16|||
163054659|NCT01079780|588911755|FG000|Overall Study|Disease progression|43|||
163054660|NCT01079780|588911756|FG001|Overall Study|Disease progression|7|||
163054661|NCT01079780|588911757|FG002|Overall Study|Disease progression|31|||
163054662|NCT01079780|588911755|FG000|Overall Study|Adverse Event|13|||
163054663|NCT01079780|588911756|FG001|Overall Study|Adverse Event|5|||
163054664|NCT01079780|588911757|FG002|Overall Study|Adverse Event|7|||
163054665|NCT01079780|588911755|FG000|Overall Study|Death|2|||
163054666|NCT01079780|588911756|FG001|Overall Study|Death|0|||
163054667|NCT01079780|588911757|FG002|Overall Study|Death|2|||
163054668|NCT01079780|588911755|FG000|Overall Study|Withdrawal by Subject|6|||
163054669|NCT01079780|588911756|FG001|Overall Study|Withdrawal by Subject|4|||
163054670|NCT01079780|588911757|FG002|Overall Study|Withdrawal by Subject|4|||
163054671|NCT01079780|588911755|FG000|Overall Study|Alternative therapy|2|||
163054672|NCT01079780|588911756|FG001|Overall Study|Alternative therapy|0|||
163054673|NCT01079780|588911757|FG002|Overall Study|Alternative therapy|2|||
163054674|NCT01079780|588911755|FG000|Overall Study|Physician Decision|1|||
163054675|NCT01079780|588911756|FG001|Overall Study|Physician Decision|0|||
163054676|NCT01079780|588911757|FG002|Overall Study|Physician Decision|1|||
163054677|NCT01079780|588911755|FG000|Overall Study|Error made in lesion measurement|1|||
163054678|NCT01079780|588911756|FG001|Overall Study|Error made in lesion measurement|0|||
163054679|NCT01079780|588911757|FG002|Overall Study|Error made in lesion measurement|0|||
163054680|NCT01079780|588911755|FG000|Overall Study|Patient had surgery|1|||
163054681|NCT01079780|588911756|FG001|Overall Study|Patient had surgery|0|||
163054682|NCT01079780|588911757|FG002|Overall Study|Patient had surgery|0|||
163054683|NCT01079780|588911755|FG000|Overall Study|Treatment cycle delay|0|||
163054684|NCT01079780|588911756|FG001|Overall Study|Treatment cycle delay|0|||
163054685|NCT01079780|588911757|FG002|Overall Study|Treatment cycle delay|1|||
163054686|NCT01079780|588911755|FG000|Overall Study|Never started treatment|1|||
163054687|NCT01079780|588911756|FG001|Overall Study|Never started treatment|0|||
163054688|NCT01079780|588911757|FG002|Overall Study|Never started treatment|2|||
163054689|NCT01178294|588911758|FG000|Overall Study|Adverse Event|4|||
163054690|NCT01178294|588911758|FG000|Overall Study|Lost to Follow-up|2|||
163054691|NCT01178294|588911758|FG000|Overall Study|Lack of Efficacy|1|||
163054692|NCT01178294|588911758|FG000|Overall Study|Death|1|||
163054693|NCT01178294|588911758|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
163054694|NCT01178294|588911758|FG000|Overall Study|Subject status is terminal|1|||
163054695|NCT01178294|588911758|FG000|Overall Study|Completion status could not be verified|1|||
162711034|NCT02042443|587652852|FG000|Overall Study|not protocol specified|1|||
162711035|NCT02042443|587652853|FG001|Overall Study|not protocol specified|1|||
162916228|NCT01231620|588393767|FG002|Overall Study|Withdrawal by Subject|8|||
162916229|NCT01231620|588393765|FG000|Overall Study|Lost to Follow-up|3|||
162916230|NCT01231620|588393766|FG001|Overall Study|Lost to Follow-up|4|||
162916231|NCT01231620|588393767|FG002|Overall Study|Lost to Follow-up|9|||
162916232|NCT02576652|588393771|FG000|Overall Study|Withdrawal by Subject|2|||
162916233|NCT04806334|588393776|FG000|Overall Study|Withdrawal by Subject|1|||
162916234|NCT02811640|588393777|FG000|Overall Study|Technology malfunction|2|||
162916235|NCT04557189|588393781|FG000|Overall Study|Adverse Event|0|||
162916236|NCT04557189|588393782|FG001|Overall Study|Adverse Event|1|||
162916237|NCT04557189|588393781|FG000|Overall Study|Lost to Follow-up|1|||
162916238|NCT04557189|588393782|FG001|Overall Study|Lost to Follow-up|1|||
162916239|NCT04557189|588393781|FG000|Overall Study|Withdrawal by Subject|2|||
162916240|NCT04557189|588393782|FG001|Overall Study|Withdrawal by Subject|1|||
162916241|NCT04557189|588393781|FG000|Overall Study|Reason not Specified|3|||
162916242|NCT04557189|588393782|FG001|Overall Study|Reason not Specified|6|||
162916243|NCT03590613|588393793|FG000|Period 2, 4 Days|Physician Decision|0|||
162916244|NCT03590613|588393794|FG001|Period 2, 4 Days|Physician Decision|0|||
163054696|NCT02783066|588911759|FG000|Overall Study|Withdrawal by Subject|13|||
163054697|NCT00551369|588911760|FG000|Overall Study|Protocol Violation|5|||
163054698|NCT00551369|588911760|FG000|Overall Study|Withdrawal by Subject|1|||
163054699|NCT00551369|588911760|FG000|Overall Study|Not treated per protocol and re|1|||
163054700|NCT01663623|588911763|FG000|Overall Study|Adverse Event|3|||
163054701|NCT01663623|588911764|FG001|Overall Study|Adverse Event|7|||
163054702|NCT01663623|588911763|FG000|Overall Study|Lack of Efficacy|5|||
163054703|NCT01663623|588911764|FG001|Overall Study|Lack of Efficacy|6|||
163054704|NCT01663623|588911763|FG000|Overall Study|Protocol Violation|0|||
163054705|NCT01663623|588911764|FG001|Overall Study|Protocol Violation|1|||
163054706|NCT01663623|588911763|FG000|Overall Study|Other-Study closed/terminated|1|||
163054707|NCT01663623|588911764|FG001|Overall Study|Other-Study closed/terminated|1|||
163054708|NCT01663623|588911763|FG000|Overall Study|Physician Decision|1|||
163054709|NCT01663623|588911764|FG001|Overall Study|Physician Decision|4|||
163054710|NCT01663623|588911763|FG000|Overall Study|Withdrawal by Subject|2|||
163054711|NCT01663623|588911764|FG001|Overall Study|Withdrawal by Subject|1|||
163054712|NCT02251275|588911765|FG000|Overall Study|Adverse Event|23|||
163054713|NCT02251275|588911766|FG001|Overall Study|Adverse Event|60|||
163054714|NCT02251275|588911767|FG002|Overall Study|Adverse Event|28|||
163054715|NCT02251275|588911768|FG003|Overall Study|Adverse Event|0|||
163054716|NCT02251275|588911769|FG004|Overall Study|Adverse Event|0|||
163054717|NCT02251275|588911765|FG000|Overall Study|Lost to Follow-up|5|||
163054718|NCT02251275|588911766|FG001|Overall Study|Lost to Follow-up|6|||
163054719|NCT02251275|588911767|FG002|Overall Study|Lost to Follow-up|4|||
163054720|NCT02251275|588911768|FG003|Overall Study|Lost to Follow-up|0|||
163054721|NCT02251275|588911769|FG004|Overall Study|Lost to Follow-up|0|||
163054722|NCT02251275|588911765|FG000|Overall Study|Physician Decision|19|||
163054723|NCT02251275|588911766|FG001|Overall Study|Physician Decision|30|||
163054724|NCT02251275|588911767|FG002|Overall Study|Physician Decision|26|||
163054725|NCT02251275|588911768|FG003|Overall Study|Physician Decision|0|||
163054726|NCT02251275|588911769|FG004|Overall Study|Physician Decision|1|||
163054727|NCT02251275|588911765|FG000|Overall Study|Protocol Deviation|0|||
163054728|NCT02251275|588911766|FG001|Overall Study|Protocol Deviation|0|||
163054729|NCT02251275|588911767|FG002|Overall Study|Protocol Deviation|1|||
163054730|NCT02251275|588911768|FG003|Overall Study|Protocol Deviation|0|||
163054731|NCT02251275|588911769|FG004|Overall Study|Protocol Deviation|0|||
163054732|NCT02251275|588911765|FG000|Overall Study|Withdrawal by Subject|25|||
163054733|NCT02251275|588911766|FG001|Overall Study|Withdrawal by Subject|51|||
163054734|NCT02251275|588911767|FG002|Overall Study|Withdrawal by Subject|35|||
163054735|NCT02251275|588911768|FG003|Overall Study|Withdrawal by Subject|1|||
163054736|NCT02251275|588911769|FG004|Overall Study|Withdrawal by Subject|0|||
163054737|NCT01004614|588911773|FG000|Washout|Withdrawal by Subject|0|||
163054738|NCT01004614|588911774|FG001|Washout|Withdrawal by Subject|1|||
163054739|NCT01004614|588911775|FG002|Washout|Withdrawal by Subject|0|||
163054740|NCT01004614|588911776|FG003|Washout|Withdrawal by Subject|0|||
163054741|NCT02834975|588911777|FG000|Overall Study|Physician Decision|2|||
163054742|NCT02834975|588911777|FG000|Overall Study|Adverse Event|1|||
163054743|NCT02834975|588911777|FG000|Overall Study|Withdrawal by Subject|1|||
163054744|NCT02834975|588911777|FG000|Overall Study|Lack of Efficacy|1|||
163054745|NCT02175121|588911780|FG000|Overall Study|Lack of Efficacy|1|||
163054746|NCT02175121|588911781|FG001|Overall Study|Lack of Efficacy|0|||
163054747|NCT02175121|588911782|FG002|Overall Study|Lack of Efficacy|0|||
163054748|NCT02175121|588911783|FG003|Overall Study|Lack of Efficacy|0|||
163054749|NCT02175121|588911784|FG004|Overall Study|Lack of Efficacy|0|||
163054750|NCT02175121|588911780|FG000|Overall Study|Lost to Follow-up|0|||
162711036|NCT02042443|587652852|FG000|Overall Study|Not eligible/not analyzable|3|||
162711037|NCT02042443|587652853|FG001|Overall Study|Not eligible/not analyzable|6|||
163054751|NCT02175121|588911781|FG001|Overall Study|Lost to Follow-up|1|||
163054752|NCT02175121|588911782|FG002|Overall Study|Lost to Follow-up|0|||
163054753|NCT02175121|588911783|FG003|Overall Study|Lost to Follow-up|1|||
163054754|NCT02175121|588911784|FG004|Overall Study|Lost to Follow-up|0|||
163054755|NCT02175121|588911780|FG000|Overall Study|Personal emergency|0|||
163054756|NCT02175121|588911781|FG001|Overall Study|Personal emergency|0|||
163054757|NCT02175121|588911782|FG002|Overall Study|Personal emergency|0|||
163054758|NCT02175121|588911783|FG003|Overall Study|Personal emergency|0|||
163054759|NCT02175121|588911784|FG004|Overall Study|Personal emergency|1|||
163054760|NCT02175121|588911780|FG000|Overall Study|Schedule conflict|0|||
163054761|NCT02175121|588911781|FG001|Overall Study|Schedule conflict|0|||
163054762|NCT02175121|588911782|FG002|Overall Study|Schedule conflict|1|||
163054763|NCT02175121|588911783|FG003|Overall Study|Schedule conflict|0|||
163054764|NCT02175121|588911784|FG004|Overall Study|Schedule conflict|0|||
163054765|NCT02175121|588911780|FG000|Overall Study|Time issues|0|||
163054766|NCT02175121|588911781|FG001|Overall Study|Time issues|0|||
163054767|NCT02175121|588911782|FG002|Overall Study|Time issues|1|||
162711038|NCT01649427|587652854|FG000|Overall Study|Adverse Event|1|||
162916245|NCT03590613|588393795|FG002|Period 2, 4 Days|Physician Decision|0|||
163054768|NCT02175121|588911783|FG003|Overall Study|Time issues|0|||
163054769|NCT02175121|588911784|FG004|Overall Study|Time issues|0|||
163054770|NCT00931632|588911789|FG000|Overall Study|Withdrawal by Subject|2|||
163054771|NCT00931632|588911790|FG001|Overall Study|Withdrawal by Subject|3|||
163054772|NCT00931632|588911789|FG000|Overall Study|Adverse Event|19|||
163054773|NCT00931632|588911790|FG001|Overall Study|Adverse Event|15|||
163054774|NCT01419314|588911791|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
163054775|NCT01419314|588911792|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
163054776|NCT01419314|588911791|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
163054777|NCT01419314|588911792|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
163054778|NCT01419314|588911791|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
163054779|NCT01419314|588911792|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
163054780|NCT01118052|588911797|FG000|Overall Study|Never treated|2|||
163054781|NCT00843492|588911798|FG000|Overall Study|Adverse Event|0|||
163054782|NCT00843492|588911799|FG001|Overall Study|Adverse Event|3|||
163054783|NCT00843492|588911798|FG000|Overall Study|Lost to Follow-up|4|||
163054784|NCT00843492|588911799|FG001|Overall Study|Lost to Follow-up|4|||
163054785|NCT00843492|588911798|FG000|Overall Study|Withdrawal by Subject|0|||
163054786|NCT00843492|588911799|FG001|Overall Study|Withdrawal by Subject|4|||
163054787|NCT00843492|588911798|FG000|Overall Study|Immobilization Stopped|1|||
163054788|NCT00843492|588911799|FG001|Overall Study|Immobilization Stopped|0|||
163054789|NCT00843492|588911798|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
163054790|NCT00843492|588911799|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
163054791|NCT00843492|588911798|FG000|Overall Study|Orthopedic Surgery|0|||
163054792|NCT00843492|588911799|FG001|Overall Study|Orthopedic Surgery|2|||
163054793|NCT00843492|588911798|FG000|Overall Study|Visit Not Performed|1|||
163054794|NCT00843492|588911799|FG001|Overall Study|Visit Not Performed|0|||
163054795|NCT00843492|588911798|FG000|Overall Study|Deep-vein Thrombosis|1|||
163054796|NCT00843492|588911799|FG001|Overall Study|Deep-vein Thrombosis|0|||
163054797|NCT01677741|588911800|FG000|Overall Study|Death|0|||
163054798|NCT01677741|588911801|FG001|Overall Study|Death|0|||
163054799|NCT01677741|588911802|FG002|Overall Study|Death|0|||
163054800|NCT01677741|588911803|FG003|Overall Study|Death|1|||
163054801|NCT01677741|588911804|FG004|Overall Study|Death|0|||
163054802|NCT01677741|588911805|FG005|Overall Study|Death|1|||
163054803|NCT01677741|588911806|FG006|Overall Study|Death|0|||
163054804|NCT01677741|588911807|FG007|Overall Study|Death|0|||
163054805|NCT01677741|588911800|FG000|Overall Study|Withdrawal by Subject|2|||
163054806|NCT01677741|588911801|FG001|Overall Study|Withdrawal by Subject|7|||
163054807|NCT01677741|588911802|FG002|Overall Study|Withdrawal by Subject|5|||
163054808|NCT01677741|588911803|FG003|Overall Study|Withdrawal by Subject|4|||
163054809|NCT01677741|588911804|FG004|Overall Study|Withdrawal by Subject|11|||
163054810|NCT01677741|588911805|FG005|Overall Study|Withdrawal by Subject|20|||
163054811|NCT01677741|588911806|FG006|Overall Study|Withdrawal by Subject|4|||
163054812|NCT01677741|588911807|FG007|Overall Study|Withdrawal by Subject|2|||
163054813|NCT01677741|588911800|FG000|Overall Study|Enrolled in a rollover study|0|||
163054814|NCT01677741|588911801|FG001|Overall Study|Enrolled in a rollover study|3|||
163054815|NCT01677741|588911802|FG002|Overall Study|Enrolled in a rollover study|2|||
163054816|NCT01677741|588911803|FG003|Overall Study|Enrolled in a rollover study|1|||
163054817|NCT01677741|588911804|FG004|Overall Study|Enrolled in a rollover study|6|||
163054818|NCT01677741|588911805|FG005|Overall Study|Enrolled in a rollover study|6|||
163054819|NCT01677741|588911806|FG006|Overall Study|Enrolled in a rollover study|7|||
163054820|NCT01677741|588911807|FG007|Overall Study|Enrolled in a rollover study|0|||
163054821|NCT01677741|588911800|FG000|Overall Study|Progressive disease|1|||
163054822|NCT01677741|588911801|FG001|Overall Study|Progressive disease|0|||
163054823|NCT01677741|588911802|FG002|Overall Study|Progressive disease|1|||
163054824|NCT01677741|588911803|FG003|Overall Study|Progressive disease|0|||
163054825|NCT01677741|588911804|FG004|Overall Study|Progressive disease|0|||
163054826|NCT01677741|588911805|FG005|Overall Study|Progressive disease|1|||
163054827|NCT01677741|588911806|FG006|Overall Study|Progressive disease|0|||
163054828|NCT01677741|588911807|FG007|Overall Study|Progressive disease|0|||
163054829|NCT00721799|588911810|FG000|Overall Study|Withdrawal by Subject|7|||
163054830|NCT00721799|588911810|FG000|Overall Study|withdraw by subject after scan 1|1|||
163054831|NCT01441973|588911811|FG000|Overall Study|Disease progression|8|||
163054832|NCT01441973|588911812|FG001|Overall Study|Disease progression|6|||
163054833|NCT01441973|588911811|FG000|Overall Study|Adverse event unrelated to study drug|3|||
163054834|NCT01441973|588911812|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163054835|NCT01441973|588911811|FG000|Overall Study|Participant request to discontinue|1|||
163054836|NCT01441973|588911812|FG001|Overall Study|Participant request to discontinue|1|||
163054837|NCT01441973|588911811|FG000|Overall Study|Poor compliance/noncompliance|0|||
163054838|NCT01441973|588911812|FG001|Overall Study|Poor compliance/noncompliance|1|||
163054839|NCT01441973|588911811|FG000|Overall Study|Administrative reason by sponsor|3|||
163054840|NCT01441973|588911812|FG001|Overall Study|Administrative reason by sponsor|5|||
162916246|NCT03590613|588393796|FG003|Period 2, 4 Days|Physician Decision|1|||
162916247|NCT04369742|588393801|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
162916248|NCT04369742|588393802|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
162916249|NCT04369742|588393801|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
162916250|NCT04369742|588393802|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
162916251|NCT01636076|588393803|FG000|Overall Study|Terminated by sponsor|1|||
162916252|NCT01636076|588393804|FG001|Overall Study|Terminated by sponsor|1|||
162916253|NCT01636076|588393803|FG000|Overall Study|Lack of Efficacy|0|||
162916254|NCT01636076|588393804|FG001|Overall Study|Lack of Efficacy|1|||
162916255|NCT01636076|588393803|FG000|Overall Study|Lost to Follow-up|1|||
162916256|NCT01636076|588393804|FG001|Overall Study|Lost to Follow-up|0|||
162916257|NCT01636076|588393803|FG000|Overall Study|Physician Decision|1|||
162916258|NCT01636076|588393804|FG001|Overall Study|Physician Decision|1|||
162916259|NCT01636076|588393803|FG000|Overall Study|Non-compliance with study treatment|1|||
162916260|NCT01636076|588393804|FG001|Overall Study|Non-compliance with study treatment|1|||
162916261|NCT01636076|588393803|FG000|Overall Study|Adverse Event|6|||
162916262|NCT01636076|588393804|FG001|Overall Study|Adverse Event|11|||
162916263|NCT01636076|588393803|FG000|Overall Study|Withdrawal by Subject|7|||
162916264|NCT01636076|588393804|FG001|Overall Study|Withdrawal by Subject|10|||
162916265|NCT01130831|588393805|FG000|Overall Study|Withdrawal by Subject|7|||
162916266|NCT01130831|588393805|FG000|Overall Study|Death|4|||
162916267|NCT01130831|588393805|FG000|Overall Study|Information was missing|3|||
162916268|NCT01159665|588393806|FG000|Overall Study|Withdrawal by Subject|0|||
162916269|NCT01159665|588393807|FG001|Overall Study|Withdrawal by Subject|1|||
162916270|NCT01159665|588393808|FG002|Overall Study|Withdrawal by Subject|0|||
162916271|NCT01159665|588393809|FG003|Overall Study|Withdrawal by Subject|0|||
162916272|NCT01159665|588393810|FG004|Overall Study|Withdrawal by Subject|0|||
162916273|NCT01159665|588393811|FG005|Overall Study|Withdrawal by Subject|0|||
162916274|NCT00951912|588393812|FG000|Overall Study|Lack of Efficacy|1|||
162916275|NCT00951912|588393813|FG001|Overall Study|Lack of Efficacy|0|||
162916276|NCT00951912|588393814|FG002|Overall Study|Lack of Efficacy|0|||
162916277|NCT00951912|588393812|FG000|Overall Study|Adverse Event|0|||
162916278|NCT00951912|588393813|FG001|Overall Study|Adverse Event|1|||
162916279|NCT00951912|588393814|FG002|Overall Study|Adverse Event|1|||
162916280|NCT00951912|588393812|FG000|Overall Study|Lost to Follow-up|2|||
162916281|NCT00951912|588393813|FG001|Overall Study|Lost to Follow-up|2|||
162916282|NCT00951912|588393814|FG002|Overall Study|Lost to Follow-up|0|||
162916283|NCT00951912|588393812|FG000|Overall Study|Physician Decision|1|||
162916284|NCT00951912|588393813|FG001|Overall Study|Physician Decision|0|||
162916285|NCT00951912|588393814|FG002|Overall Study|Physician Decision|1|||
162916286|NCT00951912|588393812|FG000|Overall Study|Withdrawal by Subject|1|||
162916287|NCT00951912|588393813|FG001|Overall Study|Withdrawal by Subject|1|||
162916288|NCT00951912|588393814|FG002|Overall Study|Withdrawal by Subject|0|||
162916289|NCT00951912|588393812|FG000|Overall Study|Other:Depression|1|||
162916290|NCT00951912|588393813|FG001|Overall Study|Other:Depression|0|||
162916291|NCT00951912|588393814|FG002|Overall Study|Other:Depression|0|||
162916292|NCT00951912|588393812|FG000|Overall Study|Other: Colon cancer|1|||
162916293|NCT00951912|588393813|FG001|Overall Study|Other: Colon cancer|0|||
162916294|NCT00951912|588393814|FG002|Overall Study|Other: Colon cancer|0|||
162916295|NCT00951912|588393812|FG000|Overall Study|Other: Stroke|0|||
162916296|NCT00951912|588393813|FG001|Overall Study|Other: Stroke|1|||
162916297|NCT00951912|588393814|FG002|Overall Study|Other: Stroke|0|||
162916298|NCT02173158|588393816|FG000|Efficacy Phase|Adverse Event|1|||
162916299|NCT01377194|588393817|FG000|Overall Study|Adverse Event|3|||
162916300|NCT01377194|588393818|FG001|Overall Study|Adverse Event|12|||
162916301|NCT01377194|588393819|FG002|Overall Study|Adverse Event|19|||
162916302|NCT01377194|588393817|FG000|Overall Study|Lack of Efficacy|3|||
162916303|NCT01377194|588393818|FG001|Overall Study|Lack of Efficacy|3|||
162916304|NCT01377194|588393819|FG002|Overall Study|Lack of Efficacy|3|||
162916305|NCT01377194|588393817|FG000|Overall Study|Protocol Violation|4|||
162916306|NCT01377194|588393818|FG001|Overall Study|Protocol Violation|10|||
162968822|NCT01709903|588586373|FG001|Overall Study|Protocol Violation|2|||
162968823|NCT01709903|588586372|FG000|Overall Study|Lack of Efficacy|3|||
162916307|NCT01377194|588393819|FG002|Overall Study|Protocol Violation|6|||
162916308|NCT01377194|588393817|FG000|Overall Study|Withdrawal by Subject|8|||
162916309|NCT01377194|588393818|FG001|Overall Study|Withdrawal by Subject|10|||
162916310|NCT01377194|588393819|FG002|Overall Study|Withdrawal by Subject|7|||
162916311|NCT01377194|588393817|FG000|Overall Study|Lost to Follow-up|14|||
162916312|NCT01377194|588393818|FG001|Overall Study|Lost to Follow-up|8|||
162916313|NCT01377194|588393819|FG002|Overall Study|Lost to Follow-up|11|||
162916314|NCT01207427|588393820|FG000|Double-blind Treatment Period|Adverse Event|0|||
162916315|NCT01207427|588393821|FG001|Double-blind Treatment Period|Adverse Event|1|||
162916316|NCT01207427|588393822|FG002|Double-blind Treatment Period|Adverse Event|0|||
162916317|NCT01207427|588393820|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162916318|NCT01207427|588393821|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162916319|NCT01207427|588393822|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
162916320|NCT01207427|588393820|FG000|Double-blind Treatment Period|Protocol Violation|2|||
162916321|NCT01207427|588393821|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163054841|NCT01441973|588911811|FG000|Overall Study|Participant withdrew consent|0|||
163054842|NCT01441973|588911812|FG001|Overall Study|Participant withdrew consent|1|||
163054843|NCT01926028|588913937|FG000|Overall Study|Lost to Follow-up|7|||
163054844|NCT01926028|588913938|FG001|Overall Study|Lost to Follow-up|6|||
163054845|NCT01926028|588913939|FG002|Overall Study|Lost to Follow-up|0|||
163054846|NCT01926028|588913937|FG000|Overall Study|Physician Decision|1|||
163054847|NCT01926028|588913938|FG001|Overall Study|Physician Decision|5|||
163054848|NCT01926028|588913939|FG002|Overall Study|Physician Decision|0|||
163054849|NCT01926028|588913937|FG000|Overall Study|Withdrawal by Subject|9|||
163054850|NCT01926028|588913938|FG001|Overall Study|Withdrawal by Subject|9|||
163054851|NCT01926028|588913939|FG002|Overall Study|Withdrawal by Subject|2|||
163054852|NCT01926028|588913937|FG000|Overall Study|Non compliance or other reasons|4|||
163054853|NCT01926028|588913938|FG001|Overall Study|Non compliance or other reasons|2|||
163054854|NCT01926028|588913939|FG002|Overall Study|Non compliance or other reasons|0|||
163054855|NCT04539275|588913940|FG000|Overall Study|Death|2|||
163054856|NCT04539275|588913941|FG001|Overall Study|Death|4|||
163054857|NCT04539275|588913940|FG000|Overall Study|Lost to Follow-up|1|||
163054858|NCT04539275|588913941|FG001|Overall Study|Lost to Follow-up|1|||
163054859|NCT04539275|588913940|FG000|Overall Study|Withdrawal by Subject|3|||
163054860|NCT04539275|588913941|FG001|Overall Study|Withdrawal by Subject|0|||
163054861|NCT01799941|588913942|FG000|Overall Study|Adverse Event|34|||
163054862|NCT01799941|588913942|FG000|Overall Study|Withdrawal by Subject|21|||
163054863|NCT01799941|588913942|FG000|Overall Study|Death|2|||
163054864|NCT01799941|588913942|FG000|Overall Study|Investigator Decision|4|||
163054865|NCT01799941|588913942|FG000|Overall Study|Lack of Efficacy|3|||
163054866|NCT01799941|588913942|FG000|Overall Study|Lost to Follow-up|17|||
162916322|NCT01207427|588393822|FG002|Double-blind Treatment Period|Protocol Violation|1|||
162916323|NCT01207427|588393820|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
162916324|NCT01207427|588393821|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
162916325|NCT01207427|588393822|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162916326|NCT00422227|588393823|FG000|Overall Study|Adverse Event|3|||
162916327|NCT00422227|588393824|FG001|Overall Study|Adverse Event|8|||
162916328|NCT00422227|588393823|FG000|Overall Study|Lost to Follow-up|1|||
162916329|NCT00422227|588393824|FG001|Overall Study|Lost to Follow-up|3|||
162916330|NCT00422227|588393823|FG000|Overall Study|Withdrawal by Subject|0|||
162916331|NCT00422227|588393824|FG001|Overall Study|Withdrawal by Subject|4|||
162916332|NCT03323034|588395471|FG000|Overall Study|Lack of Efficacy|5|||
162916333|NCT03323034|588395472|FG001|Overall Study|Lack of Efficacy|5|||
162916334|NCT03323034|588395473|FG002|Overall Study|Lack of Efficacy|6|||
162916335|NCT03323034|588395474|FG003|Overall Study|Lack of Efficacy|5|||
162916336|NCT03323034|588395475|FG004|Overall Study|Lack of Efficacy|5|||
162916337|NCT03323034|588395471|FG000|Overall Study|Physician Decision|0|||
162916338|NCT03323034|588395472|FG001|Overall Study|Physician Decision|0|||
162916339|NCT03323034|588395473|FG002|Overall Study|Physician Decision|0|||
162916340|NCT03323034|588395474|FG003|Overall Study|Physician Decision|0|||
163054867|NCT01799941|588913942|FG000|Overall Study|Other|15|||
163054868|NCT00900562|588913950|FG000|Overall Study|Progressive disease|9|||
163054869|NCT00900562|588913951|FG001|Overall Study|Progressive disease|5|||
163054870|NCT00900562|588913950|FG000|Overall Study|Toxicity|1|||
163054871|NCT00900562|588913951|FG001|Overall Study|Toxicity|0|||
163054872|NCT00900562|588913950|FG000|Overall Study|Death|1|||
163054873|NCT00900562|588913951|FG001|Overall Study|Death|1|||
162916341|NCT03323034|588395475|FG004|Overall Study|Physician Decision|1|||
162916342|NCT03323034|588395471|FG000|Overall Study|Withdrawal by Subject|1|||
163054874|NCT00900562|588913950|FG000|Overall Study|Withdrawal by Subject|0|||
163054875|NCT00900562|588913951|FG001|Overall Study|Withdrawal by Subject|1|||
163054876|NCT00900562|588913950|FG000|Overall Study|Unrelated adverse event|1|||
163054877|NCT00900562|588913951|FG001|Overall Study|Unrelated adverse event|0|||
163054878|NCT00095979|588913954|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
163054879|NCT02051296|588913960|FG000|Overall Study|Lost to Follow-up|1|||
162916343|NCT03323034|588395472|FG001|Overall Study|Withdrawal by Subject|1|||
162916344|NCT03323034|588395473|FG002|Overall Study|Withdrawal by Subject|0|||
163054880|NCT02051296|588913961|FG001|Overall Study|Lost to Follow-up|2|||
163054881|NCT02051296|588913960|FG000|Overall Study|withdraw prior to treatment|7|||
162711039|NCT01649427|587652855|FG001|Overall Study|Adverse Event|1|||
162916345|NCT03323034|588395474|FG003|Overall Study|Withdrawal by Subject|1|||
162916346|NCT03323034|588395475|FG004|Overall Study|Withdrawal by Subject|0|||
162916347|NCT02646566|588395477|FG000|Overall Study|Lost to Follow-up|5|||
163054882|NCT02051296|588913961|FG001|Overall Study|withdraw prior to treatment|7|||
163054883|NCT01569022|588913963|FG000|First Intervention|Lost to Follow-up|2|||
163054884|NCT01569022|588913964|FG001|First Intervention|Lost to Follow-up|1|||
163054885|NCT01569022|588913963|FG000|Second Intervention|Lost to Follow-up|2|||
163054886|NCT01569022|588913964|FG001|Second Intervention|Lost to Follow-up|2|||
163054887|NCT00644059|588913969|FG000|Overall Study|Lost to Follow-up|37|||
163054888|NCT00644059|588913970|FG001|Overall Study|Lost to Follow-up|34|||
162916348|NCT02646566|588395478|FG001|Overall Study|Lost to Follow-up|4|||
162916349|NCT02646566|588395479|FG002|Overall Study|Lost to Follow-up|5|||
162916350|NCT02646566|588395477|FG000|Overall Study|Treatment failure|1|||
162916351|NCT02646566|588395478|FG001|Overall Study|Treatment failure|0|||
163054889|NCT00644059|588913971|FG002|Overall Study|Lost to Follow-up|16|||
163054890|NCT00644059|588913969|FG000|Overall Study|Withdrawal by Subject|52|||
163054891|NCT00644059|588913970|FG001|Overall Study|Withdrawal by Subject|60|||
163054892|NCT00644059|588913971|FG002|Overall Study|Withdrawal by Subject|30|||
163054893|NCT00644059|588913969|FG000|Overall Study|Adverse Event|8|||
163054894|NCT00644059|588913970|FG001|Overall Study|Adverse Event|5|||
163054895|NCT00644059|588913971|FG002|Overall Study|Adverse Event|1|||
163054896|NCT00644059|588913969|FG000|Overall Study|Inappropriate Enrollment|1|||
163054897|NCT00644059|588913970|FG001|Overall Study|Inappropriate Enrollment|3|||
163054898|NCT00644059|588913971|FG002|Overall Study|Inappropriate Enrollment|0|||
163054899|NCT00644059|588913969|FG000|Overall Study|Protocol Deviation/violation|20|||
163054900|NCT00644059|588913970|FG001|Overall Study|Protocol Deviation/violation|19|||
163054901|NCT00644059|588913971|FG002|Overall Study|Protocol Deviation/violation|15|||
163054902|NCT00644059|588913969|FG000|Overall Study|Unable to classify|6|||
163054903|NCT00644059|588913970|FG001|Overall Study|Unable to classify|2|||
163054904|NCT00644059|588913971|FG002|Overall Study|Unable to classify|3|||
163054905|NCT02133508|588913972|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
163054906|NCT02133508|588913972|FG000|Overall Study|Death|12|||
163054907|NCT02133508|588913972|FG000|Overall Study|Lost to Follow-up|2|||
163054908|NCT01302899|588913973|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
163054909|NCT01302899|588913974|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
163054910|NCT01302899|588913973|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
163054911|NCT01302899|588913974|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
163054912|NCT02497469|588913976|FG000|Overall Study|Randomized but not Treated|0|||
163054913|NCT02497469|588913977|FG001|Overall Study|Randomized but not Treated|2|||
163054914|NCT02497469|588913976|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
162916352|NCT02646566|588395479|FG002|Overall Study|Treatment failure|0|||
163054915|NCT02497469|588913977|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
163054916|NCT02497469|588913976|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
163054917|NCT02497469|588913977|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
163054918|NCT02497469|588913976|FG000|Overall Study|Significant Protocol Deviation|4|||
163054919|NCT02497469|588913977|FG001|Overall Study|Significant Protocol Deviation|5|||
163054920|NCT02497469|588913976|FG000|Overall Study|Lost to Follow-up|14|||
163054921|NCT02497469|588913977|FG001|Overall Study|Lost to Follow-up|4|||
163054922|NCT02497469|588913976|FG000|Overall Study|Voluntary Withdrawal|39|||
163054923|NCT02497469|588913977|FG001|Overall Study|Voluntary Withdrawal|41|||
163054924|NCT02497469|588913976|FG000|Overall Study|Pregnancy|1|||
163054925|NCT02497469|588913977|FG001|Overall Study|Pregnancy|1|||
163054926|NCT02497469|588913976|FG000|Overall Study|Lack of Efficacy|86|||
163054927|NCT02497469|588913977|FG001|Overall Study|Lack of Efficacy|40|||
163054928|NCT02497469|588913976|FG000|Overall Study|Reason not Specified|6|||
163054929|NCT02497469|588913977|FG001|Overall Study|Reason not Specified|6|||
163054930|NCT03558516|588913978|FG000|Overall Study|Protocol Violation|2|||
163054931|NCT03558516|588913979|FG001|Overall Study|Protocol Violation|2|||
163054932|NCT00472420|588913980|FG000|Induction Treatment Period|Physician Decision|9|||
163054933|NCT00472420|588913980|FG000|Induction Treatment Period|Adverse Event|3|||
163054934|NCT00472420|588913980|FG000|Induction Treatment Period|Non-compliance|1|||
163054935|NCT00472420|588913980|FG000|Induction Treatment Period|Death|3|||
163054936|NCT00472420|588913980|FG000|Follow-up Period|Death|5|||
163054937|NCT00472420|588913980|FG000|Follow-up Period|Physician Decision|9|||
163054938|NCT00472420|588913980|FG000|Follow-up Period|Lost to Follow-up|2|||
163054939|NCT00472420|588913980|FG000|Follow-up Period|Protocol Violation|1|||
163054940|NCT02065557|588913981|FG000|Induction Period|Withdrawal by Subject|2|||
163054941|NCT02065557|588913982|FG001|Induction Period|Withdrawal by Subject|1|||
163054942|NCT02065557|588913983|FG002|Induction Period|Withdrawal by Subject|0|||
163054943|NCT02065557|588913984|FG003|Induction Period|Withdrawal by Subject|0|||
163054944|NCT02065557|588913985|FG004|Induction Period|Withdrawal by Subject|0|||
163054945|NCT02065557|588913986|FG005|Induction Period|Withdrawal by Subject|0|||
163054946|NCT02065557|588913981|FG000|Induction Period|Lack of Efficacy|2|||
163054947|NCT02065557|588913982|FG001|Induction Period|Lack of Efficacy|1|||
163054948|NCT02065557|588913983|FG002|Induction Period|Lack of Efficacy|1|||
163054949|NCT02065557|588913984|FG003|Induction Period|Lack of Efficacy|0|||
163054950|NCT02065557|588913985|FG004|Induction Period|Lack of Efficacy|0|||
163054951|NCT02065557|588913986|FG005|Induction Period|Lack of Efficacy|0|||
163054952|NCT02065557|588913981|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
162916353|NCT04341727|588395489|FG000|Overall Study|Withdrawal by Subject|0|||
163054953|NCT02065557|588913982|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
162916354|NCT04341727|588395490|FG001|Overall Study|Withdrawal by Subject|0|||
163054954|NCT02065557|588913983|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
163054955|NCT02065557|588913984|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054956|NCT02065557|588913985|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054957|NCT02065557|588913986|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163054958|NCT02065557|588913981|FG000|Induction Period|Non-Responder at Week 8|4|||
163054959|NCT02065557|588913982|FG001|Induction Period|Non-Responder at Week 8|4|||
162916355|NCT04341727|588395491|FG002|Overall Study|Withdrawal by Subject|1|||
162916356|NCT04341727|588395492|FG003|Overall Study|Withdrawal by Subject|0|||
162916357|NCT04341727|588395489|FG000|Overall Study|Lost to Follow-up|0|||
162916358|NCT04341727|588395490|FG001|Overall Study|Lost to Follow-up|0|||
162916359|NCT04341727|588395491|FG002|Overall Study|Lost to Follow-up|0|||
162916360|NCT04341727|588395492|FG003|Overall Study|Lost to Follow-up|1|||
162916361|NCT00447265|588395493|FG000|Overall Study|Physician Decision|1|||
162916362|NCT00447265|588395494|FG001|Overall Study|Physician Decision|0|||
162916363|NCT00503035|588395495|FG000|Overall Study|Lost to Follow-up|2|||
162916364|NCT00503035|588395495|FG000|Overall Study|Physician Decision|3|||
162916365|NCT00503035|588395495|FG000|Overall Study|Ineligible|15|||
162916366|NCT05028816|588395498|FG000|Overall Study|Lost to Follow-up|5|||
162916367|NCT05028816|588395499|FG001|Overall Study|Lost to Follow-up|3|||
162916368|NCT05028816|588395498|FG000|Overall Study|Withdrawal by Subject|4|||
162916369|NCT05028816|588395499|FG001|Overall Study|Withdrawal by Subject|1|||
162916370|NCT05028816|588395498|FG000|Overall Study|Physician Decision|1|||
162916371|NCT05028816|588395499|FG001|Overall Study|Physician Decision|0|||
162916372|NCT04576702|588395507|FG000|Overall Study|Death|1|||
162916373|NCT04576702|588395508|FG001|Overall Study|Death|0|||
162916374|NCT04576702|588395509|FG002|Overall Study|Death|0|||
162916375|NCT04576702|588395510|FG003|Overall Study|Death|0|||
162916376|NCT04576702|588395507|FG000|Overall Study|Withdrawal by Subject|0|||
162916377|NCT04576702|588395508|FG001|Overall Study|Withdrawal by Subject|2|||
162916378|NCT04576702|588395509|FG002|Overall Study|Withdrawal by Subject|1|||
162916379|NCT04576702|588395510|FG003|Overall Study|Withdrawal by Subject|0|||
162916380|NCT04576702|588395507|FG000|Overall Study|Lost to Follow-up|3|||
162916381|NCT04576702|588395508|FG001|Overall Study|Lost to Follow-up|3|||
162916382|NCT04576702|588395509|FG002|Overall Study|Lost to Follow-up|3|||
162916383|NCT04576702|588395510|FG003|Overall Study|Lost to Follow-up|4|||
162916384|NCT01151085|588395511|FG000|Overall Study|Lost to Follow-up|31|||
162916385|NCT01151085|588395511|FG000|Overall Study|Protocol Violation|25|||
162916386|NCT00003526|588395512|FG000|Overall Study|Not evaluable|6|||
162916387|NCT02059265|588395513|FG000|Overall Study|Ineligible|4|||
162916388|NCT00998166|588395514|FG000|Overall Study|Early Study Termination|8|||
162916389|NCT02985996|588395518|FG000|Overall Study|Withdrawal by Subject|0|||
162916390|NCT02985996|588395519|FG001|Overall Study|Withdrawal by Subject|0|||
162916391|NCT02985996|588395520|FG002|Overall Study|Withdrawal by Subject|1|||
162916392|NCT02985996|588395521|FG003|Overall Study|Withdrawal by Subject|0|||
162916393|NCT02985996|588395522|FG004|Overall Study|Withdrawal by Subject|0|||
162916394|NCT02985996|588395518|FG000|Overall Study|Protocol Violation|0|||
162916395|NCT02985996|588395519|FG001|Overall Study|Protocol Violation|1|||
162916396|NCT02985996|588395520|FG002|Overall Study|Protocol Violation|0|||
162916397|NCT02985996|588395521|FG003|Overall Study|Protocol Violation|0|||
162916398|NCT02985996|588395522|FG004|Overall Study|Protocol Violation|0|||
162916399|NCT00401726|588395523|FG000|Overall Study|Adverse Event|34|||
162916400|NCT00401726|588395524|FG001|Overall Study|Adverse Event|45|||
162916401|NCT00401726|588395523|FG000|Overall Study|Death|0|||
162916402|NCT00401726|588395524|FG001|Overall Study|Death|3|||
162916403|NCT00401726|588395523|FG000|Overall Study|Sponsor Request|0|||
162916404|NCT00401726|588395524|FG001|Overall Study|Sponsor Request|1|||
162916405|NCT00401726|588395523|FG000|Overall Study|Physician Decision|3|||
162916406|NCT00401726|588395524|FG001|Overall Study|Physician Decision|6|||
162916407|NCT00401726|588395523|FG000|Overall Study|Lost to Follow-up|23|||
162916408|NCT00401726|588395524|FG001|Overall Study|Lost to Follow-up|20|||
162916409|NCT00401726|588395523|FG000|Overall Study|Protocol Violation|6|||
162916410|NCT00401726|588395524|FG001|Overall Study|Protocol Violation|3|||
162916411|NCT00401726|588395523|FG000|Overall Study|Withdrawal by Subject|18|||
162968824|NCT01709903|588586373|FG001|Overall Study|Lack of Efficacy|3|||
162968825|NCT01709903|588586372|FG000|Overall Study|Withdrawal by Subject|6|||
162968826|NCT01709903|588586373|FG001|Overall Study|Withdrawal by Subject|6|||
162968827|NCT01709903|588586372|FG000|Overall Study|Adverse Event|11|||
162968828|NCT01709903|588586373|FG001|Overall Study|Adverse Event|18|||
162968829|NCT01751087|588586378|FG000|Overall Study|Withdrawal by Subject|1|||
162968830|NCT01751087|588586379|FG001|Overall Study|Withdrawal by Subject|0|||
162916412|NCT00401726|588395524|FG001|Overall Study|Withdrawal by Subject|24|||
162916413|NCT00401726|588395523|FG000|Overall Study|Lack of Efficacy|4|||
162916414|NCT00401726|588395524|FG001|Overall Study|Lack of Efficacy|6|||
162916415|NCT00401726|588395523|FG000|Overall Study|Protocol Deviation|9|||
162916416|NCT00401726|588395524|FG001|Overall Study|Protocol Deviation|4|||
162916417|NCT00814502|588395527|FG000|Overall Study|Adverse Event|1|||
162916418|NCT00814502|588395528|FG001|Overall Study|Adverse Event|0|||
162968831|NCT01751087|588586380|FG002|Overall Study|Withdrawal by Subject|0|||
162968832|NCT01751087|588586378|FG000|Overall Study|Physician Decision|0|||
163054960|NCT02065557|588913983|FG002|Induction Period|Non-Responder at Week 8|0|||
162916419|NCT00814502|588395527|FG000|Overall Study|Withdrawal by Subject|0|||
162916420|NCT00814502|588395528|FG001|Overall Study|Withdrawal by Subject|2|||
162916421|NCT03735849|588395530|FG000|Overall Study|Lost to Follow-up|1|||
162916422|NCT03735849|588395531|FG001|Overall Study|Lost to Follow-up|0|||
162916423|NCT03735849|588395532|FG002|Overall Study|Lost to Follow-up|0|||
162968833|NCT01751087|588586379|FG001|Overall Study|Physician Decision|0|||
163054961|NCT02065557|588913984|FG003|Induction Period|Non-Responder at Week 8|0|||
163054962|NCT02065557|588913985|FG004|Induction Period|Non-Responder at Week 8|0|||
163054963|NCT02065557|588913986|FG005|Induction Period|Non-Responder at Week 8|0|||
163054964|NCT02065557|588913981|FG000|Induction Period|Adverse Event|1|||
163054965|NCT02065557|588913982|FG001|Induction Period|Adverse Event|1|||
163054966|NCT02065557|588913983|FG002|Induction Period|Adverse Event|0|||
163054967|NCT02065557|588913984|FG003|Induction Period|Adverse Event|0|||
163054968|NCT02065557|588913985|FG004|Induction Period|Adverse Event|0|||
163054969|NCT02065557|588913986|FG005|Induction Period|Adverse Event|0|||
163054970|NCT02065557|588913981|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
162916424|NCT03735849|588395530|FG000|Overall Study|Participant unable to adhere to visit|1|||
162916425|NCT03735849|588395531|FG001|Overall Study|Participant unable to adhere to visit|0|||
162916426|NCT03735849|588395532|FG002|Overall Study|Participant unable to adhere to visit|0|||
162916427|NCT03735849|588395530|FG000|Overall Study|Not Randomized|0|||
162916428|NCT03735849|588395531|FG001|Overall Study|Not Randomized|0|||
163054971|NCT02065557|588913982|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054972|NCT02065557|588913983|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054973|NCT02065557|588913984|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
162916429|NCT03735849|588395532|FG002|Overall Study|Not Randomized|4|||
162916430|NCT01050998|588395535|FG000|Overall Study|Adverse Event|1|||
162916431|NCT01050998|588395536|FG001|Overall Study|Adverse Event|0|||
162916432|NCT01050998|588395537|FG002|Overall Study|Adverse Event|1|||
162916433|NCT01050998|588395538|FG003|Overall Study|Adverse Event|0|||
162916434|NCT01050998|588395539|FG004|Overall Study|Adverse Event|2|||
162916435|NCT01050998|588395535|FG000|Overall Study|Withdrawal by Subject|0|||
162916436|NCT01050998|588395536|FG001|Overall Study|Withdrawal by Subject|0|||
162916437|NCT01050998|588395537|FG002|Overall Study|Withdrawal by Subject|0|||
162916438|NCT01050998|588395538|FG003|Overall Study|Withdrawal by Subject|1|||
162916439|NCT01050998|588395539|FG004|Overall Study|Withdrawal by Subject|3|||
162916440|NCT01050998|588395535|FG000|Overall Study|Other|3|||
162916441|NCT01050998|588395536|FG001|Overall Study|Other|2|||
162916442|NCT01050998|588395537|FG002|Overall Study|Other|1|||
162968834|NCT01751087|588586380|FG002|Overall Study|Physician Decision|1|||
162968835|NCT05377489|588586381|FG000|Overall Study|Withdrawal by Subject|122|||
162968836|NCT05377489|588586381|FG000|Overall Study|Lost to Follow-up|21|||
162968837|NCT05377489|588586381|FG000|Overall Study|Lack of Efficacy|10|||
162968838|NCT05377489|588586381|FG000|Overall Study|Adverse Event|5|||
162968839|NCT05377489|588586381|FG000|Overall Study|Death|4|||
163054974|NCT02065557|588913985|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
163054975|NCT02065557|588913986|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
163054976|NCT02065557|588913981|FG000|Maintenance Period|Withdrawal by Subject|0|||
163054977|NCT02065557|588913982|FG001|Maintenance Period|Withdrawal by Subject|0|||
163054978|NCT02065557|588913983|FG002|Maintenance Period|Withdrawal by Subject|0|||
163054979|NCT02065557|588913984|FG003|Maintenance Period|Withdrawal by Subject|0|||
163054980|NCT02065557|588913985|FG004|Maintenance Period|Withdrawal by Subject|2|||
163054981|NCT02065557|588913986|FG005|Maintenance Period|Withdrawal by Subject|1|||
163054982|NCT02065557|588913981|FG000|Maintenance Period|Lack of Efficacy|0|||
163054983|NCT02065557|588913982|FG001|Maintenance Period|Lack of Efficacy|0|||
163054984|NCT02065557|588913983|FG002|Maintenance Period|Lack of Efficacy|0|||
163054985|NCT02065557|588913984|FG003|Maintenance Period|Lack of Efficacy|0|||
163054986|NCT02065557|588913985|FG004|Maintenance Period|Lack of Efficacy|5|||
163054987|NCT02065557|588913986|FG005|Maintenance Period|Lack of Efficacy|2|||
163054988|NCT02065557|588913981|FG000|Maintenance Period|Subject Non-Compliance|0|||
163054989|NCT02065557|588913982|FG001|Maintenance Period|Subject Non-Compliance|0|||
163054990|NCT02065557|588913983|FG002|Maintenance Period|Subject Non-Compliance|0|||
162968840|NCT05377489|588586381|FG000|Overall Study|Physician Decision|3|||
162968841|NCT05377489|588586381|FG000|Overall Study|Protocol Violation|1|||
162968842|NCT05377489|588586381|FG000|Overall Study|Other|9|||
162968843|NCT00724958|588586382|FG000|Overall Study|Adverse Event|28|||
162968844|NCT00724958|588586382|FG000|Overall Study|Loss of Response|40|||
163054991|NCT02065557|588913984|FG003|Maintenance Period|Subject Non-Compliance|0|||
163054992|NCT02065557|588913985|FG004|Maintenance Period|Subject Non-Compliance|0|||
163054993|NCT02065557|588913986|FG005|Maintenance Period|Subject Non-Compliance|1|||
163054994|NCT01462942|588913990|FG000|Overall Study|Adverse Event|7|||
163054995|NCT01462942|588913991|FG001|Overall Study|Adverse Event|12|||
163054996|NCT01462942|588913992|FG002|Overall Study|Adverse Event|10|||
163054997|NCT01462942|588913993|FG003|Overall Study|Adverse Event|11|||
163054998|NCT01462942|588913994|FG004|Overall Study|Adverse Event|11|||
162968845|NCT00724958|588586382|FG000|Overall Study|No Response|18|||
163054999|NCT01462942|588913990|FG000|Overall Study|Other, including COPD exacerbation|3|||
163055000|NCT01462942|588913991|FG001|Overall Study|Other, including COPD exacerbation|5|||
162916443|NCT01050998|588395538|FG003|Overall Study|Other|1|||
162968846|NCT00724958|588586382|FG000|Overall Study|Remission|7|||
162968847|NCT00724958|588586382|FG000|Overall Study|Other Reason|76|||
162968848|NCT00724958|588586382|FG000|Overall Study|No documentation for end of therapy|13|||
162968849|NCT00697619|588586383|FG000|Overall Study|Lack of Efficacy|2|||
162916444|NCT01050998|588395539|FG004|Overall Study|Other|5|||
162916445|NCT01050998|588395535|FG000|Overall Study|Data integrity issues|0|||
162916446|NCT01050998|588395536|FG001|Overall Study|Data integrity issues|0|||
162916447|NCT01050998|588395537|FG002|Overall Study|Data integrity issues|1|||
162916448|NCT01050998|588395538|FG003|Overall Study|Data integrity issues|1|||
162916449|NCT01050998|588395539|FG004|Overall Study|Data integrity issues|4|||
162916450|NCT04246593|588395542|FG000|Overall Study|Withdrawal by Subject|14|||
162916451|NCT04246593|588395543|FG001|Overall Study|Withdrawal by Subject|13|||
162916452|NCT04246593|588395542|FG000|Overall Study|Lost to Follow-up|124|||
162916453|NCT04246593|588395543|FG001|Overall Study|Lost to Follow-up|71|||
162916454|NCT04246593|588395542|FG000|Overall Study|Moved out of area/became ineligible|3|||
162916455|NCT04246593|588395543|FG001|Overall Study|Moved out of area/became ineligible|1|||
162916456|NCT04246593|588395542|FG000|Overall Study|Reason unknown|4|||
162916457|NCT04246593|588395543|FG001|Overall Study|Reason unknown|2|||
162916458|NCT01012765|588395546|FG000|Treatment Period 1|Adverse Event|1|||
162916459|NCT01012765|588395547|FG001|Treatment Period 1|Adverse Event|0|||
162916460|NCT01012765|588395548|FG002|Treatment Period 1|Adverse Event|1|||
162916461|NCT01012765|588395549|FG003|Treatment Period 1|Adverse Event|0|||
162916462|NCT01012765|588395550|FG004|Treatment Period 1|Adverse Event|0|||
162916463|NCT01012765|588395551|FG005|Treatment Period 1|Adverse Event|0|||
162916464|NCT01012765|588395546|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162916465|NCT01012765|588395547|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162916466|NCT01012765|588395548|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162916467|NCT01012765|588395549|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162916468|NCT01012765|588395550|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162916469|NCT01012765|588395551|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162916470|NCT01012765|588395546|FG000|Treatment Period 1|Administrative problems|0|||
162916471|NCT01012765|588395547|FG001|Treatment Period 1|Administrative problems|0|||
162916472|NCT01012765|588395548|FG002|Treatment Period 1|Administrative problems|1|||
162916473|NCT01012765|588395549|FG003|Treatment Period 1|Administrative problems|1|||
162916474|NCT01012765|588395550|FG004|Treatment Period 1|Administrative problems|1|||
162916475|NCT01012765|588395551|FG005|Treatment Period 1|Administrative problems|0|||
162916476|NCT01012765|588395546|FG000|Treatment Period 1|Protocol Violation|0|||
162916477|NCT01012765|588395547|FG001|Treatment Period 1|Protocol Violation|0|||
162916478|NCT01012765|588395548|FG002|Treatment Period 1|Protocol Violation|0|||
162916479|NCT01012765|588395549|FG003|Treatment Period 1|Protocol Violation|2|||
162916480|NCT01012765|588395550|FG004|Treatment Period 1|Protocol Violation|1|||
162916481|NCT01012765|588395551|FG005|Treatment Period 1|Protocol Violation|0|||
162916482|NCT01012765|588395546|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
162916483|NCT01012765|588395547|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
162916484|NCT01012765|588395548|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
162916485|NCT01012765|588395549|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
162916486|NCT01012765|588395550|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
162916487|NCT01012765|588395551|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
162916488|NCT01012765|588395546|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162916489|NCT01012765|588395547|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162916490|NCT01012765|588395548|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162916491|NCT01012765|588395549|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162916492|NCT01012765|588395550|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162916493|NCT01012765|588395551|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162916494|NCT01012765|588395546|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
162916495|NCT01012765|588395547|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
162916496|NCT01012765|588395548|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
162916497|NCT01012765|588395549|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
162916498|NCT01012765|588395550|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
162916499|NCT01012765|588395551|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
162916500|NCT01012765|588395546|FG000|Treatment Period 2|Adverse Event|0|||
162916501|NCT01012765|588395547|FG001|Treatment Period 2|Adverse Event|1|||
162916502|NCT01012765|588395548|FG002|Treatment Period 2|Adverse Event|1|||
162916503|NCT01012765|588395549|FG003|Treatment Period 2|Adverse Event|0|||
162916504|NCT01012765|588395550|FG004|Treatment Period 2|Adverse Event|0|||
162916505|NCT01012765|588395551|FG005|Treatment Period 2|Adverse Event|0|||
162916506|NCT01012765|588395546|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
162916507|NCT01012765|588395547|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
162916508|NCT01012765|588395548|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
162968850|NCT00697619|588586384|FG001|Overall Study|Lack of Efficacy|2|||
162968851|NCT00697619|588586383|FG000|Overall Study|Adverse Event|4|||
162968852|NCT00697619|588586384|FG001|Overall Study|Adverse Event|6|||
162916509|NCT01012765|588395549|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
162916510|NCT01012765|588395550|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
162916511|NCT01012765|588395551|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
162916512|NCT04668157|588395559|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
162968853|NCT00559637|588587789|FG000|Overall Study|Adverse Event|22|||
162916513|NCT04668157|588395560|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
162916514|NCT04668157|588395559|FG000|Treatment Period (52 Weeks)|Other|0|||
162916515|NCT04668157|588395560|FG001|Treatment Period (52 Weeks)|Other|2|||
162916516|NCT02283411|588395565|FG000|Overall Study|Withdrawal by Subject|3|||
162916517|NCT02283411|588395565|FG000|Overall Study|Screen Failed|28|||
162916518|NCT05437211|588395566|FG000|Overall Study|Patient's decision|1|||
162916519|NCT05437211|588395567|FG001|Overall Study|Patient's decision|1|||
162916520|NCT03282123|588395569|FG000|Overall Study|Withdrawal by Subject|5|||
162916521|NCT00796367|588395573|FG000|Overall Study|Adverse Event|6|||
162916522|NCT00796367|588395574|FG001|Overall Study|Adverse Event|4|||
162916523|NCT00796367|588395575|FG002|Overall Study|Adverse Event|7|||
162916524|NCT00796367|588395573|FG000|Overall Study|Lost to Follow-up|5|||
162916525|NCT00796367|588395574|FG001|Overall Study|Lost to Follow-up|4|||
162916526|NCT00796367|588395575|FG002|Overall Study|Lost to Follow-up|21|||
162916527|NCT00796367|588395573|FG000|Overall Study|Withdrawal by Subject|9|||
162916528|NCT00796367|588395574|FG001|Overall Study|Withdrawal by Subject|11|||
162916529|NCT00796367|588395575|FG002|Overall Study|Withdrawal by Subject|12|||
162916530|NCT00796367|588395573|FG000|Overall Study|Lack of Efficacy|2|||
162968854|NCT00559637|588587789|FG000|Overall Study|Withdrawal by Subject|4|||
162968855|NCT00559637|588587789|FG000|Overall Study|Protocol Violation|6|||
162968856|NCT00559637|588587789|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
162968857|NCT00559637|588587789|FG000|Overall Study|Failure to return|6|||
162968858|NCT00559637|588587789|FG000|Overall Study|Insufficient response|3|||
162968859|NCT00559637|588587789|FG000|Overall Study|Started requiring dialysis after month 7|2|||
162968860|NCT00559637|588587789|FG000|Overall Study|Suspected lung cancer|1|||
162968861|NCT00559637|588587789|FG000|Overall Study|Participation in another study|1|||
162968862|NCT00559637|588587789|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
162968863|NCT00559637|588587789|FG000|Overall Study|Change of center|1|||
162968864|NCT00559637|588587789|FG000|Overall Study|Change of home|1|||
162968865|NCT00559637|588587789|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
162968866|NCT01705717|588587790|FG000|Overall Study|Adverse Event|2|||
162968867|NCT01705717|588587791|FG001|Overall Study|Adverse Event|2|||
162968868|NCT01705717|588587790|FG000|Overall Study|Lack of Efficacy|0|||
162968869|NCT01705717|588587791|FG001|Overall Study|Lack of Efficacy|1|||
162968870|NCT01705717|588587790|FG000|Overall Study|Other|0|||
162968871|NCT01705717|588587791|FG001|Overall Study|Other|2|||
162968872|NCT02031237|588587792|FG000|Overall Study|Death|1|||
162968873|NCT02031237|588587793|FG001|Overall Study|Death|5|||
162968874|NCT02031237|588587794|FG002|Overall Study|Death|0|||
162968875|NCT02031237|588587792|FG000|Overall Study|Physician Decision|0|||
162968876|NCT02031237|588587793|FG001|Overall Study|Physician Decision|1|||
162968877|NCT02031237|588587794|FG002|Overall Study|Physician Decision|0|||
162968878|NCT02031237|588587792|FG000|Overall Study|Withdrawal by Subject|2|||
162968879|NCT02031237|588587793|FG001|Overall Study|Withdrawal by Subject|2|||
162968880|NCT02031237|588587794|FG002|Overall Study|Withdrawal by Subject|0|||
162968881|NCT02031237|588587792|FG000|Overall Study|Protocol Violation|2|||
162968882|NCT02031237|588587793|FG001|Overall Study|Protocol Violation|6|||
162968883|NCT02031237|588587794|FG002|Overall Study|Protocol Violation|0|||
162968884|NCT02031237|588587792|FG000|Overall Study|Alternate Treatment Given|0|||
162968885|NCT02031237|588587793|FG001|Overall Study|Alternate Treatment Given|0|||
162968886|NCT02031237|588587794|FG002|Overall Study|Alternate Treatment Given|3|||
162968887|NCT02293460|588587795|FG000|Overall Study|Protocol Violation|1|||
162968888|NCT02293460|588587795|FG000|Overall Study|Lack of Efficacy|2|||
162968889|NCT02293460|588587795|FG000|Overall Study|Adverse Event|2|||
162968890|NCT02293460|588587795|FG000|Overall Study|Withdrawal by Subject|1|||
162968891|NCT01074008|588587800|FG000|Overall Study|Adverse Event|0|||
162968892|NCT01074008|588587801|FG001|Overall Study|Adverse Event|1|||
162968893|NCT01074008|588587802|FG002|Overall Study|Adverse Event|0|||
162968894|NCT01074008|588587803|FG003|Overall Study|Adverse Event|0|||
162916531|NCT00796367|588395574|FG001|Overall Study|Lack of Efficacy|1|||
162916532|NCT00796367|588395575|FG002|Overall Study|Lack of Efficacy|0|||
162916533|NCT00796367|588395573|FG000|Overall Study|non compliance|3|||
162968895|NCT01074008|588587804|FG004|Overall Study|Adverse Event|0|||
162968896|NCT01074008|588587805|FG005|Overall Study|Adverse Event|0|||
162711040|NCT01649427|587652854|FG000|Overall Study|Withdrawal by Subject|8|||
162916534|NCT00796367|588395574|FG001|Overall Study|non compliance|1|||
162916535|NCT00796367|588395575|FG002|Overall Study|non compliance|1|||
162916536|NCT00796367|588395573|FG000|Overall Study|Pregnancy|1|||
162916537|NCT00796367|588395574|FG001|Overall Study|Pregnancy|0|||
162711041|NCT01649427|587652855|FG001|Overall Study|Withdrawal by Subject|7|||
162916538|NCT00796367|588395575|FG002|Overall Study|Pregnancy|1|||
162916539|NCT00796367|588395573|FG000|Overall Study|Requirement for restricted medication|2|||
162968897|NCT01074008|588587806|FG006|Overall Study|Adverse Event|0|||
162968898|NCT01074008|588587807|FG007|Overall Study|Adverse Event|0|||
162968899|NCT01074008|588587808|FG008|Overall Study|Adverse Event|0|||
162968900|NCT01074008|588587800|FG000|Overall Study|Withdrawal by Subject|1|||
162968901|NCT01074008|588587801|FG001|Overall Study|Withdrawal by Subject|1|||
162968902|NCT01074008|588587802|FG002|Overall Study|Withdrawal by Subject|1|||
162968903|NCT01074008|588587803|FG003|Overall Study|Withdrawal by Subject|0|||
162916540|NCT00796367|588395574|FG001|Overall Study|Requirement for restricted medication|0|||
162916541|NCT00796367|588395575|FG002|Overall Study|Requirement for restricted medication|2|||
162916542|NCT00796367|588395573|FG000|Overall Study|other|2|||
162916543|NCT00796367|588395574|FG001|Overall Study|other|4|||
162916544|NCT00796367|588395575|FG002|Overall Study|other|3|||
162916545|NCT04604015|588395580|FG000|Overall Study|Incomplete Data Collection|33|||
162916546|NCT02129192|588395581|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
162916547|NCT02129192|588395582|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
162916548|NCT00553319|588395583|FG000|Overall Study|Lost to Follow-up|10|||
162916549|NCT00553319|588395584|FG001|Overall Study|Lost to Follow-up|9|||
162916550|NCT00553319|588395585|FG002|Overall Study|Lost to Follow-up|5|||
162916551|NCT00553319|588395583|FG000|Overall Study|wanted treatment elsewhere|2|||
162916552|NCT00553319|588395584|FG001|Overall Study|wanted treatment elsewhere|1|||
162916553|NCT00553319|588395585|FG002|Overall Study|wanted treatment elsewhere|1|||
162916554|NCT00553319|588395583|FG000|Overall Study|non-compliance|0|||
162916555|NCT00553319|588395584|FG001|Overall Study|non-compliance|0|||
162916556|NCT00553319|588395585|FG002|Overall Study|non-compliance|2|||
162916557|NCT00553319|588395583|FG000|Overall Study|incarceration|1|||
162916558|NCT00553319|588395584|FG001|Overall Study|incarceration|0|||
162968904|NCT01074008|588587804|FG004|Overall Study|Withdrawal by Subject|1|||
162968905|NCT01074008|588587805|FG005|Overall Study|Withdrawal by Subject|0|||
162968906|NCT01074008|588587806|FG006|Overall Study|Withdrawal by Subject|0|||
162968907|NCT01074008|588587807|FG007|Overall Study|Withdrawal by Subject|0|||
162968908|NCT01074008|588587808|FG008|Overall Study|Withdrawal by Subject|0|||
162968909|NCT01074008|588587800|FG000|Overall Study|Lost to Follow-up|0|||
162968910|NCT01074008|588587801|FG001|Overall Study|Lost to Follow-up|1|||
162968911|NCT01074008|588587802|FG002|Overall Study|Lost to Follow-up|1|||
162968912|NCT01074008|588587803|FG003|Overall Study|Lost to Follow-up|1|||
162968913|NCT01074008|588587804|FG004|Overall Study|Lost to Follow-up|1|||
162968914|NCT01074008|588587805|FG005|Overall Study|Lost to Follow-up|0|||
162968915|NCT01074008|588587806|FG006|Overall Study|Lost to Follow-up|1|||
162968916|NCT01074008|588587807|FG007|Overall Study|Lost to Follow-up|0|||
162968917|NCT01074008|588587808|FG008|Overall Study|Lost to Follow-up|4|||
162968918|NCT02805309|588587811|FG000|Overall Study|Lost to Follow-up|2|||
162968919|NCT02805309|588587812|FG001|Overall Study|Lost to Follow-up|2|||
162968920|NCT02805309|588587813|FG002|Overall Study|Lost to Follow-up|2|||
162968921|NCT02805309|588587811|FG000|Overall Study|Post-Randomization Exclusion|0|||
162968922|NCT02805309|588587812|FG001|Overall Study|Post-Randomization Exclusion|2|||
162968923|NCT02805309|588587813|FG002|Overall Study|Post-Randomization Exclusion|1|||
162968924|NCT01636934|588587814|FG000|Overall Study|Withdrawal by Subject|3|||
162968925|NCT01636934|588587815|FG001|Overall Study|Withdrawal by Subject|2|||
162968926|NCT01636934|588587814|FG000|Overall Study|Chemo cancel|1|||
162968927|NCT01636934|588587815|FG001|Overall Study|Chemo cancel|0|||
162968928|NCT01636934|588587814|FG000|Overall Study|Too ill to continue|1|||
162968929|NCT01636934|588587815|FG001|Overall Study|Too ill to continue|0|||
162968930|NCT01636934|588587814|FG000|Overall Study|Never started study medication|1|||
162968931|NCT01636934|588587815|FG001|Overall Study|Never started study medication|1|||
162968932|NCT03035890|588587824|FG000|Overall Study|Death|1|||
162968933|NCT05480800|588587827|FG000|Overall Study|Withdrawal by Subject|0|||
162968934|NCT05480800|588587828|FG001|Overall Study|Withdrawal by Subject|0|||
162968935|NCT05480800|588587829|FG002|Overall Study|Withdrawal by Subject|2|||
162968936|NCT05480800|588587830|FG003|Overall Study|Withdrawal by Subject|1|||
162968937|NCT05480800|588587831|FG004|Overall Study|Withdrawal by Subject|0|||
162968938|NCT05480800|588587832|FG005|Overall Study|Withdrawal by Subject|0|||
162968939|NCT05480800|588587833|FG006|Overall Study|Withdrawal by Subject|1|||
162968940|NCT05480800|588587834|FG007|Overall Study|Withdrawal by Subject|0|||
162968941|NCT05480800|588587827|FG000|Overall Study|Other|0|||
162968942|NCT05480800|588587828|FG001|Overall Study|Other|0|||
162968943|NCT05480800|588587829|FG002|Overall Study|Other|0|||
162968944|NCT05480800|588587830|FG003|Overall Study|Other|0|||
162968945|NCT05480800|588587831|FG004|Overall Study|Other|0|||
162968946|NCT05480800|588587832|FG005|Overall Study|Other|0|||
162968947|NCT05480800|588587833|FG006|Overall Study|Other|1|||
162968948|NCT05480800|588587834|FG007|Overall Study|Other|0|||
162968949|NCT00377156|588587839|FG000|Overall Study|Death|23|||
162968950|NCT00377156|588587840|FG001|Overall Study|Death|19|||
162968951|NCT00377156|588587839|FG000|Overall Study|Withdrawal by Subject|16|||
162968952|NCT00377156|588587840|FG001|Overall Study|Withdrawal by Subject|24|||
162968953|NCT00377156|588587839|FG000|Overall Study|Had follow-up <90 d|3|||
162968954|NCT00377156|588587840|FG001|Overall Study|Had follow-up <90 d|6|||
162968955|NCT00377156|588587839|FG000|Overall Study|Cancellation|1|||
162968956|NCT00377156|588587840|FG001|Overall Study|Cancellation|0|||
162968957|NCT00377156|588587839|FG000|Overall Study|Refused testing|0|||
162968958|NCT00377156|588587840|FG001|Overall Study|Refused testing|1|||
162968959|NCT00377156|588587839|FG000|Overall Study|Ineligible|0|||
162968960|NCT00377156|588587840|FG001|Overall Study|Ineligible|1|||
162968961|NCT00377156|588587839|FG000|Overall Study|Disability or language problem|0|||
162968962|NCT00377156|588587840|FG001|Overall Study|Disability or language problem|1|||
163055001|NCT01462942|588913992|FG002|Overall Study|Other, including COPD exacerbation|2|||
163055002|NCT01462942|588913993|FG003|Overall Study|Other, including COPD exacerbation|8|||
163055003|NCT01462942|588913994|FG004|Overall Study|Other, including COPD exacerbation|5|||
163055004|NCT01462942|588913990|FG000|Overall Study|Withdrawal by Subject|14|||
163055005|NCT01462942|588913991|FG001|Overall Study|Withdrawal by Subject|10|||
163055006|NCT01462942|588913992|FG002|Overall Study|Withdrawal by Subject|14|||
163055007|NCT01462942|588913993|FG003|Overall Study|Withdrawal by Subject|16|||
163055008|NCT01462942|588913994|FG004|Overall Study|Withdrawal by Subject|19|||
163055009|NCT01462942|588913990|FG000|Overall Study|Lack of Efficacy|6|||
163055010|NCT01462942|588913991|FG001|Overall Study|Lack of Efficacy|0|||
163055011|NCT01462942|588913992|FG002|Overall Study|Lack of Efficacy|4|||
163055012|NCT01462942|588913993|FG003|Overall Study|Lack of Efficacy|5|||
163055013|NCT01462942|588913994|FG004|Overall Study|Lack of Efficacy|3|||
163055014|NCT01462942|588913990|FG000|Overall Study|Lost to Follow-up|0|||
163055015|NCT01462942|588913991|FG001|Overall Study|Lost to Follow-up|1|||
163055016|NCT01462942|588913992|FG002|Overall Study|Lost to Follow-up|1|||
162916559|NCT00553319|588395585|FG002|Overall Study|incarceration|0|||
162916560|NCT00553319|588395583|FG000|Overall Study|moved|1|||
162916561|NCT00553319|588395584|FG001|Overall Study|moved|0|||
162916562|NCT00553319|588395585|FG002|Overall Study|moved|1|||
162916563|NCT03575975|588395587|FG000|Overall Study|Lost to Follow-up|1|||
162916564|NCT03575975|588395588|FG001|Overall Study|Lost to Follow-up|0|||
162916565|NCT03575975|588395589|FG002|Overall Study|Lost to Follow-up|0|||
162916566|NCT00465894|588395590|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
162916567|NCT00465894|588395591|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
162916568|NCT00465894|588395590|FG000|Treatment For 12 Weeks|Family Issues|1|||
162916569|NCT00465894|588395591|FG001|Treatment For 12 Weeks|Family Issues|1|||
162916570|NCT00465894|588395590|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
162916571|NCT00465894|588395591|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
162916572|NCT02441517|588395592|FG000|Overall Study|Lost to Follow-up|1|||
162916573|NCT02441517|588395592|FG000|Overall Study|Withdrawal by Subject|2|||
162916574|NCT02441517|588395592|FG000|Overall Study|Study Terminated by Sponsor|1|||
162916575|NCT00129220|588395594|FG000|Study Period II|Adverse Event|9|||
162916576|NCT00129220|588395595|FG001|Study Period II|Adverse Event|5|||
162916577|NCT00129220|588395596|FG002|Study Period II|Adverse Event|7|||
162916578|NCT00129220|588395594|FG000|Study Period II|Lack of Efficacy|15|||
162916579|NCT00129220|588395595|FG001|Study Period II|Lack of Efficacy|1|||
162916580|NCT00129220|588395596|FG002|Study Period II|Lack of Efficacy|28|||
162916581|NCT00129220|588395594|FG000|Study Period II|Entry Criteria Not Met|2|||
162916582|NCT00129220|588395595|FG001|Study Period II|Entry Criteria Not Met|0|||
162916583|NCT00129220|588395596|FG002|Study Period II|Entry Criteria Not Met|2|||
162916584|NCT00129220|588395594|FG000|Study Period II|Protocol Violation|4|||
162916585|NCT00129220|588395595|FG001|Study Period II|Protocol Violation|2|||
162916586|NCT00129220|588395596|FG002|Study Period II|Protocol Violation|1|||
162916587|NCT00129220|588395594|FG000|Study Period II|Physician Decision|0|||
162916588|NCT00129220|588395595|FG001|Study Period II|Physician Decision|1|||
162916589|NCT00129220|588395596|FG002|Study Period II|Physician Decision|0|||
162916590|NCT00129220|588395594|FG000|Study Period II|Withdrawal by Subject|1|||
162916591|NCT00129220|588395595|FG001|Study Period II|Withdrawal by Subject|3|||
162916592|NCT00129220|588395596|FG002|Study Period II|Withdrawal by Subject|4|||
162916593|NCT00129220|588395594|FG000|Study Period II|Reason Not Specified|2|||
162916594|NCT00129220|588395595|FG001|Study Period II|Reason Not Specified|0|||
162916595|NCT00129220|588395596|FG002|Study Period II|Reason Not Specified|5|||
162916596|NCT00129220|588395594|FG000|Study Period III|Adverse Event|1|||
162916597|NCT00129220|588395595|FG001|Study Period III|Adverse Event|0|||
162916598|NCT00129220|588395596|FG002|Study Period III|Adverse Event|3|||
162916599|NCT00129220|588395594|FG000|Study Period III|Protocol Violation|1|||
162916600|NCT00129220|588395595|FG001|Study Period III|Protocol Violation|1|||
162916601|NCT00129220|588395596|FG002|Study Period III|Protocol Violation|2|||
162916602|NCT00129220|588395594|FG000|Study Period III|Withdrawal by Subject|1|||
162916603|NCT00129220|588395595|FG001|Study Period III|Withdrawal by Subject|0|||
162916604|NCT00129220|588395596|FG002|Study Period III|Withdrawal by Subject|3|||
162916605|NCT00129220|588395594|FG000|Study Period III|Sponsor Decision|1|||
162916606|NCT00129220|588395595|FG001|Study Period III|Sponsor Decision|0|||
162916607|NCT00129220|588395596|FG002|Study Period III|Sponsor Decision|0|||
163055017|NCT01462942|588913993|FG003|Overall Study|Lost to Follow-up|1|||
163055018|NCT01462942|588913994|FG004|Overall Study|Lost to Follow-up|1|||
163055019|NCT01462942|588913990|FG000|Overall Study|Protocol Violation|4|||
163055020|NCT01462942|588913991|FG001|Overall Study|Protocol Violation|6|||
163055021|NCT01462942|588913992|FG002|Overall Study|Protocol Violation|9|||
163055022|NCT01462942|588913993|FG003|Overall Study|Protocol Violation|9|||
163055023|NCT01462942|588913994|FG004|Overall Study|Protocol Violation|6|||
162711042|NCT01649427|587652854|FG000|Overall Study|Lost to Follow-up|0|||
162916608|NCT00129220|588395594|FG000|Study Period III|Reason Not Specified|9|||
162916609|NCT00129220|588395595|FG001|Study Period III|Reason Not Specified|0|||
162916610|NCT00129220|588395596|FG002|Study Period III|Reason Not Specified|2|||
162916611|NCT01883362|588395597|FG000|Treatment|Adverse Event|1|||
162916612|NCT01883362|588395598|FG001|Treatment|Adverse Event|8|||
162916613|NCT01883362|588395597|FG000|Treatment|Withdrawal by Subject|6|||
162916614|NCT01883362|588395598|FG001|Treatment|Withdrawal by Subject|2|||
162916615|NCT01883362|588395597|FG000|Treatment|Administrative problems|4|||
162916616|NCT01883362|588395598|FG001|Treatment|Administrative problems|1|||
162916617|NCT01883362|588395597|FG000|Treatment|Relapse|4|||
162916618|NCT01883362|588395598|FG001|Treatment|Relapse|2|||
162916619|NCT01883362|588395597|FG000|Treatment|Randomized, not treated|1|||
162916620|NCT01883362|588395598|FG001|Treatment|Randomized, not treated|1|||
162916621|NCT01883362|588395597|FG000|Post Treatment Follow-up|Protocol Violation|0|||
162916622|NCT01883362|588395598|FG001|Post Treatment Follow-up|Protocol Violation|1|||
162916623|NCT01883362|588395597|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
162711043|NCT01649427|587652855|FG001|Overall Study|Lost to Follow-up|1|||
162916624|NCT01883362|588395598|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
162916625|NCT01883362|588395597|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
162916626|NCT01883362|588395598|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
162916627|NCT01883362|588395597|FG000|Post Treatment Follow-up|Administrative problems|2|||
162916628|NCT01883362|588395598|FG001|Post Treatment Follow-up|Administrative problems|0|||
162916629|NCT01883362|588395597|FG000|Post Treatment Follow-up|Death|8|||
162916630|NCT01883362|588395598|FG001|Post Treatment Follow-up|Death|4|||
162916631|NCT01883362|588395597|FG000|Post Treatment Follow-up|Relapse|1|||
162916632|NCT01883362|588395598|FG001|Post Treatment Follow-up|Relapse|2|||
162916633|NCT01383317|588395599|FG000|Overall Study|Lost to Follow-up|2|||
162916634|NCT01383317|588395600|FG001|Overall Study|Lost to Follow-up|1|||
162916635|NCT01383317|588395599|FG000|Overall Study|Death|1|||
162916636|NCT01383317|588395600|FG001|Overall Study|Death|0|||
162916637|NCT01383317|588395599|FG000|Overall Study|Adverse Event|0|||
162916638|NCT01383317|588395600|FG001|Overall Study|Adverse Event|1|||
162916639|NCT00686894|588395602|FG000|Overall Study|Relapse|2|||
162916640|NCT00686894|588395602|FG000|Overall Study|Protocol Violation|4|||
162916641|NCT01230489|588395603|FG000|Overall Study|Death|2|||
162916642|NCT01230489|588395603|FG000|Overall Study|Adverse Event|2|||
162916643|NCT01230489|588395603|FG000|Overall Study|Treatment modality changed|1|||
162916644|NCT00967343|588395604|FG000|Overall Study|Study termination by sponsor|12|||
162916645|NCT00967343|588395604|FG000|Overall Study|Death|24|||
162916646|NCT00967343|588395604|FG000|Overall Study|Relapse|1|||
162916647|NCT00967343|588395604|FG000|Overall Study|Lost to Follow-up|1|||
162916648|NCT00869362|588397323|FG000|Overall Study|Death|0|||
162916649|NCT00869362|588397324|FG001|Overall Study|Death|2|||
162916650|NCT00869362|588397323|FG000|Overall Study|Lost to Follow-up|1|||
162916651|NCT00869362|588397324|FG001|Overall Study|Lost to Follow-up|3|||
162916652|NCT02815540|588397327|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
162916653|NCT04887922|588397335|FG000|1st Randomization|Decided not to have surgery|0|||
162916654|NCT04887922|588397336|FG001|1st Randomization|Decided not to have surgery|1|||
162916655|NCT04887922|588397337|FG002|1st Randomization|Decided not to have surgery|0|||
162916656|NCT04887922|588397338|FG003|1st Randomization|Decided not to have surgery|0|||
162916657|NCT04887922|588397339|FG004|1st Randomization|Decided not to have surgery|0|||
162916658|NCT00953017|588397340|FG000|Overall Study|DId not show up for colonoscopy|4|||
162916659|NCT00953017|588397341|FG001|Overall Study|DId not show up for colonoscopy|4|||
162916660|NCT00953017|588397342|FG002|Overall Study|DId not show up for colonoscopy|5|||
162916661|NCT00953017|588397343|FG003|Overall Study|DId not show up for colonoscopy|4|||
162916662|NCT00953017|588397340|FG000|Overall Study|Incomplete data|1|||
162916663|NCT00953017|588397341|FG001|Overall Study|Incomplete data|1|||
162916664|NCT00953017|588397342|FG002|Overall Study|Incomplete data|0|||
162916665|NCT00953017|588397343|FG003|Overall Study|Incomplete data|0|||
162916666|NCT00953017|588397340|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
162968963|NCT00377156|588587839|FG000|Overall Study|Other|5|||
162968964|NCT00377156|588587840|FG001|Overall Study|Other|2|||
162968965|NCT01802216|588587843|FG000|4 Month Visit|Participant did not show to visit|3|||
162968966|NCT01802216|588587844|FG001|4 Month Visit|Participant did not show to visit|4|||
162968967|NCT01802216|588587843|FG000|8 Month Visit|Participant did not show to visit|3|||
162916667|NCT00953017|588397341|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
162916668|NCT00953017|588397342|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
162916669|NCT00953017|588397343|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
162916670|NCT00953017|588397340|FG000|Overall Study|Brown stool prior to procedure|0|||
162916671|NCT00953017|588397341|FG001|Overall Study|Brown stool prior to procedure|0|||
162916672|NCT00953017|588397342|FG002|Overall Study|Brown stool prior to procedure|1|||
162916673|NCT00953017|588397343|FG003|Overall Study|Brown stool prior to procedure|0|||
162916674|NCT00798161|588397346|FG000|Overall Study|Adverse Event|3|||
162916675|NCT00798161|588397347|FG001|Overall Study|Adverse Event|4|||
162916676|NCT00798161|588397348|FG002|Overall Study|Adverse Event|6|||
163055024|NCT02737722|588913995|FG000|Overall Study|Physician Decision|0|||
162711044|NCT01649427|587652854|FG000|Overall Study|Graft loss|0|||
162916677|NCT00798161|588397349|FG003|Overall Study|Adverse Event|6|||
162916678|NCT00798161|588397350|FG004|Overall Study|Adverse Event|5|||
162916679|NCT00798161|588397351|FG005|Overall Study|Adverse Event|2|||
162916680|NCT00798161|588397352|FG006|Overall Study|Adverse Event|4|||
162916681|NCT00798161|588397346|FG000|Overall Study|Protocol Violation|2|||
162916682|NCT00798161|588397347|FG001|Overall Study|Protocol Violation|1|||
162916683|NCT00798161|588397348|FG002|Overall Study|Protocol Violation|3|||
162916684|NCT00798161|588397349|FG003|Overall Study|Protocol Violation|3|||
162916685|NCT00798161|588397350|FG004|Overall Study|Protocol Violation|3|||
162916686|NCT00798161|588397351|FG005|Overall Study|Protocol Violation|2|||
162916687|NCT00798161|588397352|FG006|Overall Study|Protocol Violation|0|||
162916688|NCT00798161|588397346|FG000|Overall Study|Lost to Follow-up|1|||
162916689|NCT00798161|588397347|FG001|Overall Study|Lost to Follow-up|3|||
162916690|NCT00798161|588397348|FG002|Overall Study|Lost to Follow-up|4|||
162916691|NCT00798161|588397349|FG003|Overall Study|Lost to Follow-up|3|||
162916692|NCT00798161|588397350|FG004|Overall Study|Lost to Follow-up|4|||
162916693|NCT00798161|588397351|FG005|Overall Study|Lost to Follow-up|0|||
162916694|NCT00798161|588397352|FG006|Overall Study|Lost to Follow-up|0|||
162916695|NCT00798161|588397346|FG000|Overall Study|Withdrawal by Subject|5|||
162916696|NCT00798161|588397347|FG001|Overall Study|Withdrawal by Subject|4|||
162916697|NCT00798161|588397348|FG002|Overall Study|Withdrawal by Subject|5|||
162916698|NCT00798161|588397349|FG003|Overall Study|Withdrawal by Subject|4|||
162916699|NCT00798161|588397350|FG004|Overall Study|Withdrawal by Subject|2|||
162916700|NCT00798161|588397351|FG005|Overall Study|Withdrawal by Subject|3|||
162916701|NCT00798161|588397352|FG006|Overall Study|Withdrawal by Subject|1|||
162916702|NCT00798161|588397346|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
162916703|NCT00798161|588397347|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
162916704|NCT00798161|588397348|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
162916705|NCT00798161|588397349|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
162916706|NCT00798161|588397350|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
162916707|NCT00798161|588397351|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
162916708|NCT00798161|588397352|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
162916709|NCT00594568|588397353|FG000|Initial Treatment|Adverse Event|51|||
162916710|NCT00594568|588397354|FG001|Initial Treatment|Adverse Event|121|||
162916711|NCT00594568|588397355|FG002|Initial Treatment|Adverse Event|144|||
162916712|NCT00594568|588397353|FG000|Initial Treatment|Death|6|||
162916713|NCT00594568|588397354|FG001|Initial Treatment|Death|11|||
162916714|NCT00594568|588397355|FG002|Initial Treatment|Death|15|||
162916715|NCT00594568|588397353|FG000|Initial Treatment|Lost to Follow-up|4|||
162916716|NCT00594568|588397354|FG001|Initial Treatment|Lost to Follow-up|1|||
162916717|NCT00594568|588397355|FG002|Initial Treatment|Lost to Follow-up|4|||
162916718|NCT00594568|588397353|FG000|Initial Treatment|Physician Decision|3|||
162916719|NCT00594568|588397354|FG001|Initial Treatment|Physician Decision|2|||
162916720|NCT00594568|588397355|FG002|Initial Treatment|Physician Decision|4|||
162916721|NCT00594568|588397353|FG000|Initial Treatment|Protocol Violation|2|||
162916722|NCT00594568|588397354|FG001|Initial Treatment|Protocol Violation|2|||
162916723|NCT00594568|588397355|FG002|Initial Treatment|Protocol Violation|5|||
162916724|NCT00594568|588397353|FG000|Initial Treatment|Withdrawal by Subject|25|||
162916725|NCT00594568|588397354|FG001|Initial Treatment|Withdrawal by Subject|31|||
162916726|NCT00594568|588397355|FG002|Initial Treatment|Withdrawal by Subject|46|||
162916727|NCT00594568|588397353|FG000|Initial Treatment|Sponsor decision|193|||
162916728|NCT00594568|588397354|FG001|Initial Treatment|Sponsor decision|142|||
162916729|NCT00594568|588397355|FG002|Initial Treatment|Sponsor decision|147|||
162916730|NCT00594568|588397353|FG000|Initial Treatment|Caregiver decision|21|||
162916731|NCT00594568|588397354|FG001|Initial Treatment|Caregiver decision|36|||
162916732|NCT00594568|588397355|FG002|Initial Treatment|Caregiver decision|36|||
162916733|NCT00594568|588397353|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
162916734|NCT00594568|588397354|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
162916735|NCT00594568|588397355|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
162916736|NCT00594568|588397353|FG000|Initial Treatment|Entry criteria exclusion|0|||
162916737|NCT00594568|588397354|FG001|Initial Treatment|Entry criteria exclusion|1|||
162916738|NCT00594568|588397355|FG002|Initial Treatment|Entry criteria exclusion|1|||
163055025|NCT02737722|588913996|FG001|Overall Study|Physician Decision|0|||
162916739|NCT00594568|588397353|FG000|Delayed Start|Death|0|||
162916740|NCT00594568|588397354|FG001|Delayed Start|Death|0|||
162916741|NCT00594568|588397355|FG002|Delayed Start|Death|1|||
162916742|NCT00594568|588397353|FG000|Delayed Start|Adverse Event|12|||
162916743|NCT00594568|588397354|FG001|Delayed Start|Adverse Event|2|||
162916744|NCT00594568|588397355|FG002|Delayed Start|Adverse Event|2|||
162916745|NCT00594568|588397353|FG000|Delayed Start|Withdrawal by Subject|4|||
162916746|NCT00594568|588397354|FG001|Delayed Start|Withdrawal by Subject|3|||
162916747|NCT00594568|588397355|FG002|Delayed Start|Withdrawal by Subject|0|||
162916748|NCT00594568|588397353|FG000|Delayed Start|Physician Decision|0|||
162916749|NCT00594568|588397354|FG001|Delayed Start|Physician Decision|0|||
162916750|NCT00594568|588397355|FG002|Delayed Start|Physician Decision|1|||
162916751|NCT00594568|588397353|FG000|Delayed Start|Lost to Follow-up|0|||
162916752|NCT00594568|588397354|FG001|Delayed Start|Lost to Follow-up|0|||
162916753|NCT00594568|588397355|FG002|Delayed Start|Lost to Follow-up|1|||
162916754|NCT00594568|588397353|FG000|Delayed Start|Caregiver Decision|5|||
162916755|NCT00594568|588397354|FG001|Delayed Start|Caregiver Decision|6|||
162916756|NCT00594568|588397355|FG002|Delayed Start|Caregiver Decision|2|||
162916757|NCT00594568|588397353|FG000|Delayed Start|Sponsor Decision|77|||
162916758|NCT00594568|588397354|FG001|Delayed Start|Sponsor Decision|66|||
162916759|NCT00594568|588397355|FG002|Delayed Start|Sponsor Decision|59|||
162916760|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
162916761|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
162916762|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
162916763|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
162916764|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
162916765|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
162916766|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
162916767|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
162916768|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
162916769|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
162916770|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
162916771|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
162916772|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
162916773|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
162916774|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
162916775|NCT00594568|588397353|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
162916776|NCT00594568|588397354|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
162916777|NCT00594568|588397355|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
162916778|NCT01548573|588397357|FG000|Overall Study|Death|3|||
162916779|NCT01548573|588397357|FG000|Overall Study|Withdrawal by Subject|2|||
162916780|NCT01366846|588397358|FG000|Overall Study|Withdrawal by Subject|2|||
162916781|NCT01366846|588397359|FG001|Overall Study|Withdrawal by Subject|0|||
162916782|NCT01366846|588397360|FG002|Overall Study|Withdrawal by Subject|0|||
162916783|NCT01366846|588397361|FG003|Overall Study|Withdrawal by Subject|0|||
162916784|NCT01366846|588397358|FG000|Overall Study|Communication Difficulties|1|||
162916785|NCT01366846|588397359|FG001|Overall Study|Communication Difficulties|4|||
162916786|NCT01366846|588397360|FG002|Overall Study|Communication Difficulties|0|||
162916787|NCT01366846|588397361|FG003|Overall Study|Communication Difficulties|1|||
162916788|NCT01366846|588397358|FG000|Overall Study|Scheduling Conflicts|0|||
162916789|NCT01366846|588397359|FG001|Overall Study|Scheduling Conflicts|0|||
162916790|NCT01366846|588397360|FG002|Overall Study|Scheduling Conflicts|1|||
162916791|NCT01366846|588397361|FG003|Overall Study|Scheduling Conflicts|0|||
162916792|NCT00290511|588397362|FG000|Overall Study|Adverse Event|1|||
162916793|NCT00290511|588397362|FG000|Overall Study|Death|1|||
162916794|NCT00290511|588397362|FG000|Overall Study|Physician Decision|1|||
162916795|NCT00290511|588397362|FG000|Overall Study|Withdrawal by Subject|1|||
162916796|NCT04311411|588397363|FG000|Overall Study|Adverse Event|2|||
162916797|NCT04311411|588397364|FG001|Overall Study|Adverse Event|3|||
162916798|NCT04311411|588397365|FG002|Overall Study|Adverse Event|2|||
162916799|NCT04311411|588397363|FG000|Overall Study|Withdrawal by Subject|3|||
162916800|NCT04311411|588397364|FG001|Overall Study|Withdrawal by Subject|3|||
162916801|NCT04311411|588397365|FG002|Overall Study|Withdrawal by Subject|0|||
162916802|NCT01976663|588397369|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
162916803|NCT01976663|588397369|FG000|Overall Study|Personal Reasons|6|||
162916804|NCT01976663|588397369|FG000|Overall Study|Withdrawal by Subject|4|||
162916805|NCT01976663|588397369|FG000|Overall Study|Screen Failure|3|||
162916806|NCT01976663|588397369|FG000|Overall Study|Adverse Event|2|||
162916807|NCT01976663|588397369|FG000|Overall Study|Lost to Follow-up|3|||
162916808|NCT04780776|588397372|FG000|Titration Week 1-5|Lost to Follow-up|2|||
162968968|NCT01802216|588587844|FG001|8 Month Visit|Participant did not show to visit|5|||
162968969|NCT01802216|588587843|FG000|12 Month Visit|Participant did not show to visit|3|||
162968970|NCT01802216|588587844|FG001|12 Month Visit|Participant did not show to visit|4|||
162968971|NCT02459418|588587845|FG000|Overall Study|Exclusion Criteria|4|||
162968972|NCT02459418|588587846|FG001|Overall Study|Exclusion Criteria|0|||
162968973|NCT02459418|588587845|FG000|Overall Study|Protocol Violation|0|||
162968974|NCT02459418|588587846|FG001|Overall Study|Protocol Violation|2|||
162968975|NCT02459418|588587845|FG000|Overall Study|Physician Decision|0|||
163055026|NCT02737722|588913997|FG002|Overall Study|Physician Decision|1|||
162916809|NCT04780776|588397373|FG001|Titration Week 1-5|Lost to Follow-up|8|||
162916810|NCT04780776|588397372|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
162916811|NCT04780776|588397373|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
162916812|NCT04780776|588397372|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
162916813|NCT04780776|588397373|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
162916814|NCT03113760|588397375|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
162916815|NCT03113760|588397376|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
162916816|NCT03113760|588397377|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
163055027|NCT02737722|588913998|FG003|Overall Study|Physician Decision|0|||
163055028|NCT01026493|588914001|FG000|Overall Study|Protocol Violation|0|||
163055029|NCT01026493|588914002|FG001|Overall Study|Protocol Violation|1|||
163055030|NCT01026493|588914003|FG002|Overall Study|Protocol Violation|0|||
163055031|NCT01026493|588914004|FG003|Overall Study|Protocol Violation|0|||
163055032|NCT01026493|588914005|FG004|Overall Study|Protocol Violation|2|||
163055033|NCT01026493|588914006|FG005|Overall Study|Protocol Violation|3|||
163055034|NCT01026493|588914007|FG006|Overall Study|Protocol Violation|4|||
163055035|NCT01026493|588914008|FG007|Overall Study|Protocol Violation|1|||
163055036|NCT02662569|588914009|FG000|Overall Study|Withdrawal by Subject|6|||
163055037|NCT02662569|588914010|FG001|Overall Study|Withdrawal by Subject|1|||
163055038|NCT02662569|588914011|FG002|Overall Study|Withdrawal by Subject|6|||
163055039|NCT02662569|588914012|FG003|Overall Study|Withdrawal by Subject|4|||
163055040|NCT02662569|588914009|FG000|Overall Study|Lost to Follow-up|1|||
163055041|NCT02662569|588914010|FG001|Overall Study|Lost to Follow-up|0|||
163055042|NCT02662569|588914011|FG002|Overall Study|Lost to Follow-up|0|||
163055043|NCT02662569|588914012|FG003|Overall Study|Lost to Follow-up|0|||
163055044|NCT03154086|588914013|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055045|NCT03154086|588914014|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055046|NCT03154086|588914015|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055047|NCT03154086|588914016|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
163055048|NCT03154086|588914017|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055049|NCT03154086|588914018|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055050|NCT03154086|588914019|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055051|NCT03154086|588914020|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055052|NCT03154086|588914021|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055053|NCT03154086|588914022|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055054|NCT03154086|588914023|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055055|NCT03154086|588914024|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055056|NCT03154086|588914025|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163055057|NCT03154086|588914026|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
162968976|NCT02459418|588587846|FG001|Overall Study|Physician Decision|2|||
162968977|NCT02459418|588587845|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
162968978|NCT02459418|588587846|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
162968979|NCT02459418|588587845|FG000|Overall Study|Adverse Event|0|||
162968980|NCT02459418|588587846|FG001|Overall Study|Adverse Event|1|||
162968981|NCT02459418|588587845|FG000|Overall Study|Withdrawal by Subject|1|||
162968982|NCT02459418|588587846|FG001|Overall Study|Withdrawal by Subject|1|||
162968983|NCT02459418|588587845|FG000|Overall Study|Elevated Creatine Kinase|1|||
162968984|NCT02459418|588587846|FG001|Overall Study|Elevated Creatine Kinase|0|||
162968985|NCT02459418|588587845|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
162968986|NCT02459418|588587846|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
162968987|NCT00683592|588587849|FG000|Overall Study|Adverse Event|12|||
162968988|NCT00683592|588587850|FG001|Overall Study|Adverse Event|4|||
162968989|NCT00683592|588587849|FG000|Overall Study|Withdrawal by Subject|11|||
162968990|NCT00683592|588587850|FG001|Overall Study|Withdrawal by Subject|11|||
162968991|NCT00683592|588587849|FG000|Overall Study|Lost to Follow-up|17|||
162968992|NCT00683592|588587850|FG001|Overall Study|Lost to Follow-up|17|||
162968993|NCT00683592|588587849|FG000|Overall Study|Lack of Efficacy|3|||
162968994|NCT00683592|588587850|FG001|Overall Study|Lack of Efficacy|7|||
162968995|NCT00683592|588587849|FG000|Overall Study|Physician Decision|0|||
162968996|NCT00683592|588587850|FG001|Overall Study|Physician Decision|1|||
162968997|NCT00683592|588587849|FG000|Overall Study|Non-compliance|3|||
162968998|NCT00683592|588587850|FG001|Overall Study|Non-compliance|5|||
162968999|NCT00683592|588587849|FG000|Overall Study|Other|1|||
162969000|NCT00683592|588587850|FG001|Overall Study|Other|1|||
162969001|NCT03303417|588587859|FG000|Overall Study|Withdrawal by Subject|1|||
162969002|NCT03303417|588587860|FG001|Overall Study|Withdrawal by Subject|1|||
162969003|NCT02697617|588587861|FG000|Overall Study|Withdrawal by Subject|0|||
162969004|NCT02697617|588587862|FG001|Overall Study|Withdrawal by Subject|2|||
162969005|NCT02697617|588587861|FG000|Overall Study|Pregnancy|1|||
162969006|NCT02697617|588587862|FG001|Overall Study|Pregnancy|0|||
162969007|NCT00329160|588587865|FG000|Overall Study|Adverse Event|27|||
162969008|NCT00329160|588587865|FG000|Overall Study|Withdrawal by Subject|13|||
162969009|NCT00329160|588587865|FG000|Overall Study|Protocol Violation|2|||
162969010|NCT00329160|588587865|FG000|Overall Study|Did not Receive Study Drug|1|||
162969011|NCT00329160|588587865|FG000|Overall Study|Incomplete IVUS|45|||
162969012|NCT05212948|588587870|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
162969013|NCT05212948|588587871|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
162969014|NCT05212948|588587870|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
162969015|NCT05212948|588587871|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
162969016|NCT05212948|588587870|FG000|Initial Vaccination Period|Pregnancy|20|||
162969017|NCT05212948|588587871|FG001|Initial Vaccination Period|Pregnancy|14|||
162969018|NCT05212948|588587870|FG000|Initial Vaccination Period|Physician Decision|686|||
162969019|NCT05212948|588587871|FG001|Initial Vaccination Period|Physician Decision|401|||
162969020|NCT05212948|588587870|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
162969021|NCT05212948|588587871|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
162969022|NCT05212948|588587870|FG000|Initial Vaccination Period|Death|23|||
162969023|NCT05212948|588587871|FG001|Initial Vaccination Period|Death|18|||
162969024|NCT05212948|588587870|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
162969025|NCT05212948|588587871|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
162969026|NCT05212948|588587870|FG000|Initial Vaccination Period|Adverse Event|36|||
162969027|NCT05212948|588587871|FG001|Initial Vaccination Period|Adverse Event|23|||
162969028|NCT05212948|588587870|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
162969029|NCT05212948|588587871|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
162969030|NCT05212948|588587870|FG000|Crossover Vaccination Period|Pregnancy|6|||
162969031|NCT05212948|588587871|FG001|Crossover Vaccination Period|Pregnancy|1|||
162969032|NCT05212948|588587870|FG000|Crossover Vaccination Period|Physician Decision|49|||
162969033|NCT05212948|588587871|FG001|Crossover Vaccination Period|Physician Decision|24|||
162969034|NCT05212948|588587870|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
162969035|NCT05212948|588587871|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
162969036|NCT05212948|588587870|FG000|Crossover Vaccination Period|Death|10|||
162969037|NCT05212948|588587871|FG001|Crossover Vaccination Period|Death|5|||
162969038|NCT05212948|588587870|FG000|Crossover Vaccination Period|Adverse Event|9|||
162969039|NCT05212948|588587871|FG001|Crossover Vaccination Period|Adverse Event|4|||
162969040|NCT05347693|588587872|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
162969041|NCT05347693|588587873|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
162969042|NCT05347693|588587874|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
162969043|NCT05347693|588587872|FG000|Inpatient Period|Withdrawal of consent|10|||
162969044|NCT05347693|588587873|FG001|Inpatient Period|Withdrawal of consent|0|||
162969045|NCT05347693|588587874|FG002|Inpatient Period|Withdrawal of consent|0|||
162969046|NCT05347693|588587872|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
162969047|NCT05347693|588587873|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
162969048|NCT05347693|588587874|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
162916817|NCT03113760|588397378|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
162916818|NCT03113760|588397375|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
162916819|NCT03113760|588397376|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
162916820|NCT03113760|588397377|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
162916821|NCT03113760|588397378|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
162916822|NCT03113760|588397375|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
162916823|NCT03113760|588397376|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
162916824|NCT03113760|588397377|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
162916825|NCT03113760|588397378|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
162916826|NCT00465101|588397379|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
162916827|NCT00465101|588397379|FG000|Overall Study|Change in health precluded follow up|4|||
162916828|NCT00465101|588397379|FG000|Overall Study|Did not meet study criteria|4|||
162916829|NCT00465101|588397379|FG000|Overall Study|Lost to Follow-up|5|||
162916830|NCT00465101|588397379|FG000|Overall Study|Other|6|||
162916831|NCT00465101|588397379|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
162916832|NCT00465101|588397379|FG000|Overall Study|Patient postponed procedure|1|||
162916833|NCT00465101|588397379|FG000|Overall Study|Site closed due to IRB expiration|1|||
162916834|NCT00465101|588397379|FG000|Overall Study|Unable to obtain IRB approval|1|||
162916835|NCT00465101|588397379|FG000|Overall Study|Death|3|||
162969049|NCT05347693|588587872|FG000|Inpatient Period|Screening Failure|8|||
162969050|NCT05347693|588587873|FG001|Inpatient Period|Screening Failure|0|||
162969051|NCT05347693|588587874|FG002|Inpatient Period|Screening Failure|0|||
162969052|NCT05347693|588587872|FG000|Inpatient Period|Death|2|||
162969053|NCT05347693|588587873|FG001|Inpatient Period|Death|0|||
162969054|NCT05347693|588587874|FG002|Inpatient Period|Death|0|||
162969055|NCT05347693|588587872|FG000|Inpatient Period|Physician Decision|5|||
162969056|NCT05347693|588587873|FG001|Inpatient Period|Physician Decision|0|||
162969057|NCT05347693|588587874|FG002|Inpatient Period|Physician Decision|0|||
162969058|NCT05347693|588587872|FG000|Inpatient Period|Adverse Event|3|||
162969059|NCT05347693|588587873|FG001|Inpatient Period|Adverse Event|0|||
162969060|NCT05347693|588587874|FG002|Inpatient Period|Adverse Event|0|||
162969061|NCT05347693|588587872|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
162969062|NCT05347693|588587873|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
162969063|NCT05347693|588587874|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
162969064|NCT05347693|588587872|FG000|Outpatient Period|Adverse Event|0|||
162969065|NCT05347693|588587873|FG001|Outpatient Period|Adverse Event|9|||
162969066|NCT05347693|588587874|FG002|Outpatient Period|Adverse Event|0|||
162969067|NCT05347693|588587872|FG000|Outpatient Period|Death|0|||
162969068|NCT05347693|588587873|FG001|Outpatient Period|Death|6|||
162969069|NCT05347693|588587874|FG002|Outpatient Period|Death|2|||
162969070|NCT05347693|588587872|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
162969071|NCT05347693|588587873|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
162969072|NCT05347693|588587874|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
162969073|NCT05347693|588587872|FG000|Outpatient Period|Lost to Follow-up|0|||
162969074|NCT05347693|588587873|FG001|Outpatient Period|Lost to Follow-up|0|||
162969075|NCT05347693|588587874|FG002|Outpatient Period|Lost to Follow-up|1|||
162969076|NCT05347693|588587872|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
162969077|NCT05347693|588587873|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
162969078|NCT05347693|588587874|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
162969079|NCT05347693|588587872|FG000|Outpatient Period|Scheduled hemodialysis|0|||
162969080|NCT05347693|588587873|FG001|Outpatient Period|Scheduled hemodialysis|1|||
162969081|NCT05347693|588587874|FG002|Outpatient Period|Scheduled hemodialysis|0|||
162969082|NCT05347693|588587872|FG000|Outpatient Period|Severe HK|0|||
162969083|NCT05347693|588587873|FG001|Outpatient Period|Severe HK|0|||
162969084|NCT05347693|588587874|FG002|Outpatient Period|Severe HK|1|||
162969085|NCT05347693|588587872|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
162969086|NCT05347693|588587873|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
162969087|NCT05347693|588587874|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
162969088|NCT05347693|588587872|FG000|Outpatient Period|Start of dialysis|0|||
162969089|NCT05347693|588587873|FG001|Outpatient Period|Start of dialysis|0|||
162969090|NCT05347693|588587874|FG002|Outpatient Period|Start of dialysis|1|||
162969091|NCT05347693|588587872|FG000|Outpatient Period|The participant entered hemodialysis|0|||
162969092|NCT05347693|588587873|FG001|Outpatient Period|The participant entered hemodialysis|0|||
162969093|NCT05347693|588587874|FG002|Outpatient Period|The participant entered hemodialysis|1|||
162969094|NCT05347693|588587872|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
162969095|NCT05347693|588587873|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
163055058|NCT03154086|588914027|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
162916836|NCT00465101|588397379|FG000|Overall Study|Withdrawal by Subject|25|||
162916837|NCT00465101|588397379|FG000|Overall Study|Physician Decision|1|||
162916838|NCT00465101|588397379|FG000|Overall Study|Withdrew consent prior to procedure|3|||
162916839|NCT00933543|588397381|FG000|Overall Study|Adverse Event|2|||
162916840|NCT00933543|588397382|FG001|Overall Study|Adverse Event|1|||
163055059|NCT03154086|588914013|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
162916841|NCT00933543|588397381|FG000|Overall Study|Lost to Follow-up|0|||
162916842|NCT00933543|588397382|FG001|Overall Study|Lost to Follow-up|1|||
162916843|NCT00933543|588397381|FG000|Overall Study|Withdrawal by Subject|0|||
162916844|NCT00933543|588397382|FG001|Overall Study|Withdrawal by Subject|1|||
162916845|NCT00933543|588397381|FG000|Overall Study|Lack of Efficacy|0|||
162916846|NCT00933543|588397382|FG001|Overall Study|Lack of Efficacy|3|||
162916847|NCT00933543|588397381|FG000|Overall Study|Other|1|||
162916848|NCT00933543|588397382|FG001|Overall Study|Other|1|||
162916849|NCT04988035|588397388|FG000|Overall Study|Death|19|||
162916850|NCT04988035|588397389|FG001|Overall Study|Death|13|||
162916851|NCT04988035|588397388|FG000|Overall Study|Lost to Follow-up|12|||
162916852|NCT04988035|588397389|FG001|Overall Study|Lost to Follow-up|6|||
162916853|NCT04988035|588397388|FG000|Overall Study|Protocol Violation|0|||
163055060|NCT03154086|588914014|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
163055061|NCT03154086|588914015|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055062|NCT03154086|588914016|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055063|NCT03154086|588914017|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055064|NCT03154086|588914018|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055065|NCT03154086|588914019|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055066|NCT03154086|588914020|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055067|NCT03154086|588914021|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055068|NCT03154086|588914022|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055069|NCT03154086|588914023|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055070|NCT03154086|588914024|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055071|NCT03154086|588914025|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055072|NCT03154086|588914026|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055073|NCT03154086|588914027|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
163055074|NCT03154086|588914013|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055075|NCT03154086|588914014|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055076|NCT03154086|588914015|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
163055077|NCT03154086|588914016|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055078|NCT03154086|588914017|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055079|NCT03154086|588914018|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055080|NCT03154086|588914019|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055081|NCT03154086|588914020|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055082|NCT03154086|588914021|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055083|NCT03154086|588914022|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055084|NCT03154086|588914023|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055085|NCT03154086|588914024|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055086|NCT03154086|588914025|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055087|NCT03154086|588914026|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055088|NCT03154086|588914027|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163055089|NCT03154086|588914013|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
163055090|NCT03154086|588914014|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055091|NCT03154086|588914015|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055092|NCT03154086|588914016|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055093|NCT03154086|588914017|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055094|NCT03154086|588914018|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055095|NCT03154086|588914019|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055096|NCT03154086|588914020|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055097|NCT03154086|588914021|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055098|NCT03154086|588914022|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055099|NCT03154086|588914023|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055100|NCT03154086|588914024|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
162916854|NCT04988035|588397389|FG001|Overall Study|Protocol Violation|1|||
162916855|NCT04988035|588397388|FG000|Overall Study|Withdrawal by Subject|2|||
163055101|NCT03154086|588914025|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055102|NCT03154086|588914026|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
163055103|NCT03154086|588914027|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
162711045|NCT01649427|587652855|FG001|Overall Study|Graft loss|1|||
162916856|NCT04988035|588397389|FG001|Overall Study|Withdrawal by Subject|4|||
162916857|NCT04988035|588397388|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
162916858|NCT04988035|588397389|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
162711046|NCT01649427|587652854|FG000|Overall Study|Surgical problems during nephrectomy|2|||
162916859|NCT00442572|588397390|FG000|Overall Study|Relapse|8|||
162916860|NCT00442572|588397391|FG001|Overall Study|Relapse|1|||
163055104|NCT03154086|588914013|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055105|NCT03154086|588914014|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055106|NCT03154086|588914015|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055107|NCT03154086|588914016|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055108|NCT03154086|588914017|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055109|NCT03154086|588914018|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055110|NCT03154086|588914019|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055111|NCT03154086|588914020|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055112|NCT03154086|588914021|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
163055113|NCT03154086|588914022|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055114|NCT03154086|588914023|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055115|NCT03154086|588914024|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
162711047|NCT01649427|587652855|FG001|Overall Study|Surgical problems during nephrectomy|2|||
162916861|NCT00442572|588397390|FG000|Overall Study|Lost to Follow-up|0|||
162916862|NCT00442572|588397391|FG001|Overall Study|Lost to Follow-up|1|||
162916863|NCT00442572|588397390|FG000|Overall Study|Withdrawal by Subject|0|||
162916864|NCT00442572|588397391|FG001|Overall Study|Withdrawal by Subject|1|||
162916865|NCT03532048|588397392|FG000|Overall Study|Lost to Follow-up|12|||
162916866|NCT03532048|588397393|FG001|Overall Study|Lost to Follow-up|17|||
162916867|NCT03532048|588397392|FG000|Overall Study|Withdrawal by Subject|7|||
162916868|NCT03532048|588397393|FG001|Overall Study|Withdrawal by Subject|0|||
162916869|NCT04366258|588397394|FG000|Baseline Assessments|Screen Failure|21|||
162916870|NCT04366258|588397394|FG000|Baseline Assessments|Early Termination|3|||
162916871|NCT00308555|588397396|FG000|Overall Study|Withdrawal by Subject|1|||
162916872|NCT00308555|588397397|FG001|Overall Study|Withdrawal by Subject|0|||
162916873|NCT00308555|588397396|FG000|Overall Study|Physician Decision|2|||
162916874|NCT00308555|588397397|FG001|Overall Study|Physician Decision|0|||
162916875|NCT04113746|588397404|FG000|Overall Study|Lost to Follow-up|4|||
162916876|NCT04113746|588397405|FG001|Overall Study|Lost to Follow-up|4|||
162916877|NCT00429026|588397407|FG000|Overall Study|Inevaluable for response.|40|||
162916878|NCT00499694|588397410|FG000|Overall Study|Patient never received treatment.|1|||
162916879|NCT03958045|588397413|FG000|Overall Study|Withdrawal by Subject|1|||
162916880|NCT00674440|588397414|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
162916881|NCT00674440|588397414|FG000|Overall Study|did not have surgery, so unevaluable|7|||
162916882|NCT00674440|588397414|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
162916883|NCT01463631|588397415|FG000|Overall Study|Withdrawal by Subject|0|||
162916884|NCT01463631|588397416|FG001|Overall Study|Withdrawal by Subject|0|||
162916885|NCT01463631|588397417|FG002|Overall Study|Withdrawal by Subject|0|||
162916886|NCT01463631|588397418|FG003|Overall Study|Withdrawal by Subject|1|||
162916887|NCT01463631|588397415|FG000|Overall Study|Death|0|||
162916888|NCT01463631|588397416|FG001|Overall Study|Death|0|||
162916889|NCT01463631|588397417|FG002|Overall Study|Death|1|||
162916890|NCT01463631|588397418|FG003|Overall Study|Death|0|||
162916891|NCT01463631|588397415|FG000|Overall Study|Progressive Disease|0|||
162916892|NCT01463631|588397416|FG001|Overall Study|Progressive Disease|0|||
162916893|NCT01463631|588397417|FG002|Overall Study|Progressive Disease|0|||
162916894|NCT01463631|588397418|FG003|Overall Study|Progressive Disease|5|||
162916895|NCT04409262|588397433|FG000|Overall Study|Adverse Event|0|||
162916896|NCT04409262|588397434|FG001|Overall Study|Adverse Event|2|||
162916897|NCT04409262|588397433|FG000|Overall Study|Death|55|||
162916898|NCT04409262|588397434|FG001|Overall Study|Death|97|||
162916899|NCT04409262|588397433|FG000|Overall Study|Lost to Follow-up|12|||
162916900|NCT04409262|588397434|FG001|Overall Study|Lost to Follow-up|23|||
162916901|NCT04409262|588397433|FG000|Overall Study|Lack of Staff|0|||
162916902|NCT04409262|588397434|FG001|Overall Study|Lack of Staff|1|||
162916903|NCT04409262|588397433|FG000|Overall Study|Protocol Violation|3|||
162916904|NCT04409262|588397434|FG001|Overall Study|Protocol Violation|1|||
162916905|NCT04409262|588397433|FG000|Overall Study|Withdrawal by Subject|5|||
162916906|NCT04409262|588397434|FG001|Overall Study|Withdrawal by Subject|10|||
162916907|NCT01326481|588397438|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
162916908|NCT04794491|588397439|FG000|Overall Study|Adverse Event|1|||
162916909|NCT04794491|588397439|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
162916910|NCT04794491|588397439|FG000|Overall Study|Noncompliance With Study Intervention|1|||
163055116|NCT03154086|588914025|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055117|NCT03154086|588914026|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055118|NCT03154086|588914027|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
163055119|NCT03154086|588914013|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055120|NCT03154086|588914014|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055121|NCT03154086|588914015|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055122|NCT03154086|588914016|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055123|NCT03154086|588914017|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055124|NCT03154086|588914018|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055125|NCT03154086|588914019|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055126|NCT03154086|588914020|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
163055127|NCT03154086|588914021|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055128|NCT03154086|588914022|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055129|NCT03154086|588914023|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055130|NCT03154086|588914024|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055131|NCT03154086|588914025|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055132|NCT03154086|588914026|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055133|NCT03154086|588914027|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163055134|NCT03154086|588914013|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
163055135|NCT03154086|588914014|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
163055136|NCT03154086|588914015|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
163055137|NCT03154086|588914016|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
163055138|NCT03154086|588914017|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
163055139|NCT03154086|588914018|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
163055140|NCT03154086|588914019|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
163055141|NCT03154086|588914020|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
163055142|NCT03154086|588914021|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
163055143|NCT03154086|588914022|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
163055144|NCT03154086|588914023|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
163055145|NCT03154086|588914024|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
163055146|NCT03154086|588914025|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
163055147|NCT03154086|588914026|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
163055148|NCT03154086|588914027|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
163055149|NCT01603277|588914030|FG000|Overall Study|Adverse Event|1|||
163055150|NCT01603277|588914031|FG001|Overall Study|Adverse Event|2|||
163055151|NCT01603277|588914030|FG000|Overall Study|Physician Decision|0|||
163055152|NCT01603277|588914031|FG001|Overall Study|Physician Decision|1|||
163055153|NCT01603277|588914030|FG000|Overall Study|Protocol Violation|6|||
163055154|NCT01603277|588914031|FG001|Overall Study|Protocol Violation|10|||
163055155|NCT01603277|588914030|FG000|Overall Study|Withdrawal by Subject|5|||
163055156|NCT01603277|588914031|FG001|Overall Study|Withdrawal by Subject|4|||
163055157|NCT01603277|588914030|FG000|Overall Study|Non-Compliance|2|||
163055158|NCT01603277|588914031|FG001|Overall Study|Non-Compliance|1|||
163055159|NCT01701245|588914037|FG000|Overall Study|Protocol Violation|1|||
163055160|NCT01701245|588914038|FG001|Overall Study|Protocol Violation|3|||
163055161|NCT01701245|588914037|FG000|Overall Study|Did not complete the open label period|11|||
163055162|NCT01701245|588914038|FG001|Overall Study|Did not complete the open label period|12|||
163055163|NCT02785939|588914057|FG000|Overall Study|Progression|25|||
163055164|NCT02785939|588914058|FG001|Overall Study|Progression|8|||
163055165|NCT02785939|588914057|FG000|Overall Study|Adverse Event|3|||
163055166|NCT02785939|588914058|FG001|Overall Study|Adverse Event|1|||
163055167|NCT02785939|588914057|FG000|Overall Study|Death|1|||
163055168|NCT02785939|588914058|FG001|Overall Study|Death|0|||
163055169|NCT02785939|588914057|FG000|Overall Study|Refusal|1|||
163055170|NCT02785939|588914058|FG001|Overall Study|Refusal|0|||
163055171|NCT02785939|588914057|FG000|Overall Study|Deteriorating health|1|||
162916911|NCT04794491|588397439|FG000|Overall Study|Withdrawal by Subject|2|||
162916912|NCT00948896|588397440|FG000|Randomization to 24 Months of Age|Death|1|||
162916913|NCT00948896|588397441|FG001|Randomization to 24 Months of Age|Death|0|||
162916914|NCT00948896|588397442|FG002|Randomization to 24 Months of Age|Death|0|||
163055172|NCT02785939|588914058|FG001|Overall Study|Deteriorating health|0|||
163055173|NCT02785939|588914057|FG000|Overall Study|Not protocol specified|0|||
163055174|NCT02785939|588914058|FG001|Overall Study|Not protocol specified|1|||
163055175|NCT04465422|588914059|FG000|Overall Study|Lost to Follow-up|0|||
163055176|NCT04465422|588914060|FG001|Overall Study|Lost to Follow-up|2|||
163055177|NCT01787552|588914063|FG000|Overall Study|Withdrawal by Subject|2|||
163055178|NCT01787552|588914064|FG001|Overall Study|Withdrawal by Subject|0|||
163055179|NCT01787552|588914065|FG002|Overall Study|Withdrawal by Subject|0|||
163055180|NCT01787552|588914066|FG003|Overall Study|Withdrawal by Subject|4|||
163055181|NCT01787552|588914063|FG000|Overall Study|Physician Decision|2|||
163055182|NCT01787552|588914064|FG001|Overall Study|Physician Decision|2|||
163055183|NCT01787552|588914065|FG002|Overall Study|Physician Decision|1|||
163055184|NCT01787552|588914066|FG003|Overall Study|Physician Decision|2|||
162916915|NCT00948896|588397443|FG003|Randomization to 24 Months of Age|Death|0|||
162629113|NCT02378961|587358630|FG000|Overall Study|Lack of Efficacy|4|||
162629114|NCT02378961|587358631|FG001|Overall Study|Lack of Efficacy|2|||
162629115|NCT02378961|587358632|FG002|Overall Study|Lack of Efficacy|0|||
162629116|NCT02378961|587358633|FG003|Overall Study|Lack of Efficacy|1|||
162629117|NCT02378961|587358630|FG000|Overall Study|Death|0|||
162629118|NCT02378961|587358631|FG001|Overall Study|Death|0|||
162629119|NCT02378961|587358632|FG002|Overall Study|Death|1|||
162916916|NCT00948896|588397444|FG004|Randomization to 24 Months of Age|Death|2|||
162916917|NCT00948896|588397445|FG005|Randomization to 24 Months of Age|Death|1|||
162916918|NCT00948896|588397446|FG006|Randomization to 24 Months of Age|Death|2|||
162916919|NCT00948896|588397447|FG007|Randomization to 24 Months of Age|Death|1|||
162916920|NCT00948896|588397440|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
162916921|NCT00948896|588397441|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
162916922|NCT00948896|588397442|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
162916923|NCT00948896|588397443|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
162916924|NCT00948896|588397444|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
162916925|NCT00948896|588397445|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
162916926|NCT00948896|588397446|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
162916927|NCT00948896|588397447|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
162916928|NCT00948896|588397440|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
162916929|NCT00948896|588397441|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
162916930|NCT00948896|588397442|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
162916931|NCT00948896|588397443|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
162916932|NCT00948896|588397444|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
162916933|NCT00948896|588397445|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
162916934|NCT00948896|588397446|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
162916935|NCT00948896|588397447|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
162916936|NCT00948896|588397440|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
162916937|NCT00948896|588397441|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
162916938|NCT00948896|588397442|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
162916939|NCT00948896|588397443|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
162916940|NCT00948896|588397444|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
162916941|NCT00948896|588397445|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
162916942|NCT00948896|588397446|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
162916943|NCT00948896|588397447|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
162916944|NCT00948896|588397440|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
162916945|NCT00948896|588397441|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
162916946|NCT00948896|588397442|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
162916947|NCT00948896|588397443|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
162916948|NCT00948896|588397444|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
162916949|NCT00948896|588397445|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
162916950|NCT00948896|588397446|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
162916951|NCT00948896|588397447|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
162916952|NCT00948896|588397440|FG000|24 Months of Age to 36 Months of Age|Death|0|||
162916953|NCT00948896|588397441|FG001|24 Months of Age to 36 Months of Age|Death|2|||
162916954|NCT00948896|588397442|FG002|24 Months of Age to 36 Months of Age|Death|2|||
162916955|NCT00948896|588397443|FG003|24 Months of Age to 36 Months of Age|Death|0|||
162916956|NCT00948896|588397444|FG004|24 Months of Age to 36 Months of Age|Death|0|||
162916957|NCT00948896|588397445|FG005|24 Months of Age to 36 Months of Age|Death|1|||
162916958|NCT00948896|588397446|FG006|24 Months of Age to 36 Months of Age|Death|0|||
162916959|NCT00948896|588397447|FG007|24 Months of Age to 36 Months of Age|Death|0|||
162916960|NCT00948896|588397440|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
162916961|NCT00948896|588397441|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
162916962|NCT00948896|588397442|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
162916963|NCT00948896|588397443|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
162916964|NCT00948896|588397444|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
162916965|NCT00948896|588397445|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
162916966|NCT00948896|588397446|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
162916967|NCT00948896|588397447|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
162916968|NCT00948896|588397440|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
162916969|NCT00948896|588397441|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
162916970|NCT00948896|588397442|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
162916971|NCT00948896|588397443|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
162916972|NCT00948896|588397444|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
162916973|NCT00948896|588397445|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
162629120|NCT02378961|587358633|FG003|Overall Study|Death|0|||
162629121|NCT00390468|587358634|FG000|Overall Study|Protocol Violation|2|||
162629122|NCT00390468|587358634|FG000|Overall Study|Lack of Efficacy|1|||
162916974|NCT00948896|588397446|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
162916975|NCT00948896|588397447|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
162916976|NCT00948896|588397440|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916977|NCT00948896|588397441|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916978|NCT00948896|588397442|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
162916979|NCT00948896|588397443|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916980|NCT00948896|588397444|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916981|NCT00948896|588397445|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
162916982|NCT00948896|588397446|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916983|NCT00948896|588397447|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
162916984|NCT00948896|588397440|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916985|NCT00948896|588397441|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916986|NCT00948896|588397442|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916987|NCT00948896|588397443|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
162916988|NCT00948896|588397444|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916989|NCT00948896|588397445|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916990|NCT00948896|588397446|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916991|NCT00948896|588397447|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
162916992|NCT00945815|588397448|FG000|Overall Study|Death|3|||
162916993|NCT00945815|588397448|FG000|Overall Study|Not protocol specified|1|||
162916994|NCT00945815|588397448|FG000|Overall Study|Ineligible|3|||
162916995|NCT00945815|588397448|FG000|Overall Study|Did not begin protocol therapy|1|||
162916996|NCT01990339|588397453|FG000|Overall Study|Data Not Available|49|||
162916997|NCT01990339|588397453|FG000|Overall Study|Voluntary Withdrawal|1402|||
162916998|NCT01990339|588397453|FG000|Overall Study|Lost to Follow-up|861|||
162916999|NCT01038609|588397454|FG000|Overall Study|Adverse Event|0|||
162917000|NCT01038609|588397455|FG001|Overall Study|Adverse Event|0|||
162917001|NCT01038609|588397456|FG002|Overall Study|Adverse Event|1|||
162917002|NCT01038609|588397457|FG003|Overall Study|Adverse Event|0|||
162917003|NCT01038609|588397458|FG004|Overall Study|Adverse Event|0|||
162917004|NCT01038609|588397454|FG000|Overall Study|Dosing Error|0|||
162917005|NCT01038609|588397455|FG001|Overall Study|Dosing Error|0|||
162917006|NCT01038609|588397456|FG002|Overall Study|Dosing Error|0|||
162917007|NCT01038609|588397457|FG003|Overall Study|Dosing Error|1|||
162917008|NCT01038609|588397458|FG004|Overall Study|Dosing Error|1|||
162917009|NCT01038609|588397454|FG000|Overall Study|Death in the Family|1|||
162917010|NCT01038609|588397455|FG001|Overall Study|Death in the Family|0|||
162917011|NCT01038609|588397456|FG002|Overall Study|Death in the Family|0|||
162917012|NCT01038609|588397457|FG003|Overall Study|Death in the Family|0|||
162917013|NCT01038609|588397458|FG004|Overall Study|Death in the Family|0|||
162917014|NCT01038609|588397454|FG000|Overall Study|Refusal of Blood Draws|0|||
162917015|NCT01038609|588397455|FG001|Overall Study|Refusal of Blood Draws|1|||
162917016|NCT01038609|588397456|FG002|Overall Study|Refusal of Blood Draws|0|||
162917017|NCT01038609|588397457|FG003|Overall Study|Refusal of Blood Draws|0|||
162917018|NCT01038609|588397458|FG004|Overall Study|Refusal of Blood Draws|0|||
162917019|NCT00242658|588397461|FG000|Overall Study|Lost to Follow-up|22|||
162917020|NCT00242658|588397462|FG001|Overall Study|Lost to Follow-up|19|||
162917021|NCT01590810|588397463|FG000|Overall Study|Physician Decision|0|||
162917022|NCT01590810|588397464|FG001|Overall Study|Physician Decision|1|||
162917023|NCT01590810|588397465|FG002|Overall Study|Physician Decision|1|||
162917024|NCT01590810|588397466|FG003|Overall Study|Physician Decision|0|||
162917025|NCT01590810|588397467|FG004|Overall Study|Physician Decision|0|||
162917026|NCT01087944|588397471|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
162917027|NCT01087944|588397472|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
162917028|NCT01087944|588397471|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
162917029|NCT01087944|588397472|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
162917030|NCT01731600|588397473|FG000|Overall Study|Adverse Event|2|||
162917031|NCT01731600|588397474|FG001|Overall Study|Adverse Event|0|||
162917032|NCT01731600|588397473|FG000|Overall Study|Withdrawal criteria|1|||
162917033|NCT01731600|588397474|FG001|Overall Study|Withdrawal criteria|0|||
162917034|NCT01731600|588397473|FG000|Overall Study|Other reasons|3|||
162917035|NCT01731600|588397474|FG001|Overall Study|Other reasons|0|||
162917036|NCT01349816|588397475|FG000|Overall Study|Withdrawal by Subject|4|||
162917037|NCT01349816|588397475|FG000|Overall Study|Physician Decision|1|||
162917038|NCT01349816|588397475|FG000|Overall Study|Adverse Event|14|||
162917039|NCT01349816|588397475|FG000|Overall Study|Lost to Follow-up|2|||
162917040|NCT01349816|588397475|FG000|Overall Study|Protocol Violation|1|||
162917041|NCT01349816|588397475|FG000|Overall Study|Protocol-specified criteria|8|||
162917042|NCT01479777|588399657|FG000|Overall Study|Physician Decision|2|||
162917043|NCT03575806|588399658|FG000|Overall Study|Withdrawal by Subject|0|||
162917044|NCT03575806|588399659|FG001|Overall Study|Withdrawal by Subject|2|||
162917045|NCT03575806|588399658|FG000|Overall Study|Protocol Violation|0|||
162629123|NCT01049308|587358635|FG000|Pill Counts|Withdrawal by Subject|83|||
162629124|NCT01348165|587358637|FG000|Overall Study|Adverse Event|0|||
162629125|NCT01348165|587358638|FG001|Overall Study|Adverse Event|0|||
162629126|NCT01348165|587358639|FG002|Overall Study|Adverse Event|0|||
162629127|NCT01348165|587358640|FG003|Overall Study|Adverse Event|0|||
162629128|NCT01348165|587358641|FG004|Overall Study|Adverse Event|0|||
162629129|NCT01348165|587358642|FG005|Overall Study|Adverse Event|0|||
162629130|NCT01348165|587358643|FG006|Overall Study|Adverse Event|1|||
162629131|NCT01411774|587360991|FG000|Overall Study|Withdrawal by Subject|0|||
162629132|NCT01411774|587360992|FG001|Overall Study|Withdrawal by Subject|3|||
162917046|NCT03575806|588399659|FG001|Overall Study|Protocol Violation|2|||
162917047|NCT02842736|588399663|FG000|Overall Study|Lost to Follow-up|13|||
162917048|NCT02842736|588399663|FG000|Overall Study|Intervention for menstrual bleeding|17|||
162917049|NCT02842736|588399663|FG000|Overall Study|Withdrawal by Subject|4|||
162917050|NCT02842736|588399663|FG000|Overall Study|Pregnancy|3|||
162917051|NCT02842736|588399663|FG000|Overall Study|Hysterectomy for fibroids|2|||
162917052|NCT02842736|588399663|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
162917053|NCT02842736|588399663|FG000|Overall Study|IUD: Mirena|1|||
162917054|NCT02389621|588399665|FG000|Treatment Period|Withdrawal by Subject|1|||
162917055|NCT02389621|588399666|FG001|Treatment Period|Withdrawal by Subject|1|||
162917056|NCT02389621|588399665|FG000|Posttreatment Period|Adverse Event|3|||
162917057|NCT02389621|588399666|FG001|Posttreatment Period|Adverse Event|1|||
162917058|NCT02389621|588399665|FG000|Posttreatment Period|Withdrawal by Subject|3|||
162917059|NCT02389621|588399666|FG001|Posttreatment Period|Withdrawal by Subject|2|||
162917060|NCT02389621|588399665|FG000|Posttreatment Period|Lost to Follow-up|1|||
162917061|NCT02389621|588399666|FG001|Posttreatment Period|Lost to Follow-up|1|||
162917062|NCT02389621|588399665|FG000|Posttreatment Period|Other - Miscellaneous|2|||
162917063|NCT02389621|588399666|FG001|Posttreatment Period|Other - Miscellaneous|0|||
162917064|NCT00726882|588399671|FG000|Overall Study|Withdrawal by Subject|5|||
162917065|NCT00726882|588399671|FG000|Overall Study|Lost to Follow-up|7|||
162917066|NCT00726882|588399671|FG000|Overall Study|Other|10|||
162917067|NCT00344968|588399672|FG000|Overall Study|Adverse Event|5|||
162917068|NCT00344968|588399673|FG001|Overall Study|Adverse Event|4|||
162917069|NCT00344968|588399674|FG002|Overall Study|Adverse Event|15|||
162917070|NCT00344968|588399672|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162917071|NCT00344968|588399673|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162917072|NCT00344968|588399674|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
162917073|NCT00344968|588399672|FG000|Overall Study|Protocol Violation|2|||
162917074|NCT00344968|588399673|FG001|Overall Study|Protocol Violation|2|||
162917075|NCT00344968|588399674|FG002|Overall Study|Protocol Violation|5|||
162917076|NCT00344968|588399672|FG000|Overall Study|Withdrawal by Subject|14|||
162917077|NCT00344968|588399673|FG001|Overall Study|Withdrawal by Subject|31|||
162917078|NCT00344968|588399674|FG002|Overall Study|Withdrawal by Subject|27|||
162917079|NCT00344968|588399672|FG000|Overall Study|Lost to Follow-up|24|||
162917080|NCT00344968|588399673|FG001|Overall Study|Lost to Follow-up|37|||
162917081|NCT00344968|588399674|FG002|Overall Study|Lost to Follow-up|37|||
162917082|NCT00344968|588399672|FG000|Overall Study|Death|11|||
162917083|NCT00344968|588399673|FG001|Overall Study|Death|27|||
162917084|NCT00344968|588399674|FG002|Overall Study|Death|31|||
162917085|NCT00344968|588399672|FG000|Overall Study|Other|0|||
162917086|NCT00344968|588399673|FG001|Overall Study|Other|1|||
162917087|NCT00344968|588399674|FG002|Overall Study|Other|0|||
162917088|NCT02526017|588399675|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917089|NCT02526017|588399676|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917090|NCT02526017|588399677|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917091|NCT02526017|588399678|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917092|NCT02526017|588399679|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
162917093|NCT02526017|588399680|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917094|NCT02526017|588399681|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917095|NCT02526017|588399682|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917096|NCT02526017|588399683|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
162917097|NCT03246152|588399696|FG000|Overall Study|Lost to Follow-up|2|||
162969096|NCT05347693|588587874|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
162969097|NCT05347693|588587872|FG000|Outpatient Period|Withdrawal by Subject|0|||
162969098|NCT05347693|588587873|FG001|Outpatient Period|Withdrawal by Subject|8|||
163055185|NCT01787552|588914063|FG000|Overall Study|Death|0|||
162629133|NCT03808545|587360993|FG000|Overall Study|Withdrawal by Subject|1|||
162917098|NCT03246152|588399696|FG000|Overall Study|Protocol Violation|1|||
162917099|NCT00423137|588399697|FG000|Overall Study|Lost to Follow-up|0|||
162917100|NCT00423137|588399698|FG001|Overall Study|Lost to Follow-up|0|||
162917101|NCT00423137|588399699|FG002|Overall Study|Lost to Follow-up|1|||
162917102|NCT00423137|588399700|FG003|Overall Study|Lost to Follow-up|0|||
162917103|NCT00423137|588399697|FG000|Overall Study|Protocol Violation|0|||
162917104|NCT00423137|588399698|FG001|Overall Study|Protocol Violation|0|||
162917105|NCT00423137|588399699|FG002|Overall Study|Protocol Violation|0|||
162917106|NCT00423137|588399700|FG003|Overall Study|Protocol Violation|1|||
162917107|NCT00423137|588399697|FG000|Overall Study|Adverse Event Study disease worse|1|||
162917108|NCT00423137|588399698|FG001|Overall Study|Adverse Event Study disease worse|0|||
162917109|NCT00423137|588399699|FG002|Overall Study|Adverse Event Study disease worse|3|||
162917110|NCT00423137|588399700|FG003|Overall Study|Adverse Event Study disease worse|1|||
162917111|NCT00423137|588399697|FG000|Overall Study|Adverse Event Other|0|||
162917112|NCT00423137|588399698|FG001|Overall Study|Adverse Event Other|0|||
162917113|NCT00423137|588399699|FG002|Overall Study|Adverse Event Other|2|||
162917114|NCT00423137|588399700|FG003|Overall Study|Adverse Event Other|0|||
162917115|NCT04196023|588399703|FG000|Overall Study|Withdrawal by Subject|0|||
162917116|NCT04196023|588399704|FG001|Overall Study|Withdrawal by Subject|1|||
162917117|NCT04196023|588399703|FG000|Overall Study|Adverse Event|3|||
162917118|NCT04196023|588399704|FG001|Overall Study|Adverse Event|1|||
162917119|NCT04196023|588399703|FG000|Overall Study|Lost to Follow-up|0|||
162917120|NCT04196023|588399704|FG001|Overall Study|Lost to Follow-up|1|||
162917121|NCT04359758|588399709|FG000|Overall Study|Protocol Violation|3|||
162917122|NCT04359758|588399710|FG001|Overall Study|Protocol Violation|2|||
162917123|NCT03358407|588399714|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917124|NCT03358407|588399715|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917125|NCT03358407|588399716|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
162917126|NCT03358407|588399717|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917127|NCT03358407|588399718|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917128|NCT03358407|588399719|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917129|NCT03358407|588399720|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917130|NCT03358407|588399721|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917131|NCT03358407|588399722|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917132|NCT03358407|588399723|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
162917133|NCT03358407|588399714|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917134|NCT03358407|588399715|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917135|NCT03358407|588399716|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917136|NCT03358407|588399717|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917137|NCT03358407|588399718|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
162917138|NCT03358407|588399719|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917139|NCT03358407|588399720|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917140|NCT03358407|588399721|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917141|NCT03358407|588399722|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917142|NCT03358407|588399723|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917143|NCT03358407|588399714|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917144|NCT03358407|588399715|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917145|NCT03358407|588399716|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917146|NCT03358407|588399717|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917147|NCT03358407|588399718|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917148|NCT03358407|588399719|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
162917149|NCT03358407|588399720|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917150|NCT03358407|588399721|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
162917151|NCT03358407|588399722|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917152|NCT03358407|588399723|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
162917153|NCT03358407|588399714|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917154|NCT03358407|588399715|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917155|NCT03358407|588399716|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917156|NCT03358407|588399717|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917157|NCT03358407|588399718|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917158|NCT03358407|588399719|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
162917159|NCT03358407|588399720|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917160|NCT03358407|588399721|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
162917161|NCT03358407|588399722|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917162|NCT03358407|588399723|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
162917163|NCT03358407|588399714|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917164|NCT03358407|588399715|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917165|NCT03358407|588399716|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917166|NCT03358407|588399717|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917167|NCT03358407|588399718|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917168|NCT03358407|588399719|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
162917169|NCT03358407|588399720|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
162917170|NCT03358407|588399721|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917171|NCT03358407|588399722|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917172|NCT03358407|588399723|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
162917173|NCT03358407|588399714|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917174|NCT03358407|588399715|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917175|NCT03358407|588399716|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917176|NCT03358407|588399717|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917177|NCT03358407|588399718|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917178|NCT03358407|588399719|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
162917179|NCT03358407|588399720|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
162917180|NCT03358407|588399721|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
162917181|NCT03358407|588399722|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917182|NCT03358407|588399723|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
162917183|NCT00483574|588399724|FG000|Overall Study|Adverse Event|6|||
162917184|NCT00483574|588399725|FG001|Overall Study|Adverse Event|0|||
162917185|NCT00483574|588399724|FG000|Overall Study|Protocol Violation|28|||
162917186|NCT00483574|588399725|FG001|Overall Study|Protocol Violation|9|||
162969099|NCT05347693|588587874|FG002|Outpatient Period|Withdrawal by Subject|5|||
162969100|NCT03167606|588587875|FG000|Overall Study|Lost to Follow-up|73|||
162969101|NCT03167606|588587876|FG001|Overall Study|Lost to Follow-up|64|||
162629134|NCT03808545|587360994|FG001|Overall Study|Withdrawal by Subject|1|||
162629135|NCT03292588|587360995|FG000|Overall Study|Death|1|||
162629136|NCT03292588|587360996|FG001|Overall Study|Death|0|||
162629137|NCT03292588|587360995|FG000|Overall Study|Lost to Follow-up|12|||
162629138|NCT03292588|587360996|FG001|Overall Study|Lost to Follow-up|16|||
162969102|NCT03167606|588587875|FG000|Overall Study|Withdrawal by Subject|6|||
162969103|NCT03167606|588587876|FG001|Overall Study|Withdrawal by Subject|5|||
162969104|NCT03167606|588587875|FG000|Overall Study|Withdrawal by Investigator|0|||
162969105|NCT03167606|588587876|FG001|Overall Study|Withdrawal by Investigator|2|||
162969106|NCT00413049|588587877|FG000|Overall Study|Adverse Event|10|||
162969107|NCT00413049|588587878|FG001|Overall Study|Adverse Event|8|||
162969108|NCT00413049|588587877|FG000|Overall Study|Withdrawal by Subject|7|||
162969109|NCT00413049|588587878|FG001|Overall Study|Withdrawal by Subject|5|||
162969110|NCT00413049|588587877|FG000|Overall Study|Lost to Follow-up|2|||
162969111|NCT00413049|588587878|FG001|Overall Study|Lost to Follow-up|3|||
162969112|NCT00413049|588587877|FG000|Overall Study|Protocol Violation|3|||
162969113|NCT00413049|588587878|FG001|Overall Study|Protocol Violation|1|||
162969114|NCT00413049|588587877|FG000|Overall Study|Subject no longer requires study drug|0|||
162969115|NCT00413049|588587878|FG001|Overall Study|Subject no longer requires study drug|1|||
162969116|NCT00413049|588587877|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162969117|NCT00413049|588587878|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162969118|NCT00413049|588587877|FG000|Overall Study|Lack of Efficacy|1|||
162969119|NCT00413049|588587878|FG001|Overall Study|Lack of Efficacy|0|||
162969120|NCT01755975|588587885|FG000|Overall Study|Adverse Event|0|||
162969121|NCT01755975|588587886|FG001|Overall Study|Adverse Event|0|||
162969122|NCT01755975|588587887|FG002|Overall Study|Adverse Event|1|||
162629139|NCT03292588|587360995|FG000|Overall Study|Physician Decision|0|||
162629140|NCT03292588|587360996|FG001|Overall Study|Physician Decision|1|||
162917187|NCT00483574|588399724|FG000|Overall Study|Lost to Follow-up|16|||
162969123|NCT01755975|588587888|FG003|Overall Study|Adverse Event|0|||
162629141|NCT03292588|587360995|FG000|Overall Study|Withdrawal by Subject|4|||
162969124|NCT01755975|588587889|FG004|Overall Study|Adverse Event|2|||
162969125|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
162969126|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
162917188|NCT00483574|588399725|FG001|Overall Study|Lost to Follow-up|4|||
162917189|NCT00483574|588399724|FG000|Overall Study|Withdrawal by Subject|52|||
162917190|NCT00483574|588399725|FG001|Overall Study|Withdrawal by Subject|0|||
162917191|NCT03605758|588399726|FG000|Overall Study|Lost to Follow-up|2|||
162917192|NCT03605758|588399727|FG001|Overall Study|Lost to Follow-up|1|||
162917193|NCT03605758|588399726|FG000|Overall Study|Illness|0|||
162917194|NCT03605758|588399727|FG001|Overall Study|Illness|1|||
162917195|NCT03605758|588399726|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
162917196|NCT03605758|588399727|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
162917197|NCT04753606|588399730|FG000|Overall Study|Adverse Event|1|||
162917198|NCT04753606|588399731|FG001|Overall Study|Adverse Event|0|||
162917199|NCT04753606|588399732|FG002|Overall Study|Adverse Event|0|||
162917200|NCT00489411|588399733|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
162917201|NCT00489411|588399734|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
162917202|NCT00489411|588399733|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
162917203|NCT00489411|588399734|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
162917204|NCT00489411|588399733|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
162917205|NCT00489411|588399734|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
162917206|NCT00489411|588399733|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
162917207|NCT00489411|588399734|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
162917208|NCT00489411|588399733|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
162917209|NCT00489411|588399734|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
162917210|NCT01748162|588399736|FG000|Overall Study|no additional croup episodes to evaluate|2|||
162917211|NCT01748162|588399737|FG001|Overall Study|no additional croup episodes to evaluate|2|||
162917212|NCT01748162|588399736|FG000|Overall Study|participant consented but did not begin|0|||
162917213|NCT01748162|588399737|FG001|Overall Study|participant consented but did not begin|1|||
162917214|NCT01748162|588399736|FG000|Overall Study|reasons not available|3|||
162917215|NCT01748162|588399737|FG001|Overall Study|reasons not available|2|||
162917216|NCT03219372|588399738|FG000|Overall Study|Withdrawal by Subject|1|||
162917217|NCT03219372|588399739|FG001|Overall Study|Withdrawal by Subject|0|||
162917218|NCT03841331|588399740|FG000|Overall Study|Withdrawal by Subject|4|||
162917219|NCT03841331|588399741|FG001|Overall Study|Withdrawal by Subject|9|||
162917220|NCT03841331|588399740|FG000|Overall Study|Lost to Follow-up|5|||
162917221|NCT03841331|588399741|FG001|Overall Study|Lost to Follow-up|1|||
162917222|NCT04145531|588399742|FG000|Part A|Adverse Event|2|||
162917223|NCT04145531|588399743|FG001|Part A|Adverse Event|12|||
162917224|NCT04145531|588399744|FG002|Part A|Adverse Event|6|||
162917225|NCT04145531|588399745|FG003|Part A|Adverse Event|0|||
162917226|NCT04145531|588399742|FG000|Part A|Death|1|||
162917227|NCT04145531|588399743|FG001|Part A|Death|2|||
162917228|NCT04145531|588399744|FG002|Part A|Death|0|||
162917229|NCT04145531|588399745|FG003|Part A|Death|0|||
162917230|NCT04145531|588399742|FG000|Part A|Physician Decision|2|||
162917231|NCT04145531|588399743|FG001|Part A|Physician Decision|5|||
162917232|NCT04145531|588399744|FG002|Part A|Physician Decision|2|||
162917233|NCT04145531|588399745|FG003|Part A|Physician Decision|0|||
162917234|NCT04145531|588399742|FG000|Part A|Progressive disease|0|||
162917235|NCT04145531|588399743|FG001|Part A|Progressive disease|2|||
162917236|NCT04145531|588399744|FG002|Part A|Progressive disease|1|||
162917237|NCT04145531|588399745|FG003|Part A|Progressive disease|0|||
162917238|NCT04145531|588399742|FG000|Part A|Protocol deviation|0|||
162917239|NCT04145531|588399743|FG001|Part A|Protocol deviation|0|||
162917240|NCT04145531|588399744|FG002|Part A|Protocol deviation|1|||
162917241|NCT04145531|588399745|FG003|Part A|Protocol deviation|0|||
162917242|NCT04145531|588399742|FG000|Part A|Withdrawal by parent or guardian|1|||
162917243|NCT04145531|588399743|FG001|Part A|Withdrawal by parent or guardian|0|||
162917244|NCT04145531|588399744|FG002|Part A|Withdrawal by parent or guardian|0|||
162917245|NCT04145531|588399745|FG003|Part A|Withdrawal by parent or guardian|0|||
162917246|NCT04145531|588399742|FG000|Part A|Withdrawal by participant|0|||
162917247|NCT04145531|588399743|FG001|Part A|Withdrawal by participant|0|||
162917248|NCT04145531|588399744|FG002|Part A|Withdrawal by participant|1|||
162917249|NCT04145531|588399745|FG003|Part A|Withdrawal by participant|0|||
162917250|NCT04145531|588399742|FG000|Part A|Other|0|||
162917251|NCT04145531|588399743|FG001|Part A|Other|0|||
162917252|NCT04145531|588399744|FG002|Part A|Other|1|||
162969127|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
162969128|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
162969129|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
162969130|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
162917253|NCT04145531|588399745|FG003|Part A|Other|0|||
162917254|NCT04145531|588399742|FG000|Part B|Adverse Event|0|||
162917255|NCT04145531|588399743|FG001|Part B|Adverse Event|0|||
162917256|NCT04145531|588399744|FG002|Part B|Adverse Event|0|||
162917257|NCT04145531|588399745|FG003|Part B|Adverse Event|21|||
162917258|NCT04145531|588399742|FG000|Part B|Physician Decision|0|||
162917259|NCT04145531|588399743|FG001|Part B|Physician Decision|0|||
162917260|NCT04145531|588399744|FG002|Part B|Physician Decision|0|||
162917261|NCT04145531|588399745|FG003|Part B|Physician Decision|7|||
162917262|NCT04145531|588399742|FG000|Part B|Progressive disease|0|||
162917263|NCT04145531|588399743|FG001|Part B|Progressive disease|0|||
162917264|NCT04145531|588399744|FG002|Part B|Progressive disease|0|||
162917265|NCT04145531|588399745|FG003|Part B|Progressive disease|1|||
162917266|NCT04145531|588399742|FG000|Part B|Recurrent disease|0|||
162917267|NCT04145531|588399743|FG001|Part B|Recurrent disease|0|||
162917268|NCT04145531|588399744|FG002|Part B|Recurrent disease|0|||
162917269|NCT04145531|588399745|FG003|Part B|Recurrent disease|1|||
162917270|NCT04145531|588399742|FG000|Part B|Withdrawal by parent or guardian|0|||
162917271|NCT04145531|588399743|FG001|Part B|Withdrawal by parent or guardian|0|||
162917272|NCT04145531|588399744|FG002|Part B|Withdrawal by parent or guardian|0|||
162917273|NCT04145531|588399745|FG003|Part B|Withdrawal by parent or guardian|3|||
162917274|NCT04145531|588399742|FG000|Part B|Withdrawal by participant|0|||
162917275|NCT04145531|588399743|FG001|Part B|Withdrawal by participant|0|||
162917276|NCT04145531|588399744|FG002|Part B|Withdrawal by participant|0|||
162917277|NCT04145531|588399745|FG003|Part B|Withdrawal by participant|1|||
162917278|NCT04145531|588399742|FG000|Part B|Other|0|||
162917279|NCT04145531|588399743|FG001|Part B|Other|0|||
162917280|NCT04145531|588399744|FG002|Part B|Other|0|||
162917281|NCT04145531|588399745|FG003|Part B|Other|1|||
162917282|NCT02067728|588399746|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
162917283|NCT02067728|588399747|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
162917284|NCT02067728|588399746|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
162969131|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
162969132|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
162969133|NCT03653026|588587890|FG000|Part 1: Placebo-controlled Period|Other|0|||
162969134|NCT03653026|588587891|FG001|Part 1: Placebo-controlled Period|Other|3|||
162969135|NCT03653026|588587892|FG002|Part 1: Placebo-controlled Period|Other|0|||
162969136|NCT03653026|588587893|FG003|Part 1: Placebo-controlled Period|Other|0|||
162969137|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Adverse Event|0|||
162969138|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Adverse Event|0|||
162969139|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Adverse Event|1|||
162969140|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Adverse Event|1|||
162969141|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162969142|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162969143|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
162969144|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
162969145|NCT03653026|588587890|FG000|Part 2: Open-label Extension|Other|0|||
162969146|NCT03653026|588587891|FG001|Part 2: Open-label Extension|Other|0|||
162969147|NCT03653026|588587892|FG002|Part 2: Open-label Extension|Other|1|||
162969148|NCT03653026|588587893|FG003|Part 2: Open-label Extension|Other|2|||
162969149|NCT02104817|588587896|FG000|Overall Study|Death|363|||
162969150|NCT02104817|588587897|FG001|Overall Study|Death|330|||
162969151|NCT02104817|588587896|FG000|Overall Study|Lost to Follow-up|3|||
162969152|NCT02104817|588587897|FG001|Overall Study|Lost to Follow-up|2|||
162969153|NCT02104817|588587896|FG000|Overall Study|Protocol Violation|0|||
162969154|NCT02104817|588587897|FG001|Overall Study|Protocol Violation|1|||
162969155|NCT02104817|588587896|FG000|Overall Study|Study terminated by sponsor|5854|||
162969156|NCT02104817|588587897|FG001|Overall Study|Study terminated by sponsor|5901|||
162969157|NCT02104817|588587896|FG000|Overall Study|Withdrawal by Subject|111|||
162969158|NCT02104817|588587897|FG001|Overall Study|Withdrawal by Subject|78|||
162969159|NCT02104817|588587896|FG000|Overall Study|Other reasons|128|||
162969160|NCT02104817|588587897|FG001|Overall Study|Other reasons|135|||
162969161|NCT00852917|588587898|FG000|Overall Study|Adverse Event|13|||
162969162|NCT00852917|588587899|FG001|Overall Study|Adverse Event|20|||
162969163|NCT00852917|588587900|FG002|Overall Study|Adverse Event|35|||
162969164|NCT00852917|588587901|FG003|Overall Study|Adverse Event|17|||
162969165|NCT00852917|588587898|FG000|Overall Study|Lack of Efficacy|21|||
162969166|NCT00852917|588587899|FG001|Overall Study|Lack of Efficacy|11|||
162969167|NCT00852917|588587900|FG002|Overall Study|Lack of Efficacy|11|||
162969168|NCT00852917|588587901|FG003|Overall Study|Lack of Efficacy|47|||
162969169|NCT00852917|588587898|FG000|Overall Study|Withdrawal by Subject|4|||
162969170|NCT00852917|588587899|FG001|Overall Study|Withdrawal by Subject|8|||
162969171|NCT00852917|588587900|FG002|Overall Study|Withdrawal by Subject|10|||
162969172|NCT00852917|588587901|FG003|Overall Study|Withdrawal by Subject|9|||
162969173|NCT00852917|588587898|FG000|Overall Study|Physician Decision|6|||
162969174|NCT00852917|588587899|FG001|Overall Study|Physician Decision|7|||
162969175|NCT00852917|588587900|FG002|Overall Study|Physician Decision|2|||
162969176|NCT00852917|588587901|FG003|Overall Study|Physician Decision|19|||
162969177|NCT00852917|588587898|FG000|Overall Study|Death|0|||
162969178|NCT00852917|588587899|FG001|Overall Study|Death|0|||
162917285|NCT02067728|588399747|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
162917286|NCT02067728|588399746|FG000|6 Month Measurements|Unable to attend|114|||
162917287|NCT02067728|588399747|FG001|6 Month Measurements|Unable to attend|97|||
162917288|NCT04640168|588399749|FG000|Overall Study|Withdrawal by Subject|8|||
162917289|NCT04640168|588399750|FG001|Overall Study|Withdrawal by Subject|7|||
162917290|NCT04640168|588399749|FG000|Overall Study|Lost to Follow-up|1|||
163055186|NCT01787552|588914064|FG001|Overall Study|Death|0|||
163055187|NCT01787552|588914065|FG002|Overall Study|Death|0|||
163055188|NCT01787552|588914066|FG003|Overall Study|Death|1|||
163055189|NCT01787552|588914063|FG000|Overall Study|Adverse Event|2|||
163055190|NCT01787552|588914064|FG001|Overall Study|Adverse Event|5|||
163055191|NCT01787552|588914065|FG002|Overall Study|Adverse Event|2|||
163055192|NCT01787552|588914066|FG003|Overall Study|Adverse Event|16|||
163055193|NCT01787552|588914063|FG000|Overall Study|Study terminated by Sponsor|0|||
163055194|NCT01787552|588914064|FG001|Overall Study|Study terminated by Sponsor|0|||
163055195|NCT01787552|588914065|FG002|Overall Study|Study terminated by Sponsor|1|||
163055196|NCT01787552|588914066|FG003|Overall Study|Study terminated by Sponsor|3|||
163055197|NCT01787552|588914063|FG000|Overall Study|Progressive Disease|2|||
163055198|NCT01787552|588914064|FG001|Overall Study|Progressive Disease|2|||
163055199|NCT01787552|588914065|FG002|Overall Study|Progressive Disease|1|||
163055200|NCT01787552|588914066|FG003|Overall Study|Progressive Disease|1|||
163055201|NCT01299584|588914077|FG000|Overall Study|Protocol Violation|9|||
163055202|NCT00572832|588914078|FG000|Overall Study|Lost to Follow-up|0|||
163055203|NCT00572832|588914079|FG001|Overall Study|Lost to Follow-up|11|||
163055204|NCT00572832|588914078|FG000|Overall Study|Pregnancy|0|||
163055205|NCT00572832|588914079|FG001|Overall Study|Pregnancy|1|||
163055206|NCT01604785|588914087|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
163055207|NCT01604785|588914088|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
163055208|NCT01776554|588914091|FG000|Overall Study|Adverse Event|1|||
163055209|NCT01776554|588914092|FG001|Overall Study|Adverse Event|0|||
163055210|NCT01776554|588914091|FG000|Overall Study|Withdrawal by Subject|3|||
163055211|NCT01776554|588914092|FG001|Overall Study|Withdrawal by Subject|8|||
163055212|NCT01776554|588914091|FG000|Overall Study|Lost to Follow-up|6|||
163055213|NCT01776554|588914092|FG001|Overall Study|Lost to Follow-up|9|||
163055214|NCT01776554|588914091|FG000|Overall Study|Administrative Reason|2|||
163055215|NCT01776554|588914092|FG001|Overall Study|Administrative Reason|5|||
163055216|NCT01776554|588914091|FG000|Overall Study|Protocol Violation|1|||
163055217|NCT01776554|588914092|FG001|Overall Study|Protocol Violation|0|||
163055218|NCT01776554|588914091|FG000|Overall Study|Unclassified|4|||
163055219|NCT01776554|588914092|FG001|Overall Study|Unclassified|1|||
163055220|NCT01041859|588914093|FG000|Open-Label Titration|Adverse Event|69|||
163055221|NCT01041859|588914094|FG001|Open-Label Titration|Adverse Event|0|||
163055222|NCT01041859|588914095|FG002|Open-Label Titration|Adverse Event|0|||
163055223|NCT01041859|588914093|FG000|Open-Label Titration|Lack of Efficacy|3|||
163055224|NCT01041859|588914094|FG001|Open-Label Titration|Lack of Efficacy|0|||
163055225|NCT01041859|588914095|FG002|Open-Label Titration|Lack of Efficacy|0|||
163055226|NCT01041859|588914093|FG000|Open-Label Titration|Lost to Follow-up|1|||
163055227|NCT01041859|588914094|FG001|Open-Label Titration|Lost to Follow-up|0|||
162917291|NCT04640168|588399750|FG001|Overall Study|Lost to Follow-up|0|||
162917292|NCT04640168|588399749|FG000|Overall Study|Enrolled but not treated|12|||
162917293|NCT04640168|588399750|FG001|Overall Study|Enrolled but not treated|12|||
162917294|NCT00779857|588399751|FG000|Overall Study|Death|1|||
162917295|NCT00779857|588399751|FG000|Overall Study|Withdrawal by Subject|3|||
162917296|NCT00779857|588399751|FG000|Overall Study|Missed Visit|2|||
162917297|NCT03557775|588399755|FG000|Overall Study|Withdrawal by Subject|1|||
162917298|NCT03557775|588399756|FG001|Overall Study|Withdrawal by Subject|2|||
162917299|NCT03557775|588399757|FG002|Overall Study|Withdrawal by Subject|4|||
162917300|NCT03557775|588399755|FG000|Overall Study|Physician Decision|0|||
162917301|NCT03557775|588399756|FG001|Overall Study|Physician Decision|1|||
162917302|NCT03557775|588399757|FG002|Overall Study|Physician Decision|0|||
162917303|NCT00276458|588399762|FG000|Overall Study|Adverse Event|0|||
162917304|NCT00276458|588399763|FG001|Overall Study|Adverse Event|2|||
162917305|NCT00276458|588399762|FG000|Overall Study|Lost to Follow-up|2|||
162917306|NCT00276458|588399763|FG001|Overall Study|Lost to Follow-up|2|||
162917307|NCT00276458|588399762|FG000|Overall Study|Protocol Violation|4|||
162917308|NCT00276458|588399763|FG001|Overall Study|Protocol Violation|3|||
163055228|NCT01041859|588914095|FG002|Open-Label Titration|Lost to Follow-up|0|||
163055229|NCT01041859|588914093|FG000|Open-Label Titration|Physician Decision|1|||
163055230|NCT01041859|588914094|FG001|Open-Label Titration|Physician Decision|0|||
163055231|NCT01041859|588914095|FG002|Open-Label Titration|Physician Decision|0|||
163055232|NCT01041859|588914093|FG000|Open-Label Titration|Protocol Violation|1|||
163055233|NCT01041859|588914094|FG001|Open-Label Titration|Protocol Violation|0|||
163055234|NCT01041859|588914095|FG002|Open-Label Titration|Protocol Violation|0|||
163055235|NCT01041859|588914093|FG000|Open-Label Titration|Other|7|||
163055236|NCT01041859|588914094|FG001|Open-Label Titration|Other|0|||
163055237|NCT01041859|588914095|FG002|Open-Label Titration|Other|0|||
163055238|NCT01041859|588914093|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
162917309|NCT01977625|588399769|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
162917310|NCT01977625|588399770|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
162917311|NCT01977625|588399769|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162917312|NCT01977625|588399770|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162917313|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
162917314|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
162917315|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
162917316|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
162917317|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
162917318|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Death|1|||
162917319|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Death|0|||
162917320|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Death|0|||
162917321|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Death|0|||
162917322|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Death|0|||
162917323|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
162917324|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
162917325|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
162917326|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
162917327|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
162917328|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
162917329|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
162917330|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
162917331|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
162917332|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
162917333|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
162917334|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
162917335|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
162917336|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
162969179|NCT00852917|588587900|FG002|Overall Study|Death|0|||
162969180|NCT00852917|588587901|FG003|Overall Study|Death|1|||
162969181|NCT01597479|588587905|FG000|Overall Study|Protocol Violation|1|||
162969182|NCT01597479|588587906|FG001|Overall Study|Protocol Violation|0|||
162969183|NCT01597479|588587905|FG000|Overall Study|Lost to Follow-up|1|||
162969184|NCT01597479|588587906|FG001|Overall Study|Lost to Follow-up|0|||
162969185|NCT02167594|588587907|FG000|Overall Study|Withdrawal by Subject|2|||
162969186|NCT02167594|588587908|FG001|Overall Study|Withdrawal by Subject|0|||
162969187|NCT02167594|588587909|FG002|Overall Study|Withdrawal by Subject|0|||
162969188|NCT02167594|588587907|FG000|Overall Study|Death|0|||
162969189|NCT02167594|588587908|FG001|Overall Study|Death|1|||
162969190|NCT02167594|588587909|FG002|Overall Study|Death|0|||
162969191|NCT02340780|588587910|FG000|Overall Study|Ineligible|1|||
162969192|NCT03433703|588587911|FG000|Overall Study|Study terminated by Sponsor|2|||
162969193|NCT01583530|588587914|FG000|Overall Study|Adverse Event|0|||
162969194|NCT01583530|588587915|FG001|Overall Study|Adverse Event|0|||
162969195|NCT01583530|588587916|FG002|Overall Study|Adverse Event|0|||
162969196|NCT01583530|588587917|FG003|Overall Study|Adverse Event|0|||
162969197|NCT01583530|588587918|FG004|Overall Study|Adverse Event|0|||
162969198|NCT01583530|588587919|FG005|Overall Study|Adverse Event|1|||
162969199|NCT01583530|588587914|FG000|Overall Study|Withdrawal by Subject|0|||
162969200|NCT01583530|588587915|FG001|Overall Study|Withdrawal by Subject|3|||
162969201|NCT01583530|588587916|FG002|Overall Study|Withdrawal by Subject|0|||
162969202|NCT01583530|588587917|FG003|Overall Study|Withdrawal by Subject|1|||
162969203|NCT01583530|588587918|FG004|Overall Study|Withdrawal by Subject|1|||
162969204|NCT01583530|588587919|FG005|Overall Study|Withdrawal by Subject|2|||
162969205|NCT01583530|588587914|FG000|Overall Study|Lost to Follow-up|0|||
162969206|NCT01583530|588587915|FG001|Overall Study|Lost to Follow-up|0|||
162917337|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
162969207|NCT01583530|588587916|FG002|Overall Study|Lost to Follow-up|0|||
162969208|NCT01583530|588587917|FG003|Overall Study|Lost to Follow-up|0|||
162969209|NCT01583530|588587918|FG004|Overall Study|Lost to Follow-up|3|||
162969210|NCT01583530|588587919|FG005|Overall Study|Lost to Follow-up|0|||
162969211|NCT01583530|588587914|FG000|Overall Study|Lack of compliance|0|||
162969212|NCT01583530|588587915|FG001|Overall Study|Lack of compliance|0|||
162969213|NCT01583530|588587916|FG002|Overall Study|Lack of compliance|0|||
162969214|NCT01583530|588587917|FG003|Overall Study|Lack of compliance|0|||
162969215|NCT01583530|588587918|FG004|Overall Study|Lack of compliance|1|||
162969216|NCT01583530|588587919|FG005|Overall Study|Lack of compliance|0|||
162969217|NCT02416180|588587920|FG000|Overall Study|Withdrawal by Subject|1|||
162969218|NCT00640926|588587921|FG000|Overall Study|Adverse Event|2|||
162969219|NCT00640926|588587922|FG001|Overall Study|Adverse Event|3|||
162711048|NCT02138916|587652858|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
162917338|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
162917339|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
162917340|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
162917341|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
162969220|NCT00640926|588587923|FG002|Overall Study|Adverse Event|2|||
162917342|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
162917343|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
162917344|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
162917345|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
162917346|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
162917347|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
162917348|NCT00634933|588399772|FG000|Part A: Baseline to Week 24|Other|1|||
162917349|NCT00634933|588399773|FG001|Part A: Baseline to Week 24|Other|8|||
162917350|NCT00634933|588399774|FG002|Part A: Baseline to Week 24|Other|5|||
162917351|NCT00634933|588399775|FG003|Part A: Baseline to Week 24|Other|0|||
162917352|NCT00634933|588399776|FG004|Part A: Baseline to Week 24|Other|0|||
162917353|NCT00634933|588399772|FG000|Between Part A and Part B|Physician Decision|0|||
162917354|NCT00634933|588399773|FG001|Between Part A and Part B|Physician Decision|1|||
162917355|NCT00634933|588399774|FG002|Between Part A and Part B|Physician Decision|0|||
162917356|NCT00634933|588399775|FG003|Between Part A and Part B|Physician Decision|0|||
162917357|NCT00634933|588399776|FG004|Between Part A and Part B|Physician Decision|0|||
162917358|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
162917359|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
162917360|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
162917361|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
162917362|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
162917363|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
162917364|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
162917365|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
162917366|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
162917367|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
162917368|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
162969221|NCT00640926|588587921|FG000|Overall Study|Lack of Efficacy|0|||
162969222|NCT00640926|588587922|FG001|Overall Study|Lack of Efficacy|2|||
162969223|NCT00640926|588587923|FG002|Overall Study|Lack of Efficacy|1|||
162969224|NCT00640926|588587921|FG000|Overall Study|Protocol Violation|2|||
162969225|NCT00640926|588587922|FG001|Overall Study|Protocol Violation|0|||
162969226|NCT00640926|588587923|FG002|Overall Study|Protocol Violation|2|||
162969227|NCT00640926|588587921|FG000|Overall Study|Lost to Follow-up|3|||
162969228|NCT00640926|588587922|FG001|Overall Study|Lost to Follow-up|1|||
162969229|NCT00640926|588587923|FG002|Overall Study|Lost to Follow-up|2|||
162969230|NCT00640926|588587921|FG000|Overall Study|Withdrawal by Subject|1|||
162969231|NCT00640926|588587922|FG001|Overall Study|Withdrawal by Subject|0|||
162969232|NCT00640926|588587923|FG002|Overall Study|Withdrawal by Subject|1|||
162969233|NCT02985398|588587924|FG000|Overall Study|Adverse Event|1|||
162969234|NCT02985398|588587924|FG000|Overall Study|Lost to Follow-up|4|||
162969235|NCT02985398|588587924|FG000|Overall Study|Withdrawal by Subject|8|||
162969236|NCT02985398|588587924|FG000|Overall Study|Study Burden|9|||
162969237|NCT02050321|588587925|FG000|Overall Study|Withdrawal by Subject|1|||
162969238|NCT02050321|588587925|FG000|Overall Study|Adverse Event|1|||
162969239|NCT04768114|588587926|FG000|Overall Study|Lost to Follow-up|5|||
162969240|NCT04768114|588587927|FG001|Overall Study|Lost to Follow-up|10|||
162969241|NCT04768114|588587926|FG000|Overall Study|Withdrawal by Subject|0|||
162969242|NCT04768114|588587927|FG001|Overall Study|Withdrawal by Subject|1|||
162969243|NCT00715676|588587933|FG000|Overall Study|Adverse Event|3|||
162969244|NCT00715676|588587934|FG001|Overall Study|Adverse Event|5|||
162969245|NCT00715676|588587935|FG002|Overall Study|Adverse Event|21|||
162969246|NCT00715676|588587933|FG000|Overall Study|Withdrawal by Subject|1|||
162969247|NCT00715676|588587934|FG001|Overall Study|Withdrawal by Subject|3|||
162969248|NCT00715676|588587935|FG002|Overall Study|Withdrawal by Subject|8|||
162969249|NCT00715676|588587933|FG000|Overall Study|Lost to Follow-up|1|||
162969250|NCT00715676|588587934|FG001|Overall Study|Lost to Follow-up|2|||
162969251|NCT00715676|588587935|FG002|Overall Study|Lost to Follow-up|1|||
162969252|NCT00715676|588587933|FG000|Overall Study|Terminated by Sponsor|1|||
162969253|NCT00715676|588587934|FG001|Overall Study|Terminated by Sponsor|0|||
162969254|NCT00715676|588587935|FG002|Overall Study|Terminated by Sponsor|0|||
162969255|NCT00715676|588587933|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
162969256|NCT00715676|588587934|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
162969257|NCT00715676|588587935|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
162969258|NCT00715676|588587933|FG000|Overall Study|Use of Exclusionary Medication|0|||
162629142|NCT03292588|587360996|FG001|Overall Study|Withdrawal by Subject|4|||
162969259|NCT00715676|588587934|FG001|Overall Study|Use of Exclusionary Medication|0|||
162969260|NCT00715676|588587935|FG002|Overall Study|Use of Exclusionary Medication|1|||
162969261|NCT00715676|588587933|FG000|Overall Study|Elevated Blood Glucose|0|||
162969262|NCT00715676|588587934|FG001|Overall Study|Elevated Blood Glucose|1|||
162969263|NCT00715676|588587935|FG002|Overall Study|Elevated Blood Glucose|0|||
162969264|NCT03828539|588587936|FG000|Overall Study|Adverse Event|3|||
162629143|NCT03292588|587360995|FG000|Overall Study|Move out of town|1|||
162629144|NCT03292588|587360996|FG001|Overall Study|Move out of town|0|||
162969265|NCT03828539|588587937|FG001|Overall Study|Adverse Event|12|||
162917369|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
162917370|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
162917371|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
162917372|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
162917373|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
162917374|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
162917375|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
162917376|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
162917377|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
162917378|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
162917379|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
162917380|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
162917381|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
162917382|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
162917383|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
162917384|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
162917385|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
162917386|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
162917387|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
162917388|NCT00634933|588399772|FG000|Part B: Week 24 to Week 52|Other|0|||
162917389|NCT00634933|588399773|FG001|Part B: Week 24 to Week 52|Other|0|||
162917390|NCT00634933|588399774|FG002|Part B: Week 24 to Week 52|Other|5|||
162917391|NCT00634933|588399775|FG003|Part B: Week 24 to Week 52|Other|0|||
162917392|NCT00634933|588399776|FG004|Part B: Week 24 to Week 52|Other|1|||
162917393|NCT02304484|588399777|FG000|Overall Study|Death|9|||
162917394|NCT02304484|588399777|FG000|Overall Study|Withdrawal by Subject|14|||
162917395|NCT02304484|588399777|FG000|Overall Study|Lost to Follow-up|2|||
162917396|NCT04338685|588399778|FG000|Overall Study|Death|3|||
162917397|NCT04338685|588399779|FG001|Overall Study|Death|4|||
162917398|NCT04338685|588399780|FG002|Overall Study|Death|2|||
162917399|NCT04338685|588399781|FG003|Overall Study|Death|4|||
162917400|NCT04338685|588399782|FG004|Overall Study|Death|4|||
162917401|NCT04338685|588399783|FG005|Overall Study|Death|8|||
162917402|NCT04338685|588399784|FG006|Overall Study|Death|1|||
162917403|NCT04338685|588399785|FG007|Overall Study|Death|0|||
162917404|NCT04338685|588399786|FG008|Overall Study|Death|0|||
162917405|NCT04338685|588399778|FG000|Overall Study|Study terminated by Sponsor|0|||
162917406|NCT04338685|588399779|FG001|Overall Study|Study terminated by Sponsor|0|||
162917407|NCT04338685|588399780|FG002|Overall Study|Study terminated by Sponsor|1|||
162917408|NCT04338685|588399781|FG003|Overall Study|Study terminated by Sponsor|4|||
162917409|NCT04338685|588399782|FG004|Overall Study|Study terminated by Sponsor|0|||
162917410|NCT04338685|588399783|FG005|Overall Study|Study terminated by Sponsor|5|||
162917411|NCT04338685|588399784|FG006|Overall Study|Study terminated by Sponsor|2|||
162917412|NCT04338685|588399785|FG007|Overall Study|Study terminated by Sponsor|4|||
162917413|NCT04338685|588399786|FG008|Overall Study|Study terminated by Sponsor|1|||
162917414|NCT04338685|588399778|FG000|Overall Study|Withdrawal by Subject|1|||
162917415|NCT04338685|588399779|FG001|Overall Study|Withdrawal by Subject|2|||
162917416|NCT04338685|588399780|FG002|Overall Study|Withdrawal by Subject|0|||
162969266|NCT03828539|588587936|FG000|Overall Study|Patient's/guardian's decision|3|||
162969267|NCT03828539|588587937|FG001|Overall Study|Patient's/guardian's decision|5|||
162969268|NCT03828539|588587936|FG000|Overall Study|Lost to Follow-up|4|||
162969269|NCT03828539|588587937|FG001|Overall Study|Lost to Follow-up|2|||
162969270|NCT03828539|588587936|FG000|Overall Study|Protocol Violation|3|||
162969271|NCT03828539|588587937|FG001|Overall Study|Protocol Violation|2|||
162969272|NCT03828539|588587936|FG000|Overall Study|Withdrawal of informed consent|2|||
162969273|NCT03828539|588587937|FG001|Overall Study|Withdrawal of informed consent|1|||
162969274|NCT03828539|588587936|FG000|Overall Study|New therapy for study indication|1|||
162969275|NCT03828539|588587937|FG001|Overall Study|New therapy for study indication|0|||
162969276|NCT05467540|588587943|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
162969277|NCT05467540|588587943|FG000|3-Month Follow-up|Lost to Follow-up|4|||
162969278|NCT05467540|588587943|FG000|3-Month Follow-up|Death|5|||
162711049|NCT02138916|587652859|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
162969279|NCT05467540|588587943|FG000|12-Month Follow-up|Lost to Follow-up|6|||
162969280|NCT05467540|588587943|FG000|12-Month Follow-up|Death|8|||
162969281|NCT05467540|588587943|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
162917417|NCT04338685|588399781|FG003|Overall Study|Withdrawal by Subject|2|||
162917418|NCT04338685|588399782|FG004|Overall Study|Withdrawal by Subject|0|||
162917419|NCT04338685|588399783|FG005|Overall Study|Withdrawal by Subject|5|||
162917420|NCT04338685|588399784|FG006|Overall Study|Withdrawal by Subject|1|||
162917421|NCT04338685|588399785|FG007|Overall Study|Withdrawal by Subject|1|||
162917422|NCT04338685|588399786|FG008|Overall Study|Withdrawal by Subject|0|||
162917423|NCT00234533|588399787|FG000|Overall Study|Withdrawal by Subject|6|||
162917424|NCT00234533|588399787|FG000|Overall Study|Adverse Event|2|||
162969282|NCT00653159|588589921|FG000|Overall Study|Adverse Event|4|||
162969283|NCT00653159|588589922|FG001|Overall Study|Adverse Event|1|||
162969284|NCT00653159|588589921|FG000|Overall Study|Lost to Follow-up|1|||
162969285|NCT00653159|588589922|FG001|Overall Study|Lost to Follow-up|2|||
162969286|NCT01872715|588589923|FG000|Overall Study|Adverse Event|1|||
162969287|NCT01872715|588589923|FG000|Overall Study|Protocol Violation|1|||
162969288|NCT01872715|588589923|FG000|Overall Study|Withdrawal by Subject|2|||
162969289|NCT01848210|588589924|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
162969290|NCT01848210|588589925|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
162969291|NCT01848210|588589924|FG000|Overall Study|Lost to Follow-up|24|||
162969292|NCT01848210|588589925|FG001|Overall Study|Lost to Follow-up|12|||
162969293|NCT01848210|588589924|FG000|Overall Study|Protocol Violation|3|||
162969294|NCT01848210|588589925|FG001|Overall Study|Protocol Violation|5|||
162969295|NCT01848210|588589924|FG000|Overall Study|Use of Forbidden Drugs|9|||
162969296|NCT01848210|588589925|FG001|Overall Study|Use of Forbidden Drugs|10|||
162969297|NCT01848210|588589924|FG000|Overall Study|Impedition Condition|5|||
162969298|NCT01848210|588589925|FG001|Overall Study|Impedition Condition|9|||
162969299|NCT01848210|588589924|FG000|Overall Study|Adverse Event|7|||
162969300|NCT01848210|588589925|FG001|Overall Study|Adverse Event|9|||
162969301|NCT01848210|588589924|FG000|Overall Study|Discontinuation Criterion|5|||
162969302|NCT01848210|588589925|FG001|Overall Study|Discontinuation Criterion|7|||
162969303|NCT01848210|588589924|FG000|Overall Study|Hypesensitivity|1|||
162969304|NCT01848210|588589925|FG001|Overall Study|Hypesensitivity|0|||
162969305|NCT01848210|588589924|FG000|Overall Study|Hepatic Function Alteration|4|||
162969306|NCT01848210|588589925|FG001|Overall Study|Hepatic Function Alteration|0|||
162969307|NCT01848210|588589924|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
162969308|NCT01848210|588589925|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
162969309|NCT01848210|588589924|FG000|Overall Study|Administrative|1|||
162969310|NCT01848210|588589925|FG001|Overall Study|Administrative|0|||
162969311|NCT00381849|588589926|FG000|Wash Out|Withdrawal by Subject|0|||
162969312|NCT00381849|588589927|FG001|Wash Out|Withdrawal by Subject|1|||
162969313|NCT01765270|588589931|FG000|Overall Study|Physician Decision|1|||
162969314|NCT01765270|588589932|FG001|Overall Study|Physician Decision|0|||
162969315|NCT01765270|588589931|FG000|Overall Study|Withdrawal by Subject|0|||
162969316|NCT01765270|588589932|FG001|Overall Study|Withdrawal by Subject|1|||
162969317|NCT00517192|588589933|FG000|Overall Study|Adverse Event|1|||
162969318|NCT00517192|588589934|FG001|Overall Study|Adverse Event|1|||
162969319|NCT00517192|588589933|FG000|Overall Study|Lost to Follow-up|1|||
162969320|NCT00517192|588589934|FG001|Overall Study|Lost to Follow-up|1|||
162969321|NCT00517192|588589933|FG000|Overall Study|Withdrawal by Subject|1|||
162969322|NCT00517192|588589934|FG001|Overall Study|Withdrawal by Subject|0|||
162969323|NCT00517192|588589933|FG000|Overall Study|Early termination of the trial|16|||
162969324|NCT00517192|588589934|FG001|Overall Study|Early termination of the trial|18|||
162969325|NCT04501094|588589936|FG000|Overall Study|Death (unrelated to research)|1|||
162969326|NCT04501094|588589937|FG001|Overall Study|Death (unrelated to research)|0|||
162969327|NCT05693805|588589940|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
162969328|NCT05693805|588589941|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
162969329|NCT02943993|588589942|FG000|Overall Study|Withdrawal by Subject|52|||
162969330|NCT02943993|588589942|FG000|Overall Study|Transfer to another institution|6|||
162969331|NCT02943993|588589942|FG000|Overall Study|Lost to Follow-up|135|||
162969332|NCT02943993|588589942|FG000|Overall Study|Death|98|||
162969333|NCT02943993|588589942|FG000|Overall Study|Other reason for premature termination|32|||
162969334|NCT02943993|588589942|FG000|Overall Study|Missing reason for termination|7|||
162969335|NCT02510261|588589943|FG000|Overall Study|Adverse Event|5|||
162969336|NCT02510261|588589944|FG001|Overall Study|Adverse Event|8|||
162969337|NCT02510261|588589945|FG002|Overall Study|Adverse Event|0|||
162969338|NCT02510261|588589943|FG000|Overall Study|Physician Decision|1|||
162969339|NCT02510261|588589944|FG001|Overall Study|Physician Decision|5|||
162969340|NCT02510261|588589945|FG002|Overall Study|Physician Decision|0|||
162969341|NCT02510261|588589943|FG000|Overall Study|Death|19|||
162969342|NCT02510261|588589944|FG001|Overall Study|Death|19|||
162969343|NCT02510261|588589945|FG002|Overall Study|Death|0|||
162969344|NCT02510261|588589943|FG000|Overall Study|Withdrawal by Subject|3|||
162969345|NCT02510261|588589944|FG001|Overall Study|Withdrawal by Subject|10|||
162969346|NCT02510261|588589945|FG002|Overall Study|Withdrawal by Subject|3|||
162969347|NCT02003222|588589947|FG000|Induction|Never started treatment|0|||
162969348|NCT02003222|588589948|FG001|Induction|Never started treatment|0|||
162969349|NCT02003222|588589949|FG002|Induction|Never started treatment|0|||
162969350|NCT02003222|588589950|FG003|Induction|Never started treatment|0|||
162969351|NCT02003222|588589951|FG004|Induction|Never started treatment|8|||
162917425|NCT00234533|588399787|FG000|Overall Study|Enrolled but not treated|3|||
162917426|NCT02967055|588399788|FG000|Overall Study|Excluded|40|||
162917427|NCT02967055|588399788|FG000|Overall Study|Screen fail|3|||
162917428|NCT02967055|588399788|FG000|Overall Study|Lost to Follow-up|2|||
162917429|NCT02967055|588399788|FG000|Overall Study|Stopped due to side effects|3|||
162917430|NCT02967055|588399788|FG000|Overall Study|Stopped due to drug cost|1|||
162917431|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
162917432|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
162917433|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
162917434|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
162917435|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
162917436|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
162917437|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
162917438|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
162917439|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
162917440|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
162917441|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
162917442|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
162917443|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
162917444|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
162917445|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
162917446|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
162917447|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
162917448|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
162917449|NCT00570492|588399789|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
162917450|NCT00570492|588399790|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
162917451|NCT00570492|588399791|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
162917452|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
162917453|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
162917454|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
162917455|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
162917456|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
162917457|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
162917458|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
162917459|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
162917460|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
162917461|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
162917462|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
162917463|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
162917464|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
162917465|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
162917466|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
162917467|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
162917468|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
162917469|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
162917470|NCT00570492|588399789|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
162917471|NCT00570492|588399790|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
162917472|NCT00570492|588399791|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
162917473|NCT00976989|588399792|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162917474|NCT00976989|588399793|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
162917475|NCT00976989|588399794|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
162917476|NCT00976989|588399792|FG000|Overall Study|Death|5|||
162917477|NCT00976989|588399793|FG001|Overall Study|Death|7|||
162917478|NCT00976989|588399794|FG002|Overall Study|Death|10|||
162917479|NCT00976989|588399792|FG000|Overall Study|Refused Treatment|4|||
162917480|NCT00976989|588399793|FG001|Overall Study|Refused Treatment|3|||
162917481|NCT00976989|588399794|FG002|Overall Study|Refused Treatment|5|||
162917482|NCT00976989|588399792|FG000|Overall Study|Failure to Return|2|||
162917483|NCT00976989|588399793|FG001|Overall Study|Failure to Return|1|||
162917484|NCT00976989|588399794|FG002|Overall Study|Failure to Return|0|||
162917485|NCT00976989|588399792|FG000|Overall Study|Recurrence of Disease|0|||
162917486|NCT00976989|588399793|FG001|Overall Study|Recurrence of Disease|1|||
162917487|NCT00976989|588399794|FG002|Overall Study|Recurrence of Disease|0|||
162917488|NCT00976989|588399792|FG000|Overall Study|Other|1|||
162917489|NCT00976989|588399793|FG001|Overall Study|Other|0|||
162917490|NCT00976989|588399794|FG002|Overall Study|Other|1|||
162917491|NCT00908375|588399795|FG000|Overall Study|Withdrawal by Subject|2|||
162917492|NCT00908375|588399796|FG001|Overall Study|Withdrawal by Subject|4|||
162917493|NCT00908375|588399795|FG000|Overall Study|Lost to Follow-up|8|||
162917494|NCT00908375|588399796|FG001|Overall Study|Lost to Follow-up|6|||
162917495|NCT00903357|588399797|FG000|First Intervention|Withdrawal by Subject|5|||
162917496|NCT00903357|588399798|FG001|First Intervention|Withdrawal by Subject|3|||
162917497|NCT00903357|588399797|FG000|First Intervention|Flu|0|||
162917498|NCT00903357|588399798|FG001|First Intervention|Flu|1|||
162917499|NCT00903357|588399797|FG000|Wash Out Period of 2 Weeks|Flu|0|||
162917500|NCT00903357|588399798|FG001|Wash Out Period of 2 Weeks|Flu|1|||
162917501|NCT00903357|588399797|FG000|Second Intervention|Lost to Follow-up|1|||
162917502|NCT00903357|588399798|FG001|Second Intervention|Lost to Follow-up|0|||
162917503|NCT02279888|588399800|FG000|Overall Study|Death|326|||
162917504|NCT02279888|588399800|FG000|Overall Study|Withdrawal by Subject|38|||
162917505|NCT02279888|588399800|FG000|Overall Study|Lost to Follow-up|21|||
162917506|NCT02279888|588399800|FG000|Overall Study|Physician Decision|62|||
162917507|NCT02279888|588399800|FG000|Overall Study|Subject Non-compliance|43|||
162917508|NCT02279888|588399800|FG000|Overall Study|Not implanted|14|||
162917509|NCT02279888|588399800|FG000|Overall Study|Visit not performed|26|||
162917510|NCT00752206|588399801|FG000|Overall Study|Disease progression|8|||
162917511|NCT00752206|588399802|FG001|Overall Study|Disease progression|11|||
162917512|NCT00752206|588399801|FG000|Overall Study|Pregnancy|1|||
162917513|NCT00752206|588399802|FG001|Overall Study|Pregnancy|0|||
162917514|NCT01484691|588399803|FG000|Overall Study|Withdrawal by Subject|1|||
162917515|NCT01484691|588399804|FG001|Overall Study|Withdrawal by Subject|1|||
162917516|NCT01484691|588399805|FG002|Overall Study|Withdrawal by Subject|1|||
162917517|NCT01484691|588399803|FG000|Overall Study|Physician Decision|0|||
162917518|NCT01484691|588399804|FG001|Overall Study|Physician Decision|2|||
162917519|NCT01484691|588399805|FG002|Overall Study|Physician Decision|1|||
162917520|NCT03522506|588399806|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162917521|NCT03522506|588399807|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162917522|NCT03522506|588399808|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162917523|NCT03522506|588399809|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
162917524|NCT03522506|588399806|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162917525|NCT03522506|588399807|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162917526|NCT03522506|588399808|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
162917527|NCT03522506|588399809|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
162917528|NCT03480243|588399812|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
162917529|NCT03480243|588399812|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
162917530|NCT04365387|588399813|FG000|Overall Study|Adverse Event|4|||
162917531|NCT04365387|588399814|FG001|Overall Study|Adverse Event|2|||
162917532|NCT04365387|588399813|FG000|Overall Study|Participants request|14|||
162917533|NCT04365387|588399814|FG001|Overall Study|Participants request|14|||
162917534|NCT04365387|588399813|FG000|Overall Study|Lost to Follow-up|8|||
162917535|NCT04365387|588399814|FG001|Overall Study|Lost to Follow-up|5|||
162917536|NCT04365387|588399813|FG000|Overall Study|Protocol deviation|3|||
162917537|NCT04365387|588399814|FG001|Overall Study|Protocol deviation|4|||
162917538|NCT04365387|588399813|FG000|Overall Study|Participant compliance with visit schedule|1|||
162917539|NCT04365387|588399814|FG001|Overall Study|Participant compliance with visit schedule|0|||
162917540|NCT04365387|588399813|FG000|Overall Study|Participant incarcerated|1|||
162917541|NCT04365387|588399814|FG001|Overall Study|Participant incarcerated|0|||
162917542|NCT04365387|588399813|FG000|Overall Study|Participant moved out of town (relocated)|0|||
162917543|NCT04365387|588399814|FG001|Overall Study|Participant moved out of town (relocated)|1|||
162917544|NCT04365387|588399813|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
162917545|NCT04365387|588399814|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
162917546|NCT04365387|588399813|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
162917547|NCT04365387|588399814|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
162917548|NCT05770401|588399815|FG000|Overall Study|Lost to Follow-up|5|||
162917549|NCT05770401|588399816|FG001|Overall Study|Lost to Follow-up|4|||
162917550|NCT01683565|588399819|FG000|Overall Study|Lost to Follow-up|2|||
162917551|NCT01683565|588399820|FG001|Overall Study|Lost to Follow-up|0|||
162917552|NCT01683565|588399819|FG000|Overall Study|Discontinued Intervention|1|||
162917553|NCT01683565|588399820|FG001|Overall Study|Discontinued Intervention|1|||
162917554|NCT00764465|588399821|FG000|Overall Study|Adverse Event|2|||
162917555|NCT00764465|588399822|FG001|Overall Study|Adverse Event|0|||
162917556|NCT00764465|588399823|FG002|Overall Study|Adverse Event|0|||
162917557|NCT00764465|588399824|FG003|Overall Study|Adverse Event|1|||
162917558|NCT00764465|588399825|FG004|Overall Study|Adverse Event|1|||
162917559|NCT00764465|588399826|FG005|Overall Study|Adverse Event|1|||
162917560|NCT00764465|588399821|FG000|Overall Study|Withdrawal by Subject|0|||
162917561|NCT00764465|588399822|FG001|Overall Study|Withdrawal by Subject|1|||
162917562|NCT00764465|588399823|FG002|Overall Study|Withdrawal by Subject|1|||
162917563|NCT00764465|588399824|FG003|Overall Study|Withdrawal by Subject|0|||
162917564|NCT00764465|588399825|FG004|Overall Study|Withdrawal by Subject|0|||
162917565|NCT00764465|588399826|FG005|Overall Study|Withdrawal by Subject|0|||
162917566|NCT01195662|588399827|FG000|Double Blind Treatment Period|Adverse Event|4|||
162917567|NCT01195662|588399828|FG001|Double Blind Treatment Period|Adverse Event|1|||
162917568|NCT01195662|588399829|FG002|Double Blind Treatment Period|Adverse Event|2|||
162917569|NCT01195662|588399827|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
162917570|NCT01195662|588399828|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
162917571|NCT01195662|588399829|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
162917572|NCT01195662|588399827|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
162917573|NCT01195662|588399828|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
162917574|NCT01195662|588399829|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
162917575|NCT01195662|588399827|FG000|Double Blind Treatment Period|Administrative reason|2|||
162917576|NCT01195662|588399828|FG001|Double Blind Treatment Period|Administrative reason|1|||
162917577|NCT01195662|588399829|FG002|Double Blind Treatment Period|Administrative reason|1|||
162917578|NCT01195662|588399827|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
162917579|NCT01195662|588399828|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
162917580|NCT01195662|588399829|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
162917581|NCT01195662|588399827|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
162917582|NCT01195662|588399828|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
162917583|NCT01195662|588399829|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
162917584|NCT01195662|588399827|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
162917585|NCT01195662|588399828|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
162917586|NCT01195662|588399829|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
162917587|NCT01195662|588399827|FG000|Double Blind Treatment Period|Non-specified|3|||
162917588|NCT01195662|588399828|FG001|Double Blind Treatment Period|Non-specified|0|||
162917589|NCT01195662|588399829|FG002|Double Blind Treatment Period|Non-specified|0|||
162917590|NCT01195662|588399827|FG000|Double Blind Treatment Period|Missing disposition information|0|||
162917591|NCT01195662|588399828|FG001|Double Blind Treatment Period|Missing disposition information|1|||
162917592|NCT01195662|588399829|FG002|Double Blind Treatment Period|Missing disposition information|1|||
162917593|NCT01195662|588399827|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
162917594|NCT01195662|588399828|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
162917595|NCT01195662|588399829|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
162917596|NCT01195662|588399827|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
162917597|NCT01195662|588399828|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
162917598|NCT01195662|588399829|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
162917599|NCT04524507|588399830|FG000|Overall Study|Lost to Follow-up|2|||
162917600|NCT04524507|588399831|FG001|Overall Study|Lost to Follow-up|4|||
162917601|NCT04524507|588399830|FG000|Overall Study|Withdrawal by Subject|2|||
162917602|NCT04524507|588399831|FG001|Overall Study|Withdrawal by Subject|9|||
162917603|NCT04524507|588399830|FG000|Overall Study|Death|2|||
162917604|NCT04524507|588399831|FG001|Overall Study|Death|10|||
162917605|NCT03039699|588399842|FG000|Overall Study|Incorrect inclusion|5|||
162917606|NCT03039699|588399843|FG001|Overall Study|Incorrect inclusion|4|||
162917607|NCT03039699|588399842|FG000|Overall Study|Lack of data to assess study endpoint|5|||
162917608|NCT03039699|588399843|FG001|Overall Study|Lack of data to assess study endpoint|3|||
162917609|NCT03039699|588399842|FG000|Overall Study|Bacterial infection|12|||
162917610|NCT03039699|588399843|FG001|Overall Study|Bacterial infection|28|||
162917611|NCT00540228|588399844|FG000|Overall Study|Adverse Event|2|||
162917612|NCT00540228|588399845|FG001|Overall Study|Adverse Event|0|||
162917613|NCT00540228|588399846|FG002|Overall Study|Adverse Event|0|||
162917614|NCT00540228|588399847|FG003|Overall Study|Adverse Event|0|||
162917615|NCT00540228|588399848|FG004|Overall Study|Adverse Event|0|||
162917616|NCT00540228|588399844|FG000|Overall Study|Lost to Follow-up|1|||
162917617|NCT00540228|588399845|FG001|Overall Study|Lost to Follow-up|1|||
162917618|NCT00540228|588399846|FG002|Overall Study|Lost to Follow-up|0|||
162917619|NCT00540228|588399847|FG003|Overall Study|Lost to Follow-up|0|||
162917620|NCT00540228|588399848|FG004|Overall Study|Lost to Follow-up|0|||
162917621|NCT02569996|588399849|FG000|Overall Study|Adverse Event|6|||
162917622|NCT02569996|588399849|FG000|Overall Study|Physician Decision|3|||
162917623|NCT02569996|588399849|FG000|Overall Study|Progression of the disease|18|||
162917624|NCT02569996|588399849|FG000|Overall Study|New anti-lymphoma treatment|1|||
162917625|NCT02569996|588399849|FG000|Overall Study|Non-compliance|9|||
162917626|NCT02569996|588399849|FG000|Overall Study|Withdrawal by Subject|5|||
162917627|NCT02569996|588399849|FG000|Overall Study|Lost to Follow-up|5|||
162917628|NCT02569996|588399849|FG000|Overall Study|Complete remission|7|||
162917629|NCT02569996|588399849|FG000|Overall Study|Unknown reason|1|||
162917630|NCT01397409|588399850|FG000|Stage 2|Adverse Event|0|||
162917631|NCT01397409|588399851|FG001|Stage 2|Adverse Event|0|||
162917632|NCT01397409|588399852|FG002|Stage 2|Adverse Event|0|||
162917633|NCT01397409|588399853|FG003|Stage 2|Adverse Event|0|||
162917634|NCT01397409|588399854|FG004|Stage 2|Adverse Event|6|||
162917635|NCT01397409|588399855|FG005|Stage 2|Adverse Event|3|||
162917636|NCT01397409|588399856|FG006|Stage 2|Adverse Event|0|||
162917637|NCT01397409|588399857|FG007|Stage 2|Adverse Event|0|||
162917638|NCT01397409|588399858|FG008|Stage 2|Adverse Event|0|||
162917639|NCT01397409|588399859|FG009|Stage 2|Adverse Event|0|||
162917640|NCT01397409|588399850|FG000|Stage 2|Personal Reasons|0|||
162917641|NCT01397409|588399851|FG001|Stage 2|Personal Reasons|0|||
162917642|NCT01397409|588399852|FG002|Stage 2|Personal Reasons|0|||
162917643|NCT01397409|588399853|FG003|Stage 2|Personal Reasons|0|||
162917644|NCT01397409|588399854|FG004|Stage 2|Personal Reasons|1|||
162917645|NCT01397409|588399855|FG005|Stage 2|Personal Reasons|0|||
162917646|NCT01397409|588399856|FG006|Stage 2|Personal Reasons|0|||
162917647|NCT01397409|588399857|FG007|Stage 2|Personal Reasons|0|||
162917648|NCT01397409|588399858|FG008|Stage 2|Personal Reasons|0|||
162917649|NCT01397409|588399859|FG009|Stage 2|Personal Reasons|0|||
162917650|NCT01397409|588399850|FG000|Stage 2|Other Miscellaneous Reasons|0|||
162917651|NCT01397409|588399851|FG001|Stage 2|Other Miscellaneous Reasons|0|||
162917652|NCT01397409|588399852|FG002|Stage 2|Other Miscellaneous Reasons|0|||
162917653|NCT01397409|588399853|FG003|Stage 2|Other Miscellaneous Reasons|0|||
162917654|NCT01397409|588399854|FG004|Stage 2|Other Miscellaneous Reasons|1|||
162917655|NCT01397409|588399855|FG005|Stage 2|Other Miscellaneous Reasons|1|||
162917656|NCT01397409|588399856|FG006|Stage 2|Other Miscellaneous Reasons|0|||
162917657|NCT01397409|588399857|FG007|Stage 2|Other Miscellaneous Reasons|0|||
162917658|NCT01397409|588399858|FG008|Stage 2|Other Miscellaneous Reasons|0|||
162917659|NCT01397409|588399859|FG009|Stage 2|Other Miscellaneous Reasons|0|||
162917660|NCT01397409|588399850|FG000|Stage 3|Adverse Event|0|||
162917661|NCT01397409|588399851|FG001|Stage 3|Adverse Event|0|||
162917662|NCT01397409|588399852|FG002|Stage 3|Adverse Event|0|||
162917663|NCT01397409|588399853|FG003|Stage 3|Adverse Event|0|||
162917664|NCT01397409|588399854|FG004|Stage 3|Adverse Event|0|||
162917665|NCT01397409|588399855|FG005|Stage 3|Adverse Event|0|||
162917666|NCT01397409|588399856|FG006|Stage 3|Adverse Event|0|||
162917667|NCT01397409|588399857|FG007|Stage 3|Adverse Event|1|||
162917668|NCT01397409|588399858|FG008|Stage 3|Adverse Event|0|||
162917669|NCT01397409|588399859|FG009|Stage 3|Adverse Event|0|||
162917670|NCT01397409|588399850|FG000|Stage 3|Other Miscellaneous Reasons|0|||
162917671|NCT01397409|588399851|FG001|Stage 3|Other Miscellaneous Reasons|0|||
162917672|NCT01397409|588399852|FG002|Stage 3|Other Miscellaneous Reasons|0|||
162917673|NCT01397409|588399853|FG003|Stage 3|Other Miscellaneous Reasons|0|||
162917674|NCT01397409|588399854|FG004|Stage 3|Other Miscellaneous Reasons|0|||
162917675|NCT01397409|588399855|FG005|Stage 3|Other Miscellaneous Reasons|0|||
162917676|NCT01397409|588399856|FG006|Stage 3|Other Miscellaneous Reasons|0|||
162917677|NCT01397409|588399857|FG007|Stage 3|Other Miscellaneous Reasons|1|||
162917678|NCT01397409|588399858|FG008|Stage 3|Other Miscellaneous Reasons|0|||
162917679|NCT01397409|588399859|FG009|Stage 3|Other Miscellaneous Reasons|0|||
162917680|NCT02911285|588399860|FG000|Overall Study|Lost to Follow-up|8|||
162917681|NCT02911285|588399861|FG001|Overall Study|Lost to Follow-up|5|||
162917682|NCT02911285|588399860|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
162917683|NCT02911285|588399861|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
162917684|NCT03418727|588399862|FG000|Overall Study|Adverse Event|1|||
162917685|NCT03418727|588399863|FG001|Overall Study|Adverse Event|2|||
162917686|NCT03418727|588399864|FG002|Overall Study|Adverse Event|0|||
162917687|NCT03418727|588399862|FG000|Overall Study|Withdrawal by Subject|0|||
162917688|NCT03418727|588399863|FG001|Overall Study|Withdrawal by Subject|0|||
162917689|NCT03418727|588399864|FG002|Overall Study|Withdrawal by Subject|2|||
162917690|NCT02451137|588399866|FG000|Overall Study|Randomized but not treated|19|||
162917691|NCT02451137|588399867|FG001|Overall Study|Randomized but not treated|27|||
162917692|NCT02451137|588399866|FG000|Overall Study|Adverse Event|43|||
162917693|NCT02451137|588399867|FG001|Overall Study|Adverse Event|42|||
162917694|NCT02451137|588399866|FG000|Overall Study|Lack of Efficacy|4|||
162917695|NCT02451137|588399867|FG001|Overall Study|Lack of Efficacy|9|||
162917696|NCT02451137|588399866|FG000|Overall Study|Participant decision:discontinue insulin|41|||
162917697|NCT02451137|588399867|FG001|Overall Study|Participant decision:discontinue insulin|43|||
162917698|NCT02451137|588399866|FG000|Overall Study|Hypoglycemia|2|||
162917699|NCT02451137|588399867|FG001|Overall Study|Hypoglycemia|1|||
162917700|NCT02451137|588399866|FG000|Overall Study|Investigator's decision|23|||
162917701|NCT02451137|588399867|FG001|Overall Study|Investigator's decision|19|||
162917702|NCT02451137|588399866|FG000|Overall Study|Lost to Follow-up|53|||
162917703|NCT02451137|588399867|FG001|Overall Study|Lost to Follow-up|61|||
162917704|NCT02451137|588399866|FG000|Overall Study|Physician Decision|6|||
162917705|NCT02451137|588399867|FG001|Overall Study|Physician Decision|5|||
162917706|NCT02451137|588399866|FG000|Overall Study|Sponsor decision|13|||
162917707|NCT02451137|588399867|FG001|Overall Study|Sponsor decision|25|||
162917708|NCT02451137|588399866|FG000|Overall Study|Withdrawal by Subject|40|||
162917709|NCT02451137|588399867|FG001|Overall Study|Withdrawal by Subject|63|||
162917710|NCT02451137|588399866|FG000|Overall Study|Other than specified above|2|||
162917711|NCT02451137|588399867|FG001|Overall Study|Other than specified above|3|||
162917712|NCT01740297|588401595|FG000|Overall Study|Withdrawal by Subject|4|||
162917713|NCT01740297|588401596|FG001|Overall Study|Withdrawal by Subject|16|||
162917714|NCT01740297|588401597|FG002|Overall Study|Withdrawal by Subject|17|||
162917715|NCT01740297|588401595|FG000|Overall Study|Death|8|||
162917716|NCT01740297|588401596|FG001|Overall Study|Death|46|||
162917717|NCT01740297|588401597|FG002|Overall Study|Death|40|||
162917718|NCT01740297|588401595|FG000|Overall Study|Lost to Follow-up|1|||
162917719|NCT01740297|588401596|FG001|Overall Study|Lost to Follow-up|2|||
162917720|NCT01740297|588401597|FG002|Overall Study|Lost to Follow-up|4|||
162917721|NCT03280628|588401602|FG000|Overall Study|Lost to Follow-up|8|||
162917722|NCT03280628|588401603|FG001|Overall Study|Lost to Follow-up|6|||
162917723|NCT03280628|588401604|FG002|Overall Study|Lost to Follow-up|11|||
162917724|NCT00761462|588401606|FG000|Treatment|Subjects never received study medication|23|||
162917725|NCT00761462|588401607|FG001|Treatment|Subjects never received study medication|12|||
162917726|NCT00761462|588401606|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
162917727|NCT00761462|588401607|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
162917728|NCT00761462|588401606|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
162917729|NCT00761462|588401607|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
162917730|NCT00761462|588401606|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
162917731|NCT00761462|588401607|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
162917732|NCT02163759|588401614|FG000|Overall Study|Withdrawal by Subject|1|||
162917733|NCT02163759|588401615|FG001|Overall Study|Withdrawal by Subject|5|||
162917734|NCT02163759|588401616|FG002|Overall Study|Withdrawal by Subject|1|||
162917735|NCT02163759|588401614|FG000|Overall Study|Adverse Event|0|||
162917736|NCT02163759|588401615|FG001|Overall Study|Adverse Event|0|||
162917737|NCT02163759|588401616|FG002|Overall Study|Adverse Event|1|||
162917738|NCT02163759|588401614|FG000|Overall Study|Death|0|||
162917739|NCT02163759|588401615|FG001|Overall Study|Death|0|||
162917740|NCT02163759|588401616|FG002|Overall Study|Death|1|||
162917741|NCT00451191|588401629|FG000|Overall Study|withdrawal or received alternate tx|15|||
162917742|NCT00451191|588401630|FG001|Overall Study|withdrawal or received alternate tx|11|||
162917743|NCT00656669|588401638|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
162917744|NCT00656669|588401638|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
162917745|NCT00656669|588401638|FG000|AC (Cycles 6-9)|Adverse Event|1|||
162917746|NCT00656669|588401638|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
162917747|NCT00219349|588401643|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
162917748|NCT00219349|588401643|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
162917749|NCT00219349|588401643|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
162917750|NCT00219349|588401643|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
162917751|NCT01241591|588401645|FG000|Overall Study|Lack of Efficacy|5|||
162917752|NCT01241591|588401646|FG001|Overall Study|Lack of Efficacy|2|||
162917753|NCT01241591|588401647|FG002|Overall Study|Lack of Efficacy|2|||
162917754|NCT01241591|588401648|FG003|Overall Study|Lack of Efficacy|3|||
162917755|NCT01241591|588401645|FG000|Overall Study|Protocol Violation|5|||
162917756|NCT01241591|588401646|FG001|Overall Study|Protocol Violation|2|||
162917757|NCT01241591|588401647|FG002|Overall Study|Protocol Violation|3|||
162917758|NCT01241591|588401648|FG003|Overall Study|Protocol Violation|0|||
162917759|NCT01241591|588401645|FG000|Overall Study|Lost to Follow-up|1|||
162917760|NCT01241591|588401646|FG001|Overall Study|Lost to Follow-up|2|||
162917761|NCT01241591|588401647|FG002|Overall Study|Lost to Follow-up|2|||
162917762|NCT01241591|588401648|FG003|Overall Study|Lost to Follow-up|2|||
162917763|NCT01241591|588401645|FG000|Overall Study|Screen Failure|3|||
162917764|NCT01241591|588401646|FG001|Overall Study|Screen Failure|2|||
162917765|NCT01241591|588401647|FG002|Overall Study|Screen Failure|1|||
162917766|NCT01241591|588401648|FG003|Overall Study|Screen Failure|0|||
162917767|NCT01241591|588401645|FG000|Overall Study|Withdrawal by Subject|6|||
162917768|NCT01241591|588401646|FG001|Overall Study|Withdrawal by Subject|4|||
162917769|NCT01241591|588401647|FG002|Overall Study|Withdrawal by Subject|2|||
162917770|NCT01241591|588401648|FG003|Overall Study|Withdrawal by Subject|2|||
162917771|NCT01241591|588401645|FG000|Overall Study|Other|0|||
162917772|NCT01241591|588401646|FG001|Overall Study|Other|1|||
162917773|NCT01241591|588401647|FG002|Overall Study|Other|0|||
162917774|NCT01241591|588401648|FG003|Overall Study|Other|1|||
162917775|NCT01241591|588401645|FG000|Overall Study|Adverse Event|3|||
162917776|NCT01241591|588401646|FG001|Overall Study|Adverse Event|11|||
162917777|NCT01241591|588401647|FG002|Overall Study|Adverse Event|12|||
162917778|NCT01241591|588401648|FG003|Overall Study|Adverse Event|4|||
162917779|NCT01945034|588401649|FG000|Overall Study|Medication Error|0|||
162917780|NCT01945034|588401650|FG001|Overall Study|Medication Error|1|||
163055239|NCT01041859|588914094|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
162917781|NCT01945034|588401651|FG002|Overall Study|Medication Error|0|||
162917782|NCT01945034|588401649|FG000|Overall Study|Withdrawal by Subject|0|||
162917783|NCT01945034|588401650|FG001|Overall Study|Withdrawal by Subject|3|||
162917784|NCT01945034|588401651|FG002|Overall Study|Withdrawal by Subject|1|||
162917785|NCT01945034|588401649|FG000|Overall Study|Other|0|||
162917786|NCT01945034|588401650|FG001|Overall Study|Other|1|||
162917787|NCT01945034|588401651|FG002|Overall Study|Other|3|||
162917788|NCT01945034|588401649|FG000|Overall Study|Lost to Follow-up|0|||
162917789|NCT01945034|588401650|FG001|Overall Study|Lost to Follow-up|0|||
162917790|NCT01945034|588401651|FG002|Overall Study|Lost to Follow-up|2|||
162917791|NCT01945034|588401649|FG000|Overall Study|Protocol Violation|1|||
162917792|NCT01945034|588401650|FG001|Overall Study|Protocol Violation|0|||
162917793|NCT01945034|588401651|FG002|Overall Study|Protocol Violation|1|||
162917794|NCT00700115|588401654|FG000|Overall Study|Withdrawal by Subject|1|||
162917795|NCT00700115|588401655|FG001|Overall Study|Withdrawal by Subject|0|||
162917796|NCT00700115|588401654|FG000|Overall Study|Lost to Follow-up|0|||
162917797|NCT00700115|588401655|FG001|Overall Study|Lost to Follow-up|1|||
162917798|NCT01300741|588401661|FG000|Overall Study|Lens deposits|1|||
162917799|NCT01300741|588401661|FG000|Overall Study|Lost to Follow-up|1|||
162917800|NCT01300741|588401661|FG000|Overall Study|Discomfort|1|||
162917801|NCT04854421|588401662|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
162917802|NCT04854421|588401663|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
162917803|NCT00718809|588401665|FG000|Overall Study|Disease progression|9|||
162917804|NCT00718809|588401666|FG001|Overall Study|Disease progression|7|||
162917805|NCT00718809|588401665|FG000|Overall Study|Adverse Event|1|||
162917806|NCT00718809|588401666|FG001|Overall Study|Adverse Event|1|||
162917807|NCT00718809|588401665|FG000|Overall Study|Withdrawal by Subject|0|||
162917808|NCT00718809|588401666|FG001|Overall Study|Withdrawal by Subject|1|||
162917809|NCT00718809|588401665|FG000|Overall Study|Lost to Follow-up|1|||
162917810|NCT00718809|588401666|FG001|Overall Study|Lost to Follow-up|0|||
162917811|NCT00718809|588401665|FG000|Overall Study|Noncompliance|1|||
162917812|NCT00718809|588401666|FG001|Overall Study|Noncompliance|0|||
162917813|NCT00463385|588401667|FG000|Overall Study|Other|4|||
162917814|NCT00463385|588401668|FG001|Overall Study|Other|3|||
162917815|NCT00463385|588401669|FG002|Overall Study|Other|6|||
162917816|NCT00463385|588401670|FG003|Overall Study|Other|4|||
162917817|NCT00463385|588401667|FG000|Overall Study|Adverse Event|5|||
162917818|NCT00463385|588401668|FG001|Overall Study|Adverse Event|8|||
162917819|NCT00463385|588401669|FG002|Overall Study|Adverse Event|4|||
162917820|NCT00463385|588401670|FG003|Overall Study|Adverse Event|2|||
162917821|NCT00463385|588401667|FG000|Overall Study|Lack of Efficacy|6|||
162917822|NCT00463385|588401668|FG001|Overall Study|Lack of Efficacy|6|||
162917823|NCT00463385|588401669|FG002|Overall Study|Lack of Efficacy|7|||
162917824|NCT00463385|588401670|FG003|Overall Study|Lack of Efficacy|9|||
162917825|NCT00463385|588401667|FG000|Overall Study|Withdrawal by Subject|3|||
162917826|NCT00463385|588401668|FG001|Overall Study|Withdrawal by Subject|3|||
162917827|NCT00463385|588401669|FG002|Overall Study|Withdrawal by Subject|3|||
162917828|NCT00463385|588401670|FG003|Overall Study|Withdrawal by Subject|4|||
162917829|NCT00463385|588401667|FG000|Overall Study|Lost to Follow-up|0|||
162917830|NCT00463385|588401668|FG001|Overall Study|Lost to Follow-up|0|||
162917831|NCT00463385|588401669|FG002|Overall Study|Lost to Follow-up|0|||
162917832|NCT00463385|588401670|FG003|Overall Study|Lost to Follow-up|1|||
162917833|NCT00463385|588401667|FG000|Overall Study|Death|2|||
162917834|NCT00463385|588401668|FG001|Overall Study|Death|1|||
162917835|NCT00463385|588401669|FG002|Overall Study|Death|2|||
162917836|NCT00463385|588401670|FG003|Overall Study|Death|0|||
162917837|NCT00463385|588401667|FG000|Overall Study|Missing|2|||
162917838|NCT00463385|588401668|FG001|Overall Study|Missing|0|||
162917839|NCT00463385|588401669|FG002|Overall Study|Missing|0|||
162917840|NCT00463385|588401670|FG003|Overall Study|Missing|2|||
162917841|NCT00463385|588401667|FG000|Overall Study|1 participant received commercial drug|0|||
162917842|NCT00463385|588401668|FG001|Overall Study|1 participant received commercial drug|1|||
162917843|NCT00463385|588401669|FG002|Overall Study|1 participant received commercial drug|0|||
162917844|NCT00463385|588401670|FG003|Overall Study|1 participant received commercial drug|0|||
162917845|NCT00536991|588401672|FG000|Overall Study|Withdrawal by Subject|10|||
162917846|NCT00536991|588401672|FG000|Overall Study|Physician Decision|1|||
162917847|NCT00536991|588401672|FG000|Overall Study|patient ineligible|2|||
162917848|NCT00054639|588401673|FG000|Overall Study|Lack of Efficacy|1|||
162917849|NCT00054639|588401673|FG000|Overall Study|Physician Decision|1|||
162917850|NCT01600755|588401674|FG000|Overall Study|Withdrawal by Subject|6|||
162917851|NCT00938392|588401679|FG000|Overall Study|Adverse Event|0|||
162917852|NCT00938392|588401680|FG001|Overall Study|Adverse Event|1|||
162917853|NCT00938392|588401679|FG000|Overall Study|Withdrawal by Subject|0|||
162917854|NCT00938392|588401680|FG001|Overall Study|Withdrawal by Subject|1|||
162917855|NCT00938392|588401679|FG000|Overall Study|Lost to Follow-up|2|||
162917856|NCT00938392|588401680|FG001|Overall Study|Lost to Follow-up|2|||
162917857|NCT00122954|588401681|FG000|Overall Study|Withdrawal by Subject|2|||
162917858|NCT00122954|588401682|FG001|Overall Study|Withdrawal by Subject|2|||
162917859|NCT00122954|588401681|FG000|Overall Study|Protocol Violation|0|||
162917860|NCT00122954|588401682|FG001|Overall Study|Protocol Violation|1|||
162917861|NCT02696382|588401688|FG000|Overall Study|Death|7|||
162917862|NCT02696382|588401689|FG001|Overall Study|Death|2|||
162917863|NCT02696382|588401688|FG000|Overall Study|Withdrawal by Subject|5|||
162917864|NCT02696382|588401689|FG001|Overall Study|Withdrawal by Subject|12|||
162917865|NCT02696382|588401688|FG000|Overall Study|Lost to Follow-up|4|||
162917866|NCT02696382|588401689|FG001|Overall Study|Lost to Follow-up|7|||
162711050|NCT02138916|587652860|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
162711051|NCT02138916|587652858|FG000|Overall Study|Death|14|||
162711052|NCT02138916|587652859|FG001|Overall Study|Death|11|||
162711053|NCT02138916|587652860|FG002|Overall Study|Death|12|||
162711054|NCT02138916|587652858|FG000|Overall Study|Withdrawal by Subject|27|||
162711055|NCT02138916|587652859|FG001|Overall Study|Withdrawal by Subject|31|||
162711056|NCT02138916|587652860|FG002|Overall Study|Withdrawal by Subject|32|||
162711057|NCT02138916|587652858|FG000|Overall Study|Study specific withdrawal criteria|0|||
162917867|NCT00494234|588401690|FG000|Overall Study|Withdrawal by Subject|1|||
162917868|NCT00494234|588401691|FG001|Overall Study|Withdrawal by Subject|0|||
162917869|NCT00494234|588401690|FG000|Overall Study|Disease progression|11|||
162917870|NCT00494234|588401691|FG001|Overall Study|Disease progression|8|||
162917871|NCT00494234|588401690|FG000|Overall Study|Death|2|||
162917872|NCT00494234|588401691|FG001|Overall Study|Death|1|||
162711058|NCT02138916|587652859|FG001|Overall Study|Study specific withdrawal criteria|0|||
162711059|NCT02138916|587652860|FG002|Overall Study|Study specific withdrawal criteria|1|||
162711060|NCT02138916|587652858|FG000|Overall Study|incorrect enrolment|1|||
162711061|NCT02138916|587652859|FG001|Overall Study|incorrect enrolment|1|||
162711062|NCT02138916|587652860|FG002|Overall Study|incorrect enrolment|0|||
162917873|NCT01725217|588401696|FG000|Overall Study|Withdrawal by Subject|1|||
162917874|NCT01725217|588401697|FG001|Overall Study|Withdrawal by Subject|0|||
162917875|NCT01725217|588401698|FG002|Overall Study|Withdrawal by Subject|0|||
162917876|NCT00585468|588401699|FG000|First Intervention|Withdrawal by Subject|1|||
162917877|NCT00585468|588401700|FG001|First Intervention|Withdrawal by Subject|1|||
162917878|NCT00978120|588401701|FG000|Overall Study|Death|0|||
162917879|NCT00978120|588401702|FG001|Overall Study|Death|0|||
162917880|NCT00978120|588401703|FG002|Overall Study|Death|0|||
162917881|NCT00978120|588401704|FG003|Overall Study|Death|1|||
162917882|NCT00978120|588401701|FG000|Overall Study|Lost to Follow-up|0|||
162917883|NCT00978120|588401702|FG001|Overall Study|Lost to Follow-up|0|||
162917884|NCT00978120|588401703|FG002|Overall Study|Lost to Follow-up|3|||
162917885|NCT00978120|588401704|FG003|Overall Study|Lost to Follow-up|0|||
162917886|NCT00978120|588401701|FG000|Overall Study|Withdrawal by Subject|2|||
162917887|NCT00978120|588401702|FG001|Overall Study|Withdrawal by Subject|0|||
162917888|NCT00978120|588401703|FG002|Overall Study|Withdrawal by Subject|0|||
162917889|NCT00978120|588401704|FG003|Overall Study|Withdrawal by Subject|0|||
162917890|NCT00978120|588401701|FG000|Overall Study|Moved out of state|0|||
162917891|NCT00978120|588401702|FG001|Overall Study|Moved out of state|0|||
162917892|NCT00978120|588401703|FG002|Overall Study|Moved out of state|0|||
162917893|NCT00978120|588401704|FG003|Overall Study|Moved out of state|1|||
162917894|NCT01023815|588401705|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
162917895|NCT01023815|588401706|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
162917896|NCT01023815|588401707|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
162917897|NCT01023815|588401708|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
162917898|NCT01023815|588401705|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
162969352|NCT02003222|588589947|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969353|NCT02003222|588589948|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969354|NCT02003222|588589949|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
162711063|NCT02138916|587652858|FG000|Overall Study|Severe non-compliance|1|||
162711064|NCT02138916|587652859|FG001|Overall Study|Severe non-compliance|2|||
162917899|NCT01023815|588401706|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
162917900|NCT01023815|588401707|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
162917901|NCT01023815|588401708|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
162917902|NCT01023815|588401705|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
162711065|NCT02138916|587652860|FG002|Overall Study|Severe non-compliance|1|||
162711066|NCT02138916|587652858|FG000|Overall Study|Lost to Follow-up|4|||
162711067|NCT02138916|587652859|FG001|Overall Study|Lost to Follow-up|2|||
162711068|NCT02138916|587652860|FG002|Overall Study|Lost to Follow-up|3|||
162711069|NCT02138916|587652858|FG000|Overall Study|Adverse Event|4|||
162917903|NCT01023815|588401706|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
162917904|NCT01023815|588401707|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
162917905|NCT01023815|588401708|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
162917906|NCT01023815|588401705|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
162917907|NCT01023815|588401706|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
162917908|NCT01023815|588401707|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
162917909|NCT01023815|588401708|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
162917910|NCT01023815|588401705|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
162917911|NCT01023815|588401706|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
162917912|NCT01023815|588401707|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
162917913|NCT01023815|588401708|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
162917914|NCT01298323|588401710|FG000|Overall Study|Adverse Event|2|||
162917915|NCT01298323|588401711|FG001|Overall Study|Adverse Event|4|||
162917916|NCT01298323|588401710|FG000|Overall Study|Death|11|||
162917917|NCT01298323|588401711|FG001|Overall Study|Death|16|||
162917918|NCT01298323|588401710|FG000|Overall Study|Lost to Follow-up|1|||
162917919|NCT01298323|588401711|FG001|Overall Study|Lost to Follow-up|0|||
162917920|NCT01298323|588401710|FG000|Overall Study|Withdrawal by Subject|6|||
162917921|NCT01298323|588401711|FG001|Overall Study|Withdrawal by Subject|3|||
162917922|NCT01298323|588401710|FG000|Overall Study|Protocol Violation|1|||
162917923|NCT01298323|588401711|FG001|Overall Study|Protocol Violation|0|||
162917924|NCT01298323|588401710|FG000|Overall Study|Other|10|||
162917925|NCT01298323|588401711|FG001|Overall Study|Other|9|||
162917926|NCT01298323|588401710|FG000|Overall Study|Ongoing|55|||
162917927|NCT01298323|588401711|FG001|Overall Study|Ongoing|55|||
162629145|NCT03292588|587360995|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
162629146|NCT03292588|587360996|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
162629147|NCT05526716|587361002|FG000|Overall Study|Death|1|||
162629148|NCT05526716|587361003|FG001|Overall Study|Death|2|||
162629149|NCT05526716|587361002|FG000|Overall Study|Lost to Follow-up|17|||
162629150|NCT05526716|587361003|FG001|Overall Study|Lost to Follow-up|15|||
162629151|NCT05526716|587361002|FG000|Overall Study|Physician Decision|0|||
162629152|NCT05526716|587361003|FG001|Overall Study|Physician Decision|1|||
162629153|NCT05526716|587361002|FG000|Overall Study|Randomized by mistake without study treatment|0|||
162629154|NCT05526716|587361003|FG001|Overall Study|Randomized by mistake without study treatment|1|||
162629155|NCT05526716|587361002|FG000|Overall Study|Withdrawal by Subject|12|||
162917928|NCT01298323|588401710|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162917929|NCT01298323|588401711|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162917930|NCT01761565|588401712|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
162917931|NCT02161380|588401713|FG000|Overall Study|Lost to Follow-up|0|||
162917932|NCT02161380|588401714|FG001|Overall Study|Lost to Follow-up|1|||
162917933|NCT02161380|588401715|FG002|Overall Study|Lost to Follow-up|0|||
162917934|NCT02161380|588401716|FG003|Overall Study|Lost to Follow-up|0|||
162917935|NCT03655951|588401718|FG000|Overall Study|Lost to Follow-up|39|||
162917936|NCT03655951|588401719|FG001|Overall Study|Lost to Follow-up|20|||
162917937|NCT03655951|588401718|FG000|Overall Study|Withdrawal by Subject|0|||
162917938|NCT03655951|588401719|FG001|Overall Study|Withdrawal by Subject|1|||
162917939|NCT01078974|588401724|FG000|Overall Study|Adverse Event|3|||
162917940|NCT01393444|588401725|FG000|Overall Study|Withdrawal by Subject|1|||
162917941|NCT01393444|588401725|FG000|Overall Study|Determined ineligible during screening.|2|||
162917942|NCT01791543|588401727|FG000|Overall Study|Lost to Follow-up|1|||
162917943|NCT01791543|588401727|FG000|Overall Study|Adverse Event|1|||
162629156|NCT05526716|587361003|FG001|Overall Study|Withdrawal by Subject|12|||
162629157|NCT05526716|587361002|FG000|Overall Study|Not reported|0|||
162629158|NCT05526716|587361003|FG001|Overall Study|Not reported|2|||
162629159|NCT04932096|587361006|FG000|Overall Study|Withdrawal by Subject|1|||
162917944|NCT01361308|588403110|FG000|Overall Study|Withdrawal by Subject|9|||
162917945|NCT01361308|588403111|FG001|Overall Study|Withdrawal by Subject|13|||
162917946|NCT01361308|588403110|FG000|Overall Study|Physician Decision|3|||
162917947|NCT01361308|588403111|FG001|Overall Study|Physician Decision|3|||
162917948|NCT01361308|588403110|FG000|Overall Study|Lack of Efficacy|2|||
162917949|NCT01361308|588403111|FG001|Overall Study|Lack of Efficacy|0|||
162917950|NCT01361308|588403110|FG000|Overall Study|Protocol Violation|1|||
162917951|NCT01361308|588403111|FG001|Overall Study|Protocol Violation|0|||
162917952|NCT01361308|588403110|FG000|Overall Study|Lost to Follow-up|5|||
162917953|NCT01361308|588403111|FG001|Overall Study|Lost to Follow-up|4|||
162917954|NCT01361308|588403110|FG000|Overall Study|Adverse Event|8|||
162917955|NCT01361308|588403111|FG001|Overall Study|Adverse Event|4|||
162917956|NCT01361308|588403110|FG000|Overall Study|Eligibility Criteria Not Met|2|||
162917957|NCT01361308|588403111|FG001|Overall Study|Eligibility Criteria Not Met|3|||
162917958|NCT01361308|588403110|FG000|Overall Study|Failed C-SSRS|5|||
162917959|NCT01361308|588403111|FG001|Overall Study|Failed C-SSRS|2|||
162917960|NCT01361308|588403110|FG000|Overall Study|Other|0|||
162917961|NCT01361308|588403111|FG001|Overall Study|Other|1|||
162917962|NCT03839693|588403116|FG000|Overall Study|Lost to Follow-up|0|||
162917963|NCT03839693|588403117|FG001|Overall Study|Lost to Follow-up|2|||
162917964|NCT03839693|588403118|FG002|Overall Study|Lost to Follow-up|2|||
162917965|NCT03839693|588403116|FG000|Overall Study|Withdrawal by Subject|1|||
162917966|NCT03839693|588403117|FG001|Overall Study|Withdrawal by Subject|0|||
162917967|NCT03839693|588403118|FG002|Overall Study|Withdrawal by Subject|2|||
162917968|NCT03839693|588403116|FG000|Overall Study|subject moved out of the area|1|||
162917969|NCT03839693|588403117|FG001|Overall Study|subject moved out of the area|0|||
162917970|NCT03839693|588403118|FG002|Overall Study|subject moved out of the area|0|||
162917971|NCT00270205|588403127|FG000|Overall Study|Lost to Follow-up|1|||
162917972|NCT00270205|588403128|FG001|Overall Study|Lost to Follow-up|0|||
162917973|NCT00270205|588403129|FG002|Overall Study|Lost to Follow-up|0|||
162917974|NCT00270205|588403130|FG003|Overall Study|Lost to Follow-up|1|||
162917975|NCT00066573|588403131|FG000|Overall Study|Did not received protocol treatment|28|||
162917976|NCT00066573|588403132|FG001|Overall Study|Did not received protocol treatment|28|||
162917977|NCT01646268|588403136|FG000|Overall Study|Adverse Event|6|||
162917978|NCT01646268|588403137|FG001|Overall Study|Adverse Event|7|||
162917979|NCT01646268|588403136|FG000|Overall Study|Lack of Efficacy|1|||
162917980|NCT01646268|588403137|FG001|Overall Study|Lack of Efficacy|3|||
162917981|NCT01646268|588403136|FG000|Overall Study|Protocol Violation|0|||
162917982|NCT01646268|588403137|FG001|Overall Study|Protocol Violation|1|||
162917983|NCT01646268|588403136|FG000|Overall Study|Withdrawal by Subject|2|||
162917984|NCT01646268|588403137|FG001|Overall Study|Withdrawal by Subject|5|||
162917985|NCT01646268|588403136|FG000|Overall Study|Other|2|||
162917986|NCT01646268|588403137|FG001|Overall Study|Other|0|||
162917987|NCT02222246|588403138|FG000|Overall Study|No Emergency Department Visits|27|||
162917988|NCT02222246|588403139|FG001|Overall Study|No Emergency Department Visits|26|||
162917989|NCT02222246|588403138|FG000|Overall Study|Physician Decision|0|||
162917990|NCT02222246|588403139|FG001|Overall Study|Physician Decision|1|||
162917991|NCT01473602|588403142|FG000|Overall Study|Adverse Event|1|||
162917992|NCT01473602|588403143|FG001|Overall Study|Adverse Event|2|||
162917993|NCT01473602|588403142|FG000|Overall Study|Death|0|||
162917994|NCT01473602|588403143|FG001|Overall Study|Death|1|||
162917995|NCT01473602|588403142|FG000|Overall Study|Lost to Follow-up|1|||
162917996|NCT01473602|588403143|FG001|Overall Study|Lost to Follow-up|1|||
162917997|NCT01473602|588403142|FG000|Overall Study|Withdrawal by Subject|5|||
162917998|NCT01473602|588403143|FG001|Overall Study|Withdrawal by Subject|4|||
162917999|NCT01473602|588403142|FG000|Overall Study|Physician Decision|1|||
162918000|NCT01473602|588403143|FG001|Overall Study|Physician Decision|0|||
162918001|NCT00449761|588403145|FG000|Overall Study|Disease progression|12|||
162918002|NCT00449761|588403145|FG000|Overall Study|Death|5|||
162918003|NCT00449761|588403145|FG000|Overall Study|New cancer therapy|1|||
162918004|NCT00560573|588403146|FG000|Overall Study|Death|4|||
162918005|NCT00560573|588403147|FG001|Overall Study|Death|1|||
162918006|NCT00560573|588403148|FG002|Overall Study|Death|4|||
162918007|NCT00560573|588403149|FG003|Overall Study|Death|5|||
162918008|NCT00560573|588403150|FG004|Overall Study|Death|1|||
162918009|NCT00560573|588403151|FG005|Overall Study|Death|10|||
162969355|NCT02003222|588589950|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
162969356|NCT02003222|588589951|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
162969357|NCT02003222|588589947|FG000|Induction|Adverse Event|0|||
162969358|NCT02003222|588589948|FG001|Induction|Adverse Event|0|||
162969359|NCT02003222|588589949|FG002|Induction|Adverse Event|0|||
162969360|NCT02003222|588589950|FG003|Induction|Adverse Event|0|||
162969361|NCT02003222|588589951|FG004|Induction|Adverse Event|13|||
162969362|NCT02003222|588589947|FG000|Induction|Alternative therapy|0|||
162969363|NCT02003222|588589948|FG001|Induction|Alternative therapy|0|||
162969364|NCT02003222|588589949|FG002|Induction|Alternative therapy|0|||
162969365|NCT02003222|588589950|FG003|Induction|Alternative therapy|0|||
162969366|NCT02003222|588589951|FG004|Induction|Alternative therapy|12|||
162969367|NCT02003222|588589947|FG000|Induction|Disease progression|0|||
162969368|NCT02003222|588589948|FG001|Induction|Disease progression|0|||
162918010|NCT00560573|588403146|FG000|Overall Study|Lost to Follow-up|0|||
162918011|NCT00560573|588403147|FG001|Overall Study|Lost to Follow-up|0|||
162918012|NCT00560573|588403148|FG002|Overall Study|Lost to Follow-up|0|||
162918013|NCT00560573|588403149|FG003|Overall Study|Lost to Follow-up|1|||
162918014|NCT00560573|588403150|FG004|Overall Study|Lost to Follow-up|1|||
162918015|NCT00560573|588403151|FG005|Overall Study|Lost to Follow-up|0|||
162918016|NCT00560573|588403146|FG000|Overall Study|Withdrawal by Subject|0|||
162969369|NCT02003222|588589949|FG002|Induction|Disease progression|0|||
162969370|NCT02003222|588589950|FG003|Induction|Disease progression|0|||
163055240|NCT01041859|588914095|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
163055241|NCT01041859|588914093|FG000|Open-Label Titration|Withdrawal by Subject|11|||
163055242|NCT01041859|588914094|FG001|Open-Label Titration|Withdrawal by Subject|0|||
162629160|NCT04932096|587361007|FG001|Overall Study|Withdrawal by Subject|1|||
162629161|NCT04932096|587361006|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
162629162|NCT04932096|587361007|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
162918017|NCT00560573|588403147|FG001|Overall Study|Withdrawal by Subject|0|||
162918018|NCT00560573|588403148|FG002|Overall Study|Withdrawal by Subject|0|||
162918019|NCT00560573|588403149|FG003|Overall Study|Withdrawal by Subject|1|||
162918020|NCT00560573|588403150|FG004|Overall Study|Withdrawal by Subject|1|||
162918021|NCT00560573|588403151|FG005|Overall Study|Withdrawal by Subject|0|||
162918022|NCT00560573|588403146|FG000|Overall Study|Other|2|||
162918023|NCT00560573|588403147|FG001|Overall Study|Other|2|||
162918024|NCT00560573|588403148|FG002|Overall Study|Other|2|||
162918025|NCT00560573|588403149|FG003|Overall Study|Other|3|||
162918026|NCT00560573|588403150|FG004|Overall Study|Other|3|||
162918027|NCT00560573|588403151|FG005|Overall Study|Other|3|||
162918028|NCT00560573|588403146|FG000|Overall Study|Enrolled, not treated|0|||
162918029|NCT00560573|588403147|FG001|Overall Study|Enrolled, not treated|0|||
162918030|NCT00560573|588403148|FG002|Overall Study|Enrolled, not treated|0|||
162918031|NCT00560573|588403149|FG003|Overall Study|Enrolled, not treated|0|||
162918032|NCT00560573|588403150|FG004|Overall Study|Enrolled, not treated|1|||
162918033|NCT00560573|588403151|FG005|Overall Study|Enrolled, not treated|0|||
162918034|NCT01422876|588403155|FG000|Week 24|Lost to Follow-up|1|||
162918035|NCT01422876|588403156|FG001|Week 24|Lost to Follow-up|1|||
162918036|NCT01422876|588403157|FG002|Week 24|Lost to Follow-up|2|||
162918037|NCT01422876|588403158|FG003|Week 24|Lost to Follow-up|4|||
162918038|NCT01422876|588403159|FG004|Week 24|Lost to Follow-up|2|||
162918039|NCT01422876|588403160|FG005|Week 24|Lost to Follow-up|0|||
162918040|NCT01422876|588403161|FG006|Week 24|Lost to Follow-up|1|||
162918041|NCT01422876|588403162|FG007|Week 24|Lost to Follow-up|3|||
162918042|NCT01422876|588403163|FG008|Week 24|Lost to Follow-up|3|||
162918043|NCT01422876|588403164|FG009|Week 24|Lost to Follow-up|4|||
162918044|NCT01422876|588403155|FG000|Week 24|Consent withdrawn|5|||
162918045|NCT01422876|588403156|FG001|Week 24|Consent withdrawn|1|||
162918046|NCT01422876|588403157|FG002|Week 24|Consent withdrawn|3|||
162918047|NCT01422876|588403158|FG003|Week 24|Consent withdrawn|4|||
162918048|NCT01422876|588403159|FG004|Week 24|Consent withdrawn|5|||
162918049|NCT01422876|588403160|FG005|Week 24|Consent withdrawn|6|||
162918050|NCT01422876|588403161|FG006|Week 24|Consent withdrawn|5|||
162918051|NCT01422876|588403162|FG007|Week 24|Consent withdrawn|4|||
162918052|NCT01422876|588403163|FG008|Week 24|Consent withdrawn|3|||
162918053|NCT01422876|588403164|FG009|Week 24|Consent withdrawn|6|||
162918054|NCT01422876|588403155|FG000|Week 24|Death|0|||
162918055|NCT01422876|588403156|FG001|Week 24|Death|1|||
162918056|NCT01422876|588403157|FG002|Week 24|Death|0|||
162918057|NCT01422876|588403158|FG003|Week 24|Death|0|||
162918058|NCT01422876|588403159|FG004|Week 24|Death|0|||
162918059|NCT01422876|588403160|FG005|Week 24|Death|0|||
162918060|NCT01422876|588403161|FG006|Week 24|Death|0|||
162918061|NCT01422876|588403162|FG007|Week 24|Death|0|||
162918062|NCT01422876|588403163|FG008|Week 24|Death|0|||
162918063|NCT01422876|588403164|FG009|Week 24|Death|0|||
162918064|NCT01422876|588403155|FG000|Week 52|Lost to Follow-up|3|||
162918065|NCT01422876|588403156|FG001|Week 52|Lost to Follow-up|5|||
162918066|NCT01422876|588403157|FG002|Week 52|Lost to Follow-up|7|||
162918067|NCT01422876|588403158|FG003|Week 52|Lost to Follow-up|5|||
162918068|NCT01422876|588403159|FG004|Week 52|Lost to Follow-up|8|||
162918069|NCT01422876|588403160|FG005|Week 52|Lost to Follow-up|5|||
162918070|NCT01422876|588403161|FG006|Week 52|Lost to Follow-up|5|||
162918071|NCT01422876|588403162|FG007|Week 52|Lost to Follow-up|8|||
162918072|NCT01422876|588403163|FG008|Week 52|Lost to Follow-up|7|||
162918073|NCT01422876|588403164|FG009|Week 52|Lost to Follow-up|8|||
162918074|NCT01422876|588403155|FG000|Week 52|Consent withdrawn|9|||
162918075|NCT01422876|588403156|FG001|Week 52|Consent withdrawn|4|||
162918076|NCT01422876|588403157|FG002|Week 52|Consent withdrawn|6|||
162918077|NCT01422876|588403158|FG003|Week 52|Consent withdrawn|12|||
162918078|NCT01422876|588403159|FG004|Week 52|Consent withdrawn|7|||
162918079|NCT01422876|588403160|FG005|Week 52|Consent withdrawn|12|||
162918080|NCT01422876|588403161|FG006|Week 52|Consent withdrawn|10|||
162918081|NCT01422876|588403162|FG007|Week 52|Consent withdrawn|12|||
162918082|NCT01422876|588403163|FG008|Week 52|Consent withdrawn|13|||
162918083|NCT01422876|588403164|FG009|Week 52|Consent withdrawn|9|||
162918084|NCT01422876|588403155|FG000|Week 52|Death|0|||
162918085|NCT01422876|588403156|FG001|Week 52|Death|1|||
162918086|NCT01422876|588403157|FG002|Week 52|Death|0|||
162918087|NCT01422876|588403158|FG003|Week 52|Death|1|||
162918088|NCT01422876|588403159|FG004|Week 52|Death|0|||
162918089|NCT01422876|588403160|FG005|Week 52|Death|0|||
162918090|NCT01422876|588403161|FG006|Week 52|Death|1|||
162918091|NCT01422876|588403162|FG007|Week 52|Death|3|||
162918092|NCT01422876|588403163|FG008|Week 52|Death|1|||
162918093|NCT01422876|588403164|FG009|Week 52|Death|0|||
162918094|NCT00558831|588403165|FG000|Overall Study|Lost to Follow-up|1|||
162918095|NCT02204449|588403166|FG000|Overall Study|Lost to Follow-up|7|||
162918096|NCT02204449|588403167|FG001|Overall Study|Lost to Follow-up|9|||
162918097|NCT02204449|588403166|FG000|Overall Study|Death|0|||
162918098|NCT02204449|588403167|FG001|Overall Study|Death|1|||
162918099|NCT02204449|588403166|FG000|Overall Study|Withdrawal by Subject|0|||
162918100|NCT02204449|588403167|FG001|Overall Study|Withdrawal by Subject|1|||
162918101|NCT02856282|588403168|FG000|Overall Study|Withdrawal by Subject|1|||
162918102|NCT00057330|588403169|FG000|Overall Study|Adverse Event|9|||
162918103|NCT00057330|588403170|FG001|Overall Study|Adverse Event|12|||
162918104|NCT00057330|588403169|FG000|Overall Study|Death|1|||
162918105|NCT00057330|588403170|FG001|Overall Study|Death|0|||
162918106|NCT00057330|588403169|FG000|Overall Study|Protocol Violation|1|||
162918107|NCT00057330|588403170|FG001|Overall Study|Protocol Violation|1|||
162918108|NCT00057330|588403169|FG000|Overall Study|Withdrawal by Subject|115|||
162918109|NCT00057330|588403170|FG001|Overall Study|Withdrawal by Subject|84|||
162918110|NCT00057330|588403169|FG000|Overall Study|Lost to Follow-up|745|||
162918111|NCT00057330|588403170|FG001|Overall Study|Lost to Follow-up|617|||
162918112|NCT00057330|588403169|FG000|Overall Study|Physician Decision|1|||
162918113|NCT00057330|588403170|FG001|Overall Study|Physician Decision|0|||
163055243|NCT01041859|588914095|FG002|Open-Label Titration|Withdrawal by Subject|0|||
163055244|NCT01041859|588914093|FG000|Double-Blind Maintenance|Adverse Event|0|||
162918114|NCT00057330|588403169|FG000|Overall Study|Other|260|||
162918115|NCT00057330|588403170|FG001|Overall Study|Other|206|||
162918116|NCT01491737|588403171|FG000|Overall Study|Withdrawal by Subject|20|||
162918117|NCT01491737|588403172|FG001|Overall Study|Withdrawal by Subject|17|||
162918118|NCT01491737|588403171|FG000|Overall Study|Lost to Follow-up|2|||
162918119|NCT01491737|588403172|FG001|Overall Study|Lost to Follow-up|10|||
162918120|NCT01491737|588403171|FG000|Overall Study|Death|63|||
162918121|NCT01491737|588403172|FG001|Overall Study|Death|57|||
162918122|NCT01491737|588403171|FG000|Overall Study|Study Termination by Sponsor|36|||
162918123|NCT01491737|588403172|FG001|Overall Study|Study Termination by Sponsor|36|||
162918124|NCT01491737|588403171|FG000|Overall Study|Reason Not Specified|8|||
162918125|NCT01491737|588403172|FG001|Overall Study|Reason Not Specified|9|||
162918126|NCT03772574|588403173|FG000|Overall Study|Protocol Violation|2|||
162918127|NCT03772574|588403174|FG001|Overall Study|Protocol Violation|0|||
162918128|NCT03772574|588403175|FG002|Overall Study|Protocol Violation|0|||
162918129|NCT03772574|588403173|FG000|Overall Study|Discomfort|0|||
162918130|NCT03772574|588403174|FG001|Overall Study|Discomfort|5|||
162918131|NCT03772574|588403175|FG002|Overall Study|Discomfort|4|||
162918132|NCT02743117|588403176|FG000|Overall Study|Lost to Follow-up|0|||
162918133|NCT02743117|588403177|FG001|Overall Study|Lost to Follow-up|1|||
162918134|NCT02743117|588403176|FG000|Overall Study|Other|1|||
162918135|NCT02743117|588403177|FG001|Overall Study|Other|0|||
162918136|NCT00620776|588403178|FG000|Overall Study|Did not receive treatment|3|||
162918137|NCT00620776|588403179|FG001|Overall Study|Did not receive treatment|5|||
162918138|NCT00620776|588403178|FG000|Overall Study|Adverse Event|2|||
162918139|NCT00620776|588403179|FG001|Overall Study|Adverse Event|3|||
162918140|NCT00620776|588403178|FG000|Overall Study|Lack of Efficacy|2|||
162918141|NCT00620776|588403179|FG001|Overall Study|Lack of Efficacy|1|||
162918142|NCT00620776|588403178|FG000|Overall Study|Lost to Follow-up|2|||
162918143|NCT00620776|588403179|FG001|Overall Study|Lost to Follow-up|5|||
162918144|NCT00620776|588403178|FG000|Overall Study|Withdrawal by Subject|3|||
162918145|NCT00620776|588403179|FG001|Overall Study|Withdrawal by Subject|2|||
162918146|NCT04983589|588403180|FG000|Overall Study|Withdrawal by Subject|0|||
162918147|NCT04983589|588403181|FG001|Overall Study|Withdrawal by Subject|3|||
162918148|NCT04983589|588403180|FG000|Overall Study|COVID-19 Infection|1|||
162918149|NCT04983589|588403181|FG001|Overall Study|COVID-19 Infection|0|||
162918150|NCT04983589|588403180|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
163055245|NCT01041859|588914094|FG001|Double-Blind Maintenance|Adverse Event|23|||
163055246|NCT01041859|588914095|FG002|Double-Blind Maintenance|Adverse Event|13|||
163055247|NCT01041859|588914093|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
163055248|NCT01041859|588914094|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
163055249|NCT01041859|588914095|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
162918151|NCT04983589|588403181|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
162918152|NCT00761969|588403182|FG000|Overall Study|Death|112|||
162918153|NCT00761969|588403183|FG001|Overall Study|Death|47|||
162918154|NCT00761969|588403182|FG000|Overall Study|Lost to Follow-up|88|||
162918155|NCT00761969|588403183|FG001|Overall Study|Lost to Follow-up|93|||
162918156|NCT02940392|588403186|FG000|Overall Study|Lost to Follow-up|3|||
162918157|NCT02940392|588403186|FG000|Overall Study|Retreatment|3|||
162918158|NCT02940392|588403186|FG000|Overall Study|Death|2|||
162918159|NCT00762073|588403189|FG000|Overall Study|Lack of Efficacy|1|||
162918160|NCT00762073|588403190|FG001|Overall Study|Lack of Efficacy|1|||
162918161|NCT00762073|588403191|FG002|Overall Study|Lack of Efficacy|0|||
163055250|NCT01041859|588914093|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
162918162|NCT00762073|588403192|FG003|Overall Study|Lack of Efficacy|0|||
162918163|NCT00762073|588403189|FG000|Overall Study|Adverse Event|1|||
162918164|NCT00762073|588403190|FG001|Overall Study|Adverse Event|0|||
162918165|NCT00762073|588403191|FG002|Overall Study|Adverse Event|1|||
162918166|NCT00762073|588403192|FG003|Overall Study|Adverse Event|1|||
162918167|NCT00762073|588403189|FG000|Overall Study|Significant Subject Noncompliance|0|||
162918168|NCT00762073|588403190|FG001|Overall Study|Significant Subject Noncompliance|1|||
162918169|NCT00762073|588403191|FG002|Overall Study|Significant Subject Noncompliance|0|||
162918170|NCT00762073|588403192|FG003|Overall Study|Significant Subject Noncompliance|1|||
162918171|NCT00762073|588403189|FG000|Overall Study|Withdrawal by Subject|1|||
162918172|NCT00762073|588403190|FG001|Overall Study|Withdrawal by Subject|2|||
162918173|NCT00762073|588403191|FG002|Overall Study|Withdrawal by Subject|1|||
162918174|NCT00762073|588403192|FG003|Overall Study|Withdrawal by Subject|1|||
162918175|NCT00762073|588403189|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
162918176|NCT00762073|588403190|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
162918177|NCT00762073|588403191|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
162918178|NCT00762073|588403192|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
162918179|NCT02319642|588403193|FG000|Overall Study|Adverse Event|2|||
162918180|NCT02319642|588403194|FG001|Overall Study|Adverse Event|4|||
162918181|NCT02319642|588403193|FG000|Overall Study|Lack of Efficacy|1|||
162918182|NCT02319642|588403194|FG001|Overall Study|Lack of Efficacy|1|||
162918183|NCT02319642|588403193|FG000|Overall Study|Withdrawal by Subject|1|||
162918184|NCT02319642|588403194|FG001|Overall Study|Withdrawal by Subject|1|||
162918185|NCT01265875|588403195|FG000|Overall Study|Uncooperative/unreliable|1|||
162918186|NCT01049360|588403199|FG000|Period 1|Adverse Event|0|||
162918187|NCT01049360|588403200|FG001|Period 1|Adverse Event|1|||
162918188|NCT01049360|588403201|FG002|Period 1|Adverse Event|0|||
162918189|NCT01049360|588403202|FG003|Period 1|Adverse Event|1|||
162918190|NCT01049360|588403203|FG004|Period 1|Adverse Event|0|||
162918191|NCT01049360|588403204|FG005|Period 1|Adverse Event|0|||
162918192|NCT01049360|588403205|FG006|Period 1|Adverse Event|0|||
162918193|NCT01049360|588403206|FG007|Period 1|Adverse Event|1|||
162918194|NCT01049360|588403207|FG008|Period 1|Adverse Event|0|||
162918195|NCT01049360|588403208|FG009|Period 1|Adverse Event|0|||
162918196|NCT01049360|588403209|FG010|Period 1|Adverse Event|0|||
162918197|NCT01049360|588403210|FG011|Period 1|Adverse Event|0|||
162918198|NCT01049360|588403211|FG012|Period 1|Adverse Event|1|||
162918199|NCT01049360|588403212|FG013|Period 1|Adverse Event|1|||
162918200|NCT01049360|588403213|FG014|Period 1|Adverse Event|0|||
162918201|NCT01049360|588403214|FG015|Period 1|Adverse Event|0|||
162918202|NCT01049360|588403215|FG016|Period 1|Adverse Event|1|||
162918203|NCT01049360|588403216|FG017|Period 1|Adverse Event|0|||
162918204|NCT01049360|588403217|FG018|Period 1|Adverse Event|1|||
162918205|NCT01049360|588403218|FG019|Period 1|Adverse Event|0|||
162918206|NCT01049360|588403199|FG000|Period 1|Did not meet inc/exc criteria|0|||
162918207|NCT01049360|588403200|FG001|Period 1|Did not meet inc/exc criteria|0|||
162918208|NCT01049360|588403201|FG002|Period 1|Did not meet inc/exc criteria|0|||
162918209|NCT01049360|588403202|FG003|Period 1|Did not meet inc/exc criteria|0|||
162918210|NCT01049360|588403203|FG004|Period 1|Did not meet inc/exc criteria|0|||
162918211|NCT01049360|588403204|FG005|Period 1|Did not meet inc/exc criteria|0|||
162918212|NCT01049360|588403205|FG006|Period 1|Did not meet inc/exc criteria|0|||
162918213|NCT01049360|588403206|FG007|Period 1|Did not meet inc/exc criteria|1|||
162918214|NCT01049360|588403207|FG008|Period 1|Did not meet inc/exc criteria|1|||
162918215|NCT01049360|588403208|FG009|Period 1|Did not meet inc/exc criteria|0|||
162918216|NCT01049360|588403209|FG010|Period 1|Did not meet inc/exc criteria|0|||
162918217|NCT01049360|588403210|FG011|Period 1|Did not meet inc/exc criteria|0|||
162918218|NCT01049360|588403211|FG012|Period 1|Did not meet inc/exc criteria|0|||
163055251|NCT01041859|588914094|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
163055252|NCT01041859|588914095|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
163055253|NCT01041859|588914093|FG000|Double-Blind Maintenance|Physician Decision|0|||
163055254|NCT01041859|588914094|FG001|Double-Blind Maintenance|Physician Decision|2|||
162629163|NCT01438957|587361008|FG000|Overall Study|Physician Decision|1|||
162918219|NCT01049360|588403212|FG013|Period 1|Did not meet inc/exc criteria|0|||
162918220|NCT01049360|588403213|FG014|Period 1|Did not meet inc/exc criteria|0|||
162918221|NCT01049360|588403214|FG015|Period 1|Did not meet inc/exc criteria|0|||
162918222|NCT01049360|588403215|FG016|Period 1|Did not meet inc/exc criteria|0|||
162918223|NCT01049360|588403216|FG017|Period 1|Did not meet inc/exc criteria|0|||
163055255|NCT01041859|588914095|FG002|Double-Blind Maintenance|Physician Decision|1|||
163055256|NCT01041859|588914093|FG000|Double-Blind Maintenance|Protocol Violation|0|||
162629164|NCT01438957|587361009|FG001|Overall Study|Physician Decision|1|||
162918224|NCT01049360|588403217|FG018|Period 1|Did not meet inc/exc criteria|0|||
162918225|NCT01049360|588403218|FG019|Period 1|Did not meet inc/exc criteria|0|||
162918226|NCT01049360|588403199|FG000|Period 1|Withdrawal by Subject|0|||
162918227|NCT01049360|588403200|FG001|Period 1|Withdrawal by Subject|0|||
162918228|NCT01049360|588403201|FG002|Period 1|Withdrawal by Subject|0|||
162918229|NCT01049360|588403202|FG003|Period 1|Withdrawal by Subject|0|||
162918230|NCT01049360|588403203|FG004|Period 1|Withdrawal by Subject|0|||
162918231|NCT01049360|588403204|FG005|Period 1|Withdrawal by Subject|0|||
162918232|NCT01049360|588403205|FG006|Period 1|Withdrawal by Subject|0|||
162918233|NCT01049360|588403206|FG007|Period 1|Withdrawal by Subject|0|||
163055257|NCT01041859|588914094|FG001|Double-Blind Maintenance|Protocol Violation|1|||
163055258|NCT01041859|588914095|FG002|Double-Blind Maintenance|Protocol Violation|3|||
162918234|NCT01049360|588403207|FG008|Period 1|Withdrawal by Subject|1|||
162918235|NCT01049360|588403208|FG009|Period 1|Withdrawal by Subject|0|||
162918236|NCT01049360|588403209|FG010|Period 1|Withdrawal by Subject|1|||
162918237|NCT01049360|588403210|FG011|Period 1|Withdrawal by Subject|0|||
162918238|NCT01049360|588403211|FG012|Period 1|Withdrawal by Subject|1|||
162918239|NCT01049360|588403212|FG013|Period 1|Withdrawal by Subject|0|||
162918240|NCT01049360|588403213|FG014|Period 1|Withdrawal by Subject|0|||
162918241|NCT01049360|588403214|FG015|Period 1|Withdrawal by Subject|0|||
162918242|NCT01049360|588403215|FG016|Period 1|Withdrawal by Subject|0|||
162918243|NCT01049360|588403216|FG017|Period 1|Withdrawal by Subject|0|||
162918244|NCT01049360|588403217|FG018|Period 1|Withdrawal by Subject|0|||
162918245|NCT01049360|588403218|FG019|Period 1|Withdrawal by Subject|0|||
162918246|NCT01049360|588403199|FG000|Period 2|Protocol Violation|0|||
162918247|NCT01049360|588403200|FG001|Period 2|Protocol Violation|0|||
162918248|NCT01049360|588403201|FG002|Period 2|Protocol Violation|0|||
162918249|NCT01049360|588403202|FG003|Period 2|Protocol Violation|1|||
162918250|NCT01049360|588403203|FG004|Period 2|Protocol Violation|0|||
162918251|NCT01049360|588403204|FG005|Period 2|Protocol Violation|0|||
162918252|NCT01049360|588403205|FG006|Period 2|Protocol Violation|0|||
162918253|NCT01049360|588403206|FG007|Period 2|Protocol Violation|0|||
162918254|NCT01049360|588403207|FG008|Period 2|Protocol Violation|0|||
162918255|NCT01049360|588403208|FG009|Period 2|Protocol Violation|0|||
162918256|NCT01049360|588403209|FG010|Period 2|Protocol Violation|0|||
162918257|NCT01049360|588403210|FG011|Period 2|Protocol Violation|0|||
162918258|NCT01049360|588403211|FG012|Period 2|Protocol Violation|0|||
162918259|NCT01049360|588403212|FG013|Period 2|Protocol Violation|0|||
162918260|NCT01049360|588403213|FG014|Period 2|Protocol Violation|1|||
162918261|NCT01049360|588403214|FG015|Period 2|Protocol Violation|1|||
162918262|NCT01049360|588403215|FG016|Period 2|Protocol Violation|0|||
162918263|NCT01049360|588403216|FG017|Period 2|Protocol Violation|0|||
162918264|NCT01049360|588403217|FG018|Period 2|Protocol Violation|0|||
162918265|NCT01049360|588403218|FG019|Period 2|Protocol Violation|0|||
162918266|NCT01049360|588403199|FG000|Period 2|Adverse Event|0|||
162918267|NCT01049360|588403200|FG001|Period 2|Adverse Event|1|||
162918268|NCT01049360|588403201|FG002|Period 2|Adverse Event|0|||
162918269|NCT01049360|588403202|FG003|Period 2|Adverse Event|0|||
162918270|NCT01049360|588403203|FG004|Period 2|Adverse Event|0|||
162918271|NCT01049360|588403204|FG005|Period 2|Adverse Event|0|||
162918272|NCT01049360|588403205|FG006|Period 2|Adverse Event|0|||
162918273|NCT01049360|588403206|FG007|Period 2|Adverse Event|0|||
162918274|NCT01049360|588403207|FG008|Period 2|Adverse Event|1|||
162918275|NCT01049360|588403208|FG009|Period 2|Adverse Event|0|||
162918276|NCT01049360|588403209|FG010|Period 2|Adverse Event|0|||
162918277|NCT01049360|588403210|FG011|Period 2|Adverse Event|0|||
162918278|NCT01049360|588403211|FG012|Period 2|Adverse Event|0|||
162918279|NCT01049360|588403212|FG013|Period 2|Adverse Event|0|||
162918280|NCT01049360|588403213|FG014|Period 2|Adverse Event|0|||
162918281|NCT01049360|588403214|FG015|Period 2|Adverse Event|0|||
162918282|NCT01049360|588403215|FG016|Period 2|Adverse Event|0|||
162918283|NCT01049360|588403216|FG017|Period 2|Adverse Event|0|||
162918284|NCT01049360|588403217|FG018|Period 2|Adverse Event|0|||
162918285|NCT01049360|588403218|FG019|Period 2|Adverse Event|1|||
162918286|NCT01049360|588403199|FG000|Period 2|Withdrawal by Subject|0|||
162918287|NCT01049360|588403200|FG001|Period 2|Withdrawal by Subject|0|||
162918288|NCT01049360|588403201|FG002|Period 2|Withdrawal by Subject|0|||
162918289|NCT01049360|588403202|FG003|Period 2|Withdrawal by Subject|1|||
162918290|NCT01049360|588403203|FG004|Period 2|Withdrawal by Subject|0|||
162918291|NCT01049360|588403204|FG005|Period 2|Withdrawal by Subject|0|||
162918292|NCT01049360|588403205|FG006|Period 2|Withdrawal by Subject|0|||
162918293|NCT01049360|588403206|FG007|Period 2|Withdrawal by Subject|0|||
162918294|NCT01049360|588403207|FG008|Period 2|Withdrawal by Subject|0|||
162918295|NCT01049360|588403208|FG009|Period 2|Withdrawal by Subject|0|||
162918296|NCT01049360|588403209|FG010|Period 2|Withdrawal by Subject|0|||
162969371|NCT02003222|588589951|FG004|Induction|Disease progression|22|||
162969372|NCT02003222|588589947|FG000|Induction|Death|0|||
162629165|NCT01438957|587361010|FG002|Overall Study|Physician Decision|0|||
162629166|NCT01438957|587361011|FG003|Overall Study|Physician Decision|1|||
162629167|NCT01438957|587361012|FG004|Overall Study|Physician Decision|0|||
162629168|NCT03902574|587361015|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
162629169|NCT03902574|587361016|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
162629170|NCT03902574|587361017|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
162629171|NCT00133952|587361018|FG000|Overall Study|Adverse Event|1|||
162629172|NCT00133952|587361019|FG001|Overall Study|Adverse Event|2|||
162629173|NCT00133952|587361018|FG000|Overall Study|Death|3|||
162629174|NCT00133952|587361019|FG001|Overall Study|Death|2|||
162629175|NCT00133952|587361018|FG000|Overall Study|Lost to Follow-up|9|||
162629176|NCT00133952|587361019|FG001|Overall Study|Lost to Follow-up|14|||
162918297|NCT01049360|588403210|FG011|Period 2|Withdrawal by Subject|0|||
162918298|NCT01049360|588403211|FG012|Period 2|Withdrawal by Subject|0|||
162918299|NCT01049360|588403212|FG013|Period 2|Withdrawal by Subject|0|||
162918300|NCT01049360|588403213|FG014|Period 2|Withdrawal by Subject|1|||
162918301|NCT01049360|588403214|FG015|Period 2|Withdrawal by Subject|0|||
162918302|NCT01049360|588403215|FG016|Period 2|Withdrawal by Subject|0|||
162918303|NCT01049360|588403216|FG017|Period 2|Withdrawal by Subject|0|||
162918304|NCT01049360|588403217|FG018|Period 2|Withdrawal by Subject|0|||
162969373|NCT02003222|588589948|FG001|Induction|Death|0|||
162918305|NCT01049360|588403218|FG019|Period 2|Withdrawal by Subject|1|||
162918306|NCT01049360|588403199|FG000|Period 2|Lack of Efficacy|0|||
162918307|NCT01049360|588403200|FG001|Period 2|Lack of Efficacy|0|||
162918308|NCT01049360|588403201|FG002|Period 2|Lack of Efficacy|0|||
162918309|NCT01049360|588403202|FG003|Period 2|Lack of Efficacy|0|||
162918310|NCT01049360|588403203|FG004|Period 2|Lack of Efficacy|0|||
162918311|NCT01049360|588403204|FG005|Period 2|Lack of Efficacy|1|||
162918312|NCT01049360|588403205|FG006|Period 2|Lack of Efficacy|0|||
162918313|NCT01049360|588403206|FG007|Period 2|Lack of Efficacy|0|||
162918314|NCT01049360|588403207|FG008|Period 2|Lack of Efficacy|0|||
162918315|NCT01049360|588403208|FG009|Period 2|Lack of Efficacy|0|||
162918316|NCT01049360|588403209|FG010|Period 2|Lack of Efficacy|0|||
162918317|NCT01049360|588403210|FG011|Period 2|Lack of Efficacy|0|||
162918318|NCT01049360|588403211|FG012|Period 2|Lack of Efficacy|0|||
162918319|NCT01049360|588403212|FG013|Period 2|Lack of Efficacy|0|||
162918320|NCT01049360|588403213|FG014|Period 2|Lack of Efficacy|0|||
162918321|NCT01049360|588403214|FG015|Period 2|Lack of Efficacy|0|||
162918322|NCT01049360|588403215|FG016|Period 2|Lack of Efficacy|0|||
162918323|NCT01049360|588403216|FG017|Period 2|Lack of Efficacy|0|||
162918324|NCT01049360|588403217|FG018|Period 2|Lack of Efficacy|0|||
162918325|NCT01049360|588403218|FG019|Period 2|Lack of Efficacy|0|||
162918326|NCT01049360|588403199|FG000|Period 4|Protocol Violation|0|||
162918327|NCT01049360|588403200|FG001|Period 4|Protocol Violation|0|||
162918328|NCT01049360|588403201|FG002|Period 4|Protocol Violation|0|||
162918329|NCT01049360|588403202|FG003|Period 4|Protocol Violation|0|||
162918330|NCT01049360|588403203|FG004|Period 4|Protocol Violation|0|||
162918331|NCT01049360|588403204|FG005|Period 4|Protocol Violation|0|||
162918332|NCT01049360|588403205|FG006|Period 4|Protocol Violation|0|||
162918333|NCT01049360|588403206|FG007|Period 4|Protocol Violation|0|||
162918334|NCT01049360|588403207|FG008|Period 4|Protocol Violation|0|||
162918335|NCT01049360|588403208|FG009|Period 4|Protocol Violation|0|||
162918336|NCT01049360|588403209|FG010|Period 4|Protocol Violation|0|||
162918337|NCT01049360|588403210|FG011|Period 4|Protocol Violation|0|||
162918338|NCT01049360|588403211|FG012|Period 4|Protocol Violation|0|||
162918339|NCT01049360|588403212|FG013|Period 4|Protocol Violation|0|||
162918340|NCT01049360|588403213|FG014|Period 4|Protocol Violation|0|||
162918341|NCT01049360|588403214|FG015|Period 4|Protocol Violation|0|||
162918342|NCT01049360|588403215|FG016|Period 4|Protocol Violation|0|||
162918343|NCT01049360|588403216|FG017|Period 4|Protocol Violation|1|||
162918344|NCT01049360|588403217|FG018|Period 4|Protocol Violation|0|||
162918345|NCT01049360|588403218|FG019|Period 4|Protocol Violation|0|||
162918346|NCT01049360|588403199|FG000|Period 4|Withdrawal by Subject|0|||
162918347|NCT01049360|588403200|FG001|Period 4|Withdrawal by Subject|0|||
162918348|NCT01049360|588403201|FG002|Period 4|Withdrawal by Subject|0|||
162918349|NCT01049360|588403202|FG003|Period 4|Withdrawal by Subject|1|||
162918350|NCT01049360|588403203|FG004|Period 4|Withdrawal by Subject|0|||
162918351|NCT01049360|588403204|FG005|Period 4|Withdrawal by Subject|0|||
162918352|NCT01049360|588403205|FG006|Period 4|Withdrawal by Subject|0|||
162918353|NCT01049360|588403206|FG007|Period 4|Withdrawal by Subject|0|||
162918354|NCT01049360|588403207|FG008|Period 4|Withdrawal by Subject|0|||
162918355|NCT01049360|588403208|FG009|Period 4|Withdrawal by Subject|0|||
162918356|NCT01049360|588403209|FG010|Period 4|Withdrawal by Subject|0|||
162918357|NCT01049360|588403210|FG011|Period 4|Withdrawal by Subject|0|||
162918358|NCT01049360|588403211|FG012|Period 4|Withdrawal by Subject|0|||
162918359|NCT01049360|588403212|FG013|Period 4|Withdrawal by Subject|0|||
162918360|NCT01049360|588403213|FG014|Period 4|Withdrawal by Subject|0|||
162918361|NCT01049360|588403214|FG015|Period 4|Withdrawal by Subject|0|||
162918362|NCT01049360|588403215|FG016|Period 4|Withdrawal by Subject|0|||
162918363|NCT01049360|588403216|FG017|Period 4|Withdrawal by Subject|0|||
162918364|NCT01049360|588403217|FG018|Period 4|Withdrawal by Subject|0|||
162918365|NCT01049360|588403218|FG019|Period 4|Withdrawal by Subject|0|||
162918366|NCT05147311|588403221|FG000|Overall Study|Did not complete survey|2|||
162918367|NCT05147311|588403222|FG001|Overall Study|Did not complete survey|1|||
162918368|NCT05147311|588403221|FG000|Overall Study|Patient too sick|1|||
162918369|NCT05147311|588403222|FG001|Overall Study|Patient too sick|2|||
162918370|NCT05147311|588403221|FG000|Overall Study|Death|0|||
162918371|NCT05147311|588403222|FG001|Overall Study|Death|1|||
162918372|NCT05147311|588403221|FG000|Overall Study|Declined survey|1|||
162918373|NCT05147311|588403222|FG001|Overall Study|Declined survey|0|||
162918374|NCT00145795|588403224|FG000|Overall Study|Adverse Event|1|||
162918375|NCT00145795|588403225|FG001|Overall Study|Adverse Event|0|||
162918376|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Adverse Event|6|||
162918377|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Adverse Event|6|||
162918378|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Death|14|||
162918379|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Death|11|||
162918380|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
162918381|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
162918382|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
162918383|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
162918384|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
162918385|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
162918386|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Disease Progression|1|||
162918387|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Disease Progression|0|||
162918388|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
162918389|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
162918390|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
162918391|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
162918392|NCT04419558|588403226|FG000|DB Period (48 Weeks)|Participant Decision|4|||
162918393|NCT04419558|588403227|FG001|DB Period (48 Weeks)|Participant Decision|3|||
162918394|NCT04419558|588403226|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
162918395|NCT04419558|588403227|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
162918396|NCT04419558|588403226|FG000|OLE Period (48 Weeks)|Death|4|||
162918397|NCT04419558|588403227|FG001|OLE Period (48 Weeks)|Death|6|||
162918398|NCT04419558|588403226|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
162918399|NCT04419558|588403227|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
162918400|NCT04419558|588403226|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
162918401|NCT04419558|588403227|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
162918402|NCT01539512|588403231|FG000|Overall Study|Adverse Event|9|||
162918403|NCT01539512|588403232|FG001|Overall Study|Adverse Event|7|||
162918404|NCT01539512|588403231|FG000|Overall Study|Physician Decision|1|||
162918405|NCT01539512|588403232|FG001|Overall Study|Physician Decision|1|||
162918406|NCT01539512|588403231|FG000|Overall Study|Withdrawal by Subject|12|||
162918407|NCT01539512|588403232|FG001|Overall Study|Withdrawal by Subject|5|||
162918408|NCT01539512|588403231|FG000|Overall Study|Richter's Transformation|1|||
162918409|NCT01539512|588403232|FG001|Overall Study|Richter's Transformation|0|||
162918410|NCT01015118|588403233|FG000|Overall Study|Protocol Violation|5|||
162918411|NCT01015118|588403234|FG001|Overall Study|Protocol Violation|6|||
162918412|NCT01015118|588403233|FG000|Overall Study|Withdrawal by Subject|103|||
162918413|NCT01015118|588403234|FG001|Overall Study|Withdrawal by Subject|27|||
162918414|NCT01015118|588403233|FG000|Overall Study|Other Adverse Event (AE)|141|||
162918415|NCT01015118|588403234|FG001|Overall Study|Other Adverse Event (AE)|33|||
162918416|NCT01015118|588403233|FG000|Overall Study|Worsening or AE of underlying disease|5|||
162918417|NCT01015118|588403234|FG001|Overall Study|Worsening or AE of underlying disease|4|||
162918418|NCT01015118|588403233|FG000|Overall Study|Progressive disease|364|||
162918419|NCT01015118|588403234|FG001|Overall Study|Progressive disease|229|||
162918420|NCT01015118|588403233|FG000|Overall Study|Not treated|9|||
162918421|NCT01015118|588403234|FG001|Overall Study|Not treated|5|||
162969374|NCT02003222|588589949|FG002|Induction|Death|0|||
162969375|NCT02003222|588589950|FG003|Induction|Death|0|||
162969376|NCT02003222|588589951|FG004|Induction|Death|3|||
162969377|NCT02003222|588589947|FG000|Induction|Withdrawal by Subject|0|||
162918422|NCT01015118|588403233|FG000|Overall Study|Other than stated above|42|||
162969378|NCT02003222|588589948|FG001|Induction|Withdrawal by Subject|0|||
162969379|NCT02003222|588589949|FG002|Induction|Withdrawal by Subject|0|||
162969380|NCT02003222|588589950|FG003|Induction|Withdrawal by Subject|0|||
162969381|NCT02003222|588589951|FG004|Induction|Withdrawal by Subject|8|||
162969382|NCT02003222|588589947|FG000|Induction|Other reasons|0|||
162969383|NCT02003222|588589948|FG001|Induction|Other reasons|0|||
162969384|NCT02003222|588589949|FG002|Induction|Other reasons|0|||
162969385|NCT02003222|588589950|FG003|Induction|Other reasons|0|||
162918423|NCT01015118|588403234|FG001|Overall Study|Other than stated above|23|||
162918424|NCT02388906|588403239|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
162918425|NCT02388906|588403240|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
162918426|NCT02388906|588403239|FG000|Treatment Period|Disease progression|121|||
162918427|NCT02388906|588403240|FG001|Treatment Period|Disease progression|100|||
162918428|NCT02388906|588403239|FG000|Treatment Period|Study drug toxicity|41|||
162969386|NCT02003222|588589951|FG004|Induction|Other reasons|22|||
162969387|NCT02003222|588589947|FG000|Intensification|Never started treatment|0|||
162969388|NCT02003222|588589948|FG001|Intensification|Never started treatment|0|||
162918429|NCT02388906|588403240|FG001|Treatment Period|Study drug toxicity|208|||
162969389|NCT02003222|588589949|FG002|Intensification|Never started treatment|0|||
162969390|NCT02003222|588589950|FG003|Intensification|Never started treatment|0|||
162918430|NCT02388906|588403239|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
162918431|NCT02388906|588403240|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
162918432|NCT02388906|588403239|FG000|Treatment Period|Participant request to stop treatment|5|||
162918433|NCT02388906|588403240|FG001|Treatment Period|Participant request to stop treatment|9|||
162918434|NCT02388906|588403239|FG000|Treatment Period|Participant withdrew consent|2|||
162918435|NCT02388906|588403240|FG001|Treatment Period|Participant withdrew consent|3|||
162918436|NCT02388906|588403239|FG000|Treatment Period|Poor/non-compliance|0|||
162918437|NCT02388906|588403240|FG001|Treatment Period|Poor/non-compliance|1|||
162918438|NCT02388906|588403239|FG000|Treatment Period|Participant no longer meets study criteria|0|||
162918439|NCT02388906|588403240|FG001|Treatment Period|Participant no longer meets study criteria|1|||
162918440|NCT02388906|588403239|FG000|Treatment Period|Other reasons|3|||
162918441|NCT02388906|588403240|FG001|Treatment Period|Other reasons|3|||
162918442|NCT01250418|588403249|FG000|Overall Study|monitor data failure|1|||
162918443|NCT01250418|588403250|FG001|Overall Study|monitor data failure|1|||
162918444|NCT02400281|588403252|FG000|Overall Study|Adverse Event|0|||
162918445|NCT02400281|588403253|FG001|Overall Study|Adverse Event|0|||
162918446|NCT02400281|588403254|FG002|Overall Study|Adverse Event|1|||
162918447|NCT02400281|588403255|FG003|Overall Study|Adverse Event|0|||
162918448|NCT02400281|588403256|FG004|Overall Study|Adverse Event|1|||
162918449|NCT02400281|588403257|FG005|Overall Study|Adverse Event|0|||
162918450|NCT02400281|588403252|FG000|Overall Study|Physician Decision|0|||
162918451|NCT02400281|588403253|FG001|Overall Study|Physician Decision|0|||
162918452|NCT02400281|588403254|FG002|Overall Study|Physician Decision|1|||
162918453|NCT02400281|588403255|FG003|Overall Study|Physician Decision|0|||
162918454|NCT02400281|588403256|FG004|Overall Study|Physician Decision|0|||
162918455|NCT02400281|588403257|FG005|Overall Study|Physician Decision|0|||
162918456|NCT00412360|588403258|FG000|Overall Study|Lost to Follow-up|0|||
162918457|NCT00412360|588403259|FG001|Overall Study|Lost to Follow-up|1|||
162918458|NCT00412360|588403258|FG000|Overall Study|Not Transplanted|1|||
162918459|NCT00412360|588403259|FG001|Overall Study|Not Transplanted|2|||
162918460|NCT03145207|588403261|FG000|Overall Study|volunteer started taking allergy shots|1|||
162918461|NCT03145207|588403261|FG000|Overall Study|baseline blood pressure high|1|||
162918462|NCT01790633|588403262|FG000|Overall Study|Protocol Violation|1|||
162918463|NCT01790633|588403263|FG001|Overall Study|Protocol Violation|2|||
162918464|NCT01790633|588403262|FG000|Overall Study|Did not have serology performed|47|||
162918465|NCT01790633|588403263|FG001|Overall Study|Did not have serology performed|0|||
162918466|NCT01790633|588403262|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
162918467|NCT01790633|588403263|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
162918468|NCT01396434|588403265|FG000|Overall Study|Lost to Follow-up|1|||
162918469|NCT01396434|588403266|FG001|Overall Study|Lost to Follow-up|0|||
162918470|NCT01396434|588403267|FG002|Overall Study|Lost to Follow-up|0|||
162918471|NCT01396434|588403265|FG000|Overall Study|Other|10|||
162918472|NCT01396434|588403266|FG001|Overall Study|Other|0|||
162918473|NCT01396434|588403267|FG002|Overall Study|Other|0|||
162918474|NCT04678557|588403270|FG000|Overall Study|Withdrawal by Subject|1|||
162918475|NCT04678557|588403271|FG001|Overall Study|Withdrawal by Subject|0|||
162918476|NCT04678557|588403270|FG000|Overall Study|Lack of Efficacy|0|||
162918477|NCT04678557|588403271|FG001|Overall Study|Lack of Efficacy|13|||
162918478|NCT04678557|588403270|FG000|Overall Study|Safety Evaluation|0|||
162918479|NCT04678557|588403271|FG001|Overall Study|Safety Evaluation|1|||
162918480|NCT00157157|588403272|FG000|Overall Study|Withdrawal by Subject|6|||
162918481|NCT00157157|588403272|FG000|Overall Study|Physician Decision|1|||
162918482|NCT00157157|588403272|FG000|Overall Study|Lost to Follow-up|1|||
162918483|NCT00157157|588403272|FG000|Overall Study|Enrolled in another study|1|||
162918484|NCT00157157|588403272|FG000|Overall Study|Met exclusion criteria|1|||
162918485|NCT00157157|588403272|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
162918486|NCT02260804|588403276|FG000|Induction Study Period|Protocol Violation|2|||
162918487|NCT02260804|588403277|FG001|Induction Study Period|Protocol Violation|0|||
162918488|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
162711070|NCT02138916|587652859|FG001|Overall Study|Adverse Event|4|||
162918489|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
162918490|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
162918491|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
162918492|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
162918493|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
162918494|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
162918495|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
162918496|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
162918497|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
162918498|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
162918499|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
162918500|NCT02260804|588403276|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
162918501|NCT02260804|588403277|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
162969391|NCT02003222|588589951|FG004|Intensification|Never started treatment|2|||
162969392|NCT02003222|588589947|FG000|Intensification|Adverse Event|0|||
162969393|NCT02003222|588589948|FG001|Intensification|Adverse Event|0|||
162969394|NCT02003222|588589949|FG002|Intensification|Adverse Event|0|||
162969395|NCT02003222|588589950|FG003|Intensification|Adverse Event|0|||
162969396|NCT02003222|588589951|FG004|Intensification|Adverse Event|6|||
162969397|NCT02003222|588589947|FG000|Intensification|Alternative therapy|0|||
162969398|NCT02003222|588589948|FG001|Intensification|Alternative therapy|0|||
162918502|NCT02260804|588403276|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
162918503|NCT02260804|588403277|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
162918504|NCT02260804|588403276|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
162918505|NCT02260804|588403277|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
162918506|NCT02260804|588403276|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
162918507|NCT02260804|588403277|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
162918508|NCT00563706|588404836|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
162918509|NCT00563706|588404837|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
162918510|NCT00563706|588404838|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
162918511|NCT00563706|588404839|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
162918512|NCT00563706|588404840|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
162969399|NCT02003222|588589949|FG002|Intensification|Alternative therapy|0|||
162918513|NCT00563706|588404841|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
162918514|NCT00563706|588404842|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
162918515|NCT00563706|588404843|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
162918516|NCT00563706|588404844|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
162918517|NCT00563706|588404836|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
162918518|NCT00563706|588404837|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
162918519|NCT00563706|588404838|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
162918520|NCT00563706|588404839|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
162918521|NCT00563706|588404840|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
162918522|NCT00563706|588404841|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
162918523|NCT00563706|588404842|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
162918524|NCT00563706|588404843|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
162918525|NCT00563706|588404844|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
162969400|NCT02003222|588589950|FG003|Intensification|Alternative therapy|0|||
162969401|NCT02003222|588589951|FG004|Intensification|Alternative therapy|8|||
162969402|NCT02003222|588589947|FG000|Intensification|Disease progression|0|||
162969403|NCT02003222|588589948|FG001|Intensification|Disease progression|0|||
162969404|NCT02003222|588589949|FG002|Intensification|Disease progression|0|||
162969405|NCT02003222|588589950|FG003|Intensification|Disease progression|0|||
162969406|NCT02003222|588589951|FG004|Intensification|Disease progression|18|||
162969407|NCT02003222|588589947|FG000|Intensification|Withdrawal by Subject|0|||
163055259|NCT01041859|588914093|FG000|Double-Blind Maintenance|Other|0|||
163055260|NCT01041859|588914094|FG001|Double-Blind Maintenance|Other|6|||
163055261|NCT01041859|588914095|FG002|Double-Blind Maintenance|Other|2|||
162918526|NCT00563706|588404836|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
162918527|NCT00563706|588404837|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
162918528|NCT00563706|588404838|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
162918529|NCT00563706|588404839|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
162918530|NCT00563706|588404840|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
162918531|NCT00563706|588404841|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
162918532|NCT00563706|588404842|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
162918533|NCT00563706|588404843|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
162918534|NCT00563706|588404844|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
162918535|NCT00563706|588404836|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
162918536|NCT00563706|588404837|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
163055262|NCT01041859|588914093|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
163055263|NCT01041859|588914094|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
163055264|NCT01041859|588914095|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
162918537|NCT00563706|588404838|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162969408|NCT02003222|588589948|FG001|Intensification|Withdrawal by Subject|0|||
162969409|NCT02003222|588589949|FG002|Intensification|Withdrawal by Subject|0|||
162969410|NCT02003222|588589950|FG003|Intensification|Withdrawal by Subject|0|||
162969411|NCT02003222|588589951|FG004|Intensification|Withdrawal by Subject|5|||
162969412|NCT02003222|588589947|FG000|Intensification|Other reasons|0|||
162918538|NCT00563706|588404839|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162918539|NCT00563706|588404840|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162918540|NCT00563706|588404841|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162918541|NCT00563706|588404842|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162918542|NCT00563706|588404843|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
162918543|NCT00563706|588404844|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
162918544|NCT00563706|588404836|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918545|NCT00563706|588404837|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918546|NCT00563706|588404838|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918547|NCT00563706|588404839|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918548|NCT00563706|588404840|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918549|NCT00563706|588404841|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918550|NCT00563706|588404842|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
162918551|NCT00563706|588404843|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
162918552|NCT00563706|588404844|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
162918553|NCT02503215|588404849|FG000|Overall Study|Unable to wear compression stockings|1|||
162918554|NCT02503215|588404849|FG000|Overall Study|Unable to use positive airway pressure|2|||
162918555|NCT02983305|588404854|FG000|Overall Study|incomplete data|2|||
162918556|NCT02983305|588404855|FG001|Overall Study|incomplete data|0|||
162918557|NCT00706901|588404856|FG000|Overall Study|Lost to Follow-up|2|||
162918558|NCT00706901|588404857|FG001|Overall Study|Lost to Follow-up|3|||
162918559|NCT00706901|588404858|FG002|Overall Study|Lost to Follow-up|2|||
162918560|NCT00706901|588404856|FG000|Overall Study|Withdrawal by Subject|4|||
162918561|NCT00706901|588404857|FG001|Overall Study|Withdrawal by Subject|2|||
162918562|NCT00706901|588404858|FG002|Overall Study|Withdrawal by Subject|5|||
162918563|NCT00706901|588404856|FG000|Overall Study|In Jail|1|||
162918564|NCT00706901|588404857|FG001|Overall Study|In Jail|0|||
162918565|NCT00706901|588404858|FG002|Overall Study|In Jail|1|||
162918566|NCT00706901|588404856|FG000|Overall Study|Death|1|||
162918567|NCT00706901|588404857|FG001|Overall Study|Death|0|||
162918568|NCT00706901|588404858|FG002|Overall Study|Death|0|||
162918569|NCT00822237|588404859|FG000|Dose 1 Vaccination|Not vaccinated|3|||
162918570|NCT00822237|588404860|FG001|Dose 1 Vaccination|Not vaccinated|0|||
162918571|NCT00822237|588404859|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
162918572|NCT00822237|588404860|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
162918573|NCT00822237|588404859|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
162918574|NCT00822237|588404860|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
162918575|NCT00822237|588404859|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
162918576|NCT00822237|588404860|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
162969413|NCT02003222|588589948|FG001|Intensification|Other reasons|0|||
162629177|NCT00133952|587361018|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
162629178|NCT00133952|587361019|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
162629179|NCT00133952|587361018|FG000|Overall Study|Protocol Violation|1|||
162629180|NCT00133952|587361019|FG001|Overall Study|Protocol Violation|1|||
162629181|NCT00133952|587361018|FG000|Overall Study|Withdrawal by Subject|20|||
162629182|NCT00133952|587361019|FG001|Overall Study|Withdrawal by Subject|4|||
162629183|NCT00133952|587361018|FG000|Overall Study|Physician Decision|4|||
162629184|NCT00133952|587361019|FG001|Overall Study|Physician Decision|3|||
162629185|NCT00133952|587361018|FG000|Overall Study|Sponsor Decision|0|||
162629186|NCT00133952|587361019|FG001|Overall Study|Sponsor Decision|1|||
162629187|NCT02101060|587361025|FG000|Overall Study|Adverse Event|1|||
162629188|NCT02101060|587361026|FG001|Overall Study|Adverse Event|0|||
162629189|NCT02101060|587361025|FG000|Overall Study|Withdrawal by Subject|1|||
162629190|NCT02101060|587361026|FG001|Overall Study|Withdrawal by Subject|1|||
162629191|NCT02101060|587361025|FG000|Overall Study|Lost to Follow-up|3|||
162918577|NCT00822237|588404859|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
162918578|NCT00822237|588404860|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
162918579|NCT03433482|588404861|FG000|Overall Study|Lost to Follow-up|1|||
162918580|NCT03433482|588404862|FG001|Overall Study|Lost to Follow-up|0|||
162918581|NCT03433482|588404863|FG002|Overall Study|Lost to Follow-up|1|||
162918582|NCT03433482|588404864|FG003|Overall Study|Lost to Follow-up|1|||
162711071|NCT02138916|587652860|FG002|Overall Study|Adverse Event|3|||
162711072|NCT01913340|587652861|FG000|Overall Study|Death|2|||
162711073|NCT01913340|587652862|FG001|Overall Study|Death|5|||
162711074|NCT01913340|587652861|FG000|Overall Study|Lost to Follow-up|1|||
162711075|NCT01913340|587652862|FG001|Overall Study|Lost to Follow-up|1|||
162711076|NCT05750745|587652864|FG000|Overall Study|Adverse Event|1|||
162711077|NCT05750745|587652865|FG001|Overall Study|Adverse Event|0|||
162711078|NCT05750745|587652866|FG002|Overall Study|Adverse Event|0|||
162711079|NCT05750745|587652864|FG000|Overall Study|Protocol Violation|1|||
162711080|NCT05750745|587652865|FG001|Overall Study|Protocol Violation|0|||
162711081|NCT05750745|587652866|FG002|Overall Study|Protocol Violation|0|||
162711082|NCT05750745|587652864|FG000|Overall Study|Withdrawal by Subject|0|||
162711083|NCT05750745|587652865|FG001|Overall Study|Withdrawal by Subject|1|||
162711084|NCT05750745|587652866|FG002|Overall Study|Withdrawal by Subject|0|||
162711085|NCT05096884|587652868|FG000|Overall Study|Excluded based on negative tilt table test|4|||
162711086|NCT02482233|587652869|FG000|Overall Study|Lost to Follow-up|1|||
162711087|NCT02482233|587652870|FG001|Overall Study|Lost to Follow-up|1|||
162711088|NCT04888585|587652871|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162711089|NCT04888585|587652872|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162711090|NCT04888585|587652873|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162711091|NCT04888585|587652874|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
162711092|NCT04888585|587652875|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
162711093|NCT04888585|587652876|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711094|NCT04888585|587652877|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711095|NCT04888585|587652878|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711096|NCT04888585|587652879|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711097|NCT04888585|587652880|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711098|NCT04888585|587652881|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162711099|NCT04888585|587652871|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711100|NCT04888585|587652872|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
162711101|NCT04888585|587652873|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
162711102|NCT04888585|587652874|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
162711103|NCT04888585|587652875|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
162711104|NCT04888585|587652876|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711105|NCT04888585|587652877|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711106|NCT04888585|587652878|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711107|NCT04888585|587652879|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711108|NCT04888585|587652880|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711109|NCT04888585|587652881|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162711110|NCT04888585|587652871|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711111|NCT04888585|587652872|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711112|NCT04888585|587652873|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
162711113|NCT04888585|587652874|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711114|NCT04888585|587652875|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
162711115|NCT04888585|587652876|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711116|NCT04888585|587652877|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711117|NCT04888585|587652878|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711118|NCT04888585|587652879|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711119|NCT04888585|587652880|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711120|NCT04888585|587652881|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162711121|NCT04888585|587652871|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711122|NCT04888585|587652872|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711123|NCT04888585|587652873|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711124|NCT04888585|587652874|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711125|NCT04888585|587652875|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711126|NCT04888585|587652876|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711127|NCT04888585|587652877|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711128|NCT04888585|587652878|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
162711129|NCT04888585|587652879|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711130|NCT04888585|587652880|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
162711131|NCT04888585|587652881|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
162711132|NCT04888585|587652871|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162711133|NCT04888585|587652872|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162711134|NCT04888585|587652873|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162711135|NCT04888585|587652874|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162711136|NCT04888585|587652875|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162711137|NCT04888585|587652876|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
162711138|NCT04888585|587652877|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
162711139|NCT04888585|587652878|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162711140|NCT04888585|587652879|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162711141|NCT04888585|587652880|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162711142|NCT04888585|587652881|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
162711143|NCT04888585|587652871|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162711144|NCT04888585|587652872|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162711145|NCT04888585|587652873|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162711146|NCT04888585|587652874|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162711147|NCT04888585|587652875|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162711148|NCT04888585|587652876|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
162711149|NCT04888585|587652877|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
162711150|NCT04888585|587652878|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
162711151|NCT04888585|587652879|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
162711152|NCT04888585|587652880|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
162711153|NCT04888585|587652881|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
162711154|NCT04888585|587652871|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
162711155|NCT04888585|587652872|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
162711156|NCT04888585|587652873|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
162711157|NCT04888585|587652874|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
162711158|NCT04888585|587652875|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
162711159|NCT04888585|587652876|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
162711160|NCT04888585|587652877|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
162711161|NCT04888585|587652878|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
162711162|NCT04888585|587652879|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
162711163|NCT04888585|587652880|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
162711164|NCT04888585|587652881|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
162711165|NCT04888585|587652871|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711166|NCT04888585|587652872|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711167|NCT04888585|587652873|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711168|NCT04888585|587652874|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711169|NCT04888585|587652875|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711170|NCT04888585|587652876|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711171|NCT04888585|587652877|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
162711172|NCT04888585|587652878|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
162711173|NCT04888585|587652879|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
162711174|NCT04888585|587652880|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
162711175|NCT04888585|587652881|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162711176|NCT04927975|587652882|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
162711177|NCT04927975|587652883|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
162711178|NCT04927975|587652884|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
162711179|NCT04927975|587652885|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
162711180|NCT04927975|587652886|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
162711181|NCT04927975|587652887|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
162711182|NCT04927975|587652882|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162711183|NCT04927975|587652883|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162711184|NCT04927975|587652884|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162711185|NCT04927975|587652885|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
162711186|NCT04927975|587652886|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
162711187|NCT04927975|587652887|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162711188|NCT04927975|587652882|FG000|Period 1 (Baseline-Week 24)|Death|0|||
162711189|NCT04927975|587652883|FG001|Period 1 (Baseline-Week 24)|Death|0|||
162711190|NCT04927975|587652884|FG002|Period 1 (Baseline-Week 24)|Death|0|||
162711191|NCT04927975|587652885|FG003|Period 1 (Baseline-Week 24)|Death|0|||
162711192|NCT04927975|587652886|FG004|Period 1 (Baseline-Week 24)|Death|0|||
162711193|NCT04927975|587652887|FG005|Period 1 (Baseline-Week 24)|Death|1|||
162711194|NCT04927975|587652882|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
162711195|NCT04927975|587652883|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
162711196|NCT04927975|587652884|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
162711197|NCT04927975|587652885|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
162711198|NCT04927975|587652886|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
162711199|NCT04927975|587652887|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
162711200|NCT04927975|587652882|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
162711201|NCT04927975|587652883|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162711202|NCT04927975|587652884|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162711203|NCT04927975|587652885|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
162711204|NCT04927975|587652886|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162711205|NCT04927975|587652887|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162711206|NCT03822351|587652888|FG000|Overall Study|Death|27|||
162918583|NCT03433482|588404861|FG000|Overall Study|Withdrawal by Subject|0|||
162918584|NCT03433482|588404862|FG001|Overall Study|Withdrawal by Subject|0|||
162918585|NCT03433482|588404863|FG002|Overall Study|Withdrawal by Subject|1|||
162918586|NCT03433482|588404864|FG003|Overall Study|Withdrawal by Subject|0|||
162918587|NCT03433482|588404861|FG000|Overall Study|Unknown reason|0|||
162918588|NCT03433482|588404862|FG001|Overall Study|Unknown reason|0|||
162918589|NCT03433482|588404863|FG002|Overall Study|Unknown reason|2|||
162918590|NCT03433482|588404864|FG003|Overall Study|Unknown reason|0|||
162918591|NCT00437294|588404865|FG000|Overall Study|Adverse Event|5|||
162918592|NCT00437294|588404866|FG001|Overall Study|Adverse Event|4|||
162918593|NCT00437294|588404865|FG000|Overall Study|Death|5|||
162918594|NCT00437294|588404866|FG001|Overall Study|Death|2|||
162918595|NCT00437294|588404865|FG000|Overall Study|Physician Decision|0|||
162918596|NCT00437294|588404866|FG001|Overall Study|Physician Decision|3|||
162918597|NCT00437294|588404865|FG000|Overall Study|Withdrawal by Subject|5|||
162918598|NCT00437294|588404866|FG001|Overall Study|Withdrawal by Subject|0|||
162918599|NCT00437294|588404865|FG000|Overall Study|Progressive Disease|19|||
162918600|NCT00437294|588404866|FG001|Overall Study|Progressive Disease|23|||
162918601|NCT00437294|588404865|FG000|Overall Study|Sponsor Decision|8|||
162918602|NCT00437294|588404866|FG001|Overall Study|Sponsor Decision|9|||
162918603|NCT00437294|588404865|FG000|Overall Study|Protocol Violation|0|||
162918604|NCT00437294|588404866|FG001|Overall Study|Protocol Violation|1|||
162918605|NCT00437294|588404865|FG000|Overall Study|Entry criteria not met|1|||
162918606|NCT00437294|588404866|FG001|Overall Study|Entry criteria not met|1|||
162918607|NCT02064231|588404870|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
162918608|NCT02064231|588404871|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
162918609|NCT02064231|588404872|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
162918610|NCT02064231|588404873|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
162969414|NCT02003222|588589949|FG002|Intensification|Other reasons|0|||
162969415|NCT02003222|588589950|FG003|Intensification|Other reasons|0|||
162969416|NCT02003222|588589951|FG004|Intensification|Other reasons|8|||
162969417|NCT04941768|588589956|FG000|Overall Study|Lost to Follow-up|10|||
162969418|NCT04941768|588589956|FG000|Overall Study|Death|24|||
162969419|NCT04941768|588589956|FG000|Overall Study|Progressive Disease|4|||
162969420|NCT04941768|588589956|FG000|Overall Study|Withdrawal by Subject|4|||
162918611|NCT02064231|588404870|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
162918612|NCT02064231|588404871|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
162918613|NCT02064231|588404872|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
162918614|NCT02064231|588404873|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
162918615|NCT02064231|588404870|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
162918616|NCT02064231|588404871|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
162969421|NCT04941768|588589956|FG000|Overall Study|Other|3|||
162969422|NCT04941768|588589956|FG000|Overall Study|Treatment ongoing|21|||
162969423|NCT04941768|588589956|FG000|Overall Study|Off treatment and in follow-up|21|||
162918617|NCT02064231|588404872|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
162918618|NCT02064231|588404873|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
162918619|NCT02064231|588404870|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
162629192|NCT02101060|587361026|FG001|Overall Study|Lost to Follow-up|3|||
162629193|NCT01484197|587361029|FG000|Treatment Period 1|Adverse Event|1|||
162629194|NCT01484197|587361030|FG001|Treatment Period 1|Adverse Event|0|||
162629195|NCT01484197|587361031|FG002|Treatment Period 1|Adverse Event|0|||
162629196|NCT01484197|587361032|FG003|Treatment Period 1|Adverse Event|0|||
162629197|NCT01484197|587361029|FG000|Treatment Period 2|Subject withdrew consent|0|||
162629198|NCT01484197|587361030|FG001|Treatment Period 2|Subject withdrew consent|0|||
162629199|NCT01484197|587361031|FG002|Treatment Period 2|Subject withdrew consent|0|||
162629200|NCT01484197|587361032|FG003|Treatment Period 2|Subject withdrew consent|1|||
162629201|NCT02244606|587361033|FG000|Overall Study|Adverse Event|0|||
162629202|NCT02244606|587361034|FG001|Overall Study|Adverse Event|1|||
162629203|NCT02244606|587361035|FG002|Overall Study|Adverse Event|1|||
162629204|NCT02244606|587361036|FG003|Overall Study|Adverse Event|0|||
162629205|NCT02244606|587361033|FG000|Overall Study|Lost to Follow-up|2|||
162629206|NCT02244606|587361034|FG001|Overall Study|Lost to Follow-up|2|||
162918620|NCT02064231|588404871|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
162918621|NCT02064231|588404872|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
162918622|NCT02064231|588404873|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
162918623|NCT01339273|588404875|FG000|Overall Study|Lost to Follow-up|8|||
162918624|NCT01339273|588404876|FG001|Overall Study|Lost to Follow-up|8|||
162918625|NCT04478994|588404877|FG000|Overall Study|Withdrawal by Subject|1|||
162918626|NCT04478994|588404878|FG001|Overall Study|Withdrawal by Subject|1|||
162969424|NCT03302078|588589958|FG000|Washout Period|Adverse Event|0|||
162969425|NCT03302078|588589959|FG001|Washout Period|Adverse Event|1|||
162969426|NCT01886872|588589960|FG000|Overall Study|Ineligible|7|||
162969427|NCT01886872|588589961|FG001|Overall Study|Ineligible|4|||
162969428|NCT01886872|588589962|FG002|Overall Study|Ineligible|12|||
162969429|NCT05148299|588589963|FG000|Treatment Period|Adverse Event|1|||
162969430|NCT05148299|588589963|FG000|Treatment Period|Physician Decision|1|||
162969431|NCT05148299|588589963|FG000|Treatment Period|Death|1|||
162969432|NCT05148299|588589963|FG000|Follow-up Period|Death|3|||
162969433|NCT02161549|588589964|FG000|Overall Study|Physician Decision|6|||
162969434|NCT02161549|588589965|FG001|Overall Study|Physician Decision|2|||
162969435|NCT01957150|588589966|FG000|Overall Study|Adverse Event|23|||
162969436|NCT01957150|588589967|FG001|Overall Study|Adverse Event|20|||
162969437|NCT01957150|588589966|FG000|Overall Study|Withdrawal by Subject|13|||
162969438|NCT01957150|588589967|FG001|Overall Study|Withdrawal by Subject|17|||
162969439|NCT01957150|588589966|FG000|Overall Study|Physician Decision|3|||
162969440|NCT01957150|588589967|FG001|Overall Study|Physician Decision|6|||
162969441|NCT01957150|588589966|FG000|Overall Study|Lost to Follow-up|4|||
162969442|NCT01957150|588589967|FG001|Overall Study|Lost to Follow-up|4|||
162969443|NCT01957150|588589966|FG000|Overall Study|Protocol Violation|1|||
162969444|NCT01957150|588589967|FG001|Overall Study|Protocol Violation|0|||
162969445|NCT01957150|588589966|FG000|Overall Study|Lack of Efficacy|11|||
162629207|NCT02244606|587361035|FG002|Overall Study|Lost to Follow-up|1|||
162629208|NCT02244606|587361036|FG003|Overall Study|Lost to Follow-up|0|||
162629209|NCT02244606|587361033|FG000|Overall Study|Protocol Violation|0|||
162969446|NCT01957150|588589967|FG001|Overall Study|Lack of Efficacy|11|||
162969447|NCT01856192|588589968|FG000|Overall Study|Adverse Event|12|||
162969448|NCT01856192|588589969|FG001|Overall Study|Adverse Event|4|||
162969449|NCT01856192|588589968|FG000|Overall Study|Alternative therapy|0|||
163055265|NCT01041859|588914093|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
162918627|NCT00518531|588404879|FG000|Treatment Period 1|Adverse Event|5|||
162918628|NCT00518531|588404880|FG001|Treatment Period 1|Adverse Event|0|||
162918629|NCT00518531|588404879|FG000|Treatment Period 1|Lost to Follow-up|5|||
162918630|NCT00518531|588404880|FG001|Treatment Period 1|Lost to Follow-up|3|||
162918631|NCT00518531|588404879|FG000|Treatment Period 1|Physician Decision|1|||
162918632|NCT00518531|588404880|FG001|Treatment Period 1|Physician Decision|0|||
162918633|NCT00518531|588404879|FG000|Treatment Period 1|Protocol Violation|2|||
162918634|NCT00518531|588404880|FG001|Treatment Period 1|Protocol Violation|0|||
162918635|NCT00518531|588404879|FG000|Treatment Period 1|Withdrawal by Subject|4|||
162918636|NCT00518531|588404880|FG001|Treatment Period 1|Withdrawal by Subject|6|||
162918637|NCT00518531|588404879|FG000|Treatment Period 1|Early crossover|1|||
162918638|NCT00518531|588404880|FG001|Treatment Period 1|Early crossover|3|||
162918639|NCT00518531|588404879|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162918640|NCT00518531|588404880|FG001|Treatment Period 2|Withdrawal by Subject|8|||
162918641|NCT00518531|588404879|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
162918642|NCT00518531|588404880|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
162918643|NCT00518531|588404879|FG000|Treatment Period 2|Adverse Event|1|||
162918644|NCT00518531|588404880|FG001|Treatment Period 2|Adverse Event|7|||
162918645|NCT00518531|588404879|FG000|Treatment Period 2|Protocol-specified criteria|0|||
162918646|NCT00518531|588404880|FG001|Treatment Period 2|Protocol-specified criteria|1|||
162918647|NCT00518531|588404879|FG000|Treatment Period 2|Non-compliance|1|||
162918648|NCT00518531|588404880|FG001|Treatment Period 2|Non-compliance|2|||
162918649|NCT00457249|588404881|FG000|Overall Study|Lost to Follow-up|3|||
162918650|NCT00457249|588404882|FG001|Overall Study|Lost to Follow-up|0|||
162918651|NCT00457249|588404881|FG000|Overall Study|Protocol Violation|4|||
162918652|NCT00457249|588404882|FG001|Overall Study|Protocol Violation|1|||
162918653|NCT00457249|588404881|FG000|Overall Study|Withdrawal by Subject|3|||
162918654|NCT00457249|588404882|FG001|Overall Study|Withdrawal by Subject|1|||
162918655|NCT00457249|588404881|FG000|Overall Study|Serious Adverse Events|2|||
162918656|NCT00457249|588404882|FG001|Overall Study|Serious Adverse Events|0|||
162918657|NCT04621227|588404885|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
162918658|NCT04621227|588404885|FG000|Period 3 (29 Days)|Adverse Event|1|||
162918659|NCT04621227|588404885|FG000|Period 8 (2 Days)|Adverse Event|1|||
162918660|NCT02916056|588404886|FG000|Overall Study|Adverse Event|6|||
162918661|NCT02916056|588404886|FG000|Overall Study|Lost to Follow-up|1|||
162918662|NCT02916056|588404886|FG000|Overall Study|Other|12|||
162918663|NCT02916056|588404886|FG000|Overall Study|Protocol Violation|1|||
162918664|NCT02916056|588404886|FG000|Overall Study|Withdrawal by Subject|8|||
162918665|NCT02916056|588404886|FG000|Overall Study|Study Terminated by Sponsor|269|||
162918666|NCT00124709|588404887|FG000|Overall Study|Randomized but did not take medication|3|||
162918667|NCT00124709|588404888|FG001|Overall Study|Randomized but did not take medication|1|||
162918668|NCT00124709|588404887|FG000|Overall Study|Adverse Event|3|||
162918669|NCT00124709|588404888|FG001|Overall Study|Adverse Event|0|||
162918670|NCT00124709|588404887|FG000|Overall Study|Lack of Efficacy|5|||
162918671|NCT00124709|588404888|FG001|Overall Study|Lack of Efficacy|10|||
162918672|NCT00124709|588404887|FG000|Overall Study|Protocol Violation|3|||
162918673|NCT00124709|588404888|FG001|Overall Study|Protocol Violation|5|||
162918674|NCT00124709|588404887|FG000|Overall Study|Withdrawal by Subject|127|||
162918675|NCT00124709|588404888|FG001|Overall Study|Withdrawal by Subject|136|||
162918676|NCT00124709|588404887|FG000|Overall Study|Lost to Follow-up|114|||
162918677|NCT00124709|588404888|FG001|Overall Study|Lost to Follow-up|120|||
162918678|NCT01728376|588404889|FG000|Overall Study|Adverse Event|1|||
162918679|NCT01728376|588404890|FG001|Overall Study|Adverse Event|1|||
162918680|NCT01728376|588404891|FG002|Overall Study|Adverse Event|1|||
162918681|NCT01728376|588404892|FG003|Overall Study|Adverse Event|1|||
162918682|NCT01728376|588404893|FG004|Overall Study|Adverse Event|1|||
162918683|NCT01728376|588404894|FG005|Overall Study|Adverse Event|0|||
162918684|NCT01728376|588404889|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
162918685|NCT01728376|588404890|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
162918686|NCT01728376|588404891|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
162711207|NCT03822351|587652889|FG001|Overall Study|Death|23|||
162918687|NCT01728376|588404892|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
162918688|NCT01728376|588404893|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
162918689|NCT01728376|588404894|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
162918690|NCT01728376|588404889|FG000|Overall Study|No relevant bacteria|2|||
162918691|NCT01728376|588404890|FG001|Overall Study|No relevant bacteria|0|||
162918692|NCT01728376|588404891|FG002|Overall Study|No relevant bacteria|0|||
162918693|NCT01728376|588404892|FG003|Overall Study|No relevant bacteria|0|||
162918694|NCT01728376|588404893|FG004|Overall Study|No relevant bacteria|1|||
162918695|NCT01728376|588404894|FG005|Overall Study|No relevant bacteria|1|||
162711208|NCT03822351|587652890|FG002|Overall Study|Death|24|||
162918696|NCT01728376|588404889|FG000|Overall Study|Did not receive treatment|0|||
162918697|NCT01728376|588404890|FG001|Overall Study|Did not receive treatment|1|||
162918698|NCT01728376|588404891|FG002|Overall Study|Did not receive treatment|0|||
162918699|NCT01728376|588404892|FG003|Overall Study|Did not receive treatment|0|||
162918700|NCT01728376|588404893|FG004|Overall Study|Did not receive treatment|0|||
162918701|NCT01728376|588404894|FG005|Overall Study|Did not receive treatment|0|||
162918702|NCT01728376|588404889|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
162918703|NCT01728376|588404890|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
162918704|NCT01728376|588404891|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
162918705|NCT01728376|588404892|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
162918706|NCT01728376|588404893|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
162918707|NCT01728376|588404894|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
162918708|NCT02094573|588404896|FG000|Overall Study|Adverse Event|4|||
162918709|NCT02094573|588404897|FG001|Overall Study|Adverse Event|14|||
162918710|NCT02094573|588404896|FG000|Overall Study|Clinical Progressive Disease|9|||
162918711|NCT02094573|588404897|FG001|Overall Study|Clinical Progressive Disease|13|||
162918712|NCT02094573|588404896|FG000|Overall Study|Death|11|||
162918713|NCT02094573|588404897|FG001|Overall Study|Death|3|||
162918714|NCT02094573|588404896|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
162918715|NCT02094573|588404897|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
162918716|NCT02094573|588404896|FG000|Overall Study|Non-compliance with Study Drug|1|||
162918717|NCT02094573|588404897|FG001|Overall Study|Non-compliance with Study Drug|1|||
162918718|NCT02094573|588404896|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
162918719|NCT02094573|588404897|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
163055266|NCT01041859|588914094|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
163055267|NCT01041859|588914095|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
163055268|NCT04798027|588914096|FG000|Overall Study|Protocol Violation|0|||
162918720|NCT02094573|588404896|FG000|Overall Study|Physician Decision|4|||
162918721|NCT02094573|588404897|FG001|Overall Study|Physician Decision|4|||
162918722|NCT02094573|588404896|FG000|Overall Study|Site Terminated by Sponsor|10|||
162918723|NCT02094573|588404897|FG001|Overall Study|Site Terminated by Sponsor|17|||
162918724|NCT02094573|588404896|FG000|Overall Study|Withdrawal by Subject|6|||
162918725|NCT02094573|588404897|FG001|Overall Study|Withdrawal by Subject|8|||
162918726|NCT02094573|588404896|FG000|Overall Study|Randomized but not Treated|3|||
162918727|NCT02094573|588404897|FG001|Overall Study|Randomized but not Treated|0|||
162918728|NCT02411110|588404898|FG000|Treatment Period 1|Adverse Event|4|||
162918729|NCT02411110|588404899|FG001|Treatment Period 1|Adverse Event|2|||
162918730|NCT02411110|588404898|FG000|Treatment Period 1|Lost to Follow-up|1|||
162918731|NCT02411110|588404899|FG001|Treatment Period 1|Lost to Follow-up|0|||
162918732|NCT02411110|588404898|FG000|Treatment Period 1|Personal Reasons|2|||
162918733|NCT02411110|588404899|FG001|Treatment Period 1|Personal Reasons|5|||
162918734|NCT02411110|588404898|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
162918735|NCT02411110|588404899|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
162918736|NCT02411110|588404898|FG000|Treatment Period 2|Adverse Event|1|||
162918737|NCT02411110|588404899|FG001|Treatment Period 2|Adverse Event|0|||
162918738|NCT02411110|588404898|FG000|Treatment Period 2|Lost to Follow-up|0|||
162918739|NCT02411110|588404899|FG001|Treatment Period 2|Lost to Follow-up|2|||
162918740|NCT02411110|588404898|FG000|Treatment Period 2|Personal Reasons|0|||
162918741|NCT02411110|588404899|FG001|Treatment Period 2|Personal Reasons|2|||
162918742|NCT03985982|588404902|FG000|Double-Blind Phase|Lost to Follow-up|4|||
162918743|NCT03985982|588404903|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162918744|NCT03985982|588404904|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162918745|NCT03985982|588404902|FG000|Double-Blind Phase|Physician Decision|1|||
162918746|NCT03985982|588404903|FG001|Double-Blind Phase|Physician Decision|0|||
162918747|NCT03985982|588404904|FG002|Double-Blind Phase|Physician Decision|0|||
162711209|NCT03822351|587652888|FG000|Overall Study|Lost to Follow-up|6|||
162711210|NCT03822351|587652889|FG001|Overall Study|Lost to Follow-up|2|||
162711211|NCT03822351|587652890|FG002|Overall Study|Lost to Follow-up|1|||
162711212|NCT03822351|587652888|FG000|Overall Study|Withdrawal by Subject|10|||
162711213|NCT03822351|587652889|FG001|Overall Study|Withdrawal by Subject|4|||
162711214|NCT03822351|587652890|FG002|Overall Study|Withdrawal by Subject|6|||
162711215|NCT03822351|587652888|FG000|Overall Study|Progressive Disease|2|||
162711216|NCT03822351|587652889|FG001|Overall Study|Progressive Disease|1|||
162711217|NCT03822351|587652890|FG002|Overall Study|Progressive Disease|0|||
162711218|NCT03822351|587652888|FG000|Overall Study|Not Treated|1|||
162711219|NCT03822351|587652889|FG001|Overall Study|Not Treated|1|||
162711220|NCT03822351|587652890|FG002|Overall Study|Not Treated|1|||
162711221|NCT00768066|587652893|FG000|Overall Study|Did not receive study product injection.|3|||
162711222|NCT00768066|587652894|FG001|Overall Study|Did not receive study product injection.|3|||
162711223|NCT00768066|587652895|FG002|Overall Study|Did not receive study product injection.|0|||
162711224|NCT05550337|587652896|FG000|Overall Study|Lack of Efficacy|0|||
162711225|NCT05550337|587652897|FG001|Overall Study|Lack of Efficacy|0|||
162711226|NCT05550337|587652898|FG002|Overall Study|Lack of Efficacy|1|||
162711227|NCT05550337|587652896|FG000|Overall Study|Adverse Event|1|||
162711228|NCT05550337|587652897|FG001|Overall Study|Adverse Event|5|||
162711229|NCT05550337|587652898|FG002|Overall Study|Adverse Event|0|||
162711230|NCT05550337|587652896|FG000|Overall Study|Withdrawal by Subject|8|||
162711231|NCT05550337|587652897|FG001|Overall Study|Withdrawal by Subject|14|||
162711232|NCT05550337|587652898|FG002|Overall Study|Withdrawal by Subject|10|||
162711233|NCT05550337|587652896|FG000|Overall Study|Pregnancy|0|||
162711234|NCT05550337|587652897|FG001|Overall Study|Pregnancy|0|||
162711235|NCT05550337|587652898|FG002|Overall Study|Pregnancy|1|||
162711236|NCT05550337|587652896|FG000|Overall Study|Protocol Violation|1|||
162711237|NCT05550337|587652897|FG001|Overall Study|Protocol Violation|3|||
162711238|NCT05550337|587652898|FG002|Overall Study|Protocol Violation|4|||
162711239|NCT05550337|587652896|FG000|Overall Study|Physician Decision|2|||
162711240|NCT05550337|587652897|FG001|Overall Study|Physician Decision|1|||
162711241|NCT05550337|587652898|FG002|Overall Study|Physician Decision|1|||
162711242|NCT05550337|587652896|FG000|Overall Study|Lost to Follow-up|16|||
162711243|NCT05550337|587652897|FG001|Overall Study|Lost to Follow-up|11|||
162711244|NCT05550337|587652898|FG002|Overall Study|Lost to Follow-up|11|||
162711245|NCT02189863|587652899|FG000|First 2 Weeks|Motion Sickness|4|||
162711246|NCT02189863|587652900|FG001|First 2 Weeks|Motion Sickness|2|||
162711247|NCT02926937|587652907|FG000|Overall Study|Adverse Event|0|||
162711248|NCT02926937|587652908|FG001|Overall Study|Adverse Event|1|||
162711249|NCT02926937|587652909|FG002|Overall Study|Adverse Event|1|||
162711250|NCT02926937|587652907|FG000|Overall Study|Poor Compliance to Protocol|1|||
162711251|NCT02926937|587652908|FG001|Overall Study|Poor Compliance to Protocol|0|||
162711252|NCT02926937|587652909|FG002|Overall Study|Poor Compliance to Protocol|0|||
162711253|NCT02926937|587652907|FG000|Overall Study|Lost to Follow-up|4|||
162711254|NCT02926937|587652908|FG001|Overall Study|Lost to Follow-up|5|||
162711255|NCT02926937|587652909|FG002|Overall Study|Lost to Follow-up|0|||
162711256|NCT02926937|587652907|FG000|Overall Study|At the Participant's own Request|11|||
162711257|NCT02926937|587652908|FG001|Overall Study|At the Participant's own Request|5|||
162711258|NCT02926937|587652909|FG002|Overall Study|At the Participant's own Request|8|||
162711259|NCT02926937|587652907|FG000|Overall Study|Reason not Specified|3|||
162711260|NCT02926937|587652908|FG001|Overall Study|Reason not Specified|4|||
162711261|NCT02926937|587652909|FG002|Overall Study|Reason not Specified|2|||
162711262|NCT01559090|587652910|FG000|Stage I|Withdrawal by Subject|2|||
162711263|NCT01559090|587652911|FG001|Stage I|Withdrawal by Subject|2|||
162918748|NCT03985982|588404902|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
162918749|NCT03985982|588404903|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
162918750|NCT03985982|588404904|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
162918751|NCT03985982|588404902|FG000|Double-Blind Phase|COVID-19|1|||
162918752|NCT03985982|588404903|FG001|Double-Blind Phase|COVID-19|0|||
162918753|NCT03985982|588404904|FG002|Double-Blind Phase|COVID-19|0|||
162918754|NCT03985982|588404902|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
162918755|NCT03985982|588404903|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
162918756|NCT03985982|588404904|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
162918757|NCT03985982|588404902|FG000|Open-Label Phase|Lost to Follow-up|0|||
162969450|NCT01856192|588589969|FG001|Overall Study|Alternative therapy|3|||
162918758|NCT03985982|588404903|FG001|Open-Label Phase|Lost to Follow-up|0|||
162711264|NCT01559090|587652912|FG002|Stage I|Withdrawal by Subject|3|||
162711265|NCT01559090|587652910|FG000|Stage II|Withdrawal by Subject|1|||
162711266|NCT01559090|587652911|FG001|Stage II|Withdrawal by Subject|0|||
162711267|NCT01559090|587652912|FG002|Stage II|Withdrawal by Subject|0|||
162711268|NCT03499600|587652916|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
162711269|NCT03499600|587652917|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
162711270|NCT00561574|587652918|FG000|Overall Study|Adverse Event|21|||
162711271|NCT00561574|587652919|FG001|Overall Study|Adverse Event|24|||
162711272|NCT00561574|587652918|FG000|Overall Study|Lack of Efficacy|11|||
163055269|NCT04798027|588914097|FG001|Overall Study|Protocol Violation|0|||
163055270|NCT04798027|588914098|FG002|Overall Study|Protocol Violation|0|||
163055271|NCT04798027|588914099|FG003|Overall Study|Protocol Violation|0|||
163055272|NCT04798027|588914100|FG004|Overall Study|Protocol Violation|1|||
163055273|NCT04798027|588914101|FG005|Overall Study|Protocol Violation|0|||
163055274|NCT04798027|588914102|FG006|Overall Study|Protocol Violation|0|||
163055275|NCT04798027|588914103|FG007|Overall Study|Protocol Violation|1|||
163055276|NCT04798027|588914104|FG008|Overall Study|Protocol Violation|0|||
163055277|NCT04798027|588914096|FG000|Overall Study|Withdrawal by Subject|1|||
163055278|NCT04798027|588914097|FG001|Overall Study|Withdrawal by Subject|0|||
163055279|NCT04798027|588914098|FG002|Overall Study|Withdrawal by Subject|1|||
163055280|NCT04798027|588914099|FG003|Overall Study|Withdrawal by Subject|1|||
163055281|NCT04798027|588914100|FG004|Overall Study|Withdrawal by Subject|1|||
163055282|NCT04798027|588914101|FG005|Overall Study|Withdrawal by Subject|1|||
163055283|NCT04798027|588914102|FG006|Overall Study|Withdrawal by Subject|3|||
163055284|NCT04798027|588914103|FG007|Overall Study|Withdrawal by Subject|2|||
163055285|NCT04798027|588914104|FG008|Overall Study|Withdrawal by Subject|2|||
163055286|NCT04798027|588914096|FG000|Overall Study|Lost to Follow-up|1|||
163055287|NCT04798027|588914097|FG001|Overall Study|Lost to Follow-up|3|||
163055288|NCT04798027|588914098|FG002|Overall Study|Lost to Follow-up|0|||
163055289|NCT04798027|588914099|FG003|Overall Study|Lost to Follow-up|0|||
163055290|NCT04798027|588914100|FG004|Overall Study|Lost to Follow-up|0|||
163055291|NCT04798027|588914101|FG005|Overall Study|Lost to Follow-up|1|||
163055292|NCT04798027|588914102|FG006|Overall Study|Lost to Follow-up|0|||
163055293|NCT04798027|588914103|FG007|Overall Study|Lost to Follow-up|0|||
163055294|NCT04798027|588914104|FG008|Overall Study|Lost to Follow-up|1|||
163055295|NCT04798027|588914096|FG000|Overall Study|Withdrawal by Sponsor|8|||
163055296|NCT04798027|588914097|FG001|Overall Study|Withdrawal by Sponsor|22|||
163055297|NCT04798027|588914098|FG002|Overall Study|Withdrawal by Sponsor|9|||
163055298|NCT04798027|588914099|FG003|Overall Study|Withdrawal by Sponsor|26|||
163055299|NCT04798027|588914100|FG004|Overall Study|Withdrawal by Sponsor|24|||
163055300|NCT04798027|588914101|FG005|Overall Study|Withdrawal by Sponsor|11|||
163055301|NCT04798027|588914102|FG006|Overall Study|Withdrawal by Sponsor|25|||
163055302|NCT04798027|588914103|FG007|Overall Study|Withdrawal by Sponsor|26|||
163055303|NCT04798027|588914104|FG008|Overall Study|Withdrawal by Sponsor|11|||
163055304|NCT03087058|588914108|FG000|Overall Study|Withdrawal by Subject|2|||
163055305|NCT03087058|588914109|FG001|Overall Study|Withdrawal by Subject|0|||
163055306|NCT03087058|588914110|FG002|Overall Study|Withdrawal by Subject|0|||
163055307|NCT05158140|588914114|FG000|Overall Study|Death|0|||
163055308|NCT05158140|588914115|FG001|Overall Study|Death|0|||
163055309|NCT05158140|588914116|FG002|Overall Study|Death|0|||
163055310|NCT05158140|588914117|FG003|Overall Study|Death|1|||
163055311|NCT05158140|588914114|FG000|Overall Study|Lost to Follow-up|3|||
163055312|NCT05158140|588914115|FG001|Overall Study|Lost to Follow-up|6|||
163055313|NCT05158140|588914116|FG002|Overall Study|Lost to Follow-up|4|||
163055314|NCT05158140|588914117|FG003|Overall Study|Lost to Follow-up|3|||
163055315|NCT05158140|588914114|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163055316|NCT05158140|588914115|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163055317|NCT05158140|588914116|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
163055318|NCT05158140|588914117|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163055319|NCT05158140|588914114|FG000|Overall Study|Withdrawal by Subject|3|||
163055320|NCT05158140|588914115|FG001|Overall Study|Withdrawal by Subject|7|||
163055321|NCT05158140|588914116|FG002|Overall Study|Withdrawal by Subject|3|||
163055322|NCT05158140|588914117|FG003|Overall Study|Withdrawal by Subject|7|||
163055323|NCT00617279|588914118|FG000|Overall Study|Study terminated by Sponsor|10|||
163055324|NCT00617279|588914119|FG001|Overall Study|Study terminated by Sponsor|15|||
163055325|NCT00617279|588914118|FG000|Overall Study|Graft abandonment|2|||
163055326|NCT00617279|588914119|FG001|Overall Study|Graft abandonment|0|||
163055327|NCT00617279|588914118|FG000|Overall Study|Lost to Follow-up|1|||
163055328|NCT00617279|588914119|FG001|Overall Study|Lost to Follow-up|0|||
163055329|NCT00617279|588914118|FG000|Overall Study|Death|1|||
163055330|NCT00617279|588914119|FG001|Overall Study|Death|2|||
163055331|NCT01814007|588914121|FG000|Overall Study|Withdrawal by Subject|1|||
163055332|NCT01274351|588914122|FG000|Overall Study|Lost to Follow-up|1|||
163055333|NCT01274351|588914122|FG000|Overall Study|patient not compliant with the protocol|1|||
163055334|NCT01274351|588914122|FG000|Overall Study|Pregnancy|1|||
163055335|NCT01274351|588914122|FG000|Overall Study|Death|2|||
163055336|NCT01274351|588914122|FG000|Overall Study|Withdrawal by Subject|3|||
163055337|NCT01274351|588914122|FG000|Overall Study|Adverse Event|8|||
163055338|NCT01274351|588914122|FG000|Overall Study|progression of disease|3|||
163055339|NCT01274351|588914122|FG000|Overall Study|hospitalization|1|||
163055340|NCT03861039|588915953|FG000|Overall Study|Adverse Event|2|||
163055341|NCT03861039|588915954|FG001|Overall Study|Adverse Event|5|||
163055342|NCT03861039|588915955|FG002|Overall Study|Adverse Event|11|||
162918759|NCT03985982|588404904|FG002|Open-Label Phase|Lost to Follow-up|13|||
162918760|NCT03985982|588404902|FG000|Open-Label Phase|Physician Decision|0|||
162918761|NCT03985982|588404903|FG001|Open-Label Phase|Physician Decision|0|||
162918762|NCT03985982|588404904|FG002|Open-Label Phase|Physician Decision|2|||
162918763|NCT03985982|588404902|FG000|Open-Label Phase|Withdrawal by Subject|0|||
162918764|NCT03985982|588404903|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162918765|NCT03985982|588404904|FG002|Open-Label Phase|Withdrawal by Subject|11|||
162918766|NCT05981365|588404905|FG000|Period 1|Adverse Event|1|||
162918767|NCT05981365|588404906|FG001|Period 1|Adverse Event|0|||
162918768|NCT00643006|588404910|FG000|Overall Study|Lost to Follow-up|5|||
162918769|NCT00643006|588404911|FG001|Overall Study|Lost to Follow-up|4|||
162918770|NCT01308476|588404912|FG000|Overall Study|Lost to Follow-up|2|||
163055343|NCT03861039|588915953|FG000|Overall Study|Withdrawal by Subject|1|||
163055344|NCT03861039|588915954|FG001|Overall Study|Withdrawal by Subject|3|||
163055345|NCT03861039|588915955|FG002|Overall Study|Withdrawal by Subject|4|||
163055346|NCT01113749|588915956|FG000|Overall Study|Lost to Follow-up|1|||
163055347|NCT01113749|588915957|FG001|Overall Study|Lost to Follow-up|2|||
163055348|NCT03427892|588915958|FG000|Overall Study|Lost to Follow-up|2|||
163055349|NCT02934178|588915959|FG000|Received Vaccination 2|Death|0|||
163055350|NCT02934178|588915960|FG001|Received Vaccination 2|Death|1|||
163055351|NCT02934178|588915959|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
163055352|NCT02934178|588915960|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
163055353|NCT03944616|588915965|FG000|Overall Study|Lost to Follow-up|0|||
163055354|NCT03944616|588915966|FG001|Overall Study|Lost to Follow-up|2|||
163055355|NCT01287936|588915967|FG000|Overall Study|Lost to Follow-up|0|||
163055356|NCT01287936|588915968|FG001|Overall Study|Lost to Follow-up|1|||
163055357|NCT01287936|588915969|FG002|Overall Study|Lost to Follow-up|1|||
163055358|NCT00427934|588915971|FG000|Overall Study|Adverse Event|1|||
163055359|NCT00427934|588915972|FG001|Overall Study|Adverse Event|0|||
163055360|NCT00427934|588915973|FG002|Overall Study|Adverse Event|5|||
163055361|NCT00427934|588915974|FG003|Overall Study|Adverse Event|4|||
163055362|NCT00427934|588915971|FG000|Overall Study|Lack of Efficacy|0|||
163055363|NCT00427934|588915972|FG001|Overall Study|Lack of Efficacy|0|||
163055364|NCT00427934|588915973|FG002|Overall Study|Lack of Efficacy|5|||
163055365|NCT00427934|588915974|FG003|Overall Study|Lack of Efficacy|2|||
163055366|NCT00427934|588915971|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
163055367|NCT00427934|588915972|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
163055368|NCT00427934|588915973|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
163055369|NCT00427934|588915974|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
163055370|NCT00427934|588915971|FG000|Overall Study|Other|0|||
163055371|NCT00427934|588915972|FG001|Overall Study|Other|0|||
163055372|NCT00427934|588915973|FG002|Overall Study|Other|11|||
163055373|NCT00427934|588915974|FG003|Overall Study|Other|5|||
163055374|NCT00427934|588915971|FG000|Overall Study|Withdrawal by Subject|0|||
163055375|NCT00427934|588915972|FG001|Overall Study|Withdrawal by Subject|0|||
163055376|NCT00427934|588915973|FG002|Overall Study|Withdrawal by Subject|1|||
163055377|NCT00427934|588915974|FG003|Overall Study|Withdrawal by Subject|3|||
163055378|NCT02791269|588915975|FG000|Overall Study|Lost to Follow-up|0|||
163055379|NCT02791269|588915976|FG001|Overall Study|Lost to Follow-up|1|||
163055380|NCT02683109|588915977|FG000|Overall Study|Adverse Event|1|||
163055381|NCT02683109|588915978|FG001|Overall Study|Adverse Event|0|||
163055382|NCT00368251|588915979|FG000|Overall Study|SAE, non-fatal|1|||
163055383|NCT00368251|588915980|FG001|Overall Study|SAE, non-fatal|0|||
163055384|NCT00368251|588915981|FG002|Overall Study|SAE, non-fatal|0|||
163055385|NCT00368251|588915979|FG000|Overall Study|AE, non-serious non-fatal|0|||
163055386|NCT00368251|588915980|FG001|Overall Study|AE, non-serious non-fatal|0|||
163055387|NCT00368251|588915981|FG002|Overall Study|AE, non-serious non-fatal|1|||
163055388|NCT03617588|588915982|FG000|Overall Study|Withdrawal by Subject|1|||
163055389|NCT03617588|588915983|FG001|Overall Study|Withdrawal by Subject|0|||
163055390|NCT00784875|588915990|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
163055391|NCT00784875|588915991|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
163055392|NCT00784875|588915992|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
163055393|NCT00784875|588915993|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
163055394|NCT00784875|588915990|FG000|Period A - Baseline|Adverse Event|0|||
163055395|NCT00784875|588915991|FG001|Period A - Baseline|Adverse Event|0|||
163055396|NCT00784875|588915992|FG002|Period A - Baseline|Adverse Event|0|||
163055397|NCT00784875|588915993|FG003|Period A - Baseline|Adverse Event|8|||
163055398|NCT00784875|588915990|FG000|Period A - Baseline|Protocol Violation|0|||
163055399|NCT00784875|588915991|FG001|Period A - Baseline|Protocol Violation|0|||
163055400|NCT00784875|588915992|FG002|Period A - Baseline|Protocol Violation|0|||
163055401|NCT00784875|588915993|FG003|Period A - Baseline|Protocol Violation|25|||
163055402|NCT00784875|588915990|FG000|Period A - Baseline|Withdrawal by Subject|0|||
163055403|NCT00784875|588915991|FG001|Period A - Baseline|Withdrawal by Subject|0|||
163055404|NCT00784875|588915992|FG002|Period A - Baseline|Withdrawal by Subject|0|||
163055405|NCT00784875|588915993|FG003|Period A - Baseline|Withdrawal by Subject|27|||
163055406|NCT00784875|588915990|FG000|Period A - Baseline|Physician Decision|0|||
163055407|NCT00784875|588915991|FG001|Period A - Baseline|Physician Decision|0|||
163055408|NCT00784875|588915992|FG002|Period A - Baseline|Physician Decision|0|||
163055409|NCT00784875|588915993|FG003|Period A - Baseline|Physician Decision|2|||
163055410|NCT00784875|588915990|FG000|Period A - Baseline|Sponsor Decision|0|||
163055411|NCT00784875|588915991|FG001|Period A - Baseline|Sponsor Decision|0|||
163055412|NCT00784875|588915992|FG002|Period A - Baseline|Sponsor Decision|0|||
163055413|NCT00784875|588915993|FG003|Period A - Baseline|Sponsor Decision|113|||
163055414|NCT00784875|588915990|FG000|Period A - Baseline|Lost to Follow-up|0|||
163055415|NCT00784875|588915991|FG001|Period A - Baseline|Lost to Follow-up|0|||
163055416|NCT00784875|588915992|FG002|Period A - Baseline|Lost to Follow-up|0|||
163055417|NCT00784875|588915993|FG003|Period A - Baseline|Lost to Follow-up|2|||
163055418|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
163055419|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
163055420|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
163055421|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
163055422|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
163055423|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
163055424|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
163055425|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
163055426|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
163055427|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
163055428|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
163055429|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
163055430|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055431|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
163055432|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055433|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
163055434|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
163055435|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
163055436|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
163055437|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
163055438|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
163055439|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
163055440|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
163055441|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
163055442|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
163055443|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
163055444|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
163055445|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
163055446|NCT00784875|588915990|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055447|NCT00784875|588915991|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055448|NCT00784875|588915992|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
163055449|NCT00784875|588915993|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
163055450|NCT00784875|588915990|FG000|Period C|Adverse Event|1|||
163055451|NCT00784875|588915991|FG001|Period C|Adverse Event|0|||
163055452|NCT00784875|588915992|FG002|Period C|Adverse Event|4|||
163055453|NCT00784875|588915993|FG003|Period C|Adverse Event|2|||
163055454|NCT00784875|588915990|FG000|Period C|Protocol Violation|0|||
163055455|NCT00784875|588915991|FG001|Period C|Protocol Violation|0|||
163055456|NCT00784875|588915992|FG002|Period C|Protocol Violation|1|||
163055457|NCT00784875|588915993|FG003|Period C|Protocol Violation|2|||
163055458|NCT00784875|588915990|FG000|Period C|Lack of Efficacy|0|||
163055459|NCT00784875|588915991|FG001|Period C|Lack of Efficacy|0|||
163055460|NCT00784875|588915992|FG002|Period C|Lack of Efficacy|1|||
163055461|NCT00784875|588915993|FG003|Period C|Lack of Efficacy|0|||
163055462|NCT00784875|588915990|FG000|Period C|Withdrawal by Subject|1|||
163055463|NCT00784875|588915991|FG001|Period C|Withdrawal by Subject|1|||
163055464|NCT00784875|588915992|FG002|Period C|Withdrawal by Subject|2|||
163055465|NCT00784875|588915993|FG003|Period C|Withdrawal by Subject|0|||
163055466|NCT00784875|588915990|FG000|Period C|Physician Decision|0|||
163055467|NCT00784875|588915991|FG001|Period C|Physician Decision|0|||
163055468|NCT00784875|588915992|FG002|Period C|Physician Decision|1|||
163055469|NCT00784875|588915993|FG003|Period C|Physician Decision|1|||
163055470|NCT00784875|588915990|FG000|Period C|Sponsor Decision|5|||
163055471|NCT00784875|588915991|FG001|Period C|Sponsor Decision|5|||
163055472|NCT00784875|588915992|FG002|Period C|Sponsor Decision|4|||
163055473|NCT00784875|588915993|FG003|Period C|Sponsor Decision|2|||
163055474|NCT00784875|588915990|FG000|Period D|Adverse Event|0|||
162711273|NCT00561574|587652919|FG001|Overall Study|Lack of Efficacy|21|||
162711274|NCT00561574|587652918|FG000|Overall Study|Withdrawal by Subject|4|||
162711275|NCT00561574|587652919|FG001|Overall Study|Withdrawal by Subject|4|||
162711276|NCT00561574|587652918|FG000|Overall Study|Reason Unrelated to Trial|6|||
162711277|NCT00561574|587652919|FG001|Overall Study|Reason Unrelated to Trial|2|||
162711278|NCT00561574|587652918|FG000|Overall Study|Lost to Follow-up|1|||
162918771|NCT01308476|588404913|FG001|Overall Study|Lost to Follow-up|2|||
162918772|NCT01308476|588404912|FG000|Overall Study|Other|1|||
162918773|NCT01308476|588404913|FG001|Overall Study|Other|0|||
162918774|NCT00812968|588404916|FG000|Overall Study|Relapse after erythroid response|6|||
162918775|NCT00812968|588404916|FG000|Overall Study|Disease progression|1|||
162711279|NCT00561574|587652919|FG001|Overall Study|Lost to Follow-up|0|||
162711280|NCT00561574|587652918|FG000|Overall Study|Other|5|||
162711281|NCT00561574|587652919|FG001|Overall Study|Other|7|||
162711282|NCT03971357|587652920|FG000|Overall Study|Lack of Efficacy|0|||
162711283|NCT03971357|587652921|FG001|Overall Study|Lack of Efficacy|1|||
162711284|NCT01729871|587652922|FG000|Overall Study|Adverse Event|7|||
162918776|NCT00812968|588404916|FG000|Overall Study|No further treatment required|1|||
163055475|NCT00784875|588915991|FG001|Period D|Adverse Event|2|||
162711285|NCT01729871|587652923|FG001|Overall Study|Adverse Event|7|||
162711286|NCT01729871|587652922|FG000|Overall Study|Death|0|||
163055476|NCT00784875|588915992|FG002|Period D|Adverse Event|2|||
163055477|NCT00784875|588915993|FG003|Period D|Adverse Event|0|||
163055478|NCT00784875|588915990|FG000|Period D|Protocol Violation|1|||
163055479|NCT00784875|588915991|FG001|Period D|Protocol Violation|0|||
163055480|NCT00784875|588915992|FG002|Period D|Protocol Violation|0|||
163055481|NCT00784875|588915993|FG003|Period D|Protocol Violation|0|||
163055482|NCT00784875|588915990|FG000|Period D|Withdrawal by Subject|2|||
163055483|NCT00784875|588915991|FG001|Period D|Withdrawal by Subject|0|||
163055484|NCT00784875|588915992|FG002|Period D|Withdrawal by Subject|2|||
163055485|NCT00784875|588915993|FG003|Period D|Withdrawal by Subject|0|||
163055486|NCT00784875|588915990|FG000|Period D|Physician Decision|0|||
163055487|NCT00784875|588915991|FG001|Period D|Physician Decision|1|||
163055488|NCT00784875|588915992|FG002|Period D|Physician Decision|0|||
163055489|NCT00784875|588915993|FG003|Period D|Physician Decision|0|||
163055490|NCT00784875|588915990|FG000|Period D|Sponsor Decision|1|||
163055491|NCT00784875|588915991|FG001|Period D|Sponsor Decision|1|||
163055492|NCT00784875|588915992|FG002|Period D|Sponsor Decision|1|||
163055493|NCT00784875|588915993|FG003|Period D|Sponsor Decision|0|||
163055494|NCT00784875|588915990|FG000|Period D|Lost to Follow-up|1|||
163055495|NCT00784875|588915991|FG001|Period D|Lost to Follow-up|0|||
163055496|NCT00784875|588915992|FG002|Period D|Lost to Follow-up|1|||
163055497|NCT00784875|588915993|FG003|Period D|Lost to Follow-up|1|||
163055498|NCT02300610|588915994|FG000|Overall Study|Withdrawal by Subject|1|||
163055499|NCT02300610|588915995|FG001|Overall Study|Withdrawal by Subject|0|||
163055500|NCT02300610|588915996|FG002|Overall Study|Withdrawal by Subject|1|||
163055501|NCT02515227|588915998|FG000|Overall Study|Adverse Event|0|||
163055502|NCT02515227|588915999|FG001|Overall Study|Adverse Event|2|||
163055503|NCT02515227|588915998|FG000|Overall Study|Progressive disease|2|||
163055504|NCT02515227|588915999|FG001|Overall Study|Progressive disease|9|||
163055505|NCT02111083|588916000|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
163055506|NCT02111083|588916001|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
163055507|NCT02152007|588916002|FG000|Overall Study|Withdrawal by Subject|1|||
163055508|NCT03451071|588916013|FG000|First Vaccine|Withdrawal by Subject|1|||
163055509|NCT03451071|588916013|FG000|Second Vaccine|Lost to Follow-up|19|||
163055510|NCT03451071|588916013|FG000|Third Vaccine|Lost to Follow-up|22|||
163055511|NCT03451071|588916013|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
163055512|NCT03363906|588916018|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
163055513|NCT03363906|588916019|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
163055514|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
163055515|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
163055516|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
163055517|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
163055518|NCT03363906|588916018|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
163055519|NCT03363906|588916019|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
163055520|NCT00676143|588916020|FG000|Overall Study|Adverse Event|34|||
163055521|NCT00676143|588916021|FG001|Overall Study|Adverse Event|60|||
163055522|NCT00676143|588916020|FG000|Overall Study|Death|4|||
162711287|NCT01729871|587652923|FG001|Overall Study|Death|1|||
162711288|NCT01729871|587652922|FG000|Overall Study|Lack of Efficacy|0|||
162711289|NCT01729871|587652923|FG001|Overall Study|Lack of Efficacy|1|||
162711290|NCT01729871|587652922|FG000|Overall Study|Physician Decision|0|||
162711291|NCT01729871|587652923|FG001|Overall Study|Physician Decision|2|||
162711292|NCT01729871|587652922|FG000|Overall Study|Protocol Violation|1|||
162711293|NCT01729871|587652923|FG001|Overall Study|Protocol Violation|0|||
163055523|NCT00676143|588916021|FG001|Overall Study|Death|4|||
163055524|NCT00676143|588916020|FG000|Overall Study|Lack of Efficacy|0|||
163055525|NCT00676143|588916021|FG001|Overall Study|Lack of Efficacy|6|||
163055526|NCT00676143|588916020|FG000|Overall Study|Lost to Follow-up|0|||
162918777|NCT00812968|588404916|FG000|Overall Study|Study closed due to marketing approval|3|||
162918778|NCT00505765|588404918|FG000|Overall Study|Withdrawal by Subject|1|||
162918779|NCT00505765|588404919|FG001|Overall Study|Withdrawal by Subject|0|||
162918780|NCT00505765|588404920|FG002|Overall Study|Withdrawal by Subject|0|||
162918781|NCT00505765|588404918|FG000|Overall Study|Adverse Event|1|||
162918782|NCT00505765|588404919|FG001|Overall Study|Adverse Event|2|||
162918783|NCT00505765|588404920|FG002|Overall Study|Adverse Event|0|||
162918784|NCT00505765|588404918|FG000|Overall Study|Noncompliance|0|||
162918785|NCT00505765|588404919|FG001|Overall Study|Noncompliance|1|||
162918786|NCT00505765|588404920|FG002|Overall Study|Noncompliance|3|||
162918787|NCT01207219|588404922|FG000|Overall Study|changed diagnosis during study period|5|||
162969451|NCT01856192|588589968|FG000|Overall Study|Death|3|||
162969452|NCT01856192|588589969|FG001|Overall Study|Death|5|||
162969453|NCT01856192|588589968|FG000|Overall Study|Lack of Efficacy|0|||
162969454|NCT01856192|588589969|FG001|Overall Study|Lack of Efficacy|5|||
162969455|NCT01856192|588589968|FG000|Overall Study|Withdrawal by Subject|1|||
162969456|NCT01856192|588589969|FG001|Overall Study|Withdrawal by Subject|1|||
162969457|NCT01856192|588589968|FG000|Overall Study|Other diseases|1|||
162969458|NCT01856192|588589969|FG001|Overall Study|Other diseases|0|||
162969459|NCT01856192|588589968|FG000|Overall Study|Never started treatment|7|||
162969460|NCT01856192|588589969|FG001|Overall Study|Never started treatment|5|||
162969461|NCT01856192|588589968|FG000|Overall Study|Path ineligible|20|||
162969462|NCT01856192|588589969|FG001|Overall Study|Path ineligible|34|||
162969463|NCT01856192|588589968|FG000|Overall Study|Non-path ineligible|2|||
162969464|NCT01856192|588589969|FG001|Overall Study|Non-path ineligible|2|||
162969465|NCT01856192|588589968|FG000|Overall Study|Physician Decision|1|||
162969466|NCT01856192|588589969|FG001|Overall Study|Physician Decision|1|||
162969467|NCT01856192|588589968|FG000|Overall Study|Suspicion of progressive disease|1|||
162969468|NCT01856192|588589969|FG001|Overall Study|Suspicion of progressive disease|0|||
162969469|NCT01856192|588589968|FG000|Overall Study|Non-compliance|1|||
162969470|NCT01856192|588589969|FG001|Overall Study|Non-compliance|0|||
162969471|NCT00098475|588589970|FG000|Step 1|Progressive disease|33|||
162969472|NCT00098475|588589971|FG001|Step 1|Progressive disease|35|||
162969473|NCT00098475|588589972|FG002|Step 1|Progressive disease|2|||
162969474|NCT00098475|588589973|FG003|Step 1|Progressive disease|1|||
162969475|NCT00098475|588589970|FG000|Step 1|Adverse Event|56|||
162969476|NCT00098475|588589971|FG001|Step 1|Adverse Event|37|||
162969477|NCT00098475|588589972|FG002|Step 1|Adverse Event|0|||
162969478|NCT00098475|588589973|FG003|Step 1|Adverse Event|1|||
162969479|NCT00098475|588589970|FG000|Step 1|Death|8|||
162969480|NCT00098475|588589971|FG001|Step 1|Death|5|||
163055527|NCT00676143|588916021|FG001|Overall Study|Lost to Follow-up|13|||
163055528|NCT00676143|588916020|FG000|Overall Study|Physician Decision|5|||
163055529|NCT00676143|588916021|FG001|Overall Study|Physician Decision|8|||
163055530|NCT00676143|588916020|FG000|Overall Study|Protocol Violation|4|||
163055531|NCT00676143|588916021|FG001|Overall Study|Protocol Violation|8|||
162629210|NCT02244606|587361034|FG001|Overall Study|Protocol Violation|0|||
162629211|NCT02244606|587361035|FG002|Overall Study|Protocol Violation|0|||
162629212|NCT02244606|587361036|FG003|Overall Study|Protocol Violation|1|||
162918788|NCT01207219|588404923|FG001|Overall Study|changed diagnosis during study period|3|||
162969481|NCT00098475|588589972|FG002|Step 1|Death|0|||
162629213|NCT02244606|587361033|FG000|Overall Study|Withdrawal by Subject|1|||
162969482|NCT00098475|588589973|FG003|Step 1|Death|1|||
162969483|NCT00098475|588589970|FG000|Step 1|Withdrawal by Subject|14|||
162969484|NCT00098475|588589971|FG001|Step 1|Withdrawal by Subject|11|||
162969485|NCT00098475|588589972|FG002|Step 1|Withdrawal by Subject|0|||
162969486|NCT00098475|588589973|FG003|Step 1|Withdrawal by Subject|0|||
162969487|NCT00098475|588589970|FG000|Step 1|Physician Decision|5|||
162969488|NCT00098475|588589971|FG001|Step 1|Physician Decision|2|||
163055532|NCT00676143|588916020|FG000|Overall Study|Withdrawal by Subject|24|||
163055533|NCT00676143|588916021|FG001|Overall Study|Withdrawal by Subject|42|||
163055534|NCT00676143|588916020|FG000|Overall Study|Discontinuation of study by sponsor|65|||
163055535|NCT00676143|588916021|FG001|Overall Study|Discontinuation of study by sponsor|88|||
163055536|NCT00676143|588916020|FG000|Overall Study|Failed to return|2|||
163055537|NCT00676143|588916021|FG001|Overall Study|Failed to return|1|||
163055538|NCT00676143|588916020|FG000|Overall Study|Loss of caregiver|5|||
163055539|NCT00676143|588916021|FG001|Overall Study|Loss of caregiver|3|||
163055540|NCT00676143|588916020|FG000|Overall Study|Other|11|||
163055541|NCT00676143|588916021|FG001|Overall Study|Other|20|||
163055542|NCT00676143|588916020|FG000|Overall Study|Participant participation unknown|1|||
163055543|NCT00676143|588916021|FG001|Overall Study|Participant participation unknown|4|||
163055544|NCT00676143|588916020|FG000|Overall Study|Vasogenic edema recurrence|1|||
163055545|NCT00676143|588916021|FG001|Overall Study|Vasogenic edema recurrence|3|||
163055546|NCT00929669|588916022|FG000|Overall Study|elevated glucose levels|1|||
163055547|NCT02714153|588916024|FG000|Overall Study|Death|1|||
163055548|NCT00686972|588916025|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
163055549|NCT01901185|588916026|FG000|Overall Study|Withdrawal by Subject|2|||
163055550|NCT00250588|588916029|FG000|Overall Study|Withdrawal by Subject|3|||
163055551|NCT00250588|588916030|FG001|Overall Study|Withdrawal by Subject|6|||
163055552|NCT00250588|588916031|FG002|Overall Study|Withdrawal by Subject|0|||
163055553|NCT00250588|588916029|FG000|Overall Study|Lost to Follow-up|6|||
163055554|NCT00250588|588916030|FG001|Overall Study|Lost to Follow-up|13|||
163055555|NCT00250588|588916031|FG002|Overall Study|Lost to Follow-up|13|||
163055556|NCT00706797|588916032|FG000|Overall Study|Lack of Efficacy|3|||
163055557|NCT00706797|588916033|FG001|Overall Study|Lack of Efficacy|0|||
163055558|NCT00706797|588916032|FG000|Overall Study|Adverse Event|0|||
163055559|NCT00706797|588916033|FG001|Overall Study|Adverse Event|3|||
163055560|NCT00706797|588916032|FG000|Overall Study|Withdrawal by Subject|8|||
163055561|NCT00706797|588916033|FG001|Overall Study|Withdrawal by Subject|1|||
163055562|NCT00706797|588916032|FG000|Overall Study|Death|1|||
163055563|NCT00706797|588916033|FG001|Overall Study|Death|0|||
163055564|NCT00706797|588916032|FG000|Overall Study|Discontinuation of study by sponsor|52|||
163055565|NCT00706797|588916033|FG001|Overall Study|Discontinuation of study by sponsor|63|||
163055566|NCT00706797|588916032|FG000|Overall Study|Protocol Violation|3|||
163055567|NCT00706797|588916033|FG001|Overall Study|Protocol Violation|2|||
163055568|NCT00706797|588916032|FG000|Overall Study|Lost to Follow-up|1|||
163055569|NCT00706797|588916033|FG001|Overall Study|Lost to Follow-up|2|||
163055570|NCT00706797|588916032|FG000|Overall Study|Other|1|||
163055571|NCT00706797|588916033|FG001|Overall Study|Other|0|||
163055572|NCT01670292|588916036|FG000|Overall Study|Lost to Follow-up|14|||
163055573|NCT03555149|588916040|FG000|Overall Study|Death|18|||
163055574|NCT03555149|588916041|FG001|Overall Study|Death|15|||
163055575|NCT03555149|588916042|FG002|Overall Study|Death|15|||
163055576|NCT03555149|588916043|FG003|Overall Study|Death|4|||
163055577|NCT03555149|588916044|FG004|Overall Study|Death|4|||
163055578|NCT03555149|588916045|FG005|Overall Study|Death|11|||
163055579|NCT03555149|588916046|FG006|Overall Study|Death|12|||
163055580|NCT03555149|588916047|FG007|Overall Study|Death|1|||
163055581|NCT03555149|588916040|FG000|Overall Study|Lost to Follow-up|1|||
163055582|NCT03555149|588916041|FG001|Overall Study|Lost to Follow-up|0|||
162711294|NCT01729871|587652922|FG000|Overall Study|Withdrawal by Subject|0|||
163055583|NCT03555149|588916042|FG002|Overall Study|Lost to Follow-up|0|||
163055584|NCT03555149|588916043|FG003|Overall Study|Lost to Follow-up|0|||
163055585|NCT03555149|588916044|FG004|Overall Study|Lost to Follow-up|0|||
163055586|NCT03555149|588916045|FG005|Overall Study|Lost to Follow-up|1|||
163055587|NCT03555149|588916046|FG006|Overall Study|Lost to Follow-up|0|||
163055588|NCT03555149|588916047|FG007|Overall Study|Lost to Follow-up|0|||
163055589|NCT03555149|588916040|FG000|Overall Study|Physician Decision|1|||
163055590|NCT03555149|588916041|FG001|Overall Study|Physician Decision|0|||
163055591|NCT03555149|588916042|FG002|Overall Study|Physician Decision|0|||
163055592|NCT03555149|588916043|FG003|Overall Study|Physician Decision|0|||
162711295|NCT01729871|587652923|FG001|Overall Study|Withdrawal by Subject|3|||
162711296|NCT01729871|587652922|FG000|Overall Study|Other|4|||
162711297|NCT01729871|587652923|FG001|Overall Study|Other|9|||
162711298|NCT00445692|587652924|FG000|Overall Study|Adverse Event|11|||
162711299|NCT00445692|587652924|FG000|Overall Study|Lack of Efficacy|5|||
162711300|NCT01143077|587652928|FG000|Overall Study|Lack of Efficacy|0|||
162711301|NCT01143077|587652929|FG001|Overall Study|Lack of Efficacy|2|||
162711302|NCT01143077|587652930|FG002|Overall Study|Lack of Efficacy|1|||
162711303|NCT01143077|587652928|FG000|Overall Study|Adverse Event|5|||
162711304|NCT01143077|587652929|FG001|Overall Study|Adverse Event|6|||
162711305|NCT01143077|587652930|FG002|Overall Study|Adverse Event|5|||
162711306|NCT01143077|587652928|FG000|Overall Study|Lost to Follow-up|2|||
162711307|NCT01143077|587652929|FG001|Overall Study|Lost to Follow-up|3|||
162711308|NCT01143077|587652930|FG002|Overall Study|Lost to Follow-up|4|||
162711309|NCT01143077|587652928|FG000|Overall Study|Protocol Violation|2|||
162711310|NCT01143077|587652929|FG001|Overall Study|Protocol Violation|0|||
162711311|NCT01143077|587652930|FG002|Overall Study|Protocol Violation|0|||
162918789|NCT01207219|588404924|FG002|Overall Study|changed diagnosis during study period|1|||
162918790|NCT01207219|588404922|FG000|Overall Study|Lost to Follow-up|6|||
162918791|NCT01207219|588404923|FG001|Overall Study|Lost to Follow-up|8|||
162918792|NCT01207219|588404924|FG002|Overall Study|Lost to Follow-up|6|||
162918793|NCT01012609|588404925|FG000|Overall Study|Withdrawal by Subject|1|||
162918794|NCT01012609|588404926|FG001|Overall Study|Withdrawal by Subject|1|||
162918795|NCT01453296|588404927|FG000|Treatment Period 1|Adverse Event|0|||
162918796|NCT01453296|588404928|FG001|Treatment Period 1|Adverse Event|1|||
162918797|NCT01453296|588404927|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
162918798|NCT01453296|588404928|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
162918799|NCT01453296|588404927|FG000|Treatment Period 2|Adverse Event|1|||
162918800|NCT01453296|588404928|FG001|Treatment Period 2|Adverse Event|0|||
162918801|NCT01453296|588404927|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162918802|NCT01453296|588404928|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162918803|NCT00924820|588404930|FG000|Overall Study|Death|2|||
162918804|NCT00924820|588404930|FG000|Overall Study|Ineligible, Screen Failure|5|||
162918805|NCT03205046|588404933|FG000|Overall Study|Death|10|||
162918806|NCT03205046|588404934|FG001|Overall Study|Death|6|||
162918807|NCT03205046|588404933|FG000|Overall Study|Withdrawal by Subject|1|||
162918808|NCT03205046|588404934|FG001|Overall Study|Withdrawal by Subject|2|||
162918809|NCT03205046|588404933|FG000|Overall Study|Lost to Follow-up|0|||
162918810|NCT03205046|588404934|FG001|Overall Study|Lost to Follow-up|1|||
162918811|NCT03205046|588404933|FG000|Overall Study|Study terminated by sponsor|2|||
162918812|NCT03205046|588404934|FG001|Overall Study|Study terminated by sponsor|1|||
162918813|NCT01068418|588404935|FG000|Overall Study|Physician Decision|12|||
162918814|NCT00402298|588404936|FG000|Overall Study|Withdrawal by Subject|1|||
162918815|NCT00402298|588404937|FG001|Overall Study|Withdrawal by Subject|0|||
162918816|NCT00480077|588404938|FG000|Overall Study|Death|19|||
162918817|NCT00480077|588404939|FG001|Overall Study|Death|15|||
162918818|NCT00480077|588404938|FG000|Overall Study|early exit|12|||
162918819|NCT00480077|588404939|FG001|Overall Study|early exit|11|||
162918820|NCT00938366|588404944|FG000|Overall Study|Withdrawal by Subject|1|||
162918821|NCT00938366|588404945|FG001|Overall Study|Withdrawal by Subject|0|||
162918822|NCT01215968|588404946|FG000|Overall Study|Adverse Event|0|||
162918823|NCT01215968|588404947|FG001|Overall Study|Adverse Event|2|||
162918824|NCT01215968|588404946|FG000|Overall Study|Protocol Violation|2|||
162918825|NCT01215968|588404947|FG001|Overall Study|Protocol Violation|4|||
162918826|NCT01215968|588404946|FG000|Overall Study|Not received study drug|0|||
162918827|NCT01215968|588404947|FG001|Overall Study|Not received study drug|1|||
162918828|NCT05966129|588404948|FG000|Overall Study|Death|1|||
162918829|NCT05966129|588404949|FG001|Overall Study|Death|2|||
162918830|NCT05966129|588404948|FG000|Overall Study|Lost to Follow-up|63|||
162918831|NCT05966129|588404949|FG001|Overall Study|Lost to Follow-up|66|||
162918832|NCT05966129|588404948|FG000|Overall Study|Protocol Violation|1|||
162918833|NCT05966129|588404949|FG001|Overall Study|Protocol Violation|0|||
162918834|NCT05966129|588404948|FG000|Overall Study|Withdrawal by Subject|26|||
162969489|NCT00098475|588589972|FG002|Step 1|Physician Decision|0|||
162918835|NCT05966129|588404949|FG001|Overall Study|Withdrawal by Subject|25|||
162918836|NCT05966129|588404948|FG000|Overall Study|Surgery not completed|63|||
162918837|NCT05966129|588404949|FG001|Overall Study|Surgery not completed|69|||
162918838|NCT05966129|588404948|FG000|Overall Study|Surgery logistics issue|2|||
162918839|NCT05966129|588404949|FG001|Overall Study|Surgery logistics issue|1|||
162918840|NCT05182840|588404950|FG000|Run-in Period|Not treated|0|||
162918841|NCT05182840|588404951|FG001|Run-in Period|Not treated|1|||
162918842|NCT05182840|588404952|FG002|Run-in Period|Not treated|0|||
162918843|NCT05182840|588404953|FG003|Run-in Period|Not treated|0|||
162918844|NCT05182840|588404954|FG004|Run-in Period|Not treated|0|||
162918845|NCT05182840|588404955|FG005|Run-in Period|Not treated|0|||
162918846|NCT05182840|588404956|FG006|Run-in Period|Not treated|0|||
162918847|NCT05182840|588404957|FG007|Run-in Period|Not treated|0|||
162918848|NCT05182840|588404958|FG008|Run-in Period|Not treated|0|||
162918849|NCT05182840|588404959|FG009|Run-in Period|Not treated|0|||
162969490|NCT00098475|588589973|FG003|Step 1|Physician Decision|0|||
162969491|NCT00098475|588589970|FG000|Step 1|Alternative therapy|31|||
162918850|NCT05182840|588404950|FG000|Run-in Period|Other reason but not sponsor termination|14|||
162918851|NCT05182840|588404951|FG001|Run-in Period|Other reason but not sponsor termination|18|||
162918852|NCT05182840|588404952|FG002|Run-in Period|Other reason but not sponsor termination|0|||
162918853|NCT05182840|588404953|FG003|Run-in Period|Other reason but not sponsor termination|0|||
162918854|NCT05182840|588404954|FG004|Run-in Period|Other reason but not sponsor termination|0|||
162629214|NCT02244606|587361034|FG001|Overall Study|Withdrawal by Subject|1|||
162629215|NCT02244606|587361035|FG002|Overall Study|Withdrawal by Subject|0|||
162629216|NCT02244606|587361036|FG003|Overall Study|Withdrawal by Subject|0|||
162629217|NCT02244606|587361033|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
162629218|NCT02244606|587361034|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
162629219|NCT02244606|587361035|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
162629220|NCT02244606|587361036|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
162629221|NCT02321800|587361042|FG000|Overall Study|Withdrawal by Subject|3|||
162629222|NCT02321800|587361043|FG001|Overall Study|Withdrawal by Subject|3|||
162629223|NCT02321800|587361042|FG000|Overall Study|Death|1|||
162629224|NCT02321800|587361043|FG001|Overall Study|Death|0|||
162629225|NCT02321800|587361042|FG000|Overall Study|Protocol Violation|1|||
162629226|NCT02321800|587361043|FG001|Overall Study|Protocol Violation|0|||
162629227|NCT02321800|587361042|FG000|Overall Study|Lost to Follow-up|10|||
162629228|NCT02321800|587361043|FG001|Overall Study|Lost to Follow-up|4|||
162629229|NCT02321800|587361042|FG000|Overall Study|Adverse Event|2|||
162629230|NCT02321800|587361043|FG001|Overall Study|Adverse Event|3|||
162629231|NCT02321800|587361042|FG000|Overall Study|Other, Miscellaneous|3|||
162629232|NCT02321800|587361043|FG001|Overall Study|Other, Miscellaneous|1|||
162629233|NCT00982878|587361047|FG000|Overall Study|Physician Decision|1|||
162629234|NCT00642460|587361052|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
162629235|NCT00642460|587361053|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
162629236|NCT00642460|587361054|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
162629237|NCT00642460|587361055|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
162629238|NCT00642460|587361056|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
162629239|NCT00642460|587361057|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
162629240|NCT00642460|587361052|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
162629241|NCT00642460|587361053|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162629242|NCT00642460|587361054|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162629243|NCT00642460|587361055|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162629244|NCT00642460|587361056|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162629245|NCT00642460|587361057|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162629246|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
162629247|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
162629248|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162629249|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162629250|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162629251|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162629252|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Death|0|||
162629253|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Death|1|||
162629254|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Death|0|||
162629255|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Death|2|||
162629256|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Death|0|||
162629257|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Death|0|||
162711312|NCT01143077|587652928|FG000|Overall Study|Withdrawal by Subject|4|||
162711313|NCT01143077|587652929|FG001|Overall Study|Withdrawal by Subject|3|||
162711314|NCT01143077|587652930|FG002|Overall Study|Withdrawal by Subject|3|||
162711315|NCT01143077|587652928|FG000|Overall Study|Non-compliance with study drug|0|||
162918855|NCT05182840|588404955|FG005|Run-in Period|Other reason but not sponsor termination|0|||
162918856|NCT05182840|588404956|FG006|Run-in Period|Other reason but not sponsor termination|0|||
162918857|NCT05182840|588404957|FG007|Run-in Period|Other reason but not sponsor termination|0|||
162918858|NCT05182840|588404958|FG008|Run-in Period|Other reason but not sponsor termination|0|||
162918859|NCT05182840|588404959|FG009|Run-in Period|Other reason but not sponsor termination|0|||
162918860|NCT05182840|588404950|FG000|Run-in Period|No reason available|2|||
162918861|NCT05182840|588404951|FG001|Run-in Period|No reason available|2|||
162918862|NCT05182840|588404952|FG002|Run-in Period|No reason available|0|||
162918863|NCT05182840|588404953|FG003|Run-in Period|No reason available|0|||
162918864|NCT05182840|588404954|FG004|Run-in Period|No reason available|0|||
162918865|NCT05182840|588404955|FG005|Run-in Period|No reason available|0|||
162969492|NCT00098475|588589971|FG001|Step 1|Alternative therapy|43|||
162629258|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
162629259|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
162629260|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162629261|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162629262|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162918866|NCT05182840|588404956|FG006|Run-in Period|No reason available|0|||
162969493|NCT00098475|588589972|FG002|Step 1|Alternative therapy|1|||
162711316|NCT01143077|587652929|FG001|Overall Study|Non-compliance with study drug|1|||
162711317|NCT01143077|587652930|FG002|Overall Study|Non-compliance with study drug|1|||
162711318|NCT01143077|587652928|FG000|Overall Study|Administrative|1|||
162711319|NCT01143077|587652929|FG001|Overall Study|Administrative|0|||
162711320|NCT01143077|587652930|FG002|Overall Study|Administrative|0|||
162711321|NCT01143077|587652928|FG000|Overall Study|Principal Investigator Decision|2|||
162711322|NCT01143077|587652929|FG001|Overall Study|Principal Investigator Decision|0|||
162711323|NCT01143077|587652930|FG002|Overall Study|Principal Investigator Decision|1|||
162711324|NCT00681811|587652938|FG000|Overall Study|Adverse Event|1|||
162711325|NCT00681811|587652939|FG001|Overall Study|Adverse Event|1|||
162711326|NCT00681811|587652938|FG000|Overall Study|Withdrawal by Subject|2|||
162711327|NCT00681811|587652939|FG001|Overall Study|Withdrawal by Subject|2|||
162711328|NCT00681811|587652938|FG000|Overall Study|Non-compliance|0|||
162711329|NCT00681811|587652939|FG001|Overall Study|Non-compliance|1|||
162711330|NCT01140347|587652946|FG000|Overall Study|Lost to Follow-up|5|||
162711331|NCT01140347|587652947|FG001|Overall Study|Lost to Follow-up|6|||
162711332|NCT01140347|587652946|FG000|Overall Study|Withdrawal by Subject|13|||
162711333|NCT01140347|587652947|FG001|Overall Study|Withdrawal by Subject|8|||
162711334|NCT00828919|587652948|FG000|Overall Study|Death|0|||
162711335|NCT00828919|587652949|FG001|Overall Study|Death|1|||
162711336|NCT00828919|587652950|FG002|Overall Study|Death|2|||
162711337|NCT00828919|587652951|FG003|Overall Study|Death|0|||
162711338|NCT00828919|587652952|FG004|Overall Study|Death|0|||
162711339|NCT00828919|587652948|FG000|Overall Study|Adverse Event|2|||
162711340|NCT00828919|587652949|FG001|Overall Study|Adverse Event|2|||
162711341|NCT00828919|587652950|FG002|Overall Study|Adverse Event|2|||
162711342|NCT00828919|587652951|FG003|Overall Study|Adverse Event|1|||
162711343|NCT00828919|587652952|FG004|Overall Study|Adverse Event|3|||
162711344|NCT00828919|587652948|FG000|Overall Study|Objective progression or relapse|4|||
162711345|NCT00828919|587652949|FG001|Overall Study|Objective progression or relapse|4|||
162711346|NCT00828919|587652950|FG002|Overall Study|Objective progression or relapse|11|||
162711347|NCT00828919|587652951|FG003|Overall Study|Objective progression or relapse|0|||
162711348|NCT00828919|587652952|FG004|Overall Study|Objective progression or relapse|5|||
162711349|NCT00828919|587652948|FG000|Overall Study|No longer willing to participate in study|0|||
162711350|NCT00828919|587652949|FG001|Overall Study|No longer willing to participate in study|0|||
162711351|NCT00828919|587652950|FG002|Overall Study|No longer willing to participate in study|2|||
162711352|NCT00828919|587652951|FG003|Overall Study|No longer willing to participate in study|0|||
162711353|NCT00828919|587652952|FG004|Overall Study|No longer willing to participate in study|0|||
162711354|NCT00828919|587652948|FG000|Overall Study|Insufficient Clinical Response|0|||
162711355|NCT00828919|587652949|FG001|Overall Study|Insufficient Clinical Response|1|||
162711356|NCT00828919|587652950|FG002|Overall Study|Insufficient Clinical Response|2|||
162711357|NCT00828919|587652951|FG003|Overall Study|Insufficient Clinical Response|0|||
162711358|NCT00828919|587652952|FG004|Overall Study|Insufficient Clinical Response|0|||
162711359|NCT00828919|587652948|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162711360|NCT00828919|587652949|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162711361|NCT00828919|587652950|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162711362|NCT00828919|587652951|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162711363|NCT00828919|587652952|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
162711364|NCT00828919|587652948|FG000|Overall Study|Other|1|||
162711365|NCT00828919|587652949|FG001|Overall Study|Other|0|||
162711366|NCT00828919|587652950|FG002|Overall Study|Other|1|||
162711367|NCT00828919|587652951|FG003|Overall Study|Other|1|||
162711368|NCT00828919|587652952|FG004|Overall Study|Other|0|||
162711369|NCT00828919|587652948|FG000|Overall Study|Lost to Follow-up|0|||
162711370|NCT00828919|587652949|FG001|Overall Study|Lost to Follow-up|1|||
162711371|NCT00828919|587652950|FG002|Overall Study|Lost to Follow-up|0|||
162711372|NCT00828919|587652951|FG003|Overall Study|Lost to Follow-up|0|||
162711373|NCT00828919|587652952|FG004|Overall Study|Lost to Follow-up|0|||
162711374|NCT05567159|587652953|FG000|Overall Study|Adverse Event|4|||
162711375|NCT05567159|587652953|FG000|Overall Study|Physician Decision|3|||
162711376|NCT05567159|587652953|FG000|Overall Study|Protocol deviation|1|||
162711377|NCT01259102|587654813|FG000|Overall Study|Adverse Event|1|||
162711378|NCT01259102|587654814|FG001|Overall Study|Adverse Event|0|||
162711379|NCT01259102|587654815|FG002|Overall Study|Adverse Event|1|||
162711380|NCT01259102|587654816|FG003|Overall Study|Adverse Event|1|||
162918867|NCT05182840|588404957|FG007|Run-in Period|No reason available|0|||
162918868|NCT05182840|588404958|FG008|Run-in Period|No reason available|0|||
162918869|NCT05182840|588404959|FG009|Run-in Period|No reason available|0|||
162711381|NCT01259102|587654817|FG004|Overall Study|Adverse Event|0|||
162711382|NCT01259102|587654813|FG000|Overall Study|Other|0|||
162711383|NCT01259102|587654814|FG001|Overall Study|Other|0|||
162711384|NCT01259102|587654815|FG002|Overall Study|Other|1|||
162711385|NCT01259102|587654816|FG003|Overall Study|Other|1|||
162918870|NCT05182840|588404950|FG000|Run-in Period|Burden of study procedures|2|||
162918871|NCT05182840|588404951|FG001|Run-in Period|Burden of study procedures|2|||
162711386|NCT01259102|587654817|FG004|Overall Study|Other|1|||
162711387|NCT00817635|587654818|FG000|Overall Study|Adverse Event|1|||
162711388|NCT00817635|587654819|FG001|Overall Study|Adverse Event|0|||
162711389|NCT00817635|587654820|FG002|Overall Study|Adverse Event|0|||
162711390|NCT00817635|587654821|FG003|Overall Study|Adverse Event|1|||
162711391|NCT00817635|587654822|FG004|Overall Study|Adverse Event|1|||
162711392|NCT00817635|587654818|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162711393|NCT00817635|587654819|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162711394|NCT00817635|587654820|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162711395|NCT00817635|587654821|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
162711396|NCT00817635|587654822|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
162711397|NCT00817635|587654818|FG000|Overall Study|Withdrawal by Subject|2|||
162711398|NCT00817635|587654819|FG001|Overall Study|Withdrawal by Subject|1|||
162711399|NCT00817635|587654820|FG002|Overall Study|Withdrawal by Subject|0|||
162711400|NCT00817635|587654821|FG003|Overall Study|Withdrawal by Subject|1|||
162711401|NCT00817635|587654822|FG004|Overall Study|Withdrawal by Subject|2|||
162711402|NCT00817635|587654818|FG000|Overall Study|Lost to Follow-up|0|||
162711403|NCT00817635|587654819|FG001|Overall Study|Lost to Follow-up|1|||
162711404|NCT00817635|587654820|FG002|Overall Study|Lost to Follow-up|0|||
162711405|NCT00817635|587654821|FG003|Overall Study|Lost to Follow-up|1|||
162711406|NCT00817635|587654822|FG004|Overall Study|Lost to Follow-up|0|||
162711407|NCT00817635|587654818|FG000|Overall Study|Administrative Problems|0|||
162711408|NCT00817635|587654819|FG001|Overall Study|Administrative Problems|0|||
162711409|NCT00817635|587654820|FG002|Overall Study|Administrative Problems|0|||
162711410|NCT00817635|587654821|FG003|Overall Study|Administrative Problems|0|||
162711411|NCT00817635|587654822|FG004|Overall Study|Administrative Problems|1|||
162711412|NCT00817635|587654818|FG000|Overall Study|Protocol Violation|5|||
162711413|NCT00817635|587654819|FG001|Overall Study|Protocol Violation|1|||
162711414|NCT00817635|587654820|FG002|Overall Study|Protocol Violation|3|||
162711415|NCT00817635|587654821|FG003|Overall Study|Protocol Violation|2|||
162711416|NCT00817635|587654822|FG004|Overall Study|Protocol Violation|3|||
162711417|NCT00918957|587654824|FG000|Overall Study|Adverse Event|2|||
162711418|NCT00918957|587654825|FG001|Overall Study|Adverse Event|0|||
162711419|NCT00918957|587654824|FG000|Overall Study|Withdrawal by Subject|1|||
162711420|NCT00918957|587654825|FG001|Overall Study|Withdrawal by Subject|0|||
162711421|NCT03107611|587654826|FG000|Overall Study|Adverse Event|1|||
162711422|NCT03107611|587654827|FG001|Overall Study|Adverse Event|0|||
162711423|NCT03107611|587654828|FG002|Overall Study|Adverse Event|2|||
162711424|NCT03107611|587654826|FG000|Overall Study|Lost to Follow-up|3|||
162711425|NCT03107611|587654827|FG001|Overall Study|Lost to Follow-up|3|||
162711426|NCT03107611|587654828|FG002|Overall Study|Lost to Follow-up|3|||
162711427|NCT03107611|587654826|FG000|Overall Study|Protocol Violation|0|||
162711428|NCT03107611|587654827|FG001|Overall Study|Protocol Violation|0|||
162711429|NCT03107611|587654828|FG002|Overall Study|Protocol Violation|1|||
162711430|NCT03107611|587654826|FG000|Overall Study|Withdrawal by Subject|1|||
162711431|NCT03107611|587654827|FG001|Overall Study|Withdrawal by Subject|0|||
162711432|NCT03107611|587654828|FG002|Overall Study|Withdrawal by Subject|1|||
162711433|NCT03107611|587654826|FG000|Overall Study|Worsening signs/symptoms|2|||
162711434|NCT03107611|587654827|FG001|Overall Study|Worsening signs/symptoms|1|||
162711435|NCT03107611|587654828|FG002|Overall Study|Worsening signs/symptoms|2|||
162711436|NCT01720446|587654829|FG000|Overall Study|Lost to Follow-up|12|||
162711437|NCT01720446|587654830|FG001|Overall Study|Lost to Follow-up|6|||
162711438|NCT01720446|587654831|FG002|Overall Study|Lost to Follow-up|16|||
162711439|NCT01720446|587654832|FG003|Overall Study|Lost to Follow-up|16|||
162711440|NCT01720446|587654829|FG000|Overall Study|Withdrawal by Subject|2|||
162711441|NCT01720446|587654830|FG001|Overall Study|Withdrawal by Subject|5|||
162711442|NCT01720446|587654831|FG002|Overall Study|Withdrawal by Subject|4|||
162711443|NCT01720446|587654832|FG003|Overall Study|Withdrawal by Subject|4|||
162711444|NCT01020838|587654835|FG000|Overall Study|Death|90|||
162711445|NCT01020838|587654835|FG000|Overall Study|Adverse Event|1|||
162918872|NCT05182840|588404952|FG002|Run-in Period|Burden of study procedures|0|||
162918873|NCT05182840|588404953|FG003|Run-in Period|Burden of study procedures|0|||
162918874|NCT05182840|588404954|FG004|Run-in Period|Burden of study procedures|0|||
162918875|NCT05182840|588404955|FG005|Run-in Period|Burden of study procedures|0|||
162711446|NCT01020838|587654835|FG000|Overall Study|Withdrawal by Subject|9|||
162711447|NCT01020838|587654835|FG000|Overall Study|Lost to Follow-up|6|||
162711448|NCT01020838|587654835|FG000|Overall Study|Most common: Study ended by sponsor|77|||
162711449|NCT04176458|587654836|FG000|Overall Study|Covid 19|4|||
162711450|NCT00891618|587654837|FG000|Overall Study|Withdrawal by Subject|1|||
162711451|NCT02145182|587654838|FG000|Overall Study|Adverse Event|4|||
162711452|NCT02145182|587654839|FG001|Overall Study|Adverse Event|1|||
162711453|NCT02145182|587654838|FG000|Overall Study|Death|7|||
162711454|NCT02145182|587654839|FG001|Overall Study|Death|7|||
162711455|NCT02145182|587654838|FG000|Overall Study|Lost to Follow-up|2|||
162711456|NCT02145182|587654839|FG001|Overall Study|Lost to Follow-up|2|||
162711457|NCT02145182|587654838|FG000|Overall Study|Pre-transplant Withdrawal|0|||
162711458|NCT02145182|587654839|FG001|Overall Study|Pre-transplant Withdrawal|2|||
162711459|NCT02145182|587654838|FG000|Overall Study|Withdrawal by Subject|5|||
162711460|NCT02145182|587654839|FG001|Overall Study|Withdrawal by Subject|4|||
162711461|NCT03999554|587654841|FG000|Overall Study|Lost to Follow-up|4|||
162711462|NCT03999554|587654842|FG001|Overall Study|Lost to Follow-up|5|||
162711463|NCT03999554|587654843|FG002|Overall Study|Lost to Follow-up|4|||
162711464|NCT03999554|587654844|FG003|Overall Study|Lost to Follow-up|5|||
162711465|NCT03999554|587654845|FG004|Overall Study|Lost to Follow-up|8|||
162711466|NCT03999554|587654841|FG000|Overall Study|Protocol Violation|0|||
162711467|NCT03999554|587654842|FG001|Overall Study|Protocol Violation|0|||
162711468|NCT03999554|587654843|FG002|Overall Study|Protocol Violation|5|||
162711469|NCT03999554|587654844|FG003|Overall Study|Protocol Violation|0|||
162711470|NCT03999554|587654845|FG004|Overall Study|Protocol Violation|0|||
162711471|NCT03999554|587654841|FG000|Overall Study|Pregnancy|0|||
162711472|NCT03999554|587654842|FG001|Overall Study|Pregnancy|0|||
162711473|NCT03999554|587654843|FG002|Overall Study|Pregnancy|1|||
162711474|NCT03999554|587654844|FG003|Overall Study|Pregnancy|0|||
162711475|NCT03999554|587654845|FG004|Overall Study|Pregnancy|0|||
162711476|NCT03999554|587654841|FG000|Overall Study|Withdrawal by Subject|2|||
162711477|NCT03999554|587654842|FG001|Overall Study|Withdrawal by Subject|2|||
162711478|NCT03999554|587654843|FG002|Overall Study|Withdrawal by Subject|2|||
162711479|NCT03999554|587654844|FG003|Overall Study|Withdrawal by Subject|1|||
162711480|NCT03999554|587654845|FG004|Overall Study|Withdrawal by Subject|1|||
162711481|NCT03999554|587654841|FG000|Overall Study|failure to comply with protocol requirements|0|||
162711482|NCT03999554|587654842|FG001|Overall Study|failure to comply with protocol requirements|0|||
162711483|NCT03999554|587654843|FG002|Overall Study|failure to comply with protocol requirements|0|||
162711484|NCT03999554|587654844|FG003|Overall Study|failure to comply with protocol requirements|1|||
162711485|NCT03999554|587654845|FG004|Overall Study|failure to comply with protocol requirements|0|||
162711486|NCT02082158|587654846|FG000|Overall Study|Withdrawal by Subject|0|||
162711487|NCT02082158|587654847|FG001|Overall Study|Withdrawal by Subject|0|||
162711488|NCT02082158|587654848|FG002|Overall Study|Withdrawal by Subject|0|||
162711489|NCT02082158|587654849|FG003|Overall Study|Withdrawal by Subject|0|||
162711490|NCT02082158|587654850|FG004|Overall Study|Withdrawal by Subject|1|||
162711491|NCT02082158|587654851|FG005|Overall Study|Withdrawal by Subject|0|||
162711492|NCT02082158|587654846|FG000|Overall Study|Failed Fit-testing|8|||
162711493|NCT02082158|587654847|FG001|Overall Study|Failed Fit-testing|8|||
162711494|NCT02082158|587654848|FG002|Overall Study|Failed Fit-testing|14|||
162711495|NCT02082158|587654849|FG003|Overall Study|Failed Fit-testing|4|||
162711496|NCT02082158|587654850|FG004|Overall Study|Failed Fit-testing|3|||
162711497|NCT02082158|587654851|FG005|Overall Study|Failed Fit-testing|7|||
162711498|NCT00742274|587654854|FG000|Overall Study|Death|1|||
162711499|NCT00742274|587654855|FG001|Overall Study|Death|0|||
162711500|NCT00742274|587654854|FG000|Overall Study|Withdrawal by Subject|1|||
162711501|NCT00742274|587654855|FG001|Overall Study|Withdrawal by Subject|2|||
162711502|NCT00742274|587654854|FG000|Overall Study|Removed for medical reasons|1|||
162711503|NCT00742274|587654855|FG001|Overall Study|Removed for medical reasons|1|||
162711504|NCT01101165|587654856|FG000|Period 1|Adverse Event|1|||
162711505|NCT01101165|587654857|FG001|Period 1|Adverse Event|2|||
162711506|NCT01101165|587654856|FG000|Period 1|Withdrawal by Subject|0|||
162711507|NCT01101165|587654857|FG001|Period 1|Withdrawal by Subject|2|||
162711508|NCT01101165|587654856|FG000|Period 1|Positive Drug Screen|0|||
162711509|NCT01101165|587654857|FG001|Period 1|Positive Drug Screen|1|||
162711510|NCT01101165|587654856|FG000|Period 1|Lost to Follow-up|1|||
162711511|NCT01101165|587654857|FG001|Period 1|Lost to Follow-up|0|||
162711512|NCT01101165|587654856|FG000|Period 2|Withdrawal by Subject|3|||
162711513|NCT01101165|587654857|FG001|Period 2|Withdrawal by Subject|1|||
162711514|NCT01101165|587654856|FG000|Period 2|Adverse Event|1|||
162969494|NCT00098475|588589973|FG003|Step 1|Alternative therapy|0|||
162969495|NCT00098475|588589970|FG000|Step 1|Other disease|2|||
162969496|NCT00098475|588589971|FG001|Step 1|Other disease|1|||
162969497|NCT00098475|588589972|FG002|Step 1|Other disease|1|||
162969498|NCT00098475|588589973|FG003|Step 1|Other disease|0|||
162969499|NCT00098475|588589970|FG000|Step 1|Never started treatment|0|||
162711515|NCT01101165|587654857|FG001|Period 2|Adverse Event|0|||
162711516|NCT00619151|587654859|FG000|Overall Study|Study terminated prior to followup|1|||
162711517|NCT00619151|587654860|FG001|Overall Study|Study terminated prior to followup|0|||
162711518|NCT03124108|587654866|FG000|Overall Study|Adverse Event|0|||
162711519|NCT03124108|587654867|FG001|Overall Study|Adverse Event|1|||
162711520|NCT03124108|587654868|FG002|Overall Study|Adverse Event|0|||
162711521|NCT01670019|587654878|FG000|Overall Study|Adverse Event|3|||
162711522|NCT01670019|587654879|FG001|Overall Study|Adverse Event|0|||
162711523|NCT01670019|587654878|FG000|Overall Study|Withdrawal by Subject|6|||
162711524|NCT01670019|587654879|FG001|Overall Study|Withdrawal by Subject|0|||
162711525|NCT03586167|587654881|FG000|Overall Study|Other|1|||
162711526|NCT03586167|587654882|FG001|Overall Study|Other|0|||
162711527|NCT03537651|587654885|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
162711528|NCT03537651|587654885|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
162969500|NCT00098475|588589971|FG001|Step 1|Never started treatment|2|||
162969501|NCT00098475|588589972|FG002|Step 1|Never started treatment|0|||
162969502|NCT00098475|588589973|FG003|Step 1|Never started treatment|0|||
162969503|NCT00098475|588589970|FG000|Step 1|Still on treatment as of this analysis|14|||
162969504|NCT00098475|588589971|FG001|Step 1|Still on treatment as of this analysis|27|||
162969505|NCT00098475|588589972|FG002|Step 1|Still on treatment as of this analysis|0|||
162969506|NCT00098475|588589973|FG003|Step 1|Still on treatment as of this analysis|0|||
162969507|NCT00098475|588589970|FG000|Step 1|Knee surgery|1|||
162969508|NCT00098475|588589971|FG001|Step 1|Knee surgery|0|||
162969509|NCT00098475|588589972|FG002|Step 1|Knee surgery|0|||
162969510|NCT00098475|588589973|FG003|Step 1|Knee surgery|0|||
162969511|NCT00098475|588589970|FG000|Step 1|Complications|1|||
162969512|NCT00098475|588589971|FG001|Step 1|Complications|0|||
162969513|NCT00098475|588589972|FG002|Step 1|Complications|0|||
162969514|NCT00098475|588589973|FG003|Step 1|Complications|0|||
162969515|NCT00098475|588589970|FG000|Step 1|Cannot comply due to other tx|0|||
162969516|NCT00098475|588589971|FG001|Step 1|Cannot comply due to other tx|1|||
162969517|NCT00098475|588589972|FG002|Step 1|Cannot comply due to other tx|0|||
162969518|NCT00098475|588589973|FG003|Step 1|Cannot comply due to other tx|0|||
162969519|NCT00098475|588589970|FG000|Step 1|Both patient and physician's decision|2|||
162969520|NCT00098475|588589971|FG001|Step 1|Both patient and physician's decision|1|||
162969521|NCT00098475|588589972|FG002|Step 1|Both patient and physician's decision|0|||
162969522|NCT00098475|588589973|FG003|Step 1|Both patient and physician's decision|0|||
162969523|NCT00098475|588589970|FG000|Step 1|Incorrect disease assessment|2|||
162969524|NCT00098475|588589971|FG001|Step 1|Incorrect disease assessment|0|||
162969525|NCT00098475|588589972|FG002|Step 1|Incorrect disease assessment|0|||
162969526|NCT00098475|588589973|FG003|Step 1|Incorrect disease assessment|0|||
162969527|NCT00098475|588589970|FG000|Step 1|Off treatment for > specified timeframe|1|||
162969528|NCT00098475|588589971|FG001|Step 1|Off treatment for > specified timeframe|1|||
162969529|NCT00098475|588589972|FG002|Step 1|Off treatment for > specified timeframe|0|||
162969530|NCT00098475|588589973|FG003|Step 1|Off treatment for > specified timeframe|0|||
162969531|NCT00098475|588589970|FG000|Step 1|Declining performance status|0|||
162969532|NCT00098475|588589971|FG001|Step 1|Declining performance status|1|||
162969533|NCT00098475|588589972|FG002|Step 1|Declining performance status|0|||
162969534|NCT00098475|588589973|FG003|Step 1|Declining performance status|0|||
162969535|NCT00098475|588589970|FG000|Step 1|Insurance issue|0|||
162969536|NCT00098475|588589971|FG001|Step 1|Insurance issue|1|||
162969537|NCT00098475|588589972|FG002|Step 1|Insurance issue|0|||
162969538|NCT00098475|588589973|FG003|Step 1|Insurance issue|0|||
162969539|NCT00098475|588589970|FG000|Step 1|Rising paraprotein|0|||
162969540|NCT00098475|588589971|FG001|Step 1|Rising paraprotein|1|||
162969541|NCT00098475|588589972|FG002|Step 1|Rising paraprotein|0|||
162969542|NCT00098475|588589973|FG003|Step 1|Rising paraprotein|0|||
162969543|NCT00098475|588589970|FG000|Step 1|Referred to other physicians|0|||
162969544|NCT00098475|588589971|FG001|Step 1|Referred to other physicians|1|||
162969545|NCT00098475|588589972|FG002|Step 1|Referred to other physicians|0|||
162969546|NCT00098475|588589973|FG003|Step 1|Referred to other physicians|0|||
162969547|NCT00098475|588589970|FG000|Step 1|Criteria to continue treatment not met|0|||
162969548|NCT00098475|588589971|FG001|Step 1|Criteria to continue treatment not met|1|||
162969549|NCT00098475|588589972|FG002|Step 1|Criteria to continue treatment not met|0|||
162969550|NCT00098475|588589973|FG003|Step 1|Criteria to continue treatment not met|0|||
162969551|NCT00098475|588589970|FG000|Step 1|Misinterpretation of lab data|0|||
162969552|NCT00098475|588589971|FG001|Step 1|Misinterpretation of lab data|1|||
162969553|NCT00098475|588589972|FG002|Step 1|Misinterpretation of lab data|0|||
162969554|NCT00098475|588589973|FG003|Step 1|Misinterpretation of lab data|0|||
162969555|NCT00098475|588589970|FG000|Step 1|Patient fell with fracture|1|||
162969556|NCT00098475|588589971|FG001|Step 1|Patient fell with fracture|0|||
162969557|NCT00098475|588589972|FG002|Step 1|Patient fell with fracture|0|||
162969558|NCT00098475|588589973|FG003|Step 1|Patient fell with fracture|0|||
162969559|NCT00098475|588589970|FG000|Step 1|Not documented|0|||
162969560|NCT00098475|588589971|FG001|Step 1|Not documented|1|||
162969561|NCT00098475|588589972|FG002|Step 1|Not documented|0|||
162969562|NCT00098475|588589973|FG003|Step 1|Not documented|0|||
162969563|NCT00098475|588589970|FG000|Step 2|Disease progression|1|||
162969564|NCT00098475|588589971|FG001|Step 2|Disease progression|4|||
162969565|NCT00098475|588589972|FG002|Step 2|Disease progression|0|||
162969566|NCT00098475|588589973|FG003|Step 2|Disease progression|0|||
163055593|NCT03555149|588916044|FG004|Overall Study|Physician Decision|0|||
163055594|NCT03555149|588916045|FG005|Overall Study|Physician Decision|0|||
163055595|NCT03555149|588916046|FG006|Overall Study|Physician Decision|0|||
163055596|NCT03555149|588916047|FG007|Overall Study|Physician Decision|0|||
163055597|NCT03555149|588916040|FG000|Overall Study|Study Terminated By Sponsor|1|||
163055598|NCT03555149|588916041|FG001|Overall Study|Study Terminated By Sponsor|0|||
163055599|NCT03555149|588916042|FG002|Overall Study|Study Terminated By Sponsor|0|||
163055600|NCT03555149|588916043|FG003|Overall Study|Study Terminated By Sponsor|0|||
162969567|NCT00098475|588589970|FG000|Step 2|Adverse Event|2|||
162969568|NCT00098475|588589971|FG001|Step 2|Adverse Event|0|||
162969569|NCT00098475|588589972|FG002|Step 2|Adverse Event|0|||
162969570|NCT00098475|588589973|FG003|Step 2|Adverse Event|0|||
162969571|NCT00098475|588589970|FG000|Step 2|Withdrawal by Subject|0|||
163055601|NCT03555149|588916044|FG004|Overall Study|Study Terminated By Sponsor|0|||
162969572|NCT00098475|588589971|FG001|Step 2|Withdrawal by Subject|2|||
163055602|NCT03555149|588916045|FG005|Overall Study|Study Terminated By Sponsor|2|||
163055603|NCT03555149|588916046|FG006|Overall Study|Study Terminated By Sponsor|3|||
163055604|NCT03555149|588916047|FG007|Overall Study|Study Terminated By Sponsor|1|||
163055605|NCT03555149|588916040|FG000|Overall Study|Withdrawal by Subject|3|||
163055606|NCT03555149|588916041|FG001|Overall Study|Withdrawal by Subject|0|||
163055607|NCT03555149|588916042|FG002|Overall Study|Withdrawal by Subject|0|||
163055608|NCT03555149|588916043|FG003|Overall Study|Withdrawal by Subject|2|||
163055609|NCT03555149|588916044|FG004|Overall Study|Withdrawal by Subject|0|||
163055610|NCT03555149|588916045|FG005|Overall Study|Withdrawal by Subject|1|||
163055611|NCT03555149|588916046|FG006|Overall Study|Withdrawal by Subject|0|||
163055612|NCT03555149|588916047|FG007|Overall Study|Withdrawal by Subject|0|||
163055613|NCT01692119|588916053|FG000|Overall Study|Protocol Violation|3|||
163055614|NCT01692119|588916054|FG001|Overall Study|Protocol Violation|1|||
163055615|NCT01692119|588916053|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
163055616|NCT01692119|588916054|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
163055617|NCT04656652|588916055|FG000|Overall Study|Lost to Follow-up|2|||
163055618|NCT04656652|588916056|FG001|Overall Study|Lost to Follow-up|2|||
163055619|NCT04656652|588916055|FG000|Overall Study|Death|213|||
163055620|NCT04656652|588916056|FG001|Overall Study|Death|212|||
163055621|NCT04656652|588916055|FG000|Overall Study|Other|1|||
163055622|NCT04656652|588916056|FG001|Overall Study|Other|0|||
163055623|NCT04656652|588916055|FG000|Overall Study|Withdrawal by Subject|15|||
163055624|NCT04656652|588916056|FG001|Overall Study|Withdrawal by Subject|29|||
163055625|NCT02722967|588916057|FG000|Overall Study|Adverse Event|1|||
163055626|NCT02722967|588916058|FG001|Overall Study|Adverse Event|0|||
163055627|NCT02722967|588916059|FG002|Overall Study|Adverse Event|0|||
163055628|NCT02722967|588916057|FG000|Overall Study|Lost to Follow-up|0|||
163055629|NCT02722967|588916058|FG001|Overall Study|Lost to Follow-up|1|||
163055630|NCT02722967|588916059|FG002|Overall Study|Lost to Follow-up|0|||
163055631|NCT02722967|588916057|FG000|Overall Study|Non-compliance with patch wearing|2|||
163055632|NCT02722967|588916058|FG001|Overall Study|Non-compliance with patch wearing|1|||
163055633|NCT02722967|588916059|FG002|Overall Study|Non-compliance with patch wearing|1|||
163055634|NCT02722967|588916057|FG000|Overall Study|Withdrawal by Subject|1|||
163055635|NCT02722967|588916058|FG001|Overall Study|Withdrawal by Subject|0|||
163055636|NCT02722967|588916059|FG002|Overall Study|Withdrawal by Subject|1|||
163055637|NCT02722967|588916057|FG000|Overall Study|Physician Decision|1|||
163055638|NCT02722967|588916058|FG001|Overall Study|Physician Decision|0|||
163055639|NCT02722967|588916059|FG002|Overall Study|Physician Decision|0|||
163055640|NCT02722967|588916057|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
163055641|NCT02722967|588916058|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
163055642|NCT02722967|588916059|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
163055643|NCT04142242|588916060|FG000|Stage I|Non-compliance with the protocol|1|||
163055644|NCT04142242|588916061|FG001|Stage I|Non-compliance with the protocol|0|||
163055645|NCT04142242|588916062|FG002|Stage I|Non-compliance with the protocol|0|||
163055646|NCT04142242|588916063|FG003|Stage I|Non-compliance with the protocol|0|||
163055647|NCT04142242|588916064|FG004|Stage I|Non-compliance with the protocol|0|||
163055648|NCT04142242|588916065|FG005|Stage I|Non-compliance with the protocol|1|||
163055649|NCT04142242|588916060|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055650|NCT04142242|588916061|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
163055651|NCT04142242|588916062|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055652|NCT04142242|588916063|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055653|NCT04142242|588916064|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055654|NCT04142242|588916065|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
163055655|NCT04142242|588916060|FG000|Stage II|Non-compliance with the protocol|0|||
163055656|NCT04142242|588916061|FG001|Stage II|Non-compliance with the protocol|0|||
163055657|NCT04142242|588916062|FG002|Stage II|Non-compliance with the protocol|0|||
163055658|NCT04142242|588916063|FG003|Stage II|Non-compliance with the protocol|2|||
163055659|NCT04142242|588916064|FG004|Stage II|Non-compliance with the protocol|0|||
163055660|NCT04142242|588916065|FG005|Stage II|Non-compliance with the protocol|0|||
163055661|NCT04142242|588916060|FG000|Stage II|Lost to Follow-up|0|||
163055662|NCT04142242|588916061|FG001|Stage II|Lost to Follow-up|0|||
163055663|NCT04142242|588916062|FG002|Stage II|Lost to Follow-up|1|||
163055664|NCT04142242|588916063|FG003|Stage II|Lost to Follow-up|2|||
163055665|NCT04142242|588916064|FG004|Stage II|Lost to Follow-up|0|||
163055666|NCT04142242|588916065|FG005|Stage II|Lost to Follow-up|0|||
163055667|NCT04142242|588916060|FG000|Stage II|Withdrawal by Subject|0|||
163055668|NCT04142242|588916061|FG001|Stage II|Withdrawal by Subject|0|||
163055669|NCT04142242|588916062|FG002|Stage II|Withdrawal by Subject|5|||
163055670|NCT04142242|588916063|FG003|Stage II|Withdrawal by Subject|9|||
163055671|NCT04142242|588916064|FG004|Stage II|Withdrawal by Subject|0|||
163055672|NCT04142242|588916065|FG005|Stage II|Withdrawal by Subject|0|||
163055673|NCT00846053|588916068|FG000|Overall Study|Physician Decision|3|||
163055674|NCT00846053|588916069|FG001|Overall Study|Physician Decision|0|||
163055675|NCT02027025|588916078|FG000|Overall Study|Adverse Event|0|||
163055676|NCT02027025|588916079|FG001|Overall Study|Adverse Event|1|||
162711529|NCT03537651|587654885|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
162711530|NCT03537651|587654885|FG000|Part A (Up to 96 Weeks)|Other|1|||
162711531|NCT03537651|587654885|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
162711532|NCT03537651|587654885|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
162711533|NCT03537651|587654885|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
162711534|NCT03537651|587654885|FG000|Part B (Up to 192 Weeks)|Other|1|||
162711535|NCT05487703|587654887|FG000|Overall Study|Other|19|||
162711536|NCT05487703|587654887|FG000|Overall Study|Participant not well|5|||
162711537|NCT05487703|587654887|FG000|Overall Study|Insurance Reasons|6|||
162711538|NCT05487703|587654887|FG000|Overall Study|Physician Decision|19|||
162711539|NCT05487703|587654887|FG000|Overall Study|Lack of Efficacy|60|||
162711540|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
162711541|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
162711542|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
162711543|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Death|3|||
162711544|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Death|0|||
162711545|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Death|0|||
162711546|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
162711547|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162711548|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162711549|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
162711550|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
162711551|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
162711552|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
162711553|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
162711554|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
162711555|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
162711556|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
162711557|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
162711558|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
162711559|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
162711560|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
162711561|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Other|1|||
162711562|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Other|0|||
162711563|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Other|0|||
162711564|NCT02403323|587654888|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
162711565|NCT02403323|587654889|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162711566|NCT02403323|587654890|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162711567|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
162711568|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
162711569|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
162711570|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
162711571|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
162711572|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
162711573|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
162711574|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
162711575|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
162711576|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162711577|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
162711578|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162711579|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
162711580|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
162711581|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
162711582|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
162711583|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
162711584|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
162711585|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
162711586|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
162711587|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
162711588|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
162711589|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
162918876|NCT05182840|588404956|FG006|Run-in Period|Burden of study procedures|0|||
162918877|NCT05182840|588404957|FG007|Run-in Period|Burden of study procedures|0|||
162918878|NCT05182840|588404958|FG008|Run-in Period|Burden of study procedures|0|||
162918879|NCT05182840|588404959|FG009|Run-in Period|Burden of study procedures|0|||
162711590|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
162711591|NCT02403323|587654888|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
162711592|NCT02403323|587654889|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
162969573|NCT00098475|588589972|FG002|Step 2|Withdrawal by Subject|0|||
162969574|NCT00098475|588589973|FG003|Step 2|Withdrawal by Subject|0|||
162969575|NCT00098475|588589970|FG000|Step 2|Physician Decision|0|||
162969576|NCT00098475|588589971|FG001|Step 2|Physician Decision|1|||
162969577|NCT00098475|588589972|FG002|Step 2|Physician Decision|0|||
162969578|NCT00098475|588589973|FG003|Step 2|Physician Decision|0|||
162969579|NCT00098475|588589970|FG000|Step 2|Alternative therapy|1|||
162969580|NCT00098475|588589971|FG001|Step 2|Alternative therapy|2|||
162969581|NCT00098475|588589972|FG002|Step 2|Alternative therapy|0|||
162969582|NCT00098475|588589973|FG003|Step 2|Alternative therapy|0|||
162969583|NCT00098475|588589970|FG000|Step 2|Never started treatment|1|||
162969584|NCT00098475|588589971|FG001|Step 2|Never started treatment|1|||
162969585|NCT00098475|588589972|FG002|Step 2|Never started treatment|0|||
162969586|NCT00098475|588589973|FG003|Step 2|Never started treatment|0|||
162969587|NCT03422068|588589974|FG000|Overall Study|Adverse Event|0|||
162969588|NCT03422068|588589975|FG001|Overall Study|Adverse Event|1|||
162969589|NCT03422068|588589974|FG000|Overall Study|Inconvenience to frequent study visits|0|||
162969590|NCT03422068|588589975|FG001|Overall Study|Inconvenience to frequent study visits|1|||
162969591|NCT01841073|588589977|FG000|Overall Study|Adverse Event|1|||
162969592|NCT01841073|588589978|FG001|Overall Study|Adverse Event|1|||
162969593|NCT01841073|588589977|FG000|Overall Study|Physician Decision|1|||
162969594|NCT01841073|588589978|FG001|Overall Study|Physician Decision|0|||
162969595|NCT01841073|588589977|FG000|Overall Study|Lost to Follow-up|0|||
162969596|NCT01841073|588589978|FG001|Overall Study|Lost to Follow-up|2|||
162969597|NCT02858037|588589979|FG000|Overall Study|Death|1|||
162969598|NCT02858037|588589979|FG000|Overall Study|Withdrawal by Subject|18|||
162969599|NCT02858037|588589979|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
162969600|NCT02858037|588589979|FG000|Overall Study|Lost to Follow-up|3|||
162969601|NCT02858037|588589979|FG000|Overall Study|Other|4|||
162969602|NCT00283842|588589988|FG000|Overall Study|Adverse Event|8|||
162969603|NCT00283842|588589989|FG001|Overall Study|Adverse Event|7|||
162969604|NCT00283842|588589990|FG002|Overall Study|Adverse Event|21|||
162969605|NCT00283842|588589991|FG003|Overall Study|Adverse Event|21|||
162969606|NCT00283842|588589992|FG004|Overall Study|Adverse Event|5|||
162969607|NCT00283842|588589988|FG000|Overall Study|Protocol Violation|1|||
162969608|NCT00283842|588589989|FG001|Overall Study|Protocol Violation|5|||
162969609|NCT00283842|588589990|FG002|Overall Study|Protocol Violation|4|||
162969610|NCT00283842|588589991|FG003|Overall Study|Protocol Violation|0|||
162969611|NCT00283842|588589992|FG004|Overall Study|Protocol Violation|0|||
162969612|NCT00283842|588589988|FG000|Overall Study|Protocol deviation|0|||
162969613|NCT00283842|588589989|FG001|Overall Study|Protocol deviation|0|||
162969614|NCT00283842|588589990|FG002|Overall Study|Protocol deviation|0|||
162969615|NCT00283842|588589991|FG003|Overall Study|Protocol deviation|0|||
162969616|NCT00283842|588589992|FG004|Overall Study|Protocol deviation|2|||
162969617|NCT00283842|588589988|FG000|Overall Study|Withdrawal by Subject|2|||
162969618|NCT00283842|588589989|FG001|Overall Study|Withdrawal by Subject|1|||
162969619|NCT00283842|588589990|FG002|Overall Study|Withdrawal by Subject|1|||
162969620|NCT00283842|588589991|FG003|Overall Study|Withdrawal by Subject|5|||
162969621|NCT00283842|588589992|FG004|Overall Study|Withdrawal by Subject|4|||
162969622|NCT00283842|588589988|FG000|Overall Study|Lack of Efficacy|1|||
162969623|NCT00283842|588589989|FG001|Overall Study|Lack of Efficacy|3|||
162969624|NCT00283842|588589990|FG002|Overall Study|Lack of Efficacy|1|||
162969625|NCT00283842|588589991|FG003|Overall Study|Lack of Efficacy|0|||
162969626|NCT00283842|588589992|FG004|Overall Study|Lack of Efficacy|3|||
162969627|NCT00283842|588589988|FG000|Overall Study|Lost to Follow-up|0|||
162969628|NCT00283842|588589989|FG001|Overall Study|Lost to Follow-up|2|||
162969629|NCT00283842|588589990|FG002|Overall Study|Lost to Follow-up|4|||
162969630|NCT00283842|588589991|FG003|Overall Study|Lost to Follow-up|1|||
162969631|NCT00283842|588589992|FG004|Overall Study|Lost to Follow-up|1|||
162969632|NCT00550147|588589993|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
162969633|NCT00550147|588589993|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
162969634|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
162969635|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
162969636|NCT00550147|588589993|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
162969637|NCT04320745|588589994|FG000|Overall Study|Adverse Event|26|||
162969638|NCT04320745|588589994|FG000|Overall Study|Withdrawal by Subject|4|||
162969639|NCT04320745|588589994|FG000|Overall Study|Lost to Follow-up|12|||
162969640|NCT04320745|588589994|FG000|Overall Study|Protocol Deviation|2|||
162969641|NCT04320745|588589994|FG000|Overall Study|Non-compliance With Study Drug|2|||
162969642|NCT04320745|588589994|FG000|Overall Study|Reason Not Specified|1|||
162969643|NCT02472639|588589995|FG000|Overall Study|Physician Decision|4|||
162969644|NCT02472639|588589996|FG001|Overall Study|Physician Decision|3|||
163055677|NCT02027025|588916080|FG002|Overall Study|Adverse Event|1|||
162969645|NCT00046839|588589997|FG000|Overall Study|Ineligible / No protocol treatment|0|||
162969646|NCT00046839|588589998|FG001|Overall Study|Ineligible / No protocol treatment|2|||
162969647|NCT00046839|588589997|FG000|Overall Study|Withdrawal of consent|1|||
162969648|NCT00046839|588589998|FG001|Overall Study|Withdrawal of consent|0|||
162969649|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
162711593|NCT02403323|587654890|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
162711594|NCT03885596|587654898|FG000|Overall Study|Withdrawal by Subject|2|||
162711595|NCT03885596|587654899|FG001|Overall Study|Withdrawal by Subject|1|||
162711596|NCT03885596|587654900|FG002|Overall Study|Withdrawal by Subject|0|||
162711597|NCT03885596|587654901|FG003|Overall Study|Withdrawal by Subject|0|||
162711598|NCT00746330|587654902|FG000|Period 1|Abnormal test procedure result|0|||
162711599|NCT00746330|587654903|FG001|Period 1|Abnormal test procedure result|0|||
162711600|NCT00746330|587654904|FG002|Period 1|Abnormal test procedure result|1|||
162711601|NCT00746330|587654905|FG003|Period 1|Abnormal test procedure result|0|||
162711602|NCT01076335|587654906|FG000|Overall Study|Withdrawal by Subject|3|||
162711603|NCT01076335|587654906|FG000|Overall Study|Withdrawal without treatment|1|||
162711604|NCT00517933|587654908|FG000|Period 1|Death|2|||
162711605|NCT00517933|587654909|FG001|Period 1|Death|1|||
162711606|NCT00517933|587654908|FG000|Period 1|Adverse Event|4|||
162711607|NCT00517933|587654909|FG001|Period 1|Adverse Event|4|||
162711608|NCT00517933|587654908|FG000|Period 1|Lost to Follow-up|2|||
162711609|NCT00517933|587654909|FG001|Period 1|Lost to Follow-up|0|||
162711610|NCT00517933|587654908|FG000|Period 1|Underwent lung transplant|0|||
162711611|NCT00517933|587654909|FG001|Period 1|Underwent lung transplant|1|||
162711612|NCT00517933|587654908|FG000|Period 2|Death|2|||
162711613|NCT00517933|587654909|FG001|Period 2|Death|4|||
162711614|NCT00517933|587654908|FG000|Period 2|Adverse Event|2|||
162711615|NCT00517933|587654909|FG001|Period 2|Adverse Event|4|||
162711616|NCT00517933|587654908|FG000|Period 2|Physician Decision|1|||
162711617|NCT00517933|587654909|FG001|Period 2|Physician Decision|0|||
162711618|NCT00517933|587654908|FG000|Period 2|Withdrawal by Subject|1|||
162711619|NCT00517933|587654909|FG001|Period 2|Withdrawal by Subject|3|||
163055678|NCT02027025|588916078|FG000|Overall Study|Protocol Violation|1|||
163055679|NCT02027025|588916079|FG001|Overall Study|Protocol Violation|0|||
163055680|NCT02027025|588916080|FG002|Overall Study|Protocol Violation|0|||
163055681|NCT02027025|588916078|FG000|Overall Study|Lost to Follow-up|0|||
163055682|NCT02027025|588916079|FG001|Overall Study|Lost to Follow-up|2|||
163055683|NCT02027025|588916080|FG002|Overall Study|Lost to Follow-up|0|||
163055684|NCT02027025|588916078|FG000|Overall Study|Withdrawal by Subject|0|||
163055685|NCT02027025|588916079|FG001|Overall Study|Withdrawal by Subject|1|||
163055686|NCT02027025|588916080|FG002|Overall Study|Withdrawal by Subject|0|||
163055687|NCT02027025|588916078|FG000|Overall Study|Sponsor's decision|0|||
163055688|NCT02027025|588916079|FG001|Overall Study|Sponsor's decision|1|||
163055689|NCT02027025|588916080|FG002|Overall Study|Sponsor's decision|0|||
163055690|NCT00828711|588916081|FG000|Overall Study|Lost to Follow-up|1|||
163055691|NCT00828711|588916082|FG001|Overall Study|Lost to Follow-up|0|||
163055692|NCT00828711|588916083|FG002|Overall Study|Lost to Follow-up|0|||
163055693|NCT01618968|588916084|FG000|Overall Study|Adverse Event|1|||
163055694|NCT01618968|588916085|FG001|Overall Study|Adverse Event|0|||
163055695|NCT01618968|588916086|FG002|Overall Study|Adverse Event|0|||
163055696|NCT01618968|588916087|FG003|Overall Study|Adverse Event|0|||
163055697|NCT01618968|588916084|FG000|Overall Study|Death|0|||
163055698|NCT01618968|588916085|FG001|Overall Study|Death|0|||
163055699|NCT01618968|588916086|FG002|Overall Study|Death|0|||
163055700|NCT01618968|588916087|FG003|Overall Study|Death|1|||
163055701|NCT03883386|588916088|FG000|First Assignment|Lost to Follow-up|1|||
163055702|NCT03883386|588916089|FG001|First Assignment|Lost to Follow-up|0|||
163055703|NCT03883386|588916088|FG000|First Assignment|Withdrawal by Subject|1|||
163055704|NCT03883386|588916089|FG001|First Assignment|Withdrawal by Subject|1|||
163055705|NCT01326871|588916090|FG000|Overall Study|Major surgery|0|||
163055706|NCT01326871|588916091|FG001|Overall Study|Major surgery|1|||
163055707|NCT01326871|588916092|FG002|Overall Study|Major surgery|0|||
163055708|NCT01326871|588916090|FG000|Overall Study|SAE and death|0|||
163055709|NCT01326871|588916091|FG001|Overall Study|SAE and death|2|||
163055710|NCT01326871|588916092|FG002|Overall Study|SAE and death|0|||
162711620|NCT00517933|587654908|FG000|Period 2|Underwent lung transplant|0|||
162711621|NCT00517933|587654909|FG001|Period 2|Underwent lung transplant|2|||
162711622|NCT00235495|587654917|FG000|Overall Study|Death|52|||
162711623|NCT00235495|587654918|FG001|Overall Study|Death|42|||
162711624|NCT00235495|587654917|FG000|Overall Study|Withdrawal by Subject|5|||
162711625|NCT00235495|587654918|FG001|Overall Study|Withdrawal by Subject|3|||
162711626|NCT00235495|587654917|FG000|Overall Study|Lost to Follow-up|11|||
162711627|NCT00235495|587654918|FG001|Overall Study|Lost to Follow-up|13|||
163055711|NCT01326871|588916090|FG000|Overall Study|Physician decision and decreased performance status|0|||
163055712|NCT01326871|588916091|FG001|Overall Study|Physician decision and decreased performance status|1|||
163055713|NCT01326871|588916092|FG002|Overall Study|Physician decision and decreased performance status|0|||
163055714|NCT01326871|588916090|FG000|Overall Study|Disease progression|0|||
163055715|NCT01326871|588916091|FG001|Overall Study|Disease progression|11|||
163055716|NCT01326871|588916092|FG002|Overall Study|Disease progression|5|||
162711628|NCT00235495|587654917|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
162711629|NCT00235495|587654918|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
162711630|NCT01268566|587654925|FG000|Overall Study|Lost to Follow-up|1|||
162711631|NCT01268566|587654925|FG000|Overall Study|Withdrawal by Subject|12|||
162711632|NCT01268566|587654925|FG000|Overall Study|Death|30|||
162711633|NCT02784704|587654930|FG000|Overall Study|Adverse Event|4|||
162711634|NCT02784704|587654931|FG001|Overall Study|Adverse Event|2|||
162711635|NCT02784704|587654930|FG000|Overall Study|Lost to Follow-up|6|||
162711636|NCT02784704|587654931|FG001|Overall Study|Lost to Follow-up|4|||
162711637|NCT02784704|587654930|FG000|Overall Study|Withdrawal by Subject|1|||
162711638|NCT02784704|587654931|FG001|Overall Study|Withdrawal by Subject|3|||
162711639|NCT02784704|587654930|FG000|Overall Study|Subject Non Compliance|2|||
162711640|NCT02784704|587654931|FG001|Overall Study|Subject Non Compliance|0|||
162711641|NCT00603538|587654932|FG000|Overall Study|Adverse Event|0|||
162711642|NCT00603538|587654933|FG001|Overall Study|Adverse Event|4|||
162711643|NCT00603538|587654934|FG002|Overall Study|Adverse Event|2|||
162711644|NCT00603538|587654932|FG000|Overall Study|Objective progression or relapse|3|||
162711645|NCT00603538|587654933|FG001|Overall Study|Objective progression or relapse|0|||
162711646|NCT00603538|587654934|FG002|Overall Study|Objective progression or relapse|0|||
162711647|NCT04794179|587654936|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
162711648|NCT04794179|587654937|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
162711649|NCT03781804|587654939|FG000|Overall Study|Adverse Event|2|||
162711650|NCT03781804|587654940|FG001|Overall Study|Adverse Event|2|||
162711651|NCT03781804|587654941|FG002|Overall Study|Adverse Event|3|||
162711652|NCT03781804|587654939|FG000|Overall Study|Lost to Follow-up|1|||
162711653|NCT03781804|587654940|FG001|Overall Study|Lost to Follow-up|1|||
162711654|NCT03781804|587654941|FG002|Overall Study|Lost to Follow-up|2|||
162711655|NCT03781804|587654939|FG000|Overall Study|Lack of Efficacy|4|||
162711656|NCT03781804|587654940|FG001|Overall Study|Lack of Efficacy|2|||
162711657|NCT03781804|587654941|FG002|Overall Study|Lack of Efficacy|9|||
162711658|NCT03781804|587654939|FG000|Overall Study|Protocol Violation|0|||
162711659|NCT03781804|587654940|FG001|Overall Study|Protocol Violation|0|||
162711660|NCT03781804|587654941|FG002|Overall Study|Protocol Violation|1|||
162711661|NCT03781804|587654939|FG000|Overall Study|Withdrawal by Subject|0|||
162711662|NCT03781804|587654940|FG001|Overall Study|Withdrawal by Subject|1|||
162711663|NCT03781804|587654941|FG002|Overall Study|Withdrawal by Subject|1|||
162711664|NCT03781804|587654939|FG000|Overall Study|Reason not provided|2|||
162711665|NCT03781804|587654940|FG001|Overall Study|Reason not provided|2|||
162711666|NCT03781804|587654941|FG002|Overall Study|Reason not provided|0|||
162711667|NCT04678830|587654942|FG000|Overall Study|Lack of Efficacy|2|||
162711668|NCT04678830|587654943|FG001|Overall Study|Lack of Efficacy|0|||
162711669|NCT04678830|587654942|FG000|Overall Study|Withdrawal by Subject|0|||
162711670|NCT04678830|587654943|FG001|Overall Study|Withdrawal by Subject|1|||
162711671|NCT01836458|587654946|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
162711672|NCT01836458|587654947|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162711673|NCT01836458|587654948|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
162711674|NCT01836458|587654949|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
162711675|NCT00429793|587654950|FG000|Overall Study|Improper pre-protocol treatment|3|||
162711676|NCT00429793|587654950|FG000|Overall Study|Required test not done|1|||
162711677|NCT00429793|587654950|FG000|Overall Study|Never treated|1|||
162711678|NCT00429793|587654950|FG000|Overall Study|Non-measurable|1|||
162711679|NCT00813488|587654951|FG000|Titration Period 1|Adverse Event|6|||
162711680|NCT00813488|587654952|FG001|Titration Period 1|Adverse Event|1|||
162711681|NCT00813488|587654951|FG000|Titration Period 1|Lack of Efficacy|9|||
162711682|NCT00813488|587654952|FG001|Titration Period 1|Lack of Efficacy|7|||
162711683|NCT00813488|587654951|FG000|Titration Period 1|Withdrawal by Subject|2|||
162711684|NCT00813488|587654952|FG001|Titration Period 1|Withdrawal by Subject|2|||
162711685|NCT00813488|587654951|FG000|Titration Period 1|Protocol Violation|4|||
162711686|NCT00813488|587654952|FG001|Titration Period 1|Protocol Violation|3|||
162711687|NCT00813488|587654951|FG000|Titration Period 1|Non-compliance to study medication|4|||
162711688|NCT00813488|587654952|FG001|Titration Period 1|Non-compliance to study medication|1|||
162711689|NCT00813488|587654951|FG000|Titration Period 1|Non-compliance to study procedures|2|||
162711690|NCT00813488|587654952|FG001|Titration Period 1|Non-compliance to study procedures|2|||
162711691|NCT00813488|587654951|FG000|Titration Period 1|Technical Difficulties|0|||
162711692|NCT00813488|587654952|FG001|Titration Period 1|Technical Difficulties|1|||
162711693|NCT00813488|587654951|FG000|Titration Period 2|Adverse Event|2|||
162918880|NCT05182840|588404950|FG000|Run-in Period|Change of residence|1|||
162711694|NCT00813488|587654952|FG001|Titration Period 2|Adverse Event|3|||
162711695|NCT00813488|587654951|FG000|Titration Period 2|Lack of Efficacy|8|||
162711696|NCT00813488|587654952|FG001|Titration Period 2|Lack of Efficacy|4|||
162711697|NCT00813488|587654951|FG000|Titration Period 2|Protocol Violation|3|||
162711698|NCT00813488|587654952|FG001|Titration Period 2|Protocol Violation|2|||
162711699|NCT00813488|587654951|FG000|Titration Period 2|Lost to Follow-up|1|||
162711700|NCT00813488|587654952|FG001|Titration Period 2|Lost to Follow-up|0|||
162711701|NCT00813488|587654951|FG000|Titration Period 2|Non-compliance with study procedures|2|||
162918881|NCT05182840|588404951|FG001|Run-in Period|Change of residence|0|||
163055717|NCT01326871|588916090|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
163055718|NCT01326871|588916091|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
162711702|NCT00813488|587654952|FG001|Titration Period 2|Non-compliance with study procedures|1|||
162711703|NCT00813488|587654951|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
162711704|NCT00813488|587654952|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
162711705|NCT00813488|587654951|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
162711706|NCT00813488|587654952|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
162711707|NCT00813488|587654951|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
162711708|NCT00813488|587654952|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
162711709|NCT00813488|587654951|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
162711710|NCT00813488|587654952|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
162711711|NCT00813488|587654951|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
162711712|NCT00813488|587654952|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
162711713|NCT00813488|587654951|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
162711714|NCT00813488|587654952|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
162711715|NCT00813488|587654951|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
162711716|NCT00813488|587654952|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
162711717|NCT00813488|587654951|FG000|Double-blind Treatment Period 2|Other|1|||
162711718|NCT00813488|587654952|FG001|Double-blind Treatment Period 2|Other|0|||
162711719|NCT00813488|587654951|FG000|Open-label Extension|Adverse Event|1|||
162711720|NCT00813488|587654952|FG001|Open-label Extension|Adverse Event|2|||
162711721|NCT00813488|587654951|FG000|Open-label Extension|Lack of Efficacy|3|||
162711722|NCT00813488|587654952|FG001|Open-label Extension|Lack of Efficacy|0|||
162711723|NCT00813488|587654951|FG000|Open-label Extension|Withdrawal by Subject|0|||
162711724|NCT00813488|587654952|FG001|Open-label Extension|Withdrawal by Subject|2|||
162711725|NCT00813488|587654951|FG000|Open-label Extension|Protocol Violation|1|||
162711726|NCT00813488|587654952|FG001|Open-label Extension|Protocol Violation|2|||
162711727|NCT00813488|587654951|FG000|Open-label Extension|Non-compliance study medication|4|||
162711728|NCT00813488|587654952|FG001|Open-label Extension|Non-compliance study medication|0|||
162711729|NCT00813488|587654951|FG000|Open-label Extension|Non-compliance study procedures|2|||
162711730|NCT00813488|587654952|FG001|Open-label Extension|Non-compliance study procedures|1|||
162711731|NCT00813488|587654951|FG000|Open-label Extension|Other|1|||
162711732|NCT00813488|587654952|FG001|Open-label Extension|Other|0|||
162711733|NCT01333514|587654955|FG000|Overall Study|Withdrawal by Subject|1|||
162711734|NCT01333514|587654956|FG001|Overall Study|Withdrawal by Subject|0|||
162711735|NCT00836810|587654957|FG000|Overall Study|New diagnosis|1|||
162711736|NCT00836810|587654958|FG001|Overall Study|New diagnosis|0|||
162711737|NCT00819910|587654959|FG000|Overall Study|Adverse Event|0|||
162711738|NCT00819910|587654960|FG001|Overall Study|Adverse Event|0|||
162711739|NCT00819910|587654961|FG002|Overall Study|Adverse Event|2|||
162711740|NCT00819910|587654962|FG003|Overall Study|Adverse Event|1|||
162711741|NCT00819910|587654959|FG000|Overall Study|Withdrawal by Subject|1|||
162711742|NCT00819910|587654960|FG001|Overall Study|Withdrawal by Subject|1|||
162711743|NCT00819910|587654961|FG002|Overall Study|Withdrawal by Subject|1|||
162711744|NCT00819910|587654962|FG003|Overall Study|Withdrawal by Subject|0|||
162711745|NCT00819910|587654959|FG000|Overall Study|Lost to Follow-up|1|||
162711746|NCT00819910|587654960|FG001|Overall Study|Lost to Follow-up|0|||
162711747|NCT00819910|587654961|FG002|Overall Study|Lost to Follow-up|0|||
162711748|NCT00819910|587654962|FG003|Overall Study|Lost to Follow-up|0|||
162711749|NCT00871429|587654963|FG000|Overall Study|Lost to Follow-up|6|||
162711750|NCT00871429|587654963|FG000|Overall Study|Withdrawal by Subject|17|||
162711751|NCT00871429|587654963|FG000|Overall Study|Questionnaire not completed|1|||
162711752|NCT01772719|587654965|FG000|Overall Study|Withdrawal by Subject|3|||
162711753|NCT01772719|587654965|FG000|Overall Study|Adverse Event|2|||
162711754|NCT01772719|587654965|FG000|Overall Study|Protocol Violation|1|||
162711755|NCT01772719|587654965|FG000|Overall Study|Lost to Follow-up|1|||
162711756|NCT00477412|587654966|FG000|Overall Study|Death|0|||
162711757|NCT00477412|587654967|FG001|Overall Study|Death|0|||
162711758|NCT00477412|587654968|FG002|Overall Study|Death|0|||
162711759|NCT00477412|587654969|FG003|Overall Study|Death|4|||
162711760|NCT00477412|587654966|FG000|Overall Study|Lost to Follow-up|0|||
162711761|NCT00477412|587654967|FG001|Overall Study|Lost to Follow-up|0|||
162711762|NCT00477412|587654968|FG002|Overall Study|Lost to Follow-up|0|||
162918882|NCT05182840|588404952|FG002|Run-in Period|Change of residence|0|||
162918883|NCT05182840|588404953|FG003|Run-in Period|Change of residence|0|||
162918884|NCT05182840|588404954|FG004|Run-in Period|Change of residence|0|||
162918885|NCT05182840|588404955|FG005|Run-in Period|Change of residence|0|||
162918886|NCT05182840|588404956|FG006|Run-in Period|Change of residence|0|||
162918887|NCT05182840|588404957|FG007|Run-in Period|Change of residence|0|||
162711763|NCT00477412|587654969|FG003|Overall Study|Lost to Follow-up|1|||
162711764|NCT00477412|587654966|FG000|Overall Study|Withdrawal by Subject|0|||
162711765|NCT00477412|587654967|FG001|Overall Study|Withdrawal by Subject|0|||
162711766|NCT00477412|587654968|FG002|Overall Study|Withdrawal by Subject|0|||
162711767|NCT00477412|587654969|FG003|Overall Study|Withdrawal by Subject|2|||
162711768|NCT00477412|587654966|FG000|Overall Study|Second Malignancy|0|||
162711769|NCT00477412|587654967|FG001|Overall Study|Second Malignancy|0|||
162711770|NCT00477412|587654968|FG002|Overall Study|Second Malignancy|0|||
162918888|NCT05182840|588404958|FG008|Run-in Period|Change of residence|0|||
162629263|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162629264|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
162629265|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
162629266|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162629267|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162629268|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162629269|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162629270|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
162629271|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
162629272|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
162629273|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
162629274|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
162629275|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
162629276|NCT00642460|587361052|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162629277|NCT00642460|587361053|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162629278|NCT00642460|587361054|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162629279|NCT00642460|587361055|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
162629280|NCT00642460|587361056|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162629281|NCT00642460|587361057|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162629282|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162629283|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162629284|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162629285|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162629286|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
162629287|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
162629288|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162629289|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162629290|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162629291|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162629292|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
162629293|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
162629294|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162629295|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162629296|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162629297|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162629298|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
162629299|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
162629300|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162629301|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162629302|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162629303|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162629304|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
162629305|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
162629306|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Other|0|||
162629307|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Other|0|||
162629308|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Other|0|||
162629309|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Other|0|||
162629310|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Other|2|||
162629311|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Other|2|||
162629312|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Death|0|||
162629313|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Death|0|||
162629314|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Death|0|||
162629315|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Death|0|||
162629316|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Death|0|||
162629317|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Death|3|||
162629318|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162629319|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162629320|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162629321|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162629322|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162629323|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
162629324|NCT00642460|587361052|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162629325|NCT00642460|587361053|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162629326|NCT00642460|587361054|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162629327|NCT00642460|587361055|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162918889|NCT05182840|588404959|FG009|Run-in Period|Change of residence|0|||
162629328|NCT00642460|587361056|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
162629329|NCT00642460|587361057|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
162629330|NCT04605484|587361061|FG000|Overall Study|Lost to Follow-up|0|||
162629331|NCT04605484|587361062|FG001|Overall Study|Lost to Follow-up|1|||
162629332|NCT04605484|587361063|FG002|Overall Study|Lost to Follow-up|1|||
162629333|NCT04605484|587361061|FG000|Overall Study|Other|0|||
162629334|NCT04605484|587361062|FG001|Overall Study|Other|1|||
162629335|NCT04605484|587361063|FG002|Overall Study|Other|0|||
162629336|NCT04171531|587361066|FG000|Overall Study|Lost to Follow-up|4|||
162629337|NCT04171531|587361067|FG001|Overall Study|Lost to Follow-up|5|||
162629338|NCT04171531|587361066|FG000|Overall Study|Consent only through 6 months|1|||
162629339|NCT04171531|587361067|FG001|Overall Study|Consent only through 6 months|1|||
162629340|NCT04171531|587361066|FG000|Overall Study|Insurance did not cover procedure|0|||
162629341|NCT04171531|587361067|FG001|Overall Study|Insurance did not cover procedure|1|||
162629342|NCT04171531|587361066|FG000|Overall Study|Physician Decision|0|||
162629343|NCT04171531|587361067|FG001|Overall Study|Physician Decision|3|||
162629344|NCT04171531|587361066|FG000|Overall Study|Withdrawal by Subject|1|||
162629345|NCT04171531|587361067|FG001|Overall Study|Withdrawal by Subject|5|||
162629346|NCT05537883|587361070|FG000|Overall Study|revisional surgery|4|||
162629347|NCT05537883|587361071|FG001|Overall Study|revisional surgery|2|||
162629348|NCT05537883|587361070|FG000|Overall Study|surgeries were cancelled|0|||
162629349|NCT05537883|587361071|FG001|Overall Study|surgeries were cancelled|2|||
162629350|NCT05537883|587361070|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
162629351|NCT05537883|587361071|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
162629352|NCT03366337|587361072|FG000|Overall Study|Lost to Follow-up|1|||
162629353|NCT03366337|587361073|FG001|Overall Study|Lost to Follow-up|0|||
162629354|NCT03366337|587361074|FG002|Overall Study|Lost to Follow-up|1|||
162629355|NCT03366337|587361075|FG003|Overall Study|Lost to Follow-up|0|||
162629356|NCT03366337|587361072|FG000|Overall Study|Withdrawal by Subject|2|||
162629357|NCT03366337|587361073|FG001|Overall Study|Withdrawal by Subject|0|||
162629358|NCT03366337|587361074|FG002|Overall Study|Withdrawal by Subject|1|||
162629359|NCT03366337|587361075|FG003|Overall Study|Withdrawal by Subject|1|||
162629360|NCT02296320|587361077|FG000|Overall Study|Withdrawal by Subject|4|||
162629361|NCT02296320|587361078|FG001|Overall Study|Withdrawal by Subject|0|||
162629362|NCT02296320|587361079|FG002|Overall Study|Withdrawal by Subject|2|||
162629363|NCT02296320|587361077|FG000|Overall Study|Death|24|||
162629364|NCT02296320|587361078|FG001|Overall Study|Death|3|||
162629365|NCT02296320|587361079|FG002|Overall Study|Death|27|||
162629366|NCT02296320|587361077|FG000|Overall Study|Lost to Follow-up|5|||
162629367|NCT02296320|587361078|FG001|Overall Study|Lost to Follow-up|2|||
162629368|NCT02296320|587361079|FG002|Overall Study|Lost to Follow-up|7|||
162629369|NCT02296320|587361077|FG000|Overall Study|Not treated|2|||
162629370|NCT02296320|587361078|FG001|Overall Study|Not treated|0|||
162629371|NCT02296320|587361079|FG002|Overall Study|Not treated|0|||
162629372|NCT02296320|587361077|FG000|Overall Study|Not - specified|0|||
162629373|NCT02296320|587361078|FG001|Overall Study|Not - specified|0|||
162629374|NCT02296320|587361079|FG002|Overall Study|Not - specified|1|||
162629375|NCT01697566|587361088|FG000|Overall Study|Withdrawal by Subject|0|||
162629376|NCT01697566|587361089|FG001|Overall Study|Withdrawal by Subject|0|||
162629377|NCT01697566|587361090|FG002|Overall Study|Withdrawal by Subject|1|||
162629378|NCT01697566|587361091|FG003|Overall Study|Withdrawal by Subject|1|||
162629379|NCT01697566|587361088|FG000|Overall Study|Final biopsy not obtained|0|||
162629380|NCT01697566|587361089|FG001|Overall Study|Final biopsy not obtained|0|||
162629381|NCT01697566|587361090|FG002|Overall Study|Final biopsy not obtained|1|||
162629382|NCT01697566|587361091|FG003|Overall Study|Final biopsy not obtained|0|||
162629383|NCT01447433|587361092|FG000|Overall Study|Lost to Follow-up|0|||
162629384|NCT01447433|587361093|FG001|Overall Study|Lost to Follow-up|2|||
162629385|NCT01447433|587361092|FG000|Overall Study|Withdrawal by Subject|3|||
162629386|NCT01447433|587361093|FG001|Overall Study|Withdrawal by Subject|3|||
162629387|NCT01447433|587361092|FG000|Overall Study|Protocol Violation|1|||
162629388|NCT01447433|587361093|FG001|Overall Study|Protocol Violation|1|||
162629389|NCT01578187|587361094|FG000|Usability Phase|Withdrawal by Subject|1|||
162629390|NCT02516163|587361099|FG000|Overall Study|Withdrawal by Subject|1|||
162629391|NCT02516163|587361099|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
162629392|NCT02516163|587361099|FG000|Overall Study|Unfit/delay in surgery|3|||
162629393|NCT02516163|587361099|FG000|Overall Study|Use of incorrect measurement technique|5|||
162629394|NCT02516163|587361099|FG000|Overall Study|Data not recorded|2|||
162629395|NCT02516163|587361099|FG000|Overall Study|MRI contraindication exclusion|6|||
162629396|NCT01217814|587361100|FG000|Overall Study|Adverse Event|1|||
162629397|NCT01217814|587361101|FG001|Overall Study|Adverse Event|1|||
162629398|NCT01217814|587361102|FG002|Overall Study|Adverse Event|0|||
162629399|NCT01217814|587361100|FG000|Overall Study|Lack of Efficacy|0|||
162629400|NCT01217814|587361101|FG001|Overall Study|Lack of Efficacy|0|||
162629401|NCT01217814|587361102|FG002|Overall Study|Lack of Efficacy|1|||
162629402|NCT01658072|587361105|FG000|Overall Study|Protocol Violation|4|||
162629403|NCT01658072|587361106|FG001|Overall Study|Protocol Violation|2|||
162629404|NCT00040664|587361107|FG000|Overall Study|Adverse Event|12|||
162629405|NCT00040664|587361108|FG001|Overall Study|Adverse Event|3|||
163055719|NCT01326871|588916092|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
163055720|NCT01326871|588916090|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
163055721|NCT01326871|588916091|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
163055722|NCT01326871|588916092|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
163055723|NCT01326871|588916090|FG000|Overall Study|Withdrawal by Subject|0|||
163055724|NCT01326871|588916091|FG001|Overall Study|Withdrawal by Subject|1|||
163055725|NCT01326871|588916092|FG002|Overall Study|Withdrawal by Subject|0|||
163055726|NCT01326871|588916090|FG000|Overall Study|DLT|0|||
163055727|NCT01326871|588916091|FG001|Overall Study|DLT|2|||
163055728|NCT01326871|588916092|FG002|Overall Study|DLT|0|||
163055729|NCT01326871|588916090|FG000|Overall Study|SAE, disease progression and subject decision|0|||
163055730|NCT01326871|588916091|FG001|Overall Study|SAE, disease progression and subject decision|1|||
163055731|NCT01326871|588916092|FG002|Overall Study|SAE, disease progression and subject decision|0|||
163055732|NCT01326871|588916090|FG000|Overall Study|Death|0|||
163055733|NCT01326871|588916091|FG001|Overall Study|Death|1|||
163055734|NCT01326871|588916092|FG002|Overall Study|Death|0|||
163055735|NCT01326871|588916090|FG000|Overall Study|Other|0|||
163055736|NCT01326871|588916091|FG001|Overall Study|Other|3|||
163055737|NCT01326871|588916092|FG002|Overall Study|Other|0|||
163055738|NCT01326871|588916090|FG000|Overall Study|SAE and disease progression|0|||
163055739|NCT01326871|588916091|FG001|Overall Study|SAE and disease progression|0|||
163055740|NCT01326871|588916092|FG002|Overall Study|SAE and disease progression|1|||
163055741|NCT01326871|588916090|FG000|Overall Study|SAE and physician decision|0|||
163055742|NCT01326871|588916091|FG001|Overall Study|SAE and physician decision|0|||
163055743|NCT01326871|588916092|FG002|Overall Study|SAE and physician decision|1|||
163055744|NCT01326871|588916090|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
163055745|NCT01326871|588916091|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
163055746|NCT01326871|588916092|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
163055747|NCT01326871|588916090|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
163055748|NCT01326871|588916091|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
163055749|NCT01326871|588916092|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
163055750|NCT01326871|588916090|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
163055751|NCT01326871|588916091|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
163055752|NCT01326871|588916092|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
163055753|NCT01326871|588916090|FG000|Overall Study|Physician Decision|0|||
163055754|NCT01326871|588916091|FG001|Overall Study|Physician Decision|0|||
163055755|NCT01326871|588916092|FG002|Overall Study|Physician Decision|1|||
163055756|NCT01326871|588916090|FG000|Overall Study|SAE|0|||
163055757|NCT01326871|588916091|FG001|Overall Study|SAE|0|||
163055758|NCT01326871|588916092|FG002|Overall Study|SAE|1|||
163055759|NCT01326871|588916090|FG000|Overall Study|Disease progression and death|0|||
163055760|NCT01326871|588916091|FG001|Overall Study|Disease progression and death|0|||
162918890|NCT05182840|588404950|FG000|Run-in Period|Adverse Event|5|||
162918891|NCT05182840|588404951|FG001|Run-in Period|Adverse Event|5|||
163055761|NCT01326871|588916092|FG002|Overall Study|Disease progression and death|1|||
163055762|NCT01326871|588916090|FG000|Overall Study|Subject decision|0|||
162711771|NCT00477412|587654969|FG003|Overall Study|Second Malignancy|1|||
162711772|NCT00477412|587654966|FG000|Overall Study|Adverse Event|1|||
162711773|NCT00477412|587654967|FG001|Overall Study|Adverse Event|0|||
162711774|NCT00477412|587654968|FG002|Overall Study|Adverse Event|1|||
162711775|NCT00477412|587654969|FG003|Overall Study|Adverse Event|0|||
162711776|NCT01560949|587654970|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
162711777|NCT01560949|587654970|FG000|Surgery Phase|Physician Decision|3|||
162711778|NCT05460663|587654971|FG000|Overall Study|Withdrawal by Subject|2|||
162711779|NCT05460663|587654972|FG001|Overall Study|Withdrawal by Subject|5|||
162711780|NCT04155424|587654973|FG000|Overall Study|Other than specified|3|||
162711781|NCT04155424|587654973|FG000|Overall Study|Withdrawal by Subject|1|||
162711782|NCT04155424|587654973|FG000|Overall Study|Adverse Event|1|||
162711783|NCT03068468|587656761|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
162711784|NCT03068468|587656762|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
162711785|NCT03068468|587656763|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
162711786|NCT03068468|587656764|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
162711787|NCT03068468|587656761|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
162711788|NCT03068468|587656762|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
162711789|NCT03068468|587656763|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
162711790|NCT03068468|587656764|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
162711791|NCT03068468|587656761|FG000|Placebo-Controlled Period|Adverse Event|16|||
162711792|NCT03068468|587656762|FG001|Placebo-Controlled Period|Adverse Event|21|||
162711793|NCT03068468|587656763|FG002|Placebo-Controlled Period|Adverse Event|0|||
162711794|NCT03068468|587656764|FG003|Placebo-Controlled Period|Adverse Event|0|||
162711795|NCT03068468|587656761|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
162711796|NCT03068468|587656762|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
162711797|NCT03068468|587656763|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
162711798|NCT03068468|587656764|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
162711799|NCT03068468|587656761|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162711800|NCT03068468|587656762|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
162711801|NCT03068468|587656763|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162711802|NCT03068468|587656764|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162711803|NCT03068468|587656761|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
162711804|NCT03068468|587656762|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
162711805|NCT03068468|587656763|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
162711806|NCT03068468|587656764|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
162711807|NCT03068468|587656761|FG000|Placebo-Controlled Period|Death|0|||
162711808|NCT03068468|587656762|FG001|Placebo-Controlled Period|Death|1|||
162711809|NCT03068468|587656763|FG002|Placebo-Controlled Period|Death|0|||
162711810|NCT03068468|587656764|FG003|Placebo-Controlled Period|Death|0|||
162711811|NCT03068468|587656761|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
162711812|NCT03068468|587656762|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
162711813|NCT03068468|587656763|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
162711814|NCT03068468|587656764|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
162711815|NCT03068468|587656761|FG000|Open-Label Extension Period|Adverse Event|0|||
162711816|NCT03068468|587656762|FG001|Open-Label Extension Period|Adverse Event|0|||
162711817|NCT03068468|587656763|FG002|Open-Label Extension Period|Adverse Event|13|||
162711818|NCT03068468|587656764|FG003|Open-Label Extension Period|Adverse Event|17|||
162711819|NCT03068468|587656761|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
162711820|NCT03068468|587656762|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
162711821|NCT03068468|587656763|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
162711822|NCT03068468|587656764|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
162711823|NCT03068468|587656761|FG000|Open-Label Extension Period|Death|0|||
162711824|NCT03068468|587656762|FG001|Open-Label Extension Period|Death|0|||
162711825|NCT03068468|587656763|FG002|Open-Label Extension Period|Death|0|||
162711826|NCT03068468|587656764|FG003|Open-Label Extension Period|Death|1|||
162711827|NCT03068468|587656761|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
162711828|NCT03068468|587656762|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
162711829|NCT03068468|587656763|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
162711830|NCT03068468|587656764|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
163055763|NCT01326871|588916091|FG001|Overall Study|Subject decision|0|||
162711831|NCT03068468|587656761|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162711832|NCT03068468|587656762|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162711833|NCT03068468|587656763|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
162711834|NCT03068468|587656764|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162711835|NCT03068468|587656761|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
162711836|NCT03068468|587656762|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
162711837|NCT03068468|587656763|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
162711838|NCT03068468|587656764|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
162711839|NCT03068468|587656761|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
162711840|NCT03068468|587656762|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163055764|NCT01326871|588916092|FG002|Overall Study|Subject decision|1|||
162711841|NCT03068468|587656763|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
162711842|NCT03068468|587656764|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
162711843|NCT03068468|587656761|FG000|Open-Label Extension Period|Reason not Specified|0|||
162711844|NCT03068468|587656762|FG001|Open-Label Extension Period|Reason not Specified|0|||
162711845|NCT03068468|587656763|FG002|Open-Label Extension Period|Reason not Specified|1|||
162711846|NCT03068468|587656764|FG003|Open-Label Extension Period|Reason not Specified|4|||
162918892|NCT05182840|588404952|FG002|Run-in Period|Adverse Event|0|||
163055765|NCT00251758|588916093|FG000|Overall Study|Adverse Event|7|||
162918893|NCT05182840|588404953|FG003|Run-in Period|Adverse Event|0|||
162918894|NCT05182840|588404954|FG004|Run-in Period|Adverse Event|0|||
162918895|NCT05182840|588404955|FG005|Run-in Period|Adverse Event|0|||
162918896|NCT05182840|588404956|FG006|Run-in Period|Adverse Event|0|||
162918897|NCT05182840|588404957|FG007|Run-in Period|Adverse Event|0|||
162918898|NCT05182840|588404958|FG008|Run-in Period|Adverse Event|0|||
162969650|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
162969651|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
162969652|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
162969653|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969654|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
162969655|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969656|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
162969657|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969658|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
162969659|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969660|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162969661|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
162969662|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
162969663|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
162969664|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
162969665|NCT01685008|588590003|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
162969666|NCT01685008|588590004|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
162969667|NCT01685008|588590005|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
162969668|NCT01685008|588590006|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
162969669|NCT01963260|588590010|FG000|Overall Study|Withdrawal by Subject|2|||
162969670|NCT01963260|588590011|FG001|Overall Study|Withdrawal by Subject|0|||
162969671|NCT01963260|588590012|FG002|Overall Study|Withdrawal by Subject|0|||
162969672|NCT01963260|588590013|FG003|Overall Study|Withdrawal by Subject|1|||
162969673|NCT01963260|588590014|FG004|Overall Study|Withdrawal by Subject|2|||
162969674|NCT01963260|588590015|FG005|Overall Study|Withdrawal by Subject|0|||
162969675|NCT01963260|588590016|FG006|Overall Study|Withdrawal by Subject|0|||
162969676|NCT01963260|588590017|FG007|Overall Study|Withdrawal by Subject|0|||
162969677|NCT01963260|588590018|FG008|Overall Study|Withdrawal by Subject|0|||
162969678|NCT01963260|588590019|FG009|Overall Study|Withdrawal by Subject|0|||
162969679|NCT02340962|588590020|FG000|Overall Study|Lost to Follow-up|1|||
162969680|NCT02340962|588590021|FG001|Overall Study|Lost to Follow-up|0|||
162969681|NCT04994431|588590022|FG000|Overall Study|Adverse Event|1|||
162969682|NCT04994431|588590023|FG001|Overall Study|Adverse Event|0|||
162969683|NCT01341405|588590025|FG000|Overall Study|Adverse Event|0|||
162969684|NCT01341405|588590026|FG001|Overall Study|Adverse Event|1|||
162969685|NCT01341405|588590027|FG002|Overall Study|Adverse Event|1|||
162969686|NCT01341405|588590025|FG000|Overall Study|Withdrawal by Subject|3|||
162969687|NCT01341405|588590026|FG001|Overall Study|Withdrawal by Subject|2|||
162969688|NCT01341405|588590027|FG002|Overall Study|Withdrawal by Subject|1|||
162969689|NCT02760433|588590028|FG000|Overall Study|Lost to Follow-up|1|||
162969690|NCT02760433|588590029|FG001|Overall Study|Lost to Follow-up|0|||
162969691|NCT02760433|588590030|FG002|Overall Study|Lost to Follow-up|1|||
162969692|NCT02760433|588590031|FG003|Overall Study|Lost to Follow-up|0|||
162969693|NCT02760433|588590032|FG004|Overall Study|Lost to Follow-up|0|||
162969694|NCT02760433|588590028|FG000|Overall Study|Withdrawal by Subject|23|||
162969695|NCT02760433|588590029|FG001|Overall Study|Withdrawal by Subject|9|||
162969696|NCT02760433|588590030|FG002|Overall Study|Withdrawal by Subject|0|||
162969697|NCT02760433|588590031|FG003|Overall Study|Withdrawal by Subject|2|||
162969698|NCT02760433|588590032|FG004|Overall Study|Withdrawal by Subject|9|||
162969699|NCT02760433|588590028|FG000|Overall Study|Lack of Response At Week 14|0|||
162969700|NCT02760433|588590029|FG001|Overall Study|Lack of Response At Week 14|0|||
162711847|NCT03140176|587656772|FG000|Overall Study|Reason missing|23|||
162711848|NCT03140176|587656772|FG000|Overall Study|Death|33|||
162918899|NCT05182840|588404959|FG009|Run-in Period|Adverse Event|0|||
162969701|NCT02760433|588590030|FG002|Overall Study|Lack of Response At Week 14|0|||
162969702|NCT02760433|588590031|FG003|Overall Study|Lack of Response At Week 14|0|||
163055766|NCT00251758|588916094|FG001|Overall Study|Adverse Event|9|||
163055767|NCT00251758|588916095|FG002|Overall Study|Adverse Event|11|||
162918900|NCT05182840|588404950|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
162918901|NCT05182840|588404951|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
162918902|NCT05182840|588404952|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918903|NCT05182840|588404953|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918904|NCT05182840|588404954|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918905|NCT05182840|588404955|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918906|NCT05182840|588404956|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918907|NCT05182840|588404957|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162629406|NCT00040664|587361109|FG002|Overall Study|Adverse Event|2|||
162629407|NCT00040664|587361110|FG003|Overall Study|Adverse Event|7|||
162629408|NCT00040664|587361107|FG000|Overall Study|Lack of Efficacy|9|||
162629409|NCT00040664|587361108|FG001|Overall Study|Lack of Efficacy|2|||
162629410|NCT00040664|587361109|FG002|Overall Study|Lack of Efficacy|3|||
162629411|NCT00040664|587361110|FG003|Overall Study|Lack of Efficacy|4|||
162629412|NCT00040664|587361107|FG000|Overall Study|Insufficient CD4 response|1|||
162629413|NCT00040664|587361108|FG001|Overall Study|Insufficient CD4 response|0|||
162629414|NCT00040664|587361109|FG002|Overall Study|Insufficient CD4 response|1|||
162629415|NCT00040664|587361110|FG003|Overall Study|Insufficient CD4 response|0|||
162629416|NCT00040664|587361107|FG000|Overall Study|Lost to Follow-up|4|||
162629417|NCT00040664|587361108|FG001|Overall Study|Lost to Follow-up|2|||
162629418|NCT00040664|587361109|FG002|Overall Study|Lost to Follow-up|0|||
162629419|NCT00040664|587361110|FG003|Overall Study|Lost to Follow-up|2|||
162629420|NCT00040664|587361107|FG000|Overall Study|Protocol Violation|2|||
162629421|NCT00040664|587361108|FG001|Overall Study|Protocol Violation|1|||
162629422|NCT00040664|587361109|FG002|Overall Study|Protocol Violation|0|||
162629423|NCT00040664|587361110|FG003|Overall Study|Protocol Violation|1|||
162629424|NCT00040664|587361107|FG000|Overall Study|Withdrawal by Subject|7|||
162629425|NCT00040664|587361108|FG001|Overall Study|Withdrawal by Subject|0|||
162629426|NCT00040664|587361109|FG002|Overall Study|Withdrawal by Subject|3|||
162629427|NCT00040664|587361110|FG003|Overall Study|Withdrawal by Subject|4|||
162629428|NCT00040664|587361107|FG000|Overall Study|Pregnancy|3|||
162629429|NCT00040664|587361108|FG001|Overall Study|Pregnancy|0|||
162629430|NCT00040664|587361109|FG002|Overall Study|Pregnancy|0|||
162629431|NCT00040664|587361110|FG003|Overall Study|Pregnancy|3|||
162629432|NCT00040664|587361107|FG000|Overall Study|Medication adherence/compliance problems|8|||
162629433|NCT00040664|587361108|FG001|Overall Study|Medication adherence/compliance problems|2|||
162629434|NCT00040664|587361109|FG002|Overall Study|Medication adherence/compliance problems|1|||
162629435|NCT00040664|587361110|FG003|Overall Study|Medication adherence/compliance problems|5|||
162629436|NCT00040664|587361107|FG000|Overall Study|Poor taste|2|||
162629437|NCT00040664|587361108|FG001|Overall Study|Poor taste|0|||
162629438|NCT00040664|587361109|FG002|Overall Study|Poor taste|2|||
162629439|NCT00040664|587361110|FG003|Overall Study|Poor taste|0|||
162629440|NCT00040664|587361107|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
162629441|NCT00040664|587361108|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
162629442|NCT00040664|587361109|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
162629443|NCT00040664|587361110|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
162629444|NCT00040664|587361107|FG000|Overall Study|Change of formulation|2|||
162629445|NCT00040664|587361108|FG001|Overall Study|Change of formulation|2|||
162629446|NCT00040664|587361109|FG002|Overall Study|Change of formulation|0|||
162629447|NCT00040664|587361110|FG003|Overall Study|Change of formulation|0|||
162629448|NCT00040664|587361107|FG000|Overall Study|Non-viability of oral suspension|1|||
162629449|NCT00040664|587361108|FG001|Overall Study|Non-viability of oral suspension|0|||
162629450|NCT00040664|587361109|FG002|Overall Study|Non-viability of oral suspension|1|||
162629451|NCT00040664|587361110|FG003|Overall Study|Non-viability of oral suspension|0|||
162629452|NCT01709162|587361111|FG000|Overall Study|Disease progression|3|||
162629453|NCT01709162|587361112|FG001|Overall Study|Disease progression|3|||
162629454|NCT01709162|587361111|FG000|Overall Study|Study drug toxicity|2|||
162629455|NCT01709162|587361112|FG001|Overall Study|Study drug toxicity|0|||
162629456|NCT01709162|587361111|FG000|Overall Study|Administrative reason by sponsor|0|||
162629457|NCT01709162|587361112|FG001|Overall Study|Administrative reason by sponsor|1|||
162629458|NCT01709162|587361111|FG000|Overall Study|Other|1|||
162629459|NCT01709162|587361112|FG001|Overall Study|Other|0|||
162629460|NCT01709162|587361111|FG000|Overall Study|Withdrawal by Subject|0|||
162629461|NCT01709162|587361112|FG001|Overall Study|Withdrawal by Subject|1|||
162629462|NCT04545385|587361118|FG000|Overall Study|Withdrawal by Subject|2|||
162629463|NCT04545385|587361119|FG001|Overall Study|Withdrawal by Subject|0|||
162629464|NCT04545385|587361118|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
162629465|NCT04545385|587361119|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
162629466|NCT04545385|587361118|FG000|Overall Study|Study termination|10|||
162629467|NCT04545385|587361119|FG001|Overall Study|Study termination|10|||
162629468|NCT04545385|587361118|FG000|Overall Study|Sponsor decision|2|||
162969703|NCT02760433|588590032|FG004|Overall Study|Lack of Response At Week 14|1|||
162969704|NCT02760433|588590028|FG000|Overall Study|Subject refused to continue the study|1|||
162969705|NCT02760433|588590029|FG001|Overall Study|Subject refused to continue the study|0|||
162969706|NCT02760433|588590030|FG002|Overall Study|Subject refused to continue the study|0|||
162969707|NCT02760433|588590031|FG003|Overall Study|Subject refused to continue the study|0|||
162969708|NCT02760433|588590032|FG004|Overall Study|Subject refused to continue the study|0|||
162969709|NCT02760433|588590028|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
162969710|NCT02760433|588590029|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969711|NCT02760433|588590030|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969712|NCT02760433|588590031|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969713|NCT02760433|588590032|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
162969714|NCT02760433|588590028|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969715|NCT02760433|588590029|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
162969716|NCT02760433|588590030|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969717|NCT02760433|588590031|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969718|NCT02760433|588590032|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
162969719|NCT02151149|588590033|FG000|Treatment Period|Death|2|||
162969720|NCT02151149|588590034|FG001|Treatment Period|Death|3|||
162969721|NCT02151149|588590033|FG000|Treatment Period|Adverse Event|17|||
162969722|NCT02151149|588590034|FG001|Treatment Period|Adverse Event|14|||
162969723|NCT02151149|588590033|FG000|Treatment Period|Progressive Disease|25|||
162969724|NCT02151149|588590034|FG001|Treatment Period|Progressive Disease|24|||
162969725|NCT02151149|588590033|FG000|Treatment Period|Symptomatic Deterioration|2|||
162969726|NCT02151149|588590034|FG001|Treatment Period|Symptomatic Deterioration|10|||
162969727|NCT02151149|588590033|FG000|Treatment Period|Withdrawal by Subject|13|||
162969728|NCT02151149|588590034|FG001|Treatment Period|Withdrawal by Subject|11|||
162969729|NCT02151149|588590033|FG000|Treatment Period|Miscellaneous|8|||
162969730|NCT02151149|588590034|FG001|Treatment Period|Miscellaneous|7|||
162969731|NCT02151149|588590033|FG000|Treatment Period|Participants randomized but not treated|3|||
162969732|NCT02151149|588590034|FG001|Treatment Period|Participants randomized but not treated|2|||
162969733|NCT02151149|588590033|FG000|Follow-Up Period|Lost to Follow-up|2|||
162969734|NCT02151149|588590034|FG001|Follow-Up Period|Lost to Follow-up|3|||
162969735|NCT02151149|588590033|FG000|Follow-Up Period|Death|37|||
162969736|NCT02151149|588590034|FG001|Follow-Up Period|Death|34|||
162969737|NCT03419962|588590038|FG000|Overall Study|Change to other medication|1|||
162969738|NCT03419962|588590038|FG000|Overall Study|Refusal of continuing with trial drug|1|||
162969739|NCT03419962|588590038|FG000|Overall Study|Lost to Follow-up|3|||
162969740|NCT03419962|588590038|FG000|Overall Study|Difficulty in inhaling the doses|1|||
162969741|NCT03419962|588590038|FG000|Overall Study|Missing completion data|31|||
162969742|NCT03439085|588590039|FG000|Overall Study|Death|2|||
162969743|NCT03439085|588590039|FG000|Overall Study|Screen Failure|20|||
162969744|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
162629469|NCT04545385|587361119|FG001|Overall Study|Sponsor decision|2|||
162918908|NCT05182840|588404958|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918909|NCT05182840|588404959|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
162918910|NCT05182840|588404950|FG000|Treatment Period|Reason missing|0|||
162918911|NCT05182840|588404951|FG001|Treatment Period|Reason missing|0|||
162918912|NCT05182840|588404952|FG002|Treatment Period|Reason missing|1|||
162918913|NCT05182840|588404953|FG003|Treatment Period|Reason missing|0|||
162918914|NCT05182840|588404954|FG004|Treatment Period|Reason missing|0|||
162918915|NCT05182840|588404955|FG005|Treatment Period|Reason missing|0|||
162918916|NCT05182840|588404956|FG006|Treatment Period|Reason missing|0|||
162918917|NCT05182840|588404957|FG007|Treatment Period|Reason missing|0|||
162918918|NCT05182840|588404958|FG008|Treatment Period|Reason missing|0|||
162918919|NCT05182840|588404959|FG009|Treatment Period|Reason missing|0|||
162918920|NCT05182840|588404950|FG000|Treatment Period|Other but not sponsor termination|0|||
162918921|NCT05182840|588404951|FG001|Treatment Period|Other but not sponsor termination|0|||
162918922|NCT05182840|588404952|FG002|Treatment Period|Other but not sponsor termination|8|||
162918923|NCT05182840|588404953|FG003|Treatment Period|Other but not sponsor termination|6|||
162918924|NCT05182840|588404954|FG004|Treatment Period|Other but not sponsor termination|6|||
162969745|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
162969746|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
162629470|NCT04545385|587361118|FG000|Overall Study|Other than specified|1|||
162969747|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
162969748|NCT02224053|588590040|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
162969749|NCT01898598|588590044|FG000|Overall Study|Adverse Event|1|||
162629471|NCT04545385|587361119|FG001|Overall Study|Other than specified|0|||
162969750|NCT01898598|588590045|FG001|Overall Study|Adverse Event|0|||
162969751|NCT01898598|588590044|FG000|Overall Study|Withdrawal by Subject|3|||
162918925|NCT05182840|588404955|FG005|Treatment Period|Other but not sponsor termination|7|||
162918926|NCT05182840|588404956|FG006|Treatment Period|Other but not sponsor termination|5|||
162918927|NCT05182840|588404957|FG007|Treatment Period|Other but not sponsor termination|8|||
162918928|NCT05182840|588404958|FG008|Treatment Period|Other but not sponsor termination|7|||
162918929|NCT05182840|588404959|FG009|Treatment Period|Other but not sponsor termination|2|||
162918930|NCT05182840|588404950|FG000|Treatment Period|Protocol deviation|0|||
162918931|NCT05182840|588404951|FG001|Treatment Period|Protocol deviation|0|||
162918932|NCT05182840|588404952|FG002|Treatment Period|Protocol deviation|0|||
162918933|NCT05182840|588404953|FG003|Treatment Period|Protocol deviation|0|||
162918934|NCT05182840|588404954|FG004|Treatment Period|Protocol deviation|0|||
162918935|NCT05182840|588404955|FG005|Treatment Period|Protocol deviation|0|||
162918936|NCT05182840|588404956|FG006|Treatment Period|Protocol deviation|0|||
162918937|NCT05182840|588404957|FG007|Treatment Period|Protocol deviation|0|||
162918938|NCT05182840|588404958|FG008|Treatment Period|Protocol deviation|1|||
162918939|NCT05182840|588404959|FG009|Treatment Period|Protocol deviation|0|||
162918940|NCT05182840|588404950|FG000|Treatment Period|No reason available|0|||
162969752|NCT01898598|588590045|FG001|Overall Study|Withdrawal by Subject|0|||
162969753|NCT01898598|588590044|FG000|Overall Study|Lost to Follow-up|0|||
162969754|NCT01898598|588590045|FG001|Overall Study|Lost to Follow-up|1|||
162969755|NCT01898598|588590044|FG000|Overall Study|Other|0|||
162969756|NCT01898598|588590045|FG001|Overall Study|Other|1|||
162969757|NCT03833427|588590046|FG000|Overall Study|Death|4|||
162969758|NCT03833427|588590047|FG001|Overall Study|Death|2|||
162969759|NCT03833427|588590048|FG002|Overall Study|Death|9|||
162969760|NCT03833427|588590049|FG003|Overall Study|Death|11|||
162969761|NCT03833427|588590050|FG004|Overall Study|Death|0|||
162969762|NCT03833427|588590051|FG005|Overall Study|Death|0|||
162969763|NCT03833427|588590052|FG006|Overall Study|Death|0|||
162969764|NCT03833427|588590046|FG000|Overall Study|Withdrawal by Subject|0|||
162969765|NCT03833427|588590047|FG001|Overall Study|Withdrawal by Subject|1|||
162918941|NCT05182840|588404951|FG001|Treatment Period|No reason available|0|||
162918942|NCT05182840|588404952|FG002|Treatment Period|No reason available|0|||
162918943|NCT05182840|588404953|FG003|Treatment Period|No reason available|1|||
162918944|NCT05182840|588404954|FG004|Treatment Period|No reason available|0|||
162918945|NCT05182840|588404955|FG005|Treatment Period|No reason available|2|||
162918946|NCT05182840|588404956|FG006|Treatment Period|No reason available|0|||
162918947|NCT05182840|588404957|FG007|Treatment Period|No reason available|1|||
162918948|NCT05182840|588404958|FG008|Treatment Period|No reason available|0|||
162918949|NCT05182840|588404959|FG009|Treatment Period|No reason available|0|||
162918950|NCT05182840|588404950|FG000|Treatment Period|Burden of study procedures|0|||
162918951|NCT05182840|588404951|FG001|Treatment Period|Burden of study procedures|0|||
162918952|NCT05182840|588404952|FG002|Treatment Period|Burden of study procedures|0|||
162918953|NCT05182840|588404953|FG003|Treatment Period|Burden of study procedures|0|||
162918954|NCT05182840|588404954|FG004|Treatment Period|Burden of study procedures|1|||
162918955|NCT05182840|588404955|FG005|Treatment Period|Burden of study procedures|0|||
162918956|NCT05182840|588404956|FG006|Treatment Period|Burden of study procedures|0|||
162918957|NCT05182840|588404957|FG007|Treatment Period|Burden of study procedures|0|||
162918958|NCT05182840|588404958|FG008|Treatment Period|Burden of study procedures|0|||
162918959|NCT05182840|588404959|FG009|Treatment Period|Burden of study procedures|0|||
162918960|NCT05182840|588404950|FG000|Treatment Period|Change of residence|0|||
162918961|NCT05182840|588404951|FG001|Treatment Period|Change of residence|0|||
162918962|NCT05182840|588404952|FG002|Treatment Period|Change of residence|0|||
162918963|NCT05182840|588404953|FG003|Treatment Period|Change of residence|0|||
162918964|NCT05182840|588404954|FG004|Treatment Period|Change of residence|0|||
162918965|NCT05182840|588404955|FG005|Treatment Period|Change of residence|1|||
162918966|NCT05182840|588404956|FG006|Treatment Period|Change of residence|0|||
162918967|NCT05182840|588404957|FG007|Treatment Period|Change of residence|0|||
162918968|NCT05182840|588404958|FG008|Treatment Period|Change of residence|0|||
162969766|NCT03833427|588590048|FG002|Overall Study|Withdrawal by Subject|1|||
162969767|NCT03833427|588590049|FG003|Overall Study|Withdrawal by Subject|0|||
162969768|NCT03833427|588590050|FG004|Overall Study|Withdrawal by Subject|0|||
162629472|NCT01637272|587361128|FG000|Overall Study|Adverse Event|6|||
162969769|NCT03833427|588590051|FG005|Overall Study|Withdrawal by Subject|0|||
162629473|NCT01637272|587361128|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162629474|NCT01637272|587361128|FG000|Overall Study|Withdrawal by Subject|3|||
162918969|NCT05182840|588404959|FG009|Treatment Period|Change of residence|0|||
162918970|NCT05182840|588404950|FG000|Treatment Period|Adverse Event|0|||
162918971|NCT05182840|588404951|FG001|Treatment Period|Adverse Event|0|||
162969770|NCT03833427|588590052|FG006|Overall Study|Withdrawal by Subject|0|||
162969771|NCT03833427|588590046|FG000|Overall Study|Sponsor Decision|0|||
162969772|NCT03833427|588590047|FG001|Overall Study|Sponsor Decision|0|||
162969773|NCT03833427|588590048|FG002|Overall Study|Sponsor Decision|1|||
162918972|NCT05182840|588404952|FG002|Treatment Period|Adverse Event|4|||
162969774|NCT03833427|588590049|FG003|Overall Study|Sponsor Decision|3|||
162918973|NCT05182840|588404953|FG003|Treatment Period|Adverse Event|16|||
162918974|NCT05182840|588404954|FG004|Treatment Period|Adverse Event|12|||
162918975|NCT05182840|588404955|FG005|Treatment Period|Adverse Event|6|||
162918976|NCT05182840|588404956|FG006|Treatment Period|Adverse Event|4|||
162918977|NCT05182840|588404957|FG007|Treatment Period|Adverse Event|8|||
162918978|NCT05182840|588404958|FG008|Treatment Period|Adverse Event|16|||
162918979|NCT05182840|588404959|FG009|Treatment Period|Adverse Event|5|||
162918980|NCT05182840|588404950|FG000|Treatment Period|Not treated with study drug|0|||
162918981|NCT05182840|588404951|FG001|Treatment Period|Not treated with study drug|0|||
162918982|NCT05182840|588404952|FG002|Treatment Period|Not treated with study drug|0|||
162918983|NCT05182840|588404953|FG003|Treatment Period|Not treated with study drug|1|||
162918984|NCT05182840|588404954|FG004|Treatment Period|Not treated with study drug|0|||
162918985|NCT05182840|588404955|FG005|Treatment Period|Not treated with study drug|0|||
162918986|NCT05182840|588404956|FG006|Treatment Period|Not treated with study drug|1|||
162918987|NCT05182840|588404957|FG007|Treatment Period|Not treated with study drug|1|||
162918988|NCT05182840|588404958|FG008|Treatment Period|Not treated with study drug|0|||
162918989|NCT05182840|588404959|FG009|Treatment Period|Not treated with study drug|0|||
162918990|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
162918991|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
162918992|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
162918993|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162918994|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162918995|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162918996|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162918997|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162918998|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162918999|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
162919000|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162919001|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162919002|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162919003|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
162919004|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
162919005|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919006|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
162919007|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919008|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919009|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919010|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919011|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
162919012|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919013|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
162919014|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919015|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919016|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919017|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919018|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
162919019|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
162919020|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
162919021|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919022|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919023|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919024|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919025|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919026|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919027|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
162919028|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919029|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919030|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919031|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
162919032|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919033|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919034|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
162919035|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919036|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919037|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919038|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
162919039|NCT04242498|588404962|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919040|NCT04242498|588404963|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
162919041|NCT04242498|588404964|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
162919042|NCT04242498|588404965|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919043|NCT04242498|588404966|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919044|NCT04242498|588404967|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919045|NCT04242498|588404968|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919046|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919047|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919048|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919049|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919050|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
162919051|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
162919052|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
162919053|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919054|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919055|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919056|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919057|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
162919058|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
162919059|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
162919060|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919061|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919062|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919063|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919064|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919065|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
162919066|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
162919067|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919068|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919069|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919070|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
162919071|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
162919072|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
162919073|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
162919074|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162919075|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162919076|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162919077|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
162919078|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
162919079|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
162919080|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
162919081|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162924572|NCT02406742|588426049|FG000|Overall Study|Transition to other treatment|2|||
162629475|NCT01637272|587361128|FG000|Overall Study|Lost to Follow-up|2|||
162629476|NCT01637272|587361128|FG000|Overall Study|completed core, did not enter ext. phase|4|||
162629477|NCT01637272|587361128|FG000|Overall Study|Administrative problems|1|||
162629478|NCT01637272|587361128|FG000|Overall Study|Protocol Violation|2|||
162629479|NCT01844518|587361129|FG000|Overall Study|Adverse Event|7|||
162629480|NCT01844518|587361130|FG001|Overall Study|Adverse Event|1|||
162629481|NCT01844518|587361129|FG000|Overall Study|Lack of Efficacy|17|||
162629482|NCT01844518|587361130|FG001|Overall Study|Lack of Efficacy|5|||
162629483|NCT01844518|587361129|FG000|Overall Study|Participant's request to discontinue|4|||
162629484|NCT01844518|587361130|FG001|Overall Study|Participant's request to discontinue|1|||
162629485|NCT01844518|587361129|FG000|Overall Study|Poor/Non-compliance|1|||
162629486|NCT01844518|587361130|FG001|Overall Study|Poor/Non-compliance|0|||
162629487|NCT01844518|587361129|FG000|Overall Study|No Longer Met Study Criteria|2|||
162629488|NCT01844518|587361130|FG001|Overall Study|No Longer Met Study Criteria|0|||
162629489|NCT01844518|587361129|FG000|Overall Study|Withdrawal by Subject|9|||
162629490|NCT01844518|587361130|FG001|Overall Study|Withdrawal by Subject|0|||
162629491|NCT01844518|587361129|FG000|Overall Study|Pregnancy|1|||
162629492|NCT01844518|587361130|FG001|Overall Study|Pregnancy|0|||
162711849|NCT03140176|587656772|FG000|Overall Study|Disease progression|1|||
162711850|NCT03140176|587656772|FG000|Overall Study|Physician Decision|1|||
162629493|NCT05399641|587361131|FG000|Overall Study|Adverse Event|0|||
162629494|NCT05399641|587361132|FG001|Overall Study|Adverse Event|1|||
162629495|NCT05399641|587361133|FG002|Overall Study|Adverse Event|1|||
162629496|NCT05399641|587361131|FG000|Overall Study|Lost to Follow-up|1|||
162629497|NCT05399641|587361132|FG001|Overall Study|Lost to Follow-up|2|||
162629498|NCT05399641|587361133|FG002|Overall Study|Lost to Follow-up|2|||
162629499|NCT05399641|587361131|FG000|Overall Study|Physician Decision|1|||
162711851|NCT03140176|587656772|FG000|Overall Study|Withdrawal by Subject|1|||
162711852|NCT03140176|587656772|FG000|Overall Study|Lost to Follow-up|15|||
162711853|NCT01091454|587656775|FG000|Overall Study|Ineligible|1|||
162711854|NCT01510912|587656779|FG000|Overall Study|Adverse Event|99|||
162711855|NCT01510912|587656779|FG000|Overall Study|Lack of Efficacy|12|||
162711856|NCT01510912|587656779|FG000|Overall Study|Non-compliance with trial drug|23|||
162711857|NCT01510912|587656779|FG000|Overall Study|Withdrawal by Subject|49|||
162711858|NCT01510912|587656779|FG000|Overall Study|Physician Decision|1|||
162711859|NCT01510912|587656779|FG000|Overall Study|Protocol Violation|27|||
162711860|NCT01510912|587656779|FG000|Overall Study|Lost to Follow-up|26|||
162711861|NCT01510912|587656779|FG000|Overall Study|Other, including joint replacement|5|||
162711862|NCT03179787|587656780|FG000|Overall Study|Lost to Follow-up|15|||
162711863|NCT03179787|587656780|FG000|Overall Study|Case report failures|2|||
162711864|NCT03179787|587656780|FG000|Overall Study|Treatment not administered|1|||
162711865|NCT03181958|587656781|FG000|Overall Study|Lost to Follow-up|17|||
162711866|NCT03181958|587656782|FG001|Overall Study|Lost to Follow-up|21|||
162711867|NCT03181958|587656783|FG002|Overall Study|Lost to Follow-up|15|||
162711868|NCT02030028|587656784|FG000|Overall Study|Withdrawal by Subject|4|||
162711869|NCT02030028|587656784|FG000|Overall Study|lack of transportation|1|||
162629500|NCT05399641|587361132|FG001|Overall Study|Physician Decision|3|||
162629501|NCT05399641|587361133|FG002|Overall Study|Physician Decision|3|||
162629502|NCT05399641|587361131|FG000|Overall Study|Withdrawal by Subject|4|||
162629503|NCT05399641|587361132|FG001|Overall Study|Withdrawal by Subject|11|||
162629504|NCT05399641|587361133|FG002|Overall Study|Withdrawal by Subject|7|||
162919082|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162919083|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162919084|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162919085|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
162629505|NCT05399641|587361131|FG000|Overall Study|Reason not defined|3|||
162629506|NCT05399641|587361132|FG001|Overall Study|Reason not defined|5|||
162711870|NCT00661778|587656785|FG000|Overall Study|Disease Progression|23|||
162711871|NCT00661778|587656785|FG000|Overall Study|Adverse Event|18|||
162711872|NCT00661778|587656785|FG000|Overall Study|Reason not Specified|6|||
162919086|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162919087|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
162919088|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919089|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919090|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919091|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919092|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919093|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
162919094|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
162919095|NCT04242498|588404962|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
162919096|NCT04242498|588404963|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
162919097|NCT04242498|588404964|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
162919098|NCT04242498|588404965|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
162919099|NCT04242498|588404966|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
162919100|NCT04242498|588404967|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
162919101|NCT04242498|588404968|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
162919102|NCT02396849|588404970|FG000|Overall Study|Lost to Follow-up|1|||
162919103|NCT02396849|588404971|FG001|Overall Study|Lost to Follow-up|1|||
162919104|NCT02396849|588404970|FG000|Overall Study|Did not tolerate intervention|1|||
162919105|NCT02396849|588404971|FG001|Overall Study|Did not tolerate intervention|1|||
162629507|NCT05399641|587361133|FG002|Overall Study|Reason not defined|6|||
162711873|NCT00661778|587656785|FG000|Overall Study|Protocol Violation|2|||
162629508|NCT03334539|587361138|FG000|Overall Study|Adverse Event|3|||
162629509|NCT03334539|587361139|FG001|Overall Study|Adverse Event|5|||
162711874|NCT00661778|587656785|FG000|Overall Study|Withdrawal of Consent|1|||
162711875|NCT02236559|587656792|FG000|Overall Study|Met Exclusion|3|||
162629510|NCT03334539|587361140|FG002|Overall Study|Adverse Event|0|||
162629511|NCT03334539|587361138|FG000|Overall Study|Withdrawal by Subject|0|||
162629512|NCT03334539|587361139|FG001|Overall Study|Withdrawal by Subject|1|||
163055768|NCT00251758|588916093|FG000|Overall Study|Lost to Follow-up|4|||
163055769|NCT00251758|588916094|FG001|Overall Study|Lost to Follow-up|2|||
163055770|NCT00251758|588916095|FG002|Overall Study|Lost to Follow-up|5|||
163055771|NCT00251758|588916093|FG000|Overall Study|Withdrawal by Subject|13|||
163055772|NCT00251758|588916094|FG001|Overall Study|Withdrawal by Subject|7|||
163055773|NCT00251758|588916095|FG002|Overall Study|Withdrawal by Subject|3|||
163055774|NCT00251758|588916093|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
163055775|NCT00251758|588916094|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
163055776|NCT00251758|588916095|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
163055777|NCT00251758|588916093|FG000|Overall Study|Lack of Efficacy|3|||
163055778|NCT00251758|588916094|FG001|Overall Study|Lack of Efficacy|0|||
163055779|NCT00251758|588916095|FG002|Overall Study|Lack of Efficacy|0|||
163055780|NCT00251758|588916093|FG000|Overall Study|Noncompliant|0|||
163055781|NCT00251758|588916094|FG001|Overall Study|Noncompliant|2|||
163055782|NCT00251758|588916095|FG002|Overall Study|Noncompliant|2|||
163055783|NCT00251758|588916093|FG000|Overall Study|Pregnancy|0|||
163055784|NCT00251758|588916094|FG001|Overall Study|Pregnancy|1|||
163055785|NCT00251758|588916095|FG002|Overall Study|Pregnancy|0|||
163055786|NCT00251758|588916093|FG000|Overall Study|Per Subject Request|0|||
163055787|NCT00251758|588916094|FG001|Overall Study|Per Subject Request|0|||
163055788|NCT00251758|588916095|FG002|Overall Study|Per Subject Request|1|||
163055789|NCT00251758|588916093|FG000|Overall Study|Per Investigator Request|1|||
163055790|NCT00251758|588916094|FG001|Overall Study|Per Investigator Request|0|||
163055791|NCT00251758|588916095|FG002|Overall Study|Per Investigator Request|0|||
163055792|NCT01387269|588916099|FG000|Overall Study|Death|38|||
163055793|NCT01387269|588916100|FG001|Overall Study|Death|20|||
163055794|NCT01387269|588916099|FG000|Overall Study|Other|8|||
163055795|NCT01387269|588916100|FG001|Overall Study|Other|7|||
163055796|NCT01387269|588916099|FG000|Overall Study|Unrelated AE|12|||
163055797|NCT01387269|588916100|FG001|Overall Study|Unrelated AE|3|||
163055798|NCT01387269|588916099|FG000|Overall Study|Withdrawal by patient|32|||
163055799|NCT01387269|588916100|FG001|Overall Study|Withdrawal by patient|10|||
163055800|NCT01387269|588916099|FG000|Overall Study|Study drug-related AE|1|||
163055801|NCT01387269|588916100|FG001|Overall Study|Study drug-related AE|0|||
163055802|NCT01387269|588916099|FG000|Overall Study|Lost to Follow-up|1|||
163055803|NCT01387269|588916100|FG001|Overall Study|Lost to Follow-up|0|||
163055804|NCT01200329|588916103|FG000|Overall Study|Lack of financial coverage|2|||
163055805|NCT01200329|588916103|FG000|Overall Study|Progressive disease|1|||
163055806|NCT02230891|588916106|FG000|Baseline|Did not meet inclusion|0|||
163055807|NCT02230891|588916107|FG001|Baseline|Did not meet inclusion|1|||
163055808|NCT02230891|588916108|FG002|Baseline|Did not meet inclusion|1|||
163055809|NCT02230891|588916106|FG000|2 Week|Withdrawal by Subject|2|||
163055810|NCT02230891|588916107|FG001|2 Week|Withdrawal by Subject|2|||
163055811|NCT02230891|588916108|FG002|2 Week|Withdrawal by Subject|0|||
163055812|NCT02230891|588916106|FG000|2 Week|Consent withdrawn|1|||
163055813|NCT02230891|588916107|FG001|2 Week|Consent withdrawn|0|||
163055814|NCT02230891|588916108|FG002|2 Week|Consent withdrawn|0|||
163055815|NCT02230891|588916106|FG000|6 Month|Withdrawal by Subject|1|||
163055816|NCT02230891|588916107|FG001|6 Month|Withdrawal by Subject|1|||
163055817|NCT02230891|588916108|FG002|6 Month|Withdrawal by Subject|1|||
163055818|NCT02230891|588916106|FG000|6 Month|Physician Decision|0|||
163055819|NCT02230891|588916107|FG001|6 Month|Physician Decision|2|||
163055820|NCT02230891|588916108|FG002|6 Month|Physician Decision|0|||
163055821|NCT02230891|588916106|FG000|12 Month|Death|1|||
163055822|NCT02230891|588916107|FG001|12 Month|Death|0|||
163055823|NCT02230891|588916108|FG002|12 Month|Death|0|||
163055824|NCT02230891|588916106|FG000|12 Month|Lost to Follow-up|0|||
163055825|NCT02230891|588916107|FG001|12 Month|Lost to Follow-up|1|||
163055826|NCT02230891|588916108|FG002|12 Month|Lost to Follow-up|0|||
163055827|NCT02230891|588916106|FG000|12 Month|Withdrawal by Subject|0|||
163055828|NCT02230891|588916107|FG001|12 Month|Withdrawal by Subject|2|||
163055829|NCT02230891|588916108|FG002|12 Month|Withdrawal by Subject|0|||
163055830|NCT02230891|588916106|FG000|18 Month End of Study|Death|0|||
163055831|NCT02230891|588916107|FG001|18 Month End of Study|Death|0|||
163055832|NCT02230891|588916108|FG002|18 Month End of Study|Death|1|||
163055833|NCT02230891|588916106|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
162629513|NCT03334539|587361140|FG002|Overall Study|Withdrawal by Subject|1|||
162629514|NCT03334539|587361138|FG000|Overall Study|Administrative Reasons|1|||
163055834|NCT02230891|588916107|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
163055835|NCT02230891|588916108|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
163055836|NCT03642990|588916111|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
163055837|NCT03642990|588916111|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
163055838|NCT04158219|588916120|FG000|Overall Study|Lost to Follow-up|1|||
163055839|NCT01324947|588916126|FG000|Overall Study|Adverse Event|7|||
163055840|NCT01324947|588916126|FG000|Overall Study|Death|10|||
163055841|NCT01324947|588916126|FG000|Overall Study|Other|3|||
163055842|NCT01324947|588916126|FG000|Overall Study|Progressive Disease|50|||
163055843|NCT01324947|588916126|FG000|Overall Study|Withdrawal by Subject|3|||
162711876|NCT02236559|587656793|FG001|Overall Study|Met Exclusion|6|||
162711877|NCT02236559|587656792|FG000|Overall Study|Did not Meet Inclusion|3|||
162711878|NCT02236559|587656793|FG001|Overall Study|Did not Meet Inclusion|3|||
162711879|NCT02236559|587656792|FG000|Overall Study|Subject Did Not Consent|4|||
162711880|NCT02236559|587656793|FG001|Overall Study|Subject Did Not Consent|2|||
162711881|NCT02236559|587656792|FG000|Overall Study|Physician Decision|1|||
162711882|NCT02236559|587656793|FG001|Overall Study|Physician Decision|1|||
162711883|NCT02236559|587656792|FG000|Overall Study|Withdrawal by Subject|1|||
162711884|NCT02236559|587656793|FG001|Overall Study|Withdrawal by Subject|0|||
162711885|NCT02263508|587656794|FG000|Overall Study|Withdrawal by Subject|1|||
162711886|NCT02263508|587656795|FG001|Overall Study|Withdrawal by Subject|23|||
162711887|NCT02263508|587656796|FG002|Overall Study|Withdrawal by Subject|17|||
162711888|NCT02263508|587656794|FG000|Overall Study|Sponsor Decision|12|||
162711889|NCT02263508|587656795|FG001|Overall Study|Sponsor Decision|165|||
163055844|NCT01324947|588916126|FG000|Overall Study|1 discontinued before starting drug|1|||
163055845|NCT01296412|588916129|FG000|Overall Study|Adverse Event|8|||
163055846|NCT01296412|588916130|FG001|Overall Study|Adverse Event|29|||
163055847|NCT01296412|588916129|FG000|Overall Study|Lack of Efficacy|1|||
163055848|NCT01296412|588916130|FG001|Overall Study|Lack of Efficacy|0|||
163055849|NCT01296412|588916129|FG000|Overall Study|Lost to Follow-up|10|||
163055850|NCT01296412|588916130|FG001|Overall Study|Lost to Follow-up|7|||
162711890|NCT02263508|587656796|FG002|Overall Study|Sponsor Decision|182|||
162919106|NCT03328325|588404972|FG000|Overall Study|Lost to Follow-up|4|||
162919107|NCT03328325|588404972|FG000|Overall Study|Physician Decision|1|||
162919108|NCT03328325|588404972|FG000|Overall Study|Withdrawal by Subject|3|||
162919109|NCT03328325|588404972|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
162919110|NCT00931515|588404973|FG000|Overall Study|Lost to Follow-up|2|||
162919111|NCT00931515|588404974|FG001|Overall Study|Lost to Follow-up|5|||
162919112|NCT00985114|588404976|FG000|Overall Study|Adverse Event|1|||
162919113|NCT00985114|588404977|FG001|Overall Study|Adverse Event|0|||
162919114|NCT00985114|588404976|FG000|Overall Study|Withdrawal by Subject|0|||
162919115|NCT00985114|588404977|FG001|Overall Study|Withdrawal by Subject|2|||
162919116|NCT02950831|588404978|FG000|Overall Study|Lost to Follow-up|1|||
162919117|NCT02950831|588404978|FG000|Overall Study|Withdrawal by Subject|3|||
162919118|NCT02950831|588404978|FG000|Overall Study|stimulation trail failure|5|||
162919119|NCT01119118|588404979|FG000|Overall Study|Adverse Event|1|||
162919120|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
162919121|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
162919122|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
162919123|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
162919124|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
162969775|NCT03833427|588590050|FG004|Overall Study|Sponsor Decision|0|||
162969776|NCT03833427|588590051|FG005|Overall Study|Sponsor Decision|0|||
162969777|NCT03833427|588590052|FG006|Overall Study|Sponsor Decision|0|||
162969778|NCT01499160|588590054|FG000|Overall Study|Adverse Event|1|||
162969779|NCT01499160|588590054|FG000|Overall Study|Withdrawal by Subject|1|||
162969780|NCT01438476|588590055|FG000|Overall Study|Protocol Violation|1|||
162969781|NCT01438476|588590056|FG001|Overall Study|Protocol Violation|0|||
162969782|NCT01438476|588590055|FG000|Overall Study|Withdrawal by Subject|1|||
162969783|NCT01438476|588590056|FG001|Overall Study|Withdrawal by Subject|0|||
162969784|NCT01438476|588590055|FG000|Overall Study|No Surgery- Disease|8|||
162969785|NCT01438476|588590056|FG001|Overall Study|No Surgery- Disease|10|||
162969786|NCT01438476|588590055|FG000|Overall Study|Communication barrier|0|||
162969787|NCT01438476|588590056|FG001|Overall Study|Communication barrier|1|||
162969788|NCT03294317|588590061|FG000|Overall Study|Physician Decision|1|||
162969789|NCT03294317|588590061|FG000|Overall Study|Withdrawal by Subject|6|||
162969790|NCT03294317|588590061|FG000|Overall Study|Lost to Follow-up|1|||
162969791|NCT03294317|588590061|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
162969792|NCT03294317|588590061|FG000|Overall Study|Failed HB lead implant|8|||
162969793|NCT03294317|588590061|FG000|Overall Study|Received CRT instead|1|||
162969794|NCT03294317|588590061|FG000|Overall Study|Exited after lead revision|2|||
162969795|NCT03847974|588590062|FG000|Overall Study|relocated out of region|3|||
162969796|NCT03847974|588590062|FG000|Overall Study|Withdrawal by Subject|2|||
163055851|NCT01296412|588916129|FG000|Overall Study|Non-compliance with study drug|1|||
163055852|NCT01296412|588916130|FG001|Overall Study|Non-compliance with study drug|2|||
162919125|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
162919126|NCT00828009|588404982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
162969797|NCT03847974|588590062|FG000|Overall Study|Adverse Event|1|||
162969798|NCT02911935|588590063|FG000|Overall Study|Lost to Follow-up|5|||
162969799|NCT02911935|588590064|FG001|Overall Study|Lost to Follow-up|7|||
162969800|NCT00603512|588590065|FG000|Overall Study|Adverse Event|0|||
162711891|NCT02263508|587656794|FG000|Overall Study|Lost to Follow-up|2|||
162711892|NCT02263508|587656795|FG001|Overall Study|Lost to Follow-up|7|||
162711893|NCT02263508|587656796|FG002|Overall Study|Lost to Follow-up|7|||
162969801|NCT00603512|588590066|FG001|Overall Study|Adverse Event|2|||
162969802|NCT00603512|588590067|FG002|Overall Study|Adverse Event|4|||
162969803|NCT00603512|588590068|FG003|Overall Study|Adverse Event|4|||
162969804|NCT00603512|588590069|FG004|Overall Study|Adverse Event|2|||
162969805|NCT00603512|588590065|FG000|Overall Study|Lack of Efficacy|0|||
162969806|NCT00603512|588590066|FG001|Overall Study|Lack of Efficacy|1|||
162969807|NCT00603512|588590067|FG002|Overall Study|Lack of Efficacy|0|||
162969808|NCT00603512|588590068|FG003|Overall Study|Lack of Efficacy|0|||
162969809|NCT00603512|588590069|FG004|Overall Study|Lack of Efficacy|1|||
162969810|NCT00603512|588590065|FG000|Overall Study|Other|2|||
162969811|NCT00603512|588590066|FG001|Overall Study|Other|1|||
162969812|NCT00603512|588590067|FG002|Overall Study|Other|0|||
162969813|NCT00603512|588590068|FG003|Overall Study|Other|1|||
162969814|NCT00603512|588590069|FG004|Overall Study|Other|1|||
162969815|NCT00603512|588590065|FG000|Overall Study|Withdrawal by Subject|0|||
162969816|NCT00603512|588590066|FG001|Overall Study|Withdrawal by Subject|0|||
162969817|NCT00603512|588590067|FG002|Overall Study|Withdrawal by Subject|0|||
162969818|NCT00603512|588590068|FG003|Overall Study|Withdrawal by Subject|0|||
162969819|NCT00603512|588590069|FG004|Overall Study|Withdrawal by Subject|1|||
162969820|NCT00603512|588590065|FG000|Overall Study|Randomized but not treated|0|||
162969821|NCT00603512|588590066|FG001|Overall Study|Randomized but not treated|1|||
162969822|NCT00603512|588590067|FG002|Overall Study|Randomized but not treated|1|||
162969823|NCT00603512|588590068|FG003|Overall Study|Randomized but not treated|2|||
162969824|NCT00603512|588590069|FG004|Overall Study|Randomized but not treated|0|||
162969825|NCT04979858|588590070|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
162969826|NCT04979858|588590071|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
162969827|NCT04253236|588590072|FG000|Overall Study|Adverse Event|1|||
162969828|NCT04253236|588590073|FG001|Overall Study|Adverse Event|0|||
162969829|NCT04253236|588590072|FG000|Overall Study|Safety Concerns|1|||
162969830|NCT04253236|588590073|FG001|Overall Study|Safety Concerns|0|||
162969831|NCT04253236|588590072|FG000|Overall Study|Study Terminated by Sponsor|1|||
162969832|NCT04253236|588590073|FG001|Overall Study|Study Terminated by Sponsor|0|||
162969833|NCT01896505|588590074|FG000|Overall Study|Adverse Event|1|||
162969834|NCT01896505|588590075|FG001|Overall Study|Adverse Event|0|||
162969835|NCT01896505|588590076|FG002|Overall Study|Adverse Event|2|||
162969836|NCT01896505|588590077|FG003|Overall Study|Adverse Event|1|||
162969837|NCT01896505|588590078|FG004|Overall Study|Adverse Event|1|||
162969838|NCT01896505|588590079|FG005|Overall Study|Adverse Event|0|||
162969839|NCT01896505|588590074|FG000|Overall Study|Physician Decision|1|||
162969840|NCT01896505|588590075|FG001|Overall Study|Physician Decision|3|||
162969841|NCT01896505|588590076|FG002|Overall Study|Physician Decision|2|||
162969842|NCT01896505|588590077|FG003|Overall Study|Physician Decision|0|||
162969843|NCT01896505|588590078|FG004|Overall Study|Physician Decision|0|||
162969844|NCT01896505|588590079|FG005|Overall Study|Physician Decision|1|||
162969845|NCT01896505|588590074|FG000|Overall Study|Withdrawal by Subject|1|||
162969846|NCT01896505|588590075|FG001|Overall Study|Withdrawal by Subject|0|||
162969847|NCT01896505|588590076|FG002|Overall Study|Withdrawal by Subject|3|||
162969848|NCT01896505|588590077|FG003|Overall Study|Withdrawal by Subject|1|||
162969849|NCT01896505|588590078|FG004|Overall Study|Withdrawal by Subject|0|||
162969850|NCT01896505|588590079|FG005|Overall Study|Withdrawal by Subject|0|||
162969851|NCT01896505|588590074|FG000|Overall Study|Disease Progression|7|||
162969852|NCT01896505|588590075|FG001|Overall Study|Disease Progression|5|||
162969853|NCT01896505|588590076|FG002|Overall Study|Disease Progression|8|||
162969854|NCT01896505|588590077|FG003|Overall Study|Disease Progression|4|||
162969855|NCT01896505|588590078|FG004|Overall Study|Disease Progression|4|||
162969856|NCT01896505|588590079|FG005|Overall Study|Disease Progression|4|||
162969857|NCT01896505|588590074|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
162969858|NCT01896505|588590075|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
162969859|NCT01896505|588590076|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
162969860|NCT01896505|588590077|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
162969861|NCT01896505|588590078|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
162969862|NCT01896505|588590079|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
162969863|NCT01896505|588590074|FG000|Overall Study|Intercurrent illness|0|||
162969864|NCT01896505|588590075|FG001|Overall Study|Intercurrent illness|1|||
162969865|NCT01896505|588590076|FG002|Overall Study|Intercurrent illness|0|||
162969866|NCT01896505|588590077|FG003|Overall Study|Intercurrent illness|0|||
162969867|NCT01896505|588590078|FG004|Overall Study|Intercurrent illness|0|||
162969868|NCT01896505|588590079|FG005|Overall Study|Intercurrent illness|0|||
162969869|NCT01896505|588590074|FG000|Overall Study|Death|0|||
162969870|NCT01896505|588590075|FG001|Overall Study|Death|0|||
162969871|NCT01896505|588590076|FG002|Overall Study|Death|1|||
162969872|NCT01896505|588590077|FG003|Overall Study|Death|1|||
162969873|NCT01896505|588590078|FG004|Overall Study|Death|0|||
162969874|NCT01896505|588590079|FG005|Overall Study|Death|1|||
162969875|NCT02063217|588590080|FG000|Overall Study|Withdrawal by Subject|1|||
162969876|NCT02063217|588590081|FG001|Overall Study|Withdrawal by Subject|0|||
162969877|NCT02063217|588590082|FG002|Overall Study|Withdrawal by Subject|0|||
162969878|NCT04291508|588590083|FG000|Overall Study|Withdrawal by Subject|1|||
162919127|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
162919128|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
162919129|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Death|1|||
162919130|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
162919131|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
162919132|NCT00828009|588404982|FG000|Step 2 - Maintenance Therapy|Other|1|||
162919133|NCT00509223|588407600|FG000|Overall Study|Lost to Follow-up|1|||
162919134|NCT00509223|588407601|FG001|Overall Study|Lost to Follow-up|1|||
162919135|NCT00509223|588407600|FG000|Overall Study|Adverse Event|1|||
162919136|NCT00509223|588407601|FG001|Overall Study|Adverse Event|1|||
162919137|NCT00509223|588407600|FG000|Overall Study|Withdrawal by Subject|25|||
162919138|NCT00509223|588407601|FG001|Overall Study|Withdrawal by Subject|6|||
162919139|NCT00509223|588407600|FG000|Overall Study|Including: subject change of address|5|||
162919140|NCT00509223|588407601|FG001|Overall Study|Including: subject change of address|2|||
162919141|NCT00509223|588407600|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
162919142|NCT00509223|588407601|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
162919143|NCT02985541|588407602|FG000|Overall Study|Withdrawal by Subject|33|||
162919144|NCT02985541|588407602|FG000|Overall Study|Lost to Follow-up|26|||
162919145|NCT02985541|588407602|FG000|Overall Study|Adverse Event|27|||
162919146|NCT02985541|588407602|FG000|Overall Study|Physician Decision|2|||
162919147|NCT02985541|588407602|FG000|Overall Study|Pregnancy|2|||
162919148|NCT02985541|588407602|FG000|Overall Study|Wish for pregnancy|44|||
162919149|NCT02985541|588407602|FG000|Overall Study|Other reason|5|||
162919150|NCT02985541|588407602|FG000|Overall Study|Not valid for analysis|2|||
162919151|NCT02383966|588407603|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
162919152|NCT02383966|588407604|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
162919153|NCT02383966|588407603|FG000|Overall Study|Randomized, but not treated|1|||
162919154|NCT02383966|588407604|FG001|Overall Study|Randomized, but not treated|3|||
162919155|NCT04888377|588407607|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
162919156|NCT04888377|588407608|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
162919157|NCT04888377|588407607|FG000|Overall Study|Physician Decision|6|||
162919158|NCT04888377|588407608|FG001|Overall Study|Physician Decision|6|||
162919159|NCT04888377|588407607|FG000|Overall Study|Withdrawal by Subject|7|||
162919160|NCT04888377|588407608|FG001|Overall Study|Withdrawal by Subject|3|||
162919161|NCT00526162|588407609|FG000|Overall Study|Device not implanted|3|||
162919162|NCT05279807|588407610|FG000|Overall Study|Withdrawal by Subject|1|||
162919163|NCT05279807|588407611|FG001|Overall Study|Withdrawal by Subject|0|||
162919164|NCT05279807|588407610|FG000|Overall Study|Adverse Event|0|||
162919165|NCT05279807|588407611|FG001|Overall Study|Adverse Event|1|||
162919166|NCT05279807|588407610|FG000|Overall Study|Laboratory Abnormal Results|1|||
162919167|NCT05279807|588407611|FG001|Overall Study|Laboratory Abnormal Results|0|||
162919168|NCT05299359|588407616|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
162919169|NCT05299359|588407617|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
162919170|NCT05299359|588407616|FG000|Main Part: Day 1 up to Day 366|Other|2|||
162919171|NCT05299359|588407617|FG001|Main Part: Day 1 up to Day 366|Other|0|||
162919172|NCT05299359|588407616|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
162919173|NCT05299359|588407617|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
162919174|NCT05299359|588407616|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
162919175|NCT05299359|588407617|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
162711894|NCT02263508|587656794|FG000|Overall Study|Death|6|||
162919176|NCT05299359|588407616|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
162919177|NCT05299359|588407617|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
162919178|NCT05299359|588407616|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
162919179|NCT05299359|588407617|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
162919180|NCT05299359|588407616|FG000|Extension Part: Day 1 to Day 366|Other|0|||
162919181|NCT05299359|588407617|FG001|Extension Part: Day 1 to Day 366|Other|1|||
162919182|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
162919183|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
162969879|NCT04291508|588590084|FG001|Overall Study|Withdrawal by Subject|0|||
162969880|NCT04291508|588590085|FG002|Overall Study|Withdrawal by Subject|1|||
162969881|NCT04291508|588590086|FG003|Overall Study|Withdrawal by Subject|0|||
162969882|NCT04291508|588590083|FG000|Overall Study|lost to follow up|4|||
162969883|NCT04291508|588590084|FG001|Overall Study|lost to follow up|0|||
162969884|NCT04291508|588590085|FG002|Overall Study|lost to follow up|1|||
162969885|NCT04291508|588590086|FG003|Overall Study|lost to follow up|0|||
162969886|NCT03566238|588590087|FG000|Overall Study|Adverse Event|0|||
162969887|NCT03566238|588590088|FG001|Overall Study|Adverse Event|0|||
162969888|NCT03566238|588590089|FG002|Overall Study|Adverse Event|1|||
162919184|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
162919185|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162919186|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162969889|NCT03566238|588590087|FG000|Overall Study|Lack of Efficacy|5|||
162969890|NCT03566238|588590088|FG001|Overall Study|Lack of Efficacy|4|||
162969891|NCT03566238|588590089|FG002|Overall Study|Lack of Efficacy|2|||
162969892|NCT03566238|588590087|FG000|Overall Study|Other|0|||
162969893|NCT03566238|588590088|FG001|Overall Study|Other|1|||
162919187|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162919188|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
162919189|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919190|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
162919191|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
162919192|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919193|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919194|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919195|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
162919196|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
162919197|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
162969894|NCT03566238|588590089|FG002|Overall Study|Other|0|||
162969895|NCT00593827|588590096|FG000|Overall Study|On Active Treatment/Pending|0|||
162969896|NCT00593827|588590097|FG001|Overall Study|On Active Treatment/Pending|2|||
162969897|NCT00089973|588590098|FG000|Overall Study|Adverse Event|3|||
162629515|NCT03334539|587361139|FG001|Overall Study|Administrative Reasons|0|||
162969898|NCT00089973|588590098|FG000|Overall Study|Withdrawal by Subject|1|||
162969899|NCT00089973|588590098|FG000|Overall Study|Disease progression|45|||
162969900|NCT00089973|588590098|FG000|Overall Study|Death|1|||
162969901|NCT01049581|588590101|FG000|Overall Study|Lost to Follow-up|2|||
162969902|NCT01049581|588590102|FG001|Overall Study|Lost to Follow-up|1|||
162969903|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
162969904|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
162969905|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
162629516|NCT03334539|587361140|FG002|Overall Study|Administrative Reasons|0|||
162969906|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
162969907|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
162969908|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
162969909|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
162919198|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
162919199|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919200|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919201|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919202|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
162919203|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
162919204|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
162919205|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
162919206|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919207|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919208|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919209|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
162919210|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
162919211|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
162919212|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
162919213|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
162919214|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
163055853|NCT01296412|588916129|FG000|Overall Study|Other reason not specified|20|||
162629517|NCT03334539|587361138|FG000|Overall Study|Hypertension Not Controlled|0|||
162629518|NCT03334539|587361139|FG001|Overall Study|Hypertension Not Controlled|1|||
162629519|NCT03334539|587361140|FG002|Overall Study|Hypertension Not Controlled|0|||
162629520|NCT03706456|587361144|FG000|Overall Study|Adverse Event|1|||
162629521|NCT03706456|587361144|FG000|Overall Study|Lack of Efficacy|2|||
162629522|NCT04523220|587361145|FG000|Main Treatment Period|Physician Decision|1|||
162629523|NCT04523220|587361146|FG001|Main Treatment Period|Physician Decision|1|||
162629524|NCT04523220|587361147|FG002|Main Treatment Period|Physician Decision|0|||
162629525|NCT04523220|587361145|FG000|Main Treatment Period|Other|5|||
162629526|NCT04523220|587361146|FG001|Main Treatment Period|Other|2|||
162629527|NCT04523220|587361147|FG002|Main Treatment Period|Other|4|||
162629528|NCT04523220|587361145|FG000|Main Treatment Period|Subject Decision|5|||
162629529|NCT04523220|587361146|FG001|Main Treatment Period|Subject Decision|7|||
162629530|NCT04523220|587361147|FG002|Main Treatment Period|Subject Decision|3|||
162629531|NCT04523220|587361145|FG000|Main Treatment Period|Death|5|||
162629532|NCT04523220|587361146|FG001|Main Treatment Period|Death|11|||
162629533|NCT04523220|587361147|FG002|Main Treatment Period|Death|4|||
162629534|NCT04523220|587361145|FG000|Main Treatment Period|Adverse Event|11|||
162629535|NCT04523220|587361146|FG001|Main Treatment Period|Adverse Event|9|||
162629536|NCT04523220|587361147|FG002|Main Treatment Period|Adverse Event|9|||
162629537|NCT04523220|587361145|FG000|Main Treatment Period|Withdrawal by Subject|3|||
162629538|NCT04523220|587361146|FG001|Main Treatment Period|Withdrawal by Subject|3|||
162629539|NCT04523220|587361147|FG002|Main Treatment Period|Withdrawal by Subject|4|||
162629540|NCT04523220|587361145|FG000|Main Treatment Period|Study drug never adminstered|10|||
162629541|NCT04523220|587361146|FG001|Main Treatment Period|Study drug never adminstered|3|||
162629542|NCT04523220|587361147|FG002|Main Treatment Period|Study drug never adminstered|5|||
162629543|NCT04523220|587361145|FG000|Extension Treatment Period|Physician Decision|1|||
162629544|NCT04523220|587361146|FG001|Extension Treatment Period|Physician Decision|0|||
162629545|NCT04523220|587361147|FG002|Extension Treatment Period|Physician Decision|3|||
162629546|NCT04523220|587361145|FG000|Extension Treatment Period|Other|2|||
162629547|NCT04523220|587361146|FG001|Extension Treatment Period|Other|6|||
162629548|NCT04523220|587361147|FG002|Extension Treatment Period|Other|6|||
162629549|NCT04523220|587361145|FG000|Extension Treatment Period|Subject Decision|5|||
162629550|NCT04523220|587361146|FG001|Extension Treatment Period|Subject Decision|2|||
162629551|NCT04523220|587361147|FG002|Extension Treatment Period|Subject Decision|4|||
162629552|NCT04523220|587361145|FG000|Extension Treatment Period|Death|6|||
162629553|NCT04523220|587361146|FG001|Extension Treatment Period|Death|4|||
162629554|NCT04523220|587361147|FG002|Extension Treatment Period|Death|7|||
162629555|NCT04523220|587361145|FG000|Extension Treatment Period|Adverse Event|6|||
162629556|NCT04523220|587361146|FG001|Extension Treatment Period|Adverse Event|7|||
162629557|NCT04523220|587361147|FG002|Extension Treatment Period|Adverse Event|9|||
162711895|NCT02263508|587656795|FG001|Overall Study|Death|151|||
162629558|NCT04523220|587361145|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162629559|NCT04523220|587361146|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
162629560|NCT04523220|587361147|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
162629561|NCT04523220|587361145|FG000|Extension Treatment Period|Study drug never administered|0|||
162629562|NCT04523220|587361146|FG001|Extension Treatment Period|Study drug never administered|1|||
162629563|NCT04523220|587361147|FG002|Extension Treatment Period|Study drug never administered|0|||
162629564|NCT00256750|587361149|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
162629565|NCT00256750|587361150|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
162629566|NCT00256750|587361151|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
162629567|NCT00256750|587361149|FG000|Transplanted Pre-Treatment|Other|2|||
162919215|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
162919216|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
162919217|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919218|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919219|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
162919220|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919221|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919222|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919223|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
162919224|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162919225|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162919226|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
162919227|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162629568|NCT00256750|587361150|FG001|Transplanted Pre-Treatment|Other|0|||
162629569|NCT00256750|587361151|FG002|Transplanted Pre-Treatment|Other|0|||
162629570|NCT00256750|587361149|FG000|Transplanted Pre-Treatment|Death|1|||
162629571|NCT00256750|587361150|FG001|Transplanted Pre-Treatment|Death|0|||
162629572|NCT00256750|587361151|FG002|Transplanted Pre-Treatment|Death|0|||
162629573|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
162629574|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
162629575|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
162629576|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Death|3|||
162629577|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Death|2|||
162629578|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Death|4|||
162629579|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
162629580|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
162629581|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
162629582|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
162629583|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
162629584|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
162629585|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Other|5|||
162629586|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Other|4|||
162629587|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Other|2|||
162629588|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
162629589|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
162629590|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
162629591|NCT00256750|587361149|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
162629592|NCT00256750|587361150|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
162629593|NCT00256750|587361151|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
162629594|NCT00256750|587361149|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
162629595|NCT00256750|587361150|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
162629596|NCT00256750|587361151|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
162629597|NCT00256750|587361149|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
162629598|NCT00256750|587361150|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
162919228|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162919229|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162919230|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
162919231|NCT04242446|588407618|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919232|NCT04242446|588407619|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
162919233|NCT04242446|588407620|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
162919234|NCT04242446|588407621|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919235|NCT04242446|588407622|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919236|NCT04242446|588407623|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919237|NCT04242446|588407624|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
162919238|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919239|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919240|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
162919241|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
162919242|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
162919243|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
162629599|NCT00256750|587361151|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
162629600|NCT00256750|587361149|FG000|Post-Transplant Treated (24 Months)|Death|3|||
162629601|NCT00256750|587361150|FG001|Post-Transplant Treated (24 Months)|Death|0|||
162629602|NCT00256750|587361151|FG002|Post-Transplant Treated (24 Months)|Death|0|||
162919244|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
162919245|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919246|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
163055854|NCT01296412|588916130|FG001|Overall Study|Other reason not specified|15|||
163055855|NCT01296412|588916129|FG000|Overall Study|Physician Decision|1|||
162711896|NCT02263508|587656796|FG002|Overall Study|Death|140|||
162711897|NCT04148937|587656797|FG000|Overall Study|Withdrawal by Subject|0|||
162711898|NCT04148937|587656798|FG001|Overall Study|Withdrawal by Subject|0|||
162711899|NCT04148937|587656799|FG002|Overall Study|Withdrawal by Subject|0|||
162711900|NCT04148937|587656800|FG003|Overall Study|Withdrawal by Subject|1|||
162711901|NCT04148937|587656801|FG004|Overall Study|Withdrawal by Subject|0|||
162711902|NCT04148937|587656802|FG005|Overall Study|Withdrawal by Subject|1|||
162919247|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
162919248|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
162919249|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
162919250|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
162711903|NCT04148937|587656803|FG006|Overall Study|Withdrawal by Subject|1|||
162711904|NCT04148937|587656804|FG007|Overall Study|Withdrawal by Subject|0|||
162711905|NCT04148937|587656797|FG000|Overall Study|Lost to Follow-up|0|||
162711906|NCT04148937|587656798|FG001|Overall Study|Lost to Follow-up|0|||
162711907|NCT04148937|587656799|FG002|Overall Study|Lost to Follow-up|1|||
162711908|NCT04148937|587656800|FG003|Overall Study|Lost to Follow-up|0|||
162919251|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
162919252|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919253|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919254|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
162919255|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
162919256|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
162919257|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
162919258|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
162919259|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919260|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919261|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
162919262|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
162919263|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
162919264|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
162919265|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
162919266|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162919267|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162711909|NCT04148937|587656801|FG004|Overall Study|Lost to Follow-up|0|||
162711910|NCT04148937|587656802|FG005|Overall Study|Lost to Follow-up|2|||
162711911|NCT04148937|587656803|FG006|Overall Study|Lost to Follow-up|0|||
162711912|NCT04148937|587656804|FG007|Overall Study|Lost to Follow-up|0|||
162919268|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
162919269|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
162919270|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
162919271|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
162919272|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
163055856|NCT01296412|588916130|FG001|Overall Study|Physician Decision|3|||
163055857|NCT01296412|588916129|FG000|Overall Study|Pregnancy|0|||
163055858|NCT01296412|588916130|FG001|Overall Study|Pregnancy|1|||
163055859|NCT01296412|588916129|FG000|Overall Study|Withdrawal by Subject|10|||
163055860|NCT01296412|588916130|FG001|Overall Study|Withdrawal by Subject|13|||
163055861|NCT02160626|588916131|FG000|Overall Study|Adverse Event|1|||
163055862|NCT02160626|588916132|FG001|Overall Study|Adverse Event|0|||
163055863|NCT02160626|588916133|FG002|Overall Study|Adverse Event|0|||
163055864|NCT02160626|588916131|FG000|Overall Study|Schedule not conducive to study visits|0|||
163055865|NCT02160626|588916132|FG001|Overall Study|Schedule not conducive to study visits|0|||
163055866|NCT02160626|588916133|FG002|Overall Study|Schedule not conducive to study visits|1|||
163055867|NCT02160626|588916131|FG000|Overall Study|Withdrawal by Subject|0|||
163055868|NCT02160626|588916132|FG001|Overall Study|Withdrawal by Subject|1|||
163055869|NCT02160626|588916133|FG002|Overall Study|Withdrawal by Subject|0|||
163055870|NCT04239924|588916134|FG000|Overall Study|Lost to Follow-up|2|||
163055871|NCT04194814|588916135|FG000|Overall Study|Physician Decision|3|||
162711913|NCT01149681|587656805|FG000|Overall Study|Withdrawal by Subject|7|||
162711914|NCT01149681|587656805|FG000|Overall Study|Progressive disease|1|||
162711915|NCT01149681|587656805|FG000|Overall Study|Physician Decision|2|||
162711916|NCT01149681|587656805|FG000|Overall Study|adverse events nonrelated study drug|2|||
162711917|NCT00686517|587656806|FG000|Treatment|Serious Adverse Event|1|||
162711918|NCT00686517|587656807|FG001|Treatment|Serious Adverse Event|2|||
162711919|NCT00686517|587656808|FG002|Treatment|Serious Adverse Event|1|||
162711920|NCT00686517|587656806|FG000|Treatment|Adverse Event|2|||
162711921|NCT00686517|587656807|FG001|Treatment|Adverse Event|0|||
162711922|NCT00686517|587656808|FG002|Treatment|Adverse Event|0|||
162711923|NCT00686517|587656806|FG000|Treatment|Poor Protocol Compliance|1|||
162919273|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
162919274|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
162919275|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
162919276|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
162919277|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
162919278|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163055872|NCT04194814|588916136|FG001|Overall Study|Physician Decision|0|||
163055873|NCT04194814|588916135|FG000|Overall Study|Withdrawal by Subject|0|||
163055874|NCT04194814|588916136|FG001|Overall Study|Withdrawal by Subject|2|||
163055875|NCT03255187|588918265|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
163055876|NCT03255187|588918266|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
163055877|NCT03255187|588918265|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
163055878|NCT03255187|588918266|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
163055879|NCT00720278|588918267|FG000|Overall Study|Adverse Event|5|||
163055880|NCT00720278|588918268|FG001|Overall Study|Adverse Event|3|||
163055881|NCT00720278|588918269|FG002|Overall Study|Adverse Event|4|||
163055882|NCT00720278|588918267|FG000|Overall Study|Withdrawal by Subject|0|||
163055883|NCT00720278|588918268|FG001|Overall Study|Withdrawal by Subject|1|||
163055884|NCT00720278|588918269|FG002|Overall Study|Withdrawal by Subject|0|||
163055885|NCT00720278|588918267|FG000|Overall Study|Lost to Follow-up|0|||
163055886|NCT00720278|588918268|FG001|Overall Study|Lost to Follow-up|0|||
163055887|NCT00720278|588918269|FG002|Overall Study|Lost to Follow-up|1|||
163055888|NCT00720278|588918267|FG000|Overall Study|Non-compliance|1|||
163055889|NCT00720278|588918268|FG001|Overall Study|Non-compliance|0|||
163055890|NCT00720278|588918269|FG002|Overall Study|Non-compliance|0|||
163055891|NCT00720278|588918267|FG000|Overall Study|eligibility criteria violation|1|||
163055892|NCT00720278|588918268|FG001|Overall Study|eligibility criteria violation|0|||
163055893|NCT00720278|588918269|FG002|Overall Study|eligibility criteria violation|1|||
163055894|NCT01075048|588918270|FG000|Overall Study|Death|4|||
163055895|NCT01075048|588918271|FG001|Overall Study|Death|17|||
163055896|NCT01075048|588918272|FG002|Overall Study|Death|12|||
163055897|NCT01075048|588918270|FG000|Overall Study|Start of other or new therapy|4|||
163055898|NCT01075048|588918271|FG001|Overall Study|Start of other or new therapy|36|||
163055899|NCT01075048|588918272|FG002|Overall Study|Start of other or new therapy|46|||
163055900|NCT01075048|588918270|FG000|Overall Study|Withdrawal by Subject|1|||
163055901|NCT01075048|588918271|FG001|Overall Study|Withdrawal by Subject|6|||
163055902|NCT01075048|588918272|FG002|Overall Study|Withdrawal by Subject|3|||
163055903|NCT01075048|588918270|FG000|Overall Study|Lost to Follow-up|0|||
163055904|NCT01075048|588918271|FG001|Overall Study|Lost to Follow-up|1|||
163055905|NCT01075048|588918272|FG002|Overall Study|Lost to Follow-up|1|||
163055906|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055907|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055908|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
163055909|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055910|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
163055911|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
163055912|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
163055913|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055914|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055915|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
163055916|NCT00408499|588918274|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
163055917|NCT00408499|588918275|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
163055918|NCT00408499|588918276|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055919|NCT00408499|588918277|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055920|NCT00408499|588918278|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
163055921|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Adverse Event|0|||
163055922|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Adverse Event|0|||
163055923|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Adverse Event|0|||
163055924|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Adverse Event|0|||
163055925|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Adverse Event|9|||
163055926|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Death|0|||
163055927|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Death|0|||
162919279|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
163055928|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Death|0|||
163055929|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Death|0|||
163055930|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Death|2|||
163055931|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Physician Decision|0|||
163055932|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Physician Decision|0|||
163055933|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Physician Decision|0|||
163055934|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Physician Decision|0|||
163055935|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Physician Decision|1|||
162919280|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919281|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919282|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919283|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919284|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
162919285|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919286|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
162919287|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919288|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919289|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919290|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919291|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
162919292|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919293|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
162919294|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919295|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919296|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919297|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919298|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
162919299|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919300|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
162919301|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919302|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919303|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919304|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919305|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
162919306|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919307|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
162919308|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919309|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919310|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919311|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919312|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
162919313|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919314|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
162919315|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919316|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919317|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919318|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919319|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919320|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
162919321|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
162919322|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919323|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919324|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919325|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919326|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919327|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
162919328|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
162919329|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
162919330|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
162919331|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
162919332|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
163055936|NCT00408499|588918274|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055937|NCT00408499|588918275|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
162919333|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
162969910|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
163055938|NCT00408499|588918276|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055939|NCT00408499|588918277|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
163055940|NCT00408499|588918278|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
163055941|NCT00408499|588918274|FG000|Phase II- MTD Expansion|treatment delay|0|||
163055942|NCT00408499|588918275|FG001|Phase II- MTD Expansion|treatment delay|0|||
163055943|NCT00408499|588918276|FG002|Phase II- MTD Expansion|treatment delay|0|||
163055944|NCT00408499|588918277|FG003|Phase II- MTD Expansion|treatment delay|0|||
163055945|NCT00408499|588918278|FG004|Phase II- MTD Expansion|treatment delay|3|||
163055946|NCT01586195|588918283|FG000|Overall Study|Death|11|||
163055947|NCT01586195|588918283|FG000|Overall Study|Withdrawal of Consent|5|||
163055948|NCT01586195|588918283|FG000|Overall Study|Started new anti-melanoma therapy|1|||
163055949|NCT01586195|588918283|FG000|Overall Study|Reason not specified|9|||
163055950|NCT00997334|588918285|FG000|Overall Study|still on therapy|12|||
163055951|NCT00997334|588918285|FG000|Overall Study|Adverse Event|3|||
162919334|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
162919335|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
162919336|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919337|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919338|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919339|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919340|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919341|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
162919342|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
162919343|NCT04242446|588407618|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919344|NCT04242446|588407619|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919345|NCT04242446|588407620|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919346|NCT04242446|588407621|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919347|NCT04242446|588407622|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919348|NCT04242446|588407623|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
162919349|NCT04242446|588407624|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
162919350|NCT03587116|588407625|FG000|Overall Study|Lost to Follow-up|0|||
162919351|NCT03587116|588407626|FG001|Overall Study|Lost to Follow-up|1|||
162919352|NCT03587116|588407625|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
162969911|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
162969912|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
162969913|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
162969914|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
162969915|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
162969916|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
162969917|NCT04592419|588591898|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
162969918|NCT04592419|588591899|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
162969919|NCT04592419|588591898|FG000|Open-Label Extension Period|Adverse Event|1|||
162969920|NCT04592419|588591899|FG001|Open-Label Extension Period|Adverse Event|2|||
162969921|NCT04592419|588591898|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
162969922|NCT04592419|588591899|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
162969923|NCT04592419|588591898|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
162969924|NCT04592419|588591899|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
162969925|NCT04592419|588591898|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
162969926|NCT04592419|588591899|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
162969927|NCT04592419|588591898|FG000|Open-Label Extension Period|Sponsor Request|73|||
162969928|NCT04592419|588591899|FG001|Open-Label Extension Period|Sponsor Request|84|||
163055952|NCT00997334|588918285|FG000|Overall Study|Patient non-compliance|1|||
162969929|NCT04241133|588591902|FG000|Overall Study|COVID19 Precautions|14|||
162969930|NCT04241133|588591903|FG001|Overall Study|COVID19 Precautions|34|||
163055953|NCT00997334|588918285|FG000|Overall Study|Withdrawal by Subject|3|||
163055954|NCT00997334|588918285|FG000|Overall Study|Death|2|||
162711924|NCT00686517|587656807|FG001|Treatment|Poor Protocol Compliance|0|||
162711925|NCT00686517|587656808|FG002|Treatment|Poor Protocol Compliance|0|||
162919353|NCT03587116|588407626|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
162919354|NCT03587116|588407625|FG000|Overall Study|Withdrawal by Subject|4|||
162919355|NCT03587116|588407626|FG001|Overall Study|Withdrawal by Subject|0|||
162919356|NCT05993299|588407627|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
162919357|NCT05993299|588407627|FG000|Overall Study|Ongoing|4|||
162919358|NCT05644756|588407628|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
162919359|NCT05644756|588407628|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
162919360|NCT03110107|588407629|FG000|Treatment Period|Disease Progression|3|||
162919361|NCT03110107|588407630|FG001|Treatment Period|Disease Progression|9|||
162919362|NCT03110107|588407631|FG002|Treatment Period|Disease Progression|8|||
162919363|NCT03110107|588407632|FG003|Treatment Period|Disease Progression|11|||
162919364|NCT03110107|588407633|FG004|Treatment Period|Disease Progression|8|||
162919365|NCT03110107|588407634|FG005|Treatment Period|Disease Progression|4|||
162919366|NCT03110107|588407635|FG006|Treatment Period|Disease Progression|6|||
162919367|NCT03110107|588407636|FG007|Treatment Period|Disease Progression|7|||
162919368|NCT03110107|588407637|FG008|Treatment Period|Disease Progression|2|||
162919369|NCT03110107|588407638|FG009|Treatment Period|Disease Progression|10|||
162919370|NCT03110107|588407639|FG010|Treatment Period|Disease Progression|5|||
162919371|NCT03110107|588407640|FG011|Treatment Period|Disease Progression|2|||
162919372|NCT03110107|588407641|FG012|Treatment Period|Disease Progression|0|||
162919373|NCT03110107|588407642|FG013|Treatment Period|Disease Progression|5|||
162919374|NCT03110107|588407643|FG014|Treatment Period|Disease Progression|14|||
162919375|NCT03110107|588407644|FG015|Treatment Period|Disease Progression|14|||
162919376|NCT03110107|588407645|FG016|Treatment Period|Disease Progression|4|||
162919377|NCT03110107|588407646|FG017|Treatment Period|Disease Progression|3|||
162919378|NCT03110107|588407647|FG018|Treatment Period|Disease Progression|16|||
162919379|NCT03110107|588407648|FG019|Treatment Period|Disease Progression|14|||
162919380|NCT03110107|588407649|FG020|Treatment Period|Disease Progression|12|||
162919381|NCT03110107|588407650|FG021|Treatment Period|Disease Progression|16|||
162919382|NCT03110107|588407651|FG022|Treatment Period|Disease Progression|18|||
162919383|NCT03110107|588407652|FG023|Treatment Period|Disease Progression|13|||
162919384|NCT03110107|588407653|FG024|Treatment Period|Disease Progression|16|||
162919385|NCT03110107|588407654|FG025|Treatment Period|Disease Progression|31|||
162969931|NCT02152982|588591910|FG000|Overall Study|Withdrawal by Subject|17|||
162969932|NCT02152982|588591911|FG001|Overall Study|Withdrawal by Subject|16|||
162969933|NCT02152982|588591910|FG000|Overall Study|Did not start treatment|11|||
162969934|NCT02152982|588591911|FG001|Overall Study|Did not start treatment|5|||
162711926|NCT00686517|587656806|FG000|Treatment|Protocol Violation|2|||
162711927|NCT00686517|587656807|FG001|Treatment|Protocol Violation|1|||
162711928|NCT00686517|587656808|FG002|Treatment|Protocol Violation|0|||
162711929|NCT01803646|587656809|FG000|Overall Study|Protocol Violation|1|||
162711930|NCT01803646|587656810|FG001|Overall Study|Protocol Violation|0|||
162711931|NCT01803646|587656809|FG000|Overall Study|Adverse Event|1|||
162711932|NCT01803646|587656810|FG001|Overall Study|Adverse Event|1|||
162711933|NCT01803646|587656809|FG000|Overall Study|Withdrawal by Subject|9|||
162711934|NCT01803646|587656810|FG001|Overall Study|Withdrawal by Subject|6|||
162711935|NCT01803646|587656809|FG000|Overall Study|Randomization error|1|||
162711936|NCT01803646|587656810|FG001|Overall Study|Randomization error|2|||
162711937|NCT01803646|587656809|FG000|Overall Study|Lost to Follow-up|5|||
162711938|NCT01803646|587656810|FG001|Overall Study|Lost to Follow-up|1|||
162711939|NCT01167426|587656811|FG000|Overall Study|Lost to Follow-up|6|||
162711940|NCT01167426|587656811|FG000|Overall Study|Protocol Violation|1|||
162711941|NCT01167426|587656811|FG000|Overall Study|Withdrawal by Subject|2|||
162711942|NCT01167426|587656811|FG000|Overall Study|Sponsor Decision|1|||
162711943|NCT02993471|587656812|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
162711944|NCT02993471|587656812|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
162711945|NCT04044664|587656821|FG000|Stage 1|Adverse Event|3|||
162919386|NCT03110107|588407629|FG000|Treatment Period|Study drug toxicity|1|||
162969935|NCT02152982|588591910|FG000|Overall Study|Disease progression|41|||
162969936|NCT02152982|588591911|FG001|Overall Study|Disease progression|52|||
163055955|NCT00997334|588918285|FG000|Overall Study|Urgent Palliative Care|2|||
162711946|NCT04044664|587656822|FG001|Stage 1|Adverse Event|3|||
162711947|NCT04044664|587656823|FG002|Stage 1|Adverse Event|1|||
162711948|NCT04044664|587656821|FG000|Stage 1|Lost to Follow-up|3|||
162711949|NCT04044664|587656822|FG001|Stage 1|Lost to Follow-up|2|||
162711950|NCT04044664|587656823|FG002|Stage 1|Lost to Follow-up|2|||
162711951|NCT04044664|587656821|FG000|Stage 1|Withdrawal by Subject|9|||
162711952|NCT04044664|587656822|FG001|Stage 1|Withdrawal by Subject|1|||
162919387|NCT03110107|588407630|FG001|Treatment Period|Study drug toxicity|0|||
162919388|NCT03110107|588407631|FG002|Treatment Period|Study drug toxicity|1|||
162919389|NCT03110107|588407632|FG003|Treatment Period|Study drug toxicity|2|||
162919390|NCT03110107|588407633|FG004|Treatment Period|Study drug toxicity|0|||
162919391|NCT03110107|588407634|FG005|Treatment Period|Study drug toxicity|3|||
162969937|NCT02152982|588591910|FG000|Overall Study|Adverse Event|7|||
162969938|NCT02152982|588591911|FG001|Overall Study|Adverse Event|12|||
162711953|NCT04044664|587656823|FG002|Stage 1|Withdrawal by Subject|0|||
162711954|NCT04044664|587656821|FG000|Stage 1|noncompliance, personal reason|2|||
162711955|NCT04044664|587656822|FG001|Stage 1|noncompliance, personal reason|0|||
162711956|NCT04044664|587656823|FG002|Stage 1|noncompliance, personal reason|0|||
162711957|NCT04044664|587656821|FG000|Stage 1|randomization error|0|||
162711958|NCT04044664|587656822|FG001|Stage 1|randomization error|1|||
162711959|NCT04044664|587656823|FG002|Stage 1|randomization error|0|||
162711960|NCT04044664|587656821|FG000|Stage 2|Adverse Event|2|||
162711961|NCT04044664|587656822|FG001|Stage 2|Adverse Event|0|||
162711962|NCT04044664|587656823|FG002|Stage 2|Adverse Event|0|||
162711963|NCT04044664|587656821|FG000|Stage 2|Lost to Follow-up|3|||
162711964|NCT04044664|587656822|FG001|Stage 2|Lost to Follow-up|2|||
162711965|NCT04044664|587656823|FG002|Stage 2|Lost to Follow-up|1|||
162711966|NCT04044664|587656821|FG000|Stage 2|Withdrawal by Subject|3|||
162711967|NCT04044664|587656822|FG001|Stage 2|Withdrawal by Subject|0|||
162711968|NCT04044664|587656823|FG002|Stage 2|Withdrawal by Subject|0|||
162711969|NCT04044664|587656821|FG000|Stage 2|protocol deviation|1|||
162711970|NCT04044664|587656822|FG001|Stage 2|protocol deviation|0|||
162711971|NCT04044664|587656823|FG002|Stage 2|protocol deviation|0|||
162711972|NCT00001575|587656827|FG000|Overall Study|Screening failures-Ph I portion|22|||
162711973|NCT00001575|587656827|FG000|Overall Study|Withdrawn/deaths|23|||
162711974|NCT00831792|587656830|FG000|Overall Study|Not Eligible|3|||
162711975|NCT00831792|587656830|FG000|Overall Study|Adverse Event|1|||
162711976|NCT00831792|587656830|FG000|Overall Study|Death|1|||
162711977|NCT00831792|587656830|FG000|Overall Study|Lack of Efficacy|1|||
162711978|NCT03736785|587656831|FG000|Overall Study|Adverse Event|1|||
162711979|NCT03736785|587656832|FG001|Overall Study|Adverse Event|1|||
162711980|NCT03736785|587656833|FG002|Overall Study|Adverse Event|1|||
162711981|NCT03736785|587656831|FG000|Overall Study|Death|1|||
162711982|NCT03736785|587656832|FG001|Overall Study|Death|0|||
162711983|NCT03736785|587656833|FG002|Overall Study|Death|1|||
162711984|NCT03736785|587656831|FG000|Overall Study|Lost to Follow-up|0|||
162711985|NCT03736785|587656832|FG001|Overall Study|Lost to Follow-up|2|||
162711986|NCT03736785|587656833|FG002|Overall Study|Lost to Follow-up|3|||
162711987|NCT03736785|587656831|FG000|Overall Study|Non compliance with study drug|1|||
162711988|NCT03736785|587656832|FG001|Overall Study|Non compliance with study drug|1|||
162711989|NCT03736785|587656833|FG002|Overall Study|Non compliance with study drug|0|||
162711990|NCT03736785|587656831|FG000|Overall Study|Physician Decision|0|||
162711991|NCT03736785|587656832|FG001|Overall Study|Physician Decision|1|||
162711992|NCT03736785|587656833|FG002|Overall Study|Physician Decision|1|||
162711993|NCT03736785|587656831|FG000|Overall Study|Protocol Violation|1|||
162711994|NCT03736785|587656832|FG001|Overall Study|Protocol Violation|4|||
162711995|NCT03736785|587656833|FG002|Overall Study|Protocol Violation|3|||
162711996|NCT03736785|587656831|FG000|Overall Study|Sponsor Decision|1|||
162711997|NCT03736785|587656832|FG001|Overall Study|Sponsor Decision|0|||
162711998|NCT03736785|587656833|FG002|Overall Study|Sponsor Decision|0|||
162711999|NCT03736785|587656831|FG000|Overall Study|Unknown/Missing data|3|||
162712000|NCT03736785|587656832|FG001|Overall Study|Unknown/Missing data|2|||
162712001|NCT03736785|587656833|FG002|Overall Study|Unknown/Missing data|1|||
162712002|NCT03736785|587656831|FG000|Overall Study|Withdrawal by Subject|9|||
162712003|NCT03736785|587656832|FG001|Overall Study|Withdrawal by Subject|6|||
162712004|NCT03736785|587656833|FG002|Overall Study|Withdrawal by Subject|4|||
162712005|NCT02974010|587656836|FG000|Overall Study|Lost to Follow-up|3|||
162712006|NCT02974010|587656837|FG001|Overall Study|Lost to Follow-up|1|||
162712007|NCT02974010|587656838|FG002|Overall Study|Lost to Follow-up|0|||
162712008|NCT02974010|587656839|FG003|Overall Study|Lost to Follow-up|0|||
162712009|NCT02974010|587656836|FG000|Overall Study|Withdrawal by Subject|2|||
162712010|NCT02974010|587656837|FG001|Overall Study|Withdrawal by Subject|1|||
162969939|NCT02152982|588591910|FG000|Overall Study|Complicating disease|1|||
162969940|NCT02152982|588591911|FG001|Overall Study|Complicating disease|1|||
162969941|NCT02152982|588591910|FG000|Overall Study|Death|0|||
162712011|NCT02974010|587656838|FG002|Overall Study|Withdrawal by Subject|0|||
162712012|NCT02974010|587656839|FG003|Overall Study|Withdrawal by Subject|0|||
162712013|NCT02974010|587656836|FG000|Overall Study|Adverse Event|0|||
162712014|NCT02974010|587656837|FG001|Overall Study|Adverse Event|1|||
162712015|NCT02974010|587656838|FG002|Overall Study|Adverse Event|0|||
162969942|NCT02152982|588591911|FG001|Overall Study|Death|3|||
162712016|NCT02974010|587656839|FG003|Overall Study|Adverse Event|0|||
162712017|NCT02974010|587656836|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
162712018|NCT02974010|587656837|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
162712019|NCT02974010|587656838|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
162712020|NCT02974010|587656839|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
162712021|NCT02974010|587656836|FG000|Overall Study|Lack of Efficacy|0|||
162712022|NCT02974010|587656837|FG001|Overall Study|Lack of Efficacy|0|||
162712023|NCT02974010|587656838|FG002|Overall Study|Lack of Efficacy|1|||
162712024|NCT02974010|587656839|FG003|Overall Study|Lack of Efficacy|0|||
162712025|NCT03256344|587656840|FG000|Overall Study|Death|6|||
162969943|NCT02152982|588591910|FG000|Overall Study|Physician Decision|3|||
162969944|NCT02152982|588591911|FG001|Overall Study|Physician Decision|0|||
162969945|NCT04968925|588591914|FG000|Phase I- Period 1|COVID-19 related|0|||
162969946|NCT04968925|588591915|FG001|Phase I- Period 1|COVID-19 related|1|||
162969947|NCT04968925|588591916|FG002|Phase I- Period 1|COVID-19 related|0|||
162969948|NCT04968925|588591917|FG003|Phase I- Period 1|COVID-19 related|0|||
162969949|NCT04968925|588591914|FG000|Phase I- Period 1|Subject enrolled in error|1|||
162969950|NCT04968925|588591915|FG001|Phase I- Period 1|Subject enrolled in error|1|||
162969951|NCT04968925|588591916|FG002|Phase I- Period 1|Subject enrolled in error|0|||
162969952|NCT04968925|588591917|FG003|Phase I- Period 1|Subject enrolled in error|0|||
162969953|NCT04968925|588591914|FG000|Phase II- Period 1|COVID-19 Related|0|||
162969954|NCT04968925|588591915|FG001|Phase II- Period 1|COVID-19 Related|0|||
162969955|NCT04968925|588591916|FG002|Phase II- Period 1|COVID-19 Related|6|||
162969956|NCT04968925|588591917|FG003|Phase II- Period 1|COVID-19 Related|6|||
162969957|NCT04968925|588591914|FG000|Phase II- Period 1|Subject enrolled in error|0|||
162969958|NCT04968925|588591915|FG001|Phase II- Period 1|Subject enrolled in error|0|||
162969959|NCT04968925|588591916|FG002|Phase II- Period 1|Subject enrolled in error|1|||
162969960|NCT04968925|588591917|FG003|Phase II- Period 1|Subject enrolled in error|0|||
162969961|NCT04968925|588591914|FG000|Phase II -Period 2|COVID-19 related|0|||
162969962|NCT04968925|588591915|FG001|Phase II -Period 2|COVID-19 related|0|||
162969963|NCT04968925|588591916|FG002|Phase II -Period 2|COVID-19 related|4|||
162969964|NCT04968925|588591917|FG003|Phase II -Period 2|COVID-19 related|3|||
162969965|NCT04968925|588591914|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
162969966|NCT04968925|588591915|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
162969967|NCT04968925|588591916|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
162969968|NCT04968925|588591917|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
162969969|NCT00835796|588591923|FG000|First Intervention|Withdrawal by Subject|0|||
162969970|NCT00835796|588591924|FG001|First Intervention|Withdrawal by Subject|1|||
162969971|NCT00396630|588591925|FG000|Overall Study|Lost to Follow-up|1|||
162969972|NCT00396630|588591926|FG001|Overall Study|Lost to Follow-up|1|||
162969973|NCT00396630|588591925|FG000|Overall Study|Withdrawal by Subject|1|||
162969974|NCT00396630|588591926|FG001|Overall Study|Withdrawal by Subject|1|||
162969975|NCT00396630|588591925|FG000|Overall Study|Not vaccinated at Visit 3|3|||
162969976|NCT00396630|588591926|FG001|Overall Study|Not vaccinated at Visit 3|3|||
162969977|NCT00876265|588591927|FG000|Overall Study|Miscellaneous reasons|4|||
162969978|NCT00876265|588591927|FG000|Overall Study|Lost to Follow-up|6|||
162969979|NCT00876265|588591927|FG000|Overall Study|Withdrawal by Subject|2|||
162969980|NCT02327325|588591928|FG000|Overall Study|Withdrawal by Subject|1|||
162969981|NCT02327325|588591929|FG001|Overall Study|Withdrawal by Subject|4|||
162969982|NCT02327325|588591930|FG002|Overall Study|Withdrawal by Subject|4|||
162969983|NCT02327325|588591928|FG000|Overall Study|Excluded by Study Team|0|||
162969984|NCT02327325|588591929|FG001|Overall Study|Excluded by Study Team|0|||
162969985|NCT02327325|588591930|FG002|Overall Study|Excluded by Study Team|1|||
162969986|NCT00651183|588591933|FG000|Overall Study|Lack of Efficacy|1|||
162969987|NCT00651183|588591934|FG001|Overall Study|Lack of Efficacy|0|||
162969988|NCT00651183|588591933|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
162969989|NCT00651183|588591934|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
162969990|NCT00651183|588591933|FG000|Overall Study|Tolerability insufficient|5|||
162919392|NCT03110107|588407635|FG006|Treatment Period|Study drug toxicity|1|||
162919393|NCT03110107|588407636|FG007|Treatment Period|Study drug toxicity|1|||
162919394|NCT03110107|588407637|FG008|Treatment Period|Study drug toxicity|3|||
162919395|NCT03110107|588407638|FG009|Treatment Period|Study drug toxicity|2|||
162919396|NCT03110107|588407639|FG010|Treatment Period|Study drug toxicity|0|||
162919397|NCT03110107|588407640|FG011|Treatment Period|Study drug toxicity|2|||
162919398|NCT03110107|588407641|FG012|Treatment Period|Study drug toxicity|0|||
162919399|NCT03110107|588407642|FG013|Treatment Period|Study drug toxicity|0|||
162919400|NCT03110107|588407643|FG014|Treatment Period|Study drug toxicity|2|||
162919401|NCT03110107|588407644|FG015|Treatment Period|Study drug toxicity|3|||
162919402|NCT03110107|588407645|FG016|Treatment Period|Study drug toxicity|3|||
162919403|NCT03110107|588407646|FG017|Treatment Period|Study drug toxicity|3|||
162919404|NCT03110107|588407647|FG018|Treatment Period|Study drug toxicity|1|||
162919405|NCT03110107|588407648|FG019|Treatment Period|Study drug toxicity|2|||
162919406|NCT03110107|588407649|FG020|Treatment Period|Study drug toxicity|2|||
162919407|NCT03110107|588407650|FG021|Treatment Period|Study drug toxicity|0|||
162919408|NCT03110107|588407651|FG022|Treatment Period|Study drug toxicity|2|||
162919409|NCT03110107|588407652|FG023|Treatment Period|Study drug toxicity|6|||
162969991|NCT00651183|588591934|FG001|Overall Study|Tolerability insufficient|2|||
162969992|NCT00651183|588591933|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
162969993|NCT00651183|588591934|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
162969994|NCT00651183|588591933|FG000|Overall Study|Withdrawal by Subject|6|||
162969995|NCT00651183|588591934|FG001|Overall Study|Withdrawal by Subject|3|||
162969996|NCT00651183|588591933|FG000|Overall Study|Lost to Follow-up|3|||
162969997|NCT00651183|588591934|FG001|Overall Study|Lost to Follow-up|1|||
162969998|NCT00651183|588591933|FG000|Overall Study|Other reasons|4|||
162969999|NCT00651183|588591934|FG001|Overall Study|Other reasons|2|||
162970000|NCT00651183|588591933|FG000|Overall Study|missing|1|||
162629603|NCT00256750|587361149|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
162629604|NCT00256750|587361150|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
162629605|NCT00256750|587361151|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
162629606|NCT00256750|587361149|FG000|Post-Transplant Treated (24 Months)|Other|2|||
162629607|NCT00256750|587361150|FG001|Post-Transplant Treated (24 Months)|Other|0|||
162629608|NCT00256750|587361151|FG002|Post-Transplant Treated (24 Months)|Other|1|||
162629609|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
162629610|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
162629611|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
162629612|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
162629613|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
162629614|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
162629615|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Death|0|||
162629616|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Death|2|||
162629617|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Death|1|||
162629618|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
162629619|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
162629620|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
162629621|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
162629622|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
162629623|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
162629624|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
162629625|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
162629626|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
162629627|NCT00256750|587361149|FG000|Post-Transplant Treated (36 Months)|Other|0|||
162629628|NCT00256750|587361150|FG001|Post-Transplant Treated (36 Months)|Other|1|||
162629629|NCT00256750|587361151|FG002|Post-Transplant Treated (36 Months)|Other|1|||
162629630|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
162629631|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
162629632|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
162629633|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
162629634|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
162629635|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
162629636|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
162629637|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
162970001|NCT00651183|588591934|FG001|Overall Study|missing|0|||
162970002|NCT00695110|588591937|FG000|Treatment Period 1|Adverse Event|1|||
162970003|NCT00695110|588591937|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162970004|NCT00695110|588591937|FG000|Treatment Period 3|Withdrawal by Subject|1|||
162970005|NCT00695110|588591937|FG000|Treatment Period 4|Adverse Event|1|||
162970006|NCT04675775|588591944|FG000|Overall Study|Withdrawal by Subject|7|||
162970007|NCT00108082|588591947|FG000|Overall Study|Adverse Event|14|||
162970008|NCT00108082|588591948|FG001|Overall Study|Adverse Event|12|||
162970009|NCT00108082|588591949|FG002|Overall Study|Adverse Event|17|||
162970010|NCT00108082|588591947|FG000|Overall Study|Lost to Follow-up|6|||
162970011|NCT00108082|588591948|FG001|Overall Study|Lost to Follow-up|3|||
162970012|NCT00108082|588591949|FG002|Overall Study|Lost to Follow-up|7|||
162970013|NCT00108082|588591947|FG000|Overall Study|Consent Withdrawn|3|||
162970014|NCT00108082|588591948|FG001|Overall Study|Consent Withdrawn|3|||
162970015|NCT00108082|588591949|FG002|Overall Study|Consent Withdrawn|5|||
162970016|NCT00108082|588591947|FG000|Overall Study|Protocol Violation|1|||
162970017|NCT00108082|588591948|FG001|Overall Study|Protocol Violation|2|||
162970018|NCT00108082|588591949|FG002|Overall Study|Protocol Violation|0|||
162970019|NCT00108082|588591947|FG000|Overall Study|Lack of Efficacy|3|||
162970020|NCT00108082|588591948|FG001|Overall Study|Lack of Efficacy|1|||
162970021|NCT00108082|588591949|FG002|Overall Study|Lack of Efficacy|2|||
162970022|NCT00108082|588591947|FG000|Overall Study|Amendment 4: > Month 12|5|||
162970023|NCT00108082|588591948|FG001|Overall Study|Amendment 4: > Month 12|7|||
162970024|NCT00108082|588591949|FG002|Overall Study|Amendment 4: > Month 12|5|||
162970025|NCT00108082|588591947|FG000|Overall Study|Woman of Child-bearing Potential|2|||
162970026|NCT00108082|588591948|FG001|Overall Study|Woman of Child-bearing Potential|0|||
162970027|NCT00108082|588591949|FG002|Overall Study|Woman of Child-bearing Potential|2|||
162970028|NCT00108082|588591947|FG000|Overall Study|Incorrectly Randomized|0|||
162970029|NCT00108082|588591948|FG001|Overall Study|Incorrectly Randomized|0|||
162970030|NCT00108082|588591949|FG002|Overall Study|Incorrectly Randomized|2|||
162970031|NCT00108082|588591947|FG000|Overall Study|Non-compliance|1|||
162970032|NCT00108082|588591948|FG001|Overall Study|Non-compliance|0|||
162629638|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
162629639|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
162629640|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
162629641|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
162970033|NCT00108082|588591949|FG002|Overall Study|Non-compliance|2|||
162970034|NCT00108082|588591947|FG000|Overall Study|Stopped Study Medication|0|||
162970035|NCT00108082|588591948|FG001|Overall Study|Stopped Study Medication|0|||
162629642|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
162629643|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
162629644|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
162629645|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
162629646|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
162629647|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
162629648|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
162629649|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
162629650|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
162629651|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
162629652|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
162629653|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
162629654|NCT00256750|587361149|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
162629655|NCT00256750|587361150|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
162629656|NCT00256750|587361151|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
162629657|NCT02439138|587361156|FG000|Overall Study|Adverse Event|1|||
162629658|NCT02439138|587361156|FG000|Overall Study|PI decision to terminate the study|2|||
162629659|NCT04659161|587361157|FG000|Overall Study|Adverse Event|10|||
162629660|NCT04659161|587361158|FG001|Overall Study|Adverse Event|6|||
162629661|NCT04659161|587361157|FG000|Overall Study|Withdrawal by Subject|13|||
162629662|NCT04659161|587361158|FG001|Overall Study|Withdrawal by Subject|12|||
162629663|NCT04659161|587361157|FG000|Overall Study|Other|9|||
162629664|NCT04659161|587361158|FG001|Overall Study|Other|8|||
162629665|NCT01929343|587361159|FG000|Overall Study|Physician Decision|0|||
162629666|NCT01929343|587361160|FG001|Overall Study|Physician Decision|2|||
162629667|NCT01929343|587361161|FG002|Overall Study|Physician Decision|0|||
162629668|NCT01929343|587361159|FG000|Overall Study|Withdrawal by Subject|1|||
162629669|NCT01929343|587361160|FG001|Overall Study|Withdrawal by Subject|0|||
162629670|NCT01929343|587361161|FG002|Overall Study|Withdrawal by Subject|0|||
162629671|NCT02197130|587361164|FG000|Overall Study|Adverse Event|13|||
162629672|NCT02197130|587361165|FG001|Overall Study|Adverse Event|4|||
162629673|NCT02197130|587361166|FG002|Overall Study|Adverse Event|23|||
162629674|NCT02197130|587361164|FG000|Overall Study|Death|0|||
162629675|NCT02197130|587361165|FG001|Overall Study|Death|1|||
162629676|NCT02197130|587361166|FG002|Overall Study|Death|0|||
162629677|NCT02197130|587361164|FG000|Overall Study|Lost to Follow-up|2|||
162629678|NCT02197130|587361165|FG001|Overall Study|Lost to Follow-up|0|||
162629679|NCT02197130|587361166|FG002|Overall Study|Lost to Follow-up|1|||
162629680|NCT02197130|587361164|FG000|Overall Study|Does not meet entrance criteria|0|||
162629681|NCT02197130|587361165|FG001|Overall Study|Does not meet entrance criteria|0|||
162629682|NCT02197130|587361166|FG002|Overall Study|Does not meet entrance criteria|1|||
162629683|NCT02197130|587361164|FG000|Overall Study|Withdrawal by Subject|0|||
162629684|NCT02197130|587361165|FG001|Overall Study|Withdrawal by Subject|3|||
162629685|NCT02197130|587361166|FG002|Overall Study|Withdrawal by Subject|4|||
162629686|NCT02197130|587361164|FG000|Overall Study|Other|1|||
162629687|NCT02197130|587361165|FG001|Overall Study|Other|0|||
162629688|NCT02197130|587361166|FG002|Overall Study|Other|3|||
162629689|NCT02615145|587361167|FG000|Overall Study|Did Not Start Treatment|0|||
162629690|NCT02615145|587361168|FG001|Overall Study|Did Not Start Treatment|0|||
162629691|NCT02615145|587361169|FG002|Overall Study|Did Not Start Treatment|1|||
162629692|NCT02615145|587361170|FG003|Overall Study|Did Not Start Treatment|1|||
162629693|NCT02615145|587361167|FG000|Overall Study|Failure to Return|20|||
162629694|NCT02615145|587361168|FG001|Overall Study|Failure to Return|10|||
162629695|NCT02615145|587361169|FG002|Overall Study|Failure to Return|7|||
162629696|NCT02615145|587361170|FG003|Overall Study|Failure to Return|0|||
162629697|NCT02615145|587361167|FG000|Overall Study|Death|2|||
162629698|NCT02615145|587361168|FG001|Overall Study|Death|3|||
162629699|NCT02615145|587361169|FG002|Overall Study|Death|0|||
162629700|NCT02615145|587361170|FG003|Overall Study|Death|0|||
162629701|NCT02615145|587361167|FG000|Overall Study|Other, Not Specified|5|||
162629702|NCT02615145|587361168|FG001|Overall Study|Other, Not Specified|2|||
162629703|NCT02615145|587361169|FG002|Overall Study|Other, Not Specified|0|||
162629704|NCT02615145|587361170|FG003|Overall Study|Other, Not Specified|0|||
162629705|NCT00006237|587361171|FG000|Overall Study|Adverse Event|39|||
162629706|NCT00006237|587361172|FG001|Overall Study|Adverse Event|29|||
162629707|NCT00006237|587361171|FG000|Overall Study|Death|1|||
162629708|NCT00006237|587361172|FG001|Overall Study|Death|0|||
162629709|NCT00006237|587361171|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
162629710|NCT00006237|587361172|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
162629711|NCT00006237|587361171|FG000|Overall Study|Progression/relapse|54|||
162629712|NCT00006237|587361172|FG001|Overall Study|Progression/relapse|2|||
162629713|NCT00006237|587361171|FG000|Overall Study|Not eligible|9|||
162629714|NCT00006237|587361172|FG001|Overall Study|Not eligible|20|||
162629715|NCT00006237|587361171|FG000|Overall Study|Withdrawal by Subject|0|||
162712026|NCT03256344|587656841|FG001|Overall Study|Death|22|||
162712027|NCT03256344|587656840|FG000|Overall Study|Withdrawal by Subject|3|||
162712028|NCT03256344|587656841|FG001|Overall Study|Withdrawal by Subject|3|||
162712029|NCT03256344|587656840|FG000|Overall Study|Sponsor Decision|1|||
162712030|NCT03256344|587656841|FG001|Overall Study|Sponsor Decision|0|||
162712031|NCT00880906|587656842|FG000|Overall Study|Lost to Follow-up|0|||
162712032|NCT00880906|587656843|FG001|Overall Study|Lost to Follow-up|1|||
162712033|NCT00880906|587656842|FG000|Overall Study|Did not meet criteria following patholog|12|||
162712034|NCT00880906|587656843|FG001|Overall Study|Did not meet criteria following patholog|6|||
162712035|NCT04163458|587656844|FG000|Overall Study|Protocol Deviation|7|||
162712036|NCT04163458|587656845|FG001|Overall Study|Protocol Deviation|13|||
162712037|NCT04163458|587656844|FG000|Overall Study|Adverse Event|5|||
162712038|NCT04163458|587656845|FG001|Overall Study|Adverse Event|8|||
162712039|NCT04163458|587656844|FG000|Overall Study|Due to COVID-19 pandemic|4|||
162712040|NCT04163458|587656845|FG001|Overall Study|Due to COVID-19 pandemic|2|||
162712041|NCT04163458|587656844|FG000|Overall Study|Participant withdrew consent|2|||
162712042|NCT04163458|587656845|FG001|Overall Study|Participant withdrew consent|3|||
162712043|NCT04163458|587656844|FG000|Overall Study|Randomization failure|2|||
162712044|NCT04163458|587656845|FG001|Overall Study|Randomization failure|2|||
162712045|NCT04163458|587656844|FG000|Overall Study|Other|4|||
162712046|NCT04163458|587656845|FG001|Overall Study|Other|2|||
162712047|NCT03852433|587656846|FG000|Overall Study|Withdrawal of consent|5|||
162712048|NCT03852433|587656847|FG001|Overall Study|Withdrawal of consent|8|||
162712049|NCT03852433|587656848|FG002|Overall Study|Withdrawal of consent|1|||
162712050|NCT03852433|587656849|FG003|Overall Study|Withdrawal of consent|1|||
162712051|NCT03852433|587656846|FG000|Overall Study|Adverse Event|1|||
162712052|NCT03852433|587656847|FG001|Overall Study|Adverse Event|1|||
162712053|NCT03852433|587656848|FG002|Overall Study|Adverse Event|1|||
162712054|NCT03852433|587656849|FG003|Overall Study|Adverse Event|1|||
162712055|NCT03852433|587656846|FG000|Overall Study|Lost to Follow-up|0|||
162712056|NCT03852433|587656847|FG001|Overall Study|Lost to Follow-up|1|||
162712057|NCT03852433|587656848|FG002|Overall Study|Lost to Follow-up|0|||
162712058|NCT03852433|587656849|FG003|Overall Study|Lost to Follow-up|1|||
162712059|NCT03852433|587656846|FG000|Overall Study|Pregnancy|0|||
162712060|NCT03852433|587656847|FG001|Overall Study|Pregnancy|1|||
162970036|NCT00108082|588591949|FG002|Overall Study|Stopped Study Medication|1|||
162629716|NCT00006237|587361172|FG001|Overall Study|Withdrawal by Subject|1|||
162629717|NCT00006237|587361171|FG000|Overall Study|Not protocol specified|14|||
162629718|NCT00006237|587361172|FG001|Overall Study|Not protocol specified|5|||
162629719|NCT03648983|587361182|FG000|Overall Study|Study was terminated due to PI departure|95|||
162629720|NCT01943292|587362561|FG000|Overall Study|Withdrawal by Subject|1|||
162629721|NCT01943292|587362562|FG001|Overall Study|Withdrawal by Subject|0|||
162629722|NCT01943292|587362563|FG002|Overall Study|Withdrawal by Subject|0|||
162629723|NCT00911820|587362564|FG000|Overall Study|RECIST progression|12|||
162629724|NCT00911820|587362565|FG001|Overall Study|RECIST progression|8|||
162629725|NCT00911820|587362564|FG000|Overall Study|Adverse Event|8|||
162629726|NCT00911820|587362565|FG001|Overall Study|Adverse Event|8|||
162629727|NCT00911820|587362564|FG000|Overall Study|Clinical Progression|7|||
162629728|NCT00911820|587362565|FG001|Overall Study|Clinical Progression|5|||
162629729|NCT00911820|587362564|FG000|Overall Study|Physician Decision|5|||
162629730|NCT00911820|587362565|FG001|Overall Study|Physician Decision|9|||
162629731|NCT00911820|587362564|FG000|Overall Study|Decline in Performance Status|4|||
162629732|NCT00911820|587362565|FG001|Overall Study|Decline in Performance Status|2|||
162629733|NCT00911820|587362564|FG000|Overall Study|Withdrawal by Subject|3|||
162629734|NCT00911820|587362565|FG001|Overall Study|Withdrawal by Subject|4|||
162629735|NCT00911820|587362564|FG000|Overall Study|Death|1|||
162629736|NCT00911820|587362565|FG001|Overall Study|Death|2|||
162629737|NCT00911820|587362564|FG000|Overall Study|Pursue surgery|1|||
162629738|NCT00911820|587362565|FG001|Overall Study|Pursue surgery|1|||
162629739|NCT00911820|587362564|FG000|Overall Study|Pursue Radiation|1|||
162629740|NCT00911820|587362565|FG001|Overall Study|Pursue Radiation|0|||
162629741|NCT00911820|587362564|FG000|Overall Study|Still on Therapy|2|||
162629742|NCT00911820|587362565|FG001|Overall Study|Still on Therapy|2|||
162629743|NCT00911820|587362564|FG000|Overall Study|Pathology Not Confirmed|1|||
162629744|NCT00911820|587362565|FG001|Overall Study|Pathology Not Confirmed|0|||
162712061|NCT03852433|587656848|FG002|Overall Study|Pregnancy|1|||
162712062|NCT03852433|587656849|FG003|Overall Study|Pregnancy|0|||
162712063|NCT03852433|587656846|FG000|Overall Study|Protocol Violation|0|||
162712064|NCT03852433|587656847|FG001|Overall Study|Protocol Violation|0|||
162712065|NCT03852433|587656848|FG002|Overall Study|Protocol Violation|1|||
162712066|NCT03852433|587656849|FG003|Overall Study|Protocol Violation|1|||
162712067|NCT03852433|587656846|FG000|Overall Study|Death|0|||
162970037|NCT00108082|588591947|FG000|Overall Study|Site Closed Study|0|||
162629745|NCT00911820|587362564|FG000|Overall Study|Withdraw before Receive Treatment|0|||
162629746|NCT00911820|587362565|FG001|Overall Study|Withdraw before Receive Treatment|2|||
162712068|NCT03852433|587656847|FG001|Overall Study|Death|0|||
162712069|NCT03852433|587656848|FG002|Overall Study|Death|1|||
162712070|NCT03852433|587656849|FG003|Overall Study|Death|0|||
162712071|NCT03852433|587656846|FG000|Overall Study|Lack of Efficacy|0|||
162712072|NCT03852433|587656847|FG001|Overall Study|Lack of Efficacy|1|||
162712073|NCT03852433|587656848|FG002|Overall Study|Lack of Efficacy|0|||
162712074|NCT03852433|587656849|FG003|Overall Study|Lack of Efficacy|0|||
162712075|NCT03852433|587656846|FG000|Overall Study|Non-compliance with study drug|0|||
162712076|NCT03852433|587656847|FG001|Overall Study|Non-compliance with study drug|0|||
162712077|NCT03852433|587656848|FG002|Overall Study|Non-compliance with study drug|0|||
162712078|NCT03852433|587656849|FG003|Overall Study|Non-compliance with study drug|1|||
162712079|NCT03852433|587656846|FG000|Overall Study|Physician Decision|1|||
162712080|NCT03852433|587656847|FG001|Overall Study|Physician Decision|0|||
162712081|NCT03852433|587656848|FG002|Overall Study|Physician Decision|0|||
162712082|NCT03852433|587656849|FG003|Overall Study|Physician Decision|0|||
162712083|NCT03852433|587656846|FG000|Overall Study|Randomized but never treated|1|||
162712084|NCT03852433|587656847|FG001|Overall Study|Randomized but never treated|0|||
162712085|NCT03852433|587656848|FG002|Overall Study|Randomized but never treated|0|||
162712086|NCT03852433|587656849|FG003|Overall Study|Randomized but never treated|0|||
162712087|NCT03717194|587656860|FG000|Overall Study|Withdrawal by Subject|2|||
162712088|NCT03717194|587656861|FG001|Overall Study|Withdrawal by Subject|4|||
162712089|NCT03717194|587656860|FG000|Overall Study|Adverse Event|1|||
162712090|NCT03717194|587656861|FG001|Overall Study|Adverse Event|1|||
162712091|NCT03102242|587656862|FG000|Overall Study|Adverse Event|2|||
162712092|NCT00389519|587656863|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
162712093|NCT00389519|587656864|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
162712094|NCT00389519|587656865|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
162712095|NCT00389519|587656866|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
162712096|NCT00389519|587656863|FG000|Placebo Run-In|Withdrawal by Subject|19|||
162712097|NCT00389519|587656864|FG001|Placebo Run-In|Withdrawal by Subject|0|||
162712098|NCT00389519|587656865|FG002|Placebo Run-In|Withdrawal by Subject|0|||
162712099|NCT00389519|587656866|FG003|Placebo Run-In|Withdrawal by Subject|0|||
162712100|NCT00389519|587656863|FG000|Placebo Run-In|Reason not specified|40|||
162712101|NCT00389519|587656864|FG001|Placebo Run-In|Reason not specified|0|||
162712102|NCT00389519|587656865|FG002|Placebo Run-In|Reason not specified|0|||
162712103|NCT00389519|587656866|FG003|Placebo Run-In|Reason not specified|0|||
162712104|NCT00389519|587656863|FG000|Randomized|Did not receive study drug|2|||
162712105|NCT00389519|587656864|FG001|Randomized|Did not receive study drug|0|||
162712106|NCT00389519|587656865|FG002|Randomized|Did not receive study drug|0|||
162712107|NCT00389519|587656866|FG003|Randomized|Did not receive study drug|0|||
162712108|NCT00389519|587656863|FG000|Treated|Adverse Event|1|||
162712109|NCT00389519|587656864|FG001|Treated|Adverse Event|0|||
162712110|NCT00389519|587656865|FG002|Treated|Adverse Event|0|||
162712111|NCT00389519|587656866|FG003|Treated|Adverse Event|2|||
162712112|NCT00389519|587656863|FG000|Treated|Reason not specified|1|||
162712113|NCT00389519|587656864|FG001|Treated|Reason not specified|1|||
162712114|NCT00389519|587656865|FG002|Treated|Reason not specified|0|||
162712115|NCT00389519|587656866|FG003|Treated|Reason not specified|2|||
162712116|NCT03425539|587656869|FG000|Overall Study|Randomized but not treated|0|||
162712117|NCT03425539|587656870|FG001|Overall Study|Randomized but not treated|1|||
162712118|NCT03425539|587656869|FG000|Overall Study|Adverse Event|2|||
162712119|NCT03425539|587656870|FG001|Overall Study|Adverse Event|2|||
162712120|NCT03425539|587656869|FG000|Overall Study|Withdrawal by Subject|3|||
162712121|NCT03425539|587656870|FG001|Overall Study|Withdrawal by Subject|0|||
162712122|NCT03425539|587656869|FG000|Overall Study|Lost to Follow-up|0|||
162712123|NCT03425539|587656870|FG001|Overall Study|Lost to Follow-up|1|||
162712124|NCT02040844|587656871|FG000|Overall Study|Adverse Event|0|||
162712125|NCT02040844|587656872|FG001|Overall Study|Adverse Event|0|||
162712126|NCT02040844|587656873|FG002|Overall Study|Adverse Event|1|||
162712127|NCT02040844|587656871|FG000|Overall Study|Withdrawal by Subject|16|||
162712128|NCT02040844|587656872|FG001|Overall Study|Withdrawal by Subject|22|||
162712129|NCT02040844|587656873|FG002|Overall Study|Withdrawal by Subject|25|||
162712130|NCT02040844|587656871|FG000|Overall Study|Lost to Follow-up|12|||
162712131|NCT02040844|587656872|FG001|Overall Study|Lost to Follow-up|9|||
162712132|NCT02040844|587656873|FG002|Overall Study|Lost to Follow-up|13|||
162712133|NCT02040844|587656871|FG000|Overall Study|Missing|13|||
162712134|NCT02040844|587656872|FG001|Overall Study|Missing|3|||
162712135|NCT02040844|587656873|FG002|Overall Study|Missing|2|||
162712136|NCT02040844|587656871|FG000|Overall Study|Non-specified|8|||
162712137|NCT02040844|587656872|FG001|Overall Study|Non-specified|2|||
162712138|NCT02040844|587656873|FG002|Overall Study|Non-specified|5|||
162712139|NCT02040844|587656871|FG000|Overall Study|Concomitant medication|1|||
162712140|NCT02040844|587656872|FG001|Overall Study|Concomitant medication|3|||
162712141|NCT02040844|587656873|FG002|Overall Study|Concomitant medication|1|||
162712142|NCT00946192|587656874|FG000|Overall Study|Lost to Follow-up|6|||
162712143|NCT00946192|587656875|FG001|Overall Study|Lost to Follow-up|11|||
162712144|NCT00946192|587656876|FG002|Overall Study|Lost to Follow-up|9|||
162712145|NCT00946192|587656874|FG000|Overall Study|Withdrawal by Subject|10|||
162712146|NCT00946192|587656875|FG001|Overall Study|Withdrawal by Subject|7|||
162712147|NCT00946192|587656876|FG002|Overall Study|Withdrawal by Subject|3|||
162712148|NCT00946192|587656874|FG000|Overall Study|Did not start medication|2|||
163055956|NCT00997334|588918285|FG000|Overall Study|No lesion amenable|1|||
163055957|NCT00997334|588918285|FG000|Overall Study|Ineligible|1|||
163055958|NCT01855958|588918286|FG000|Overall Study|Withdrawal by Subject|1|||
163055959|NCT01855958|588918287|FG001|Overall Study|Withdrawal by Subject|0|||
163055960|NCT00296244|588918288|FG000|Overall Study|Underwent retransplant|0|||
163055961|NCT00296244|588918289|FG001|Overall Study|Underwent retransplant|1|||
163055962|NCT00266708|588918294|FG000|Overall Study|No renal function|1|||
163055963|NCT00266708|588918295|FG001|Overall Study|No renal function|1|||
163055964|NCT00266708|588918294|FG000|Overall Study|Refused biopsy|3|||
163055965|NCT00266708|588918295|FG001|Overall Study|Refused biopsy|6|||
163055966|NCT00266708|588918294|FG000|Overall Study|Asthma|0|||
163055967|NCT00266708|588918295|FG001|Overall Study|Asthma|2|||
163055968|NCT00703534|588918296|FG000|Overall Study|Adverse Event|14|||
163055969|NCT00703534|588918297|FG001|Overall Study|Adverse Event|3|||
163055970|NCT00703534|588918296|FG000|Overall Study|Withdrawal by Subject|8|||
163055971|NCT00703534|588918297|FG001|Overall Study|Withdrawal by Subject|7|||
163055972|NCT00703534|588918296|FG000|Overall Study|Incorrect Enrollment|6|||
163055973|NCT00703534|588918297|FG001|Overall Study|Incorrect Enrollment|6|||
163055974|NCT00703534|588918296|FG000|Overall Study|Lost to Follow-up|1|||
163055975|NCT00703534|588918297|FG001|Overall Study|Lost to Follow-up|4|||
163055976|NCT00703534|588918296|FG000|Overall Study|Severe Non Compliance|1|||
163055977|NCT00703534|588918297|FG001|Overall Study|Severe Non Compliance|5|||
163055978|NCT01125930|588918298|FG000|Overall Study|Adverse Event|0|||
163055979|NCT01125930|588918299|FG001|Overall Study|Adverse Event|1|||
163055980|NCT01125930|588918298|FG000|Overall Study|Withdrawal by Subject|1|||
163055981|NCT01125930|588918299|FG001|Overall Study|Withdrawal by Subject|6|||
163055982|NCT01125930|588918298|FG000|Overall Study|Protocol Violation|0|||
163055983|NCT01125930|588918299|FG001|Overall Study|Protocol Violation|1|||
163055984|NCT01125930|588918298|FG000|Overall Study|Lost to Follow-up|0|||
163055985|NCT01125930|588918299|FG001|Overall Study|Lost to Follow-up|2|||
163055986|NCT01715831|588918304|FG000|Overall Study|Adverse Event|1|||
163055987|NCT03261401|588918305|FG000|Overall Study|Withdrawal by Subject|0|||
163055988|NCT03261401|588918306|FG001|Overall Study|Withdrawal by Subject|0|||
163055989|NCT03261401|588918307|FG002|Overall Study|Withdrawal by Subject|0|||
163055990|NCT03261401|588918308|FG003|Overall Study|Withdrawal by Subject|0|||
163055991|NCT03261401|588918309|FG004|Overall Study|Withdrawal by Subject|0|||
163055992|NCT03261401|588918310|FG005|Overall Study|Withdrawal by Subject|1|||
163055993|NCT03261401|588918311|FG006|Overall Study|Withdrawal by Subject|0|||
163055994|NCT03261401|588918312|FG007|Overall Study|Withdrawal by Subject|0|||
163055995|NCT03261401|588918313|FG008|Overall Study|Withdrawal by Subject|0|||
163055996|NCT03261401|588918314|FG009|Overall Study|Withdrawal by Subject|0|||
163055997|NCT03261401|588918315|FG010|Overall Study|Withdrawal by Subject|0|||
163055998|NCT03261401|588918316|FG011|Overall Study|Withdrawal by Subject|0|||
163055999|NCT03261401|588918317|FG012|Overall Study|Withdrawal by Subject|0|||
163056000|NCT03261401|588918305|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
163056001|NCT03261401|588918306|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
163056002|NCT03261401|588918307|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
163056003|NCT03261401|588918308|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
163056004|NCT03261401|588918309|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
163056005|NCT03261401|588918310|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
163056006|NCT03261401|588918311|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
163056007|NCT03261401|588918312|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
163056008|NCT03261401|588918313|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
163056009|NCT03261401|588918314|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
163056010|NCT03261401|588918315|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
163056011|NCT03261401|588918316|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
163056012|NCT03261401|588918317|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
163056013|NCT01516216|588918318|FG000|Overall Study|Adverse Event|2|||
163056014|NCT01516216|588918319|FG001|Overall Study|Adverse Event|4|||
163056015|NCT01516216|588918318|FG000|Overall Study|Disease Progression|38|||
163056016|NCT01516216|588918319|FG001|Overall Study|Disease Progression|34|||
163056017|NCT01516216|588918318|FG000|Overall Study|Withdrawal by Subject|9|||
163056018|NCT01516216|588918319|FG001|Overall Study|Withdrawal by Subject|11|||
163056019|NCT01516216|588918318|FG000|Overall Study|Potentially Curative Resection|6|||
163056020|NCT01516216|588918319|FG001|Overall Study|Potentially Curative Resection|12|||
163056021|NCT01516216|588918318|FG000|Overall Study|Nonadherence|2|||
163056022|NCT01516216|588918319|FG001|Overall Study|Nonadherence|3|||
162919410|NCT03110107|588407653|FG024|Treatment Period|Study drug toxicity|7|||
162919411|NCT03110107|588407654|FG025|Treatment Period|Study drug toxicity|6|||
163056023|NCT01516216|588918318|FG000|Overall Study|Physician Decision|6|||
163056024|NCT01516216|588918319|FG001|Overall Study|Physician Decision|3|||
163056025|NCT01516216|588918318|FG000|Overall Study|Prolonged Treatment Delay|5|||
163056026|NCT01516216|588918319|FG001|Overall Study|Prolonged Treatment Delay|1|||
163056027|NCT01516216|588918318|FG000|Overall Study|Intercurrent Illness|1|||
162712149|NCT00946192|587656875|FG001|Overall Study|Did not start medication|0|||
162712150|NCT00946192|587656876|FG002|Overall Study|Did not start medication|0|||
162712151|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
162712152|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
162712153|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
162712154|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
162712155|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
162712156|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
162712157|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
162712158|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
162712159|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Death|1|||
162712160|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Death|0|||
162712161|NCT01080131|587656877|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
162712162|NCT01080131|587656878|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
162712163|NCT01080131|587656877|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
162712164|NCT01080131|587656878|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
162712165|NCT01080131|587656877|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
162712166|NCT01080131|587656878|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
162712167|NCT01080131|587656877|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
162712168|NCT01080131|587656878|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
162712169|NCT01080131|587656877|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
162712170|NCT01080131|587656878|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
162712171|NCT01080131|587656877|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
162712172|NCT01080131|587656878|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
162712173|NCT01080131|587656877|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
162712174|NCT01080131|587656878|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
162712175|NCT01080131|587656877|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
162712176|NCT01080131|587656878|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
162712177|NCT02014558|587656879|FG000|Overall Study|Never Received Study Drug|0|||
162712178|NCT02014558|587656880|FG001|Overall Study|Never Received Study Drug|0|||
162712179|NCT02014558|587656881|FG002|Overall Study|Never Received Study Drug|0|||
162712180|NCT02014558|587656882|FG003|Overall Study|Never Received Study Drug|0|||
162712181|NCT02014558|587656883|FG004|Overall Study|Never Received Study Drug|1|||
162712182|NCT02014558|587656884|FG005|Overall Study|Never Received Study Drug|0|||
162712183|NCT02014558|587656885|FG006|Overall Study|Never Received Study Drug|1|||
162712184|NCT02014558|587656886|FG007|Overall Study|Never Received Study Drug|0|||
162712185|NCT02014558|587656887|FG008|Overall Study|Never Received Study Drug|2|||
162712186|NCT02014558|587656888|FG009|Overall Study|Never Received Study Drug|0|||
162712187|NCT02014558|587656889|FG010|Overall Study|Never Received Study Drug|2|||
162712188|NCT02014558|587656890|FG011|Overall Study|Never Received Study Drug|2|||
162712189|NCT02014558|587656891|FG012|Overall Study|Never Received Study Drug|0|||
162712190|NCT02014558|587656879|FG000|Overall Study|Adverse Event|0|||
162712191|NCT02014558|587656880|FG001|Overall Study|Adverse Event|0|||
162712192|NCT02014558|587656881|FG002|Overall Study|Adverse Event|0|||
162712193|NCT02014558|587656882|FG003|Overall Study|Adverse Event|0|||
162712194|NCT02014558|587656883|FG004|Overall Study|Adverse Event|1|||
162712195|NCT02014558|587656884|FG005|Overall Study|Adverse Event|0|||
162712196|NCT02014558|587656885|FG006|Overall Study|Adverse Event|0|||
162712197|NCT02014558|587656886|FG007|Overall Study|Adverse Event|0|||
162712198|NCT02014558|587656887|FG008|Overall Study|Adverse Event|2|||
162712199|NCT02014558|587656888|FG009|Overall Study|Adverse Event|2|||
162712200|NCT02014558|587656889|FG010|Overall Study|Adverse Event|5|||
162712201|NCT02014558|587656890|FG011|Overall Study|Adverse Event|21|||
162712202|NCT02014558|587656891|FG012|Overall Study|Adverse Event|3|||
162712203|NCT02014558|587656879|FG000|Overall Study|Death|1|||
162712204|NCT02014558|587656880|FG001|Overall Study|Death|0|||
162712205|NCT02014558|587656881|FG002|Overall Study|Death|0|||
162712206|NCT02014558|587656882|FG003|Overall Study|Death|0|||
162712207|NCT02014558|587656883|FG004|Overall Study|Death|0|||
162712208|NCT02014558|587656884|FG005|Overall Study|Death|0|||
162712209|NCT02014558|587656885|FG006|Overall Study|Death|1|||
162712210|NCT02014558|587656886|FG007|Overall Study|Death|1|||
162712211|NCT02014558|587656887|FG008|Overall Study|Death|2|||
162712212|NCT02014558|587656888|FG009|Overall Study|Death|5|||
162712213|NCT02014558|587656889|FG010|Overall Study|Death|5|||
162712214|NCT02014558|587656890|FG011|Overall Study|Death|19|||
162712215|NCT02014558|587656891|FG012|Overall Study|Death|2|||
162712216|NCT02014558|587656879|FG000|Overall Study|Lack of Efficacy|1|||
162712217|NCT02014558|587656880|FG001|Overall Study|Lack of Efficacy|2|||
162712218|NCT02014558|587656881|FG002|Overall Study|Lack of Efficacy|1|||
162712219|NCT02014558|587656882|FG003|Overall Study|Lack of Efficacy|1|||
162712220|NCT02014558|587656883|FG004|Overall Study|Lack of Efficacy|0|||
162712221|NCT02014558|587656884|FG005|Overall Study|Lack of Efficacy|0|||
162712222|NCT02014558|587656885|FG006|Overall Study|Lack of Efficacy|1|||
162712223|NCT02014558|587656886|FG007|Overall Study|Lack of Efficacy|3|||
162712224|NCT02014558|587656887|FG008|Overall Study|Lack of Efficacy|3|||
162712225|NCT02014558|587656888|FG009|Overall Study|Lack of Efficacy|3|||
162712226|NCT02014558|587656889|FG010|Overall Study|Lack of Efficacy|16|||
162712227|NCT02014558|587656890|FG011|Overall Study|Lack of Efficacy|8|||
162712228|NCT02014558|587656891|FG012|Overall Study|Lack of Efficacy|5|||
162712229|NCT02014558|587656879|FG000|Overall Study|Lost to Follow-up|0|||
162712230|NCT02014558|587656880|FG001|Overall Study|Lost to Follow-up|0|||
162712231|NCT02014558|587656881|FG002|Overall Study|Lost to Follow-up|0|||
162712232|NCT02014558|587656882|FG003|Overall Study|Lost to Follow-up|0|||
162712233|NCT02014558|587656883|FG004|Overall Study|Lost to Follow-up|0|||
162712234|NCT02014558|587656884|FG005|Overall Study|Lost to Follow-up|0|||
162712235|NCT02014558|587656885|FG006|Overall Study|Lost to Follow-up|0|||
162712236|NCT02014558|587656886|FG007|Overall Study|Lost to Follow-up|0|||
162712237|NCT02014558|587656887|FG008|Overall Study|Lost to Follow-up|0|||
162712238|NCT02014558|587656888|FG009|Overall Study|Lost to Follow-up|0|||
162712239|NCT02014558|587656889|FG010|Overall Study|Lost to Follow-up|1|||
162712240|NCT02014558|587656890|FG011|Overall Study|Lost to Follow-up|0|||
162712241|NCT02014558|587656891|FG012|Overall Study|Lost to Follow-up|0|||
162712242|NCT02014558|587656879|FG000|Overall Study|Progressive Disease|1|||
162712243|NCT02014558|587656880|FG001|Overall Study|Progressive Disease|0|||
162712244|NCT02014558|587656881|FG002|Overall Study|Progressive Disease|1|||
162712245|NCT02014558|587656882|FG003|Overall Study|Progressive Disease|1|||
162712246|NCT02014558|587656883|FG004|Overall Study|Progressive Disease|1|||
162712247|NCT02014558|587656884|FG005|Overall Study|Progressive Disease|2|||
162712248|NCT02014558|587656885|FG006|Overall Study|Progressive Disease|1|||
162712249|NCT02014558|587656886|FG007|Overall Study|Progressive Disease|6|||
162712250|NCT02014558|587656887|FG008|Overall Study|Progressive Disease|5|||
162712251|NCT02014558|587656888|FG009|Overall Study|Progressive Disease|6|||
162712252|NCT02014558|587656889|FG010|Overall Study|Progressive Disease|22|||
162712253|NCT02014558|587656890|FG011|Overall Study|Progressive Disease|31|||
162712254|NCT02014558|587656891|FG012|Overall Study|Progressive Disease|6|||
162712255|NCT02014558|587656879|FG000|Overall Study|Withdrawal by Subject|0|||
162712256|NCT02014558|587656880|FG001|Overall Study|Withdrawal by Subject|0|||
162712257|NCT02014558|587656881|FG002|Overall Study|Withdrawal by Subject|0|||
162712258|NCT02014558|587656882|FG003|Overall Study|Withdrawal by Subject|0|||
162712259|NCT02014558|587656883|FG004|Overall Study|Withdrawal by Subject|1|||
162712260|NCT02014558|587656884|FG005|Overall Study|Withdrawal by Subject|0|||
162712261|NCT02014558|587656885|FG006|Overall Study|Withdrawal by Subject|0|||
162712262|NCT02014558|587656886|FG007|Overall Study|Withdrawal by Subject|0|||
162712263|NCT02014558|587656887|FG008|Overall Study|Withdrawal by Subject|0|||
162712264|NCT02014558|587656888|FG009|Overall Study|Withdrawal by Subject|2|||
162712265|NCT02014558|587656889|FG010|Overall Study|Withdrawal by Subject|6|||
162712266|NCT02014558|587656890|FG011|Overall Study|Withdrawal by Subject|10|||
162712267|NCT02014558|587656891|FG012|Overall Study|Withdrawal by Subject|0|||
162712268|NCT02014558|587656879|FG000|Overall Study|Miscellaneous|2|||
162712269|NCT02014558|587656880|FG001|Overall Study|Miscellaneous|1|||
162712270|NCT02014558|587656881|FG002|Overall Study|Miscellaneous|1|||
162712271|NCT02014558|587656882|FG003|Overall Study|Miscellaneous|1|||
162712272|NCT02014558|587656883|FG004|Overall Study|Miscellaneous|0|||
162712273|NCT02014558|587656884|FG005|Overall Study|Miscellaneous|1|||
162712274|NCT02014558|587656885|FG006|Overall Study|Miscellaneous|0|||
162712275|NCT02014558|587656886|FG007|Overall Study|Miscellaneous|1|||
162712276|NCT02014558|587656887|FG008|Overall Study|Miscellaneous|1|||
162712277|NCT02014558|587656888|FG009|Overall Study|Miscellaneous|3|||
162712278|NCT02014558|587656889|FG010|Overall Study|Miscellaneous|12|||
162712279|NCT02014558|587656890|FG011|Overall Study|Miscellaneous|11|||
162712280|NCT02014558|587656891|FG012|Overall Study|Miscellaneous|1|||
162712281|NCT05273801|587656892|FG000|Overall Study|Physician Decision|1|||
162712282|NCT04159506|587656895|FG000|Overall Study|Lost to Follow-up|2|||
162712283|NCT04159506|587656896|FG001|Overall Study|Lost to Follow-up|5|||
162712284|NCT04257058|587658446|FG000|Overall Study|Lost to Follow-up|31|||
162712285|NCT03227757|587658447|FG000|Overall Study|Death|25|||
162712286|NCT03227757|587658447|FG000|Overall Study|Withdrawal|10|||
162712287|NCT03227757|587658447|FG000|Overall Study|Missed visits|1|||
162712288|NCT03227757|587658447|FG000|Overall Study|Lost to Follow-up|2|||
162712289|NCT05570006|587658448|FG000|Overall Study|Lost to Follow-up|2|||
162712290|NCT05570006|587658448|FG000|Overall Study|Withdrawal by Subject|5|||
162712291|NCT05570006|587658448|FG000|Overall Study|Other than Specified|5|||
162712292|NCT01144468|587658451|FG000|Overall Study|Lost to Follow-up|4|||
162712293|NCT01144468|587658452|FG001|Overall Study|Lost to Follow-up|7|||
162712294|NCT01144468|587658451|FG000|Overall Study|Adverse Event|3|||
162712295|NCT01144468|587658452|FG001|Overall Study|Adverse Event|2|||
162712296|NCT01144468|587658451|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
162712297|NCT01144468|587658452|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
162712298|NCT02960659|587658453|FG000|Overall Study|Withdrawal by Subject|1|||
162712299|NCT02960659|587658454|FG001|Overall Study|Withdrawal by Subject|0|||
162712300|NCT02960659|587658453|FG000|Overall Study|Poor compliance|0|||
162712301|NCT02960659|587658454|FG001|Overall Study|Poor compliance|1|||
162712302|NCT04199728|587658460|FG000|Overall Study|Adverse Event|1|||
162712303|NCT04199728|587658461|FG001|Overall Study|Adverse Event|0|||
162712304|NCT04199728|587658460|FG000|Overall Study|Withdrawal by Subject|8|||
162712305|NCT04199728|587658461|FG001|Overall Study|Withdrawal by Subject|3|||
162712306|NCT04199728|587658460|FG000|Overall Study|Screen fail after consent|0|||
162712307|NCT04199728|587658461|FG001|Overall Study|Screen fail after consent|1|||
162712308|NCT04199728|587658460|FG000|Overall Study|Early withdraw criteria met|0|||
162712309|NCT04199728|587658461|FG001|Overall Study|Early withdraw criteria met|1|||
162712310|NCT04199728|587658460|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
162712311|NCT04199728|587658461|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
162712312|NCT01875250|587658462|FG000|Overall Study|Adverse Event|2|||
162712313|NCT01875250|587658463|FG001|Overall Study|Adverse Event|0|||
162712314|NCT04057196|587658464|FG000|Overall Study|Withdrawal by Subject|3|||
162712315|NCT04057196|587658464|FG000|Overall Study|Death|3|||
162712316|NCT03895034|587658466|FG000|Overall Study|Lost to Follow-up|2|||
162712317|NCT01118377|587658467|FG000|Overall Study|Did Not Receive Study Medication|1|||
162712318|NCT01118377|587658467|FG000|Overall Study|Death|38|||
162712319|NCT01118377|587658467|FG000|Overall Study|Failure to Return|3|||
162970038|NCT00108082|588591948|FG001|Overall Study|Site Closed Study|2|||
162970039|NCT00108082|588591949|FG002|Overall Study|Site Closed Study|0|||
162970040|NCT00108082|588591947|FG000|Overall Study|Protocol Amendment|0|||
162970041|NCT00108082|588591948|FG001|Overall Study|Protocol Amendment|1|||
162970042|NCT00108082|588591949|FG002|Overall Study|Protocol Amendment|0|||
162970043|NCT00108082|588591947|FG000|Overall Study|Study Medication Not Tapered|0|||
162712320|NCT00739102|587658468|FG000|Overall Study|Death|5|||
162712321|NCT00739102|587658468|FG000|Overall Study|Withdrawal by Subject|10|||
162712322|NCT01331824|587658470|FG000|Overall Study|Adverse Event|2|||
162712323|NCT01331824|587658470|FG000|Overall Study|Death|1|||
162712324|NCT01331824|587658470|FG000|Overall Study|Disease Progression|9|||
162712325|NCT01331824|587658470|FG000|Overall Study|Withdrawal by Subject|1|||
162712326|NCT00149630|587658477|FG000|Overall Study|Incarceration|2|||
162712327|NCT00149630|587658478|FG001|Overall Study|Incarceration|0|||
162712328|NCT00149630|587658477|FG000|Overall Study|Treatment Programs|4|||
162712329|NCT00149630|587658478|FG001|Overall Study|Treatment Programs|5|||
162712330|NCT00149630|587658477|FG000|Overall Study|Adverse Event|2|||
162712331|NCT00149630|587658478|FG001|Overall Study|Adverse Event|0|||
162712332|NCT00991276|587658489|FG000|First Intervention Period|Adverse Event|0|||
162970044|NCT00108082|588591948|FG001|Overall Study|Study Medication Not Tapered|1|||
162970045|NCT00108082|588591949|FG002|Overall Study|Study Medication Not Tapered|0|||
162970046|NCT00108082|588591947|FG000|Overall Study|Subject Left Site Location|1|||
162970047|NCT00108082|588591948|FG001|Overall Study|Subject Left Site Location|0|||
162970048|NCT00108082|588591949|FG002|Overall Study|Subject Left Site Location|0|||
162970049|NCT00108082|588591947|FG000|Overall Study|Investigator Not at Site|1|||
162970050|NCT00108082|588591948|FG001|Overall Study|Investigator Not at Site|0|||
162970051|NCT00108082|588591949|FG002|Overall Study|Investigator Not at Site|0|||
162970052|NCT00108082|588591947|FG000|Overall Study|Blood Pressure Not Controlled|1|||
162970053|NCT00108082|588591948|FG001|Overall Study|Blood Pressure Not Controlled|0|||
162970054|NCT00108082|588591949|FG002|Overall Study|Blood Pressure Not Controlled|0|||
162970055|NCT01091103|588591953|FG000|Overall Study|Adverse Event|1|||
162970056|NCT01091103|588591953|FG000|Overall Study|Progressive Disease|3|||
162970057|NCT02780167|588591954|FG000|Overall Study|Adverse Event|9|||
162970058|NCT02780167|588591955|FG001|Overall Study|Adverse Event|8|||
162970059|NCT02780167|588591956|FG002|Overall Study|Adverse Event|8|||
162970060|NCT02780167|588591957|FG003|Overall Study|Adverse Event|12|||
162970061|NCT02780167|588591958|FG004|Overall Study|Adverse Event|8|||
162970062|NCT02780167|588591954|FG000|Overall Study|Lack of Efficacy|6|||
162970063|NCT02780167|588591955|FG001|Overall Study|Lack of Efficacy|5|||
162970064|NCT02780167|588591956|FG002|Overall Study|Lack of Efficacy|6|||
162970065|NCT02780167|588591957|FG003|Overall Study|Lack of Efficacy|1|||
162970066|NCT02780167|588591958|FG004|Overall Study|Lack of Efficacy|0|||
162970067|NCT02780167|588591954|FG000|Overall Study|Lost to Follow-up|2|||
162970068|NCT02780167|588591955|FG001|Overall Study|Lost to Follow-up|0|||
162970069|NCT02780167|588591956|FG002|Overall Study|Lost to Follow-up|1|||
162970070|NCT02780167|588591957|FG003|Overall Study|Lost to Follow-up|0|||
162970071|NCT02780167|588591958|FG004|Overall Study|Lost to Follow-up|0|||
162970072|NCT02780167|588591954|FG000|Overall Study|Does not meet entrance criteria|0|||
162712333|NCT00991276|587658490|FG001|First Intervention Period|Adverse Event|1|||
162712334|NCT00991276|587658491|FG002|First Intervention Period|Adverse Event|0|||
162712335|NCT00991276|587658492|FG003|First Intervention Period|Adverse Event|1|||
162712336|NCT00991276|587658493|FG004|First Intervention Period|Adverse Event|0|||
162712337|NCT00991276|587658494|FG005|First Intervention Period|Adverse Event|0|||
162970073|NCT02780167|588591955|FG001|Overall Study|Does not meet entrance criteria|0|||
162970074|NCT02780167|588591956|FG002|Overall Study|Does not meet entrance criteria|1|||
162712338|NCT00991276|587658489|FG000|First Intervention Period|Protocol Violation|0|||
162970075|NCT02780167|588591957|FG003|Overall Study|Does not meet entrance criteria|0|||
162712339|NCT00991276|587658490|FG001|First Intervention Period|Protocol Violation|0|||
162712340|NCT00991276|587658491|FG002|First Intervention Period|Protocol Violation|0|||
162712341|NCT00991276|587658492|FG003|First Intervention Period|Protocol Violation|0|||
162712342|NCT00991276|587658493|FG004|First Intervention Period|Protocol Violation|2|||
162712343|NCT00991276|587658494|FG005|First Intervention Period|Protocol Violation|0|||
162712344|NCT00991276|587658489|FG000|First Intervention Period|Insufficient clinical response|0|||
162712345|NCT00991276|587658490|FG001|First Intervention Period|Insufficient clinical response|0|||
162712346|NCT00991276|587658491|FG002|First Intervention Period|Insufficient clinical response|0|||
162712347|NCT00991276|587658492|FG003|First Intervention Period|Insufficient clinical response|0|||
162712348|NCT00991276|587658493|FG004|First Intervention Period|Insufficient clinical response|1|||
162712349|NCT00991276|587658494|FG005|First Intervention Period|Insufficient clinical response|0|||
162712350|NCT00991276|587658489|FG000|First Intervention Period|Other|0|||
162712351|NCT00991276|587658490|FG001|First Intervention Period|Other|0|||
162712352|NCT00991276|587658491|FG002|First Intervention Period|Other|0|||
162712353|NCT00991276|587658492|FG003|First Intervention Period|Other|1|||
162970076|NCT02780167|588591958|FG004|Overall Study|Does not meet entrance criteria|0|||
162970077|NCT02780167|588591954|FG000|Overall Study|No longer meets eligibility criteria|0|||
162970078|NCT02780167|588591955|FG001|Overall Study|No longer meets eligibility criteria|0|||
162970079|NCT02780167|588591956|FG002|Overall Study|No longer meets eligibility criteria|0|||
162970080|NCT02780167|588591957|FG003|Overall Study|No longer meets eligibility criteria|1|||
162970081|NCT02780167|588591958|FG004|Overall Study|No longer meets eligibility criteria|1|||
162970082|NCT02780167|588591954|FG000|Overall Study|Protocol Violation|5|||
162970083|NCT02780167|588591955|FG001|Overall Study|Protocol Violation|5|||
162970084|NCT02780167|588591956|FG002|Overall Study|Protocol Violation|1|||
162970085|NCT02780167|588591957|FG003|Overall Study|Protocol Violation|1|||
162970086|NCT02780167|588591958|FG004|Overall Study|Protocol Violation|2|||
162970087|NCT02780167|588591954|FG000|Overall Study|Withdrawal by Subject|6|||
162970088|NCT02780167|588591955|FG001|Overall Study|Withdrawal by Subject|4|||
162970089|NCT02780167|588591956|FG002|Overall Study|Withdrawal by Subject|4|||
162970090|NCT02780167|588591957|FG003|Overall Study|Withdrawal by Subject|3|||
162970091|NCT02780167|588591958|FG004|Overall Study|Withdrawal by Subject|4|||
162970092|NCT02780167|588591954|FG000|Overall Study|Other|0|||
162970093|NCT02780167|588591955|FG001|Overall Study|Other|0|||
162970094|NCT02780167|588591956|FG002|Overall Study|Other|3|||
162970095|NCT02780167|588591957|FG003|Overall Study|Other|1|||
162970096|NCT02780167|588591958|FG004|Overall Study|Other|2|||
162970097|NCT02315066|588591960|FG000|Overall Study|Lost to Follow-up|0|||
162970098|NCT02315066|588591961|FG001|Overall Study|Lost to Follow-up|1|||
162970099|NCT02315066|588591962|FG002|Overall Study|Lost to Follow-up|1|||
162970100|NCT02315066|588591963|FG003|Overall Study|Lost to Follow-up|0|||
162970101|NCT02315066|588591964|FG004|Overall Study|Lost to Follow-up|1|||
162970102|NCT02315066|588591965|FG005|Overall Study|Lost to Follow-up|0|||
162970103|NCT02315066|588591966|FG006|Overall Study|Lost to Follow-up|2|||
162970104|NCT02315066|588591967|FG007|Overall Study|Lost to Follow-up|1|||
162970105|NCT02315066|588591968|FG008|Overall Study|Lost to Follow-up|0|||
162970106|NCT02315066|588591969|FG009|Overall Study|Lost to Follow-up|0|||
162970107|NCT02315066|588591970|FG010|Overall Study|Lost to Follow-up|1|||
162970108|NCT02315066|588591971|FG011|Overall Study|Lost to Follow-up|2|||
162970109|NCT02315066|588591972|FG012|Overall Study|Lost to Follow-up|0|||
162970110|NCT02315066|588591973|FG013|Overall Study|Lost to Follow-up|4|||
162970111|NCT02315066|588591960|FG000|Overall Study|Death|2|||
162970112|NCT02315066|588591961|FG001|Overall Study|Death|7|||
162970113|NCT02315066|588591962|FG002|Overall Study|Death|6|||
162970114|NCT02315066|588591963|FG003|Overall Study|Death|11|||
162970115|NCT02315066|588591964|FG004|Overall Study|Death|10|||
162970116|NCT02315066|588591965|FG005|Overall Study|Death|3|||
162970117|NCT02315066|588591966|FG006|Overall Study|Death|9|||
162970118|NCT02315066|588591967|FG007|Overall Study|Death|9|||
162970119|NCT02315066|588591968|FG008|Overall Study|Death|10|||
162970120|NCT02315066|588591969|FG009|Overall Study|Death|8|||
162970121|NCT02315066|588591970|FG010|Overall Study|Death|10|||
162970122|NCT02315066|588591971|FG011|Overall Study|Death|7|||
162970123|NCT02315066|588591972|FG012|Overall Study|Death|8|||
162970124|NCT02315066|588591973|FG013|Overall Study|Death|21|||
162970125|NCT02315066|588591960|FG000|Overall Study|Other|0|||
162970126|NCT02315066|588591961|FG001|Overall Study|Other|0|||
162970127|NCT02315066|588591962|FG002|Overall Study|Other|0|||
162970128|NCT02315066|588591963|FG003|Overall Study|Other|0|||
162970129|NCT02315066|588591964|FG004|Overall Study|Other|0|||
162970130|NCT02315066|588591965|FG005|Overall Study|Other|0|||
162970131|NCT02315066|588591966|FG006|Overall Study|Other|0|||
162970132|NCT02315066|588591967|FG007|Overall Study|Other|1|||
162970133|NCT02315066|588591968|FG008|Overall Study|Other|1|||
162970134|NCT02315066|588591969|FG009|Overall Study|Other|2|||
162970135|NCT02315066|588591970|FG010|Overall Study|Other|0|||
162970136|NCT02315066|588591971|FG011|Overall Study|Other|0|||
162970137|NCT02315066|588591972|FG012|Overall Study|Other|0|||
162970138|NCT02315066|588591973|FG013|Overall Study|Other|0|||
162970139|NCT02315066|588591960|FG000|Overall Study|Subject refused further follow-up|0|||
163056028|NCT01516216|588918319|FG001|Overall Study|Intercurrent Illness|0|||
163056029|NCT01516216|588918318|FG000|Overall Study|Death|1|||
163056030|NCT01516216|588918319|FG001|Overall Study|Death|1|||
163056031|NCT03098979|588918320|FG000|Overall Study|Adverse Event|1|||
163056032|NCT03098979|588918321|FG001|Overall Study|Adverse Event|0|||
163056033|NCT03098979|588918322|FG002|Overall Study|Adverse Event|1|||
163056034|NCT03098979|588918323|FG003|Overall Study|Adverse Event|4|||
163056035|NCT03098979|588918324|FG004|Overall Study|Adverse Event|6|||
163056036|NCT03098979|588918325|FG005|Overall Study|Adverse Event|1|||
163056037|NCT03098979|588918320|FG000|Overall Study|Withdrawal by Subject|2|||
163056038|NCT03098979|588918321|FG001|Overall Study|Withdrawal by Subject|1|||
163056039|NCT03098979|588918322|FG002|Overall Study|Withdrawal by Subject|1|||
163056040|NCT03098979|588918323|FG003|Overall Study|Withdrawal by Subject|1|||
163056041|NCT03098979|588918324|FG004|Overall Study|Withdrawal by Subject|2|||
163056042|NCT03098979|588918325|FG005|Overall Study|Withdrawal by Subject|1|||
163056043|NCT03098979|588918320|FG000|Overall Study|Death|1|||
163056044|NCT03098979|588918321|FG001|Overall Study|Death|0|||
163056045|NCT03098979|588918322|FG002|Overall Study|Death|2|||
163056046|NCT03098979|588918323|FG003|Overall Study|Death|0|||
163056047|NCT03098979|588918324|FG004|Overall Study|Death|1|||
163056048|NCT03098979|588918325|FG005|Overall Study|Death|0|||
163056049|NCT03098979|588918320|FG000|Overall Study|Physician Decision|2|||
163056050|NCT03098979|588918321|FG001|Overall Study|Physician Decision|1|||
163056051|NCT03098979|588918322|FG002|Overall Study|Physician Decision|0|||
163056052|NCT03098979|588918323|FG003|Overall Study|Physician Decision|0|||
162629747|NCT00996216|587362566|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
163056053|NCT03098979|588918324|FG004|Overall Study|Physician Decision|0|||
163056054|NCT03098979|588918325|FG005|Overall Study|Physician Decision|0|||
163056055|NCT03098979|588918320|FG000|Overall Study|Non-compliance|0|||
163056056|NCT03098979|588918321|FG001|Overall Study|Non-compliance|0|||
163056057|NCT03098979|588918322|FG002|Overall Study|Non-compliance|0|||
163056058|NCT03098979|588918323|FG003|Overall Study|Non-compliance|0|||
163056059|NCT03098979|588918324|FG004|Overall Study|Non-compliance|0|||
163056060|NCT03098979|588918325|FG005|Overall Study|Non-compliance|1|||
163056061|NCT03098979|588918320|FG000|Overall Study|Protocol Violation|0|||
163056062|NCT03098979|588918321|FG001|Overall Study|Protocol Violation|0|||
163056063|NCT03098979|588918322|FG002|Overall Study|Protocol Violation|0|||
163056064|NCT03098979|588918323|FG003|Overall Study|Protocol Violation|0|||
163056065|NCT03098979|588918324|FG004|Overall Study|Protocol Violation|0|||
163056066|NCT03098979|588918325|FG005|Overall Study|Protocol Violation|1|||
163056067|NCT01715298|588918326|FG000|Overall Study|Lost to Follow-up|0|||
162629748|NCT00996216|587362566|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
162629749|NCT00996216|587362566|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
162629750|NCT00187486|587362573|FG000|Overall Study|Protocol Violation|1|||
162629751|NCT03489720|587362574|FG000|Overall Study|Withdrawal by Subject|2|||
162629752|NCT03489720|587362575|FG001|Overall Study|Withdrawal by Subject|0|||
162629753|NCT02511184|587362576|FG000|Overall Study|Death|1|||
162629754|NCT02511184|587362577|FG001|Overall Study|Death|0|||
162629755|NCT02511184|587362576|FG000|Overall Study|Lost to Follow-up|0|||
162629756|NCT02511184|587362577|FG001|Overall Study|Lost to Follow-up|1|||
162629757|NCT02511184|587362576|FG000|Overall Study|Study terminated by sponsor|1|||
162629758|NCT02511184|587362577|FG001|Overall Study|Study terminated by sponsor|5|||
162629759|NCT02511184|587362576|FG000|Overall Study|Withdrawal by Subject|0|||
162629760|NCT02511184|587362577|FG001|Overall Study|Withdrawal by Subject|1|||
162629761|NCT01806545|587362578|FG000|Overall Study|Adverse Event|2|||
162629762|NCT01806545|587362579|FG001|Overall Study|Adverse Event|3|||
162629763|NCT01806545|587362578|FG000|Overall Study|Lost to Follow-up|1|||
162629764|NCT01806545|587362579|FG001|Overall Study|Lost to Follow-up|0|||
162629765|NCT01806545|587362578|FG000|Overall Study|Withdrawal by Subject|3|||
162629766|NCT01806545|587362579|FG001|Overall Study|Withdrawal by Subject|2|||
162629767|NCT00884312|587362580|FG000|Overall Study|Non-fatal Progressive Disease|0|||
162629768|NCT00884312|587362581|FG001|Overall Study|Non-fatal Progressive Disease|8|||
162629769|NCT00884312|587362580|FG000|Overall Study|Fatal Progressive Disease|0|||
162629770|NCT00884312|587362581|FG001|Overall Study|Fatal Progressive Disease|1|||
162629771|NCT00884312|587362580|FG000|Overall Study|Non-fatal Adverse Event|1|||
162629772|NCT00884312|587362581|FG001|Overall Study|Non-fatal Adverse Event|0|||
162629773|NCT00884312|587362580|FG000|Overall Study|Fatal Adverse Event|1|||
163056068|NCT01715298|588918327|FG001|Overall Study|Lost to Follow-up|2|||
162629774|NCT00884312|587362581|FG001|Overall Study|Fatal Adverse Event|4|||
162629775|NCT00884312|587362580|FG000|Overall Study|Withdrawal by Subject|0|||
163056069|NCT01715298|588918326|FG000|Overall Study|Patient/guardian decision|7|||
163056070|NCT01715298|588918327|FG001|Overall Study|Patient/guardian decision|9|||
163056071|NCT02419807|588918328|FG000|Overall Study|Withdrawal by Subject|4|||
163056072|NCT02419807|588918328|FG000|Overall Study|Physician Decision|1|||
163056073|NCT02419807|588918328|FG000|Overall Study|Protocol Violation|5|||
163056074|NCT01499511|588918331|FG000|Overall Study|Death|1|||
163056075|NCT01499511|588918332|FG001|Overall Study|Death|0|||
163056076|NCT01006629|588918333|FG000|Overall Study|Adverse Event|1|||
163056077|NCT01006629|588918333|FG000|Overall Study|Parent refused to continue participation|1|||
162919412|NCT03110107|588407629|FG000|Treatment Period|Death|0|||
162919413|NCT03110107|588407630|FG001|Treatment Period|Death|0|||
162919414|NCT03110107|588407631|FG002|Treatment Period|Death|0|||
162919415|NCT03110107|588407632|FG003|Treatment Period|Death|0|||
162919416|NCT03110107|588407633|FG004|Treatment Period|Death|0|||
162919417|NCT03110107|588407634|FG005|Treatment Period|Death|0|||
162919418|NCT03110107|588407635|FG006|Treatment Period|Death|0|||
162919419|NCT03110107|588407636|FG007|Treatment Period|Death|0|||
162919420|NCT03110107|588407637|FG008|Treatment Period|Death|0|||
162919421|NCT03110107|588407638|FG009|Treatment Period|Death|0|||
162919422|NCT03110107|588407639|FG010|Treatment Period|Death|0|||
162919423|NCT03110107|588407640|FG011|Treatment Period|Death|0|||
162919424|NCT03110107|588407641|FG012|Treatment Period|Death|1|||
162919425|NCT03110107|588407642|FG013|Treatment Period|Death|0|||
162919426|NCT03110107|588407643|FG014|Treatment Period|Death|0|||
162919427|NCT03110107|588407644|FG015|Treatment Period|Death|0|||
162919428|NCT03110107|588407645|FG016|Treatment Period|Death|0|||
162919429|NCT03110107|588407646|FG017|Treatment Period|Death|0|||
162919430|NCT03110107|588407647|FG018|Treatment Period|Death|0|||
162919431|NCT03110107|588407648|FG019|Treatment Period|Death|0|||
162919432|NCT03110107|588407649|FG020|Treatment Period|Death|0|||
162919433|NCT03110107|588407650|FG021|Treatment Period|Death|0|||
162919434|NCT03110107|588407651|FG022|Treatment Period|Death|0|||
162919435|NCT03110107|588407652|FG023|Treatment Period|Death|0|||
162919436|NCT03110107|588407653|FG024|Treatment Period|Death|0|||
162919437|NCT03110107|588407654|FG025|Treatment Period|Death|0|||
162919438|NCT03110107|588407629|FG000|Treatment Period|Adverse Event|0|||
162919439|NCT03110107|588407630|FG001|Treatment Period|Adverse Event|0|||
162919440|NCT03110107|588407631|FG002|Treatment Period|Adverse Event|1|||
162919441|NCT03110107|588407632|FG003|Treatment Period|Adverse Event|0|||
162919442|NCT03110107|588407633|FG004|Treatment Period|Adverse Event|0|||
162970140|NCT02315066|588591961|FG001|Overall Study|Subject refused further follow-up|2|||
162970141|NCT02315066|588591962|FG002|Overall Study|Subject refused further follow-up|2|||
162970142|NCT02315066|588591963|FG003|Overall Study|Subject refused further follow-up|0|||
162970143|NCT02315066|588591964|FG004|Overall Study|Subject refused further follow-up|0|||
162970144|NCT02315066|588591965|FG005|Overall Study|Subject refused further follow-up|0|||
162970145|NCT02315066|588591966|FG006|Overall Study|Subject refused further follow-up|2|||
162970146|NCT02315066|588591967|FG007|Overall Study|Subject refused further follow-up|3|||
162970147|NCT02315066|588591968|FG008|Overall Study|Subject refused further follow-up|0|||
162970148|NCT02315066|588591969|FG009|Overall Study|Subject refused further follow-up|1|||
162970149|NCT02315066|588591970|FG010|Overall Study|Subject refused further follow-up|1|||
162970150|NCT02315066|588591971|FG011|Overall Study|Subject refused further follow-up|2|||
162970151|NCT02315066|588591972|FG012|Overall Study|Subject refused further follow-up|2|||
162970152|NCT02315066|588591973|FG013|Overall Study|Subject refused further follow-up|4|||
162970153|NCT02315066|588591960|FG000|Overall Study|Study ongoing at date of cut-off|0|||
162970154|NCT02315066|588591961|FG001|Overall Study|Study ongoing at date of cut-off|0|||
162970155|NCT02315066|588591962|FG002|Overall Study|Study ongoing at date of cut-off|0|||
163056078|NCT01006629|588918333|FG000|Overall Study|Parent unable to perform site visit|4|||
163056079|NCT00998946|588918335|FG000|Overall Study|Lost to Follow-up|1|||
162629776|NCT00884312|587362581|FG001|Overall Study|Withdrawal by Subject|6|||
162629777|NCT00884312|587362580|FG000|Overall Study|Physician Decision|0|||
162919443|NCT03110107|588407634|FG005|Treatment Period|Adverse Event|2|||
162919444|NCT03110107|588407635|FG006|Treatment Period|Adverse Event|0|||
162919445|NCT03110107|588407636|FG007|Treatment Period|Adverse Event|2|||
162919446|NCT03110107|588407637|FG008|Treatment Period|Adverse Event|0|||
162919447|NCT03110107|588407638|FG009|Treatment Period|Adverse Event|1|||
162919448|NCT03110107|588407639|FG010|Treatment Period|Adverse Event|0|||
162919449|NCT03110107|588407640|FG011|Treatment Period|Adverse Event|0|||
162919450|NCT03110107|588407641|FG012|Treatment Period|Adverse Event|0|||
162919451|NCT03110107|588407642|FG013|Treatment Period|Adverse Event|0|||
162919452|NCT03110107|588407643|FG014|Treatment Period|Adverse Event|0|||
162919453|NCT03110107|588407644|FG015|Treatment Period|Adverse Event|2|||
162629778|NCT00884312|587362581|FG001|Overall Study|Physician Decision|1|||
162629779|NCT00884312|587362580|FG000|Overall Study|Other|0|||
162629780|NCT00884312|587362581|FG001|Overall Study|Other|4|||
162919454|NCT03110107|588407645|FG016|Treatment Period|Adverse Event|0|||
162919455|NCT03110107|588407646|FG017|Treatment Period|Adverse Event|1|||
162919456|NCT03110107|588407647|FG018|Treatment Period|Adverse Event|2|||
163056080|NCT00998946|588918335|FG000|Overall Study|Withdrawal by Subject|1|||
162919457|NCT03110107|588407648|FG019|Treatment Period|Adverse Event|1|||
162919458|NCT03110107|588407649|FG020|Treatment Period|Adverse Event|4|||
162919459|NCT03110107|588407650|FG021|Treatment Period|Adverse Event|2|||
162919460|NCT03110107|588407651|FG022|Treatment Period|Adverse Event|2|||
162919461|NCT03110107|588407652|FG023|Treatment Period|Adverse Event|2|||
162919462|NCT03110107|588407653|FG024|Treatment Period|Adverse Event|2|||
162919463|NCT03110107|588407654|FG025|Treatment Period|Adverse Event|4|||
162919464|NCT03110107|588407629|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
162919465|NCT03110107|588407630|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
162919466|NCT03110107|588407631|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
162919467|NCT03110107|588407632|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
162919468|NCT03110107|588407633|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
162919469|NCT03110107|588407634|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
162919470|NCT03110107|588407635|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
162919471|NCT03110107|588407636|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
162919472|NCT03110107|588407637|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
162919473|NCT03110107|588407638|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
162919474|NCT03110107|588407639|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
162919475|NCT03110107|588407640|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
162919476|NCT03110107|588407641|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
162919477|NCT03110107|588407642|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
162919478|NCT03110107|588407643|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
162919479|NCT03110107|588407644|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
162919480|NCT03110107|588407645|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
162919481|NCT03110107|588407646|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
162919482|NCT03110107|588407647|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
162919483|NCT03110107|588407648|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
162919484|NCT03110107|588407649|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
162919485|NCT03110107|588407650|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
162919486|NCT03110107|588407651|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
162919487|NCT03110107|588407652|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
162919488|NCT03110107|588407653|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
162919489|NCT03110107|588407654|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
162919490|NCT03110107|588407629|FG000|Treatment Period|Participant withdrew consent|0|||
162919491|NCT03110107|588407630|FG001|Treatment Period|Participant withdrew consent|0|||
162919492|NCT03110107|588407631|FG002|Treatment Period|Participant withdrew consent|1|||
163056081|NCT00998946|588918335|FG000|Overall Study|Death|2|||
163056082|NCT00998946|588918335|FG000|Overall Study|Reason Unspecified|3|||
163056083|NCT00998946|588918335|FG000|Overall Study|Enrolled but not Dosed|2|||
163056084|NCT01065818|588918337|FG000|Overall Study|Withdrawal by Subject|1|||
163056085|NCT01065818|588918337|FG000|Overall Study|Not a candidate for surgery|1|||
163056086|NCT04459338|588918338|FG000|Overall Study|Loss of IV during study|1|||
162919493|NCT03110107|588407632|FG003|Treatment Period|Participant withdrew consent|0|||
162919494|NCT03110107|588407633|FG004|Treatment Period|Participant withdrew consent|4|||
162919495|NCT03110107|588407634|FG005|Treatment Period|Participant withdrew consent|3|||
162919496|NCT03110107|588407635|FG006|Treatment Period|Participant withdrew consent|0|||
162919497|NCT03110107|588407636|FG007|Treatment Period|Participant withdrew consent|0|||
162919498|NCT03110107|588407637|FG008|Treatment Period|Participant withdrew consent|0|||
162919499|NCT03110107|588407638|FG009|Treatment Period|Participant withdrew consent|1|||
162919500|NCT03110107|588407639|FG010|Treatment Period|Participant withdrew consent|0|||
162919501|NCT03110107|588407640|FG011|Treatment Period|Participant withdrew consent|0|||
162919502|NCT03110107|588407641|FG012|Treatment Period|Participant withdrew consent|0|||
162919503|NCT03110107|588407642|FG013|Treatment Period|Participant withdrew consent|0|||
162919504|NCT03110107|588407643|FG014|Treatment Period|Participant withdrew consent|0|||
162919505|NCT03110107|588407644|FG015|Treatment Period|Participant withdrew consent|0|||
162919506|NCT03110107|588407645|FG016|Treatment Period|Participant withdrew consent|0|||
162919507|NCT03110107|588407646|FG017|Treatment Period|Participant withdrew consent|0|||
162919508|NCT03110107|588407647|FG018|Treatment Period|Participant withdrew consent|0|||
162919509|NCT03110107|588407648|FG019|Treatment Period|Participant withdrew consent|1|||
162919510|NCT03110107|588407649|FG020|Treatment Period|Participant withdrew consent|0|||
162919511|NCT03110107|588407650|FG021|Treatment Period|Participant withdrew consent|2|||
162919512|NCT03110107|588407651|FG022|Treatment Period|Participant withdrew consent|0|||
162919513|NCT03110107|588407652|FG023|Treatment Period|Participant withdrew consent|0|||
162919514|NCT03110107|588407653|FG024|Treatment Period|Participant withdrew consent|0|||
162919515|NCT03110107|588407654|FG025|Treatment Period|Participant withdrew consent|2|||
162919516|NCT03110107|588407629|FG000|Treatment Period|Participants no longer meets study criteria|0|||
162919517|NCT03110107|588407630|FG001|Treatment Period|Participants no longer meets study criteria|0|||
162919518|NCT03110107|588407631|FG002|Treatment Period|Participants no longer meets study criteria|0|||
162919519|NCT03110107|588407632|FG003|Treatment Period|Participants no longer meets study criteria|0|||
162919520|NCT03110107|588407633|FG004|Treatment Period|Participants no longer meets study criteria|0|||
162919521|NCT03110107|588407634|FG005|Treatment Period|Participants no longer meets study criteria|0|||
162919522|NCT03110107|588407635|FG006|Treatment Period|Participants no longer meets study criteria|0|||
162919523|NCT03110107|588407636|FG007|Treatment Period|Participants no longer meets study criteria|0|||
162919524|NCT03110107|588407637|FG008|Treatment Period|Participants no longer meets study criteria|0|||
162919525|NCT03110107|588407638|FG009|Treatment Period|Participants no longer meets study criteria|0|||
162919526|NCT03110107|588407639|FG010|Treatment Period|Participants no longer meets study criteria|0|||
162919527|NCT03110107|588407640|FG011|Treatment Period|Participants no longer meets study criteria|0|||
162919528|NCT03110107|588407641|FG012|Treatment Period|Participants no longer meets study criteria|0|||
162919529|NCT03110107|588407642|FG013|Treatment Period|Participants no longer meets study criteria|0|||
162919530|NCT03110107|588407643|FG014|Treatment Period|Participants no longer meets study criteria|0|||
162919531|NCT03110107|588407644|FG015|Treatment Period|Participants no longer meets study criteria|0|||
162919532|NCT03110107|588407645|FG016|Treatment Period|Participants no longer meets study criteria|0|||
162919533|NCT03110107|588407646|FG017|Treatment Period|Participants no longer meets study criteria|0|||
162919534|NCT03110107|588407647|FG018|Treatment Period|Participants no longer meets study criteria|0|||
162919535|NCT03110107|588407648|FG019|Treatment Period|Participants no longer meets study criteria|0|||
162919536|NCT03110107|588407649|FG020|Treatment Period|Participants no longer meets study criteria|0|||
162919537|NCT03110107|588407650|FG021|Treatment Period|Participants no longer meets study criteria|0|||
162919538|NCT03110107|588407651|FG022|Treatment Period|Participants no longer meets study criteria|0|||
162919539|NCT03110107|588407652|FG023|Treatment Period|Participants no longer meets study criteria|1|||
162919540|NCT03110107|588407653|FG024|Treatment Period|Participants no longer meets study criteria|0|||
162919541|NCT03110107|588407654|FG025|Treatment Period|Participants no longer meets study criteria|0|||
162919542|NCT03110107|588407629|FG000|Treatment Period|Other Reasons|0|||
162919543|NCT03110107|588407630|FG001|Treatment Period|Other Reasons|0|||
162919544|NCT03110107|588407631|FG002|Treatment Period|Other Reasons|1|||
162919545|NCT03110107|588407632|FG003|Treatment Period|Other Reasons|1|||
162919546|NCT03110107|588407633|FG004|Treatment Period|Other Reasons|0|||
162919547|NCT03110107|588407634|FG005|Treatment Period|Other Reasons|1|||
162919548|NCT03110107|588407635|FG006|Treatment Period|Other Reasons|0|||
162919549|NCT03110107|588407636|FG007|Treatment Period|Other Reasons|0|||
162919550|NCT03110107|588407637|FG008|Treatment Period|Other Reasons|0|||
162919551|NCT03110107|588407638|FG009|Treatment Period|Other Reasons|0|||
162919552|NCT03110107|588407639|FG010|Treatment Period|Other Reasons|0|||
162919553|NCT03110107|588407640|FG011|Treatment Period|Other Reasons|0|||
162919554|NCT03110107|588407641|FG012|Treatment Period|Other Reasons|0|||
162919555|NCT03110107|588407642|FG013|Treatment Period|Other Reasons|0|||
162919556|NCT03110107|588407643|FG014|Treatment Period|Other Reasons|0|||
162919557|NCT03110107|588407644|FG015|Treatment Period|Other Reasons|0|||
162919558|NCT03110107|588407645|FG016|Treatment Period|Other Reasons|0|||
162919559|NCT03110107|588407646|FG017|Treatment Period|Other Reasons|0|||
162919560|NCT03110107|588407647|FG018|Treatment Period|Other Reasons|0|||
162919561|NCT03110107|588407648|FG019|Treatment Period|Other Reasons|0|||
162919562|NCT03110107|588407649|FG020|Treatment Period|Other Reasons|0|||
162919563|NCT03110107|588407650|FG021|Treatment Period|Other Reasons|0|||
162919564|NCT03110107|588407651|FG022|Treatment Period|Other Reasons|0|||
162919565|NCT03110107|588407652|FG023|Treatment Period|Other Reasons|0|||
162919566|NCT03110107|588407653|FG024|Treatment Period|Other Reasons|1|||
162919567|NCT03110107|588407654|FG025|Treatment Period|Other Reasons|0|||
162919568|NCT03526549|588407659|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
162919569|NCT03526549|588407660|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
162919570|NCT03526549|588407659|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
162919571|NCT03526549|588407660|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
162919572|NCT03526549|588407659|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
162919573|NCT03526549|588407660|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
162919574|NCT03526549|588407659|FG000|Open-label Phase|Adverse Event|4|||
162919575|NCT03526549|588407660|FG001|Open-label Phase|Adverse Event|0|||
162919576|NCT03526549|588407659|FG000|Open-label Phase|Withdrawal by Subject|54|||
162919577|NCT03526549|588407660|FG001|Open-label Phase|Withdrawal by Subject|0|||
162919578|NCT03526549|588407659|FG000|Open-label Phase|Lost to Follow-up|35|||
162919579|NCT03526549|588407660|FG001|Open-label Phase|Lost to Follow-up|0|||
162919580|NCT03526549|588407659|FG000|Open-label Phase|Other than Specified|5|||
162919581|NCT03526549|588407660|FG001|Open-label Phase|Other than Specified|0|||
162919582|NCT03927989|588407663|FG000|Overall Study|Withdrawal by Subject|0|||
162919583|NCT03927989|588407664|FG001|Overall Study|Withdrawal by Subject|1|||
162919584|NCT02593175|588407665|FG000|Overall Study|Adverse Event|5|||
162919585|NCT02593175|588407665|FG000|Overall Study|Disease progression|4|||
162919586|NCT00478933|588407666|FG000|Overall Study|Protocol Violation|22|||
162919587|NCT00478933|588407666|FG000|Overall Study|Informed consent not verified|3|||
162919588|NCT00478933|588407666|FG000|Overall Study|Inadequate data available|53|||
162919589|NCT02506101|588407668|FG000|Overall Study|Transportation issues|1|||
162919590|NCT02506101|588407669|FG001|Overall Study|Transportation issues|0|||
162919591|NCT02506101|588407668|FG000|Overall Study|No enrollment and staff unavailability|1|||
162629781|NCT00884312|587362580|FG000|Overall Study|Did Not Receive Study Drug|0|||
162629782|NCT00884312|587362581|FG001|Overall Study|Did Not Receive Study Drug|1|||
162629783|NCT03521934|587362591|FG000|Overall Study|Death|65|||
162629784|NCT03521934|587362592|FG001|Overall Study|Death|73|||
162629785|NCT03521934|587362591|FG000|Overall Study|Withdrawal by Subject|18|||
162629786|NCT03521934|587362592|FG001|Overall Study|Withdrawal by Subject|23|||
162629787|NCT03521934|587362591|FG000|Overall Study|Site Terminated by Sponsor|39|||
162629788|NCT03521934|587362592|FG001|Overall Study|Site Terminated by Sponsor|35|||
162629789|NCT03521934|587362591|FG000|Overall Study|Study Terminated by Sponsor|483|||
162629790|NCT03521934|587362592|FG001|Overall Study|Study Terminated by Sponsor|477|||
162629791|NCT03521934|587362591|FG000|Overall Study|Reason not Specified|3|||
162629792|NCT03521934|587362592|FG001|Overall Study|Reason not Specified|6|||
162629793|NCT00284050|587362595|FG000|Overall Study|Adverse Event|1|||
162629794|NCT00284050|587362596|FG001|Overall Study|Adverse Event|1|||
162629795|NCT00284050|587362597|FG002|Overall Study|Adverse Event|1|||
162629796|NCT00284050|587362595|FG000|Overall Study|Lack of Efficacy|0|||
162629797|NCT00284050|587362596|FG001|Overall Study|Lack of Efficacy|1|||
162629798|NCT00284050|587362597|FG002|Overall Study|Lack of Efficacy|3|||
162629799|NCT00284050|587362595|FG000|Overall Study|Protocol Violation|0|||
162629800|NCT00284050|587362596|FG001|Overall Study|Protocol Violation|1|||
162629801|NCT00284050|587362597|FG002|Overall Study|Protocol Violation|2|||
162629802|NCT00284050|587362595|FG000|Overall Study|Withdrawal by Subject|2|||
162629803|NCT00284050|587362596|FG001|Overall Study|Withdrawal by Subject|2|||
162629804|NCT00284050|587362597|FG002|Overall Study|Withdrawal by Subject|2|||
162629805|NCT00284050|587362595|FG000|Overall Study|Lost to Follow-up|1|||
162629806|NCT00284050|587362596|FG001|Overall Study|Lost to Follow-up|0|||
162629807|NCT00284050|587362597|FG002|Overall Study|Lost to Follow-up|1|||
162629808|NCT00284050|587362595|FG000|Overall Study|Death|1|||
162629809|NCT00284050|587362596|FG001|Overall Study|Death|0|||
162629810|NCT00284050|587362597|FG002|Overall Study|Death|0|||
162629811|NCT00545168|587362604|FG000|Overall Study|Lost to Follow-up|5|||
162629812|NCT00545168|587362605|FG001|Overall Study|Lost to Follow-up|5|||
162629813|NCT00545168|587362606|FG002|Overall Study|Lost to Follow-up|5|||
162629814|NCT00545168|587362604|FG000|Overall Study|Withdrawal by Subject|9|||
162629815|NCT00545168|587362605|FG001|Overall Study|Withdrawal by Subject|0|||
162629816|NCT00545168|587362606|FG002|Overall Study|Withdrawal by Subject|13|||
162712354|NCT00991276|587658493|FG004|First Intervention Period|Other|1|||
162919592|NCT02506101|588407669|FG001|Overall Study|No enrollment and staff unavailability|0|||
162919593|NCT03586427|588407673|FG000|Overall Study|Lost to Follow-up|0|||
162919594|NCT03586427|588407674|FG001|Overall Study|Lost to Follow-up|3|||
162919595|NCT03586427|588407675|FG002|Overall Study|Lost to Follow-up|1|||
162919596|NCT03586427|588407676|FG003|Overall Study|Lost to Follow-up|3|||
162629817|NCT00545168|587362604|FG000|Overall Study|Protocol Violation|1|||
162629818|NCT00545168|587362605|FG001|Overall Study|Protocol Violation|0|||
162629819|NCT00545168|587362606|FG002|Overall Study|Protocol Violation|1|||
162629820|NCT00545168|587362604|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
162919597|NCT03586427|588407677|FG004|Overall Study|Lost to Follow-up|3|||
162919598|NCT03586427|588407673|FG000|Overall Study|Withdrawal by Subject|0|||
162919599|NCT03586427|588407674|FG001|Overall Study|Withdrawal by Subject|1|||
162919600|NCT03586427|588407675|FG002|Overall Study|Withdrawal by Subject|2|||
162919601|NCT03586427|588407676|FG003|Overall Study|Withdrawal by Subject|1|||
162919602|NCT03586427|588407677|FG004|Overall Study|Withdrawal by Subject|1|||
162919603|NCT03586427|588407673|FG000|Overall Study|Adverse Event|0|||
162919604|NCT03586427|588407674|FG001|Overall Study|Adverse Event|0|||
162919605|NCT03586427|588407675|FG002|Overall Study|Adverse Event|1|||
162919606|NCT03586427|588407676|FG003|Overall Study|Adverse Event|0|||
162919607|NCT03586427|588407677|FG004|Overall Study|Adverse Event|0|||
162919608|NCT03586427|588407673|FG000|Overall Study|Protocol Violation|0|||
162919609|NCT03586427|588407674|FG001|Overall Study|Protocol Violation|0|||
162919610|NCT03586427|588407675|FG002|Overall Study|Protocol Violation|1|||
162919611|NCT03586427|588407676|FG003|Overall Study|Protocol Violation|0|||
162919612|NCT03586427|588407677|FG004|Overall Study|Protocol Violation|1|||
162919613|NCT03586427|588407673|FG000|Overall Study|Noncompliance with study drug|0|||
162919614|NCT03586427|588407674|FG001|Overall Study|Noncompliance with study drug|0|||
162919615|NCT03586427|588407675|FG002|Overall Study|Noncompliance with study drug|1|||
162919616|NCT03586427|588407676|FG003|Overall Study|Noncompliance with study drug|0|||
162712355|NCT00991276|587658494|FG005|First Intervention Period|Other|0|||
162919617|NCT03586427|588407677|FG004|Overall Study|Noncompliance with study drug|0|||
162919618|NCT03193996|588407680|FG000|Overall Study|Withdrawal by Subject|4|||
162919619|NCT03193996|588407680|FG000|Overall Study|Lost to Follow-up|4|||
162919620|NCT03193996|588407680|FG000|Overall Study|Physician Decision|2|||
162919621|NCT03193996|588407680|FG000|Overall Study|Pregnancy|1|||
162919622|NCT03193996|588407680|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
162919623|NCT03193996|588407680|FG000|Overall Study|Complicating disease|1|||
162919624|NCT00593385|588407687|FG000|Overall Study|Death|14|||
162919625|NCT00593385|588407687|FG000|Overall Study|Lost to Follow-up|17|||
162919626|NCT00593385|588407687|FG000|Overall Study|Withdrawal by Subject|9|||
162919627|NCT01471197|588407688|FG000|Overall Study|Disease Progression|4|||
162919628|NCT01471197|588407689|FG001|Overall Study|Disease Progression|2|||
162919629|NCT01471197|588407688|FG000|Overall Study|Death|1|||
162919630|NCT01471197|588407689|FG001|Overall Study|Death|0|||
162919631|NCT01471197|588407688|FG000|Overall Study|Study Drug Toxicity|1|||
162919632|NCT01471197|588407689|FG001|Overall Study|Study Drug Toxicity|0|||
162919633|NCT00924313|588407692|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
162919634|NCT01298362|588407693|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
162919635|NCT01298362|588407694|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
162919636|NCT01353586|588407695|FG000|Overall Study|Procedure terminated prior to ablation|3|||
162919637|NCT01353586|588407696|FG001|Overall Study|Procedure terminated prior to ablation|0|||
162919638|NCT01353586|588407695|FG000|Overall Study|Never had insertion of study catheter|4|||
162919639|NCT01353586|588407696|FG001|Overall Study|Never had insertion of study catheter|1|||
162919640|NCT01353586|588407695|FG000|Overall Study|Neurological exam not done|0|||
162919641|NCT01353586|588407696|FG001|Overall Study|Neurological exam not done|1|||
162919642|NCT03253809|588407697|FG000|Overall Study|Unable to obtain study related data|14|||
162919643|NCT03992456|588407698|FG000|Overall Study|Withdrawal by Subject|1|||
162919644|NCT03992456|588407699|FG001|Overall Study|Withdrawal by Subject|0|||
162919645|NCT03992456|588407698|FG000|Overall Study|Disease progression|4|||
162919646|NCT03992456|588407699|FG001|Overall Study|Disease progression|5|||
162712356|NCT00991276|587658489|FG000|First Intervention Period|Withdrawal by Subject|0|||
162712357|NCT00991276|587658490|FG001|First Intervention Period|Withdrawal by Subject|1|||
162919647|NCT03992456|588407698|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
162919648|NCT03992456|588407699|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
162919649|NCT04637815|588407702|FG000|Overall Study|Death|1|||
162919650|NCT04637815|588407703|FG001|Overall Study|Death|0|||
162919651|NCT04637815|588407702|FG000|Overall Study|Lost to Follow-up|5|||
162919652|NCT04637815|588407703|FG001|Overall Study|Lost to Follow-up|2|||
162919653|NCT00326625|588407704|FG000|Overall Study|Adverse Event|20|||
162919654|NCT00326625|588407705|FG001|Overall Study|Adverse Event|9|||
162712358|NCT00991276|587658491|FG002|First Intervention Period|Withdrawal by Subject|0|||
162712359|NCT00991276|587658492|FG003|First Intervention Period|Withdrawal by Subject|1|||
162712360|NCT00991276|587658493|FG004|First Intervention Period|Withdrawal by Subject|0|||
162919655|NCT00326625|588407704|FG000|Overall Study|Withdrawal by Subject|15|||
162919656|NCT00326625|588407705|FG001|Overall Study|Withdrawal by Subject|12|||
162919657|NCT00326625|588407704|FG000|Overall Study|Death|18|||
162919658|NCT00326625|588407705|FG001|Overall Study|Death|16|||
162712361|NCT00991276|587658494|FG005|First Intervention Period|Withdrawal by Subject|1|||
162712362|NCT00991276|587658489|FG000|First Intervention Period|Lost to Follow-up|0|||
162919659|NCT00326625|588407704|FG000|Overall Study|Lost to Follow-up|1|||
162919660|NCT00326625|588407705|FG001|Overall Study|Lost to Follow-up|0|||
162919661|NCT00326625|588407704|FG000|Overall Study|prescheduled medical intervention|0|||
162919662|NCT00326625|588407705|FG001|Overall Study|prescheduled medical intervention|1|||
162919663|NCT02594384|588407706|FG000|Overall Study|Disease Progression|3|||
162919664|NCT02594384|588407707|FG001|Overall Study|Disease Progression|7|||
162919665|NCT02594384|588407708|FG002|Overall Study|Disease Progression|0|||
162919666|NCT02594384|588407709|FG003|Overall Study|Disease Progression|2|||
162919667|NCT02594384|588407710|FG004|Overall Study|Disease Progression|2|||
162919668|NCT02594384|588407711|FG005|Overall Study|Disease Progression|12|||
162919669|NCT02594384|588407712|FG006|Overall Study|Disease Progression|5|||
162919670|NCT02594384|588407713|FG007|Overall Study|Disease Progression|5|||
162919671|NCT02594384|588407706|FG000|Overall Study|Adverse Event|0|||
162919672|NCT02594384|588407707|FG001|Overall Study|Adverse Event|1|||
162919673|NCT02594384|588407708|FG002|Overall Study|Adverse Event|4|||
162919674|NCT02594384|588407709|FG003|Overall Study|Adverse Event|1|||
162919675|NCT02594384|588407710|FG004|Overall Study|Adverse Event|0|||
162919676|NCT02594384|588407711|FG005|Overall Study|Adverse Event|6|||
162919677|NCT02594384|588407712|FG006|Overall Study|Adverse Event|1|||
162919678|NCT02594384|588407713|FG007|Overall Study|Adverse Event|1|||
162919679|NCT02594384|588407706|FG000|Overall Study|Withdrawal by Subject|0|||
162919680|NCT02594384|588407707|FG001|Overall Study|Withdrawal by Subject|0|||
162919681|NCT02594384|588407708|FG002|Overall Study|Withdrawal by Subject|0|||
162919682|NCT02594384|588407709|FG003|Overall Study|Withdrawal by Subject|1|||
162919683|NCT02594384|588407710|FG004|Overall Study|Withdrawal by Subject|0|||
162919684|NCT02594384|588407711|FG005|Overall Study|Withdrawal by Subject|0|||
162919685|NCT02594384|588407712|FG006|Overall Study|Withdrawal by Subject|0|||
162919686|NCT02594384|588407713|FG007|Overall Study|Withdrawal by Subject|1|||
162919687|NCT02594384|588407706|FG000|Overall Study|Physician Decision|0|||
162919688|NCT02594384|588407707|FG001|Overall Study|Physician Decision|0|||
162919689|NCT02594384|588407708|FG002|Overall Study|Physician Decision|0|||
162919690|NCT02594384|588407709|FG003|Overall Study|Physician Decision|0|||
162919691|NCT02594384|588407710|FG004|Overall Study|Physician Decision|0|||
162919692|NCT02594384|588407711|FG005|Overall Study|Physician Decision|1|||
162919693|NCT02594384|588407712|FG006|Overall Study|Physician Decision|2|||
162919694|NCT02594384|588407713|FG007|Overall Study|Physician Decision|0|||
162919695|NCT02594384|588407706|FG000|Overall Study|Progressive Leukocytosis|0|||
162629821|NCT00545168|587362605|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
162629822|NCT00545168|587362606|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
162629823|NCT01833520|587362611|FG000|Overall Study|Lack of Efficacy|3|||
162629824|NCT01833520|587362612|FG001|Overall Study|Lack of Efficacy|3|||
162629825|NCT01833520|587362613|FG002|Overall Study|Lack of Efficacy|8|||
162629826|NCT01833520|587362614|FG003|Overall Study|Lack of Efficacy|3|||
162629827|NCT00489541|587362622|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
162629828|NCT00489541|587362623|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
162629829|NCT00489541|587362622|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
162629830|NCT00489541|587362623|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
162629831|NCT00489541|587362622|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
162629832|NCT00489541|587362623|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
162629833|NCT00489541|587362622|FG000|12-Month Clinical Follow-up|Death|3|||
162629834|NCT00489541|587362623|FG001|12-Month Clinical Follow-up|Death|2|||
162629835|NCT00489541|587362622|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
162629836|NCT00489541|587362623|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
162629837|NCT00489541|587362622|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
162629838|NCT00489541|587362623|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
162629839|NCT04182763|587362626|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
162629840|NCT04182763|587362627|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
162629841|NCT04182763|587362628|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
162629842|NCT04182763|587362629|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
162629843|NCT04182763|587362630|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
162629844|NCT04182763|587362626|FG000|Double-Blind Period, initial 6 months|Death|0|||
162629845|NCT04182763|587362627|FG001|Double-Blind Period, initial 6 months|Death|1|||
162629846|NCT04182763|587362628|FG002|Double-Blind Period, initial 6 months|Death|0|||
162629847|NCT04182763|587362629|FG003|Double-Blind Period, initial 6 months|Death|0|||
162629848|NCT04182763|587362630|FG004|Double-Blind Period, initial 6 months|Death|0|||
162629849|NCT04182763|587362626|FG000|Open-Label Period, subsequent 18 months|Death|3|||
162629850|NCT04182763|587362627|FG001|Open-Label Period, subsequent 18 months|Death|2|||
162919696|NCT02594384|588407707|FG001|Overall Study|Progressive Leukocytosis|0|||
162919697|NCT02594384|588407708|FG002|Overall Study|Progressive Leukocytosis|1|||
162919698|NCT02594384|588407709|FG003|Overall Study|Progressive Leukocytosis|0|||
162919699|NCT02594384|588407710|FG004|Overall Study|Progressive Leukocytosis|0|||
162919700|NCT02594384|588407711|FG005|Overall Study|Progressive Leukocytosis|0|||
162919701|NCT02594384|588407712|FG006|Overall Study|Progressive Leukocytosis|0|||
162629851|NCT04182763|587362628|FG002|Open-Label Period, subsequent 18 months|Death|2|||
162629852|NCT04182763|587362629|FG003|Open-Label Period, subsequent 18 months|Death|0|||
162629853|NCT04182763|587362630|FG004|Open-Label Period, subsequent 18 months|Death|1|||
162629854|NCT04182763|587362626|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
162919702|NCT02594384|588407713|FG007|Overall Study|Progressive Leukocytosis|0|||
162919703|NCT02594384|588407706|FG000|Overall Study|Lack of Efficacy|0|||
162919704|NCT02594384|588407707|FG001|Overall Study|Lack of Efficacy|0|||
162919705|NCT02594384|588407708|FG002|Overall Study|Lack of Efficacy|0|||
162919706|NCT02594384|588407709|FG003|Overall Study|Lack of Efficacy|0|||
162919707|NCT02594384|588407710|FG004|Overall Study|Lack of Efficacy|1|||
162919708|NCT02594384|588407711|FG005|Overall Study|Lack of Efficacy|0|||
162919709|NCT02594384|588407712|FG006|Overall Study|Lack of Efficacy|0|||
162919710|NCT02594384|588407713|FG007|Overall Study|Lack of Efficacy|0|||
162919711|NCT02594384|588407706|FG000|Overall Study|Substantial noncompliance|0|||
162919712|NCT02594384|588407707|FG001|Overall Study|Substantial noncompliance|0|||
162919713|NCT02594384|588407708|FG002|Overall Study|Substantial noncompliance|0|||
162919714|NCT02594384|588407709|FG003|Overall Study|Substantial noncompliance|0|||
162919715|NCT02594384|588407710|FG004|Overall Study|Substantial noncompliance|0|||
162919716|NCT02594384|588407711|FG005|Overall Study|Substantial noncompliance|0|||
162919717|NCT02594384|588407712|FG006|Overall Study|Substantial noncompliance|1|||
162919718|NCT02594384|588407713|FG007|Overall Study|Substantial noncompliance|0|||
162919719|NCT03919669|588407716|FG000|Overall Study|Withdrawal by Subject|1|||
162919720|NCT03919669|588407717|FG001|Overall Study|Withdrawal by Subject|0|||
162919721|NCT03919669|588407718|FG002|Overall Study|Withdrawal by Subject|0|||
162919722|NCT00625846|588407719|FG000|Overall Study|Withdrawal by Subject|2|||
162919723|NCT00625846|588407720|FG001|Overall Study|Withdrawal by Subject|0|||
162919724|NCT00625846|588407721|FG002|Overall Study|Withdrawal by Subject|1|||
162919725|NCT00625846|588407722|FG003|Overall Study|Withdrawal by Subject|2|||
162919726|NCT00483119|588407727|FG000|Overall Study|Adverse Event|0|||
162919727|NCT00483119|588407728|FG001|Overall Study|Adverse Event|1|||
162919728|NCT00483119|588407727|FG000|Overall Study|Physician Decision|1|||
162919729|NCT00483119|588407728|FG001|Overall Study|Physician Decision|0|||
162919730|NCT02369874|588407729|FG000|Overall Study|Lost to Follow-up|2|||
162919731|NCT02369874|588407730|FG001|Overall Study|Lost to Follow-up|2|||
162919732|NCT02369874|588407731|FG002|Overall Study|Lost to Follow-up|2|||
162919733|NCT02369874|588407729|FG000|Overall Study|Withdrawal by Subject|7|||
162919734|NCT02369874|588407730|FG001|Overall Study|Withdrawal by Subject|9|||
162919735|NCT02369874|588407731|FG002|Overall Study|Withdrawal by Subject|27|||
162919736|NCT02369874|588407729|FG000|Overall Study|Miscellaneous|1|||
162919737|NCT02369874|588407730|FG001|Overall Study|Miscellaneous|1|||
162919738|NCT02369874|588407731|FG002|Overall Study|Miscellaneous|0|||
162919739|NCT02369874|588407729|FG000|Overall Study|On Treatment/Off Study|34|||
162919740|NCT02369874|588407730|FG001|Overall Study|On Treatment/Off Study|45|||
162919741|NCT02369874|588407731|FG002|Overall Study|On Treatment/Off Study|32|||
162919742|NCT02058849|588407732|FG000|Overall Study|Hospitalization|1|||
162919743|NCT02058849|588407733|FG001|Overall Study|Hospitalization|1|||
162919744|NCT02058849|588407732|FG000|Overall Study|Death|1|||
162919745|NCT02058849|588407733|FG001|Overall Study|Death|0|||
162919746|NCT02058849|588407732|FG000|Overall Study|Lost to Follow-up|1|||
162919747|NCT02058849|588407733|FG001|Overall Study|Lost to Follow-up|0|||
162919748|NCT02058849|588407732|FG000|Overall Study|Withdrawal by Subject|4|||
162919749|NCT02058849|588407733|FG001|Overall Study|Withdrawal by Subject|0|||
162919750|NCT02331680|588407734|FG000|Overall Study|Adverse Event|3|||
162919751|NCT02331680|588407735|FG001|Overall Study|Adverse Event|0|||
162919752|NCT02331680|588407736|FG002|Overall Study|Adverse Event|2|||
162919753|NCT02331680|588407734|FG000|Overall Study|Physician Decision|1|||
162919754|NCT02331680|588407735|FG001|Overall Study|Physician Decision|1|||
162919755|NCT02331680|588407736|FG002|Overall Study|Physician Decision|2|||
162919756|NCT02331680|588407734|FG000|Overall Study|Withdrawal by Subject|0|||
162919757|NCT02331680|588407735|FG001|Overall Study|Withdrawal by Subject|1|||
162919758|NCT02331680|588407736|FG002|Overall Study|Withdrawal by Subject|2|||
162919759|NCT02331680|588407734|FG000|Overall Study|Met withdrawal criteria|2|||
163056087|NCT04459338|588918339|FG001|Overall Study|Loss of IV during study|0|||
162919760|NCT02331680|588407735|FG001|Overall Study|Met withdrawal criteria|2|||
162919761|NCT02331680|588407736|FG002|Overall Study|Met withdrawal criteria|5|||
162919762|NCT02331680|588407734|FG000|Overall Study|Non-compliance with study drug|0|||
162919763|NCT02331680|588407735|FG001|Overall Study|Non-compliance with study drug|0|||
162919764|NCT02331680|588407736|FG002|Overall Study|Non-compliance with study drug|1|||
162919765|NCT02331680|588407734|FG000|Overall Study|Protocol Violation|0|||
162919766|NCT02331680|588407735|FG001|Overall Study|Protocol Violation|0|||
162919767|NCT02331680|588407736|FG002|Overall Study|Protocol Violation|3|||
162919768|NCT02219477|588407737|FG000|Overall Study|Adverse Event|0|||
162919769|NCT02219477|588407738|FG001|Overall Study|Adverse Event|1|||
162919770|NCT02219477|588407739|FG002|Overall Study|Adverse Event|1|||
162919771|NCT02219477|588407737|FG000|Overall Study|Withdrawal by Subject|0|||
162919772|NCT02219477|588407738|FG001|Overall Study|Withdrawal by Subject|1|||
162919773|NCT02219477|588407739|FG002|Overall Study|Withdrawal by Subject|0|||
162919774|NCT00596466|588407740|FG000|Overall Study|Lack of Efficacy|5|||
162919775|NCT00596466|588407740|FG000|Overall Study|Adverse Event|4|||
162919776|NCT00596466|588407740|FG000|Overall Study|Withdrawal by Subject|2|||
162919777|NCT00596466|588407740|FG000|Overall Study|Protocol Violation|2|||
162919778|NCT00596466|588407740|FG000|Overall Study|Unpecified|2|||
162919779|NCT00596466|588407740|FG000|Overall Study|Enrolled, not treated|2|||
162919780|NCT04505592|588407741|FG000|Overall Study|Death|2|||
162919781|NCT04505592|588407742|FG001|Overall Study|Death|1|||
162919782|NCT01891669|588407744|FG000|Overall Study|Death|0|||
162919783|NCT01891669|588407745|FG001|Overall Study|Death|0|||
162919784|NCT01891669|588407746|FG002|Overall Study|Death|0|||
162919785|NCT01891669|588407747|FG003|Overall Study|Death|0|||
162919786|NCT01891669|588407748|FG004|Overall Study|Death|0|||
162919787|NCT01891669|588407749|FG005|Overall Study|Death|0|||
162919788|NCT01891669|588407750|FG006|Overall Study|Death|0|||
162919789|NCT01891669|588407751|FG007|Overall Study|Death|1|||
162919790|NCT01891669|588407752|FG008|Overall Study|Death|0|||
162919791|NCT01891669|588407753|FG009|Overall Study|Death|1|||
162919792|NCT01891669|588407744|FG000|Overall Study|Withdrawal by Subject|1|||
162919793|NCT01891669|588407745|FG001|Overall Study|Withdrawal by Subject|1|||
162919794|NCT01891669|588407746|FG002|Overall Study|Withdrawal by Subject|0|||
162919795|NCT01891669|588407747|FG003|Overall Study|Withdrawal by Subject|0|||
162919796|NCT01891669|588407748|FG004|Overall Study|Withdrawal by Subject|0|||
162919797|NCT01891669|588407749|FG005|Overall Study|Withdrawal by Subject|0|||
162919798|NCT01891669|588407750|FG006|Overall Study|Withdrawal by Subject|1|||
162919799|NCT01891669|588407751|FG007|Overall Study|Withdrawal by Subject|2|||
162919800|NCT01891669|588407752|FG008|Overall Study|Withdrawal by Subject|1|||
162919801|NCT01891669|588407753|FG009|Overall Study|Withdrawal by Subject|1|||
162919802|NCT01891669|588407744|FG000|Overall Study|Other|1|||
162919803|NCT01891669|588407745|FG001|Overall Study|Other|0|||
162919804|NCT01891669|588407746|FG002|Overall Study|Other|0|||
162919805|NCT01891669|588407747|FG003|Overall Study|Other|0|||
162919806|NCT01891669|588407748|FG004|Overall Study|Other|0|||
162919807|NCT01891669|588407749|FG005|Overall Study|Other|0|||
162919808|NCT01891669|588407750|FG006|Overall Study|Other|0|||
162919809|NCT01891669|588407751|FG007|Overall Study|Other|1|||
162919810|NCT01891669|588407752|FG008|Overall Study|Other|0|||
162919811|NCT01891669|588407753|FG009|Overall Study|Other|0|||
162919812|NCT04298229|588407758|FG000|Overall Study|Physician Decision|1|||
162919813|NCT04298229|588407759|FG001|Overall Study|Physician Decision|1|||
162919814|NCT04298229|588407758|FG000|Overall Study|Withdrawal by Subject|1|||
162919815|NCT04298229|588407759|FG001|Overall Study|Withdrawal by Subject|1|||
162919816|NCT04298229|588407758|FG000|Overall Study|Did not receive IV loop diuretics|2|||
162919817|NCT04298229|588407759|FG001|Overall Study|Did not receive IV loop diuretics|0|||
162712363|NCT00991276|587658490|FG001|First Intervention Period|Lost to Follow-up|1|||
162712364|NCT00991276|587658491|FG002|First Intervention Period|Lost to Follow-up|0|||
162712365|NCT00991276|587658492|FG003|First Intervention Period|Lost to Follow-up|1|||
162712366|NCT00991276|587658493|FG004|First Intervention Period|Lost to Follow-up|0|||
162712367|NCT00991276|587658494|FG005|First Intervention Period|Lost to Follow-up|0|||
162712368|NCT00991276|587658489|FG000|Second Intervention Period|Adverse Event|0|||
162712369|NCT00991276|587658490|FG001|Second Intervention Period|Adverse Event|2|||
162712370|NCT00991276|587658491|FG002|Second Intervention Period|Adverse Event|0|||
162712371|NCT00991276|587658492|FG003|Second Intervention Period|Adverse Event|1|||
162712372|NCT00991276|587658493|FG004|Second Intervention Period|Adverse Event|1|||
162712373|NCT00991276|587658494|FG005|Second Intervention Period|Adverse Event|0|||
162919818|NCT00262119|588407760|FG000|Overall Study|Lost to Follow-up|38|||
162919819|NCT00262119|588407761|FG001|Overall Study|Lost to Follow-up|51|||
162919820|NCT00262119|588407762|FG002|Overall Study|Lost to Follow-up|42|||
162919821|NCT00262119|588407760|FG000|Overall Study|Death|20|||
162919822|NCT00262119|588407761|FG001|Overall Study|Death|19|||
162919823|NCT00262119|588407762|FG002|Overall Study|Death|16|||
162919824|NCT00859313|588407763|FG000|Overall Study|Lack of Efficacy|2|||
162919825|NCT00859313|588407763|FG000|Overall Study|Adverse Event|1|||
162970156|NCT02315066|588591963|FG003|Overall Study|Study ongoing at date of cut-off|0|||
162970157|NCT02315066|588591964|FG004|Overall Study|Study ongoing at date of cut-off|0|||
162970158|NCT02315066|588591965|FG005|Overall Study|Study ongoing at date of cut-off|0|||
162919826|NCT00859313|588407763|FG000|Overall Study|staff error|1|||
162919827|NCT00071006|588407764|FG000|Overall Study|Lack of Efficacy|7|||
162919828|NCT00071006|588407764|FG000|Overall Study|Adverse Event|1|||
162919829|NCT00071006|588407764|FG000|Overall Study|Withdrawal by Subject|1|||
162919830|NCT00071006|588407764|FG000|Overall Study|Other|3|||
162970159|NCT02315066|588591966|FG006|Overall Study|Study ongoing at date of cut-off|0|||
162970160|NCT02315066|588591967|FG007|Overall Study|Study ongoing at date of cut-off|0|||
162919831|NCT05261126|588407769|FG000|Overall Study|Death|0|||
162919832|NCT05261126|588407770|FG001|Overall Study|Death|0|||
162919833|NCT05261126|588407771|FG002|Overall Study|Death|1|||
162919834|NCT05261126|588407772|FG003|Overall Study|Death|0|||
162919835|NCT05261126|588407773|FG004|Overall Study|Death|0|||
162919836|NCT05261126|588407769|FG000|Overall Study|Lost to Follow-up|0|||
162919837|NCT05261126|588407770|FG001|Overall Study|Lost to Follow-up|0|||
162919838|NCT05261126|588407771|FG002|Overall Study|Lost to Follow-up|0|||
162919839|NCT05261126|588407772|FG003|Overall Study|Lost to Follow-up|0|||
162712374|NCT00991276|587658489|FG000|Second Intervention Period|Protocol Violation|1|||
162712375|NCT00991276|587658490|FG001|Second Intervention Period|Protocol Violation|0|||
162712376|NCT00991276|587658491|FG002|Second Intervention Period|Protocol Violation|0|||
162712377|NCT00991276|587658492|FG003|Second Intervention Period|Protocol Violation|0|||
162712378|NCT00991276|587658493|FG004|Second Intervention Period|Protocol Violation|0|||
162712379|NCT00991276|587658494|FG005|Second Intervention Period|Protocol Violation|0|||
162712380|NCT00991276|587658489|FG000|Second Intervention Period|Other|0|||
162712381|NCT00991276|587658490|FG001|Second Intervention Period|Other|0|||
162712382|NCT00991276|587658491|FG002|Second Intervention Period|Other|0|||
162712383|NCT00991276|587658492|FG003|Second Intervention Period|Other|1|||
162919840|NCT05261126|588407773|FG004|Overall Study|Lost to Follow-up|1|||
162919841|NCT05261126|588407769|FG000|Overall Study|Physician Decision|1|||
162919842|NCT05261126|588407770|FG001|Overall Study|Physician Decision|0|||
162919843|NCT05261126|588407771|FG002|Overall Study|Physician Decision|0|||
162919844|NCT05261126|588407772|FG003|Overall Study|Physician Decision|0|||
162919845|NCT05261126|588407773|FG004|Overall Study|Physician Decision|0|||
162919846|NCT05261126|588407769|FG000|Overall Study|Screen Failure|0|||
162919847|NCT05261126|588407770|FG001|Overall Study|Screen Failure|0|||
162919848|NCT05261126|588407771|FG002|Overall Study|Screen Failure|0|||
162970161|NCT02315066|588591968|FG008|Overall Study|Study ongoing at date of cut-off|0|||
162712384|NCT00991276|587658493|FG004|Second Intervention Period|Other|0|||
162712385|NCT00991276|587658494|FG005|Second Intervention Period|Other|1|||
162712386|NCT00991276|587658489|FG000|Third Intervention Period|Protocol Violation|1|||
162712387|NCT00991276|587658490|FG001|Third Intervention Period|Protocol Violation|0|||
162712388|NCT00991276|587658491|FG002|Third Intervention Period|Protocol Violation|0|||
162712389|NCT00991276|587658492|FG003|Third Intervention Period|Protocol Violation|0|||
162712390|NCT00991276|587658493|FG004|Third Intervention Period|Protocol Violation|0|||
162712391|NCT00991276|587658494|FG005|Third Intervention Period|Protocol Violation|0|||
162712392|NCT00991276|587658489|FG000|Third Intervention Period|Other|0|||
162712393|NCT00991276|587658490|FG001|Third Intervention Period|Other|0|||
162712394|NCT00991276|587658491|FG002|Third Intervention Period|Other|0|||
162712395|NCT00991276|587658492|FG003|Third Intervention Period|Other|0|||
162712396|NCT00991276|587658493|FG004|Third Intervention Period|Other|0|||
162712397|NCT00991276|587658494|FG005|Third Intervention Period|Other|1|||
162712398|NCT00991276|587658489|FG000|Third Intervention Period|Adverse Event|0|||
162712399|NCT00991276|587658490|FG001|Third Intervention Period|Adverse Event|0|||
162712400|NCT00991276|587658491|FG002|Third Intervention Period|Adverse Event|1|||
162712401|NCT00991276|587658492|FG003|Third Intervention Period|Adverse Event|0|||
162712402|NCT00991276|587658493|FG004|Third Intervention Period|Adverse Event|0|||
162712403|NCT00991276|587658494|FG005|Third Intervention Period|Adverse Event|0|||
162712404|NCT00991276|587658489|FG000|Third Intervention Period|Withdrawal by Subject|0|||
162712405|NCT00991276|587658490|FG001|Third Intervention Period|Withdrawal by Subject|0|||
162712406|NCT00991276|587658491|FG002|Third Intervention Period|Withdrawal by Subject|0|||
162712407|NCT00991276|587658492|FG003|Third Intervention Period|Withdrawal by Subject|1|||
162712408|NCT00991276|587658493|FG004|Third Intervention Period|Withdrawal by Subject|0|||
162712409|NCT00991276|587658494|FG005|Third Intervention Period|Withdrawal by Subject|0|||
162712410|NCT01268891|587658496|FG000|Overall Study|Adverse Event|3|||
162712411|NCT01268891|587658497|FG001|Overall Study|Adverse Event|7|||
162712412|NCT01268891|587658496|FG000|Overall Study|Lack of Efficacy|1|||
162712413|NCT01268891|587658497|FG001|Overall Study|Lack of Efficacy|0|||
162712414|NCT01268891|587658496|FG000|Overall Study|Withdrawal of Consent|3|||
162712415|NCT01268891|587658497|FG001|Overall Study|Withdrawal of Consent|1|||
162712416|NCT01268891|587658496|FG000|Overall Study|Administrative or other reason(s)|1|||
162712417|NCT01268891|587658497|FG001|Overall Study|Administrative or other reason(s)|0|||
162712418|NCT02001623|587658499|FG000|Overall Study|Disease Progression|2|||
162712419|NCT02001623|587658500|FG001|Overall Study|Disease Progression|2|||
162712420|NCT02001623|587658501|FG002|Overall Study|Disease Progression|3|||
162712421|NCT02001623|587658502|FG003|Overall Study|Disease Progression|2|||
162712422|NCT02001623|587658503|FG004|Overall Study|Disease Progression|3|||
162970162|NCT02315066|588591969|FG009|Overall Study|Study ongoing at date of cut-off|0|||
162970163|NCT02315066|588591970|FG010|Overall Study|Study ongoing at date of cut-off|0|||
162970164|NCT02315066|588591971|FG011|Overall Study|Study ongoing at date of cut-off|0|||
162970165|NCT02315066|588591972|FG012|Overall Study|Study ongoing at date of cut-off|0|||
162712423|NCT02001623|587658504|FG005|Overall Study|Disease Progression|2|||
162712424|NCT02001623|587658505|FG006|Overall Study|Disease Progression|3|||
162712425|NCT02001623|587658506|FG007|Overall Study|Disease Progression|3|||
162712426|NCT02001623|587658507|FG008|Overall Study|Disease Progression|7|||
162712427|NCT02001623|587658508|FG009|Overall Study|Disease Progression|40|||
162712428|NCT02001623|587658509|FG010|Overall Study|Disease Progression|5|||
162712429|NCT02001623|587658510|FG011|Overall Study|Disease Progression|9|||
162919849|NCT05261126|588407772|FG003|Overall Study|Screen Failure|0|||
162970166|NCT02315066|588591973|FG013|Overall Study|Study ongoing at date of cut-off|1|||
162970167|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
162712430|NCT02001623|587658511|FG012|Overall Study|Disease Progression|9|||
162919850|NCT05261126|588407773|FG004|Overall Study|Screen Failure|1|||
162919851|NCT05261126|588407769|FG000|Overall Study|Withdrawal by Subject|1|||
162919852|NCT05261126|588407770|FG001|Overall Study|Withdrawal by Subject|0|||
162919853|NCT05261126|588407771|FG002|Overall Study|Withdrawal by Subject|1|||
162919854|NCT05261126|588407772|FG003|Overall Study|Withdrawal by Subject|1|||
162919855|NCT05261126|588407773|FG004|Overall Study|Withdrawal by Subject|0|||
162919856|NCT05261126|588407769|FG000|Overall Study|Not Recorded|0|||
162919857|NCT05261126|588407770|FG001|Overall Study|Not Recorded|0|||
162919858|NCT05261126|588407771|FG002|Overall Study|Not Recorded|0|||
162919859|NCT05261126|588407772|FG003|Overall Study|Not Recorded|1|||
162919860|NCT05261126|588407773|FG004|Overall Study|Not Recorded|0|||
162919861|NCT05939388|588407774|FG000|Overall Study|Lost to Follow-up|1|||
162919862|NCT03901274|588407775|FG000|Overall Study|Lost to Follow-up|120|||
162919863|NCT03901274|588407776|FG001|Overall Study|Lost to Follow-up|124|||
162919864|NCT03901274|588407775|FG000|Overall Study|Withdrawal by Subject|0|||
162919865|NCT03901274|588407776|FG001|Overall Study|Withdrawal by Subject|6|||
162919866|NCT05570604|588407777|FG000|Overall Study|Lost to Follow-up|1|||
162919867|NCT05570604|588407778|FG001|Overall Study|Lost to Follow-up|5|||
162919868|NCT05570604|588407777|FG000|Overall Study|Illness|2|||
162919869|NCT05570604|588407778|FG001|Overall Study|Illness|2|||
162712431|NCT02001623|587658512|FG013|Overall Study|Disease Progression|20|||
162919870|NCT04527380|588407785|FG000|Overall Study|Lack of Efficacy|0|||
162919871|NCT04527380|588407786|FG001|Overall Study|Lack of Efficacy|1|||
162919872|NCT04527380|588407785|FG000|Overall Study|Withdrawal by Subject|1|||
162919873|NCT04527380|588407786|FG001|Overall Study|Withdrawal by Subject|0|||
162919874|NCT05116241|588407801|FG000|Study|Withdrawal by Subject|5|||
162919875|NCT05116241|588407802|FG001|Study|Withdrawal by Subject|2|||
162712432|NCT02001623|587658513|FG014|Overall Study|Disease Progression|9|||
162712433|NCT02001623|587658499|FG000|Overall Study|Physician Decision|0|||
162712434|NCT02001623|587658500|FG001|Overall Study|Physician Decision|0|||
162919876|NCT05116241|588407803|FG002|Study|Withdrawal by Subject|1|||
162919877|NCT05116241|588407801|FG000|Study|Lost to Follow-up|0|||
162919878|NCT05116241|588407802|FG001|Study|Lost to Follow-up|2|||
162919879|NCT05116241|588407803|FG002|Study|Lost to Follow-up|2|||
162919880|NCT04410991|588407804|FG000|Overall Study|Poor compliance to protocol|5|||
162919881|NCT04410991|588407805|FG001|Overall Study|Poor compliance to protocol|4|||
162919882|NCT04410991|588407804|FG000|Overall Study|Withdrawal by Subject|59|||
162919883|NCT04410991|588407805|FG001|Overall Study|Withdrawal by Subject|55|||
162919884|NCT04410991|588407804|FG000|Overall Study|Other|10|||
162919885|NCT04410991|588407805|FG001|Overall Study|Other|4|||
162919886|NCT01958619|588407815|FG000|Overall Study|Protocol Violation|2|||
162919887|NCT01958619|588407816|FG001|Overall Study|Protocol Violation|0|||
162919888|NCT01958619|588407817|FG002|Overall Study|Protocol Violation|1|||
162919889|NCT01958619|588407818|FG003|Overall Study|Protocol Violation|0|||
162919890|NCT01054443|588407819|FG000|Overall Study|Withdrawal by Subject|0|||
162919891|NCT01054443|588407820|FG001|Overall Study|Withdrawal by Subject|0|||
162919892|NCT01054443|588407821|FG002|Overall Study|Withdrawal by Subject|0|||
162919893|NCT01054443|588407822|FG003|Overall Study|Withdrawal by Subject|1|||
162919894|NCT03099265|588409096|FG000|Overall Study|Adverse Event|1|||
162919895|NCT00396318|588409101|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
162919896|NCT00602927|588409102|FG000|Period 1: 13 Days|Protocol Violation|2|||
162970168|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
162970169|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
162970170|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
162970171|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
162970172|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
162712435|NCT02001623|587658501|FG002|Overall Study|Physician Decision|0|||
162919897|NCT00602927|588409103|FG001|Period 1: 13 Days|Protocol Violation|4|||
162919898|NCT00602927|588409102|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
162919899|NCT00602927|588409103|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
162919900|NCT00602927|588409102|FG000|Period 1: 13 Days|Time|1|||
162919901|NCT00602927|588409103|FG001|Period 1: 13 Days|Time|0|||
162919902|NCT00602927|588409102|FG000|Period 1: 13 Days|Claustrophobia|0|||
162919903|NCT00602927|588409103|FG001|Period 1: 13 Days|Claustrophobia|1|||
162919904|NCT00602927|588409102|FG000|Period 2: 14 Days|Protocol Violation|0|||
162919905|NCT00602927|588409103|FG001|Period 2: 14 Days|Protocol Violation|2|||
162919906|NCT00602927|588409102|FG000|Period 3: 13 Days|Protocol Violation|0|||
162919907|NCT00602927|588409103|FG001|Period 3: 13 Days|Protocol Violation|1|||
162919908|NCT00602927|588409102|FG000|Period 3: 13 Days|MRI data quality|2|||
162919909|NCT00602927|588409103|FG001|Period 3: 13 Days|MRI data quality|2|||
162919910|NCT01741259|588409112|FG000|Overall Study|Protocol Violation|6|||
162970173|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
162712436|NCT02001623|587658502|FG003|Overall Study|Physician Decision|0|||
162712437|NCT02001623|587658503|FG004|Overall Study|Physician Decision|0|||
162919911|NCT01741259|588409113|FG001|Overall Study|Protocol Violation|4|||
162919912|NCT01741259|588409112|FG000|Overall Study|Withdrawal by Subject|0|||
162919913|NCT01741259|588409113|FG001|Overall Study|Withdrawal by Subject|2|||
162919914|NCT05604521|588409117|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
162970174|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
162919915|NCT05604521|588409118|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
162919916|NCT05604521|588409117|FG000|Overall Study|Adverse Event|1|||
162919917|NCT05604521|588409118|FG001|Overall Study|Adverse Event|0|||
162919918|NCT02875340|588409119|FG000|Overall Study|Death|2|||
162919919|NCT02875340|588409119|FG000|Overall Study|Withdrawal by Subject|2|||
162919920|NCT02875340|588409119|FG000|Overall Study|Physician Decision|3|||
162919921|NCT02875340|588409119|FG000|Overall Study|Adverse Event|1|||
162919922|NCT00630994|588409122|FG000|Overall Study|Adverse Event|1|||
162919923|NCT00630994|588409122|FG000|Overall Study|Disease Progression|1|||
162919924|NCT00630994|588409122|FG000|Overall Study|Lack of Efficacy|1|||
162919925|NCT00630994|588409122|FG000|Overall Study|Other|1|||
162919926|NCT05553600|588409125|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
162919927|NCT05553600|588409126|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
162919928|NCT05553600|588409127|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
162919929|NCT05553600|588409128|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
162919930|NCT05553600|588409125|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
162919931|NCT05553600|588409126|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
162919932|NCT05553600|588409127|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
162919933|NCT05553600|588409128|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
162919934|NCT05553600|588409125|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
162919935|NCT05553600|588409126|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
162919936|NCT05553600|588409127|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
162919937|NCT05553600|588409128|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
162919938|NCT05553600|588409125|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
162919939|NCT05553600|588409126|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
162919940|NCT05553600|588409127|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
162919941|NCT05553600|588409128|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
162919942|NCT05553600|588409125|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
162919943|NCT05553600|588409126|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
162919944|NCT05553600|588409127|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
162919945|NCT05553600|588409128|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
162919946|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
162919947|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
162919948|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
162919949|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
162919950|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
162919951|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
162919952|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
162919953|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
162919954|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
162919955|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
162919956|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
162919957|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
162919958|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
162919959|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
162919960|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
162919961|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
162919962|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
162919963|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
162919964|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
162919965|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
162919966|NCT05553600|588409125|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
162919967|NCT05553600|588409126|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
162919968|NCT05553600|588409127|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
162919969|NCT05553600|588409128|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
162919970|NCT05553600|588409125|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
162919971|NCT05553600|588409126|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
162919972|NCT05553600|588409127|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
162919973|NCT05553600|588409128|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
162919974|NCT05027958|588409138|FG000|Overall Study|Lost to Follow-up|1|||
162919975|NCT05027958|588409139|FG001|Overall Study|Lost to Follow-up|1|||
162919976|NCT05027958|588409138|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
162919977|NCT05027958|588409139|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
162919978|NCT05027958|588409138|FG000|Overall Study|Physician Decision|1|||
162970175|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
162919979|NCT05027958|588409139|FG001|Overall Study|Physician Decision|4|||
162919980|NCT05027958|588409138|FG000|Overall Study|Adverse Event|0|||
162919981|NCT05027958|588409139|FG001|Overall Study|Adverse Event|1|||
162919982|NCT03155269|588409140|FG000|Overall Study|Withdrawal by Subject|4|||
162919983|NCT03155269|588409141|FG001|Overall Study|Withdrawal by Subject|5|||
162919984|NCT03155269|588409140|FG000|Overall Study|Lost to Follow-up|1|||
162919985|NCT03155269|588409141|FG001|Overall Study|Lost to Follow-up|2|||
162919986|NCT02871921|588409142|FG000|Overall Study|Withdrawal by Subject|34|||
162919987|NCT02871921|588409143|FG001|Overall Study|Withdrawal by Subject|27|||
162919988|NCT02871921|588409144|FG002|Overall Study|Withdrawal by Subject|27|||
162919989|NCT02871921|588409145|FG003|Overall Study|Withdrawal by Subject|30|||
162919990|NCT00910000|588409146|FG000|Overall Study|Adverse Event|0|||
162919991|NCT00910000|588409147|FG001|Overall Study|Adverse Event|3|||
162919992|NCT00910000|588409148|FG002|Overall Study|Adverse Event|2|||
162919993|NCT00910000|588409149|FG003|Overall Study|Adverse Event|2|||
162919994|NCT00910000|588409150|FG004|Overall Study|Adverse Event|0|||
162919995|NCT00910000|588409151|FG005|Overall Study|Adverse Event|1|||
162919996|NCT00910000|588409146|FG000|Overall Study|Withdrawal by Subject|0|||
162919997|NCT00910000|588409147|FG001|Overall Study|Withdrawal by Subject|0|||
162919998|NCT00910000|588409148|FG002|Overall Study|Withdrawal by Subject|1|||
162919999|NCT00910000|588409149|FG003|Overall Study|Withdrawal by Subject|0|||
162920000|NCT00910000|588409150|FG004|Overall Study|Withdrawal by Subject|1|||
162920001|NCT00910000|588409151|FG005|Overall Study|Withdrawal by Subject|0|||
162920002|NCT00455923|588409157|FG000|Overall Study|Pregnancy|0|||
162920003|NCT00455923|588409158|FG001|Overall Study|Pregnancy|2|||
162920004|NCT00455923|588409157|FG000|Overall Study|Other|3|||
162920005|NCT00455923|588409158|FG001|Overall Study|Other|1|||
162920006|NCT02353572|588409159|FG000|Overall Study|Withdrawal by Subject|1|||
162920007|NCT02353572|588409159|FG000|Overall Study|Study terminated|2|||
162920008|NCT02686749|588409168|FG000|Overall Study|terminated for poor enrollment|2|||
162920009|NCT02686749|588409169|FG001|Overall Study|terminated for poor enrollment|2|||
162920010|NCT01244516|588409170|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
162920011|NCT01244516|588409171|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
162970176|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
162970177|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
162970178|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
162970179|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
162970180|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
162970181|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
162970182|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
162970183|NCT01067521|588591974|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
162970184|NCT01067521|588591975|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
162970185|NCT01067521|588591974|FG000|Open-Label Period|Death|3|||
162970186|NCT01067521|588591975|FG001|Open-Label Period|Death|1|||
162970187|NCT01067521|588591974|FG000|Open-Label Period|Adverse Event|30|||
162970188|NCT01067521|588591975|FG001|Open-Label Period|Adverse Event|28|||
162970189|NCT01067521|588591974|FG000|Open-Label Period|Withdrawal by Subject|160|||
162970190|NCT01067521|588591975|FG001|Open-Label Period|Withdrawal by Subject|88|||
162970191|NCT01067521|588591974|FG000|Open-Label Period|Physician Decision|13|||
162920012|NCT01244516|588409172|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
162920013|NCT01244516|588409170|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
162920014|NCT01244516|588409171|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
162970192|NCT01067521|588591975|FG001|Open-Label Period|Physician Decision|11|||
162970193|NCT01067521|588591974|FG000|Open-Label Period|Non-compliance with study drug|5|||
162970194|NCT01067521|588591975|FG001|Open-Label Period|Non-compliance with study drug|0|||
162970195|NCT01067521|588591974|FG000|Open-Label Period|Protocol Violation|3|||
162970196|NCT01067521|588591975|FG001|Open-Label Period|Protocol Violation|0|||
162970197|NCT01067521|588591974|FG000|Open-Label Period|Pregnancy|14|||
162970198|NCT01067521|588591975|FG001|Open-Label Period|Pregnancy|8|||
162970199|NCT01067521|588591974|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
162970200|NCT01067521|588591975|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
162970201|NCT01067521|588591974|FG000|Open-Label Period|Lost to Follow-up|21|||
162970202|NCT01067521|588591975|FG001|Open-Label Period|Lost to Follow-up|20|||
163056088|NCT03157089|588918340|FG000|Overall Study|Treated only with pembrolizumab|1|||
163056089|NCT03157089|588918341|FG001|Overall Study|Treated only with pembrolizumab|0|||
163056090|NCT03157089|588918340|FG000|Overall Study|Adverse Event|5|||
163056091|NCT03157089|588918341|FG001|Overall Study|Adverse Event|4|||
163056092|NCT03157089|588918340|FG000|Overall Study|Progressive disease|6|||
163056093|NCT03157089|588918341|FG001|Overall Study|Progressive disease|8|||
162920015|NCT01244516|588409172|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
162970203|NCT00057941|588591981|FG000|Overall Study|Death|1|||
162970204|NCT00057941|588591982|FG001|Overall Study|Death|2|||
162970205|NCT00057941|588591981|FG000|Overall Study|Adverse Event|7|||
163056094|NCT00958074|588918342|FG000|Overall Study|Withdrawal by Subject|0|||
162920016|NCT01244516|588409170|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
162920017|NCT01244516|588409171|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
162920018|NCT01244516|588409172|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
162920019|NCT01244516|588409170|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
162920020|NCT01244516|588409171|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
162920021|NCT01244516|588409172|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
162920022|NCT01244516|588409170|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
162920023|NCT01244516|588409171|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
162920024|NCT01244516|588409172|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
162920025|NCT01244516|588409170|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
162920026|NCT01244516|588409171|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
162920027|NCT01244516|588409172|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
162920028|NCT01244516|588409170|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
162920029|NCT01244516|588409171|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
162920030|NCT01244516|588409172|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
162970206|NCT00057941|588591982|FG001|Overall Study|Adverse Event|9|||
162970207|NCT00057941|588591981|FG000|Overall Study|Lack of Efficacy|54|||
162920031|NCT04409509|588409176|FG000|Overall Study|Failure to meet randomization requirement|1|||
162970208|NCT00057941|588591982|FG001|Overall Study|Lack of Efficacy|53|||
162970209|NCT00057941|588591981|FG000|Overall Study|Withdrawal by Subject|6|||
162970210|NCT00057941|588591982|FG001|Overall Study|Withdrawal by Subject|1|||
162970211|NCT00057941|588591981|FG000|Overall Study|still on treatment|3|||
162970212|NCT00057941|588591982|FG001|Overall Study|still on treatment|1|||
162970213|NCT00057941|588591981|FG000|Overall Study|insurance, symptomatic deterioration|1|||
162970214|NCT00057941|588591982|FG001|Overall Study|insurance, symptomatic deterioration|3|||
162970215|NCT00057941|588591981|FG000|Overall Study|Ineligible|2|||
162970216|NCT00057941|588591982|FG001|Overall Study|Ineligible|5|||
162970217|NCT04142658|588591983|FG000|Overall Study|Death|2|||
162970218|NCT04142658|588591984|FG001|Overall Study|Death|1|||
162970219|NCT04142658|588591983|FG000|Overall Study|Lost to Follow-up|4|||
162970220|NCT04142658|588591984|FG001|Overall Study|Lost to Follow-up|13|||
162970221|NCT04142658|588591983|FG000|Overall Study|Withdrawal by Subject|9|||
162970222|NCT04142658|588591984|FG001|Overall Study|Withdrawal by Subject|16|||
162970223|NCT01781234|588591985|FG000|Overall Study|Adverse Event|2|||
162970224|NCT01781234|588591986|FG001|Overall Study|Adverse Event|0|||
162970225|NCT01781234|588591985|FG000|Overall Study|Protocol Violation|3|||
162970226|NCT01781234|588591986|FG001|Overall Study|Protocol Violation|0|||
162970227|NCT01781234|588591985|FG000|Overall Study|Withdrawal by Subject|4|||
162970228|NCT01781234|588591986|FG001|Overall Study|Withdrawal by Subject|3|||
162970229|NCT01685216|588591993|FG000|Overall Study|Did not receive study drug|1|||
162970230|NCT01294449|588591994|FG000|Overall Study|Death|11|||
162970231|NCT01294449|588591995|FG001|Overall Study|Death|12|||
162970232|NCT01294449|588591994|FG000|Overall Study|Withdrawal by Subject|1|||
162970233|NCT01294449|588591995|FG001|Overall Study|Withdrawal by Subject|3|||
162970234|NCT02466386|588591996|FG000|Overall Study|Adverse Event|5|||
162970235|NCT02466386|588591996|FG000|Overall Study|Protocol Violation|2|||
162970236|NCT02466386|588591996|FG000|Overall Study|Withdrawal by Subject|14|||
162970237|NCT02466386|588591996|FG000|Overall Study|Lost to Follow-up|5|||
162970238|NCT02466386|588591996|FG000|Overall Study|Lack of Efficacy|8|||
162970239|NCT02466386|588591996|FG000|Overall Study|Other|10|||
162970240|NCT05317195|588591997|FG000|Randomization|Withdrawal by Subject|1|||
162970241|NCT05317195|588591997|FG000|Randomization|Discontinued|6|||
162970242|NCT05317195|588591997|FG000|Admission|Withdrawal by Subject|2|||
162970243|NCT03259789|588591998|FG000|Overall Study|Adverse Event|3|||
162970244|NCT03259789|588591999|FG001|Overall Study|Adverse Event|2|||
162970245|NCT03259789|588592000|FG002|Overall Study|Adverse Event|1|||
162970246|NCT03259789|588591998|FG000|Overall Study|Withdrawal by Subject|9|||
162970247|NCT03259789|588591999|FG001|Overall Study|Withdrawal by Subject|5|||
162970248|NCT03259789|588592000|FG002|Overall Study|Withdrawal by Subject|1|||
162970249|NCT03259789|588591998|FG000|Overall Study|Lost to Follow-up|5|||
162970250|NCT03259789|588591999|FG001|Overall Study|Lost to Follow-up|9|||
162970251|NCT03259789|588592000|FG002|Overall Study|Lost to Follow-up|4|||
162970252|NCT03259789|588591998|FG000|Overall Study|Physician Decision|0|||
162970253|NCT03259789|588591999|FG001|Overall Study|Physician Decision|1|||
162970254|NCT03259789|588592000|FG002|Overall Study|Physician Decision|0|||
162970255|NCT00889252|588592001|FG000|Overall Study|Adverse Event|2|||
162970256|NCT00889252|588592002|FG001|Overall Study|Adverse Event|4|||
162970257|NCT00889252|588592001|FG000|Overall Study|Withdrawal by Subject|3|||
162970258|NCT00889252|588592002|FG001|Overall Study|Withdrawal by Subject|0|||
162970259|NCT00889252|588592001|FG000|Overall Study|Protocol Violation|2|||
162970260|NCT00889252|588592002|FG001|Overall Study|Protocol Violation|0|||
162970261|NCT01833169|588592003|FG000|Overall Study|Disease Progression|99|||
162970262|NCT01833169|588592003|FG000|Overall Study|Adverse Event|33|||
162970263|NCT01833169|588592003|FG000|Overall Study|Withdrawal by Subject|9|||
162970264|NCT01833169|588592003|FG000|Overall Study|Death|3|||
162920032|NCT04409509|588409177|FG001|Overall Study|Failure to meet randomization requirement|0|||
162920033|NCT04409509|588409176|FG000|Overall Study|Adverse Event|0|||
162920034|NCT04409509|588409177|FG001|Overall Study|Adverse Event|1|||
162920035|NCT04409509|588409176|FG000|Overall Study|Death|11|||
162920036|NCT04409509|588409177|FG001|Overall Study|Death|10|||
162920037|NCT04409509|588409176|FG000|Overall Study|Non-compliance with study drug|0|||
162920038|NCT04409509|588409177|FG001|Overall Study|Non-compliance with study drug|1|||
162920039|NCT04409509|588409176|FG000|Overall Study|Lost to Follow-up|0|||
162920040|NCT04409509|588409177|FG001|Overall Study|Lost to Follow-up|3|||
162920041|NCT04409509|588409176|FG000|Overall Study|Withdrawal by Subject|0|||
162920042|NCT04409509|588409177|FG001|Overall Study|Withdrawal by Subject|3|||
162920043|NCT04409509|588409176|FG000|Overall Study|Randomized by mistake|0|||
162920044|NCT04409509|588409177|FG001|Overall Study|Randomized by mistake|1|||
162920045|NCT04409509|588409176|FG000|Overall Study|Other|1|||
162920046|NCT04409509|588409177|FG001|Overall Study|Other|1|||
162920047|NCT04668066|588409178|FG000|Part 1: Treatment Phase|Adverse Event|0|||
162920048|NCT04668066|588409179|FG001|Part 1: Treatment Phase|Adverse Event|0|||
162920049|NCT04668066|588409180|FG002|Part 1: Treatment Phase|Adverse Event|0|||
162920050|NCT04668066|588409181|FG003|Part 1: Treatment Phase|Adverse Event|0|||
162920051|NCT04668066|588409182|FG004|Part 1: Treatment Phase|Adverse Event|0|||
162920052|NCT04668066|588409183|FG005|Part 1: Treatment Phase|Adverse Event|0|||
162920053|NCT04668066|588409184|FG006|Part 1: Treatment Phase|Adverse Event|0|||
162920054|NCT04668066|588409185|FG007|Part 1: Treatment Phase|Adverse Event|0|||
162920055|NCT04668066|588409186|FG008|Part 1: Treatment Phase|Adverse Event|0|||
162920056|NCT04668066|588409187|FG009|Part 1: Treatment Phase|Adverse Event|0|||
162920057|NCT04668066|588409188|FG010|Part 1: Treatment Phase|Adverse Event|0|||
162920058|NCT04668066|588409189|FG011|Part 1: Treatment Phase|Adverse Event|1|||
162712438|NCT02001623|587658504|FG005|Overall Study|Physician Decision|0|||
162712439|NCT02001623|587658505|FG006|Overall Study|Physician Decision|0|||
162712440|NCT02001623|587658506|FG007|Overall Study|Physician Decision|0|||
162712441|NCT02001623|587658507|FG008|Overall Study|Physician Decision|3|||
162712442|NCT02001623|587658508|FG009|Overall Study|Physician Decision|2|||
162712443|NCT02001623|587658509|FG010|Overall Study|Physician Decision|3|||
162712444|NCT02001623|587658510|FG011|Overall Study|Physician Decision|3|||
162712445|NCT02001623|587658511|FG012|Overall Study|Physician Decision|1|||
162920059|NCT04668066|588409190|FG012|Part 1: Treatment Phase|Adverse Event|1|||
162920060|NCT04668066|588409191|FG013|Part 1: Treatment Phase|Adverse Event|0|||
162920061|NCT04668066|588409192|FG014|Part 1: Treatment Phase|Adverse Event|0|||
162920062|NCT04668066|588409193|FG015|Part 1: Treatment Phase|Adverse Event|0|||
162920063|NCT04668066|588409194|FG016|Part 1: Treatment Phase|Adverse Event|0|||
162920064|NCT04668066|588409195|FG017|Part 1: Treatment Phase|Adverse Event|0|||
162920065|NCT04668066|588409196|FG018|Part 1: Treatment Phase|Adverse Event|0|||
162920066|NCT04668066|588409178|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920067|NCT04668066|588409179|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920068|NCT04668066|588409180|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
162920069|NCT04668066|588409181|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920070|NCT04668066|588409182|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920071|NCT04668066|588409183|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920072|NCT04668066|588409184|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920073|NCT04668066|588409185|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920074|NCT04668066|588409186|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920075|NCT04668066|588409187|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920076|NCT04668066|588409188|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920077|NCT04668066|588409189|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920078|NCT04668066|588409190|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920079|NCT04668066|588409191|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920080|NCT04668066|588409192|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920081|NCT04668066|588409193|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920082|NCT04668066|588409194|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
162970265|NCT01833169|588592003|FG000|Overall Study|Physician Decision|2|||
162970266|NCT04718129|588592011|FG000|Overall Study|Lost to Follow-up|6|||
162970267|NCT04718129|588592012|FG001|Overall Study|Lost to Follow-up|7|||
162970268|NCT02212457|588592013|FG000|Overall Study|Adverse Event|1|||
162712446|NCT02001623|587658512|FG013|Overall Study|Physician Decision|2|||
162970269|NCT02212457|588592014|FG001|Overall Study|Adverse Event|2|||
162970270|NCT02212457|588592015|FG002|Overall Study|Adverse Event|2|||
162970271|NCT02212457|588592016|FG003|Overall Study|Adverse Event|2|||
162920083|NCT04668066|588409195|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920084|NCT04668066|588409196|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
162920085|NCT04668066|588409178|FG000|Part 1: Treatment Phase|Other|0|||
162920086|NCT04668066|588409179|FG001|Part 1: Treatment Phase|Other|0|||
162920087|NCT04668066|588409180|FG002|Part 1: Treatment Phase|Other|0|||
162920088|NCT04668066|588409181|FG003|Part 1: Treatment Phase|Other|0|||
162970272|NCT02212457|588592017|FG004|Overall Study|Adverse Event|0|||
162970273|NCT02212457|588592018|FG005|Overall Study|Adverse Event|1|||
162712447|NCT02001623|587658513|FG014|Overall Study|Physician Decision|1|||
162970274|NCT02212457|588592013|FG000|Overall Study|Withdrawal by Subject|8|||
162920089|NCT04668066|588409182|FG004|Part 1: Treatment Phase|Other|0|||
162920090|NCT04668066|588409183|FG005|Part 1: Treatment Phase|Other|0|||
162920091|NCT04668066|588409184|FG006|Part 1: Treatment Phase|Other|0|||
162920092|NCT04668066|588409185|FG007|Part 1: Treatment Phase|Other|0|||
162920093|NCT04668066|588409186|FG008|Part 1: Treatment Phase|Other|0|||
162920094|NCT04668066|588409187|FG009|Part 1: Treatment Phase|Other|0|||
162920095|NCT04668066|588409188|FG010|Part 1: Treatment Phase|Other|0|||
162920096|NCT04668066|588409189|FG011|Part 1: Treatment Phase|Other|1|||
162920097|NCT04668066|588409190|FG012|Part 1: Treatment Phase|Other|0|||
162920098|NCT04668066|588409191|FG013|Part 1: Treatment Phase|Other|0|||
162920099|NCT04668066|588409192|FG014|Part 1: Treatment Phase|Other|0|||
162920100|NCT04668066|588409193|FG015|Part 1: Treatment Phase|Other|0|||
162920101|NCT04668066|588409194|FG016|Part 1: Treatment Phase|Other|0|||
162920102|NCT04668066|588409195|FG017|Part 1: Treatment Phase|Other|0|||
162920103|NCT04668066|588409196|FG018|Part 1: Treatment Phase|Other|0|||
162920104|NCT04668066|588409178|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920105|NCT04668066|588409179|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920106|NCT04668066|588409180|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920107|NCT04668066|588409181|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920108|NCT04668066|588409182|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920109|NCT04668066|588409183|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920110|NCT04668066|588409184|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920111|NCT04668066|588409185|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920112|NCT04668066|588409186|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920113|NCT04668066|588409187|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920114|NCT04668066|588409188|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920115|NCT04668066|588409189|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920116|NCT04668066|588409190|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
162920117|NCT04668066|588409191|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920118|NCT04668066|588409192|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920119|NCT04668066|588409193|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
162920120|NCT04668066|588409194|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920121|NCT04668066|588409195|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920122|NCT04668066|588409196|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
162920123|NCT04668066|588409178|FG000|Part 1: Follow-Up|Adverse Event|0|||
162920124|NCT04668066|588409179|FG001|Part 1: Follow-Up|Adverse Event|0|||
162920125|NCT04668066|588409180|FG002|Part 1: Follow-Up|Adverse Event|0|||
162920126|NCT04668066|588409181|FG003|Part 1: Follow-Up|Adverse Event|0|||
162920127|NCT04668066|588409182|FG004|Part 1: Follow-Up|Adverse Event|0|||
162920128|NCT04668066|588409183|FG005|Part 1: Follow-Up|Adverse Event|0|||
162920129|NCT04668066|588409184|FG006|Part 1: Follow-Up|Adverse Event|0|||
162920130|NCT04668066|588409185|FG007|Part 1: Follow-Up|Adverse Event|0|||
162920131|NCT04668066|588409186|FG008|Part 1: Follow-Up|Adverse Event|0|||
162920132|NCT04668066|588409187|FG009|Part 1: Follow-Up|Adverse Event|0|||
162920133|NCT04668066|588409188|FG010|Part 1: Follow-Up|Adverse Event|0|||
162920134|NCT04668066|588409189|FG011|Part 1: Follow-Up|Adverse Event|1|||
162920135|NCT04668066|588409190|FG012|Part 1: Follow-Up|Adverse Event|0|||
162920136|NCT04668066|588409191|FG013|Part 1: Follow-Up|Adverse Event|0|||
162920137|NCT04668066|588409192|FG014|Part 1: Follow-Up|Adverse Event|0|||
162920138|NCT04668066|588409193|FG015|Part 1: Follow-Up|Adverse Event|0|||
162920139|NCT04668066|588409194|FG016|Part 1: Follow-Up|Adverse Event|0|||
162920140|NCT04668066|588409195|FG017|Part 1: Follow-Up|Adverse Event|0|||
162920141|NCT04668066|588409196|FG018|Part 1: Follow-Up|Adverse Event|0|||
162920142|NCT04668066|588409178|FG000|Part 1: Follow-Up|Other|0|||
162920143|NCT04668066|588409179|FG001|Part 1: Follow-Up|Other|0|||
162920144|NCT04668066|588409180|FG002|Part 1: Follow-Up|Other|0|||
162920145|NCT04668066|588409181|FG003|Part 1: Follow-Up|Other|0|||
162920146|NCT04668066|588409182|FG004|Part 1: Follow-Up|Other|0|||
162920147|NCT04668066|588409183|FG005|Part 1: Follow-Up|Other|0|||
162920148|NCT04668066|588409184|FG006|Part 1: Follow-Up|Other|0|||
162920149|NCT04668066|588409185|FG007|Part 1: Follow-Up|Other|0|||
162920150|NCT04668066|588409186|FG008|Part 1: Follow-Up|Other|0|||
162920151|NCT04668066|588409187|FG009|Part 1: Follow-Up|Other|0|||
162920152|NCT04668066|588409188|FG010|Part 1: Follow-Up|Other|0|||
162920153|NCT04668066|588409189|FG011|Part 1: Follow-Up|Other|1|||
162920154|NCT04668066|588409190|FG012|Part 1: Follow-Up|Other|1|||
162920155|NCT04668066|588409191|FG013|Part 1: Follow-Up|Other|0|||
162920156|NCT04668066|588409192|FG014|Part 1: Follow-Up|Other|0|||
162920157|NCT04668066|588409193|FG015|Part 1: Follow-Up|Other|0|||
162920158|NCT04668066|588409194|FG016|Part 1: Follow-Up|Other|0|||
162920159|NCT04668066|588409195|FG017|Part 1: Follow-Up|Other|0|||
162920160|NCT04668066|588409196|FG018|Part 1: Follow-Up|Other|0|||
162920161|NCT04668066|588409178|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920162|NCT04668066|588409179|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920163|NCT04668066|588409180|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920164|NCT04668066|588409181|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920165|NCT04668066|588409182|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920166|NCT04668066|588409183|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920167|NCT04668066|588409184|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920168|NCT04668066|588409185|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920169|NCT04668066|588409186|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920170|NCT04668066|588409187|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920171|NCT04668066|588409188|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920172|NCT04668066|588409189|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920173|NCT04668066|588409190|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
162920174|NCT04668066|588409191|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920175|NCT04668066|588409192|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920176|NCT04668066|588409193|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
162920177|NCT04668066|588409194|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920178|NCT04668066|588409195|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920179|NCT04668066|588409196|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
162920180|NCT04668066|588409178|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920181|NCT04668066|588409179|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920182|NCT04668066|588409180|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920183|NCT04668066|588409181|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920184|NCT04668066|588409182|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920185|NCT04668066|588409183|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920186|NCT04668066|588409184|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920187|NCT04668066|588409185|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920188|NCT04668066|588409186|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920189|NCT04668066|588409187|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920190|NCT04668066|588409188|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920191|NCT04668066|588409189|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920192|NCT04668066|588409190|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920193|NCT04668066|588409191|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920194|NCT04668066|588409192|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920195|NCT04668066|588409193|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920196|NCT04668066|588409194|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920197|NCT04668066|588409195|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
162920198|NCT04668066|588409196|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
162920199|NCT04668066|588409178|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920200|NCT04668066|588409179|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920201|NCT04668066|588409180|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920202|NCT04668066|588409181|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920203|NCT04668066|588409182|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920204|NCT04668066|588409183|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920205|NCT04668066|588409184|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920206|NCT04668066|588409185|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920207|NCT04668066|588409186|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920208|NCT04668066|588409187|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920209|NCT04668066|588409188|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920210|NCT04668066|588409189|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920211|NCT04668066|588409190|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920212|NCT04668066|588409191|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920213|NCT04668066|588409192|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920214|NCT04668066|588409193|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
162629855|NCT04182763|587362627|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
162629856|NCT04182763|587362628|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
162629857|NCT04182763|587362629|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
162629858|NCT04182763|587362630|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
162629859|NCT04182763|587362626|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162629860|NCT04182763|587362627|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
162629861|NCT04182763|587362628|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162629862|NCT04182763|587362629|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162920215|NCT04668066|588409194|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920216|NCT04668066|588409195|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
162920217|NCT04668066|588409196|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
162920218|NCT04668066|588409178|FG000|Part 2: Treatment Phase|Other|0|||
162920219|NCT04668066|588409179|FG001|Part 2: Treatment Phase|Other|0|||
162920220|NCT04668066|588409180|FG002|Part 2: Treatment Phase|Other|0|||
162920221|NCT04668066|588409181|FG003|Part 2: Treatment Phase|Other|0|||
162920222|NCT04668066|588409182|FG004|Part 2: Treatment Phase|Other|0|||
162970275|NCT02212457|588592014|FG001|Overall Study|Withdrawal by Subject|10|||
162920223|NCT04668066|588409183|FG005|Part 2: Treatment Phase|Other|0|||
162920224|NCT04668066|588409184|FG006|Part 2: Treatment Phase|Other|0|||
162920225|NCT04668066|588409185|FG007|Part 2: Treatment Phase|Other|0|||
162920226|NCT04668066|588409186|FG008|Part 2: Treatment Phase|Other|0|||
162920227|NCT04668066|588409187|FG009|Part 2: Treatment Phase|Other|0|||
162920228|NCT04668066|588409188|FG010|Part 2: Treatment Phase|Other|0|||
163056095|NCT00958074|588918343|FG001|Overall Study|Withdrawal by Subject|1|||
163056096|NCT00853385|588918344|FG000|Overall Study|Death|0|||
162920229|NCT04668066|588409189|FG011|Part 2: Treatment Phase|Other|0|||
162920230|NCT04668066|588409190|FG012|Part 2: Treatment Phase|Other|0|||
162920231|NCT04668066|588409191|FG013|Part 2: Treatment Phase|Other|0|||
162920232|NCT04668066|588409192|FG014|Part 2: Treatment Phase|Other|0|||
162920233|NCT04668066|588409193|FG015|Part 2: Treatment Phase|Other|0|||
162920234|NCT04668066|588409194|FG016|Part 2: Treatment Phase|Other|0|||
162920235|NCT04668066|588409195|FG017|Part 2: Treatment Phase|Other|0|||
162920236|NCT04668066|588409196|FG018|Part 2: Treatment Phase|Other|1|||
162920237|NCT04668066|588409178|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920238|NCT04668066|588409179|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920239|NCT04668066|588409180|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920240|NCT04668066|588409181|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920241|NCT04668066|588409182|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920242|NCT04668066|588409183|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920243|NCT04668066|588409184|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920244|NCT04668066|588409185|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920245|NCT04668066|588409186|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920246|NCT04668066|588409187|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920247|NCT04668066|588409188|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920248|NCT04668066|588409189|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920249|NCT04668066|588409190|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920250|NCT04668066|588409191|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920251|NCT04668066|588409192|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920252|NCT04668066|588409193|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920253|NCT04668066|588409194|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920254|NCT04668066|588409195|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
162920255|NCT04668066|588409196|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
162920256|NCT04479358|588409199|FG000|Overall Study|Withdrawal by Subject|0|||
162920257|NCT04479358|588409200|FG001|Overall Study|Withdrawal by Subject|0|||
162920258|NCT04479358|588409201|FG002|Overall Study|Withdrawal by Subject|1|||
162920259|NCT04479358|588409202|FG003|Overall Study|Withdrawal by Subject|0|||
162920260|NCT04479358|588409203|FG004|Overall Study|Withdrawal by Subject|0|||
162920261|NCT04479358|588409204|FG005|Overall Study|Withdrawal by Subject|1|||
162920262|NCT03795233|588409219|FG000|Overall Study|Withdrawal by Subject|2|||
162920263|NCT03795233|588409220|FG001|Overall Study|Withdrawal by Subject|1|||
162970276|NCT02212457|588592015|FG002|Overall Study|Withdrawal by Subject|8|||
162970277|NCT02212457|588592016|FG003|Overall Study|Withdrawal by Subject|6|||
162970278|NCT02212457|588592017|FG004|Overall Study|Withdrawal by Subject|5|||
162970279|NCT02212457|588592018|FG005|Overall Study|Withdrawal by Subject|4|||
162970280|NCT02212457|588592013|FG000|Overall Study|Lost to Follow-up|6|||
162970281|NCT02212457|588592014|FG001|Overall Study|Lost to Follow-up|7|||
162970282|NCT02212457|588592015|FG002|Overall Study|Lost to Follow-up|4|||
162970283|NCT02212457|588592016|FG003|Overall Study|Lost to Follow-up|1|||
162970284|NCT02212457|588592017|FG004|Overall Study|Lost to Follow-up|8|||
162970285|NCT02212457|588592018|FG005|Overall Study|Lost to Follow-up|4|||
162970286|NCT02212457|588592013|FG000|Overall Study|Protocol Violation|2|||
162970287|NCT02212457|588592014|FG001|Overall Study|Protocol Violation|1|||
162970288|NCT02212457|588592015|FG002|Overall Study|Protocol Violation|0|||
162970289|NCT02212457|588592016|FG003|Overall Study|Protocol Violation|1|||
162970290|NCT02212457|588592017|FG004|Overall Study|Protocol Violation|2|||
162970291|NCT02212457|588592018|FG005|Overall Study|Protocol Violation|3|||
162970292|NCT02212457|588592013|FG000|Overall Study|Other|2|||
162920264|NCT03795233|588409219|FG000|Overall Study|Lost to Follow-up|1|||
162920265|NCT03795233|588409220|FG001|Overall Study|Lost to Follow-up|0|||
162970293|NCT02212457|588592014|FG001|Overall Study|Other|1|||
162970294|NCT02212457|588592015|FG002|Overall Study|Other|2|||
162712448|NCT02001623|587658499|FG000|Overall Study|Death|0|||
162712449|NCT02001623|587658500|FG001|Overall Study|Death|1|||
162920266|NCT03795233|588409219|FG000|Overall Study|Death|1|||
162920267|NCT03795233|588409220|FG001|Overall Study|Death|0|||
162920268|NCT02756182|588409221|FG000|Overall Study|StudyTechnical Difficulties|4|||
162920269|NCT01965600|588409225|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
162920270|NCT01965600|588409226|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
162970295|NCT02212457|588592016|FG003|Overall Study|Other|1|||
162970296|NCT02212457|588592017|FG004|Overall Study|Other|0|||
163056097|NCT00853385|588918345|FG001|Overall Study|Death|0|||
162970297|NCT02212457|588592018|FG005|Overall Study|Other|1|||
162970298|NCT01120691|588592021|FG000|Overall Study|Adverse Event|59|||
162920271|NCT01965600|588409227|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
162920272|NCT01965600|588409228|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
162920273|NCT01965600|588409225|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
162920274|NCT01965600|588409226|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
162920275|NCT01965600|588409227|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
162920276|NCT01965600|588409228|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
162920277|NCT01965600|588409225|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
162920278|NCT01965600|588409226|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
162970299|NCT01120691|588592022|FG001|Overall Study|Adverse Event|67|||
162970300|NCT01120691|588592023|FG002|Overall Study|Adverse Event|47|||
162970301|NCT01120691|588592021|FG000|Overall Study|Subject withdrew consent|33|||
162970302|NCT01120691|588592022|FG001|Overall Study|Subject withdrew consent|50|||
162970303|NCT01120691|588592023|FG002|Overall Study|Subject withdrew consent|44|||
162970304|NCT01120691|588592021|FG000|Overall Study|Death|21|||
162970305|NCT01120691|588592022|FG001|Overall Study|Death|22|||
162970306|NCT01120691|588592023|FG002|Overall Study|Death|24|||
162629863|NCT04182763|587362630|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
162629864|NCT00003479|587362632|FG000|Overall Study|Not evaluable|3|||
162629865|NCT02551731|587362634|FG000|Overall Study|Withdrawal by Subject|2|||
162629866|NCT01727297|587362647|FG000|Overall Study|Death|13|||
162629867|NCT01727297|587362648|FG001|Overall Study|Death|0|||
162629868|NCT01727297|587362647|FG000|Overall Study|Protocol Violation|1|||
162629869|NCT01727297|587362648|FG001|Overall Study|Protocol Violation|10|||
162629870|NCT01727297|587362647|FG000|Overall Study|Adverse Event|3|||
162629871|NCT01727297|587362648|FG001|Overall Study|Adverse Event|1|||
162629872|NCT01727297|587362647|FG000|Overall Study|Lost to Follow-up|11|||
162629873|NCT01727297|587362648|FG001|Overall Study|Lost to Follow-up|0|||
162629874|NCT01727297|587362647|FG000|Overall Study|Withdrawal by Subject|26|||
162629875|NCT01727297|587362648|FG001|Overall Study|Withdrawal by Subject|27|||
162629876|NCT01727297|587362647|FG000|Overall Study|Physician Decision|19|||
162629877|NCT01727297|587362648|FG001|Overall Study|Physician Decision|5|||
162629878|NCT01727297|587362647|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
162629879|NCT01727297|587362648|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
162629880|NCT01192516|587362649|FG000|Overall Study|Lost to Follow-up|7|||
162629881|NCT01192516|587362650|FG001|Overall Study|Lost to Follow-up|10|||
162629882|NCT01192516|587362651|FG002|Overall Study|Lost to Follow-up|7|||
162629883|NCT01192516|587362649|FG000|Overall Study|Withdrawal by Subject|4|||
162629884|NCT01192516|587362650|FG001|Overall Study|Withdrawal by Subject|4|||
162629885|NCT01192516|587362651|FG002|Overall Study|Withdrawal by Subject|1|||
162629886|NCT01192516|587362649|FG000|Overall Study|started new treatment|5|||
162629887|NCT01192516|587362650|FG001|Overall Study|started new treatment|1|||
162629888|NCT01192516|587362651|FG002|Overall Study|started new treatment|0|||
162629889|NCT01192516|587362649|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
162629890|NCT01192516|587362650|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
162629891|NCT01192516|587362651|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
162629892|NCT05228132|587362656|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
162629893|NCT05228132|587362656|FG000|Overall Study|Adverse Event|3|||
162629894|NCT05228132|587362656|FG000|Overall Study|Lost to Follow-up|1|||
162629895|NCT05228132|587362656|FG000|Overall Study|Arteriovenous-fistula mature|1|||
162629896|NCT02627144|587362657|FG000|Overall Study|Serious adverse event|32|||
162629897|NCT02627144|587362657|FG000|Overall Study|Cancer progression|171|||
162629898|NCT02627144|587362657|FG000|Overall Study|Death from cancer|20|||
162629899|NCT02627144|587362657|FG000|Overall Study|Death from other cause|8|||
162629900|NCT02627144|587362657|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
162629901|NCT02627144|587362657|FG000|Overall Study|Administrative reasons|65|||
162629902|NCT02627144|587362657|FG000|Overall Study|Lost to Follow-up|8|||
162629903|NCT02627144|587362657|FG000|Overall Study|Enrolled, not treated|6|||
162629904|NCT02627144|587362657|FG000|Overall Study|Other|17|||
162629905|NCT01217801|587362662|FG000|Period 1|Protocol Violation|1|||
162629906|NCT01217801|587362663|FG001|Period 1|Protocol Violation|1|||
162920279|NCT01965600|588409227|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
162920280|NCT01965600|588409228|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
162920281|NCT01965600|588409225|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
162920282|NCT01965600|588409226|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
163056098|NCT00853385|588918346|FG002|Overall Study|Death|0|||
162629907|NCT01217801|587362662|FG000|Period 1|Withdrawal by Subject|0|||
162629908|NCT01217801|587362663|FG001|Period 1|Withdrawal by Subject|1|||
162629909|NCT00291577|587362665|FG000|Overall Study|Adverse Event|1|||
162629910|NCT00291577|587362665|FG000|Overall Study|Other|4|||
162629911|NCT00291577|587362665|FG000|Overall Study|Withdrawal by Subject|2|||
162629912|NCT00291577|587362665|FG000|Overall Study|Lack of Efficacy|14|||
162629913|NCT04584645|587362666|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
162712450|NCT02001623|587658501|FG002|Overall Study|Death|0|||
163056099|NCT00853385|588918347|FG003|Overall Study|Death|0|||
163056100|NCT00853385|588918348|FG004|Overall Study|Death|1|||
162920283|NCT01965600|588409227|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
162920284|NCT01965600|588409228|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
162920285|NCT01965600|588409225|FG000|Second Intervention|Study terminated by Sponsor|0|||
162920286|NCT01965600|588409226|FG001|Second Intervention|Study terminated by Sponsor|0|||
162920287|NCT01965600|588409227|FG002|Second Intervention|Study terminated by Sponsor|2|||
162920288|NCT01965600|588409228|FG003|Second Intervention|Study terminated by Sponsor|2|||
162920289|NCT02711306|588409236|FG000|Overall Study|Withdrawal by Subject|2|||
162920290|NCT02711306|588409237|FG001|Overall Study|Withdrawal by Subject|2|||
162920291|NCT01100073|588410798|FG000|Overall Study|Lack of Efficacy|4|||
162920292|NCT01100073|588410798|FG000|Overall Study|Insufficient Tolerability|21|||
162920293|NCT01100073|588410798|FG000|Overall Study|Withdrawal by Subject|13|||
162920294|NCT01100073|588410798|FG000|Overall Study|Lost to Follow-up|39|||
162920295|NCT01100073|588410798|FG000|Overall Study|Lack of effect + patient's wish|2|||
162920296|NCT01100073|588410798|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
162920297|NCT01100073|588410798|FG000|Overall Study|Other|8|||
162920298|NCT01100073|588410798|FG000|Overall Study|Missing|5|||
162920299|NCT00299546|588410799|FG000|Overall Study|Death|3|||
162920300|NCT00299546|588410800|FG001|Overall Study|Death|2|||
162920301|NCT00299546|588410801|FG002|Overall Study|Death|0|||
162920302|NCT00299546|588410799|FG000|Overall Study|Lost to Follow-up|2|||
162920303|NCT00299546|588410800|FG001|Overall Study|Lost to Follow-up|2|||
162920304|NCT00299546|588410801|FG002|Overall Study|Lost to Follow-up|5|||
162920305|NCT00299546|588410799|FG000|Overall Study|Adverse Event|37|||
162920306|NCT00299546|588410800|FG001|Overall Study|Adverse Event|22|||
162920307|NCT00299546|588410801|FG002|Overall Study|Adverse Event|27|||
162920308|NCT00299546|588410799|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
162920309|NCT00299546|588410800|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
162920310|NCT00299546|588410801|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
162920311|NCT00299546|588410799|FG000|Overall Study|Other|24|||
162920312|NCT00299546|588410800|FG001|Overall Study|Other|26|||
162920313|NCT00299546|588410801|FG002|Overall Study|Other|19|||
162920314|NCT00299546|588410799|FG000|Overall Study|Not treated|0|||
162920315|NCT00299546|588410800|FG001|Overall Study|Not treated|1|||
162920316|NCT00299546|588410801|FG002|Overall Study|Not treated|1|||
162920317|NCT01656850|588410805|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
162920318|NCT01656850|588410806|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
162920319|NCT00326118|588410807|FG000|Active Phase|Withdrawal by Subject|4|||
162920320|NCT00326118|588410808|FG001|Active Phase|Withdrawal by Subject|1|||
162920321|NCT01160770|588410813|FG000|Overall Study|Adverse Event|10|||
162920322|NCT01160770|588410813|FG000|Overall Study|Protocol Violation|2|||
162920323|NCT01160770|588410813|FG000|Overall Study|Subject/parent/caregiver request|33|||
162920324|NCT01160770|588410813|FG000|Overall Study|Physician Decision|1|||
162920325|NCT01160770|588410813|FG000|Overall Study|Lost to Follow-up|7|||
162920326|NCT01160770|588410813|FG000|Overall Study|Study termination or sponsor request|1|||
162920327|NCT01160770|588410813|FG000|Overall Study|Death|9|||
162920328|NCT01160770|588410813|FG000|Overall Study|Lack of Efficacy|15|||
162920329|NCT01160770|588410813|FG000|Overall Study|Other Reasons|1|||
162920330|NCT00242567|588410814|FG000|Overall Study|Adverse Event|70|||
162920331|NCT00242567|588410815|FG001|Overall Study|Adverse Event|43|||
162629914|NCT04584645|587362667|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
162920332|NCT00242567|588410814|FG000|Overall Study|Disease Progression|17|||
162920333|NCT00242567|588410815|FG001|Overall Study|Disease Progression|22|||
162920334|NCT00242567|588410814|FG000|Overall Study|Symptomatic deterioration|9|||
162920335|NCT00242567|588410815|FG001|Overall Study|Symptomatic deterioration|3|||
162920336|NCT00242567|588410814|FG000|Overall Study|Lack of Efficacy|2|||
162920337|NCT00242567|588410815|FG001|Overall Study|Lack of Efficacy|2|||
162920338|NCT00242567|588410814|FG000|Overall Study|Lost to Follow-up|9|||
162920339|NCT00242567|588410815|FG001|Overall Study|Lost to Follow-up|19|||
162920340|NCT00242567|588410814|FG000|Overall Study|Withdrawal by Subject|33|||
162920341|NCT00242567|588410815|FG001|Overall Study|Withdrawal by Subject|28|||
162920342|NCT00242567|588410814|FG000|Overall Study|Protocol Violation|12|||
162920343|NCT00242567|588410815|FG001|Overall Study|Protocol Violation|12|||
162920344|NCT00242567|588410814|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
162629915|NCT03845985|587362674|FG000|Overall Study|Lost to Follow-up|2|||
162629916|NCT03845985|587362675|FG001|Overall Study|Lost to Follow-up|1|||
162920345|NCT00242567|588410815|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
162920346|NCT00242567|588410814|FG000|Overall Study|Other|14|||
162920347|NCT00242567|588410815|FG001|Overall Study|Other|9|||
162920348|NCT00320801|588410816|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
162920349|NCT00320801|588410817|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
162920350|NCT00320801|588410818|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
162920351|NCT00320801|588410819|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
162920352|NCT00320801|588410816|FG000|Open-label Run-in Period|Adverse Event|33|||
163056101|NCT00853385|588918344|FG000|Overall Study|Adverse Event|24|||
162920353|NCT00320801|588410817|FG001|Open-label Run-in Period|Adverse Event|0|||
162920354|NCT00320801|588410818|FG002|Open-label Run-in Period|Adverse Event|0|||
162920355|NCT00320801|588410819|FG003|Open-label Run-in Period|Adverse Event|0|||
162920356|NCT00320801|588410816|FG000|Open-label Run-in Period|Administrative|10|||
162920357|NCT00320801|588410817|FG001|Open-label Run-in Period|Administrative|0|||
162920358|NCT00320801|588410818|FG002|Open-label Run-in Period|Administrative|0|||
162920359|NCT00320801|588410819|FG003|Open-label Run-in Period|Administrative|0|||
162920360|NCT00320801|588410816|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
162920361|NCT00320801|588410817|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
162920362|NCT00320801|588410818|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
162920363|NCT00320801|588410819|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
162920364|NCT00320801|588410816|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
162920365|NCT00320801|588410817|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
162920366|NCT00320801|588410818|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
162920367|NCT00320801|588410819|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
162920368|NCT00320801|588410816|FG000|Open-label Run-in Period|Did not qualify|1|||
162920369|NCT00320801|588410817|FG001|Open-label Run-in Period|Did not qualify|0|||
162920370|NCT00320801|588410818|FG002|Open-label Run-in Period|Did not qualify|0|||
162920371|NCT00320801|588410819|FG003|Open-label Run-in Period|Did not qualify|0|||
162970307|NCT01120691|588592021|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
162970308|NCT01120691|588592022|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
162970309|NCT01120691|588592023|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
162970310|NCT01120691|588592021|FG000|Overall Study|Administrative problems|15|||
162970311|NCT01120691|588592022|FG001|Overall Study|Administrative problems|8|||
162970312|NCT01120691|588592023|FG002|Overall Study|Administrative problems|9|||
162970313|NCT01120691|588592021|FG000|Overall Study|Protocol deviation|13|||
162970314|NCT01120691|588592022|FG001|Overall Study|Protocol deviation|12|||
162970315|NCT01120691|588592023|FG002|Overall Study|Protocol deviation|12|||
162970316|NCT01120691|588592021|FG000|Overall Study|Lost to Follow-up|5|||
162970317|NCT01120691|588592022|FG001|Overall Study|Lost to Follow-up|6|||
162970318|NCT01120691|588592023|FG002|Overall Study|Lost to Follow-up|4|||
162970319|NCT01120691|588592021|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162970320|NCT01120691|588592022|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162970321|NCT01120691|588592023|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162970322|NCT01120691|588592021|FG000|Overall Study|Patient's inability to use the device|3|||
162970323|NCT01120691|588592022|FG001|Overall Study|Patient's inability to use the device|1|||
162970324|NCT01120691|588592023|FG002|Overall Study|Patient's inability to use the device|0|||
162970325|NCT01120691|588592021|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162970326|NCT01120691|588592022|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162970327|NCT01120691|588592023|FG002|Overall Study|Abnormal laboratory value(s)|4|||
162970328|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
162970329|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
162970330|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
162970331|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
162970332|NCT00772148|588592025|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
162970333|NCT00772148|588592026|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
162970334|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Death|2|||
162970335|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Death|2|||
162970336|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
162970337|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
162970338|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
162970339|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
162970340|NCT00772148|588592025|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
162970341|NCT00772148|588592026|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
162970342|NCT00688844|588592027|FG000|Overall Study|Lost to Follow-up|10|||
162970343|NCT01321697|588592031|FG000|Overall Study|Study Terminated|7|||
162970344|NCT00857818|588592032|FG000|Overall Study|Lack of Efficacy|1|||
162970345|NCT00857818|588592033|FG001|Overall Study|Lack of Efficacy|0|||
162970346|NCT00857818|588592032|FG000|Overall Study|Adverse Event|3|||
162970347|NCT00857818|588592033|FG001|Overall Study|Adverse Event|0|||
162970348|NCT00857818|588592032|FG000|Overall Study|Withdrawal by Subject|0|||
162970349|NCT00857818|588592033|FG001|Overall Study|Withdrawal by Subject|4|||
162970350|NCT00857818|588592032|FG000|Overall Study|Sponsor terminated study|6|||
162970351|NCT00857818|588592033|FG001|Overall Study|Sponsor terminated study|4|||
162970352|NCT00857818|588592032|FG000|Overall Study|Investigator decision|1|||
162970353|NCT00857818|588592033|FG001|Overall Study|Investigator decision|0|||
162970354|NCT02061280|588592037|FG000|Overall Study|Protocol Violation|12|||
162970355|NCT02061280|588592038|FG001|Overall Study|Protocol Violation|8|||
162970356|NCT02061280|588592037|FG000|Overall Study|moved out of state|0|||
162970357|NCT02061280|588592038|FG001|Overall Study|moved out of state|1|||
163056102|NCT00853385|588918345|FG001|Overall Study|Adverse Event|24|||
162970358|NCT02061280|588592037|FG000|Overall Study|Withdrawal by Subject|1|||
163056103|NCT00853385|588918346|FG002|Overall Study|Adverse Event|2|||
162920372|NCT00320801|588410816|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162920373|NCT00320801|588410817|FG001|Double-blind Phase|Withdrawal by Subject|0|||
162920374|NCT00320801|588410818|FG002|Double-blind Phase|Withdrawal by Subject|1|||
162920375|NCT00320801|588410819|FG003|Double-blind Phase|Withdrawal by Subject|0|||
162920376|NCT00320801|588410816|FG000|Double-blind Phase|Adverse Event|0|||
162920377|NCT00320801|588410817|FG001|Double-blind Phase|Adverse Event|2|||
162920378|NCT00320801|588410818|FG002|Double-blind Phase|Adverse Event|8|||
162920379|NCT00320801|588410819|FG003|Double-blind Phase|Adverse Event|0|||
162920380|NCT00320801|588410816|FG000|Double-blind Phase|Administrative|0|||
162920381|NCT00320801|588410817|FG001|Double-blind Phase|Administrative|0|||
162920382|NCT00320801|588410818|FG002|Double-blind Phase|Administrative|4|||
162920383|NCT00320801|588410819|FG003|Double-blind Phase|Administrative|0|||
162920384|NCT00320801|588410816|FG000|Double-blind Phase|Lack of Efficacy|0|||
162920385|NCT00320801|588410817|FG001|Double-blind Phase|Lack of Efficacy|9|||
162920386|NCT00320801|588410818|FG002|Double-blind Phase|Lack of Efficacy|1|||
162920387|NCT00320801|588410819|FG003|Double-blind Phase|Lack of Efficacy|0|||
162920388|NCT00320801|588410816|FG000|Extension Phase|Withdrawal by Subject|0|||
162920389|NCT00320801|588410817|FG001|Extension Phase|Withdrawal by Subject|0|||
162920390|NCT00320801|588410818|FG002|Extension Phase|Withdrawal by Subject|0|||
162920391|NCT00320801|588410819|FG003|Extension Phase|Withdrawal by Subject|6|||
162920392|NCT00320801|588410816|FG000|Extension Phase|Adverse Event|0|||
162920393|NCT00320801|588410817|FG001|Extension Phase|Adverse Event|0|||
162920394|NCT00320801|588410818|FG002|Extension Phase|Adverse Event|0|||
162920395|NCT00320801|588410819|FG003|Extension Phase|Adverse Event|8|||
162920396|NCT00320801|588410816|FG000|Extension Phase|Administrative|0|||
162920397|NCT00320801|588410817|FG001|Extension Phase|Administrative|0|||
162920398|NCT00320801|588410818|FG002|Extension Phase|Administrative|0|||
162920399|NCT00320801|588410819|FG003|Extension Phase|Administrative|29|||
162920400|NCT00320801|588410816|FG000|Extension Phase|Lack of Efficacy|0|||
162920401|NCT00320801|588410817|FG001|Extension Phase|Lack of Efficacy|0|||
162920402|NCT00320801|588410818|FG002|Extension Phase|Lack of Efficacy|0|||
162920403|NCT00320801|588410819|FG003|Extension Phase|Lack of Efficacy|2|||
162920404|NCT00320801|588410816|FG000|Extension Phase|Lost to Follow-up|0|||
162920405|NCT00320801|588410817|FG001|Extension Phase|Lost to Follow-up|0|||
162920406|NCT00320801|588410818|FG002|Extension Phase|Lost to Follow-up|0|||
162920407|NCT00320801|588410819|FG003|Extension Phase|Lost to Follow-up|3|||
162920408|NCT00337727|588410820|FG000|Overall Study|Adverse Event|5|||
162920409|NCT00337727|588410821|FG001|Overall Study|Adverse Event|3|||
162920410|NCT00337727|588410820|FG000|Overall Study|Lost to Follow-up|5|||
162920411|NCT00337727|588410821|FG001|Overall Study|Lost to Follow-up|4|||
162920412|NCT00337727|588410820|FG000|Overall Study|Physician Decision|1|||
162920413|NCT00337727|588410821|FG001|Overall Study|Physician Decision|0|||
162920414|NCT00337727|588410820|FG000|Overall Study|Protocol Violation|4|||
162920415|NCT00337727|588410821|FG001|Overall Study|Protocol Violation|0|||
162920416|NCT00337727|588410820|FG000|Overall Study|Withdrawal by Subject|3|||
162920417|NCT00337727|588410821|FG001|Overall Study|Withdrawal by Subject|5|||
162920418|NCT02060188|588410824|FG000|Overall Study|Disease Progression|36|||
162920419|NCT02060188|588410825|FG001|Overall Study|Disease Progression|42|||
162920420|NCT02060188|588410826|FG002|Overall Study|Disease Progression|8|||
162920421|NCT02060188|588410827|FG003|Overall Study|Disease Progression|5|||
162920422|NCT02060188|588410828|FG004|Overall Study|Disease Progression|6|||
162920423|NCT02060188|588410829|FG005|Overall Study|Disease Progression|3|||
162920424|NCT02060188|588410830|FG006|Overall Study|Disease Progression|23|||
162920425|NCT02060188|588410831|FG007|Overall Study|Disease Progression|20|||
162920426|NCT02060188|588410832|FG008|Overall Study|Disease Progression|43|||
162920427|NCT02060188|588410824|FG000|Overall Study|Study Drug Toxicity|10|||
162920428|NCT02060188|588410825|FG001|Overall Study|Study Drug Toxicity|18|||
162920429|NCT02060188|588410826|FG002|Overall Study|Study Drug Toxicity|7|||
162920430|NCT02060188|588410827|FG003|Overall Study|Study Drug Toxicity|4|||
162970359|NCT02061280|588592038|FG001|Overall Study|Withdrawal by Subject|2|||
162970360|NCT02061280|588592037|FG000|Overall Study|Lost to Follow-up|5|||
162970361|NCT02061280|588592038|FG001|Overall Study|Lost to Follow-up|1|||
162970362|NCT01977456|588592039|FG000|Overall Study|Death|5|||
162920431|NCT02060188|588410828|FG004|Overall Study|Study Drug Toxicity|3|||
162920432|NCT02060188|588410829|FG005|Overall Study|Study Drug Toxicity|0|||
162920433|NCT02060188|588410830|FG006|Overall Study|Study Drug Toxicity|2|||
162920434|NCT02060188|588410831|FG007|Overall Study|Study Drug Toxicity|5|||
162920435|NCT02060188|588410832|FG008|Overall Study|Study Drug Toxicity|0|||
162920436|NCT02060188|588410824|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162920437|NCT02060188|588410825|FG001|Overall Study|Adverse event unrelated to study drug|5|||
162920438|NCT02060188|588410826|FG002|Overall Study|Adverse event unrelated to study drug|6|||
162920439|NCT02060188|588410827|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162920440|NCT02060188|588410828|FG004|Overall Study|Adverse event unrelated to study drug|1|||
162920441|NCT02060188|588410829|FG005|Overall Study|Adverse event unrelated to study drug|0|||
162920442|NCT02060188|588410830|FG006|Overall Study|Adverse event unrelated to study drug|4|||
162920443|NCT02060188|588410831|FG007|Overall Study|Adverse event unrelated to study drug|4|||
162920444|NCT02060188|588410832|FG008|Overall Study|Adverse event unrelated to study drug|1|||
162920445|NCT02060188|588410824|FG000|Overall Study|Participant request to discontinue study treatment|7|||
162970363|NCT00493792|588593836|FG000|Overall Study|Death|55|||
162920446|NCT02060188|588410825|FG001|Overall Study|Participant request to discontinue study treatment|7|||
162920447|NCT02060188|588410826|FG002|Overall Study|Participant request to discontinue study treatment|4|||
162920448|NCT02060188|588410827|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162920449|NCT02060188|588410828|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162920450|NCT02060188|588410829|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162920451|NCT02060188|588410830|FG006|Overall Study|Participant request to discontinue study treatment|1|||
162920452|NCT02060188|588410831|FG007|Overall Study|Participant request to discontinue study treatment|1|||
162920453|NCT02060188|588410832|FG008|Overall Study|Participant request to discontinue study treatment|0|||
162920454|NCT02060188|588410824|FG000|Overall Study|Participant withdrew consent|3|||
162920455|NCT02060188|588410825|FG001|Overall Study|Participant withdrew consent|0|||
162920456|NCT02060188|588410826|FG002|Overall Study|Participant withdrew consent|0|||
162920457|NCT02060188|588410827|FG003|Overall Study|Participant withdrew consent|0|||
162920458|NCT02060188|588410828|FG004|Overall Study|Participant withdrew consent|0|||
162920459|NCT02060188|588410829|FG005|Overall Study|Participant withdrew consent|0|||
162920460|NCT02060188|588410830|FG006|Overall Study|Participant withdrew consent|0|||
162920461|NCT02060188|588410831|FG007|Overall Study|Participant withdrew consent|0|||
162920462|NCT02060188|588410832|FG008|Overall Study|Participant withdrew consent|0|||
162920463|NCT02060188|588410824|FG000|Overall Study|Maximum clinical benefit|13|||
162920464|NCT02060188|588410825|FG001|Overall Study|Maximum clinical benefit|38|||
162920465|NCT02060188|588410826|FG002|Overall Study|Maximum clinical benefit|19|||
162920466|NCT02060188|588410827|FG003|Overall Study|Maximum clinical benefit|0|||
162920467|NCT02060188|588410828|FG004|Overall Study|Maximum clinical benefit|0|||
162920468|NCT02060188|588410829|FG005|Overall Study|Maximum clinical benefit|0|||
162920469|NCT02060188|588410830|FG006|Overall Study|Maximum clinical benefit|0|||
162920470|NCT02060188|588410831|FG007|Overall Study|Maximum clinical benefit|10|||
162920471|NCT02060188|588410832|FG008|Overall Study|Maximum clinical benefit|0|||
162920472|NCT02060188|588410824|FG000|Overall Study|Other reason|3|||
162920473|NCT02060188|588410825|FG001|Overall Study|Other reason|7|||
162920474|NCT02060188|588410826|FG002|Overall Study|Other reason|0|||
162920475|NCT02060188|588410827|FG003|Overall Study|Other reason|1|||
162920476|NCT02060188|588410828|FG004|Overall Study|Other reason|0|||
162920477|NCT02060188|588410829|FG005|Overall Study|Other reason|0|||
162920478|NCT02060188|588410830|FG006|Overall Study|Other reason|0|||
162920479|NCT02060188|588410831|FG007|Overall Study|Other reason|9|||
162920480|NCT02060188|588410832|FG008|Overall Study|Other reason|0|||
162920481|NCT02060188|588410824|FG000|Overall Study|Death|0|||
162920482|NCT02060188|588410825|FG001|Overall Study|Death|1|||
162920483|NCT02060188|588410826|FG002|Overall Study|Death|0|||
162920484|NCT02060188|588410827|FG003|Overall Study|Death|0|||
162920485|NCT02060188|588410828|FG004|Overall Study|Death|0|||
162920486|NCT02060188|588410829|FG005|Overall Study|Death|0|||
162920487|NCT02060188|588410830|FG006|Overall Study|Death|0|||
162920488|NCT02060188|588410831|FG007|Overall Study|Death|1|||
162920489|NCT02060188|588410832|FG008|Overall Study|Death|0|||
162920490|NCT02060188|588410824|FG000|Overall Study|Administrative reasons by sponsor|0|||
162920491|NCT02060188|588410825|FG001|Overall Study|Administrative reasons by sponsor|1|||
162920492|NCT02060188|588410826|FG002|Overall Study|Administrative reasons by sponsor|0|||
162920493|NCT02060188|588410827|FG003|Overall Study|Administrative reasons by sponsor|0|||
162920494|NCT02060188|588410828|FG004|Overall Study|Administrative reasons by sponsor|0|||
162920495|NCT02060188|588410829|FG005|Overall Study|Administrative reasons by sponsor|0|||
162920496|NCT02060188|588410830|FG006|Overall Study|Administrative reasons by sponsor|0|||
162920497|NCT02060188|588410831|FG007|Overall Study|Administrative reasons by sponsor|0|||
162920498|NCT02060188|588410832|FG008|Overall Study|Administrative reasons by sponsor|0|||
162920499|NCT02060188|588410824|FG000|Overall Study|Lost to Follow-up|0|||
162920500|NCT02060188|588410825|FG001|Overall Study|Lost to Follow-up|0|||
162920501|NCT02060188|588410826|FG002|Overall Study|Lost to Follow-up|1|||
162920502|NCT02060188|588410827|FG003|Overall Study|Lost to Follow-up|0|||
162920503|NCT02060188|588410828|FG004|Overall Study|Lost to Follow-up|0|||
162920504|NCT02060188|588410829|FG005|Overall Study|Lost to Follow-up|0|||
162920505|NCT02060188|588410830|FG006|Overall Study|Lost to Follow-up|0|||
162920506|NCT02060188|588410831|FG007|Overall Study|Lost to Follow-up|0|||
162920507|NCT02060188|588410832|FG008|Overall Study|Lost to Follow-up|0|||
162920508|NCT04456998|588410835|FG000|Overall Study|Adverse Event|0|||
162920509|NCT04456998|588410836|FG001|Overall Study|Adverse Event|4|||
162970364|NCT00493792|588593837|FG001|Overall Study|Death|50|||
162629917|NCT03845985|587362674|FG000|Overall Study|Physician Decision|1|||
162920510|NCT04456998|588410835|FG000|Overall Study|Protocol Deviation|0|||
162920511|NCT04456998|588410836|FG001|Overall Study|Protocol Deviation|1|||
162920512|NCT04456998|588410835|FG000|Overall Study|Withdrawal by Subject|0|||
162920513|NCT04456998|588410836|FG001|Overall Study|Withdrawal by Subject|1|||
162970365|NCT00493792|588593836|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
163056104|NCT00853385|588918347|FG003|Overall Study|Adverse Event|5|||
162629918|NCT03845985|587362675|FG001|Overall Study|Physician Decision|0|||
162629919|NCT03845985|587362674|FG000|Overall Study|Withdrawal by Subject|4|||
162920514|NCT03707145|588410840|FG000|Overall Study|Lost to Follow-up|0|||
162920515|NCT03707145|588410841|FG001|Overall Study|Lost to Follow-up|1|||
162920516|NCT03707145|588410842|FG002|Overall Study|Lost to Follow-up|1|||
162920517|NCT03707145|588410843|FG003|Overall Study|Lost to Follow-up|0|||
162920518|NCT04221477|588410844|FG000|Overall Study|Adverse Event|1|||
162920519|NCT04221477|588410845|FG001|Overall Study|Adverse Event|1|||
162920520|NCT04221477|588410844|FG000|Overall Study|Death|5|||
162920521|NCT04221477|588410845|FG001|Overall Study|Death|4|||
162920522|NCT04221477|588410844|FG000|Overall Study|Lack of Efficacy|1|||
162920523|NCT04221477|588410845|FG001|Overall Study|Lack of Efficacy|2|||
162920524|NCT04221477|588410844|FG000|Overall Study|Lost to Follow-up|1|||
162920525|NCT04221477|588410845|FG001|Overall Study|Lost to Follow-up|2|||
162920526|NCT04221477|588410844|FG000|Overall Study|Non-compliance with Study Drug|1|||
162920527|NCT04221477|588410845|FG001|Overall Study|Non-compliance with Study Drug|0|||
162920528|NCT04221477|588410844|FG000|Overall Study|Reason not Specified|0|||
162920529|NCT04221477|588410845|FG001|Overall Study|Reason not Specified|5|||
162920530|NCT04221477|588410844|FG000|Overall Study|Physician Decision|0|||
162920531|NCT04221477|588410845|FG001|Overall Study|Physician Decision|6|||
162920532|NCT04221477|588410844|FG000|Overall Study|Withdrawal by Subject|10|||
162920533|NCT04221477|588410845|FG001|Overall Study|Withdrawal by Subject|14|||
162920534|NCT04221477|588410844|FG000|Overall Study|Ongoing in the Study|116|||
162920535|NCT04221477|588410845|FG001|Overall Study|Ongoing in the Study|102|||
162920536|NCT04784455|588410846|FG000|Overall Study|Death|4|||
162920537|NCT04882085|588410847|FG000|Overall Study|Death|6|||
162920538|NCT04882085|588410848|FG001|Overall Study|Death|9|||
162920539|NCT04882085|588410847|FG000|Overall Study|Withdrawal by Subject|0|||
162920540|NCT04882085|588410848|FG001|Overall Study|Withdrawal by Subject|3|||
162920541|NCT04882085|588410847|FG000|Overall Study|Randomized not treated|1|||
162920542|NCT04882085|588410848|FG001|Overall Study|Randomized not treated|0|||
162920543|NCT04455620|588410849|FG000|Overall Study|Withdrawal by Subject|0|||
162920544|NCT04455620|588410850|FG001|Overall Study|Withdrawal by Subject|0|||
162920545|NCT04455620|588410851|FG002|Overall Study|Withdrawal by Subject|2|||
162920546|NCT04455620|588410852|FG003|Overall Study|Withdrawal by Subject|0|||
162920547|NCT04455620|588410853|FG004|Overall Study|Withdrawal by Subject|1|||
162920548|NCT04455620|588410849|FG000|Overall Study|Lost to Follow-up|0|||
162920549|NCT04455620|588410850|FG001|Overall Study|Lost to Follow-up|0|||
162920550|NCT04455620|588410851|FG002|Overall Study|Lost to Follow-up|1|||
162920551|NCT04455620|588410852|FG003|Overall Study|Lost to Follow-up|1|||
162920552|NCT04455620|588410853|FG004|Overall Study|Lost to Follow-up|0|||
162920553|NCT04455620|588410849|FG000|Overall Study|Death|1|||
162920554|NCT04455620|588410850|FG001|Overall Study|Death|6|||
162920555|NCT04455620|588410851|FG002|Overall Study|Death|20|||
162920556|NCT04455620|588410852|FG003|Overall Study|Death|1|||
162920557|NCT04455620|588410853|FG004|Overall Study|Death|7|||
162920558|NCT04455620|588410849|FG000|Overall Study|Study Termination|0|||
162920559|NCT04455620|588410850|FG001|Overall Study|Study Termination|2|||
162920560|NCT04455620|588410851|FG002|Overall Study|Study Termination|1|||
162920561|NCT04455620|588410852|FG003|Overall Study|Study Termination|0|||
162920562|NCT04455620|588410853|FG004|Overall Study|Study Termination|6|||
162920563|NCT00965562|588410854|FG000|Overall Study|Lost to Follow-up|1|||
162920564|NCT00965562|588410855|FG001|Overall Study|Lost to Follow-up|2|||
162920565|NCT00965562|588410856|FG002|Overall Study|Lost to Follow-up|3|||
162920566|NCT00965562|588410854|FG000|Overall Study|Withdrawal by Subject|2|||
162920567|NCT00965562|588410855|FG001|Overall Study|Withdrawal by Subject|2|||
162920568|NCT00965562|588410856|FG002|Overall Study|Withdrawal by Subject|0|||
162920569|NCT05681715|588410857|FG000|Training Period (6-weeks)|Adverse Event|3|||
162920570|NCT05681715|588410858|FG001|Training Period (6-weeks)|Adverse Event|0|||
162920571|NCT05681715|588410859|FG002|Training Period (6-weeks)|Adverse Event|0|||
162920572|NCT05681715|588410857|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
162970366|NCT00493792|588593837|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
162970367|NCT00685035|588593838|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
162920573|NCT05681715|588410858|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
162920574|NCT05681715|588410859|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
162970368|NCT00685035|588593839|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
162970369|NCT02426541|588593843|FG000|Overall Study|Protocol Violation|1|||
162970370|NCT02426541|588593844|FG001|Overall Study|Protocol Violation|0|||
162970371|NCT00784979|588593847|FG000|Overall Study|incomplete data|6|||
162970372|NCT00894933|588593851|FG000|Overall Study|Lost to Follow-up|2|||
162629920|NCT03845985|587362675|FG001|Overall Study|Withdrawal by Subject|1|||
162629921|NCT02756013|587362676|FG000|Overall Study|Adverse Event|1|||
162920575|NCT05681715|588410857|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
162920576|NCT05681715|588410858|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
162970373|NCT00894933|588593851|FG000|Overall Study|Cancelled Procedure|1|||
162970374|NCT00894933|588593851|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
162920577|NCT05681715|588410859|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
162629922|NCT02756013|587362676|FG000|Overall Study|Hypersensitivity|1|||
162629923|NCT03926169|587362677|FG000|Period A|Adverse Event|2|||
162629924|NCT03926169|587362678|FG001|Period A|Adverse Event|2|||
162629925|NCT03926169|587362679|FG002|Period A|Adverse Event|1|||
162629926|NCT03926169|587362677|FG000|Period A|Withdrawal by Subject|2|||
162629927|NCT03926169|587362678|FG001|Period A|Withdrawal by Subject|2|||
162629928|NCT03926169|587362679|FG002|Period A|Withdrawal by Subject|2|||
162629929|NCT03926169|587362677|FG000|Period A|Lost to Follow-up|3|||
162629930|NCT03926169|587362678|FG001|Period A|Lost to Follow-up|1|||
162629931|NCT03926169|587362679|FG002|Period A|Lost to Follow-up|0|||
162629932|NCT03926169|587362677|FG000|Period A|Lack of Efficacy|0|||
162629933|NCT03926169|587362678|FG001|Period A|Lack of Efficacy|2|||
162629934|NCT03926169|587362679|FG002|Period A|Lack of Efficacy|2|||
162629935|NCT03926169|587362677|FG000|Period A|COVID-19 Infection|0|||
162629936|NCT03926169|587362678|FG001|Period A|COVID-19 Infection|1|||
162629937|NCT03926169|587362679|FG002|Period A|COVID-19 Infection|0|||
162629938|NCT03926169|587362677|FG000|Period A|COVID-19 Logistical Restrictions|0|||
162629939|NCT03926169|587362678|FG001|Period A|COVID-19 Logistical Restrictions|2|||
162629940|NCT03926169|587362679|FG002|Period A|COVID-19 Logistical Restrictions|1|||
162629941|NCT03926169|587362677|FG000|Period A|Other, Not Specified|1|||
162629942|NCT03926169|587362678|FG001|Period A|Other, Not Specified|0|||
162629943|NCT03926169|587362679|FG002|Period A|Other, Not Specified|0|||
162629944|NCT03926169|587362677|FG000|Period B|Adverse Event|3|||
162629945|NCT03926169|587362678|FG001|Period B|Adverse Event|1|||
162629946|NCT03926169|587362679|FG002|Period B|Adverse Event|1|||
162629947|NCT03926169|587362677|FG000|Period B|Withdrawal by Subject|1|||
162629948|NCT03926169|587362678|FG001|Period B|Withdrawal by Subject|3|||
162629949|NCT03926169|587362679|FG002|Period B|Withdrawal by Subject|0|||
162629950|NCT03926169|587362677|FG000|Period B|Lack of Efficacy|3|||
162629951|NCT03926169|587362678|FG001|Period B|Lack of Efficacy|1|||
162629952|NCT03926169|587362679|FG002|Period B|Lack of Efficacy|1|||
162629953|NCT03926169|587362677|FG000|Period B|Lost to Follow-up|1|||
162629954|NCT03926169|587362678|FG001|Period B|Lost to Follow-up|1|||
162629955|NCT03926169|587362679|FG002|Period B|Lost to Follow-up|4|||
162629956|NCT03926169|587362677|FG000|Period B|Other, Not Specified|62|||
162629957|NCT03926169|587362678|FG001|Period B|Other, Not Specified|57|||
162629958|NCT03926169|587362679|FG002|Period B|Other, Not Specified|65|||
162629959|NCT00968201|587362680|FG000|Base Study - (Period II)|Adverse Event|8|||
162629960|NCT00968201|587362681|FG001|Base Study - (Period II)|Adverse Event|0|||
162629961|NCT00968201|587362682|FG002|Base Study - (Period II)|Adverse Event|16|||
162629962|NCT00968201|587362680|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
162629963|NCT00968201|587362681|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
162629964|NCT00968201|587362682|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
162629965|NCT00968201|587362680|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
162629966|NCT00968201|587362681|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
162629967|NCT00968201|587362682|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
162629968|NCT00968201|587362680|FG000|Base Study - (Period II)|Protocol Violation|12|||
162629969|NCT00968201|587362681|FG001|Base Study - (Period II)|Protocol Violation|0|||
162920578|NCT05681715|588410857|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
162920579|NCT05681715|588410858|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
162920580|NCT05681715|588410859|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
162920581|NCT05681715|588410857|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
162920582|NCT05681715|588410858|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
162920583|NCT05681715|588410859|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
162920584|NCT05681715|588410857|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
162920585|NCT05681715|588410858|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
162920586|NCT05681715|588410859|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
162920587|NCT05681715|588410857|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
162920588|NCT05681715|588410858|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
162920589|NCT05681715|588410859|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
162920590|NCT05681715|588410857|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
162920591|NCT05681715|588410858|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
162920592|NCT05681715|588410859|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
162920593|NCT05455684|588410860|FG000|Overall Study|Withdrawal by Subject|7|||
162920594|NCT05455684|588410861|FG001|Overall Study|Withdrawal by Subject|4|||
162920595|NCT05455684|588410860|FG000|Overall Study|Lost to Follow-up|3|||
162920596|NCT05455684|588410861|FG001|Overall Study|Lost to Follow-up|3|||
162920597|NCT05455684|588410860|FG000|Overall Study|Adverse Event|2|||
162920598|NCT05455684|588410861|FG001|Overall Study|Adverse Event|3|||
162920599|NCT05455684|588410860|FG000|Overall Study|Protocol Violation|1|||
162920600|NCT05455684|588410861|FG001|Overall Study|Protocol Violation|1|||
162920601|NCT05455684|588410860|FG000|Overall Study|Non-Compliant with study drug|0|||
163056105|NCT00853385|588918348|FG004|Overall Study|Adverse Event|22|||
163056106|NCT00853385|588918344|FG000|Overall Study|Lack of Efficacy|6|||
163056107|NCT00853385|588918345|FG001|Overall Study|Lack of Efficacy|7|||
163056108|NCT00853385|588918346|FG002|Overall Study|Lack of Efficacy|3|||
163056109|NCT00853385|588918347|FG003|Overall Study|Lack of Efficacy|3|||
163056110|NCT00853385|588918348|FG004|Overall Study|Lack of Efficacy|6|||
163056111|NCT00853385|588918344|FG000|Overall Study|Lost to Follow-up|2|||
163056112|NCT00853385|588918345|FG001|Overall Study|Lost to Follow-up|1|||
163056113|NCT00853385|588918346|FG002|Overall Study|Lost to Follow-up|0|||
163056114|NCT00853385|588918347|FG003|Overall Study|Lost to Follow-up|0|||
163056115|NCT00853385|588918348|FG004|Overall Study|Lost to Follow-up|0|||
163056116|NCT00853385|588918344|FG000|Overall Study|Withdrawal by Subject|4|||
163056117|NCT00853385|588918345|FG001|Overall Study|Withdrawal by Subject|2|||
163056118|NCT00853385|588918346|FG002|Overall Study|Withdrawal by Subject|0|||
163056119|NCT00853385|588918347|FG003|Overall Study|Withdrawal by Subject|1|||
163056120|NCT00853385|588918348|FG004|Overall Study|Withdrawal by Subject|1|||
163056121|NCT00853385|588918344|FG000|Overall Study|Other|18|||
163056122|NCT00853385|588918345|FG001|Overall Study|Other|9|||
163056123|NCT00853385|588918346|FG002|Overall Study|Other|4|||
163056124|NCT00853385|588918347|FG003|Overall Study|Other|4|||
163056125|NCT00853385|588918348|FG004|Overall Study|Other|12|||
163056126|NCT00915525|588918349|FG000|Overall Study|Protocol Violation|9|||
163056127|NCT00915525|588918350|FG001|Overall Study|Protocol Violation|4|||
163056128|NCT00915525|588918349|FG000|Overall Study|Withdrawal by Subject|59|||
163056129|NCT00915525|588918350|FG001|Overall Study|Withdrawal by Subject|21|||
163056130|NCT00915525|588918349|FG000|Overall Study|Lost to Follow-up|27|||
163056131|NCT00915525|588918350|FG001|Overall Study|Lost to Follow-up|16|||
163056132|NCT00915525|588918349|FG000|Overall Study|Pregnancy|2|||
163056133|NCT00915525|588918350|FG001|Overall Study|Pregnancy|0|||
163056134|NCT00915525|588918349|FG000|Overall Study|Lack of Efficacy|15|||
163056135|NCT00915525|588918350|FG001|Overall Study|Lack of Efficacy|32|||
163056136|NCT00915525|588918349|FG000|Overall Study|Adverse Event|29|||
163056137|NCT00915525|588918350|FG001|Overall Study|Adverse Event|13|||
163056138|NCT00915525|588918349|FG000|Overall Study|Missing|12|||
163056139|NCT00915525|588918350|FG001|Overall Study|Missing|1|||
163056140|NCT00915525|588918349|FG000|Overall Study|Other Reason|35|||
163056141|NCT00915525|588918350|FG001|Overall Study|Other Reason|12|||
163056142|NCT00915525|588918349|FG000|Overall Study|Site Closed|27|||
163056143|NCT00915525|588918350|FG001|Overall Study|Site Closed|9|||
163056144|NCT00915525|588918349|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
163056145|NCT00915525|588918350|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
163056146|NCT00915525|588918349|FG000|Overall Study|Study Burden|28|||
163056147|NCT00915525|588918350|FG001|Overall Study|Study Burden|12|||
163056148|NCT00915525|588918349|FG000|Overall Study|Non-Compliance|3|||
163056149|NCT00915525|588918350|FG001|Overall Study|Non-Compliance|1|||
163056150|NCT00915525|588918349|FG000|Overall Study|Patient Moved|15|||
163056151|NCT00915525|588918350|FG001|Overall Study|Patient Moved|9|||
163056152|NCT00941928|588918355|FG000|Overall Study|Withdrawal by Subject|1|||
163056153|NCT00941928|588918355|FG000|Overall Study|Disease Progression|1|||
163056154|NCT00577408|588918356|FG000|Overall Study|Stopped attending study visits|9|||
163056155|NCT00577408|588918357|FG001|Overall Study|Stopped attending study visits|11|||
163056156|NCT00577408|588918356|FG000|Overall Study|Continued opioid use|3|||
162920602|NCT05455684|588410861|FG001|Overall Study|Non-Compliant with study drug|1|||
162920603|NCT05455684|588410860|FG000|Overall Study|Other|1|||
162920604|NCT05455684|588410861|FG001|Overall Study|Other|2|||
162920605|NCT05455684|588410860|FG000|Overall Study|Randomized but not treated|1|||
162920606|NCT05455684|588410861|FG001|Overall Study|Randomized but not treated|0|||
163056157|NCT00577408|588918357|FG001|Overall Study|Continued opioid use|2|||
163056158|NCT00577408|588918356|FG000|Overall Study|Non-compliance with study meds|0|||
162920607|NCT05204563|588410862|FG000|Overall Study|Other than Specified|2|||
162920608|NCT05204563|588410863|FG001|Overall Study|Other than Specified|1|||
163056159|NCT00577408|588918357|FG001|Overall Study|Non-compliance with study meds|3|||
163056160|NCT00577408|588918356|FG000|Overall Study|Refused Oral Naltrexone|0|||
163056161|NCT00577408|588918357|FG001|Overall Study|Refused Oral Naltrexone|1|||
163056162|NCT00577408|588918356|FG000|Overall Study|Moved out of state|0|||
163056163|NCT00577408|588918357|FG001|Overall Study|Moved out of state|1|||
163056164|NCT00577408|588918356|FG000|Overall Study|Scheduling Issues|0|||
163056165|NCT00577408|588918357|FG001|Overall Study|Scheduling Issues|3|||
163056166|NCT00577408|588918356|FG000|Overall Study|Death|0|||
163056167|NCT00577408|588918357|FG001|Overall Study|Death|1|||
163056168|NCT00577408|588918356|FG000|Overall Study|Psychiatric hospitalization|0|||
163056169|NCT00577408|588918357|FG001|Overall Study|Psychiatric hospitalization|1|||
163056170|NCT01829347|588918358|FG000|VTI-210|Death|5|||
163056171|NCT01829347|588918359|FG001|VTI-210|Death|3|||
163056172|NCT01829347|588918358|FG000|VTI-210|Withdrawal by Subject|1|||
163056173|NCT01829347|588918359|FG001|VTI-210|Withdrawal by Subject|0|||
163056174|NCT01829347|588918358|FG000|VTI-210E|Death|2|||
163056175|NCT01829347|588918359|FG001|VTI-210E|Death|1|||
163056176|NCT01829347|588918358|FG000|VTI-210E|Study terminated prematurely|1|||
163056177|NCT01829347|588918359|FG001|VTI-210E|Study terminated prematurely|5|||
162920609|NCT05204563|588410862|FG000|Overall Study|Death|18|||
162920610|NCT05204563|588410863|FG001|Overall Study|Death|4|||
162920611|NCT05204563|588410862|FG000|Overall Study|Lost to Follow-up|6|||
162920612|NCT05204563|588410863|FG001|Overall Study|Lost to Follow-up|3|||
162712451|NCT02001623|587658502|FG003|Overall Study|Death|0|||
162920613|NCT05204563|588410862|FG000|Overall Study|Withdrawal by Subject|12|||
162920614|NCT05204563|588410863|FG001|Overall Study|Withdrawal by Subject|3|||
162920615|NCT05204563|588410862|FG000|Overall Study|Enrolled, Not Treated|1|||
162920616|NCT05204563|588410863|FG001|Overall Study|Enrolled, Not Treated|0|||
162920617|NCT05643573|588410864|FG000|Overall Study|Adverse Event|117|||
162920618|NCT05643573|588410865|FG001|Overall Study|Adverse Event|90|||
162920619|NCT05643573|588410864|FG000|Overall Study|Death|53|||
162920620|NCT05643573|588410865|FG001|Overall Study|Death|57|||
162920621|NCT05643573|588410864|FG000|Overall Study|Lost to Follow-up|6|||
162920622|NCT05643573|588410865|FG001|Overall Study|Lost to Follow-up|3|||
162920623|NCT05643573|588410864|FG000|Overall Study|Other|18|||
162920624|NCT05643573|588410865|FG001|Overall Study|Other|15|||
162920625|NCT05643573|588410864|FG000|Overall Study|Outcome event|64|||
162920626|NCT05643573|588410865|FG001|Overall Study|Outcome event|36|||
162920627|NCT05643573|588410864|FG000|Overall Study|Physician Decision|33|||
162920628|NCT05643573|588410865|FG001|Overall Study|Physician Decision|19|||
162920629|NCT05643573|588410864|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
162920630|NCT05643573|588410865|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
162920631|NCT05643573|588410864|FG000|Overall Study|Site terminated by sponsor|10|||
162920632|NCT05643573|588410865|FG001|Overall Study|Site terminated by sponsor|10|||
162920633|NCT05643573|588410864|FG000|Overall Study|Study terminated by sponsor|1|||
162920634|NCT05643573|588410865|FG001|Overall Study|Study terminated by sponsor|0|||
162920635|NCT05643573|588410864|FG000|Overall Study|Withdrawal by Subject|178|||
162920636|NCT05643573|588410865|FG001|Overall Study|Withdrawal by Subject|130|||
162920637|NCT02268214|588410869|FG000|Overall Study|Subject no longer meets study criteria|0|||
162920638|NCT02268214|588410870|FG001|Overall Study|Subject no longer meets study criteria|2|||
162920639|NCT02268214|588410871|FG002|Overall Study|Subject no longer meets study criteria|0|||
162920640|NCT02268214|588410869|FG000|Overall Study|Pregnancy|2|||
162920641|NCT02268214|588410870|FG001|Overall Study|Pregnancy|2|||
162920642|NCT02268214|588410871|FG002|Overall Study|Pregnancy|1|||
162920643|NCT02268214|588410869|FG000|Overall Study|Lost to Follow-up|3|||
162920644|NCT02268214|588410870|FG001|Overall Study|Lost to Follow-up|3|||
162920645|NCT02268214|588410871|FG002|Overall Study|Lost to Follow-up|4|||
162920646|NCT02268214|588410869|FG000|Overall Study|Lack of Efficacy|1|||
162920647|NCT02268214|588410870|FG001|Overall Study|Lack of Efficacy|0|||
162920648|NCT02268214|588410871|FG002|Overall Study|Lack of Efficacy|2|||
162920649|NCT02268214|588410869|FG000|Overall Study|Adverse Event|11|||
162920650|NCT02268214|588410870|FG001|Overall Study|Adverse Event|14|||
162920651|NCT02268214|588410871|FG002|Overall Study|Adverse Event|9|||
162920652|NCT02268214|588410869|FG000|Overall Study|Withdrawal by Subject|4|||
162920653|NCT02268214|588410870|FG001|Overall Study|Withdrawal by Subject|5|||
162920654|NCT02268214|588410871|FG002|Overall Study|Withdrawal by Subject|10|||
162920655|NCT02268214|588410869|FG000|Overall Study|Subject request to discontinue treatment|10|||
162920656|NCT02268214|588410870|FG001|Overall Study|Subject request to discontinue treatment|8|||
162920657|NCT02268214|588410871|FG002|Overall Study|Subject request to discontinue treatment|6|||
162970375|NCT00631007|588593853|FG000|Overall Study|Adverse Event|0|||
162970376|NCT00631007|588593854|FG001|Overall Study|Adverse Event|2|||
162970377|NCT00631007|588593855|FG002|Overall Study|Adverse Event|0|||
162970378|NCT00631007|588593856|FG003|Overall Study|Adverse Event|2|||
162970379|NCT00631007|588593857|FG004|Overall Study|Adverse Event|3|||
162970380|NCT00631007|588593858|FG005|Overall Study|Adverse Event|2|||
162970381|NCT00631007|588593853|FG000|Overall Study|Lost to Follow-up|2|||
162970382|NCT00631007|588593854|FG001|Overall Study|Lost to Follow-up|1|||
162970383|NCT00631007|588593855|FG002|Overall Study|Lost to Follow-up|2|||
162970384|NCT00631007|588593856|FG003|Overall Study|Lost to Follow-up|4|||
162970385|NCT00631007|588593857|FG004|Overall Study|Lost to Follow-up|5|||
162970386|NCT00631007|588593858|FG005|Overall Study|Lost to Follow-up|3|||
162970387|NCT00631007|588593853|FG000|Overall Study|Physician Decision|1|||
162970388|NCT00631007|588593854|FG001|Overall Study|Physician Decision|0|||
162970389|NCT00631007|588593855|FG002|Overall Study|Physician Decision|1|||
162970390|NCT00631007|588593856|FG003|Overall Study|Physician Decision|0|||
162970391|NCT00631007|588593857|FG004|Overall Study|Physician Decision|0|||
162970392|NCT00631007|588593858|FG005|Overall Study|Physician Decision|2|||
162970393|NCT00631007|588593853|FG000|Overall Study|Persistent Hyperglycemia|2|||
162970394|NCT00631007|588593854|FG001|Overall Study|Persistent Hyperglycemia|2|||
162970395|NCT00631007|588593855|FG002|Overall Study|Persistent Hyperglycemia|5|||
162970396|NCT00631007|588593856|FG003|Overall Study|Persistent Hyperglycemia|1|||
162970397|NCT00631007|588593857|FG004|Overall Study|Persistent Hyperglycemia|2|||
162970398|NCT00631007|588593858|FG005|Overall Study|Persistent Hyperglycemia|5|||
162970399|NCT00631007|588593853|FG000|Overall Study|Withdrawal by Subject|4|||
162970400|NCT00631007|588593854|FG001|Overall Study|Withdrawal by Subject|5|||
162970401|NCT00631007|588593855|FG002|Overall Study|Withdrawal by Subject|2|||
162970402|NCT00631007|588593856|FG003|Overall Study|Withdrawal by Subject|2|||
162970403|NCT00631007|588593857|FG004|Overall Study|Withdrawal by Subject|1|||
162970404|NCT00631007|588593858|FG005|Overall Study|Withdrawal by Subject|3|||
162970405|NCT00631007|588593853|FG000|Overall Study|Other|2|||
162970406|NCT00631007|588593854|FG001|Overall Study|Other|1|||
162970407|NCT00631007|588593855|FG002|Overall Study|Other|0|||
162970408|NCT00631007|588593856|FG003|Overall Study|Other|0|||
162970409|NCT00631007|588593857|FG004|Overall Study|Other|1|||
162970410|NCT00631007|588593858|FG005|Overall Study|Other|0|||
162970411|NCT02674633|588593859|FG000|Overall Study|Lost to Follow-up|3|||
162970412|NCT02674633|588593860|FG001|Overall Study|Lost to Follow-up|2|||
162970413|NCT02674633|588593859|FG000|Overall Study|Physician Decision|1|||
162970414|NCT02674633|588593860|FG001|Overall Study|Physician Decision|0|||
162970415|NCT02674633|588593859|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162970416|NCT02674633|588593860|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162970417|NCT00683787|588593861|FG000|Overall Study|Progression|3|||
162970418|NCT00683787|588593862|FG001|Overall Study|Progression|3|||
162970419|NCT00683787|588593863|FG002|Overall Study|Progression|0|||
162970420|NCT00683787|588593861|FG000|Overall Study|Adverse Event|0|||
162970421|NCT00683787|588593862|FG001|Overall Study|Adverse Event|0|||
162970422|NCT00683787|588593863|FG002|Overall Study|Adverse Event|2|||
162970423|NCT01235715|588593864|FG000|Overall Study|Physician Decision|0|||
162970424|NCT01235715|588593865|FG001|Overall Study|Physician Decision|2|||
162970425|NCT02344745|588593866|FG000|Overall Study|Data collection sheets were lost|2|||
162970426|NCT02344745|588593867|FG001|Overall Study|Data collection sheets were lost|0|||
162970427|NCT02788513|588593868|FG000|Overall Study|Withdrawal by Subject|3|||
162970428|NCT02788513|588593869|FG001|Overall Study|Withdrawal by Subject|0|||
162970429|NCT02788513|588593870|FG002|Overall Study|Withdrawal by Subject|2|||
162970430|NCT02788513|588593871|FG003|Overall Study|Withdrawal by Subject|3|||
162970431|NCT02788513|588593872|FG004|Overall Study|Withdrawal by Subject|1|||
162970432|NCT02788513|588593868|FG000|Overall Study|Lost to Follow-up|1|||
162970433|NCT02788513|588593869|FG001|Overall Study|Lost to Follow-up|0|||
162970434|NCT02788513|588593870|FG002|Overall Study|Lost to Follow-up|0|||
162970435|NCT02788513|588593871|FG003|Overall Study|Lost to Follow-up|0|||
162970436|NCT02788513|588593872|FG004|Overall Study|Lost to Follow-up|1|||
162970437|NCT02788513|588593868|FG000|Overall Study|Adverse Event|5|||
162970438|NCT02788513|588593869|FG001|Overall Study|Adverse Event|8|||
162970439|NCT02788513|588593870|FG002|Overall Study|Adverse Event|4|||
162970440|NCT02788513|588593871|FG003|Overall Study|Adverse Event|2|||
162970441|NCT02788513|588593872|FG004|Overall Study|Adverse Event|2|||
162970442|NCT02788513|588593868|FG000|Overall Study|Protocol Violation|0|||
162970443|NCT02788513|588593869|FG001|Overall Study|Protocol Violation|0|||
162970444|NCT02788513|588593870|FG002|Overall Study|Protocol Violation|1|||
162970445|NCT02788513|588593871|FG003|Overall Study|Protocol Violation|1|||
162970446|NCT02788513|588593872|FG004|Overall Study|Protocol Violation|0|||
162970447|NCT02788513|588593868|FG000|Overall Study|Subject decided to stop taking treatment|0|||
162970448|NCT02788513|588593869|FG001|Overall Study|Subject decided to stop taking treatment|0|||
162970449|NCT02788513|588593870|FG002|Overall Study|Subject decided to stop taking treatment|1|||
162970450|NCT02788513|588593871|FG003|Overall Study|Subject decided to stop taking treatment|0|||
162970451|NCT02788513|588593872|FG004|Overall Study|Subject decided to stop taking treatment|0|||
162970452|NCT02788513|588593868|FG000|Overall Study|Decision by the study team|0|||
162970453|NCT02788513|588593869|FG001|Overall Study|Decision by the study team|0|||
162970454|NCT02788513|588593870|FG002|Overall Study|Decision by the study team|0|||
162970455|NCT02788513|588593871|FG003|Overall Study|Decision by the study team|0|||
162970456|NCT02788513|588593872|FG004|Overall Study|Decision by the study team|1|||
162970457|NCT03230487|588593876|FG000|Overall Study|Adverse Event|0|||
162970458|NCT03230487|588593877|FG001|Overall Study|Adverse Event|0|||
162970459|NCT03230487|588593878|FG002|Overall Study|Adverse Event|0|||
162970460|NCT03230487|588593879|FG003|Overall Study|Adverse Event|1|||
162970461|NCT03230487|588593880|FG004|Overall Study|Adverse Event|0|||
162970462|NCT03230487|588593881|FG005|Overall Study|Adverse Event|0|||
162970463|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
162970464|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
162970465|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
162970466|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
162970467|NCT01933919|588593889|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
162970468|NCT01933919|588593890|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
162970469|NCT01933919|588593889|FG000|Open-label Long-term Phase|Adverse Event|2|||
162970470|NCT01933919|588593890|FG001|Open-label Long-term Phase|Adverse Event|0|||
162970471|NCT01933919|588593889|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
162970472|NCT01933919|588593890|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
162970473|NCT01933919|588593889|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
162712452|NCT02001623|587658503|FG004|Overall Study|Death|0|||
163056178|NCT03435055|588918360|FG000|Screening|Physician Decision|2|||
163056179|NCT03435055|588918360|FG000|Received Intervention|Did not complete nitrous administration|3|||
163056180|NCT02732639|588918366|FG000|Overall Study|Lost to Follow-up|1|||
163056181|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
163056182|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
163056183|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
163056184|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
162970474|NCT01933919|588593890|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
163056185|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
163056186|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056187|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056188|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
163056189|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
163056190|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
163056191|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
163056192|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
163056193|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
163056194|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056195|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056196|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
163056197|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
163056198|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
163056199|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
163056200|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
163056201|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
163056202|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
163056203|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
162712453|NCT02001623|587658504|FG005|Overall Study|Death|0|||
162970475|NCT01933919|588593889|FG000|Open-label Long-term Phase|Other|1|||
162970476|NCT01933919|588593890|FG001|Open-label Long-term Phase|Other|2|||
162970477|NCT01961882|588593891|FG000|Overall Study|Adverse Event|3|||
162970478|NCT01961882|588593892|FG001|Overall Study|Adverse Event|2|||
162970479|NCT01961882|588593891|FG000|Overall Study|Physician Decision|1|||
162970480|NCT01961882|588593892|FG001|Overall Study|Physician Decision|0|||
162970481|NCT01961882|588593891|FG000|Overall Study|Withdrawal by Subject|4|||
162970482|NCT01961882|588593892|FG001|Overall Study|Withdrawal by Subject|1|||
162970483|NCT01961882|588593891|FG000|Overall Study|Relapse of AML|39|||
162970484|NCT01961882|588593892|FG001|Overall Study|Relapse of AML|37|||
162970485|NCT01961882|588593891|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
162970486|NCT01961882|588593892|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
162970487|NCT01961882|588593891|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
162970488|NCT01961882|588593892|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
162970489|NCT01901848|588593893|FG000|Randomized and Treated|Lost to Follow-up|3|||
162970490|NCT01901848|588593894|FG001|Randomized and Treated|Lost to Follow-up|6|||
162970491|NCT01901848|588593893|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
162970492|NCT01901848|588593894|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
162970493|NCT02575339|588593895|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
162970494|NCT02575339|588593896|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162970495|NCT02575339|588593897|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162970496|NCT02575339|588593895|FG000|Study Treatment|Disease Progression|5|||
162970497|NCT02575339|588593896|FG001|Study Treatment|Disease Progression|2|||
162970498|NCT02575339|588593897|FG002|Study Treatment|Disease Progression|0|||
162970499|NCT02575339|588593895|FG000|Study Treatment|Adverse Event|1|||
162970500|NCT02575339|588593896|FG001|Study Treatment|Adverse Event|2|||
162970501|NCT02575339|588593897|FG002|Study Treatment|Adverse Event|0|||
162970502|NCT02575339|588593895|FG000|Follow up|Death|6|||
162970503|NCT02575339|588593896|FG001|Follow up|Death|2|||
162970504|NCT02575339|588593897|FG002|Follow up|Death|0|||
162970505|NCT02575339|588593895|FG000|Follow up|Study Terminated|0|||
162970506|NCT02575339|588593896|FG001|Follow up|Study Terminated|2|||
162970507|NCT02575339|588593897|FG002|Follow up|Study Terminated|0|||
163056204|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
162970508|NCT02575339|588593895|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
163056205|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
163056206|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056207|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056208|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
163056209|NCT01668797|588918367|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
162970509|NCT02575339|588593896|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
162970510|NCT02575339|588593897|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
162970511|NCT01270620|588593898|FG000|Overall Study|Withdrawal by Subject|1|||
162920658|NCT02268214|588410869|FG000|Overall Study|Poor/non-compliance|2|||
163056210|NCT01668797|588918368|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056211|NCT01668797|588918369|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056212|NCT01668797|588918370|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
163056213|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056214|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
163056215|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056216|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
163056217|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056218|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
163056219|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056220|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
163056221|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
163056222|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
163056223|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
163056224|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
163056225|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056226|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
163056227|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056228|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
163056229|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056230|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
163056231|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056232|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
163056233|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056234|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
163056235|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056236|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
163056237|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056238|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
163056239|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056240|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
163056241|NCT01668797|588918367|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056242|NCT01668797|588918368|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
163056243|NCT01668797|588918369|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056244|NCT01668797|588918370|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
163056245|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
163056246|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
163056247|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
163056248|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
163056249|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
163056250|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
163056251|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
163056252|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
163056253|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
163056254|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
163056255|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
163056256|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
163056257|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
163056258|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
163056259|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
163056260|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
163056261|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
163056262|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
163056263|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
163056264|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
162920659|NCT02268214|588410870|FG001|Overall Study|Poor/non-compliance|1|||
162920660|NCT02268214|588410871|FG002|Overall Study|Poor/non-compliance|2|||
163056265|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
163056266|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
163056267|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
163056268|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
162629970|NCT00968201|587362682|FG002|Base Study - (Period II)|Protocol Violation|12|||
162629971|NCT00968201|587362680|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
162712454|NCT02001623|587658505|FG006|Overall Study|Death|0|||
162712455|NCT02001623|587658506|FG007|Overall Study|Death|0|||
162712456|NCT02001623|587658507|FG008|Overall Study|Death|0|||
162712457|NCT02001623|587658508|FG009|Overall Study|Death|0|||
162712458|NCT02001623|587658509|FG010|Overall Study|Death|0|||
162712459|NCT02001623|587658510|FG011|Overall Study|Death|0|||
162712460|NCT02001623|587658511|FG012|Overall Study|Death|0|||
162920661|NCT02268214|588410869|FG000|Overall Study|Other reasons|7|||
162920662|NCT02268214|588410870|FG001|Overall Study|Other reasons|3|||
162920663|NCT02268214|588410871|FG002|Overall Study|Other reasons|3|||
162920664|NCT02268214|588410869|FG000|Overall Study|Not entering long-term period|2|||
162920665|NCT02268214|588410870|FG001|Overall Study|Not entering long-term period|3|||
162920666|NCT02268214|588410871|FG002|Overall Study|Not entering long-term period|5|||
162920667|NCT02951130|588410872|FG000|Overall Study|Protocol Violation|1|||
162920668|NCT02951130|588410873|FG001|Overall Study|Protocol Violation|1|||
162920669|NCT02500732|588410875|FG000|Overall Study|Physician Decision|0|||
162920670|NCT02500732|588410876|FG001|Overall Study|Physician Decision|1|||
162920671|NCT03205605|588410879|FG000|Overall Study|Withdrawal by Subject|1|||
162920672|NCT01233284|588410887|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
162920673|NCT01233284|588410888|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162920674|NCT01233284|588410889|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162920675|NCT01233284|588410890|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162920676|NCT01233284|588410891|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162920677|NCT01233284|588410887|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162920678|NCT01233284|588410888|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
162920679|NCT01233284|588410889|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162920680|NCT01233284|588410890|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162920681|NCT01233284|588410891|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162920682|NCT01233284|588410887|FG000|Period 1 (4 Weeks)|Other|0|||
162920683|NCT01233284|588410888|FG001|Period 1 (4 Weeks)|Other|0|||
162920684|NCT01233284|588410889|FG002|Period 1 (4 Weeks)|Other|1|||
162920685|NCT01233284|588410890|FG003|Period 1 (4 Weeks)|Other|0|||
162920686|NCT01233284|588410891|FG004|Period 1 (4 Weeks)|Other|0|||
162920687|NCT01233284|588410887|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162920688|NCT01233284|588410888|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162920689|NCT01233284|588410889|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
162920690|NCT01233284|588410890|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162920691|NCT01233284|588410891|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162920692|NCT01233284|588410887|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
162920693|NCT01233284|588410888|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
162920694|NCT01233284|588410889|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
162920695|NCT01233284|588410890|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
162920696|NCT01233284|588410891|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
162920697|NCT01233284|588410887|FG000|Period 3 (4 Weeks)|Other|0|||
162920698|NCT01233284|588410888|FG001|Period 3 (4 Weeks)|Other|0|||
162920699|NCT01233284|588410889|FG002|Period 3 (4 Weeks)|Other|0|||
162920700|NCT01233284|588410890|FG003|Period 3 (4 Weeks)|Other|1|||
162920701|NCT01233284|588410891|FG004|Period 3 (4 Weeks)|Other|0|||
162920702|NCT01233284|588410887|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
162920703|NCT01233284|588410888|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
162920704|NCT01233284|588410889|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
162920705|NCT01233284|588410890|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
162920706|NCT01233284|588410891|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
162920707|NCT01233284|588410887|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
162920708|NCT01233284|588410888|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
162920709|NCT01233284|588410889|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
162920710|NCT01233284|588410890|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
162920711|NCT01233284|588410891|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
162920712|NCT03759340|588410892|FG000|Overall Study|Adverse Event|2|||
162920713|NCT03759340|588410892|FG000|Overall Study|Lost to Follow-up|1|||
162920714|NCT03759340|588410892|FG000|Overall Study|Withdrawal by Subject|15|||
162920715|NCT03759340|588410892|FG000|Overall Study|Study Terminated by Sponsor|38|||
162920716|NCT01003691|588410893|FG000|Overall Study|Adverse Event|0|||
162920717|NCT01003691|588410894|FG001|Overall Study|Adverse Event|0|||
162920718|NCT01003691|588410895|FG002|Overall Study|Adverse Event|0|||
162920719|NCT01003691|588410896|FG003|Overall Study|Adverse Event|1|||
162920720|NCT01869959|588410900|FG000|Randomization Period|Physician Decision|0|||
162920721|NCT01869959|588410901|FG001|Randomization Period|Physician Decision|0|||
162920722|NCT01869959|588410902|FG002|Randomization Period|Physician Decision|0|||
162920723|NCT01869959|588410903|FG003|Randomization Period|Physician Decision|0|||
162920724|NCT01869959|588410904|FG004|Randomization Period|Physician Decision|1|||
162920725|NCT01869959|588410900|FG000|Treatment Period|Adverse Event|1|||
162920726|NCT01869959|588410901|FG001|Treatment Period|Adverse Event|0|||
162920727|NCT01869959|588410902|FG002|Treatment Period|Adverse Event|3|||
162920728|NCT01869959|588410903|FG003|Treatment Period|Adverse Event|1|||
162712461|NCT02001623|587658512|FG013|Overall Study|Death|0|||
162712462|NCT02001623|587658513|FG014|Overall Study|Death|0|||
162920729|NCT01869959|588410904|FG004|Treatment Period|Adverse Event|0|||
162920730|NCT01869959|588410900|FG000|Treatment Period|Sponsor decision|0|||
162920731|NCT01869959|588410901|FG001|Treatment Period|Sponsor decision|1|||
163056269|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
163056270|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
163056271|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
163056272|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
163056273|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
163056274|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
163056275|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
163056276|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
163056277|NCT01668797|588918367|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
163056278|NCT01668797|588918368|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
163056279|NCT01668797|588918369|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
163056280|NCT01668797|588918370|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
163056281|NCT00827567|588918371|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
163056282|NCT03502798|588918374|FG000|Overall Study|equipment failure|0|||
162920732|NCT01869959|588410902|FG002|Treatment Period|Sponsor decision|0|||
162920733|NCT01869959|588410903|FG003|Treatment Period|Sponsor decision|1|||
162920734|NCT01869959|588410904|FG004|Treatment Period|Sponsor decision|0|||
162920735|NCT01869959|588410900|FG000|Treatment Period|Withdrawal by Subject|0|||
162920736|NCT01869959|588410901|FG001|Treatment Period|Withdrawal by Subject|1|||
162920737|NCT01869959|588410902|FG002|Treatment Period|Withdrawal by Subject|0|||
162920738|NCT01869959|588410903|FG003|Treatment Period|Withdrawal by Subject|0|||
162920739|NCT01869959|588410904|FG004|Treatment Period|Withdrawal by Subject|0|||
162920743|NCT00157820|588410917|FG000|Randomized|Physician Decision|4|||
162920744|NCT00157820|588410918|FG001|Randomized|Physician Decision|2|||
162920745|NCT00157820|588410919|FG002|Randomized|Physician Decision|3|||
162920746|NCT00157820|588410917|FG000|Randomized|Withdrawal by Subject|1|||
162920747|NCT00157820|588410918|FG001|Randomized|Withdrawal by Subject|2|||
162920748|NCT00157820|588410919|FG002|Randomized|Withdrawal by Subject|3|||
162920749|NCT00157820|588410917|FG000|Randomized|Protocol Violation|2|||
162920750|NCT00157820|588410918|FG001|Randomized|Protocol Violation|1|||
162920751|NCT00157820|588410919|FG002|Randomized|Protocol Violation|2|||
162920752|NCT00157820|588410917|FG000|1st 8 Month|Death|7|||
162920753|NCT00157820|588410918|FG001|1st 8 Month|Death|8|||
162920754|NCT00157820|588410919|FG002|1st 8 Month|Death|3|||
162920755|NCT00157820|588410917|FG000|1st 8 Month|Lost to Follow-up|1|||
162920756|NCT00157820|588410918|FG001|1st 8 Month|Lost to Follow-up|2|||
162970512|NCT01270620|588593899|FG001|Overall Study|Withdrawal by Subject|3|||
162970513|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
162970514|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
162970515|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
162970516|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
162970517|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
162970518|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
162970519|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
162970520|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
162970521|NCT01045707|588593900|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
162970522|NCT01045707|588593901|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
162970523|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
162970524|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
162970525|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
162970526|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
162629972|NCT00968201|587362681|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
162629973|NCT00968201|587362682|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
162629974|NCT00968201|587362680|FG000|Base Study - (Period II)|Site Error|0|||
162629975|NCT00968201|587362681|FG001|Base Study - (Period II)|Site Error|0|||
162970527|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
162970528|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
162970529|NCT01045707|588593900|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
162970530|NCT01045707|588593901|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
162920757|NCT00157820|588410919|FG002|1st 8 Month|Lost to Follow-up|1|||
162920758|NCT00157820|588410917|FG000|1st 8 Month|Premature cross-over|0|||
162920759|NCT00157820|588410918|FG001|1st 8 Month|Premature cross-over|2|||
162920760|NCT00157820|588410919|FG002|1st 8 Month|Premature cross-over|2|||
162920761|NCT00157820|588410917|FG000|2nd 8 Months|Death|3|||
162920762|NCT00157820|588410918|FG001|2nd 8 Months|Death|1|||
162920763|NCT00157820|588410919|FG002|2nd 8 Months|Death|3|||
162920764|NCT00157820|588410917|FG000|2nd 8 Months|Lost to Follow-up|1|||
162920765|NCT00157820|588410918|FG001|2nd 8 Months|Lost to Follow-up|5|||
162920766|NCT00157820|588410919|FG002|2nd 8 Months|Lost to Follow-up|2|||
162920767|NCT00157820|588410917|FG000|2nd 8 Months|Premature cross-over|1|||
162920768|NCT00157820|588410918|FG001|2nd 8 Months|Premature cross-over|7|||
162920769|NCT00157820|588410919|FG002|2nd 8 Months|Premature cross-over|9|||
162920770|NCT01676818|588410920|FG000|Overall Study|Physician Decision|1|||
162920771|NCT01676818|588410920|FG000|Overall Study|Withdrawal by Subject|1|||
162920772|NCT02207413|588410928|FG000|Overall Study|Withdrawal by Subject|1|||
162920773|NCT02207413|588410929|FG001|Overall Study|Withdrawal by Subject|0|||
162920774|NCT02207413|588410930|FG002|Overall Study|Withdrawal by Subject|0|||
162920775|NCT02207413|588410931|FG003|Overall Study|Withdrawal by Subject|0|||
162920776|NCT02207413|588410932|FG004|Overall Study|Withdrawal by Subject|3|||
162920777|NCT02207413|588410933|FG005|Overall Study|Withdrawal by Subject|7|||
162920778|NCT02207413|588410928|FG000|Overall Study|Lost to Follow-up|0|||
162920779|NCT02207413|588410929|FG001|Overall Study|Lost to Follow-up|0|||
162920780|NCT02207413|588410930|FG002|Overall Study|Lost to Follow-up|0|||
162920781|NCT02207413|588410931|FG003|Overall Study|Lost to Follow-up|1|||
162920782|NCT02207413|588410932|FG004|Overall Study|Lost to Follow-up|1|||
162920783|NCT02207413|588410933|FG005|Overall Study|Lost to Follow-up|5|||
162920784|NCT02207413|588410928|FG000|Overall Study|Adverse Event|0|||
162920785|NCT02207413|588410929|FG001|Overall Study|Adverse Event|0|||
162920786|NCT02207413|588410930|FG002|Overall Study|Adverse Event|0|||
162920787|NCT02207413|588410931|FG003|Overall Study|Adverse Event|0|||
162920788|NCT02207413|588410932|FG004|Overall Study|Adverse Event|2|||
162920789|NCT02207413|588410933|FG005|Overall Study|Adverse Event|1|||
162920790|NCT02207413|588410928|FG000|Overall Study|Migrated/moved from study area|0|||
162920791|NCT02207413|588410929|FG001|Overall Study|Migrated/moved from study area|0|||
162920792|NCT02207413|588410930|FG002|Overall Study|Migrated/moved from study area|0|||
162920793|NCT02207413|588410931|FG003|Overall Study|Migrated/moved from study area|0|||
162920794|NCT02207413|588410932|FG004|Overall Study|Migrated/moved from study area|1|||
162920795|NCT02207413|588410933|FG005|Overall Study|Migrated/moved from study area|0|||
162920796|NCT04075656|588410934|FG000|Overall Study|Withdrawal by Subject|5|||
162920797|NCT04075656|588410935|FG001|Overall Study|Withdrawal by Subject|5|||
162920798|NCT01519635|588412802|FG000|Overall Study|Withdrawal by Subject|0|||
162920799|NCT01519635|588412803|FG001|Overall Study|Withdrawal by Subject|1|||
162920800|NCT01519635|588412802|FG000|Overall Study|No possibility to put a catheter|1|||
162920801|NCT01519635|588412803|FG001|Overall Study|No possibility to put a catheter|2|||
162920802|NCT00347776|588412804|FG000|1.5 Month Follow-up|Death|2|||
162920803|NCT00347776|588412805|FG001|1.5 Month Follow-up|Death|0|||
162920804|NCT00347776|588412806|FG002|1.5 Month Follow-up|Death|0|||
162920805|NCT00347776|588412804|FG000|1.5 Month Follow-up|reached the endpoint|12|||
162920806|NCT00347776|588412805|FG001|1.5 Month Follow-up|reached the endpoint|8|||
162920807|NCT00347776|588412806|FG002|1.5 Month Follow-up|reached the endpoint|12|||
162920808|NCT00347776|588412804|FG000|6 Month Follow-up|Death|2|||
162920809|NCT00347776|588412805|FG001|6 Month Follow-up|Death|1|||
162920810|NCT00347776|588412806|FG002|6 Month Follow-up|Death|3|||
162920811|NCT00347776|588412804|FG000|6 Month Follow-up|reached endpont|20|||
162920812|NCT00347776|588412805|FG001|6 Month Follow-up|reached endpont|12|||
162920813|NCT00347776|588412806|FG002|6 Month Follow-up|reached endpont|15|||
162920814|NCT00347776|588412804|FG000|12 Month Follow-up|Lost to Follow-up|7|||
162920815|NCT00347776|588412805|FG001|12 Month Follow-up|Lost to Follow-up|6|||
162920816|NCT00347776|588412806|FG002|12 Month Follow-up|Lost to Follow-up|6|||
162920817|NCT00347776|588412804|FG000|12 Month Follow-up|Death|3|||
162920818|NCT00347776|588412805|FG001|12 Month Follow-up|Death|4|||
162920819|NCT00347776|588412806|FG002|12 Month Follow-up|Death|4|||
162920820|NCT00347776|588412804|FG000|12 Month Follow-up|Reached endpoint|13|||
162920821|NCT00347776|588412805|FG001|12 Month Follow-up|Reached endpoint|6|||
162920822|NCT00347776|588412806|FG002|12 Month Follow-up|Reached endpoint|9|||
162920823|NCT00968539|588412807|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
163056283|NCT03502798|588918375|FG001|Overall Study|equipment failure|7|||
163056284|NCT00062166|588918379|FG000|Overall Study|Withdrawal by Subject|6|||
163056285|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
163056286|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
162920824|NCT00968539|588412808|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162920825|NCT02074982|588412809|FG000|Overall Study|Adverse Event|15|||
162920826|NCT02074982|588412810|FG001|Overall Study|Adverse Event|7|||
162920827|NCT02074982|588412809|FG000|Overall Study|Lack of Efficacy|6|||
163056287|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
162920828|NCT02074982|588412810|FG001|Overall Study|Lack of Efficacy|1|||
162920829|NCT02074982|588412809|FG000|Overall Study|Lost to Follow-up|9|||
162920830|NCT02074982|588412810|FG001|Overall Study|Lost to Follow-up|10|||
162920831|NCT02074982|588412809|FG000|Overall Study|Non-compliance with study treatment|0|||
162920832|NCT02074982|588412810|FG001|Overall Study|Non-compliance with study treatment|2|||
162920833|NCT02074982|588412809|FG000|Overall Study|Physician Decision|1|||
162920834|NCT02074982|588412810|FG001|Overall Study|Physician Decision|1|||
162920835|NCT02074982|588412809|FG000|Overall Study|Pregnancy|1|||
162920836|NCT02074982|588412810|FG001|Overall Study|Pregnancy|2|||
162920837|NCT02074982|588412809|FG000|Overall Study|Protocol deviation|4|||
162920838|NCT02074982|588412810|FG001|Overall Study|Protocol deviation|3|||
162920839|NCT02074982|588412809|FG000|Overall Study|Technical problems|0|||
162920840|NCT02074982|588412810|FG001|Overall Study|Technical problems|2|||
162920841|NCT02074982|588412809|FG000|Overall Study|Subject/guardian decision|15|||
162920842|NCT02074982|588412810|FG001|Overall Study|Subject/guardian decision|24|||
162920843|NCT02074982|588412809|FG000|Overall Study|Death|0|||
162920844|NCT02074982|588412810|FG001|Overall Study|Death|2|||
162920845|NCT02525627|588412815|FG000|Overall Study|Revision|1|||
162920846|NCT02525627|588412816|FG001|Overall Study|Revision|1|||
162920847|NCT02525627|588412815|FG000|Overall Study|Withdrawal by Subject|1|||
162920848|NCT02525627|588412816|FG001|Overall Study|Withdrawal by Subject|2|||
162920849|NCT02525627|588412815|FG000|Overall Study|Death|1|||
162920850|NCT02525627|588412816|FG001|Overall Study|Death|0|||
162920851|NCT02525627|588412815|FG000|Overall Study|Site terminated|11|||
162920852|NCT02525627|588412816|FG001|Overall Study|Site terminated|10|||
162920853|NCT02116309|588412831|FG000|Overall Study|Lost to Follow-up|0|||
162920854|NCT02116309|588412832|FG001|Overall Study|Lost to Follow-up|1|||
162920855|NCT03292731|588412833|FG000|Overall Study|Protocol Violation|4|||
162920856|NCT03292731|588412834|FG001|Overall Study|Protocol Violation|11|||
162920857|NCT03292731|588412835|FG002|Overall Study|Protocol Violation|1|||
162920858|NCT00471237|588412836|FG000|Overall Study|Adverse Event|6|||
162920859|NCT00471237|588412837|FG001|Overall Study|Adverse Event|5|||
162920860|NCT00471237|588412838|FG002|Overall Study|Adverse Event|4|||
162920861|NCT00471237|588412839|FG003|Overall Study|Adverse Event|8|||
162920862|NCT00471237|588412840|FG004|Overall Study|Adverse Event|7|||
162970531|NCT00348816|588593902|FG000|Overall Study|Noncompliance with radiation treatment|1|||
162970532|NCT00809965|588593903|FG000|Overall Study|Death|194|||
162970533|NCT00809965|588593904|FG001|Overall Study|Death|147|||
162970534|NCT00809965|588593905|FG002|Overall Study|Death|196|||
162970535|NCT00809965|588593903|FG000|Overall Study|Lost to Follow-up|17|||
162970536|NCT00809965|588593904|FG001|Overall Study|Lost to Follow-up|10|||
162970537|NCT00809965|588593905|FG002|Overall Study|Lost to Follow-up|18|||
162970538|NCT00809965|588593903|FG000|Overall Study|Withdrawal by Subject|405|||
162970539|NCT00809965|588593904|FG001|Overall Study|Withdrawal by Subject|448|||
162970540|NCT00809965|588593905|FG002|Overall Study|Withdrawal by Subject|441|||
162970541|NCT00809965|588593903|FG000|Overall Study|Other Reason|167|||
162970542|NCT00809965|588593904|FG001|Overall Study|Other Reason|170|||
162970543|NCT00809965|588593905|FG002|Overall Study|Other Reason|189|||
162970544|NCT05552261|588593906|FG000|Overall Study|Withdrawal by Subject|1|||
162970545|NCT05552261|588593906|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
162970546|NCT04886063|588593909|FG000|Overall Study|Adverse Event|50|||
162970547|NCT04886063|588593909|FG000|Overall Study|Lack of Efficacy|31|||
162970548|NCT04886063|588593909|FG000|Overall Study|Withdrawal by Subject|45|||
162970549|NCT04886063|588593909|FG000|Overall Study|Physician Decision|3|||
162970550|NCT04886063|588593909|FG000|Overall Study|Protocol Violation|3|||
162970551|NCT04886063|588593909|FG000|Overall Study|Site closure|4|||
162970552|NCT04886063|588593909|FG000|Overall Study|Nursing home replacement|3|||
162970553|NCT04886063|588593909|FG000|Overall Study|Lost to Follow-up|5|||
162970554|NCT04886063|588593909|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
162970555|NCT04886063|588593909|FG000|Overall Study|>1 reason|20|||
162970556|NCT01628549|588593910|FG000|Overall Study|Adverse Event|1|||
162970557|NCT01628549|588593911|FG001|Overall Study|Adverse Event|1|||
162970558|NCT01628549|588593912|FG002|Overall Study|Adverse Event|0|||
162970559|NCT01628549|588593913|FG003|Overall Study|Adverse Event|4|||
162970560|NCT01628549|588593910|FG000|Overall Study|Lost to Follow-up|3|||
162970561|NCT01628549|588593911|FG001|Overall Study|Lost to Follow-up|4|||
162970562|NCT01628549|588593912|FG002|Overall Study|Lost to Follow-up|3|||
162970563|NCT01628549|588593913|FG003|Overall Study|Lost to Follow-up|3|||
162970564|NCT01628549|588593910|FG000|Overall Study|Withdrawal by Subject|3|||
162970565|NCT01628549|588593911|FG001|Overall Study|Withdrawal by Subject|4|||
162712463|NCT02001623|587658499|FG000|Overall Study|Adverse Event|0|||
162920863|NCT00471237|588412841|FG005|Overall Study|Adverse Event|5|||
162920864|NCT00471237|588412842|FG006|Overall Study|Adverse Event|0|||
162920865|NCT00471237|588412836|FG000|Overall Study|Lost to Follow-up|1|||
162920866|NCT00471237|588412837|FG001|Overall Study|Lost to Follow-up|1|||
162920867|NCT00471237|588412838|FG002|Overall Study|Lost to Follow-up|0|||
162920868|NCT00471237|588412839|FG003|Overall Study|Lost to Follow-up|2|||
162970566|NCT01628549|588593912|FG002|Overall Study|Withdrawal by Subject|4|||
162970567|NCT01628549|588593913|FG003|Overall Study|Withdrawal by Subject|1|||
162970568|NCT01628549|588593910|FG000|Overall Study|Protocol Violation|2|||
162970569|NCT01628549|588593911|FG001|Overall Study|Protocol Violation|1|||
162970570|NCT01628549|588593912|FG002|Overall Study|Protocol Violation|1|||
162970571|NCT01628549|588593913|FG003|Overall Study|Protocol Violation|0|||
162970572|NCT01628549|588593910|FG000|Overall Study|withdrawn for noncompliance|0|||
162970573|NCT01628549|588593911|FG001|Overall Study|withdrawn for noncompliance|2|||
162920869|NCT00471237|588412840|FG004|Overall Study|Lost to Follow-up|3|||
162920870|NCT00471237|588412841|FG005|Overall Study|Lost to Follow-up|0|||
162920871|NCT00471237|588412842|FG006|Overall Study|Lost to Follow-up|0|||
162920872|NCT00471237|588412836|FG000|Overall Study|Protocol Violation|3|||
162920873|NCT00471237|588412837|FG001|Overall Study|Protocol Violation|6|||
162920874|NCT00471237|588412838|FG002|Overall Study|Protocol Violation|3|||
162920875|NCT00471237|588412839|FG003|Overall Study|Protocol Violation|2|||
162920876|NCT00471237|588412840|FG004|Overall Study|Protocol Violation|2|||
162920877|NCT00471237|588412841|FG005|Overall Study|Protocol Violation|4|||
162920878|NCT00471237|588412842|FG006|Overall Study|Protocol Violation|1|||
162920879|NCT00471237|588412836|FG000|Overall Study|Withdrawal by Subject|8|||
162920880|NCT00471237|588412837|FG001|Overall Study|Withdrawal by Subject|6|||
162920881|NCT00471237|588412838|FG002|Overall Study|Withdrawal by Subject|5|||
162920882|NCT00471237|588412839|FG003|Overall Study|Withdrawal by Subject|8|||
162920883|NCT00471237|588412840|FG004|Overall Study|Withdrawal by Subject|7|||
162920884|NCT00471237|588412841|FG005|Overall Study|Withdrawal by Subject|4|||
162920885|NCT00471237|588412842|FG006|Overall Study|Withdrawal by Subject|2|||
162920886|NCT00471237|588412836|FG000|Overall Study|Sponsor terminated study|20|||
162920887|NCT00471237|588412837|FG001|Overall Study|Sponsor terminated study|23|||
162920888|NCT00471237|588412838|FG002|Overall Study|Sponsor terminated study|19|||
162920889|NCT00471237|588412839|FG003|Overall Study|Sponsor terminated study|22|||
162920890|NCT00471237|588412840|FG004|Overall Study|Sponsor terminated study|18|||
162920891|NCT00471237|588412841|FG005|Overall Study|Sponsor terminated study|24|||
162920892|NCT00471237|588412842|FG006|Overall Study|Sponsor terminated study|0|||
162920893|NCT00471237|588412836|FG000|Overall Study|Non-compliance|0|||
162920894|NCT00471237|588412837|FG001|Overall Study|Non-compliance|1|||
162920895|NCT00471237|588412838|FG002|Overall Study|Non-compliance|0|||
162920896|NCT00471237|588412839|FG003|Overall Study|Non-compliance|1|||
162920897|NCT00471237|588412840|FG004|Overall Study|Non-compliance|0|||
162920898|NCT00471237|588412841|FG005|Overall Study|Non-compliance|0|||
162920899|NCT00471237|588412842|FG006|Overall Study|Non-compliance|0|||
162920900|NCT00471237|588412836|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
162920901|NCT00471237|588412837|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
162920902|NCT00471237|588412838|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
162920903|NCT00471237|588412839|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
162920904|NCT00471237|588412840|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
162920905|NCT00471237|588412841|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
162920906|NCT00471237|588412842|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
162920907|NCT00471237|588412836|FG000|Overall Study|Early stopping due to non-efficacy|1|||
162920908|NCT00471237|588412837|FG001|Overall Study|Early stopping due to non-efficacy|0|||
162920909|NCT00471237|588412838|FG002|Overall Study|Early stopping due to non-efficacy|0|||
162920910|NCT00471237|588412839|FG003|Overall Study|Early stopping due to non-efficacy|0|||
162920911|NCT00471237|588412840|FG004|Overall Study|Early stopping due to non-efficacy|1|||
162920912|NCT00471237|588412841|FG005|Overall Study|Early stopping due to non-efficacy|0|||
162920913|NCT00471237|588412842|FG006|Overall Study|Early stopping due to non-efficacy|0|||
162920914|NCT00471237|588412836|FG000|Overall Study|Participant planned to travel to abraod|1|||
162920915|NCT00471237|588412837|FG001|Overall Study|Participant planned to travel to abraod|0|||
162920916|NCT00471237|588412838|FG002|Overall Study|Participant planned to travel to abraod|0|||
162920917|NCT00471237|588412839|FG003|Overall Study|Participant planned to travel to abraod|0|||
162920918|NCT00471237|588412840|FG004|Overall Study|Participant planned to travel to abraod|0|||
162920919|NCT00471237|588412841|FG005|Overall Study|Participant planned to travel to abraod|1|||
162920920|NCT00471237|588412842|FG006|Overall Study|Participant planned to travel to abraod|0|||
162920921|NCT00471237|588412836|FG000|Overall Study|High parathyroid hormone|0|||
162920922|NCT00471237|588412837|FG001|Overall Study|High parathyroid hormone|0|||
162920923|NCT00471237|588412838|FG002|Overall Study|High parathyroid hormone|1|||
162920924|NCT00471237|588412839|FG003|Overall Study|High parathyroid hormone|0|||
162920925|NCT00471237|588412840|FG004|Overall Study|High parathyroid hormone|0|||
162920926|NCT00471237|588412841|FG005|Overall Study|High parathyroid hormone|0|||
162920927|NCT00471237|588412842|FG006|Overall Study|High parathyroid hormone|0|||
162920928|NCT00471237|588412836|FG000|Overall Study|Participant lost medication|0|||
162920929|NCT00471237|588412837|FG001|Overall Study|Participant lost medication|0|||
162920930|NCT00471237|588412838|FG002|Overall Study|Participant lost medication|0|||
162920931|NCT00471237|588412839|FG003|Overall Study|Participant lost medication|0|||
162920932|NCT00471237|588412840|FG004|Overall Study|Participant lost medication|1|||
162920933|NCT00471237|588412841|FG005|Overall Study|Participant lost medication|0|||
162920934|NCT00471237|588412842|FG006|Overall Study|Participant lost medication|0|||
162920935|NCT00471237|588412836|FG000|Overall Study|Administration of prohibited medicine|0|||
162920936|NCT00471237|588412837|FG001|Overall Study|Administration of prohibited medicine|0|||
162920937|NCT00471237|588412838|FG002|Overall Study|Administration of prohibited medicine|0|||
162920938|NCT00471237|588412839|FG003|Overall Study|Administration of prohibited medicine|0|||
162920939|NCT00471237|588412840|FG004|Overall Study|Administration of prohibited medicine|1|||
162920940|NCT00471237|588412841|FG005|Overall Study|Administration of prohibited medicine|0|||
162920941|NCT00471237|588412842|FG006|Overall Study|Administration of prohibited medicine|0|||
162920942|NCT00471237|588412836|FG000|Overall Study|Participant shifted residence|0|||
162920943|NCT00471237|588412837|FG001|Overall Study|Participant shifted residence|0|||
162920944|NCT00471237|588412838|FG002|Overall Study|Participant shifted residence|0|||
162920945|NCT00471237|588412839|FG003|Overall Study|Participant shifted residence|0|||
162920946|NCT00471237|588412840|FG004|Overall Study|Participant shifted residence|1|||
162920947|NCT00471237|588412841|FG005|Overall Study|Participant shifted residence|0|||
162920948|NCT00471237|588412842|FG006|Overall Study|Participant shifted residence|0|||
162920949|NCT00471237|588412836|FG000|Overall Study|Participant's decision|0|||
162920950|NCT00471237|588412837|FG001|Overall Study|Participant's decision|0|||
162920951|NCT00471237|588412838|FG002|Overall Study|Participant's decision|0|||
162920952|NCT00471237|588412839|FG003|Overall Study|Participant's decision|0|||
162920953|NCT00471237|588412840|FG004|Overall Study|Participant's decision|0|||
162920954|NCT00471237|588412841|FG005|Overall Study|Participant's decision|1|||
162920955|NCT00471237|588412842|FG006|Overall Study|Participant's decision|0|||
162920956|NCT00848965|588412843|FG000|Overall Study|Adverse Event|1|||
162920957|NCT00848965|588412843|FG000|Overall Study|Withdrawal by Subject|1|||
162920958|NCT00348348|588412844|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
162920959|NCT00348348|588412845|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
162920960|NCT00348348|588412844|FG000|Overall Study|Lack of Efficacy|1|||
162920961|NCT00348348|588412845|FG001|Overall Study|Lack of Efficacy|1|||
162920962|NCT00348348|588412844|FG000|Overall Study|Lost to Follow-up|8|||
162920963|NCT00348348|588412845|FG001|Overall Study|Lost to Follow-up|10|||
162920964|NCT00348348|588412844|FG000|Overall Study|Withdrawal by Subject|4|||
162920965|NCT00348348|588412845|FG001|Overall Study|Withdrawal by Subject|1|||
162920966|NCT00348348|588412844|FG000|Overall Study|Other|7|||
162920967|NCT00348348|588412845|FG001|Overall Study|Other|4|||
162920968|NCT00348348|588412844|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
162920969|NCT00348348|588412845|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
162920970|NCT00348348|588412844|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
162920971|NCT00348348|588412845|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
162920972|NCT00348348|588412844|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
162920973|NCT00348348|588412845|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
162920974|NCT00348348|588412844|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
162920975|NCT00348348|588412845|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
162920976|NCT00348348|588412844|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
162920977|NCT00348348|588412845|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
162920978|NCT00348348|588412844|FG000|Overall Study|Adverse event probably related to study|1|||
162920979|NCT00348348|588412845|FG001|Overall Study|Adverse event probably related to study|0|||
162920980|NCT03710824|588412846|FG000|Overall Study|Withdrawal by Subject|1|||
162920981|NCT03710824|588412846|FG000|Overall Study|Lost to Follow-up|3|||
162920982|NCT03710824|588412846|FG000|Overall Study|Adverse Event|25|||
162920983|NCT03710824|588412846|FG000|Overall Study|Treatment discontinuation|2|||
162920984|NCT01301625|588412856|FG000|Overall Study|Death|5|||
162920985|NCT01301625|588412856|FG000|Overall Study|Not Due|21|||
162920986|NCT01301625|588412856|FG000|Overall Study|Expected|8|||
162920987|NCT01301625|588412856|FG000|Overall Study|Lost to Follow-up|1|||
162920988|NCT05102162|588412862|FG000|Overall Study|Withdrawal by Subject|3|||
162920989|NCT05102162|588412863|FG001|Overall Study|Withdrawal by Subject|0|||
162920990|NCT05102162|588412862|FG000|Overall Study|Baseline cultures negative|4|||
162920991|NCT05102162|588412863|FG001|Overall Study|Baseline cultures negative|2|||
162920992|NCT05102162|588412862|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
162920993|NCT05102162|588412863|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
162920994|NCT05102162|588412862|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
162920995|NCT05102162|588412863|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
162920996|NCT02181673|588412866|FG000|Up to Week 24|Adverse Event|2|||
162920997|NCT02181673|588412867|FG001|Up to Week 24|Adverse Event|0|||
162920998|NCT02181673|588412868|FG002|Up to Week 24|Adverse Event|3|||
162920999|NCT02181673|588412866|FG000|Up to Week 24|Death|1|||
162921000|NCT02181673|588412867|FG001|Up to Week 24|Death|0|||
162921001|NCT02181673|588412868|FG002|Up to Week 24|Death|0|||
162921002|NCT02181673|588412866|FG000|Up to Week 24|Lack of Efficacy|1|||
162921003|NCT02181673|588412867|FG001|Up to Week 24|Lack of Efficacy|0|||
162921004|NCT02181673|588412868|FG002|Up to Week 24|Lack of Efficacy|0|||
162921005|NCT02181673|588412866|FG000|Up to Week 24|Lost to Follow-up|1|||
162921006|NCT02181673|588412867|FG001|Up to Week 24|Lost to Follow-up|0|||
162921007|NCT02181673|588412868|FG002|Up to Week 24|Lost to Follow-up|0|||
162921008|NCT02181673|588412866|FG000|Up to Week 24|Physician Decision|0|||
162921009|NCT02181673|588412867|FG001|Up to Week 24|Physician Decision|0|||
162921010|NCT02181673|588412868|FG002|Up to Week 24|Physician Decision|3|||
162921011|NCT02181673|588412866|FG000|Up to Week 24|Withdrawal by Subject|10|||
162921012|NCT02181673|588412867|FG001|Up to Week 24|Withdrawal by Subject|0|||
162921013|NCT02181673|588412868|FG002|Up to Week 24|Withdrawal by Subject|1|||
162921014|NCT02181673|588412866|FG000|Up to Week 24|Other|2|||
162921015|NCT02181673|588412867|FG001|Up to Week 24|Other|0|||
162921016|NCT02181673|588412868|FG002|Up to Week 24|Other|3|||
162921017|NCT02181673|588412866|FG000|Up to Week 24|Randomized not Treated|0|||
162921018|NCT02181673|588412867|FG001|Up to Week 24|Randomized not Treated|0|||
162921019|NCT02181673|588412868|FG002|Up to Week 24|Randomized not Treated|1|||
162921020|NCT02181673|588412866|FG000|Week 24-Week 60|Adverse Event|0|||
162921021|NCT02181673|588412867|FG001|Week 24-Week 60|Adverse Event|4|||
162921022|NCT02181673|588412868|FG002|Week 24-Week 60|Adverse Event|10|||
162921023|NCT02181673|588412866|FG000|Week 24-Week 60|Other|0|||
162921024|NCT02181673|588412867|FG001|Week 24-Week 60|Other|2|||
162921025|NCT02181673|588412868|FG002|Week 24-Week 60|Other|1|||
162921026|NCT02181673|588412866|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
162921027|NCT02181673|588412867|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
162921028|NCT02181673|588412868|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
162921029|NCT02181673|588412866|FG000|Week 24-Week 60|Pregnancy|0|||
162921030|NCT02181673|588412867|FG001|Week 24-Week 60|Pregnancy|0|||
162921031|NCT02181673|588412868|FG002|Week 24-Week 60|Pregnancy|1|||
162921032|NCT02181673|588412866|FG000|Week 24-Week 60|Lack of Efficacy|0|||
162921033|NCT02181673|588412867|FG001|Week 24-Week 60|Lack of Efficacy|0|||
162921034|NCT02181673|588412868|FG002|Week 24-Week 60|Lack of Efficacy|1|||
162921035|NCT02181673|588412866|FG000|Week 24-Week 60|Lost to Follow-up|0|||
162921036|NCT02181673|588412867|FG001|Week 24-Week 60|Lost to Follow-up|0|||
162921037|NCT02181673|588412868|FG002|Week 24-Week 60|Lost to Follow-up|1|||
162921038|NCT02181673|588412866|FG000|Week 24-Week 60|Physician Decision|0|||
162921039|NCT02181673|588412867|FG001|Week 24-Week 60|Physician Decision|0|||
162921040|NCT02181673|588412868|FG002|Week 24-Week 60|Physician Decision|1|||
162921041|NCT00433771|588412869|FG000|Overall Study|screen fail|14|||
162921042|NCT00433771|588412869|FG000|Overall Study|Treated and later found to be ineligible|2|||
162921043|NCT00433771|588412869|FG000|Overall Study|Death|2|||
162921044|NCT00433771|588412869|FG000|Overall Study|Failure to deploy stent|1|||
162921045|NCT00138658|588412870|FG000|Overall Study|Adverse Event|23|||
162921046|NCT00138658|588412870|FG000|Overall Study|Death|1|||
162921047|NCT00138658|588412870|FG000|Overall Study|Disease Progression|21|||
162921048|NCT00138658|588412870|FG000|Overall Study|Physician Decision|11|||
162921049|NCT00138658|588412870|FG000|Overall Study|Withdrawal by Subject|5|||
162921050|NCT00491322|588412876|FG000|Overall Study|Protocol Violation|1|||
162921051|NCT00491322|588412877|FG001|Overall Study|Protocol Violation|0|||
162921052|NCT00491322|588412876|FG000|Overall Study|Pregnancy|0|||
162921053|NCT00491322|588412877|FG001|Overall Study|Pregnancy|1|||
162921054|NCT06067191|588412883|FG000|Overall Study|Withdrawal by Subject|0|||
162921055|NCT06067191|588412884|FG001|Overall Study|Withdrawal by Subject|1|||
162921056|NCT00890409|588412885|FG000|Overall Study|Lost to Follow-up|20|||
162921057|NCT00890409|588412886|FG001|Overall Study|Lost to Follow-up|21|||
162921058|NCT01870921|588412889|FG000|Overall Study|Subject decision|80|||
162921059|NCT01870921|588412889|FG000|Overall Study|Severe non-compliance to protocol|7|||
162921060|NCT01870921|588412889|FG000|Overall Study|Subject Lost to Follow up|2|||
162921061|NCT01870921|588412889|FG000|Overall Study|Other|1|||
162921062|NCT00806416|588412890|FG000|Period 1 - Part I|Adverse Event|0|||
162921063|NCT00806416|588412891|FG001|Period 1 - Part I|Adverse Event|1|||
162921064|NCT00806416|588412892|FG002|Period 1 - Part I|Adverse Event|0|||
162921065|NCT00806416|588412893|FG003|Period 1 - Part I|Adverse Event|0|||
162921066|NCT00806416|588412890|FG000|Period 1 - Part I|Lost to Follow-up|0|||
162921067|NCT00806416|588412891|FG001|Period 1 - Part I|Lost to Follow-up|2|||
162921068|NCT00806416|588412892|FG002|Period 1 - Part I|Lost to Follow-up|0|||
162921069|NCT00806416|588412893|FG003|Period 1 - Part I|Lost to Follow-up|0|||
162921070|NCT00806416|588412890|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
162921071|NCT00806416|588412891|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
162921072|NCT00806416|588412892|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
162921073|NCT00806416|588412893|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
162921074|NCT00806416|588412890|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
162921075|NCT00806416|588412891|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
162921076|NCT00806416|588412892|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
162921077|NCT00806416|588412893|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
162921078|NCT01102972|588412899|FG000|Overall Study|Adverse Event|8|||
162921079|NCT01102972|588412900|FG001|Overall Study|Adverse Event|2|||
162921080|NCT01102972|588412899|FG000|Overall Study|Lack of Efficacy|2|||
162921081|NCT01102972|588412900|FG001|Overall Study|Lack of Efficacy|1|||
162921082|NCT01102972|588412899|FG000|Overall Study|Protocol Violation|1|||
162921083|NCT01102972|588412900|FG001|Overall Study|Protocol Violation|0|||
162921084|NCT01102972|588412899|FG000|Overall Study|Lost to Follow-up|10|||
162921085|NCT01102972|588412900|FG001|Overall Study|Lost to Follow-up|5|||
162921086|NCT01102972|588412899|FG000|Overall Study|Investigator Discretion|2|||
162921087|NCT01102972|588412900|FG001|Overall Study|Investigator Discretion|0|||
162921088|NCT01102972|588412899|FG000|Overall Study|Withdrawal by Subject|6|||
162921089|NCT01102972|588412900|FG001|Overall Study|Withdrawal by Subject|6|||
162921090|NCT03664024|588412904|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
162921091|NCT03664024|588412904|FG000|Overall Study|Lost to Follow-up|2|||
162921092|NCT03664024|588412904|FG000|Overall Study|Withdrawal by Subject|2|||
162921093|NCT03664024|588412904|FG000|Overall Study|Death|80|||
162921094|NCT01157065|588412905|FG000|Overall Study|Death|0|||
162921095|NCT01157065|588412906|FG001|Overall Study|Death|1|||
162921096|NCT03426995|588412909|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921097|NCT03426995|588412910|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921098|NCT03426995|588412911|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
162921099|NCT03426995|588412912|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921100|NCT03426995|588412913|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921101|NCT03426995|588412914|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921102|NCT03426995|588412915|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921103|NCT03426995|588412916|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921104|NCT03426995|588412917|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921105|NCT03426995|588412918|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921106|NCT03426995|588412919|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921107|NCT03426995|588412920|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921108|NCT03426995|588412921|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921109|NCT03426995|588412922|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921110|NCT03426995|588412923|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921111|NCT03426995|588412924|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921112|NCT03426995|588412925|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921113|NCT03426995|588412926|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921114|NCT03426995|588412927|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
162921115|NCT03426995|588412909|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921116|NCT03426995|588412910|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921117|NCT03426995|588412911|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921118|NCT03426995|588412912|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921119|NCT03426995|588412913|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921120|NCT03426995|588412914|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
162921121|NCT03426995|588412915|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921122|NCT03426995|588412916|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921123|NCT03426995|588412917|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921124|NCT03426995|588412918|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921125|NCT03426995|588412919|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921126|NCT03426995|588412920|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921127|NCT03426995|588412921|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921128|NCT03426995|588412922|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921129|NCT03426995|588412923|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921130|NCT03426995|588412924|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921131|NCT03426995|588412925|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921132|NCT03426995|588412926|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921133|NCT03426995|588412927|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
162921134|NCT03426995|588412909|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921135|NCT03426995|588412910|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921136|NCT03426995|588412911|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921137|NCT03426995|588412912|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921138|NCT03426995|588412913|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
162921139|NCT03426995|588412914|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
162921140|NCT03426995|588412915|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921141|NCT03426995|588412916|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921142|NCT03426995|588412917|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921143|NCT03426995|588412918|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921144|NCT03426995|588412919|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921145|NCT03426995|588412920|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921146|NCT03426995|588412921|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921147|NCT03426995|588412922|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921148|NCT03426995|588412923|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921149|NCT03426995|588412924|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921150|NCT03426995|588412925|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921151|NCT03426995|588412926|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921152|NCT03426995|588412927|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
162921153|NCT03426995|588412909|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921154|NCT03426995|588412910|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921155|NCT03426995|588412911|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921156|NCT03426995|588412912|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921157|NCT03426995|588412913|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921158|NCT03426995|588412914|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921159|NCT03426995|588412915|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921160|NCT03426995|588412916|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921161|NCT03426995|588412917|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921162|NCT03426995|588412918|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921163|NCT03426995|588412919|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
162921164|NCT03426995|588412920|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921165|NCT03426995|588412921|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921166|NCT03426995|588412922|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921167|NCT03426995|588412923|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921168|NCT03426995|588412924|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921169|NCT03426995|588412925|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921170|NCT03426995|588412926|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921171|NCT03426995|588412927|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
162921172|NCT03426995|588412909|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921173|NCT03426995|588412910|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921174|NCT03426995|588412911|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921175|NCT03426995|588412912|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921176|NCT03426995|588412913|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921177|NCT03426995|588412914|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921178|NCT03426995|588412915|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921179|NCT03426995|588412916|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
162921180|NCT03426995|588412917|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921181|NCT03426995|588412918|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921182|NCT03426995|588412919|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921183|NCT03426995|588412920|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921184|NCT03426995|588412921|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921185|NCT03426995|588412922|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921186|NCT03426995|588412923|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921187|NCT03426995|588412924|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921188|NCT03426995|588412925|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921189|NCT03426995|588412926|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921190|NCT03426995|588412927|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
162921191|NCT03426995|588412909|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921192|NCT03426995|588412910|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921193|NCT03426995|588412911|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921194|NCT03426995|588412912|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921195|NCT03426995|588412913|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921196|NCT03426995|588412914|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921197|NCT03426995|588412915|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921198|NCT03426995|588412916|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921199|NCT03426995|588412917|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921200|NCT03426995|588412918|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921201|NCT03426995|588412919|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921202|NCT03426995|588412920|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921203|NCT03426995|588412921|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921204|NCT03426995|588412922|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921205|NCT03426995|588412923|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
162921206|NCT03426995|588412924|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
162921207|NCT03426995|588412925|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921208|NCT03426995|588412926|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162970574|NCT01628549|588593912|FG002|Overall Study|withdrawn for noncompliance|1|||
162970575|NCT01628549|588593913|FG003|Overall Study|withdrawn for noncompliance|0|||
162970576|NCT01628549|588593910|FG000|Overall Study|abnormal laboratory test results|0|||
162970577|NCT01628549|588593911|FG001|Overall Study|abnormal laboratory test results|0|||
162970578|NCT01628549|588593912|FG002|Overall Study|abnormal laboratory test results|1|||
162970579|NCT01628549|588593913|FG003|Overall Study|abnormal laboratory test results|0|||
162970580|NCT01628549|588593910|FG000|Overall Study|positive pregnancy test|0|||
162921209|NCT03426995|588412927|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
162921210|NCT03426995|588412909|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921211|NCT03426995|588412910|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921212|NCT03426995|588412911|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921213|NCT03426995|588412912|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921214|NCT03426995|588412913|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921215|NCT03426995|588412914|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921216|NCT03426995|588412915|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921217|NCT03426995|588412916|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921218|NCT03426995|588412917|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921219|NCT03426995|588412918|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921220|NCT03426995|588412919|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921221|NCT03426995|588412920|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921222|NCT03426995|588412921|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921223|NCT03426995|588412922|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921224|NCT03426995|588412923|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
162921225|NCT03426995|588412924|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
162921226|NCT03426995|588412925|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921227|NCT03426995|588412926|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921228|NCT03426995|588412927|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
162921229|NCT01886105|588412928|FG000|Overall Study|Lack of Efficacy|3|||
162921230|NCT01360021|588412931|FG000|Overall Study|Eligibility criteria + other|2|||
162921231|NCT01360021|588412932|FG001|Overall Study|Eligibility criteria + other|1|||
162921232|NCT01360021|588412933|FG002|Overall Study|Eligibility criteria + other|1|||
162921233|NCT01360021|588412931|FG000|Overall Study|Protocol Violation|0|||
162921234|NCT01360021|588412932|FG001|Overall Study|Protocol Violation|0|||
162921235|NCT01360021|588412933|FG002|Overall Study|Protocol Violation|1|||
162921236|NCT01360021|588412931|FG000|Overall Study|Withdrawal by Subject|4|||
162921237|NCT01360021|588412932|FG001|Overall Study|Withdrawal by Subject|0|||
162921238|NCT01360021|588412933|FG002|Overall Study|Withdrawal by Subject|2|||
162921239|NCT01360021|588412931|FG000|Overall Study|Adverse Event|2|||
162921240|NCT01360021|588412932|FG001|Overall Study|Adverse Event|3|||
162921241|NCT01360021|588412933|FG002|Overall Study|Adverse Event|3|||
162921242|NCT03075826|588412936|FG000|Overall Study|Withdrawal by Subject|1|||
162921243|NCT03075826|588412936|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
162921244|NCT00650806|588412938|FG000|Overall Study|Adverse Event|0|||
162921245|NCT00650806|588412939|FG001|Overall Study|Adverse Event|5|||
162921246|NCT00650806|588412940|FG002|Overall Study|Adverse Event|3|||
162921247|NCT00650806|588412941|FG003|Overall Study|Adverse Event|4|||
162921248|NCT00650806|588412938|FG000|Overall Study|Lost to Follow-up|7|||
162921249|NCT00650806|588412939|FG001|Overall Study|Lost to Follow-up|6|||
162921250|NCT00650806|588412940|FG002|Overall Study|Lost to Follow-up|11|||
162921251|NCT00650806|588412941|FG003|Overall Study|Lost to Follow-up|10|||
162921252|NCT00650806|588412938|FG000|Overall Study|Protocol Violation|0|||
162921253|NCT00650806|588412939|FG001|Overall Study|Protocol Violation|0|||
162970581|NCT01628549|588593911|FG001|Overall Study|positive pregnancy test|0|||
162970582|NCT01628549|588593912|FG002|Overall Study|positive pregnancy test|0|||
162970583|NCT01628549|588593913|FG003|Overall Study|positive pregnancy test|1|||
162970584|NCT03807440|588593919|FG000|Overall Study|No documentation of index date 2|320|||
162970585|NCT03807440|588593919|FG000|Overall Study|No informed consent for index date 2|117|||
162712464|NCT02001623|587658500|FG001|Overall Study|Adverse Event|0|||
162712465|NCT02001623|587658501|FG002|Overall Study|Adverse Event|0|||
162712466|NCT02001623|587658502|FG003|Overall Study|Adverse Event|0|||
162712467|NCT02001623|587658503|FG004|Overall Study|Adverse Event|0|||
162712468|NCT02001623|587658504|FG005|Overall Study|Adverse Event|1|||
162712469|NCT02001623|587658505|FG006|Overall Study|Adverse Event|0|||
162712470|NCT02001623|587658506|FG007|Overall Study|Adverse Event|3|||
162712471|NCT02001623|587658507|FG008|Overall Study|Adverse Event|4|||
162712472|NCT02001623|587658508|FG009|Overall Study|Adverse Event|6|||
162712473|NCT02001623|587658509|FG010|Overall Study|Adverse Event|4|||
162712474|NCT02001623|587658510|FG011|Overall Study|Adverse Event|0|||
162712475|NCT02001623|587658511|FG012|Overall Study|Adverse Event|3|||
162712476|NCT02001623|587658512|FG013|Overall Study|Adverse Event|5|||
162712477|NCT02001623|587658513|FG014|Overall Study|Adverse Event|6|||
162712478|NCT02001623|587658499|FG000|Overall Study|Other - Miscellaneous|0|||
162712479|NCT02001623|587658500|FG001|Overall Study|Other - Miscellaneous|0|||
162712480|NCT02001623|587658501|FG002|Overall Study|Other - Miscellaneous|0|||
162712481|NCT02001623|587658502|FG003|Overall Study|Other - Miscellaneous|0|||
162712482|NCT02001623|587658503|FG004|Overall Study|Other - Miscellaneous|0|||
162712483|NCT02001623|587658504|FG005|Overall Study|Other - Miscellaneous|0|||
162712484|NCT02001623|587658505|FG006|Overall Study|Other - Miscellaneous|0|||
162712485|NCT02001623|587658506|FG007|Overall Study|Other - Miscellaneous|0|||
162921254|NCT00650806|588412940|FG002|Overall Study|Protocol Violation|0|||
162921255|NCT00650806|588412941|FG003|Overall Study|Protocol Violation|1|||
162921256|NCT00650806|588412938|FG000|Overall Study|Pregnancy|0|||
162921257|NCT00650806|588412939|FG001|Overall Study|Pregnancy|0|||
162921258|NCT00650806|588412940|FG002|Overall Study|Pregnancy|0|||
162921259|NCT00650806|588412941|FG003|Overall Study|Pregnancy|1|||
162921260|NCT00650806|588412938|FG000|Overall Study|Withdrawal by Subject|7|||
162921261|NCT00650806|588412939|FG001|Overall Study|Withdrawal by Subject|5|||
162921262|NCT00650806|588412940|FG002|Overall Study|Withdrawal by Subject|8|||
162921263|NCT00650806|588412941|FG003|Overall Study|Withdrawal by Subject|6|||
162970586|NCT02451358|588593920|FG000|Overall Study|Withdrawal by Subject|1|||
162712486|NCT02001623|587658507|FG008|Overall Study|Other - Miscellaneous|0|||
162712487|NCT02001623|587658508|FG009|Overall Study|Other - Miscellaneous|1|||
162712488|NCT02001623|587658509|FG010|Overall Study|Other - Miscellaneous|0|||
162629976|NCT00968201|587362682|FG002|Base Study - (Period II)|Site Error|1|||
162629977|NCT00968201|587362680|FG000|Extension Study - (Period III)|Adverse Event|0|||
162629978|NCT00968201|587362681|FG001|Extension Study - (Period III)|Adverse Event|5|||
162921264|NCT00650806|588412938|FG000|Overall Study|Noncompliance with study drug regimen|1|||
162921265|NCT00650806|588412939|FG001|Overall Study|Noncompliance with study drug regimen|1|||
162921266|NCT00650806|588412940|FG002|Overall Study|Noncompliance with study drug regimen|0|||
162921267|NCT00650806|588412941|FG003|Overall Study|Noncompliance with study drug regimen|0|||
162921268|NCT00650806|588412938|FG000|Overall Study|Study terminated by sponsor|2|||
162921269|NCT00650806|588412939|FG001|Overall Study|Study terminated by sponsor|3|||
162921270|NCT00650806|588412940|FG002|Overall Study|Study terminated by sponsor|5|||
162921271|NCT00650806|588412941|FG003|Overall Study|Study terminated by sponsor|4|||
162921272|NCT00650806|588412938|FG000|Overall Study|Other|1|||
162921273|NCT00650806|588412939|FG001|Overall Study|Other|1|||
162921274|NCT00650806|588412940|FG002|Overall Study|Other|2|||
162921275|NCT00650806|588412941|FG003|Overall Study|Other|0|||
162921276|NCT02242942|588412942|FG000|Overall Study|Death|17|||
162921277|NCT02242942|588412943|FG001|Overall Study|Death|20|||
162921278|NCT02242942|588412944|FG002|Overall Study|Death|2|||
162921279|NCT02242942|588412942|FG000|Overall Study|Physician Decision|1|||
162921280|NCT02242942|588412943|FG001|Overall Study|Physician Decision|0|||
162921281|NCT02242942|588412944|FG002|Overall Study|Physician Decision|0|||
162921282|NCT02242942|588412942|FG000|Overall Study|Withdrawal by Subject|8|||
162921283|NCT02242942|588412943|FG001|Overall Study|Withdrawal by Subject|10|||
162921284|NCT02242942|588412944|FG002|Overall Study|Withdrawal by Subject|0|||
162921285|NCT02242942|588412942|FG000|Overall Study|On-going in Study|190|||
162921286|NCT02242942|588412943|FG001|Overall Study|On-going in Study|186|||
162921287|NCT02242942|588412944|FG002|Overall Study|On-going in Study|11|||
162921288|NCT04228107|588412948|FG000|Overall Study|Protocol Violation|1|||
162921289|NCT04228107|588412949|FG001|Overall Study|Protocol Violation|0|||
162921290|NCT04228107|588412948|FG000|Overall Study|Withdrawal by Subject|6|||
162921291|NCT04228107|588412949|FG001|Overall Study|Withdrawal by Subject|0|||
162921292|NCT04228107|588412948|FG000|Overall Study|Lost to Follow-up|18|||
162921293|NCT04228107|588412949|FG001|Overall Study|Lost to Follow-up|0|||
162921294|NCT04228107|588412948|FG000|Overall Study|No controller use data|1|||
162921295|NCT04228107|588412949|FG001|Overall Study|No controller use data|0|||
162921296|NCT04228107|588412948|FG000|Overall Study|No medication data collected|1|||
162921297|NCT04228107|588412949|FG001|Overall Study|No medication data collected|0|||
162921298|NCT03792633|588412950|FG000|Overall Study|Alternative Treatment|17|||
162921299|NCT03792633|588412951|FG001|Overall Study|Alternative Treatment|19|||
162921300|NCT03792633|588412950|FG000|Overall Study|Death|2|||
162921301|NCT03792633|588412951|FG001|Overall Study|Death|0|||
162921302|NCT03792633|588412950|FG000|Overall Study|Disease progression|8|||
162921303|NCT03792633|588412951|FG001|Overall Study|Disease progression|9|||
162921304|NCT03792633|588412950|FG000|Overall Study|Lost to Follow-up|1|||
162921305|NCT03792633|588412951|FG001|Overall Study|Lost to Follow-up|1|||
162921306|NCT03792633|588412950|FG000|Overall Study|Screen fail|1|||
162921307|NCT03792633|588412951|FG001|Overall Study|Screen fail|0|||
162921308|NCT03792633|588412950|FG000|Overall Study|Second malignancy|0|||
162921309|NCT03792633|588412951|FG001|Overall Study|Second malignancy|1|||
162921310|NCT00145119|588412952|FG000|Overall Study|Death|45|||
162921311|NCT04411641|588412953|FG000|DB Period|Other|7|||
162921312|NCT04411641|588412954|FG001|DB Period|Other|27|||
162921313|NCT04411641|588412955|FG002|DB Period|Other|0|||
162921314|NCT04411641|588412956|FG003|DB Period|Other|0|||
162921315|NCT04411641|588412953|FG000|DB Period|Withdrawal by Subject|67|||
162921316|NCT04411641|588412954|FG001|DB Period|Withdrawal by Subject|122|||
162921317|NCT04411641|588412955|FG002|DB Period|Withdrawal by Subject|0|||
162921318|NCT04411641|588412956|FG003|DB Period|Withdrawal by Subject|0|||
162921319|NCT04411641|588412953|FG000|DB Period|Progressive disease|76|||
162921320|NCT04411641|588412954|FG001|DB Period|Progressive disease|116|||
162921321|NCT04411641|588412955|FG002|DB Period|Progressive disease|0|||
162921322|NCT04411641|588412956|FG003|DB Period|Progressive disease|0|||
162921323|NCT04411641|588412953|FG000|DB Period|Poor compliance to protocol|1|||
162921324|NCT04411641|588412954|FG001|DB Period|Poor compliance to protocol|5|||
162921325|NCT04411641|588412955|FG002|DB Period|Poor compliance to protocol|0|||
162921326|NCT04411641|588412956|FG003|DB Period|Poor compliance to protocol|0|||
162921327|NCT04411641|588412953|FG000|DB Period|Lack of Efficacy|19|||
162921328|NCT04411641|588412954|FG001|DB Period|Lack of Efficacy|19|||
162921329|NCT04411641|588412955|FG002|DB Period|Lack of Efficacy|0|||
162921330|NCT04411641|588412956|FG003|DB Period|Lack of Efficacy|0|||
162921331|NCT04411641|588412953|FG000|DB Period|Adverse Event|13|||
162921332|NCT04411641|588412954|FG001|DB Period|Adverse Event|29|||
162921333|NCT04411641|588412955|FG002|DB Period|Adverse Event|0|||
162921334|NCT04411641|588412956|FG003|DB Period|Adverse Event|0|||
162921335|NCT04411641|588412953|FG000|DB Period|Randomized and not treated|2|||
162970587|NCT02451358|588593921|FG001|Overall Study|Withdrawal by Subject|1|||
162970588|NCT02451358|588593922|FG002|Overall Study|Withdrawal by Subject|0|||
162970589|NCT02451358|588593923|FG003|Overall Study|Withdrawal by Subject|0|||
162970590|NCT02451358|588593920|FG000|Overall Study|Protocol Violation|0|||
162970591|NCT02451358|588593921|FG001|Overall Study|Protocol Violation|1|||
162921336|NCT04411641|588412954|FG001|DB Period|Randomized and not treated|2|||
162921337|NCT04411641|588412955|FG002|DB Period|Randomized and not treated|0|||
162921338|NCT04411641|588412956|FG003|DB Period|Randomized and not treated|0|||
162921339|NCT04411641|588412953|FG000|OL|Withdrawal by Subject|0|||
162921340|NCT04411641|588412954|FG001|OL|Withdrawal by Subject|0|||
162921341|NCT04411641|588412955|FG002|OL|Withdrawal by Subject|6|||
162921342|NCT04411641|588412956|FG003|OL|Withdrawal by Subject|17|||
162921343|NCT04411641|588412953|FG000|OL|Progressive disease|0|||
162921344|NCT04411641|588412954|FG001|OL|Progressive disease|0|||
162921345|NCT04411641|588412955|FG002|OL|Progressive disease|1|||
162921346|NCT04411641|588412956|FG003|OL|Progressive disease|2|||
162921347|NCT04411641|588412953|FG000|OL|Poor compliance to protocol|0|||
162921348|NCT04411641|588412954|FG001|OL|Poor compliance to protocol|0|||
162921349|NCT04411641|588412955|FG002|OL|Poor compliance to protocol|1|||
162921350|NCT04411641|588412956|FG003|OL|Poor compliance to protocol|0|||
162921351|NCT04411641|588412953|FG000|OL|Adverse Event|0|||
162921352|NCT04411641|588412954|FG001|OL|Adverse Event|0|||
162921353|NCT04411641|588412955|FG002|OL|Adverse Event|1|||
162921354|NCT04411641|588412956|FG003|OL|Adverse Event|0|||
162921355|NCT04411641|588412953|FG000|OL|Other|0|||
162921356|NCT04411641|588412954|FG001|OL|Other|0|||
162921357|NCT04411641|588412955|FG002|OL|Other|0|||
162921358|NCT04411641|588412956|FG003|OL|Other|6|||
162921359|NCT04342390|588412957|FG000|Overall Study|Lost to Follow-up|3|||
162921360|NCT04342390|588412958|FG001|Overall Study|Lost to Follow-up|0|||
162921361|NCT04584294|588412959|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
162921362|NCT04584294|588412960|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
162921363|NCT04584294|588412959|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
162921364|NCT04584294|588412960|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
162921365|NCT04584294|588412959|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
162921366|NCT04584294|588412960|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
162921367|NCT04584294|588412959|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
162921368|NCT04584294|588412960|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
162921369|NCT04584294|588412959|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
162921370|NCT04584294|588412960|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
162921371|NCT04584294|588412959|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
162921372|NCT04584294|588412960|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
162921373|NCT01392469|588414505|FG000|Overall Study|Adverse Event|2|||
162921374|NCT01392469|588414505|FG000|Overall Study|Withdrawal by Subject|1|||
162921375|NCT01392469|588414505|FG000|Overall Study|Protocol Violation|1|||
162921376|NCT03443973|588414512|FG000|Double-blind Treatment Period|Adverse Event|5|||
162921377|NCT03443973|588414513|FG001|Double-blind Treatment Period|Adverse Event|19|||
162921378|NCT03443973|588414514|FG002|Double-blind Treatment Period|Adverse Event|0|||
162921379|NCT03443973|588414515|FG003|Double-blind Treatment Period|Adverse Event|0|||
162921380|NCT03443973|588414512|FG000|Double-blind Treatment Period|Death|5|||
162921381|NCT03443973|588414513|FG001|Double-blind Treatment Period|Death|7|||
162921382|NCT03443973|588414514|FG002|Double-blind Treatment Period|Death|0|||
162921383|NCT03443973|588414515|FG003|Double-blind Treatment Period|Death|0|||
162921384|NCT03443973|588414512|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
162921385|NCT03443973|588414513|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
162921386|NCT03443973|588414514|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162921387|NCT03443973|588414515|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
162921388|NCT03443973|588414512|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162970592|NCT02451358|588593922|FG002|Overall Study|Protocol Violation|1|||
162921389|NCT03443973|588414513|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
162921390|NCT03443973|588414514|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
162921391|NCT03443973|588414515|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162921392|NCT03443973|588414512|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
162921393|NCT03443973|588414513|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
162921394|NCT03443973|588414514|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
162921395|NCT03443973|588414515|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
162921396|NCT03443973|588414512|FG000|Double-blind Treatment Period|Physician Decision|5|||
162921397|NCT03443973|588414513|FG001|Double-blind Treatment Period|Physician Decision|6|||
162921398|NCT03443973|588414514|FG002|Double-blind Treatment Period|Physician Decision|0|||
162921399|NCT03443973|588414515|FG003|Double-blind Treatment Period|Physician Decision|0|||
162921400|NCT03443973|588414512|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
162921401|NCT03443973|588414513|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
162921402|NCT03443973|588414514|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
162921403|NCT03443973|588414515|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
162629979|NCT00968201|587362682|FG002|Extension Study - (Period III)|Adverse Event|22|||
162921404|NCT03443973|588414512|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
162921405|NCT03443973|588414513|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
162921406|NCT03443973|588414514|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162921407|NCT03443973|588414515|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
162921408|NCT03443973|588414512|FG000|Open-label Extension Period|Reason Not Specified|0|||
162921409|NCT03443973|588414513|FG001|Open-label Extension Period|Reason Not Specified|0|||
162921410|NCT03443973|588414514|FG002|Open-label Extension Period|Reason Not Specified|3|||
162921411|NCT03443973|588414515|FG003|Open-label Extension Period|Reason Not Specified|0|||
162921412|NCT03443973|588414512|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162921413|NCT03443973|588414513|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
162921414|NCT03443973|588414514|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
162921415|NCT03443973|588414515|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
162921416|NCT04930536|588414516|FG000|Overall Study|Adverse Event|1|||
162921417|NCT04930536|588414517|FG001|Overall Study|Adverse Event|0|||
162921418|NCT04930536|588414516|FG000|Overall Study|Disease Progression|2|||
162921419|NCT04930536|588414517|FG001|Overall Study|Disease Progression|0|||
162921420|NCT04930536|588414516|FG000|Overall Study|Patient Decision|4|||
162921421|NCT04930536|588414517|FG001|Overall Study|Patient Decision|2|||
162921422|NCT04930536|588414516|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
162921423|NCT04930536|588414517|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
162921424|NCT00267020|588414518|FG000|Overall Study|Adverse Event|22|||
162921425|NCT00267020|588414519|FG001|Overall Study|Adverse Event|5|||
162921426|NCT00267020|588414518|FG000|Overall Study|Death|2|||
162921427|NCT00267020|588414519|FG001|Overall Study|Death|1|||
162921428|NCT00267020|588414518|FG000|Overall Study|Withdrawal by Subject|17|||
162921429|NCT00267020|588414519|FG001|Overall Study|Withdrawal by Subject|7|||
162921430|NCT00267020|588414518|FG000|Overall Study|Physician Decision|3|||
162921431|NCT00267020|588414519|FG001|Overall Study|Physician Decision|2|||
162921432|NCT00267020|588414518|FG000|Overall Study|Disease Progression|39|||
162921433|NCT00267020|588414519|FG001|Overall Study|Disease Progression|25|||
162921434|NCT00267020|588414518|FG000|Overall Study|Unrelated Complication|1|||
162921435|NCT00267020|588414519|FG001|Overall Study|Unrelated Complication|1|||
162921436|NCT00267020|588414518|FG000|Overall Study|Sponsor Request|1|||
162921437|NCT00267020|588414519|FG001|Overall Study|Sponsor Request|0|||
162921438|NCT00267020|588414518|FG000|Overall Study|Other|1|||
162921439|NCT00267020|588414519|FG001|Overall Study|Other|2|||
162921440|NCT04292171|588414523|FG000|Overall Study|Pharmacy error|2|||
162921441|NCT04292171|588414524|FG001|Overall Study|Pharmacy error|0|||
162921442|NCT04292171|588414523|FG000|Overall Study|Delivered prior to procedure|0|||
162921443|NCT04292171|588414524|FG001|Overall Study|Delivered prior to procedure|1|||
162921444|NCT04465916|588414525|FG000|Overall Study|Withdrawal by Subject|0|||
162921445|NCT04465916|588414526|FG001|Overall Study|Withdrawal by Subject|1|||
162921446|NCT04633434|588414527|FG000|Overall Study|Lost to Follow-up|32|||
162921447|NCT04633434|588414528|FG001|Overall Study|Lost to Follow-up|32|||
162921448|NCT02329834|588414529|FG000|Overall Study|Physician Decision|1|||
162921449|NCT02329834|588414530|FG001|Overall Study|Physician Decision|0|||
162921450|NCT01605370|588414533|FG000|Overall Study|Adverse Event|1|||
162921451|NCT01605370|588414534|FG001|Overall Study|Adverse Event|0|||
162921452|NCT00578448|588414535|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
162921453|NCT00578448|588414535|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
162921454|NCT00578448|588414535|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
162921455|NCT00578448|588414535|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
162921456|NCT01976104|588414539|FG000|Overall Study|Adverse Event|0|||
162921457|NCT01976104|588414540|FG001|Overall Study|Adverse Event|0|||
162921458|NCT01976104|588414541|FG002|Overall Study|Adverse Event|1|||
162921459|NCT01976104|588414542|FG003|Overall Study|Adverse Event|0|||
162921460|NCT01976104|588414539|FG000|Overall Study|Lost to Follow-up|3|||
162921461|NCT01976104|588414540|FG001|Overall Study|Lost to Follow-up|0|||
162629980|NCT00968201|587362680|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
162921462|NCT01976104|588414541|FG002|Overall Study|Lost to Follow-up|1|||
162970593|NCT02451358|588593923|FG003|Overall Study|Protocol Violation|0|||
162970594|NCT06128525|588593924|FG000|Overall Study|Patient withdrew consent|1|||
162970595|NCT03414034|588593929|FG000|Overall Study|Adverse Event|6|||
162970596|NCT03414034|588593930|FG001|Overall Study|Adverse Event|1|||
162970597|NCT03414034|588593931|FG002|Overall Study|Adverse Event|1|||
162629981|NCT00968201|587362681|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
162629982|NCT00968201|587362682|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
162921463|NCT01976104|588414542|FG003|Overall Study|Lost to Follow-up|1|||
162921464|NCT01976104|588414539|FG000|Overall Study|Subject Choice|0|||
162921465|NCT01976104|588414540|FG001|Overall Study|Subject Choice|1|||
162921466|NCT01976104|588414541|FG002|Overall Study|Subject Choice|0|||
162921467|NCT01976104|588414542|FG003|Overall Study|Subject Choice|1|||
162921468|NCT01976104|588414539|FG000|Overall Study|Withdrawal by Subject|3|||
162921469|NCT01976104|588414540|FG001|Overall Study|Withdrawal by Subject|0|||
162970598|NCT03414034|588593929|FG000|Overall Study|Death|0|||
162921470|NCT01976104|588414541|FG002|Overall Study|Withdrawal by Subject|0|||
162921471|NCT01976104|588414542|FG003|Overall Study|Withdrawal by Subject|1|||
162921472|NCT01976104|588414539|FG000|Overall Study|Other|0|||
162921473|NCT01976104|588414540|FG001|Overall Study|Other|1|||
162921474|NCT01976104|588414541|FG002|Overall Study|Other|0|||
162921475|NCT01976104|588414542|FG003|Overall Study|Other|0|||
162921476|NCT01317199|588414543|FG000|Dose-escalation Phase 1|Physician Decision|5|||
162921477|NCT01317199|588414544|FG001|Dose-escalation Phase 1|Physician Decision|0|||
162921478|NCT01317199|588414545|FG002|Dose-escalation Phase 1|Physician Decision|0|||
162921479|NCT01317199|588414546|FG003|Dose-escalation Phase 1|Physician Decision|0|||
162921480|NCT01317199|588414543|FG000|Dose-escalation Phase 1|Disease progression|1|||
162921481|NCT01317199|588414544|FG001|Dose-escalation Phase 1|Disease progression|0|||
162921482|NCT01317199|588414545|FG002|Dose-escalation Phase 1|Disease progression|0|||
162921483|NCT01317199|588414546|FG003|Dose-escalation Phase 1|Disease progression|0|||
162921484|NCT01317199|588414543|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
162921485|NCT01317199|588414544|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
162921486|NCT01317199|588414545|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
162921487|NCT01317199|588414546|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
162921488|NCT01317199|588414543|FG000|Randomized Phase 2|Disease progression|0|||
162921489|NCT01317199|588414544|FG001|Randomized Phase 2|Disease progression|3|||
162921490|NCT01317199|588414545|FG002|Randomized Phase 2|Disease progression|7|||
162921491|NCT01317199|588414546|FG003|Randomized Phase 2|Disease progression|5|||
162921492|NCT01317199|588414543|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
162921493|NCT01317199|588414544|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
162921494|NCT01317199|588414545|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
162921495|NCT01317199|588414546|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
162921496|NCT01317199|588414543|FG000|Randomized Phase 2|Adverse Event|0|||
162921497|NCT01317199|588414544|FG001|Randomized Phase 2|Adverse Event|0|||
162921498|NCT01317199|588414545|FG002|Randomized Phase 2|Adverse Event|0|||
162921499|NCT01317199|588414546|FG003|Randomized Phase 2|Adverse Event|1|||
162921500|NCT01317199|588414543|FG000|Randomized Phase 2|Comorbidities|0|||
162921501|NCT01317199|588414544|FG001|Randomized Phase 2|Comorbidities|2|||
162921502|NCT01317199|588414545|FG002|Randomized Phase 2|Comorbidities|2|||
162921503|NCT01317199|588414546|FG003|Randomized Phase 2|Comorbidities|2|||
162921504|NCT01317199|588414543|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
162921505|NCT01317199|588414544|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
162921506|NCT01317199|588414545|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
162921507|NCT01317199|588414546|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
162921508|NCT01317199|588414543|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
162921509|NCT01317199|588414544|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
162921510|NCT01317199|588414545|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
162921511|NCT01317199|588414546|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
162921512|NCT01317199|588414543|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
162921513|NCT01317199|588414544|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
162921514|NCT01317199|588414545|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
162921515|NCT01317199|588414546|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
162921516|NCT01317199|588414543|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
162921517|NCT01317199|588414544|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
162921518|NCT01317199|588414545|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
162921519|NCT01317199|588414546|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
162921520|NCT01353209|588414547|FG000|Overall Study|Adverse Event|1|||
162921521|NCT01353209|588414548|FG001|Overall Study|Adverse Event|1|||
162921522|NCT01283009|588414549|FG000|Overall Study|Death|83|||
162921523|NCT01283009|588414550|FG001|Overall Study|Death|78|||
162921524|NCT01283009|588414549|FG000|Overall Study|Study ended early|23|||
162921525|NCT01283009|588414550|FG001|Overall Study|Study ended early|26|||
162921526|NCT01283009|588414549|FG000|Overall Study|Withdrawal by Subject|10|||
162921527|NCT01283009|588414550|FG001|Overall Study|Withdrawal by Subject|8|||
162921528|NCT01283009|588414549|FG000|Overall Study|Physician Decision|1|||
162921529|NCT01283009|588414550|FG001|Overall Study|Physician Decision|1|||
162921530|NCT01283009|588414549|FG000|Overall Study|Lost to Follow-up|1|||
162970599|NCT03414034|588593930|FG001|Overall Study|Death|0|||
162970600|NCT03414034|588593931|FG002|Overall Study|Death|1|||
162921531|NCT01283009|588414550|FG001|Overall Study|Lost to Follow-up|0|||
162921532|NCT01283009|588414549|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
162921533|NCT01283009|588414550|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
162921534|NCT03237325|588414554|FG000|Overall Study|Lost to Follow-up|3|||
162921535|NCT03237325|588414555|FG001|Overall Study|Lost to Follow-up|5|||
162970601|NCT03414034|588593929|FG000|Overall Study|Non-compliance With Study Drug|0|||
162970602|NCT03414034|588593930|FG001|Overall Study|Non-compliance With Study Drug|0|||
162970603|NCT03414034|588593931|FG002|Overall Study|Non-compliance With Study Drug|1|||
162970604|NCT03414034|588593929|FG000|Overall Study|Physician Decision|1|||
162970605|NCT03414034|588593930|FG001|Overall Study|Physician Decision|3|||
162970606|NCT03414034|588593931|FG002|Overall Study|Physician Decision|2|||
162970607|NCT03414034|588593929|FG000|Overall Study|Withdrawal of Informed Consent|2|||
162970608|NCT03414034|588593930|FG001|Overall Study|Withdrawal of Informed Consent|1|||
162970609|NCT03414034|588593931|FG002|Overall Study|Withdrawal of Informed Consent|4|||
162970610|NCT03414034|588593929|FG000|Overall Study|Progressive Disease|15|||
162970611|NCT03414034|588593930|FG001|Overall Study|Progressive Disease|15|||
162970612|NCT03414034|588593931|FG002|Overall Study|Progressive Disease|17|||
162970613|NCT03414034|588593929|FG000|Overall Study|Miscellaneous|0|||
162970614|NCT03414034|588593930|FG001|Overall Study|Miscellaneous|0|||
162970615|NCT03414034|588593931|FG002|Overall Study|Miscellaneous|2|||
162970616|NCT01332968|588593933|FG000|Induction Period|Adverse Event|23|||
162970617|NCT01332968|588593934|FG001|Induction Period|Adverse Event|26|||
162970618|NCT01332968|588593935|FG002|Induction Period|Adverse Event|0|||
162970619|NCT01332968|588593936|FG003|Induction Period|Adverse Event|0|||
162970620|NCT01332968|588593937|FG004|Induction Period|Adverse Event|0|||
162970621|NCT01332968|588593938|FG005|Induction Period|Adverse Event|0|||
163056288|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056289|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056290|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056291|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
163056292|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
163056293|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056294|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056295|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056296|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056297|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056298|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
163056299|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056300|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
163056301|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056302|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056303|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056304|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056305|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
163056306|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056307|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056308|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
163056309|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056310|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056311|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056312|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163056313|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056314|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056315|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
163056316|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056317|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056318|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056319|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
163056320|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056321|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056322|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
162629983|NCT00968201|587362680|FG000|Extension Study - (Period III)|Protocol Violation|0|||
162970622|NCT01332968|588593939|FG006|Induction Period|Adverse Event|0|||
162970623|NCT01332968|588593940|FG007|Induction Period|Adverse Event|0|||
162970624|NCT01332968|588593933|FG000|Induction Period|Death|1|||
162970625|NCT01332968|588593934|FG001|Induction Period|Death|4|||
162970626|NCT01332968|588593935|FG002|Induction Period|Death|0|||
162970627|NCT01332968|588593936|FG003|Induction Period|Death|0|||
162970628|NCT01332968|588593937|FG004|Induction Period|Death|0|||
162970629|NCT01332968|588593938|FG005|Induction Period|Death|0|||
162970630|NCT01332968|588593939|FG006|Induction Period|Death|0|||
162970631|NCT01332968|588593940|FG007|Induction Period|Death|0|||
162970632|NCT01332968|588593933|FG000|Induction Period|Non-compliance|1|||
162970633|NCT01332968|588593934|FG001|Induction Period|Non-compliance|0|||
162970634|NCT01332968|588593935|FG002|Induction Period|Non-compliance|0|||
162921536|NCT03237325|588414554|FG000|Overall Study|Physician Decision|2|||
162921537|NCT03237325|588414555|FG001|Overall Study|Physician Decision|4|||
162921538|NCT03237325|588414554|FG000|Overall Study|Withdrawal by Subject|9|||
163056323|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056324|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056325|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
163056326|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
162921539|NCT03237325|588414555|FG001|Overall Study|Withdrawal by Subject|12|||
162921540|NCT03237325|588414554|FG000|Overall Study|Noncompliance with Study Procedures|1|||
162921541|NCT03237325|588414555|FG001|Overall Study|Noncompliance with Study Procedures|1|||
162921542|NCT03237325|588414554|FG000|Overall Study|Termination by Sponsor|0|||
162921543|NCT03237325|588414555|FG001|Overall Study|Termination by Sponsor|1|||
162921544|NCT03237325|588414554|FG000|Overall Study|Reason other than described|0|||
162921545|NCT03237325|588414555|FG001|Overall Study|Reason other than described|2|||
162921546|NCT02684370|588414556|FG000|Part A|Adverse Event|2|||
162921547|NCT02684370|588414557|FG001|Part A|Adverse Event|0|||
162921548|NCT02684370|588414558|FG002|Part A|Adverse Event|1|||
162921549|NCT02684370|588414559|FG003|Part A|Adverse Event|0|||
162921550|NCT02684370|588414560|FG004|Part A|Adverse Event|0|||
162921551|NCT02684370|588414561|FG005|Part A|Adverse Event|0|||
162921552|NCT02684370|588414556|FG000|Part A|Lost to Follow-up|1|||
162921553|NCT02684370|588414557|FG001|Part A|Lost to Follow-up|1|||
162921554|NCT02684370|588414558|FG002|Part A|Lost to Follow-up|0|||
163056327|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056328|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056329|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056330|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
163056331|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056332|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056333|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
163056334|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056335|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056336|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056337|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
163056338|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056339|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056340|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
163056341|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056342|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056343|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056344|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056345|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
162921555|NCT02684370|588414559|FG003|Part A|Lost to Follow-up|0|||
162921556|NCT02684370|588414560|FG004|Part A|Lost to Follow-up|0|||
162921557|NCT02684370|588414561|FG005|Part A|Lost to Follow-up|0|||
162921558|NCT02684370|588414556|FG000|Part A|Subject Withdrawal|1|||
162921559|NCT02684370|588414557|FG001|Part A|Subject Withdrawal|0|||
162921560|NCT02684370|588414558|FG002|Part A|Subject Withdrawal|3|||
162921561|NCT02684370|588414559|FG003|Part A|Subject Withdrawal|0|||
162921562|NCT02684370|588414560|FG004|Part A|Subject Withdrawal|0|||
162921563|NCT02684370|588414561|FG005|Part A|Subject Withdrawal|0|||
162921564|NCT02684370|588414556|FG000|Part A|Other|0|||
162921565|NCT02684370|588414557|FG001|Part A|Other|0|||
162921566|NCT02684370|588414558|FG002|Part A|Other|1|||
162921567|NCT02684370|588414559|FG003|Part A|Other|0|||
162921568|NCT02684370|588414560|FG004|Part A|Other|0|||
162921569|NCT02684370|588414561|FG005|Part A|Other|0|||
162921570|NCT02684370|588414556|FG000|Part B|Adverse Event|0|||
162921571|NCT02684370|588414557|FG001|Part B|Adverse Event|0|||
162921572|NCT02684370|588414558|FG002|Part B|Adverse Event|0|||
162921573|NCT02684370|588414559|FG003|Part B|Adverse Event|0|||
162921574|NCT02684370|588414560|FG004|Part B|Adverse Event|2|||
162921575|NCT02684370|588414561|FG005|Part B|Adverse Event|1|||
162712489|NCT02001623|587658510|FG011|Overall Study|Other - Miscellaneous|0|||
162712490|NCT02001623|587658511|FG012|Overall Study|Other - Miscellaneous|0|||
162712491|NCT02001623|587658512|FG013|Overall Study|Other - Miscellaneous|1|||
162712492|NCT02001623|587658513|FG014|Overall Study|Other - Miscellaneous|0|||
162712493|NCT02001623|587658499|FG000|Overall Study|Withdrawal by Subject|1|||
162712494|NCT02001623|587658500|FG001|Overall Study|Withdrawal by Subject|0|||
162712495|NCT02001623|587658501|FG002|Overall Study|Withdrawal by Subject|0|||
162712496|NCT02001623|587658502|FG003|Overall Study|Withdrawal by Subject|0|||
162712497|NCT02001623|587658503|FG004|Overall Study|Withdrawal by Subject|0|||
162712498|NCT02001623|587658504|FG005|Overall Study|Withdrawal by Subject|0|||
162712499|NCT02001623|587658505|FG006|Overall Study|Withdrawal by Subject|0|||
162712500|NCT02001623|587658506|FG007|Overall Study|Withdrawal by Subject|0|||
162712501|NCT02001623|587658507|FG008|Overall Study|Withdrawal by Subject|1|||
162712502|NCT02001623|587658508|FG009|Overall Study|Withdrawal by Subject|3|||
162712503|NCT02001623|587658509|FG010|Overall Study|Withdrawal by Subject|2|||
162712504|NCT02001623|587658510|FG011|Overall Study|Withdrawal by Subject|2|||
162712505|NCT02001623|587658511|FG012|Overall Study|Withdrawal by Subject|1|||
162712506|NCT02001623|587658512|FG013|Overall Study|Withdrawal by Subject|5|||
162712507|NCT02001623|587658513|FG014|Overall Study|Withdrawal by Subject|2|||
162712508|NCT02001623|587658499|FG000|Overall Study|Lost to Follow-up|0|||
162712509|NCT02001623|587658500|FG001|Overall Study|Lost to Follow-up|0|||
162712510|NCT02001623|587658501|FG002|Overall Study|Lost to Follow-up|0|||
162921576|NCT02684370|588414556|FG000|Part B|Lost to Follow-up|0|||
162921577|NCT02684370|588414557|FG001|Part B|Lost to Follow-up|0|||
162712511|NCT02001623|587658502|FG003|Overall Study|Lost to Follow-up|0|||
162712512|NCT02001623|587658503|FG004|Overall Study|Lost to Follow-up|0|||
162921578|NCT02684370|588414558|FG002|Part B|Lost to Follow-up|0|||
162921579|NCT02684370|588414559|FG003|Part B|Lost to Follow-up|1|||
162921580|NCT02684370|588414560|FG004|Part B|Lost to Follow-up|2|||
162712513|NCT02001623|587658504|FG005|Overall Study|Lost to Follow-up|0|||
162712514|NCT02001623|587658505|FG006|Overall Study|Lost to Follow-up|0|||
162712515|NCT02001623|587658506|FG007|Overall Study|Lost to Follow-up|0|||
162921581|NCT02684370|588414561|FG005|Part B|Lost to Follow-up|5|||
162921582|NCT02684370|588414556|FG000|Part B|Subject Withdrawal|0|||
162921583|NCT02684370|588414557|FG001|Part B|Subject Withdrawal|0|||
162921584|NCT02684370|588414558|FG002|Part B|Subject Withdrawal|0|||
162921585|NCT02684370|588414559|FG003|Part B|Subject Withdrawal|1|||
162921586|NCT02684370|588414560|FG004|Part B|Subject Withdrawal|1|||
162921587|NCT02684370|588414561|FG005|Part B|Subject Withdrawal|2|||
162921588|NCT00627094|588414563|FG000|Overall Study|Adverse Event|8|||
162921589|NCT00627094|588414564|FG001|Overall Study|Adverse Event|7|||
162921590|NCT00627094|588414563|FG000|Overall Study|Lost to Follow-up|1|||
162921591|NCT00627094|588414564|FG001|Overall Study|Lost to Follow-up|0|||
162921592|NCT00627094|588414563|FG000|Overall Study|Withdrawal by Subject|1|||
162921593|NCT00627094|588414564|FG001|Overall Study|Withdrawal by Subject|1|||
162921594|NCT00627094|588414563|FG000|Overall Study|ulcer healed|1|||
162921595|NCT00627094|588414564|FG001|Overall Study|ulcer healed|7|||
162921596|NCT00627094|588414563|FG000|Overall Study|Other reason|1|||
162921597|NCT00627094|588414564|FG001|Overall Study|Other reason|0|||
162921598|NCT00183170|588414566|FG000|First Intervention|Did not complete study|1|||
162921599|NCT00183170|588414567|FG001|First Intervention|Did not complete study|0|||
162921600|NCT00183170|588414566|FG000|First Intervention|Did not meet targeted BrAC|1|||
162921601|NCT00183170|588414567|FG001|First Intervention|Did not meet targeted BrAC|0|||
162921602|NCT00183170|588414566|FG000|Washout 1 Week|Did not complete study|6|||
162921603|NCT00183170|588414567|FG001|Washout 1 Week|Did not complete study|8|||
162921604|NCT00183170|588414566|FG000|Second Intervention|Did not complete study|1|||
162921605|NCT00183170|588414567|FG001|Second Intervention|Did not complete study|0|||
162921606|NCT00183170|588414566|FG000|Second Intervention|Did not meet targeted BrAC|0|||
162921607|NCT00183170|588414567|FG001|Second Intervention|Did not meet targeted BrAC|2|||
162921608|NCT01165424|588414568|FG000|Overall Study|Clinical adverse experiences|1|||
162921609|NCT01165424|588414568|FG000|Overall Study|Laboratory adverse experiences|1|||
162921610|NCT01165424|588414568|FG000|Overall Study|Did not meet entry criteria|1|||
162921611|NCT01165424|588414568|FG000|Overall Study|Participant moved (relocated)|1|||
162921612|NCT02050373|588414574|FG000|Overall Study|Adverse Event|4|||
162970635|NCT01332968|588593936|FG003|Induction Period|Non-compliance|0|||
162970636|NCT01332968|588593937|FG004|Induction Period|Non-compliance|0|||
162970637|NCT01332968|588593938|FG005|Induction Period|Non-compliance|0|||
162970638|NCT01332968|588593939|FG006|Induction Period|Non-compliance|0|||
162970639|NCT01332968|588593940|FG007|Induction Period|Non-compliance|0|||
162970640|NCT01332968|588593933|FG000|Induction Period|Other|2|||
162970641|NCT01332968|588593934|FG001|Induction Period|Other|2|||
162970642|NCT01332968|588593935|FG002|Induction Period|Other|0|||
162921613|NCT02050373|588414575|FG001|Overall Study|Adverse Event|7|||
162921614|NCT02050373|588414574|FG000|Overall Study|Death|3|||
162921615|NCT02050373|588414575|FG001|Overall Study|Death|3|||
162921616|NCT00807040|588414579|FG000|Overall Study|Death|24|||
162921617|NCT00807040|588414580|FG001|Overall Study|Death|29|||
162921618|NCT00807040|588414579|FG000|Overall Study|Withdrawal by Subject|8|||
162921619|NCT00807040|588414580|FG001|Overall Study|Withdrawal by Subject|6|||
162921620|NCT00807040|588414579|FG000|Overall Study|Lost to Follow-up|4|||
162921621|NCT00807040|588414580|FG001|Overall Study|Lost to Follow-up|6|||
162921622|NCT01067339|588414581|FG000|Overall Study|Withdrawal by Subject|6|||
162921623|NCT01067339|588414582|FG001|Overall Study|Withdrawal by Subject|5|||
162921624|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
162921625|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
162921626|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
162921627|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
162921628|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
162921629|NCT01179191|588414583|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
162921630|NCT01179191|588414583|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
162921631|NCT01179191|588414583|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
162921632|NCT01179191|588414583|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
162921633|NCT01179191|588414583|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
162921634|NCT01179191|588414583|FG000|Maintenance Phase (8 Weeks)|Other|66|||
162921635|NCT00572910|588414588|FG000|Overall Study|Adverse Event|1|||
162921636|NCT00572910|588414589|FG001|Overall Study|Adverse Event|2|||
162921637|NCT00572910|588414590|FG002|Overall Study|Adverse Event|0|||
162970643|NCT01332968|588593936|FG003|Induction Period|Other|0|||
162970644|NCT01332968|588593937|FG004|Induction Period|Other|0|||
162970645|NCT01332968|588593938|FG005|Induction Period|Other|0|||
162970646|NCT01332968|588593939|FG006|Induction Period|Other|0|||
162970647|NCT01332968|588593940|FG007|Induction Period|Other|0|||
162970648|NCT01332968|588593933|FG000|Induction Period|Physician Decision|6|||
162970649|NCT01332968|588593934|FG001|Induction Period|Physician Decision|1|||
162970650|NCT01332968|588593935|FG002|Induction Period|Physician Decision|0|||
162970651|NCT01332968|588593936|FG003|Induction Period|Physician Decision|0|||
162970652|NCT01332968|588593937|FG004|Induction Period|Physician Decision|0|||
162970653|NCT01332968|588593938|FG005|Induction Period|Physician Decision|0|||
162970654|NCT01332968|588593939|FG006|Induction Period|Physician Decision|0|||
162970655|NCT01332968|588593940|FG007|Induction Period|Physician Decision|0|||
162970656|NCT01332968|588593933|FG000|Induction Period|Progressive Disease|15|||
162970657|NCT01332968|588593934|FG001|Induction Period|Progressive Disease|7|||
162970658|NCT01332968|588593935|FG002|Induction Period|Progressive Disease|0|||
162970659|NCT01332968|588593936|FG003|Induction Period|Progressive Disease|0|||
162970660|NCT01332968|588593937|FG004|Induction Period|Progressive Disease|0|||
162970661|NCT01332968|588593938|FG005|Induction Period|Progressive Disease|0|||
162970662|NCT01332968|588593939|FG006|Induction Period|Progressive Disease|0|||
162970663|NCT01332968|588593940|FG007|Induction Period|Progressive Disease|0|||
162970664|NCT01332968|588593933|FG000|Induction Period|Protocol Violation|3|||
162970665|NCT01332968|588593934|FG001|Induction Period|Protocol Violation|4|||
162970666|NCT01332968|588593935|FG002|Induction Period|Protocol Violation|0|||
162970667|NCT01332968|588593936|FG003|Induction Period|Protocol Violation|0|||
162970668|NCT01332968|588593937|FG004|Induction Period|Protocol Violation|0|||
162970669|NCT01332968|588593938|FG005|Induction Period|Protocol Violation|0|||
162970670|NCT01332968|588593939|FG006|Induction Period|Protocol Violation|0|||
162970671|NCT01332968|588593940|FG007|Induction Period|Protocol Violation|0|||
162970672|NCT01332968|588593933|FG000|Induction Period|Withdrawal by Subject|3|||
162970673|NCT01332968|588593934|FG001|Induction Period|Withdrawal by Subject|5|||
162970674|NCT01332968|588593935|FG002|Induction Period|Withdrawal by Subject|0|||
162970675|NCT01332968|588593936|FG003|Induction Period|Withdrawal by Subject|0|||
162970676|NCT01332968|588593937|FG004|Induction Period|Withdrawal by Subject|0|||
162970677|NCT01332968|588593938|FG005|Induction Period|Withdrawal by Subject|0|||
162970678|NCT01332968|588593939|FG006|Induction Period|Withdrawal by Subject|0|||
162970679|NCT01332968|588593940|FG007|Induction Period|Withdrawal by Subject|0|||
162970680|NCT01332968|588593933|FG000|Induction Period|Randomised but not treated|4|||
162970681|NCT01332968|588593934|FG001|Induction Period|Randomised but not treated|7|||
162970682|NCT01332968|588593935|FG002|Induction Period|Randomised but not treated|0|||
162970683|NCT01332968|588593936|FG003|Induction Period|Randomised but not treated|0|||
162970684|NCT01332968|588593937|FG004|Induction Period|Randomised but not treated|0|||
162970685|NCT01332968|588593938|FG005|Induction Period|Randomised but not treated|0|||
162970686|NCT01332968|588593939|FG006|Induction Period|Randomised but not treated|0|||
162970687|NCT01332968|588593940|FG007|Induction Period|Randomised but not treated|0|||
162970688|NCT01332968|588593933|FG000|Maintenance/Observation Period|Adverse Event|0|||
162970689|NCT01332968|588593934|FG001|Maintenance/Observation Period|Adverse Event|0|||
162970690|NCT01332968|588593935|FG002|Maintenance/Observation Period|Adverse Event|53|||
162970691|NCT01332968|588593936|FG003|Maintenance/Observation Period|Adverse Event|66|||
162970692|NCT01332968|588593937|FG004|Maintenance/Observation Period|Adverse Event|0|||
162970693|NCT01332968|588593938|FG005|Maintenance/Observation Period|Adverse Event|0|||
162970694|NCT01332968|588593939|FG006|Maintenance/Observation Period|Adverse Event|0|||
162921638|NCT00572910|588414591|FG003|Overall Study|Adverse Event|2|||
162921639|NCT00572910|588414592|FG004|Overall Study|Adverse Event|0|||
162921640|NCT00572910|588414593|FG005|Overall Study|Adverse Event|0|||
162921641|NCT00572910|588414594|FG006|Overall Study|Adverse Event|4|||
162921642|NCT00572910|588414595|FG007|Overall Study|Adverse Event|2|||
162921643|NCT00572910|588414596|FG008|Overall Study|Adverse Event|1|||
162921644|NCT00572910|588414597|FG009|Overall Study|Adverse Event|3|||
162921645|NCT00572910|588414598|FG010|Overall Study|Adverse Event|2|||
162921646|NCT00572910|588414588|FG000|Overall Study|Lost to Follow-up|0|||
162921647|NCT00572910|588414589|FG001|Overall Study|Lost to Follow-up|1|||
162921648|NCT00572910|588414590|FG002|Overall Study|Lost to Follow-up|1|||
162921649|NCT00572910|588414591|FG003|Overall Study|Lost to Follow-up|2|||
162921650|NCT00572910|588414592|FG004|Overall Study|Lost to Follow-up|1|||
162921651|NCT00572910|588414593|FG005|Overall Study|Lost to Follow-up|0|||
162921652|NCT00572910|588414594|FG006|Overall Study|Lost to Follow-up|0|||
162921653|NCT00572910|588414595|FG007|Overall Study|Lost to Follow-up|0|||
162921654|NCT00572910|588414596|FG008|Overall Study|Lost to Follow-up|0|||
162921655|NCT00572910|588414597|FG009|Overall Study|Lost to Follow-up|1|||
162921656|NCT00572910|588414598|FG010|Overall Study|Lost to Follow-up|0|||
162921657|NCT00572910|588414588|FG000|Overall Study|Withdrawal by Subject|3|||
162921658|NCT00572910|588414589|FG001|Overall Study|Withdrawal by Subject|0|||
162921659|NCT00572910|588414590|FG002|Overall Study|Withdrawal by Subject|1|||
162921660|NCT00572910|588414591|FG003|Overall Study|Withdrawal by Subject|0|||
162921661|NCT00572910|588414592|FG004|Overall Study|Withdrawal by Subject|1|||
162921662|NCT00572910|588414593|FG005|Overall Study|Withdrawal by Subject|3|||
162921663|NCT00572910|588414594|FG006|Overall Study|Withdrawal by Subject|0|||
162921664|NCT00572910|588414595|FG007|Overall Study|Withdrawal by Subject|2|||
162921665|NCT00572910|588414596|FG008|Overall Study|Withdrawal by Subject|2|||
162921666|NCT00572910|588414597|FG009|Overall Study|Withdrawal by Subject|2|||
162921667|NCT00572910|588414598|FG010|Overall Study|Withdrawal by Subject|1|||
162921668|NCT01833897|588414604|FG000|Overall Study|Lack of Efficacy|1|||
162921669|NCT05275673|588414607|FG000|Overall Study|Study Termination by Sponsor|2|||
162921670|NCT05275673|588414608|FG001|Overall Study|Study Termination by Sponsor|3|||
162921671|NCT05275673|588414607|FG000|Overall Study|Death|1|||
162921672|NCT05275673|588414608|FG001|Overall Study|Death|0|||
162921673|NCT05275673|588414607|FG000|Overall Study|Withdrawal by Subject|1|||
162921674|NCT05275673|588414608|FG001|Overall Study|Withdrawal by Subject|0|||
162921675|NCT02325739|588414609|FG000|Phase I Part|Adverse Event|1|||
162921676|NCT02325739|588414610|FG001|Phase I Part|Adverse Event|0|||
162921677|NCT02325739|588414611|FG002|Phase I Part|Adverse Event|1|||
162921678|NCT02325739|588414612|FG003|Phase I Part|Adverse Event|2|||
162921679|NCT02325739|588414613|FG004|Phase I Part|Adverse Event|3|||
162921680|NCT02325739|588414614|FG005|Phase I Part|Adverse Event|1|||
162921681|NCT02325739|588414615|FG006|Phase I Part|Adverse Event|0|||
162921682|NCT02325739|588414616|FG007|Phase I Part|Adverse Event|2|||
162921683|NCT02325739|588414617|FG008|Phase I Part|Adverse Event|0|||
162921684|NCT02325739|588414618|FG009|Phase I Part|Adverse Event|0|||
162921685|NCT02325739|588414619|FG010|Phase I Part|Adverse Event|0|||
162921686|NCT02325739|588414609|FG000|Phase I Part|Progressive disease|9|||
162921687|NCT02325739|588414610|FG001|Phase I Part|Progressive disease|6|||
162921688|NCT02325739|588414611|FG002|Phase I Part|Progressive disease|3|||
162921689|NCT02325739|588414612|FG003|Phase I Part|Progressive disease|23|||
162921690|NCT02325739|588414613|FG004|Phase I Part|Progressive disease|14|||
162921691|NCT02325739|588414614|FG005|Phase I Part|Progressive disease|6|||
162921692|NCT02325739|588414615|FG006|Phase I Part|Progressive disease|6|||
162921693|NCT02325739|588414616|FG007|Phase I Part|Progressive disease|3|||
162921694|NCT02325739|588414617|FG008|Phase I Part|Progressive disease|0|||
162921695|NCT02325739|588414618|FG009|Phase I Part|Progressive disease|0|||
162921696|NCT02325739|588414619|FG010|Phase I Part|Progressive disease|0|||
162921697|NCT02325739|588414609|FG000|Phase I Part|Subject/guardian decision|1|||
162921698|NCT02325739|588414610|FG001|Phase I Part|Subject/guardian decision|0|||
162921699|NCT02325739|588414611|FG002|Phase I Part|Subject/guardian decision|1|||
162921700|NCT02325739|588414612|FG003|Phase I Part|Subject/guardian decision|1|||
162921701|NCT02325739|588414613|FG004|Phase I Part|Subject/guardian decision|0|||
162921702|NCT02325739|588414614|FG005|Phase I Part|Subject/guardian decision|0|||
162921703|NCT02325739|588414615|FG006|Phase I Part|Subject/guardian decision|0|||
162921704|NCT02325739|588414616|FG007|Phase I Part|Subject/guardian decision|1|||
162921705|NCT02325739|588414617|FG008|Phase I Part|Subject/guardian decision|0|||
162921706|NCT02325739|588414618|FG009|Phase I Part|Subject/guardian decision|0|||
162921707|NCT02325739|588414619|FG010|Phase I Part|Subject/guardian decision|0|||
162921708|NCT02325739|588414609|FG000|Phase I Part|Death|0|||
162921709|NCT02325739|588414610|FG001|Phase I Part|Death|0|||
162921710|NCT02325739|588414611|FG002|Phase I Part|Death|0|||
162921711|NCT02325739|588414612|FG003|Phase I Part|Death|0|||
162921712|NCT02325739|588414613|FG004|Phase I Part|Death|2|||
162921713|NCT02325739|588414614|FG005|Phase I Part|Death|0|||
162921714|NCT02325739|588414615|FG006|Phase I Part|Death|0|||
162921715|NCT02325739|588414616|FG007|Phase I Part|Death|0|||
162921716|NCT02325739|588414617|FG008|Phase I Part|Death|0|||
162921717|NCT02325739|588414618|FG009|Phase I Part|Death|0|||
162921718|NCT02325739|588414619|FG010|Phase I Part|Death|0|||
162921719|NCT02325739|588414609|FG000|Phase II Part|Adverse Event|0|||
162921720|NCT02325739|588414610|FG001|Phase II Part|Adverse Event|0|||
162921721|NCT02325739|588414611|FG002|Phase II Part|Adverse Event|0|||
162921722|NCT02325739|588414612|FG003|Phase II Part|Adverse Event|0|||
162921723|NCT02325739|588414613|FG004|Phase II Part|Adverse Event|0|||
162921724|NCT02325739|588414614|FG005|Phase II Part|Adverse Event|0|||
162921725|NCT02325739|588414615|FG006|Phase II Part|Adverse Event|0|||
162921726|NCT02325739|588414616|FG007|Phase II Part|Adverse Event|0|||
162921727|NCT02325739|588414617|FG008|Phase II Part|Adverse Event|4|||
162921728|NCT02325739|588414618|FG009|Phase II Part|Adverse Event|5|||
162921729|NCT02325739|588414619|FG010|Phase II Part|Adverse Event|1|||
162921730|NCT02325739|588414609|FG000|Phase II Part|Physician Decision|0|||
162921731|NCT02325739|588414610|FG001|Phase II Part|Physician Decision|0|||
162921732|NCT02325739|588414611|FG002|Phase II Part|Physician Decision|0|||
162921733|NCT02325739|588414612|FG003|Phase II Part|Physician Decision|0|||
162921734|NCT02325739|588414613|FG004|Phase II Part|Physician Decision|0|||
162921735|NCT02325739|588414614|FG005|Phase II Part|Physician Decision|0|||
162921736|NCT02325739|588414615|FG006|Phase II Part|Physician Decision|0|||
162921737|NCT02325739|588414616|FG007|Phase II Part|Physician Decision|0|||
162921738|NCT02325739|588414617|FG008|Phase II Part|Physician Decision|0|||
162921739|NCT02325739|588414618|FG009|Phase II Part|Physician Decision|1|||
162921740|NCT02325739|588414619|FG010|Phase II Part|Physician Decision|0|||
162921741|NCT02325739|588414609|FG000|Phase II Part|Progressive disease|0|||
162921742|NCT02325739|588414610|FG001|Phase II Part|Progressive disease|0|||
162921743|NCT02325739|588414611|FG002|Phase II Part|Progressive disease|0|||
162921744|NCT02325739|588414612|FG003|Phase II Part|Progressive disease|0|||
162921745|NCT02325739|588414613|FG004|Phase II Part|Progressive disease|0|||
162921746|NCT02325739|588414614|FG005|Phase II Part|Progressive disease|0|||
162921747|NCT02325739|588414615|FG006|Phase II Part|Progressive disease|0|||
162921748|NCT02325739|588414616|FG007|Phase II Part|Progressive disease|0|||
162921749|NCT02325739|588414617|FG008|Phase II Part|Progressive disease|22|||
162921750|NCT02325739|588414618|FG009|Phase II Part|Progressive disease|29|||
162921751|NCT02325739|588414619|FG010|Phase II Part|Progressive disease|18|||
162921752|NCT02325739|588414609|FG000|Phase II Part|Subject/guardian decision|0|||
162921753|NCT02325739|588414610|FG001|Phase II Part|Subject/guardian decision|0|||
162921754|NCT02325739|588414611|FG002|Phase II Part|Subject/guardian decision|0|||
162921755|NCT02325739|588414612|FG003|Phase II Part|Subject/guardian decision|0|||
162921756|NCT02325739|588414613|FG004|Phase II Part|Subject/guardian decision|0|||
162921757|NCT02325739|588414614|FG005|Phase II Part|Subject/guardian decision|0|||
162921758|NCT02325739|588414615|FG006|Phase II Part|Subject/guardian decision|0|||
162921759|NCT02325739|588414616|FG007|Phase II Part|Subject/guardian decision|0|||
162921760|NCT02325739|588414617|FG008|Phase II Part|Subject/guardian decision|4|||
162921761|NCT02325739|588414618|FG009|Phase II Part|Subject/guardian decision|1|||
162921762|NCT02325739|588414619|FG010|Phase II Part|Subject/guardian decision|1|||
162921763|NCT00227591|588414620|FG000|Overall Study|Withdrawal by Subject|1|||
162921764|NCT05048875|588414622|FG000|Overall Study|Withdrawal by Subject|1|||
162921765|NCT05048875|588414623|FG001|Overall Study|Withdrawal by Subject|0|||
162921766|NCT05048875|588414624|FG002|Overall Study|Withdrawal by Subject|0|||
162921767|NCT05048875|588414625|FG003|Overall Study|Withdrawal by Subject|0|||
162921768|NCT05048875|588414626|FG004|Overall Study|Withdrawal by Subject|0|||
162921769|NCT05048875|588414627|FG005|Overall Study|Withdrawal by Subject|0|||
162921770|NCT05048875|588414628|FG006|Overall Study|Withdrawal by Subject|0|||
162921771|NCT05048875|588414629|FG007|Overall Study|Withdrawal by Subject|0|||
162970695|NCT01332968|588593940|FG007|Maintenance/Observation Period|Adverse Event|0|||
162970696|NCT01332968|588593933|FG000|Maintenance/Observation Period|Death|0|||
162970697|NCT01332968|588593934|FG001|Maintenance/Observation Period|Death|0|||
162970698|NCT01332968|588593935|FG002|Maintenance/Observation Period|Death|5|||
162629984|NCT00968201|587362681|FG001|Extension Study - (Period III)|Protocol Violation|17|||
162629985|NCT00968201|587362682|FG002|Extension Study - (Period III)|Protocol Violation|14|||
162629986|NCT00968201|587362680|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
162629987|NCT00968201|587362681|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
162629988|NCT00968201|587362682|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
162629989|NCT00968201|587362680|FG000|Extension Study - (Period III)|Patient Relocated|0|||
162921772|NCT05048875|588414622|FG000|Overall Study|Adverse Event|0|||
162921773|NCT05048875|588414623|FG001|Overall Study|Adverse Event|0|||
162921774|NCT05048875|588414624|FG002|Overall Study|Adverse Event|0|||
162921775|NCT05048875|588414625|FG003|Overall Study|Adverse Event|1|||
162921776|NCT05048875|588414626|FG004|Overall Study|Adverse Event|0|||
162921777|NCT05048875|588414627|FG005|Overall Study|Adverse Event|0|||
162921778|NCT05048875|588414628|FG006|Overall Study|Adverse Event|0|||
162921779|NCT05048875|588414629|FG007|Overall Study|Adverse Event|0|||
162921780|NCT02255422|588414630|FG000|Overall Study|Withdrawal by Subject|0|||
162712516|NCT02001623|587658507|FG008|Overall Study|Lost to Follow-up|0|||
162921781|NCT02255422|588414631|FG001|Overall Study|Withdrawal by Subject|0|||
162921782|NCT02255422|588414632|FG002|Overall Study|Withdrawal by Subject|0|||
162921783|NCT02255422|588414633|FG003|Overall Study|Withdrawal by Subject|0|||
162921784|NCT02255422|588414634|FG004|Overall Study|Withdrawal by Subject|0|||
162712517|NCT02001623|587658508|FG009|Overall Study|Lost to Follow-up|1|||
162712518|NCT02001623|587658509|FG010|Overall Study|Lost to Follow-up|0|||
162712519|NCT02001623|587658510|FG011|Overall Study|Lost to Follow-up|0|||
162712520|NCT02001623|587658511|FG012|Overall Study|Lost to Follow-up|0|||
162712521|NCT02001623|587658512|FG013|Overall Study|Lost to Follow-up|0|||
162712522|NCT02001623|587658513|FG014|Overall Study|Lost to Follow-up|0|||
162921785|NCT02255422|588414635|FG005|Overall Study|Withdrawal by Subject|0|||
162921786|NCT02255422|588414636|FG006|Overall Study|Withdrawal by Subject|2|||
162712523|NCT02001623|587658499|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
162712524|NCT02001623|587658500|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
162921787|NCT02255422|588414630|FG000|Overall Study|Lost to Follow-up|0|||
162921788|NCT02255422|588414631|FG001|Overall Study|Lost to Follow-up|0|||
162921789|NCT02255422|588414632|FG002|Overall Study|Lost to Follow-up|1|||
162921790|NCT02255422|588414633|FG003|Overall Study|Lost to Follow-up|0|||
162712525|NCT02001623|587658501|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
162712526|NCT02001623|587658502|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
162712527|NCT02001623|587658503|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
162712528|NCT02001623|587658504|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
162712529|NCT02001623|587658505|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
162712530|NCT02001623|587658506|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
162712531|NCT02001623|587658507|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
162712532|NCT02001623|587658508|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
162712533|NCT02001623|587658509|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
162712534|NCT02001623|587658510|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
162712535|NCT02001623|587658511|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
162712536|NCT02001623|587658512|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
162712537|NCT02001623|587658513|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
162712538|NCT02001623|587658499|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
162712539|NCT02001623|587658500|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
162712540|NCT02001623|587658501|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
162712541|NCT02001623|587658502|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
162712542|NCT02001623|587658503|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
162712543|NCT02001623|587658504|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
162712544|NCT02001623|587658505|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
162712545|NCT02001623|587658506|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
162712546|NCT02001623|587658507|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
162712547|NCT02001623|587658508|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
162712548|NCT02001623|587658509|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
162712549|NCT02001623|587658510|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
162712550|NCT02001623|587658511|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
162712551|NCT02001623|587658512|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
162712552|NCT02001623|587658513|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
162712553|NCT01063036|587658516|FG000|Participants Treated With Study Drug|Adverse Event|1|||
162921791|NCT02255422|588414634|FG004|Overall Study|Lost to Follow-up|0|||
162921792|NCT02255422|588414635|FG005|Overall Study|Lost to Follow-up|0|||
162921793|NCT02255422|588414636|FG006|Overall Study|Lost to Follow-up|0|||
162921794|NCT03179462|588414644|FG000|Overall Study|screening failure|1|||
162921795|NCT03179462|588414645|FG001|Overall Study|screening failure|2|||
162921796|NCT03179462|588414646|FG002|Overall Study|screening failure|0|||
162921797|NCT04410978|588414655|FG000|Overall Study|Poor compliance to protocol|2|||
162921798|NCT04410978|588414656|FG001|Overall Study|Poor compliance to protocol|4|||
162921799|NCT04410978|588414655|FG000|Overall Study|Withdrawal by Subject|64|||
162921800|NCT04410978|588414656|FG001|Overall Study|Withdrawal by Subject|66|||
162921801|NCT04410978|588414655|FG000|Overall Study|Other|6|||
162921802|NCT04410978|588414656|FG001|Overall Study|Other|7|||
162921803|NCT04410978|588414655|FG000|Overall Study|Missing study status|1|||
162921804|NCT04410978|588414656|FG001|Overall Study|Missing study status|0|||
162921805|NCT05153629|588414657|FG000|Overall Study|Withdrawal by Subject|0|||
162921806|NCT05153629|588414658|FG001|Overall Study|Withdrawal by Subject|2|||
162921807|NCT04089566|588414661|FG000|Overall Study|Death|0|||
162921808|NCT04089566|588414662|FG001|Overall Study|Death|6|||
162712554|NCT01063036|587658516|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
162712555|NCT01063036|587658516|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
162921809|NCT04089566|588414663|FG002|Overall Study|Death|10|||
162970699|NCT01332968|588593936|FG003|Maintenance/Observation Period|Death|6|||
162970700|NCT01332968|588593937|FG004|Maintenance/Observation Period|Death|0|||
162970701|NCT01332968|588593938|FG005|Maintenance/Observation Period|Death|0|||
162970702|NCT01332968|588593939|FG006|Maintenance/Observation Period|Death|0|||
162970703|NCT01332968|588593940|FG007|Maintenance/Observation Period|Death|0|||
162970704|NCT01332968|588593933|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
162970705|NCT01332968|588593934|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
162970706|NCT01332968|588593935|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
162970707|NCT01332968|588593936|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
162921810|NCT04089566|588414664|FG003|Overall Study|Death|0|||
162921811|NCT04089566|588414665|FG004|Overall Study|Death|0|||
162921812|NCT04089566|588414666|FG005|Overall Study|Death|0|||
163056346|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056347|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163056348|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056349|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056350|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
162921813|NCT04089566|588414661|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
162921814|NCT04089566|588414662|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
162921815|NCT04089566|588414663|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
162921816|NCT04089566|588414664|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
162921817|NCT04089566|588414665|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
163056351|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056352|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
163056353|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056354|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
163056355|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056356|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056357|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056358|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056359|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
163056360|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056361|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163056362|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056363|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056364|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056365|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056366|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
163056367|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056368|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
163056369|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056370|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056371|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056372|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056373|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056374|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
163056375|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
163056376|NCT01791595|588918380|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056377|NCT01791595|588918381|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056378|NCT01791595|588918382|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056379|NCT01791595|588918383|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056380|NCT01791595|588918384|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056381|NCT01791595|588918385|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
163056382|NCT01791595|588918386|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163056383|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056384|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056385|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056386|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056387|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056388|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
163056389|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
163056390|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056391|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056392|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
162921818|NCT04089566|588414666|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
162921819|NCT04089566|588414661|FG000|Overall Study|Reason not Specified|0|||
162921820|NCT04089566|588414662|FG001|Overall Study|Reason not Specified|4|||
162921821|NCT04089566|588414663|FG002|Overall Study|Reason not Specified|4|||
162921822|NCT04089566|588414664|FG003|Overall Study|Reason not Specified|1|||
163056393|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056394|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
163056395|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
162629990|NCT00968201|587362681|FG001|Extension Study - (Period III)|Patient Relocated|1|||
162921823|NCT04089566|588414665|FG004|Overall Study|Reason not Specified|0|||
162629991|NCT00968201|587362682|FG002|Extension Study - (Period III)|Patient Relocated|1|||
163056396|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
162921824|NCT04089566|588414666|FG005|Overall Study|Reason not Specified|0|||
162921825|NCT01083121|588414667|FG000|Overall Study|Use of Humira outside the approved label|81|||
162921826|NCT05403502|588414669|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
162921827|NCT05403502|588414669|FG000|Humalog Lead-In Period|Physician Decision|2|||
162921828|NCT05403502|588414669|FG000|Humalog Lead-In Period|Protocol Violation|1|||
162921829|NCT05403502|588414669|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
162921830|NCT05403502|588414669|FG000|Lyumjev Treatment Period|Physician Decision|2|||
162921831|NCT01593761|588414670|FG000|Overall Study|Lost to Follow-up|1|||
162921832|NCT01593761|588414670|FG000|Overall Study|culture negative for MRSA at baseline|5|||
162921833|NCT01593761|588414670|FG000|Overall Study|positive for hepatitis C virus|1|||
162921834|NCT01593761|588414670|FG000|Overall Study|secondary cellulitis|1|||
162921835|NCT02576951|588414671|FG000|Overall Study|Lost to Follow-up|0|||
162921836|NCT02576951|588414672|FG001|Overall Study|Lost to Follow-up|0|||
162921837|NCT02576951|588414673|FG002|Overall Study|Lost to Follow-up|2|||
162921838|NCT02576951|588414674|FG003|Overall Study|Lost to Follow-up|2|||
162921839|NCT02576951|588414671|FG000|Overall Study|Withdrawal by Subject|1|||
162921840|NCT02576951|588414672|FG001|Overall Study|Withdrawal by Subject|0|||
162921841|NCT02576951|588414673|FG002|Overall Study|Withdrawal by Subject|0|||
162921842|NCT02576951|588414674|FG003|Overall Study|Withdrawal by Subject|2|||
162921843|NCT02576951|588414671|FG000|Overall Study|Protocol Violation|0|||
162921844|NCT02576951|588414672|FG001|Overall Study|Protocol Violation|0|||
162921845|NCT02576951|588414673|FG002|Overall Study|Protocol Violation|0|||
162921846|NCT02576951|588414674|FG003|Overall Study|Protocol Violation|1|||
162921847|NCT00223990|588414675|FG000|Overall Study|Moved from area|2|||
162921848|NCT00223990|588414676|FG001|Overall Study|Moved from area|1|||
162921849|NCT00223990|588414675|FG000|Overall Study|Withdrawal by Subject|4|||
162921850|NCT00223990|588414676|FG001|Overall Study|Withdrawal by Subject|8|||
162921851|NCT00223990|588414675|FG000|Overall Study|Lost to Follow-up|1|||
162921852|NCT00223990|588414676|FG001|Overall Study|Lost to Follow-up|0|||
162921853|NCT03505606|588416676|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
162921854|NCT03505606|588416677|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
162921855|NCT03505606|588416678|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
162921856|NCT03505606|588416676|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
162921857|NCT03505606|588416677|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
162921858|NCT03505606|588416678|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
162921859|NCT03505606|588416676|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
162921860|NCT03505606|588416677|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
162921861|NCT03505606|588416678|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
162921862|NCT03505606|588416676|FG000|Overall Study|Poor compliance with refractive correction|0|||
162921863|NCT03505606|588416677|FG001|Overall Study|Poor compliance with refractive correction|0|||
162921864|NCT03505606|588416678|FG002|Overall Study|Poor compliance with refractive correction|1|||
162921865|NCT03505606|588416676|FG000|Overall Study|Insufficient anisometropia|0|||
162921866|NCT03505606|588416677|FG001|Overall Study|Insufficient anisometropia|0|||
162921867|NCT03505606|588416678|FG002|Overall Study|Insufficient anisometropia|2|||
162921868|NCT03505606|588416676|FG000|Overall Study|Ectopia Lentis|0|||
162921869|NCT03505606|588416677|FG001|Overall Study|Ectopia Lentis|0|||
162921870|NCT03505606|588416678|FG002|Overall Study|Ectopia Lentis|1|||
162921871|NCT03505606|588416676|FG000|Overall Study|alternation of amblyopic eye|0|||
162921872|NCT03505606|588416677|FG001|Overall Study|alternation of amblyopic eye|1|||
162921873|NCT03505606|588416678|FG002|Overall Study|alternation of amblyopic eye|0|||
162921874|NCT02087865|588416681|FG000|Overall Study|Withdrawal by Subject|6|||
162921875|NCT02087865|588416682|FG001|Overall Study|Withdrawal by Subject|0|||
162921876|NCT02087865|588416683|FG002|Overall Study|Withdrawal by Subject|1|||
162921877|NCT02087865|588416681|FG000|Overall Study|Lost to Follow-up|0|||
162921878|NCT02087865|588416682|FG001|Overall Study|Lost to Follow-up|0|||
162921879|NCT02087865|588416683|FG002|Overall Study|Lost to Follow-up|1|||
162921880|NCT02087865|588416681|FG000|Overall Study|Drug Non-compliance|0|||
162921881|NCT02087865|588416682|FG001|Overall Study|Drug Non-compliance|2|||
162921882|NCT02087865|588416683|FG002|Overall Study|Drug Non-compliance|0|||
162921883|NCT02087865|588416681|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
162921884|NCT02087865|588416682|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
162921885|NCT02087865|588416683|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
162921886|NCT01319994|588416684|FG000|Overall Study|Protocol Violation|7|||
162970708|NCT01332968|588593937|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
162921887|NCT01319994|588416685|FG001|Overall Study|Protocol Violation|6|||
162921888|NCT01340794|588416686|FG000|Overall Study|Withdrawal by Subject|0|||
162921889|NCT01340794|588416687|FG001|Overall Study|Withdrawal by Subject|1|||
162921890|NCT01432600|588416694|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
162921891|NCT01432600|588416695|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
162921892|NCT01432600|588416696|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
162921893|NCT00398632|588416697|FG000|Overall Study|Withdrawal by Subject|1|||
162921894|NCT00398632|588416697|FG000|Overall Study|Lack of Efficacy|1|||
162921895|NCT00640614|588416698|FG000|Overall Study|Lost to Follow-up|1|||
162921896|NCT00640614|588416699|FG001|Overall Study|Lost to Follow-up|0|||
162921897|NCT01005680|588416706|FG000|Overall Study|Lost to Follow-up|4|||
162921898|NCT01005680|588416707|FG001|Overall Study|Lost to Follow-up|6|||
162921899|NCT01005680|588416706|FG000|Overall Study|Withdrawal by Subject|1|||
162921900|NCT01005680|588416707|FG001|Overall Study|Withdrawal by Subject|4|||
162921901|NCT01005680|588416706|FG000|Overall Study|Physician Decision|1|||
162921902|NCT01005680|588416707|FG001|Overall Study|Physician Decision|1|||
162921903|NCT00297882|588416709|FG000|Day 14|Lack of Efficacy|12|||
162921904|NCT00297882|588416710|FG001|Day 14|Lack of Efficacy|49|||
162921905|NCT00297882|588416709|FG000|Day 28|Lost to Follow-up|13|||
162921906|NCT00297882|588416710|FG001|Day 28|Lost to Follow-up|23|||
162921907|NCT00297882|588416709|FG000|Day 28|Lack of Efficacy|3|||
162921908|NCT00297882|588416710|FG001|Day 28|Lack of Efficacy|0|||
162921909|NCT02118896|588416711|FG000|Overall Study|Death|4|||
162921910|NCT02118896|588416712|FG001|Overall Study|Death|0|||
162921911|NCT02118896|588416713|FG002|Overall Study|Death|4|||
162921912|NCT02118896|588416714|FG003|Overall Study|Death|6|||
162921913|NCT02118896|588416715|FG004|Overall Study|Death|3|||
162921914|NCT02118896|588416716|FG005|Overall Study|Death|1|||
162921915|NCT02118896|588416717|FG006|Overall Study|Death|0|||
162921916|NCT02118896|588416718|FG007|Overall Study|Death|0|||
162921917|NCT02118896|588416719|FG008|Overall Study|Death|0|||
162921918|NCT02118896|588416720|FG009|Overall Study|Death|0|||
162921919|NCT02118896|588416711|FG000|Overall Study|Adverse Event|5|||
162921920|NCT02118896|588416712|FG001|Overall Study|Adverse Event|4|||
162921921|NCT02118896|588416713|FG002|Overall Study|Adverse Event|4|||
162921922|NCT02118896|588416714|FG003|Overall Study|Adverse Event|5|||
162921923|NCT02118896|588416715|FG004|Overall Study|Adverse Event|5|||
162921924|NCT02118896|588416716|FG005|Overall Study|Adverse Event|9|||
162921925|NCT02118896|588416717|FG006|Overall Study|Adverse Event|1|||
162921926|NCT02118896|588416718|FG007|Overall Study|Adverse Event|1|||
162921927|NCT02118896|588416719|FG008|Overall Study|Adverse Event|4|||
162921928|NCT02118896|588416720|FG009|Overall Study|Adverse Event|0|||
162921929|NCT02118896|588416711|FG000|Overall Study|Consent withdrawn|2|||
162921930|NCT02118896|588416712|FG001|Overall Study|Consent withdrawn|0|||
162921931|NCT02118896|588416713|FG002|Overall Study|Consent withdrawn|3|||
162921932|NCT02118896|588416714|FG003|Overall Study|Consent withdrawn|4|||
162921933|NCT02118896|588416715|FG004|Overall Study|Consent withdrawn|1|||
162921934|NCT02118896|588416716|FG005|Overall Study|Consent withdrawn|4|||
162921935|NCT02118896|588416717|FG006|Overall Study|Consent withdrawn|0|||
162921936|NCT02118896|588416718|FG007|Overall Study|Consent withdrawn|0|||
162921937|NCT02118896|588416719|FG008|Overall Study|Consent withdrawn|0|||
162921938|NCT02118896|588416720|FG009|Overall Study|Consent withdrawn|0|||
162921939|NCT02118896|588416711|FG000|Overall Study|Non-compliance|2|||
162921940|NCT02118896|588416712|FG001|Overall Study|Non-compliance|1|||
162921941|NCT02118896|588416713|FG002|Overall Study|Non-compliance|1|||
162921942|NCT02118896|588416714|FG003|Overall Study|Non-compliance|5|||
162921943|NCT02118896|588416715|FG004|Overall Study|Non-compliance|0|||
162921944|NCT02118896|588416716|FG005|Overall Study|Non-compliance|1|||
162921945|NCT02118896|588416717|FG006|Overall Study|Non-compliance|0|||
162921946|NCT02118896|588416718|FG007|Overall Study|Non-compliance|1|||
162921947|NCT02118896|588416719|FG008|Overall Study|Non-compliance|0|||
162921948|NCT02118896|588416720|FG009|Overall Study|Non-compliance|0|||
162921949|NCT02118896|588416711|FG000|Overall Study|Pregnancy|1|||
162921950|NCT02118896|588416712|FG001|Overall Study|Pregnancy|1|||
162921951|NCT02118896|588416713|FG002|Overall Study|Pregnancy|0|||
162921952|NCT02118896|588416714|FG003|Overall Study|Pregnancy|0|||
162921953|NCT02118896|588416715|FG004|Overall Study|Pregnancy|1|||
162921954|NCT02118896|588416716|FG005|Overall Study|Pregnancy|3|||
162921955|NCT02118896|588416717|FG006|Overall Study|Pregnancy|1|||
162921956|NCT02118896|588416718|FG007|Overall Study|Pregnancy|0|||
162921957|NCT02118896|588416719|FG008|Overall Study|Pregnancy|0|||
162921958|NCT02118896|588416720|FG009|Overall Study|Pregnancy|0|||
162921959|NCT02118896|588416711|FG000|Overall Study|Lost to Follow-up|1|||
162921960|NCT02118896|588416712|FG001|Overall Study|Lost to Follow-up|2|||
162921961|NCT02118896|588416713|FG002|Overall Study|Lost to Follow-up|1|||
162921962|NCT02118896|588416714|FG003|Overall Study|Lost to Follow-up|0|||
162921963|NCT02118896|588416715|FG004|Overall Study|Lost to Follow-up|2|||
162921964|NCT02118896|588416716|FG005|Overall Study|Lost to Follow-up|1|||
162921965|NCT02118896|588416717|FG006|Overall Study|Lost to Follow-up|0|||
162921966|NCT02118896|588416718|FG007|Overall Study|Lost to Follow-up|0|||
162921967|NCT02118896|588416719|FG008|Overall Study|Lost to Follow-up|0|||
162921968|NCT02118896|588416720|FG009|Overall Study|Lost to Follow-up|0|||
162921969|NCT02118896|588416711|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
162921970|NCT02118896|588416712|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
162921971|NCT02118896|588416713|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
162921972|NCT02118896|588416714|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
162921973|NCT02118896|588416715|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
162921974|NCT02118896|588416716|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
162921975|NCT02118896|588416717|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
162921976|NCT02118896|588416718|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
163056397|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056398|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
162921977|NCT02118896|588416719|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
162921978|NCT02118896|588416720|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
162921979|NCT02118896|588416711|FG000|Overall Study|Prohibited medication|0|||
162921980|NCT02118896|588416712|FG001|Overall Study|Prohibited medication|0|||
162921981|NCT02118896|588416713|FG002|Overall Study|Prohibited medication|0|||
162921982|NCT02118896|588416714|FG003|Overall Study|Prohibited medication|0|||
162921983|NCT02118896|588416715|FG004|Overall Study|Prohibited medication|1|||
162921984|NCT02118896|588416716|FG005|Overall Study|Prohibited medication|3|||
162921985|NCT02118896|588416717|FG006|Overall Study|Prohibited medication|0|||
162921986|NCT02118896|588416718|FG007|Overall Study|Prohibited medication|0|||
162921987|NCT02118896|588416719|FG008|Overall Study|Prohibited medication|0|||
162921988|NCT02118896|588416720|FG009|Overall Study|Prohibited medication|0|||
162921989|NCT02118896|588416711|FG000|Overall Study|Miscellaneous|1|||
162921990|NCT02118896|588416712|FG001|Overall Study|Miscellaneous|2|||
162921991|NCT02118896|588416713|FG002|Overall Study|Miscellaneous|0|||
162921992|NCT02118896|588416714|FG003|Overall Study|Miscellaneous|2|||
162921993|NCT02118896|588416715|FG004|Overall Study|Miscellaneous|0|||
162921994|NCT02118896|588416716|FG005|Overall Study|Miscellaneous|4|||
162921995|NCT02118896|588416717|FG006|Overall Study|Miscellaneous|0|||
162921996|NCT02118896|588416718|FG007|Overall Study|Miscellaneous|0|||
162921997|NCT02118896|588416719|FG008|Overall Study|Miscellaneous|0|||
162921998|NCT02118896|588416720|FG009|Overall Study|Miscellaneous|0|||
162921999|NCT04242264|588416721|FG000|Overall Study|Lost to Follow-up|2|||
162922000|NCT04242264|588416722|FG001|Overall Study|Lost to Follow-up|2|||
162922001|NCT04242264|588416723|FG002|Overall Study|Lost to Follow-up|1|||
162922002|NCT04242264|588416724|FG003|Overall Study|Lost to Follow-up|1|||
162922003|NCT04242264|588416721|FG000|Overall Study|Withdrawal by Subject|1|||
162922004|NCT04242264|588416722|FG001|Overall Study|Withdrawal by Subject|0|||
162922005|NCT04242264|588416723|FG002|Overall Study|Withdrawal by Subject|0|||
162922006|NCT04242264|588416724|FG003|Overall Study|Withdrawal by Subject|0|||
162922007|NCT04221373|588416725|FG000|Overall Study|Physician Decision|4|||
162922008|NCT04221373|588416726|FG001|Overall Study|Physician Decision|0|||
162922009|NCT04139642|588416736|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
162922010|NCT04139642|588416737|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
162922011|NCT00577031|588416746|FG000|Overall Study|Adverse Event|52|||
162922012|NCT00577031|588416746|FG000|Overall Study|Progression of disease|93|||
162922013|NCT00577031|588416746|FG000|Overall Study|Protocol Violation|5|||
162922014|NCT00577031|588416746|FG000|Overall Study|Participant withdrew consent|13|||
162922015|NCT00577031|588416746|FG000|Overall Study|Participant non-compliance|5|||
162922016|NCT00577031|588416746|FG000|Overall Study|Need for surgery|17|||
162922017|NCT00577031|588416746|FG000|Overall Study|Medical decision|14|||
163056399|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056400|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056401|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056402|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163056403|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
163056404|NCT01791595|588918380|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056405|NCT01791595|588918381|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056406|NCT01791595|588918382|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
162629992|NCT00968201|587362680|FG000|Extension Study - (Period III)|Noncompliance|0|||
162629993|NCT00968201|587362681|FG001|Extension Study - (Period III)|Noncompliance|0|||
162629994|NCT00968201|587362682|FG002|Extension Study - (Period III)|Noncompliance|3|||
162629995|NCT00968201|587362680|FG000|Extension Study - (Period III)|Other|0|||
162922018|NCT00577031|588416746|FG000|Overall Study|Death|6|||
162922019|NCT00557830|588416747|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
162922020|NCT00557830|588416748|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
162922021|NCT00557830|588416749|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
162922022|NCT00557830|588416747|FG000|Screening Treatment Phase|Adverse Event|2|||
162922023|NCT00557830|588416748|FG001|Screening Treatment Phase|Adverse Event|0|||
162922024|NCT00557830|588416749|FG002|Screening Treatment Phase|Adverse Event|0|||
162629996|NCT00968201|587362681|FG001|Extension Study - (Period III)|Other|0|||
162629997|NCT00968201|587362682|FG002|Extension Study - (Period III)|Other|2|||
162629998|NCT00968201|587362680|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
162922025|NCT00557830|588416747|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
162922026|NCT00557830|588416748|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
162922027|NCT00557830|588416749|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
162922028|NCT00538473|588416751|FG000|Overall Study|Adverse Event|1|||
162922029|NCT00538473|588416752|FG001|Overall Study|Adverse Event|0|||
162922030|NCT01569074|588416753|FG000|Overall Study|Study stopped|6|||
163056407|NCT01791595|588918383|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
162629999|NCT00968201|587362681|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
162922031|NCT01569074|588416754|FG001|Overall Study|Study stopped|6|||
162922032|NCT01569074|588416755|FG002|Overall Study|Study stopped|8|||
162922033|NCT01569074|588416756|FG003|Overall Study|Study stopped|7|||
162922034|NCT01569074|588416757|FG004|Overall Study|Study stopped|7|||
162922035|NCT01569074|588416753|FG000|Overall Study|Study-specific discontinuation criteria|0|||
162922036|NCT01569074|588416754|FG001|Overall Study|Study-specific discontinuation criteria|1|||
162922037|NCT01569074|588416755|FG002|Overall Study|Study-specific discontinuation criteria|0|||
162922038|NCT01569074|588416756|FG003|Overall Study|Study-specific discontinuation criteria|0|||
162922039|NCT01569074|588416757|FG004|Overall Study|Study-specific discontinuation criteria|0|||
162922040|NCT01569074|588416753|FG000|Overall Study|Severe non-compliance to protocol|0|||
162922041|NCT01569074|588416754|FG001|Overall Study|Severe non-compliance to protocol|0|||
162922042|NCT01569074|588416755|FG002|Overall Study|Severe non-compliance to protocol|1|||
162922043|NCT01569074|588416756|FG003|Overall Study|Severe non-compliance to protocol|0|||
162922044|NCT01569074|588416757|FG004|Overall Study|Severe non-compliance to protocol|0|||
162922045|NCT01569074|588416753|FG000|Overall Study|eg change in circumstances|0|||
162922046|NCT01569074|588416754|FG001|Overall Study|eg change in circumstances|2|||
162922047|NCT01569074|588416755|FG002|Overall Study|eg change in circumstances|0|||
162922048|NCT01569074|588416756|FG003|Overall Study|eg change in circumstances|1|||
162922049|NCT01569074|588416757|FG004|Overall Study|eg change in circumstances|1|||
162922050|NCT01569074|588416753|FG000|Overall Study|Adverse Event|1|||
162922051|NCT01569074|588416754|FG001|Overall Study|Adverse Event|0|||
162922052|NCT01569074|588416755|FG002|Overall Study|Adverse Event|3|||
162922053|NCT01569074|588416756|FG003|Overall Study|Adverse Event|0|||
162922054|NCT01569074|588416757|FG004|Overall Study|Adverse Event|0|||
162922055|NCT00669110|588416758|FG000|Overall Study|Adverse Event|4|||
162922056|NCT00669110|588416759|FG001|Overall Study|Adverse Event|3|||
162922057|NCT00669110|588416758|FG000|Overall Study|Caregiver request|3|||
162922058|NCT00669110|588416759|FG001|Overall Study|Caregiver request|2|||
162922059|NCT00669110|588416758|FG000|Overall Study|Physician Decision|0|||
162922060|NCT00669110|588416759|FG001|Overall Study|Physician Decision|1|||
162922061|NCT00669110|588416758|FG000|Overall Study|Lost to Follow-up|1|||
162922062|NCT00669110|588416759|FG001|Overall Study|Lost to Follow-up|0|||
162922063|NCT00669110|588416758|FG000|Overall Study|Protocol Violation|0|||
162922064|NCT00669110|588416759|FG001|Overall Study|Protocol Violation|5|||
162922065|NCT00669110|588416758|FG000|Overall Study|Withdrawal by Subject|0|||
162922066|NCT00669110|588416759|FG001|Overall Study|Withdrawal by Subject|2|||
162922067|NCT05168657|588416762|FG000|Overall Study|Adverse Event|0|||
162922068|NCT05168657|588416763|FG001|Overall Study|Adverse Event|0|||
162922069|NCT05168657|588416764|FG002|Overall Study|Adverse Event|1|||
162922070|NCT05168657|588416765|FG003|Overall Study|Adverse Event|0|||
162922071|NCT05168657|588416766|FG004|Overall Study|Adverse Event|0|||
162922072|NCT05168657|588416767|FG005|Overall Study|Adverse Event|0|||
162922073|NCT05168657|588416768|FG006|Overall Study|Adverse Event|0|||
162922074|NCT05168657|588416769|FG007|Overall Study|Adverse Event|0|||
162922075|NCT00962013|588416770|FG000|Overall Study|Did not have surgery|1|||
162922076|NCT00962013|588416770|FG000|Overall Study|Death|8|||
162922077|NCT00962013|588416770|FG000|Overall Study|Lost to Follow-up|12|||
162922078|NCT00962013|588416770|FG000|Overall Study|Unable/Unwilling to return|6|||
162922079|NCT00962013|588416770|FG000|Overall Study|Withdrawal by Subject|8|||
162922080|NCT00962013|588416770|FG000|Overall Study|Removal of study device|3|||
162922081|NCT00962013|588416770|FG000|Overall Study|Site Termination|24|||
162922082|NCT00962013|588416770|FG000|Overall Study|No 5 year evaluation|6|||
162922083|NCT02335411|588416771|FG000|Overall Study|Death|223|||
162922084|NCT02335411|588416772|FG001|Overall Study|Death|22|||
162922085|NCT02335411|588416773|FG002|Overall Study|Death|26|||
162922086|NCT02335411|588416771|FG000|Overall Study|Physician Decision|3|||
162922087|NCT02335411|588416772|FG001|Overall Study|Physician Decision|0|||
162970709|NCT01332968|588593938|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
162970710|NCT01332968|588593939|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
162970711|NCT01332968|588593940|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
162970712|NCT01332968|588593933|FG000|Maintenance/Observation Period|Non-compliance|0|||
162970713|NCT01332968|588593934|FG001|Maintenance/Observation Period|Non-compliance|0|||
162970714|NCT01332968|588593935|FG002|Maintenance/Observation Period|Non-compliance|4|||
162970715|NCT01332968|588593936|FG003|Maintenance/Observation Period|Non-compliance|3|||
162970716|NCT01332968|588593937|FG004|Maintenance/Observation Period|Non-compliance|0|||
162970717|NCT01332968|588593938|FG005|Maintenance/Observation Period|Non-compliance|0|||
162970718|NCT01332968|588593939|FG006|Maintenance/Observation Period|Non-compliance|0|||
162922088|NCT02335411|588416773|FG002|Overall Study|Physician Decision|0|||
162922089|NCT02335411|588416771|FG000|Overall Study|Protocol Violation|1|||
162922090|NCT02335411|588416772|FG001|Overall Study|Protocol Violation|0|||
162922091|NCT02335411|588416773|FG002|Overall Study|Protocol Violation|0|||
162922092|NCT02335411|588416771|FG000|Overall Study|Withdrawal by Subject|11|||
162922093|NCT02335411|588416772|FG001|Overall Study|Withdrawal by Subject|0|||
162922094|NCT02335411|588416773|FG002|Overall Study|Withdrawal by Subject|3|||
162922095|NCT02335411|588416771|FG000|Overall Study|Sponsor Decision|12|||
162922096|NCT02335411|588416772|FG001|Overall Study|Sponsor Decision|3|||
162970719|NCT01332968|588593940|FG007|Maintenance/Observation Period|Non-compliance|0|||
162922097|NCT02335411|588416773|FG002|Overall Study|Sponsor Decision|2|||
162922098|NCT02335411|588416771|FG000|Overall Study|Adverse Event|9|||
162922099|NCT02335411|588416772|FG001|Overall Study|Adverse Event|0|||
162922100|NCT02335411|588416773|FG002|Overall Study|Adverse Event|0|||
162922101|NCT03843775|588416774|FG000|Overall Study|Adverse Event|1|||
162922102|NCT03843775|588416775|FG001|Overall Study|Adverse Event|1|||
162922103|NCT03843775|588416774|FG000|Overall Study|Lack of Efficacy|2|||
162922104|NCT03843775|588416775|FG001|Overall Study|Lack of Efficacy|6|||
162922105|NCT03843775|588416774|FG000|Overall Study|Withdrawal by Subject|0|||
162922106|NCT03843775|588416775|FG001|Overall Study|Withdrawal by Subject|1|||
162922107|NCT00530621|588416780|FG000|Overall Study|Adverse Event|11|||
162922108|NCT00530621|588416781|FG001|Overall Study|Adverse Event|8|||
162922109|NCT00530621|588416780|FG000|Overall Study|Physician Decision|2|||
162922110|NCT00530621|588416781|FG001|Overall Study|Physician Decision|4|||
162922111|NCT00530621|588416780|FG000|Overall Study|Progressive Disease (PD)|47|||
162922112|NCT00530621|588416781|FG001|Overall Study|Progressive Disease (PD)|40|||
162922113|NCT00530621|588416780|FG000|Overall Study|Sponsor Decision|12|||
162922114|NCT00530621|588416781|FG001|Overall Study|Sponsor Decision|15|||
162922115|NCT00530621|588416780|FG000|Overall Study|Subject Decision|4|||
162922116|NCT00530621|588416781|FG001|Overall Study|Subject Decision|7|||
162922117|NCT00530621|588416780|FG000|Overall Study|Death|3|||
162922118|NCT00530621|588416781|FG001|Overall Study|Death|6|||
162922119|NCT00530621|588416780|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
162922120|NCT00530621|588416781|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
162922121|NCT02596009|588416782|FG000|Overall Study|Administrative problems|0|||
162922122|NCT02596009|588416783|FG001|Overall Study|Administrative problems|1|||
162922123|NCT02596009|588416784|FG002|Overall Study|Administrative problems|0|||
162922124|NCT02596009|588416785|FG003|Overall Study|Administrative problems|0|||
162922125|NCT02596009|588416786|FG004|Overall Study|Administrative problems|0|||
162922126|NCT02596009|588416787|FG005|Overall Study|Administrative problems|0|||
162922127|NCT04611152|588416790|FG000|Overall Study|Adverse Event|9|||
162922128|NCT04611152|588416791|FG001|Overall Study|Adverse Event|8|||
162922129|NCT04611152|588416790|FG000|Overall Study|Non-compliance with study schedule|1|||
162922130|NCT04611152|588416791|FG001|Overall Study|Non-compliance with study schedule|3|||
162922131|NCT04611152|588416790|FG000|Overall Study|Withdrawal by Subject|5|||
162922132|NCT04611152|588416791|FG001|Overall Study|Withdrawal by Subject|6|||
162922133|NCT04611152|588416790|FG000|Overall Study|Lost to Follow-up|11|||
162922134|NCT04611152|588416791|FG001|Overall Study|Lost to Follow-up|2|||
162922135|NCT01275170|588416797|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
162922136|NCT01275170|588416798|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922137|NCT01275170|588416799|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922138|NCT01275170|588416800|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922139|NCT01275170|588416801|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922140|NCT01275170|588416802|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922141|NCT01275170|588416803|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922142|NCT01275170|588416804|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
162922143|NCT03917654|588416806|FG000|Year 1|Withdrawal by Subject|1|||
162922144|NCT03917654|588416807|FG001|Year 1|Withdrawal by Subject|0|||
162922145|NCT03917654|588416808|FG002|Year 1|Withdrawal by Subject|0|||
162922146|NCT03917654|588416809|FG003|Year 1|Withdrawal by Subject|0|||
162922147|NCT03917654|588416810|FG004|Year 1|Withdrawal by Subject|0|||
162922148|NCT03917654|588416811|FG005|Year 1|Withdrawal by Subject|1|||
162922149|NCT03917654|588416812|FG006|Year 1|Withdrawal by Subject|6|||
162922150|NCT03917654|588416813|FG007|Year 1|Withdrawal by Subject|2|||
162922151|NCT03917654|588416814|FG008|Year 1|Withdrawal by Subject|5|||
162922152|NCT03917654|588416815|FG009|Year 1|Withdrawal by Subject|3|||
162922153|NCT03917654|588416816|FG010|Year 1|Withdrawal by Subject|1|||
162922154|NCT03917654|588416817|FG011|Year 1|Withdrawal by Subject|0|||
162922155|NCT03917654|588416806|FG000|Year 1|Travel|0|||
162922156|NCT03917654|588416807|FG001|Year 1|Travel|1|||
162922157|NCT03917654|588416808|FG002|Year 1|Travel|1|||
162922158|NCT03917654|588416809|FG003|Year 1|Travel|0|||
162922159|NCT03917654|588416810|FG004|Year 1|Travel|4|||
162922160|NCT03917654|588416811|FG005|Year 1|Travel|4|||
162922161|NCT03917654|588416812|FG006|Year 1|Travel|10|||
162922162|NCT03917654|588416813|FG007|Year 1|Travel|8|||
162922163|NCT03917654|588416814|FG008|Year 1|Travel|2|||
162922164|NCT03917654|588416815|FG009|Year 1|Travel|5|||
162922165|NCT03917654|588416816|FG010|Year 1|Travel|3|||
162922166|NCT03917654|588416817|FG011|Year 1|Travel|3|||
162922167|NCT03917654|588416806|FG000|Year 1|Subject moved away from site|0|||
162922168|NCT03917654|588416807|FG001|Year 1|Subject moved away from site|1|||
163056408|NCT01791595|588918384|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
162630000|NCT00968201|587362682|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
162970720|NCT01332968|588593933|FG000|Maintenance/Observation Period|Other|0|||
162970721|NCT01332968|588593934|FG001|Maintenance/Observation Period|Other|0|||
162970722|NCT01332968|588593935|FG002|Maintenance/Observation Period|Other|4|||
162970723|NCT01332968|588593936|FG003|Maintenance/Observation Period|Other|7|||
162922169|NCT03917654|588416808|FG002|Year 1|Subject moved away from site|0|||
162922170|NCT03917654|588416809|FG003|Year 1|Subject moved away from site|0|||
162922171|NCT03917654|588416810|FG004|Year 1|Subject moved away from site|0|||
162922172|NCT03917654|588416811|FG005|Year 1|Subject moved away from site|0|||
162922173|NCT03917654|588416812|FG006|Year 1|Subject moved away from site|1|||
162922174|NCT03917654|588416813|FG007|Year 1|Subject moved away from site|2|||
162922175|NCT03917654|588416814|FG008|Year 1|Subject moved away from site|1|||
162922176|NCT03917654|588416815|FG009|Year 1|Subject moved away from site|0|||
162922177|NCT03917654|588416816|FG010|Year 1|Subject moved away from site|0|||
162922178|NCT03917654|588416817|FG011|Year 1|Subject moved away from site|3|||
162922179|NCT03917654|588416806|FG000|Year 1|Spouse/Family member request|0|||
162922180|NCT03917654|588416807|FG001|Year 1|Spouse/Family member request|0|||
162922181|NCT03917654|588416808|FG002|Year 1|Spouse/Family member request|1|||
162922182|NCT03917654|588416809|FG003|Year 1|Spouse/Family member request|0|||
162922183|NCT03917654|588416810|FG004|Year 1|Spouse/Family member request|1|||
162922184|NCT03917654|588416811|FG005|Year 1|Spouse/Family member request|0|||
162922185|NCT03917654|588416812|FG006|Year 1|Spouse/Family member request|0|||
162922186|NCT03917654|588416813|FG007|Year 1|Spouse/Family member request|2|||
162922187|NCT03917654|588416814|FG008|Year 1|Spouse/Family member request|0|||
162922188|NCT03917654|588416815|FG009|Year 1|Spouse/Family member request|0|||
162922189|NCT03917654|588416816|FG010|Year 1|Spouse/Family member request|0|||
162922190|NCT03917654|588416817|FG011|Year 1|Spouse/Family member request|1|||
162922191|NCT03917654|588416806|FG000|Year 1|Death|0|||
162922192|NCT03917654|588416807|FG001|Year 1|Death|0|||
162922193|NCT03917654|588416808|FG002|Year 1|Death|0|||
162922194|NCT03917654|588416809|FG003|Year 1|Death|0|||
162922195|NCT03917654|588416810|FG004|Year 1|Death|0|||
162922196|NCT03917654|588416811|FG005|Year 1|Death|0|||
162922197|NCT03917654|588416812|FG006|Year 1|Death|0|||
162922198|NCT03917654|588416813|FG007|Year 1|Death|0|||
162970724|NCT01332968|588593937|FG004|Maintenance/Observation Period|Other|0|||
162970725|NCT01332968|588593938|FG005|Maintenance/Observation Period|Other|0|||
162970726|NCT01332968|588593939|FG006|Maintenance/Observation Period|Other|0|||
162970727|NCT01332968|588593940|FG007|Maintenance/Observation Period|Other|0|||
162970728|NCT01332968|588593933|FG000|Maintenance/Observation Period|Physician Decision|0|||
162970729|NCT01332968|588593934|FG001|Maintenance/Observation Period|Physician Decision|0|||
162970730|NCT01332968|588593935|FG002|Maintenance/Observation Period|Physician Decision|14|||
162970731|NCT01332968|588593936|FG003|Maintenance/Observation Period|Physician Decision|19|||
162970732|NCT01332968|588593937|FG004|Maintenance/Observation Period|Physician Decision|0|||
162970733|NCT01332968|588593938|FG005|Maintenance/Observation Period|Physician Decision|1|||
162970734|NCT01332968|588593939|FG006|Maintenance/Observation Period|Physician Decision|0|||
162970735|NCT01332968|588593940|FG007|Maintenance/Observation Period|Physician Decision|0|||
162970736|NCT01332968|588593933|FG000|Maintenance/Observation Period|Progressive Disease|0|||
162970737|NCT01332968|588593934|FG001|Maintenance/Observation Period|Progressive Disease|0|||
162970738|NCT01332968|588593935|FG002|Maintenance/Observation Period|Progressive Disease|72|||
162970739|NCT01332968|588593936|FG003|Maintenance/Observation Period|Progressive Disease|40|||
162970740|NCT01332968|588593937|FG004|Maintenance/Observation Period|Progressive Disease|0|||
162970741|NCT01332968|588593938|FG005|Maintenance/Observation Period|Progressive Disease|0|||
162970742|NCT01332968|588593939|FG006|Maintenance/Observation Period|Progressive Disease|0|||
162970743|NCT01332968|588593940|FG007|Maintenance/Observation Period|Progressive Disease|0|||
162970744|NCT01332968|588593933|FG000|Maintenance/Observation Period|Protocol Violation|0|||
162970745|NCT01332968|588593934|FG001|Maintenance/Observation Period|Protocol Violation|0|||
162970746|NCT01332968|588593935|FG002|Maintenance/Observation Period|Protocol Violation|1|||
162970747|NCT01332968|588593936|FG003|Maintenance/Observation Period|Protocol Violation|1|||
162970748|NCT01332968|588593937|FG004|Maintenance/Observation Period|Protocol Violation|0|||
162970749|NCT01332968|588593938|FG005|Maintenance/Observation Period|Protocol Violation|0|||
162970750|NCT01332968|588593939|FG006|Maintenance/Observation Period|Protocol Violation|0|||
162970751|NCT01332968|588593940|FG007|Maintenance/Observation Period|Protocol Violation|0|||
162970752|NCT01332968|588593933|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
162922199|NCT03917654|588416814|FG008|Year 1|Death|1|||
162922200|NCT03917654|588416815|FG009|Year 1|Death|1|||
162922201|NCT03917654|588416816|FG010|Year 1|Death|0|||
162922202|NCT03917654|588416817|FG011|Year 1|Death|0|||
162922203|NCT03917654|588416806|FG000|Year 1|Lost to Follow-up|0|||
162922204|NCT03917654|588416807|FG001|Year 1|Lost to Follow-up|0|||
162922205|NCT03917654|588416808|FG002|Year 1|Lost to Follow-up|0|||
162922206|NCT03917654|588416809|FG003|Year 1|Lost to Follow-up|0|||
162922207|NCT03917654|588416810|FG004|Year 1|Lost to Follow-up|0|||
162922208|NCT03917654|588416811|FG005|Year 1|Lost to Follow-up|0|||
162712556|NCT01063036|587658516|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
162712557|NCT01063036|587658516|FG000|Participants Treated With Study Drug|Pregnancy|1|||
162712558|NCT01063036|587658516|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
162712559|NCT01063036|587658516|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
162712560|NCT01063036|587658516|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
162712561|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
162712562|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
162712563|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
162712564|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
162712565|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Adverse Event|198|||
162712566|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Adverse Event|0|||
162712567|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Adverse Event|0|||
162712568|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Adverse Event|0|||
162712569|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Death|62|||
162712570|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Death|0|||
162712571|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Death|0|||
162712572|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Death|0|||
162712573|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
162712574|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
162712575|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
162712576|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
162712577|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Complicating disease|13|||
162712578|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Complicating disease|0|||
162712579|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Complicating disease|0|||
162712580|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Complicating disease|0|||
162712581|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
162712582|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
162712583|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
162712584|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
162712585|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
162712586|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162712587|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162712588|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162712589|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Non-compliance|4|||
162712590|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Non-compliance|0|||
162712591|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Non-compliance|0|||
162712592|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Non-compliance|0|||
162712593|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Pain|4|||
162712594|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Pain|0|||
162712595|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Pain|0|||
162712596|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Pain|0|||
162712597|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
162712598|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
162712599|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
162712600|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
162712601|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Hospice care|1|||
162712602|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Hospice care|0|||
162712603|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Hospice care|0|||
162922209|NCT03917654|588416812|FG006|Year 1|Lost to Follow-up|2|||
162922210|NCT03917654|588416813|FG007|Year 1|Lost to Follow-up|0|||
162922211|NCT03917654|588416814|FG008|Year 1|Lost to Follow-up|0|||
162922212|NCT03917654|588416815|FG009|Year 1|Lost to Follow-up|0|||
162922213|NCT03917654|588416816|FG010|Year 1|Lost to Follow-up|0|||
162922214|NCT03917654|588416817|FG011|Year 1|Lost to Follow-up|0|||
162922215|NCT03917654|588416806|FG000|Year 1|Missed visits|0|||
162970753|NCT01332968|588593934|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970754|NCT01332968|588593935|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
162970755|NCT01332968|588593936|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
162712604|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Hospice care|0|||
162712605|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Physician Decision|1|||
162712606|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Physician Decision|0|||
162712607|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Physician Decision|0|||
162712608|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Physician Decision|0|||
162712609|NCT01107626|587658517|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
162712610|NCT01107626|587658518|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162712611|NCT01107626|587658519|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162712612|NCT01107626|587658520|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162922216|NCT03917654|588416807|FG001|Year 1|Missed visits|0|||
162922217|NCT03917654|588416808|FG002|Year 1|Missed visits|0|||
162922218|NCT03917654|588416809|FG003|Year 1|Missed visits|0|||
162922219|NCT03917654|588416810|FG004|Year 1|Missed visits|0|||
162922220|NCT03917654|588416811|FG005|Year 1|Missed visits|0|||
162970756|NCT01332968|588593937|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
162922221|NCT03917654|588416812|FG006|Year 1|Missed visits|0|||
162922222|NCT03917654|588416813|FG007|Year 1|Missed visits|0|||
162922223|NCT03917654|588416814|FG008|Year 1|Missed visits|0|||
162922224|NCT03917654|588416815|FG009|Year 1|Missed visits|0|||
162922225|NCT03917654|588416816|FG010|Year 1|Missed visits|1|||
162922226|NCT03917654|588416817|FG011|Year 1|Missed visits|1|||
162922227|NCT03917654|588416806|FG000|Year 1|Pregnancy|0|||
162922228|NCT03917654|588416807|FG001|Year 1|Pregnancy|0|||
162922229|NCT03917654|588416808|FG002|Year 1|Pregnancy|0|||
162922230|NCT03917654|588416809|FG003|Year 1|Pregnancy|0|||
162922231|NCT03917654|588416810|FG004|Year 1|Pregnancy|0|||
162922232|NCT03917654|588416811|FG005|Year 1|Pregnancy|0|||
162922233|NCT03917654|588416812|FG006|Year 1|Pregnancy|0|||
162922234|NCT03917654|588416813|FG007|Year 1|Pregnancy|1|||
162922235|NCT03917654|588416814|FG008|Year 1|Pregnancy|0|||
162922236|NCT03917654|588416815|FG009|Year 1|Pregnancy|1|||
162922237|NCT03917654|588416816|FG010|Year 1|Pregnancy|0|||
162922238|NCT03917654|588416817|FG011|Year 1|Pregnancy|0|||
162922239|NCT03917654|588416806|FG000|Year 2|Travel|1|||
162922240|NCT03917654|588416807|FG001|Year 2|Travel|0|||
162922241|NCT03917654|588416808|FG002|Year 2|Travel|0|||
162922242|NCT03917654|588416809|FG003|Year 2|Travel|0|||
162922243|NCT03917654|588416810|FG004|Year 2|Travel|1|||
162922244|NCT03917654|588416811|FG005|Year 2|Travel|1|||
162922245|NCT03917654|588416812|FG006|Year 2|Travel|2|||
162922246|NCT03917654|588416813|FG007|Year 2|Travel|1|||
162922247|NCT03917654|588416814|FG008|Year 2|Travel|0|||
162922248|NCT03917654|588416815|FG009|Year 2|Travel|1|||
162922249|NCT03917654|588416816|FG010|Year 2|Travel|0|||
162922250|NCT03917654|588416817|FG011|Year 2|Travel|1|||
162922251|NCT03917654|588416806|FG000|Year 2|Married|1|||
162922252|NCT03917654|588416807|FG001|Year 2|Married|0|||
162922253|NCT03917654|588416808|FG002|Year 2|Married|0|||
162922254|NCT03917654|588416809|FG003|Year 2|Married|0|||
162922255|NCT03917654|588416810|FG004|Year 2|Married|0|||
162922256|NCT03917654|588416811|FG005|Year 2|Married|0|||
162922257|NCT03917654|588416812|FG006|Year 2|Married|1|||
162922258|NCT03917654|588416813|FG007|Year 2|Married|1|||
162922259|NCT03917654|588416814|FG008|Year 2|Married|0|||
162922260|NCT03917654|588416815|FG009|Year 2|Married|0|||
162970757|NCT01332968|588593938|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970758|NCT01332968|588593939|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
162970759|NCT01332968|588593940|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
162630001|NCT04974697|587362683|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
162630002|NCT04974697|587362683|FG000|Overall Study|Lens discomfort|1|||
162630003|NCT03302234|587362684|FG000|Overall Study|Death|191|||
162630004|NCT03302234|587362685|FG001|Overall Study|Death|192|||
162630005|NCT03302234|587362684|FG000|Overall Study|Withdrawal by Subject|2|||
162630006|NCT03302234|587362685|FG001|Overall Study|Withdrawal by Subject|2|||
162630007|NCT03302234|587362684|FG000|Overall Study|Sponsor Decision|90|||
162630008|NCT03302234|587362685|FG001|Overall Study|Sponsor Decision|89|||
162630009|NCT03302234|587362684|FG000|Overall Study|Laryngeal carcinoma|0|||
162630010|NCT03302234|587362685|FG001|Overall Study|Laryngeal carcinoma|1|||
162630011|NCT03302234|587362684|FG000|Overall Study|Not Reported|1|||
162630012|NCT03302234|587362685|FG001|Overall Study|Not Reported|0|||
162630013|NCT04112784|587362687|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
162630014|NCT04112784|587362687|FG000|Overall Study|Screen Failures|4|||
162630015|NCT00221403|587362688|FG000|Overall Study|Protocol Violation|1|||
162630016|NCT00221403|587362689|FG001|Overall Study|Protocol Violation|0|||
162630017|NCT00221403|587362690|FG002|Overall Study|Protocol Violation|0|||
162630018|NCT00221403|587362688|FG000|Overall Study|Physician Decision|1|||
162922261|NCT03917654|588416816|FG010|Year 2|Married|0|||
162922262|NCT03917654|588416817|FG011|Year 2|Married|0|||
162922263|NCT03917654|588416806|FG000|Year 2|Subject moved away from site|1|||
162922264|NCT03917654|588416807|FG001|Year 2|Subject moved away from site|0|||
162922265|NCT03917654|588416808|FG002|Year 2|Subject moved away from site|0|||
162922266|NCT03917654|588416809|FG003|Year 2|Subject moved away from site|0|||
162922267|NCT03917654|588416810|FG004|Year 2|Subject moved away from site|1|||
162922268|NCT03917654|588416811|FG005|Year 2|Subject moved away from site|0|||
162922269|NCT03917654|588416812|FG006|Year 2|Subject moved away from site|2|||
162922270|NCT03917654|588416813|FG007|Year 2|Subject moved away from site|3|||
162970760|NCT01332968|588593933|FG000|Follow-Up Period|Adverse Event|0|||
162630019|NCT00221403|587362689|FG001|Overall Study|Physician Decision|0|||
162630020|NCT00221403|587362690|FG002|Overall Study|Physician Decision|0|||
162630021|NCT00221403|587362688|FG000|Overall Study|Withdrawal by Subject|0|||
162630022|NCT00221403|587362689|FG001|Overall Study|Withdrawal by Subject|3|||
162630023|NCT00221403|587362690|FG002|Overall Study|Withdrawal by Subject|0|||
162630024|NCT00221403|587362688|FG000|Overall Study|Lack of Efficacy|0|||
162922271|NCT03917654|588416814|FG008|Year 2|Subject moved away from site|0|||
162922272|NCT03917654|588416815|FG009|Year 2|Subject moved away from site|2|||
162922273|NCT03917654|588416816|FG010|Year 2|Subject moved away from site|0|||
162922274|NCT03917654|588416817|FG011|Year 2|Subject moved away from site|1|||
162922275|NCT03917654|588416806|FG000|Year 2|Year 2 Screening failure|0|||
162922276|NCT03917654|588416807|FG001|Year 2|Year 2 Screening failure|1|||
162922277|NCT03917654|588416808|FG002|Year 2|Year 2 Screening failure|0|||
163056409|NCT01791595|588918385|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163056410|NCT01791595|588918386|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
163056411|NCT06494761|588918390|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
163056412|NCT06494761|588918390|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
163056413|NCT04865289|588918391|FG000|Overall Study|Death|34|||
163056414|NCT04865289|588918392|FG001|Overall Study|Death|25|||
163056415|NCT04865289|588918391|FG000|Overall Study|Physician Decision|27|||
163056416|NCT04865289|588918392|FG001|Overall Study|Physician Decision|27|||
163056417|NCT04865289|588918391|FG000|Overall Study|Sponsor Decision|11|||
163056418|NCT04865289|588918392|FG001|Overall Study|Sponsor Decision|1|||
163056419|NCT04865289|588918391|FG000|Overall Study|Withdrawal by Subject|2|||
163056420|NCT04865289|588918392|FG001|Overall Study|Withdrawal by Subject|3|||
163056421|NCT03104374|588918393|FG000|Period 1|Adverse Event|7|||
163056422|NCT03104374|588918394|FG001|Period 1|Adverse Event|7|||
163056423|NCT03104374|588918395|FG002|Period 1|Adverse Event|12|||
163056424|NCT03104374|588918396|FG003|Period 1|Adverse Event|14|||
163056425|NCT03104374|588918393|FG000|Period 1|Withdrawal by Subject|18|||
163056426|NCT03104374|588918394|FG001|Period 1|Withdrawal by Subject|9|||
163056427|NCT03104374|588918395|FG002|Period 1|Withdrawal by Subject|10|||
163056428|NCT03104374|588918396|FG003|Period 1|Withdrawal by Subject|17|||
163056429|NCT03104374|588918393|FG000|Period 1|Lost to Follow-up|4|||
163056430|NCT03104374|588918394|FG001|Period 1|Lost to Follow-up|4|||
163056431|NCT03104374|588918395|FG002|Period 1|Lost to Follow-up|6|||
163056432|NCT03104374|588918396|FG003|Period 1|Lost to Follow-up|8|||
163056433|NCT03104374|588918393|FG000|Period 1|Lack of Efficacy|6|||
163056434|NCT03104374|588918394|FG001|Period 1|Lack of Efficacy|7|||
163056435|NCT03104374|588918395|FG002|Period 1|Lack of Efficacy|12|||
163056436|NCT03104374|588918396|FG003|Period 1|Lack of Efficacy|6|||
163056437|NCT03104374|588918393|FG000|Period 1|Other|2|||
163056438|NCT03104374|588918394|FG001|Period 1|Other|2|||
163056439|NCT03104374|588918395|FG002|Period 1|Other|4|||
163056440|NCT03104374|588918396|FG003|Period 1|Other|7|||
163056441|NCT03104374|588918393|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056442|NCT03104374|588918394|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056443|NCT03104374|588918395|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
163056444|NCT03104374|588918396|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
163056445|NCT03104374|588918393|FG000|Period 2|Adverse Event|4|||
163056446|NCT03104374|588918394|FG001|Period 2|Adverse Event|7|||
163056447|NCT03104374|588918395|FG002|Period 2|Adverse Event|10|||
163056448|NCT03104374|588918396|FG003|Period 2|Adverse Event|10|||
163056449|NCT03104374|588918393|FG000|Period 2|Withdrawal by Subject|3|||
163056450|NCT03104374|588918394|FG001|Period 2|Withdrawal by Subject|7|||
163056451|NCT03104374|588918395|FG002|Period 2|Withdrawal by Subject|13|||
163056452|NCT03104374|588918396|FG003|Period 2|Withdrawal by Subject|16|||
163056453|NCT03104374|588918393|FG000|Period 2|Lost to Follow-up|2|||
163056454|NCT03104374|588918394|FG001|Period 2|Lost to Follow-up|2|||
163056455|NCT03104374|588918395|FG002|Period 2|Lost to Follow-up|3|||
163056456|NCT03104374|588918396|FG003|Period 2|Lost to Follow-up|5|||
163056457|NCT03104374|588918393|FG000|Period 2|Lack of Efficacy|2|||
163056458|NCT03104374|588918394|FG001|Period 2|Lack of Efficacy|4|||
163056459|NCT03104374|588918395|FG002|Period 2|Lack of Efficacy|7|||
163056460|NCT03104374|588918396|FG003|Period 2|Lack of Efficacy|4|||
163056461|NCT03104374|588918393|FG000|Period 2|COVID-19 Infection|0|||
163056462|NCT03104374|588918394|FG001|Period 2|COVID-19 Infection|0|||
163056463|NCT03104374|588918395|FG002|Period 2|COVID-19 Infection|1|||
163056464|NCT03104374|588918396|FG003|Period 2|COVID-19 Infection|0|||
163056465|NCT03104374|588918393|FG000|Period 2|Other|3|||
163056466|NCT03104374|588918394|FG001|Period 2|Other|2|||
163056467|NCT03104374|588918395|FG002|Period 2|Other|2|||
163056468|NCT03104374|588918396|FG003|Period 2|Other|4|||
163056469|NCT03210714|588918397|FG000|Overall Study|Adverse Event|6|||
163056470|NCT03210714|588918397|FG000|Overall Study|Physician Decision|1|||
163056471|NCT03210714|588918397|FG000|Overall Study|Progressive disease|11|||
163056472|NCT03210714|588918397|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
163056473|NCT00803179|588918398|FG000|Overall Study|Lost to Follow-up|3|||
163056474|NCT04158648|588918399|FG000|Overall Study|Ongoing in the Study|69|||
163056475|NCT04158648|588918399|FG000|Overall Study|Withdrawal by Subject|4|||
163056476|NCT04609514|588918400|FG000|Overall Study|Lost to Follow-up|5|||
163056477|NCT04609514|588918401|FG001|Overall Study|Lost to Follow-up|4|||
163056478|NCT04609514|588918400|FG000|Overall Study|Withdrawal by PI|0|||
163056479|NCT04609514|588918401|FG001|Overall Study|Withdrawal by PI|2|||
163056480|NCT00885118|588918402|FG000|Overall Study|Adverse Event|1|||
163056481|NCT00885118|588918403|FG001|Overall Study|Adverse Event|0|||
163056482|NCT00885118|588918404|FG002|Overall Study|Adverse Event|0|||
163056483|NCT00885118|588918405|FG003|Overall Study|Adverse Event|0|||
163056484|NCT00885118|588918406|FG004|Overall Study|Adverse Event|0|||
163056485|NCT00885118|588918402|FG000|Overall Study|Withdrawal by Subject|0|||
163056486|NCT00885118|588918403|FG001|Overall Study|Withdrawal by Subject|0|||
163056487|NCT00885118|588918404|FG002|Overall Study|Withdrawal by Subject|0|||
163056488|NCT00885118|588918405|FG003|Overall Study|Withdrawal by Subject|0|||
163056489|NCT00885118|588918406|FG004|Overall Study|Withdrawal by Subject|1|||
163056490|NCT00885118|588918402|FG000|Overall Study|Other reason not defined above|0|||
163056491|NCT00885118|588918403|FG001|Overall Study|Other reason not defined above|0|||
163056492|NCT00885118|588918404|FG002|Overall Study|Other reason not defined above|1|||
163056493|NCT00885118|588918405|FG003|Overall Study|Other reason not defined above|0|||
163056494|NCT00885118|588918406|FG004|Overall Study|Other reason not defined above|0|||
163056495|NCT01265498|588918415|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
163056496|NCT01265498|588918416|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
163056497|NCT05399680|588919659|FG000|Overall Study|Lost to Follow-up|1|||
163056498|NCT05399680|588919660|FG001|Overall Study|Lost to Follow-up|0|||
163056499|NCT05399680|588919659|FG000|Overall Study|Death|0|||
163056500|NCT05399680|588919660|FG001|Overall Study|Death|1|||
163056501|NCT00959751|588919662|FG000|Overall Study|Lost to Follow-up|2|||
163056502|NCT00959751|588919663|FG001|Overall Study|Lost to Follow-up|3|||
163056503|NCT00959751|588919662|FG000|Overall Study|Consent Withdrawn|0|||
163056504|NCT00959751|588919663|FG001|Overall Study|Consent Withdrawn|1|||
163056505|NCT00959751|588919662|FG000|Overall Study|Non-compliance to Study Procedures|0|||
163056506|NCT00959751|588919663|FG001|Overall Study|Non-compliance to Study Procedures|1|||
163056507|NCT00959751|588919662|FG000|Overall Study|No migraine headache without aura|7|||
163056508|NCT00959751|588919663|FG001|Overall Study|No migraine headache without aura|7|||
163056509|NCT03737994|588919664|FG000|Overall Study|Withdrawal by Subject|0|||
163056510|NCT03737994|588919665|FG001|Overall Study|Withdrawal by Subject|0|||
163056511|NCT03737994|588919666|FG002|Overall Study|Withdrawal by Subject|0|||
163056512|NCT03737994|588919667|FG003|Overall Study|Withdrawal by Subject|0|||
163056513|NCT03737994|588919668|FG004|Overall Study|Withdrawal by Subject|0|||
163056514|NCT03737994|588919669|FG005|Overall Study|Withdrawal by Subject|0|||
163056515|NCT03737994|588919670|FG006|Overall Study|Withdrawal by Subject|1|||
163056516|NCT01373164|588919671|FG000|Overall Study|Lost to Follow-up|0|||
163056517|NCT01373164|588919672|FG001|Overall Study|Lost to Follow-up|0|||
163056518|NCT01373164|588919673|FG002|Overall Study|Lost to Follow-up|1|||
163056519|NCT01373164|588919674|FG003|Overall Study|Lost to Follow-up|2|||
163056520|NCT01373164|588919675|FG004|Overall Study|Lost to Follow-up|0|||
163056521|NCT01373164|588919671|FG000|Overall Study|Withdrawal by Subject|0|||
163056522|NCT01373164|588919672|FG001|Overall Study|Withdrawal by Subject|1|||
163056523|NCT01373164|588919673|FG002|Overall Study|Withdrawal by Subject|0|||
163056524|NCT01373164|588919674|FG003|Overall Study|Withdrawal by Subject|10|||
163056525|NCT01373164|588919675|FG004|Overall Study|Withdrawal by Subject|2|||
163056526|NCT00761319|588919676|FG000|Overall Study|Protocol Violation|21|||
163056527|NCT00761319|588919677|FG001|Overall Study|Protocol Violation|14|||
163056528|NCT00761319|588919676|FG000|Overall Study|Adverse Event|11|||
163056529|NCT00761319|588919677|FG001|Overall Study|Adverse Event|7|||
163056530|NCT00761319|588919676|FG000|Overall Study|Withdrawal by Subject|8|||
163056531|NCT00761319|588919677|FG001|Overall Study|Withdrawal by Subject|7|||
163056532|NCT00761319|588919676|FG000|Overall Study|Noncompliance|4|||
163056533|NCT00761319|588919677|FG001|Overall Study|Noncompliance|3|||
163056534|NCT00761319|588919676|FG000|Overall Study|Lost to Follow-up|1|||
163056535|NCT00761319|588919677|FG001|Overall Study|Lost to Follow-up|1|||
163056536|NCT00761319|588919676|FG000|Overall Study|Nonspecified|2|||
163056537|NCT00761319|588919677|FG001|Overall Study|Nonspecified|2|||
163056538|NCT00761319|588919676|FG000|Overall Study|Missing|1|||
163056539|NCT00761319|588919677|FG001|Overall Study|Missing|0|||
163056540|NCT03055013|588919682|FG000|Overall Study|Adverse Event|78|||
163056541|NCT03055013|588919683|FG001|Overall Study|Adverse Event|0|||
163056542|NCT03055013|588919682|FG000|Overall Study|Death|6|||
163056543|NCT03055013|588919683|FG001|Overall Study|Death|0|||
163056544|NCT03055013|588919682|FG000|Overall Study|Disease relapse|33|||
163056545|NCT03055013|588919683|FG001|Overall Study|Disease relapse|0|||
163056546|NCT03055013|588919682|FG000|Overall Study|Withdrawal by Subject|28|||
163056547|NCT03055013|588919683|FG001|Overall Study|Withdrawal by Subject|0|||
163056548|NCT03055013|588919682|FG000|Overall Study|Other complicating disease|5|||
163056549|NCT03055013|588919683|FG001|Overall Study|Other complicating disease|0|||
163056550|NCT03055013|588919682|FG000|Overall Study|Physician Decision|1|||
163056551|NCT03055013|588919683|FG001|Overall Study|Physician Decision|0|||
163056552|NCT03055013|588919682|FG000|Overall Study|Benign mass/non-RCC|4|||
163056553|NCT03055013|588919683|FG001|Overall Study|Benign mass/non-RCC|0|||
163056554|NCT03055013|588919682|FG000|Overall Study|Enrolled in another trial|1|||
163056555|NCT03055013|588919683|FG001|Overall Study|Enrolled in another trial|0|||
163056556|NCT03055013|588919682|FG000|Overall Study|Non-protocol therapy|1|||
163056557|NCT03055013|588919683|FG001|Overall Study|Non-protocol therapy|0|||
163056558|NCT03055013|588919682|FG000|Overall Study|Incompliance|1|||
163056559|NCT03055013|588919683|FG001|Overall Study|Incompliance|0|||
163056560|NCT03055013|588919682|FG000|Overall Study|Insurance issues|1|||
163056561|NCT03055013|588919683|FG001|Overall Study|Insurance issues|0|||
163056562|NCT03055013|588919682|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
163056563|NCT03055013|588919683|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
163056564|NCT03055013|588919682|FG000|Overall Study|Did not receive nivolumab|10|||
163056565|NCT03055013|588919683|FG001|Overall Study|Did not receive nivolumab|0|||
163056566|NCT03055013|588919682|FG000|Overall Study|Did not receive surgery|0|||
163056567|NCT03055013|588919683|FG001|Overall Study|Did not receive surgery|28|||
163056568|NCT02765035|588919688|FG000|First Intervention (90 Days)|Adverse Event|1|||
163056569|NCT02765035|588919689|FG001|First Intervention (90 Days)|Adverse Event|1|||
163056570|NCT02765035|588919688|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
163056571|NCT02765035|588919689|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
163056572|NCT00671749|588919691|FG000|Overall Study|Adverse Event|2|||
163056573|NCT00671749|588919691|FG000|Overall Study|Withdrawal by Subject|4|||
163056574|NCT00671749|588919691|FG000|Overall Study|Protocol Violation|1|||
162922278|NCT03917654|588416809|FG003|Year 2|Year 2 Screening failure|0|||
162922279|NCT03917654|588416810|FG004|Year 2|Year 2 Screening failure|2|||
162922280|NCT03917654|588416811|FG005|Year 2|Year 2 Screening failure|0|||
162922281|NCT03917654|588416812|FG006|Year 2|Year 2 Screening failure|4|||
163056575|NCT00671749|588919691|FG000|Overall Study|Lost to Follow-up|1|||
163056576|NCT01259245|588919697|FG000|Overall Study|Withdrawal by Subject|27|||
162922282|NCT03917654|588416813|FG007|Year 2|Year 2 Screening failure|3|||
162922283|NCT03917654|588416814|FG008|Year 2|Year 2 Screening failure|10|||
163056577|NCT01259245|588919698|FG001|Overall Study|Withdrawal by Subject|24|||
163056578|NCT01259245|588919697|FG000|Overall Study|Death|1|||
163056579|NCT01259245|588919698|FG001|Overall Study|Death|2|||
163056580|NCT03937778|588919699|FG000|Overall Study|Withdrawal by Subject|1|||
163056581|NCT03937778|588919699|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
163056582|NCT01200355|588919701|FG000|Overall Study|Death|7|||
163056583|NCT01200355|588919702|FG001|Overall Study|Death|2|||
163056584|NCT00485303|588919703|FG000|Overall Study|Adverse Event|5|||
163056585|NCT00485303|588919703|FG000|Overall Study|Progressive Disease|44|||
163056586|NCT00485303|588919703|FG000|Overall Study|Other|3|||
163056587|NCT00485303|588919703|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
163056588|NCT00485303|588919703|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
163056589|NCT00296335|588919708|FG000|Overall Study|Recurrence|3|||
163056590|NCT00296335|588919709|FG001|Overall Study|Recurrence|51|||
163056591|NCT00296335|588919708|FG000|Overall Study|Adverse Event|17|||
163056592|NCT00296335|588919709|FG001|Overall Study|Adverse Event|27|||
163056593|NCT00296335|588919708|FG000|Overall Study|Lost to Follow-up|7|||
163056594|NCT00296335|588919709|FG001|Overall Study|Lost to Follow-up|33|||
163056595|NCT00296335|588919708|FG000|Overall Study|Physician Decision|3|||
163056596|NCT00296335|588919709|FG001|Overall Study|Physician Decision|11|||
163056597|NCT01027845|588919710|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
163056598|NCT01027845|588919711|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
163056599|NCT01027845|588919712|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
163056600|NCT01027845|588919713|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
163056601|NCT01027845|588919710|FG000|Primary Vaccination Phase|Adverse Event|1|||
163056602|NCT01027845|588919711|FG001|Primary Vaccination Phase|Adverse Event|0|||
163056603|NCT01027845|588919712|FG002|Primary Vaccination Phase|Adverse Event|0|||
163056604|NCT01027845|588919713|FG003|Primary Vaccination Phase|Adverse Event|0|||
163056605|NCT01027845|588919710|FG000|Primary Vaccination Phase|Protocol Violation|1|||
163056606|NCT01027845|588919711|FG001|Primary Vaccination Phase|Protocol Violation|0|||
163056607|NCT01027845|588919712|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163056608|NCT01027845|588919713|FG003|Primary Vaccination Phase|Protocol Violation|0|||
163056609|NCT01027845|588919710|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056610|NCT01027845|588919711|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
163056611|NCT01027845|588919712|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056612|NCT01027845|588919713|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
163056613|NCT01027845|588919710|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
162922284|NCT03917654|588416815|FG009|Year 2|Year 2 Screening failure|2|||
162922285|NCT03917654|588416816|FG010|Year 2|Year 2 Screening failure|1|||
163056614|NCT01027845|588919711|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056615|NCT01027845|588919712|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056616|NCT01027845|588919713|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
163056617|NCT01027845|588919710|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
163056618|NCT01027845|588919711|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056619|NCT01027845|588919712|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056620|NCT01027845|588919713|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
163056621|NCT01281306|588919714|FG000|Overall Study|Lack of Efficacy|0|||
163056622|NCT01281306|588919715|FG001|Overall Study|Lack of Efficacy|1|||
163056623|NCT01281306|588919716|FG002|Overall Study|Lack of Efficacy|3|||
163056624|NCT01281306|588919717|FG003|Overall Study|Lack of Efficacy|0|||
163056625|NCT01281306|588919718|FG004|Overall Study|Lack of Efficacy|2|||
162712613|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
162922286|NCT03917654|588416817|FG011|Year 2|Year 2 Screening failure|1|||
162712614|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
162922287|NCT03917654|588416806|FG000|Year 2|Death|0|||
162922288|NCT03917654|588416807|FG001|Year 2|Death|0|||
162922289|NCT03917654|588416808|FG002|Year 2|Death|0|||
162922290|NCT03917654|588416809|FG003|Year 2|Death|0|||
162922291|NCT03917654|588416810|FG004|Year 2|Death|0|||
162922292|NCT03917654|588416811|FG005|Year 2|Death|1|||
162922293|NCT03917654|588416812|FG006|Year 2|Death|0|||
162922294|NCT03917654|588416813|FG007|Year 2|Death|0|||
162922295|NCT03917654|588416814|FG008|Year 2|Death|1|||
162922296|NCT03917654|588416815|FG009|Year 2|Death|1|||
162922297|NCT03917654|588416816|FG010|Year 2|Death|0|||
162922298|NCT03917654|588416817|FG011|Year 2|Death|0|||
162922299|NCT03917654|588416806|FG000|Year 2|Withdrawal by Subject|0|||
162922300|NCT03917654|588416807|FG001|Year 2|Withdrawal by Subject|0|||
162922301|NCT03917654|588416808|FG002|Year 2|Withdrawal by Subject|0|||
162922302|NCT03917654|588416809|FG003|Year 2|Withdrawal by Subject|0|||
162922303|NCT03917654|588416810|FG004|Year 2|Withdrawal by Subject|0|||
162922304|NCT03917654|588416811|FG005|Year 2|Withdrawal by Subject|0|||
162922305|NCT03917654|588416812|FG006|Year 2|Withdrawal by Subject|3|||
162922306|NCT03917654|588416813|FG007|Year 2|Withdrawal by Subject|0|||
162922307|NCT03917654|588416814|FG008|Year 2|Withdrawal by Subject|2|||
162922308|NCT03917654|588416815|FG009|Year 2|Withdrawal by Subject|5|||
162922309|NCT03917654|588416816|FG010|Year 2|Withdrawal by Subject|0|||
162922310|NCT03917654|588416817|FG011|Year 2|Withdrawal by Subject|0|||
162922311|NCT03917654|588416806|FG000|Year 2|Spouse/family member request|0|||
162922312|NCT03917654|588416807|FG001|Year 2|Spouse/family member request|0|||
162922313|NCT03917654|588416808|FG002|Year 2|Spouse/family member request|0|||
162922314|NCT03917654|588416809|FG003|Year 2|Spouse/family member request|0|||
162922315|NCT03917654|588416810|FG004|Year 2|Spouse/family member request|0|||
162922316|NCT03917654|588416811|FG005|Year 2|Spouse/family member request|0|||
162922317|NCT03917654|588416812|FG006|Year 2|Spouse/family member request|1|||
162922318|NCT03917654|588416813|FG007|Year 2|Spouse/family member request|0|||
162922319|NCT03917654|588416814|FG008|Year 2|Spouse/family member request|0|||
162922320|NCT03917654|588416815|FG009|Year 2|Spouse/family member request|0|||
162922321|NCT03917654|588416816|FG010|Year 2|Spouse/family member request|0|||
162922322|NCT03917654|588416817|FG011|Year 2|Spouse/family member request|0|||
162922323|NCT03917654|588416806|FG000|Year 2|Lost to Follow-up|0|||
162922324|NCT03917654|588416807|FG001|Year 2|Lost to Follow-up|0|||
162922325|NCT03917654|588416808|FG002|Year 2|Lost to Follow-up|0|||
162922326|NCT03917654|588416809|FG003|Year 2|Lost to Follow-up|0|||
162922327|NCT03917654|588416810|FG004|Year 2|Lost to Follow-up|0|||
162922328|NCT03917654|588416811|FG005|Year 2|Lost to Follow-up|0|||
162922329|NCT03917654|588416812|FG006|Year 2|Lost to Follow-up|1|||
162922330|NCT03917654|588416813|FG007|Year 2|Lost to Follow-up|0|||
162922331|NCT03917654|588416814|FG008|Year 2|Lost to Follow-up|1|||
162922332|NCT03917654|588416815|FG009|Year 2|Lost to Follow-up|0|||
162922333|NCT03917654|588416816|FG010|Year 2|Lost to Follow-up|0|||
162922334|NCT03917654|588416817|FG011|Year 2|Lost to Follow-up|1|||
162922335|NCT03917654|588416806|FG000|Year 2|Adverse Event|0|||
162922336|NCT03917654|588416807|FG001|Year 2|Adverse Event|0|||
162922337|NCT03917654|588416808|FG002|Year 2|Adverse Event|0|||
162922338|NCT03917654|588416809|FG003|Year 2|Adverse Event|0|||
162922339|NCT03917654|588416810|FG004|Year 2|Adverse Event|0|||
162922340|NCT03917654|588416811|FG005|Year 2|Adverse Event|0|||
162922341|NCT03917654|588416812|FG006|Year 2|Adverse Event|0|||
162922342|NCT03917654|588416813|FG007|Year 2|Adverse Event|0|||
162922343|NCT03917654|588416814|FG008|Year 2|Adverse Event|0|||
162922344|NCT03917654|588416815|FG009|Year 2|Adverse Event|1|||
162922345|NCT03917654|588416816|FG010|Year 2|Adverse Event|0|||
162922346|NCT03917654|588416817|FG011|Year 2|Adverse Event|0|||
162922347|NCT05012943|588416818|FG000|Overall Study|Adverse Event|2|||
162922348|NCT05012943|588416819|FG001|Overall Study|Adverse Event|1|||
162922349|NCT05012943|588416820|FG002|Overall Study|Adverse Event|0|||
162922350|NCT05012943|588416818|FG000|Overall Study|Withdrawal by Subject|1052|||
162922351|NCT05012943|588416819|FG001|Overall Study|Withdrawal by Subject|1006|||
162922352|NCT05012943|588416820|FG002|Overall Study|Withdrawal by Subject|20|||
162922353|NCT05012943|588416818|FG000|Overall Study|Death|25|||
162922354|NCT05012943|588416819|FG001|Overall Study|Death|17|||
162922355|NCT05012943|588416820|FG002|Overall Study|Death|4|||
162922356|NCT05012943|588416818|FG000|Overall Study|Lost to Follow-up|11|||
162922357|NCT05012943|588416819|FG001|Overall Study|Lost to Follow-up|24|||
162922358|NCT05012943|588416820|FG002|Overall Study|Lost to Follow-up|3|||
162922359|NCT05012943|588416818|FG000|Overall Study|Physician Decision|1|||
162922360|NCT05012943|588416819|FG001|Overall Study|Physician Decision|1|||
162922361|NCT05012943|588416820|FG002|Overall Study|Physician Decision|0|||
162922362|NCT05012943|588416818|FG000|Overall Study|Other than Specified|2|||
162922363|NCT05012943|588416819|FG001|Overall Study|Other than Specified|1|||
162922364|NCT05012943|588416820|FG002|Overall Study|Other than Specified|0|||
162922365|NCT00400985|588416821|FG000|Overall Study|Withdrawal by Subject|5|||
162922366|NCT00400985|588416821|FG000|Overall Study|system modification|8|||
162922367|NCT00400985|588416821|FG000|Overall Study|Death|30|||
162922368|NCT00400985|588416821|FG000|Overall Study|Lost to Follow-up|9|||
162922369|NCT04755283|588416824|FG000|Overall Study|Withdrawal by Subject|14|||
162922370|NCT04755283|588416825|FG001|Overall Study|Withdrawal by Subject|3|||
162922371|NCT04755283|588416826|FG002|Overall Study|Withdrawal by Subject|6|||
162922372|NCT04755283|588416824|FG000|Overall Study|Lost to Follow-up|0|||
162922373|NCT04755283|588416825|FG001|Overall Study|Lost to Follow-up|0|||
162922374|NCT04755283|588416826|FG002|Overall Study|Lost to Follow-up|1|||
162922375|NCT04755283|588416824|FG000|Overall Study|Death|31|||
162922376|NCT04755283|588416825|FG001|Overall Study|Death|36|||
162922377|NCT04755283|588416826|FG002|Overall Study|Death|34|||
162922378|NCT02851069|588416827|FG000|Overall Study|Failure to Return|3|||
162922379|NCT02851069|588416827|FG000|Overall Study|Other|3|||
162922380|NCT02684162|588416828|FG000|Overall Study|Physician Decision|0|||
162922381|NCT02684162|588416829|FG001|Overall Study|Physician Decision|1|||
162922382|NCT02684162|588416830|FG002|Overall Study|Physician Decision|0|||
162922383|NCT03743571|588416833|FG000|Overall Study|Withdrawal by Subject|1|||
162922384|NCT03743571|588416834|FG001|Overall Study|Withdrawal by Subject|1|||
162922385|NCT03743571|588416833|FG000|Overall Study|Lost to Follow-up|1|||
162922386|NCT03743571|588416834|FG001|Overall Study|Lost to Follow-up|2|||
162922387|NCT01489865|588416835|FG000|Overall Study|Progression of Disease|4|||
162922388|NCT01489865|588416836|FG001|Overall Study|Progression of Disease|2|||
162922389|NCT01489865|588416837|FG002|Overall Study|Progression of Disease|2|||
162922390|NCT01489865|588416838|FG003|Overall Study|Progression of Disease|3|||
162922391|NCT01489865|588416839|FG004|Overall Study|Progression of Disease|1|||
162922392|NCT01489865|588416840|FG005|Overall Study|Progression of Disease|6|||
162922393|NCT01489865|588416841|FG006|Overall Study|Progression of Disease|3|||
162922394|NCT01489865|588416842|FG007|Overall Study|Progression of Disease|0|||
162922395|NCT01489865|588416843|FG008|Overall Study|Progression of Disease|23|||
162922396|NCT01489865|588416835|FG000|Overall Study|Adverse Event|2|||
162922397|NCT01489865|588416836|FG001|Overall Study|Adverse Event|0|||
162922398|NCT01489865|588416837|FG002|Overall Study|Adverse Event|0|||
162922399|NCT01489865|588416838|FG003|Overall Study|Adverse Event|0|||
162922400|NCT01489865|588416839|FG004|Overall Study|Adverse Event|1|||
162922401|NCT01489865|588416840|FG005|Overall Study|Adverse Event|0|||
162922402|NCT01489865|588416841|FG006|Overall Study|Adverse Event|2|||
162922403|NCT01489865|588416842|FG007|Overall Study|Adverse Event|0|||
162922404|NCT01489865|588416843|FG008|Overall Study|Adverse Event|5|||
162922405|NCT01489865|588416835|FG000|Overall Study|Death|0|||
162922406|NCT01489865|588416836|FG001|Overall Study|Death|1|||
162922407|NCT01489865|588416837|FG002|Overall Study|Death|0|||
162922408|NCT01489865|588416838|FG003|Overall Study|Death|0|||
162922409|NCT01489865|588416839|FG004|Overall Study|Death|1|||
162922410|NCT01489865|588416840|FG005|Overall Study|Death|0|||
162922411|NCT01489865|588416841|FG006|Overall Study|Death|0|||
162922412|NCT01489865|588416842|FG007|Overall Study|Death|0|||
162922413|NCT01489865|588416843|FG008|Overall Study|Death|2|||
162922414|NCT01489865|588416835|FG000|Overall Study|Withdrawal by Subject|0|||
162922415|NCT01489865|588416836|FG001|Overall Study|Withdrawal by Subject|0|||
162922416|NCT01489865|588416837|FG002|Overall Study|Withdrawal by Subject|0|||
162922417|NCT01489865|588416838|FG003|Overall Study|Withdrawal by Subject|0|||
162922418|NCT01489865|588416839|FG004|Overall Study|Withdrawal by Subject|0|||
162922419|NCT01489865|588416840|FG005|Overall Study|Withdrawal by Subject|1|||
162922420|NCT01489865|588416841|FG006|Overall Study|Withdrawal by Subject|1|||
162922421|NCT01489865|588416842|FG007|Overall Study|Withdrawal by Subject|0|||
162922422|NCT01489865|588416843|FG008|Overall Study|Withdrawal by Subject|2|||
162922423|NCT01489865|588416835|FG000|Overall Study|Shifted|0|||
162922424|NCT01489865|588416836|FG001|Overall Study|Shifted|0|||
162922425|NCT01489865|588416837|FG002|Overall Study|Shifted|1|||
162922426|NCT01489865|588416838|FG003|Overall Study|Shifted|0|||
162922427|NCT01489865|588416839|FG004|Overall Study|Shifted|0|||
162922428|NCT01489865|588416840|FG005|Overall Study|Shifted|0|||
162922429|NCT01489865|588416841|FG006|Overall Study|Shifted|0|||
162922430|NCT01489865|588416842|FG007|Overall Study|Shifted|0|||
162922431|NCT01489865|588416843|FG008|Overall Study|Shifted|0|||
162922432|NCT04115488|588416844|FG000|Overall Study|Adverse Event|8|||
162922433|NCT04115488|588416845|FG001|Overall Study|Adverse Event|4|||
162922434|NCT04115488|588416844|FG000|Overall Study|Withdrawal by Subject|3|||
162922435|NCT04115488|588416845|FG001|Overall Study|Withdrawal by Subject|6|||
162922436|NCT04115488|588416844|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
162922437|NCT04115488|588416845|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
162922438|NCT04115488|588416844|FG000|Overall Study|Patient 's location change|1|||
162922439|NCT04115488|588416845|FG001|Overall Study|Patient 's location change|0|||
162922440|NCT04115488|588416844|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
162922441|NCT04115488|588416845|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
162922442|NCT00885677|588416846|FG000|Overall Study|Death|40|||
162922443|NCT00885677|588416847|FG001|Overall Study|Death|34|||
162922444|NCT00885677|588416846|FG000|Overall Study|Lost to Follow-up|15|||
162922445|NCT00885677|588416847|FG001|Overall Study|Lost to Follow-up|13|||
162922446|NCT00885677|588416846|FG000|Overall Study|Protocol Violation|54|||
162922447|NCT00885677|588416847|FG001|Overall Study|Protocol Violation|54|||
162922448|NCT00885677|588416846|FG000|Overall Study|premature study closure|41|||
162922449|NCT00885677|588416847|FG001|Overall Study|premature study closure|44|||
162922450|NCT00885677|588416846|FG000|Overall Study|device/lead revision or replacement|7|||
162922451|NCT00885677|588416847|FG001|Overall Study|device/lead revision or replacement|6|||
162922452|NCT00885677|588416846|FG000|Overall Study|Heart transplantation|1|||
162922453|NCT00885677|588416847|FG001|Overall Study|Heart transplantation|0|||
162922454|NCT00885677|588416846|FG000|Overall Study|Inclusion/exclusion not met|25|||
162922455|NCT00885677|588416847|FG001|Overall Study|Inclusion/exclusion not met|27|||
162922456|NCT00972309|588416848|FG000|Overall Study|Switched to alternative treatment|0|||
162922457|NCT00972309|588416849|FG001|Overall Study|Switched to alternative treatment|2|||
162922458|NCT00972309|588416848|FG000|Overall Study|Refused further treatment|0|||
162922459|NCT00972309|588416849|FG001|Overall Study|Refused further treatment|1|||
162922460|NCT00972309|588416848|FG000|Overall Study|Late determination of ineligibility|0|||
162922461|NCT00972309|588416849|FG001|Overall Study|Late determination of ineligibility|1|||
162922462|NCT00972309|588416848|FG000|Overall Study|Second malignancy|1|||
162922463|NCT00972309|588416849|FG001|Overall Study|Second malignancy|1|||
162922464|NCT00972309|588416848|FG000|Overall Study|Visa issues|0|||
163056626|NCT01281306|588919719|FG005|Overall Study|Lack of Efficacy|0|||
163056627|NCT01281306|588919720|FG006|Overall Study|Lack of Efficacy|1|||
163056628|NCT01281306|588919714|FG000|Overall Study|Withdrawal by Subject|1|||
163056629|NCT01281306|588919715|FG001|Overall Study|Withdrawal by Subject|0|||
163056630|NCT01281306|588919716|FG002|Overall Study|Withdrawal by Subject|2|||
162922465|NCT00972309|588416849|FG001|Overall Study|Visa issues|1|||
162922466|NCT00972309|588416848|FG000|Overall Study|Secondary cancer (SCC)|0|||
162922467|NCT00972309|588416849|FG001|Overall Study|Secondary cancer (SCC)|1|||
162922468|NCT00972309|588416848|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
162922469|NCT00972309|588416849|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
163056631|NCT01281306|588919717|FG003|Overall Study|Withdrawal by Subject|4|||
163056632|NCT01281306|588919718|FG004|Overall Study|Withdrawal by Subject|1|||
163056633|NCT01281306|588919719|FG005|Overall Study|Withdrawal by Subject|3|||
163056634|NCT01281306|588919720|FG006|Overall Study|Withdrawal by Subject|1|||
163056635|NCT01281306|588919714|FG000|Overall Study|Protocol deviation|0|||
163056636|NCT01281306|588919715|FG001|Overall Study|Protocol deviation|1|||
163056637|NCT01281306|588919716|FG002|Overall Study|Protocol deviation|1|||
163056638|NCT01281306|588919717|FG003|Overall Study|Protocol deviation|1|||
163056639|NCT01281306|588919718|FG004|Overall Study|Protocol deviation|1|||
163056640|NCT01281306|588919719|FG005|Overall Study|Protocol deviation|0|||
163056641|NCT01281306|588919720|FG006|Overall Study|Protocol deviation|0|||
163056642|NCT01281306|588919714|FG000|Overall Study|Condition no longer requires study drug|1|||
163056643|NCT01281306|588919715|FG001|Overall Study|Condition no longer requires study drug|0|||
163056644|NCT01281306|588919716|FG002|Overall Study|Condition no longer requires study drug|0|||
163056645|NCT01281306|588919717|FG003|Overall Study|Condition no longer requires study drug|0|||
162630025|NCT00221403|587362689|FG001|Overall Study|Lack of Efficacy|1|||
162922470|NCT00972309|588416848|FG000|Overall Study|Lost to Follow-up|1|||
162922471|NCT00972309|588416849|FG001|Overall Study|Lost to Follow-up|1|||
162922472|NCT00972309|588416848|FG000|Overall Study|Disease progression on study|10|||
162922473|NCT00972309|588416849|FG001|Overall Study|Disease progression on study|4|||
162922474|NCT01058707|588416861|FG000|Overall Study|Disease Progression|15|||
162922475|NCT01058707|588416862|FG001|Overall Study|Disease Progression|20|||
162922476|NCT01058707|588416863|FG002|Overall Study|Disease Progression|20|||
162922477|NCT01058707|588416864|FG003|Overall Study|Disease Progression|15|||
162922478|NCT01058707|588416865|FG004|Overall Study|Disease Progression|23|||
162922479|NCT01058707|588416866|FG005|Overall Study|Disease Progression|10|||
162922480|NCT01058707|588416867|FG006|Overall Study|Disease Progression|12|||
162922481|NCT01058707|588416861|FG000|Overall Study|Adverse Event|11|||
162922482|NCT01058707|588416862|FG001|Overall Study|Adverse Event|4|||
162922483|NCT01058707|588416863|FG002|Overall Study|Adverse Event|7|||
162922484|NCT01058707|588416864|FG003|Overall Study|Adverse Event|6|||
162922485|NCT01058707|588416865|FG004|Overall Study|Adverse Event|7|||
163056646|NCT01281306|588919718|FG004|Overall Study|Condition no longer requires study drug|0|||
163056647|NCT01281306|588919719|FG005|Overall Study|Condition no longer requires study drug|1|||
163056648|NCT01281306|588919720|FG006|Overall Study|Condition no longer requires study drug|1|||
163056649|NCT01281306|588919714|FG000|Overall Study|Lost to Follow-up|1|||
163056650|NCT01281306|588919715|FG001|Overall Study|Lost to Follow-up|0|||
163056651|NCT01281306|588919716|FG002|Overall Study|Lost to Follow-up|0|||
163056652|NCT01281306|588919717|FG003|Overall Study|Lost to Follow-up|2|||
163056653|NCT01281306|588919718|FG004|Overall Study|Lost to Follow-up|0|||
163056654|NCT01281306|588919719|FG005|Overall Study|Lost to Follow-up|0|||
162630026|NCT00221403|587362690|FG002|Overall Study|Lack of Efficacy|0|||
162922486|NCT01058707|588416866|FG005|Overall Study|Adverse Event|3|||
162922487|NCT01058707|588416867|FG006|Overall Study|Adverse Event|1|||
162922488|NCT01058707|588416861|FG000|Overall Study|Subject Decision|5|||
162922489|NCT01058707|588416862|FG001|Overall Study|Subject Decision|3|||
162922490|NCT01058707|588416863|FG002|Overall Study|Subject Decision|3|||
162922491|NCT01058707|588416864|FG003|Overall Study|Subject Decision|1|||
162922492|NCT01058707|588416865|FG004|Overall Study|Subject Decision|2|||
162922493|NCT01058707|588416866|FG005|Overall Study|Subject Decision|3|||
162922494|NCT01058707|588416867|FG006|Overall Study|Subject Decision|6|||
162922495|NCT01058707|588416861|FG000|Overall Study|Lost to Follow-up|0|||
162922496|NCT01058707|588416862|FG001|Overall Study|Lost to Follow-up|0|||
162922497|NCT01058707|588416863|FG002|Overall Study|Lost to Follow-up|1|||
162922498|NCT01058707|588416864|FG003|Overall Study|Lost to Follow-up|0|||
162922499|NCT01058707|588416865|FG004|Overall Study|Lost to Follow-up|0|||
162922500|NCT01058707|588416866|FG005|Overall Study|Lost to Follow-up|0|||
162922501|NCT01058707|588416867|FG006|Overall Study|Lost to Follow-up|0|||
162922502|NCT01058707|588416861|FG000|Overall Study|Reason Not Specified|0|||
162922503|NCT01058707|588416862|FG001|Overall Study|Reason Not Specified|3|||
162922504|NCT01058707|588416863|FG002|Overall Study|Reason Not Specified|2|||
162922505|NCT01058707|588416864|FG003|Overall Study|Reason Not Specified|0|||
162922506|NCT01058707|588416865|FG004|Overall Study|Reason Not Specified|7|||
162922507|NCT01058707|588416866|FG005|Overall Study|Reason Not Specified|1|||
162922508|NCT01058707|588416867|FG006|Overall Study|Reason Not Specified|7|||
162922509|NCT00167414|588416870|FG000|Overall Study|Death|10|||
162922510|NCT00795886|588416875|FG000|Overall Study|Death|10|||
162922511|NCT05554471|588416876|FG000|Overall Study|Physician Decision|2|||
162922512|NCT05554471|588416877|FG001|Overall Study|Physician Decision|1|||
162922513|NCT05554471|588416876|FG000|Overall Study|Lost to Follow-up|2|||
162922514|NCT05554471|588416877|FG001|Overall Study|Lost to Follow-up|1|||
162922515|NCT05554471|588416876|FG000|Overall Study|Death|0|||
162922516|NCT05554471|588416877|FG001|Overall Study|Death|1|||
162922517|NCT02062385|588416880|FG000|Overall Study|Adverse Event|19|||
162922518|NCT02062385|588416881|FG001|Overall Study|Adverse Event|13|||
162922519|NCT02062385|588416882|FG002|Overall Study|Adverse Event|1|||
162922520|NCT02062385|588416883|FG003|Overall Study|Adverse Event|0|||
162922521|NCT02062385|588416880|FG000|Overall Study|Protocol Violation|1|||
162922522|NCT02062385|588416881|FG001|Overall Study|Protocol Violation|0|||
162922523|NCT02062385|588416882|FG002|Overall Study|Protocol Violation|0|||
162922524|NCT02062385|588416883|FG003|Overall Study|Protocol Violation|0|||
162922525|NCT02062385|588416880|FG000|Overall Study|Incomplete EPI by database lock|2|||
162922526|NCT02062385|588416881|FG001|Overall Study|Incomplete EPI by database lock|0|||
162922527|NCT02062385|588416882|FG002|Overall Study|Incomplete EPI by database lock|0|||
162922528|NCT02062385|588416883|FG003|Overall Study|Incomplete EPI by database lock|0|||
162922529|NCT02062385|588416880|FG000|Overall Study|Moved|10|||
162922530|NCT02062385|588416881|FG001|Overall Study|Moved|11|||
162922531|NCT02062385|588416882|FG002|Overall Study|Moved|1|||
162922532|NCT02062385|588416883|FG003|Overall Study|Moved|0|||
162922533|NCT02062385|588416880|FG000|Overall Study|Withdrawn by parent/guardian|46|||
162922534|NCT02062385|588416881|FG001|Overall Study|Withdrawn by parent/guardian|41|||
162922535|NCT02062385|588416882|FG002|Overall Study|Withdrawn by parent/guardian|9|||
162922536|NCT02062385|588416883|FG003|Overall Study|Withdrawn by parent/guardian|8|||
162922537|NCT02062385|588416880|FG000|Overall Study|Death|0|||
162922538|NCT02062385|588416881|FG001|Overall Study|Death|0|||
162922539|NCT02062385|588416882|FG002|Overall Study|Death|0|||
162922540|NCT02062385|588416883|FG003|Overall Study|Death|1|||
162922541|NCT02062385|588416880|FG000|Overall Study|Lost to Follow-up|0|||
162922542|NCT02062385|588416881|FG001|Overall Study|Lost to Follow-up|0|||
162922543|NCT02062385|588416882|FG002|Overall Study|Lost to Follow-up|1|||
162922544|NCT02062385|588416883|FG003|Overall Study|Lost to Follow-up|0|||
162922545|NCT03188991|588416884|FG000|Overall Study|Withdrawal by Subject|0|||
162922546|NCT03188991|588416885|FG001|Overall Study|Withdrawal by Subject|0|||
162922547|NCT03188991|588416886|FG002|Overall Study|Withdrawal by Subject|0|||
162922548|NCT03188991|588416887|FG003|Overall Study|Withdrawal by Subject|1|||
162922549|NCT02674568|588418644|FG000|Overall Study|Withdrawal by Subject|5|||
162922550|NCT02674568|588418644|FG000|Overall Study|Death|303|||
162922551|NCT02674568|588418644|FG000|Overall Study|Physician Decision|2|||
162970761|NCT01332968|588593934|FG001|Follow-Up Period|Adverse Event|0|||
162970762|NCT01332968|588593935|FG002|Follow-Up Period|Adverse Event|0|||
162970763|NCT01332968|588593936|FG003|Follow-Up Period|Adverse Event|0|||
162970764|NCT01332968|588593937|FG004|Follow-Up Period|Adverse Event|0|||
162922552|NCT02674568|588418644|FG000|Overall Study|Lost to Follow-up|9|||
162922553|NCT02674568|588418644|FG000|Overall Study|Other, Not Specified|20|||
162922554|NCT01808508|588418647|FG000|Overall Study|Lost to Follow-up|1|||
162922555|NCT01808508|588418648|FG001|Overall Study|Lost to Follow-up|0|||
162922556|NCT01808508|588418649|FG002|Overall Study|Lost to Follow-up|0|||
162970765|NCT01332968|588593938|FG005|Follow-Up Period|Adverse Event|0|||
162970766|NCT01332968|588593939|FG006|Follow-Up Period|Adverse Event|0|||
162970767|NCT01332968|588593940|FG007|Follow-Up Period|Adverse Event|4|||
162922557|NCT01118949|588418650|FG000|Overall Study|Adverse Event|5|||
162922558|NCT01118949|588418650|FG000|Overall Study|Withdrawal by Subject|4|||
162922559|NCT03255226|588418651|FG000|Overall Study|Adverse Event|2|||
162922560|NCT03255226|588418651|FG000|Overall Study|Physician Decision|3|||
162922561|NCT03255226|588418651|FG000|Overall Study|Withdrawal by Subject|1|||
162970768|NCT01332968|588593933|FG000|Follow-Up Period|Death|0|||
162970769|NCT01332968|588593934|FG001|Follow-Up Period|Death|0|||
162970770|NCT01332968|588593935|FG002|Follow-Up Period|Death|0|||
162970771|NCT01332968|588593936|FG003|Follow-Up Period|Death|0|||
162970772|NCT01332968|588593937|FG004|Follow-Up Period|Death|0|||
162970773|NCT01332968|588593938|FG005|Follow-Up Period|Death|0|||
162970774|NCT01332968|588593939|FG006|Follow-Up Period|Death|27|||
162970775|NCT01332968|588593940|FG007|Follow-Up Period|Death|30|||
162970776|NCT01332968|588593933|FG000|Follow-Up Period|Lost to Follow-up|0|||
162970777|NCT01332968|588593934|FG001|Follow-Up Period|Lost to Follow-up|0|||
162970778|NCT01332968|588593935|FG002|Follow-Up Period|Lost to Follow-up|0|||
162970779|NCT01332968|588593936|FG003|Follow-Up Period|Lost to Follow-up|0|||
162970780|NCT01332968|588593937|FG004|Follow-Up Period|Lost to Follow-up|0|||
162970781|NCT01332968|588593938|FG005|Follow-Up Period|Lost to Follow-up|0|||
162970782|NCT01332968|588593939|FG006|Follow-Up Period|Lost to Follow-up|11|||
162970783|NCT01332968|588593940|FG007|Follow-Up Period|Lost to Follow-up|15|||
162970784|NCT01332968|588593933|FG000|Follow-Up Period|Non-compliance|0|||
162970785|NCT01332968|588593934|FG001|Follow-Up Period|Non-compliance|0|||
162970786|NCT01332968|588593935|FG002|Follow-Up Period|Non-compliance|0|||
162970787|NCT01332968|588593936|FG003|Follow-Up Period|Non-compliance|0|||
162970788|NCT01332968|588593937|FG004|Follow-Up Period|Non-compliance|0|||
162970789|NCT01332968|588593938|FG005|Follow-Up Period|Non-compliance|0|||
162970790|NCT01332968|588593939|FG006|Follow-Up Period|Non-compliance|4|||
162970791|NCT01332968|588593940|FG007|Follow-Up Period|Non-compliance|9|||
162970792|NCT01332968|588593933|FG000|Follow-Up Period|Other|0|||
162970793|NCT01332968|588593934|FG001|Follow-Up Period|Other|0|||
162970794|NCT01332968|588593935|FG002|Follow-Up Period|Other|0|||
162970795|NCT01332968|588593936|FG003|Follow-Up Period|Other|0|||
162970796|NCT01332968|588593937|FG004|Follow-Up Period|Other|0|||
162970797|NCT01332968|588593938|FG005|Follow-Up Period|Other|0|||
162970798|NCT01332968|588593939|FG006|Follow-Up Period|Other|18|||
162970799|NCT01332968|588593940|FG007|Follow-Up Period|Other|21|||
162970800|NCT01332968|588593933|FG000|Follow-Up Period|Physician Decision|0|||
162970801|NCT01332968|588593934|FG001|Follow-Up Period|Physician Decision|0|||
162970802|NCT01332968|588593935|FG002|Follow-Up Period|Physician Decision|0|||
162970803|NCT01332968|588593936|FG003|Follow-Up Period|Physician Decision|0|||
162970804|NCT01332968|588593937|FG004|Follow-Up Period|Physician Decision|0|||
162970805|NCT01332968|588593938|FG005|Follow-Up Period|Physician Decision|0|||
162970806|NCT01332968|588593939|FG006|Follow-Up Period|Physician Decision|12|||
162970807|NCT01332968|588593940|FG007|Follow-Up Period|Physician Decision|15|||
162970808|NCT01332968|588593933|FG000|Follow-Up Period|Progressive Disease|0|||
162970809|NCT01332968|588593934|FG001|Follow-Up Period|Progressive Disease|0|||
162970810|NCT01332968|588593935|FG002|Follow-Up Period|Progressive Disease|0|||
162970811|NCT01332968|588593936|FG003|Follow-Up Period|Progressive Disease|0|||
162970812|NCT01332968|588593937|FG004|Follow-Up Period|Progressive Disease|0|||
162970813|NCT01332968|588593938|FG005|Follow-Up Period|Progressive Disease|0|||
162970814|NCT01332968|588593939|FG006|Follow-Up Period|Progressive Disease|126|||
162970815|NCT01332968|588593940|FG007|Follow-Up Period|Progressive Disease|106|||
162970816|NCT01332968|588593933|FG000|Follow-Up Period|Protocol Violation|0|||
162970817|NCT01332968|588593934|FG001|Follow-Up Period|Protocol Violation|0|||
162970818|NCT01332968|588593935|FG002|Follow-Up Period|Protocol Violation|0|||
162970819|NCT01332968|588593936|FG003|Follow-Up Period|Protocol Violation|0|||
162970820|NCT01332968|588593937|FG004|Follow-Up Period|Protocol Violation|0|||
162970821|NCT01332968|588593938|FG005|Follow-Up Period|Protocol Violation|0|||
162970822|NCT01332968|588593939|FG006|Follow-Up Period|Protocol Violation|1|||
162970823|NCT01332968|588593940|FG007|Follow-Up Period|Protocol Violation|0|||
162970824|NCT01332968|588593933|FG000|Follow-Up Period|Withdrawal by Subject|0|||
162970825|NCT01332968|588593934|FG001|Follow-Up Period|Withdrawal by Subject|0|||
162970826|NCT01332968|588593935|FG002|Follow-Up Period|Withdrawal by Subject|0|||
162970827|NCT01332968|588593936|FG003|Follow-Up Period|Withdrawal by Subject|0|||
162970828|NCT01332968|588593937|FG004|Follow-Up Period|Withdrawal by Subject|0|||
162970829|NCT01332968|588593938|FG005|Follow-Up Period|Withdrawal by Subject|0|||
162970830|NCT01332968|588593939|FG006|Follow-Up Period|Withdrawal by Subject|29|||
162970831|NCT01332968|588593940|FG007|Follow-Up Period|Withdrawal by Subject|32|||
162970832|NCT01332968|588593933|FG000|Follow-Up Period|No reason provided|0|||
162970833|NCT01332968|588593934|FG001|Follow-Up Period|No reason provided|0|||
162970834|NCT01332968|588593935|FG002|Follow-Up Period|No reason provided|0|||
162970835|NCT01332968|588593936|FG003|Follow-Up Period|No reason provided|0|||
162970836|NCT01332968|588593937|FG004|Follow-Up Period|No reason provided|0|||
162970837|NCT01332968|588593938|FG005|Follow-Up Period|No reason provided|0|||
162970838|NCT01332968|588593939|FG006|Follow-Up Period|No reason provided|2|||
162970839|NCT01332968|588593940|FG007|Follow-Up Period|No reason provided|3|||
162970840|NCT00721955|588593941|FG000|Overall Study|Adverse Event|0|||
162970841|NCT00721955|588593942|FG001|Overall Study|Adverse Event|0|||
162970842|NCT00721955|588593943|FG002|Overall Study|Adverse Event|2|||
162970843|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
162970844|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
162970845|NCT04194008|588593948|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
162970846|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
163056655|NCT01281306|588919720|FG006|Overall Study|Lost to Follow-up|1|||
163056656|NCT01281306|588919714|FG000|Overall Study|Death|1|||
163056657|NCT01281306|588919715|FG001|Overall Study|Death|0|||
163056658|NCT01281306|588919716|FG002|Overall Study|Death|0|||
163056659|NCT01281306|588919717|FG003|Overall Study|Death|0|||
163056660|NCT01281306|588919718|FG004|Overall Study|Death|0|||
163056661|NCT01281306|588919719|FG005|Overall Study|Death|0|||
163056662|NCT01281306|588919720|FG006|Overall Study|Death|0|||
163056663|NCT01281306|588919714|FG000|Overall Study|Adverse Event|3|||
163056664|NCT01281306|588919715|FG001|Overall Study|Adverse Event|2|||
163056665|NCT01281306|588919716|FG002|Overall Study|Adverse Event|2|||
163056666|NCT01281306|588919717|FG003|Overall Study|Adverse Event|3|||
163056667|NCT01281306|588919718|FG004|Overall Study|Adverse Event|5|||
163056668|NCT01281306|588919719|FG005|Overall Study|Adverse Event|3|||
163056669|NCT01281306|588919720|FG006|Overall Study|Adverse Event|3|||
163056670|NCT01281306|588919714|FG000|Overall Study|Randomized in error|1|||
163056671|NCT01281306|588919715|FG001|Overall Study|Randomized in error|0|||
163056672|NCT01281306|588919716|FG002|Overall Study|Randomized in error|0|||
163056673|NCT01281306|588919717|FG003|Overall Study|Randomized in error|1|||
163056674|NCT01281306|588919718|FG004|Overall Study|Randomized in error|0|||
163056675|NCT01281306|588919719|FG005|Overall Study|Randomized in error|0|||
163056676|NCT01281306|588919720|FG006|Overall Study|Randomized in error|0|||
163056677|NCT00368550|588919721|FG000|Overall Study|Adverse Event|7|||
163056678|NCT00368550|588919722|FG001|Overall Study|Adverse Event|4|||
163056679|NCT00368550|588919721|FG000|Overall Study|Lack of Efficacy|4|||
163056680|NCT00368550|588919722|FG001|Overall Study|Lack of Efficacy|9|||
163056681|NCT00368550|588919721|FG000|Overall Study|Withdrawal by Subject|17|||
163056682|NCT00368550|588919722|FG001|Overall Study|Withdrawal by Subject|10|||
163056683|NCT01401322|588919723|FG000|Overall Study|Withdrawal by Subject|1|||
163056684|NCT01401322|588919723|FG000|Overall Study|Physician Decision|1|||
163056685|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056686|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
163056687|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056688|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056689|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
163056690|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
163056691|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
163056692|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056693|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056694|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
163056695|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
163056696|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
163056697|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056698|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056699|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
163056700|NCT03466346|588919726|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
163056701|NCT03466346|588919727|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
163056702|NCT03466346|588919728|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056703|NCT03466346|588919729|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056704|NCT03466346|588919730|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
163056705|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163056706|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163056707|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
163056708|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
163056709|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
163056710|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056711|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056712|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
163056713|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
163056714|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
163056715|NCT03466346|588919726|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
163056716|NCT03466346|588919727|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
163056717|NCT03466346|588919728|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
163056718|NCT03466346|588919729|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
163056719|NCT03466346|588919730|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
163056720|NCT02410629|588919732|FG000|Overall Study|Family cannot commit to the study|2|||
163056721|NCT02410629|588919733|FG001|Overall Study|Family cannot commit to the study|1|||
163056722|NCT02410629|588919732|FG000|Overall Study|Subject returned to work|1|||
163056723|NCT02410629|588919733|FG001|Overall Study|Subject returned to work|0|||
163056724|NCT02410629|588919732|FG000|Overall Study|Subject moved back to home country|0|||
163056725|NCT02410629|588919733|FG001|Overall Study|Subject moved back to home country|1|||
163056726|NCT02410629|588919732|FG000|Overall Study|Subject underwent heart surgery|0|||
163056727|NCT02410629|588919733|FG001|Overall Study|Subject underwent heart surgery|1|||
163056728|NCT00087178|588919734|FG000|Overall Study|No follow up data|5|||
163056729|NCT00087178|588919735|FG001|Overall Study|No follow up data|15|||
163056730|NCT00087178|588919734|FG000|Overall Study|No clinical assessment|1|||
163056731|NCT00087178|588919735|FG001|Overall Study|No clinical assessment|2|||
163056732|NCT00087178|588919734|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
163056733|NCT00087178|588919735|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
163056734|NCT03451045|588919736|FG000|Overall Study|Lack of Efficacy|3|||
163056735|NCT03451045|588919737|FG001|Overall Study|Lack of Efficacy|2|||
163056736|NCT03451045|588919738|FG002|Overall Study|Lack of Efficacy|2|||
163056737|NCT03451045|588919736|FG000|Overall Study|Physician Decision|1|||
163056738|NCT03451045|588919737|FG001|Overall Study|Physician Decision|1|||
163056739|NCT03451045|588919738|FG002|Overall Study|Physician Decision|1|||
163056740|NCT03451045|588919736|FG000|Overall Study|Withdrawal by Subject|4|||
163056741|NCT03451045|588919737|FG001|Overall Study|Withdrawal by Subject|0|||
163056742|NCT03451045|588919738|FG002|Overall Study|Withdrawal by Subject|5|||
163056743|NCT03451045|588919736|FG000|Overall Study|Pregnancy|0|||
163056744|NCT03451045|588919737|FG001|Overall Study|Pregnancy|0|||
162922562|NCT03255226|588418651|FG000|Overall Study|Serum or blood sodium increased|4|||
162922563|NCT03255226|588418651|FG000|Overall Study|Serum or blood potassium increased|4|||
162922564|NCT00648739|588418652|FG000|Overall Study|Adverse Event|1|||
162922565|NCT00648739|588418653|FG001|Overall Study|Adverse Event|0|||
162922566|NCT00648739|588418654|FG002|Overall Study|Adverse Event|1|||
162922567|NCT00648739|588418655|FG003|Overall Study|Adverse Event|2|||
162922568|NCT00648739|588418656|FG004|Overall Study|Adverse Event|1|||
162922569|NCT00648739|588418657|FG005|Overall Study|Adverse Event|0|||
162922570|NCT00648739|588418658|FG006|Overall Study|Adverse Event|0|||
162922571|NCT00648739|588418652|FG000|Overall Study|Withdrawal by Subject|1|||
162922572|NCT00648739|588418653|FG001|Overall Study|Withdrawal by Subject|0|||
162922573|NCT00648739|588418654|FG002|Overall Study|Withdrawal by Subject|1|||
162922574|NCT00648739|588418655|FG003|Overall Study|Withdrawal by Subject|0|||
162922575|NCT00648739|588418656|FG004|Overall Study|Withdrawal by Subject|0|||
162922576|NCT00648739|588418657|FG005|Overall Study|Withdrawal by Subject|2|||
162922577|NCT00648739|588418658|FG006|Overall Study|Withdrawal by Subject|0|||
162922578|NCT00648739|588418652|FG000|Overall Study|Lack of Efficacy|0|||
162922579|NCT00648739|588418653|FG001|Overall Study|Lack of Efficacy|0|||
162922580|NCT00648739|588418654|FG002|Overall Study|Lack of Efficacy|0|||
162922581|NCT00648739|588418655|FG003|Overall Study|Lack of Efficacy|0|||
162922582|NCT00648739|588418656|FG004|Overall Study|Lack of Efficacy|1|||
162922583|NCT00648739|588418657|FG005|Overall Study|Lack of Efficacy|2|||
162922584|NCT00648739|588418658|FG006|Overall Study|Lack of Efficacy|0|||
162922585|NCT00648739|588418652|FG000|Overall Study|Investigator Considered it Advisable|0|||
162922586|NCT00648739|588418653|FG001|Overall Study|Investigator Considered it Advisable|0|||
162922587|NCT00648739|588418654|FG002|Overall Study|Investigator Considered it Advisable|0|||
162922588|NCT00648739|588418655|FG003|Overall Study|Investigator Considered it Advisable|0|||
162922589|NCT00648739|588418656|FG004|Overall Study|Investigator Considered it Advisable|0|||
162922590|NCT00648739|588418657|FG005|Overall Study|Investigator Considered it Advisable|1|||
162922591|NCT00648739|588418658|FG006|Overall Study|Investigator Considered it Advisable|1|||
162922592|NCT00648739|588418652|FG000|Overall Study|Death|0|||
162922593|NCT00648739|588418653|FG001|Overall Study|Death|1|||
163056745|NCT03451045|588919738|FG002|Overall Study|Pregnancy|2|||
162922594|NCT00648739|588418654|FG002|Overall Study|Death|0|||
162922595|NCT00648739|588418655|FG003|Overall Study|Death|0|||
162922596|NCT00648739|588418656|FG004|Overall Study|Death|0|||
162922597|NCT00648739|588418657|FG005|Overall Study|Death|0|||
162922598|NCT00648739|588418658|FG006|Overall Study|Death|0|||
163056746|NCT03451045|588919736|FG000|Overall Study|Adverse Event|7|||
163056747|NCT03451045|588919737|FG001|Overall Study|Adverse Event|1|||
163056748|NCT03451045|588919738|FG002|Overall Study|Adverse Event|3|||
162922599|NCT00648739|588418652|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
162922600|NCT00648739|588418653|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
163056749|NCT03451045|588919736|FG000|Overall Study|Non-compliance with study|2|||
162922601|NCT00648739|588418654|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
162922602|NCT00648739|588418655|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
162922603|NCT00648739|588418656|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
162922604|NCT00648739|588418657|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
162922605|NCT00648739|588418658|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
163056750|NCT03451045|588919737|FG001|Overall Study|Non-compliance with study|0|||
162922606|NCT00648739|588418652|FG000|Overall Study|Follow-up Visits Not Completed|0|||
162922607|NCT00648739|588418653|FG001|Overall Study|Follow-up Visits Not Completed|1|||
162922608|NCT00648739|588418654|FG002|Overall Study|Follow-up Visits Not Completed|0|||
162922609|NCT00648739|588418655|FG003|Overall Study|Follow-up Visits Not Completed|0|||
162922610|NCT00648739|588418656|FG004|Overall Study|Follow-up Visits Not Completed|0|||
162922611|NCT00648739|588418657|FG005|Overall Study|Follow-up Visits Not Completed|0|||
162922612|NCT00648739|588418658|FG006|Overall Study|Follow-up Visits Not Completed|0|||
162922613|NCT03387423|588418663|FG000|Overall Study|Lost to Follow-up|16|||
162922614|NCT03387423|588418664|FG001|Overall Study|Lost to Follow-up|12|||
162922615|NCT03387423|588418665|FG002|Overall Study|Lost to Follow-up|1|||
162922616|NCT03387423|588418666|FG003|Overall Study|Lost to Follow-up|0|||
162922617|NCT03387423|588418663|FG000|Overall Study|Other|0|||
162922618|NCT03387423|588418664|FG001|Overall Study|Other|3|||
162922619|NCT03387423|588418665|FG002|Overall Study|Other|0|||
162922620|NCT03387423|588418666|FG003|Overall Study|Other|0|||
162922621|NCT03387423|588418663|FG000|Overall Study|Administrative Reason|166|||
162922622|NCT03387423|588418664|FG001|Overall Study|Administrative Reason|89|||
162922623|NCT03387423|588418665|FG002|Overall Study|Administrative Reason|17|||
162922624|NCT03387423|588418666|FG003|Overall Study|Administrative Reason|19|||
162922625|NCT03387423|588418663|FG000|Overall Study|Revocation Consent|76|||
162922626|NCT03387423|588418664|FG001|Overall Study|Revocation Consent|32|||
162922627|NCT03387423|588418665|FG002|Overall Study|Revocation Consent|3|||
162922628|NCT03387423|588418666|FG003|Overall Study|Revocation Consent|5|||
162922629|NCT03862807|588418673|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
162922630|NCT04362761|588418674|FG000|Part A (48 Weeks)|Adverse Event|2|||
162922631|NCT04362761|588418674|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
162922632|NCT04362761|588418674|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
162922633|NCT04362761|588418674|FG000|Part A (48 Weeks)|Other|5|||
162922634|NCT04362761|588418674|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
162922635|NCT04362761|588418674|FG000|Part B (86 Weeks)|Other|4|||
162922636|NCT00798707|588418682|FG000|Overall Study|Adverse Event|6|||
162922637|NCT00798707|588418683|FG001|Overall Study|Adverse Event|8|||
162922638|NCT00798707|588418684|FG002|Overall Study|Adverse Event|8|||
162922639|NCT00798707|588418682|FG000|Overall Study|Failed to return|2|||
162922640|NCT00798707|588418683|FG001|Overall Study|Failed to return|2|||
162922641|NCT00798707|588418684|FG002|Overall Study|Failed to return|0|||
162922642|NCT00798707|588418682|FG000|Overall Study|Investigator|0|||
162922643|NCT00798707|588418683|FG001|Overall Study|Investigator|1|||
162922644|NCT00798707|588418684|FG002|Overall Study|Investigator|2|||
162922645|NCT00798707|588418682|FG000|Overall Study|Lack of Efficacy|2|||
162922646|NCT00798707|588418683|FG001|Overall Study|Lack of Efficacy|2|||
162922647|NCT00798707|588418684|FG002|Overall Study|Lack of Efficacy|1|||
162922648|NCT00798707|588418682|FG000|Overall Study|Lost to Follow-up|5|||
162922649|NCT00798707|588418683|FG001|Overall Study|Lost to Follow-up|6|||
162922650|NCT00798707|588418684|FG002|Overall Study|Lost to Follow-up|6|||
162922651|NCT00798707|588418682|FG000|Overall Study|Other|0|||
162922652|NCT00798707|588418683|FG001|Overall Study|Other|1|||
162922653|NCT00798707|588418684|FG002|Overall Study|Other|0|||
162922654|NCT00798707|588418682|FG000|Overall Study|Protocol Violation|4|||
162922655|NCT00798707|588418683|FG001|Overall Study|Protocol Violation|0|||
162922656|NCT00798707|588418684|FG002|Overall Study|Protocol Violation|2|||
162922657|NCT00798707|588418682|FG000|Overall Study|Withdrawal by Subject|3|||
162922658|NCT00798707|588418683|FG001|Overall Study|Withdrawal by Subject|8|||
162922659|NCT00798707|588418684|FG002|Overall Study|Withdrawal by Subject|2|||
162922660|NCT00798707|588418682|FG000|Overall Study|Randomized not treated|4|||
162922661|NCT00798707|588418683|FG001|Overall Study|Randomized not treated|5|||
162922662|NCT00798707|588418684|FG002|Overall Study|Randomized not treated|1|||
162970847|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Missing data|4|||
162970848|NCT04194008|588593948|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
162970849|NCT01785615|588593949|FG000|Dietary Phase|Lost to Follow-up|0|||
162970850|NCT01785615|588593950|FG001|Dietary Phase|Lost to Follow-up|0|||
162970851|NCT01785615|588593951|FG002|Dietary Phase|Lost to Follow-up|0|||
162970852|NCT01785615|588593952|FG003|Dietary Phase|Lost to Follow-up|24|||
162970853|NCT02522780|588593953|FG000|Overall Study|Consent withdrawn by subject|5|||
162970854|NCT02522780|588593954|FG001|Overall Study|Consent withdrawn by subject|7|||
162970855|NCT02522780|588593953|FG000|Overall Study|Protocol deviation|1|||
162970856|NCT02522780|588593954|FG001|Overall Study|Protocol deviation|3|||
162970857|NCT02522780|588593953|FG000|Overall Study|Subject refused endoscopic procedure|0|||
162970858|NCT02522780|588593954|FG001|Overall Study|Subject refused endoscopic procedure|1|||
162970859|NCT02522780|588593953|FG000|Overall Study|Adverse event, non-fatal|11|||
162970860|NCT02522780|588593954|FG001|Overall Study|Adverse event, non-fatal|16|||
162970861|NCT00926367|588593955|FG000|Overall Study|Withdrawal by Subject|0|||
162970862|NCT00926367|588593956|FG001|Overall Study|Withdrawal by Subject|1|||
162970863|NCT00926367|588593955|FG000|Overall Study|Lost to Follow-up|1|||
162970864|NCT00926367|588593956|FG001|Overall Study|Lost to Follow-up|0|||
162970865|NCT00926367|588593955|FG000|Overall Study|Skin Irritation|1|||
162970866|NCT00926367|588593956|FG001|Overall Study|Skin Irritation|2|||
162922663|NCT01473589|588418685|FG000|Overall Study|Adverse Event|1|||
162922664|NCT01473589|588418686|FG001|Overall Study|Adverse Event|1|||
162922665|NCT01473589|588418685|FG000|Overall Study|Death|2|||
162922666|NCT01473589|588418686|FG001|Overall Study|Death|0|||
162922667|NCT01473589|588418685|FG000|Overall Study|Lost to Follow-up|2|||
162922668|NCT01473589|588418686|FG001|Overall Study|Lost to Follow-up|2|||
162922669|NCT01473589|588418685|FG000|Overall Study|Protocol Violation|1|||
162922670|NCT01473589|588418686|FG001|Overall Study|Protocol Violation|0|||
162922671|NCT01473589|588418685|FG000|Overall Study|Withdrawal by Subject|5|||
162922672|NCT01473589|588418686|FG001|Overall Study|Withdrawal by Subject|11|||
162922673|NCT01473589|588418685|FG000|Overall Study|Physician Decision|0|||
162922674|NCT01473589|588418686|FG001|Overall Study|Physician Decision|1|||
162922675|NCT01473589|588418685|FG000|Overall Study|Entry criteria not met|0|||
162922676|NCT01473589|588418686|FG001|Overall Study|Entry criteria not met|1|||
162922677|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
162922678|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
162922679|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
162922680|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
162922681|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
162922682|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
162922683|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
162922684|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
162922685|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
162922686|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
162922687|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
162922688|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
162922689|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
162922690|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
162922691|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
162922692|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
162922693|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
162970867|NCT01517867|588593957|FG000|Overall Study|never started treatment|29|||
162970868|NCT01517867|588593958|FG001|Overall Study|never started treatment|32|||
162970869|NCT01517867|588593957|FG000|Overall Study|Withdrawal by Subject|34|||
162970870|NCT01517867|588593958|FG001|Overall Study|Withdrawal by Subject|30|||
162970871|NCT01517867|588593957|FG000|Overall Study|Still in treatment at study end|0|||
162970872|NCT01517867|588593958|FG001|Overall Study|Still in treatment at study end|3|||
162970873|NCT00860262|588593962|FG000|Overall Study|Adverse Event|9|||
162970874|NCT00860262|588593963|FG001|Overall Study|Adverse Event|6|||
162970875|NCT00860262|588593964|FG002|Overall Study|Adverse Event|7|||
162970876|NCT00860262|588593962|FG000|Overall Study|Protocol Violation|0|||
162970877|NCT00860262|588593963|FG001|Overall Study|Protocol Violation|1|||
162970878|NCT00860262|588593964|FG002|Overall Study|Protocol Violation|0|||
162970879|NCT00860262|588593962|FG000|Overall Study|Lost to Follow-up|2|||
162970880|NCT00860262|588593963|FG001|Overall Study|Lost to Follow-up|0|||
162970881|NCT00860262|588593964|FG002|Overall Study|Lost to Follow-up|1|||
162970882|NCT00860262|588593962|FG000|Overall Study|Withdrawal by Subject|4|||
162970883|NCT00860262|588593963|FG001|Overall Study|Withdrawal by Subject|8|||
162970884|NCT00860262|588593964|FG002|Overall Study|Withdrawal by Subject|6|||
162970885|NCT00860262|588593962|FG000|Overall Study|Lack of Efficacy|0|||
162970886|NCT00860262|588593963|FG001|Overall Study|Lack of Efficacy|4|||
162970887|NCT00860262|588593964|FG002|Overall Study|Lack of Efficacy|3|||
162970888|NCT00860262|588593962|FG000|Overall Study|Other|5|||
162970889|NCT00860262|588593963|FG001|Overall Study|Other|3|||
162970890|NCT00860262|588593964|FG002|Overall Study|Other|1|||
162970891|NCT01183884|588593965|FG000|Overall Study|Progressive Disease|26|||
162970892|NCT01183884|588593965|FG000|Overall Study|Adverse Event|3|||
162970893|NCT01183884|588593965|FG000|Overall Study|Withdrawal by Subject|1|||
162970894|NCT01183884|588593965|FG000|Overall Study|Other Complicating Disease|3|||
162970895|NCT01183884|588593965|FG000|Overall Study|Not Treated|1|||
162970896|NCT01183884|588593965|FG000|Overall Study|Other|4|||
162970897|NCT02169336|588593966|FG000|Overall Study|Lack of Efficacy|1|||
162970898|NCT02169336|588593967|FG001|Overall Study|Lack of Efficacy|1|||
162970899|NCT02169336|588593968|FG002|Overall Study|Lack of Efficacy|0|||
162970900|NCT02169336|588593966|FG000|Overall Study|Adverse Event|2|||
162970901|NCT02169336|588593967|FG001|Overall Study|Adverse Event|3|||
162970902|NCT02169336|588593968|FG002|Overall Study|Adverse Event|1|||
162970903|NCT02169336|588593966|FG000|Overall Study|Withdrawal by Subject|1|||
162970904|NCT02169336|588593967|FG001|Overall Study|Withdrawal by Subject|0|||
163056751|NCT03451045|588919738|FG002|Overall Study|Non-compliance with study|1|||
162922694|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
162922695|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
162922696|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
162922697|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
162970905|NCT02169336|588593968|FG002|Overall Study|Withdrawal by Subject|0|||
162970906|NCT02169336|588593966|FG000|Overall Study|Physician Decision|0|||
162712615|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
162712616|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
162712617|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
162712618|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
162712619|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
162712620|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
162712621|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Death|0|||
162712622|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Death|8|||
162712623|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Death|2|||
162712624|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Death|13|||
162712625|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
162712626|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
162712627|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
162712628|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
162712629|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
162712630|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
162712631|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
162712632|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
162712633|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
162712634|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
162712635|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
162712636|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
162712637|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
162712638|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
162712639|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
162712640|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
162712641|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
162712642|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
162712643|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
162712644|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
162712645|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
162712646|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
162712647|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
162712648|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
162712649|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
162712650|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
162712651|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
162712652|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
162712653|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
162712654|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
162712655|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
162712656|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
162712657|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
162712658|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
162712659|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
162712660|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
162712661|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
162712662|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
162712663|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
162712664|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
162712665|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Pain|0|||
162712666|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Pain|0|||
162712667|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Pain|0|||
162712668|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Pain|1|||
162712669|NCT01107626|587658517|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
162712670|NCT01107626|587658518|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
162712671|NCT01107626|587658519|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
162922698|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
162922699|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
162922700|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
162922701|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
162922702|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
162922703|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
162922704|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
162922705|NCT01299272|588418689|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
162922706|NCT01299272|588418690|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
162922707|NCT01299272|588418691|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
162922708|NCT01299272|588418692|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
162922709|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
162922710|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
162922711|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
162922712|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
162922713|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
162922714|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
162922715|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
163056752|NCT03451045|588919736|FG000|Overall Study|any other reason|10|||
163056753|NCT03451045|588919737|FG001|Overall Study|any other reason|2|||
163056754|NCT03451045|588919738|FG002|Overall Study|any other reason|13|||
163056755|NCT00863707|588919739|FG000|Overall Study|Randomized, but drug not received|4|||
163056756|NCT00863707|588919740|FG001|Overall Study|Randomized, but drug not received|3|||
163056757|NCT00830128|588919741|FG000|Overall Study|Adverse Event|5|||
163056758|NCT00830128|588919741|FG000|Overall Study|Lack of Efficacy|7|||
163056759|NCT00830128|588919741|FG000|Overall Study|Protocol Violation|1|||
163056760|NCT00830128|588919741|FG000|Overall Study|Withdrawal by Subject|2|||
163056761|NCT00830128|588919741|FG000|Overall Study|Family obligation|1|||
163056762|NCT00830128|588919741|FG000|Overall Study|Relocation|1|||
163056763|NCT00830128|588919741|FG000|Overall Study|Work obligation|1|||
163056764|NCT00830128|588919741|FG000|Overall Study|Operating a vehicle|1|||
162922716|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
162922717|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
162922718|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
162922719|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
162922720|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
162922721|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
162922722|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
162922723|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
162922724|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
162922725|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
162922726|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
162922727|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
162922728|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
162970907|NCT02169336|588593967|FG001|Overall Study|Physician Decision|0|||
162970908|NCT02169336|588593968|FG002|Overall Study|Physician Decision|1|||
162970909|NCT02169336|588593966|FG000|Overall Study|Subject declined to continue dosing|0|||
162970910|NCT02169336|588593967|FG001|Overall Study|Subject declined to continue dosing|0|||
162970911|NCT02169336|588593968|FG002|Overall Study|Subject declined to continue dosing|1|||
162970912|NCT01598896|588593969|FG000|Overall Study|Withdrawal by Subject|0|||
162970913|NCT01598896|588593970|FG001|Overall Study|Withdrawal by Subject|1|||
162970914|NCT01598896|588593969|FG000|Overall Study|Lack of Efficacy|0|||
162970915|NCT01598896|588593970|FG001|Overall Study|Lack of Efficacy|1|||
162970916|NCT00420095|588593971|FG000|Overall Study|Adverse Event|1|||
162970917|NCT00420095|588593972|FG001|Overall Study|Adverse Event|0|||
162970918|NCT00420095|588593971|FG000|Overall Study|Protocol Violation|1|||
162970919|NCT00420095|588593972|FG001|Overall Study|Protocol Violation|1|||
162970920|NCT00420095|588593971|FG000|Overall Study|Lost to Follow-up|1|||
162970921|NCT00420095|588593972|FG001|Overall Study|Lost to Follow-up|0|||
162970922|NCT00393705|588593973|FG000|Overall Study|Adverse Event|0|||
162970923|NCT00393705|588593974|FG001|Overall Study|Adverse Event|2|||
162970924|NCT00393705|588593973|FG000|Overall Study|Death|0|||
162970925|NCT00393705|588593974|FG001|Overall Study|Death|1|||
162970926|NCT00393705|588593973|FG000|Overall Study|Lost to Follow-up|2|||
162970927|NCT00393705|588593974|FG001|Overall Study|Lost to Follow-up|2|||
162970928|NCT00393705|588593973|FG000|Overall Study|Entry Criteria Not Met|10|||
162970929|NCT00393705|588593974|FG001|Overall Study|Entry Criteria Not Met|10|||
162970930|NCT00393705|588593973|FG000|Overall Study|Protocol Violation|4|||
162970931|NCT00393705|588593974|FG001|Overall Study|Protocol Violation|3|||
162970932|NCT00393705|588593973|FG000|Overall Study|Withdrawal by Subject|5|||
162970933|NCT00393705|588593974|FG001|Overall Study|Withdrawal by Subject|3|||
163056765|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
163056766|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
163056767|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
163056768|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
163056769|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
162970934|NCT00393705|588593973|FG000|Overall Study|Physician Decision|2|||
162712672|NCT01107626|587658520|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
162712673|NCT02715258|587658521|FG000|Overall Study|Withdrawal by Subject|6|||
162970935|NCT00393705|588593974|FG001|Overall Study|Physician Decision|2|||
162970936|NCT04553406|588593977|FG000|Overall Study|Study Discontinuation|0|||
162970937|NCT04553406|588593978|FG001|Overall Study|Study Discontinuation|1|||
162970938|NCT03370510|588593979|FG000|Overall Study|COVID-19|2|||
163056770|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
163056771|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
163056772|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
163056773|NCT03040726|588919742|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
163056774|NCT03040726|588919743|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
163056775|NCT05063448|588919746|FG000|Overall Study|Withdrawal by Subject|1|||
162922729|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
162922730|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
162922731|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
162922732|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
162922733|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
162922734|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
162922735|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
162922736|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
162922737|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
162922738|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
162922739|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
162922740|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
162922741|NCT01299272|588418689|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
162922742|NCT01299272|588418690|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
162922743|NCT01299272|588418691|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
162922744|NCT01299272|588418692|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
162922745|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
162922746|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
162922747|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
162922748|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
162922749|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
162922750|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
162970939|NCT03370510|588593980|FG001|Overall Study|COVID-19|0|||
162970940|NCT01841060|588595585|FG000|Overall Study|Protocol Violation|10|||
162970941|NCT05258630|588595586|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
162970942|NCT05258630|588595587|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
162970943|NCT05258630|588595586|FG000|Overall Study|Lost to Follow-up|0|||
162970944|NCT05258630|588595587|FG001|Overall Study|Lost to Follow-up|2|||
162970945|NCT03431337|588595588|FG000|Overall Study|Lost to Follow-up|21|||
162970946|NCT03431337|588595589|FG001|Overall Study|Lost to Follow-up|19|||
162970947|NCT03431337|588595588|FG000|Overall Study|Withdrawal by Subject|8|||
162970948|NCT03431337|588595589|FG001|Overall Study|Withdrawal by Subject|3|||
162970949|NCT02419573|588595590|FG000|Overall Study|Lost to Follow-up|3|||
162970950|NCT02419573|588595591|FG001|Overall Study|Lost to Follow-up|0|||
162970951|NCT02419573|588595590|FG000|Overall Study|Withdrawal by Subject|1|||
162970952|NCT02419573|588595591|FG001|Overall Study|Withdrawal by Subject|0|||
162970953|NCT04167618|588595596|FG000|Overall Study|Trial terminated by sponsor|1|||
162970954|NCT04167618|588595597|FG001|Overall Study|Trial terminated by sponsor|1|||
162970955|NCT00460109|588595598|FG000|Overall Study|Death|1|||
162970956|NCT02994394|588595599|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970957|NCT02994394|588595600|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970958|NCT02994394|588595601|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
162970959|NCT02994394|588595602|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
163056776|NCT03641508|588919750|FG000|First Injection|Lost to Follow-up|2|||
163056777|NCT03641508|588919751|FG001|First Injection|Lost to Follow-up|0|||
163056778|NCT00094445|588919752|FG000|Overall Study|Withdrawal by Subject|3|||
163056779|NCT00094445|588919752|FG000|Overall Study|Lost to Follow-up|1|||
163056780|NCT00094445|588919752|FG000|Overall Study|Progressive Disease|2|||
163056781|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
163056782|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
163056783|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056784|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056785|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
163056786|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
163056787|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
163056788|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056789|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056790|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163056791|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
162970960|NCT02994394|588595603|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970961|NCT02994394|588595604|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
162970962|NCT02994394|588595599|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
163056792|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
163056793|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
163056794|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
162922751|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
162922752|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
162922753|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
162922754|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
162922755|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
162922756|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
162922757|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
162922758|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
162922759|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
162922760|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
162922761|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
162922762|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
162922763|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
162922764|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
162922765|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
162922766|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
162922767|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
162922768|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
162922769|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
162922770|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
162922771|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
162922772|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
162922773|NCT01299272|588418689|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
162922774|NCT01299272|588418690|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
162922775|NCT01299272|588418691|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
162922776|NCT01299272|588418692|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
162922777|NCT00464308|588418693|FG000|Overall Study|Adverse Event|22|||
162922778|NCT00464308|588418694|FG001|Overall Study|Adverse Event|27|||
162922779|NCT00464308|588418695|FG002|Overall Study|Adverse Event|16|||
162922780|NCT00464308|588418693|FG000|Overall Study|Lost to Follow-up|29|||
162922781|NCT00464308|588418694|FG001|Overall Study|Lost to Follow-up|19|||
162922782|NCT00464308|588418695|FG002|Overall Study|Lost to Follow-up|20|||
162922783|NCT00464308|588418693|FG000|Overall Study|Patient discontinued and other reasons|17|||
162922784|NCT00464308|588418694|FG001|Overall Study|Patient discontinued and other reasons|17|||
162922785|NCT00464308|588418695|FG002|Overall Study|Patient discontinued and other reasons|23|||
162922786|NCT00464308|588418693|FG000|Overall Study|Physician Decision|1|||
162922787|NCT00464308|588418694|FG001|Overall Study|Physician Decision|0|||
162922788|NCT00464308|588418695|FG002|Overall Study|Physician Decision|0|||
162922789|NCT01721200|588418696|FG000|Overall Study|Lost to Follow-up|3|||
162922790|NCT01721200|588418697|FG001|Overall Study|Lost to Follow-up|5|||
162922791|NCT01513759|588418698|FG000|Overall Study|Protocol Violation|4|||
162922792|NCT01513759|588418698|FG000|Overall Study|Death during catheter placement|1|||
162922793|NCT03606109|588418699|FG000|Overall Study|Lost to Follow-up|2|||
162922794|NCT03606109|588418700|FG001|Overall Study|Lost to Follow-up|1|||
162922795|NCT03926728|588418701|FG000|Overall Study|Withdrawal by Subject|0|||
162922796|NCT03926728|588418702|FG001|Overall Study|Withdrawal by Subject|1|||
162922797|NCT03926728|588418703|FG002|Overall Study|Withdrawal by Subject|1|||
163056795|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
163056796|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
163056797|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
163056798|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
162922798|NCT03926728|588418704|FG003|Overall Study|Withdrawal by Subject|0|||
163056799|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163056800|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163056801|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
163056802|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
163056803|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163056804|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163056805|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
162922799|NCT03926728|588418705|FG004|Overall Study|Withdrawal by Subject|0|||
162922800|NCT03926728|588418706|FG005|Overall Study|Withdrawal by Subject|1|||
162922801|NCT03926728|588418707|FG006|Overall Study|Withdrawal by Subject|1|||
162922802|NCT03926728|588418708|FG007|Overall Study|Withdrawal by Subject|0|||
162922803|NCT03926728|588418709|FG008|Overall Study|Withdrawal by Subject|0|||
162922804|NCT03926728|588418710|FG009|Overall Study|Withdrawal by Subject|1|||
162922805|NCT03926728|588418711|FG010|Overall Study|Withdrawal by Subject|0|||
162922806|NCT03926728|588418712|FG011|Overall Study|Withdrawal by Subject|0|||
162922807|NCT03669640|588418717|FG000|Overall Study|Study Terminated by Sponsor|0|||
162922808|NCT03669640|588418718|FG001|Overall Study|Study Terminated by Sponsor|0|||
162922809|NCT03669640|588418719|FG002|Overall Study|Study Terminated by Sponsor|0|||
162922810|NCT03669640|588418720|FG003|Overall Study|Study Terminated by Sponsor|0|||
162922811|NCT03669640|588418721|FG004|Overall Study|Study Terminated by Sponsor|1|||
162922812|NCT03669640|588418722|FG005|Overall Study|Study Terminated by Sponsor|0|||
162922813|NCT03669640|588418717|FG000|Overall Study|Lost to Follow-up|0|||
162922814|NCT03669640|588418718|FG001|Overall Study|Lost to Follow-up|0|||
162922815|NCT03669640|588418719|FG002|Overall Study|Lost to Follow-up|2|||
162712674|NCT02715258|587658522|FG001|Overall Study|Withdrawal by Subject|1|||
162712675|NCT02715258|587658521|FG000|Overall Study|Lost to Follow-up|7|||
162922816|NCT03669640|588418720|FG003|Overall Study|Lost to Follow-up|0|||
162922817|NCT03669640|588418721|FG004|Overall Study|Lost to Follow-up|0|||
162922818|NCT03669640|588418722|FG005|Overall Study|Lost to Follow-up|0|||
162922819|NCT03669640|588418717|FG000|Overall Study|Death|0|||
162922820|NCT03669640|588418718|FG001|Overall Study|Death|0|||
162922821|NCT03669640|588418719|FG002|Overall Study|Death|1|||
162922822|NCT03669640|588418720|FG003|Overall Study|Death|0|||
162922823|NCT03669640|588418721|FG004|Overall Study|Death|0|||
162922824|NCT03669640|588418722|FG005|Overall Study|Death|0|||
162922825|NCT03669640|588418717|FG000|Overall Study|Withdrawal by Subject|1|||
162922826|NCT03669640|588418718|FG001|Overall Study|Withdrawal by Subject|2|||
162922827|NCT03669640|588418719|FG002|Overall Study|Withdrawal by Subject|1|||
162922828|NCT03669640|588418720|FG003|Overall Study|Withdrawal by Subject|0|||
162922829|NCT03669640|588418721|FG004|Overall Study|Withdrawal by Subject|1|||
162922830|NCT03669640|588418722|FG005|Overall Study|Withdrawal by Subject|3|||
162922831|NCT03669640|588418717|FG000|Overall Study|Protocol Violation|1|||
162922832|NCT03669640|588418718|FG001|Overall Study|Protocol Violation|0|||
162922833|NCT03669640|588418719|FG002|Overall Study|Protocol Violation|0|||
162922834|NCT03669640|588418720|FG003|Overall Study|Protocol Violation|0|||
162922835|NCT03669640|588418721|FG004|Overall Study|Protocol Violation|0|||
162922836|NCT03669640|588418722|FG005|Overall Study|Protocol Violation|0|||
162922837|NCT03669640|588418717|FG000|Overall Study|Physician Decision|0|||
162922838|NCT03669640|588418718|FG001|Overall Study|Physician Decision|2|||
162922839|NCT03669640|588418719|FG002|Overall Study|Physician Decision|0|||
162922840|NCT03669640|588418720|FG003|Overall Study|Physician Decision|0|||
162922841|NCT03669640|588418721|FG004|Overall Study|Physician Decision|0|||
162922842|NCT03669640|588418722|FG005|Overall Study|Physician Decision|0|||
162922843|NCT03669640|588418717|FG000|Overall Study|Disease Relapse|1|||
162922844|NCT03669640|588418718|FG001|Overall Study|Disease Relapse|0|||
162922845|NCT03669640|588418719|FG002|Overall Study|Disease Relapse|0|||
162922846|NCT03669640|588418720|FG003|Overall Study|Disease Relapse|0|||
163056806|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
163056807|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
162922847|NCT03669640|588418721|FG004|Overall Study|Disease Relapse|0|||
162922848|NCT03669640|588418722|FG005|Overall Study|Disease Relapse|0|||
162922849|NCT03669640|588418717|FG000|Overall Study|Adverse Event|2|||
162922850|NCT03669640|588418718|FG001|Overall Study|Adverse Event|1|||
162922851|NCT03669640|588418719|FG002|Overall Study|Adverse Event|0|||
162922852|NCT03669640|588418720|FG003|Overall Study|Adverse Event|0|||
162922853|NCT03669640|588418721|FG004|Overall Study|Adverse Event|1|||
162922854|NCT03669640|588418722|FG005|Overall Study|Adverse Event|0|||
162922855|NCT03722849|588418725|FG000|Overall Study|Withdrawal by Subject|1|||
162922856|NCT03722849|588418726|FG001|Overall Study|Withdrawal by Subject|1|||
162922857|NCT03993288|588418727|FG000|Overall Study|Lost to Follow-up|2|||
162922858|NCT03993288|588418728|FG001|Overall Study|Lost to Follow-up|1|||
162922859|NCT03993288|588418727|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
162922860|NCT03993288|588418728|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
162922861|NCT03993288|588418727|FG000|Overall Study|wrong randomization|0|||
162922862|NCT03993288|588418728|FG001|Overall Study|wrong randomization|1|||
162922863|NCT03993288|588418727|FG000|Overall Study|improper enrollment|0|||
162922864|NCT03993288|588418728|FG001|Overall Study|improper enrollment|1|||
163056808|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056809|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056810|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
163056811|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
163056812|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
163056813|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056814|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056815|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
163056816|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
162922865|NCT03993288|588418727|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
162970963|NCT02994394|588595600|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
163056817|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
163056818|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056819|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056820|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
163056821|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
163056822|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056823|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056824|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056825|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
163056826|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
163056827|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
162970964|NCT02994394|588595601|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
163056828|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
163056829|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
163056830|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
163056831|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
163056832|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
163056833|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
163056834|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
163056835|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
162922866|NCT03993288|588418728|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
162922867|NCT03993288|588418727|FG000|Overall Study|developed SAE|2|||
162922868|NCT03993288|588418728|FG001|Overall Study|developed SAE|0|||
162922869|NCT03993288|588418727|FG000|Overall Study|consent withdrawal|1|||
162922870|NCT03993288|588418728|FG001|Overall Study|consent withdrawal|0|||
162922871|NCT03993288|588418727|FG000|Overall Study|did not follow the treatment schedule|1|||
162970965|NCT02994394|588595602|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
162970966|NCT02994394|588595603|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
162970967|NCT02994394|588595604|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
162970968|NCT03619876|588595605|FG000|Overall Study|Withdrawal by Subject|1|||
162970969|NCT03619876|588595606|FG001|Overall Study|Withdrawal by Subject|2|||
162970970|NCT03619876|588595605|FG000|Overall Study|Withdrawal due to incidental finding|0|||
162970971|NCT03619876|588595606|FG001|Overall Study|Withdrawal due to incidental finding|2|||
162970972|NCT04982445|588595608|FG000|Overall Study|Protocol Violation|1|||
162970973|NCT04982445|588595608|FG000|Overall Study|Withdrawal by Subject|4|||
162970974|NCT04982445|588595608|FG000|Overall Study|Lost to Follow-up|1|||
162970975|NCT00763555|588595609|FG000|Overall Study|Adverse Event|2|||
162922872|NCT03993288|588418728|FG001|Overall Study|did not follow the treatment schedule|0|||
162922873|NCT03993288|588418727|FG000|Overall Study|did not follow the treatment regimen|1|||
162922874|NCT03993288|588418728|FG001|Overall Study|did not follow the treatment regimen|0|||
162922875|NCT03993288|588418727|FG000|Overall Study|Adverse Event|1|||
162922876|NCT03993288|588418728|FG001|Overall Study|Adverse Event|0|||
162922877|NCT03993288|588418727|FG000|Overall Study|Withdrawal by Subject|1|||
162922878|NCT03993288|588418728|FG001|Overall Study|Withdrawal by Subject|1|||
162922879|NCT02729545|588418729|FG000|Overall Study|Pregnancy|1|||
162922880|NCT02729545|588418730|FG001|Overall Study|Pregnancy|1|||
162922881|NCT02729545|588418729|FG000|Overall Study|Lost to Follow-up|0|||
162922882|NCT02729545|588418730|FG001|Overall Study|Lost to Follow-up|1|||
162922883|NCT02729545|588418729|FG000|Overall Study|Withdrawal by Subject|2|||
162922884|NCT02729545|588418730|FG001|Overall Study|Withdrawal by Subject|3|||
162922885|NCT03533608|588418731|FG000|Overall Study|Withdrawal by Subject|3|||
162922886|NCT03533608|588418731|FG000|Overall Study|Physician Decision|2|||
162922887|NCT00915473|588418732|FG000|Screening|Withdrawal by Subject|1|||
162922888|NCT00915473|588418733|FG001|Screening|Withdrawal by Subject|0|||
162922889|NCT00915473|588418732|FG000|4-week Follow Up|Lost to Follow-up|1|||
162922890|NCT00915473|588418733|FG001|4-week Follow Up|Lost to Follow-up|5|||
162922891|NCT01389024|588418734|FG000|Overall Study|Withdrawal by Subject|0|||
162922892|NCT01389024|588418735|FG001|Overall Study|Withdrawal by Subject|1|||
162922893|NCT01389024|588418734|FG000|Overall Study|Lost to Follow-up|1|||
162922894|NCT01389024|588418735|FG001|Overall Study|Lost to Follow-up|0|||
162922895|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
162922896|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
162922897|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
162922898|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Death|1|||
162922899|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
162922900|NCT00529802|588418737|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
162922901|NCT00529802|588418737|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
162922902|NCT02209454|588418738|FG000|Second Period|Adverse Event|1|||
162922903|NCT02209454|588418739|FG001|Second Period|Adverse Event|0|||
162922904|NCT00366678|588418740|FG000|Infant Series|Withdrawal by Subject|8|||
162922905|NCT00366678|588418741|FG001|Infant Series|Withdrawal by Subject|6|||
162922906|NCT00366678|588418742|FG002|Infant Series|Withdrawal by Subject|0|||
162922907|NCT00366678|588418740|FG000|Infant Series|Protocol Violation|4|||
162922908|NCT00366678|588418741|FG001|Infant Series|Protocol Violation|3|||
162922909|NCT00366678|588418742|FG002|Infant Series|Protocol Violation|0|||
162922910|NCT00366678|588418740|FG000|Infant Series|Failed to return|1|||
162922911|NCT00366678|588418741|FG001|Infant Series|Failed to return|1|||
162922912|NCT00366678|588418742|FG002|Infant Series|Failed to return|0|||
162922913|NCT00366678|588418740|FG000|Infant Series|Adverse Event|1|||
162922914|NCT00366678|588418741|FG001|Infant Series|Adverse Event|0|||
162922915|NCT00366678|588418742|FG002|Infant Series|Adverse Event|0|||
162922916|NCT00366678|588418740|FG000|After Infant|Withdrawal by Subject|8|||
162922917|NCT00366678|588418741|FG001|After Infant|Withdrawal by Subject|4|||
162922918|NCT00366678|588418742|FG002|After Infant|Withdrawal by Subject|0|||
162922919|NCT00366678|588418740|FG000|After Infant|Lost to Follow-up|2|||
162922920|NCT00366678|588418741|FG001|After Infant|Lost to Follow-up|1|||
162630027|NCT00221403|587362688|FG000|Overall Study|Adverse Event|0|||
162630028|NCT00221403|587362689|FG001|Overall Study|Adverse Event|1|||
162922921|NCT00366678|588418742|FG002|After Infant|Lost to Follow-up|0|||
162922922|NCT00366678|588418740|FG000|After Infant|Failed to return|5|||
162922923|NCT00366678|588418741|FG001|After Infant|Failed to return|5|||
162922924|NCT00366678|588418742|FG002|After Infant|Failed to return|0|||
162922925|NCT00366678|588418740|FG000|After Infant|Adverse Event|1|||
162922926|NCT00366678|588418741|FG001|After Infant|Adverse Event|0|||
162922927|NCT00366678|588418742|FG002|After Infant|Adverse Event|0|||
162922928|NCT00366678|588418740|FG000|After Infant|Protocol Violation|1|||
162922929|NCT00366678|588418741|FG001|After Infant|Protocol Violation|0|||
162922930|NCT00366678|588418742|FG002|After Infant|Protocol Violation|0|||
162922931|NCT00366678|588418740|FG000|Toddler Dose|Protocol Violation|2|||
162922932|NCT00366678|588418741|FG001|Toddler Dose|Protocol Violation|1|||
162922933|NCT00366678|588418742|FG002|Toddler Dose|Protocol Violation|0|||
162922934|NCT00366678|588418740|FG000|Toddler Dose|Failed to return|1|||
162922935|NCT00366678|588418741|FG001|Toddler Dose|Failed to return|0|||
162922936|NCT00366678|588418742|FG002|Toddler Dose|Failed to return|0|||
162922937|NCT00366678|588418740|FG000|Toddler Dose|Withdrawal by Subject|1|||
162922938|NCT00366678|588418741|FG001|Toddler Dose|Withdrawal by Subject|0|||
162922939|NCT00366678|588418742|FG002|Toddler Dose|Withdrawal by Subject|0|||
162922940|NCT00366678|588418740|FG000|Toddler Dose|protocol deviation|1|||
162922941|NCT00366678|588418741|FG001|Toddler Dose|protocol deviation|0|||
162922942|NCT00366678|588418742|FG002|Toddler Dose|protocol deviation|0|||
162922943|NCT00826176|588418752|FG000|Overall Study|Lost to Follow-up|1|||
162922944|NCT00826176|588418753|FG001|Overall Study|Lost to Follow-up|0|||
162922945|NCT00826176|588418752|FG000|Overall Study|Subject Withdrew Consent|3|||
162922946|NCT00826176|588418753|FG001|Overall Study|Subject Withdrew Consent|0|||
162630029|NCT00221403|587362690|FG002|Overall Study|Adverse Event|0|||
162922947|NCT00826176|588418752|FG000|Overall Study|Administrative|9|||
162922948|NCT00826176|588418753|FG001|Overall Study|Administrative|0|||
162922949|NCT00740480|588418754|FG000|Overall Study|Adverse Event|1|||
162922950|NCT00740480|588418754|FG000|Overall Study|Physician Decision|1|||
163056836|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
163056837|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
162922951|NCT03079869|588418760|FG000|Overall Study|Adverse Event|6|||
162922952|NCT03079869|588418761|FG001|Overall Study|Adverse Event|8|||
162922953|NCT03079869|588418760|FG000|Overall Study|Withdrawal by Subject|4|||
162922954|NCT03079869|588418761|FG001|Overall Study|Withdrawal by Subject|1|||
162922955|NCT03079869|588418760|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
162922956|NCT03079869|588418761|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
162922957|NCT01325701|588418762|FG000|Overall Study|Adverse Event|12|||
162922958|NCT01325701|588418763|FG001|Overall Study|Adverse Event|0|||
162922959|NCT01325701|588418762|FG000|Overall Study|Protocol Violation|1|||
162922960|NCT01325701|588418763|FG001|Overall Study|Protocol Violation|0|||
162922961|NCT01325701|588418762|FG000|Overall Study|Physician Decision|2|||
162922962|NCT01325701|588418763|FG001|Overall Study|Physician Decision|2|||
162922963|NCT01325701|588418762|FG000|Overall Study|Withdrawal by Subject|2|||
162922964|NCT01325701|588418763|FG001|Overall Study|Withdrawal by Subject|1|||
162922965|NCT01325701|588418762|FG000|Overall Study|Rollerover Extension Study|4|||
162922966|NCT01325701|588418763|FG001|Overall Study|Rollerover Extension Study|0|||
163056838|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056839|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056840|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
163056841|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
163056842|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
162630030|NCT02216591|587362693|FG000|Overall Study|Lost to Follow-up|0|||
162922967|NCT04484805|588418772|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
162922968|NCT04484805|588418773|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
162922969|NCT04484805|588418772|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
162922970|NCT04484805|588418773|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
162922971|NCT00539006|588418774|FG000|Pre-treatment|Other|0|||
162922972|NCT00539006|588418775|FG001|Pre-treatment|Other|1|||
162922973|NCT00539006|588418776|FG002|Pre-treatment|Other|0|||
162922974|NCT00539006|588418777|FG003|Pre-treatment|Other|0|||
162922975|NCT00539006|588418774|FG000|Treatment Period 1|Lost to Follow-up|0|||
162922976|NCT00539006|588418775|FG001|Treatment Period 1|Lost to Follow-up|0|||
162922977|NCT00539006|588418776|FG002|Treatment Period 1|Lost to Follow-up|1|||
162922978|NCT00539006|588418777|FG003|Treatment Period 1|Lost to Follow-up|0|||
162922979|NCT00539006|588418774|FG000|Treatment Period 1|Protocol Violation|0|||
162922980|NCT00539006|588418775|FG001|Treatment Period 1|Protocol Violation|0|||
162922981|NCT00539006|588418776|FG002|Treatment Period 1|Protocol Violation|1|||
162922982|NCT00539006|588418777|FG003|Treatment Period 1|Protocol Violation|0|||
162922983|NCT00539006|588418774|FG000|Treatment Period 1|Lack of Efficacy|0|||
162922984|NCT00539006|588418775|FG001|Treatment Period 1|Lack of Efficacy|0|||
162922985|NCT00539006|588418776|FG002|Treatment Period 1|Lack of Efficacy|0|||
162922986|NCT00539006|588418777|FG003|Treatment Period 1|Lack of Efficacy|1|||
162922987|NCT00539006|588418774|FG000|Washout|Adverse Event|2|||
162922988|NCT00539006|588418775|FG001|Washout|Adverse Event|1|||
162922989|NCT00539006|588418776|FG002|Washout|Adverse Event|0|||
162922990|NCT00539006|588418777|FG003|Washout|Adverse Event|0|||
162922991|NCT00539006|588418774|FG000|Washout|Protocol Violation|1|||
162922992|NCT00539006|588418775|FG001|Washout|Protocol Violation|1|||
162922993|NCT00539006|588418776|FG002|Washout|Protocol Violation|0|||
162922994|NCT00539006|588418777|FG003|Washout|Protocol Violation|0|||
162922995|NCT00539006|588418774|FG000|Washout|Withdrawal by Subject|0|||
162922996|NCT00539006|588418775|FG001|Washout|Withdrawal by Subject|2|||
162922997|NCT00539006|588418776|FG002|Washout|Withdrawal by Subject|0|||
162922998|NCT00539006|588418777|FG003|Washout|Withdrawal by Subject|0|||
162922999|NCT00539006|588418774|FG000|Washout|Failed to meet continuation criteria|16|||
162923000|NCT00539006|588418775|FG001|Washout|Failed to meet continuation criteria|5|||
162923001|NCT00539006|588418776|FG002|Washout|Failed to meet continuation criteria|14|||
162923002|NCT00539006|588418777|FG003|Washout|Failed to meet continuation criteria|6|||
162923003|NCT00539006|588418774|FG000|Washout|Other|1|||
162923004|NCT00539006|588418775|FG001|Washout|Other|1|||
162923005|NCT00539006|588418776|FG002|Washout|Other|2|||
162630031|NCT02216591|587362694|FG001|Overall Study|Lost to Follow-up|1|||
162923006|NCT00539006|588418777|FG003|Washout|Other|3|||
162923007|NCT00539006|588418774|FG000|Treatment Period 2|Protocol Violation|1|||
162923008|NCT00539006|588418775|FG001|Treatment Period 2|Protocol Violation|0|||
162923009|NCT00539006|588418776|FG002|Treatment Period 2|Protocol Violation|0|||
162923010|NCT00539006|588418777|FG003|Treatment Period 2|Protocol Violation|0|||
162630032|NCT01950741|587362696|FG000|Overall Study|Lost to Follow-up|1|||
162923011|NCT00539006|588418774|FG000|Treatment Period 2|Other|0|||
162923012|NCT00539006|588418775|FG001|Treatment Period 2|Other|1|||
162923013|NCT00539006|588418776|FG002|Treatment Period 2|Other|0|||
162712676|NCT02715258|587658522|FG001|Overall Study|Lost to Follow-up|1|||
162712677|NCT02715258|587658521|FG000|Overall Study|Terminated by Sponsor|0|||
162712678|NCT02715258|587658522|FG001|Overall Study|Terminated by Sponsor|1|||
162712679|NCT02715258|587658521|FG000|Overall Study|Death|0|||
162712680|NCT02715258|587658522|FG001|Overall Study|Death|1|||
162712681|NCT02715258|587658521|FG000|Overall Study|Subject non-compliant|1|||
162712682|NCT02715258|587658522|FG001|Overall Study|Subject non-compliant|1|||
162712683|NCT02715258|587658521|FG000|Overall Study|GCP violation|2|||
162712684|NCT02715258|587658522|FG001|Overall Study|GCP violation|1|||
162712685|NCT01117480|587658532|FG000|Overall Study|Protocol Violation|8|||
162712686|NCT01117480|587658532|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
162712687|NCT01280591|587658533|FG000|Overall Study|Withdrawal by Subject|0|||
162712688|NCT01280591|587658534|FG001|Overall Study|Withdrawal by Subject|0|||
162712689|NCT01280591|587658535|FG002|Overall Study|Withdrawal by Subject|0|||
162712690|NCT01280591|587658536|FG003|Overall Study|Withdrawal by Subject|2|||
162712691|NCT01280591|587658533|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
162712692|NCT01280591|587658534|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
162712693|NCT01280591|587658535|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
162712694|NCT01280591|587658536|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
162712695|NCT02955069|587658538|FG000|Overall Study|Adverse Event|7|||
162712696|NCT02955069|587658539|FG001|Overall Study|Adverse Event|2|||
162712697|NCT02955069|587658538|FG000|Overall Study|Death|7|||
162712698|NCT02955069|587658539|FG001|Overall Study|Death|3|||
162712699|NCT02955069|587658538|FG000|Overall Study|Physician Decision|10|||
162712700|NCT02955069|587658539|FG001|Overall Study|Physician Decision|2|||
162712701|NCT02955069|587658538|FG000|Overall Study|Progressive disease|64|||
162712702|NCT02955069|587658539|FG001|Overall Study|Progressive disease|13|||
162712703|NCT02955069|587658538|FG000|Overall Study|Study terminated by sponsor|4|||
162712704|NCT02955069|587658539|FG001|Overall Study|Study terminated by sponsor|0|||
162712705|NCT02955069|587658538|FG000|Overall Study|Subject/Guardian decision|3|||
162712706|NCT02955069|587658539|FG001|Overall Study|Subject/Guardian decision|1|||
162712707|NCT03721016|587658540|FG000|Overall Study|Adverse Event|0|||
162712708|NCT03721016|587658541|FG001|Overall Study|Adverse Event|1|||
162712709|NCT03721016|587658542|FG002|Overall Study|Adverse Event|1|||
162712710|NCT03721016|587658540|FG000|Overall Study|Withdrawal by Subject|8|||
162712711|NCT03721016|587658541|FG001|Overall Study|Withdrawal by Subject|16|||
162712712|NCT03721016|587658542|FG002|Overall Study|Withdrawal by Subject|13|||
162712713|NCT03721016|587658540|FG000|Overall Study|Lost to Follow-up|4|||
162712714|NCT03721016|587658541|FG001|Overall Study|Lost to Follow-up|6|||
162712715|NCT03721016|587658542|FG002|Overall Study|Lost to Follow-up|5|||
162923014|NCT00539006|588418777|FG003|Treatment Period 2|Other|0|||
162923015|NCT03733301|588418778|FG000|Overall Study|Screen Fail|1|||
162923016|NCT03733301|588418779|FG001|Overall Study|Screen Fail|0|||
162923017|NCT03733301|588418780|FG002|Overall Study|Screen Fail|0|||
162923018|NCT03733301|588418778|FG000|Overall Study|Non-compliance|1|||
162923019|NCT03733301|588418779|FG001|Overall Study|Non-compliance|0|||
162923020|NCT03733301|588418780|FG002|Overall Study|Non-compliance|0|||
162923021|NCT03733301|588418778|FG000|Overall Study|Lack of Efficacy|2|||
162923022|NCT03733301|588418779|FG001|Overall Study|Lack of Efficacy|3|||
162923023|NCT03733301|588418780|FG002|Overall Study|Lack of Efficacy|0|||
162923024|NCT03733301|588418778|FG000|Overall Study|Adverse Event|0|||
162923025|NCT03733301|588418779|FG001|Overall Study|Adverse Event|1|||
162923026|NCT03733301|588418780|FG002|Overall Study|Adverse Event|3|||
162923027|NCT03733301|588418778|FG000|Overall Study|Withdrawal by Subject|3|||
162923028|NCT03733301|588418779|FG001|Overall Study|Withdrawal by Subject|5|||
162923029|NCT03733301|588418780|FG002|Overall Study|Withdrawal by Subject|1|||
162923030|NCT01965431|588418781|FG000|Overall Study|Adverse Event|0|||
162923031|NCT01965431|588418782|FG001|Overall Study|Adverse Event|1|||
162923032|NCT01965431|588418783|FG002|Overall Study|Adverse Event|0|||
162923033|NCT01965431|588418784|FG003|Overall Study|Adverse Event|0|||
162923034|NCT01965431|588418785|FG004|Overall Study|Adverse Event|0|||
162923035|NCT01965431|588418786|FG005|Overall Study|Adverse Event|0|||
162923036|NCT01965431|588418781|FG000|Overall Study|Other than stated above|6|||
162712716|NCT03721016|587658540|FG000|Overall Study|Physician Decision|0|||
162712717|NCT03721016|587658541|FG001|Overall Study|Physician Decision|1|||
162712718|NCT03721016|587658542|FG002|Overall Study|Physician Decision|2|||
162712719|NCT03721016|587658540|FG000|Overall Study|Protocol Violation|0|||
162712720|NCT03721016|587658541|FG001|Overall Study|Protocol Violation|1|||
162712721|NCT03721016|587658542|FG002|Overall Study|Protocol Violation|0|||
162712722|NCT03721016|587658540|FG000|Overall Study|Site terminated by sponsor|3|||
162712723|NCT03721016|587658541|FG001|Overall Study|Site terminated by sponsor|7|||
162712724|NCT03721016|587658542|FG002|Overall Study|Site terminated by sponsor|6|||
162923037|NCT01965431|588418782|FG001|Overall Study|Other than stated above|5|||
162923038|NCT01965431|588418783|FG002|Overall Study|Other than stated above|6|||
162923039|NCT01965431|588418784|FG003|Overall Study|Other than stated above|6|||
162923040|NCT01965431|588418785|FG004|Overall Study|Other than stated above|6|||
162970976|NCT00763555|588595610|FG001|Overall Study|Adverse Event|1|||
162970977|NCT00763555|588595609|FG000|Overall Study|Withdrawal by Subject|2|||
162970978|NCT00763555|588595610|FG001|Overall Study|Withdrawal by Subject|6|||
162970979|NCT00763555|588595609|FG000|Overall Study|Lost to Follow-up|0|||
162970980|NCT00763555|588595610|FG001|Overall Study|Lost to Follow-up|3|||
162970981|NCT00684567|588595612|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
162970982|NCT00684567|588595612|FG000|Monotherapy Period|Adverse Event|2|||
162970983|NCT00684567|588595612|FG000|Monotherapy Period|Death|1|||
162970984|NCT00684567|588595612|FG000|Monotherapy Period|Progression of primary disease|11|||
162970985|NCT02916693|588595613|FG000|Overall Study|Lost to Follow-up|7|||
162970986|NCT00979212|588595617|FG000|Overall Study|Protocol Violation|1|||
162970987|NCT00979212|588595618|FG001|Overall Study|Protocol Violation|8|||
162970988|NCT00979212|588595617|FG000|Overall Study|No protocol therapy received|1|||
162970989|NCT00979212|588595618|FG001|Overall Study|No protocol therapy received|0|||
162970990|NCT00035555|588595619|FG000|Overall Study|Adverse Event|5|||
162970991|NCT00035555|588595620|FG001|Overall Study|Adverse Event|8|||
162970992|NCT00035555|588595621|FG002|Overall Study|Adverse Event|9|||
162970993|NCT00035555|588595619|FG000|Overall Study|Allograft loss|1|||
162970994|NCT00035555|588595620|FG001|Overall Study|Allograft loss|1|||
162970995|NCT00035555|588595621|FG002|Overall Study|Allograft loss|2|||
162970996|NCT00035555|588595619|FG000|Overall Study|Death|0|||
162970997|NCT00035555|588595620|FG001|Overall Study|Death|0|||
162970998|NCT00035555|588595621|FG002|Overall Study|Death|2|||
162970999|NCT00035555|588595619|FG000|Overall Study|Lost to Follow-up|0|||
162971000|NCT00035555|588595620|FG001|Overall Study|Lost to Follow-up|0|||
162971001|NCT00035555|588595621|FG002|Overall Study|Lost to Follow-up|1|||
162971002|NCT00035555|588595619|FG000|Overall Study|Noncompliance|0|||
162971003|NCT00035555|588595620|FG001|Overall Study|Noncompliance|1|||
162971004|NCT00035555|588595621|FG002|Overall Study|Noncompliance|1|||
162971005|NCT00035555|588595619|FG000|Overall Study|Prohibited medication|1|||
162971006|NCT00035555|588595620|FG001|Overall Study|Prohibited medication|1|||
162971007|NCT00035555|588595621|FG002|Overall Study|Prohibited medication|0|||
162971008|NCT00035555|588595619|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
162971009|NCT00035555|588595620|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
162971010|NCT00035555|588595621|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
162971011|NCT00035555|588595619|FG000|Overall Study|Withdrawal by Subject|2|||
162971012|NCT00035555|588595620|FG001|Overall Study|Withdrawal by Subject|0|||
162971013|NCT00035555|588595621|FG002|Overall Study|Withdrawal by Subject|2|||
162971014|NCT00035555|588595619|FG000|Overall Study|Investigator deemed not a good candidate|0|||
162971015|NCT00035555|588595620|FG001|Overall Study|Investigator deemed not a good candidate|0|||
162971016|NCT00035555|588595621|FG002|Overall Study|Investigator deemed not a good candidate|1|||
162971017|NCT00035555|588595619|FG000|Overall Study|Received cyclosporin in error|0|||
162971018|NCT00035555|588595620|FG001|Overall Study|Received cyclosporin in error|0|||
162971019|NCT00035555|588595621|FG002|Overall Study|Received cyclosporin in error|1|||
162971020|NCT00337428|588595622|FG000|Overall Study|Withdrawal by Subject|1|||
162971021|NCT00337428|588595623|FG001|Overall Study|Withdrawal by Subject|2|||
162971022|NCT00337428|588595622|FG000|Overall Study|Lack of Time|1|||
162971023|NCT00337428|588595623|FG001|Overall Study|Lack of Time|1|||
162971024|NCT00337428|588595622|FG000|Overall Study|Unwilling to Continue|1|||
162971025|NCT00337428|588595623|FG001|Overall Study|Unwilling to Continue|0|||
162971026|NCT00337428|588595622|FG000|Overall Study|Anorexia|1|||
162923041|NCT01965431|588418786|FG005|Overall Study|Other than stated above|6|||
162923042|NCT00605839|588418787|FG000|Overall Study|Protocol Violation|1|||
162923043|NCT00605839|588418788|FG001|Overall Study|Protocol Violation|0|||
162923044|NCT00605839|588418789|FG002|Overall Study|Protocol Violation|0|||
162923045|NCT04636437|588418793|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
162923046|NCT04636437|588418794|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
162923047|NCT04636437|588418795|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
162923048|NCT04636437|588418793|FG000|Overall Study|Started weight loss drug/program|2|||
162923049|NCT04636437|588418794|FG001|Overall Study|Started weight loss drug/program|1|||
162923050|NCT04636437|588418795|FG002|Overall Study|Started weight loss drug/program|1|||
162923051|NCT04636437|588418793|FG000|Overall Study|Lost to Follow-up|3|||
162923052|NCT04636437|588418794|FG001|Overall Study|Lost to Follow-up|1|||
162923053|NCT04636437|588418795|FG002|Overall Study|Lost to Follow-up|4|||
162923054|NCT04636437|588418793|FG000|Overall Study|Participant or physician decision|3|||
162923055|NCT04636437|588418794|FG001|Overall Study|Participant or physician decision|1|||
162923056|NCT04636437|588418795|FG002|Overall Study|Participant or physician decision|1|||
162923057|NCT00816166|588418796|FG000|Overall Study|Lost to Follow-up|6|||
162923058|NCT00816166|588418797|FG001|Overall Study|Lost to Follow-up|10|||
162923059|NCT00816166|588418796|FG000|Overall Study|Death|4|||
162923060|NCT00816166|588418797|FG001|Overall Study|Death|2|||
162923061|NCT01071278|588418798|FG000|Overall Study|Premature Discontinuation|254|||
162923062|NCT01071278|588418798|FG000|Overall Study|Completion Status Unknown|459|||
162923063|NCT01821391|588418800|FG000|Overall Study|Adverse Event|1|||
162923064|NCT01821391|588418801|FG001|Overall Study|Adverse Event|0|||
162923065|NCT03417102|588418803|FG000|Overall Study|Adverse Event|0|||
162923066|NCT03417102|588418804|FG001|Overall Study|Adverse Event|1|||
162923067|NCT03417102|588418803|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
162923068|NCT03417102|588418804|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
162923069|NCT03417102|588418803|FG000|Overall Study|Other|0|||
162923070|NCT03417102|588418804|FG001|Overall Study|Other|1|||
162923071|NCT01017731|588420208|FG000|Overall Study|Lost to Follow-up|2|||
162923072|NCT01017731|588420208|FG000|Overall Study|Withdrawal by Subject|3|||
162923073|NCT01017731|588420208|FG000|Overall Study|Physician Decision|2|||
162923074|NCT01017731|588420208|FG000|Overall Study|Adverse Event|1|||
162923075|NCT01035229|588420209|FG000|Overall Study|Adverse Event|61|||
162923076|NCT01035229|588420210|FG001|Overall Study|Adverse Event|14|||
162923077|NCT01035229|588420209|FG000|Overall Study|Withdrawal by Subject|20|||
162923078|NCT01035229|588420210|FG001|Overall Study|Withdrawal by Subject|7|||
162923079|NCT01035229|588420209|FG000|Overall Study|Lost to Follow-up|1|||
162923080|NCT01035229|588420210|FG001|Overall Study|Lost to Follow-up|0|||
162923081|NCT01035229|588420209|FG000|Overall Study|Administrative problems|1|||
162923082|NCT01035229|588420210|FG001|Overall Study|Administrative problems|1|||
162923083|NCT01035229|588420209|FG000|Overall Study|Death|13|||
162923084|NCT01035229|588420210|FG001|Overall Study|Death|5|||
162923085|NCT01035229|588420209|FG000|Overall Study|New cancer therapy|2|||
162923086|NCT01035229|588420210|FG001|Overall Study|New cancer therapy|0|||
162923087|NCT01035229|588420209|FG000|Overall Study|Protocol Violation|0|||
162923088|NCT01035229|588420210|FG001|Overall Study|Protocol Violation|2|||
162923089|NCT01035229|588420209|FG000|Overall Study|Sponsor's decision to end study|3|||
162923090|NCT01035229|588420210|FG001|Overall Study|Sponsor's decision to end study|3|||
162923091|NCT01035229|588420209|FG000|Overall Study|Disease Progression|261|||
162923092|NCT01035229|588420210|FG001|Overall Study|Disease Progression|152|||
162923093|NCT00685763|588420212|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
162923094|NCT00685763|588420212|FG000|Overall Study|Protocol Violation|1|||
162923095|NCT00698009|588420216|FG000|Overall Study|Withdrawal by Subject|1|||
162923096|NCT00564486|588420220|FG000|Overall Study|Adverse Event|0|||
162923097|NCT00564486|588420221|FG001|Overall Study|Adverse Event|1|||
162923098|NCT00564486|588420222|FG002|Overall Study|Adverse Event|0|||
162923099|NCT00564486|588420223|FG003|Overall Study|Adverse Event|0|||
162923100|NCT00564486|588420220|FG000|Overall Study|Withdrawal by Subject|4|||
162923101|NCT00564486|588420221|FG001|Overall Study|Withdrawal by Subject|0|||
162971027|NCT00337428|588595623|FG001|Overall Study|Anorexia|0|||
162971028|NCT02618382|588595624|FG000|Overall Study|Physician Decision|1|||
162923102|NCT00564486|588420222|FG002|Overall Study|Withdrawal by Subject|0|||
162923103|NCT00564486|588420223|FG003|Overall Study|Withdrawal by Subject|5|||
162923104|NCT00564486|588420220|FG000|Overall Study|Subject refused to have blood drawn|0|||
162923105|NCT00564486|588420221|FG001|Overall Study|Subject refused to have blood drawn|0|||
162923106|NCT00564486|588420222|FG002|Overall Study|Subject refused to have blood drawn|1|||
162923107|NCT00564486|588420223|FG003|Overall Study|Subject refused to have blood drawn|0|||
162923108|NCT00564486|588420220|FG000|Overall Study|Lost to Follow-up|3|||
162971029|NCT02618382|588595624|FG000|Overall Study|Withdrawal by Subject|1|||
162971030|NCT02618382|588595624|FG000|Overall Study|Protocol Violation|1|||
162923109|NCT00564486|588420221|FG001|Overall Study|Lost to Follow-up|0|||
162923110|NCT00564486|588420222|FG002|Overall Study|Lost to Follow-up|2|||
162923111|NCT00564486|588420223|FG003|Overall Study|Lost to Follow-up|2|||
162923112|NCT03457727|588420227|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
162971031|NCT03223909|588595625|FG000|Overall Study|Protocol Violation|48|||
162712725|NCT03721016|587658540|FG000|Overall Study|Subject exited early due to COVID-19|1|||
162712726|NCT03721016|587658541|FG001|Overall Study|Subject exited early due to COVID-19|0|||
162712727|NCT03721016|587658542|FG002|Overall Study|Subject exited early due to COVID-19|0|||
162923113|NCT03457727|588420228|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
162923114|NCT03457727|588420229|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
162923115|NCT03457727|588420230|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
162923116|NCT00929201|588420231|FG000|Period 1|Withdrawal by Subject|0|||
162923117|NCT00929201|588420232|FG001|Period 1|Withdrawal by Subject|1|||
162923118|NCT03286426|588420236|FG000|Overall Study|Physician Decision|3|||
162923119|NCT01817764|588420237|FG000|Overall Study|Adverse Event|7|||
162923120|NCT01817764|588420238|FG001|Overall Study|Adverse Event|10|||
162923121|NCT01817764|588420237|FG000|Overall Study|Lack of Efficacy|9|||
162923122|NCT01817764|588420238|FG001|Overall Study|Lack of Efficacy|7|||
162923123|NCT01817764|588420237|FG000|Overall Study|Protocol Violation|7|||
162923124|NCT01817764|588420238|FG001|Overall Study|Protocol Violation|5|||
162923125|NCT01817764|588420237|FG000|Overall Study|Lost to Follow-up|1|||
162923126|NCT01817764|588420238|FG001|Overall Study|Lost to Follow-up|4|||
162923127|NCT01817764|588420237|FG000|Overall Study|Withdrawal by Subject|10|||
162923128|NCT01817764|588420238|FG001|Overall Study|Withdrawal by Subject|12|||
162923129|NCT01956123|588420239|FG000|COS Cycle 2|Protocol Violation|8|||
162923130|NCT01956123|588420240|FG001|COS Cycle 2|Protocol Violation|3|||
162923131|NCT01956123|588420241|FG002|COS Cycle 2|Protocol Violation|0|||
162923132|NCT01956123|588420242|FG003|COS Cycle 2|Protocol Violation|0|||
162923133|NCT01956123|588420239|FG000|COS Cycle 2|Adverse Event|3|||
162923134|NCT01956123|588420240|FG001|COS Cycle 2|Adverse Event|4|||
162923135|NCT01956123|588420241|FG002|COS Cycle 2|Adverse Event|0|||
162923136|NCT01956123|588420242|FG003|COS Cycle 2|Adverse Event|0|||
162923137|NCT01956123|588420239|FG000|COS Cycle 2|Personal Reasons|2|||
162923138|NCT01956123|588420240|FG001|COS Cycle 2|Personal Reasons|0|||
162923139|NCT01956123|588420241|FG002|COS Cycle 2|Personal Reasons|0|||
162923140|NCT01956123|588420242|FG003|COS Cycle 2|Personal Reasons|0|||
162923141|NCT01956123|588420239|FG000|COS Cycle 2|Withdrawal by Subject|1|||
162923142|NCT01956123|588420240|FG001|COS Cycle 2|Withdrawal by Subject|0|||
162923143|NCT01956123|588420241|FG002|COS Cycle 2|Withdrawal by Subject|0|||
162923144|NCT01956123|588420242|FG003|COS Cycle 2|Withdrawal by Subject|0|||
162923145|NCT01956123|588420239|FG000|COS Cycle 3|Protocol Violation|0|||
162923146|NCT01956123|588420240|FG001|COS Cycle 3|Protocol Violation|0|||
162923147|NCT01956123|588420241|FG002|COS Cycle 3|Protocol Violation|2|||
162923148|NCT01956123|588420242|FG003|COS Cycle 3|Protocol Violation|1|||
162923149|NCT01956123|588420239|FG000|COS Cycle 3|Adverse Event|0|||
162923150|NCT01956123|588420240|FG001|COS Cycle 3|Adverse Event|0|||
162923151|NCT01956123|588420241|FG002|COS Cycle 3|Adverse Event|3|||
162923152|NCT01956123|588420242|FG003|COS Cycle 3|Adverse Event|0|||
162923153|NCT01956123|588420239|FG000|COS Cycle 3|Personal Reasons|0|||
162923154|NCT01956123|588420240|FG001|COS Cycle 3|Personal Reasons|0|||
162923155|NCT01956123|588420241|FG002|COS Cycle 3|Personal Reasons|1|||
162923156|NCT01956123|588420242|FG003|COS Cycle 3|Personal Reasons|0|||
162923157|NCT01956123|588420239|FG000|COS Cycle 3|Withdrawal by Subject|0|||
162923158|NCT01956123|588420240|FG001|COS Cycle 3|Withdrawal by Subject|0|||
162923159|NCT01956123|588420241|FG002|COS Cycle 3|Withdrawal by Subject|0|||
162923160|NCT01956123|588420242|FG003|COS Cycle 3|Withdrawal by Subject|1|||
162923161|NCT00388674|588420251|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
162923162|NCT00388674|588420252|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
162923163|NCT00388674|588420251|FG000|Initial Treatment|Adverse Event|22|||
162923164|NCT00388674|588420252|FG001|Initial Treatment|Adverse Event|87|||
162923165|NCT00388674|588420251|FG000|Initial Treatment|Death|215|||
162923166|NCT00388674|588420252|FG001|Initial Treatment|Death|216|||
162712728|NCT03357341|587658543|FG000|Overall Study|Withdrawal by Subject|3|||
162712729|NCT03357341|587658544|FG001|Overall Study|Withdrawal by Subject|6|||
162712730|NCT03357341|587658543|FG000|Overall Study|Lost to Follow-up|4|||
162712731|NCT03357341|587658544|FG001|Overall Study|Lost to Follow-up|5|||
162923167|NCT00388674|588420251|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
162923168|NCT00388674|588420252|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
162923169|NCT00388674|588420251|FG000|Initial Treatment|HCC|12|||
162971032|NCT03223909|588595626|FG001|Overall Study|Protocol Violation|45|||
162971033|NCT03223909|588595627|FG002|Overall Study|Protocol Violation|16|||
162712732|NCT03357341|587658543|FG000|Overall Study|Death|0|||
162923170|NCT00388674|588420252|FG001|Initial Treatment|HCC|20|||
162971034|NCT00177164|588595636|FG000|Overall Study|Protocol Violation|0|||
162923171|NCT00388674|588420251|FG000|Initial Treatment|Lost to Follow-up|526|||
162923172|NCT00388674|588420252|FG001|Initial Treatment|Lost to Follow-up|624|||
162923173|NCT00388674|588420251|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
162923174|NCT00388674|588420252|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
162923175|NCT00388674|588420251|FG000|Initial Treatment|Never Treated with Study Medication|1|||
162971035|NCT00177164|588595637|FG001|Overall Study|Protocol Violation|7|||
162923176|NCT00388674|588420252|FG001|Initial Treatment|Never Treated with Study Medication|7|||
162712733|NCT03357341|587658544|FG001|Overall Study|Death|1|||
162923177|NCT00388674|588420251|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
163056843|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056844|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056845|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
163056846|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056847|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
163056848|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056849|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056850|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
163056851|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
163056852|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
163056853|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056854|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056855|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
163056856|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056857|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
163056858|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056859|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056860|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
163056861|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
163056862|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056863|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056864|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056865|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
163056866|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056867|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
163056868|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056869|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
162630033|NCT01950741|587362696|FG000|Overall Study|Death|1|||
162630034|NCT01950741|587362696|FG000|Overall Study|Withdrawal by Subject|1|||
162630035|NCT00558558|587362699|FG000|Overall Study|Unable to swallow|1|||
162630036|NCT00558558|587362699|FG000|Overall Study|Withdrawal by Subject|1|||
162630037|NCT00558558|587362699|FG000|Overall Study|Lack of Efficacy|4|||
162630038|NCT02549937|587362701|FG000|Overall Study|Death|0|||
162630039|NCT02549937|587362702|FG001|Overall Study|Death|1|||
162630040|NCT02549937|587362703|FG002|Overall Study|Death|0|||
162630041|NCT02549937|587362704|FG003|Overall Study|Death|1|||
162630042|NCT02549937|587362705|FG004|Overall Study|Death|0|||
162630043|NCT02549937|587362706|FG005|Overall Study|Death|8|||
162630044|NCT02549937|587362707|FG006|Overall Study|Death|0|||
162630045|NCT02549937|587362708|FG007|Overall Study|Death|0|||
162630046|NCT02549937|587362709|FG008|Overall Study|Death|19|||
162630047|NCT02549937|587362701|FG000|Overall Study|No follow up required|3|||
162630048|NCT02549937|587362702|FG001|Overall Study|No follow up required|6|||
162923178|NCT00388674|588420252|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
162923179|NCT00388674|588420251|FG000|Initial Treatment|Not Defined|125|||
162923180|NCT00388674|588420252|FG001|Initial Treatment|Not Defined|172|||
162923181|NCT00388674|588420251|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
162923182|NCT00388674|588420252|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
162630049|NCT02549937|587362703|FG002|Overall Study|No follow up required|3|||
162630050|NCT02549937|587362704|FG003|Overall Study|No follow up required|8|||
162630051|NCT02549937|587362705|FG004|Overall Study|No follow up required|12|||
162630052|NCT02549937|587362706|FG005|Overall Study|No follow up required|21|||
162630053|NCT02549937|587362707|FG006|Overall Study|No follow up required|9|||
162630054|NCT02549937|587362708|FG007|Overall Study|No follow up required|11|||
162630055|NCT02549937|587362709|FG008|Overall Study|No follow up required|0|||
162630056|NCT02549937|587362701|FG000|Overall Study|Other|0|||
162630057|NCT02549937|587362702|FG001|Overall Study|Other|0|||
162630058|NCT02549937|587362703|FG002|Overall Study|Other|0|||
162630059|NCT02549937|587362704|FG003|Overall Study|Other|0|||
162630060|NCT02549937|587362705|FG004|Overall Study|Other|1|||
162712734|NCT01908634|587658548|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
162712735|NCT01908634|587658548|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
162712736|NCT01072357|587658549|FG000|Overall Study|Lost to Follow-up|0|||
162712737|NCT01072357|587658550|FG001|Overall Study|Lost to Follow-up|1|||
162712738|NCT01876511|587658551|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
162712739|NCT01876511|587658552|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
162712740|NCT01876511|587658553|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
162712741|NCT01876511|587658551|FG000|Overall Study|Death (unrelated)|3|||
162712742|NCT01876511|587658552|FG001|Overall Study|Death (unrelated)|0|||
162712743|NCT01876511|587658553|FG002|Overall Study|Death (unrelated)|2|||
162712744|NCT01876511|587658551|FG000|Overall Study|Drug-related Toxicity|5|||
162712745|NCT01876511|587658552|FG001|Overall Study|Drug-related Toxicity|1|||
162712746|NCT01876511|587658553|FG002|Overall Study|Drug-related Toxicity|6|||
162712747|NCT01876511|587658551|FG000|Overall Study|Patient Decision|3|||
162712748|NCT01876511|587658552|FG001|Overall Study|Patient Decision|0|||
162712749|NCT01876511|587658553|FG002|Overall Study|Patient Decision|6|||
162712750|NCT01876511|587658551|FG000|Overall Study|Physician Decision|1|||
162712751|NCT01876511|587658552|FG001|Overall Study|Physician Decision|0|||
162712752|NCT01876511|587658553|FG002|Overall Study|Physician Decision|1|||
162712753|NCT02131324|587658554|FG000|Overall Study|Withdrawal by Subject|1|||
162712754|NCT02131324|587658555|FG001|Overall Study|Withdrawal by Subject|2|||
162712755|NCT02131324|587658554|FG000|Overall Study|Lost to Follow-up|1|||
162712756|NCT02131324|587658555|FG001|Overall Study|Lost to Follow-up|1|||
162712757|NCT05790408|587658556|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
162712758|NCT01048788|587658557|FG000|Overall Study|Adverse Event|5|||
162712759|NCT01048788|587658558|FG001|Overall Study|Adverse Event|1|||
162712760|NCT01048788|587658559|FG002|Overall Study|Adverse Event|1|||
162712761|NCT01048788|587658557|FG000|Overall Study|Lack of Efficacy|0|||
162712762|NCT01048788|587658558|FG001|Overall Study|Lack of Efficacy|0|||
162712763|NCT01048788|587658559|FG002|Overall Study|Lack of Efficacy|1|||
162712764|NCT01048788|587658557|FG000|Overall Study|Withdrawal by Subject|0|||
162712765|NCT01048788|587658558|FG001|Overall Study|Withdrawal by Subject|1|||
162712766|NCT01048788|587658559|FG002|Overall Study|Withdrawal by Subject|0|||
163056870|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
163056871|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
163056872|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056873|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056874|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056875|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163056876|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163056877|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
163056878|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163056879|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
162630061|NCT02549937|587362706|FG005|Overall Study|Other|0|||
162630062|NCT02549937|587362707|FG006|Overall Study|Other|3|||
162630063|NCT02549937|587362708|FG007|Overall Study|Other|2|||
162630064|NCT02549937|587362709|FG008|Overall Study|Other|3|||
162630065|NCT02549937|587362701|FG000|Overall Study|Lost to Follow-up|0|||
162630066|NCT02549937|587362702|FG001|Overall Study|Lost to Follow-up|0|||
162630067|NCT02549937|587362703|FG002|Overall Study|Lost to Follow-up|0|||
162630068|NCT02549937|587362704|FG003|Overall Study|Lost to Follow-up|0|||
162630069|NCT02549937|587362705|FG004|Overall Study|Lost to Follow-up|0|||
162630070|NCT02549937|587362706|FG005|Overall Study|Lost to Follow-up|0|||
162630071|NCT02549937|587362707|FG006|Overall Study|Lost to Follow-up|0|||
162630072|NCT02549937|587362708|FG007|Overall Study|Lost to Follow-up|0|||
162630073|NCT02549937|587362709|FG008|Overall Study|Lost to Follow-up|3|||
162712767|NCT01233050|587658560|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
162712768|NCT01233050|587658561|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
162712769|NCT04582877|587658566|FG000|Overall Study|Did not use device measurement|5|||
163056880|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
162630074|NCT02549937|587362701|FG000|Overall Study|Withdrawal by Subject|0|||
162630075|NCT02549937|587362702|FG001|Overall Study|Withdrawal by Subject|0|||
162630076|NCT02549937|587362703|FG002|Overall Study|Withdrawal by Subject|0|||
162630077|NCT02549937|587362704|FG003|Overall Study|Withdrawal by Subject|0|||
162630078|NCT02549937|587362705|FG004|Overall Study|Withdrawal by Subject|0|||
162712770|NCT04582877|587658566|FG000|Overall Study|No fractional flow reserve test results|2|||
162712771|NCT04582877|587658566|FG000|Overall Study|Protocol Violation|1|||
162712772|NCT01664104|587658573|FG000|Overall Study|Adverse Event|6|||
162712773|NCT01664104|587658573|FG000|Overall Study|Lack of Efficacy|2|||
162712774|NCT01664104|587658573|FG000|Overall Study|Withdrawal by Subject|1|||
162630079|NCT02549937|587362706|FG005|Overall Study|Withdrawal by Subject|1|||
162630080|NCT02549937|587362707|FG006|Overall Study|Withdrawal by Subject|4|||
162630081|NCT02549937|587362708|FG007|Overall Study|Withdrawal by Subject|3|||
162630082|NCT02549937|587362709|FG008|Overall Study|Withdrawal by Subject|2|||
162630083|NCT02549937|587362701|FG000|Overall Study|Sponsor Decision|0|||
162630084|NCT02549937|587362702|FG001|Overall Study|Sponsor Decision|0|||
162630085|NCT02549937|587362703|FG002|Overall Study|Sponsor Decision|0|||
162630086|NCT02549937|587362704|FG003|Overall Study|Sponsor Decision|0|||
162630087|NCT02549937|587362705|FG004|Overall Study|Sponsor Decision|0|||
162630088|NCT02549937|587362706|FG005|Overall Study|Sponsor Decision|0|||
162630089|NCT02549937|587362707|FG006|Overall Study|Sponsor Decision|0|||
162630090|NCT02549937|587362708|FG007|Overall Study|Sponsor Decision|0|||
162630091|NCT02549937|587362709|FG008|Overall Study|Sponsor Decision|6|||
162630092|NCT02144012|587362712|FG000|Overall Study|Adverse Event|1|||
162630093|NCT02144012|587362713|FG001|Overall Study|Adverse Event|0|||
162630094|NCT02144012|587362712|FG000|Overall Study|Death|1|||
162630095|NCT02144012|587362713|FG001|Overall Study|Death|0|||
162630096|NCT02144012|587362712|FG000|Overall Study|Withdrawal by Subject|11|||
162630097|NCT02144012|587362713|FG001|Overall Study|Withdrawal by Subject|3|||
162630098|NCT02144012|587362712|FG000|Overall Study|Study Terminated by Sponsor|18|||
162630099|NCT02144012|587362713|FG001|Overall Study|Study Terminated by Sponsor|12|||
162630100|NCT02144012|587362712|FG000|Overall Study|Other|3|||
162630101|NCT02144012|587362713|FG001|Overall Study|Other|0|||
162630102|NCT00317356|587362714|FG000|Overall Study|Adverse Event|0|||
162630103|NCT00317356|587362715|FG001|Overall Study|Adverse Event|0|||
162630104|NCT00317356|587362716|FG002|Overall Study|Adverse Event|1|||
162630105|NCT00317356|587362717|FG003|Overall Study|Adverse Event|0|||
162630106|NCT00317356|587362714|FG000|Overall Study|Lack of Efficacy|1|||
162630107|NCT00317356|587362715|FG001|Overall Study|Lack of Efficacy|1|||
162630108|NCT00317356|587362716|FG002|Overall Study|Lack of Efficacy|0|||
162630109|NCT00317356|587362717|FG003|Overall Study|Lack of Efficacy|3|||
162630110|NCT00317356|587362714|FG000|Overall Study|Physician Decision|0|||
162630111|NCT00317356|587362715|FG001|Overall Study|Physician Decision|1|||
162630112|NCT00317356|587362716|FG002|Overall Study|Physician Decision|0|||
162630113|NCT00317356|587362717|FG003|Overall Study|Physician Decision|0|||
162630114|NCT04342897|587362718|FG000|Overall Study|Death|7|||
162630115|NCT04342897|587362719|FG001|Overall Study|Death|4|||
162630116|NCT04342897|587362718|FG000|Overall Study|Lost to Follow-up|6|||
162630117|NCT04342897|587362719|FG001|Overall Study|Lost to Follow-up|6|||
162630118|NCT04342897|587362718|FG000|Overall Study|Withdrawal by Subject|1|||
162630119|NCT04342897|587362719|FG001|Overall Study|Withdrawal by Subject|2|||
162712775|NCT01664104|587658573|FG000|Overall Study|Lost to Follow-up|4|||
162923183|NCT00388674|588420251|FG000|Initial Treatment|Pregnancy|26|||
162923184|NCT00388674|588420252|FG001|Initial Treatment|Pregnancy|16|||
162923185|NCT00388674|588420251|FG000|Initial Treatment|Study Drug Toxicity|5|||
162923186|NCT00388674|588420252|FG001|Initial Treatment|Study Drug Toxicity|92|||
162923187|NCT00388674|588420251|FG000|Initial Treatment|Participant Request|501|||
162923188|NCT00388674|588420252|FG001|Initial Treatment|Participant Request|673|||
162923189|NCT00388674|588420251|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
162923190|NCT00388674|588420252|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
162923191|NCT00388674|588420251|FG000|Initial Treatment|Not Reported|10|||
162923192|NCT00388674|588420252|FG001|Initial Treatment|Not Reported|12|||
162923193|NCT00388674|588420251|FG000|End of Study|Administrative Reason By Sponsor|299|||
162923194|NCT00388674|588420252|FG001|End of Study|Administrative Reason By Sponsor|253|||
162923195|NCT00388674|588420251|FG000|End of Study|Death|239|||
162923196|NCT00388674|588420252|FG001|End of Study|Death|262|||
162923197|NCT00388674|588420251|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
162923198|NCT00388674|588420252|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
162923199|NCT00388674|588420251|FG000|End of Study|HCC|8|||
162923200|NCT00388674|588420252|FG001|End of Study|HCC|7|||
162923201|NCT00388674|588420251|FG000|End of Study|Lost to Follow-up|587|||
162923202|NCT00388674|588420252|FG001|End of Study|Lost to Follow-up|715|||
162923203|NCT00388674|588420251|FG000|End of Study|Malignancy (Non-HCC)|1|||
162923204|NCT00388674|588420252|FG001|End of Study|Malignancy (Non-HCC)|1|||
162923205|NCT00388674|588420251|FG000|End of Study|Non-Study Related Comorbidities|3|||
162923206|NCT00388674|588420252|FG001|End of Study|Non-Study Related Comorbidities|4|||
162923207|NCT00388674|588420251|FG000|End of Study|Not Defined|135|||
162923208|NCT00388674|588420252|FG001|End of Study|Not Defined|214|||
162923209|NCT00388674|588420251|FG000|End of Study|Participant Withdrew Consent|437|||
162923210|NCT00388674|588420252|FG001|End of Study|Participant Withdrew Consent|673|||
162923211|NCT00388674|588420251|FG000|End of Study|No Off-Treatment Status Data|22|||
162923212|NCT00388674|588420252|FG001|End of Study|No Off-Treatment Status Data|30|||
162630120|NCT02674529|587365063|FG000|Overall Study|Lost to Follow-up|1|||
162630121|NCT02674529|587365064|FG001|Overall Study|Lost to Follow-up|2|||
162630122|NCT02674529|587365063|FG000|Overall Study|Withdrawal by Subject|2|||
162630123|NCT02674529|587365064|FG001|Overall Study|Withdrawal by Subject|1|||
162630124|NCT02674529|587365063|FG000|Overall Study|Physician Decision|0|||
162630125|NCT02674529|587365064|FG001|Overall Study|Physician Decision|1|||
162630126|NCT02674529|587365063|FG000|Overall Study|Protocol Violation|0|||
162630127|NCT02674529|587365064|FG001|Overall Study|Protocol Violation|1|||
162630128|NCT02141282|587365066|FG000|Overall Study|Adverse event, not related to progression|8|||
162630129|NCT02141282|587365067|FG001|Overall Study|Adverse event, not related to progression|1|||
162923213|NCT00388674|588420251|FG000|End of Study|Not Reported|0|||
162923214|NCT00388674|588420252|FG001|End of Study|Not Reported|1|||
162923215|NCT03576131|588420259|FG000|Overall Study|Investigator decision|0|||
162923216|NCT03576131|588420260|FG001|Overall Study|Investigator decision|0|||
162923217|NCT03576131|588420261|FG002|Overall Study|Investigator decision|0|||
162923218|NCT03576131|588420262|FG003|Overall Study|Investigator decision|1|||
162923219|NCT03576131|588420263|FG004|Overall Study|Investigator decision|0|||
162923220|NCT03576131|588420264|FG005|Overall Study|Investigator decision|1|||
162923221|NCT03576131|588420265|FG006|Overall Study|Investigator decision|0|||
162923222|NCT03576131|588420266|FG007|Overall Study|Investigator decision|0|||
162923223|NCT03576131|588420259|FG000|Overall Study|Withdrawal by Subject|1|||
162923224|NCT03576131|588420260|FG001|Overall Study|Withdrawal by Subject|1|||
162923225|NCT03576131|588420261|FG002|Overall Study|Withdrawal by Subject|0|||
162923226|NCT03576131|588420262|FG003|Overall Study|Withdrawal by Subject|1|||
162923227|NCT03576131|588420263|FG004|Overall Study|Withdrawal by Subject|2|||
162923228|NCT03576131|588420264|FG005|Overall Study|Withdrawal by Subject|3|||
162923229|NCT03576131|588420265|FG006|Overall Study|Withdrawal by Subject|1|||
162923230|NCT03576131|588420266|FG007|Overall Study|Withdrawal by Subject|0|||
162923231|NCT03576131|588420259|FG000|Overall Study|Death|3|||
162923232|NCT03576131|588420260|FG001|Overall Study|Death|3|||
162923233|NCT03576131|588420261|FG002|Overall Study|Death|1|||
162923234|NCT03576131|588420262|FG003|Overall Study|Death|5|||
162923235|NCT03576131|588420263|FG004|Overall Study|Death|4|||
162923236|NCT03576131|588420264|FG005|Overall Study|Death|1|||
162923237|NCT03576131|588420265|FG006|Overall Study|Death|0|||
162923238|NCT03576131|588420266|FG007|Overall Study|Death|1|||
162923239|NCT03576131|588420259|FG000|Overall Study|New anti-cancer treatment|5|||
162923240|NCT03576131|588420260|FG001|Overall Study|New anti-cancer treatment|1|||
162923241|NCT03576131|588420261|FG002|Overall Study|New anti-cancer treatment|2|||
162923242|NCT03576131|588420262|FG003|Overall Study|New anti-cancer treatment|3|||
162923243|NCT03576131|588420263|FG004|Overall Study|New anti-cancer treatment|0|||
162923244|NCT03576131|588420264|FG005|Overall Study|New anti-cancer treatment|0|||
162923245|NCT03576131|588420265|FG006|Overall Study|New anti-cancer treatment|0|||
162923246|NCT03576131|588420266|FG007|Overall Study|New anti-cancer treatment|0|||
162923247|NCT03576131|588420259|FG000|Overall Study|Unspecified reason|0|||
162923248|NCT03576131|588420260|FG001|Overall Study|Unspecified reason|0|||
162923249|NCT03576131|588420261|FG002|Overall Study|Unspecified reason|1|||
162923250|NCT03576131|588420262|FG003|Overall Study|Unspecified reason|1|||
162923251|NCT03576131|588420263|FG004|Overall Study|Unspecified reason|1|||
162923252|NCT03576131|588420264|FG005|Overall Study|Unspecified reason|1|||
162923253|NCT03576131|588420265|FG006|Overall Study|Unspecified reason|0|||
162923254|NCT03576131|588420266|FG007|Overall Study|Unspecified reason|0|||
162923255|NCT03576131|588420259|FG000|Overall Study|Subject non-compliance|0|||
162923256|NCT03576131|588420260|FG001|Overall Study|Subject non-compliance|0|||
162923257|NCT03576131|588420261|FG002|Overall Study|Subject non-compliance|0|||
162923258|NCT03576131|588420262|FG003|Overall Study|Subject non-compliance|0|||
162971036|NCT00177164|588595636|FG000|Overall Study|Lost to Follow-up|4|||
162971037|NCT00177164|588595637|FG001|Overall Study|Lost to Follow-up|5|||
162971038|NCT00177164|588595636|FG000|Overall Study|increase in alcohol and drug use|1|||
162971039|NCT00177164|588595637|FG001|Overall Study|increase in alcohol and drug use|2|||
162971040|NCT00177164|588595636|FG000|Overall Study|Adverse Event|1|||
162971041|NCT00177164|588595637|FG001|Overall Study|Adverse Event|0|||
162971042|NCT00177164|588595636|FG000|Overall Study|discharge from hospital|1|||
162971043|NCT00177164|588595637|FG001|Overall Study|discharge from hospital|0|||
162971044|NCT00177164|588595636|FG000|Overall Study|Lack of Efficacy|2|||
162971045|NCT00177164|588595637|FG001|Overall Study|Lack of Efficacy|1|||
162971046|NCT00177164|588595636|FG000|Overall Study|Pregnancy|0|||
162971047|NCT00177164|588595637|FG001|Overall Study|Pregnancy|1|||
162971048|NCT00965757|588595638|FG000|Double-blind Phase|Progression of concomitant disease|1|||
162971049|NCT00965757|588595639|FG001|Double-blind Phase|Progression of concomitant disease|2|||
162971050|NCT00965757|588595640|FG002|Double-blind Phase|Progression of concomitant disease|0|||
162971051|NCT00965757|588595641|FG003|Double-blind Phase|Progression of concomitant disease|0|||
162971052|NCT00965757|588595638|FG000|Double-blind Phase|Adverse drug reaction|2|||
162971053|NCT00965757|588595639|FG001|Double-blind Phase|Adverse drug reaction|1|||
162971054|NCT00965757|588595640|FG002|Double-blind Phase|Adverse drug reaction|0|||
162923259|NCT03576131|588420263|FG004|Overall Study|Subject non-compliance|0|||
162630130|NCT02141282|587365068|FG002|Overall Study|Adverse event, not related to progression|3|||
162923260|NCT03576131|588420264|FG005|Overall Study|Subject non-compliance|1|||
162923261|NCT03576131|588420265|FG006|Overall Study|Subject non-compliance|0|||
162923262|NCT03576131|588420266|FG007|Overall Study|Subject non-compliance|0|||
162923263|NCT01569594|588420271|FG000|Overall Study|Physician Decision|4|||
162923264|NCT01569594|588420271|FG000|Overall Study|Death|13|||
162923265|NCT01569594|588420271|FG000|Overall Study|Lost to Follow-up|22|||
162923266|NCT01569594|588420271|FG000|Overall Study|Adverse Event|2|||
162971055|NCT00965757|588595641|FG003|Double-blind Phase|Adverse drug reaction|0|||
162971056|NCT00965757|588595638|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
163056881|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
162630131|NCT02141282|587365069|FG003|Overall Study|Adverse event, not related to progression|1|||
162923267|NCT01569594|588420271|FG000|Overall Study|Withdrawal by Subject|13|||
162923268|NCT01569594|588420271|FG000|Overall Study|Other|4|||
162923269|NCT01569594|588420271|FG000|Overall Study|No ECM used|9|||
162923270|NCT04635631|588420272|FG000|Overall Study|Adverse Event|1|||
162923271|NCT04635631|588420272|FG000|Overall Study|Progressive disease|13|||
162923272|NCT04635631|588420272|FG000|Overall Study|Withdrawal by Subject|1|||
162923273|NCT00943826|588420273|FG000|Concurrent Phase|Adverse Event|50|||
162923274|NCT00943826|588420274|FG001|Concurrent Phase|Adverse Event|27|||
162923275|NCT00943826|588420273|FG000|Concurrent Phase|Withdrew consent|3|||
162923276|NCT00943826|588420274|FG001|Concurrent Phase|Withdrew consent|7|||
162923277|NCT00943826|588420273|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
162923278|NCT00943826|588420274|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
162923279|NCT00943826|588420273|FG000|Concurrent Phase|Administrative reasons|2|||
162923280|NCT00943826|588420274|FG001|Concurrent Phase|Administrative reasons|1|||
162923281|NCT00943826|588420273|FG000|Concurrent Phase|Protocol Violation|1|||
162923282|NCT00943826|588420274|FG001|Concurrent Phase|Protocol Violation|0|||
162923283|NCT00943826|588420273|FG000|Maintenance Phase|Adverse Event|31|||
162923284|NCT00943826|588420274|FG001|Maintenance Phase|Adverse Event|30|||
162923285|NCT00943826|588420273|FG000|Maintenance Phase|Withdrew consent|2|||
162923286|NCT00943826|588420274|FG001|Maintenance Phase|Withdrew consent|4|||
162923287|NCT00943826|588420273|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
162923288|NCT00943826|588420274|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
162923289|NCT00943826|588420273|FG000|Maintenance Phase|Administrative reasons|4|||
162923290|NCT00943826|588420274|FG001|Maintenance Phase|Administrative reasons|1|||
162923291|NCT00943826|588420273|FG000|Maintenance Phase|Failure to return|0|||
162923292|NCT00943826|588420274|FG001|Maintenance Phase|Failure to return|1|||
162923293|NCT00943826|588420273|FG000|Monotherapy Phase|Adverse Event|42|||
162923294|NCT00943826|588420274|FG001|Monotherapy Phase|Adverse Event|5|||
162923295|NCT00943826|588420273|FG000|Monotherapy Phase|Administrative reasons|11|||
162923296|NCT00943826|588420274|FG001|Monotherapy Phase|Administrative reasons|5|||
162923297|NCT00943826|588420273|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
162923298|NCT00943826|588420274|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
162923299|NCT00943826|588420273|FG000|Monotherapy Phase|Withdrew Consent|2|||
162923300|NCT00943826|588420274|FG001|Monotherapy Phase|Withdrew Consent|3|||
162923301|NCT00943826|588420273|FG000|Monotherapy Phase|Failure to return|2|||
162923302|NCT00943826|588420274|FG001|Monotherapy Phase|Failure to return|1|||
162923303|NCT00943826|588420273|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
162923304|NCT00943826|588420274|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
162923305|NCT00943826|588420273|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
162923306|NCT00943826|588420274|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
162923307|NCT00943826|588420273|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
162923308|NCT00943826|588420274|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
162923309|NCT00943826|588420273|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
162923310|NCT00943826|588420274|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
162923311|NCT04764669|588420275|FG000|Overall Study|Adverse Event|1|||
162923312|NCT04764669|588420276|FG001|Overall Study|Adverse Event|0|||
162923313|NCT04764669|588420277|FG002|Overall Study|Adverse Event|1|||
162923314|NCT04764669|588420278|FG003|Overall Study|Adverse Event|0|||
162923315|NCT04764669|588420275|FG000|Overall Study|Subject Choice|0|||
162923316|NCT04764669|588420276|FG001|Overall Study|Subject Choice|0|||
162923317|NCT04764669|588420277|FG002|Overall Study|Subject Choice|1|||
162923318|NCT04764669|588420278|FG003|Overall Study|Subject Choice|0|||
162923319|NCT04764669|588420275|FG000|Overall Study|Withdrawal by Subject|2|||
162923320|NCT04764669|588420276|FG001|Overall Study|Withdrawal by Subject|0|||
162923321|NCT04764669|588420277|FG002|Overall Study|Withdrawal by Subject|0|||
162923322|NCT04764669|588420278|FG003|Overall Study|Withdrawal by Subject|0|||
162923323|NCT00877799|588420280|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
162971057|NCT00965757|588595639|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
162971058|NCT00965757|588595640|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
162971059|NCT00965757|588595641|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
162971060|NCT00965757|588595638|FG000|Double-blind Phase|Lack of Efficacy|7|||
162971061|NCT00965757|588595639|FG001|Double-blind Phase|Lack of Efficacy|11|||
162971062|NCT00965757|588595640|FG002|Double-blind Phase|Lack of Efficacy|0|||
162971063|NCT00965757|588595641|FG003|Double-blind Phase|Lack of Efficacy|0|||
162971064|NCT00965757|588595638|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
162971065|NCT00965757|588595639|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
162712776|NCT01664104|587658573|FG000|Overall Study|Other|1|||
162923324|NCT00877799|588420281|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
162923325|NCT00877799|588420282|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
162971066|NCT00965757|588595640|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
162971067|NCT00965757|588595641|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
162923326|NCT00877799|588420283|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
162971068|NCT00965757|588595638|FG000|Double-blind Phase|Lost to Follow-up|0|||
162971069|NCT00965757|588595639|FG001|Double-blind Phase|Lost to Follow-up|1|||
162971070|NCT00965757|588595640|FG002|Double-blind Phase|Lost to Follow-up|0|||
162971071|NCT00965757|588595641|FG003|Double-blind Phase|Lost to Follow-up|0|||
162971072|NCT00965757|588595638|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
162971073|NCT00965757|588595639|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
162971074|NCT00965757|588595640|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
162971075|NCT00965757|588595641|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
162971076|NCT00965757|588595638|FG000|Double-blind Phase|Other|1|||
162971077|NCT00965757|588595639|FG001|Double-blind Phase|Other|0|||
162971078|NCT00965757|588595640|FG002|Double-blind Phase|Other|0|||
162971079|NCT00965757|588595641|FG003|Double-blind Phase|Other|0|||
162971080|NCT00965757|588595638|FG000|Extension Phase|Progression of concomitant disease|0|||
162971081|NCT00965757|588595639|FG001|Extension Phase|Progression of concomitant disease|0|||
162971082|NCT00965757|588595640|FG002|Extension Phase|Progression of concomitant disease|4|||
162971083|NCT00965757|588595641|FG003|Extension Phase|Progression of concomitant disease|2|||
162971084|NCT00965757|588595638|FG000|Extension Phase|Adverse drug reaction|0|||
162971085|NCT00965757|588595639|FG001|Extension Phase|Adverse drug reaction|0|||
162971086|NCT00965757|588595640|FG002|Extension Phase|Adverse drug reaction|6|||
162971087|NCT00965757|588595641|FG003|Extension Phase|Adverse drug reaction|3|||
162971088|NCT00965757|588595638|FG000|Extension Phase|Abnormal Laboratory Value|0|||
162971089|NCT00965757|588595639|FG001|Extension Phase|Abnormal Laboratory Value|0|||
162971090|NCT00965757|588595640|FG002|Extension Phase|Abnormal Laboratory Value|6|||
162971091|NCT00965757|588595641|FG003|Extension Phase|Abnormal Laboratory Value|1|||
162971092|NCT00965757|588595638|FG000|Extension Phase|Lack of Efficacy|0|||
162971093|NCT00965757|588595639|FG001|Extension Phase|Lack of Efficacy|0|||
162971094|NCT00965757|588595640|FG002|Extension Phase|Lack of Efficacy|8|||
162971095|NCT00965757|588595641|FG003|Extension Phase|Lack of Efficacy|12|||
162971096|NCT00965757|588595638|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971097|NCT00965757|588595639|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971098|NCT00965757|588595640|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
162971099|NCT00965757|588595641|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
162971100|NCT00965757|588595638|FG000|Extension Phase|Lost to Follow-up|0|||
162971101|NCT00965757|588595639|FG001|Extension Phase|Lost to Follow-up|0|||
162971102|NCT00965757|588595640|FG002|Extension Phase|Lost to Follow-up|0|||
162971103|NCT00965757|588595641|FG003|Extension Phase|Lost to Follow-up|1|||
162971104|NCT00965757|588595638|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
162971105|NCT00965757|588595639|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
162971106|NCT00965757|588595640|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
162971107|NCT00965757|588595641|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
162971108|NCT00965757|588595638|FG000|Extension Phase|Protocol Violation|0|||
162971109|NCT00965757|588595639|FG001|Extension Phase|Protocol Violation|0|||
162971110|NCT00965757|588595640|FG002|Extension Phase|Protocol Violation|0|||
162971111|NCT00965757|588595641|FG003|Extension Phase|Protocol Violation|1|||
162971112|NCT00965757|588595638|FG000|Extension Phase|Other|0|||
162971113|NCT00965757|588595639|FG001|Extension Phase|Other|0|||
162971114|NCT00965757|588595640|FG002|Extension Phase|Other|2|||
162971115|NCT00965757|588595641|FG003|Extension Phase|Other|1|||
162971116|NCT01344018|588595645|FG000|Overall Study|Death|22|||
162971117|NCT01344018|588595646|FG001|Overall Study|Death|25|||
162971118|NCT01344018|588595645|FG000|Overall Study|Lost to Follow-up|4|||
162971119|NCT01344018|588595646|FG001|Overall Study|Lost to Follow-up|7|||
162971120|NCT02351167|588595647|FG000|Overall Study|Withdrawal by Subject|19|||
162971121|NCT02351167|588595648|FG001|Overall Study|Withdrawal by Subject|18|||
162971122|NCT02351167|588595649|FG002|Overall Study|Withdrawal by Subject|21|||
162971123|NCT04010227|588595650|FG000|Overall Study|Death|1|||
162971124|NCT04010227|588595651|FG001|Overall Study|Death|2|||
162971125|NCT04010227|588595650|FG000|Overall Study|Medical Reasons|4|||
162971126|NCT04010227|588595651|FG001|Overall Study|Medical Reasons|3|||
162971127|NCT04010227|588595650|FG000|Overall Study|Withdrawal by Subject|2|||
162971128|NCT04010227|588595651|FG001|Overall Study|Withdrawal by Subject|0|||
162971129|NCT04010227|588595650|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
162971130|NCT04010227|588595651|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
162971131|NCT00194792|588595652|FG000|Overall Study|Withdrawal by Subject|1|||
162971132|NCT02448563|588595653|FG000|Overall Study|Lost to Follow-up|16|||
162971133|NCT02448563|588595654|FG001|Overall Study|Lost to Follow-up|10|||
162971134|NCT02448563|588595653|FG000|Overall Study|Withdrawal by Subject|0|||
162971135|NCT02448563|588595654|FG001|Overall Study|Withdrawal by Subject|1|||
162971136|NCT00702507|588595656|FG000|Initial Treatment Phase|Adverse Event|2|||
162971137|NCT00702507|588595656|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
162971138|NCT00702507|588595656|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
162971139|NCT00702507|588595656|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
162971140|NCT00702507|588595656|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
162971141|NCT00702507|588595656|FG000|Follow-up Phase|Protocol Violation|2|||
162971142|NCT00702507|588595656|FG000|Follow-up Phase|Lost to Follow-up|23|||
162971143|NCT00702507|588595656|FG000|Follow-up Phase|Late Enrollment|1|||
162630132|NCT02141282|587365066|FG000|Overall Study|Adverse event, related to progression|1|||
162630133|NCT02141282|587365067|FG001|Overall Study|Adverse event, related to progression|0|||
162630134|NCT02141282|587365068|FG002|Overall Study|Adverse event, related to progression|2|||
162630135|NCT02141282|587365069|FG003|Overall Study|Adverse event, related to progression|0|||
162630136|NCT02141282|587365066|FG000|Overall Study|COVID-19 infection|1|||
162630137|NCT02141282|587365067|FG001|Overall Study|COVID-19 infection|0|||
162630138|NCT02141282|587365068|FG002|Overall Study|COVID-19 infection|0|||
162630139|NCT02141282|587365069|FG003|Overall Study|COVID-19 infection|0|||
163056882|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056883|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056884|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056885|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
163056886|NCT02717195|588919753|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
163056887|NCT02717195|588919754|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056888|NCT02717195|588919755|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056889|NCT02717195|588919756|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056890|NCT02717195|588919757|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163056891|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
163056892|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
163056893|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
163056894|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
163056895|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
163056896|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
163056897|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
163056898|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
163056899|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
163056900|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
163056901|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
163056902|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
163056903|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
163056904|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
163056905|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
163056906|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056907|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056908|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
163056909|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
163056910|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
163056911|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163056912|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163056913|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
163056914|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
163056915|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
163056916|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056917|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056918|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
163056919|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
163056920|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
163056921|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056922|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056923|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
163056924|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056925|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
163056926|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056927|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056928|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
163056929|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
163056930|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
163056931|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
162630140|NCT02141282|587365066|FG000|Overall Study|Lost to Follow-up|0|||
162630141|NCT02141282|587365067|FG001|Overall Study|Lost to Follow-up|0|||
162630142|NCT02141282|587365068|FG002|Overall Study|Lost to Follow-up|4|||
162630143|NCT02141282|587365069|FG003|Overall Study|Lost to Follow-up|2|||
162712777|NCT01664104|587658573|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
163056932|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
163056933|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
163056934|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
162630144|NCT02141282|587365066|FG000|Overall Study|Other, not specified|14|||
162630145|NCT02141282|587365067|FG001|Overall Study|Other, not specified|11|||
162630146|NCT02141282|587365068|FG002|Overall Study|Other, not specified|23|||
162630147|NCT02141282|587365069|FG003|Overall Study|Other, not specified|9|||
162630148|NCT02141282|587365066|FG000|Overall Study|Progressive disease, Richter's|4|||
162630149|NCT02141282|587365067|FG001|Overall Study|Progressive disease, Richter's|1|||
162630150|NCT02141282|587365068|FG002|Overall Study|Progressive disease, Richter's|1|||
162630151|NCT02141282|587365069|FG003|Overall Study|Progressive disease, Richter's|1|||
162630152|NCT02141282|587365066|FG000|Overall Study|Progressive disease per protocol|12|||
162630153|NCT02141282|587365067|FG001|Overall Study|Progressive disease per protocol|7|||
162630154|NCT02141282|587365068|FG002|Overall Study|Progressive disease per protocol|9|||
162630155|NCT02141282|587365069|FG003|Overall Study|Progressive disease per protocol|2|||
162630156|NCT02141282|587365066|FG000|Overall Study|Stem cell transplant|1|||
162630157|NCT02141282|587365067|FG001|Overall Study|Stem cell transplant|0|||
162630158|NCT02141282|587365068|FG002|Overall Study|Stem cell transplant|1|||
162630159|NCT02141282|587365069|FG003|Overall Study|Stem cell transplant|0|||
162630160|NCT02141282|587365066|FG000|Overall Study|Study terminated by Sponsor|0|||
162630161|NCT02141282|587365067|FG001|Overall Study|Study terminated by Sponsor|1|||
162630162|NCT02141282|587365068|FG002|Overall Study|Study terminated by Sponsor|0|||
162630163|NCT02141282|587365069|FG003|Overall Study|Study terminated by Sponsor|0|||
162630164|NCT02141282|587365066|FG000|Overall Study|Subject non-compliance|0|||
162630165|NCT02141282|587365067|FG001|Overall Study|Subject non-compliance|0|||
162630166|NCT02141282|587365068|FG002|Overall Study|Subject non-compliance|1|||
162630167|NCT02141282|587365069|FG003|Overall Study|Subject non-compliance|0|||
162630168|NCT02141282|587365066|FG000|Overall Study|Withdrew consent|2|||
162630169|NCT02141282|587365067|FG001|Overall Study|Withdrew consent|0|||
162971144|NCT02308696|588595657|FG000|Overall Study|Lost to Follow-up|28|||
162971145|NCT02308696|588595658|FG001|Overall Study|Lost to Follow-up|21|||
162971146|NCT02308696|588595657|FG000|Overall Study|Death|8|||
162971147|NCT02308696|588595658|FG001|Overall Study|Death|4|||
162971148|NCT02308696|588595657|FG000|Overall Study|Moved to a Higher Level of Care|17|||
162971149|NCT02308696|588595658|FG001|Overall Study|Moved to a Higher Level of Care|6|||
162971150|NCT00113919|588595659|FG000|Overall Study|Physician Decision|8|||
162971151|NCT00113919|588595659|FG000|Overall Study|Death|6|||
162971152|NCT02914457|588595662|FG000|Overall Study|Withdrawal by Subject|1|||
162971153|NCT02914457|588595662|FG000|Overall Study|Physician Decision|1|||
163056935|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
162630170|NCT02141282|587365068|FG002|Overall Study|Withdrew consent|4|||
162971154|NCT02914457|588595662|FG000|Overall Study|No veins available for lead placement|1|||
162971155|NCT02914457|588595662|FG000|Overall Study|Electrical instability of patient|1|||
162971156|NCT02914457|588595662|FG000|Overall Study|ECG acquisition error due to sweating|1|||
162971157|NCT02914457|588595662|FG000|Overall Study|Protocol Violation|1|||
162971158|NCT01055886|588595668|FG000|Overall Study|Withdrawal by Subject|4|||
162971159|NCT01055886|588595669|FG001|Overall Study|Withdrawal by Subject|9|||
162630171|NCT02141282|587365069|FG003|Overall Study|Withdrew consent|0|||
162630172|NCT00963547|587365072|FG000|Overall Study|Adverse Event|0|||
162630173|NCT00963547|587365073|FG001|Overall Study|Adverse Event|1|||
162971160|NCT01055886|588595668|FG000|Overall Study|Lost to Follow-up|1|||
162630174|NCT00963547|587365074|FG002|Overall Study|Adverse Event|0|||
162971161|NCT01055886|588595669|FG001|Overall Study|Lost to Follow-up|1|||
162971162|NCT01055886|588595668|FG000|Overall Study|Withdrawal by PI|0|||
162971163|NCT01055886|588595669|FG001|Overall Study|Withdrawal by PI|1|||
162971164|NCT04254809|588595672|FG000|Overall Study|Lost to Follow-up|5|||
162971165|NCT04254809|588595673|FG001|Overall Study|Lost to Follow-up|10|||
162971166|NCT02972515|588595674|FG000|Overall Study|Lost to Follow-up|78|||
162971167|NCT01928615|588595675|FG000|Overall Study|Study Terminated by Sponsor|2|||
162971168|NCT04531527|588595676|FG000|Overall Study|Found to be Ineligible|3|||
162971169|NCT01266603|588595677|FG000|Overall Study|Adverse Event|1|||
162971170|NCT01266603|588595677|FG000|Overall Study|Lack of Efficacy|14|||
162971171|NCT01266603|588595677|FG000|Overall Study|Withdrawal by Subject|1|||
162971172|NCT01266603|588595677|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
162971173|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
162971174|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
162971175|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
162971176|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
162971177|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
162971178|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
162971179|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
162971180|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
162971181|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
162971182|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Other|1|||
162971183|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Other|4|||
162971184|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Other|5|||
162971185|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
162971186|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
162971187|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
162971188|NCT02725411|588595680|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
162971189|NCT02725411|588595681|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
162971190|NCT02725411|588595682|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
162971191|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
162971192|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
162971193|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
162971194|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
162971195|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
162971196|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
162971197|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
162971198|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
162971199|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
162971200|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Other|1|||
162971201|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Other|4|||
162971202|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Other|2|||
162971203|NCT02725411|588595680|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
162971204|NCT02725411|588595681|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
162971205|NCT02725411|588595682|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
162971206|NCT04307849|588595683|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
162630175|NCT00963547|587365075|FG003|Overall Study|Adverse Event|1|||
162630176|NCT00963547|587365076|FG004|Overall Study|Adverse Event|0|||
162971207|NCT04307849|588595684|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
162971208|NCT04307849|588595685|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
162630177|NCT00963547|587365077|FG005|Overall Study|Adverse Event|0|||
162630178|NCT00963547|587365078|FG006|Overall Study|Adverse Event|0|||
162971209|NCT04307849|588595686|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
162971210|NCT04307849|588595687|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
162971211|NCT04307849|588595688|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
162971212|NCT04307849|588595683|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971213|NCT04307849|588595684|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971214|NCT04307849|588595685|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
162971215|NCT04307849|588595686|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971216|NCT04307849|588595687|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971217|NCT04307849|588595688|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
162971218|NCT04307849|588595683|FG000|Overall Study|Family member did not want them to continue|0|||
162971219|NCT04307849|588595684|FG001|Overall Study|Family member did not want them to continue|0|||
162971220|NCT04307849|588595685|FG002|Overall Study|Family member did not want them to continue|1|||
162971221|NCT04307849|588595686|FG003|Overall Study|Family member did not want them to continue|0|||
162971222|NCT04307849|588595687|FG004|Overall Study|Family member did not want them to continue|0|||
162971223|NCT04307849|588595688|FG005|Overall Study|Family member did not want them to continue|0|||
162971224|NCT04307849|588595683|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
162971225|NCT04307849|588595684|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
162971226|NCT04307849|588595685|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
162971227|NCT04307849|588595686|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
162971228|NCT04307849|588595687|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
162971229|NCT04307849|588595688|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
162971230|NCT02654015|588595691|FG000|Overall Study|Death|12|||
162971231|NCT02654015|588595691|FG000|Overall Study|Lost to Follow-up|3|||
162971232|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971233|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
162971234|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971235|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971236|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
162971237|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
162971238|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
162971239|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
162971240|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
162971241|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
162971242|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
162971243|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971244|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971245|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971246|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
162971247|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971248|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
162971249|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
162971250|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971251|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
162971252|NCT02418754|588595694|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971253|NCT02418754|588595695|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971254|NCT02418754|588595696|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
162971255|NCT02418754|588595697|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971256|NCT02418754|588595698|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162971257|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
162971258|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
162971259|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
162971260|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
162971261|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
162971262|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
162971263|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971264|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971265|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971266|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
162971267|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
162971268|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
162971269|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
162971270|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
162630179|NCT00963547|587365072|FG000|Overall Study|Physician Decision|1|||
162971271|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
162630180|NCT00963547|587365073|FG001|Overall Study|Physician Decision|1|||
162630181|NCT00963547|587365074|FG002|Overall Study|Physician Decision|0|||
162630182|NCT00963547|587365075|FG003|Overall Study|Physician Decision|0|||
162630183|NCT00963547|587365076|FG004|Overall Study|Physician Decision|0|||
162630184|NCT00963547|587365077|FG005|Overall Study|Physician Decision|0|||
162630185|NCT00963547|587365078|FG006|Overall Study|Physician Decision|0|||
162630186|NCT00963547|587365072|FG000|Overall Study|Progressive Disease|3|||
162630187|NCT00963547|587365073|FG001|Overall Study|Progressive Disease|8|||
162630188|NCT00963547|587365074|FG002|Overall Study|Progressive Disease|9|||
162630189|NCT00963547|587365075|FG003|Overall Study|Progressive Disease|5|||
162630190|NCT00963547|587365076|FG004|Overall Study|Progressive Disease|0|||
162630191|NCT00963547|587365077|FG005|Overall Study|Progressive Disease|0|||
162630192|NCT00963547|587365078|FG006|Overall Study|Progressive Disease|0|||
162630193|NCT00963547|587365072|FG000|Overall Study|Withdrawal by Subject|0|||
162630194|NCT00963547|587365073|FG001|Overall Study|Withdrawal by Subject|0|||
162630195|NCT00963547|587365074|FG002|Overall Study|Withdrawal by Subject|3|||
162630196|NCT00963547|587365075|FG003|Overall Study|Withdrawal by Subject|0|||
162630197|NCT00963547|587365076|FG004|Overall Study|Withdrawal by Subject|0|||
162630198|NCT00963547|587365077|FG005|Overall Study|Withdrawal by Subject|0|||
162630199|NCT00963547|587365078|FG006|Overall Study|Withdrawal by Subject|0|||
162630200|NCT00963547|587365072|FG000|Overall Study|Reason Unknown|0|||
162630201|NCT00963547|587365073|FG001|Overall Study|Reason Unknown|1|||
162630202|NCT00963547|587365074|FG002|Overall Study|Reason Unknown|0|||
162630203|NCT00963547|587365075|FG003|Overall Study|Reason Unknown|0|||
162630204|NCT00963547|587365076|FG004|Overall Study|Reason Unknown|0|||
162630205|NCT00963547|587365077|FG005|Overall Study|Reason Unknown|0|||
162630206|NCT00963547|587365078|FG006|Overall Study|Reason Unknown|0|||
162971272|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
162971273|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
162971274|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
162971275|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
162971276|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
162971277|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
162971278|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
162971279|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
162971280|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
162971281|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
162971282|NCT02418754|588595694|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971283|NCT02418754|588595695|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
162971284|NCT02418754|588595696|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971285|NCT02418754|588595697|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
162971286|NCT02418754|588595698|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
162971287|NCT00761176|588595703|FG000|Overall Study|Death|1|||
162971288|NCT00761176|588595704|FG001|Overall Study|Death|0|||
162971289|NCT00761176|588595703|FG000|Overall Study|Withdrawal by Subject|1|||
162971290|NCT00761176|588595704|FG001|Overall Study|Withdrawal by Subject|1|||
162971291|NCT02762994|588595705|FG000|Overall Study|Withdrawal by Subject|0|||
162971292|NCT02762994|588595706|FG001|Overall Study|Withdrawal by Subject|1|||
162971293|NCT02762994|588595707|FG002|Overall Study|Withdrawal by Subject|2|||
162971294|NCT02762994|588595708|FG003|Overall Study|Withdrawal by Subject|0|||
162971295|NCT02762994|588595705|FG000|Overall Study|Protocol Violation|1|||
162971296|NCT02762994|588595706|FG001|Overall Study|Protocol Violation|0|||
162971297|NCT02762994|588595707|FG002|Overall Study|Protocol Violation|0|||
162971298|NCT02762994|588595708|FG003|Overall Study|Protocol Violation|2|||
162971299|NCT05103657|588595711|FG000|Overall Study|Other reasons than listed|9|||
162971300|NCT05103657|588595712|FG001|Overall Study|Other reasons than listed|8|||
162971301|NCT05103657|588595711|FG000|Overall Study|Protocol deviation|2|||
162971302|NCT05103657|588595712|FG001|Overall Study|Protocol deviation|2|||
162971303|NCT05103657|588595711|FG000|Overall Study|No reason available|5|||
162971304|NCT05103657|588595712|FG001|Overall Study|No reason available|4|||
162971305|NCT05103657|588595711|FG000|Overall Study|Burden of study procedures|3|||
162630207|NCT00331682|587365079|FG000|Overall Study|Adverse Event|1|||
162971306|NCT05103657|588595712|FG001|Overall Study|Burden of study procedures|1|||
162630208|NCT03761277|587365080|FG000|Enrollment to Implant|Screen Failure|17|||
162630209|NCT03761277|587365080|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
162630210|NCT03761277|587365080|FG000|Enrollment to Implant|Physician Decision|2|||
162630211|NCT03761277|587365080|FG000|Enrollment to Implant|Site Closure|3|||
162630212|NCT03761277|587365080|FG000|Enrollment to Implant|Sponsor Request|2|||
162971307|NCT05103657|588595711|FG000|Overall Study|Perceived lack of efficacy|1|||
162630213|NCT03761277|587365080|FG000|Post-Implant to 6 Months|Adverse Event|2|||
162971308|NCT05103657|588595712|FG001|Overall Study|Perceived lack of efficacy|1|||
162971309|NCT05103657|588595711|FG000|Overall Study|Adverse Event|6|||
162630214|NCT03761277|587365080|FG000|Post-Implant to 6 Months|Death|1|||
162712778|NCT02449044|587658581|FG000|Overall Study|Lost to Follow-up|2|||
162971310|NCT05103657|588595712|FG001|Overall Study|Adverse Event|14|||
162971311|NCT05103657|588595711|FG000|Overall Study|Not Treated|1|||
162971312|NCT05103657|588595712|FG001|Overall Study|Not Treated|1|||
162971313|NCT02020967|588595713|FG000|Overall Study|Withdrawal by Subject|51|||
162971314|NCT02387762|588595716|FG000|Overall Study|Withdrawal by Subject|1|||
162971315|NCT02387762|588595717|FG001|Overall Study|Withdrawal by Subject|0|||
162971316|NCT04203667|588595718|FG000|Overall Study|Withdrawal by Subject|1|||
162971317|NCT04203667|588595718|FG000|Overall Study|Lost to Follow-up|1|||
162971318|NCT04203667|588595718|FG000|Overall Study|Death|1|||
162971319|NCT04203667|588595718|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
162971320|NCT01160640|588595719|FG000|Overall Study|Physician Decision|3|||
162971321|NCT01160640|588595720|FG001|Overall Study|Physician Decision|3|||
162971322|NCT01160640|588595719|FG000|Overall Study|Incarceration|1|||
162971323|NCT01160640|588595720|FG001|Overall Study|Incarceration|0|||
162971324|NCT01160640|588595719|FG000|Overall Study|Withdrawal by Subject|0|||
162971325|NCT01160640|588595720|FG001|Overall Study|Withdrawal by Subject|3|||
162971326|NCT00642811|588595723|FG000|Overall Study|Adverse Event|2|||
162971327|NCT00642811|588595724|FG001|Overall Study|Adverse Event|3|||
162971328|NCT00642811|588595725|FG002|Overall Study|Adverse Event|0|||
162971329|NCT00642811|588595726|FG003|Overall Study|Adverse Event|0|||
162971330|NCT00642811|588595727|FG004|Overall Study|Adverse Event|0|||
162971331|NCT00642811|588595728|FG005|Overall Study|Adverse Event|1|||
162971332|NCT00642811|588595723|FG000|Overall Study|Developement of discontinuation criteria|0|||
162971333|NCT00642811|588595724|FG001|Overall Study|Developement of discontinuation criteria|0|||
162971334|NCT00642811|588595725|FG002|Overall Study|Developement of discontinuation criteria|0|||
162971335|NCT00642811|588595726|FG003|Overall Study|Developement of discontinuation criteria|0|||
162971336|NCT00642811|588595727|FG004|Overall Study|Developement of discontinuation criteria|1|||
162971337|NCT00642811|588595728|FG005|Overall Study|Developement of discontinuation criteria|0|||
162971338|NCT00642811|588595723|FG000|Overall Study|Severe Non-compliance to protocol|1|||
162971339|NCT00642811|588595724|FG001|Overall Study|Severe Non-compliance to protocol|0|||
162971340|NCT00642811|588595725|FG002|Overall Study|Severe Non-compliance to protocol|0|||
162971341|NCT00642811|588595726|FG003|Overall Study|Severe Non-compliance to protocol|0|||
162971342|NCT00642811|588595727|FG004|Overall Study|Severe Non-compliance to protocol|0|||
162971343|NCT00642811|588595728|FG005|Overall Study|Severe Non-compliance to protocol|0|||
162971344|NCT00642811|588595723|FG000|Overall Study|Other|0|||
162971345|NCT00642811|588595724|FG001|Overall Study|Other|1|||
162971346|NCT00642811|588595725|FG002|Overall Study|Other|0|||
162971347|NCT00642811|588595726|FG003|Overall Study|Other|1|||
162971348|NCT00642811|588595727|FG004|Overall Study|Other|0|||
162971349|NCT00642811|588595728|FG005|Overall Study|Other|0|||
162971350|NCT01525628|588595729|FG000|Overall Study|Adverse Event|1|||
162971351|NCT01525628|588595730|FG001|Overall Study|Adverse Event|1|||
162971352|NCT01525628|588595731|FG002|Overall Study|Adverse Event|2|||
162971353|NCT01525628|588595732|FG003|Overall Study|Adverse Event|0|||
162971354|NCT01525628|588595733|FG004|Overall Study|Adverse Event|1|||
162971355|NCT01525628|588595729|FG000|Overall Study|Lack of Efficacy|0|||
162971356|NCT01525628|588595730|FG001|Overall Study|Lack of Efficacy|2|||
162971357|NCT01525628|588595731|FG002|Overall Study|Lack of Efficacy|2|||
163056936|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056937|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056938|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056939|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
163056940|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
163056941|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056942|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056943|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
163056944|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
163056945|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
162971358|NCT01525628|588595732|FG003|Overall Study|Lack of Efficacy|1|||
162971359|NCT01525628|588595733|FG004|Overall Study|Lack of Efficacy|2|||
162971360|NCT01525628|588595729|FG000|Overall Study|Protocol Violation|0|||
162971361|NCT01525628|588595730|FG001|Overall Study|Protocol Violation|0|||
163056946|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
162971362|NCT01525628|588595731|FG002|Overall Study|Protocol Violation|1|||
162971363|NCT01525628|588595732|FG003|Overall Study|Protocol Violation|0|||
162971364|NCT01525628|588595733|FG004|Overall Study|Protocol Violation|0|||
162971365|NCT01525628|588595729|FG000|Overall Study|Lost to Follow-up|1|||
162971366|NCT01525628|588595730|FG001|Overall Study|Lost to Follow-up|1|||
162971367|NCT01525628|588595731|FG002|Overall Study|Lost to Follow-up|0|||
162971368|NCT01525628|588595732|FG003|Overall Study|Lost to Follow-up|0|||
162971369|NCT01525628|588595733|FG004|Overall Study|Lost to Follow-up|0|||
162971370|NCT01525628|588595729|FG000|Overall Study|Withdrawal by Subject|0|||
162971371|NCT01525628|588595730|FG001|Overall Study|Withdrawal by Subject|1|||
162971372|NCT01525628|588595731|FG002|Overall Study|Withdrawal by Subject|0|||
162971373|NCT01525628|588595732|FG003|Overall Study|Withdrawal by Subject|0|||
162971374|NCT01525628|588595733|FG004|Overall Study|Withdrawal by Subject|0|||
162971375|NCT01525628|588595729|FG000|Overall Study|Other reason not defined above|0|||
162971376|NCT01525628|588595730|FG001|Overall Study|Other reason not defined above|0|||
162971377|NCT01525628|588595731|FG002|Overall Study|Other reason not defined above|0|||
162971378|NCT01525628|588595732|FG003|Overall Study|Other reason not defined above|3|||
162971379|NCT01525628|588595733|FG004|Overall Study|Other reason not defined above|0|||
162971380|NCT02614898|588595734|FG000|Overall Study|Participated until study termination|10|||
162971381|NCT02614898|588595735|FG001|Overall Study|Participated until study termination|26|||
162971382|NCT02614898|588595734|FG000|Overall Study|Lost to Follow-up|0|||
162971383|NCT02614898|588595735|FG001|Overall Study|Lost to Follow-up|2|||
162971384|NCT02614898|588595734|FG000|Overall Study|Physician Decision|1|||
162971385|NCT02614898|588595735|FG001|Overall Study|Physician Decision|8|||
162971386|NCT02614898|588595734|FG000|Overall Study|Study Terminated by Sponsor|3|||
162971387|NCT02614898|588595735|FG001|Overall Study|Study Terminated by Sponsor|0|||
162971388|NCT02614898|588595734|FG000|Overall Study|Withdrawal by Subject|0|||
162971389|NCT02614898|588595735|FG001|Overall Study|Withdrawal by Subject|2|||
162971390|NCT02614898|588595734|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162971391|NCT02614898|588595735|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162971392|NCT02614898|588595734|FG000|Overall Study|Other-Additional Information Unavailable|0|||
162971393|NCT02614898|588595735|FG001|Overall Study|Other-Additional Information Unavailable|11|||
162971394|NCT02614898|588595734|FG000|Overall Study|Missing|0|||
162971395|NCT02614898|588595735|FG001|Overall Study|Missing|1|||
162971396|NCT00787605|588595736|FG000|Overall Study|Administrative Problems|3|||
162971397|NCT00787605|588595737|FG001|Overall Study|Administrative Problems|0|||
162971398|NCT00787605|588595736|FG000|Overall Study|Adverse Event|14|||
162971399|NCT00787605|588595737|FG001|Overall Study|Adverse Event|25|||
162971400|NCT00787605|588595736|FG000|Overall Study|Lost to Follow-up|3|||
162971401|NCT00787605|588595737|FG001|Overall Study|Lost to Follow-up|6|||
162971402|NCT00787605|588595736|FG000|Overall Study|Protocol Violation|7|||
162971403|NCT00787605|588595737|FG001|Overall Study|Protocol Violation|3|||
162971404|NCT00787605|588595736|FG000|Overall Study|Withdrawal by Subject|6|||
162971405|NCT00787605|588595737|FG001|Overall Study|Withdrawal by Subject|13|||
162971406|NCT00787605|588595736|FG000|Overall Study|Lack of Efficacy|13|||
162971407|NCT00787605|588595737|FG001|Overall Study|Lack of Efficacy|9|||
162971408|NCT01223027|588595738|FG000|Overall Study|Adverse Event|20|||
162971409|NCT01223027|588595739|FG001|Overall Study|Adverse Event|10|||
162971410|NCT01223027|588595738|FG000|Overall Study|Death|42|||
162971411|NCT01223027|588595739|FG001|Overall Study|Death|42|||
162971412|NCT01223027|588595738|FG000|Overall Study|Lost to Follow-up|2|||
162971413|NCT01223027|588595739|FG001|Overall Study|Lost to Follow-up|1|||
162971414|NCT01223027|588595738|FG000|Overall Study|Physician Decision|4|||
162971415|NCT01223027|588595739|FG001|Overall Study|Physician Decision|8|||
162971416|NCT01223027|588595738|FG000|Overall Study|Progressive Disease|167|||
162971417|NCT01223027|588595739|FG001|Overall Study|Progressive Disease|183|||
162971418|NCT01223027|588595738|FG000|Overall Study|Protocol Violation|2|||
162971419|NCT01223027|588595739|FG001|Overall Study|Protocol Violation|1|||
162971420|NCT01223027|588595738|FG000|Overall Study|Subject/guardian decicion|18|||
162971421|NCT01223027|588595739|FG001|Overall Study|Subject/guardian decicion|16|||
162971422|NCT01223027|588595738|FG000|Overall Study|New therapy for study indication|17|||
162971423|NCT01223027|588595739|FG001|Overall Study|New therapy for study indication|8|||
162971424|NCT01223027|588595738|FG000|Overall Study|Study terminated by sponsor|2|||
162971425|NCT01223027|588595739|FG001|Overall Study|Study terminated by sponsor|8|||
162971426|NCT03493919|588595740|FG000|Overall Study|Other|2|||
162971427|NCT03493919|588595741|FG001|Overall Study|Other|0|||
162971428|NCT03493919|588595742|FG002|Overall Study|Other|1|||
162971429|NCT03493919|588595743|FG003|Overall Study|Other|0|||
162971430|NCT03493919|588595740|FG000|Overall Study|Withdrawal by Subject|9|||
162630215|NCT03761277|587365080|FG000|Post-Implant to 6 Months|Site Closure|2|||
162630216|NCT03761277|587365080|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
162630217|NCT03761277|587365080|FG000|6 Months to 12 Months|Physician Decision|2|||
162971431|NCT03493919|588595741|FG001|Overall Study|Withdrawal by Subject|3|||
162971432|NCT03493919|588595742|FG002|Overall Study|Withdrawal by Subject|1|||
162971433|NCT03493919|588595743|FG003|Overall Study|Withdrawal by Subject|1|||
162971434|NCT03493919|588595740|FG000|Overall Study|Lost to Follow-up|5|||
162971435|NCT03493919|588595741|FG001|Overall Study|Lost to Follow-up|0|||
162971436|NCT03493919|588595742|FG002|Overall Study|Lost to Follow-up|0|||
162971437|NCT03493919|588595743|FG003|Overall Study|Lost to Follow-up|3|||
162971438|NCT03493919|588595740|FG000|Overall Study|Adverse Event|0|||
162971439|NCT03493919|588595741|FG001|Overall Study|Adverse Event|1|||
162971440|NCT03493919|588595742|FG002|Overall Study|Adverse Event|0|||
162971441|NCT03493919|588595743|FG003|Overall Study|Adverse Event|0|||
162971442|NCT04428645|588595744|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
162971443|NCT00401245|588597882|FG000|Double Blind Titration Phase|Adverse Event|3|||
162971444|NCT00401245|588597883|FG001|Double Blind Titration Phase|Adverse Event|2|||
162971445|NCT00401245|588597884|FG002|Double Blind Titration Phase|Adverse Event|5|||
162971446|NCT00401245|588597885|FG003|Double Blind Titration Phase|Adverse Event|12|||
162971447|NCT00401245|588597886|FG004|Double Blind Titration Phase|Adverse Event|0|||
162971448|NCT00401245|588597887|FG005|Double Blind Titration Phase|Adverse Event|0|||
162971449|NCT00401245|588597888|FG006|Double Blind Titration Phase|Adverse Event|0|||
162971450|NCT00401245|588597889|FG007|Double Blind Titration Phase|Adverse Event|0|||
162971451|NCT00401245|588597882|FG000|Double Blind Titration Phase|Other|0|||
162971452|NCT00401245|588597883|FG001|Double Blind Titration Phase|Other|0|||
162971453|NCT00401245|588597884|FG002|Double Blind Titration Phase|Other|1|||
162971454|NCT00401245|588597885|FG003|Double Blind Titration Phase|Other|0|||
162971455|NCT00401245|588597886|FG004|Double Blind Titration Phase|Other|0|||
162971456|NCT00401245|588597887|FG005|Double Blind Titration Phase|Other|0|||
162971457|NCT00401245|588597888|FG006|Double Blind Titration Phase|Other|0|||
162971458|NCT00401245|588597889|FG007|Double Blind Titration Phase|Other|0|||
162971459|NCT00401245|588597882|FG000|Double Blind Titration Phase|Protocol Violation|0|||
162971460|NCT00401245|588597883|FG001|Double Blind Titration Phase|Protocol Violation|0|||
162971461|NCT00401245|588597884|FG002|Double Blind Titration Phase|Protocol Violation|0|||
162971462|NCT00401245|588597885|FG003|Double Blind Titration Phase|Protocol Violation|1|||
162971463|NCT00401245|588597886|FG004|Double Blind Titration Phase|Protocol Violation|0|||
162971464|NCT00401245|588597887|FG005|Double Blind Titration Phase|Protocol Violation|0|||
162971465|NCT00401245|588597888|FG006|Double Blind Titration Phase|Protocol Violation|0|||
162971466|NCT00401245|588597889|FG007|Double Blind Titration Phase|Protocol Violation|0|||
162971467|NCT00401245|588597882|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
162971468|NCT00401245|588597883|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
162971469|NCT00401245|588597884|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971470|NCT00401245|588597885|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
162971471|NCT00401245|588597886|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971472|NCT00401245|588597887|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971473|NCT00401245|588597888|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971474|NCT00401245|588597889|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
162971475|NCT00401245|588597882|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971476|NCT00401245|588597883|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
162971477|NCT00401245|588597884|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971478|NCT00401245|588597885|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
162971479|NCT00401245|588597886|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971480|NCT00401245|588597887|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971481|NCT00401245|588597888|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971482|NCT00401245|588597889|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
162971483|NCT00401245|588597882|FG000|Open Label Phase|Adverse Event|5|||
162971484|NCT00401245|588597883|FG001|Open Label Phase|Adverse Event|14|||
163056947|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056948|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056949|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
163056950|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
163056951|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056952|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056953|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
163056954|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
162630218|NCT03761277|587365080|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
162630219|NCT00759031|587365081|FG000|First Intervention (1 Day)|Physician Decision|1|||
162630220|NCT00759031|587365082|FG001|First Intervention (1 Day)|Physician Decision|0|||
162630221|NCT00759031|587365081|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
162630222|NCT00759031|587365082|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
162971485|NCT00401245|588597884|FG002|Open Label Phase|Adverse Event|6|||
162630223|NCT00759031|587365081|FG000|First Intervention (1 Day)|Screening failure|1|||
162630224|NCT00759031|587365082|FG001|First Intervention (1 Day)|Screening failure|0|||
162630225|NCT00543140|587365083|FG000|Overall Study|Lost to Follow-up|33|||
162971486|NCT00401245|588597885|FG003|Open Label Phase|Adverse Event|7|||
162630226|NCT00543140|587365083|FG000|Overall Study|Withdrawal by Subject|13|||
162971487|NCT00401245|588597886|FG004|Open Label Phase|Adverse Event|0|||
162971488|NCT00401245|588597887|FG005|Open Label Phase|Adverse Event|0|||
162971489|NCT00401245|588597888|FG006|Open Label Phase|Adverse Event|0|||
162971490|NCT00401245|588597889|FG007|Open Label Phase|Adverse Event|0|||
162971491|NCT00401245|588597882|FG000|Open Label Phase|Lost to Follow-up|5|||
162971492|NCT00401245|588597883|FG001|Open Label Phase|Lost to Follow-up|7|||
162971493|NCT00401245|588597884|FG002|Open Label Phase|Lost to Follow-up|5|||
162971494|NCT00401245|588597885|FG003|Open Label Phase|Lost to Follow-up|4|||
162971495|NCT00401245|588597886|FG004|Open Label Phase|Lost to Follow-up|0|||
162971496|NCT00401245|588597887|FG005|Open Label Phase|Lost to Follow-up|0|||
162971497|NCT00401245|588597888|FG006|Open Label Phase|Lost to Follow-up|0|||
162971498|NCT00401245|588597889|FG007|Open Label Phase|Lost to Follow-up|0|||
162971499|NCT00401245|588597882|FG000|Open Label Phase|Other|4|||
162971500|NCT00401245|588597883|FG001|Open Label Phase|Other|8|||
162971501|NCT00401245|588597884|FG002|Open Label Phase|Other|7|||
162971502|NCT00401245|588597885|FG003|Open Label Phase|Other|8|||
162971503|NCT00401245|588597886|FG004|Open Label Phase|Other|0|||
162971504|NCT00401245|588597887|FG005|Open Label Phase|Other|0|||
162971505|NCT00401245|588597888|FG006|Open Label Phase|Other|0|||
162971506|NCT00401245|588597889|FG007|Open Label Phase|Other|0|||
162971507|NCT00401245|588597882|FG000|Open Label Phase|Protocol Violation|0|||
162971508|NCT00401245|588597883|FG001|Open Label Phase|Protocol Violation|1|||
162971509|NCT00401245|588597884|FG002|Open Label Phase|Protocol Violation|0|||
162971510|NCT00401245|588597885|FG003|Open Label Phase|Protocol Violation|1|||
162971511|NCT00401245|588597886|FG004|Open Label Phase|Protocol Violation|0|||
162971512|NCT00401245|588597887|FG005|Open Label Phase|Protocol Violation|0|||
162971513|NCT00401245|588597888|FG006|Open Label Phase|Protocol Violation|0|||
162971514|NCT00401245|588597889|FG007|Open Label Phase|Protocol Violation|0|||
162971515|NCT00401245|588597882|FG000|Open Label Phase|Withdrawal by Subject|3|||
162971516|NCT00401245|588597883|FG001|Open Label Phase|Withdrawal by Subject|3|||
162971517|NCT00401245|588597884|FG002|Open Label Phase|Withdrawal by Subject|2|||
162971518|NCT00401245|588597885|FG003|Open Label Phase|Withdrawal by Subject|1|||
162971519|NCT00401245|588597886|FG004|Open Label Phase|Withdrawal by Subject|0|||
162971520|NCT00401245|588597887|FG005|Open Label Phase|Withdrawal by Subject|0|||
162971521|NCT00401245|588597888|FG006|Open Label Phase|Withdrawal by Subject|0|||
162971522|NCT00401245|588597889|FG007|Open Label Phase|Withdrawal by Subject|0|||
162971523|NCT00401245|588597882|FG000|Open Label Phase|Lack of Efficacy|4|||
162971524|NCT00401245|588597883|FG001|Open Label Phase|Lack of Efficacy|2|||
162971525|NCT00401245|588597884|FG002|Open Label Phase|Lack of Efficacy|3|||
162971526|NCT00401245|588597885|FG003|Open Label Phase|Lack of Efficacy|0|||
162971527|NCT00401245|588597886|FG004|Open Label Phase|Lack of Efficacy|0|||
162971528|NCT00401245|588597887|FG005|Open Label Phase|Lack of Efficacy|0|||
162971529|NCT00401245|588597888|FG006|Open Label Phase|Lack of Efficacy|0|||
162971530|NCT00401245|588597889|FG007|Open Label Phase|Lack of Efficacy|0|||
162971531|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Adverse Event|0|||
162971532|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Adverse Event|0|||
162971533|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Adverse Event|0|||
162971534|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Adverse Event|0|||
162971535|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Adverse Event|1|||
162971536|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Adverse Event|1|||
162971537|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Adverse Event|2|||
162971538|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Adverse Event|4|||
162971539|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Investigator request|0|||
162971540|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Investigator request|0|||
162971541|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Investigator request|0|||
162971542|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Investigator request|0|||
162971543|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Investigator request|0|||
162971544|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Investigator request|0|||
162971545|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Investigator request|0|||
163056955|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
163056956|NCT02717195|588919753|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056957|NCT02717195|588919754|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056958|NCT02717195|588919755|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
163056959|NCT02717195|588919756|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
163056960|NCT02717195|588919757|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
163056961|NCT02078817|588919758|FG000|Overall Study|Withdrawal by Subject|1|||
163056962|NCT00769561|588919759|FG000|Overall Study|Withdrawal by Subject|2|||
162971546|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Investigator request|1|||
162971547|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Other|0|||
162971548|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Other|0|||
162971549|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Other|0|||
162971550|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Other|0|||
162971551|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Other|1|||
162971552|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Other|0|||
162971553|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Other|2|||
162971554|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Other|2|||
162971555|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971556|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
163056963|NCT00769561|588919760|FG001|Overall Study|Withdrawal by Subject|2|||
163056964|NCT00769561|588919759|FG000|Overall Study|Lost to Follow-up|1|||
163056965|NCT00769561|588919760|FG001|Overall Study|Lost to Follow-up|3|||
163056966|NCT01773928|588919761|FG000|Overall Study|Adverse Event|0|||
162971557|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971558|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971559|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
162971560|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
162971561|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
162971562|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162971563|NCT00401245|588597882|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971564|NCT00401245|588597883|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971565|NCT00401245|588597884|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971566|NCT00401245|588597885|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971567|NCT00401245|588597886|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971568|NCT00401245|588597887|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
162971569|NCT00401245|588597888|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971570|NCT00401245|588597889|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
162971571|NCT02014441|588597891|FG000|Overall Study|Withdrawal by Subject|12|||
162971572|NCT00996437|588597893|FG000|Overall Study|Death|1|||
162971573|NCT00996437|588597894|FG001|Overall Study|Death|0|||
162971574|NCT00996437|588597893|FG000|Overall Study|Dropped|2|||
162971575|NCT00996437|588597894|FG001|Overall Study|Dropped|2|||
162971576|NCT00996437|588597893|FG000|Overall Study|Missed|2|||
162971577|NCT00996437|588597894|FG001|Overall Study|Missed|5|||
162971578|NCT02576717|588597895|FG000|Overall Study|Other Reasons|16|||
162971579|NCT02576717|588597896|FG001|Overall Study|Other Reasons|18|||
162923327|NCT00877799|588420284|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
162923328|NCT00877799|588420280|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
162923329|NCT00877799|588420281|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
162923330|NCT00877799|588420282|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
162971580|NCT02576717|588597897|FG002|Overall Study|Other Reasons|15|||
162971581|NCT02576717|588597895|FG000|Overall Study|Covid-19 Pandemic|0|||
162971582|NCT02576717|588597896|FG001|Overall Study|Covid-19 Pandemic|1|||
162971583|NCT02576717|588597897|FG002|Overall Study|Covid-19 Pandemic|1|||
162971584|NCT02576717|588597895|FG000|Overall Study|Sponsor Decision|0|||
162923331|NCT00877799|588420283|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
162923332|NCT00877799|588420284|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
162923333|NCT00877799|588420280|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
162923334|NCT00877799|588420281|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
162923335|NCT00877799|588420282|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
162923336|NCT00877799|588420283|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
162923337|NCT00877799|588420284|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
162923338|NCT00877799|588420280|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
162923339|NCT00877799|588420281|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
162923340|NCT00877799|588420282|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
162923341|NCT00877799|588420283|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
162923342|NCT00877799|588420284|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
162923343|NCT00877799|588420280|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
163056967|NCT01773928|588919762|FG001|Overall Study|Adverse Event|0|||
162971585|NCT02576717|588597896|FG001|Overall Study|Sponsor Decision|0|||
162971586|NCT02576717|588597897|FG002|Overall Study|Sponsor Decision|1|||
162971587|NCT02576717|588597895|FG000|Overall Study|Physician Decision|3|||
162971588|NCT02576717|588597896|FG001|Overall Study|Physician Decision|8|||
162971589|NCT02576717|588597897|FG002|Overall Study|Physician Decision|9|||
162971590|NCT02576717|588597895|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
162971591|NCT02576717|588597896|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
162971592|NCT02576717|588597897|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
162971593|NCT02576717|588597895|FG000|Overall Study|Death|3|||
162971594|NCT02576717|588597896|FG001|Overall Study|Death|5|||
162971595|NCT02576717|588597897|FG002|Overall Study|Death|3|||
162971596|NCT02576717|588597895|FG000|Overall Study|Lost to Follow-up|9|||
162971597|NCT02576717|588597896|FG001|Overall Study|Lost to Follow-up|10|||
162971598|NCT02576717|588597897|FG002|Overall Study|Lost to Follow-up|19|||
162971599|NCT02576717|588597895|FG000|Overall Study|Protocol Violation|4|||
162971600|NCT02576717|588597896|FG001|Overall Study|Protocol Violation|0|||
162971601|NCT02576717|588597897|FG002|Overall Study|Protocol Violation|5|||
162971602|NCT02576717|588597895|FG000|Overall Study|Lack of Efficacy|24|||
162971603|NCT02576717|588597896|FG001|Overall Study|Lack of Efficacy|28|||
162971604|NCT02576717|588597897|FG002|Overall Study|Lack of Efficacy|20|||
162971605|NCT02576717|588597895|FG000|Overall Study|Adverse Event|26|||
162971606|NCT02576717|588597896|FG001|Overall Study|Adverse Event|32|||
162971607|NCT02576717|588597897|FG002|Overall Study|Adverse Event|26|||
162971608|NCT01363011|588597898|FG000|Main Study|Adverse Event|2|||
162971609|NCT01363011|588597899|FG001|Main Study|Adverse Event|3|||
162971610|NCT01363011|588597898|FG000|Main Study|Investigator's Discretion|1|||
162971611|NCT01363011|588597899|FG001|Main Study|Investigator's Discretion|1|||
162971612|NCT01363011|588597898|FG000|Main Study|Withdrew Consent|1|||
162971613|NCT01363011|588597899|FG001|Main Study|Withdrew Consent|4|||
162971614|NCT01363011|588597898|FG000|Main Study|Protocol Violation|0|||
162971615|NCT01363011|588597899|FG001|Main Study|Protocol Violation|1|||
162971616|NCT01363011|588597898|FG000|Extension Phase|Adverse Event|1|||
162971617|NCT01363011|588597899|FG001|Extension Phase|Adverse Event|1|||
162971618|NCT01363011|588597898|FG000|Extension Phase|Lack of Efficacy|0|||
162971619|NCT01363011|588597899|FG001|Extension Phase|Lack of Efficacy|1|||
162971620|NCT01363011|588597898|FG000|Extension Phase|Investigator's Discretion|2|||
162971621|NCT01363011|588597899|FG001|Extension Phase|Investigator's Discretion|2|||
162971622|NCT01363011|588597898|FG000|Extension Phase|Withdrew Consent|0|||
162971623|NCT01363011|588597899|FG001|Extension Phase|Withdrew Consent|1|||
162971624|NCT01363011|588597898|FG000|Extension Phase|Lost to Follow-up|0|||
162971625|NCT01363011|588597899|FG001|Extension Phase|Lost to Follow-up|2|||
162971626|NCT01363011|588597898|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
162971627|NCT01363011|588597899|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
162971628|NCT00114231|588597900|FG000|Overall Study|No consent|2|||
162971629|NCT00114231|588597901|FG001|Overall Study|No consent|0|||
162971630|NCT00114231|588597900|FG000|Overall Study|QARC requirement not met|1|||
162971631|NCT00114231|588597901|FG001|Overall Study|QARC requirement not met|0|||
162971632|NCT00114231|588597900|FG000|Overall Study|Suspected metastatic disease|1|||
162971633|NCT00114231|588597901|FG001|Overall Study|Suspected metastatic disease|0|||
162971634|NCT00114231|588597900|FG000|Overall Study|No adenocarcinoma|1|||
162971635|NCT00114231|588597901|FG001|Overall Study|No adenocarcinoma|0|||
162971636|NCT00114231|588597900|FG000|Overall Study|Low creatinine clearance|0|||
162971637|NCT00114231|588597901|FG001|Overall Study|Low creatinine clearance|1|||
162971638|NCT00114231|588597900|FG000|Overall Study|Tumor size > 4cm|1|||
162971639|NCT00114231|588597901|FG001|Overall Study|Tumor size > 4cm|0|||
162971640|NCT00114231|588597900|FG000|Overall Study|Tumor fixed on digital exam|0|||
162971641|NCT00114231|588597901|FG001|Overall Study|Tumor fixed on digital exam|1|||
162971642|NCT00114231|588597900|FG000|Overall Study|No Absolute Neutrophil Count|2|||
162971643|NCT00114231|588597901|FG001|Overall Study|No Absolute Neutrophil Count|0|||
162971644|NCT00114231|588597900|FG000|Overall Study|Biopsy done after registration|1|||
162971645|NCT00114231|588597901|FG001|Overall Study|Biopsy done after registration|0|||
162971646|NCT03330236|588597906|FG000|Overall Study|Death|2|||
162971647|NCT03330236|588597907|FG001|Overall Study|Death|1|||
162971648|NCT03330236|588597906|FG000|Overall Study|Withdrawal by Subject|2|||
162971649|NCT03330236|588597907|FG001|Overall Study|Withdrawal by Subject|4|||
162971650|NCT03330236|588597906|FG000|Overall Study|Lost to Follow-up|0|||
162971651|NCT03330236|588597907|FG001|Overall Study|Lost to Follow-up|2|||
162971652|NCT03330236|588597906|FG000|Overall Study|Physician Decision|2|||
162971653|NCT03330236|588597907|FG001|Overall Study|Physician Decision|0|||
162971654|NCT03330236|588597906|FG000|Overall Study|Protocol Violation|4|||
162971655|NCT03330236|588597907|FG001|Overall Study|Protocol Violation|3|||
162971656|NCT03330236|588597906|FG000|Overall Study|SedLine malfunction/blinding|19|||
162971657|NCT03330236|588597907|FG001|Overall Study|SedLine malfunction/blinding|14|||
162971658|NCT03330236|588597906|FG000|Overall Study|Volatile anesthetics used|11|||
162971659|NCT03330236|588597907|FG001|Overall Study|Volatile anesthetics used|8|||
162971660|NCT03330236|588597906|FG000|Overall Study|Surgery aborted/converted to open|60|||
162971661|NCT03330236|588597907|FG001|Overall Study|Surgery aborted/converted to open|52|||
162971662|NCT01729026|588597913|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
162971663|NCT01729026|588597914|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
162971664|NCT01729026|588597913|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
162971665|NCT01729026|588597914|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
162971666|NCT00407745|588597921|FG000|Overall Study|Lack of Efficacy|1|||
162971667|NCT00407745|588597922|FG001|Overall Study|Lack of Efficacy|2|||
162971668|NCT00407745|588597921|FG000|Overall Study|Withdrawal by Subject|3|||
162971669|NCT00407745|588597922|FG001|Overall Study|Withdrawal by Subject|3|||
162971670|NCT00407745|588597921|FG000|Overall Study|Protocol Violation|5|||
162971671|NCT00407745|588597922|FG001|Overall Study|Protocol Violation|3|||
162971672|NCT00407745|588597921|FG000|Overall Study|Adverse Event|8|||
162971673|NCT00407745|588597922|FG001|Overall Study|Adverse Event|8|||
162971674|NCT00407745|588597921|FG000|Overall Study|Other|2|||
162971675|NCT00407745|588597922|FG001|Overall Study|Other|0|||
162971676|NCT00407745|588597921|FG000|Overall Study|Randomized, unknown if treated|0|||
162971677|NCT00407745|588597922|FG001|Overall Study|Randomized, unknown if treated|1|||
162971678|NCT02940730|588597925|FG000|Intervention 2|Physician Decision|7|||
162971679|NCT02940730|588597926|FG001|Intervention 2|Physician Decision|0|||
162971680|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
162971681|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
162971682|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
162971683|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
162971684|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
162971685|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
162971686|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
162971687|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
162971688|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
162971689|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971690|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971691|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
162971692|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
162971693|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
162971694|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
162971695|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
162971696|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971697|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971698|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
162971699|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
162971700|NCT02960438|588597927|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
162971701|NCT02960438|588597928|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
162971702|NCT02960438|588597929|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
162971703|NCT02960438|588597930|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
162971704|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
162971705|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
162971706|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
162971707|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
162971708|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971709|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971710|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
162971711|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
162971712|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971713|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971714|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
162971715|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
162971716|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
162971717|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
162971718|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
162971719|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
162971720|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
162971721|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
162971722|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
162971723|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
162971724|NCT02960438|588597927|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
162971725|NCT02960438|588597928|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
162971726|NCT02960438|588597929|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
162971727|NCT02960438|588597930|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
163056968|NCT01773928|588919763|FG002|Overall Study|Adverse Event|0|||
162923344|NCT00877799|588420281|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
162923345|NCT00877799|588420282|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
162971728|NCT01522950|588597931|FG000|Overall Study|Withdrawal by Subject|3|||
162971729|NCT01522950|588597932|FG001|Overall Study|Withdrawal by Subject|2|||
162971730|NCT01522950|588597933|FG002|Overall Study|Withdrawal by Subject|1|||
162971731|NCT01522950|588597931|FG000|Overall Study|Adverse Event|3|||
162971732|NCT01522950|588597932|FG001|Overall Study|Adverse Event|1|||
162971733|NCT01522950|588597933|FG002|Overall Study|Adverse Event|1|||
162971734|NCT01522950|588597931|FG000|Overall Study|Protocol Violation|0|||
162971735|NCT01522950|588597932|FG001|Overall Study|Protocol Violation|0|||
162971736|NCT01522950|588597933|FG002|Overall Study|Protocol Violation|2|||
162971737|NCT01522950|588597931|FG000|Overall Study|Death|0|||
162971738|NCT01522950|588597932|FG001|Overall Study|Death|1|||
162971739|NCT01522950|588597933|FG002|Overall Study|Death|1|||
162971740|NCT01522950|588597931|FG000|Overall Study|Study Medication Sensitivity|0|||
162971741|NCT01522950|588597932|FG001|Overall Study|Study Medication Sensitivity|1|||
162971742|NCT01522950|588597933|FG002|Overall Study|Study Medication Sensitivity|0|||
162971743|NCT00298740|588597938|FG000|Overall Study|Lack of Efficacy|6|||
162971744|NCT00298740|588597938|FG000|Overall Study|Withdrawal by Subject|3|||
162971745|NCT03449199|588597939|FG000|Overall Study|Lost to Follow-up|1|||
162971746|NCT03449199|588597940|FG001|Overall Study|Lost to Follow-up|1|||
162971747|NCT03449199|588597941|FG002|Overall Study|Lost to Follow-up|0|||
162971748|NCT03449199|588597939|FG000|Overall Study|Protocol Deviation|0|||
162971749|NCT03449199|588597940|FG001|Overall Study|Protocol Deviation|0|||
162971750|NCT03449199|588597941|FG002|Overall Study|Protocol Deviation|1|||
162971751|NCT03449199|588597939|FG000|Overall Study|Withdrawal by Subject|0|||
162971752|NCT03449199|588597940|FG001|Overall Study|Withdrawal by Subject|0|||
162971753|NCT03449199|588597941|FG002|Overall Study|Withdrawal by Subject|1|||
162971754|NCT00848042|588597943|FG000|Overall Study|Death|1|||
162971755|NCT00848042|588597944|FG001|Overall Study|Death|2|||
162971756|NCT00848042|588597945|FG002|Overall Study|Death|0|||
162923346|NCT00877799|588420283|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
162923347|NCT00877799|588420284|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
162923348|NCT04054011|588420285|FG000|Overall Study|COVID|3|||
162923349|NCT00592007|588420286|FG000|Overall Study|Withdrawal by Subject|1|||
162923350|NCT00592007|588420286|FG000|Overall Study|patient ineligible (out of lab range)|1|||
162923351|NCT01785472|588420287|FG000|Overall Study|Adverse Event|5|||
162923352|NCT01785472|588420288|FG001|Overall Study|Adverse Event|4|||
162923353|NCT01785472|588420289|FG002|Overall Study|Adverse Event|6|||
162923354|NCT01785472|588420287|FG000|Overall Study|Lack of Efficacy|2|||
162923355|NCT01785472|588420288|FG001|Overall Study|Lack of Efficacy|0|||
162923356|NCT01785472|588420289|FG002|Overall Study|Lack of Efficacy|1|||
162923357|NCT01785472|588420287|FG000|Overall Study|Lost to Follow-up|1|||
162923358|NCT01785472|588420288|FG001|Overall Study|Lost to Follow-up|2|||
162923359|NCT01785472|588420289|FG002|Overall Study|Lost to Follow-up|0|||
162923360|NCT01785472|588420287|FG000|Overall Study|Physician Decision|1|||
162923361|NCT01785472|588420288|FG001|Overall Study|Physician Decision|1|||
162923362|NCT01785472|588420289|FG002|Overall Study|Physician Decision|1|||
162923363|NCT01785472|588420287|FG000|Overall Study|Protocol deviation|0|||
162923364|NCT01785472|588420288|FG001|Overall Study|Protocol deviation|2|||
162923365|NCT01785472|588420289|FG002|Overall Study|Protocol deviation|2|||
162923366|NCT01785472|588420287|FG000|Overall Study|Subject/guardian decision|15|||
162923367|NCT01785472|588420288|FG001|Overall Study|Subject/guardian decision|10|||
162923368|NCT01785472|588420289|FG002|Overall Study|Subject/guardian decision|11|||
162923369|NCT01785472|588420287|FG000|Overall Study|Technical problems|0|||
162923370|NCT01785472|588420288|FG001|Overall Study|Technical problems|0|||
162923371|NCT01785472|588420289|FG002|Overall Study|Technical problems|1|||
162923372|NCT00595127|588420290|FG000|Overall Study|Death|6|||
162923373|NCT00595127|588420290|FG000|Overall Study|Relapsed|3|||
162923374|NCT00595127|588420290|FG000|Overall Study|joined another trial|1|||
162923375|NCT01803464|588420293|FG000|Overall Study|Incomplete data|0|||
162923376|NCT01803464|588420294|FG001|Overall Study|Incomplete data|0|||
162923377|NCT01803464|588420295|FG002|Overall Study|Incomplete data|4|||
162923378|NCT01803464|588420296|FG003|Overall Study|Incomplete data|0|||
162923379|NCT01803464|588420293|FG000|Overall Study|Withdrawal by Subject|1|||
162923380|NCT01803464|588420294|FG001|Overall Study|Withdrawal by Subject|0|||
162923381|NCT01803464|588420295|FG002|Overall Study|Withdrawal by Subject|0|||
162923382|NCT01803464|588420296|FG003|Overall Study|Withdrawal by Subject|0|||
162923383|NCT02860039|588420302|FG000|Overall Study|Death|4|||
162923384|NCT02860039|588420303|FG001|Overall Study|Death|0|||
162923385|NCT02860039|588420302|FG000|Overall Study|Lost to Follow-up|2|||
162923386|NCT02860039|588420303|FG001|Overall Study|Lost to Follow-up|2|||
162923387|NCT02860039|588420302|FG000|Overall Study|Protocol Violation|3|||
162971757|NCT00848042|588597943|FG000|Overall Study|Other Therapy|3|||
162971758|NCT00848042|588597944|FG001|Overall Study|Other Therapy|0|||
162971759|NCT00848042|588597945|FG002|Overall Study|Other Therapy|0|||
162971760|NCT02744755|588597946|FG000|Study Period 1|Protocol Violation|2|||
162971761|NCT02744755|588597947|FG001|Study Period 1|Protocol Violation|1|||
162971762|NCT02744755|588597946|FG000|Study Period 1|not defined|0|||
163056969|NCT01773928|588919764|FG003|Overall Study|Adverse Event|0|||
163056970|NCT01773928|588919765|FG004|Overall Study|Adverse Event|0|||
163056971|NCT01773928|588919766|FG005|Overall Study|Adverse Event|0|||
163056972|NCT01773928|588919767|FG006|Overall Study|Adverse Event|0|||
163056973|NCT01773928|588919768|FG007|Overall Study|Adverse Event|1|||
163056974|NCT01773928|588919769|FG008|Overall Study|Adverse Event|0|||
163056975|NCT01773928|588919761|FG000|Overall Study|Physician Decision|0|||
163056976|NCT01773928|588919762|FG001|Overall Study|Physician Decision|0|||
163056977|NCT01773928|588919763|FG002|Overall Study|Physician Decision|0|||
163056978|NCT01773928|588919764|FG003|Overall Study|Physician Decision|1|||
162971763|NCT02744755|588597947|FG001|Study Period 1|not defined|1|||
162971764|NCT02744755|588597946|FG000|Study Period 1|Pregnancy|1|||
162971765|NCT02744755|588597947|FG001|Study Period 1|Pregnancy|0|||
162971766|NCT02744755|588597946|FG000|Study Period 1|Adverse Event|1|||
162971767|NCT02744755|588597947|FG001|Study Period 1|Adverse Event|1|||
162971768|NCT02744755|588597946|FG000|Study Period 1|Lost to Follow-up|1|||
162971769|NCT02744755|588597947|FG001|Study Period 1|Lost to Follow-up|1|||
162971770|NCT02744755|588597946|FG000|Study Period 1|Lack of Efficacy|1|||
162971771|NCT02744755|588597947|FG001|Study Period 1|Lack of Efficacy|0|||
163056979|NCT01773928|588919765|FG004|Overall Study|Physician Decision|0|||
163056980|NCT01773928|588919766|FG005|Overall Study|Physician Decision|0|||
163056981|NCT01773928|588919767|FG006|Overall Study|Physician Decision|0|||
163056982|NCT01773928|588919768|FG007|Overall Study|Physician Decision|0|||
162630227|NCT00543140|587365083|FG000|Overall Study|Protocol Violation|10|||
162971772|NCT02744755|588597946|FG000|Study Period 1|Withdrawal by Subject|8|||
162971773|NCT02744755|588597947|FG001|Study Period 1|Withdrawal by Subject|4|||
163056983|NCT01773928|588919769|FG008|Overall Study|Physician Decision|0|||
163056984|NCT01773928|588919761|FG000|Overall Study|Withdrawal by Subject|5|||
162971774|NCT02744755|588597946|FG000|Study Period 2|Adverse Event|5|||
162971775|NCT02744755|588597947|FG001|Study Period 2|Adverse Event|0|||
162971776|NCT02744755|588597946|FG000|Study Period 2|Protocol Violation|1|||
162971777|NCT02744755|588597947|FG001|Study Period 2|Protocol Violation|0|||
162971778|NCT02744755|588597946|FG000|Study Period 2|not defined|3|||
162971779|NCT02744755|588597947|FG001|Study Period 2|not defined|2|||
162971780|NCT02744755|588597946|FG000|Study Period 2|Lost to Follow-up|0|||
162971781|NCT02744755|588597947|FG001|Study Period 2|Lost to Follow-up|2|||
162971782|NCT02744755|588597946|FG000|Study Period 2|Withdrawal by Subject|2|||
162971783|NCT02744755|588597947|FG001|Study Period 2|Withdrawal by Subject|2|||
162971784|NCT02744755|588597946|FG000|Study Period 2|Lack of Efficacy|3|||
162971785|NCT02744755|588597947|FG001|Study Period 2|Lack of Efficacy|2|||
162971786|NCT01652729|588597948|FG000|Overall Study|Withdrawal by Subject|14|||
162971787|NCT01652729|588597949|FG001|Overall Study|Withdrawal by Subject|7|||
162971788|NCT01652729|588597950|FG002|Overall Study|Withdrawal by Subject|7|||
162971789|NCT01652729|588597948|FG000|Overall Study|Adverse Event|4|||
162971790|NCT01652729|588597949|FG001|Overall Study|Adverse Event|0|||
162971791|NCT01652729|588597950|FG002|Overall Study|Adverse Event|3|||
162971792|NCT01652729|588597948|FG000|Overall Study|Physician Decision|1|||
162971793|NCT01652729|588597949|FG001|Overall Study|Physician Decision|0|||
162971794|NCT01652729|588597950|FG002|Overall Study|Physician Decision|1|||
162971795|NCT01652729|588597948|FG000|Overall Study|Protocol Violation|1|||
162971796|NCT01652729|588597949|FG001|Overall Study|Protocol Violation|0|||
162971797|NCT01652729|588597950|FG002|Overall Study|Protocol Violation|0|||
162971798|NCT01652729|588597948|FG000|Overall Study|Lost to Follow-up|6|||
162971799|NCT01652729|588597949|FG001|Overall Study|Lost to Follow-up|6|||
162971800|NCT01652729|588597950|FG002|Overall Study|Lost to Follow-up|3|||
162971801|NCT01652729|588597948|FG000|Overall Study|Administrative|1|||
162971802|NCT01652729|588597949|FG001|Overall Study|Administrative|0|||
162971803|NCT01652729|588597950|FG002|Overall Study|Administrative|0|||
162971804|NCT00483548|588597951|FG000|Overall Study|Randomized; not treated with study drug|1|||
162971805|NCT00483548|588597952|FG001|Overall Study|Randomized; not treated with study drug|3|||
162971806|NCT00483548|588597951|FG000|Overall Study|Adverse Event|25|||
162971807|NCT00483548|588597952|FG001|Overall Study|Adverse Event|14|||
162971808|NCT00483548|588597951|FG000|Overall Study|Laboratory abnormality|1|||
162971809|NCT00483548|588597952|FG001|Overall Study|Laboratory abnormality|2|||
162971810|NCT00483548|588597951|FG000|Overall Study|Lack of Efficacy|4|||
162971811|NCT00483548|588597952|FG001|Overall Study|Lack of Efficacy|8|||
162971812|NCT00483548|588597951|FG000|Overall Study|Protocol Violation|11|||
162971813|NCT00483548|588597952|FG001|Overall Study|Protocol Violation|7|||
162971814|NCT00483548|588597951|FG000|Overall Study|Pregnancy|1|||
162971815|NCT00483548|588597952|FG001|Overall Study|Pregnancy|0|||
162971816|NCT00483548|588597951|FG000|Overall Study|Protocol required discontinuation|6|||
162971817|NCT00483548|588597952|FG001|Overall Study|Protocol required discontinuation|6|||
162971818|NCT00483548|588597951|FG000|Overall Study|Unable to comply with protocol schedule|1|||
162971819|NCT00483548|588597952|FG001|Overall Study|Unable to comply with protocol schedule|0|||
162971820|NCT00483548|588597951|FG000|Overall Study|Non-compliance with medication|2|||
162971821|NCT00483548|588597952|FG001|Overall Study|Non-compliance with medication|0|||
162971822|NCT00483548|588597951|FG000|Overall Study|Lost to Follow-up|3|||
162971823|NCT00483548|588597952|FG001|Overall Study|Lost to Follow-up|4|||
162971824|NCT00483548|588597951|FG000|Overall Study|Withdrawal by Subject|5|||
162971825|NCT00483548|588597952|FG001|Overall Study|Withdrawal by Subject|2|||
162971826|NCT04364737|588597956|FG000|Overall Study|Withdrawal by Subject|4|||
162971827|NCT04364737|588597957|FG001|Overall Study|Withdrawal by Subject|9|||
162971828|NCT04364737|588597956|FG000|Overall Study|Lost to Follow-up|1|||
162971829|NCT04364737|588597957|FG001|Overall Study|Lost to Follow-up|1|||
162971830|NCT01220609|588597958|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
162971831|NCT01220609|588597958|FG000|Overall Study|Ineligible- Wrong cell type|1|||
162971832|NCT01220609|588597958|FG000|Overall Study|Ineligible-Never treated|1|||
162971833|NCT00112294|588597959|FG000|Overall Study|Still on study|5|||
162971834|NCT00112294|588597960|FG001|Overall Study|Still on study|0|||
162971835|NCT01190930|588597964|FG000|Induction|Adverse Event|17|||
162971836|NCT01190930|588597965|FG001|Induction|Adverse Event|0|||
162971837|NCT01190930|588597966|FG002|Induction|Adverse Event|0|||
162971838|NCT01190930|588597967|FG003|Induction|Adverse Event|0|||
162971839|NCT01190930|588597968|FG004|Induction|Adverse Event|0|||
162971840|NCT01190930|588597969|FG005|Induction|Adverse Event|0|||
163056985|NCT01773928|588919762|FG001|Overall Study|Withdrawal by Subject|4|||
162712779|NCT02449044|587658581|FG000|Overall Study|Withdrawal by Subject|13|||
162971841|NCT01190930|588597970|FG006|Induction|Adverse Event|0|||
162971842|NCT01190930|588597971|FG007|Induction|Adverse Event|0|||
162971843|NCT01190930|588597972|FG008|Induction|Adverse Event|0|||
162971844|NCT01190930|588597973|FG009|Induction|Adverse Event|0|||
162971845|NCT01190930|588597964|FG000|Induction|Death|34|||
162971846|NCT01190930|588597965|FG001|Induction|Death|0|||
162971847|NCT01190930|588597966|FG002|Induction|Death|0|||
162971848|NCT01190930|588597967|FG003|Induction|Death|0|||
162971849|NCT01190930|588597968|FG004|Induction|Death|0|||
162971850|NCT01190930|588597969|FG005|Induction|Death|0|||
162971851|NCT01190930|588597970|FG006|Induction|Death|0|||
162923388|NCT02860039|588420303|FG001|Overall Study|Protocol Violation|1|||
162923389|NCT02860039|588420302|FG000|Overall Study|Withdrawal by Subject|1|||
162923390|NCT02860039|588420303|FG001|Overall Study|Withdrawal by Subject|0|||
162923391|NCT02860039|588420302|FG000|Overall Study|Not otherwise eligible|1|||
162923392|NCT02860039|588420303|FG001|Overall Study|Not otherwise eligible|1|||
162923393|NCT01125358|588420306|FG000|Overall Study|Adverse Event|3|||
162923394|NCT01125358|588420307|FG001|Overall Study|Adverse Event|0|||
162923395|NCT01125358|588420308|FG002|Overall Study|Adverse Event|0|||
162923396|NCT01125358|588420309|FG003|Overall Study|Adverse Event|2|||
162923397|NCT01125358|588420306|FG000|Overall Study|Perceived Lack of Efficacy|6|||
162923398|NCT01125358|588420307|FG001|Overall Study|Perceived Lack of Efficacy|3|||
162923399|NCT01125358|588420308|FG002|Overall Study|Perceived Lack of Efficacy|7|||
162923400|NCT01125358|588420309|FG003|Overall Study|Perceived Lack of Efficacy|4|||
162923401|NCT01125358|588420306|FG000|Overall Study|Protocol Violation|1|||
162923402|NCT01125358|588420307|FG001|Overall Study|Protocol Violation|0|||
162923403|NCT01125358|588420308|FG002|Overall Study|Protocol Violation|0|||
162923404|NCT01125358|588420309|FG003|Overall Study|Protocol Violation|0|||
162923405|NCT01125358|588420306|FG000|Overall Study|Sponsor Decision|0|||
162923406|NCT01125358|588420307|FG001|Overall Study|Sponsor Decision|0|||
162923407|NCT01125358|588420308|FG002|Overall Study|Sponsor Decision|1|||
162923408|NCT01125358|588420309|FG003|Overall Study|Sponsor Decision|1|||
162923409|NCT01125358|588420306|FG000|Overall Study|Withdrawal by Subject|2|||
162923410|NCT01125358|588420307|FG001|Overall Study|Withdrawal by Subject|1|||
162923411|NCT01125358|588420308|FG002|Overall Study|Withdrawal by Subject|1|||
162923412|NCT01125358|588420309|FG003|Overall Study|Withdrawal by Subject|1|||
162923413|NCT04935931|588420315|FG000|Overall Study|Withdrawal by Subject|1|||
162923414|NCT02628418|588420318|FG000|Overall Study|Lost to Follow-up|1|||
162923415|NCT02628418|588420319|FG001|Overall Study|Lost to Follow-up|2|||
162923416|NCT03159611|588420323|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
162923417|NCT03159611|588420324|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
162923418|NCT03159611|588420323|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
162923419|NCT03159611|588420324|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
162923420|NCT03159611|588420323|FG000|Overall Study|Protocol Violation|7|||
162923421|NCT03159611|588420324|FG001|Overall Study|Protocol Violation|4|||
162923422|NCT03159611|588420323|FG000|Overall Study|Adverse Event|1|||
162923423|NCT03159611|588420324|FG001|Overall Study|Adverse Event|0|||
162923424|NCT03159611|588420323|FG000|Overall Study|Withdrawal by Subject|1|||
162923425|NCT03159611|588420324|FG001|Overall Study|Withdrawal by Subject|1|||
162923426|NCT03159611|588420323|FG000|Overall Study|Non-compliance with protocol requirement|3|||
162923427|NCT03159611|588420324|FG001|Overall Study|Non-compliance with protocol requirement|2|||
162923428|NCT03159611|588420323|FG000|Overall Study|Inability to perform procedures|1|||
162923429|NCT03159611|588420324|FG001|Overall Study|Inability to perform procedures|0|||
162923430|NCT01984229|588420325|FG000|Safety Follow-up Period|Adverse Event|1|||
162923431|NCT01984229|588420326|FG001|Safety Follow-up Period|Adverse Event|1|||
162923432|NCT01984229|588420325|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
162923433|NCT01984229|588420326|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
162923434|NCT02072174|588420327|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
162923435|NCT02072174|588420328|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
162923436|NCT02072174|588420327|FG000|Overall Study|Protocol Violation|16|||
162923437|NCT02072174|588420328|FG001|Overall Study|Protocol Violation|23|||
162923438|NCT02072174|588420327|FG000|Overall Study|Physician Decision|0|||
162923439|NCT02072174|588420328|FG001|Overall Study|Physician Decision|1|||
162923440|NCT02072174|588420327|FG000|Overall Study|Non-compliance with protocol requirement|2|||
162923441|NCT02072174|588420328|FG001|Overall Study|Non-compliance with protocol requirement|0|||
162923442|NCT00352664|588420336|FG000|Overall Study|Withdrawal by Subject|7|||
162923443|NCT00352664|588420337|FG001|Overall Study|Withdrawal by Subject|0|||
162923444|NCT01608321|588420342|FG000|Overall Study|Withdrawal by Subject|1|||
162923445|NCT01608321|588420343|FG001|Overall Study|Withdrawal by Subject|0|||
162923446|NCT01875731|588420344|FG000|Overall Study|Fail to obtain lab sample|1|||
162923447|NCT01875731|588420345|FG001|Overall Study|Fail to obtain lab sample|0|||
162923448|NCT03222856|588420348|FG000|Overall Study|Adverse Event|6|||
162923449|NCT03222856|588420348|FG000|Overall Study|Death|1|||
162923450|NCT00359073|588422139|FG000|Overall Study|Withdrawal by Subject|1|||
162923451|NCT00359073|588422140|FG001|Overall Study|Withdrawal by Subject|1|||
162923452|NCT00359073|588422139|FG000|Overall Study|Eligibility criteria no longer met|3|||
162923453|NCT00359073|588422140|FG001|Overall Study|Eligibility criteria no longer met|0|||
162923454|NCT00359073|588422139|FG000|Overall Study|developed RV16 antibody|0|||
162923455|NCT00359073|588422140|FG001|Overall Study|developed RV16 antibody|1|||
162923456|NCT00684645|588422141|FG000|Overall Study|Death|2|||
162923457|NCT00684645|588422141|FG000|Overall Study|Progressive disease|67|||
162923458|NCT00684645|588422141|FG000|Overall Study|Adverse Event|27|||
162923459|NCT00684645|588422141|FG000|Overall Study|Lost to Follow-up|3|||
162923460|NCT00684645|588422141|FG000|Overall Study|Other|15|||
162923461|NCT01819467|588422146|FG000|Overall Study|Physician Decision|20|||
163056986|NCT01773928|588919763|FG002|Overall Study|Withdrawal by Subject|4|||
163056987|NCT01773928|588919764|FG003|Overall Study|Withdrawal by Subject|4|||
163056988|NCT01773928|588919765|FG004|Overall Study|Withdrawal by Subject|7|||
163056989|NCT01773928|588919766|FG005|Overall Study|Withdrawal by Subject|1|||
163056990|NCT01773928|588919767|FG006|Overall Study|Withdrawal by Subject|0|||
163056991|NCT01773928|588919768|FG007|Overall Study|Withdrawal by Subject|0|||
163056992|NCT01773928|588919769|FG008|Overall Study|Withdrawal by Subject|1|||
163056993|NCT01773928|588919761|FG000|Overall Study|Lost to Follow-up|0|||
163056994|NCT01773928|588919762|FG001|Overall Study|Lost to Follow-up|0|||
163056995|NCT01773928|588919763|FG002|Overall Study|Lost to Follow-up|0|||
162971852|NCT01190930|588597971|FG007|Induction|Death|0|||
162971853|NCT01190930|588597972|FG008|Induction|Death|0|||
162971854|NCT01190930|588597973|FG009|Induction|Death|0|||
162971855|NCT01190930|588597964|FG000|Induction|Lost to Follow-up|1|||
162971856|NCT01190930|588597965|FG001|Induction|Lost to Follow-up|0|||
162971857|NCT01190930|588597966|FG002|Induction|Lost to Follow-up|0|||
162971858|NCT01190930|588597967|FG003|Induction|Lost to Follow-up|0|||
162971859|NCT01190930|588597968|FG004|Induction|Lost to Follow-up|0|||
162971860|NCT01190930|588597969|FG005|Induction|Lost to Follow-up|0|||
162971861|NCT01190930|588597970|FG006|Induction|Lost to Follow-up|0|||
162971862|NCT01190930|588597971|FG007|Induction|Lost to Follow-up|0|||
162971863|NCT01190930|588597972|FG008|Induction|Lost to Follow-up|0|||
162971864|NCT01190930|588597973|FG009|Induction|Lost to Follow-up|0|||
162971865|NCT01190930|588597964|FG000|Induction|Physician Decision|125|||
162971866|NCT01190930|588597965|FG001|Induction|Physician Decision|3|||
162923462|NCT01819467|588422147|FG001|Overall Study|Physician Decision|9|||
162923463|NCT03514121|588422148|FG000|Overall Study|Withdrawal by Subject|0|||
162923464|NCT03514121|588422149|FG001|Overall Study|Withdrawal by Subject|0|||
162923465|NCT03514121|588422150|FG002|Overall Study|Withdrawal by Subject|0|||
162923466|NCT03514121|588422151|FG003|Overall Study|Withdrawal by Subject|0|||
162923467|NCT03514121|588422152|FG004|Overall Study|Withdrawal by Subject|1|||
162923468|NCT03514121|588422153|FG005|Overall Study|Withdrawal by Subject|2|||
162923469|NCT03514121|588422154|FG006|Overall Study|Withdrawal by Subject|1|||
162923470|NCT03514121|588422155|FG007|Overall Study|Withdrawal by Subject|1|||
162923471|NCT03514121|588422156|FG008|Overall Study|Withdrawal by Subject|7|||
162923472|NCT03514121|588422157|FG009|Overall Study|Withdrawal by Subject|2|||
162923473|NCT03514121|588422148|FG000|Overall Study|Death|0|||
162923474|NCT03514121|588422149|FG001|Overall Study|Death|0|||
162923475|NCT03514121|588422150|FG002|Overall Study|Death|0|||
162923476|NCT03514121|588422151|FG003|Overall Study|Death|0|||
162923477|NCT03514121|588422152|FG004|Overall Study|Death|0|||
162923478|NCT03514121|588422153|FG005|Overall Study|Death|3|||
162923479|NCT03514121|588422154|FG006|Overall Study|Death|2|||
162923480|NCT03514121|588422155|FG007|Overall Study|Death|1|||
162923481|NCT03514121|588422156|FG008|Overall Study|Death|26|||
162923482|NCT03514121|588422157|FG009|Overall Study|Death|3|||
162923483|NCT03514121|588422148|FG000|Overall Study|Lost to Follow-up|0|||
162923484|NCT03514121|588422149|FG001|Overall Study|Lost to Follow-up|0|||
162923485|NCT03514121|588422150|FG002|Overall Study|Lost to Follow-up|1|||
162923486|NCT03514121|588422151|FG003|Overall Study|Lost to Follow-up|0|||
162923487|NCT03514121|588422152|FG004|Overall Study|Lost to Follow-up|0|||
162923488|NCT03514121|588422153|FG005|Overall Study|Lost to Follow-up|0|||
162923489|NCT03514121|588422154|FG006|Overall Study|Lost to Follow-up|0|||
162923490|NCT03514121|588422155|FG007|Overall Study|Lost to Follow-up|0|||
162923491|NCT03514121|588422156|FG008|Overall Study|Lost to Follow-up|1|||
162923492|NCT03514121|588422157|FG009|Overall Study|Lost to Follow-up|0|||
162923493|NCT03514121|588422148|FG000|Overall Study|Adverse Event|0|||
162923494|NCT03514121|588422149|FG001|Overall Study|Adverse Event|0|||
162923495|NCT03514121|588422150|FG002|Overall Study|Adverse Event|0|||
162923496|NCT03514121|588422151|FG003|Overall Study|Adverse Event|0|||
162923497|NCT03514121|588422152|FG004|Overall Study|Adverse Event|0|||
162923498|NCT03514121|588422153|FG005|Overall Study|Adverse Event|0|||
162923499|NCT03514121|588422154|FG006|Overall Study|Adverse Event|1|||
162923500|NCT03514121|588422155|FG007|Overall Study|Adverse Event|0|||
162923501|NCT03514121|588422156|FG008|Overall Study|Adverse Event|0|||
162923502|NCT03514121|588422157|FG009|Overall Study|Adverse Event|0|||
162923503|NCT03514121|588422148|FG000|Overall Study|Other|0|||
162923504|NCT03514121|588422149|FG001|Overall Study|Other|1|||
162923505|NCT03514121|588422150|FG002|Overall Study|Other|1|||
162923506|NCT03514121|588422151|FG003|Overall Study|Other|0|||
162923507|NCT03514121|588422152|FG004|Overall Study|Other|1|||
162923508|NCT03514121|588422153|FG005|Overall Study|Other|2|||
162923509|NCT03514121|588422154|FG006|Overall Study|Other|3|||
162923510|NCT03514121|588422155|FG007|Overall Study|Other|2|||
162923511|NCT03514121|588422156|FG008|Overall Study|Other|7|||
162923512|NCT03514121|588422157|FG009|Overall Study|Other|3|||
162923513|NCT03514121|588422148|FG000|Overall Study|Study termination by Sponsor|0|||
162923514|NCT03514121|588422149|FG001|Overall Study|Study termination by Sponsor|0|||
162923515|NCT03514121|588422150|FG002|Overall Study|Study termination by Sponsor|0|||
162923516|NCT03514121|588422151|FG003|Overall Study|Study termination by Sponsor|0|||
162923517|NCT03514121|588422152|FG004|Overall Study|Study termination by Sponsor|0|||
162923518|NCT03514121|588422153|FG005|Overall Study|Study termination by Sponsor|0|||
162923519|NCT03514121|588422154|FG006|Overall Study|Study termination by Sponsor|0|||
162923520|NCT03514121|588422155|FG007|Overall Study|Study termination by Sponsor|0|||
162923521|NCT03514121|588422156|FG008|Overall Study|Study termination by Sponsor|11|||
162923522|NCT03514121|588422157|FG009|Overall Study|Study termination by Sponsor|3|||
162923523|NCT03514121|588422148|FG000|Overall Study|Investigator decision|0|||
162923524|NCT03514121|588422149|FG001|Overall Study|Investigator decision|0|||
162923525|NCT03514121|588422150|FG002|Overall Study|Investigator decision|0|||
162971867|NCT01190930|588597966|FG002|Induction|Physician Decision|0|||
162971868|NCT01190930|588597967|FG003|Induction|Physician Decision|0|||
162971869|NCT01190930|588597968|FG004|Induction|Physician Decision|0|||
162971870|NCT01190930|588597969|FG005|Induction|Physician Decision|0|||
162971871|NCT01190930|588597970|FG006|Induction|Physician Decision|0|||
162971872|NCT01190930|588597971|FG007|Induction|Physician Decision|0|||
162971873|NCT01190930|588597972|FG008|Induction|Physician Decision|0|||
162971874|NCT01190930|588597973|FG009|Induction|Physician Decision|0|||
162971875|NCT01190930|588597964|FG000|Induction|Withdrawal by Subject|9|||
162971876|NCT01190930|588597965|FG001|Induction|Withdrawal by Subject|0|||
162971877|NCT01190930|588597966|FG002|Induction|Withdrawal by Subject|0|||
162971878|NCT01190930|588597967|FG003|Induction|Withdrawal by Subject|0|||
162971879|NCT01190930|588597968|FG004|Induction|Withdrawal by Subject|0|||
162971880|NCT01190930|588597969|FG005|Induction|Withdrawal by Subject|0|||
162971881|NCT01190930|588597970|FG006|Induction|Withdrawal by Subject|0|||
162971882|NCT01190930|588597971|FG007|Induction|Withdrawal by Subject|0|||
162971883|NCT01190930|588597972|FG008|Induction|Withdrawal by Subject|0|||
162971884|NCT01190930|588597973|FG009|Induction|Withdrawal by Subject|0|||
162971885|NCT01190930|588597964|FG000|Induction|Refusal|235|||
162971886|NCT01190930|588597965|FG001|Induction|Refusal|0|||
162971887|NCT01190930|588597966|FG002|Induction|Refusal|0|||
162971888|NCT01190930|588597967|FG003|Induction|Refusal|0|||
162971889|NCT01190930|588597968|FG004|Induction|Refusal|0|||
162971890|NCT01190930|588597969|FG005|Induction|Refusal|0|||
162971891|NCT01190930|588597970|FG006|Induction|Refusal|0|||
162971892|NCT01190930|588597971|FG007|Induction|Refusal|0|||
162971893|NCT01190930|588597972|FG008|Induction|Refusal|0|||
162971894|NCT01190930|588597973|FG009|Induction|Refusal|0|||
162971895|NCT01190930|588597964|FG000|Induction|Inevaluable|23|||
162971896|NCT01190930|588597965|FG001|Induction|Inevaluable|1|||
162971897|NCT01190930|588597966|FG002|Induction|Inevaluable|0|||
162971898|NCT01190930|588597967|FG003|Induction|Inevaluable|0|||
162971899|NCT01190930|588597968|FG004|Induction|Inevaluable|0|||
162971900|NCT01190930|588597969|FG005|Induction|Inevaluable|0|||
162971901|NCT01190930|588597970|FG006|Induction|Inevaluable|0|||
162971902|NCT01190930|588597971|FG007|Induction|Inevaluable|0|||
162971903|NCT01190930|588597972|FG008|Induction|Inevaluable|0|||
162971904|NCT01190930|588597973|FG009|Induction|Inevaluable|0|||
162971905|NCT01190930|588597964|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
162971906|NCT01190930|588597965|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971907|NCT01190930|588597966|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971908|NCT01190930|588597967|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971909|NCT01190930|588597968|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971910|NCT01190930|588597969|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971911|NCT01190930|588597970|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971912|NCT01190930|588597971|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971913|NCT01190930|588597972|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971914|NCT01190930|588597973|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162971915|NCT01190930|588597964|FG000|Induction|High Risk Downs|80|||
162971916|NCT01190930|588597965|FG001|Induction|High Risk Downs|0|||
162971917|NCT01190930|588597966|FG002|Induction|High Risk Downs|0|||
162971918|NCT01190930|588597967|FG003|Induction|High Risk Downs|0|||
162971919|NCT01190930|588597968|FG004|Induction|High Risk Downs|0|||
162971920|NCT01190930|588597969|FG005|Induction|High Risk Downs|0|||
162971921|NCT01190930|588597970|FG006|Induction|High Risk Downs|0|||
162971922|NCT01190930|588597971|FG007|Induction|High Risk Downs|0|||
162971923|NCT01190930|588597972|FG008|Induction|High Risk Downs|0|||
162971924|NCT01190930|588597973|FG009|Induction|High Risk Downs|0|||
162971925|NCT01190930|588597964|FG000|Induction|Enrollment onto another COG Protocol|1|||
162971926|NCT01190930|588597965|FG001|Induction|Enrollment onto another COG Protocol|0|||
162971927|NCT01190930|588597966|FG002|Induction|Enrollment onto another COG Protocol|0|||
162971928|NCT01190930|588597967|FG003|Induction|Enrollment onto another COG Protocol|0|||
162971929|NCT01190930|588597968|FG004|Induction|Enrollment onto another COG Protocol|0|||
162971930|NCT01190930|588597969|FG005|Induction|Enrollment onto another COG Protocol|0|||
162971931|NCT01190930|588597970|FG006|Induction|Enrollment onto another COG Protocol|0|||
162971932|NCT01190930|588597971|FG007|Induction|Enrollment onto another COG Protocol|0|||
162971933|NCT01190930|588597972|FG008|Induction|Enrollment onto another COG Protocol|0|||
162971934|NCT01190930|588597973|FG009|Induction|Enrollment onto another COG Protocol|0|||
162971935|NCT01190930|588597964|FG000|Induction|Average Risk|1847|||
162971936|NCT01190930|588597965|FG001|Induction|Average Risk|0|||
162971937|NCT01190930|588597966|FG002|Induction|Average Risk|0|||
162971938|NCT01190930|588597967|FG003|Induction|Average Risk|0|||
162971939|NCT01190930|588597968|FG004|Induction|Average Risk|0|||
162971940|NCT01190930|588597969|FG005|Induction|Average Risk|0|||
162971941|NCT01190930|588597970|FG006|Induction|Average Risk|0|||
162971942|NCT01190930|588597971|FG007|Induction|Average Risk|0|||
162971943|NCT01190930|588597972|FG008|Induction|Average Risk|0|||
162971944|NCT01190930|588597973|FG009|Induction|Average Risk|0|||
162971945|NCT01190930|588597964|FG000|Induction|High Risk|1227|||
163056996|NCT01773928|588919764|FG003|Overall Study|Lost to Follow-up|0|||
162971946|NCT01190930|588597965|FG001|Induction|High Risk|0|||
162971947|NCT01190930|588597966|FG002|Induction|High Risk|0|||
162971948|NCT01190930|588597967|FG003|Induction|High Risk|0|||
162971949|NCT01190930|588597968|FG004|Induction|High Risk|0|||
162971950|NCT01190930|588597969|FG005|Induction|High Risk|0|||
162971951|NCT01190930|588597970|FG006|Induction|High Risk|0|||
162971952|NCT01190930|588597971|FG007|Induction|High Risk|0|||
162971953|NCT01190930|588597972|FG008|Induction|High Risk|0|||
162971954|NCT01190930|588597973|FG009|Induction|High Risk|0|||
162971955|NCT01190930|588597964|FG000|Induction|Low Risk|443|||
162971956|NCT01190930|588597965|FG001|Induction|Low Risk|0|||
162971957|NCT01190930|588597966|FG002|Induction|Low Risk|0|||
162971958|NCT01190930|588597967|FG003|Induction|Low Risk|0|||
162971959|NCT01190930|588597968|FG004|Induction|Low Risk|0|||
162971960|NCT01190930|588597969|FG005|Induction|Low Risk|0|||
162971961|NCT01190930|588597970|FG006|Induction|Low Risk|0|||
162971962|NCT01190930|588597971|FG007|Induction|Low Risk|0|||
162971963|NCT01190930|588597972|FG008|Induction|Low Risk|0|||
162971964|NCT01190930|588597973|FG009|Induction|Low Risk|0|||
162971965|NCT01190930|588597964|FG000|Induction|Very High Risk|1012|||
162971966|NCT01190930|588597965|FG001|Induction|Very High Risk|0|||
162971967|NCT01190930|588597966|FG002|Induction|Very High Risk|0|||
162971968|NCT01190930|588597967|FG003|Induction|Very High Risk|0|||
162971969|NCT01190930|588597968|FG004|Induction|Very High Risk|0|||
162971970|NCT01190930|588597969|FG005|Induction|Very High Risk|0|||
162971971|NCT01190930|588597970|FG006|Induction|Very High Risk|0|||
162971972|NCT01190930|588597971|FG007|Induction|Very High Risk|0|||
162971973|NCT01190930|588597972|FG008|Induction|Very High Risk|0|||
162971974|NCT01190930|588597973|FG009|Induction|Very High Risk|0|||
162971975|NCT01190930|588597964|FG000|Induction|Philadelphia chromosome-positive|99|||
162971976|NCT01190930|588597965|FG001|Induction|Philadelphia chromosome-positive|0|||
162971977|NCT01190930|588597966|FG002|Induction|Philadelphia chromosome-positive|0|||
162971978|NCT01190930|588597967|FG003|Induction|Philadelphia chromosome-positive|0|||
162971979|NCT01190930|588597968|FG004|Induction|Philadelphia chromosome-positive|0|||
162971980|NCT01190930|588597969|FG005|Induction|Philadelphia chromosome-positive|0|||
162971981|NCT01190930|588597970|FG006|Induction|Philadelphia chromosome-positive|0|||
162971982|NCT01190930|588597971|FG007|Induction|Philadelphia chromosome-positive|0|||
162971983|NCT01190930|588597972|FG008|Induction|Philadelphia chromosome-positive|0|||
162971984|NCT01190930|588597973|FG009|Induction|Philadelphia chromosome-positive|0|||
162971985|NCT01190930|588597964|FG000|Induction|Incomplete Induction data|63|||
162971986|NCT01190930|588597965|FG001|Induction|Incomplete Induction data|0|||
162971987|NCT01190930|588597966|FG002|Induction|Incomplete Induction data|0|||
162971988|NCT01190930|588597967|FG003|Induction|Incomplete Induction data|0|||
162971989|NCT01190930|588597968|FG004|Induction|Incomplete Induction data|0|||
162971990|NCT01190930|588597969|FG005|Induction|Incomplete Induction data|0|||
162971991|NCT01190930|588597970|FG006|Induction|Incomplete Induction data|0|||
162971992|NCT01190930|588597971|FG007|Induction|Incomplete Induction data|0|||
162971993|NCT01190930|588597972|FG008|Induction|Incomplete Induction data|0|||
162971994|NCT01190930|588597973|FG009|Induction|Incomplete Induction data|0|||
162971995|NCT01190930|588597964|FG000|Induction|Progressive disease|0|||
162971996|NCT01190930|588597965|FG001|Induction|Progressive disease|1|||
162971997|NCT01190930|588597966|FG002|Induction|Progressive disease|0|||
162971998|NCT01190930|588597967|FG003|Induction|Progressive disease|0|||
162971999|NCT01190930|588597968|FG004|Induction|Progressive disease|0|||
162972000|NCT01190930|588597969|FG005|Induction|Progressive disease|0|||
162972001|NCT01190930|588597970|FG006|Induction|Progressive disease|0|||
162972002|NCT01190930|588597971|FG007|Induction|Progressive disease|0|||
162972003|NCT01190930|588597972|FG008|Induction|Progressive disease|0|||
162972004|NCT01190930|588597973|FG009|Induction|Progressive disease|0|||
162972005|NCT01190930|588597964|FG000|Induction|No treatment|3|||
162972006|NCT01190930|588597965|FG001|Induction|No treatment|0|||
162972007|NCT01190930|588597966|FG002|Induction|No treatment|0|||
163056997|NCT01773928|588919765|FG004|Overall Study|Lost to Follow-up|0|||
163056998|NCT01773928|588919766|FG005|Overall Study|Lost to Follow-up|1|||
163056999|NCT01773928|588919767|FG006|Overall Study|Lost to Follow-up|0|||
163057000|NCT01773928|588919768|FG007|Overall Study|Lost to Follow-up|0|||
163057001|NCT01773928|588919769|FG008|Overall Study|Lost to Follow-up|0|||
163057002|NCT01773928|588919761|FG000|Overall Study|Subject misrepresented age|0|||
163057003|NCT01773928|588919762|FG001|Overall Study|Subject misrepresented age|1|||
163057004|NCT01773928|588919763|FG002|Overall Study|Subject misrepresented age|0|||
162972008|NCT01190930|588597967|FG003|Induction|No treatment|0|||
162972009|NCT01190930|588597968|FG004|Induction|No treatment|0|||
162972010|NCT01190930|588597969|FG005|Induction|No treatment|0|||
162972011|NCT01190930|588597970|FG006|Induction|No treatment|0|||
162972012|NCT01190930|588597971|FG007|Induction|No treatment|0|||
162972013|NCT01190930|588597972|FG008|Induction|No treatment|0|||
162972014|NCT01190930|588597973|FG009|Induction|No treatment|0|||
163057005|NCT01773928|588919764|FG003|Overall Study|Subject misrepresented age|0|||
162712780|NCT02449044|587658581|FG000|Overall Study|Adverse Event|30|||
162712781|NCT02449044|587658581|FG000|Overall Study|Met Withdrawal Criteria|7|||
162972015|NCT01190930|588597964|FG000|Induction|Ineligible|69|||
162972016|NCT01190930|588597965|FG001|Induction|Ineligible|4|||
162972017|NCT01190930|588597966|FG002|Induction|Ineligible|0|||
162972018|NCT01190930|588597967|FG003|Induction|Ineligible|0|||
162972019|NCT01190930|588597968|FG004|Induction|Ineligible|0|||
162972020|NCT01190930|588597969|FG005|Induction|Ineligible|0|||
162923526|NCT03514121|588422151|FG003|Overall Study|Investigator decision|0|||
162923527|NCT03514121|588422152|FG004|Overall Study|Investigator decision|0|||
162972021|NCT01190930|588597970|FG006|Induction|Ineligible|0|||
162972022|NCT01190930|588597971|FG007|Induction|Ineligible|0|||
162972023|NCT01190930|588597972|FG008|Induction|Ineligible|0|||
162972024|NCT01190930|588597973|FG009|Induction|Ineligible|0|||
162972025|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
162972026|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
162972027|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
162972028|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
162972029|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
162972030|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
162972031|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
162972032|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
162972033|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
162972034|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
162972035|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Death|0|||
162972036|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Death|0|||
162972037|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Death|8|||
162972038|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Death|4|||
162972039|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Death|0|||
162972040|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Death|0|||
163057006|NCT01773928|588919765|FG004|Overall Study|Subject misrepresented age|0|||
163057007|NCT01773928|588919766|FG005|Overall Study|Subject misrepresented age|0|||
163057008|NCT01773928|588919767|FG006|Overall Study|Subject misrepresented age|0|||
163057009|NCT01773928|588919768|FG007|Overall Study|Subject misrepresented age|0|||
163057010|NCT01773928|588919769|FG008|Overall Study|Subject misrepresented age|0|||
163057011|NCT01773928|588919761|FG000|Overall Study|Subject met exclusion criteria|0|||
163057012|NCT01773928|588919762|FG001|Overall Study|Subject met exclusion criteria|0|||
163057013|NCT01773928|588919763|FG002|Overall Study|Subject met exclusion criteria|0|||
162972041|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Death|0|||
162972042|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Death|0|||
162972043|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Death|0|||
162972044|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Death|0|||
162972045|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
162972046|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
162972047|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
162972048|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
162972049|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
162972050|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
162972051|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
162972052|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
162972053|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
162972054|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
162972055|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972056|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
162972057|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
162972058|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
162923528|NCT03514121|588422153|FG005|Overall Study|Investigator decision|0|||
162972059|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
163057014|NCT01773928|588919764|FG003|Overall Study|Subject met exclusion criteria|0|||
162923529|NCT03514121|588422154|FG006|Overall Study|Investigator decision|0|||
162923530|NCT03514121|588422155|FG007|Overall Study|Investigator decision|0|||
162923531|NCT03514121|588422156|FG008|Overall Study|Investigator decision|1|||
162923532|NCT03514121|588422157|FG009|Overall Study|Investigator decision|0|||
162923533|NCT00391092|588422158|FG000|Overall Study|Death|78|||
162923534|NCT00391092|588422159|FG001|Overall Study|Death|81|||
162923535|NCT00391092|588422158|FG000|Overall Study|Lost to Follow-up|13|||
162972060|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972061|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972062|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972063|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972064|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
162972065|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Refusal|0|||
162972066|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Refusal|2|||
162972067|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Refusal|694|||
162972068|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Refusal|4|||
162972069|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Refusal|0|||
162972070|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Refusal|3|||
162972071|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Refusal|0|||
162972072|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Refusal|0|||
162972073|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Refusal|0|||
162972074|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Refusal|0|||
162972075|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
162972076|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
162972077|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
162972078|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
162972079|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
162972080|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
162972081|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
162972082|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
162972083|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
162972084|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
162972085|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972086|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
162972087|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972088|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972089|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972090|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972091|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972092|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972093|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972094|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
162972095|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
162972096|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
162972097|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
162972098|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
162972099|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
162972100|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
162972101|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
162972102|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
162972103|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
162972104|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
162972105|NCT01190930|588597964|FG000|Post Induction Pre-Maintenance|Relapse|0|||
162972106|NCT01190930|588597965|FG001|Post Induction Pre-Maintenance|Relapse|0|||
162972107|NCT01190930|588597966|FG002|Post Induction Pre-Maintenance|Relapse|1|||
162972108|NCT01190930|588597967|FG003|Post Induction Pre-Maintenance|Relapse|0|||
162972109|NCT01190930|588597968|FG004|Post Induction Pre-Maintenance|Relapse|0|||
162972110|NCT01190930|588597969|FG005|Post Induction Pre-Maintenance|Relapse|0|||
162972111|NCT01190930|588597970|FG006|Post Induction Pre-Maintenance|Relapse|0|||
162972112|NCT01190930|588597971|FG007|Post Induction Pre-Maintenance|Relapse|0|||
162972113|NCT01190930|588597972|FG008|Post Induction Pre-Maintenance|Relapse|0|||
162972114|NCT01190930|588597973|FG009|Post Induction Pre-Maintenance|Relapse|0|||
162972115|NCT01190930|588597964|FG000|Maintenance|Adverse Event|0|||
162972116|NCT01190930|588597965|FG001|Maintenance|Adverse Event|0|||
163057015|NCT01773928|588919765|FG004|Overall Study|Subject met exclusion criteria|0|||
163057016|NCT01773928|588919766|FG005|Overall Study|Subject met exclusion criteria|0|||
163057017|NCT01773928|588919767|FG006|Overall Study|Subject met exclusion criteria|0|||
162972117|NCT01190930|588597966|FG002|Maintenance|Adverse Event|0|||
162972118|NCT01190930|588597967|FG003|Maintenance|Adverse Event|0|||
162972119|NCT01190930|588597968|FG004|Maintenance|Adverse Event|0|||
162972120|NCT01190930|588597969|FG005|Maintenance|Adverse Event|1|||
162972121|NCT01190930|588597970|FG006|Maintenance|Adverse Event|1|||
163057018|NCT01773928|588919768|FG007|Overall Study|Subject met exclusion criteria|0|||
162972122|NCT01190930|588597971|FG007|Maintenance|Adverse Event|3|||
162972123|NCT01190930|588597972|FG008|Maintenance|Adverse Event|3|||
163057019|NCT01773928|588919769|FG008|Overall Study|Subject met exclusion criteria|1|||
162972124|NCT01190930|588597973|FG009|Maintenance|Adverse Event|0|||
162972125|NCT01190930|588597964|FG000|Maintenance|Death|0|||
162972126|NCT01190930|588597965|FG001|Maintenance|Death|0|||
162972127|NCT01190930|588597966|FG002|Maintenance|Death|0|||
162972128|NCT01190930|588597967|FG003|Maintenance|Death|1|||
162972129|NCT01190930|588597968|FG004|Maintenance|Death|0|||
162972130|NCT01190930|588597969|FG005|Maintenance|Death|0|||
162972131|NCT01190930|588597970|FG006|Maintenance|Death|2|||
162972132|NCT01190930|588597971|FG007|Maintenance|Death|2|||
162972133|NCT01190930|588597972|FG008|Maintenance|Death|2|||
162972134|NCT01190930|588597973|FG009|Maintenance|Death|2|||
162972135|NCT01190930|588597964|FG000|Maintenance|Lost to Follow-up|0|||
162972136|NCT01190930|588597965|FG001|Maintenance|Lost to Follow-up|0|||
163057020|NCT01773928|588919761|FG000|Overall Study|Randomized, had to leave, never returned|0|||
163057021|NCT01773928|588919762|FG001|Overall Study|Randomized, had to leave, never returned|0|||
163057022|NCT01773928|588919763|FG002|Overall Study|Randomized, had to leave, never returned|0|||
163057023|NCT01773928|588919764|FG003|Overall Study|Randomized, had to leave, never returned|1|||
163057024|NCT01773928|588919765|FG004|Overall Study|Randomized, had to leave, never returned|0|||
163057025|NCT01773928|588919766|FG005|Overall Study|Randomized, had to leave, never returned|0|||
163057026|NCT01773928|588919767|FG006|Overall Study|Randomized, had to leave, never returned|0|||
163057027|NCT01773928|588919768|FG007|Overall Study|Randomized, had to leave, never returned|0|||
163057028|NCT01773928|588919769|FG008|Overall Study|Randomized, had to leave, never returned|0|||
163057029|NCT01773928|588919761|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
163057030|NCT01773928|588919762|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
163057031|NCT01773928|588919763|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
163057032|NCT01773928|588919764|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
163057033|NCT01773928|588919765|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
163057034|NCT01773928|588919766|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
163057035|NCT01773928|588919767|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
163057036|NCT01773928|588919768|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
163057037|NCT01773928|588919769|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
163057038|NCT02370511|588919770|FG000|Overall Study|Death|10|||
163057039|NCT02370511|588919771|FG001|Overall Study|Death|7|||
163057040|NCT02370511|588919772|FG002|Overall Study|Death|1|||
163057041|NCT02370511|588919770|FG000|Overall Study|Withdrawal by Subject|2|||
163057042|NCT02370511|588919771|FG001|Overall Study|Withdrawal by Subject|0|||
163057043|NCT02370511|588919772|FG002|Overall Study|Withdrawal by Subject|0|||
163057044|NCT02370511|588919770|FG000|Overall Study|Lost to Follow-up|0|||
163057045|NCT02370511|588919771|FG001|Overall Study|Lost to Follow-up|4|||
163057046|NCT02370511|588919772|FG002|Overall Study|Lost to Follow-up|0|||
163057047|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
163057048|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057049|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057050|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
163057051|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
163057052|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
162972137|NCT01190930|588597966|FG002|Maintenance|Lost to Follow-up|0|||
162972138|NCT01190930|588597967|FG003|Maintenance|Lost to Follow-up|0|||
162972139|NCT01190930|588597968|FG004|Maintenance|Lost to Follow-up|0|||
162972140|NCT01190930|588597969|FG005|Maintenance|Lost to Follow-up|0|||
163057053|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
163057054|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
163057055|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
163057056|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057057|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057058|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
163057059|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
163057060|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
163057061|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
163057062|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
163057063|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
163057064|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057065|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057066|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
163057067|NCT01149655|588919773|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
163057068|NCT01149655|588919774|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
163057069|NCT01149655|588919775|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
162972141|NCT01190930|588597970|FG006|Maintenance|Lost to Follow-up|1|||
162972142|NCT01190930|588597971|FG007|Maintenance|Lost to Follow-up|1|||
162972143|NCT01190930|588597972|FG008|Maintenance|Lost to Follow-up|1|||
163057070|NCT01149655|588919776|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
162972144|NCT01190930|588597973|FG009|Maintenance|Lost to Follow-up|0|||
162972145|NCT01190930|588597964|FG000|Maintenance|Physician Decision|0|||
162972146|NCT01190930|588597965|FG001|Maintenance|Physician Decision|1|||
162972147|NCT01190930|588597966|FG002|Maintenance|Physician Decision|0|||
163057071|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
162923536|NCT00391092|588422159|FG001|Overall Study|Lost to Follow-up|18|||
162923537|NCT00391092|588422158|FG000|Overall Study|Alive on treatment|29|||
162923538|NCT00391092|588422159|FG001|Overall Study|Alive on treatment|33|||
162923539|NCT00391092|588422158|FG000|Overall Study|Alive in follow-up|88|||
162923540|NCT00391092|588422159|FG001|Overall Study|Alive in follow-up|84|||
162923541|NCT02545868|588422164|FG000|Overall Study|Lack of Efficacy|1|||
162923542|NCT02545868|588422165|FG001|Overall Study|Lack of Efficacy|1|||
162923543|NCT02545868|588422166|FG002|Overall Study|Lack of Efficacy|0|||
162923544|NCT02545868|588422164|FG000|Overall Study|Lost to Follow-up|1|||
162923545|NCT02545868|588422165|FG001|Overall Study|Lost to Follow-up|5|||
162923546|NCT02545868|588422166|FG002|Overall Study|Lost to Follow-up|1|||
162923547|NCT02545868|588422164|FG000|Overall Study|Non-compliance|1|||
162923548|NCT02545868|588422165|FG001|Overall Study|Non-compliance|1|||
162923549|NCT02545868|588422166|FG002|Overall Study|Non-compliance|1|||
162923550|NCT02545868|588422164|FG000|Overall Study|Treatment change|21|||
162923551|NCT02545868|588422165|FG001|Overall Study|Treatment change|19|||
162923552|NCT02545868|588422166|FG002|Overall Study|Treatment change|22|||
162923553|NCT02545868|588422164|FG000|Overall Study|Physician Decision|1|||
162923554|NCT02545868|588422165|FG001|Overall Study|Physician Decision|1|||
162923555|NCT02545868|588422166|FG002|Overall Study|Physician Decision|1|||
162923556|NCT02545868|588422164|FG000|Overall Study|Withdrawal by Subject|6|||
162923557|NCT02545868|588422165|FG001|Overall Study|Withdrawal by Subject|7|||
162923558|NCT02545868|588422166|FG002|Overall Study|Withdrawal by Subject|9|||
162923559|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
162923560|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
162923561|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
162923562|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
162923563|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
162923564|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
162923565|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
162923566|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
162923567|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
162923568|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
162923569|NCT01777191|588422167|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
162923570|NCT01777191|588422168|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
162923571|NCT01777191|588422167|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
162630228|NCT00543140|587365083|FG000|Overall Study|Insufficient weight loss|10|||
162630229|NCT00543140|587365083|FG000|Overall Study|SAE leading to explant of SAGB|3|||
162630230|NCT00543140|587365083|FG000|Overall Study|Death|1|||
162630231|NCT00543140|587365083|FG000|Overall Study|Subject moved|1|||
162630232|NCT00543140|587365083|FG000|Overall Study|Conversion to different procedure|1|||
162630233|NCT04532164|587365084|FG000|Overall Study|Adverse Event|1|||
162630234|NCT04532164|587365084|FG000|Overall Study|Protocol Violation|5|||
162630235|NCT04532164|587365084|FG000|Overall Study|Lost to Follow-up|1|||
162630236|NCT04532164|587365084|FG000|Overall Study|Found to be Ineligible|3|||
162630237|NCT04532164|587365084|FG000|Overall Study|Withdrawal by Subject|14|||
162630238|NCT02483520|587365085|FG000|Overall Study|Lost to Follow-up|3|||
162630239|NCT02483520|587365086|FG001|Overall Study|Lost to Follow-up|4|||
162972148|NCT01190930|588597967|FG003|Maintenance|Physician Decision|5|||
162972149|NCT01190930|588597968|FG004|Maintenance|Physician Decision|9|||
162972150|NCT01190930|588597969|FG005|Maintenance|Physician Decision|4|||
162972151|NCT01190930|588597970|FG006|Maintenance|Physician Decision|8|||
162972152|NCT01190930|588597971|FG007|Maintenance|Physician Decision|8|||
162972153|NCT01190930|588597972|FG008|Maintenance|Physician Decision|10|||
162972154|NCT01190930|588597973|FG009|Maintenance|Physician Decision|17|||
162972155|NCT01190930|588597964|FG000|Maintenance|Withdrawal by Subject|0|||
162972156|NCT01190930|588597965|FG001|Maintenance|Withdrawal by Subject|0|||
162972157|NCT01190930|588597966|FG002|Maintenance|Withdrawal by Subject|0|||
162972158|NCT01190930|588597967|FG003|Maintenance|Withdrawal by Subject|0|||
162972159|NCT01190930|588597968|FG004|Maintenance|Withdrawal by Subject|0|||
162972160|NCT01190930|588597969|FG005|Maintenance|Withdrawal by Subject|0|||
162972161|NCT01190930|588597970|FG006|Maintenance|Withdrawal by Subject|2|||
162972162|NCT01190930|588597971|FG007|Maintenance|Withdrawal by Subject|1|||
162972163|NCT01190930|588597972|FG008|Maintenance|Withdrawal by Subject|4|||
162972164|NCT01190930|588597973|FG009|Maintenance|Withdrawal by Subject|1|||
162972165|NCT01190930|588597964|FG000|Maintenance|Refusal|0|||
162972166|NCT01190930|588597965|FG001|Maintenance|Refusal|1|||
162972167|NCT01190930|588597966|FG002|Maintenance|Refusal|0|||
162972168|NCT01190930|588597967|FG003|Maintenance|Refusal|2|||
162972169|NCT01190930|588597968|FG004|Maintenance|Refusal|0|||
162972170|NCT01190930|588597969|FG005|Maintenance|Refusal|4|||
162972171|NCT01190930|588597970|FG006|Maintenance|Refusal|5|||
162972172|NCT01190930|588597971|FG007|Maintenance|Refusal|17|||
162630240|NCT02483520|587365085|FG000|Overall Study|Withdrawal by Subject|4|||
162630241|NCT02483520|587365086|FG001|Overall Study|Withdrawal by Subject|14|||
162630242|NCT02483520|587365085|FG000|Overall Study|Hospitalized|2|||
162923572|NCT01777191|588422168|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
162923573|NCT01777191|588422167|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
162923574|NCT01777191|588422168|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
162923575|NCT01777191|588422167|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
162923576|NCT01777191|588422168|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
162923577|NCT01777191|588422167|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
162923578|NCT01777191|588422168|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
162923579|NCT01777191|588422167|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
162923580|NCT01777191|588422168|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
162923581|NCT03286400|588422173|FG000|Overall Study|Death|10|||
162923582|NCT03286400|588422173|FG000|Overall Study|Lost to Follow-up|10|||
162923583|NCT03286400|588422173|FG000|Overall Study|Physician Decision|1|||
162923584|NCT03286400|588422173|FG000|Overall Study|Scheduling difficulty|4|||
162923585|NCT00568776|588422174|FG000|Overall Study|Adverse Event|8|||
162923586|NCT00568776|588422175|FG001|Overall Study|Adverse Event|8|||
162923587|NCT00568776|588422176|FG002|Overall Study|Adverse Event|10|||
162923588|NCT00568776|588422177|FG003|Overall Study|Adverse Event|8|||
162923589|NCT00568776|588422174|FG000|Overall Study|Death|0|||
162923590|NCT00568776|588422175|FG001|Overall Study|Death|1|||
162923591|NCT00568776|588422176|FG002|Overall Study|Death|4|||
162923592|NCT00568776|588422177|FG003|Overall Study|Death|3|||
162923593|NCT00568776|588422174|FG000|Overall Study|Physician Decision|0|||
162923594|NCT00568776|588422175|FG001|Overall Study|Physician Decision|2|||
162923595|NCT00568776|588422176|FG002|Overall Study|Physician Decision|0|||
162923596|NCT00568776|588422177|FG003|Overall Study|Physician Decision|0|||
162923597|NCT00568776|588422174|FG000|Overall Study|Lack of Efficacy|2|||
162923598|NCT00568776|588422175|FG001|Overall Study|Lack of Efficacy|2|||
162923599|NCT00568776|588422176|FG002|Overall Study|Lack of Efficacy|2|||
162923600|NCT00568776|588422177|FG003|Overall Study|Lack of Efficacy|4|||
162923601|NCT00568776|588422174|FG000|Overall Study|Lost to Follow-up|1|||
162923602|NCT00568776|588422175|FG001|Overall Study|Lost to Follow-up|1|||
162972173|NCT01190930|588597972|FG008|Maintenance|Refusal|13|||
162972174|NCT01190930|588597973|FG009|Maintenance|Refusal|6|||
162972175|NCT01190930|588597964|FG000|Maintenance|second malignant neoplasm|0|||
162630243|NCT02483520|587365086|FG001|Overall Study|Hospitalized|3|||
162923603|NCT00568776|588422176|FG002|Overall Study|Lost to Follow-up|1|||
163057072|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
163057073|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
163057074|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
163057075|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057076|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
163057077|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057078|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
163057079|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
163057080|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
163057081|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
163057082|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
163057083|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057084|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
163057085|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057086|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
163057087|NCT01149655|588919773|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057088|NCT01149655|588919774|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
163057089|NCT01149655|588919775|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057090|NCT01149655|588919776|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
163057091|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
163057092|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
163057093|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
163057094|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
163057095|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057096|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057097|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
163057098|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
163057099|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
163057100|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
163057101|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
163057102|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
163057103|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
163057104|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
163057105|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
163057106|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
163057107|NCT01149655|588919773|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
163057108|NCT01149655|588919774|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
163057109|NCT01149655|588919775|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
163057110|NCT01149655|588919776|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
163057111|NCT03092752|588919779|FG000|Overall Study|Aged <40 years|14209|||
163057112|NCT03092752|588919779|FG000|Overall Study|At least one claim with T2DM|61299|||
163057113|NCT03092752|588919779|FG000|Overall Study|Having no claim of study drugs|29282|||
163057114|NCT03092752|588919779|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
163057115|NCT03092752|588919779|FG000|Overall Study|<6 month history|245900|||
163057116|NCT00921024|588919783|FG000|Overall Study|Lost to Follow-up|2|||
163057117|NCT00921024|588919784|FG001|Overall Study|Lost to Follow-up|0|||
163057118|NCT00921024|588919783|FG000|Overall Study|Received concomittant therapy|2|||
163057119|NCT00921024|588919784|FG001|Overall Study|Received concomittant therapy|0|||
163057120|NCT00921024|588919783|FG000|Overall Study|Withdrawal by Subject|0|||
163057121|NCT00921024|588919784|FG001|Overall Study|Withdrawal by Subject|3|||
163057122|NCT03882918|588919785|FG000|Overall Study|Study terminated by sponsor|98|||
163057123|NCT03882918|588919785|FG000|Overall Study|Protocol Violation|1|||
163057124|NCT03882918|588919785|FG000|Overall Study|Other|9|||
163057125|NCT03882918|588919785|FG000|Overall Study|Lack of Efficacy|14|||
163057126|NCT03882918|588919785|FG000|Overall Study|Adverse Event|13|||
163057127|NCT03882918|588919785|FG000|Overall Study|Withdrawal by Subject|5|||
163057128|NCT06996301|588919786|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
163057129|NCT06996301|588919787|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
162630244|NCT02483520|587365085|FG000|Overall Study|Moved to LTC|2|||
162630245|NCT02483520|587365086|FG001|Overall Study|Moved to LTC|3|||
162630246|NCT01104493|587365089|FG000|Overall Study|Lost to Follow-up|0|||
163057130|NCT06996301|588919786|FG000|Overall Study|Patients with discordant diagnostic results|107|||
163057131|NCT06996301|588919787|FG001|Overall Study|Patients with discordant diagnostic results|90|||
163057132|NCT06996301|588919786|FG000|Overall Study|Lost to Follow-up|31|||
163057133|NCT06996301|588919787|FG001|Overall Study|Lost to Follow-up|56|||
162630247|NCT01104493|587365090|FG001|Overall Study|Lost to Follow-up|2|||
162630248|NCT00743340|587365094|FG000|Overall Study|Study medication non-compliance|1|||
162630249|NCT00743340|587365094|FG000|Overall Study|Lost to Follow-up|1|||
162630250|NCT00743340|587365094|FG000|Overall Study|Withdrawal from the Study|5|||
162630251|NCT00743340|587365094|FG000|Overall Study|Protocol Violation|1|||
162630252|NCT00743340|587365094|FG000|Overall Study|Virologic failure|8|||
162630253|NCT00743340|587365094|FG000|Overall Study|Pregnancy|1|||
162630254|NCT00743340|587365094|FG000|Overall Study|Rolled over to other Gilead Study|23|||
163057134|NCT06996301|588919786|FG000|Overall Study|Withdrawal by Subject|12|||
163057135|NCT06996301|588919787|FG001|Overall Study|Withdrawal by Subject|7|||
163057136|NCT04030598|588919788|FG000|Overall Study|Voluntary Withdrawal|0|||
163057137|NCT04030598|588919789|FG001|Overall Study|Voluntary Withdrawal|1|||
163057138|NCT04030598|588919790|FG002|Overall Study|Voluntary Withdrawal|0|||
163057139|NCT02097823|588919791|FG000|Overall Study|Withdrawal by Subject|1|||
163057140|NCT02097823|588919792|FG001|Overall Study|Withdrawal by Subject|1|||
163057141|NCT01419535|588919793|FG000|Overall Study|could not maintain iv line|1|||
163057142|NCT01419535|588919794|FG001|Overall Study|could not maintain iv line|1|||
163057143|NCT01419535|588919793|FG000|Overall Study|Withdrawal by Subject|0|||
163057144|NCT01419535|588919794|FG001|Overall Study|Withdrawal by Subject|1|||
163057145|NCT02659865|588921180|FG000|Period 1|Withdrawal by Subject|1|||
163057146|NCT02659865|588921181|FG001|Period 1|Withdrawal by Subject|0|||
163057147|NCT02659865|588921182|FG002|Period 1|Withdrawal by Subject|0|||
163057148|NCT02659865|588921183|FG003|Period 1|Withdrawal by Subject|0|||
162630255|NCT00743340|587365094|FG000|Overall Study|Participant Relocated|1|||
162630256|NCT00127660|587365095|FG000|Overall Study|Protocol Violation|3|||
162630257|NCT00127660|587365096|FG001|Overall Study|Protocol Violation|3|||
162630258|NCT00127660|587365097|FG002|Overall Study|Protocol Violation|5|||
162630259|NCT00127660|587365098|FG003|Overall Study|Protocol Violation|0|||
162630260|NCT01987505|587365099|FG000|Overall Study|Other|9|||
162630261|NCT01987505|587365099|FG000|Overall Study|Withdrawal by Subject|2|||
162972176|NCT01190930|588597965|FG001|Maintenance|second malignant neoplasm|0|||
162972177|NCT01190930|588597966|FG002|Maintenance|second malignant neoplasm|0|||
162972178|NCT01190930|588597967|FG003|Maintenance|second malignant neoplasm|1|||
162972179|NCT01190930|588597968|FG004|Maintenance|second malignant neoplasm|0|||
162972180|NCT01190930|588597969|FG005|Maintenance|second malignant neoplasm|1|||
162972181|NCT01190930|588597970|FG006|Maintenance|second malignant neoplasm|0|||
162972182|NCT01190930|588597971|FG007|Maintenance|second malignant neoplasm|0|||
162972183|NCT01190930|588597972|FG008|Maintenance|second malignant neoplasm|1|||
162972184|NCT01190930|588597973|FG009|Maintenance|second malignant neoplasm|0|||
162972185|NCT01190930|588597964|FG000|Maintenance|Inevaluable|0|||
162972186|NCT01190930|588597965|FG001|Maintenance|Inevaluable|0|||
162972187|NCT01190930|588597966|FG002|Maintenance|Inevaluable|0|||
162972188|NCT01190930|588597967|FG003|Maintenance|Inevaluable|0|||
163057149|NCT02659865|588921184|FG004|Period 1|Withdrawal by Subject|0|||
163057150|NCT02659865|588921180|FG000|Period 1|Adverse Event|0|||
163057151|NCT02659865|588921181|FG001|Period 1|Adverse Event|0|||
163057152|NCT02659865|588921182|FG002|Period 1|Adverse Event|0|||
163057153|NCT02659865|588921183|FG003|Period 1|Adverse Event|0|||
163057154|NCT02659865|588921184|FG004|Period 1|Adverse Event|1|||
163057155|NCT02325414|588921185|FG000|Overall Study|Withdrawal by Subject|3|||
162630262|NCT01987505|587365099|FG000|Overall Study|Other Reason|2|||
162972189|NCT01190930|588597968|FG004|Maintenance|Inevaluable|0|||
162972190|NCT01190930|588597969|FG005|Maintenance|Inevaluable|1|||
162972191|NCT01190930|588597970|FG006|Maintenance|Inevaluable|1|||
163057156|NCT02325414|588921186|FG001|Overall Study|Withdrawal by Subject|1|||
163057157|NCT02325414|588921185|FG000|Overall Study|Lost to Follow-up|5|||
163057158|NCT02325414|588921186|FG001|Overall Study|Lost to Follow-up|5|||
162630263|NCT01987505|587365099|FG000|Overall Study|Lost to Follow-up|15|||
162630264|NCT01987505|587365099|FG000|Overall Study|Investigator Decision|2|||
162630265|NCT01987505|587365099|FG000|Overall Study|Death|4|||
162630266|NCT01425281|587365100|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
163057159|NCT02775851|588921189|FG000|Overall Study|Adverse Event|1|||
163057160|NCT02775851|588921190|FG001|Overall Study|Adverse Event|10|||
163057161|NCT02775851|588921189|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
163057162|NCT02775851|588921190|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
163057163|NCT02775851|588921189|FG000|Overall Study|Progression/Relapse|0|||
162972192|NCT01190930|588597971|FG007|Maintenance|Inevaluable|1|||
162972193|NCT01190930|588597972|FG008|Maintenance|Inevaluable|0|||
162972194|NCT01190930|588597973|FG009|Maintenance|Inevaluable|0|||
162972195|NCT01190930|588597964|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
162972196|NCT01190930|588597965|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
162972197|NCT01190930|588597966|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
162972198|NCT01190930|588597967|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
162972199|NCT01190930|588597968|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
162972200|NCT01190930|588597969|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
162972201|NCT01190930|588597970|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
162972202|NCT01190930|588597971|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
162972203|NCT01190930|588597972|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
162972204|NCT01190930|588597973|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
162972205|NCT01190930|588597964|FG000|Maintenance|Relapse|0|||
162972206|NCT01190930|588597965|FG001|Maintenance|Relapse|0|||
162972207|NCT01190930|588597966|FG002|Maintenance|Relapse|0|||
162972208|NCT01190930|588597967|FG003|Maintenance|Relapse|2|||
162972209|NCT01190930|588597968|FG004|Maintenance|Relapse|0|||
162972210|NCT01190930|588597969|FG005|Maintenance|Relapse|1|||
162972211|NCT01190930|588597970|FG006|Maintenance|Relapse|6|||
162972212|NCT01190930|588597971|FG007|Maintenance|Relapse|13|||
162972213|NCT01190930|588597972|FG008|Maintenance|Relapse|11|||
162972214|NCT01190930|588597973|FG009|Maintenance|Relapse|11|||
162972215|NCT01190930|588597964|FG000|Maintenance|Still on therapy|0|||
162972216|NCT01190930|588597965|FG001|Maintenance|Still on therapy|8|||
162972217|NCT01190930|588597966|FG002|Maintenance|Still on therapy|0|||
162972218|NCT01190930|588597967|FG003|Maintenance|Still on therapy|29|||
162972219|NCT01190930|588597968|FG004|Maintenance|Still on therapy|0|||
162972220|NCT01190930|588597969|FG005|Maintenance|Still on therapy|0|||
162972221|NCT01190930|588597970|FG006|Maintenance|Still on therapy|0|||
162972222|NCT01190930|588597971|FG007|Maintenance|Still on therapy|0|||
162972223|NCT01190930|588597972|FG008|Maintenance|Still on therapy|0|||
162972224|NCT01190930|588597973|FG009|Maintenance|Still on therapy|0|||
162972225|NCT05070754|588597980|FG000|Overall Study|Withdrawal by Subject|0|||
162972226|NCT05070754|588597981|FG001|Overall Study|Withdrawal by Subject|0|||
162972227|NCT05070754|588597982|FG002|Overall Study|Withdrawal by Subject|0|||
162972228|NCT05070754|588597983|FG003|Overall Study|Withdrawal by Subject|1|||
162972229|NCT05070754|588597980|FG000|Overall Study|Protocol Violation|0|||
162972230|NCT05070754|588597981|FG001|Overall Study|Protocol Violation|0|||
162972231|NCT05070754|588597982|FG002|Overall Study|Protocol Violation|0|||
162972232|NCT05070754|588597983|FG003|Overall Study|Protocol Violation|1|||
162972233|NCT01398787|588597984|FG000|Overall Study|Adverse Event|1|||
162972234|NCT00529217|588597987|FG000|Overall Study|Lack of Efficacy|2|||
162972235|NCT00529217|588597987|FG000|Overall Study|Unable to adhere to study schedule|2|||
162972236|NCT00372996|588597990|FG000|Overall Study|Death|11|||
162972237|NCT00372996|588597991|FG001|Overall Study|Death|4|||
162972238|NCT00372996|588597992|FG002|Overall Study|Death|8|||
162972239|NCT00372996|588597993|FG003|Overall Study|Death|7|||
162972240|NCT00372996|588597990|FG000|Overall Study|Lost to Follow-up|0|||
162972241|NCT00372996|588597991|FG001|Overall Study|Lost to Follow-up|2|||
162972242|NCT00372996|588597992|FG002|Overall Study|Lost to Follow-up|0|||
162972243|NCT00372996|588597993|FG003|Overall Study|Lost to Follow-up|1|||
162972244|NCT00372996|588597990|FG000|Overall Study|Withdrawal by Subject|12|||
162972245|NCT00372996|588597991|FG001|Overall Study|Withdrawal by Subject|6|||
162972246|NCT00372996|588597992|FG002|Overall Study|Withdrawal by Subject|9|||
162972247|NCT00372996|588597993|FG003|Overall Study|Withdrawal by Subject|5|||
162972248|NCT00372996|588597990|FG000|Overall Study|Study Terminated by Sponsor|4|||
162972249|NCT00372996|588597991|FG001|Overall Study|Study Terminated by Sponsor|0|||
162972250|NCT00372996|588597992|FG002|Overall Study|Study Terminated by Sponsor|4|||
162972251|NCT00372996|588597993|FG003|Overall Study|Study Terminated by Sponsor|0|||
162972252|NCT00372996|588597990|FG000|Overall Study|Other|10|||
162972253|NCT00372996|588597991|FG001|Overall Study|Other|2|||
162972254|NCT00372996|588597992|FG002|Overall Study|Other|7|||
162972255|NCT00372996|588597993|FG003|Overall Study|Other|7|||
162972256|NCT01077258|588598001|FG000|Overall Study|Lost to Follow-up|1390|||
162712782|NCT02449044|587658581|FG000|Overall Study|Physician Decision|9|||
162972257|NCT01077258|588598001|FG000|Overall Study|Adverse drug reaction|218|||
162972258|NCT01077258|588598001|FG000|Overall Study|Lack of Efficacy|663|||
162972259|NCT01077258|588598001|FG000|Overall Study|Clinical remission|37|||
163057164|NCT02775851|588921190|FG001|Overall Study|Progression/Relapse|4|||
163057165|NCT02775851|588921189|FG000|Overall Study|Other - Not Protocol Specified|0|||
162712783|NCT02449044|587658581|FG000|Overall Study|Sponsor Discontinued Trial|3|||
163057166|NCT02775851|588921190|FG001|Overall Study|Other - Not Protocol Specified|7|||
162712784|NCT05298111|587660742|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
162972260|NCT01077258|588598001|FG000|Overall Study|Other reasons|260|||
162972261|NCT00726895|588598002|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162972262|NCT00726895|588598003|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163057167|NCT02775851|588921189|FG000|Overall Study|Withdrawal by Subject|1|||
162972263|NCT01881737|588598005|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
162972264|NCT01881737|588598005|FG000|Overall Study|Withdrawal by Subject|1|||
162972265|NCT01881737|588598005|FG000|Overall Study|Worsening of baseline behavior|1|||
162972266|NCT03496298|588598008|FG000|Overall Study|Adverse Event|49|||
162972267|NCT03496298|588598009|FG001|Overall Study|Adverse Event|68|||
162972268|NCT03496298|588598010|FG002|Overall Study|Adverse Event|79|||
162972269|NCT03496298|588598008|FG000|Overall Study|Study terminated by Sponsor|1050|||
162972270|NCT03496298|588598009|FG001|Overall Study|Study terminated by Sponsor|1063|||
162972271|NCT03496298|588598010|FG002|Overall Study|Study terminated by Sponsor|1071|||
162972272|NCT03496298|588598008|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
162972273|NCT03496298|588598009|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
162972274|NCT03496298|588598010|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
162972275|NCT03496298|588598008|FG000|Overall Study|Withdrawal by Subject|176|||
162972276|NCT03496298|588598009|FG001|Overall Study|Withdrawal by Subject|154|||
162972277|NCT03496298|588598010|FG002|Overall Study|Withdrawal by Subject|151|||
162972278|NCT03496298|588598008|FG000|Overall Study|Other|29|||
162972279|NCT03496298|588598009|FG001|Overall Study|Other|20|||
162972280|NCT03496298|588598010|FG002|Overall Study|Other|23|||
162972281|NCT03496298|588598008|FG000|Overall Study|Randomized and not treated|1|||
162972282|NCT03496298|588598009|FG001|Overall Study|Randomized and not treated|1|||
162972283|NCT03496298|588598010|FG002|Overall Study|Randomized and not treated|1|||
162972284|NCT00676494|588598013|FG000|Overall Study|Missed Visit|8|||
162972285|NCT00676494|588598013|FG000|Overall Study|Withdrawal by Subject|6|||
162972286|NCT02608476|588598014|FG000|Overall Study|Withdrawal by Subject|30|||
162972287|NCT02608476|588598015|FG001|Overall Study|Withdrawal by Subject|37|||
162972288|NCT02608476|588598014|FG000|Overall Study|Lost to Follow-up|24|||
162972289|NCT02608476|588598015|FG001|Overall Study|Lost to Follow-up|24|||
162972290|NCT02608476|588598014|FG000|Overall Study|Adverse Event|2|||
162972291|NCT02608476|588598015|FG001|Overall Study|Adverse Event|8|||
162972292|NCT02608476|588598014|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
162972293|NCT02608476|588598015|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
162972294|NCT02608476|588598014|FG000|Overall Study|Noncompliance with treatment|1|||
162972295|NCT02608476|588598015|FG001|Overall Study|Noncompliance with treatment|5|||
162972296|NCT02608476|588598014|FG000|Overall Study|Lack of Efficacy|3|||
162972297|NCT02608476|588598015|FG001|Overall Study|Lack of Efficacy|1|||
162972298|NCT02608476|588598014|FG000|Overall Study|Other|0|||
162972299|NCT02608476|588598015|FG001|Overall Study|Other|1|||
162972300|NCT02608476|588598014|FG000|Overall Study|Physician Decision|1|||
162972301|NCT02608476|588598015|FG001|Overall Study|Physician Decision|0|||
162972302|NCT02608476|588598014|FG000|Overall Study|Pregnancy|0|||
162972303|NCT02608476|588598015|FG001|Overall Study|Pregnancy|1|||
162972304|NCT02608476|588598014|FG000|Overall Study|Progressive disease|1|||
162972305|NCT02608476|588598015|FG001|Overall Study|Progressive disease|0|||
162972306|NCT02058160|588598016|FG000|Overall Study|Randomized but not treated|2|||
162972307|NCT02058160|588598017|FG001|Overall Study|Randomized but not treated|4|||
162972308|NCT02058160|588598016|FG000|Overall Study|Poor compliance to protocol|4|||
162972309|NCT02058160|588598017|FG001|Overall Study|Poor compliance to protocol|1|||
162972310|NCT02058160|588598016|FG000|Overall Study|Adverse Event|12|||
162972311|NCT02058160|588598017|FG001|Overall Study|Adverse Event|3|||
163057168|NCT02775851|588921190|FG001|Overall Study|Withdrawal by Subject|0|||
163057169|NCT06125964|588921191|FG000|Overall Study|Lost to Follow-up|0|||
162972312|NCT02058160|588598016|FG000|Overall Study|Lost to Follow-up|1|||
162972313|NCT02058160|588598017|FG001|Overall Study|Lost to Follow-up|0|||
162972314|NCT02058160|588598016|FG000|Overall Study|Other than specified above|12|||
162972315|NCT02058160|588598017|FG001|Overall Study|Other than specified above|6|||
162972316|NCT01203917|588598019|FG000|Overall Study|Death|29|||
162972317|NCT01203917|588598019|FG000|Overall Study|Lost to Follow-up|2|||
162972318|NCT01203917|588598019|FG000|Overall Study|Withdrawal by Subject|3|||
162972319|NCT01203917|588598019|FG000|Overall Study|Due to objective disease progression|1|||
162972320|NCT01203917|588598019|FG000|Overall Study|Due to EGFR M+I patient|1|||
162972321|NCT04106817|588598020|FG000|Overall Study|Lost to Follow-up|1|||
162972322|NCT04106817|588598021|FG001|Overall Study|Lost to Follow-up|0|||
162972323|NCT04106817|588598022|FG002|Overall Study|Lost to Follow-up|0|||
162972324|NCT02260635|588598023|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
162972325|NCT02260635|588598024|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
162972326|NCT02260635|588598023|FG000|Open-Label Extension|Study Termination|25|||
162972327|NCT02260635|588598024|FG001|Open-Label Extension|Study Termination|25|||
162972328|NCT02260635|588598023|FG000|Open-Label Extension|Withdrawal by Subject|1|||
162972329|NCT02260635|588598024|FG001|Open-Label Extension|Withdrawal by Subject|0|||
162972330|NCT03310619|588598025|FG000|Pre-Treatment Period|Death|1|||
162972331|NCT03310619|588598026|FG001|Pre-Treatment Period|Death|0|||
162972332|NCT03310619|588598027|FG002|Pre-Treatment Period|Death|0|||
162972333|NCT03310619|588598028|FG003|Pre-Treatment Period|Death|0|||
162972334|NCT03310619|588598029|FG004|Pre-Treatment Period|Death|1|||
162972335|NCT03310619|588598030|FG005|Pre-Treatment Period|Death|0|||
162972336|NCT03310619|588598031|FG006|Pre-Treatment Period|Death|0|||
162972337|NCT03310619|588598032|FG007|Pre-Treatment Period|Death|0|||
162972338|NCT03310619|588598025|FG000|Pre-Treatment Period|Other reasons|2|||
162972339|NCT03310619|588598026|FG001|Pre-Treatment Period|Other reasons|1|||
162972340|NCT03310619|588598027|FG002|Pre-Treatment Period|Other reasons|2|||
162972341|NCT03310619|588598028|FG003|Pre-Treatment Period|Other reasons|0|||
162972342|NCT03310619|588598029|FG004|Pre-Treatment Period|Other reasons|0|||
162972343|NCT03310619|588598030|FG005|Pre-Treatment Period|Other reasons|0|||
162972344|NCT03310619|588598031|FG006|Pre-Treatment Period|Other reasons|2|||
162972345|NCT03310619|588598032|FG007|Pre-Treatment Period|Other reasons|0|||
162972346|NCT03310619|588598025|FG000|Treatment Period|Death|1|||
162972347|NCT03310619|588598026|FG001|Treatment Period|Death|2|||
162972348|NCT03310619|588598027|FG002|Treatment Period|Death|0|||
162972349|NCT03310619|588598028|FG003|Treatment Period|Death|0|||
162972350|NCT03310619|588598029|FG004|Treatment Period|Death|1|||
162972351|NCT03310619|588598030|FG005|Treatment Period|Death|0|||
162972352|NCT03310619|588598031|FG006|Treatment Period|Death|2|||
162972353|NCT03310619|588598032|FG007|Treatment Period|Death|0|||
162972354|NCT03310619|588598025|FG000|Treatment Period|Adverse Event|0|||
162972355|NCT03310619|588598026|FG001|Treatment Period|Adverse Event|1|||
162972356|NCT03310619|588598027|FG002|Treatment Period|Adverse Event|4|||
162972357|NCT03310619|588598028|FG003|Treatment Period|Adverse Event|1|||
162972358|NCT03310619|588598029|FG004|Treatment Period|Adverse Event|0|||
162972359|NCT03310619|588598030|FG005|Treatment Period|Adverse Event|0|||
162972360|NCT03310619|588598031|FG006|Treatment Period|Adverse Event|0|||
162972361|NCT03310619|588598032|FG007|Treatment Period|Adverse Event|0|||
162972362|NCT03310619|588598025|FG000|Treatment Period|Withdrawal by participant|0|||
162972363|NCT03310619|588598026|FG001|Treatment Period|Withdrawal by participant|0|||
162972364|NCT03310619|588598027|FG002|Treatment Period|Withdrawal by participant|1|||
162972365|NCT03310619|588598028|FG003|Treatment Period|Withdrawal by participant|0|||
162972366|NCT03310619|588598029|FG004|Treatment Period|Withdrawal by participant|0|||
162972367|NCT03310619|588598030|FG005|Treatment Period|Withdrawal by participant|0|||
162972368|NCT03310619|588598031|FG006|Treatment Period|Withdrawal by participant|0|||
162972369|NCT03310619|588598032|FG007|Treatment Period|Withdrawal by participant|0|||
162972370|NCT03310619|588598025|FG000|Treatment Period|Lost to Follow-up|0|||
162972371|NCT03310619|588598026|FG001|Treatment Period|Lost to Follow-up|0|||
163057170|NCT06125964|588921192|FG001|Overall Study|Lost to Follow-up|1|||
163057171|NCT06125964|588921193|FG002|Overall Study|Lost to Follow-up|0|||
162972372|NCT03310619|588598027|FG002|Treatment Period|Lost to Follow-up|0|||
162972373|NCT03310619|588598028|FG003|Treatment Period|Lost to Follow-up|0|||
162972374|NCT03310619|588598029|FG004|Treatment Period|Lost to Follow-up|0|||
162972375|NCT03310619|588598030|FG005|Treatment Period|Lost to Follow-up|0|||
162972376|NCT03310619|588598031|FG006|Treatment Period|Lost to Follow-up|0|||
162972377|NCT03310619|588598032|FG007|Treatment Period|Lost to Follow-up|1|||
163057172|NCT06125964|588921194|FG003|Overall Study|Lost to Follow-up|0|||
163057173|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
162972378|NCT03310619|588598025|FG000|Treatment Period|Study terminated by sponsor|0|||
162972379|NCT03310619|588598026|FG001|Treatment Period|Study terminated by sponsor|0|||
162972380|NCT03310619|588598027|FG002|Treatment Period|Study terminated by sponsor|0|||
162972381|NCT03310619|588598028|FG003|Treatment Period|Study terminated by sponsor|0|||
162972382|NCT03310619|588598029|FG004|Treatment Period|Study terminated by sponsor|0|||
162972383|NCT03310619|588598030|FG005|Treatment Period|Study terminated by sponsor|0|||
162972384|NCT03310619|588598031|FG006|Treatment Period|Study terminated by sponsor|0|||
162972385|NCT03310619|588598032|FG007|Treatment Period|Study terminated by sponsor|1|||
162972386|NCT03310619|588598025|FG000|Treatment Period|Physician Decision|0|||
162972387|NCT03310619|588598026|FG001|Treatment Period|Physician Decision|0|||
162972388|NCT03310619|588598027|FG002|Treatment Period|Physician Decision|0|||
162972389|NCT03310619|588598028|FG003|Treatment Period|Physician Decision|0|||
162972390|NCT03310619|588598029|FG004|Treatment Period|Physician Decision|3|||
162972391|NCT03310619|588598030|FG005|Treatment Period|Physician Decision|0|||
162972392|NCT03310619|588598031|FG006|Treatment Period|Physician Decision|0|||
162972393|NCT03310619|588598032|FG007|Treatment Period|Physician Decision|0|||
162972394|NCT03310619|588598025|FG000|Treatment Period|Other reasons|1|||
162972395|NCT03310619|588598026|FG001|Treatment Period|Other reasons|0|||
162972396|NCT03310619|588598027|FG002|Treatment Period|Other reasons|2|||
162972397|NCT03310619|588598028|FG003|Treatment Period|Other reasons|0|||
162972398|NCT03310619|588598029|FG004|Treatment Period|Other reasons|0|||
162972399|NCT03310619|588598030|FG005|Treatment Period|Other reasons|0|||
162972400|NCT03310619|588598031|FG006|Treatment Period|Other reasons|0|||
162972401|NCT03310619|588598032|FG007|Treatment Period|Other reasons|0|||
162972402|NCT00152516|588598037|FG000|Overall Study|Adverse Event|18|||
162972403|NCT00152516|588598037|FG000|Overall Study|Lack and Loss of Efficacy|30|||
162972404|NCT00152516|588598037|FG000|Overall Study|Lost to Follow-up|5|||
162972405|NCT00152516|588598037|FG000|Overall Study|Withdrawal by Subject|8|||
162972406|NCT00152516|588598037|FG000|Overall Study|Protocol Violation|3|||
162972407|NCT00152516|588598037|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
162972408|NCT00152516|588598037|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
162972409|NCT00152516|588598037|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
162972410|NCT00152516|588598037|FG000|Overall Study|Other: Non-Compliance|2|||
162972411|NCT00152516|588598037|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
162972412|NCT00152516|588598037|FG000|Overall Study|Other: Moved Out Of State|1|||
162972413|NCT00152516|588598037|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
162972414|NCT00152516|588598037|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
162972415|NCT04660032|588598040|FG000|Overall Study|Protocol Violation|1|||
162972416|NCT04660032|588598041|FG001|Overall Study|Protocol Violation|1|||
162972417|NCT00090753|588598042|FG000|First Treatment Period|Adverse Event|20|||
162972418|NCT00090753|588598043|FG001|First Treatment Period|Adverse Event|8|||
162972419|NCT00090753|588598042|FG000|First Treatment Period|Death|88|||
162972420|NCT00090753|588598043|FG001|First Treatment Period|Death|62|||
162972421|NCT00090753|588598042|FG000|First Treatment Period|Lack of Efficacy|2|||
162972422|NCT00090753|588598043|FG001|First Treatment Period|Lack of Efficacy|1|||
162972423|NCT00090753|588598042|FG000|First Treatment Period|Refused Treatment|32|||
162972424|NCT00090753|588598043|FG001|First Treatment Period|Refused Treatment|25|||
162972425|NCT00090753|588598042|FG000|First Treatment Period|Lost to Follow-up|4|||
162972426|NCT00090753|588598043|FG001|First Treatment Period|Lost to Follow-up|4|||
162972427|NCT00090753|588598042|FG000|First Treatment Period|Renal Transplant|70|||
162972428|NCT00090753|588598043|FG001|First Treatment Period|Renal Transplant|50|||
162972429|NCT00090753|588598042|FG000|First Treatment Period|Mircera Commercialization|1|||
162972430|NCT00090753|588598043|FG001|First Treatment Period|Mircera Commercialization|0|||
162972431|NCT00090753|588598042|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
162972432|NCT00090753|588598043|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
162972433|NCT00090753|588598042|FG000|Extended Treatment Period|Adverse Event|11|||
162972434|NCT00090753|588598043|FG001|Extended Treatment Period|Adverse Event|0|||
162972435|NCT00090753|588598042|FG000|Extended Treatment Period|Death|58|||
162972436|NCT00090753|588598043|FG001|Extended Treatment Period|Death|30|||
162972437|NCT00090753|588598042|FG000|Extended Treatment Period|Lack of Efficacy|1|||
162972438|NCT00090753|588598043|FG001|Extended Treatment Period|Lack of Efficacy|0|||
162972439|NCT00090753|588598042|FG000|Extended Treatment Period|Refused Treatment|18|||
162972440|NCT00090753|588598043|FG001|Extended Treatment Period|Refused Treatment|12|||
162972441|NCT00090753|588598042|FG000|Extended Treatment Period|Lost to Follow-up|3|||
162972442|NCT00090753|588598043|FG001|Extended Treatment Period|Lost to Follow-up|1|||
162972443|NCT00090753|588598042|FG000|Extended Treatment Period|Renal Transplant|15|||
162972444|NCT00090753|588598043|FG001|Extended Treatment Period|Renal Transplant|12|||
162972445|NCT00090753|588598042|FG000|Extended Treatment Period|Mircera Commercialization|188|||
162972446|NCT00090753|588598043|FG001|Extended Treatment Period|Mircera Commercialization|93|||
162972447|NCT00090753|588598042|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
162972448|NCT00090753|588598043|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
162972449|NCT00756717|588598052|FG000|Overall Study|Withdrawal by Subject|2|||
162972450|NCT03573336|588598053|FG000|Overall Study|Study terminated|2|||
162972451|NCT03573336|588598054|FG001|Overall Study|Study terminated|4|||
162972452|NCT03573336|588598055|FG002|Overall Study|Study terminated|2|||
162972453|NCT03108820|588598056|FG000|Overall Study|Lost to Follow-up|30|||
162972454|NCT03108820|588598057|FG001|Overall Study|Lost to Follow-up|28|||
162972455|NCT03108820|588598056|FG000|Overall Study|Withdrawal by Subject|32|||
162972456|NCT03108820|588598057|FG001|Overall Study|Withdrawal by Subject|24|||
162972457|NCT03108820|588598056|FG000|Overall Study|Death|6|||
162972458|NCT03108820|588598057|FG001|Overall Study|Death|11|||
163057174|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
162972459|NCT01488448|588598059|FG000|Overall Study|Withdrawal by Subject|3|||
162972460|NCT01488448|588598060|FG001|Overall Study|Withdrawal by Subject|1|||
162972461|NCT01488448|588598059|FG000|Overall Study|Adverse Event|9|||
162972462|NCT01488448|588598060|FG001|Overall Study|Adverse Event|4|||
162972463|NCT01488448|588598059|FG000|Overall Study|Physician Decision|4|||
162972464|NCT01488448|588598060|FG001|Overall Study|Physician Decision|9|||
162972465|NCT01488448|588598059|FG000|Overall Study|Protocol Violation|4|||
162972466|NCT01488448|588598060|FG001|Overall Study|Protocol Violation|3|||
162972467|NCT01992094|588598061|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
162972468|NCT01992094|588598062|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
162972469|NCT01992094|588598063|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
162972470|NCT01992094|588598061|FG000|Overall Study|Adverse Event|1|||
162972471|NCT01992094|588598062|FG001|Overall Study|Adverse Event|0|||
162972472|NCT01992094|588598063|FG002|Overall Study|Adverse Event|0|||
162972473|NCT01992094|588598061|FG000|Overall Study|Death|5|||
162972474|NCT01992094|588598062|FG001|Overall Study|Death|5|||
162972475|NCT01992094|588598063|FG002|Overall Study|Death|2|||
162972476|NCT01992094|588598061|FG000|Overall Study|Lost to Follow-up|26|||
162972477|NCT01992094|588598062|FG001|Overall Study|Lost to Follow-up|9|||
162972478|NCT01992094|588598063|FG002|Overall Study|Lost to Follow-up|13|||
162972479|NCT01992094|588598061|FG000|Overall Study|OTHER|4|||
162972480|NCT01992094|588598062|FG001|Overall Study|OTHER|0|||
162972481|NCT01992094|588598063|FG002|Overall Study|OTHER|0|||
162972482|NCT01992094|588598061|FG000|Overall Study|Protocol Violation|1|||
162972483|NCT01992094|588598062|FG001|Overall Study|Protocol Violation|0|||
162972484|NCT01992094|588598063|FG002|Overall Study|Protocol Violation|1|||
162972485|NCT01992094|588598061|FG000|Overall Study|Withdrawal by Subject|7|||
162972486|NCT01992094|588598062|FG001|Overall Study|Withdrawal by Subject|3|||
162972487|NCT01992094|588598063|FG002|Overall Study|Withdrawal by Subject|4|||
162972488|NCT01475487|588598064|FG000|Overall Study|had to leave early for personal reasons|2|||
163057175|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
163057176|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Death|1|||
163057177|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Death|1|||
163057178|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Death|0|||
163057179|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
163057180|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
163057181|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
163057182|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
163057183|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
163057184|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
163057185|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
163057186|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
162923604|NCT00568776|588422177|FG003|Overall Study|Lost to Follow-up|1|||
162923605|NCT00568776|588422174|FG000|Overall Study|Protocol Violation|1|||
162923606|NCT00568776|588422175|FG001|Overall Study|Protocol Violation|0|||
162923607|NCT00568776|588422176|FG002|Overall Study|Protocol Violation|1|||
162923608|NCT00568776|588422177|FG003|Overall Study|Protocol Violation|1|||
162923609|NCT00568776|588422174|FG000|Overall Study|Withdrawal by Subject|13|||
162923610|NCT00568776|588422175|FG001|Overall Study|Withdrawal by Subject|15|||
162923611|NCT00568776|588422176|FG002|Overall Study|Withdrawal by Subject|13|||
162923612|NCT00568776|588422177|FG003|Overall Study|Withdrawal by Subject|7|||
162923613|NCT00568776|588422174|FG000|Overall Study|Loss of Caregiver|0|||
162923614|NCT00568776|588422175|FG001|Overall Study|Loss of Caregiver|2|||
162923615|NCT00568776|588422176|FG002|Overall Study|Loss of Caregiver|1|||
162923616|NCT00568776|588422177|FG003|Overall Study|Loss of Caregiver|2|||
162923617|NCT00568776|588422174|FG000|Overall Study|Sponsor Decision|2|||
162923618|NCT00568776|588422175|FG001|Overall Study|Sponsor Decision|2|||
162923619|NCT00568776|588422176|FG002|Overall Study|Sponsor Decision|41|||
162923620|NCT00568776|588422177|FG003|Overall Study|Sponsor Decision|42|||
162923621|NCT00568776|588422174|FG000|Overall Study|Miscellaeneous|3|||
162923622|NCT00568776|588422175|FG001|Overall Study|Miscellaeneous|3|||
162923623|NCT00568776|588422176|FG002|Overall Study|Miscellaeneous|1|||
162923624|NCT00568776|588422177|FG003|Overall Study|Miscellaeneous|4|||
162923625|NCT01563029|588422178|FG000|Overall Study|Adverse Event|1|||
162923626|NCT01563029|588422179|FG001|Overall Study|Adverse Event|0|||
162923627|NCT01563029|588422180|FG002|Overall Study|Adverse Event|1|||
162923628|NCT01563029|588422181|FG003|Overall Study|Adverse Event|2|||
162923629|NCT01563029|588422182|FG004|Overall Study|Adverse Event|1|||
162923630|NCT01563029|588422178|FG000|Overall Study|Lack of Efficacy|42|||
162972489|NCT01475487|588598065|FG001|Overall Study|had to leave early for personal reasons|1|||
162972490|NCT03168906|588598068|FG000|Overall Study|Lack of Efficacy|6|||
162972491|NCT03168906|588598069|FG001|Overall Study|Lack of Efficacy|6|||
162972492|NCT00434590|588598070|FG000|Overall Study|Administrative problems|5|||
162972493|NCT00434590|588598071|FG001|Overall Study|Administrative problems|5|||
162972494|NCT02839798|588599583|FG000|Overall Study|Withdrawal by Subject|2|||
162972495|NCT03180528|588599584|FG000|Overall Study|Adverse Event|1|||
162972496|NCT03180528|588599584|FG000|Overall Study|Withdrawal by Subject|1|||
162972497|NCT03180528|588599584|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
162972498|NCT02447887|588599585|FG000|Overall Study|Study was terminated|3|||
162972499|NCT03429049|588599586|FG000|Overall Study|Adverse Event|2|||
162972500|NCT03429049|588599587|FG001|Overall Study|Adverse Event|3|||
162972501|NCT03429049|588599586|FG000|Overall Study|Death|0|||
162972502|NCT03429049|588599587|FG001|Overall Study|Death|1|||
162972503|NCT03429049|588599586|FG000|Overall Study|Lack of Efficacy|4|||
162972504|NCT03429049|588599587|FG001|Overall Study|Lack of Efficacy|2|||
162972505|NCT03429049|588599586|FG000|Overall Study|Lost to Follow-up|9|||
162972506|NCT03429049|588599587|FG001|Overall Study|Lost to Follow-up|8|||
162972507|NCT03429049|588599586|FG000|Overall Study|Physician Decision|1|||
162972508|NCT03429049|588599587|FG001|Overall Study|Physician Decision|0|||
162972509|NCT03429049|588599586|FG000|Overall Study|Protocol Violation|3|||
162972510|NCT03429049|588599587|FG001|Overall Study|Protocol Violation|0|||
162712785|NCT05298111|587660743|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
162972511|NCT03429049|588599586|FG000|Overall Study|Sponsor Decision|2|||
162972512|NCT03429049|588599587|FG001|Overall Study|Sponsor Decision|0|||
162972513|NCT03429049|588599586|FG000|Overall Study|Withdrawal by Subject|4|||
162972514|NCT03429049|588599587|FG001|Overall Study|Withdrawal by Subject|20|||
162972515|NCT03429049|588599586|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
162972516|NCT03429049|588599587|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
162972517|NCT04703855|588599588|FG000|Overall Study|Heart Transplant|1|||
162972518|NCT00399893|588599589|FG000|Overall Study|Withdrawal by Subject|1|||
162972519|NCT00399893|588599590|FG001|Overall Study|Withdrawal by Subject|0|||
162972520|NCT04412057|588599591|FG000|Overall Study|Death|3|||
162972521|NCT04412057|588599592|FG001|Overall Study|Death|7|||
162972522|NCT04412057|588599591|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
162972523|NCT04412057|588599592|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
162972524|NCT02457819|588599593|FG000|Overall Study|reason not given|8|||
162972525|NCT02457819|588599593|FG000|Overall Study|Withdrawal by Subject|24|||
162972526|NCT02457819|588599593|FG000|Overall Study|Protocol Violation|1|||
162972527|NCT02457819|588599593|FG000|Overall Study|non compliance with study drug|4|||
162972528|NCT02457819|588599593|FG000|Overall Study|Lost to Follow-up|10|||
162972529|NCT02457819|588599593|FG000|Overall Study|Lack of Efficacy|19|||
162972530|NCT02457819|588599593|FG000|Overall Study|Adverse Event|33|||
162972531|NCT01064531|588599596|FG000|Overall Study|Lost to Follow-up|0|||
162972532|NCT01064531|588599597|FG001|Overall Study|Lost to Follow-up|2|||
162972533|NCT01064531|588599596|FG000|Overall Study|Physician Decision|0|||
162972534|NCT01064531|588599597|FG001|Overall Study|Physician Decision|1|||
162972535|NCT01064531|588599596|FG000|Overall Study|Withdrawal by Subject|2|||
162972536|NCT01064531|588599597|FG001|Overall Study|Withdrawal by Subject|2|||
162972537|NCT01064531|588599596|FG000|Overall Study|Revision due to femoral stem loosening|1|||
162972538|NCT01064531|588599597|FG001|Overall Study|Revision due to femoral stem loosening|0|||
162972539|NCT01064531|588599596|FG000|Overall Study|Revision due to dislocation|0|||
162972540|NCT01064531|588599597|FG001|Overall Study|Revision due to dislocation|1|||
162972541|NCT01064531|588599596|FG000|Overall Study|Death|0|||
162972542|NCT01064531|588599597|FG001|Overall Study|Death|1|||
162972543|NCT03136406|588599601|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
162972544|NCT01201759|588599602|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
162972545|NCT01201759|588599603|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
162972546|NCT01201759|588599602|FG000|Visit 3 - Washout|Adverse Event|0|||
162972547|NCT01201759|588599603|FG001|Visit 3 - Washout|Adverse Event|3|||
162972548|NCT01201759|588599602|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
162712786|NCT00109967|587660748|FG000|Overall Study|Cancel Prior to Treatment|2|||
162972549|NCT01201759|588599603|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
162972550|NCT01201759|588599602|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
162972551|NCT01201759|588599603|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
162972552|NCT00906373|588599604|FG000|Overall Study|Withdrawal by Subject|0|||
162972553|NCT00906373|588599605|FG001|Overall Study|Withdrawal by Subject|5|||
162972554|NCT00906373|588599604|FG000|Overall Study|Other|0|||
162972555|NCT00906373|588599605|FG001|Overall Study|Other|1|||
162972556|NCT00906373|588599604|FG000|Overall Study|Still on treatment at cutoff date|0|||
162972557|NCT00906373|588599605|FG001|Overall Study|Still on treatment at cutoff date|2|||
162972558|NCT02418455|588599608|FG000|48-Week Treatment Period|Other- Not Specified|1|||
162972559|NCT02418455|588599608|FG000|Continuation Period|Sponsor Decision|7|||
162972560|NCT02001051|588599611|FG000|Overall Study|Deemed not eligible following enrollment|0|||
162972561|NCT02001051|588599612|FG001|Overall Study|Deemed not eligible following enrollment|1|||
162630267|NCT01425281|587365101|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
162630268|NCT01425281|587365100|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
162972562|NCT04205162|588599622|FG000|Overall Study|Lost to Follow-up|1|||
162972563|NCT04205162|588599623|FG001|Overall Study|Lost to Follow-up|0|||
162972564|NCT04205162|588599622|FG000|Overall Study|Withdrawal by Subject|2|||
162972565|NCT04205162|588599623|FG001|Overall Study|Withdrawal by Subject|0|||
162972566|NCT04205162|588599622|FG000|Overall Study|University closure due to COVID-19|1|||
162972567|NCT04205162|588599623|FG001|Overall Study|University closure due to COVID-19|0|||
162972568|NCT01999894|588599624|FG000|Overall Study|Adverse Event|9|||
162972569|NCT01999894|588599624|FG000|Overall Study|Lack of Efficacy|5|||
162972570|NCT01999894|588599624|FG000|Overall Study|Protocol Violation|1|||
162972571|NCT01999894|588599624|FG000|Overall Study|Withdrawal by Subject|7|||
162972572|NCT01999894|588599624|FG000|Overall Study|Lost to Follow-up|10|||
162972573|NCT01999894|588599624|FG000|Overall Study|Other Reason|3|||
162972574|NCT01999894|588599624|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
162972575|NCT01546519|588599626|FG000|Overall Study|Adverse Event|0|||
162972576|NCT01546519|588599627|FG001|Overall Study|Adverse Event|0|||
162972577|NCT01546519|588599628|FG002|Overall Study|Adverse Event|1|||
162972578|NCT01546519|588599629|FG003|Overall Study|Adverse Event|1|||
162972579|NCT01546519|588599626|FG000|Overall Study|Death|0|||
162972580|NCT01546519|588599627|FG001|Overall Study|Death|1|||
162972581|NCT01546519|588599628|FG002|Overall Study|Death|3|||
162972582|NCT01546519|588599629|FG003|Overall Study|Death|1|||
162972583|NCT01546519|588599626|FG000|Overall Study|related to disease progression|2|||
162972584|NCT01546519|588599627|FG001|Overall Study|related to disease progression|2|||
162972585|NCT01546519|588599628|FG002|Overall Study|related to disease progression|2|||
162972586|NCT01546519|588599629|FG003|Overall Study|related to disease progression|1|||
162972587|NCT01546519|588599626|FG000|Overall Study|Physician Decision|6|||
162972588|NCT01546519|588599627|FG001|Overall Study|Physician Decision|5|||
162972589|NCT01546519|588599628|FG002|Overall Study|Physician Decision|2|||
162972590|NCT01546519|588599629|FG003|Overall Study|Physician Decision|3|||
162972591|NCT01546519|588599626|FG000|Overall Study|Withdrawal by Subject|1|||
162972592|NCT01546519|588599627|FG001|Overall Study|Withdrawal by Subject|0|||
162972593|NCT01546519|588599628|FG002|Overall Study|Withdrawal by Subject|0|||
162972594|NCT01546519|588599629|FG003|Overall Study|Withdrawal by Subject|0|||
162972595|NCT00779402|588599630|FG000|Treatment Phase 1|Disease Progression|1|||
162972596|NCT00779402|588599631|FG001|Treatment Phase 1|Disease Progression|0|||
162972597|NCT00779402|588599630|FG000|Treatment Phase 1|Adverse Event|2|||
162972598|NCT00779402|588599631|FG001|Treatment Phase 1|Adverse Event|0|||
162972599|NCT00779402|588599630|FG000|Treatment Phase 1|Protocol Violation|1|||
162972600|NCT00779402|588599631|FG001|Treatment Phase 1|Protocol Violation|0|||
162972601|NCT00779402|588599630|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
162972602|NCT00779402|588599631|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
162972603|NCT00779402|588599630|FG000|Treatment Phase 1|Lost to Follow-up|0|||
162972604|NCT00779402|588599631|FG001|Treatment Phase 1|Lost to Follow-up|1|||
162972605|NCT00779402|588599630|FG000|Treatment Phase 1|Death|0|||
162972606|NCT00779402|588599631|FG001|Treatment Phase 1|Death|1|||
162972607|NCT00779402|588599630|FG000|Treatment Phase 1|Intercurrent Illness|1|||
162972608|NCT00779402|588599631|FG001|Treatment Phase 1|Intercurrent Illness|1|||
162972609|NCT00779402|588599630|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
162972610|NCT00779402|588599631|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
162972611|NCT00779402|588599630|FG000|Treatment Phase 1|Other|4|||
162972612|NCT00779402|588599631|FG001|Treatment Phase 1|Other|2|||
162972613|NCT00779402|588599630|FG000|Treatment Phase 1|Closure of Study|3|||
162972614|NCT00779402|588599631|FG001|Treatment Phase 1|Closure of Study|2|||
162972615|NCT00779402|588599630|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
162972616|NCT00779402|588599631|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
162972617|NCT00779402|588599630|FG000|Surveillance Phase|Protocol Violation|0|||
162972618|NCT00779402|588599631|FG001|Surveillance Phase|Protocol Violation|1|||
162972619|NCT00779402|588599630|FG000|Surveillance Phase|Patient refused to continue|22|||
162630269|NCT01425281|587365101|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
162630270|NCT01425281|587365100|FG000|At 180-day Clinical Follow-up|Death|0|||
162630271|NCT01425281|587365101|FG001|At 180-day Clinical Follow-up|Death|1|||
162972620|NCT00779402|588599631|FG001|Surveillance Phase|Patient refused to continue|14|||
162972621|NCT00779402|588599630|FG000|Surveillance Phase|Lost to Follow-up|2|||
162972622|NCT00779402|588599631|FG001|Surveillance Phase|Lost to Follow-up|1|||
162972623|NCT00779402|588599630|FG000|Surveillance Phase|Death|0|||
162972624|NCT00779402|588599631|FG001|Surveillance Phase|Death|1|||
162972625|NCT00779402|588599630|FG000|Surveillance Phase|Intercurrent Illness|2|||
162972626|NCT00779402|588599631|FG001|Surveillance Phase|Intercurrent Illness|0|||
162972627|NCT00779402|588599630|FG000|Surveillance Phase|Other|5|||
162972628|NCT00779402|588599631|FG001|Surveillance Phase|Other|5|||
162972629|NCT00779402|588599630|FG000|Surveillance Phase|Withdrawal by Subject|4|||
162972630|NCT00779402|588599631|FG001|Surveillance Phase|Withdrawal by Subject|1|||
162972631|NCT00779402|588599630|FG000|Surveillance Phase|Closure of study|5|||
162972632|NCT00779402|588599631|FG001|Surveillance Phase|Closure of study|6|||
163057187|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
163057188|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
163057189|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
163057190|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
163057191|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
163057192|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
163057193|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
163057194|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
163057195|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
163057196|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
163057197|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
163057198|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
163057199|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
163057200|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
163057201|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
163057202|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
163057203|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Other|10|||
163057204|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Other|4|||
163057205|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Other|0|||
163057206|NCT04006457|588921195|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
163057207|NCT04006457|588921196|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
163057208|NCT04006457|588921197|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
163057209|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
163057210|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
163057211|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
163057212|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
163057213|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
163057214|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
163057215|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
163057216|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
163057217|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
163057218|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
163057219|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
163057220|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
163057221|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
163057222|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
163057223|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
163057224|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Other|2|||
163057225|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Other|3|||
163057226|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Other|0|||
163057227|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
163057228|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
163057229|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
163057230|NCT04006457|588921195|FG000|Main Study: Treatment Period 2|Ongoing|86|||
163057231|NCT04006457|588921196|FG001|Main Study: Treatment Period 2|Ongoing|96|||
163057232|NCT04006457|588921197|FG002|Main Study: Treatment Period 2|Ongoing|0|||
163057233|NCT04006457|588921195|FG000|Main Study Observation Period|Adverse Event|1|||
163057234|NCT04006457|588921196|FG001|Main Study Observation Period|Adverse Event|1|||
163057235|NCT04006457|588921197|FG002|Main Study Observation Period|Adverse Event|0|||
163057236|NCT04006457|588921195|FG000|Main Study Observation Period|Lost to Follow-up|0|||
163057237|NCT04006457|588921196|FG001|Main Study Observation Period|Lost to Follow-up|1|||
163057238|NCT04006457|588921197|FG002|Main Study Observation Period|Lost to Follow-up|0|||
163057239|NCT04006457|588921195|FG000|Main Study Observation Period|Pregnancy|1|||
163057240|NCT04006457|588921196|FG001|Main Study Observation Period|Pregnancy|0|||
163057241|NCT04006457|588921197|FG002|Main Study Observation Period|Pregnancy|0|||
163057242|NCT04006457|588921195|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
163057243|NCT04006457|588921196|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
163057244|NCT04006457|588921197|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
163057245|NCT04006457|588921195|FG000|Main Study Observation Period|Other|8|||
163057246|NCT04006457|588921196|FG001|Main Study Observation Period|Other|16|||
163057247|NCT04006457|588921197|FG002|Main Study Observation Period|Other|0|||
163057248|NCT04006457|588921195|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
163057249|NCT04006457|588921196|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
163057250|NCT04006457|588921197|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
163057251|NCT04006457|588921195|FG000|Main Study Observation Period|Ongoing|2|||
162972633|NCT00779402|588599630|FG000|Surveillance Phase|Completed Protocol Visits|3|||
162972634|NCT00779402|588599631|FG001|Surveillance Phase|Completed Protocol Visits|2|||
162972635|NCT00779402|588599630|FG000|Long-term Follow-up|Patient refused to continue|2|||
162972636|NCT00779402|588599631|FG001|Long-term Follow-up|Patient refused to continue|0|||
162972637|NCT00779402|588599630|FG000|Long-term Follow-up|Other|5|||
162972638|NCT00779402|588599631|FG001|Long-term Follow-up|Other|0|||
162972639|NCT00779402|588599630|FG000|Long-term Follow-up|Closure of Study|8|||
162972640|NCT00779402|588599631|FG001|Long-term Follow-up|Closure of Study|4|||
162972641|NCT00779402|588599630|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
162972642|NCT00779402|588599631|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
162972643|NCT01519947|588599632|FG000|Overall Study|Death|0|||
162972644|NCT01519947|588599633|FG001|Overall Study|Death|0|||
162972645|NCT01519947|588599634|FG002|Overall Study|Death|0|||
162972646|NCT01519947|588599635|FG003|Overall Study|Death|1|||
162972647|NCT01519947|588599632|FG000|Overall Study|Protocol Violation|0|||
162972648|NCT01519947|588599633|FG001|Overall Study|Protocol Violation|0|||
162972649|NCT01519947|588599634|FG002|Overall Study|Protocol Violation|2|||
162972650|NCT01519947|588599635|FG003|Overall Study|Protocol Violation|1|||
162972651|NCT01519947|588599632|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
162972652|NCT01519947|588599633|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
162972653|NCT01519947|588599634|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
162972654|NCT01519947|588599635|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
162972655|NCT01519947|588599632|FG000|Overall Study|Development of Anemia|0|||
162972656|NCT01519947|588599633|FG001|Overall Study|Development of Anemia|1|||
162972657|NCT01519947|588599634|FG002|Overall Study|Development of Anemia|0|||
162972658|NCT01519947|588599635|FG003|Overall Study|Development of Anemia|1|||
162972659|NCT01519947|588599632|FG000|Overall Study|Blood Transfusion|0|||
162972660|NCT01519947|588599633|FG001|Overall Study|Blood Transfusion|1|||
162972661|NCT01519947|588599634|FG002|Overall Study|Blood Transfusion|1|||
162972662|NCT01519947|588599635|FG003|Overall Study|Blood Transfusion|0|||
162972663|NCT01519947|588599632|FG000|Overall Study|Withdrawal by Subject|0|||
162972664|NCT01519947|588599633|FG001|Overall Study|Withdrawal by Subject|1|||
162972665|NCT01519947|588599634|FG002|Overall Study|Withdrawal by Subject|0|||
162972666|NCT01519947|588599635|FG003|Overall Study|Withdrawal by Subject|1|||
162972667|NCT01519947|588599632|FG000|Overall Study|Lost to Follow-up|0|||
162972668|NCT01519947|588599633|FG001|Overall Study|Lost to Follow-up|0|||
162972669|NCT01519947|588599634|FG002|Overall Study|Lost to Follow-up|3|||
162972670|NCT01519947|588599635|FG003|Overall Study|Lost to Follow-up|2|||
162972671|NCT01519947|588599632|FG000|Overall Study|Poor Response|1|||
162972672|NCT01519947|588599633|FG001|Overall Study|Poor Response|0|||
162972673|NCT01519947|588599634|FG002|Overall Study|Poor Response|0|||
162972674|NCT01519947|588599635|FG003|Overall Study|Poor Response|1|||
162972675|NCT01519947|588599632|FG000|Overall Study|Adverse Event|1|||
162972676|NCT01519947|588599633|FG001|Overall Study|Adverse Event|0|||
162972677|NCT01519947|588599634|FG002|Overall Study|Adverse Event|1|||
162972678|NCT01519947|588599635|FG003|Overall Study|Adverse Event|1|||
162972679|NCT00693225|588599636|FG000|Overall Study|Lost to Follow-up|1|||
162972680|NCT00693225|588599637|FG001|Overall Study|Lost to Follow-up|2|||
162972681|NCT00693225|588599636|FG000|Overall Study|Adverse Event|1|||
162972682|NCT00693225|588599637|FG001|Overall Study|Adverse Event|3|||
162972683|NCT01186016|588599640|FG000|Overall Study|Withdrawal by Subject|46|||
162972684|NCT01186016|588599641|FG001|Overall Study|Withdrawal by Subject|29|||
162972685|NCT03750695|588599643|FG000|Overall Study|Lost to Follow-up|0|||
162972686|NCT03750695|588599644|FG001|Overall Study|Lost to Follow-up|1|||
162972687|NCT03173560|588599645|FG000|Overall Study|Death|70|||
162972688|NCT03173560|588599646|FG001|Overall Study|Death|60|||
162972689|NCT03173560|588599645|FG000|Overall Study|Lost to Follow-up|1|||
162972690|NCT03173560|588599646|FG001|Overall Study|Lost to Follow-up|4|||
162972691|NCT03173560|588599645|FG000|Overall Study|Withdrawal by Subject|10|||
162972692|NCT03173560|588599646|FG001|Overall Study|Withdrawal by Subject|5|||
162972693|NCT03173560|588599645|FG000|Overall Study|Other|0|||
162972694|NCT03173560|588599646|FG001|Overall Study|Other|1|||
162972695|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
162972696|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972697|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972698|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
162972699|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972700|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972701|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
162972702|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
162972703|NCT02174276|588599647|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
162972704|NCT02174276|588599648|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
162972705|NCT02174276|588599649|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
162972706|NCT02174276|588599650|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
162972707|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
162972708|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
162972709|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
162972710|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
162972711|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972712|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972713|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
162972714|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
162972715|NCT02174276|588599647|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
162972716|NCT02174276|588599648|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
162972717|NCT02174276|588599649|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
162972718|NCT02174276|588599650|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
162972719|NCT02661022|588599653|FG000|Overall Study|Withdrawal by Subject|3|||
162972720|NCT02661022|588599654|FG001|Overall Study|Withdrawal by Subject|0|||
162972721|NCT02661022|588599653|FG000|Overall Study|Adverse Event|1|||
162972722|NCT02661022|588599654|FG001|Overall Study|Adverse Event|1|||
162972723|NCT02661022|588599653|FG000|Overall Study|Physician Decision|1|||
162972724|NCT02661022|588599654|FG001|Overall Study|Physician Decision|0|||
162972725|NCT02661022|588599653|FG000|Overall Study|Progressive Disease|2|||
162972726|NCT02661022|588599654|FG001|Overall Study|Progressive Disease|1|||
162972727|NCT00725764|588599656|FG000|Overall Study|Withdrawal by Subject|2|||
162972728|NCT00725764|588599656|FG000|Overall Study|Physician Decision|1|||
162972729|NCT00725764|588599656|FG000|Overall Study|Progressive Disease|7|||
162972730|NCT00725764|588599656|FG000|Overall Study|Lost to Follow-up|1|||
162972731|NCT00725764|588599656|FG000|Overall Study|Death|1|||
162972732|NCT00725764|588599656|FG000|Overall Study|Participant non compliant with protocol|1|||
162972733|NCT00725764|588599656|FG000|Overall Study|Decline in performance status|1|||
162972734|NCT04480307|588599657|FG000|Overall Study|Withdrawal by Subject|0|||
162972735|NCT04480307|588599658|FG001|Overall Study|Withdrawal by Subject|1|||
162972736|NCT04480307|588599659|FG002|Overall Study|Withdrawal by Subject|0|||
162972737|NCT04480307|588599660|FG003|Overall Study|Withdrawal by Subject|0|||
162972738|NCT04480307|588599657|FG000|Overall Study|Adverse Event|0|||
162972739|NCT04480307|588599658|FG001|Overall Study|Adverse Event|0|||
162972740|NCT04480307|588599659|FG002|Overall Study|Adverse Event|0|||
162972741|NCT04480307|588599660|FG003|Overall Study|Adverse Event|1|||
162972742|NCT00609154|588599661|FG000|Overall Study|Protocol Violation|1|||
162972743|NCT00609154|588599662|FG001|Overall Study|Protocol Violation|2|||
162972744|NCT00609154|588599661|FG000|Overall Study|Unable to establish IV access|0|||
162972745|NCT00609154|588599662|FG001|Overall Study|Unable to establish IV access|4|||
162972746|NCT00609154|588599661|FG000|Overall Study|Adverse Event|0|||
162972747|NCT00609154|588599662|FG001|Overall Study|Adverse Event|2|||
162972748|NCT00434837|588599665|FG000|Overall Study|Lost to Follow-up|20|||
162972749|NCT00434837|588599666|FG001|Overall Study|Lost to Follow-up|23|||
162972750|NCT00434837|588599667|FG002|Overall Study|Lost to Follow-up|30|||
162972751|NCT03023137|588599669|FG000|Overall Study|Multiple pregnancy|2|||
162972752|NCT03023137|588599670|FG001|Overall Study|Multiple pregnancy|4|||
162972753|NCT03023137|588599669|FG000|Overall Study|Lost to Follow-up|1|||
162972754|NCT03023137|588599670|FG001|Overall Study|Lost to Follow-up|1|||
162972755|NCT03023137|588599669|FG000|Overall Study|Protocol Violation|0|||
162972756|NCT03023137|588599670|FG001|Overall Study|Protocol Violation|4|||
162972757|NCT03023137|588599669|FG000|Overall Study|Lost the baby in a car accident|1|||
162972758|NCT03023137|588599670|FG001|Overall Study|Lost the baby in a car accident|0|||
162972759|NCT01450800|588599671|FG000|Overall Study|Protocol Violation|1|||
162972760|NCT01450800|588599672|FG001|Overall Study|Protocol Violation|3|||
162972761|NCT00250705|588599681|FG000|Overall Study|Lack of Efficacy|2|||
162972762|NCT00587431|588599682|FG000|Overall Study|Adverse Event|1|||
162972763|NCT00587431|588599683|FG001|Overall Study|Adverse Event|0|||
162972764|NCT00587431|588599682|FG000|Overall Study|Withdrawal by Subject|0|||
162972765|NCT00587431|588599683|FG001|Overall Study|Withdrawal by Subject|1|||
162972766|NCT05467982|588599684|FG000|Overall Study|Death|0|||
162972767|NCT05467982|588599685|FG001|Overall Study|Death|1|||
162972768|NCT05467982|588599684|FG000|Overall Study|Lost to Follow-up|3|||
162972769|NCT05467982|588599685|FG001|Overall Study|Lost to Follow-up|1|||
162972770|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
162972771|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
162972772|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
162972773|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
162972774|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
162972775|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
162972776|NCT03507686|588599694|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
162972777|NCT03507686|588599695|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
162972778|NCT03507686|588599694|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
162972779|NCT03507686|588599695|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
162972780|NCT03507686|588599694|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
162972781|NCT03507686|588599695|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
162972782|NCT00585312|588599696|FG000|Overall Study|Adverse Event|3|||
162972783|NCT00585312|588599697|FG001|Overall Study|Adverse Event|0|||
162972784|NCT00585312|588599696|FG000|Overall Study|Lack of Efficacy|6|||
162972785|NCT00585312|588599697|FG001|Overall Study|Lack of Efficacy|11|||
162972786|NCT00585312|588599696|FG000|Overall Study|Lost to Follow-up|1|||
162972787|NCT00585312|588599697|FG001|Overall Study|Lost to Follow-up|1|||
162972788|NCT00585312|588599696|FG000|Overall Study|Reason not specified|2|||
162972789|NCT00585312|588599697|FG001|Overall Study|Reason not specified|0|||
162972790|NCT00585312|588599696|FG000|Overall Study|Withdrawal by Subject|5|||
162972791|NCT00585312|588599697|FG001|Overall Study|Withdrawal by Subject|1|||
162972792|NCT00585312|588599696|FG000|Overall Study|Study terminated by the sponsor|34|||
162972793|NCT00585312|588599697|FG001|Overall Study|Study terminated by the sponsor|31|||
162972794|NCT01263561|588599698|FG000|Overall Study|Death|1|||
162972795|NCT01263561|588599699|FG001|Overall Study|Death|2|||
162972796|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
162972797|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
162972798|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
162972799|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
162972800|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
162972801|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
162972802|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
162972803|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
162972804|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
162972805|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
162972806|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
162972807|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
162972808|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
162972809|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
162972810|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972811|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972812|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
162972813|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
162972814|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972815|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972816|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
162972817|NCT00879684|588599700|FG000|Stage 1: Dose Escalation|Death|0|||
162972818|NCT00879684|588599701|FG001|Stage 1: Dose Escalation|Death|0|||
162972819|NCT00879684|588599702|FG002|Stage 1: Dose Escalation|Death|1|||
162972820|NCT00879684|588599703|FG003|Stage 1: Dose Escalation|Death|0|||
162972821|NCT00879684|588599704|FG004|Stage 1: Dose Escalation|Death|0|||
162972822|NCT00879684|588599705|FG005|Stage 1: Dose Escalation|Death|0|||
162972823|NCT00879684|588599706|FG006|Stage 1: Dose Escalation|Death|0|||
162972824|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972825|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972826|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972827|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972828|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972829|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
162972830|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
162972831|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972832|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972833|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972834|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972835|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972836|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
162972837|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
162972838|NCT00879684|588599700|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972839|NCT00879684|588599701|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972840|NCT00879684|588599702|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972841|NCT00879684|588599703|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972842|NCT00879684|588599704|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972843|NCT00879684|588599705|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
162972844|NCT00879684|588599706|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
162972845|NCT03185741|588599711|FG000|Baseline|Withdrawal by Subject|1|||
162972846|NCT03185741|588599712|FG001|Baseline|Withdrawal by Subject|3|||
162972847|NCT03185741|588599713|FG002|Baseline|Withdrawal by Subject|2|||
162972848|NCT03185741|588599711|FG000|Baseline|Lost to Follow-up|1|||
163057252|NCT04006457|588921196|FG001|Main Study Observation Period|Ongoing|1|||
163057253|NCT04006457|588921197|FG002|Main Study Observation Period|Ongoing|0|||
162972849|NCT03185741|588599712|FG001|Baseline|Lost to Follow-up|2|||
162972850|NCT03185741|588599713|FG002|Baseline|Lost to Follow-up|3|||
162972851|NCT03185741|588599711|FG000|3Month|Death|1|||
162972852|NCT03185741|588599712|FG001|3Month|Death|1|||
162972853|NCT03185741|588599713|FG002|3Month|Death|2|||
162972854|NCT03185741|588599711|FG000|3Month|Withdrawal by Subject|1|||
163057254|NCT04006457|588921195|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
162972855|NCT03185741|588599712|FG001|3Month|Withdrawal by Subject|5|||
162972856|NCT03185741|588599713|FG002|3Month|Withdrawal by Subject|1|||
162972857|NCT03185741|588599711|FG000|3Month|Lost to Follow-up|7|||
162972858|NCT03185741|588599712|FG001|3Month|Lost to Follow-up|9|||
162972859|NCT03185741|588599713|FG002|3Month|Lost to Follow-up|8|||
162972860|NCT03185741|588599711|FG000|3Month|Unavailable for 3Month|11|||
162972861|NCT03185741|588599712|FG001|3Month|Unavailable for 3Month|10|||
162972862|NCT03185741|588599713|FG002|3Month|Unavailable for 3Month|11|||
162972863|NCT03185741|588599711|FG000|3Month|Protocol Violation|0|||
162972864|NCT03185741|588599712|FG001|3Month|Protocol Violation|0|||
162972865|NCT03185741|588599713|FG002|3Month|Protocol Violation|3|||
162972866|NCT03185741|588599711|FG000|6Month|Death|1|||
162972867|NCT03185741|588599712|FG001|6Month|Death|1|||
162972868|NCT03185741|588599713|FG002|6Month|Death|2|||
162972869|NCT03185741|588599711|FG000|6Month|Withdrawal by Subject|2|||
162972870|NCT03185741|588599712|FG001|6Month|Withdrawal by Subject|3|||
162972871|NCT03185741|588599713|FG002|6Month|Withdrawal by Subject|1|||
162972872|NCT03185741|588599711|FG000|6Month|Lost to Follow-up|16|||
162972873|NCT03185741|588599712|FG001|6Month|Lost to Follow-up|15|||
162972874|NCT03185741|588599713|FG002|6Month|Lost to Follow-up|16|||
162972875|NCT00654641|588599720|FG000|Overall Study|Lost to Follow-up|2|||
162972876|NCT00654641|588599721|FG001|Overall Study|Lost to Follow-up|3|||
162972877|NCT01214239|588599722|FG000|Overall Study|Adverse Event|3|||
162972878|NCT01214239|588599723|FG001|Overall Study|Adverse Event|4|||
162972879|NCT01214239|588599722|FG000|Overall Study|Protocol Violation|2|||
162972880|NCT01214239|588599723|FG001|Overall Study|Protocol Violation|1|||
162972881|NCT01214239|588599722|FG000|Overall Study|Lost to Follow-up|1|||
162972882|NCT01214239|588599723|FG001|Overall Study|Lost to Follow-up|1|||
162972883|NCT01214239|588599722|FG000|Overall Study|Withdrawal by Subject|4|||
162972884|NCT01214239|588599723|FG001|Overall Study|Withdrawal by Subject|9|||
162972885|NCT01214239|588599722|FG000|Overall Study|Lack of Efficacy|1|||
162972886|NCT01214239|588599723|FG001|Overall Study|Lack of Efficacy|2|||
162972887|NCT01214239|588599722|FG000|Overall Study|patient's private reason|1|||
162972888|NCT01214239|588599723|FG001|Overall Study|patient's private reason|1|||
162972889|NCT00810602|588599724|FG000|Overall Study|Withdrawal by Subject|8|||
162972890|NCT00810602|588599725|FG001|Overall Study|Withdrawal by Subject|3|||
162972891|NCT03840382|588599726|FG000|Overall Study|Lost to Follow-up|11|||
162972892|NCT01142661|588599727|FG000|Overall Study|Adverse Event|2|||
162972893|NCT01142661|588599727|FG000|Overall Study|Withdrawal by Subject|1|||
162972894|NCT01142661|588599727|FG000|Overall Study|Physician Decision|1|||
162972895|NCT00965731|588599730|FG000|Overall Study|Death|0|||
162972896|NCT00965731|588599731|FG001|Overall Study|Death|4|||
162972897|NCT00965731|588599730|FG000|Overall Study|Withdrawal by Subject|0|||
162972898|NCT00965731|588599731|FG001|Overall Study|Withdrawal by Subject|1|||
162972899|NCT00965731|588599730|FG000|Overall Study|Other|7|||
162972900|NCT00965731|588599731|FG001|Overall Study|Other|15|||
162972901|NCT04773600|588599732|FG000|Overall Study|Withdrawal by Subject|15|||
162972902|NCT04773600|588599733|FG001|Overall Study|Withdrawal by Subject|9|||
162972903|NCT04773600|588599732|FG000|Overall Study|Lost to Follow-up|10|||
162972904|NCT04773600|588599733|FG001|Overall Study|Lost to Follow-up|6|||
162972905|NCT04773600|588599732|FG000|Overall Study|Adverse Event|8|||
162972906|NCT04773600|588599733|FG001|Overall Study|Adverse Event|2|||
162972907|NCT04773600|588599732|FG000|Overall Study|Lack of Efficacy|2|||
162972908|NCT04773600|588599733|FG001|Overall Study|Lack of Efficacy|3|||
162972909|NCT04773600|588599732|FG000|Overall Study|Noncompliance|2|||
162972910|NCT04773600|588599733|FG001|Overall Study|Noncompliance|0|||
162972911|NCT04773600|588599732|FG000|Overall Study|Protocol Violation|2|||
162972912|NCT04773600|588599733|FG001|Overall Study|Protocol Violation|0|||
162972913|NCT04773600|588599732|FG000|Overall Study|Physician Decision|0|||
162972914|NCT04773600|588599733|FG001|Overall Study|Physician Decision|1|||
162972915|NCT04773600|588599732|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
162972916|NCT04773600|588599733|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
162972917|NCT04773600|588599732|FG000|Overall Study|Emergency Travel Out of Country|1|||
162972918|NCT04773600|588599733|FG001|Overall Study|Emergency Travel Out of Country|0|||
162972919|NCT01923311|588601578|FG000|Overall Study|Pregnancy|1|||
162972920|NCT01923311|588601579|FG001|Overall Study|Pregnancy|0|||
162972921|NCT01923311|588601578|FG000|Overall Study|Investigator's Discretion|1|||
162972922|NCT01923311|588601579|FG001|Overall Study|Investigator's Discretion|0|||
162972923|NCT01923311|588601578|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162972924|NCT01923311|588601579|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162972925|NCT01923311|588601578|FG000|Overall Study|Withdrew Consent|1|||
162972926|NCT01923311|588601579|FG001|Overall Study|Withdrew Consent|0|||
162972927|NCT01923311|588601578|FG000|Overall Study|Study Terminated by Sponsor|12|||
162972928|NCT01923311|588601579|FG001|Overall Study|Study Terminated by Sponsor|0|||
162972929|NCT04129944|588601582|FG000|Overall Study|Death|0|||
162972930|NCT04129944|588601583|FG001|Overall Study|Death|0|||
162972931|NCT04129944|588601584|FG002|Overall Study|Death|0|||
162972932|NCT04129944|588601585|FG003|Overall Study|Death|1|||
162972933|NCT04129944|588601582|FG000|Overall Study|Lost to Follow-up|1|||
162972934|NCT04129944|588601583|FG001|Overall Study|Lost to Follow-up|0|||
162972935|NCT04129944|588601584|FG002|Overall Study|Lost to Follow-up|0|||
162972936|NCT04129944|588601585|FG003|Overall Study|Lost to Follow-up|0|||
163057255|NCT04006457|588921196|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
163057256|NCT04006457|588921197|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
163057257|NCT03370172|588921198|FG000|Overall Study|Withdrawal by Subject|0|||
163057258|NCT03370172|588921199|FG001|Overall Study|Withdrawal by Subject|1|||
163057259|NCT05918055|588921200|FG000|Phase I - Dose Level 1|Ineligible|0|||
163057260|NCT05918055|588921201|FG001|Phase I - Dose Level 1|Ineligible|0|||
163057261|NCT05918055|588921202|FG002|Phase I - Dose Level 1|Ineligible|1|||
163057262|NCT05918055|588921200|FG000|Phase I - Dose Level -1|Physician Decision|1|||
163057263|NCT05918055|588921201|FG001|Phase I - Dose Level -1|Physician Decision|0|||
163057264|NCT05918055|588921202|FG002|Phase I - Dose Level -1|Physician Decision|0|||
163057265|NCT02194465|588921203|FG000|Overall Study|Adverse Event|6|||
163057266|NCT02194465|588921204|FG001|Overall Study|Adverse Event|1|||
162972937|NCT04129944|588601582|FG000|Overall Study|Withdrawal by Subject|1|||
162972938|NCT04129944|588601583|FG001|Overall Study|Withdrawal by Subject|0|||
162972939|NCT04129944|588601584|FG002|Overall Study|Withdrawal by Subject|1|||
162972940|NCT04129944|588601585|FG003|Overall Study|Withdrawal by Subject|2|||
162972941|NCT01560819|588601586|FG000|Overall Study|Physician Decision|1|||
162972942|NCT01560819|588601587|FG001|Overall Study|Physician Decision|0|||
162972943|NCT02012452|588601590|FG000|Overall Study|Lost to Follow-up|2|||
162972944|NCT02012452|588601591|FG001|Overall Study|Lost to Follow-up|1|||
162972945|NCT02012452|588601590|FG000|Overall Study|Withdrawal by Subject|4|||
162972946|NCT02012452|588601591|FG001|Overall Study|Withdrawal by Subject|0|||
162972947|NCT04403399|588601592|FG000|Period 2|Physician Decision|0|||
162972948|NCT04403399|588601593|FG001|Period 2|Physician Decision|1|||
162972949|NCT00831233|588601596|FG000|Overall Study|Adverse Event|0|||
162972950|NCT00831233|588601597|FG001|Overall Study|Adverse Event|1|||
162972951|NCT00831233|588601596|FG000|Overall Study|Protocol Violation|1|||
162972952|NCT00831233|588601597|FG001|Overall Study|Protocol Violation|0|||
162972953|NCT00831233|588601596|FG000|Overall Study|Selection Criteria Not Met|2|||
162972954|NCT00831233|588601597|FG001|Overall Study|Selection Criteria Not Met|0|||
162972955|NCT00991510|588601598|FG000|Period I (Days 1-14)|Adverse Event|1|||
162972956|NCT00991510|588601599|FG001|Period I (Days 1-14)|Adverse Event|0|||
162972957|NCT00991510|588601598|FG000|Period III (Days 29-112)|Adverse Event|1|||
162972958|NCT00991510|588601599|FG001|Period III (Days 29-112)|Adverse Event|1|||
163057267|NCT02194465|588921205|FG002|Overall Study|Adverse Event|4|||
163057268|NCT02194465|588921206|FG003|Overall Study|Adverse Event|4|||
163057269|NCT02194465|588921207|FG004|Overall Study|Adverse Event|4|||
163057270|NCT02194465|588921208|FG005|Overall Study|Adverse Event|2|||
163057271|NCT02194465|588921209|FG006|Overall Study|Adverse Event|0|||
163057272|NCT02194465|588921203|FG000|Overall Study|Lost to Follow-up|0|||
163057273|NCT02194465|588921204|FG001|Overall Study|Lost to Follow-up|0|||
163057274|NCT02194465|588921205|FG002|Overall Study|Lost to Follow-up|0|||
162972959|NCT03710590|588601600|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
162972960|NCT03710590|588601601|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
162972961|NCT02488824|588601602|FG000|Overall Study|Adverse Event|1|||
162972962|NCT02488824|588601603|FG001|Overall Study|Adverse Event|1|||
162972963|NCT01976728|588601604|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
162972964|NCT01976728|588601605|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
162972965|NCT01976728|588601606|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
162972966|NCT01976728|588601607|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
162972967|NCT02356211|588601608|FG000|Overall Study|Withdrawal by Subject|2|||
162972968|NCT02356211|588601609|FG001|Overall Study|Withdrawal by Subject|2|||
162972969|NCT02356211|588601608|FG000|Overall Study|ineligible|1|||
162972970|NCT02356211|588601609|FG001|Overall Study|ineligible|8|||
162972971|NCT01563237|588601611|FG000|Overall Study|Lost to Follow-up|6|||
162972972|NCT01563237|588601612|FG001|Overall Study|Lost to Follow-up|0|||
163057275|NCT02194465|588921206|FG003|Overall Study|Lost to Follow-up|1|||
163057276|NCT02194465|588921207|FG004|Overall Study|Lost to Follow-up|0|||
163057277|NCT02194465|588921208|FG005|Overall Study|Lost to Follow-up|1|||
162972973|NCT01563237|588601611|FG000|Overall Study|Withdrawal by Subject|1|||
162972974|NCT01563237|588601612|FG001|Overall Study|Withdrawal by Subject|0|||
163057278|NCT02194465|588921209|FG006|Overall Study|Lost to Follow-up|0|||
163057279|NCT02194465|588921203|FG000|Overall Study|Physician Decision|1|||
163057280|NCT02194465|588921204|FG001|Overall Study|Physician Decision|0|||
163057281|NCT02194465|588921205|FG002|Overall Study|Physician Decision|0|||
163057282|NCT02194465|588921206|FG003|Overall Study|Physician Decision|0|||
162630272|NCT01425281|587365100|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
162972975|NCT01563237|588601611|FG000|Overall Study|Adverse Event|1|||
162972976|NCT01563237|588601612|FG001|Overall Study|Adverse Event|0|||
162972977|NCT01563237|588601611|FG000|Overall Study|Medical Reasons|1|||
162972978|NCT01563237|588601612|FG001|Overall Study|Medical Reasons|0|||
162972979|NCT01563237|588601611|FG000|Overall Study|Death|1|||
162972980|NCT01563237|588601612|FG001|Overall Study|Death|0|||
162972981|NCT02211014|588601613|FG000|Overall Study|Adverse Event|0|||
162972982|NCT02211014|588601614|FG001|Overall Study|Adverse Event|2|||
162972983|NCT02211014|588601613|FG000|Overall Study|Physician Decision|1|||
162972984|NCT02211014|588601614|FG001|Overall Study|Physician Decision|2|||
162972985|NCT02211014|588601613|FG000|Overall Study|Started another cancer therapy|1|||
162972986|NCT02211014|588601614|FG001|Overall Study|Started another cancer therapy|0|||
162972987|NCT02211014|588601613|FG000|Overall Study|Withdrawal by Subject|0|||
162972988|NCT02211014|588601614|FG001|Overall Study|Withdrawal by Subject|1|||
162972989|NCT02211014|588601613|FG000|Overall Study|In agreement with patient, no benefit|0|||
162972990|NCT02211014|588601614|FG001|Overall Study|In agreement with patient, no benefit|1|||
162972991|NCT03180801|588601616|FG000|Overall Study|Physician Decision|3|||
162972992|NCT03180801|588601617|FG001|Overall Study|Physician Decision|3|||
162972993|NCT03180801|588601618|FG002|Overall Study|Physician Decision|1|||
162972994|NCT03180801|588601616|FG000|Overall Study|Non-compliance|1|||
162972995|NCT03180801|588601617|FG001|Overall Study|Non-compliance|4|||
162972996|NCT03180801|588601618|FG002|Overall Study|Non-compliance|0|||
162972997|NCT03180801|588601616|FG000|Overall Study|Inoculation Target Reached|1|||
162972998|NCT03180801|588601617|FG001|Overall Study|Inoculation Target Reached|1|||
162972999|NCT03180801|588601618|FG002|Overall Study|Inoculation Target Reached|3|||
162973000|NCT03180801|588601616|FG000|Overall Study|Adverse Event|1|||
162973001|NCT03180801|588601617|FG001|Overall Study|Adverse Event|0|||
162973002|NCT03180801|588601618|FG002|Overall Study|Adverse Event|2|||
162973003|NCT03180801|588601616|FG000|Overall Study|Withdrawal by Subject|2|||
162973004|NCT03180801|588601617|FG001|Overall Study|Withdrawal by Subject|2|||
162973005|NCT03180801|588601618|FG002|Overall Study|Withdrawal by Subject|1|||
162973006|NCT03180801|588601616|FG000|Overall Study|Lost to Follow-up|0|||
162973007|NCT03180801|588601617|FG001|Overall Study|Lost to Follow-up|2|||
162973008|NCT03180801|588601618|FG002|Overall Study|Lost to Follow-up|3|||
162973009|NCT00573170|588601621|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
162973010|NCT00573170|588601622|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
162973011|NCT00573170|588601623|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
162973012|NCT00573170|588601624|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
162973013|NCT00573170|588601625|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
162973014|NCT00573170|588601626|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
162973015|NCT00573170|588601621|FG000|First Washout Period|Adverse Event|1|||
162973016|NCT00573170|588601622|FG001|First Washout Period|Adverse Event|1|||
162973017|NCT00573170|588601623|FG002|First Washout Period|Adverse Event|0|||
162973018|NCT00573170|588601624|FG003|First Washout Period|Adverse Event|0|||
162973019|NCT00573170|588601625|FG004|First Washout Period|Adverse Event|0|||
162973020|NCT00573170|588601626|FG005|First Washout Period|Adverse Event|1|||
162973021|NCT00573170|588601621|FG000|First Washout Period|Lack of Efficacy|0|||
162973022|NCT00573170|588601622|FG001|First Washout Period|Lack of Efficacy|0|||
162973023|NCT00573170|588601623|FG002|First Washout Period|Lack of Efficacy|0|||
162973024|NCT00573170|588601624|FG003|First Washout Period|Lack of Efficacy|0|||
162973025|NCT00573170|588601625|FG004|First Washout Period|Lack of Efficacy|0|||
162973026|NCT00573170|588601626|FG005|First Washout Period|Lack of Efficacy|1|||
162973027|NCT00573170|588601621|FG000|First Washout Period|Lost to Follow-up|1|||
162973028|NCT00573170|588601622|FG001|First Washout Period|Lost to Follow-up|1|||
162973029|NCT00573170|588601623|FG002|First Washout Period|Lost to Follow-up|0|||
162973030|NCT00573170|588601624|FG003|First Washout Period|Lost to Follow-up|2|||
162973031|NCT00573170|588601625|FG004|First Washout Period|Lost to Follow-up|0|||
162973032|NCT00573170|588601626|FG005|First Washout Period|Lost to Follow-up|2|||
162973033|NCT00573170|588601621|FG000|First Washout Period|Withdrawal by Subject|2|||
162973034|NCT00573170|588601622|FG001|First Washout Period|Withdrawal by Subject|0|||
162973035|NCT00573170|588601623|FG002|First Washout Period|Withdrawal by Subject|0|||
162973036|NCT00573170|588601624|FG003|First Washout Period|Withdrawal by Subject|2|||
162973037|NCT00573170|588601625|FG004|First Washout Period|Withdrawal by Subject|3|||
162973038|NCT00573170|588601626|FG005|First Washout Period|Withdrawal by Subject|3|||
162973039|NCT00573170|588601621|FG000|First Washout Period|Other|4|||
162973040|NCT00573170|588601622|FG001|First Washout Period|Other|0|||
162973041|NCT00573170|588601623|FG002|First Washout Period|Other|1|||
162973042|NCT00573170|588601624|FG003|First Washout Period|Other|1|||
162973043|NCT00573170|588601625|FG004|First Washout Period|Other|0|||
162973044|NCT00573170|588601626|FG005|First Washout Period|Other|0|||
162973045|NCT00573170|588601621|FG000|Second Washout Period|Adverse Event|1|||
162973046|NCT00573170|588601622|FG001|Second Washout Period|Adverse Event|0|||
162973047|NCT00573170|588601623|FG002|Second Washout Period|Adverse Event|0|||
162973048|NCT00573170|588601624|FG003|Second Washout Period|Adverse Event|0|||
162973049|NCT00573170|588601625|FG004|Second Washout Period|Adverse Event|1|||
163057283|NCT02194465|588921207|FG004|Overall Study|Physician Decision|0|||
163057284|NCT02194465|588921208|FG005|Overall Study|Physician Decision|0|||
163057285|NCT02194465|588921209|FG006|Overall Study|Physician Decision|0|||
163057286|NCT02194465|588921203|FG000|Overall Study|Protocol Violation|1|||
163057287|NCT02194465|588921204|FG001|Overall Study|Protocol Violation|1|||
163057288|NCT02194465|588921205|FG002|Overall Study|Protocol Violation|2|||
163057289|NCT02194465|588921206|FG003|Overall Study|Protocol Violation|1|||
163057290|NCT02194465|588921207|FG004|Overall Study|Protocol Violation|1|||
162923631|NCT01563029|588422179|FG001|Overall Study|Lack of Efficacy|16|||
162923632|NCT01563029|588422180|FG002|Overall Study|Lack of Efficacy|23|||
162923633|NCT01563029|588422181|FG003|Overall Study|Lack of Efficacy|21|||
162923634|NCT01563029|588422182|FG004|Overall Study|Lack of Efficacy|19|||
162923635|NCT01563029|588422178|FG000|Overall Study|Protocol Violation|1|||
162923636|NCT01563029|588422179|FG001|Overall Study|Protocol Violation|2|||
162923637|NCT01563029|588422180|FG002|Overall Study|Protocol Violation|3|||
162923638|NCT01563029|588422181|FG003|Overall Study|Protocol Violation|1|||
162923639|NCT01563029|588422182|FG004|Overall Study|Protocol Violation|3|||
162923640|NCT01563029|588422178|FG000|Overall Study|Protocol defined stopping criteria|1|||
162923641|NCT01563029|588422179|FG001|Overall Study|Protocol defined stopping criteria|0|||
162923642|NCT01563029|588422180|FG002|Overall Study|Protocol defined stopping criteria|0|||
162923643|NCT01563029|588422181|FG003|Overall Study|Protocol defined stopping criteria|0|||
162923644|NCT01563029|588422182|FG004|Overall Study|Protocol defined stopping criteria|0|||
162923645|NCT01563029|588422178|FG000|Overall Study|Lost to Follow-up|1|||
162923646|NCT01563029|588422179|FG001|Overall Study|Lost to Follow-up|0|||
162923647|NCT01563029|588422180|FG002|Overall Study|Lost to Follow-up|1|||
162923648|NCT01563029|588422181|FG003|Overall Study|Lost to Follow-up|1|||
162923649|NCT01563029|588422182|FG004|Overall Study|Lost to Follow-up|1|||
162923650|NCT01563029|588422178|FG000|Overall Study|Physician Decision|3|||
162923651|NCT01563029|588422179|FG001|Overall Study|Physician Decision|5|||
162923652|NCT01563029|588422180|FG002|Overall Study|Physician Decision|2|||
162923653|NCT01563029|588422181|FG003|Overall Study|Physician Decision|4|||
162923654|NCT01563029|588422182|FG004|Overall Study|Physician Decision|2|||
162923655|NCT01563029|588422178|FG000|Overall Study|Withdrawal by Subject|4|||
162923656|NCT01563029|588422179|FG001|Overall Study|Withdrawal by Subject|1|||
162923657|NCT01563029|588422180|FG002|Overall Study|Withdrawal by Subject|3|||
162923658|NCT01563029|588422181|FG003|Overall Study|Withdrawal by Subject|4|||
162923659|NCT01563029|588422182|FG004|Overall Study|Withdrawal by Subject|3|||
162923660|NCT03069365|588422183|FG000|Overall Study|Adverse Event|1|||
162923661|NCT02780115|588422184|FG000|Overall Study|Withdrawal by Subject|0|||
162923662|NCT02780115|588422185|FG001|Overall Study|Withdrawal by Subject|1|||
162923663|NCT02780115|588422186|FG002|Overall Study|Withdrawal by Subject|1|||
162923664|NCT02780115|588422187|FG003|Overall Study|Withdrawal by Subject|0|||
162923665|NCT02780115|588422188|FG004|Overall Study|Withdrawal by Subject|0|||
162923666|NCT02780115|588422184|FG000|Overall Study|Adverse Event|0|||
162923667|NCT02780115|588422185|FG001|Overall Study|Adverse Event|0|||
162923668|NCT02780115|588422186|FG002|Overall Study|Adverse Event|0|||
162923669|NCT02780115|588422187|FG003|Overall Study|Adverse Event|1|||
162923670|NCT02780115|588422188|FG004|Overall Study|Adverse Event|1|||
162923671|NCT00769132|588422189|FG000|Period 1|Adverse Event|1|||
162923672|NCT00769132|588422190|FG001|Period 1|Adverse Event|0|||
162923673|NCT00769132|588422191|FG002|Period 1|Adverse Event|0|||
162923674|NCT00769132|588422192|FG003|Period 1|Adverse Event|1|||
162923675|NCT00769132|588422189|FG000|Period 2|Withdrawal by Subject|0|||
162923676|NCT00769132|588422190|FG001|Period 2|Withdrawal by Subject|0|||
162923677|NCT00769132|588422191|FG002|Period 2|Withdrawal by Subject|0|||
162923678|NCT00769132|588422192|FG003|Period 2|Withdrawal by Subject|1|||
162923679|NCT00769132|588422189|FG000|Period 3|Withdrawal by Subject|1|||
162923680|NCT00769132|588422190|FG001|Period 3|Withdrawal by Subject|0|||
162923681|NCT00769132|588422191|FG002|Period 3|Withdrawal by Subject|0|||
162923682|NCT00769132|588422192|FG003|Period 3|Withdrawal by Subject|0|||
162923683|NCT00769132|588422189|FG000|Period 4|Withdrawal by Subject|0|||
162923684|NCT00769132|588422190|FG001|Period 4|Withdrawal by Subject|1|||
162923685|NCT00769132|588422191|FG002|Period 4|Withdrawal by Subject|0|||
162923686|NCT00769132|588422192|FG003|Period 4|Withdrawal by Subject|0|||
162923687|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
162923688|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
162923689|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
162923690|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
162923691|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
162923692|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
162923693|NCT00566631|588422193|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
162923694|NCT00566631|588422193|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
162923695|NCT00566631|588422193|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
162923696|NCT00566631|588422193|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
162973050|NCT00573170|588601626|FG005|Second Washout Period|Adverse Event|0|||
162973051|NCT00573170|588601621|FG000|Second Washout Period|Protocol Violation|2|||
162973052|NCT00573170|588601622|FG001|Second Washout Period|Protocol Violation|1|||
162973053|NCT00573170|588601623|FG002|Second Washout Period|Protocol Violation|1|||
162973054|NCT00573170|588601624|FG003|Second Washout Period|Protocol Violation|0|||
162973055|NCT00573170|588601625|FG004|Second Washout Period|Protocol Violation|0|||
162973056|NCT00573170|588601626|FG005|Second Washout Period|Protocol Violation|0|||
162973057|NCT00573170|588601621|FG000|Second Washout Period|Withdrawal by Subject|1|||
162973058|NCT00573170|588601622|FG001|Second Washout Period|Withdrawal by Subject|1|||
162973059|NCT00573170|588601623|FG002|Second Washout Period|Withdrawal by Subject|2|||
162973060|NCT00573170|588601624|FG003|Second Washout Period|Withdrawal by Subject|0|||
162973061|NCT00573170|588601625|FG004|Second Washout Period|Withdrawal by Subject|1|||
162973062|NCT00573170|588601626|FG005|Second Washout Period|Withdrawal by Subject|0|||
162973063|NCT00573170|588601621|FG000|Second Washout Period|Lost to Follow-up|0|||
162973064|NCT00573170|588601622|FG001|Second Washout Period|Lost to Follow-up|0|||
162973065|NCT00573170|588601623|FG002|Second Washout Period|Lost to Follow-up|0|||
162973066|NCT00573170|588601624|FG003|Second Washout Period|Lost to Follow-up|1|||
162973067|NCT00573170|588601625|FG004|Second Washout Period|Lost to Follow-up|0|||
162973068|NCT00573170|588601626|FG005|Second Washout Period|Lost to Follow-up|0|||
162973069|NCT00573170|588601621|FG000|Second Washout Period|Other|1|||
162973070|NCT00573170|588601622|FG001|Second Washout Period|Other|2|||
162973071|NCT00573170|588601623|FG002|Second Washout Period|Other|1|||
162973072|NCT00573170|588601624|FG003|Second Washout Period|Other|4|||
162973073|NCT00573170|588601625|FG004|Second Washout Period|Other|6|||
162973074|NCT00573170|588601626|FG005|Second Washout Period|Other|2|||
162973075|NCT00573170|588601621|FG000|Third Treatment Period|Withdrawal by Subject|1|||
162973076|NCT00573170|588601622|FG001|Third Treatment Period|Withdrawal by Subject|0|||
162973077|NCT00573170|588601623|FG002|Third Treatment Period|Withdrawal by Subject|0|||
162973078|NCT00573170|588601624|FG003|Third Treatment Period|Withdrawal by Subject|0|||
162973079|NCT00573170|588601625|FG004|Third Treatment Period|Withdrawal by Subject|0|||
162973080|NCT00573170|588601626|FG005|Third Treatment Period|Withdrawal by Subject|0|||
162973081|NCT00573170|588601621|FG000|Third Treatment Period|Lost to Follow-up|0|||
162973082|NCT00573170|588601622|FG001|Third Treatment Period|Lost to Follow-up|0|||
162973083|NCT00573170|588601623|FG002|Third Treatment Period|Lost to Follow-up|0|||
162973084|NCT00573170|588601624|FG003|Third Treatment Period|Lost to Follow-up|0|||
162973085|NCT00573170|588601625|FG004|Third Treatment Period|Lost to Follow-up|0|||
162973086|NCT00573170|588601626|FG005|Third Treatment Period|Lost to Follow-up|2|||
162973087|NCT05966090|588601627|FG000|Overall Study|Lost to Follow-up|6|||
162973088|NCT05966090|588601628|FG001|Overall Study|Lost to Follow-up|6|||
162973089|NCT05966090|588601627|FG000|Overall Study|Adverse Event|1|||
162973090|NCT05966090|588601628|FG001|Overall Study|Adverse Event|1|||
162973091|NCT05966090|588601627|FG000|Overall Study|Withdrawal by Subject|1|||
162973092|NCT05966090|588601628|FG001|Overall Study|Withdrawal by Subject|1|||
162973093|NCT05966090|588601627|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162973094|NCT05966090|588601628|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
162973095|NCT05966090|588601627|FG000|Overall Study|Other|1|||
162973096|NCT05966090|588601628|FG001|Overall Study|Other|1|||
162973097|NCT03585959|588601635|FG000|Overall Study|Physician Decision|1|||
162973098|NCT03585959|588601635|FG000|Overall Study|Unsuccessful Procedure|2|||
162973099|NCT01386125|588601637|FG000|Overall Study|Lost to Follow-up|3|||
162973100|NCT01386125|588601638|FG001|Overall Study|Lost to Follow-up|9|||
162973101|NCT01386125|588601637|FG000|Overall Study|Physician Decision|0|||
162973102|NCT01386125|588601638|FG001|Overall Study|Physician Decision|1|||
162973103|NCT01386125|588601637|FG000|Overall Study|Protocol Violation|5|||
162973104|NCT01386125|588601638|FG001|Overall Study|Protocol Violation|7|||
162973105|NCT01386125|588601637|FG000|Overall Study|Disease Progress|1|||
162973106|NCT01386125|588601638|FG001|Overall Study|Disease Progress|2|||
163057291|NCT02194465|588921208|FG005|Overall Study|Protocol Violation|0|||
163057292|NCT02194465|588921209|FG006|Overall Study|Protocol Violation|0|||
163057293|NCT02194465|588921203|FG000|Overall Study|Withdrawal by Subject|1|||
163057294|NCT02194465|588921204|FG001|Overall Study|Withdrawal by Subject|3|||
162973107|NCT01386125|588601637|FG000|Overall Study|Withdrawal by Subject|13|||
162973108|NCT01386125|588601638|FG001|Overall Study|Withdrawal by Subject|12|||
162973109|NCT01386125|588601637|FG000|Overall Study|Adverse Event|2|||
162973110|NCT01386125|588601638|FG001|Overall Study|Adverse Event|5|||
162973111|NCT01386125|588601637|FG000|Overall Study|Lack of Efficacy|0|||
162973112|NCT01386125|588601638|FG001|Overall Study|Lack of Efficacy|1|||
162973113|NCT01386125|588601637|FG000|Overall Study|Participant Leaving Country|1|||
162973114|NCT01386125|588601638|FG001|Overall Study|Participant Leaving Country|0|||
162973115|NCT01098539|588601639|FG000|Overall Study|Adverse Event|26|||
163057295|NCT02194465|588921205|FG002|Overall Study|Withdrawal by Subject|1|||
162973116|NCT01098539|588601640|FG001|Overall Study|Adverse Event|26|||
162973117|NCT01098539|588601639|FG000|Overall Study|Protocol Violation|1|||
162973118|NCT01098539|588601640|FG001|Overall Study|Protocol Violation|4|||
162973119|NCT01098539|588601639|FG000|Overall Study|Noncompliance|3|||
162973120|NCT01098539|588601640|FG001|Overall Study|Noncompliance|5|||
163057296|NCT02194465|588921206|FG003|Overall Study|Withdrawal by Subject|2|||
162973121|NCT01098539|588601639|FG000|Overall Study|Lost to Follow-up|4|||
162973122|NCT01098539|588601640|FG001|Overall Study|Lost to Follow-up|4|||
162973123|NCT01098539|588601639|FG000|Overall Study|Withdrawal by Subject|12|||
162973124|NCT01098539|588601640|FG001|Overall Study|Withdrawal by Subject|26|||
162973125|NCT01098539|588601639|FG000|Overall Study|Physician Decision|5|||
162973126|NCT01098539|588601640|FG001|Overall Study|Physician Decision|3|||
162973127|NCT03843125|588601641|FG000|Overall Study|Adverse Event|17|||
162973128|NCT03843125|588601642|FG001|Overall Study|Adverse Event|13|||
162973129|NCT03843125|588601643|FG002|Overall Study|Adverse Event|5|||
162973130|NCT03843125|588601644|FG003|Overall Study|Adverse Event|9|||
162973131|NCT03843125|588601641|FG000|Overall Study|Death|0|||
162973132|NCT03843125|588601642|FG001|Overall Study|Death|6|||
162973133|NCT03843125|588601643|FG002|Overall Study|Death|2|||
162973134|NCT03843125|588601644|FG003|Overall Study|Death|0|||
162973135|NCT03843125|588601641|FG000|Overall Study|Lack of Efficacy|14|||
162973136|NCT03843125|588601642|FG001|Overall Study|Lack of Efficacy|11|||
162973137|NCT03843125|588601643|FG002|Overall Study|Lack of Efficacy|9|||
162973138|NCT03843125|588601644|FG003|Overall Study|Lack of Efficacy|4|||
162973139|NCT03843125|588601641|FG000|Overall Study|Lost to Follow-up|3|||
162973140|NCT03843125|588601642|FG001|Overall Study|Lost to Follow-up|4|||
162973141|NCT03843125|588601643|FG002|Overall Study|Lost to Follow-up|0|||
162973142|NCT03843125|588601644|FG003|Overall Study|Lost to Follow-up|2|||
162973143|NCT03843125|588601641|FG000|Overall Study|Other|12|||
162973144|NCT03843125|588601642|FG001|Overall Study|Other|14|||
162973145|NCT03843125|588601643|FG002|Overall Study|Other|3|||
162973146|NCT03843125|588601644|FG003|Overall Study|Other|4|||
162973147|NCT03843125|588601641|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
162973148|NCT03843125|588601642|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
162973149|NCT03843125|588601643|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
162973150|NCT03843125|588601644|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
162973151|NCT03843125|588601641|FG000|Overall Study|Study Terminated by Sponsor|318|||
162973152|NCT03843125|588601642|FG001|Overall Study|Study Terminated by Sponsor|318|||
162973153|NCT03843125|588601643|FG002|Overall Study|Study Terminated by Sponsor|163|||
162973154|NCT03843125|588601644|FG003|Overall Study|Study Terminated by Sponsor|163|||
162973155|NCT03843125|588601641|FG000|Overall Study|Withdrawal by Subject|23|||
162973156|NCT03843125|588601642|FG001|Overall Study|Withdrawal by Subject|12|||
162973157|NCT03843125|588601643|FG002|Overall Study|Withdrawal by Subject|6|||
162973158|NCT03843125|588601644|FG003|Overall Study|Withdrawal by Subject|9|||
162973159|NCT03843125|588601641|FG000|Overall Study|Missing data|0|||
162973160|NCT03843125|588601642|FG001|Overall Study|Missing data|1|||
162973161|NCT03843125|588601643|FG002|Overall Study|Missing data|1|||
162973162|NCT03843125|588601644|FG003|Overall Study|Missing data|0|||
162973163|NCT01292837|588601645|FG000|Overall Study|Adverse Event|1|||
162973164|NCT01292837|588601645|FG000|Overall Study|Further treatment determined|1|||
162973165|NCT02359864|588601646|FG000|Overall Study|Withdrawal by Subject|1|||
162973166|NCT02359864|588601647|FG001|Overall Study|Withdrawal by Subject|0|||
162973167|NCT00515216|588601651|FG000|Overall Study|Withdrawal by Subject|1|||
162973168|NCT00732160|588601661|FG000|Overall Study|Adverse Event|1|||
162973169|NCT00732160|588601662|FG001|Overall Study|Adverse Event|0|||
162973170|NCT00732160|588601663|FG002|Overall Study|Adverse Event|1|||
162973171|NCT00732160|588601664|FG003|Overall Study|Adverse Event|1|||
162973172|NCT00732160|588601661|FG000|Overall Study|scheduling|4|||
162973173|NCT00732160|588601662|FG001|Overall Study|scheduling|4|||
162973174|NCT00732160|588601663|FG002|Overall Study|scheduling|2|||
162973175|NCT00732160|588601664|FG003|Overall Study|scheduling|1|||
162973176|NCT02427399|588601667|FG000|Overall Study|Protocol Violation|14|||
162973177|NCT02427399|588601668|FG001|Overall Study|Protocol Violation|16|||
162973178|NCT02427399|588601669|FG002|Overall Study|Protocol Violation|12|||
162973179|NCT02427399|588601670|FG003|Overall Study|Protocol Violation|18|||
162973180|NCT02427399|588601671|FG004|Overall Study|Protocol Violation|15|||
162973181|NCT00605176|588601674|FG000|Overall Study|Adverse Event|2|||
162973182|NCT00605176|588601675|FG001|Overall Study|Adverse Event|1|||
162973183|NCT00605176|588601676|FG002|Overall Study|Adverse Event|3|||
162973184|NCT00605176|588601674|FG000|Overall Study|Withdrawal by Subject|4|||
162973185|NCT00605176|588601675|FG001|Overall Study|Withdrawal by Subject|2|||
162973186|NCT00605176|588601676|FG002|Overall Study|Withdrawal by Subject|4|||
162973187|NCT00605176|588601674|FG000|Overall Study|Lost to Follow-up|2|||
162973188|NCT00605176|588601675|FG001|Overall Study|Lost to Follow-up|2|||
162973189|NCT00605176|588601676|FG002|Overall Study|Lost to Follow-up|1|||
162973190|NCT00605176|588601674|FG000|Overall Study|Non-complicance with study procedures|1|||
162973191|NCT00605176|588601675|FG001|Overall Study|Non-complicance with study procedures|0|||
162973192|NCT00605176|588601676|FG002|Overall Study|Non-complicance with study procedures|0|||
162973193|NCT00605176|588601674|FG000|Overall Study|Use of concomitant therapy|1|||
162973194|NCT00605176|588601675|FG001|Overall Study|Use of concomitant therapy|0|||
162973195|NCT00605176|588601676|FG002|Overall Study|Use of concomitant therapy|1|||
162973196|NCT00605176|588601674|FG000|Overall Study|Other (not due to AE)|1|||
162973197|NCT00605176|588601675|FG001|Overall Study|Other (not due to AE)|1|||
162973198|NCT00605176|588601676|FG002|Overall Study|Other (not due to AE)|0|||
162973199|NCT01086969|588601677|FG000|Overall Study|Withdrawal by Subject|1|||
162973200|NCT01086969|588601678|FG001|Overall Study|Withdrawal by Subject|2|||
162973201|NCT01086969|588601679|FG002|Overall Study|Withdrawal by Subject|0|||
162973202|NCT01609582|588601684|FG000|Overall Study|Adverse Event|20|||
162973203|NCT01609582|588601685|FG001|Overall Study|Adverse Event|18|||
162973204|NCT01609582|588601684|FG000|Overall Study|Lost to Follow-up|10|||
162973205|NCT01609582|588601685|FG001|Overall Study|Lost to Follow-up|10|||
162973206|NCT01609582|588601684|FG000|Overall Study|Withdrawal by Subject|21|||
162973207|NCT01609582|588601685|FG001|Overall Study|Withdrawal by Subject|15|||
162973208|NCT01609582|588601684|FG000|Overall Study|Study Terminated by Sponsor|1543|||
162973209|NCT01609582|588601685|FG001|Overall Study|Study Terminated by Sponsor|1548|||
162973210|NCT01609582|588601684|FG000|Overall Study|Other|9|||
162973211|NCT01609582|588601685|FG001|Overall Study|Other|10|||
162973212|NCT01609582|588601684|FG000|Overall Study|Randomized, but not treated|0|||
162973213|NCT01609582|588601685|FG001|Overall Study|Randomized, but not treated|3|||
162973214|NCT00685750|588601686|FG000|Overall Study|Tumor sampling failure|0|||
162973215|NCT00685750|588601687|FG001|Overall Study|Tumor sampling failure|0|||
162973216|NCT00685750|588601688|FG002|Overall Study|Tumor sampling failure|1|||
162973217|NCT00685750|588601689|FG003|Overall Study|Tumor sampling failure|0|||
162973218|NCT00685750|588601690|FG004|Overall Study|Tumor sampling failure|0|||
162973219|NCT00685750|588601691|FG005|Overall Study|Tumor sampling failure|0|||
162973220|NCT00685750|588601692|FG006|Overall Study|Tumor sampling failure|0|||
162973221|NCT00685750|588601686|FG000|Overall Study|Patient didn't receive the treatment|0|||
162973222|NCT00685750|588601687|FG001|Overall Study|Patient didn't receive the treatment|0|||
162973223|NCT00685750|588601688|FG002|Overall Study|Patient didn't receive the treatment|0|||
162973224|NCT00685750|588601689|FG003|Overall Study|Patient didn't receive the treatment|0|||
162973225|NCT00685750|588601690|FG004|Overall Study|Patient didn't receive the treatment|0|||
162973226|NCT00685750|588601691|FG005|Overall Study|Patient didn't receive the treatment|0|||
162973227|NCT00685750|588601692|FG006|Overall Study|Patient didn't receive the treatment|1|||
162973228|NCT00685750|588601686|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162973229|NCT00685750|588601687|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162973230|NCT00685750|588601688|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162973231|NCT00685750|588601689|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
162973232|NCT00685750|588601690|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
162973233|NCT00685750|588601691|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
162973234|NCT00685750|588601692|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
162973235|NCT04974580|588601695|FG000|Overall Study|Lost to Follow-up|33|||
162973236|NCT04974580|588601696|FG001|Overall Study|Lost to Follow-up|39|||
162973237|NCT04974580|588601697|FG002|Overall Study|Lost to Follow-up|30|||
162973238|NCT04974580|588601698|FG003|Overall Study|Lost to Follow-up|29|||
162973239|NCT00129116|588601699|FG000|Primary Phase|Lost to Follow-up|1|||
162973240|NCT00129116|588601700|FG001|Primary Phase|Lost to Follow-up|1|||
162973241|NCT00129116|588601701|FG002|Primary Phase|Lost to Follow-up|0|||
162973242|NCT00129116|588601702|FG003|Primary Phase|Lost to Follow-up|1|||
162973243|NCT00129116|588601703|FG004|Primary Phase|Lost to Follow-up|1|||
162973244|NCT00129116|588601699|FG000|Primary Phase|Protocol Violation|0|||
162973245|NCT00129116|588601700|FG001|Primary Phase|Protocol Violation|1|||
162973246|NCT00129116|588601701|FG002|Primary Phase|Protocol Violation|0|||
162973247|NCT00129116|588601702|FG003|Primary Phase|Protocol Violation|0|||
162973248|NCT00129116|588601703|FG004|Primary Phase|Protocol Violation|0|||
162973249|NCT00129116|588601699|FG000|Primary Phase|Adverse Event|1|||
162973250|NCT00129116|588601700|FG001|Primary Phase|Adverse Event|1|||
162973251|NCT00129116|588601701|FG002|Primary Phase|Adverse Event|0|||
162973252|NCT00129116|588601702|FG003|Primary Phase|Adverse Event|0|||
162973253|NCT00129116|588601703|FG004|Primary Phase|Adverse Event|0|||
162973254|NCT00129116|588601699|FG000|Primary Phase|Withdrawal by Subject|0|||
162973255|NCT00129116|588601700|FG001|Primary Phase|Withdrawal by Subject|1|||
162973256|NCT00129116|588601701|FG002|Primary Phase|Withdrawal by Subject|0|||
162973257|NCT00129116|588601702|FG003|Primary Phase|Withdrawal by Subject|0|||
162973258|NCT00129116|588601703|FG004|Primary Phase|Withdrawal by Subject|0|||
162973259|NCT00129116|588601699|FG000|Primary Phase|Other|0|||
162630273|NCT01425281|587365101|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
162630274|NCT01425281|587365100|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
162630275|NCT01425281|587365101|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
162973260|NCT00129116|588601700|FG001|Primary Phase|Other|0|||
162973261|NCT00129116|588601701|FG002|Primary Phase|Other|1|||
162973262|NCT00129116|588601702|FG003|Primary Phase|Other|0|||
162973263|NCT00129116|588601703|FG004|Primary Phase|Other|0|||
162973264|NCT00129116|588601699|FG000|Booster Phase|Lost to Follow-up|2|||
162973265|NCT00129116|588601700|FG001|Booster Phase|Lost to Follow-up|0|||
162973266|NCT00129116|588601701|FG002|Booster Phase|Lost to Follow-up|0|||
162973267|NCT00129116|588601702|FG003|Booster Phase|Lost to Follow-up|0|||
162973268|NCT00129116|588601703|FG004|Booster Phase|Lost to Follow-up|1|||
162973269|NCT02539368|588601704|FG000|Overall Study|Death|4|||
162973270|NCT02539368|588601705|FG001|Overall Study|Death|2|||
162973271|NCT02539368|588601706|FG002|Overall Study|Death|1|||
162973272|NCT02539368|588601707|FG003|Overall Study|Death|0|||
162973273|NCT02539368|588601708|FG004|Overall Study|Death|0|||
162973274|NCT02539368|588601704|FG000|Overall Study|Withdrawal by Subject|44|||
162973275|NCT02539368|588601705|FG001|Overall Study|Withdrawal by Subject|35|||
162973276|NCT02539368|588601706|FG002|Overall Study|Withdrawal by Subject|9|||
162973277|NCT02539368|588601707|FG003|Overall Study|Withdrawal by Subject|1|||
162973278|NCT02539368|588601708|FG004|Overall Study|Withdrawal by Subject|3|||
162973279|NCT02539368|588601704|FG000|Overall Study|Physician Decision|49|||
162973280|NCT02539368|588601705|FG001|Overall Study|Physician Decision|15|||
162973281|NCT02539368|588601706|FG002|Overall Study|Physician Decision|7|||
162973282|NCT02539368|588601707|FG003|Overall Study|Physician Decision|0|||
162973283|NCT02539368|588601708|FG004|Overall Study|Physician Decision|2|||
162973284|NCT02539368|588601704|FG000|Overall Study|Lost to Follow-up|96|||
162973285|NCT02539368|588601705|FG001|Overall Study|Lost to Follow-up|21|||
162973286|NCT02539368|588601706|FG002|Overall Study|Lost to Follow-up|16|||
162973287|NCT02539368|588601707|FG003|Overall Study|Lost to Follow-up|4|||
162973288|NCT02539368|588601708|FG004|Overall Study|Lost to Follow-up|3|||
162973289|NCT02539368|588601704|FG000|Overall Study|Adverse Event|44|||
162973290|NCT02539368|588601705|FG001|Overall Study|Adverse Event|5|||
162973291|NCT02539368|588601706|FG002|Overall Study|Adverse Event|9|||
162973292|NCT02539368|588601707|FG003|Overall Study|Adverse Event|0|||
162973293|NCT02539368|588601708|FG004|Overall Study|Adverse Event|3|||
162973294|NCT02539368|588601704|FG000|Overall Study|Participant Non-compliant|13|||
162973295|NCT02539368|588601705|FG001|Overall Study|Participant Non-compliant|2|||
162973296|NCT02539368|588601706|FG002|Overall Study|Participant Non-compliant|1|||
162973297|NCT02539368|588601707|FG003|Overall Study|Participant Non-compliant|1|||
162973298|NCT02539368|588601708|FG004|Overall Study|Participant Non-compliant|0|||
162973299|NCT02539368|588601704|FG000|Overall Study|Other|145|||
162973300|NCT02539368|588601705|FG001|Overall Study|Other|18|||
162973301|NCT02539368|588601706|FG002|Overall Study|Other|24|||
162973302|NCT02539368|588601707|FG003|Overall Study|Other|1|||
162973303|NCT02539368|588601708|FG004|Overall Study|Other|3|||
162973304|NCT02539368|588601704|FG000|Overall Study|Missing|10|||
162973305|NCT02539368|588601705|FG001|Overall Study|Missing|3|||
162973306|NCT02539368|588601706|FG002|Overall Study|Missing|0|||
162973307|NCT02539368|588601707|FG003|Overall Study|Missing|0|||
162973308|NCT02539368|588601708|FG004|Overall Study|Missing|0|||
162973309|NCT03558139|588601711|FG000|Overall Study|Consent Withdrawn|1|||
162973310|NCT03558139|588601712|FG001|Overall Study|Consent Withdrawn|1|||
162973311|NCT03558139|588601713|FG002|Overall Study|Consent Withdrawn|4|||
162973312|NCT03558139|588601711|FG000|Overall Study|Death|5|||
162973313|NCT03558139|588601712|FG001|Overall Study|Death|3|||
162973314|NCT03558139|588601713|FG002|Overall Study|Death|8|||
162973315|NCT03558139|588601711|FG000|Overall Study|Lost to Follow-up|0|||
162973316|NCT03558139|588601712|FG001|Overall Study|Lost to Follow-up|0|||
162973317|NCT03558139|588601713|FG002|Overall Study|Lost to Follow-up|3|||
162973318|NCT03558139|588601711|FG000|Overall Study|Study Ended Per Protocol|0|||
162973319|NCT03558139|588601712|FG001|Overall Study|Study Ended Per Protocol|3|||
162973320|NCT03558139|588601713|FG002|Overall Study|Study Ended Per Protocol|6|||
162973321|NCT02752802|588601714|FG000|Overall Study|Contrast Volume Not Collected|1|||
162973322|NCT02752802|588601715|FG001|Overall Study|Contrast Volume Not Collected|0|||
162973323|NCT00251316|588601716|FG000|Overall Study|Physician Decision|2|||
162973324|NCT00251316|588601717|FG001|Overall Study|Physician Decision|3|||
162973325|NCT00398073|588601718|FG000|Overall Study|Withdrawal by Subject|1|||
162973326|NCT00398073|588601719|FG001|Overall Study|Withdrawal by Subject|0|||
162973327|NCT00708682|588601720|FG000|Infant Series|Adverse Event|1|||
162973328|NCT00708682|588601720|FG000|Infant Series|Lost to Follow-up|4|||
162973329|NCT00708682|588601720|FG000|Infant Series|Protocol Violation|1|||
162973330|NCT00708682|588601720|FG000|Infant Series|Parent/legal guardian request|6|||
162973331|NCT00708682|588601720|FG000|Infant Series|Failed to return|2|||
162973332|NCT00708682|588601720|FG000|Infant Series|Other|19|||
162973333|NCT00708682|588601720|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
162973334|NCT00708682|588601720|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
162973335|NCT00708682|588601720|FG000|Toddler Dose|Lost to Follow-up|3|||
162973336|NCT00708682|588601720|FG000|Toddler Dose|Failed to Return|4|||
162973337|NCT03689894|588601723|FG000|Overall Study|Adverse Event|1|||
162973338|NCT00569777|588601724|FG000|Overall Study|Withdrawal by Subject|4|||
162973339|NCT00569777|588601725|FG001|Overall Study|Withdrawal by Subject|0|||
162973340|NCT00569777|588601724|FG000|Overall Study|Adverse Event|3|||
162973341|NCT00569777|588601725|FG001|Overall Study|Adverse Event|0|||
162973342|NCT00569777|588601724|FG000|Overall Study|Lost to Follow-up|1|||
162973343|NCT00569777|588601725|FG001|Overall Study|Lost to Follow-up|0|||
162973344|NCT00569777|588601724|FG000|Overall Study|scheduled eye surgery|0|||
162973345|NCT00569777|588601725|FG001|Overall Study|scheduled eye surgery|1|||
162973346|NCT00569777|588601724|FG000|Overall Study|did not meet exclusion criteria|1|||
162973347|NCT00569777|588601725|FG001|Overall Study|did not meet exclusion criteria|2|||
162973348|NCT00569777|588601724|FG000|Overall Study|pregnant|1|||
162973349|NCT00569777|588601725|FG001|Overall Study|pregnant|0|||
162973350|NCT02056652|588601731|FG000|Overall Study|Withdrawal by Subject|1|||
162973351|NCT02056652|588601732|FG001|Overall Study|Withdrawal by Subject|0|||
162973352|NCT02056652|588601731|FG000|Overall Study|Lost to Follow-up|0|||
162973353|NCT02056652|588601732|FG001|Overall Study|Lost to Follow-up|3|||
162973354|NCT00239005|588601737|FG000|Overall Study|Adverse Event|6|||
162973355|NCT00239005|588601738|FG001|Overall Study|Adverse Event|6|||
162973356|NCT00239005|588601737|FG000|Overall Study|Withdrawal by Subject|3|||
162973357|NCT00239005|588601738|FG001|Overall Study|Withdrawal by Subject|4|||
162973358|NCT00239005|588601737|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
162973359|NCT00239005|588601738|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
162973360|NCT00239005|588601737|FG000|Overall Study|Protocol Violation|1|||
162973361|NCT00239005|588601738|FG001|Overall Study|Protocol Violation|0|||
162973362|NCT00239005|588601737|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
162973363|NCT00239005|588601738|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
162973364|NCT00239005|588601737|FG000|Overall Study|Lost to Follow-up|0|||
162973365|NCT00239005|588601738|FG001|Overall Study|Lost to Follow-up|1|||
162973366|NCT00987831|588601740|FG000|Overall Study|Never flared in 12 months|1|||
162973367|NCT00987831|588601741|FG001|Overall Study|Never flared in 12 months|0|||
162973368|NCT00987831|588601742|FG002|Overall Study|Never flared in 12 months|0|||
162973369|NCT00987831|588601740|FG000|Overall Study|Lost to Follow-up|0|||
162973370|NCT00987831|588601741|FG001|Overall Study|Lost to Follow-up|3|||
162973371|NCT00987831|588601742|FG002|Overall Study|Lost to Follow-up|0|||
162973372|NCT03253094|588601743|FG000|Overall Study|Adverse Event|2|||
162973373|NCT03253094|588601744|FG001|Overall Study|Adverse Event|0|||
162973374|NCT03253094|588601745|FG002|Overall Study|Adverse Event|0|||
162973375|NCT03253094|588601746|FG003|Overall Study|Adverse Event|0|||
162973376|NCT03253094|588601747|FG004|Overall Study|Adverse Event|0|||
162973377|NCT03253094|588601748|FG005|Overall Study|Adverse Event|0|||
162973378|NCT03253094|588601743|FG000|Overall Study|Lack of Efficacy|0|||
162973379|NCT03253094|588601744|FG001|Overall Study|Lack of Efficacy|0|||
162973380|NCT03253094|588601745|FG002|Overall Study|Lack of Efficacy|2|||
162973381|NCT03253094|588601746|FG003|Overall Study|Lack of Efficacy|1|||
162973382|NCT03253094|588601747|FG004|Overall Study|Lack of Efficacy|2|||
162973383|NCT03253094|588601748|FG005|Overall Study|Lack of Efficacy|1|||
162973384|NCT03253094|588601743|FG000|Overall Study|Lost to Follow-up|0|||
162973385|NCT03253094|588601744|FG001|Overall Study|Lost to Follow-up|0|||
162973386|NCT03253094|588601745|FG002|Overall Study|Lost to Follow-up|1|||
162973387|NCT03253094|588601746|FG003|Overall Study|Lost to Follow-up|1|||
162973388|NCT03253094|588601747|FG004|Overall Study|Lost to Follow-up|0|||
162973389|NCT03253094|588601748|FG005|Overall Study|Lost to Follow-up|1|||
162973390|NCT03253094|588601743|FG000|Overall Study|Physician Decision|1|||
162973391|NCT03253094|588601744|FG001|Overall Study|Physician Decision|0|||
162973392|NCT03253094|588601745|FG002|Overall Study|Physician Decision|0|||
162973393|NCT03253094|588601746|FG003|Overall Study|Physician Decision|1|||
162973394|NCT03253094|588601747|FG004|Overall Study|Physician Decision|0|||
162973395|NCT03253094|588601748|FG005|Overall Study|Physician Decision|2|||
162973396|NCT03253094|588601743|FG000|Overall Study|Withdrawal by Subject|1|||
162973397|NCT03253094|588601744|FG001|Overall Study|Withdrawal by Subject|2|||
162973398|NCT03253094|588601745|FG002|Overall Study|Withdrawal by Subject|1|||
162973399|NCT03253094|588601746|FG003|Overall Study|Withdrawal by Subject|0|||
162973400|NCT03253094|588601747|FG004|Overall Study|Withdrawal by Subject|3|||
162973401|NCT03253094|588601748|FG005|Overall Study|Withdrawal by Subject|0|||
162973402|NCT03253094|588601743|FG000|Overall Study|Other|0|||
162973403|NCT03253094|588601744|FG001|Overall Study|Other|1|||
162973404|NCT03253094|588601745|FG002|Overall Study|Other|2|||
162973405|NCT03253094|588601746|FG003|Overall Study|Other|1|||
162973406|NCT03253094|588601747|FG004|Overall Study|Other|0|||
162973407|NCT03253094|588601748|FG005|Overall Study|Other|0|||
162973408|NCT00824369|588601749|FG000|Overall Study|Nolonger willing to participate in study|1|||
162973409|NCT00824369|588601750|FG001|Overall Study|Nolonger willing to participate in study|0|||
162973410|NCT00824369|588601751|FG002|Overall Study|Nolonger willing to participate in study|1|||
162973411|NCT00824369|588601752|FG003|Overall Study|Nolonger willing to participate in study|2|||
162973412|NCT00824369|588601753|FG004|Overall Study|Nolonger willing to participate in study|0|||
162973413|NCT00824369|588601754|FG005|Overall Study|Nolonger willing to participate in study|1|||
162973414|NCT00824369|588601749|FG000|Overall Study|Lost to Follow-up|0|||
162973415|NCT00824369|588601750|FG001|Overall Study|Lost to Follow-up|0|||
162973416|NCT00824369|588601751|FG002|Overall Study|Lost to Follow-up|0|||
162973417|NCT00824369|588601752|FG003|Overall Study|Lost to Follow-up|0|||
162973418|NCT00824369|588601753|FG004|Overall Study|Lost to Follow-up|1|||
162973419|NCT00824369|588601754|FG005|Overall Study|Lost to Follow-up|0|||
162973420|NCT02413294|588601755|FG000|Overall Study|Withdrawal by Subject|1|||
162973421|NCT02625974|588601756|FG000|Part 1|Lost to Follow-up|9|||
162973422|NCT02625974|588601757|FG001|Part 1|Lost to Follow-up|3|||
162973423|NCT02625974|588601756|FG000|Part 2|Lost to Follow-up|4|||
162973424|NCT02625974|588601757|FG001|Part 2|Lost to Follow-up|6|||
162973425|NCT02625974|588601756|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
162973426|NCT02625974|588601757|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
162973427|NCT03941834|588603198|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
162973428|NCT03941834|588603199|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
162973429|NCT03941834|588603200|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
162973430|NCT03941834|588603198|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
162973431|NCT03941834|588603199|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
162973432|NCT03941834|588603200|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
162973433|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
162973434|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
162973435|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
162973436|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
162973437|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
162973438|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
162973439|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
162973440|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
162973441|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
162973442|NCT03941834|588603198|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
162973443|NCT03941834|588603199|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
162973444|NCT03941834|588603200|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
162973445|NCT01124695|588603203|FG000|Overall Study|Disease progression|77|||
162973446|NCT01124695|588603203|FG000|Overall Study|Adverse Event|11|||
162973447|NCT01124695|588603203|FG000|Overall Study|Death|1|||
162973448|NCT01124695|588603203|FG000|Overall Study|Withdrawal by Subject|7|||
162973449|NCT01124695|588603203|FG000|Overall Study|Physician Decision|3|||
162973450|NCT01124695|588603203|FG000|Overall Study|Alternative therapy|9|||
162973451|NCT01124695|588603203|FG000|Overall Study|No documentation that patient went off treatment|4|||
162973452|NCT01124695|588603203|FG000|Overall Study|Ineligible|9|||
162973453|NCT01124695|588603203|FG000|Overall Study|Ineligible and never start treatment|2|||
162973454|NCT00097786|588603207|FG000|Overall Study|lost to follow-up for all-cause death|296|||
162973455|NCT00097786|588603208|FG001|Overall Study|lost to follow-up for all-cause death|292|||
162973456|NCT00097786|588603209|FG002|Overall Study|lost to follow-up for all-cause death|313|||
162973457|NCT00097786|588603210|FG003|Overall Study|lost to follow-up for all-cause death|310|||
162973458|NCT02668822|588603211|FG000|Overall Study|Protocol Violation|2|||
162973459|NCT02668822|588603212|FG001|Overall Study|Protocol Violation|0|||
162973460|NCT02668822|588603211|FG000|Overall Study|Study Terminated by Sponsor|7|||
162973461|NCT02668822|588603212|FG001|Overall Study|Study Terminated by Sponsor|9|||
162973462|NCT01647711|588603215|FG000|Overall Study|Progressive disease|6|||
162973463|NCT01647711|588603216|FG001|Overall Study|Progressive disease|2|||
162973464|NCT01647711|588603217|FG002|Overall Study|Progressive disease|6|||
162973465|NCT01647711|588603218|FG003|Overall Study|Progressive disease|8|||
162973466|NCT01647711|588603219|FG004|Overall Study|Progressive disease|2|||
162973467|NCT01647711|588603215|FG000|Overall Study|Other adverse event|0|||
162973468|NCT01647711|588603216|FG001|Overall Study|Other adverse event|0|||
162973469|NCT01647711|588603217|FG002|Overall Study|Other adverse event|2|||
162973470|NCT01647711|588603218|FG003|Overall Study|Other adverse event|0|||
162973471|NCT01647711|588603219|FG004|Overall Study|Other adverse event|2|||
162973472|NCT01647711|588603215|FG000|Overall Study|Protocol Violation|0|||
162973473|NCT01647711|588603216|FG001|Overall Study|Protocol Violation|0|||
162973474|NCT01647711|588603217|FG002|Overall Study|Protocol Violation|0|||
162973475|NCT01647711|588603218|FG003|Overall Study|Protocol Violation|0|||
162973476|NCT01647711|588603219|FG004|Overall Study|Protocol Violation|1|||
162973477|NCT01647711|588603215|FG000|Overall Study|Refused to continue taking medication|0|||
162973478|NCT01647711|588603216|FG001|Overall Study|Refused to continue taking medication|0|||
162973479|NCT01647711|588603217|FG002|Overall Study|Refused to continue taking medication|0|||
162973480|NCT01647711|588603218|FG003|Overall Study|Refused to continue taking medication|2|||
162973481|NCT01647711|588603219|FG004|Overall Study|Refused to continue taking medication|1|||
162973482|NCT01647711|588603215|FG000|Overall Study|Other reason not defined|0|||
163057297|NCT02194465|588921207|FG004|Overall Study|Withdrawal by Subject|2|||
162973483|NCT01647711|588603216|FG001|Overall Study|Other reason not defined|1|||
163057298|NCT02194465|588921208|FG005|Overall Study|Withdrawal by Subject|1|||
162973484|NCT01647711|588603217|FG002|Overall Study|Other reason not defined|1|||
162973485|NCT01647711|588603218|FG003|Overall Study|Other reason not defined|1|||
162973486|NCT01647711|588603219|FG004|Overall Study|Other reason not defined|0|||
162973487|NCT03036839|588603220|FG000|Overall Study|Adverse Event|0|||
162973488|NCT03036839|588603221|FG001|Overall Study|Adverse Event|0|||
162973489|NCT03036839|588603222|FG002|Overall Study|Adverse Event|1|||
162973490|NCT03036839|588603220|FG000|Overall Study|Death|3|||
162973491|NCT03036839|588603221|FG001|Overall Study|Death|0|||
162973492|NCT03036839|588603222|FG002|Overall Study|Death|3|||
162973493|NCT03036839|588603220|FG000|Overall Study|Withdrew Consent|0|||
162973494|NCT03036839|588603221|FG001|Overall Study|Withdrew Consent|0|||
162973495|NCT03036839|588603222|FG002|Overall Study|Withdrew Consent|1|||
162973496|NCT01316419|588603223|FG000|Overall Study|Not treated|103|||
162973497|NCT01316419|588603223|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
162973498|NCT01316419|588603223|FG000|Overall Study|Lost to Follow-up|19|||
162973499|NCT00412737|588603225|FG000|Overall Study|Death|1|||
162973500|NCT00412737|588603226|FG001|Overall Study|Death|0|||
162973501|NCT00412737|588603225|FG000|Overall Study|Adverse Event|3|||
162973502|NCT00412737|588603226|FG001|Overall Study|Adverse Event|2|||
162973503|NCT00412737|588603225|FG000|Overall Study|Refused Treatment|6|||
162973504|NCT00412737|588603226|FG001|Overall Study|Refused Treatment|2|||
162973505|NCT00412737|588603225|FG000|Overall Study|Failure to Return|6|||
162973506|NCT00412737|588603226|FG001|Overall Study|Failure to Return|2|||
162973507|NCT00983918|588603227|FG000|Overall Study|conversion to open cholecystectomy|0|||
162973508|NCT00983918|588603228|FG001|Overall Study|conversion to open cholecystectomy|2|||
162973509|NCT00983918|588603229|FG002|Overall Study|conversion to open cholecystectomy|2|||
162973510|NCT00983918|588603230|FG003|Overall Study|conversion to open cholecystectomy|2|||
162973511|NCT01345318|588603254|FG000|Overall Study|Adverse Event|16|||
162973512|NCT01345318|588603254|FG000|Overall Study|Lack of Efficacy|17|||
162973513|NCT01345318|588603254|FG000|Overall Study|Lost to Follow-up|2|||
162973514|NCT01345318|588603254|FG000|Overall Study|Protocol Violation|1|||
162973515|NCT01345318|588603254|FG000|Overall Study|Withdrawal by Subject|41|||
162973516|NCT01345318|588603254|FG000|Overall Study|Other|3|||
162973517|NCT01685073|588603255|FG000|Overall Study|Lost to Follow-up|6|||
162973518|NCT01685073|588603256|FG001|Overall Study|Lost to Follow-up|8|||
162973519|NCT01685073|588603255|FG000|Overall Study|Withdrawal by Subject|24|||
162973520|NCT01685073|588603256|FG001|Overall Study|Withdrawal by Subject|24|||
162973521|NCT01049412|588603259|FG000|Period I|Withdrawal by Subject|4|||
162973522|NCT01049412|588603260|FG001|Period I|Withdrawal by Subject|6|||
162973523|NCT01049412|588603259|FG000|Period I|Lost to Follow-up|2|||
162973524|NCT01049412|588603260|FG001|Period I|Lost to Follow-up|2|||
162973525|NCT01049412|588603259|FG000|Period I|Physician Decision|0|||
162973526|NCT01049412|588603260|FG001|Period I|Physician Decision|3|||
162973527|NCT01049412|588603259|FG000|Period I|Protocol Violation|1|||
162973528|NCT01049412|588603260|FG001|Period I|Protocol Violation|2|||
162973529|NCT01049412|588603259|FG000|Period I|Adverse Event|1|||
162973530|NCT01049412|588603260|FG001|Period I|Adverse Event|0|||
162973531|NCT01049412|588603259|FG000|Period II|Withdrawal by Subject|2|||
162973532|NCT01049412|588603260|FG001|Period II|Withdrawal by Subject|3|||
162973533|NCT01049412|588603259|FG000|Period II|Adverse Event|1|||
162973534|NCT01049412|588603260|FG001|Period II|Adverse Event|0|||
162973535|NCT01049412|588603259|FG000|Period II|Lost to Follow-up|1|||
162973536|NCT01049412|588603260|FG001|Period II|Lost to Follow-up|0|||
162973537|NCT00804141|588603261|FG000|Overall Study|Adverse Event|157|||
162973538|NCT00804141|588603261|FG000|Overall Study|Death|4|||
162973539|NCT00804141|588603261|FG000|Overall Study|Failed to return|96|||
162973540|NCT00804141|588603261|FG000|Overall Study|Investigator request|8|||
162973541|NCT00804141|588603261|FG000|Overall Study|Protocol Violation|85|||
162973542|NCT00804141|588603261|FG000|Overall Study|Withdrawal by Subject|131|||
162973543|NCT00804141|588603261|FG000|Overall Study|Lack of Efficacy|46|||
162973544|NCT00804141|588603261|FG000|Overall Study|Other than specified|30|||
162973545|NCT00804141|588603261|FG000|Overall Study|Enrolled but not treated|6|||
162973546|NCT01142908|588603262|FG000|Overall Study|Lost to Follow-up|19|||
162973547|NCT01142908|588603263|FG001|Overall Study|Lost to Follow-up|13|||
162973548|NCT01142908|588603262|FG000|Overall Study|Death|1|||
162973549|NCT01142908|588603263|FG001|Overall Study|Death|4|||
162973550|NCT01142908|588603262|FG000|Overall Study|Excluded - did not meet criteria|9|||
162973551|NCT01142908|588603263|FG001|Overall Study|Excluded - did not meet criteria|5|||
162973552|NCT01142908|588603262|FG000|Overall Study|Withdrawal by Subject|3|||
162973553|NCT01142908|588603263|FG001|Overall Study|Withdrawal by Subject|0|||
162973554|NCT03235479|588603265|FG000|Overall Study|Lost to Follow-up|8|||
162973555|NCT03235479|588603266|FG001|Overall Study|Lost to Follow-up|11|||
162973556|NCT03235479|588603265|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
162973557|NCT03235479|588603266|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
162973558|NCT03235479|588603265|FG000|Overall Study|Pregnancy|1|||
162973559|NCT03235479|588603266|FG001|Overall Study|Pregnancy|0|||
162973560|NCT03235479|588603265|FG000|Overall Study|Protocol Deviation|1|||
162973561|NCT03235479|588603266|FG001|Overall Study|Protocol Deviation|3|||
162973562|NCT03235479|588603265|FG000|Overall Study|Technical Problems|3|||
162973563|NCT03235479|588603266|FG001|Overall Study|Technical Problems|2|||
162973564|NCT03235479|588603265|FG000|Overall Study|Withdrawal by Subject|2|||
162973565|NCT03235479|588603266|FG001|Overall Study|Withdrawal by Subject|2|||
162973566|NCT03235479|588603265|FG000|Overall Study|Other Reasons|3|||
162973567|NCT03235479|588603266|FG001|Overall Study|Other Reasons|5|||
162973568|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
162973569|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
162973570|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
162973571|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
162973572|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
162973573|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
162973574|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162973575|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
162973576|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
162973577|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
162973578|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
162973579|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
162973580|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
162973581|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
162973582|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
162973583|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
162973584|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Death|2|||
162973585|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Death|1|||
162973586|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Death|0|||
162973587|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Death|0|||
162973588|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
162973589|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
162973590|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
162973591|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
162973592|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
162973593|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
162973594|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
162973595|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
162973596|NCT03110380|588603272|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973597|NCT03110380|588603273|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
162973598|NCT03110380|588603274|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973599|NCT03110380|588603275|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
162973600|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162973601|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162973602|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
162973603|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
162973604|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
162973605|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
162973606|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
162973607|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
162973608|NCT03110380|588603272|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973609|NCT03110380|588603273|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973610|NCT03110380|588603274|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162973611|NCT03110380|588603275|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
162973612|NCT01206439|588603278|FG000|Overall Study|subject did not meet inclusion criteria|1|||
162973613|NCT05889039|588603280|FG000|Overall Study|error in completing survey|0|||
162973614|NCT05889039|588603281|FG001|Overall Study|error in completing survey|2|||
162973615|NCT05889039|588603282|FG002|Overall Study|error in completing survey|0|||
162973616|NCT05889039|588603283|FG003|Overall Study|error in completing survey|0|||
162973617|NCT05889039|588603280|FG000|Overall Study|Lost to Follow-up|4|||
162973618|NCT05889039|588603281|FG001|Overall Study|Lost to Follow-up|0|||
162973619|NCT05889039|588603282|FG002|Overall Study|Lost to Follow-up|0|||
162973620|NCT05889039|588603283|FG003|Overall Study|Lost to Follow-up|0|||
162973621|NCT02795676|588603284|FG000|Overall Study|Adverse Event|2|||
162973622|NCT02795676|588603285|FG001|Overall Study|Adverse Event|0|||
162973623|NCT02795676|588603284|FG000|Overall Study|Withdrawal by Subject|3|||
162973624|NCT02795676|588603285|FG001|Overall Study|Withdrawal by Subject|1|||
162973625|NCT01115933|588603288|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
162973626|NCT00819767|588603289|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162973627|NCT00819767|588603290|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162973628|NCT00220727|588603314|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
162973629|NCT00220727|588603315|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
162973630|NCT00476593|588603316|FG000|Overall Study|Lost to Follow-up|10|||
162973631|NCT00476593|588603317|FG001|Overall Study|Lost to Follow-up|2|||
162973632|NCT00476593|588603318|FG002|Overall Study|Lost to Follow-up|8|||
162973633|NCT00476593|588603319|FG003|Overall Study|Lost to Follow-up|22|||
162973634|NCT03430011|588603320|FG000|Pre-Treatment|Death|1|||
162973635|NCT03430011|588603321|FG001|Pre-Treatment|Death|0|||
162973636|NCT03430011|588603322|FG002|Pre-Treatment|Death|0|||
162973637|NCT03430011|588603323|FG003|Pre-Treatment|Death|0|||
162973638|NCT03430011|588603324|FG004|Pre-Treatment|Death|1|||
162973639|NCT03430011|588603325|FG005|Pre-Treatment|Death|0|||
162973640|NCT03430011|588603326|FG006|Pre-Treatment|Death|1|||
162973641|NCT03430011|588603327|FG007|Pre-Treatment|Death|0|||
162973642|NCT03430011|588603320|FG000|Pre-Treatment|Screen Fail|0|||
162973643|NCT03430011|588603321|FG001|Pre-Treatment|Screen Fail|0|||
162973644|NCT03430011|588603322|FG002|Pre-Treatment|Screen Fail|0|||
162973645|NCT03430011|588603323|FG003|Pre-Treatment|Screen Fail|0|||
162973646|NCT03430011|588603324|FG004|Pre-Treatment|Screen Fail|1|||
162973647|NCT03430011|588603325|FG005|Pre-Treatment|Screen Fail|0|||
162973648|NCT03430011|588603326|FG006|Pre-Treatment|Screen Fail|0|||
162973649|NCT03430011|588603327|FG007|Pre-Treatment|Screen Fail|0|||
162973650|NCT03430011|588603320|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973651|NCT03430011|588603321|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973652|NCT03430011|588603322|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
162973653|NCT03430011|588603323|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973654|NCT03430011|588603324|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973655|NCT03430011|588603325|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973656|NCT03430011|588603326|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973657|NCT03430011|588603327|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
162973658|NCT03430011|588603320|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
162973659|NCT03430011|588603321|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
162973660|NCT03430011|588603322|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
162973661|NCT03430011|588603323|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
162973662|NCT03430011|588603324|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
162973663|NCT03430011|588603325|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
162973664|NCT03430011|588603326|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
162973665|NCT03430011|588603327|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
162973666|NCT03430011|588603320|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
162973667|NCT03430011|588603321|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
162973668|NCT03430011|588603322|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
162973669|NCT03430011|588603323|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
162973670|NCT03430011|588603324|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
162973671|NCT03430011|588603325|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
162973672|NCT03430011|588603326|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
162973673|NCT03430011|588603327|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
162973674|NCT03430011|588603320|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
162973675|NCT03430011|588603321|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
162973676|NCT03430011|588603322|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
162973677|NCT03430011|588603323|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
162973678|NCT03430011|588603324|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
162973679|NCT03430011|588603325|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
162973680|NCT03430011|588603326|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
162973681|NCT03430011|588603327|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
162973682|NCT03430011|588603320|FG000|JCARH125 Treatment|Death|4|||
162973683|NCT03430011|588603321|FG001|JCARH125 Treatment|Death|19|||
162973684|NCT03430011|588603322|FG002|JCARH125 Treatment|Death|10|||
162973685|NCT03430011|588603323|FG003|JCARH125 Treatment|Death|8|||
162973686|NCT03430011|588603324|FG004|JCARH125 Treatment|Death|5|||
162973687|NCT03430011|588603325|FG005|JCARH125 Treatment|Death|3|||
162973688|NCT03430011|588603326|FG006|JCARH125 Treatment|Death|4|||
162973689|NCT03430011|588603327|FG007|JCARH125 Treatment|Death|2|||
162973690|NCT03430011|588603320|FG000|JCARH125 Treatment|Other reasons|1|||
162973691|NCT03430011|588603321|FG001|JCARH125 Treatment|Other reasons|0|||
162973692|NCT03430011|588603322|FG002|JCARH125 Treatment|Other reasons|4|||
162973693|NCT03430011|588603323|FG003|JCARH125 Treatment|Other reasons|2|||
162973694|NCT03430011|588603324|FG004|JCARH125 Treatment|Other reasons|2|||
162973695|NCT03430011|588603325|FG005|JCARH125 Treatment|Other reasons|1|||
162973696|NCT03430011|588603326|FG006|JCARH125 Treatment|Other reasons|3|||
162973697|NCT03430011|588603327|FG007|JCARH125 Treatment|Other reasons|2|||
162973698|NCT00559364|588603329|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
162973699|NCT00559364|588603330|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
162973700|NCT04126343|588603331|FG000|Overall Study|Adverse Event|0|||
162973701|NCT04126343|588603332|FG001|Overall Study|Adverse Event|0|||
162973702|NCT04126343|588603333|FG002|Overall Study|Adverse Event|0|||
162973703|NCT04126343|588603334|FG003|Overall Study|Adverse Event|0|||
162712787|NCT00109967|587660749|FG001|Overall Study|Cancel Prior to Treatment|0|||
162712788|NCT00109967|587660748|FG000|Overall Study|Adverse Event|12|||
162973704|NCT04126343|588603335|FG004|Overall Study|Adverse Event|0|||
162973705|NCT04126343|588603336|FG005|Overall Study|Adverse Event|1|||
162973706|NCT04126343|588603331|FG000|Overall Study|Withdrawal by Subject|0|||
162973707|NCT04126343|588603332|FG001|Overall Study|Withdrawal by Subject|0|||
162973708|NCT04126343|588603333|FG002|Overall Study|Withdrawal by Subject|0|||
162973709|NCT04126343|588603334|FG003|Overall Study|Withdrawal by Subject|1|||
162973710|NCT04126343|588603335|FG004|Overall Study|Withdrawal by Subject|0|||
162973711|NCT04126343|588603336|FG005|Overall Study|Withdrawal by Subject|0|||
162973712|NCT04126343|588603331|FG000|Overall Study|Related to COVID-19 pandemic|3|||
162973713|NCT04126343|588603332|FG001|Overall Study|Related to COVID-19 pandemic|4|||
162973714|NCT04126343|588603333|FG002|Overall Study|Related to COVID-19 pandemic|3|||
162973715|NCT04126343|588603334|FG003|Overall Study|Related to COVID-19 pandemic|3|||
162973716|NCT04126343|588603335|FG004|Overall Study|Related to COVID-19 pandemic|3|||
162973717|NCT04126343|588603336|FG005|Overall Study|Related to COVID-19 pandemic|3|||
162973718|NCT01235442|588603337|FG000|Overall Study|Lost to Follow-up|12|||
162973719|NCT01235442|588603338|FG001|Overall Study|Lost to Follow-up|10|||
162973720|NCT01235442|588603337|FG000|Overall Study|Death|0|||
162973721|NCT01235442|588603338|FG001|Overall Study|Death|2|||
162973722|NCT01235442|588603337|FG000|Overall Study|Pregnancy|1|||
162973723|NCT01235442|588603338|FG001|Overall Study|Pregnancy|1|||
162973724|NCT01235442|588603337|FG000|Overall Study|Ineligibility determined|5|||
162973725|NCT01235442|588603338|FG001|Overall Study|Ineligibility determined|4|||
162973726|NCT01235442|588603337|FG000|Overall Study|Protocol Violation|3|||
162973727|NCT01235442|588603338|FG001|Overall Study|Protocol Violation|3|||
162973728|NCT01235442|588603337|FG000|Overall Study|Adverse Event|4|||
162973729|NCT01235442|588603338|FG001|Overall Study|Adverse Event|6|||
162973730|NCT01235442|588603337|FG000|Overall Study|Withdrawal by Subject|15|||
162973731|NCT01235442|588603338|FG001|Overall Study|Withdrawal by Subject|9|||
162973732|NCT01235442|588603337|FG000|Overall Study|Lack of Efficacy|1|||
162973733|NCT01235442|588603338|FG001|Overall Study|Lack of Efficacy|3|||
162973734|NCT01235442|588603337|FG000|Overall Study|Noncompliance|1|||
162973735|NCT01235442|588603338|FG001|Overall Study|Noncompliance|2|||
162973736|NCT01235442|588603337|FG000|Overall Study|Administrative decision|1|||
162973737|NCT01235442|588603338|FG001|Overall Study|Administrative decision|2|||
162973738|NCT01235442|588603337|FG000|Overall Study|Other unspecified|1|||
162973739|NCT01235442|588603338|FG001|Overall Study|Other unspecified|2|||
162973740|NCT01701973|588603345|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973741|NCT01701973|588603346|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
162973742|NCT01701973|588603347|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973743|NCT01701973|588603348|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973744|NCT01701973|588603349|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973745|NCT01701973|588603350|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973746|NCT01701973|588603351|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973747|NCT01701973|588603352|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
162973748|NCT02663882|588603353|FG000|Overall Study|Lost to Follow-up|4|||
162973749|NCT02663882|588603354|FG001|Overall Study|Lost to Follow-up|2|||
162973750|NCT03712124|588603355|FG000|Overall Study|Protocol Violation|1|||
162973751|NCT03712124|588603356|FG001|Overall Study|Protocol Violation|0|||
162973752|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
162973753|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
162973754|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
162973755|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
162973756|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
162973757|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
162973758|NCT00602537|588603360|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
162973759|NCT00602537|588603361|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
162973760|NCT00602537|588603360|FG000|Follow Up Study Comparison|Adverse Event|1|||
162973761|NCT00602537|588603361|FG001|Follow Up Study Comparison|Adverse Event|0|||
162973762|NCT00602537|588603360|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
162973763|NCT00602537|588603361|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
162973764|NCT00602537|588603360|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
162973765|NCT00602537|588603361|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
162973766|NCT02941523|588603362|FG000|Monotherapy|Withdrawal by Subject|0|||
162973767|NCT02941523|588603363|FG001|Monotherapy|Withdrawal by Subject|1|||
162973768|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
162973769|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
162973770|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Death|1|||
162973771|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Death|2|||
162973772|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Disease progression|2|||
162973773|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Disease progression|0|||
162973774|NCT02941523|588603362|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
162973775|NCT02941523|588603363|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
162973776|NCT04330157|588603364|FG000|Overall Study|Protocol Violation|4|||
162973777|NCT04330157|588603364|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
162973778|NCT04314843|588603365|FG000|Overall Study|Death|2|||
162973779|NCT04314843|588603366|FG001|Overall Study|Death|2|||
162973780|NCT04314843|588603365|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
162973781|NCT04314843|588603366|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
162973782|NCT00869440|588603367|FG000|Overall Study|Withdrawal by Subject|1|||
162973783|NCT00869440|588603368|FG001|Overall Study|Withdrawal by Subject|0|||
162973784|NCT00869440|588603369|FG002|Overall Study|Withdrawal by Subject|0|||
162973785|NCT00869440|588603370|FG003|Overall Study|Withdrawal by Subject|0|||
162973786|NCT00869440|588603367|FG000|Overall Study|Physician Decision|1|||
162973787|NCT00869440|588603368|FG001|Overall Study|Physician Decision|1|||
162973788|NCT00869440|588603369|FG002|Overall Study|Physician Decision|0|||
162973789|NCT00869440|588603370|FG003|Overall Study|Physician Decision|0|||
162973790|NCT01899326|588603371|FG000|Overall Study|Withdrawal by Subject|1|||
162973791|NCT01899326|588603371|FG000|Overall Study|Adverse Event|2|||
162973792|NCT01899326|588603371|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
162973793|NCT03581188|588605592|FG000|Overall Study|Inclusion criteria not met|3|||
162973794|NCT03581188|588605593|FG001|Overall Study|Inclusion criteria not met|2|||
162973795|NCT03581188|588605592|FG000|Overall Study|Lost to Follow-up|5|||
162973796|NCT03581188|588605593|FG001|Overall Study|Lost to Follow-up|5|||
162973797|NCT03581188|588605592|FG000|Overall Study|Discontinued intervention|11|||
162973798|NCT03581188|588605593|FG001|Overall Study|Discontinued intervention|8|||
162973799|NCT00109837|588605596|FG000|Overall Study|Adverse Event|2|||
162973800|NCT00109837|588605596|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
162973801|NCT00109837|588605596|FG000|Overall Study|Death|1|||
162973802|NCT00109837|588605596|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
162973803|NCT00109837|588605596|FG000|Overall Study|Not treated|1|||
162973804|NCT00109837|588605596|FG000|Overall Study|Ineligible|1|||
162973805|NCT01989676|588605597|FG000|Overall Study|Death|52|||
162973806|NCT01989676|588605598|FG001|Overall Study|Death|60|||
162973807|NCT01989676|588605597|FG000|Overall Study|Protocol Violation|2|||
162973808|NCT01989676|588605598|FG001|Overall Study|Protocol Violation|1|||
162973809|NCT01989676|588605597|FG000|Overall Study|Lost to Follow-up|8|||
162973810|NCT01989676|588605598|FG001|Overall Study|Lost to Follow-up|18|||
162973811|NCT01989676|588605597|FG000|Overall Study|No longer willing to participate in study|26|||
162973812|NCT01989676|588605598|FG001|Overall Study|No longer willing to participate in study|26|||
162973813|NCT01989676|588605597|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
162973814|NCT01989676|588605598|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
162973815|NCT01989676|588605597|FG000|Overall Study|Other|4|||
162973816|NCT01989676|588605598|FG001|Overall Study|Other|3|||
162973817|NCT01619579|588605599|FG000|Overall Study|Withdrawal by Subject|0|||
162973818|NCT01619579|588605600|FG001|Overall Study|Withdrawal by Subject|3|||
162973819|NCT02190279|588605602|FG000|Overall Study|Withdrawal consent|1|||
162973820|NCT02190279|588605603|FG001|Overall Study|Withdrawal consent|0|||
162973821|NCT02190279|588605604|FG002|Overall Study|Withdrawal consent|1|||
162973822|NCT02190279|588605602|FG000|Overall Study|Lost to Follow-up|2|||
162973823|NCT02190279|588605603|FG001|Overall Study|Lost to Follow-up|0|||
162973824|NCT02190279|588605604|FG002|Overall Study|Lost to Follow-up|0|||
162973825|NCT02190279|588605602|FG000|Overall Study|Refused further treatment|0|||
162973826|NCT02190279|588605603|FG001|Overall Study|Refused further treatment|0|||
162973827|NCT02190279|588605604|FG002|Overall Study|Refused further treatment|1|||
162973828|NCT02190279|588605602|FG000|Overall Study|Screening failure|0|||
162973829|NCT02190279|588605603|FG001|Overall Study|Screening failure|0|||
162973830|NCT02190279|588605604|FG002|Overall Study|Screening failure|1|||
162973831|NCT02688387|588605605|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973832|NCT02688387|588605606|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973833|NCT02688387|588605607|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
162973834|NCT02688387|588605608|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162630276|NCT01425281|587365100|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
162630277|NCT01425281|587365101|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
162630278|NCT01425281|587365100|FG000|At 2-year Clinical Follow-up|Death|2|||
162630279|NCT01425281|587365101|FG001|At 2-year Clinical Follow-up|Death|0|||
162973835|NCT02688387|588605609|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973836|NCT02688387|588605610|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973837|NCT02688387|588605611|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973838|NCT02688387|588605612|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973839|NCT02688387|588605613|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973840|NCT02688387|588605614|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973841|NCT02688387|588605615|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973842|NCT02688387|588605616|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973843|NCT02688387|588605617|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973844|NCT02688387|588605618|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973845|NCT02688387|588605619|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973846|NCT02688387|588605620|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973847|NCT02688387|588605621|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973848|NCT02688387|588605622|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973849|NCT02688387|588605623|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973850|NCT02688387|588605624|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973851|NCT02688387|588605625|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973852|NCT02688387|588605626|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
162973853|NCT02688387|588605605|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973854|NCT02688387|588605606|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973855|NCT02688387|588605607|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973856|NCT02688387|588605608|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
162973857|NCT02688387|588605609|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973858|NCT02688387|588605610|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973859|NCT02688387|588605611|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973860|NCT02688387|588605612|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973861|NCT02688387|588605613|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973862|NCT02688387|588605614|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973863|NCT02688387|588605615|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973864|NCT02688387|588605616|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973865|NCT02688387|588605617|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973866|NCT02688387|588605618|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973867|NCT02688387|588605619|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973868|NCT02688387|588605620|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973869|NCT02688387|588605621|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973870|NCT02688387|588605622|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973871|NCT02688387|588605623|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973872|NCT02688387|588605624|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973873|NCT02688387|588605625|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973874|NCT02688387|588605626|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973875|NCT02688387|588605605|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973876|NCT02688387|588605606|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
162973877|NCT02688387|588605607|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973878|NCT02688387|588605608|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973879|NCT02688387|588605609|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973880|NCT02688387|588605610|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973881|NCT02688387|588605611|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973882|NCT02688387|588605612|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973883|NCT02688387|588605613|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973884|NCT02688387|588605614|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973885|NCT02688387|588605615|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973886|NCT02688387|588605616|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973887|NCT02688387|588605617|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973888|NCT02688387|588605618|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973889|NCT02688387|588605619|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973890|NCT02688387|588605620|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973891|NCT02688387|588605621|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973892|NCT02688387|588605622|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973893|NCT02688387|588605623|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973894|NCT02688387|588605624|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973895|NCT02688387|588605625|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973896|NCT02688387|588605626|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162973897|NCT02688387|588605605|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973898|NCT02688387|588605606|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973899|NCT02688387|588605607|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
162973900|NCT02688387|588605608|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973901|NCT02688387|588605609|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
162973902|NCT02688387|588605610|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973903|NCT02688387|588605611|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973904|NCT02688387|588605612|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973905|NCT02688387|588605613|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973906|NCT02688387|588605614|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973907|NCT02688387|588605615|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973908|NCT02688387|588605616|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973909|NCT02688387|588605617|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973910|NCT02688387|588605618|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973911|NCT02688387|588605619|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973912|NCT02688387|588605620|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973913|NCT02688387|588605621|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973914|NCT02688387|588605622|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973915|NCT02688387|588605623|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973916|NCT02688387|588605624|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973917|NCT02688387|588605625|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973918|NCT02688387|588605626|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
162973919|NCT02688387|588605605|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
162712789|NCT00109967|587660749|FG001|Overall Study|Adverse Event|1|||
162973920|NCT02688387|588605606|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973921|NCT02688387|588605607|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973922|NCT02688387|588605608|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973923|NCT02688387|588605609|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973924|NCT02688387|588605610|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973925|NCT02688387|588605611|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973926|NCT02688387|588605612|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973927|NCT02688387|588605613|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973928|NCT02688387|588605614|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973929|NCT02688387|588605615|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973930|NCT02688387|588605616|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973931|NCT02688387|588605617|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973932|NCT02688387|588605618|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973933|NCT02688387|588605619|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973934|NCT02688387|588605620|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973935|NCT02688387|588605621|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973936|NCT02688387|588605622|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973937|NCT02688387|588605623|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973938|NCT02688387|588605624|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973939|NCT02688387|588605625|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973940|NCT02688387|588605626|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162973941|NCT02688387|588605605|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973942|NCT02688387|588605606|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973943|NCT02688387|588605607|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973944|NCT02688387|588605608|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973945|NCT02688387|588605609|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973946|NCT02688387|588605610|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973947|NCT02688387|588605611|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973948|NCT02688387|588605612|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973949|NCT02688387|588605613|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973950|NCT02688387|588605614|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973951|NCT02688387|588605615|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
162973952|NCT02688387|588605616|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973953|NCT02688387|588605617|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973954|NCT02688387|588605618|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973955|NCT02688387|588605619|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973956|NCT02688387|588605620|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973957|NCT02688387|588605621|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973958|NCT02688387|588605622|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973959|NCT02688387|588605623|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973960|NCT02688387|588605624|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973961|NCT02688387|588605625|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973962|NCT02688387|588605626|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162973963|NCT02688387|588605605|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973964|NCT02688387|588605606|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973965|NCT02688387|588605607|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973966|NCT02688387|588605608|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973967|NCT02688387|588605609|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973968|NCT02688387|588605610|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973969|NCT02688387|588605611|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973970|NCT02688387|588605612|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973971|NCT02688387|588605613|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973972|NCT02688387|588605614|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973973|NCT02688387|588605615|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973974|NCT02688387|588605616|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973975|NCT02688387|588605617|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973976|NCT02688387|588605618|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973977|NCT02688387|588605619|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
162973978|NCT02688387|588605620|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973979|NCT02688387|588605621|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973980|NCT02688387|588605622|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973981|NCT02688387|588605623|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973982|NCT02688387|588605624|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973983|NCT02688387|588605625|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973984|NCT02688387|588605626|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162973985|NCT02688387|588605605|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973986|NCT02688387|588605606|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
163057299|NCT02194465|588921209|FG006|Overall Study|Withdrawal by Subject|2|||
163057300|NCT02194465|588921203|FG000|Overall Study|Discontinued follow-up period|0|||
163057301|NCT02194465|588921204|FG001|Overall Study|Discontinued follow-up period|2|||
163057302|NCT02194465|588921205|FG002|Overall Study|Discontinued follow-up period|1|||
163057303|NCT02194465|588921206|FG003|Overall Study|Discontinued follow-up period|0|||
163057304|NCT02194465|588921207|FG004|Overall Study|Discontinued follow-up period|2|||
163057305|NCT02194465|588921208|FG005|Overall Study|Discontinued follow-up period|0|||
162973987|NCT02688387|588605607|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973988|NCT02688387|588605608|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973989|NCT02688387|588605609|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973990|NCT02688387|588605610|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973991|NCT02688387|588605611|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973992|NCT02688387|588605612|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973993|NCT02688387|588605613|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973994|NCT02688387|588605614|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973995|NCT02688387|588605615|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973996|NCT02688387|588605616|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973997|NCT02688387|588605617|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
163057306|NCT02194465|588921209|FG006|Overall Study|Discontinued follow-up period|0|||
163057307|NCT00420745|588921210|FG000|Overall Study|Adverse Event|2|||
163057308|NCT00420745|588921211|FG001|Overall Study|Adverse Event|2|||
163057309|NCT00420745|588921210|FG000|Overall Study|Lost to Follow-up|10|||
162973998|NCT02688387|588605618|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162973999|NCT02688387|588605619|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974000|NCT02688387|588605620|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974001|NCT02688387|588605621|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974002|NCT02688387|588605622|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974003|NCT02688387|588605623|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974004|NCT02688387|588605624|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974005|NCT02688387|588605625|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
162974006|NCT02688387|588605626|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
162974007|NCT02688387|588605605|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974008|NCT02688387|588605606|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974009|NCT02688387|588605607|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974010|NCT02688387|588605608|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974011|NCT02688387|588605609|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
163057310|NCT00420745|588921211|FG001|Overall Study|Lost to Follow-up|2|||
163057311|NCT00420745|588921210|FG000|Overall Study|Protocol Violation|1|||
163057312|NCT00420745|588921211|FG001|Overall Study|Protocol Violation|0|||
163057313|NCT00420745|588921210|FG000|Overall Study|Physician Decision|1|||
163057314|NCT00420745|588921211|FG001|Overall Study|Physician Decision|1|||
163057315|NCT00420745|588921210|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
163057316|NCT00420745|588921211|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
163057317|NCT00420745|588921210|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
163057318|NCT00420745|588921211|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
163057319|NCT02058095|588921212|FG000|Overall Study|Adverse Event|1|||
163057320|NCT02058095|588921213|FG001|Overall Study|Adverse Event|0|||
163057321|NCT00726453|588921214|FG000|Primary Enrollment Group|Death|18|||
163057322|NCT00726453|588921215|FG001|Primary Enrollment Group|Death|0|||
163057323|NCT00726453|588921214|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
163057324|NCT00726453|588921215|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
163057325|NCT00726453|588921214|FG000|38 mm Length Group|Death|0|||
163057326|NCT00726453|588921215|FG001|38 mm Length Group|Death|3|||
163057327|NCT01983930|588921218|FG000|Overall Study|Withdrawal by Subject|9|||
163057328|NCT01983930|588921219|FG001|Overall Study|Withdrawal by Subject|8|||
163057329|NCT01983930|588921218|FG000|Overall Study|Adverse Event|0|||
162630280|NCT01425281|587365100|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
162630281|NCT01425281|587365101|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
162630282|NCT01425281|587365100|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
162630283|NCT01425281|587365101|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
162630284|NCT01425281|587365100|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
162974012|NCT02688387|588605610|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974013|NCT02688387|588605611|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974014|NCT02688387|588605612|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974015|NCT02688387|588605613|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974016|NCT02688387|588605614|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
163057330|NCT01983930|588921219|FG001|Overall Study|Adverse Event|1|||
163057331|NCT01454284|588921220|FG000|Overall Study|Adverse Event|20|||
163057332|NCT01454284|588921221|FG001|Overall Study|Adverse Event|7|||
163057333|NCT01454284|588921220|FG000|Overall Study|Death|0|||
163057334|NCT01454284|588921221|FG001|Overall Study|Death|3|||
162974017|NCT02688387|588605615|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974018|NCT02688387|588605616|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974019|NCT02688387|588605617|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974020|NCT02688387|588605618|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974021|NCT02688387|588605619|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974022|NCT02688387|588605620|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974023|NCT02688387|588605621|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974024|NCT02688387|588605622|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974025|NCT02688387|588605623|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
162974026|NCT02688387|588605624|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974027|NCT02688387|588605625|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
162974028|NCT02688387|588605626|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
162974029|NCT02688387|588605605|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974030|NCT02688387|588605606|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974031|NCT02688387|588605607|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974032|NCT02688387|588605608|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974033|NCT02688387|588605609|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974034|NCT02688387|588605610|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974035|NCT02688387|588605611|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974036|NCT02688387|588605612|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974037|NCT02688387|588605613|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
163057335|NCT01454284|588921220|FG000|Overall Study|Lost to Follow-up|13|||
163057336|NCT01454284|588921221|FG001|Overall Study|Lost to Follow-up|8|||
163057337|NCT01454284|588921220|FG000|Overall Study|Protocol Violation|9|||
162974038|NCT02688387|588605614|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974039|NCT02688387|588605615|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974040|NCT02688387|588605616|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974041|NCT02688387|588605617|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974042|NCT02688387|588605618|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974043|NCT02688387|588605619|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974044|NCT02688387|588605620|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974045|NCT02688387|588605621|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974046|NCT02688387|588605622|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974047|NCT02688387|588605623|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974048|NCT02688387|588605624|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
162974049|NCT02688387|588605625|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974050|NCT02688387|588605626|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162974051|NCT02938442|588605627|FG000|Overall Study|Death|0|||
162974052|NCT02938442|588605628|FG001|Overall Study|Death|1|||
162974053|NCT02938442|588605627|FG000|Overall Study|Lost to Follow-up|0|||
162974054|NCT02938442|588605628|FG001|Overall Study|Lost to Follow-up|1|||
162974055|NCT02938442|588605627|FG000|Overall Study|Physician Decision|0|||
162974056|NCT02938442|588605628|FG001|Overall Study|Physician Decision|1|||
162974057|NCT02938442|588605627|FG000|Overall Study|Withdrawal by Subject|2|||
162974058|NCT02938442|588605628|FG001|Overall Study|Withdrawal by Subject|0|||
162974059|NCT00802178|588605629|FG000|Overall Study|Lack of Efficacy|36|||
162974060|NCT00802178|588605629|FG000|Overall Study|Insufficient tolerability (IT)|17|||
162974061|NCT00802178|588605629|FG000|Overall Study|Withdrawal by Subject|18|||
162974062|NCT00802178|588605629|FG000|Overall Study|Other|32|||
162974063|NCT00802178|588605629|FG000|Overall Study|Lack of efficacy and patient wish|1|||
162974064|NCT00802178|588605629|FG000|Overall Study|IT and patient wish|8|||
162974065|NCT00802178|588605629|FG000|Overall Study|Patients wish and other reason|1|||
162974066|NCT01606228|588605630|FG000|Overall Study|Lost to Follow-up|20|||
162974067|NCT01606228|588605630|FG000|Overall Study|Withdrawal by Subject|3|||
162974068|NCT01606228|588605630|FG000|Overall Study|Non-compliant|3|||
162974069|NCT01606228|588605630|FG000|Overall Study|Lack of Efficacy|2|||
162974070|NCT01606228|588605630|FG000|Overall Study|Adverse Event|1|||
162974071|NCT01115855|588605631|FG000|Overall Study|Adverse Event|16|||
162974072|NCT01115855|588605632|FG001|Overall Study|Adverse Event|18|||
162974073|NCT01115855|588605631|FG000|Overall Study|Death|6|||
162974074|NCT01115855|588605632|FG001|Overall Study|Death|5|||
163057338|NCT01454284|588921221|FG001|Overall Study|Protocol Violation|6|||
163057339|NCT01454284|588921220|FG000|Overall Study|Withdrawal by Subject|58|||
163057340|NCT01454284|588921221|FG001|Overall Study|Withdrawal by Subject|36|||
163057341|NCT01454284|588921220|FG000|Overall Study|Physician Decision|16|||
163057342|NCT01454284|588921221|FG001|Overall Study|Physician Decision|11|||
162974075|NCT01115855|588605631|FG000|Overall Study|Lab Abnormality|1|||
162974076|NCT01115855|588605632|FG001|Overall Study|Lab Abnormality|1|||
162974077|NCT01115855|588605631|FG000|Overall Study|Protocol Violation|0|||
162974078|NCT01115855|588605632|FG001|Overall Study|Protocol Violation|1|||
162974079|NCT01115855|588605631|FG000|Overall Study|Withdrawal by Subject|5|||
163057343|NCT01454284|588921220|FG000|Overall Study|Sponsor Decision|0|||
163057344|NCT01454284|588921221|FG001|Overall Study|Sponsor Decision|2|||
162974080|NCT01115855|588605632|FG001|Overall Study|Withdrawal by Subject|5|||
162974081|NCT01115855|588605631|FG000|Overall Study|Other|8|||
162974082|NCT01115855|588605632|FG001|Overall Study|Other|6|||
162974083|NCT04100096|588605633|FG000|Overall Study|Adverse Event|19|||
162974084|NCT04100096|588605634|FG001|Overall Study|Adverse Event|7|||
162974085|NCT04100096|588605633|FG000|Overall Study|Lack of Efficacy|0|||
162974086|NCT04100096|588605634|FG001|Overall Study|Lack of Efficacy|1|||
162974087|NCT04100096|588605633|FG000|Overall Study|Lost to Follow-up|13|||
162974088|NCT04100096|588605634|FG001|Overall Study|Lost to Follow-up|11|||
162974089|NCT04100096|588605633|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162974090|NCT04100096|588605634|FG001|Overall Study|Non-Compliance With Study Drug|3|||
162974091|NCT04100096|588605633|FG000|Overall Study|Protocol Deviation|1|||
162974092|NCT04100096|588605634|FG001|Overall Study|Protocol Deviation|1|||
162974093|NCT04100096|588605633|FG000|Overall Study|Withdrawal by Participant|13|||
162974094|NCT04100096|588605634|FG001|Overall Study|Withdrawal by Participant|15|||
162974095|NCT01684215|588605635|FG000|Phase 1, Part 1|Adverse Event|1|||
162974096|NCT01684215|588605636|FG001|Phase 1, Part 1|Adverse Event|0|||
162974097|NCT01684215|588605637|FG002|Phase 1, Part 1|Adverse Event|0|||
162974098|NCT01684215|588605638|FG003|Phase 1, Part 1|Adverse Event|0|||
162974099|NCT01684215|588605635|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
162974100|NCT01684215|588605636|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
162974101|NCT01684215|588605637|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
162974102|NCT01684215|588605638|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
162974103|NCT01684215|588605635|FG000|Phase 1, Part 2|Adverse Event|0|||
162974104|NCT01684215|588605636|FG001|Phase 1, Part 2|Adverse Event|0|||
162974105|NCT01684215|588605637|FG002|Phase 1, Part 2|Adverse Event|1|||
162974106|NCT01684215|588605638|FG003|Phase 1, Part 2|Adverse Event|0|||
162974107|NCT01684215|588605635|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974108|NCT01684215|588605636|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974109|NCT01684215|588605637|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
162974110|NCT01684215|588605638|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162974111|NCT01684215|588605635|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
162974112|NCT01684215|588605636|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
162974113|NCT01684215|588605637|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
162974114|NCT01684215|588605638|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
162974115|NCT01684215|588605635|FG000|Phase 2|Death|0|||
162974116|NCT01684215|588605636|FG001|Phase 2|Death|0|||
162974117|NCT01684215|588605637|FG002|Phase 2|Death|0|||
162974118|NCT01684215|588605638|FG003|Phase 2|Death|8|||
162974119|NCT01684215|588605635|FG000|Phase 2|Study terminated by sponsor|0|||
162974120|NCT01684215|588605636|FG001|Phase 2|Study terminated by sponsor|0|||
162974121|NCT01684215|588605637|FG002|Phase 2|Study terminated by sponsor|0|||
162974122|NCT01684215|588605638|FG003|Phase 2|Study terminated by sponsor|30|||
162974123|NCT01684215|588605635|FG000|Phase 2|Enrolled but not treated|0|||
162974124|NCT01684215|588605636|FG001|Phase 2|Enrolled but not treated|0|||
162974125|NCT01684215|588605637|FG002|Phase 2|Enrolled but not treated|0|||
162974126|NCT01684215|588605638|FG003|Phase 2|Enrolled but not treated|1|||
162974127|NCT01684215|588605635|FG000|Phase 2|Lost to Follow-up|0|||
162974128|NCT01684215|588605636|FG001|Phase 2|Lost to Follow-up|0|||
162974129|NCT01684215|588605637|FG002|Phase 2|Lost to Follow-up|0|||
162974130|NCT01684215|588605638|FG003|Phase 2|Lost to Follow-up|4|||
162974131|NCT00480324|588605639|FG000|Overall Study|Adverse Event|1|||
162974132|NCT00480324|588605640|FG001|Overall Study|Adverse Event|1|||
162974133|NCT00480324|588605639|FG000|Overall Study|Protocol Violation|0|||
162974134|NCT00480324|588605640|FG001|Overall Study|Protocol Violation|1|||
162974135|NCT00480324|588605639|FG000|Overall Study|Withdrawal by Subject|14|||
162630285|NCT01425281|587365101|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
162630286|NCT01425281|587365100|FG000|At 3-year Clinical Follow-up|Death|2|||
162630287|NCT01425281|587365101|FG001|At 3-year Clinical Follow-up|Death|3|||
162630288|NCT01425281|587365100|FG000|At 4-year Clinical Follow-up|Death|7|||
162630289|NCT01425281|587365101|FG001|At 4-year Clinical Follow-up|Death|3|||
162630290|NCT01425281|587365100|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
162630291|NCT01425281|587365101|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
162630292|NCT01425281|587365100|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
162630293|NCT01425281|587365101|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
162630294|NCT01425281|587365100|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
162974136|NCT00480324|588605640|FG001|Overall Study|Withdrawal by Subject|5|||
162974137|NCT00480324|588605639|FG000|Overall Study|Lost to Follow-up|17|||
162974138|NCT00480324|588605640|FG001|Overall Study|Lost to Follow-up|8|||
162974139|NCT00480324|588605639|FG000|Overall Study|Subject's mother pregnant|0|||
162974140|NCT00480324|588605640|FG001|Overall Study|Subject's mother pregnant|1|||
162974141|NCT00784134|588605641|FG000|Overall Study|Lost to Follow-up|3|||
162974142|NCT00784134|588605642|FG001|Overall Study|Lost to Follow-up|6|||
162974143|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
162974144|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
162974145|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
162923697|NCT00566631|588422193|FG000|Part 2: Extension Phase|Adverse Event|11|||
162923698|NCT00566631|588422193|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
162923699|NCT00566631|588422193|FG000|Part 2: Extension Phase|Death|1|||
162923700|NCT00566631|588422193|FG000|Part 2: Extension Phase|Other|5|||
162923701|NCT01257737|588422194|FG000|Overall Study|Lost to Follow-up|1|||
162923702|NCT01257737|588422195|FG001|Overall Study|Lost to Follow-up|2|||
162923703|NCT01257737|588422194|FG000|Overall Study|Liver transplant|1|||
162923704|NCT01257737|588422195|FG001|Overall Study|Liver transplant|0|||
162974146|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
162974147|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
162974148|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
162974149|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
162974150|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
162974151|NCT03785145|588605643|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
162974152|NCT03785145|588605644|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
162974153|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
162974154|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
162974155|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
162974156|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
162974157|NCT03785145|588605643|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
162974158|NCT03785145|588605644|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
162974159|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
162974160|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
162974161|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
162974162|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
162974163|NCT03785145|588605643|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
162974164|NCT03785145|588605644|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
162974165|NCT01796964|588605647|FG000|Overall Study|Adverse Event|1|||
162974166|NCT01796964|588605648|FG001|Overall Study|Adverse Event|1|||
162974167|NCT01796964|588605647|FG000|Overall Study|Death|1|||
162974168|NCT01796964|588605648|FG001|Overall Study|Death|0|||
162974169|NCT01796964|588605647|FG000|Overall Study|Protocol Violation|0|||
162974170|NCT01796964|588605648|FG001|Overall Study|Protocol Violation|1|||
162974171|NCT01796964|588605647|FG000|Overall Study|Withdrawal by Subject|1|||
162974172|NCT01796964|588605648|FG001|Overall Study|Withdrawal by Subject|1|||
162974173|NCT04025684|588605649|FG000|Overall Study|Withdrawal by Subject|1|||
162974174|NCT04025684|588605650|FG001|Overall Study|Withdrawal by Subject|1|||
162974175|NCT04025684|588605651|FG002|Overall Study|Withdrawal by Subject|0|||
162974176|NCT04025684|588605652|FG003|Overall Study|Withdrawal by Subject|0|||
162974177|NCT04025684|588605649|FG000|Overall Study|Multiple reasons|1|||
162974178|NCT04025684|588605650|FG001|Overall Study|Multiple reasons|3|||
162974179|NCT04025684|588605651|FG002|Overall Study|Multiple reasons|0|||
162974180|NCT04025684|588605652|FG003|Overall Study|Multiple reasons|1|||
162974181|NCT01613378|588605653|FG000|Overall Study|Lack of Efficacy|13|||
162974182|NCT01613378|588605653|FG000|Overall Study|Adverse Event|11|||
162974183|NCT01613378|588605653|FG000|Overall Study|Withdrawal by Subject|8|||
162974184|NCT01613378|588605653|FG000|Overall Study|Death|2|||
162923705|NCT01257737|588422194|FG000|Overall Study|Relocation out of the country|0|||
162923706|NCT01257737|588422195|FG001|Overall Study|Relocation out of the country|1|||
162923707|NCT01257737|588422194|FG000|Overall Study|Withdrew from study|0|||
162974185|NCT01613378|588605653|FG000|Overall Study|Lost to Follow-up|1|||
162974186|NCT01613378|588605653|FG000|Overall Study|Other Reason|4|||
162974187|NCT01239472|588605654|FG000|Overall Study|Withdrawal by Subject|5|||
163057345|NCT02842866|588921224|FG000|Overall Study|Serious Adverse Event|0|||
163057346|NCT02842866|588921225|FG001|Overall Study|Serious Adverse Event|1|||
163057347|NCT02842866|588921224|FG000|Overall Study|Protocol Violation|4|||
163057348|NCT02842866|588921225|FG001|Overall Study|Protocol Violation|2|||
163057349|NCT02842866|588921224|FG000|Overall Study|Lost to Follow-up|2|||
163057350|NCT02842866|588921225|FG001|Overall Study|Lost to Follow-up|0|||
163057351|NCT02842866|588921224|FG000|Overall Study|Withdrawal by Subject|1|||
163057352|NCT02842866|588921225|FG001|Overall Study|Withdrawal by Subject|0|||
163057353|NCT01432327|588921226|FG000|Posttest 3 Months|depression|3|||
163057354|NCT01432327|588921227|FG001|Posttest 3 Months|depression|0|||
163057355|NCT01432327|588921228|FG002|Posttest 3 Months|depression|0|||
163057356|NCT01432327|588921229|FG003|Posttest 3 Months|depression|0|||
163057357|NCT01432327|588921226|FG000|Posttest 3 Months|Lost to Follow-up|1|||
163057358|NCT01432327|588921227|FG001|Posttest 3 Months|Lost to Follow-up|0|||
163057359|NCT01432327|588921228|FG002|Posttest 3 Months|Lost to Follow-up|2|||
163057360|NCT01432327|588921229|FG003|Posttest 3 Months|Lost to Follow-up|1|||
163057361|NCT01432327|588921226|FG000|Posttest 3 Months|Allergic reaction|0|||
163057362|NCT01432327|588921227|FG001|Posttest 3 Months|Allergic reaction|2|||
163057363|NCT01432327|588921228|FG002|Posttest 3 Months|Allergic reaction|0|||
163057364|NCT01432327|588921229|FG003|Posttest 3 Months|Allergic reaction|0|||
163057365|NCT01432327|588921226|FG000|Posttest 6 Months|Lost to Follow-up|0|||
163057366|NCT01432327|588921227|FG001|Posttest 6 Months|Lost to Follow-up|0|||
163057367|NCT01432327|588921228|FG002|Posttest 6 Months|Lost to Follow-up|3|||
163057368|NCT01432327|588921229|FG003|Posttest 6 Months|Lost to Follow-up|2|||
163057369|NCT01432327|588921226|FG000|Posttest 6 Months|Allergic reaction|0|||
163057370|NCT01432327|588921227|FG001|Posttest 6 Months|Allergic reaction|0|||
162974188|NCT01239472|588605655|FG001|Overall Study|Withdrawal by Subject|1|||
162974189|NCT01239472|588605654|FG000|Overall Study|Adverse Event|0|||
162974190|NCT01239472|588605655|FG001|Overall Study|Adverse Event|1|||
162974191|NCT01239472|588605654|FG000|Overall Study|Lack of Efficacy|0|||
162974192|NCT01239472|588605655|FG001|Overall Study|Lack of Efficacy|1|||
162974193|NCT00418522|588605659|FG000|Overall Study|Adverse Event|7|||
162974194|NCT00418522|588605660|FG001|Overall Study|Adverse Event|1|||
162974195|NCT00418522|588605659|FG000|Overall Study|Lack of Efficacy|1|||
162974196|NCT00418522|588605660|FG001|Overall Study|Lack of Efficacy|3|||
162974197|NCT00418522|588605659|FG000|Overall Study|Lost to Follow-up|10|||
162974198|NCT00418522|588605660|FG001|Overall Study|Lost to Follow-up|4|||
162974199|NCT00418522|588605659|FG000|Overall Study|Withdrawal by Subject|31|||
162974200|NCT00418522|588605660|FG001|Overall Study|Withdrawal by Subject|7|||
162974201|NCT00418522|588605659|FG000|Overall Study|Other|27|||
162974202|NCT00418522|588605660|FG001|Overall Study|Other|23|||
162974203|NCT00418522|588605659|FG000|Overall Study|Randomized but did not receive treatment|7|||
162974204|NCT00418522|588605660|FG001|Overall Study|Randomized but did not receive treatment|4|||
162974205|NCT02695719|588605661|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
162974206|NCT02695719|588605662|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
162974207|NCT02695719|588605661|FG000|Overall Study|Significant Protocol Deviation|0|||
162974208|NCT02695719|588605662|FG001|Overall Study|Significant Protocol Deviation|1|||
162974209|NCT02695719|588605661|FG000|Overall Study|Voluntary Withdrawal|1|||
162974210|NCT02695719|588605662|FG001|Overall Study|Voluntary Withdrawal|0|||
162974211|NCT00868296|588605665|FG000|Overall Study|Adverse Event|0|||
162974212|NCT00868296|588605666|FG001|Overall Study|Adverse Event|2|||
162974213|NCT00868296|588605665|FG000|Overall Study|Withdrawal by Subject|0|||
162974214|NCT00868296|588605666|FG001|Overall Study|Withdrawal by Subject|1|||
162974215|NCT01714739|588605667|FG000|Overall Study|Disease progression|3|||
162974216|NCT01714739|588605668|FG001|Overall Study|Disease progression|5|||
162974217|NCT01714739|588605669|FG002|Overall Study|Disease progression|5|||
162974218|NCT01714739|588605670|FG003|Overall Study|Disease progression|204|||
162974219|NCT01714739|588605671|FG004|Overall Study|Disease progression|1|||
162974220|NCT01714739|588605672|FG005|Overall Study|Disease progression|3|||
162974221|NCT01714739|588605673|FG006|Overall Study|Disease progression|5|||
162974222|NCT01714739|588605667|FG000|Overall Study|Study drug toxicity|1|||
162974223|NCT01714739|588605668|FG001|Overall Study|Study drug toxicity|1|||
162974224|NCT01714739|588605669|FG002|Overall Study|Study drug toxicity|1|||
162974225|NCT01714739|588605670|FG003|Overall Study|Study drug toxicity|15|||
162974226|NCT01714739|588605671|FG004|Overall Study|Study drug toxicity|0|||
162974227|NCT01714739|588605672|FG005|Overall Study|Study drug toxicity|0|||
162974228|NCT01714739|588605673|FG006|Overall Study|Study drug toxicity|5|||
162974229|NCT01714739|588605667|FG000|Overall Study|Death|0|||
162974230|NCT01714739|588605668|FG001|Overall Study|Death|0|||
162974231|NCT01714739|588605669|FG002|Overall Study|Death|0|||
162974232|NCT01714739|588605670|FG003|Overall Study|Death|1|||
162974233|NCT01714739|588605671|FG004|Overall Study|Death|0|||
163057371|NCT01432327|588921228|FG002|Posttest 6 Months|Allergic reaction|1|||
163057372|NCT01432327|588921229|FG003|Posttest 6 Months|Allergic reaction|0|||
163057373|NCT01432327|588921226|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
163057374|NCT01432327|588921227|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
163057375|NCT01432327|588921228|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
163057376|NCT01432327|588921229|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
162974234|NCT01714739|588605672|FG005|Overall Study|Death|0|||
162974235|NCT01714739|588605673|FG006|Overall Study|Death|0|||
162974236|NCT01714739|588605667|FG000|Overall Study|Adverse Event unrelated to drug|0|||
162974237|NCT01714739|588605668|FG001|Overall Study|Adverse Event unrelated to drug|0|||
162974238|NCT01714739|588605669|FG002|Overall Study|Adverse Event unrelated to drug|3|||
162974239|NCT01714739|588605670|FG003|Overall Study|Adverse Event unrelated to drug|21|||
162974240|NCT01714739|588605671|FG004|Overall Study|Adverse Event unrelated to drug|0|||
162974241|NCT01714739|588605672|FG005|Overall Study|Adverse Event unrelated to drug|0|||
162974242|NCT01714739|588605673|FG006|Overall Study|Adverse Event unrelated to drug|0|||
162974243|NCT01714739|588605667|FG000|Overall Study|Participant request to stop therapy|0|||
162974244|NCT01714739|588605668|FG001|Overall Study|Participant request to stop therapy|1|||
162974245|NCT01714739|588605669|FG002|Overall Study|Participant request to stop therapy|0|||
162974246|NCT01714739|588605670|FG003|Overall Study|Participant request to stop therapy|6|||
162974247|NCT01714739|588605671|FG004|Overall Study|Participant request to stop therapy|0|||
162974248|NCT01714739|588605672|FG005|Overall Study|Participant request to stop therapy|0|||
162974249|NCT01714739|588605673|FG006|Overall Study|Participant request to stop therapy|0|||
162974250|NCT01714739|588605667|FG000|Overall Study|Participant withdrew consent|0|||
162974251|NCT01714739|588605668|FG001|Overall Study|Participant withdrew consent|1|||
162974252|NCT01714739|588605669|FG002|Overall Study|Participant withdrew consent|0|||
162974253|NCT01714739|588605670|FG003|Overall Study|Participant withdrew consent|8|||
162974254|NCT01714739|588605671|FG004|Overall Study|Participant withdrew consent|0|||
162974255|NCT01714739|588605672|FG005|Overall Study|Participant withdrew consent|0|||
162974256|NCT01714739|588605673|FG006|Overall Study|Participant withdrew consent|0|||
162974257|NCT01714739|588605667|FG000|Overall Study|Lost to Follow-up|0|||
162974258|NCT01714739|588605668|FG001|Overall Study|Lost to Follow-up|0|||
162974259|NCT01714739|588605669|FG002|Overall Study|Lost to Follow-up|0|||
162974260|NCT01714739|588605670|FG003|Overall Study|Lost to Follow-up|1|||
162974261|NCT01714739|588605671|FG004|Overall Study|Lost to Follow-up|0|||
162974262|NCT01714739|588605672|FG005|Overall Study|Lost to Follow-up|0|||
162974263|NCT01714739|588605673|FG006|Overall Study|Lost to Follow-up|0|||
162974264|NCT01714739|588605667|FG000|Overall Study|Maximum clinical benefit|0|||
162974265|NCT01714739|588605668|FG001|Overall Study|Maximum clinical benefit|1|||
162974266|NCT01714739|588605669|FG002|Overall Study|Maximum clinical benefit|1|||
162974267|NCT01714739|588605670|FG003|Overall Study|Maximum clinical benefit|3|||
162974268|NCT01714739|588605671|FG004|Overall Study|Maximum clinical benefit|0|||
162974269|NCT01714739|588605672|FG005|Overall Study|Maximum clinical benefit|0|||
162974270|NCT01714739|588605673|FG006|Overall Study|Maximum clinical benefit|0|||
162974271|NCT01714739|588605667|FG000|Overall Study|Poor/non-comliance|0|||
162974272|NCT01714739|588605668|FG001|Overall Study|Poor/non-comliance|1|||
162974273|NCT01714739|588605669|FG002|Overall Study|Poor/non-comliance|0|||
162974274|NCT01714739|588605670|FG003|Overall Study|Poor/non-comliance|1|||
162974275|NCT01714739|588605671|FG004|Overall Study|Poor/non-comliance|0|||
162974276|NCT01714739|588605672|FG005|Overall Study|Poor/non-comliance|0|||
162974277|NCT01714739|588605673|FG006|Overall Study|Poor/non-comliance|0|||
162974278|NCT01714739|588605667|FG000|Overall Study|No longer meets study criteria|0|||
162974279|NCT01714739|588605668|FG001|Overall Study|No longer meets study criteria|0|||
162974280|NCT01714739|588605669|FG002|Overall Study|No longer meets study criteria|0|||
162974281|NCT01714739|588605670|FG003|Overall Study|No longer meets study criteria|1|||
162974282|NCT01714739|588605671|FG004|Overall Study|No longer meets study criteria|0|||
162974283|NCT01714739|588605672|FG005|Overall Study|No longer meets study criteria|0|||
162974284|NCT01714739|588605673|FG006|Overall Study|No longer meets study criteria|0|||
162974285|NCT01714739|588605667|FG000|Overall Study|Other reason|0|||
162974286|NCT01714739|588605668|FG001|Overall Study|Other reason|0|||
162974287|NCT01714739|588605669|FG002|Overall Study|Other reason|0|||
162974288|NCT01714739|588605670|FG003|Overall Study|Other reason|3|||
162974289|NCT01714739|588605671|FG004|Overall Study|Other reason|1|||
162974290|NCT01714739|588605672|FG005|Overall Study|Other reason|0|||
162974291|NCT01714739|588605673|FG006|Overall Study|Other reason|0|||
162974292|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
162974293|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
162974294|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
162974295|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
162974296|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
162974297|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
162974298|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
162974299|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
162974300|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
162974301|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
162974302|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
162974303|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
162974304|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
162974305|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
162974306|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
162974307|NCT02250651|588605674|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
162974308|NCT02250651|588605675|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
162974309|NCT02250651|588605676|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
162974310|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
162974311|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
162974312|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
162974313|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
162974314|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
162974315|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
162974316|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
162974317|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
162974318|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
162974319|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
162974320|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
162974321|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
162974322|NCT02250651|588605674|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
162974323|NCT02250651|588605675|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
162974324|NCT02250651|588605676|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
162974325|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
162974326|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
162974327|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
162974328|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
162974329|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
162974330|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
162974331|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
162974332|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
162974333|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
162974334|NCT02250651|588605674|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
162974335|NCT02250651|588605675|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
162974336|NCT02250651|588605676|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
162923708|NCT01257737|588422195|FG001|Overall Study|Withdrew from study|1|||
162923709|NCT02723786|588422198|FG000|Overall Study|Lost to Follow-up|1|||
162923710|NCT00127192|588422201|FG000|Overall Study|Adverse Event|0|||
162974337|NCT01557920|588605679|FG000|Overall Study|Withdrawal by Subject|2|||
162974338|NCT01557920|588605680|FG001|Overall Study|Withdrawal by Subject|3|||
162974339|NCT01557920|588605679|FG000|Overall Study|Lack of Efficacy|1|||
162974340|NCT01557920|588605680|FG001|Overall Study|Lack of Efficacy|0|||
162974341|NCT01466036|588605681|FG000|Overall Study|Death|1|||
162974342|NCT01466036|588605682|FG001|Overall Study|Death|1|||
163057377|NCT01432327|588921226|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
162923711|NCT00127192|588422202|FG001|Overall Study|Adverse Event|1|||
162923712|NCT00127192|588422203|FG002|Overall Study|Adverse Event|1|||
162923713|NCT00127192|588422204|FG003|Overall Study|Adverse Event|1|||
162923714|NCT00127192|588422205|FG004|Overall Study|Adverse Event|0|||
162923715|NCT00127192|588422201|FG000|Overall Study|Lack of Efficacy|2|||
162923716|NCT00127192|588422202|FG001|Overall Study|Lack of Efficacy|0|||
162923717|NCT00127192|588422203|FG002|Overall Study|Lack of Efficacy|0|||
162923718|NCT00127192|588422204|FG003|Overall Study|Lack of Efficacy|0|||
162923719|NCT00127192|588422205|FG004|Overall Study|Lack of Efficacy|2|||
162923720|NCT00127192|588422201|FG000|Overall Study|Withdrawal by Subject|0|||
162923721|NCT00127192|588422202|FG001|Overall Study|Withdrawal by Subject|0|||
162923722|NCT00127192|588422203|FG002|Overall Study|Withdrawal by Subject|1|||
162923723|NCT00127192|588422204|FG003|Overall Study|Withdrawal by Subject|0|||
162923724|NCT00127192|588422205|FG004|Overall Study|Withdrawal by Subject|3|||
162923725|NCT00127192|588422201|FG000|Overall Study|Adverse event in pre-treatment period|1|||
162923726|NCT00127192|588422202|FG001|Overall Study|Adverse event in pre-treatment period|0|||
162923727|NCT00127192|588422203|FG002|Overall Study|Adverse event in pre-treatment period|0|||
162923728|NCT00127192|588422204|FG003|Overall Study|Adverse event in pre-treatment period|0|||
162923729|NCT00127192|588422205|FG004|Overall Study|Adverse event in pre-treatment period|0|||
162923730|NCT03170271|588422207|FG000|Overall Study|Adverse Event|7|||
162923731|NCT03170271|588422208|FG001|Overall Study|Adverse Event|2|||
162923732|NCT03170271|588422207|FG000|Overall Study|Lost to Follow-up|0|||
162923733|NCT03170271|588422208|FG001|Overall Study|Lost to Follow-up|1|||
162923734|NCT03170271|588422207|FG000|Overall Study|Physician Decision|1|||
162923735|NCT03170271|588422208|FG001|Overall Study|Physician Decision|0|||
162923736|NCT03170271|588422207|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
162974343|NCT01466036|588605681|FG000|Overall Study|Physician Decision|0|||
162974344|NCT01466036|588605682|FG001|Overall Study|Physician Decision|4|||
162974345|NCT01466036|588605681|FG000|Overall Study|Adverse Event|2|||
162974346|NCT01466036|588605682|FG001|Overall Study|Adverse Event|6|||
162974347|NCT01466036|588605681|FG000|Overall Study|Withdrawal by Subject|2|||
162974348|NCT01466036|588605682|FG001|Overall Study|Withdrawal by Subject|8|||
162974349|NCT01466036|588605681|FG000|Overall Study|progression/relapse|14|||
162974350|NCT01466036|588605682|FG001|Overall Study|progression/relapse|21|||
162974351|NCT01466036|588605681|FG000|Overall Study|prolonged treatment delay|1|||
162974352|NCT01466036|588605682|FG001|Overall Study|prolonged treatment delay|1|||
162974353|NCT01808248|588605691|FG000|Overall Study|Lack of Efficacy|3|||
162974354|NCT01808248|588605691|FG000|Overall Study|Withdrawal by Subject|1|||
162974355|NCT01808248|588605691|FG000|Overall Study|Lost to Follow-up|1|||
162974356|NCT01175473|588605703|FG000|Overall Study|Adverse Event|2|||
162974357|NCT01175473|588605704|FG001|Overall Study|Adverse Event|2|||
162974358|NCT02508116|588605707|FG000|Overall Study|Lost to Follow-up|2|||
162974359|NCT02508116|588605708|FG001|Overall Study|Lost to Follow-up|3|||
162974360|NCT02508116|588605707|FG000|Overall Study|Withdrawal by Subject|3|||
162974361|NCT02508116|588605708|FG001|Overall Study|Withdrawal by Subject|2|||
162974362|NCT02508116|588605707|FG000|Overall Study|Protocol Violation|1|||
162974363|NCT02508116|588605708|FG001|Overall Study|Protocol Violation|2|||
162974364|NCT02508116|588605707|FG000|Overall Study|Physician Decision|2|||
162974365|NCT02508116|588605708|FG001|Overall Study|Physician Decision|0|||
162974366|NCT00109850|588605712|FG000|Overall Study|Adverse Event|1|||
162974367|NCT00109850|588605712|FG000|Overall Study|Death|2|||
162974368|NCT00109850|588605712|FG000|Overall Study|Ineligible|1|||
162974369|NCT04234464|588605713|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
162974370|NCT04234464|588605714|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
162974371|NCT03635983|588605715|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
162974372|NCT03635983|588605716|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
162974373|NCT03635983|588605715|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
162974374|NCT03635983|588605716|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
162974375|NCT03635983|588605715|FG000|Pre-Treatment Period|Other reasons|0|||
162974376|NCT03635983|588605716|FG001|Pre-Treatment Period|Other reasons|1|||
162974377|NCT03635983|588605715|FG000|Pre-Treatment Period|Disease Progression|0|||
162974378|NCT03635983|588605716|FG001|Pre-Treatment Period|Disease Progression|1|||
162974379|NCT03635983|588605715|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
162974380|NCT03635983|588605716|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
162974381|NCT03635983|588605715|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
162974382|NCT03635983|588605716|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
162974383|NCT03635983|588605715|FG000|Treatment Period|Withdrawal by Subject|3|||
162974384|NCT03635983|588605716|FG001|Treatment Period|Withdrawal by Subject|5|||
162974385|NCT03635983|588605715|FG000|Treatment Period|Death|3|||
162974386|NCT03635983|588605716|FG001|Treatment Period|Death|5|||
162974387|NCT03635983|588605715|FG000|Treatment Period|Poor/Non-compliance|2|||
162974388|NCT03635983|588605716|FG001|Treatment Period|Poor/Non-compliance|1|||
162974389|NCT03635983|588605715|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
162974390|NCT03635983|588605716|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
162974391|NCT03635983|588605715|FG000|Treatment Period|Other reasons|7|||
162974392|NCT03635983|588605716|FG001|Treatment Period|Other reasons|4|||
162974393|NCT03635983|588605715|FG000|Treatment Period|Disease progression|230|||
162974394|NCT03635983|588605716|FG001|Treatment Period|Disease progression|201|||
162974395|NCT03635983|588605715|FG000|Treatment Period|Study drug toxicity|35|||
162974396|NCT03635983|588605716|FG001|Treatment Period|Study drug toxicity|36|||
162974397|NCT03635983|588605715|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
162974398|NCT03635983|588605716|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
162974399|NCT03635983|588605715|FG000|Treatment Period|Maximum clinical benefit|3|||
162974400|NCT03635983|588605716|FG001|Treatment Period|Maximum clinical benefit|5|||
162974401|NCT03635983|588605715|FG000|Treatment Period|Administrative reason by the sponsor|1|||
162974402|NCT03635983|588605716|FG001|Treatment Period|Administrative reason by the sponsor|2|||
162974403|NCT03635983|588605715|FG000|Treatment Period|Lost to Follow-up|0|||
162974404|NCT03635983|588605716|FG001|Treatment Period|Lost to Follow-up|1|||
162974405|NCT00330460|588605721|FG000|Overall Study|Physician Decision|1|||
162974406|NCT00330460|588605722|FG001|Overall Study|Physician Decision|0|||
162974407|NCT00330460|588605721|FG000|Overall Study|Adverse Event|10|||
162974408|NCT00330460|588605722|FG001|Overall Study|Adverse Event|8|||
162974409|NCT00330460|588605721|FG000|Overall Study|Withdrawal by Subject|18|||
162974410|NCT00330460|588605722|FG001|Overall Study|Withdrawal by Subject|17|||
162974411|NCT00330460|588605721|FG000|Overall Study|Death|1|||
162974412|NCT00330460|588605722|FG001|Overall Study|Death|1|||
162974413|NCT00330460|588605721|FG000|Overall Study|Ineligibility determined|1|||
162974414|NCT00330460|588605722|FG001|Overall Study|Ineligibility determined|3|||
162630295|NCT01425281|587365101|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
162974415|NCT00330460|588605721|FG000|Overall Study|Lost to Follow-up|8|||
162974416|NCT00330460|588605722|FG001|Overall Study|Lost to Follow-up|3|||
162974417|NCT00330460|588605721|FG000|Overall Study|Noncompliance|2|||
162974418|NCT00330460|588605722|FG001|Overall Study|Noncompliance|1|||
162974419|NCT00330460|588605721|FG000|Overall Study|Other|1|||
162974420|NCT00330460|588605722|FG001|Overall Study|Other|0|||
162974421|NCT01857973|588605723|FG000|Overall Study|Subject did not meet required BG range|3|||
162974422|NCT01857973|588605723|FG000|Overall Study|drop out after 3 failed attempts|1|||
162974423|NCT01857973|588605723|FG000|Overall Study|Physician Decision|1|||
162974424|NCT00388037|588605726|FG000|Overall Study|Protocol Violation|1|||
162974425|NCT01435031|588605728|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
162974426|NCT01435031|588605728|FG000|ITT at 1 Month|Death|1|||
162974427|NCT01435031|588605728|FG000|ITT at 1 Month|Lost to Follow-up|4|||
162974428|NCT01435031|588605728|FG000|ITT at 6 Months|Death|2|||
162974429|NCT01435031|588605728|FG000|ITT at 6 Months|Lost to Follow-up|3|||
162974430|NCT01435031|588605728|FG000|ITT at 1 Year|Death|1|||
162974431|NCT01435031|588605728|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
162974432|NCT01435031|588605728|FG000|ITT at 1 Year|Lost to Follow-up|6|||
162974433|NCT01435031|588605728|FG000|ITT at 2 Years|Death|7|||
162974434|NCT01435031|588605728|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
162974435|NCT01435031|588605728|FG000|ITT at 2 Years|Lost to Follow-up|4|||
162974436|NCT01435031|588605728|FG000|ITT at 3 Years|Death|5|||
162974437|NCT01435031|588605728|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
162974438|NCT01435031|588605728|FG000|ITT at 3 Years|Lost to Follow-up|4|||
162974439|NCT01435031|588605728|FG000|ITT at 4 Years|Death|4|||
162974440|NCT01435031|588605728|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
162974441|NCT01435031|588605728|FG000|ITT at 4 Years|Lost to Follow-up|1|||
162974442|NCT00104247|588605729|FG000|Overall Study|Withdrawal by Subject|1|||
162974443|NCT00104247|588605730|FG001|Overall Study|Withdrawal by Subject|0|||
162974444|NCT00104247|588605729|FG000|Overall Study|Noncompliant with dosing|0|||
162974445|NCT00104247|588605730|FG001|Overall Study|Noncompliant with dosing|1|||
162974446|NCT03718117|588605731|FG000|Overall Study|Death|12|||
162974447|NCT03718117|588605732|FG001|Overall Study|Death|11|||
162974448|NCT03718117|588605733|FG002|Overall Study|Death|0|||
162974449|NCT03718117|588605731|FG000|Overall Study|Other|0|||
162974450|NCT03718117|588605732|FG001|Overall Study|Other|1|||
162974451|NCT03718117|588605733|FG002|Overall Study|Other|0|||
162974452|NCT03718117|588605731|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
162974453|NCT03718117|588605732|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
162974454|NCT03718117|588605733|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
162974455|NCT03718117|588605731|FG000|Overall Study|Participant not met eligibility criteria|0|||
162974456|NCT03718117|588605732|FG001|Overall Study|Participant not met eligibility criteria|0|||
162974457|NCT03718117|588605733|FG002|Overall Study|Participant not met eligibility criteria|2|||
162974458|NCT01378962|588605734|FG000|Overall Study|Death|14|||
162974459|NCT01378962|588605734|FG000|Overall Study|Lost to Follow-up|1|||
162974460|NCT01378962|588605734|FG000|Overall Study|Other|2|||
162974461|NCT02030535|588605735|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
162974462|NCT01588548|588605736|FG000|Overall Study|Withdrawal by Subject|0|||
162974463|NCT01588548|588605737|FG001|Overall Study|Withdrawal by Subject|1|||
162974464|NCT01588548|588605738|FG002|Overall Study|Withdrawal by Subject|1|||
162974465|NCT01588548|588605739|FG003|Overall Study|Withdrawal by Subject|1|||
162974466|NCT01588548|588605740|FG004|Overall Study|Withdrawal by Subject|2|||
162974467|NCT01588548|588605741|FG005|Overall Study|Withdrawal by Subject|3|||
162974468|NCT01588548|588605736|FG000|Overall Study|Adverse Event|0|||
162974469|NCT01588548|588605737|FG001|Overall Study|Adverse Event|0|||
162974470|NCT01588548|588605738|FG002|Overall Study|Adverse Event|1|||
162974471|NCT01588548|588605739|FG003|Overall Study|Adverse Event|2|||
162974472|NCT01588548|588605740|FG004|Overall Study|Adverse Event|1|||
162974473|NCT01588548|588605741|FG005|Overall Study|Adverse Event|0|||
162974474|NCT01588548|588605736|FG000|Overall Study|Condition Under Investigation Worsened|3|||
162974475|NCT01588548|588605737|FG001|Overall Study|Condition Under Investigation Worsened|6|||
162974476|NCT01588548|588605738|FG002|Overall Study|Condition Under Investigation Worsened|4|||
162712790|NCT00109967|587660748|FG000|Overall Study|Withdrawal by Subject|5|||
162974477|NCT01588548|588605739|FG003|Overall Study|Condition Under Investigation Worsened|4|||
162974478|NCT01588548|588605740|FG004|Overall Study|Condition Under Investigation Worsened|3|||
162974479|NCT01588548|588605741|FG005|Overall Study|Condition Under Investigation Worsened|3|||
162974480|NCT01634854|588605742|FG000|Overall Study|Cesarean delivery|2|||
162974481|NCT01634854|588605743|FG001|Overall Study|Cesarean delivery|7|||
162974482|NCT03257254|588605744|FG000|Overall Study|Withdrawal by Subject|7|||
162974483|NCT03257254|588605744|FG000|Overall Study|Lost to Follow-up|9|||
162974484|NCT03257254|588605744|FG000|Overall Study|Study discontinued by sponsor|5|||
162974485|NCT02219308|588605745|FG000|Overall Study|Withdrawal by Subject|1|||
162712791|NCT00109967|587660749|FG001|Overall Study|Withdrawal by Subject|0|||
162974486|NCT02219308|588605746|FG001|Overall Study|Withdrawal by Subject|2|||
162974487|NCT04149535|588605750|FG000|Overall Study|Death|11|||
162974488|NCT04149535|588605751|FG001|Overall Study|Death|7|||
162974489|NCT04149535|588605750|FG000|Overall Study|Physician Decision|10|||
162974490|NCT04149535|588605751|FG001|Overall Study|Physician Decision|4|||
162974491|NCT04149535|588605750|FG000|Overall Study|Withdrawal by Subject|6|||
162974492|NCT04149535|588605751|FG001|Overall Study|Withdrawal by Subject|7|||
162974493|NCT04149535|588605750|FG000|Overall Study|Not described|2|||
162974494|NCT04149535|588605751|FG001|Overall Study|Not described|0|||
162974495|NCT00966381|588607634|FG000|Overall Study|Withdrawal by Subject|2|||
162974496|NCT00966381|588607635|FG001|Overall Study|Withdrawal by Subject|2|||
162974497|NCT01915940|588607636|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
162974498|NCT01915940|588607637|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
162974499|NCT01915940|588607638|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
162974500|NCT01915940|588607636|FG000|Treatment Period|Decision of Participant|0|||
162974501|NCT01915940|588607637|FG001|Treatment Period|Decision of Participant|1|||
162974502|NCT01915940|588607638|FG002|Treatment Period|Decision of Participant|3|||
162974503|NCT01915940|588607636|FG000|Treatment Period|Adverse Event|0|||
162974504|NCT01915940|588607637|FG001|Treatment Period|Adverse Event|9|||
162974505|NCT01915940|588607638|FG002|Treatment Period|Adverse Event|1|||
162974506|NCT01915940|588607636|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
162974507|NCT01915940|588607637|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
162974508|NCT01915940|588607638|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
162974509|NCT03686150|588607639|FG000|Overall Study|Withdrawal by Subject|1|||
162974510|NCT03686150|588607640|FG001|Overall Study|Withdrawal by Subject|1|||
162974511|NCT03686150|588607641|FG002|Overall Study|Withdrawal by Subject|1|||
162974512|NCT03686150|588607642|FG003|Overall Study|Withdrawal by Subject|0|||
162974513|NCT03686150|588607643|FG004|Overall Study|Withdrawal by Subject|1|||
162974514|NCT03686150|588607644|FG005|Overall Study|Withdrawal by Subject|2|||
162974515|NCT03686150|588607639|FG000|Overall Study|Physician Decision|1|||
162974516|NCT03686150|588607640|FG001|Overall Study|Physician Decision|0|||
162974517|NCT03686150|588607641|FG002|Overall Study|Physician Decision|0|||
162974518|NCT03686150|588607642|FG003|Overall Study|Physician Decision|0|||
162974519|NCT03686150|588607643|FG004|Overall Study|Physician Decision|0|||
162974520|NCT03686150|588607644|FG005|Overall Study|Physician Decision|1|||
162974521|NCT03686150|588607639|FG000|Overall Study|Lost to Follow-up|0|||
162974522|NCT03686150|588607640|FG001|Overall Study|Lost to Follow-up|1|||
162974523|NCT03686150|588607641|FG002|Overall Study|Lost to Follow-up|0|||
162974524|NCT03686150|588607642|FG003|Overall Study|Lost to Follow-up|0|||
162974525|NCT03686150|588607643|FG004|Overall Study|Lost to Follow-up|0|||
162974526|NCT03686150|588607644|FG005|Overall Study|Lost to Follow-up|0|||
162974527|NCT02443324|588607645|FG000|Overall Study|Death|4|||
162974528|NCT02443324|588607646|FG001|Overall Study|Death|1|||
162974529|NCT02443324|588607647|FG002|Overall Study|Death|0|||
162974530|NCT02443324|588607648|FG003|Overall Study|Death|3|||
162974531|NCT02443324|588607649|FG004|Overall Study|Death|1|||
162974532|NCT02443324|588607650|FG005|Overall Study|Death|3|||
162974533|NCT02443324|588607651|FG006|Overall Study|Death|2|||
162974534|NCT02443324|588607645|FG000|Overall Study|Lost to Follow-up|0|||
162974535|NCT02443324|588607646|FG001|Overall Study|Lost to Follow-up|0|||
162974536|NCT02443324|588607647|FG002|Overall Study|Lost to Follow-up|0|||
162974537|NCT02443324|588607648|FG003|Overall Study|Lost to Follow-up|1|||
162974538|NCT02443324|588607649|FG004|Overall Study|Lost to Follow-up|0|||
162974539|NCT02443324|588607650|FG005|Overall Study|Lost to Follow-up|1|||
162974540|NCT02443324|588607651|FG006|Overall Study|Lost to Follow-up|0|||
162974541|NCT02443324|588607645|FG000|Overall Study|Physician Decision|0|||
162974542|NCT02443324|588607646|FG001|Overall Study|Physician Decision|3|||
162974543|NCT02443324|588607647|FG002|Overall Study|Physician Decision|5|||
162974544|NCT02443324|588607648|FG003|Overall Study|Physician Decision|1|||
162974545|NCT02443324|588607649|FG004|Overall Study|Physician Decision|1|||
162974546|NCT02443324|588607650|FG005|Overall Study|Physician Decision|0|||
162974547|NCT02443324|588607651|FG006|Overall Study|Physician Decision|2|||
162974548|NCT02443324|588607645|FG000|Overall Study|Progressive Disease|20|||
162974549|NCT02443324|588607646|FG001|Overall Study|Progressive Disease|20|||
162974550|NCT02443324|588607647|FG002|Overall Study|Progressive Disease|13|||
162974551|NCT02443324|588607648|FG003|Overall Study|Progressive Disease|10|||
162974552|NCT02443324|588607649|FG004|Overall Study|Progressive Disease|13|||
163057378|NCT01432327|588921227|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
163057379|NCT01432327|588921228|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
163057380|NCT01432327|588921229|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
163057381|NCT01432327|588921226|FG000|Posttest 1 Year|Lost to Follow-up|0|||
162630296|NCT01425281|587365100|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
163057382|NCT01432327|588921227|FG001|Posttest 1 Year|Lost to Follow-up|0|||
163057383|NCT01432327|588921228|FG002|Posttest 1 Year|Lost to Follow-up|4|||
163057384|NCT01432327|588921229|FG003|Posttest 1 Year|Lost to Follow-up|2|||
163057385|NCT01432327|588921226|FG000|Posttest 1 Year|Allergic reaction|0|||
163057386|NCT01432327|588921227|FG001|Posttest 1 Year|Allergic reaction|0|||
163057387|NCT01432327|588921228|FG002|Posttest 1 Year|Allergic reaction|1|||
162974553|NCT02443324|588607650|FG005|Overall Study|Progressive Disease|17|||
162974554|NCT02443324|588607651|FG006|Overall Study|Progressive Disease|10|||
162974555|NCT02443324|588607645|FG000|Overall Study|Withdrawal by Subject|0|||
163057388|NCT01432327|588921229|FG003|Posttest 1 Year|Allergic reaction|1|||
163057389|NCT03248037|588921230|FG000|Overall Study|Withdrawal by Subject|6|||
163057390|NCT03248037|588921231|FG001|Overall Study|Withdrawal by Subject|9|||
163057391|NCT03248037|588921230|FG000|Overall Study|Adverse Event|15|||
163057392|NCT03248037|588921231|FG001|Overall Study|Adverse Event|0|||
162974556|NCT02443324|588607646|FG001|Overall Study|Withdrawal by Subject|0|||
162974557|NCT02443324|588607647|FG002|Overall Study|Withdrawal by Subject|3|||
162974558|NCT02443324|588607648|FG003|Overall Study|Withdrawal by Subject|1|||
162974559|NCT02443324|588607649|FG004|Overall Study|Withdrawal by Subject|1|||
162974560|NCT02443324|588607650|FG005|Overall Study|Withdrawal by Subject|0|||
162974561|NCT02443324|588607651|FG006|Overall Study|Withdrawal by Subject|1|||
162974562|NCT02443324|588607645|FG000|Overall Study|Adverse Event|0|||
162974563|NCT02443324|588607646|FG001|Overall Study|Adverse Event|1|||
162974564|NCT02443324|588607647|FG002|Overall Study|Adverse Event|3|||
162974565|NCT02443324|588607648|FG003|Overall Study|Adverse Event|0|||
162974566|NCT02443324|588607649|FG004|Overall Study|Adverse Event|4|||
162974567|NCT02443324|588607650|FG005|Overall Study|Adverse Event|3|||
162974568|NCT02443324|588607651|FG006|Overall Study|Adverse Event|3|||
162974569|NCT02443324|588607645|FG000|Overall Study|Enrolled but Never Treated|0|||
162974570|NCT02443324|588607646|FG001|Overall Study|Enrolled but Never Treated|0|||
162974571|NCT02443324|588607647|FG002|Overall Study|Enrolled but Never Treated|1|||
162974572|NCT02443324|588607648|FG003|Overall Study|Enrolled but Never Treated|0|||
162974573|NCT02443324|588607649|FG004|Overall Study|Enrolled but Never Treated|1|||
162974574|NCT02443324|588607650|FG005|Overall Study|Enrolled but Never Treated|0|||
162974575|NCT02443324|588607651|FG006|Overall Study|Enrolled but Never Treated|1|||
162974576|NCT03346070|588607654|FG000|Overall Study|Death|0|||
162974577|NCT03346070|588607655|FG001|Overall Study|Death|0|||
162974578|NCT03346070|588607656|FG002|Overall Study|Death|0|||
162974579|NCT03346070|588607657|FG003|Overall Study|Death|0|||
162974580|NCT03346070|588607658|FG004|Overall Study|Death|1|||
162974581|NCT03346070|588607654|FG000|Overall Study|Lost to Follow-up|0|||
162974582|NCT03346070|588607655|FG001|Overall Study|Lost to Follow-up|1|||
162974583|NCT03346070|588607656|FG002|Overall Study|Lost to Follow-up|2|||
162974584|NCT03346070|588607657|FG003|Overall Study|Lost to Follow-up|0|||
162974585|NCT03346070|588607658|FG004|Overall Study|Lost to Follow-up|0|||
162974586|NCT03346070|588607654|FG000|Overall Study|Physician Decision|0|||
162974587|NCT03346070|588607655|FG001|Overall Study|Physician Decision|0|||
162974588|NCT03346070|588607656|FG002|Overall Study|Physician Decision|0|||
162974589|NCT03346070|588607657|FG003|Overall Study|Physician Decision|1|||
162974590|NCT03346070|588607658|FG004|Overall Study|Physician Decision|1|||
162974591|NCT03346070|588607654|FG000|Overall Study|Withdrawal by Subject|1|||
162974592|NCT03346070|588607655|FG001|Overall Study|Withdrawal by Subject|0|||
162974593|NCT03346070|588607656|FG002|Overall Study|Withdrawal by Subject|0|||
162974594|NCT03346070|588607657|FG003|Overall Study|Withdrawal by Subject|1|||
162974595|NCT03346070|588607658|FG004|Overall Study|Withdrawal by Subject|0|||
162974596|NCT03346070|588607654|FG000|Overall Study|Study medication not received as planned|2|||
162974597|NCT03346070|588607655|FG001|Overall Study|Study medication not received as planned|3|||
162974598|NCT03346070|588607656|FG002|Overall Study|Study medication not received as planned|2|||
162974599|NCT03346070|588607657|FG003|Overall Study|Study medication not received as planned|3|||
162974600|NCT03346070|588607658|FG004|Overall Study|Study medication not received as planned|2|||
162974601|NCT03346070|588607654|FG000|Overall Study|Screen Failure|0|||
162974602|NCT03346070|588607655|FG001|Overall Study|Screen Failure|0|||
162974603|NCT03346070|588607656|FG002|Overall Study|Screen Failure|0|||
162974604|NCT03346070|588607657|FG003|Overall Study|Screen Failure|1|||
162974605|NCT03346070|588607658|FG004|Overall Study|Screen Failure|1|||
162974606|NCT01844531|588607661|FG000|Overall Study|Withdrawal by Subject|0|||
162974607|NCT01844531|588607662|FG001|Overall Study|Withdrawal by Subject|1|||
162974608|NCT01844531|588607663|FG002|Overall Study|Withdrawal by Subject|0|||
162974609|NCT01844531|588607664|FG003|Overall Study|Withdrawal by Subject|0|||
162974610|NCT01546922|588607665|FG000|First Period of 10 Weeks|Protocol Violation|3|||
162974611|NCT01546922|588607666|FG001|First Period of 10 Weeks|Protocol Violation|1|||
162974612|NCT01546922|588607665|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
162974613|NCT01546922|588607666|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
162974614|NCT01546922|588607665|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
162974615|NCT01546922|588607666|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
162974616|NCT01546922|588607665|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
162974617|NCT01546922|588607666|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
163057393|NCT02897349|588921233|FG000|Overall Study|Lost to Follow-up|2|||
163057394|NCT02897349|588921234|FG001|Overall Study|Lost to Follow-up|2|||
162630297|NCT01425281|587365101|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
162974618|NCT01546922|588607665|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
162974619|NCT01546922|588607666|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
162974620|NCT00317642|588607674|FG000|Overall Study|Not Received Either Study Drug|1|||
162974621|NCT00317642|588607675|FG001|Overall Study|Not Received Either Study Drug|3|||
162974622|NCT00317642|588607674|FG000|Overall Study|Physician Decision|15|||
162974623|NCT00317642|588607675|FG001|Overall Study|Physician Decision|7|||
163057395|NCT02897349|588921233|FG000|Overall Study|Adverse Event|3|||
162974624|NCT00317642|588607674|FG000|Overall Study|Participant declined treatment|14|||
162974625|NCT00317642|588607675|FG001|Overall Study|Participant declined treatment|3|||
162974626|NCT00317642|588607674|FG000|Overall Study|Adverse Event|17|||
162974627|NCT00317642|588607675|FG001|Overall Study|Adverse Event|5|||
162974628|NCT00317642|588607674|FG000|Overall Study|Treatment Failure|56|||
162974629|NCT00317642|588607675|FG001|Overall Study|Treatment Failure|102|||
162974630|NCT00317642|588607674|FG000|Overall Study|Disease Recurrence|1|||
162974631|NCT00317642|588607675|FG001|Overall Study|Disease Recurrence|2|||
162974632|NCT00317642|588607674|FG000|Overall Study|Death|14|||
162974633|NCT00317642|588607675|FG001|Overall Study|Death|7|||
162974634|NCT00317642|588607674|FG000|Overall Study|Not Continue to Consolidation|2|||
162974635|NCT00317642|588607675|FG001|Overall Study|Not Continue to Consolidation|0|||
162974636|NCT00317642|588607674|FG000|Overall Study|Withdrawal by Subject|0|||
162974637|NCT00317642|588607675|FG001|Overall Study|Withdrawal by Subject|1|||
162974638|NCT00317642|588607674|FG000|Overall Study|Referred For Transplantation|1|||
162974639|NCT00317642|588607675|FG001|Overall Study|Referred For Transplantation|0|||
162974640|NCT00317642|588607674|FG000|Overall Study|AML Not Centrally Confirmed|1|||
162974641|NCT00317642|588607675|FG001|Overall Study|AML Not Centrally Confirmed|5|||
162974642|NCT00792623|588607676|FG000|Overall Study|Adverse Event|2|||
162974643|NCT00792623|588607676|FG000|Overall Study|Withdrawal by Subject|5|||
162974644|NCT00880087|588607678|FG000|Overall Study|Lost to Follow-up|0|||
162974645|NCT00880087|588607679|FG001|Overall Study|Lost to Follow-up|2|||
162974646|NCT01005329|588607682|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
162974647|NCT00608517|588607683|FG000|Overall Study|Death|1|||
162974648|NCT00608517|588607684|FG001|Overall Study|Death|0|||
162974649|NCT00608517|588607685|FG002|Overall Study|Death|0|||
162974650|NCT00572039|588607686|FG000|Overall Study|Withdrawal by Subject|9|||
162974651|NCT00572039|588607687|FG001|Overall Study|Withdrawal by Subject|6|||
162974652|NCT00572039|588607686|FG000|Overall Study|Death|2|||
162974653|NCT00572039|588607687|FG001|Overall Study|Death|3|||
162974654|NCT00572039|588607686|FG000|Overall Study|Ill|5|||
162974655|NCT00572039|588607687|FG001|Overall Study|Ill|1|||
162974656|NCT02147587|588607688|FG000|Overall Study|Adverse Event|9|||
162974657|NCT02147587|588607689|FG001|Overall Study|Adverse Event|4|||
162974658|NCT02147587|588607688|FG000|Overall Study|Lack of Efficacy|2|||
162974659|NCT02147587|588607689|FG001|Overall Study|Lack of Efficacy|1|||
162974660|NCT01315028|588607694|FG000|Overall Study|Lost to Follow-up|1|||
162974661|NCT01315028|588607695|FG001|Overall Study|Lost to Follow-up|0|||
162974662|NCT01315028|588607694|FG000|Overall Study|Death|0|||
162974663|NCT01315028|588607695|FG001|Overall Study|Death|1|||
162974664|NCT02531594|588607696|FG000|Overall Study|Withdrawal by Subject|7|||
162974665|NCT02531594|588607697|FG001|Overall Study|Withdrawal by Subject|8|||
162974666|NCT01264835|588607702|FG000|Overall Study|Lost to Follow-up|1|||
162974667|NCT00436917|588607709|FG000|Overall Study|Withdrawal by Subject|13|||
162974668|NCT00436917|588607709|FG000|Overall Study|Adverse Event|2|||
162974669|NCT00436917|588607709|FG000|Overall Study|Physician Decision|1|||
162974670|NCT00436917|588607709|FG000|Overall Study|Death|1|||
162974671|NCT00436917|588607709|FG000|Overall Study|Lost to Follow-up|1|||
162974672|NCT00436917|588607709|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
162974673|NCT00436917|588607709|FG000|Overall Study|Increased creatinine|1|||
162974674|NCT00436917|588607709|FG000|Overall Study|Personal conflicts of patient|1|||
162974675|NCT03170869|588607710|FG000|Overall Study|Protocol Violation|5|||
162974676|NCT03170869|588607710|FG000|Overall Study|Early study termination|3|||
162974677|NCT00983528|588607713|FG000|Overall Study|Death|4|||
162974678|NCT00983528|588607713|FG000|Overall Study|Lost to Follow-up|1|||
162974679|NCT00983528|588607713|FG000|Overall Study|Study Terminated|1|||
162974680|NCT00373425|588607715|FG000|Overall Study|Relapse of NSCLC|116|||
162974681|NCT00373425|588607716|FG001|Overall Study|Relapse of NSCLC|104|||
162974682|NCT00373425|588607717|FG002|Overall Study|Relapse of NSCLC|19|||
162974683|NCT00373425|588607718|FG003|Overall Study|Relapse of NSCLC|2|||
162974684|NCT00373425|588607719|FG004|Overall Study|Relapse of NSCLC|26|||
162974685|NCT00373425|588607715|FG000|Overall Study|Adverse Event|191|||
162974686|NCT00373425|588607716|FG001|Overall Study|Adverse Event|22|||
162974687|NCT00373425|588607717|FG002|Overall Study|Adverse Event|59|||
162974688|NCT00373425|588607718|FG003|Overall Study|Adverse Event|0|||
162974689|NCT00373425|588607719|FG004|Overall Study|Adverse Event|34|||
162974690|NCT00373425|588607715|FG000|Overall Study|Patient request|35|||
162974691|NCT00373425|588607716|FG001|Overall Study|Patient request|18|||
162974692|NCT00373425|588607717|FG002|Overall Study|Patient request|43|||
162974693|NCT00373425|588607718|FG003|Overall Study|Patient request|6|||
162974694|NCT00373425|588607719|FG004|Overall Study|Patient request|7|||
162974695|NCT00373425|588607715|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
162974696|NCT00373425|588607716|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
162974697|NCT00373425|588607717|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
162974698|NCT00373425|588607718|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
162974699|NCT00373425|588607719|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
162974700|NCT00373425|588607715|FG000|Overall Study|Death|7|||
162974701|NCT00373425|588607716|FG001|Overall Study|Death|0|||
162974702|NCT00373425|588607717|FG002|Overall Study|Death|3|||
162974703|NCT00373425|588607718|FG003|Overall Study|Death|1|||
162974704|NCT00373425|588607719|FG004|Overall Study|Death|0|||
162974705|NCT00551616|588607722|FG000|Overall Study|Lost to Follow-up|48|||
162974706|NCT00551616|588607723|FG001|Overall Study|Lost to Follow-up|40|||
162974707|NCT02808819|588607724|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
162974708|NCT02808819|588607725|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
162974709|NCT02808819|588607724|FG000|Overall Study|Withdrawal by Subject|10|||
162974710|NCT02808819|588607725|FG001|Overall Study|Withdrawal by Subject|13|||
162974711|NCT02808819|588607724|FG000|Overall Study|Site terminated by sponsor|2|||
162974712|NCT02808819|588607725|FG001|Overall Study|Site terminated by sponsor|0|||
162974713|NCT02808819|588607724|FG000|Overall Study|Pregnancy|1|||
162974714|NCT02808819|588607725|FG001|Overall Study|Pregnancy|0|||
162974715|NCT02808819|588607724|FG000|Overall Study|Lost to Follow-up|1|||
162974716|NCT02808819|588607725|FG001|Overall Study|Lost to Follow-up|6|||
162974717|NCT02808819|588607724|FG000|Overall Study|Protocol Violation|0|||
162974718|NCT02808819|588607725|FG001|Overall Study|Protocol Violation|1|||
162974719|NCT02808819|588607724|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
162974720|NCT02808819|588607725|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
162974721|NCT02808819|588607724|FG000|Overall Study|Death|1|||
162974722|NCT02808819|588607725|FG001|Overall Study|Death|0|||
162974723|NCT02808819|588607724|FG000|Overall Study|Adverse Event|3|||
162974724|NCT02808819|588607725|FG001|Overall Study|Adverse Event|4|||
162974725|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
162974726|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
162974727|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974728|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974729|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162974730|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
162974731|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
162974732|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974733|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974734|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162974735|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
162974736|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
162974737|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974738|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974739|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
162974740|NCT03297294|588607726|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
162974741|NCT03297294|588607727|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
162974742|NCT03297294|588607728|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974743|NCT03297294|588607729|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974744|NCT03297294|588607730|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
162974745|NCT03297294|588607726|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974746|NCT03297294|588607727|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974747|NCT03297294|588607728|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974748|NCT03297294|588607729|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
162974749|NCT03297294|588607730|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162974750|NCT02692482|588607731|FG000|Overall Study|Death|2|||
162974751|NCT02692482|588607732|FG001|Overall Study|Death|2|||
162974752|NCT02692482|588607731|FG000|Overall Study|Withdrawal by Subject|1|||
162974753|NCT02692482|588607732|FG001|Overall Study|Withdrawal by Subject|2|||
162974754|NCT00105157|588607735|FG000|Double-Blind (DB)|Never Treated|1|||
162974755|NCT00105157|588607736|FG001|Double-Blind (DB)|Never Treated|0|||
162974756|NCT00105157|588607737|FG002|Double-Blind (DB)|Never Treated|0|||
162974757|NCT00105157|588607738|FG003|Double-Blind (DB)|Never Treated|0|||
162974758|NCT00105157|588607735|FG000|Double-Blind (DB)|Adverse Event|2|||
162974759|NCT00105157|588607736|FG001|Double-Blind (DB)|Adverse Event|0|||
162974760|NCT00105157|588607737|FG002|Double-Blind (DB)|Adverse Event|1|||
162974761|NCT00105157|588607738|FG003|Double-Blind (DB)|Adverse Event|1|||
162974762|NCT00105157|588607735|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
162974763|NCT00105157|588607736|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
162974764|NCT00105157|588607737|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
162974765|NCT00105157|588607738|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
162974766|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Adverse Event|3|||
162974767|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Adverse Event|1|||
163057396|NCT02897349|588921234|FG001|Overall Study|Adverse Event|3|||
162974768|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Adverse Event|0|||
162974769|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Adverse Event|0|||
162974770|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
162974771|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
162974772|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
162974773|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
162974774|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974775|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974776|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
162974777|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
162974778|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
162974779|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
162974780|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
162974781|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
162974782|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
162974783|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974784|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974785|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162974786|NCT00105157|588607735|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
162974787|NCT00105157|588607736|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
162974788|NCT00105157|588607737|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
162974789|NCT00105157|588607738|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
162974790|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974791|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974792|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
162974793|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
162974794|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
162974795|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
162974796|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
162974797|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
162974798|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
162974799|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
162974800|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
162974801|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
162974802|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974803|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974804|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
162974805|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
162974806|NCT00105157|588607735|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974807|NCT00105157|588607736|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
162974808|NCT00105157|588607737|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974809|NCT00105157|588607738|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
162974810|NCT03314662|588607742|FG000|Overall Study|Withdrawal by Subject|1|||
162974811|NCT03314662|588607743|FG001|Overall Study|Withdrawal by Subject|1|||
162974812|NCT03314662|588607744|FG002|Overall Study|Withdrawal by Subject|1|||
162974813|NCT03314662|588607742|FG000|Overall Study|Lost to Follow-up|5|||
162974814|NCT03314662|588607743|FG001|Overall Study|Lost to Follow-up|4|||
162974815|NCT03314662|588607744|FG002|Overall Study|Lost to Follow-up|4|||
162974816|NCT03314662|588607742|FG000|Overall Study|Death|2|||
162974817|NCT03314662|588607743|FG001|Overall Study|Death|0|||
162974818|NCT03314662|588607744|FG002|Overall Study|Death|0|||
162974819|NCT01117766|588607749|FG000|First Intervention|Adverse Event|0|||
162974820|NCT01117766|588607750|FG001|First Intervention|Adverse Event|1|||
162974821|NCT01117766|588607749|FG000|First Intervention|Protocol Violation|1|||
162974822|NCT01117766|588607750|FG001|First Intervention|Protocol Violation|0|||
162974823|NCT01117766|588607749|FG000|Washout Period|Protocol Violation|0|||
162974824|NCT01117766|588607750|FG001|Washout Period|Protocol Violation|2|||
162974825|NCT01117766|588607749|FG000|Second Intervention|Lost to Follow-up|1|||
162974826|NCT01117766|588607750|FG001|Second Intervention|Lost to Follow-up|0|||
162974827|NCT01117766|588607749|FG000|Second Intervention|Other|1|||
162974828|NCT01117766|588607750|FG001|Second Intervention|Other|2|||
162974829|NCT01117766|588607749|FG000|Second Intervention|Adverse Event|0|||
162974830|NCT01117766|588607750|FG001|Second Intervention|Adverse Event|2|||
162974831|NCT01117766|588607749|FG000|Second Intervention|Withdrawal by Subject|0|||
162974832|NCT01117766|588607750|FG001|Second Intervention|Withdrawal by Subject|1|||
162974833|NCT04405739|588607751|FG000|Overall Study|Adverse Event|0|||
162974834|NCT04405739|588607752|FG001|Overall Study|Adverse Event|1|||
162974835|NCT04405739|588607753|FG002|Overall Study|Adverse Event|0|||
162974836|NCT04405739|588607754|FG003|Overall Study|Adverse Event|0|||
162974837|NCT04405739|588607751|FG000|Overall Study|Lost to Follow-up|0|||
162974838|NCT04405739|588607752|FG001|Overall Study|Lost to Follow-up|2|||
162974839|NCT04405739|588607753|FG002|Overall Study|Lost to Follow-up|1|||
162974840|NCT04405739|588607754|FG003|Overall Study|Lost to Follow-up|3|||
162974841|NCT04405739|588607751|FG000|Overall Study|Withdrawal by Subject|0|||
162974842|NCT04405739|588607752|FG001|Overall Study|Withdrawal by Subject|2|||
162974843|NCT04405739|588607753|FG002|Overall Study|Withdrawal by Subject|1|||
162974844|NCT04405739|588607754|FG003|Overall Study|Withdrawal by Subject|1|||
162974845|NCT04405739|588607751|FG000|Overall Study|Death|0|||
162974846|NCT04405739|588607752|FG001|Overall Study|Death|0|||
162974847|NCT04405739|588607753|FG002|Overall Study|Death|1|||
162974848|NCT04405739|588607754|FG003|Overall Study|Death|0|||
162974849|NCT04405739|588607751|FG000|Overall Study|Transferred to rehab|0|||
162974850|NCT04405739|588607752|FG001|Overall Study|Transferred to rehab|0|||
162974851|NCT04405739|588607753|FG002|Overall Study|Transferred to rehab|0|||
162974852|NCT04405739|588607754|FG003|Overall Study|Transferred to rehab|1|||
162974853|NCT04405739|588607751|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
162974854|NCT04405739|588607752|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
162974855|NCT04405739|588607753|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
162974856|NCT04405739|588607754|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
162974857|NCT05766787|588607755|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
162974858|NCT05766787|588607756|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
162974859|NCT05766787|588607755|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
162974860|NCT05766787|588607756|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
162974861|NCT05766787|588607755|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
162974862|NCT05766787|588607756|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
162974863|NCT00438659|588607757|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
162974864|NCT00438659|588607758|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
162974865|NCT00438659|588607757|FG000|Overall Study|Cancel|5|||
162974866|NCT00438659|588607758|FG001|Overall Study|Cancel|2|||
162974867|NCT01867606|588607759|FG000|Overall Study|Withdrawal by Subject|10|||
162974868|NCT01867606|588607760|FG001|Overall Study|Withdrawal by Subject|14|||
162974869|NCT01867606|588607759|FG000|Overall Study|Protocol Violation|0|||
162974870|NCT01867606|588607760|FG001|Overall Study|Protocol Violation|1|||
162974871|NCT00206102|588607761|FG000|Overall Study|Adverse Event|119|||
162974872|NCT00206102|588607762|FG001|Overall Study|Adverse Event|82|||
162974873|NCT00206102|588607761|FG000|Overall Study|Protocol Violation|0|||
162974874|NCT00206102|588607762|FG001|Overall Study|Protocol Violation|2|||
162974875|NCT00206102|588607761|FG000|Overall Study|Lack of therapeutic response|16|||
162974876|NCT00206102|588607762|FG001|Overall Study|Lack of therapeutic response|11|||
162974877|NCT00206102|588607761|FG000|Overall Study|Lost to Follow-up|95|||
162974878|NCT00206102|588607762|FG001|Overall Study|Lost to Follow-up|66|||
162974879|NCT00206102|588607761|FG000|Overall Study|Withdrawal by Subject|118|||
162974880|NCT00206102|588607762|FG001|Overall Study|Withdrawal by Subject|101|||
162974881|NCT00206102|588607761|FG000|Overall Study|Study-specific discontinuation criteria|18|||
162974882|NCT00206102|588607762|FG001|Overall Study|Study-specific discontinuation criteria|17|||
162974883|NCT00206102|588607761|FG000|Overall Study|None of those categories|42|||
162974884|NCT00206102|588607762|FG001|Overall Study|None of those categories|36|||
162974885|NCT01917968|588607763|FG000|Overall Study|Death|3|||
162974886|NCT01917968|588607764|FG001|Overall Study|Death|2|||
162974887|NCT01917968|588607763|FG000|Overall Study|Lost to Follow-up|21|||
162974888|NCT01917968|588607764|FG001|Overall Study|Lost to Follow-up|39|||
162974889|NCT01917968|588607763|FG000|Overall Study|Physician Decision|1|||
162974890|NCT01917968|588607764|FG001|Overall Study|Physician Decision|2|||
162974891|NCT01917968|588607763|FG000|Overall Study|Withdrawal by Subject|20|||
162974892|NCT01917968|588607764|FG001|Overall Study|Withdrawal by Subject|35|||
162974893|NCT01917968|588607763|FG000|Overall Study|Subject Relocation|5|||
162974894|NCT01917968|588607764|FG001|Overall Study|Subject Relocation|1|||
162974895|NCT01917968|588607763|FG000|Overall Study|36M Missed Visit|3|||
162974896|NCT01917968|588607764|FG001|Overall Study|36M Missed Visit|2|||
162974897|NCT01917968|588607763|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
162974898|NCT01917968|588607764|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
162974899|NCT01917968|588607763|FG000|Overall Study|Change in Family Circumstances|0|||
162974900|NCT01917968|588607764|FG001|Overall Study|Change in Family Circumstances|1|||
162974901|NCT01917968|588607763|FG000|Overall Study|No Data Available|0|||
162974902|NCT01917968|588607764|FG001|Overall Study|No Data Available|2|||
162974903|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
162974904|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
162974905|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
162974906|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
162974907|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
162974908|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
162974909|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
162974910|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
162974911|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
162974912|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
162974913|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
162974914|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
162974915|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
162974916|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
162974917|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
162974918|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
162974919|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
162974920|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
162974921|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
162974922|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
162974923|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
162974924|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
162974925|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
162974926|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
162974927|NCT01435928|588607766|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
162974928|NCT01435928|588607767|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
162974929|NCT01435928|588607768|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
162974930|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
162974931|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
162974932|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
162974933|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
162974934|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
162974935|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
162974936|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
162974937|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
162974938|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
162974939|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
162974940|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
162974941|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
162974942|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
162974943|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
162974944|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
162974945|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
162974946|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
162974947|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
162974948|NCT01435928|588607766|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
162974949|NCT01435928|588607767|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
162974950|NCT01435928|588607768|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
162974951|NCT01835548|588607774|FG000|Dose Optimization Period|Adverse Event|0|||
162974952|NCT01835548|588607775|FG001|Dose Optimization Period|Adverse Event|0|||
162974953|NCT01835548|588607776|FG002|Dose Optimization Period|Adverse Event|1|||
162974954|NCT01835548|588607774|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
162974955|NCT01835548|588607775|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
162974956|NCT01835548|588607776|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
162974957|NCT01835548|588607774|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162974958|NCT01835548|588607775|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162974959|NCT01835548|588607776|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162974960|NCT01835548|588607774|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162974961|NCT01835548|588607775|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162974962|NCT01835548|588607776|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163057397|NCT02897349|588921233|FG000|Overall Study|Other than listed above|0|||
163057398|NCT02897349|588921234|FG001|Overall Study|Other than listed above|1|||
162974963|NCT01169038|588607777|FG000|Overall Study|Death|1|||
162974964|NCT01169038|588607777|FG000|Overall Study|Adverse Event|5|||
162974965|NCT01169038|588607777|FG000|Overall Study|Required antibiotic administration|1|||
162974966|NCT02490800|588607778|FG000|Overall Study|Adverse Event|0|||
162974967|NCT02490800|588607779|FG001|Overall Study|Adverse Event|0|||
162974968|NCT02490800|588607780|FG002|Overall Study|Adverse Event|0|||
162974969|NCT02490800|588607781|FG003|Overall Study|Adverse Event|2|||
162974970|NCT02490800|588607782|FG004|Overall Study|Adverse Event|3|||
162974971|NCT02490800|588607783|FG005|Overall Study|Adverse Event|2|||
162974972|NCT02490800|588607784|FG006|Overall Study|Adverse Event|0|||
162974973|NCT02490800|588607785|FG007|Overall Study|Adverse Event|0|||
163057399|NCT03817528|588921243|FG000|Overall Study|Withdrawal by Subject|1|||
162974974|NCT02490800|588607786|FG008|Overall Study|Adverse Event|0|||
162974975|NCT02490800|588607787|FG009|Overall Study|Adverse Event|0|||
162974976|NCT02490800|588607788|FG010|Overall Study|Adverse Event|0|||
162974977|NCT02490800|588607789|FG011|Overall Study|Adverse Event|2|||
162974978|NCT02490800|588607790|FG012|Overall Study|Adverse Event|2|||
162974979|NCT02490800|588607778|FG000|Overall Study|Withdrawal by Subject|0|||
162974980|NCT02490800|588607779|FG001|Overall Study|Withdrawal by Subject|0|||
162974981|NCT02490800|588607780|FG002|Overall Study|Withdrawal by Subject|0|||
162974982|NCT02490800|588607781|FG003|Overall Study|Withdrawal by Subject|1|||
162974983|NCT02490800|588607782|FG004|Overall Study|Withdrawal by Subject|0|||
162974984|NCT02490800|588607783|FG005|Overall Study|Withdrawal by Subject|0|||
162974985|NCT02490800|588607784|FG006|Overall Study|Withdrawal by Subject|0|||
162974986|NCT02490800|588607785|FG007|Overall Study|Withdrawal by Subject|0|||
162974987|NCT02490800|588607786|FG008|Overall Study|Withdrawal by Subject|1|||
162974988|NCT02490800|588607787|FG009|Overall Study|Withdrawal by Subject|0|||
162974989|NCT02490800|588607788|FG010|Overall Study|Withdrawal by Subject|0|||
162974990|NCT02490800|588607789|FG011|Overall Study|Withdrawal by Subject|0|||
162974991|NCT02490800|588607790|FG012|Overall Study|Withdrawal by Subject|0|||
162974992|NCT02490800|588607778|FG000|Overall Study|Progressive disease|3|||
162974993|NCT02490800|588607779|FG001|Overall Study|Progressive disease|3|||
162974994|NCT02490800|588607780|FG002|Overall Study|Progressive disease|3|||
162974995|NCT02490800|588607781|FG003|Overall Study|Progressive disease|4|||
162974996|NCT02490800|588607782|FG004|Overall Study|Progressive disease|4|||
162974997|NCT02490800|588607783|FG005|Overall Study|Progressive disease|1|||
162974998|NCT02490800|588607784|FG006|Overall Study|Progressive disease|4|||
162974999|NCT02490800|588607785|FG007|Overall Study|Progressive disease|3|||
162975000|NCT02490800|588607786|FG008|Overall Study|Progressive disease|6|||
162975001|NCT02490800|588607787|FG009|Overall Study|Progressive disease|2|||
162975002|NCT02490800|588607788|FG010|Overall Study|Progressive disease|7|||
162975003|NCT02490800|588607789|FG011|Overall Study|Progressive disease|1|||
162975004|NCT02490800|588607790|FG012|Overall Study|Progressive disease|10|||
162975005|NCT02490800|588607778|FG000|Overall Study|Patient enrolled in post-trial access|0|||
162975006|NCT02490800|588607779|FG001|Overall Study|Patient enrolled in post-trial access|0|||
162975007|NCT02490800|588607780|FG002|Overall Study|Patient enrolled in post-trial access|0|||
162975008|NCT02490800|588607781|FG003|Overall Study|Patient enrolled in post-trial access|0|||
162975009|NCT02490800|588607782|FG004|Overall Study|Patient enrolled in post-trial access|0|||
162975010|NCT02490800|588607783|FG005|Overall Study|Patient enrolled in post-trial access|0|||
162975011|NCT02490800|588607784|FG006|Overall Study|Patient enrolled in post-trial access|0|||
162975012|NCT02490800|588607785|FG007|Overall Study|Patient enrolled in post-trial access|0|||
162975013|NCT02490800|588607786|FG008|Overall Study|Patient enrolled in post-trial access|0|||
162975014|NCT02490800|588607787|FG009|Overall Study|Patient enrolled in post-trial access|1|||
162975015|NCT02490800|588607788|FG010|Overall Study|Patient enrolled in post-trial access|1|||
162975016|NCT02490800|588607789|FG011|Overall Study|Patient enrolled in post-trial access|0|||
162975017|NCT02490800|588607790|FG012|Overall Study|Patient enrolled in post-trial access|6|||
162975018|NCT03365791|588607791|FG000|Overall Study|Adverse Event|5|||
162975019|NCT03365791|588607791|FG000|Overall Study|Death|1|||
162975020|NCT03365791|588607791|FG000|Overall Study|Lost to Follow-up|1|||
162975021|NCT03365791|588607791|FG000|Overall Study|Physician Decision|9|||
162975022|NCT03365791|588607791|FG000|Overall Study|Progressive disease|51|||
162975023|NCT03365791|588607791|FG000|Overall Study|Subject/guardian decision|5|||
162975024|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
162975025|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975026|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975027|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975028|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975029|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975030|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975031|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975032|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162975033|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
162975034|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975035|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975036|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975037|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975038|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975039|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975040|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975041|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
162975042|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
162975043|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975044|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975045|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975046|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975047|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975048|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975049|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975050|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
162975051|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
162975052|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975053|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975054|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975055|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975056|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975057|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975058|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975059|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162975060|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
162975061|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975062|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975063|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975064|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975065|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975066|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975067|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975068|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
162975069|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
162975070|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975071|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975072|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975073|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975074|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975075|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975076|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975077|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162975078|NCT00739973|588607792|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
162975079|NCT00739973|588607793|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975080|NCT00739973|588607794|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975081|NCT00739973|588607795|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975082|NCT00739973|588607796|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975083|NCT00739973|588607797|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975084|NCT00739973|588607798|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975085|NCT00739973|588607799|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975086|NCT00739973|588607800|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
162975087|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975088|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975089|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
162975090|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
162975091|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
162975092|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
162975093|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
162975094|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
162975095|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
162975096|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975097|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975098|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975099|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
163057400|NCT03817528|588921243|FG000|Overall Study|Adverse Event|2|||
163057401|NCT03895086|588921244|FG000|Overall Study|Early termination study|1|||
163057402|NCT03895086|588921245|FG001|Overall Study|Early termination study|0|||
163057403|NCT01192815|588921246|FG000|Overall Study|Withdrawal by Subject|1|||
162712792|NCT00109967|587660748|FG000|Overall Study|Physician Decision|1|||
162975100|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
162975101|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975102|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975103|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
162975104|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
162975105|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
162975106|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
162975107|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975108|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975109|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975110|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975111|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975112|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975113|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
162975114|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
162975115|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
162975116|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
162975117|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
162975118|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975119|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975120|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
162975121|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
162975122|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
162975123|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975124|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975125|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
162975126|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975127|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975128|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975129|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975130|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162975131|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
162630298|NCT01425281|587365100|FG000|At 5-year Clinical Follow-up|Death|2|||
162630299|NCT01425281|587365101|FG001|At 5-year Clinical Follow-up|Death|0|||
162630300|NCT01425281|587365100|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
162975132|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975133|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
162975134|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975135|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
162975136|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975137|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975138|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
162975139|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
162975140|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
162975141|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
162975142|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975143|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
162975144|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
162975145|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975146|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
162975147|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
162975148|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
162975149|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
162975150|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975151|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975152|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975153|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975154|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975155|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975156|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
162975157|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975158|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162975159|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
162975160|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975161|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
162975162|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975163|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975164|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
162975165|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975166|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162975167|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
162975168|NCT00739973|588607792|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975169|NCT00739973|588607793|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
162975170|NCT00739973|588607794|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975171|NCT00739973|588607795|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975172|NCT00739973|588607796|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975173|NCT00739973|588607797|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975174|NCT00739973|588607798|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
162975175|NCT00739973|588607799|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975176|NCT00739973|588607800|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162975177|NCT00576303|588607801|FG000|Dose Titration Period|Early withdrawal|17|||
162975178|NCT00576303|588607801|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
162975179|NCT00576303|588607801|FG000|Long Term Safety Period|Early withdrawal|16|||
162975180|NCT02843659|588607805|FG000|Overall Study|Subject Withdrew Consent|0|||
162975181|NCT02843659|588607806|FG001|Overall Study|Subject Withdrew Consent|0|||
162975182|NCT02843659|588607807|FG002|Overall Study|Subject Withdrew Consent|1|||
162975183|NCT02843659|588607805|FG000|Overall Study|Administrative Reason by Sponsor|4|||
162975184|NCT02843659|588607806|FG001|Overall Study|Administrative Reason by Sponsor|5|||
162975185|NCT02843659|588607807|FG002|Overall Study|Administrative Reason by Sponsor|4|||
162975186|NCT02843659|588607805|FG000|Overall Study|Adverse Event|0|||
162975187|NCT02843659|588607806|FG001|Overall Study|Adverse Event|1|||
162975188|NCT02843659|588607807|FG002|Overall Study|Adverse Event|0|||
162975189|NCT03203642|588607808|FG000|Overall Study|Adverse Event|3|||
162975190|NCT03203642|588607809|FG001|Overall Study|Adverse Event|1|||
162975191|NCT03203642|588607808|FG000|Overall Study|Withdrawal by Subject|6|||
162975192|NCT03203642|588607809|FG001|Overall Study|Withdrawal by Subject|6|||
162975193|NCT03203642|588607808|FG000|Overall Study|Lost to Follow-up|2|||
162975194|NCT03203642|588607809|FG001|Overall Study|Lost to Follow-up|1|||
162975195|NCT03203642|588607808|FG000|Overall Study|Termination of the study by sponsor|1|||
162975196|NCT03203642|588607809|FG001|Overall Study|Termination of the study by sponsor|1|||
162975197|NCT03203642|588607808|FG000|Overall Study|Participant moved|0|||
162975198|NCT03203642|588607809|FG001|Overall Study|Participant moved|1|||
162975199|NCT03203642|588607808|FG000|Overall Study|Investigator's decision|3|||
162975200|NCT03203642|588607809|FG001|Overall Study|Investigator's decision|0|||
162975201|NCT03203642|588607808|FG000|Overall Study|Other than above specified|0|||
162975202|NCT03203642|588607809|FG001|Overall Study|Other than above specified|1|||
162975203|NCT02175368|588607810|FG000|Overall Study|Lost to Follow-up|1|||
162975204|NCT02875028|588607811|FG000|Washout Period|Withdrawal by Subject|0|||
162975205|NCT02875028|588607812|FG001|Washout Period|Withdrawal by Subject|1|||
162975206|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
162975207|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
162975208|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975209|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975210|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975211|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975212|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975213|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
162975214|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975215|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975216|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
162975217|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975218|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162630301|NCT01425281|587365101|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
162975219|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975220|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162630302|NCT01425281|587365100|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
162975221|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
162975222|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
162975223|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
162975224|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
162975225|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
162975226|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
162975227|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975228|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975229|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
162975230|NCT05068284|588607813|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975231|NCT05068284|588607814|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975232|NCT05068284|588607815|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
162975233|NCT05068284|588607816|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975234|NCT05068284|588607817|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
162975235|NCT05068284|588607818|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975236|NCT05068284|588607819|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975237|NCT05068284|588607820|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162975238|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975239|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975240|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975241|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
162975242|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975243|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975244|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975245|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162975246|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975247|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975248|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
162975249|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
162975250|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975251|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975252|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975253|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
162975254|NCT05068284|588607813|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975255|NCT05068284|588607814|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975256|NCT05068284|588607815|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
162975257|NCT05068284|588607816|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975258|NCT05068284|588607817|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975259|NCT05068284|588607818|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975260|NCT05068284|588607819|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975261|NCT05068284|588607820|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
162975262|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
162975263|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975264|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975265|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975266|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975267|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975268|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975269|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162975270|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
162975271|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975272|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975273|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975274|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975275|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
162975276|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
163057404|NCT01192815|588921246|FG000|Overall Study|Lack of Efficacy|1|||
162712793|NCT00109967|587660749|FG001|Overall Study|Physician Decision|3|||
162712794|NCT00109967|587660748|FG000|Overall Study|Death|0|||
162712795|NCT00109967|587660749|FG001|Overall Study|Death|2|||
162712796|NCT04381494|587660756|FG000|Overall Study|Early termination of trial|19|||
162712797|NCT04381494|587660756|FG000|Overall Study|Investigator's discretion|1|||
162975277|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
162975278|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
162975279|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975280|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975281|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975282|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975283|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975284|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
162975285|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
162975286|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
162975287|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975288|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975289|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975290|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975291|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975292|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975293|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162975294|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
162975295|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975296|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975297|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975298|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975299|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975300|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975301|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
162975302|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
162975303|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975304|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975305|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975306|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162975307|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
162975308|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
162975309|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
162975310|NCT05068284|588607813|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975311|NCT05068284|588607814|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975312|NCT05068284|588607815|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975313|NCT05068284|588607816|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975314|NCT05068284|588607817|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975315|NCT05068284|588607818|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975316|NCT05068284|588607819|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
162975317|NCT05068284|588607820|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
162975318|NCT03250299|588609485|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
162975319|NCT03250299|588609486|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
162975320|NCT03250299|588609487|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
162975321|NCT03250299|588609488|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
162975322|NCT03250299|588609489|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
162975323|NCT03250299|588609485|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
162975324|NCT03250299|588609486|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
162975325|NCT03250299|588609487|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
162975326|NCT03250299|588609488|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
162975327|NCT03250299|588609489|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
162975328|NCT03250299|588609485|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975329|NCT03250299|588609486|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975330|NCT03250299|588609487|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
162975331|NCT03250299|588609488|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975332|NCT03250299|588609489|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
162975333|NCT03250299|588609485|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
162975334|NCT03250299|588609486|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
162975335|NCT03250299|588609487|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
162975336|NCT03250299|588609488|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
162631099|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162975337|NCT03250299|588609489|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
162975338|NCT00977548|588609491|FG000|Overall Study|Ineligible|4|||
162975339|NCT00977548|588609491|FG000|Overall Study|Adverse Event|8|||
162975340|NCT00977548|588609491|FG000|Overall Study|Withdrawal by Subject|1|||
162975341|NCT00988208|588609492|FG000|Overall Study|Adverse Event|71|||
162975342|NCT00988208|588609493|FG001|Overall Study|Adverse Event|122|||
162975343|NCT00988208|588609492|FG000|Overall Study|Disease Progression|103|||
162975344|NCT00988208|588609493|FG001|Overall Study|Disease Progression|89|||
162975345|NCT00988208|588609492|FG000|Overall Study|Withdrawal by Subject|50|||
162975346|NCT00988208|588609493|FG001|Overall Study|Withdrawal by Subject|57|||
162975347|NCT00988208|588609492|FG000|Overall Study|Death|9|||
162975348|NCT00988208|588609493|FG001|Overall Study|Death|15|||
162975349|NCT00988208|588609492|FG000|Overall Study|Lost to Follow-up|2|||
162975350|NCT00988208|588609493|FG001|Overall Study|Lost to Follow-up|3|||
162975351|NCT00988208|588609492|FG000|Overall Study|Protocol Violation|9|||
162975352|NCT00988208|588609493|FG001|Overall Study|Protocol Violation|2|||
162975353|NCT00988208|588609492|FG000|Overall Study|Sponsor Decision|102|||
162975354|NCT00988208|588609493|FG001|Overall Study|Sponsor Decision|78|||
162975355|NCT00988208|588609492|FG000|Overall Study|Clinical Progression|17|||
162975356|NCT00988208|588609493|FG001|Overall Study|Clinical Progression|16|||
162975357|NCT00988208|588609492|FG000|Overall Study|Biochemical Progression|21|||
162975358|NCT00988208|588609493|FG001|Overall Study|Biochemical Progression|7|||
162975359|NCT00988208|588609492|FG000|Overall Study|Clinical Deterioration|7|||
162975360|NCT00988208|588609493|FG001|Overall Study|Clinical Deterioration|14|||
162975361|NCT00988208|588609492|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
162975362|NCT00988208|588609493|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
162975363|NCT00988208|588609492|FG000|Overall Study|Other|8|||
162975364|NCT00988208|588609493|FG001|Overall Study|Other|3|||
162975365|NCT02000531|588609498|FG000|Overall Study|Lost to Follow-up|1|||
162975366|NCT02000531|588609499|FG001|Overall Study|Lost to Follow-up|0|||
162975367|NCT02000531|588609498|FG000|Overall Study|Discontinued due to data cut-off|3|||
162975368|NCT02000531|588609499|FG001|Overall Study|Discontinued due to data cut-off|8|||
162975369|NCT00794417|588609500|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975370|NCT00794417|588609501|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975371|NCT00794417|588609502|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
162975372|NCT00794417|588609503|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162975373|NCT00794417|588609500|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
162975374|NCT00794417|588609501|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
162975375|NCT00794417|588609502|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
162975376|NCT00794417|588609503|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
162975377|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975378|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975379|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
162975380|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
162975381|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975382|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975383|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
162975384|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
162975385|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975386|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975387|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
162975388|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
162975389|NCT00794417|588609500|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975390|NCT00794417|588609501|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975391|NCT00794417|588609502|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162975392|NCT00794417|588609503|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
162975393|NCT01546142|588609506|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
162975394|NCT01546142|588609507|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
162975395|NCT01546142|588609506|FG000|Overall Study|Subject Noncompliance|1|||
162975396|NCT01546142|588609507|FG001|Overall Study|Subject Noncompliance|1|||
162975397|NCT01546142|588609506|FG000|Overall Study|Adverse Event|6|||
162975398|NCT01546142|588609507|FG001|Overall Study|Adverse Event|3|||
162975399|NCT01546142|588609506|FG000|Overall Study|Lost to Follow-up|20|||
162975400|NCT01546142|588609507|FG001|Overall Study|Lost to Follow-up|15|||
162975401|NCT01546142|588609506|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
162975402|NCT01546142|588609507|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
162975403|NCT01546142|588609506|FG000|Overall Study|Subject Randomized but Not Treated|1|||
162975404|NCT01546142|588609507|FG001|Overall Study|Subject Randomized but Not Treated|0|||
162975405|NCT01213836|588609508|FG000|Period 1, First Intervention|Adverse Event|2|||
162975406|NCT01213836|588609509|FG001|Period 1, First Intervention|Adverse Event|1|||
162975407|NCT01213836|588609508|FG000|Period 1, First Intervention|Protocol Violation|0|||
162975408|NCT01213836|588609509|FG001|Period 1, First Intervention|Protocol Violation|1|||
162975409|NCT01213836|588609508|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
162975410|NCT01213836|588609509|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
162975411|NCT00255151|588609511|FG000|Overall Study|Adverse Event|10|||
162975412|NCT00255151|588609512|FG001|Overall Study|Adverse Event|6|||
162975413|NCT00255151|588609513|FG002|Overall Study|Adverse Event|9|||
162975414|NCT00255151|588609511|FG000|Overall Study|Lost to Follow-up|4|||
162975415|NCT00255151|588609512|FG001|Overall Study|Lost to Follow-up|3|||
162975416|NCT00255151|588609513|FG002|Overall Study|Lost to Follow-up|4|||
162975417|NCT00255151|588609511|FG000|Overall Study|Withdrawal by Subject|18|||
162975418|NCT00255151|588609512|FG001|Overall Study|Withdrawal by Subject|17|||
162975419|NCT00255151|588609513|FG002|Overall Study|Withdrawal by Subject|8|||
162975420|NCT00255151|588609511|FG000|Overall Study|Noncompliance|0|||
162975421|NCT00255151|588609512|FG001|Overall Study|Noncompliance|1|||
162975422|NCT00255151|588609513|FG002|Overall Study|Noncompliance|2|||
162975423|NCT00255151|588609511|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
162975424|NCT00255151|588609512|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
162975425|NCT00255151|588609513|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
162975426|NCT00255151|588609511|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
162975427|NCT00255151|588609512|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
162975428|NCT00255151|588609513|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
162975429|NCT00255151|588609511|FG000|Overall Study|Possible Barrett's Esophagus|1|||
162975430|NCT00255151|588609512|FG001|Overall Study|Possible Barrett's Esophagus|3|||
162975431|NCT00255151|588609513|FG002|Overall Study|Possible Barrett's Esophagus|8|||
162975432|NCT00255151|588609511|FG000|Overall Study|Esophageal Stricture|0|||
162975433|NCT00255151|588609512|FG001|Overall Study|Esophageal Stricture|0|||
162975434|NCT00255151|588609513|FG002|Overall Study|Esophageal Stricture|1|||
162975435|NCT00255151|588609511|FG000|Overall Study|Therapeutic Failure|11|||
162975436|NCT00255151|588609512|FG001|Overall Study|Therapeutic Failure|2|||
162975437|NCT00255151|588609513|FG002|Overall Study|Therapeutic Failure|3|||
162975438|NCT00743509|588609521|FG000|Overall Study|Withdrawal by Subject|2|||
162975439|NCT00892281|588609524|FG000|Overall Study|Adverse Event|65|||
163057405|NCT01142336|588921248|FG000|Overall Study|Adverse Event|1|||
163057406|NCT01142336|588921249|FG001|Overall Study|Adverse Event|1|||
163057407|NCT01142336|588921248|FG000|Overall Study|Lost to Follow-up|0|||
163057408|NCT01142336|588921249|FG001|Overall Study|Lost to Follow-up|1|||
163057409|NCT03025035|588921265|FG000|Overall Study|Death|2|||
163057410|NCT03025035|588921265|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
163057411|NCT01218802|588921268|FG000|Overall Study|Lost to Follow-up|5|||
163057412|NCT01218802|588921269|FG001|Overall Study|Lost to Follow-up|6|||
163057413|NCT01218802|588921268|FG000|Overall Study|Withdrawal by Subject|3|||
163057414|NCT01218802|588921269|FG001|Overall Study|Withdrawal by Subject|10|||
163057415|NCT01218802|588921268|FG000|Overall Study|Adverse Event|0|||
163057416|NCT01218802|588921269|FG001|Overall Study|Adverse Event|2|||
163057417|NCT01218802|588921268|FG000|Overall Study|Incarcerated|2|||
163057418|NCT01218802|588921269|FG001|Overall Study|Incarcerated|0|||
163057419|NCT01123655|588921274|FG000|Overall Study|Medication for RA had to be changed|1|||
163057420|NCT01123655|588921275|FG001|Overall Study|Medication for RA had to be changed|0|||
163057421|NCT01123655|588921276|FG002|Overall Study|Medication for RA had to be changed|0|||
163057422|NCT01123655|588921274|FG000|Overall Study|new illness|0|||
163057423|NCT01123655|588921275|FG001|Overall Study|new illness|1|||
162975440|NCT00892281|588609525|FG001|Overall Study|Adverse Event|8|||
162975441|NCT00892281|588609524|FG000|Overall Study|Lost to Follow-up|81|||
162975442|NCT00892281|588609525|FG001|Overall Study|Lost to Follow-up|8|||
163057424|NCT01123655|588921276|FG002|Overall Study|new illness|0|||
163057425|NCT01123655|588921274|FG000|Overall Study|began prohibitive drug|0|||
163057426|NCT01123655|588921275|FG001|Overall Study|began prohibitive drug|0|||
162630303|NCT01425281|587365101|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
162975443|NCT00892281|588609524|FG000|Overall Study|Pregnancy|1|||
162975444|NCT00892281|588609525|FG001|Overall Study|Pregnancy|0|||
162975445|NCT00892281|588609524|FG000|Overall Study|Protocol Violation|7|||
162975446|NCT00892281|588609525|FG001|Overall Study|Protocol Violation|2|||
162975447|NCT00892281|588609524|FG000|Overall Study|Withdrawal by Subject|86|||
162975448|NCT00892281|588609525|FG001|Overall Study|Withdrawal by Subject|14|||
163057427|NCT01123655|588921276|FG002|Overall Study|began prohibitive drug|1|||
163057428|NCT02475369|588921283|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
163057429|NCT02475369|588921284|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
162630304|NCT01425281|587365100|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
162975449|NCT00892281|588609524|FG000|Overall Study|Subject failed to return for final visit|2|||
163057430|NCT00471497|588921285|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
162975450|NCT00892281|588609525|FG001|Overall Study|Subject failed to return for final visit|0|||
163057431|NCT00471497|588921286|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
163057432|NCT00471497|588921287|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
163057433|NCT00471497|588921285|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
163057434|NCT00471497|588921286|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
163057435|NCT00471497|588921287|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
162975451|NCT00892281|588609524|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
162975452|NCT00892281|588609525|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
162975453|NCT00892281|588609524|FG000|Overall Study|Final visit completed 4 weeks late|0|||
162975454|NCT00892281|588609525|FG001|Overall Study|Final visit completed 4 weeks late|1|||
162975455|NCT00892281|588609524|FG000|Overall Study|Subject completed day after study closed|1|||
162975456|NCT00892281|588609525|FG001|Overall Study|Subject completed day after study closed|0|||
162975457|NCT00892281|588609524|FG000|Overall Study|Family emergency|1|||
162975458|NCT00892281|588609525|FG001|Overall Study|Family emergency|0|||
162975459|NCT00892281|588609524|FG000|Overall Study|Last visit not done - death in family|1|||
162975460|NCT00892281|588609525|FG001|Overall Study|Last visit not done - death in family|0|||
162975461|NCT00892281|588609524|FG000|Overall Study|Did not meet incl/excl criteria|1|||
162975462|NCT00892281|588609525|FG001|Overall Study|Did not meet incl/excl criteria|0|||
162975463|NCT00892281|588609524|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
162975464|NCT00892281|588609525|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
162975465|NCT00892281|588609524|FG000|Overall Study|Unable to redeem the drug voucher|1|||
162975466|NCT00892281|588609525|FG001|Overall Study|Unable to redeem the drug voucher|0|||
162975467|NCT00892281|588609524|FG000|Overall Study|Subject not good candidate for study|1|||
162975468|NCT00892281|588609525|FG001|Overall Study|Subject not good candidate for study|0|||
162975469|NCT00892281|588609524|FG000|Overall Study|Subject did not return for any visits|1|||
162975470|NCT00892281|588609525|FG001|Overall Study|Subject did not return for any visits|0|||
162975471|NCT00892281|588609524|FG000|Overall Study|Subject missed several visits/lost meds|1|||
162975472|NCT00892281|588609525|FG001|Overall Study|Subject missed several visits/lost meds|0|||
162975473|NCT00892281|588609524|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
162975474|NCT00892281|588609525|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
162975475|NCT00892281|588609524|FG000|Overall Study|Scheduled for knee replacement|0|||
162975476|NCT00892281|588609525|FG001|Overall Study|Scheduled for knee replacement|1|||
162975477|NCT00892281|588609524|FG000|Overall Study|PI complained of inadequate compensation|3|||
162975478|NCT00892281|588609525|FG001|Overall Study|PI complained of inadequate compensation|0|||
162975479|NCT00892281|588609524|FG000|Overall Study|Subject lost interest in program|0|||
162975480|NCT00892281|588609525|FG001|Overall Study|Subject lost interest in program|1|||
162975481|NCT00892281|588609524|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
162975482|NCT00892281|588609525|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
162975483|NCT00892281|588609524|FG000|Overall Study|Death in family|1|||
162975484|NCT00892281|588609525|FG001|Overall Study|Death in family|0|||
162975485|NCT00892281|588609524|FG000|Overall Study|Lack of efficacy of study product|2|||
162975486|NCT00892281|588609525|FG001|Overall Study|Lack of efficacy of study product|0|||
162975487|NCT00892281|588609524|FG000|Overall Study|Subject not seen by PI at final visit|1|||
162975488|NCT00892281|588609525|FG001|Overall Study|Subject not seen by PI at final visit|0|||
162975489|NCT00892281|588609524|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
162975490|NCT00892281|588609525|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
162975491|NCT00892281|588609524|FG000|Overall Study|Missed multiple visits|1|||
162975492|NCT00892281|588609525|FG001|Overall Study|Missed multiple visits|0|||
162975493|NCT00892281|588609524|FG000|Overall Study|Missed visits rescheduled out of window|1|||
162975494|NCT00892281|588609525|FG001|Overall Study|Missed visits rescheduled out of window|0|||
162975495|NCT00892281|588609524|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
162975496|NCT00892281|588609525|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
162975497|NCT00892281|588609524|FG000|Overall Study|Subject had history of drug abuse|1|||
162975498|NCT00892281|588609525|FG001|Overall Study|Subject had history of drug abuse|0|||
162975499|NCT00892281|588609524|FG000|Overall Study|Rash on hand|1|||
162975500|NCT00892281|588609525|FG001|Overall Study|Rash on hand|0|||
162975501|NCT00892281|588609524|FG000|Overall Study|Visit 4 date out of window|1|||
162975502|NCT00892281|588609525|FG001|Overall Study|Visit 4 date out of window|0|||
162975503|NCT01534078|588609526|FG000|Overall Study|Death|1|||
162975504|NCT01534078|588609526|FG000|Overall Study|Withdrawal by Subject|1|||
162975505|NCT01280617|588609530|FG000|Overall Study|Adverse Event|0|||
162975506|NCT01280617|588609531|FG001|Overall Study|Adverse Event|1|||
162975507|NCT00986570|588609532|FG000|Overall Study|Lost to Follow-up|6|||
162975508|NCT00986570|588609532|FG000|Overall Study|Potential bias for objective assessment|1|||
162975509|NCT02225665|588609533|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
162975510|NCT02225665|588609534|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
162975511|NCT02225665|588609533|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
162975512|NCT02225665|588609534|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
162975513|NCT01311557|588609535|FG000|Overall Study|Serious adverse event|0|||
162975514|NCT01311557|588609536|FG001|Overall Study|Serious adverse event|1|||
162975515|NCT01311557|588609535|FG000|Overall Study|Protocol Violation|4|||
162975516|NCT01311557|588609536|FG001|Overall Study|Protocol Violation|2|||
162975517|NCT01311557|588609535|FG000|Overall Study|Lost to Follow-up|0|||
162975518|NCT01311557|588609536|FG001|Overall Study|Lost to Follow-up|1|||
162975519|NCT01311557|588609535|FG000|Overall Study|Withdrawal by Subject|1|||
162975520|NCT01311557|588609536|FG001|Overall Study|Withdrawal by Subject|2|||
163057436|NCT00471497|588921285|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
163057437|NCT00471497|588921286|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
163057438|NCT00471497|588921287|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
163057439|NCT00471497|588921285|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
163057440|NCT00471497|588921286|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
163057441|NCT00471497|588921287|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
163057442|NCT00471497|588921285|FG000|Core Treatment Phase|Lost to Follow-up|6|||
163057443|NCT00471497|588921286|FG001|Core Treatment Phase|Lost to Follow-up|6|||
163057444|NCT00471497|588921287|FG002|Core Treatment Phase|Lost to Follow-up|3|||
163057445|NCT00471497|588921285|FG000|Core Treatment Phase|Death|3|||
163057446|NCT00471497|588921286|FG001|Core Treatment Phase|Death|9|||
163057447|NCT00471497|588921287|FG002|Core Treatment Phase|Death|3|||
163057448|NCT00471497|588921285|FG000|Core Treatment Phase|Disease Progression|10|||
163057449|NCT00471497|588921286|FG001|Core Treatment Phase|Disease Progression|2|||
163057450|NCT00471497|588921287|FG002|Core Treatment Phase|Disease Progression|4|||
163057451|NCT00471497|588921285|FG000|Core Treatment Phase|Protocol Violation|6|||
163057452|NCT00471497|588921286|FG001|Core Treatment Phase|Protocol Violation|15|||
163057453|NCT00471497|588921287|FG002|Core Treatment Phase|Protocol Violation|11|||
163057454|NCT00471497|588921285|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
163057455|NCT00471497|588921286|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
163057456|NCT00471497|588921287|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
163057457|NCT00471497|588921285|FG000|Core Treatment Phase|Administrative problems|14|||
163057458|NCT00471497|588921286|FG001|Core Treatment Phase|Administrative problems|14|||
163057459|NCT00471497|588921287|FG002|Core Treatment Phase|Administrative problems|12|||
163057460|NCT00471497|588921285|FG000|Core Treatment Phase|Adverse Event|43|||
163057461|NCT00471497|588921286|FG001|Core Treatment Phase|Adverse Event|53|||
163057462|NCT00471497|588921287|FG002|Core Treatment Phase|Adverse Event|89|||
163057463|NCT00471497|588921285|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
163057464|NCT00471497|588921286|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
163057465|NCT00471497|588921287|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
163057466|NCT00471497|588921285|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
163057467|NCT00471497|588921286|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
163057468|NCT00471497|588921287|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
163057469|NCT00471497|588921285|FG000|Extension Phase|Adverse Event|9|||
163057470|NCT00471497|588921286|FG001|Extension Phase|Adverse Event|5|||
163057471|NCT00471497|588921287|FG002|Extension Phase|Adverse Event|1|||
163057472|NCT00471497|588921285|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
163057473|NCT00471497|588921286|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
163057474|NCT00471497|588921287|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
163057475|NCT00471497|588921285|FG000|Extension Phase|Withdrawal by Subject|3|||
163057476|NCT00471497|588921286|FG001|Extension Phase|Withdrawal by Subject|1|||
163057477|NCT00471497|588921287|FG002|Extension Phase|Withdrawal by Subject|0|||
163057478|NCT00471497|588921285|FG000|Extension Phase|Lost to Follow-up|2|||
163057479|NCT00471497|588921286|FG001|Extension Phase|Lost to Follow-up|0|||
163057480|NCT00471497|588921287|FG002|Extension Phase|Lost to Follow-up|0|||
163057481|NCT00471497|588921285|FG000|Extension Phase|Death|1|||
163057482|NCT00471497|588921286|FG001|Extension Phase|Death|0|||
163057483|NCT00471497|588921287|FG002|Extension Phase|Death|0|||
163057484|NCT00471497|588921285|FG000|Extension Phase|Disease progression|2|||
163057485|NCT00471497|588921286|FG001|Extension Phase|Disease progression|0|||
163057486|NCT00471497|588921287|FG002|Extension Phase|Disease progression|0|||
163057487|NCT00471497|588921285|FG000|Extension Phase|Protocol Violation|2|||
163057488|NCT00471497|588921286|FG001|Extension Phase|Protocol Violation|2|||
163057489|NCT00471497|588921287|FG002|Extension Phase|Protocol Violation|0|||
163057490|NCT03329885|588921289|FG000|Overall Study|Sponsor discontinued the study early|0|||
163057491|NCT03329885|588921290|FG001|Overall Study|Sponsor discontinued the study early|0|||
163057492|NCT03329885|588921291|FG002|Overall Study|Sponsor discontinued the study early|0|||
163057493|NCT03329885|588921292|FG003|Overall Study|Sponsor discontinued the study early|0|||
163057494|NCT03329885|588921293|FG004|Overall Study|Sponsor discontinued the study early|0|||
163057495|NCT03329885|588921294|FG005|Overall Study|Sponsor discontinued the study early|0|||
162712798|NCT04381494|587660756|FG000|Overall Study|Withdrawal by Subject|9|||
162712799|NCT04381494|587660756|FG000|Overall Study|NSCLC disease progression|4|||
162712800|NCT04381494|587660756|FG000|Overall Study|Device-Related Adverse Event|2|||
162712801|NCT01977612|587660757|FG000|Overall Study|Lost to Follow-up|1|||
163057496|NCT03329885|588921295|FG006|Overall Study|Sponsor discontinued the study early|1|||
163057497|NCT03329885|588921296|FG007|Overall Study|Sponsor discontinued the study early|1|||
163057498|NCT03329885|588921297|FG008|Overall Study|Sponsor discontinued the study early|0|||
163057499|NCT01991795|588921298|FG000|Overall Study|Lost to Follow-up|6|||
163057500|NCT01991795|588921299|FG001|Overall Study|Lost to Follow-up|4|||
163057501|NCT01991795|588921298|FG000|Overall Study|Withdrawal by Subject|117|||
163057502|NCT01991795|588921299|FG001|Overall Study|Withdrawal by Subject|94|||
163057503|NCT01991795|588921298|FG000|Overall Study|Site prematurely closed by sponsor|26|||
162975521|NCT01470417|588609539|FG000|Overall Study|Disease progression|0|||
162975522|NCT01470417|588609540|FG001|Overall Study|Disease progression|2|||
162975523|NCT02973321|588609543|FG000|Overall Study|Other than specified|0|||
162975524|NCT02973321|588609544|FG001|Overall Study|Other than specified|5|||
162975525|NCT02973321|588609545|FG002|Overall Study|Other than specified|3|||
162975526|NCT02973321|588609546|FG003|Overall Study|Other than specified|3|||
162975527|NCT02973321|588609547|FG004|Overall Study|Other than specified|1|||
162975528|NCT02973321|588609543|FG000|Overall Study|Lack of Efficacy|0|||
162975529|NCT02973321|588609544|FG001|Overall Study|Lack of Efficacy|0|||
162975530|NCT02973321|588609545|FG002|Overall Study|Lack of Efficacy|0|||
162975531|NCT02973321|588609546|FG003|Overall Study|Lack of Efficacy|0|||
162975532|NCT02973321|588609547|FG004|Overall Study|Lack of Efficacy|1|||
162975533|NCT02973321|588609543|FG000|Overall Study|Adverse Event|1|||
162975534|NCT02973321|588609544|FG001|Overall Study|Adverse Event|10|||
162975535|NCT02973321|588609545|FG002|Overall Study|Adverse Event|11|||
162975536|NCT02973321|588609546|FG003|Overall Study|Adverse Event|13|||
162975537|NCT02973321|588609547|FG004|Overall Study|Adverse Event|3|||
162975538|NCT01098110|588609551|FG000|Overall Study|Withdrawal by Subject|14|||
162975539|NCT01098110|588609552|FG001|Overall Study|Withdrawal by Subject|24|||
162975540|NCT01098110|588609553|FG002|Overall Study|Withdrawal by Subject|19|||
162975541|NCT01098110|588609551|FG000|Overall Study|Adverse Event|30|||
162975542|NCT01098110|588609552|FG001|Overall Study|Adverse Event|32|||
162975543|NCT01098110|588609553|FG002|Overall Study|Adverse Event|43|||
162975544|NCT01098110|588609551|FG000|Overall Study|Lack of Efficacy|13|||
162975545|NCT01098110|588609552|FG001|Overall Study|Lack of Efficacy|9|||
162975546|NCT01098110|588609553|FG002|Overall Study|Lack of Efficacy|27|||
162975547|NCT01098110|588609551|FG000|Overall Study|Other|4|||
162975548|NCT01098110|588609552|FG001|Overall Study|Other|7|||
162975549|NCT01098110|588609553|FG002|Overall Study|Other|5|||
162975550|NCT01098110|588609551|FG000|Overall Study|Untreated|1|||
162975551|NCT01098110|588609552|FG001|Overall Study|Untreated|1|||
162975552|NCT01098110|588609553|FG002|Overall Study|Untreated|0|||
162975553|NCT01355302|588609554|FG000|Phase 1b|Death|4|||
162975554|NCT01355302|588609555|FG001|Phase 1b|Death|0|||
162975555|NCT01355302|588609556|FG002|Phase 1b|Death|0|||
162975556|NCT01355302|588609554|FG000|Phase 1b|Study terminated by sponsor|2|||
162975557|NCT01355302|588609555|FG001|Phase 1b|Study terminated by sponsor|0|||
162975558|NCT01355302|588609556|FG002|Phase 1b|Study terminated by sponsor|0|||
162975559|NCT02274948|588609559|FG000|Overall Study|Lost to Follow-up|28|||
162975560|NCT02274948|588609560|FG001|Overall Study|Lost to Follow-up|25|||
162975561|NCT02274948|588609559|FG000|Overall Study|Withdrawal by Subject|64|||
162975562|NCT02274948|588609560|FG001|Overall Study|Withdrawal by Subject|58|||
162975563|NCT02274948|588609559|FG000|Overall Study|Stopped on family Practitioner advice|2|||
162975564|NCT02274948|588609560|FG001|Overall Study|Stopped on family Practitioner advice|5|||
162975565|NCT02274948|588609559|FG000|Overall Study|Left the area|4|||
162975566|NCT02274948|588609560|FG001|Overall Study|Left the area|3|||
162975567|NCT00707434|588609561|FG000|Overall Study|Adverse Event|1|||
162975568|NCT05212883|588609562|FG000|Overall Study|Invalid test result|125|||
162975569|NCT02502734|588609563|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
162975570|NCT02502734|588609564|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
162975571|NCT02502734|588609563|FG000|Washout Period|Adverse Event|1|||
162975572|NCT02502734|588609564|FG001|Washout Period|Adverse Event|0|||
162975573|NCT00614822|588609565|FG000|Overall Study|Adverse Event|3|||
162975574|NCT03649412|588609574|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
162975575|NCT03649412|588609575|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
162975576|NCT03649412|588609574|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
162975577|NCT03649412|588609575|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
162975578|NCT03649412|588609574|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162975579|NCT03649412|588609575|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162975580|NCT03649412|588609574|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
162975581|NCT03649412|588609575|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
162975582|NCT03649412|588609574|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
162975583|NCT03649412|588609575|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
162975584|NCT03649412|588609574|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
162975585|NCT03649412|588609575|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
162975586|NCT00865514|588609576|FG000|Overall Study|Infusion cost exceeded funding|2|||
162712802|NCT01977612|587660758|FG001|Overall Study|Lost to Follow-up|1|||
162975587|NCT02865395|588609577|FG000|Overall Study|Physician Decision|6|||
162975588|NCT02865395|588609578|FG001|Overall Study|Physician Decision|10|||
162975589|NCT02865395|588609579|FG002|Overall Study|Physician Decision|7|||
162975590|NCT00530348|588609580|FG000|Overall Study|Adverse Event|5|||
162975591|NCT00530348|588609581|FG001|Overall Study|Adverse Event|1|||
162712803|NCT04310579|587660760|FG000|Overall Study|Adverse Event|0|||
162712804|NCT04310579|587660761|FG001|Overall Study|Adverse Event|0|||
162975592|NCT00530348|588609580|FG000|Overall Study|Death|0|||
162975593|NCT00530348|588609581|FG001|Overall Study|Death|1|||
162975594|NCT00530348|588609580|FG000|Overall Study|Lack of Efficacy|2|||
162975595|NCT00530348|588609581|FG001|Overall Study|Lack of Efficacy|0|||
162712805|NCT04310579|587660762|FG002|Overall Study|Adverse Event|0|||
162975596|NCT00530348|588609580|FG000|Overall Study|Lost to Follow-up|0|||
162975597|NCT00530348|588609581|FG001|Overall Study|Lost to Follow-up|2|||
162975598|NCT00530348|588609580|FG000|Overall Study|Physician Decision|1|||
162975599|NCT00530348|588609581|FG001|Overall Study|Physician Decision|2|||
162975600|NCT00530348|588609580|FG000|Overall Study|Pregnancy|1|||
162975601|NCT00530348|588609581|FG001|Overall Study|Pregnancy|0|||
162975602|NCT00530348|588609580|FG000|Overall Study|Withdrawal by Subject|12|||
162975603|NCT00530348|588609581|FG001|Overall Study|Withdrawal by Subject|12|||
162975604|NCT00530348|588609580|FG000|Overall Study|Randomised in error|1|||
162975605|NCT00530348|588609581|FG001|Overall Study|Randomised in error|0|||
162975606|NCT00530348|588609580|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
162975607|NCT00530348|588609581|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
162975608|NCT04364763|588609582|FG000|Overall Study|Death|1|||
162975609|NCT04364763|588609583|FG001|Overall Study|Death|2|||
162975610|NCT04364763|588609582|FG000|Overall Study|Lost to Follow-up|1|||
162975611|NCT04364763|588609583|FG001|Overall Study|Lost to Follow-up|0|||
162975612|NCT01256060|588609584|FG000|Overall Study|Lost to Follow-up|0|||
162975613|NCT01256060|588609585|FG001|Overall Study|Lost to Follow-up|1|||
162975614|NCT01256060|588609586|FG002|Overall Study|Lost to Follow-up|0|||
162975615|NCT01256060|588609587|FG003|Overall Study|Lost to Follow-up|0|||
162975616|NCT00985231|588609590|FG000|Overall Study|ineligible|1|||
162975617|NCT00985231|588609591|FG001|Overall Study|ineligible|0|||
162975618|NCT00985231|588609590|FG000|Overall Study|Protocol Violation|1|||
162975619|NCT00985231|588609591|FG001|Overall Study|Protocol Violation|0|||
162975620|NCT00985231|588609590|FG000|Overall Study|Withdrawal by Subject|1|||
162975621|NCT00985231|588609591|FG001|Overall Study|Withdrawal by Subject|0|||
162975622|NCT00985231|588609590|FG000|Overall Study|Lost to Follow-up|0|||
162975623|NCT00985231|588609591|FG001|Overall Study|Lost to Follow-up|1|||
162975624|NCT00985231|588609590|FG000|Overall Study|Study related symptoms & complaints|0|||
162975625|NCT00985231|588609591|FG001|Overall Study|Study related symptoms & complaints|2|||
162975626|NCT00089076|588609592|FG000|Overall Study|Alternate Therapy|1|||
162975627|NCT00089076|588609592|FG000|Overall Study|Withdrawal by Subject|2|||
162975628|NCT00089076|588609592|FG000|Overall Study|Progression|7|||
162975629|NCT00931463|588609593|FG000|Overall Study|Death|8|||
162975630|NCT00931463|588609594|FG001|Overall Study|Death|4|||
162975631|NCT00931463|588609593|FG000|Overall Study|Withdrawal by Subject|5|||
162975632|NCT00931463|588609594|FG001|Overall Study|Withdrawal by Subject|0|||
162975633|NCT00931463|588609593|FG000|Overall Study|Lost to Follow-up|4|||
162975634|NCT00931463|588609594|FG001|Overall Study|Lost to Follow-up|1|||
162975635|NCT00808509|588609595|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
162975636|NCT00808509|588609596|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
162975637|NCT00808509|588609595|FG000|Randomized Phase|Reduced methotrexate dose|1|||
162975638|NCT00808509|588609596|FG001|Randomized Phase|Reduced methotrexate dose|2|||
162712806|NCT04310579|587660763|FG003|Overall Study|Adverse Event|0|||
162975639|NCT00808509|588609595|FG000|Randomized Phase|Patient refused rescue therapy|0|||
162975640|NCT00808509|588609596|FG001|Randomized Phase|Patient refused rescue therapy|3|||
162975641|NCT02169791|588609599|FG000|Overall Study|Death|6|||
162975642|NCT02169791|588609599|FG000|Overall Study|patient withdrew consent|1|||
162975643|NCT00127166|588609603|FG000|Period I|Protocol Violation|0|||
162975644|NCT00127166|588609604|FG001|Period I|Protocol Violation|2|||
162975645|NCT00127166|588609603|FG000|Period I|Withdrawal by Subject|2|||
162975646|NCT00127166|588609604|FG001|Period I|Withdrawal by Subject|0|||
162975647|NCT00127166|588609603|FG000|Period I|Patient did not meet inclusion criteria|1|||
162975648|NCT00127166|588609604|FG001|Period I|Patient did not meet inclusion criteria|0|||
162975649|NCT00127166|588609603|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
162975650|NCT00127166|588609604|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
162975651|NCT00127166|588609603|FG000|Period II|Withdrawal by Subject|2|||
162975652|NCT00127166|588609604|FG001|Period II|Withdrawal by Subject|0|||
162975653|NCT00127166|588609603|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
162975654|NCT00127166|588609604|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
162975655|NCT01396421|588609605|FG000|Overall Study|Lost to Follow-up|0|||
162975656|NCT01396421|588609606|FG001|Overall Study|Lost to Follow-up|0|||
162975657|NCT01396421|588609607|FG002|Overall Study|Lost to Follow-up|0|||
162975658|NCT01396421|588609608|FG003|Overall Study|Lost to Follow-up|1|||
162975659|NCT01396421|588609605|FG000|Overall Study|Adverse Event|17|||
162975660|NCT01396421|588609606|FG001|Overall Study|Adverse Event|15|||
162975661|NCT01396421|588609607|FG002|Overall Study|Adverse Event|12|||
162975662|NCT01396421|588609608|FG003|Overall Study|Adverse Event|32|||
162975663|NCT01396421|588609605|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
162975664|NCT01396421|588609606|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
162975665|NCT01396421|588609607|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
162975666|NCT01396421|588609608|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
162975667|NCT01396421|588609605|FG000|Overall Study|Physician Decision|1|||
162975668|NCT01396421|588609606|FG001|Overall Study|Physician Decision|1|||
162975669|NCT01396421|588609607|FG002|Overall Study|Physician Decision|0|||
162975670|NCT01396421|588609608|FG003|Overall Study|Physician Decision|3|||
163057504|NCT01991795|588921299|FG001|Overall Study|Site prematurely closed by sponsor|25|||
163057505|NCT04004000|588921300|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
163057506|NCT02121210|588921301|FG000|Overall Study|Adverse Event|5|||
163057507|NCT02121210|588921302|FG001|Overall Study|Adverse Event|7|||
163057508|NCT02121210|588921301|FG000|Overall Study|Lack of Efficacy|2|||
163057509|NCT02121210|588921302|FG001|Overall Study|Lack of Efficacy|0|||
163057510|NCT02121210|588921301|FG000|Overall Study|Other than specified above|0|||
163057511|NCT02121210|588921302|FG001|Overall Study|Other than specified above|2|||
163057512|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
163057513|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
163057514|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057515|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057516|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057517|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057518|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057519|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057520|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057521|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
163057522|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
163057523|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
163057524|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057525|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057526|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057527|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057528|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057529|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057530|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057531|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163057532|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
163057533|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057534|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057535|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057536|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057537|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057538|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057539|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057540|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057541|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
163057542|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
163057543|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
163057544|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057545|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057546|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057547|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057548|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057549|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057550|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057551|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163057552|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
163057553|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
163057554|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057555|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057556|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057557|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057558|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057559|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057560|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057561|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
163057562|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
163057563|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
163057564|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
162975671|NCT01396421|588609605|FG000|Overall Study|Withdrawal by Subject|31|||
162975672|NCT01396421|588609606|FG001|Overall Study|Withdrawal by Subject|24|||
162975673|NCT01396421|588609607|FG002|Overall Study|Withdrawal by Subject|13|||
162975674|NCT01396421|588609608|FG003|Overall Study|Withdrawal by Subject|21|||
162975675|NCT01396421|588609605|FG000|Overall Study|Protocol Deviation|2|||
162975676|NCT01396421|588609606|FG001|Overall Study|Protocol Deviation|1|||
162975677|NCT01396421|588609607|FG002|Overall Study|Protocol Deviation|1|||
162975678|NCT01396421|588609608|FG003|Overall Study|Protocol Deviation|0|||
162975679|NCT01396421|588609605|FG000|Overall Study|Lack of Efficacy|7|||
162975680|NCT01396421|588609606|FG001|Overall Study|Lack of Efficacy|17|||
162975681|NCT01396421|588609607|FG002|Overall Study|Lack of Efficacy|7|||
162975682|NCT01396421|588609608|FG003|Overall Study|Lack of Efficacy|18|||
162975683|NCT01610063|588609617|FG000|Overall Study|Lost to Follow-up|42|||
162975684|NCT01610063|588609618|FG001|Overall Study|Lost to Follow-up|20|||
162975685|NCT00442546|588609619|FG000|Overall Study|Adverse Event|11|||
162975686|NCT00442546|588609620|FG001|Overall Study|Adverse Event|17|||
162975687|NCT00442546|588609621|FG002|Overall Study|Adverse Event|13|||
162975688|NCT00442546|588609619|FG000|Overall Study|Lost to Follow-up|1|||
162975689|NCT00442546|588609620|FG001|Overall Study|Lost to Follow-up|2|||
162975690|NCT00442546|588609621|FG002|Overall Study|Lost to Follow-up|1|||
162975691|NCT00442546|588609619|FG000|Overall Study|Other|4|||
162975692|NCT00442546|588609620|FG001|Overall Study|Other|9|||
162975693|NCT00442546|588609621|FG002|Overall Study|Other|6|||
162975694|NCT00442546|588609619|FG000|Overall Study|Withdrawal by Subject|5|||
162975695|NCT00442546|588609620|FG001|Overall Study|Withdrawal by Subject|5|||
162975696|NCT00442546|588609621|FG002|Overall Study|Withdrawal by Subject|7|||
162975697|NCT00442546|588609619|FG000|Overall Study|Randomized But Not Treated|5|||
162975698|NCT00442546|588609620|FG001|Overall Study|Randomized But Not Treated|4|||
162975699|NCT00442546|588609621|FG002|Overall Study|Randomized But Not Treated|6|||
162975700|NCT01301482|588611674|FG000|Overall Study|Withdrawal by Subject|1|||
162975701|NCT04039919|588611678|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162975702|NCT04039919|588611679|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162975703|NCT04039919|588611680|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162975704|NCT04039919|588611681|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162975705|NCT04039919|588611682|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162975706|NCT04039919|588611678|FG000|Treatment Period 1|Sponsor's decision|0|||
162975707|NCT04039919|588611679|FG001|Treatment Period 1|Sponsor's decision|0|||
162975708|NCT04039919|588611680|FG002|Treatment Period 1|Sponsor's decision|0|||
162975709|NCT04039919|588611681|FG003|Treatment Period 1|Sponsor's decision|0|||
162975710|NCT04039919|588611682|FG004|Treatment Period 1|Sponsor's decision|16|||
162975711|NCT04039919|588611678|FG000|Treatment Period 5|Withdrawal by Subject|1|||
162975712|NCT04039919|588611679|FG001|Treatment Period 5|Withdrawal by Subject|0|||
162975713|NCT04039919|588611680|FG002|Treatment Period 5|Withdrawal by Subject|0|||
162975714|NCT04039919|588611681|FG003|Treatment Period 5|Withdrawal by Subject|0|||
162975715|NCT04039919|588611682|FG004|Treatment Period 5|Withdrawal by Subject|0|||
162975716|NCT00706095|588611683|FG000|Overall Study|Progressive Disease|4|||
162975717|NCT00706095|588611684|FG001|Overall Study|Progressive Disease|5|||
162975718|NCT00706095|588611685|FG002|Overall Study|Progressive Disease|3|||
162975719|NCT00706095|588611683|FG000|Overall Study|Clinical Progression|1|||
162975720|NCT00706095|588611684|FG001|Overall Study|Clinical Progression|2|||
162975721|NCT00706095|588611685|FG002|Overall Study|Clinical Progression|2|||
162975722|NCT00706095|588611683|FG000|Overall Study|Withdrawal by Subject|1|||
162975723|NCT00706095|588611684|FG001|Overall Study|Withdrawal by Subject|0|||
162975724|NCT00706095|588611685|FG002|Overall Study|Withdrawal by Subject|0|||
162975725|NCT00263887|588611687|FG000|Overall Study|Withdrawal by Subject|1|||
162975726|NCT00263887|588611688|FG001|Overall Study|Withdrawal by Subject|1|||
162975727|NCT00263887|588611687|FG000|Overall Study|Lung transplantation|1|||
162975728|NCT00263887|588611688|FG001|Overall Study|Lung transplantation|2|||
162975729|NCT00263887|588611687|FG000|Overall Study|Too ill to attend visit|1|||
162975730|NCT00263887|588611688|FG001|Overall Study|Too ill to attend visit|0|||
162975731|NCT00263887|588611687|FG000|Overall Study|Adverse Event|0|||
162975732|NCT00263887|588611688|FG001|Overall Study|Adverse Event|2|||
162975733|NCT00263887|588611687|FG000|Overall Study|Disease progression|0|||
162975734|NCT00263887|588611688|FG001|Overall Study|Disease progression|1|||
162975735|NCT00263887|588611687|FG000|Overall Study|Lack of Efficacy|0|||
162975736|NCT00263887|588611688|FG001|Overall Study|Lack of Efficacy|1|||
162975737|NCT03095118|588611689|FG000|Overall Study|Adverse Event|1|||
162975738|NCT03095118|588611689|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
162975739|NCT01009515|588611692|FG000|Overall Study|Withdrawal by Subject|3|||
162975740|NCT01501110|588611694|FG000|Overall Study|Death|0|||
162975741|NCT01501110|588611695|FG001|Overall Study|Death|1|||
162975742|NCT02075606|588611699|FG000|Overall Study|Adverse Event|5|||
162975743|NCT02075606|588611699|FG000|Overall Study|Withdrawal by Subject|1|||
162975744|NCT02075606|588611699|FG000|Overall Study|Death|1|||
162975745|NCT02075606|588611699|FG000|Overall Study|Investigator's decision|1|||
162975746|NCT02075606|588611699|FG000|Overall Study|Symptom management|1|||
162975747|NCT02075606|588611699|FG000|Overall Study|Increasing Symptoms|1|||
162975748|NCT00983476|588611700|FG000|Overall Study|Did not receive intervention|17|||
162975749|NCT00983476|588611701|FG001|Overall Study|Did not receive intervention|22|||
162975750|NCT00983476|588611702|FG002|Overall Study|Did not receive intervention|0|||
162975751|NCT01439724|588611704|FG000|Overall Study|missing consultation|9|||
162975752|NCT01439724|588611705|FG001|Overall Study|missing consultation|8|||
162975753|NCT00575380|588611710|FG000|Overall Study|Withdrawal by Subject|1|||
162975754|NCT00575380|588611711|FG001|Overall Study|Withdrawal by Subject|0|||
162975755|NCT00575380|588611710|FG000|Overall Study|Adverse Event|0|||
162975756|NCT00575380|588611711|FG001|Overall Study|Adverse Event|1|||
162975757|NCT00575380|588611710|FG000|Overall Study|Various|0|||
162975758|NCT00575380|588611711|FG001|Overall Study|Various|2|||
162975759|NCT04019054|588611712|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
162975760|NCT04019054|588611713|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
162975761|NCT04019054|588611712|FG000|Overall Study|Withdrawal by Subject|3|||
162975762|NCT04019054|588611713|FG001|Overall Study|Withdrawal by Subject|1|||
162975763|NCT01040793|588611714|FG000|Overall Study|Adverse Event|5|||
162975764|NCT01040793|588611715|FG001|Overall Study|Adverse Event|3|||
162975765|NCT01040793|588611716|FG002|Overall Study|Adverse Event|0|||
162975766|NCT01040793|588611717|FG003|Overall Study|Adverse Event|2|||
162975767|NCT01040793|588611718|FG004|Overall Study|Adverse Event|2|||
162975768|NCT01040793|588611719|FG005|Overall Study|Adverse Event|1|||
162975769|NCT01040793|588611714|FG000|Overall Study|Protocol Violation|1|||
162975770|NCT01040793|588611715|FG001|Overall Study|Protocol Violation|1|||
162975771|NCT01040793|588611716|FG002|Overall Study|Protocol Violation|1|||
162975772|NCT01040793|588611717|FG003|Overall Study|Protocol Violation|0|||
162975773|NCT01040793|588611718|FG004|Overall Study|Protocol Violation|1|||
162975774|NCT01040793|588611719|FG005|Overall Study|Protocol Violation|0|||
162975775|NCT01040793|588611714|FG000|Overall Study|Lost to Follow-up|0|||
162975776|NCT01040793|588611715|FG001|Overall Study|Lost to Follow-up|1|||
162975777|NCT01040793|588611716|FG002|Overall Study|Lost to Follow-up|1|||
162975778|NCT01040793|588611717|FG003|Overall Study|Lost to Follow-up|0|||
162975779|NCT01040793|588611718|FG004|Overall Study|Lost to Follow-up|0|||
162975780|NCT01040793|588611719|FG005|Overall Study|Lost to Follow-up|0|||
162975781|NCT01040793|588611714|FG000|Overall Study|Withdrawal by Subject|0|||
162975782|NCT01040793|588611715|FG001|Overall Study|Withdrawal by Subject|0|||
162975783|NCT01040793|588611716|FG002|Overall Study|Withdrawal by Subject|0|||
162975784|NCT01040793|588611717|FG003|Overall Study|Withdrawal by Subject|2|||
162975785|NCT01040793|588611718|FG004|Overall Study|Withdrawal by Subject|0|||
162975786|NCT01040793|588611719|FG005|Overall Study|Withdrawal by Subject|0|||
162975787|NCT01040793|588611714|FG000|Overall Study|Other reasons not listed above|0|||
162975788|NCT01040793|588611715|FG001|Overall Study|Other reasons not listed above|0|||
162975789|NCT01040793|588611716|FG002|Overall Study|Other reasons not listed above|1|||
162975790|NCT01040793|588611717|FG003|Overall Study|Other reasons not listed above|0|||
162975791|NCT01040793|588611718|FG004|Overall Study|Other reasons not listed above|1|||
162975792|NCT01040793|588611719|FG005|Overall Study|Other reasons not listed above|0|||
162975793|NCT02412722|588611724|FG000|Overall Study|Adverse Event|0|||
162975794|NCT02412722|588611725|FG001|Overall Study|Adverse Event|2|||
162975795|NCT02412722|588611726|FG002|Overall Study|Adverse Event|0|||
162975796|NCT02412722|588611727|FG003|Overall Study|Adverse Event|3|||
162975797|NCT02412722|588611728|FG004|Overall Study|Adverse Event|0|||
162975798|NCT02412722|588611729|FG005|Overall Study|Adverse Event|3|||
162975799|NCT02412722|588611724|FG000|Overall Study|Progressive Disease|6|||
162975800|NCT02412722|588611725|FG001|Overall Study|Progressive Disease|4|||
162975801|NCT02412722|588611726|FG002|Overall Study|Progressive Disease|4|||
162975802|NCT02412722|588611727|FG003|Overall Study|Progressive Disease|9|||
162975803|NCT02412722|588611728|FG004|Overall Study|Progressive Disease|3|||
162975804|NCT02412722|588611729|FG005|Overall Study|Progressive Disease|3|||
162975805|NCT02412722|588611724|FG000|Overall Study|Withdrawal by Subject|2|||
162975806|NCT02412722|588611725|FG001|Overall Study|Withdrawal by Subject|0|||
162975807|NCT02412722|588611726|FG002|Overall Study|Withdrawal by Subject|1|||
162975808|NCT02412722|588611727|FG003|Overall Study|Withdrawal by Subject|2|||
162975809|NCT02412722|588611728|FG004|Overall Study|Withdrawal by Subject|1|||
162630305|NCT01425281|587365101|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
162630306|NCT01749514|587365102|FG000|Overall Study|Lost to Follow-up|0|||
162975810|NCT02412722|588611729|FG005|Overall Study|Withdrawal by Subject|1|||
162975811|NCT02412722|588611724|FG000|Overall Study|Lost to Follow-up|0|||
162975812|NCT02412722|588611725|FG001|Overall Study|Lost to Follow-up|0|||
162975813|NCT02412722|588611726|FG002|Overall Study|Lost to Follow-up|0|||
162975814|NCT02412722|588611727|FG003|Overall Study|Lost to Follow-up|0|||
162975815|NCT02412722|588611728|FG004|Overall Study|Lost to Follow-up|1|||
162975816|NCT02412722|588611729|FG005|Overall Study|Lost to Follow-up|0|||
162975817|NCT02412722|588611724|FG000|Overall Study|Received drug in run-in and discontinued|0|||
162975818|NCT02412722|588611725|FG001|Overall Study|Received drug in run-in and discontinued|2|||
162975819|NCT02412722|588611726|FG002|Overall Study|Received drug in run-in and discontinued|0|||
162975820|NCT02412722|588611727|FG003|Overall Study|Received drug in run-in and discontinued|0|||
162975821|NCT02412722|588611728|FG004|Overall Study|Received drug in run-in and discontinued|0|||
162975822|NCT02412722|588611729|FG005|Overall Study|Received drug in run-in and discontinued|0|||
162975823|NCT02412722|588611724|FG000|Overall Study|Reason not Specified|3|||
162975824|NCT02412722|588611725|FG001|Overall Study|Reason not Specified|0|||
162975825|NCT02412722|588611726|FG002|Overall Study|Reason not Specified|2|||
162975826|NCT02412722|588611727|FG003|Overall Study|Reason not Specified|1|||
162975827|NCT02412722|588611728|FG004|Overall Study|Reason not Specified|2|||
162975828|NCT02412722|588611729|FG005|Overall Study|Reason not Specified|6|||
162975829|NCT01083680|588611730|FG000|Overall Study|Lost to Follow-up|2758|||
162975830|NCT01083680|588611730|FG000|Overall Study|Withdrawal by Subject|1086|||
162975831|NCT03877926|588611731|FG000|Overall Study|Adverse Event|1|||
162975832|NCT03877926|588611732|FG001|Overall Study|Adverse Event|0|||
162975833|NCT03877926|588611733|FG002|Overall Study|Adverse Event|0|||
162975834|NCT03877926|588611734|FG003|Overall Study|Adverse Event|0|||
162975835|NCT03877926|588611731|FG000|Overall Study|Death|2|||
162975836|NCT03877926|588611732|FG001|Overall Study|Death|2|||
162975837|NCT03877926|588611733|FG002|Overall Study|Death|2|||
162975838|NCT03877926|588611734|FG003|Overall Study|Death|0|||
162975839|NCT03877926|588611731|FG000|Overall Study|Lost to Follow-up|41|||
162975840|NCT03877926|588611732|FG001|Overall Study|Lost to Follow-up|52|||
162975841|NCT03877926|588611733|FG002|Overall Study|Lost to Follow-up|45|||
162975842|NCT03877926|588611734|FG003|Overall Study|Lost to Follow-up|17|||
162975843|NCT03877926|588611731|FG000|Overall Study|Physician Decision|2|||
162975844|NCT03877926|588611732|FG001|Overall Study|Physician Decision|0|||
162975845|NCT03877926|588611733|FG002|Overall Study|Physician Decision|2|||
162975846|NCT03877926|588611734|FG003|Overall Study|Physician Decision|0|||
162975847|NCT03877926|588611731|FG000|Overall Study|Withdrawal by Subject|18|||
162975848|NCT03877926|588611732|FG001|Overall Study|Withdrawal by Subject|21|||
162975849|NCT03877926|588611733|FG002|Overall Study|Withdrawal by Subject|12|||
162975850|NCT03877926|588611734|FG003|Overall Study|Withdrawal by Subject|4|||
162975851|NCT03877926|588611731|FG000|Overall Study|Other - Various|4|||
162975852|NCT03877926|588611732|FG001|Overall Study|Other - Various|1|||
162975853|NCT03877926|588611733|FG002|Overall Study|Other - Various|1|||
162975854|NCT03877926|588611734|FG003|Overall Study|Other - Various|0|||
162975855|NCT03877926|588611731|FG000|Overall Study|Not Treated|3|||
162975856|NCT03877926|588611732|FG001|Overall Study|Not Treated|1|||
162975857|NCT03877926|588611733|FG002|Overall Study|Not Treated|1|||
162975858|NCT03877926|588611734|FG003|Overall Study|Not Treated|0|||
162975859|NCT03546647|588611735|FG000|Overall Study|Adverse Event|1|||
162975860|NCT03546647|588611736|FG001|Overall Study|Adverse Event|0|||
162975861|NCT02400476|588611737|FG000|Overall Study|Adverse Event|57|||
162975862|NCT02400476|588611738|FG001|Overall Study|Adverse Event|10|||
162975863|NCT02400476|588611739|FG002|Overall Study|Adverse Event|22|||
162975864|NCT02400476|588611740|FG003|Overall Study|Adverse Event|19|||
162975865|NCT02400476|588611741|FG004|Overall Study|Adverse Event|5|||
162975866|NCT02400476|588611742|FG005|Overall Study|Adverse Event|8|||
162975867|NCT02400476|588611737|FG000|Overall Study|Withdrawal by Subject|4|||
162975868|NCT02400476|588611738|FG001|Overall Study|Withdrawal by Subject|1|||
162975869|NCT02400476|588611739|FG002|Overall Study|Withdrawal by Subject|12|||
162975870|NCT02400476|588611740|FG003|Overall Study|Withdrawal by Subject|7|||
162975871|NCT02400476|588611741|FG004|Overall Study|Withdrawal by Subject|5|||
162975872|NCT02400476|588611742|FG005|Overall Study|Withdrawal by Subject|5|||
162975873|NCT02400476|588611737|FG000|Overall Study|Lost to Follow-up|0|||
162975874|NCT02400476|588611738|FG001|Overall Study|Lost to Follow-up|0|||
162975875|NCT02400476|588611739|FG002|Overall Study|Lost to Follow-up|0|||
162975876|NCT02400476|588611740|FG003|Overall Study|Lost to Follow-up|1|||
162975877|NCT02400476|588611741|FG004|Overall Study|Lost to Follow-up|3|||
162975878|NCT02400476|588611742|FG005|Overall Study|Lost to Follow-up|1|||
162975879|NCT02400476|588611737|FG000|Overall Study|Physician Decision|0|||
162975880|NCT02400476|588611738|FG001|Overall Study|Physician Decision|0|||
162975881|NCT02400476|588611739|FG002|Overall Study|Physician Decision|1|||
162975882|NCT02400476|588611740|FG003|Overall Study|Physician Decision|1|||
162975883|NCT02400476|588611741|FG004|Overall Study|Physician Decision|0|||
162975884|NCT02400476|588611742|FG005|Overall Study|Physician Decision|1|||
162975885|NCT02400476|588611737|FG000|Overall Study|Other, Disease Progression|0|||
162975886|NCT02400476|588611738|FG001|Overall Study|Other, Disease Progression|1|||
162975887|NCT02400476|588611739|FG002|Overall Study|Other, Disease Progression|2|||
162975888|NCT02400476|588611740|FG003|Overall Study|Other, Disease Progression|1|||
162975889|NCT02400476|588611741|FG004|Overall Study|Other, Disease Progression|2|||
162975890|NCT02400476|588611742|FG005|Overall Study|Other, Disease Progression|1|||
162975891|NCT02400476|588611737|FG000|Overall Study|Other, Decreased Quality of Life|0|||
162975892|NCT02400476|588611738|FG001|Overall Study|Other, Decreased Quality of Life|0|||
162975893|NCT02400476|588611739|FG002|Overall Study|Other, Decreased Quality of Life|2|||
162975894|NCT02400476|588611740|FG003|Overall Study|Other, Decreased Quality of Life|0|||
162975895|NCT02400476|588611741|FG004|Overall Study|Other, Decreased Quality of Life|0|||
162975896|NCT02400476|588611742|FG005|Overall Study|Other, Decreased Quality of Life|0|||
162975897|NCT02400476|588611737|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975898|NCT02400476|588611738|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975899|NCT02400476|588611739|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
163057565|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057566|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057567|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057568|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057569|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057570|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
162975900|NCT02400476|588611740|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
162975901|NCT02400476|588611741|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975902|NCT02400476|588611742|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162975903|NCT00124462|588611743|FG000|Overall Study|Lost to Follow-up|3|||
162975904|NCT00124462|588611744|FG001|Overall Study|Lost to Follow-up|3|||
162975905|NCT00124462|588611743|FG000|Overall Study|Physician Decision|3|||
162975906|NCT00124462|588611744|FG001|Overall Study|Physician Decision|4|||
162975907|NCT00124462|588611743|FG000|Overall Study|Withdrawal by Subject|4|||
162975908|NCT00124462|588611744|FG001|Overall Study|Withdrawal by Subject|5|||
162975909|NCT00124462|588611743|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
162975910|NCT00124462|588611744|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
162975911|NCT00003531|588611745|FG000|Overall Study|Not evaluable|10|||
162975912|NCT00588731|588611746|FG000|Overall Study|Withdrawal by Subject|3|||
162975913|NCT00588731|588611747|FG001|Overall Study|Withdrawal by Subject|2|||
162975914|NCT00346164|588611748|FG000|Overall Study|Adverse Event|0|||
162975915|NCT00346164|588611749|FG001|Overall Study|Adverse Event|0|||
162975916|NCT00346164|588611750|FG002|Overall Study|Adverse Event|0|||
163057571|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
163057572|NCT01232283|588921305|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
163057573|NCT01232283|588921306|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
163057574|NCT01232283|588921307|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057575|NCT01232283|588921308|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057576|NCT01232283|588921309|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057577|NCT01232283|588921310|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057578|NCT01232283|588921311|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057579|NCT01232283|588921312|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057580|NCT01232283|588921313|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057581|NCT01232283|588921314|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
163057582|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057583|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057584|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
163057585|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
163057586|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057587|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057588|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057589|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057590|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057591|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
163057592|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057593|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057594|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
163057595|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
163057596|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057597|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057598|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057599|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
162975917|NCT00346164|588611751|FG003|Overall Study|Adverse Event|1|||
163057600|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057601|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
163057602|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057603|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057604|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
163057605|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057606|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057607|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057608|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057609|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057610|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057611|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163057612|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
162975918|NCT00346164|588611748|FG000|Overall Study|Lack of Efficacy|0|||
162975919|NCT00346164|588611749|FG001|Overall Study|Lack of Efficacy|1|||
162975920|NCT00346164|588611750|FG002|Overall Study|Lack of Efficacy|7|||
163057613|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057614|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
162975921|NCT00346164|588611751|FG003|Overall Study|Lack of Efficacy|25|||
162975922|NCT00346164|588611748|FG000|Overall Study|Physician Decision|0|||
162975923|NCT00346164|588611749|FG001|Overall Study|Physician Decision|1|||
162975924|NCT00346164|588611750|FG002|Overall Study|Physician Decision|2|||
163057615|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
163057616|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057617|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057618|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057619|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057620|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057621|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
163057622|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057623|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057624|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
163057625|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
163057626|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057627|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057628|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057629|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057630|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057631|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
163057632|NCT01232283|588921305|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
163057633|NCT01232283|588921306|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
163057634|NCT01232283|588921307|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
163057635|NCT01232283|588921308|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
163057636|NCT01232283|588921309|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
163057637|NCT01232283|588921310|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
162975925|NCT00346164|588611751|FG003|Overall Study|Physician Decision|27|||
162975926|NCT00346164|588611748|FG000|Overall Study|Protocol Violation|6|||
162975927|NCT00346164|588611749|FG001|Overall Study|Protocol Violation|2|||
162975928|NCT00346164|588611750|FG002|Overall Study|Protocol Violation|10|||
162975929|NCT00346164|588611751|FG003|Overall Study|Protocol Violation|4|||
162975930|NCT00346164|588611748|FG000|Overall Study|Withdrawal by Subject|0|||
162975931|NCT00346164|588611749|FG001|Overall Study|Withdrawal by Subject|0|||
162975932|NCT00346164|588611750|FG002|Overall Study|Withdrawal by Subject|2|||
162975933|NCT00346164|588611751|FG003|Overall Study|Withdrawal by Subject|0|||
162975934|NCT00346164|588611748|FG000|Overall Study|Ineligible|11|||
162975935|NCT00346164|588611749|FG001|Overall Study|Ineligible|2|||
162975936|NCT00346164|588611750|FG002|Overall Study|Ineligible|2|||
162975937|NCT00346164|588611751|FG003|Overall Study|Ineligible|23|||
162975938|NCT00346164|588611748|FG000|Overall Study|Refusal of further protocol therapy|0|||
162975939|NCT00346164|588611749|FG001|Overall Study|Refusal of further protocol therapy|1|||
162975940|NCT00346164|588611750|FG002|Overall Study|Refusal of further protocol therapy|3|||
162975941|NCT00346164|588611751|FG003|Overall Study|Refusal of further protocol therapy|15|||
162975942|NCT00346164|588611748|FG000|Overall Study|Inability to start week 16 tx on time|0|||
162975943|NCT00346164|588611749|FG001|Overall Study|Inability to start week 16 tx on time|0|||
162975944|NCT00346164|588611750|FG002|Overall Study|Inability to start week 16 tx on time|0|||
162975945|NCT00346164|588611751|FG003|Overall Study|Inability to start week 16 tx on time|11|||
162975946|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
162975947|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
162975948|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
162975949|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
162975950|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Death|15|||
163057638|NCT01232283|588921311|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
162975951|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Death|20|||
162975952|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Death|0|||
162975953|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Death|0|||
162975954|NCT01684878|588611753|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
162975955|NCT01684878|588611754|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
163057639|NCT01232283|588921312|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
163057640|NCT01232283|588921313|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
163057641|NCT01232283|588921314|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
163057642|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057643|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
162975956|NCT01684878|588611755|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
163057644|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
162975957|NCT01684878|588611756|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
162975958|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
162975959|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
162975960|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
162975961|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
162975962|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975963|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975964|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
162975965|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
162975966|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Death|0|||
162975967|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Death|0|||
162975968|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Death|62|||
162975969|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Death|68|||
162975970|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
162975971|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
162975972|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
162975973|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
162975974|NCT01684878|588611753|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
162975975|NCT01684878|588611754|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
162975976|NCT01684878|588611755|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
162975977|NCT01684878|588611756|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
162975978|NCT02087176|588611760|FG000|Overall Study|Withdrawal by Subject|1|||
162975979|NCT02087176|588611760|FG000|Overall Study|Death|10|||
162975980|NCT02087176|588611760|FG000|Overall Study|Censored|19|||
162975981|NCT02087176|588611760|FG000|Overall Study|Study Terminated by Sponsor|2|||
162975982|NCT02927834|588611761|FG000|Overall Study|Lost to Follow-up|1|||
162975983|NCT02927834|588611762|FG001|Overall Study|Lost to Follow-up|2|||
162975984|NCT02927834|588611763|FG002|Overall Study|Lost to Follow-up|2|||
162975985|NCT03812991|588611765|FG000|Overall Study|Lost to Follow-up|3|||
162975986|NCT03812991|588611766|FG001|Overall Study|Lost to Follow-up|1|||
162975987|NCT03942211|588611767|FG000|Overall Study|Death|1|||
162975988|NCT03942211|588611768|FG001|Overall Study|Death|0|||
162975989|NCT03942211|588611767|FG000|Overall Study|Study terminated by sponsor|5|||
162975990|NCT03942211|588611768|FG001|Overall Study|Study terminated by sponsor|3|||
162975991|NCT03942211|588611767|FG000|Overall Study|Adverse Event|0|||
162975992|NCT03942211|588611768|FG001|Overall Study|Adverse Event|1|||
162975993|NCT01955044|588611769|FG000|Overall Study|Death|1|||
162975994|NCT01955044|588611770|FG001|Overall Study|Death|1|||
162975995|NCT01955044|588611771|FG002|Overall Study|Death|0|||
162975996|NCT01148225|588611772|FG000|Overall Study|Other|185|||
162975997|NCT04798482|588611773|FG000|Overall Study|Physician Decision|1|||
162975998|NCT04798482|588611773|FG000|Overall Study|Lost eligibility|1|||
162975999|NCT00605917|588611778|FG000|Overall Study|Protocol Violation|79|||
162976000|NCT01506908|588611779|FG000|Overall Study|Adverse Event|1|||
162976001|NCT01506908|588611780|FG001|Overall Study|Adverse Event|0|||
162976002|NCT00925301|588611783|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976003|NCT00925301|588611784|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
162976004|NCT00925301|588611785|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976005|NCT00925301|588611786|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
162976006|NCT00925301|588611783|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976007|NCT00925301|588611784|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
162976008|NCT00925301|588611785|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976009|NCT00925301|588611786|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
162976010|NCT00925301|588611783|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976011|NCT00925301|588611784|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976012|NCT00925301|588611785|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
162976013|NCT00925301|588611786|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
162976014|NCT00925301|588611783|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976015|NCT00925301|588611784|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976016|NCT00925301|588611785|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
162976017|NCT00925301|588611786|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
162976018|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976019|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976020|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
162976021|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
162630307|NCT01749514|587365103|FG001|Overall Study|Lost to Follow-up|0|||
162630308|NCT01749514|587365104|FG002|Overall Study|Lost to Follow-up|0|||
162976022|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976023|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976024|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
162976025|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
162976026|NCT00925301|588611783|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976027|NCT00925301|588611784|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976028|NCT00925301|588611785|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
162976029|NCT00925301|588611786|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
162976030|NCT03043560|588611787|FG000|Overall Study|Discontinued Intervention|1|||
162976031|NCT03043560|588611788|FG001|Overall Study|Discontinued Intervention|2|||
162976032|NCT03043560|588611787|FG000|Overall Study|Lost to Follow-up|0|||
162976033|NCT03043560|588611788|FG001|Overall Study|Lost to Follow-up|1|||
162976034|NCT00292227|588611789|FG000|Patch Period|Adverse Event|1|||
162976035|NCT00292227|588611790|FG001|Patch Period|Adverse Event|0|||
162976036|NCT00292227|588611791|FG002|Patch Period|Adverse Event|2|||
162976037|NCT00292227|588611789|FG000|Patch Period|Withdrawal by Subject|0|||
162976038|NCT00292227|588611790|FG001|Patch Period|Withdrawal by Subject|0|||
162976039|NCT00292227|588611791|FG002|Patch Period|Withdrawal by Subject|1|||
162976040|NCT04232540|588611795|FG000|Overall Study|Lost to Follow-up|1|||
162976041|NCT04232540|588611796|FG001|Overall Study|Lost to Follow-up|0|||
162976042|NCT00537017|588611797|FG000|Treatment Phase|Adverse Event|19|||
162976043|NCT00537017|588611797|FG000|Treatment Phase|Withdrawal by Subject|13|||
162976044|NCT00537017|588611797|FG000|Treatment Phase|Protocol Violation|2|||
162976045|NCT00537017|588611797|FG000|Follow-up Phase|Withdrawal by Subject|9|||
162976046|NCT03234608|588611799|FG000|Overall Study|Lost to Follow-up|23|||
162976047|NCT03234608|588611800|FG001|Overall Study|Lost to Follow-up|21|||
162976048|NCT02105701|588611801|FG000|Overall Study|Lost to Follow-up|1|||
162976049|NCT02105701|588611802|FG001|Overall Study|Lost to Follow-up|0|||
162976050|NCT02105701|588611803|FG002|Overall Study|Lost to Follow-up|2|||
162976051|NCT02105701|588611804|FG003|Overall Study|Lost to Follow-up|1|||
162976052|NCT02105701|588611801|FG000|Overall Study|Protocol Violation|0|||
162976053|NCT02105701|588611802|FG001|Overall Study|Protocol Violation|0|||
162976054|NCT02105701|588611803|FG002|Overall Study|Protocol Violation|1|||
162976055|NCT02105701|588611804|FG003|Overall Study|Protocol Violation|0|||
162976056|NCT02105701|588611801|FG000|Overall Study|Withdrawal by Subject|2|||
162976057|NCT02105701|588611802|FG001|Overall Study|Withdrawal by Subject|1|||
162976058|NCT02105701|588611803|FG002|Overall Study|Withdrawal by Subject|0|||
162976059|NCT02105701|588611804|FG003|Overall Study|Withdrawal by Subject|1|||
162976060|NCT02105701|588611801|FG000|Overall Study|Death|1|||
162976061|NCT02105701|588611802|FG001|Overall Study|Death|0|||
162976062|NCT02105701|588611803|FG002|Overall Study|Death|0|||
162976063|NCT02105701|588611804|FG003|Overall Study|Death|0|||
162976064|NCT02329431|588611805|FG000|Overall Study|Lost to Follow-up|20|||
162976065|NCT02329431|588611806|FG001|Overall Study|Lost to Follow-up|13|||
162976066|NCT01362296|588611807|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
162976067|NCT01362296|588611808|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
162976068|NCT01362296|588611809|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
162976069|NCT01362296|588611810|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
162976070|NCT01362296|588611807|FG000|Randomized Phase (RP)|Physician Decision|1|||
162976071|NCT01362296|588611808|FG001|Randomized Phase (RP)|Physician Decision|9|||
162976072|NCT01362296|588611809|FG002|Randomized Phase (RP)|Physician Decision|0|||
162976073|NCT01362296|588611810|FG003|Randomized Phase (RP)|Physician Decision|0|||
162976074|NCT01362296|588611807|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
162976075|NCT01362296|588611808|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
162976076|NCT01362296|588611809|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
162976077|NCT01362296|588611810|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
162976078|NCT01362296|588611807|FG000|Randomized Phase (RP)|Adverse Event|20|||
162976079|NCT01362296|588611808|FG001|Randomized Phase (RP)|Adverse Event|4|||
162976080|NCT01362296|588611809|FG002|Randomized Phase (RP)|Adverse Event|0|||
162976081|NCT01362296|588611810|FG003|Randomized Phase (RP)|Adverse Event|0|||
162976082|NCT01362296|588611807|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
162976083|NCT01362296|588611808|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
162976084|NCT01362296|588611809|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
162976085|NCT01362296|588611810|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
162976086|NCT01362296|588611807|FG000|Crossover Phase|PD including Death due to PD|0|||
162976087|NCT01362296|588611808|FG001|Crossover Phase|PD including Death due to PD|0|||
162976088|NCT01362296|588611809|FG002|Crossover Phase|PD including Death due to PD|16|||
162976089|NCT01362296|588611810|FG003|Crossover Phase|PD including Death due to PD|1|||
162976090|NCT01362296|588611807|FG000|Crossover Phase|Withdrawal by Subject|0|||
162976091|NCT01362296|588611808|FG001|Crossover Phase|Withdrawal by Subject|0|||
162976092|NCT01362296|588611809|FG002|Crossover Phase|Withdrawal by Subject|2|||
162976093|NCT01362296|588611810|FG003|Crossover Phase|Withdrawal by Subject|1|||
162976094|NCT01362296|588611807|FG000|Crossover Phase|Adverse Event|0|||
162976095|NCT01362296|588611808|FG001|Crossover Phase|Adverse Event|0|||
162976096|NCT01362296|588611809|FG002|Crossover Phase|Adverse Event|4|||
162976097|NCT01362296|588611810|FG003|Crossover Phase|Adverse Event|0|||
162976098|NCT01362296|588611807|FG000|Crossover Phase|Study Closed/Terminated|0|||
162976099|NCT01362296|588611808|FG001|Crossover Phase|Study Closed/Terminated|0|||
162976100|NCT01362296|588611809|FG002|Crossover Phase|Study Closed/Terminated|1|||
162976101|NCT01362296|588611810|FG003|Crossover Phase|Study Closed/Terminated|0|||
162976102|NCT01662362|588611812|FG000|Overall Study|Lost to Follow-up|38|||
163057645|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
162976103|NCT02339090|588611813|FG000|Overall Study|Adverse Event|1|||
162976104|NCT02339090|588611814|FG001|Overall Study|Adverse Event|0|||
162976105|NCT02339090|588611813|FG000|Overall Study|Lost to Follow-up|0|||
162976106|NCT02339090|588611814|FG001|Overall Study|Lost to Follow-up|1|||
162976107|NCT02339090|588611813|FG000|Overall Study|Non-compliance With Study Drug|0|||
162976108|NCT02339090|588611814|FG001|Overall Study|Non-compliance With Study Drug|1|||
162976109|NCT02339090|588611813|FG000|Overall Study|Withdrawal by Subject|2|||
162976110|NCT02339090|588611814|FG001|Overall Study|Withdrawal by Subject|1|||
162976111|NCT02339090|588611813|FG000|Overall Study|Poor Growth|3|||
162976112|NCT02339090|588611814|FG001|Overall Study|Poor Growth|0|||
162976113|NCT02339090|588611813|FG000|Overall Study|Randomized but not treated|0|||
162976114|NCT02339090|588611814|FG001|Overall Study|Randomized but not treated|2|||
162976115|NCT01253317|588611820|FG000|Overall Study|Adverse Event|2|||
162976116|NCT03183141|588611821|FG000|Overall Study|Withdrawal by Subject|2|||
162976117|NCT03183141|588611822|FG001|Overall Study|Withdrawal by Subject|4|||
162976118|NCT03183141|588611821|FG000|Overall Study|Death|0|||
162976119|NCT03183141|588611822|FG001|Overall Study|Death|8|||
162976120|NCT01507090|588611826|FG000|Overall Study|incomplete dataset|18|||
162976121|NCT02953678|588611843|FG000|Overall Study|Adverse Event|20|||
162976122|NCT02953678|588611843|FG000|Overall Study|Death|7|||
162976123|NCT02953678|588611843|FG000|Overall Study|Physician Decision|23|||
162976124|NCT02953678|588611843|FG000|Overall Study|Progressive Disease of GVHD|7|||
162976125|NCT02953678|588611843|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
162976126|NCT02953678|588611843|FG000|Overall Study|Withdrawal by participant|3|||
162976127|NCT02953678|588611843|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
162976128|NCT02953678|588611843|FG000|Overall Study|Participants were transferred to commercial product.|3|||
162976129|NCT00546910|588613970|FG000|Overall Study|Adverse Event|2|||
162976130|NCT00546910|588613971|FG001|Overall Study|Adverse Event|3|||
162976131|NCT00546910|588613970|FG000|Overall Study|Lack of Efficacy|5|||
162976132|NCT00546910|588613971|FG001|Overall Study|Lack of Efficacy|7|||
162976133|NCT00546910|588613970|FG000|Overall Study|Physician Decision|0|||
162976134|NCT00546910|588613971|FG001|Overall Study|Physician Decision|1|||
162976135|NCT00546910|588613970|FG000|Overall Study|Withdrawal by Subject|2|||
162976136|NCT00546910|588613971|FG001|Overall Study|Withdrawal by Subject|0|||
162976137|NCT01333072|588613975|FG000|Overall Study|Lost to Follow-up|3|||
162976138|NCT01333072|588613976|FG001|Overall Study|Lost to Follow-up|0|||
162976139|NCT01333072|588613975|FG000|Overall Study|Adverse Event|2|||
162976140|NCT01333072|588613976|FG001|Overall Study|Adverse Event|4|||
162976141|NCT01333072|588613975|FG000|Overall Study|Physician Decision|1|||
162976142|NCT01333072|588613976|FG001|Overall Study|Physician Decision|0|||
162976143|NCT02457611|588613977|FG000|Overall Study|Lost to Follow-up|3|||
162976144|NCT00493454|588613978|FG000|Overall Study|Withdrawal by Subject|1|||
162976145|NCT01011556|588613979|FG000|Overall Study|Adverse Event|1|||
162976146|NCT01011556|588613980|FG001|Overall Study|Adverse Event|3|||
162976147|NCT01011556|588613981|FG002|Overall Study|Adverse Event|2|||
162976148|NCT01011556|588613982|FG003|Overall Study|Adverse Event|1|||
162976149|NCT01011556|588613979|FG000|Overall Study|Lost to Follow-up|1|||
162976150|NCT01011556|588613980|FG001|Overall Study|Lost to Follow-up|0|||
162976151|NCT01011556|588613981|FG002|Overall Study|Lost to Follow-up|0|||
162976152|NCT01011556|588613982|FG003|Overall Study|Lost to Follow-up|0|||
162976153|NCT01011556|588613979|FG000|Overall Study|Physician Decision|1|||
162976154|NCT01011556|588613980|FG001|Overall Study|Physician Decision|0|||
162976155|NCT01011556|588613981|FG002|Overall Study|Physician Decision|0|||
162976156|NCT01011556|588613982|FG003|Overall Study|Physician Decision|1|||
162976157|NCT01011556|588613979|FG000|Overall Study|Protocol Violation|0|||
162976158|NCT01011556|588613980|FG001|Overall Study|Protocol Violation|1|||
162976159|NCT01011556|588613981|FG002|Overall Study|Protocol Violation|0|||
162976160|NCT01011556|588613982|FG003|Overall Study|Protocol Violation|0|||
162976161|NCT01011556|588613979|FG000|Overall Study|Withdrawal by Subject|1|||
162976162|NCT01011556|588613980|FG001|Overall Study|Withdrawal by Subject|2|||
162976163|NCT01011556|588613981|FG002|Overall Study|Withdrawal by Subject|4|||
162976164|NCT01011556|588613982|FG003|Overall Study|Withdrawal by Subject|4|||
162976165|NCT01011556|588613979|FG000|Overall Study|Sponsor decision|0|||
162976166|NCT01011556|588613980|FG001|Overall Study|Sponsor decision|1|||
162976167|NCT01011556|588613981|FG002|Overall Study|Sponsor decision|1|||
162976168|NCT01011556|588613982|FG003|Overall Study|Sponsor decision|2|||
162976169|NCT01011556|588613979|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
162976170|NCT01011556|588613980|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
162976171|NCT01011556|588613981|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
162976172|NCT01011556|588613982|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
162976173|NCT03920280|588613983|FG000|Overall Study|Adverse Event|2|||
162976174|NCT03920280|588613984|FG001|Overall Study|Adverse Event|3|||
162976175|NCT03920280|588613983|FG000|Overall Study|Lost to Follow-up|0|||
162976176|NCT03920280|588613984|FG001|Overall Study|Lost to Follow-up|1|||
162976177|NCT03920280|588613983|FG000|Overall Study|Withdrawal by Subject|1|||
162976178|NCT03920280|588613984|FG001|Overall Study|Withdrawal by Subject|1|||
162976179|NCT03920280|588613983|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
162976180|NCT03920280|588613984|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
162976181|NCT04220775|588613991|FG000|Overall Study|Adverse Event|1|||
162976182|NCT04220775|588613992|FG001|Overall Study|Adverse Event|0|||
162976183|NCT04220775|588613991|FG000|Overall Study|Disease Progression|1|||
162976184|NCT04220775|588613992|FG001|Overall Study|Disease Progression|0|||
162976185|NCT01857206|588613994|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
162976186|NCT01857206|588613995|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
162976187|NCT01857206|588613994|FG000|Overall Study|Lost to Follow-up|9|||
162976188|NCT01857206|588613995|FG001|Overall Study|Lost to Follow-up|6|||
162976189|NCT01857206|588613994|FG000|Overall Study|Unclassified|3|||
162976190|NCT01857206|588613995|FG001|Overall Study|Unclassified|3|||
162976191|NCT01857206|588613994|FG000|Overall Study|Withdrawal by Subject|1|||
162976192|NCT01857206|588613995|FG001|Overall Study|Withdrawal by Subject|0|||
162976193|NCT01483625|588613998|FG000|Overall Study|Adverse Event|1|||
162976194|NCT01483625|588613999|FG001|Overall Study|Adverse Event|1|||
162976195|NCT01483625|588613998|FG000|Overall Study|Refused to continue medication|2|||
162976196|NCT01483625|588613999|FG001|Overall Study|Refused to continue medication|1|||
162976197|NCT01483625|588613998|FG000|Overall Study|Due to other reason|1|||
162976198|NCT01483625|588613999|FG001|Overall Study|Due to other reason|0|||
162976199|NCT00084799|588614000|FG000|Overall Study|Disease Progression|1|||
162976200|NCT00084799|588614001|FG001|Overall Study|Disease Progression|0|||
162976201|NCT01261624|588614006|FG000|Week 0 to Week 12|Disease Progression|1|||
162976202|NCT01261624|588614007|FG001|Week 0 to Week 12|Disease Progression|1|||
162976203|NCT01261624|588614006|FG000|Week 0 to Week 12|Insufficient Response|0|||
162976204|NCT01261624|588614007|FG001|Week 0 to Week 12|Insufficient Response|2|||
162976205|NCT01261624|588614006|FG000|Week 13 to Week 24|Insufficient Response|0|||
162976206|NCT01261624|588614007|FG001|Week 13 to Week 24|Insufficient Response|1|||
162976207|NCT00271024|588614008|FG000|Overall Study|Lost Interest|3|||
162976208|NCT00271024|588614009|FG001|Overall Study|Lost Interest|4|||
162976209|NCT00271024|588614010|FG002|Overall Study|Lost Interest|2|||
162976210|NCT00271024|588614011|FG003|Overall Study|Lost Interest|3|||
162976211|NCT00271024|588614008|FG000|Overall Study|Unknown/Unspecified|11|||
162976212|NCT00271024|588614009|FG001|Overall Study|Unknown/Unspecified|11|||
162976213|NCT00271024|588614010|FG002|Overall Study|Unknown/Unspecified|8|||
162976214|NCT00271024|588614011|FG003|Overall Study|Unknown/Unspecified|4|||
162976215|NCT00271024|588614008|FG000|Overall Study|Protocol Violation|1|||
162976216|NCT00271024|588614009|FG001|Overall Study|Protocol Violation|6|||
162976217|NCT00271024|588614010|FG002|Overall Study|Protocol Violation|5|||
162976218|NCT00271024|588614011|FG003|Overall Study|Protocol Violation|11|||
162976219|NCT00271024|588614008|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
162976220|NCT00271024|588614009|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
162976221|NCT00271024|588614010|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
162976222|NCT00271024|588614011|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
162976223|NCT00271024|588614008|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
162976224|NCT00271024|588614009|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
162976225|NCT00271024|588614010|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
162976226|NCT00271024|588614011|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
163057646|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
163057647|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
163057648|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057649|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
163057650|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057651|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163057652|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057653|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057654|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057655|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057656|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
163057657|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057658|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
163057659|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
163057660|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057661|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
163057662|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057663|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
162976227|NCT02094261|588614015|FG000|Overall Study|Death|24|||
162976228|NCT02094261|588614015|FG000|Overall Study|Lost to Follow-up|1|||
162976229|NCT02094261|588614015|FG000|Overall Study|Withdrawal by Subject|4|||
162976230|NCT02094261|588614015|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
162976231|NCT04449341|588614016|FG000|Overall Study|Protocol Violation|1|||
162976232|NCT04449341|588614017|FG001|Overall Study|Protocol Violation|0|||
162976233|NCT04499482|588614018|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
162976234|NCT01020526|588614020|FG000|Overall Study|Withdrawal by Subject|5|||
162976235|NCT01020526|588614020|FG000|Overall Study|Other reasons|3|||
162976236|NCT01020526|588614020|FG000|Overall Study|Insufficient clinical response|3|||
162976237|NCT01020526|588614020|FG000|Overall Study|Lost to Follow-up|1|||
162976238|NCT01020526|588614020|FG000|Overall Study|Adverse Event|2|||
162976239|NCT02363439|588614021|FG000|Overall Study|Lack of Efficacy|4|||
162976240|NCT02010255|588614026|FG000|Overall Study|Death|0|||
162976241|NCT02010255|588614027|FG001|Overall Study|Death|1|||
162976242|NCT02010255|588614028|FG002|Overall Study|Death|4|||
162976243|NCT02010255|588614029|FG003|Overall Study|Death|4|||
162976244|NCT02010255|588614030|FG004|Overall Study|Death|2|||
162976245|NCT02010255|588614031|FG005|Overall Study|Death|0|||
162976246|NCT02010255|588614032|FG006|Overall Study|Death|1|||
162976247|NCT02010255|588614033|FG007|Overall Study|Death|1|||
162976248|NCT02010255|588614034|FG008|Overall Study|Death|1|||
162976249|NCT02010255|588614035|FG009|Overall Study|Death|0|||
162976250|NCT02010255|588614036|FG010|Overall Study|Death|1|||
162976251|NCT02010255|588614037|FG011|Overall Study|Death|1|||
162976252|NCT02010255|588614038|FG012|Overall Study|Death|0|||
162976253|NCT02010255|588614039|FG013|Overall Study|Death|0|||
162976254|NCT02010255|588614026|FG000|Overall Study|Lack of Efficacy|4|||
162976255|NCT02010255|588614027|FG001|Overall Study|Lack of Efficacy|1|||
162976256|NCT02010255|588614028|FG002|Overall Study|Lack of Efficacy|2|||
162976257|NCT02010255|588614029|FG003|Overall Study|Lack of Efficacy|1|||
162976258|NCT02010255|588614030|FG004|Overall Study|Lack of Efficacy|1|||
162976259|NCT02010255|588614031|FG005|Overall Study|Lack of Efficacy|0|||
162976260|NCT02010255|588614032|FG006|Overall Study|Lack of Efficacy|0|||
162976261|NCT02010255|588614033|FG007|Overall Study|Lack of Efficacy|0|||
162976262|NCT02010255|588614034|FG008|Overall Study|Lack of Efficacy|0|||
162976263|NCT02010255|588614035|FG009|Overall Study|Lack of Efficacy|0|||
162976264|NCT02010255|588614036|FG010|Overall Study|Lack of Efficacy|1|||
162976265|NCT02010255|588614037|FG011|Overall Study|Lack of Efficacy|0|||
162976266|NCT02010255|588614038|FG012|Overall Study|Lack of Efficacy|0|||
162976267|NCT02010255|588614039|FG013|Overall Study|Lack of Efficacy|0|||
162976268|NCT02010255|588614026|FG000|Overall Study|Withdrew Consent|1|||
162976269|NCT02010255|588614027|FG001|Overall Study|Withdrew Consent|0|||
162976270|NCT02010255|588614028|FG002|Overall Study|Withdrew Consent|0|||
162976271|NCT02010255|588614029|FG003|Overall Study|Withdrew Consent|1|||
162976272|NCT02010255|588614030|FG004|Overall Study|Withdrew Consent|0|||
162976273|NCT02010255|588614031|FG005|Overall Study|Withdrew Consent|0|||
162976274|NCT02010255|588614032|FG006|Overall Study|Withdrew Consent|0|||
162976275|NCT02010255|588614033|FG007|Overall Study|Withdrew Consent|0|||
162976276|NCT02010255|588614034|FG008|Overall Study|Withdrew Consent|0|||
162976277|NCT02010255|588614035|FG009|Overall Study|Withdrew Consent|0|||
162976278|NCT02010255|588614036|FG010|Overall Study|Withdrew Consent|0|||
162976279|NCT02010255|588614037|FG011|Overall Study|Withdrew Consent|0|||
162976280|NCT02010255|588614038|FG012|Overall Study|Withdrew Consent|0|||
162976281|NCT02010255|588614039|FG013|Overall Study|Withdrew Consent|0|||
162976282|NCT02010255|588614026|FG000|Overall Study|Adverse Event|1|||
162976283|NCT02010255|588614027|FG001|Overall Study|Adverse Event|0|||
162976284|NCT02010255|588614028|FG002|Overall Study|Adverse Event|0|||
162976285|NCT02010255|588614029|FG003|Overall Study|Adverse Event|0|||
162976286|NCT02010255|588614030|FG004|Overall Study|Adverse Event|0|||
162976287|NCT02010255|588614031|FG005|Overall Study|Adverse Event|0|||
162976288|NCT02010255|588614032|FG006|Overall Study|Adverse Event|0|||
162976289|NCT02010255|588614033|FG007|Overall Study|Adverse Event|0|||
162976290|NCT02010255|588614034|FG008|Overall Study|Adverse Event|0|||
162976291|NCT02010255|588614035|FG009|Overall Study|Adverse Event|0|||
162976292|NCT02010255|588614036|FG010|Overall Study|Adverse Event|0|||
162976293|NCT02010255|588614037|FG011|Overall Study|Adverse Event|0|||
162976294|NCT02010255|588614038|FG012|Overall Study|Adverse Event|0|||
162976295|NCT02010255|588614039|FG013|Overall Study|Adverse Event|0|||
163057664|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057665|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057666|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
163057667|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
162976296|NCT02010255|588614026|FG000|Overall Study|Lost to Follow-up|0|||
162976297|NCT02010255|588614027|FG001|Overall Study|Lost to Follow-up|0|||
162976298|NCT02010255|588614028|FG002|Overall Study|Lost to Follow-up|1|||
162976299|NCT02010255|588614029|FG003|Overall Study|Lost to Follow-up|0|||
162976300|NCT02010255|588614030|FG004|Overall Study|Lost to Follow-up|1|||
162976301|NCT02010255|588614031|FG005|Overall Study|Lost to Follow-up|0|||
162976302|NCT02010255|588614032|FG006|Overall Study|Lost to Follow-up|0|||
162976303|NCT02010255|588614033|FG007|Overall Study|Lost to Follow-up|0|||
162976304|NCT02010255|588614034|FG008|Overall Study|Lost to Follow-up|0|||
162976305|NCT02010255|588614035|FG009|Overall Study|Lost to Follow-up|0|||
162976306|NCT02010255|588614036|FG010|Overall Study|Lost to Follow-up|0|||
162976307|NCT02010255|588614037|FG011|Overall Study|Lost to Follow-up|0|||
162976308|NCT02010255|588614038|FG012|Overall Study|Lost to Follow-up|0|||
162976309|NCT02010255|588614039|FG013|Overall Study|Lost to Follow-up|0|||
162976310|NCT02010255|588614026|FG000|Overall Study|Randomized but Not Treated|0|||
162976311|NCT02010255|588614027|FG001|Overall Study|Randomized but Not Treated|0|||
162976312|NCT02010255|588614028|FG002|Overall Study|Randomized but Not Treated|0|||
162976313|NCT02010255|588614029|FG003|Overall Study|Randomized but Not Treated|0|||
162976314|NCT02010255|588614030|FG004|Overall Study|Randomized but Not Treated|0|||
162976315|NCT02010255|588614031|FG005|Overall Study|Randomized but Not Treated|0|||
162976316|NCT02010255|588614032|FG006|Overall Study|Randomized but Not Treated|0|||
162976317|NCT02010255|588614033|FG007|Overall Study|Randomized but Not Treated|0|||
162976318|NCT02010255|588614034|FG008|Overall Study|Randomized but Not Treated|0|||
162976319|NCT02010255|588614035|FG009|Overall Study|Randomized but Not Treated|0|||
162976320|NCT02010255|588614036|FG010|Overall Study|Randomized but Not Treated|0|||
162976321|NCT02010255|588614037|FG011|Overall Study|Randomized but Not Treated|0|||
162976322|NCT02010255|588614038|FG012|Overall Study|Randomized but Not Treated|0|||
162976323|NCT02010255|588614039|FG013|Overall Study|Randomized but Not Treated|1|||
162976324|NCT03573817|588614040|FG000|Overall Study|Adverse Event|0|||
162976325|NCT03573817|588614041|FG001|Overall Study|Adverse Event|2|||
162976326|NCT03573817|588614040|FG000|Overall Study|Protocol Violation|0|||
162976327|NCT03573817|588614041|FG001|Overall Study|Protocol Violation|1|||
162976328|NCT03573817|588614040|FG000|Overall Study|Withdrawal by Subject|1|||
162976329|NCT03573817|588614041|FG001|Overall Study|Withdrawal by Subject|1|||
162976330|NCT00508027|588614050|FG000|Dose Level 1|Lost to Follow-up|4|||
162976331|NCT00508027|588614050|FG000|Dose Level 1|Withdrawal by Subject|2|||
162976332|NCT00508027|588614050|FG000|Dose Level 1|Physician Decision|2|||
162976333|NCT00508027|588614050|FG000|Dose Level 2|Lost to Follow-up|2|||
162976334|NCT00508027|588614050|FG000|Dose Level 2|Withdrawal by Subject|2|||
162976335|NCT01719562|588614051|FG000|Overall Study|Lost to Follow-up|1|||
162976336|NCT01719562|588614052|FG001|Overall Study|Lost to Follow-up|0|||
162976337|NCT01719562|588614051|FG000|Overall Study|Death|1|||
162976338|NCT01719562|588614052|FG001|Overall Study|Death|0|||
162976339|NCT01719562|588614051|FG000|Overall Study|New cancer diagnosis|1|||
162976340|NCT01719562|588614052|FG001|Overall Study|New cancer diagnosis|0|||
162976341|NCT02013531|588614053|FG000|Overall Study|Lost to Follow-up|3|||
162976342|NCT02013531|588614053|FG000|Overall Study|Met Withdrawal Criteria|1|||
162976343|NCT02013531|588614053|FG000|Overall Study|Withdrawal by Subject|1|||
162976344|NCT03554317|588614057|FG000|Overall Study|Withdrawal by Subject|1|||
162976345|NCT03554317|588614057|FG000|Overall Study|PSA Progression|3|||
162976346|NCT03554317|588614057|FG000|Overall Study|Radiographic Progression|4|||
162976347|NCT02487082|588614060|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
162976348|NCT02487082|588614061|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
162976349|NCT02487082|588614060|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
162976350|NCT02487082|588614061|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
162976351|NCT00537199|588614062|FG000|Overall Study|Study Terminated|1|||
162976352|NCT00612677|588614063|FG000|Overall Study|study closed before treatment started|1|||
162976353|NCT03139240|588614064|FG000|Overall Study|Lost to Follow-up|0|||
162976354|NCT03139240|588614065|FG001|Overall Study|Lost to Follow-up|1|||
162976355|NCT03139240|588614066|FG002|Overall Study|Lost to Follow-up|1|||
162976356|NCT03139240|588614067|FG003|Overall Study|Lost to Follow-up|0|||
162976357|NCT00860743|588614069|FG000|Overall Study|Withdrawal by Subject|3|||
162976358|NCT00860743|588614070|FG001|Overall Study|Withdrawal by Subject|0|||
162976359|NCT00823199|588614074|FG000|Overall Study|Withdrawal by Subject|2|||
162976360|NCT02776553|588614075|FG000|Overall Study|Lost to Follow-up|1|||
162976361|NCT02776553|588614076|FG001|Overall Study|Lost to Follow-up|0|||
162712807|NCT04310579|587660764|FG004|Overall Study|Adverse Event|0|||
162976362|NCT02776553|588614075|FG000|Overall Study|got liver transplant|1|||
162976363|NCT02776553|588614076|FG001|Overall Study|got liver transplant|2|||
162976364|NCT02776553|588614075|FG000|Overall Study|had other surgery|1|||
162976365|NCT02776553|588614076|FG001|Overall Study|had other surgery|0|||
162976366|NCT02776553|588614075|FG000|Overall Study|Protocol Violation|0|||
162976367|NCT02776553|588614076|FG001|Overall Study|Protocol Violation|1|||
162976368|NCT00941720|588614077|FG000|Overall Study|Withdrawal by Subject|1|||
162712808|NCT04310579|587660765|FG005|Overall Study|Adverse Event|0|||
162712809|NCT04310579|587660766|FG006|Overall Study|Adverse Event|2|||
162712810|NCT04310579|587660767|FG007|Overall Study|Adverse Event|0|||
162712811|NCT04310579|587660768|FG008|Overall Study|Adverse Event|1|||
162712812|NCT04310579|587660769|FG009|Overall Study|Adverse Event|1|||
162712813|NCT04310579|587660770|FG010|Overall Study|Adverse Event|0|||
162712814|NCT04310579|587660760|FG000|Overall Study|Withdrawal by Subject|0|||
162712815|NCT04310579|587660761|FG001|Overall Study|Withdrawal by Subject|0|||
162976369|NCT00941720|588614077|FG000|Overall Study|Insurance denied participation|11|||
162976370|NCT00941720|588614077|FG000|Overall Study|ineligible|2|||
162976371|NCT00171340|588614078|FG000|Overall Study|Adverse Event|46|||
162976372|NCT00171340|588614079|FG001|Overall Study|Adverse Event|42|||
162976373|NCT00171340|588614078|FG000|Overall Study|Lack of Efficacy|29|||
162976374|NCT00171340|588614079|FG001|Overall Study|Lack of Efficacy|41|||
162976375|NCT00171340|588614078|FG000|Overall Study|Protocol Violation|7|||
162712816|NCT04310579|587660762|FG002|Overall Study|Withdrawal by Subject|0|||
162976376|NCT00171340|588614079|FG001|Overall Study|Protocol Violation|8|||
162976377|NCT00171340|588614078|FG000|Overall Study|Withdrawal by Subject|22|||
162976378|NCT00171340|588614079|FG001|Overall Study|Withdrawal by Subject|19|||
162976379|NCT00171340|588614078|FG000|Overall Study|Lost to Follow-up|0|||
162976380|NCT00171340|588614079|FG001|Overall Study|Lost to Follow-up|5|||
162976381|NCT00171340|588614078|FG000|Overall Study|Abnormal Laboratory Results|2|||
162976382|NCT00171340|588614079|FG001|Overall Study|Abnormal Laboratory Results|0|||
162976383|NCT00171340|588614078|FG000|Overall Study|Abnormal Test Procedure Results|6|||
162976384|NCT00171340|588614079|FG001|Overall Study|Abnormal Test Procedure Results|11|||
162976385|NCT00171340|588614078|FG000|Overall Study|No Longer Required Study Drug|1|||
162976386|NCT00171340|588614079|FG001|Overall Study|No Longer Required Study Drug|1|||
162976387|NCT00171340|588614078|FG000|Overall Study|Administrative Problems|5|||
162976388|NCT00171340|588614079|FG001|Overall Study|Administrative Problems|2|||
162976389|NCT00171340|588614078|FG000|Overall Study|Death|6|||
162976390|NCT00171340|588614079|FG001|Overall Study|Death|6|||
162976391|NCT03827018|588614080|FG000|Overall Study|Adverse Event|1|||
162976392|NCT03827018|588614081|FG001|Overall Study|Adverse Event|0|||
162976393|NCT03827018|588614080|FG000|Overall Study|Withdrawal by Subject|2|||
162976394|NCT03827018|588614081|FG001|Overall Study|Withdrawal by Subject|2|||
162976395|NCT03827018|588614080|FG000|Overall Study|Lack of Efficacy|0|||
162976396|NCT03827018|588614081|FG001|Overall Study|Lack of Efficacy|1|||
162976397|NCT01998243|588614084|FG000|Overall Study|Pregnancy|0|||
162976398|NCT01998243|588614085|FG001|Overall Study|Pregnancy|1|||
162976399|NCT01998243|588614084|FG000|Overall Study|Protocol Violation|5|||
162976400|NCT01998243|588614085|FG001|Overall Study|Protocol Violation|2|||
162976401|NCT01998243|588614084|FG000|Overall Study|Withdrawal by Subject|3|||
162976402|NCT01998243|588614085|FG001|Overall Study|Withdrawal by Subject|4|||
162976403|NCT00268892|588614089|FG000|Overall Study|Adverse Event|14|||
162976404|NCT00268892|588614090|FG001|Overall Study|Adverse Event|17|||
162976405|NCT00268892|588614091|FG002|Overall Study|Adverse Event|20|||
162976406|NCT00268892|588614089|FG000|Overall Study|Lack of Efficacy|1|||
162976407|NCT00268892|588614090|FG001|Overall Study|Lack of Efficacy|3|||
162976408|NCT00268892|588614091|FG002|Overall Study|Lack of Efficacy|0|||
162976409|NCT00268892|588614089|FG000|Overall Study|Withdrawal by Subject|14|||
162976410|NCT00268892|588614090|FG001|Overall Study|Withdrawal by Subject|15|||
162976411|NCT00268892|588614091|FG002|Overall Study|Withdrawal by Subject|13|||
162976412|NCT00268892|588614089|FG000|Overall Study|Physician Decision|0|||
162976413|NCT00268892|588614090|FG001|Overall Study|Physician Decision|1|||
162976414|NCT00268892|588614091|FG002|Overall Study|Physician Decision|0|||
162976415|NCT00268892|588614089|FG000|Overall Study|Lost to Follow-up|5|||
162976416|NCT00268892|588614090|FG001|Overall Study|Lost to Follow-up|2|||
162976417|NCT00268892|588614091|FG002|Overall Study|Lost to Follow-up|4|||
162976418|NCT00268892|588614089|FG000|Overall Study|Protocol Violation|0|||
162976419|NCT00268892|588614090|FG001|Overall Study|Protocol Violation|1|||
162976420|NCT00268892|588614091|FG002|Overall Study|Protocol Violation|0|||
162976421|NCT00268892|588614089|FG000|Overall Study|Disease Progression|1|||
162976422|NCT00268892|588614090|FG001|Overall Study|Disease Progression|1|||
162976423|NCT00268892|588614091|FG002|Overall Study|Disease Progression|0|||
162976424|NCT00268892|588614089|FG000|Overall Study|Trial Site Closed|4|||
162976425|NCT00268892|588614090|FG001|Overall Study|Trial Site Closed|2|||
162976426|NCT00268892|588614091|FG002|Overall Study|Trial Site Closed|2|||
162976427|NCT04569786|588614095|FG000|Overall Study|Lost to Follow-up|1|||
162976428|NCT04569786|588614096|FG001|Overall Study|Lost to Follow-up|0|||
162976429|NCT04569786|588614097|FG002|Overall Study|Lost to Follow-up|4|||
162976430|NCT04569786|588614098|FG003|Overall Study|Lost to Follow-up|1|||
162976431|NCT04569786|588614099|FG004|Overall Study|Lost to Follow-up|0|||
162976432|NCT04569786|588614095|FG000|Overall Study|Withdrawal by Subject|0|||
162976433|NCT04569786|588614096|FG001|Overall Study|Withdrawal by Subject|0|||
162976434|NCT04569786|588614097|FG002|Overall Study|Withdrawal by Subject|0|||
162976435|NCT04569786|588614098|FG003|Overall Study|Withdrawal by Subject|5|||
162976436|NCT04569786|588614099|FG004|Overall Study|Withdrawal by Subject|1|||
162976437|NCT04569786|588614095|FG000|Overall Study|Physician Decision|0|||
162976438|NCT04569786|588614096|FG001|Overall Study|Physician Decision|0|||
162976439|NCT04569786|588614097|FG002|Overall Study|Physician Decision|0|||
162976440|NCT04569786|588614098|FG003|Overall Study|Physician Decision|1|||
162976441|NCT04569786|588614099|FG004|Overall Study|Physician Decision|0|||
162976442|NCT01640184|588614108|FG000|Overall Study|Death|1|||
162976443|NCT01640184|588614109|FG001|Overall Study|Death|0|||
162976444|NCT01640184|588614110|FG002|Overall Study|Death|0|||
162976445|NCT01640184|588614108|FG000|Overall Study|Lost to Follow-up|4|||
162976446|NCT01640184|588614109|FG001|Overall Study|Lost to Follow-up|1|||
162976447|NCT01640184|588614110|FG002|Overall Study|Lost to Follow-up|0|||
162976448|NCT01640184|588614108|FG000|Overall Study|Physician Decision|3|||
162976449|NCT01640184|588614109|FG001|Overall Study|Physician Decision|0|||
162976450|NCT01640184|588614110|FG002|Overall Study|Physician Decision|0|||
162976451|NCT01640184|588614108|FG000|Overall Study|Withdrawal by Subject|0|||
162976452|NCT01640184|588614109|FG001|Overall Study|Withdrawal by Subject|1|||
162976453|NCT01640184|588614110|FG002|Overall Study|Withdrawal by Subject|1|||
162976454|NCT01640184|588614108|FG000|Overall Study|Protocol Violation|0|||
162976455|NCT01640184|588614109|FG001|Overall Study|Protocol Violation|0|||
162976456|NCT01640184|588614110|FG002|Overall Study|Protocol Violation|1|||
162976457|NCT00680186|588614111|FG000|Overall Study|Adverse Event|47|||
162976458|NCT00680186|588614112|FG001|Overall Study|Adverse Event|44|||
162976459|NCT00680186|588614111|FG000|Overall Study|Protocol Violation|31|||
162976460|NCT00680186|588614112|FG001|Overall Study|Protocol Violation|26|||
162976461|NCT00680186|588614111|FG000|Overall Study|Lost to Follow-up|11|||
162976462|NCT00680186|588614112|FG001|Overall Study|Lost to Follow-up|6|||
162976463|NCT00680186|588614111|FG000|Overall Study|Withdrawal by Subject|32|||
162976464|NCT00680186|588614112|FG001|Overall Study|Withdrawal by Subject|39|||
162976465|NCT00680186|588614111|FG000|Overall Study|Other|4|||
162976466|NCT00680186|588614112|FG001|Overall Study|Other|1|||
162976467|NCT01351350|588614115|FG000|Overall Study|Disease Progression|5|||
162976468|NCT01351350|588614116|FG001|Overall Study|Disease Progression|13|||
162976469|NCT01351350|588614117|FG002|Overall Study|Disease Progression|6|||
162976470|NCT01351350|588614118|FG003|Overall Study|Disease Progression|8|||
162976471|NCT01351350|588614119|FG004|Overall Study|Disease Progression|5|||
162976472|NCT01351350|588614115|FG000|Overall Study|Adverse Event|1|||
162976473|NCT01351350|588614116|FG001|Overall Study|Adverse Event|10|||
162976474|NCT01351350|588614117|FG002|Overall Study|Adverse Event|1|||
162976475|NCT01351350|588614118|FG003|Overall Study|Adverse Event|2|||
162976476|NCT01351350|588614119|FG004|Overall Study|Adverse Event|0|||
162976477|NCT01351350|588614115|FG000|Overall Study|Participant Decision|2|||
162976478|NCT01351350|588614116|FG001|Overall Study|Participant Decision|6|||
162976479|NCT01351350|588614117|FG002|Overall Study|Participant Decision|3|||
162976480|NCT01351350|588614118|FG003|Overall Study|Participant Decision|3|||
162976481|NCT01351350|588614119|FG004|Overall Study|Participant Decision|2|||
162976482|NCT01351350|588614115|FG000|Overall Study|Enrolled but not Treated|0|||
162976483|NCT01351350|588614116|FG001|Overall Study|Enrolled but not Treated|0|||
162976484|NCT01351350|588614117|FG002|Overall Study|Enrolled but not Treated|1|||
162976485|NCT01351350|588614118|FG003|Overall Study|Enrolled but not Treated|0|||
162976486|NCT01351350|588614119|FG004|Overall Study|Enrolled but not Treated|0|||
162976487|NCT04647383|588614120|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976488|NCT04647383|588614121|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
163057668|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
162630309|NCT01749514|587365105|FG003|Overall Study|Lost to Follow-up|0|||
162976489|NCT04647383|588614122|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976490|NCT04647383|588614123|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
162976491|NCT00479388|588614128|FG000|Overall Study|Adverse Event|90|||
162976492|NCT00479388|588614129|FG001|Overall Study|Adverse Event|45|||
162976493|NCT00479388|588614128|FG000|Overall Study|Lost to Follow-up|0|||
162976494|NCT00479388|588614129|FG001|Overall Study|Lost to Follow-up|2|||
162976495|NCT00479388|588614128|FG000|Overall Study|Protocol Violation|10|||
162976496|NCT00479388|588614129|FG001|Overall Study|Protocol Violation|9|||
162976497|NCT00479388|588614128|FG000|Overall Study|Withdrawal by Subject|32|||
162976498|NCT00479388|588614129|FG001|Overall Study|Withdrawal by Subject|17|||
162976499|NCT01876368|588614135|FG000|Overall Study|Adverse Event|2|||
162976500|NCT01876368|588614136|FG001|Overall Study|Adverse Event|5|||
162976501|NCT01876368|588614135|FG000|Overall Study|Lack of Efficacy|1|||
162976502|NCT01876368|588614136|FG001|Overall Study|Lack of Efficacy|0|||
162976503|NCT01876368|588614135|FG000|Overall Study|Lost to Follow-up|0|||
162976504|NCT01876368|588614136|FG001|Overall Study|Lost to Follow-up|1|||
162976505|NCT01876368|588614135|FG000|Overall Study|Non-compliance with study treatment|0|||
162976506|NCT01876368|588614136|FG001|Overall Study|Non-compliance with study treatment|1|||
162976507|NCT01876368|588614135|FG000|Overall Study|Physician Decision|0|||
162976508|NCT01876368|588614136|FG001|Overall Study|Physician Decision|2|||
162976509|NCT01876368|588614135|FG000|Overall Study|Protocol deviation|3|||
162976510|NCT01876368|588614136|FG001|Overall Study|Protocol deviation|3|||
163057669|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
163057670|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057671|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
163057672|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057673|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057674|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057675|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057676|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
163057677|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057678|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057679|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057680|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057681|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
163057682|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057683|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057684|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057685|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057686|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
163057687|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057688|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
162976511|NCT01876368|588614135|FG000|Overall Study|Subject/guardian decision|3|||
162976512|NCT01876368|588614136|FG001|Overall Study|Subject/guardian decision|1|||
162976513|NCT02260258|588614140|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
162976514|NCT02260258|588614141|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
162976515|NCT01644149|588614142|FG000|Overall Study|Withdrawal by Subject|1|||
162976516|NCT01644149|588614143|FG001|Overall Study|Withdrawal by Subject|0|||
162976517|NCT01644149|588614142|FG000|Overall Study|Lost to Follow-up|3|||
162976518|NCT01644149|588614143|FG001|Overall Study|Lost to Follow-up|1|||
162976519|NCT00690482|588614144|FG000|Overall Study|Adverse Event|2|||
162976520|NCT00690482|588614145|FG001|Overall Study|Adverse Event|1|||
162976521|NCT00690482|588614144|FG000|Overall Study|Incorrect enrolment|0|||
162976522|NCT00690482|588614145|FG001|Overall Study|Incorrect enrolment|1|||
162976523|NCT00690482|588614144|FG000|Overall Study|Study-specific discontinuation criteria|1|||
162976524|NCT00690482|588614145|FG001|Overall Study|Study-specific discontinuation criteria|0|||
162976525|NCT00690482|588614144|FG000|Overall Study|Intake of prohibited medicine|1|||
162976526|NCT00690482|588614145|FG001|Overall Study|Intake of prohibited medicine|0|||
162976527|NCT00690482|588614144|FG000|Overall Study|withdrew consent at rand.day|0|||
162976528|NCT00690482|588614145|FG001|Overall Study|withdrew consent at rand.day|1|||
162976529|NCT03693950|588614146|FG000|Overall Study|Withdrawal by Subject|1|||
162976530|NCT03693950|588614147|FG001|Overall Study|Withdrawal by Subject|0|||
162976531|NCT04230876|588614148|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
162976532|NCT04230876|588614149|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
162630310|NCT01749514|587365106|FG004|Overall Study|Lost to Follow-up|0|||
162630311|NCT01749514|587365107|FG005|Overall Study|Lost to Follow-up|0|||
162976533|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976534|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
162976535|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976536|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
162976537|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
162976538|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
163057689|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
163057690|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
162976539|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
162976540|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
162976541|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
162976542|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976543|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976544|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
162976545|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Death|0|||
162976546|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Death|1|||
162976547|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Death|0|||
162976548|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Death|0|||
162976549|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
162976550|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
162976551|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
162976552|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
162976553|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
162976554|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976555|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976556|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162976557|NCT00545688|588614151|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
162976558|NCT00545688|588614152|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
163057691|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
163057692|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057693|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057694|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057695|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057696|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057697|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057698|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057699|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
163057700|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
162976559|NCT00545688|588614153|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
162976560|NCT00545688|588614154|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
162976561|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Disease Progression|3|||
162976562|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Disease Progression|3|||
162976563|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Disease Progression|0|||
162976564|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Disease Progression|7|||
163057701|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163057702|NCT01232283|588921305|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057703|NCT01232283|588921306|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057704|NCT01232283|588921307|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057705|NCT01232283|588921308|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057706|NCT01232283|588921309|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057707|NCT01232283|588921310|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
163057708|NCT01232283|588921311|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057709|NCT01232283|588921312|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057710|NCT01232283|588921313|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057711|NCT01232283|588921314|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
163057712|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057713|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
162976565|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
162976566|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
162976567|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
162976568|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
162976569|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
162976570|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
162976571|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
162976572|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
162976573|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Adverse Event|0|||
162976574|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Adverse Event|3|||
162712817|NCT04310579|587660763|FG003|Overall Study|Withdrawal by Subject|0|||
162976575|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Adverse Event|2|||
162976576|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Adverse Event|2|||
162976577|NCT00545688|588614151|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
162976578|NCT00545688|588614152|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
162976579|NCT00545688|588614153|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
162976580|NCT00545688|588614154|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
162976581|NCT00545688|588614151|FG000|Follow-Up Period|Death|4|||
162976582|NCT00545688|588614152|FG001|Follow-Up Period|Death|2|||
162976583|NCT00545688|588614153|FG002|Follow-Up Period|Death|2|||
162976584|NCT00545688|588614154|FG003|Follow-Up Period|Death|6|||
162976585|NCT00545688|588614151|FG000|Follow-Up Period|Disease Progression|6|||
162976586|NCT00545688|588614152|FG001|Follow-Up Period|Disease Progression|5|||
162976587|NCT00545688|588614153|FG002|Follow-Up Period|Disease Progression|9|||
162976588|NCT00545688|588614154|FG003|Follow-Up Period|Disease Progression|9|||
162976589|NCT00545688|588614151|FG000|Follow-Up Period|Refused Treatment|6|||
162976590|NCT00545688|588614152|FG001|Follow-Up Period|Refused Treatment|2|||
162976591|NCT00545688|588614153|FG002|Follow-Up Period|Refused Treatment|0|||
162976592|NCT00545688|588614154|FG003|Follow-Up Period|Refused Treatment|2|||
162976593|NCT00545688|588614151|FG000|Follow-Up Period|Lost to Follow-up|3|||
162976594|NCT00545688|588614152|FG001|Follow-Up Period|Lost to Follow-up|3|||
162976595|NCT00545688|588614153|FG002|Follow-Up Period|Lost to Follow-up|3|||
162976596|NCT00545688|588614154|FG003|Follow-Up Period|Lost to Follow-up|1|||
162976597|NCT00545688|588614151|FG000|Follow-Up Period|Unspecified Reason|2|||
162976598|NCT00545688|588614152|FG001|Follow-Up Period|Unspecified Reason|5|||
162976599|NCT00545688|588614153|FG002|Follow-Up Period|Unspecified Reason|6|||
162976600|NCT00545688|588614154|FG003|Follow-Up Period|Unspecified Reason|8|||
162976601|NCT00545688|588614151|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
162976602|NCT00545688|588614152|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
162976603|NCT00545688|588614153|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
162976604|NCT00545688|588614154|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
162976605|NCT02792218|588614158|FG000|Overall Study|Patient/guardian decision|15|||
162976606|NCT02792218|588614159|FG001|Overall Study|Patient/guardian decision|42|||
162976607|NCT02792218|588614158|FG000|Overall Study|Adverse Event|15|||
162976608|NCT02792218|588614159|FG001|Overall Study|Adverse Event|14|||
162976609|NCT02792218|588614158|FG000|Overall Study|Lost to Follow-up|10|||
162976610|NCT02792218|588614159|FG001|Overall Study|Lost to Follow-up|5|||
162976611|NCT02792218|588614158|FG000|Overall Study|Lack of Efficacy|1|||
162976612|NCT02792218|588614159|FG001|Overall Study|Lack of Efficacy|12|||
162976613|NCT02792218|588614158|FG000|Overall Study|Physician Decision|4|||
162976614|NCT02792218|588614159|FG001|Overall Study|Physician Decision|4|||
162976615|NCT02792218|588614158|FG000|Overall Study|Protocol deviation|3|||
162976616|NCT02792218|588614159|FG001|Overall Study|Protocol deviation|2|||
162976617|NCT02792218|588614158|FG000|Overall Study|New therapy for study indication|0|||
162976618|NCT02792218|588614159|FG001|Overall Study|New therapy for study indication|1|||
162976619|NCT02792218|588614158|FG000|Overall Study|Non-compliance with study treatment|0|||
162976620|NCT02792218|588614159|FG001|Overall Study|Non-compliance with study treatment|1|||
162976621|NCT02792218|588614158|FG000|Overall Study|Pregnancy|1|||
162976622|NCT02792218|588614159|FG001|Overall Study|Pregnancy|0|||
162976623|NCT00248170|588614160|FG000|Overall Study|Withdrawal by Subject|71|||
162976624|NCT00248170|588614161|FG001|Overall Study|Withdrawal by Subject|79|||
162976625|NCT00248170|588614160|FG000|Overall Study|Protocol Violation|35|||
162976626|NCT00248170|588614161|FG001|Overall Study|Protocol Violation|30|||
162976627|NCT00248170|588614160|FG000|Overall Study|Lost to Follow-up|28|||
162976628|NCT00248170|588614161|FG001|Overall Study|Lost to Follow-up|35|||
162976629|NCT00248170|588614160|FG000|Overall Study|Disease progression|196|||
162976630|NCT00248170|588614161|FG001|Overall Study|Disease progression|216|||
162976631|NCT00248170|588614160|FG000|Overall Study|Death|28|||
162976632|NCT00248170|588614161|FG001|Overall Study|Death|47|||
162976633|NCT00248170|588614160|FG000|Overall Study|Adverse Event|311|||
162976634|NCT00248170|588614161|FG001|Overall Study|Adverse Event|296|||
162976635|NCT00248170|588614160|FG000|Overall Study|Administrative problems|22|||
162976636|NCT00248170|588614161|FG001|Overall Study|Administrative problems|25|||
162976637|NCT00248170|588614160|FG000|Overall Study|Abnormal test procedure(s) result|49|||
162976638|NCT00248170|588614161|FG001|Overall Study|Abnormal test procedure(s) result|61|||
162976639|NCT00248170|588614160|FG000|Overall Study|Abnormal laboratory values|4|||
162976640|NCT00248170|588614161|FG001|Overall Study|Abnormal laboratory values|0|||
162976641|NCT00248170|588614160|FG000|Overall Study|Protocol deviation|17|||
162976642|NCT00248170|588614161|FG001|Overall Study|Protocol deviation|19|||
162976643|NCT03123783|588614162|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976644|NCT03123783|588614163|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
162976645|NCT03123783|588614164|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976646|NCT03123783|588614165|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976647|NCT03123783|588614166|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976648|NCT03123783|588614167|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976649|NCT03123783|588614168|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
162976650|NCT03123783|588614162|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
162976651|NCT03123783|588614163|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
162976652|NCT03123783|588614164|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
162976653|NCT03123783|588614165|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
162976654|NCT03123783|588614166|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
162976655|NCT03123783|588614167|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
162976656|NCT03123783|588614168|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
162976657|NCT03123783|588614162|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976658|NCT03123783|588614163|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976659|NCT03123783|588614164|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
162976660|NCT03123783|588614165|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
162976661|NCT03123783|588614166|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
162976662|NCT03123783|588614167|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
162976663|NCT03123783|588614168|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
162976664|NCT03123783|588614162|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976665|NCT03123783|588614163|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976666|NCT03123783|588614164|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976667|NCT03123783|588614165|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976668|NCT03123783|588614166|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
162976669|NCT03123783|588614167|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976670|NCT03123783|588614168|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
162976671|NCT01557582|588614169|FG000|Overall Study|Protocol Violation|4|||
162976672|NCT01557582|588614169|FG000|Overall Study|Operator error|2|||
162976673|NCT00749411|588614173|FG000|Overall Study|Adverse Event|0|||
162976674|NCT00749411|588614174|FG001|Overall Study|Adverse Event|2|||
162712818|NCT04310579|587660764|FG004|Overall Study|Withdrawal by Subject|0|||
162976675|NCT00749411|588614173|FG000|Overall Study|Lack of Efficacy|0|||
162976676|NCT00749411|588614174|FG001|Overall Study|Lack of Efficacy|1|||
162976677|NCT00749411|588614173|FG000|Overall Study|Protocol Violation|1|||
162976678|NCT00749411|588614174|FG001|Overall Study|Protocol Violation|1|||
162976679|NCT00749411|588614173|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162976680|NCT00749411|588614174|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162976681|NCT02070757|588615432|FG000|Overall Study|Adverse Event|107|||
162976682|NCT02070757|588615433|FG001|Overall Study|Adverse Event|99|||
162976683|NCT02070757|588615432|FG000|Overall Study|Lost to Follow-up|7|||
162976684|NCT02070757|588615433|FG001|Overall Study|Lost to Follow-up|4|||
162976685|NCT02070757|588615432|FG000|Overall Study|Protocol Violation|0|||
162976686|NCT02070757|588615433|FG001|Overall Study|Protocol Violation|4|||
162976687|NCT02070757|588615432|FG000|Overall Study|Withdrawal by Subject|1|||
162976688|NCT02070757|588615433|FG001|Overall Study|Withdrawal by Subject|3|||
162976689|NCT02070757|588615432|FG000|Overall Study|Investigator Decision|0|||
162976690|NCT02070757|588615433|FG001|Overall Study|Investigator Decision|2|||
162976691|NCT02070757|588615432|FG000|Overall Study|Discharged from Study Hospital|2|||
162976692|NCT02070757|588615433|FG001|Overall Study|Discharged from Study Hospital|2|||
162976693|NCT04086641|588615434|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
162976694|NCT04086641|588615435|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
162976695|NCT00126126|588615446|FG000|Overall Study|Lost to Follow-up|0|||
162976696|NCT00126126|588615447|FG001|Overall Study|Lost to Follow-up|2|||
162976697|NCT01570283|588615451|FG000|Cohort 1: Dose Level 1|Death|0|||
162976698|NCT01570283|588615452|FG001|Cohort 1: Dose Level 1|Death|1|||
162976699|NCT01570283|588615453|FG002|Cohort 1: Dose Level 1|Death|0|||
162976700|NCT01570283|588615454|FG003|Cohort 1: Dose Level 1|Death|0|||
162976701|NCT01570283|588615455|FG004|Cohort 1: Dose Level 1|Death|0|||
162976702|NCT01570283|588615456|FG005|Cohort 1: Dose Level 1|Death|0|||
162976703|NCT01570283|588615451|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976704|NCT01570283|588615452|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
162976705|NCT01570283|588615453|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976706|NCT01570283|588615454|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976707|NCT01570283|588615455|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976708|NCT01570283|588615456|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
162976709|NCT01570283|588615451|FG000|Cohort 2: Dose Level 2|Death|0|||
162976710|NCT01570283|588615452|FG001|Cohort 2: Dose Level 2|Death|0|||
162976711|NCT01570283|588615453|FG002|Cohort 2: Dose Level 2|Death|1|||
162976712|NCT01570283|588615454|FG003|Cohort 2: Dose Level 2|Death|0|||
162976713|NCT01570283|588615455|FG004|Cohort 2: Dose Level 2|Death|0|||
162976714|NCT01570283|588615456|FG005|Cohort 2: Dose Level 2|Death|0|||
162976715|NCT01570283|588615451|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976716|NCT01570283|588615452|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976717|NCT01570283|588615453|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976718|NCT01570283|588615454|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
162976719|NCT01570283|588615455|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976720|NCT01570283|588615456|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
162976721|NCT01570283|588615451|FG000|Cohort 3: Dose Level 3|Death|0|||
162976722|NCT01570283|588615452|FG001|Cohort 3: Dose Level 3|Death|0|||
162976723|NCT01570283|588615453|FG002|Cohort 3: Dose Level 3|Death|0|||
162976724|NCT01570283|588615454|FG003|Cohort 3: Dose Level 3|Death|0|||
162976725|NCT01570283|588615455|FG004|Cohort 3: Dose Level 3|Death|0|||
162976726|NCT01570283|588615456|FG005|Cohort 3: Dose Level 3|Death|1|||
162976727|NCT01570283|588615451|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976728|NCT01570283|588615452|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162712819|NCT04310579|587660765|FG005|Overall Study|Withdrawal by Subject|1|||
162976729|NCT01570283|588615453|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976730|NCT01570283|588615454|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976731|NCT01570283|588615455|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
162976732|NCT01570283|588615456|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
162976733|NCT01833533|588615457|FG000|Overall Study|Adverse Event|0|||
162976734|NCT01833533|588615458|FG001|Overall Study|Adverse Event|1|||
162976735|NCT01833533|588615457|FG000|Overall Study|Lost to Follow-up|4|||
162712820|NCT04310579|587660766|FG006|Overall Study|Withdrawal by Subject|0|||
162976736|NCT01833533|588615458|FG001|Overall Study|Lost to Follow-up|9|||
162976737|NCT01833533|588615457|FG000|Overall Study|To Enter an Extension Study|0|||
162976738|NCT01833533|588615458|FG001|Overall Study|To Enter an Extension Study|4|||
162712821|NCT04310579|587660767|FG007|Overall Study|Withdrawal by Subject|0|||
162976739|NCT01833533|588615457|FG000|Overall Study|Other|2|||
162976740|NCT01833533|588615458|FG001|Overall Study|Other|7|||
162976741|NCT02017860|588615459|FG000|Overall Study|Adverse Event|1|||
162976742|NCT02017860|588615459|FG000|Overall Study|Withdrawal by Subject|1|||
162976743|NCT01048502|588615462|FG000|Overall Study|Lost to Follow-up|2|||
162976744|NCT01048502|588615463|FG001|Overall Study|Lost to Follow-up|0|||
162976745|NCT01048502|588615464|FG002|Overall Study|Lost to Follow-up|0|||
162976746|NCT01048502|588615465|FG003|Overall Study|Lost to Follow-up|0|||
162976747|NCT01048502|588615462|FG000|Overall Study|Adverse Event|1|||
162976748|NCT01048502|588615463|FG001|Overall Study|Adverse Event|0|||
162976749|NCT01048502|588615464|FG002|Overall Study|Adverse Event|0|||
162976750|NCT01048502|588615465|FG003|Overall Study|Adverse Event|0|||
162976751|NCT01048502|588615462|FG000|Overall Study|Withdrawal by Subject|1|||
162976752|NCT01048502|588615463|FG001|Overall Study|Withdrawal by Subject|4|||
162976753|NCT01048502|588615464|FG002|Overall Study|Withdrawal by Subject|5|||
162976754|NCT01048502|588615465|FG003|Overall Study|Withdrawal by Subject|3|||
162976755|NCT01048502|588615462|FG000|Overall Study|Physician Decision|0|||
162976756|NCT01048502|588615463|FG001|Overall Study|Physician Decision|3|||
162976757|NCT01048502|588615464|FG002|Overall Study|Physician Decision|0|||
162976758|NCT01048502|588615465|FG003|Overall Study|Physician Decision|1|||
162976759|NCT01463982|588615467|FG000|Overall Study|Withdrawal by Subject|0|||
162976760|NCT01463982|588615468|FG001|Overall Study|Withdrawal by Subject|1|||
162976761|NCT01463982|588615469|FG002|Overall Study|Withdrawal by Subject|1|||
162976762|NCT01463982|588615470|FG003|Overall Study|Withdrawal by Subject|0|||
162976763|NCT01463982|588615467|FG000|Overall Study|Treatment delay over 5 week|0|||
162976764|NCT01463982|588615468|FG001|Overall Study|Treatment delay over 5 week|0|||
162976765|NCT01463982|588615469|FG002|Overall Study|Treatment delay over 5 week|1|||
162976766|NCT01463982|588615470|FG003|Overall Study|Treatment delay over 5 week|0|||
162976767|NCT04668274|588615471|FG000|Part 1 Study Period 1|Adverse Event|3|||
162976768|NCT04668274|588615472|FG001|Part 1 Study Period 1|Adverse Event|0|||
162976769|NCT04668274|588615473|FG002|Part 1 Study Period 1|Adverse Event|0|||
162976770|NCT04668274|588615474|FG003|Part 1 Study Period 1|Adverse Event|0|||
162976771|NCT04668274|588615471|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
162976772|NCT04668274|588615472|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976773|NCT04668274|588615473|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976774|NCT04668274|588615474|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
162976775|NCT04668274|588615471|FG000|Part 1 Study Period 2|Other|0|||
162976776|NCT04668274|588615472|FG001|Part 1 Study Period 2|Other|1|||
162976777|NCT04668274|588615473|FG002|Part 1 Study Period 2|Other|0|||
162976778|NCT04668274|588615474|FG003|Part 1 Study Period 2|Other|0|||
162976779|NCT04668274|588615471|FG000|Part 1 Study Period 3|Adverse Event|0|||
162976780|NCT04668274|588615472|FG001|Part 1 Study Period 3|Adverse Event|0|||
162976781|NCT04668274|588615473|FG002|Part 1 Study Period 3|Adverse Event|1|||
162976782|NCT04668274|588615474|FG003|Part 1 Study Period 3|Adverse Event|0|||
162976783|NCT04668274|588615471|FG000|Part 1 Study Period 3|Other|0|||
162976784|NCT04668274|588615472|FG001|Part 1 Study Period 3|Other|0|||
162976785|NCT04668274|588615473|FG002|Part 1 Study Period 3|Other|2|||
162976786|NCT04668274|588615474|FG003|Part 1 Study Period 3|Other|0|||
162976787|NCT04668274|588615471|FG000|Part 2 Study Period 4|Other|0|||
162976788|NCT04668274|588615472|FG001|Part 2 Study Period 4|Other|0|||
162976789|NCT04668274|588615473|FG002|Part 2 Study Period 4|Other|0|||
162976790|NCT04668274|588615474|FG003|Part 2 Study Period 4|Other|1|||
162976791|NCT00467831|588615479|FG000|Overall Study|Death|2|||
162976792|NCT00467831|588615479|FG000|Overall Study|Withdrawal by Subject|1|||
162976793|NCT01832402|588615482|FG000|Overall Study|Lost to Follow-up|2|||
162976794|NCT01832402|588615483|FG001|Overall Study|Lost to Follow-up|0|||
162976795|NCT01832402|588615482|FG000|Overall Study|Withdrawal by Subject|3|||
162976796|NCT01832402|588615483|FG001|Overall Study|Withdrawal by Subject|3|||
162976797|NCT01832402|588615482|FG000|Overall Study|Declining Performance status|2|||
162976798|NCT01832402|588615483|FG001|Overall Study|Declining Performance status|1|||
162976799|NCT01198873|588615484|FG000|Overall Study|Adverse Event|4|||
162976800|NCT01198873|588615485|FG001|Overall Study|Adverse Event|7|||
162976801|NCT01198873|588615484|FG000|Overall Study|Study closure|29|||
162976802|NCT01198873|588615485|FG001|Overall Study|Study closure|23|||
162976803|NCT01198873|588615484|FG000|Overall Study|Other than above|4|||
162976804|NCT01198873|588615485|FG001|Overall Study|Other than above|2|||
162976805|NCT00895037|588615494|FG000|Overall Study|Death|0|||
162976806|NCT00895037|588615495|FG001|Overall Study|Death|2|||
162976807|NCT00895037|588615496|FG002|Overall Study|Death|1|||
162976808|NCT01930175|588615506|FG000|Core Study|Lost to Follow-up|0|||
162976809|NCT01930175|588615507|FG001|Core Study|Lost to Follow-up|1|||
162976810|NCT01930175|588615508|FG002|Core Study|Lost to Follow-up|0|||
162976811|NCT01930175|588615506|FG000|Core Study|Adverse Event|0|||
162976812|NCT01930175|588615507|FG001|Core Study|Adverse Event|0|||
162976813|NCT01930175|588615508|FG002|Core Study|Adverse Event|1|||
162976814|NCT02820740|588615509|FG000|Overall Study|Did not have procedure|2|||
162976815|NCT00890552|588615510|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
162976816|NCT00890552|588615510|FG000|On-treatment|Early prog disease/ death|10|||
162976817|NCT04965389|588615511|FG000|Overall Study|Other reasons|1|||
162976818|NCT04965389|588615512|FG001|Overall Study|Other reasons|0|||
162976819|NCT04965389|588615513|FG002|Overall Study|Other reasons|0|||
162976820|NCT04965389|588615514|FG003|Overall Study|Other reasons|0|||
162976821|NCT04965389|588615511|FG000|Overall Study|Participant withdrew consent|0|||
162976822|NCT04965389|588615512|FG001|Overall Study|Participant withdrew consent|1|||
162976823|NCT04965389|588615513|FG002|Overall Study|Participant withdrew consent|0|||
162976824|NCT04965389|588615514|FG003|Overall Study|Participant withdrew consent|0|||
162976825|NCT04965389|588615511|FG000|Overall Study|Poor/Non-compliance|0|||
162976826|NCT04965389|588615512|FG001|Overall Study|Poor/Non-compliance|1|||
162976827|NCT04965389|588615513|FG002|Overall Study|Poor/Non-compliance|0|||
162976828|NCT04965389|588615514|FG003|Overall Study|Poor/Non-compliance|0|||
162976829|NCT03903159|588615515|FG000|Overall Study|Discharged with Staff Approval|2|||
162976830|NCT03903159|588615515|FG000|Overall Study|Discharged at Staff Request|2|||
162976831|NCT03903159|588615515|FG000|Overall Study|Discharged Against Staff Advice|1|||
162976832|NCT01436643|588615518|FG000|2-week Pre-treatment|Abnormal test result|0|||
162976833|NCT01436643|588615519|FG001|2-week Pre-treatment|Abnormal test result|0|||
162976834|NCT01436643|588615520|FG002|2-week Pre-treatment|Abnormal test result|0|||
162976835|NCT01436643|588615521|FG003|2-week Pre-treatment|Abnormal test result|1|||
162976836|NCT01436643|588615518|FG000|2-week Pre-treatment|Adverse Event|0|||
162976837|NCT01436643|588615519|FG001|2-week Pre-treatment|Adverse Event|0|||
162976838|NCT01436643|588615520|FG002|2-week Pre-treatment|Adverse Event|0|||
162976839|NCT01436643|588615521|FG003|2-week Pre-treatment|Adverse Event|5|||
162976840|NCT01436643|588615518|FG000|2-week Pre-treatment|Protocol Violation|0|||
162976841|NCT01436643|588615519|FG001|2-week Pre-treatment|Protocol Violation|0|||
162976842|NCT01436643|588615520|FG002|2-week Pre-treatment|Protocol Violation|0|||
162976843|NCT01436643|588615521|FG003|2-week Pre-treatment|Protocol Violation|4|||
162976844|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
162976845|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
162976846|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
162976847|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
162976848|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976849|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976850|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
162976851|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
162976852|NCT01436643|588615518|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
162976853|NCT01436643|588615519|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
162976854|NCT01436643|588615520|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
162976855|NCT01436643|588615521|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
163057714|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
162976856|NCT01382251|588615522|FG000|Overall Study|Surgeries cancelled or delayed|16|||
162976857|NCT01382251|588615523|FG001|Overall Study|Surgeries cancelled or delayed|16|||
162976858|NCT01382251|588615522|FG000|Overall Study|Lost to Follow-up|4|||
162976859|NCT01382251|588615523|FG001|Overall Study|Lost to Follow-up|4|||
162976860|NCT01382251|588615522|FG000|Overall Study|Contacted after study closed|1|||
162976861|NCT01382251|588615523|FG001|Overall Study|Contacted after study closed|1|||
162976862|NCT01117987|588615524|FG000|Overall Study|Protocol deviation|0|||
162976863|NCT01117987|588615525|FG001|Overall Study|Protocol deviation|1|||
162976864|NCT01117987|588615524|FG000|Overall Study|Subject no longer requires study drug|1|||
162976865|NCT01117987|588615525|FG001|Overall Study|Subject no longer requires study drug|0|||
162976866|NCT01117987|588615524|FG000|Overall Study|Lost to Follow-up|1|||
163057715|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057716|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057717|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057718|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057719|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
163057720|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
163057721|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
163057722|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057723|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057724|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057725|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057726|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057727|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057728|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057729|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
163057730|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
163057731|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
163057732|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057733|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057734|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057735|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057736|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057737|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057738|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057739|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
163057740|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
163057741|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
163057742|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057743|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057744|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057745|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057746|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057747|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057748|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057749|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
163057750|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
163057751|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
162923737|NCT03170271|588422208|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
162923738|NCT03170271|588422207|FG000|Overall Study|Withdrawal by Subject|17|||
162923739|NCT03170271|588422208|FG001|Overall Study|Withdrawal by Subject|5|||
162923740|NCT03170271|588422207|FG000|Overall Study|Other|2|||
162923741|NCT03170271|588422208|FG001|Overall Study|Other|2|||
162923742|NCT03170271|588422207|FG000|Overall Study|Randomized in error|4|||
162923743|NCT03170271|588422208|FG001|Overall Study|Randomized in error|0|||
162923744|NCT01036594|588422222|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
162923745|NCT01036594|588422223|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
162923746|NCT01036594|588422222|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
162923747|NCT01036594|588422223|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
162923748|NCT01036594|588422222|FG000|Week 12 Evaluation|Adverse Event|5|||
162923749|NCT01036594|588422223|FG001|Week 12 Evaluation|Adverse Event|0|||
162923750|NCT01036594|588422222|FG000|Week 12 Evaluation|Physician Decision|1|||
162923751|NCT01036594|588422223|FG001|Week 12 Evaluation|Physician Decision|0|||
162923752|NCT01036594|588422222|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
162923753|NCT01036594|588422223|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
162923754|NCT01036594|588422222|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
162923755|NCT01036594|588422223|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
162923756|NCT01036594|588422222|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
162923757|NCT01036594|588422223|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
162923758|NCT01036594|588422222|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
162923759|NCT01036594|588422223|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
162923760|NCT01036594|588422222|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
162923761|NCT01036594|588422223|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
162923762|NCT01612780|588422226|FG000|Overall Study|Treatment not completed|1|||
162923763|NCT01612780|588422226|FG000|Overall Study|Withdrawal by Subject|5|||
162923764|NCT03466060|588422227|FG000|Period 1|Test Lens Damage|0|||
162923765|NCT03466060|588422228|FG001|Period 1|Test Lens Damage|2|||
162923766|NCT03466060|588422229|FG002|Period 1|Test Lens Damage|0|||
162923767|NCT03466060|588422230|FG003|Period 1|Test Lens Damage|0|||
162976867|NCT01117987|588615525|FG001|Overall Study|Lost to Follow-up|1|||
162976868|NCT01117987|588615524|FG000|Overall Study|Abnormal test procedure result|2|||
162976869|NCT01117987|588615525|FG001|Overall Study|Abnormal test procedure result|0|||
162976870|NCT01117987|588615524|FG000|Overall Study|Lack of Efficacy|3|||
162976871|NCT01117987|588615525|FG001|Overall Study|Lack of Efficacy|4|||
162976872|NCT01117987|588615524|FG000|Overall Study|Death|5|||
162976873|NCT01117987|588615525|FG001|Overall Study|Death|10|||
162976874|NCT01117987|588615524|FG000|Overall Study|Withdrawal by Subject|5|||
163057752|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057753|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057754|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057755|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057756|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057757|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057758|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057759|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
163057760|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
163057761|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
163057762|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057763|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057764|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
162976875|NCT01117987|588615525|FG001|Overall Study|Withdrawal by Subject|10|||
162976876|NCT01117987|588615524|FG000|Overall Study|Adverse Event|19|||
162976877|NCT01117987|588615525|FG001|Overall Study|Adverse Event|26|||
162976878|NCT01117987|588615524|FG000|Overall Study|Administrative problems|25|||
163057765|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
162976879|NCT01117987|588615525|FG001|Overall Study|Administrative problems|22|||
162976880|NCT00702208|588615531|FG000|Overall Study|Lost to Follow-up|28|||
162976881|NCT00702208|588615531|FG000|Overall Study|Did not self-lavage|1|||
162976882|NCT00702208|588615531|FG000|Overall Study|Unsatisfactory colposcopy|2|||
162976883|NCT00562120|588615532|FG000|First Intervention Period|Adverse Event|1|||
162976884|NCT00562120|588615533|FG001|First Intervention Period|Adverse Event|0|||
162976885|NCT00562120|588615534|FG002|First Intervention Period|Adverse Event|0|||
162976886|NCT00562120|588615535|FG003|First Intervention Period|Adverse Event|0|||
162976887|NCT00562120|588615532|FG000|First Intervention Period|Randomized but not Treated|1|||
162976888|NCT00562120|588615533|FG001|First Intervention Period|Randomized but not Treated|0|||
162976889|NCT00562120|588615534|FG002|First Intervention Period|Randomized but not Treated|0|||
162976890|NCT00562120|588615535|FG003|First Intervention Period|Randomized but not Treated|0|||
162976891|NCT02148445|588615536|FG000|Overall Study|Death|1|||
162976892|NCT02148445|588615537|FG001|Overall Study|Death|3|||
162976893|NCT03450629|588615538|FG000|Overall Study|Adverse Event|15|||
162976894|NCT03450629|588615539|FG001|Overall Study|Adverse Event|14|||
162976895|NCT03450629|588615538|FG000|Overall Study|Physician Decision|2|||
162976896|NCT03450629|588615539|FG001|Overall Study|Physician Decision|2|||
162976897|NCT03450629|588615538|FG000|Overall Study|Lack of Efficacy|2|||
162976898|NCT03450629|588615539|FG001|Overall Study|Lack of Efficacy|0|||
162976899|NCT03450629|588615538|FG000|Overall Study|Lost to Follow-up|4|||
162976900|NCT03450629|588615539|FG001|Overall Study|Lost to Follow-up|2|||
162976901|NCT03450629|588615538|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162976902|NCT03450629|588615539|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
162976903|NCT03450629|588615538|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162976904|NCT03450629|588615539|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162976905|NCT03450629|588615538|FG000|Overall Study|Protocol Violation|11|||
162976906|NCT03450629|588615539|FG001|Overall Study|Protocol Violation|8|||
162976907|NCT03450629|588615538|FG000|Overall Study|Withdrawal by Subject|12|||
162976908|NCT03450629|588615539|FG001|Overall Study|Withdrawal by Subject|6|||
162976909|NCT03366194|588615540|FG000|Overall Study|Lost to Follow-up|2|||
162976910|NCT02093923|588615541|FG000|Overall Study|Lost to Follow-up|0|||
162976911|NCT02093923|588615542|FG001|Overall Study|Lost to Follow-up|0|||
162976912|NCT02093923|588615543|FG002|Overall Study|Lost to Follow-up|0|||
162976913|NCT02093923|588615544|FG003|Overall Study|Lost to Follow-up|1|||
162976914|NCT02093923|588615545|FG004|Overall Study|Lost to Follow-up|0|||
162976915|NCT02093923|588615541|FG000|Overall Study|Screen failure after randomization|0|||
163057766|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057767|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
162976916|NCT02093923|588615542|FG001|Overall Study|Screen failure after randomization|0|||
162630312|NCT01749514|587365108|FG006|Overall Study|Lost to Follow-up|0|||
162976917|NCT02093923|588615543|FG002|Overall Study|Screen failure after randomization|0|||
162976918|NCT02093923|588615544|FG003|Overall Study|Screen failure after randomization|1|||
162976919|NCT02093923|588615545|FG004|Overall Study|Screen failure after randomization|0|||
162976920|NCT03438006|588615546|FG000|Overall Study|Adverse Event|1|||
162976921|NCT03438006|588615546|FG000|Overall Study|Lost to Follow-up|67|||
162976922|NCT03438006|588615546|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
162712822|NCT04310579|587660768|FG008|Overall Study|Withdrawal by Subject|0|||
162712823|NCT04310579|587660769|FG009|Overall Study|Withdrawal by Subject|0|||
162976923|NCT03438006|588615546|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
162976924|NCT01181531|588615547|FG000|Overall Study|Other|17|||
162976925|NCT01181531|588615548|FG001|Overall Study|Other|12|||
162976926|NCT01181531|588615547|FG000|Overall Study|Partial consent by subject withdrawn|0|||
162976927|NCT01181531|588615548|FG001|Overall Study|Partial consent by subject withdrawn|1|||
162976928|NCT01181531|588615547|FG000|Overall Study|Physician Decision|3|||
162976929|NCT01181531|588615548|FG001|Overall Study|Physician Decision|1|||
162976930|NCT01181531|588615547|FG000|Overall Study|Noncompliance|2|||
162976931|NCT01181531|588615548|FG001|Overall Study|Noncompliance|2|||
162976932|NCT01181531|588615547|FG000|Overall Study|Ineligibility determined|1|||
162976933|NCT01181531|588615548|FG001|Overall Study|Ineligibility determined|2|||
162976934|NCT01181531|588615547|FG000|Overall Study|Protocol Specified Criteria|15|||
162976935|NCT01181531|588615548|FG001|Overall Study|Protocol Specified Criteria|8|||
162976936|NCT01181531|588615547|FG000|Overall Study|Pregnancy|0|||
162976937|NCT01181531|588615548|FG001|Overall Study|Pregnancy|1|||
162976938|NCT01181531|588615547|FG000|Overall Study|Withdrawal by Subject|8|||
162976939|NCT01181531|588615548|FG001|Overall Study|Withdrawal by Subject|7|||
162712824|NCT04310579|587660770|FG010|Overall Study|Withdrawal by Subject|0|||
162712825|NCT04310579|587660760|FG000|Overall Study|Positive COVID-19 test|0|||
162976940|NCT01181531|588615547|FG000|Overall Study|Protocol Violation|6|||
162976941|NCT01181531|588615548|FG001|Overall Study|Protocol Violation|6|||
162976942|NCT01181531|588615547|FG000|Overall Study|Death|9|||
162976943|NCT01181531|588615548|FG001|Overall Study|Death|12|||
162976944|NCT01181531|588615547|FG000|Overall Study|Adverse Event|0|||
162976945|NCT01181531|588615548|FG001|Overall Study|Adverse Event|1|||
162976946|NCT02737592|588615549|FG000|Overall Study|Withdrawal by Subject|1|||
162976947|NCT00955721|588615550|FG000|Overall Study|Physician Decision|1|||
162630313|NCT01749514|587365109|FG007|Overall Study|Lost to Follow-up|1|||
162630314|NCT01749514|587365102|FG000|Overall Study|Withdrawal by Subject|0|||
162630315|NCT01749514|587365103|FG001|Overall Study|Withdrawal by Subject|0|||
162630316|NCT01749514|587365104|FG002|Overall Study|Withdrawal by Subject|0|||
162630317|NCT01749514|587365105|FG003|Overall Study|Withdrawal by Subject|0|||
163057768|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057769|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057770|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
163057771|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
163057772|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057773|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057774|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057775|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057776|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057777|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057778|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057779|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057780|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
163057781|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
163057782|NCT01232283|588921305|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057783|NCT01232283|588921306|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057784|NCT01232283|588921307|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057785|NCT01232283|588921308|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057786|NCT01232283|588921309|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057787|NCT01232283|588921310|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057788|NCT01232283|588921311|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057789|NCT01232283|588921312|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
163057790|NCT01232283|588921313|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
163057791|NCT01232283|588921314|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
163057792|NCT02404545|588921315|FG000|Overall Study|Sponsor Termination|6|||
163057793|NCT02404545|588921316|FG001|Overall Study|Sponsor Termination|6|||
163057794|NCT00855218|588921319|FG000|Overall Study|Adverse Event|43|||
163057795|NCT00855218|588921320|FG001|Overall Study|Adverse Event|27|||
163057796|NCT00855218|588921319|FG000|Overall Study|Withdrawal by Subject|10|||
163057797|NCT00855218|588921320|FG001|Overall Study|Withdrawal by Subject|6|||
163057798|NCT00855218|588921319|FG000|Overall Study|Physician Decision|18|||
163057799|NCT00855218|588921320|FG001|Overall Study|Physician Decision|11|||
163057800|NCT00855218|588921319|FG000|Overall Study|Lost to Follow-up|0|||
163057801|NCT00855218|588921320|FG001|Overall Study|Lost to Follow-up|1|||
163057802|NCT00855218|588921319|FG000|Overall Study|Protocol Violation|5|||
163057803|NCT00855218|588921320|FG001|Overall Study|Protocol Violation|9|||
163057804|NCT00855218|588921319|FG000|Overall Study|non-compliant with study drug|3|||
163057805|NCT00855218|588921320|FG001|Overall Study|non-compliant with study drug|1|||
163057806|NCT00855218|588921319|FG000|Overall Study|patient convenience|2|||
163057807|NCT00855218|588921320|FG001|Overall Study|patient convenience|0|||
163057808|NCT00855218|588921319|FG000|Overall Study|technical problems|2|||
163057809|NCT00855218|588921320|FG001|Overall Study|technical problems|1|||
163057810|NCT00855218|588921319|FG000|Overall Study|Still treated with study medication|0|||
163057811|NCT00855218|588921320|FG001|Overall Study|Still treated with study medication|1|||
163057812|NCT00855218|588921319|FG000|Overall Study|Untreatable disease progression|54|||
163057813|NCT00855218|588921320|FG001|Overall Study|Untreatable disease progression|67|||
163057814|NCT00855218|588921319|FG000|Overall Study|Second malignancy|0|||
163057815|NCT00855218|588921320|FG001|Overall Study|Second malignancy|1|||
163057816|NCT00855218|588921319|FG000|Overall Study|Progression measurement proven|7|||
163057817|NCT00855218|588921320|FG001|Overall Study|Progression measurement proven|15|||
163057818|NCT00855218|588921319|FG000|Overall Study|Clinical endpoint reached|10|||
163057819|NCT00855218|588921320|FG001|Overall Study|Clinical endpoint reached|13|||
163057820|NCT03824561|588921328|FG000|Overall Study|Protocol Violation|19|||
163057821|NCT05117060|588921334|FG000|Overall Study|Adverse Event|3|||
163057822|NCT05117060|588921335|FG001|Overall Study|Adverse Event|5|||
163057823|NCT05117060|588921336|FG002|Overall Study|Adverse Event|6|||
163057824|NCT05117060|588921337|FG003|Overall Study|Adverse Event|1|||
163057825|NCT05117060|588921334|FG000|Overall Study|Lost to Follow-up|0|||
163057826|NCT05117060|588921335|FG001|Overall Study|Lost to Follow-up|0|||
163057827|NCT05117060|588921336|FG002|Overall Study|Lost to Follow-up|0|||
163057828|NCT05117060|588921337|FG003|Overall Study|Lost to Follow-up|1|||
163057829|NCT05117060|588921334|FG000|Overall Study|Lack of Efficacy|4|||
163057830|NCT05117060|588921335|FG001|Overall Study|Lack of Efficacy|5|||
163057831|NCT05117060|588921336|FG002|Overall Study|Lack of Efficacy|2|||
163057832|NCT05117060|588921337|FG003|Overall Study|Lack of Efficacy|6|||
163057833|NCT05117060|588921334|FG000|Overall Study|Withdrawal by Subject|8|||
163057834|NCT05117060|588921335|FG001|Overall Study|Withdrawal by Subject|5|||
163057835|NCT05117060|588921336|FG002|Overall Study|Withdrawal by Subject|5|||
163057836|NCT05117060|588921337|FG003|Overall Study|Withdrawal by Subject|6|||
163057837|NCT05117060|588921334|FG000|Overall Study|Other|2|||
163057838|NCT05117060|588921335|FG001|Overall Study|Other|1|||
163057839|NCT05117060|588921336|FG002|Overall Study|Other|3|||
163057840|NCT05117060|588921337|FG003|Overall Study|Other|1|||
162630318|NCT01749514|587365106|FG004|Overall Study|Withdrawal by Subject|0|||
162630319|NCT01749514|587365107|FG005|Overall Study|Withdrawal by Subject|1|||
162630320|NCT01749514|587365108|FG006|Overall Study|Withdrawal by Subject|0|||
162976948|NCT00955721|588615551|FG001|Overall Study|Physician Decision|0|||
162976949|NCT00955721|588615550|FG000|Overall Study|Death|1|||
162976950|NCT00955721|588615551|FG001|Overall Study|Death|0|||
162976951|NCT00955721|588615550|FG000|Overall Study|Withdrawal by Subject|1|||
162976952|NCT00955721|588615551|FG001|Overall Study|Withdrawal by Subject|0|||
162976953|NCT04034355|588615566|FG000|Overall Study|Study terminated by Sponsor|10|||
162976954|NCT04034355|588615567|FG001|Overall Study|Study terminated by Sponsor|17|||
162976955|NCT04034355|588615566|FG000|Overall Study|Withdrawal by Subject|12|||
162976956|NCT04034355|588615567|FG001|Overall Study|Withdrawal by Subject|11|||
162976957|NCT04034355|588615566|FG000|Overall Study|Site terminated by Sponsor|4|||
162976958|NCT04034355|588615567|FG001|Overall Study|Site terminated by Sponsor|5|||
162976959|NCT04034355|588615566|FG000|Overall Study|Adverse Event|2|||
162976960|NCT04034355|588615567|FG001|Overall Study|Adverse Event|0|||
162976961|NCT04034355|588615566|FG000|Overall Study|Death|1|||
162976962|NCT04034355|588615567|FG001|Overall Study|Death|1|||
162976963|NCT04034355|588615566|FG000|Overall Study|Not reported|2|||
162976964|NCT04034355|588615567|FG001|Overall Study|Not reported|0|||
162976965|NCT04034355|588615566|FG000|Overall Study|Lost to Follow-up|1|||
162976966|NCT04034355|588615567|FG001|Overall Study|Lost to Follow-up|0|||
162976967|NCT04034355|588615566|FG000|Overall Study|Physician Decision|1|||
162976968|NCT04034355|588615567|FG001|Overall Study|Physician Decision|0|||
162976969|NCT04034355|588615566|FG000|Overall Study|Protocol Violation|0|||
162976970|NCT04034355|588615567|FG001|Overall Study|Protocol Violation|1|||
162976971|NCT04034355|588615566|FG000|Overall Study|Progressive disease|1|||
162976972|NCT04034355|588615567|FG001|Overall Study|Progressive disease|0|||
162976973|NCT04678817|588616541|FG000|Overall Study|Lost to Follow-up|28|||
162976974|NCT04678817|588616542|FG001|Overall Study|Lost to Follow-up|0|||
162976975|NCT04678817|588616543|FG002|Overall Study|Lost to Follow-up|0|||
162976976|NCT03064438|588616546|FG000|Overall Study|Lost to Follow-up|1|||
162976977|NCT03064438|588616547|FG001|Overall Study|Lost to Follow-up|0|||
162976978|NCT03064438|588616546|FG000|Overall Study|Withdrawal by Subject|0|||
162976979|NCT03064438|588616547|FG001|Overall Study|Withdrawal by Subject|1|||
162976980|NCT01937351|588616548|FG000|Overall Study|Withdrawal by Subject|4|||
162976981|NCT01937351|588616549|FG001|Overall Study|Withdrawal by Subject|2|||
162976982|NCT01937351|588616548|FG000|Overall Study|Death|1|||
162976983|NCT01937351|588616549|FG001|Overall Study|Death|0|||
162976984|NCT01937351|588616548|FG000|Overall Study|Not treated w device, per protocol fail|4|||
162976985|NCT01937351|588616549|FG001|Overall Study|Not treated w device, per protocol fail|0|||
162976986|NCT01961687|588616550|FG000|Overall Study|Lost to Follow-up|19|||
162976987|NCT01961687|588616550|FG000|Overall Study|Re-operation|17|||
162976988|NCT01961687|588616550|FG000|Overall Study|Death|7|||
162976989|NCT01961687|588616550|FG000|Overall Study|Withdrawal by Subject|6|||
162976990|NCT01961687|588616550|FG000|Overall Study|Adverse Event|6|||
162976991|NCT01961687|588616550|FG000|Overall Study|Moved to area without study site|2|||
162976992|NCT01961687|588616550|FG000|Overall Study|Sponsor decision|2|||
162976993|NCT01961687|588616550|FG000|Overall Study|Physician Decision|1|||
162976994|NCT01961687|588616550|FG000|Overall Study|Unable to meet follow-up requirements|1|||
162976995|NCT00614926|588616557|FG000|Overall Study|Burden of travel|1|||
162976996|NCT00614926|588616558|FG001|Overall Study|Burden of travel|0|||
162976997|NCT00614926|588616557|FG000|Overall Study|Adverse Event|3|||
162976998|NCT00614926|588616558|FG001|Overall Study|Adverse Event|0|||
162976999|NCT02999984|588616563|FG000|Overall Study|Treatment Failure|1|||
162977000|NCT00754013|588616567|FG000|Overall Study|Lost to Follow-up|1|||
162977001|NCT00754013|588616568|FG001|Overall Study|Lost to Follow-up|1|||
162977002|NCT00754013|588616567|FG000|Overall Study|didn't return after study termed|3|||
162977003|NCT00754013|588616568|FG001|Overall Study|didn't return after study termed|4|||
162977004|NCT02310789|588616569|FG000|Overall Study|Adverse Event|1|||
162630321|NCT01749514|587365109|FG007|Overall Study|Withdrawal by Subject|1|||
162630322|NCT01749514|587365102|FG000|Overall Study|Not Reported|0|||
162630323|NCT01749514|587365103|FG001|Overall Study|Not Reported|0|||
162630324|NCT01749514|587365104|FG002|Overall Study|Not Reported|0|||
162977005|NCT01197417|588616573|FG000|Overall Study|Physician Decision|3|||
162977006|NCT01197417|588616574|FG001|Overall Study|Physician Decision|2|||
162977007|NCT01197417|588616573|FG000|Overall Study|Withdrawal by Subject|2|||
162977008|NCT01197417|588616574|FG001|Overall Study|Withdrawal by Subject|4|||
162977009|NCT01197417|588616573|FG000|Overall Study|Site miscommunication|0|||
162977010|NCT01197417|588616574|FG001|Overall Study|Site miscommunication|1|||
162977011|NCT01197417|588616573|FG000|Overall Study|Subject transferred to intensive care|0|||
162630325|NCT01749514|587365105|FG003|Overall Study|Not Reported|0|||
162977012|NCT01197417|588616574|FG001|Overall Study|Subject transferred to intensive care|1|||
162977013|NCT01197417|588616573|FG000|Overall Study|Not consented in time to receive drug|0|||
162977014|NCT01197417|588616574|FG001|Overall Study|Not consented in time to receive drug|1|||
162977015|NCT01197417|588616573|FG000|Overall Study|Hypotension|1|||
162977016|NCT01197417|588616574|FG001|Overall Study|Hypotension|2|||
162977017|NCT01197417|588616573|FG000|Overall Study|Found to be ineligible|2|||
163057841|NCT03141359|588921338|FG000|Overall Study|Death|32|||
163057842|NCT03141359|588921338|FG000|Overall Study|Still On Study (in follow up)|29|||
163057843|NCT03675308|588922764|FG000|Overall Study|Adverse Event|3|||
163057844|NCT03675308|588922765|FG001|Overall Study|Adverse Event|2|||
163057845|NCT03675308|588922764|FG000|Overall Study|Withdrawal by Subject|6|||
163057846|NCT03675308|588922765|FG001|Overall Study|Withdrawal by Subject|4|||
163057847|NCT03675308|588922764|FG000|Overall Study|Lost to Follow-up|3|||
163057848|NCT03675308|588922765|FG001|Overall Study|Lost to Follow-up|0|||
163057849|NCT03675308|588922764|FG000|Overall Study|Lack of Efficacy|1|||
163057850|NCT03675308|588922765|FG001|Overall Study|Lack of Efficacy|1|||
163057851|NCT03675308|588922764|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
163057852|NCT03675308|588922765|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
163057853|NCT03675308|588922764|FG000|Overall Study|Other|0|||
163057854|NCT03675308|588922765|FG001|Overall Study|Other|1|||
163057855|NCT05722522|588922766|FG000|Overall Study|Adverse Event|0|||
163057856|NCT05722522|588922767|FG001|Overall Study|Adverse Event|1|||
163057857|NCT00109343|588922770|FG000|Overall Study|Adverse Event|1|||
162977018|NCT01197417|588616574|FG001|Overall Study|Found to be ineligible|5|||
162977019|NCT01197417|588616573|FG000|Overall Study|No 25-hour magnesium level|0|||
162977020|NCT01197417|588616574|FG001|Overall Study|No 25-hour magnesium level|2|||
162977021|NCT01432574|588616575|FG000|Overall Study|Moved|2|||
163057858|NCT00109343|588922771|FG001|Overall Study|Adverse Event|0|||
162977022|NCT01432574|588616575|FG000|Overall Study|Not interested|1|||
162977023|NCT02813421|588616582|FG000|Overall Study|Withdrawal by Subject|1|||
162977024|NCT02813421|588616583|FG001|Overall Study|Withdrawal by Subject|2|||
162977025|NCT02813421|588616582|FG000|Overall Study|Lost to Follow-up|1|||
162977026|NCT02813421|588616583|FG001|Overall Study|Lost to Follow-up|1|||
162977027|NCT03135899|588616584|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977028|NCT03135899|588616585|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977029|NCT03135899|588616586|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977030|NCT03135899|588616587|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977031|NCT03135899|588616588|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977032|NCT03135899|588616589|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
163057859|NCT00109343|588922772|FG002|Overall Study|Adverse Event|2|||
163057860|NCT00109343|588922770|FG000|Overall Study|Lack of Efficacy|1|||
163057861|NCT00109343|588922771|FG001|Overall Study|Lack of Efficacy|0|||
163057862|NCT00109343|588922772|FG002|Overall Study|Lack of Efficacy|0|||
163057863|NCT00109343|588922770|FG000|Overall Study|Lost to Follow-up|35|||
163057864|NCT00109343|588922771|FG001|Overall Study|Lost to Follow-up|20|||
163057865|NCT00109343|588922772|FG002|Overall Study|Lost to Follow-up|14|||
163057866|NCT00109343|588922770|FG000|Overall Study|Protocol Violation|1|||
163057867|NCT00109343|588922771|FG001|Overall Study|Protocol Violation|2|||
163057868|NCT00109343|588922772|FG002|Overall Study|Protocol Violation|2|||
163057869|NCT00109343|588922770|FG000|Overall Study|Withdrawal by Subject|15|||
163057870|NCT00109343|588922771|FG001|Overall Study|Withdrawal by Subject|11|||
163057871|NCT00109343|588922772|FG002|Overall Study|Withdrawal by Subject|10|||
163057872|NCT00109343|588922770|FG000|Overall Study|Subject Moved|6|||
163057873|NCT00109343|588922771|FG001|Overall Study|Subject Moved|2|||
163057874|NCT00109343|588922772|FG002|Overall Study|Subject Moved|1|||
163057875|NCT00109343|588922770|FG000|Overall Study|Other|5|||
163057876|NCT00109343|588922771|FG001|Overall Study|Other|2|||
163057877|NCT00109343|588922772|FG002|Overall Study|Other|1|||
163057878|NCT01721798|588922775|FG000|Overall Study|Death|0|||
163057879|NCT01721798|588922776|FG001|Overall Study|Death|0|||
163057880|NCT01721798|588922777|FG002|Overall Study|Death|1|||
163057881|NCT01721798|588922778|FG003|Overall Study|Death|1|||
163057882|NCT01721798|588922775|FG000|Overall Study|Lost to Follow-up|2|||
163057883|NCT01721798|588922776|FG001|Overall Study|Lost to Follow-up|2|||
163057884|NCT01721798|588922777|FG002|Overall Study|Lost to Follow-up|9|||
163057885|NCT01721798|588922778|FG003|Overall Study|Lost to Follow-up|9|||
162977033|NCT03135899|588616590|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
162977034|NCT03135899|588616591|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
162977035|NCT03135899|588616584|FG000|Overall Study|Withdrawal by Subject|0|||
162977036|NCT03135899|588616585|FG001|Overall Study|Withdrawal by Subject|0|||
162977037|NCT03135899|588616586|FG002|Overall Study|Withdrawal by Subject|0|||
163057886|NCT01721798|588922775|FG000|Overall Study|Pregnancy|0|||
163057887|NCT01721798|588922776|FG001|Overall Study|Pregnancy|0|||
163057888|NCT01721798|588922777|FG002|Overall Study|Pregnancy|1|||
163057889|NCT01721798|588922778|FG003|Overall Study|Pregnancy|1|||
163057890|NCT01721798|588922775|FG000|Overall Study|Withdrawal by Subject|1|||
163057891|NCT01721798|588922776|FG001|Overall Study|Withdrawal by Subject|0|||
163057892|NCT01721798|588922777|FG002|Overall Study|Withdrawal by Subject|2|||
163057893|NCT01721798|588922778|FG003|Overall Study|Withdrawal by Subject|1|||
163057894|NCT01721798|588922775|FG000|Overall Study|Not eligible for 24 month visit|1|||
163057895|NCT01721798|588922776|FG001|Overall Study|Not eligible for 24 month visit|0|||
162977038|NCT03135899|588616587|FG003|Overall Study|Withdrawal by Subject|0|||
162977039|NCT03135899|588616588|FG004|Overall Study|Withdrawal by Subject|0|||
162977040|NCT03135899|588616589|FG005|Overall Study|Withdrawal by Subject|2|||
162977041|NCT03135899|588616590|FG006|Overall Study|Withdrawal by Subject|0|||
162977042|NCT03135899|588616591|FG007|Overall Study|Withdrawal by Subject|0|||
162977043|NCT04373551|588616592|FG000|Overall Study|Lost to Follow-up|15|||
162977044|NCT04373551|588616592|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
162630326|NCT01749514|587365106|FG004|Overall Study|Not Reported|0|||
162630327|NCT01749514|587365107|FG005|Overall Study|Not Reported|0|||
162630328|NCT01749514|587365108|FG006|Overall Study|Not Reported|0|||
162977045|NCT02914236|588616593|FG000|Overall Study|Lost to Follow-up|1|||
162977046|NCT01042535|588616594|FG000|Overall Study|disease progression prior to treatment|3|||
162977047|NCT01042535|588616594|FG000|Overall Study|disease progression during treatment|3|||
162977048|NCT01042535|588616594|FG000|Overall Study|complications from other disease|2|||
162977049|NCT03438539|588616601|FG000|Overall Study|Lost to Follow-up|8|||
162977050|NCT03438539|588616602|FG001|Overall Study|Lost to Follow-up|4|||
162977051|NCT03438539|588616603|FG002|Overall Study|Lost to Follow-up|10|||
162977052|NCT03438539|588616604|FG003|Overall Study|Lost to Follow-up|9|||
162977053|NCT03438539|588616605|FG004|Overall Study|Lost to Follow-up|3|||
162977054|NCT03438539|588616606|FG005|Overall Study|Lost to Follow-up|8|||
162977055|NCT00655850|588616613|FG000|Overall Study|Death|2|||
162977056|NCT00655850|588616613|FG000|Overall Study|Withdrawal by Subject|1|||
162977057|NCT02129647|588616614|FG000|Overall Study|Adverse Event|2|||
162977058|NCT02129647|588616614|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
162977059|NCT00918463|588616615|FG000|Overall Study|Death|1|||
162977060|NCT00918463|588616615|FG000|Overall Study|Lack of Efficacy|1|||
162977061|NCT01715896|588616616|FG000|Overall Study|Lost to Follow-up|0|||
162977062|NCT01715896|588616617|FG001|Overall Study|Lost to Follow-up|2|||
162977063|NCT01715896|588616616|FG000|Overall Study|Withdrawal by Subject|1|||
162977064|NCT01715896|588616617|FG001|Overall Study|Withdrawal by Subject|4|||
162977065|NCT01715896|588616616|FG000|Overall Study|Other|2|||
162977066|NCT01715896|588616617|FG001|Overall Study|Other|5|||
162977067|NCT01045993|588616619|FG000|Overall Study|Treated-later found eligibility not met|0|||
162977068|NCT01045993|588616620|FG001|Overall Study|Treated-later found eligibility not met|1|||
162977069|NCT01045993|588616621|FG002|Overall Study|Treated-later found eligibility not met|0|||
162977070|NCT01045993|588616622|FG003|Overall Study|Treated-later found eligibility not met|0|||
162977071|NCT01659736|588616623|FG000|Treatment Period|Adverse Event|1|||
162977072|NCT01659736|588616624|FG001|Treatment Period|Adverse Event|1|||
162977073|NCT01659736|588616623|FG000|Treatment Period|Protocol Violation|3|||
162977074|NCT01659736|588616624|FG001|Treatment Period|Protocol Violation|1|||
162977075|NCT01659736|588616623|FG000|Treatment Period|Withdrawal by Subject|1|||
162977076|NCT01659736|588616624|FG001|Treatment Period|Withdrawal by Subject|0|||
162977077|NCT01659736|588616623|FG000|3-month Follow-up|Lost to Follow-up|0|||
162977078|NCT01659736|588616624|FG001|3-month Follow-up|Lost to Follow-up|1|||
162977079|NCT02772562|588616629|FG000|Overall Study|Withdrawal by Subject|1|||
162977080|NCT02772562|588616629|FG000|Overall Study|Protocol Violation|1|||
162977081|NCT03336242|588616632|FG000|Overall Study|Adverse Event|0|||
162977082|NCT03336242|588616633|FG001|Overall Study|Adverse Event|1|||
162977083|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
162977084|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
162977085|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
162977086|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
162977087|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
162977088|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
162977089|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
162977090|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
162977091|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
162977092|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
162977093|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
162977094|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
162977095|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
162977096|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
162630329|NCT01749514|587365109|FG007|Overall Study|Not Reported|5|||
162977097|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
162977098|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
162977099|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
162977100|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
163057896|NCT01721798|588922777|FG002|Overall Study|Not eligible for 24 month visit|8|||
162977101|NCT00384293|588616634|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
162977102|NCT00384293|588616635|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
163057897|NCT01721798|588922778|FG003|Overall Study|Not eligible for 24 month visit|7|||
163057898|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
163057899|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
163057900|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
163057901|NCT00961064|588922779|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
163057902|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
163057903|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
163057904|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
163057905|NCT00961064|588922779|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
163057906|NCT01408641|588922780|FG000|Overall Study|Physician Decision|1|||
163057907|NCT01408641|588922781|FG001|Overall Study|Physician Decision|0|||
163057908|NCT01316614|588922782|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
163057909|NCT01316614|588922782|FG000|Overall Study|Cytology slides not available for review|4|||
163057910|NCT01316614|588922782|FG000|Overall Study|Cystic lesion|5|||
163057911|NCT01316614|588922782|FG000|Overall Study|Inadequate number of passes|2|||
163057912|NCT01316614|588922782|FG000|Overall Study|Medically unstable|1|||
163057913|NCT00076570|588922783|FG000|Overall Study|Drug intolerance|8|||
163057914|NCT00076570|588922784|FG001|Overall Study|Drug intolerance|8|||
163057915|NCT00089648|588922785|FG000|Overall Study|Adverse Event|7|||
163057916|NCT00089648|588922785|FG000|Overall Study|Withdrawal by Subject|1|||
163057917|NCT00089648|588922785|FG000|Overall Study|Lack of Efficacy|33|||
163057918|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
163057919|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
163057920|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
163057921|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
163057922|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
163057923|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
163057924|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
163057925|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
163057926|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
163057927|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
163057928|NCT03979313|588922786|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
163057929|NCT03979313|588922787|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
163057930|NCT03979313|588922786|FG000|All Subjects|Any Other Reason|16|||
163057931|NCT03979313|588922787|FG001|All Subjects|Any Other Reason|23|||
163057932|NCT03979313|588922786|FG000|All Subjects|Covid-19|1|||
163057933|NCT03979313|588922787|FG001|All Subjects|Covid-19|3|||
163057934|NCT03979313|588922786|FG000|All Subjects|Withdrawal by Subject|35|||
163057935|NCT03979313|588922787|FG001|All Subjects|Withdrawal by Subject|44|||
163057936|NCT03979313|588922786|FG000|All Subjects|Death|0|||
163057937|NCT03979313|588922787|FG001|All Subjects|Death|5|||
163057938|NCT03979313|588922786|FG000|All Subjects|Lost to Follow-up|28|||
163057939|NCT03979313|588922787|FG001|All Subjects|Lost to Follow-up|61|||
163057940|NCT00423605|588922788|FG000|Overall Study|Adverse Event|129|||
163057941|NCT00423605|588922788|FG000|Overall Study|Withdrawal by Subject|36|||
163057942|NCT00423605|588922788|FG000|Overall Study|Lost to Follow-up|15|||
163057943|NCT00423605|588922788|FG000|Overall Study|Lack of Efficacy|38|||
163057944|NCT00423605|588922788|FG000|Overall Study|Sponsor Decision|3|||
163057945|NCT00423605|588922788|FG000|Overall Study|Physician Decision|8|||
163057946|NCT00423605|588922788|FG000|Overall Study|Protocol Violation|7|||
163057947|NCT00423605|588922788|FG000|Overall Study|Not one of the pre-specified options|5|||
163057948|NCT03183908|588922789|FG000|Overall Study|Missing Symptom Diary Data|0|||
163057949|NCT03183908|588922790|FG001|Overall Study|Missing Symptom Diary Data|2|||
163057950|NCT01588509|588922793|FG000|Overall Study|Lost to Follow-up|1|||
163057951|NCT01588509|588922794|FG001|Overall Study|Lost to Follow-up|0|||
163057952|NCT00393367|588922795|FG000|Overall Study|Protocol Violation|2|||
163057953|NCT00393367|588922796|FG001|Overall Study|Protocol Violation|5|||
163057954|NCT00393367|588922795|FG000|Overall Study|Withdrawal by Subject|0|||
163057955|NCT00393367|588922796|FG001|Overall Study|Withdrawal by Subject|2|||
163057956|NCT01712178|588922799|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
163057957|NCT01712178|588922800|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
162712826|NCT04310579|587660761|FG001|Overall Study|Positive COVID-19 test|0|||
163057958|NCT01712178|588922799|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
163057959|NCT01712178|588922800|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
163057960|NCT01712178|588922799|FG000|Overall Study|Lost to Follow-up|0|||
162923768|NCT03466060|588422231|FG004|Period 1|Test Lens Damage|0|||
163057961|NCT01712178|588922800|FG001|Overall Study|Lost to Follow-up|1|||
163057962|NCT00856180|588922801|FG000|Overall Study|Adverse Event|4|||
163057963|NCT00856180|588922801|FG000|Overall Study|Progressive Disease|16|||
163057964|NCT00819039|588922804|FG000|Overall Study|Physician Decision|1|||
163057965|NCT00819039|588922805|FG001|Overall Study|Physician Decision|0|||
163057966|NCT00819039|588922806|FG002|Overall Study|Physician Decision|1|||
163057967|NCT00819039|588922804|FG000|Overall Study|Protocol Violation|1|||
163057968|NCT00819039|588922805|FG001|Overall Study|Protocol Violation|0|||
163057969|NCT00819039|588922806|FG002|Overall Study|Protocol Violation|0|||
163057970|NCT04796415|588922807|FG000|Overall Study|not interested|12|||
162923769|NCT03466060|588422232|FG005|Period 1|Test Lens Damage|0|||
162923770|NCT03466060|588422227|FG000|Period 1|Withdrawal by Subject|0|||
162923771|NCT03466060|588422228|FG001|Period 1|Withdrawal by Subject|0|||
162923772|NCT03466060|588422229|FG002|Period 1|Withdrawal by Subject|2|||
162923773|NCT03466060|588422230|FG003|Period 1|Withdrawal by Subject|0|||
162923774|NCT03466060|588422231|FG004|Period 1|Withdrawal by Subject|0|||
162923775|NCT03466060|588422232|FG005|Period 1|Withdrawal by Subject|0|||
162923776|NCT03466060|588422227|FG000|Period 1|Lost to Follow-up|0|||
162923777|NCT03466060|588422228|FG001|Period 1|Lost to Follow-up|0|||
162923778|NCT03466060|588422229|FG002|Period 1|Lost to Follow-up|0|||
162923779|NCT03466060|588422230|FG003|Period 1|Lost to Follow-up|1|||
162923780|NCT03466060|588422231|FG004|Period 1|Lost to Follow-up|0|||
162923781|NCT03466060|588422232|FG005|Period 1|Lost to Follow-up|0|||
162923782|NCT03466060|588422227|FG000|Period 1|Grade 2 Conjunctivitis|0|||
162923783|NCT03466060|588422228|FG001|Period 1|Grade 2 Conjunctivitis|0|||
162923784|NCT03466060|588422229|FG002|Period 1|Grade 2 Conjunctivitis|1|||
162923785|NCT03466060|588422230|FG003|Period 1|Grade 2 Conjunctivitis|0|||
162923786|NCT03466060|588422231|FG004|Period 1|Grade 2 Conjunctivitis|0|||
162923787|NCT03466060|588422232|FG005|Period 1|Grade 2 Conjunctivitis|0|||
162923788|NCT03466060|588422227|FG000|Period 2|Lens Handling Difficulties|0|||
162923789|NCT03466060|588422228|FG001|Period 2|Lens Handling Difficulties|0|||
162923790|NCT03466060|588422229|FG002|Period 2|Lens Handling Difficulties|1|||
162923791|NCT03466060|588422230|FG003|Period 2|Lens Handling Difficulties|0|||
162923792|NCT03466060|588422231|FG004|Period 2|Lens Handling Difficulties|0|||
162923793|NCT03466060|588422232|FG005|Period 2|Lens Handling Difficulties|0|||
162923794|NCT03345485|588422235|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
162923795|NCT03345485|588422236|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
162923796|NCT03345485|588422237|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
162923797|NCT03345485|588422238|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
162923798|NCT03345485|588422239|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
162923799|NCT03345485|588422240|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
162923800|NCT03345485|588422241|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
162923801|NCT03345485|588422242|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
162923802|NCT03345485|588422243|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
162923803|NCT03345485|588422244|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
162923804|NCT03345485|588422245|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
162977103|NCT00384293|588616636|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
162977104|NCT00384293|588616634|FG000|Post-randomization Period|Adverse Event|0|||
162977105|NCT00384293|588616635|FG001|Post-randomization Period|Adverse Event|23|||
162977106|NCT00384293|588616636|FG002|Post-randomization Period|Adverse Event|7|||
162977107|NCT00384293|588616634|FG000|Post-randomization Period|Lost to Follow-up|0|||
162977108|NCT00384293|588616635|FG001|Post-randomization Period|Lost to Follow-up|2|||
162977109|NCT00384293|588616636|FG002|Post-randomization Period|Lost to Follow-up|1|||
162977110|NCT00384293|588616634|FG000|Post-randomization Period|Protocol Violation|0|||
162977111|NCT00384293|588616635|FG001|Post-randomization Period|Protocol Violation|1|||
162977112|NCT00384293|588616636|FG002|Post-randomization Period|Protocol Violation|0|||
162977113|NCT00384293|588616634|FG000|Post-randomization Period|Withdrawal by Subject|0|||
162977114|NCT00384293|588616635|FG001|Post-randomization Period|Withdrawal by Subject|8|||
162977115|NCT00384293|588616636|FG002|Post-randomization Period|Withdrawal by Subject|6|||
162977116|NCT00384293|588616634|FG000|Post-randomization Period|Trial Termination|0|||
162977117|NCT00384293|588616635|FG001|Post-randomization Period|Trial Termination|180|||
162977118|NCT00384293|588616636|FG002|Post-randomization Period|Trial Termination|204|||
162977119|NCT00384293|588616634|FG000|Post-randomization Period|Patient Randomized in Error|0|||
162977120|NCT00384293|588616635|FG001|Post-randomization Period|Patient Randomized in Error|0|||
162977121|NCT00384293|588616636|FG002|Post-randomization Period|Patient Randomized in Error|1|||
162977122|NCT02039063|588616643|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
162977123|NCT02039063|588616644|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
162977124|NCT02039063|588616645|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
162977125|NCT02039063|588616646|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
162977126|NCT02039063|588616643|FG000|Treatment Phase|Progression of disease|0|||
162977127|NCT02039063|588616644|FG001|Treatment Phase|Progression of disease|0|||
162977128|NCT02039063|588616645|FG002|Treatment Phase|Progression of disease|1|||
162977129|NCT02039063|588616646|FG003|Treatment Phase|Progression of disease|1|||
162977130|NCT02039063|588616643|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162977131|NCT02039063|588616644|FG001|Extension Phase|Inadequate therapeutic effect|1|||
162977132|NCT02039063|588616645|FG002|Extension Phase|Inadequate therapeutic effect|2|||
162977133|NCT02039063|588616646|FG003|Extension Phase|Inadequate therapeutic effect|0|||
162977134|NCT02039063|588616643|FG000|Extension Phase|Progression of disease|0|||
162977135|NCT02039063|588616644|FG001|Extension Phase|Progression of disease|0|||
162977136|NCT02039063|588616645|FG002|Extension Phase|Progression of disease|0|||
162977137|NCT02039063|588616646|FG003|Extension Phase|Progression of disease|1|||
162977138|NCT02039063|588616643|FG000|Extension Phase|Adverse Event|0|||
162977139|NCT02039063|588616644|FG001|Extension Phase|Adverse Event|0|||
162977140|NCT02039063|588616645|FG002|Extension Phase|Adverse Event|1|||
162977141|NCT02039063|588616646|FG003|Extension Phase|Adverse Event|0|||
162977142|NCT00775528|588616650|FG000|Overall Study|Protocol Violation|1|||
162977143|NCT02492841|588616651|FG000|Overall Study|Lost to Follow-up|34|||
162977144|NCT02492841|588616652|FG001|Overall Study|Lost to Follow-up|31|||
162977145|NCT02492841|588616653|FG002|Overall Study|Lost to Follow-up|35|||
162977146|NCT00613730|588616656|FG000|Overall Study|Disease progression|2|||
162977147|NCT00613730|588616656|FG000|Overall Study|Administrative decision|1|||
162977148|NCT01192399|588616657|FG000|Overall Study|Lack of Efficacy|2|||
162977149|NCT02244424|588616661|FG000|Overall Study|Lost to Follow-up|20|||
162977150|NCT02244424|588616662|FG001|Overall Study|Lost to Follow-up|10|||
162630330|NCT02509156|587365110|FG000|Randomized Phase|Death|1|||
162630331|NCT02509156|587365111|FG001|Randomized Phase|Death|0|||
162630332|NCT02509156|587365110|FG000|Randomized Phase|Withdrawal by Subject|1|||
162630333|NCT02509156|587365111|FG001|Randomized Phase|Withdrawal by Subject|1|||
162630334|NCT05131646|587365112|FG000|Overall Study|Withdrawal by Subject|1|||
162630335|NCT05131646|587365113|FG001|Overall Study|Withdrawal by Subject|0|||
162630336|NCT05131646|587365114|FG002|Overall Study|Withdrawal by Subject|0|||
162630337|NCT02128113|587365115|FG000|Overall Study|Withdrawal by Subject|3|||
162630338|NCT02128113|587365116|FG001|Overall Study|Withdrawal by Subject|1|||
162630339|NCT02128113|587365117|FG002|Overall Study|Withdrawal by Subject|0|||
162630340|NCT02128113|587365115|FG000|Overall Study|Protocol Violation|0|||
162630341|NCT02128113|587365116|FG001|Overall Study|Protocol Violation|1|||
162630342|NCT02128113|587365117|FG002|Overall Study|Protocol Violation|0|||
162630343|NCT02128113|587365115|FG000|Overall Study|Surgery cancelled|0|||
162630344|NCT02128113|587365116|FG001|Overall Study|Surgery cancelled|1|||
162977151|NCT02377063|588616663|FG000|Overall Study|Non-compliance|5|||
162630345|NCT02128113|587365117|FG002|Overall Study|Surgery cancelled|0|||
162977152|NCT01524913|588616664|FG000|Overall Study|Lost to Follow-up|4|||
162977153|NCT01524913|588616665|FG001|Overall Study|Lost to Follow-up|0|||
162977154|NCT01524913|588616666|FG002|Overall Study|Lost to Follow-up|0|||
162977155|NCT02723773|588618618|FG000|Overall Study|Adverse Event|934|||
162977156|NCT02723773|588618619|FG001|Overall Study|Adverse Event|3|||
162977157|NCT02723773|588618620|FG002|Overall Study|Adverse Event|1|||
162977158|NCT02723773|588618621|FG003|Overall Study|Adverse Event|9|||
162977159|NCT02723773|588618618|FG000|Overall Study|Protocol Violation|1|||
162630346|NCT02128113|587365115|FG000|Overall Study|Adverse Event|0|||
162977160|NCT02723773|588618619|FG001|Overall Study|Protocol Violation|0|||
162630347|NCT02128113|587365116|FG001|Overall Study|Adverse Event|0|||
162630348|NCT02128113|587365117|FG002|Overall Study|Adverse Event|1|||
162630349|NCT01750242|587365118|FG000|Overall Study|Unreadable Images|3|||
162630350|NCT03765918|587365119|FG000|Overall Study|Death|109|||
162630351|NCT03765918|587365120|FG001|Overall Study|Death|127|||
162630352|NCT03765918|587365119|FG000|Overall Study|Lost to Follow-up|2|||
162630353|NCT03765918|587365120|FG001|Overall Study|Lost to Follow-up|3|||
162630354|NCT03765918|587365119|FG000|Overall Study|Withdrawal by Subject|12|||
162630355|NCT03765918|587365120|FG001|Overall Study|Withdrawal by Subject|16|||
162630356|NCT03765918|587365119|FG000|Overall Study|Participants Ongoing|240|||
162630357|NCT03765918|587365120|FG001|Overall Study|Participants Ongoing|205|||
162630358|NCT04202965|587365121|FG000|Overall Study|Adverse Event|3|||
162630359|NCT04202965|587365121|FG000|Overall Study|Did not meet inclusion criteria|1|||
162630360|NCT02969369|587365122|FG000|Study|Adverse Event|1|||
162630361|NCT02969369|587365123|FG001|Study|Adverse Event|6|||
162630362|NCT02969369|587365122|FG000|Study|Lack of Efficacy|0|||
162630363|NCT02969369|587365123|FG001|Study|Lack of Efficacy|1|||
162630364|NCT02969369|587365122|FG000|Study|Lost to Follow-up|0|||
162630365|NCT02969369|587365123|FG001|Study|Lost to Follow-up|1|||
162630366|NCT02969369|587365122|FG000|Study|Withdrawal by Subject|3|||
162630367|NCT02969369|587365123|FG001|Study|Withdrawal by Subject|5|||
162630368|NCT02969369|587365122|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
162630369|NCT02969369|587365123|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
162630370|NCT02969369|587365122|FG000|Double-blind Period|Adverse Event|1|||
162630371|NCT02969369|587365123|FG001|Double-blind Period|Adverse Event|5|||
162630372|NCT02969369|587365122|FG000|Double-blind Period|Lost to Follow-up|0|||
162630373|NCT02969369|587365123|FG001|Double-blind Period|Lost to Follow-up|1|||
162630374|NCT02969369|587365122|FG000|Double-blind Period|Withdrawal by Subject|2|||
162630375|NCT02969369|587365123|FG001|Double-blind Period|Withdrawal by Subject|3|||
162630376|NCT02969369|587365122|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
162977161|NCT02723773|588618620|FG002|Overall Study|Protocol Violation|0|||
162977162|NCT02723773|588618621|FG003|Overall Study|Protocol Violation|0|||
162977163|NCT02723773|588618618|FG000|Overall Study|Withdrawal by Subject|360|||
162977164|NCT02723773|588618619|FG001|Overall Study|Withdrawal by Subject|5|||
162977165|NCT02723773|588618620|FG002|Overall Study|Withdrawal by Subject|6|||
162977166|NCT02723773|588618621|FG003|Overall Study|Withdrawal by Subject|10|||
162977167|NCT02723773|588618618|FG000|Overall Study|Migrated/moved from study area|37|||
162977168|NCT02723773|588618619|FG001|Overall Study|Migrated/moved from study area|0|||
162977169|NCT02723773|588618620|FG002|Overall Study|Migrated/moved from study area|0|||
162977170|NCT02723773|588618621|FG003|Overall Study|Migrated/moved from study area|1|||
162977171|NCT02723773|588618618|FG000|Overall Study|Lost to Follow-up|198|||
162977172|NCT02723773|588618619|FG001|Overall Study|Lost to Follow-up|0|||
162977173|NCT02723773|588618620|FG002|Overall Study|Lost to Follow-up|0|||
162977174|NCT02723773|588618621|FG003|Overall Study|Lost to Follow-up|0|||
162977175|NCT02723773|588618618|FG000|Overall Study|Other|189|||
162977176|NCT02723773|588618619|FG001|Overall Study|Other|1|||
162977177|NCT02723773|588618620|FG002|Overall Study|Other|2|||
162977178|NCT02723773|588618621|FG003|Overall Study|Other|2|||
162977179|NCT05168774|588618622|FG000|Overall Study|Lack of Efficacy|1|||
162977180|NCT05168774|588618623|FG001|Overall Study|Lack of Efficacy|2|||
162977181|NCT05168774|588618622|FG000|Overall Study|Withdrawal by Subject|1|||
162977182|NCT05168774|588618623|FG001|Overall Study|Withdrawal by Subject|2|||
162977183|NCT05168774|588618622|FG000|Overall Study|Adverse Event|2|||
162977184|NCT05168774|588618623|FG001|Overall Study|Adverse Event|0|||
162977185|NCT02124902|588618625|FG000|Overall Study|Adverse Event|7|||
162977186|NCT02124902|588618626|FG001|Overall Study|Adverse Event|2|||
162977187|NCT02124902|588618625|FG000|Overall Study|Went to alternative treatment|4|||
162977188|NCT02124902|588618626|FG001|Overall Study|Went to alternative treatment|0|||
162977189|NCT02124902|588618625|FG000|Overall Study|Withdrawal by Subject|2|||
162977190|NCT02124902|588618626|FG001|Overall Study|Withdrawal by Subject|1|||
162977191|NCT02124902|588618625|FG000|Overall Study|Physician Decision|2|||
162977192|NCT02124902|588618626|FG001|Overall Study|Physician Decision|0|||
162977193|NCT02124902|588618625|FG000|Overall Study|Not eligible|1|||
162977194|NCT02124902|588618626|FG001|Overall Study|Not eligible|0|||
162977195|NCT02124902|588618625|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
162977196|NCT02124902|588618626|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
162977197|NCT01314118|588618627|FG000|Overall Study|Adverse Event|10|||
162977198|NCT01314118|588618627|FG000|Overall Study|Progressive disease|3|||
162977199|NCT01314118|588618627|FG000|Overall Study|Death|8|||
162977200|NCT01314118|588618627|FG000|Overall Study|Physician Decision|13|||
162977201|NCT01314118|588618627|FG000|Overall Study|Sponsor Decision|1|||
162977202|NCT01314118|588618627|FG000|Overall Study|Protocol Violation|2|||
162630377|NCT02969369|587365123|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
162630378|NCT02969369|587365122|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
162630379|NCT02969369|587365123|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
162630380|NCT02969369|587365122|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
162977203|NCT01314118|588618627|FG000|Overall Study|Withdrawal by Subject|26|||
162977204|NCT01314118|588618627|FG000|Overall Study|Other|21|||
163057971|NCT04796415|588922807|FG000|Overall Study|health issue|8|||
163057972|NCT04796415|588922807|FG000|Overall Study|Other|4|||
163057973|NCT04796415|588922807|FG000|Overall Study|discharged from home health service|3|||
163057974|NCT04796415|588922807|FG000|Overall Study|re-hospitalization|2|||
163057975|NCT04796415|588922807|FG000|Overall Study|moving to nursing home|1|||
163057976|NCT04796415|588922807|FG000|Overall Study|lost contact|1|||
163057977|NCT00486044|588922811|FG000|Overall Study|Withdrawal by Subject|2|||
163057978|NCT00486044|588922812|FG001|Overall Study|Withdrawal by Subject|1|||
163057979|NCT00486044|588922811|FG000|Overall Study|Adverse Event|0|||
163057980|NCT00486044|588922812|FG001|Overall Study|Adverse Event|1|||
163057981|NCT00486044|588922811|FG000|Overall Study|Lost to Follow-up|0|||
163057982|NCT00486044|588922812|FG001|Overall Study|Lost to Follow-up|1|||
163057983|NCT02701634|588922813|FG000|Overall Study|Adverse Event|2|||
163057984|NCT02701634|588922814|FG001|Overall Study|Adverse Event|3|||
163057985|NCT02701634|588922813|FG000|Overall Study|Death|1|||
163057986|NCT02701634|588922814|FG001|Overall Study|Death|0|||
163057987|NCT02701634|588922813|FG000|Overall Study|Investigator's Discretion|7|||
163057988|NCT02701634|588922814|FG001|Overall Study|Investigator's Discretion|4|||
163057989|NCT02701634|588922813|FG000|Overall Study|Study terminated by Sponsor|15|||
163057990|NCT02701634|588922814|FG001|Overall Study|Study terminated by Sponsor|17|||
163057991|NCT02701634|588922813|FG000|Overall Study|Withdrew Consent|6|||
163057992|NCT02701634|588922814|FG001|Overall Study|Withdrew Consent|7|||
163057993|NCT02701634|588922813|FG000|Overall Study|Randomized but not treated|1|||
163057994|NCT02701634|588922814|FG001|Overall Study|Randomized but not treated|0|||
162712827|NCT04310579|587660762|FG002|Overall Study|Positive COVID-19 test|0|||
162712828|NCT04310579|587660763|FG003|Overall Study|Positive COVID-19 test|0|||
162712829|NCT04310579|587660764|FG004|Overall Study|Positive COVID-19 test|0|||
162712830|NCT04310579|587660765|FG005|Overall Study|Positive COVID-19 test|0|||
162712831|NCT04310579|587660766|FG006|Overall Study|Positive COVID-19 test|0|||
162712832|NCT04310579|587660767|FG007|Overall Study|Positive COVID-19 test|0|||
162712833|NCT04310579|587660768|FG008|Overall Study|Positive COVID-19 test|0|||
162712834|NCT04310579|587660769|FG009|Overall Study|Positive COVID-19 test|0|||
162712835|NCT04310579|587660770|FG010|Overall Study|Positive COVID-19 test|1|||
162712836|NCT04083976|587660771|FG000|Overall Study|Lost to Follow-up|3|||
162712837|NCT04083976|587660772|FG001|Overall Study|Lost to Follow-up|0|||
162712838|NCT04083976|587660773|FG002|Overall Study|Lost to Follow-up|0|||
162712839|NCT04083976|587660774|FG003|Overall Study|Lost to Follow-up|1|||
162712840|NCT04083976|587660771|FG000|Overall Study|Withdrawal by Subject|16|||
162712841|NCT04083976|587660772|FG001|Overall Study|Withdrawal by Subject|1|||
162712842|NCT04083976|587660773|FG002|Overall Study|Withdrawal by Subject|9|||
162712843|NCT04083976|587660774|FG003|Overall Study|Withdrawal by Subject|0|||
162712844|NCT04083976|587660771|FG000|Overall Study|Sponsor Decision|14|||
162712845|NCT04083976|587660772|FG001|Overall Study|Sponsor Decision|0|||
162712846|NCT04083976|587660773|FG002|Overall Study|Sponsor Decision|0|||
162712847|NCT04083976|587660774|FG003|Overall Study|Sponsor Decision|7|||
162712848|NCT04083976|587660771|FG000|Overall Study|Other|1|||
162712849|NCT04083976|587660772|FG001|Overall Study|Other|0|||
162712850|NCT04083976|587660773|FG002|Overall Study|Other|1|||
162712851|NCT04083976|587660774|FG003|Overall Study|Other|0|||
162712852|NCT00943605|587660775|FG000|Overall Study|Study termination|30|||
162712853|NCT00943605|587660776|FG001|Overall Study|Study termination|30|||
162712854|NCT02232178|587660778|FG000|Overall Study|Lost to Follow-up|0|||
162712855|NCT02232178|587660779|FG001|Overall Study|Lost to Follow-up|1|||
162712856|NCT02232178|587660780|FG002|Overall Study|Lost to Follow-up|0|||
162712857|NCT02232178|587660778|FG000|Overall Study|ineligibility|0|||
162712858|NCT02232178|587660779|FG001|Overall Study|ineligibility|0|||
162712859|NCT02232178|587660780|FG002|Overall Study|ineligibility|1|||
162712860|NCT02232178|587660778|FG000|Overall Study|surgical complication|1|||
162712861|NCT02232178|587660779|FG001|Overall Study|surgical complication|0|||
162712862|NCT02232178|587660780|FG002|Overall Study|surgical complication|0|||
162712863|NCT01956669|587660783|FG000|Overall Study|Disease Progression|12|||
162712864|NCT01956669|587660784|FG001|Overall Study|Disease Progression|7|||
162712865|NCT01956669|587660785|FG002|Overall Study|Disease Progression|7|||
162712866|NCT01956669|587660786|FG003|Overall Study|Disease Progression|8|||
162712867|NCT01956669|587660787|FG004|Overall Study|Disease Progression|4|||
162977205|NCT01467479|588618633|FG000|Overall Study|No Study Medication|1|||
162977206|NCT01467479|588618634|FG001|Overall Study|No Study Medication|0|||
162977207|NCT01467479|588618635|FG002|Overall Study|No Study Medication|2|||
162977208|NCT01467479|588618633|FG000|Overall Study|Adverse Event|1|||
162977209|NCT01467479|588618634|FG001|Overall Study|Adverse Event|2|||
162712868|NCT01956669|587660788|FG005|Overall Study|Disease Progression|3|||
162712869|NCT01956669|587660789|FG006|Overall Study|Disease Progression|5|||
162712870|NCT01956669|587660783|FG000|Overall Study|Adverse Event|0|||
162712871|NCT01956669|587660784|FG001|Overall Study|Adverse Event|2|||
162712872|NCT01956669|587660785|FG002|Overall Study|Adverse Event|2|||
162712873|NCT01956669|587660786|FG003|Overall Study|Adverse Event|1|||
162712874|NCT01956669|587660787|FG004|Overall Study|Adverse Event|0|||
162977210|NCT01467479|588618635|FG002|Overall Study|Adverse Event|0|||
162977211|NCT01467479|588618633|FG000|Overall Study|Death|0|||
162977212|NCT01467479|588618634|FG001|Overall Study|Death|0|||
162977213|NCT01467479|588618635|FG002|Overall Study|Death|1|||
162977214|NCT01467479|588618633|FG000|Overall Study|Lost to Follow-up|2|||
162977215|NCT01467479|588618634|FG001|Overall Study|Lost to Follow-up|5|||
162977216|NCT01467479|588618635|FG002|Overall Study|Lost to Follow-up|3|||
162977217|NCT01467479|588618633|FG000|Overall Study|Withdrawal of Consent|3|||
162977218|NCT01467479|588618634|FG001|Overall Study|Withdrawal of Consent|7|||
162977219|NCT01467479|588618635|FG002|Overall Study|Withdrawal of Consent|7|||
162977220|NCT01467479|588618633|FG000|Overall Study|Study Terminated by Sponsor|1|||
162977221|NCT01467479|588618634|FG001|Overall Study|Study Terminated by Sponsor|3|||
162977222|NCT01467479|588618635|FG002|Overall Study|Study Terminated by Sponsor|3|||
162977223|NCT01467479|588618633|FG000|Overall Study|Other|1|||
162977224|NCT01467479|588618634|FG001|Overall Study|Other|0|||
162977225|NCT01467479|588618635|FG002|Overall Study|Other|0|||
162977226|NCT01730040|588618638|FG000|Overall Study|Randomized but not treated|0|||
162977227|NCT01730040|588618639|FG001|Overall Study|Randomized but not treated|0|||
162977228|NCT01730040|588618640|FG002|Overall Study|Randomized but not treated|0|||
162977229|NCT01730040|588618641|FG003|Overall Study|Randomized but not treated|0|||
162977230|NCT01730040|588618642|FG004|Overall Study|Randomized but not treated|0|||
162977231|NCT01730040|588618643|FG005|Overall Study|Randomized but not treated|1|||
162977232|NCT01730040|588618644|FG006|Overall Study|Randomized but not treated|0|||
162977233|NCT01730040|588618638|FG000|Overall Study|Subject moved|0|||
162977234|NCT01730040|588618639|FG001|Overall Study|Subject moved|0|||
162977235|NCT01730040|588618640|FG002|Overall Study|Subject moved|1|||
162977236|NCT01730040|588618641|FG003|Overall Study|Subject moved|0|||
162630381|NCT02969369|587365123|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
162630382|NCT02969369|587365122|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
162630383|NCT02969369|587365123|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
162630384|NCT01980992|587365126|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
162630385|NCT01980992|587365127|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
162630386|NCT01980992|587365126|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
162630387|NCT01980992|587365127|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
162630388|NCT01980992|587365126|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
162630389|NCT01980992|587365127|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
162630390|NCT01980992|587365126|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
162630391|NCT01980992|587365127|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
162630392|NCT01980992|587365126|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
162630393|NCT01980992|587365127|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
162630394|NCT01980992|587365126|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
162630395|NCT01980992|587365127|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
162630396|NCT00299975|587365128|FG000|Overall Study|Adverse Event|1|||
162630397|NCT00299975|587365129|FG001|Overall Study|Adverse Event|0|||
162630398|NCT00299975|587365130|FG002|Overall Study|Adverse Event|2|||
162630399|NCT00299975|587365128|FG000|Overall Study|Pregnancy|0|||
162630400|NCT00299975|587365129|FG001|Overall Study|Pregnancy|0|||
162630401|NCT00299975|587365130|FG002|Overall Study|Pregnancy|1|||
162630402|NCT00299975|587365128|FG000|Overall Study|Lack of Efficacy|1|||
162630403|NCT00299975|587365129|FG001|Overall Study|Lack of Efficacy|0|||
162630404|NCT00299975|587365130|FG002|Overall Study|Lack of Efficacy|1|||
162630405|NCT00299975|587365128|FG000|Overall Study|Lost to Follow-up|1|||
162630406|NCT00299975|587365129|FG001|Overall Study|Lost to Follow-up|0|||
162630407|NCT00299975|587365130|FG002|Overall Study|Lost to Follow-up|0|||
162630408|NCT00299975|587365128|FG000|Overall Study|Withdrawal by Subject|0|||
162630409|NCT00299975|587365129|FG001|Overall Study|Withdrawal by Subject|1|||
162630410|NCT00299975|587365130|FG002|Overall Study|Withdrawal by Subject|3|||
162630411|NCT00299975|587365128|FG000|Overall Study|Physician Decision|0|||
162630412|NCT00299975|587365129|FG001|Overall Study|Physician Decision|0|||
162630413|NCT00299975|587365130|FG002|Overall Study|Physician Decision|1|||
162630414|NCT01169493|587365134|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
162630415|NCT01169493|587365135|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
162923805|NCT03345485|588422246|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
162923806|NCT03345485|588422247|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
162923807|NCT02985515|588422248|FG000|Olfaction Testing|Lost to Follow-up|0|||
162923808|NCT02985515|588422249|FG001|Olfaction Testing|Lost to Follow-up|5|||
162923809|NCT02985515|588422248|FG000|Olfaction Testing|Protocol Violation|0|||
162923810|NCT02985515|588422249|FG001|Olfaction Testing|Protocol Violation|3|||
162923811|NCT01610284|588422250|FG000|Randomization Phase|Adverse Event|1|||
162923812|NCT01610284|588422251|FG001|Randomization Phase|Adverse Event|0|||
162923813|NCT01610284|588422250|FG000|Randomization Phase|Physician Decision|1|||
162923814|NCT01610284|588422251|FG001|Randomization Phase|Physician Decision|1|||
162630416|NCT01169493|587365136|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
162923815|NCT01610284|588422250|FG000|Randomization Phase|Death|0|||
162923816|NCT01610284|588422251|FG001|Randomization Phase|Death|1|||
162977237|NCT01730040|588618642|FG004|Overall Study|Subject moved|0|||
162977238|NCT01730040|588618643|FG005|Overall Study|Subject moved|0|||
162977239|NCT01730040|588618644|FG006|Overall Study|Subject moved|1|||
162630417|NCT01169493|587365137|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
162630418|NCT01169493|587365138|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
162630419|NCT01169493|587365139|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
162630420|NCT01169493|587365134|FG000|Period 3 (6 Months)|Adverse Event|0|||
162630421|NCT01169493|587365135|FG001|Period 3 (6 Months)|Adverse Event|1|||
162630422|NCT01169493|587365136|FG002|Period 3 (6 Months)|Adverse Event|0|||
162630423|NCT01169493|587365137|FG003|Period 3 (6 Months)|Adverse Event|0|||
162977240|NCT01730040|588618638|FG000|Overall Study|Physician Decision|0|||
162977241|NCT01730040|588618639|FG001|Overall Study|Physician Decision|0|||
162977242|NCT01730040|588618640|FG002|Overall Study|Physician Decision|0|||
162977243|NCT01730040|588618641|FG003|Overall Study|Physician Decision|0|||
162977244|NCT01730040|588618642|FG004|Overall Study|Physician Decision|0|||
162977245|NCT01730040|588618643|FG005|Overall Study|Physician Decision|1|||
162977246|NCT01730040|588618644|FG006|Overall Study|Physician Decision|1|||
162977247|NCT01730040|588618638|FG000|Overall Study|Other than specified|7|||
162977248|NCT01730040|588618639|FG001|Overall Study|Other than specified|8|||
162977249|NCT01730040|588618640|FG002|Overall Study|Other than specified|5|||
162977250|NCT01730040|588618641|FG003|Overall Study|Other than specified|5|||
162977251|NCT01730040|588618642|FG004|Overall Study|Other than specified|5|||
162977252|NCT01730040|588618643|FG005|Overall Study|Other than specified|4|||
162977253|NCT01730040|588618644|FG006|Overall Study|Other than specified|4|||
162977254|NCT01730040|588618638|FG000|Overall Study|Adverse Event|4|||
162977255|NCT01730040|588618639|FG001|Overall Study|Adverse Event|3|||
162977256|NCT01730040|588618640|FG002|Overall Study|Adverse Event|5|||
162977257|NCT01730040|588618641|FG003|Overall Study|Adverse Event|3|||
162977258|NCT01730040|588618642|FG004|Overall Study|Adverse Event|1|||
162977259|NCT01730040|588618643|FG005|Overall Study|Adverse Event|1|||
162977260|NCT01730040|588618644|FG006|Overall Study|Adverse Event|2|||
162977261|NCT01730040|588618638|FG000|Overall Study|Poor compliance to protocol|2|||
162977262|NCT01730040|588618639|FG001|Overall Study|Poor compliance to protocol|4|||
162977263|NCT01730040|588618640|FG002|Overall Study|Poor compliance to protocol|0|||
162977264|NCT01730040|588618641|FG003|Overall Study|Poor compliance to protocol|0|||
162977265|NCT01730040|588618642|FG004|Overall Study|Poor compliance to protocol|0|||
162977266|NCT01730040|588618643|FG005|Overall Study|Poor compliance to protocol|0|||
162977267|NCT01730040|588618644|FG006|Overall Study|Poor compliance to protocol|1|||
162977268|NCT00544817|588618647|FG000|Combined Modality|Lack of Efficacy|2|||
162977269|NCT00544817|588618647|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
162977270|NCT00544817|588618647|FG000|Combined Modality|Adverse Event|2|||
162977271|NCT00544817|588618647|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
162977272|NCT00544817|588618647|FG000|No Treatment Interval|Lack of Efficacy|8|||
162977273|NCT00544817|588618647|FG000|No Treatment Interval|Physician Decision|3|||
162977274|NCT00544817|588618647|FG000|No Treatment Interval|Adverse Event|1|||
162977275|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
162977276|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
162977277|NCT00544817|588618647|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
162977278|NCT01552369|588618648|FG000|Overall Study|Did not consent to extended follow up|8|||
162977279|NCT01552369|588618649|FG001|Overall Study|Did not consent to extended follow up|9|||
162630424|NCT01169493|587365138|FG004|Period 3 (6 Months)|Adverse Event|0|||
162630425|NCT01169493|587365139|FG005|Period 3 (6 Months)|Adverse Event|0|||
162630426|NCT01169493|587365134|FG000|Period 3 (6 Months)|Physician Decision|0|||
162630427|NCT01169493|587365135|FG001|Period 3 (6 Months)|Physician Decision|1|||
162630428|NCT01169493|587365136|FG002|Period 3 (6 Months)|Physician Decision|1|||
162630429|NCT01169493|587365137|FG003|Period 3 (6 Months)|Physician Decision|0|||
162630430|NCT01169493|587365138|FG004|Period 3 (6 Months)|Physician Decision|0|||
162630431|NCT01169493|587365139|FG005|Period 3 (6 Months)|Physician Decision|0|||
162630432|NCT00496470|587365146|FG000|Overall Study|Adverse Event|8|||
162630433|NCT00496470|587365147|FG001|Overall Study|Adverse Event|10|||
162630434|NCT00496470|587365146|FG000|Overall Study|Withdrawal by Subject|5|||
162630435|NCT00496470|587365147|FG001|Overall Study|Withdrawal by Subject|12|||
162630436|NCT00496470|587365146|FG000|Overall Study|Incorrectly enrolled|13|||
162630437|NCT00496470|587365147|FG001|Overall Study|Incorrectly enrolled|5|||
162630438|NCT00496470|587365146|FG000|Overall Study|Other reason|0|||
162630439|NCT00496470|587365147|FG001|Overall Study|Other reason|2|||
162630440|NCT01370356|587365148|FG000|Overall Study|Death|1|||
162630441|NCT01370356|587365149|FG001|Overall Study|Death|0|||
162630442|NCT01370356|587365148|FG000|Overall Study|Lack of Efficacy|6|||
162977280|NCT01221090|588618651|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
162977281|NCT01221090|588618652|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
162977282|NCT01221090|588618653|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
162977283|NCT01221090|588618654|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
162977284|NCT01221090|588618651|FG000|Overall Study|Withdrawal by Subject|0|||
162977285|NCT01221090|588618652|FG001|Overall Study|Withdrawal by Subject|22|||
162977286|NCT01221090|588618653|FG002|Overall Study|Withdrawal by Subject|27|||
162630443|NCT01370356|587365149|FG001|Overall Study|Lack of Efficacy|28|||
162630444|NCT01370356|587365148|FG000|Overall Study|Lost to Follow-up|76|||
162630445|NCT01370356|587365149|FG001|Overall Study|Lost to Follow-up|81|||
162712875|NCT01956669|587660788|FG005|Overall Study|Adverse Event|0|||
162712876|NCT01956669|587660789|FG006|Overall Study|Adverse Event|0|||
162712877|NCT01956669|587660783|FG000|Overall Study|Physician Decision|0|||
162630446|NCT01370356|587365148|FG000|Overall Study|Withdrawal by Subject|54|||
162630447|NCT01370356|587365149|FG001|Overall Study|Withdrawal by Subject|59|||
162630448|NCT01370356|587365148|FG000|Overall Study|Reason not specified|39|||
162630449|NCT01370356|587365149|FG001|Overall Study|Reason not specified|43|||
162630450|NCT01370356|587365148|FG000|Overall Study|Protocol Violation|3|||
162630451|NCT01370356|587365149|FG001|Overall Study|Protocol Violation|3|||
162630452|NCT01370356|587365148|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
162630453|NCT01370356|587365149|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
162630454|NCT01370356|587365148|FG000|Overall Study|AE Not Related to Study Drug|1|||
162630455|NCT01370356|587365149|FG001|Overall Study|AE Not Related to Study Drug|4|||
162630456|NCT00799422|587365156|FG000|First Week of Wear|Lost to Follow-up|0|||
162630457|NCT00799422|587365157|FG001|First Week of Wear|Lost to Follow-up|0|||
162630458|NCT00799422|587365158|FG002|First Week of Wear|Lost to Follow-up|1|||
162630459|NCT00799422|587365159|FG003|First Week of Wear|Lost to Follow-up|0|||
162630460|NCT00799422|587365160|FG004|First Week of Wear|Lost to Follow-up|0|||
162630461|NCT00799422|587365161|FG005|First Week of Wear|Lost to Follow-up|0|||
162630462|NCT00799422|587365156|FG000|First Week of Wear|Adverse Event|0|||
162630463|NCT00799422|587365157|FG001|First Week of Wear|Adverse Event|0|||
162630464|NCT00799422|587365158|FG002|First Week of Wear|Adverse Event|0|||
162630465|NCT00799422|587365159|FG003|First Week of Wear|Adverse Event|1|||
162630466|NCT00799422|587365160|FG004|First Week of Wear|Adverse Event|0|||
162630467|NCT00799422|587365161|FG005|First Week of Wear|Adverse Event|0|||
162630468|NCT01496612|587365164|FG000|1st Intervention|Adverse Event|1|||
162630469|NCT01496612|587365165|FG001|1st Intervention|Adverse Event|0|||
162630470|NCT01496612|587365164|FG000|1st Intervention|Withdrawal by Subject|1|||
162630471|NCT01496612|587365165|FG001|1st Intervention|Withdrawal by Subject|0|||
162630472|NCT03129100|587365167|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
162630473|NCT03129100|587365168|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
162630474|NCT03129100|587365169|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
162630475|NCT03129100|587365170|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
162630476|NCT03129100|587365171|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
162630477|NCT03129100|587365172|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
162630478|NCT03129100|587365173|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
162630479|NCT03129100|587365174|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
162630480|NCT03129100|587365175|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
162630481|NCT03129100|587365176|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
162630482|NCT03129100|587365177|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
162630483|NCT03129100|587365178|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
162630484|NCT03129100|587365179|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
162630485|NCT03129100|587365180|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
162630486|NCT03129100|587365181|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
162630487|NCT03129100|587365182|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
162630488|NCT03129100|587365183|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
162630489|NCT03129100|587365184|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
162630490|NCT03129100|587365185|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
162630491|NCT03129100|587365186|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
162630492|NCT03129100|587365187|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
162630493|NCT03129100|587365188|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
162630494|NCT03129100|587365189|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
162630495|NCT03129100|587365190|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
162630496|NCT03129100|587365191|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
162712878|NCT01956669|587660784|FG001|Overall Study|Physician Decision|2|||
162712879|NCT01956669|587660785|FG002|Overall Study|Physician Decision|0|||
162712880|NCT01956669|587660786|FG003|Overall Study|Physician Decision|0|||
162712881|NCT01956669|587660787|FG004|Overall Study|Physician Decision|0|||
162712882|NCT01956669|587660788|FG005|Overall Study|Physician Decision|1|||
162712883|NCT01956669|587660789|FG006|Overall Study|Physician Decision|0|||
162712884|NCT01956669|587660783|FG000|Overall Study|Withdrawal by Subject|0|||
162712885|NCT01956669|587660784|FG001|Overall Study|Withdrawal by Subject|0|||
162712886|NCT01956669|587660785|FG002|Overall Study|Withdrawal by Subject|1|||
162712887|NCT01956669|587660786|FG003|Overall Study|Withdrawal by Subject|1|||
163057995|NCT01206764|588922815|FG000|Overall Study|Adverse Event|20|||
162630497|NCT03129100|587365192|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
162630498|NCT03129100|587365167|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
162630499|NCT03129100|587365168|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630500|NCT03129100|587365169|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630501|NCT03129100|587365170|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630502|NCT03129100|587365171|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630503|NCT03129100|587365172|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162712888|NCT01956669|587660787|FG004|Overall Study|Withdrawal by Subject|0|||
162712889|NCT01956669|587660788|FG005|Overall Study|Withdrawal by Subject|0|||
162712890|NCT01956669|587660789|FG006|Overall Study|Withdrawal by Subject|1|||
162712891|NCT01570751|587660790|FG000|Period A (16 Weeks)|Protocol Violation|1|||
162630504|NCT03129100|587365173|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630505|NCT03129100|587365174|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630506|NCT03129100|587365175|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630507|NCT03129100|587365176|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630508|NCT03129100|587365177|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630509|NCT03129100|587365178|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630510|NCT03129100|587365179|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630511|NCT03129100|587365180|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630512|NCT03129100|587365181|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630513|NCT03129100|587365182|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630514|NCT03129100|587365183|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630515|NCT03129100|587365184|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630516|NCT03129100|587365185|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630517|NCT03129100|587365186|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630518|NCT03129100|587365187|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162712892|NCT01570751|587660791|FG001|Period A (16 Weeks)|Protocol Violation|1|||
162712893|NCT01570751|587660790|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
162712894|NCT01570751|587660791|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
162712895|NCT01570751|587660790|FG000|Period A (16 Weeks)|Unclassified|2|||
162712896|NCT01570751|587660791|FG001|Period A (16 Weeks)|Unclassified|3|||
162712897|NCT01570751|587660790|FG000|Period B (16 Weeks)|Adverse Event|1|||
162712898|NCT01570751|587660791|FG001|Period B (16 Weeks)|Adverse Event|0|||
162712899|NCT01570751|587660790|FG000|Period B (16 Weeks)|Protocol Violation|0|||
162712900|NCT01570751|587660791|FG001|Period B (16 Weeks)|Protocol Violation|1|||
162712901|NCT01131494|587660796|FG000|Overall Study|Withdrawal by Subject|2|||
162712902|NCT01196988|587660797|FG000|Overall Study|Adverse Event|1|||
162712903|NCT01196988|587660798|FG001|Overall Study|Adverse Event|2|||
162712904|NCT01196988|587660799|FG002|Overall Study|Adverse Event|0|||
162712905|NCT01196988|587660800|FG003|Overall Study|Adverse Event|0|||
162712906|NCT01196988|587660797|FG000|Overall Study|Withdrawal by Subject|5|||
162712907|NCT01196988|587660798|FG001|Overall Study|Withdrawal by Subject|1|||
162630519|NCT03129100|587365188|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630520|NCT03129100|587365189|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630521|NCT03129100|587365190|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162630522|NCT03129100|587365191|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162977287|NCT01221090|588618654|FG003|Overall Study|Withdrawal by Subject|2|||
162630523|NCT03129100|587365192|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162977288|NCT00440466|588618656|FG000|Overall Study|Death|3|||
162977289|NCT00440466|588618657|FG001|Overall Study|Death|2|||
162977290|NCT00440466|588618658|FG002|Overall Study|Death|9|||
162977291|NCT00440466|588618656|FG000|Overall Study|Adverse Event|3|||
162977292|NCT00440466|588618657|FG001|Overall Study|Adverse Event|4|||
162977293|NCT00440466|588618658|FG002|Overall Study|Adverse Event|11|||
162977294|NCT00440466|588618656|FG000|Overall Study|Lost to Follow-up|1|||
162977295|NCT00440466|588618657|FG001|Overall Study|Lost to Follow-up|0|||
162977296|NCT00440466|588618658|FG002|Overall Study|Lost to Follow-up|2|||
162977297|NCT00440466|588618656|FG000|Overall Study|Physician Decision|2|||
162977298|NCT00440466|588618657|FG001|Overall Study|Physician Decision|0|||
162977299|NCT00440466|588618658|FG002|Overall Study|Physician Decision|1|||
162977300|NCT00440466|588618656|FG000|Overall Study|Protocol Violation|2|||
162977301|NCT00440466|588618657|FG001|Overall Study|Protocol Violation|0|||
162977302|NCT00440466|588618658|FG002|Overall Study|Protocol Violation|4|||
162977303|NCT00440466|588618656|FG000|Overall Study|Withdrawal by Subject|2|||
162977304|NCT00440466|588618657|FG001|Overall Study|Withdrawal by Subject|5|||
162977305|NCT00440466|588618658|FG002|Overall Study|Withdrawal by Subject|9|||
162977306|NCT00440466|588618656|FG000|Overall Study|Began Dialysis|0|||
162977307|NCT00440466|588618657|FG001|Overall Study|Began Dialysis|0|||
162977308|NCT00440466|588618658|FG002|Overall Study|Began Dialysis|1|||
162977309|NCT00440466|588618656|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
162977310|NCT00440466|588618657|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
162977311|NCT00440466|588618658|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
162977312|NCT01223235|588618661|FG000|Overall Study|Withdrawal by Subject|1|||
162977313|NCT03756883|588618664|FG000|Overall Study|Adverse Event|2|||
162977314|NCT03756883|588618665|FG001|Overall Study|Adverse Event|2|||
162977315|NCT03756883|588618666|FG002|Overall Study|Adverse Event|2|||
162977316|NCT03756883|588618664|FG000|Overall Study|Lack of Efficacy|0|||
162630524|NCT03129100|587365167|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
162712908|NCT01196988|587660799|FG002|Overall Study|Withdrawal by Subject|4|||
162977317|NCT03756883|588618665|FG001|Overall Study|Lack of Efficacy|1|||
162977318|NCT03756883|588618666|FG002|Overall Study|Lack of Efficacy|2|||
162712909|NCT01196988|587660800|FG003|Overall Study|Withdrawal by Subject|0|||
162712910|NCT01196988|587660797|FG000|Overall Study|Lost to Follow-up|16|||
162712911|NCT01196988|587660798|FG001|Overall Study|Lost to Follow-up|29|||
162977319|NCT03756883|588618664|FG000|Overall Study|Lost to Follow-up|3|||
162977320|NCT03756883|588618665|FG001|Overall Study|Lost to Follow-up|3|||
162712912|NCT01196988|587660799|FG002|Overall Study|Lost to Follow-up|21|||
162630525|NCT03129100|587365168|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
162630526|NCT03129100|587365169|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630527|NCT03129100|587365170|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630528|NCT03129100|587365171|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630529|NCT03129100|587365172|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630530|NCT03129100|587365173|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630531|NCT03129100|587365174|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630532|NCT03129100|587365175|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630533|NCT03129100|587365176|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630534|NCT03129100|587365177|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630535|NCT03129100|587365178|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630536|NCT03129100|587365179|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630537|NCT03129100|587365180|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630538|NCT03129100|587365181|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630539|NCT03129100|587365182|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630540|NCT03129100|587365183|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630541|NCT03129100|587365184|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630542|NCT03129100|587365185|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630543|NCT03129100|587365186|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630544|NCT03129100|587365187|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630545|NCT03129100|587365188|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630546|NCT03129100|587365189|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630547|NCT03129100|587365190|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162977321|NCT03756883|588618666|FG002|Overall Study|Lost to Follow-up|0|||
162630548|NCT03129100|587365191|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630549|NCT03129100|587365192|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162630550|NCT03129100|587365167|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
162630551|NCT03129100|587365168|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
162630552|NCT03129100|587365169|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630553|NCT03129100|587365170|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630554|NCT03129100|587365171|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630555|NCT03129100|587365172|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630556|NCT03129100|587365173|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630557|NCT03129100|587365174|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630558|NCT03129100|587365175|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630559|NCT03129100|587365176|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630560|NCT03129100|587365177|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630561|NCT03129100|587365178|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630562|NCT03129100|587365179|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630563|NCT03129100|587365180|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630564|NCT03129100|587365181|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630565|NCT03129100|587365182|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630566|NCT03129100|587365183|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630567|NCT03129100|587365184|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630568|NCT03129100|587365185|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162923817|NCT01610284|588422250|FG000|Treatment Phase|Adverse Event|80|||
162923818|NCT01610284|588422251|FG001|Treatment Phase|Adverse Event|12|||
162923819|NCT01610284|588422250|FG000|Treatment Phase|Lost to Follow-up|1|||
162923820|NCT01610284|588422251|FG001|Treatment Phase|Lost to Follow-up|0|||
162923821|NCT01610284|588422250|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
162923822|NCT01610284|588422251|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
162923823|NCT01610284|588422250|FG000|Treatment Phase|Physician Decision|27|||
162923824|NCT01610284|588422251|FG001|Treatment Phase|Physician Decision|24|||
162923825|NCT01610284|588422250|FG000|Treatment Phase|Progressive Disease|377|||
162923826|NCT01610284|588422251|FG001|Treatment Phase|Progressive Disease|486|||
162923827|NCT01610284|588422250|FG000|Treatment Phase|Protocol Deviation|2|||
162923828|NCT01610284|588422251|FG001|Treatment Phase|Protocol Deviation|3|||
162923829|NCT01610284|588422250|FG000|Treatment Phase|Study terminated by Sponsor|18|||
162923830|NCT01610284|588422251|FG001|Treatment Phase|Study terminated by Sponsor|15|||
162923831|NCT01610284|588422250|FG000|Treatment Phase|Subject/Guardian Decision|55|||
162923832|NCT01610284|588422251|FG001|Treatment Phase|Subject/Guardian Decision|23|||
162923833|NCT01610284|588422250|FG000|Treatment Phase|Death|6|||
162923834|NCT01610284|588422251|FG001|Treatment Phase|Death|5|||
162923835|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
162923836|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
162923837|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
162923838|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
162923839|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
162923840|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
162923841|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
162923842|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
162923843|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
162923844|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
162923845|NCT01610284|588422250|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
162923846|NCT01610284|588422251|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
162923847|NCT03020966|588422252|FG000|Overall Study|Withdrawal by Subject|2|||
162923848|NCT03020966|588422253|FG001|Overall Study|Withdrawal by Subject|0|||
162923849|NCT01856257|588422254|FG000|Overall Study|Death|2|||
162923850|NCT01856257|588422255|FG001|Overall Study|Death|0|||
162923851|NCT01856257|588422256|FG002|Overall Study|Death|0|||
162923852|NCT01856257|588422257|FG003|Overall Study|Death|0|||
162923853|NCT01856257|588422254|FG000|Overall Study|Physician Decision|0|||
162923854|NCT01856257|588422255|FG001|Overall Study|Physician Decision|0|||
162923855|NCT01856257|588422256|FG002|Overall Study|Physician Decision|0|||
162923856|NCT01856257|588422257|FG003|Overall Study|Physician Decision|1|||
162923857|NCT01856257|588422254|FG000|Overall Study|Withdrawal by Subject|1|||
162923858|NCT01856257|588422255|FG001|Overall Study|Withdrawal by Subject|1|||
162923859|NCT01856257|588422256|FG002|Overall Study|Withdrawal by Subject|0|||
162923860|NCT01856257|588422257|FG003|Overall Study|Withdrawal by Subject|0|||
162923861|NCT01856257|588422254|FG000|Overall Study|Donor complication|0|||
162923862|NCT01856257|588422255|FG001|Overall Study|Donor complication|0|||
162923863|NCT01856257|588422256|FG002|Overall Study|Donor complication|0|||
162923864|NCT01856257|588422257|FG003|Overall Study|Donor complication|1|||
162923865|NCT01060007|588422261|FG000|Overall Study|Withdrawal by Subject|1|||
162923866|NCT01060007|588422261|FG000|Overall Study|Inevaluable for response at surgery|3|||
162923867|NCT00424632|588422262|FG000|Overall Study|Death|0|||
162923868|NCT00424632|588422263|FG001|Overall Study|Death|0|||
162923869|NCT00424632|588422264|FG002|Overall Study|Death|0|||
162630569|NCT03129100|587365186|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630570|NCT03129100|587365187|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630571|NCT03129100|587365188|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630572|NCT03129100|587365189|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630573|NCT03129100|587365190|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630574|NCT03129100|587365191|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630575|NCT03129100|587365192|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162630576|NCT03129100|587365167|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
162977322|NCT03756883|588618664|FG000|Overall Study|Protocol Violation|2|||
162977323|NCT03756883|588618665|FG001|Overall Study|Protocol Violation|0|||
162977324|NCT03756883|588618666|FG002|Overall Study|Protocol Violation|1|||
162977325|NCT03756883|588618664|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
162977326|NCT03756883|588618665|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
162977327|NCT03756883|588618666|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
162977328|NCT03756883|588618664|FG000|Overall Study|Withdrawal by Subject|4|||
162977329|NCT03756883|588618665|FG001|Overall Study|Withdrawal by Subject|1|||
162977330|NCT03756883|588618666|FG002|Overall Study|Withdrawal by Subject|0|||
162977331|NCT03756883|588618664|FG000|Overall Study|Other Reasons|2|||
162977332|NCT03756883|588618665|FG001|Overall Study|Other Reasons|4|||
162977333|NCT03756883|588618666|FG002|Overall Study|Other Reasons|0|||
162977334|NCT00685802|588618667|FG000|Washout Period of 7 Days|Protocol Violation|2|||
162977335|NCT00685802|588618668|FG001|Washout Period of 7 Days|Protocol Violation|0|||
162977336|NCT00685802|588618667|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
162977337|NCT00685802|588618668|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
162977338|NCT00754442|588618669|FG000|Overall Study|Withdrawal by Subject|5|||
162977339|NCT00754442|588618670|FG001|Overall Study|Withdrawal by Subject|3|||
162977340|NCT03005067|588618671|FG000|Overall Study|Withdrawal by Subject|3|||
162630577|NCT03129100|587365168|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
162630578|NCT03129100|587365169|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630579|NCT03129100|587365170|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
162712913|NCT01196988|587660800|FG003|Overall Study|Lost to Follow-up|1|||
162712914|NCT01196988|587660797|FG000|Overall Study|Other|2|||
162712915|NCT01196988|587660798|FG001|Overall Study|Other|0|||
162712916|NCT01196988|587660799|FG002|Overall Study|Other|0|||
162712917|NCT01196988|587660800|FG003|Overall Study|Other|0|||
162630580|NCT03129100|587365171|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630581|NCT03129100|587365172|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630582|NCT03129100|587365173|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630583|NCT03129100|587365174|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630584|NCT03129100|587365175|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630585|NCT03129100|587365176|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630586|NCT03129100|587365177|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630587|NCT03129100|587365178|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630588|NCT03129100|587365179|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630589|NCT03129100|587365180|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630590|NCT03129100|587365181|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630591|NCT03129100|587365182|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630592|NCT03129100|587365183|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630593|NCT03129100|587365184|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630594|NCT03129100|587365185|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630595|NCT03129100|587365186|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630596|NCT03129100|587365187|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630597|NCT03129100|587365188|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630598|NCT03129100|587365189|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630599|NCT03129100|587365190|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630600|NCT03129100|587365191|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630601|NCT03129100|587365192|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
162630602|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630603|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630604|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
162630605|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
162630606|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630607|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
162630608|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162712918|NCT05419557|587660802|FG000|Overall Study|Lost to Follow-up|11|||
162712919|NCT05419557|587660803|FG001|Overall Study|Lost to Follow-up|4|||
162712920|NCT02281318|587660805|FG000|Overall Study|Adverse Event|2|||
162712921|NCT02281318|587660806|FG001|Overall Study|Adverse Event|2|||
162712922|NCT02281318|587660805|FG000|Overall Study|Lack of Efficacy|2|||
162712923|NCT02281318|587660806|FG001|Overall Study|Lack of Efficacy|0|||
162712924|NCT02281318|587660805|FG000|Overall Study|Lost to Follow-up|2|||
162712925|NCT02281318|587660806|FG001|Overall Study|Lost to Follow-up|1|||
162712926|NCT02281318|587660805|FG000|Overall Study|Physician Decision|2|||
162712927|NCT02281318|587660806|FG001|Overall Study|Physician Decision|0|||
162712928|NCT02281318|587660805|FG000|Overall Study|Withdrawal by Subject|6|||
162712929|NCT02281318|587660806|FG001|Overall Study|Withdrawal by Subject|2|||
162712930|NCT05257798|587660807|FG000|Follow-up Phase|Lost to Follow-up|1|||
162712931|NCT05257798|587660808|FG001|Follow-up Phase|Lost to Follow-up|0|||
162712932|NCT00703911|587660809|FG000|Overall Study|Death|1|||
162712933|NCT00703911|587660809|FG000|Overall Study|Physician Decision|6|||
162630609|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630610|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630611|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630612|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162712934|NCT00703911|587660809|FG000|Overall Study|Lost to Follow-up|1|||
162712935|NCT00703911|587660809|FG000|Overall Study|Withdrawal by Subject|2|||
162712936|NCT01064817|587660810|FG000|Study Completion|Physician Decision|1|||
162712937|NCT01064817|587660811|FG001|Study Completion|Physician Decision|0|||
162712938|NCT01064817|587660810|FG000|Study Completion|Withdrawal by Subject|1|||
162712939|NCT01064817|587660811|FG001|Study Completion|Withdrawal by Subject|0|||
162923870|NCT00424632|588422265|FG003|Overall Study|Death|0|||
162923871|NCT00424632|588422266|FG004|Overall Study|Death|0|||
162923872|NCT00424632|588422267|FG005|Overall Study|Death|2|||
162923873|NCT00424632|588422268|FG006|Overall Study|Death|0|||
163057996|NCT01206764|588922815|FG000|Overall Study|Abnormal laboratory value|2|||
163057997|NCT01206764|588922815|FG000|Overall Study|Abnormal test procedure result|1|||
163057998|NCT01206764|588922815|FG000|Overall Study|Patient withdrew consent|5|||
163057999|NCT01206764|588922815|FG000|Overall Study|Lost to Follow-up|6|||
163058000|NCT01206764|588922815|FG000|Overall Study|Death|11|||
163058001|NCT01206764|588922815|FG000|Overall Study|New cancer therapy|2|||
163058002|NCT01206764|588922815|FG000|Overall Study|Disease progression|88|||
163058003|NCT01206764|588922815|FG000|Overall Study|Protocol deviation|3|||
163058004|NCT04494646|588922816|FG000|Overall Study|Adverse Event|0|||
163058005|NCT04494646|588922817|FG001|Overall Study|Adverse Event|1|||
163058006|NCT04494646|588922816|FG000|Overall Study|Withdrawal by Subject|0|||
163058007|NCT04494646|588922817|FG001|Overall Study|Withdrawal by Subject|1|||
163058008|NCT00997893|588922820|FG000|Overall Study|Adverse Event|1|||
163058009|NCT00997893|588922821|FG001|Overall Study|Adverse Event|0|||
163058010|NCT00997893|588922822|FG002|Overall Study|Adverse Event|0|||
163058011|NCT00997893|588922820|FG000|Overall Study|Unable to meet study timelines|1|||
163058012|NCT00997893|588922821|FG001|Overall Study|Unable to meet study timelines|0|||
163058013|NCT00997893|588922822|FG002|Overall Study|Unable to meet study timelines|0|||
163058014|NCT00997893|588922820|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
163058015|NCT00997893|588922821|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
163058016|NCT00997893|588922822|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
163058017|NCT03620162|588922823|FG000|Overall Study|Physician Decision|4|||
163058018|NCT03620162|588922824|FG001|Overall Study|Physician Decision|0|||
163058019|NCT03620162|588922825|FG002|Overall Study|Physician Decision|1|||
163058020|NCT03620162|588922826|FG003|Overall Study|Physician Decision|0|||
163058021|NCT03620162|588922827|FG004|Overall Study|Physician Decision|2|||
163058022|NCT03620162|588922823|FG000|Overall Study|Lost to Follow-up|2|||
163058023|NCT03620162|588922824|FG001|Overall Study|Lost to Follow-up|6|||
163058024|NCT03620162|588922825|FG002|Overall Study|Lost to Follow-up|7|||
163058025|NCT03620162|588922826|FG003|Overall Study|Lost to Follow-up|3|||
162977341|NCT03005067|588618672|FG001|Overall Study|Withdrawal by Subject|2|||
162977342|NCT03005067|588618671|FG000|Overall Study|Adverse Event|4|||
162977343|NCT03005067|588618672|FG001|Overall Study|Adverse Event|3|||
162630613|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630614|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630615|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162977344|NCT03005067|588618671|FG000|Overall Study|Other (reason not specified)|3|||
162977345|NCT03005067|588618672|FG001|Overall Study|Other (reason not specified)|1|||
162977346|NCT03005067|588618671|FG000|Overall Study|Protocol Violation|0|||
162977347|NCT03005067|588618672|FG001|Overall Study|Protocol Violation|1|||
162977348|NCT00103038|588618677|FG000|Overall Study|Withdrawal by Subject|8|||
162977349|NCT00103038|588618677|FG000|Overall Study|Screen failure|3|||
162977350|NCT00103038|588618677|FG000|Overall Study|Death|1|||
162977351|NCT00103038|588618677|FG000|Overall Study|Physician Decision|1|||
162977352|NCT00355472|588618680|FG000|Overall Study|Physician Decision|1|||
162977353|NCT05445843|588618681|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
162977354|NCT05445843|588618682|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
162977355|NCT05445843|588618681|FG000|Overall Study|Progressive disease|17|||
162977356|NCT05445843|588618682|FG001|Overall Study|Progressive disease|9|||
162977357|NCT05445843|588618681|FG000|Overall Study|Physician Decision|16|||
162977358|NCT05445843|588618682|FG001|Overall Study|Physician Decision|4|||
162977359|NCT05445843|588618681|FG000|Overall Study|Death|6|||
162923874|NCT00424632|588422269|FG007|Overall Study|Death|0|||
162923875|NCT00424632|588422270|FG008|Overall Study|Death|0|||
162923876|NCT00424632|588422271|FG009|Overall Study|Death|0|||
162923877|NCT00424632|588422262|FG000|Overall Study|Adverse Event|0|||
162923878|NCT00424632|588422263|FG001|Overall Study|Adverse Event|0|||
162923879|NCT00424632|588422264|FG002|Overall Study|Adverse Event|0|||
162923880|NCT00424632|588422265|FG003|Overall Study|Adverse Event|0|||
162923881|NCT00424632|588422266|FG004|Overall Study|Adverse Event|0|||
162923882|NCT00424632|588422267|FG005|Overall Study|Adverse Event|0|||
162923883|NCT00424632|588422268|FG006|Overall Study|Adverse Event|0|||
162923884|NCT00424632|588422269|FG007|Overall Study|Adverse Event|0|||
162923885|NCT00424632|588422270|FG008|Overall Study|Adverse Event|3|||
162923886|NCT00424632|588422271|FG009|Overall Study|Adverse Event|2|||
162923887|NCT00424632|588422262|FG000|Overall Study|Global deterioration of health status|0|||
162923888|NCT00424632|588422263|FG001|Overall Study|Global deterioration of health status|0|||
162923889|NCT00424632|588422264|FG002|Overall Study|Global deterioration of health status|0|||
162923890|NCT00424632|588422265|FG003|Overall Study|Global deterioration of health status|1|||
162923891|NCT00424632|588422266|FG004|Overall Study|Global deterioration of health status|1|||
162923892|NCT00424632|588422267|FG005|Overall Study|Global deterioration of health status|0|||
162923893|NCT00424632|588422268|FG006|Overall Study|Global deterioration of health status|0|||
162923894|NCT00424632|588422269|FG007|Overall Study|Global deterioration of health status|0|||
162923895|NCT00424632|588422270|FG008|Overall Study|Global deterioration of health status|0|||
162923896|NCT00424632|588422271|FG009|Overall Study|Global deterioration of health status|0|||
162923897|NCT00424632|588422262|FG000|Overall Study|Objective progression or relapse|1|||
162923898|NCT00424632|588422263|FG001|Overall Study|Objective progression or relapse|1|||
162923899|NCT00424632|588422264|FG002|Overall Study|Objective progression or relapse|1|||
162923900|NCT00424632|588422265|FG003|Overall Study|Objective progression or relapse|2|||
162923901|NCT00424632|588422266|FG004|Overall Study|Objective progression or relapse|2|||
162923902|NCT00424632|588422267|FG005|Overall Study|Objective progression or relapse|13|||
162923903|NCT00424632|588422268|FG006|Overall Study|Objective progression or relapse|7|||
162923904|NCT00424632|588422269|FG007|Overall Study|Objective progression or relapse|3|||
162923905|NCT00424632|588422270|FG008|Overall Study|Objective progression or relapse|12|||
162923906|NCT00424632|588422271|FG009|Overall Study|Objective progression or relapse|4|||
162923907|NCT00424632|588422262|FG000|Overall Study|Other|0|||
162923908|NCT00424632|588422263|FG001|Overall Study|Other|0|||
162923909|NCT00424632|588422264|FG002|Overall Study|Other|0|||
162923910|NCT00424632|588422265|FG003|Overall Study|Other|1|||
162923911|NCT00424632|588422266|FG004|Overall Study|Other|0|||
162923912|NCT00424632|588422267|FG005|Overall Study|Other|0|||
162923913|NCT00424632|588422268|FG006|Overall Study|Other|0|||
162923914|NCT00424632|588422269|FG007|Overall Study|Other|0|||
162923915|NCT00424632|588422270|FG008|Overall Study|Other|1|||
162923916|NCT00424632|588422271|FG009|Overall Study|Other|0|||
162923917|NCT05674721|588422273|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
162923918|NCT05674721|588422274|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
162923919|NCT05674721|588422273|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
162923920|NCT05674721|588422274|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
162923921|NCT03506425|588422289|FG000|Overall Study|Adverse Event|1|||
162923922|NCT03506425|588422290|FG001|Overall Study|Adverse Event|3|||
162923923|NCT03506425|588422291|FG002|Overall Study|Adverse Event|0|||
162923924|NCT03506425|588422289|FG000|Overall Study|Death|1|||
162923925|NCT03506425|588422290|FG001|Overall Study|Death|0|||
162923926|NCT03506425|588422291|FG002|Overall Study|Death|0|||
162923927|NCT03506425|588422289|FG000|Overall Study|Withdrawal by Subject|0|||
162630616|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630617|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630618|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630619|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630620|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630621|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630622|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630623|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630624|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630625|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630626|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630627|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162630628|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Death|0|||
162630629|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Death|0|||
162630630|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Death|1|||
162630631|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Death|0|||
162630632|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Death|0|||
162630633|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Death|0|||
162630634|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Death|0|||
162630635|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Death|0|||
162630636|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Death|0|||
162630637|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Death|0|||
162630638|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Death|0|||
162630639|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Death|0|||
162630640|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Death|0|||
162630641|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Death|0|||
162630642|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Death|0|||
162630643|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Death|0|||
162630644|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Death|0|||
162630645|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Death|0|||
162630646|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Death|0|||
162630647|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Death|0|||
162630648|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Death|0|||
162630649|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Death|0|||
162630650|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Death|0|||
162630651|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Death|0|||
162630652|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Death|0|||
162630653|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Death|0|||
162630654|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630655|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630656|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
162630657|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
162630658|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
162630659|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
162630660|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
162630661|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630662|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630663|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630664|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630665|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630666|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630667|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630668|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630669|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630670|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630671|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630672|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162977360|NCT05445843|588618682|FG001|Overall Study|Death|3|||
162977361|NCT05445843|588618681|FG000|Overall Study|Subject decision|6|||
162977362|NCT05445843|588618682|FG001|Overall Study|Subject decision|2|||
162630673|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630674|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630675|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162977363|NCT05445843|588618681|FG000|Overall Study|Adverse Event|2|||
162977364|NCT05445843|588618682|FG001|Overall Study|Adverse Event|0|||
162630676|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162977365|NCT05307679|588618687|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
162977366|NCT05307679|588618688|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
162977367|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977368|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977369|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
162977370|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
162977371|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
162977372|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
163058026|NCT03620162|588922827|FG004|Overall Study|Lost to Follow-up|2|||
162630677|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630678|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630679|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162630680|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630681|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630682|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
162630683|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630684|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630685|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630686|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630687|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630688|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630689|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630690|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630691|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630692|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630693|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630694|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630695|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630696|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630697|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630698|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630699|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630700|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630701|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630702|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630703|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630704|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630705|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162630706|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630707|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630708|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
162630709|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630710|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630711|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630712|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630713|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630714|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630715|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630716|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630717|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630718|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630719|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630720|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630721|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630722|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630723|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630724|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630725|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630726|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630727|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630728|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630729|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630730|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630731|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162630732|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630733|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630734|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
162630735|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630736|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630737|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162712940|NCT03102710|587660812|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
162977373|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
162977374|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
162977375|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
162977376|NCT02310763|588618693|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
162977377|NCT02310763|588618694|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
162977378|NCT02310763|588618695|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
162977379|NCT02310763|588618693|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
162630738|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630739|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630740|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630741|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630742|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630743|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630744|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630745|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630746|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630747|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630748|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630749|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630750|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630751|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630752|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630753|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630754|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630755|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630756|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630757|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162630758|NCT03129100|587365167|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630759|NCT03129100|587365168|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630760|NCT03129100|587365169|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630761|NCT03129100|587365170|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630762|NCT03129100|587365171|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
162630763|NCT03129100|587365172|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
162630764|NCT03129100|587365173|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
162630765|NCT03129100|587365174|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630766|NCT03129100|587365175|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630767|NCT03129100|587365176|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630768|NCT03129100|587365177|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630769|NCT03129100|587365178|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630770|NCT03129100|587365179|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630771|NCT03129100|587365180|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630772|NCT03129100|587365181|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630773|NCT03129100|587365182|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630774|NCT03129100|587365183|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630775|NCT03129100|587365184|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630776|NCT03129100|587365185|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630777|NCT03129100|587365186|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630778|NCT03129100|587365187|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630779|NCT03129100|587365188|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630780|NCT03129100|587365189|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630781|NCT03129100|587365190|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630782|NCT03129100|587365191|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630783|NCT03129100|587365192|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162630784|NCT03129100|587365167|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630785|NCT03129100|587365168|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630786|NCT03129100|587365169|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630787|NCT03129100|587365170|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630788|NCT03129100|587365171|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630789|NCT03129100|587365172|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162977380|NCT02310763|588618694|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
162977381|NCT02310763|588618695|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
162977382|NCT01731886|588618697|FG000|Overall Study|Death|1|||
162977383|NCT01731886|588618698|FG001|Overall Study|Death|0|||
162977384|NCT01731886|588618697|FG000|Overall Study|Never started treatment|0|||
162977385|NCT01731886|588618698|FG001|Overall Study|Never started treatment|1|||
162923928|NCT03506425|588422290|FG001|Overall Study|Withdrawal by Subject|0|||
162923929|NCT03506425|588422291|FG002|Overall Study|Withdrawal by Subject|1|||
162923930|NCT02057549|588422292|FG000|Overall Study|Lost to Follow-up|1|||
162923931|NCT02057549|588422293|FG001|Overall Study|Lost to Follow-up|0|||
162923932|NCT02057549|588422292|FG000|Overall Study|Physician Decision|1|||
162923933|NCT02057549|588422293|FG001|Overall Study|Physician Decision|0|||
162923934|NCT02057549|588422292|FG000|Overall Study|Withdrawal by Subject|1|||
162923935|NCT02057549|588422293|FG001|Overall Study|Withdrawal by Subject|0|||
162923936|NCT04150107|588422296|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
162923937|NCT04150107|588422297|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
162923938|NCT04150107|588422296|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
162923939|NCT04150107|588422297|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
162923940|NCT00440193|588422302|FG000|Treatment Period|Adverse Event|74|||
162923941|NCT00440193|588422303|FG001|Treatment Period|Adverse Event|67|||
162923942|NCT00440193|588422302|FG000|Treatment Period|Death|19|||
162923943|NCT00440193|588422303|FG001|Treatment Period|Death|22|||
162923944|NCT00440193|588422302|FG000|Treatment Period|Lack of Efficacy|0|||
162923945|NCT00440193|588422303|FG001|Treatment Period|Lack of Efficacy|1|||
162923946|NCT00440193|588422302|FG000|Treatment Period|Lost to Follow-up|12|||
162923947|NCT00440193|588422303|FG001|Treatment Period|Lost to Follow-up|18|||
162923948|NCT00440193|588422302|FG000|Treatment Period|Physician Decision|3|||
162923949|NCT00440193|588422303|FG001|Treatment Period|Physician Decision|6|||
162977386|NCT01731886|588618697|FG000|Overall Study|Non-compliant|1|||
162977387|NCT01731886|588618698|FG001|Overall Study|Non-compliant|0|||
162977388|NCT02280187|588618699|FG000|Overall Study|Lost to Follow-up|218|||
162923950|NCT00440193|588422302|FG000|Treatment Period|Protocol Violation|16|||
162923951|NCT00440193|588422303|FG001|Treatment Period|Protocol Violation|19|||
162923952|NCT00440193|588422302|FG000|Treatment Period|Withdrawal by Subject|36|||
162923953|NCT00440193|588422303|FG001|Treatment Period|Withdrawal by Subject|77|||
162923954|NCT00440193|588422302|FG000|Treatment Period|Clinical endpoint reached|28|||
162923955|NCT00440193|588422303|FG001|Treatment Period|Clinical endpoint reached|25|||
162923956|NCT00440193|588422302|FG000|Treatment Period|Study terminated by sponsor|102|||
162923957|NCT00440193|588422303|FG001|Treatment Period|Study terminated by sponsor|94|||
162923958|NCT00440193|588422302|FG000|Treatment Period|Protocol driven decision point|2|||
162923959|NCT00440193|588422303|FG001|Treatment Period|Protocol driven decision point|2|||
162923960|NCT00440193|588422302|FG000|Treatment Period|Switch to commercial drug|0|||
162923961|NCT00440193|588422303|FG001|Treatment Period|Switch to commercial drug|2|||
162923962|NCT00440193|588422302|FG000|Treatment Period|Technical problems|1|||
162923963|NCT00440193|588422303|FG001|Treatment Period|Technical problems|1|||
162923964|NCT00440193|588422302|FG000|Treatment Period|Participant convenience|5|||
162923965|NCT00440193|588422303|FG001|Treatment Period|Participant convenience|2|||
162923966|NCT00440193|588422302|FG000|Treatment Period|Participant did not receive treatment|7|||
162923967|NCT00440193|588422303|FG001|Treatment Period|Participant did not receive treatment|13|||
162923968|NCT00440193|588422302|FG000|Treatment Period|Site closed by investigator|0|||
162630790|NCT03129100|587365173|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630791|NCT03129100|587365174|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162977389|NCT00939627|588618700|FG000|Overall Study|Disease Progression|16|||
162977390|NCT00939627|588618701|FG001|Overall Study|Disease Progression|12|||
162977391|NCT00939627|588618702|FG002|Overall Study|Disease Progression|0|||
162977392|NCT00939627|588618700|FG000|Overall Study|Adverse Event|6|||
162630792|NCT03129100|587365175|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630793|NCT03129100|587365176|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
162630794|NCT03129100|587365177|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630795|NCT03129100|587365178|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630796|NCT03129100|587365179|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630797|NCT03129100|587365180|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630798|NCT03129100|587365181|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630799|NCT03129100|587365182|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630800|NCT03129100|587365183|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630801|NCT03129100|587365184|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630802|NCT03129100|587365185|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630803|NCT03129100|587365186|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630804|NCT03129100|587365187|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630805|NCT03129100|587365188|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630806|NCT03129100|587365189|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630807|NCT03129100|587365190|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630808|NCT03129100|587365191|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630809|NCT03129100|587365192|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162630810|NCT03129100|587365167|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630811|NCT03129100|587365168|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630812|NCT03129100|587365169|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630813|NCT03129100|587365170|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630814|NCT03129100|587365171|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630815|NCT03129100|587365172|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630816|NCT03129100|587365173|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630817|NCT03129100|587365174|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630818|NCT03129100|587365175|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630819|NCT03129100|587365176|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630820|NCT03129100|587365177|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630821|NCT03129100|587365178|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
162630822|NCT03129100|587365179|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630823|NCT03129100|587365180|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162977393|NCT00939627|588618701|FG001|Overall Study|Adverse Event|7|||
162977394|NCT00939627|588618702|FG002|Overall Study|Adverse Event|0|||
162977395|NCT00939627|588618700|FG000|Overall Study|Death|0|||
162977396|NCT00939627|588618701|FG001|Overall Study|Death|2|||
162977397|NCT00939627|588618702|FG002|Overall Study|Death|0|||
162977398|NCT00939627|588618700|FG000|Overall Study|Withdrawal by Subject|2|||
162977399|NCT00939627|588618701|FG001|Overall Study|Withdrawal by Subject|4|||
162977400|NCT00939627|588618702|FG002|Overall Study|Withdrawal by Subject|0|||
162977401|NCT00939627|588618700|FG000|Overall Study|Other complicating disease|1|||
162977402|NCT00939627|588618701|FG001|Overall Study|Other complicating disease|1|||
162977403|NCT00939627|588618702|FG002|Overall Study|Other complicating disease|0|||
162977404|NCT00939627|588618700|FG000|Overall Study|Not compliant|2|||
162977405|NCT00939627|588618701|FG001|Overall Study|Not compliant|0|||
162977406|NCT00939627|588618702|FG002|Overall Study|Not compliant|0|||
162977407|NCT00939627|588618700|FG000|Overall Study|No off-tx reason given|0|||
162977408|NCT00939627|588618701|FG001|Overall Study|No off-tx reason given|2|||
162977409|NCT00939627|588618702|FG002|Overall Study|No off-tx reason given|0|||
162977410|NCT03417830|588618705|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
162977411|NCT03417830|588618706|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
162977412|NCT02563769|588618707|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
162977413|NCT02563769|588618708|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
162977414|NCT02563769|588618709|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
162977415|NCT00303667|588618721|FG000|Overall Study|Death|0|||
162977416|NCT00303667|588618722|FG001|Overall Study|Death|4|||
162977417|NCT00724373|588618723|FG000|Overall Study|Adverse Event|41|||
162977418|NCT00724373|588618723|FG000|Overall Study|Lack of Efficacy|82|||
162630824|NCT03129100|587365181|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630825|NCT03129100|587365182|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162977419|NCT00724373|588618723|FG000|Overall Study|Lost to Follow-up|7|||
162977420|NCT00724373|588618723|FG000|Overall Study|Non-compliance|2|||
162977421|NCT00724373|588618723|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
162712941|NCT03102710|587660813|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
162712942|NCT03102710|587660814|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
162712943|NCT03102710|587660812|FG000|Overall Study|Technical issues during final MRI scan|0|||
162712944|NCT03102710|587660813|FG001|Overall Study|Technical issues during final MRI scan|1|||
162712945|NCT03102710|587660814|FG002|Overall Study|Technical issues during final MRI scan|0|||
162712946|NCT03102710|587660812|FG000|Overall Study|Nausea during MRI scan|0|||
162712947|NCT03102710|587660813|FG001|Overall Study|Nausea during MRI scan|1|||
162712948|NCT03102710|587660814|FG002|Overall Study|Nausea during MRI scan|0|||
162712949|NCT03102710|587660812|FG000|Overall Study|Subject unable to attend final session|0|||
162712950|NCT03102710|587660813|FG001|Overall Study|Subject unable to attend final session|1|||
162712951|NCT03102710|587660814|FG002|Overall Study|Subject unable to attend final session|0|||
162712952|NCT01368406|587660815|FG000|Overall Study|Lost to Follow-up|8|||
162712953|NCT01368406|587660816|FG001|Overall Study|Lost to Follow-up|4|||
162712954|NCT01368406|587660815|FG000|Overall Study|Withdrawal by Subject|8|||
162712955|NCT01368406|587660816|FG001|Overall Study|Withdrawal by Subject|4|||
162712956|NCT01368406|587660815|FG000|Overall Study|relapse of the disease|3|||
162712957|NCT01368406|587660816|FG001|Overall Study|relapse of the disease|2|||
162712958|NCT01368406|587660815|FG000|Overall Study|started working|2|||
162712959|NCT01368406|587660816|FG001|Overall Study|started working|3|||
162712960|NCT04304534|587660817|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
162712961|NCT04304534|587660818|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
162712962|NCT04304534|587660819|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
162977422|NCT00724373|588618723|FG000|Overall Study|Participant moved away|1|||
162977423|NCT00724373|588618723|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
162977424|NCT00724373|588618723|FG000|Overall Study|Only to have 24 week regimen|1|||
162977425|NCT00724373|588618723|FG000|Overall Study|Viral Relapse|1|||
162977426|NCT00724373|588618723|FG000|Overall Study|Acute HCV infection|1|||
162977427|NCT00724373|588618723|FG000|Overall Study|Drug Relapse|1|||
162977428|NCT00724373|588618723|FG000|Overall Study|Tolerability|23|||
162977429|NCT02083926|588618724|FG000|Overall Study|Withdrawal by Subject|1|||
162977430|NCT02083926|588618725|FG001|Overall Study|Withdrawal by Subject|0|||
162977431|NCT00384176|588618726|FG000|Overall Study|Death|239|||
162977432|NCT00384176|588618727|FG001|Overall Study|Death|247|||
162977433|NCT00384176|588618728|FG002|Overall Study|Death|105|||
162977434|NCT00384176|588618726|FG000|Overall Study|Withdrawal by Subject|52|||
162977435|NCT00384176|588618727|FG001|Overall Study|Withdrawal by Subject|48|||
162977436|NCT00384176|588618728|FG002|Overall Study|Withdrawal by Subject|22|||
162977437|NCT00384176|588618726|FG000|Overall Study|Lost to Follow-up|16|||
162977438|NCT00384176|588618727|FG001|Overall Study|Lost to Follow-up|18|||
162977439|NCT00384176|588618728|FG002|Overall Study|Lost to Follow-up|4|||
162977440|NCT00384176|588618726|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
162977441|NCT00384176|588618727|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
162977442|NCT00384176|588618728|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
162977443|NCT00384176|588618726|FG000|Overall Study|Longer QTC as Visit 1|1|||
163058027|NCT03620162|588922823|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
162712963|NCT04304534|587660820|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
162712964|NCT04304534|587660817|FG000|Overall Study|Non-Compliance with study drug|0|||
162712965|NCT04304534|587660818|FG001|Overall Study|Non-Compliance with study drug|1|||
162712966|NCT04304534|587660819|FG002|Overall Study|Non-Compliance with study drug|1|||
162977444|NCT00384176|588618727|FG001|Overall Study|Longer QTC as Visit 1|0|||
162712967|NCT04304534|587660820|FG003|Overall Study|Non-Compliance with study drug|1|||
162712968|NCT04304534|587660817|FG000|Overall Study|Lost to Follow-up|0|||
162712969|NCT04304534|587660818|FG001|Overall Study|Lost to Follow-up|1|||
162712970|NCT04304534|587660819|FG002|Overall Study|Lost to Follow-up|2|||
162712971|NCT04304534|587660820|FG003|Overall Study|Lost to Follow-up|3|||
162712972|NCT04304534|587660817|FG000|Overall Study|Unspecific|4|||
162712973|NCT04304534|587660818|FG001|Overall Study|Unspecific|2|||
162712974|NCT04304534|587660819|FG002|Overall Study|Unspecific|2|||
162712975|NCT04304534|587660820|FG003|Overall Study|Unspecific|2|||
162712976|NCT04304534|587660817|FG000|Overall Study|Technical Problems|2|||
162712977|NCT04304534|587660818|FG001|Overall Study|Technical Problems|2|||
162712978|NCT04304534|587660819|FG002|Overall Study|Technical Problems|3|||
162712979|NCT04304534|587660820|FG003|Overall Study|Technical Problems|4|||
162712980|NCT04304534|587660817|FG000|Overall Study|Death|7|||
162712981|NCT04304534|587660818|FG001|Overall Study|Death|2|||
162712982|NCT04304534|587660819|FG002|Overall Study|Death|4|||
162712983|NCT04304534|587660820|FG003|Overall Study|Death|3|||
162712984|NCT04304534|587660817|FG000|Overall Study|Withdrawal by Subject|7|||
162712985|NCT04304534|587660818|FG001|Overall Study|Withdrawal by Subject|2|||
162712986|NCT04304534|587660819|FG002|Overall Study|Withdrawal by Subject|7|||
162712987|NCT04304534|587660820|FG003|Overall Study|Withdrawal by Subject|4|||
162712988|NCT04304534|587660817|FG000|Overall Study|Physician Decision|4|||
162712989|NCT04304534|587660818|FG001|Overall Study|Physician Decision|9|||
162712990|NCT04304534|587660819|FG002|Overall Study|Physician Decision|9|||
162712991|NCT04304534|587660820|FG003|Overall Study|Physician Decision|5|||
162712992|NCT04304534|587660817|FG000|Overall Study|Subject Decision|34|||
162712993|NCT04304534|587660818|FG001|Overall Study|Subject Decision|25|||
162712994|NCT04304534|587660819|FG002|Overall Study|Subject Decision|25|||
162712995|NCT04304534|587660820|FG003|Overall Study|Subject Decision|26|||
162712996|NCT04304534|587660817|FG000|Overall Study|Adverse Event|35|||
162712997|NCT04304534|587660818|FG001|Overall Study|Adverse Event|40|||
162712998|NCT04304534|587660819|FG002|Overall Study|Adverse Event|39|||
162712999|NCT04304534|587660820|FG003|Overall Study|Adverse Event|44|||
162713000|NCT04012853|587660821|FG000|Overall Study|Withdrawal by Subject|1|||
162713001|NCT04012853|587660822|FG001|Overall Study|Withdrawal by Subject|1|||
162713002|NCT04012853|587660821|FG000|Overall Study|Protocol Violation|1|||
162713003|NCT04012853|587660822|FG001|Overall Study|Protocol Violation|0|||
162713004|NCT04012853|587660821|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
162713005|NCT04012853|587660822|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
162713006|NCT01313182|587660823|FG000|Overall Study|Protocol Violation|66|||
162713007|NCT01313182|587660824|FG001|Overall Study|Protocol Violation|92|||
162713008|NCT01695317|587660825|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
162713009|NCT01695317|587660826|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
162713010|NCT01695317|587660825|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
162713011|NCT01695317|587660826|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
162713012|NCT00003656|587660827|FG000|Overall Study|Adverse Event|0|||
162713013|NCT00003656|587660828|FG001|Overall Study|Adverse Event|1|||
162713014|NCT00464672|587660829|FG000|Overall Study|withdrawal of consent|0|||
162977445|NCT00384176|588618728|FG002|Overall Study|Longer QTC as Visit 1|0|||
162977446|NCT00384176|588618726|FG000|Overall Study|Toxicity of treatment|1|||
162977447|NCT00384176|588618727|FG001|Overall Study|Toxicity of treatment|0|||
162977448|NCT00384176|588618728|FG002|Overall Study|Toxicity of treatment|0|||
162977449|NCT00384176|588618726|FG000|Overall Study|Did not receive study treatment|0|||
162977450|NCT00384176|588618727|FG001|Overall Study|Did not receive study treatment|1|||
162977451|NCT00384176|588618728|FG002|Overall Study|Did not receive study treatment|1|||
162977452|NCT00384176|588618726|FG000|Overall Study|Physician Decision|0|||
162977453|NCT00384176|588618727|FG001|Overall Study|Physician Decision|2|||
162977454|NCT00384176|588618728|FG002|Overall Study|Physician Decision|0|||
162977455|NCT00384176|588618726|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
162977456|NCT00384176|588618727|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
162977457|NCT00384176|588618728|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
163058028|NCT03620162|588922824|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
162713015|NCT00464672|587660830|FG001|Overall Study|withdrawal of consent|0|||
162713016|NCT00464672|587660831|FG002|Overall Study|withdrawal of consent|0|||
162713017|NCT00464672|587660832|FG003|Overall Study|withdrawal of consent|1|||
162977458|NCT00842530|588618729|FG000|Overall Study|Serious adverse event|0|||
162977459|NCT00842530|588618730|FG001|Overall Study|Serious adverse event|6|||
162713018|NCT00464672|587660833|FG004|Overall Study|withdrawal of consent|9|||
162713019|NCT00464672|587660834|FG005|Overall Study|withdrawal of consent|4|||
162713020|NCT00464672|587660829|FG000|Overall Study|Lost to Follow-up|25|||
162713021|NCT00464672|587660830|FG001|Overall Study|Lost to Follow-up|10|||
162713022|NCT00464672|587660831|FG002|Overall Study|Lost to Follow-up|0|||
162713023|NCT00464672|587660832|FG003|Overall Study|Lost to Follow-up|0|||
162713024|NCT00464672|587660833|FG004|Overall Study|Lost to Follow-up|1|||
162713025|NCT00464672|587660834|FG005|Overall Study|Lost to Follow-up|0|||
162630826|NCT03129100|587365183|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162977460|NCT00842530|588618729|FG000|Overall Study|Other adverse event|6|||
162977461|NCT00842530|588618730|FG001|Overall Study|Other adverse event|1|||
162977462|NCT00842530|588618729|FG000|Overall Study|Protocol Violation|32|||
162977463|NCT00842530|588618730|FG001|Overall Study|Protocol Violation|14|||
162977464|NCT00842530|588618729|FG000|Overall Study|Lost to Follow-up|6|||
162630827|NCT03129100|587365184|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162977465|NCT00842530|588618730|FG001|Overall Study|Lost to Follow-up|8|||
162977466|NCT00842530|588618729|FG000|Overall Study|Withdrawal by Subject|73|||
162977467|NCT00842530|588618730|FG001|Overall Study|Withdrawal by Subject|28|||
162977468|NCT02939950|588618731|FG000|Overall Study|Lost to Follow-up|13|||
162977469|NCT02939950|588618732|FG001|Overall Study|Lost to Follow-up|16|||
162977470|NCT02939950|588618731|FG000|Overall Study|Positive slit lamp findings|0|||
162977471|NCT02939950|588618732|FG001|Overall Study|Positive slit lamp findings|1|||
162977472|NCT02939950|588618731|FG000|Overall Study|Chalazion upper lid|0|||
162977473|NCT02939950|588618732|FG001|Overall Study|Chalazion upper lid|1|||
162977474|NCT02939950|588618731|FG000|Overall Study|Lack of motivation|0|||
162977475|NCT02939950|588618732|FG001|Overall Study|Lack of motivation|2|||
162977476|NCT02939950|588618731|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
162977477|NCT02939950|588618732|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
162977478|NCT02939950|588618731|FG000|Overall Study|Military orders|1|||
162977479|NCT02939950|588618732|FG001|Overall Study|Military orders|0|||
162977480|NCT02939950|588618731|FG000|Overall Study|Participant Relocated|5|||
162977481|NCT02939950|588618732|FG001|Overall Study|Participant Relocated|3|||
162977482|NCT02939950|588618731|FG000|Overall Study|Study related symptoms|8|||
162977483|NCT02939950|588618732|FG001|Overall Study|Study related symptoms|8|||
162977484|NCT02939950|588618731|FG000|Overall Study|Unacceptable lens movement|2|||
162977485|NCT02939950|588618732|FG001|Overall Study|Unacceptable lens movement|0|||
162977486|NCT02939950|588618731|FG000|Overall Study|Protocol Violation|6|||
162977487|NCT02939950|588618732|FG001|Overall Study|Protocol Violation|3|||
162630828|NCT03129100|587365185|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630829|NCT03129100|587365186|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630830|NCT03129100|587365187|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630831|NCT03129100|587365188|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630832|NCT03129100|587365189|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630833|NCT03129100|587365190|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630834|NCT03129100|587365191|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630835|NCT03129100|587365192|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162630836|NCT03129100|587365167|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630837|NCT03129100|587365168|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630838|NCT03129100|587365169|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630839|NCT03129100|587365170|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630840|NCT03129100|587365171|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630841|NCT03129100|587365172|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630842|NCT03129100|587365173|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162713026|NCT03055767|587660835|FG000|Open-Label Period|Lost to Follow-up|0|||
162713027|NCT03055767|587660836|FG001|Open-Label Period|Lost to Follow-up|0|||
162713028|NCT03055767|587660837|FG002|Open-Label Period|Lost to Follow-up|2|||
162713029|NCT03055767|587660838|FG003|Open-Label Period|Lost to Follow-up|0|||
162713030|NCT03055767|587660835|FG000|Open-Label Period|Withdrawal by Subject|0|||
162713031|NCT03055767|587660836|FG001|Open-Label Period|Withdrawal by Subject|0|||
162977488|NCT02939950|588618731|FG000|Overall Study|Physician Decision|2|||
162977489|NCT02939950|588618732|FG001|Overall Study|Physician Decision|0|||
162977490|NCT02939950|588618731|FG000|Overall Study|Pregnancy|6|||
162977491|NCT02939950|588618732|FG001|Overall Study|Pregnancy|7|||
162977492|NCT02939950|588618731|FG000|Overall Study|Withdrawal by Subject|12|||
162977493|NCT02939950|588618732|FG001|Overall Study|Withdrawal by Subject|28|||
162977494|NCT02939950|588618731|FG000|Overall Study|Adverse Event|7|||
162977495|NCT02939950|588618732|FG001|Overall Study|Adverse Event|3|||
162977496|NCT02939950|588618731|FG000|Overall Study|Randomized, not dispensed|1|||
163058029|NCT03620162|588922825|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
162630843|NCT03129100|587365174|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162713032|NCT03055767|587660837|FG002|Open-Label Period|Withdrawal by Subject|0|||
162977497|NCT02939950|588618732|FG001|Overall Study|Randomized, not dispensed|0|||
162977498|NCT02939950|588618731|FG000|Overall Study|Ineligible at Baseline|2|||
162977499|NCT02939950|588618732|FG001|Overall Study|Ineligible at Baseline|8|||
162977500|NCT02243293|588618733|FG000|Overall Study|Adverse Event|1|||
162977501|NCT02243293|588618734|FG001|Overall Study|Adverse Event|0|||
162977502|NCT02243293|588618735|FG002|Overall Study|Adverse Event|0|||
162977503|NCT02243293|588618736|FG003|Overall Study|Adverse Event|0|||
162977504|NCT02243293|588618737|FG004|Overall Study|Adverse Event|0|||
162977505|NCT02243293|588618738|FG005|Overall Study|Adverse Event|0|||
162977506|NCT02243293|588618739|FG006|Overall Study|Adverse Event|0|||
162977507|NCT02243293|588618740|FG007|Overall Study|Adverse Event|0|||
162713033|NCT03055767|587660838|FG003|Open-Label Period|Withdrawal by Subject|1|||
162977508|NCT02243293|588618741|FG008|Overall Study|Adverse Event|0|||
162977509|NCT02243293|588618742|FG009|Overall Study|Adverse Event|0|||
162977510|NCT02243293|588618743|FG010|Overall Study|Adverse Event|0|||
162977511|NCT02243293|588618744|FG011|Overall Study|Adverse Event|0|||
162977512|NCT02243293|588618745|FG012|Overall Study|Adverse Event|0|||
162977513|NCT02243293|588618746|FG013|Overall Study|Adverse Event|0|||
162977514|NCT02243293|588618747|FG014|Overall Study|Adverse Event|0|||
162977515|NCT02243293|588618748|FG015|Overall Study|Adverse Event|1|||
162713034|NCT02759731|587660841|FG000|Overall Study|Did not complete treatment.|8|||
162630844|NCT03129100|587365175|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630845|NCT03129100|587365176|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630846|NCT03129100|587365177|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630847|NCT03129100|587365178|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
162630848|NCT03129100|587365179|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
162630849|NCT03129100|587365180|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
162630850|NCT03129100|587365181|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
162630851|NCT03129100|587365182|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630852|NCT03129100|587365183|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630853|NCT03129100|587365184|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630854|NCT03129100|587365185|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630855|NCT03129100|587365186|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630856|NCT03129100|587365187|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630857|NCT03129100|587365188|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630858|NCT03129100|587365189|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630859|NCT03129100|587365190|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630860|NCT03129100|587365191|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630861|NCT03129100|587365192|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162630862|NCT03129100|587365167|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630863|NCT03129100|587365168|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630864|NCT03129100|587365169|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630865|NCT03129100|587365170|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630866|NCT03129100|587365171|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630867|NCT03129100|587365172|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630868|NCT03129100|587365173|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630869|NCT03129100|587365174|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630870|NCT03129100|587365175|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630871|NCT03129100|587365176|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630872|NCT03129100|587365177|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630873|NCT03129100|587365178|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162630874|NCT03129100|587365179|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630875|NCT03129100|587365180|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162630876|NCT03129100|587365181|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162630877|NCT03129100|587365182|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630878|NCT03129100|587365183|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630879|NCT03129100|587365184|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630880|NCT03129100|587365185|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630881|NCT03129100|587365186|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162977516|NCT02243293|588618749|FG016|Overall Study|Adverse Event|0|||
162977517|NCT02243293|588618750|FG017|Overall Study|Adverse Event|0|||
162977518|NCT02243293|588618751|FG018|Overall Study|Adverse Event|0|||
162977519|NCT02243293|588618752|FG019|Overall Study|Adverse Event|0|||
162977520|NCT02243293|588618753|FG020|Overall Study|Adverse Event|1|||
162977521|NCT02243293|588618754|FG021|Overall Study|Adverse Event|0|||
162977522|NCT02243293|588618733|FG000|Overall Study|Withdrawal by Subject|1|||
162977523|NCT02243293|588618734|FG001|Overall Study|Withdrawal by Subject|0|||
162977524|NCT02243293|588618735|FG002|Overall Study|Withdrawal by Subject|0|||
162977525|NCT02243293|588618736|FG003|Overall Study|Withdrawal by Subject|0|||
162977526|NCT02243293|588618737|FG004|Overall Study|Withdrawal by Subject|0|||
162977527|NCT02243293|588618738|FG005|Overall Study|Withdrawal by Subject|0|||
162977528|NCT02243293|588618739|FG006|Overall Study|Withdrawal by Subject|0|||
162977529|NCT02243293|588618740|FG007|Overall Study|Withdrawal by Subject|0|||
162977530|NCT02243293|588618741|FG008|Overall Study|Withdrawal by Subject|0|||
162977531|NCT02243293|588618742|FG009|Overall Study|Withdrawal by Subject|1|||
162977532|NCT02243293|588618743|FG010|Overall Study|Withdrawal by Subject|0|||
162977533|NCT02243293|588618744|FG011|Overall Study|Withdrawal by Subject|1|||
162977534|NCT02243293|588618745|FG012|Overall Study|Withdrawal by Subject|0|||
162977535|NCT02243293|588618746|FG013|Overall Study|Withdrawal by Subject|0|||
162977536|NCT02243293|588618747|FG014|Overall Study|Withdrawal by Subject|0|||
163058030|NCT03620162|588922826|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
163058031|NCT03620162|588922827|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
163058032|NCT04009837|588922830|FG000|Overall Study|Withdrawal by Subject|5|||
162630882|NCT03129100|587365187|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162977537|NCT02243293|588618748|FG015|Overall Study|Withdrawal by Subject|0|||
162977538|NCT02243293|588618749|FG016|Overall Study|Withdrawal by Subject|0|||
162977539|NCT02243293|588618750|FG017|Overall Study|Withdrawal by Subject|0|||
163058033|NCT04009837|588922831|FG001|Overall Study|Withdrawal by Subject|4|||
162977540|NCT02243293|588618751|FG018|Overall Study|Withdrawal by Subject|0|||
162977541|NCT02243293|588618752|FG019|Overall Study|Withdrawal by Subject|0|||
162977542|NCT02243293|588618753|FG020|Overall Study|Withdrawal by Subject|0|||
162977543|NCT02243293|588618754|FG021|Overall Study|Withdrawal by Subject|1|||
162977544|NCT02243293|588618733|FG000|Overall Study|Lost to Follow-up|0|||
162977545|NCT02243293|588618734|FG001|Overall Study|Lost to Follow-up|1|||
162977546|NCT02243293|588618735|FG002|Overall Study|Lost to Follow-up|1|||
162977547|NCT02243293|588618736|FG003|Overall Study|Lost to Follow-up|1|||
162977548|NCT02243293|588618737|FG004|Overall Study|Lost to Follow-up|0|||
162977549|NCT02243293|588618738|FG005|Overall Study|Lost to Follow-up|0|||
162977550|NCT02243293|588618739|FG006|Overall Study|Lost to Follow-up|3|||
162977551|NCT02243293|588618740|FG007|Overall Study|Lost to Follow-up|0|||
162977552|NCT02243293|588618741|FG008|Overall Study|Lost to Follow-up|0|||
162977553|NCT02243293|588618742|FG009|Overall Study|Lost to Follow-up|0|||
162977554|NCT02243293|588618743|FG010|Overall Study|Lost to Follow-up|0|||
162977555|NCT02243293|588618744|FG011|Overall Study|Lost to Follow-up|2|||
162977556|NCT02243293|588618745|FG012|Overall Study|Lost to Follow-up|0|||
162977557|NCT02243293|588618746|FG013|Overall Study|Lost to Follow-up|0|||
162977558|NCT02243293|588618747|FG014|Overall Study|Lost to Follow-up|0|||
162977559|NCT02243293|588618748|FG015|Overall Study|Lost to Follow-up|0|||
162977560|NCT02243293|588618749|FG016|Overall Study|Lost to Follow-up|3|||
162977561|NCT02243293|588618750|FG017|Overall Study|Lost to Follow-up|1|||
162977562|NCT02243293|588618751|FG018|Overall Study|Lost to Follow-up|0|||
162977563|NCT02243293|588618752|FG019|Overall Study|Lost to Follow-up|0|||
162977564|NCT02243293|588618753|FG020|Overall Study|Lost to Follow-up|1|||
162977565|NCT02243293|588618754|FG021|Overall Study|Lost to Follow-up|2|||
162977566|NCT02243293|588618733|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
162977567|NCT02243293|588618734|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
162977568|NCT02243293|588618735|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
162977569|NCT02243293|588618736|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
162977570|NCT02243293|588618737|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
162977571|NCT02243293|588618738|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
162977572|NCT02243293|588618739|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
162977573|NCT02243293|588618740|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
162977574|NCT02243293|588618741|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
162977575|NCT02243293|588618742|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
162977576|NCT02243293|588618743|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
162977577|NCT02243293|588618744|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
162977578|NCT02243293|588618745|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
162977579|NCT02243293|588618746|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
162977580|NCT02243293|588618747|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
162977581|NCT02243293|588618748|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
162977582|NCT02243293|588618749|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
162977583|NCT02243293|588618750|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
162977584|NCT02243293|588618751|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
162977585|NCT02243293|588618752|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
162977586|NCT02243293|588618753|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
162977587|NCT02243293|588618754|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
162630883|NCT03129100|587365188|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630884|NCT03129100|587365189|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630885|NCT03129100|587365190|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630886|NCT03129100|587365191|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630887|NCT03129100|587365192|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162630888|NCT03129100|587365167|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630889|NCT03129100|587365168|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630890|NCT03129100|587365169|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630891|NCT03129100|587365170|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630892|NCT03129100|587365171|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162977588|NCT02243293|588618733|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
162977589|NCT02243293|588618734|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
162977590|NCT02243293|588618735|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
162977591|NCT02243293|588618736|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
162977592|NCT02243293|588618737|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
162977593|NCT02243293|588618738|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
162977594|NCT02243293|588618739|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
162630893|NCT03129100|587365172|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630894|NCT03129100|587365173|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162977595|NCT02243293|588618740|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
162977596|NCT02243293|588618741|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
162977597|NCT02243293|588618742|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
162977598|NCT02243293|588618743|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
162977599|NCT02243293|588618744|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
162977600|NCT02243293|588618745|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
162977601|NCT02243293|588618746|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
162977602|NCT02243293|588618747|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
162977603|NCT02243293|588618748|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
162977604|NCT02243293|588618749|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
162977605|NCT02243293|588618750|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
162977606|NCT02243293|588618751|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
162977607|NCT02243293|588618752|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
162977608|NCT02243293|588618753|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
162977609|NCT02243293|588618754|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
162977610|NCT04117945|588618755|FG000|Overall Study|Death|1|||
162977611|NCT04117945|588618756|FG001|Overall Study|Death|0|||
162977612|NCT04117945|588618755|FG000|Overall Study|Withdrawal by Subject|3|||
162977613|NCT04117945|588618756|FG001|Overall Study|Withdrawal by Subject|1|||
162977614|NCT04117945|588618755|FG000|Overall Study|Disease Progression|0|||
162977615|NCT04117945|588618756|FG001|Overall Study|Disease Progression|2|||
162977616|NCT04117945|588618755|FG000|Overall Study|Ineligible|8|||
162977617|NCT04117945|588618756|FG001|Overall Study|Ineligible|7|||
162977618|NCT00402025|588618760|FG000|Overall Study|Adverse Event|0|||
162977619|NCT00402025|588618761|FG001|Overall Study|Adverse Event|0|||
162977620|NCT00402025|588618762|FG002|Overall Study|Adverse Event|2|||
162977621|NCT00402025|588618760|FG000|Overall Study|Death|0|||
162977622|NCT00402025|588618761|FG001|Overall Study|Death|1|||
162977623|NCT00402025|588618762|FG002|Overall Study|Death|5|||
162977624|NCT00402025|588618760|FG000|Overall Study|Disease Progression|1|||
162977625|NCT00402025|588618761|FG001|Overall Study|Disease Progression|1|||
162977626|NCT00402025|588618762|FG002|Overall Study|Disease Progression|2|||
162977627|NCT00402025|588618760|FG000|Overall Study|Physician Decision|1|||
162977628|NCT00402025|588618761|FG001|Overall Study|Physician Decision|1|||
162977629|NCT00402025|588618762|FG002|Overall Study|Physician Decision|0|||
162977630|NCT00402025|588618760|FG000|Overall Study|Participant Decision|0|||
162977631|NCT00402025|588618761|FG001|Overall Study|Participant Decision|0|||
162977632|NCT00402025|588618762|FG002|Overall Study|Participant Decision|1|||
162977633|NCT01172821|588618797|FG000|Overall Study|Adverse Event|5|||
162977634|NCT01172821|588618798|FG001|Overall Study|Adverse Event|2|||
162977635|NCT01172821|588618799|FG002|Overall Study|Adverse Event|2|||
162977636|NCT01172821|588618800|FG003|Overall Study|Adverse Event|7|||
162977637|NCT01172821|588618797|FG000|Overall Study|Protocol Violation|0|||
162977638|NCT01172821|588618798|FG001|Overall Study|Protocol Violation|2|||
162977639|NCT01172821|588618799|FG002|Overall Study|Protocol Violation|1|||
162977640|NCT01172821|588618800|FG003|Overall Study|Protocol Violation|2|||
162977641|NCT01172821|588618797|FG000|Overall Study|Lost to Follow-up|4|||
162977642|NCT01172821|588618798|FG001|Overall Study|Lost to Follow-up|1|||
162977643|NCT01172821|588618799|FG002|Overall Study|Lost to Follow-up|2|||
162977644|NCT01172821|588618800|FG003|Overall Study|Lost to Follow-up|2|||
162977645|NCT01172821|588618797|FG000|Overall Study|Withdrawal by Subject|2|||
162977646|NCT01172821|588618798|FG001|Overall Study|Withdrawal by Subject|3|||
162977647|NCT01172821|588618799|FG002|Overall Study|Withdrawal by Subject|3|||
162977648|NCT01172821|588618800|FG003|Overall Study|Withdrawal by Subject|3|||
162977649|NCT01172821|588618797|FG000|Overall Study|Other|3|||
162977650|NCT01172821|588618798|FG001|Overall Study|Other|4|||
162977651|NCT01172821|588618799|FG002|Overall Study|Other|5|||
162977652|NCT01172821|588618800|FG003|Overall Study|Other|3|||
162977653|NCT02985879|588618801|FG000|Overall Study|Adverse Event|7|||
162977654|NCT02985879|588618802|FG001|Overall Study|Adverse Event|9|||
162977655|NCT02985879|588618803|FG002|Overall Study|Adverse Event|7|||
162977656|NCT02985879|588618801|FG000|Overall Study|Withdrew consent|6|||
162977657|NCT02985879|588618802|FG001|Overall Study|Withdrew consent|8|||
162977658|NCT02985879|588618803|FG002|Overall Study|Withdrew consent|10|||
162977659|NCT02985879|588618801|FG000|Overall Study|Lost to Follow-up|1|||
162977660|NCT02985879|588618802|FG001|Overall Study|Lost to Follow-up|0|||
162977661|NCT02985879|588618803|FG002|Overall Study|Lost to Follow-up|2|||
162977662|NCT02985879|588618801|FG000|Overall Study|Other, not specified|62|||
162977663|NCT02985879|588618802|FG001|Overall Study|Other, not specified|58|||
162977664|NCT02985879|588618803|FG002|Overall Study|Other, not specified|58|||
162977665|NCT03940703|588620647|FG000|Overall Study|Still under treatment|31|||
162977666|NCT03940703|588620648|FG001|Overall Study|Still under treatment|0|||
162977667|NCT04079712|588620649|FG000|Overall Study|Disease progression before starting treatment|1|||
162977668|NCT02658487|588620650|FG000|Overall Study|Death|2|||
162977669|NCT02658487|588620650|FG000|Overall Study|Disease progression|10|||
162977670|NCT02658487|588620650|FG000|Overall Study|Alternative therapy|1|||
162977671|NCT02658487|588620650|FG000|Overall Study|Adverse Event|1|||
162977672|NCT02658487|588620650|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
162977673|NCT02658487|588620650|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
162977674|NCT02284347|588620660|FG000|Overall Study|Lost to Follow-up|2|||
162977675|NCT02284347|588620660|FG000|Overall Study|Withdrawn prior to treatment|1|||
163058034|NCT04009837|588922830|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
163058035|NCT04009837|588922831|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
163058036|NCT05569174|588922832|FG000|Overall Study|Adverse Event|0|||
163058037|NCT05569174|588922833|FG001|Overall Study|Adverse Event|1|||
163058038|NCT05569174|588922832|FG000|Overall Study|Lack of compliance|0|||
163058039|NCT05569174|588922833|FG001|Overall Study|Lack of compliance|1|||
163058040|NCT05569174|588922832|FG000|Overall Study|Withdrawal of consent|0|||
163058041|NCT05569174|588922833|FG001|Overall Study|Withdrawal of consent|1|||
163058042|NCT05569174|588922832|FG000|Overall Study|Participant wish|0|||
163058043|NCT05569174|588922833|FG001|Overall Study|Participant wish|1|||
163058044|NCT05569174|588922832|FG000|Overall Study|Lost to Follow-up|0|||
163058045|NCT05569174|588922833|FG001|Overall Study|Lost to Follow-up|1|||
163058046|NCT00112957|588922834|FG000|Overall Study|Progressive disease|18|||
163058047|NCT00112957|588922834|FG000|Overall Study|Physician Decision|1|||
163058048|NCT00961415|588922839|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
162630895|NCT03129100|587365174|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630896|NCT03129100|587365175|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630897|NCT03129100|587365176|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630898|NCT03129100|587365177|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630899|NCT03129100|587365178|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630900|NCT03129100|587365179|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630901|NCT03129100|587365180|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162977676|NCT01885182|588620661|FG000|Overall Study|Adverse Event|11|||
162977677|NCT01885182|588620662|FG001|Overall Study|Adverse Event|13|||
162977678|NCT01885182|588620661|FG000|Overall Study|Withdrawal by Subject|13|||
162977679|NCT01885182|588620662|FG001|Overall Study|Withdrawal by Subject|6|||
162977680|NCT01885182|588620661|FG000|Overall Study|Lost to Follow-up|2|||
162977681|NCT01885182|588620662|FG001|Overall Study|Lost to Follow-up|2|||
162977682|NCT01885182|588620661|FG000|Overall Study|Lack of Efficacy|8|||
162977683|NCT01885182|588620662|FG001|Overall Study|Lack of Efficacy|1|||
162977684|NCT00380692|588620665|FG000|Study Period II - Double Blind|Adverse Event|1|||
162977685|NCT00380692|588620666|FG001|Study Period II - Double Blind|Adverse Event|0|||
162977686|NCT00380692|588620665|FG000|Study Period II - Double Blind|Protocol Violation|2|||
162977687|NCT00380692|588620666|FG001|Study Period II - Double Blind|Protocol Violation|2|||
162977688|NCT00380692|588620665|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
162977689|NCT00380692|588620666|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
162977690|NCT00380692|588620665|FG000|Study Period II - Double Blind|Physician Decision|0|||
162977691|NCT00380692|588620666|FG001|Study Period II - Double Blind|Physician Decision|1|||
162977692|NCT00380692|588620665|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
162977693|NCT00380692|588620666|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
162977694|NCT00380692|588620665|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
162977695|NCT00380692|588620666|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
162977696|NCT00380692|588620665|FG000|Study Period III - Open Label|Adverse Event|5|||
162977697|NCT00380692|588620666|FG001|Study Period III - Open Label|Adverse Event|3|||
162977698|NCT00380692|588620665|FG000|Study Period III - Open Label|Protocol Violation|0|||
162977699|NCT00380692|588620666|FG001|Study Period III - Open Label|Protocol Violation|0|||
162977700|NCT00380692|588620665|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
162977701|NCT00380692|588620666|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
162977702|NCT00380692|588620665|FG000|Study Period III - Open Label|Physician Decision|0|||
162977703|NCT00380692|588620666|FG001|Study Period III - Open Label|Physician Decision|3|||
162977704|NCT00380692|588620665|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
162977705|NCT00380692|588620666|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
162977706|NCT00380692|588620665|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
162977707|NCT00380692|588620666|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
162977708|NCT04507126|588620667|FG000|Overall Study|Withdrawal by Subject|3|||
162977709|NCT04507126|588620667|FG000|Overall Study|Protocol Violation|4|||
162977710|NCT00708708|588620668|FG000|Overall Study|Another therapy instead of Enbrel|141|||
162977711|NCT00708708|588620668|FG000|Overall Study|Lost to Follow-up|52|||
162977712|NCT00708708|588620668|FG000|Overall Study|Withdrawal by Subject|51|||
162977713|NCT00708708|588620668|FG000|Overall Study|Intolerance|42|||
163058049|NCT00961415|588922840|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
163058050|NCT00961415|588922841|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
163058051|NCT00961415|588922839|FG000|Induction Treatment Phase|Death|77|||
163058052|NCT00961415|588922840|FG001|Induction Treatment Phase|Death|0|||
163058053|NCT00961415|588922841|FG002|Induction Treatment Phase|Death|0|||
163058054|NCT00961415|588922839|FG000|Induction Treatment Phase|Protocol Violation|1|||
162977714|NCT00708708|588620668|FG000|Overall Study|Another therapy along with Enbrel|15|||
162977715|NCT00708708|588620668|FG000|Overall Study|Other unspecified|11|||
162977716|NCT00708708|588620668|FG000|Overall Study|Good effectiveness|9|||
162977717|NCT00708708|588620668|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
162977718|NCT00708708|588620668|FG000|Overall Study|Administrative reasons|7|||
162977719|NCT00708708|588620668|FG000|Overall Study|Lack of effectiveness|4|||
162977720|NCT00708708|588620668|FG000|Overall Study|Lack of compliance|3|||
162977721|NCT00708708|588620668|FG000|Overall Study|Pregnancy|3|||
162977722|NCT00708708|588620668|FG000|Overall Study|Adverse Event|3|||
162977723|NCT00708708|588620668|FG000|Overall Study|Missing values|392|||
162977724|NCT04213209|588620669|FG000|Overall Study|Protocol Violation|1|||
162977725|NCT04213209|588620670|FG001|Overall Study|Protocol Violation|0|||
162977726|NCT04213209|588620671|FG002|Overall Study|Protocol Violation|0|||
162977727|NCT04213209|588620672|FG003|Overall Study|Protocol Violation|0|||
162977728|NCT04213209|588620673|FG004|Overall Study|Protocol Violation|0|||
162977729|NCT04213209|588620674|FG005|Overall Study|Protocol Violation|0|||
162977730|NCT02065713|588620675|FG000|Overall Study|Adverse Event|0|||
162977731|NCT02065713|588620676|FG001|Overall Study|Adverse Event|1|||
162977732|NCT02065713|588620675|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162977733|NCT02065713|588620676|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162977734|NCT00140413|588620677|FG000|Overall Study|Lost to Follow-up|1|||
162977735|NCT00140413|588620678|FG001|Overall Study|Lost to Follow-up|0|||
162977736|NCT00140413|588620677|FG000|Overall Study|Withdrawal by Subject|2|||
162977737|NCT00140413|588620678|FG001|Overall Study|Withdrawal by Subject|0|||
162977738|NCT02459665|588620679|FG000|Overall Study|Withdrawal by Subject|0|||
162977739|NCT02459665|588620680|FG001|Overall Study|Withdrawal by Subject|1|||
162977740|NCT02459665|588620681|FG002|Overall Study|Withdrawal by Subject|1|||
162977741|NCT02459665|588620682|FG003|Overall Study|Withdrawal by Subject|2|||
162977742|NCT00865098|588620686|FG000|Overall Study|Progressive disease|1|||
162977743|NCT01014624|588620687|FG000|Overall Study|Adverse Event|0|||
162977744|NCT01014624|588620688|FG001|Overall Study|Adverse Event|1|||
162977745|NCT01014624|588620687|FG000|Overall Study|Protocol Violation|1|||
162977746|NCT01014624|588620688|FG001|Overall Study|Protocol Violation|0|||
162977747|NCT01014624|588620687|FG000|Overall Study|Withdrawal by Subject|1|||
162977748|NCT01014624|588620688|FG001|Overall Study|Withdrawal by Subject|0|||
162977749|NCT05560763|588620703|FG000|Overall Study|Withdrawal by Subject|4|||
162977750|NCT00296491|588620706|FG000|Overall Study|Low Pollen Counts|18|||
162977751|NCT00296491|588620707|FG001|Overall Study|Low Pollen Counts|26|||
162977752|NCT00296491|588620708|FG002|Overall Study|Low Pollen Counts|25|||
162977753|NCT00296491|588620709|FG003|Overall Study|Low Pollen Counts|16|||
162977754|NCT00296491|588620706|FG000|Overall Study|Protocol Violation|4|||
162977755|NCT00296491|588620707|FG001|Overall Study|Protocol Violation|6|||
162977756|NCT00296491|588620708|FG002|Overall Study|Protocol Violation|2|||
162977757|NCT00296491|588620709|FG003|Overall Study|Protocol Violation|3|||
162977758|NCT00296491|588620706|FG000|Overall Study|Adverse Event|1|||
162977759|NCT00296491|588620707|FG001|Overall Study|Adverse Event|3|||
162977760|NCT00296491|588620708|FG002|Overall Study|Adverse Event|1|||
162977761|NCT00296491|588620709|FG003|Overall Study|Adverse Event|4|||
162977762|NCT00296491|588620706|FG000|Overall Study|Withdrawn due to Asthma|0|||
162977763|NCT00296491|588620707|FG001|Overall Study|Withdrawn due to Asthma|0|||
162977764|NCT00296491|588620708|FG002|Overall Study|Withdrawn due to Asthma|0|||
162977765|NCT00296491|588620709|FG003|Overall Study|Withdrawn due to Asthma|4|||
162977766|NCT00296491|588620706|FG000|Overall Study|Withdrawal by Subject|7|||
162977767|NCT00296491|588620707|FG001|Overall Study|Withdrawal by Subject|3|||
162977768|NCT00296491|588620708|FG002|Overall Study|Withdrawal by Subject|3|||
162977769|NCT00296491|588620709|FG003|Overall Study|Withdrawal by Subject|2|||
162977770|NCT00296491|588620706|FG000|Overall Study|Non-Compliance|12|||
162977771|NCT00296491|588620707|FG001|Overall Study|Non-Compliance|13|||
162977772|NCT00296491|588620708|FG002|Overall Study|Non-Compliance|10|||
162977773|NCT00296491|588620709|FG003|Overall Study|Non-Compliance|14|||
162977774|NCT00296491|588620706|FG000|Overall Study|Lost to Follow-up|0|||
162977775|NCT00296491|588620707|FG001|Overall Study|Lost to Follow-up|2|||
162977776|NCT00296491|588620708|FG002|Overall Study|Lost to Follow-up|2|||
162977777|NCT00296491|588620709|FG003|Overall Study|Lost to Follow-up|0|||
162977778|NCT01929395|588620714|FG000|Overall Study|Did not complete - non-related toxicity|1|||
162977779|NCT01929395|588620715|FG001|Overall Study|Did not complete - non-related toxicity|0|||
162977780|NCT01929395|588620716|FG002|Overall Study|Did not complete - non-related toxicity|0|||
162977781|NCT01929395|588620714|FG000|Overall Study|Withdrawal by Subject|0|||
162977782|NCT01929395|588620715|FG001|Overall Study|Withdrawal by Subject|1|||
162977783|NCT01929395|588620716|FG002|Overall Study|Withdrawal by Subject|0|||
162977784|NCT01929395|588620714|FG000|Overall Study|Screen Fail|0|||
162977785|NCT01929395|588620715|FG001|Overall Study|Screen Fail|0|||
162977786|NCT01929395|588620716|FG002|Overall Study|Screen Fail|1|||
162977787|NCT00484419|588620718|FG000|Overall Study|Adverse Event|3|||
162977788|NCT00484419|588620719|FG001|Overall Study|Adverse Event|0|||
162977789|NCT00484419|588620720|FG002|Overall Study|Adverse Event|0|||
162977790|NCT00484419|588620718|FG000|Overall Study|Lost to Follow-up|1|||
162977791|NCT00484419|588620719|FG001|Overall Study|Lost to Follow-up|0|||
162977792|NCT00484419|588620720|FG002|Overall Study|Lost to Follow-up|2|||
162977793|NCT00484419|588620718|FG000|Overall Study|Withdrawal by Subject|3|||
162977794|NCT00484419|588620719|FG001|Overall Study|Withdrawal by Subject|1|||
162977795|NCT00484419|588620720|FG002|Overall Study|Withdrawal by Subject|1|||
162977796|NCT00484419|588620718|FG000|Overall Study|subject met discontinuation criteria|2|||
162977797|NCT00484419|588620719|FG001|Overall Study|subject met discontinuation criteria|2|||
162977798|NCT00484419|588620720|FG002|Overall Study|subject met discontinuation criteria|4|||
162977799|NCT00484419|588620718|FG000|Overall Study|required restricted medication|1|||
162977800|NCT00484419|588620719|FG001|Overall Study|required restricted medication|0|||
162630902|NCT03129100|587365181|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630903|NCT03129100|587365182|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
162630904|NCT03129100|587365183|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630905|NCT03129100|587365184|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630906|NCT03129100|587365185|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630907|NCT03129100|587365186|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162977801|NCT00484419|588620720|FG002|Overall Study|required restricted medication|1|||
162977802|NCT00484419|588620718|FG000|Overall Study|Physician Decision|1|||
162977803|NCT00484419|588620719|FG001|Overall Study|Physician Decision|1|||
162977804|NCT00484419|588620720|FG002|Overall Study|Physician Decision|1|||
162977805|NCT00484419|588620718|FG000|Overall Study|subject unable to receive medication|1|||
162977806|NCT00484419|588620719|FG001|Overall Study|subject unable to receive medication|0|||
162977807|NCT00484419|588620720|FG002|Overall Study|subject unable to receive medication|0|||
162977808|NCT00484419|588620718|FG000|Overall Study|subject relocated|0|||
162977809|NCT00484419|588620719|FG001|Overall Study|subject relocated|1|||
162977810|NCT00484419|588620720|FG002|Overall Study|subject relocated|0|||
162977811|NCT00484419|588620718|FG000|Overall Study|sponsor decision, randomized in error|0|||
162977812|NCT00484419|588620719|FG001|Overall Study|sponsor decision, randomized in error|0|||
162977813|NCT00484419|588620720|FG002|Overall Study|sponsor decision, randomized in error|2|||
162977814|NCT03604341|588620721|FG000|Overall Study|Withdrawal by Subject|1|||
162977815|NCT03604341|588620722|FG001|Overall Study|Withdrawal by Subject|1|||
162977816|NCT03604341|588620721|FG000|Overall Study|Adverse Event|1|||
162977817|NCT03604341|588620722|FG001|Overall Study|Adverse Event|0|||
162977818|NCT03604341|588620721|FG000|Overall Study|Protocol Violation|0|||
162977819|NCT03604341|588620722|FG001|Overall Study|Protocol Violation|1|||
162977820|NCT01829113|588620723|FG000|Overall Study|Disease Progression|37|||
162977821|NCT01829113|588620724|FG001|Overall Study|Disease Progression|48|||
162977822|NCT01829113|588620723|FG000|Overall Study|Adverse Event|14|||
162977823|NCT01829113|588620724|FG001|Overall Study|Adverse Event|10|||
162977824|NCT01829113|588620723|FG000|Overall Study|Withdrawal by Subject|17|||
162977825|NCT01829113|588620724|FG001|Overall Study|Withdrawal by Subject|10|||
162977826|NCT01829113|588620723|FG000|Overall Study|Death|4|||
162977827|NCT01829113|588620724|FG001|Overall Study|Death|6|||
162977828|NCT01829113|588620723|FG000|Overall Study|Sponsor Decision|1|||
162977829|NCT01829113|588620724|FG001|Overall Study|Sponsor Decision|1|||
162977830|NCT01829113|588620723|FG000|Overall Study|No Study Treatment Received|3|||
162977831|NCT01829113|588620724|FG001|Overall Study|No Study Treatment Received|2|||
163058055|NCT00961415|588922840|FG001|Induction Treatment Phase|Protocol Violation|0|||
163058056|NCT00961415|588922841|FG002|Induction Treatment Phase|Protocol Violation|0|||
163058057|NCT00961415|588922839|FG000|Induction Treatment Phase|Physician Decision|2|||
163058058|NCT00961415|588922840|FG001|Induction Treatment Phase|Physician Decision|0|||
163058059|NCT00961415|588922841|FG002|Induction Treatment Phase|Physician Decision|0|||
163058060|NCT00961415|588922839|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
163058061|NCT00961415|588922840|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
163058062|NCT00961415|588922841|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
162630908|NCT03129100|587365187|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630909|NCT03129100|587365188|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630910|NCT03129100|587365189|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630911|NCT03129100|587365190|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630912|NCT03129100|587365191|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162630913|NCT03129100|587365192|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162977832|NCT01829113|588620723|FG000|Overall Study|Physician Decision|1|||
162977833|NCT01829113|588620724|FG001|Overall Study|Physician Decision|1|||
162977834|NCT01740791|588620725|FG000|Overall Study|Randomized but never treated|5|||
162977835|NCT01740791|588620726|FG001|Overall Study|Randomized but never treated|3|||
162977836|NCT01740791|588620727|FG002|Overall Study|Randomized but never treated|2|||
162977837|NCT01740791|588620728|FG003|Overall Study|Randomized but never treated|2|||
162977838|NCT01740791|588620729|FG004|Overall Study|Randomized but never treated|1|||
162713035|NCT00957229|587660847|FG000|Study Start|Adverse Event|0|||
162713036|NCT00957229|587660848|FG001|Study Start|Adverse Event|3|||
162977839|NCT01740791|588620730|FG005|Overall Study|Randomized but never treated|3|||
162977840|NCT01740791|588620725|FG000|Overall Study|Lost to Follow-up|2|||
162977841|NCT01740791|588620726|FG001|Overall Study|Lost to Follow-up|0|||
162630914|NCT03129100|587365167|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162977842|NCT01740791|588620727|FG002|Overall Study|Lost to Follow-up|2|||
162977843|NCT01740791|588620728|FG003|Overall Study|Lost to Follow-up|3|||
162977844|NCT01740791|588620729|FG004|Overall Study|Lost to Follow-up|2|||
162977845|NCT01740791|588620730|FG005|Overall Study|Lost to Follow-up|3|||
162977846|NCT01740791|588620725|FG000|Overall Study|Withdrew Consent|4|||
162977847|NCT01740791|588620726|FG001|Overall Study|Withdrew Consent|0|||
162977848|NCT01740791|588620727|FG002|Overall Study|Withdrew Consent|1|||
162713037|NCT00957229|587660847|FG000|Study Start|Disease Progression|1|||
162713038|NCT00957229|587660848|FG001|Study Start|Disease Progression|0|||
162713039|NCT00957229|587660847|FG000|Reallocated to or Continued Vismodegib|Death|1|||
162923969|NCT00440193|588422303|FG001|Treatment Period|Site closed by investigator|2|||
162923970|NCT00440193|588422302|FG000|Observational Period|Adverse Event|2|||
162923971|NCT00440193|588422303|FG001|Observational Period|Adverse Event|2|||
162923972|NCT00440193|588422302|FG000|Observational Period|Death|15|||
162923973|NCT00440193|588422303|FG001|Observational Period|Death|20|||
162923974|NCT00440193|588422302|FG000|Observational Period|Lost to Follow-up|12|||
162923975|NCT00440193|588422303|FG001|Observational Period|Lost to Follow-up|8|||
162923976|NCT00440193|588422302|FG000|Observational Period|Protocol Violation|1|||
162923977|NCT00440193|588422303|FG001|Observational Period|Protocol Violation|0|||
162923978|NCT00440193|588422302|FG000|Observational Period|Withdrawal by Subject|11|||
162923979|NCT00440193|588422303|FG001|Observational Period|Withdrawal by Subject|8|||
162923980|NCT00440193|588422302|FG000|Observational Period|Physician Decision|1|||
162923981|NCT00440193|588422303|FG001|Observational Period|Physician Decision|0|||
162923982|NCT00440193|588422302|FG000|Observational Period|Clinical endpoint reached|1|||
162923983|NCT00440193|588422303|FG001|Observational Period|Clinical endpoint reached|0|||
162923984|NCT00440193|588422302|FG000|Observational Period|Participant convenience|2|||
162923985|NCT00440193|588422303|FG001|Observational Period|Participant convenience|0|||
162923986|NCT00834366|588422304|FG000|Treatment Period 1|Adverse Event|1|||
162923987|NCT00834366|588422305|FG001|Treatment Period 1|Adverse Event|1|||
162923988|NCT03409328|588422311|FG000|Overall Study|Lost to Follow-up|6|||
162923989|NCT03409328|588422312|FG001|Overall Study|Lost to Follow-up|3|||
162923990|NCT00478673|588422313|FG000|30-Days Post-Procedure|Death|2|||
162923991|NCT00478673|588422313|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
162923992|NCT00478673|588422313|FG000|30-Days Post-Procedure|Missed Visit|7|||
162923993|NCT00478673|588422313|FG000|12-Months Post-Procedure|Death|23|||
162713040|NCT00957229|587660848|FG001|Reallocated to or Continued Vismodegib|Death|1|||
162977849|NCT01740791|588620728|FG003|Overall Study|Withdrew Consent|2|||
162977850|NCT01740791|588620729|FG004|Overall Study|Withdrew Consent|0|||
162977851|NCT01740791|588620730|FG005|Overall Study|Withdrew Consent|3|||
162977852|NCT01740791|588620725|FG000|Overall Study|Investigator's discretion|1|||
162977853|NCT01740791|588620726|FG001|Overall Study|Investigator's discretion|0|||
162977854|NCT01740791|588620727|FG002|Overall Study|Investigator's discretion|1|||
162977855|NCT01740791|588620728|FG003|Overall Study|Investigator's discretion|0|||
162977856|NCT01740791|588620729|FG004|Overall Study|Investigator's discretion|0|||
162977857|NCT01740791|588620730|FG005|Overall Study|Investigator's discretion|1|||
162977858|NCT01740791|588620725|FG000|Overall Study|Adverse Event|0|||
162977859|NCT01740791|588620726|FG001|Overall Study|Adverse Event|0|||
162977860|NCT01740791|588620727|FG002|Overall Study|Adverse Event|0|||
162977861|NCT01740791|588620728|FG003|Overall Study|Adverse Event|0|||
162977862|NCT01740791|588620729|FG004|Overall Study|Adverse Event|0|||
162977863|NCT01740791|588620730|FG005|Overall Study|Adverse Event|1|||
162977864|NCT02674386|588620731|FG000|Overall Study|Lost to Follow-up|0|||
162977865|NCT02674386|588620732|FG001|Overall Study|Lost to Follow-up|1|||
162977866|NCT02674386|588620733|FG002|Overall Study|Lost to Follow-up|1|||
162977867|NCT02674386|588620731|FG000|Overall Study|Withdrawal by Subject|0|||
162977868|NCT02674386|588620732|FG001|Overall Study|Withdrawal by Subject|4|||
162977869|NCT02674386|588620733|FG002|Overall Study|Withdrawal by Subject|0|||
162977870|NCT02674386|588620731|FG000|Overall Study|Other|0|||
162977871|NCT02674386|588620732|FG001|Overall Study|Other|1|||
162977872|NCT02674386|588620733|FG002|Overall Study|Other|0|||
162977873|NCT02674386|588620731|FG000|Overall Study|Enrolled but not evaluated|0|||
162977874|NCT02674386|588620732|FG001|Overall Study|Enrolled but not evaluated|4|||
162977875|NCT02674386|588620733|FG002|Overall Study|Enrolled but not evaluated|0|||
162977876|NCT02462486|588620738|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162977877|NCT02462486|588620739|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
162977878|NCT02462486|588620740|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
162977879|NCT02462486|588620738|FG000|Overall Study|Adverse Event|53|||
162977880|NCT02462486|588620739|FG001|Overall Study|Adverse Event|48|||
162977881|NCT02462486|588620740|FG002|Overall Study|Adverse Event|21|||
162977882|NCT02462486|588620738|FG000|Overall Study|Lack of Efficacy|6|||
162977883|NCT02462486|588620739|FG001|Overall Study|Lack of Efficacy|12|||
162977884|NCT02462486|588620740|FG002|Overall Study|Lack of Efficacy|3|||
162977885|NCT02462486|588620738|FG000|Overall Study|Lost to Follow-up|3|||
162977886|NCT02462486|588620739|FG001|Overall Study|Lost to Follow-up|4|||
162977887|NCT02462486|588620740|FG002|Overall Study|Lost to Follow-up|2|||
162977888|NCT02462486|588620738|FG000|Overall Study|Withdrawal by Subject|25|||
162977889|NCT02462486|588620739|FG001|Overall Study|Withdrawal by Subject|22|||
162977890|NCT02462486|588620740|FG002|Overall Study|Withdrawal by Subject|19|||
162977891|NCT02462486|588620738|FG000|Overall Study|Protocol Violation|3|||
162977892|NCT02462486|588620739|FG001|Overall Study|Protocol Violation|1|||
162977893|NCT02462486|588620740|FG002|Overall Study|Protocol Violation|1|||
162977894|NCT02462486|588620738|FG000|Overall Study|Reason not Specified|3|||
162977895|NCT02462486|588620739|FG001|Overall Study|Reason not Specified|4|||
162977896|NCT02462486|588620740|FG002|Overall Study|Reason not Specified|3|||
162977897|NCT04706507|588620741|FG000|Overall Study|Death|45|||
162977898|NCT04706507|588620742|FG001|Overall Study|Death|22|||
162977899|NCT04706507|588620741|FG000|Overall Study|Unable to adhere|0|||
162977900|NCT04706507|588620742|FG001|Overall Study|Unable to adhere|2|||
162977901|NCT04706507|588620741|FG000|Overall Study|Lost to Follow-up|13|||
162977902|NCT04706507|588620742|FG001|Overall Study|Lost to Follow-up|12|||
162977903|NCT04706507|588620741|FG000|Overall Study|Withdrawal of consent|1|||
162977904|NCT04706507|588620742|FG001|Overall Study|Withdrawal of consent|1|||
162977905|NCT04706507|588620741|FG000|Overall Study|Patient or LAR refuses further participation|0|||
162977906|NCT04706507|588620742|FG001|Overall Study|Patient or LAR refuses further participation|3|||
162977907|NCT00873119|588620747|FG000|Overall Study|Patient request|4|||
162977908|NCT00873119|588620748|FG001|Overall Study|Patient request|2|||
162977909|NCT00873119|588620747|FG000|Overall Study|Adverse Event|8|||
162977910|NCT00873119|588620748|FG001|Overall Study|Adverse Event|0|||
162977911|NCT00873119|588620747|FG000|Overall Study|Progressive disease|26|||
162977912|NCT00873119|588620748|FG001|Overall Study|Progressive disease|18|||
162977913|NCT00873119|588620747|FG000|Overall Study|Death|2|||
162977914|NCT00873119|588620748|FG001|Overall Study|Death|1|||
162977915|NCT00873119|588620747|FG000|Overall Study|Other|2|||
162977916|NCT00873119|588620748|FG001|Overall Study|Other|5|||
162977917|NCT00873119|588620747|FG000|Overall Study|Not treated|2|||
162977918|NCT00873119|588620748|FG001|Overall Study|Not treated|0|||
162977919|NCT03648879|588620749|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
162977920|NCT00285584|588620750|FG000|Month 3|Lost to Follow-up|3|||
162977921|NCT00285584|588620751|FG001|Month 3|Lost to Follow-up|3|||
163058063|NCT00961415|588922839|FG000|Induction Treatment Phase|Other Reason|5|||
163058064|NCT00961415|588922840|FG001|Induction Treatment Phase|Other Reason|0|||
162977922|NCT00285584|588620750|FG000|Month 3|Withdrawal by Subject|1|||
162977923|NCT00285584|588620751|FG001|Month 3|Withdrawal by Subject|0|||
162977924|NCT00285584|588620750|FG000|Month 6|Lost to Follow-up|0|||
162630915|NCT03129100|587365168|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630916|NCT03129100|587365169|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630917|NCT03129100|587365170|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630918|NCT03129100|587365171|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630919|NCT03129100|587365172|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630920|NCT03129100|587365173|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630921|NCT03129100|587365174|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630922|NCT03129100|587365175|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630923|NCT03129100|587365176|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630924|NCT03129100|587365177|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630925|NCT03129100|587365178|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630926|NCT03129100|587365179|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
162630927|NCT03129100|587365180|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630928|NCT03129100|587365181|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
162630929|NCT03129100|587365182|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
162630930|NCT03129100|587365183|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630931|NCT03129100|587365184|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630932|NCT03129100|587365185|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630933|NCT03129100|587365186|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630934|NCT03129100|587365187|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630935|NCT03129100|587365188|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630936|NCT03129100|587365189|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630937|NCT03129100|587365190|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630938|NCT03129100|587365191|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630939|NCT03129100|587365192|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162630940|NCT03129100|587365167|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630941|NCT03129100|587365168|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630942|NCT03129100|587365169|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630943|NCT03129100|587365170|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630944|NCT03129100|587365171|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630945|NCT03129100|587365172|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630946|NCT03129100|587365173|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630947|NCT03129100|587365174|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630948|NCT03129100|587365175|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630949|NCT03129100|587365176|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630950|NCT03129100|587365177|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630951|NCT03129100|587365178|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630952|NCT03129100|587365179|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630953|NCT03129100|587365180|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630954|NCT03129100|587365181|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630955|NCT03129100|587365182|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630956|NCT03129100|587365183|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630957|NCT03129100|587365184|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
162630958|NCT03129100|587365185|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630959|NCT03129100|587365186|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
162630960|NCT03129100|587365187|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630961|NCT03129100|587365188|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162977925|NCT00285584|588620751|FG001|Month 6|Lost to Follow-up|1|||
162977926|NCT01884688|588620752|FG000|Overall Study|Screen Failure|2|||
162977927|NCT04099641|588620753|FG000|Overall Study|Death|46|||
162977928|NCT04099641|588620754|FG001|Overall Study|Death|12|||
162977929|NCT04099641|588620753|FG000|Overall Study|Lost to Follow-up|1|||
162977930|NCT04099641|588620754|FG001|Overall Study|Lost to Follow-up|0|||
162977931|NCT04099641|588620753|FG000|Overall Study|Withdrawal by Subject|2|||
162977932|NCT04099641|588620754|FG001|Overall Study|Withdrawal by Subject|0|||
162977933|NCT02470091|588620756|FG000|Overall Study|Withdrawal by Subject|1|||
162977934|NCT02470091|588620757|FG001|Overall Study|Withdrawal by Subject|0|||
162977935|NCT02470091|588620756|FG000|Overall Study|Ineligible|0|||
162977936|NCT02470091|588620757|FG001|Overall Study|Ineligible|2|||
162977937|NCT01523587|588620758|FG000|Overall Study|Other than listed|5|||
162977938|NCT01523587|588620759|FG001|Overall Study|Other than listed|5|||
162977939|NCT01523587|588620758|FG000|Overall Study|Worsening of underlying cancer disease|19|||
162977940|NCT01523587|588620759|FG001|Overall Study|Worsening of underlying cancer disease|34|||
162630962|NCT03129100|587365189|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630963|NCT03129100|587365190|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630964|NCT03129100|587365191|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162977941|NCT01523587|588620758|FG000|Overall Study|Adverse Event|68|||
162977942|NCT01523587|588620759|FG001|Overall Study|Adverse Event|52|||
162977943|NCT01523587|588620758|FG000|Overall Study|Protocol Violation|5|||
162977944|NCT01523587|588620759|FG001|Overall Study|Protocol Violation|3|||
162977945|NCT01523587|588620758|FG000|Overall Study|Lost to Follow-up|2|||
162977946|NCT01523587|588620759|FG001|Overall Study|Lost to Follow-up|2|||
162977947|NCT01523587|588620758|FG000|Overall Study|Withdrawal by Subject|28|||
162977948|NCT01523587|588620759|FG001|Overall Study|Withdrawal by Subject|20|||
162977949|NCT01523587|588620758|FG000|Overall Study|Withdrew due to Progressive disease|265|||
162977950|NCT01523587|588620759|FG001|Overall Study|Withdrew due to Progressive disease|279|||
162977951|NCT01523587|588620758|FG000|Overall Study|Randomised but bot treated|6|||
162977952|NCT01523587|588620759|FG001|Overall Study|Randomised but bot treated|2|||
162977953|NCT02709486|588620760|FG000|Overall Study|Adverse Event|2|||
162977954|NCT02709486|588620761|FG001|Overall Study|Adverse Event|5|||
162977955|NCT02709486|588620762|FG002|Overall Study|Adverse Event|3|||
162977956|NCT02709486|588620760|FG000|Overall Study|Death|0|||
162977957|NCT02709486|588620761|FG001|Overall Study|Death|0|||
162977958|NCT02709486|588620762|FG002|Overall Study|Death|2|||
162977959|NCT02709486|588620760|FG000|Overall Study|Insufficient clinical response|7|||
162977960|NCT02709486|588620761|FG001|Overall Study|Insufficient clinical response|3|||
162977961|NCT02709486|588620762|FG002|Overall Study|Insufficient clinical response|3|||
162977962|NCT02709486|588620760|FG000|Overall Study|Lost to Follow-up|3|||
162977963|NCT02709486|588620761|FG001|Overall Study|Lost to Follow-up|2|||
162977964|NCT02709486|588620762|FG002|Overall Study|Lost to Follow-up|2|||
162977965|NCT02709486|588620760|FG000|Overall Study|Other|0|||
162977966|NCT02709486|588620761|FG001|Overall Study|Other|2|||
162977967|NCT02709486|588620762|FG002|Overall Study|Other|3|||
162977968|NCT02709486|588620760|FG000|Overall Study|Withdrawal by Subject|32|||
162977969|NCT02709486|588620761|FG001|Overall Study|Withdrawal by Subject|22|||
162977970|NCT02709486|588620762|FG002|Overall Study|Withdrawal by Subject|32|||
162977971|NCT00536484|588620767|FG000|Overall Study|Adverse Event|21|||
162977972|NCT00536484|588620768|FG001|Overall Study|Adverse Event|34|||
162977973|NCT00536484|588620767|FG000|Overall Study|Withdrawal by Subject|11|||
162977974|NCT00536484|588620768|FG001|Overall Study|Withdrawal by Subject|11|||
162977975|NCT00536484|588620767|FG000|Overall Study|Lost to Follow-up|8|||
162977976|NCT00536484|588620768|FG001|Overall Study|Lost to Follow-up|6|||
162977977|NCT00536484|588620767|FG000|Overall Study|Lack of Efficacy|16|||
162977978|NCT00536484|588620768|FG001|Overall Study|Lack of Efficacy|5|||
162977979|NCT00536484|588620767|FG000|Overall Study|Other|4|||
162977980|NCT00536484|588620768|FG001|Overall Study|Other|0|||
162977981|NCT00706355|588620769|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
162977982|NCT00706355|588620770|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977983|NCT00706355|588620771|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977984|NCT00706355|588620772|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162977985|NCT00706355|588620769|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
162977986|NCT00706355|588620770|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977987|NCT00706355|588620771|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977988|NCT00706355|588620772|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162977989|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977990|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
162977991|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977992|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
162977993|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977994|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
162977995|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977996|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162977997|NCT00706355|588620769|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162977998|NCT00706355|588620770|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
162977999|NCT00706355|588620771|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162978000|NCT00706355|588620772|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
162978001|NCT00706355|588620769|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978002|NCT00706355|588620770|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978003|NCT00706355|588620771|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
162978004|NCT00706355|588620772|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
162978005|NCT00706355|588620769|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978006|NCT00706355|588620770|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978007|NCT00706355|588620771|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
162978008|NCT00706355|588620772|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
162978009|NCT00706355|588620769|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
162978010|NCT00706355|588620770|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
162978011|NCT00706355|588620771|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
162978012|NCT00706355|588620772|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
162978013|NCT00706355|588620769|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978014|NCT00706355|588620770|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978015|NCT00706355|588620771|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
162978016|NCT00706355|588620772|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
162978017|NCT02549573|588620775|FG000|Overall Study|Withdrawal by Subject|0|||
162978018|NCT02549573|588620776|FG001|Overall Study|Withdrawal by Subject|2|||
162978019|NCT02549573|588620775|FG000|Overall Study|Protocol Violation|0|||
162978020|NCT02549573|588620776|FG001|Overall Study|Protocol Violation|1|||
162978021|NCT02610816|588620779|FG000|Phase 1|Withdrawal by Subject|2|||
162978022|NCT02610816|588620780|FG001|Phase 1|Withdrawal by Subject|6|||
162978023|NCT02610816|588620781|FG002|Phase 1|Withdrawal by Subject|0|||
162978024|NCT02610816|588620782|FG003|Phase 1|Withdrawal by Subject|0|||
162978025|NCT02610816|588620779|FG000|Phase 1|Lost to Follow-up|2|||
162978026|NCT02610816|588620780|FG001|Phase 1|Lost to Follow-up|1|||
162978027|NCT02610816|588620781|FG002|Phase 1|Lost to Follow-up|0|||
162978028|NCT02610816|588620782|FG003|Phase 1|Lost to Follow-up|0|||
162978029|NCT02610816|588620779|FG000|Phase 1|Physician Decision|0|||
162978030|NCT02610816|588620780|FG001|Phase 1|Physician Decision|1|||
162978031|NCT02610816|588620781|FG002|Phase 1|Physician Decision|0|||
162978032|NCT02610816|588620782|FG003|Phase 1|Physician Decision|0|||
162978033|NCT02610816|588620779|FG000|Phase 2|Withdrawal by Subject|0|||
162978034|NCT02610816|588620780|FG001|Phase 2|Withdrawal by Subject|0|||
162978035|NCT02610816|588620781|FG002|Phase 2|Withdrawal by Subject|9|||
162978036|NCT02610816|588620782|FG003|Phase 2|Withdrawal by Subject|3|||
162978037|NCT02610816|588620779|FG000|Phase 2|Lost to Follow-up|0|||
162978038|NCT02610816|588620780|FG001|Phase 2|Lost to Follow-up|0|||
162978039|NCT02610816|588620781|FG002|Phase 2|Lost to Follow-up|2|||
162978040|NCT02610816|588620782|FG003|Phase 2|Lost to Follow-up|0|||
162978041|NCT02610816|588620779|FG000|Phase 2|Physician Decision|0|||
162978042|NCT02610816|588620780|FG001|Phase 2|Physician Decision|0|||
162978043|NCT02610816|588620781|FG002|Phase 2|Physician Decision|0|||
162978044|NCT02610816|588620782|FG003|Phase 2|Physician Decision|2|||
162978045|NCT02610816|588620779|FG000|Phase 2|Pregnancy|0|||
162978046|NCT02610816|588620780|FG001|Phase 2|Pregnancy|0|||
162978047|NCT02610816|588620781|FG002|Phase 2|Pregnancy|0|||
162978048|NCT02610816|588620782|FG003|Phase 2|Pregnancy|1|||
162978049|NCT02691741|588620785|FG000|Overall Study|Adverse Event|0|||
162978050|NCT02691741|588620786|FG001|Overall Study|Adverse Event|2|||
162978051|NCT02691741|588620785|FG000|Overall Study|Lost to Follow-up|1|||
162978052|NCT02691741|588620786|FG001|Overall Study|Lost to Follow-up|0|||
162978053|NCT02691741|588620785|FG000|Overall Study|Physician Decision|0|||
162978054|NCT02691741|588620786|FG001|Overall Study|Physician Decision|1|||
162978055|NCT02691741|588620785|FG000|Overall Study|Withdrawal by Subject|0|||
162978056|NCT02691741|588620786|FG001|Overall Study|Withdrawal by Subject|4|||
162978057|NCT03465436|588620787|FG000|Period 1|Protocol Violation|0|||
162978058|NCT03465436|588620788|FG001|Period 1|Protocol Violation|0|||
162978059|NCT03465436|588620789|FG002|Period 1|Protocol Violation|1|||
162978060|NCT03465436|588620790|FG003|Period 1|Protocol Violation|0|||
162978061|NCT03465436|588620787|FG000|Period 2|Protocol Violation|0|||
162978062|NCT03465436|588620788|FG001|Period 2|Protocol Violation|1|||
162978063|NCT03465436|588620789|FG002|Period 2|Protocol Violation|0|||
162978064|NCT03465436|588620790|FG003|Period 2|Protocol Violation|0|||
162978065|NCT03465436|588620787|FG000|Period 3|Protocol Violation|1|||
162978066|NCT03465436|588620788|FG001|Period 3|Protocol Violation|1|||
162978067|NCT03465436|588620789|FG002|Period 3|Protocol Violation|0|||
162978068|NCT03465436|588620790|FG003|Period 3|Protocol Violation|0|||
162978069|NCT03465436|588620787|FG000|Period 4|Protocol Violation|0|||
162978070|NCT03465436|588620788|FG001|Period 4|Protocol Violation|0|||
162978071|NCT03465436|588620789|FG002|Period 4|Protocol Violation|1|||
162978072|NCT03465436|588620790|FG003|Period 4|Protocol Violation|0|||
162978073|NCT01425528|588620791|FG000|Overall Study|Withdrawal by Subject|1|||
162978074|NCT01425528|588620792|FG001|Overall Study|Withdrawal by Subject|1|||
162978075|NCT02697773|588620793|FG000|Overall Study|Adverse Event|2|||
162978076|NCT02697773|588620794|FG001|Overall Study|Adverse Event|1|||
162978077|NCT02697773|588620795|FG002|Overall Study|Adverse Event|2|||
162978078|NCT02697773|588620793|FG000|Overall Study|Death|0|||
162978079|NCT02697773|588620794|FG001|Overall Study|Death|0|||
162978080|NCT02697773|588620795|FG002|Overall Study|Death|2|||
162978081|NCT02697773|588620793|FG000|Overall Study|Lack of Efficacy|4|||
162978082|NCT02697773|588620794|FG001|Overall Study|Lack of Efficacy|6|||
162978083|NCT02697773|588620795|FG002|Overall Study|Lack of Efficacy|6|||
162978084|NCT02697773|588620793|FG000|Overall Study|Lost to Follow-up|5|||
162978085|NCT02697773|588620794|FG001|Overall Study|Lost to Follow-up|5|||
162978086|NCT02697773|588620795|FG002|Overall Study|Lost to Follow-up|7|||
162978087|NCT02697773|588620793|FG000|Overall Study|Other|15|||
162978088|NCT02697773|588620794|FG001|Overall Study|Other|11|||
162978089|NCT02697773|588620795|FG002|Overall Study|Other|10|||
162978090|NCT02697773|588620793|FG000|Overall Study|Protocol Violation|1|||
162978091|NCT02697773|588620794|FG001|Overall Study|Protocol Violation|1|||
162978092|NCT02697773|588620795|FG002|Overall Study|Protocol Violation|0|||
162978093|NCT02697773|588620793|FG000|Overall Study|Withdrawal by Subject|10|||
162978094|NCT02697773|588620794|FG001|Overall Study|Withdrawal by Subject|13|||
162978095|NCT02697773|588620795|FG002|Overall Study|Withdrawal by Subject|13|||
162978096|NCT02697773|588620793|FG000|Overall Study|Randomized but not treated|1|||
162978097|NCT02697773|588620794|FG001|Overall Study|Randomized but not treated|1|||
162630965|NCT03129100|587365192|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162630966|NCT03129100|587365167|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630967|NCT03129100|587365168|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630968|NCT03129100|587365169|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630969|NCT03129100|587365170|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630970|NCT03129100|587365171|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630971|NCT03129100|587365172|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630972|NCT03129100|587365173|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630973|NCT03129100|587365174|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630974|NCT03129100|587365175|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630975|NCT03129100|587365176|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630976|NCT03129100|587365177|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630977|NCT03129100|587365178|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630978|NCT03129100|587365179|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630979|NCT03129100|587365180|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630980|NCT03129100|587365181|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630981|NCT03129100|587365182|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630982|NCT03129100|587365183|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630983|NCT03129100|587365184|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630984|NCT03129100|587365185|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630985|NCT03129100|587365186|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630986|NCT03129100|587365187|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
162630987|NCT03129100|587365188|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630988|NCT03129100|587365189|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630989|NCT03129100|587365190|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630990|NCT03129100|587365191|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162630991|NCT03129100|587365192|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162978098|NCT02697773|588620795|FG002|Overall Study|Randomized but not treated|0|||
162978099|NCT00613834|588620796|FG000|Overall Study|Withdrawal by Subject|0|||
162978100|NCT00613834|588620797|FG001|Overall Study|Withdrawal by Subject|3|||
162978101|NCT02756637|588620798|FG000|Overall Study|Not eligible for initial SWOG study|10|||
162978102|NCT02756637|588620799|FG001|Overall Study|Not eligible for initial SWOG study|10|||
162978103|NCT02756637|588620798|FG000|Overall Study|No available NLR value|44|||
162978104|NCT02756637|588620799|FG001|Overall Study|No available NLR value|44|||
162978105|NCT02756637|588620798|FG000|Overall Study|Did not complete curative therapy|33|||
162978106|NCT02756637|588620799|FG001|Overall Study|Did not complete curative therapy|0|||
162978107|NCT01475253|588621652|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
162978108|NCT01475253|588621653|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
162978109|NCT01475253|588621654|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
162978110|NCT01475253|588621655|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
162978111|NCT01475253|588621652|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
162978112|NCT01475253|588621653|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
162978113|NCT01475253|588621654|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
162978114|NCT01475253|588621655|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
162978115|NCT03919448|588621661|FG000|Overall Study|Withdrawal by Subject|1|||
162978116|NCT03919448|588621662|FG001|Overall Study|Withdrawal by Subject|0|||
162978117|NCT03919448|588621663|FG002|Overall Study|Withdrawal by Subject|0|||
162978118|NCT01567826|588621671|FG000|Overall Study|Lost to Follow-up|3|||
162978119|NCT01567826|588621672|FG001|Overall Study|Lost to Follow-up|2|||
162978120|NCT03265288|588621675|FG000|Overall Study|Adverse Event|0|||
162978121|NCT03265288|588621676|FG001|Overall Study|Adverse Event|1|||
162978122|NCT03265288|588621675|FG000|Overall Study|Withdrawal by Subject|13|||
162978123|NCT03265288|588621676|FG001|Overall Study|Withdrawal by Subject|5|||
162978124|NCT03265288|588621675|FG000|Overall Study|Drug Withdrawn|3|||
162978125|NCT03265288|588621676|FG001|Overall Study|Drug Withdrawn|3|||
162978126|NCT03265288|588621675|FG000|Overall Study|Any Other Reason|7|||
162978127|NCT03265288|588621676|FG001|Overall Study|Any Other Reason|3|||
162978128|NCT04976621|588621693|FG000|Overall Study|Lost to Follow-up|2|||
162978129|NCT04976621|588621694|FG001|Overall Study|Lost to Follow-up|2|||
162978130|NCT04976621|588621693|FG000|Overall Study|Withdrawal by Subject|1|||
162978131|NCT04976621|588621694|FG001|Overall Study|Withdrawal by Subject|1|||
162978132|NCT01478828|588621695|FG000|Overall Study|Adverse Event|1|||
162978133|NCT01557842|588621696|FG000|Overall Study|Lost to Follow-up|0|||
162978134|NCT01557842|588621697|FG001|Overall Study|Lost to Follow-up|1|||
162978135|NCT01557842|588621696|FG000|Overall Study|Death|1|||
162978136|NCT01557842|588621697|FG001|Overall Study|Death|0|||
162630992|NCT03129100|587365167|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
162630993|NCT03129100|587365168|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
162630994|NCT03129100|587365169|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
162978137|NCT01557842|588621696|FG000|Overall Study|Lack of Efficacy|0|||
162978138|NCT01557842|588621697|FG001|Overall Study|Lack of Efficacy|1|||
162978139|NCT01557842|588621696|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
162978140|NCT01557842|588621697|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
162978141|NCT01557842|588621696|FG000|Overall Study|Study Terminated by Sponsor|3|||
162978142|NCT01557842|588621697|FG001|Overall Study|Study Terminated by Sponsor|4|||
162978143|NCT01557842|588621696|FG000|Overall Study|Not Ablated|2|||
162978144|NCT01557842|588621697|FG001|Overall Study|Not Ablated|0|||
162978145|NCT05611996|588621698|FG000|Overall Study|Ineligible|1|||
162978146|NCT05611996|588621698|FG000|Overall Study|Withdrawal by Subject|9|||
162630995|NCT03129100|587365170|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
162630996|NCT03129100|587365171|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
162630997|NCT03129100|587365172|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
162630998|NCT03129100|587365173|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
162630999|NCT03129100|587365174|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
162978147|NCT04479475|588621702|FG000|Overall Study|Withdrawal by Subject|7|||
162978148|NCT00619359|588621705|FG000|Overall Study|Adverse Event|32|||
162978149|NCT00619359|588621706|FG001|Overall Study|Adverse Event|36|||
162978150|NCT00619359|588621705|FG000|Overall Study|Lost to Follow-up|12|||
162978151|NCT00619359|588621706|FG001|Overall Study|Lost to Follow-up|16|||
162978152|NCT00619359|588621705|FG000|Overall Study|Physician Decision|0|||
162978153|NCT00619359|588621706|FG001|Overall Study|Physician Decision|7|||
162978154|NCT00619359|588621705|FG000|Overall Study|Protocol Violation|1|||
162978155|NCT00619359|588621706|FG001|Overall Study|Protocol Violation|1|||
162978156|NCT00619359|588621705|FG000|Overall Study|Withdrawal by Subject|19|||
162978157|NCT00619359|588621706|FG001|Overall Study|Withdrawal by Subject|20|||
162978158|NCT00619359|588621705|FG000|Overall Study|Progressive Disease|3|||
162978159|NCT00619359|588621706|FG001|Overall Study|Progressive Disease|1|||
162978160|NCT06972251|588621709|FG000|Overall Study|Withdrawal by Subject|1|||
162978161|NCT06972251|588621710|FG001|Overall Study|Withdrawal by Subject|0|||
162978162|NCT06972251|588621709|FG000|Overall Study|Lost to Follow-up|10|||
162978163|NCT06972251|588621710|FG001|Overall Study|Lost to Follow-up|2|||
162978164|NCT05575063|588621711|FG000|Overall Study|Withdrawal by Subject|1|||
162978165|NCT00949988|588621712|FG000|Overall Study|Withdrawal by Subject|3|||
162978166|NCT02654587|588621715|FG000|Overall Study|patient alive at end of study|22|||
162978167|NCT02654587|588621716|FG001|Overall Study|patient alive at end of study|8|||
162978168|NCT02654587|588621715|FG000|Overall Study|Withdrawal by Subject|1|||
162978169|NCT02654587|588621716|FG001|Overall Study|Withdrawal by Subject|7|||
162978170|NCT01825837|588621717|FG000|PART I|Withdrawal by Subject|0|||
162978171|NCT01825837|588621718|FG001|PART I|Withdrawal by Subject|0|||
162978172|NCT01825837|588621719|FG002|PART I|Withdrawal by Subject|0|||
162978173|NCT01825837|588621720|FG003|PART I|Withdrawal by Subject|6|||
162978174|NCT01825837|588621717|FG000|PART I|Patient non-compliance|0|||
162978175|NCT01825837|588621718|FG001|PART I|Patient non-compliance|0|||
162978176|NCT01825837|588621719|FG002|PART I|Patient non-compliance|0|||
162978177|NCT01825837|588621720|FG003|PART I|Patient non-compliance|1|||
162978178|NCT01825837|588621717|FG000|PART I|Treatment failure|0|||
162978179|NCT01825837|588621718|FG001|PART I|Treatment failure|0|||
162978180|NCT01825837|588621719|FG002|PART I|Treatment failure|0|||
162978181|NCT01825837|588621720|FG003|PART I|Treatment failure|7|||
162978182|NCT01825837|588621717|FG000|PART I|reason unspecified|0|||
162978183|NCT01825837|588621718|FG001|PART I|reason unspecified|0|||
162978184|NCT01825837|588621719|FG002|PART I|reason unspecified|0|||
162978185|NCT01825837|588621720|FG003|PART I|reason unspecified|3|||
162978186|NCT01825837|588621717|FG000|PART II|Withdrawal by Subject|3|||
162978187|NCT01825837|588621718|FG001|PART II|Withdrawal by Subject|3|||
162978188|NCT01825837|588621719|FG002|PART II|Withdrawal by Subject|7|||
162978189|NCT01825837|588621720|FG003|PART II|Withdrawal by Subject|0|||
162978190|NCT01825837|588621717|FG000|PART II|Patient non-compliance|5|||
162978191|NCT01825837|588621718|FG001|PART II|Patient non-compliance|2|||
162978192|NCT01825837|588621719|FG002|PART II|Patient non-compliance|4|||
162978193|NCT01825837|588621720|FG003|PART II|Patient non-compliance|0|||
162978194|NCT01825837|588621717|FG000|PART II|Adverse Event|3|||
162978195|NCT01825837|588621718|FG001|PART II|Adverse Event|3|||
162978196|NCT01825837|588621719|FG002|PART II|Adverse Event|1|||
162978197|NCT01825837|588621720|FG003|PART II|Adverse Event|0|||
162978198|NCT01825837|588621717|FG000|PART II|Treatment failure|6|||
162978199|NCT01825837|588621718|FG001|PART II|Treatment failure|4|||
162978200|NCT01825837|588621719|FG002|PART II|Treatment failure|5|||
162978201|NCT01825837|588621720|FG003|PART II|Treatment failure|0|||
162978202|NCT01825837|588621717|FG000|PART II|reason unspecified|2|||
162978203|NCT01825837|588621718|FG001|PART II|reason unspecified|2|||
162978204|NCT01825837|588621719|FG002|PART II|reason unspecified|2|||
162631000|NCT03129100|587365175|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
162978205|NCT01825837|588621720|FG003|PART II|reason unspecified|0|||
162978206|NCT00904748|588621723|FG000|Overall Study|Withdrawal by Subject|1|||
162978207|NCT00904748|588621724|FG001|Overall Study|Withdrawal by Subject|1|||
162978208|NCT00904748|588621725|FG002|Overall Study|Withdrawal by Subject|1|||
162978209|NCT00904748|588621726|FG003|Overall Study|Withdrawal by Subject|2|||
162978210|NCT00904748|588621727|FG004|Overall Study|Withdrawal by Subject|0|||
162978211|NCT00904748|588621728|FG005|Overall Study|Withdrawal by Subject|0|||
162978212|NCT00904748|588621723|FG000|Overall Study|Adverse Event|0|||
162978213|NCT00904748|588621724|FG001|Overall Study|Adverse Event|0|||
162978214|NCT00904748|588621725|FG002|Overall Study|Adverse Event|0|||
162978215|NCT00904748|588621726|FG003|Overall Study|Adverse Event|0|||
162978216|NCT00904748|588621727|FG004|Overall Study|Adverse Event|1|||
162978217|NCT00904748|588621728|FG005|Overall Study|Adverse Event|0|||
162978218|NCT01682148|588621729|FG000|Overall Study|Withdrawal by Subject|2|||
162978219|NCT01682148|588621730|FG001|Overall Study|Withdrawal by Subject|0|||
162978220|NCT01682148|588621729|FG000|Overall Study|Lost to Follow-up|1|||
162978221|NCT01682148|588621730|FG001|Overall Study|Lost to Follow-up|2|||
162978222|NCT01682148|588621729|FG000|Overall Study|Protocol Violation|1|||
162978223|NCT01682148|588621730|FG001|Overall Study|Protocol Violation|1|||
162978224|NCT01202877|588621731|FG000|Overall Study|Disease Progression|0|||
162978225|NCT01202877|588621732|FG001|Overall Study|Disease Progression|1|||
162978226|NCT01202877|588621733|FG002|Overall Study|Disease Progression|2|||
162978227|NCT01202877|588621731|FG000|Overall Study|Adverse Event|0|||
162978228|NCT01202877|588621732|FG001|Overall Study|Adverse Event|0|||
162978229|NCT01202877|588621733|FG002|Overall Study|Adverse Event|2|||
162978230|NCT01202877|588621731|FG000|Overall Study|Withdrawal by Subject|0|||
162978231|NCT01202877|588621732|FG001|Overall Study|Withdrawal by Subject|0|||
162978232|NCT01202877|588621733|FG002|Overall Study|Withdrawal by Subject|1|||
162978233|NCT01202877|588621731|FG000|Overall Study|Death|0|||
162978234|NCT01202877|588621732|FG001|Overall Study|Death|0|||
162978235|NCT01202877|588621733|FG002|Overall Study|Death|1|||
162978236|NCT00396331|588621734|FG000|Overall Study|Failed to mobilize - no transplant|8|||
162978237|NCT00396331|588621734|FG000|Overall Study|Did not go on to transplant|5|||
162978238|NCT00396331|588621734|FG000|Overall Study|Lost to Follow-up|3|||
162978239|NCT00396331|588621734|FG000|Overall Study|Death|16|||
162978240|NCT01029392|588621744|FG000|Overall Study|Withdrawal by Subject|18|||
162978241|NCT01029392|588621745|FG001|Overall Study|Withdrawal by Subject|11|||
162978242|NCT01029392|588621744|FG000|Overall Study|Physician Decision|2|||
162978243|NCT01029392|588621745|FG001|Overall Study|Physician Decision|0|||
162978244|NCT01103479|588621746|FG000|Overall Study|Up to date with CRC screening|1|||
162978245|NCT01103479|588621747|FG001|Overall Study|Up to date with CRC screening|9|||
162978246|NCT01103479|588621748|FG002|Overall Study|Up to date with CRC screening|12|||
162978247|NCT01103479|588621746|FG000|Overall Study|Family history of CRC|1|||
162978248|NCT01103479|588621747|FG001|Overall Study|Family history of CRC|0|||
162978249|NCT01103479|588621748|FG002|Overall Study|Family history of CRC|2|||
162978250|NCT01103479|588621746|FG000|Overall Study|Active cancer|1|||
162978251|NCT01103479|588621747|FG001|Overall Study|Active cancer|0|||
162978252|NCT01103479|588621748|FG002|Overall Study|Active cancer|0|||
162978253|NCT01103479|588621746|FG000|Overall Study|Saw non-study physician|2|||
162978254|NCT01103479|588621747|FG001|Overall Study|Saw non-study physician|0|||
162978255|NCT01103479|588621748|FG002|Overall Study|Saw non-study physician|0|||
162978256|NCT01298778|588621749|FG000|Overall Study|Lost to Follow-up|2|||
162978257|NCT01298778|588621750|FG001|Overall Study|Lost to Follow-up|3|||
162978258|NCT01298778|588621749|FG000|Overall Study|Incorrect use of VAS|1|||
162978259|NCT01298778|588621750|FG001|Overall Study|Incorrect use of VAS|0|||
162978260|NCT01298778|588621749|FG000|Overall Study|Withdrawal by Subject|0|||
162978261|NCT01298778|588621750|FG001|Overall Study|Withdrawal by Subject|1|||
162978262|NCT01298778|588621749|FG000|Overall Study|Protocol Violation|0|||
162978263|NCT01298778|588621750|FG001|Overall Study|Protocol Violation|1|||
162978264|NCT01298778|588621749|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
162978265|NCT01298778|588621750|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
162978266|NCT02377921|588621751|FG000|Overall Study|Subject non-compliance|1|||
162978267|NCT02377921|588621752|FG001|Overall Study|Subject non-compliance|1|||
162978268|NCT02443545|588621753|FG000|Overall Study|Adverse Event|1|||
162978269|NCT02443545|588621754|FG001|Overall Study|Adverse Event|1|||
162978270|NCT02443545|588621753|FG000|Overall Study|Lost to Follow-up|0|||
162978271|NCT02443545|588621754|FG001|Overall Study|Lost to Follow-up|2|||
162978272|NCT02443545|588621753|FG000|Overall Study|Physician Decision|3|||
162978273|NCT02443545|588621754|FG001|Overall Study|Physician Decision|0|||
162978274|NCT02443545|588621753|FG000|Overall Study|Protocol Violation|8|||
162978275|NCT02443545|588621754|FG001|Overall Study|Protocol Violation|1|||
162978276|NCT02443545|588621753|FG000|Overall Study|Pregnancy|1|||
162978277|NCT02443545|588621754|FG001|Overall Study|Pregnancy|1|||
162978278|NCT02443545|588621753|FG000|Overall Study|Withdrawal by Subject|6|||
162978279|NCT02443545|588621754|FG001|Overall Study|Withdrawal by Subject|3|||
162978280|NCT02443545|588621753|FG000|Overall Study|Termination of study|20|||
162978281|NCT02443545|588621754|FG001|Overall Study|Termination of study|11|||
162978282|NCT02139124|588621757|FG000|Overall Study|Adverse Event|2|||
162978283|NCT02139124|588621758|FG001|Overall Study|Adverse Event|0|||
163058065|NCT00961415|588922841|FG002|Induction Treatment Phase|Other Reason|0|||
162978284|NCT02139124|588621759|FG002|Overall Study|Adverse Event|1|||
162978285|NCT02139124|588621760|FG003|Overall Study|Adverse Event|2|||
162978286|NCT02139124|588621761|FG004|Overall Study|Adverse Event|5|||
162978287|NCT02139124|588621757|FG000|Overall Study|Withdrawal by Subject|2|||
162978288|NCT02139124|588621758|FG001|Overall Study|Withdrawal by Subject|2|||
162978289|NCT02139124|588621759|FG002|Overall Study|Withdrawal by Subject|2|||
162978290|NCT02139124|588621760|FG003|Overall Study|Withdrawal by Subject|2|||
162978291|NCT02139124|588621761|FG004|Overall Study|Withdrawal by Subject|3|||
162631001|NCT03129100|587365176|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
162631002|NCT03129100|587365177|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
162631003|NCT03129100|587365178|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
162631004|NCT03129100|587365179|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
162631005|NCT03129100|587365180|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
162631006|NCT03129100|587365181|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
162631007|NCT03129100|587365182|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
162978292|NCT02139124|588621757|FG000|Overall Study|Protocol Violation|0|||
162978293|NCT02139124|588621758|FG001|Overall Study|Protocol Violation|0|||
162978294|NCT02139124|588621759|FG002|Overall Study|Protocol Violation|0|||
162978295|NCT02139124|588621760|FG003|Overall Study|Protocol Violation|1|||
162631008|NCT03129100|587365183|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
162631009|NCT03129100|587365184|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
162631010|NCT03129100|587365185|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
162631011|NCT03129100|587365186|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
162631012|NCT03129100|587365187|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
162923994|NCT00478673|588422313|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
162923995|NCT00478673|588422313|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
162923996|NCT00478673|588422313|FG000|12-Months Post-Procedure|Missed Visit|25|||
162923997|NCT00478673|588422313|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
162923998|NCT03930615|588422314|FG000|Overall Study|Death|9|||
162923999|NCT03930615|588422315|FG001|Overall Study|Death|3|||
162924000|NCT03930615|588422314|FG000|Overall Study|Lost to Follow-up|1|||
162924001|NCT03930615|588422315|FG001|Overall Study|Lost to Follow-up|2|||
162924002|NCT03930615|588422314|FG000|Overall Study|Physician Decision|3|||
162924003|NCT03930615|588422315|FG001|Overall Study|Physician Decision|4|||
162924004|NCT03930615|588422314|FG000|Overall Study|Withdrawal by Subject|13|||
162924005|NCT03930615|588422315|FG001|Overall Study|Withdrawal by Subject|2|||
162924006|NCT03930615|588422314|FG000|Overall Study|Not treated|1|||
162924007|NCT03930615|588422315|FG001|Overall Study|Not treated|1|||
162924008|NCT02864953|588422316|FG000|Overall Study|Adverse Event|22|||
162924009|NCT02864953|588422317|FG001|Overall Study|Adverse Event|19|||
162924010|NCT02864953|588422316|FG000|Overall Study|Withdrawal by Subject|1|||
162924011|NCT02864953|588422317|FG001|Overall Study|Withdrawal by Subject|0|||
162924012|NCT02864953|588422316|FG000|Overall Study|Physician Decision|4|||
162924013|NCT02864953|588422317|FG001|Overall Study|Physician Decision|2|||
162924014|NCT02864953|588422316|FG000|Overall Study|Death|3|||
162924015|NCT02864953|588422317|FG001|Overall Study|Death|13|||
162924016|NCT02864953|588422316|FG000|Overall Study|Reason not specified|14|||
162924017|NCT02864953|588422317|FG001|Overall Study|Reason not specified|12|||
162924018|NCT02864953|588422316|FG000|Overall Study|Withdrew Prior to Dosing|9|||
162924019|NCT02864953|588422317|FG001|Overall Study|Withdrew Prior to Dosing|8|||
162924020|NCT00981019|588422318|FG000|Overall Study|Did not respond|65|||
162924021|NCT00981019|588422318|FG000|Overall Study|Did not match target population|94|||
162924022|NCT00981019|588422318|FG000|Overall Study|Inadvertent exclusion|239|||
162924023|NCT00981019|588422318|FG000|Overall Study|Hit the survey after closure|79|||
162924024|NCT00358670|588422319|FG000|Overall Study|Adverse Event|26|||
162924025|NCT00358670|588422320|FG001|Overall Study|Adverse Event|29|||
162924026|NCT00358670|588422319|FG000|Overall Study|Lack of Efficacy|20|||
162924027|NCT00358670|588422320|FG001|Overall Study|Lack of Efficacy|23|||
162924028|NCT00358670|588422319|FG000|Overall Study|Protocol Violation|6|||
162924029|NCT00358670|588422320|FG001|Overall Study|Protocol Violation|9|||
162924030|NCT00358670|588422319|FG000|Overall Study|Lost to Follow-up|4|||
162924031|NCT00358670|588422320|FG001|Overall Study|Lost to Follow-up|5|||
162924032|NCT00358670|588422319|FG000|Overall Study|Withdrawal by Subject|13|||
162924033|NCT00358670|588422320|FG001|Overall Study|Withdrawal by Subject|24|||
162924034|NCT00358670|588422319|FG000|Overall Study|Protocol Defined Clinical Event|0|||
162924035|NCT00358670|588422320|FG001|Overall Study|Protocol Defined Clinical Event|1|||
162924036|NCT00358670|588422319|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162924037|NCT00358670|588422320|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
162924038|NCT00358670|588422319|FG000|Overall Study|Administrative|153|||
162924039|NCT00358670|588422320|FG001|Overall Study|Administrative|125|||
162924040|NCT00865306|588422321|FG000|Controlled Trial|Lost to Follow-up|1|||
162924041|NCT00865306|588422322|FG001|Controlled Trial|Lost to Follow-up|1|||
162924042|NCT00865306|588422321|FG000|Controlled Trial|Difficulty commuting|2|||
162924043|NCT00865306|588422322|FG001|Controlled Trial|Difficulty commuting|0|||
162924044|NCT00865306|588422321|FG000|Controlled Trial|Improved btw baseline and first session|1|||
162924045|NCT00865306|588422322|FG001|Controlled Trial|Improved btw baseline and first session|0|||
162924046|NCT00865306|588422321|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
162924047|NCT00865306|588422322|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
162924048|NCT00865306|588422321|FG000|Controlled Trial|Withdrawal by Subject|0|||
162924049|NCT00865306|588422322|FG001|Controlled Trial|Withdrawal by Subject|1|||
162924050|NCT05083559|588422323|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
162924051|NCT05083559|588422324|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
162978296|NCT02139124|588621761|FG004|Overall Study|Protocol Violation|1|||
162978297|NCT02139124|588621757|FG000|Overall Study|non-compliant|1|||
162978298|NCT02139124|588621758|FG001|Overall Study|non-compliant|0|||
162978299|NCT02139124|588621759|FG002|Overall Study|non-compliant|0|||
162978300|NCT02139124|588621760|FG003|Overall Study|non-compliant|2|||
162978301|NCT02139124|588621761|FG004|Overall Study|non-compliant|0|||
162978302|NCT02139124|588621757|FG000|Overall Study|incarceration|0|||
162978303|NCT02139124|588621758|FG001|Overall Study|incarceration|0|||
162978304|NCT02139124|588621759|FG002|Overall Study|incarceration|1|||
162978305|NCT02139124|588621760|FG003|Overall Study|incarceration|0|||
162631013|NCT03129100|587365188|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
162631014|NCT03129100|587365189|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
162631015|NCT03129100|587365190|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
162631016|NCT03129100|587365191|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
162631017|NCT03129100|587365192|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
162631018|NCT03129100|587365167|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631019|NCT03129100|587365168|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631020|NCT03129100|587365169|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631021|NCT03129100|587365170|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631022|NCT03129100|587365171|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162978306|NCT02139124|588621761|FG004|Overall Study|incarceration|0|||
162978307|NCT02139124|588621757|FG000|Overall Study|subject moved|1|||
162978308|NCT02139124|588621758|FG001|Overall Study|subject moved|0|||
162978309|NCT02139124|588621759|FG002|Overall Study|subject moved|0|||
162978310|NCT02139124|588621760|FG003|Overall Study|subject moved|0|||
162978311|NCT02139124|588621761|FG004|Overall Study|subject moved|0|||
162978312|NCT02139124|588621757|FG000|Overall Study|Lost to Follow-up|3|||
162978313|NCT02139124|588621758|FG001|Overall Study|Lost to Follow-up|2|||
162978314|NCT02139124|588621759|FG002|Overall Study|Lost to Follow-up|0|||
162978315|NCT02139124|588621760|FG003|Overall Study|Lost to Follow-up|5|||
162978316|NCT02139124|588621761|FG004|Overall Study|Lost to Follow-up|4|||
162978317|NCT03821272|588623398|FG000|Overall Study|Death|1|||
162978318|NCT03821272|588623399|FG001|Overall Study|Death|0|||
162978319|NCT03821272|588623398|FG000|Overall Study|Physician Decision|1|||
162978320|NCT03821272|588623399|FG001|Overall Study|Physician Decision|0|||
162978321|NCT03821272|588623398|FG000|Overall Study|Withdrawal by Subject|1|||
162978322|NCT03821272|588623399|FG001|Overall Study|Withdrawal by Subject|0|||
162978323|NCT05904769|588623400|FG000|Overall Study|Physician Decision|0|||
162978324|NCT05904769|588623401|FG001|Overall Study|Physician Decision|6|||
162978325|NCT05626803|588623407|FG000|Overall Study|Lost to Follow-up|0|||
162978326|NCT05626803|588623408|FG001|Overall Study|Lost to Follow-up|1|||
162978327|NCT05626803|588623409|FG002|Overall Study|Lost to Follow-up|0|||
162978328|NCT05626803|588623410|FG003|Overall Study|Lost to Follow-up|0|||
162978329|NCT04974619|588623411|FG000|Overall Study|Lost to Follow-up|0|||
162978330|NCT04974619|588623412|FG001|Overall Study|Lost to Follow-up|0|||
162978331|NCT04974619|588623413|FG002|Overall Study|Lost to Follow-up|1|||
162978332|NCT04974619|588623411|FG000|Overall Study|Withdrawal by Subject|0|||
162978333|NCT04974619|588623412|FG001|Overall Study|Withdrawal by Subject|0|||
162978334|NCT04974619|588623413|FG002|Overall Study|Withdrawal by Subject|1|||
162978335|NCT04974619|588623411|FG000|Overall Study|Protocol Violation|0|||
162978336|NCT04974619|588623412|FG001|Overall Study|Protocol Violation|1|||
162978337|NCT04974619|588623413|FG002|Overall Study|Protocol Violation|0|||
162978338|NCT01688466|588623414|FG000|Overall Study|Withdrawal by Subject|2|||
162978339|NCT01688466|588623415|FG001|Overall Study|Withdrawal by Subject|1|||
162978340|NCT01688466|588623414|FG000|Overall Study|Death|0|||
162978341|NCT01688466|588623415|FG001|Overall Study|Death|1|||
162978342|NCT01688466|588623414|FG000|Overall Study|Adverse Event|0|||
162978343|NCT01688466|588623415|FG001|Overall Study|Adverse Event|4|||
162978344|NCT01688466|588623414|FG000|Overall Study|Not evaluable|0|||
162978345|NCT01688466|588623415|FG001|Overall Study|Not evaluable|1|||
162978346|NCT03310957|588623416|FG000|Overall Study|Withdrawal by Subject|1|||
162978347|NCT03310957|588623417|FG001|Overall Study|Withdrawal by Subject|1|||
163058066|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Death|0|||
162631023|NCT03129100|587365172|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631024|NCT03129100|587365173|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631025|NCT03129100|587365174|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631026|NCT03129100|587365175|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162978348|NCT03310957|588623418|FG002|Overall Study|Withdrawal by Subject|1|||
162978349|NCT03310957|588623419|FG003|Overall Study|Withdrawal by Subject|5|||
162978350|NCT03310957|588623420|FG004|Overall Study|Withdrawal by Subject|0|||
163058067|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Death|42|||
162978351|NCT03310957|588623421|FG005|Overall Study|Withdrawal by Subject|4|||
162978352|NCT03310957|588623422|FG006|Overall Study|Withdrawal by Subject|3|||
162978353|NCT03310957|588623416|FG000|Overall Study|Site Terminated|0|||
162978354|NCT03310957|588623417|FG001|Overall Study|Site Terminated|1|||
162978355|NCT03310957|588623418|FG002|Overall Study|Site Terminated|1|||
162978356|NCT03310957|588623419|FG003|Overall Study|Site Terminated|1|||
162978357|NCT03310957|588623420|FG004|Overall Study|Site Terminated|0|||
162978358|NCT03310957|588623421|FG005|Overall Study|Site Terminated|2|||
162631027|NCT03129100|587365176|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631028|NCT03129100|587365177|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631029|NCT03129100|587365178|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631030|NCT03129100|587365179|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631031|NCT03129100|587365180|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631032|NCT03129100|587365181|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631033|NCT03129100|587365182|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631034|NCT03129100|587365183|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162978359|NCT03310957|588623422|FG006|Overall Study|Site Terminated|8|||
162978360|NCT03310957|588623416|FG000|Overall Study|Lost to Follow-up|1|||
162978361|NCT03310957|588623417|FG001|Overall Study|Lost to Follow-up|1|||
162978362|NCT03310957|588623418|FG002|Overall Study|Lost to Follow-up|1|||
162978363|NCT03310957|588623419|FG003|Overall Study|Lost to Follow-up|4|||
162978364|NCT03310957|588623420|FG004|Overall Study|Lost to Follow-up|0|||
162978365|NCT03310957|588623421|FG005|Overall Study|Lost to Follow-up|4|||
162978366|NCT03310957|588623422|FG006|Overall Study|Lost to Follow-up|2|||
162978367|NCT03310957|588623416|FG000|Overall Study|Death|5|||
162978368|NCT03310957|588623417|FG001|Overall Study|Death|8|||
162978369|NCT03310957|588623418|FG002|Overall Study|Death|18|||
162978370|NCT03310957|588623419|FG003|Overall Study|Death|31|||
162978371|NCT03310957|588623420|FG004|Overall Study|Death|1|||
162978372|NCT03310957|588623421|FG005|Overall Study|Death|29|||
162978373|NCT03310957|588623422|FG006|Overall Study|Death|7|||
162978374|NCT03310957|588623416|FG000|Overall Study|Discontinuation per sponsor|0|||
162978375|NCT03310957|588623417|FG001|Overall Study|Discontinuation per sponsor|1|||
162978376|NCT03310957|588623418|FG002|Overall Study|Discontinuation per sponsor|2|||
162978377|NCT03310957|588623419|FG003|Overall Study|Discontinuation per sponsor|4|||
162978378|NCT03310957|588623420|FG004|Overall Study|Discontinuation per sponsor|1|||
162978379|NCT03310957|588623421|FG005|Overall Study|Discontinuation per sponsor|9|||
162978380|NCT03310957|588623422|FG006|Overall Study|Discontinuation per sponsor|12|||
162978381|NCT03310957|588623416|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
162978382|NCT03310957|588623417|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
162978383|NCT03310957|588623418|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
162978384|NCT03310957|588623419|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
162978385|NCT03310957|588623420|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
162978386|NCT03310957|588623421|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
162978387|NCT03310957|588623422|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
162978388|NCT03310957|588623416|FG000|Overall Study|Treatment landscape|0|||
162978389|NCT03310957|588623417|FG001|Overall Study|Treatment landscape|0|||
162978390|NCT03310957|588623418|FG002|Overall Study|Treatment landscape|1|||
162978391|NCT03310957|588623419|FG003|Overall Study|Treatment landscape|1|||
162978392|NCT03310957|588623420|FG004|Overall Study|Treatment landscape|0|||
162631035|NCT03129100|587365184|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631036|NCT03129100|587365185|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631037|NCT03129100|587365186|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631038|NCT03129100|587365187|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
162631039|NCT03129100|587365188|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631040|NCT03129100|587365189|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631041|NCT03129100|587365190|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162631042|NCT03129100|587365191|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162978393|NCT03310957|588623421|FG005|Overall Study|Treatment landscape|1|||
162978394|NCT03310957|588623422|FG006|Overall Study|Treatment landscape|0|||
162978395|NCT03310957|588623416|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978396|NCT03310957|588623417|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978397|NCT03310957|588623418|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978398|NCT03310957|588623419|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978399|NCT03310957|588623420|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
162978400|NCT03310957|588623421|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978401|NCT03310957|588623422|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
162978402|NCT03310957|588623416|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978403|NCT03310957|588623417|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978404|NCT03310957|588623418|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
162978405|NCT03310957|588623419|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978406|NCT03310957|588623420|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978407|NCT03310957|588623421|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978408|NCT03310957|588623422|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
162978409|NCT03310957|588623416|FG000|Overall Study|Hospice|0|||
162978410|NCT03310957|588623417|FG001|Overall Study|Hospice|0|||
162978411|NCT03310957|588623418|FG002|Overall Study|Hospice|0|||
162978412|NCT03310957|588623419|FG003|Overall Study|Hospice|0|||
162978413|NCT03310957|588623420|FG004|Overall Study|Hospice|0|||
162978414|NCT03310957|588623421|FG005|Overall Study|Hospice|1|||
162978415|NCT03310957|588623422|FG006|Overall Study|Hospice|0|||
162978416|NCT03310957|588623416|FG000|Overall Study|Progressive|0|||
162978417|NCT03310957|588623417|FG001|Overall Study|Progressive|0|||
162978418|NCT03310957|588623418|FG002|Overall Study|Progressive|1|||
162978419|NCT03310957|588623419|FG003|Overall Study|Progressive|0|||
162978420|NCT03310957|588623420|FG004|Overall Study|Progressive|0|||
162978421|NCT03310957|588623421|FG005|Overall Study|Progressive|0|||
162978422|NCT03310957|588623422|FG006|Overall Study|Progressive|0|||
162978423|NCT02516410|588623427|FG000|Overall Study|Adverse Event|0|||
162978424|NCT02516410|588623428|FG001|Overall Study|Adverse Event|1|||
162978425|NCT02516410|588623427|FG000|Overall Study|Withdrawal by Subject|0|||
162978426|NCT02516410|588623428|FG001|Overall Study|Withdrawal by Subject|1|||
162978427|NCT04146363|588623431|FG000|Induction Period|Adverse Event|1|||
162978428|NCT04146363|588623432|FG001|Induction Period|Adverse Event|2|||
162978429|NCT04146363|588623433|FG002|Induction Period|Adverse Event|0|||
162978430|NCT04146363|588623434|FG003|Induction Period|Adverse Event|0|||
162978431|NCT04146363|588623435|FG004|Induction Period|Adverse Event|0|||
162978432|NCT04146363|588623436|FG005|Induction Period|Adverse Event|0|||
162978433|NCT04146363|588623437|FG006|Induction Period|Adverse Event|0|||
162978434|NCT04146363|588623438|FG007|Induction Period|Adverse Event|0|||
162978435|NCT04146363|588623439|FG008|Induction Period|Adverse Event|0|||
162978436|NCT04146363|588623440|FG009|Induction Period|Adverse Event|0|||
162978437|NCT04146363|588623441|FG010|Induction Period|Adverse Event|0|||
162978438|NCT04146363|588623431|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
162978439|NCT04146363|588623432|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
162978440|NCT04146363|588623433|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
162978441|NCT04146363|588623434|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
162978442|NCT04146363|588623435|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
162978443|NCT04146363|588623436|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
162978444|NCT04146363|588623437|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
162978445|NCT04146363|588623438|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
162978446|NCT04146363|588623439|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
162978447|NCT04146363|588623440|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
162978448|NCT04146363|588623441|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
162978449|NCT04146363|588623431|FG000|Induction Period|Lack of Efficacy|7|||
162978450|NCT04146363|588623432|FG001|Induction Period|Lack of Efficacy|2|||
162978451|NCT04146363|588623433|FG002|Induction Period|Lack of Efficacy|0|||
162978452|NCT04146363|588623434|FG003|Induction Period|Lack of Efficacy|0|||
162978453|NCT04146363|588623435|FG004|Induction Period|Lack of Efficacy|0|||
162978454|NCT04146363|588623436|FG005|Induction Period|Lack of Efficacy|0|||
162978455|NCT04146363|588623437|FG006|Induction Period|Lack of Efficacy|0|||
162978456|NCT04146363|588623438|FG007|Induction Period|Lack of Efficacy|0|||
162978457|NCT04146363|588623439|FG008|Induction Period|Lack of Efficacy|0|||
162978458|NCT04146363|588623440|FG009|Induction Period|Lack of Efficacy|0|||
162978459|NCT04146363|588623441|FG010|Induction Period|Lack of Efficacy|0|||
162978460|NCT04146363|588623431|FG000|Induction Period|Lost to Follow-up|1|||
162978461|NCT04146363|588623432|FG001|Induction Period|Lost to Follow-up|4|||
162978462|NCT04146363|588623433|FG002|Induction Period|Lost to Follow-up|0|||
162978463|NCT04146363|588623434|FG003|Induction Period|Lost to Follow-up|0|||
162978464|NCT04146363|588623435|FG004|Induction Period|Lost to Follow-up|0|||
162978465|NCT04146363|588623436|FG005|Induction Period|Lost to Follow-up|0|||
162978466|NCT04146363|588623437|FG006|Induction Period|Lost to Follow-up|0|||
162978467|NCT04146363|588623438|FG007|Induction Period|Lost to Follow-up|0|||
162978468|NCT04146363|588623439|FG008|Induction Period|Lost to Follow-up|0|||
162978469|NCT04146363|588623440|FG009|Induction Period|Lost to Follow-up|0|||
162978470|NCT04146363|588623441|FG010|Induction Period|Lost to Follow-up|0|||
162978471|NCT04146363|588623431|FG000|Induction Period|Positive quantiferon test|0|||
162978472|NCT04146363|588623432|FG001|Induction Period|Positive quantiferon test|1|||
162978473|NCT04146363|588623433|FG002|Induction Period|Positive quantiferon test|0|||
162978474|NCT04146363|588623434|FG003|Induction Period|Positive quantiferon test|0|||
162978475|NCT04146363|588623435|FG004|Induction Period|Positive quantiferon test|0|||
162978476|NCT04146363|588623436|FG005|Induction Period|Positive quantiferon test|0|||
162978477|NCT04146363|588623437|FG006|Induction Period|Positive quantiferon test|0|||
162978478|NCT04146363|588623438|FG007|Induction Period|Positive quantiferon test|0|||
162978479|NCT04146363|588623439|FG008|Induction Period|Positive quantiferon test|0|||
162978480|NCT04146363|588623440|FG009|Induction Period|Positive quantiferon test|0|||
162978481|NCT04146363|588623441|FG010|Induction Period|Positive quantiferon test|0|||
162978482|NCT04146363|588623431|FG000|Induction Period|Protocol Deviation|5|||
162978483|NCT04146363|588623432|FG001|Induction Period|Protocol Deviation|6|||
162978484|NCT04146363|588623433|FG002|Induction Period|Protocol Deviation|0|||
162978485|NCT04146363|588623434|FG003|Induction Period|Protocol Deviation|0|||
162978486|NCT04146363|588623435|FG004|Induction Period|Protocol Deviation|0|||
162978487|NCT04146363|588623436|FG005|Induction Period|Protocol Deviation|0|||
162978488|NCT04146363|588623437|FG006|Induction Period|Protocol Deviation|0|||
162978489|NCT04146363|588623438|FG007|Induction Period|Protocol Deviation|0|||
162978490|NCT04146363|588623439|FG008|Induction Period|Protocol Deviation|0|||
162978491|NCT04146363|588623440|FG009|Induction Period|Protocol Deviation|0|||
162978492|NCT04146363|588623441|FG010|Induction Period|Protocol Deviation|0|||
162978493|NCT04146363|588623431|FG000|Induction Period|Withdrawal by Subject|6|||
162978494|NCT04146363|588623432|FG001|Induction Period|Withdrawal by Subject|3|||
162978495|NCT04146363|588623433|FG002|Induction Period|Withdrawal by Subject|0|||
162978496|NCT04146363|588623434|FG003|Induction Period|Withdrawal by Subject|0|||
162631043|NCT03129100|587365192|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162978497|NCT04146363|588623435|FG004|Induction Period|Withdrawal by Subject|0|||
162978498|NCT04146363|588623436|FG005|Induction Period|Withdrawal by Subject|0|||
162978499|NCT04146363|588623437|FG006|Induction Period|Withdrawal by Subject|0|||
162978500|NCT04146363|588623438|FG007|Induction Period|Withdrawal by Subject|0|||
162978501|NCT04146363|588623439|FG008|Induction Period|Withdrawal by Subject|0|||
162978502|NCT04146363|588623440|FG009|Induction Period|Withdrawal by Subject|0|||
162978503|NCT04146363|588623441|FG010|Induction Period|Withdrawal by Subject|0|||
162978504|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978505|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978506|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978507|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978508|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978509|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978510|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
162978511|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
162978512|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978513|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978514|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
162978515|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978516|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978517|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978518|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978519|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978520|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978521|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978522|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
162978523|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978524|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978525|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
162978526|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978527|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978528|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978529|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978530|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978531|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978532|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
162978533|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
162978534|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978535|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978536|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
162978537|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978538|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978539|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
162978540|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978541|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978542|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
162978543|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978544|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978545|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978546|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978547|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
162978548|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978549|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978550|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978551|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978552|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
162978553|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
162978554|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
162978555|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
162978556|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162631044|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
162631045|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
162713041|NCT00957229|587660847|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
162713042|NCT00957229|587660848|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
162713043|NCT00763282|587660849|FG000|Overall Study|Withdrawal by Subject|6|||
162713044|NCT00763282|587660850|FG001|Overall Study|Withdrawal by Subject|5|||
162713045|NCT00763282|587660849|FG000|Overall Study|Death|4|||
162713046|NCT00763282|587660850|FG001|Overall Study|Death|3|||
162713047|NCT00763282|587660849|FG000|Overall Study|Lost to Follow-up|22|||
162713048|NCT00763282|587660850|FG001|Overall Study|Lost to Follow-up|26|||
162713049|NCT00606580|587660851|FG000|Overall Study|Lost to Follow-up|1|||
162713050|NCT00606580|587660852|FG001|Overall Study|Lost to Follow-up|1|||
162713051|NCT00606580|587660853|FG002|Overall Study|Lost to Follow-up|4|||
162713052|NCT00606580|587660851|FG000|Overall Study|Clinical failures|1|||
162713053|NCT00606580|587660852|FG001|Overall Study|Clinical failures|0|||
162713054|NCT00606580|587660853|FG002|Overall Study|Clinical failures|12|||
162713055|NCT00606580|587660851|FG000|Overall Study|Withdrawal by investigator|0|||
162713056|NCT00606580|587660852|FG001|Overall Study|Withdrawal by investigator|1|||
162713057|NCT00606580|587660853|FG002|Overall Study|Withdrawal by investigator|6|||
162713058|NCT00606580|587660851|FG000|Overall Study|Withdrawal by Subject|0|||
162713059|NCT00606580|587660852|FG001|Overall Study|Withdrawal by Subject|1|||
162713060|NCT00606580|587660853|FG002|Overall Study|Withdrawal by Subject|0|||
162713061|NCT04580303|587660854|FG000|Overall Study|Adverse Event|0|||
162713062|NCT04580303|587660855|FG001|Overall Study|Adverse Event|1|||
162713063|NCT04580303|587660856|FG002|Overall Study|Adverse Event|0|||
162713064|NCT04580303|587660857|FG003|Overall Study|Adverse Event|0|||
162713065|NCT04580303|587660854|FG000|Overall Study|Withdrawal by Subject|0|||
162713066|NCT04580303|587660855|FG001|Overall Study|Withdrawal by Subject|0|||
162713067|NCT04580303|587660856|FG002|Overall Study|Withdrawal by Subject|1|||
162713068|NCT04580303|587660857|FG003|Overall Study|Withdrawal by Subject|0|||
162713069|NCT01833065|587660859|FG000|Overall Study|Adverse Event|6|||
162713070|NCT01833065|587660860|FG001|Overall Study|Adverse Event|1|||
162713071|NCT01833065|587660861|FG002|Overall Study|Adverse Event|0|||
162713072|NCT01833065|587660862|FG003|Overall Study|Adverse Event|2|||
162713073|NCT01833065|587660863|FG004|Overall Study|Adverse Event|3|||
162713074|NCT01833065|587660859|FG000|Overall Study|Protocol Violation|1|||
162713075|NCT01833065|587660860|FG001|Overall Study|Protocol Violation|0|||
162713076|NCT01833065|587660861|FG002|Overall Study|Protocol Violation|0|||
162713077|NCT01833065|587660862|FG003|Overall Study|Protocol Violation|0|||
162713078|NCT01833065|587660863|FG004|Overall Study|Protocol Violation|2|||
162713079|NCT01833065|587660859|FG000|Overall Study|Lost to Follow-up|1|||
162713080|NCT01833065|587660860|FG001|Overall Study|Lost to Follow-up|0|||
162713081|NCT01833065|587660861|FG002|Overall Study|Lost to Follow-up|0|||
162713082|NCT01833065|587660862|FG003|Overall Study|Lost to Follow-up|0|||
162713083|NCT01833065|587660863|FG004|Overall Study|Lost to Follow-up|3|||
162713084|NCT01833065|587660859|FG000|Overall Study|Withdrawal by Subject|6|||
162713085|NCT01833065|587660860|FG001|Overall Study|Withdrawal by Subject|2|||
162713086|NCT01833065|587660861|FG002|Overall Study|Withdrawal by Subject|4|||
162713087|NCT01833065|587660862|FG003|Overall Study|Withdrawal by Subject|3|||
162713088|NCT01833065|587660863|FG004|Overall Study|Withdrawal by Subject|11|||
162713089|NCT01833065|587660859|FG000|Overall Study|Subject's substantial non-compliance|0|||
162713090|NCT01833065|587660860|FG001|Overall Study|Subject's substantial non-compliance|1|||
162713091|NCT01833065|587660861|FG002|Overall Study|Subject's substantial non-compliance|0|||
162713092|NCT01833065|587660862|FG003|Overall Study|Subject's substantial non-compliance|0|||
162713093|NCT01833065|587660863|FG004|Overall Study|Subject's substantial non-compliance|0|||
162713094|NCT01833065|587660859|FG000|Overall Study|Trial terminated by sponsor|8|||
162713095|NCT01833065|587660860|FG001|Overall Study|Trial terminated by sponsor|8|||
162713096|NCT01833065|587660861|FG002|Overall Study|Trial terminated by sponsor|7|||
162713097|NCT01833065|587660862|FG003|Overall Study|Trial terminated by sponsor|3|||
162713098|NCT01833065|587660863|FG004|Overall Study|Trial terminated by sponsor|13|||
162713099|NCT01833065|587660859|FG000|Overall Study|Others|2|||
162713100|NCT01833065|587660860|FG001|Overall Study|Others|1|||
162713101|NCT01833065|587660861|FG002|Overall Study|Others|1|||
162713102|NCT01833065|587660862|FG003|Overall Study|Others|1|||
162713103|NCT01833065|587660863|FG004|Overall Study|Others|4|||
162713104|NCT00543725|587660866|FG000|Overall Study|Adverse Event|18|||
162713105|NCT00543725|587660867|FG001|Overall Study|Adverse Event|27|||
162713106|NCT00543725|587660866|FG000|Overall Study|Sponsor's Decision|0|||
162978557|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162713107|NCT00543725|587660867|FG001|Overall Study|Sponsor's Decision|1|||
162713108|NCT00543725|587660866|FG000|Overall Study|Subject Non-Compliant|4|||
162713109|NCT00543725|587660867|FG001|Overall Study|Subject Non-Compliant|4|||
162713110|NCT00543725|587660866|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
162713111|NCT00543725|587660867|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
162713112|NCT00543725|587660866|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
162713113|NCT00543725|587660867|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
162713114|NCT00543725|587660866|FG000|Overall Study|Protocol Violation|0|||
162713115|NCT00543725|587660867|FG001|Overall Study|Protocol Violation|1|||
162978558|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
162978559|NCT04146363|588623431|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978560|NCT04146363|588623432|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978561|NCT04146363|588623433|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
162978562|NCT04146363|588623434|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978563|NCT04146363|588623435|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978564|NCT04146363|588623436|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
162978565|NCT04146363|588623437|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
162978566|NCT04146363|588623438|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
162978567|NCT04146363|588623439|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978568|NCT04146363|588623440|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978569|NCT04146363|588623441|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
162978570|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978571|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978572|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978573|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978574|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
162924052|NCT05083559|588422323|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
162978575|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978576|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978577|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978578|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
162978579|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
162978580|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
162978581|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978582|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978583|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978584|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978585|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978586|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978587|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163058068|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Death|34|||
162924053|NCT05083559|588422324|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
162924054|NCT05083559|588422323|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
162924055|NCT05083559|588422324|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
162924056|NCT02704130|588422325|FG000|Overall Study|Physician Decision|5|||
162924057|NCT02704130|588422326|FG001|Overall Study|Physician Decision|3|||
162924058|NCT05378269|588423768|FG000|Overall Study|Protocol Violation|1|||
162924059|NCT05378269|588423769|FG001|Overall Study|Protocol Violation|0|||
162924060|NCT05378269|588423770|FG002|Overall Study|Protocol Violation|2|||
162924061|NCT05378269|588423771|FG003|Overall Study|Protocol Violation|0|||
162924062|NCT05378269|588423772|FG004|Overall Study|Protocol Violation|0|||
162924063|NCT00602979|588423775|FG000|Overall Study|Lost to Follow-up|3|||
162924064|NCT00602979|588423776|FG001|Overall Study|Lost to Follow-up|2|||
162924065|NCT00602979|588423777|FG002|Overall Study|Lost to Follow-up|3|||
162924066|NCT00602979|588423778|FG003|Overall Study|Lost to Follow-up|2|||
162924067|NCT00602979|588423779|FG004|Overall Study|Lost to Follow-up|3|||
162924068|NCT00602979|588423775|FG000|Overall Study|Failed Intubation|0|||
162924069|NCT00602979|588423776|FG001|Overall Study|Failed Intubation|1|||
162924070|NCT00602979|588423777|FG002|Overall Study|Failed Intubation|0|||
162924071|NCT00602979|588423778|FG003|Overall Study|Failed Intubation|1|||
162924072|NCT00602979|588423779|FG004|Overall Study|Failed Intubation|0|||
162924073|NCT01461369|588423780|FG000|Overall Study|Lack of Efficacy|2|||
162924074|NCT01461369|588423781|FG001|Overall Study|Lack of Efficacy|0|||
162924075|NCT01461369|588423782|FG002|Overall Study|Lack of Efficacy|6|||
162924076|NCT01461369|588423780|FG000|Overall Study|Lost to Follow-up|0|||
162924077|NCT01461369|588423781|FG001|Overall Study|Lost to Follow-up|0|||
162924078|NCT01461369|588423782|FG002|Overall Study|Lost to Follow-up|3|||
162924079|NCT01461369|588423780|FG000|Overall Study|Adverse Event|9|||
162924080|NCT01461369|588423781|FG001|Overall Study|Adverse Event|12|||
162924081|NCT01461369|588423782|FG002|Overall Study|Adverse Event|4|||
162924082|NCT01461369|588423780|FG000|Overall Study|Protocol Violation|1|||
162924083|NCT01461369|588423781|FG001|Overall Study|Protocol Violation|2|||
162924084|NCT01461369|588423782|FG002|Overall Study|Protocol Violation|2|||
162924085|NCT01461369|588423780|FG000|Overall Study|Withdrawal by Subject|1|||
162924086|NCT01461369|588423781|FG001|Overall Study|Withdrawal by Subject|3|||
162924087|NCT01461369|588423782|FG002|Overall Study|Withdrawal by Subject|2|||
162924088|NCT00734617|588423787|FG000|Overall Study|Adverse Event|4|||
162924089|NCT00734617|588423788|FG001|Overall Study|Adverse Event|7|||
162924090|NCT00734617|588423787|FG000|Overall Study|Withdrawal by Subject|103|||
162924091|NCT00734617|588423788|FG001|Overall Study|Withdrawal by Subject|95|||
162924092|NCT03692078|588423791|FG000|Overall Study|Adverse Event|0|||
163058069|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Investigators decision|0|||
163058070|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Investigators decision|2|||
163058071|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Investigators decision|0|||
163058072|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163058073|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
163058074|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
163058075|NCT00961415|588922839|FG000|Maintenance Treatment Phase|Other reason|0|||
163058076|NCT00961415|588922840|FG001|Maintenance Treatment Phase|Other reason|1|||
163058077|NCT00961415|588922841|FG002|Maintenance Treatment Phase|Other reason|3|||
163058078|NCT02309359|588922842|FG000|Overall Study|Adverse Event|4|||
163058079|NCT02309359|588922843|FG001|Overall Study|Adverse Event|5|||
163058080|NCT02309359|588922844|FG002|Overall Study|Adverse Event|5|||
163058081|NCT02309359|588922845|FG003|Overall Study|Adverse Event|4|||
163058082|NCT02309359|588922846|FG004|Overall Study|Adverse Event|4|||
163058083|NCT02309359|588922842|FG000|Overall Study|Death|1|||
163058084|NCT02309359|588922843|FG001|Overall Study|Death|0|||
163058085|NCT02309359|588922844|FG002|Overall Study|Death|0|||
162978588|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
162978589|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
162978590|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
162978591|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
162978592|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978593|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978594|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978595|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978596|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978597|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978598|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978599|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978600|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
162978601|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
162978602|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
162978603|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978604|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978605|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978606|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978607|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978608|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978609|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978610|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978611|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
162978612|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
162978613|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
162978614|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978615|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978616|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978617|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978618|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978619|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978620|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978621|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
162978622|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
162978623|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
162978624|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
162978625|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978626|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978627|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978628|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
163058086|NCT02309359|588922845|FG003|Overall Study|Death|0|||
162978629|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978630|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978631|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978632|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978633|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
163058087|NCT02309359|588922846|FG004|Overall Study|Death|0|||
163058088|NCT02309359|588922842|FG000|Overall Study|Withdrawal by Subject|2|||
163058089|NCT02309359|588922843|FG001|Overall Study|Withdrawal by Subject|2|||
163058090|NCT02309359|588922844|FG002|Overall Study|Withdrawal by Subject|4|||
163058091|NCT02309359|588922845|FG003|Overall Study|Withdrawal by Subject|4|||
162713116|NCT00543725|587660866|FG000|Overall Study|Withdrawal by Subject|4|||
162713117|NCT00543725|587660867|FG001|Overall Study|Withdrawal by Subject|13|||
162713118|NCT00543725|587660866|FG000|Overall Study|Lost to Follow-up|15|||
162713119|NCT00543725|587660867|FG001|Overall Study|Lost to Follow-up|11|||
162713120|NCT00543725|587660866|FG000|Overall Study|Other|3|||
162713121|NCT00543725|587660867|FG001|Overall Study|Other|3|||
162713122|NCT01250002|587660868|FG000|Overall Study|Change to open surgical procedure|4|||
162713123|NCT01250002|587660869|FG001|Overall Study|Change to open surgical procedure|3|||
162713124|NCT02317705|587660870|FG000|Overall Study|Withdrawal by Subject|3|||
162713125|NCT02317705|587660870|FG000|Overall Study|Physician Decision|1|||
162713126|NCT02317705|587660870|FG000|Overall Study|Drug not usable|1|||
162713127|NCT03095508|587660871|FG000|Overall Study|Adverse Event|0|||
162713128|NCT03095508|587660872|FG001|Overall Study|Adverse Event|1|||
162713129|NCT00335556|587660873|FG000|Overall Study|Death|0|||
162713130|NCT00335556|587660874|FG001|Overall Study|Death|5|||
162713131|NCT00335556|587660875|FG002|Overall Study|Death|0|||
162713132|NCT00335556|587660876|FG003|Overall Study|Death|0|||
162713133|NCT00335556|587660877|FG004|Overall Study|Death|1|||
162713134|NCT00335556|587660878|FG005|Overall Study|Death|0|||
162713135|NCT00335556|587660873|FG000|Overall Study|Lack of Efficacy|0|||
162713136|NCT00335556|587660874|FG001|Overall Study|Lack of Efficacy|19|||
162713137|NCT00335556|587660875|FG002|Overall Study|Lack of Efficacy|3|||
162713138|NCT00335556|587660876|FG003|Overall Study|Lack of Efficacy|3|||
162713139|NCT00335556|587660877|FG004|Overall Study|Lack of Efficacy|0|||
162978634|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
162978635|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
162978636|NCT04146363|588623431|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978637|NCT04146363|588623432|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978638|NCT04146363|588623433|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978639|NCT04146363|588623434|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978640|NCT04146363|588623435|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978641|NCT04146363|588623436|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978642|NCT04146363|588623437|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978643|NCT04146363|588623438|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978644|NCT04146363|588623439|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978645|NCT04146363|588623440|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
162978646|NCT04146363|588623441|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
162978647|NCT02676284|588623442|FG000|Overall Study|Withdrawal by Subject|1|||
162978648|NCT00107042|588623443|FG000|Overall Study|Lost to Follow-up|9|||
162978649|NCT00107042|588623444|FG001|Overall Study|Lost to Follow-up|7|||
162978650|NCT00107042|588623443|FG000|Overall Study|Withdrawal by Subject|6|||
162978651|NCT00107042|588623444|FG001|Overall Study|Withdrawal by Subject|1|||
162978652|NCT00107042|588623443|FG000|Overall Study|Moved out of area|5|||
162978653|NCT00107042|588623444|FG001|Overall Study|Moved out of area|3|||
162978654|NCT00107042|588623443|FG000|Overall Study|Pregnancy|1|||
162978655|NCT00107042|588623444|FG001|Overall Study|Pregnancy|1|||
162978656|NCT00107042|588623443|FG000|Overall Study|Inadvertent enrollment|0|||
162978657|NCT00107042|588623444|FG001|Overall Study|Inadvertent enrollment|1|||
162978658|NCT00107042|588623443|FG000|Overall Study|vaccinated outside window|1|||
162978659|NCT00107042|588623444|FG001|Overall Study|vaccinated outside window|1|||
162978660|NCT00107042|588623443|FG000|Overall Study|Disallowed medications|0|||
162978661|NCT00107042|588623444|FG001|Overall Study|Disallowed medications|2|||
162978662|NCT04776746|588623445|FG000|Overall Study|Study terminated by sponsor|61|||
162978663|NCT04776746|588623445|FG000|Overall Study|Adverse Event|5|||
162978664|NCT04776746|588623445|FG000|Overall Study|Death|4|||
162978665|NCT04776746|588623445|FG000|Overall Study|Lack of Efficacy|3|||
162978666|NCT04776746|588623445|FG000|Overall Study|Noncompliance with study drug|2|||
162978667|NCT04776746|588623445|FG000|Overall Study|Not related to COVID-19|2|||
162978668|NCT01286558|588623448|FG000|Overall Study|Adverse Event|1|||
162713140|NCT00335556|587660878|FG005|Overall Study|Lack of Efficacy|1|||
162713141|NCT00335556|587660873|FG000|Overall Study|Physician Decision|0|||
162713142|NCT00335556|587660874|FG001|Overall Study|Physician Decision|6|||
162978669|NCT01286558|588623449|FG001|Overall Study|Adverse Event|1|||
162978670|NCT01286558|588623448|FG000|Overall Study|Withdrawal by Subject|0|||
162978671|NCT01286558|588623449|FG001|Overall Study|Withdrawal by Subject|1|||
162978672|NCT01220297|588623450|FG000|Overall Study|Death|2|||
162713143|NCT00335556|587660875|FG002|Overall Study|Physician Decision|2|||
162978673|NCT01220297|588623450|FG000|Overall Study|Lost to Follow-up|1|||
162978674|NCT01287039|588623452|FG000|Overall Study|Noncompliance with study procedures|0|||
162713144|NCT00335556|587660876|FG003|Overall Study|Physician Decision|1|||
162713145|NCT00335556|587660877|FG004|Overall Study|Physician Decision|0|||
162713146|NCT00335556|587660878|FG005|Overall Study|Physician Decision|0|||
162713147|NCT00335556|587660873|FG000|Overall Study|Ineligible|2|||
162713148|NCT00335556|587660874|FG001|Overall Study|Ineligible|0|||
162713149|NCT00335556|587660875|FG002|Overall Study|Ineligible|0|||
162978675|NCT01287039|588623453|FG001|Overall Study|Noncompliance with study procedures|1|||
162924093|NCT03692078|588423792|FG001|Overall Study|Adverse Event|0|||
162924094|NCT03692078|588423793|FG002|Overall Study|Adverse Event|0|||
162924095|NCT03692078|588423794|FG003|Overall Study|Adverse Event|0|||
162924096|NCT03692078|588423795|FG004|Overall Study|Adverse Event|0|||
162924097|NCT03692078|588423796|FG005|Overall Study|Adverse Event|1|||
162924098|NCT03692078|588423797|FG006|Overall Study|Adverse Event|0|||
162924099|NCT03692078|588423791|FG000|Overall Study|Enrollment Closed|5|||
162924100|NCT03692078|588423792|FG001|Overall Study|Enrollment Closed|0|||
162924101|NCT03692078|588423793|FG002|Overall Study|Enrollment Closed|0|||
162924102|NCT03692078|588423794|FG003|Overall Study|Enrollment Closed|0|||
162924103|NCT03692078|588423795|FG004|Overall Study|Enrollment Closed|0|||
162924104|NCT03692078|588423796|FG005|Overall Study|Enrollment Closed|0|||
162924105|NCT03692078|588423797|FG006|Overall Study|Enrollment Closed|0|||
162924106|NCT03692078|588423791|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
162924107|NCT03692078|588423792|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
162924108|NCT03692078|588423793|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
162924109|NCT03692078|588423794|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
162924110|NCT03692078|588423795|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
162924111|NCT03692078|588423796|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
162924112|NCT03692078|588423797|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
162924113|NCT03692078|588423791|FG000|Overall Study|Withdrawal by Subject|0|||
162924114|NCT03692078|588423792|FG001|Overall Study|Withdrawal by Subject|2|||
162924115|NCT03692078|588423793|FG002|Overall Study|Withdrawal by Subject|0|||
162924116|NCT03692078|588423794|FG003|Overall Study|Withdrawal by Subject|1|||
162924117|NCT03692078|588423795|FG004|Overall Study|Withdrawal by Subject|5|||
162924118|NCT03692078|588423796|FG005|Overall Study|Withdrawal by Subject|3|||
162924119|NCT03692078|588423797|FG006|Overall Study|Withdrawal by Subject|3|||
162924120|NCT00996632|588423800|FG000|Overall Study|Physician Decision|0|||
162924121|NCT00996632|588423801|FG001|Overall Study|Physician Decision|0|||
162924122|NCT01615822|588423803|FG000|Period 1|Withdrawal by Subject|0|||
162924123|NCT01615822|588423804|FG001|Period 1|Withdrawal by Subject|1|||
162924124|NCT01615822|588423805|FG002|Period 1|Withdrawal by Subject|0|||
162924125|NCT01615822|588423803|FG000|Period 1|Adverse Event|1|||
162924126|NCT01615822|588423804|FG001|Period 1|Adverse Event|1|||
162924127|NCT01615822|588423805|FG002|Period 1|Adverse Event|0|||
162924128|NCT01615822|588423803|FG000|Period 2|Lost to Follow-up|0|||
162924129|NCT01615822|588423804|FG001|Period 2|Lost to Follow-up|1|||
162924130|NCT01615822|588423805|FG002|Period 2|Lost to Follow-up|2|||
162924131|NCT02861534|588423806|FG000|Overall Study|Death|541|||
162924132|NCT02861534|588423807|FG001|Overall Study|Death|552|||
162924133|NCT02861534|588423806|FG000|Overall Study|Lost to Follow-up|14|||
162924134|NCT02861534|588423807|FG001|Overall Study|Lost to Follow-up|14|||
162924135|NCT02861534|588423806|FG000|Overall Study|Site Terminated by Sponsor|4|||
162924136|NCT02861534|588423807|FG001|Overall Study|Site Terminated by Sponsor|3|||
162924137|NCT02861534|588423806|FG000|Overall Study|Withdrawal by Subject|15|||
162924138|NCT02861534|588423807|FG001|Overall Study|Withdrawal by Subject|18|||
162924139|NCT02886494|588423808|FG000|Overall Study|Adverse Event|1|||
162924140|NCT02886494|588423809|FG001|Overall Study|Adverse Event|0|||
162924141|NCT02886494|588423808|FG000|Overall Study|Withdrawal by Subject|12|||
162924142|NCT02886494|588423809|FG001|Overall Study|Withdrawal by Subject|3|||
162924143|NCT02886494|588423808|FG000|Overall Study|Protocol Violation|4|||
162924144|NCT02886494|588423809|FG001|Overall Study|Protocol Violation|1|||
162924145|NCT00537056|588423816|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
162924146|NCT00244881|588423817|FG000|Overall Study|Withdrawal by Subject|3|||
162924147|NCT00445458|588423818|FG000|Overall Study|Disease Progression|3|||
162924148|NCT00445458|588423819|FG001|Overall Study|Disease Progression|4|||
162924149|NCT00445458|588423820|FG002|Overall Study|Disease Progression|54|||
162924150|NCT00445458|588423821|FG003|Overall Study|Disease Progression|27|||
162924151|NCT00445458|588423818|FG000|Overall Study|Withdrawal by Subject|0|||
162924152|NCT00445458|588423819|FG001|Overall Study|Withdrawal by Subject|0|||
162924153|NCT00445458|588423820|FG002|Overall Study|Withdrawal by Subject|7|||
162924154|NCT00445458|588423821|FG003|Overall Study|Withdrawal by Subject|0|||
162924155|NCT00445458|588423818|FG000|Overall Study|Adverse Event|0|||
162924156|NCT00445458|588423819|FG001|Overall Study|Adverse Event|0|||
162924157|NCT00445458|588423820|FG002|Overall Study|Adverse Event|3|||
162924158|NCT00445458|588423821|FG003|Overall Study|Adverse Event|0|||
162924159|NCT00445458|588423818|FG000|Overall Study|Death|0|||
163058092|NCT02309359|588922846|FG004|Overall Study|Withdrawal by Subject|0|||
162924160|NCT00445458|588423819|FG001|Overall Study|Death|1|||
162924161|NCT00445458|588423820|FG002|Overall Study|Death|2|||
162924162|NCT00445458|588423821|FG003|Overall Study|Death|0|||
162924163|NCT00445458|588423818|FG000|Overall Study|Physician Decision|0|||
162924164|NCT00445458|588423819|FG001|Overall Study|Physician Decision|0|||
162924165|NCT00445458|588423820|FG002|Overall Study|Physician Decision|1|||
162924166|NCT00445458|588423821|FG003|Overall Study|Physician Decision|1|||
162924167|NCT00445458|588423818|FG000|Overall Study|Surgery|0|||
162978676|NCT01287039|588623452|FG000|Overall Study|Change of location/residence|0|||
162978677|NCT01287039|588623453|FG001|Overall Study|Change of location/residence|3|||
162978678|NCT01287039|588623452|FG000|Overall Study|Elective surgery|0|||
162978679|NCT01287039|588623453|FG001|Overall Study|Elective surgery|1|||
162978680|NCT01287039|588623452|FG000|Overall Study|Protocol Violation|2|||
162978681|NCT01287039|588623453|FG001|Overall Study|Protocol Violation|3|||
162978682|NCT01287039|588623452|FG000|Overall Study|Excluded medication taken|1|||
162978683|NCT01287039|588623453|FG001|Overall Study|Excluded medication taken|0|||
162978684|NCT01287039|588623452|FG000|Overall Study|Noncompliance with study medication|0|||
162978685|NCT01287039|588623453|FG001|Overall Study|Noncompliance with study medication|1|||
162978686|NCT01287039|588623452|FG000|Overall Study|Problem with travel|0|||
162978687|NCT01287039|588623453|FG001|Overall Study|Problem with travel|1|||
162978688|NCT01287039|588623452|FG000|Overall Study|Death|1|||
162978689|NCT01287039|588623453|FG001|Overall Study|Death|0|||
162978690|NCT01287039|588623452|FG000|Overall Study|Change of residence|1|||
162978691|NCT01287039|588623453|FG001|Overall Study|Change of residence|0|||
162978692|NCT01287039|588623452|FG000|Overall Study|Adverse Event|7|||
162978693|NCT01287039|588623453|FG001|Overall Study|Adverse Event|4|||
162978694|NCT01287039|588623452|FG000|Overall Study|Withdrawal by Subject|14|||
162978695|NCT01287039|588623453|FG001|Overall Study|Withdrawal by Subject|11|||
162978696|NCT01287039|588623452|FG000|Overall Study|Lost to Follow-up|3|||
162978697|NCT01287039|588623453|FG001|Overall Study|Lost to Follow-up|2|||
162978698|NCT01117337|588623455|FG000|Overall Study|Lost to Follow-up|4|||
162978699|NCT01117337|588623456|FG001|Overall Study|Lost to Follow-up|0|||
162978700|NCT03575871|588623457|FG000|Overall Study|Adverse Event|5|||
162978701|NCT03575871|588623458|FG001|Overall Study|Adverse Event|5|||
162978702|NCT03575871|588623459|FG002|Overall Study|Adverse Event|8|||
162978703|NCT03575871|588623457|FG000|Overall Study|Death|1|||
162978704|NCT03575871|588623458|FG001|Overall Study|Death|0|||
162978705|NCT03575871|588623459|FG002|Overall Study|Death|0|||
162978706|NCT03575871|588623457|FG000|Overall Study|Lack of Efficacy|5|||
162978707|NCT03575871|588623458|FG001|Overall Study|Lack of Efficacy|4|||
162978708|NCT03575871|588623459|FG002|Overall Study|Lack of Efficacy|7|||
162978709|NCT03575871|588623457|FG000|Overall Study|Lost to Follow-up|1|||
162978710|NCT03575871|588623458|FG001|Overall Study|Lost to Follow-up|1|||
162978711|NCT03575871|588623459|FG002|Overall Study|Lost to Follow-up|1|||
162978712|NCT03575871|588623457|FG000|Overall Study|Protocol Deviation|1|||
162978713|NCT03575871|588623458|FG001|Overall Study|Protocol Deviation|1|||
162978714|NCT03575871|588623459|FG002|Overall Study|Protocol Deviation|1|||
162978715|NCT03575871|588623457|FG000|Overall Study|Withdrawal by Subject|6|||
162978716|NCT03575871|588623458|FG001|Overall Study|Withdrawal by Subject|1|||
162978717|NCT03575871|588623459|FG002|Overall Study|Withdrawal by Subject|9|||
162978718|NCT03575871|588623457|FG000|Overall Study|Other than specified|2|||
162978719|NCT03575871|588623458|FG001|Overall Study|Other than specified|2|||
162978720|NCT03575871|588623459|FG002|Overall Study|Other than specified|0|||
162978721|NCT05444556|588623460|FG000|Overall Study|Withdrawal by Subject|0|||
162978722|NCT05444556|588623461|FG001|Overall Study|Withdrawal by Subject|0|||
162978723|NCT05444556|588623462|FG002|Overall Study|Withdrawal by Subject|2|||
162978724|NCT05444556|588623463|FG003|Overall Study|Withdrawal by Subject|1|||
162978725|NCT02791893|588623465|FG000|Blinded Phase|Lost to Follow-up|2|||
162978726|NCT02791893|588623466|FG001|Blinded Phase|Lost to Follow-up|2|||
162978727|NCT02791893|588623465|FG000|Blinded Phase|Withdrawal by Subject|1|||
162978728|NCT02791893|588623466|FG001|Blinded Phase|Withdrawal by Subject|2|||
162978729|NCT02791893|588623465|FG000|Open Label Phase|Lost to Follow-up|3|||
162978730|NCT02791893|588623466|FG001|Open Label Phase|Lost to Follow-up|0|||
162978731|NCT02791893|588623465|FG000|Open Label Phase|Withdrawal by Subject|0|||
162978732|NCT02791893|588623466|FG001|Open Label Phase|Withdrawal by Subject|2|||
162978733|NCT00171301|588623468|FG000|Overall Study|Death|1|||
162978734|NCT00171301|588623469|FG001|Overall Study|Death|2|||
162978735|NCT00171301|588623468|FG000|Overall Study|Adverse Event|1|||
162978736|NCT00171301|588623469|FG001|Overall Study|Adverse Event|2|||
162978737|NCT00171301|588623468|FG000|Overall Study|Lost to Follow-up|6|||
162978738|NCT00171301|588623469|FG001|Overall Study|Lost to Follow-up|2|||
162978739|NCT00171301|588623468|FG000|Overall Study|Protocol Violation|0|||
162978740|NCT00171301|588623469|FG001|Overall Study|Protocol Violation|2|||
162978741|NCT00171301|588623468|FG000|Overall Study|Withdrawal by Subject|0|||
162978742|NCT00171301|588623469|FG001|Overall Study|Withdrawal by Subject|1|||
162978743|NCT04319159|588623471|FG000|Overall Study|Screening failure|13|||
162978744|NCT04319159|588623471|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
162978745|NCT04319159|588623471|FG000|Overall Study|Withdrawal by Subject|1|||
162978746|NCT02100319|588623474|FG000|Overall Study|Case Report Forms Uncollected|11|||
162978747|NCT02100319|588623474|FG000|Overall Study|Protocol Deviation|5|||
162978748|NCT02589522|588623477|FG000|Overall Study|Physician Decision|1|||
162978749|NCT02589522|588623478|FG001|Overall Study|Physician Decision|2|||
162978750|NCT02589522|588623479|FG002|Overall Study|Physician Decision|0|||
162978751|NCT02589522|588623477|FG000|Overall Study|Did not start treatment|1|||
162978752|NCT02589522|588623478|FG001|Overall Study|Did not start treatment|0|||
162978753|NCT02589522|588623479|FG002|Overall Study|Did not start treatment|0|||
163058093|NCT02309359|588922842|FG000|Overall Study|Lack of Efficacy|3|||
163058094|NCT02309359|588922843|FG001|Overall Study|Lack of Efficacy|1|||
163058095|NCT02309359|588922844|FG002|Overall Study|Lack of Efficacy|0|||
163058096|NCT02309359|588922845|FG003|Overall Study|Lack of Efficacy|0|||
163058097|NCT02309359|588922846|FG004|Overall Study|Lack of Efficacy|3|||
163058098|NCT02309359|588922842|FG000|Overall Study|Lost to Follow-up|0|||
163058099|NCT02309359|588922843|FG001|Overall Study|Lost to Follow-up|0|||
163058100|NCT02309359|588922844|FG002|Overall Study|Lost to Follow-up|0|||
163058101|NCT02309359|588922845|FG003|Overall Study|Lost to Follow-up|1|||
163058102|NCT02309359|588922846|FG004|Overall Study|Lost to Follow-up|0|||
163058103|NCT02309359|588922842|FG000|Overall Study|Other|2|||
163058104|NCT02309359|588922843|FG001|Overall Study|Other|0|||
163058105|NCT02309359|588922844|FG002|Overall Study|Other|2|||
163058106|NCT02309359|588922845|FG003|Overall Study|Other|3|||
163058107|NCT02309359|588922846|FG004|Overall Study|Other|2|||
163058108|NCT06129149|588922848|FG000|Overall Study|Death|1|||
163058109|NCT04649359|588922849|FG000|Overall Study|Withdrawal by Subject|7|||
163058110|NCT04649359|588922850|FG001|Overall Study|Withdrawal by Subject|7|||
163058111|NCT04649359|588922849|FG000|Overall Study|Death|41|||
163058112|NCT04649359|588922850|FG001|Overall Study|Death|26|||
163058113|NCT04649359|588922849|FG000|Overall Study|Ongoing in the study|75|||
163058114|NCT04649359|588922850|FG001|Overall Study|Ongoing in the study|31|||
163058115|NCT03307174|588922851|FG000|Overall Study|Unplanned ICU Administrion|5|||
162978754|NCT05224544|588623483|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
162978755|NCT05224544|588623484|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
162978756|NCT00351351|588623485|FG000|Overall Study|surgical access pbs; device issues|9|||
162978757|NCT00351351|588623486|FG001|Overall Study|surgical access pbs; device issues|4|||
162978758|NCT01341587|588623487|FG000|Overall Study|Lost to Follow-up|2|||
162978759|NCT01341587|588623488|FG001|Overall Study|Lost to Follow-up|0|||
162978760|NCT01341587|588623487|FG000|Overall Study|stopped using the meters|2|||
162978761|NCT01341587|588623488|FG001|Overall Study|stopped using the meters|10|||
162978762|NCT03891329|588623491|FG000|Overall Study|Death|5|||
162978763|NCT03891329|588623491|FG000|Overall Study|Lost to Follow-up|4|||
162978764|NCT03891329|588623491|FG000|Overall Study|Physician Decision|4|||
162978765|NCT03891329|588623491|FG000|Overall Study|Device explanted|3|||
162978766|NCT03891329|588623491|FG000|Overall Study|No study device implanted|3|||
162978767|NCT03176784|588623492|FG000|Overall Study|Lost to Follow-up|77|||
162978768|NCT03176784|588623493|FG001|Overall Study|Lost to Follow-up|79|||
162978769|NCT03176784|588623494|FG002|Overall Study|Lost to Follow-up|79|||
163058116|NCT03307174|588922852|FG001|Overall Study|Unplanned ICU Administrion|3|||
163058117|NCT03307174|588922851|FG000|Overall Study|Aborted Surgery|1|||
163058118|NCT03307174|588922852|FG001|Overall Study|Aborted Surgery|2|||
163058119|NCT03307174|588922851|FG000|Overall Study|Hypotension|6|||
163058120|NCT03307174|588922852|FG001|Overall Study|Hypotension|0|||
163058121|NCT03307174|588922851|FG000|Overall Study|Nonfunctional epidural|1|||
163058122|NCT03307174|588922852|FG001|Overall Study|Nonfunctional epidural|1|||
163058123|NCT03307174|588922851|FG000|Overall Study|Planned epidural removal|1|||
163058124|NCT03307174|588922852|FG001|Overall Study|Planned epidural removal|0|||
163058125|NCT03307174|588922851|FG000|Overall Study|Intrathecal catheter placement|0|||
163058126|NCT03307174|588922852|FG001|Overall Study|Intrathecal catheter placement|1|||
163058127|NCT05911841|588922853|FG000|Induction Period|Study Terminated by Sponsor|2|||
163058128|NCT05911841|588922854|FG001|Induction Period|Study Terminated by Sponsor|0|||
163058129|NCT05911841|588922855|FG002|Induction Period|Study Terminated by Sponsor|14|||
163058130|NCT05911841|588922856|FG003|Induction Period|Study Terminated by Sponsor|6|||
163058131|NCT05911841|588922857|FG004|Induction Period|Study Terminated by Sponsor|0|||
163058132|NCT05911841|588922858|FG005|Induction Period|Study Terminated by Sponsor|0|||
163058133|NCT05911841|588922859|FG006|Induction Period|Study Terminated by Sponsor|0|||
163058134|NCT05911841|588922860|FG007|Induction Period|Study Terminated by Sponsor|0|||
163058135|NCT05911841|588922861|FG008|Induction Period|Study Terminated by Sponsor|0|||
163058136|NCT05911841|588922862|FG009|Induction Period|Study Terminated by Sponsor|0|||
163058137|NCT05911841|588922853|FG000|Induction Period|Withdrawal by Subject|4|||
163058138|NCT05911841|588922854|FG001|Induction Period|Withdrawal by Subject|3|||
163058139|NCT05911841|588922855|FG002|Induction Period|Withdrawal by Subject|4|||
163058140|NCT05911841|588922856|FG003|Induction Period|Withdrawal by Subject|6|||
163058141|NCT05911841|588922857|FG004|Induction Period|Withdrawal by Subject|0|||
163058142|NCT05911841|588922858|FG005|Induction Period|Withdrawal by Subject|0|||
163058143|NCT05911841|588922859|FG006|Induction Period|Withdrawal by Subject|0|||
163058144|NCT05911841|588922860|FG007|Induction Period|Withdrawal by Subject|0|||
162978770|NCT03176784|588623495|FG003|Overall Study|Lost to Follow-up|49|||
163058145|NCT05911841|588922861|FG008|Induction Period|Withdrawal by Subject|0|||
163058146|NCT05911841|588922862|FG009|Induction Period|Withdrawal by Subject|0|||
162978771|NCT03176784|588623492|FG000|Overall Study|Withdrawal by Subject|28|||
162978772|NCT03176784|588623493|FG001|Overall Study|Withdrawal by Subject|34|||
162978773|NCT03176784|588623494|FG002|Overall Study|Withdrawal by Subject|34|||
162978774|NCT03176784|588623495|FG003|Overall Study|Withdrawal by Subject|21|||
163058147|NCT05911841|588922853|FG000|Induction Period|Lack of Efficacy|3|||
163058148|NCT05911841|588922854|FG001|Induction Period|Lack of Efficacy|0|||
163058149|NCT05911841|588922855|FG002|Induction Period|Lack of Efficacy|3|||
163058150|NCT05911841|588922856|FG003|Induction Period|Lack of Efficacy|3|||
163058151|NCT05911841|588922857|FG004|Induction Period|Lack of Efficacy|0|||
163058152|NCT05911841|588922858|FG005|Induction Period|Lack of Efficacy|0|||
163058153|NCT05911841|588922859|FG006|Induction Period|Lack of Efficacy|0|||
163058154|NCT05911841|588922860|FG007|Induction Period|Lack of Efficacy|0|||
163058155|NCT05911841|588922861|FG008|Induction Period|Lack of Efficacy|0|||
163058156|NCT05911841|588922862|FG009|Induction Period|Lack of Efficacy|0|||
163058157|NCT05911841|588922853|FG000|Induction Period|Adverse Event|3|||
163058158|NCT05911841|588922854|FG001|Induction Period|Adverse Event|1|||
163058159|NCT05911841|588922855|FG002|Induction Period|Adverse Event|2|||
163058160|NCT05911841|588922856|FG003|Induction Period|Adverse Event|0|||
163058161|NCT05911841|588922857|FG004|Induction Period|Adverse Event|0|||
163058162|NCT05911841|588922858|FG005|Induction Period|Adverse Event|0|||
163058163|NCT05911841|588922859|FG006|Induction Period|Adverse Event|0|||
163058164|NCT05911841|588922860|FG007|Induction Period|Adverse Event|0|||
163058165|NCT05911841|588922861|FG008|Induction Period|Adverse Event|0|||
163058166|NCT05911841|588922862|FG009|Induction Period|Adverse Event|0|||
163058167|NCT05911841|588922853|FG000|Induction Period|Assigned Treatment by Mistake|0|||
163058168|NCT05911841|588922854|FG001|Induction Period|Assigned Treatment by Mistake|1|||
163058169|NCT05911841|588922855|FG002|Induction Period|Assigned Treatment by Mistake|0|||
163058170|NCT05911841|588922856|FG003|Induction Period|Assigned Treatment by Mistake|1|||
163058171|NCT05911841|588922857|FG004|Induction Period|Assigned Treatment by Mistake|0|||
163058172|NCT05911841|588922858|FG005|Induction Period|Assigned Treatment by Mistake|0|||
163058173|NCT05911841|588922859|FG006|Induction Period|Assigned Treatment by Mistake|0|||
163058174|NCT05911841|588922860|FG007|Induction Period|Assigned Treatment by Mistake|0|||
163058175|NCT05911841|588922861|FG008|Induction Period|Assigned Treatment by Mistake|0|||
163058176|NCT05911841|588922862|FG009|Induction Period|Assigned Treatment by Mistake|0|||
163058177|NCT05911841|588922853|FG000|Induction Period|Lost to Follow-up|0|||
163058178|NCT05911841|588922854|FG001|Induction Period|Lost to Follow-up|0|||
163058179|NCT05911841|588922855|FG002|Induction Period|Lost to Follow-up|1|||
163058180|NCT05911841|588922856|FG003|Induction Period|Lost to Follow-up|1|||
163058181|NCT05911841|588922857|FG004|Induction Period|Lost to Follow-up|0|||
163058182|NCT05911841|588922858|FG005|Induction Period|Lost to Follow-up|0|||
163058183|NCT05911841|588922859|FG006|Induction Period|Lost to Follow-up|0|||
163058184|NCT05911841|588922860|FG007|Induction Period|Lost to Follow-up|0|||
163058185|NCT05911841|588922861|FG008|Induction Period|Lost to Follow-up|0|||
163058186|NCT05911841|588922862|FG009|Induction Period|Lost to Follow-up|0|||
163058187|NCT05911841|588922853|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
163058188|NCT05911841|588922854|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
163058189|NCT05911841|588922855|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
163058190|NCT05911841|588922856|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
163058191|NCT05911841|588922857|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
163058192|NCT05911841|588922858|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
163058193|NCT05911841|588922859|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
163058194|NCT05911841|588922860|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
163058195|NCT05911841|588922861|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
163058196|NCT05911841|588922862|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
163058197|NCT05911841|588922853|FG000|Maintenance Period|Lack of Efficacy|0|||
163058198|NCT05911841|588922854|FG001|Maintenance Period|Lack of Efficacy|0|||
163058199|NCT05911841|588922855|FG002|Maintenance Period|Lack of Efficacy|0|||
163058200|NCT05911841|588922856|FG003|Maintenance Period|Lack of Efficacy|0|||
163058201|NCT05911841|588922857|FG004|Maintenance Period|Lack of Efficacy|1|||
162978775|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
162978776|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
162978777|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
162978778|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
162978779|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
162978780|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
162978781|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
162978782|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
162978783|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
163058202|NCT05911841|588922858|FG005|Maintenance Period|Lack of Efficacy|0|||
163058203|NCT05911841|588922859|FG006|Maintenance Period|Lack of Efficacy|1|||
163058204|NCT05911841|588922860|FG007|Maintenance Period|Lack of Efficacy|0|||
162978784|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
163058205|NCT05911841|588922861|FG008|Maintenance Period|Lack of Efficacy|0|||
163058206|NCT05911841|588922862|FG009|Maintenance Period|Lack of Efficacy|0|||
163058207|NCT05911841|588922853|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
163058208|NCT05911841|588922854|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
163058209|NCT05911841|588922855|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
163058210|NCT05911841|588922856|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
162713150|NCT00335556|587660876|FG003|Overall Study|Ineligible|0|||
162713151|NCT00335556|587660877|FG004|Overall Study|Ineligible|0|||
162713152|NCT00335556|587660878|FG005|Overall Study|Ineligible|0|||
162713153|NCT00335556|587660873|FG000|Overall Study|Refusal of further protocol therapy|0|||
162713154|NCT00335556|587660874|FG001|Overall Study|Refusal of further protocol therapy|4|||
162713155|NCT00335556|587660875|FG002|Overall Study|Refusal of further protocol therapy|0|||
162713156|NCT00335556|587660876|FG003|Overall Study|Refusal of further protocol therapy|1|||
162713157|NCT00335556|587660877|FG004|Overall Study|Refusal of further protocol therapy|0|||
162713158|NCT00335556|587660878|FG005|Overall Study|Refusal of further protocol therapy|0|||
162713159|NCT01674569|587660879|FG000|Overall Study|Adverse Event|0|||
162713160|NCT01674569|587660880|FG001|Overall Study|Adverse Event|2|||
162713161|NCT01674569|587660881|FG002|Overall Study|Adverse Event|0|||
162713162|NCT01674569|587660882|FG003|Overall Study|Adverse Event|1|||
162713163|NCT01674569|587660883|FG004|Overall Study|Adverse Event|2|||
162713164|NCT01674569|587660884|FG005|Overall Study|Adverse Event|2|||
162713165|NCT01674569|587660879|FG000|Overall Study|Protocol Violation|0|||
162713166|NCT01674569|587660880|FG001|Overall Study|Protocol Violation|1|||
162713167|NCT01674569|587660881|FG002|Overall Study|Protocol Violation|1|||
162713168|NCT01674569|587660882|FG003|Overall Study|Protocol Violation|0|||
162713169|NCT01674569|587660883|FG004|Overall Study|Protocol Violation|0|||
162713170|NCT01674569|587660884|FG005|Overall Study|Protocol Violation|0|||
162713171|NCT01674569|587660879|FG000|Overall Study|Withdrawal by Subject|0|||
162713172|NCT01674569|587660880|FG001|Overall Study|Withdrawal by Subject|0|||
162713173|NCT01674569|587660881|FG002|Overall Study|Withdrawal by Subject|1|||
162713174|NCT01674569|587660882|FG003|Overall Study|Withdrawal by Subject|0|||
162713175|NCT01674569|587660883|FG004|Overall Study|Withdrawal by Subject|0|||
162713176|NCT01674569|587660884|FG005|Overall Study|Withdrawal by Subject|0|||
162713177|NCT01599325|587660892|FG000|Primary Parent Phase|Adverse Event|5|||
162713178|NCT01599325|587660892|FG000|Primary Parent Phase|Disease Progression|7|||
162713179|NCT01599325|587660892|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
162713180|NCT01599325|587660892|FG000|Primary Parent Phase|Death|13|||
162713181|NCT01599325|587660892|FG000|Primary Parent Phase|Protocol Violation|1|||
162713182|NCT01599325|587660892|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
162713183|NCT01599325|587660892|FG000|Primary Parent Phase|Other|2|||
162713184|NCT01599325|587660892|FG000|Extension Phase|Study Closure|1|||
162713185|NCT01599325|587660892|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
162713186|NCT01599325|587660892|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
162713187|NCT01599325|587660892|FG000|Extension Phase|Disease Progression|1|||
162713188|NCT01599325|587660892|FG000|Extension Phase|Withdrawal by Subject|8|||
163058211|NCT05911841|588922857|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
163058212|NCT05911841|588922858|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
163058213|NCT05911841|588922859|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
163058214|NCT05911841|588922860|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
163058215|NCT05911841|588922861|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
163058216|NCT05911841|588922862|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
163058217|NCT05911841|588922853|FG000|Maintenance Period|Withdrawal by Subject|0|||
163058218|NCT05911841|588922854|FG001|Maintenance Period|Withdrawal by Subject|0|||
163058219|NCT05911841|588922855|FG002|Maintenance Period|Withdrawal by Subject|0|||
163058220|NCT05911841|588922856|FG003|Maintenance Period|Withdrawal by Subject|0|||
163058221|NCT05911841|588922857|FG004|Maintenance Period|Withdrawal by Subject|0|||
163058222|NCT05911841|588922858|FG005|Maintenance Period|Withdrawal by Subject|1|||
163058223|NCT05911841|588922859|FG006|Maintenance Period|Withdrawal by Subject|0|||
163058224|NCT05911841|588922860|FG007|Maintenance Period|Withdrawal by Subject|1|||
163058225|NCT05911841|588922861|FG008|Maintenance Period|Withdrawal by Subject|0|||
163058226|NCT05911841|588922862|FG009|Maintenance Period|Withdrawal by Subject|0|||
163058227|NCT05911841|588922853|FG000|Maintenance Period|Adverse Event|0|||
163058228|NCT05911841|588922854|FG001|Maintenance Period|Adverse Event|0|||
163058229|NCT05911841|588922855|FG002|Maintenance Period|Adverse Event|0|||
163058230|NCT05911841|588922856|FG003|Maintenance Period|Adverse Event|0|||
163058231|NCT05911841|588922857|FG004|Maintenance Period|Adverse Event|0|||
163058232|NCT05911841|588922858|FG005|Maintenance Period|Adverse Event|0|||
163058233|NCT05911841|588922859|FG006|Maintenance Period|Adverse Event|0|||
163058234|NCT05911841|588922860|FG007|Maintenance Period|Adverse Event|1|||
163058235|NCT05911841|588922861|FG008|Maintenance Period|Adverse Event|0|||
163058236|NCT05911841|588922862|FG009|Maintenance Period|Adverse Event|0|||
163058237|NCT05911841|588922853|FG000|Escape Period|Adverse Event|0|||
163058238|NCT05911841|588922854|FG001|Escape Period|Adverse Event|0|||
163058239|NCT05911841|588922855|FG002|Escape Period|Adverse Event|0|||
163058240|NCT05911841|588922856|FG003|Escape Period|Adverse Event|0|||
162713189|NCT02365298|587660893|FG000|Period 2|incorrect Rx dispensed|1|||
162713190|NCT02365298|587660894|FG001|Period 2|incorrect Rx dispensed|0|||
162713191|NCT02365298|587660893|FG000|Period 2|Discontinued at request of Sponsor|1|||
162713192|NCT02365298|587660894|FG001|Period 2|Discontinued at request of Sponsor|0|||
162713193|NCT02365298|587660893|FG000|Period 2|Test Article longer available|0|||
162713194|NCT02365298|587660894|FG001|Period 2|Test Article longer available|1|||
162713195|NCT02365298|587660893|FG000|Period 2|Protocol Violation|0|||
163058241|NCT05911841|588922857|FG004|Escape Period|Adverse Event|0|||
162713196|NCT02365298|587660894|FG001|Period 2|Protocol Violation|1|||
162713197|NCT01878890|587660895|FG000|Overall Study|Protocol Violation|0|||
162713198|NCT01878890|587660896|FG001|Overall Study|Protocol Violation|1|||
162713199|NCT01878890|587660897|FG002|Overall Study|Protocol Violation|0|||
162713200|NCT01878890|587660898|FG003|Overall Study|Protocol Violation|0|||
162713201|NCT01710514|587660903|FG000|Overall Study|Adverse Event|6|||
162713202|NCT01710514|587660904|FG001|Overall Study|Adverse Event|7|||
162713203|NCT01710514|587660903|FG000|Overall Study|Withdrawal by Subject|1|||
162713204|NCT01710514|587660904|FG001|Overall Study|Withdrawal by Subject|0|||
162713205|NCT02846415|587660905|FG000|Overall Study|Lost to Follow-up|2|||
162713206|NCT02846415|587660906|FG001|Overall Study|Lost to Follow-up|0|||
162713207|NCT02846415|587660905|FG000|Overall Study|Withdrawal by Subject|1|||
162713208|NCT02846415|587660906|FG001|Overall Study|Withdrawal by Subject|1|||
162978785|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
162978786|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
162978787|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978788|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162713209|NCT03404843|587660907|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
162713210|NCT03404843|587660908|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
162713211|NCT00567164|587660909|FG000|Overall Study|Withdrawal by Subject|171|||
162713212|NCT00567164|587660910|FG001|Overall Study|Withdrawal by Subject|21|||
162713213|NCT00567164|587660911|FG002|Overall Study|Withdrawal by Subject|17|||
162713214|NCT00567164|587660909|FG000|Overall Study|Protocol Violation|23|||
162713215|NCT00567164|587660910|FG001|Overall Study|Protocol Violation|4|||
162713216|NCT00567164|587660911|FG002|Overall Study|Protocol Violation|2|||
162713217|NCT00567164|587660909|FG000|Overall Study|Adverse Event|92|||
162713218|NCT00567164|587660910|FG001|Overall Study|Adverse Event|13|||
162713219|NCT00567164|587660911|FG002|Overall Study|Adverse Event|9|||
162713220|NCT00567164|587660909|FG000|Overall Study|Death|0|||
162713221|NCT00567164|587660910|FG001|Overall Study|Death|0|||
162713222|NCT00567164|587660911|FG002|Overall Study|Death|1|||
162713223|NCT00567164|587660909|FG000|Overall Study|Lost to Follow-up|202|||
162713224|NCT00567164|587660910|FG001|Overall Study|Lost to Follow-up|23|||
162713225|NCT00567164|587660911|FG002|Overall Study|Lost to Follow-up|21|||
162713226|NCT00567164|587660909|FG000|Overall Study|Pregnancy|20|||
162713227|NCT00567164|587660910|FG001|Overall Study|Pregnancy|4|||
162713228|NCT00567164|587660911|FG002|Overall Study|Pregnancy|6|||
162713229|NCT00567164|587660909|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
162713230|NCT00567164|587660910|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
162713231|NCT00567164|587660911|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
162713232|NCT00567164|587660909|FG000|Overall Study|Missing|1|||
162713233|NCT00567164|587660910|FG001|Overall Study|Missing|0|||
162713234|NCT00567164|587660911|FG002|Overall Study|Missing|0|||
162978789|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978790|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978791|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
162978792|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
162978793|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
162978794|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
162978795|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
162978796|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
162978797|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
162978798|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
162978799|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
162978800|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
162978801|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
162978802|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
162978803|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Death|0|||
162978804|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Death|1|||
162978805|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Death|0|||
162978806|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Death|0|||
162978807|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
162978808|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
162978809|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
162978810|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
163058242|NCT05911841|588922858|FG005|Escape Period|Adverse Event|0|||
162713235|NCT02595398|587660918|FG000|Overall Study|Non-compliance|1|||
162978811|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
163058243|NCT05911841|588922859|FG006|Escape Period|Adverse Event|0|||
162713236|NCT02595398|587660919|FG001|Overall Study|Non-compliance|0|||
162713237|NCT02595398|587660918|FG000|Overall Study|Withdrawal by Subject|2|||
162978812|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
162713238|NCT02595398|587660919|FG001|Overall Study|Withdrawal by Subject|1|||
162713239|NCT02595398|587660918|FG000|Overall Study|Lost to Follow-up|1|||
162713240|NCT02595398|587660919|FG001|Overall Study|Lost to Follow-up|0|||
162978813|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
162978814|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
162978815|NCT02990806|588623496|FG000|Stage 1 (22 Weeks)|Other|1|||
162978816|NCT02990806|588623497|FG001|Stage 1 (22 Weeks)|Other|3|||
162978817|NCT02990806|588623498|FG002|Stage 1 (22 Weeks)|Other|0|||
162978818|NCT02990806|588623499|FG003|Stage 1 (22 Weeks)|Other|0|||
162978819|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
162978820|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
162978821|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
162978822|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
162978823|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Death|1|||
162978824|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Death|0|||
162978825|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Death|0|||
162978826|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Death|0|||
162978827|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
162978828|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
162978829|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
162978830|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
162978831|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
162978832|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
162978833|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
162978834|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
162978835|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978836|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
162978837|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978838|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
162978839|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
162978840|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
162978841|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
162978842|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
162978843|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978844|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978845|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
162978846|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
162978847|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
162978848|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
162978849|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
162978850|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
162978851|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
162978852|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
162978853|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
162978854|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
162978855|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
162978856|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
162978857|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
162978858|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
162978859|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
162978860|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
162978861|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
162978862|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
162978863|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Other|3|||
162978864|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Other|0|||
162978865|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Other|4|||
162978866|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Other|1|||
162978867|NCT02990806|588623496|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978868|NCT02990806|588623497|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978869|NCT02990806|588623498|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
162978870|NCT02990806|588623499|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
162978871|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
162978872|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
162978873|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
162978874|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
162978875|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978876|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
162978877|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978878|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162978879|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978880|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162978881|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
163058244|NCT05911841|588922860|FG007|Escape Period|Adverse Event|0|||
163058245|NCT05911841|588922861|FG008|Escape Period|Adverse Event|0|||
163058246|NCT05911841|588922862|FG009|Escape Period|Adverse Event|1|||
163058247|NCT05911841|588922853|FG000|Escape Period|Lack of Efficacy|0|||
163058248|NCT05911841|588922854|FG001|Escape Period|Lack of Efficacy|0|||
163058249|NCT05911841|588922855|FG002|Escape Period|Lack of Efficacy|0|||
163058250|NCT05911841|588922856|FG003|Escape Period|Lack of Efficacy|0|||
163058251|NCT05911841|588922857|FG004|Escape Period|Lack of Efficacy|0|||
163058252|NCT05911841|588922858|FG005|Escape Period|Lack of Efficacy|0|||
163058253|NCT05911841|588922859|FG006|Escape Period|Lack of Efficacy|0|||
163058254|NCT05911841|588922860|FG007|Escape Period|Lack of Efficacy|0|||
163058255|NCT05911841|588922861|FG008|Escape Period|Lack of Efficacy|0|||
163058256|NCT05911841|588922862|FG009|Escape Period|Lack of Efficacy|31|||
163058257|NCT05911841|588922853|FG000|Escape Period|Lost to Follow-up|0|||
163058258|NCT05911841|588922854|FG001|Escape Period|Lost to Follow-up|0|||
163058259|NCT05911841|588922855|FG002|Escape Period|Lost to Follow-up|0|||
163058260|NCT05911841|588922856|FG003|Escape Period|Lost to Follow-up|0|||
163058261|NCT05911841|588922857|FG004|Escape Period|Lost to Follow-up|0|||
163058262|NCT05911841|588922858|FG005|Escape Period|Lost to Follow-up|0|||
162713241|NCT00502593|587660920|FG000|Overall Study|Withdrawn unspecified reason|1|||
162713242|NCT00502593|587660921|FG001|Overall Study|Withdrawn unspecified reason|1|||
162713243|NCT00502593|587660922|FG002|Overall Study|Withdrawn unspecified reason|3|||
162713244|NCT00502593|587660923|FG003|Overall Study|Withdrawn unspecified reason|1|||
162713245|NCT00502593|587660924|FG004|Overall Study|Withdrawn unspecified reason|2|||
162713246|NCT00502593|587660925|FG005|Overall Study|Withdrawn unspecified reason|0|||
162713247|NCT00502593|587660926|FG006|Overall Study|Withdrawn unspecified reason|2|||
162713248|NCT00502593|587660927|FG007|Overall Study|Withdrawn unspecified reason|0|||
162713249|NCT00502593|587660928|FG008|Overall Study|Withdrawn unspecified reason|0|||
163058263|NCT05911841|588922859|FG006|Escape Period|Lost to Follow-up|0|||
163058264|NCT05911841|588922860|FG007|Escape Period|Lost to Follow-up|0|||
163058265|NCT05911841|588922861|FG008|Escape Period|Lost to Follow-up|0|||
163058266|NCT05911841|588922862|FG009|Escape Period|Lost to Follow-up|1|||
163058267|NCT05911841|588922853|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058268|NCT05911841|588922854|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058269|NCT05911841|588922855|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058270|NCT05911841|588922856|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058271|NCT05911841|588922857|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058272|NCT05911841|588922858|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058273|NCT05911841|588922859|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058274|NCT05911841|588922860|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058275|NCT05911841|588922861|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
163058276|NCT05911841|588922862|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
163058277|NCT05911841|588922853|FG000|Escape Period|Site Terminated by Sponsor|0|||
163058278|NCT05911841|588922854|FG001|Escape Period|Site Terminated by Sponsor|0|||
163058279|NCT05911841|588922855|FG002|Escape Period|Site Terminated by Sponsor|0|||
163058280|NCT05911841|588922856|FG003|Escape Period|Site Terminated by Sponsor|0|||
163058281|NCT05911841|588922857|FG004|Escape Period|Site Terminated by Sponsor|0|||
163058282|NCT05911841|588922858|FG005|Escape Period|Site Terminated by Sponsor|0|||
163058283|NCT05911841|588922859|FG006|Escape Period|Site Terminated by Sponsor|0|||
163058284|NCT05911841|588922860|FG007|Escape Period|Site Terminated by Sponsor|0|||
163058285|NCT05911841|588922861|FG008|Escape Period|Site Terminated by Sponsor|0|||
163058286|NCT05911841|588922862|FG009|Escape Period|Site Terminated by Sponsor|1|||
163058287|NCT05911841|588922853|FG000|Escape Period|Study Terminated by Sponsor|0|||
163058288|NCT05911841|588922854|FG001|Escape Period|Study Terminated by Sponsor|0|||
162713250|NCT00502593|587660929|FG009|Overall Study|Withdrawn unspecified reason|0|||
162713251|NCT00502593|587660930|FG010|Overall Study|Withdrawn unspecified reason|0|||
162713252|NCT00502593|587660931|FG011|Overall Study|Withdrawn unspecified reason|0|||
162713253|NCT00502593|587660920|FG000|Overall Study|Withdrawal by Subject|0|||
163058289|NCT05911841|588922855|FG002|Escape Period|Study Terminated by Sponsor|0|||
163058290|NCT05911841|588922856|FG003|Escape Period|Study Terminated by Sponsor|0|||
163058291|NCT05911841|588922857|FG004|Escape Period|Study Terminated by Sponsor|0|||
163058292|NCT05911841|588922858|FG005|Escape Period|Study Terminated by Sponsor|0|||
162713254|NCT00502593|587660921|FG001|Overall Study|Withdrawal by Subject|0|||
162713255|NCT00502593|587660922|FG002|Overall Study|Withdrawal by Subject|6|||
162713256|NCT00502593|587660923|FG003|Overall Study|Withdrawal by Subject|2|||
163058293|NCT05911841|588922859|FG006|Escape Period|Study Terminated by Sponsor|0|||
163058294|NCT05911841|588922860|FG007|Escape Period|Study Terminated by Sponsor|0|||
163058295|NCT05911841|588922861|FG008|Escape Period|Study Terminated by Sponsor|0|||
163058296|NCT05911841|588922862|FG009|Escape Period|Study Terminated by Sponsor|34|||
163058297|NCT05911841|588922853|FG000|Escape Period|Withdrawal by Subject|0|||
163058298|NCT05911841|588922854|FG001|Escape Period|Withdrawal by Subject|0|||
163058299|NCT05911841|588922855|FG002|Escape Period|Withdrawal by Subject|0|||
162713257|NCT00502593|587660924|FG004|Overall Study|Withdrawal by Subject|2|||
162713258|NCT00502593|587660925|FG005|Overall Study|Withdrawal by Subject|0|||
162713259|NCT00502593|587660926|FG006|Overall Study|Withdrawal by Subject|3|||
162713260|NCT00502593|587660927|FG007|Overall Study|Withdrawal by Subject|0|||
162713261|NCT00502593|587660928|FG008|Overall Study|Withdrawal by Subject|3|||
162713262|NCT00502593|587660929|FG009|Overall Study|Withdrawal by Subject|0|||
162713263|NCT00502593|587660930|FG010|Overall Study|Withdrawal by Subject|1|||
162713264|NCT00502593|587660931|FG011|Overall Study|Withdrawal by Subject|0|||
162713265|NCT00502593|587660920|FG000|Overall Study|Lost to Follow-up|2|||
162713266|NCT00502593|587660921|FG001|Overall Study|Lost to Follow-up|1|||
162713267|NCT00502593|587660922|FG002|Overall Study|Lost to Follow-up|1|||
162713268|NCT00502593|587660923|FG003|Overall Study|Lost to Follow-up|1|||
162713269|NCT00502593|587660924|FG004|Overall Study|Lost to Follow-up|0|||
162713270|NCT00502593|587660925|FG005|Overall Study|Lost to Follow-up|0|||
162713271|NCT00502593|587660926|FG006|Overall Study|Lost to Follow-up|0|||
162713272|NCT00502593|587660927|FG007|Overall Study|Lost to Follow-up|0|||
162713273|NCT00502593|587660928|FG008|Overall Study|Lost to Follow-up|3|||
162713274|NCT00502593|587660929|FG009|Overall Study|Lost to Follow-up|0|||
162713275|NCT00502593|587660930|FG010|Overall Study|Lost to Follow-up|1|||
162713276|NCT00502593|587660931|FG011|Overall Study|Lost to Follow-up|0|||
162713277|NCT00544440|587660932|FG000|Overall Study|Other|1|||
162713278|NCT00544440|587660932|FG000|Overall Study|Adverse Event|1|||
162713279|NCT00544440|587660932|FG000|Overall Study|Withdrawal by Subject|2|||
162713280|NCT00544440|587660932|FG000|Overall Study|Subject Non-compliance|1|||
162713281|NCT00544440|587660932|FG000|Overall Study|Progressive Disease|47|||
162713282|NCT00544440|587660932|FG000|Overall Study|Other|5|||
162713283|NCT03601507|587660933|FG000|Overall Study|Adverse Event|1|||
162713284|NCT00559949|587660936|FG000|Overall Study|Progressive Disease during cycle 1|1|||
162713285|NCT00559949|587660936|FG000|Overall Study|Adverse Event|1|||
162713286|NCT00559949|587660936|FG000|Overall Study|Withdrawal by Subject|4|||
162713287|NCT00559949|587660936|FG000|Overall Study|No disease evaluation per protocol|1|||
162713288|NCT03381274|587660937|FG000|Overall Study|Death|2|||
162713289|NCT03381274|587660938|FG001|Overall Study|Death|9|||
162713290|NCT03381274|587660939|FG002|Overall Study|Death|3|||
162713291|NCT03381274|587660940|FG003|Overall Study|Death|2|||
162713292|NCT03381274|587660941|FG004|Overall Study|Death|3|||
162713293|NCT03381274|587660937|FG000|Overall Study|Lost to Follow-up|0|||
162713294|NCT03381274|587660938|FG001|Overall Study|Lost to Follow-up|0|||
162713295|NCT03381274|587660939|FG002|Overall Study|Lost to Follow-up|0|||
162713296|NCT03381274|587660940|FG003|Overall Study|Lost to Follow-up|1|||
162713297|NCT03381274|587660941|FG004|Overall Study|Lost to Follow-up|0|||
162713298|NCT03381274|587660937|FG000|Overall Study|Withdrawal by Subject|2|||
162713299|NCT03381274|587660938|FG001|Overall Study|Withdrawal by Subject|1|||
162713300|NCT03381274|587660939|FG002|Overall Study|Withdrawal by Subject|3|||
162713301|NCT03381274|587660940|FG003|Overall Study|Withdrawal by Subject|1|||
162713302|NCT03381274|587660941|FG004|Overall Study|Withdrawal by Subject|0|||
162713303|NCT03381274|587660937|FG000|Overall Study|Other|1|||
162713304|NCT03381274|587660938|FG001|Overall Study|Other|11|||
162713305|NCT03381274|587660939|FG002|Overall Study|Other|0|||
162713306|NCT03381274|587660940|FG003|Overall Study|Other|2|||
162713307|NCT03381274|587660941|FG004|Overall Study|Other|2|||
162713308|NCT01458275|587660942|FG000|Overall Study|Adverse Event|3|||
162713309|NCT01458275|587660943|FG001|Overall Study|Adverse Event|4|||
162713310|NCT01458275|587660944|FG002|Overall Study|Adverse Event|1|||
162713311|NCT01458275|587660942|FG000|Overall Study|Lost to Follow-up|3|||
162713312|NCT01458275|587660943|FG001|Overall Study|Lost to Follow-up|2|||
162713313|NCT01458275|587660944|FG002|Overall Study|Lost to Follow-up|5|||
162713314|NCT01458275|587660942|FG000|Overall Study|Protocol Violation|5|||
162713315|NCT01458275|587660943|FG001|Overall Study|Protocol Violation|5|||
162713316|NCT01458275|587660944|FG002|Overall Study|Protocol Violation|2|||
162713317|NCT01458275|587660942|FG000|Overall Study|Withdrawal by Subject|3|||
162713318|NCT01458275|587660943|FG001|Overall Study|Withdrawal by Subject|2|||
162713319|NCT01458275|587660944|FG002|Overall Study|Withdrawal by Subject|1|||
162713320|NCT00751036|587660945|FG000|Overall Study|Disease Progression|28|||
162713321|NCT00751036|587660946|FG001|Overall Study|Disease Progression|29|||
162713322|NCT00751036|587660945|FG000|Overall Study|Adverse Event|6|||
162713323|NCT00751036|587660946|FG001|Overall Study|Adverse Event|4|||
162713324|NCT00751036|587660945|FG000|Overall Study|Administrative Problems|3|||
162713325|NCT00751036|587660946|FG001|Overall Study|Administrative Problems|4|||
162713326|NCT00751036|587660945|FG000|Overall Study|Withdrawal by Subject|5|||
162713327|NCT00751036|587660946|FG001|Overall Study|Withdrawal by Subject|2|||
162713328|NCT00751036|587660945|FG000|Overall Study|Death|3|||
162713329|NCT00751036|587660946|FG001|Overall Study|Death|3|||
162713330|NCT00751036|587660945|FG000|Overall Study|Lost to Follow-up|0|||
162713331|NCT00751036|587660946|FG001|Overall Study|Lost to Follow-up|1|||
162713332|NCT00751036|587660945|FG000|Overall Study|Protocol Violation|1|||
162713333|NCT00751036|587660946|FG001|Overall Study|Protocol Violation|0|||
162713334|NCT00751036|587660945|FG000|Overall Study|Missing end of Treatment Page|2|||
162713335|NCT00751036|587660946|FG001|Overall Study|Missing end of Treatment Page|3|||
162713336|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
162713337|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
162713338|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
162713339|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162713340|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162713341|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162713342|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
162713343|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
162713344|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
162713345|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
162713346|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
163058300|NCT05911841|588922856|FG003|Escape Period|Withdrawal by Subject|0|||
163058301|NCT05911841|588922857|FG004|Escape Period|Withdrawal by Subject|0|||
163058302|NCT05911841|588922858|FG005|Escape Period|Withdrawal by Subject|0|||
163058303|NCT05911841|588922859|FG006|Escape Period|Withdrawal by Subject|0|||
163058304|NCT05911841|588922860|FG007|Escape Period|Withdrawal by Subject|0|||
163058305|NCT05911841|588922861|FG008|Escape Period|Withdrawal by Subject|0|||
163058306|NCT05911841|588922862|FG009|Escape Period|Withdrawal by Subject|10|||
163058307|NCT05595369|588922863|FG000|Overall Study|Adverse Event|2|||
163058308|NCT05595369|588922864|FG001|Overall Study|Adverse Event|0|||
163058309|NCT05595369|588922865|FG002|Overall Study|Adverse Event|0|||
163058310|NCT05595369|588922863|FG000|Overall Study|Lost to Follow-up|11|||
162713347|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
162713348|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162713349|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162713350|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162713351|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
162713352|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162713353|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162713354|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
162713355|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
162713356|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
162713357|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713358|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713359|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713360|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713361|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713362|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162713363|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
162713364|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
162713365|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
162713366|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713367|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713368|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713369|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713370|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713371|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162713372|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
162713373|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
162713374|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
162713375|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162713376|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162713377|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163058311|NCT05595369|588922864|FG001|Overall Study|Lost to Follow-up|10|||
163058312|NCT05595369|588922865|FG002|Overall Study|Lost to Follow-up|10|||
163058313|NCT05595369|588922863|FG000|Overall Study|Physician Decision|1|||
163058314|NCT05595369|588922864|FG001|Overall Study|Physician Decision|0|||
163058315|NCT05595369|588922865|FG002|Overall Study|Physician Decision|0|||
163058316|NCT05595369|588922863|FG000|Overall Study|Withdrawal by Subject|5|||
163058317|NCT05595369|588922864|FG001|Overall Study|Withdrawal by Subject|7|||
163058318|NCT05595369|588922865|FG002|Overall Study|Withdrawal by Subject|6|||
163058319|NCT05595369|588922863|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163058320|NCT05595369|588922864|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
163058321|NCT05595369|588922865|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
162713378|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
162713379|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162713380|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162713381|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
163058322|NCT05595369|588922863|FG000|Overall Study|Study Drug Non-compliance|0|||
163058323|NCT05595369|588922864|FG001|Overall Study|Study Drug Non-compliance|1|||
163058324|NCT05595369|588922865|FG002|Overall Study|Study Drug Non-compliance|0|||
163058325|NCT05595369|588922863|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
163058326|NCT05595369|588922864|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
163058327|NCT05595369|588922865|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
163058328|NCT01981616|588922872|FG000|Overall Study|Adverse Event|0|||
163058329|NCT01981616|588922873|FG001|Overall Study|Adverse Event|1|||
163058330|NCT01981616|588922872|FG000|Overall Study|Protocol Violation|1|||
163058331|NCT01981616|588922873|FG001|Overall Study|Protocol Violation|0|||
163058332|NCT05079321|588922878|FG000|Overall Study|Withdrawal by Subject|2|||
163058333|NCT05079321|588922879|FG001|Overall Study|Withdrawal by Subject|2|||
163058334|NCT05079321|588922878|FG000|Overall Study|Lost to Follow-up|0|||
163058335|NCT05079321|588922879|FG001|Overall Study|Lost to Follow-up|1|||
163058336|NCT01081626|588922880|FG000|Overall Study|Dosing error|1|||
163058337|NCT01081626|588922881|FG001|Overall Study|Dosing error|1|||
163058338|NCT01081626|588922880|FG000|Overall Study|Missing Estradiol|25|||
163058339|NCT01081626|588922881|FG001|Overall Study|Missing Estradiol|28|||
163058340|NCT01081626|588922880|FG000|Overall Study|Low antral follicle count|1|||
163058341|NCT01081626|588922881|FG001|Overall Study|Low antral follicle count|0|||
163058342|NCT01081626|588922880|FG000|Overall Study|Overstimulation|0|||
163058343|NCT01081626|588922881|FG001|Overall Study|Overstimulation|1|||
163058344|NCT01081626|588922880|FG000|Overall Study|Lost to Follow-up|0|||
163058345|NCT01081626|588922881|FG001|Overall Study|Lost to Follow-up|1|||
163058346|NCT01081626|588922880|FG000|Overall Study|Other|33|||
163058347|NCT01081626|588922881|FG001|Overall Study|Other|30|||
163058348|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Other than specified|2|||
163058349|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Other than specified|4|||
163058350|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
163058351|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
163058352|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Pregnancy|0|||
163058353|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Pregnancy|2|||
163058354|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Physician Decision|1|||
163058355|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Physician Decision|1|||
163058356|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
163058357|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
163058358|NCT02003144|588922882|FG000|Open Label Maintenance Phase|Adverse Event|2|||
163058359|NCT02003144|588922883|FG001|Open Label Maintenance Phase|Adverse Event|1|||
163058360|NCT02074514|588922887|FG000|Overall Study|Lack of Efficacy|3|||
163058361|NCT02074514|588922888|FG001|Overall Study|Lack of Efficacy|2|||
163058362|NCT02074514|588922887|FG000|Overall Study|Lost to Follow-up|0|||
163058363|NCT02074514|588922888|FG001|Overall Study|Lost to Follow-up|1|||
163058364|NCT02074514|588922887|FG000|Overall Study|Withdrew Consent|0|||
163058365|NCT02074514|588922888|FG001|Overall Study|Withdrew Consent|1|||
163058366|NCT00666237|588922891|FG000|Overall Study|Death|5|||
163058367|NCT00666237|588922892|FG001|Overall Study|Death|5|||
163058368|NCT00666237|588922891|FG000|Overall Study|Lost to Follow-up|29|||
163058369|NCT00666237|588922892|FG001|Overall Study|Lost to Follow-up|25|||
163058370|NCT02839707|588922894|FG000|Phase I|Not eligible for analysis|9|||
163058371|NCT02839707|588922895|FG001|Phase I|Not eligible for analysis|0|||
163058372|NCT02839707|588922896|FG002|Phase I|Not eligible for analysis|0|||
163058373|NCT02839707|588922894|FG000|Phase II|Not treated according to protocol|4|||
163058374|NCT02839707|588922895|FG001|Phase II|Not treated according to protocol|0|||
163058375|NCT02839707|588922896|FG002|Phase II|Not treated according to protocol|2|||
163058376|NCT02839707|588922894|FG000|Phase III|Not treated according to protocol|0|||
163058377|NCT02839707|588922895|FG001|Phase III|Not treated according to protocol|0|||
163058378|NCT02839707|588922896|FG002|Phase III|Not treated according to protocol|4|||
163058379|NCT05507437|588924223|FG000|Overall Study|Withdrawal by Subject|1|||
163058380|NCT05507437|588924224|FG001|Overall Study|Withdrawal by Subject|1|||
163058381|NCT05507437|588924223|FG000|Overall Study|Death|3|||
163058382|NCT05507437|588924224|FG001|Overall Study|Death|0|||
163058383|NCT06583096|588924225|FG000|Overall Study|Lost to Follow-up|4|||
163058384|NCT06583096|588924226|FG001|Overall Study|Lost to Follow-up|10|||
163058385|NCT06583096|588924225|FG000|Overall Study|Withdrawal by Subject|0|||
163058386|NCT06583096|588924226|FG001|Overall Study|Withdrawal by Subject|2|||
163058387|NCT05172609|588924227|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
163058388|NCT05172609|588924228|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
163058389|NCT05172609|588924227|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
163058390|NCT05172609|588924228|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
162713382|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162924168|NCT00445458|588423819|FG001|Overall Study|Surgery|0|||
163058391|NCT05172609|588924227|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
163058392|NCT05172609|588924228|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
163058393|NCT05610605|588924231|FG000|6-month Assessment|Death|1|||
163058394|NCT05610605|588924232|FG001|6-month Assessment|Death|1|||
163058395|NCT05610605|588924231|FG000|6-month Assessment|Lost to Follow-up|20|||
163058396|NCT05610605|588924232|FG001|6-month Assessment|Lost to Follow-up|0|||
163058397|NCT05610605|588924231|FG000|6-month Assessment|Institutionalized|1|||
163058398|NCT05610605|588924232|FG001|6-month Assessment|Institutionalized|2|||
163058399|NCT05610605|588924231|FG000|12-month Assessment|Death|2|||
163058400|NCT05610605|588924232|FG001|12-month Assessment|Death|1|||
163058401|NCT05610605|588924231|FG000|12-month Assessment|Lost to Follow-up|1|||
163058402|NCT05610605|588924232|FG001|12-month Assessment|Lost to Follow-up|4|||
163058403|NCT05610605|588924231|FG000|12-month Assessment|Institutionalized|2|||
163058404|NCT05610605|588924232|FG001|12-month Assessment|Institutionalized|1|||
163058405|NCT00753519|588924233|FG000|Overall Study|Withdrawal by Subject|0|||
163058406|NCT00753519|588924234|FG001|Overall Study|Withdrawal by Subject|2|||
163058407|NCT00042289|588924235|FG000|Overall Study|Lost to Follow-up|3|||
163058408|NCT00042289|588924236|FG001|Overall Study|Lost to Follow-up|0|||
163058409|NCT00042289|588924237|FG002|Overall Study|Lost to Follow-up|0|||
163058410|NCT00042289|588924238|FG003|Overall Study|Lost to Follow-up|1|||
163058411|NCT00042289|588924239|FG004|Overall Study|Lost to Follow-up|3|||
163058412|NCT00042289|588924240|FG005|Overall Study|Lost to Follow-up|3|||
163058413|NCT00042289|588924241|FG006|Overall Study|Lost to Follow-up|6|||
163058414|NCT00042289|588924242|FG007|Overall Study|Lost to Follow-up|1|||
163058415|NCT00042289|588924243|FG008|Overall Study|Lost to Follow-up|1|||
163058416|NCT00042289|588924244|FG009|Overall Study|Lost to Follow-up|0|||
163058417|NCT00042289|588924245|FG010|Overall Study|Lost to Follow-up|0|||
163058418|NCT00042289|588924246|FG011|Overall Study|Lost to Follow-up|0|||
163058419|NCT00042289|588924247|FG012|Overall Study|Lost to Follow-up|0|||
163058420|NCT00042289|588924248|FG013|Overall Study|Lost to Follow-up|0|||
163058421|NCT00042289|588924249|FG014|Overall Study|Lost to Follow-up|0|||
163058422|NCT00042289|588924250|FG015|Overall Study|Lost to Follow-up|1|||
163058423|NCT00042289|588924251|FG016|Overall Study|Lost to Follow-up|1|||
163058424|NCT00042289|588924252|FG017|Overall Study|Lost to Follow-up|0|||
163058425|NCT00042289|588924253|FG018|Overall Study|Lost to Follow-up|3|||
163058426|NCT00042289|588924254|FG019|Overall Study|Lost to Follow-up|2|||
163058427|NCT00042289|588924255|FG020|Overall Study|Lost to Follow-up|0|||
163058428|NCT00042289|588924256|FG021|Overall Study|Lost to Follow-up|0|||
163058429|NCT00042289|588924257|FG022|Overall Study|Lost to Follow-up|0|||
163058430|NCT00042289|588924258|FG023|Overall Study|Lost to Follow-up|0|||
163058431|NCT00042289|588924259|FG024|Overall Study|Lost to Follow-up|0|||
163058432|NCT00042289|588924260|FG025|Overall Study|Lost to Follow-up|0|||
163058433|NCT00042289|588924261|FG026|Overall Study|Lost to Follow-up|2|||
163058434|NCT00042289|588924262|FG027|Overall Study|Lost to Follow-up|2|||
163058435|NCT00042289|588924263|FG028|Overall Study|Lost to Follow-up|2|||
163058436|NCT00042289|588924264|FG029|Overall Study|Lost to Follow-up|0|||
163058437|NCT00042289|588924265|FG030|Overall Study|Lost to Follow-up|0|||
163058438|NCT00042289|588924266|FG031|Overall Study|Lost to Follow-up|2|||
163058439|NCT00042289|588924267|FG032|Overall Study|Lost to Follow-up|1|||
163058440|NCT00042289|588924268|FG033|Overall Study|Lost to Follow-up|1|||
163058441|NCT00042289|588924269|FG034|Overall Study|Lost to Follow-up|1|||
163058442|NCT00042289|588924270|FG035|Overall Study|Lost to Follow-up|2|||
163058443|NCT00042289|588924271|FG036|Overall Study|Lost to Follow-up|1|||
163058444|NCT00042289|588924272|FG037|Overall Study|Lost to Follow-up|1|||
163058445|NCT00042289|588924273|FG038|Overall Study|Lost to Follow-up|0|||
163058446|NCT00042289|588924274|FG039|Overall Study|Lost to Follow-up|5|||
163058447|NCT00042289|588924275|FG040|Overall Study|Lost to Follow-up|0|||
163058448|NCT00042289|588924276|FG041|Overall Study|Lost to Follow-up|2|||
163058449|NCT00042289|588924277|FG042|Overall Study|Lost to Follow-up|2|||
163058450|NCT00042289|588924278|FG043|Overall Study|Lost to Follow-up|0|||
163058451|NCT00042289|588924279|FG044|Overall Study|Lost to Follow-up|0|||
163058452|NCT00042289|588924280|FG045|Overall Study|Lost to Follow-up|1|||
163058453|NCT00042289|588924281|FG046|Overall Study|Lost to Follow-up|0|||
163058454|NCT00042289|588924235|FG000|Overall Study|Other reason|0|||
163058455|NCT00042289|588924236|FG001|Overall Study|Other reason|0|||
162713383|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163058456|NCT00042289|588924237|FG002|Overall Study|Other reason|0|||
163058457|NCT00042289|588924238|FG003|Overall Study|Other reason|2|||
163058458|NCT00042289|588924239|FG004|Overall Study|Other reason|0|||
163058459|NCT00042289|588924240|FG005|Overall Study|Other reason|0|||
163058460|NCT00042289|588924241|FG006|Overall Study|Other reason|0|||
163058461|NCT00042289|588924242|FG007|Overall Study|Other reason|0|||
163058462|NCT00042289|588924243|FG008|Overall Study|Other reason|0|||
163058463|NCT00042289|588924244|FG009|Overall Study|Other reason|0|||
163058464|NCT00042289|588924245|FG010|Overall Study|Other reason|0|||
163058465|NCT00042289|588924246|FG011|Overall Study|Other reason|0|||
163058466|NCT00042289|588924247|FG012|Overall Study|Other reason|0|||
163058467|NCT00042289|588924248|FG013|Overall Study|Other reason|0|||
163058468|NCT00042289|588924249|FG014|Overall Study|Other reason|0|||
163058469|NCT00042289|588924250|FG015|Overall Study|Other reason|0|||
163058470|NCT00042289|588924251|FG016|Overall Study|Other reason|0|||
163058471|NCT00042289|588924252|FG017|Overall Study|Other reason|0|||
163058472|NCT00042289|588924253|FG018|Overall Study|Other reason|1|||
163058473|NCT00042289|588924254|FG019|Overall Study|Other reason|0|||
163058474|NCT00042289|588924255|FG020|Overall Study|Other reason|0|||
162713384|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162713385|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162713386|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162978882|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162978883|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
162978884|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
162978885|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
162978886|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
162978887|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
162978888|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
162978889|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
162978890|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
162978891|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978892|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978893|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
162978894|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
162978895|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978896|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978897|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
162978898|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
162978899|NCT02990806|588623496|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978900|NCT02990806|588623497|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978901|NCT02990806|588623498|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
162978902|NCT02990806|588623499|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
162978903|NCT04403763|588623500|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
162978904|NCT04403763|588623501|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
162978905|NCT04403763|588623502|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978906|NCT04403763|588623503|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978907|NCT04403763|588623504|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978908|NCT04403763|588623505|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978909|NCT04403763|588623506|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
162978910|NCT04403763|588623500|FG000|Stage 1|Early termination due to PK tube failure|0|||
162978911|NCT04403763|588623501|FG001|Stage 1|Early termination due to PK tube failure|0|||
162978912|NCT04403763|588623502|FG002|Stage 1|Early termination due to PK tube failure|1|||
162978913|NCT04403763|588623503|FG003|Stage 1|Early termination due to PK tube failure|0|||
162978914|NCT04403763|588623504|FG004|Stage 1|Early termination due to PK tube failure|0|||
162978915|NCT04403763|588623505|FG005|Stage 1|Early termination due to PK tube failure|0|||
162978916|NCT04403763|588623506|FG006|Stage 1|Early termination due to PK tube failure|0|||
162978917|NCT04403763|588623500|FG000|Stage 2A|Adverse Event|0|||
162978918|NCT04403763|588623501|FG001|Stage 2A|Adverse Event|0|||
162978919|NCT04403763|588623502|FG002|Stage 2A|Adverse Event|0|||
162978920|NCT04403763|588623503|FG003|Stage 2A|Adverse Event|0|||
162978921|NCT04403763|588623504|FG004|Stage 2A|Adverse Event|0|||
162978922|NCT04403763|588623505|FG005|Stage 2A|Adverse Event|0|||
162978923|NCT04403763|588623506|FG006|Stage 2A|Adverse Event|1|||
162978924|NCT00350402|588623507|FG000|Overall Study|Lost to Follow-up|1|||
162978925|NCT00350402|588623508|FG001|Overall Study|Lost to Follow-up|1|||
162978926|NCT01376310|588623509|FG000|Overall Study|Study closed/terminated|1|||
162978927|NCT01376310|588623510|FG001|Overall Study|Study closed/terminated|2|||
162978928|NCT01376310|588623509|FG000|Overall Study|Withdrawal by Subject|8|||
162978929|NCT01376310|588623510|FG001|Overall Study|Withdrawal by Subject|2|||
162978930|NCT01376310|588623509|FG000|Overall Study|Physician Decision|26|||
162978931|NCT01376310|588623510|FG001|Overall Study|Physician Decision|7|||
162978932|NCT01376310|588623509|FG000|Overall Study|Lost to Follow-up|1|||
162978933|NCT01376310|588623510|FG001|Overall Study|Lost to Follow-up|0|||
162978934|NCT00645944|588623511|FG000|Randomized|Withdrawal by Subject|1|||
162978935|NCT00645944|588623512|FG001|Randomized|Withdrawal by Subject|2|||
162978936|NCT00645944|588623511|FG000|Received Medication|Adverse Event|2|||
162978937|NCT00645944|588623512|FG001|Received Medication|Adverse Event|1|||
162978938|NCT00645944|588623511|FG000|Received Medication|Withdrawal by Subject|1|||
162978939|NCT00645944|588623512|FG001|Received Medication|Withdrawal by Subject|1|||
162978940|NCT00645944|588623511|FG000|Received Medication|Lost to Follow-up|1|||
162978941|NCT00645944|588623512|FG001|Received Medication|Lost to Follow-up|0|||
162978942|NCT00645944|588623511|FG000|Received Medication|Protocol Violation|2|||
162978943|NCT00645944|588623512|FG001|Received Medication|Protocol Violation|1|||
162978944|NCT01534637|588623513|FG000|Overall Study|Physician Decision|3|||
162978945|NCT01534637|588623513|FG000|Overall Study|Lack of Efficacy|3|||
162978946|NCT01534637|588623513|FG000|Overall Study|Withdrawal by Subject|1|||
162978947|NCT01534637|588623513|FG000|Overall Study|Adverse Event|1|||
162978948|NCT01534637|588623513|FG000|Overall Study|Liver Mets before treatment|1|||
162978949|NCT00834899|588623514|FG000|Overall Study|Withdrawal by Subject|1|||
162713387|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162713388|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162713389|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162713390|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713391|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
162713392|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713393|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713394|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713395|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713396|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713397|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713398|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713399|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713400|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713401|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
162713402|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713403|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713404|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713405|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713406|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163058475|NCT00042289|588924256|FG021|Overall Study|Other reason|0|||
163058476|NCT00042289|588924257|FG022|Overall Study|Other reason|0|||
163058477|NCT00042289|588924258|FG023|Overall Study|Other reason|1|||
163058478|NCT00042289|588924259|FG024|Overall Study|Other reason|0|||
163058479|NCT00042289|588924260|FG025|Overall Study|Other reason|0|||
163058480|NCT00042289|588924261|FG026|Overall Study|Other reason|1|||
163058481|NCT00042289|588924262|FG027|Overall Study|Other reason|0|||
163058482|NCT00042289|588924263|FG028|Overall Study|Other reason|3|||
163058483|NCT00042289|588924264|FG029|Overall Study|Other reason|0|||
163058484|NCT00042289|588924265|FG030|Overall Study|Other reason|0|||
163058485|NCT00042289|588924266|FG031|Overall Study|Other reason|1|||
163058486|NCT00042289|588924267|FG032|Overall Study|Other reason|0|||
163058487|NCT00042289|588924268|FG033|Overall Study|Other reason|1|||
163058488|NCT00042289|588924269|FG034|Overall Study|Other reason|0|||
163058489|NCT00042289|588924270|FG035|Overall Study|Other reason|2|||
163058490|NCT00042289|588924271|FG036|Overall Study|Other reason|0|||
163058491|NCT00042289|588924272|FG037|Overall Study|Other reason|0|||
163058492|NCT00042289|588924273|FG038|Overall Study|Other reason|0|||
163058493|NCT00042289|588924274|FG039|Overall Study|Other reason|0|||
163058494|NCT00042289|588924275|FG040|Overall Study|Other reason|0|||
163058495|NCT00042289|588924276|FG041|Overall Study|Other reason|0|||
163058496|NCT00042289|588924277|FG042|Overall Study|Other reason|0|||
163058497|NCT00042289|588924278|FG043|Overall Study|Other reason|1|||
163058498|NCT00042289|588924279|FG044|Overall Study|Other reason|0|||
163058499|NCT00042289|588924280|FG045|Overall Study|Other reason|0|||
163058500|NCT00042289|588924281|FG046|Overall Study|Other reason|0|||
163058501|NCT00042289|588924235|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163058502|NCT00042289|588924236|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163058503|NCT00042289|588924237|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163058504|NCT00042289|588924238|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163058505|NCT00042289|588924239|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163058506|NCT00042289|588924240|FG005|Overall Study|Severe debilitation, unable to continue|0|||
163058507|NCT00042289|588924241|FG006|Overall Study|Severe debilitation, unable to continue|0|||
163058508|NCT00042289|588924242|FG007|Overall Study|Severe debilitation, unable to continue|0|||
163058509|NCT00042289|588924243|FG008|Overall Study|Severe debilitation, unable to continue|0|||
163058510|NCT00042289|588924244|FG009|Overall Study|Severe debilitation, unable to continue|0|||
162713407|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162713408|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
162713409|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713410|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162924169|NCT00445458|588423820|FG002|Overall Study|Surgery|1|||
163058511|NCT00042289|588924245|FG010|Overall Study|Severe debilitation, unable to continue|0|||
163058512|NCT00042289|588924246|FG011|Overall Study|Severe debilitation, unable to continue|0|||
163058513|NCT00042289|588924247|FG012|Overall Study|Severe debilitation, unable to continue|0|||
163058514|NCT00042289|588924248|FG013|Overall Study|Severe debilitation, unable to continue|0|||
163058515|NCT00042289|588924249|FG014|Overall Study|Severe debilitation, unable to continue|0|||
163058516|NCT00042289|588924250|FG015|Overall Study|Severe debilitation, unable to continue|0|||
163058517|NCT00042289|588924251|FG016|Overall Study|Severe debilitation, unable to continue|0|||
163058518|NCT00042289|588924252|FG017|Overall Study|Severe debilitation, unable to continue|0|||
162713411|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713412|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713413|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713414|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162713415|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162924170|NCT00445458|588423821|FG003|Overall Study|Surgery|0|||
162924171|NCT01393626|588423825|FG000|Overall Study|Adverse Event|2|||
162924172|NCT01393626|588423826|FG001|Overall Study|Adverse Event|1|||
162924173|NCT01393626|588423827|FG002|Overall Study|Adverse Event|5|||
163058519|NCT00042289|588924253|FG018|Overall Study|Severe debilitation, unable to continue|0|||
163058520|NCT00042289|588924254|FG019|Overall Study|Severe debilitation, unable to continue|0|||
163058521|NCT00042289|588924255|FG020|Overall Study|Severe debilitation, unable to continue|0|||
163058522|NCT00042289|588924256|FG021|Overall Study|Severe debilitation, unable to continue|1|||
163058523|NCT00042289|588924257|FG022|Overall Study|Severe debilitation, unable to continue|0|||
163058524|NCT00042289|588924258|FG023|Overall Study|Severe debilitation, unable to continue|1|||
163058525|NCT00042289|588924259|FG024|Overall Study|Severe debilitation, unable to continue|0|||
163058526|NCT00042289|588924260|FG025|Overall Study|Severe debilitation, unable to continue|0|||
163058527|NCT00042289|588924261|FG026|Overall Study|Severe debilitation, unable to continue|0|||
162924174|NCT01393626|588423828|FG003|Overall Study|Adverse Event|0|||
162924175|NCT01393626|588423825|FG000|Overall Study|Did not meet entrance criteria|1|||
162978950|NCT00834899|588623515|FG001|Overall Study|Withdrawal by Subject|1|||
162978951|NCT00606502|588623516|FG000|Randomization|Randomized but not treated|3|||
162978952|NCT00606502|588623517|FG001|Randomization|Randomized but not treated|0|||
162978953|NCT00606502|588623516|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
162978954|NCT00606502|588623517|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
162978955|NCT02080832|588623527|FG000|Overall Study|Excluded from analysis by MRI|9|||
162978956|NCT02080832|588623528|FG001|Overall Study|Excluded from analysis by MRI|10|||
162978957|NCT02080832|588623529|FG002|Overall Study|Excluded from analysis by MRI|14|||
162978958|NCT02080832|588623527|FG000|Overall Study|Lost to Follow-up|0|||
162978959|NCT02080832|588623528|FG001|Overall Study|Lost to Follow-up|2|||
162978960|NCT02080832|588623529|FG002|Overall Study|Lost to Follow-up|2|||
162978961|NCT00560937|588623530|FG000|Overall Study|Withdrawal by Subject|0|||
162978962|NCT00560937|588623531|FG001|Overall Study|Withdrawal by Subject|1|||
162978963|NCT00560937|588623530|FG000|Overall Study|Physician Decision|1|||
162978964|NCT00560937|588623531|FG001|Overall Study|Physician Decision|1|||
162978965|NCT00440115|588623532|FG000|Overall Study|Death|7|||
162978966|NCT00440115|588623533|FG001|Overall Study|Death|9|||
162978967|NCT00440115|588623534|FG002|Overall Study|Death|5|||
162978968|NCT00440115|588623532|FG000|Overall Study|Incarceration|0|||
162978969|NCT00440115|588623533|FG001|Overall Study|Incarceration|2|||
162978970|NCT00440115|588623534|FG002|Overall Study|Incarceration|1|||
162978971|NCT03069417|588623535|FG000|Overall Study|Lost to Follow-up|2|||
162978972|NCT03069417|588623536|FG001|Overall Study|Lost to Follow-up|0|||
162978973|NCT03069417|588623535|FG000|Overall Study|Reason Unknown|4|||
162978974|NCT03069417|588623536|FG001|Overall Study|Reason Unknown|7|||
163058528|NCT00042289|588924262|FG027|Overall Study|Severe debilitation, unable to continue|1|||
162924176|NCT01393626|588423826|FG001|Overall Study|Did not meet entrance criteria|0|||
162924177|NCT01393626|588423827|FG002|Overall Study|Did not meet entrance criteria|0|||
162924178|NCT01393626|588423828|FG003|Overall Study|Did not meet entrance criteria|0|||
162924179|NCT01393626|588423825|FG000|Overall Study|Lack of Efficacy|6|||
162924180|NCT01393626|588423826|FG001|Overall Study|Lack of Efficacy|6|||
162924181|NCT01393626|588423827|FG002|Overall Study|Lack of Efficacy|4|||
162924182|NCT01393626|588423828|FG003|Overall Study|Lack of Efficacy|1|||
162924183|NCT01393626|588423825|FG000|Overall Study|Lost to Follow-up|1|||
162924184|NCT01393626|588423826|FG001|Overall Study|Lost to Follow-up|1|||
162924185|NCT01393626|588423827|FG002|Overall Study|Lost to Follow-up|1|||
162924186|NCT01393626|588423828|FG003|Overall Study|Lost to Follow-up|0|||
162924187|NCT01393626|588423825|FG000|Overall Study|Withdrawal by Subject|6|||
162924188|NCT01393626|588423826|FG001|Overall Study|Withdrawal by Subject|4|||
162924189|NCT01393626|588423827|FG002|Overall Study|Withdrawal by Subject|0|||
162924190|NCT01393626|588423828|FG003|Overall Study|Withdrawal by Subject|0|||
162924191|NCT01393626|588423825|FG000|Overall Study|Other|1|||
162924192|NCT01393626|588423826|FG001|Overall Study|Other|0|||
162924193|NCT01393626|588423827|FG002|Overall Study|Other|0|||
162924194|NCT01393626|588423828|FG003|Overall Study|Other|0|||
162924195|NCT01393626|588423825|FG000|Overall Study|Protocol Violation|1|||
162924196|NCT01393626|588423826|FG001|Overall Study|Protocol Violation|0|||
162924197|NCT01393626|588423827|FG002|Overall Study|Protocol Violation|2|||
162924198|NCT01393626|588423828|FG003|Overall Study|Protocol Violation|0|||
162924199|NCT02426125|588423829|FG000|Overall Study|Lost to Follow-up|14|||
162924200|NCT02426125|588423830|FG001|Overall Study|Lost to Follow-up|12|||
162924201|NCT02426125|588423829|FG000|Overall Study|Withdrawal by Subject|13|||
162924202|NCT02426125|588423830|FG001|Overall Study|Withdrawal by Subject|14|||
162978975|NCT01660022|588623538|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
162713434|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162713435|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713436|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
162713437|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
162713438|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713439|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713440|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713441|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713442|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713443|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162713444|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
162713445|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
162713446|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713447|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713448|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713449|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713450|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713451|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713452|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162713453|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713454|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
162713455|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713456|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713457|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713458|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713459|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713460|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713461|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162713462|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713463|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
162713464|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713465|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713466|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713467|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713468|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713469|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713470|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162713471|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713472|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713473|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
162713474|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713475|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713476|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713477|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713478|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713479|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162713480|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713481|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713482|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
162713483|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713484|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713485|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713486|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713487|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713488|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162713489|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713490|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713491|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
162713492|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713493|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713494|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713495|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713496|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713497|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162713498|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713499|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713500|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713501|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713502|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713503|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713504|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
162713505|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713506|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162713507|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
162713508|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
162713509|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713510|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713511|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713512|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713513|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713514|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713515|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162713516|NCT03598790|587662540|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713517|NCT03598790|587662541|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713518|NCT03598790|587662542|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
162713519|NCT03598790|587662543|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713520|NCT03598790|587662544|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713521|NCT03598790|587662545|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713522|NCT03598790|587662546|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713523|NCT03598790|587662547|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713524|NCT03598790|587662548|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162713525|NCT03598790|587662540|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713526|NCT03598790|587662541|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713527|NCT03598790|587662542|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713528|NCT03598790|587662543|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162713529|NCT03598790|587662544|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162713530|NCT03598790|587662545|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162713531|NCT03598790|587662546|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713532|NCT03598790|587662547|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713533|NCT03598790|587662548|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162713534|NCT03598790|587662540|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713535|NCT03598790|587662541|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713536|NCT03598790|587662542|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713537|NCT03598790|587662543|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
162713538|NCT03598790|587662544|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713539|NCT03598790|587662545|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713540|NCT03598790|587662546|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713541|NCT03598790|587662547|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163058603|NCT00042289|588924243|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
162713542|NCT03598790|587662548|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162713543|NCT03598790|587662540|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713544|NCT03598790|587662541|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713545|NCT03598790|587662542|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713546|NCT03598790|587662543|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
162713547|NCT03598790|587662544|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713548|NCT03598790|587662545|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713549|NCT03598790|587662546|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713550|NCT03598790|587662547|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713551|NCT03598790|587662548|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162713552|NCT03598790|587662540|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713553|NCT03598790|587662541|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713554|NCT03598790|587662542|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713555|NCT03598790|587662543|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
162713556|NCT03598790|587662544|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
162713557|NCT03598790|587662545|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713558|NCT03598790|587662546|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713559|NCT03598790|587662547|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713560|NCT03598790|587662548|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162713561|NCT03598790|587662540|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713562|NCT03598790|587662541|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713563|NCT03598790|587662542|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713564|NCT03598790|587662543|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
162713565|NCT03598790|587662544|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713566|NCT03598790|587662545|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713567|NCT03598790|587662546|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713568|NCT03598790|587662547|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713569|NCT03598790|587662548|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162713570|NCT03410992|587662550|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713571|NCT03410992|587662551|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
162713572|NCT03410992|587662552|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713573|NCT03410992|587662553|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713574|NCT03410992|587662554|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713575|NCT03410992|587662555|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713576|NCT03410992|587662556|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713577|NCT03410992|587662557|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713578|NCT03410992|587662558|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713579|NCT03410992|587662559|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713580|NCT03410992|587662560|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162713581|NCT03410992|587662550|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
162713582|NCT03410992|587662551|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
162713583|NCT03410992|587662552|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713584|NCT03410992|587662553|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713585|NCT03410992|587662554|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713586|NCT03410992|587662555|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713587|NCT03410992|587662556|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713588|NCT03410992|587662557|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713589|NCT03410992|587662558|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713590|NCT03410992|587662559|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713591|NCT03410992|587662560|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162713592|NCT03410992|587662550|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
162713593|NCT03410992|587662551|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
162713594|NCT03410992|587662552|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713595|NCT03410992|587662553|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713596|NCT03410992|587662554|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713597|NCT03410992|587662555|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713598|NCT03410992|587662556|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713599|NCT03410992|587662557|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713600|NCT03410992|587662558|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713601|NCT03410992|587662559|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713602|NCT03410992|587662560|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162713603|NCT03410992|587662550|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
162713604|NCT03410992|587662551|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162736233|NCT03699709|587744922|FG000|Overall Study|Lost to Follow-up|10|||
162713605|NCT03410992|587662552|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713606|NCT03410992|587662553|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713607|NCT03410992|587662554|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713608|NCT03410992|587662555|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713609|NCT03410992|587662556|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713610|NCT03410992|587662557|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713611|NCT03410992|587662558|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713612|NCT03410992|587662559|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713613|NCT03410992|587662560|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162713614|NCT03410992|587662550|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
162713615|NCT03410992|587662551|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
162713616|NCT03410992|587662552|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713617|NCT03410992|587662553|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713618|NCT03410992|587662554|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713619|NCT03410992|587662555|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713620|NCT03410992|587662556|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713621|NCT03410992|587662557|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713622|NCT03410992|587662558|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713623|NCT03410992|587662559|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713624|NCT03410992|587662560|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162713625|NCT03410992|587662550|FG000|Week 16 Assessment|Incorrect escapers|0|||
162713626|NCT03410992|587662551|FG001|Week 16 Assessment|Incorrect escapers|6|||
162713627|NCT03410992|587662552|FG002|Week 16 Assessment|Incorrect escapers|0|||
162713628|NCT03410992|587662553|FG003|Week 16 Assessment|Incorrect escapers|0|||
162713629|NCT03410992|587662554|FG004|Week 16 Assessment|Incorrect escapers|0|||
162713630|NCT03410992|587662555|FG005|Week 16 Assessment|Incorrect escapers|0|||
162713631|NCT03410992|587662556|FG006|Week 16 Assessment|Incorrect escapers|0|||
162713632|NCT03410992|587662557|FG007|Week 16 Assessment|Incorrect escapers|0|||
162713633|NCT03410992|587662558|FG008|Week 16 Assessment|Incorrect escapers|0|||
162713634|NCT03410992|587662559|FG009|Week 16 Assessment|Incorrect escapers|0|||
162713635|NCT03410992|587662560|FG010|Week 16 Assessment|Incorrect escapers|0|||
162713636|NCT03410992|587662550|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713637|NCT03410992|587662551|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713638|NCT03410992|587662552|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713639|NCT03410992|587662553|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
162713640|NCT03410992|587662554|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
162713641|NCT03410992|587662555|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713642|NCT03410992|587662556|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713643|NCT03410992|587662557|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713644|NCT03410992|587662558|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713645|NCT03410992|587662559|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713646|NCT03410992|587662560|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162713647|NCT03410992|587662550|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713648|NCT03410992|587662551|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713649|NCT03410992|587662552|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713650|NCT03410992|587662553|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
162713651|NCT03410992|587662554|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
162713652|NCT03410992|587662555|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
162713653|NCT03410992|587662556|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713654|NCT03410992|587662557|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713655|NCT03410992|587662558|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713656|NCT03410992|587662559|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713657|NCT03410992|587662560|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162713658|NCT03410992|587662550|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713659|NCT03410992|587662551|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713660|NCT03410992|587662552|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713661|NCT03410992|587662553|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713662|NCT03410992|587662554|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713663|NCT03410992|587662555|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
162713664|NCT03410992|587662556|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713665|NCT03410992|587662557|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713666|NCT03410992|587662558|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162979008|NCT01277718|588623551|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
162979009|NCT01277718|588623552|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
162979010|NCT01277718|588623551|FG000|Period 2 - Second Intervention|Physician Decision|0|||
162979011|NCT01277718|588623552|FG001|Period 2 - Second Intervention|Physician Decision|2|||
162979012|NCT03919162|588623555|FG000|Overall Study|Adverse Event|3|||
162979013|NCT03919162|588623556|FG001|Overall Study|Adverse Event|2|||
162979014|NCT03919162|588623555|FG000|Overall Study|Death|2|||
162979015|NCT03919162|588623556|FG001|Overall Study|Death|0|||
162979016|NCT03919162|588623555|FG000|Overall Study|Lost to Follow-up|1|||
162979017|NCT03919162|588623556|FG001|Overall Study|Lost to Follow-up|0|||
162979018|NCT03919162|588623555|FG000|Overall Study|Withdrawal by Subject|12|||
162979019|NCT03919162|588623556|FG001|Overall Study|Withdrawal by Subject|12|||
162979020|NCT03919162|588623555|FG000|Overall Study|Study terminated by Sponsor|20|||
162979021|NCT03919162|588623556|FG001|Overall Study|Study terminated by Sponsor|24|||
162979022|NCT03919162|588623555|FG000|Overall Study|Screen failure|1|||
162979023|NCT03919162|588623556|FG001|Overall Study|Screen failure|0|||
163058604|NCT00042289|588924244|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
163058605|NCT00042289|588924245|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
163058606|NCT00042289|588924246|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
163058607|NCT00042289|588924247|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
163058608|NCT00042289|588924248|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
163058609|NCT00042289|588924249|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
163058610|NCT00042289|588924250|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
163058611|NCT00042289|588924251|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
163058612|NCT00042289|588924252|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
163058613|NCT00042289|588924253|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
163058614|NCT00042289|588924254|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
163058615|NCT00042289|588924255|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
163058616|NCT00042289|588924256|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
163058617|NCT00042289|588924257|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
163058618|NCT00042289|588924258|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
163058619|NCT00042289|588924259|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
163058620|NCT00042289|588924260|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
163058621|NCT00042289|588924261|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
163058622|NCT00042289|588924262|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
163058623|NCT00042289|588924263|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
163058624|NCT00042289|588924264|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
163058625|NCT00042289|588924265|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
163058626|NCT00042289|588924266|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
163058627|NCT00042289|588924267|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
163058628|NCT00042289|588924268|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
162631100|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631101|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631102|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631103|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631104|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631105|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631106|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631107|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631108|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631109|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631110|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631111|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631112|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631113|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631114|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631115|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162979024|NCT03919162|588623555|FG000|Overall Study|Missing|1|||
162979025|NCT03919162|588623556|FG001|Overall Study|Missing|1|||
163058629|NCT00042289|588924269|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
163058630|NCT00042289|588924270|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
163058631|NCT00042289|588924271|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
163058632|NCT00042289|588924272|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
163058633|NCT00042289|588924273|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
163058634|NCT00042289|588924274|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
163058635|NCT00042289|588924275|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
163058636|NCT00042289|588924276|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
163058637|NCT00042289|588924277|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
162979026|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
162713667|NCT03410992|587662559|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713668|NCT03410992|587662560|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162713669|NCT03410992|587662550|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713670|NCT03410992|587662551|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713671|NCT03410992|587662552|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713672|NCT03410992|587662553|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
162713673|NCT03410992|587662554|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
162713674|NCT03410992|587662555|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
162713675|NCT03410992|587662556|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713676|NCT03410992|587662557|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713677|NCT03410992|587662558|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713678|NCT03410992|587662559|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713679|NCT03410992|587662560|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162713680|NCT03410992|587662550|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713681|NCT03410992|587662551|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
162979027|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
162979028|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
162979029|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
162979030|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
162979031|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
162979032|NCT03078478|588623557|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
162979033|NCT03078478|588623558|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
162979034|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
162979035|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
162979036|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
162713682|NCT03410992|587662552|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
162979037|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
162979038|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
162979039|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
162979040|NCT03078478|588623557|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
162979041|NCT03078478|588623558|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
162979042|NCT01688726|588623559|FG000|Overall Study|Adverse Event|1|||
162979043|NCT01688726|588623560|FG001|Overall Study|Adverse Event|0|||
162979044|NCT01688726|588623559|FG000|Overall Study|Relocated abroad|0|||
162979045|NCT01688726|588623560|FG001|Overall Study|Relocated abroad|1|||
162979046|NCT03861481|588625048|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
162979047|NCT03861481|588625049|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
162979048|NCT03861481|588625048|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
162979049|NCT03861481|588625049|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
162979050|NCT03861481|588625048|FG000|Overall Study|Relapse|1|||
162979051|NCT03861481|588625049|FG001|Overall Study|Relapse|0|||
162979052|NCT03861481|588625048|FG000|Overall Study|Withdrawal by Subject|0|||
162979053|NCT03861481|588625049|FG001|Overall Study|Withdrawal by Subject|1|||
162979054|NCT03861481|588625048|FG000|Overall Study|Lack of Efficacy|4|||
162979055|NCT03861481|588625049|FG001|Overall Study|Lack of Efficacy|5|||
162979056|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
162979057|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
162979058|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
162979059|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
162979060|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
162979061|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
162979062|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
162979063|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
162979064|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
162979065|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
162979066|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
162979067|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
162979068|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
162979069|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
162979070|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
162979071|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
162979072|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162979073|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162713683|NCT03410992|587662553|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
162979074|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
163058638|NCT00042289|588924278|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
162713684|NCT03410992|587662554|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713685|NCT03410992|587662555|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713686|NCT03410992|587662556|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713687|NCT03410992|587662557|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
162713688|NCT03410992|587662558|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713689|NCT03410992|587662559|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713690|NCT03410992|587662560|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
162713691|NCT03410992|587662550|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713692|NCT03410992|587662551|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713693|NCT03410992|587662552|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713694|NCT03410992|587662553|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713695|NCT03410992|587662554|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713696|NCT03410992|587662555|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713697|NCT03410992|587662556|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713698|NCT03410992|587662557|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713699|NCT03410992|587662558|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
162713700|NCT03410992|587662559|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713701|NCT03410992|587662560|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162713702|NCT04988295|587662566|FG000|Overall Study|Withdrawal by Subject|9|||
162713703|NCT04988295|587662567|FG001|Overall Study|Withdrawal by Subject|29|||
162713704|NCT04988295|587662568|FG002|Overall Study|Withdrawal by Subject|6|||
162713705|NCT04988295|587662569|FG003|Overall Study|Withdrawal by Subject|0|||
162713706|NCT04988295|587662566|FG000|Overall Study|Lost to Follow-up|1|||
162713707|NCT04988295|587662567|FG001|Overall Study|Lost to Follow-up|0|||
162713708|NCT04988295|587662568|FG002|Overall Study|Lost to Follow-up|0|||
162713709|NCT04988295|587662569|FG003|Overall Study|Lost to Follow-up|0|||
162713710|NCT04988295|587662566|FG000|Overall Study|Study participation ongoing|186|||
162713711|NCT04988295|587662567|FG001|Overall Study|Study participation ongoing|169|||
162713712|NCT04988295|587662568|FG002|Overall Study|Study participation ongoing|99|||
162713713|NCT04988295|587662569|FG003|Overall Study|Study participation ongoing|119|||
162713714|NCT00930813|587662574|FG000|Overall Study|Death|4|||
162713715|NCT00930813|587662575|FG001|Overall Study|Death|5|||
162713716|NCT00930813|587662574|FG000|Overall Study|Withdrawal by Subject|2|||
162713717|NCT00930813|587662575|FG001|Overall Study|Withdrawal by Subject|5|||
162713718|NCT00930813|587662574|FG000|Overall Study|Lost to Follow-up|2|||
162713719|NCT00930813|587662575|FG001|Overall Study|Lost to Follow-up|4|||
162713720|NCT01693614|587662576|FG000|Overall Study|Adverse Event|7|||
162713721|NCT01693614|587662577|FG001|Overall Study|Adverse Event|11|||
162713722|NCT01693614|587662578|FG002|Overall Study|Adverse Event|5|||
162713723|NCT01693614|587662576|FG000|Overall Study|Disease progression|11|||
162713724|NCT01693614|587662577|FG001|Overall Study|Disease progression|8|||
162713725|NCT01693614|587662578|FG002|Overall Study|Disease progression|7|||
162713726|NCT01693614|587662576|FG000|Overall Study|Protocol Violation|5|||
162713727|NCT01693614|587662577|FG001|Overall Study|Protocol Violation|2|||
162713728|NCT01693614|587662578|FG002|Overall Study|Protocol Violation|1|||
162713729|NCT01693614|587662576|FG000|Overall Study|Death|1|||
162713730|NCT01693614|587662577|FG001|Overall Study|Death|0|||
162713731|NCT01693614|587662578|FG002|Overall Study|Death|0|||
162713732|NCT01693614|587662576|FG000|Overall Study|Physician Decision|1|||
162713733|NCT01693614|587662577|FG001|Overall Study|Physician Decision|1|||
162713734|NCT01693614|587662578|FG002|Overall Study|Physician Decision|4|||
162713735|NCT01693614|587662576|FG000|Overall Study|Withdrawal by subject/guardian|0|||
162713736|NCT01693614|587662577|FG001|Overall Study|Withdrawal by subject/guardian|0|||
162713737|NCT01693614|587662578|FG002|Overall Study|Withdrawal by subject/guardian|2|||
162713738|NCT01693614|587662576|FG000|Overall Study|Withdrawal by Subject|1|||
162713739|NCT01693614|587662577|FG001|Overall Study|Withdrawal by Subject|0|||
162713740|NCT01693614|587662578|FG002|Overall Study|Withdrawal by Subject|5|||
162713741|NCT04618471|587662579|FG000|Overall Study|Screen Failure|62|||
162713742|NCT04618471|587662579|FG000|Overall Study|Withdrawal by Subject|6|||
162713743|NCT04618471|587662579|FG000|Overall Study|Physician Decision|2|||
162713744|NCT04618471|587662579|FG000|Overall Study|Lost to Follow-up|1|||
162713745|NCT04618471|587662579|FG000|Overall Study|Various other reasons|2|||
162736234|NCT03699709|587744923|FG001|Overall Study|Lost to Follow-up|3|||
162713746|NCT04618471|587662579|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
162713747|NCT00588666|587662580|FG000|Overall Study|Adverse Event|4|||
162713748|NCT00927823|587662583|FG000|Continuous Dosing Period|Death|0|||
162713749|NCT00927823|587662584|FG001|Continuous Dosing Period|Death|0|||
162713750|NCT00927823|587662585|FG002|Continuous Dosing Period|Death|6|||
162713751|NCT00927823|587662586|FG003|Continuous Dosing Period|Death|0|||
162713752|NCT00927823|587662583|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
162713753|NCT00927823|587662584|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
162713754|NCT00927823|587662585|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
162713755|NCT00927823|587662586|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
162713756|NCT00927823|587662583|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
162713757|NCT00927823|587662584|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
162713758|NCT00927823|587662585|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
162713759|NCT00927823|587662586|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
162713760|NCT00927823|587662583|FG000|Continuous Dosing Period|Other|1|||
162713761|NCT00927823|587662584|FG001|Continuous Dosing Period|Other|2|||
162713762|NCT00927823|587662585|FG002|Continuous Dosing Period|Other|9|||
162713763|NCT00927823|587662586|FG003|Continuous Dosing Period|Other|3|||
162713764|NCT02299635|587662587|FG000|Overall Study|Adverse Event|2|||
162713765|NCT02299635|587662587|FG000|Overall Study|Death|1|||
162713766|NCT02299635|587662587|FG000|Overall Study|Global deterioration of health status|1|||
162713767|NCT02299635|587662587|FG000|Overall Study|Objective progression or relapse|10|||
162713768|NCT02299635|587662587|FG000|Overall Study|Withdrawal by Subject|2|||
162713769|NCT02299635|587662587|FG000|Overall Study|Other|3|||
162713770|NCT00828672|587662588|FG000|Study Treatment|Lost to Follow-up|1|||
162713771|NCT00828672|587662589|FG001|Study Treatment|Lost to Follow-up|0|||
162713772|NCT00828672|587662588|FG000|Study Treatment|Adverse Event|0|||
162713773|NCT00828672|587662589|FG001|Study Treatment|Adverse Event|1|||
162713774|NCT00828672|587662588|FG000|Study Treatment|Complete response, no surgery|1|||
162713775|NCT00828672|587662589|FG001|Study Treatment|Complete response, no surgery|1|||
162713776|NCT00828672|587662588|FG000|Post-surgery (<30 Days)|No central review materials|0|||
162713777|NCT00828672|587662589|FG001|Post-surgery (<30 Days)|No central review materials|1|||
162713778|NCT04889118|587662590|FG000|Overall Study|Death|49|||
162713779|NCT04889118|587662591|FG001|Overall Study|Death|47|||
162713780|NCT04889118|587662590|FG000|Overall Study|Sponsor Decision|15|||
162713781|NCT04889118|587662591|FG001|Overall Study|Sponsor Decision|20|||
162713782|NCT00601640|587662593|FG000|Overall Study|Withdrawal by Subject|3|||
162713783|NCT00601640|587662594|FG001|Overall Study|Withdrawal by Subject|0|||
162713784|NCT00601640|587662595|FG002|Overall Study|Withdrawal by Subject|7|||
162713785|NCT00601640|587662593|FG000|Overall Study|Death|1|||
162713786|NCT00601640|587662594|FG001|Overall Study|Death|0|||
162713787|NCT00601640|587662595|FG002|Overall Study|Death|0|||
162713788|NCT00601640|587662593|FG000|Overall Study|Adverse Event|0|||
162713789|NCT00601640|587662594|FG001|Overall Study|Adverse Event|4|||
162713790|NCT00601640|587662595|FG002|Overall Study|Adverse Event|2|||
162713791|NCT00601640|587662593|FG000|Overall Study|intercurrent illness|1|||
162713792|NCT00601640|587662594|FG001|Overall Study|intercurrent illness|0|||
162713793|NCT00601640|587662595|FG002|Overall Study|intercurrent illness|0|||
162713794|NCT00601640|587662593|FG000|Overall Study|change in eligibility status|0|||
162713795|NCT00601640|587662594|FG001|Overall Study|change in eligibility status|1|||
162713796|NCT00601640|587662595|FG002|Overall Study|change in eligibility status|1|||
162713797|NCT00015457|587662596|FG000|First Intervention|Adverse Event|0|||
162713798|NCT00015457|587662597|FG001|First Intervention|Adverse Event|2|||
162713799|NCT00015457|587662596|FG000|First Intervention|Lack of Efficacy|0|||
162713800|NCT00015457|587662597|FG001|First Intervention|Lack of Efficacy|1|||
162713801|NCT00015457|587662596|FG000|Second Intervention|Withdrawal by Subject|1|||
162713802|NCT00015457|587662597|FG001|Second Intervention|Withdrawal by Subject|0|||
162713803|NCT01456936|587662598|FG000|Overall Study|Other reason|41|||
162713804|NCT01456936|587662599|FG001|Overall Study|Other reason|30|||
162713805|NCT01456936|587662600|FG002|Overall Study|Other reason|36|||
162713806|NCT01456936|587662601|FG003|Overall Study|Other reason|33|||
162713807|NCT01456936|587662598|FG000|Overall Study|No longer meets eligibility criteria|4|||
162713808|NCT01456936|587662599|FG001|Overall Study|No longer meets eligibility criteria|8|||
162713809|NCT01456936|587662600|FG002|Overall Study|No longer meets eligibility criteria|6|||
162713810|NCT01456936|587662601|FG003|Overall Study|No longer meets eligibility criteria|5|||
162713811|NCT01456936|587662598|FG000|Overall Study|Protocol Violation|4|||
162713812|NCT01456936|587662599|FG001|Overall Study|Protocol Violation|2|||
162713813|NCT01456936|587662600|FG002|Overall Study|Protocol Violation|5|||
162713814|NCT01456936|587662601|FG003|Overall Study|Protocol Violation|5|||
162713815|NCT01456936|587662598|FG000|Overall Study|Pregnancy|1|||
162713816|NCT01456936|587662599|FG001|Overall Study|Pregnancy|0|||
162713817|NCT01456936|587662600|FG002|Overall Study|Pregnancy|0|||
162713818|NCT01456936|587662601|FG003|Overall Study|Pregnancy|1|||
162713819|NCT01456936|587662598|FG000|Overall Study|Insufficient clinical response|4|||
162713820|NCT01456936|587662599|FG001|Overall Study|Insufficient clinical response|4|||
162713821|NCT01456936|587662600|FG002|Overall Study|Insufficient clinical response|14|||
162713822|NCT01456936|587662601|FG003|Overall Study|Insufficient clinical response|13|||
162713823|NCT01456936|587662598|FG000|Overall Study|No longer willing to participate|195|||
162713824|NCT01456936|587662599|FG001|Overall Study|No longer willing to participate|218|||
162713825|NCT01456936|587662600|FG002|Overall Study|No longer willing to participate|224|||
162713826|NCT01456936|587662601|FG003|Overall Study|No longer willing to participate|248|||
162713827|NCT01456936|587662598|FG000|Overall Study|Lost to Follow-up|135|||
162713828|NCT01456936|587662599|FG001|Overall Study|Lost to Follow-up|126|||
162713829|NCT01456936|587662600|FG002|Overall Study|Lost to Follow-up|144|||
162713830|NCT01456936|587662601|FG003|Overall Study|Lost to Follow-up|127|||
162713831|NCT01456936|587662598|FG000|Overall Study|Medication error|0|||
162713832|NCT01456936|587662599|FG001|Overall Study|Medication error|1|||
162713833|NCT01456936|587662600|FG002|Overall Study|Medication error|0|||
162713834|NCT01456936|587662601|FG003|Overall Study|Medication error|1|||
162713835|NCT01456936|587662598|FG000|Overall Study|Adverse event (study drug)|25|||
162713836|NCT01456936|587662599|FG001|Overall Study|Adverse event (study drug)|21|||
162713837|NCT01456936|587662600|FG002|Overall Study|Adverse event (study drug)|26|||
162713838|NCT01456936|587662601|FG003|Overall Study|Adverse event (study drug)|17|||
162713839|NCT01456936|587662598|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
162713840|NCT01456936|587662599|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
162713841|NCT01456936|587662600|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
162713842|NCT01456936|587662601|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
162713843|NCT01456936|587662598|FG000|Overall Study|Death|0|||
162713844|NCT01456936|587662599|FG001|Overall Study|Death|3|||
162713845|NCT01456936|587662600|FG002|Overall Study|Death|1|||
162713846|NCT01456936|587662601|FG003|Overall Study|Death|3|||
162713847|NCT01456936|587662598|FG000|Overall Study|Randomized but not treated|21|||
162713848|NCT01456936|587662599|FG001|Overall Study|Randomized but not treated|28|||
162713849|NCT01456936|587662600|FG002|Overall Study|Randomized but not treated|16|||
162713850|NCT01456936|587662601|FG003|Overall Study|Randomized but not treated|21|||
162713851|NCT00906698|587662602|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
162713852|NCT00906698|587662603|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
162713853|NCT00906698|587662604|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
162713854|NCT00906698|587662605|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162713855|NCT00906698|587662606|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
162713856|NCT00906698|587662607|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
162713857|NCT00906698|587662602|FG000|Overall Study|Adverse Event|0|||
162713858|NCT00906698|587662603|FG001|Overall Study|Adverse Event|0|||
162713859|NCT00906698|587662604|FG002|Overall Study|Adverse Event|2|||
162713860|NCT00906698|587662605|FG003|Overall Study|Adverse Event|0|||
162713861|NCT00906698|587662606|FG004|Overall Study|Adverse Event|4|||
162713862|NCT00906698|587662607|FG005|Overall Study|Adverse Event|1|||
162713863|NCT00906698|587662602|FG000|Overall Study|Disease progression|3|||
162713864|NCT00906698|587662603|FG001|Overall Study|Disease progression|12|||
162713865|NCT00906698|587662604|FG002|Overall Study|Disease progression|4|||
162713866|NCT00906698|587662605|FG003|Overall Study|Disease progression|4|||
162713867|NCT00906698|587662606|FG004|Overall Study|Disease progression|12|||
162713868|NCT00906698|587662607|FG005|Overall Study|Disease progression|4|||
162713869|NCT00906698|587662602|FG000|Overall Study|Withdrawal by Subject|0|||
162713870|NCT00906698|587662603|FG001|Overall Study|Withdrawal by Subject|0|||
162713871|NCT00906698|587662604|FG002|Overall Study|Withdrawal by Subject|0|||
162713872|NCT00906698|587662605|FG003|Overall Study|Withdrawal by Subject|0|||
162713873|NCT00906698|587662606|FG004|Overall Study|Withdrawal by Subject|1|||
162713874|NCT00906698|587662607|FG005|Overall Study|Withdrawal by Subject|0|||
162713875|NCT00906698|587662602|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
162713876|NCT00906698|587662603|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
162713877|NCT00906698|587662604|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
162713878|NCT00906698|587662605|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
162713879|NCT00906698|587662606|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
163058639|NCT00042289|588924279|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
163058640|NCT00042289|588924280|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
163058641|NCT00042289|588924281|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
163058642|NCT00042289|588924235|FG000|Overall Study|Protocol Violation|0|||
163058643|NCT00042289|588924236|FG001|Overall Study|Protocol Violation|0|||
162713880|NCT00906698|587662607|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
162713881|NCT01744691|587662610|FG000|Overall Study|Progressive Disease|18|||
162713882|NCT01744691|587662610|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
162713883|NCT01744691|587662610|FG000|Overall Study|Withdrawal of consent for treatment|3|||
162713884|NCT01744691|587662610|FG000|Overall Study|Physician Decision|4|||
162713885|NCT02701361|587662611|FG000|Overall Study|Lost to Follow-up|5|||
162713886|NCT02701361|587662612|FG001|Overall Study|Lost to Follow-up|2|||
162713887|NCT02701361|587662613|FG002|Overall Study|Lost to Follow-up|1|||
163058644|NCT00042289|588924237|FG002|Overall Study|Protocol Violation|0|||
162713888|NCT02701361|587662611|FG000|Overall Study|Withdrawal by Subject|4|||
162713889|NCT02701361|587662612|FG001|Overall Study|Withdrawal by Subject|0|||
162713890|NCT02701361|587662613|FG002|Overall Study|Withdrawal by Subject|0|||
162979075|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979076|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979077|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979078|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979079|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
162979080|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
162979081|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979082|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979083|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
162979084|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979085|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
162979086|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
162979087|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
162979088|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
162979089|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
163058645|NCT00042289|588924238|FG003|Overall Study|Protocol Violation|0|||
162631116|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631117|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631118|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162631119|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
162631120|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
162631121|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
162631122|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631123|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631124|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631125|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631126|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631127|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631128|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631129|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631130|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631131|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631132|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631133|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631134|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631135|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631136|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631137|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631138|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631139|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631140|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631141|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631142|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631143|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631144|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631145|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631146|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
162631147|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162631148|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631149|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631150|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631151|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631152|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631153|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
163058646|NCT00042289|588924239|FG004|Overall Study|Protocol Violation|0|||
163058647|NCT00042289|588924240|FG005|Overall Study|Protocol Violation|1|||
163058648|NCT00042289|588924241|FG006|Overall Study|Protocol Violation|0|||
163058649|NCT00042289|588924242|FG007|Overall Study|Protocol Violation|1|||
163058650|NCT00042289|588924243|FG008|Overall Study|Protocol Violation|0|||
163058651|NCT00042289|588924244|FG009|Overall Study|Protocol Violation|0|||
163058652|NCT00042289|588924245|FG010|Overall Study|Protocol Violation|0|||
163058653|NCT00042289|588924246|FG011|Overall Study|Protocol Violation|0|||
163058654|NCT00042289|588924247|FG012|Overall Study|Protocol Violation|0|||
163058655|NCT00042289|588924248|FG013|Overall Study|Protocol Violation|0|||
162713891|NCT02701361|587662611|FG000|Overall Study|timed out in rehab center|0|||
162631154|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631155|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631156|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631157|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631158|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631159|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631160|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631161|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631162|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631163|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631164|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631165|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631166|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631167|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631168|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631169|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631170|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631171|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631172|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162631173|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
162631174|NCT03129100|587365167|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
162631175|NCT03129100|587365168|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
162631176|NCT03129100|587365169|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
162631177|NCT03129100|587365170|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
162631178|NCT03129100|587365171|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
162631179|NCT03129100|587365172|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
162631180|NCT03129100|587365173|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
162631181|NCT03129100|587365174|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
162631182|NCT03129100|587365175|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
162631183|NCT03129100|587365176|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
162631184|NCT03129100|587365177|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
162631185|NCT03129100|587365178|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
162631186|NCT03129100|587365179|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
162631187|NCT03129100|587365180|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
162631188|NCT03129100|587365181|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
162631189|NCT03129100|587365182|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
162631190|NCT03129100|587365183|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
162631191|NCT03129100|587365184|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
162631192|NCT03129100|587365185|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
162631193|NCT03129100|587365186|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
162631194|NCT03129100|587365187|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
162631195|NCT03129100|587365188|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
162631196|NCT03129100|587365189|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
162631197|NCT03129100|587365190|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
162631198|NCT03129100|587365191|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
162631199|NCT03129100|587365192|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
162631200|NCT03708328|587365195|FG000|Overall Study|Death|3|||
162631201|NCT03708328|587365196|FG001|Overall Study|Death|3|||
162631202|NCT03708328|587365197|FG002|Overall Study|Death|4|||
162631203|NCT03708328|587365198|FG003|Overall Study|Death|2|||
162631204|NCT03708328|587365199|FG004|Overall Study|Death|2|||
162631205|NCT03708328|587365200|FG005|Overall Study|Death|13|||
162631206|NCT03708328|587365201|FG006|Overall Study|Death|26|||
162631207|NCT03708328|587365202|FG007|Overall Study|Death|18|||
162631208|NCT03708328|587365203|FG008|Overall Study|Death|13|||
162631209|NCT03708328|587365204|FG009|Overall Study|Death|8|||
162631210|NCT03708328|587365195|FG000|Overall Study|Lost to Follow-up|0|||
162631211|NCT03708328|587365196|FG001|Overall Study|Lost to Follow-up|1|||
162631212|NCT03708328|587365197|FG002|Overall Study|Lost to Follow-up|0|||
162631213|NCT03708328|587365198|FG003|Overall Study|Lost to Follow-up|1|||
162631214|NCT03708328|587365199|FG004|Overall Study|Lost to Follow-up|0|||
162631215|NCT03708328|587365200|FG005|Overall Study|Lost to Follow-up|3|||
162631216|NCT03708328|587365201|FG006|Overall Study|Lost to Follow-up|3|||
162631217|NCT03708328|587365202|FG007|Overall Study|Lost to Follow-up|0|||
162631218|NCT03708328|587365203|FG008|Overall Study|Lost to Follow-up|0|||
162631219|NCT03708328|587365204|FG009|Overall Study|Lost to Follow-up|1|||
162631220|NCT03708328|587365195|FG000|Overall Study|Physician Decision|0|||
162631221|NCT03708328|587365196|FG001|Overall Study|Physician Decision|0|||
162631222|NCT03708328|587365197|FG002|Overall Study|Physician Decision|0|||
162631223|NCT03708328|587365198|FG003|Overall Study|Physician Decision|0|||
162631224|NCT03708328|587365199|FG004|Overall Study|Physician Decision|0|||
162631225|NCT03708328|587365200|FG005|Overall Study|Physician Decision|1|||
162631226|NCT03708328|587365201|FG006|Overall Study|Physician Decision|0|||
162631227|NCT03708328|587365202|FG007|Overall Study|Physician Decision|0|||
162979090|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
162979091|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
162979092|NCT00773734|588625050|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979093|NCT00773734|588625051|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979094|NCT00773734|588625052|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979095|NCT00773734|588625053|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
162979096|NCT00773734|588625054|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
162979097|NCT00773734|588625055|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
162979098|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979099|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
162979100|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979101|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
162979102|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
162979103|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
162979104|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979105|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
162979106|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
162979107|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
162979108|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979109|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
162979110|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979111|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
162979112|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
162979113|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979114|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
162979115|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
162979116|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979117|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
162979118|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
162631228|NCT03708328|587365203|FG008|Overall Study|Physician Decision|0|||
162631229|NCT03708328|587365204|FG009|Overall Study|Physician Decision|0|||
162631230|NCT03708328|587365195|FG000|Overall Study|Withdrawal by Subject|0|||
162979119|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979120|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162631231|NCT03708328|587365196|FG001|Overall Study|Withdrawal by Subject|0|||
162631232|NCT03708328|587365197|FG002|Overall Study|Withdrawal by Subject|0|||
162631233|NCT03708328|587365198|FG003|Overall Study|Withdrawal by Subject|0|||
162631234|NCT03708328|587365199|FG004|Overall Study|Withdrawal by Subject|1|||
162631235|NCT03708328|587365200|FG005|Overall Study|Withdrawal by Subject|0|||
162631236|NCT03708328|587365201|FG006|Overall Study|Withdrawal by Subject|2|||
162631237|NCT03708328|587365202|FG007|Overall Study|Withdrawal by Subject|4|||
162631238|NCT03708328|587365203|FG008|Overall Study|Withdrawal by Subject|1|||
162631239|NCT03708328|587365204|FG009|Overall Study|Withdrawal by Subject|5|||
162631240|NCT03708328|587365195|FG000|Overall Study|Study Closed Locally|0|||
162631241|NCT03708328|587365196|FG001|Overall Study|Study Closed Locally|0|||
162631242|NCT03708328|587365197|FG002|Overall Study|Study Closed Locally|0|||
162631243|NCT03708328|587365198|FG003|Overall Study|Study Closed Locally|0|||
162631244|NCT03708328|587365199|FG004|Overall Study|Study Closed Locally|0|||
162631245|NCT03708328|587365200|FG005|Overall Study|Study Closed Locally|0|||
162631246|NCT03708328|587365201|FG006|Overall Study|Study Closed Locally|0|||
162631247|NCT03708328|587365202|FG007|Overall Study|Study Closed Locally|1|||
162631248|NCT03708328|587365203|FG008|Overall Study|Study Closed Locally|0|||
162631249|NCT03708328|587365204|FG009|Overall Study|Study Closed Locally|0|||
162631250|NCT03708328|587365195|FG000|Overall Study|Study Ended By Sponsor|0|||
162631251|NCT03708328|587365196|FG001|Overall Study|Study Ended By Sponsor|0|||
162631252|NCT03708328|587365197|FG002|Overall Study|Study Ended By Sponsor|0|||
162631253|NCT03708328|587365198|FG003|Overall Study|Study Ended By Sponsor|0|||
162631254|NCT03708328|587365199|FG004|Overall Study|Study Ended By Sponsor|0|||
162631255|NCT03708328|587365200|FG005|Overall Study|Study Ended By Sponsor|1|||
162631256|NCT03708328|587365201|FG006|Overall Study|Study Ended By Sponsor|0|||
162631257|NCT03708328|587365202|FG007|Overall Study|Study Ended By Sponsor|1|||
162631258|NCT03708328|587365203|FG008|Overall Study|Study Ended By Sponsor|0|||
162631259|NCT03708328|587365204|FG009|Overall Study|Study Ended By Sponsor|0|||
162631260|NCT03708328|587365195|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631261|NCT03708328|587365196|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631262|NCT03708328|587365197|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631263|NCT03708328|587365198|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631264|NCT03708328|587365199|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631265|NCT03708328|587365200|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631266|NCT03708328|587365201|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631267|NCT03708328|587365202|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631268|NCT03708328|587365203|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
162631269|NCT03708328|587365204|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162631270|NCT00571948|587365205|FG000|Overall Study|Lost to Follow-up|2|||
162631271|NCT00571948|587365206|FG001|Overall Study|Lost to Follow-up|0|||
162631272|NCT00571948|587365205|FG000|Overall Study|Withdrawal by Subject|1|||
162631273|NCT00571948|587365206|FG001|Overall Study|Withdrawal by Subject|2|||
163058656|NCT00042289|588924249|FG014|Overall Study|Protocol Violation|0|||
162631274|NCT00571948|587365205|FG000|Overall Study|Protocol Violation|3|||
162631275|NCT00571948|587365206|FG001|Overall Study|Protocol Violation|3|||
162979121|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
162979122|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
162979123|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979124|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979125|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979126|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
162979127|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
162979128|NCT00773734|588625050|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
162979129|NCT00773734|588625051|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
162979130|NCT00773734|588625052|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
162979131|NCT00773734|588625053|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
162631276|NCT00571948|587365205|FG000|Overall Study|infant refused study meal|3|||
162631277|NCT00571948|587365206|FG001|Overall Study|infant refused study meal|4|||
162631278|NCT00571948|587365205|FG000|Overall Study|Parent were afraid of blood colection|2|||
162631279|NCT00571948|587365206|FG001|Overall Study|Parent were afraid of blood colection|5|||
162631280|NCT01845831|587365208|FG000|Inpatient Phase|Withdrawal by Subject|1|||
162631281|NCT01845831|587365209|FG001|Inpatient Phase|Withdrawal by Subject|1|||
162631282|NCT01845831|587365210|FG002|Inpatient Phase|Withdrawal by Subject|0|||
162631283|NCT01845831|587365211|FG003|Inpatient Phase|Withdrawal by Subject|0|||
162631284|NCT01845831|587365212|FG004|Inpatient Phase|Withdrawal by Subject|0|||
162631285|NCT02010775|587365213|FG000|Overall Study|Adverse Event|0|||
162631286|NCT02010775|587365214|FG001|Overall Study|Adverse Event|0|||
162631287|NCT02010775|587365215|FG002|Overall Study|Adverse Event|0|||
162631288|NCT02010775|587365216|FG003|Overall Study|Adverse Event|0|||
162631289|NCT02010775|587365217|FG004|Overall Study|Adverse Event|1|||
162631290|NCT02010775|587365213|FG000|Overall Study|Pregnancy|0|||
162631291|NCT02010775|587365214|FG001|Overall Study|Pregnancy|0|||
162631292|NCT02010775|587365215|FG002|Overall Study|Pregnancy|2|||
162631293|NCT02010775|587365216|FG003|Overall Study|Pregnancy|0|||
162631294|NCT02010775|587365217|FG004|Overall Study|Pregnancy|0|||
162631295|NCT02010775|587365213|FG000|Overall Study|Lost to Follow-up|2|||
162631296|NCT02010775|587365214|FG001|Overall Study|Lost to Follow-up|0|||
162631297|NCT02010775|587365215|FG002|Overall Study|Lost to Follow-up|0|||
162631298|NCT02010775|587365216|FG003|Overall Study|Lost to Follow-up|1|||
162631299|NCT02010775|587365217|FG004|Overall Study|Lost to Follow-up|1|||
162631300|NCT02010775|587365213|FG000|Overall Study|Personal Reasons|3|||
162631301|NCT02010775|587365214|FG001|Overall Study|Personal Reasons|3|||
162631302|NCT02010775|587365215|FG002|Overall Study|Personal Reasons|1|||
162631303|NCT02010775|587365216|FG003|Overall Study|Personal Reasons|2|||
162631304|NCT02010775|587365217|FG004|Overall Study|Personal Reasons|4|||
162631305|NCT02030041|587365218|FG000|Overall Study|Withdrawal by Subject|2|||
162631306|NCT02030041|587365219|FG001|Overall Study|Withdrawal by Subject|2|||
162631307|NCT02030041|587365220|FG002|Overall Study|Withdrawal by Subject|1|||
162631308|NCT02006719|587365222|FG000|Overall Study|Withdrawal by Subject|10|||
162631309|NCT02006719|587365223|FG001|Overall Study|Withdrawal by Subject|2|||
163058657|NCT00042289|588924250|FG015|Overall Study|Protocol Violation|0|||
162979132|NCT00773734|588625054|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
162979133|NCT00773734|588625055|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
162979134|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979135|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979136|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162979137|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
162631310|NCT02006719|587365222|FG000|Overall Study|Lost to Follow-up|5|||
162631311|NCT02006719|587365223|FG001|Overall Study|Lost to Follow-up|1|||
162631312|NCT02006719|587365222|FG000|Overall Study|Protocol Violation|2|||
162631313|NCT02006719|587365223|FG001|Overall Study|Protocol Violation|0|||
162631314|NCT02006719|587365222|FG000|Overall Study|Adverse Event|1|||
162631315|NCT02006719|587365223|FG001|Overall Study|Adverse Event|1|||
162631316|NCT02006719|587365222|FG000|Overall Study|Other/Unknown|0|||
162631317|NCT02006719|587365223|FG001|Overall Study|Other/Unknown|1|||
162631318|NCT00496054|587365227|FG000|Overall Study|Adverse Event|1|||
162631319|NCT00496054|587365227|FG000|Overall Study|Lost to Follow-up|7|||
162631320|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631321|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162631322|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631323|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162631324|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162631325|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631326|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631327|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631328|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631329|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631330|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631331|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631332|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631333|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631334|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162631335|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
162631336|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
162631337|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
162631338|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631339|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631340|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631341|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631342|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631343|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631344|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631345|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631346|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631347|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631348|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631349|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162631350|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631351|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631352|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631353|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
162631354|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631355|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631356|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631357|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631358|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631359|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631360|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631361|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631362|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631363|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631364|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
162631365|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631366|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
162631367|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631368|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631369|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631370|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631371|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162979138|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
162631372|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631373|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162979139|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
162979140|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
162979141|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
162979142|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
162979143|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
162979144|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
162979145|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
162979146|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
162979147|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
162979148|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
162979149|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
162979150|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
162979151|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
162979152|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
162979153|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
162979154|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
162979155|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
163058658|NCT00042289|588924251|FG016|Overall Study|Protocol Violation|0|||
163058659|NCT00042289|588924252|FG017|Overall Study|Protocol Violation|0|||
163058660|NCT00042289|588924253|FG018|Overall Study|Protocol Violation|0|||
163058661|NCT00042289|588924254|FG019|Overall Study|Protocol Violation|0|||
163058662|NCT00042289|588924255|FG020|Overall Study|Protocol Violation|0|||
163058663|NCT00042289|588924256|FG021|Overall Study|Protocol Violation|0|||
163058664|NCT00042289|588924257|FG022|Overall Study|Protocol Violation|0|||
163058665|NCT00042289|588924258|FG023|Overall Study|Protocol Violation|1|||
163058666|NCT00042289|588924259|FG024|Overall Study|Protocol Violation|1|||
163058667|NCT00042289|588924260|FG025|Overall Study|Protocol Violation|0|||
163058668|NCT00042289|588924261|FG026|Overall Study|Protocol Violation|2|||
162979156|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
162979157|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
163058669|NCT00042289|588924262|FG027|Overall Study|Protocol Violation|0|||
163058670|NCT00042289|588924263|FG028|Overall Study|Protocol Violation|0|||
163058671|NCT00042289|588924264|FG029|Overall Study|Protocol Violation|0|||
163058672|NCT00042289|588924265|FG030|Overall Study|Protocol Violation|1|||
163058673|NCT00042289|588924266|FG031|Overall Study|Protocol Violation|0|||
163058674|NCT00042289|588924267|FG032|Overall Study|Protocol Violation|0|||
163058675|NCT00042289|588924268|FG033|Overall Study|Protocol Violation|0|||
163058676|NCT00042289|588924269|FG034|Overall Study|Protocol Violation|0|||
163058677|NCT00042289|588924270|FG035|Overall Study|Protocol Violation|0|||
163058678|NCT00042289|588924271|FG036|Overall Study|Protocol Violation|0|||
163058679|NCT00042289|588924272|FG037|Overall Study|Protocol Violation|0|||
163058680|NCT00042289|588924273|FG038|Overall Study|Protocol Violation|0|||
163058681|NCT00042289|588924274|FG039|Overall Study|Protocol Violation|0|||
163058682|NCT00042289|588924275|FG040|Overall Study|Protocol Violation|0|||
163058683|NCT00042289|588924276|FG041|Overall Study|Protocol Violation|1|||
163058684|NCT00042289|588924277|FG042|Overall Study|Protocol Violation|1|||
163058685|NCT00042289|588924278|FG043|Overall Study|Protocol Violation|1|||
163058686|NCT00042289|588924279|FG044|Overall Study|Protocol Violation|0|||
163058687|NCT00042289|588924280|FG045|Overall Study|Protocol Violation|0|||
163058688|NCT00042289|588924281|FG046|Overall Study|Protocol Violation|0|||
163058689|NCT00042289|588924235|FG000|Overall Study|Withdrawal by Subject|4|||
163058690|NCT00042289|588924236|FG001|Overall Study|Withdrawal by Subject|1|||
163058691|NCT00042289|588924237|FG002|Overall Study|Withdrawal by Subject|0|||
163058692|NCT00042289|588924238|FG003|Overall Study|Withdrawal by Subject|2|||
163058693|NCT00042289|588924239|FG004|Overall Study|Withdrawal by Subject|0|||
163058694|NCT00042289|588924240|FG005|Overall Study|Withdrawal by Subject|2|||
163058695|NCT00042289|588924241|FG006|Overall Study|Withdrawal by Subject|0|||
163058696|NCT00042289|588924242|FG007|Overall Study|Withdrawal by Subject|0|||
163058697|NCT00042289|588924243|FG008|Overall Study|Withdrawal by Subject|0|||
163058698|NCT00042289|588924244|FG009|Overall Study|Withdrawal by Subject|1|||
163058699|NCT00042289|588924245|FG010|Overall Study|Withdrawal by Subject|0|||
163058700|NCT00042289|588924246|FG011|Overall Study|Withdrawal by Subject|0|||
163058701|NCT00042289|588924247|FG012|Overall Study|Withdrawal by Subject|2|||
163058702|NCT00042289|588924248|FG013|Overall Study|Withdrawal by Subject|0|||
162979158|NCT00773734|588625050|FG000|Extension: Active Treatment Week 24-52|Other|0|||
162979159|NCT00773734|588625051|FG001|Extension: Active Treatment Week 24-52|Other|0|||
162979160|NCT00773734|588625052|FG002|Extension: Active Treatment Week 24-52|Other|1|||
162979161|NCT00773734|588625053|FG003|Extension: Active Treatment Week 24-52|Other|2|||
162979162|NCT00773734|588625054|FG004|Extension: Active Treatment Week 24-52|Other|0|||
162979163|NCT00773734|588625055|FG005|Extension: Active Treatment Week 24-52|Other|1|||
162979164|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979165|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979166|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979167|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
162979168|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979169|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
162979170|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
163058703|NCT00042289|588924249|FG014|Overall Study|Withdrawal by Subject|0|||
163058704|NCT00042289|588924250|FG015|Overall Study|Withdrawal by Subject|0|||
163058705|NCT00042289|588924251|FG016|Overall Study|Withdrawal by Subject|0|||
163058706|NCT00042289|588924252|FG017|Overall Study|Withdrawal by Subject|0|||
163058707|NCT00042289|588924253|FG018|Overall Study|Withdrawal by Subject|0|||
163058708|NCT00042289|588924254|FG019|Overall Study|Withdrawal by Subject|0|||
163058709|NCT00042289|588924255|FG020|Overall Study|Withdrawal by Subject|0|||
163058710|NCT00042289|588924256|FG021|Overall Study|Withdrawal by Subject|1|||
163058711|NCT00042289|588924257|FG022|Overall Study|Withdrawal by Subject|1|||
163058712|NCT00042289|588924258|FG023|Overall Study|Withdrawal by Subject|1|||
163058713|NCT00042289|588924259|FG024|Overall Study|Withdrawal by Subject|0|||
163058714|NCT00042289|588924260|FG025|Overall Study|Withdrawal by Subject|0|||
163058715|NCT00042289|588924261|FG026|Overall Study|Withdrawal by Subject|1|||
163058716|NCT00042289|588924262|FG027|Overall Study|Withdrawal by Subject|0|||
163058717|NCT00042289|588924263|FG028|Overall Study|Withdrawal by Subject|2|||
163058718|NCT00042289|588924264|FG029|Overall Study|Withdrawal by Subject|0|||
163058719|NCT00042289|588924265|FG030|Overall Study|Withdrawal by Subject|0|||
163058720|NCT00042289|588924266|FG031|Overall Study|Withdrawal by Subject|1|||
163058721|NCT00042289|588924267|FG032|Overall Study|Withdrawal by Subject|2|||
163058722|NCT00042289|588924268|FG033|Overall Study|Withdrawal by Subject|1|||
163058723|NCT00042289|588924269|FG034|Overall Study|Withdrawal by Subject|0|||
162979171|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979172|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
162979173|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
162979174|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979175|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
162979176|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979177|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979178|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
162979179|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
162979180|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979181|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
162979182|NCT00773734|588625050|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979183|NCT00773734|588625051|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979184|NCT00773734|588625052|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
162979185|NCT00773734|588625053|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
163058724|NCT00042289|588924270|FG035|Overall Study|Withdrawal by Subject|0|||
162631374|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631375|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631376|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631377|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631378|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631379|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162631380|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631381|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631382|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631383|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631384|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
162631385|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631386|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631387|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631388|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631389|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631390|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631391|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631392|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631393|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631394|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162631395|NCT01737697|587365228|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631396|NCT01737697|587365229|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162631397|NCT01737697|587365230|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162631398|NCT01737697|587365231|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
162631399|NCT01737697|587365232|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162631400|NCT01737697|587365233|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631401|NCT01737697|587365234|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631402|NCT01737697|587365235|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631403|NCT01737697|587365236|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631404|NCT01737697|587365237|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631405|NCT01737697|587365238|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631406|NCT01737697|587365239|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631407|NCT01737697|587365240|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631408|NCT01737697|587365241|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631409|NCT01737697|587365242|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162631410|NCT01737697|587365228|FG000|Subacute Phase|Adverse Event|0|||
162631411|NCT01737697|587365229|FG001|Subacute Phase|Adverse Event|0|||
162631412|NCT01737697|587365230|FG002|Subacute Phase|Adverse Event|0|||
162631413|NCT01737697|587365231|FG003|Subacute Phase|Adverse Event|0|||
162631414|NCT01737697|587365232|FG004|Subacute Phase|Adverse Event|0|||
162631415|NCT01737697|587365233|FG005|Subacute Phase|Adverse Event|1|||
162631416|NCT01737697|587365234|FG006|Subacute Phase|Adverse Event|1|||
162631417|NCT01737697|587365235|FG007|Subacute Phase|Adverse Event|1|||
162631418|NCT01737697|587365236|FG008|Subacute Phase|Adverse Event|1|||
162631419|NCT01737697|587365237|FG009|Subacute Phase|Adverse Event|1|||
162631420|NCT01737697|587365238|FG010|Subacute Phase|Adverse Event|4|||
162631421|NCT01737697|587365239|FG011|Subacute Phase|Adverse Event|1|||
162631422|NCT01737697|587365240|FG012|Subacute Phase|Adverse Event|1|||
162979186|NCT00773734|588625054|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162979187|NCT00773734|588625055|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
162631423|NCT01737697|587365241|FG013|Subacute Phase|Adverse Event|0|||
162631424|NCT01737697|587365242|FG014|Subacute Phase|Adverse Event|0|||
162631425|NCT01737697|587365228|FG000|Subacute Phase|Withdrawal by Subject|0|||
162631426|NCT01737697|587365229|FG001|Subacute Phase|Withdrawal by Subject|0|||
162979188|NCT00856830|588625059|FG000|Irinotecan & Bendamustine|Death|0|||
162979189|NCT00856830|588625060|FG001|Irinotecan & Bendamustine|Death|0|||
162979190|NCT00856830|588625061|FG002|Irinotecan & Bendamustine|Death|0|||
162979191|NCT00856830|588625062|FG003|Irinotecan & Bendamustine|Death|2|||
162979192|NCT00856830|588625059|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
162979193|NCT00856830|588625060|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
162979194|NCT00856830|588625061|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
162979195|NCT00856830|588625062|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
162979196|NCT03768726|588625063|FG000|Treatment Phase|Adverse Event|2|||
162979197|NCT03768726|588625064|FG001|Treatment Phase|Adverse Event|2|||
162979198|NCT03768726|588625063|FG000|Treatment Phase|Lost to Follow-up|1|||
162979199|NCT03768726|588625064|FG001|Treatment Phase|Lost to Follow-up|0|||
163058725|NCT00042289|588924271|FG036|Overall Study|Withdrawal by Subject|0|||
162631427|NCT01737697|587365230|FG002|Subacute Phase|Withdrawal by Subject|0|||
162631428|NCT01737697|587365231|FG003|Subacute Phase|Withdrawal by Subject|0|||
162631429|NCT01737697|587365232|FG004|Subacute Phase|Withdrawal by Subject|0|||
162631430|NCT01737697|587365233|FG005|Subacute Phase|Withdrawal by Subject|1|||
162631431|NCT01737697|587365234|FG006|Subacute Phase|Withdrawal by Subject|0|||
162631432|NCT01737697|587365235|FG007|Subacute Phase|Withdrawal by Subject|2|||
162631433|NCT01737697|587365236|FG008|Subacute Phase|Withdrawal by Subject|0|||
162631434|NCT01737697|587365237|FG009|Subacute Phase|Withdrawal by Subject|1|||
162631435|NCT01737697|587365238|FG010|Subacute Phase|Withdrawal by Subject|0|||
162631436|NCT01737697|587365239|FG011|Subacute Phase|Withdrawal by Subject|1|||
162631437|NCT01737697|587365240|FG012|Subacute Phase|Withdrawal by Subject|1|||
162631438|NCT01737697|587365241|FG013|Subacute Phase|Withdrawal by Subject|1|||
162631439|NCT01737697|587365242|FG014|Subacute Phase|Withdrawal by Subject|0|||
162631440|NCT01737697|587365228|FG000|Subacute Phase|Lost to Follow-up|0|||
162631441|NCT01737697|587365229|FG001|Subacute Phase|Lost to Follow-up|0|||
162631442|NCT01737697|587365230|FG002|Subacute Phase|Lost to Follow-up|0|||
162631443|NCT01737697|587365231|FG003|Subacute Phase|Lost to Follow-up|0|||
162631444|NCT01737697|587365232|FG004|Subacute Phase|Lost to Follow-up|0|||
162631445|NCT01737697|587365233|FG005|Subacute Phase|Lost to Follow-up|0|||
162631446|NCT01737697|587365234|FG006|Subacute Phase|Lost to Follow-up|0|||
162631447|NCT01737697|587365235|FG007|Subacute Phase|Lost to Follow-up|0|||
162631448|NCT01737697|587365236|FG008|Subacute Phase|Lost to Follow-up|0|||
162631449|NCT01737697|587365237|FG009|Subacute Phase|Lost to Follow-up|0|||
162631450|NCT01737697|587365238|FG010|Subacute Phase|Lost to Follow-up|0|||
162631451|NCT01737697|587365239|FG011|Subacute Phase|Lost to Follow-up|0|||
162631452|NCT01737697|587365240|FG012|Subacute Phase|Lost to Follow-up|0|||
162631453|NCT01737697|587365241|FG013|Subacute Phase|Lost to Follow-up|0|||
162631454|NCT01737697|587365242|FG014|Subacute Phase|Lost to Follow-up|1|||
162631455|NCT01737697|587365228|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
162631456|NCT01737697|587365229|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
162631457|NCT01737697|587365230|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
162631458|NCT01737697|587365231|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
162631459|NCT01737697|587365232|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
162631460|NCT01737697|587365233|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
162631461|NCT01737697|587365234|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
162631462|NCT01737697|587365235|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
162631463|NCT01737697|587365236|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
162631464|NCT01737697|587365237|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
162631465|NCT01737697|587365238|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
162631466|NCT01737697|587365239|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
162631467|NCT01737697|587365240|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
162631468|NCT01737697|587365241|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
162631469|NCT01737697|587365242|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
162631470|NCT01737697|587365228|FG000|Subacute Phase|Protocol Violation|0|||
162631471|NCT01737697|587365229|FG001|Subacute Phase|Protocol Violation|0|||
162631472|NCT01737697|587365230|FG002|Subacute Phase|Protocol Violation|0|||
162631473|NCT01737697|587365231|FG003|Subacute Phase|Protocol Violation|0|||
162631474|NCT01737697|587365232|FG004|Subacute Phase|Protocol Violation|0|||
162631475|NCT01737697|587365233|FG005|Subacute Phase|Protocol Violation|1|||
162631476|NCT01737697|587365234|FG006|Subacute Phase|Protocol Violation|0|||
162631477|NCT01737697|587365235|FG007|Subacute Phase|Protocol Violation|0|||
162631478|NCT01737697|587365236|FG008|Subacute Phase|Protocol Violation|0|||
162631479|NCT01737697|587365237|FG009|Subacute Phase|Protocol Violation|0|||
162631480|NCT01737697|587365238|FG010|Subacute Phase|Protocol Violation|1|||
162631481|NCT01737697|587365239|FG011|Subacute Phase|Protocol Violation|0|||
162631482|NCT01737697|587365240|FG012|Subacute Phase|Protocol Violation|0|||
162631483|NCT01737697|587365241|FG013|Subacute Phase|Protocol Violation|0|||
162631484|NCT01737697|587365242|FG014|Subacute Phase|Protocol Violation|0|||
162631485|NCT01737697|587365228|FG000|Subacute Phase|Physician Decision|0|||
162979200|NCT03768726|588625063|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
162631486|NCT01737697|587365229|FG001|Subacute Phase|Physician Decision|0|||
162631487|NCT01737697|587365230|FG002|Subacute Phase|Physician Decision|0|||
162631488|NCT01737697|587365231|FG003|Subacute Phase|Physician Decision|0|||
162979201|NCT03768726|588625064|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
162631489|NCT01737697|587365232|FG004|Subacute Phase|Physician Decision|0|||
163058726|NCT00042289|588924272|FG037|Overall Study|Withdrawal by Subject|1|||
163058727|NCT00042289|588924273|FG038|Overall Study|Withdrawal by Subject|0|||
163058728|NCT00042289|588924274|FG039|Overall Study|Withdrawal by Subject|0|||
163058729|NCT00042289|588924275|FG040|Overall Study|Withdrawal by Subject|0|||
163058730|NCT00042289|588924276|FG041|Overall Study|Withdrawal by Subject|0|||
163058731|NCT00042289|588924277|FG042|Overall Study|Withdrawal by Subject|1|||
163058732|NCT00042289|588924278|FG043|Overall Study|Withdrawal by Subject|0|||
163058733|NCT00042289|588924279|FG044|Overall Study|Withdrawal by Subject|0|||
163058734|NCT00042289|588924280|FG045|Overall Study|Withdrawal by Subject|0|||
162631490|NCT01737697|587365233|FG005|Subacute Phase|Physician Decision|0|||
162631491|NCT01737697|587365234|FG006|Subacute Phase|Physician Decision|0|||
162631492|NCT01737697|587365235|FG007|Subacute Phase|Physician Decision|0|||
162631493|NCT01737697|587365236|FG008|Subacute Phase|Physician Decision|1|||
162631494|NCT01737697|587365237|FG009|Subacute Phase|Physician Decision|0|||
162631495|NCT01737697|587365238|FG010|Subacute Phase|Physician Decision|0|||
162631496|NCT01737697|587365239|FG011|Subacute Phase|Physician Decision|0|||
162631497|NCT01737697|587365240|FG012|Subacute Phase|Physician Decision|0|||
162631498|NCT01737697|587365241|FG013|Subacute Phase|Physician Decision|0|||
162631499|NCT01737697|587365242|FG014|Subacute Phase|Physician Decision|0|||
162631500|NCT01737697|587365228|FG000|Subacute Phase|Death|0|||
162631501|NCT01737697|587365229|FG001|Subacute Phase|Death|0|||
162631502|NCT01737697|587365230|FG002|Subacute Phase|Death|0|||
162631503|NCT01737697|587365231|FG003|Subacute Phase|Death|0|||
162631504|NCT01737697|587365232|FG004|Subacute Phase|Death|0|||
162631505|NCT01737697|587365233|FG005|Subacute Phase|Death|0|||
162631506|NCT01737697|587365234|FG006|Subacute Phase|Death|0|||
162631507|NCT01737697|587365235|FG007|Subacute Phase|Death|0|||
162631508|NCT01737697|587365236|FG008|Subacute Phase|Death|0|||
162631509|NCT01737697|587365237|FG009|Subacute Phase|Death|0|||
162631510|NCT01737697|587365238|FG010|Subacute Phase|Death|1|||
162631511|NCT01737697|587365239|FG011|Subacute Phase|Death|0|||
162631512|NCT01737697|587365240|FG012|Subacute Phase|Death|0|||
162631513|NCT01737697|587365241|FG013|Subacute Phase|Death|0|||
162631514|NCT01737697|587365242|FG014|Subacute Phase|Death|0|||
162631515|NCT02854631|587365249|FG000|Overall Study|Adverse Event|1|||
162631516|NCT02854631|587365250|FG001|Overall Study|Adverse Event|2|||
162631517|NCT02854631|587365249|FG000|Overall Study|Withdrew Consent|3|||
162631518|NCT02854631|587365250|FG001|Overall Study|Withdrew Consent|2|||
162631519|NCT02854631|587365249|FG000|Overall Study|Investigator's Discretion|2|||
162631520|NCT02854631|587365250|FG001|Overall Study|Investigator's Discretion|0|||
162631521|NCT02854631|587365249|FG000|Overall Study|Death|12|||
162631522|NCT02854631|587365250|FG001|Overall Study|Death|8|||
162631523|NCT02854631|587365249|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
162631524|NCT02854631|587365250|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
162631525|NCT02854631|587365249|FG000|Overall Study|Protocol Violation|0|||
162631526|NCT02854631|587365250|FG001|Overall Study|Protocol Violation|1|||
162631527|NCT02854631|587365249|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
162631528|NCT02854631|587365250|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
162631529|NCT02854631|587365249|FG000|Overall Study|Lost to Follow-up|4|||
162631530|NCT02854631|587365250|FG001|Overall Study|Lost to Follow-up|2|||
162631531|NCT03930797|587365251|FG000|Overall Study|Lost to Follow-up|3|||
162631532|NCT03930797|587365252|FG001|Overall Study|Lost to Follow-up|10|||
162631533|NCT01962896|587365253|FG000|Overall Study|Lack of Efficacy|4|||
162631534|NCT00753415|587365255|FG000|Part A|Disease progression|1|||
162631535|NCT00753415|587365256|FG001|Part A|Disease progression|0|||
162631536|NCT00753415|587365257|FG002|Part A|Disease progression|1|||
162631537|NCT00753415|587365258|FG003|Part A|Disease progression|2|||
162631538|NCT00753415|587365259|FG004|Part A|Disease progression|0|||
162631539|NCT00753415|587365260|FG005|Part A|Disease progression|0|||
162631540|NCT00753415|587365261|FG006|Part A|Disease progression|0|||
162631541|NCT00753415|587365262|FG007|Part A|Disease progression|0|||
162713892|NCT02701361|587662612|FG001|Overall Study|timed out in rehab center|1|||
163058735|NCT00042289|588924281|FG046|Overall Study|Withdrawal by Subject|0|||
163058736|NCT00548327|588924286|FG000|Overall Study|Adverse Event|0|||
163058737|NCT00548327|588924287|FG001|Overall Study|Adverse Event|1|||
162631542|NCT00753415|587365263|FG008|Part A|Disease progression|0|||
162631543|NCT00753415|587365264|FG009|Part A|Disease progression|0|||
162631544|NCT00753415|587365255|FG000|Part A|Withdrawal by Subject|0|||
162631545|NCT00753415|587365256|FG001|Part A|Withdrawal by Subject|0|||
162631546|NCT00753415|587365257|FG002|Part A|Withdrawal by Subject|1|||
162631547|NCT00753415|587365258|FG003|Part A|Withdrawal by Subject|0|||
162631548|NCT00753415|587365259|FG004|Part A|Withdrawal by Subject|0|||
162631549|NCT00753415|587365260|FG005|Part A|Withdrawal by Subject|0|||
162631550|NCT00753415|587365261|FG006|Part A|Withdrawal by Subject|0|||
162713893|NCT02701361|587662613|FG002|Overall Study|timed out in rehab center|0|||
162713894|NCT02701361|587662611|FG000|Overall Study|incarceration|0|||
162713895|NCT02701361|587662612|FG001|Overall Study|incarceration|0|||
162713896|NCT02701361|587662613|FG002|Overall Study|incarceration|1|||
162713897|NCT00404079|587662620|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
162713898|NCT00404079|587662621|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
162713899|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Other|4|||
162713900|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Other|0|||
162713901|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
162713902|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
162713903|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
162713904|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
162713905|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
162979202|NCT03768726|588625063|FG000|Treatment Phase|Withdrawal by Subject|3|||
162979203|NCT03768726|588625064|FG001|Treatment Phase|Withdrawal by Subject|1|||
162979204|NCT03768726|588625063|FG000|Follow-Up|Adverse Event|2|||
162979205|NCT03768726|588625064|FG001|Follow-Up|Adverse Event|2|||
162979206|NCT03768726|588625063|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
162979207|NCT03768726|588625064|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
162979208|NCT03768726|588625063|FG000|Follow-Up|Withdrawal by Subject|2|||
162979209|NCT03768726|588625064|FG001|Follow-Up|Withdrawal by Subject|0|||
162979210|NCT03768726|588625063|FG000|Follow-Up|Other|1|||
162979211|NCT03768726|588625064|FG001|Follow-Up|Other|0|||
162979212|NCT01787279|588625065|FG000|Overall Study|Lost to Follow-up|2|||
162979213|NCT01787279|588625065|FG000|Overall Study|Lack of Efficacy|1|||
162979214|NCT02148913|588625066|FG000|Overall Study|Death|0|||
162979215|NCT02148913|588625067|FG001|Overall Study|Death|1|||
162979216|NCT02148913|588625068|FG002|Overall Study|Death|0|||
162979217|NCT02148913|588625069|FG003|Overall Study|Death|0|||
162979218|NCT01360866|588625071|FG000|Overall Study|Lost to Follow-up|11|||
162979219|NCT01360866|588625072|FG001|Overall Study|Lost to Follow-up|28|||
162979220|NCT01360866|588625073|FG002|Overall Study|Lost to Follow-up|41|||
162979221|NCT01360866|588625074|FG003|Overall Study|Lost to Follow-up|0|||
162979222|NCT01360866|588625071|FG000|Overall Study|Adverse Event|56|||
162979223|NCT01360866|588625072|FG001|Overall Study|Adverse Event|61|||
162979224|NCT01360866|588625073|FG002|Overall Study|Adverse Event|134|||
162631551|NCT00753415|587365262|FG007|Part A|Withdrawal by Subject|0|||
162631552|NCT00753415|587365263|FG008|Part A|Withdrawal by Subject|0|||
162631553|NCT00753415|587365264|FG009|Part A|Withdrawal by Subject|0|||
162631554|NCT00753415|587365255|FG000|Part B|Lost to Follow-up|0|||
162631555|NCT00753415|587365256|FG001|Part B|Lost to Follow-up|0|||
162631556|NCT00753415|587365257|FG002|Part B|Lost to Follow-up|0|||
162631557|NCT00753415|587365258|FG003|Part B|Lost to Follow-up|0|||
162631558|NCT00753415|587365259|FG004|Part B|Lost to Follow-up|0|||
162631559|NCT00753415|587365260|FG005|Part B|Lost to Follow-up|0|||
162631560|NCT00753415|587365261|FG006|Part B|Lost to Follow-up|0|||
162631561|NCT00753415|587365262|FG007|Part B|Lost to Follow-up|1|||
162631562|NCT00753415|587365263|FG008|Part B|Lost to Follow-up|1|||
162631563|NCT00753415|587365264|FG009|Part B|Lost to Follow-up|0|||
162631564|NCT00753415|587365255|FG000|Part B|Disease progression|0|||
162713906|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
162713907|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
162979225|NCT01360866|588625074|FG003|Overall Study|Adverse Event|6|||
162631565|NCT00753415|587365256|FG001|Part B|Disease progression|0|||
162631566|NCT00753415|587365257|FG002|Part B|Disease progression|0|||
162631567|NCT00753415|587365258|FG003|Part B|Disease progression|0|||
162631568|NCT00753415|587365259|FG004|Part B|Disease progression|0|||
162631569|NCT00753415|587365260|FG005|Part B|Disease progression|0|||
162631570|NCT00753415|587365261|FG006|Part B|Disease progression|0|||
162631571|NCT00753415|587365262|FG007|Part B|Disease progression|0|||
162631572|NCT00753415|587365263|FG008|Part B|Disease progression|2|||
162631573|NCT00753415|587365264|FG009|Part B|Disease progression|1|||
162979226|NCT01360866|588625071|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
162631574|NCT00621153|587365265|FG000|Overall Study|Safety Reason|8|||
162631575|NCT00621153|587365266|FG001|Overall Study|Safety Reason|7|||
162631576|NCT00621153|587365265|FG000|Overall Study|Adverse Event|3|||
162979227|NCT01360866|588625072|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
162979228|NCT01360866|588625073|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
162631577|NCT00621153|587365266|FG001|Overall Study|Adverse Event|2|||
162631578|NCT00621153|587365265|FG000|Overall Study|Lost to Follow-up|5|||
162631579|NCT00621153|587365266|FG001|Overall Study|Lost to Follow-up|1|||
162631580|NCT00621153|587365265|FG000|Overall Study|Withdrawal by Subject|4|||
162631581|NCT00621153|587365266|FG001|Overall Study|Withdrawal by Subject|5|||
162631582|NCT03727347|587365271|FG000|Overall Study|Withdrawal by Subject|2|||
162631583|NCT03727347|587365271|FG000|Overall Study|Lost to Follow-up|1|||
162631584|NCT04292743|587365272|FG000|Overall Study|Physician Decision|1|||
162631585|NCT04292743|587365273|FG001|Overall Study|Physician Decision|3|||
162631586|NCT04292743|587365274|FG002|Overall Study|Physician Decision|0|||
162631587|NCT04292743|587365275|FG003|Overall Study|Physician Decision|0|||
162631588|NCT04292743|587365272|FG000|Overall Study|Withdrawal by Subject|0|||
162631589|NCT04292743|587365273|FG001|Overall Study|Withdrawal by Subject|5|||
162631590|NCT04292743|587365274|FG002|Overall Study|Withdrawal by Subject|0|||
162631591|NCT04292743|587365275|FG003|Overall Study|Withdrawal by Subject|0|||
162631592|NCT04292743|587365272|FG000|Overall Study|Death|0|||
162631593|NCT04292743|587365273|FG001|Overall Study|Death|1|||
162631594|NCT04292743|587365274|FG002|Overall Study|Death|0|||
162631595|NCT04292743|587365275|FG003|Overall Study|Death|0|||
162631596|NCT04292743|587365272|FG000|Overall Study|Progression of Disease|2|||
162631597|NCT04292743|587365273|FG001|Overall Study|Progression of Disease|5|||
162631598|NCT04292743|587365274|FG002|Overall Study|Progression of Disease|0|||
162631599|NCT04292743|587365275|FG003|Overall Study|Progression of Disease|0|||
162631600|NCT04292743|587365272|FG000|Overall Study|No Treatment per protocol|0|||
162631601|NCT04292743|587365273|FG001|Overall Study|No Treatment per protocol|2|||
162631602|NCT04292743|587365274|FG002|Overall Study|No Treatment per protocol|0|||
162631603|NCT04292743|587365275|FG003|Overall Study|No Treatment per protocol|0|||
162631604|NCT05330702|587365276|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
162631605|NCT05330702|587365277|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
162631606|NCT05330702|587365278|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
162631607|NCT02881554|587365279|FG000|Overall Study|Withdrawal by Subject|2|||
162631608|NCT02881554|587365280|FG001|Overall Study|Withdrawal by Subject|0|||
162631609|NCT01852110|587367269|FG000|Overall Study|Adverse Event|12|||
162631610|NCT01852110|587367270|FG001|Overall Study|Adverse Event|5|||
162631611|NCT01852110|587367271|FG002|Overall Study|Adverse Event|0|||
162631612|NCT01852110|587367272|FG003|Overall Study|Adverse Event|0|||
162631613|NCT01852110|587367273|FG004|Overall Study|Adverse Event|0|||
162631614|NCT01852110|587367274|FG005|Overall Study|Adverse Event|0|||
162631615|NCT01852110|587367269|FG000|Overall Study|Lost to Follow-up|1|||
162631616|NCT01852110|587367270|FG001|Overall Study|Lost to Follow-up|3|||
162631617|NCT01852110|587367271|FG002|Overall Study|Lost to Follow-up|0|||
162631618|NCT01852110|587367272|FG003|Overall Study|Lost to Follow-up|0|||
162631619|NCT01852110|587367273|FG004|Overall Study|Lost to Follow-up|0|||
162631620|NCT01852110|587367274|FG005|Overall Study|Lost to Follow-up|0|||
162631621|NCT01852110|587367269|FG000|Overall Study|Non-compliance with Study Drug|2|||
162631622|NCT01852110|587367270|FG001|Overall Study|Non-compliance with Study Drug|1|||
162631623|NCT01852110|587367271|FG002|Overall Study|Non-compliance with Study Drug|0|||
162631624|NCT01852110|587367272|FG003|Overall Study|Non-compliance with Study Drug|0|||
162631625|NCT01852110|587367273|FG004|Overall Study|Non-compliance with Study Drug|0|||
162631626|NCT01852110|587367274|FG005|Overall Study|Non-compliance with Study Drug|0|||
162631627|NCT01852110|587367269|FG000|Overall Study|Physician Decision|1|||
162631628|NCT01852110|587367270|FG001|Overall Study|Physician Decision|0|||
162631629|NCT01852110|587367271|FG002|Overall Study|Physician Decision|0|||
162631630|NCT01852110|587367272|FG003|Overall Study|Physician Decision|0|||
162631631|NCT01852110|587367273|FG004|Overall Study|Physician Decision|0|||
162631632|NCT01852110|587367274|FG005|Overall Study|Physician Decision|0|||
162631633|NCT01852110|587367269|FG000|Overall Study|Protocol Violation|0|||
162631634|NCT01852110|587367270|FG001|Overall Study|Protocol Violation|1|||
162631635|NCT01852110|587367271|FG002|Overall Study|Protocol Violation|0|||
162631636|NCT01852110|587367272|FG003|Overall Study|Protocol Violation|0|||
162631637|NCT01852110|587367273|FG004|Overall Study|Protocol Violation|0|||
162631638|NCT01852110|587367274|FG005|Overall Study|Protocol Violation|0|||
162631639|NCT01852110|587367269|FG000|Overall Study|Study Terminated by Sponsor|30|||
162631640|NCT01852110|587367270|FG001|Overall Study|Study Terminated by Sponsor|32|||
162631641|NCT01852110|587367271|FG002|Overall Study|Study Terminated by Sponsor|0|||
162713908|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
162713909|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
162631642|NCT01852110|587367272|FG003|Overall Study|Study Terminated by Sponsor|0|||
162631643|NCT01852110|587367273|FG004|Overall Study|Study Terminated by Sponsor|0|||
162631644|NCT01852110|587367274|FG005|Overall Study|Study Terminated by Sponsor|0|||
162631645|NCT01852110|587367269|FG000|Overall Study|Withdrawal by Subject|4|||
162631646|NCT01852110|587367270|FG001|Overall Study|Withdrawal by Subject|4|||
162631647|NCT01852110|587367271|FG002|Overall Study|Withdrawal by Subject|0|||
162979229|NCT01360866|588625074|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
162979230|NCT01360866|588625071|FG000|Overall Study|Withdrawn by Investigator|9|||
162979231|NCT01360866|588625072|FG001|Overall Study|Withdrawn by Investigator|8|||
162979232|NCT01360866|588625073|FG002|Overall Study|Withdrawn by Investigator|31|||
162631648|NCT01852110|587367272|FG003|Overall Study|Withdrawal by Subject|0|||
163058738|NCT04460885|588924292|FG000|Overall Study|Withdrawal by Subject|6|||
163058739|NCT04460885|588924293|FG001|Overall Study|Withdrawal by Subject|8|||
163058740|NCT04460885|588924292|FG000|Overall Study|Site closure|1|||
163058741|NCT04460885|588924293|FG001|Overall Study|Site closure|0|||
163058742|NCT04460885|588924292|FG000|Overall Study|Death|5|||
163058743|NCT04460885|588924293|FG001|Overall Study|Death|4|||
163058744|NCT04460885|588924292|FG000|Overall Study|Physician Decision|2|||
163058745|NCT04460885|588924293|FG001|Overall Study|Physician Decision|1|||
163058746|NCT04460885|588924292|FG000|Overall Study|Lost to Follow-up|4|||
163058747|NCT04460885|588924293|FG001|Overall Study|Lost to Follow-up|4|||
163058748|NCT05001620|588924294|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
163058749|NCT05001620|588924295|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
163058750|NCT00537277|588924296|FG000|Overall Study|Adverse Event|1|||
163058751|NCT00537277|588924296|FG000|Overall Study|Lack of Efficacy|2|||
163058752|NCT00537277|588924296|FG000|Overall Study|Lost to Follow-up|12|||
163058753|NCT00537277|588924296|FG000|Overall Study|Protocol Violation|11|||
163058754|NCT00537277|588924296|FG000|Overall Study|Unclassified|4|||
163058755|NCT00537277|588924296|FG000|Overall Study|Inability to tolerate trial medication|4|||
163058756|NCT00537277|588924296|FG000|Overall Study|Non-compliance with trial procedures|15|||
163058757|NCT05282823|588924297|FG000|Overall Study|Withdrawal by Subject|9|||
163058758|NCT05282823|588924297|FG000|Overall Study|Adverse Event|1|||
163058759|NCT05282823|588924297|FG000|Overall Study|did not meet protocol criteria|2|||
163058760|NCT05282823|588924297|FG000|Overall Study|Withdrawal by Subject|7|||
163058761|NCT05352815|588924298|FG000|Overall Study|Withdrawal by Subject|28|||
163058762|NCT05352815|588924299|FG001|Overall Study|Withdrawal by Subject|24|||
163058763|NCT05352815|588924298|FG000|Overall Study|Lost to Follow-up|4|||
163058764|NCT05352815|588924299|FG001|Overall Study|Lost to Follow-up|7|||
163058765|NCT05352815|588924298|FG000|Overall Study|Death|2|||
163058766|NCT05352815|588924299|FG001|Overall Study|Death|3|||
163058767|NCT05352815|588924298|FG000|Overall Study|Site closure|1|||
163058768|NCT05352815|588924299|FG001|Overall Study|Site closure|0|||
163058769|NCT00226655|588924300|FG000|Overall Study|Death|13|||
163058770|NCT00226655|588924300|FG000|Overall Study|Withdrawal by Subject|15|||
163058771|NCT00226655|588924300|FG000|Overall Study|Adverse Event|35|||
163058772|NCT00226655|588924300|FG000|Overall Study|Physician Decision|6|||
163058773|NCT00226655|588924300|FG000|Overall Study|Clinical deterioration|10|||
163058774|NCT05144945|588924301|FG000|Overall Study|Withdrawal by Subject|1|||
163058775|NCT05144945|588924302|FG001|Overall Study|Withdrawal by Subject|0|||
163058776|NCT02592824|588924308|FG000|Overall Study|Protocol Violation|5|||
163058777|NCT02592824|588924309|FG001|Overall Study|Protocol Violation|3|||
163058778|NCT02592824|588924308|FG000|Overall Study|Lost to Follow-up|2|||
163058779|NCT02592824|588924309|FG001|Overall Study|Lost to Follow-up|1|||
163058780|NCT01704261|588924310|FG000|Overall Study|Withdrawal by Subject|12|||
163058781|NCT01704261|588924311|FG001|Overall Study|Withdrawal by Subject|15|||
163058782|NCT01704261|588924310|FG000|Overall Study|Lost to Follow-up|1|||
163058783|NCT01704261|588924311|FG001|Overall Study|Lost to Follow-up|0|||
163058784|NCT02391337|588924312|FG000|6 Months Follow-up|Death|5|||
163058785|NCT02391337|588924313|FG001|6 Months Follow-up|Death|4|||
163058786|NCT02391337|588924312|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
163058787|NCT02391337|588924313|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
163058788|NCT02391337|588924312|FG000|12 Months Follow-up|Death|2|||
163058789|NCT02391337|588924313|FG001|12 Months Follow-up|Death|0|||
163058790|NCT02391337|588924312|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
163058791|NCT02391337|588924313|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
163058792|NCT02391337|588924312|FG000|12 Months Follow-up|Lost to Follow-up|0|||
163058793|NCT02391337|588924313|FG001|12 Months Follow-up|Lost to Follow-up|2|||
163058794|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
163058795|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
163058796|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
163058797|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
163058798|NCT02855268|588924315|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
163058799|NCT02855268|588924316|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
163058800|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
163058801|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
163058802|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
163058803|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
163058804|NCT02855268|588924315|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
163058805|NCT02855268|588924316|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
163058806|NCT00465517|588924319|FG000|Overall Study|Adverse Event|7|||
163058807|NCT00465517|588924320|FG001|Overall Study|Adverse Event|3|||
163058808|NCT00465517|588924319|FG000|Overall Study|Lost to Follow-up|1|||
163058809|NCT00465517|588924320|FG001|Overall Study|Lost to Follow-up|0|||
163058810|NCT00465517|588924319|FG000|Overall Study|Withdrawal by Subject|4|||
163058811|NCT00465517|588924320|FG001|Overall Study|Withdrawal by Subject|1|||
163058812|NCT01286129|588924321|FG000|Overall Study|Withdrawal by Subject|4|||
163058813|NCT01286129|588924322|FG001|Overall Study|Withdrawal by Subject|1|||
163058814|NCT01286129|588924321|FG000|Overall Study|Could not comply with study requirements|4|||
163058815|NCT01286129|588924322|FG001|Overall Study|Could not comply with study requirements|4|||
163058816|NCT00111761|588924325|FG000|Part 1|Physician Decision|0|||
163058817|NCT00111761|588924326|FG001|Part 1|Physician Decision|1|||
163058818|NCT00111761|588924325|FG000|Part 1|Death|0|||
163058819|NCT00111761|588924326|FG001|Part 1|Death|2|||
163058820|NCT00111761|588924325|FG000|Part 1|Other|0|||
163058821|NCT00111761|588924326|FG001|Part 1|Other|1|||
163058822|NCT00111761|588924325|FG000|Part 1|Withdrawal by Subject|0|||
163058823|NCT00111761|588924326|FG001|Part 1|Withdrawal by Subject|1|||
163058824|NCT00111761|588924325|FG000|Part 2|Adverse Event|1|||
163058825|NCT00111761|588924326|FG001|Part 2|Adverse Event|0|||
163058826|NCT00111761|588924325|FG000|Part 2|Physician Decision|1|||
163058827|NCT00111761|588924326|FG001|Part 2|Physician Decision|0|||
163058828|NCT00111761|588924325|FG000|Part 2|Death|1|||
163058829|NCT00111761|588924326|FG001|Part 2|Death|0|||
163058830|NCT00111761|588924325|FG000|Part 2|Disease progression|3|||
163058831|NCT00111761|588924326|FG001|Part 2|Disease progression|0|||
163058832|NCT00111761|588924325|FG000|Part 2|Protocol-specified criteria|1|||
162631649|NCT01852110|587367273|FG004|Overall Study|Withdrawal by Subject|0|||
162631650|NCT01852110|587367274|FG005|Overall Study|Withdrawal by Subject|0|||
162631651|NCT00903695|587367280|FG000|Overall Study|medical exclusion after 1st testing|1|||
162631652|NCT00903695|587367281|FG001|Overall Study|medical exclusion after 1st testing|0|||
162631653|NCT00903695|587367280|FG000|Overall Study|lung cancer|1|||
162631654|NCT00903695|587367281|FG001|Overall Study|lung cancer|0|||
162631655|NCT01549860|587367282|FG000|Overall Study|Withdrawal by Subject|1|||
162631656|NCT01549860|587367283|FG001|Overall Study|Withdrawal by Subject|0|||
162631657|NCT01549860|587367282|FG000|Overall Study|Physician Decision|1|||
162631658|NCT01549860|587367283|FG001|Overall Study|Physician Decision|1|||
162631659|NCT01366521|587367285|FG000|Overall Study|Adverse Event|1|||
162631660|NCT01366521|587367286|FG001|Overall Study|Adverse Event|0|||
162631661|NCT01366521|587367287|FG002|Overall Study|Adverse Event|0|||
162631662|NCT01366521|587367288|FG003|Overall Study|Adverse Event|0|||
162631663|NCT01366521|587367285|FG000|Overall Study|Protocol Violation|0|||
162631664|NCT01366521|587367286|FG001|Overall Study|Protocol Violation|0|||
162631665|NCT01366521|587367287|FG002|Overall Study|Protocol Violation|1|||
162631666|NCT01366521|587367288|FG003|Overall Study|Protocol Violation|0|||
162631667|NCT01366521|587367285|FG000|Overall Study|Physician Decision|0|||
162631668|NCT01366521|587367286|FG001|Overall Study|Physician Decision|0|||
162631669|NCT01366521|587367287|FG002|Overall Study|Physician Decision|1|||
162631670|NCT01366521|587367288|FG003|Overall Study|Physician Decision|0|||
162631671|NCT01366521|587367285|FG000|Overall Study|Withdrawal by Subject|0|||
162631672|NCT01366521|587367286|FG001|Overall Study|Withdrawal by Subject|1|||
162631673|NCT01366521|587367287|FG002|Overall Study|Withdrawal by Subject|0|||
162631674|NCT01366521|587367288|FG003|Overall Study|Withdrawal by Subject|0|||
162631675|NCT02430311|587367289|FG000|Part A|Adverse Event|0|||
162631676|NCT02430311|587367290|FG001|Part A|Adverse Event|1|||
162631677|NCT02430311|587367289|FG000|Part A|Withdrawal by Subject|1|||
162631678|NCT02430311|587367290|FG001|Part A|Withdrawal by Subject|0|||
162631679|NCT02430311|587367289|FG000|Part B|Meet study-specific withdrawal criteria|6|||
162631680|NCT02430311|587367290|FG001|Part B|Meet study-specific withdrawal criteria|6|||
162631681|NCT02430311|587367289|FG000|Part B|Withdrawal by Subject|2|||
162631682|NCT02430311|587367290|FG001|Part B|Withdrawal by Subject|2|||
162631683|NCT02430311|587367289|FG000|Part B|Adverse Event|1|||
162631684|NCT02430311|587367290|FG001|Part B|Adverse Event|0|||
162631685|NCT02430311|587367289|FG000|Part B|Death|1|||
162631686|NCT02430311|587367290|FG001|Part B|Death|0|||
162631687|NCT00578812|587367291|FG000|Overall Study|Not treated|6|||
162631688|NCT00578812|587367292|FG001|Overall Study|Not treated|7|||
162631689|NCT01599234|587367306|FG000|Overall Study|Adverse Event|9|||
162631690|NCT01599234|587367307|FG001|Overall Study|Adverse Event|5|||
162631691|NCT01599234|587367306|FG000|Overall Study|Withdrawal by Subject|2|||
162631692|NCT01599234|587367307|FG001|Overall Study|Withdrawal by Subject|1|||
162631693|NCT01599234|587367306|FG000|Overall Study|Lost to Follow-up|1|||
162631694|NCT01599234|587367307|FG001|Overall Study|Lost to Follow-up|2|||
162631695|NCT01599234|587367306|FG000|Overall Study|Lack of Efficacy|2|||
162631696|NCT01599234|587367307|FG001|Overall Study|Lack of Efficacy|4|||
163058833|NCT00111761|588924326|FG001|Part 2|Protocol-specified criteria|0|||
163058834|NCT00111761|588924325|FG000|Part 2|Other|1|||
163058835|NCT00111761|588924326|FG001|Part 2|Other|0|||
163058836|NCT02029417|588924331|FG000|Overall Study|Death|1|||
162631697|NCT01599234|587367306|FG000|Overall Study|Unable to operate spray|1|||
162631698|NCT01599234|587367307|FG001|Overall Study|Unable to operate spray|0|||
162631699|NCT01599234|587367306|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
162631700|NCT01599234|587367307|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
162631701|NCT01599234|587367306|FG000|Overall Study|Death|1|||
162631702|NCT01599234|587367307|FG001|Overall Study|Death|0|||
162631703|NCT01599234|587367306|FG000|Overall Study|Patient would not stop driving|1|||
162631704|NCT01599234|587367307|FG001|Overall Study|Patient would not stop driving|0|||
162631705|NCT01599234|587367306|FG000|Overall Study|Contra-indication discovered|0|||
163058837|NCT02029417|588924331|FG000|Overall Study|Adverse Event|1|||
163058838|NCT00071981|588924332|FG000|Overall Study|Lack of Efficacy|37|||
163058839|NCT00071981|588924333|FG001|Overall Study|Lack of Efficacy|29|||
163058840|NCT00071981|588924334|FG002|Overall Study|Lack of Efficacy|30|||
163058841|NCT00071981|588924335|FG003|Overall Study|Lack of Efficacy|43|||
162631706|NCT01599234|587367307|FG001|Overall Study|Contra-indication discovered|1|||
162631707|NCT01599234|587367306|FG000|Overall Study|Pregnancy|0|||
163058842|NCT00071981|588924332|FG000|Overall Study|Adverse Event|4|||
163058843|NCT00071981|588924333|FG001|Overall Study|Adverse Event|4|||
163058844|NCT00071981|588924334|FG002|Overall Study|Adverse Event|3|||
163058845|NCT00071981|588924335|FG003|Overall Study|Adverse Event|1|||
163058846|NCT00071981|588924332|FG000|Overall Study|Death|0|||
163058847|NCT00071981|588924333|FG001|Overall Study|Death|0|||
163058848|NCT00071981|588924334|FG002|Overall Study|Death|1|||
163058849|NCT00071981|588924335|FG003|Overall Study|Death|1|||
163058850|NCT00071981|588924332|FG000|Overall Study|Withdrawal by Subject|3|||
163058851|NCT00071981|588924333|FG001|Overall Study|Withdrawal by Subject|1|||
163058852|NCT00071981|588924334|FG002|Overall Study|Withdrawal by Subject|0|||
163058853|NCT00071981|588924335|FG003|Overall Study|Withdrawal by Subject|0|||
163058854|NCT00071981|588924332|FG000|Overall Study|No protocol therapy|2|||
163058855|NCT00071981|588924333|FG001|Overall Study|No protocol therapy|5|||
163058856|NCT00071981|588924334|FG002|Overall Study|No protocol therapy|1|||
163058857|NCT00071981|588924335|FG003|Overall Study|No protocol therapy|0|||
163058858|NCT00071981|588924332|FG000|Overall Study|others (not specified in the study)|0|||
163058859|NCT00071981|588924333|FG001|Overall Study|others (not specified in the study)|2|||
163058860|NCT00071981|588924334|FG002|Overall Study|others (not specified in the study)|2|||
163058861|NCT00071981|588924335|FG003|Overall Study|others (not specified in the study)|0|||
163058862|NCT04458922|588924336|FG000|Overall Study|Withdrawal by Subject|1|||
163058863|NCT04458922|588924337|FG001|Overall Study|Withdrawal by Subject|0|||
163058864|NCT04458922|588924338|FG002|Overall Study|Withdrawal by Subject|2|||
163058865|NCT04458922|588924336|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
163058866|NCT04458922|588924337|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
162631708|NCT01599234|587367307|FG001|Overall Study|Pregnancy|1|||
162631709|NCT01513473|587367314|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
162631710|NCT01513473|587367315|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
162631711|NCT01513473|587367314|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
162631712|NCT01513473|587367315|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
162631713|NCT01513473|587367314|FG000|Main Trial (26 Weeks)|Unclassified|0|||
162631714|NCT01513473|587367315|FG001|Main Trial (26 Weeks)|Unclassified|2|||
162631715|NCT01513473|587367314|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
162631716|NCT01513473|587367315|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
162631717|NCT01513473|587367314|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
162631718|NCT01513473|587367315|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
162631719|NCT04016285|587367316|FG000|Overall Study|Did not progress to surgery|2|||
162631720|NCT04016285|587367317|FG001|Overall Study|Did not progress to surgery|5|||
162631721|NCT04016285|587367316|FG000|Overall Study|Failed to collect outcome data|5|||
162631722|NCT04016285|587367317|FG001|Overall Study|Failed to collect outcome data|3|||
162631723|NCT03462082|587367318|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162631724|NCT03462082|587367319|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162631725|NCT03462082|587367320|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
163058867|NCT04458922|588924338|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
163058868|NCT04458922|588924336|FG000|Overall Study|Adverse Event|1|||
163058869|NCT04458922|588924337|FG001|Overall Study|Adverse Event|0|||
163058870|NCT04458922|588924338|FG002|Overall Study|Adverse Event|0|||
163058871|NCT04458922|588924336|FG000|Overall Study|Started new study|0|||
162631726|NCT03462082|587367321|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162631727|NCT03462082|587367322|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162631728|NCT03462082|587367323|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162713910|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
162713911|NCT00853827|587662628|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
162713912|NCT00853827|587662629|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
162713913|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
162631729|NCT03462082|587367324|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
162631730|NCT03462082|587367325|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
162631731|NCT00166114|587367328|FG000|Overall Study|Protocol Violation|2|||
162631732|NCT00166114|587367329|FG001|Overall Study|Protocol Violation|1|||
162631733|NCT00166114|587367328|FG000|Overall Study|Withdrawal by Subject|10|||
162631734|NCT00166114|587367329|FG001|Overall Study|Withdrawal by Subject|4|||
162631735|NCT00166114|587367328|FG000|Overall Study|Adverse Event|2|||
162631736|NCT00166114|587367329|FG001|Overall Study|Adverse Event|1|||
162631737|NCT02708121|587367334|FG000|Overall Study|Withdrawn by Study Team|1|||
162631738|NCT02708121|587367335|FG001|Overall Study|Withdrawn by Study Team|1|||
162631739|NCT02708121|587367334|FG000|Overall Study|Withdrawal by Subject|0|||
162631740|NCT02708121|587367335|FG001|Overall Study|Withdrawal by Subject|4|||
162631741|NCT03266107|587367338|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
162631742|NCT03266107|587367338|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
162631743|NCT03266107|587367338|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
162631744|NCT03266107|587367338|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
162631745|NCT02548650|587367341|FG000|Triple Therapy|Adverse Event|1|||
162631746|NCT02548650|587367342|FG001|Triple Therapy|Adverse Event|0|||
162631747|NCT02548650|587367341|FG000|Triple Therapy|Withdrawal by Subject|0|||
162713914|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
162631748|NCT02548650|587367342|FG001|Triple Therapy|Withdrawal by Subject|4|||
162631749|NCT02548650|587367341|FG000|Double Therapy|Adverse Event|1|||
162631750|NCT02548650|587367342|FG001|Double Therapy|Adverse Event|1|||
162631751|NCT02548650|587367341|FG000|Double Therapy|Withdrawal by Subject|0|||
162631752|NCT02548650|587367342|FG001|Double Therapy|Withdrawal by Subject|1|||
162631753|NCT01191801|587367343|FG000|Overall Study|Death|36|||
162631754|NCT01191801|587367344|FG001|Overall Study|Death|12|||
162631755|NCT01191801|587367343|FG000|Overall Study|Lack of Efficacy|176|||
162631756|NCT01191801|587367344|FG001|Overall Study|Lack of Efficacy|258|||
162631757|NCT01191801|587367343|FG000|Overall Study|Adverse Event|9|||
162631758|NCT01191801|587367344|FG001|Overall Study|Adverse Event|8|||
162631759|NCT01191801|587367343|FG000|Overall Study|Protocol Violation|2|||
162631760|NCT01191801|587367344|FG001|Overall Study|Protocol Violation|4|||
162631761|NCT01191801|587367343|FG000|Overall Study|Physician Decision|47|||
162631762|NCT01191801|587367344|FG001|Overall Study|Physician Decision|24|||
162631763|NCT01191801|587367343|FG000|Overall Study|Withdrawal by Subject|1|||
162631764|NCT01191801|587367344|FG001|Overall Study|Withdrawal by Subject|4|||
162631765|NCT01191801|587367343|FG000|Overall Study|Not Provided|45|||
162631766|NCT01191801|587367344|FG001|Overall Study|Not Provided|27|||
162631767|NCT02651922|587367348|FG000|Overall Study|due to exclusion criteria|2|||
162631768|NCT01366209|587367349|FG000|Overall Study|Adverse Event|6|||
162631769|NCT01366209|587367350|FG001|Overall Study|Adverse Event|7|||
162631770|NCT01366209|587367349|FG000|Overall Study|Withdrawal by Subject|4|||
162631771|NCT01366209|587367350|FG001|Overall Study|Withdrawal by Subject|4|||
162631772|NCT01366209|587367349|FG000|Overall Study|Death|12|||
162631773|NCT01366209|587367350|FG001|Overall Study|Death|19|||
162631774|NCT01366209|587367349|FG000|Overall Study|Lung transplantation|6|||
162631775|NCT01366209|587367350|FG001|Overall Study|Lung transplantation|1|||
162631776|NCT01366209|587367349|FG000|Overall Study|Lost to Follow-up|2|||
162631777|NCT01366209|587367350|FG001|Overall Study|Lost to Follow-up|1|||
162713915|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
163058872|NCT04458922|588924337|FG001|Overall Study|Started new study|0|||
162631778|NCT01366209|587367349|FG000|Overall Study|Physician Decision|1|||
162631779|NCT01366209|587367350|FG001|Overall Study|Physician Decision|0|||
162631780|NCT01366209|587367349|FG000|Overall Study|Sponsors decision|0|||
162631781|NCT01366209|587367350|FG001|Overall Study|Sponsors decision|1|||
162631782|NCT01366209|587367349|FG000|Overall Study|Withdrew consent|4|||
162631783|NCT01366209|587367350|FG001|Overall Study|Withdrew consent|3|||
162631784|NCT03018704|587367351|FG000|Overall Study|Lost to Follow-up|1|||
162631785|NCT03018704|587367352|FG001|Overall Study|Lost to Follow-up|1|||
162631786|NCT00320411|587367353|FG000|Overall Study|No investigational product admin.|4|||
162631787|NCT02088047|587367356|FG000|Overall Study|Withdrawal by Subject|1|||
162631788|NCT02088047|587367357|FG001|Overall Study|Withdrawal by Subject|0|||
162631789|NCT00211809|587367360|FG000|Overall Study|Lack of Efficacy|1|||
162631790|NCT00211809|587367360|FG000|Overall Study|Lost to Follow-up|2|||
162631791|NCT00211809|587367360|FG000|Overall Study|Pregnancy|1|||
162631792|NCT00211809|587367360|FG000|Overall Study|side effects|2|||
162631793|NCT01417234|587367361|FG000|Overall Study|Subject non-compliant|3|||
162631794|NCT00023764|587367362|FG000|Overall Study|Other|1|||
162631795|NCT00023764|587367362|FG000|Overall Study|Adverse Event|4|||
162631796|NCT00023764|587367362|FG000|Overall Study|Withdrawal by Subject|1|||
162631797|NCT00023764|587367362|FG000|Overall Study|Progression of disease|6|||
162631798|NCT00023764|587367362|FG000|Overall Study|patient received other treatment|1|||
162631799|NCT00023764|587367362|FG000|Overall Study|delay in obtaining staging images|1|||
162631800|NCT01537393|587367363|FG000|Overall Study|Exclude prior to study|32|||
162631801|NCT01537393|587367364|FG001|Overall Study|Exclude prior to study|44|||
162631802|NCT01537393|587367363|FG000|Overall Study|Death|20|||
162631803|NCT01537393|587367364|FG001|Overall Study|Death|32|||
162631804|NCT01537393|587367363|FG000|Overall Study|Withdrawal by Subject|18|||
162631805|NCT01537393|587367364|FG001|Overall Study|Withdrawal by Subject|17|||
162631806|NCT01537393|587367363|FG000|Overall Study|Lost to Follow-up|53|||
162631807|NCT01537393|587367364|FG001|Overall Study|Lost to Follow-up|48|||
162631808|NCT01537393|587367363|FG000|Overall Study|Failure - Regrafted|28|||
162631809|NCT01537393|587367364|FG001|Overall Study|Failure - Regrafted|43|||
162631810|NCT01537393|587367363|FG000|Overall Study|Failure - Not regrafted|2|||
162631811|NCT01537393|587367364|FG001|Overall Study|Failure - Not regrafted|6|||
162631812|NCT01537393|587367363|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
162631813|NCT01537393|587367364|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
162631814|NCT00459953|587367366|FG000|Overall Study|not analyzed-household member in study|1|||
162631815|NCT00459953|587367367|FG001|Overall Study|not analyzed-household member in study|1|||
162631816|NCT00036270|587367368|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
162631817|NCT00036270|587367369|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
162631818|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
162631819|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
162631820|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
162631821|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
162631822|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
162631823|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
162631824|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Other|277|||
162631825|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Other|288|||
162631826|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
162631827|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
162631828|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
162631829|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
162631830|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
162631831|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
162631832|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
162631833|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
162631834|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
162631835|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
162631836|NCT00036270|587367368|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
162631837|NCT00036270|587367369|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
162631838|NCT01218243|587367371|FG000|Overall Study|Lack of Efficacy|1|||
162631839|NCT01218243|587367372|FG001|Overall Study|Lack of Efficacy|1|||
162631840|NCT01218243|587367371|FG000|Overall Study|Lost to Follow-up|3|||
162631841|NCT01218243|587367372|FG001|Overall Study|Lost to Follow-up|3|||
162631842|NCT01218243|587367371|FG000|Overall Study|Protocol Violation|5|||
162631843|NCT01218243|587367372|FG001|Overall Study|Protocol Violation|10|||
162631844|NCT01197560|587367373|FG000|Overall Study|Adverse Event|6|||
162631845|NCT01197560|587367374|FG001|Overall Study|Adverse Event|8|||
162631846|NCT01197560|587367373|FG000|Overall Study|Death|3|||
162631847|NCT01197560|587367374|FG001|Overall Study|Death|5|||
162631848|NCT01197560|587367373|FG000|Overall Study|Withdrawal by Subject|1|||
162631849|NCT01197560|587367374|FG001|Overall Study|Withdrawal by Subject|1|||
162631850|NCT01197560|587367373|FG000|Overall Study|Disease progression|40|||
162631851|NCT01197560|587367374|FG001|Overall Study|Disease progression|35|||
162631852|NCT01197560|587367373|FG000|Overall Study|Miscellaneous|4|||
163058873|NCT04458922|588924338|FG002|Overall Study|Started new study|1|||
163058874|NCT04458922|588924336|FG000|Overall Study|Progressive disease|6|||
163058875|NCT04458922|588924337|FG001|Overall Study|Progressive disease|8|||
163058876|NCT04458922|588924338|FG002|Overall Study|Progressive disease|2|||
163058877|NCT04458922|588924336|FG000|Overall Study|Death|1|||
163058878|NCT04458922|588924337|FG001|Overall Study|Death|0|||
162631853|NCT01197560|587367374|FG001|Overall Study|Miscellaneous|3|||
162631854|NCT01197560|587367373|FG000|Overall Study|Missing|0|||
162631855|NCT01197560|587367374|FG001|Overall Study|Missing|1|||
162631856|NCT00211510|587367377|FG000|Overall Study|Physician Decision|3|||
162631857|NCT00211510|587367378|FG001|Overall Study|Physician Decision|1|||
162631858|NCT00211510|587367377|FG000|Overall Study|Withdrawal by Subject|3|||
162631859|NCT00211510|587367378|FG001|Overall Study|Withdrawal by Subject|1|||
162631860|NCT01487200|587367379|FG000|Overall Study|Withdrawal by Subject|0|||
163058879|NCT04458922|588924338|FG002|Overall Study|Death|2|||
162631861|NCT01487200|587367380|FG001|Overall Study|Withdrawal by Subject|1|||
162631862|NCT01487200|587367381|FG002|Overall Study|Withdrawal by Subject|0|||
162631863|NCT01487200|587367382|FG003|Overall Study|Withdrawal by Subject|0|||
162631864|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
162631865|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
162631866|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
162631867|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631868|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631869|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631870|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631871|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631872|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631873|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631874|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162631875|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
162631876|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631877|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
162631878|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163058880|NCT04458922|588924336|FG000|Overall Study|Participant started chemotherapy|0|||
162631879|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631880|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
163058881|NCT04458922|588924337|FG001|Overall Study|Participant started chemotherapy|1|||
163058882|NCT04458922|588924338|FG002|Overall Study|Participant started chemotherapy|0|||
163058883|NCT02867592|588924340|FG000|Overall Study|Adverse Event|3|||
163058884|NCT02867592|588924341|FG001|Overall Study|Adverse Event|0|||
163058885|NCT02867592|588924342|FG002|Overall Study|Adverse Event|2|||
163058886|NCT02867592|588924343|FG003|Overall Study|Adverse Event|1|||
163058887|NCT02867592|588924344|FG004|Overall Study|Adverse Event|1|||
163058888|NCT02867592|588924345|FG005|Overall Study|Adverse Event|5|||
163058889|NCT02867592|588924340|FG000|Overall Study|Death|0|||
163058890|NCT02867592|588924341|FG001|Overall Study|Death|0|||
163058891|NCT02867592|588924342|FG002|Overall Study|Death|0|||
163058892|NCT02867592|588924343|FG003|Overall Study|Death|1|||
163058893|NCT02867592|588924344|FG004|Overall Study|Death|0|||
163058894|NCT02867592|588924345|FG005|Overall Study|Death|1|||
163058895|NCT02867592|588924340|FG000|Overall Study|Lack of Efficacy|8|||
163058896|NCT02867592|588924341|FG001|Overall Study|Lack of Efficacy|10|||
163058897|NCT02867592|588924342|FG002|Overall Study|Lack of Efficacy|8|||
163058898|NCT02867592|588924343|FG003|Overall Study|Lack of Efficacy|8|||
163058899|NCT02867592|588924344|FG004|Overall Study|Lack of Efficacy|12|||
163058900|NCT02867592|588924345|FG005|Overall Study|Lack of Efficacy|17|||
163058901|NCT02867592|588924340|FG000|Overall Study|Physician Decision|1|||
163058902|NCT02867592|588924341|FG001|Overall Study|Physician Decision|2|||
163058903|NCT02867592|588924342|FG002|Overall Study|Physician Decision|2|||
163058904|NCT02867592|588924343|FG003|Overall Study|Physician Decision|0|||
163058905|NCT02867592|588924344|FG004|Overall Study|Physician Decision|5|||
163058906|NCT02867592|588924345|FG005|Overall Study|Physician Decision|1|||
163058907|NCT02867592|588924340|FG000|Overall Study|Protocol Violation|0|||
163058908|NCT02867592|588924341|FG001|Overall Study|Protocol Violation|0|||
163058909|NCT02867592|588924342|FG002|Overall Study|Protocol Violation|0|||
163058910|NCT02867592|588924343|FG003|Overall Study|Protocol Violation|0|||
163058911|NCT02867592|588924344|FG004|Overall Study|Protocol Violation|1|||
163058912|NCT02867592|588924345|FG005|Overall Study|Protocol Violation|1|||
162631881|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631882|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631883|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631884|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631885|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162631886|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
162631887|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
162631888|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
162631889|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631890|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631891|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631892|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631893|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631894|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631895|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631896|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162631897|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
162631898|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
162631899|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631900|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631901|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631902|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631903|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631904|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631905|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631906|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631907|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162631908|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
162631909|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
162631910|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
162713916|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
162979233|NCT01360866|588625074|FG003|Overall Study|Withdrawn by Investigator|2|||
162979234|NCT01360866|588625071|FG000|Overall Study|Withdrawal by participant|79|||
162979235|NCT01360866|588625072|FG001|Overall Study|Withdrawal by participant|89|||
162979236|NCT01360866|588625073|FG002|Overall Study|Withdrawal by participant|168|||
162979237|NCT01360866|588625074|FG003|Overall Study|Withdrawal by participant|8|||
162979238|NCT01360866|588625071|FG000|Overall Study|Protocol Deviation|25|||
162979239|NCT01360866|588625072|FG001|Overall Study|Protocol Deviation|33|||
162979240|NCT01360866|588625073|FG002|Overall Study|Protocol Deviation|61|||
162979241|NCT01360866|588625074|FG003|Overall Study|Protocol Deviation|2|||
162979242|NCT01360866|588625071|FG000|Overall Study|Lack of Efficacy|30|||
162631911|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631912|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631913|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631914|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631915|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631916|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631917|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631918|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162631919|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631920|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
162631921|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
162631922|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631923|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631924|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631925|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631926|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631927|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631928|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631929|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162631930|NCT02207244|587367385|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631931|NCT02207244|587367386|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
162631932|NCT02207244|587367387|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631933|NCT02207244|587367388|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631934|NCT02207244|587367389|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631935|NCT02207244|587367390|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631936|NCT02207244|587367391|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631937|NCT02207244|587367392|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631938|NCT02207244|587367393|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631939|NCT02207244|587367394|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631940|NCT02207244|587367395|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
162631941|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631942|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631943|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631944|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631945|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
162631946|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
162631947|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631948|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631949|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631950|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631951|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162631952|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631953|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631954|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631955|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631956|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631957|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
162631958|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631959|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631960|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631961|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631962|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162631963|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631964|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631965|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631966|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
162631967|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
162631968|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
162631969|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631970|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631971|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631972|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162631973|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162979243|NCT01360866|588625072|FG001|Overall Study|Lack of Efficacy|40|||
162979244|NCT01360866|588625073|FG002|Overall Study|Lack of Efficacy|30|||
162979245|NCT01360866|588625074|FG003|Overall Study|Lack of Efficacy|4|||
162979246|NCT05016622|588625075|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
162979247|NCT05016622|588625075|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
162979248|NCT05506358|588625083|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
162979249|NCT05506358|588625084|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979250|NCT05506358|588625085|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979251|NCT05506358|588625086|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979252|NCT05506358|588625087|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
162979253|NCT05506358|588625083|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
162979254|NCT05506358|588625084|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979255|NCT05506358|588625085|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979256|NCT05506358|588625086|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979257|NCT05506358|588625087|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
162979258|NCT05506358|588625083|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979259|NCT05506358|588625084|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979260|NCT05506358|588625085|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979261|NCT05506358|588625086|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
162979262|NCT05506358|588625087|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
162979263|NCT05506358|588625083|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
162979264|NCT05506358|588625084|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
162979265|NCT05506358|588625085|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
162979266|NCT05506358|588625086|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
162979267|NCT05506358|588625087|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
162979268|NCT05506358|588625083|FG000|Overall Study|HbE trait|0|||
162979269|NCT05506358|588625084|FG001|Overall Study|HbE trait|0|||
162979270|NCT05506358|588625085|FG002|Overall Study|HbE trait|0|||
162979271|NCT05506358|588625086|FG003|Overall Study|HbE trait|1|||
162979272|NCT05506358|588625087|FG004|Overall Study|HbE trait|0|||
162979273|NCT01744093|588625094|FG000|Overall Study|Withdrawal by Subject|6|||
162979274|NCT01744093|588625095|FG001|Overall Study|Withdrawal by Subject|1|||
162979275|NCT02006628|588625096|FG000|Overall Study|Adverse Event|1|||
162979276|NCT02006628|588625097|FG001|Overall Study|Adverse Event|1|||
162979277|NCT02006628|588625096|FG000|Overall Study|Withdrawal by Subject|2|||
162979278|NCT02006628|588625097|FG001|Overall Study|Withdrawal by Subject|1|||
162979279|NCT03578237|588625100|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
162979280|NCT03578237|588625101|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
162979281|NCT01173471|588625102|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162979282|NCT01173471|588625103|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162979283|NCT01173471|588625104|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162979284|NCT01173471|588625105|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162979285|NCT01173471|588625102|FG000|Overall Study|Condition under investigation worsened|2|||
162979286|NCT01173471|588625103|FG001|Overall Study|Condition under investigation worsened|0|||
162979287|NCT01173471|588625104|FG002|Overall Study|Condition under investigation worsened|0|||
162979288|NCT01173471|588625105|FG003|Overall Study|Condition under investigation worsened|0|||
162979289|NCT01173471|588625102|FG000|Overall Study|Lost to Follow-up|0|||
162979290|NCT01173471|588625103|FG001|Overall Study|Lost to Follow-up|0|||
162979291|NCT01173471|588625104|FG002|Overall Study|Lost to Follow-up|1|||
162979292|NCT01173471|588625105|FG003|Overall Study|Lost to Follow-up|0|||
162979293|NCT01173471|588625102|FG000|Overall Study|Reason given as Other|0|||
162713917|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
163058913|NCT02867592|588924340|FG000|Overall Study|Withdrawal by Subject|0|||
162713918|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
162979294|NCT01173471|588625103|FG001|Overall Study|Reason given as Other|0|||
162979295|NCT01173471|588625104|FG002|Overall Study|Reason given as Other|1|||
162979296|NCT01173471|588625105|FG003|Overall Study|Reason given as Other|0|||
162979297|NCT00584844|588625107|FG000|Overall Study|Withdrawal by Subject|59|||
162979298|NCT00584844|588625107|FG000|Overall Study|Screen Failure|20|||
162979299|NCT02370914|588625113|FG000|Overall Study|Protocol Violation|2|||
162979300|NCT05206448|588625114|FG000|Overall Study|Lost to Follow-up|2|||
162979301|NCT05206448|588625115|FG001|Overall Study|Lost to Follow-up|2|||
162713919|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
162713920|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
162713921|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
162713922|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
162713923|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
162713924|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
162713925|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
162713926|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
162713927|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
162713928|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
162713929|NCT00853827|587662628|FG000|Double Blind Period (103 Weeks)|Death|1|||
162713930|NCT00853827|587662629|FG001|Double Blind Period (103 Weeks)|Death|6|||
162713931|NCT00580801|587662634|FG000|Overall Study|Physician Decision|1|||
162713932|NCT00580801|587662635|FG001|Overall Study|Physician Decision|0|||
162979302|NCT05206448|588625114|FG000|Overall Study|Withdrawal by Subject|2|||
162979303|NCT05206448|588625115|FG001|Overall Study|Withdrawal by Subject|0|||
162979304|NCT05206448|588625114|FG000|Overall Study|found ineligible after randomization|1|||
162713933|NCT00580801|587662636|FG002|Overall Study|Physician Decision|0|||
162713934|NCT00580801|587662634|FG000|Overall Study|Adverse Event|2|||
162713935|NCT00580801|587662635|FG001|Overall Study|Adverse Event|0|||
162713936|NCT00580801|587662636|FG002|Overall Study|Adverse Event|0|||
162713937|NCT00580801|587662634|FG000|Overall Study|Lost to Follow-up|2|||
162713938|NCT00580801|587662635|FG001|Overall Study|Lost to Follow-up|0|||
162713939|NCT00580801|587662636|FG002|Overall Study|Lost to Follow-up|0|||
162713940|NCT00580801|587662634|FG000|Overall Study|Reached a virologic endpoint|0|||
162713941|NCT00580801|587662635|FG001|Overall Study|Reached a virologic endpoint|1|||
162713942|NCT00580801|587662636|FG002|Overall Study|Reached a virologic endpoint|2|||
162713943|NCT00580801|587662634|FG000|Overall Study|Participant non-compliant|0|||
162713944|NCT00580801|587662635|FG001|Overall Study|Participant non-compliant|0|||
162713945|NCT00580801|587662636|FG002|Overall Study|Participant non-compliant|1|||
162713946|NCT00580801|587662634|FG000|Overall Study|Travel|1|||
162713947|NCT00580801|587662635|FG001|Overall Study|Travel|0|||
162979305|NCT05206448|588625115|FG001|Overall Study|found ineligible after randomization|1|||
162979306|NCT05206448|588625114|FG000|Overall Study|unable to complete study due to personal constraints|1|||
162979307|NCT05206448|588625115|FG001|Overall Study|unable to complete study due to personal constraints|0|||
162979308|NCT05206448|588625114|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
162979309|NCT05206448|588625115|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
162979310|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Adverse Event|1|||
162979311|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Adverse Event|2|||
162979312|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Adverse Event|0|||
162979313|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Adverse Event|0|||
162979314|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Subject choice|0|||
162979315|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Subject choice|2|||
162979316|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Subject choice|0|||
162979317|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Subject choice|0|||
162979318|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
162979319|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979320|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979321|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
162979322|NCT04572243|588625118|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
162979323|NCT04572243|588625119|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
162979324|NCT04572243|588625120|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
162979325|NCT04572243|588625121|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
162979326|NCT03847194|588625122|FG000|Overall Study|Lost to Follow-up|2|||
162979327|NCT03847194|588625123|FG001|Overall Study|Lost to Follow-up|5|||
162979328|NCT03847194|588625122|FG000|Overall Study|Withdrawal by Subject|1|||
162979329|NCT03847194|588625123|FG001|Overall Study|Withdrawal by Subject|2|||
162979330|NCT03847194|588625122|FG000|Overall Study|Death|0|||
162979331|NCT03847194|588625123|FG001|Overall Study|Death|1|||
162979332|NCT04179019|588625128|FG000|Overall Study|Lost to Follow-up|2|||
162979333|NCT04179019|588625128|FG000|Overall Study|Physician Decision|2|||
162979334|NCT04179019|588625128|FG000|Overall Study|Withdrawal by Subject|5|||
162713948|NCT00580801|587662636|FG002|Overall Study|Travel|0|||
162713949|NCT05576051|587662637|FG000|Overall Study|Lack of Efficacy|543|||
162713950|NCT05576051|587662638|FG001|Overall Study|Lack of Efficacy|343|||
162979335|NCT04179019|588625128|FG000|Overall Study|Adverse Event|4|||
162979336|NCT01560507|588625132|FG000|Overall Study|Lost to Follow-up|3|||
162979337|NCT01560507|588625133|FG001|Overall Study|Lost to Follow-up|1|||
162979338|NCT01560507|588625134|FG002|Overall Study|Lost to Follow-up|2|||
162979339|NCT01560507|588625132|FG000|Overall Study|Withdrawal by Subject|1|||
162979340|NCT01560507|588625133|FG001|Overall Study|Withdrawal by Subject|1|||
162979341|NCT01560507|588625134|FG002|Overall Study|Withdrawal by Subject|0|||
162979342|NCT02746627|588625137|FG000|Overall Study|Withdrawal by Subject|1|||
162979343|NCT02746627|588625138|FG001|Overall Study|Withdrawal by Subject|1|||
162979344|NCT02746627|588625139|FG002|Overall Study|Withdrawal by Subject|1|||
162979345|NCT02858726|588625140|FG000|Overall Study|Adverse Event|4|||
162631974|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631975|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631976|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631977|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
162631978|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
162631979|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
162631980|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631981|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631982|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631983|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631984|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162631985|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631986|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631987|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631988|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
162631989|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631990|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
162631991|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631992|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631993|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631994|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631995|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162631996|NCT02207244|587367385|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
162631997|NCT02207244|587367386|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
162631998|NCT02207244|587367387|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
162631999|NCT02207244|587367388|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
162632000|NCT02207244|587367389|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632001|NCT02207244|587367390|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632002|NCT02207244|587367391|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632003|NCT02207244|587367392|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632004|NCT02207244|587367393|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632005|NCT02207244|587367394|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632006|NCT02207244|587367395|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
162632007|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632008|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632009|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632010|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632011|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632012|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632013|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
162632014|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
162632015|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
162632016|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
162632017|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162632018|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632019|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632020|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162979346|NCT02858726|588625141|FG001|Overall Study|Adverse Event|4|||
162979347|NCT02858726|588625142|FG002|Overall Study|Adverse Event|9|||
162979348|NCT02858726|588625143|FG003|Overall Study|Adverse Event|1|||
162979349|NCT02858726|588625140|FG000|Overall Study|Physician Decision|0|||
162979350|NCT02858726|588625141|FG001|Overall Study|Physician Decision|0|||
162979351|NCT02858726|588625142|FG002|Overall Study|Physician Decision|1|||
162979352|NCT02858726|588625143|FG003|Overall Study|Physician Decision|0|||
162979353|NCT02858726|588625140|FG000|Overall Study|Protocol Violation|0|||
162979354|NCT02858726|588625141|FG001|Overall Study|Protocol Violation|0|||
162979355|NCT02858726|588625142|FG002|Overall Study|Protocol Violation|0|||
162979356|NCT02858726|588625143|FG003|Overall Study|Protocol Violation|1|||
162979357|NCT02858726|588625140|FG000|Overall Study|Study Terminated by Sponsor|0|||
162979358|NCT02858726|588625141|FG001|Overall Study|Study Terminated by Sponsor|0|||
162979359|NCT02858726|588625142|FG002|Overall Study|Study Terminated by Sponsor|0|||
162979360|NCT02858726|588625143|FG003|Overall Study|Study Terminated by Sponsor|1|||
162979361|NCT02858726|588625140|FG000|Overall Study|Withdrawal by Subject|1|||
162979362|NCT02858726|588625141|FG001|Overall Study|Withdrawal by Subject|2|||
162632021|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632022|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632023|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632024|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632025|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
162632026|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632027|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632028|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162632029|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632030|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632031|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632032|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632033|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632034|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162632035|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
162632036|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
162632037|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
162632038|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
162632039|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162979363|NCT02858726|588625142|FG002|Overall Study|Withdrawal by Subject|1|||
162979364|NCT02858726|588625143|FG003|Overall Study|Withdrawal by Subject|0|||
162979365|NCT02858726|588625140|FG000|Overall Study|Noncompliance|0|||
162979366|NCT02858726|588625141|FG001|Overall Study|Noncompliance|1|||
162979367|NCT02858726|588625142|FG002|Overall Study|Noncompliance|0|||
162979368|NCT02858726|588625143|FG003|Overall Study|Noncompliance|0|||
162979369|NCT00233987|588625148|FG000|Overall Study|Withdrawal by Subject|1|||
162979370|NCT00233987|588625148|FG000|Overall Study|Lack of Efficacy|2|||
162979371|NCT00233987|588625148|FG000|Overall Study|Reason Under Review|1|||
162979372|NCT00233987|588625148|FG000|Overall Study|Other - Not Protocol Specified|5|||
162979373|NCT00233987|588625148|FG000|Overall Study|Eligible but No Treatment Received|2|||
162979374|NCT00233987|588625148|FG000|Overall Study|Ineligible|4|||
162979375|NCT04553913|588625151|FG000|Overall Study|patient's block resolved prior to PACU|1|||
162979376|NCT04553913|588625151|FG000|Overall Study|did not use the device properly|5|||
162979377|NCT01481324|588625153|FG000|Overall Study|Missing Data|0|||
162979378|NCT01481324|588625154|FG001|Overall Study|Missing Data|2|||
162979379|NCT01481324|588625155|FG002|Overall Study|Missing Data|2|||
162979380|NCT00710749|588625157|FG000|First Intervention|Withdrawal by Subject|1|||
162979381|NCT00710749|588625158|FG001|First Intervention|Withdrawal by Subject|0|||
162979382|NCT05478252|588625159|FG000|Overall Study|Withdrawal by Subject|2|||
162979383|NCT05478252|588625160|FG001|Overall Study|Withdrawal by Subject|3|||
162979384|NCT05478252|588625159|FG000|Overall Study|Lost to Follow-up|4|||
162979385|NCT05478252|588625160|FG001|Overall Study|Lost to Follow-up|2|||
162979386|NCT05478252|588625159|FG000|Overall Study|Physician Decision|1|||
162979387|NCT05478252|588625160|FG001|Overall Study|Physician Decision|1|||
162979388|NCT05478252|588625159|FG000|Overall Study|Death|1|||
162979389|NCT05478252|588625160|FG001|Overall Study|Death|0|||
162979390|NCT04846881|588625161|FG000|Overall Study|Adverse Event|14|||
162979391|NCT04846881|588625162|FG001|Overall Study|Adverse Event|15|||
162979392|NCT04846881|588625161|FG000|Overall Study|Burden of study procedures|7|||
162979393|NCT04846881|588625162|FG001|Overall Study|Burden of study procedures|3|||
162979394|NCT04846881|588625161|FG000|Overall Study|Protocol deviation|6|||
162979395|NCT04846881|588625162|FG001|Overall Study|Protocol deviation|4|||
163058914|NCT02867592|588924341|FG001|Overall Study|Withdrawal by Subject|1|||
162632040|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632041|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632042|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632043|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632044|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632045|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632046|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
162632047|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
162979396|NCT04846881|588625161|FG000|Overall Study|Perceived lack of efficacy|5|||
162979397|NCT04846881|588625162|FG001|Overall Study|Perceived lack of efficacy|2|||
162979398|NCT04846881|588625161|FG000|Overall Study|Change of residence|2|||
162979399|NCT04846881|588625162|FG001|Overall Study|Change of residence|0|||
162979400|NCT04846881|588625161|FG000|Overall Study|Technical problems|0|||
162979401|NCT04846881|588625162|FG001|Overall Study|Technical problems|1|||
162979402|NCT04846881|588625161|FG000|Overall Study|Other than listed|3|||
162632048|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632049|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
162632050|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162632051|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632052|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632053|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632054|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632055|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632056|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632057|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162632058|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
162632059|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162632060|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162632061|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162632062|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632063|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632064|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632065|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632066|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632067|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632068|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632069|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
162632070|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
162632071|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632072|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162632073|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632074|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632075|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632076|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632077|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632078|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632079|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632080|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632081|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
162632082|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632083|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162632084|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632085|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632086|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632087|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632088|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632089|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632090|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632091|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
162632092|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632093|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632094|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162632095|NCT02207244|587367385|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632096|NCT02207244|587367386|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632097|NCT02207244|587367387|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632098|NCT02207244|587367388|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632099|NCT02207244|587367389|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632100|NCT02207244|587367390|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632101|NCT02207244|587367391|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
162632102|NCT02207244|587367392|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162979403|NCT04846881|588625162|FG001|Overall Study|Other than listed|10|||
162979404|NCT04846881|588625161|FG000|Overall Study|No reason available|1|||
162979405|NCT04846881|588625162|FG001|Overall Study|No reason available|3|||
162979406|NCT04846881|588625161|FG000|Overall Study|Patient randomised in error|1|||
162979407|NCT04846881|588625162|FG001|Overall Study|Patient randomised in error|0|||
162979408|NCT04560998|588625163|FG000|Overall Study|Withdrawal by Subject|18|||
162979409|NCT04560998|588625164|FG001|Overall Study|Withdrawal by Subject|12|||
162979410|NCT04560998|588625163|FG000|Overall Study|Lost to Follow-up|8|||
162979411|NCT04560998|588625164|FG001|Overall Study|Lost to Follow-up|5|||
162632103|NCT02207244|587367393|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632104|NCT02207244|587367394|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632105|NCT02207244|587367395|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162632106|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632107|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632108|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632109|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632110|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632111|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632112|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632113|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632114|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
162632115|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162632116|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
162632117|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632118|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632119|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632120|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632121|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632122|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632123|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632124|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632125|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
162632126|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162632127|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
162632128|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632129|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632130|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632131|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632132|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632133|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632134|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632135|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632136|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
162632137|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162632138|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
162632139|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632140|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632141|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632142|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632143|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632144|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632145|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632146|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632147|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
162632148|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162632149|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
162632150|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
162632151|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
162632152|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
162632153|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
162632154|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
162632155|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
162632156|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
162632157|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
162632158|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
162632159|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
162632160|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
162632161|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
162632162|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
162632163|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
162632164|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
162632165|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
162632166|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
162632167|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
162632168|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
162632169|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
162632170|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
162713951|NCT05576051|587662639|FG002|Overall Study|Lack of Efficacy|108|||
162713952|NCT05576051|587662640|FG003|Overall Study|Lack of Efficacy|72|||
162713953|NCT05576051|587662641|FG004|Overall Study|Lack of Efficacy|28|||
162713954|NCT05576051|587662642|FG005|Overall Study|Lack of Efficacy|50|||
162713955|NCT05576051|587662637|FG000|Overall Study|Safety|78|||
162713956|NCT05576051|587662638|FG001|Overall Study|Safety|74|||
162713957|NCT05576051|587662639|FG002|Overall Study|Safety|16|||
162713958|NCT05576051|587662640|FG003|Overall Study|Safety|14|||
162713959|NCT05576051|587662641|FG004|Overall Study|Safety|4|||
162713960|NCT05576051|587662642|FG005|Overall Study|Safety|5|||
162713961|NCT05576051|587662637|FG000|Overall Study|Efficacy + Safety|10|||
162713962|NCT05576051|587662638|FG001|Overall Study|Efficacy + Safety|7|||
162713963|NCT05576051|587662639|FG002|Overall Study|Efficacy + Safety|3|||
162713964|NCT05576051|587662640|FG003|Overall Study|Efficacy + Safety|0|||
162713965|NCT05576051|587662641|FG004|Overall Study|Efficacy + Safety|0|||
162713966|NCT05576051|587662642|FG005|Overall Study|Efficacy + Safety|0|||
162713967|NCT05576051|587662637|FG000|Overall Study|Other|231|||
162713968|NCT05576051|587662638|FG001|Overall Study|Other|127|||
162713969|NCT05576051|587662639|FG002|Overall Study|Other|35|||
162713970|NCT05576051|587662640|FG003|Overall Study|Other|14|||
162713971|NCT05576051|587662641|FG004|Overall Study|Other|6|||
162713972|NCT05576051|587662642|FG005|Overall Study|Other|0|||
162713973|NCT04154943|587662643|FG000|Overall Study|Study Ongoing|68|||
162713974|NCT04154943|587662643|FG000|Overall Study|Lost to Follow-up|1|||
162713975|NCT04154943|587662643|FG000|Overall Study|Decision by the Investigator|1|||
162713976|NCT04154943|587662643|FG000|Overall Study|Death|5|||
162713977|NCT04154943|587662643|FG000|Overall Study|Withdrawal by Subject|4|||
162713978|NCT02107014|587662644|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
162713979|NCT00591838|587662645|FG000|Overall Study|Withdrawal by Subject|0|||
162713980|NCT00591838|587662646|FG001|Overall Study|Withdrawal by Subject|0|||
162713981|NCT00591838|587662647|FG002|Overall Study|Withdrawal by Subject|0|||
162713982|NCT00591838|587662648|FG003|Overall Study|Withdrawal by Subject|1|||
162713983|NCT00591838|587662649|FG004|Overall Study|Withdrawal by Subject|0|||
162713984|NCT00586339|587662650|FG000|Overall Study|Withdrawal by Subject|1|||
162713985|NCT00586339|587662651|FG001|Overall Study|Withdrawal by Subject|3|||
162713986|NCT00586339|587662652|FG002|Overall Study|Withdrawal by Subject|1|||
162713987|NCT00586339|587662650|FG000|Overall Study|Migrated/moved from study area|3|||
162713988|NCT00586339|587662651|FG001|Overall Study|Migrated/moved from study area|2|||
162713989|NCT00586339|587662652|FG002|Overall Study|Migrated/moved from study area|4|||
162713990|NCT00586339|587662650|FG000|Overall Study|Lost to Follow-up|3|||
162632171|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
162632172|NCT02207244|587367385|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632173|NCT02207244|587367386|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632174|NCT02207244|587367387|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632175|NCT02207244|587367388|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632176|NCT02207244|587367389|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632177|NCT02207244|587367390|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632178|NCT02207244|587367391|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632179|NCT02207244|587367392|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632180|NCT02207244|587367393|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632181|NCT02207244|587367394|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162632182|NCT02207244|587367395|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
162632183|NCT01866930|587367401|FG000|Treatment Period|Other|1|||
162632184|NCT01866930|587367402|FG001|Treatment Period|Other|0|||
162632185|NCT01866930|587367401|FG000|Treatment Period|Death|0|||
162632186|NCT01866930|587367402|FG001|Treatment Period|Death|2|||
162713991|NCT00586339|587662651|FG001|Overall Study|Lost to Follow-up|2|||
162713992|NCT00586339|587662652|FG002|Overall Study|Lost to Follow-up|1|||
162713993|NCT02512042|587662653|FG000|Overall Study|Adverse Event|0|||
162713994|NCT02512042|587662654|FG001|Overall Study|Adverse Event|4|||
162713995|NCT02512042|587662653|FG000|Overall Study|Withdrawal by Subject|6|||
162713996|NCT02512042|587662654|FG001|Overall Study|Withdrawal by Subject|6|||
162713997|NCT02512042|587662653|FG000|Overall Study|Non-compliance with study drug|1|||
162979412|NCT04560998|588625163|FG000|Overall Study|Physician Decision|4|||
162979413|NCT04560998|588625164|FG001|Overall Study|Physician Decision|0|||
162979414|NCT01000610|588626748|FG000|Overall Study|Adverse Event|1|||
162979415|NCT01000610|588626748|FG000|Overall Study|Lost to Follow-up|4|||
162713998|NCT02512042|587662654|FG001|Overall Study|Non-compliance with study drug|2|||
162713999|NCT02512042|587662653|FG000|Overall Study|Lost to Follow-up|5|||
162714000|NCT02512042|587662654|FG001|Overall Study|Lost to Follow-up|2|||
162714001|NCT02512042|587662653|FG000|Overall Study|Other|11|||
162714002|NCT02512042|587662654|FG001|Overall Study|Other|11|||
162714003|NCT01467700|587662656|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
162714004|NCT01467700|587662657|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
162632187|NCT01866930|587367401|FG000|Treatment Period|Poor/non compliance|0|||
162632188|NCT01866930|587367402|FG001|Treatment Period|Poor/non compliance|2|||
162714005|NCT01467700|587662658|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
162979416|NCT01000610|588626748|FG000|Overall Study|Treatment failure|1|||
162714006|NCT01467700|587662659|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
162714007|NCT01467700|587662656|FG000|Overall Study|Major Protocol Deviation|3|||
162714008|NCT01467700|587662657|FG001|Overall Study|Major Protocol Deviation|3|||
162979417|NCT01010126|588626749|FG000|Overall Study|Withdrawal by Subject|1|||
162979418|NCT01010126|588626750|FG001|Overall Study|Withdrawal by Subject|0|||
162979419|NCT01010126|588626751|FG002|Overall Study|Withdrawal by Subject|1|||
162979420|NCT01010126|588626752|FG003|Overall Study|Withdrawal by Subject|0|||
162979421|NCT01010126|588626753|FG004|Overall Study|Withdrawal by Subject|3|||
162979422|NCT01010126|588626754|FG005|Overall Study|Withdrawal by Subject|0|||
162979423|NCT04495283|588626757|FG000|Overall Study|Physician Decision|0|||
162979424|NCT04495283|588626758|FG001|Overall Study|Physician Decision|0|||
162979425|NCT04495283|588626759|FG002|Overall Study|Physician Decision|1|||
162979426|NCT04495283|588626757|FG000|Overall Study|Withdrawal by Subject|0|||
162979427|NCT04495283|588626758|FG001|Overall Study|Withdrawal by Subject|1|||
162979428|NCT04495283|588626759|FG002|Overall Study|Withdrawal by Subject|1|||
162979429|NCT04495283|588626757|FG000|Overall Study|Other|1|||
162979430|NCT04495283|588626758|FG001|Overall Study|Other|0|||
162979431|NCT04495283|588626759|FG002|Overall Study|Other|1|||
162979432|NCT03341000|588626773|FG000|Overall Study|Adverse Event|1|||
162979433|NCT04718194|588626778|FG000|Overall Study|Withdrawal by Subject|3|||
162979434|NCT04718194|588626779|FG001|Overall Study|Withdrawal by Subject|0|||
162979435|NCT04718194|588626778|FG000|Overall Study|Lost to Follow-up|3|||
162979436|NCT04718194|588626779|FG001|Overall Study|Lost to Follow-up|0|||
162979437|NCT01215513|588626780|FG000|Overall Study|Not completed CS42|9|||
162979438|NCT01215513|588626780|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
162979439|NCT01215513|588626780|FG000|Overall Study|Adverse event (CS42A)|2|||
162979440|NCT01215513|588626780|FG000|Overall Study|Physician decision (CS42A)|6|||
162979441|NCT01215513|588626780|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
162979442|NCT01215513|588626780|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
162979443|NCT00821873|588626781|FG000|Overall Study|Lost to Follow-up|4|||
162979444|NCT02698865|588626786|FG000|Overall Study|Other|11|||
162979445|NCT02698865|588626787|FG001|Overall Study|Other|11|||
162979446|NCT02698865|588626786|FG000|Overall Study|Withdrawal by Subject|20|||
162979447|NCT02698865|588626787|FG001|Overall Study|Withdrawal by Subject|16|||
162979448|NCT02698865|588626786|FG000|Overall Study|Physician Decision|0|||
162979449|NCT02698865|588626787|FG001|Overall Study|Physician Decision|4|||
162979450|NCT02698865|588626786|FG000|Overall Study|Lost to Follow-up|4|||
162979451|NCT02698865|588626787|FG001|Overall Study|Lost to Follow-up|2|||
162979452|NCT01386684|588626791|FG000|Overall Study|Lost to Follow-up|51|||
162979453|NCT01386684|588626791|FG000|Overall Study|Other|51|||
162979454|NCT01386684|588626791|FG000|Overall Study|Death|47|||
162979455|NCT01386684|588626791|FG000|Overall Study|Withdrawal of Consent|44|||
162979456|NCT01386684|588626791|FG000|Overall Study|Alternative Therapy Required|37|||
162979457|NCT01386684|588626791|FG000|Overall Study|Disease Progression|28|||
162979458|NCT01386684|588626791|FG000|Overall Study|Adverse Event|20|||
162979459|NCT01386684|588626791|FG000|Overall Study|Noncompliance|8|||
162979460|NCT01386684|588626791|FG000|Overall Study|Protocol Violation|4|||
162979461|NCT01386684|588626791|FG000|Overall Study|Missing|3|||
162979462|NCT02694549|588626797|FG000|Overall Study|screen failures|2|||
162979463|NCT01996332|588626798|FG000|Overall Study|Adverse Event|117|||
162979464|NCT01996332|588626798|FG000|Overall Study|Lack of Efficacy|1245|||
162979465|NCT01996332|588626798|FG000|Overall Study|Death|264|||
162979466|NCT01996332|588626798|FG000|Overall Study|Protocol Violation|9|||
162979467|NCT01996332|588626798|FG000|Overall Study|Withdrawal by Subject|71|||
162979468|NCT01996332|588626798|FG000|Overall Study|Other|20|||
162979469|NCT01996332|588626798|FG000|Overall Study|Clinical Deterioration|28|||
162979470|NCT01996332|588626798|FG000|Overall Study|Physician Decision|17|||
162979471|NCT01996332|588626798|FG000|Overall Study|Lost to Follow-up|34|||
162979472|NCT02113189|588626799|FG000|Overall Study|Lost to follow up|2|||
162979473|NCT02113189|588626800|FG001|Overall Study|Lost to follow up|1|||
162979474|NCT02113189|588626801|FG002|Overall Study|Lost to follow up|3|||
162979475|NCT00099268|588626804|FG000|Overall Study|Withdrawal by Subject|46|||
162979476|NCT00099268|588626805|FG001|Overall Study|Withdrawal by Subject|28|||
163058915|NCT02867592|588924342|FG002|Overall Study|Withdrawal by Subject|0|||
162714009|NCT01467700|587662658|FG002|Overall Study|Major Protocol Deviation|2|||
162714010|NCT01467700|587662659|FG003|Overall Study|Major Protocol Deviation|3|||
162979477|NCT00099268|588626804|FG000|Overall Study|Adverse Event|19|||
162979478|NCT00099268|588626805|FG001|Overall Study|Adverse Event|19|||
162979479|NCT00099268|588626804|FG000|Overall Study|Protocol Violation|9|||
162979480|NCT00099268|588626805|FG001|Overall Study|Protocol Violation|8|||
162979481|NCT00099268|588626804|FG000|Overall Study|Lost to Follow-up|6|||
162979482|NCT00099268|588626805|FG001|Overall Study|Lost to Follow-up|4|||
162979483|NCT00099268|588626804|FG000|Overall Study|Lack of Efficacy|5|||
162979484|NCT00099268|588626805|FG001|Overall Study|Lack of Efficacy|18|||
162979485|NCT00099268|588626804|FG000|Overall Study|Administrative problems|4|||
162979486|NCT00099268|588626805|FG001|Overall Study|Administrative problems|4|||
162979487|NCT00099268|588626804|FG000|Overall Study|Death|3|||
162979488|NCT00099268|588626805|FG001|Overall Study|Death|1|||
162979489|NCT03702049|588626806|FG000|Overall Study|Lost to Follow-up|4|||
162632189|NCT01866930|587367401|FG000|Treatment Period|No longer meets study criteria|0|||
162632190|NCT01866930|587367402|FG001|Treatment Period|No longer meets study criteria|1|||
162632191|NCT01866930|587367401|FG000|Treatment Period|Withdrawal by Subject|2|||
162632192|NCT01866930|587367402|FG001|Treatment Period|Withdrawal by Subject|8|||
162632193|NCT01866930|587367401|FG000|Treatment Period|Lack of Efficacy|1|||
162632194|NCT01866930|587367402|FG001|Treatment Period|Lack of Efficacy|9|||
162632195|NCT01866930|587367401|FG000|Treatment Period|Adverse Event|4|||
162632196|NCT01866930|587367402|FG001|Treatment Period|Adverse Event|12|||
162632197|NCT01866930|587367401|FG000|Treatment Period|Lost to Follow-up|1|||
162632198|NCT01866930|587367402|FG001|Treatment Period|Lost to Follow-up|1|||
162632199|NCT01866930|587367401|FG000|Follow-up Period|Lost to Follow-up|1|||
162632200|NCT01866930|587367402|FG001|Follow-up Period|Lost to Follow-up|1|||
162632201|NCT01866930|587367401|FG000|Follow-up Period|Other|1|||
162632202|NCT01866930|587367402|FG001|Follow-up Period|Other|5|||
162632203|NCT01866930|587367401|FG000|Follow-up Period|No longer required per protocol|1|||
162632204|NCT01866930|587367402|FG001|Follow-up Period|No longer required per protocol|0|||
162632205|NCT01866930|587367401|FG000|Follow-up Period|Withdrawal by Subject|3|||
162632206|NCT01866930|587367402|FG001|Follow-up Period|Withdrawal by Subject|3|||
162632207|NCT02521870|587367403|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632208|NCT02521870|587367404|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
162632209|NCT02521870|587367405|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632210|NCT02521870|587367406|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632211|NCT02521870|587367407|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632212|NCT02521870|587367408|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632213|NCT02521870|587367409|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632214|NCT02521870|587367410|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632215|NCT02521870|587367411|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632216|NCT02521870|587367412|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632217|NCT02521870|587367413|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632218|NCT02521870|587367414|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162632219|NCT02521870|587367403|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
162632220|NCT02521870|587367404|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
162632221|NCT02521870|587367405|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
162632222|NCT02521870|587367406|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
162632223|NCT02521870|587367407|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
162632224|NCT02521870|587367408|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
162632225|NCT02521870|587367409|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
162632226|NCT02521870|587367410|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
162632227|NCT02521870|587367411|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
162632228|NCT02521870|587367412|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
162632229|NCT02521870|587367413|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
162632230|NCT02521870|587367414|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
162632231|NCT02521870|587367403|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
162632232|NCT02521870|587367404|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
162632233|NCT02521870|587367405|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
162632234|NCT02521870|587367406|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
162632235|NCT02521870|587367407|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
162632236|NCT02521870|587367408|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
162632237|NCT02521870|587367409|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
162632238|NCT02521870|587367410|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
162632239|NCT02521870|587367411|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
162632240|NCT02521870|587367412|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
162632241|NCT02521870|587367413|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
162632242|NCT02521870|587367414|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
162632243|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632244|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632245|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632246|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632247|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
162632248|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162632249|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162632250|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632251|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162714011|NCT01467700|587662656|FG000|Overall Study|Lost to Follow-up|6|||
162714012|NCT01467700|587662657|FG001|Overall Study|Lost to Follow-up|5|||
162632252|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162632253|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
162632254|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162632255|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
162632256|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
162714013|NCT01467700|587662658|FG002|Overall Study|Lost to Follow-up|2|||
162632257|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
162632258|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
162979490|NCT03702049|588626806|FG000|Overall Study|Physician Decision|1|||
162979491|NCT02954159|588626807|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
162979492|NCT02954159|588626808|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
162979493|NCT02954159|588626807|FG000|Overall Study|Withdrawal by Subject|0|||
162979494|NCT02954159|588626808|FG001|Overall Study|Withdrawal by Subject|1|||
162979495|NCT03438396|588626809|FG000|Overall Study|Reason Not Specified|9|||
162979496|NCT03438396|588626809|FG000|Overall Study|Withdrawal by Subject|5|||
162979497|NCT03438396|588626809|FG000|Overall Study|Lost to Follow-up|2|||
162979498|NCT03438396|588626809|FG000|Overall Study|Death|85|||
162979499|NCT03438396|588626809|FG000|Overall Study|Not treated|1|||
162979500|NCT00262041|588626810|FG000|Overall Study|Withdrawal by Subject|0|||
162979501|NCT00262041|588626811|FG001|Overall Study|Withdrawal by Subject|3|||
162979502|NCT00262041|588626812|FG002|Overall Study|Withdrawal by Subject|1|||
162979503|NCT00262041|588626810|FG000|Overall Study|Lost to Follow-up|1|||
162979504|NCT00262041|588626811|FG001|Overall Study|Lost to Follow-up|1|||
162979505|NCT00262041|588626812|FG002|Overall Study|Lost to Follow-up|5|||
162979506|NCT00262041|588626810|FG000|Overall Study|Unable to classify|1|||
162979507|NCT00262041|588626811|FG001|Overall Study|Unable to classify|0|||
162979508|NCT00262041|588626812|FG002|Overall Study|Unable to classify|0|||
162979509|NCT03028740|588626813|FG000|Overall Study|Did not Receive Study Drug|4|||
162979510|NCT03028740|588626814|FG001|Overall Study|Did not Receive Study Drug|5|||
162979511|NCT03028740|588626813|FG000|Overall Study|Adverse Event|8|||
162979512|NCT03028740|588626814|FG001|Overall Study|Adverse Event|26|||
162979513|NCT03028740|588626813|FG000|Overall Study|Lack of Efficacy|0|||
162979514|NCT03028740|588626814|FG001|Overall Study|Lack of Efficacy|1|||
162979515|NCT03028740|588626813|FG000|Overall Study|Withdrawal by Subject|48|||
162979516|NCT03028740|588626814|FG001|Overall Study|Withdrawal by Subject|101|||
162979517|NCT03028740|588626813|FG000|Overall Study|Lost to Follow-up|30|||
162979518|NCT03028740|588626814|FG001|Overall Study|Lost to Follow-up|54|||
162979519|NCT03028740|588626813|FG000|Overall Study|Physician Decision|4|||
162979520|NCT03028740|588626814|FG001|Overall Study|Physician Decision|11|||
162979521|NCT03028740|588626813|FG000|Overall Study|Protocol Violation|4|||
162979522|NCT03028740|588626814|FG001|Overall Study|Protocol Violation|8|||
162979523|NCT03028740|588626813|FG000|Overall Study|Non-compliance with Study Drug|0|||
162979524|NCT03028740|588626814|FG001|Overall Study|Non-compliance with Study Drug|2|||
162979525|NCT03028740|588626813|FG000|Overall Study|Study Terminated by Sponsor|467|||
162979526|NCT03028740|588626814|FG001|Overall Study|Study Terminated by Sponsor|917|||
162979527|NCT03028740|588626813|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
162979528|NCT03028740|588626814|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
162979529|NCT03028740|588626813|FG000|Overall Study|Reason not Specified|1|||
162979530|NCT03028740|588626814|FG001|Overall Study|Reason not Specified|5|||
162979531|NCT00252174|588626815|FG000|Overall Study|Withdrawal by Subject|0|||
162979532|NCT00252174|588626816|FG001|Overall Study|Withdrawal by Subject|1|||
162979533|NCT00252174|588626817|FG002|Overall Study|Withdrawal by Subject|0|||
162979534|NCT01138826|588626818|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979535|NCT01138826|588626819|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979536|NCT01138826|588626820|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979537|NCT01138826|588626821|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979538|NCT01138826|588626822|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
162979539|NCT01138826|588626823|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
162979540|NCT02566993|588626824|FG000|Overall Study|Randomized but not treated|5|||
162979541|NCT02566993|588626825|FG001|Overall Study|Randomized but not treated|16|||
162979542|NCT02566993|588626824|FG000|Overall Study|Progressive disease|213|||
162979543|NCT02566993|588626825|FG001|Overall Study|Progressive disease|152|||
162979544|NCT02566993|588626824|FG000|Overall Study|Withdrawal by Subject|12|||
162979545|NCT02566993|588626825|FG001|Overall Study|Withdrawal by Subject|28|||
162979546|NCT02566993|588626824|FG000|Overall Study|Death|17|||
162979547|NCT02566993|588626825|FG001|Overall Study|Death|23|||
162979548|NCT02566993|588626824|FG000|Overall Study|Physician Decision|10|||
162979549|NCT02566993|588626825|FG001|Overall Study|Physician Decision|17|||
162979550|NCT02566993|588626824|FG000|Overall Study|Study drug-related adverse event|20|||
162979551|NCT02566993|588626825|FG001|Overall Study|Study drug-related adverse event|41|||
162979552|NCT02566993|588626824|FG000|Overall Study|Non study drug-related adverse event|9|||
162979553|NCT02566993|588626825|FG001|Overall Study|Non study drug-related adverse event|9|||
162979554|NCT02566993|588626824|FG000|Overall Study|Symptomatic deterioration|9|||
162979555|NCT02566993|588626825|FG001|Overall Study|Symptomatic deterioration|16|||
162979556|NCT02566993|588626824|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
162979557|NCT02566993|588626825|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
162979558|NCT02566993|588626824|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
162979559|NCT02566993|588626825|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
162979560|NCT02566993|588626824|FG000|Overall Study|Screening failure|2|||
162979561|NCT02566993|588626825|FG001|Overall Study|Screening failure|0|||
163058916|NCT02867592|588924343|FG003|Overall Study|Withdrawal by Subject|1|||
162979562|NCT02566993|588626824|FG000|Overall Study|Lost to Follow-up|0|||
162632259|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
162632260|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
162632261|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
162632262|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
162632263|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
162632264|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
162632265|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
162632266|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
162632267|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
162632268|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
162632269|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
162632270|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
162632271|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
162632272|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
162632273|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
162632274|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
162632275|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
162632276|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
162632277|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
162632278|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
162632279|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Death|0|||
162632280|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Death|0|||
162632281|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Death|0|||
162632282|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Death|0|||
162632283|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Death|1|||
162632284|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Death|1|||
162632285|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Death|3|||
162632286|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Death|1|||
162979563|NCT02566993|588626825|FG001|Overall Study|Lost to Follow-up|1|||
162979564|NCT02566993|588626824|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
162979565|NCT02566993|588626825|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
162979566|NCT01661881|588626826|FG000|Overall Study|Disease Progression|1|||
162632287|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Death|1|||
162979567|NCT01790113|588626827|FG000|Overall Study|Adverse Event|2|||
162979568|NCT01790113|588626828|FG001|Overall Study|Adverse Event|7|||
162632288|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Death|5|||
162632289|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Death|2|||
162632290|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Death|2|||
162632291|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Other|0|||
162632292|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Other|0|||
162632293|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Other|0|||
162632294|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Other|0|||
162632295|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Other|10|||
162632296|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Other|3|||
162632297|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Other|2|||
162632298|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Other|0|||
162632299|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Other|10|||
162632300|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Other|5|||
162632301|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Other|1|||
162632302|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Other|7|||
162632303|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632304|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632305|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632306|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162979569|NCT01790113|588626827|FG000|Overall Study|Study ended due to FDA clearance|1|||
162979570|NCT01790113|588626828|FG001|Overall Study|Study ended due to FDA clearance|68|||
162979571|NCT03451006|588626829|FG000|Overall Study|Withdrawal by Subject|2|||
162979572|NCT03451006|588626830|FG001|Overall Study|Withdrawal by Subject|2|||
162979573|NCT00775606|588626831|FG000|Overall Study|Study sponsor terminated funding|3|||
162979574|NCT00775606|588626832|FG001|Overall Study|Study sponsor terminated funding|0|||
162979575|NCT02278718|588626833|FG000|Overall Study|Adverse Event|1|||
162979576|NCT02278718|588626834|FG001|Overall Study|Adverse Event|0|||
162979577|NCT02278718|588626833|FG000|Overall Study|Lost to Follow-up|2|||
162632307|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
162632308|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632309|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632310|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632311|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632312|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632313|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632314|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162632315|NCT02521870|587367403|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632316|NCT02521870|587367404|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632317|NCT02521870|587367405|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162979578|NCT02278718|588626834|FG001|Overall Study|Lost to Follow-up|4|||
162714014|NCT01467700|587662659|FG003|Overall Study|Lost to Follow-up|3|||
162979579|NCT02278718|588626833|FG000|Overall Study|Withdrawal by Subject|1|||
162979580|NCT02278718|588626834|FG001|Overall Study|Withdrawal by Subject|4|||
162979581|NCT02278718|588626833|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
162979582|NCT02278718|588626834|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
162979583|NCT02278718|588626833|FG000|Overall Study|Missing|0|||
162979584|NCT02278718|588626834|FG001|Overall Study|Missing|1|||
162979585|NCT04440449|588626835|FG000|Overall Study|Lost to Follow-up|2|||
162979586|NCT04440449|588626836|FG001|Overall Study|Lost to Follow-up|0|||
162979587|NCT02547766|588626837|FG000|Overall Study|Withdrawal by Subject|1|||
162979588|NCT03212794|588626838|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
162979589|NCT03212794|588626839|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
162979590|NCT03212794|588626838|FG000|Overall Study|Lost to Follow-up|5|||
162979591|NCT03212794|588626839|FG001|Overall Study|Lost to Follow-up|6|||
162979592|NCT03212794|588626838|FG000|Overall Study|Incarcerated; unable to participate|2|||
162979593|NCT03212794|588626839|FG001|Overall Study|Incarcerated; unable to participate|0|||
162979594|NCT03212794|588626838|FG000|Overall Study|Withdrawal by Subject|1|||
162979595|NCT03212794|588626839|FG001|Overall Study|Withdrawal by Subject|0|||
162979596|NCT03212794|588626838|FG000|Overall Study|Death|0|||
162979597|NCT03212794|588626839|FG001|Overall Study|Death|1|||
162979598|NCT03212794|588626838|FG000|Overall Study|Found to be ineligible after allocation|0|||
162979599|NCT03212794|588626839|FG001|Overall Study|Found to be ineligible after allocation|1|||
162979600|NCT03212794|588626838|FG000|Overall Study|Relocated out of area|2|||
162979601|NCT03212794|588626839|FG001|Overall Study|Relocated out of area|0|||
162979602|NCT01763918|588626842|FG000|Overall Study|Withdrawal by Subject|2|||
162979603|NCT01763918|588626843|FG001|Overall Study|Withdrawal by Subject|1|||
162979604|NCT01763918|588626844|FG002|Overall Study|Withdrawal by Subject|1|||
162979605|NCT01763918|588626845|FG003|Overall Study|Withdrawal by Subject|2|||
162979606|NCT01763918|588626842|FG000|Overall Study|Sponsor Decision|4|||
162979607|NCT01763918|588626843|FG001|Overall Study|Sponsor Decision|0|||
162979608|NCT01763918|588626844|FG002|Overall Study|Sponsor Decision|9|||
162979609|NCT01763918|588626845|FG003|Overall Study|Sponsor Decision|0|||
162979610|NCT00897949|588626846|FG000|Overall Study|Adverse Event|1|||
162979611|NCT00897949|588626847|FG001|Overall Study|Adverse Event|1|||
162979612|NCT00897949|588626848|FG002|Overall Study|Adverse Event|0|||
162979613|NCT00897949|588626846|FG000|Overall Study|Lost to Follow-up|0|||
162979614|NCT00897949|588626847|FG001|Overall Study|Lost to Follow-up|2|||
162979615|NCT00897949|588626848|FG002|Overall Study|Lost to Follow-up|1|||
162979616|NCT00897949|588626846|FG000|Overall Study|Protocol Violation|6|||
162979617|NCT00897949|588626847|FG001|Overall Study|Protocol Violation|3|||
162979618|NCT00897949|588626848|FG002|Overall Study|Protocol Violation|1|||
162979619|NCT00897949|588626846|FG000|Overall Study|Withdrawal by Subject|1|||
162632318|NCT02521870|587367406|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632319|NCT02521870|587367407|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
162632320|NCT02521870|587367408|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632321|NCT02521870|587367409|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632322|NCT02521870|587367410|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632323|NCT02521870|587367411|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632324|NCT02521870|587367412|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632325|NCT02521870|587367413|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632326|NCT02521870|587367414|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162632327|NCT00519831|587367415|FG000|Overall Study|Adverse Event|3|||
162632328|NCT00471328|587367416|FG000|Core Phase|Adverse Event|18|||
162632329|NCT00471328|587367417|FG001|Core Phase|Adverse Event|6|||
162632330|NCT00471328|587367416|FG000|Core Phase|Death|8|||
162632331|NCT00471328|587367417|FG001|Core Phase|Death|4|||
162632332|NCT00471328|587367416|FG000|Core Phase|Withdrawal by Subject|2|||
162632333|NCT00471328|587367417|FG001|Core Phase|Withdrawal by Subject|2|||
162632334|NCT00471328|587367416|FG000|Core Phase|Abnormal laboratory value|1|||
162632335|NCT00471328|587367417|FG001|Core Phase|Abnormal laboratory value|0|||
162632336|NCT00471328|587367416|FG000|Core Phase|Disease Progression|78|||
162632337|NCT00471328|587367417|FG001|Core Phase|Disease Progression|53|||
162632338|NCT00471328|587367416|FG000|Core Phase|Administrative Problem|0|||
162632339|NCT00471328|587367417|FG001|Core Phase|Administrative Problem|1|||
162632340|NCT00471328|587367416|FG000|Core Phase|Protocol Deviation|0|||
162632341|NCT00471328|587367417|FG001|Core Phase|Protocol Deviation|1|||
162632342|NCT00471328|587367416|FG000|Extension Phase|Adverse Event|3|||
162632343|NCT00471328|587367417|FG001|Extension Phase|Adverse Event|12|||
162632344|NCT00471328|587367416|FG000|Extension Phase|Withdrawal by Subject|0|||
162632345|NCT00471328|587367417|FG001|Extension Phase|Withdrawal by Subject|2|||
162632346|NCT00471328|587367416|FG000|Extension Phase|Death|1|||
162632347|NCT00471328|587367417|FG001|Extension Phase|Death|7|||
162632348|NCT00471328|587367416|FG000|Extension Phase|Protocol Deviation|3|||
162632349|NCT00471328|587367417|FG001|Extension Phase|Protocol Deviation|1|||
162632350|NCT00471328|587367416|FG000|Extension Phase|Treatment duration as per protocol|0|||
162632351|NCT00471328|587367417|FG001|Extension Phase|Treatment duration as per protocol|1|||
162632352|NCT00471328|587367416|FG000|Extension Phase|Disease Progression|32|||
162632353|NCT00471328|587367417|FG001|Extension Phase|Disease Progression|44|||
162979620|NCT00897949|588626847|FG001|Overall Study|Withdrawal by Subject|2|||
162979621|NCT00897949|588626848|FG002|Overall Study|Withdrawal by Subject|0|||
162979622|NCT00897949|588626846|FG000|Overall Study|Patient Uncoorperative|0|||
162979623|NCT00897949|588626847|FG001|Overall Study|Patient Uncoorperative|2|||
162979624|NCT00897949|588626848|FG002|Overall Study|Patient Uncoorperative|1|||
162979625|NCT00897949|588626846|FG000|Overall Study|Lost to Follow-up|30|||
162979626|NCT00897949|588626847|FG001|Overall Study|Lost to Follow-up|23|||
162979627|NCT00897949|588626848|FG002|Overall Study|Lost to Follow-up|17|||
162979628|NCT00897949|588626846|FG000|Overall Study|Withdrawal by Subject|24|||
162979629|NCT00897949|588626847|FG001|Overall Study|Withdrawal by Subject|31|||
162979630|NCT00897949|588626848|FG002|Overall Study|Withdrawal by Subject|17|||
162979631|NCT00897949|588626846|FG000|Overall Study|Abnormal Prestudy Labs|2|||
162979632|NCT00897949|588626847|FG001|Overall Study|Abnormal Prestudy Labs|3|||
162979633|NCT00897949|588626848|FG002|Overall Study|Abnormal Prestudy Labs|4|||
162979634|NCT00897949|588626846|FG000|Overall Study|Abnormal Baseline ECG|2|||
162979635|NCT00897949|588626847|FG001|Overall Study|Abnormal Baseline ECG|2|||
162979636|NCT00897949|588626848|FG002|Overall Study|Abnormal Baseline ECG|4|||
162979637|NCT00897949|588626846|FG000|Overall Study|Need for Concom. Med.|0|||
162979638|NCT00897949|588626847|FG001|Overall Study|Need for Concom. Med.|1|||
162979639|NCT00897949|588626848|FG002|Overall Study|Need for Concom. Med.|1|||
162979640|NCT00897949|588626846|FG000|Overall Study|Lack of Migraine Attack|29|||
162979641|NCT00897949|588626847|FG001|Overall Study|Lack of Migraine Attack|30|||
162979642|NCT00897949|588626848|FG002|Overall Study|Lack of Migraine Attack|19|||
162979643|NCT00897949|588626846|FG000|Overall Study|Did not take study drug|9|||
162979644|NCT00897949|588626847|FG001|Overall Study|Did not take study drug|3|||
162979645|NCT00897949|588626848|FG002|Overall Study|Did not take study drug|4|||
162979646|NCT01553747|588626849|FG000|Overall Study|Protocol Violation|0|||
162979647|NCT01553747|588626850|FG001|Overall Study|Protocol Violation|2|||
162979648|NCT01553747|588626851|FG002|Overall Study|Protocol Violation|0|||
162979649|NCT01553747|588626849|FG000|Overall Study|Voluntarily withdrew|70|||
162632354|NCT00471328|587367416|FG000|Extension Phase|New cancer Therapy|1|||
162979650|NCT01553747|588626850|FG001|Overall Study|Voluntarily withdrew|66|||
162979651|NCT01553747|588626851|FG002|Overall Study|Voluntarily withdrew|74|||
162632355|NCT00471328|587367417|FG001|Extension Phase|New cancer Therapy|0|||
162632356|NCT00471328|587367416|FG000|Extension Phase|Administrative Problem|1|||
162632357|NCT00471328|587367417|FG001|Extension Phase|Administrative Problem|0|||
162979652|NCT01553747|588626849|FG000|Overall Study|Adverse event or SAE|32|||
162979653|NCT01553747|588626850|FG001|Overall Study|Adverse event or SAE|28|||
162979654|NCT01553747|588626851|FG002|Overall Study|Adverse event or SAE|19|||
162979655|NCT01553747|588626849|FG000|Overall Study|Physician decision: other|10|||
162979656|NCT01553747|588626850|FG001|Overall Study|Physician decision: other|8|||
162979657|NCT01553747|588626851|FG002|Overall Study|Physician decision: other|7|||
162979658|NCT01553747|588626849|FG000|Overall Study|Lost to Follow-up|11|||
162979659|NCT01553747|588626850|FG001|Overall Study|Lost to Follow-up|5|||
162979660|NCT01553747|588626851|FG002|Overall Study|Lost to Follow-up|6|||
162979661|NCT01553747|588626849|FG000|Overall Study|Sponsor decision, specify|7|||
162979662|NCT01553747|588626850|FG001|Overall Study|Sponsor decision, specify|5|||
162979663|NCT01553747|588626851|FG002|Overall Study|Sponsor decision, specify|0|||
162979664|NCT01553747|588626849|FG000|Overall Study|Physician decision: lack of efficacy|1|||
162979665|NCT01553747|588626850|FG001|Overall Study|Physician decision: lack of efficacy|5|||
162979666|NCT01553747|588626851|FG002|Overall Study|Physician decision: lack of efficacy|3|||
162979667|NCT00102687|588626852|FG000|Initial Period|Withdrawal by Subject|6|||
162979668|NCT00102687|588626853|FG001|Initial Period|Withdrawal by Subject|3|||
162979669|NCT00102687|588626854|FG002|Initial Period|Withdrawal by Subject|5|||
162979670|NCT00102687|588626855|FG003|Initial Period|Withdrawal by Subject|0|||
162979671|NCT00102687|588626856|FG004|Initial Period|Withdrawal by Subject|0|||
162979672|NCT00102687|588626852|FG000|Initial Period|Adverse Event|4|||
162979673|NCT00102687|588626853|FG001|Initial Period|Adverse Event|7|||
162979674|NCT00102687|588626854|FG002|Initial Period|Adverse Event|9|||
162979675|NCT00102687|588626855|FG003|Initial Period|Adverse Event|0|||
162979676|NCT00102687|588626856|FG004|Initial Period|Adverse Event|0|||
162979677|NCT00102687|588626852|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
162979678|NCT00102687|588626853|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
162979679|NCT00102687|588626854|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
162979680|NCT00102687|588626855|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
162979681|NCT00102687|588626856|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
162632358|NCT04051008|587367418|FG000|Overall Study|Withdrawal by Subject|2|||
162632359|NCT04051008|587367419|FG001|Overall Study|Withdrawal by Subject|0|||
163058917|NCT02867592|588924344|FG004|Overall Study|Withdrawal by Subject|3|||
163058918|NCT02867592|588924345|FG005|Overall Study|Withdrawal by Subject|3|||
163058919|NCT02867592|588924340|FG000|Overall Study|Ineligible|1|||
163058920|NCT02867592|588924341|FG001|Overall Study|Ineligible|1|||
163058921|NCT02867592|588924342|FG002|Overall Study|Ineligible|0|||
163058922|NCT02867592|588924343|FG003|Overall Study|Ineligible|0|||
163058923|NCT02867592|588924344|FG004|Overall Study|Ineligible|2|||
163058924|NCT02867592|588924345|FG005|Overall Study|Ineligible|0|||
163058925|NCT02867592|588924340|FG000|Overall Study|No Treatment|1|||
163058926|NCT02867592|588924341|FG001|Overall Study|No Treatment|0|||
163058927|NCT02867592|588924342|FG002|Overall Study|No Treatment|0|||
163058928|NCT02867592|588924343|FG003|Overall Study|No Treatment|0|||
163058929|NCT02867592|588924344|FG004|Overall Study|No Treatment|0|||
163058930|NCT02867592|588924345|FG005|Overall Study|No Treatment|0|||
163058931|NCT02867592|588924340|FG000|Overall Study|Still on Therapy|0|||
163058932|NCT02867592|588924341|FG001|Overall Study|Still on Therapy|0|||
163058933|NCT02867592|588924342|FG002|Overall Study|Still on Therapy|0|||
163058934|NCT02867592|588924343|FG003|Overall Study|Still on Therapy|0|||
163058935|NCT02867592|588924344|FG004|Overall Study|Still on Therapy|1|||
163058936|NCT02867592|588924345|FG005|Overall Study|Still on Therapy|0|||
163058937|NCT02867592|588924340|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058938|NCT02867592|588924341|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058939|NCT02867592|588924342|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058940|NCT02867592|588924343|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
163058941|NCT02867592|588924344|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
162632360|NCT04051008|587367420|FG002|Overall Study|Withdrawal by Subject|1|||
162632361|NCT02862171|587367421|FG000|Overall Study|Death|1|||
162632362|NCT02862171|587367421|FG000|Overall Study|Lost to Follow-up|13|||
162632363|NCT02862171|587367421|FG000|Overall Study|Withdrawal by Subject|57|||
162632364|NCT02862171|587367421|FG000|Overall Study|Non-compliance|4|||
162632365|NCT02862171|587367421|FG000|Overall Study|HIV-1 seroconversion|18|||
162632366|NCT00662012|587367422|FG000|Overall Study|Lost to Follow-up|85|||
162632367|NCT00662012|587367422|FG000|Overall Study|Death|1|||
162632368|NCT00662012|587367422|FG000|Overall Study|Withdrawal by Subject|1|||
162632369|NCT04212650|587367426|FG000|Overall Study|Withdrawal by Subject|1|||
162632370|NCT04212650|587367427|FG001|Overall Study|Withdrawal by Subject|0|||
162632371|NCT00838578|587367428|FG000|Overall Study|Protocol Violation|2|||
162632372|NCT00598832|587367429|FG000|Overall Study|Lack of Efficacy|3|||
162632373|NCT00598832|587367430|FG001|Overall Study|Lack of Efficacy|7|||
162632374|NCT00598832|587367429|FG000|Overall Study|Adverse Event|6|||
162632375|NCT00598832|587367430|FG001|Overall Study|Adverse Event|2|||
162632376|NCT00598832|587367429|FG000|Overall Study|Withdrawal by Subject|25|||
162632377|NCT00598832|587367430|FG001|Overall Study|Withdrawal by Subject|36|||
162632378|NCT00598832|587367429|FG000|Overall Study|Protocol Violation|0|||
162632379|NCT00598832|587367430|FG001|Overall Study|Protocol Violation|2|||
162632380|NCT00598832|587367429|FG000|Overall Study|Lost to Follow-up|24|||
162632381|NCT00598832|587367430|FG001|Overall Study|Lost to Follow-up|29|||
162632382|NCT00598832|587367429|FG000|Overall Study|Pregnancy|2|||
162632383|NCT00598832|587367430|FG001|Overall Study|Pregnancy|2|||
162632384|NCT00598832|587367429|FG000|Overall Study|Physician Decision|1|||
162632385|NCT00598832|587367430|FG001|Overall Study|Physician Decision|4|||
162632386|NCT00598832|587367429|FG000|Overall Study|Non compliance|1|||
162632387|NCT00598832|587367430|FG001|Overall Study|Non compliance|0|||
162632388|NCT00357968|587367435|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
162632389|NCT00357968|587367436|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
162632390|NCT00357968|587367435|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
162632391|NCT00357968|587367436|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
162632392|NCT03919799|587367437|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
162632393|NCT03919799|587367438|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
162632394|NCT03919799|587367439|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
162632395|NCT03919799|587367440|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
162632396|NCT03919799|587367441|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
162632397|NCT03919799|587367437|FG000|DB Period (28 Weeks)|Adverse Event|1|||
162632398|NCT03919799|587367438|FG001|DB Period (28 Weeks)|Adverse Event|1|||
162632399|NCT03919799|587367439|FG002|DB Period (28 Weeks)|Adverse Event|1|||
162632400|NCT03919799|587367440|FG003|DB Period (28 Weeks)|Adverse Event|0|||
162632401|NCT03919799|587367441|FG004|DB Period (28 Weeks)|Adverse Event|0|||
162632402|NCT03919799|587367437|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162979682|NCT00102687|588626852|FG000|Initial Period|Protocol Violation|0|||
162979683|NCT00102687|588626853|FG001|Initial Period|Protocol Violation|0|||
162979684|NCT00102687|588626854|FG002|Initial Period|Protocol Violation|2|||
162979685|NCT00102687|588626855|FG003|Initial Period|Protocol Violation|0|||
162979686|NCT00102687|588626856|FG004|Initial Period|Protocol Violation|0|||
162979687|NCT00102687|588626852|FG000|Initial Period|Physician Decision|2|||
162979688|NCT00102687|588626853|FG001|Initial Period|Physician Decision|9|||
162979689|NCT00102687|588626854|FG002|Initial Period|Physician Decision|6|||
162979690|NCT00102687|588626855|FG003|Initial Period|Physician Decision|0|||
162979691|NCT00102687|588626856|FG004|Initial Period|Physician Decision|0|||
162979692|NCT00102687|588626852|FG000|Initial Period|Sponsor's decision|0|||
162979693|NCT00102687|588626853|FG001|Initial Period|Sponsor's decision|1|||
162979694|NCT00102687|588626854|FG002|Initial Period|Sponsor's decision|1|||
162979695|NCT00102687|588626855|FG003|Initial Period|Sponsor's decision|0|||
162979696|NCT00102687|588626856|FG004|Initial Period|Sponsor's decision|0|||
162979697|NCT00102687|588626852|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
162979698|NCT00102687|588626853|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
162632403|NCT03919799|587367438|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
162632404|NCT03919799|587367439|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162632405|NCT03919799|587367440|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162632406|NCT03919799|587367441|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162979699|NCT00102687|588626854|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
162979700|NCT00102687|588626855|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
162979701|NCT00102687|588626856|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
162979702|NCT00102687|588626852|FG000|Initial Period|Death|1|||
162979703|NCT00102687|588626853|FG001|Initial Period|Death|1|||
162979704|NCT00102687|588626854|FG002|Initial Period|Death|1|||
162632407|NCT03919799|587367437|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162632408|NCT03919799|587367438|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
162632409|NCT03919799|587367439|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162632410|NCT03919799|587367440|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162632411|NCT03919799|587367441|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162632412|NCT03919799|587367437|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
162632413|NCT03919799|587367438|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
162632414|NCT03919799|587367439|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
162632415|NCT03919799|587367440|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
162632416|NCT03919799|587367441|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
162632417|NCT02142959|587367442|FG000|Overall Study|Adverse Event|1|||
162632418|NCT02142959|587367443|FG001|Overall Study|Adverse Event|0|||
162632419|NCT02142959|587367444|FG002|Overall Study|Adverse Event|0|||
162632420|NCT02142959|587367442|FG000|Overall Study|Death|0|||
162632421|NCT02142959|587367443|FG001|Overall Study|Death|1|||
162632422|NCT02142959|587367444|FG002|Overall Study|Death|0|||
162632423|NCT02142959|587367442|FG000|Overall Study|Withdrawal by Subject|3|||
162632424|NCT02142959|587367443|FG001|Overall Study|Withdrawal by Subject|1|||
162632425|NCT02142959|587367444|FG002|Overall Study|Withdrawal by Subject|3|||
162632426|NCT02142959|587367442|FG000|Overall Study|Administrative Reasons|1|||
162632427|NCT02142959|587367443|FG001|Overall Study|Administrative Reasons|0|||
162632428|NCT02142959|587367444|FG002|Overall Study|Administrative Reasons|1|||
162632429|NCT02142959|587367442|FG000|Overall Study|Missing|0|||
162632430|NCT02142959|587367443|FG001|Overall Study|Missing|1|||
162632431|NCT02142959|587367444|FG002|Overall Study|Missing|0|||
162632432|NCT02142959|587367442|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
162632433|NCT02142959|587367443|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
162632434|NCT02142959|587367444|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
162632435|NCT02142959|587367442|FG000|Overall Study|Patient didn't complete end of study visit|0|||
162632436|NCT02142959|587367443|FG001|Overall Study|Patient didn't complete end of study visit|0|||
162632437|NCT02142959|587367444|FG002|Overall Study|Patient didn't complete end of study visit|1|||
162632438|NCT03547687|587367447|FG000|Overall Study|Withdrawal by Subject|1|||
162632439|NCT03547687|587367447|FG000|Overall Study|Death|1|||
162632440|NCT00646776|587367448|FG000|Overall Study|Adverse Event|1|||
162632441|NCT00646776|587367449|FG001|Overall Study|Adverse Event|9|||
162632442|NCT00646776|587367448|FG000|Overall Study|Investigator discretion|0|||
162632443|NCT00646776|587367449|FG001|Overall Study|Investigator discretion|4|||
162632444|NCT01753856|587367454|FG000|Overall Study|Adverse Event|1|||
162632445|NCT01753856|587367455|FG001|Overall Study|Adverse Event|0|||
162632446|NCT01753856|587367454|FG000|Overall Study|Withdrawal by Subject|0|||
162632447|NCT01753856|587367455|FG001|Overall Study|Withdrawal by Subject|2|||
162632448|NCT01753856|587367454|FG000|Overall Study|Sponsor Decision|2|||
162632449|NCT01753856|587367455|FG001|Overall Study|Sponsor Decision|0|||
162632450|NCT05980182|587367456|FG000|Overall Study|Lost to Follow-up|10|||
162632451|NCT04419714|587367464|FG000|Overall Study|Technical Fault|5|||
162632452|NCT04419714|587367464|FG000|Overall Study|Protocol Deviation|2|||
162632453|NCT04419714|587367464|FG000|Overall Study|Withdrawal by Subject|1|||
162632454|NCT04023526|587368971|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
162632455|NCT04023526|587368972|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
162632456|NCT04023526|587368971|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
162632457|NCT04023526|587368972|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
162632458|NCT01955733|587368973|FG000|Period 1|Lost to Follow-up|1|||
162632459|NCT01955733|587368974|FG001|Period 1|Lost to Follow-up|0|||
162632460|NCT01955733|587368975|FG002|Period 1|Lost to Follow-up|0|||
162632461|NCT01955733|587368973|FG000|Period 2|Adverse Event|1|||
162632462|NCT01955733|587368974|FG001|Period 2|Adverse Event|0|||
162979705|NCT00102687|588626855|FG003|Initial Period|Death|0|||
162979706|NCT00102687|588626856|FG004|Initial Period|Death|0|||
162979707|NCT00102687|588626852|FG000|Maintenance Period|Withdrawal by Subject|4|||
162979708|NCT00102687|588626853|FG001|Maintenance Period|Withdrawal by Subject|0|||
162979709|NCT00102687|588626854|FG002|Maintenance Period|Withdrawal by Subject|2|||
162979710|NCT00102687|588626855|FG003|Maintenance Period|Withdrawal by Subject|3|||
162979711|NCT00102687|588626856|FG004|Maintenance Period|Withdrawal by Subject|1|||
162979712|NCT00102687|588626852|FG000|Maintenance Period|Adverse Event|1|||
162979713|NCT00102687|588626853|FG001|Maintenance Period|Adverse Event|0|||
163058942|NCT02867592|588924345|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
163058943|NCT02867592|588924340|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
162979714|NCT00102687|588626854|FG002|Maintenance Period|Adverse Event|0|||
163058944|NCT02867592|588924341|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
162632463|NCT01955733|587368975|FG002|Period 2|Adverse Event|0|||
162632464|NCT01955733|587368973|FG000|Period 2|Physician Decision|0|||
162632465|NCT01955733|587368974|FG001|Period 2|Physician Decision|0|||
162632466|NCT01955733|587368975|FG002|Period 2|Physician Decision|1|||
162979715|NCT00102687|588626855|FG003|Maintenance Period|Adverse Event|1|||
162632467|NCT01955733|587368973|FG000|Period 2|Withdrawal by Subject|1|||
162632468|NCT01955733|587368974|FG001|Period 2|Withdrawal by Subject|3|||
162632469|NCT01955733|587368975|FG002|Period 2|Withdrawal by Subject|2|||
162632470|NCT01955733|587368973|FG000|Period 2|Study terminated by sponsor|8|||
162632471|NCT01955733|587368974|FG001|Period 2|Study terminated by sponsor|14|||
162632472|NCT01955733|587368975|FG002|Period 2|Study terminated by sponsor|16|||
162979716|NCT00102687|588626856|FG004|Maintenance Period|Adverse Event|3|||
162979717|NCT00102687|588626852|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979718|NCT00102687|588626853|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
162979719|NCT00102687|588626854|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979720|NCT00102687|588626855|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
162979721|NCT00102687|588626856|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
162979722|NCT00102687|588626852|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979723|NCT00102687|588626853|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979724|NCT00102687|588626854|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
162979725|NCT00102687|588626855|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
162979726|NCT00102687|588626856|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
162979727|NCT00102687|588626852|FG000|Maintenance Period|Death|0|||
162979728|NCT00102687|588626853|FG001|Maintenance Period|Death|0|||
162979729|NCT00102687|588626854|FG002|Maintenance Period|Death|0|||
162979730|NCT00102687|588626855|FG003|Maintenance Period|Death|1|||
162979731|NCT00102687|588626856|FG004|Maintenance Period|Death|1|||
162979732|NCT00102687|588626852|FG000|Maintenance Period|Physician Decision|1|||
162979733|NCT00102687|588626853|FG001|Maintenance Period|Physician Decision|2|||
163058945|NCT02867592|588924342|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
163058946|NCT02867592|588924343|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
163058947|NCT02867592|588924344|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
163058948|NCT02867592|588924345|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
163058949|NCT00909870|588924346|FG000|Overall Study|Adverse Event|13|||
163058950|NCT00909870|588924347|FG001|Overall Study|Adverse Event|7|||
163058951|NCT00909870|588924346|FG000|Overall Study|Protocol Violation|1|||
163058952|NCT00909870|588924347|FG001|Overall Study|Protocol Violation|2|||
163058953|NCT00909870|588924346|FG000|Overall Study|Withdrawal by Subject|5|||
163058954|NCT00909870|588924347|FG001|Overall Study|Withdrawal by Subject|8|||
163058955|NCT00909870|588924346|FG000|Overall Study|Lost to Follow-up|3|||
163058956|NCT00909870|588924347|FG001|Overall Study|Lost to Follow-up|3|||
163058957|NCT00909870|588924346|FG000|Overall Study|Physician Decision|0|||
163058958|NCT00909870|588924347|FG001|Overall Study|Physician Decision|2|||
163058959|NCT00909870|588924346|FG000|Overall Study|Other|1|||
163058960|NCT00909870|588924347|FG001|Overall Study|Other|5|||
163058961|NCT01420536|588924358|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
163058962|NCT01420536|588924359|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
163058963|NCT04711005|588924360|FG000|Overall Study|Withdrawal by Subject|0|||
163058964|NCT04711005|588924361|FG001|Overall Study|Withdrawal by Subject|0|||
163058965|NCT04711005|588924362|FG002|Overall Study|Withdrawal by Subject|0|||
163058966|NCT04711005|588924363|FG003|Overall Study|Withdrawal by Subject|0|||
163058967|NCT04711005|588924364|FG004|Overall Study|Withdrawal by Subject|0|||
163058968|NCT04711005|588924365|FG005|Overall Study|Withdrawal by Subject|0|||
163058969|NCT04711005|588924366|FG006|Overall Study|Withdrawal by Subject|0|||
163058970|NCT04711005|588924367|FG007|Overall Study|Withdrawal by Subject|1|||
163058971|NCT04711005|588924368|FG008|Overall Study|Withdrawal by Subject|0|||
163058972|NCT04711005|588924369|FG009|Overall Study|Withdrawal by Subject|0|||
163058973|NCT04711005|588924360|FG000|Overall Study|Physician Decision|0|||
163058974|NCT04711005|588924361|FG001|Overall Study|Physician Decision|0|||
163058975|NCT04711005|588924362|FG002|Overall Study|Physician Decision|0|||
163058976|NCT04711005|588924363|FG003|Overall Study|Physician Decision|0|||
163058977|NCT04711005|588924364|FG004|Overall Study|Physician Decision|0|||
163058978|NCT04711005|588924365|FG005|Overall Study|Physician Decision|0|||
163058979|NCT04711005|588924366|FG006|Overall Study|Physician Decision|0|||
163058980|NCT04711005|588924367|FG007|Overall Study|Physician Decision|2|||
163058981|NCT04711005|588924368|FG008|Overall Study|Physician Decision|1|||
163058982|NCT04711005|588924369|FG009|Overall Study|Physician Decision|0|||
163058983|NCT00764790|588924370|FG000|Overall Study|Protocol Violation|0|||
163058984|NCT00764790|588924371|FG001|Overall Study|Protocol Violation|0|||
163058985|NCT00764790|588924372|FG002|Overall Study|Protocol Violation|1|||
163058986|NCT00764790|588924370|FG000|Overall Study|Withdrawal by Subject|10|||
163058987|NCT00764790|588924371|FG001|Overall Study|Withdrawal by Subject|12|||
163058988|NCT00764790|588924372|FG002|Overall Study|Withdrawal by Subject|6|||
163058989|NCT00764790|588924370|FG000|Overall Study|Lost to Follow-up|28|||
163058990|NCT00764790|588924371|FG001|Overall Study|Lost to Follow-up|29|||
163058991|NCT00764790|588924372|FG002|Overall Study|Lost to Follow-up|23|||
163058992|NCT03191552|588924373|FG000|Overall Study|Lost to Follow-up|1|||
162979734|NCT00102687|588626854|FG002|Maintenance Period|Physician Decision|3|||
162979735|NCT00102687|588626855|FG003|Maintenance Period|Physician Decision|0|||
162979736|NCT00102687|588626856|FG004|Maintenance Period|Physician Decision|4|||
162979737|NCT03253744|588626862|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
163058993|NCT03191552|588924374|FG001|Overall Study|Lost to Follow-up|0|||
163058994|NCT03191552|588924375|FG002|Overall Study|Lost to Follow-up|0|||
162979738|NCT03253744|588626863|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
162979739|NCT03253744|588626864|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
162979740|NCT03253744|588626865|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
162979741|NCT06279871|588626866|FG000|Overall Study|Death|0|||
162979742|NCT06279871|588626867|FG001|Overall Study|Death|0|||
162979743|NCT06279871|588626868|FG002|Overall Study|Death|0|||
162979744|NCT06279871|588626869|FG003|Overall Study|Death|0|||
162979745|NCT06279871|588626870|FG004|Overall Study|Death|0|||
162979746|NCT06279871|588626871|FG005|Overall Study|Death|1|||
162979747|NCT06279871|588626872|FG006|Overall Study|Death|0|||
162979748|NCT06279871|588626866|FG000|Overall Study|Other than Specified|1|||
162979749|NCT06279871|588626867|FG001|Overall Study|Other than Specified|0|||
162979750|NCT06279871|588626868|FG002|Overall Study|Other than Specified|4|||
162979751|NCT06279871|588626869|FG003|Overall Study|Other than Specified|0|||
162979752|NCT06279871|588626870|FG004|Overall Study|Other than Specified|0|||
162979753|NCT06279871|588626871|FG005|Overall Study|Other than Specified|0|||
162979754|NCT06279871|588626872|FG006|Overall Study|Other than Specified|0|||
162979755|NCT06279871|588626866|FG000|Overall Study|Withdrawal by Subject|4|||
162979756|NCT06279871|588626867|FG001|Overall Study|Withdrawal by Subject|8|||
162979757|NCT06279871|588626868|FG002|Overall Study|Withdrawal by Subject|4|||
162632473|NCT01955733|587368973|FG000|Period 2|Lost to Follow-up|2|||
162632474|NCT01955733|587368974|FG001|Period 2|Lost to Follow-up|0|||
162632475|NCT01955733|587368975|FG002|Period 2|Lost to Follow-up|0|||
162714015|NCT01467700|587662656|FG000|Overall Study|Voluntary Withdrawal|5|||
162714016|NCT01467700|587662657|FG001|Overall Study|Voluntary Withdrawal|7|||
162714017|NCT01467700|587662658|FG002|Overall Study|Voluntary Withdrawal|6|||
162714018|NCT01467700|587662659|FG003|Overall Study|Voluntary Withdrawal|2|||
162714019|NCT01467700|587662656|FG000|Overall Study|Study Termination|6|||
162714020|NCT01467700|587662657|FG001|Overall Study|Study Termination|5|||
162714021|NCT01467700|587662658|FG002|Overall Study|Study Termination|10|||
162714022|NCT01467700|587662659|FG003|Overall Study|Study Termination|7|||
162714023|NCT01467700|587662656|FG000|Overall Study|Pregnancy|0|||
162632476|NCT01955733|587368973|FG000|Period 2|Other not defined above|0|||
162632477|NCT01955733|587368974|FG001|Period 2|Other not defined above|2|||
162714024|NCT01467700|587662657|FG001|Overall Study|Pregnancy|1|||
162714025|NCT01467700|587662658|FG002|Overall Study|Pregnancy|1|||
162632478|NCT01955733|587368975|FG002|Period 2|Other not defined above|2|||
162632479|NCT02324569|587368985|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162632480|NCT02324569|587368986|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
162632481|NCT02324569|587368985|FG000|Overall Study|Voluntary Withdrawal|3|||
162632482|NCT02324569|587368986|FG001|Overall Study|Voluntary Withdrawal|6|||
162632483|NCT02324569|587368985|FG000|Overall Study|Lack of Efficacy|2|||
162632484|NCT02324569|587368986|FG001|Overall Study|Lack of Efficacy|3|||
162632485|NCT02324569|587368985|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
162632486|NCT02324569|587368986|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
162632487|NCT02324569|587368985|FG000|Overall Study|Inconvenient Schedule|2|||
162632488|NCT02324569|587368986|FG001|Overall Study|Inconvenient Schedule|0|||
162632489|NCT00793403|587368995|FG000|Overall Study|Other|73|||
162632490|NCT02961751|587369004|FG000|Overall Study|Lost to Follow-up|11|||
162632491|NCT02961751|587369004|FG000|Overall Study|Physician Decision|2|||
162714026|NCT01467700|587662659|FG003|Overall Study|Pregnancy|0|||
162714027|NCT01467700|587662656|FG000|Overall Study|Lack of Efficacy|2|||
162714028|NCT01467700|587662657|FG001|Overall Study|Lack of Efficacy|0|||
162714029|NCT01467700|587662658|FG002|Overall Study|Lack of Efficacy|2|||
162714030|NCT01467700|587662659|FG003|Overall Study|Lack of Efficacy|1|||
162714031|NCT01467700|587662656|FG000|Overall Study|Reason not Specified|1|||
162714032|NCT01467700|587662657|FG001|Overall Study|Reason not Specified|3|||
162714033|NCT01467700|587662658|FG002|Overall Study|Reason not Specified|2|||
162714034|NCT01467700|587662659|FG003|Overall Study|Reason not Specified|8|||
162714035|NCT00121199|587662660|FG000|Overall Study|Adverse Event|11|||
162714036|NCT00121199|587662660|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
162714037|NCT00121199|587662660|FG000|Overall Study|Progression/Relapse|1|||
162714038|NCT00121199|587662660|FG000|Overall Study|Death|3|||
162714039|NCT00121199|587662660|FG000|Overall Study|Other - Not Protocol Specified|3|||
162979758|NCT06279871|588626869|FG003|Overall Study|Withdrawal by Subject|2|||
162979759|NCT06279871|588626870|FG004|Overall Study|Withdrawal by Subject|0|||
162632492|NCT02961751|587369004|FG000|Overall Study|Not Eligible at Enrollment|1|||
162632493|NCT02961751|587369004|FG000|Overall Study|Protocol Violation|1|||
162632494|NCT00842712|587369005|FG000|Safety Run-in Part|Adverse Event|0|||
162632495|NCT00842712|587369006|FG001|Safety Run-in Part|Adverse Event|1|||
162632496|NCT00842712|587369007|FG002|Safety Run-in Part|Adverse Event|0|||
162714040|NCT00121199|587662660|FG000|Overall Study|Ineligible|9|||
162979760|NCT06279871|588626871|FG005|Overall Study|Withdrawal by Subject|0|||
162979761|NCT06279871|588626872|FG006|Overall Study|Withdrawal by Subject|0|||
162979762|NCT06279871|588626866|FG000|Overall Study|Lost to Follow-up|11|||
162979763|NCT06279871|588626867|FG001|Overall Study|Lost to Follow-up|10|||
162979764|NCT06279871|588626868|FG002|Overall Study|Lost to Follow-up|8|||
162714041|NCT03168438|587662661|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
162632497|NCT00842712|587369008|FG003|Safety Run-in Part|Adverse Event|0|||
162632498|NCT00842712|587369009|FG004|Safety Run-in Part|Adverse Event|0|||
162979765|NCT06279871|588626869|FG003|Overall Study|Lost to Follow-up|0|||
162979766|NCT06279871|588626870|FG004|Overall Study|Lost to Follow-up|0|||
162979767|NCT06279871|588626871|FG005|Overall Study|Lost to Follow-up|0|||
162979768|NCT06279871|588626872|FG006|Overall Study|Lost to Follow-up|0|||
162979769|NCT06279871|588626866|FG000|Overall Study|Adverse Event|0|||
162979770|NCT06279871|588626867|FG001|Overall Study|Adverse Event|1|||
162979771|NCT06279871|588626868|FG002|Overall Study|Adverse Event|0|||
162979772|NCT06279871|588626869|FG003|Overall Study|Adverse Event|0|||
162979773|NCT06279871|588626870|FG004|Overall Study|Adverse Event|0|||
162979774|NCT06279871|588626871|FG005|Overall Study|Adverse Event|0|||
162979775|NCT06279871|588626872|FG006|Overall Study|Adverse Event|0|||
162979776|NCT01144403|588626878|FG000|Overall Study|Lost to Follow-up|3|||
162979777|NCT01144403|588626878|FG000|Overall Study|Death|1|||
162979778|NCT01144403|588626878|FG000|Overall Study|Adverse Event|1|||
162979779|NCT02339740|588626881|FG000|Overall Study|Death|1|||
162979780|NCT02339740|588626882|FG001|Overall Study|Death|0|||
162979781|NCT02339740|588626881|FG000|Overall Study|Physician Decision|0|||
162979782|NCT02339740|588626882|FG001|Overall Study|Physician Decision|2|||
162979783|NCT02339740|588626881|FG000|Overall Study|Withdrawal by Subject|5|||
162979784|NCT02339740|588626882|FG001|Overall Study|Withdrawal by Subject|1|||
162979785|NCT02339740|588626881|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
162979786|NCT02339740|588626882|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
162979787|NCT01807117|588626883|FG000|Overall Study|Physician Decision|2|||
162979788|NCT01807117|588626883|FG000|Overall Study|Disease diagnosis not a study disease|1|||
162979789|NCT02777918|588626889|FG000|Overall Study|Medical reasons|1|||
162979790|NCT02777918|588626890|FG001|Overall Study|Medical reasons|2|||
162979791|NCT02777918|588626889|FG000|Overall Study|Too busy / stressed|1|||
162979792|NCT02777918|588626890|FG001|Overall Study|Too busy / stressed|1|||
162979793|NCT02777918|588626889|FG000|Overall Study|Withdrawal by Subject|1|||
162979794|NCT02777918|588626890|FG001|Overall Study|Withdrawal by Subject|1|||
162979795|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
162979796|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
162979797|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
162979798|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
162979799|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
162979800|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
162979801|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
162979802|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
162979803|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
162979804|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
162979805|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
162979806|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
162979807|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
162979808|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
162979809|NCT02510014|588626894|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
162979810|NCT02510014|588626895|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
162979811|NCT02510014|588626894|FG000|Treatment Period|Adverse Event|11|||
162979812|NCT02510014|588626895|FG001|Treatment Period|Adverse Event|4|||
162979813|NCT02510014|588626894|FG000|Treatment Period|Withdrawal symptoms|3|||
162979814|NCT02510014|588626895|FG001|Treatment Period|Withdrawal symptoms|0|||
162979815|NCT02510014|588626894|FG000|Treatment Period|Lost to Follow-up|80|||
162979816|NCT02510014|588626895|FG001|Treatment Period|Lost to Follow-up|19|||
162979817|NCT02510014|588626894|FG000|Treatment Period|Physician Decision|5|||
162979818|NCT02510014|588626895|FG001|Treatment Period|Physician Decision|0|||
162979819|NCT02510014|588626894|FG000|Treatment Period|Withdrawal by Subject|67|||
162979820|NCT02510014|588626895|FG001|Treatment Period|Withdrawal by Subject|24|||
162979821|NCT02510014|588626894|FG000|Treatment Period|Withdrawn by the investigator|7|||
162979822|NCT02510014|588626895|FG001|Treatment Period|Withdrawn by the investigator|1|||
162632499|NCT00842712|587369010|FG005|Safety Run-in Part|Adverse Event|0|||
162632500|NCT00842712|587369011|FG006|Safety Run-in Part|Adverse Event|0|||
162632501|NCT00842712|587369005|FG000|Safety Run-in Part|Progressive disease|3|||
162979823|NCT02510014|588626894|FG000|Treatment Period|Protocol Violation|4|||
162979824|NCT02510014|588626895|FG001|Treatment Period|Protocol Violation|4|||
162632502|NCT00842712|587369006|FG001|Safety Run-in Part|Progressive disease|1|||
162632503|NCT00842712|587369007|FG002|Safety Run-in Part|Progressive disease|0|||
162632504|NCT00842712|587369008|FG003|Safety Run-in Part|Progressive disease|1|||
162632505|NCT00842712|587369009|FG004|Safety Run-in Part|Progressive disease|0|||
162979825|NCT02510014|588626894|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
162979826|NCT02510014|588626895|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
162979827|NCT01949116|588626897|FG000|Overall Study|Death|2|||
162979828|NCT01949116|588626898|FG001|Overall Study|Death|0|||
162979829|NCT01949116|588626897|FG000|Overall Study|Lost to Follow-up|1|||
162979830|NCT01949116|588626898|FG001|Overall Study|Lost to Follow-up|3|||
162979831|NCT01949116|588626897|FG000|Overall Study|Withdrawal by Subject|5|||
163058995|NCT03191552|588924373|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
162979832|NCT01949116|588626898|FG001|Overall Study|Withdrawal by Subject|3|||
162979833|NCT01855048|588626909|FG000|Overall Study|Withdrawal by Subject|0|||
162979834|NCT01855048|588626910|FG001|Overall Study|Withdrawal by Subject|1|||
162979835|NCT01855048|588626911|FG002|Overall Study|Withdrawal by Subject|0|||
162979836|NCT01855048|588626912|FG003|Overall Study|Withdrawal by Subject|0|||
162979837|NCT01855048|588626913|FG004|Overall Study|Withdrawal by Subject|1|||
162979838|NCT01855048|588626914|FG005|Overall Study|Withdrawal by Subject|0|||
162979839|NCT02972502|588626919|FG000|Overall Study|Lost to Follow-up|3|||
162979840|NCT02972502|588626920|FG001|Overall Study|Lost to Follow-up|1|||
162979841|NCT02972502|588626919|FG000|Overall Study|Withdrawal by Subject|1|||
162979842|NCT02972502|588626920|FG001|Overall Study|Withdrawal by Subject|1|||
162979843|NCT03832738|588626921|FG000|Overall Study|Withdrawal by Subject|6|||
162979844|NCT03832738|588626922|FG001|Overall Study|Withdrawal by Subject|7|||
162979845|NCT03832738|588626923|FG002|Overall Study|Withdrawal by Subject|16|||
162979846|NCT03832738|588626921|FG000|Overall Study|Physician Decision|0|||
162979847|NCT03832738|588626922|FG001|Overall Study|Physician Decision|1|||
162979848|NCT03832738|588626923|FG002|Overall Study|Physician Decision|2|||
162979849|NCT03832738|588626921|FG000|Overall Study|Adverse Event|2|||
162979850|NCT03832738|588626922|FG001|Overall Study|Adverse Event|3|||
162979851|NCT03832738|588626923|FG002|Overall Study|Adverse Event|1|||
162979852|NCT03832738|588626921|FG000|Overall Study|Pregnancy|0|||
162979853|NCT03832738|588626922|FG001|Overall Study|Pregnancy|1|||
162979854|NCT03832738|588626923|FG002|Overall Study|Pregnancy|0|||
162979855|NCT03852459|588626924|FG000|Overall Study|Adverse Event|2|||
162979856|NCT03852459|588626925|FG001|Overall Study|Adverse Event|2|||
162979857|NCT03852459|588626924|FG000|Overall Study|Withdrawal by Subject|1|||
162979858|NCT03852459|588626925|FG001|Overall Study|Withdrawal by Subject|1|||
162979859|NCT00049842|588626926|FG000|Treatment Phase|Adverse Event|47|||
162979860|NCT00049842|588626927|FG001|Treatment Phase|Adverse Event|12|||
162979861|NCT00049842|588626926|FG000|Treatment Phase|Withdrawal by Subject|35|||
162979862|NCT00049842|588626927|FG001|Treatment Phase|Withdrawal by Subject|46|||
162979863|NCT00049842|588626926|FG000|Treatment Phase|Non-compliance with protocol|7|||
162979864|NCT00049842|588626927|FG001|Treatment Phase|Non-compliance with protocol|8|||
162979865|NCT00049842|588626926|FG000|Treatment Phase|Lost to Follow-up|4|||
162979866|NCT00049842|588626927|FG001|Treatment Phase|Lost to Follow-up|8|||
162979867|NCT00049842|588626926|FG000|Treatment Phase|Administrative|0|||
162979868|NCT00049842|588626927|FG001|Treatment Phase|Administrative|3|||
162979869|NCT00049842|588626926|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
162979870|NCT00049842|588626927|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
162979871|NCT00049842|588626926|FG000|Follow-up Phase|Adverse Event|6|||
162979872|NCT00049842|588626927|FG001|Follow-up Phase|Adverse Event|1|||
162979873|NCT00049842|588626926|FG000|Follow-up Phase|Other|1|||
162979874|NCT00049842|588626927|FG001|Follow-up Phase|Other|4|||
162979875|NCT05486065|588626929|FG000|Overall Study|Withdrawal by Subject|1|||
162979876|NCT05486065|588626930|FG001|Overall Study|Withdrawal by Subject|5|||
162979877|NCT05486065|588626931|FG002|Overall Study|Withdrawal by Subject|4|||
162979878|NCT05486065|588626932|FG003|Overall Study|Withdrawal by Subject|3|||
162979879|NCT05486065|588626929|FG000|Overall Study|Lost to Follow-up|4|||
162979880|NCT05486065|588626930|FG001|Overall Study|Lost to Follow-up|2|||
162979881|NCT05486065|588626931|FG002|Overall Study|Lost to Follow-up|2|||
162979882|NCT05486065|588626932|FG003|Overall Study|Lost to Follow-up|2|||
162979883|NCT05486065|588626929|FG000|Overall Study|Physician Decision|0|||
162979884|NCT05486065|588626930|FG001|Overall Study|Physician Decision|1|||
162979885|NCT05486065|588626931|FG002|Overall Study|Physician Decision|1|||
162979886|NCT05486065|588626932|FG003|Overall Study|Physician Decision|0|||
162979887|NCT05486065|588626929|FG000|Overall Study|Failure to meet randomization criteria|0|||
162979888|NCT05486065|588626930|FG001|Overall Study|Failure to meet randomization criteria|0|||
162979889|NCT05486065|588626931|FG002|Overall Study|Failure to meet randomization criteria|0|||
162979890|NCT05486065|588626932|FG003|Overall Study|Failure to meet randomization criteria|1|||
162979891|NCT00307931|588626933|FG000|Overall Study|Adverse Event|1|||
162979892|NCT00493246|588629161|FG000|Overall Study|Withdrawal by Subject|0|||
162979893|NCT00493246|588629162|FG001|Overall Study|Withdrawal by Subject|0|||
162979894|NCT00493246|588629163|FG002|Overall Study|Withdrawal by Subject|0|||
162979895|NCT00493246|588629164|FG003|Overall Study|Withdrawal by Subject|0|||
162979896|NCT00493246|588629165|FG004|Overall Study|Withdrawal by Subject|1|||
162979897|NCT00493246|588629166|FG005|Overall Study|Withdrawal by Subject|0|||
162979898|NCT00493246|588629167|FG006|Overall Study|Withdrawal by Subject|0|||
162979899|NCT00493246|588629168|FG007|Overall Study|Withdrawal by Subject|0|||
162979900|NCT00493246|588629161|FG000|Overall Study|No access to draw blood|0|||
162979901|NCT00493246|588629162|FG001|Overall Study|No access to draw blood|0|||
162979902|NCT00493246|588629163|FG002|Overall Study|No access to draw blood|0|||
162979903|NCT00493246|588629164|FG003|Overall Study|No access to draw blood|0|||
162979904|NCT00493246|588629165|FG004|Overall Study|No access to draw blood|0|||
162632506|NCT00842712|587369010|FG005|Safety Run-in Part|Progressive disease|0|||
162632507|NCT00842712|587369011|FG006|Safety Run-in Part|Progressive disease|0|||
162632508|NCT00842712|587369005|FG000|Randomized Part|Randomized but not treated|0|||
162632509|NCT00842712|587369006|FG001|Randomized Part|Randomized but not treated|0|||
162632510|NCT00842712|587369007|FG002|Randomized Part|Randomized but not treated|0|||
162632511|NCT00842712|587369008|FG003|Randomized Part|Randomized but not treated|0|||
162632512|NCT00842712|587369009|FG004|Randomized Part|Randomized but not treated|0|||
162979905|NCT00493246|588629166|FG005|Overall Study|No access to draw blood|1|||
162979906|NCT00493246|588629167|FG006|Overall Study|No access to draw blood|0|||
162979907|NCT00493246|588629168|FG007|Overall Study|No access to draw blood|0|||
162979908|NCT00493246|588629161|FG000|Overall Study|Lost to Follow-up|0|||
162979909|NCT00493246|588629162|FG001|Overall Study|Lost to Follow-up|0|||
162979910|NCT00493246|588629163|FG002|Overall Study|Lost to Follow-up|0|||
162979911|NCT00493246|588629164|FG003|Overall Study|Lost to Follow-up|0|||
162979912|NCT00493246|588629165|FG004|Overall Study|Lost to Follow-up|0|||
162979913|NCT00493246|588629166|FG005|Overall Study|Lost to Follow-up|0|||
162979914|NCT00493246|588629167|FG006|Overall Study|Lost to Follow-up|1|||
162979915|NCT00493246|588629168|FG007|Overall Study|Lost to Follow-up|0|||
162979916|NCT00595335|588629169|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
162979917|NCT00595335|588629170|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
162979918|NCT00595335|588629169|FG000|Baseline to Six Months|Disease Progression|1|||
162979919|NCT00595335|588629170|FG001|Baseline to Six Months|Disease Progression|1|||
162979920|NCT00595335|588629169|FG000|Baseline to Six Months|Adverse Event|1|||
162979921|NCT00595335|588629170|FG001|Baseline to Six Months|Adverse Event|0|||
162979922|NCT00595335|588629169|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
162979923|NCT00595335|588629170|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
162979924|NCT00595335|588629169|FG000|Six Months to Twelve Months|Disease Progression|1|||
162979925|NCT00595335|588629170|FG001|Six Months to Twelve Months|Disease Progression|0|||
162979926|NCT01013649|588629175|FG000|First Step|Withdrawal by Subject|36|||
162979927|NCT01013649|588629176|FG001|First Step|Withdrawal by Subject|19|||
162979928|NCT01013649|588629177|FG002|First Step|Withdrawal by Subject|0|||
162979929|NCT01013649|588629178|FG003|First Step|Withdrawal by Subject|0|||
162979930|NCT01013649|588629175|FG000|First Step|Progression|58|||
162979931|NCT01013649|588629176|FG001|First Step|Progression|23|||
162979932|NCT01013649|588629177|FG002|First Step|Progression|0|||
162979933|NCT01013649|588629178|FG003|First Step|Progression|0|||
162979934|NCT01013649|588629175|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
162979935|NCT01013649|588629176|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
162979936|NCT01013649|588629177|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
162979937|NCT01013649|588629178|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
162979938|NCT01013649|588629175|FG000|First Step|Death|3|||
162979939|NCT01013649|588629176|FG001|First Step|Death|4|||
162979940|NCT01013649|588629177|FG002|First Step|Death|0|||
162979941|NCT01013649|588629178|FG003|First Step|Death|0|||
162979942|NCT01013649|588629175|FG000|First Step|Adverse Event|9|||
162979943|NCT01013649|588629176|FG001|First Step|Adverse Event|5|||
162979944|NCT01013649|588629177|FG002|First Step|Adverse Event|0|||
162979945|NCT01013649|588629178|FG003|First Step|Adverse Event|0|||
162979946|NCT01013649|588629175|FG000|First Step|Other|4|||
162979947|NCT01013649|588629176|FG001|First Step|Other|6|||
162979948|NCT01013649|588629177|FG002|First Step|Other|0|||
162979949|NCT01013649|588629178|FG003|First Step|Other|0|||
162979950|NCT01647958|588629179|FG000|Initial Study|Lost to Follow-up|2|||
162979951|NCT01647958|588629180|FG001|Initial Study|Lost to Follow-up|3|||
162979952|NCT01647958|588629179|FG000|Continuation Phase|treatment received during Overall Study|39|||
162979953|NCT01647958|588629180|FG001|Continuation Phase|treatment received during Overall Study|0|||
162632513|NCT00842712|587369010|FG005|Randomized Part|Randomized but not treated|1|||
162632514|NCT00842712|587369011|FG006|Randomized Part|Randomized but not treated|4|||
162632515|NCT00842712|587369005|FG000|Randomized Part|Ongoing at cut-off date|0|||
162632516|NCT00842712|587369006|FG001|Randomized Part|Ongoing at cut-off date|0|||
162979954|NCT01647958|588629179|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
162979955|NCT01647958|588629180|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
162979956|NCT01131299|588629181|FG000|Overall Study|Withdrawal by Subject|4|||
162979957|NCT01131299|588629182|FG001|Overall Study|Withdrawal by Subject|7|||
163058996|NCT03191552|588924374|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
163058997|NCT03191552|588924375|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
162979958|NCT01207440|588629190|FG000|Overall Study|Adverse Event|46|||
162979959|NCT01207440|588629191|FG001|Overall Study|Adverse Event|11|||
162979960|NCT01207440|588629192|FG002|Overall Study|Adverse Event|7|||
162979961|NCT01207440|588629193|FG003|Overall Study|Adverse Event|2|||
162979962|NCT01207440|588629194|FG004|Overall Study|Adverse Event|6|||
162979963|NCT01207440|588629195|FG005|Overall Study|Adverse Event|6|||
162632517|NCT00842712|587369007|FG002|Randomized Part|Ongoing at cut-off date|0|||
162979964|NCT01207440|588629196|FG006|Overall Study|Adverse Event|2|||
162979965|NCT01207440|588629190|FG000|Overall Study|Death|6|||
163058998|NCT05965752|588924377|FG000|Overall Study|Adverse Event|0|||
162979966|NCT01207440|588629191|FG001|Overall Study|Death|3|||
162979967|NCT01207440|588629192|FG002|Overall Study|Death|2|||
162979968|NCT01207440|588629193|FG003|Overall Study|Death|2|||
162979969|NCT01207440|588629194|FG004|Overall Study|Death|7|||
162979970|NCT01207440|588629195|FG005|Overall Study|Death|5|||
162979971|NCT01207440|588629196|FG006|Overall Study|Death|1|||
162979972|NCT01207440|588629190|FG000|Overall Study|Lack of Efficacy|13|||
162632518|NCT00842712|587369008|FG003|Randomized Part|Ongoing at cut-off date|0|||
162632519|NCT00842712|587369009|FG004|Randomized Part|Ongoing at cut-off date|0|||
162632520|NCT00842712|587369010|FG005|Randomized Part|Ongoing at cut-off date|0|||
162632521|NCT00842712|587369011|FG006|Randomized Part|Ongoing at cut-off date|2|||
162632522|NCT01384760|587369018|FG000|Overall Study|Lost to Follow-up|0|||
162632523|NCT01384760|587369019|FG001|Overall Study|Lost to Follow-up|6|||
162632524|NCT01384760|587369018|FG000|Overall Study|Protocol Violation|16|||
162632525|NCT01384760|587369019|FG001|Overall Study|Protocol Violation|0|||
162632526|NCT00309387|587369030|FG000|Overall Study|Death|72|||
162632527|NCT00309387|587369031|FG001|Overall Study|Death|73|||
162632528|NCT00309387|587369030|FG000|Overall Study|Lost to Follow-up|70|||
162632529|NCT00309387|587369031|FG001|Overall Study|Lost to Follow-up|86|||
162632530|NCT02899988|587369034|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
162632531|NCT02899988|587369035|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
162632532|NCT02899988|587369036|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632533|NCT02899988|587369037|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632534|NCT02899988|587369038|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632535|NCT02899988|587369039|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632536|NCT02899988|587369040|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632537|NCT02899988|587369041|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632538|NCT02899988|587369042|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632539|NCT02899988|587369043|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632540|NCT02899988|587369044|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162632541|NCT02899988|587369034|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
162632542|NCT02899988|587369035|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
162632543|NCT02899988|587369036|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
162632544|NCT02899988|587369037|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
162632545|NCT02899988|587369038|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
162632546|NCT02899988|587369039|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
162632547|NCT02899988|587369040|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
162632548|NCT02899988|587369041|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
162632549|NCT02899988|587369042|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
162632550|NCT02899988|587369043|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
162632551|NCT02899988|587369044|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
162714042|NCT03168438|587662662|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
162714043|NCT04109118|587662665|FG000|Overall Study|Lost to Follow-up|3|||
162979973|NCT01207440|588629191|FG001|Overall Study|Lack of Efficacy|2|||
162979974|NCT01207440|588629192|FG002|Overall Study|Lack of Efficacy|5|||
162979975|NCT01207440|588629193|FG003|Overall Study|Lack of Efficacy|1|||
162979976|NCT01207440|588629194|FG004|Overall Study|Lack of Efficacy|2|||
162979977|NCT01207440|588629195|FG005|Overall Study|Lack of Efficacy|3|||
162979978|NCT01207440|588629196|FG006|Overall Study|Lack of Efficacy|0|||
162979979|NCT01207440|588629190|FG000|Overall Study|Lost to Follow-up|0|||
162979980|NCT01207440|588629191|FG001|Overall Study|Lost to Follow-up|0|||
162979981|NCT01207440|588629192|FG002|Overall Study|Lost to Follow-up|2|||
162979982|NCT01207440|588629193|FG003|Overall Study|Lost to Follow-up|1|||
162979983|NCT01207440|588629194|FG004|Overall Study|Lost to Follow-up|0|||
162979984|NCT01207440|588629195|FG005|Overall Study|Lost to Follow-up|0|||
162979985|NCT01207440|588629196|FG006|Overall Study|Lost to Follow-up|0|||
162979986|NCT01207440|588629190|FG000|Overall Study|Non-compliance with Study Drug|3|||
162979987|NCT01207440|588629191|FG001|Overall Study|Non-compliance with Study Drug|0|||
162979988|NCT01207440|588629192|FG002|Overall Study|Non-compliance with Study Drug|1|||
162979989|NCT01207440|588629193|FG003|Overall Study|Non-compliance with Study Drug|0|||
162979990|NCT01207440|588629194|FG004|Overall Study|Non-compliance with Study Drug|0|||
162979991|NCT01207440|588629195|FG005|Overall Study|Non-compliance with Study Drug|0|||
162714044|NCT03235349|587662668|FG000|Overall Study|Adverse Event|1|||
162714045|NCT03235349|587662668|FG000|Overall Study|Other|1|||
162979992|NCT01207440|588629196|FG006|Overall Study|Non-compliance with Study Drug|0|||
162979993|NCT01207440|588629190|FG000|Overall Study|Physician Decision|6|||
162714046|NCT03394027|587662669|FG000|Overall Study|Ineligible|3|||
162979994|NCT01207440|588629191|FG001|Overall Study|Physician Decision|5|||
162979995|NCT01207440|588629192|FG002|Overall Study|Physician Decision|5|||
162979996|NCT01207440|588629193|FG003|Overall Study|Physician Decision|0|||
162979997|NCT01207440|588629194|FG004|Overall Study|Physician Decision|1|||
163058999|NCT05965752|588924378|FG001|Overall Study|Adverse Event|1|||
162632552|NCT02899988|587369034|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
162632553|NCT02899988|587369035|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
162632554|NCT02899988|587369036|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
162632555|NCT02899988|587369037|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
162714047|NCT03394027|587662670|FG001|Overall Study|Ineligible|1|||
162979998|NCT01207440|588629195|FG005|Overall Study|Physician Decision|0|||
162979999|NCT01207440|588629196|FG006|Overall Study|Physician Decision|0|||
162980000|NCT01207440|588629190|FG000|Overall Study|Progressive Disease|19|||
162980001|NCT01207440|588629191|FG001|Overall Study|Progressive Disease|10|||
162980002|NCT01207440|588629192|FG002|Overall Study|Progressive Disease|19|||
162980003|NCT01207440|588629193|FG003|Overall Study|Progressive Disease|7|||
162980004|NCT01207440|588629194|FG004|Overall Study|Progressive Disease|23|||
162980005|NCT01207440|588629195|FG005|Overall Study|Progressive Disease|27|||
162980006|NCT01207440|588629196|FG006|Overall Study|Progressive Disease|0|||
162980007|NCT01207440|588629190|FG000|Overall Study|Protocol Violation|2|||
162980008|NCT01207440|588629191|FG001|Overall Study|Protocol Violation|0|||
162980009|NCT01207440|588629192|FG002|Overall Study|Protocol Violation|0|||
162980010|NCT01207440|588629193|FG003|Overall Study|Protocol Violation|0|||
162980011|NCT01207440|588629194|FG004|Overall Study|Protocol Violation|0|||
162980012|NCT01207440|588629195|FG005|Overall Study|Protocol Violation|0|||
162980013|NCT01207440|588629196|FG006|Overall Study|Protocol Violation|0|||
162980014|NCT01207440|588629190|FG000|Overall Study|Site Terminated by Sponsor|69|||
162980015|NCT01207440|588629191|FG001|Overall Study|Site Terminated by Sponsor|19|||
162980016|NCT01207440|588629192|FG002|Overall Study|Site Terminated by Sponsor|12|||
162980017|NCT01207440|588629193|FG003|Overall Study|Site Terminated by Sponsor|2|||
162980018|NCT01207440|588629194|FG004|Overall Study|Site Terminated by Sponsor|3|||
162632556|NCT02899988|587369038|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
162632557|NCT02899988|587369039|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
162632558|NCT02899988|587369040|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
162632559|NCT02899988|587369041|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
162632560|NCT02899988|587369042|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
162632561|NCT02899988|587369043|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
162632562|NCT02899988|587369044|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
162632563|NCT02899988|587369034|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
162632564|NCT02899988|587369035|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
162632565|NCT02899988|587369036|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
162632566|NCT02899988|587369037|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
162632567|NCT02899988|587369038|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
162632568|NCT02899988|587369039|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
162632569|NCT02899988|587369040|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
162632570|NCT02899988|587369041|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
162632571|NCT02899988|587369042|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
162632572|NCT02899988|587369043|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
162632573|NCT02899988|587369044|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
162632574|NCT02899988|587369034|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632575|NCT02899988|587369035|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632576|NCT02899988|587369036|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632577|NCT02899988|587369037|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632578|NCT02899988|587369038|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632579|NCT02899988|587369039|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
162632580|NCT02899988|587369040|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632581|NCT02899988|587369041|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
162632582|NCT02899988|587369042|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632583|NCT02899988|587369043|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632584|NCT02899988|587369044|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162632585|NCT02899988|587369034|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162632586|NCT02899988|587369035|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162632587|NCT02899988|587369036|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162632588|NCT02899988|587369037|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162632589|NCT02899988|587369038|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
162632590|NCT02899988|587369039|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162632591|NCT02899988|587369040|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
162980019|NCT01207440|588629195|FG005|Overall Study|Site Terminated by Sponsor|0|||
162980020|NCT01207440|588629196|FG006|Overall Study|Site Terminated by Sponsor|2|||
162980021|NCT01207440|588629190|FG000|Overall Study|Withdrawal by Subject|29|||
162980022|NCT01207440|588629191|FG001|Overall Study|Withdrawal by Subject|4|||
162980023|NCT01207440|588629192|FG002|Overall Study|Withdrawal by Subject|5|||
162980024|NCT01207440|588629193|FG003|Overall Study|Withdrawal by Subject|3|||
162980025|NCT01207440|588629194|FG004|Overall Study|Withdrawal by Subject|2|||
163059000|NCT05965752|588924379|FG002|Overall Study|Adverse Event|0|||
163059001|NCT05965752|588924380|FG003|Overall Study|Adverse Event|1|||
162632592|NCT02899988|587369041|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
162632593|NCT02899988|587369042|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
162632594|NCT02899988|587369043|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162714048|NCT03394027|587662671|FG002|Overall Study|Ineligible|3|||
162980026|NCT01207440|588629195|FG005|Overall Study|Withdrawal by Subject|2|||
162980027|NCT01207440|588629196|FG006|Overall Study|Withdrawal by Subject|0|||
162980028|NCT01207440|588629190|FG000|Overall Study|Reason Not Specified|10|||
162980029|NCT01207440|588629191|FG001|Overall Study|Reason Not Specified|10|||
162980030|NCT01207440|588629192|FG002|Overall Study|Reason Not Specified|7|||
162980031|NCT01207440|588629193|FG003|Overall Study|Reason Not Specified|0|||
162980032|NCT01207440|588629194|FG004|Overall Study|Reason Not Specified|4|||
162980033|NCT01207440|588629195|FG005|Overall Study|Reason Not Specified|3|||
162980034|NCT01207440|588629196|FG006|Overall Study|Reason Not Specified|0|||
162632595|NCT02899988|587369044|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
162632596|NCT02041286|587369045|FG000|Overall Study|Adverse Event|1|||
162632597|NCT03138889|587369053|FG000|Overall Study|Withdrawal by Subject|5|||
162632598|NCT03138889|587369054|FG001|Overall Study|Withdrawal by Subject|5|||
162632599|NCT03138889|587369055|FG002|Overall Study|Withdrawal by Subject|0|||
162632600|NCT03138889|587369056|FG003|Overall Study|Withdrawal by Subject|2|||
162632601|NCT03138889|587369057|FG004|Overall Study|Withdrawal by Subject|1|||
162632602|NCT03138889|587369058|FG005|Overall Study|Withdrawal by Subject|3|||
162632603|NCT03138889|587369059|FG006|Overall Study|Withdrawal by Subject|0|||
162632604|NCT03138889|587369060|FG007|Overall Study|Withdrawal by Subject|1|||
162632605|NCT00085631|587369061|FG000|Overall Study|Missing Data|4|||
162632606|NCT00085631|587369062|FG001|Overall Study|Missing Data|11|||
162632607|NCT00085631|587369063|FG002|Overall Study|Missing Data|7|||
162632608|NCT00411645|587369064|FG000|Overall Study|Consent Withdrawn|13|||
162632609|NCT00411645|587369065|FG001|Overall Study|Consent Withdrawn|22|||
162632610|NCT00411645|587369064|FG000|Overall Study|Death|56|||
162632611|NCT00411645|587369065|FG001|Overall Study|Death|135|||
162632612|NCT00411645|587369064|FG000|Overall Study|Investigator/Sponsor Decision|10|||
162632613|NCT00411645|587369065|FG001|Overall Study|Investigator/Sponsor Decision|7|||
162632614|NCT00411645|587369064|FG000|Overall Study|Lost to Follow-up|2|||
162632615|NCT00411645|587369065|FG001|Overall Study|Lost to Follow-up|0|||
162632616|NCT01349790|587369066|FG000|Overall Study|Investigator Judgement|3|||
162632617|NCT01349790|587369066|FG000|Overall Study|Death|2|||
162632618|NCT01349790|587369066|FG000|Overall Study|Withdrawal by Patient|2|||
162632619|NCT01349790|587369066|FG000|Overall Study|Adverse Event|1|||
162632620|NCT01349790|587369066|FG000|Overall Study|Lost to Follow-up|1|||
162632621|NCT02289690|587369067|FG000|Overall Study|Adverse Event Related to Progression|0|||
162632622|NCT02289690|587369068|FG001|Overall Study|Adverse Event Related to Progression|1|||
162632623|NCT02289690|587369069|FG002|Overall Study|Adverse Event Related to Progression|1|||
162632624|NCT02289690|587369070|FG003|Overall Study|Adverse Event Related to Progression|0|||
162632625|NCT02289690|587369071|FG004|Overall Study|Adverse Event Related to Progression|1|||
162632626|NCT02289690|587369072|FG005|Overall Study|Adverse Event Related to Progression|0|||
162632627|NCT02289690|587369073|FG006|Overall Study|Adverse Event Related to Progression|1|||
162632628|NCT02289690|587369074|FG007|Overall Study|Adverse Event Related to Progression|0|||
162632629|NCT02289690|587369075|FG008|Overall Study|Adverse Event Related to Progression|0|||
162632630|NCT02289690|587369076|FG009|Overall Study|Adverse Event Related to Progression|0|||
162632631|NCT02289690|587369067|FG000|Overall Study|Withdrawal by Subject|1|||
162632632|NCT02289690|587369068|FG001|Overall Study|Withdrawal by Subject|0|||
162632633|NCT02289690|587369069|FG002|Overall Study|Withdrawal by Subject|0|||
162632634|NCT02289690|587369070|FG003|Overall Study|Withdrawal by Subject|0|||
162632635|NCT02289690|587369071|FG004|Overall Study|Withdrawal by Subject|1|||
162632636|NCT02289690|587369072|FG005|Overall Study|Withdrawal by Subject|1|||
162632637|NCT02289690|587369073|FG006|Overall Study|Withdrawal by Subject|0|||
162632638|NCT02289690|587369074|FG007|Overall Study|Withdrawal by Subject|0|||
162632639|NCT02289690|587369075|FG008|Overall Study|Withdrawal by Subject|4|||
162632640|NCT02289690|587369076|FG009|Overall Study|Withdrawal by Subject|2|||
162632641|NCT02289690|587369067|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
162632642|NCT02289690|587369068|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
162632643|NCT02289690|587369069|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
162632644|NCT02289690|587369070|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
162632645|NCT02289690|587369071|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
162632646|NCT02289690|587369072|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
162632647|NCT02289690|587369073|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
162632648|NCT02289690|587369074|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
162632649|NCT02289690|587369075|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
162632650|NCT02289690|587369076|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
162632651|NCT02289690|587369067|FG000|Overall Study|Lost to Follow-up|0|||
162632652|NCT02289690|587369068|FG001|Overall Study|Lost to Follow-up|0|||
162632653|NCT02289690|587369069|FG002|Overall Study|Lost to Follow-up|0|||
162632654|NCT02289690|587369070|FG003|Overall Study|Lost to Follow-up|0|||
162632655|NCT02289690|587369071|FG004|Overall Study|Lost to Follow-up|0|||
162736235|NCT03699709|587744922|FG000|Overall Study|Withdrawal by Subject|5|||
162632656|NCT02289690|587369072|FG005|Overall Study|Lost to Follow-up|0|||
162632657|NCT02289690|587369073|FG006|Overall Study|Lost to Follow-up|0|||
162632658|NCT02289690|587369074|FG007|Overall Study|Lost to Follow-up|1|||
162632659|NCT02289690|587369075|FG008|Overall Study|Lost to Follow-up|0|||
162632660|NCT02289690|587369076|FG009|Overall Study|Lost to Follow-up|2|||
162632661|NCT02289690|587369067|FG000|Overall Study|Death|0|||
162980035|NCT01592721|588629197|FG000|Long-term Follow-up|Death|1|||
162980036|NCT01408563|588629200|FG000|Overall Study|Ineligible after consent/ registration|2|||
162980037|NCT02119286|588629205|FG000|Overall Study|Adverse Event|9|||
162980038|NCT02119286|588629206|FG001|Overall Study|Adverse Event|7|||
162980039|NCT02119286|588629207|FG002|Overall Study|Adverse Event|2|||
162980040|NCT02119286|588629205|FG000|Overall Study|Lack of Efficacy|11|||
162980041|NCT02119286|588629206|FG001|Overall Study|Lack of Efficacy|3|||
162980042|NCT02119286|588629207|FG002|Overall Study|Lack of Efficacy|4|||
162980043|NCT02119286|588629205|FG000|Overall Study|Lost to Follow-up|2|||
162980044|NCT02119286|588629206|FG001|Overall Study|Lost to Follow-up|0|||
162980045|NCT02119286|588629207|FG002|Overall Study|Lost to Follow-up|1|||
162980046|NCT02119286|588629205|FG000|Overall Study|Withdrawal by Subject|4|||
162980047|NCT02119286|588629206|FG001|Overall Study|Withdrawal by Subject|1|||
162980048|NCT02119286|588629207|FG002|Overall Study|Withdrawal by Subject|0|||
162980049|NCT04109313|588629208|FG000|Overall Study|Pregnancy|1|||
162980050|NCT04109313|588629208|FG000|Overall Study|Adverse Event|11|||
162980051|NCT04109313|588629208|FG000|Overall Study|Lack of Efficacy|11|||
162980052|NCT04109313|588629208|FG000|Overall Study|Lost to Follow-up|1|||
162980053|NCT04109313|588629208|FG000|Overall Study|Physician Decision|2|||
162980054|NCT04109313|588629208|FG000|Overall Study|Subject Decision|13|||
162980055|NCT04109313|588629208|FG000|Overall Study|Covid-19 situation|2|||
162980056|NCT01272921|588629209|FG000|Overall Study|Protocol Violation|2|||
162980057|NCT01272921|588629210|FG001|Overall Study|Protocol Violation|1|||
162980058|NCT01132664|588629211|FG000|Phase lb|Adverse Event|0|||
162980059|NCT01132664|588629212|FG001|Phase lb|Adverse Event|1|||
162980060|NCT01132664|588629213|FG002|Phase lb|Adverse Event|0|||
162980061|NCT01132664|588629214|FG003|Phase lb|Adverse Event|0|||
162980062|NCT01132664|588629215|FG004|Phase lb|Adverse Event|0|||
162980063|NCT01132664|588629211|FG000|Phase lb|Withdrawal by Subject|1|||
162980064|NCT01132664|588629212|FG001|Phase lb|Withdrawal by Subject|2|||
162980065|NCT01132664|588629213|FG002|Phase lb|Withdrawal by Subject|0|||
162980066|NCT01132664|588629214|FG003|Phase lb|Withdrawal by Subject|0|||
162980067|NCT01132664|588629215|FG004|Phase lb|Withdrawal by Subject|0|||
162980068|NCT01132664|588629211|FG000|Phase lb|Disease Progression|4|||
162980069|NCT01132664|588629212|FG001|Phase lb|Disease Progression|9|||
162980070|NCT01132664|588629213|FG002|Phase lb|Disease Progression|0|||
162980071|NCT01132664|588629214|FG003|Phase lb|Disease Progression|0|||
162980072|NCT01132664|588629215|FG004|Phase lb|Disease Progression|0|||
162980073|NCT01132664|588629211|FG000|Phase ll|Death|0|||
162980074|NCT01132664|588629212|FG001|Phase ll|Death|0|||
162980075|NCT01132664|588629213|FG002|Phase ll|Death|2|||
162980076|NCT01132664|588629214|FG003|Phase ll|Death|0|||
162980077|NCT01132664|588629215|FG004|Phase ll|Death|0|||
162980078|NCT01132664|588629211|FG000|Phase ll|Adverse Event|0|||
162980079|NCT01132664|588629212|FG001|Phase ll|Adverse Event|0|||
162980080|NCT01132664|588629213|FG002|Phase ll|Adverse Event|10|||
162980081|NCT01132664|588629214|FG003|Phase ll|Adverse Event|0|||
162980082|NCT01132664|588629215|FG004|Phase ll|Adverse Event|0|||
162980083|NCT01132664|588629211|FG000|Phase ll|Withdrawal by Subject|0|||
162980084|NCT01132664|588629212|FG001|Phase ll|Withdrawal by Subject|0|||
162980085|NCT01132664|588629213|FG002|Phase ll|Withdrawal by Subject|3|||
162980086|NCT01132664|588629214|FG003|Phase ll|Withdrawal by Subject|0|||
162980087|NCT01132664|588629215|FG004|Phase ll|Withdrawal by Subject|0|||
162980088|NCT01132664|588629211|FG000|Phase ll|Disease progression|0|||
162980089|NCT01132664|588629212|FG001|Phase ll|Disease progression|0|||
162980090|NCT01132664|588629213|FG002|Phase ll|Disease progression|35|||
162980091|NCT01132664|588629214|FG003|Phase ll|Disease progression|0|||
162980092|NCT01132664|588629215|FG004|Phase ll|Disease progression|0|||
162980093|NCT01132664|588629211|FG000|BM Cohort|Disease progression|0|||
162980094|NCT01132664|588629212|FG001|BM Cohort|Disease progression|0|||
162980095|NCT01132664|588629213|FG002|BM Cohort|Disease progression|0|||
162980096|NCT01132664|588629214|FG003|BM Cohort|Disease progression|3|||
162980097|NCT01132664|588629215|FG004|BM Cohort|Disease progression|4|||
162980098|NCT01132664|588629211|FG000|BM Cohort|Adverse Event|0|||
162980099|NCT01132664|588629212|FG001|BM Cohort|Adverse Event|0|||
162980100|NCT01132664|588629213|FG002|BM Cohort|Adverse Event|0|||
162980101|NCT01132664|588629214|FG003|BM Cohort|Adverse Event|0|||
163059002|NCT05965752|588924381|FG004|Overall Study|Adverse Event|3|||
163059003|NCT05965752|588924377|FG000|Overall Study|Lost to Follow-up|2|||
162980102|NCT01132664|588629215|FG004|BM Cohort|Adverse Event|1|||
162980103|NCT01132664|588629211|FG000|BM Cohort|Withdrawal by Subject|0|||
162980104|NCT01132664|588629212|FG001|BM Cohort|Withdrawal by Subject|0|||
162980105|NCT01132664|588629213|FG002|BM Cohort|Withdrawal by Subject|0|||
162980106|NCT01132664|588629214|FG003|BM Cohort|Withdrawal by Subject|0|||
162980107|NCT01132664|588629215|FG004|BM Cohort|Withdrawal by Subject|1|||
162980108|NCT04271735|588629217|FG000|Overall Study|Physician Decision|2|||
162980109|NCT04271735|588629218|FG001|Overall Study|Physician Decision|0|||
162980110|NCT04268316|588629219|FG000|Overall Study|Withdrawal by Subject|2|||
162980111|NCT04268316|588629220|FG001|Overall Study|Withdrawal by Subject|1|||
162980112|NCT04268316|588629221|FG002|Overall Study|Withdrawal by Subject|0|||
162980113|NCT02040779|588629223|FG000|Overall Study|Adverse Event|1|||
162980114|NCT02040779|588629224|FG001|Overall Study|Adverse Event|0|||
162980115|NCT02040779|588629225|FG002|Overall Study|Adverse Event|0|||
162980116|NCT02040779|588629223|FG000|Overall Study|Withdrawal by Subject|4|||
162980117|NCT02040779|588629224|FG001|Overall Study|Withdrawal by Subject|1|||
162632662|NCT02289690|587369068|FG001|Overall Study|Death|0|||
162980118|NCT02040779|588629225|FG002|Overall Study|Withdrawal by Subject|3|||
162980119|NCT02040779|588629223|FG000|Overall Study|Non-compliance|0|||
162980120|NCT02040779|588629224|FG001|Overall Study|Non-compliance|1|||
162980121|NCT02040779|588629225|FG002|Overall Study|Non-compliance|0|||
162980122|NCT02040779|588629223|FG000|Overall Study|Protocol Violation|2|||
162980123|NCT02040779|588629224|FG001|Overall Study|Protocol Violation|1|||
162980124|NCT02040779|588629225|FG002|Overall Study|Protocol Violation|0|||
162980125|NCT02040779|588629223|FG000|Overall Study|Lost to Follow-up|1|||
162980126|NCT02040779|588629224|FG001|Overall Study|Lost to Follow-up|2|||
162980127|NCT02040779|588629225|FG002|Overall Study|Lost to Follow-up|1|||
162980128|NCT02040779|588629223|FG000|Overall Study|Lack of Efficacy|4|||
162980129|NCT02040779|588629224|FG001|Overall Study|Lack of Efficacy|2|||
162980130|NCT02040779|588629225|FG002|Overall Study|Lack of Efficacy|0|||
162980131|NCT02132637|588629226|FG000|Study Period 1|Withdrawal by Subject|0|||
162980132|NCT02132637|588629227|FG001|Study Period 1|Withdrawal by Subject|4|||
162980133|NCT02132637|588629226|FG000|Study Period 1|Physician Decision|1|||
162980134|NCT02132637|588629227|FG001|Study Period 1|Physician Decision|0|||
162980135|NCT02132637|588629226|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
162980136|NCT02132637|588629227|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
162980137|NCT02132637|588629226|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
162980138|NCT02132637|588629227|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
162980139|NCT00922272|588629230|FG000|Open-label Phase|Adverse Event|5|||
162980140|NCT00922272|588629231|FG001|Open-label Phase|Adverse Event|0|||
162980141|NCT00922272|588629230|FG000|Open-label Phase|Protocol Violation|1|||
162980142|NCT00922272|588629231|FG001|Open-label Phase|Protocol Violation|0|||
162980143|NCT00922272|588629230|FG000|Open-label Phase|Withdrawal by Subject|11|||
162980144|NCT00922272|588629231|FG001|Open-label Phase|Withdrawal by Subject|0|||
162980145|NCT00922272|588629230|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
162980146|NCT00922272|588629231|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
162980147|NCT00922272|588629230|FG000|Open-label Phase|Withdrawal criteria met|5|||
162980148|NCT00922272|588629231|FG001|Open-label Phase|Withdrawal criteria met|0|||
162980149|NCT00922272|588629230|FG000|Double-blind Phase|Adverse Event|1|||
162980150|NCT00922272|588629231|FG001|Double-blind Phase|Adverse Event|1|||
162980151|NCT00922272|588629230|FG000|Double-blind Phase|Withdrawal by Subject|1|||
162980152|NCT00922272|588629231|FG001|Double-blind Phase|Withdrawal by Subject|1|||
162980153|NCT00922272|588629230|FG000|Double-blind Phase|Lost to Follow-up|2|||
162980154|NCT00922272|588629231|FG001|Double-blind Phase|Lost to Follow-up|1|||
162980155|NCT00922272|588629230|FG000|Double-blind Phase|Withdrawal criteria met|1|||
162980156|NCT00922272|588629231|FG001|Double-blind Phase|Withdrawal criteria met|1|||
162980157|NCT00922272|588629230|FG000|Double-blind Phase|Noncompliance|1|||
162980158|NCT00922272|588629231|FG001|Double-blind Phase|Noncompliance|1|||
162980159|NCT00922272|588629230|FG000|Double-blind Phase|Positive urine drug screen|1|||
162980160|NCT00922272|588629231|FG001|Double-blind Phase|Positive urine drug screen|1|||
162980161|NCT03197558|588629232|FG000|Overall Study|Tubes not placed|1|||
162980162|NCT02581163|588629234|FG000|Overall Study|Failure to return|15|||
162980163|NCT02581163|588629234|FG000|Overall Study|Insufficient virological response|3|||
162980164|NCT02581163|588629234|FG000|Overall Study|Withdrew consent|1|||
162980165|NCT02581163|588629234|FG000|Overall Study|Death|1|||
162980166|NCT02581163|588629234|FG000|Overall Study|Other, not specified|9|||
162980167|NCT02384941|588629244|FG000|Overall Study|Adverse Event|11|||
163059004|NCT05965752|588924378|FG001|Overall Study|Lost to Follow-up|0|||
163059005|NCT05965752|588924379|FG002|Overall Study|Lost to Follow-up|1|||
163059006|NCT05965752|588924380|FG003|Overall Study|Lost to Follow-up|1|||
163059007|NCT05965752|588924381|FG004|Overall Study|Lost to Follow-up|1|||
163059008|NCT05965752|588924377|FG000|Overall Study|Withdrawal by Subject|2|||
163059009|NCT05965752|588924378|FG001|Overall Study|Withdrawal by Subject|2|||
162632663|NCT02289690|587369069|FG002|Overall Study|Death|0|||
162632664|NCT02289690|587369070|FG003|Overall Study|Death|0|||
163059010|NCT05965752|588924379|FG002|Overall Study|Withdrawal by Subject|1|||
163059011|NCT05965752|588924380|FG003|Overall Study|Withdrawal by Subject|5|||
163059012|NCT05965752|588924381|FG004|Overall Study|Withdrawal by Subject|0|||
163059013|NCT05965752|588924377|FG000|Overall Study|Disease Relapse|1|||
163059014|NCT05965752|588924378|FG001|Overall Study|Disease Relapse|0|||
162632665|NCT02289690|587369071|FG004|Overall Study|Death|0|||
162632666|NCT02289690|587369072|FG005|Overall Study|Death|0|||
162632667|NCT02289690|587369073|FG006|Overall Study|Death|0|||
162980168|NCT02384941|588629245|FG001|Overall Study|Adverse Event|13|||
162980169|NCT02384941|588629246|FG002|Overall Study|Adverse Event|17|||
162980170|NCT02384941|588629244|FG000|Overall Study|Lost to Follow-up|3|||
162980171|NCT02384941|588629245|FG001|Overall Study|Lost to Follow-up|2|||
162980172|NCT02384941|588629246|FG002|Overall Study|Lost to Follow-up|1|||
162980173|NCT02384941|588629244|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162980174|NCT02384941|588629245|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162980175|NCT02384941|588629246|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162980176|NCT02384941|588629244|FG000|Overall Study|Physician Decision|1|||
162980177|NCT02384941|588629245|FG001|Overall Study|Physician Decision|1|||
162980178|NCT02384941|588629246|FG002|Overall Study|Physician Decision|0|||
162980179|NCT02384941|588629244|FG000|Overall Study|Protocol Violation|3|||
162980180|NCT02384941|588629245|FG001|Overall Study|Protocol Violation|0|||
162980181|NCT02384941|588629246|FG002|Overall Study|Protocol Violation|0|||
162980182|NCT02384941|588629244|FG000|Overall Study|Withdrawal by Subject|26|||
162980183|NCT02384941|588629245|FG001|Overall Study|Withdrawal by Subject|19|||
162980184|NCT02384941|588629246|FG002|Overall Study|Withdrawal by Subject|20|||
162980185|NCT02384941|588629244|FG000|Overall Study|Pregnancy|0|||
162980186|NCT02384941|588629245|FG001|Overall Study|Pregnancy|0|||
162980187|NCT02384941|588629246|FG002|Overall Study|Pregnancy|1|||
162980188|NCT02384941|588629244|FG000|Overall Study|Other than specified above|4|||
162980189|NCT02384941|588629245|FG001|Overall Study|Other than specified above|0|||
162980190|NCT02384941|588629246|FG002|Overall Study|Other than specified above|1|||
162980191|NCT06005597|588629247|FG000|Overall Study|Lost to Follow-up|1|||
162980192|NCT06005597|588629248|FG001|Overall Study|Lost to Follow-up|2|||
162980193|NCT06005597|588629249|FG002|Overall Study|Lost to Follow-up|1|||
162980194|NCT06005597|588629250|FG003|Overall Study|Lost to Follow-up|2|||
162980195|NCT06005597|588629247|FG000|Overall Study|Death|1|||
162980196|NCT06005597|588629248|FG001|Overall Study|Death|1|||
162980197|NCT06005597|588629249|FG002|Overall Study|Death|1|||
162980198|NCT06005597|588629250|FG003|Overall Study|Death|0|||
162980199|NCT01134627|588629255|FG000|Overall Study|Adverse Event|47|||
162980200|NCT01134627|588629256|FG001|Overall Study|Adverse Event|31|||
162980201|NCT01134627|588629255|FG000|Overall Study|Lost to Follow-up|1|||
162980202|NCT01134627|588629256|FG001|Overall Study|Lost to Follow-up|2|||
162980203|NCT01134627|588629255|FG000|Overall Study|Protocol Violation|3|||
162980204|NCT01134627|588629256|FG001|Overall Study|Protocol Violation|5|||
162980205|NCT01134627|588629255|FG000|Overall Study|Lack of Efficacy|2|||
162980206|NCT01134627|588629256|FG001|Overall Study|Lack of Efficacy|12|||
162980207|NCT01134627|588629255|FG000|Overall Study|Withdrawal by Subject|4|||
162980208|NCT01134627|588629256|FG001|Overall Study|Withdrawal by Subject|3|||
162980209|NCT01134627|588629255|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
162980210|NCT01134627|588629256|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
162980211|NCT01134627|588629255|FG000|Overall Study|Other|11|||
162980212|NCT01134627|588629256|FG001|Overall Study|Other|14|||
162980213|NCT00977431|588629257|FG000|Overall Study|Other than listed|1|||
162980214|NCT00977431|588629258|FG001|Overall Study|Other than listed|0|||
162980215|NCT00977431|588629259|FG002|Overall Study|Other than listed|0|||
162980216|NCT00977431|588629260|FG003|Overall Study|Other than listed|0|||
162980217|NCT00977431|588629261|FG004|Overall Study|Other than listed|2|||
162980218|NCT00977431|588629257|FG000|Overall Study|Protocol Violation|0|||
162980219|NCT00977431|588629258|FG001|Overall Study|Protocol Violation|0|||
162980220|NCT00977431|588629259|FG002|Overall Study|Protocol Violation|1|||
162980221|NCT00977431|588629260|FG003|Overall Study|Protocol Violation|0|||
162980222|NCT00977431|588629261|FG004|Overall Study|Protocol Violation|0|||
162980223|NCT00977431|588629257|FG000|Overall Study|Adverse Event|3|||
162980224|NCT00977431|588629258|FG001|Overall Study|Adverse Event|0|||
162980225|NCT00977431|588629259|FG002|Overall Study|Adverse Event|4|||
162980226|NCT00977431|588629260|FG003|Overall Study|Adverse Event|0|||
163059015|NCT05965752|588924379|FG002|Overall Study|Disease Relapse|1|||
163059016|NCT05965752|588924380|FG003|Overall Study|Disease Relapse|0|||
162980227|NCT00977431|588629261|FG004|Overall Study|Adverse Event|6|||
162980228|NCT00977431|588629257|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
162980229|NCT00977431|588629258|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980230|NCT00977431|588629259|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
162980231|NCT00977431|588629260|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980232|NCT00977431|588629261|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
162980233|NCT00977431|588629257|FG000|Overall Study|Progressive disease|2|||
162980234|NCT00977431|588629258|FG001|Overall Study|Progressive disease|6|||
162980235|NCT00977431|588629259|FG002|Overall Study|Progressive disease|1|||
162980236|NCT00977431|588629260|FG003|Overall Study|Progressive disease|3|||
162980237|NCT00977431|588629261|FG004|Overall Study|Progressive disease|5|||
162980238|NCT03739138|588629268|FG000|Overall Study|Death|0|||
162714049|NCT03394027|587662669|FG000|Overall Study|Participant declined to participate before treatment started|0|||
162714050|NCT03394027|587662670|FG001|Overall Study|Participant declined to participate before treatment started|0|||
162714051|NCT03394027|587662671|FG002|Overall Study|Participant declined to participate before treatment started|1|||
162714052|NCT02824432|587662676|FG000|Overall Study|Major Protocol Deviation|1|||
162714053|NCT02824432|587662677|FG001|Overall Study|Major Protocol Deviation|0|||
162714054|NCT01348087|587662678|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
162714055|NCT01348087|587662678|FG000|Overall Study|Administrative problems|79|||
162714056|NCT01348087|587662678|FG000|Overall Study|protocol deviation|1|||
162714057|NCT01348087|587662678|FG000|Overall Study|Lost to Follow-up|1|||
162714058|NCT01348087|587662678|FG000|Overall Study|Subject withdrew consent|7|||
162714059|NCT01348087|587662678|FG000|Overall Study|Adverse Event|25|||
162714060|NCT02081391|587662681|FG000|12-hour Treatment|Withdrawal by Subject|3|||
162714061|NCT02081391|587662682|FG001|12-hour Treatment|Withdrawal by Subject|2|||
162714062|NCT02081391|587662683|FG002|12-hour Treatment|Withdrawal by Subject|0|||
162714063|NCT02081391|587662684|FG003|12-hour Treatment|Withdrawal by Subject|0|||
162714064|NCT02081391|587662681|FG000|12-hour Treatment|Physician Decision|4|||
162714065|NCT02081391|587662682|FG001|12-hour Treatment|Physician Decision|1|||
162714066|NCT02081391|587662683|FG002|12-hour Treatment|Physician Decision|0|||
162714067|NCT02081391|587662684|FG003|12-hour Treatment|Physician Decision|0|||
162714068|NCT02081391|587662681|FG000|12-hour Treatment|Lack of Efficacy|3|||
162714069|NCT02081391|587662682|FG001|12-hour Treatment|Lack of Efficacy|0|||
162714070|NCT02081391|587662683|FG002|12-hour Treatment|Lack of Efficacy|0|||
162714071|NCT02081391|587662684|FG003|12-hour Treatment|Lack of Efficacy|0|||
162980239|NCT03739138|588629269|FG001|Overall Study|Death|7|||
162980240|NCT03739138|588629270|FG002|Overall Study|Death|4|||
162980241|NCT03739138|588629271|FG003|Overall Study|Death|13|||
162980242|NCT03739138|588629272|FG004|Overall Study|Death|0|||
162980243|NCT03739138|588629268|FG000|Overall Study|Lost to Follow-up|0|||
162980244|NCT03739138|588629269|FG001|Overall Study|Lost to Follow-up|0|||
162980245|NCT03739138|588629270|FG002|Overall Study|Lost to Follow-up|1|||
162980246|NCT03739138|588629271|FG003|Overall Study|Lost to Follow-up|0|||
162980247|NCT03739138|588629272|FG004|Overall Study|Lost to Follow-up|0|||
162980248|NCT03739138|588629268|FG000|Overall Study|Study Terminated By Sponsor|0|||
162980249|NCT03739138|588629269|FG001|Overall Study|Study Terminated By Sponsor|0|||
162980250|NCT03739138|588629270|FG002|Overall Study|Study Terminated By Sponsor|0|||
162980251|NCT03739138|588629271|FG003|Overall Study|Study Terminated By Sponsor|4|||
162980252|NCT03739138|588629272|FG004|Overall Study|Study Terminated By Sponsor|0|||
162980253|NCT03739138|588629268|FG000|Overall Study|Withdrawal by Subject|0|||
162980254|NCT03739138|588629269|FG001|Overall Study|Withdrawal by Subject|0|||
162980255|NCT03739138|588629270|FG002|Overall Study|Withdrawal by Subject|0|||
162980256|NCT03739138|588629271|FG003|Overall Study|Withdrawal by Subject|1|||
162980257|NCT03739138|588629272|FG004|Overall Study|Withdrawal by Subject|0|||
162980258|NCT01056640|588629273|FG000|Overall Study|Withdrawal by Subject|11|||
162980259|NCT01056640|588629274|FG001|Overall Study|Withdrawal by Subject|8|||
162980260|NCT01056640|588629273|FG000|Overall Study|Death|15|||
162980261|NCT01056640|588629274|FG001|Overall Study|Death|4|||
162980262|NCT01803269|588629275|FG000|Overall Study|Withdrawal by Subject|3|||
162980263|NCT01803269|588629276|FG001|Overall Study|Withdrawal by Subject|0|||
162980264|NCT01803269|588629277|FG002|Overall Study|Withdrawal by Subject|0|||
162980265|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
162980266|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
162980267|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
162980268|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
162980269|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
162980270|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
162980271|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
162980272|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
162980273|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
162980274|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
162980275|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Subject decision|1|||
162980276|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Subject decision|1|||
162980277|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
162980278|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
162980279|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
162980280|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
162980281|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
162980282|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
162980283|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
162980284|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
163059017|NCT05965752|588924381|FG004|Overall Study|Disease Relapse|0|||
162714072|NCT02081391|587662681|FG000|12-hour Treatment|Adverse Event|4|||
162714073|NCT02081391|587662682|FG001|12-hour Treatment|Adverse Event|2|||
162980285|NCT00518882|588629280|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
162980286|NCT00518882|588629281|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
162980287|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
163059018|NCT05965752|588924377|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163059019|NCT05965752|588924378|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163059020|NCT05965752|588924379|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163059021|NCT05965752|588924380|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
163059022|NCT05965752|588924381|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
163059023|NCT05965752|588924377|FG000|Overall Study|Unable to Return for Study Visits|0|||
163059024|NCT05965752|588924378|FG001|Overall Study|Unable to Return for Study Visits|1|||
163059025|NCT05965752|588924379|FG002|Overall Study|Unable to Return for Study Visits|0|||
163059026|NCT05965752|588924380|FG003|Overall Study|Unable to Return for Study Visits|3|||
163059027|NCT05965752|588924381|FG004|Overall Study|Unable to Return for Study Visits|1|||
163059028|NCT05965752|588924377|FG000|Overall Study|Early Termination|0|||
163059029|NCT05965752|588924378|FG001|Overall Study|Early Termination|0|||
163059030|NCT05965752|588924379|FG002|Overall Study|Early Termination|1|||
163059031|NCT05965752|588924380|FG003|Overall Study|Early Termination|0|||
163059032|NCT05965752|588924381|FG004|Overall Study|Early Termination|0|||
163059033|NCT05965752|588924377|FG000|Overall Study|Reported Unwanted Symptoms|0|||
163059034|NCT05965752|588924378|FG001|Overall Study|Reported Unwanted Symptoms|0|||
163059035|NCT05965752|588924379|FG002|Overall Study|Reported Unwanted Symptoms|0|||
162980288|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
162980289|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
162980290|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
162980291|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
162980292|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
162980293|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
162980294|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
162980295|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
162980296|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
162980297|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
162980298|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
162980299|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
162980300|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
162980301|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
162980302|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
162980303|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
162980304|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
162980305|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
162980306|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
162980307|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
162980308|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
162980309|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
162980310|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
163059036|NCT05965752|588924380|FG003|Overall Study|Reported Unwanted Symptoms|0|||
163059037|NCT05965752|588924381|FG004|Overall Study|Reported Unwanted Symptoms|1|||
163059038|NCT05965752|588924377|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059039|NCT05965752|588924378|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059040|NCT05965752|588924379|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059041|NCT05965752|588924380|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
163059042|NCT05965752|588924381|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
163059043|NCT00834041|588924383|FG000|Overall Study|Withdrawal by Subject|1|||
163059044|NCT00834041|588924384|FG001|Overall Study|Withdrawal by Subject|0|||
163059045|NCT00834041|588924383|FG000|Overall Study|Lost to Follow-up|0|||
163059046|NCT00834041|588924384|FG001|Overall Study|Lost to Follow-up|1|||
163059047|NCT02634710|588924387|FG000|Overall Study|Death|4|||
163059048|NCT04530630|588926285|FG000|Overall Study|Physician Decision|1|||
163059049|NCT01288430|588926292|FG000|Part 1|Progressive disease|2|||
163059050|NCT01288430|588926293|FG001|Part 1|Progressive disease|1|||
163059051|NCT01288430|588926294|FG002|Part 1|Progressive disease|1|||
163059052|NCT01288430|588926295|FG003|Part 1|Progressive disease|6|||
163059053|NCT01288430|588926296|FG004|Part 1|Progressive disease|2|||
163059054|NCT01288430|588926297|FG005|Part 1|Progressive disease|4|||
163059055|NCT01288430|588926298|FG006|Part 1|Progressive disease|2|||
163059056|NCT01288430|588926299|FG007|Part 1|Progressive disease|0|||
163059057|NCT01288430|588926300|FG008|Part 1|Progressive disease|0|||
163059058|NCT01288430|588926301|FG009|Part 1|Progressive disease|0|||
162980311|NCT00518882|588629280|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
163059059|NCT01288430|588926292|FG000|Part 1|Clinical disease progression|0|||
163059060|NCT01288430|588926293|FG001|Part 1|Clinical disease progression|0|||
162980312|NCT00518882|588629281|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
162980313|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
162980314|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
162980315|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
162980316|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
162980317|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
162980318|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
162980319|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
162980320|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
162980321|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
162980322|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
162980323|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
162980324|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
162980325|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
162980326|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
162980327|NCT04740931|588629282|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
162980328|NCT04740931|588629283|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
162980329|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
162980330|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
162980331|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
162980332|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
162980333|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
162980334|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
162980335|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
162980336|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
162980337|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
162980338|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
162980339|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
162980340|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
162980341|NCT04740931|588629282|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
162980342|NCT04740931|588629283|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
162980343|NCT02696031|588629285|FG000|Up to Week 24|Adverse Event|2|||
162980344|NCT02696031|588629286|FG001|Up to Week 24|Adverse Event|4|||
162980345|NCT02696031|588629287|FG002|Up to Week 24|Adverse Event|2|||
162980346|NCT02696031|588629288|FG003|Up to Week 24|Adverse Event|0|||
162980347|NCT02696031|588629289|FG004|Up to Week 24|Adverse Event|0|||
162980348|NCT02696031|588629290|FG005|Up to Week 24|Adverse Event|0|||
162980349|NCT02696031|588629285|FG000|Up to Week 24|Lack of Efficacy|2|||
162980350|NCT02696031|588629286|FG001|Up to Week 24|Lack of Efficacy|1|||
162980351|NCT02696031|588629287|FG002|Up to Week 24|Lack of Efficacy|2|||
162980352|NCT02696031|588629288|FG003|Up to Week 24|Lack of Efficacy|0|||
162980353|NCT02696031|588629289|FG004|Up to Week 24|Lack of Efficacy|0|||
162980354|NCT02696031|588629290|FG005|Up to Week 24|Lack of Efficacy|0|||
162980355|NCT02696031|588629285|FG000|Up to Week 24|Lost to Follow-up|0|||
162980356|NCT02696031|588629286|FG001|Up to Week 24|Lost to Follow-up|1|||
162980357|NCT02696031|588629287|FG002|Up to Week 24|Lost to Follow-up|1|||
162980358|NCT02696031|588629288|FG003|Up to Week 24|Lost to Follow-up|0|||
162980359|NCT02696031|588629289|FG004|Up to Week 24|Lost to Follow-up|0|||
162980360|NCT02696031|588629290|FG005|Up to Week 24|Lost to Follow-up|0|||
162980361|NCT02696031|588629285|FG000|Up to Week 24|Physician Decision|1|||
162980362|NCT02696031|588629286|FG001|Up to Week 24|Physician Decision|0|||
162980363|NCT02696031|588629287|FG002|Up to Week 24|Physician Decision|1|||
162980364|NCT02696031|588629288|FG003|Up to Week 24|Physician Decision|0|||
162980365|NCT02696031|588629289|FG004|Up to Week 24|Physician Decision|0|||
162980366|NCT02696031|588629290|FG005|Up to Week 24|Physician Decision|0|||
162980367|NCT02696031|588629285|FG000|Up to Week 24|Protocol Violation|1|||
162980368|NCT02696031|588629286|FG001|Up to Week 24|Protocol Violation|0|||
162980369|NCT02696031|588629287|FG002|Up to Week 24|Protocol Violation|0|||
162980370|NCT02696031|588629288|FG003|Up to Week 24|Protocol Violation|0|||
162980371|NCT02696031|588629289|FG004|Up to Week 24|Protocol Violation|0|||
162980372|NCT02696031|588629290|FG005|Up to Week 24|Protocol Violation|0|||
162980373|NCT02696031|588629285|FG000|Up to Week 24|Withdrawal by Subject|4|||
162980374|NCT02696031|588629286|FG001|Up to Week 24|Withdrawal by Subject|1|||
162980375|NCT02696031|588629287|FG002|Up to Week 24|Withdrawal by Subject|5|||
162980376|NCT02696031|588629288|FG003|Up to Week 24|Withdrawal by Subject|0|||
162980377|NCT02696031|588629289|FG004|Up to Week 24|Withdrawal by Subject|0|||
162980378|NCT02696031|588629290|FG005|Up to Week 24|Withdrawal by Subject|0|||
162980379|NCT02696031|588629285|FG000|Up to Week 52|Adverse Event|4|||
162714074|NCT02081391|587662683|FG002|12-hour Treatment|Adverse Event|0|||
162980380|NCT02696031|588629286|FG001|Up to Week 52|Adverse Event|5|||
162980381|NCT02696031|588629287|FG002|Up to Week 52|Adverse Event|3|||
162980382|NCT02696031|588629288|FG003|Up to Week 52|Adverse Event|0|||
162980383|NCT02696031|588629289|FG004|Up to Week 52|Adverse Event|0|||
162980384|NCT02696031|588629290|FG005|Up to Week 52|Adverse Event|0|||
162980385|NCT02696031|588629285|FG000|Up to Week 52|Lack of Efficacy|10|||
162980386|NCT02696031|588629286|FG001|Up to Week 52|Lack of Efficacy|7|||
162980387|NCT02696031|588629287|FG002|Up to Week 52|Lack of Efficacy|11|||
162980388|NCT02696031|588629288|FG003|Up to Week 52|Lack of Efficacy|0|||
162980389|NCT02696031|588629289|FG004|Up to Week 52|Lack of Efficacy|0|||
162980390|NCT02696031|588629290|FG005|Up to Week 52|Lack of Efficacy|0|||
162980391|NCT02696031|588629285|FG000|Up to Week 52|Lost to Follow-up|1|||
162980392|NCT02696031|588629286|FG001|Up to Week 52|Lost to Follow-up|1|||
162980393|NCT02696031|588629287|FG002|Up to Week 52|Lost to Follow-up|1|||
162980394|NCT02696031|588629288|FG003|Up to Week 52|Lost to Follow-up|0|||
162980395|NCT02696031|588629289|FG004|Up to Week 52|Lost to Follow-up|0|||
162980396|NCT02696031|588629290|FG005|Up to Week 52|Lost to Follow-up|0|||
162980397|NCT02696031|588629285|FG000|Up to Week 52|Physician Decision|1|||
162980398|NCT02696031|588629286|FG001|Up to Week 52|Physician Decision|1|||
162980399|NCT02696031|588629287|FG002|Up to Week 52|Physician Decision|2|||
162980400|NCT02696031|588629288|FG003|Up to Week 52|Physician Decision|0|||
162980401|NCT02696031|588629289|FG004|Up to Week 52|Physician Decision|0|||
162980402|NCT02696031|588629290|FG005|Up to Week 52|Physician Decision|0|||
162980403|NCT02696031|588629285|FG000|Up to Week 52|Pregnancy|0|||
162980404|NCT02696031|588629286|FG001|Up to Week 52|Pregnancy|2|||
162980405|NCT02696031|588629287|FG002|Up to Week 52|Pregnancy|0|||
162980406|NCT02696031|588629288|FG003|Up to Week 52|Pregnancy|0|||
162980407|NCT02696031|588629289|FG004|Up to Week 52|Pregnancy|0|||
162980408|NCT02696031|588629290|FG005|Up to Week 52|Pregnancy|0|||
162980409|NCT02696031|588629285|FG000|Up to Week 52|Protocol Violation|1|||
162980410|NCT02696031|588629286|FG001|Up to Week 52|Protocol Violation|0|||
162980411|NCT02696031|588629287|FG002|Up to Week 52|Protocol Violation|0|||
162980412|NCT02696031|588629288|FG003|Up to Week 52|Protocol Violation|0|||
162980413|NCT02696031|588629289|FG004|Up to Week 52|Protocol Violation|0|||
162980414|NCT02696031|588629290|FG005|Up to Week 52|Protocol Violation|0|||
162980415|NCT02696031|588629285|FG000|Up to Week 52|Withdrawal by Subject|12|||
162980416|NCT02696031|588629286|FG001|Up to Week 52|Withdrawal by Subject|3|||
162980417|NCT02696031|588629287|FG002|Up to Week 52|Withdrawal by Subject|9|||
162980418|NCT02696031|588629288|FG003|Up to Week 52|Withdrawal by Subject|0|||
162980419|NCT02696031|588629289|FG004|Up to Week 52|Withdrawal by Subject|0|||
162980420|NCT02696031|588629290|FG005|Up to Week 52|Withdrawal by Subject|0|||
162980421|NCT02696031|588629285|FG000|Up to Week 104|Pregnancy|0|||
162980422|NCT02696031|588629286|FG001|Up to Week 104|Pregnancy|2|||
162980423|NCT02696031|588629287|FG002|Up to Week 104|Pregnancy|1|||
162980424|NCT02696031|588629288|FG003|Up to Week 104|Pregnancy|0|||
162980425|NCT02696031|588629289|FG004|Up to Week 104|Pregnancy|0|||
162980426|NCT02696031|588629290|FG005|Up to Week 104|Pregnancy|0|||
162980427|NCT02696031|588629285|FG000|Up to Week 104|Withdrawal by Subject|15|||
162980428|NCT02696031|588629286|FG001|Up to Week 104|Withdrawal by Subject|10|||
162980429|NCT02696031|588629287|FG002|Up to Week 104|Withdrawal by Subject|16|||
162980430|NCT02696031|588629288|FG003|Up to Week 104|Withdrawal by Subject|0|||
162980431|NCT02696031|588629289|FG004|Up to Week 104|Withdrawal by Subject|0|||
162980432|NCT02696031|588629290|FG005|Up to Week 104|Withdrawal by Subject|0|||
162980433|NCT02696031|588629285|FG000|Up to Week 104|Protocol Violation|1|||
162980434|NCT02696031|588629286|FG001|Up to Week 104|Protocol Violation|0|||
162980435|NCT02696031|588629287|FG002|Up to Week 104|Protocol Violation|0|||
162980436|NCT02696031|588629288|FG003|Up to Week 104|Protocol Violation|0|||
162980437|NCT02696031|588629289|FG004|Up to Week 104|Protocol Violation|0|||
162980438|NCT02696031|588629290|FG005|Up to Week 104|Protocol Violation|0|||
162980439|NCT02696031|588629285|FG000|Up to Week 104|Physician Decision|1|||
162980440|NCT02696031|588629286|FG001|Up to Week 104|Physician Decision|2|||
162980441|NCT02696031|588629287|FG002|Up to Week 104|Physician Decision|3|||
162980442|NCT02696031|588629288|FG003|Up to Week 104|Physician Decision|0|||
162980443|NCT02696031|588629289|FG004|Up to Week 104|Physician Decision|0|||
162980444|NCT02696031|588629290|FG005|Up to Week 104|Physician Decision|0|||
162980445|NCT02696031|588629285|FG000|Up to Week 104|Lost to Follow-up|2|||
162980446|NCT02696031|588629286|FG001|Up to Week 104|Lost to Follow-up|3|||
162980447|NCT02696031|588629287|FG002|Up to Week 104|Lost to Follow-up|1|||
162980448|NCT02696031|588629288|FG003|Up to Week 104|Lost to Follow-up|0|||
162980449|NCT02696031|588629289|FG004|Up to Week 104|Lost to Follow-up|0|||
162980450|NCT02696031|588629290|FG005|Up to Week 104|Lost to Follow-up|0|||
162980451|NCT02696031|588629285|FG000|Up to Week 104|Lack of Efficacy|13|||
162980452|NCT02696031|588629286|FG001|Up to Week 104|Lack of Efficacy|12|||
162980453|NCT02696031|588629287|FG002|Up to Week 104|Lack of Efficacy|11|||
162980454|NCT02696031|588629288|FG003|Up to Week 104|Lack of Efficacy|0|||
162980455|NCT02696031|588629289|FG004|Up to Week 104|Lack of Efficacy|0|||
162980456|NCT02696031|588629290|FG005|Up to Week 104|Lack of Efficacy|0|||
162980457|NCT02696031|588629285|FG000|Up to Week 104|Adverse Event|7|||
162980458|NCT02696031|588629286|FG001|Up to Week 104|Adverse Event|11|||
162980459|NCT02696031|588629287|FG002|Up to Week 104|Adverse Event|5|||
162980460|NCT02696031|588629288|FG003|Up to Week 104|Adverse Event|0|||
163059061|NCT01288430|588926294|FG002|Part 1|Clinical disease progression|1|||
162980461|NCT02696031|588629289|FG004|Up to Week 104|Adverse Event|0|||
162980462|NCT02696031|588629290|FG005|Up to Week 104|Adverse Event|0|||
162980463|NCT02696031|588629285|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980464|NCT02696031|588629286|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
162980465|NCT02696031|588629287|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980466|NCT02696031|588629288|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980467|NCT02696031|588629289|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980468|NCT02696031|588629290|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
162980469|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980470|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980471|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
162980472|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
162980473|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
162980474|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
162980475|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980476|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980477|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980478|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
162980479|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
163059062|NCT01288430|588926295|FG003|Part 1|Clinical disease progression|0|||
163059063|NCT01288430|588926296|FG004|Part 1|Clinical disease progression|0|||
163059064|NCT01288430|588926297|FG005|Part 1|Clinical disease progression|2|||
163059065|NCT01288430|588926298|FG006|Part 1|Clinical disease progression|2|||
163059066|NCT01288430|588926299|FG007|Part 1|Clinical disease progression|0|||
163059067|NCT01288430|588926300|FG008|Part 1|Clinical disease progression|0|||
163059068|NCT01288430|588926301|FG009|Part 1|Clinical disease progression|0|||
163059069|NCT01288430|588926292|FG000|Part 1|Death due to disease progression|0|||
163059070|NCT01288430|588926293|FG001|Part 1|Death due to disease progression|0|||
163059071|NCT01288430|588926294|FG002|Part 1|Death due to disease progression|0|||
163059072|NCT01288430|588926295|FG003|Part 1|Death due to disease progression|0|||
163059073|NCT01288430|588926296|FG004|Part 1|Death due to disease progression|1|||
163059074|NCT01288430|588926297|FG005|Part 1|Death due to disease progression|0|||
162632668|NCT02289690|587369074|FG007|Overall Study|Death|49|||
162632669|NCT02289690|587369075|FG008|Overall Study|Death|45|||
162632670|NCT02289690|587369076|FG009|Overall Study|Death|41|||
162632671|NCT02289690|587369067|FG000|Overall Study|Sponsor Discontinued Study|0|||
162632672|NCT02289690|587369068|FG001|Overall Study|Sponsor Discontinued Study|0|||
162632673|NCT02289690|587369069|FG002|Overall Study|Sponsor Discontinued Study|0|||
162632674|NCT02289690|587369070|FG003|Overall Study|Sponsor Discontinued Study|0|||
162632675|NCT02289690|587369071|FG004|Overall Study|Sponsor Discontinued Study|0|||
162632676|NCT02289690|587369072|FG005|Overall Study|Sponsor Discontinued Study|0|||
162632677|NCT02289690|587369073|FG006|Overall Study|Sponsor Discontinued Study|0|||
162632678|NCT02289690|587369074|FG007|Overall Study|Sponsor Discontinued Study|9|||
162632679|NCT02289690|587369075|FG008|Overall Study|Sponsor Discontinued Study|7|||
162632680|NCT02289690|587369076|FG009|Overall Study|Sponsor Discontinued Study|15|||
162632681|NCT02289690|587369067|FG000|Overall Study|Other|0|||
162632682|NCT02289690|587369068|FG001|Overall Study|Other|0|||
162632683|NCT02289690|587369069|FG002|Overall Study|Other|0|||
162632684|NCT02289690|587369070|FG003|Overall Study|Other|1|||
162632685|NCT02289690|587369071|FG004|Overall Study|Other|1|||
162632686|NCT02289690|587369072|FG005|Overall Study|Other|0|||
162632687|NCT02289690|587369073|FG006|Overall Study|Other|1|||
162632688|NCT02289690|587369074|FG007|Overall Study|Other|2|||
162632689|NCT02289690|587369075|FG008|Overall Study|Other|3|||
162632690|NCT02289690|587369076|FG009|Overall Study|Other|1|||
162632691|NCT04166435|587369079|FG000|Overall Study|2 patients ineligible for response|2|||
162632692|NCT00299104|587369081|FG000|Treatment Period|Adverse Event|14|||
162632693|NCT00299104|587369082|FG001|Treatment Period|Adverse Event|9|||
162632694|NCT00299104|587369083|FG002|Treatment Period|Adverse Event|7|||
162632695|NCT00299104|587369081|FG000|Treatment Period|Death|1|||
162980480|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
162980481|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980482|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980483|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980484|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
162980485|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980486|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
162980487|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980488|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980489|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980490|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980491|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
162980492|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
162980493|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980494|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980495|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
162980496|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
162980497|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
162980498|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
162980499|NCT02696031|588629285|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980500|NCT02696031|588629286|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980501|NCT02696031|588629287|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
162980502|NCT02696031|588629288|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
162980503|NCT02696031|588629289|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
162980504|NCT02696031|588629290|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
162980505|NCT00063882|588629293|FG000|Overall Study|Protocol Violation|3|||
162980506|NCT00063882|588629294|FG001|Overall Study|Protocol Violation|3|||
162980507|NCT00063882|588629293|FG000|Overall Study|Withdrawal by Subject|2|||
162980508|NCT00063882|588629294|FG001|Overall Study|Withdrawal by Subject|1|||
162980509|NCT02903238|588629295|FG000|Overall Study|Lost to Follow-up|4|||
162980510|NCT01813071|588629297|FG000|Overall Study|Protocol Violation|0|||
162980511|NCT01813071|588629298|FG001|Overall Study|Protocol Violation|0|||
162980512|NCT01813071|588629299|FG002|Overall Study|Protocol Violation|0|||
162980513|NCT01813071|588629300|FG003|Overall Study|Protocol Violation|0|||
162632696|NCT00299104|587369082|FG001|Treatment Period|Death|1|||
162632697|NCT00299104|587369083|FG002|Treatment Period|Death|1|||
162632698|NCT00299104|587369081|FG000|Treatment Period|Insufficient therapeutic response|34|||
162632699|NCT00299104|587369082|FG001|Treatment Period|Insufficient therapeutic response|13|||
162632700|NCT00299104|587369083|FG002|Treatment Period|Insufficient therapeutic response|8|||
162632701|NCT00299104|587369081|FG000|Treatment Period|Failure to return|9|||
162632702|NCT00299104|587369082|FG001|Treatment Period|Failure to return|8|||
162632703|NCT00299104|587369083|FG002|Treatment Period|Failure to return|8|||
162632704|NCT00299104|587369081|FG000|Treatment Period|Violation of selection criteria|1|||
162632705|NCT00299104|587369082|FG001|Treatment Period|Violation of selection criteria|2|||
162632706|NCT00299104|587369083|FG002|Treatment Period|Violation of selection criteria|0|||
162632707|NCT00299104|587369081|FG000|Treatment Period|Protocol Violation|1|||
162632708|NCT00299104|587369082|FG001|Treatment Period|Protocol Violation|1|||
162632709|NCT00299104|587369083|FG002|Treatment Period|Protocol Violation|0|||
162980514|NCT01813071|588629301|FG004|Overall Study|Protocol Violation|1|||
162980515|NCT01813071|588629302|FG005|Overall Study|Protocol Violation|4|||
162980516|NCT01813071|588629303|FG006|Overall Study|Protocol Violation|2|||
162980517|NCT01813071|588629304|FG007|Overall Study|Protocol Violation|4|||
162980518|NCT01813071|588629305|FG008|Overall Study|Protocol Violation|2|||
162980519|NCT01813071|588629297|FG000|Overall Study|Withdrawal by Subject|0|||
162980520|NCT01813071|588629298|FG001|Overall Study|Withdrawal by Subject|0|||
162980521|NCT01813071|588629299|FG002|Overall Study|Withdrawal by Subject|0|||
162980522|NCT01813071|588629300|FG003|Overall Study|Withdrawal by Subject|0|||
162980523|NCT01813071|588629301|FG004|Overall Study|Withdrawal by Subject|0|||
162980524|NCT01813071|588629302|FG005|Overall Study|Withdrawal by Subject|1|||
162980525|NCT01813071|588629303|FG006|Overall Study|Withdrawal by Subject|0|||
162980526|NCT01813071|588629304|FG007|Overall Study|Withdrawal by Subject|0|||
162980527|NCT01813071|588629305|FG008|Overall Study|Withdrawal by Subject|0|||
162980528|NCT01813071|588629297|FG000|Overall Study|Adverse Event|0|||
162980529|NCT01813071|588629298|FG001|Overall Study|Adverse Event|0|||
162980530|NCT01813071|588629299|FG002|Overall Study|Adverse Event|0|||
162980531|NCT01813071|588629300|FG003|Overall Study|Adverse Event|0|||
162980532|NCT01813071|588629301|FG004|Overall Study|Adverse Event|0|||
162980533|NCT01813071|588629302|FG005|Overall Study|Adverse Event|1|||
162632710|NCT00299104|587369081|FG000|Treatment Period|Refused treatment|9|||
162632711|NCT00299104|587369082|FG001|Treatment Period|Refused treatment|2|||
162632712|NCT00299104|587369083|FG002|Treatment Period|Refused treatment|2|||
162632713|NCT00299104|587369081|FG000|Treatment Period|Withdrew consent|14|||
162632714|NCT00299104|587369082|FG001|Treatment Period|Withdrew consent|19|||
162632715|NCT00299104|587369083|FG002|Treatment Period|Withdrew consent|9|||
162632716|NCT00299104|587369081|FG000|Treatment Period|Administrative reasons|106|||
162632717|NCT00299104|587369082|FG001|Treatment Period|Administrative reasons|120|||
162632718|NCT00299104|587369083|FG002|Treatment Period|Administrative reasons|137|||
162632719|NCT00299104|587369081|FG000|Safety Follow-Up (SFU) Period|Death|3|||
162632720|NCT00299104|587369082|FG001|Safety Follow-Up (SFU) Period|Death|2|||
162632721|NCT00299104|587369083|FG002|Safety Follow-Up (SFU) Period|Death|1|||
162632722|NCT00299104|587369081|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
162632723|NCT00299104|587369082|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
162632724|NCT00299104|587369083|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
162632725|NCT00299104|587369081|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
162632726|NCT00299104|587369082|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
162632727|NCT00299104|587369083|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
162632728|NCT00299104|587369081|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
162632729|NCT00299104|587369082|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
162632730|NCT00299104|587369083|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
162632731|NCT00299104|587369081|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
162632732|NCT00299104|587369082|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
162632733|NCT00299104|587369083|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
162632734|NCT00299104|587369081|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162632735|NCT00299104|587369082|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162632736|NCT00299104|587369083|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162632737|NCT00299104|587369081|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
162632738|NCT00299104|587369082|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
162632739|NCT00299104|587369083|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
162632740|NCT00299104|587369081|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
162632741|NCT00299104|587369082|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
162632742|NCT00299104|587369083|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
162632743|NCT00814164|587369086|FG000|Overall Study|Progression|7|||
162632744|NCT00814164|587369086|FG000|Overall Study|not stated|7|||
162632745|NCT00814164|587369086|FG000|Overall Study|Death|5|||
162632746|NCT03167411|587369087|FG000|Overall Study|Adverse Event|0|||
162632747|NCT03167411|587369088|FG001|Overall Study|Adverse Event|1|||
162632748|NCT01053221|587369089|FG000|Overall Study|The study was closed prematurely|5|||
162632749|NCT01053221|587369090|FG001|Overall Study|The study was closed prematurely|9|||
162632750|NCT00420927|587369091|FG000|Period 1|Adverse Event|19|||
162632751|NCT00420927|587369092|FG001|Period 1|Adverse Event|15|||
162632752|NCT00420927|587369093|FG002|Period 1|Adverse Event|0|||
162632753|NCT00420927|587369094|FG003|Period 1|Adverse Event|0|||
162632754|NCT00420927|587369095|FG004|Period 1|Adverse Event|0|||
162632755|NCT00420927|587369096|FG005|Period 1|Adverse Event|0|||
162632756|NCT00420927|587369097|FG006|Period 1|Adverse Event|0|||
162632757|NCT00420927|587369091|FG000|Period 1|Withdrawal by Subject|7|||
162632758|NCT00420927|587369092|FG001|Period 1|Withdrawal by Subject|12|||
162632759|NCT00420927|587369093|FG002|Period 1|Withdrawal by Subject|0|||
162632760|NCT00420927|587369094|FG003|Period 1|Withdrawal by Subject|0|||
162632761|NCT00420927|587369095|FG004|Period 1|Withdrawal by Subject|0|||
162632762|NCT00420927|587369096|FG005|Period 1|Withdrawal by Subject|0|||
162632763|NCT00420927|587369097|FG006|Period 1|Withdrawal by Subject|0|||
162714075|NCT02081391|587662684|FG003|12-hour Treatment|Adverse Event|0|||
162714076|NCT02081391|587662681|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
162980534|NCT01813071|588629303|FG006|Overall Study|Adverse Event|0|||
162980535|NCT01813071|588629304|FG007|Overall Study|Adverse Event|0|||
162980536|NCT01813071|588629305|FG008|Overall Study|Adverse Event|0|||
162980537|NCT01813071|588629297|FG000|Overall Study|Physician Decision|0|||
162980538|NCT01813071|588629298|FG001|Overall Study|Physician Decision|0|||
162980539|NCT01813071|588629299|FG002|Overall Study|Physician Decision|0|||
162980540|NCT01813071|588629300|FG003|Overall Study|Physician Decision|0|||
162980541|NCT01813071|588629301|FG004|Overall Study|Physician Decision|0|||
163059075|NCT01288430|588926298|FG006|Part 1|Death due to disease progression|0|||
162632764|NCT00420927|587369091|FG000|Period 1|Lost to Follow-up|8|||
162632765|NCT00420927|587369092|FG001|Period 1|Lost to Follow-up|6|||
162632766|NCT00420927|587369093|FG002|Period 1|Lost to Follow-up|0|||
162632767|NCT00420927|587369094|FG003|Period 1|Lost to Follow-up|0|||
162632768|NCT00420927|587369095|FG004|Period 1|Lost to Follow-up|0|||
162632769|NCT00420927|587369096|FG005|Period 1|Lost to Follow-up|0|||
162632770|NCT00420927|587369097|FG006|Period 1|Lost to Follow-up|0|||
162632771|NCT00420927|587369091|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
162632772|NCT00420927|587369092|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
162632773|NCT00420927|587369093|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
162632774|NCT00420927|587369094|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
162980542|NCT01813071|588629302|FG005|Overall Study|Physician Decision|0|||
162980543|NCT01813071|588629303|FG006|Overall Study|Physician Decision|1|||
162980544|NCT01813071|588629304|FG007|Overall Study|Physician Decision|0|||
162980545|NCT01813071|588629305|FG008|Overall Study|Physician Decision|0|||
162980546|NCT01813071|588629297|FG000|Overall Study|Met inc/exc criteria|0|||
162980547|NCT01813071|588629298|FG001|Overall Study|Met inc/exc criteria|0|||
162980548|NCT01813071|588629299|FG002|Overall Study|Met inc/exc criteria|0|||
162980549|NCT01813071|588629300|FG003|Overall Study|Met inc/exc criteria|0|||
162980550|NCT01813071|588629301|FG004|Overall Study|Met inc/exc criteria|0|||
162980551|NCT01813071|588629302|FG005|Overall Study|Met inc/exc criteria|1|||
162980552|NCT01813071|588629303|FG006|Overall Study|Met inc/exc criteria|0|||
162980553|NCT01813071|588629304|FG007|Overall Study|Met inc/exc criteria|1|||
162980554|NCT01813071|588629305|FG008|Overall Study|Met inc/exc criteria|1|||
162980555|NCT02442271|588629310|FG000|Overall Study|Adverse Event|1|||
162980556|NCT02442271|588629310|FG000|Overall Study|Withdrew Consent|1|||
162980557|NCT02442271|588629310|FG000|Overall Study|Lost to Follow-up|1|||
162980558|NCT02442271|588629310|FG000|Overall Study|Other|1|||
162980559|NCT00831623|588629314|FG000|Overall Study|Withdrawal by Subject|9|||
162980560|NCT00831623|588629314|FG000|Overall Study|Lost to Follow-up|1|||
162980561|NCT00831623|588629314|FG000|Overall Study|Not 2 years post-treatment|12|||
162980562|NCT01138111|588629319|FG000|Overall Study|Withdrawal by Subject|5|||
162980563|NCT01138111|588629319|FG000|Overall Study|Adverse Event|1|||
162980564|NCT01138111|588629319|FG000|Overall Study|Death|1|||
162980565|NCT01138111|588629319|FG000|Overall Study|Lost to Follow-up|2|||
162980566|NCT01118117|588629320|FG000|Overall Study|Death|8|||
162980567|NCT01118117|588629321|FG001|Overall Study|Death|0|||
162980568|NCT01118117|588629320|FG000|Overall Study|Lost to Follow-up|6|||
162980569|NCT01118117|588629321|FG001|Overall Study|Lost to Follow-up|0|||
162980570|NCT01118117|588629320|FG000|Overall Study|Missed 12 Month Visit|7|||
162980571|NCT01118117|588629321|FG001|Overall Study|Missed 12 Month Visit|0|||
162980572|NCT02149121|588629322|FG000|Main Study Period|Lack of Efficacy|2|||
162980573|NCT02149121|588629323|FG001|Main Study Period|Lack of Efficacy|2|||
162980574|NCT02149121|588629324|FG002|Main Study Period|Lack of Efficacy|1|||
162980575|NCT02149121|588629325|FG003|Main Study Period|Lack of Efficacy|0|||
162980576|NCT02149121|588629326|FG004|Main Study Period|Lack of Efficacy|0|||
162980577|NCT02149121|588629327|FG005|Main Study Period|Lack of Efficacy|0|||
162980578|NCT02149121|588629328|FG006|Main Study Period|Lack of Efficacy|0|||
162980579|NCT02149121|588629322|FG000|Main Study Period|Withdrawal by Subject|9|||
162980580|NCT02149121|588629323|FG001|Main Study Period|Withdrawal by Subject|5|||
162980581|NCT02149121|588629324|FG002|Main Study Period|Withdrawal by Subject|1|||
162980582|NCT02149121|588629325|FG003|Main Study Period|Withdrawal by Subject|0|||
162980583|NCT02149121|588629326|FG004|Main Study Period|Withdrawal by Subject|0|||
162980584|NCT02149121|588629327|FG005|Main Study Period|Withdrawal by Subject|0|||
162980585|NCT02149121|588629328|FG006|Main Study Period|Withdrawal by Subject|0|||
162980586|NCT02149121|588629322|FG000|Main Study Period|Adverse Event|2|||
162980587|NCT02149121|588629323|FG001|Main Study Period|Adverse Event|5|||
162980588|NCT02149121|588629324|FG002|Main Study Period|Adverse Event|1|||
162980589|NCT02149121|588629325|FG003|Main Study Period|Adverse Event|0|||
162980590|NCT02149121|588629326|FG004|Main Study Period|Adverse Event|0|||
162980591|NCT02149121|588629327|FG005|Main Study Period|Adverse Event|0|||
162980592|NCT02149121|588629328|FG006|Main Study Period|Adverse Event|0|||
162980593|NCT02149121|588629322|FG000|Main Study Period|Protocol Violation|2|||
162980594|NCT02149121|588629323|FG001|Main Study Period|Protocol Violation|0|||
162980595|NCT02149121|588629324|FG002|Main Study Period|Protocol Violation|0|||
162980596|NCT02149121|588629325|FG003|Main Study Period|Protocol Violation|0|||
162980597|NCT02149121|588629326|FG004|Main Study Period|Protocol Violation|0|||
162980598|NCT02149121|588629327|FG005|Main Study Period|Protocol Violation|0|||
162980599|NCT02149121|588629328|FG006|Main Study Period|Protocol Violation|0|||
162980600|NCT02149121|588629322|FG000|Main Study Period|Lost to Follow-up|2|||
162980601|NCT02149121|588629323|FG001|Main Study Period|Lost to Follow-up|1|||
162980602|NCT02149121|588629324|FG002|Main Study Period|Lost to Follow-up|0|||
162980603|NCT02149121|588629325|FG003|Main Study Period|Lost to Follow-up|0|||
162980604|NCT02149121|588629326|FG004|Main Study Period|Lost to Follow-up|0|||
162980605|NCT02149121|588629327|FG005|Main Study Period|Lost to Follow-up|0|||
162980606|NCT02149121|588629328|FG006|Main Study Period|Lost to Follow-up|0|||
162980607|NCT02149121|588629322|FG000|Main Study Period|Death|1|||
162980608|NCT02149121|588629323|FG001|Main Study Period|Death|0|||
162980609|NCT02149121|588629324|FG002|Main Study Period|Death|0|||
162980610|NCT02149121|588629325|FG003|Main Study Period|Death|0|||
162980611|NCT02149121|588629326|FG004|Main Study Period|Death|0|||
162980612|NCT02149121|588629327|FG005|Main Study Period|Death|0|||
162980613|NCT02149121|588629328|FG006|Main Study Period|Death|0|||
162980614|NCT02149121|588629322|FG000|Main Study Period|Physician Decision|1|||
162980615|NCT02149121|588629323|FG001|Main Study Period|Physician Decision|0|||
162980616|NCT02149121|588629324|FG002|Main Study Period|Physician Decision|0|||
162980617|NCT02149121|588629325|FG003|Main Study Period|Physician Decision|0|||
162980618|NCT02149121|588629326|FG004|Main Study Period|Physician Decision|0|||
162980619|NCT02149121|588629327|FG005|Main Study Period|Physician Decision|0|||
162980620|NCT02149121|588629328|FG006|Main Study Period|Physician Decision|0|||
162980621|NCT02149121|588629322|FG000|Main Study Period|Developed any malignancy|0|||
162980622|NCT02149121|588629323|FG001|Main Study Period|Developed any malignancy|1|||
162980623|NCT02149121|588629324|FG002|Main Study Period|Developed any malignancy|1|||
162980624|NCT02149121|588629325|FG003|Main Study Period|Developed any malignancy|0|||
162980625|NCT02149121|588629326|FG004|Main Study Period|Developed any malignancy|0|||
162980626|NCT02149121|588629327|FG005|Main Study Period|Developed any malignancy|0|||
162980627|NCT02149121|588629328|FG006|Main Study Period|Developed any malignancy|0|||
162980628|NCT02149121|588629322|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
162980629|NCT02149121|588629323|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
162980630|NCT02149121|588629324|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
162980631|NCT02149121|588629325|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
162980632|NCT02149121|588629326|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
162980633|NCT02149121|588629327|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
162980634|NCT02149121|588629328|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
162980635|NCT02149121|588629322|FG000|Main Study Period|Disease progression|0|||
162980636|NCT02149121|588629323|FG001|Main Study Period|Disease progression|1|||
162980637|NCT02149121|588629324|FG002|Main Study Period|Disease progression|0|||
162980638|NCT02149121|588629325|FG003|Main Study Period|Disease progression|0|||
162980639|NCT02149121|588629326|FG004|Main Study Period|Disease progression|0|||
162980640|NCT02149121|588629327|FG005|Main Study Period|Disease progression|0|||
162980641|NCT02149121|588629328|FG006|Main Study Period|Disease progression|0|||
162980642|NCT02149121|588629322|FG000|Extension Study Period|Withdrawal by Subject|0|||
162980643|NCT02149121|588629323|FG001|Extension Study Period|Withdrawal by Subject|0|||
162980644|NCT02149121|588629324|FG002|Extension Study Period|Withdrawal by Subject|0|||
162980645|NCT02149121|588629325|FG003|Extension Study Period|Withdrawal by Subject|1|||
162980646|NCT02149121|588629326|FG004|Extension Study Period|Withdrawal by Subject|0|||
162980647|NCT02149121|588629327|FG005|Extension Study Period|Withdrawal by Subject|2|||
162980648|NCT02149121|588629328|FG006|Extension Study Period|Withdrawal by Subject|0|||
162980649|NCT02177136|588630965|FG000|DB Phase|Withdrawal by Subject|2|||
162980650|NCT02177136|588630966|FG001|DB Phase|Withdrawal by Subject|0|||
162980651|NCT02177136|588630967|FG002|DB Phase|Withdrawal by Subject|0|||
162980652|NCT02177136|588630968|FG003|DB Phase|Withdrawal by Subject|0|||
162980653|NCT02177136|588630965|FG000|DB Phase|Discontinued Due to Pruritus|1|||
162980654|NCT02177136|588630966|FG001|DB Phase|Discontinued Due to Pruritus|3|||
162980655|NCT02177136|588630967|FG002|DB Phase|Discontinued Due to Pruritus|0|||
162980656|NCT02177136|588630968|FG003|DB Phase|Discontinued Due to Pruritus|0|||
162980657|NCT02177136|588630965|FG000|DB Phase|Adverse Event|3|||
162980658|NCT02177136|588630966|FG001|DB Phase|Adverse Event|2|||
162980659|NCT02177136|588630967|FG002|DB Phase|Adverse Event|3|||
162980660|NCT02177136|588630968|FG003|DB Phase|Adverse Event|0|||
162980661|NCT02177136|588630965|FG000|DB Phase|Protocol Violation|0|||
162980662|NCT02177136|588630966|FG001|DB Phase|Protocol Violation|0|||
162980663|NCT02177136|588630967|FG002|DB Phase|Protocol Violation|1|||
162980664|NCT02177136|588630968|FG003|DB Phase|Protocol Violation|0|||
162980665|NCT02177136|588630965|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
162980666|NCT02177136|588630966|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980667|NCT02177136|588630967|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980668|NCT02177136|588630968|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
162980669|NCT02177136|588630965|FG000|LTSE Phase|Withdrawal by Subject|0|||
162980670|NCT02177136|588630966|FG001|LTSE Phase|Withdrawal by Subject|0|||
162980671|NCT02177136|588630967|FG002|LTSE Phase|Withdrawal by Subject|0|||
162980672|NCT02177136|588630968|FG003|LTSE Phase|Withdrawal by Subject|6|||
162980673|NCT02177136|588630965|FG000|LTSE Phase|Adverse Event|0|||
162980674|NCT02177136|588630966|FG001|LTSE Phase|Adverse Event|0|||
162980675|NCT02177136|588630967|FG002|LTSE Phase|Adverse Event|0|||
162980676|NCT02177136|588630968|FG003|LTSE Phase|Adverse Event|10|||
162980677|NCT02177136|588630965|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
162980678|NCT02177136|588630966|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
163059076|NCT01288430|588926299|FG007|Part 1|Death due to disease progression|0|||
163059077|NCT01288430|588926300|FG008|Part 1|Death due to disease progression|0|||
163059078|NCT01288430|588926301|FG009|Part 1|Death due to disease progression|0|||
163059079|NCT01288430|588926292|FG000|Part 1|Adverse Event|0|||
163059080|NCT01288430|588926293|FG001|Part 1|Adverse Event|0|||
163059081|NCT01288430|588926294|FG002|Part 1|Adverse Event|3|||
162980679|NCT02177136|588630967|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
162980680|NCT02177136|588630968|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
162980681|NCT02177136|588630965|FG000|LTSE Phase|Physician Decision|0|||
163059082|NCT01288430|588926295|FG003|Part 1|Adverse Event|1|||
162714077|NCT02081391|587662682|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
162714078|NCT02081391|587662683|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
163059083|NCT01288430|588926296|FG004|Part 1|Adverse Event|0|||
163059084|NCT01288430|588926297|FG005|Part 1|Adverse Event|0|||
162980682|NCT02177136|588630966|FG001|LTSE Phase|Physician Decision|0|||
162980683|NCT02177136|588630967|FG002|LTSE Phase|Physician Decision|0|||
162980684|NCT02177136|588630968|FG003|LTSE Phase|Physician Decision|2|||
162980685|NCT02177136|588630965|FG000|LTSE Phase|Lost to Follow-up|0|||
163059085|NCT01288430|588926298|FG006|Part 1|Adverse Event|2|||
162980686|NCT02177136|588630966|FG001|LTSE Phase|Lost to Follow-up|0|||
162980687|NCT02177136|588630967|FG002|LTSE Phase|Lost to Follow-up|0|||
162980688|NCT02177136|588630968|FG003|LTSE Phase|Lost to Follow-up|1|||
162980689|NCT02177136|588630965|FG000|LTSE Phase|Participant Moved|0|||
162980690|NCT02177136|588630966|FG001|LTSE Phase|Participant Moved|0|||
162980691|NCT02177136|588630967|FG002|LTSE Phase|Participant Moved|0|||
162980692|NCT02177136|588630968|FG003|LTSE Phase|Participant Moved|1|||
162980693|NCT02054130|588630969|FG000|Overall Study|Withdrawal by Subject|4|||
162980694|NCT02054130|588630970|FG001|Overall Study|Withdrawal by Subject|4|||
162980695|NCT02054130|588630971|FG002|Overall Study|Withdrawal by Subject|7|||
162980696|NCT02054130|588630972|FG003|Overall Study|Withdrawal by Subject|10|||
162980697|NCT02054130|588630969|FG000|Overall Study|Death|0|||
162980698|NCT02054130|588630970|FG001|Overall Study|Death|1|||
162980699|NCT02054130|588630971|FG002|Overall Study|Death|0|||
162980700|NCT02054130|588630972|FG003|Overall Study|Death|0|||
162980701|NCT02054130|588630969|FG000|Overall Study|Lost to Follow-up|0|||
162980702|NCT02054130|588630970|FG001|Overall Study|Lost to Follow-up|0|||
162980703|NCT02054130|588630971|FG002|Overall Study|Lost to Follow-up|1|||
162980704|NCT02054130|588630972|FG003|Overall Study|Lost to Follow-up|2|||
162980705|NCT02054130|588630969|FG000|Overall Study|Missed dose|4|||
162980706|NCT02054130|588630970|FG001|Overall Study|Missed dose|6|||
162980707|NCT02054130|588630971|FG002|Overall Study|Missed dose|7|||
162980708|NCT02054130|588630972|FG003|Overall Study|Missed dose|10|||
162980709|NCT01304693|588630987|FG000|Overall Study|Adverse Event|0|||
162980710|NCT01304693|588630988|FG001|Overall Study|Adverse Event|0|||
162980711|NCT01304693|588630989|FG002|Overall Study|Adverse Event|0|||
162980712|NCT01304693|588630990|FG003|Overall Study|Adverse Event|0|||
162980713|NCT01304693|588630991|FG004|Overall Study|Adverse Event|1|||
162980714|NCT01304693|588630987|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980715|NCT01304693|588630988|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980716|NCT01304693|588630989|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
162980717|NCT01304693|588630990|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
162980718|NCT01304693|588630991|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
162980719|NCT00931268|588630992|FG000|Overall Study|Lost to Follow-up|6|||
162980720|NCT04132336|588630993|FG000|Overall Study|Investigator Decision|0|||
162980721|NCT04132336|588630994|FG001|Overall Study|Investigator Decision|1|||
162980722|NCT04132336|588630995|FG002|Overall Study|Investigator Decision|0|||
162980723|NCT04132336|588630996|FG003|Overall Study|Investigator Decision|0|||
162980724|NCT04132336|588630997|FG004|Overall Study|Investigator Decision|0|||
162980725|NCT04132336|588630998|FG005|Overall Study|Investigator Decision|0|||
162980726|NCT04132336|588630999|FG006|Overall Study|Investigator Decision|0|||
162980727|NCT02488330|588631000|FG000|Overall Study|Adverse Event|1|||
162980728|NCT02488330|588631000|FG000|Overall Study|Physician Decision|2|||
162980729|NCT02488330|588631000|FG000|Overall Study|Death|2|||
162980730|NCT02488330|588631000|FG000|Overall Study|Disease Progression|3|||
162980731|NCT02488330|588631000|FG000|Overall Study|Study Termination by Sponsor|4|||
162980732|NCT02493777|588631001|FG000|Overall Study|Lost to Follow-up|0|||
162980733|NCT02493777|588631002|FG001|Overall Study|Lost to Follow-up|1|||
162980734|NCT00468728|588631003|FG000|Treatment|criteria for mITT population|4|||
162980735|NCT00468728|588631004|FG001|Treatment|criteria for mITT population|11|||
162980736|NCT00468728|588631003|FG000|Follow-up|mITT failure|34|||
162980737|NCT00468728|588631004|FG001|Follow-up|mITT failure|31|||
162980738|NCT01705236|588631005|FG000|Overall Study|Lost to Follow-up|1|||
162980739|NCT01705236|588631005|FG000|Overall Study|Administrative problems|2|||
162980740|NCT01705236|588631005|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
162980741|NCT01705236|588631005|FG000|Overall Study|Protocol Violation|3|||
162980742|NCT01705236|588631005|FG000|Overall Study|Abnormal test procedure result(s)|4|||
162980743|NCT01705236|588631005|FG000|Overall Study|Abnormal laboratory value(s)|4|||
162980744|NCT01705236|588631005|FG000|Overall Study|Withdrawal by Subject|5|||
162980745|NCT01705236|588631005|FG000|Overall Study|Adverse Event|5|||
162980746|NCT02224573|588631006|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
162980747|NCT02224573|588631007|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
162632775|NCT00420927|587369095|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
162632776|NCT00420927|587369096|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
162632777|NCT00420927|587369097|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
162980748|NCT02224573|588631006|FG000|Treatment Phase|Started on Other IMP|1|||
162980749|NCT02224573|588631007|FG001|Treatment Phase|Started on Other IMP|0|||
162980750|NCT02224573|588631006|FG000|Treatment Phase|Participant Discontinued IMP|0|||
162980751|NCT02224573|588631007|FG001|Treatment Phase|Participant Discontinued IMP|1|||
162980752|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficacy|15|||
162632778|NCT00420927|587369091|FG000|Period 1|Death|2|||
162632779|NCT00420927|587369092|FG001|Period 1|Death|0|||
162980753|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficacy|8|||
162980754|NCT02224573|588631006|FG000|Treatment Phase|Began Commercial Product|1|||
162980755|NCT02224573|588631007|FG001|Treatment Phase|Began Commercial Product|0|||
163059086|NCT01288430|588926299|FG007|Part 1|Adverse Event|0|||
162632780|NCT00420927|587369093|FG002|Period 1|Death|0|||
162632781|NCT00420927|587369094|FG003|Period 1|Death|0|||
162632782|NCT00420927|587369095|FG004|Period 1|Death|0|||
162632783|NCT00420927|587369096|FG005|Period 1|Death|0|||
162980756|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
162980757|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
162980758|NCT02224573|588631006|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
162980759|NCT02224573|588631007|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
162980760|NCT02224573|588631006|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
162980761|NCT02224573|588631007|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
162980762|NCT02224573|588631006|FG000|Treatment Phase|Continued Compassionate Use|1|||
162980763|NCT02224573|588631007|FG001|Treatment Phase|Continued Compassionate Use|0|||
162980764|NCT02224573|588631006|FG000|Treatment Phase|Lack of Efficiency|2|||
162980765|NCT02224573|588631007|FG001|Treatment Phase|Lack of Efficiency|1|||
162980766|NCT02224573|588631006|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
162980767|NCT02224573|588631007|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
162980768|NCT02224573|588631006|FG000|Treatment Phase|Participant Moved|2|||
162980769|NCT02224573|588631007|FG001|Treatment Phase|Participant Moved|0|||
162980770|NCT02224573|588631006|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
162980771|NCT02224573|588631007|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
162980772|NCT02224573|588631006|FG000|Treatment Phase|Refused Medication|1|||
162980773|NCT02224573|588631007|FG001|Treatment Phase|Refused Medication|1|||
162980774|NCT02224573|588631006|FG000|Treatment Phase|Adverse Event|26|||
162980775|NCT02224573|588631007|FG001|Treatment Phase|Adverse Event|38|||
162980776|NCT02224573|588631006|FG000|Treatment Phase|Placed in Group Home|0|||
162980777|NCT02224573|588631007|FG001|Treatment Phase|Placed in Group Home|1|||
162980778|NCT02224573|588631006|FG000|Treatment Phase|Pursued Other Trials|1|||
162980779|NCT02224573|588631007|FG001|Treatment Phase|Pursued Other Trials|0|||
162980780|NCT02224573|588631006|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
162980781|NCT02224573|588631007|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
162980782|NCT02224573|588631006|FG000|Treatment Phase|Lost to Follow-up|2|||
162980783|NCT02224573|588631007|FG001|Treatment Phase|Lost to Follow-up|1|||
162980784|NCT02224573|588631006|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
162980785|NCT02224573|588631007|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
162980786|NCT02224573|588631006|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
162980787|NCT02224573|588631007|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
162980788|NCT02224573|588631006|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
162980789|NCT02224573|588631007|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
162980790|NCT02224573|588631006|FG000|Taper Phase|Adverse Event|1|||
162980791|NCT02224573|588631007|FG001|Taper Phase|Adverse Event|1|||
162980792|NCT02546362|588631008|FG000|4-week Treatment Period|Lost to Follow-up|1|||
162980793|NCT02546362|588631008|FG000|4-week Treatment Period|Change in medication|2|||
162980794|NCT02546362|588631008|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
162980795|NCT02546362|588631008|FG000|12-week Treatment Period|Lost to Follow-up|2|||
162980796|NCT02546362|588631008|FG000|12-week Treatment Period|Change in medication|1|||
162980797|NCT02025010|588631009|FG000|Overall Study|Symptomatic or radiographic progression|36|||
162980798|NCT02025010|588631009|FG000|Overall Study|Adverse Event|6|||
162980799|NCT02025010|588631009|FG000|Overall Study|Physician Decision|7|||
162980800|NCT02025010|588631009|FG000|Overall Study|Withdrawal by Subject|3|||
162980801|NCT02025010|588631009|FG000|Overall Study|Intercurrent illness|3|||
162980802|NCT02025010|588631009|FG000|Overall Study|Patients still on treatment|3|||
162980803|NCT02025010|588631009|FG000|Overall Study|Never initiate the treatment|2|||
162980804|NCT01621191|588631014|FG000|Overall Study|Adverse Event|9|||
162980805|NCT01621191|588631014|FG000|Overall Study|Withdrawal by Subject|8|||
162980806|NCT01621191|588631014|FG000|Overall Study|Lack of Efficacy|6|||
162980807|NCT01621191|588631014|FG000|Overall Study|Lost to Follow-up|1|||
162980808|NCT01621191|588631014|FG000|Overall Study|Site Removed From Study|1|||
162980809|NCT04355663|588631016|FG000|Overall Study|Physician Decision|2|||
162980810|NCT04355663|588631017|FG001|Overall Study|Physician Decision|7|||
162980811|NCT04355663|588631018|FG002|Overall Study|Physician Decision|0|||
162980812|NCT04355663|588631016|FG000|Overall Study|Adverse Event|0|||
162980813|NCT04355663|588631017|FG001|Overall Study|Adverse Event|0|||
162980814|NCT04355663|588631018|FG002|Overall Study|Adverse Event|1|||
163059087|NCT01288430|588926300|FG008|Part 1|Adverse Event|0|||
163059088|NCT01288430|588926301|FG009|Part 1|Adverse Event|0|||
162632784|NCT00420927|587369097|FG006|Period 1|Death|0|||
162632785|NCT00420927|587369091|FG000|Period 1|Subject moved/relocated|0|||
162632786|NCT00420927|587369092|FG001|Period 1|Subject moved/relocated|2|||
162980815|NCT04355663|588631016|FG000|Overall Study|Withdrawal by Subject|0|||
162980816|NCT04355663|588631017|FG001|Overall Study|Withdrawal by Subject|8|||
162980817|NCT04355663|588631018|FG002|Overall Study|Withdrawal by Subject|3|||
162980818|NCT02787408|588631024|FG000|Overall Study|Death|16|||
162980819|NCT02787408|588631024|FG000|Overall Study|Withdrawal by Subject|1|||
162980820|NCT02787408|588631024|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
163059089|NCT01288430|588926292|FG000|Part 1|Other|0|||
162632787|NCT00420927|587369093|FG002|Period 1|Subject moved/relocated|0|||
162632788|NCT00420927|587369094|FG003|Period 1|Subject moved/relocated|0|||
162980821|NCT05444543|588631027|FG000|Overall Study|Withdrawal by Subject|1|||
162980822|NCT05444543|588631028|FG001|Overall Study|Withdrawal by Subject|0|||
162980823|NCT05444543|588631027|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
162980824|NCT05444543|588631028|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
162980825|NCT05444543|588631027|FG000|Overall Study|Adverse Event|0|||
162980826|NCT05444543|588631028|FG001|Overall Study|Adverse Event|1|||
162980827|NCT05444543|588631027|FG000|Overall Study|Family relocating at a distance from study site|0|||
162980828|NCT05444543|588631028|FG001|Overall Study|Family relocating at a distance from study site|1|||
162980829|NCT02408120|588631031|FG000|Overall Study|Withdrawal by Subject|0|||
162980830|NCT02408120|588631032|FG001|Overall Study|Withdrawal by Subject|1|||
162980831|NCT02408120|588631031|FG000|Overall Study|Treatment Refusal|1|||
162980832|NCT02408120|588631032|FG001|Overall Study|Treatment Refusal|0|||
162980833|NCT02408120|588631031|FG000|Overall Study|Received Steroids|1|||
162980834|NCT02408120|588631032|FG001|Overall Study|Received Steroids|1|||
162980835|NCT02408120|588631031|FG000|Overall Study|Discharged same day|1|||
162980836|NCT02408120|588631032|FG001|Overall Study|Discharged same day|1|||
162980837|NCT02408120|588631031|FG000|Overall Study|Did not receive insulin|1|||
162980838|NCT02408120|588631032|FG001|Overall Study|Did not receive insulin|2|||
162980839|NCT01010750|588631033|FG000|Second Intervention|Adverse Event|0|||
162980840|NCT01010750|588631034|FG001|Second Intervention|Adverse Event|1|||
162980841|NCT01010750|588631035|FG002|Second Intervention|Adverse Event|0|||
162980842|NCT01010750|588631036|FG003|Second Intervention|Adverse Event|0|||
162980843|NCT01010750|588631037|FG004|Second Intervention|Adverse Event|0|||
162980844|NCT01010750|588631038|FG005|Second Intervention|Adverse Event|0|||
162980845|NCT00466726|588631039|FG000|Overall Study|Not evaluable for response|14|||
162980846|NCT00597116|588631040|FG000|Overall Study|Adverse Event|2|||
162980847|NCT00597116|588631041|FG001|Overall Study|Adverse Event|1|||
162980848|NCT00597116|588631040|FG000|Overall Study|Withdrawal by Subject|0|||
162980849|NCT00597116|588631041|FG001|Overall Study|Withdrawal by Subject|2|||
162980850|NCT00597116|588631040|FG000|Overall Study|Physician Decision|0|||
162980851|NCT00597116|588631041|FG001|Overall Study|Physician Decision|1|||
162980852|NCT00597116|588631040|FG000|Overall Study|Death|0|||
162980853|NCT00597116|588631041|FG001|Overall Study|Death|1|||
162980854|NCT00597116|588631040|FG000|Overall Study|Lost to Follow-up|1|||
162980855|NCT00597116|588631041|FG001|Overall Study|Lost to Follow-up|0|||
162980856|NCT00597116|588631040|FG000|Overall Study|Progressive disease|11|||
162980857|NCT00597116|588631041|FG001|Overall Study|Progressive disease|6|||
162980858|NCT02096588|588631042|FG000|Overall Study|Lack of Efficacy|2|||
162980859|NCT02096588|588631043|FG001|Overall Study|Lack of Efficacy|0|||
162980860|NCT02096588|588631042|FG000|Overall Study|Withdrawal by Subject|0|||
162980861|NCT02096588|588631043|FG001|Overall Study|Withdrawal by Subject|1|||
162980862|NCT01258101|588631044|FG000|Overall Study|Adverse Event|5|||
162980863|NCT01258101|588631045|FG001|Overall Study|Adverse Event|6|||
162980864|NCT01258101|588631046|FG002|Overall Study|Adverse Event|0|||
162980865|NCT01258101|588631047|FG003|Overall Study|Adverse Event|0|||
162980866|NCT01258101|588631044|FG000|Overall Study|Extra exclusion criterion amended|2|||
162980867|NCT01258101|588631045|FG001|Overall Study|Extra exclusion criterion amended|1|||
162980868|NCT01258101|588631046|FG002|Overall Study|Extra exclusion criterion amended|1|||
162980869|NCT01258101|588631047|FG003|Overall Study|Extra exclusion criterion amended|1|||
162980870|NCT01258101|588631044|FG000|Overall Study|Informed consent has been withdrawn|2|||
162980871|NCT01258101|588631045|FG001|Overall Study|Informed consent has been withdrawn|2|||
162980872|NCT01258101|588631046|FG002|Overall Study|Informed consent has been withdrawn|1|||
162980873|NCT01258101|588631047|FG003|Overall Study|Informed consent has been withdrawn|1|||
162980874|NCT01258101|588631044|FG000|Overall Study|Patient is not able to attend visits|8|||
162980875|NCT01258101|588631045|FG001|Overall Study|Patient is not able to attend visits|9|||
162980876|NCT01258101|588631046|FG002|Overall Study|Patient is not able to attend visits|7|||
162980877|NCT01258101|588631047|FG003|Overall Study|Patient is not able to attend visits|6|||
162980878|NCT01258101|588631044|FG000|Overall Study|Patient´s compliance|4|||
162980879|NCT01258101|588631045|FG001|Overall Study|Patient´s compliance|3|||
162980880|NCT01258101|588631046|FG002|Overall Study|Patient´s compliance|1|||
162980881|NCT01258101|588631047|FG003|Overall Study|Patient´s compliance|2|||
162980882|NCT01258101|588631044|FG000|Overall Study|Lost to Follow-up|5|||
163059090|NCT01288430|588926293|FG001|Part 1|Other|2|||
162632789|NCT00420927|587369095|FG004|Period 1|Subject moved/relocated|0|||
163059091|NCT01288430|588926294|FG002|Part 1|Other|0|||
162632790|NCT00420927|587369096|FG005|Period 1|Subject moved/relocated|0|||
162632791|NCT00420927|587369097|FG006|Period 1|Subject moved/relocated|0|||
162632792|NCT00420927|587369091|FG000|Period 1|Noncompliant with study drug|1|||
162632793|NCT00420927|587369092|FG001|Period 1|Noncompliant with study drug|1|||
162632794|NCT00420927|587369093|FG002|Period 1|Noncompliant with study drug|0|||
162632795|NCT00420927|587369094|FG003|Period 1|Noncompliant with study drug|0|||
162980883|NCT01258101|588631045|FG001|Overall Study|Lost to Follow-up|5|||
162980884|NCT01258101|588631046|FG002|Overall Study|Lost to Follow-up|0|||
162980885|NCT01258101|588631047|FG003|Overall Study|Lost to Follow-up|6|||
162980886|NCT01258101|588631044|FG000|Overall Study|PCR positive at week 24|0|||
162980887|NCT01258101|588631045|FG001|Overall Study|PCR positive at week 24|0|||
163059092|NCT01288430|588926295|FG003|Part 1|Other|0|||
162980888|NCT01258101|588631046|FG002|Overall Study|PCR positive at week 24|0|||
162980889|NCT01258101|588631047|FG003|Overall Study|PCR positive at week 24|1|||
162980890|NCT01258101|588631044|FG000|Overall Study|Other reason|7|||
162980891|NCT01258101|588631045|FG001|Overall Study|Other reason|8|||
162980892|NCT01258101|588631046|FG002|Overall Study|Other reason|1|||
162980893|NCT01258101|588631047|FG003|Overall Study|Other reason|8|||
162980894|NCT00958126|588631053|FG000|Overall Study|Serious Adverse Event|0|||
162980895|NCT00958126|588631054|FG001|Overall Study|Serious Adverse Event|2|||
162980896|NCT00958126|588631055|FG002|Overall Study|Serious Adverse Event|0|||
162980897|NCT00958126|588631056|FG003|Overall Study|Serious Adverse Event|0|||
162980898|NCT00958126|588631057|FG004|Overall Study|Serious Adverse Event|0|||
162980899|NCT00958126|588631058|FG005|Overall Study|Serious Adverse Event|0|||
162980900|NCT00958126|588631059|FG006|Overall Study|Serious Adverse Event|1|||
162980901|NCT00958126|588631060|FG007|Overall Study|Serious Adverse Event|0|||
162980902|NCT00958126|588631053|FG000|Overall Study|Withdrawal by Subject|0|||
162980903|NCT00958126|588631054|FG001|Overall Study|Withdrawal by Subject|2|||
162980904|NCT00958126|588631055|FG002|Overall Study|Withdrawal by Subject|0|||
162980905|NCT00958126|588631056|FG003|Overall Study|Withdrawal by Subject|0|||
162980906|NCT00958126|588631057|FG004|Overall Study|Withdrawal by Subject|0|||
162980907|NCT00958126|588631058|FG005|Overall Study|Withdrawal by Subject|0|||
162980908|NCT00958126|588631059|FG006|Overall Study|Withdrawal by Subject|0|||
162980909|NCT00958126|588631060|FG007|Overall Study|Withdrawal by Subject|0|||
162980910|NCT00958126|588631053|FG000|Overall Study|Moved away from study area|0|||
162980911|NCT00958126|588631054|FG001|Overall Study|Moved away from study area|0|||
162980912|NCT00958126|588631055|FG002|Overall Study|Moved away from study area|1|||
162980913|NCT00958126|588631056|FG003|Overall Study|Moved away from study area|1|||
162980914|NCT00958126|588631057|FG004|Overall Study|Moved away from study area|0|||
162980915|NCT00958126|588631058|FG005|Overall Study|Moved away from study area|0|||
162980916|NCT00958126|588631059|FG006|Overall Study|Moved away from study area|0|||
162980917|NCT00958126|588631060|FG007|Overall Study|Moved away from study area|0|||
162980918|NCT00958126|588631053|FG000|Overall Study|Lost to Follow-up|1|||
162980919|NCT00958126|588631054|FG001|Overall Study|Lost to Follow-up|5|||
162980920|NCT00958126|588631055|FG002|Overall Study|Lost to Follow-up|9|||
162980921|NCT00958126|588631056|FG003|Overall Study|Lost to Follow-up|8|||
162980922|NCT00958126|588631057|FG004|Overall Study|Lost to Follow-up|0|||
162980923|NCT00958126|588631058|FG005|Overall Study|Lost to Follow-up|0|||
162980924|NCT00958126|588631059|FG006|Overall Study|Lost to Follow-up|0|||
162980925|NCT00958126|588631060|FG007|Overall Study|Lost to Follow-up|0|||
162980926|NCT00958126|588631053|FG000|Overall Study|Sponsor/Investigator decision|0|||
162980927|NCT00958126|588631054|FG001|Overall Study|Sponsor/Investigator decision|0|||
162980928|NCT00958126|588631055|FG002|Overall Study|Sponsor/Investigator decision|0|||
162980929|NCT00958126|588631056|FG003|Overall Study|Sponsor/Investigator decision|1|||
162980930|NCT00958126|588631057|FG004|Overall Study|Sponsor/Investigator decision|0|||
162980931|NCT00958126|588631058|FG005|Overall Study|Sponsor/Investigator decision|0|||
162980932|NCT00958126|588631059|FG006|Overall Study|Sponsor/Investigator decision|0|||
162980933|NCT00958126|588631060|FG007|Overall Study|Sponsor/Investigator decision|0|||
162980934|NCT00958126|588631053|FG000|Overall Study|Other Reason|0|||
162980935|NCT00958126|588631054|FG001|Overall Study|Other Reason|0|||
162980936|NCT00958126|588631055|FG002|Overall Study|Other Reason|0|||
162980937|NCT00958126|588631056|FG003|Overall Study|Other Reason|1|||
162980938|NCT00958126|588631057|FG004|Overall Study|Other Reason|0|||
162980939|NCT00958126|588631058|FG005|Overall Study|Other Reason|1|||
162980940|NCT00958126|588631059|FG006|Overall Study|Other Reason|0|||
163059093|NCT01288430|588926296|FG004|Part 1|Other|0|||
163059094|NCT01288430|588926297|FG005|Part 1|Other|0|||
163059095|NCT01288430|588926298|FG006|Part 1|Other|1|||
163059096|NCT01288430|588926299|FG007|Part 1|Other|0|||
163059097|NCT01288430|588926300|FG008|Part 1|Other|0|||
163059098|NCT01288430|588926301|FG009|Part 1|Other|0|||
163059099|NCT01288430|588926292|FG000|Part 2|Progressive disease|0|||
163059100|NCT01288430|588926293|FG001|Part 2|Progressive disease|0|||
163059101|NCT01288430|588926294|FG002|Part 2|Progressive disease|0|||
163059102|NCT01288430|588926295|FG003|Part 2|Progressive disease|0|||
162980941|NCT00958126|588631060|FG007|Overall Study|Other Reason|0|||
162980942|NCT00720226|588631061|FG000|Overall Study|Withdrawal by Subject|7|||
163059103|NCT01288430|588926296|FG004|Part 2|Progressive disease|0|||
163059104|NCT01288430|588926297|FG005|Part 2|Progressive disease|0|||
162980943|NCT00720226|588631062|FG001|Overall Study|Withdrawal by Subject|4|||
163059105|NCT01288430|588926298|FG006|Part 2|Progressive disease|0|||
162980944|NCT00733369|588631063|FG000|Overall Study|Lost to Follow-up|2|||
162980945|NCT00733369|588631064|FG001|Overall Study|Lost to Follow-up|1|||
162980946|NCT00733369|588631063|FG000|Overall Study|Adverse Event|4|||
163059106|NCT01288430|588926299|FG007|Part 2|Progressive disease|8|||
163059107|NCT01288430|588926300|FG008|Part 2|Progressive disease|7|||
163059108|NCT01288430|588926301|FG009|Part 2|Progressive disease|2|||
162980947|NCT00733369|588631064|FG001|Overall Study|Adverse Event|4|||
162980948|NCT00733369|588631063|FG000|Overall Study|Protocol Violation|4|||
162980949|NCT00733369|588631064|FG001|Overall Study|Protocol Violation|4|||
162980950|NCT03401073|588631067|FG000|Overall Study|Lost to Follow-up|1|||
162980951|NCT03401073|588631068|FG001|Overall Study|Lost to Follow-up|2|||
162980952|NCT01470612|588631069|FG000|Overall Study|Adverse Event|20|||
162980953|NCT01470612|588631070|FG001|Overall Study|Adverse Event|80|||
162980954|NCT01470612|588631069|FG000|Overall Study|Death|0|||
162980955|NCT01470612|588631070|FG001|Overall Study|Death|1|||
162980956|NCT01470612|588631069|FG000|Overall Study|Lack of Efficacy|20|||
162980957|NCT01470612|588631070|FG001|Overall Study|Lack of Efficacy|326|||
162980958|NCT01470612|588631069|FG000|Overall Study|Lost to Follow-up|2|||
162980959|NCT01470612|588631070|FG001|Overall Study|Lost to Follow-up|5|||
162980960|NCT01470612|588631069|FG000|Overall Study|Did not meet entrance criteria|0|||
162980961|NCT01470612|588631070|FG001|Overall Study|Did not meet entrance criteria|1|||
162980962|NCT01470612|588631069|FG000|Overall Study|Pregnancy|2|||
162980963|NCT01470612|588631070|FG001|Overall Study|Pregnancy|10|||
162980964|NCT01470612|588631069|FG000|Overall Study|Protocol Violation|2|||
162980965|NCT01470612|588631070|FG001|Overall Study|Protocol Violation|7|||
162980966|NCT01470612|588631069|FG000|Overall Study|Withdrawal by Subject|24|||
162980967|NCT01470612|588631070|FG001|Overall Study|Withdrawal by Subject|79|||
162980968|NCT01470612|588631069|FG000|Overall Study|Other|14|||
162980969|NCT01470612|588631070|FG001|Overall Study|Other|156|||
162980970|NCT01020799|588631071|FG000|Overall Study|Adverse Event|4|||
162980971|NCT01020799|588631072|FG001|Overall Study|Adverse Event|3|||
162980972|NCT01020799|588631073|FG002|Overall Study|Adverse Event|2|||
162980973|NCT01020799|588631071|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
162980974|NCT01020799|588631072|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
162980975|NCT01020799|588631073|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
162980976|NCT01020799|588631071|FG000|Overall Study|Protocol Violation|3|||
162980977|NCT01020799|588631072|FG001|Overall Study|Protocol Violation|2|||
162980978|NCT01020799|588631073|FG002|Overall Study|Protocol Violation|0|||
162980979|NCT01020799|588631071|FG000|Overall Study|Withdrawal by Subject|2|||
162980980|NCT01020799|588631072|FG001|Overall Study|Withdrawal by Subject|2|||
162980981|NCT01020799|588631073|FG002|Overall Study|Withdrawal by Subject|3|||
162980982|NCT01020799|588631071|FG000|Overall Study|Lost to Follow-up|6|||
162980983|NCT01020799|588631072|FG001|Overall Study|Lost to Follow-up|4|||
162980984|NCT01020799|588631073|FG002|Overall Study|Lost to Follow-up|2|||
162980985|NCT02556307|588631076|FG000|Overall Study|Premature treatment interruption|11|||
162980986|NCT02556307|588631076|FG000|Overall Study|Lost to Follow-up|36|||
162980987|NCT02556307|588631076|FG000|Overall Study|Change to triple therapy|4|||
162980988|NCT02556307|588631076|FG000|Overall Study|Enrolled but not treated|2|||
162980989|NCT03438227|588631077|FG000|Overall Study|Withdrawal by Subject|10|||
162980990|NCT03438227|588631078|FG001|Overall Study|Withdrawal by Subject|5|||
162980991|NCT03977701|588631079|FG000|Overall Study|COVID-19 pandemic|0|||
162980992|NCT03977701|588631080|FG001|Overall Study|COVID-19 pandemic|0|||
162980993|NCT03977701|588631081|FG002|Overall Study|COVID-19 pandemic|0|||
162980994|NCT03977701|588631082|FG003|Overall Study|COVID-19 pandemic|0|||
162980995|NCT03977701|588631083|FG004|Overall Study|COVID-19 pandemic|0|||
162980996|NCT03977701|588631084|FG005|Overall Study|COVID-19 pandemic|1|||
162980997|NCT03977701|588631085|FG006|Overall Study|COVID-19 pandemic|0|||
162980998|NCT03977701|588631086|FG007|Overall Study|COVID-19 pandemic|1|||
162980999|NCT03977701|588631087|FG008|Overall Study|COVID-19 pandemic|0|||
162981000|NCT03977701|588631088|FG009|Overall Study|COVID-19 pandemic|0|||
162981001|NCT02429934|588631089|FG000|Overall Study|Withdrawal by Subject|0|||
162981002|NCT02429934|588631090|FG001|Overall Study|Withdrawal by Subject|2|||
162981003|NCT02429934|588631089|FG000|Overall Study|Adverse Event|2|||
162981004|NCT02429934|588631090|FG001|Overall Study|Adverse Event|0|||
162981005|NCT02429934|588631089|FG000|Overall Study|Lost to Follow-up|1|||
162981006|NCT02429934|588631090|FG001|Overall Study|Lost to Follow-up|1|||
162981007|NCT02429934|588631089|FG000|Overall Study|Physician Decision|1|||
162981008|NCT02429934|588631090|FG001|Overall Study|Physician Decision|0|||
162981009|NCT00293202|588631091|FG000|Overall Study|Withdrawal by Subject|1|||
162981010|NCT00293202|588631092|FG001|Overall Study|Withdrawal by Subject|2|||
162981011|NCT00293202|588631091|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
162981012|NCT00293202|588631092|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
162981013|NCT00293202|588631091|FG000|Overall Study|on-hold due to fistula maturation time|1|||
162981014|NCT00293202|588631092|FG001|Overall Study|on-hold due to fistula maturation time|0|||
162981015|NCT01244061|588631095|FG000|Overall Study|Death|1|||
162981016|NCT01244061|588631096|FG001|Overall Study|Death|0|||
162981017|NCT01244061|588631095|FG000|Overall Study|Did not meet entrance criteria|1|||
162981018|NCT01244061|588631096|FG001|Overall Study|Did not meet entrance criteria|0|||
162981019|NCT01244061|588631095|FG000|Overall Study|Lack of Efficacy|1|||
162981020|NCT01244061|588631096|FG001|Overall Study|Lack of Efficacy|3|||
162981021|NCT01244061|588631095|FG000|Overall Study|Lost to Follow-up|34|||
162981022|NCT01244061|588631096|FG001|Overall Study|Lost to Follow-up|30|||
162981023|NCT01244061|588631095|FG000|Overall Study|Withdrawal by Subject|29|||
162981024|NCT01244061|588631096|FG001|Overall Study|Withdrawal by Subject|46|||
162981025|NCT01244061|588631095|FG000|Overall Study|Other|8|||
162981026|NCT01244061|588631096|FG001|Overall Study|Other|19|||
162981027|NCT01244061|588631095|FG000|Overall Study|Protocol Violation|1|||
162981028|NCT01244061|588631096|FG001|Overall Study|Protocol Violation|1|||
162981029|NCT01244061|588631095|FG000|Overall Study|Adverse Event|5|||
162981030|NCT01244061|588631096|FG001|Overall Study|Adverse Event|2|||
162981031|NCT01244061|588631095|FG000|Overall Study|Randomized but not treated|2|||
162981032|NCT01244061|588631096|FG001|Overall Study|Randomized but not treated|2|||
162981033|NCT03166124|588631097|FG000|Treatment Period 1|Adverse Event|0|||
162981034|NCT03166124|588631098|FG001|Treatment Period 1|Adverse Event|0|||
162981035|NCT03166124|588631099|FG002|Treatment Period 1|Adverse Event|1|||
162981036|NCT03166124|588631100|FG003|Treatment Period 1|Adverse Event|0|||
162981037|NCT03166124|588631097|FG000|Wash-out Period|Withdrawal by Subject|0|||
162981038|NCT03166124|588631098|FG001|Wash-out Period|Withdrawal by Subject|1|||
162981039|NCT03166124|588631099|FG002|Wash-out Period|Withdrawal by Subject|0|||
162981040|NCT03166124|588631100|FG003|Wash-out Period|Withdrawal by Subject|1|||
162981041|NCT03166124|588631097|FG000|Wash-out Period|Adverse Event|0|||
162981042|NCT03166124|588631098|FG001|Wash-out Period|Adverse Event|1|||
162981043|NCT03166124|588631099|FG002|Wash-out Period|Adverse Event|1|||
162981044|NCT03166124|588631100|FG003|Wash-out Period|Adverse Event|0|||
162981045|NCT00788593|588631101|FG000|Placebo Run-in Phase|Adverse Event|2|||
162981046|NCT00788593|588631102|FG001|Placebo Run-in Phase|Adverse Event|0|||
162981047|NCT00788593|588631103|FG002|Placebo Run-in Phase|Adverse Event|0|||
162981048|NCT00788593|588631101|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
162981049|NCT00788593|588631102|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
162981050|NCT00788593|588631103|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
162981051|NCT00788593|588631101|FG000|Placebo Run-in Phase|Protocol Violation|2|||
162981052|NCT00788593|588631102|FG001|Placebo Run-in Phase|Protocol Violation|0|||
162981053|NCT00788593|588631103|FG002|Placebo Run-in Phase|Protocol Violation|0|||
162981054|NCT00788593|588631101|FG000|First Intervention Period|Adverse Event|0|||
162981055|NCT00788593|588631102|FG001|First Intervention Period|Adverse Event|1|||
162981056|NCT00788593|588631103|FG002|First Intervention Period|Adverse Event|0|||
162981057|NCT00788593|588631101|FG000|Second Intervention Period|Lost to Follow-up|0|||
162981058|NCT00788593|588631102|FG001|Second Intervention Period|Lost to Follow-up|1|||
162981059|NCT00788593|588631103|FG002|Second Intervention Period|Lost to Follow-up|0|||
162981060|NCT00788593|588631101|FG000|Second Intervention Period|Other|0|||
162981061|NCT00788593|588631102|FG001|Second Intervention Period|Other|0|||
162981062|NCT00788593|588631103|FG002|Second Intervention Period|Other|1|||
162981063|NCT01392326|588631104|FG000|Overall Study|Death|2|||
162981064|NCT01392326|588631105|FG001|Overall Study|Death|0|||
162981065|NCT01392326|588631106|FG002|Overall Study|Death|0|||
162981066|NCT01392326|588631104|FG000|Overall Study|Withdrawal by Subject|12|||
162981067|NCT01392326|588631105|FG001|Overall Study|Withdrawal by Subject|11|||
162981068|NCT01392326|588631106|FG002|Overall Study|Withdrawal by Subject|15|||
162981069|NCT01392326|588631104|FG000|Overall Study|Protocol Violation|2|||
162981070|NCT01392326|588631105|FG001|Overall Study|Protocol Violation|0|||
162981071|NCT01392326|588631106|FG002|Overall Study|Protocol Violation|0|||
162981072|NCT01392326|588631104|FG000|Overall Study|Pregnancy|0|||
162981073|NCT01392326|588631105|FG001|Overall Study|Pregnancy|0|||
162981074|NCT01392326|588631106|FG002|Overall Study|Pregnancy|1|||
162981075|NCT01392326|588631104|FG000|Overall Study|Physician Decision|7|||
162981076|NCT01392326|588631105|FG001|Overall Study|Physician Decision|5|||
162981077|NCT01392326|588631106|FG002|Overall Study|Physician Decision|2|||
162981078|NCT01392326|588631104|FG000|Overall Study|Lost to Follow-up|1|||
162981079|NCT01392326|588631105|FG001|Overall Study|Lost to Follow-up|3|||
162981080|NCT01392326|588631106|FG002|Overall Study|Lost to Follow-up|4|||
163059109|NCT01288430|588926292|FG000|Part 2|Clinical disease progression|0|||
163059110|NCT01288430|588926293|FG001|Part 2|Clinical disease progression|0|||
162981081|NCT01392326|588631104|FG000|Overall Study|Lack of Efficacy|14|||
162981082|NCT01392326|588631105|FG001|Overall Study|Lack of Efficacy|10|||
162981083|NCT01392326|588631106|FG002|Overall Study|Lack of Efficacy|15|||
162981084|NCT01392326|588631104|FG000|Overall Study|Adverse Event|9|||
162981085|NCT01392326|588631105|FG001|Overall Study|Adverse Event|6|||
163059111|NCT01288430|588926294|FG002|Part 2|Clinical disease progression|0|||
162981086|NCT01392326|588631106|FG002|Overall Study|Adverse Event|11|||
162981087|NCT00123955|588631109|FG000|Overall Study|Adverse Event|1|||
162981088|NCT00123955|588631110|FG001|Overall Study|Adverse Event|0|||
162981089|NCT00123955|588631109|FG000|Overall Study|Withdrawal by Subject|4|||
162981090|NCT00123955|588631110|FG001|Overall Study|Withdrawal by Subject|3|||
162981091|NCT00123955|588631109|FG000|Overall Study|Death|0|||
162981092|NCT00123955|588631110|FG001|Overall Study|Death|1|||
162981093|NCT04459715|588631115|FG000|Overall Study|Adverse Event|3|||
162981094|NCT04459715|588631116|FG001|Overall Study|Adverse Event|3|||
162981095|NCT04459715|588631115|FG000|Overall Study|Death|111|||
162981096|NCT04459715|588631116|FG001|Overall Study|Death|93|||
162981097|NCT04459715|588631115|FG000|Overall Study|Lost to Follow-up|10|||
162981098|NCT04459715|588631116|FG001|Overall Study|Lost to Follow-up|9|||
162981099|NCT04459715|588631115|FG000|Overall Study|Other Reasons|4|||
162981100|NCT04459715|588631116|FG001|Overall Study|Other Reasons|5|||
162981101|NCT04459715|588631115|FG000|Overall Study|PROTOCOL DEVIATION|0|||
162981102|NCT04459715|588631116|FG001|Overall Study|PROTOCOL DEVIATION|1|||
162981103|NCT04459715|588631115|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
162981104|NCT04459715|588631116|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
162981105|NCT04459715|588631115|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
162981106|NCT04459715|588631116|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
162981107|NCT04459715|588631115|FG000|Overall Study|Withdrawal by Subject|22|||
162981108|NCT04459715|588631116|FG001|Overall Study|Withdrawal by Subject|22|||
162981109|NCT02427984|588631119|FG000|Overall Study|Lost to Follow-up|13|||
162632796|NCT00420927|587369095|FG004|Period 1|Noncompliant with study drug|0|||
162632797|NCT00420927|587369096|FG005|Period 1|Noncompliant with study drug|0|||
162981110|NCT02427984|588631120|FG001|Overall Study|Lost to Follow-up|5|||
162981111|NCT02427984|588631121|FG002|Overall Study|Lost to Follow-up|18|||
162981112|NCT03959527|588632948|FG000|Overall Study|Withdrawal by Subject|8|||
162981113|NCT03959527|588632949|FG001|Overall Study|Withdrawal by Subject|3|||
162981114|NCT03959527|588632948|FG000|Overall Study|Lost to Follow-up|31|||
162981115|NCT03959527|588632949|FG001|Overall Study|Lost to Follow-up|15|||
162981116|NCT03959527|588632948|FG000|Overall Study|Did not meet eligibility criteria|1|||
162981117|NCT03959527|588632949|FG001|Overall Study|Did not meet eligibility criteria|1|||
162981118|NCT03959527|588632948|FG000|Overall Study|Protocol Violation|10|||
162981119|NCT03959527|588632949|FG001|Overall Study|Protocol Violation|5|||
162981120|NCT06029959|588632950|FG000|Overall Study|Physician Decision|6|||
162981121|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
162981122|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981123|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981124|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
162981125|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
162981126|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
162981127|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
162981128|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
162981129|NCT02960893|588632956|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981130|NCT02960893|588632957|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
162981131|NCT02960893|588632958|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981132|NCT02960893|588632959|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
162981133|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
162981134|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
162981135|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
162981136|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
162981137|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
162981138|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
162981139|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
162981140|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
162981141|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
162981142|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
162981143|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
162981144|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
162981145|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
162981146|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
162981147|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
162981148|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
162981149|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
162981150|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
162981151|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
162981152|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
162981153|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
162981154|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
162981155|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
162981156|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
162981157|NCT02960893|588632956|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
162632798|NCT00420927|587369097|FG006|Period 1|Noncompliant with study drug|0|||
162632799|NCT00420927|587369091|FG000|Period 1|Randomization error|1|||
162632800|NCT00420927|587369092|FG001|Period 1|Randomization error|0|||
162632801|NCT00420927|587369093|FG002|Period 1|Randomization error|0|||
162981158|NCT02960893|588632957|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
162981159|NCT02960893|588632958|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
162981160|NCT02960893|588632959|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
162632802|NCT00420927|587369094|FG003|Period 1|Randomization error|0|||
162981161|NCT02631876|588632964|FG000|Overall Study|Death|96|||
162981162|NCT02631876|588632965|FG001|Overall Study|Death|50|||
162981163|NCT02631876|588632964|FG000|Overall Study|Investigator's discretion|1|||
162632803|NCT00420927|587369095|FG004|Period 1|Randomization error|0|||
162981164|NCT02631876|588632965|FG001|Overall Study|Investigator's discretion|0|||
162981165|NCT02631876|588632964|FG000|Overall Study|Lost to Follow-up|2|||
162981166|NCT02631876|588632965|FG001|Overall Study|Lost to Follow-up|0|||
162981167|NCT02631876|588632964|FG000|Overall Study|Withdrawal by Subject|16|||
162981168|NCT02631876|588632965|FG001|Overall Study|Withdrawal by Subject|9|||
162981169|NCT02631876|588632964|FG000|Overall Study|Other than specified|4|||
162981170|NCT02631876|588632965|FG001|Overall Study|Other than specified|4|||
162981171|NCT04285567|588632966|FG000|Overall Study|Death|3|||
162981172|NCT04285567|588632967|FG001|Overall Study|Death|3|||
162981173|NCT04285567|588632966|FG000|Overall Study|Lost to Follow-up|1|||
162981174|NCT04285567|588632967|FG001|Overall Study|Lost to Follow-up|1|||
162981175|NCT04285567|588632966|FG000|Overall Study|Reason Not Specified|1|||
162981176|NCT04285567|588632967|FG001|Overall Study|Reason Not Specified|1|||
162981177|NCT04285567|588632966|FG000|Overall Study|Physician Decision|2|||
162981178|NCT04285567|588632967|FG001|Overall Study|Physician Decision|1|||
162981179|NCT04285567|588632966|FG000|Overall Study|Withdrawal by Subject|2|||
162981180|NCT04285567|588632967|FG001|Overall Study|Withdrawal by Subject|6|||
162981181|NCT04285567|588632966|FG000|Overall Study|Adverse Event|1|||
162981182|NCT04285567|588632967|FG001|Overall Study|Adverse Event|0|||
162981183|NCT04285567|588632966|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
162981184|NCT04285567|588632967|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
162981185|NCT00493779|588632968|FG000|Overall Study|Logistical issue at site|1|||
162981186|NCT02091141|588632970|FG000|Overall Study|Death|280|||
162981187|NCT02091141|588632971|FG001|Overall Study|Death|118|||
162981188|NCT02091141|588632972|FG002|Overall Study|Death|46|||
162981189|NCT02091141|588632973|FG003|Overall Study|Death|13|||
162981190|NCT02091141|588632974|FG004|Overall Study|Death|31|||
162981191|NCT02091141|588632975|FG005|Overall Study|Death|16|||
162981192|NCT02091141|588632976|FG006|Overall Study|Death|12|||
162981193|NCT02091141|588632970|FG000|Overall Study|Withdrawal by Subject|21|||
162981194|NCT02091141|588632971|FG001|Overall Study|Withdrawal by Subject|13|||
162981195|NCT02091141|588632972|FG002|Overall Study|Withdrawal by Subject|3|||
162981196|NCT02091141|588632973|FG003|Overall Study|Withdrawal by Subject|2|||
162981197|NCT02091141|588632974|FG004|Overall Study|Withdrawal by Subject|2|||
162981198|NCT02091141|588632975|FG005|Overall Study|Withdrawal by Subject|3|||
162981199|NCT02091141|588632976|FG006|Overall Study|Withdrawal by Subject|0|||
162981200|NCT02091141|588632970|FG000|Overall Study|Lost to Follow-up|21|||
162981201|NCT02091141|588632971|FG001|Overall Study|Lost to Follow-up|5|||
162981202|NCT02091141|588632972|FG002|Overall Study|Lost to Follow-up|1|||
162981203|NCT02091141|588632973|FG003|Overall Study|Lost to Follow-up|0|||
162981204|NCT02091141|588632974|FG004|Overall Study|Lost to Follow-up|1|||
162981205|NCT02091141|588632975|FG005|Overall Study|Lost to Follow-up|2|||
162981206|NCT02091141|588632976|FG006|Overall Study|Lost to Follow-up|0|||
162981207|NCT02091141|588632970|FG000|Overall Study|Reason Not Specified|6|||
162981208|NCT02091141|588632971|FG001|Overall Study|Reason Not Specified|5|||
162981209|NCT02091141|588632972|FG002|Overall Study|Reason Not Specified|2|||
162981210|NCT02091141|588632973|FG003|Overall Study|Reason Not Specified|0|||
162981211|NCT02091141|588632974|FG004|Overall Study|Reason Not Specified|0|||
162632804|NCT00420927|587369096|FG005|Period 1|Randomization error|0|||
162632805|NCT00420927|587369097|FG006|Period 1|Randomization error|0|||
162632806|NCT00420927|587369091|FG000|Period 1|Suspected tuberculosis/positive test|1|||
162632807|NCT00420927|587369092|FG001|Period 1|Suspected tuberculosis/positive test|1|||
162632808|NCT00420927|587369093|FG002|Period 1|Suspected tuberculosis/positive test|0|||
162632809|NCT00420927|587369094|FG003|Period 1|Suspected tuberculosis/positive test|0|||
162981212|NCT02091141|588632975|FG005|Overall Study|Reason Not Specified|0|||
162981213|NCT02091141|588632976|FG006|Overall Study|Reason Not Specified|1|||
162981214|NCT02091141|588632970|FG000|Overall Study|Study Ended by Sponsor|1|||
162632810|NCT00420927|587369095|FG004|Period 1|Suspected tuberculosis/positive test|0|||
162632811|NCT00420927|587369096|FG005|Period 1|Suspected tuberculosis/positive test|0|||
162632812|NCT00420927|587369097|FG006|Period 1|Suspected tuberculosis/positive test|0|||
162632813|NCT00420927|587369091|FG000|Period 1|Study site closure|0|||
162632814|NCT00420927|587369092|FG001|Period 1|Study site closure|1|||
162632815|NCT00420927|587369093|FG002|Period 1|Study site closure|0|||
162632816|NCT00420927|587369094|FG003|Period 1|Study site closure|0|||
162632817|NCT00420927|587369095|FG004|Period 1|Study site closure|0|||
162632818|NCT00420927|587369096|FG005|Period 1|Study site closure|0|||
162632819|NCT00420927|587369097|FG006|Period 1|Study site closure|0|||
162981215|NCT02091141|588632971|FG001|Overall Study|Study Ended by Sponsor|9|||
162981216|NCT02091141|588632972|FG002|Overall Study|Study Ended by Sponsor|0|||
162981217|NCT02091141|588632973|FG003|Overall Study|Study Ended by Sponsor|0|||
162981218|NCT02091141|588632974|FG004|Overall Study|Study Ended by Sponsor|0|||
162981219|NCT02091141|588632975|FG005|Overall Study|Study Ended by Sponsor|0|||
162981220|NCT02091141|588632976|FG006|Overall Study|Study Ended by Sponsor|0|||
162981221|NCT02091141|588632970|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
162632820|NCT00420927|587369091|FG000|Period 1|Subject received new diagnosis|0|||
162632821|NCT00420927|587369092|FG001|Period 1|Subject received new diagnosis|2|||
162981222|NCT02091141|588632971|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
162981223|NCT02091141|588632972|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981224|NCT02091141|588632973|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981225|NCT02091141|588632974|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981226|NCT02091141|588632975|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981227|NCT02091141|588632976|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
162981228|NCT02246439|588632977|FG000|Overall Study|Adverse Event|3|||
162981229|NCT02246439|588632978|FG001|Overall Study|Adverse Event|0|||
162981230|NCT02246439|588632977|FG000|Overall Study|Lost to Follow-up|7|||
162981231|NCT02246439|588632978|FG001|Overall Study|Lost to Follow-up|5|||
162981232|NCT02246439|588632977|FG000|Overall Study|Protocol Violation|0|||
162981233|NCT02246439|588632978|FG001|Overall Study|Protocol Violation|2|||
162981234|NCT02246439|588632977|FG000|Overall Study|Physician Decision|0|||
162981235|NCT02246439|588632978|FG001|Overall Study|Physician Decision|1|||
162981236|NCT02246439|588632977|FG000|Overall Study|Unkonwn|1|||
162981237|NCT02246439|588632978|FG001|Overall Study|Unkonwn|3|||
162981238|NCT02246439|588632977|FG000|Overall Study|Withdrawal by Subject|1|||
162981239|NCT02246439|588632978|FG001|Overall Study|Withdrawal by Subject|0|||
162981240|NCT03439852|588632981|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
162981241|NCT03439852|588632982|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
162981242|NCT03439852|588632981|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
162981243|NCT03439852|588632982|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
162981244|NCT03439852|588632981|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
162981245|NCT03439852|588632982|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
162981246|NCT04551911|588632983|FG000|Overall Study|Lost to Follow-up|2|||
162981247|NCT04551911|588632984|FG001|Overall Study|Lost to Follow-up|1|||
162981248|NCT04551911|588632983|FG000|Overall Study|Withdrawal by Subject|10|||
162981249|NCT04551911|588632984|FG001|Overall Study|Withdrawal by Subject|10|||
162981250|NCT04551911|588632983|FG000|Overall Study|Did not receive the study drug|3|||
162981251|NCT04551911|588632984|FG001|Overall Study|Did not receive the study drug|4|||
162981252|NCT00866658|588632995|FG000|Overall Study|Adverse Event|5|||
162981253|NCT00866658|588632996|FG001|Overall Study|Adverse Event|14|||
162981254|NCT00866658|588632995|FG000|Overall Study|Lack of Efficacy|2|||
162981255|NCT00866658|588632996|FG001|Overall Study|Lack of Efficacy|1|||
162981256|NCT00866658|588632995|FG000|Overall Study|Withdrawal by Subject|1|||
162981257|NCT00866658|588632996|FG001|Overall Study|Withdrawal by Subject|0|||
162981258|NCT00866658|588632995|FG000|Overall Study|Protocol Violation|1|||
162981259|NCT00866658|588632996|FG001|Overall Study|Protocol Violation|1|||
162981260|NCT00866658|588632995|FG000|Overall Study|Familial and Personal Reasons|4|||
162981261|NCT00866658|588632996|FG001|Overall Study|Familial and Personal Reasons|5|||
162981262|NCT02072148|588632997|FG000|Overall Study|withdrew prior to surgery|23|||
162981263|NCT02072148|588632998|FG001|Overall Study|withdrew prior to surgery|0|||
162981264|NCT02072148|588632999|FG002|Overall Study|withdrew prior to surgery|0|||
162981265|NCT02072148|588632997|FG000|Overall Study|Death|0|||
162981266|NCT02072148|588632998|FG001|Overall Study|Death|0|||
162981267|NCT02072148|588632999|FG002|Overall Study|Death|1|||
162981268|NCT02072148|588632997|FG000|Overall Study|Withdrawal by Subject|0|||
162981269|NCT02072148|588632998|FG001|Overall Study|Withdrawal by Subject|13|||
162981270|NCT02072148|588632999|FG002|Overall Study|Withdrawal by Subject|12|||
162981271|NCT00430495|588633001|FG000|Overall Study|Adverse Event|2|||
162981272|NCT00430495|588633002|FG001|Overall Study|Adverse Event|3|||
162632822|NCT00420927|587369093|FG002|Period 1|Subject received new diagnosis|0|||
162632823|NCT00420927|587369094|FG003|Period 1|Subject received new diagnosis|0|||
162632824|NCT00420927|587369095|FG004|Period 1|Subject received new diagnosis|0|||
162632825|NCT00420927|587369096|FG005|Period 1|Subject received new diagnosis|0|||
162632826|NCT00420927|587369097|FG006|Period 1|Subject received new diagnosis|0|||
162632827|NCT00420927|587369091|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
162632828|NCT00420927|587369092|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
162632829|NCT00420927|587369093|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
162632830|NCT00420927|587369094|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
162981273|NCT00430495|588633003|FG002|Overall Study|Adverse Event|2|||
162981274|NCT00430495|588633004|FG003|Overall Study|Adverse Event|0|||
162981275|NCT00430495|588633001|FG000|Overall Study|Death|0|||
162981276|NCT00430495|588633002|FG001|Overall Study|Death|0|||
162981277|NCT00430495|588633003|FG002|Overall Study|Death|1|||
162981278|NCT00430495|588633004|FG003|Overall Study|Death|0|||
162981279|NCT00430495|588633001|FG000|Overall Study|Lost to Follow-up|0|||
162632831|NCT00420927|587369095|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
162981280|NCT00430495|588633002|FG001|Overall Study|Lost to Follow-up|1|||
162981281|NCT00430495|588633003|FG002|Overall Study|Lost to Follow-up|4|||
162981282|NCT00430495|588633004|FG003|Overall Study|Lost to Follow-up|0|||
162981283|NCT00430495|588633001|FG000|Overall Study|Protocol Violation|1|||
162981284|NCT00430495|588633002|FG001|Overall Study|Protocol Violation|0|||
162981285|NCT00430495|588633003|FG002|Overall Study|Protocol Violation|1|||
162981286|NCT00430495|588633004|FG003|Overall Study|Protocol Violation|0|||
162981287|NCT00430495|588633001|FG000|Overall Study|Disease Progression|1|||
162981288|NCT00430495|588633002|FG001|Overall Study|Disease Progression|1|||
162981289|NCT00430495|588633003|FG002|Overall Study|Disease Progression|0|||
162981290|NCT00430495|588633004|FG003|Overall Study|Disease Progression|0|||
162981291|NCT00430495|588633001|FG000|Overall Study|Other|8|||
162981292|NCT00430495|588633002|FG001|Overall Study|Other|2|||
162981293|NCT00430495|588633003|FG002|Overall Study|Other|5|||
162981294|NCT00430495|588633004|FG003|Overall Study|Other|4|||
162981295|NCT00430495|588633001|FG000|Overall Study|Randomized but not Treated|2|||
162981296|NCT00430495|588633002|FG001|Overall Study|Randomized but not Treated|0|||
162981297|NCT00430495|588633003|FG002|Overall Study|Randomized but not Treated|0|||
162981298|NCT00430495|588633004|FG003|Overall Study|Randomized but not Treated|0|||
162981299|NCT00158756|588633005|FG000|Overall Study|Withdrawal by Subject|5|||
162981300|NCT00158756|588633006|FG001|Overall Study|Withdrawal by Subject|0|||
162981301|NCT00158756|588633007|FG002|Overall Study|Withdrawal by Subject|6|||
162981302|NCT00158756|588633008|FG003|Overall Study|Withdrawal by Subject|1|||
162981303|NCT00158756|588633009|FG004|Overall Study|Withdrawal by Subject|3|||
162981304|NCT00158756|588633005|FG000|Overall Study|Adverse Event|0|||
162981305|NCT00158756|588633006|FG001|Overall Study|Adverse Event|0|||
162981306|NCT00158756|588633007|FG002|Overall Study|Adverse Event|1|||
162981307|NCT00158756|588633008|FG003|Overall Study|Adverse Event|0|||
162981308|NCT00158756|588633009|FG004|Overall Study|Adverse Event|0|||
162981309|NCT00158756|588633005|FG000|Overall Study|Serious adverse event|0|||
162981310|NCT00158756|588633006|FG001|Overall Study|Serious adverse event|0|||
162981311|NCT00158756|588633007|FG002|Overall Study|Serious adverse event|1|||
162981312|NCT00158756|588633008|FG003|Overall Study|Serious adverse event|0|||
162981313|NCT00158756|588633009|FG004|Overall Study|Serious adverse event|0|||
162981314|NCT03656874|588633010|FG000|Overall Study|Lost to Follow-up|3|||
162981315|NCT03656874|588633011|FG001|Overall Study|Lost to Follow-up|17|||
162981316|NCT01206816|588633012|FG000|Overall Study|Protocol Violation|0|||
162981317|NCT01206816|588633013|FG001|Overall Study|Protocol Violation|0|||
162632832|NCT00420927|587369096|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
162632833|NCT00420927|587369097|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
162632834|NCT00420927|587369091|FG000|Period 1|Failed to meet entry criteria|8|||
162632835|NCT00420927|587369092|FG001|Period 1|Failed to meet entry criteria|7|||
162632836|NCT00420927|587369093|FG002|Period 1|Failed to meet entry criteria|0|||
162632837|NCT00420927|587369094|FG003|Period 1|Failed to meet entry criteria|0|||
162981318|NCT01206816|588633014|FG002|Overall Study|Protocol Violation|1|||
162981319|NCT01206816|588633015|FG003|Overall Study|Protocol Violation|0|||
162981320|NCT01206816|588633016|FG004|Overall Study|Protocol Violation|0|||
162981321|NCT01206816|588633017|FG005|Overall Study|Protocol Violation|0|||
162981322|NCT01206816|588633018|FG006|Overall Study|Protocol Violation|0|||
162981323|NCT01206816|588633012|FG000|Overall Study|Withdrawal by Subject|0|||
162981324|NCT01206816|588633013|FG001|Overall Study|Withdrawal by Subject|0|||
162981325|NCT01206816|588633014|FG002|Overall Study|Withdrawal by Subject|1|||
162981326|NCT01206816|588633015|FG003|Overall Study|Withdrawal by Subject|0|||
162981327|NCT01206816|588633016|FG004|Overall Study|Withdrawal by Subject|0|||
162981328|NCT01206816|588633017|FG005|Overall Study|Withdrawal by Subject|0|||
162981329|NCT01206816|588633018|FG006|Overall Study|Withdrawal by Subject|0|||
162981330|NCT01206816|588633012|FG000|Overall Study|Progressive disease|3|||
162981331|NCT01206816|588633013|FG001|Overall Study|Progressive disease|3|||
162981332|NCT01206816|588633014|FG002|Overall Study|Progressive disease|13|||
162981333|NCT01206816|588633015|FG003|Overall Study|Progressive disease|3|||
162981334|NCT01206816|588633016|FG004|Overall Study|Progressive disease|3|||
162981335|NCT01206816|588633017|FG005|Overall Study|Progressive disease|16|||
162981336|NCT01206816|588633018|FG006|Overall Study|Progressive disease|3|||
162981337|NCT01206816|588633012|FG000|Overall Study|Other AE|0|||
162981338|NCT01206816|588633013|FG001|Overall Study|Other AE|0|||
162981339|NCT01206816|588633014|FG002|Overall Study|Other AE|4|||
162981340|NCT01206816|588633015|FG003|Overall Study|Other AE|0|||
162981341|NCT01206816|588633016|FG004|Overall Study|Other AE|0|||
162981342|NCT01206816|588633017|FG005|Overall Study|Other AE|3|||
162981343|NCT01206816|588633018|FG006|Overall Study|Other AE|2|||
162981344|NCT01206816|588633012|FG000|Overall Study|other than stated above|0|||
162981345|NCT01206816|588633013|FG001|Overall Study|other than stated above|0|||
162632838|NCT00420927|587369095|FG004|Period 1|Failed to meet entry criteria|0|||
162981346|NCT01206816|588633014|FG002|Overall Study|other than stated above|1|||
162981347|NCT01206816|588633015|FG003|Overall Study|other than stated above|0|||
162981348|NCT01206816|588633016|FG004|Overall Study|other than stated above|0|||
162981349|NCT01206816|588633017|FG005|Overall Study|other than stated above|0|||
162981350|NCT01206816|588633018|FG006|Overall Study|other than stated above|1|||
162981351|NCT02528123|588633020|FG000|Overall Study|Lost to Follow-up|1|||
162981352|NCT01939496|588633021|FG000|Overall Study|Adverse Event|2|||
162981353|NCT01939496|588633022|FG001|Overall Study|Adverse Event|0|||
162981354|NCT01939496|588633023|FG002|Overall Study|Adverse Event|0|||
162981355|NCT01939496|588633021|FG000|Overall Study|Lost to Follow-up|1|||
162981356|NCT01939496|588633022|FG001|Overall Study|Lost to Follow-up|1|||
162632839|NCT00420927|587369096|FG005|Period 1|Failed to meet entry criteria|0|||
162632840|NCT00420927|587369097|FG006|Period 1|Failed to meet entry criteria|0|||
162632841|NCT00420927|587369091|FG000|Period 1|Took prohibited medication|1|||
162981357|NCT01939496|588633023|FG002|Overall Study|Lost to Follow-up|0|||
162981358|NCT01939496|588633021|FG000|Overall Study|Physician Decision|1|||
162981359|NCT01939496|588633022|FG001|Overall Study|Physician Decision|0|||
162981360|NCT01939496|588633023|FG002|Overall Study|Physician Decision|0|||
162981361|NCT01939496|588633021|FG000|Overall Study|Protocol Violation|3|||
162981362|NCT01939496|588633022|FG001|Overall Study|Protocol Violation|0|||
162981363|NCT01939496|588633023|FG002|Overall Study|Protocol Violation|0|||
162981364|NCT01939496|588633021|FG000|Overall Study|Withdrawal by Subject|0|||
162981365|NCT01939496|588633022|FG001|Overall Study|Withdrawal by Subject|1|||
162981366|NCT01939496|588633023|FG002|Overall Study|Withdrawal by Subject|1|||
162981367|NCT01939496|588633021|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
162981368|NCT01939496|588633022|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
162981369|NCT01939496|588633023|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
162981370|NCT01939496|588633021|FG000|Overall Study|Other|2|||
162981371|NCT01939496|588633022|FG001|Overall Study|Other|0|||
162981372|NCT01939496|588633023|FG002|Overall Study|Other|1|||
162981373|NCT00506129|588633026|FG000|Overall Study|Disease Progression/Relapse|15|||
162981374|NCT00506129|588633026|FG000|Overall Study|Death|7|||
162981375|NCT01642914|588633027|FG000|Overall Study|Adverse Event|11|||
162981376|NCT01642914|588633028|FG001|Overall Study|Adverse Event|7|||
162981377|NCT01642914|588633029|FG002|Overall Study|Adverse Event|15|||
162981378|NCT01642914|588633027|FG000|Overall Study|Lack of Efficacy|9|||
162981379|NCT01642914|588633028|FG001|Overall Study|Lack of Efficacy|4|||
162981380|NCT01642914|588633029|FG002|Overall Study|Lack of Efficacy|2|||
162981381|NCT01642914|588633027|FG000|Overall Study|Protocol Violation|15|||
162981382|NCT01642914|588633028|FG001|Overall Study|Protocol Violation|13|||
162981383|NCT01642914|588633029|FG002|Overall Study|Protocol Violation|6|||
162981384|NCT01642914|588633027|FG000|Overall Study|Withdrawal by Subject|5|||
162981385|NCT01642914|588633028|FG001|Overall Study|Withdrawal by Subject|5|||
162981386|NCT01642914|588633029|FG002|Overall Study|Withdrawal by Subject|10|||
162981387|NCT01642914|588633027|FG000|Overall Study|Lost to Follow-up|5|||
162981388|NCT01642914|588633028|FG001|Overall Study|Lost to Follow-up|3|||
162981389|NCT01642914|588633029|FG002|Overall Study|Lost to Follow-up|7|||
162981390|NCT01642914|588633027|FG000|Overall Study|Other Reason|1|||
162981391|NCT01642914|588633028|FG001|Overall Study|Other Reason|0|||
162981392|NCT01642914|588633029|FG002|Overall Study|Other Reason|0|||
162981393|NCT04295135|588633030|FG000|Overall Study|Withdrawal by Subject|2|||
162981394|NCT04295135|588633031|FG001|Overall Study|Withdrawal by Subject|1|||
162981395|NCT04295135|588633030|FG000|Overall Study|Subject left organization|8|||
162981396|NCT04295135|588633031|FG001|Overall Study|Subject left organization|4|||
162981397|NCT02923674|588633032|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
162981398|NCT02923674|588633033|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
162981399|NCT02923674|588633034|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
162981400|NCT02923674|588633032|FG000|Overall Study|Lost to Follow-up|7|||
162981401|NCT02923674|588633033|FG001|Overall Study|Lost to Follow-up|12|||
162981402|NCT02923674|588633034|FG002|Overall Study|Lost to Follow-up|7|||
162981403|NCT02923674|588633032|FG000|Overall Study|Problem with intervention|2|||
162981404|NCT02923674|588633033|FG001|Overall Study|Problem with intervention|2|||
162981405|NCT02923674|588633034|FG002|Overall Study|Problem with intervention|1|||
162981406|NCT02923674|588633032|FG000|Overall Study|Adverse Event|3|||
162981407|NCT02923674|588633033|FG001|Overall Study|Adverse Event|1|||
162981408|NCT02923674|588633034|FG002|Overall Study|Adverse Event|1|||
162981409|NCT02923674|588633032|FG000|Overall Study|Withdrawal by Subject|2|||
162981410|NCT02923674|588633033|FG001|Overall Study|Withdrawal by Subject|2|||
162981411|NCT02923674|588633034|FG002|Overall Study|Withdrawal by Subject|2|||
162981412|NCT02712333|588633038|FG000|First Period|Withdrawal by Subject|3|||
162981413|NCT02712333|588633039|FG001|First Period|Withdrawal by Subject|2|||
162981414|NCT03463993|588633040|FG000|Overall Study|Lost to Follow-up|7|||
162632842|NCT00420927|587369092|FG001|Period 1|Took prohibited medication|3|||
162632843|NCT00420927|587369093|FG002|Period 1|Took prohibited medication|0|||
162632844|NCT00420927|587369094|FG003|Period 1|Took prohibited medication|0|||
162632845|NCT00420927|587369095|FG004|Period 1|Took prohibited medication|0|||
162632846|NCT00420927|587369096|FG005|Period 1|Took prohibited medication|0|||
162981415|NCT03463993|588633041|FG001|Overall Study|Lost to Follow-up|8|||
162981416|NCT03463993|588633040|FG000|Overall Study|Withdrawal by Subject|2|||
162981417|NCT03463993|588633041|FG001|Overall Study|Withdrawal by Subject|0|||
162981418|NCT03463993|588633040|FG000|Overall Study|Protocol Violation|4|||
162981419|NCT03463993|588633041|FG001|Overall Study|Protocol Violation|1|||
162981420|NCT03463993|588633040|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
162981421|NCT03463993|588633041|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
162981422|NCT03463993|588633040|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
162632847|NCT00420927|587369097|FG006|Period 1|Took prohibited medication|0|||
162632848|NCT00420927|587369091|FG000|Period 2|Adverse Event|0|||
163059112|NCT01288430|588926295|FG003|Part 2|Clinical disease progression|0|||
162632849|NCT00420927|587369092|FG001|Period 2|Adverse Event|0|||
162632850|NCT00420927|587369093|FG002|Period 2|Adverse Event|7|||
162632851|NCT00420927|587369094|FG003|Period 2|Adverse Event|3|||
162632852|NCT00420927|587369095|FG004|Period 2|Adverse Event|17|||
162632853|NCT00420927|587369096|FG005|Period 2|Adverse Event|6|||
162632854|NCT00420927|587369097|FG006|Period 2|Adverse Event|20|||
162632855|NCT00420927|587369091|FG000|Period 2|Withdrawal by Subject|0|||
162632856|NCT00420927|587369092|FG001|Period 2|Withdrawal by Subject|0|||
162632857|NCT00420927|587369093|FG002|Period 2|Withdrawal by Subject|1|||
162632858|NCT00420927|587369094|FG003|Period 2|Withdrawal by Subject|3|||
162632859|NCT00420927|587369095|FG004|Period 2|Withdrawal by Subject|11|||
162632860|NCT00420927|587369096|FG005|Period 2|Withdrawal by Subject|2|||
162632861|NCT00420927|587369097|FG006|Period 2|Withdrawal by Subject|12|||
162632862|NCT00420927|587369091|FG000|Period 2|Lost to Follow-up|0|||
162632863|NCT00420927|587369092|FG001|Period 2|Lost to Follow-up|0|||
162632864|NCT00420927|587369093|FG002|Period 2|Lost to Follow-up|2|||
162632865|NCT00420927|587369094|FG003|Period 2|Lost to Follow-up|2|||
162632866|NCT00420927|587369095|FG004|Period 2|Lost to Follow-up|6|||
162632867|NCT00420927|587369096|FG005|Period 2|Lost to Follow-up|3|||
162632868|NCT00420927|587369097|FG006|Period 2|Lost to Follow-up|9|||
162714079|NCT02081391|587662684|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
162714080|NCT02081391|587662681|FG000|12-hour Treatment|Further reasons|2|||
162714081|NCT02081391|587662682|FG001|12-hour Treatment|Further reasons|1|||
162981423|NCT03463993|588633041|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
162981424|NCT01231373|588633048|FG000|Overall Study|Withdrew consent prior to randomization|2|||
162981425|NCT01231373|588633049|FG001|Overall Study|Withdrew consent prior to randomization|1|||
162981426|NCT01231373|588633050|FG002|Overall Study|Withdrew consent prior to randomization|0|||
162981427|NCT01231373|588633051|FG003|Overall Study|Withdrew consent prior to randomization|0|||
162981428|NCT01231373|588633048|FG000|Overall Study|Lost to Follow-up|0|||
162981429|NCT01231373|588633049|FG001|Overall Study|Lost to Follow-up|0|||
162981430|NCT01231373|588633050|FG002|Overall Study|Lost to Follow-up|0|||
162981431|NCT01231373|588633051|FG003|Overall Study|Lost to Follow-up|1|||
162981432|NCT01231373|588633048|FG000|Overall Study|Withdrew Consent|1|||
162981433|NCT01231373|588633049|FG001|Overall Study|Withdrew Consent|0|||
162981434|NCT01231373|588633050|FG002|Overall Study|Withdrew Consent|0|||
162981435|NCT01231373|588633051|FG003|Overall Study|Withdrew Consent|0|||
162981436|NCT01782482|588633052|FG000|Overall Study|Adverse Event|2|||
162981437|NCT01782482|588633053|FG001|Overall Study|Adverse Event|1|||
162981438|NCT01782482|588633052|FG000|Overall Study|Lost to Follow-up|2|||
162981439|NCT01782482|588633053|FG001|Overall Study|Lost to Follow-up|3|||
162981440|NCT01782482|588633052|FG000|Overall Study|Physician Decision|1|||
162981441|NCT01782482|588633053|FG001|Overall Study|Physician Decision|0|||
162981442|NCT01782482|588633052|FG000|Overall Study|Protocol Violation|1|||
162981443|NCT01782482|588633053|FG001|Overall Study|Protocol Violation|0|||
162981444|NCT01782482|588633052|FG000|Overall Study|Withdrawal by Subject|2|||
162981445|NCT01782482|588633053|FG001|Overall Study|Withdrawal by Subject|3|||
162981446|NCT01782482|588633052|FG000|Overall Study|Randomized in Error|2|||
162981447|NCT01782482|588633053|FG001|Overall Study|Randomized in Error|2|||
162981448|NCT01782482|588633052|FG000|Overall Study|Habitually wearing toric lens OS|0|||
162981449|NCT01782482|588633053|FG001|Overall Study|Habitually wearing toric lens OS|1|||
162981450|NCT00757848|588633054|FG000|Overall Study|Voluntary discontinuation|1|||
162981451|NCT00757848|588633055|FG001|Overall Study|Voluntary discontinuation|0|||
162981452|NCT00757848|588633054|FG000|Overall Study|Adverse Event|1|||
162981453|NCT00757848|588633055|FG001|Overall Study|Adverse Event|2|||
162981454|NCT00757848|588633054|FG000|Overall Study|Incorrect enrolment|1|||
162981455|NCT00757848|588633055|FG001|Overall Study|Incorrect enrolment|0|||
162981456|NCT02039414|588633058|FG000|Overall Study|Delivered|1|||
162981457|NCT02039414|588633059|FG001|Overall Study|Delivered|1|||
162981458|NCT02039414|588633058|FG000|Overall Study|Lost to Follow-up|2|||
162981459|NCT02039414|588633059|FG001|Overall Study|Lost to Follow-up|0|||
162981460|NCT02039414|588633058|FG000|Overall Study|Protocol Violation|3|||
162981461|NCT02039414|588633059|FG001|Overall Study|Protocol Violation|1|||
163059113|NCT01288430|588926296|FG004|Part 2|Clinical disease progression|0|||
163059114|NCT01288430|588926297|FG005|Part 2|Clinical disease progression|0|||
162632869|NCT00420927|587369091|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
162632870|NCT00420927|587369092|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
162632871|NCT00420927|587369093|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
162632872|NCT00420927|587369094|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
162714082|NCT02081391|587662683|FG002|12-hour Treatment|Further reasons|0|||
162714083|NCT02081391|587662684|FG003|12-hour Treatment|Further reasons|0|||
162981462|NCT00430950|588633061|FG000|Overall Study|Adverse Event|7|||
162981463|NCT00430950|588633062|FG001|Overall Study|Adverse Event|6|||
162981464|NCT00430950|588633061|FG000|Overall Study|Withdrawal by Subject|1|||
162981465|NCT00430950|588633062|FG001|Overall Study|Withdrawal by Subject|0|||
162632873|NCT00420927|587369095|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
162632874|NCT00420927|587369096|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
162632875|NCT00420927|587369097|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
162632876|NCT00420927|587369091|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
162632877|NCT00420927|587369092|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
162981466|NCT00430950|588633061|FG000|Overall Study|concomitant medication,etc.|5|||
162981467|NCT00430950|588633062|FG001|Overall Study|concomitant medication,etc.|7|||
162981468|NCT00869024|588633063|FG000|Overall Study|Death|2|||
162981469|NCT00869024|588633064|FG001|Overall Study|Death|3|||
162981470|NCT00869024|588633063|FG000|Overall Study|Lost to Follow-up|0|||
162981471|NCT00869024|588633064|FG001|Overall Study|Lost to Follow-up|1|||
162981472|NCT00869024|588633063|FG000|Overall Study|Protocol Violation|0|||
162981473|NCT00869024|588633064|FG001|Overall Study|Protocol Violation|1|||
162632878|NCT00420927|587369093|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
162632879|NCT00420927|587369094|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
162981474|NCT01564459|588633065|FG000|Run-In|Adverse Event|7|||
162981475|NCT01564459|588633066|FG001|Run-In|Adverse Event|0|||
162981476|NCT01564459|588633067|FG002|Run-In|Adverse Event|0|||
162981477|NCT01564459|588633065|FG000|Run-In|Lost to Follow-up|1|||
162981478|NCT01564459|588633066|FG001|Run-In|Lost to Follow-up|0|||
162981479|NCT01564459|588633067|FG002|Run-In|Lost to Follow-up|0|||
162981480|NCT01564459|588633065|FG000|Run-In|Non-compliance with study drug|2|||
162981481|NCT01564459|588633066|FG001|Run-In|Non-compliance with study drug|0|||
162981482|NCT01564459|588633067|FG002|Run-In|Non-compliance with study drug|0|||
162981483|NCT01564459|588633065|FG000|Run-In|Protocol Violation|1|||
162981484|NCT01564459|588633066|FG001|Run-In|Protocol Violation|0|||
162981485|NCT01564459|588633067|FG002|Run-In|Protocol Violation|0|||
162981486|NCT01564459|588633065|FG000|Run-In|Withdrawal by Subject|1|||
162981487|NCT01564459|588633066|FG001|Run-In|Withdrawal by Subject|0|||
162981488|NCT01564459|588633067|FG002|Run-In|Withdrawal by Subject|0|||
162981489|NCT01564459|588633065|FG000|Double-blind Treatment|Adverse Event|0|||
162981490|NCT01564459|588633066|FG001|Double-blind Treatment|Adverse Event|0|||
162981491|NCT01564459|588633067|FG002|Double-blind Treatment|Adverse Event|1|||
162981492|NCT00706992|588633068|FG000|Overall Study|Study termination|5|||
162981493|NCT00706992|588633069|FG001|Overall Study|Study termination|5|||
162981494|NCT00706992|588633070|FG002|Overall Study|Study termination|6|||
162981495|NCT00706992|588633071|FG003|Overall Study|Study termination|2|||
162981496|NCT00706992|588633072|FG004|Overall Study|Study termination|3|||
162981497|NCT00706992|588633073|FG005|Overall Study|Study termination|2|||
162981498|NCT00706992|588633074|FG006|Overall Study|Study termination|3|||
162981499|NCT00706992|588633068|FG000|Overall Study|Disease progression before treatment|0|||
162981500|NCT00706992|588633069|FG001|Overall Study|Disease progression before treatment|0|||
162981501|NCT00706992|588633070|FG002|Overall Study|Disease progression before treatment|0|||
162981502|NCT00706992|588633071|FG003|Overall Study|Disease progression before treatment|0|||
162981503|NCT00706992|588633072|FG004|Overall Study|Disease progression before treatment|1|||
162981504|NCT00706992|588633073|FG005|Overall Study|Disease progression before treatment|0|||
162981505|NCT00706992|588633074|FG006|Overall Study|Disease progression before treatment|0|||
162981506|NCT02025751|588633080|FG000|Overall Study|Lost to Follow-up|1|||
162981507|NCT02025751|588633081|FG001|Overall Study|Lost to Follow-up|0|||
162981508|NCT02025751|588633080|FG000|Overall Study|Adverse Event|0|||
162981509|NCT02025751|588633081|FG001|Overall Study|Adverse Event|1|||
162981510|NCT02025751|588633080|FG000|Overall Study|Physician Decision|0|||
162981511|NCT02025751|588633081|FG001|Overall Study|Physician Decision|1|||
162981512|NCT02025751|588633080|FG000|Overall Study|Withdrawal by Subject|0|||
162981513|NCT02025751|588633081|FG001|Overall Study|Withdrawal by Subject|1|||
162981514|NCT02687360|588633084|FG000|Overall Study|Withdrawal by Subject|3|||
162981515|NCT02687360|588633085|FG001|Overall Study|Withdrawal by Subject|0|||
162981516|NCT00653991|588633086|FG000|3 Month Follow-up|Participant would not respond|150|||
162981517|NCT00653991|588633087|FG001|3 Month Follow-up|Participant would not respond|157|||
162981518|NCT00653991|588633086|FG000|6 Month Follow-up|Participant would not respond|133|||
162981519|NCT00653991|588633087|FG001|6 Month Follow-up|Participant would not respond|141|||
162981520|NCT01568866|588633088|FG000|Overall Study|Disease Progression|208|||
162981521|NCT01568866|588633089|FG001|Overall Study|Disease Progression|183|||
162981522|NCT01568866|588633088|FG000|Overall Study|Adverse Event|94|||
162981523|NCT01568866|588633089|FG001|Overall Study|Adverse Event|96|||
162981524|NCT01568866|588633088|FG000|Overall Study|Patient Request|55|||
162981525|NCT01568866|588633089|FG001|Overall Study|Patient Request|71|||
162632880|NCT00420927|587369095|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
162632881|NCT00420927|587369096|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
162981526|NCT01568866|588633088|FG000|Overall Study|Physician Decision|40|||
162981527|NCT01568866|588633089|FG001|Overall Study|Physician Decision|32|||
162981528|NCT01568866|588633088|FG000|Overall Study|Withdrawal by Subject|19|||
162981529|NCT01568866|588633089|FG001|Overall Study|Withdrawal by Subject|11|||
162981530|NCT01568866|588633088|FG000|Overall Study|Death|10|||
162981531|NCT01568866|588633089|FG001|Overall Study|Death|18|||
162981532|NCT01568866|588633088|FG000|Overall Study|Protocol Non-compliance|2|||
162981533|NCT01568866|588633089|FG001|Overall Study|Protocol Non-compliance|4|||
162981534|NCT01568866|588633088|FG000|Overall Study|Lost to Follow-up|1|||
162981535|NCT01568866|588633089|FG001|Overall Study|Lost to Follow-up|0|||
162981536|NCT01568866|588633088|FG000|Overall Study|Randomized but Not Dosed|9|||
162981537|NCT01568866|588633089|FG001|Overall Study|Randomized but Not Dosed|1|||
162981538|NCT01698775|588633090|FG000|Phase A|Adverse Event|2|||
162981539|NCT01698775|588633091|FG001|Phase A|Adverse Event|1|||
162981540|NCT01698775|588633090|FG000|Phase A|Death|1|||
162981541|NCT01698775|588633091|FG001|Phase A|Death|1|||
162981542|NCT01698775|588633090|FG000|Phase A|Lack of Efficacy|1|||
162981543|NCT01698775|588633091|FG001|Phase A|Lack of Efficacy|0|||
162981544|NCT01698775|588633090|FG000|Phase A|Lost to Follow-up|1|||
162981545|NCT01698775|588633091|FG001|Phase A|Lost to Follow-up|2|||
162981546|NCT01698775|588633090|FG000|Phase A|Protocol Violation|1|||
162981547|NCT01698775|588633091|FG001|Phase A|Protocol Violation|0|||
162981548|NCT01698775|588633090|FG000|Phase A|Withdrawal by Subject|3|||
162981549|NCT01698775|588633091|FG001|Phase A|Withdrawal by Subject|4|||
162981550|NCT01698775|588633090|FG000|Phase A|Kidney [transplant]|0|||
162981551|NCT01698775|588633091|FG001|Phase A|Kidney [transplant]|1|||
162981552|NCT01698775|588633090|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
162981553|NCT01698775|588633091|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
162981554|NCT01698775|588633090|FG000|Phase B|Adverse Event|6|||
162981555|NCT01698775|588633091|FG001|Phase B|Adverse Event|3|||
162981556|NCT01698775|588633090|FG000|Phase B|Death|0|||
162981557|NCT01698775|588633091|FG001|Phase B|Death|1|||
162981558|NCT01698775|588633090|FG000|Phase B|Lack of Efficacy|0|||
162981559|NCT01698775|588633091|FG001|Phase B|Lack of Efficacy|1|||
162981560|NCT01698775|588633090|FG000|Phase B|Lost to Follow-up|0|||
162981561|NCT01698775|588633091|FG001|Phase B|Lost to Follow-up|1|||
162981562|NCT01698775|588633090|FG000|Phase B|Physician Decision|1|||
162981563|NCT01698775|588633091|FG001|Phase B|Physician Decision|1|||
162981564|NCT01698775|588633090|FG000|Phase B|Protocol Violation|1|||
162981565|NCT01698775|588633091|FG001|Phase B|Protocol Violation|1|||
162981566|NCT01698775|588633090|FG000|Phase B|Withdrawal by Subject|6|||
162981567|NCT01698775|588633091|FG001|Phase B|Withdrawal by Subject|2|||
162981568|NCT03864042|588633092|FG000|DDI Phase|Adverse Event|2|||
162981569|NCT03864042|588633093|FG001|DDI Phase|Adverse Event|0|||
162981570|NCT03864042|588633094|FG002|DDI Phase|Adverse Event|0|||
162981571|NCT03864042|588633092|FG000|DDI Phase|Physician Decision|1|||
162981572|NCT03864042|588633093|FG001|DDI Phase|Physician Decision|0|||
162981573|NCT03864042|588633094|FG002|DDI Phase|Physician Decision|0|||
162981574|NCT03864042|588633092|FG000|DDI Phase|Progressive Disease|1|||
162981575|NCT03864042|588633093|FG001|DDI Phase|Progressive Disease|0|||
162981576|NCT03864042|588633094|FG002|DDI Phase|Progressive Disease|0|||
162981577|NCT03864042|588633092|FG000|Post-DDI Phase|Adverse Event|5|||
162981578|NCT03864042|588633093|FG001|Post-DDI Phase|Adverse Event|3|||
162981579|NCT03864042|588633094|FG002|Post-DDI Phase|Adverse Event|2|||
162981580|NCT03864042|588633092|FG000|Post-DDI Phase|Progressive Disease|11|||
162981581|NCT03864042|588633093|FG001|Post-DDI Phase|Progressive Disease|6|||
162981582|NCT03864042|588633094|FG002|Post-DDI Phase|Progressive Disease|13|||
162981583|NCT03864042|588633092|FG000|Post-DDI Phase|Discretion of investigator|1|||
162981584|NCT03864042|588633093|FG001|Post-DDI Phase|Discretion of investigator|1|||
162981585|NCT03864042|588633094|FG002|Post-DDI Phase|Discretion of investigator|0|||
162981586|NCT03864042|588633092|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
162981587|NCT03864042|588633093|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
162981588|NCT03864042|588633094|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
162981589|NCT03864042|588633092|FG000|Post-DDI Phase|Withdrawal of consent|1|||
163059115|NCT01288430|588926298|FG006|Part 2|Clinical disease progression|0|||
163059116|NCT01288430|588926299|FG007|Part 2|Clinical disease progression|2|||
163059117|NCT01288430|588926300|FG008|Part 2|Clinical disease progression|0|||
163059118|NCT01288430|588926301|FG009|Part 2|Clinical disease progression|0|||
163059119|NCT01288430|588926292|FG000|Part 2|Withdrawal by Subject|0|||
162632882|NCT00420927|587369097|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
162632883|NCT00420927|587369091|FG000|Period 2|Subject unable to find transportation|0|||
162632884|NCT00420927|587369092|FG001|Period 2|Subject unable to find transportation|0|||
162632885|NCT00420927|587369093|FG002|Period 2|Subject unable to find transportation|0|||
162981590|NCT03864042|588633093|FG001|Post-DDI Phase|Withdrawal of consent|2|||
162981591|NCT03864042|588633094|FG002|Post-DDI Phase|Withdrawal of consent|0|||
162981592|NCT00766831|588633099|FG000|Overall Study|Withdrawal by Subject|4|||
162981593|NCT00766831|588633099|FG000|Overall Study|Lost to Follow-up|3|||
162632886|NCT00420927|587369094|FG003|Period 2|Subject unable to find transportation|0|||
162632887|NCT00420927|587369095|FG004|Period 2|Subject unable to find transportation|0|||
162981594|NCT00766831|588633099|FG000|Overall Study|Adverse Event|20|||
162981595|NCT00766831|588633099|FG000|Overall Study|Protocol Violation|15|||
162981596|NCT00766831|588633099|FG000|Overall Study|Physician Decision|5|||
162981597|NCT00766831|588633099|FG000|Overall Study|Withdrawal of consent|26|||
162981598|NCT00766831|588633099|FG000|Overall Study|Non cooperation by participants|14|||
162981599|NCT00766831|588633099|FG000|Overall Study|Other|28|||
162981600|NCT00515034|588633102|FG000|Overall Study|Adverse Event|2|||
162981601|NCT00515034|588633103|FG001|Overall Study|Adverse Event|0|||
162981602|NCT00515034|588633104|FG002|Overall Study|Adverse Event|1|||
162981603|NCT00515034|588633105|FG003|Overall Study|Adverse Event|0|||
162981604|NCT00515034|588633102|FG000|Overall Study|Death|4|||
162981605|NCT00515034|588633103|FG001|Overall Study|Death|2|||
162981606|NCT00515034|588633104|FG002|Overall Study|Death|1|||
162981607|NCT00515034|588633105|FG003|Overall Study|Death|3|||
162632888|NCT00420927|587369096|FG005|Period 2|Subject unable to find transportation|0|||
162632889|NCT00420927|587369097|FG006|Period 2|Subject unable to find transportation|1|||
162632890|NCT00420927|587369091|FG000|Period 2|Physician Decision|0|||
162632891|NCT00420927|587369092|FG001|Period 2|Physician Decision|0|||
162632892|NCT00420927|587369093|FG002|Period 2|Physician Decision|0|||
162632893|NCT00420927|587369094|FG003|Period 2|Physician Decision|0|||
162632894|NCT00420927|587369095|FG004|Period 2|Physician Decision|1|||
162632895|NCT00420927|587369096|FG005|Period 2|Physician Decision|1|||
162632896|NCT00420927|587369097|FG006|Period 2|Physician Decision|0|||
162632897|NCT00420927|587369091|FG000|Period 2|Sponsor decision|0|||
162632898|NCT00420927|587369092|FG001|Period 2|Sponsor decision|0|||
162632899|NCT00420927|587369093|FG002|Period 2|Sponsor decision|1|||
162632900|NCT00420927|587369094|FG003|Period 2|Sponsor decision|0|||
162632901|NCT00420927|587369095|FG004|Period 2|Sponsor decision|0|||
162632902|NCT00420927|587369096|FG005|Period 2|Sponsor decision|0|||
162632903|NCT00420927|587369097|FG006|Period 2|Sponsor decision|1|||
162632904|NCT00420927|587369091|FG000|Period 2|Randomization error|0|||
162632905|NCT00420927|587369092|FG001|Period 2|Randomization error|0|||
162632906|NCT00420927|587369093|FG002|Period 2|Randomization error|0|||
162632907|NCT00420927|587369094|FG003|Period 2|Randomization error|0|||
162632908|NCT00420927|587369095|FG004|Period 2|Randomization error|1|||
162632909|NCT00420927|587369096|FG005|Period 2|Randomization error|1|||
162632910|NCT00420927|587369097|FG006|Period 2|Randomization error|0|||
162632911|NCT00420927|587369091|FG000|Period 2|Noncompliant with study drug|0|||
162632912|NCT00420927|587369092|FG001|Period 2|Noncompliant with study drug|0|||
162632913|NCT00420927|587369093|FG002|Period 2|Noncompliant with study drug|0|||
162632914|NCT00420927|587369094|FG003|Period 2|Noncompliant with study drug|1|||
162632915|NCT00420927|587369095|FG004|Period 2|Noncompliant with study drug|0|||
162632916|NCT00420927|587369096|FG005|Period 2|Noncompliant with study drug|0|||
162632917|NCT00420927|587369097|FG006|Period 2|Noncompliant with study drug|2|||
162632918|NCT00420927|587369091|FG000|Period 2|Methotrexate intolerance|0|||
162632919|NCT00420927|587369092|FG001|Period 2|Methotrexate intolerance|0|||
162632920|NCT00420927|587369093|FG002|Period 2|Methotrexate intolerance|0|||
162632921|NCT00420927|587369094|FG003|Period 2|Methotrexate intolerance|0|||
162632922|NCT00420927|587369095|FG004|Period 2|Methotrexate intolerance|0|||
162632923|NCT00420927|587369096|FG005|Period 2|Methotrexate intolerance|0|||
162632924|NCT00420927|587369097|FG006|Period 2|Methotrexate intolerance|1|||
162632925|NCT00420927|587369091|FG000|Period 2|Took prohibited medication|0|||
162632926|NCT00420927|587369092|FG001|Period 2|Took prohibited medication|0|||
162632927|NCT00420927|587369093|FG002|Period 2|Took prohibited medication|0|||
162632928|NCT00420927|587369094|FG003|Period 2|Took prohibited medication|0|||
162632929|NCT00420927|587369095|FG004|Period 2|Took prohibited medication|1|||
162632930|NCT00420927|587369096|FG005|Period 2|Took prohibited medication|0|||
162632931|NCT00420927|587369097|FG006|Period 2|Took prohibited medication|0|||
162632932|NCT04448171|587369098|FG000|Overall Study|Procedure Cancelled|1|||
162632933|NCT04448171|587369099|FG001|Overall Study|Procedure Cancelled|0|||
162632934|NCT04448171|587369098|FG000|Overall Study|Protocol Violation|1|||
162632935|NCT04448171|587369099|FG001|Overall Study|Protocol Violation|0|||
162632936|NCT01025752|587369100|FG000|Overall Study|Lost to Follow-up|7|||
162632937|NCT01025752|587369101|FG001|Overall Study|Lost to Follow-up|10|||
162632938|NCT01025752|587369100|FG000|Overall Study|Physician Decision|1|||
162632939|NCT01025752|587369101|FG001|Overall Study|Physician Decision|3|||
162632940|NCT00855920|587369102|FG000|Overall Study|Protocol Violation|0|||
162632941|NCT00855920|587369103|FG001|Overall Study|Protocol Violation|0|||
162632942|NCT00855920|587369104|FG002|Overall Study|Protocol Violation|2|||
162632943|NCT00855920|587369102|FG000|Overall Study|Adverse Event|2|||
162981608|NCT00515034|588633102|FG000|Overall Study|Withdrawal by Subject|1|||
162981609|NCT00515034|588633103|FG001|Overall Study|Withdrawal by Subject|0|||
162981610|NCT00515034|588633104|FG002|Overall Study|Withdrawal by Subject|3|||
162981611|NCT00515034|588633105|FG003|Overall Study|Withdrawal by Subject|0|||
162981612|NCT00515034|588633102|FG000|Overall Study|Physician Decision|0|||
162632944|NCT00855920|587369103|FG001|Overall Study|Adverse Event|1|||
162632945|NCT00855920|587369104|FG002|Overall Study|Adverse Event|1|||
162632946|NCT00855920|587369102|FG000|Overall Study|Lack of Efficacy|2|||
162632947|NCT00855920|587369103|FG001|Overall Study|Lack of Efficacy|2|||
162632948|NCT00855920|587369104|FG002|Overall Study|Lack of Efficacy|2|||
162632949|NCT00855920|587369102|FG000|Overall Study|Withdrawal by Subject|2|||
162632950|NCT00855920|587369103|FG001|Overall Study|Withdrawal by Subject|3|||
162632951|NCT00855920|587369104|FG002|Overall Study|Withdrawal by Subject|2|||
162632952|NCT00855920|587369102|FG000|Overall Study|Lost to Follow-up|1|||
162632953|NCT00855920|587369103|FG001|Overall Study|Lost to Follow-up|0|||
162632954|NCT00855920|587369104|FG002|Overall Study|Lost to Follow-up|2|||
162632955|NCT00855920|587369102|FG000|Overall Study|Death|0|||
162632956|NCT00855920|587369103|FG001|Overall Study|Death|1|||
162632957|NCT00855920|587369104|FG002|Overall Study|Death|0|||
162632958|NCT00855920|587369102|FG000|Overall Study|Decision by the sponsor|0|||
162632959|NCT00855920|587369103|FG001|Overall Study|Decision by the sponsor|1|||
162632960|NCT00855920|587369104|FG002|Overall Study|Decision by the sponsor|1|||
162632961|NCT00855920|587369102|FG000|Overall Study|Other than specified above|1|||
162981613|NCT00515034|588633103|FG001|Overall Study|Physician Decision|0|||
162632962|NCT00855920|587369103|FG001|Overall Study|Other than specified above|1|||
162632963|NCT00855920|587369104|FG002|Overall Study|Other than specified above|1|||
162632964|NCT01032837|587369107|FG000|Overall Study|Adverse event/internal illness|0|||
162632965|NCT01032837|587369108|FG001|Overall Study|Adverse event/internal illness|1|||
162632966|NCT01032837|587369109|FG002|Overall Study|Adverse event/internal illness|0|||
162632967|NCT01032837|587369110|FG003|Overall Study|Adverse event/internal illness|1|||
162632968|NCT01032837|587369107|FG000|Overall Study|Withdrew consent|0|||
162632969|NCT01032837|587369108|FG001|Overall Study|Withdrew consent|2|||
162632970|NCT01032837|587369109|FG002|Overall Study|Withdrew consent|0|||
162632971|NCT01032837|587369110|FG003|Overall Study|Withdrew consent|1|||
162632972|NCT01032837|587369107|FG000|Overall Study|Failed to return|0|||
162632973|NCT01032837|587369108|FG001|Overall Study|Failed to return|0|||
162632974|NCT01032837|587369109|FG002|Overall Study|Failed to return|1|||
162632975|NCT01032837|587369110|FG003|Overall Study|Failed to return|0|||
162632976|NCT01032837|587369107|FG000|Overall Study|Refused treatment|0|||
162632977|NCT01032837|587369108|FG001|Overall Study|Refused treatment|0|||
162632978|NCT01032837|587369109|FG002|Overall Study|Refused treatment|0|||
162632979|NCT01032837|587369110|FG003|Overall Study|Refused treatment|1|||
162632980|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
162632981|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
162632982|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162632983|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162632984|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162632985|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162632986|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
162632987|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
162632988|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162632989|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162632990|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162632991|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162632992|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
162632993|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
162632994|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162632995|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162632996|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162632997|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162632998|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
162632999|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
162633000|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162633001|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162633002|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162633003|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162633004|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
162633005|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
162633006|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162633007|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162633008|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162633009|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162633010|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162633011|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
162633012|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162633013|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162633014|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162633015|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162633016|NCT00843024|587369111|FG000|Single-blind Placebo Run-In Phase|Other|0|||
162633017|NCT00843024|587369112|FG001|Single-blind Placebo Run-In Phase|Other|1|||
162633018|NCT00843024|587369113|FG002|Single-blind Placebo Run-In Phase|Other|0|||
162633019|NCT00843024|587369114|FG003|Single-blind Placebo Run-In Phase|Other|0|||
162633020|NCT00843024|587369115|FG004|Single-blind Placebo Run-In Phase|Other|0|||
162633021|NCT00843024|587369116|FG005|Single-blind Placebo Run-In Phase|Other|0|||
162633022|NCT00843024|587369111|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
162633023|NCT00843024|587369112|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
162633024|NCT00843024|587369113|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
162633025|NCT00843024|587369114|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
162633026|NCT00843024|587369115|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
162633027|NCT00843024|587369116|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
162714084|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
162981614|NCT00515034|588633104|FG002|Overall Study|Physician Decision|1|||
162981615|NCT00515034|588633105|FG003|Overall Study|Physician Decision|1|||
162981616|NCT00515034|588633102|FG000|Overall Study|Other|1|||
162981617|NCT00515034|588633103|FG001|Overall Study|Other|0|||
162981618|NCT00515034|588633104|FG002|Overall Study|Other|2|||
162981619|NCT00515034|588633105|FG003|Overall Study|Other|1|||
162981620|NCT03487848|588633106|FG000|Overall Study|Lost to Follow-up|1|||
162981621|NCT00094094|588633107|FG000|Overall Study|Death|2|||
162981622|NCT00094094|588633107|FG000|Overall Study|Lack of Efficacy|23|||
162981623|NCT00094094|588633107|FG000|Overall Study|Adverse Event|7|||
162981624|NCT04189445|588634452|FG000|Overall Study|Withdrawal of consent|8|||
162981625|NCT04189445|588634453|FG001|Overall Study|Withdrawal of consent|1|||
162981626|NCT04189445|588634454|FG002|Overall Study|Withdrawal of consent|0|||
162981627|NCT04189445|588634452|FG000|Overall Study|Study Terminated by Sponsor|25|||
162981628|NCT04189445|588634453|FG001|Overall Study|Study Terminated by Sponsor|3|||
162981629|NCT04189445|588634454|FG002|Overall Study|Study Terminated by Sponsor|0|||
162981630|NCT04189445|588634452|FG000|Overall Study|Death|54|||
162981631|NCT04189445|588634453|FG001|Overall Study|Death|24|||
162981632|NCT04189445|588634454|FG002|Overall Study|Death|0|||
162981633|NCT00003138|588634455|FG000|Step 1|Reasons off treatment not documented|60|||
162981634|NCT00003138|588634456|FG001|Step 1|Reasons off treatment not documented|57|||
162981635|NCT00003138|588634455|FG000|Step 1|Never started treatment|1|||
162981636|NCT00003138|588634456|FG001|Step 1|Never started treatment|0|||
162981637|NCT00003138|588634455|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
162981638|NCT00003138|588634456|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
162981639|NCT00003138|588634455|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
162981640|NCT00003138|588634456|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
162981641|NCT00003138|588634455|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
162981642|NCT00003138|588634456|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
162981643|NCT00003138|588634455|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
162981644|NCT00003138|588634456|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
162981645|NCT05142566|588634457|FG000|Overall Study|Protocol Violation|1|||
162981646|NCT04556552|588634458|FG000|Overall Study|Lost to Follow-up|1|||
162981647|NCT04556552|588634459|FG001|Overall Study|Lost to Follow-up|0|||
162981648|NCT04556552|588634458|FG000|Overall Study|Claustrophobia|0|||
162981649|NCT04556552|588634459|FG001|Overall Study|Claustrophobia|1|||
162981650|NCT04556552|588634458|FG000|Overall Study|Inability to continue|0|||
162981651|NCT04556552|588634459|FG001|Overall Study|Inability to continue|1|||
162981652|NCT00605865|588634460|FG000|Overall Study|Protocol Violation|115|||
162981653|NCT02856880|588634466|FG000|Overall Study|Withdrawal of consent|1|||
162981654|NCT00094458|588634467|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
162981655|NCT00094458|588634468|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
162981656|NCT00094458|588634469|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
162981657|NCT00094458|588634470|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981658|NCT00094458|588634471|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981659|NCT00094458|588634472|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
162981660|NCT00094458|588634467|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
162981661|NCT00094458|588634468|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
162981662|NCT00094458|588634469|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
162981663|NCT00094458|588634470|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
162981664|NCT00094458|588634471|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
162981665|NCT00094458|588634472|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
162981666|NCT00094458|588634467|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
162981667|NCT00094458|588634468|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
162981668|NCT00094458|588634469|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
162981669|NCT00094458|588634470|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981670|NCT00094458|588634471|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981671|NCT00094458|588634472|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
162981672|NCT00094458|588634467|FG000|Main Study: Through Week 30|Adverse Event|38|||
162981673|NCT00094458|588634468|FG001|Main Study: Through Week 30|Adverse Event|20|||
162981674|NCT00094458|588634469|FG002|Main Study: Through Week 30|Adverse Event|28|||
162981675|NCT00094458|588634470|FG003|Main Study: Through Week 30|Adverse Event|0|||
162981676|NCT00094458|588634471|FG004|Main Study: Through Week 30|Adverse Event|0|||
162981677|NCT00094458|588634472|FG005|Main Study: Through Week 30|Adverse Event|0|||
162981678|NCT00094458|588634467|FG000|Main Study: Through Week 30|Death|1|||
162981679|NCT00094458|588634468|FG001|Main Study: Through Week 30|Death|0|||
162981680|NCT00094458|588634469|FG002|Main Study: Through Week 30|Death|0|||
162981681|NCT00094458|588634470|FG003|Main Study: Through Week 30|Death|0|||
162981682|NCT00094458|588634471|FG004|Main Study: Through Week 30|Death|0|||
162981683|NCT00094458|588634472|FG005|Main Study: Through Week 30|Death|0|||
162981684|NCT00094458|588634467|FG000|Main Study: Through Week 30|Other|19|||
162981685|NCT00094458|588634468|FG001|Main Study: Through Week 30|Other|16|||
162981686|NCT00094458|588634469|FG002|Main Study: Through Week 30|Other|9|||
162981687|NCT00094458|588634470|FG003|Main Study: Through Week 30|Other|0|||
162981688|NCT00094458|588634471|FG004|Main Study: Through Week 30|Other|0|||
162981689|NCT00094458|588634472|FG005|Main Study: Through Week 30|Other|0|||
162633028|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162633029|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
162633030|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
162633031|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
162633032|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
162633033|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
162633034|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162633035|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162633036|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162633037|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
162633038|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162633039|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
162633040|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
162633041|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
162633042|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
162633043|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
162633044|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
162633045|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
162633046|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Physician Decision|0|||
162633047|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Physician Decision|0|||
162633048|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Physician Decision|0|||
162633049|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Physician Decision|3|||
162633050|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Physician Decision|1|||
162633051|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Physician Decision|1|||
162633052|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Adverse Event|0|||
162633053|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Adverse Event|0|||
162633054|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Adverse Event|0|||
162633055|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Adverse Event|0|||
162633056|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Adverse Event|1|||
162633057|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Adverse Event|1|||
162633058|NCT00843024|587369111|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
162633059|NCT00843024|587369112|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
162633060|NCT00843024|587369113|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
162633061|NCT00843024|587369114|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
162633062|NCT00843024|587369115|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
162633063|NCT00843024|587369116|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
162633064|NCT05201703|587369117|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
162633065|NCT05201703|587369118|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
162633066|NCT05201703|587369117|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
162633067|NCT05201703|587369118|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
162633068|NCT00844896|587369119|FG000|Overall Study|Lost to Follow-up|12|||
162633069|NCT00844896|587369120|FG001|Overall Study|Lost to Follow-up|16|||
162633070|NCT00844896|587369119|FG000|Overall Study|Parents did not have time to complete|0|||
162633071|NCT00844896|587369120|FG001|Overall Study|Parents did not have time to complete|1|||
162633072|NCT00458211|587369121|FG000|Overall Study|Lack of Efficacy|12|||
162633073|NCT00458211|587369121|FG000|Overall Study|Withdrawal by Subject|2|||
162633074|NCT00458211|587369121|FG000|Overall Study|Protocol Violation|2|||
162981690|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
162981691|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
162981692|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
162633075|NCT02132130|587369122|FG000|Overall Study|Lost to Follow-up|0|||
162633076|NCT02132130|587369123|FG001|Overall Study|Lost to Follow-up|2|||
162633077|NCT02132130|587369124|FG002|Overall Study|Lost to Follow-up|0|||
162633078|NCT02132130|587369125|FG003|Overall Study|Lost to Follow-up|0|||
162633079|NCT02132130|587369122|FG000|Overall Study|Withdrawal by Subject|0|||
162633080|NCT02132130|587369123|FG001|Overall Study|Withdrawal by Subject|0|||
162633081|NCT02132130|587369124|FG002|Overall Study|Withdrawal by Subject|0|||
162633082|NCT02132130|587369125|FG003|Overall Study|Withdrawal by Subject|1|||
162633083|NCT00679302|587369126|FG000|Overall Study|Lost to Follow-up|8|||
162633084|NCT00679302|587369127|FG001|Overall Study|Lost to Follow-up|4|||
162633085|NCT04656691|587369128|FG000|Overall Study|Adverse Event|1|||
162633086|NCT00439244|587369131|FG000|Overall Study|Adverse Event|5|||
162633087|NCT00439244|587369132|FG001|Overall Study|Adverse Event|2|||
162633088|NCT00439244|587369133|FG002|Overall Study|Adverse Event|3|||
162633089|NCT00439244|587369131|FG000|Overall Study|Withdrawal by Subject|3|||
162633090|NCT00439244|587369132|FG001|Overall Study|Withdrawal by Subject|1|||
162633091|NCT00439244|587369133|FG002|Overall Study|Withdrawal by Subject|2|||
162633092|NCT00439244|587369131|FG000|Overall Study|Lost to Follow-up|2|||
162633093|NCT00439244|587369132|FG001|Overall Study|Lost to Follow-up|1|||
162633094|NCT00439244|587369133|FG002|Overall Study|Lost to Follow-up|2|||
162633095|NCT00439244|587369131|FG000|Overall Study|Death|0|||
162633096|NCT00439244|587369132|FG001|Overall Study|Death|1|||
162633097|NCT00439244|587369133|FG002|Overall Study|Death|0|||
162633098|NCT00439244|587369131|FG000|Overall Study|Protocol Violation|0|||
162633099|NCT00439244|587369132|FG001|Overall Study|Protocol Violation|1|||
162633100|NCT00439244|587369133|FG002|Overall Study|Protocol Violation|0|||
162633101|NCT00439244|587369131|FG000|Overall Study|Administrative problems|1|||
162633102|NCT00439244|587369132|FG001|Overall Study|Administrative problems|0|||
162633103|NCT00439244|587369133|FG002|Overall Study|Administrative problems|0|||
162633104|NCT04600921|587369134|FG000|Overall Study|Withdrawal by Subject|3|||
162633105|NCT04600921|587369135|FG001|Overall Study|Withdrawal by Subject|5|||
162633106|NCT04600921|587369134|FG000|Overall Study|Death|0|||
162633107|NCT04600921|587369135|FG001|Overall Study|Death|1|||
162633108|NCT05425745|587369139|FG000|Overall Study|Withdrawal of Consent|3|||
162633109|NCT05425745|587369140|FG001|Overall Study|Withdrawal of Consent|3|||
162633110|NCT05425745|587369139|FG000|Overall Study|Death|2|||
162633111|NCT05425745|587369140|FG001|Overall Study|Death|3|||
162633112|NCT05425745|587369139|FG000|Overall Study|Lost to Follow-up|1|||
162633113|NCT05425745|587369140|FG001|Overall Study|Lost to Follow-up|2|||
162633114|NCT05425745|587369139|FG000|Overall Study|Adverse Event|0|||
162633115|NCT05425745|587369140|FG001|Overall Study|Adverse Event|1|||
162633116|NCT05425745|587369139|FG000|Overall Study|Did not return for end of study visit|0|||
162633117|NCT05425745|587369140|FG001|Overall Study|Did not return for end of study visit|1|||
162633118|NCT05425745|587369139|FG000|Overall Study|End of study visit completed by phone|1|||
162633119|NCT05425745|587369140|FG001|Overall Study|End of study visit completed by phone|0|||
162633120|NCT05425745|587369139|FG000|Overall Study|Subject decision|1|||
162633121|NCT05425745|587369140|FG001|Overall Study|Subject decision|0|||
162633122|NCT02700815|587370533|FG000|Overall Study|Adverse Event|0|||
162633123|NCT02700815|587370534|FG001|Overall Study|Adverse Event|6|||
162633124|NCT02700815|587370535|FG002|Overall Study|Adverse Event|2|||
162633125|NCT02700815|587370536|FG003|Overall Study|Adverse Event|3|||
162633126|NCT02700815|587370533|FG000|Overall Study|Lack of Efficacy|0|||
162633127|NCT02700815|587370534|FG001|Overall Study|Lack of Efficacy|0|||
162633128|NCT02700815|587370535|FG002|Overall Study|Lack of Efficacy|1|||
162633129|NCT02700815|587370536|FG003|Overall Study|Lack of Efficacy|2|||
162633130|NCT02700815|587370533|FG000|Overall Study|Lost to Follow-up|1|||
162633131|NCT02700815|587370534|FG001|Overall Study|Lost to Follow-up|0|||
162633132|NCT02700815|587370535|FG002|Overall Study|Lost to Follow-up|0|||
162633133|NCT02700815|587370536|FG003|Overall Study|Lost to Follow-up|1|||
162633134|NCT02700815|587370533|FG000|Overall Study|Refusal to continue medication|0|||
162633135|NCT02700815|587370534|FG001|Overall Study|Refusal to continue medication|1|||
162633136|NCT02700815|587370535|FG002|Overall Study|Refusal to continue medication|0|||
162633137|NCT02700815|587370536|FG003|Overall Study|Refusal to continue medication|1|||
162633138|NCT02700815|587370533|FG000|Overall Study|Withdrawal by Subject|0|||
162633139|NCT02700815|587370534|FG001|Overall Study|Withdrawal by Subject|0|||
162633140|NCT02700815|587370535|FG002|Overall Study|Withdrawal by Subject|1|||
162633141|NCT02700815|587370536|FG003|Overall Study|Withdrawal by Subject|0|||
162633142|NCT02239978|587370540|FG000|Overall Study|Withdrawal by Subject|2|||
162633143|NCT02239978|587370541|FG001|Overall Study|Withdrawal by Subject|0|||
162633144|NCT03909295|587370545|FG000|Overall Study|Adverse Event|2|||
162633145|NCT03909295|587370545|FG000|Overall Study|Study terminated by sponsor|50|||
162633146|NCT03312933|587370549|FG000|Overall Study|Protocol Violation|15|||
162633147|NCT03312933|587370549|FG000|Overall Study|Lost to Follow-up|36|||
162633148|NCT03312933|587370549|FG000|Overall Study|Withdrawal by Subject|3|||
162633149|NCT00848081|587370551|FG000|Overall Study|Adverse Event|6|||
162633150|NCT00848081|587370552|FG001|Overall Study|Adverse Event|7|||
162633151|NCT00848081|587370551|FG000|Overall Study|Protocol Violation|8|||
162633152|NCT00848081|587370552|FG001|Overall Study|Protocol Violation|5|||
162633153|NCT00848081|587370551|FG000|Overall Study|Lost to Follow-up|1|||
162633154|NCT00848081|587370552|FG001|Overall Study|Lost to Follow-up|0|||
162633155|NCT00848081|587370551|FG000|Overall Study|Physician Decision|0|||
162633156|NCT00848081|587370552|FG001|Overall Study|Physician Decision|3|||
162633157|NCT00848081|587370551|FG000|Overall Study|Withdrawal by Subject|5|||
162633158|NCT00848081|587370552|FG001|Overall Study|Withdrawal by Subject|3|||
162633159|NCT01752907|587370553|FG000|Overall Study|Withdrawal by Subject|4|||
162633160|NCT01752907|587370554|FG001|Overall Study|Withdrawal by Subject|10|||
162633161|NCT01752907|587370553|FG000|Overall Study|Lost to Follow-up|2|||
162633162|NCT01752907|587370554|FG001|Overall Study|Lost to Follow-up|1|||
162633163|NCT01752907|587370553|FG000|Overall Study|Decision by Sponsor|6|||
162633164|NCT01752907|587370554|FG001|Overall Study|Decision by Sponsor|9|||
162633165|NCT03098550|587370555|FG000|Overall Study|Disease Progression|30|||
162633166|NCT03098550|587370556|FG001|Overall Study|Disease Progression|19|||
162633167|NCT03098550|587370557|FG002|Overall Study|Disease Progression|41|||
162633168|NCT03098550|587370555|FG000|Overall Study|Study Drug Toxicity|2|||
162633169|NCT03098550|587370556|FG001|Overall Study|Study Drug Toxicity|1|||
162633170|NCT03098550|587370557|FG002|Overall Study|Study Drug Toxicity|0|||
162633171|NCT03098550|587370555|FG000|Overall Study|Death|1|||
162633172|NCT03098550|587370556|FG001|Overall Study|Death|0|||
162633173|NCT03098550|587370557|FG002|Overall Study|Death|0|||
162633174|NCT03098550|587370555|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
162633175|NCT03098550|587370556|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
162633176|NCT03098550|587370557|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
162633177|NCT03098550|587370555|FG000|Overall Study|Administrative reason by sponsor|0|||
162633178|NCT03098550|587370556|FG001|Overall Study|Administrative reason by sponsor|0|||
162633179|NCT03098550|587370557|FG002|Overall Study|Administrative reason by sponsor|1|||
162633180|NCT03098550|587370555|FG000|Overall Study|Other reasons|2|||
162633181|NCT03098550|587370556|FG001|Overall Study|Other reasons|0|||
162633182|NCT03098550|587370557|FG002|Overall Study|Other reasons|0|||
162633183|NCT00630396|587370561|FG000|Overall Study|Death|4|||
162633184|NCT00630396|587370561|FG000|Overall Study|Lost to Follow-up|3|||
162633185|NCT02990910|587370565|FG000|Overall Study|Lack of Efficacy|6|||
162633186|NCT02990910|587370566|FG001|Overall Study|Lack of Efficacy|10|||
162633187|NCT02064868|587370568|FG000|Overall Study|Lost to Follow-up|14|||
162633188|NCT02064868|587370569|FG001|Overall Study|Lost to Follow-up|8|||
162633189|NCT02064868|587370568|FG000|Overall Study|Physician Decision|1|||
162633190|NCT02064868|587370569|FG001|Overall Study|Physician Decision|0|||
162633191|NCT02064868|587370568|FG000|Overall Study|Withdrawal by Subject|14|||
162633192|NCT02064868|587370569|FG001|Overall Study|Withdrawal by Subject|3|||
162633193|NCT02064868|587370568|FG000|Overall Study|Technical Problems or Missing|5|||
162633194|NCT02064868|587370569|FG001|Overall Study|Technical Problems or Missing|2|||
162633195|NCT00482612|587370570|FG000|In-treatment Period|No study medication administered|0|||
162633196|NCT00482612|587370571|FG001|In-treatment Period|No study medication administered|0|||
162633197|NCT00482612|587370572|FG002|In-treatment Period|No study medication administered|1|||
162633198|NCT00482612|587370573|FG003|In-treatment Period|No study medication administered|0|||
162633199|NCT00482612|587370570|FG000|Follow-up Period|Other|4|||
162633200|NCT00482612|587370571|FG001|Follow-up Period|Other|2|||
162633201|NCT00482612|587370572|FG002|Follow-up Period|Other|1|||
162633202|NCT00482612|587370573|FG003|Follow-up Period|Other|2|||
162633203|NCT00482612|587370570|FG000|Follow-up Period|Lack of compliance|0|||
162633204|NCT00482612|587370571|FG001|Follow-up Period|Lack of compliance|0|||
162633205|NCT00482612|587370572|FG002|Follow-up Period|Lack of compliance|1|||
162633206|NCT00482612|587370573|FG003|Follow-up Period|Lack of compliance|0|||
162633207|NCT00482612|587370570|FG000|Follow-up Period|Lost to Follow-up|0|||
162633208|NCT00482612|587370571|FG001|Follow-up Period|Lost to Follow-up|4|||
162633209|NCT00482612|587370572|FG002|Follow-up Period|Lost to Follow-up|2|||
162633210|NCT00482612|587370573|FG003|Follow-up Period|Lost to Follow-up|1|||
162633211|NCT00482612|587370570|FG000|Follow-up Period|Adverse Event|4|||
162633212|NCT00482612|587370571|FG001|Follow-up Period|Adverse Event|7|||
162633213|NCT00482612|587370572|FG002|Follow-up Period|Adverse Event|9|||
162633214|NCT00482612|587370573|FG003|Follow-up Period|Adverse Event|0|||
162633215|NCT00482612|587370570|FG000|Follow-up Period|Lack of Efficacy|2|||
162633216|NCT00482612|587370571|FG001|Follow-up Period|Lack of Efficacy|0|||
162633217|NCT00482612|587370572|FG002|Follow-up Period|Lack of Efficacy|1|||
162633218|NCT00482612|587370573|FG003|Follow-up Period|Lack of Efficacy|0|||
162633219|NCT00482612|587370570|FG000|Follow-up Period|Withdrawal by Subject|3|||
162633220|NCT00482612|587370571|FG001|Follow-up Period|Withdrawal by Subject|5|||
162633221|NCT00482612|587370572|FG002|Follow-up Period|Withdrawal by Subject|7|||
162633222|NCT00482612|587370573|FG003|Follow-up Period|Withdrawal by Subject|2|||
162633223|NCT00482612|587370570|FG000|Follow-up Period|Reasons not related to trial|1|||
162633224|NCT00482612|587370571|FG001|Follow-up Period|Reasons not related to trial|0|||
162633225|NCT00482612|587370572|FG002|Follow-up Period|Reasons not related to trial|1|||
162714085|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
162633226|NCT00482612|587370573|FG003|Follow-up Period|Reasons not related to trial|3|||
162633227|NCT00660023|587370574|FG000|Overall Study|Adverse Event|2|||
162633228|NCT00660023|587370574|FG000|Overall Study|Death|8|||
162633229|NCT00660023|587370574|FG000|Overall Study|Blood Transfusion|5|||
162633230|NCT00660023|587370574|FG000|Overall Study|Renal Transplantation|3|||
162633231|NCT00660023|587370574|FG000|Overall Study|Withdrawal by Subject|1|||
162633232|NCT00660023|587370574|FG000|Overall Study|Missed Pregnancy Test|1|||
162633233|NCT00660023|587370574|FG000|Overall Study|Other Screening Failure|9|||
162633234|NCT04180488|587370576|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162633235|NCT04180488|587370577|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
162633236|NCT04180488|587370578|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
162633237|NCT04180488|587370579|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
162633238|NCT04180488|587370580|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162633239|NCT04180488|587370581|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162633240|NCT04180488|587370576|FG000|Overall Study|Withdrawal by Subject|8|||
162633241|NCT04180488|587370577|FG001|Overall Study|Withdrawal by Subject|4|||
162633242|NCT04180488|587370578|FG002|Overall Study|Withdrawal by Subject|5|||
162633243|NCT04180488|587370579|FG003|Overall Study|Withdrawal by Subject|2|||
162633244|NCT04180488|587370580|FG004|Overall Study|Withdrawal by Subject|8|||
162981693|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981694|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981695|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
162981696|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
162981697|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981698|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
162981699|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981700|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981701|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
162981702|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
162981703|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
162981704|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
162981705|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
163059120|NCT01288430|588926293|FG001|Part 2|Withdrawal by Subject|0|||
163059121|NCT01288430|588926294|FG002|Part 2|Withdrawal by Subject|0|||
163059122|NCT01288430|588926295|FG003|Part 2|Withdrawal by Subject|0|||
163059123|NCT01288430|588926296|FG004|Part 2|Withdrawal by Subject|0|||
163059124|NCT01288430|588926297|FG005|Part 2|Withdrawal by Subject|0|||
163059125|NCT01288430|588926298|FG006|Part 2|Withdrawal by Subject|0|||
163059126|NCT01288430|588926299|FG007|Part 2|Withdrawal by Subject|1|||
163059127|NCT01288430|588926300|FG008|Part 2|Withdrawal by Subject|4|||
163059128|NCT01288430|588926301|FG009|Part 2|Withdrawal by Subject|0|||
163059129|NCT01288430|588926292|FG000|Part 2|Adverse Event|0|||
163059130|NCT01288430|588926293|FG001|Part 2|Adverse Event|0|||
163059131|NCT01288430|588926294|FG002|Part 2|Adverse Event|0|||
163059132|NCT01288430|588926295|FG003|Part 2|Adverse Event|0|||
163059133|NCT01288430|588926296|FG004|Part 2|Adverse Event|0|||
163059134|NCT01288430|588926297|FG005|Part 2|Adverse Event|0|||
163059135|NCT01288430|588926298|FG006|Part 2|Adverse Event|0|||
163059136|NCT01288430|588926299|FG007|Part 2|Adverse Event|1|||
163059137|NCT01288430|588926300|FG008|Part 2|Adverse Event|1|||
163059138|NCT01288430|588926301|FG009|Part 2|Adverse Event|0|||
163059139|NCT01288430|588926292|FG000|Part 2|Other|0|||
163059140|NCT01288430|588926293|FG001|Part 2|Other|0|||
163059141|NCT01288430|588926294|FG002|Part 2|Other|0|||
163059142|NCT01288430|588926295|FG003|Part 2|Other|0|||
163059143|NCT01288430|588926296|FG004|Part 2|Other|0|||
163059144|NCT01288430|588926297|FG005|Part 2|Other|0|||
163059145|NCT01288430|588926298|FG006|Part 2|Other|0|||
163059146|NCT01288430|588926299|FG007|Part 2|Other|0|||
163059147|NCT01288430|588926300|FG008|Part 2|Other|0|||
163059148|NCT01288430|588926301|FG009|Part 2|Other|1|||
163059149|NCT00788671|588926304|FG000|Overall Study|Death|2|||
163059150|NCT00788671|588926304|FG000|Overall Study|Unable to biopsy|1|||
163059151|NCT00788671|588926304|FG000|Overall Study|Withdrawal by Subject|4|||
163059152|NCT00788671|588926304|FG000|Overall Study|IUD expulsed|1|||
163059153|NCT00788671|588926304|FG000|Overall Study|Lost to follow up|2|||
163059154|NCT04780659|588926305|FG000|Overall Study|Adverse event, serious fatal|3|||
163059155|NCT04780659|588926306|FG001|Overall Study|Adverse event, serious fatal|0|||
163059156|NCT04780659|588926305|FG000|Overall Study|Withdrawal by Subject|3|||
163059157|NCT04780659|588926306|FG001|Overall Study|Withdrawal by Subject|0|||
163059158|NCT04780659|588926305|FG000|Overall Study|Physician Decision|1|||
163059159|NCT04780659|588926306|FG001|Overall Study|Physician Decision|0|||
163059160|NCT04780659|588926305|FG000|Overall Study|Died in original disease|2|||
163059161|NCT04780659|588926306|FG001|Overall Study|Died in original disease|0|||
163059162|NCT04780659|588926305|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
163059163|NCT04780659|588926306|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
163059164|NCT03729362|588926307|FG000|Overall Study|Withdrawal by Subject|2|||
163059165|NCT03729362|588926308|FG001|Overall Study|Withdrawal by Subject|0|||
163059166|NCT03729362|588926307|FG000|Overall Study|Physician Decision|1|||
163059167|NCT03729362|588926308|FG001|Overall Study|Physician Decision|0|||
163059168|NCT03729362|588926307|FG000|Overall Study|COVID-19 Pandemic|1|||
163059169|NCT03729362|588926308|FG001|Overall Study|COVID-19 Pandemic|0|||
163059170|NCT03729362|588926307|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
163059171|NCT03729362|588926308|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
163059172|NCT03729362|588926307|FG000|Overall Study|Adverse Event|0|||
163059173|NCT03729362|588926308|FG001|Overall Study|Adverse Event|1|||
163059174|NCT03729362|588926307|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
163059175|NCT03729362|588926308|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
163059176|NCT03405870|588926309|FG000|Overall Study|Withdrawal|1|||
163059177|NCT03405870|588926310|FG001|Overall Study|Withdrawal|0|||
163059178|NCT03405870|588926311|FG002|Overall Study|Withdrawal|1|||
163059179|NCT03405870|588926312|FG003|Overall Study|Withdrawal|0|||
163059180|NCT03405870|588926313|FG004|Overall Study|Withdrawal|0|||
163059181|NCT03405870|588926314|FG005|Overall Study|Withdrawal|0|||
163059182|NCT03405870|588926315|FG006|Overall Study|Withdrawal|1|||
163059183|NCT03405870|588926316|FG007|Overall Study|Withdrawal|0|||
163059184|NCT02807259|588926319|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
163059185|NCT02807259|588926320|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
163059186|NCT02807259|588926319|FG000|Midline (3 Months)|migration, refusal, not available|30|||
163059187|NCT02807259|588926320|FG001|Midline (3 Months)|migration, refusal, not available|34|||
163059188|NCT02807259|588926319|FG000|Endline (3 Months)|migration, refusal, not available|35|||
163059189|NCT02807259|588926320|FG001|Endline (3 Months)|migration, refusal, not available|87|||
163059190|NCT01171534|588926321|FG000|Overall Study|Lost to Follow-up|0|||
163059191|NCT01171534|588926322|FG001|Overall Study|Lost to Follow-up|2|||
163059192|NCT01171534|588926321|FG000|Overall Study|screen failure|0|||
163059193|NCT01171534|588926322|FG001|Overall Study|screen failure|1|||
163059194|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
163059195|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
163059196|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
163059197|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
163059198|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
162714086|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
162714087|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
162714088|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
162714089|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
162714090|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
162714091|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
162714092|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
162714093|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
162714094|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
162714095|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
162714096|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
162714097|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
162714098|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
162714099|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
162981706|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
162981707|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
162633245|NCT04180488|587370581|FG005|Overall Study|Withdrawal by Subject|6|||
162633246|NCT04180488|587370576|FG000|Overall Study|Adverse Event|3|||
162633247|NCT04180488|587370577|FG001|Overall Study|Adverse Event|2|||
162633248|NCT04180488|587370578|FG002|Overall Study|Adverse Event|0|||
162633249|NCT04180488|587370579|FG003|Overall Study|Adverse Event|0|||
162633250|NCT04180488|587370580|FG004|Overall Study|Adverse Event|0|||
162633251|NCT04180488|587370581|FG005|Overall Study|Adverse Event|0|||
162633252|NCT04180488|587370576|FG000|Overall Study|Poor compliance to protocol|0|||
162633253|NCT04180488|587370577|FG001|Overall Study|Poor compliance to protocol|0|||
162633254|NCT04180488|587370578|FG002|Overall Study|Poor compliance to protocol|1|||
162633255|NCT04180488|587370579|FG003|Overall Study|Poor compliance to protocol|0|||
162633256|NCT04180488|587370580|FG004|Overall Study|Poor compliance to protocol|0|||
162633257|NCT04180488|587370581|FG005|Overall Study|Poor compliance to protocol|0|||
162633258|NCT03506815|587370582|FG000|Overall Study|Adverse Event|8|||
162633259|NCT03506815|587370583|FG001|Overall Study|Adverse Event|0|||
162633260|NCT03506815|587370582|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
162714100|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
162714101|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
162714102|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
162714103|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
162714104|NCT02081391|587662681|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
162981708|NCT00094458|588634467|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
162633261|NCT03506815|587370583|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
162633262|NCT03506815|587370582|FG000|Overall Study|Protocol Violation|1|||
162633263|NCT03506815|587370583|FG001|Overall Study|Protocol Violation|0|||
162633264|NCT03506815|587370582|FG000|Overall Study|Elective Surgery|1|||
162633265|NCT03506815|587370583|FG001|Overall Study|Elective Surgery|0|||
162633266|NCT00381095|587370587|FG000|Overall Study|Death|3|||
162633267|NCT00381095|587370588|FG001|Overall Study|Death|4|||
162633268|NCT00381095|587370587|FG000|Overall Study|Lack of Efficacy|2|||
162981709|NCT00094458|588634468|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
162981710|NCT00094458|588634469|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
162981711|NCT00094458|588634470|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
162981712|NCT00094458|588634471|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
162981713|NCT00094458|588634472|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
162981714|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Adverse Event|0|||
162981715|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Adverse Event|0|||
162981716|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Adverse Event|0|||
162981717|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Adverse Event|0|||
162981718|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Adverse Event|3|||
162981719|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Adverse Event|4|||
162981720|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981721|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981722|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981723|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
162981724|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
162981725|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
162981726|NCT00094458|588634467|FG000|OLE: Open-Label Extension|Patient decision|0|||
162981727|NCT00094458|588634468|FG001|OLE: Open-Label Extension|Patient decision|0|||
162981728|NCT00094458|588634469|FG002|OLE: Open-Label Extension|Patient decision|0|||
162981729|NCT00094458|588634470|FG003|OLE: Open-Label Extension|Patient decision|0|||
162981730|NCT00094458|588634471|FG004|OLE: Open-Label Extension|Patient decision|1|||
162981731|NCT00094458|588634472|FG005|OLE: Open-Label Extension|Patient decision|0|||
162981732|NCT03247517|588634473|FG000|Overall Study|Adverse Event|0|||
162981733|NCT03247517|588634474|FG001|Overall Study|Adverse Event|4|||
162981734|NCT03247517|588634475|FG002|Overall Study|Adverse Event|2|||
162981735|NCT03247517|588634473|FG000|Overall Study|Lost to Follow-up|2|||
162981736|NCT03247517|588634474|FG001|Overall Study|Lost to Follow-up|6|||
162981737|NCT03247517|588634475|FG002|Overall Study|Lost to Follow-up|4|||
162981738|NCT03247517|588634473|FG000|Overall Study|Consent withdrawn by caregiver|1|||
162981739|NCT03247517|588634474|FG001|Overall Study|Consent withdrawn by caregiver|4|||
162981740|NCT03247517|588634475|FG002|Overall Study|Consent withdrawn by caregiver|7|||
162981741|NCT03247517|588634473|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
162981742|NCT03247517|588634474|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
162981743|NCT03247517|588634475|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
162981744|NCT03247517|588634473|FG000|Overall Study|Protocol Violation|0|||
162981745|NCT03247517|588634474|FG001|Overall Study|Protocol Violation|2|||
162981746|NCT03247517|588634475|FG002|Overall Study|Protocol Violation|0|||
162981747|NCT03247517|588634473|FG000|Overall Study|Multiple reasons|3|||
162981748|NCT03247517|588634474|FG001|Overall Study|Multiple reasons|1|||
162981749|NCT03247517|588634475|FG002|Overall Study|Multiple reasons|0|||
162981750|NCT03310411|588634476|FG000|Period 1|Adverse Event|0|||
162981751|NCT03310411|588634477|FG001|Period 1|Adverse Event|0|||
162981752|NCT03310411|588634478|FG002|Period 1|Adverse Event|0|||
162981753|NCT03310411|588634479|FG003|Period 1|Adverse Event|1|||
162981754|NCT03573505|588634480|FG000|Overall Study|Adverse Event|1|||
162981755|NCT03573505|588634481|FG001|Overall Study|Adverse Event|1|||
162981756|NCT03573505|588634480|FG000|Overall Study|Consent withdrawn|0|||
162981757|NCT03573505|588634481|FG001|Overall Study|Consent withdrawn|1|||
162981758|NCT03573505|588634480|FG000|Overall Study|Disease progression|0|||
162633269|NCT00381095|587370588|FG001|Overall Study|Lack of Efficacy|4|||
162633270|NCT00381095|587370587|FG000|Overall Study|Other|2|||
162714105|NCT02081391|587662682|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
162981759|NCT03573505|588634481|FG001|Overall Study|Disease progression|1|||
162981760|NCT03573505|588634480|FG000|Overall Study|Site Terminated by Sponsor|1|||
162981761|NCT03573505|588634481|FG001|Overall Study|Site Terminated by Sponsor|1|||
162981762|NCT03573505|588634480|FG000|Overall Study|Study terminated by sponsor|50|||
162981763|NCT03573505|588634481|FG001|Overall Study|Study terminated by sponsor|45|||
162981764|NCT03573505|588634480|FG000|Overall Study|Reason not specified|0|||
162981765|NCT03573505|588634481|FG001|Overall Study|Reason not specified|1|||
162981766|NCT03573505|588634480|FG000|Overall Study|Death|0|||
162981767|NCT03573505|588634481|FG001|Overall Study|Death|4|||
162981768|NCT00515541|588634482|FG000|Overall Study|Physician Decision|0|||
162981769|NCT00515541|588634483|FG001|Overall Study|Physician Decision|2|||
162981770|NCT00515541|588634484|FG002|Overall Study|Physician Decision|0|||
162633271|NCT00381095|587370588|FG001|Overall Study|Other|2|||
162633272|NCT00381095|587370587|FG000|Overall Study|Protocol Violation|1|||
162714106|NCT02081391|587662683|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
162714107|NCT02081391|587662684|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
162714108|NCT00124982|587662686|FG000|Short-term Period|Death|1|||
162714109|NCT00124982|587662687|FG001|Short-term Period|Death|1|||
163059199|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
162633273|NCT00381095|587370588|FG001|Overall Study|Protocol Violation|1|||
162633274|NCT00381095|587370587|FG000|Overall Study|Withdrawal by Subject|3|||
162633275|NCT00381095|587370588|FG001|Overall Study|Withdrawal by Subject|3|||
162633276|NCT00381095|587370587|FG000|Overall Study|Adverse Event|2|||
162633277|NCT00381095|587370588|FG001|Overall Study|Adverse Event|7|||
162633278|NCT03562481|587370589|FG000|First Intervention|Lost to Follow-up|1|||
162633279|NCT03562481|587370590|FG001|First Intervention|Lost to Follow-up|0|||
162633280|NCT00856284|587370592|FG000|Overall Study|Hyperglycemic rescue|231|||
162633281|NCT00856284|587370593|FG001|Overall Study|Hyperglycemic rescue|201|||
162633282|NCT00856284|587370594|FG002|Overall Study|Hyperglycemic rescue|235|||
162633283|NCT00856284|587370592|FG000|Overall Study|Adverse Event|60|||
162633284|NCT00856284|587370593|FG001|Overall Study|Adverse Event|74|||
162633285|NCT00856284|587370594|FG002|Overall Study|Adverse Event|82|||
162633286|NCT00856284|587370592|FG000|Overall Study|Major protocol deviation|24|||
162633287|NCT00856284|587370593|FG001|Overall Study|Major protocol deviation|16|||
162633288|NCT00856284|587370594|FG002|Overall Study|Major protocol deviation|15|||
162633289|NCT00856284|587370592|FG000|Overall Study|Lost to Follow-up|20|||
162633290|NCT00856284|587370593|FG001|Overall Study|Lost to Follow-up|22|||
162633291|NCT00856284|587370594|FG002|Overall Study|Lost to Follow-up|28|||
162633292|NCT00856284|587370592|FG000|Overall Study|Voluntary withdrawal|48|||
162633293|NCT00856284|587370593|FG001|Overall Study|Voluntary withdrawal|52|||
162633294|NCT00856284|587370594|FG002|Overall Study|Voluntary withdrawal|62|||
162633295|NCT00856284|587370592|FG000|Overall Study|Pregnancy|1|||
162633296|NCT00856284|587370593|FG001|Overall Study|Pregnancy|2|||
162633297|NCT00856284|587370594|FG002|Overall Study|Pregnancy|0|||
162633298|NCT00856284|587370592|FG000|Overall Study|Investigator discretion|9|||
162633299|NCT00856284|587370593|FG001|Overall Study|Investigator discretion|8|||
162633300|NCT00856284|587370594|FG002|Overall Study|Investigator discretion|10|||
162633301|NCT00856284|587370592|FG000|Overall Study|Other|15|||
162633302|NCT00856284|587370593|FG001|Overall Study|Other|17|||
162633303|NCT00856284|587370594|FG002|Overall Study|Other|14|||
162633304|NCT00856284|587370592|FG000|Overall Study|Randomized in error|0|||
162633305|NCT00856284|587370593|FG001|Overall Study|Randomized in error|0|||
162633306|NCT00856284|587370594|FG002|Overall Study|Randomized in error|1|||
162633307|NCT04271605|587370595|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
162633308|NCT02485301|587370596|FG000|Overall Study|Serious Adverse Events|2|||
162633309|NCT02485301|587370597|FG001|Overall Study|Serious Adverse Events|1|||
162633310|NCT02485301|587370596|FG000|Overall Study|Protocol Violation|0|||
162633311|NCT02485301|587370597|FG001|Overall Study|Protocol Violation|1|||
162633312|NCT02485301|587370596|FG000|Overall Study|Withdrawal by Subject|6|||
162633313|NCT02485301|587370597|FG001|Overall Study|Withdrawal by Subject|7|||
162633314|NCT02485301|587370596|FG000|Overall Study|Migrated/moved from study area|10|||
162633315|NCT02485301|587370597|FG001|Overall Study|Migrated/moved from study area|19|||
162633316|NCT02485301|587370596|FG000|Overall Study|Lost to Follow-up|17|||
162633317|NCT02485301|587370597|FG001|Overall Study|Lost to Follow-up|17|||
162633318|NCT02485301|587370596|FG000|Overall Study|Other|3|||
162633319|NCT02485301|587370597|FG001|Overall Study|Other|4|||
162633320|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633321|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633322|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633323|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633324|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633325|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162633326|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
162633327|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162633328|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162633329|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162633330|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162633331|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162714110|NCT00124982|587662688|FG002|Short-term Period|Death|0|||
162714111|NCT00124982|587662686|FG000|Short-term Period|Adverse Event|17|||
162633332|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162633333|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
162633334|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
162633335|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
162633336|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
162633337|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
162633338|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
162714112|NCT00124982|587662687|FG001|Short-term Period|Adverse Event|22|||
163059200|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
163059201|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
163059202|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
163059203|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
163059204|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
163059205|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
163059206|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
163059207|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
163059208|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
163059209|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
163059210|NCT00849056|588926323|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163059211|NCT00849056|588926324|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
163059212|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163059213|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
163059214|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
162633339|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
162714113|NCT00124982|587662688|FG002|Short-term Period|Adverse Event|0|||
162714114|NCT00124982|587662686|FG000|Short-term Period|Lack of Efficacy|32|||
162714115|NCT00124982|587662687|FG001|Short-term Period|Lack of Efficacy|73|||
162714116|NCT00124982|587662688|FG002|Short-term Period|Lack of Efficacy|0|||
162714117|NCT00124982|587662686|FG000|Short-term Period|Lost to Follow-up|8|||
162714118|NCT00124982|587662687|FG001|Short-term Period|Lost to Follow-up|5|||
162714119|NCT00124982|587662688|FG002|Short-term Period|Lost to Follow-up|0|||
162714120|NCT00124982|587662686|FG000|Short-term Period|Withdrawal of Consent|7|||
162714121|NCT00124982|587662687|FG001|Short-term Period|Withdrawal of Consent|9|||
162714122|NCT00124982|587662688|FG002|Short-term Period|Withdrawal of Consent|0|||
162714123|NCT00124982|587662686|FG000|Short-term Period|Poor/Non-compliance|3|||
162714124|NCT00124982|587662687|FG001|Short-term Period|Poor/Non-compliance|1|||
162714125|NCT00124982|587662688|FG002|Short-term Period|Poor/Non-compliance|0|||
162714126|NCT00124982|587662686|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
162714127|NCT00124982|587662687|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
162714128|NCT00124982|587662688|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
162714129|NCT00124982|587662686|FG000|Short-term Period|Participant Decision|1|||
162714130|NCT00124982|587662687|FG001|Short-term Period|Participant Decision|0|||
162714131|NCT00124982|587662688|FG002|Short-term Period|Participant Decision|0|||
162714132|NCT00124982|587662686|FG000|Short-term Period|Participant Chose Own Doctor|0|||
162714133|NCT00124982|587662687|FG001|Short-term Period|Participant Chose Own Doctor|1|||
162714134|NCT00124982|587662688|FG002|Short-term Period|Participant Chose Own Doctor|0|||
162714135|NCT00124982|587662686|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
162714136|NCT00124982|587662687|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
162714137|NCT00124982|587662688|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
162714138|NCT00124982|587662686|FG000|Short-term Period|Participant Had Lymphopenia|1|||
162714139|NCT00124982|587662687|FG001|Short-term Period|Participant Had Lymphopenia|0|||
162633340|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
162633341|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633342|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633343|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633344|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633345|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633346|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162633347|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
162633348|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
162633349|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
162633350|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
162633351|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
162633352|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
162633353|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
162633354|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
162633355|NCT01059825|587370601|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
162633356|NCT01059825|587370602|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
162633357|NCT01059825|587370603|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
162633358|NCT01059825|587370604|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
162633359|NCT01059825|587370605|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
162633360|NCT01059825|587370606|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
162714140|NCT00124982|587662688|FG002|Short-term Period|Participant Had Lymphopenia|0|||
162714141|NCT00124982|587662686|FG000|Long-term Period|Death|0|||
162714142|NCT00124982|587662687|FG001|Long-term Period|Death|0|||
162714143|NCT00124982|587662688|FG002|Long-term Period|Death|1|||
162714144|NCT00124982|587662686|FG000|Long-term Period|Adverse Event|0|||
162714145|NCT00124982|587662687|FG001|Long-term Period|Adverse Event|0|||
162714146|NCT00124982|587662688|FG002|Long-term Period|Adverse Event|17|||
162633361|NCT01059825|587370607|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
162633362|NCT01059825|587370601|FG000|Treatment Period|Lost to Follow-up|2|||
162633363|NCT01059825|587370602|FG001|Treatment Period|Lost to Follow-up|1|||
162633364|NCT01059825|587370603|FG002|Treatment Period|Lost to Follow-up|0|||
162633365|NCT01059825|587370604|FG003|Treatment Period|Lost to Follow-up|1|||
162633366|NCT01059825|587370605|FG004|Treatment Period|Lost to Follow-up|2|||
162633367|NCT01059825|587370606|FG005|Treatment Period|Lost to Follow-up|0|||
162633368|NCT01059825|587370607|FG006|Treatment Period|Lost to Follow-up|0|||
162633369|NCT01059825|587370601|FG000|Treatment Period|Withdrawal by Subject|3|||
162633370|NCT01059825|587370602|FG001|Treatment Period|Withdrawal by Subject|0|||
162633371|NCT01059825|587370603|FG002|Treatment Period|Withdrawal by Subject|1|||
162633372|NCT01059825|587370604|FG003|Treatment Period|Withdrawal by Subject|5|||
162633373|NCT01059825|587370605|FG004|Treatment Period|Withdrawal by Subject|4|||
162633374|NCT01059825|587370606|FG005|Treatment Period|Withdrawal by Subject|1|||
162633375|NCT01059825|587370607|FG006|Treatment Period|Withdrawal by Subject|0|||
162633376|NCT01059825|587370601|FG000|Treatment Period|Other reason not specified|1|||
162633377|NCT01059825|587370602|FG001|Treatment Period|Other reason not specified|2|||
162633378|NCT01059825|587370603|FG002|Treatment Period|Other reason not specified|1|||
162633379|NCT01059825|587370604|FG003|Treatment Period|Other reason not specified|2|||
162633380|NCT01059825|587370605|FG004|Treatment Period|Other reason not specified|0|||
162633381|NCT01059825|587370606|FG005|Treatment Period|Other reason not specified|0|||
162633382|NCT01059825|587370607|FG006|Treatment Period|Other reason not specified|0|||
162633383|NCT01059825|587370601|FG000|Treatment Period|Protocol Violation|0|||
162633384|NCT01059825|587370602|FG001|Treatment Period|Protocol Violation|0|||
162633385|NCT01059825|587370603|FG002|Treatment Period|Protocol Violation|1|||
162633386|NCT01059825|587370604|FG003|Treatment Period|Protocol Violation|1|||
162633387|NCT01059825|587370605|FG004|Treatment Period|Protocol Violation|1|||
162633388|NCT01059825|587370606|FG005|Treatment Period|Protocol Violation|1|||
162633389|NCT01059825|587370607|FG006|Treatment Period|Protocol Violation|0|||
162633390|NCT01059825|587370601|FG000|Treatment Period|Adverse event related to study drug|1|||
162633391|NCT01059825|587370602|FG001|Treatment Period|Adverse event related to study drug|0|||
162633392|NCT01059825|587370603|FG002|Treatment Period|Adverse event related to study drug|1|||
162633393|NCT01059825|587370604|FG003|Treatment Period|Adverse event related to study drug|1|||
162633394|NCT01059825|587370605|FG004|Treatment Period|Adverse event related to study drug|0|||
162633395|NCT01059825|587370606|FG005|Treatment Period|Adverse event related to study drug|0|||
162633396|NCT01059825|587370607|FG006|Treatment Period|Adverse event related to study drug|0|||
162633397|NCT01059825|587370601|FG000|Treatment Period|Insufficient clinical response|3|||
162633398|NCT01059825|587370602|FG001|Treatment Period|Insufficient clinical response|0|||
162633399|NCT01059825|587370603|FG002|Treatment Period|Insufficient clinical response|0|||
162633400|NCT01059825|587370604|FG003|Treatment Period|Insufficient clinical response|0|||
162633401|NCT01059825|587370605|FG004|Treatment Period|Insufficient clinical response|0|||
162633402|NCT01059825|587370606|FG005|Treatment Period|Insufficient clinical response|0|||
162633403|NCT01059825|587370607|FG006|Treatment Period|Insufficient clinical response|0|||
162633404|NCT01059825|587370601|FG000|Treatment Period|Adverse event not related to study drug|0|||
162633405|NCT01059825|587370602|FG001|Treatment Period|Adverse event not related to study drug|1|||
162633406|NCT01059825|587370603|FG002|Treatment Period|Adverse event not related to study drug|2|||
162633407|NCT01059825|587370604|FG003|Treatment Period|Adverse event not related to study drug|1|||
162714147|NCT00124982|587662686|FG000|Long-term Period|Lack of Efficacy|0|||
162981771|NCT00515541|588634485|FG003|Overall Study|Physician Decision|1|||
162981772|NCT00515541|588634482|FG000|Overall Study|No show for appointments|0|||
162981773|NCT00515541|588634483|FG001|Overall Study|No show for appointments|1|||
162981774|NCT00515541|588634484|FG002|Overall Study|No show for appointments|0|||
162981775|NCT00515541|588634485|FG003|Overall Study|No show for appointments|2|||
162981776|NCT00515541|588634482|FG000|Overall Study|Withdrawal by Subject|0|||
162981777|NCT00515541|588634483|FG001|Overall Study|Withdrawal by Subject|2|||
162981778|NCT00515541|588634484|FG002|Overall Study|Withdrawal by Subject|0|||
162981779|NCT00515541|588634485|FG003|Overall Study|Withdrawal by Subject|2|||
162981780|NCT02145026|588634487|FG000|Overall Study|Adverse Event|2|||
162981781|NCT02145026|588634487|FG000|Overall Study|Death|4|||
162981782|NCT02145026|588634487|FG000|Overall Study|Withdrawal by Subject|2|||
162981783|NCT02145026|588634487|FG000|Overall Study|Physician Decision|4|||
162981784|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
162981785|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
162981786|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
162981787|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
162633408|NCT01059825|587370605|FG004|Treatment Period|Adverse event not related to study drug|1|||
162633409|NCT01059825|587370606|FG005|Treatment Period|Adverse event not related to study drug|1|||
162714148|NCT00124982|587662687|FG001|Long-term Period|Lack of Efficacy|0|||
162981788|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
162714149|NCT00124982|587662688|FG002|Long-term Period|Lack of Efficacy|46|||
162981789|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
163059215|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
163059216|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
163059217|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
163059218|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
163059219|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
163059220|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163059221|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163059222|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
162633410|NCT01059825|587370607|FG006|Treatment Period|Adverse event not related to study drug|0|||
162633411|NCT03342690|587370610|FG000|Overall Study|Missing Information|9|||
162633412|NCT03342690|587370610|FG000|Overall Study|Protocol Violation|16|||
162633413|NCT00105482|587370621|FG000|Overall Study|Adverse Event|1|||
162633414|NCT00105482|587370622|FG001|Overall Study|Adverse Event|1|||
162633415|NCT00105482|587370621|FG000|Overall Study|Lost to Follow-up|26|||
162633416|NCT00105482|587370622|FG001|Overall Study|Lost to Follow-up|17|||
162633417|NCT00105482|587370621|FG000|Overall Study|Withdrawal by Subject|0|||
162633418|NCT00105482|587370622|FG001|Overall Study|Withdrawal by Subject|1|||
162633419|NCT00105482|587370621|FG000|Overall Study|Lost Interest|29|||
162633420|NCT00105482|587370622|FG001|Overall Study|Lost Interest|32|||
162633421|NCT00105482|587370621|FG000|Overall Study|Scheduling Conflict|2|||
162633422|NCT00105482|587370622|FG001|Overall Study|Scheduling Conflict|3|||
162633423|NCT00105482|587370621|FG000|Overall Study|Withdrawn by PI|1|||
162633424|NCT00105482|587370622|FG001|Overall Study|Withdrawn by PI|1|||
162633425|NCT02495168|587370628|FG000|Overall Study|Other than Specified|18|||
162633426|NCT02495168|587370629|FG001|Overall Study|Other than Specified|22|||
162633427|NCT02495168|587370630|FG002|Overall Study|Other than Specified|5|||
162633428|NCT02495168|587370628|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
162633429|NCT02495168|587370629|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
162633430|NCT02495168|587370630|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
162633431|NCT02495168|587370628|FG000|Overall Study|Physician Decision|1|||
162633432|NCT02495168|587370629|FG001|Overall Study|Physician Decision|1|||
162633433|NCT02495168|587370630|FG002|Overall Study|Physician Decision|0|||
162633434|NCT02495168|587370628|FG000|Overall Study|Lost to Follow-up|10|||
162633435|NCT02495168|587370629|FG001|Overall Study|Lost to Follow-up|6|||
162633436|NCT02495168|587370630|FG002|Overall Study|Lost to Follow-up|1|||
162633437|NCT02495168|587370628|FG000|Overall Study|Withdrawal by Subject|1|||
162633438|NCT02495168|587370629|FG001|Overall Study|Withdrawal by Subject|4|||
162633439|NCT02495168|587370630|FG002|Overall Study|Withdrawal by Subject|2|||
162633440|NCT02495168|587370628|FG000|Overall Study|Protocol Violation|0|||
162981790|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
162981791|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
162981792|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
162981793|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
162981794|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
162981795|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
162981796|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
162981797|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
162981798|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
162981799|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
162981800|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
162981801|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
162981802|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
162981803|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
162981804|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
162981805|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
162981806|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
162981807|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
162981808|NCT01421342|588634488|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
162981809|NCT01421342|588634489|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
162981810|NCT01421342|588634490|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
162981811|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
162981812|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
162981813|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
162981814|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
162981815|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
162981816|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
162981817|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
162981818|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
162981819|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
162981820|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
162981821|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
162981822|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
162981823|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
162981824|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
162633441|NCT02495168|587370629|FG001|Overall Study|Protocol Violation|10|||
162633442|NCT02495168|587370630|FG002|Overall Study|Protocol Violation|1|||
162633443|NCT02495168|587370628|FG000|Overall Study|Adverse Event|4|||
162633444|NCT02495168|587370629|FG001|Overall Study|Adverse Event|8|||
162633445|NCT02495168|587370630|FG002|Overall Study|Adverse Event|3|||
162633446|NCT02495168|587370628|FG000|Overall Study|Lack of Efficacy|0|||
162633447|NCT02495168|587370629|FG001|Overall Study|Lack of Efficacy|0|||
162633448|NCT02495168|587370630|FG002|Overall Study|Lack of Efficacy|3|||
162633449|NCT00644995|587370631|FG000|Overall Study|Lost to Follow-up|1|||
163059223|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
163059224|NCT00849056|588926323|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
163059225|NCT00849056|588926324|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
163059226|NCT04588259|588926325|FG000|Run-in period|Run-in failure|0|||
163059227|NCT04588259|588926326|FG001|Run-in period|Run-in failure|23|||
163059228|NCT04588259|588926325|FG000|Run-in period|Withdrawn before randomisation|0|||
163059229|NCT04588259|588926326|FG001|Run-in period|Withdrawn before randomisation|8|||
163059230|NCT04588259|588926325|FG000|Treatment period|Withdrawal by Subject|6|||
163059231|NCT04588259|588926326|FG001|Treatment period|Withdrawal by Subject|6|||
163059232|NCT01673386|588926327|FG000|Overall Study|Study terminated by sponsor|16|||
163059233|NCT01673386|588926328|FG001|Overall Study|Study terminated by sponsor|22|||
163059234|NCT01673386|588926327|FG000|Overall Study|Adverse Event|5|||
163059235|NCT01673386|588926328|FG001|Overall Study|Adverse Event|2|||
163059236|NCT01673386|588926327|FG000|Overall Study|Progressive disease|4|||
163059237|NCT01673386|588926328|FG001|Overall Study|Progressive disease|1|||
163059238|NCT01673386|588926327|FG000|Overall Study|Withdrawal by Subject|0|||
163059239|NCT01673386|588926328|FG001|Overall Study|Withdrawal by Subject|2|||
163059240|NCT00274456|588926329|FG000|Overall Study|Still on treatment|2|||
163059241|NCT00274456|588926330|FG001|Overall Study|Still on treatment|3|||
163059242|NCT00274456|588926331|FG002|Overall Study|Still on treatment|5|||
163059243|NCT00274456|588926332|FG003|Overall Study|Still on treatment|1|||
163059244|NCT00274456|588926329|FG000|Overall Study|Unacceptable toxicity|10|||
163059245|NCT00274456|588926330|FG001|Overall Study|Unacceptable toxicity|5|||
163059246|NCT00274456|588926331|FG002|Overall Study|Unacceptable toxicity|12|||
163059247|NCT00274456|588926332|FG003|Overall Study|Unacceptable toxicity|16|||
163059248|NCT00274456|588926329|FG000|Overall Study|Adverse Event|0|||
163059249|NCT00274456|588926330|FG001|Overall Study|Adverse Event|1|||
163059250|NCT00274456|588926331|FG002|Overall Study|Adverse Event|2|||
163059251|NCT00274456|588926332|FG003|Overall Study|Adverse Event|2|||
163059252|NCT00274456|588926329|FG000|Overall Study|Physician Decision|7|||
163059253|NCT00274456|588926330|FG001|Overall Study|Physician Decision|5|||
163059254|NCT00274456|588926331|FG002|Overall Study|Physician Decision|6|||
163059255|NCT00274456|588926332|FG003|Overall Study|Physician Decision|13|||
163059256|NCT00274456|588926329|FG000|Overall Study|Lost to Follow-up|0|||
163059257|NCT00274456|588926330|FG001|Overall Study|Lost to Follow-up|0|||
163059258|NCT00274456|588926331|FG002|Overall Study|Lost to Follow-up|1|||
163059259|NCT00274456|588926332|FG003|Overall Study|Lost to Follow-up|0|||
163059260|NCT00274456|588926329|FG000|Overall Study|Withdrawal by Subject|18|||
163059261|NCT00274456|588926330|FG001|Overall Study|Withdrawal by Subject|13|||
163059262|NCT00274456|588926331|FG002|Overall Study|Withdrawal by Subject|9|||
163059263|NCT00274456|588926332|FG003|Overall Study|Withdrawal by Subject|13|||
163059264|NCT04476043|588926339|FG000|Overall Study|Withdrawal by Subject|1|||
163059265|NCT04476043|588926340|FG001|Overall Study|Withdrawal by Subject|3|||
163059266|NCT04476043|588926341|FG002|Overall Study|Withdrawal by Subject|4|||
163059267|NCT04476043|588926342|FG003|Overall Study|Withdrawal by Subject|1|||
163059268|NCT04476043|588926339|FG000|Overall Study|Lost to Follow-up|1|||
162633450|NCT00644995|587370632|FG001|Overall Study|Lost to Follow-up|4|||
162633451|NCT00644995|587370631|FG000|Overall Study|Refused|1|||
162633452|NCT00644995|587370632|FG001|Overall Study|Refused|0|||
162633453|NCT03247530|587370633|FG000|Overall Study|Withdrawal by caregiver|19|||
162633454|NCT03247530|587370634|FG001|Overall Study|Withdrawal by caregiver|8|||
162633455|NCT03247530|587370635|FG002|Overall Study|Withdrawal by caregiver|10|||
162633456|NCT03247530|587370633|FG000|Overall Study|Lost to Follow-up|3|||
162633457|NCT03247530|587370634|FG001|Overall Study|Lost to Follow-up|9|||
162633458|NCT03247530|587370635|FG002|Overall Study|Lost to Follow-up|6|||
162633459|NCT03247530|587370633|FG000|Overall Study|Adverse Event|2|||
162714150|NCT00124982|587662686|FG000|Long-term Period|Lost to Follow-up|0|||
162714151|NCT00124982|587662687|FG001|Long-term Period|Lost to Follow-up|0|||
162714152|NCT00124982|587662688|FG002|Long-term Period|Lost to Follow-up|4|||
162714153|NCT00124982|587662686|FG000|Long-term Period|Withdrawal by Subject|0|||
163059269|NCT04476043|588926340|FG001|Overall Study|Lost to Follow-up|1|||
163059270|NCT04476043|588926341|FG002|Overall Study|Lost to Follow-up|2|||
163059271|NCT04476043|588926342|FG003|Overall Study|Lost to Follow-up|1|||
163059272|NCT04476043|588926339|FG000|Overall Study|Adverse Event|2|||
163059273|NCT04476043|588926340|FG001|Overall Study|Adverse Event|0|||
163059274|NCT04476043|588926341|FG002|Overall Study|Adverse Event|1|||
163059275|NCT04476043|588926342|FG003|Overall Study|Adverse Event|0|||
163059276|NCT04476043|588926339|FG000|Overall Study|Protocol Violation|0|||
163059277|NCT04476043|588926340|FG001|Overall Study|Protocol Violation|1|||
163059278|NCT04476043|588926341|FG002|Overall Study|Protocol Violation|0|||
163059279|NCT04476043|588926342|FG003|Overall Study|Protocol Violation|0|||
163059280|NCT02100631|588926343|FG000|Overall Study|Withdrawal by Subject|1|||
163059281|NCT02100631|588926344|FG001|Overall Study|Withdrawal by Subject|0|||
163059282|NCT02100631|588926345|FG002|Overall Study|Withdrawal by Subject|0|||
163059283|NCT02100631|588926343|FG000|Overall Study|Lost to Follow-up|3|||
162633460|NCT03247530|587370634|FG001|Overall Study|Adverse Event|5|||
162633461|NCT03247530|587370635|FG002|Overall Study|Adverse Event|2|||
162633462|NCT03247530|587370633|FG000|Overall Study|Failure to follow procedure|1|||
162633463|NCT03247530|587370634|FG001|Overall Study|Failure to follow procedure|1|||
162633464|NCT03247530|587370635|FG002|Overall Study|Failure to follow procedure|1|||
162633465|NCT03247530|587370633|FG000|Overall Study|Withdrawal by Subject|1|||
162633466|NCT03247530|587370634|FG001|Overall Study|Withdrawal by Subject|1|||
162633467|NCT03247530|587370635|FG002|Overall Study|Withdrawal by Subject|0|||
162633468|NCT03247530|587370633|FG000|Overall Study|Study medication misuse|0|||
162633469|NCT03247530|587370634|FG001|Overall Study|Study medication misuse|1|||
162633470|NCT03247530|587370635|FG002|Overall Study|Study medication misuse|0|||
162633471|NCT03247530|587370633|FG000|Overall Study|Other, multiple categories|1|||
162633472|NCT03247530|587370634|FG001|Overall Study|Other, multiple categories|3|||
162633473|NCT03247530|587370635|FG002|Overall Study|Other, multiple categories|1|||
162633474|NCT03042533|587370636|FG000|Overall Study|MD left program|1|||
162633475|NCT03042533|587370637|FG001|Overall Study|MD left program|4|||
162633476|NCT03042533|587370638|FG002|Overall Study|MD left program|1|||
162633477|NCT01587001|587370639|FG000|Overall Study|Lost to Follow-up|2|||
162633478|NCT01587001|587370640|FG001|Overall Study|Lost to Follow-up|0|||
162633479|NCT01587001|587370639|FG000|Overall Study|Insufficient samples to complete testing|4|||
162633480|NCT01587001|587370640|FG001|Overall Study|Insufficient samples to complete testing|1|||
162633481|NCT04786990|587370641|FG000|Overall Study|Withdrawal by Subject|1|||
162633482|NCT04786990|587370641|FG000|Overall Study|Adverse Event|1|||
162633483|NCT04786990|587370641|FG000|Overall Study|Lost to Follow-up|1|||
162633484|NCT04786990|587370641|FG000|Overall Study|Noncompliance|1|||
162633485|NCT04786990|587370641|FG000|Overall Study|Unable to complete site visits|1|||
162633486|NCT04786990|587370641|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
162633487|NCT02233647|587370642|FG000|Overall Study|Adverse Event|1|||
162633488|NCT02846779|587370646|FG000|Overall Study|Lost Enrollment|83|||
162633489|NCT02846779|587370647|FG001|Overall Study|Lost Enrollment|82|||
162633490|NCT02846779|587370648|FG002|Overall Study|Lost Enrollment|86|||
162633491|NCT02846779|587370646|FG000|Overall Study|Less than 31 days of follow-up|56|||
162633492|NCT02846779|587370647|FG001|Overall Study|Less than 31 days of follow-up|45|||
162633493|NCT02846779|587370648|FG002|Overall Study|Less than 31 days of follow-up|52|||
162633494|NCT00887978|587370651|FG000|Overall Study|Adverse Event|18|||
162633495|NCT00887978|587370652|FG001|Overall Study|Adverse Event|5|||
162633496|NCT00887978|587370651|FG000|Overall Study|Clinical Worsening|4|||
162633497|NCT00887978|587370652|FG001|Overall Study|Clinical Worsening|4|||
162633498|NCT00887978|587370651|FG000|Overall Study|Death|2|||
162633499|NCT00887978|587370652|FG001|Overall Study|Death|3|||
162633500|NCT00887978|587370651|FG000|Overall Study|Withdrawal by Subject|1|||
162633501|NCT00887978|587370652|FG001|Overall Study|Withdrawal by Subject|2|||
162633502|NCT00887978|587370651|FG000|Overall Study|Lost to Follow-up|0|||
162633503|NCT00887978|587370652|FG001|Overall Study|Lost to Follow-up|1|||
162633504|NCT05353985|587370655|FG000|Overall Study|Adverse Event|5|||
162633505|NCT05353985|587370656|FG001|Overall Study|Adverse Event|7|||
162633506|NCT05353985|587370655|FG000|Overall Study|Lost to Follow-up|1|||
162633507|NCT05353985|587370656|FG001|Overall Study|Lost to Follow-up|1|||
162633508|NCT05353985|587370655|FG000|Overall Study|Protocol Violation|1|||
162633509|NCT05353985|587370656|FG001|Overall Study|Protocol Violation|0|||
162633510|NCT05353985|587370655|FG000|Overall Study|Withdrawal by Subject|13|||
162633511|NCT05353985|587370656|FG001|Overall Study|Withdrawal by Subject|17|||
162633512|NCT05353985|587370655|FG000|Overall Study|Reason Not Specified|1|||
162633513|NCT05353985|587370656|FG001|Overall Study|Reason Not Specified|0|||
162633514|NCT05353985|587370655|FG000|Overall Study|Randomized in Error & Not Treated|0|||
162633515|NCT05353985|587370656|FG001|Overall Study|Randomized in Error & Not Treated|1|||
162633516|NCT00524368|587372283|FG000|Overall Study|Adverse Event|10|||
162633517|NCT00524368|587372284|FG001|Overall Study|Adverse Event|12|||
162633518|NCT00524368|587372283|FG000|Overall Study|Lost to Follow-up|9|||
162633519|NCT00524368|587372284|FG001|Overall Study|Lost to Follow-up|13|||
162633520|NCT00524368|587372283|FG000|Overall Study|Withdrawal by Subject|4|||
162633521|NCT00524368|587372284|FG001|Overall Study|Withdrawal by Subject|5|||
162633522|NCT00524368|587372283|FG000|Overall Study|Non-compliant|8|||
162633523|NCT00524368|587372284|FG001|Overall Study|Non-compliant|9|||
162633524|NCT00524368|587372283|FG000|Overall Study|Reached a Virologic Endpoint|3|||
162633525|NCT00524368|587372284|FG001|Overall Study|Reached a Virologic Endpoint|2|||
162633526|NCT00524368|587372283|FG000|Overall Study|Sponsor's Decision|2|||
162633527|NCT00524368|587372284|FG001|Overall Study|Sponsor's Decision|0|||
162633528|NCT00524368|587372283|FG000|Overall Study|Ineligible to Continue the study|2|||
162633529|NCT00524368|587372284|FG001|Overall Study|Ineligible to Continue the study|5|||
162633530|NCT00524368|587372283|FG000|Overall Study|Other|3|||
162981825|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
162981826|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
162981827|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
162633531|NCT00524368|587372284|FG001|Overall Study|Other|2|||
162633532|NCT04221009|587372287|FG000|Overall Study|Withdrawal by Subject|4|||
162633533|NCT00793598|587372288|FG000|Overall Study|Patient Request|0|||
162633534|NCT00793598|587372289|FG001|Overall Study|Patient Request|1|||
162981828|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
162633535|NCT00793598|587372290|FG002|Overall Study|Patient Request|0|||
162633536|NCT00793598|587372291|FG003|Overall Study|Patient Request|0|||
162633537|NCT00793598|587372292|FG004|Overall Study|Patient Request|0|||
162633538|NCT00793598|587372293|FG005|Overall Study|Patient Request|0|||
162633539|NCT00793598|587372294|FG006|Overall Study|Patient Request|0|||
162633540|NCT00793598|587372295|FG007|Overall Study|Patient Request|0|||
162633541|NCT00793598|587372288|FG000|Overall Study|Protocol Violation|0|||
162633542|NCT00793598|587372289|FG001|Overall Study|Protocol Violation|0|||
162633543|NCT00793598|587372290|FG002|Overall Study|Protocol Violation|0|||
162633544|NCT00793598|587372291|FG003|Overall Study|Protocol Violation|0|||
162633545|NCT00793598|587372292|FG004|Overall Study|Protocol Violation|0|||
162633546|NCT00793598|587372293|FG005|Overall Study|Protocol Violation|0|||
162633547|NCT00793598|587372294|FG006|Overall Study|Protocol Violation|0|||
162633548|NCT00793598|587372295|FG007|Overall Study|Protocol Violation|1|||
162633549|NCT00793598|587372288|FG000|Overall Study|Subject not dosed|0|||
162633550|NCT00793598|587372289|FG001|Overall Study|Subject not dosed|0|||
162633551|NCT00793598|587372290|FG002|Overall Study|Subject not dosed|0|||
162633552|NCT00793598|587372291|FG003|Overall Study|Subject not dosed|0|||
162633553|NCT00793598|587372292|FG004|Overall Study|Subject not dosed|0|||
162633554|NCT00793598|587372293|FG005|Overall Study|Subject not dosed|1|||
162633555|NCT00793598|587372294|FG006|Overall Study|Subject not dosed|0|||
162633556|NCT00793598|587372295|FG007|Overall Study|Subject not dosed|0|||
162633557|NCT02762266|587372296|FG000|Overall Study|Physician Decision|2|||
162633558|NCT02762266|587372297|FG001|Overall Study|Physician Decision|0|||
162633559|NCT02373202|587372303|FG000|Overall Study|Adverse Event|2|||
162633560|NCT02373202|587372304|FG001|Overall Study|Adverse Event|5|||
162633561|NCT02373202|587372305|FG002|Overall Study|Adverse Event|2|||
162633562|NCT02373202|587372306|FG003|Overall Study|Adverse Event|1|||
162633563|NCT02373202|587372303|FG000|Overall Study|Lack of Efficacy|0|||
162633564|NCT02373202|587372304|FG001|Overall Study|Lack of Efficacy|0|||
162633565|NCT02373202|587372305|FG002|Overall Study|Lack of Efficacy|1|||
162633566|NCT02373202|587372306|FG003|Overall Study|Lack of Efficacy|0|||
162633567|NCT02373202|587372303|FG000|Overall Study|Other|0|||
162633568|NCT02373202|587372304|FG001|Overall Study|Other|1|||
162633569|NCT02373202|587372305|FG002|Overall Study|Other|0|||
162633570|NCT02373202|587372306|FG003|Overall Study|Other|0|||
162633571|NCT00410046|587372307|FG000|Overall Study|Adverse Event|3|||
162633572|NCT00410046|587372307|FG000|Overall Study|Withdrawal by Subject|1|||
162633573|NCT00410046|587372307|FG000|Overall Study|Lost to Follow-up|1|||
162633574|NCT03010254|587372308|FG000|Overall Study|Adverse Event|0|||
162633575|NCT03010254|587372309|FG001|Overall Study|Adverse Event|1|||
162633576|NCT03010254|587372308|FG000|Overall Study|Lost to Follow-up|4|||
162633577|NCT03010254|587372309|FG001|Overall Study|Lost to Follow-up|0|||
162633578|NCT03010254|587372308|FG000|Overall Study|Withdrawal by Subject|1|||
162633579|NCT03010254|587372309|FG001|Overall Study|Withdrawal by Subject|1|||
162633580|NCT03010254|587372308|FG000|Overall Study|Other|2|||
162633581|NCT03010254|587372309|FG001|Overall Study|Other|3|||
162633582|NCT01404325|587372316|FG000|Overall Study|Lost to Follow-up|1|||
162633583|NCT01404325|587372317|FG001|Overall Study|Lost to Follow-up|0|||
162633584|NCT01404325|587372316|FG000|Overall Study|Death|2|||
162633585|NCT01404325|587372317|FG001|Overall Study|Death|0|||
162633586|NCT01404325|587372316|FG000|Overall Study|Graft loss/Retransplantation|1|||
162633587|NCT01404325|587372317|FG001|Overall Study|Graft loss/Retransplantation|0|||
162633588|NCT01404325|587372316|FG000|Overall Study|non-specified reason|0|||
162633589|NCT01404325|587372317|FG001|Overall Study|non-specified reason|2|||
162633590|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162633591|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162633592|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162633593|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162633594|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
162633595|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
162633596|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162633597|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162633598|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162633599|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162633600|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|Other|1|||
162633601|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|Other|1|||
162633602|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|Other|0|||
162633603|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|Other|0|||
162633604|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|Other|0|||
162633605|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162633606|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162633607|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162633608|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
162633609|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
162633610|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162633611|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162633612|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162633613|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
162633614|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
163059284|NCT02100631|588926344|FG001|Overall Study|Lost to Follow-up|4|||
163059285|NCT02100631|588926345|FG002|Overall Study|Lost to Follow-up|0|||
163059286|NCT02100631|588926343|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
163059287|NCT02100631|588926344|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
163059288|NCT02100631|588926345|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
163059289|NCT00336544|588926346|FG000|Overall Study|Lack of Efficacy|8|||
163059290|NCT00336544|588926347|FG001|Overall Study|Lack of Efficacy|5|||
163059291|NCT00336544|588926346|FG000|Overall Study|Adverse Event|4|||
163059292|NCT00336544|588926347|FG001|Overall Study|Adverse Event|9|||
163059293|NCT00336544|588926346|FG000|Overall Study|Withdrawal by Subject|4|||
163059294|NCT00336544|588926347|FG001|Overall Study|Withdrawal by Subject|3|||
163059295|NCT00336544|588926346|FG000|Overall Study|Other|3|||
163059296|NCT00336544|588926347|FG001|Overall Study|Other|5|||
163059297|NCT00576758|588926348|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
163059298|NCT00576758|588926349|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
163059299|NCT00576758|588926348|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
163059300|NCT00576758|588926349|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
163059301|NCT00576758|588926348|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
163059302|NCT00576758|588926349|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
163059303|NCT00576758|588926348|FG000|Induction Treatment Period|Death|1|||
163059304|NCT00576758|588926349|FG001|Induction Treatment Period|Death|0|||
163059305|NCT00576758|588926348|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
163059306|NCT00576758|588926349|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
163059307|NCT00576758|588926348|FG000|Induction Treatment Period|Withdrew consent|1|||
163059308|NCT00576758|588926349|FG001|Induction Treatment Period|Withdrew consent|0|||
163059309|NCT00576758|588926348|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
163059310|NCT00576758|588926349|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
163059311|NCT00576758|588926348|FG000|Extension Treatment Period|Death|1|||
163059312|NCT00576758|588926349|FG001|Extension Treatment Period|Death|1|||
163059313|NCT00576758|588926348|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
163059314|NCT00576758|588926349|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
163059315|NCT00576758|588926348|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
163059316|NCT00576758|588926349|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
163059317|NCT00576758|588926348|FG000|Extension Treatment Period|Administrative/Other|3|||
163059318|NCT00576758|588926349|FG001|Extension Treatment Period|Administrative/Other|1|||
163059319|NCT00576758|588926348|FG000|Follow-up Period|Administrative/Other|6|||
163059320|NCT00576758|588926349|FG001|Follow-up Period|Administrative/Other|8|||
163059321|NCT00576758|588926348|FG000|Follow-up Period|Death|3|||
163059322|NCT00576758|588926349|FG001|Follow-up Period|Death|3|||
163059323|NCT00576758|588926348|FG000|Follow-up Period|Insufficient therapeutic response|16|||
163059324|NCT00576758|588926349|FG001|Follow-up Period|Insufficient therapeutic response|5|||
163059325|NCT00576758|588926348|FG000|Follow-up Period|Withdrew consent|2|||
163059326|NCT00576758|588926349|FG001|Follow-up Period|Withdrew consent|1|||
163059327|NCT03427411|588926350|FG000|Overall Study|Screen failure - platelets too low|0|||
163059328|NCT03427411|588926351|FG001|Overall Study|Screen failure - platelets too low|1|||
163059329|NCT00903968|588926352|FG000|Overall Study|Adverse Event|0|||
163059330|NCT00903968|588926353|FG001|Overall Study|Adverse Event|0|||
163059331|NCT00903968|588926354|FG002|Overall Study|Adverse Event|0|||
163059332|NCT00903968|588926355|FG003|Overall Study|Adverse Event|0|||
163059333|NCT00903968|588926356|FG004|Overall Study|Adverse Event|0|||
163059334|NCT00903968|588926357|FG005|Overall Study|Adverse Event|0|||
163059335|NCT00903968|588926358|FG006|Overall Study|Adverse Event|1|||
163059336|NCT00903968|588926359|FG007|Overall Study|Adverse Event|8|||
163059337|NCT00903968|588926352|FG000|Overall Study|DLT|0|||
163059338|NCT00903968|588926353|FG001|Overall Study|DLT|0|||
163059339|NCT00903968|588926354|FG002|Overall Study|DLT|0|||
162981829|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
162981830|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
162981831|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
162981832|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
162981833|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
162981834|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
162981835|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
162981836|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
162981837|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
162981838|NCT01421342|588634488|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
162981839|NCT01421342|588634489|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
162981840|NCT01421342|588634490|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
162981841|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
162981842|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
162981843|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
162981844|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
162981845|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
163059340|NCT00903968|588926355|FG003|Overall Study|DLT|0|||
163059341|NCT00903968|588926356|FG004|Overall Study|DLT|0|||
163059342|NCT00903968|588926357|FG005|Overall Study|DLT|0|||
163059343|NCT00903968|588926358|FG006|Overall Study|DLT|2|||
163059344|NCT00903968|588926359|FG007|Overall Study|DLT|0|||
163059345|NCT00903968|588926352|FG000|Overall Study|Withdrawal by Subject|1|||
162714154|NCT00124982|587662687|FG001|Long-term Period|Withdrawal by Subject|0|||
162714155|NCT00124982|587662688|FG002|Long-term Period|Withdrawal by Subject|16|||
162714156|NCT00124982|587662686|FG000|Long-term Period|Pregnancy|0|||
162714157|NCT00124982|587662687|FG001|Long-term Period|Pregnancy|0|||
162714158|NCT00124982|587662688|FG002|Long-term Period|Pregnancy|1|||
162714159|NCT00124982|587662686|FG000|Long-term Period|Poor/Non-compliance|0|||
162714160|NCT00124982|587662687|FG001|Long-term Period|Poor/Non-compliance|0|||
162714161|NCT00124982|587662688|FG002|Long-term Period|Poor/Non-compliance|2|||
162714162|NCT00124982|587662686|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
162714163|NCT00124982|587662687|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
162714164|NCT00124982|587662688|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
162714165|NCT00124982|587662686|FG000|Long-term Period|Neurologist Recommendation|0|||
162714166|NCT00124982|587662687|FG001|Long-term Period|Neurologist Recommendation|0|||
162714167|NCT00124982|587662688|FG002|Long-term Period|Neurologist Recommendation|1|||
162714168|NCT00980538|587662689|FG000|Overall Study|Lost to Follow-up|20|||
162714169|NCT00980538|587662689|FG000|Overall Study|Sponsor's Decision|4|||
162714170|NCT00980538|587662689|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
163059346|NCT00903968|588926353|FG001|Overall Study|Withdrawal by Subject|0|||
163059347|NCT00903968|588926354|FG002|Overall Study|Withdrawal by Subject|1|||
163059348|NCT00903968|588926355|FG003|Overall Study|Withdrawal by Subject|0|||
162714171|NCT00980538|587662689|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
162714172|NCT00980538|587662689|FG000|Overall Study|Switch to Commercially Available Medication|25|||
162714173|NCT00980538|587662689|FG000|Overall Study|Participant Non-Compliant|9|||
162714174|NCT00980538|587662689|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
162714175|NCT00980538|587662689|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
162714176|NCT00980538|587662689|FG000|Overall Study|Other|60|||
162714177|NCT00980538|587662689|FG000|Overall Study|Other|1|||
162714178|NCT05663866|587662690|FG000|Overall Study|Adverse Event|0|||
162714179|NCT05663866|587662691|FG001|Overall Study|Adverse Event|0|||
162714180|NCT05663866|587662692|FG002|Overall Study|Adverse Event|1|||
162714181|NCT05663866|587662693|FG003|Overall Study|Adverse Event|0|||
162714182|NCT05663866|587662690|FG000|Overall Study|Physician Decision|0|||
162714183|NCT05663866|587662691|FG001|Overall Study|Physician Decision|0|||
162714184|NCT05663866|587662692|FG002|Overall Study|Physician Decision|0|||
162714185|NCT05663866|587662693|FG003|Overall Study|Physician Decision|1|||
162714186|NCT05663866|587662690|FG000|Overall Study|Withdrawal by Subject|0|||
162714187|NCT05663866|587662691|FG001|Overall Study|Withdrawal by Subject|2|||
162714188|NCT05663866|587662692|FG002|Overall Study|Withdrawal by Subject|1|||
162714189|NCT05663866|587662693|FG003|Overall Study|Withdrawal by Subject|2|||
162714190|NCT05663866|587662690|FG000|Overall Study|Progressive disease|4|||
162714191|NCT05663866|587662691|FG001|Overall Study|Progressive disease|8|||
162714192|NCT05663866|587662692|FG002|Overall Study|Progressive disease|5|||
162714193|NCT05663866|587662693|FG003|Overall Study|Progressive disease|2|||
162714194|NCT05663866|587662690|FG000|Overall Study|Other|1|||
162714195|NCT05663866|587662691|FG001|Overall Study|Other|0|||
162714196|NCT05663866|587662692|FG002|Overall Study|Other|0|||
162714197|NCT05663866|587662693|FG003|Overall Study|Other|0|||
162714198|NCT05663866|587662690|FG000|Overall Study|Ongoing|1|||
162714199|NCT05663866|587662691|FG001|Overall Study|Ongoing|27|||
162714200|NCT05663866|587662692|FG002|Overall Study|Ongoing|6|||
162714201|NCT05663866|587662693|FG003|Overall Study|Ongoing|1|||
162714202|NCT04018066|587663939|FG000|Overall Study|participants started taking medications during the study period|3|||
162714203|NCT04018066|587663939|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
162714204|NCT03568318|587663940|FG000|Overall Study|Adverse Event|3|||
162714205|NCT03568318|587663941|FG001|Overall Study|Adverse Event|1|||
162714206|NCT03568318|587663942|FG002|Overall Study|Adverse Event|1|||
162714207|NCT03568318|587663943|FG003|Overall Study|Adverse Event|0|||
162714208|NCT03568318|587663944|FG004|Overall Study|Adverse Event|1|||
162714209|NCT03568318|587663945|FG005|Overall Study|Adverse Event|0|||
162714210|NCT03568318|587663940|FG000|Overall Study|Withdrawal by Subject|6|||
162714211|NCT03568318|587663941|FG001|Overall Study|Withdrawal by Subject|5|||
162714212|NCT03568318|587663942|FG002|Overall Study|Withdrawal by Subject|2|||
162714213|NCT03568318|587663943|FG003|Overall Study|Withdrawal by Subject|1|||
162714214|NCT03568318|587663944|FG004|Overall Study|Withdrawal by Subject|0|||
162714215|NCT03568318|587663945|FG005|Overall Study|Withdrawal by Subject|0|||
162714216|NCT03568318|587663940|FG000|Overall Study|Lost to Follow-up|3|||
162714217|NCT03568318|587663941|FG001|Overall Study|Lost to Follow-up|2|||
162714218|NCT03568318|587663942|FG002|Overall Study|Lost to Follow-up|2|||
162714219|NCT03568318|587663943|FG003|Overall Study|Lost to Follow-up|2|||
162714220|NCT03568318|587663944|FG004|Overall Study|Lost to Follow-up|1|||
162714221|NCT03568318|587663945|FG005|Overall Study|Lost to Follow-up|0|||
162714222|NCT03568318|587663940|FG000|Overall Study|Other|3|||
162714223|NCT03568318|587663941|FG001|Overall Study|Other|1|||
162633615|NCT02310568|587372320|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162633616|NCT02310568|587372321|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162633617|NCT02310568|587372322|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162633618|NCT02310568|587372323|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
162633619|NCT02310568|587372324|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162633620|NCT02310568|587372320|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
162633621|NCT02310568|587372321|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162633622|NCT02310568|587372322|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162633623|NCT02310568|587372323|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
162633624|NCT02310568|587372324|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162633625|NCT02310568|587372320|FG000|Stage 2 (4 Weeks)|Other|0|||
162633626|NCT02310568|587372321|FG001|Stage 2 (4 Weeks)|Other|1|||
162633627|NCT02310568|587372322|FG002|Stage 2 (4 Weeks)|Other|1|||
162714224|NCT03568318|587663942|FG002|Overall Study|Other|3|||
162714225|NCT03568318|587663943|FG003|Overall Study|Other|0|||
162714226|NCT03568318|587663944|FG004|Overall Study|Other|0|||
162714227|NCT03568318|587663945|FG005|Overall Study|Other|0|||
162714228|NCT03568318|587663940|FG000|Overall Study|Ongoing at Time of Analysis|5|||
162714229|NCT03568318|587663941|FG001|Overall Study|Ongoing at Time of Analysis|3|||
162714230|NCT03568318|587663942|FG002|Overall Study|Ongoing at Time of Analysis|2|||
162714231|NCT03568318|587663943|FG003|Overall Study|Ongoing at Time of Analysis|1|||
162714232|NCT03568318|587663944|FG004|Overall Study|Ongoing at Time of Analysis|0|||
162714233|NCT03568318|587663945|FG005|Overall Study|Ongoing at Time of Analysis|0|||
162714234|NCT01249092|587663947|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
162714235|NCT01249092|587663947|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
162633628|NCT02310568|587372323|FG003|Stage 2 (4 Weeks)|Other|0|||
162714236|NCT03518112|587663948|FG000|Overall Study|Withdrawal by Subject|1|||
162633629|NCT02310568|587372324|FG004|Stage 2 (4 Weeks)|Other|0|||
162633630|NCT02310568|587372320|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
162633631|NCT02310568|587372321|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
162633632|NCT02310568|587372322|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
162633633|NCT02310568|587372323|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
162633634|NCT02310568|587372324|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
162633635|NCT02310568|587372320|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
162633636|NCT02310568|587372321|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
162633637|NCT02310568|587372322|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
162633638|NCT02310568|587372323|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
162633639|NCT02310568|587372324|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
162633640|NCT02310568|587372320|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162633641|NCT02310568|587372321|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162633642|NCT02310568|587372322|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162633643|NCT02310568|587372323|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
162633644|NCT02310568|587372324|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162633645|NCT02989194|587372329|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
162633646|NCT02989194|587372330|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
162633647|NCT02989194|587372331|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
162633648|NCT02989194|587372329|FG000|Overall Study|Lost to Follow-up|0|||
162633649|NCT02989194|587372330|FG001|Overall Study|Lost to Follow-up|1|||
162633650|NCT02989194|587372331|FG002|Overall Study|Lost to Follow-up|0|||
162633651|NCT02989194|587372329|FG000|Overall Study|Withdrawal by Subject|0|||
162633652|NCT02989194|587372330|FG001|Overall Study|Withdrawal by Subject|1|||
162633653|NCT02989194|587372331|FG002|Overall Study|Withdrawal by Subject|0|||
162633654|NCT04160091|587372334|FG000|Overall Study|Terminated by Sponsor|7|||
162633655|NCT04160091|587372335|FG001|Overall Study|Terminated by Sponsor|3|||
162633656|NCT04160091|587372336|FG002|Overall Study|Terminated by Sponsor|5|||
162633657|NCT04160091|587372337|FG003|Overall Study|Terminated by Sponsor|2|||
162633658|NCT04160091|587372334|FG000|Overall Study|Noncompliance|0|||
162633659|NCT04160091|587372335|FG001|Overall Study|Noncompliance|0|||
162633660|NCT04160091|587372336|FG002|Overall Study|Noncompliance|0|||
162633661|NCT04160091|587372337|FG003|Overall Study|Noncompliance|1|||
162633662|NCT04160091|587372334|FG000|Overall Study|Withdrawal by Subject|0|||
162633663|NCT04160091|587372335|FG001|Overall Study|Withdrawal by Subject|0|||
162633664|NCT04160091|587372336|FG002|Overall Study|Withdrawal by Subject|0|||
162633665|NCT04160091|587372337|FG003|Overall Study|Withdrawal by Subject|1|||
162633666|NCT00609492|587372340|FG000|Overall Study|Withdrawal by Subject|0|||
162633667|NCT00609492|587372341|FG001|Overall Study|Withdrawal by Subject|2|||
162633668|NCT00609492|587372342|FG002|Overall Study|Withdrawal by Subject|3|||
162633669|NCT00609492|587372340|FG000|Overall Study|Lost to Follow-up|1|||
162633670|NCT00609492|587372341|FG001|Overall Study|Lost to Follow-up|1|||
162633671|NCT00609492|587372342|FG002|Overall Study|Lost to Follow-up|4|||
162633672|NCT02057406|587372343|FG000|Overall Study|Physician Decision|0|||
162633673|NCT02057406|587372344|FG001|Overall Study|Physician Decision|0|||
162633674|NCT02057406|587372345|FG002|Overall Study|Physician Decision|2|||
162633675|NCT02057406|587372343|FG000|Overall Study|Withdrawal by Subject|0|||
162633676|NCT02057406|587372344|FG001|Overall Study|Withdrawal by Subject|2|||
162633677|NCT02057406|587372345|FG002|Overall Study|Withdrawal by Subject|0|||
162633678|NCT02057406|587372343|FG000|Overall Study|Lost to Follow-up|0|||
162633679|NCT02057406|587372344|FG001|Overall Study|Lost to Follow-up|0|||
162633680|NCT02057406|587372345|FG002|Overall Study|Lost to Follow-up|1|||
162633681|NCT02057406|587372343|FG000|Overall Study|Death|1|||
162633682|NCT02057406|587372344|FG001|Overall Study|Death|0|||
162633683|NCT02057406|587372345|FG002|Overall Study|Death|0|||
162633684|NCT02057406|587372343|FG000|Overall Study|Protocol Violation|0|||
162633685|NCT02057406|587372344|FG001|Overall Study|Protocol Violation|1|||
162633686|NCT02057406|587372345|FG002|Overall Study|Protocol Violation|0|||
162633687|NCT02057406|587372343|FG000|Overall Study|Patient transportation issues|0|||
162633688|NCT02057406|587372344|FG001|Overall Study|Patient transportation issues|0|||
162633689|NCT02057406|587372345|FG002|Overall Study|Patient transportation issues|1|||
162633690|NCT01224431|587372346|FG000|Overall Study|not randomized|0|||
162633691|NCT01224431|587372347|FG001|Overall Study|not randomized|4|||
162633692|NCT01224431|587372346|FG000|Overall Study|no video record|0|||
162633693|NCT01224431|587372347|FG001|Overall Study|no video record|1|||
162633694|NCT04492618|587372348|FG000|Overall Study|Withdrawal by Subject|1|||
162633695|NCT01401283|587372349|FG000|Overall Study|surgery cancelled|5|||
162633696|NCT01401283|587372350|FG001|Overall Study|surgery cancelled|8|||
162633697|NCT01401283|587372349|FG000|Overall Study|preoperative arrhythmia|5|||
162633698|NCT01401283|587372350|FG001|Overall Study|preoperative arrhythmia|0|||
162633699|NCT01401283|587372349|FG000|Overall Study|no central venous access|0|||
162633700|NCT01401283|587372350|FG001|Overall Study|no central venous access|1|||
162633701|NCT01401283|587372349|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
162633702|NCT01401283|587372350|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
162633703|NCT02433483|587372351|FG000|Overall Study|Unacceptable toxicity|1|||
162633704|NCT02433483|587372351|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
162714237|NCT05197049|587663954|FG000|Overall Study|Death|0|||
162714238|NCT05197049|587663955|FG001|Overall Study|Death|1|||
162714239|NCT05197049|587663956|FG002|Overall Study|Death|0|||
162714240|NCT05197049|587663954|FG000|Overall Study|Lost to Follow-up|3|||
162714241|NCT05197049|587663955|FG001|Overall Study|Lost to Follow-up|1|||
162714242|NCT05197049|587663956|FG002|Overall Study|Lost to Follow-up|0|||
162714243|NCT05197049|587663954|FG000|Overall Study|Withdrawal by Subject|15|||
162714244|NCT05197049|587663955|FG001|Overall Study|Withdrawal by Subject|3|||
162714245|NCT05197049|587663956|FG002|Overall Study|Withdrawal by Subject|1|||
162714246|NCT05197049|587663954|FG000|Overall Study|GCP non-compliance|1|||
162714247|NCT05197049|587663955|FG001|Overall Study|GCP non-compliance|2|||
162714248|NCT05197049|587663956|FG002|Overall Study|GCP non-compliance|0|||
162714249|NCT05650333|587663958|FG000|Treatment Period (7 Days)|Adverse Event|1|||
162714250|NCT01460342|587663959|FG000|Overall Study|Adverse Event|5|||
162714251|NCT01460342|587663960|FG001|Overall Study|Adverse Event|4|||
162714252|NCT01460342|587663959|FG000|Overall Study|Lost to Follow-up|1|||
162714253|NCT01460342|587663960|FG001|Overall Study|Lost to Follow-up|2|||
162714254|NCT01460342|587663959|FG000|Overall Study|Protocol Violation|0|||
162714255|NCT01460342|587663960|FG001|Overall Study|Protocol Violation|1|||
162714256|NCT01460342|587663959|FG000|Overall Study|Withdrawal by Subject|3|||
162714257|NCT01460342|587663960|FG001|Overall Study|Withdrawal by Subject|4|||
162714258|NCT01460342|587663959|FG000|Overall Study|Physician Decision|1|||
162714259|NCT01460342|587663960|FG001|Overall Study|Physician Decision|3|||
162714260|NCT01460342|587663959|FG000|Overall Study|Lack of Efficacy|1|||
162714261|NCT01460342|587663960|FG001|Overall Study|Lack of Efficacy|0|||
162714262|NCT03761784|587663961|FG000|Overall Study|Adverse Event|4|||
162714263|NCT03761784|587663962|FG001|Overall Study|Adverse Event|0|||
162714264|NCT03761784|587663961|FG000|Overall Study|Lost to Follow-up|10|||
162714265|NCT03761784|587663962|FG001|Overall Study|Lost to Follow-up|7|||
162714266|NCT03761784|587663961|FG000|Overall Study|Pregnancy|1|||
162714267|NCT03761784|587663962|FG001|Overall Study|Pregnancy|0|||
162981846|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
162981847|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
162981848|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
162981849|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
162981850|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
162981851|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
162981852|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
162981853|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
162981854|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
162981855|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
162981856|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
162981857|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
162981858|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
162981859|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
162981860|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
162981861|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
162981862|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981863|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981864|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
162981865|NCT01421342|588634488|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
162981866|NCT01421342|588634489|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
162981867|NCT01421342|588634490|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
162981868|NCT03052322|588634491|FG000|Overall Study|Other un-specified|1|||
162981869|NCT03052322|588634492|FG001|Overall Study|Other un-specified|2|||
162981870|NCT03052322|588634491|FG000|Overall Study|Withdrawal by Subject|10|||
162981871|NCT03052322|588634492|FG001|Overall Study|Withdrawal by Subject|9|||
162981872|NCT03052322|588634491|FG000|Overall Study|Death|0|||
162981873|NCT03052322|588634492|FG001|Overall Study|Death|2|||
162981874|NCT03052322|588634491|FG000|Overall Study|Lack of Efficacy|1|||
162981875|NCT03052322|588634492|FG001|Overall Study|Lack of Efficacy|2|||
163059349|NCT00903968|588926356|FG004|Overall Study|Withdrawal by Subject|1|||
163059350|NCT00903968|588926357|FG005|Overall Study|Withdrawal by Subject|1|||
162714268|NCT03761784|587663961|FG000|Overall Study|Protocol Violation|2|||
162714269|NCT03761784|587663962|FG001|Overall Study|Protocol Violation|0|||
162714270|NCT03761784|587663961|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
162714271|NCT03761784|587663962|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
162714272|NCT03761784|587663961|FG000|Overall Study|Withdrawal by Subject|9|||
162714273|NCT03761784|587663962|FG001|Overall Study|Withdrawal by Subject|4|||
162714274|NCT03761784|587663961|FG000|Overall Study|Physician Decision|1|||
162714275|NCT03761784|587663962|FG001|Overall Study|Physician Decision|0|||
162981876|NCT03052322|588634491|FG000|Overall Study|Protocol Violation|1|||
162714276|NCT03761784|587663961|FG000|Overall Study|Other Than Specified|1|||
162714277|NCT03761784|587663962|FG001|Overall Study|Other Than Specified|0|||
162981877|NCT03052322|588634492|FG001|Overall Study|Protocol Violation|0|||
162981878|NCT03052322|588634491|FG000|Overall Study|Lost to Follow-up|2|||
162981879|NCT03052322|588634492|FG001|Overall Study|Lost to Follow-up|4|||
162981880|NCT03052322|588634491|FG000|Overall Study|Adverse Event|6|||
162981881|NCT03052322|588634492|FG001|Overall Study|Adverse Event|13|||
162981882|NCT05065983|588634493|FG000|Overall Study|Lost to Follow-up|2|||
162981883|NCT04505293|588634496|FG000|Overall Study|Lost to Follow-up|2|||
162981884|NCT04505293|588634496|FG000|Overall Study|Withdrawal by Subject|6|||
162981885|NCT04505293|588634496|FG000|Overall Study|CT scan unreadable|277|||
162981886|NCT00003875|588634497|FG000|Overall Study|Screen Failed|1|||
162981887|NCT01300052|588634498|FG000|Overall Study|Adverse Event|3|||
162981888|NCT01300052|588634499|FG001|Overall Study|Adverse Event|0|||
162981889|NCT01300052|588634498|FG000|Overall Study|Withdrawal by Subject|2|||
162981890|NCT01300052|588634499|FG001|Overall Study|Withdrawal by Subject|2|||
162981891|NCT01300052|588634498|FG000|Overall Study|Protocol Violation|1|||
162981892|NCT01300052|588634499|FG001|Overall Study|Protocol Violation|1|||
162981893|NCT01546649|588634500|FG000|Overall Study|Adverse Event|4|||
162981894|NCT01546649|588634501|FG001|Overall Study|Adverse Event|5|||
162981895|NCT01546649|588634500|FG000|Overall Study|Protocol Violation|1|||
162981896|NCT01546649|588634501|FG001|Overall Study|Protocol Violation|0|||
162981897|NCT01546649|588634500|FG000|Overall Study|Lack of Efficacy|1|||
162981898|NCT01546649|588634501|FG001|Overall Study|Lack of Efficacy|0|||
162981899|NCT01546649|588634500|FG000|Overall Study|Recurrence|1|||
162981900|NCT01546649|588634501|FG001|Overall Study|Recurrence|1|||
162981901|NCT01546649|588634500|FG000|Overall Study|Discovery of secondary cancer|0|||
162981902|NCT01546649|588634501|FG001|Overall Study|Discovery of secondary cancer|1|||
162981903|NCT01546649|588634500|FG000|Overall Study|Withdrawal by Subject|1|||
162981904|NCT01546649|588634501|FG001|Overall Study|Withdrawal by Subject|2|||
162981905|NCT01550744|588634502|FG000|Open-Label|Lost to Follow-up|7|||
162981906|NCT01550744|588634503|FG001|Open-Label|Lost to Follow-up|0|||
162981907|NCT01550744|588634504|FG002|Open-Label|Lost to Follow-up|0|||
162981908|NCT01550744|588634502|FG000|Open-Label|Withdrawal by Subject|13|||
162981909|NCT01550744|588634503|FG001|Open-Label|Withdrawal by Subject|0|||
162981910|NCT01550744|588634504|FG002|Open-Label|Withdrawal by Subject|0|||
162981911|NCT01550744|588634502|FG000|Open-Label|Adverse Event|11|||
162981912|NCT01550744|588634503|FG001|Open-Label|Adverse Event|0|||
162981913|NCT01550744|588634504|FG002|Open-Label|Adverse Event|0|||
162981914|NCT01550744|588634502|FG000|Open-Label|Lack of Efficacy|4|||
163059351|NCT00903968|588926358|FG006|Overall Study|Withdrawal by Subject|0|||
163059352|NCT00903968|588926359|FG007|Overall Study|Withdrawal by Subject|4|||
163059353|NCT00903968|588926352|FG000|Overall Study|Non-Compliance|0|||
162981915|NCT01550744|588634503|FG001|Open-Label|Lack of Efficacy|0|||
162981916|NCT01550744|588634504|FG002|Open-Label|Lack of Efficacy|0|||
162981917|NCT01550744|588634502|FG000|Open-Label|Protocol Violation|4|||
162981918|NCT01550744|588634503|FG001|Open-Label|Protocol Violation|0|||
162981919|NCT01550744|588634504|FG002|Open-Label|Protocol Violation|0|||
162981920|NCT01550744|588634502|FG000|Open-Label|Not all 3 study drug injections received|2|||
162981921|NCT01550744|588634503|FG001|Open-Label|Not all 3 study drug injections received|0|||
162981922|NCT01550744|588634504|FG002|Open-Label|Not all 3 study drug injections received|0|||
162633705|NCT01327885|587372360|FG000|Overall Study|Disease progression-according to RECIST|173|||
162633706|NCT01327885|587372361|FG001|Overall Study|Disease progression-according to RECIST|165|||
162981923|NCT01550744|588634502|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
162981924|NCT01550744|588634503|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
162981925|NCT01550744|588634504|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
162981926|NCT01550744|588634502|FG000|Open-Label|Other|1|||
162981927|NCT01550744|588634503|FG001|Open-Label|Other|0|||
162981928|NCT01550744|588634504|FG002|Open-Label|Other|0|||
162981929|NCT01550744|588634502|FG000|Double-Blind|Lost to Follow-up|0|||
162981930|NCT01550744|588634503|FG001|Double-Blind|Lost to Follow-up|6|||
162981931|NCT01550744|588634504|FG002|Double-Blind|Lost to Follow-up|12|||
162633707|NCT01327885|587372360|FG000|Overall Study|Clinical progression|24|||
162633708|NCT01327885|587372361|FG001|Overall Study|Clinical progression|27|||
162633709|NCT01327885|587372360|FG000|Overall Study|Adverse Event|14|||
162633710|NCT01327885|587372361|FG001|Overall Study|Adverse Event|10|||
162633711|NCT01327885|587372360|FG000|Overall Study|Subject choice|5|||
162633712|NCT01327885|587372361|FG001|Overall Study|Subject choice|10|||
162633713|NCT01327885|587372360|FG000|Overall Study|Other|8|||
162633714|NCT01327885|587372361|FG001|Overall Study|Other|6|||
162633715|NCT01327885|587372360|FG000|Overall Study|Withdrawal of consent from study|3|||
162633716|NCT01327885|587372361|FG001|Overall Study|Withdrawal of consent from study|4|||
162633717|NCT01327885|587372360|FG000|Overall Study|Not treated|1|||
162633718|NCT01327885|587372361|FG001|Overall Study|Not treated|1|||
162633719|NCT01327885|587372360|FG000|Overall Study|Administrative decision|0|||
162633720|NCT01327885|587372361|FG001|Overall Study|Administrative decision|1|||
162633721|NCT03824912|587372367|FG000|Overall Study|Lost to Follow-up|18|||
162633722|NCT03824912|587372368|FG001|Overall Study|Lost to Follow-up|15|||
162633723|NCT03824912|587372369|FG002|Overall Study|Lost to Follow-up|8|||
162633724|NCT03824912|587372367|FG000|Overall Study|Negative Baseline Culture Result|118|||
162633725|NCT03824912|587372368|FG001|Overall Study|Negative Baseline Culture Result|112|||
162633726|NCT03824912|587372369|FG002|Overall Study|Negative Baseline Culture Result|57|||
162633727|NCT03824912|587372367|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162633728|NCT03824912|587372368|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162633729|NCT03824912|587372369|FG002|Overall Study|Non-Compliance with Study Drug|1|||
162633730|NCT03824912|587372367|FG000|Overall Study|Protocol Violation|1|||
162633731|NCT03824912|587372368|FG001|Overall Study|Protocol Violation|4|||
162633732|NCT03824912|587372369|FG002|Overall Study|Protocol Violation|1|||
162633733|NCT03824912|587372367|FG000|Overall Study|Withdrawal by Subject|3|||
162633734|NCT03824912|587372368|FG001|Overall Study|Withdrawal by Subject|2|||
162633735|NCT03824912|587372369|FG002|Overall Study|Withdrawal by Subject|1|||
162633736|NCT03824912|587372367|FG000|Overall Study|Participation in another study|0|||
162633737|NCT03824912|587372368|FG001|Overall Study|Participation in another study|1|||
162633738|NCT03824912|587372369|FG002|Overall Study|Participation in another study|0|||
162633739|NCT00549302|587372374|FG000|Double-Blind|Death|2|||
162633740|NCT00549302|587372375|FG001|Double-Blind|Death|9|||
162633741|NCT00549302|587372376|FG002|Double-Blind|Death|0|||
162633742|NCT00549302|587372374|FG000|Double-Blind|Adverse Event|3|||
162633743|NCT00549302|587372375|FG001|Double-Blind|Adverse Event|16|||
162633744|NCT00549302|587372376|FG002|Double-Blind|Adverse Event|0|||
162633745|NCT00549302|587372374|FG000|Double-Blind|Withdrawal by Subject|3|||
162633746|NCT00549302|587372375|FG001|Double-Blind|Withdrawal by Subject|8|||
162633747|NCT00549302|587372376|FG002|Double-Blind|Withdrawal by Subject|0|||
162633748|NCT00549302|587372374|FG000|Double-Blind|Investigator Decision|1|||
162633749|NCT00549302|587372375|FG001|Double-Blind|Investigator Decision|5|||
162633750|NCT00549302|587372376|FG002|Double-Blind|Investigator Decision|0|||
162633751|NCT00549302|587372374|FG000|Double-Blind|Sponsor Decision|0|||
162633752|NCT00549302|587372375|FG001|Double-Blind|Sponsor Decision|1|||
162633753|NCT00549302|587372376|FG002|Double-Blind|Sponsor Decision|0|||
162633754|NCT00549302|587372374|FG000|Double-Blind|Lost to Follow-up|1|||
162633755|NCT00549302|587372375|FG001|Double-Blind|Lost to Follow-up|2|||
162633756|NCT00549302|587372376|FG002|Double-Blind|Lost to Follow-up|0|||
162633757|NCT00549302|587372374|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
162633758|NCT00549302|587372375|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
162633759|NCT00549302|587372376|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
162633760|NCT00549302|587372374|FG000|Double-Blind|New condition or starts new therapy|0|||
162633761|NCT00549302|587372375|FG001|Double-Blind|New condition or starts new therapy|2|||
162633762|NCT00549302|587372376|FG002|Double-Blind|New condition or starts new therapy|0|||
162633763|NCT00549302|587372374|FG000|Open-Label|Adverse Event|0|||
162633764|NCT00549302|587372375|FG001|Open-Label|Adverse Event|0|||
162633765|NCT00549302|587372376|FG002|Open-Label|Adverse Event|11|||
162633766|NCT00549302|587372374|FG000|Open-Label|Death|0|||
162633767|NCT00549302|587372375|FG001|Open-Label|Death|0|||
162633768|NCT00549302|587372376|FG002|Open-Label|Death|40|||
162633769|NCT00549302|587372374|FG000|Open-Label|Investigator Decision|0|||
162633770|NCT00549302|587372375|FG001|Open-Label|Investigator Decision|0|||
162633771|NCT00549302|587372376|FG002|Open-Label|Investigator Decision|5|||
162633772|NCT00549302|587372374|FG000|Open-Label|Lost to Follow-up|0|||
162633773|NCT00549302|587372375|FG001|Open-Label|Lost to Follow-up|0|||
162633774|NCT00549302|587372376|FG002|Open-Label|Lost to Follow-up|2|||
162633775|NCT00549302|587372374|FG000|Open-Label|Other|0|||
162633776|NCT00549302|587372375|FG001|Open-Label|Other|0|||
162633777|NCT00549302|587372376|FG002|Open-Label|Other|3|||
162633778|NCT00549302|587372374|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
162633779|NCT00549302|587372375|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
162633780|NCT00549302|587372376|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
162633781|NCT00549302|587372374|FG000|Open-Label|Withdrawal by Subject|0|||
162633782|NCT00549302|587372375|FG001|Open-Label|Withdrawal by Subject|0|||
162633783|NCT00549302|587372376|FG002|Open-Label|Withdrawal by Subject|6|||
162633784|NCT01414114|587372377|FG000|Overall Study|Adverse Event|2|||
162633785|NCT01414114|587372377|FG000|Overall Study|Withdrawal by Subject|1|||
162633786|NCT01414114|587372377|FG000|Overall Study|Other|2|||
163059354|NCT00903968|588926353|FG001|Overall Study|Non-Compliance|0|||
163059355|NCT00903968|588926354|FG002|Overall Study|Non-Compliance|0|||
163059356|NCT00903968|588926355|FG003|Overall Study|Non-Compliance|0|||
163059357|NCT00903968|588926356|FG004|Overall Study|Non-Compliance|0|||
163059358|NCT00903968|588926357|FG005|Overall Study|Non-Compliance|1|||
163059359|NCT00903968|588926358|FG006|Overall Study|Non-Compliance|0|||
163059360|NCT00903968|588926359|FG007|Overall Study|Non-Compliance|0|||
163059361|NCT00903968|588926352|FG000|Overall Study|Physician Decision|0|||
163059362|NCT00903968|588926353|FG001|Overall Study|Physician Decision|0|||
163059363|NCT00903968|588926354|FG002|Overall Study|Physician Decision|0|||
163059364|NCT00903968|588926355|FG003|Overall Study|Physician Decision|0|||
163059365|NCT00903968|588926356|FG004|Overall Study|Physician Decision|0|||
163059366|NCT00903968|588926357|FG005|Overall Study|Physician Decision|1|||
163059367|NCT00903968|588926358|FG006|Overall Study|Physician Decision|0|||
163059368|NCT00903968|588926359|FG007|Overall Study|Physician Decision|0|||
163059369|NCT00903968|588926352|FG000|Overall Study|Progressive Disease|2|||
163059370|NCT00903968|588926353|FG001|Overall Study|Progressive Disease|3|||
163059371|NCT00903968|588926354|FG002|Overall Study|Progressive Disease|2|||
163059372|NCT00903968|588926355|FG003|Overall Study|Progressive Disease|3|||
163059373|NCT00903968|588926356|FG004|Overall Study|Progressive Disease|3|||
163059374|NCT00903968|588926357|FG005|Overall Study|Progressive Disease|3|||
163059375|NCT00903968|588926358|FG006|Overall Study|Progressive Disease|0|||
163059376|NCT00903968|588926359|FG007|Overall Study|Progressive Disease|18|||
163059377|NCT00903968|588926352|FG000|Overall Study|Lack of Efficacy|0|||
162633787|NCT00865124|587372378|FG000|Overall Study|Physician Decision|2|||
162633788|NCT00865124|587372379|FG001|Overall Study|Physician Decision|1|||
162633789|NCT00865124|587372380|FG002|Overall Study|Physician Decision|0|||
162633790|NCT00865124|587372378|FG000|Overall Study|Withdrawn consent|2|||
162633791|NCT00865124|587372379|FG001|Overall Study|Withdrawn consent|0|||
162633792|NCT00865124|587372380|FG002|Overall Study|Withdrawn consent|0|||
162633793|NCT02743520|587372381|FG000|Overall Study|Withdrawal by Subject|1|||
162633794|NCT01111149|587372388|FG000|Overall Study|Protocol Violation|1|||
162633795|NCT01111149|587372389|FG001|Overall Study|Protocol Violation|1|||
162633796|NCT01111149|587372390|FG002|Overall Study|Protocol Violation|2|||
162633797|NCT01111149|587372388|FG000|Overall Study|Withdrawal by Subject|1|||
162633798|NCT01111149|587372389|FG001|Overall Study|Withdrawal by Subject|0|||
162633799|NCT01111149|587372390|FG002|Overall Study|Withdrawal by Subject|2|||
162633800|NCT00006903|587372393|FG000|Overall Study|Still receiving treatment|0|||
162633801|NCT00006903|587372394|FG001|Overall Study|Still receiving treatment|0|||
162633802|NCT00006903|587372395|FG002|Overall Study|Still receiving treatment|1|||
162633803|NCT00006903|587372393|FG000|Overall Study|Refused further treatment|0|||
162633804|NCT00006903|587372394|FG001|Overall Study|Refused further treatment|2|||
162633805|NCT00006903|587372395|FG002|Overall Study|Refused further treatment|1|||
162633806|NCT00006903|587372393|FG000|Overall Study|Adverse Event|0|||
162633807|NCT00006903|587372394|FG001|Overall Study|Adverse Event|0|||
162633808|NCT00006903|587372395|FG002|Overall Study|Adverse Event|1|||
162633809|NCT00006903|587372393|FG000|Overall Study|Death|0|||
162633810|NCT00006903|587372394|FG001|Overall Study|Death|1|||
162633811|NCT00006903|587372395|FG002|Overall Study|Death|0|||
162633812|NCT00006903|587372393|FG000|Overall Study|Patient never treated|0|||
162633813|NCT00006903|587372394|FG001|Overall Study|Patient never treated|0|||
162633814|NCT00006903|587372395|FG002|Overall Study|Patient never treated|1|||
162633815|NCT00006903|587372393|FG000|Overall Study|Ineligible|10|||
162633816|NCT00006903|587372394|FG001|Overall Study|Ineligible|1|||
162633817|NCT00006903|587372395|FG002|Overall Study|Ineligible|2|||
162633818|NCT02794883|587372396|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
162633819|NCT02794883|587372397|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
162633820|NCT02794883|587372398|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
162633821|NCT02794883|587372396|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
162633822|NCT02794883|587372397|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
162633823|NCT02794883|587372398|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
163059378|NCT00903968|588926353|FG001|Overall Study|Lack of Efficacy|0|||
163059379|NCT00903968|588926354|FG002|Overall Study|Lack of Efficacy|0|||
162633824|NCT02794883|587372396|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
162633825|NCT02794883|587372397|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
162633826|NCT02794883|587372398|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
162633827|NCT02794883|587372396|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
162633828|NCT02794883|587372397|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
162633829|NCT02794883|587372398|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
162633830|NCT02794883|587372396|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
162633831|NCT02794883|587372397|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
162633832|NCT02794883|587372398|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
163059380|NCT00903968|588926355|FG003|Overall Study|Lack of Efficacy|0|||
163059381|NCT00903968|588926356|FG004|Overall Study|Lack of Efficacy|0|||
163059382|NCT00903968|588926357|FG005|Overall Study|Lack of Efficacy|0|||
163059383|NCT00903968|588926358|FG006|Overall Study|Lack of Efficacy|0|||
163059384|NCT00903968|588926359|FG007|Overall Study|Lack of Efficacy|3|||
162633833|NCT02794883|587372396|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
162633834|NCT02794883|587372397|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
162633835|NCT02794883|587372398|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
162633836|NCT02794883|587372396|FG000|Follow-up Period (up to 2 Years)|Death|12|||
162633837|NCT02794883|587372397|FG001|Follow-up Period (up to 2 Years)|Death|10|||
162633838|NCT02794883|587372398|FG002|Follow-up Period (up to 2 Years)|Death|10|||
162633839|NCT01906008|587372400|FG000|Overall Study|Lost to Follow-up|2|||
162633840|NCT01906008|587372401|FG001|Overall Study|Lost to Follow-up|0|||
162633841|NCT01906008|587372400|FG000|Overall Study|Oxaliplatin toxicity|2|||
162633842|NCT01906008|587372401|FG001|Overall Study|Oxaliplatin toxicity|0|||
162633843|NCT01906008|587372400|FG000|Overall Study|Protocol Violation|0|||
162633844|NCT01906008|587372401|FG001|Overall Study|Protocol Violation|1|||
162633845|NCT01906008|587372400|FG000|Overall Study|Withdrawal by Subject|1|||
162633846|NCT01906008|587372401|FG001|Overall Study|Withdrawal by Subject|5|||
162633847|NCT01906008|587372400|FG000|Overall Study|Did not start study med|3|||
162633848|NCT01906008|587372401|FG001|Overall Study|Did not start study med|4|||
162633849|NCT01906008|587372400|FG000|Overall Study|Oxaliplatin stops|10|||
162633850|NCT01906008|587372401|FG001|Overall Study|Oxaliplatin stops|8|||
162633851|NCT01906008|587372400|FG000|Overall Study|Hospice|1|||
162633852|NCT01906008|587372401|FG001|Overall Study|Hospice|0|||
162633853|NCT01906008|587372400|FG000|Overall Study|Physician Decision|3|||
162633854|NCT01906008|587372401|FG001|Overall Study|Physician Decision|3|||
162633855|NCT01906008|587372400|FG000|Overall Study|Lack of compliance of study med|5|||
162633856|NCT01906008|587372401|FG001|Overall Study|Lack of compliance of study med|3|||
162633857|NCT01906008|587372400|FG000|Overall Study|Adverse Event|0|||
162633858|NCT01906008|587372401|FG001|Overall Study|Adverse Event|3|||
162633859|NCT01574326|587372402|FG000|Overall Study|Randomized but not treated|0|||
162633860|NCT01574326|587372403|FG001|Overall Study|Randomized but not treated|1|||
162633861|NCT01574326|587372402|FG000|Overall Study|Withdrawal by Participant|2|||
162633862|NCT01574326|587372403|FG001|Overall Study|Withdrawal by Participant|4|||
162633863|NCT01574326|587372402|FG000|Overall Study|Physician Decision|5|||
162633864|NCT01574326|587372403|FG001|Overall Study|Physician Decision|3|||
162981932|NCT01550744|588634502|FG000|Double-Blind|Withdrawal by Subject|0|||
162981933|NCT01550744|588634503|FG001|Double-Blind|Withdrawal by Subject|2|||
162981934|NCT01550744|588634504|FG002|Double-Blind|Withdrawal by Subject|15|||
162981935|NCT01550744|588634502|FG000|Double-Blind|Adverse Event|0|||
162981936|NCT01550744|588634503|FG001|Double-Blind|Adverse Event|4|||
162981937|NCT01550744|588634504|FG002|Double-Blind|Adverse Event|15|||
162981938|NCT01550744|588634502|FG000|Double-Blind|Death|0|||
162981939|NCT01550744|588634503|FG001|Double-Blind|Death|1|||
162981940|NCT01550744|588634504|FG002|Double-Blind|Death|0|||
162981941|NCT01550744|588634502|FG000|Double-Blind|Lack of Efficacy|0|||
162981942|NCT01550744|588634503|FG001|Double-Blind|Lack of Efficacy|2|||
162981943|NCT01550744|588634504|FG002|Double-Blind|Lack of Efficacy|8|||
162981944|NCT01550744|588634502|FG000|Double-Blind|Protocol Violation|0|||
162981945|NCT01550744|588634503|FG001|Double-Blind|Protocol Violation|0|||
162981946|NCT01550744|588634504|FG002|Double-Blind|Protocol Violation|4|||
162981947|NCT01550744|588634502|FG000|Double-Blind|Pregnancy|0|||
162981948|NCT01550744|588634503|FG001|Double-Blind|Pregnancy|0|||
162981949|NCT01550744|588634504|FG002|Double-Blind|Pregnancy|3|||
162981950|NCT01550744|588634502|FG000|Double-Blind|Other|0|||
162981951|NCT01550744|588634503|FG001|Double-Blind|Other|2|||
162981952|NCT01550744|588634504|FG002|Double-Blind|Other|10|||
162981953|NCT00706381|588634507|FG000|Overall Study|Lost to Follow-up|0|||
162981954|NCT00706381|588634508|FG001|Overall Study|Lost to Follow-up|1|||
162981955|NCT00706381|588634509|FG002|Overall Study|Lost to Follow-up|1|||
162981956|NCT00706381|588634510|FG003|Overall Study|Lost to Follow-up|0|||
162981957|NCT05420012|588634511|FG000|Overall Study|Lost to Follow-up|0|||
162981958|NCT05420012|588634512|FG001|Overall Study|Lost to Follow-up|1|||
162981959|NCT00767520|588634516|FG000|Overall Study|Participants still on treatment|11|||
162981960|NCT00767520|588634517|FG001|Overall Study|Participants still on treatment|15|||
162981961|NCT00767520|588634516|FG000|Overall Study|Randomized in error and Never treated|0|||
162981962|NCT00767520|588634517|FG001|Overall Study|Randomized in error and Never treated|2|||
162981963|NCT01901874|588634527|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
162981964|NCT01901874|588634527|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
162981965|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
162981966|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
162981967|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
162633865|NCT01574326|587372402|FG000|Overall Study|Adverse Event|1|||
162633866|NCT01574326|587372403|FG001|Overall Study|Adverse Event|3|||
162633867|NCT01574326|587372402|FG000|Overall Study|Other: Mainly kidney transplant|8|||
162633868|NCT01574326|587372403|FG001|Overall Study|Other: Mainly kidney transplant|8|||
162633869|NCT00137046|587372404|FG000|Overall Study|Death|2|||
162633870|NCT00137046|587372405|FG001|Overall Study|Death|1|||
162633871|NCT00137046|587372404|FG000|Overall Study|Adverse Event|16|||
162633872|NCT00137046|587372405|FG001|Overall Study|Adverse Event|5|||
162981968|NCT01901874|588634527|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
162981969|NCT03078582|588634528|FG000|Overall Study|Adverse Event|0|||
162714278|NCT01549652|587663963|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
162714279|NCT01549652|587663964|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
162714280|NCT01549652|587663965|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
162714281|NCT01549652|587663966|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
162714282|NCT01549652|587663963|FG000|Overall Study|Study Drug Titration Failure|5|||
162714283|NCT01549652|587663964|FG001|Overall Study|Study Drug Titration Failure|6|||
162714284|NCT01549652|587663965|FG002|Overall Study|Study Drug Titration Failure|0|||
162714285|NCT01549652|587663966|FG003|Overall Study|Study Drug Titration Failure|0|||
162714286|NCT01549652|587663963|FG000|Overall Study|Withdrawal Effect|0|||
162714287|NCT01549652|587663964|FG001|Overall Study|Withdrawal Effect|2|||
162714288|NCT01549652|587663965|FG002|Overall Study|Withdrawal Effect|0|||
162714289|NCT01549652|587663966|FG003|Overall Study|Withdrawal Effect|0|||
162714290|NCT01549652|587663963|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
162714291|NCT01549652|587663964|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
162714292|NCT01549652|587663965|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
162714293|NCT01549652|587663966|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
162714294|NCT01549652|587663963|FG000|Overall Study|Problem with Infusion|1|||
162714295|NCT01549652|587663964|FG001|Overall Study|Problem with Infusion|0|||
162714296|NCT01549652|587663965|FG002|Overall Study|Problem with Infusion|0|||
162714297|NCT01549652|587663966|FG003|Overall Study|Problem with Infusion|0|||
162714298|NCT01549652|587663963|FG000|Overall Study|Titration Non-Compliance|1|||
162714299|NCT01549652|587663964|FG001|Overall Study|Titration Non-Compliance|3|||
162714300|NCT01549652|587663965|FG002|Overall Study|Titration Non-Compliance|4|||
162714301|NCT01549652|587663966|FG003|Overall Study|Titration Non-Compliance|5|||
162714302|NCT01549652|587663963|FG000|Overall Study|Titration Side Effects|0|||
162714303|NCT01549652|587663964|FG001|Overall Study|Titration Side Effects|0|||
162714304|NCT01549652|587663965|FG002|Overall Study|Titration Side Effects|6|||
162714305|NCT01549652|587663966|FG003|Overall Study|Titration Side Effects|3|||
162714306|NCT01549652|587663963|FG000|Overall Study|Withdrawal by Subject|0|||
162714307|NCT01549652|587663964|FG001|Overall Study|Withdrawal by Subject|0|||
162714308|NCT01549652|587663965|FG002|Overall Study|Withdrawal by Subject|5|||
162714309|NCT01549652|587663966|FG003|Overall Study|Withdrawal by Subject|3|||
162714310|NCT01194258|587663969|FG000|Titration Period|Withdrawal by Subject|6|||
162714311|NCT01194258|587663970|FG001|Titration Period|Withdrawal by Subject|0|||
162714312|NCT01194258|587663971|FG002|Titration Period|Withdrawal by Subject|0|||
162714313|NCT01194258|587663972|FG003|Titration Period|Withdrawal by Subject|0|||
162714314|NCT01194258|587663973|FG004|Titration Period|Withdrawal by Subject|0|||
162714315|NCT01194258|587663969|FG000|Titration Period|Lost to Follow-up|2|||
162714316|NCT01194258|587663970|FG001|Titration Period|Lost to Follow-up|0|||
162714317|NCT01194258|587663971|FG002|Titration Period|Lost to Follow-up|0|||
162714318|NCT01194258|587663972|FG003|Titration Period|Lost to Follow-up|0|||
162714319|NCT01194258|587663973|FG004|Titration Period|Lost to Follow-up|0|||
162714320|NCT01194258|587663969|FG000|Titration Period|Titration failure|3|||
162714321|NCT01194258|587663970|FG001|Titration Period|Titration failure|0|||
162714322|NCT01194258|587663971|FG002|Titration Period|Titration failure|0|||
162714323|NCT01194258|587663972|FG003|Titration Period|Titration failure|0|||
162714324|NCT01194258|587663973|FG004|Titration Period|Titration failure|0|||
162714325|NCT01194258|587663969|FG000|Period 1 (12 Weeks)|Death|0|||
162981970|NCT03078582|588634529|FG001|Overall Study|Adverse Event|8|||
162981971|NCT01491035|588634543|FG000|Overall Study|Lost to Follow-up|0|||
162981972|NCT01491035|588634544|FG001|Overall Study|Lost to Follow-up|0|||
162981973|NCT01491035|588634545|FG002|Overall Study|Lost to Follow-up|0|||
162981974|NCT01491035|588634546|FG003|Overall Study|Lost to Follow-up|0|||
162981975|NCT01491035|588634547|FG004|Overall Study|Lost to Follow-up|1|||
162981976|NCT01491035|588634548|FG005|Overall Study|Lost to Follow-up|0|||
162981977|NCT01491035|588634549|FG006|Overall Study|Lost to Follow-up|0|||
162981978|NCT01491035|588634550|FG007|Overall Study|Lost to Follow-up|0|||
162981979|NCT02181296|588634552|FG000|Overall Study|Lost to Follow-up|7|||
162981980|NCT02181296|588634553|FG001|Overall Study|Lost to Follow-up|6|||
162981981|NCT02340221|588634558|FG000|Overall Study|Death|100|||
162981982|NCT02340221|588634559|FG001|Overall Study|Death|197|||
162981983|NCT02340221|588634558|FG000|Overall Study|Withdrawal by Participant|24|||
162714326|NCT01194258|587663970|FG001|Period 1 (12 Weeks)|Death|0|||
162714327|NCT01194258|587663971|FG002|Period 1 (12 Weeks)|Death|0|||
162714328|NCT01194258|587663972|FG003|Period 1 (12 Weeks)|Death|0|||
162714329|NCT01194258|587663973|FG004|Period 1 (12 Weeks)|Death|1|||
162714330|NCT01194258|587663969|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162714331|NCT01194258|587663970|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162714332|NCT01194258|587663971|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162981984|NCT02340221|588634559|FG001|Overall Study|Withdrawal by Participant|37|||
162981985|NCT02340221|588634558|FG000|Overall Study|Lost to Follow-up|4|||
162981986|NCT02340221|588634559|FG001|Overall Study|Lost to Follow-up|15|||
162714333|NCT01194258|587663972|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162714334|NCT01194258|587663973|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
162714335|NCT01194258|587663969|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
162981987|NCT02340221|588634558|FG000|Overall Study|Reason Not Specified|85|||
162714336|NCT01194258|587663970|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
162714337|NCT01194258|587663971|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
162714338|NCT01194258|587663972|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
162714339|NCT01194258|587663973|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
162714340|NCT01194258|587663969|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162714341|NCT01194258|587663970|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162714342|NCT01194258|587663971|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162714343|NCT01194258|587663972|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162714344|NCT01194258|587663973|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162714345|NCT02873754|587663974|FG000|Overall Study|Lost to Follow-up|5|||
162714346|NCT02873754|587663974|FG000|Overall Study|Couldn't complete study procedures|1|||
162714347|NCT02059980|587663979|FG000|Overall Study|Lost to Follow-up|2|||
162714348|NCT02059980|587663980|FG001|Overall Study|Lost to Follow-up|1|||
162714349|NCT01321606|587663981|FG000|Overall Study|Lost to Follow-up|0|||
162714350|NCT01321606|587663982|FG001|Overall Study|Lost to Follow-up|0|||
162714351|NCT01321606|587663983|FG002|Overall Study|Lost to Follow-up|0|||
162714352|NCT01321606|587663984|FG003|Overall Study|Lost to Follow-up|1|||
162714353|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
162714354|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
162714355|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
162714356|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
162714357|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
162714358|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
162714359|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
162714360|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
162714361|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
162714362|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
162714363|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
162714364|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
162714365|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
162714366|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
162714367|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
162714368|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
162714369|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
162714370|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
162714371|NCT03412747|587663985|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
162714372|NCT03412747|587663986|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
162714373|NCT03412747|587663987|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
162714374|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
162714375|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
162714376|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
162714377|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
162714378|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
162714379|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
162714380|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
162714381|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
162714382|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
162714383|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
162714384|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
162714385|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
162714386|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
162714387|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
162714388|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
162633873|NCT00137046|587372404|FG000|Overall Study|Laboratory Abnormality|2|||
162633874|NCT00137046|587372405|FG001|Overall Study|Laboratory Abnormality|0|||
162633875|NCT00137046|587372404|FG000|Overall Study|Lack of Efficacy|13|||
162633876|NCT00137046|587372405|FG001|Overall Study|Lack of Efficacy|1|||
162633877|NCT00137046|587372404|FG000|Overall Study|Lost to Follow-up|8|||
162633878|NCT00137046|587372405|FG001|Overall Study|Lost to Follow-up|24|||
162633879|NCT00137046|587372404|FG000|Overall Study|Other|23|||
162633880|NCT00137046|587372405|FG001|Overall Study|Other|19|||
162633881|NCT00137046|587372404|FG000|Overall Study|Withdrawal by Subject|33|||
162633882|NCT00137046|587372405|FG001|Overall Study|Withdrawal by Subject|42|||
162633883|NCT00137046|587372404|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
162633884|NCT00137046|587372405|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
162633885|NCT00137046|587372404|FG000|Overall Study|Withdrew prior to study treatment|1|||
162633886|NCT00137046|587372405|FG001|Overall Study|Withdrew prior to study treatment|1|||
162633887|NCT02268084|587372412|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
162633888|NCT02268084|587372413|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
162633889|NCT02268084|587372412|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
162633890|NCT02268084|587372413|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
162633891|NCT05227027|587372414|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
162633892|NCT05227027|587372415|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
162633893|NCT06149247|587372416|FG000|Overall Study|Adverse Event|0|||
162633894|NCT06149247|587372417|FG001|Overall Study|Adverse Event|1|||
162633895|NCT00371137|587372424|FG000|Overall Study|Adverse Event|20|||
162633896|NCT00371137|587372425|FG001|Overall Study|Adverse Event|35|||
162633897|NCT00371137|587372426|FG002|Overall Study|Adverse Event|42|||
162633898|NCT00371137|587372424|FG000|Overall Study|Withdrawal by Subject|11|||
162633899|NCT00371137|587372425|FG001|Overall Study|Withdrawal by Subject|10|||
162633900|NCT00371137|587372426|FG002|Overall Study|Withdrawal by Subject|15|||
162633901|NCT00371137|587372424|FG000|Overall Study|Lost to Follow-up|6|||
162633902|NCT00371137|587372425|FG001|Overall Study|Lost to Follow-up|3|||
162633903|NCT00371137|587372426|FG002|Overall Study|Lost to Follow-up|5|||
162633904|NCT00371137|587372424|FG000|Overall Study|Lack of Efficacy|30|||
162633905|NCT00371137|587372425|FG001|Overall Study|Lack of Efficacy|12|||
162981988|NCT02340221|588634559|FG001|Overall Study|Reason Not Specified|165|||
162981989|NCT02340221|588634558|FG000|Overall Study|Study Terminated by Sponsor|1|||
162981990|NCT02340221|588634559|FG001|Overall Study|Study Terminated by Sponsor|3|||
162981991|NCT00518622|588634560|FG000|Overall Study|Lost to Follow-up|0|||
162981992|NCT00518622|588634561|FG001|Overall Study|Lost to Follow-up|0|||
162981993|NCT00518622|588634562|FG002|Overall Study|Lost to Follow-up|1|||
162981994|NCT00518622|588634563|FG003|Overall Study|Lost to Follow-up|0|||
162981995|NCT00518622|588634564|FG004|Overall Study|Lost to Follow-up|0|||
162981996|NCT00518622|588634565|FG005|Overall Study|Lost to Follow-up|0|||
162981997|NCT00518622|588634566|FG006|Overall Study|Lost to Follow-up|0|||
162981998|NCT00518622|588634567|FG007|Overall Study|Lost to Follow-up|0|||
162981999|NCT00518622|588634560|FG000|Overall Study|Study medication taken incorrectly|0|||
162982000|NCT00518622|588634561|FG001|Overall Study|Study medication taken incorrectly|1|||
162982001|NCT00518622|588634562|FG002|Overall Study|Study medication taken incorrectly|0|||
162982002|NCT00518622|588634563|FG003|Overall Study|Study medication taken incorrectly|0|||
162982003|NCT00518622|588634564|FG004|Overall Study|Study medication taken incorrectly|0|||
162982004|NCT00518622|588634565|FG005|Overall Study|Study medication taken incorrectly|0|||
162982005|NCT00518622|588634566|FG006|Overall Study|Study medication taken incorrectly|0|||
162982006|NCT00518622|588634567|FG007|Overall Study|Study medication taken incorrectly|0|||
162982007|NCT03499119|588634568|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982008|NCT03499119|588634569|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982009|NCT03499119|588634570|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
162982010|NCT03499119|588634571|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
162982011|NCT03499119|588634568|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
162982012|NCT03499119|588634569|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
162982013|NCT03499119|588634570|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
162982014|NCT03499119|588634571|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
162982015|NCT03499119|588634568|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
162982016|NCT03499119|588634569|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
162982017|NCT03499119|588634570|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
162633906|NCT00371137|587372426|FG002|Overall Study|Lack of Efficacy|13|||
162982018|NCT03499119|588634571|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
162982019|NCT03499119|588634568|FG000|Optional Extension Phase|Lost to Follow-up|0|||
162982020|NCT03499119|588634569|FG001|Optional Extension Phase|Lost to Follow-up|0|||
162982021|NCT03499119|588634570|FG002|Optional Extension Phase|Lost to Follow-up|0|||
162982022|NCT03499119|588634571|FG003|Optional Extension Phase|Lost to Follow-up|1|||
162982023|NCT03499119|588634568|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
162982024|NCT03499119|588634569|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
162982025|NCT03499119|588634570|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
162982026|NCT03499119|588634571|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
162982027|NCT03499119|588634568|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
162982028|NCT03499119|588634569|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
162982029|NCT03499119|588634570|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
162982030|NCT03499119|588634571|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
162982031|NCT01558297|588634572|FG000|Overall Study|Withdrawal by Subject|2|||
162982032|NCT01558297|588634573|FG001|Overall Study|Withdrawal by Subject|2|||
162982033|NCT01558297|588634574|FG002|Overall Study|Withdrawal by Subject|1|||
162982034|NCT02655016|588634577|FG000|Overall Study|Disease progression|6|||
162982035|NCT02655016|588634578|FG001|Overall Study|Disease progression|4|||
162982036|NCT02655016|588634577|FG000|Overall Study|Site closed|0|||
162982037|NCT02655016|588634578|FG001|Overall Study|Site closed|1|||
162982038|NCT02655016|588634577|FG000|Overall Study|Death|30|||
162982039|NCT02655016|588634578|FG001|Overall Study|Death|48|||
162982040|NCT02655016|588634577|FG000|Overall Study|Lost to Follow-up|1|||
162982041|NCT02655016|588634578|FG001|Overall Study|Lost to Follow-up|1|||
162982042|NCT02655016|588634577|FG000|Overall Study|Withdrawal by Subject|18|||
162982043|NCT02655016|588634578|FG001|Overall Study|Withdrawal by Subject|36|||
162982044|NCT00952276|588634581|FG000|Overall Study|Withdrawal by Subject|1|||
162982045|NCT00952276|588634582|FG001|Overall Study|Withdrawal by Subject|0|||
162982046|NCT00952276|588634583|FG002|Overall Study|Withdrawal by Subject|0|||
162982047|NCT00952276|588634584|FG003|Overall Study|Withdrawal by Subject|1|||
162982048|NCT00952276|588634585|FG004|Overall Study|Withdrawal by Subject|0|||
162982049|NCT02522403|588636004|FG000|Overall Study|Lost to Follow-up|2|||
162982050|NCT02522403|588636005|FG001|Overall Study|Lost to Follow-up|2|||
162982051|NCT02522403|588636004|FG000|Overall Study|Withdrawal by Subject|2|||
162982052|NCT02522403|588636005|FG001|Overall Study|Withdrawal by Subject|4|||
162982053|NCT01553279|588636006|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
162982054|NCT01553279|588636007|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
162982055|NCT01553279|588636006|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
162982056|NCT01553279|588636007|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
162982057|NCT01553279|588636006|FG000|Interim Period|Withdrawal by Subject|2|||
162982058|NCT01553279|588636007|FG001|Interim Period|Withdrawal by Subject|2|||
162982059|NCT01553279|588636006|FG000|Interim Period|Lost to Follow-up|1|||
162982060|NCT01553279|588636007|FG001|Interim Period|Lost to Follow-up|0|||
162982061|NCT01553279|588636006|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
162982062|NCT01553279|588636007|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
162982063|NCT01553279|588636006|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
162982064|NCT01553279|588636007|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
162982065|NCT00619112|588636008|FG000|Overall Study|Adverse Event|1|||
162982066|NCT00619112|588636009|FG001|Overall Study|Adverse Event|2|||
162982067|NCT00729248|588636010|FG000|Overall Study|Physician Decision|2|||
162982068|NCT02588950|588636011|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
162982069|NCT02588950|588636012|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
162982070|NCT02588950|588636013|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
162982071|NCT02588950|588636014|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
162982072|NCT02588950|588636011|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
162633907|NCT00371137|587372424|FG000|Overall Study|Sponsor Decision|2|||
162633908|NCT00371137|587372425|FG001|Overall Study|Sponsor Decision|1|||
162633909|NCT00371137|587372426|FG002|Overall Study|Sponsor Decision|2|||
162633910|NCT00371137|587372424|FG000|Overall Study|Physician Decision|1|||
162633911|NCT00371137|587372425|FG001|Overall Study|Physician Decision|1|||
162633912|NCT00371137|587372426|FG002|Overall Study|Physician Decision|1|||
162633913|NCT00371137|587372424|FG000|Overall Study|Protocol Violation|2|||
162633914|NCT00371137|587372425|FG001|Overall Study|Protocol Violation|1|||
162633915|NCT00371137|587372426|FG002|Overall Study|Protocol Violation|1|||
162633916|NCT01756898|587372427|FG000|Overall Study|Adverse Event|7|||
162982073|NCT02588950|588636012|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
162982074|NCT02588950|588636013|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
162633917|NCT01756898|587372428|FG001|Overall Study|Adverse Event|1|||
162633918|NCT01756898|587372429|FG002|Overall Study|Adverse Event|0|||
162633919|NCT01756898|587372430|FG003|Overall Study|Adverse Event|0|||
162633920|NCT01756898|587372427|FG000|Overall Study|Lack of Efficacy|4|||
162982075|NCT02588950|588636014|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
162982076|NCT00652028|588636017|FG000|Overall Study|Adverse Event|1|||
162633921|NCT01756898|587372428|FG001|Overall Study|Lack of Efficacy|7|||
162633922|NCT01756898|587372429|FG002|Overall Study|Lack of Efficacy|6|||
162982077|NCT00652028|588636018|FG001|Overall Study|Adverse Event|0|||
162982078|NCT00652028|588636019|FG002|Overall Study|Adverse Event|0|||
162982079|NCT00652028|588636020|FG003|Overall Study|Adverse Event|0|||
162982080|NCT00652028|588636017|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
162633923|NCT01756898|587372430|FG003|Overall Study|Lack of Efficacy|6|||
162982081|NCT00652028|588636018|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
162982082|NCT00652028|588636019|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
162982083|NCT00652028|588636020|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
162982084|NCT00652028|588636017|FG000|Overall Study|Physician Decision|0|||
162982085|NCT00652028|588636018|FG001|Overall Study|Physician Decision|0|||
162982086|NCT00652028|588636019|FG002|Overall Study|Physician Decision|1|||
162982087|NCT00652028|588636020|FG003|Overall Study|Physician Decision|0|||
162982088|NCT02072824|588636021|FG000|Overall Study|Insufficient clinical response|1|||
162982089|NCT02072824|588636022|FG001|Overall Study|Insufficient clinical response|0|||
162982090|NCT02072824|588636023|FG002|Overall Study|Insufficient clinical response|1|||
162982091|NCT02072824|588636021|FG000|Overall Study|No longer willing to participate|1|||
162982092|NCT02072824|588636022|FG001|Overall Study|No longer willing to participate|0|||
163059385|NCT01294046|588926360|FG000|Overall Study|Infection and surgical explant|1|||
163059386|NCT01294046|588926360|FG000|Overall Study|Eligibility criteria expanded|1|||
163059387|NCT01294046|588926360|FG000|Overall Study|Stimulation response inadqequate|1|||
163059388|NCT03738696|588926366|FG000|Overall Study|Withdrawal by Subject|0|||
163059389|NCT03738696|588926367|FG001|Overall Study|Withdrawal by Subject|1|||
163059390|NCT03738696|588926366|FG000|Overall Study|Lost to Follow-up|8|||
163059391|NCT03738696|588926367|FG001|Overall Study|Lost to Follow-up|14|||
163059392|NCT02690727|588926370|FG000|Overall Study|Adverse Event|2|||
163059393|NCT02690727|588926371|FG001|Overall Study|Adverse Event|2|||
163059394|NCT04757636|588926372|FG000|Overall Study|Adverse Event|25|||
163059395|NCT04757636|588926373|FG001|Overall Study|Adverse Event|8|||
163059396|NCT04757636|588926374|FG002|Overall Study|Adverse Event|11|||
163059397|NCT04757636|588926372|FG000|Overall Study|Death|9|||
163059398|NCT04757636|588926373|FG001|Overall Study|Death|12|||
163059399|NCT04757636|588926374|FG002|Overall Study|Death|6|||
163059400|NCT04757636|588926372|FG000|Overall Study|Lack of Efficacy|2|||
163059401|NCT04757636|588926373|FG001|Overall Study|Lack of Efficacy|0|||
163059402|NCT04757636|588926374|FG002|Overall Study|Lack of Efficacy|0|||
163059403|NCT04757636|588926372|FG000|Overall Study|Lost to Follow-up|1|||
163059404|NCT04757636|588926373|FG001|Overall Study|Lost to Follow-up|6|||
163059405|NCT04757636|588926374|FG002|Overall Study|Lost to Follow-up|7|||
163059406|NCT04757636|588926372|FG000|Overall Study|Physician Decision|1|||
163059407|NCT04757636|588926373|FG001|Overall Study|Physician Decision|3|||
163059408|NCT04757636|588926374|FG002|Overall Study|Physician Decision|4|||
163059409|NCT04757636|588926372|FG000|Overall Study|Withdrawal by Subject|20|||
163059410|NCT04757636|588926373|FG001|Overall Study|Withdrawal by Subject|23|||
163059411|NCT04757636|588926374|FG002|Overall Study|Withdrawal by Subject|18|||
163059412|NCT04757636|588926372|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
163059413|NCT04757636|588926373|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
163059414|NCT04757636|588926374|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
163059415|NCT04757636|588926372|FG000|Overall Study|Study Terminated by Sponsor|103|||
163059416|NCT04757636|588926373|FG001|Overall Study|Study Terminated by Sponsor|104|||
163059417|NCT04757636|588926374|FG002|Overall Study|Study Terminated by Sponsor|114|||
163059418|NCT04757636|588926372|FG000|Overall Study|Sponsor Decision|0|||
163059419|NCT04757636|588926373|FG001|Overall Study|Sponsor Decision|0|||
163059420|NCT04757636|588926374|FG002|Overall Study|Sponsor Decision|1|||
163059421|NCT04757636|588926372|FG000|Overall Study|Randomized in Error|0|||
163059422|NCT04757636|588926373|FG001|Overall Study|Randomized in Error|0|||
163059423|NCT04757636|588926374|FG002|Overall Study|Randomized in Error|2|||
163059424|NCT00091819|588926375|FG000|Overall Study|Adverse Event|1|||
163059425|NCT00091819|588926376|FG001|Overall Study|Adverse Event|1|||
163059426|NCT00091819|588926375|FG000|Overall Study|Death|4|||
163059427|NCT00091819|588926376|FG001|Overall Study|Death|5|||
163059428|NCT00091819|588926375|FG000|Overall Study|Lost to Follow-up|26|||
163059429|NCT00091819|588926376|FG001|Overall Study|Lost to Follow-up|23|||
163059430|NCT00091819|588926375|FG000|Overall Study|Withdrawal by Subject|5|||
163059431|NCT00091819|588926376|FG001|Overall Study|Withdrawal by Subject|8|||
163059432|NCT00091819|588926375|FG000|Overall Study|Protocol Violation|1|||
163059433|NCT00091819|588926376|FG001|Overall Study|Protocol Violation|2|||
163059434|NCT00091819|588926375|FG000|Overall Study|Other|2|||
163059435|NCT00091819|588926376|FG001|Overall Study|Other|3|||
162633924|NCT01756898|587372427|FG000|Overall Study|Lost to Follow-up|2|||
163059436|NCT00091819|588926375|FG000|Overall Study|Never received study treatment|3|||
162633925|NCT01756898|587372428|FG001|Overall Study|Lost to Follow-up|4|||
163059437|NCT00091819|588926376|FG001|Overall Study|Never received study treatment|4|||
163059438|NCT02606253|588926377|FG000|Overall Study|Adverse Event|2|||
162633926|NCT01756898|587372429|FG002|Overall Study|Lost to Follow-up|2|||
162982093|NCT02072824|588636023|FG002|Overall Study|No longer willing to participate|1|||
162982094|NCT02072824|588636021|FG000|Overall Study|Medication error|0|||
163059439|NCT02606253|588926378|FG001|Overall Study|Adverse Event|0|||
163059440|NCT02606253|588926379|FG002|Overall Study|Adverse Event|0|||
163059441|NCT02606253|588926377|FG000|Overall Study|Protocol Violation|2|||
163059442|NCT02606253|588926378|FG001|Overall Study|Protocol Violation|1|||
163059443|NCT02606253|588926379|FG002|Overall Study|Protocol Violation|0|||
162982095|NCT02072824|588636022|FG001|Overall Study|Medication error|1|||
163059444|NCT02606253|588926377|FG000|Overall Study|Physician Decision|1|||
163059445|NCT02606253|588926378|FG001|Overall Study|Physician Decision|1|||
163059446|NCT02606253|588926379|FG002|Overall Study|Physician Decision|0|||
163059447|NCT00701363|588926380|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
162982096|NCT02072824|588636023|FG002|Overall Study|Medication error|0|||
162982097|NCT02072824|588636021|FG000|Overall Study|Adverse Event|0|||
162982098|NCT02072824|588636022|FG001|Overall Study|Adverse Event|0|||
162982099|NCT02072824|588636023|FG002|Overall Study|Adverse Event|1|||
162982100|NCT01859130|588636024|FG000|Overall Study|Death|4|||
162982101|NCT01859130|588636024|FG000|Overall Study|Lost to Follow-up|16|||
162982102|NCT01859130|588636024|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
162982103|NCT01859130|588636024|FG000|Overall Study|Physician Decision|6|||
162982104|NCT01859130|588636024|FG000|Overall Study|Withdrawal by Subject|17|||
162982105|NCT01859130|588636024|FG000|Overall Study|Adverse Event|11|||
162982106|NCT03835325|588636028|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
162982107|NCT03835325|588636028|FG000|Overall Study|Selection failure|1|||
162982108|NCT01370213|588636031|FG000|Overall Study|Early Death|1|||
162982109|NCT01370213|588636032|FG001|Overall Study|Early Death|0|||
162982110|NCT01370213|588636033|FG002|Overall Study|Early Death|0|||
162982111|NCT01370213|588636031|FG000|Overall Study|Not evaluable|0|||
162982112|NCT01370213|588636032|FG001|Overall Study|Not evaluable|2|||
162982113|NCT01370213|588636033|FG002|Overall Study|Not evaluable|0|||
162982114|NCT00038649|588636037|FG000|Overall Study|Adverse Event|9|||
162982115|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
162982116|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
162982117|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
162982118|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
162982119|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
162982120|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
162982121|NCT03395639|588636038|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
162982122|NCT03395639|588636039|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
162982123|NCT03395639|588636040|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
162982124|NCT03395639|588636038|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
162982125|NCT03395639|588636039|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
162982126|NCT03395639|588636040|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
162982127|NCT03395639|588636038|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
162982128|NCT03395639|588636039|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
162982129|NCT03395639|588636040|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
162982130|NCT00942331|588636041|FG000|Overall Study|Did not start treatment|15|||
162982131|NCT00942331|588636042|FG001|Overall Study|Did not start treatment|22|||
162982132|NCT00567476|588636047|FG000|Overall Study|Adverse Event|2|||
162982133|NCT00567476|588636048|FG001|Overall Study|Adverse Event|0|||
162982134|NCT00567476|588636047|FG000|Overall Study|Pregnancy|1|||
162982135|NCT00567476|588636048|FG001|Overall Study|Pregnancy|0|||
162982136|NCT00567476|588636047|FG000|Overall Study|Protocol Violation|4|||
162982137|NCT00567476|588636048|FG001|Overall Study|Protocol Violation|1|||
162982138|NCT00567476|588636047|FG000|Overall Study|Lost to Follow-up|0|||
162982139|NCT00567476|588636048|FG001|Overall Study|Lost to Follow-up|1|||
162982140|NCT00567476|588636047|FG000|Overall Study|Administrative issues|1|||
162982141|NCT00567476|588636048|FG001|Overall Study|Administrative issues|0|||
162982142|NCT00567476|588636047|FG000|Overall Study|Medical Decision|0|||
162982143|NCT00567476|588636048|FG001|Overall Study|Medical Decision|1|||
162982144|NCT00567476|588636047|FG000|Overall Study|Non-adherence to protocol|0|||
162982145|NCT00567476|588636048|FG001|Overall Study|Non-adherence to protocol|1|||
162982146|NCT00995085|588636049|FG000|Overall Study|Withdrawal by Subject|5|||
162982147|NCT01194973|588636051|FG000|Screening Period|Screen Failure|3|||
162982148|NCT01194973|588636051|FG000|26 Week Treatment Period|Adverse Event|1|||
162982149|NCT01194973|588636051|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
162982150|NCT01194973|588636051|FG000|26 Week Treatment Period|Pregnancy|1|||
162982151|NCT01338987|588636054|FG000|Overall Study|enrolled on new protocol|0|||
162982152|NCT01338987|588636055|FG001|Overall Study|enrolled on new protocol|0|||
162982153|NCT01338987|588636056|FG002|Overall Study|enrolled on new protocol|1|||
162982154|NCT01338987|588636057|FG003|Overall Study|enrolled on new protocol|0|||
162982155|NCT01338987|588636058|FG004|Overall Study|enrolled on new protocol|0|||
162982156|NCT01338987|588636054|FG000|Overall Study|Disease progression on study|2|||
162982157|NCT01338987|588636055|FG001|Overall Study|Disease progression on study|1|||
162982158|NCT01338987|588636056|FG002|Overall Study|Disease progression on study|1|||
162982159|NCT01338987|588636057|FG003|Overall Study|Disease progression on study|0|||
162982160|NCT01338987|588636058|FG004|Overall Study|Disease progression on study|0|||
162982161|NCT03856593|588636061|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
162982162|NCT03856593|588636062|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
162982163|NCT02595008|588636063|FG000|Overall Study|Enrolled In Error|1|||
162982164|NCT02595008|588636064|FG001|Overall Study|Enrolled In Error|0|||
162982165|NCT03407118|588636065|FG000|Period 2|Withdrawal by Subject|1|||
162982166|NCT03407118|588636066|FG001|Period 2|Withdrawal by Subject|0|||
162982167|NCT02999477|588636083|FG000|Overall Study|found ineligible after first dose|0|||
162982168|NCT02999477|588636084|FG001|Overall Study|found ineligible after first dose|1|||
162982169|NCT02999477|588636083|FG000|Overall Study|Withdrawal by Subject|1|||
162982170|NCT02999477|588636084|FG001|Overall Study|Withdrawal by Subject|1|||
162982171|NCT01846273|588636087|FG000|Overall Study|Adverse Event|9|||
162982172|NCT01846273|588636088|FG001|Overall Study|Adverse Event|7|||
162982173|NCT01846273|588636089|FG002|Overall Study|Adverse Event|0|||
162982174|NCT01846273|588636087|FG000|Overall Study|Subject withdrew consent|5|||
162982175|NCT01846273|588636088|FG001|Overall Study|Subject withdrew consent|8|||
162982176|NCT01846273|588636089|FG002|Overall Study|Subject withdrew consent|0|||
162982177|NCT01846273|588636087|FG000|Overall Study|Lost to Follow-up|2|||
162982178|NCT01846273|588636088|FG001|Overall Study|Lost to Follow-up|1|||
162982179|NCT01846273|588636089|FG002|Overall Study|Lost to Follow-up|0|||
162982180|NCT01846273|588636087|FG000|Overall Study|Administrative problems|1|||
162982181|NCT01846273|588636088|FG001|Overall Study|Administrative problems|0|||
162982182|NCT01846273|588636089|FG002|Overall Study|Administrative problems|0|||
162982183|NCT01846273|588636087|FG000|Overall Study|Death|2|||
162982184|NCT01846273|588636088|FG001|Overall Study|Death|1|||
162982185|NCT01846273|588636089|FG002|Overall Study|Death|0|||
162982186|NCT01846273|588636087|FG000|Overall Study|Disease Progression|0|||
162982187|NCT01846273|588636088|FG001|Overall Study|Disease Progression|4|||
162982188|NCT01846273|588636089|FG002|Overall Study|Disease Progression|0|||
162982189|NCT01846273|588636087|FG000|Overall Study|Protocol Deviation|2|||
162982190|NCT01846273|588636088|FG001|Overall Study|Protocol Deviation|3|||
162982191|NCT01846273|588636089|FG002|Overall Study|Protocol Deviation|0|||
162982192|NCT01846273|588636087|FG000|Overall Study|Physician Decision|1|||
162982193|NCT01846273|588636088|FG001|Overall Study|Physician Decision|2|||
162982194|NCT01846273|588636089|FG002|Overall Study|Physician Decision|0|||
162982195|NCT02939014|588636090|FG000|Overall Study|Lost to Follow-up|1|||
162982196|NCT02939014|588636091|FG001|Overall Study|Lost to Follow-up|0|||
162982197|NCT02939014|588636090|FG000|Overall Study|Death|4|||
162982198|NCT02939014|588636091|FG001|Overall Study|Death|3|||
162982199|NCT00851643|588636092|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
162982200|NCT00851643|588636093|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982201|NCT00851643|588636094|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982202|NCT00851643|588636095|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982203|NCT00851643|588636096|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982204|NCT00851643|588636097|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
162982205|NCT00851643|588636092|FG000|Base Study (Up to 12 Months)|Other|0|||
162982206|NCT00851643|588636093|FG001|Base Study (Up to 12 Months)|Other|0|||
162982207|NCT00851643|588636094|FG002|Base Study (Up to 12 Months)|Other|0|||
162982208|NCT00851643|588636095|FG003|Base Study (Up to 12 Months)|Other|0|||
162982209|NCT00851643|588636096|FG004|Base Study (Up to 12 Months)|Other|0|||
162982210|NCT00851643|588636097|FG005|Base Study (Up to 12 Months)|Other|1|||
162982211|NCT00851643|588636092|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
162982212|NCT00851643|588636093|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
162982213|NCT00851643|588636094|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
162982214|NCT00851643|588636095|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
162982215|NCT00851643|588636096|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
162982216|NCT00851643|588636097|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
162982217|NCT00851643|588636092|FG000|Extension Study (Up to 36 Months)|Moved|0|||
162982218|NCT00851643|588636093|FG001|Extension Study (Up to 36 Months)|Moved|2|||
162982219|NCT00851643|588636094|FG002|Extension Study (Up to 36 Months)|Moved|1|||
162982220|NCT00851643|588636095|FG003|Extension Study (Up to 36 Months)|Moved|1|||
162982221|NCT00851643|588636096|FG004|Extension Study (Up to 36 Months)|Moved|0|||
162982222|NCT00851643|588636097|FG005|Extension Study (Up to 36 Months)|Moved|1|||
162982223|NCT00359788|588636098|FG000|Overall Study|Adverse Event|11|||
162982224|NCT00359788|588636099|FG001|Overall Study|Adverse Event|10|||
162982225|NCT00359788|588636098|FG000|Overall Study|Lack of Efficacy|1|||
162982226|NCT00359788|588636099|FG001|Overall Study|Lack of Efficacy|2|||
162982227|NCT00359788|588636098|FG000|Overall Study|Lost to Follow-up|3|||
162982228|NCT00359788|588636099|FG001|Overall Study|Lost to Follow-up|2|||
162982229|NCT00359788|588636098|FG000|Overall Study|Withdrawal by Subject|4|||
162982230|NCT00359788|588636099|FG001|Overall Study|Withdrawal by Subject|1|||
162982231|NCT00359788|588636098|FG000|Overall Study|Protocol Violation|4|||
162982232|NCT00359788|588636099|FG001|Overall Study|Protocol Violation|2|||
162982233|NCT02143583|588636102|FG000|Overall Study|Withdrawal by Subject|1|||
162982234|NCT02143583|588636103|FG001|Overall Study|Withdrawal by Subject|0|||
162982235|NCT02143583|588636104|FG002|Overall Study|Withdrawal by Subject|1|||
162982236|NCT02143583|588636102|FG000|Overall Study|husband illness|0|||
162982237|NCT02143583|588636103|FG001|Overall Study|husband illness|0|||
162982238|NCT02143583|588636104|FG002|Overall Study|husband illness|1|||
162982239|NCT01641133|588636105|FG000|Overall Study|Protocol Violation|0|||
162982240|NCT01641133|588636106|FG001|Overall Study|Protocol Violation|1|||
162982241|NCT01641133|588636107|FG002|Overall Study|Protocol Violation|1|||
162982242|NCT01641133|588636105|FG000|Overall Study|Migrated/moved from study area|5|||
162982243|NCT01641133|588636106|FG001|Overall Study|Migrated/moved from study area|3|||
162982244|NCT01641133|588636107|FG002|Overall Study|Migrated/moved from study area|1|||
162982245|NCT01641133|588636105|FG000|Overall Study|Adverse Event|0|||
162982246|NCT01641133|588636106|FG001|Overall Study|Adverse Event|0|||
162982247|NCT01641133|588636107|FG002|Overall Study|Adverse Event|1|||
162982248|NCT01641133|588636105|FG000|Overall Study|Withdrawal by Subject|5|||
162982249|NCT01641133|588636106|FG001|Overall Study|Withdrawal by Subject|3|||
162982250|NCT01641133|588636107|FG002|Overall Study|Withdrawal by Subject|3|||
162982251|NCT01641133|588636105|FG000|Overall Study|Lost to Follow-up|0|||
162982252|NCT01641133|588636106|FG001|Overall Study|Lost to Follow-up|2|||
162982253|NCT01641133|588636107|FG002|Overall Study|Lost to Follow-up|2|||
162982254|NCT02220725|588636108|FG000|Overall Study|Lost to Follow-up|0|||
162982255|NCT02220725|588636109|FG001|Overall Study|Lost to Follow-up|0|||
162982256|NCT02220725|588636110|FG002|Overall Study|Lost to Follow-up|0|||
162982257|NCT02220725|588636111|FG003|Overall Study|Lost to Follow-up|1|||
162982258|NCT02220725|588636108|FG000|Overall Study|Withdrawal by Subject|0|||
162982259|NCT02220725|588636109|FG001|Overall Study|Withdrawal by Subject|0|||
162982260|NCT02220725|588636110|FG002|Overall Study|Withdrawal by Subject|0|||
162982261|NCT02220725|588636111|FG003|Overall Study|Withdrawal by Subject|1|||
162982262|NCT03351231|588636112|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
162982263|NCT03351231|588636112|FG000|Combination Therapy Period|Disease progression|2|||
162982264|NCT03351231|588636112|FG000|Combination Therapy Period|Study drug toxicity|1|||
162982265|NCT03351231|588636112|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
162982266|NCT03351231|588636112|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
162982267|NCT03351231|588636112|FG000|Safety Follow-Up Period|Other reason|2|||
162982268|NCT00103402|588636115|FG000|Overall Study|Adverse Event|3|||
162982269|NCT00103402|588636116|FG001|Overall Study|Adverse Event|4|||
162982270|NCT00103402|588636115|FG000|Overall Study|Lost to Follow-up|8|||
162982271|NCT00103402|588636116|FG001|Overall Study|Lost to Follow-up|7|||
162982272|NCT00103402|588636115|FG000|Overall Study|Dissatisfied/No longer interested|6|||
162982273|NCT00103402|588636116|FG001|Overall Study|Dissatisfied/No longer interested|6|||
162982274|NCT00103402|588636115|FG000|Overall Study|Personal constraints/Other|5|||
162982275|NCT00103402|588636116|FG001|Overall Study|Personal constraints/Other|0|||
162982276|NCT02333487|588636117|FG000|Overall Study|Adverse Event|0|||
162982277|NCT02333487|588636118|FG001|Overall Study|Adverse Event|2|||
162982278|NCT02333487|588636119|FG002|Overall Study|Adverse Event|0|||
162982279|NCT01297322|588636120|FG000|Overall Study|Lost to Follow-up|1|||
162982280|NCT01297322|588636121|FG001|Overall Study|Lost to Follow-up|0|||
162982281|NCT01297322|588636120|FG000|Overall Study|Withdrawal by Subject|0|||
162982282|NCT01297322|588636121|FG001|Overall Study|Withdrawal by Subject|1|||
162982283|NCT01297322|588636120|FG000|Overall Study|Protocol Violation|0|||
162982284|NCT01297322|588636121|FG001|Overall Study|Protocol Violation|3|||
162982285|NCT01111019|588636122|FG000|Overall Study|Withdrew Prematurely|2|||
162982286|NCT01111019|588636122|FG000|Overall Study|Other|1|||
162982287|NCT02013375|588636125|FG000|Overall Study|Did not engraft|1|||
162982288|NCT02013375|588636125|FG000|Overall Study|Did not engraft|1|||
162982289|NCT00712985|588636126|FG000|Overall Study|1 withdrew prior to start of drug|1|||
162982290|NCT00712985|588636126|FG000|Overall Study|1 patient moved out of state|1|||
162982291|NCT00712985|588636126|FG000|Overall Study|Lack of Efficacy|3|||
162982292|NCT01663727|588636127|FG000|Overall Study|Death|161|||
162982293|NCT01663727|588636128|FG001|Overall Study|Death|155|||
162982294|NCT01663727|588636127|FG000|Overall Study|Lost to Follow-up|10|||
162982295|NCT01663727|588636128|FG001|Overall Study|Lost to Follow-up|8|||
162633927|NCT01756898|587372430|FG003|Overall Study|Lost to Follow-up|3|||
162633928|NCT01756898|587372427|FG000|Overall Study|Protocol Violation|1|||
162982296|NCT01663727|588636127|FG000|Overall Study|Withdrawal by Subject|18|||
162982297|NCT01663727|588636128|FG001|Overall Study|Withdrawal by Subject|25|||
162982298|NCT01663727|588636127|FG000|Overall Study|Study Terminated|51|||
162982299|NCT01663727|588636128|FG001|Overall Study|Study Terminated|50|||
162982300|NCT01663727|588636127|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
162982301|NCT01663727|588636128|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
162982302|NCT01663727|588636127|FG000|Overall Study|Withdrawal prior to dosing.|1|||
162982303|NCT01663727|588636128|FG001|Overall Study|Withdrawal prior to dosing.|0|||
162982304|NCT01902628|588636129|FG000|Overall Study|Withdrawal of participant's consent|7|||
162982305|NCT01902628|588636129|FG000|Overall Study|Adverse Event|41|||
162982306|NCT01902628|588636129|FG000|Overall Study|Lost to Follow-up|35|||
162982307|NCT04385277|588638612|FG000|Overall Study|Physician Decision|2|||
162982308|NCT04385277|588638612|FG000|Overall Study|Ineligible|1|||
162982309|NCT04385277|588638612|FG000|Overall Study|Patient/Parent Refusal|2|||
162982310|NCT04905290|588638613|FG000|Overall Study|Adverse Event|4|||
162982311|NCT04905290|588638613|FG000|Overall Study|Death|2|||
162982312|NCT04905290|588638613|FG000|Overall Study|Withdrawal by Subject|4|||
162982313|NCT04905290|588638613|FG000|Overall Study|Physician Decision|2|||
162982314|NCT04905290|588638613|FG000|Overall Study|Lost to Follow-up|2|||
162982315|NCT04905290|588638613|FG000|Overall Study|Screen Failure|2|||
162982316|NCT04905290|588638613|FG000|Overall Study|Unsuccessful Procedure|2|||
162982317|NCT03303625|588638614|FG000|Overall Study|Withdrawal by Subject|2|||
162982318|NCT03303625|588638615|FG001|Overall Study|Withdrawal by Subject|0|||
163059448|NCT00701363|588926381|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059449|NCT00701363|588926382|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059450|NCT00701363|588926383|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
163059451|NCT00701363|588926380|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
163059452|NCT00701363|588926381|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
163059453|NCT00701363|588926382|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
163059454|NCT00701363|588926383|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
163059455|NCT00701363|588926380|FG000|Treatment Phase 1|Adverse Event|7|||
163059456|NCT00701363|588926381|FG001|Treatment Phase 1|Adverse Event|0|||
163059457|NCT00701363|588926382|FG002|Treatment Phase 1|Adverse Event|0|||
163059458|NCT00701363|588926383|FG003|Treatment Phase 1|Adverse Event|0|||
163059459|NCT00701363|588926380|FG000|Treatment Phase 1|Protocol Violation|1|||
163059460|NCT00701363|588926381|FG001|Treatment Phase 1|Protocol Violation|0|||
163059461|NCT00701363|588926382|FG002|Treatment Phase 1|Protocol Violation|0|||
163059462|NCT00701363|588926383|FG003|Treatment Phase 1|Protocol Violation|0|||
163059463|NCT00701363|588926380|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
163059464|NCT00701363|588926381|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
163059465|NCT00701363|588926382|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
163059466|NCT00701363|588926383|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
163059467|NCT00701363|588926380|FG000|Treatment Phase 1|Lack of Efficacy|1|||
162982319|NCT03303625|588638616|FG002|Overall Study|Withdrawal by Subject|0|||
162982320|NCT03303625|588638617|FG003|Overall Study|Withdrawal by Subject|0|||
162633929|NCT01756898|587372428|FG001|Overall Study|Protocol Violation|2|||
162982321|NCT01045421|588638619|FG000|Phase 1|Progressive Disease|0|||
162982322|NCT01045421|588638620|FG001|Phase 1|Progressive Disease|0|||
162982323|NCT01045421|588638621|FG002|Phase 1|Progressive Disease|0|||
162982324|NCT01045421|588638622|FG003|Phase 1|Progressive Disease|0|||
162982325|NCT01045421|588638623|FG004|Phase 1|Progressive Disease|1|||
162982326|NCT01045421|588638624|FG005|Phase 1|Progressive Disease|0|||
162982327|NCT01045421|588638625|FG006|Phase 1|Progressive Disease|0|||
162982328|NCT01045421|588638626|FG007|Phase 1|Progressive Disease|0|||
162982329|NCT01045421|588638627|FG008|Phase 1|Progressive Disease|0|||
162982330|NCT01045421|588638628|FG009|Phase 1|Progressive Disease|0|||
162982331|NCT01045421|588638629|FG010|Phase 1|Progressive Disease|0|||
162982332|NCT01045421|588638619|FG000|Phase 1|Withdrawal by Subject|0|||
162982333|NCT01045421|588638620|FG001|Phase 1|Withdrawal by Subject|0|||
162982334|NCT01045421|588638621|FG002|Phase 1|Withdrawal by Subject|0|||
162982335|NCT01045421|588638622|FG003|Phase 1|Withdrawal by Subject|1|||
162982336|NCT01045421|588638623|FG004|Phase 1|Withdrawal by Subject|0|||
162982337|NCT01045421|588638624|FG005|Phase 1|Withdrawal by Subject|0|||
162982338|NCT01045421|588638625|FG006|Phase 1|Withdrawal by Subject|0|||
162982339|NCT01045421|588638626|FG007|Phase 1|Withdrawal by Subject|0|||
162982340|NCT01045421|588638627|FG008|Phase 1|Withdrawal by Subject|0|||
162982341|NCT01045421|588638628|FG009|Phase 1|Withdrawal by Subject|0|||
162982342|NCT01045421|588638629|FG010|Phase 1|Withdrawal by Subject|0|||
162982343|NCT01045421|588638619|FG000|Phase 2|Progressive Disease|0|||
162982344|NCT01045421|588638620|FG001|Phase 2|Progressive Disease|0|||
162982345|NCT01045421|588638621|FG002|Phase 2|Progressive Disease|0|||
162982346|NCT01045421|588638622|FG003|Phase 2|Progressive Disease|0|||
162982347|NCT01045421|588638623|FG004|Phase 2|Progressive Disease|0|||
162982348|NCT01045421|588638624|FG005|Phase 2|Progressive Disease|0|||
162982349|NCT01045421|588638625|FG006|Phase 2|Progressive Disease|0|||
163059468|NCT00701363|588926381|FG001|Treatment Phase 1|Lack of Efficacy|0|||
163059469|NCT00701363|588926382|FG002|Treatment Phase 1|Lack of Efficacy|0|||
163059470|NCT00701363|588926383|FG003|Treatment Phase 1|Lack of Efficacy|0|||
163059471|NCT00701363|588926380|FG000|Treatment Phase 2|Adverse Event|0|||
163059472|NCT00701363|588926381|FG001|Treatment Phase 2|Adverse Event|0|||
162982350|NCT01045421|588638626|FG007|Phase 2|Progressive Disease|1|||
162982351|NCT01045421|588638627|FG008|Phase 2|Progressive Disease|1|||
162982352|NCT01045421|588638628|FG009|Phase 2|Progressive Disease|1|||
162633930|NCT01756898|587372429|FG002|Overall Study|Protocol Violation|2|||
162633931|NCT01756898|587372430|FG003|Overall Study|Protocol Violation|1|||
162633932|NCT01756898|587372427|FG000|Overall Study|Withdrew Consent|5|||
162633933|NCT01756898|587372428|FG001|Overall Study|Withdrew Consent|3|||
162633934|NCT01756898|587372429|FG002|Overall Study|Withdrew Consent|5|||
162633935|NCT01756898|587372430|FG003|Overall Study|Withdrew Consent|6|||
162982353|NCT01045421|588638629|FG010|Phase 2|Progressive Disease|1|||
162982354|NCT01045421|588638619|FG000|Phase 2|Death|0|||
162982355|NCT01045421|588638620|FG001|Phase 2|Death|0|||
162982356|NCT01045421|588638621|FG002|Phase 2|Death|0|||
162982357|NCT01045421|588638622|FG003|Phase 2|Death|0|||
162982358|NCT01045421|588638623|FG004|Phase 2|Death|0|||
162982359|NCT01045421|588638624|FG005|Phase 2|Death|0|||
162982360|NCT01045421|588638625|FG006|Phase 2|Death|0|||
162982361|NCT01045421|588638626|FG007|Phase 2|Death|1|||
162982362|NCT01045421|588638627|FG008|Phase 2|Death|1|||
163059473|NCT00701363|588926382|FG002|Treatment Phase 2|Adverse Event|1|||
163059474|NCT00701363|588926383|FG003|Treatment Phase 2|Adverse Event|0|||
163059475|NCT00701363|588926380|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
163059476|NCT00701363|588926381|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
162633936|NCT01756898|587372427|FG000|Overall Study|Other|0|||
162633937|NCT01756898|587372428|FG001|Overall Study|Other|2|||
162633938|NCT01756898|587372429|FG002|Overall Study|Other|2|||
162633939|NCT01756898|587372430|FG003|Overall Study|Other|0|||
162633940|NCT01500694|587372431|FG000|Overall Study|Adverse Event|4|||
162982363|NCT01045421|588638628|FG009|Phase 2|Death|2|||
162982364|NCT01045421|588638629|FG010|Phase 2|Death|0|||
162982365|NCT01045421|588638619|FG000|Phase 2|Other|0|||
162982366|NCT01045421|588638620|FG001|Phase 2|Other|0|||
162982367|NCT01045421|588638621|FG002|Phase 2|Other|0|||
162982368|NCT01045421|588638622|FG003|Phase 2|Other|0|||
162982369|NCT01045421|588638623|FG004|Phase 2|Other|0|||
162982370|NCT01045421|588638624|FG005|Phase 2|Other|0|||
162982371|NCT01045421|588638625|FG006|Phase 2|Other|0|||
162982372|NCT01045421|588638626|FG007|Phase 2|Other|3|||
162982373|NCT01045421|588638627|FG008|Phase 2|Other|0|||
162982374|NCT01045421|588638628|FG009|Phase 2|Other|0|||
162982375|NCT01045421|588638629|FG010|Phase 2|Other|1|||
162982376|NCT01884311|588638631|FG000|Overall Study|Withdrawal by Subject|3|||
162982377|NCT01884311|588638631|FG000|Overall Study|withdrew consent due to AEs|1|||
162982378|NCT01884311|588638631|FG000|Overall Study|Precautionary measure|1|||
162982379|NCT02858492|588638632|FG000|Overall Study|Withdrawal by Subject|0|||
162982380|NCT02858492|588638633|FG001|Overall Study|Withdrawal by Subject|1|||
162982381|NCT02858492|588638634|FG002|Overall Study|Withdrawal by Subject|0|||
162982382|NCT02858492|588638635|FG003|Overall Study|Withdrawal by Subject|1|||
162982383|NCT02858492|588638632|FG000|Overall Study|Adverse Event|0|||
162982384|NCT02858492|588638633|FG001|Overall Study|Adverse Event|0|||
162982385|NCT02858492|588638634|FG002|Overall Study|Adverse Event|0|||
162982386|NCT02858492|588638635|FG003|Overall Study|Adverse Event|3|||
162982387|NCT02858492|588638632|FG000|Overall Study|Lack of Efficacy|0|||
162982388|NCT02858492|588638633|FG001|Overall Study|Lack of Efficacy|0|||
162982389|NCT02858492|588638634|FG002|Overall Study|Lack of Efficacy|0|||
162982390|NCT02858492|588638635|FG003|Overall Study|Lack of Efficacy|1|||
162982391|NCT02858492|588638632|FG000|Overall Study|Protocol defined stopping criteria|0|||
162982392|NCT02858492|588638633|FG001|Overall Study|Protocol defined stopping criteria|0|||
162982393|NCT02858492|588638634|FG002|Overall Study|Protocol defined stopping criteria|0|||
162982394|NCT02858492|588638635|FG003|Overall Study|Protocol defined stopping criteria|1|||
162982395|NCT02944383|588638636|FG000|Overall Study|Lost to Follow-up|0|||
162982396|NCT02944383|588638637|FG001|Overall Study|Lost to Follow-up|0|||
162982397|NCT02944383|588638638|FG002|Overall Study|Lost to Follow-up|1|||
162982398|NCT02944383|588638636|FG000|Overall Study|Withdrawal by Subject|1|||
162982399|NCT02944383|588638637|FG001|Overall Study|Withdrawal by Subject|0|||
162982400|NCT02944383|588638638|FG002|Overall Study|Withdrawal by Subject|0|||
162982401|NCT01995266|588638640|FG000|Overall Study|Death|1|||
162982402|NCT01995266|588638640|FG000|Overall Study|Lack of Efficacy|6|||
162982403|NCT01995266|588638640|FG000|Overall Study|Adverse Event|2|||
162982404|NCT03853148|588638641|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
162982405|NCT03853148|588638642|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
162982406|NCT03853148|588638643|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
162982407|NCT03853148|588638644|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
162982408|NCT00090610|588638645|FG000|Overall Study|Withdrawal by Subject|1|||
162982409|NCT00090610|588638646|FG001|Overall Study|Withdrawal by Subject|1|||
162982410|NCT03623386|588638649|FG000|Overall Study|Protocol Violation|3|||
162982411|NCT03623386|588638650|FG001|Overall Study|Protocol Violation|2|||
162982412|NCT03623386|588638651|FG002|Overall Study|Protocol Violation|0|||
162982413|NCT03623386|588638649|FG000|Overall Study|Physician Decision|1|||
162982414|NCT03623386|588638650|FG001|Overall Study|Physician Decision|1|||
162982415|NCT03623386|588638651|FG002|Overall Study|Physician Decision|0|||
162982416|NCT03623386|588638649|FG000|Overall Study|Lost to Follow-up|0|||
162982417|NCT03623386|588638650|FG001|Overall Study|Lost to Follow-up|2|||
162633941|NCT01500694|587372432|FG001|Overall Study|Adverse Event|3|||
162633942|NCT01500694|587372431|FG000|Overall Study|Protocol Violation|0|||
162633943|NCT01500694|587372432|FG001|Overall Study|Protocol Violation|1|||
162633944|NCT01500694|587372431|FG000|Overall Study|Withdrawal by Subject|23|||
162714389|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
162982418|NCT03623386|588638651|FG002|Overall Study|Lost to Follow-up|0|||
162982419|NCT03623386|588638649|FG000|Overall Study|COVID-19|0|||
162982420|NCT03623386|588638650|FG001|Overall Study|COVID-19|1|||
162982421|NCT03623386|588638651|FG002|Overall Study|COVID-19|0|||
162982422|NCT00599521|588638656|FG000|Overall Study|Lack of Efficacy|4|||
162982423|NCT00599521|588638657|FG001|Overall Study|Lack of Efficacy|8|||
162982424|NCT00599521|588638656|FG000|Overall Study|Adverse Event|4|||
162982425|NCT00599521|588638657|FG001|Overall Study|Adverse Event|1|||
162982426|NCT00599521|588638656|FG000|Overall Study|Withdrawal by Subject|28|||
162982427|NCT00599521|588638657|FG001|Overall Study|Withdrawal by Subject|34|||
162633945|NCT01500694|587372432|FG001|Overall Study|Withdrawal by Subject|14|||
162982428|NCT00599521|588638656|FG000|Overall Study|Protocol Violation|1|||
162982429|NCT00599521|588638657|FG001|Overall Study|Protocol Violation|1|||
162982430|NCT00599521|588638656|FG000|Overall Study|Lost to Follow-up|23|||
162982431|NCT00599521|588638657|FG001|Overall Study|Lost to Follow-up|23|||
162982432|NCT00599521|588638656|FG000|Overall Study|Pregnancy|0|||
162982433|NCT00599521|588638657|FG001|Overall Study|Pregnancy|2|||
162982434|NCT05855616|588638658|FG000|Overall Study|Lost to Follow-up|1|||
162982435|NCT05855616|588638659|FG001|Overall Study|Lost to Follow-up|2|||
162982436|NCT01388166|588638660|FG000|Overall Study|Adverse Event|16|||
162982437|NCT01388166|588638660|FG000|Overall Study|Lost to Follow-up|30|||
162982438|NCT01388166|588638660|FG000|Overall Study|Others than specified above|13|||
162982439|NCT00127036|588638662|FG000|Overall Study|Insufficient Data for Analysis|6|||
162982440|NCT00127036|588638663|FG001|Overall Study|Insufficient Data for Analysis|11|||
162982441|NCT00127036|588638662|FG000|Overall Study|Screen Failure|2|||
162982442|NCT00127036|588638663|FG001|Overall Study|Screen Failure|0|||
162982443|NCT01429051|588638666|FG000|Titration Phase|Death|1|||
162982444|NCT01429051|588638666|FG000|Titration Phase|Withdrawal by Subject|7|||
162982445|NCT01429051|588638666|FG000|Titration Phase|Physician Decision|1|||
162982446|NCT01429051|588638666|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
162982447|NCT01429051|588638666|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
162982448|NCT01429051|588638666|FG000|Efficacy Phase|Adverse Event|1|||
162982449|NCT01429051|588638666|FG000|Efficacy Phase|Death|1|||
162982450|NCT01429051|588638666|FG000|Tolerability Phase|Death|5|||
162982451|NCT01429051|588638666|FG000|Tolerability Phase|Adverse Event|2|||
162982452|NCT01429051|588638666|FG000|Tolerability Phase|Withdrawal by Subject|5|||
162982453|NCT01429051|588638666|FG000|Tolerability Phase|Physician Decision|1|||
162982454|NCT01429051|588638666|FG000|Tolerability Phase|Other|2|||
162982455|NCT03001219|588638674|FG000|Proof of Concept|Study Termination by Sponsor|0|||
162982456|NCT03001219|588638675|FG001|Proof of Concept|Study Termination by Sponsor|1|||
162982457|NCT03001219|588638674|FG000|Proof of Concept|Withdrawal by Subject|0|||
162982458|NCT03001219|588638675|FG001|Proof of Concept|Withdrawal by Subject|4|||
162982459|NCT03001219|588638674|FG000|Proof of Concept|Protocol Deviation|0|||
162982460|NCT03001219|588638675|FG001|Proof of Concept|Protocol Deviation|1|||
162982461|NCT03001219|588638674|FG000|Proof of Concept|Adverse Event|1|||
162982462|NCT03001219|588638675|FG001|Proof of Concept|Adverse Event|1|||
162982463|NCT03001219|588638674|FG000|Proof of Concept|Physician Decision|1|||
162982464|NCT03001219|588638675|FG001|Proof of Concept|Physician Decision|0|||
162982465|NCT03001219|588638674|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
162982466|NCT03001219|588638675|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
162982467|NCT03001219|588638674|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
162982468|NCT03001219|588638675|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
162982469|NCT03001219|588638674|FG000|Extension Period Analysis|Physician Decision|0|||
162982470|NCT03001219|588638675|FG001|Extension Period Analysis|Physician Decision|1|||
162982471|NCT03001219|588638674|FG000|Extension Period Analysis|Adverse Event|1|||
162982472|NCT03001219|588638675|FG001|Extension Period Analysis|Adverse Event|1|||
162982473|NCT03001219|588638674|FG000|Extension Period Analysis|Protocol Deviation|0|||
162982474|NCT03001219|588638675|FG001|Extension Period Analysis|Protocol Deviation|1|||
162982475|NCT03001219|588638674|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
162982476|NCT03001219|588638675|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
162982477|NCT01797835|588638676|FG000|Overall Study|Lost to Follow-up|31|||
162982478|NCT01797835|588638677|FG001|Overall Study|Lost to Follow-up|27|||
162982479|NCT01403064|588638678|FG000|Overall Study|Death|0|||
162982480|NCT01403064|588638679|FG001|Overall Study|Death|0|||
162982481|NCT01403064|588638680|FG002|Overall Study|Death|1|||
162982482|NCT01403064|588638681|FG003|Overall Study|Death|1|||
162982483|NCT01403064|588638678|FG000|Overall Study|Withdrawal by Subject|0|||
162982484|NCT01403064|588638679|FG001|Overall Study|Withdrawal by Subject|0|||
162982485|NCT01403064|588638680|FG002|Overall Study|Withdrawal by Subject|1|||
162982486|NCT01403064|588638681|FG003|Overall Study|Withdrawal by Subject|1|||
162982487|NCT01403064|588638678|FG000|Overall Study|Other|1|||
162982488|NCT01403064|588638679|FG001|Overall Study|Other|0|||
162982489|NCT01403064|588638680|FG002|Overall Study|Other|2|||
162982490|NCT01403064|588638681|FG003|Overall Study|Other|1|||
163059477|NCT00701363|588926382|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
163059478|NCT00701363|588926383|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
162714390|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
162982491|NCT00973765|588638682|FG000|Overall Study|Lost to Follow-up|8|||
162982492|NCT00973765|588638683|FG001|Overall Study|Lost to Follow-up|14|||
162982493|NCT02669940|588638684|FG000|Overall Study|Failure to return|0|||
162982494|NCT02669940|588638685|FG001|Overall Study|Failure to return|3|||
162982495|NCT02669940|588638684|FG000|Overall Study|Insufficient follow-up data|1|||
162714391|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
162982496|NCT02669940|588638685|FG001|Overall Study|Insufficient follow-up data|0|||
162982497|NCT01892657|588638686|FG000|Overall Study|Withdrawal by Subject|6|||
162982498|NCT01892657|588638686|FG000|Overall Study|Protocol Violation|12|||
162982499|NCT00986180|588638687|FG000|Overall Study|Adverse Event|21|||
163059479|NCT03426878|588926384|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
163059480|NCT03426878|588926384|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
163059481|NCT03426878|588926384|FG000|Overall Study|Declined to receive results|3|||
163059482|NCT03426878|588926384|FG000|Overall Study|Received negative results by mailed letter|65|||
163059483|NCT03426878|588926384|FG000|Overall Study|Lost to Follow-up|177|||
163059484|NCT03704064|588926385|FG000|Overall Study|Lost to Follow-up|8|||
163059485|NCT03704064|588926386|FG001|Overall Study|Lost to Follow-up|4|||
163059486|NCT03704064|588926385|FG000|Overall Study|Withdrawal by Subject|1|||
163059487|NCT03704064|588926386|FG001|Overall Study|Withdrawal by Subject|1|||
163059488|NCT03704064|588926385|FG000|Overall Study|No longer available for study visits|0|||
163059489|NCT03704064|588926386|FG001|Overall Study|No longer available for study visits|1|||
163059490|NCT03704064|588926385|FG000|Overall Study|Censoring event|1|||
163059491|NCT03704064|588926386|FG001|Overall Study|Censoring event|0|||
163059492|NCT00726609|588926390|FG000|Overall Study|Adverse Event|10|||
163059493|NCT00726609|588926390|FG000|Overall Study|Withdrawal by Subject|2|||
163059494|NCT00726609|588926390|FG000|Overall Study|Lack of Efficacy|25|||
163059495|NCT00726609|588926390|FG000|Overall Study|Other|16|||
163059496|NCT00726609|588926390|FG000|Overall Study|Missing|42|||
163059497|NCT00726609|588926390|FG000|Overall Study|Other|3|||
163059498|NCT00746551|588926392|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
163059499|NCT00746551|588926393|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
163059500|NCT00746551|588926392|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
163059501|NCT00746551|588926393|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
163059502|NCT00746551|588926392|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
163059503|NCT00746551|588926393|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
163059504|NCT00465179|588926397|FG000|Overall Study|Adverse Event|4|||
163059505|NCT00465179|588926397|FG000|Overall Study|Withdrawal by Subject|2|||
163059506|NCT00465179|588926397|FG000|Overall Study|Progression of Disease|47|||
163059507|NCT00833755|588926401|FG000|Overall Study|Physician Decision|4|||
163059508|NCT00833755|588926402|FG001|Overall Study|Physician Decision|4|||
163059509|NCT00833755|588926403|FG002|Overall Study|Physician Decision|2|||
163059510|NCT00833755|588926404|FG003|Overall Study|Physician Decision|6|||
163059511|NCT00833755|588926401|FG000|Overall Study|Subject had scheduling issues|0|||
163059512|NCT00833755|588926402|FG001|Overall Study|Subject had scheduling issues|1|||
163059513|NCT00833755|588926403|FG002|Overall Study|Subject had scheduling issues|0|||
163059514|NCT00833755|588926404|FG003|Overall Study|Subject had scheduling issues|0|||
162982500|NCT00986180|588638688|FG001|Overall Study|Adverse Event|23|||
162982501|NCT00986180|588638687|FG000|Overall Study|Lack of Efficacy|4|||
162982502|NCT00986180|588638688|FG001|Overall Study|Lack of Efficacy|3|||
162982503|NCT00986180|588638687|FG000|Overall Study|Lost to Follow-up|5|||
162982504|NCT00986180|588638688|FG001|Overall Study|Lost to Follow-up|7|||
162982505|NCT00986180|588638687|FG000|Overall Study|Physician Decision|1|||
162982506|NCT00986180|588638688|FG001|Overall Study|Physician Decision|3|||
162982507|NCT00986180|588638687|FG000|Overall Study|Protocol Violation|2|||
162982508|NCT00986180|588638688|FG001|Overall Study|Protocol Violation|0|||
162982509|NCT00986180|588638687|FG000|Overall Study|Withdrawal by Subject|1|||
162982510|NCT00986180|588638688|FG001|Overall Study|Withdrawal by Subject|9|||
162982511|NCT00986180|588638687|FG000|Overall Study|Miscellanies|10|||
162982512|NCT00986180|588638688|FG001|Overall Study|Miscellanies|11|||
162982513|NCT01249365|588638698|FG000|Overall Study|Lost to Follow-up|1|||
162982514|NCT03579966|588638699|FG000|Overall Study|Adverse Event|6|||
162982515|NCT03579966|588638699|FG000|Overall Study|Lost to Follow-up|4|||
162982516|NCT03579966|588638699|FG000|Overall Study|Physician Decision|10|||
162982517|NCT03579966|588638699|FG000|Overall Study|Pregnancy|1|||
162982518|NCT03579966|588638699|FG000|Overall Study|Withdrawal by Subject|16|||
162982519|NCT03579966|588638699|FG000|Overall Study|Study terminated by Sponsor|22|||
162982520|NCT03579966|588638699|FG000|Overall Study|Protocol Violation|1|||
162982521|NCT02408068|588638700|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982522|NCT02408068|588638701|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982523|NCT02408068|588638702|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
162982524|NCT02408068|588638703|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982525|NCT02408068|588638704|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
163059515|NCT00262925|588926405|FG000|Overall Study|Lack of Efficacy|3|||
163059516|NCT00262925|588926405|FG000|Overall Study|Adverse Event|4|||
163059517|NCT00262925|588926405|FG000|Overall Study|Death|2|||
163059518|NCT00262925|588926405|FG000|Overall Study|alternative therapy|1|||
163059519|NCT00262925|588926405|FG000|Overall Study|Other|1|||
163059520|NCT04682301|588926407|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
163059521|NCT04682301|588926407|FG000|Overall Study|Death|2|||
162982526|NCT02408068|588638705|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
162982527|NCT03484117|588638706|FG000|Overall Study|Lost to Follow-up|1|||
162982528|NCT03484117|588638707|FG001|Overall Study|Lost to Follow-up|3|||
162982529|NCT03484117|588638706|FG000|Overall Study|Declined participation in exit assess|1|||
162982530|NCT03484117|588638707|FG001|Overall Study|Declined participation in exit assess|1|||
162982531|NCT03551496|588638711|FG000|Overall Study|Death|11|||
162982532|NCT03551496|588638712|FG001|Overall Study|Death|7|||
162633946|NCT01500694|587372431|FG000|Overall Study|Lost to Follow-up|2|||
162633947|NCT01500694|587372432|FG001|Overall Study|Lost to Follow-up|3|||
162633948|NCT01500694|587372431|FG000|Overall Study|Lack of Efficacy|14|||
162633949|NCT01500694|587372432|FG001|Overall Study|Lack of Efficacy|5|||
162633950|NCT01500694|587372431|FG000|Overall Study|Other|9|||
162633951|NCT01500694|587372432|FG001|Overall Study|Other|3|||
162633952|NCT02837783|587372433|FG000|Overall Study|Adverse Event|1|||
162633953|NCT02837783|587372434|FG001|Overall Study|Adverse Event|0|||
162633954|NCT02837783|587372433|FG000|Overall Study|Other, Not Specified|1|||
162633955|NCT02837783|587372434|FG001|Overall Study|Other, Not Specified|2|||
162633956|NCT01438424|587374261|FG000|Overall Study|Continuing treatment|29|||
162633957|NCT01438424|587374261|FG000|Overall Study|Minimal virologic response|95|||
162633958|NCT01438424|587374261|FG000|Overall Study|Not identified|55|||
162633959|NCT01438424|587374261|FG000|Overall Study|Withdrawal by Subject|104|||
162633960|NCT01438424|587374261|FG000|Overall Study|Progression of chronic hepatitis B|22|||
162633961|NCT01438424|587374261|FG000|Overall Study|Death|22|||
162633962|NCT01438424|587374261|FG000|Overall Study|Adverse Event|17|||
162633963|NCT01438424|587374261|FG000|Overall Study|Lost to Follow-up|17|||
162633964|NCT01438424|587374261|FG000|Overall Study|Abnormal laboratory test result|14|||
162633965|NCT01438424|587374261|FG000|Overall Study|Need for drug prohibited by protocol|14|||
162633966|NCT01438424|587374261|FG000|Overall Study|Pregnancy|7|||
162633967|NCT01438424|587374261|FG000|Overall Study|No longer met inclusion criteria|1|||
162633968|NCT01438424|587374261|FG000|Overall Study|Participant noncompliance|20|||
162982533|NCT03551496|588638711|FG000|Overall Study|Withdrawal by Subject|4|||
162633969|NCT02927080|587374262|FG000|Overall Study|Withdrawal by Subject|0|||
162633970|NCT02927080|587374263|FG001|Overall Study|Withdrawal by Subject|0|||
162633971|NCT02927080|587374264|FG002|Overall Study|Withdrawal by Subject|0|||
162633972|NCT02927080|587374265|FG003|Overall Study|Withdrawal by Subject|0|||
162633973|NCT02927080|587374266|FG004|Overall Study|Withdrawal by Subject|1|||
162633974|NCT02927080|587374267|FG005|Overall Study|Withdrawal by Subject|0|||
162633975|NCT02927080|587374268|FG006|Overall Study|Withdrawal by Subject|1|||
162633976|NCT02927080|587374269|FG007|Overall Study|Withdrawal by Subject|1|||
162633977|NCT02927080|587374270|FG008|Overall Study|Withdrawal by Subject|0|||
162633978|NCT02927080|587374271|FG009|Overall Study|Withdrawal by Subject|2|||
162633979|NCT02927080|587374262|FG000|Overall Study|Willingness to comply with protocol|0|||
162633980|NCT02927080|587374263|FG001|Overall Study|Willingness to comply with protocol|0|||
162633981|NCT02927080|587374264|FG002|Overall Study|Willingness to comply with protocol|0|||
162633982|NCT02927080|587374265|FG003|Overall Study|Willingness to comply with protocol|0|||
162633983|NCT02927080|587374266|FG004|Overall Study|Willingness to comply with protocol|0|||
162982534|NCT03551496|588638712|FG001|Overall Study|Withdrawal by Subject|3|||
162982535|NCT03551496|588638711|FG000|Overall Study|Other Reasons|1|||
162982536|NCT03551496|588638712|FG001|Overall Study|Other Reasons|0|||
162982537|NCT02303041|588638715|FG000|Overall Study|Adverse Event|1|||
162982538|NCT02303041|588638716|FG001|Overall Study|Adverse Event|2|||
162982539|NCT00886288|588638717|FG000|Overall Study|no respect of the 12 weeks period|657|||
162982540|NCT00886288|588638718|FG001|Overall Study|no respect of the 12 weeks period|227|||
162982541|NCT00886288|588638717|FG000|Overall Study|Lost to Follow-up|86|||
162982542|NCT00886288|588638718|FG001|Overall Study|Lost to Follow-up|0|||
162982543|NCT01070771|588638719|FG000|Overall Study|Adverse Event|2|||
162633984|NCT02927080|587374267|FG005|Overall Study|Willingness to comply with protocol|0|||
162633985|NCT02927080|587374268|FG006|Overall Study|Willingness to comply with protocol|0|||
162633986|NCT02927080|587374269|FG007|Overall Study|Willingness to comply with protocol|0|||
162633987|NCT02927080|587374270|FG008|Overall Study|Willingness to comply with protocol|0|||
162633988|NCT02927080|587374271|FG009|Overall Study|Willingness to comply with protocol|1|||
162633989|NCT02927080|587374262|FG000|Overall Study|Study terminated by Sponsor|0|||
162633990|NCT02927080|587374263|FG001|Overall Study|Study terminated by Sponsor|0|||
162633991|NCT02927080|587374264|FG002|Overall Study|Study terminated by Sponsor|0|||
162633992|NCT02927080|587374265|FG003|Overall Study|Study terminated by Sponsor|0|||
162633993|NCT02927080|587374266|FG004|Overall Study|Study terminated by Sponsor|0|||
162633994|NCT02927080|587374267|FG005|Overall Study|Study terminated by Sponsor|0|||
162633995|NCT02927080|587374268|FG006|Overall Study|Study terminated by Sponsor|6|||
162633996|NCT02927080|587374269|FG007|Overall Study|Study terminated by Sponsor|7|||
162633997|NCT02927080|587374270|FG008|Overall Study|Study terminated by Sponsor|2|||
162633998|NCT02927080|587374271|FG009|Overall Study|Study terminated by Sponsor|3|||
162633999|NCT02927080|587374262|FG000|Overall Study|Adverse Event|0|||
162634000|NCT02927080|587374263|FG001|Overall Study|Adverse Event|1|||
162634001|NCT02927080|587374264|FG002|Overall Study|Adverse Event|0|||
162634002|NCT02927080|587374265|FG003|Overall Study|Adverse Event|0|||
162634003|NCT02927080|587374266|FG004|Overall Study|Adverse Event|0|||
162714392|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
162714393|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
162982544|NCT01070771|588638719|FG000|Overall Study|Protocol Violation|1|||
162982545|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
162982546|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
162634004|NCT02927080|587374267|FG005|Overall Study|Adverse Event|0|||
162634005|NCT02927080|587374268|FG006|Overall Study|Adverse Event|0|||
163059522|NCT00560404|588926408|FG000|Overall Study|Adverse Event|2|||
162634006|NCT02927080|587374269|FG007|Overall Study|Adverse Event|1|||
162634007|NCT02927080|587374270|FG008|Overall Study|Adverse Event|0|||
162634008|NCT02927080|587374271|FG009|Overall Study|Adverse Event|1|||
162634009|NCT02927080|587374262|FG000|Overall Study|Other|0|||
162634010|NCT02927080|587374263|FG001|Overall Study|Other|0|||
162634011|NCT02927080|587374264|FG002|Overall Study|Other|0|||
162634012|NCT02927080|587374265|FG003|Overall Study|Other|0|||
162634013|NCT02927080|587374266|FG004|Overall Study|Other|0|||
162634014|NCT02927080|587374267|FG005|Overall Study|Other|0|||
162634015|NCT02927080|587374268|FG006|Overall Study|Other|1|||
162634016|NCT02927080|587374269|FG007|Overall Study|Other|0|||
162634017|NCT02927080|587374270|FG008|Overall Study|Other|1|||
162634018|NCT02927080|587374271|FG009|Overall Study|Other|0|||
162634019|NCT01411228|587374273|FG000|Overall Study|Lost to Follow-up|0|||
162634020|NCT01411228|587374274|FG001|Overall Study|Lost to Follow-up|0|||
162634021|NCT01411228|587374275|FG002|Overall Study|Lost to Follow-up|1|||
162634022|NCT01411228|587374273|FG000|Overall Study|Withdrawal by Subject|1|||
162634023|NCT01411228|587374274|FG001|Overall Study|Withdrawal by Subject|0|||
162634024|NCT01411228|587374275|FG002|Overall Study|Withdrawal by Subject|0|||
162634025|NCT00664742|587374276|FG000|Overall Study|Withdrawn due to adverse events|3|||
162634026|NCT00664742|587374276|FG000|Overall Study|Withdrawal by Subject|31|||
162634027|NCT00664742|587374276|FG000|Overall Study|Lost to Follow-up|92|||
162634028|NCT02670083|587374277|FG000|Overall Study|Adverse Event|16|||
162634029|NCT02670083|587374278|FG001|Overall Study|Adverse Event|13|||
162634030|NCT02670083|587374277|FG000|Overall Study|Death|4|||
162634031|NCT02670083|587374278|FG001|Overall Study|Death|6|||
162634032|NCT02670083|587374277|FG000|Overall Study|Lost to Follow-up|2|||
162634033|NCT02670083|587374278|FG001|Overall Study|Lost to Follow-up|2|||
162634034|NCT02670083|587374277|FG000|Overall Study|Multiple Reasons|9|||
162634035|NCT02670083|587374278|FG001|Overall Study|Multiple Reasons|9|||
162634036|NCT02670083|587374277|FG000|Overall Study|Physician Decision|0|||
162634037|NCT02670083|587374278|FG001|Overall Study|Physician Decision|2|||
162634038|NCT02670083|587374277|FG000|Overall Study|Study Terminated By Sponsor|257|||
162634039|NCT02670083|587374278|FG001|Overall Study|Study Terminated By Sponsor|254|||
162634040|NCT02670083|587374277|FG000|Overall Study|Symptomatic Deterioration|0|||
162634041|NCT02670083|587374278|FG001|Overall Study|Symptomatic Deterioration|2|||
162634042|NCT02670083|587374277|FG000|Overall Study|Withdrawal by Subject|32|||
162634043|NCT02670083|587374278|FG001|Overall Study|Withdrawal by Subject|31|||
162634044|NCT02670083|587374277|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162634045|NCT02670083|587374278|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162634046|NCT02825992|587374279|FG000|Overall Study|Withdrawal by Subject|4|||
162634047|NCT02825992|587374279|FG000|Overall Study|Lost to Follow-up|2|||
162634048|NCT02825992|587374279|FG000|Overall Study|Procedure terminated|2|||
162634049|NCT05620563|587374280|FG000|Overall Study|Adverse Event|3|||
162634050|NCT05620563|587374281|FG001|Overall Study|Adverse Event|1|||
162634051|NCT05620563|587374280|FG000|Overall Study|Lost to Follow-up|0|||
162634052|NCT05620563|587374281|FG001|Overall Study|Lost to Follow-up|2|||
162634053|NCT05620563|587374280|FG000|Overall Study|Protocol Deviation|1|||
162634054|NCT05620563|587374281|FG001|Overall Study|Protocol Deviation|2|||
162634055|NCT05620563|587374280|FG000|Overall Study|Withdrawal by Subject|3|||
162634056|NCT05620563|587374281|FG001|Overall Study|Withdrawal by Subject|3|||
162634057|NCT05620563|587374280|FG000|Overall Study|Physician Decision|0|||
162634058|NCT05620563|587374281|FG001|Overall Study|Physician Decision|1|||
162634059|NCT00779467|587374282|FG000|Overall Study|Lack of Efficacy|11|||
162634060|NCT00779467|587374283|FG001|Overall Study|Lack of Efficacy|2|||
162634061|NCT00779467|587374284|FG002|Overall Study|Lack of Efficacy|6|||
162634062|NCT00779467|587374285|FG003|Overall Study|Lack of Efficacy|11|||
162634063|NCT00779467|587374282|FG000|Overall Study|failed inclusion criteria|3|||
162634064|NCT00779467|587374283|FG001|Overall Study|failed inclusion criteria|3|||
162714394|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
163059523|NCT00560404|588926409|FG001|Overall Study|Adverse Event|3|||
162634065|NCT00779467|587374284|FG002|Overall Study|failed inclusion criteria|1|||
162634066|NCT00779467|587374285|FG003|Overall Study|failed inclusion criteria|2|||
162634067|NCT00779467|587374282|FG000|Overall Study|missing data|1|||
162634068|NCT00779467|587374283|FG001|Overall Study|missing data|0|||
162634069|NCT00779467|587374284|FG002|Overall Study|missing data|1|||
162634070|NCT00779467|587374285|FG003|Overall Study|missing data|4|||
162634071|NCT00779467|587374282|FG000|Overall Study|technical issue|0|||
162634072|NCT00779467|587374283|FG001|Overall Study|technical issue|0|||
163059524|NCT00560404|588926408|FG000|Overall Study|Death|3|||
162634073|NCT00779467|587374284|FG002|Overall Study|technical issue|2|||
162634074|NCT00779467|587374285|FG003|Overall Study|technical issue|1|||
162634075|NCT00779467|587374282|FG000|Overall Study|unavailable research staff|0|||
162634076|NCT00779467|587374283|FG001|Overall Study|unavailable research staff|0|||
162634077|NCT00779467|587374284|FG002|Overall Study|unavailable research staff|0|||
162634078|NCT00779467|587374285|FG003|Overall Study|unavailable research staff|1|||
162634079|NCT00460408|587374292|FG000|Overall Study|Adverse Event|1|||
162634080|NCT00460408|587374293|FG001|Overall Study|Adverse Event|0|||
162634081|NCT00460408|587374294|FG002|Overall Study|Adverse Event|0|||
162714395|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
162714396|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
162714397|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
162714398|NCT03412747|587663985|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
162714399|NCT03412747|587663986|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
162714400|NCT03412747|587663987|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
162714401|NCT01582945|587663988|FG000|Overall Study|Intolerable side-effects|1|||
162714402|NCT01582945|587663988|FG000|Overall Study|Scheduling conflicts|1|||
162714403|NCT04982575|587663993|FG000|Overall Study|Withdrawal by Subject|2|||
162714404|NCT04982575|587663994|FG001|Overall Study|Withdrawal by Subject|0|||
162714405|NCT04982575|587663995|FG002|Overall Study|Withdrawal by Subject|2|||
162714406|NCT03038022|587663998|FG000|Overall Study|Withdrawal by Subject|2|||
162714407|NCT03038022|587663999|FG001|Overall Study|Withdrawal by Subject|0|||
162714408|NCT03038022|587663998|FG000|Overall Study|Adverse Event|4|||
162714409|NCT03038022|587663999|FG001|Overall Study|Adverse Event|2|||
162714410|NCT01467427|587664000|FG000|Overall Study|Withdrawal by Subject|1|||
162714411|NCT01467427|587664001|FG001|Overall Study|Withdrawal by Subject|0|||
162714412|NCT01467427|587664000|FG000|Overall Study|Not continuing in extension phase|0|||
162714413|NCT01467427|587664001|FG001|Overall Study|Not continuing in extension phase|2|||
162714414|NCT01467427|587664000|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
162714415|NCT01467427|587664001|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
162714416|NCT01467427|587664000|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
162714417|NCT01467427|587664001|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
162714418|NCT01467427|587664000|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
162714419|NCT01467427|587664001|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
162714420|NCT01467427|587664000|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
162714421|NCT01467427|587664001|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
162714422|NCT04269200|587664002|FG000|Global Cohort|Death|72|||
162714423|NCT04269200|587664003|FG001|Global Cohort|Death|54|||
162714424|NCT04269200|587664004|FG002|Global Cohort|Death|49|||
162714425|NCT04269200|587664002|FG000|Global Cohort|Lost to Follow-up|0|||
162714426|NCT04269200|587664003|FG001|Global Cohort|Lost to Follow-up|0|||
162714427|NCT04269200|587664004|FG002|Global Cohort|Lost to Follow-up|2|||
162714428|NCT04269200|587664002|FG000|Global Cohort|Withdrawal by Subject|22|||
162714429|NCT04269200|587664003|FG001|Global Cohort|Withdrawal by Subject|25|||
162714430|NCT04269200|587664004|FG002|Global Cohort|Withdrawal by Subject|18|||
162714431|NCT04269200|587664002|FG000|China Cohort|Death|12|||
162714432|NCT04269200|587664003|FG001|China Cohort|Death|11|||
162714433|NCT04269200|587664004|FG002|China Cohort|Death|13|||
162714434|NCT04269200|587664002|FG000|China Cohort|Lost to Follow-up|0|||
162714435|NCT04269200|587664003|FG001|China Cohort|Lost to Follow-up|1|||
162714436|NCT04269200|587664004|FG002|China Cohort|Lost to Follow-up|1|||
162714437|NCT04269200|587664002|FG000|China Cohort|Withdrawal by Subject|2|||
162714438|NCT04269200|587664003|FG001|China Cohort|Withdrawal by Subject|2|||
162714439|NCT04269200|587664004|FG002|China Cohort|Withdrawal by Subject|4|||
162714440|NCT03887936|587664005|FG000|Overall Study|Relocation|2|||
162714441|NCT03887936|587664006|FG001|Overall Study|Relocation|2|||
162714442|NCT03887936|587664005|FG000|Overall Study|Physician Decision|0|||
162714443|NCT03887936|587664006|FG001|Overall Study|Physician Decision|1|||
162714444|NCT03887936|587664005|FG000|Overall Study|Withdrawal by Subject|0|||
162714445|NCT03887936|587664006|FG001|Overall Study|Withdrawal by Subject|1|||
162714446|NCT00117988|587664011|FG000|Overall Study|Death|3|||
162714447|NCT00117988|587664011|FG000|Overall Study|Adverse Event|1|||
162714448|NCT05824351|587664012|FG000|Overall Study|Adverse Event|6|||
162714449|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
162714450|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
162714451|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
162714452|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
162714453|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
162714454|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
162714455|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
162714456|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
162714457|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
162714458|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
162714459|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
162714460|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
162714461|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
162714462|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
162714463|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
162714464|NCT02137850|587664013|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
162714465|NCT02137850|587664014|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
162714466|NCT02137850|587664015|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
162714467|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162634082|NCT00460408|587374295|FG003|Overall Study|Adverse Event|0|||
162634083|NCT00460408|587374292|FG000|Overall Study|Death|7|||
162634084|NCT00460408|587374293|FG001|Overall Study|Death|0|||
162634085|NCT00460408|587374294|FG002|Overall Study|Death|0|||
162634086|NCT00460408|587374295|FG003|Overall Study|Death|0|||
162634087|NCT00460408|587374292|FG000|Overall Study|Lost to Follow-up|11|||
162634088|NCT00460408|587374293|FG001|Overall Study|Lost to Follow-up|0|||
162634089|NCT00460408|587374294|FG002|Overall Study|Lost to Follow-up|1|||
162634090|NCT00460408|587374295|FG003|Overall Study|Lost to Follow-up|0|||
162634091|NCT00460408|587374292|FG000|Overall Study|Withdrawal by Subject|31|||
162634092|NCT00460408|587374293|FG001|Overall Study|Withdrawal by Subject|0|||
162634093|NCT00460408|587374294|FG002|Overall Study|Withdrawal by Subject|0|||
162714468|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
162634094|NCT00460408|587374295|FG003|Overall Study|Withdrawal by Subject|0|||
162634095|NCT00460408|587374292|FG000|Overall Study|Insufficient clinical response|5|||
162634096|NCT00460408|587374293|FG001|Overall Study|Insufficient clinical response|1|||
162634097|NCT00460408|587374294|FG002|Overall Study|Insufficient clinical response|5|||
162634098|NCT00460408|587374295|FG003|Overall Study|Insufficient clinical response|0|||
162634099|NCT00460408|587374292|FG000|Overall Study|Other|12|||
162634100|NCT00460408|587374293|FG001|Overall Study|Other|2|||
162634101|NCT00460408|587374294|FG002|Overall Study|Other|0|||
162634102|NCT00460408|587374295|FG003|Overall Study|Other|0|||
162634103|NCT02573350|587374296|FG000|Overall Study|Lost to Follow-up|2|||
162634104|NCT02573350|587374297|FG001|Overall Study|Lost to Follow-up|1|||
162634105|NCT02573350|587374296|FG000|Overall Study|Adverse Event|3|||
162634106|NCT02573350|587374297|FG001|Overall Study|Adverse Event|4|||
162634107|NCT02573350|587374296|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
162634108|NCT02573350|587374297|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
162634109|NCT02573350|587374296|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
162634110|NCT02573350|587374297|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
162634111|NCT02573350|587374296|FG000|Overall Study|Subject withdrew consent to participate|6|||
162634112|NCT02573350|587374297|FG001|Overall Study|Subject withdrew consent to participate|1|||
162634113|NCT02573350|587374296|FG000|Overall Study|Protocol Deviation|1|||
162634114|NCT02573350|587374297|FG001|Overall Study|Protocol Deviation|1|||
162634115|NCT01442493|587374299|FG000|Overall Study|withdrawn from study|3|||
162634116|NCT01442493|587374300|FG001|Overall Study|withdrawn from study|2|||
162634117|NCT02547649|587374303|FG000|Overall Study|Lost to Follow-up|3|||
162634118|NCT02547649|587374304|FG001|Overall Study|Lost to Follow-up|1|||
162634119|NCT02547649|587374305|FG002|Overall Study|Lost to Follow-up|1|||
162634120|NCT02547649|587374303|FG000|Overall Study|Not vaccinated|0|||
162634121|NCT02547649|587374304|FG001|Overall Study|Not vaccinated|0|||
162634122|NCT02547649|587374305|FG002|Overall Study|Not vaccinated|1|||
162634123|NCT02547649|587374303|FG000|Overall Study|Withdrawal by Subject|0|||
162634124|NCT02547649|587374304|FG001|Overall Study|Withdrawal by Subject|4|||
162634125|NCT02547649|587374305|FG002|Overall Study|Withdrawal by Subject|2|||
162634126|NCT04326231|587374306|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
162634127|NCT03303079|587374307|FG000|Overall Study|Adverse Event|0|||
162634128|NCT03303079|587374308|FG001|Overall Study|Adverse Event|1|||
162634129|NCT03303079|587374309|FG002|Overall Study|Adverse Event|3|||
162634130|NCT03303079|587374307|FG000|Overall Study|Protocol Violation|5|||
162634131|NCT03303079|587374308|FG001|Overall Study|Protocol Violation|4|||
162634132|NCT03303079|587374309|FG002|Overall Study|Protocol Violation|7|||
162634133|NCT03303079|587374307|FG000|Overall Study|Withdrawal by Subject|2|||
162634134|NCT03303079|587374308|FG001|Overall Study|Withdrawal by Subject|4|||
162634135|NCT03303079|587374309|FG002|Overall Study|Withdrawal by Subject|2|||
162634136|NCT03303079|587374307|FG000|Overall Study|Other than specified|0|||
162634137|NCT03303079|587374308|FG001|Overall Study|Other than specified|2|||
162634138|NCT03303079|587374309|FG002|Overall Study|Other than specified|0|||
162634139|NCT03454997|587374310|FG000|Overall Study|Staff Coach - Left Oranization|1|||
162634140|NCT03454997|587374311|FG001|Overall Study|Staff Coach - Left Oranization|1|||
162634141|NCT03454997|587374310|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
162634142|NCT03454997|587374311|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
162634143|NCT03454997|587374310|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
162634144|NCT03454997|587374311|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
162634145|NCT03454997|587374310|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
162634146|NCT03454997|587374311|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
162634147|NCT03454997|587374310|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
162634148|NCT03454997|587374311|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
162634149|NCT03454997|587374310|FG000|Overall Study|Client with SMI - Left organization|0|||
162634150|NCT03454997|587374311|FG001|Overall Study|Client with SMI - Left organization|1|||
162634151|NCT03454997|587374310|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
162634152|NCT03454997|587374311|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
162634153|NCT01909674|587374320|FG000|Overall Study|Withdrawal by Subject|5|||
162634154|NCT01909674|587374321|FG001|Overall Study|Withdrawal by Subject|2|||
162634155|NCT01678911|587374324|FG000|Second Intervention|Lost to Follow-up|2|||
162634156|NCT01678911|587374325|FG001|Second Intervention|Lost to Follow-up|0|||
162634157|NCT01830972|587374326|FG000|Part II|Withdrawal by Subject|2|||
162634158|NCT01830972|587374327|FG001|Part II|Withdrawal by Subject|2|||
162634159|NCT01830972|587374326|FG000|Part III|Withdrawal by Subject|1|||
162634160|NCT01830972|587374327|FG001|Part III|Withdrawal by Subject|0|||
162634161|NCT01830972|587374326|FG000|Part III|Noncompliance|1|||
162634162|NCT01830972|587374327|FG001|Part III|Noncompliance|0|||
162634163|NCT01830972|587374326|FG000|Part IV|Withdrawal by Subject|2|||
162634164|NCT01830972|587374327|FG001|Part IV|Withdrawal by Subject|1|||
162634165|NCT01830972|587374326|FG000|Part IV|Non-Compliance|1|||
162634166|NCT01830972|587374327|FG001|Part IV|Non-Compliance|0|||
162634167|NCT02117648|587374328|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
162982547|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
162634168|NCT02117648|587374328|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
162634169|NCT02117648|587374328|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
162634170|NCT02117648|587374328|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
162634171|NCT02117648|587374328|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
162634172|NCT02117648|587374328|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
162634173|NCT02117648|587374328|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
162634174|NCT02117648|587374328|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
162634175|NCT02117648|587374328|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
162634176|NCT02117648|587374328|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
162634177|NCT02117648|587374328|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
162634178|NCT05025241|587374330|FG000|Screening|Failed Screening|5|||
162634179|NCT05025241|587374330|FG000|Treatment and Follow Up|Adverse Event|3|||
162634180|NCT02670837|587374331|FG000|Overall Study|Death|2|||
162634181|NCT02670837|587374332|FG001|Overall Study|Death|0|||
162634182|NCT02670837|587374333|FG002|Overall Study|Death|0|||
162634183|NCT02220205|587374334|FG000|Overall Study|Withdrawal by Subject|1|||
162634184|NCT02220205|587374335|FG001|Overall Study|Withdrawal by Subject|0|||
162634185|NCT02266225|587374336|FG000|Overall Study|Lost to Follow-up|2|||
162634186|NCT02266225|587374336|FG000|Overall Study|Death|1|||
162634187|NCT02266225|587374336|FG000|Overall Study|Withdrawal by Subject|13|||
162634188|NCT00660309|587374339|FG000|Overall Study|Adverse Event|2|||
162634189|NCT00660309|587374340|FG001|Overall Study|Adverse Event|0|||
162634190|NCT00660309|587374339|FG000|Overall Study|Withdrawal by Subject|0|||
162634191|NCT00660309|587374340|FG001|Overall Study|Withdrawal by Subject|3|||
162634192|NCT02532972|587374344|FG000|Overall Study|Withdrawal by Subject|1|||
162634193|NCT00110149|587374345|FG000|Overall Study|Physician Decision|3|||
162634194|NCT01018186|587374346|FG000|2-week Run-in Period|Protocol Violation|1|||
162634195|NCT01018186|587374347|FG001|2-week Run-in Period|Protocol Violation|0|||
162634196|NCT01018186|587374348|FG002|2-week Run-in Period|Protocol Violation|0|||
162634197|NCT01018186|587374349|FG003|2-week Run-in Period|Protocol Violation|0|||
162634198|NCT01018186|587374346|FG000|2-week Run-in Period|Lost to Follow-up|2|||
162634199|NCT01018186|587374347|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162634200|NCT01018186|587374348|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162634201|NCT01018186|587374349|FG003|2-week Run-in Period|Lost to Follow-up|0|||
162634202|NCT01018186|587374346|FG000|2-week Run-in Period|Physician Decision|3|||
162634203|NCT01018186|587374347|FG001|2-week Run-in Period|Physician Decision|0|||
162634204|NCT01018186|587374348|FG002|2-week Run-in Period|Physician Decision|0|||
162634205|NCT01018186|587374349|FG003|2-week Run-in Period|Physician Decision|0|||
162634206|NCT01018186|587374346|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
162634207|NCT01018186|587374347|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162634208|NCT01018186|587374348|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162634209|NCT01018186|587374349|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
162634210|NCT01018186|587374346|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
162634211|NCT01018186|587374347|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162634212|NCT01018186|587374348|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162634213|NCT01018186|587374349|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162634214|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
162634215|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
162634216|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
162634217|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
162634218|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
162634219|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
162634220|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
162634221|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
162634222|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
162634223|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
162634224|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
162634225|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
162634226|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
162634227|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
162634228|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
162634229|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
162634230|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
162634231|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
162634232|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
162634233|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
162634234|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
162634235|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
162634236|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
162634237|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
162634238|NCT01018186|587374346|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
162634239|NCT01018186|587374347|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
162634240|NCT01018186|587374348|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
162634241|NCT01018186|587374349|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
162634242|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162634243|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
162634244|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162634245|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162634246|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162634247|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162634248|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
162634249|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
162634250|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
162634251|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
162634252|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
162634253|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
162634254|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
162634255|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162634256|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
162634257|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162634258|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
162634259|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162634260|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162634261|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162634262|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162634263|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162634264|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
162634265|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162634266|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162634267|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
162634268|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162634269|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162634270|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162634271|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162634272|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
162634273|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162634274|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162634275|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
162634276|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162634277|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
162634278|NCT02603419|587374350|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162634279|NCT02603419|587374351|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162634280|NCT02603419|587374352|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162634281|NCT02603419|587374353|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
162634282|NCT02603419|587374354|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162634283|NCT02603419|587374355|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162634284|NCT02603419|587374350|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162634285|NCT02603419|587374351|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162634286|NCT02603419|587374352|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162634287|NCT02603419|587374353|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162634288|NCT02603419|587374354|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162634289|NCT02603419|587374355|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
162634290|NCT02603419|587374350|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162634291|NCT02603419|587374351|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162634292|NCT02603419|587374352|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162634293|NCT02603419|587374353|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162634294|NCT02603419|587374354|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162634295|NCT02603419|587374355|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
162634296|NCT02603419|587374350|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162634297|NCT02603419|587374351|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162634298|NCT02603419|587374352|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162634299|NCT02603419|587374353|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162714469|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163059525|NCT00560404|588926409|FG001|Overall Study|Death|3|||
162714470|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
162714471|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
162714472|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
162714473|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
162714474|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
162714475|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
162714476|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
162714477|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
162714478|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
162714479|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Other|0|||
162714480|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Other|1|||
162714481|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Other|0|||
162714482|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
162714483|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
162714484|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
162714485|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Early site closure|0|||
162714486|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Early site closure|2|||
162714487|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Early site closure|0|||
162714488|NCT02137850|587664013|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
162714489|NCT02137850|587664014|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
162714490|NCT02137850|587664015|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
162714491|NCT02137850|587664013|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
162714492|NCT02137850|587664014|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
162714493|NCT02137850|587664015|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
162714494|NCT02137850|587664013|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
162714495|NCT02137850|587664014|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
162714496|NCT02137850|587664015|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
162714497|NCT02137850|587664013|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
162714498|NCT02137850|587664014|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
162714499|NCT02137850|587664015|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
162714500|NCT02137850|587664013|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
162714501|NCT02137850|587664014|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
162714502|NCT02137850|587664015|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
162714503|NCT02137850|587664013|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
162714504|NCT02137850|587664014|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
162714505|NCT02137850|587664015|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
162714506|NCT02137850|587664013|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162714507|NCT02137850|587664014|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
162714508|NCT02137850|587664015|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162714509|NCT02137850|587664013|FG000|Extension Phase: Prophylaxis|Other|0|||
162714510|NCT02137850|587664014|FG001|Extension Phase: Prophylaxis|Other|1|||
162714511|NCT02137850|587664015|FG002|Extension Phase: Prophylaxis|Other|0|||
162714512|NCT02137850|587664013|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
162714513|NCT02137850|587664014|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
162714514|NCT02137850|587664015|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
162714515|NCT02912260|587664016|FG000|Main Study|Lost to Follow-up|5|||
162714516|NCT02912260|587664017|FG001|Main Study|Lost to Follow-up|4|||
162714517|NCT02912260|587664016|FG000|Main Study|Withdrawal by Subject|2|||
162714518|NCT02912260|587664017|FG001|Main Study|Withdrawal by Subject|2|||
162714519|NCT02912260|587664016|FG000|Main Study|Adverse Event|3|||
162714520|NCT02912260|587664017|FG001|Main Study|Adverse Event|0|||
162714521|NCT02912260|587664016|FG000|Main Study|Physician Decision|0|||
162714522|NCT02912260|587664017|FG001|Main Study|Physician Decision|1|||
162714523|NCT02912260|587664016|FG000|Extension Study|Withdrawal by Subject|1|||
162714524|NCT02912260|587664017|FG001|Extension Study|Withdrawal by Subject|1|||
162714525|NCT01311713|587664019|FG000|Overall Study|Death|0|||
162714526|NCT01311713|587664020|FG001|Overall Study|Death|0|||
162714527|NCT01311713|587664021|FG002|Overall Study|Death|1|||
162714528|NCT01311713|587664022|FG003|Overall Study|Death|1|||
162714529|NCT01311713|587664023|FG004|Overall Study|Death|0|||
162714530|NCT01311713|587664024|FG005|Overall Study|Death|1|||
162714531|NCT01311713|587664025|FG006|Overall Study|Death|0|||
162714532|NCT01311713|587664019|FG000|Overall Study|Adverse Event|0|||
163059526|NCT00560404|588926408|FG000|Overall Study|Protocol Violation|12|||
162714533|NCT01311713|587664020|FG001|Overall Study|Adverse Event|1|||
162714534|NCT01311713|587664021|FG002|Overall Study|Adverse Event|0|||
162714535|NCT01311713|587664022|FG003|Overall Study|Adverse Event|2|||
162714536|NCT01311713|587664023|FG004|Overall Study|Adverse Event|0|||
162714537|NCT01311713|587664024|FG005|Overall Study|Adverse Event|0|||
162714538|NCT01311713|587664025|FG006|Overall Study|Adverse Event|2|||
162714539|NCT01311713|587664019|FG000|Overall Study|Withdrawal by Subject|0|||
162714540|NCT01311713|587664020|FG001|Overall Study|Withdrawal by Subject|1|||
162714541|NCT01311713|587664021|FG002|Overall Study|Withdrawal by Subject|1|||
163059527|NCT00560404|588926409|FG001|Overall Study|Protocol Violation|7|||
163059528|NCT00560404|588926408|FG000|Overall Study|Administrative Reasons|1|||
163059529|NCT00560404|588926409|FG001|Overall Study|Administrative Reasons|1|||
163059530|NCT00560404|588926408|FG000|Overall Study|Withdrew Consent|4|||
163059531|NCT00560404|588926409|FG001|Overall Study|Withdrew Consent|0|||
163059532|NCT00560404|588926408|FG000|Overall Study|Failure to return|1|||
163059533|NCT00560404|588926409|FG001|Overall Study|Failure to return|2|||
163059534|NCT00560404|588926408|FG000|Overall Study|Other withdrawal reason|13|||
163059535|NCT00560404|588926409|FG001|Overall Study|Other withdrawal reason|5|||
163059536|NCT02642042|588926416|FG000|Overall Study|Adverse Event|22|||
163059537|NCT02642042|588926416|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163059538|NCT02642042|588926416|FG000|Overall Study|Progression/Relapse|28|||
163059539|NCT02642042|588926416|FG000|Overall Study|Death|1|||
163059540|NCT02642042|588926416|FG000|Overall Study|Not Protocol Specified|2|||
163059541|NCT04108468|588926417|FG000|Overall Study|Physician Decision|0|||
162634300|NCT02603419|587374354|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162634301|NCT02603419|587374355|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
162634302|NCT03552198|587374356|FG000|Overall Study|Lost to Follow-up|42|||
162634303|NCT03552198|587374357|FG001|Overall Study|Lost to Follow-up|48|||
162634304|NCT03552198|587374358|FG002|Overall Study|Lost to Follow-up|15|||
162634305|NCT03552198|587374359|FG003|Overall Study|Lost to Follow-up|19|||
162634306|NCT03552198|587374356|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
162634307|NCT03552198|587374357|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
162634308|NCT03552198|587374358|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
162634309|NCT03552198|587374359|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
162634310|NCT03552198|587374356|FG000|Overall Study|Did not receive air alerts|1|||
162634311|NCT03552198|587374357|FG001|Overall Study|Did not receive air alerts|0|||
162634312|NCT03552198|587374358|FG002|Overall Study|Did not receive air alerts|0|||
162634313|NCT03552198|587374359|FG003|Overall Study|Did not receive air alerts|1|||
162634314|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
162634315|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
162634316|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
162634317|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
162634318|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
162634319|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
162634320|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
162634321|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
162634322|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Other|1|||
162634323|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Other|4|||
162634324|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Other|3|||
162634325|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Other|6|||
162634326|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
162634327|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
162634328|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
162634329|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
162634330|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
163059542|NCT04108468|588926418|FG001|Overall Study|Physician Decision|1|||
163059543|NCT04108468|588926417|FG000|Overall Study|Lost to Follow-up|0|||
163059544|NCT04108468|588926418|FG001|Overall Study|Lost to Follow-up|1|||
163059545|NCT04108468|588926417|FG000|Overall Study|Non-compliance|1|||
163059546|NCT04108468|588926418|FG001|Overall Study|Non-compliance|1|||
163059547|NCT04108468|588926417|FG000|Overall Study|Unable to attend final visit|2|||
163059548|NCT04108468|588926418|FG001|Overall Study|Unable to attend final visit|0|||
163059549|NCT04108468|588926417|FG000|Overall Study|Missed study medication|0|||
162714542|NCT01311713|587664022|FG003|Overall Study|Withdrawal by Subject|0|||
162714543|NCT01311713|587664023|FG004|Overall Study|Withdrawal by Subject|0|||
162714544|NCT01311713|587664024|FG005|Overall Study|Withdrawal by Subject|1|||
162714545|NCT01311713|587664025|FG006|Overall Study|Withdrawal by Subject|2|||
162714546|NCT01311713|587664019|FG000|Overall Study|Disease progression|3|||
162714547|NCT01311713|587664020|FG001|Overall Study|Disease progression|4|||
162714548|NCT01311713|587664021|FG002|Overall Study|Disease progression|3|||
162714549|NCT01311713|587664022|FG003|Overall Study|Disease progression|2|||
162714550|NCT01311713|587664023|FG004|Overall Study|Disease progression|4|||
162714551|NCT01311713|587664024|FG005|Overall Study|Disease progression|4|||
162714552|NCT01311713|587664025|FG006|Overall Study|Disease progression|5|||
162714553|NCT01311713|587664019|FG000|Overall Study|Lost to Follow-up|0|||
162714554|NCT01311713|587664020|FG001|Overall Study|Lost to Follow-up|0|||
162714555|NCT01311713|587664021|FG002|Overall Study|Lost to Follow-up|1|||
162714556|NCT01311713|587664022|FG003|Overall Study|Lost to Follow-up|0|||
162714557|NCT01311713|587664023|FG004|Overall Study|Lost to Follow-up|0|||
162714558|NCT01311713|587664024|FG005|Overall Study|Lost to Follow-up|0|||
162714559|NCT01311713|587664025|FG006|Overall Study|Lost to Follow-up|0|||
162714560|NCT01311713|587664019|FG000|Overall Study|Stopped taking study medication|0|||
162714561|NCT01311713|587664020|FG001|Overall Study|Stopped taking study medication|0|||
162714562|NCT01311713|587664021|FG002|Overall Study|Stopped taking study medication|0|||
162714563|NCT01311713|587664022|FG003|Overall Study|Stopped taking study medication|1|||
162714564|NCT01311713|587664023|FG004|Overall Study|Stopped taking study medication|1|||
162714565|NCT01311713|587664024|FG005|Overall Study|Stopped taking study medication|0|||
162714566|NCT01311713|587664025|FG006|Overall Study|Stopped taking study medication|0|||
162714567|NCT01311713|587664019|FG000|Overall Study|Enrolled but not treated|0|||
162714568|NCT01311713|587664020|FG001|Overall Study|Enrolled but not treated|0|||
162714569|NCT01311713|587664021|FG002|Overall Study|Enrolled but not treated|1|||
162714570|NCT01311713|587664022|FG003|Overall Study|Enrolled but not treated|0|||
162714571|NCT01311713|587664023|FG004|Overall Study|Enrolled but not treated|0|||
162714572|NCT01311713|587664024|FG005|Overall Study|Enrolled but not treated|0|||
162714573|NCT01311713|587664025|FG006|Overall Study|Enrolled but not treated|0|||
162714574|NCT01311713|587664019|FG000|Overall Study|Other than specified|0|||
162714575|NCT01311713|587664020|FG001|Overall Study|Other than specified|1|||
162714576|NCT01311713|587664021|FG002|Overall Study|Other than specified|2|||
162714577|NCT01311713|587664022|FG003|Overall Study|Other than specified|0|||
162714578|NCT01311713|587664023|FG004|Overall Study|Other than specified|0|||
162714579|NCT01311713|587664024|FG005|Overall Study|Other than specified|0|||
162714580|NCT01311713|587664025|FG006|Overall Study|Other than specified|0|||
162714581|NCT03878446|587664028|FG000|Overall Study|Withdrawn by parent or guardian|1|||
162714582|NCT03878446|587664029|FG001|Overall Study|Withdrawn by parent or guardian|0|||
162714583|NCT03878446|587664030|FG002|Overall Study|Withdrawn by parent or guardian|0|||
162714584|NCT03878446|587664031|FG003|Overall Study|Withdrawn by parent or guardian|0|||
162714585|NCT03878446|587664032|FG004|Overall Study|Withdrawn by parent or guardian|0|||
162714586|NCT05803720|587664033|FG000|Overall Study|Lost to Follow-up|3|||
162714587|NCT05803720|587664034|FG001|Overall Study|Lost to Follow-up|4|||
162714588|NCT05803720|587664033|FG000|Overall Study|Family leave/emergency|1|||
162714589|NCT05803720|587664034|FG001|Overall Study|Family leave/emergency|1|||
162714590|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
162714591|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
162714592|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
162714593|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
162714594|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
162714595|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
162714596|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Death|1|||
162714597|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Death|1|||
162714598|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Death|1|||
162714599|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Death|0|||
162714600|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Death|0|||
162714601|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Death|0|||
162714602|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
162714603|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
162714604|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162714605|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162714606|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162714607|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162714608|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162714609|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162714610|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
162714611|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162714612|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162634331|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
162634332|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
162634333|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
162634334|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
162634335|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
162634336|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
162634337|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
162634338|NCT02925494|587374360|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
162634339|NCT02925494|587374361|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
162634340|NCT02925494|587374362|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
162634341|NCT02925494|587374363|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
162634342|NCT01666782|587374369|FG000|Overall Study|Received 2 doses of vaccine|0|||
162634343|NCT01666782|587374370|FG001|Overall Study|Received 2 doses of vaccine|1|||
162634344|NCT01666782|587374369|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
162634345|NCT01666782|587374370|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
162634346|NCT02007109|587374373|FG000|Overall Study|Diary not returned or excluded|102|||
162634347|NCT02007109|587374373|FG000|Overall Study|Excluded - Age<7yo|9|||
162634348|NCT03572062|587374374|FG000|Overall Study|Adverse Event|0|||
162634349|NCT03572062|587374375|FG001|Overall Study|Adverse Event|0|||
162634350|NCT03572062|587374376|FG002|Overall Study|Adverse Event|0|||
162634351|NCT03572062|587374377|FG003|Overall Study|Adverse Event|0|||
162634352|NCT03572062|587374378|FG004|Overall Study|Adverse Event|0|||
162634353|NCT03572062|587374379|FG005|Overall Study|Adverse Event|0|||
162634354|NCT03572062|587374380|FG006|Overall Study|Adverse Event|0|||
162634355|NCT03572062|587374381|FG007|Overall Study|Adverse Event|0|||
162634356|NCT03572062|587374382|FG008|Overall Study|Adverse Event|1|||
162634357|NCT03572062|587374383|FG009|Overall Study|Adverse Event|3|||
162634358|NCT03572062|587374374|FG000|Overall Study|Death|0|||
162634359|NCT03572062|587374375|FG001|Overall Study|Death|0|||
162634360|NCT03572062|587374376|FG002|Overall Study|Death|0|||
162634361|NCT03572062|587374377|FG003|Overall Study|Death|0|||
162634362|NCT03572062|587374378|FG004|Overall Study|Death|0|||
162634363|NCT03572062|587374379|FG005|Overall Study|Death|1|||
162634364|NCT03572062|587374380|FG006|Overall Study|Death|0|||
162634365|NCT03572062|587374381|FG007|Overall Study|Death|0|||
162634366|NCT03572062|587374382|FG008|Overall Study|Death|0|||
162634367|NCT03572062|587374383|FG009|Overall Study|Death|0|||
162634368|NCT03572062|587374374|FG000|Overall Study|Lost to Follow-up|0|||
162634369|NCT03572062|587374375|FG001|Overall Study|Lost to Follow-up|0|||
162634370|NCT03572062|587374376|FG002|Overall Study|Lost to Follow-up|0|||
162634371|NCT03572062|587374377|FG003|Overall Study|Lost to Follow-up|0|||
162634372|NCT03572062|587374378|FG004|Overall Study|Lost to Follow-up|0|||
162634373|NCT03572062|587374379|FG005|Overall Study|Lost to Follow-up|1|||
162634374|NCT03572062|587374380|FG006|Overall Study|Lost to Follow-up|1|||
162634375|NCT03572062|587374381|FG007|Overall Study|Lost to Follow-up|0|||
162634376|NCT03572062|587374382|FG008|Overall Study|Lost to Follow-up|0|||
162634377|NCT03572062|587374383|FG009|Overall Study|Lost to Follow-up|0|||
162634378|NCT03572062|587374374|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634379|NCT03572062|587374375|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634380|NCT03572062|587374376|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634381|NCT03572062|587374377|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634382|NCT03572062|587374378|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634383|NCT03572062|587374379|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634384|NCT03572062|587374380|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634385|NCT03572062|587374381|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634386|NCT03572062|587374382|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
162634387|NCT03572062|587374383|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
162634388|NCT03572062|587374374|FG000|Overall Study|Study Terminated By Sponsor|0|||
162634389|NCT03572062|587374375|FG001|Overall Study|Study Terminated By Sponsor|0|||
162634390|NCT03572062|587374376|FG002|Overall Study|Study Terminated By Sponsor|0|||
162634391|NCT03572062|587374377|FG003|Overall Study|Study Terminated By Sponsor|0|||
162634392|NCT03572062|587374378|FG004|Overall Study|Study Terminated By Sponsor|0|||
162634393|NCT03572062|587374379|FG005|Overall Study|Study Terminated By Sponsor|0|||
162634394|NCT03572062|587374380|FG006|Overall Study|Study Terminated By Sponsor|0|||
162634395|NCT03572062|587374381|FG007|Overall Study|Study Terminated By Sponsor|0|||
162634396|NCT03572062|587374382|FG008|Overall Study|Study Terminated By Sponsor|29|||
162634397|NCT03572062|587374383|FG009|Overall Study|Study Terminated By Sponsor|27|||
162714613|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162982548|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
162634398|NCT03572062|587374374|FG000|Overall Study|Physician Decision|0|||
162634399|NCT03572062|587374375|FG001|Overall Study|Physician Decision|0|||
162634400|NCT03572062|587374376|FG002|Overall Study|Physician Decision|0|||
162634401|NCT03572062|587374377|FG003|Overall Study|Physician Decision|0|||
162634402|NCT03572062|587374378|FG004|Overall Study|Physician Decision|0|||
162634403|NCT03572062|587374379|FG005|Overall Study|Physician Decision|0|||
162634404|NCT03572062|587374380|FG006|Overall Study|Physician Decision|0|||
162634405|NCT03572062|587374381|FG007|Overall Study|Physician Decision|0|||
162634406|NCT03572062|587374382|FG008|Overall Study|Physician Decision|1|||
162634407|NCT03572062|587374383|FG009|Overall Study|Physician Decision|0|||
162634408|NCT03572062|587374374|FG000|Overall Study|Withdrawal by Subject|0|||
162634409|NCT03572062|587374375|FG001|Overall Study|Withdrawal by Subject|0|||
162634410|NCT03572062|587374376|FG002|Overall Study|Withdrawal by Subject|0|||
162634411|NCT03572062|587374377|FG003|Overall Study|Withdrawal by Subject|0|||
162634412|NCT03572062|587374378|FG004|Overall Study|Withdrawal by Subject|0|||
162634413|NCT03572062|587374379|FG005|Overall Study|Withdrawal by Subject|0|||
162634414|NCT03572062|587374380|FG006|Overall Study|Withdrawal by Subject|0|||
162634415|NCT03572062|587374381|FG007|Overall Study|Withdrawal by Subject|0|||
162634416|NCT03572062|587374382|FG008|Overall Study|Withdrawal by Subject|0|||
162634417|NCT03572062|587374383|FG009|Overall Study|Withdrawal by Subject|1|||
162634418|NCT03572062|587374374|FG000|Overall Study|Randomized But Not Treated|0|||
162634419|NCT03572062|587374375|FG001|Overall Study|Randomized But Not Treated|0|||
162634420|NCT03572062|587374376|FG002|Overall Study|Randomized But Not Treated|0|||
162634421|NCT03572062|587374377|FG003|Overall Study|Randomized But Not Treated|0|||
162634422|NCT03572062|587374378|FG004|Overall Study|Randomized But Not Treated|1|||
162634423|NCT03572062|587374379|FG005|Overall Study|Randomized But Not Treated|2|||
162634424|NCT03572062|587374380|FG006|Overall Study|Randomized But Not Treated|0|||
162634425|NCT03572062|587374381|FG007|Overall Study|Randomized But Not Treated|1|||
162634426|NCT03572062|587374382|FG008|Overall Study|Randomized But Not Treated|0|||
162634427|NCT03572062|587374383|FG009|Overall Study|Randomized But Not Treated|0|||
162634428|NCT01858389|587374384|FG000|Overall Study|Death|1|||
162634429|NCT01858389|587374385|FG001|Overall Study|Death|3|||
162634430|NCT01858389|587374384|FG000|Overall Study|Study terminated by sponsor|0|||
162634431|NCT01858389|587374385|FG001|Overall Study|Study terminated by sponsor|2|||
162634432|NCT01858389|587374384|FG000|Overall Study|Withdrawal by Subject|0|||
162634433|NCT01858389|587374385|FG001|Overall Study|Withdrawal by Subject|1|||
162634434|NCT01858389|587374384|FG000|Overall Study|Progressive disease|10|||
162634435|NCT01858389|587374385|FG001|Overall Study|Progressive disease|11|||
162634436|NCT01858389|587374384|FG000|Overall Study|Other|2|||
162634437|NCT01858389|587374385|FG001|Overall Study|Other|4|||
162634438|NCT01858389|587374384|FG000|Overall Study|Adverse Event|3|||
162634439|NCT01858389|587374385|FG001|Overall Study|Adverse Event|1|||
162634440|NCT01858389|587374384|FG000|Overall Study|Did not receive treatment|0|||
162634441|NCT01858389|587374385|FG001|Overall Study|Did not receive treatment|3|||
162634442|NCT01691781|587374386|FG000|Overall Study|Withdrawal by Subject|4|||
162634443|NCT01691781|587374387|FG001|Overall Study|Withdrawal by Subject|3|||
162634444|NCT01691781|587374386|FG000|Overall Study|Physician Decision|1|||
162634445|NCT01691781|587374387|FG001|Overall Study|Physician Decision|1|||
162634446|NCT01691781|587374386|FG000|Overall Study|Protocol Violation|2|||
162634447|NCT01691781|587374387|FG001|Overall Study|Protocol Violation|2|||
162634448|NCT01691781|587374386|FG000|Overall Study|Adverse Event|0|||
162634449|NCT01691781|587374387|FG001|Overall Study|Adverse Event|1|||
162634450|NCT03978520|587374388|FG000|Overall Study|Adverse Event|2|||
162634451|NCT03978520|587374389|FG001|Overall Study|Adverse Event|5|||
162634452|NCT03978520|587374390|FG002|Overall Study|Adverse Event|3|||
162634453|NCT03978520|587374391|FG003|Overall Study|Adverse Event|5|||
162634454|NCT03978520|587374392|FG004|Overall Study|Adverse Event|6|||
162634455|NCT03978520|587374388|FG000|Overall Study|Withdrawal by Subject|10|||
162634456|NCT03978520|587374389|FG001|Overall Study|Withdrawal by Subject|4|||
162634457|NCT03978520|587374390|FG002|Overall Study|Withdrawal by Subject|5|||
162634458|NCT03978520|587374391|FG003|Overall Study|Withdrawal by Subject|6|||
162634459|NCT03978520|587374392|FG004|Overall Study|Withdrawal by Subject|5|||
162634460|NCT03978520|587374388|FG000|Overall Study|Lost to Follow-up|2|||
162634461|NCT03978520|587374389|FG001|Overall Study|Lost to Follow-up|2|||
162634462|NCT03978520|587374390|FG002|Overall Study|Lost to Follow-up|2|||
162634463|NCT03978520|587374391|FG003|Overall Study|Lost to Follow-up|0|||
162634464|NCT03978520|587374392|FG004|Overall Study|Lost to Follow-up|1|||
162634465|NCT03978520|587374388|FG000|Overall Study|COVID-19 infection|0|||
162634466|NCT03978520|587374389|FG001|Overall Study|COVID-19 infection|1|||
162634467|NCT03978520|587374390|FG002|Overall Study|COVID-19 infection|0|||
162634468|NCT03978520|587374391|FG003|Overall Study|COVID-19 infection|0|||
162634469|NCT03978520|587374392|FG004|Overall Study|COVID-19 infection|0|||
162634470|NCT03978520|587374388|FG000|Overall Study|Other, not specified|9|||
162634471|NCT03978520|587374389|FG001|Overall Study|Other, not specified|4|||
162634472|NCT03978520|587374390|FG002|Overall Study|Other, not specified|1|||
162634473|NCT03978520|587374391|FG003|Overall Study|Other, not specified|1|||
162634474|NCT03978520|587374392|FG004|Overall Study|Other, not specified|2|||
162634475|NCT03978520|587374388|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
162634476|NCT03978520|587374389|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
162634477|NCT03978520|587374390|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
162634478|NCT03978520|587374391|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
162634479|NCT03978520|587374392|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
162634480|NCT02760069|587374393|FG000|Overall Study|Withdrawal by Subject|0|||
162982549|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
162982550|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
162982551|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982552|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
162982553|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982554|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
162982555|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
162982556|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
162982557|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
162982558|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
162982559|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
162982560|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
162982561|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
162982562|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
162982563|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
162982564|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
162982565|NCT00700817|588638724|FG000|Week 0-26 (Main Period)|Unclassified|14|||
162982566|NCT00700817|588638725|FG001|Week 0-26 (Main Period)|Unclassified|4|||
162982567|NCT00700817|588638726|FG002|Week 0-26 (Main Period)|Unclassified|8|||
162982568|NCT00700817|588638727|FG003|Week 0-26 (Main Period)|Unclassified|0|||
162982569|NCT00700817|588638728|FG004|Week 0-26 (Main Period)|Unclassified|0|||
162982570|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
162982571|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
162982572|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
162982573|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
162982574|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
162982575|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
162982576|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
162982577|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
162982578|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
162982579|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
162982580|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
162982581|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
162982582|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
162982583|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
162982584|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
162982585|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
162982586|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
162982587|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
162982588|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
162982589|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
162982590|NCT00700817|588638724|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
162982591|NCT00700817|588638725|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
162982592|NCT00700817|588638726|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
162982593|NCT00700817|588638727|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
162634481|NCT02760069|587374394|FG001|Overall Study|Withdrawal by Subject|1|||
162634482|NCT02760069|587374395|FG002|Overall Study|Withdrawal by Subject|1|||
162634483|NCT00600483|587374398|FG000|Overall Study|Lost to Follow-up|26|||
162634484|NCT00600483|587374399|FG001|Overall Study|Lost to Follow-up|47|||
162634485|NCT00600483|587374398|FG000|Overall Study|Randomized but not treated|10|||
162634486|NCT00600483|587374399|FG001|Overall Study|Randomized but not treated|0|||
162634487|NCT03031678|587374405|FG000|Overall Study|Study closed prior to completion|1|||
162634488|NCT03694821|587374406|FG000|Overall Study|Study terminated|4|||
162634489|NCT03694821|587374407|FG001|Overall Study|Study terminated|8|||
162634490|NCT03694821|587374408|FG002|Overall Study|Study terminated|4|||
162634491|NCT05109442|587374413|FG000|Overall Study|Withdrawal by Subject|0|||
162634492|NCT05109442|587374414|FG001|Overall Study|Withdrawal by Subject|0|||
162634493|NCT05109442|587374415|FG002|Overall Study|Withdrawal by Subject|1|||
162634494|NCT05109442|587374416|FG003|Overall Study|Withdrawal by Subject|0|||
162634495|NCT05109442|587374417|FG004|Overall Study|Withdrawal by Subject|0|||
162634496|NCT05109442|587374418|FG005|Overall Study|Withdrawal by Subject|0|||
162634497|NCT05109442|587374413|FG000|Overall Study|Adverse Event|0|||
162634498|NCT05109442|587374414|FG001|Overall Study|Adverse Event|1|||
162634499|NCT05109442|587374415|FG002|Overall Study|Adverse Event|5|||
162634500|NCT05109442|587374416|FG003|Overall Study|Adverse Event|0|||
162982594|NCT00700817|588638728|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
162982595|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
162982596|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
162982597|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
162634501|NCT05109442|587374417|FG004|Overall Study|Adverse Event|0|||
162634502|NCT05109442|587374418|FG005|Overall Study|Adverse Event|2|||
162634503|NCT05109442|587374413|FG000|Overall Study|Death|0|||
162634504|NCT05109442|587374414|FG001|Overall Study|Death|0|||
162982598|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
162982599|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
162982600|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982601|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
162982602|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
162982603|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982604|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
162982605|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
162982606|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
162982607|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
162982608|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
162982609|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
162634505|NCT05109442|587374415|FG002|Overall Study|Death|4|||
162634506|NCT05109442|587374416|FG003|Overall Study|Death|0|||
162634507|NCT05109442|587374417|FG004|Overall Study|Death|0|||
162634508|NCT05109442|587374418|FG005|Overall Study|Death|1|||
162982610|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
162982611|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
162982612|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
162982613|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
162982614|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
162982615|NCT00700817|588638724|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
162982616|NCT00700817|588638725|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
162982617|NCT00700817|588638726|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
162982618|NCT00700817|588638727|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
162982619|NCT00700817|588638728|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
162982620|NCT00058214|588638729|FG000|Overall Study|Adverse Event|1|||
162982621|NCT01347866|588638730|FG000|Overall Study|Death|0|||
162982622|NCT01347866|588638731|FG001|Overall Study|Death|0|||
162982623|NCT01347866|588638732|FG002|Overall Study|Death|0|||
162982624|NCT01347866|588638733|FG003|Overall Study|Death|1|||
162982625|NCT01347866|588638734|FG004|Overall Study|Death|2|||
162982626|NCT01347866|588638735|FG005|Overall Study|Death|2|||
162982627|NCT01347866|588638736|FG006|Overall Study|Death|1|||
162982628|NCT01347866|588638737|FG007|Overall Study|Death|0|||
162982629|NCT01347866|588638738|FG008|Overall Study|Death|4|||
162982630|NCT01347866|588638739|FG009|Overall Study|Death|1|||
162982631|NCT01347866|588638740|FG010|Overall Study|Death|3|||
162982632|NCT01347866|588638741|FG011|Overall Study|Death|1|||
162982633|NCT01347866|588638742|FG012|Overall Study|Death|2|||
162982634|NCT01347866|588638743|FG013|Overall Study|Death|0|||
162982635|NCT01347866|588638744|FG014|Overall Study|Death|0|||
162982636|NCT01347866|588638745|FG015|Overall Study|Death|1|||
162982637|NCT01347866|588638746|FG016|Overall Study|Death|0|||
162982638|NCT01347866|588638730|FG000|Overall Study|Lost to Follow-up|0|||
162982639|NCT01347866|588638731|FG001|Overall Study|Lost to Follow-up|0|||
162982640|NCT01347866|588638732|FG002|Overall Study|Lost to Follow-up|0|||
162982641|NCT01347866|588638733|FG003|Overall Study|Lost to Follow-up|0|||
162982642|NCT01347866|588638734|FG004|Overall Study|Lost to Follow-up|0|||
162982643|NCT01347866|588638735|FG005|Overall Study|Lost to Follow-up|0|||
162982644|NCT01347866|588638736|FG006|Overall Study|Lost to Follow-up|0|||
162982645|NCT01347866|588638737|FG007|Overall Study|Lost to Follow-up|1|||
162982646|NCT01347866|588638738|FG008|Overall Study|Lost to Follow-up|1|||
162982647|NCT01347866|588638739|FG009|Overall Study|Lost to Follow-up|0|||
162982648|NCT01347866|588638740|FG010|Overall Study|Lost to Follow-up|0|||
162982649|NCT01347866|588638741|FG011|Overall Study|Lost to Follow-up|0|||
162982650|NCT01347866|588638742|FG012|Overall Study|Lost to Follow-up|0|||
162982651|NCT01347866|588638743|FG013|Overall Study|Lost to Follow-up|0|||
162982652|NCT01347866|588638744|FG014|Overall Study|Lost to Follow-up|0|||
162982653|NCT01347866|588638745|FG015|Overall Study|Lost to Follow-up|0|||
162982654|NCT01347866|588638746|FG016|Overall Study|Lost to Follow-up|0|||
162982655|NCT01347866|588638730|FG000|Overall Study|Other|3|||
162982656|NCT01347866|588638731|FG001|Overall Study|Other|1|||
162982657|NCT01347866|588638732|FG002|Overall Study|Other|1|||
162982658|NCT01347866|588638733|FG003|Overall Study|Other|4|||
162982659|NCT01347866|588638734|FG004|Overall Study|Other|5|||
162982660|NCT01347866|588638735|FG005|Overall Study|Other|0|||
162982661|NCT01347866|588638736|FG006|Overall Study|Other|5|||
162982662|NCT01347866|588638737|FG007|Overall Study|Other|3|||
162982663|NCT01347866|588638738|FG008|Overall Study|Other|22|||
162982664|NCT01347866|588638739|FG009|Overall Study|Other|5|||
162982665|NCT01347866|588638740|FG010|Overall Study|Other|0|||
162982666|NCT01347866|588638741|FG011|Overall Study|Other|3|||
162982667|NCT01347866|588638742|FG012|Overall Study|Other|4|||
162982668|NCT01347866|588638743|FG013|Overall Study|Other|4|||
162982669|NCT01347866|588638744|FG014|Overall Study|Other|2|||
162634509|NCT05109442|587374413|FG000|Overall Study|Physician Decision|1|||
162634510|NCT05109442|587374414|FG001|Overall Study|Physician Decision|0|||
162982670|NCT01347866|588638745|FG015|Overall Study|Other|3|||
162982671|NCT01347866|588638746|FG016|Overall Study|Other|0|||
163059550|NCT04108468|588926418|FG001|Overall Study|Missed study medication|1|||
163059551|NCT03260023|588926419|FG000|Overall Study|Adverse Event|0|||
162634511|NCT05109442|587374415|FG002|Overall Study|Physician Decision|1|||
162634512|NCT05109442|587374416|FG003|Overall Study|Physician Decision|0|||
163059552|NCT03260023|588926420|FG001|Overall Study|Adverse Event|0|||
163059553|NCT03260023|588926421|FG002|Overall Study|Adverse Event|4|||
163059554|NCT03260023|588926422|FG003|Overall Study|Adverse Event|4|||
163059555|NCT03260023|588926423|FG004|Overall Study|Adverse Event|4|||
162634513|NCT05109442|587374417|FG004|Overall Study|Physician Decision|0|||
162634514|NCT05109442|587374418|FG005|Overall Study|Physician Decision|2|||
162634515|NCT05109442|587374413|FG000|Overall Study|Other than listed|0|||
162982672|NCT01347866|588638730|FG000|Overall Study|Subject refused further follow-up|2|||
162982673|NCT01347866|588638731|FG001|Overall Study|Subject refused further follow-up|0|||
162982674|NCT01347866|588638732|FG002|Overall Study|Subject refused further follow-up|0|||
162982675|NCT01347866|588638733|FG003|Overall Study|Subject refused further follow-up|2|||
162982676|NCT01347866|588638734|FG004|Overall Study|Subject refused further follow-up|0|||
162982677|NCT01347866|588638735|FG005|Overall Study|Subject refused further follow-up|1|||
162982678|NCT01347866|588638736|FG006|Overall Study|Subject refused further follow-up|0|||
162982679|NCT01347866|588638737|FG007|Overall Study|Subject refused further follow-up|0|||
162982680|NCT01347866|588638738|FG008|Overall Study|Subject refused further follow-up|4|||
162982681|NCT01347866|588638739|FG009|Overall Study|Subject refused further follow-up|1|||
162982682|NCT01347866|588638740|FG010|Overall Study|Subject refused further follow-up|0|||
162982683|NCT01347866|588638741|FG011|Overall Study|Subject refused further follow-up|0|||
162982684|NCT01347866|588638742|FG012|Overall Study|Subject refused further follow-up|1|||
162982685|NCT01347866|588638743|FG013|Overall Study|Subject refused further follow-up|3|||
162982686|NCT01347866|588638744|FG014|Overall Study|Subject refused further follow-up|1|||
162982687|NCT01347866|588638745|FG015|Overall Study|Subject refused further follow-up|0|||
162982688|NCT01347866|588638746|FG016|Overall Study|Subject refused further follow-up|2|||
162982689|NCT00891839|588638747|FG000|Overall Study|Adverse Event|2|||
162982690|NCT00891839|588638747|FG000|Overall Study|Withdrawal by Subject|2|||
162982691|NCT00891839|588638747|FG000|Overall Study|Disease progression|3|||
162982692|NCT01673698|588638748|FG000|Overall Study|Lost to Follow-up|51|||
162982693|NCT01673698|588638749|FG001|Overall Study|Lost to Follow-up|13|||
162982694|NCT01583218|588638750|FG000|Overall Study|Withdrawal by Subject|43|||
162982695|NCT01583218|588638751|FG001|Overall Study|Withdrawal by Subject|29|||
162982696|NCT01583218|588638750|FG000|Overall Study|Death|206|||
162982697|NCT01583218|588638751|FG001|Overall Study|Death|211|||
162982698|NCT01583218|588638750|FG000|Overall Study|Lost to Follow-up|11|||
162982699|NCT01583218|588638751|FG001|Overall Study|Lost to Follow-up|17|||
162982700|NCT01583218|588638750|FG000|Overall Study|Adverse event or serious adverse event|3|||
162982701|NCT01583218|588638751|FG001|Overall Study|Adverse event or serious adverse event|3|||
162982702|NCT01583218|588638750|FG000|Overall Study|Patient /Family decision|3|||
162982703|NCT01583218|588638751|FG001|Overall Study|Patient /Family decision|0|||
162982704|NCT01583218|588638750|FG000|Overall Study|Cannot contact patient directly|1|||
162982705|NCT01583218|588638751|FG001|Overall Study|Cannot contact patient directly|2|||
162982706|NCT01583218|588638750|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
162982707|NCT01583218|588638751|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
162982708|NCT01583218|588638750|FG000|Overall Study|Patient did not wish to attend visits|0|||
162982709|NCT01583218|588638751|FG001|Overall Study|Patient did not wish to attend visits|1|||
162982710|NCT01583218|588638750|FG000|Overall Study|Patient randomized but not dosed|17|||
162982711|NCT01583218|588638751|FG001|Overall Study|Patient randomized but not dosed|16|||
162982712|NCT01583218|588638750|FG000|Overall Study|Patient was assessed via phone in person|1|||
162982713|NCT01583218|588638751|FG001|Overall Study|Patient was assessed via phone in person|0|||
162982714|NCT01583218|588638750|FG000|Overall Study|Patient deemed ineligible after random|2|||
162982715|NCT01583218|588638751|FG001|Overall Study|Patient deemed ineligible after random|0|||
162982716|NCT01583218|588638750|FG000|Overall Study|Patient was early terminated from study|0|||
162982717|NCT01583218|588638751|FG001|Overall Study|Patient was early terminated from study|1|||
163059556|NCT03260023|588926424|FG005|Overall Study|Adverse Event|1|||
163059557|NCT03260023|588926425|FG006|Overall Study|Adverse Event|2|||
163059558|NCT03260023|588926419|FG000|Overall Study|Clinical Progression|0|||
163059559|NCT03260023|588926420|FG001|Overall Study|Clinical Progression|1|||
162634516|NCT05109442|587374414|FG001|Overall Study|Other than listed|0|||
162634517|NCT05109442|587374415|FG002|Overall Study|Other than listed|9|||
162634518|NCT05109442|587374416|FG003|Overall Study|Other than listed|2|||
162634519|NCT05109442|587374417|FG004|Overall Study|Other than listed|0|||
162634520|NCT05109442|587374418|FG005|Overall Study|Other than listed|8|||
162634521|NCT05109442|587374413|FG000|Overall Study|Lack of Efficacy|3|||
162634522|NCT05109442|587374414|FG001|Overall Study|Lack of Efficacy|5|||
162634523|NCT05109442|587374415|FG002|Overall Study|Lack of Efficacy|29|||
162634524|NCT05109442|587374416|FG003|Overall Study|Lack of Efficacy|10|||
162634525|NCT05109442|587374417|FG004|Overall Study|Lack of Efficacy|11|||
162982718|NCT01583218|588638750|FG000|Overall Study|Patient was randomized due to mistake|1|||
162982719|NCT01583218|588638751|FG001|Overall Study|Patient was randomized due to mistake|0|||
162982720|NCT01583218|588638750|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
162982721|NCT01583218|588638751|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
162982722|NCT01583218|588638750|FG000|Overall Study|Withdraw of consent on day of random|1|||
162982723|NCT01583218|588638751|FG001|Overall Study|Withdraw of consent on day of random|0|||
162982724|NCT02674061|588638752|FG000|Overall Study|Death|229|||
162982725|NCT02674061|588638753|FG001|Overall Study|Death|77|||
162982726|NCT02674061|588638752|FG000|Overall Study|Lost to Follow-up|3|||
162982727|NCT02674061|588638753|FG001|Overall Study|Lost to Follow-up|3|||
162982728|NCT02674061|588638752|FG000|Overall Study|Withdrawal by Subject|9|||
162982729|NCT02674061|588638753|FG001|Overall Study|Withdrawal by Subject|1|||
162982730|NCT02674061|588638752|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
162982731|NCT02674061|588638753|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
162982732|NCT03334721|588638756|FG000|Overall Study|Withdrawal by Subject|1|||
162982733|NCT03334721|588638757|FG001|Overall Study|Withdrawal by Subject|0|||
162982734|NCT03334721|588638756|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
162982735|NCT03334721|588638757|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
162982736|NCT01232491|588638759|FG000|Overall Study|Adverse Event|13|||
162982737|NCT01232491|588638760|FG001|Overall Study|Adverse Event|8|||
162982738|NCT01232491|588638759|FG000|Overall Study|Lack of Efficacy|1|||
162982739|NCT01232491|588638760|FG001|Overall Study|Lack of Efficacy|5|||
162982740|NCT01232491|588638759|FG000|Overall Study|Protocol Violation|13|||
162982741|NCT01232491|588638760|FG001|Overall Study|Protocol Violation|11|||
162982742|NCT01232491|588638759|FG000|Overall Study|Withdrawal Criteria|12|||
162982743|NCT01232491|588638760|FG001|Overall Study|Withdrawal Criteria|21|||
162982744|NCT01232491|588638759|FG000|Overall Study|Other|21|||
162982745|NCT01232491|588638760|FG001|Overall Study|Other|18|||
162982746|NCT02932228|588638761|FG000|Overall Study|Death|8|||
162982747|NCT02932228|588638762|FG001|Overall Study|Death|23|||
162982748|NCT02932228|588638761|FG000|Overall Study|not eligible upon chart review|2|||
162982749|NCT02932228|588638762|FG001|Overall Study|not eligible upon chart review|5|||
162982750|NCT04062448|588640358|FG000|Overall Study|Lost to Follow-up|1|||
162982751|NCT04062448|588640358|FG000|Overall Study|Withdrawal by Subject|2|||
162982752|NCT03340064|588640362|FG000|First Period|Adverse Event, non-fatal|2|||
162982753|NCT03340064|588640363|FG001|First Period|Adverse Event, non-fatal|0|||
162982754|NCT03340064|588640362|FG000|First Period|Lack of Efficacy|3|||
162982755|NCT03340064|588640363|FG001|First Period|Lack of Efficacy|0|||
162982756|NCT03340064|588640362|FG000|Second Period|Adverse Event, non-fatal|1|||
162982757|NCT03340064|588640363|FG001|Second Period|Adverse Event, non-fatal|1|||
162982758|NCT03340064|588640362|FG000|Second Period|Lack of Efficacy|11|||
162982759|NCT03340064|588640363|FG001|Second Period|Lack of Efficacy|0|||
162982760|NCT03340064|588640362|FG000|Second Period|Physician Decision|3|||
162982761|NCT03340064|588640363|FG001|Second Period|Physician Decision|0|||
162982762|NCT03340064|588640362|FG000|Second Period|Withdrawal by Subject|2|||
162982763|NCT03340064|588640363|FG001|Second Period|Withdrawal by Subject|1|||
162982764|NCT03340064|588640362|FG000|Second Period|Approved Drug Available For Indication|1|||
162982765|NCT03340064|588640363|FG001|Second Period|Approved Drug Available For Indication|0|||
162982766|NCT03340064|588640362|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
162982767|NCT03340064|588640363|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
162982768|NCT00856973|588640364|FG000|Overall Study|Adverse Event|5|||
162982769|NCT00856973|588640365|FG001|Overall Study|Adverse Event|5|||
162982770|NCT00856973|588640366|FG002|Overall Study|Adverse Event|3|||
162982771|NCT00856973|588640364|FG000|Overall Study|Lost to Follow-up|6|||
162982772|NCT00856973|588640365|FG001|Overall Study|Lost to Follow-up|3|||
162982773|NCT00856973|588640366|FG002|Overall Study|Lost to Follow-up|5|||
162982774|NCT00856973|588640364|FG000|Overall Study|Physician Decision|0|||
162982775|NCT00856973|588640365|FG001|Overall Study|Physician Decision|3|||
162982776|NCT00856973|588640366|FG002|Overall Study|Physician Decision|1|||
162982777|NCT00856973|588640364|FG000|Overall Study|Protocol Violation|1|||
162982778|NCT00856973|588640365|FG001|Overall Study|Protocol Violation|2|||
162982779|NCT00856973|588640366|FG002|Overall Study|Protocol Violation|1|||
162982780|NCT00856973|588640364|FG000|Overall Study|Withdrawal by Subject|13|||
162982781|NCT00856973|588640365|FG001|Overall Study|Withdrawal by Subject|16|||
162982782|NCT00856973|588640366|FG002|Overall Study|Withdrawal by Subject|15|||
162982783|NCT00856973|588640364|FG000|Overall Study|Other|11|||
162982784|NCT00856973|588640365|FG001|Overall Study|Other|12|||
162982785|NCT00856973|588640366|FG002|Overall Study|Other|13|||
162982786|NCT02751359|588640371|FG000|Overall Study|Lost to Follow-up|1|||
162982787|NCT01196078|588640372|FG000|Overall Study|Withdrawal by Subject|3|||
162982788|NCT01196078|588640373|FG001|Overall Study|Withdrawal by Subject|5|||
162982789|NCT01196078|588640372|FG000|Overall Study|Adverse Event|4|||
162982790|NCT01196078|588640373|FG001|Overall Study|Adverse Event|4|||
162982791|NCT01196078|588640372|FG000|Overall Study|Protocol Violation|2|||
162982792|NCT01196078|588640373|FG001|Overall Study|Protocol Violation|1|||
162982793|NCT01196078|588640372|FG000|Overall Study|Lack of Efficacy|17|||
162982794|NCT01196078|588640373|FG001|Overall Study|Lack of Efficacy|23|||
162982795|NCT01196078|588640372|FG000|Overall Study|Lost to Follow-up|1|||
162982796|NCT01196078|588640373|FG001|Overall Study|Lost to Follow-up|0|||
162982797|NCT01196078|588640372|FG000|Overall Study|Death|6|||
162982798|NCT01196078|588640373|FG001|Overall Study|Death|4|||
162982799|NCT02667288|588640374|FG000|Overall Study|Protocol Violation|5|||
162982800|NCT02667288|588640374|FG000|Overall Study|Lost to Follow-up|3|||
162634526|NCT05109442|587374418|FG005|Overall Study|Lack of Efficacy|17|||
162634527|NCT03278613|587374424|FG000|Overall Study|Lost to Follow-up|3|||
162982801|NCT02667288|588640374|FG000|Overall Study|Withdrawal by Subject|5|||
162982802|NCT02400671|588640375|FG000|Overall Study|Death|5|||
162982803|NCT02400671|588640376|FG001|Overall Study|Death|3|||
162982804|NCT02400671|588640377|FG002|Overall Study|Death|4|||
162982805|NCT02400671|588640375|FG000|Overall Study|Lost to Follow-up|20|||
162982806|NCT02400671|588640376|FG001|Overall Study|Lost to Follow-up|27|||
162982807|NCT02400671|588640377|FG002|Overall Study|Lost to Follow-up|24|||
162982808|NCT02400671|588640375|FG000|Overall Study|Withdrawal by Subject|2|||
162982809|NCT02400671|588640376|FG001|Overall Study|Withdrawal by Subject|2|||
162982810|NCT02400671|588640377|FG002|Overall Study|Withdrawal by Subject|0|||
162982811|NCT04397445|588640380|FG000|Overall Study|Withdrawal by Subject|1|||
162982812|NCT04397445|588640381|FG001|Overall Study|Withdrawal by Subject|0|||
162982813|NCT04397445|588640382|FG002|Overall Study|Withdrawal by Subject|0|||
162982814|NCT04397445|588640383|FG003|Overall Study|Withdrawal by Subject|0|||
162982815|NCT03921151|588640384|FG000|Overall Study|Withdrawal by Subject|11|||
162634528|NCT03278613|587374425|FG001|Overall Study|Lost to Follow-up|1|||
162982816|NCT03921151|588640385|FG001|Overall Study|Withdrawal by Subject|16|||
162982817|NCT00857792|588640387|FG000|Overall Study|inadequate image quality for analysis|12|||
162982818|NCT03760250|588640388|FG000|Overall Study|Withdrawal by Subject|1|||
162982819|NCT03760250|588640388|FG000|Overall Study|Physician Decision|1|||
162982820|NCT03733210|588640390|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
162982821|NCT03733210|588640391|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
162982822|NCT00307034|588640392|FG000|Overall Study|Adverse Event|1|||
162982823|NCT00307034|588640393|FG001|Overall Study|Adverse Event|2|||
162982824|NCT00307034|588640392|FG000|Overall Study|Withdrawal by Subject|1|||
162982825|NCT00307034|588640393|FG001|Overall Study|Withdrawal by Subject|2|||
162982826|NCT00307034|588640392|FG000|Overall Study|Lost to Follow-up|0|||
162982827|NCT00307034|588640393|FG001|Overall Study|Lost to Follow-up|3|||
162982828|NCT02011113|588640402|FG000|Overall Study|Adverse Event|4|||
162982829|NCT02011113|588640402|FG000|Overall Study|Disease Progression (DP)|16|||
162982830|NCT02011113|588640402|FG000|Overall Study|Death|1|||
162982831|NCT02011113|588640402|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
163059560|NCT03260023|588926421|FG002|Overall Study|Clinical Progression|3|||
163059561|NCT03260023|588926422|FG003|Overall Study|Clinical Progression|1|||
162982832|NCT02011113|588640402|FG000|Overall Study|Investigator's judgement- DP|3|||
162982833|NCT02011113|588640402|FG000|Overall Study|Study terminated by sponsor|11|||
162982834|NCT04688931|588640405|FG000|Overall Study|Adverse Event|4|||
162982835|NCT04688931|588640406|FG001|Overall Study|Adverse Event|1|||
162982836|NCT04688931|588640405|FG000|Overall Study|Withdrawal by Subject|5|||
163059562|NCT03260023|588926423|FG004|Overall Study|Clinical Progression|0|||
163059563|NCT03260023|588926424|FG005|Overall Study|Clinical Progression|0|||
163059564|NCT03260023|588926425|FG006|Overall Study|Clinical Progression|0|||
162634529|NCT01405456|587374426|FG000|Overall Study|Lost to Follow-up|2|||
163059565|NCT03260023|588926419|FG000|Overall Study|Physician Decision|0|||
163059566|NCT03260023|588926420|FG001|Overall Study|Physician Decision|0|||
162634530|NCT01405456|587374427|FG001|Overall Study|Lost to Follow-up|1|||
162634531|NCT01405456|587374426|FG000|Overall Study|Physician Decision|1|||
162634532|NCT01405456|587374427|FG001|Overall Study|Physician Decision|0|||
162982837|NCT04688931|588640406|FG001|Overall Study|Withdrawal by Subject|16|||
162982838|NCT04688931|588640405|FG000|Overall Study|Physician Decision|3|||
162982839|NCT04688931|588640406|FG001|Overall Study|Physician Decision|5|||
162982840|NCT04688931|588640405|FG000|Overall Study|Noncompliance|0|||
162982841|NCT04688931|588640406|FG001|Overall Study|Noncompliance|1|||
162982842|NCT04688931|588640405|FG000|Overall Study|Lost to Follow-up|1|||
162982843|NCT04688931|588640406|FG001|Overall Study|Lost to Follow-up|3|||
162982844|NCT04688931|588640405|FG000|Overall Study|Randomization Error|3|||
162982845|NCT04688931|588640406|FG001|Overall Study|Randomization Error|0|||
162982846|NCT04688931|588640405|FG000|Overall Study|Not Eligible|1|||
162982847|NCT04688931|588640406|FG001|Overall Study|Not Eligible|3|||
162982848|NCT04688931|588640405|FG000|Overall Study|Disease Progression|0|||
162982849|NCT04688931|588640406|FG001|Overall Study|Disease Progression|2|||
162982850|NCT04688931|588640405|FG000|Overall Study|Sponsor Requirement|1|||
162982851|NCT04688931|588640406|FG001|Overall Study|Sponsor Requirement|1|||
162982852|NCT04688931|588640405|FG000|Overall Study|Other Reason|1|||
162982853|NCT04688931|588640406|FG001|Overall Study|Other Reason|2|||
162982854|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Adverse Event|9|||
162982855|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Adverse Event|4|||
162982856|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Adverse Event|5|||
162982857|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Adverse Event|9|||
162982858|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Adverse Event|8|||
162982859|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Adverse Event|0|||
162982860|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Adverse Event|0|||
162982861|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
162982862|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982863|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982864|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
162982865|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
162982866|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982867|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
162982868|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Death|1|||
162982869|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Death|1|||
162982870|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Death|1|||
162982871|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Death|1|||
162982872|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Death|0|||
162982873|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Death|0|||
162982874|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Death|0|||
162982875|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
162982876|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982877|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982878|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
162982879|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
162982880|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
162982881|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
162982882|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982883|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982884|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
162982885|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982886|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982887|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982888|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
162982889|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
162982890|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
162982891|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
162982892|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
162982893|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
162982894|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
162982895|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
162982896|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Other|2|||
162982897|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Other|9|||
162982898|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Other|9|||
162982899|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Other|3|||
162982900|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Other|2|||
162982901|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Other|0|||
162982902|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Other|0|||
162982903|NCT00361335|588640409|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
162982904|NCT00361335|588640410|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
162982905|NCT00361335|588640411|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
162982906|NCT00361335|588640412|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
162982907|NCT00361335|588640413|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
162982908|NCT00361335|588640414|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
162982909|NCT00361335|588640415|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
162982910|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
162634533|NCT05475236|587374429|FG000|Overall Study|Withdrawal by Subject|0|||
162634534|NCT05475236|587374430|FG001|Overall Study|Withdrawal by Subject|1|||
162634535|NCT02154490|587376509|FG000|Overall Study|No tissue submitted|23|||
162982911|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982912|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
162982913|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982914|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
162982915|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
162982916|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
162982917|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982918|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982919|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982920|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982921|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982922|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162982923|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
162982924|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Death|0|||
162982925|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Death|0|||
162982926|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Death|0|||
162982927|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Death|0|||
162982928|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Death|0|||
162982929|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Death|0|||
162982930|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Death|1|||
162982931|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982932|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982933|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982934|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
162982935|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982936|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162982937|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
162634536|NCT02154490|587376509|FG000|Overall Study|No biomarker results|167|||
162634537|NCT02154490|587376509|FG000|Overall Study|Not assigned to a sub-study|270|||
162634538|NCT02154490|587376509|FG000|Overall Study|Did not register to a sub-study|749|||
162634539|NCT02692716|587376511|FG000|Overall Study|Lost to Follow-up|2|||
162634540|NCT02692716|587376512|FG001|Overall Study|Lost to Follow-up|5|||
162634541|NCT02692716|587376511|FG000|Overall Study|Withdrawal by Subject|3|||
162634542|NCT02692716|587376512|FG001|Overall Study|Withdrawal by Subject|1|||
162634543|NCT02904512|587376522|FG000|Overall Study|Withdrawal by Subject|1|||
162714614|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162714615|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
162714616|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162714617|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162714618|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162714619|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162714620|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
162714621|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
162714622|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
162982938|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Other|1|||
162982939|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Other|0|||
162634544|NCT02904512|587376523|FG001|Overall Study|Withdrawal by Subject|0|||
162634545|NCT02904512|587376522|FG000|Overall Study|Transferred to ICU|1|||
162634546|NCT02904512|587376523|FG001|Overall Study|Transferred to ICU|0|||
162634547|NCT02904512|587376522|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
162634548|NCT02904512|587376523|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
162634549|NCT01963403|587376530|FG000|Overall Study|Lost to Follow-up|2|||
162634550|NCT01963403|587376531|FG001|Overall Study|Lost to Follow-up|3|||
162634551|NCT01963403|587376530|FG000|Overall Study|Implant removal|0|||
162714623|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162714624|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162714625|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162982940|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Other|0|||
162982941|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Other|1|||
162982942|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Other|0|||
162982943|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Other|1|||
162982944|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Other|2|||
162982945|NCT00361335|588640409|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162634552|NCT01963403|587376531|FG001|Overall Study|Implant removal|1|||
162982946|NCT00361335|588640410|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162634553|NCT02564042|587376532|FG000|Overall Study|Adverse Event|4|||
162634554|NCT02564042|587376533|FG001|Overall Study|Adverse Event|4|||
162634555|NCT02564042|587376534|FG002|Overall Study|Adverse Event|3|||
162634556|NCT02564042|587376535|FG003|Overall Study|Adverse Event|0|||
162982947|NCT00361335|588640411|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
162982948|NCT00361335|588640412|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982949|NCT00361335|588640413|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982950|NCT00361335|588640414|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
162982951|NCT00361335|588640415|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
162982952|NCT02034058|588640416|FG000|Overall Study|Death|3|||
162982953|NCT01765582|588640425|FG000|Overall Study|Other|3|||
162982954|NCT01765582|588640426|FG001|Overall Study|Other|6|||
162982955|NCT01765582|588640427|FG002|Overall Study|Other|9|||
162982956|NCT01765582|588640425|FG000|Overall Study|Lost to Follow-up|2|||
162982957|NCT01765582|588640426|FG001|Overall Study|Lost to Follow-up|2|||
162982958|NCT01765582|588640427|FG002|Overall Study|Lost to Follow-up|1|||
162982959|NCT01765582|588640425|FG000|Overall Study|Death|31|||
162982960|NCT01765582|588640426|FG001|Overall Study|Death|36|||
162982961|NCT01765582|588640427|FG002|Overall Study|Death|33|||
162982962|NCT01765582|588640425|FG000|Overall Study|Sponsor Decision|46|||
162982963|NCT01765582|588640426|FG001|Overall Study|Sponsor Decision|42|||
162982964|NCT01765582|588640427|FG002|Overall Study|Sponsor Decision|42|||
162982965|NCT01765582|588640425|FG000|Overall Study|Withdrawal of Consent|11|||
162982966|NCT01765582|588640426|FG001|Overall Study|Withdrawal of Consent|6|||
162982967|NCT01765582|588640427|FG002|Overall Study|Withdrawal of Consent|10|||
162982968|NCT03251963|588640430|FG000|Overall Study|inappropriate Xa level timing|6|||
162982969|NCT03251963|588640431|FG001|Overall Study|inappropriate Xa level timing|3|||
162982970|NCT03251963|588640430|FG000|Overall Study|no peak Xa level drawn|2|||
162982971|NCT03251963|588640431|FG001|Overall Study|no peak Xa level drawn|0|||
162982972|NCT03251963|588640430|FG000|Overall Study|bled prior to Xa level|1|||
162982973|NCT03251963|588640431|FG001|Overall Study|bled prior to Xa level|2|||
162982974|NCT00616941|588640432|FG000|Overall Study|Progressive Disease|1|||
162982975|NCT00616941|588640433|FG001|Overall Study|Progressive Disease|2|||
162982976|NCT00616941|588640434|FG002|Overall Study|Progressive Disease|1|||
162982977|NCT00616941|588640432|FG000|Overall Study|Adverse Event|0|||
162982978|NCT00616941|588640433|FG001|Overall Study|Adverse Event|1|||
162982979|NCT00616941|588640434|FG002|Overall Study|Adverse Event|1|||
162982980|NCT00616941|588640432|FG000|Overall Study|Subject Non-compliance|0|||
162982981|NCT00616941|588640433|FG001|Overall Study|Subject Non-compliance|0|||
162982982|NCT00616941|588640434|FG002|Overall Study|Subject Non-compliance|1|||
162982983|NCT00616941|588640432|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
162982984|NCT00616941|588640433|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
162982985|NCT00616941|588640434|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
162982986|NCT00616941|588640432|FG000|Overall Study|Vaccination Suspended|0|||
162982987|NCT00616941|588640433|FG001|Overall Study|Vaccination Suspended|0|||
162982988|NCT00616941|588640434|FG002|Overall Study|Vaccination Suspended|3|||
162982989|NCT00714493|588640445|FG000|Overall Study|Adverse Event|11|||
162982990|NCT00714493|588640445|FG000|Overall Study|Death|3|||
162982991|NCT00714493|588640445|FG000|Overall Study|Lack of Efficacy|10|||
162982992|NCT00714493|588640445|FG000|Overall Study|Lost to Follow-up|3|||
162982993|NCT00714493|588640445|FG000|Overall Study|Protocol Violation|12|||
162982994|NCT00714493|588640445|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
162982995|NCT00714493|588640445|FG000|Overall Study|OTHER|2|||
162982996|NCT00076804|588640446|FG000|Overall Study|Death|9|||
162982997|NCT00076804|588640447|FG001|Overall Study|Death|20|||
162982998|NCT00076804|588640446|FG000|Overall Study|Lost to Follow-up|9|||
162982999|NCT00076804|588640447|FG001|Overall Study|Lost to Follow-up|9|||
162983000|NCT00076804|588640446|FG000|Overall Study|Withdrawal by Subject|10|||
162983001|NCT00076804|588640447|FG001|Overall Study|Withdrawal by Subject|8|||
162983002|NCT00076804|588640446|FG000|Overall Study|Early study Closure|32|||
162983003|NCT00076804|588640447|FG001|Overall Study|Early study Closure|32|||
162983004|NCT00354341|588640448|FG000|Overall Study|Adverse Event|1|||
162983005|NCT00354341|588640449|FG001|Overall Study|Adverse Event|0|||
163059567|NCT03260023|588926421|FG002|Overall Study|Physician Decision|0|||
163059568|NCT03260023|588926422|FG003|Overall Study|Physician Decision|1|||
162983006|NCT00354341|588640448|FG000|Overall Study|Death|0|||
162983007|NCT00354341|588640449|FG001|Overall Study|Death|2|||
162983008|NCT00354341|588640448|FG000|Overall Study|Refused treatment|1|||
162983009|NCT00354341|588640449|FG001|Overall Study|Refused treatment|2|||
162983010|NCT00354341|588640448|FG000|Overall Study|Failure to return|0|||
163059569|NCT03260023|588926423|FG004|Overall Study|Physician Decision|1|||
162634557|NCT02564042|587376536|FG004|Overall Study|Adverse Event|0|||
162983011|NCT00354341|588640449|FG001|Overall Study|Failure to return|1|||
162983012|NCT00354341|588640448|FG000|Overall Study|Other|1|||
162983013|NCT00354341|588640449|FG001|Overall Study|Other|2|||
162983014|NCT00251719|588640450|FG000|Overall Study|Adverse Event|14|||
162983015|NCT00251719|588640451|FG001|Overall Study|Adverse Event|8|||
162983016|NCT00251719|588640452|FG002|Overall Study|Adverse Event|7|||
162983017|NCT00251719|588640450|FG000|Overall Study|Protocol Violation|1|||
162634558|NCT02564042|587376537|FG005|Overall Study|Adverse Event|1|||
162983018|NCT00251719|588640451|FG001|Overall Study|Protocol Violation|1|||
163059570|NCT03260023|588926424|FG005|Overall Study|Physician Decision|0|||
162983019|NCT00251719|588640452|FG002|Overall Study|Protocol Violation|1|||
162983020|NCT00251719|588640450|FG000|Overall Study|Lost to Follow-up|5|||
162983021|NCT00251719|588640451|FG001|Overall Study|Lost to Follow-up|11|||
162983022|NCT00251719|588640452|FG002|Overall Study|Lost to Follow-up|8|||
162983023|NCT00251719|588640450|FG000|Overall Study|Withdrawal by Subject|14|||
162983024|NCT00251719|588640451|FG001|Overall Study|Withdrawal by Subject|12|||
162983025|NCT00251719|588640452|FG002|Overall Study|Withdrawal by Subject|11|||
163059571|NCT03260023|588926425|FG006|Overall Study|Physician Decision|0|||
162634559|NCT02564042|587376532|FG000|Overall Study|Lost to Follow-up|1|||
162634560|NCT02564042|587376533|FG001|Overall Study|Lost to Follow-up|1|||
162634561|NCT02564042|587376534|FG002|Overall Study|Lost to Follow-up|1|||
162634562|NCT02564042|587376535|FG003|Overall Study|Lost to Follow-up|0|||
162634563|NCT02564042|587376536|FG004|Overall Study|Lost to Follow-up|1|||
162634564|NCT02564042|587376537|FG005|Overall Study|Lost to Follow-up|1|||
162634565|NCT02564042|587376532|FG000|Overall Study|Physician Decision|1|||
162634566|NCT02564042|587376533|FG001|Overall Study|Physician Decision|0|||
162983026|NCT00251719|588640450|FG000|Overall Study|Lack of Efficacy|2|||
162983027|NCT00251719|588640451|FG001|Overall Study|Lack of Efficacy|1|||
162983028|NCT00251719|588640452|FG002|Overall Study|Lack of Efficacy|0|||
162983029|NCT00251719|588640450|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
162983030|NCT00251719|588640451|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
162983031|NCT00251719|588640452|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
162983032|NCT00251719|588640450|FG000|Overall Study|Investigator decision|1|||
162983033|NCT00251719|588640451|FG001|Overall Study|Investigator decision|1|||
162983034|NCT00251719|588640452|FG002|Overall Study|Investigator decision|0|||
162983035|NCT00251719|588640450|FG000|Overall Study|Noncompliance|2|||
162983036|NCT00251719|588640451|FG001|Overall Study|Noncompliance|3|||
162983037|NCT00251719|588640452|FG002|Overall Study|Noncompliance|1|||
162983038|NCT00251719|588640450|FG000|Overall Study|Barrett's esophagus|2|||
162983039|NCT00251719|588640451|FG001|Overall Study|Barrett's esophagus|2|||
162983040|NCT00251719|588640452|FG002|Overall Study|Barrett's esophagus|0|||
162983041|NCT01449279|588640453|FG000|Overall Study|Lack of Efficacy|5|||
162983042|NCT01449279|588640453|FG000|Overall Study|Toxicity|2|||
162983043|NCT01732874|588640455|FG000|Overall Study|Withdrawal by Subject|5|||
162983044|NCT01732874|588640456|FG001|Overall Study|Withdrawal by Subject|1|||
162983045|NCT01732874|588640455|FG000|Overall Study|Death of Infant|3|||
162983046|NCT01732874|588640456|FG001|Overall Study|Death of Infant|2|||
162983047|NCT03709823|588640457|FG000|Overall Study|Adverse Event|0|||
162983048|NCT03709823|588640458|FG001|Overall Study|Adverse Event|0|||
162983049|NCT03709823|588640459|FG002|Overall Study|Adverse Event|1|||
162983050|NCT03709823|588640460|FG003|Overall Study|Adverse Event|0|||
162983051|NCT03709823|588640461|FG004|Overall Study|Adverse Event|0|||
162983052|NCT03709823|588640462|FG005|Overall Study|Adverse Event|0|||
162983053|NCT03709823|588640457|FG000|Overall Study|Lost to Follow-up|2|||
162983054|NCT03709823|588640458|FG001|Overall Study|Lost to Follow-up|2|||
162983055|NCT03709823|588640459|FG002|Overall Study|Lost to Follow-up|2|||
162983056|NCT03709823|588640460|FG003|Overall Study|Lost to Follow-up|1|||
162983057|NCT03709823|588640461|FG004|Overall Study|Lost to Follow-up|1|||
162983058|NCT03709823|588640462|FG005|Overall Study|Lost to Follow-up|0|||
162983059|NCT03709823|588640457|FG000|Overall Study|Withdrawal by Subject|1|||
162983060|NCT03709823|588640458|FG001|Overall Study|Withdrawal by Subject|3|||
162983061|NCT03709823|588640459|FG002|Overall Study|Withdrawal by Subject|0|||
162983062|NCT03709823|588640460|FG003|Overall Study|Withdrawal by Subject|0|||
162983063|NCT03709823|588640461|FG004|Overall Study|Withdrawal by Subject|0|||
162983064|NCT03709823|588640462|FG005|Overall Study|Withdrawal by Subject|0|||
162983065|NCT03709823|588640457|FG000|Overall Study|Other, Not Specified|0|||
162983066|NCT03709823|588640458|FG001|Overall Study|Other, Not Specified|0|||
162983067|NCT03709823|588640459|FG002|Overall Study|Other, Not Specified|0|||
162983068|NCT03709823|588640460|FG003|Overall Study|Other, Not Specified|1|||
162983069|NCT03709823|588640461|FG004|Overall Study|Other, Not Specified|0|||
162983070|NCT03709823|588640462|FG005|Overall Study|Other, Not Specified|0|||
162983071|NCT00688376|588640465|FG000|Double-Blind Phase|Adverse Event|4|||
162983072|NCT00688376|588640466|FG001|Double-Blind Phase|Adverse Event|4|||
162983073|NCT00688376|588640465|FG000|Double-Blind Phase|Protocol Violation|1|||
162983074|NCT00688376|588640466|FG001|Double-Blind Phase|Protocol Violation|2|||
162983075|NCT00688376|588640465|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
162983076|NCT00688376|588640466|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
162983077|NCT00688376|588640465|FG000|Double-Blind Phase|Not treated|0|||
162983078|NCT00688376|588640466|FG001|Double-Blind Phase|Not treated|1|||
162634567|NCT02564042|587376534|FG002|Overall Study|Physician Decision|0|||
162634568|NCT02564042|587376535|FG003|Overall Study|Physician Decision|1|||
162634569|NCT02564042|587376536|FG004|Overall Study|Physician Decision|0|||
162634570|NCT02564042|587376537|FG005|Overall Study|Physician Decision|0|||
162634571|NCT02564042|587376532|FG000|Overall Study|Withdrawal by Subject|5|||
162634572|NCT02564042|587376533|FG001|Overall Study|Withdrawal by Subject|3|||
162634573|NCT02564042|587376534|FG002|Overall Study|Withdrawal by Subject|2|||
162634574|NCT02564042|587376535|FG003|Overall Study|Withdrawal by Subject|2|||
162634575|NCT02564042|587376536|FG004|Overall Study|Withdrawal by Subject|10|||
162634576|NCT02564042|587376537|FG005|Overall Study|Withdrawal by Subject|12|||
162634577|NCT01356966|587376538|FG000|Overall Study|Withdrawal by Subject|1|||
162634578|NCT01356966|587376539|FG001|Overall Study|Withdrawal by Subject|2|||
162634579|NCT01356966|587376538|FG000|Overall Study|Physician Decision|1|||
162634580|NCT01356966|587376539|FG001|Overall Study|Physician Decision|0|||
162634581|NCT02692703|587376542|FG000|Overall Study|Lost to Follow-up|1|||
162634582|NCT02692703|587376542|FG000|Overall Study|Other|1|||
162634583|NCT01979016|587376547|FG000|Overall Study|Withdrawal by Subject|2|||
162634584|NCT01979016|587376548|FG001|Overall Study|Withdrawal by Subject|0|||
162634585|NCT01979016|587376547|FG000|Overall Study|Adverse Event|0|||
162634586|NCT01979016|587376548|FG001|Overall Study|Adverse Event|1|||
162634587|NCT00938639|587376549|FG000|Overall Study|Moved away from study area|0|||
162634588|NCT00938639|587376550|FG001|Overall Study|Moved away from study area|1|||
162634589|NCT00938639|587376549|FG000|Overall Study|Lost to Follow-up|1|||
162634590|NCT00938639|587376550|FG001|Overall Study|Lost to Follow-up|2|||
162634591|NCT00938639|587376549|FG000|Overall Study|Family issues|1|||
162634592|NCT00938639|587376550|FG001|Overall Study|Family issues|1|||
162634593|NCT00938639|587376549|FG000|Overall Study|Participant noncompliance|1|||
162634594|NCT00938639|587376550|FG001|Overall Study|Participant noncompliance|0|||
162634595|NCT02706691|587376553|FG000|Overall Study|Adverse Event|1|||
162634596|NCT00171730|587376559|FG000|Overall Study|Adverse Event|3|||
162634597|NCT00171730|587376559|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162634598|NCT00171730|587376559|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
162634599|NCT00171730|587376559|FG000|Overall Study|Withdrawal by Subject|3|||
162634600|NCT01985867|587376560|FG000|Overall Study|Lost to Follow-up|3|||
162634601|NCT01985867|587376561|FG001|Overall Study|Lost to Follow-up|4|||
162634602|NCT01985867|587376560|FG000|Overall Study|Adverse Event|3|||
162634603|NCT01985867|587376561|FG001|Overall Study|Adverse Event|2|||
162634604|NCT01985867|587376560|FG000|Overall Study|Lack of Efficacy|1|||
162634605|NCT01985867|587376561|FG001|Overall Study|Lack of Efficacy|0|||
162634606|NCT01829191|587376562|FG000|Overall Study|Relocation|0|||
162634607|NCT01829191|587376563|FG001|Overall Study|Relocation|1|||
162634608|NCT01829191|587376562|FG000|Overall Study|Lens discomfort|0|||
162634609|NCT01829191|587376563|FG001|Overall Study|Lens discomfort|3|||
162634610|NCT01829191|587376562|FG000|Overall Study|Lens handling difficulty|1|||
162983079|NCT00688376|588640465|FG000|Blinded Extension Phase|Adverse Event|3|||
162983080|NCT00688376|588640466|FG001|Blinded Extension Phase|Adverse Event|4|||
162983081|NCT00688376|588640465|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
162983082|NCT00688376|588640466|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
162983083|NCT00688376|588640465|FG000|Blinded Extension Phase|Physician Decision|1|||
162983084|NCT00688376|588640466|FG001|Blinded Extension Phase|Physician Decision|0|||
162983085|NCT00688376|588640465|FG000|Blinded Extension Phase|Other|1|||
162983086|NCT00688376|588640466|FG001|Blinded Extension Phase|Other|0|||
162983087|NCT00557076|588640467|FG000|Overall Study|Unblinding|0|||
162983088|NCT00557076|588640468|FG001|Overall Study|Unblinding|1|||
162983089|NCT00846521|588640469|FG000|Overall Study|Withdrawal by Subject|5|||
162983090|NCT00846521|588640469|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
162983091|NCT00846521|588640469|FG000|Overall Study|Protocol Violation|1|||
162983092|NCT02792959|588640471|FG000|Overall Study|Protocol Violation|1|||
162983093|NCT03201250|588640472|FG000|Overall Study|screen failures|3|||
162634611|NCT01829191|587376563|FG001|Overall Study|Lens handling difficulty|4|||
162634612|NCT01829191|587376562|FG000|Overall Study|Protocol Violation|4|||
162634613|NCT01829191|587376563|FG001|Overall Study|Protocol Violation|1|||
162634614|NCT01829191|587376562|FG000|Overall Study|Withdrawal by Subject|2|||
162634615|NCT01829191|587376563|FG001|Overall Study|Withdrawal by Subject|3|||
162634616|NCT01829191|587376562|FG000|Overall Study|Lost to Follow-up|0|||
162634617|NCT01829191|587376563|FG001|Overall Study|Lost to Follow-up|1|||
162634618|NCT01829191|587376562|FG000|Overall Study|Subject was fit for ortho - k|0|||
162634619|NCT01829191|587376563|FG001|Overall Study|Subject was fit for ortho - k|1|||
162634620|NCT01276353|587376566|FG000|Double-blind|Adverse Event|2|||
162634621|NCT01276353|587376567|FG001|Double-blind|Adverse Event|0|||
162634622|NCT01276353|587376566|FG000|Double-blind|Withdrawal by Subject|1|||
162983094|NCT03201250|588640473|FG001|Overall Study|screen failures|0|||
162983095|NCT03201250|588640474|FG002|Overall Study|screen failures|0|||
162983096|NCT02575911|588640477|FG000|Overall Study|Lost to Follow-up|1|||
162634623|NCT01276353|587376567|FG001|Double-blind|Withdrawal by Subject|0|||
162634624|NCT01276353|587376566|FG000|Extension|Adverse Event|2|||
162634625|NCT01276353|587376567|FG001|Extension|Adverse Event|5|||
162634626|NCT01276353|587376566|FG000|Extension|Withdrawal by Subject|1|||
163059572|NCT03260023|588926419|FG000|Overall Study|Withdrawal by Subject|0|||
163059573|NCT03260023|588926420|FG001|Overall Study|Withdrawal by Subject|0|||
163059574|NCT03260023|588926421|FG002|Overall Study|Withdrawal by Subject|0|||
163059575|NCT03260023|588926422|FG003|Overall Study|Withdrawal by Subject|0|||
163059576|NCT03260023|588926423|FG004|Overall Study|Withdrawal by Subject|3|||
163059577|NCT03260023|588926424|FG005|Overall Study|Withdrawal by Subject|0|||
163059578|NCT03260023|588926425|FG006|Overall Study|Withdrawal by Subject|0|||
163059579|NCT03260023|588926419|FG000|Overall Study|Under trial intervention|0|||
163059580|NCT03260023|588926420|FG001|Overall Study|Under trial intervention|0|||
163059581|NCT03260023|588926421|FG002|Overall Study|Under trial intervention|2|||
163059582|NCT03260023|588926422|FG003|Overall Study|Under trial intervention|5|||
163059583|NCT03260023|588926423|FG004|Overall Study|Under trial intervention|3|||
163059584|NCT03260023|588926424|FG005|Overall Study|Under trial intervention|0|||
163059585|NCT03260023|588926425|FG006|Overall Study|Under trial intervention|0|||
163059586|NCT05035407|588926428|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
163059587|NCT05035407|588926429|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059588|NCT05035407|588926430|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059589|NCT05035407|588926431|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059590|NCT05035407|588926432|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059591|NCT05035407|588926433|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
163059592|NCT04220021|588926434|FG000|Overall Study|Withdrawal by Subject|11|||
163059593|NCT04220021|588926434|FG000|Overall Study|Physician Decision|2|||
163059594|NCT04220021|588926434|FG000|Overall Study|Non-study related illness|5|||
163059595|NCT06121609|588926436|FG000|Overall Study|Lack of Efficacy|0|||
163059596|NCT06121609|588926437|FG001|Overall Study|Lack of Efficacy|0|||
163059597|NCT06121609|588926438|FG002|Overall Study|Lack of Efficacy|45|||
163059598|NCT00848497|588926439|FG000|Overall Study|Screen failure|2|||
163059599|NCT00848497|588926440|FG001|Overall Study|Screen failure|0|||
163059600|NCT00848497|588926439|FG000|Overall Study|Withdrawal by Subject|0|||
163059601|NCT00848497|588926440|FG001|Overall Study|Withdrawal by Subject|1|||
163059602|NCT04935879|588926441|FG000|Overall Study|Adverse Event|2|||
163059603|NCT04935879|588926442|FG001|Overall Study|Adverse Event|1|||
163059604|NCT04935879|588926441|FG000|Overall Study|Lost to Follow-up|1|||
162983097|NCT02335983|588640478|FG000|Overall Study|Sponsor Decision|0|||
162983098|NCT02335983|588640479|FG001|Overall Study|Sponsor Decision|0|||
162983099|NCT02335983|588640480|FG002|Overall Study|Sponsor Decision|1|||
162983100|NCT02335983|588640481|FG003|Overall Study|Sponsor Decision|1|||
162983101|NCT02335983|588640482|FG004|Overall Study|Sponsor Decision|0|||
162983102|NCT02335983|588640483|FG005|Overall Study|Sponsor Decision|1|||
162983103|NCT02335983|588640478|FG000|Overall Study|Withdrawal by Subject|3|||
162983104|NCT02335983|588640479|FG001|Overall Study|Withdrawal by Subject|2|||
162983105|NCT02335983|588640480|FG002|Overall Study|Withdrawal by Subject|2|||
162983106|NCT02335983|588640481|FG003|Overall Study|Withdrawal by Subject|1|||
162983107|NCT02335983|588640482|FG004|Overall Study|Withdrawal by Subject|3|||
162983108|NCT02335983|588640483|FG005|Overall Study|Withdrawal by Subject|9|||
162983109|NCT02335983|588640478|FG000|Overall Study|Death|0|||
162983110|NCT02335983|588640479|FG001|Overall Study|Death|0|||
162983111|NCT02335983|588640480|FG002|Overall Study|Death|2|||
162983112|NCT02335983|588640481|FG003|Overall Study|Death|0|||
162983113|NCT02335983|588640482|FG004|Overall Study|Death|0|||
162983114|NCT02335983|588640483|FG005|Overall Study|Death|0|||
162983115|NCT02335983|588640478|FG000|Overall Study|Lost to Follow-up|0|||
162983116|NCT02335983|588640479|FG001|Overall Study|Lost to Follow-up|0|||
162983117|NCT02335983|588640480|FG002|Overall Study|Lost to Follow-up|0|||
162983118|NCT02335983|588640481|FG003|Overall Study|Lost to Follow-up|0|||
162983119|NCT02335983|588640482|FG004|Overall Study|Lost to Follow-up|0|||
162983120|NCT02335983|588640483|FG005|Overall Study|Lost to Follow-up|1|||
162983121|NCT02335983|588640478|FG000|Overall Study|Protocol Specified Criteria|5|||
162983122|NCT02335983|588640479|FG001|Overall Study|Protocol Specified Criteria|7|||
162983123|NCT02335983|588640480|FG002|Overall Study|Protocol Specified Criteria|27|||
162983124|NCT02335983|588640481|FG003|Overall Study|Protocol Specified Criteria|7|||
162983125|NCT02335983|588640482|FG004|Overall Study|Protocol Specified Criteria|5|||
162983126|NCT02335983|588640483|FG005|Overall Study|Protocol Specified Criteria|21|||
163059605|NCT04935879|588926442|FG001|Overall Study|Lost to Follow-up|1|||
162983127|NCT00629265|588640488|FG000|Overall Study|Lost to Follow-up|4|||
163059606|NCT04935879|588926441|FG000|Overall Study|Pregnancy|2|||
163059607|NCT04935879|588926442|FG001|Overall Study|Pregnancy|3|||
163059608|NCT04935879|588926441|FG000|Overall Study|Withdrawal by Subject|8|||
162983128|NCT00629265|588640489|FG001|Overall Study|Lost to Follow-up|5|||
162983129|NCT00629265|588640488|FG000|Overall Study|Withdrawal by Subject|11|||
162983130|NCT00629265|588640489|FG001|Overall Study|Withdrawal by Subject|8|||
162983131|NCT00629265|588640488|FG000|Overall Study|Death|1|||
162983132|NCT00629265|588640489|FG001|Overall Study|Death|0|||
162983133|NCT00629265|588640488|FG000|Overall Study|Adverse Event|2|||
162983134|NCT00629265|588640489|FG001|Overall Study|Adverse Event|0|||
162983135|NCT00629265|588640488|FG000|Overall Study|HNC Recurrence|4|||
162983136|NCT00629265|588640489|FG001|Overall Study|HNC Recurrence|0|||
162983137|NCT00629265|588640488|FG000|Overall Study|Other CA Requiring Treatment|1|||
162983138|NCT00629265|588640489|FG001|Overall Study|Other CA Requiring Treatment|3|||
162983139|NCT00629265|588640488|FG000|Overall Study|Needed Esophageal Dilation|4|||
162983140|NCT00629265|588640489|FG001|Overall Study|Needed Esophageal Dilation|1|||
162983141|NCT00629265|588640488|FG000|Overall Study|Unrelated Medical Complications|3|||
162983142|NCT00629265|588640489|FG001|Overall Study|Unrelated Medical Complications|1|||
162983143|NCT00629265|588640488|FG000|Overall Study|Unknown Reason|2|||
162983144|NCT00629265|588640489|FG001|Overall Study|Unknown Reason|2|||
162983145|NCT04465630|588640490|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
162983146|NCT04465630|588640490|FG000|Overall Study|Screen failure|8|||
162983147|NCT04465630|588640490|FG000|Overall Study|Baseline failure|16|||
162983148|NCT01732484|588640494|FG000|Overall Study|Death|7|||
162983149|NCT01732484|588640494|FG000|Overall Study|Lost to Follow-up|14|||
162983150|NCT01732484|588640494|FG000|Overall Study|chronical illness|5|||
162983151|NCT00289874|588640495|FG000|Overall Study|Adverse Event|1|||
162983152|NCT00289874|588640496|FG001|Overall Study|Adverse Event|5|||
162983153|NCT00289874|588640495|FG000|Overall Study|Lost to Follow-up|1|||
162983154|NCT00289874|588640496|FG001|Overall Study|Lost to Follow-up|1|||
162983155|NCT00289874|588640495|FG000|Overall Study|Protocol Violation|3|||
162983156|NCT00289874|588640496|FG001|Overall Study|Protocol Violation|2|||
162983157|NCT00289874|588640495|FG000|Overall Study|Did not meet eligibility|1|||
162983158|NCT00289874|588640496|FG001|Overall Study|Did not meet eligibility|0|||
162983159|NCT01087489|588640497|FG000|Overall Study|enrolled in another VA study|0|||
162983160|NCT01087489|588640498|FG001|Overall Study|enrolled in another VA study|1|||
162983161|NCT01087489|588640497|FG000|Overall Study|Death|0|||
162983162|NCT01087489|588640498|FG001|Overall Study|Death|1|||
162983163|NCT01087489|588640497|FG000|Overall Study|unable to survey by telephone|0|||
162983164|NCT01087489|588640498|FG001|Overall Study|unable to survey by telephone|1|||
162983165|NCT05070546|588640506|FG000|Overall Study|Death|0|||
162983166|NCT05070546|588640507|FG001|Overall Study|Death|0|||
162983167|NCT05070546|588640508|FG002|Overall Study|Death|0|||
162983168|NCT05070546|588640509|FG003|Overall Study|Death|0|||
162983169|NCT05070546|588640510|FG004|Overall Study|Death|0|||
162983170|NCT05070546|588640511|FG005|Overall Study|Death|1|||
162983171|NCT05070546|588640506|FG000|Overall Study|Lost to Follow-up|8|||
162983172|NCT05070546|588640507|FG001|Overall Study|Lost to Follow-up|2|||
162983173|NCT05070546|588640508|FG002|Overall Study|Lost to Follow-up|7|||
162983174|NCT05070546|588640509|FG003|Overall Study|Lost to Follow-up|1|||
162983175|NCT05070546|588640510|FG004|Overall Study|Lost to Follow-up|2|||
162983176|NCT05070546|588640511|FG005|Overall Study|Lost to Follow-up|0|||
162983177|NCT05070546|588640506|FG000|Overall Study|Withdrawal by Subject|1|||
162983178|NCT05070546|588640507|FG001|Overall Study|Withdrawal by Subject|1|||
162983179|NCT05070546|588640508|FG002|Overall Study|Withdrawal by Subject|3|||
162983180|NCT05070546|588640509|FG003|Overall Study|Withdrawal by Subject|0|||
162983181|NCT05070546|588640510|FG004|Overall Study|Withdrawal by Subject|0|||
162983182|NCT05070546|588640511|FG005|Overall Study|Withdrawal by Subject|0|||
162983183|NCT05070546|588640506|FG000|Overall Study|Other|0|||
162983184|NCT05070546|588640507|FG001|Overall Study|Other|0|||
162983185|NCT05070546|588640508|FG002|Overall Study|Other|0|||
162983186|NCT05070546|588640509|FG003|Overall Study|Other|0|||
162983187|NCT05070546|588640510|FG004|Overall Study|Other|3|||
162983188|NCT05070546|588640511|FG005|Overall Study|Other|0|||
162983189|NCT05070546|588640506|FG000|Overall Study|Randomized but not vaccinated|1|||
162983190|NCT05070546|588640507|FG001|Overall Study|Randomized but not vaccinated|0|||
162983191|NCT05070546|588640508|FG002|Overall Study|Randomized but not vaccinated|1|||
162983192|NCT05070546|588640509|FG003|Overall Study|Randomized but not vaccinated|1|||
162983193|NCT05070546|588640510|FG004|Overall Study|Randomized but not vaccinated|3|||
162983194|NCT05070546|588640511|FG005|Overall Study|Randomized but not vaccinated|0|||
162983195|NCT02643355|588640512|FG000|Overall Study|Withdrawal by Subject|1|||
162983196|NCT02643355|588640513|FG001|Overall Study|Withdrawal by Subject|3|||
162983197|NCT02643355|588640512|FG000|Overall Study|Protocol Violation|0|||
162983198|NCT02643355|588640513|FG001|Overall Study|Protocol Violation|2|||
162983199|NCT01615263|588640525|FG000|Overall Study|Post-randomization exclusion|0|||
162983200|NCT01615263|588640526|FG001|Overall Study|Post-randomization exclusion|2|||
162983201|NCT00988065|588640531|FG000|Overall Study|Adverse Event|4|||
162983202|NCT00988065|588640532|FG001|Overall Study|Adverse Event|10|||
162983203|NCT00988065|588640533|FG002|Overall Study|Adverse Event|2|||
162983204|NCT00988065|588640531|FG000|Overall Study|Lost to Follow-up|1|||
162983205|NCT00988065|588640532|FG001|Overall Study|Lost to Follow-up|2|||
162983206|NCT00988065|588640533|FG002|Overall Study|Lost to Follow-up|2|||
162983207|NCT00988065|588640531|FG000|Overall Study|Subject withdrew consent|3|||
162983208|NCT00988065|588640532|FG001|Overall Study|Subject withdrew consent|5|||
162983209|NCT00988065|588640533|FG002|Overall Study|Subject withdrew consent|2|||
162983210|NCT00988065|588640531|FG000|Overall Study|Noncompliance with protocol|5|||
162983211|NCT00988065|588640532|FG001|Overall Study|Noncompliance with protocol|6|||
162983212|NCT00988065|588640533|FG002|Overall Study|Noncompliance with protocol|9|||
163059609|NCT04935879|588926442|FG001|Overall Study|Withdrawal by Subject|6|||
163059610|NCT04935879|588926441|FG000|Overall Study|Other|3|||
163059611|NCT04935879|588926442|FG001|Overall Study|Other|3|||
163059612|NCT03054428|588926443|FG000|Overall Study|Physician Decision|0|||
163059613|NCT03054428|588926444|FG001|Overall Study|Physician Decision|1|||
163059614|NCT03054428|588926445|FG002|Overall Study|Physician Decision|1|||
163059615|NCT03054428|588926443|FG000|Overall Study|Lack of Efficacy|3|||
163059616|NCT03054428|588926444|FG001|Overall Study|Lack of Efficacy|1|||
163059617|NCT03054428|588926445|FG002|Overall Study|Lack of Efficacy|0|||
163059618|NCT03054428|588926443|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
163059619|NCT03054428|588926444|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
163059620|NCT03054428|588926445|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
163059621|NCT03054428|588926443|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
163059622|NCT03054428|588926444|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
163059623|NCT03054428|588926445|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
163059624|NCT03054428|588926443|FG000|Overall Study|Transitioned to OLE study|76|||
163059625|NCT03054428|588926444|FG001|Overall Study|Transitioned to OLE study|76|||
163059626|NCT03054428|588926445|FG002|Overall Study|Transitioned to OLE study|73|||
163059627|NCT03054428|588926443|FG000|Overall Study|Withdrawal by Subject|3|||
163059628|NCT03054428|588926444|FG001|Overall Study|Withdrawal by Subject|2|||
163059629|NCT03054428|588926445|FG002|Overall Study|Withdrawal by Subject|3|||
163059630|NCT03054428|588926443|FG000|Overall Study|Lost to Follow-up|0|||
163059631|NCT03054428|588926444|FG001|Overall Study|Lost to Follow-up|0|||
163059632|NCT03054428|588926445|FG002|Overall Study|Lost to Follow-up|1|||
163059633|NCT01652690|588926446|FG000|Overall Study|Withdrawal by Subject|16|||
163059634|NCT01652690|588926447|FG001|Overall Study|Withdrawal by Subject|4|||
163059635|NCT01652690|588926446|FG000|Overall Study|Other|8|||
163059636|NCT01652690|588926447|FG001|Overall Study|Other|9|||
163059637|NCT01652690|588926446|FG000|Overall Study|Lost to Follow-up|6|||
163059638|NCT01652690|588926447|FG001|Overall Study|Lost to Follow-up|6|||
163059639|NCT01652690|588926446|FG000|Overall Study|Death|5|||
163059640|NCT01652690|588926447|FG001|Overall Study|Death|2|||
163059641|NCT03225287|588926450|FG000|Overall Study|Adverse Event|0|||
163059642|NCT03225287|588926451|FG001|Overall Study|Adverse Event|0|||
163059643|NCT03225287|588926452|FG002|Overall Study|Adverse Event|1|||
163059644|NCT03225287|588926450|FG000|Overall Study|Protocol non-compliance|0|||
163059645|NCT03225287|588926451|FG001|Overall Study|Protocol non-compliance|0|||
163059646|NCT03225287|588926452|FG002|Overall Study|Protocol non-compliance|1|||
163059647|NCT03225287|588926450|FG000|Overall Study|Subject withdraws consent|3|||
163059648|NCT03225287|588926451|FG001|Overall Study|Subject withdraws consent|0|||
163059649|NCT03225287|588926452|FG002|Overall Study|Subject withdraws consent|0|||
163059650|NCT03225287|588926450|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
163059651|NCT03225287|588926451|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
163059652|NCT03225287|588926452|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
163059653|NCT03225287|588926450|FG000|Overall Study|Trial drug not effective|0|||
163059654|NCT03225287|588926451|FG001|Overall Study|Trial drug not effective|1|||
163059655|NCT03225287|588926452|FG002|Overall Study|Trial drug not effective|0|||
163059656|NCT03225287|588926450|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
163059657|NCT03225287|588926451|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
163059658|NCT03225287|588926452|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
163059659|NCT03225287|588926450|FG000|Overall Study|Stem cell transplantation|0|||
163059660|NCT03225287|588926451|FG001|Overall Study|Stem cell transplantation|1|||
163059661|NCT03225287|588926452|FG002|Overall Study|Stem cell transplantation|0|||
163059662|NCT06070610|588926454|FG000|Washout period|Adverse Event|1|||
163059663|NCT06070610|588926454|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
163059664|NCT01499810|588926455|FG000|Overall Study|Lost to Follow-up|10|||
163059665|NCT01499810|588926455|FG000|Overall Study|Protocol Violation|1|||
163059666|NCT01499810|588926455|FG000|Overall Study|Withdrawal by Subject|1|||
163059667|NCT01884597|588926456|FG000|Overall Study|Adverse Event|0|||
163059668|NCT01884597|588926457|FG001|Overall Study|Adverse Event|0|||
163059669|NCT01884597|588926458|FG002|Overall Study|Adverse Event|1|||
163059670|NCT01884597|588926456|FG000|Overall Study|Lack of Efficacy|1|||
163059671|NCT01884597|588926457|FG001|Overall Study|Lack of Efficacy|0|||
162983213|NCT03295318|588642158|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
162983214|NCT03295318|588642159|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
162983215|NCT03295318|588642160|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
162983216|NCT03295318|588642158|FG000|Overall Study|Death|1|||
162983217|NCT03295318|588642159|FG001|Overall Study|Death|1|||
162983218|NCT03295318|588642160|FG002|Overall Study|Death|1|||
162983219|NCT03295318|588642158|FG000|Overall Study|Protocol Violation|4|||
162983220|NCT03295318|588642159|FG001|Overall Study|Protocol Violation|3|||
162983221|NCT03295318|588642160|FG002|Overall Study|Protocol Violation|3|||
162983222|NCT03295318|588642158|FG000|Overall Study|Withdrawal by Subject|0|||
162983223|NCT03295318|588642159|FG001|Overall Study|Withdrawal by Subject|0|||
162983224|NCT03295318|588642160|FG002|Overall Study|Withdrawal by Subject|1|||
162983225|NCT03295318|588642158|FG000|Overall Study|Subject discontinued due to travel|0|||
162983226|NCT03295318|588642159|FG001|Overall Study|Subject discontinued due to travel|1|||
162983227|NCT03295318|588642160|FG002|Overall Study|Subject discontinued due to travel|0|||
162983228|NCT04319718|588642161|FG000|Overall Study|Adverse Event|0|||
162983229|NCT04319718|588642162|FG001|Overall Study|Adverse Event|2|||
162983230|NCT04319718|588642161|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
162983231|NCT04319718|588642162|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
162983232|NCT03955471|588642164|FG000|Overall Study|Death|22|||
162983233|NCT03955471|588642164|FG000|Overall Study|Lost to Follow-up|1|||
162983234|NCT03955471|588642164|FG000|Overall Study|Withdrawal by Subject|6|||
162983235|NCT03955471|588642164|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
162983236|NCT01030341|588642165|FG000|Overall Study|Withdrawal by Subject|1|||
162983237|NCT01030341|588642165|FG000|Overall Study|Lost to Follow-up|2|||
162983238|NCT02307266|588642166|FG000|Overall Study|Adverse Event|3|||
162983239|NCT02307266|588642167|FG001|Overall Study|Adverse Event|1|||
162983240|NCT02307266|588642168|FG002|Overall Study|Adverse Event|5|||
162983241|NCT02307266|588642166|FG000|Overall Study|Withdrawal by Subject|2|||
162983242|NCT02307266|588642167|FG001|Overall Study|Withdrawal by Subject|0|||
162983243|NCT02307266|588642168|FG002|Overall Study|Withdrawal by Subject|1|||
162983244|NCT02307266|588642166|FG000|Overall Study|Lost to Follow-up|3|||
162983245|NCT02307266|588642167|FG001|Overall Study|Lost to Follow-up|0|||
162983246|NCT02307266|588642168|FG002|Overall Study|Lost to Follow-up|0|||
162983247|NCT00793780|588642169|FG000|Overall Study|Withdrawal by Subject|2|||
162983248|NCT00793780|588642170|FG001|Overall Study|Withdrawal by Subject|1|||
162983249|NCT00573157|588642171|FG000|Overall Study|Adverse Event|3|||
162983250|NCT00573157|588642172|FG001|Overall Study|Adverse Event|1|||
162983251|NCT00573157|588642171|FG000|Overall Study|Other|1|||
162983252|NCT00573157|588642172|FG001|Overall Study|Other|1|||
162983253|NCT01032018|588642173|FG000|Overall Study|Lost to Follow-up|6|||
162983254|NCT01032018|588642174|FG001|Overall Study|Lost to Follow-up|5|||
162983255|NCT01032018|588642173|FG000|Overall Study|Death|0|||
162983256|NCT01032018|588642174|FG001|Overall Study|Death|1|||
162983257|NCT00858143|588642176|FG000|Overall Study|Adverse Event|16|||
163059672|NCT01884597|588926458|FG002|Overall Study|Lack of Efficacy|0|||
163059673|NCT01884597|588926456|FG000|Overall Study|Death|0|||
162634627|NCT01276353|587376567|FG001|Extension|Withdrawal by Subject|2|||
162634628|NCT01276353|587376566|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
162634629|NCT01276353|587376567|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
162634630|NCT01276353|587376566|FG000|Extension|Physician Decision|1|||
162634631|NCT01276353|587376567|FG001|Extension|Physician Decision|0|||
162634632|NCT01276353|587376566|FG000|Extension|Prohibited concomitant medications|0|||
162634633|NCT01276353|587376567|FG001|Extension|Prohibited concomitant medications|1|||
162634634|NCT00553514|587376571|FG000|Overall Study|Protocol deviation|0|||
162634635|NCT00553514|587376572|FG001|Overall Study|Protocol deviation|0|||
162634636|NCT00553514|587376573|FG002|Overall Study|Protocol deviation|0|||
162634637|NCT00553514|587376574|FG003|Overall Study|Protocol deviation|1|||
162634638|NCT00553514|587376575|FG004|Overall Study|Protocol deviation|0|||
162634639|NCT00553514|587376571|FG000|Overall Study|Lack of ovarian response|4|||
162634640|NCT00553514|587376572|FG001|Overall Study|Lack of ovarian response|5|||
162634641|NCT00553514|587376573|FG002|Overall Study|Lack of ovarian response|5|||
162634642|NCT00553514|587376574|FG003|Overall Study|Lack of ovarian response|5|||
162983258|NCT00858143|588642176|FG000|Overall Study|Lack of Efficacy|4|||
162983259|NCT00858143|588642176|FG000|Overall Study|Death|7|||
162983260|NCT00858143|588642176|FG000|Overall Study|Other|23|||
162634643|NCT00553514|587376575|FG004|Overall Study|Lack of ovarian response|6|||
162634644|NCT00553514|587376571|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
162634645|NCT00553514|587376572|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162983261|NCT01293539|588642178|FG000|Overall Study|Physician Decision|1|||
162983262|NCT04032158|588642180|FG000|Overall Study|Study Termination|2|||
162983263|NCT04032158|588642181|FG001|Overall Study|Study Termination|1|||
162983264|NCT00059787|588642182|FG000|Overall Study|Adverse Event|13|||
162983265|NCT00059787|588642182|FG000|Overall Study|disease progression|2|||
162983266|NCT00059787|588642182|FG000|Overall Study|ineligible|1|||
162983267|NCT00059787|588642182|FG000|Overall Study|Other|4|||
163059674|NCT01884597|588926457|FG001|Overall Study|Death|1|||
162983268|NCT01248013|588642185|FG000|Overall Study|Withdrawal by Subject|14|||
162983269|NCT04325204|588642188|FG000|Overall Study|Death|0|||
162983270|NCT04325204|588642189|FG001|Overall Study|Death|1|||
162983271|NCT04325204|588642188|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
162983272|NCT04325204|588642189|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
162983273|NCT04325204|588642188|FG000|Overall Study|Lost to Follow-up|8|||
162983274|NCT04325204|588642189|FG001|Overall Study|Lost to Follow-up|8|||
162983275|NCT04325204|588642188|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
162634646|NCT00553514|587376573|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162634647|NCT00553514|587376574|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162634648|NCT00553514|587376575|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162634649|NCT00553514|587376571|FG000|Overall Study|Risk of multiple pregnancy|0|||
162983276|NCT04325204|588642189|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
162983277|NCT00841906|588642190|FG000|Overall Study|Withdrawal by Subject|2|||
162983278|NCT00841906|588642191|FG001|Overall Study|Withdrawal by Subject|0|||
162983279|NCT04710979|588642194|FG000|Overall Study|Lost to Follow-up|2|||
162983280|NCT04710979|588642195|FG001|Overall Study|Lost to Follow-up|4|||
162983281|NCT04710979|588642194|FG000|Overall Study|Withdrawal by Subject|1|||
162983282|NCT04710979|588642195|FG001|Overall Study|Withdrawal by Subject|0|||
162983283|NCT00891371|588642203|FG000|Pre-assignment|Inclusion/exclusion|5|||
162983284|NCT00891371|588642203|FG000|Pre-assignment|Consent withdrawal|1|||
162983285|NCT00891371|588642203|FG000|Treatment|Lack of Efficacy|5|||
162983286|NCT00891371|588642203|FG000|Treatment|Adverse Event|2|||
162983287|NCT00891371|588642203|FG000|Treatment|Death|1|||
162983288|NCT00891371|588642203|FG000|Treatment|Lost to Follow-up|1|||
162983289|NCT04421586|588642212|FG000|Overall Study|Death|0|||
162983290|NCT04421586|588642213|FG001|Overall Study|Death|1|||
162983291|NCT04421586|588642212|FG000|Overall Study|Lost to Follow-up|2|||
162983292|NCT04421586|588642213|FG001|Overall Study|Lost to Follow-up|2|||
162983293|NCT04421586|588642212|FG000|Overall Study|Withdrawn by PI|1|||
162983294|NCT04421586|588642213|FG001|Overall Study|Withdrawn by PI|0|||
162983295|NCT04421586|588642212|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
162983296|NCT04421586|588642213|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
162983297|NCT02963441|588642214|FG000|Overall Study|Protocol violation or withdrawn|8|||
162983298|NCT02963441|588642214|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
162983299|NCT02963441|588642214|FG000|Overall Study|IDx-DR insufficient quality|33|||
162983300|NCT04920916|588642215|FG000|Phase IIa 60 Day Study|Death|2|||
162983301|NCT04920916|588642216|FG001|Phase IIa 60 Day Study|Death|5|||
162983302|NCT04920916|588642215|FG000|1 Year Follow up (Phone Call)|Death|1|||
162983303|NCT04920916|588642216|FG001|1 Year Follow up (Phone Call)|Death|3|||
162983304|NCT04920916|588642215|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
162983305|NCT04920916|588642216|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
162983306|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
162983307|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
162983308|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
162983309|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
162983310|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
162983311|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
162983312|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
162983313|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
162983314|NCT00974974|588642217|FG000|IR CD-LD Dose Adjustment|Various|0|||
162983315|NCT00974974|588642218|FG001|IR CD-LD Dose Adjustment|Various|9|||
162983316|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Adverse Event|23|||
162983317|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Adverse Event|0|||
162983318|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Death|2|||
162983319|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Death|0|||
162983320|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
162983321|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
162983322|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
162983323|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
162983324|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Various|3|||
162983325|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Various|0|||
162983326|NCT00974974|588642217|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
162983327|NCT00974974|588642218|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
162983328|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
162983329|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
162983330|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
162983331|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
162983332|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
162983333|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
162983334|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
162983335|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
162983336|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
162983337|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
162983338|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
162983339|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
162983340|NCT00974974|588642217|FG000|Maintenance - Double Blind Treatment|Various|4|||
162983341|NCT00974974|588642218|FG001|Maintenance - Double Blind Treatment|Various|0|||
162983342|NCT04392583|588642219|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
162983343|NCT01340768|588642220|FG000|Overall Study|Lost to Follow-up|10|||
162983344|NCT01340768|588642221|FG001|Overall Study|Lost to Follow-up|4|||
162983345|NCT01340768|588642220|FG000|Overall Study|Withdrawal by Subject|5|||
162983346|NCT01340768|588642221|FG001|Overall Study|Withdrawal by Subject|1|||
162983347|NCT01340768|588642220|FG000|Overall Study|Other|2|||
162983348|NCT01340768|588642221|FG001|Overall Study|Other|0|||
162983349|NCT03052959|588642226|FG000|Overall Study|Lost to Follow-up|4|||
162983350|NCT03052959|588642227|FG001|Overall Study|Lost to Follow-up|5|||
162983351|NCT02397408|588642228|FG000|Overall Study|Physician Decision|4|||
162983352|NCT02397408|588642228|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
162983353|NCT00985712|588642229|FG000|Overall Study|Adverse Event|0|||
162983354|NCT00985712|588642230|FG001|Overall Study|Adverse Event|1|||
162983355|NCT00985712|588642229|FG000|Overall Study|Lost to Follow-up|2|||
162983356|NCT00985712|588642230|FG001|Overall Study|Lost to Follow-up|2|||
162983357|NCT00985712|588642229|FG000|Overall Study|Protocol Violation|0|||
162983358|NCT00985712|588642230|FG001|Overall Study|Protocol Violation|1|||
162983359|NCT00985712|588642229|FG000|Overall Study|Withdrawal by Subject|4|||
162983360|NCT00985712|588642230|FG001|Overall Study|Withdrawal by Subject|1|||
162983361|NCT00985712|588642229|FG000|Overall Study|Sponsor decision|0|||
162983362|NCT00985712|588642230|FG001|Overall Study|Sponsor decision|2|||
162983363|NCT03096847|588642236|FG000|Overall Study|Other|2|||
162983364|NCT03096847|588642237|FG001|Overall Study|Other|1|||
162983365|NCT03096847|588642238|FG002|Overall Study|Other|2|||
162983366|NCT03096847|588642236|FG000|Overall Study|Lost to Follow-up|1|||
162983367|NCT03096847|588642237|FG001|Overall Study|Lost to Follow-up|0|||
162983368|NCT03096847|588642238|FG002|Overall Study|Lost to Follow-up|1|||
162983369|NCT03096847|588642236|FG000|Overall Study|Death|6|||
162983370|NCT03096847|588642237|FG001|Overall Study|Death|0|||
162983371|NCT03096847|588642238|FG002|Overall Study|Death|2|||
162983372|NCT03096847|588642236|FG000|Overall Study|Protocol Violation|3|||
162983373|NCT03096847|588642237|FG001|Overall Study|Protocol Violation|0|||
162983374|NCT03096847|588642238|FG002|Overall Study|Protocol Violation|6|||
162983375|NCT03096847|588642236|FG000|Overall Study|Physician Decision|12|||
163059675|NCT01884597|588926458|FG002|Overall Study|Death|0|||
163059676|NCT03834961|588928185|FG000|Overall Study|Lack of Efficacy|1|||
163059677|NCT03834961|588928186|FG001|Overall Study|Lack of Efficacy|1|||
163059678|NCT03834961|588928187|FG002|Overall Study|Lack of Efficacy|0|||
163059679|NCT03834961|588928185|FG000|Overall Study|Physician Decision|0|||
163059680|NCT03834961|588928186|FG001|Overall Study|Physician Decision|1|||
163059681|NCT03834961|588928187|FG002|Overall Study|Physician Decision|0|||
163059682|NCT00715208|588928190|FG000|Overall Study|Withdrawal by Subject|1|||
163059683|NCT00715208|588928191|FG001|Overall Study|Withdrawal by Subject|1|||
163059684|NCT00715208|588928190|FG000|Overall Study|Adverse Event|0|||
162983376|NCT03096847|588642237|FG001|Overall Study|Physician Decision|2|||
162983377|NCT03096847|588642238|FG002|Overall Study|Physician Decision|8|||
162983378|NCT03096847|588642236|FG000|Overall Study|Withdrawal by Subject|24|||
162983379|NCT03096847|588642237|FG001|Overall Study|Withdrawal by Subject|1|||
162983380|NCT03096847|588642238|FG002|Overall Study|Withdrawal by Subject|12|||
162983381|NCT03096847|588642236|FG000|Overall Study|Adverse Event|72|||
162983382|NCT03096847|588642237|FG001|Overall Study|Adverse Event|6|||
162983383|NCT03096847|588642238|FG002|Overall Study|Adverse Event|28|||
162983384|NCT03096847|588642236|FG000|Overall Study|Progressive disease|97|||
163059685|NCT00715208|588928191|FG001|Overall Study|Adverse Event|6|||
163059686|NCT00715208|588928190|FG000|Overall Study|Lack of Efficacy|0|||
163059687|NCT00715208|588928191|FG001|Overall Study|Lack of Efficacy|2|||
163059688|NCT01648764|588928192|FG000|Overall Study|Progressive Disease|0|||
162983385|NCT03096847|588642237|FG001|Overall Study|Progressive disease|10|||
163059689|NCT01648764|588928193|FG001|Overall Study|Progressive Disease|1|||
163059690|NCT01648764|588928194|FG002|Overall Study|Progressive Disease|0|||
162983386|NCT03096847|588642238|FG002|Overall Study|Progressive disease|78|||
162983387|NCT03096847|588642236|FG000|Overall Study|Non-compliance with study medication|1|||
162983388|NCT03096847|588642237|FG001|Overall Study|Non-compliance with study medication|0|||
162983389|NCT03096847|588642238|FG002|Overall Study|Non-compliance with study medication|0|||
162983390|NCT03096847|588642236|FG000|Overall Study|New therapy for study indication|1|||
162983391|NCT03096847|588642237|FG001|Overall Study|New therapy for study indication|0|||
162983392|NCT03096847|588642238|FG002|Overall Study|New therapy for study indication|1|||
162983393|NCT00359632|588642242|FG000|Overall Study|Death|2|||
162634650|NCT00553514|587376572|FG001|Overall Study|Risk of multiple pregnancy|2|||
162634651|NCT00553514|587376573|FG002|Overall Study|Risk of multiple pregnancy|0|||
162634652|NCT00553514|587376574|FG003|Overall Study|Risk of multiple pregnancy|1|||
162634653|NCT00553514|587376575|FG004|Overall Study|Risk of multiple pregnancy|0|||
162983394|NCT00359632|588642243|FG001|Overall Study|Death|0|||
162983395|NCT00359632|588642242|FG000|Overall Study|Adverse Event|1|||
162983396|NCT00359632|588642243|FG001|Overall Study|Adverse Event|0|||
162983397|NCT00359632|588642242|FG000|Overall Study|Non-compliance with visit schedule|1|||
162983398|NCT00359632|588642243|FG001|Overall Study|Non-compliance with visit schedule|0|||
162983399|NCT03978091|588642246|FG000|Overall Study|Lost to Follow-up|0|||
162983400|NCT03978091|588642247|FG001|Overall Study|Lost to Follow-up|0|||
162983401|NCT03978091|588642248|FG002|Overall Study|Lost to Follow-up|1|||
162983402|NCT03978091|588642249|FG003|Overall Study|Lost to Follow-up|0|||
162983403|NCT03978091|588642250|FG004|Overall Study|Lost to Follow-up|0|||
162983404|NCT03978091|588642251|FG005|Overall Study|Lost to Follow-up|0|||
162983405|NCT03978091|588642246|FG000|Overall Study|Withdrawal by Subject|0|||
162983406|NCT03978091|588642247|FG001|Overall Study|Withdrawal by Subject|0|||
162983407|NCT03978091|588642248|FG002|Overall Study|Withdrawal by Subject|0|||
162983408|NCT03978091|588642249|FG003|Overall Study|Withdrawal by Subject|1|||
162983409|NCT03978091|588642250|FG004|Overall Study|Withdrawal by Subject|1|||
162983410|NCT03978091|588642251|FG005|Overall Study|Withdrawal by Subject|0|||
162983411|NCT04700280|588642255|FG000|Overall Study|Adverse Event|4|||
162983412|NCT04700280|588642256|FG001|Overall Study|Adverse Event|0|||
162983413|NCT04700280|588642255|FG000|Overall Study|Lack of Efficacy|1|||
162983414|NCT04700280|588642256|FG001|Overall Study|Lack of Efficacy|0|||
162983415|NCT04700280|588642255|FG000|Overall Study|Study terminated by sponsor|5|||
162983416|NCT04700280|588642256|FG001|Overall Study|Study terminated by sponsor|3|||
162983417|NCT04700280|588642255|FG000|Overall Study|Other than specified|1|||
162983418|NCT04700280|588642256|FG001|Overall Study|Other than specified|0|||
162983419|NCT01843348|588642257|FG000|Overall Study|Withdrawal by Subject|4|||
162983420|NCT01843348|588642258|FG001|Overall Study|Withdrawal by Subject|16|||
162983421|NCT01843348|588642259|FG002|Overall Study|Withdrawal by Subject|18|||
162983422|NCT01843348|588642257|FG000|Overall Study|Lost to Follow-up|5|||
162983423|NCT01843348|588642258|FG001|Overall Study|Lost to Follow-up|4|||
162983424|NCT01843348|588642259|FG002|Overall Study|Lost to Follow-up|2|||
162983425|NCT01843348|588642257|FG000|Overall Study|Death|5|||
162983426|NCT01843348|588642258|FG001|Overall Study|Death|3|||
162983427|NCT01843348|588642259|FG002|Overall Study|Death|4|||
162983428|NCT01843348|588642257|FG000|Overall Study|Graft loss/retransplantation|5|||
162983429|NCT01843348|588642258|FG001|Overall Study|Graft loss/retransplantation|8|||
162983430|NCT01843348|588642259|FG002|Overall Study|Graft loss/retransplantation|11|||
162983431|NCT01843348|588642257|FG000|Overall Study|Various reasons|4|||
162983432|NCT01843348|588642258|FG001|Overall Study|Various reasons|9|||
162983433|NCT01843348|588642259|FG002|Overall Study|Various reasons|6|||
162983434|NCT02093221|588642260|FG000|Overall Study|Adverse Event|1|||
162983435|NCT02093221|588642261|FG001|Overall Study|Adverse Event|0|||
162983436|NCT02093221|588642262|FG002|Overall Study|Adverse Event|0|||
162983437|NCT02093221|588642263|FG003|Overall Study|Adverse Event|0|||
162983438|NCT02093221|588642264|FG004|Overall Study|Adverse Event|0|||
162983439|NCT02093221|588642260|FG000|Overall Study|Withdrawal by Subject|1|||
162983440|NCT02093221|588642261|FG001|Overall Study|Withdrawal by Subject|1|||
162983441|NCT02093221|588642262|FG002|Overall Study|Withdrawal by Subject|4|||
162983442|NCT02093221|588642263|FG003|Overall Study|Withdrawal by Subject|1|||
162983443|NCT02093221|588642264|FG004|Overall Study|Withdrawal by Subject|1|||
162983444|NCT02093221|588642260|FG000|Overall Study|Lost to Follow-up|2|||
162634654|NCT00553514|587376571|FG000|Overall Study|Other|1|||
162634655|NCT00553514|587376572|FG001|Overall Study|Other|1|||
162634656|NCT00553514|587376573|FG002|Overall Study|Other|0|||
162634657|NCT00553514|587376574|FG003|Overall Study|Other|0|||
162634658|NCT00553514|587376575|FG004|Overall Study|Other|1|||
162634659|NCT01465997|587376576|FG000|Overall Study|Adverse Event|12|||
162634660|NCT01465997|587376577|FG001|Overall Study|Adverse Event|22|||
162634661|NCT01465997|587376576|FG000|Overall Study|Lack of Efficacy|13|||
162634662|NCT01465997|587376577|FG001|Overall Study|Lack of Efficacy|1|||
162634663|NCT01465997|587376576|FG000|Overall Study|Protocol Violation|1|||
162634664|NCT01465997|587376577|FG001|Overall Study|Protocol Violation|4|||
162983445|NCT02093221|588642261|FG001|Overall Study|Lost to Follow-up|0|||
162983446|NCT02093221|588642262|FG002|Overall Study|Lost to Follow-up|1|||
162983447|NCT02093221|588642263|FG003|Overall Study|Lost to Follow-up|1|||
162983448|NCT02093221|588642264|FG004|Overall Study|Lost to Follow-up|0|||
162983449|NCT02093221|588642260|FG000|Overall Study|Death|0|||
162983450|NCT02093221|588642261|FG001|Overall Study|Death|1|||
162983451|NCT02093221|588642262|FG002|Overall Study|Death|0|||
162983452|NCT02093221|588642263|FG003|Overall Study|Death|0|||
163059691|NCT01648764|588928195|FG003|Overall Study|Progressive Disease|0|||
162983453|NCT02093221|588642264|FG004|Overall Study|Death|0|||
162983454|NCT02093221|588642260|FG000|Overall Study|Protocol Violation|0|||
162983455|NCT02093221|588642261|FG001|Overall Study|Protocol Violation|1|||
162634665|NCT01465997|587376576|FG000|Overall Study|Lost to Follow-up|6|||
162634666|NCT01465997|587376577|FG001|Overall Study|Lost to Follow-up|9|||
162714626|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
162714627|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
162714628|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
162634667|NCT01465997|587376576|FG000|Overall Study|Withdrawal by Subject|32|||
162634668|NCT01465997|587376577|FG001|Overall Study|Withdrawal by Subject|35|||
162634669|NCT01465997|587376576|FG000|Overall Study|investigator's decision|1|||
162634670|NCT01465997|587376577|FG001|Overall Study|investigator's decision|1|||
162714629|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
162714630|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
162714631|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
162714632|NCT03370133|587664035|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
162714633|NCT03370133|587664036|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
162714634|NCT03370133|587664037|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
162714635|NCT03370133|587664038|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
162714636|NCT03370133|587664039|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
162714637|NCT03370133|587664040|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
162714638|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162714639|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162714640|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162714641|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
162983456|NCT02093221|588642262|FG002|Overall Study|Protocol Violation|0|||
162634671|NCT01465997|587376576|FG000|Overall Study|Death|0|||
162983457|NCT02093221|588642263|FG003|Overall Study|Protocol Violation|0|||
162983458|NCT02093221|588642264|FG004|Overall Study|Protocol Violation|0|||
162983459|NCT02093221|588642260|FG000|Overall Study|Study termination|6|||
162983460|NCT02093221|588642261|FG001|Overall Study|Study termination|5|||
162983461|NCT02093221|588642262|FG002|Overall Study|Study termination|4|||
162983462|NCT02093221|588642263|FG003|Overall Study|Study termination|6|||
162983463|NCT02093221|588642264|FG004|Overall Study|Study termination|7|||
162983464|NCT00257920|588642265|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
162983465|NCT00257920|588642266|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
162983466|NCT00257920|588642265|FG000|Period: Second Intervention|Other|2|||
162983467|NCT00257920|588642266|FG001|Period: Second Intervention|Other|1|||
162983468|NCT00770692|588642267|FG000|Overall Study|Withdrawal by Subject|7|||
162983469|NCT00770692|588642268|FG001|Overall Study|Withdrawal by Subject|9|||
162983470|NCT00770692|588642269|FG002|Overall Study|Withdrawal by Subject|9|||
162983471|NCT00770692|588642270|FG003|Overall Study|Withdrawal by Subject|6|||
162983472|NCT00770692|588642267|FG000|Overall Study|Adverse Event|3|||
162983473|NCT00770692|588642268|FG001|Overall Study|Adverse Event|0|||
162983474|NCT00770692|588642269|FG002|Overall Study|Adverse Event|4|||
162983475|NCT00770692|588642270|FG003|Overall Study|Adverse Event|4|||
162983476|NCT00770692|588642267|FG000|Overall Study|Investigator judgment|2|||
162983477|NCT00770692|588642268|FG001|Overall Study|Investigator judgment|0|||
162983478|NCT00770692|588642269|FG002|Overall Study|Investigator judgment|1|||
162983479|NCT00770692|588642270|FG003|Overall Study|Investigator judgment|1|||
162983480|NCT01230892|588642271|FG000|Overall Study|Withdrawal by Subject|1|||
162983481|NCT01230892|588642272|FG001|Overall Study|Withdrawal by Subject|1|||
162983482|NCT01230892|588642271|FG000|Overall Study|Lost to Follow-up|2|||
162983483|NCT01230892|588642272|FG001|Overall Study|Lost to Follow-up|0|||
162983484|NCT00725621|588642273|FG000|Overall Study|Adverse Event|25|||
162983485|NCT00725621|588642273|FG000|Overall Study|Lack of Efficacy|46|||
162983486|NCT00725621|588642273|FG000|Overall Study|Withdrawal by Subject|57|||
162634672|NCT01465997|587376577|FG001|Overall Study|Death|1|||
162634673|NCT01465997|587376576|FG000|Overall Study|sponsor's decision|1|||
162634674|NCT01465997|587376577|FG001|Overall Study|sponsor's decision|1|||
162634675|NCT01465997|587376576|FG000|Overall Study|subject withdrew consent|1|||
162634676|NCT01465997|587376577|FG001|Overall Study|subject withdrew consent|0|||
162634677|NCT01465997|587376576|FG000|Overall Study|local lab unblinded site|1|||
162714642|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
162714643|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
162714644|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162983487|NCT00725621|588642273|FG000|Overall Study|Physician Decision|19|||
162983488|NCT00725621|588642273|FG000|Overall Study|Lost to Follow-up|52|||
162983489|NCT00725621|588642273|FG000|Overall Study|Non-compliance|8|||
162983490|NCT00725621|588642273|FG000|Overall Study|Continued treatment by other physician|6|||
163059692|NCT01648764|588928196|FG004|Overall Study|Progressive Disease|0|||
162983491|NCT00725621|588642273|FG000|Overall Study|Switched to other study|1|||
162983492|NCT00725621|588642273|FG000|Overall Study|Switched to other drug|1|||
162983493|NCT00725621|588642273|FG000|Overall Study|Prepared for elective surgery|1|||
162983494|NCT00725621|588642273|FG000|Overall Study|Reason not specified|55|||
162983495|NCT01189500|588642274|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
162983496|NCT01189500|588642274|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
162983497|NCT00062751|588642275|FG000|Overall Study|Disease progression|24|||
162983498|NCT00062751|588642276|FG001|Overall Study|Disease progression|17|||
162983499|NCT00062751|588642277|FG002|Overall Study|Disease progression|24|||
162983500|NCT00062751|588642278|FG003|Overall Study|Disease progression|2|||
162983501|NCT00062751|588642279|FG004|Overall Study|Disease progression|2|||
162983502|NCT00062751|588642275|FG000|Overall Study|Adverse Event|4|||
162983503|NCT00062751|588642276|FG001|Overall Study|Adverse Event|7|||
162983504|NCT00062751|588642277|FG002|Overall Study|Adverse Event|2|||
162983505|NCT00062751|588642278|FG003|Overall Study|Adverse Event|2|||
162983506|NCT00062751|588642279|FG004|Overall Study|Adverse Event|2|||
162983507|NCT00062751|588642275|FG000|Overall Study|Other|2|||
162983508|NCT00062751|588642276|FG001|Overall Study|Other|3|||
162983509|NCT00062751|588642277|FG002|Overall Study|Other|1|||
162983510|NCT00062751|588642278|FG003|Overall Study|Other|0|||
162983511|NCT00062751|588642279|FG004|Overall Study|Other|1|||
162983512|NCT00062751|588642275|FG000|Overall Study|Withdrawal by Subject|1|||
162983513|NCT00062751|588642276|FG001|Overall Study|Withdrawal by Subject|2|||
162983514|NCT00062751|588642277|FG002|Overall Study|Withdrawal by Subject|2|||
162983515|NCT00062751|588642278|FG003|Overall Study|Withdrawal by Subject|1|||
162983516|NCT00062751|588642279|FG004|Overall Study|Withdrawal by Subject|0|||
162983517|NCT00062751|588642275|FG000|Overall Study|Symptomatic deterioration|1|||
162983518|NCT00062751|588642276|FG001|Overall Study|Symptomatic deterioration|1|||
162983519|NCT00062751|588642277|FG002|Overall Study|Symptomatic deterioration|0|||
162983520|NCT00062751|588642278|FG003|Overall Study|Symptomatic deterioration|0|||
162983521|NCT00062751|588642279|FG004|Overall Study|Symptomatic deterioration|1|||
162983522|NCT00062751|588642275|FG000|Overall Study|Death|1|||
162983523|NCT00062751|588642276|FG001|Overall Study|Death|0|||
162983524|NCT00062751|588642277|FG002|Overall Study|Death|1|||
162983525|NCT00062751|588642278|FG003|Overall Study|Death|0|||
162983526|NCT00062751|588642279|FG004|Overall Study|Death|0|||
162983527|NCT03097588|588642286|FG000|Overall Study|Adverse Event|1|||
162983528|NCT01144364|588642287|FG000|Induction Phase|Disease progression|14|||
162983529|NCT01144364|588642288|FG001|Induction Phase|Disease progression|0|||
162983530|NCT01144364|588642289|FG002|Induction Phase|Disease progression|0|||
162983531|NCT01144364|588642287|FG000|Induction Phase|Adverse Event|9|||
162983532|NCT01144364|588642288|FG001|Induction Phase|Adverse Event|0|||
162983533|NCT01144364|588642289|FG002|Induction Phase|Adverse Event|0|||
162983534|NCT01144364|588642287|FG000|Induction Phase|Death|1|||
162983535|NCT01144364|588642288|FG001|Induction Phase|Death|0|||
162983536|NCT01144364|588642289|FG002|Induction Phase|Death|0|||
162983537|NCT01144364|588642287|FG000|Induction Phase|Withdrawal by Subject|1|||
162983538|NCT01144364|588642288|FG001|Induction Phase|Withdrawal by Subject|0|||
162983539|NCT01144364|588642289|FG002|Induction Phase|Withdrawal by Subject|0|||
162983540|NCT01144364|588642287|FG000|Induction Phase|Lost to Follow-up|2|||
162983541|NCT01144364|588642288|FG001|Induction Phase|Lost to Follow-up|0|||
162983542|NCT01144364|588642289|FG002|Induction Phase|Lost to Follow-up|0|||
162983543|NCT01144364|588642287|FG000|Induction Phase|Physician Decision|1|||
162983544|NCT01144364|588642288|FG001|Induction Phase|Physician Decision|0|||
162983545|NCT01144364|588642289|FG002|Induction Phase|Physician Decision|0|||
162983546|NCT01144364|588642287|FG000|Induction Phase|Stable disease|2|||
162983547|NCT01144364|588642288|FG001|Induction Phase|Stable disease|0|||
162983548|NCT01144364|588642289|FG002|Induction Phase|Stable disease|0|||
162983549|NCT01144364|588642287|FG000|Induction Phase|Secondary neoplasia|1|||
162983550|NCT01144364|588642288|FG001|Induction Phase|Secondary neoplasia|0|||
162983551|NCT01144364|588642289|FG002|Induction Phase|Secondary neoplasia|0|||
162983552|NCT01144364|588642287|FG000|Induction Phase|Protocol Violation|1|||
162983553|NCT01144364|588642288|FG001|Induction Phase|Protocol Violation|0|||
162714645|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162983554|NCT01144364|588642289|FG002|Induction Phase|Protocol Violation|0|||
162983555|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
162983556|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
162983557|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
162983558|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
162983559|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
162983560|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
162983561|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Death|0|||
163059693|NCT01648764|588928197|FG005|Overall Study|Progressive Disease|1|||
162714646|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162983562|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Death|2|||
162983563|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Death|0|||
162983564|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
162983565|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
162983566|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
162983567|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
162983568|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
162983569|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
162983570|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
162983571|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
162983572|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
162983573|NCT01144364|588642287|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
162983574|NCT01144364|588642288|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
162983575|NCT01144364|588642289|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
162983576|NCT02037165|588642290|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983577|NCT02037165|588642291|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983578|NCT02037165|588642292|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983579|NCT02037165|588642293|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
162983580|NCT02037165|588642294|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
162983581|NCT00673933|588642295|FG000|Overall Study|Withdrawal by Subject|2|||
162983582|NCT00673933|588642295|FG000|Overall Study|Lost to Follow-up|1|||
162983583|NCT04932941|588642296|FG000|Overall Study|Lost to Follow-up|3|||
162983584|NCT04932941|588642297|FG001|Overall Study|Lost to Follow-up|1|||
162983585|NCT04932941|588642296|FG000|Overall Study|Withdrawal by Subject|7|||
162983586|NCT04932941|588642297|FG001|Overall Study|Withdrawal by Subject|4|||
162983587|NCT04932941|588642296|FG000|Overall Study|Other|4|||
162983588|NCT04932941|588642297|FG001|Overall Study|Other|2|||
162983589|NCT02206620|588642298|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162983590|NCT02206620|588642299|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162983591|NCT02206620|588642298|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
162983592|NCT02206620|588642299|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
162983593|NCT05816200|588642300|FG000|Overall Study|Lost to Follow-up|2|||
162983594|NCT05816200|588642301|FG001|Overall Study|Lost to Follow-up|1|||
162983595|NCT02394730|588642302|FG000|Overall Study|Lost to Follow-up|1|||
162983596|NCT02394730|588642303|FG001|Overall Study|Lost to Follow-up|0|||
162983597|NCT02394730|588642302|FG000|Overall Study|Withdrawal by Subject|0|||
162983598|NCT02394730|588642303|FG001|Overall Study|Withdrawal by Subject|1|||
162983599|NCT00588640|588642304|FG000|Overall Study|Physician Decision|1|||
162983600|NCT00588640|588642304|FG000|Overall Study|Ineligible Patient|1|||
162983601|NCT01393730|588642305|FG000|Overall Study|Withdrawal by Subject|3|||
162983602|NCT01393730|588642305|FG000|Overall Study|Other|2|||
162983603|NCT01393730|588642305|FG000|Overall Study|Adverse Event|1|||
162983604|NCT03510182|588642310|FG000|Overall Study|Withdrawal by Subject|2|||
162983605|NCT00375492|588642311|FG000|Overall Study|Adverse Event|4|||
162983606|NCT00375492|588642312|FG001|Overall Study|Adverse Event|5|||
162983607|NCT00375492|588642311|FG000|Overall Study|Entry Criteria Not Met|0|||
162983608|NCT00375492|588642312|FG001|Overall Study|Entry Criteria Not Met|1|||
162983609|NCT00375492|588642311|FG000|Overall Study|Loss of Glucose Control|0|||
162983610|NCT00375492|588642312|FG001|Overall Study|Loss of Glucose Control|1|||
162983611|NCT00375492|588642311|FG000|Overall Study|Lost to Follow-up|10|||
162983612|NCT00375492|588642312|FG001|Overall Study|Lost to Follow-up|5|||
162983613|NCT00375492|588642311|FG000|Overall Study|Physician Decision|0|||
162983614|NCT00375492|588642312|FG001|Overall Study|Physician Decision|4|||
162983615|NCT00375492|588642311|FG000|Overall Study|Protocol Violation|6|||
162983616|NCT00375492|588642312|FG001|Overall Study|Protocol Violation|3|||
162983617|NCT00375492|588642311|FG000|Overall Study|Sponsor Decision|0|||
162983618|NCT00375492|588642312|FG001|Overall Study|Sponsor Decision|1|||
162983619|NCT00375492|588642311|FG000|Overall Study|Withdrawal by Subject|6|||
162983620|NCT00375492|588642312|FG001|Overall Study|Withdrawal by Subject|6|||
162983621|NCT03747601|588644006|FG000|Overall Study|COVID halt to visits|4|||
162983622|NCT02221037|588644007|FG000|Overall Study|Physician Decision|0|||
162983623|NCT02221037|588644008|FG001|Overall Study|Physician Decision|0|||
162983624|NCT02221037|588644009|FG002|Overall Study|Physician Decision|1|||
162983625|NCT02221037|588644010|FG003|Overall Study|Physician Decision|0|||
162983626|NCT00609518|588644013|FG000|Overall Study|Death from Study Disease|32|||
162983627|NCT00609518|588644014|FG001|Overall Study|Death from Study Disease|32|||
162983628|NCT00609518|588644013|FG000|Overall Study|Withdrawal by Subject|5|||
162983629|NCT00609518|588644014|FG001|Overall Study|Withdrawal by Subject|3|||
162983630|NCT00609518|588644013|FG000|Overall Study|Lost to Follow-up|3|||
162983631|NCT00609518|588644014|FG001|Overall Study|Lost to Follow-up|0|||
162983632|NCT00609518|588644013|FG000|Overall Study|Physician Decision|1|||
162983633|NCT00609518|588644014|FG001|Overall Study|Physician Decision|3|||
163059694|NCT01648764|588928198|FG006|Overall Study|Progressive Disease|1|||
162983634|NCT00609518|588644013|FG000|Overall Study|Death from Adverse Event|2|||
162983635|NCT00609518|588644014|FG001|Overall Study|Death from Adverse Event|2|||
162983636|NCT00394524|588644015|FG000|Overall Study|Protocol Violation|2|||
162983637|NCT00394524|588644016|FG001|Overall Study|Protocol Violation|3|||
162983638|NCT00394524|588644015|FG000|Overall Study|Death|1|||
162983639|NCT00394524|588644016|FG001|Overall Study|Death|0|||
162983640|NCT00394524|588644015|FG000|Overall Study|Withdrawal by Subject|0|||
163059695|NCT01648764|588928199|FG007|Overall Study|Progressive Disease|0|||
163059696|NCT01648764|588928200|FG008|Overall Study|Progressive Disease|0|||
163059697|NCT01648764|588928201|FG009|Overall Study|Progressive Disease|2|||
163059698|NCT01648764|588928202|FG010|Overall Study|Progressive Disease|0|||
163059699|NCT01648764|588928203|FG011|Overall Study|Progressive Disease|1|||
163059700|NCT01648764|588928204|FG012|Overall Study|Progressive Disease|2|||
163059701|NCT01648764|588928205|FG013|Overall Study|Progressive Disease|1|||
163059702|NCT01648764|588928192|FG000|Overall Study|Adverse Event|0|||
163059703|NCT01648764|588928193|FG001|Overall Study|Adverse Event|0|||
163059704|NCT01648764|588928194|FG002|Overall Study|Adverse Event|0|||
163059705|NCT01648764|588928195|FG003|Overall Study|Adverse Event|0|||
163059706|NCT01648764|588928196|FG004|Overall Study|Adverse Event|0|||
163059707|NCT01648764|588928197|FG005|Overall Study|Adverse Event|1|||
163059708|NCT01648764|588928198|FG006|Overall Study|Adverse Event|0|||
163059709|NCT01648764|588928199|FG007|Overall Study|Adverse Event|0|||
163059710|NCT01648764|588928200|FG008|Overall Study|Adverse Event|0|||
163059711|NCT01648764|588928201|FG009|Overall Study|Adverse Event|1|||
163059712|NCT01648764|588928202|FG010|Overall Study|Adverse Event|0|||
163059713|NCT01648764|588928203|FG011|Overall Study|Adverse Event|3|||
163059714|NCT01648764|588928204|FG012|Overall Study|Adverse Event|1|||
163059715|NCT01648764|588928205|FG013|Overall Study|Adverse Event|1|||
162714647|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162983641|NCT00394524|588644016|FG001|Overall Study|Withdrawal by Subject|1|||
162983642|NCT03827564|588644017|FG000|Overall Study|Discontinued due to Study Termination|1|||
162983643|NCT03827564|588644018|FG001|Overall Study|Discontinued due to Study Termination|0|||
162983644|NCT02238626|588644019|FG000|Overall Study|Adverse Event|3|||
162983645|NCT02238626|588644020|FG001|Overall Study|Adverse Event|5|||
162983646|NCT02238626|588644021|FG002|Overall Study|Adverse Event|0|||
162983647|NCT02238626|588644022|FG003|Overall Study|Adverse Event|3|||
162983648|NCT02238626|588644019|FG000|Overall Study|Lost to Follow-up|2|||
162983649|NCT02238626|588644020|FG001|Overall Study|Lost to Follow-up|4|||
162983650|NCT02238626|588644021|FG002|Overall Study|Lost to Follow-up|2|||
162983651|NCT02238626|588644022|FG003|Overall Study|Lost to Follow-up|2|||
162983652|NCT02238626|588644019|FG000|Overall Study|Withdrawal by Subject|0|||
162983653|NCT02238626|588644020|FG001|Overall Study|Withdrawal by Subject|3|||
162983654|NCT02238626|588644021|FG002|Overall Study|Withdrawal by Subject|0|||
162983655|NCT02238626|588644022|FG003|Overall Study|Withdrawal by Subject|1|||
162983656|NCT02238626|588644019|FG000|Overall Study|Death|0|||
162983657|NCT02238626|588644020|FG001|Overall Study|Death|0|||
162983658|NCT02238626|588644021|FG002|Overall Study|Death|1|||
162983659|NCT02238626|588644022|FG003|Overall Study|Death|1|||
162983660|NCT02238626|588644019|FG000|Overall Study|Other|0|||
162983661|NCT02238626|588644020|FG001|Overall Study|Other|2|||
162983662|NCT02238626|588644021|FG002|Overall Study|Other|0|||
162983663|NCT02238626|588644022|FG003|Overall Study|Other|0|||
162983664|NCT02621034|588644023|FG000|Overall Study|Lost to Follow-up|3|||
162983665|NCT02621034|588644024|FG001|Overall Study|Lost to Follow-up|2|||
162983666|NCT02621034|588644025|FG002|Overall Study|Lost to Follow-up|5|||
162983667|NCT01959035|588644033|FG000|Overall Study|Adverse Event|5|||
162983668|NCT01959035|588644033|FG000|Overall Study|Withdrawal by Subject|4|||
162983669|NCT01959035|588644033|FG000|Overall Study|Lost to Follow-up|1|||
162983670|NCT01959035|588644033|FG000|Overall Study|Other (no primary reason given)|1|||
162983671|NCT00450619|588644034|FG000|Overall Study|refused treatment after randomization|2|||
162983672|NCT00450619|588644035|FG001|Overall Study|refused treatment after randomization|0|||
162983673|NCT00450619|588644034|FG000|Overall Study|did not progress; refused further trmt|1|||
162983674|NCT00450619|588644035|FG001|Overall Study|did not progress; refused further trmt|1|||
163059716|NCT01648764|588928192|FG000|Overall Study|Death|0|||
163059717|NCT01648764|588928193|FG001|Overall Study|Death|0|||
163059718|NCT01648764|588928194|FG002|Overall Study|Death|0|||
163059719|NCT01648764|588928195|FG003|Overall Study|Death|0|||
163059720|NCT01648764|588928196|FG004|Overall Study|Death|0|||
163059721|NCT01648764|588928197|FG005|Overall Study|Death|0|||
163059722|NCT01648764|588928198|FG006|Overall Study|Death|1|||
163059723|NCT01648764|588928199|FG007|Overall Study|Death|0|||
163059724|NCT01648764|588928200|FG008|Overall Study|Death|0|||
163059725|NCT01648764|588928201|FG009|Overall Study|Death|0|||
162983675|NCT00450619|588644034|FG000|Overall Study|Adverse Event|1|||
162983676|NCT00450619|588644035|FG001|Overall Study|Adverse Event|0|||
163059726|NCT01648764|588928202|FG010|Overall Study|Death|0|||
163059727|NCT01648764|588928203|FG011|Overall Study|Death|0|||
163059728|NCT01648764|588928204|FG012|Overall Study|Death|0|||
162983677|NCT03254602|588644036|FG000|Overall Study|Lost to Follow-up|4|||
162983678|NCT02963311|588644039|FG000|Overall Study|Withdrawal by Subject|1|||
162983679|NCT02963311|588644039|FG000|Overall Study|Screen Failure|4|||
162983680|NCT01691820|588644040|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
163059729|NCT01648764|588928205|FG013|Overall Study|Death|1|||
163059730|NCT01648764|588928192|FG000|Overall Study|Withdrawal by Subject|0|||
163059731|NCT01648764|588928193|FG001|Overall Study|Withdrawal by Subject|0|||
163059732|NCT01648764|588928194|FG002|Overall Study|Withdrawal by Subject|0|||
163059733|NCT01648764|588928195|FG003|Overall Study|Withdrawal by Subject|0|||
162983681|NCT01691820|588644041|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
162983682|NCT01691820|588644040|FG000|Overall Study|Migrated/moved from study area|7|||
162634678|NCT01465997|587376577|FG001|Overall Study|local lab unblinded site|0|||
162634679|NCT01465997|587376576|FG000|Overall Study|withdrew before follow-up|0|||
162634680|NCT01465997|587376577|FG001|Overall Study|withdrew before follow-up|13|||
162634681|NCT01465997|587376576|FG000|Overall Study|decision by site staff|0|||
162634682|NCT01465997|587376577|FG001|Overall Study|decision by site staff|1|||
162634683|NCT01465997|587376576|FG000|Overall Study|subject left participation SP0993|0|||
162634684|NCT01465997|587376577|FG001|Overall Study|subject left participation SP0993|1|||
162983683|NCT01691820|588644041|FG001|Overall Study|Migrated/moved from study area|4|||
162983684|NCT01691820|588644040|FG000|Overall Study|Lost to Follow-up|6|||
162983685|NCT01691820|588644041|FG001|Overall Study|Lost to Follow-up|17|||
162983686|NCT01691820|588644040|FG000|Overall Study|Other (unspecified)|4|||
162983687|NCT01691820|588644041|FG001|Overall Study|Other (unspecified)|1|||
162983688|NCT04442490|588644044|FG000|Overall Study|Withdrawal by Subject|18|||
162983689|NCT04442490|588644045|FG001|Overall Study|Withdrawal by Subject|10|||
162983690|NCT04442490|588644044|FG000|Overall Study|Lost to Follow-up|7|||
162983691|NCT04442490|588644045|FG001|Overall Study|Lost to Follow-up|7|||
162983692|NCT04442490|588644044|FG000|Overall Study|Adverse Event|2|||
162983693|NCT04442490|588644045|FG001|Overall Study|Adverse Event|6|||
162983694|NCT04442490|588644044|FG000|Overall Study|Noncompliance|3|||
162983695|NCT04442490|588644045|FG001|Overall Study|Noncompliance|1|||
162983696|NCT04442490|588644044|FG000|Overall Study|Physician Decision|2|||
162983697|NCT04442490|588644045|FG001|Overall Study|Physician Decision|1|||
162983698|NCT04442490|588644044|FG000|Overall Study|Reason not Specified|2|||
162983699|NCT04442490|588644045|FG001|Overall Study|Reason not Specified|1|||
162983700|NCT04442490|588644044|FG000|Overall Study|Randomized but not Treated|3|||
162983701|NCT04442490|588644045|FG001|Overall Study|Randomized but not Treated|3|||
162983702|NCT01968694|588644047|FG000|Washout (1 Month)|Lost to Follow-up|0|||
162983703|NCT01968694|588644048|FG001|Washout (1 Month)|Lost to Follow-up|1|||
162983704|NCT02836496|588644049|FG000|Overall Study|Adverse Event|2|||
162983705|NCT02836496|588644050|FG001|Overall Study|Adverse Event|1|||
162983706|NCT02836496|588644049|FG000|Overall Study|Withdrawal by Subject|0|||
162983707|NCT02836496|588644050|FG001|Overall Study|Withdrawal by Subject|1|||
162983708|NCT01400919|588644051|FG000|Overall Study|Withdrawal by Subject|4|||
162983709|NCT01400919|588644051|FG000|Overall Study|Lost to Follow-up|2|||
162983710|NCT01400919|588644051|FG000|Overall Study|Missed visit|2|||
162983711|NCT01246011|588644052|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
162983712|NCT01246011|588644053|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
162983713|NCT01246011|588644054|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
162983714|NCT01246011|588644052|FG000|Overall Study|Withdrawal by Subject|0|||
162983715|NCT01246011|588644053|FG001|Overall Study|Withdrawal by Subject|0|||
162983716|NCT01246011|588644054|FG002|Overall Study|Withdrawal by Subject|1|||
162983717|NCT00415194|588644058|FG000|Overall Study|Adverse Event|37|||
162983718|NCT00415194|588644059|FG001|Overall Study|Adverse Event|32|||
162983719|NCT00415194|588644058|FG000|Overall Study|Entry Criteria Not Met|4|||
162983720|NCT00415194|588644059|FG001|Overall Study|Entry Criteria Not Met|8|||
162983721|NCT00415194|588644058|FG000|Overall Study|Lost to Follow-up|1|||
162983722|NCT00415194|588644059|FG001|Overall Study|Lost to Follow-up|0|||
162983723|NCT00415194|588644058|FG000|Overall Study|Physician Decision|10|||
162983724|NCT00415194|588644059|FG001|Overall Study|Physician Decision|16|||
162983725|NCT00415194|588644058|FG000|Overall Study|Progressive Disease|180|||
162983726|NCT00415194|588644059|FG001|Overall Study|Progressive Disease|217|||
162983727|NCT00415194|588644058|FG000|Overall Study|Protocol Violation|4|||
162983728|NCT00415194|588644059|FG001|Overall Study|Protocol Violation|2|||
162983729|NCT00415194|588644058|FG000|Overall Study|Withdrawal by Subject|28|||
162983730|NCT00415194|588644059|FG001|Overall Study|Withdrawal by Subject|21|||
162983731|NCT00415194|588644058|FG000|Overall Study|Death Due to Study Disease|26|||
162983732|NCT00415194|588644059|FG001|Overall Study|Death Due to Study Disease|29|||
162983733|NCT00415194|588644058|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
162983734|NCT00415194|588644059|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
162983735|NCT00415194|588644058|FG000|Overall Study|Death Due to Procedural Related AE|0|||
162983736|NCT00415194|588644059|FG001|Overall Study|Death Due to Procedural Related AE|1|||
162983737|NCT00415194|588644058|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
162983738|NCT00415194|588644059|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
162983739|NCT01297465|588644060|FG000|Overall Study|Lack of Ovarian Response|1|||
162983740|NCT01297465|588644061|FG001|Overall Study|Lack of Ovarian Response|1|||
162983741|NCT01297465|588644060|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162983742|NCT01297465|588644061|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162983743|NCT01297465|588644060|FG000|Overall Study|No Oocytes Retrieved|1|||
162983744|NCT01297465|588644061|FG001|Overall Study|No Oocytes Retrieved|1|||
162983745|NCT01297465|588644060|FG000|Overall Study|Poor oocyte quality|0|||
162983746|NCT01297465|588644061|FG001|Overall Study|Poor oocyte quality|1|||
162983747|NCT01297465|588644060|FG000|Overall Study|No Fertilization|6|||
162983748|NCT01297465|588644061|FG001|Overall Study|No Fertilization|4|||
162634685|NCT02205814|587376578|FG000|Overall Study|Lost to Follow-up|0|||
163059734|NCT01648764|588928196|FG004|Overall Study|Withdrawal by Subject|0|||
163059735|NCT01648764|588928197|FG005|Overall Study|Withdrawal by Subject|0|||
162983749|NCT01297465|588644060|FG000|Overall Study|All Embryos Discarded|0|||
162983750|NCT01297465|588644061|FG001|Overall Study|All Embryos Discarded|1|||
162983751|NCT01297465|588644060|FG000|Overall Study|Intention to Freeze all Embryos|0|||
162983752|NCT01297465|588644061|FG001|Overall Study|Intention to Freeze all Embryos|1|||
162983753|NCT00969540|588644062|FG000|Overall Study|Lost to Follow-up|1|||
162983754|NCT00969540|588644063|FG001|Overall Study|Lost to Follow-up|1|||
163059736|NCT01648764|588928198|FG006|Overall Study|Withdrawal by Subject|2|||
163059737|NCT01648764|588928199|FG007|Overall Study|Withdrawal by Subject|0|||
162983755|NCT01683838|588644064|FG000|Overall Study|Adverse Event|12|||
162983756|NCT01683838|588644065|FG001|Overall Study|Adverse Event|2|||
162983757|NCT01683838|588644064|FG000|Overall Study|Protocol Violation|3|||
162983758|NCT01683838|588644065|FG001|Overall Study|Protocol Violation|1|||
162983759|NCT01683838|588644064|FG000|Overall Study|Withdrawal by Subject|6|||
162983760|NCT01683838|588644065|FG001|Overall Study|Withdrawal by Subject|5|||
162983761|NCT01683838|588644064|FG000|Overall Study|Lost to Follow-up|1|||
162983762|NCT01683838|588644065|FG001|Overall Study|Lost to Follow-up|1|||
162983763|NCT01683838|588644064|FG000|Overall Study|Other|4|||
162983764|NCT01683838|588644065|FG001|Overall Study|Other|3|||
162983765|NCT01646138|588644066|FG000|Overall Study|Lost to Follow-up|0|||
162983766|NCT01646138|588644067|FG001|Overall Study|Lost to Follow-up|0|||
162983767|NCT01646138|588644068|FG002|Overall Study|Lost to Follow-up|0|||
162983768|NCT01646138|588644069|FG003|Overall Study|Lost to Follow-up|0|||
162983769|NCT01646138|588644070|FG004|Overall Study|Lost to Follow-up|2|||
162983770|NCT01524679|588644071|FG000|Overall Study|Lost to Follow-up|1|||
162983771|NCT01524679|588644072|FG001|Overall Study|Lost to Follow-up|4|||
162983772|NCT01524679|588644071|FG000|Overall Study|Withdrawal by Subject|4|||
162983773|NCT01524679|588644072|FG001|Overall Study|Withdrawal by Subject|4|||
162983774|NCT01524679|588644071|FG000|Overall Study|Adverse Event|9|||
162983775|NCT01524679|588644072|FG001|Overall Study|Adverse Event|0|||
162983776|NCT01524679|588644071|FG000|Overall Study|Protocol Violation|1|||
162983777|NCT01524679|588644072|FG001|Overall Study|Protocol Violation|0|||
162983778|NCT01524679|588644071|FG000|Overall Study|Lack of Efficacy|2|||
162983779|NCT01524679|588644072|FG001|Overall Study|Lack of Efficacy|0|||
162983780|NCT01524679|588644071|FG000|Overall Study|e.g.wish for children, relocation|6|||
162983781|NCT01524679|588644072|FG001|Overall Study|e.g.wish for children, relocation|1|||
162983782|NCT00801099|588644073|FG000|Overall Study|Lost to Follow-up|101|||
162983783|NCT04078126|588644076|FG000|Washout|Study put on hold due to COVID-19|0|||
162983784|NCT04078126|588644077|FG001|Washout|Study put on hold due to COVID-19|2|||
162983785|NCT04078126|588644076|FG000|Period 2|Study put on hold due to COVID-19|1|||
162983786|NCT04078126|588644077|FG001|Period 2|Study put on hold due to COVID-19|1|||
162983787|NCT03321630|588644080|FG000|Overall Study|Adverse Event|1|||
162983788|NCT03321630|588644080|FG000|Overall Study|Investigator Discretion|2|||
162983789|NCT03321630|588644080|FG000|Overall Study|Withdrawal by Subject|1|||
162983790|NCT00140426|588644081|FG000|Overall Study|Withdrawal by Subject|0|||
162983791|NCT00140426|588644082|FG001|Overall Study|Withdrawal by Subject|3|||
162983792|NCT02149108|588644083|FG000|Overall Study|Not treated|1|||
162983793|NCT02149108|588644084|FG001|Overall Study|Not treated|2|||
162983794|NCT02149108|588644083|FG000|Overall Study|Progressive Disease (PD)|324|||
162983795|NCT02149108|588644084|FG001|Overall Study|Progressive Disease (PD)|318|||
162983796|NCT02149108|588644083|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
162983797|NCT02149108|588644084|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
162983798|NCT02149108|588644083|FG000|Overall Study|Other Adverse Event (AE)|8|||
162983799|NCT02149108|588644084|FG001|Overall Study|Other Adverse Event (AE)|18|||
162983800|NCT02149108|588644083|FG000|Overall Study|Other not defined above|0|||
162983801|NCT02149108|588644084|FG001|Overall Study|Other not defined above|2|||
162983802|NCT02149108|588644083|FG000|Overall Study|Refusal to continue trial medication|15|||
163059738|NCT01648764|588928200|FG008|Overall Study|Withdrawal by Subject|0|||
163059739|NCT01648764|588928201|FG009|Overall Study|Withdrawal by Subject|0|||
163059740|NCT01648764|588928202|FG010|Overall Study|Withdrawal by Subject|0|||
162634686|NCT02205814|587376579|FG001|Overall Study|Lost to Follow-up|0|||
162983803|NCT02149108|588644084|FG001|Overall Study|Refusal to continue trial medication|11|||
162983804|NCT02149108|588644083|FG000|Overall Study|Lost to Follow-up|1|||
162983805|NCT02149108|588644084|FG001|Overall Study|Lost to Follow-up|0|||
162983806|NCT00950963|588644085|FG000|Overall Study|Lost to Follow-up|29|||
162983807|NCT00950963|588644086|FG001|Overall Study|Lost to Follow-up|24|||
162983808|NCT04168190|588644087|FG000|Overall Study|Lost to Follow-up|0|||
162983809|NCT04168190|588644088|FG001|Overall Study|Lost to Follow-up|1|||
162983810|NCT04168190|588644089|FG002|Overall Study|Lost to Follow-up|0|||
162983811|NCT04168190|588644090|FG003|Overall Study|Lost to Follow-up|7|||
162983812|NCT04168190|588644091|FG004|Overall Study|Lost to Follow-up|5|||
162983813|NCT04168190|588644087|FG000|Overall Study|Withdrawal by Subject|1|||
162983814|NCT04168190|588644088|FG001|Overall Study|Withdrawal by Subject|0|||
162983815|NCT04168190|588644089|FG002|Overall Study|Withdrawal by Subject|0|||
162983816|NCT04168190|588644090|FG003|Overall Study|Withdrawal by Subject|2|||
162983817|NCT04168190|588644091|FG004|Overall Study|Withdrawal by Subject|4|||
162983818|NCT04168190|588644087|FG000|Overall Study|Death|0|||
162983819|NCT04168190|588644088|FG001|Overall Study|Death|0|||
162983820|NCT04168190|588644089|FG002|Overall Study|Death|0|||
162983821|NCT04168190|588644090|FG003|Overall Study|Death|1|||
162983822|NCT04168190|588644091|FG004|Overall Study|Death|0|||
162983823|NCT02325518|588644092|FG000|Overall Study|Adverse Event|4|||
162983824|NCT02325518|588644093|FG001|Overall Study|Adverse Event|1|||
162983825|NCT02325518|588644092|FG000|Overall Study|Physician Decision|0|||
162983826|NCT02325518|588644093|FG001|Overall Study|Physician Decision|1|||
162983827|NCT02325518|588644092|FG000|Overall Study|Withdrawal by Subject|0|||
162983828|NCT02325518|588644093|FG001|Overall Study|Withdrawal by Subject|1|||
162983829|NCT01675661|588644094|FG000|Overall Study|Lost to Follow-up|22|||
162983830|NCT01675661|588644095|FG001|Overall Study|Lost to Follow-up|23|||
162983831|NCT01675661|588644094|FG000|Overall Study|Practical problems|9|||
162983832|NCT01675661|588644095|FG001|Overall Study|Practical problems|5|||
162983833|NCT01675661|588644094|FG000|Overall Study|Moved away|5|||
162983834|NCT01675661|588644095|FG001|Overall Study|Moved away|6|||
162983835|NCT01675661|588644094|FG000|Overall Study|Withdrawal by Subject|3|||
162983836|NCT01675661|588644095|FG001|Overall Study|Withdrawal by Subject|7|||
162983837|NCT01675661|588644094|FG000|Overall Study|Physician Decision|0|||
162983838|NCT01675661|588644095|FG001|Overall Study|Physician Decision|2|||
162983839|NCT01675661|588644094|FG000|Overall Study|Death|0|||
162983840|NCT01675661|588644095|FG001|Overall Study|Death|1|||
162983841|NCT01675661|588644094|FG000|Overall Study|Other reason|1|||
162983842|NCT01675661|588644095|FG001|Overall Study|Other reason|2|||
162983843|NCT04765384|588644096|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
162983844|NCT04765384|588644097|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
162983845|NCT04765384|588644098|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
162983846|NCT04765384|588644099|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
162983847|NCT04765384|588644100|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
162983848|NCT04765384|588644101|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
162983849|NCT04765384|588644096|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
162983850|NCT04765384|588644097|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
162983851|NCT04765384|588644098|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
162983852|NCT04765384|588644099|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
162983853|NCT04765384|588644100|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
162983854|NCT04765384|588644101|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
162983855|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983856|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983857|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983858|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983859|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
162983860|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
162983861|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Death|0|||
162983862|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Death|0|||
162983863|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Death|0|||
162983864|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Death|1|||
162983865|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Death|0|||
162983866|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Death|0|||
162983867|NCT04765384|588644096|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983868|NCT04765384|588644097|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983869|NCT04765384|588644098|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983870|NCT04765384|588644099|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983871|NCT04765384|588644100|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
162983872|NCT04765384|588644101|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
162983873|NCT00987389|588644102|FG000|Overall Study|Ineligible|0|||
162983874|NCT00987389|588644103|FG001|Overall Study|Ineligible|3|||
162983875|NCT00987389|588644104|FG002|Overall Study|Ineligible|0|||
162983876|NCT00987389|588644105|FG003|Overall Study|Ineligible|0|||
162983877|NCT00987389|588644102|FG000|Overall Study|Lost to Follow-up|4|||
162983878|NCT00987389|588644103|FG001|Overall Study|Lost to Follow-up|1|||
162983879|NCT00987389|588644104|FG002|Overall Study|Lost to Follow-up|3|||
162983880|NCT00987389|588644105|FG003|Overall Study|Lost to Follow-up|1|||
162983881|NCT00987389|588644102|FG000|Overall Study|Withdrawal by Subject|4|||
162983882|NCT00987389|588644103|FG001|Overall Study|Withdrawal by Subject|3|||
162983883|NCT00987389|588644104|FG002|Overall Study|Withdrawal by Subject|2|||
162983884|NCT00987389|588644105|FG003|Overall Study|Withdrawal by Subject|1|||
162983885|NCT00987389|588644102|FG000|Overall Study|Withdrawn from Treatment|0|||
162983886|NCT00987389|588644103|FG001|Overall Study|Withdrawn from Treatment|1|||
162983887|NCT00987389|588644104|FG002|Overall Study|Withdrawn from Treatment|0|||
162983888|NCT00987389|588644105|FG003|Overall Study|Withdrawn from Treatment|0|||
162983889|NCT00987389|588644102|FG000|Overall Study|Multiple different reasons|1|||
162983890|NCT00987389|588644103|FG001|Overall Study|Multiple different reasons|0|||
162983891|NCT00987389|588644104|FG002|Overall Study|Multiple different reasons|3|||
162983892|NCT00987389|588644105|FG003|Overall Study|Multiple different reasons|1|||
162983893|NCT02992418|588644108|FG000|Overall Study|Withdrawal by Subject|11|||
162983894|NCT02992418|588644109|FG001|Overall Study|Withdrawal by Subject|12|||
162983895|NCT02992418|588644108|FG000|Overall Study|Non-compliance with the protocol|308|||
162983896|NCT02992418|588644109|FG001|Overall Study|Non-compliance with the protocol|308|||
162983897|NCT02992418|588644108|FG000|Overall Study|Lost to Follow-up|27|||
162983898|NCT02992418|588644109|FG001|Overall Study|Lost to Follow-up|22|||
162983899|NCT00289536|588644110|FG000|Period 3|Lost to Follow-up|0|||
162983900|NCT00289536|588644111|FG001|Period 3|Lost to Follow-up|0|||
162983901|NCT00289536|588644112|FG002|Period 3|Lost to Follow-up|1|||
162983902|NCT03246126|588644113|FG000|Overall Study|Withdrawal by Subject|0|||
162983903|NCT03246126|588644114|FG001|Overall Study|Withdrawal by Subject|1|||
162983904|NCT01006135|588644117|FG000|Overall Study|Adverse Event|22|||
162983905|NCT01006135|588644117|FG000|Overall Study|Protocol Violation|14|||
162983906|NCT01006135|588644117|FG000|Overall Study|Lost to Follow-up|32|||
162983907|NCT01006135|588644117|FG000|Overall Study|Other|72|||
162983908|NCT05297578|588644118|FG000|Overall Study|Lost to Follow-up|1|||
162983909|NCT05297578|588644119|FG001|Overall Study|Lost to Follow-up|1|||
162983910|NCT05297578|588644120|FG002|Overall Study|Lost to Follow-up|2|||
162983911|NCT05297578|588644121|FG003|Overall Study|Lost to Follow-up|1|||
162983912|NCT05297578|588644118|FG000|Overall Study|Death|0|||
162983913|NCT05297578|588644119|FG001|Overall Study|Death|1|||
162983914|NCT05297578|588644120|FG002|Overall Study|Death|0|||
162983915|NCT05297578|588644121|FG003|Overall Study|Death|0|||
162983916|NCT05297578|588644118|FG000|Overall Study|Withdrawal by Subject|0|||
162983917|NCT05297578|588644119|FG001|Overall Study|Withdrawal by Subject|0|||
162983918|NCT05297578|588644120|FG002|Overall Study|Withdrawal by Subject|1|||
162983919|NCT05297578|588644121|FG003|Overall Study|Withdrawal by Subject|0|||
162983920|NCT03127644|588644122|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162983921|NCT03127644|588644123|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162983922|NCT03127644|588644124|FG002|Overall Study|Study-specific withdrawal criteria|2|||
162983923|NCT02032706|588644127|FG000|Overall Study|Did not qualify|5|||
162983924|NCT02032706|588644127|FG000|Overall Study|Protocol Violation|1|||
162983925|NCT01156142|588644128|FG000|Overall Study|Withdrawal by Subject|8|||
162983926|NCT01156142|588644129|FG001|Overall Study|Withdrawal by Subject|6|||
162983927|NCT01156142|588644128|FG000|Overall Study|Ineligible|0|||
162983928|NCT01156142|588644129|FG001|Overall Study|Ineligible|1|||
162983929|NCT00893737|588644130|FG000|Overall Study|Adverse Event|4|||
162983930|NCT00893737|588644130|FG000|Overall Study|Withdrawal by Subject|2|||
162983931|NCT00893737|588644130|FG000|Overall Study|Lost to Follow-up|6|||
162983932|NCT00928707|588644131|FG000|Overall Study|Protocol Violation|1|||
162983933|NCT00928707|588644132|FG001|Overall Study|Protocol Violation|0|||
162983934|NCT00132028|588644133|FG000|Overall Study|Adverse Event|7|||
162983935|NCT00132028|588644133|FG000|Overall Study|Death|2|||
162983936|NCT00132028|588644133|FG000|Overall Study|Lack of Efficacy|11|||
162983937|NCT00132028|588644133|FG000|Overall Study|Withdrawal by Subject|2|||
162983938|NCT00132028|588644133|FG000|Overall Study|not eligible|2|||
162983939|NCT00132028|588644133|FG000|Overall Study|Physician Decision|3|||
162983940|NCT02140411|588644134|FG000|Overall Study|Adverse Event|1|||
162983941|NCT03981419|588644137|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
162983942|NCT03981419|588644138|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
162983943|NCT01330459|588644139|FG000|Overall Study|Physician Decision|0|||
162983944|NCT01330459|588644140|FG001|Overall Study|Physician Decision|2|||
162983945|NCT02272634|588644148|FG000|Overall Study|Adverse Event|1|||
162983946|NCT02272634|588644149|FG001|Overall Study|Adverse Event|0|||
162983947|NCT02272634|588644150|FG002|Overall Study|Adverse Event|0|||
162983948|NCT02272634|588644148|FG000|Overall Study|Protocol Violation|0|||
162983949|NCT02272634|588644149|FG001|Overall Study|Protocol Violation|0|||
162983950|NCT02272634|588644150|FG002|Overall Study|Protocol Violation|1|||
162983951|NCT02272634|588644148|FG000|Overall Study|Withdrawal by Subject|0|||
162983952|NCT02272634|588644149|FG001|Overall Study|Withdrawal by Subject|1|||
162983953|NCT02272634|588644150|FG002|Overall Study|Withdrawal by Subject|0|||
162983954|NCT01437943|588644151|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
162983955|NCT01437943|588644152|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
162983956|NCT01437943|588644151|FG000|Overall Study|Subject expressed pregnancy plans|1|||
162983957|NCT01437943|588644152|FG001|Overall Study|Subject expressed pregnancy plans|0|||
162983958|NCT01437943|588644151|FG000|Overall Study|Adverse Event|2|||
162983959|NCT01437943|588644152|FG001|Overall Study|Adverse Event|0|||
162983960|NCT04647721|588644153|FG000|Overall Study|Withdrawal by Subject|0|||
162983961|NCT04647721|588644154|FG001|Overall Study|Withdrawal by Subject|2|||
162983962|NCT04647721|588644153|FG000|Overall Study|Lost to Follow-up|2|||
162983963|NCT04647721|588644154|FG001|Overall Study|Lost to Follow-up|0|||
162983964|NCT01974440|588644157|FG000|Overall Study|Lost to Follow-up|7|||
162983965|NCT01974440|588644158|FG001|Overall Study|Lost to Follow-up|7|||
162983966|NCT01974440|588644157|FG000|Overall Study|Withdrawal by Subject|24|||
162983967|NCT01974440|588644158|FG001|Overall Study|Withdrawal by Subject|20|||
162634687|NCT02205814|587376580|FG002|Overall Study|Lost to Follow-up|0|||
162983968|NCT01974440|588644157|FG000|Overall Study|Sponsor decision|109|||
162983969|NCT01974440|588644158|FG001|Overall Study|Sponsor decision|110|||
162983970|NCT00136318|588644159|FG000|Overall Study|Adverse Event|5|||
162983971|NCT00136318|588644160|FG001|Overall Study|Adverse Event|5|||
162983972|NCT00136318|588644159|FG000|Overall Study|Withdrawal by Subject|2|||
162983973|NCT00136318|588644160|FG001|Overall Study|Withdrawal by Subject|2|||
162983974|NCT02005887|588644161|FG000|Overall Study|Protocol Violation|0|||
162983975|NCT02005887|588644162|FG001|Overall Study|Protocol Violation|2|||
162983976|NCT02749292|588644164|FG000|Overall Study|Physician Decision|1|||
162634688|NCT02205814|587376581|FG003|Overall Study|Lost to Follow-up|1|||
162634689|NCT02205814|587376578|FG000|Overall Study|Lack of Efficacy|1|||
162634690|NCT02205814|587376579|FG001|Overall Study|Lack of Efficacy|0|||
162634691|NCT02205814|587376580|FG002|Overall Study|Lack of Efficacy|1|||
162634692|NCT02205814|587376581|FG003|Overall Study|Lack of Efficacy|1|||
162634693|NCT02205814|587376578|FG000|Overall Study|Physician Decision|0|||
162634694|NCT02205814|587376579|FG001|Overall Study|Physician Decision|0|||
162634695|NCT02205814|587376580|FG002|Overall Study|Physician Decision|1|||
162634696|NCT02205814|587376581|FG003|Overall Study|Physician Decision|0|||
162983977|NCT02749292|588644165|FG001|Overall Study|Physician Decision|0|||
162983978|NCT02749292|588644164|FG000|Overall Study|Withdrawal by Subject|5|||
162983979|NCT02749292|588644165|FG001|Overall Study|Withdrawal by Subject|7|||
162983980|NCT02749292|588644164|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
162983981|NCT02749292|588644165|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
162983982|NCT02749292|588644164|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
162983983|NCT02749292|588644165|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
162983984|NCT02749292|588644164|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
162983985|NCT02749292|588644165|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
162983986|NCT02749292|588644164|FG000|Overall Study|Adverse Event|4|||
162983987|NCT02749292|588644165|FG001|Overall Study|Adverse Event|1|||
162983988|NCT02749292|588644164|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
162983989|NCT02749292|588644165|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
162983990|NCT02749292|588644164|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
162983991|NCT02749292|588644165|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
162983992|NCT02749292|588644164|FG000|Overall Study|Requiring glucocorticoids|0|||
162983993|NCT02749292|588644165|FG001|Overall Study|Requiring glucocorticoids|3|||
162983994|NCT02749292|588644164|FG000|Overall Study|Cancer|1|||
162983995|NCT02749292|588644165|FG001|Overall Study|Cancer|0|||
162983996|NCT00251641|588644166|FG000|Overall Study|Adverse Event|80|||
162983997|NCT00251641|588644167|FG001|Overall Study|Adverse Event|8|||
162983998|NCT00251641|588644166|FG000|Overall Study|Lack of Efficacy|2|||
162983999|NCT00251641|588644167|FG001|Overall Study|Lack of Efficacy|1|||
162984000|NCT00251641|588644166|FG000|Overall Study|Progression of Disease|0|||
162984001|NCT00251641|588644167|FG001|Overall Study|Progression of Disease|2|||
162984002|NCT00251641|588644166|FG000|Overall Study|Lost to Follow-up|3|||
162984003|NCT00251641|588644167|FG001|Overall Study|Lost to Follow-up|3|||
162984004|NCT00251641|588644166|FG000|Overall Study|Withdrawal by Subject|6|||
162984005|NCT00251641|588644167|FG001|Overall Study|Withdrawal by Subject|8|||
162984006|NCT00251641|588644166|FG000|Overall Study|Protocol Violation|10|||
162984007|NCT00251641|588644167|FG001|Overall Study|Protocol Violation|2|||
162984008|NCT00251641|588644166|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
162984009|NCT00251641|588644167|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
162984010|NCT00251641|588644166|FG000|Overall Study|Switched Treatment|9|||
162984011|NCT00251641|588644167|FG001|Overall Study|Switched Treatment|63|||
162984012|NCT00876018|588644168|FG000|Overall Study|Lost to Follow-up|0|||
162984013|NCT00876018|588644169|FG001|Overall Study|Lost to Follow-up|1|||
162984014|NCT00876018|588644170|FG002|Overall Study|Lost to Follow-up|1|||
162984015|NCT00876018|588644168|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
162984016|NCT00876018|588644169|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
162634697|NCT02205814|587376578|FG000|Overall Study|Protocol Violation|1|||
162634698|NCT02205814|587376579|FG001|Overall Study|Protocol Violation|0|||
162634699|NCT02205814|587376580|FG002|Overall Study|Protocol Violation|0|||
162634700|NCT02205814|587376581|FG003|Overall Study|Protocol Violation|1|||
162634701|NCT02205814|587376578|FG000|Overall Study|Withdrawal by Subject|0|||
162634702|NCT02205814|587376579|FG001|Overall Study|Withdrawal by Subject|1|||
162984017|NCT00876018|588644170|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
162984018|NCT01000493|588644173|FG000|Overall Study|Adverse Event|3|||
162984019|NCT01000493|588644174|FG001|Overall Study|Adverse Event|6|||
162984020|NCT01000493|588644173|FG000|Overall Study|Lack of Efficacy|1|||
162984021|NCT01000493|588644174|FG001|Overall Study|Lack of Efficacy|1|||
162634703|NCT02205814|587376580|FG002|Overall Study|Withdrawal by Subject|2|||
162634704|NCT02205814|587376581|FG003|Overall Study|Withdrawal by Subject|1|||
162984022|NCT01000493|588644173|FG000|Overall Study|Protocol Violation|1|||
162984023|NCT01000493|588644174|FG001|Overall Study|Protocol Violation|8|||
162984024|NCT01000493|588644173|FG000|Overall Study|Study closed/terminated|25|||
162984025|NCT01000493|588644174|FG001|Overall Study|Study closed/terminated|23|||
162984026|NCT01000493|588644173|FG000|Overall Study|Lost to Follow-up|5|||
162984027|NCT01000493|588644174|FG001|Overall Study|Lost to Follow-up|9|||
162984028|NCT01000493|588644173|FG000|Overall Study|Physician Decision|1|||
162984029|NCT01000493|588644174|FG001|Overall Study|Physician Decision|1|||
162984030|NCT01000493|588644173|FG000|Overall Study|Withdrawal by Subject|3|||
162984031|NCT01000493|588644174|FG001|Overall Study|Withdrawal by Subject|7|||
162984032|NCT03629028|588644175|FG000|Overall Study|Lost to Follow-up|26|||
162984033|NCT03629028|588644176|FG001|Overall Study|Lost to Follow-up|23|||
162984034|NCT03629028|588644175|FG000|Overall Study|Pregnancy|4|||
162984035|NCT03629028|588644176|FG001|Overall Study|Pregnancy|2|||
162984036|NCT03629028|588644175|FG000|Overall Study|intolerance to examination|2|||
162984037|NCT03629028|588644176|FG001|Overall Study|intolerance to examination|0|||
162984038|NCT03828448|588644178|FG000|Overall Study|Sponsor's Discretion|34|||
162984039|NCT02192164|588644182|FG000|Overall Study|Other|8|||
162984040|NCT02192164|588644182|FG000|Overall Study|Withdrawal by Subject|1|||
162984041|NCT02192164|588644182|FG000|Overall Study|Physician Decision|4|||
162984042|NCT02192164|588644182|FG000|Overall Study|Did not meet the exclusion criteria|1|||
162984043|NCT03123861|588644183|FG000|Overall Study|Protocol Violation|1|||
162984044|NCT03123861|588644184|FG001|Overall Study|Protocol Violation|1|||
162984045|NCT03123861|588644183|FG000|Overall Study|Withdrawal by Subject|2|||
162984046|NCT03123861|588644184|FG001|Overall Study|Withdrawal by Subject|2|||
162984047|NCT05011123|588645408|FG000|Overall Study|Withdrawal by Subject|4|||
162984048|NCT05011123|588645409|FG001|Overall Study|Withdrawal by Subject|2|||
162984049|NCT05011123|588645408|FG000|Overall Study|Lost to Follow-up|7|||
162984050|NCT05011123|588645409|FG001|Overall Study|Lost to Follow-up|6|||
162984051|NCT05011123|588645408|FG000|Overall Study|Ongoing at the time of DBL date|36|||
162984052|NCT05011123|588645409|FG001|Overall Study|Ongoing at the time of DBL date|10|||
162984053|NCT05011123|588645408|FG000|Overall Study|Randomized but did not receive vaccination|1|||
162984054|NCT05011123|588645409|FG001|Overall Study|Randomized but did not receive vaccination|0|||
162984055|NCT00461253|588645410|FG000|Overall Study|Death|985|||
162984056|NCT00461253|588645411|FG001|Overall Study|Death|0|||
162984057|NCT00461253|588645410|FG000|Overall Study|Protocol Violation|613|||
162984058|NCT00461253|588645411|FG001|Overall Study|Protocol Violation|236|||
162984059|NCT00461253|588645410|FG000|Overall Study|no response|2609|||
162984060|NCT00461253|588645411|FG001|Overall Study|no response|11789|||
162984061|NCT00461253|588645410|FG000|Overall Study|administrative|773|||
162984062|NCT00461253|588645411|FG001|Overall Study|administrative|7773|||
162984063|NCT01933113|588645412|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
162984064|NCT02297438|588645413|FG000|Overall Study|Death|79|||
162984065|NCT02297438|588645414|FG001|Overall Study|Death|86|||
162984066|NCT02297438|588645413|FG000|Overall Study|Lost to Follow-up|9|||
162984067|NCT02297438|588645414|FG001|Overall Study|Lost to Follow-up|7|||
162984068|NCT02297438|588645413|FG000|Overall Study|Withdrawal by Subject|7|||
162984069|NCT02297438|588645414|FG001|Overall Study|Withdrawal by Subject|0|||
162984070|NCT02297438|588645413|FG000|Overall Study|Other|9|||
162984071|NCT02297438|588645414|FG001|Overall Study|Other|5|||
162984072|NCT02297438|588645413|FG000|Overall Study|Ongoing|65|||
162984073|NCT02297438|588645414|FG001|Overall Study|Ongoing|73|||
162984074|NCT00321828|588645415|FG000|Overall Study|Ineligible|3|||
162984075|NCT00321828|588645415|FG000|Overall Study|No follow up data|1|||
162984076|NCT00678041|588645427|FG000|Overall Study|Physician Decision|5|||
162984077|NCT00678041|588645428|FG001|Overall Study|Physician Decision|5|||
162984078|NCT02358343|588645429|FG000|Screening Intervention|Death|0|||
162984079|NCT02358343|588645430|FG001|Screening Intervention|Death|2|||
163059741|NCT01648764|588928203|FG011|Overall Study|Withdrawal by Subject|0|||
163059742|NCT01648764|588928204|FG012|Overall Study|Withdrawal by Subject|1|||
163059743|NCT01648764|588928205|FG013|Overall Study|Withdrawal by Subject|0|||
163059744|NCT01648764|588928192|FG000|Overall Study|Investigator Decision|0|||
163059745|NCT01648764|588928193|FG001|Overall Study|Investigator Decision|0|||
163059746|NCT01648764|588928194|FG002|Overall Study|Investigator Decision|0|||
162984080|NCT02358343|588645431|FG002|Screening Intervention|Death|0|||
162984081|NCT02358343|588645432|FG003|Screening Intervention|Death|0|||
162984082|NCT02358343|588645433|FG004|Screening Intervention|Death|0|||
162984083|NCT02358343|588645429|FG000|Screening Intervention|Withdrawal by Subject|1|||
162984084|NCT02358343|588645430|FG001|Screening Intervention|Withdrawal by Subject|0|||
163059747|NCT01648764|588928195|FG003|Overall Study|Investigator Decision|0|||
163059748|NCT01648764|588928196|FG004|Overall Study|Investigator Decision|0|||
163059749|NCT01648764|588928197|FG005|Overall Study|Investigator Decision|0|||
163059750|NCT01648764|588928198|FG006|Overall Study|Investigator Decision|1|||
163059751|NCT01648764|588928199|FG007|Overall Study|Investigator Decision|0|||
163059752|NCT01648764|588928200|FG008|Overall Study|Investigator Decision|0|||
163059753|NCT01648764|588928201|FG009|Overall Study|Investigator Decision|0|||
163059754|NCT01648764|588928202|FG010|Overall Study|Investigator Decision|0|||
163059755|NCT01648764|588928203|FG011|Overall Study|Investigator Decision|1|||
163059756|NCT01648764|588928204|FG012|Overall Study|Investigator Decision|0|||
163059757|NCT01648764|588928205|FG013|Overall Study|Investigator Decision|0|||
162634705|NCT02205814|587376578|FG000|Overall Study|not compliant with study procedures|0|||
162634706|NCT02205814|587376579|FG001|Overall Study|not compliant with study procedures|0|||
162984085|NCT02358343|588645431|FG002|Screening Intervention|Withdrawal by Subject|0|||
162984086|NCT02358343|588645432|FG003|Screening Intervention|Withdrawal by Subject|0|||
162984087|NCT02358343|588645433|FG004|Screening Intervention|Withdrawal by Subject|0|||
162984088|NCT02358343|588645429|FG000|Screening Intervention|Determined Ineligible|5|||
162984089|NCT02358343|588645430|FG001|Screening Intervention|Determined Ineligible|6|||
162984090|NCT02358343|588645431|FG002|Screening Intervention|Determined Ineligible|0|||
162984091|NCT02358343|588645432|FG003|Screening Intervention|Determined Ineligible|0|||
162984092|NCT02358343|588645433|FG004|Screening Intervention|Determined Ineligible|0|||
162984093|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Death|0|||
162984094|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Death|0|||
162984095|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Death|2|||
162984096|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Death|0|||
162984097|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Death|0|||
162984098|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
162984099|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
162984100|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984101|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984102|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
162984103|NCT02358343|588645429|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984104|NCT02358343|588645430|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984105|NCT02358343|588645431|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
162984106|NCT02358343|588645432|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984107|NCT02358343|588645433|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
162984108|NCT00577395|588645436|FG000|Overall Study|Study was terminated early by Sponsor|7|||
162984109|NCT00577395|588645437|FG001|Overall Study|Study was terminated early by Sponsor|6|||
162984110|NCT04322149|588645438|FG000|Overall Study|Adverse Event|1|||
162984111|NCT04322149|588645439|FG001|Overall Study|Adverse Event|1|||
162984112|NCT04322149|588645440|FG002|Overall Study|Adverse Event|0|||
162984113|NCT04322149|588645441|FG003|Overall Study|Adverse Event|0|||
162984114|NCT04322149|588645438|FG000|Overall Study|Withdrawal by Subject|0|||
162984115|NCT04322149|588645439|FG001|Overall Study|Withdrawal by Subject|0|||
162984116|NCT04322149|588645440|FG002|Overall Study|Withdrawal by Subject|0|||
162984117|NCT04322149|588645441|FG003|Overall Study|Withdrawal by Subject|2|||
162984118|NCT04322149|588645438|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984119|NCT04322149|588645439|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
162984120|NCT04322149|588645440|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984121|NCT04322149|588645441|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
162984122|NCT01700049|588645444|FG000|Overall Study|Withdrawal by Subject|1|||
162984123|NCT00792935|588645445|FG000|Overall Study|Adverse Event|2|||
162984124|NCT00792935|588645446|FG001|Overall Study|Adverse Event|1|||
162984125|NCT00792935|588645445|FG000|Overall Study|Lost to Follow-up|0|||
162984126|NCT00792935|588645446|FG001|Overall Study|Lost to Follow-up|1|||
162984127|NCT00792935|588645445|FG000|Overall Study|Protocol Violation|2|||
162984128|NCT00792935|588645446|FG001|Overall Study|Protocol Violation|0|||
162984129|NCT00792935|588645445|FG000|Overall Study|Withdrawal by Subject|0|||
162984130|NCT00792935|588645446|FG001|Overall Study|Withdrawal by Subject|1|||
162984131|NCT03084367|588645450|FG000|Overall Study|Lost to Follow-up|32|||
162984132|NCT03084367|588645450|FG000|Overall Study|Withdrawal by Subject|4|||
162984133|NCT03084367|588645450|FG000|Overall Study|Other|1|||
162984134|NCT01206101|588645451|FG000|Overall Study|Adverse Event|1|||
162984135|NCT01206101|588645452|FG001|Overall Study|Adverse Event|0|||
162984136|NCT01206101|588645451|FG000|Overall Study|Physician Decision|0|||
162984137|NCT01206101|588645452|FG001|Overall Study|Physician Decision|1|||
162984138|NCT01206101|588645451|FG000|Overall Study|Unclassified|1|||
162984139|NCT01206101|588645452|FG001|Overall Study|Unclassified|0|||
162984140|NCT00368979|588645458|FG000|Overall Study|Adverse Event|9|||
162984141|NCT00368979|588645459|FG001|Overall Study|Adverse Event|16|||
162984142|NCT00368979|588645458|FG000|Overall Study|Lack of Efficacy|5|||
163059758|NCT03801252|588928206|FG000|Overall Study|Protocol Violation|1|||
162634707|NCT02205814|587376580|FG002|Overall Study|not compliant with study procedures|1|||
162634708|NCT02205814|587376581|FG003|Overall Study|not compliant with study procedures|0|||
162634709|NCT01426373|587376582|FG000|Overall Study|Adverse Event|6|||
162634710|NCT01426373|587376582|FG000|Overall Study|Lost to Follow-up|14|||
162634711|NCT01426373|587376582|FG000|Overall Study|Participant Convenience|10|||
162634712|NCT01426373|587376582|FG000|Overall Study|Miscellaneous Reasons|4|||
162634713|NCT00726661|587376585|FG000|Overall Study|Lost to Follow-up|36|||
162634714|NCT00726661|587376586|FG001|Overall Study|Lost to Follow-up|11|||
162634715|NCT00726661|587376585|FG000|Overall Study|Withdrawal by Subject|17|||
162984143|NCT00368979|588645459|FG001|Overall Study|Lack of Efficacy|3|||
162984144|NCT00368979|588645458|FG000|Overall Study|Other|3|||
162984145|NCT00368979|588645459|FG001|Overall Study|Other|1|||
162984146|NCT00368979|588645458|FG000|Overall Study|Lost to Follow-up|1|||
162984147|NCT00368979|588645459|FG001|Overall Study|Lost to Follow-up|0|||
162984148|NCT00368979|588645458|FG000|Overall Study|Protocol Violation|2|||
162984149|NCT00368979|588645459|FG001|Overall Study|Protocol Violation|1|||
162984150|NCT00368979|588645458|FG000|Overall Study|Withdrawal by Subject|5|||
162984151|NCT00368979|588645459|FG001|Overall Study|Withdrawal by Subject|9|||
162984152|NCT00103311|588645460|FG000|Overall Study|Lost to Follow-up|1|||
162984153|NCT00103311|588645461|FG001|Overall Study|Lost to Follow-up|0|||
162984154|NCT00103311|588645460|FG000|Overall Study|Withdrawal by Subject|2|||
162984155|NCT00103311|588645461|FG001|Overall Study|Withdrawal by Subject|1|||
162984156|NCT00103311|588645460|FG000|Overall Study|Adverse Event|1|||
162984157|NCT00103311|588645461|FG001|Overall Study|Adverse Event|0|||
162984158|NCT00912093|588645462|FG000|The Controlled Phase|Death|0|||
162984159|NCT00912093|588645463|FG001|The Controlled Phase|Death|1|||
162984160|NCT00912093|588645464|FG002|The Controlled Phase|Death|0|||
162984161|NCT00912093|588645465|FG003|The Controlled Phase|Death|0|||
162984162|NCT00912093|588645466|FG004|The Controlled Phase|Death|0|||
162984163|NCT00912093|588645462|FG000|The Controlled Phase|Medical Condition|0|||
162984164|NCT00912093|588645463|FG001|The Controlled Phase|Medical Condition|1|||
162984165|NCT00912093|588645464|FG002|The Controlled Phase|Medical Condition|0|||
162984166|NCT00912093|588645465|FG003|The Controlled Phase|Medical Condition|0|||
162984167|NCT00912093|588645466|FG004|The Controlled Phase|Medical Condition|0|||
162984168|NCT00912093|588645462|FG000|The Controlled Phase|Lost to Follow-up|0|||
162984169|NCT00912093|588645463|FG001|The Controlled Phase|Lost to Follow-up|0|||
162984170|NCT00912093|588645464|FG002|The Controlled Phase|Lost to Follow-up|0|||
162984171|NCT00912093|588645465|FG003|The Controlled Phase|Lost to Follow-up|0|||
162984172|NCT00912093|588645466|FG004|The Controlled Phase|Lost to Follow-up|1|||
162984173|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Other|2|||
162984174|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Other|0|||
162984175|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Other|0|||
162984176|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
162984177|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
162984178|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
162984179|NCT01462318|588645469|FG000|Main Study / TP-DI Study|Adverse Event|4|||
162984180|NCT01462318|588645470|FG001|Main Study / TP-DI Study|Adverse Event|0|||
162984181|NCT01462318|588645471|FG002|Main Study / TP-DI Study|Adverse Event|0|||
162984182|NCT01462318|588645469|FG000|Extension Phase|Lost to Follow-up|0|||
162984183|NCT01462318|588645470|FG001|Extension Phase|Lost to Follow-up|0|||
162984184|NCT01462318|588645471|FG002|Extension Phase|Lost to Follow-up|1|||
162984185|NCT01462318|588645469|FG000|Extension Phase|Other|0|||
162984186|NCT01462318|588645470|FG001|Extension Phase|Other|0|||
162984187|NCT01462318|588645471|FG002|Extension Phase|Other|1|||
162984188|NCT01462318|588645469|FG000|Extension Phase|Disease Progression|0|||
162984189|NCT01462318|588645470|FG001|Extension Phase|Disease Progression|0|||
162984190|NCT01462318|588645471|FG002|Extension Phase|Disease Progression|1|||
162634716|NCT00726661|587376586|FG001|Overall Study|Withdrawal by Subject|13|||
162634717|NCT00726661|587376585|FG000|Overall Study|Trial terminated by sponsor|214|||
162634718|NCT00726661|587376586|FG001|Overall Study|Trial terminated by sponsor|187|||
162634719|NCT00726661|587376585|FG000|Overall Study|Death|475|||
162634720|NCT00726661|587376586|FG001|Overall Study|Death|159|||
162634721|NCT00726661|587376585|FG000|Overall Study|Physician Decision|25|||
162634722|NCT00726661|587376586|FG001|Overall Study|Physician Decision|13|||
162634723|NCT00726661|587376585|FG000|Overall Study|Other|47|||
162634724|NCT00726661|587376586|FG001|Overall Study|Other|35|||
162634725|NCT02557646|587376589|FG000|Overall Study|Adverse Event|40|||
162634726|NCT02557646|587376589|FG000|Overall Study|Death|1|||
162634727|NCT02557646|587376589|FG000|Overall Study|Lack of Efficacy|186|||
162634728|NCT02557646|587376589|FG000|Overall Study|Withdrawal by Subject|18|||
162634729|NCT02557646|587376589|FG000|Overall Study|Lost to Follow-up|17|||
162634730|NCT02557646|587376589|FG000|Overall Study|Other|14|||
162634731|NCT00005937|587376595|FG000|Overall Study|Lack of Efficacy|5|||
162634732|NCT00160251|587376596|FG000|Prior to Amendment 2|Adverse Event|2|||
162634733|NCT00160251|587376597|FG001|Prior to Amendment 2|Adverse Event|1|||
162634734|NCT00160251|587376598|FG002|Prior to Amendment 2|Adverse Event|3|||
162984191|NCT01462318|588645469|FG000|Extension Phase|Withdrawal by Subject|0|||
162984192|NCT01462318|588645470|FG001|Extension Phase|Withdrawal by Subject|0|||
162984193|NCT01462318|588645471|FG002|Extension Phase|Withdrawal by Subject|15|||
162984194|NCT01462318|588645469|FG000|Extension Phase|Investigator Decision|0|||
162984195|NCT01462318|588645470|FG001|Extension Phase|Investigator Decision|0|||
162984196|NCT01462318|588645471|FG002|Extension Phase|Investigator Decision|5|||
162984197|NCT01462318|588645469|FG000|Extension Phase|Adverse Event|0|||
162984198|NCT01462318|588645470|FG001|Extension Phase|Adverse Event|0|||
162984199|NCT01462318|588645471|FG002|Extension Phase|Adverse Event|22|||
162984200|NCT00270257|588645472|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
162984201|NCT00270257|588645473|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
162984202|NCT01195103|588645476|FG000|Overall Study|Withdrawal by Subject|1|||
162984203|NCT01195103|588645477|FG001|Overall Study|Withdrawal by Subject|0|||
162984204|NCT01195103|588645478|FG002|Overall Study|Withdrawal by Subject|0|||
162984205|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
162984206|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
162984207|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
162984208|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
162984209|NCT01155024|588645480|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
162984210|NCT01155024|588645481|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
162984211|NCT01593696|588645482|FG000|Dose Escalation|Progressive Disease|2|||
162634735|NCT00160251|587376599|FG003|Prior to Amendment 2|Adverse Event|1|||
162634736|NCT00160251|587376600|FG004|Prior to Amendment 2|Adverse Event|1|||
162634737|NCT00160251|587376601|FG005|Prior to Amendment 2|Adverse Event|1|||
162634738|NCT00160251|587376602|FG006|Prior to Amendment 2|Adverse Event|1|||
162634739|NCT00160251|587376603|FG007|Prior to Amendment 2|Adverse Event|0|||
162634740|NCT00160251|587376596|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
162634741|NCT00160251|587376597|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
162984212|NCT01593696|588645483|FG001|Dose Escalation|Progressive Disease|0|||
162984213|NCT01593696|588645484|FG002|Dose Escalation|Progressive Disease|0|||
162634742|NCT00160251|587376598|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
162634743|NCT00160251|587376599|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
162634744|NCT00160251|587376600|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
162634745|NCT00160251|587376601|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
162634746|NCT00160251|587376602|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
162634747|NCT00160251|587376603|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
162634748|NCT00160251|587376596|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
162634749|NCT00160251|587376597|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
162634750|NCT00160251|587376598|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
162634751|NCT00160251|587376599|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
162634752|NCT00160251|587376600|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
162634753|NCT00160251|587376601|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
162634754|NCT00160251|587376602|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
162634755|NCT00160251|587376603|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
162634756|NCT00160251|587376596|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
162634757|NCT00160251|587376597|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
162634758|NCT00160251|587376598|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
162634759|NCT00160251|587376599|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
162634760|NCT00160251|587376600|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
162634761|NCT00160251|587376601|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
162634762|NCT00160251|587376602|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
162634763|NCT00160251|587376603|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
162634764|NCT00160251|587376596|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
162634765|NCT00160251|587376597|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
162634766|NCT00160251|587376598|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
162634767|NCT00160251|587376599|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
162634768|NCT00160251|587376600|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
162634769|NCT00160251|587376601|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
162634770|NCT00160251|587376602|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
162634771|NCT00160251|587376603|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
162634772|NCT00160251|587376596|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
162634773|NCT00160251|587376597|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
162634774|NCT00160251|587376598|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
162634775|NCT00160251|587376599|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
162634776|NCT00160251|587376600|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
162634777|NCT00160251|587376601|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
162634778|NCT00160251|587376602|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
162634779|NCT00160251|587376603|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
162634780|NCT00160251|587376596|FG000|Post-amendment 2|Adverse Event|0|||
162634781|NCT00160251|587376597|FG001|Post-amendment 2|Adverse Event|0|||
162634782|NCT00160251|587376598|FG002|Post-amendment 2|Adverse Event|0|||
162634783|NCT00160251|587376599|FG003|Post-amendment 2|Adverse Event|0|||
162634784|NCT00160251|587376600|FG004|Post-amendment 2|Adverse Event|0|||
162984214|NCT01593696|588645485|FG003|Dose Escalation|Progressive Disease|0|||
162984215|NCT01593696|588645482|FG000|Dose Expansion|Fungal infection|0|||
162714648|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
162714649|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
162714650|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162714651|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162714652|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162714653|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
162714654|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
162714655|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162714656|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162714657|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162714658|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162714659|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162714660|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
162714661|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
162714662|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162714663|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162714664|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162714665|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
162714666|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
162714667|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
162714668|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162714669|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162714670|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162714671|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162714672|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
162714673|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162714674|NCT03370133|587664035|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162714675|NCT03370133|587664036|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162714676|NCT03370133|587664037|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162714677|NCT03370133|587664038|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162714678|NCT03370133|587664039|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162714679|NCT03370133|587664040|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
162714680|NCT06688370|587664041|FG000|Overall Study|Discontinued the treatment|1|||
162714681|NCT06688370|587664041|FG000|Overall Study|Prohibited treatment taken|4|||
162714682|NCT02501811|587664042|FG000|Overall Study|Death|1|||
162714683|NCT02501811|587664043|FG001|Overall Study|Death|3|||
162714684|NCT02501811|587664044|FG002|Overall Study|Death|2|||
162714685|NCT02501811|587664045|FG003|Overall Study|Death|3|||
162714686|NCT02501811|587664042|FG000|Overall Study|Withdrawal by Subject|3|||
162714687|NCT02501811|587664043|FG001|Overall Study|Withdrawal by Subject|3|||
162714688|NCT02501811|587664044|FG002|Overall Study|Withdrawal by Subject|2|||
162714689|NCT02501811|587664045|FG003|Overall Study|Withdrawal by Subject|3|||
162714690|NCT02501811|587664042|FG000|Overall Study|Lost to Follow-up|0|||
162714691|NCT02501811|587664043|FG001|Overall Study|Lost to Follow-up|0|||
162714692|NCT02501811|587664044|FG002|Overall Study|Lost to Follow-up|2|||
162714693|NCT02501811|587664045|FG003|Overall Study|Lost to Follow-up|1|||
162714694|NCT04804605|587665745|FG000|Overall Study|Withdrawal by Subject|46|||
162714695|NCT04804605|587665746|FG001|Overall Study|Withdrawal by Subject|26|||
162714696|NCT04804605|587665747|FG002|Overall Study|Withdrawal by Subject|37|||
162714697|NCT04804605|587665748|FG003|Overall Study|Withdrawal by Subject|21|||
162714698|NCT04804605|587665745|FG000|Overall Study|Lost to Follow-up|47|||
162714699|NCT04804605|587665746|FG001|Overall Study|Lost to Follow-up|21|||
162714700|NCT04804605|587665747|FG002|Overall Study|Lost to Follow-up|30|||
162714701|NCT04804605|587665748|FG003|Overall Study|Lost to Follow-up|17|||
162714702|NCT04804605|587665745|FG000|Overall Study|Lack of Efficacy|28|||
162714703|NCT04804605|587665746|FG001|Overall Study|Lack of Efficacy|11|||
162714704|NCT04804605|587665747|FG002|Overall Study|Lack of Efficacy|37|||
162714705|NCT04804605|587665748|FG003|Overall Study|Lack of Efficacy|8|||
162714706|NCT04804605|587665745|FG000|Overall Study|Adverse Event|10|||
162714707|NCT04804605|587665746|FG001|Overall Study|Adverse Event|10|||
162714708|NCT04804605|587665747|FG002|Overall Study|Adverse Event|10|||
162714709|NCT04804605|587665748|FG003|Overall Study|Adverse Event|7|||
162714710|NCT04804605|587665745|FG000|Overall Study|Non-compliance|8|||
162714711|NCT04804605|587665746|FG001|Overall Study|Non-compliance|3|||
162714712|NCT04804605|587665747|FG002|Overall Study|Non-compliance|5|||
162714713|NCT04804605|587665748|FG003|Overall Study|Non-compliance|1|||
162714714|NCT04804605|587665745|FG000|Overall Study|Physician Decision|3|||
162714715|NCT04804605|587665746|FG001|Overall Study|Physician Decision|0|||
162714716|NCT04804605|587665747|FG002|Overall Study|Physician Decision|5|||
162714717|NCT04804605|587665748|FG003|Overall Study|Physician Decision|0|||
162714718|NCT04804605|587665745|FG000|Overall Study|Protocol Violation|1|||
162984216|NCT01593696|588645483|FG001|Dose Expansion|Fungal infection|0|||
162984217|NCT01593696|588645484|FG002|Dose Expansion|Fungal infection|1|||
162984218|NCT01593696|588645485|FG003|Dose Expansion|Fungal infection|0|||
162984219|NCT00369655|588645486|FG000|Overall Study|Refusal of further treatment|2|||
162984220|NCT04049617|588645487|FG000|Overall Study|Adverse Event|0|||
162984221|NCT04049617|588645488|FG001|Overall Study|Adverse Event|0|||
162634785|NCT00160251|587376601|FG005|Post-amendment 2|Adverse Event|0|||
162634786|NCT00160251|587376602|FG006|Post-amendment 2|Adverse Event|0|||
162634787|NCT00160251|587376603|FG007|Post-amendment 2|Adverse Event|20|||
162634788|NCT00160251|587376596|FG000|Post-amendment 2|Lack of Efficacy|0|||
162634789|NCT00160251|587376597|FG001|Post-amendment 2|Lack of Efficacy|0|||
162634790|NCT00160251|587376598|FG002|Post-amendment 2|Lack of Efficacy|0|||
162634791|NCT00160251|587376599|FG003|Post-amendment 2|Lack of Efficacy|0|||
162634792|NCT00160251|587376600|FG004|Post-amendment 2|Lack of Efficacy|0|||
162634793|NCT00160251|587376601|FG005|Post-amendment 2|Lack of Efficacy|0|||
162634794|NCT00160251|587376602|FG006|Post-amendment 2|Lack of Efficacy|0|||
162634795|NCT00160251|587376603|FG007|Post-amendment 2|Lack of Efficacy|24|||
162634796|NCT00160251|587376596|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634797|NCT00160251|587376597|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634798|NCT00160251|587376598|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634799|NCT00160251|587376599|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634800|NCT00160251|587376600|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634801|NCT00160251|587376601|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634802|NCT00160251|587376602|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162634803|NCT00160251|587376603|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
162634804|NCT01288469|587376604|FG000|Overall Study|Adverse Event|4|||
162634805|NCT01288469|587376605|FG001|Overall Study|Adverse Event|1|||
162634806|NCT01288469|587376606|FG002|Overall Study|Adverse Event|1|||
162634807|NCT01288469|587376604|FG000|Overall Study|Poor compliance to protocol|0|||
162634808|NCT01288469|587376605|FG001|Overall Study|Poor compliance to protocol|1|||
162634809|NCT01288469|587376606|FG002|Overall Study|Poor compliance to protocol|0|||
162634810|NCT01288469|587376604|FG000|Overall Study|Participant Moved|1|||
162634811|NCT01288469|587376605|FG001|Overall Study|Participant Moved|0|||
162634812|NCT01288469|587376606|FG002|Overall Study|Participant Moved|0|||
162634813|NCT01288469|587376604|FG000|Overall Study|Consent withdrawn by subject|1|||
162634814|NCT01288469|587376605|FG001|Overall Study|Consent withdrawn by subject|1|||
163059759|NCT03801252|588928207|FG001|Overall Study|Protocol Violation|2|||
163059760|NCT01732692|588928211|FG000|Overall Study|Adverse Event|0|||
163059761|NCT01732692|588928212|FG001|Overall Study|Adverse Event|1|||
163059762|NCT01027949|588928213|FG000|Overall Study|Death|174|||
163059763|NCT01027949|588928213|FG000|Overall Study|Progressive Disease|163|||
163059764|NCT01027949|588928213|FG000|Overall Study|Adverse Event|172|||
163059765|NCT01027949|588928213|FG000|Overall Study|Withdrawal by Subject|113|||
163059766|NCT01027949|588928213|FG000|Overall Study|Lost to Follow-up|17|||
163059767|NCT01027949|588928213|FG000|Overall Study|Protocol Violation|13|||
163059768|NCT01027949|588928213|FG000|Overall Study|PI Decision|8|||
163059769|NCT01027949|588928213|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
163059770|NCT01027949|588928213|FG000|Overall Study|Non-compliance with Study Procedures|7|||
163059771|NCT01027949|588928213|FG000|Overall Study|Lung Transplant|5|||
163059772|NCT01027949|588928213|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
163059773|NCT01027949|588928213|FG000|Overall Study|Use of Excluded Medication|2|||
163059774|NCT01027949|588928213|FG000|Overall Study|Patient Self-discontinuation|1|||
163059775|NCT01027949|588928213|FG000|Overall Study|Pregnancy|1|||
163059776|NCT01027949|588928213|FG000|Overall Study|Surgery|1|||
163059777|NCT00656617|588928214|FG000|Overall Study|Adverse Event|1|||
163059778|NCT00656617|588928214|FG000|Overall Study|Death|2|||
163059779|NCT00656617|588928214|FG000|Overall Study|Insurance Issues|2|||
163059780|NCT00656617|588928214|FG000|Overall Study|Move to different clinical trial|2|||
163059781|NCT02030600|588928217|FG000|Treatment Period 1|Adverse Event|5|||
163059782|NCT02030600|588928218|FG001|Treatment Period 1|Adverse Event|7|||
163059783|NCT02030600|588928217|FG000|Treatment Period 1|Lack of Efficacy|0|||
162984222|NCT04049617|588645489|FG002|Overall Study|Adverse Event|0|||
163059784|NCT02030600|588928218|FG001|Treatment Period 1|Lack of Efficacy|1|||
163059785|NCT02030600|588928217|FG000|Treatment Period 1|Lost to Follow-up|11|||
162634815|NCT01288469|587376606|FG002|Overall Study|Consent withdrawn by subject|1|||
162634816|NCT01288469|587376604|FG000|Overall Study|Exclusion criteria finally met|1|||
162634817|NCT01288469|587376605|FG001|Overall Study|Exclusion criteria finally met|0|||
162634818|NCT01288469|587376606|FG002|Overall Study|Exclusion criteria finally met|0|||
162634819|NCT01574612|587376607|FG000|Overall Study|Adverse Event|3|||
162634820|NCT01574612|587376607|FG000|Overall Study|non compliant with drug|2|||
162984223|NCT04049617|588645490|FG003|Overall Study|Adverse Event|1|||
162984224|NCT04049617|588645491|FG004|Overall Study|Adverse Event|0|||
163059786|NCT02030600|588928218|FG001|Treatment Period 1|Lost to Follow-up|3|||
163059787|NCT02030600|588928217|FG000|Treatment Period 1|Protocol Violation|22|||
163059788|NCT02030600|588928218|FG001|Treatment Period 1|Protocol Violation|17|||
163059789|NCT02030600|588928217|FG000|Treatment Period 1|Withdrawal by Subject|13|||
162634821|NCT01574612|587376607|FG000|Overall Study|Withdrawal by Subject|1|||
162634822|NCT01574612|587376607|FG000|Overall Study|Lost to Follow-up|2|||
162634823|NCT00582166|587376608|FG000|Overall Study|Death|1|||
162634824|NCT00582166|587376608|FG000|Overall Study|Ineligible pathology|1|||
162634825|NCT01606436|587376609|FG000|Overall Study|Withdrawal by Subject|0|||
162984225|NCT04049617|588645492|FG005|Overall Study|Adverse Event|0|||
162984226|NCT04049617|588645487|FG000|Overall Study|Death|0|||
162984227|NCT04049617|588645488|FG001|Overall Study|Death|0|||
162984228|NCT04049617|588645489|FG002|Overall Study|Death|0|||
162984229|NCT04049617|588645490|FG003|Overall Study|Death|0|||
162984230|NCT04049617|588645491|FG004|Overall Study|Death|0|||
162984231|NCT04049617|588645492|FG005|Overall Study|Death|1|||
162984232|NCT04049617|588645487|FG000|Overall Study|Lost to Follow-up|0|||
162984233|NCT04049617|588645488|FG001|Overall Study|Lost to Follow-up|0|||
162984234|NCT04049617|588645489|FG002|Overall Study|Lost to Follow-up|0|||
162984235|NCT04049617|588645490|FG003|Overall Study|Lost to Follow-up|1|||
162984236|NCT04049617|588645491|FG004|Overall Study|Lost to Follow-up|0|||
162984237|NCT04049617|588645492|FG005|Overall Study|Lost to Follow-up|0|||
162984238|NCT04049617|588645487|FG000|Overall Study|Withdrew consent|0|||
162984239|NCT04049617|588645488|FG001|Overall Study|Withdrew consent|0|||
162984240|NCT04049617|588645489|FG002|Overall Study|Withdrew consent|1|||
162984241|NCT04049617|588645490|FG003|Overall Study|Withdrew consent|0|||
162984242|NCT04049617|588645491|FG004|Overall Study|Withdrew consent|0|||
162984243|NCT04049617|588645492|FG005|Overall Study|Withdrew consent|0|||
162984244|NCT01780987|588645493|FG000|Overall Study|Adverse Event|0|||
162984245|NCT01780987|588645494|FG001|Overall Study|Adverse Event|4|||
162984246|NCT01780987|588645493|FG000|Overall Study|Withdrawal by Subject|2|||
162984247|NCT01780987|588645494|FG001|Overall Study|Withdrawal by Subject|0|||
162984248|NCT01780987|588645493|FG000|Overall Study|Request of Changing Hospital|0|||
162984249|NCT01780987|588645494|FG001|Overall Study|Request of Changing Hospital|1|||
162984250|NCT01780987|588645493|FG000|Overall Study|Changing Residence|1|||
162984251|NCT01780987|588645494|FG001|Overall Study|Changing Residence|0|||
162984252|NCT01780987|588645493|FG000|Overall Study|Not Receiving any Study Medication|0|||
162984253|NCT01780987|588645494|FG001|Overall Study|Not Receiving any Study Medication|1|||
162984254|NCT03402750|588645495|FG000|Overall Study|Lost to Follow-up|2|||
162984255|NCT03402750|588645496|FG001|Overall Study|Lost to Follow-up|1|||
162984256|NCT02981303|588645497|FG000|Overall Study|Progressive Disease|17|||
162984257|NCT02981303|588645498|FG001|Overall Study|Progressive Disease|37|||
162984258|NCT02981303|588645497|FG000|Overall Study|Adverse Event|1|||
162984259|NCT02981303|588645498|FG001|Overall Study|Adverse Event|4|||
162984260|NCT02981303|588645497|FG000|Overall Study|Withdrawal by Subject|0|||
162984261|NCT02981303|588645498|FG001|Overall Study|Withdrawal by Subject|1|||
162984262|NCT00302081|588645499|FG000|Overall Study|Adverse Event|6|||
162984263|NCT00302081|588645500|FG001|Overall Study|Adverse Event|5|||
162984264|NCT00302081|588645501|FG002|Overall Study|Adverse Event|4|||
162984265|NCT00302081|588645499|FG000|Overall Study|Lost to Follow-up|21|||
162984266|NCT00302081|588645500|FG001|Overall Study|Lost to Follow-up|18|||
162984267|NCT00302081|588645501|FG002|Overall Study|Lost to Follow-up|28|||
162984268|NCT00302081|588645499|FG000|Overall Study|Withdrawal by Subject|8|||
162984269|NCT00302081|588645500|FG001|Overall Study|Withdrawal by Subject|12|||
162984270|NCT00302081|588645501|FG002|Overall Study|Withdrawal by Subject|8|||
162984271|NCT00302081|588645499|FG000|Overall Study|Protocol Violation|5|||
162984272|NCT00302081|588645500|FG001|Overall Study|Protocol Violation|1|||
162984273|NCT00302081|588645501|FG002|Overall Study|Protocol Violation|2|||
162984274|NCT00302081|588645499|FG000|Overall Study|Lack of Efficacy|1|||
162984275|NCT00302081|588645500|FG001|Overall Study|Lack of Efficacy|0|||
162984276|NCT00302081|588645501|FG002|Overall Study|Lack of Efficacy|5|||
162984277|NCT00302081|588645499|FG000|Overall Study|Death|2|||
162984278|NCT00302081|588645500|FG001|Overall Study|Death|1|||
162984279|NCT00302081|588645501|FG002|Overall Study|Death|0|||
162984280|NCT00302081|588645499|FG000|Overall Study|Other|13|||
162984281|NCT00302081|588645500|FG001|Overall Study|Other|6|||
163059790|NCT02030600|588928218|FG001|Treatment Period 1|Withdrawal by Subject|17|||
163059791|NCT02030600|588928217|FG000|Treatment Period 1|Casebook Unsigned|1|||
162984282|NCT00302081|588645501|FG002|Overall Study|Other|5|||
162984283|NCT02701413|588645502|FG000|Overall Study|Withdrawal by Subject|7|||
162984284|NCT02701413|588645503|FG001|Overall Study|Withdrawal by Subject|11|||
162984285|NCT02138136|588645504|FG000|Overall Study|Protocol Violation|4|||
162984286|NCT02138136|588645504|FG000|Overall Study|Physician Decision|7|||
163059792|NCT02030600|588928218|FG001|Treatment Period 1|Casebook Unsigned|0|||
163059793|NCT02030600|588928217|FG000|Treatment Period 1|Unclassified|1|||
162984287|NCT02138136|588645504|FG000|Overall Study|Lack of Efficacy|35|||
162984288|NCT02138136|588645504|FG000|Overall Study|Pregnancy|2|||
162984289|NCT02138136|588645504|FG000|Overall Study|Adverse Event|18|||
162984290|NCT02138136|588645504|FG000|Overall Study|Withdrawal by Subject|36|||
162984291|NCT02138136|588645504|FG000|Overall Study|Lost to Follow-up|32|||
162984292|NCT02138136|588645504|FG000|Overall Study|Withdrawn by Sponsor|5|||
162984293|NCT01660334|588645509|FG000|Overall Study|Lost to Follow-up|1|||
162984294|NCT00536263|588645510|FG000|Overall Study|Adverse Event|5|||
163059794|NCT02030600|588928218|FG001|Treatment Period 1|Unclassified|0|||
162984295|NCT00536263|588645511|FG001|Overall Study|Adverse Event|5|||
162984296|NCT00536263|588645512|FG002|Overall Study|Adverse Event|7|||
162984297|NCT00536263|588645510|FG000|Overall Study|Lost to Follow-up|3|||
162984298|NCT00536263|588645511|FG001|Overall Study|Lost to Follow-up|4|||
162984299|NCT00536263|588645512|FG002|Overall Study|Lost to Follow-up|4|||
162984300|NCT00536263|588645510|FG000|Overall Study|Subject withdrew - not treatment related|2|||
162984301|NCT00536263|588645511|FG001|Overall Study|Subject withdrew - not treatment related|0|||
162984302|NCT00536263|588645512|FG002|Overall Study|Subject withdrew - not treatment related|5|||
162984303|NCT00536263|588645510|FG000|Overall Study|Subject withdrew - treatment related|0|||
162984304|NCT00536263|588645511|FG001|Overall Study|Subject withdrew - treatment related|3|||
162984305|NCT00536263|588645512|FG002|Overall Study|Subject withdrew - treatment related|2|||
162984306|NCT00536263|588645510|FG000|Overall Study|Noncompliance with protocol|0|||
162984307|NCT00536263|588645511|FG001|Overall Study|Noncompliance with protocol|0|||
162984308|NCT00536263|588645512|FG002|Overall Study|Noncompliance with protocol|1|||
162634826|NCT01606436|587376610|FG001|Overall Study|Withdrawal by Subject|0|||
162984309|NCT00536263|588645510|FG000|Overall Study|Did not meet protocol eligibility|1|||
162984310|NCT00536263|588645511|FG001|Overall Study|Did not meet protocol eligibility|2|||
162984311|NCT00536263|588645512|FG002|Overall Study|Did not meet protocol eligibility|2|||
162984312|NCT00160641|588645519|FG000|Overall Study|Adverse Event|102|||
162984313|NCT00160641|588645519|FG000|Overall Study|Withdrawal by Subject|87|||
162984314|NCT00160641|588645519|FG000|Overall Study|Lost to Follow-up|8|||
162984315|NCT00160641|588645519|FG000|Overall Study|Lack of Efficacy|12|||
162984316|NCT00160641|588645519|FG000|Overall Study|Protocol Violation|3|||
162984317|NCT00160641|588645519|FG000|Overall Study|Other|9|||
162984318|NCT01640873|588645524|FG000|Overall Study|Protocol Violation|2|||
162984319|NCT01640873|588645525|FG001|Overall Study|Protocol Violation|1|||
162984320|NCT01321008|588645526|FG000|Overall Study|Early Study Termination|1|||
162984321|NCT02458092|588645527|FG000|Overall Study|Withdrawal by Subject|1|||
162984322|NCT02458092|588645528|FG001|Overall Study|Withdrawal by Subject|0|||
162984323|NCT00679913|588645529|FG000|Overall Study|Protocol Violation|18|||
162984324|NCT00679913|588645530|FG001|Overall Study|Protocol Violation|13|||
162984325|NCT00456495|588645535|FG000|Overall Study|Physician Decision|2|||
162984326|NCT01301508|588645536|FG000|Overall Study|Withdrawal by Subject|1|||
162984327|NCT01301508|588645537|FG001|Overall Study|Withdrawal by Subject|2|||
162984328|NCT01301508|588645536|FG000|Overall Study|Lost to Follow-up|0|||
162984329|NCT01301508|588645537|FG001|Overall Study|Lost to Follow-up|1|||
162634827|NCT01606436|587376611|FG002|Overall Study|Withdrawal by Subject|1|||
162634828|NCT01606436|587376612|FG003|Overall Study|Withdrawal by Subject|1|||
162634829|NCT01606436|587376613|FG004|Overall Study|Withdrawal by Subject|1|||
162634830|NCT01606436|587376614|FG005|Overall Study|Withdrawal by Subject|0|||
162634831|NCT01606436|587376609|FG000|Overall Study|Adverse Event|0|||
162634832|NCT01606436|587376610|FG001|Overall Study|Adverse Event|0|||
162634833|NCT01606436|587376611|FG002|Overall Study|Adverse Event|1|||
162634834|NCT01606436|587376612|FG003|Overall Study|Adverse Event|0|||
162634835|NCT01606436|587376613|FG004|Overall Study|Adverse Event|0|||
162634836|NCT01606436|587376614|FG005|Overall Study|Adverse Event|0|||
162634837|NCT01606436|587376609|FG000|Overall Study|Sponsor Decision|0|||
162634838|NCT01606436|587376610|FG001|Overall Study|Sponsor Decision|0|||
162634839|NCT01606436|587376611|FG002|Overall Study|Sponsor Decision|0|||
162634840|NCT01606436|587376612|FG003|Overall Study|Sponsor Decision|1|||
162634841|NCT01606436|587376613|FG004|Overall Study|Sponsor Decision|0|||
162634842|NCT01606436|587376614|FG005|Overall Study|Sponsor Decision|0|||
162634843|NCT02859454|587376617|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
162634844|NCT02452398|587376622|FG000|Overall Study|Adverse Event|1|||
162634845|NCT02452398|587376622|FG000|Overall Study|Lost to Follow-up|28|||
162634846|NCT02452398|587376622|FG000|Overall Study|Physician Decision|2|||
162714719|NCT04804605|587665746|FG001|Overall Study|Protocol Violation|0|||
162714720|NCT04804605|587665747|FG002|Overall Study|Protocol Violation|0|||
162714721|NCT04804605|587665748|FG003|Overall Study|Protocol Violation|1|||
162714722|NCT04804605|587665745|FG000|Overall Study|Miscellaneous|7|||
162984330|NCT05069155|588645542|FG000|Overall Study|Withdrawal by Subject|1|||
162984331|NCT05069155|588645543|FG001|Overall Study|Withdrawal by Subject|3|||
162984332|NCT01346774|588645544|FG000|Overall Study|Did not take a single dose|6|||
162984333|NCT01346774|588645545|FG001|Overall Study|Did not take a single dose|4|||
162984334|NCT01346774|588645544|FG000|Overall Study|Lost to Follow-up|3|||
162984335|NCT01346774|588645545|FG001|Overall Study|Lost to Follow-up|4|||
162984336|NCT01346774|588645544|FG000|Overall Study|Withdrawal by Subject|1|||
163059795|NCT02030600|588928217|FG000|Treatment Period 2|Adverse Event|4|||
162634847|NCT02452398|587376622|FG000|Overall Study|Withdrawal by Subject|6|||
162634848|NCT02452398|587376622|FG000|Overall Study|Moved away|4|||
162634849|NCT00748033|587376623|FG000|Overall Study|Adverse Event|0|||
162714723|NCT04804605|587665746|FG001|Overall Study|Miscellaneous|3|||
162984337|NCT01346774|588645545|FG001|Overall Study|Withdrawal by Subject|4|||
162984338|NCT01346774|588645544|FG000|Overall Study|Protocol Violation|2|||
162984339|NCT01346774|588645545|FG001|Overall Study|Protocol Violation|3|||
163059796|NCT02030600|588928218|FG001|Treatment Period 2|Adverse Event|4|||
162634850|NCT00748033|587376624|FG001|Overall Study|Adverse Event|1|||
162634851|NCT03334448|587376625|FG000|Washout|Personal Reason|0|||
162634852|NCT03334448|587376626|FG001|Washout|Personal Reason|1|||
162984340|NCT01346774|588645544|FG000|Overall Study|Adverse Event|1|||
162984341|NCT01346774|588645545|FG001|Overall Study|Adverse Event|2|||
162634853|NCT03334448|587376627|FG002|Washout|Personal Reason|0|||
162634854|NCT03334448|587376628|FG003|Washout|Personal Reason|0|||
162634855|NCT03334448|587376625|FG000|Washout|Protocol Violation|0|||
162634856|NCT03334448|587376626|FG001|Washout|Protocol Violation|0|||
162634857|NCT03334448|587376627|FG002|Washout|Protocol Violation|0|||
162634858|NCT03334448|587376628|FG003|Washout|Protocol Violation|1|||
162984342|NCT01929031|588645546|FG000|Overall Study|Adverse Event|3|||
162984343|NCT01929031|588645547|FG001|Overall Study|Adverse Event|1|||
162984344|NCT01929031|588645548|FG002|Overall Study|Adverse Event|1|||
162984345|NCT01929031|588645549|FG003|Overall Study|Adverse Event|0|||
162984346|NCT01929031|588645550|FG004|Overall Study|Adverse Event|0|||
162984347|NCT01929031|588645551|FG005|Overall Study|Adverse Event|0|||
162984348|NCT01929031|588645546|FG000|Overall Study|Protocol Violation|1|||
162984349|NCT01929031|588645547|FG001|Overall Study|Protocol Violation|0|||
162984350|NCT01929031|588645548|FG002|Overall Study|Protocol Violation|0|||
162984351|NCT01929031|588645549|FG003|Overall Study|Protocol Violation|0|||
162984352|NCT01929031|588645550|FG004|Overall Study|Protocol Violation|0|||
162984353|NCT01929031|588645551|FG005|Overall Study|Protocol Violation|1|||
162984354|NCT01929031|588645546|FG000|Overall Study|Reason other than specified above|0|||
162984355|NCT01929031|588645547|FG001|Overall Study|Reason other than specified above|1|||
162984356|NCT01929031|588645548|FG002|Overall Study|Reason other than specified above|0|||
162984357|NCT01929031|588645549|FG003|Overall Study|Reason other than specified above|0|||
162984358|NCT01929031|588645550|FG004|Overall Study|Reason other than specified above|1|||
162984359|NCT01929031|588645551|FG005|Overall Study|Reason other than specified above|0|||
162984360|NCT01366443|588645552|FG000|Overall Study|Lost to Follow-up|2|||
162984361|NCT01366443|588645552|FG000|Overall Study|Under 18 yo|1|||
162984362|NCT00369382|588645558|FG000|Overall Study|Death|0|||
162984363|NCT00369382|588645559|FG001|Overall Study|Death|2|||
162984364|NCT00369382|588645558|FG000|Overall Study|Physician Decision|2|||
162984365|NCT00369382|588645559|FG001|Overall Study|Physician Decision|1|||
162984366|NCT00369382|588645558|FG000|Overall Study|Withdrawal by Subject|5|||
162984367|NCT00369382|588645559|FG001|Overall Study|Withdrawal by Subject|0|||
162984368|NCT00369382|588645558|FG000|Overall Study|Randomized, not treated|2|||
162984369|NCT00369382|588645559|FG001|Overall Study|Randomized, not treated|0|||
162984370|NCT00369382|588645558|FG000|Overall Study|Other|1|||
162984371|NCT00369382|588645559|FG001|Overall Study|Other|0|||
162984372|NCT00448136|588645562|FG000|Overall Study|Death|3|||
162984373|NCT00448136|588645563|FG001|Overall Study|Death|8|||
162984374|NCT00448136|588645562|FG000|Overall Study|Investigator's decision (progression)|1|||
162984375|NCT00448136|588645563|FG001|Overall Study|Investigator's decision (progression)|0|||
162984376|NCT03407430|588645564|FG000|Washout|Protocol Violation|1|||
162984377|NCT03407430|588645565|FG001|Washout|Protocol Violation|0|||
162984378|NCT00922987|588645567|FG000|Overall Study|Insufficient clinical response|1|||
162984379|NCT00922987|588645567|FG000|Overall Study|Protocol Violation|2|||
162984380|NCT00922987|588645567|FG000|Overall Study|Adverse Event|1|||
162984381|NCT01334710|588645574|FG000|Overall Study|Trial was terminated|3|||
162984382|NCT04221789|588647319|FG000|Overall Study|deviation from protoco|22|||
162984383|NCT04221789|588647320|FG001|Overall Study|deviation from protoco|8|||
162984384|NCT04394351|588647323|FG000|Part A (16 Weeks)|Adverse Event|1|||
162984385|NCT04394351|588647324|FG001|Part A (16 Weeks)|Adverse Event|0|||
162984386|NCT04394351|588647325|FG002|Part A (16 Weeks)|Adverse Event|0|||
162984387|NCT04394351|588647326|FG003|Part A (16 Weeks)|Adverse Event|0|||
162984388|NCT04394351|588647327|FG004|Part A (16 Weeks)|Adverse Event|0|||
162984389|NCT04394351|588647328|FG005|Part A (16 Weeks)|Adverse Event|0|||
162984390|NCT04394351|588647329|FG006|Part A (16 Weeks)|Adverse Event|0|||
162984391|NCT04394351|588647330|FG007|Part A (16 Weeks)|Adverse Event|0|||
162984392|NCT04394351|588647323|FG000|Part A (16 Weeks)|Physician Decision|0|||
162984393|NCT04394351|588647324|FG001|Part A (16 Weeks)|Physician Decision|1|||
162984394|NCT04394351|588647325|FG002|Part A (16 Weeks)|Physician Decision|0|||
162984395|NCT04394351|588647326|FG003|Part A (16 Weeks)|Physician Decision|0|||
162984396|NCT04394351|588647327|FG004|Part A (16 Weeks)|Physician Decision|0|||
162984397|NCT04394351|588647328|FG005|Part A (16 Weeks)|Physician Decision|0|||
162984398|NCT04394351|588647329|FG006|Part A (16 Weeks)|Physician Decision|0|||
162984399|NCT04394351|588647330|FG007|Part A (16 Weeks)|Physician Decision|0|||
162984400|NCT04394351|588647323|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
162634859|NCT02326025|587376629|FG000|Overall Study|Adverse Event|3|||
162634860|NCT02326025|587376630|FG001|Overall Study|Adverse Event|0|||
162634861|NCT02326025|587376629|FG000|Overall Study|Physician Decision|1|||
162634862|NCT02326025|587376630|FG001|Overall Study|Physician Decision|2|||
162984401|NCT04394351|588647324|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
162984402|NCT04394351|588647325|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984403|NCT04394351|588647326|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984404|NCT04394351|588647327|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984405|NCT04394351|588647328|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984406|NCT04394351|588647329|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
162634863|NCT02326025|587376629|FG000|Overall Study|Physician and Participant Decision|1|||
162984407|NCT04394351|588647330|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
162984408|NCT04394351|588647323|FG000|Part B (36 Weeks)|Adverse Event|0|||
162984409|NCT04394351|588647324|FG001|Part B (36 Weeks)|Adverse Event|0|||
162984410|NCT04394351|588647325|FG002|Part B (36 Weeks)|Adverse Event|0|||
162984411|NCT04394351|588647326|FG003|Part B (36 Weeks)|Adverse Event|0|||
162984412|NCT04394351|588647327|FG004|Part B (36 Weeks)|Adverse Event|0|||
162984413|NCT04394351|588647328|FG005|Part B (36 Weeks)|Adverse Event|0|||
162634864|NCT02326025|587376630|FG001|Overall Study|Physician and Participant Decision|0|||
162634865|NCT02326025|587376629|FG000|Overall Study|Withdrawal by Subject|0|||
162984414|NCT04394351|588647329|FG006|Part B (36 Weeks)|Adverse Event|1|||
162984415|NCT04394351|588647330|FG007|Part B (36 Weeks)|Adverse Event|0|||
162984416|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984417|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984418|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984419|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984420|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984421|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984422|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
162984423|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
162984424|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984425|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984426|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984427|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984428|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984429|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984430|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
162984431|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
162984432|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984433|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984434|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984435|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984436|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984437|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984438|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
162984439|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
162984440|NCT04394351|588647323|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984441|NCT04394351|588647324|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984442|NCT04394351|588647325|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984443|NCT04394351|588647326|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984444|NCT04394351|588647327|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984445|NCT04394351|588647328|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984446|NCT04394351|588647329|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
162984447|NCT04394351|588647330|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
162984448|NCT03653507|588647331|FG000|Overall Study|Miscellaneous|28|||
162984449|NCT03653507|588647332|FG001|Overall Study|Miscellaneous|19|||
162984450|NCT03653507|588647331|FG000|Overall Study|Withdrawal by Subject|37|||
162984451|NCT03653507|588647332|FG001|Overall Study|Withdrawal by Subject|22|||
162984452|NCT03653507|588647331|FG000|Overall Study|Protocol Deviation|2|||
162984453|NCT03653507|588647332|FG001|Overall Study|Protocol Deviation|1|||
162984454|NCT03653507|588647331|FG000|Overall Study|Progressive disease|117|||
162984455|NCT03653507|588647332|FG001|Overall Study|Progressive disease|168|||
162984456|NCT03653507|588647331|FG000|Overall Study|Lost to Follow-up|1|||
162984457|NCT03653507|588647332|FG001|Overall Study|Lost to Follow-up|1|||
162984458|NCT03653507|588647331|FG000|Overall Study|Death|25|||
162634866|NCT02326025|587376630|FG001|Overall Study|Withdrawal by Subject|2|||
162634867|NCT02326025|587376629|FG000|Overall Study|Protocol Violation|0|||
162634868|NCT02326025|587376630|FG001|Overall Study|Protocol Violation|1|||
162984459|NCT03653507|588647332|FG001|Overall Study|Death|22|||
162984460|NCT03653507|588647331|FG000|Overall Study|Adverse Event|35|||
162984461|NCT03653507|588647332|FG001|Overall Study|Adverse Event|14|||
162984462|NCT01288053|588647339|FG000|Overall Study|Death|1|||
162984463|NCT00144781|588647340|FG000|Overall Study|Adverse Event|0|||
162984464|NCT00144781|588647341|FG001|Overall Study|Adverse Event|1|||
162984465|NCT00144781|588647342|FG002|Overall Study|Adverse Event|0|||
162984466|NCT00144781|588647343|FG003|Overall Study|Adverse Event|0|||
162984467|NCT00144781|588647340|FG000|Overall Study|Non-compliant|0|||
162984468|NCT00144781|588647341|FG001|Overall Study|Non-compliant|1|||
162984469|NCT00144781|588647342|FG002|Overall Study|Non-compliant|0|||
162984470|NCT00144781|588647343|FG003|Overall Study|Non-compliant|0|||
162634869|NCT01365910|587376631|FG000|Overall Study|Withdrawal by Subject|7|||
162634870|NCT01365910|587376631|FG000|Overall Study|disease progression|18|||
162984471|NCT03696953|588647344|FG000|Overall Study|Withdrawal by Subject|6|||
162984472|NCT03696953|588647345|FG001|Overall Study|Withdrawal by Subject|1|||
162984473|NCT03696953|588647344|FG000|Overall Study|missed GBS swabs|2|||
162984474|NCT03696953|588647345|FG001|Overall Study|missed GBS swabs|2|||
162984475|NCT03696953|588647344|FG000|Overall Study|lost study bottle containing capsules|2|||
162984476|NCT03696953|588647345|FG001|Overall Study|lost study bottle containing capsules|0|||
162984477|NCT03696953|588647344|FG000|Overall Study|Premature birth|1|||
162984478|NCT03696953|588647345|FG001|Overall Study|Premature birth|4|||
162984479|NCT03696953|588647344|FG000|Overall Study|Gestational hypertension|1|||
162984480|NCT03696953|588647345|FG001|Overall Study|Gestational hypertension|1|||
162984481|NCT03696953|588647344|FG000|Overall Study|Gestational diabetes|2|||
162984482|NCT03696953|588647345|FG001|Overall Study|Gestational diabetes|1|||
162984483|NCT03696953|588647344|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
162984484|NCT03696953|588647345|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
162984485|NCT03696953|588647344|FG000|Overall Study|Changed prenatal provider|1|||
162984486|NCT03696953|588647345|FG001|Overall Study|Changed prenatal provider|1|||
162984487|NCT03502707|588647346|FG000|Overall Study|Adverse Event|0|||
162984488|NCT03502707|588647347|FG001|Overall Study|Adverse Event|0|||
162984489|NCT03502707|588647348|FG002|Overall Study|Adverse Event|0|||
162984490|NCT03502707|588647349|FG003|Overall Study|Adverse Event|0|||
162984491|NCT03502707|588647350|FG004|Overall Study|Adverse Event|0|||
162984492|NCT03502707|588647351|FG005|Overall Study|Adverse Event|0|||
162984493|NCT03502707|588647352|FG006|Overall Study|Adverse Event|0|||
162634871|NCT01365910|587376631|FG000|Overall Study|Adverse Event|3|||
162634872|NCT01365910|587376631|FG000|Overall Study|other complicating disease|1|||
162634873|NCT01365910|587376631|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
162634874|NCT02013791|587376632|FG000|Period 1|Lost to Follow-up|0|||
162634875|NCT02013791|587376633|FG001|Period 1|Lost to Follow-up|0|||
162634876|NCT02013791|587376634|FG002|Period 1|Lost to Follow-up|0|||
162634877|NCT02013791|587376635|FG003|Period 1|Lost to Follow-up|1|||
162634878|NCT02013791|587376636|FG004|Period 1|Lost to Follow-up|0|||
162634879|NCT02013791|587376637|FG005|Period 1|Lost to Follow-up|0|||
162634880|NCT02013791|587376638|FG006|Period 1|Lost to Follow-up|1|||
162634881|NCT02013791|587376639|FG007|Period 1|Lost to Follow-up|1|||
162634882|NCT02013791|587376640|FG008|Period 1|Lost to Follow-up|0|||
162634883|NCT02013791|587376632|FG000|Period 1|Other Miscellaneous Reasons|0|||
162634884|NCT02013791|587376633|FG001|Period 1|Other Miscellaneous Reasons|2|||
162634885|NCT02013791|587376634|FG002|Period 1|Other Miscellaneous Reasons|0|||
162634886|NCT02013791|587376635|FG003|Period 1|Other Miscellaneous Reasons|0|||
162634887|NCT02013791|587376636|FG004|Period 1|Other Miscellaneous Reasons|0|||
162634888|NCT02013791|587376637|FG005|Period 1|Other Miscellaneous Reasons|0|||
162634889|NCT02013791|587376638|FG006|Period 1|Other Miscellaneous Reasons|0|||
162634890|NCT02013791|587376639|FG007|Period 1|Other Miscellaneous Reasons|0|||
162634891|NCT02013791|587376640|FG008|Period 1|Other Miscellaneous Reasons|0|||
162634892|NCT03798483|587376641|FG000|Overall Study|Lost to Follow-up|2|||
162634893|NCT02643082|587376642|FG000|Period 1|Adverse Event|1|||
162634894|NCT02643082|587376643|FG001|Period 1|Adverse Event|0|||
162634895|NCT02289417|587376644|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
162634896|NCT02289417|587376645|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634897|NCT02289417|587376646|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
162634898|NCT02289417|587376647|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634899|NCT02289417|587376648|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634900|NCT02289417|587376649|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634901|NCT02289417|587376650|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634902|NCT02289417|587376651|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634903|NCT02289417|587376652|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162634904|NCT02289417|587376644|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
162634905|NCT02289417|587376645|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
162634906|NCT02289417|587376646|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
162634907|NCT02289417|587376647|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162634908|NCT02289417|587376648|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162634909|NCT02289417|587376649|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162984494|NCT03502707|588647353|FG007|Overall Study|Adverse Event|0|||
162984495|NCT03502707|588647354|FG008|Overall Study|Adverse Event|0|||
162984496|NCT03502707|588647355|FG009|Overall Study|Adverse Event|0|||
162984497|NCT03502707|588647356|FG010|Overall Study|Adverse Event|0|||
162984498|NCT03502707|588647357|FG011|Overall Study|Adverse Event|0|||
162634910|NCT02289417|587376650|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162634911|NCT02289417|587376651|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162634912|NCT02289417|587376652|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162634913|NCT02289417|587376644|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634914|NCT02289417|587376645|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
162714724|NCT04804605|587665747|FG002|Overall Study|Miscellaneous|4|||
162984499|NCT03502707|588647358|FG012|Overall Study|Adverse Event|0|||
162984500|NCT03502707|588647359|FG013|Overall Study|Adverse Event|0|||
162984501|NCT03502707|588647360|FG014|Overall Study|Adverse Event|0|||
162984502|NCT03502707|588647361|FG015|Overall Study|Adverse Event|1|||
162984503|NCT03502707|588647362|FG016|Overall Study|Adverse Event|5|||
162984504|NCT03502707|588647363|FG017|Overall Study|Adverse Event|0|||
162984505|NCT03502707|588647346|FG000|Overall Study|Death|0|||
162984506|NCT03502707|588647347|FG001|Overall Study|Death|0|||
162984507|NCT03502707|588647348|FG002|Overall Study|Death|0|||
162984508|NCT03502707|588647349|FG003|Overall Study|Death|1|||
162984509|NCT03502707|588647350|FG004|Overall Study|Death|0|||
162984510|NCT03502707|588647351|FG005|Overall Study|Death|0|||
162984511|NCT03502707|588647352|FG006|Overall Study|Death|0|||
162984512|NCT03502707|588647353|FG007|Overall Study|Death|0|||
162984513|NCT03502707|588647354|FG008|Overall Study|Death|1|||
162984514|NCT03502707|588647355|FG009|Overall Study|Death|1|||
162984515|NCT03502707|588647356|FG010|Overall Study|Death|0|||
162984516|NCT03502707|588647357|FG011|Overall Study|Death|0|||
162984517|NCT03502707|588647358|FG012|Overall Study|Death|1|||
162984518|NCT03502707|588647359|FG013|Overall Study|Death|0|||
162984519|NCT03502707|588647360|FG014|Overall Study|Death|0|||
162984520|NCT03502707|588647361|FG015|Overall Study|Death|1|||
162984521|NCT03502707|588647362|FG016|Overall Study|Death|0|||
162984522|NCT03502707|588647363|FG017|Overall Study|Death|0|||
162984523|NCT03502707|588647346|FG000|Overall Study|Lost to Follow-up|0|||
162984524|NCT03502707|588647347|FG001|Overall Study|Lost to Follow-up|0|||
162984525|NCT03502707|588647348|FG002|Overall Study|Lost to Follow-up|0|||
162984526|NCT03502707|588647349|FG003|Overall Study|Lost to Follow-up|0|||
162984527|NCT03502707|588647350|FG004|Overall Study|Lost to Follow-up|0|||
162984528|NCT03502707|588647351|FG005|Overall Study|Lost to Follow-up|0|||
162984529|NCT03502707|588647352|FG006|Overall Study|Lost to Follow-up|0|||
162984530|NCT03502707|588647353|FG007|Overall Study|Lost to Follow-up|5|||
162984531|NCT03502707|588647354|FG008|Overall Study|Lost to Follow-up|0|||
162984532|NCT03502707|588647355|FG009|Overall Study|Lost to Follow-up|2|||
162984533|NCT03502707|588647356|FG010|Overall Study|Lost to Follow-up|1|||
162984534|NCT03502707|588647357|FG011|Overall Study|Lost to Follow-up|2|||
162984535|NCT03502707|588647358|FG012|Overall Study|Lost to Follow-up|1|||
162984536|NCT03502707|588647359|FG013|Overall Study|Lost to Follow-up|1|||
162984537|NCT03502707|588647360|FG014|Overall Study|Lost to Follow-up|0|||
162984538|NCT03502707|588647361|FG015|Overall Study|Lost to Follow-up|4|||
162984539|NCT03502707|588647362|FG016|Overall Study|Lost to Follow-up|9|||
162634915|NCT02289417|587376646|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634916|NCT02289417|587376647|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634917|NCT02289417|587376648|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634918|NCT02289417|587376649|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634919|NCT02289417|587376650|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634920|NCT02289417|587376651|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634921|NCT02289417|587376652|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162634922|NCT02289417|587376644|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
162634923|NCT02289417|587376645|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634924|NCT02289417|587376646|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634925|NCT02289417|587376647|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634926|NCT02289417|587376648|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634927|NCT02289417|587376649|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634928|NCT02289417|587376650|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634929|NCT02289417|587376651|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634930|NCT02289417|587376652|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162634931|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162634932|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
162634933|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
162634934|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
162634935|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
162634936|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
162634937|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162714725|NCT04804605|587665748|FG003|Overall Study|Miscellaneous|2|||
162714726|NCT00567879|587665751|FG000|Overall Study|Adverse Event|2|||
162984540|NCT03502707|588647363|FG017|Overall Study|Lost to Follow-up|2|||
162984541|NCT03502707|588647346|FG000|Overall Study|Physician Decision|0|||
162984542|NCT03502707|588647347|FG001|Overall Study|Physician Decision|0|||
162984543|NCT03502707|588647348|FG002|Overall Study|Physician Decision|0|||
162984544|NCT03502707|588647349|FG003|Overall Study|Physician Decision|0|||
162984545|NCT03502707|588647350|FG004|Overall Study|Physician Decision|0|||
162984546|NCT03502707|588647351|FG005|Overall Study|Physician Decision|0|||
162984547|NCT03502707|588647352|FG006|Overall Study|Physician Decision|0|||
162714727|NCT00567879|587665752|FG001|Overall Study|Adverse Event|0|||
162984548|NCT03502707|588647353|FG007|Overall Study|Physician Decision|0|||
162984549|NCT03502707|588647354|FG008|Overall Study|Physician Decision|2|||
162984550|NCT03502707|588647355|FG009|Overall Study|Physician Decision|1|||
162984551|NCT03502707|588647356|FG010|Overall Study|Physician Decision|0|||
162984552|NCT03502707|588647357|FG011|Overall Study|Physician Decision|0|||
162984553|NCT03502707|588647358|FG012|Overall Study|Physician Decision|0|||
162984554|NCT03502707|588647359|FG013|Overall Study|Physician Decision|0|||
162984555|NCT03502707|588647360|FG014|Overall Study|Physician Decision|1|||
162984556|NCT03502707|588647361|FG015|Overall Study|Physician Decision|3|||
162984557|NCT03502707|588647362|FG016|Overall Study|Physician Decision|0|||
162984558|NCT03502707|588647363|FG017|Overall Study|Physician Decision|0|||
162984559|NCT03502707|588647346|FG000|Overall Study|Protocol Violation|0|||
162984560|NCT03502707|588647347|FG001|Overall Study|Protocol Violation|0|||
162984561|NCT03502707|588647348|FG002|Overall Study|Protocol Violation|0|||
162984562|NCT03502707|588647349|FG003|Overall Study|Protocol Violation|0|||
162984563|NCT03502707|588647350|FG004|Overall Study|Protocol Violation|0|||
162984564|NCT03502707|588647351|FG005|Overall Study|Protocol Violation|0|||
162984565|NCT03502707|588647352|FG006|Overall Study|Protocol Violation|0|||
162984566|NCT03502707|588647353|FG007|Overall Study|Protocol Violation|0|||
162984567|NCT03502707|588647354|FG008|Overall Study|Protocol Violation|0|||
162984568|NCT03502707|588647355|FG009|Overall Study|Protocol Violation|0|||
162984569|NCT03502707|588647356|FG010|Overall Study|Protocol Violation|0|||
162984570|NCT03502707|588647357|FG011|Overall Study|Protocol Violation|0|||
162984571|NCT03502707|588647358|FG012|Overall Study|Protocol Violation|0|||
162984572|NCT03502707|588647359|FG013|Overall Study|Protocol Violation|0|||
162984573|NCT03502707|588647360|FG014|Overall Study|Protocol Violation|0|||
162984574|NCT03502707|588647361|FG015|Overall Study|Protocol Violation|1|||
162984575|NCT03502707|588647362|FG016|Overall Study|Protocol Violation|0|||
162984576|NCT03502707|588647363|FG017|Overall Study|Protocol Violation|0|||
162714728|NCT00567879|587665753|FG002|Overall Study|Adverse Event|1|||
162984577|NCT03502707|588647346|FG000|Overall Study|Withdrawal by Subject|1|||
162984578|NCT03502707|588647347|FG001|Overall Study|Withdrawal by Subject|1|||
162984579|NCT03502707|588647348|FG002|Overall Study|Withdrawal by Subject|0|||
162984580|NCT03502707|588647349|FG003|Overall Study|Withdrawal by Subject|0|||
162984581|NCT03502707|588647350|FG004|Overall Study|Withdrawal by Subject|0|||
162984582|NCT03502707|588647351|FG005|Overall Study|Withdrawal by Subject|2|||
162984583|NCT03502707|588647352|FG006|Overall Study|Withdrawal by Subject|0|||
162714729|NCT00567879|587665754|FG003|Overall Study|Adverse Event|0|||
162714730|NCT00567879|587665755|FG004|Overall Study|Adverse Event|1|||
162714731|NCT00567879|587665756|FG005|Overall Study|Adverse Event|0|||
162714732|NCT00567879|587665751|FG000|Overall Study|Abnormal test procedure(s)|0|||
162714733|NCT00567879|587665752|FG001|Overall Study|Abnormal test procedure(s)|0|||
162714734|NCT00567879|587665753|FG002|Overall Study|Abnormal test procedure(s)|1|||
162984584|NCT03502707|588647353|FG007|Overall Study|Withdrawal by Subject|3|||
162984585|NCT03502707|588647354|FG008|Overall Study|Withdrawal by Subject|1|||
162984586|NCT03502707|588647355|FG009|Overall Study|Withdrawal by Subject|2|||
162984587|NCT03502707|588647356|FG010|Overall Study|Withdrawal by Subject|12|||
162984588|NCT03502707|588647357|FG011|Overall Study|Withdrawal by Subject|23|||
162984589|NCT03502707|588647358|FG012|Overall Study|Withdrawal by Subject|5|||
162984590|NCT03502707|588647359|FG013|Overall Study|Withdrawal by Subject|3|||
162984591|NCT03502707|588647360|FG014|Overall Study|Withdrawal by Subject|3|||
162984592|NCT03502707|588647361|FG015|Overall Study|Withdrawal by Subject|43|||
162984593|NCT03502707|588647362|FG016|Overall Study|Withdrawal by Subject|44|||
162984594|NCT03502707|588647363|FG017|Overall Study|Withdrawal by Subject|18|||
162984595|NCT03502707|588647346|FG000|Overall Study|Sponsor's Decision|1|||
162984596|NCT03502707|588647347|FG001|Overall Study|Sponsor's Decision|0|||
162984597|NCT03502707|588647348|FG002|Overall Study|Sponsor's Decision|0|||
162984598|NCT03502707|588647349|FG003|Overall Study|Sponsor's Decision|0|||
162984599|NCT03502707|588647350|FG004|Overall Study|Sponsor's Decision|0|||
162984600|NCT03502707|588647351|FG005|Overall Study|Sponsor's Decision|0|||
162984601|NCT03502707|588647352|FG006|Overall Study|Sponsor's Decision|0|||
162984602|NCT03502707|588647353|FG007|Overall Study|Sponsor's Decision|0|||
162984603|NCT03502707|588647354|FG008|Overall Study|Sponsor's Decision|0|||
162984604|NCT03502707|588647355|FG009|Overall Study|Sponsor's Decision|1|||
162984605|NCT03502707|588647356|FG010|Overall Study|Sponsor's Decision|0|||
162984606|NCT03502707|588647357|FG011|Overall Study|Sponsor's Decision|0|||
162984607|NCT03502707|588647358|FG012|Overall Study|Sponsor's Decision|0|||
162984608|NCT03502707|588647359|FG013|Overall Study|Sponsor's Decision|0|||
162984609|NCT03502707|588647360|FG014|Overall Study|Sponsor's Decision|0|||
162984610|NCT03502707|588647361|FG015|Overall Study|Sponsor's Decision|2|||
162984611|NCT03502707|588647362|FG016|Overall Study|Sponsor's Decision|1|||
162984612|NCT03502707|588647363|FG017|Overall Study|Sponsor's Decision|0|||
162984613|NCT03502707|588647346|FG000|Overall Study|Initiated Prohibited Medication|0|||
162984614|NCT03502707|588647347|FG001|Overall Study|Initiated Prohibited Medication|0|||
162984615|NCT03502707|588647348|FG002|Overall Study|Initiated Prohibited Medication|0|||
162984616|NCT03502707|588647349|FG003|Overall Study|Initiated Prohibited Medication|0|||
162984617|NCT03502707|588647350|FG004|Overall Study|Initiated Prohibited Medication|0|||
162984618|NCT03502707|588647351|FG005|Overall Study|Initiated Prohibited Medication|0|||
162984619|NCT03502707|588647352|FG006|Overall Study|Initiated Prohibited Medication|0|||
162984620|NCT03502707|588647353|FG007|Overall Study|Initiated Prohibited Medication|0|||
162984621|NCT03502707|588647354|FG008|Overall Study|Initiated Prohibited Medication|0|||
162984622|NCT03502707|588647355|FG009|Overall Study|Initiated Prohibited Medication|0|||
162984623|NCT03502707|588647356|FG010|Overall Study|Initiated Prohibited Medication|0|||
162634938|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162634939|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162634940|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634941|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634942|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
162634943|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634944|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634945|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634946|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634947|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634948|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162634949|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162634950|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
162634951|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
162634952|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
162634953|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
162634954|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
162634955|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162634956|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162634957|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162634958|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634959|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634960|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162634961|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634962|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162634963|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162634964|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634965|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634966|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162634967|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634968|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634969|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634970|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634971|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634972|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634973|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
162634974|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634975|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162634976|NCT02289417|587376644|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634977|NCT02289417|587376645|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162984624|NCT03502707|588647357|FG011|Overall Study|Initiated Prohibited Medication|0|||
162984625|NCT03502707|588647358|FG012|Overall Study|Initiated Prohibited Medication|0|||
162984626|NCT03502707|588647359|FG013|Overall Study|Initiated Prohibited Medication|0|||
162984627|NCT03502707|588647360|FG014|Overall Study|Initiated Prohibited Medication|0|||
162984628|NCT03502707|588647361|FG015|Overall Study|Initiated Prohibited Medication|0|||
162984629|NCT03502707|588647362|FG016|Overall Study|Initiated Prohibited Medication|1|||
162984630|NCT03502707|588647363|FG017|Overall Study|Initiated Prohibited Medication|0|||
162984631|NCT03502707|588647346|FG000|Overall Study|Other|0|||
162984632|NCT03502707|588647347|FG001|Overall Study|Other|0|||
162984633|NCT03502707|588647348|FG002|Overall Study|Other|0|||
162984634|NCT03502707|588647349|FG003|Overall Study|Other|0|||
162984635|NCT03502707|588647350|FG004|Overall Study|Other|0|||
162984636|NCT03502707|588647351|FG005|Overall Study|Other|0|||
162984637|NCT03502707|588647352|FG006|Overall Study|Other|0|||
162984638|NCT03502707|588647353|FG007|Overall Study|Other|0|||
162984639|NCT03502707|588647354|FG008|Overall Study|Other|1|||
162984640|NCT03502707|588647355|FG009|Overall Study|Other|1|||
162984641|NCT03502707|588647356|FG010|Overall Study|Other|2|||
162984642|NCT03502707|588647357|FG011|Overall Study|Other|0|||
162984643|NCT03502707|588647358|FG012|Overall Study|Other|0|||
162984644|NCT03502707|588647359|FG013|Overall Study|Other|0|||
162984645|NCT03502707|588647360|FG014|Overall Study|Other|0|||
162984646|NCT03502707|588647361|FG015|Overall Study|Other|4|||
162984647|NCT03502707|588647362|FG016|Overall Study|Other|1|||
162984648|NCT03502707|588647363|FG017|Overall Study|Other|0|||
162984649|NCT03502707|588647346|FG000|Overall Study|Randomized but not vaccinated|0|||
162984650|NCT03502707|588647347|FG001|Overall Study|Randomized but not vaccinated|0|||
162984651|NCT03502707|588647348|FG002|Overall Study|Randomized but not vaccinated|0|||
162984652|NCT03502707|588647349|FG003|Overall Study|Randomized but not vaccinated|0|||
162984653|NCT03502707|588647350|FG004|Overall Study|Randomized but not vaccinated|0|||
162984654|NCT03502707|588647351|FG005|Overall Study|Randomized but not vaccinated|0|||
162984655|NCT03502707|588647352|FG006|Overall Study|Randomized but not vaccinated|0|||
162984656|NCT03502707|588647353|FG007|Overall Study|Randomized but not vaccinated|0|||
162984657|NCT03502707|588647354|FG008|Overall Study|Randomized but not vaccinated|0|||
162984658|NCT03502707|588647355|FG009|Overall Study|Randomized but not vaccinated|0|||
162984659|NCT03502707|588647356|FG010|Overall Study|Randomized but not vaccinated|0|||
162984660|NCT03502707|588647357|FG011|Overall Study|Randomized but not vaccinated|1|||
162984661|NCT03502707|588647358|FG012|Overall Study|Randomized but not vaccinated|0|||
162984662|NCT03502707|588647359|FG013|Overall Study|Randomized but not vaccinated|0|||
162634978|NCT02289417|587376646|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634979|NCT02289417|587376647|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
162634980|NCT02289417|587376648|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634981|NCT02289417|587376649|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634982|NCT02289417|587376650|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
162634983|NCT02289417|587376651|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634984|NCT02289417|587376652|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162634985|NCT02289417|587376644|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
162634986|NCT02289417|587376645|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
162634987|NCT02289417|587376646|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
162634988|NCT02289417|587376647|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
162634989|NCT02289417|587376648|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
162634990|NCT02289417|587376649|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
162634991|NCT02289417|587376650|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
162634992|NCT02289417|587376651|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
162634993|NCT02289417|587376652|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
162634994|NCT02289417|587376644|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162634995|NCT02289417|587376645|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162634996|NCT02289417|587376646|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162634997|NCT02289417|587376647|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162634998|NCT02289417|587376648|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162634999|NCT02289417|587376649|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162635000|NCT02289417|587376650|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162635001|NCT02289417|587376651|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
162635002|NCT02289417|587376652|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
162635003|NCT02289417|587376644|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635004|NCT02289417|587376645|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635005|NCT02289417|587376646|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635006|NCT02289417|587376647|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635007|NCT02289417|587376648|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635008|NCT02289417|587376649|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635009|NCT02289417|587376650|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162635010|NCT02289417|587376651|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
162635011|NCT02289417|587376652|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
162984663|NCT03502707|588647360|FG014|Overall Study|Randomized but not vaccinated|0|||
162984664|NCT03502707|588647361|FG015|Overall Study|Randomized but not vaccinated|0|||
162984665|NCT03502707|588647362|FG016|Overall Study|Randomized but not vaccinated|0|||
162984666|NCT03502707|588647363|FG017|Overall Study|Randomized but not vaccinated|1|||
162984667|NCT04092894|588647364|FG000|Overall Study|Withdrawal by Subject|2|||
162984668|NCT04092894|588647365|FG001|Overall Study|Withdrawal by Subject|4|||
162984669|NCT04092894|588647364|FG000|Overall Study|Discontinued EEG after randomization|10|||
162984670|NCT04092894|588647365|FG001|Overall Study|Discontinued EEG after randomization|6|||
162984671|NCT01106014|588647366|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
162984672|NCT01106014|588647367|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
162984673|NCT01106014|588647366|FG000|Overall Study|Adverse Event|78|||
162984674|NCT01106014|588647367|FG001|Overall Study|Adverse Event|42|||
162984675|NCT01106014|588647366|FG000|Overall Study|Withdrawal by Subject|43|||
162984676|NCT01106014|588647367|FG001|Overall Study|Withdrawal by Subject|37|||
162984677|NCT01106014|588647366|FG000|Overall Study|Administrative reason|7|||
162984678|NCT01106014|588647367|FG001|Overall Study|Administrative reason|6|||
162984679|NCT01106014|588647366|FG000|Overall Study|Lost to Follow-up|2|||
162984680|NCT01106014|588647367|FG001|Overall Study|Lost to Follow-up|3|||
162984681|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
162984682|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984683|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984684|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984685|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
162984686|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
162984687|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
162635012|NCT02289417|587376644|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
162635013|NCT02289417|587376645|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
162635014|NCT02289417|587376646|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
162635015|NCT02289417|587376647|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
162635016|NCT02289417|587376648|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
162984688|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
162984689|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
162984690|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
162984691|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984692|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
162984693|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984694|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984695|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
162984696|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
162984697|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
162984698|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
162984699|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
162984700|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
162635017|NCT02289417|587376649|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
162984701|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
162984702|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
162984703|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
162984704|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
162635018|NCT02289417|587376650|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
162635019|NCT02289417|587376651|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
162635020|NCT02289417|587376652|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
163059797|NCT02030600|588928217|FG000|Treatment Period 2|Lack of Efficacy|2|||
162635021|NCT02725710|587376653|FG000|Overall Study|Lost to Follow-up|1|||
162635022|NCT02725710|587376654|FG001|Overall Study|Lost to Follow-up|0|||
162635023|NCT02505867|587376655|FG000|Overall Study|Lack of Efficacy|6|||
162635024|NCT02505867|587376656|FG001|Overall Study|Lack of Efficacy|6|||
162635025|NCT01782222|587376657|FG000|Overall Study|Adverse Event|4|||
162635026|NCT01782222|587376658|FG001|Overall Study|Adverse Event|5|||
162635027|NCT01782222|587376659|FG002|Overall Study|Adverse Event|3|||
162635028|NCT01782222|587376657|FG000|Overall Study|Lack of Efficacy|2|||
162635029|NCT01782222|587376658|FG001|Overall Study|Lack of Efficacy|1|||
162635030|NCT01782222|587376659|FG002|Overall Study|Lack of Efficacy|0|||
162635031|NCT01782222|587376657|FG000|Overall Study|Protocol Violation|1|||
162635032|NCT01782222|587376658|FG001|Overall Study|Protocol Violation|0|||
162635033|NCT01782222|587376659|FG002|Overall Study|Protocol Violation|0|||
162635034|NCT01782222|587376657|FG000|Overall Study|Withdrawal by Subject|1|||
162635035|NCT01782222|587376658|FG001|Overall Study|Withdrawal by Subject|4|||
162635036|NCT01782222|587376659|FG002|Overall Study|Withdrawal by Subject|1|||
162635037|NCT01782222|587376657|FG000|Overall Study|Moved to other state|0|||
162635038|NCT01782222|587376658|FG001|Overall Study|Moved to other state|1|||
162635039|NCT01782222|587376659|FG002|Overall Study|Moved to other state|0|||
162635040|NCT03200860|587376660|FG000|Overall Study|Withdrawal by Subject|1|||
162635041|NCT03200860|587376661|FG001|Overall Study|Withdrawal by Subject|0|||
162635042|NCT01605877|587376662|FG000|Overall Study|Withdrawal by Subject|1|||
162984705|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
162984706|NCT02935686|588647368|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
163059798|NCT02030600|588928218|FG001|Treatment Period 2|Lack of Efficacy|1|||
162635043|NCT01918085|587376667|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
162635044|NCT01918085|587376668|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
162984707|NCT02935686|588647369|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
162984708|NCT02935686|588647370|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984709|NCT02935686|588647371|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984710|NCT02935686|588647372|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
162984711|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
162984712|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
162984713|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984714|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984715|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
162984716|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984717|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
162984718|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984719|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984720|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
162984721|NCT02935686|588647368|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984722|NCT02935686|588647369|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
162984723|NCT02935686|588647370|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984724|NCT02935686|588647371|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984725|NCT02935686|588647372|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
162984726|NCT02935686|588647368|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984727|NCT02935686|588647369|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984728|NCT02935686|588647370|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984729|NCT02935686|588647371|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
162984730|NCT02935686|588647372|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
162984731|NCT02935686|588647368|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984732|NCT02935686|588647369|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984733|NCT02935686|588647370|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
162984734|NCT02935686|588647371|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
162984735|NCT02935686|588647372|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
162984736|NCT00062010|588647375|FG000|Overall Study|Ineligible|3|||
162984737|NCT00852969|588647378|FG000|Overall Study|Adverse Event|0|||
162984738|NCT00852969|588647379|FG001|Overall Study|Adverse Event|1|||
162984739|NCT00852969|588647378|FG000|Overall Study|Lost to Follow-up|0|||
162984740|NCT00852969|588647379|FG001|Overall Study|Lost to Follow-up|1|||
162984741|NCT01951885|588647384|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
162984742|NCT01951885|588647385|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
162984743|NCT01951885|588647384|FG000|Overall Study|Adverse Event|1|||
162984744|NCT01951885|588647385|FG001|Overall Study|Adverse Event|0|||
162984745|NCT01951885|588647384|FG000|Overall Study|Withdrawal by Subject|0|||
162984746|NCT01951885|588647385|FG001|Overall Study|Withdrawal by Subject|1|||
162984747|NCT01951885|588647384|FG000|Overall Study|ineligible due to a change in donor|0|||
162984748|NCT01951885|588647385|FG001|Overall Study|ineligible due to a change in donor|1|||
162984749|NCT01951885|588647384|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
162984750|NCT01951885|588647385|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
162984751|NCT01687478|588647386|FG000|Overall Study|Adverse Event|3|||
162635045|NCT02634320|587376672|FG000|Overall Study|Adverse Event|2|||
162635046|NCT02634320|587376672|FG000|Overall Study|Lost to Follow-up|3|||
162635047|NCT02634320|587376672|FG000|Overall Study|Moved out of area|2|||
162635048|NCT02634320|587376672|FG000|Overall Study|Out of window for study visits|1|||
162635049|NCT02634320|587376672|FG000|Overall Study|Protocol Violation|1|||
162635050|NCT02634320|587376672|FG000|Overall Study|Withdrawal by Subject|5|||
162635051|NCT02634320|587376672|FG000|Overall Study|Lack of Efficacy|2|||
162635052|NCT00687323|587376673|FG000|Overall Study|Death|25|||
162635053|NCT00687323|587376673|FG000|Overall Study|Withdrawal by Subject|1|||
162635054|NCT00687323|587376673|FG000|Overall Study|Excluded from efficacy evaluations|6|||
162635055|NCT00687323|587376673|FG000|Overall Study|Screen failure|148|||
162635056|NCT03655691|587376681|FG000|Overall Study|Adverse Event|0|||
162635057|NCT03655691|587376682|FG001|Overall Study|Adverse Event|0|||
162635058|NCT03655691|587376683|FG002|Overall Study|Adverse Event|1|||
162635059|NCT03655691|587376681|FG000|Overall Study|Lost to Follow-up|1|||
162635060|NCT03655691|587376682|FG001|Overall Study|Lost to Follow-up|1|||
162635061|NCT03655691|587376683|FG002|Overall Study|Lost to Follow-up|2|||
162635062|NCT03655691|587376681|FG000|Overall Study|Protocol Violation|0|||
162635063|NCT03655691|587376682|FG001|Overall Study|Protocol Violation|1|||
162635064|NCT03655691|587376683|FG002|Overall Study|Protocol Violation|0|||
162984752|NCT01687478|588647387|FG001|Overall Study|Adverse Event|10|||
162984753|NCT01687478|588647386|FG000|Overall Study|Lost to Follow-up|1|||
162984754|NCT01687478|588647387|FG001|Overall Study|Lost to Follow-up|3|||
162984755|NCT01687478|588647386|FG000|Overall Study|Protocol Violation|0|||
162984756|NCT01687478|588647387|FG001|Overall Study|Protocol Violation|2|||
162984757|NCT01687478|588647386|FG000|Overall Study|Withdrawal by Subject|21|||
162635065|NCT03655691|587376681|FG000|Overall Study|Withdrawal by Subject|1|||
162984758|NCT01687478|588647387|FG001|Overall Study|Withdrawal by Subject|19|||
162984759|NCT01687478|588647386|FG000|Overall Study|Physician Decision|1|||
162984760|NCT01687478|588647387|FG001|Overall Study|Physician Decision|3|||
162984761|NCT01687478|588647386|FG000|Overall Study|Entry Criteria Not Met|6|||
162984762|NCT01687478|588647387|FG001|Overall Study|Entry Criteria Not Met|2|||
162984763|NCT03188718|588647388|FG000|Overall Study|Participant noncompliance|4|||
162984764|NCT03188718|588647388|FG000|Overall Study|Withdrawal by Subject|1|||
162984765|NCT03188718|588647388|FG000|Overall Study|Device failure|3|||
162984766|NCT02534844|588647398|FG000|Part B|Withdrawal by Subject|0|||
162984767|NCT02534844|588647399|FG001|Part B|Withdrawal by Subject|0|||
162984768|NCT02534844|588647400|FG002|Part B|Withdrawal by Subject|0|||
162984769|NCT02534844|588647401|FG003|Part B|Withdrawal by Subject|0|||
162984770|NCT02534844|588647402|FG004|Part B|Withdrawal by Subject|2|||
162984771|NCT02534844|588647403|FG005|Part B|Withdrawal by Subject|1|||
162984772|NCT01971970|588647404|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
162984773|NCT01971970|588647405|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
162984774|NCT01971970|588647404|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
162984775|NCT01971970|588647405|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
162984776|NCT01971970|588647404|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
162984777|NCT01971970|588647405|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
162984778|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
162984779|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
162984780|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
162984781|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
162984782|NCT01971970|588647404|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
162984783|NCT01971970|588647405|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
162984784|NCT01971970|588647404|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
162984785|NCT01971970|588647405|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
162984786|NCT00848107|588647406|FG000|Overall Study|Lost to Follow-up|2|||
162984787|NCT00848107|588647406|FG000|Overall Study|Withdrawal by Subject|8|||
162984788|NCT00848107|588647406|FG000|Overall Study|Adverse Event|9|||
162984789|NCT00848107|588647406|FG000|Overall Study|Death|1|||
162984790|NCT00848107|588647406|FG000|Overall Study|Pregnancy|1|||
162984791|NCT01831765|588647407|FG000|Overall Study|Lack of Efficacy|1|||
162984792|NCT01831765|588647408|FG001|Overall Study|Lack of Efficacy|0|||
162984793|NCT01831765|588647409|FG002|Overall Study|Lack of Efficacy|0|||
162984794|NCT01831765|588647407|FG000|Overall Study|Other, sponsor withdrew subject|0|||
162984795|NCT01831765|588647408|FG001|Overall Study|Other, sponsor withdrew subject|1|||
162984796|NCT01831765|588647409|FG002|Overall Study|Other, sponsor withdrew subject|0|||
162984797|NCT01831765|588647407|FG000|Overall Study|Pregnancy|1|||
162984798|NCT01831765|588647408|FG001|Overall Study|Pregnancy|1|||
162984799|NCT01831765|588647409|FG002|Overall Study|Pregnancy|2|||
162984800|NCT01831765|588647407|FG000|Overall Study|Death|0|||
162984801|NCT01831765|588647408|FG001|Overall Study|Death|1|||
162984802|NCT01831765|588647409|FG002|Overall Study|Death|1|||
162984803|NCT01831765|588647407|FG000|Overall Study|Other, site closed|1|||
162984804|NCT01831765|588647408|FG001|Overall Study|Other, site closed|1|||
162635066|NCT03655691|587376682|FG001|Overall Study|Withdrawal by Subject|1|||
162635067|NCT03655691|587376683|FG002|Overall Study|Withdrawal by Subject|0|||
162984805|NCT01831765|588647409|FG002|Overall Study|Other, site closed|0|||
162984806|NCT01831765|588647407|FG000|Overall Study|Adverse Event|5|||
162984807|NCT01831765|588647408|FG001|Overall Study|Adverse Event|3|||
162984808|NCT01831765|588647409|FG002|Overall Study|Adverse Event|3|||
162984809|NCT01831765|588647407|FG000|Overall Study|Withdrawal by Subject|22|||
162984810|NCT01831765|588647408|FG001|Overall Study|Withdrawal by Subject|7|||
162984811|NCT01831765|588647409|FG002|Overall Study|Withdrawal by Subject|17|||
162984812|NCT01831765|588647407|FG000|Overall Study|Withdrawal criteria|12|||
162984813|NCT01831765|588647408|FG001|Overall Study|Withdrawal criteria|10|||
162984814|NCT01831765|588647409|FG002|Overall Study|Withdrawal criteria|16|||
162984815|NCT01831765|588647407|FG000|Overall Study|Lost to Follow-up|2|||
162984816|NCT01831765|588647408|FG001|Overall Study|Lost to Follow-up|3|||
162984817|NCT01831765|588647409|FG002|Overall Study|Lost to Follow-up|3|||
162984818|NCT00859586|588647410|FG000|Overall Study|Donors|4|||
162984819|NCT00080938|588647411|FG000|Overall Study|Adverse Event|3|||
162984820|NCT00080938|588647411|FG000|Overall Study|Withdrawal by Subject|6|||
162635068|NCT04557371|587376684|FG000|Overall Study|Covid-19-related|0|||
162984821|NCT00080938|588647411|FG000|Overall Study|Death|2|||
162984822|NCT00080938|588647411|FG000|Overall Study|Lack of Efficacy|7|||
162984823|NCT00080938|588647411|FG000|Overall Study|other disease|1|||
162984824|NCT00080938|588647411|FG000|Overall Study|Not started protocol therapy|1|||
162984825|NCT00080938|588647411|FG000|Overall Study|Ineligible|4|||
162984826|NCT00706511|588647414|FG000|Overall Study|Withdrawal by Subject|1|||
162984827|NCT00706511|588647415|FG001|Overall Study|Withdrawal by Subject|0|||
162984828|NCT00706511|588647416|FG002|Overall Study|Withdrawal by Subject|0|||
162984829|NCT00706511|588647417|FG003|Overall Study|Withdrawal by Subject|0|||
162984830|NCT02116608|588647420|FG000|Overall Study|Lost to Follow-up|0|||
162984831|NCT02116608|588647421|FG001|Overall Study|Lost to Follow-up|0|||
162984832|NCT02116608|588647422|FG002|Overall Study|Lost to Follow-up|1|||
162984833|NCT02116608|588647420|FG000|Overall Study|Physician Decision|0|||
162984834|NCT02116608|588647421|FG001|Overall Study|Physician Decision|1|||
162984835|NCT02116608|588647422|FG002|Overall Study|Physician Decision|0|||
162984836|NCT02116608|588647420|FG000|Overall Study|Death|0|||
162984837|NCT02116608|588647421|FG001|Overall Study|Death|1|||
162984838|NCT02116608|588647422|FG002|Overall Study|Death|0|||
162984839|NCT01169532|588647427|FG000|Overall Study|Withdrawal by Subject|1|||
162984840|NCT00117325|588647428|FG000|Overall Study|Adverse Event|3|||
162984841|NCT00117325|588647429|FG001|Overall Study|Adverse Event|3|||
162984842|NCT00117325|588647428|FG000|Overall Study|Lost to Follow-up|1|||
162984843|NCT00117325|588647429|FG001|Overall Study|Lost to Follow-up|1|||
162984844|NCT00117325|588647428|FG000|Overall Study|Protocol Violation|2|||
162984845|NCT00117325|588647429|FG001|Overall Study|Protocol Violation|3|||
162984846|NCT00117325|588647428|FG000|Overall Study|Withdrawal by Subject|3|||
162984847|NCT00117325|588647429|FG001|Overall Study|Withdrawal by Subject|2|||
162984848|NCT00117325|588647428|FG000|Overall Study|Lack of Efficacy|1|||
162984849|NCT00117325|588647429|FG001|Overall Study|Lack of Efficacy|0|||
162984850|NCT00117325|588647428|FG000|Overall Study|Use of prohibited medicine|1|||
162984851|NCT00117325|588647429|FG001|Overall Study|Use of prohibited medicine|2|||
162984852|NCT00117325|588647428|FG000|Overall Study|Early termination|1|||
162984853|NCT00117325|588647429|FG001|Overall Study|Early termination|1|||
162984854|NCT00117325|588647428|FG000|Overall Study|Admisnitrative|1|||
162984855|NCT00117325|588647429|FG001|Overall Study|Admisnitrative|0|||
162984856|NCT01468818|588647433|FG000|Overall Study|Death during treatment|2|||
162984857|NCT02266134|588647434|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
162984858|NCT02266134|588647435|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
162984859|NCT02266134|588647436|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
162984860|NCT02266134|588647437|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
162984861|NCT02266134|588647434|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
162984862|NCT02266134|588647435|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
162984863|NCT02266134|588647436|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
162984864|NCT02266134|588647437|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
162984865|NCT02266134|588647434|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
162984866|NCT02266134|588647435|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
162984867|NCT02266134|588647436|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
162984868|NCT02266134|588647437|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
162984869|NCT02266134|588647434|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
162984870|NCT02266134|588647435|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984871|NCT02266134|588647436|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984872|NCT02266134|588647437|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
162984873|NCT02266134|588647434|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
162984874|NCT02266134|588647435|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
162984875|NCT02266134|588647436|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
162984876|NCT02266134|588647437|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
162984877|NCT02266134|588647434|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
162984878|NCT02266134|588647435|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984879|NCT02266134|588647436|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984880|NCT02266134|588647437|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
162984881|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
162984882|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
162984883|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
162984884|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
162984885|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
162984886|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
162984887|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
162984888|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
162984889|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
162984890|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
162984891|NCT04771403|588647441|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
162984892|NCT04771403|588647442|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
162984893|NCT04771403|588647441|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
162635069|NCT04557371|587376685|FG001|Overall Study|Covid-19-related|1|||
162984894|NCT04771403|588647442|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
162984895|NCT04771403|588647441|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
162984896|NCT04771403|588647442|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
162984897|NCT00857259|588647443|FG000|Overall Study|Protocol Violation|1|||
162984898|NCT00857259|588647444|FG001|Overall Study|Protocol Violation|0|||
162984899|NCT00857259|588647445|FG002|Overall Study|Protocol Violation|1|||
162984900|NCT01359644|588647446|FG000|Treatment Period|Lack of Efficacy|0|||
162984901|NCT01359644|588647447|FG001|Treatment Period|Lack of Efficacy|1|||
162984902|NCT01359644|588647448|FG002|Treatment Period|Lack of Efficacy|0|||
162984903|NCT01359644|588647449|FG003|Treatment Period|Lack of Efficacy|0|||
162984904|NCT01359644|588647450|FG004|Treatment Period|Lack of Efficacy|0|||
162984905|NCT01359644|588647451|FG005|Treatment Period|Lack of Efficacy|0|||
162984906|NCT01359644|588647452|FG006|Treatment Period|Lack of Efficacy|0|||
162984907|NCT01359644|588647453|FG007|Treatment Period|Lack of Efficacy|0|||
162984908|NCT01359644|588647454|FG008|Treatment Period|Lack of Efficacy|0|||
162984909|NCT01359644|588647455|FG009|Treatment Period|Lack of Efficacy|0|||
162984910|NCT01359644|588647446|FG000|Treatment Period|Adverse Event|0|||
162984911|NCT01359644|588647447|FG001|Treatment Period|Adverse Event|0|||
162984912|NCT01359644|588647448|FG002|Treatment Period|Adverse Event|1|||
162984913|NCT01359644|588647449|FG003|Treatment Period|Adverse Event|0|||
162984914|NCT01359644|588647450|FG004|Treatment Period|Adverse Event|0|||
162984915|NCT01359644|588647451|FG005|Treatment Period|Adverse Event|1|||
162984916|NCT01359644|588647452|FG006|Treatment Period|Adverse Event|0|||
162984917|NCT01359644|588647453|FG007|Treatment Period|Adverse Event|0|||
162984918|NCT01359644|588647454|FG008|Treatment Period|Adverse Event|0|||
162984919|NCT01359644|588647455|FG009|Treatment Period|Adverse Event|0|||
162984920|NCT01359644|588647446|FG000|Treatment Period|Lost to Follow-up|0|||
162984921|NCT01359644|588647447|FG001|Treatment Period|Lost to Follow-up|0|||
162984922|NCT01359644|588647448|FG002|Treatment Period|Lost to Follow-up|0|||
162984923|NCT01359644|588647449|FG003|Treatment Period|Lost to Follow-up|0|||
162984924|NCT01359644|588647450|FG004|Treatment Period|Lost to Follow-up|0|||
162984925|NCT01359644|588647451|FG005|Treatment Period|Lost to Follow-up|1|||
162984926|NCT01359644|588647452|FG006|Treatment Period|Lost to Follow-up|0|||
162984927|NCT01359644|588647453|FG007|Treatment Period|Lost to Follow-up|0|||
162984928|NCT01359644|588647454|FG008|Treatment Period|Lost to Follow-up|0|||
162984929|NCT01359644|588647455|FG009|Treatment Period|Lost to Follow-up|0|||
162984930|NCT01359644|588647446|FG000|Follow-up Period|Withdrawal by Subject|0|||
162984931|NCT01359644|588647447|FG001|Follow-up Period|Withdrawal by Subject|0|||
162984932|NCT01359644|588647448|FG002|Follow-up Period|Withdrawal by Subject|0|||
162984933|NCT01359644|588647449|FG003|Follow-up Period|Withdrawal by Subject|0|||
162984934|NCT01359644|588647450|FG004|Follow-up Period|Withdrawal by Subject|0|||
162984935|NCT01359644|588647451|FG005|Follow-up Period|Withdrawal by Subject|1|||
162984936|NCT01359644|588647452|FG006|Follow-up Period|Withdrawal by Subject|0|||
162984937|NCT01359644|588647453|FG007|Follow-up Period|Withdrawal by Subject|0|||
162984938|NCT01359644|588647454|FG008|Follow-up Period|Withdrawal by Subject|0|||
162984939|NCT01359644|588647455|FG009|Follow-up Period|Withdrawal by Subject|0|||
162984940|NCT01359644|588647446|FG000|Follow-up Period|Lost to Follow-up|0|||
162984941|NCT01359644|588647447|FG001|Follow-up Period|Lost to Follow-up|0|||
162984942|NCT01359644|588647448|FG002|Follow-up Period|Lost to Follow-up|0|||
162984943|NCT01359644|588647449|FG003|Follow-up Period|Lost to Follow-up|0|||
162984944|NCT01359644|588647450|FG004|Follow-up Period|Lost to Follow-up|0|||
162984945|NCT01359644|588647451|FG005|Follow-up Period|Lost to Follow-up|0|||
162984946|NCT01359644|588647452|FG006|Follow-up Period|Lost to Follow-up|1|||
162984947|NCT01359644|588647453|FG007|Follow-up Period|Lost to Follow-up|2|||
162984948|NCT01359644|588647454|FG008|Follow-up Period|Lost to Follow-up|0|||
162984949|NCT01359644|588647455|FG009|Follow-up Period|Lost to Follow-up|0|||
162984950|NCT00311311|588647457|FG000|Overall Study|Adverse Event|3|||
162984951|NCT00311311|588647458|FG001|Overall Study|Adverse Event|2|||
162984952|NCT00311311|588647457|FG000|Overall Study|Withdrawal by Subject|1|||
162984953|NCT00311311|588647458|FG001|Overall Study|Withdrawal by Subject|1|||
162984954|NCT00311311|588647457|FG000|Overall Study|Noncompliance|0|||
162984955|NCT00311311|588647458|FG001|Overall Study|Noncompliance|1|||
162984956|NCT00311311|588647457|FG000|Overall Study|Study Termination by Sponsor|3|||
162984957|NCT00311311|588647458|FG001|Overall Study|Study Termination by Sponsor|4|||
163059799|NCT02030600|588928217|FG000|Treatment Period 2|Lost to Follow-up|4|||
162984958|NCT00311311|588647457|FG000|Overall Study|Death|1|||
162984959|NCT00311311|588647458|FG001|Overall Study|Death|0|||
162984960|NCT00311311|588647457|FG000|Overall Study|Lack of ancillary assistance|0|||
162984961|NCT00311311|588647458|FG001|Overall Study|Lack of ancillary assistance|1|||
162984962|NCT00826449|588647459|FG000|Overall Study|Disease Progression|4|||
162984963|NCT00826449|588647459|FG000|Overall Study|Withdrawal by Subject|1|||
162984964|NCT01875471|588647472|FG000|Overall Study|Adverse Event|0|||
162984965|NCT01875471|588647473|FG001|Overall Study|Adverse Event|1|||
162984966|NCT01875471|588647472|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
162984967|NCT01875471|588647473|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
162984968|NCT01300923|588647480|FG000|Overall Study|Physician Decision|0|||
162984969|NCT01300923|588647481|FG001|Overall Study|Physician Decision|2|||
162984970|NCT02707861|588647482|FG000|Overall Study|Went onto commercial drug|30|||
162984971|NCT02707861|588647483|FG001|Overall Study|Went onto commercial drug|23|||
162984972|NCT02707861|588647482|FG000|Overall Study|Adverse Event|2|||
162984973|NCT02707861|588647483|FG001|Overall Study|Adverse Event|3|||
162984974|NCT02707861|588647482|FG000|Overall Study|Death|5|||
162984975|NCT02707861|588647483|FG001|Overall Study|Death|2|||
162984976|NCT02707861|588647482|FG000|Overall Study|Lack of Efficacy|0|||
162984977|NCT02707861|588647483|FG001|Overall Study|Lack of Efficacy|2|||
162984978|NCT02707861|588647482|FG000|Overall Study|Physician Decision|1|||
162984979|NCT02707861|588647483|FG001|Overall Study|Physician Decision|4|||
162984980|NCT02707861|588647482|FG000|Overall Study|Withdrawal by Subject|2|||
162984981|NCT02707861|588647483|FG001|Overall Study|Withdrawal by Subject|1|||
162984982|NCT02707861|588647482|FG000|Overall Study|Lost to Follow-up|1|||
162984983|NCT02707861|588647483|FG001|Overall Study|Lost to Follow-up|3|||
162984984|NCT00731549|588647486|FG000|Overall Study|Lost to Follow-up|19|||
162984985|NCT00731549|588647486|FG000|Overall Study|Met withdrawal criteria|24|||
162984986|NCT00731549|588647486|FG000|Overall Study|Physician Decision|16|||
162984987|NCT00731549|588647486|FG000|Overall Study|Withdrawal by Subject|89|||
162984988|NCT00731549|588647486|FG000|Overall Study|Protocol deviation|1|||
162984989|NCT00731549|588647486|FG000|Overall Study|Adverse Event|31|||
162984990|NCT00731549|588647486|FG000|Overall Study|Lack of efficacy with AE|37|||
162984991|NCT00731549|588647486|FG000|Overall Study|Lack of efficacy without AE|6|||
162984992|NCT00507546|588647487|FG000|Overall Study|Withdrawal by Subject|1|||
162984993|NCT00507546|588647488|FG001|Overall Study|Withdrawal by Subject|0|||
162984994|NCT00507546|588647487|FG000|Overall Study|Protocol Violation|1|||
162984995|NCT00507546|588647488|FG001|Overall Study|Protocol Violation|0|||
162984996|NCT00507546|588647487|FG000|Overall Study|Physician Decision|0|||
162984997|NCT00507546|588647488|FG001|Overall Study|Physician Decision|1|||
162984998|NCT00609466|588647492|FG000|Overall Study|Withdrawal by Subject|0|||
162984999|NCT00609466|588647493|FG001|Overall Study|Withdrawal by Subject|1|||
162985000|NCT00609466|588647494|FG002|Overall Study|Withdrawal by Subject|1|||
162985001|NCT00609466|588647492|FG000|Overall Study|Adverse Event|2|||
162985002|NCT00609466|588647493|FG001|Overall Study|Adverse Event|3|||
162985003|NCT00609466|588647494|FG002|Overall Study|Adverse Event|1|||
162985004|NCT00609466|588647492|FG000|Overall Study|Lack of Efficacy|0|||
162985005|NCT00609466|588647493|FG001|Overall Study|Lack of Efficacy|2|||
162985006|NCT00609466|588647494|FG002|Overall Study|Lack of Efficacy|2|||
162985007|NCT03512262|588647495|FG000|Overall Study|Adverse Event|8|||
162985008|NCT03512262|588647496|FG001|Overall Study|Adverse Event|3|||
162985009|NCT03512262|588647495|FG000|Overall Study|Death (non-treatment emergent)|1|||
162985010|NCT03512262|588647496|FG001|Overall Study|Death (non-treatment emergent)|0|||
162985011|NCT03512262|588647495|FG000|Overall Study|Withdrawal by Subject|17|||
162985012|NCT03512262|588647496|FG001|Overall Study|Withdrawal by Subject|9|||
162985013|NCT03512262|588647495|FG000|Overall Study|Lost to Follow-up|7|||
162985014|NCT03512262|588647496|FG001|Overall Study|Lost to Follow-up|1|||
162985015|NCT03512262|588647495|FG000|Overall Study|Other than Specified|2|||
162985016|NCT03512262|588647496|FG001|Overall Study|Other than Specified|2|||
162985017|NCT01299805|588647499|FG000|Overall Study|Adverse Event|2|||
162985018|NCT01299805|588647500|FG001|Overall Study|Adverse Event|0|||
162985019|NCT03188666|588649858|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985020|NCT03188666|588649859|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
162985021|NCT03188666|588649860|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985022|NCT03188666|588649861|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
162985023|NCT03188666|588649858|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
162985024|NCT03188666|588649859|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
162985025|NCT03188666|588649860|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
162985026|NCT03188666|588649861|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
162985027|NCT03188666|588649858|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985028|NCT03188666|588649859|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985029|NCT03188666|588649860|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
162985030|NCT03188666|588649861|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
162985031|NCT03188666|588649858|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
163059800|NCT02030600|588928218|FG001|Treatment Period 2|Lost to Follow-up|2|||
163059801|NCT02030600|588928217|FG000|Treatment Period 2|Protocol Violation|1|||
162635070|NCT04557371|587376686|FG002|Overall Study|Covid-19-related|0|||
162985032|NCT03188666|588649859|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
162985033|NCT03188666|588649860|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
162985034|NCT03188666|588649861|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
162985035|NCT02068092|588649862|FG000|Overall Study|Physician Decision|2|||
162985036|NCT02068092|588649862|FG000|Overall Study|Adverse Event|2|||
162985037|NCT02068092|588649862|FG000|Overall Study|Lost to Follow-up|4|||
162985038|NCT02068092|588649862|FG000|Overall Study|Withdrawal by Subject|2|||
162985039|NCT02128217|588649867|FG000|Overall Study|Lost to Follow-up|0|||
162985040|NCT02128217|588649868|FG001|Overall Study|Lost to Follow-up|1|||
162985041|NCT05071313|588649871|FG000|Overall Study|Lost to Follow-up|17|||
162985042|NCT05071313|588649872|FG001|Overall Study|Lost to Follow-up|10|||
162985043|NCT05071313|588649871|FG000|Overall Study|Physician Decision|1|||
162985044|NCT05071313|588649872|FG001|Overall Study|Physician Decision|6|||
162985045|NCT05071313|588649871|FG000|Overall Study|Death|1|||
162985046|NCT05071313|588649872|FG001|Overall Study|Death|0|||
162985047|NCT05071313|588649871|FG000|Overall Study|Withdrawal by Subject|10|||
162985048|NCT05071313|588649872|FG001|Overall Study|Withdrawal by Subject|15|||
162985049|NCT05071313|588649871|FG000|Overall Study|Other|1|||
162985050|NCT05071313|588649872|FG001|Overall Study|Other|0|||
162985051|NCT05071313|588649871|FG000|Overall Study|Randomized but not vaccinated|4|||
162985052|NCT05071313|588649872|FG001|Overall Study|Randomized but not vaccinated|2|||
162985053|NCT00541970|588649873|FG000|Month 7|Protocol Violation|9|||
162985054|NCT00541970|588649874|FG001|Month 7|Protocol Violation|13|||
162985055|NCT00541970|588649875|FG002|Month 7|Protocol Violation|11|||
162985056|NCT00541970|588649876|FG003|Month 7|Protocol Violation|5|||
162985057|NCT00541970|588649873|FG000|Month 12|Adverse Event|0|||
162985058|NCT00541970|588649874|FG001|Month 12|Adverse Event|1|||
162985059|NCT00541970|588649875|FG002|Month 12|Adverse Event|1|||
162985060|NCT00541970|588649876|FG003|Month 12|Adverse Event|1|||
162985061|NCT00541970|588649873|FG000|Month 12|Protocol Violation|12|||
162985062|NCT00541970|588649874|FG001|Month 12|Protocol Violation|21|||
162985063|NCT00541970|588649875|FG002|Month 12|Protocol Violation|20|||
162985064|NCT00541970|588649876|FG003|Month 12|Protocol Violation|15|||
162985065|NCT00541970|588649873|FG000|Month 18|Adverse Event|0|||
162985066|NCT00541970|588649874|FG001|Month 18|Adverse Event|1|||
162985067|NCT00541970|588649875|FG002|Month 18|Adverse Event|1|||
162985068|NCT00541970|588649876|FG003|Month 18|Adverse Event|1|||
162985069|NCT00541970|588649873|FG000|Month 18|Protocol Violation|14|||
162985070|NCT00541970|588649874|FG001|Month 18|Protocol Violation|23|||
162985071|NCT00541970|588649875|FG002|Month 18|Protocol Violation|24|||
162985072|NCT00541970|588649876|FG003|Month 18|Protocol Violation|16|||
162985073|NCT00541970|588649873|FG000|Month 24|Adverse Event|0|||
162985074|NCT00541970|588649874|FG001|Month 24|Adverse Event|1|||
162985075|NCT00541970|588649875|FG002|Month 24|Adverse Event|1|||
162985076|NCT00541970|588649876|FG003|Month 24|Adverse Event|1|||
162985077|NCT00541970|588649873|FG000|Month 24|Protocol Violation|29|||
162985078|NCT00541970|588649874|FG001|Month 24|Protocol Violation|31|||
162985079|NCT00541970|588649875|FG002|Month 24|Protocol Violation|31|||
162985080|NCT00541970|588649876|FG003|Month 24|Protocol Violation|21|||
162985081|NCT00541970|588649873|FG000|Month 36|Protocol Violation|61|||
162985082|NCT00541970|588649874|FG001|Month 36|Protocol Violation|66|||
162985083|NCT00541970|588649875|FG002|Month 36|Protocol Violation|66|||
162985084|NCT00541970|588649876|FG003|Month 36|Protocol Violation|60|||
162635071|NCT04557371|587376684|FG000|Overall Study|Withdrawal by Subject|0|||
162635072|NCT04557371|587376685|FG001|Overall Study|Withdrawal by Subject|1|||
162985085|NCT00541970|588649873|FG000|Month 48|Withdrawal by Subject|2|||
162985086|NCT00541970|588649874|FG001|Month 48|Withdrawal by Subject|4|||
162985087|NCT00541970|588649875|FG002|Month 48|Withdrawal by Subject|4|||
162985088|NCT00541970|588649876|FG003|Month 48|Withdrawal by Subject|2|||
162985089|NCT00541970|588649873|FG000|Month 48|Other|3|||
162985090|NCT00541970|588649874|FG001|Month 48|Other|1|||
162985091|NCT00541970|588649875|FG002|Month 48|Other|1|||
162985092|NCT00541970|588649876|FG003|Month 48|Other|0|||
162985093|NCT00541970|588649873|FG000|Month 48|Lost to Follow-up|66|||
162985094|NCT00541970|588649874|FG001|Month 48|Lost to Follow-up|68|||
162985095|NCT00541970|588649875|FG002|Month 48|Lost to Follow-up|68|||
162985096|NCT00541970|588649876|FG003|Month 48|Lost to Follow-up|73|||
162985097|NCT00541970|588649873|FG000|Month 60|Protocol Violation|78|||
162985098|NCT00541970|588649874|FG001|Month 60|Protocol Violation|77|||
162635073|NCT04557371|587376686|FG002|Overall Study|Withdrawal by Subject|0|||
162635074|NCT04557371|587376684|FG000|Overall Study|Adverse Event|1|||
162635075|NCT04557371|587376685|FG001|Overall Study|Adverse Event|0|||
162635076|NCT04557371|587376686|FG002|Overall Study|Adverse Event|0|||
162985099|NCT00541970|588649875|FG002|Month 60|Protocol Violation|82|||
162635077|NCT01428453|587376689|FG000|Overall Study|Adverse Event|2|||
162635078|NCT01428453|587376690|FG001|Overall Study|Adverse Event|7|||
163059802|NCT02030600|588928218|FG001|Treatment Period 2|Protocol Violation|2|||
162635079|NCT01428453|587376689|FG000|Overall Study|Protocol Violation|1|||
162985100|NCT00541970|588649876|FG003|Month 60|Protocol Violation|72|||
162985101|NCT03107026|588649877|FG000|Overall Study|Adverse Event|2|||
162985102|NCT03107026|588649878|FG001|Overall Study|Adverse Event|14|||
162985103|NCT03107026|588649879|FG002|Overall Study|Adverse Event|23|||
162985104|NCT03107026|588649877|FG000|Overall Study|Lost to Follow-up|12|||
162985105|NCT03107026|588649878|FG001|Overall Study|Lost to Follow-up|12|||
162985106|NCT03107026|588649879|FG002|Overall Study|Lost to Follow-up|13|||
162985107|NCT03107026|588649877|FG000|Overall Study|Protocol Violation|1|||
162985108|NCT03107026|588649878|FG001|Overall Study|Protocol Violation|2|||
162985109|NCT03107026|588649879|FG002|Overall Study|Protocol Violation|0|||
162985110|NCT03107026|588649877|FG000|Overall Study|Pregnancy|1|||
162985111|NCT03107026|588649878|FG001|Overall Study|Pregnancy|0|||
162985112|NCT03107026|588649879|FG002|Overall Study|Pregnancy|0|||
162985113|NCT03107026|588649877|FG000|Overall Study|Withdrawal by Subject|13|||
162985114|NCT03107026|588649878|FG001|Overall Study|Withdrawal by Subject|5|||
162985115|NCT03107026|588649879|FG002|Overall Study|Withdrawal by Subject|17|||
162985116|NCT03107026|588649877|FG000|Overall Study|non compliance with study visits|1|||
162985117|NCT03107026|588649878|FG001|Overall Study|non compliance with study visits|2|||
162985118|NCT03107026|588649879|FG002|Overall Study|non compliance with study visits|0|||
162985119|NCT03107026|588649877|FG000|Overall Study|non-compliance with study drug|2|||
162985120|NCT03107026|588649878|FG001|Overall Study|non-compliance with study drug|2|||
162985121|NCT03107026|588649879|FG002|Overall Study|non-compliance with study drug|3|||
162985122|NCT03107026|588649877|FG000|Overall Study|Physician Decision|0|||
162985123|NCT03107026|588649878|FG001|Overall Study|Physician Decision|1|||
162985124|NCT03107026|588649879|FG002|Overall Study|Physician Decision|0|||
162985125|NCT01183221|588649880|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
162985126|NCT01183221|588649881|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
162985127|NCT03596151|588649886|FG000|Overall Study|Withdrawal by Subject|1|||
162985128|NCT00807248|588649888|FG000|Overall Study|Adverse Event|1|||
162985129|NCT00807248|588649889|FG001|Overall Study|Adverse Event|2|||
162985130|NCT00807248|588649890|FG002|Overall Study|Adverse Event|2|||
162985131|NCT00807248|588649891|FG003|Overall Study|Adverse Event|6|||
162985132|NCT00807248|588649888|FG000|Overall Study|Lack of Efficacy|14|||
162985133|NCT00807248|588649889|FG001|Overall Study|Lack of Efficacy|4|||
162985134|NCT00807248|588649890|FG002|Overall Study|Lack of Efficacy|8|||
162985135|NCT00807248|588649891|FG003|Overall Study|Lack of Efficacy|3|||
162985136|NCT00807248|588649888|FG000|Overall Study|Protocol Violation|0|||
162985137|NCT00807248|588649889|FG001|Overall Study|Protocol Violation|1|||
162985138|NCT00807248|588649890|FG002|Overall Study|Protocol Violation|1|||
162985139|NCT00807248|588649891|FG003|Overall Study|Protocol Violation|0|||
162985140|NCT00807248|588649888|FG000|Overall Study|Withdrawal of Consent|5|||
162985141|NCT00807248|588649889|FG001|Overall Study|Withdrawal of Consent|5|||
162985142|NCT00807248|588649890|FG002|Overall Study|Withdrawal of Consent|5|||
162985143|NCT00807248|588649891|FG003|Overall Study|Withdrawal of Consent|5|||
162985144|NCT00807248|588649888|FG000|Overall Study|Lost to Follow-up|1|||
162985145|NCT00807248|588649889|FG001|Overall Study|Lost to Follow-up|0|||
162985146|NCT00807248|588649890|FG002|Overall Study|Lost to Follow-up|0|||
162985147|NCT00807248|588649891|FG003|Overall Study|Lost to Follow-up|0|||
162985148|NCT00807248|588649888|FG000|Overall Study|Other Reason|0|||
162985149|NCT00807248|588649889|FG001|Overall Study|Other Reason|0|||
162985150|NCT00807248|588649890|FG002|Overall Study|Other Reason|2|||
162985151|NCT00807248|588649891|FG003|Overall Study|Other Reason|0|||
162985152|NCT02444793|588649892|FG000|Overall Study|Lost to Follow-up|2|||
162985153|NCT02444793|588649893|FG001|Overall Study|Lost to Follow-up|2|||
162985154|NCT02444793|588649894|FG002|Overall Study|Lost to Follow-up|0|||
162985155|NCT02444793|588649895|FG003|Overall Study|Lost to Follow-up|0|||
162985156|NCT02444793|588649892|FG000|Overall Study|Death|0|||
162985157|NCT02444793|588649893|FG001|Overall Study|Death|3|||
162985158|NCT02444793|588649894|FG002|Overall Study|Death|0|||
162985159|NCT02444793|588649895|FG003|Overall Study|Death|0|||
162985160|NCT02444793|588649892|FG000|Overall Study|Other|0|||
162985161|NCT02444793|588649893|FG001|Overall Study|Other|0|||
162985162|NCT02444793|588649894|FG002|Overall Study|Other|2|||
162985163|NCT02444793|588649895|FG003|Overall Study|Other|0|||
162985164|NCT02444793|588649892|FG000|Overall Study|Objective progression or relapse|9|||
162985165|NCT02444793|588649893|FG001|Overall Study|Objective progression or relapse|1|||
162635080|NCT01428453|587376690|FG001|Overall Study|Protocol Violation|0|||
162635081|NCT01428453|587376689|FG000|Overall Study|Lost to Follow-up|0|||
162635082|NCT01428453|587376690|FG001|Overall Study|Lost to Follow-up|1|||
162635083|NCT01428453|587376689|FG000|Overall Study|Withdrawal by Subject|3|||
162635084|NCT01428453|587376690|FG001|Overall Study|Withdrawal by Subject|1|||
162635085|NCT01996709|587376691|FG000|Overall Study|Withdrawal by Subject|1|||
162635086|NCT01996709|587376692|FG001|Overall Study|Withdrawal by Subject|0|||
162635087|NCT01996709|587376691|FG000|Overall Study|Lost to Follow-up|3|||
162635088|NCT01996709|587376692|FG001|Overall Study|Lost to Follow-up|0|||
162635089|NCT01996709|587376691|FG000|Overall Study|Subject Non-Compliant|1|||
162635090|NCT01996709|587376692|FG001|Overall Study|Subject Non-Compliant|0|||
162635091|NCT01996709|587376691|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
162635092|NCT01996709|587376692|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
162635093|NCT03918447|587376697|FG000|Overall Study|Death|1|||
162635094|NCT03918447|587376698|FG001|Overall Study|Death|0|||
162635095|NCT03918447|587376697|FG000|Overall Study|Lost to Follow-up|13|||
162985166|NCT02444793|588649894|FG002|Overall Study|Objective progression or relapse|2|||
162985167|NCT02444793|588649895|FG003|Overall Study|Objective progression or relapse|3|||
162985168|NCT02504671|588649897|FG000|Overall Study|Withdrawal by Subject|1|||
162985169|NCT02504671|588649898|FG001|Overall Study|Withdrawal by Subject|5|||
162985170|NCT02504671|588649899|FG002|Overall Study|Withdrawal by Subject|4|||
162985171|NCT02504671|588649900|FG003|Overall Study|Withdrawal by Subject|4|||
162985172|NCT02504671|588649901|FG004|Overall Study|Withdrawal by Subject|5|||
162985173|NCT02504671|588649902|FG005|Overall Study|Withdrawal by Subject|3|||
162985174|NCT02504671|588649897|FG000|Overall Study|Lack of Efficacy|1|||
162985175|NCT02504671|588649898|FG001|Overall Study|Lack of Efficacy|3|||
162985176|NCT02504671|588649899|FG002|Overall Study|Lack of Efficacy|1|||
162985177|NCT02504671|588649900|FG003|Overall Study|Lack of Efficacy|0|||
162985178|NCT02504671|588649901|FG004|Overall Study|Lack of Efficacy|4|||
162985179|NCT02504671|588649902|FG005|Overall Study|Lack of Efficacy|4|||
162985180|NCT02504671|588649897|FG000|Overall Study|Adverse Event|1|||
162985181|NCT02504671|588649898|FG001|Overall Study|Adverse Event|1|||
162985182|NCT02504671|588649899|FG002|Overall Study|Adverse Event|0|||
162985183|NCT02504671|588649900|FG003|Overall Study|Adverse Event|1|||
162985184|NCT02504671|588649901|FG004|Overall Study|Adverse Event|0|||
162985185|NCT02504671|588649902|FG005|Overall Study|Adverse Event|2|||
162985186|NCT02504671|588649897|FG000|Overall Study|Protocol Violation|2|||
162985187|NCT02504671|588649898|FG001|Overall Study|Protocol Violation|1|||
162985188|NCT02504671|588649899|FG002|Overall Study|Protocol Violation|0|||
162985189|NCT02504671|588649900|FG003|Overall Study|Protocol Violation|0|||
162985190|NCT02504671|588649901|FG004|Overall Study|Protocol Violation|0|||
162985191|NCT02504671|588649902|FG005|Overall Study|Protocol Violation|1|||
162985192|NCT02504671|588649897|FG000|Overall Study|Lost to Follow-up|0|||
162985193|NCT02504671|588649898|FG001|Overall Study|Lost to Follow-up|0|||
162985194|NCT02504671|588649899|FG002|Overall Study|Lost to Follow-up|2|||
162985195|NCT02504671|588649900|FG003|Overall Study|Lost to Follow-up|0|||
162985196|NCT02504671|588649901|FG004|Overall Study|Lost to Follow-up|0|||
162985197|NCT02504671|588649902|FG005|Overall Study|Lost to Follow-up|1|||
162985198|NCT02504671|588649897|FG000|Overall Study|Protocol defined stopping criteria|7|||
162985199|NCT02504671|588649898|FG001|Overall Study|Protocol defined stopping criteria|4|||
162985200|NCT02504671|588649899|FG002|Overall Study|Protocol defined stopping criteria|3|||
162985201|NCT02504671|588649900|FG003|Overall Study|Protocol defined stopping criteria|5|||
162985202|NCT02504671|588649901|FG004|Overall Study|Protocol defined stopping criteria|3|||
162985203|NCT02504671|588649902|FG005|Overall Study|Protocol defined stopping criteria|3|||
162985204|NCT00210249|588649903|FG000|Overall Study|Lost to Follow-up|5|||
162985205|NCT00210249|588649903|FG000|Overall Study|Protocol Violation|11|||
162985206|NCT04280705|588649904|FG000|Overall Study|Enrolled but not treated|4|||
162985207|NCT04280705|588649905|FG001|Overall Study|Enrolled but not treated|10|||
162985208|NCT04280705|588649904|FG000|Overall Study|Physician Decision|1|||
162985209|NCT04280705|588649905|FG001|Overall Study|Physician Decision|0|||
162985210|NCT04280705|588649904|FG000|Overall Study|Withdrawal by Subject|7|||
162985211|NCT04280705|588649905|FG001|Overall Study|Withdrawal by Subject|9|||
162985212|NCT04280705|588649904|FG000|Overall Study|Adverse Event|0|||
162985213|NCT04280705|588649905|FG001|Overall Study|Adverse Event|4|||
162985214|NCT04280705|588649904|FG000|Overall Study|Transferred to another hospital|1|||
162985215|NCT04280705|588649905|FG001|Overall Study|Transferred to another hospital|1|||
162985216|NCT03222583|588649908|FG000|Overall Study|Withdrawal by Subject|3|||
162985217|NCT03222583|588649909|FG001|Overall Study|Withdrawal by Subject|3|||
162985218|NCT03222583|588649908|FG000|Overall Study|Lost to Follow-up|1|||
162985219|NCT03222583|588649909|FG001|Overall Study|Lost to Follow-up|0|||
162985220|NCT03222583|588649908|FG000|Overall Study|Other|1|||
162985221|NCT03222583|588649909|FG001|Overall Study|Other|3|||
162985222|NCT02518919|588649910|FG000|Overall Study|Protocol Violation|1|||
162985223|NCT02518919|588649911|FG001|Overall Study|Protocol Violation|1|||
162985224|NCT02518919|588649912|FG002|Overall Study|Protocol Violation|2|||
162985225|NCT04498403|588649913|FG000|Overall Study|Adverse Event|1|||
162985226|NCT04498403|588649914|FG001|Overall Study|Adverse Event|0|||
162985227|NCT04498403|588649913|FG000|Overall Study|Study Terminated By Sponsor|29|||
162985228|NCT04498403|588649914|FG001|Overall Study|Study Terminated By Sponsor|10|||
162985229|NCT03986138|588649915|FG000|First MRI Examination|Physician Decision|0|||
162985230|NCT03986138|588649916|FG001|First MRI Examination|Physician Decision|1|||
162985231|NCT03986138|588649915|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
162985232|NCT03986138|588649916|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
162985233|NCT03986138|588649915|FG000|Washout|Withdrawal by Subject|4|||
162985234|NCT03986138|588649916|FG001|Washout|Withdrawal by Subject|5|||
162985235|NCT03986138|588649915|FG000|Washout|Lost to Follow-up|0|||
162985236|NCT03986138|588649916|FG001|Washout|Lost to Follow-up|2|||
162985237|NCT03986138|588649915|FG000|Washout|Adverse Event|1|||
162985238|NCT03986138|588649916|FG001|Washout|Adverse Event|1|||
162985239|NCT03986138|588649915|FG000|Washout|Other reason|5|||
162985240|NCT03986138|588649916|FG001|Washout|Other reason|5|||
162985241|NCT03986138|588649915|FG000|Second MRI Examination|Withdrawal by Subject|0|||
162985242|NCT03986138|588649916|FG001|Second MRI Examination|Withdrawal by Subject|2|||
162985243|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
162635096|NCT03918447|587376698|FG001|Overall Study|Lost to Follow-up|6|||
162635097|NCT03918447|587376697|FG000|Overall Study|Withdrawal by Subject|19|||
162635098|NCT03918447|587376698|FG001|Overall Study|Withdrawal by Subject|17|||
162985244|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
162985245|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
162985246|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
162985247|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
162985248|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
162985249|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
162985250|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
162985251|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
162985252|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
162985253|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
162985254|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
162985255|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
162985256|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
162985257|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
162985258|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
162985259|NCT03182244|588649920|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
162985260|NCT03182244|588649921|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
162985261|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
162985262|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
162985263|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
162985264|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
162985265|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
162985266|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
162985267|NCT03182244|588649920|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
162985268|NCT03182244|588649921|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
162985269|NCT02049450|588649922|FG000|Overall Study|Adverse Event|2|||
162985270|NCT02049450|588649922|FG000|Overall Study|Withdrawal by Subject|1|||
162985271|NCT02049450|588649922|FG000|Overall Study|Patients/guardian decision|1|||
162985272|NCT03186781|588649923|FG000|Overall Study|Lost to Follow-up|0|||
162985273|NCT03186781|588649924|FG001|Overall Study|Lost to Follow-up|0|||
162985274|NCT03186781|588649925|FG002|Overall Study|Lost to Follow-up|1|||
162985275|NCT03186781|588649926|FG003|Overall Study|Lost to Follow-up|0|||
162985276|NCT03186781|588649927|FG004|Overall Study|Lost to Follow-up|1|||
162985277|NCT03186781|588649928|FG005|Overall Study|Lost to Follow-up|0|||
162985278|NCT03186781|588649923|FG000|Overall Study|Moved from Area|0|||
162985279|NCT03186781|588649924|FG001|Overall Study|Moved from Area|0|||
162985280|NCT03186781|588649925|FG002|Overall Study|Moved from Area|0|||
162985281|NCT03186781|588649926|FG003|Overall Study|Moved from Area|0|||
162985282|NCT03186781|588649927|FG004|Overall Study|Moved from Area|1|||
162985283|NCT03186781|588649928|FG005|Overall Study|Moved from Area|0|||
162985284|NCT03186781|588649923|FG000|Overall Study|Withdrawal by Subject|0|||
162985285|NCT03186781|588649924|FG001|Overall Study|Withdrawal by Subject|0|||
162985286|NCT03186781|588649925|FG002|Overall Study|Withdrawal by Subject|0|||
162985287|NCT03186781|588649926|FG003|Overall Study|Withdrawal by Subject|0|||
162985288|NCT03186781|588649927|FG004|Overall Study|Withdrawal by Subject|1|||
162985289|NCT03186781|588649928|FG005|Overall Study|Withdrawal by Subject|0|||
162985290|NCT04709835|588649929|FG000|Overall Study|Withdrawal by Subject|0|||
162985291|NCT04709835|588649930|FG001|Overall Study|Withdrawal by Subject|1|||
162985292|NCT04709835|588649931|FG002|Overall Study|Withdrawal by Subject|0|||
162985293|NCT01570686|588649932|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162985294|NCT01570686|588649933|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162985295|NCT01570686|588649932|FG000|Overall Study|Administrative problems|0|||
162985296|NCT01570686|588649933|FG001|Overall Study|Administrative problems|1|||
162985297|NCT01570686|588649932|FG000|Overall Study|Adverse Event|8|||
162985298|NCT01570686|588649933|FG001|Overall Study|Adverse Event|6|||
162635099|NCT03918447|587376697|FG000|Overall Study|Study Terminated by Sponsor|195|||
162635100|NCT03918447|587376698|FG001|Overall Study|Study Terminated by Sponsor|197|||
162985299|NCT01570686|588649932|FG000|Overall Study|Lost to Follow-up|4|||
162985300|NCT01570686|588649933|FG001|Overall Study|Lost to Follow-up|3|||
162985301|NCT01570686|588649932|FG000|Overall Study|Protocol Deviation|3|||
162985302|NCT01570686|588649933|FG001|Overall Study|Protocol Deviation|0|||
162985303|NCT01570686|588649932|FG000|Overall Study|Withdrawal by Subject|4|||
162985304|NCT01570686|588649933|FG001|Overall Study|Withdrawal by Subject|4|||
162985305|NCT01570686|588649932|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162985306|NCT01570686|588649933|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162985307|NCT02372071|588649934|FG000|Overall Study|Protocol Violation|18|||
162985308|NCT03347422|588649938|FG000|Part A (26 Weeks)|Adverse Event|3|||
162985309|NCT03347422|588649939|FG001|Part A (26 Weeks)|Adverse Event|0|||
162985310|NCT03347422|588649938|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
162635101|NCT03918447|587376697|FG000|Overall Study|Reason not Specified|0|||
162985311|NCT03347422|588649939|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
162985312|NCT03347422|588649938|FG000|Part B (149 Weeks)|Adverse Event|0|||
162985313|NCT03347422|588649939|FG001|Part B (149 Weeks)|Adverse Event|1|||
162985314|NCT03347422|588649938|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
162985315|NCT03347422|588649939|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
162985316|NCT03347422|588649938|FG000|Part B (149 Weeks)|Other|1|||
162985317|NCT03347422|588649939|FG001|Part B (149 Weeks)|Other|0|||
162985318|NCT00622466|588649947|FG000|Overall Study|Death|1|||
162985319|NCT00622466|588649947|FG000|Overall Study|Adverse Event|1|||
162985320|NCT00622466|588649947|FG000|Overall Study|Withdrawal by Subject|2|||
162985321|NCT01936623|588649961|FG000|Overall Study|Lost to Follow-up|0|||
162985322|NCT01936623|588649962|FG001|Overall Study|Lost to Follow-up|5|||
162985323|NCT01383135|588649963|FG000|Overall Study|Not Scanned / Imaged|1|||
162985324|NCT01383135|588649964|FG001|Overall Study|Not Scanned / Imaged|0|||
162985325|NCT01383135|588649965|FG002|Overall Study|Not Scanned / Imaged|1|||
162985326|NCT01383135|588649966|FG003|Overall Study|Not Scanned / Imaged|0|||
162985327|NCT03397771|588649971|FG000|Overall Study|2 erroneously randomized, never treated|3|||
162985328|NCT03397771|588649972|FG001|Overall Study|2 erroneously randomized, never treated|1|||
162985329|NCT03397771|588649971|FG000|Overall Study|Withdrawal by Subject|1|||
162985330|NCT03397771|588649972|FG001|Overall Study|Withdrawal by Subject|3|||
162985331|NCT03397771|588649971|FG000|Overall Study|Protocol Violation|2|||
162985332|NCT03397771|588649972|FG001|Overall Study|Protocol Violation|2|||
162985333|NCT03397771|588649971|FG000|Overall Study|Adverse Event|2|||
162985334|NCT03397771|588649972|FG001|Overall Study|Adverse Event|1|||
162985335|NCT02669758|588649973|FG000|Overall Study|Withdrawal by Subject|43|||
162985336|NCT02669758|588649973|FG000|Overall Study|Lost to Follow-up|19|||
162985337|NCT02669758|588649973|FG000|Overall Study|Adverse Event|16|||
162985338|NCT02669758|588649973|FG000|Overall Study|Non-Compliance with Study Drug|8|||
162985339|NCT02669758|588649973|FG000|Overall Study|Lack of Efficacy|5|||
162985340|NCT02669758|588649973|FG000|Overall Study|Pregnancy|1|||
162985341|NCT02669758|588649973|FG000|Overall Study|Study noncompliance|1|||
163059803|NCT02030600|588928217|FG000|Treatment Period 2|Withdrawal by Subject|13|||
163059804|NCT02030600|588928218|FG001|Treatment Period 2|Withdrawal by Subject|9|||
162635102|NCT03918447|587376698|FG001|Overall Study|Reason not Specified|1|||
162635103|NCT00477971|587376699|FG000|Overall Study|Disease progression|6|||
162635104|NCT00477971|587376700|FG001|Overall Study|Disease progression|0|||
162635105|NCT00477971|587376699|FG000|Overall Study|Withdrawal by Subject|3|||
162635106|NCT00477971|587376700|FG001|Overall Study|Withdrawal by Subject|1|||
162635107|NCT00477971|587376699|FG000|Overall Study|Adverse Event|3|||
162635108|NCT00477971|587376700|FG001|Overall Study|Adverse Event|0|||
162635109|NCT00477971|587376699|FG000|Overall Study|Death|2|||
162635110|NCT00477971|587376700|FG001|Overall Study|Death|4|||
162635111|NCT00477971|587376699|FG000|Overall Study|Alternative treatment|3|||
162635112|NCT00477971|587376700|FG001|Overall Study|Alternative treatment|1|||
162635113|NCT01774968|587376701|FG000|Overall Study|Adverse Event|4|||
162635114|NCT01774968|587376702|FG001|Overall Study|Adverse Event|4|||
162635115|NCT01774968|587376701|FG000|Overall Study|Death|0|||
162635116|NCT01774968|587376702|FG001|Overall Study|Death|1|||
162635117|NCT01774968|587376701|FG000|Overall Study|Lost to Follow-up|1|||
162635118|NCT01774968|587376702|FG001|Overall Study|Lost to Follow-up|3|||
162635119|NCT01774968|587376701|FG000|Overall Study|Physician Decision|5|||
162635120|NCT01774968|587376702|FG001|Overall Study|Physician Decision|1|||
162635121|NCT01774968|587376701|FG000|Overall Study|Protocol Violation|14|||
162635122|NCT01774968|587376702|FG001|Overall Study|Protocol Violation|13|||
162635123|NCT01774968|587376701|FG000|Overall Study|Sponsor Decision|0|||
162635124|NCT01774968|587376702|FG001|Overall Study|Sponsor Decision|2|||
162635125|NCT01774968|587376701|FG000|Overall Study|Withdrawal by Subject|6|||
162635126|NCT01774968|587376702|FG001|Overall Study|Withdrawal by Subject|11|||
162635127|NCT05355805|587376703|FG000|Overall Study|Lost to Follow-up|6|||
162635128|NCT05355805|587376704|FG001|Overall Study|Lost to Follow-up|11|||
162635129|NCT05355805|587376705|FG002|Overall Study|Lost to Follow-up|10|||
162635130|NCT05355805|587376706|FG003|Overall Study|Lost to Follow-up|6|||
162635131|NCT05355805|587376703|FG000|Overall Study|Decision by Sponsor|0|||
162635132|NCT05355805|587376704|FG001|Overall Study|Decision by Sponsor|0|||
162635133|NCT05355805|587376705|FG002|Overall Study|Decision by Sponsor|1|||
162635134|NCT05355805|587376706|FG003|Overall Study|Decision by Sponsor|0|||
162635135|NCT05355805|587376703|FG000|Overall Study|Withdrawal by Subject|7|||
162635136|NCT05355805|587376704|FG001|Overall Study|Withdrawal by Subject|14|||
162635137|NCT05355805|587376705|FG002|Overall Study|Withdrawal by Subject|15|||
162635138|NCT05355805|587376706|FG003|Overall Study|Withdrawal by Subject|13|||
162635139|NCT01986855|587378100|FG000|Overall Study|Adverse Event|1|||
162635140|NCT01986855|587378101|FG001|Overall Study|Adverse Event|0|||
162635141|NCT01986855|587378102|FG002|Overall Study|Adverse Event|0|||
162635142|NCT01986855|587378100|FG000|Overall Study|Death|3|||
162985342|NCT02669758|588649973|FG000|Overall Study|Protocol Violation|1|||
162985343|NCT02455050|588649974|FG000|Treatment Period 1|Lost to Follow-up|1|||
162985344|NCT02455050|588649975|FG001|Treatment Period 1|Lost to Follow-up|1|||
162635143|NCT01986855|587378101|FG001|Overall Study|Death|4|||
162635144|NCT01986855|587378102|FG002|Overall Study|Death|4|||
162985345|NCT02455050|588649976|FG002|Treatment Period 1|Lost to Follow-up|1|||
162985346|NCT02455050|588649977|FG003|Treatment Period 1|Lost to Follow-up|2|||
162985347|NCT02455050|588649974|FG000|Treatment Period 2|Lost to Follow-up|1|||
162985348|NCT02455050|588649975|FG001|Treatment Period 2|Lost to Follow-up|0|||
162985349|NCT02455050|588649976|FG002|Treatment Period 2|Lost to Follow-up|2|||
162985350|NCT02455050|588649977|FG003|Treatment Period 2|Lost to Follow-up|1|||
162985351|NCT03393806|588649980|FG000|Overall Study|Physician Decision|1|||
162985352|NCT03393806|588649981|FG001|Overall Study|Physician Decision|0|||
162985353|NCT01259115|588649982|FG000|Period 1|Adverse Event|1|||
162985354|NCT01259115|588649983|FG001|Period 1|Adverse Event|0|||
162985355|NCT01259115|588649982|FG000|Period 1|Protocol Violation|2|||
162985356|NCT01259115|588649983|FG001|Period 1|Protocol Violation|0|||
162985357|NCT01259115|588649982|FG000|Period 1|Lost to Follow-up|0|||
162985358|NCT01259115|588649983|FG001|Period 1|Lost to Follow-up|1|||
162985359|NCT01259115|588649982|FG000|Period 2|Adverse Event|1|||
162985360|NCT01259115|588649983|FG001|Period 2|Adverse Event|0|||
162985361|NCT02605993|588649984|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985362|NCT02605993|588649985|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985363|NCT02605993|588649986|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
162985364|NCT02605993|588649987|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
162985365|NCT03493386|588649990|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985366|NCT03493386|588649991|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162985367|NCT03493386|588649992|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985368|NCT03493386|588649993|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162985369|NCT00988442|588649999|FG000|Overall Study|Death|1|||
162985370|NCT00988442|588650000|FG001|Overall Study|Death|2|||
162985371|NCT00988442|588649999|FG000|Overall Study|Lost to Follow-up|0|||
162985372|NCT00988442|588650000|FG001|Overall Study|Lost to Follow-up|1|||
162985373|NCT00988442|588649999|FG000|Overall Study|Early Study Closure|29|||
162985374|NCT00988442|588650000|FG001|Overall Study|Early Study Closure|25|||
162985375|NCT04620135|588650003|FG000|Study Completion|Adverse Event|2|||
162985376|NCT04620135|588650004|FG001|Study Completion|Adverse Event|3|||
162985377|NCT04620135|588650003|FG000|Study Completion|Withdrawal by Subject|2|||
162985378|NCT04620135|588650004|FG001|Study Completion|Withdrawal by Subject|0|||
162985379|NCT01442688|588650006|FG000|First Intervention|Withdrawal by Subject|1|||
162985380|NCT01442688|588650007|FG001|First Intervention|Withdrawal by Subject|0|||
162985381|NCT01442688|588650006|FG000|First Intervention|subject incarcerated|1|||
162985382|NCT01442688|588650007|FG001|First Intervention|subject incarcerated|0|||
162985383|NCT01442688|588650006|FG000|Second Intervention|Adverse Event|1|||
162985384|NCT01442688|588650007|FG001|Second Intervention|Adverse Event|0|||
162985385|NCT00762437|588650008|FG000|Overall Study|Lost to Follow-up|7|||
162985386|NCT00762437|588650008|FG000|Overall Study|Missed final study visit|11|||
162985387|NCT00762437|588650008|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
162985388|NCT04480021|588650009|FG000|Overall Study|Lost to Follow-up|3|||
162985389|NCT04480021|588650010|FG001|Overall Study|Lost to Follow-up|4|||
162985390|NCT00546572|588650011|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
162985391|NCT00546572|588650012|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
162985392|NCT00546572|588650011|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
162985393|NCT00546572|588650012|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
162985394|NCT00546572|588650011|FG000|Vax 1 / Year 0|Protocol Violation|3|||
162985395|NCT00546572|588650012|FG001|Vax 1 / Year 0|Protocol Violation|4|||
162985396|NCT00546572|588650011|FG000|Vax 1 / Year 0|Death|2|||
162985397|NCT00546572|588650012|FG001|Vax 1 / Year 0|Death|2|||
162985398|NCT00546572|588650011|FG000|Vax 1 / Year 0|Adverse Event|0|||
162985399|NCT00546572|588650012|FG001|Vax 1 / Year 0|Adverse Event|1|||
162985400|NCT00546572|588650011|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
162985401|NCT00546572|588650012|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
162985402|NCT00546572|588650011|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
162635145|NCT01986855|587378100|FG000|Overall Study|Lost to Follow-up|2|||
162635146|NCT01986855|587378101|FG001|Overall Study|Lost to Follow-up|1|||
162635147|NCT01986855|587378102|FG002|Overall Study|Lost to Follow-up|0|||
162635148|NCT01986855|587378100|FG000|Overall Study|Screen Failure|0|||
162635149|NCT01986855|587378101|FG001|Overall Study|Screen Failure|1|||
162635150|NCT01986855|587378102|FG002|Overall Study|Screen Failure|0|||
162635151|NCT01986855|587378100|FG000|Overall Study|Participant Moved|0|||
162635152|NCT01986855|587378101|FG001|Overall Study|Participant Moved|0|||
162985403|NCT00546572|588650012|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
162985404|NCT00546572|588650011|FG000|Vax 2 / Year 1|Other|1|||
162985405|NCT00546572|588650012|FG001|Vax 2 / Year 1|Other|1|||
162985406|NCT00546572|588650011|FG000|Vax 2 / Year 1|Adverse Event|1|||
162985407|NCT00546572|588650012|FG001|Vax 2 / Year 1|Adverse Event|0|||
162985408|NCT00546572|588650011|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
162985409|NCT00546572|588650012|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
163059805|NCT02030600|588928217|FG000|Treatment Period 2|Unclassified|1|||
162635153|NCT01986855|587378102|FG002|Overall Study|Participant Moved|2|||
162985410|NCT03979820|588650013|FG000|Overall Study|Protocol Violation|1|||
162985411|NCT03979820|588650014|FG001|Overall Study|Protocol Violation|0|||
162985412|NCT03979820|588650015|FG002|Overall Study|Protocol Violation|0|||
162985413|NCT03979820|588650016|FG003|Overall Study|Protocol Violation|0|||
162985414|NCT03979820|588650013|FG000|Overall Study|Withdrawal by Subject|0|||
162985415|NCT03979820|588650014|FG001|Overall Study|Withdrawal by Subject|0|||
162985416|NCT03979820|588650015|FG002|Overall Study|Withdrawal by Subject|1|||
162985417|NCT03979820|588650016|FG003|Overall Study|Withdrawal by Subject|0|||
162985418|NCT03979820|588650013|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
162985419|NCT03979820|588650014|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
162985420|NCT03979820|588650015|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
162985421|NCT03979820|588650016|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
162985422|NCT02685202|588650017|FG000|Overall Study|Lost to Follow-up|9|||
162985423|NCT01229735|588650018|FG000|Overall Study|Lack of Efficacy|8|||
162985424|NCT01229735|588650019|FG001|Overall Study|Lack of Efficacy|8|||
162985425|NCT01229735|588650018|FG000|Overall Study|Protocol Violation|13|||
162985426|NCT01229735|588650019|FG001|Overall Study|Protocol Violation|8|||
162985427|NCT01229735|588650018|FG000|Overall Study|Lost to Follow-up|0|||
162985428|NCT01229735|588650019|FG001|Overall Study|Lost to Follow-up|2|||
162985429|NCT01229735|588650018|FG000|Overall Study|Withdrawal by Subject|18|||
162985430|NCT01229735|588650019|FG001|Overall Study|Withdrawal by Subject|17|||
162985431|NCT01229735|588650018|FG000|Overall Study|Other Reason|13|||
162985432|NCT01229735|588650019|FG001|Overall Study|Other Reason|10|||
162985433|NCT01229735|588650018|FG000|Overall Study|SAE, non-fatal|0|||
162985434|NCT01229735|588650019|FG001|Overall Study|SAE, non-fatal|4|||
162985435|NCT01229735|588650018|FG000|Overall Study|AE, non-serious non-fatal|13|||
162985436|NCT01229735|588650019|FG001|Overall Study|AE, non-serious non-fatal|17|||
162985437|NCT01229735|588650018|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162985438|NCT01229735|588650019|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162985439|NCT02130882|588650020|FG000|Overall Study|Withdrawal by Subject|0|||
162985440|NCT02130882|588650021|FG001|Overall Study|Withdrawal by Subject|1|||
162985441|NCT04453202|588650026|FG000|Overall Study|Adverse Event|0|||
162985442|NCT04453202|588650027|FG001|Overall Study|Adverse Event|0|||
162985443|NCT04453202|588650028|FG002|Overall Study|Adverse Event|0|||
162985444|NCT04453202|588650029|FG003|Overall Study|Adverse Event|0|||
162635154|NCT01986855|587378100|FG000|Overall Study|Withdrawal by Subject|7|||
162635155|NCT01986855|587378101|FG001|Overall Study|Withdrawal by Subject|8|||
162635156|NCT01986855|587378102|FG002|Overall Study|Withdrawal by Subject|5|||
162635157|NCT04317066|587378103|FG000|Overall Study|Sponsor decision|5|||
162635158|NCT04317066|587378103|FG000|Overall Study|Death|2|||
162635159|NCT02014597|587378107|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
162635160|NCT02014597|587378108|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
162635161|NCT02279173|587378110|FG000|Overall Study|Protocol-specified Criteria|67|||
162635162|NCT02279173|587378110|FG000|Overall Study|Withdrawal by Subject|20|||
162635163|NCT02279173|587378110|FG000|Overall Study|Decision by Sponsor|4|||
162635164|NCT02279173|587378110|FG000|Overall Study|Lost to Follow-up|3|||
162635165|NCT00754624|587378112|FG000|Overall Study|Adverse Event|16|||
162635166|NCT00754624|587378112|FG000|Overall Study|Death|1|||
162635167|NCT00754624|587378112|FG000|Overall Study|Physician Decision|8|||
162635168|NCT00754624|587378112|FG000|Overall Study|Protocol Violation|1|||
162635169|NCT00754624|587378112|FG000|Overall Study|Withdrawal by Subject|28|||
162635170|NCT00754624|587378112|FG000|Overall Study|Various|12|||
162635171|NCT00754624|587378112|FG000|Overall Study|Lost to Follow-up|3|||
162635172|NCT03585504|587378117|FG000|Overall Study|Lost to Follow-up|26|||
162635173|NCT03585504|587378118|FG001|Overall Study|Lost to Follow-up|29|||
162635174|NCT02743806|587378119|FG000|Overall Study|Adverse Event|9|||
162635175|NCT02743806|587378119|FG000|Overall Study|Lost to Follow-up|8|||
162635176|NCT02743806|587378119|FG000|Overall Study|Voluntary Withdrawal|54|||
162635177|NCT02743806|587378119|FG000|Overall Study|Study Termination|65|||
162635178|NCT02743806|587378119|FG000|Overall Study|Pregnancy|6|||
162635179|NCT02743806|587378119|FG000|Overall Study|No Longer Clinically Benefiting|27|||
162635180|NCT02743806|587378119|FG000|Overall Study|Reason Not Specified|12|||
162635181|NCT00849381|587378121|FG000|Overall Study|Adverse Event|1|||
162635182|NCT00849381|587378121|FG000|Overall Study|Lost to Follow-up|129|||
162985445|NCT04453202|588650030|FG004|Overall Study|Adverse Event|0|||
162985446|NCT04453202|588650031|FG005|Overall Study|Adverse Event|0|||
162985447|NCT04453202|588650032|FG006|Overall Study|Adverse Event|1|||
162985448|NCT04453202|588650033|FG007|Overall Study|Adverse Event|0|||
162635183|NCT00849381|587378121|FG000|Overall Study|Protocol Violation|5|||
162635184|NCT00849381|587378121|FG000|Overall Study|Withdrawal by Subject|6|||
162635185|NCT00849381|587378121|FG000|Overall Study|Other|4|||
162635186|NCT04429061|587378125|FG000|Overall Study|Lost to Follow-up|62|||
162635187|NCT04429061|587378126|FG001|Overall Study|Lost to Follow-up|87|||
162635188|NCT04429061|587378125|FG000|Overall Study|Withdrawal by Subject|3|||
162985449|NCT04453202|588650034|FG008|Overall Study|Adverse Event|0|||
162985450|NCT04453202|588650035|FG009|Overall Study|Adverse Event|0|||
162635189|NCT04429061|587378126|FG001|Overall Study|Withdrawal by Subject|4|||
162985451|NCT04453202|588650036|FG010|Overall Study|Adverse Event|0|||
162985452|NCT04453202|588650026|FG000|Overall Study|Death|0|||
162985453|NCT04453202|588650027|FG001|Overall Study|Death|0|||
162985454|NCT04453202|588650028|FG002|Overall Study|Death|0|||
162985455|NCT04453202|588650029|FG003|Overall Study|Death|0|||
162985456|NCT04453202|588650030|FG004|Overall Study|Death|0|||
162985457|NCT04453202|588650031|FG005|Overall Study|Death|0|||
162985458|NCT04453202|588650032|FG006|Overall Study|Death|0|||
162985459|NCT04453202|588650033|FG007|Overall Study|Death|0|||
162985460|NCT04453202|588650034|FG008|Overall Study|Death|0|||
162985461|NCT04453202|588650035|FG009|Overall Study|Death|1|||
162985462|NCT04453202|588650036|FG010|Overall Study|Death|0|||
162985463|NCT04453202|588650026|FG000|Overall Study|Lost to Follow-up|0|||
162985464|NCT04453202|588650027|FG001|Overall Study|Lost to Follow-up|1|||
162985465|NCT04453202|588650028|FG002|Overall Study|Lost to Follow-up|0|||
162985466|NCT04453202|588650029|FG003|Overall Study|Lost to Follow-up|1|||
162985467|NCT04453202|588650030|FG004|Overall Study|Lost to Follow-up|0|||
162985468|NCT04453202|588650031|FG005|Overall Study|Lost to Follow-up|0|||
162985469|NCT04453202|588650032|FG006|Overall Study|Lost to Follow-up|0|||
162985470|NCT04453202|588650033|FG007|Overall Study|Lost to Follow-up|0|||
162985471|NCT04453202|588650034|FG008|Overall Study|Lost to Follow-up|0|||
162985472|NCT04453202|588650035|FG009|Overall Study|Lost to Follow-up|1|||
162985473|NCT04453202|588650036|FG010|Overall Study|Lost to Follow-up|1|||
162985474|NCT04453202|588650026|FG000|Overall Study|Withdrawal by Subject|1|||
162985475|NCT04453202|588650027|FG001|Overall Study|Withdrawal by Subject|2|||
162985476|NCT04453202|588650028|FG002|Overall Study|Withdrawal by Subject|1|||
162985477|NCT04453202|588650029|FG003|Overall Study|Withdrawal by Subject|2|||
162985478|NCT04453202|588650030|FG004|Overall Study|Withdrawal by Subject|1|||
162985479|NCT04453202|588650031|FG005|Overall Study|Withdrawal by Subject|1|||
162985480|NCT04453202|588650032|FG006|Overall Study|Withdrawal by Subject|0|||
162985481|NCT04453202|588650033|FG007|Overall Study|Withdrawal by Subject|0|||
162985482|NCT04453202|588650034|FG008|Overall Study|Withdrawal by Subject|0|||
162985483|NCT04453202|588650035|FG009|Overall Study|Withdrawal by Subject|1|||
162985484|NCT04453202|588650036|FG010|Overall Study|Withdrawal by Subject|0|||
162985485|NCT04453202|588650026|FG000|Overall Study|Adverse Event|0|||
162985486|NCT04453202|588650027|FG001|Overall Study|Adverse Event|0|||
162985487|NCT04453202|588650028|FG002|Overall Study|Adverse Event|0|||
162985488|NCT04453202|588650029|FG003|Overall Study|Adverse Event|0|||
162985489|NCT04453202|588650030|FG004|Overall Study|Adverse Event|0|||
162985490|NCT04453202|588650031|FG005|Overall Study|Adverse Event|1|||
162985491|NCT04453202|588650032|FG006|Overall Study|Adverse Event|0|||
162985492|NCT04453202|588650033|FG007|Overall Study|Adverse Event|0|||
162985493|NCT04453202|588650034|FG008|Overall Study|Adverse Event|0|||
162985494|NCT04453202|588650035|FG009|Overall Study|Adverse Event|0|||
162985495|NCT04453202|588650036|FG010|Overall Study|Adverse Event|0|||
162985496|NCT01355159|588650041|FG000|Overall Study|Withdrew consent|39|||
162635190|NCT02085785|587378127|FG000|Overall Study|Withdrawal by Subject|2|||
162635191|NCT02085785|587378128|FG001|Overall Study|Withdrawal by Subject|1|||
162635192|NCT02085785|587378127|FG000|Overall Study|Lost to Follow-up|0|||
162635193|NCT02085785|587378128|FG001|Overall Study|Lost to Follow-up|1|||
162635194|NCT03590041|587378129|FG000|Overall Study|Protocol Violation|4|||
162635195|NCT03590041|587378130|FG001|Overall Study|Protocol Violation|3|||
162635196|NCT03590041|587378129|FG000|Overall Study|No session data recorded|14|||
162635197|NCT03590041|587378130|FG001|Overall Study|No session data recorded|2|||
162635198|NCT04118166|587378131|FG000|Overall Study|Adverse Event|1|||
162635199|NCT03519932|587378132|FG000|First Intervention|Adverse Event|1|||
162635200|NCT03519932|587378133|FG001|First Intervention|Adverse Event|3|||
162635201|NCT02254486|587378134|FG000|Overall Study|Adverse Event|1|||
162635202|NCT02254486|587378135|FG001|Overall Study|Adverse Event|1|||
162635203|NCT02254486|587378134|FG000|Overall Study|Lack of Efficacy|1|||
162635204|NCT02254486|587378135|FG001|Overall Study|Lack of Efficacy|0|||
162635205|NCT02254486|587378134|FG000|Overall Study|Lost to Follow-up|2|||
162635206|NCT02254486|587378135|FG001|Overall Study|Lost to Follow-up|4|||
162635207|NCT02254486|587378134|FG000|Overall Study|Protocol Violation|1|||
162635208|NCT02254486|587378135|FG001|Overall Study|Protocol Violation|2|||
162635209|NCT02254486|587378134|FG000|Overall Study|Withdrawal by Subject|17|||
162714735|NCT00567879|587665754|FG003|Overall Study|Abnormal test procedure(s)|0|||
162985497|NCT01355159|588650042|FG001|Overall Study|Withdrew consent|47|||
162985498|NCT01355159|588650041|FG000|Overall Study|No primary outcome data|17|||
162985499|NCT01355159|588650042|FG001|Overall Study|No primary outcome data|11|||
162985500|NCT01355159|588650041|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
162985501|NCT01355159|588650042|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
162635210|NCT02254486|587378135|FG001|Overall Study|Withdrawal by Subject|15|||
162635211|NCT02254486|587378134|FG000|Overall Study|GFR<60mL/min|16|||
162635212|NCT02254486|587378135|FG001|Overall Study|GFR<60mL/min|21|||
162635213|NCT02254486|587378134|FG000|Overall Study|Various|12|||
162635214|NCT02254486|587378135|FG001|Overall Study|Various|12|||
162985502|NCT01355159|588650041|FG000|Overall Study|Early intrauterine fetal death|6|||
162985503|NCT01355159|588650042|FG001|Overall Study|Early intrauterine fetal death|6|||
162635215|NCT01350414|587378136|FG000|Overall Study|Lost to Follow-up|13|||
162985504|NCT03276221|588650043|FG000|Overall Study|Lost to Follow-up|6|||
162985505|NCT03276221|588650044|FG001|Overall Study|Lost to Follow-up|2|||
162985506|NCT03276221|588650045|FG002|Overall Study|Lost to Follow-up|0|||
162985507|NCT03276221|588650043|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
162985508|NCT03276221|588650044|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
162985509|NCT03276221|588650045|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
162985510|NCT00424775|588650046|FG000|Overall Study|Adverse Event|2|||
162985511|NCT00424775|588650047|FG001|Overall Study|Adverse Event|0|||
162985512|NCT00424775|588650046|FG000|Overall Study|Lack of Efficacy|1|||
162985513|NCT00424775|588650047|FG001|Overall Study|Lack of Efficacy|0|||
162985514|NCT02615171|588650048|FG000|Overall Study|Lost to Follow-up|2|||
162985515|NCT02615171|588650049|FG001|Overall Study|Lost to Follow-up|1|||
162985516|NCT00975286|588650050|FG000|Overall Study|Adverse Event|9|||
162985517|NCT00975286|588650051|FG001|Overall Study|Adverse Event|19|||
162985518|NCT00975286|588650050|FG000|Overall Study|Protocol Violation|1|||
162985519|NCT00975286|588650051|FG001|Overall Study|Protocol Violation|2|||
162985520|NCT00975286|588650050|FG000|Overall Study|Withdrawal by Subject|0|||
162985521|NCT00975286|588650051|FG001|Overall Study|Withdrawal by Subject|2|||
162985522|NCT00975286|588650050|FG000|Overall Study|Familial and Personal Reasons|2|||
162985523|NCT00975286|588650051|FG001|Overall Study|Familial and Personal Reasons|2|||
162985524|NCT00975286|588650050|FG000|Overall Study|Poor Compliance to Protocol|0|||
162985525|NCT00975286|588650051|FG001|Overall Study|Poor Compliance to Protocol|2|||
162985526|NCT00975286|588650050|FG000|Overall Study|Sponsor Decision|0|||
162985527|NCT00975286|588650051|FG001|Overall Study|Sponsor Decision|2|||
162985528|NCT02384850|588650055|FG000|Overall Study|Withdrawal by Subject|2|||
162985529|NCT02384850|588650056|FG001|Overall Study|Withdrawal by Subject|2|||
162985530|NCT02312063|588650057|FG000|Overall Study|Withdrawal by Subject|0|||
162985531|NCT02312063|588650058|FG001|Overall Study|Withdrawal by Subject|1|||
162985532|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
162985533|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
162985534|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
162985535|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
162985536|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
162985537|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
162985538|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
162985539|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
162985540|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
162985541|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
162985542|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
162985543|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
162985544|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
162985545|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
162985546|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
162985547|NCT02788045|588652329|FG000|Main Study (Up to Week 72)|Other|3|||
162985548|NCT02788045|588652330|FG001|Main Study (Up to Week 72)|Other|0|||
162985549|NCT02788045|588652331|FG002|Main Study (Up to Week 72)|Other|0|||
162985550|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
162985551|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
162985552|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
162985553|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
162985554|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
162985555|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
162985556|NCT02788045|588652329|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
162985557|NCT02788045|588652330|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
162985558|NCT02788045|588652331|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
162985559|NCT00372411|588652334|FG000|Overall Study|Withdrawal by Subject|3|||
162985560|NCT00372411|588652335|FG001|Overall Study|Withdrawal by Subject|4|||
162985561|NCT00372411|588652336|FG002|Overall Study|Withdrawal by Subject|1|||
162985562|NCT00372411|588652334|FG000|Overall Study|Death|0|||
162985563|NCT00372411|588652335|FG001|Overall Study|Death|2|||
162985564|NCT00372411|588652336|FG002|Overall Study|Death|1|||
162985565|NCT00372411|588652334|FG000|Overall Study|Lost to Follow-up|1|||
162985566|NCT00372411|588652335|FG001|Overall Study|Lost to Follow-up|1|||
163059806|NCT02030600|588928218|FG001|Treatment Period 2|Unclassified|0|||
163059807|NCT01155323|588928225|FG000|First Intervention|exclusion criteria|1|||
162635216|NCT01350414|587378136|FG000|Overall Study|Withdrawal by Subject|4|||
162635217|NCT01350414|587378136|FG000|Overall Study|Physician Decision|2|||
162635218|NCT00267046|587378142|FG000|Overall Study|Disease progression|4|||
162635219|NCT00267046|587378143|FG001|Overall Study|Disease progression|2|||
162635220|NCT00267046|587378142|FG000|Overall Study|Chemotoxicity|2|||
162635221|NCT00267046|587378143|FG001|Overall Study|Chemotoxicity|0|||
162635222|NCT00267046|587378142|FG000|Overall Study|Open-label palifermin|2|||
162635223|NCT00267046|587378143|FG001|Overall Study|Open-label palifermin|7|||
162635224|NCT00267046|587378142|FG000|Overall Study|Surgery|3|||
162635225|NCT00267046|587378143|FG001|Overall Study|Surgery|1|||
162985567|NCT00372411|588652336|FG002|Overall Study|Lost to Follow-up|1|||
162985568|NCT00372411|588652334|FG000|Overall Study|Adverse Event|1|||
162985569|NCT00372411|588652335|FG001|Overall Study|Adverse Event|1|||
162985570|NCT00372411|588652336|FG002|Overall Study|Adverse Event|0|||
162985571|NCT00667810|588652339|FG000|Overall Study|Adverse Event|13|||
162985572|NCT00667810|588652340|FG001|Overall Study|Adverse Event|14|||
162985573|NCT00667810|588652341|FG002|Overall Study|Adverse Event|19|||
162985574|NCT00667810|588652342|FG003|Overall Study|Adverse Event|1|||
162985575|NCT00667810|588652339|FG000|Overall Study|Death|1|||
162985576|NCT00667810|588652340|FG001|Overall Study|Death|1|||
162985577|NCT00667810|588652341|FG002|Overall Study|Death|3|||
162985578|NCT00667810|588652342|FG003|Overall Study|Death|0|||
162985579|NCT00667810|588652339|FG000|Overall Study|Lack of Efficacy|1|||
162985580|NCT00667810|588652340|FG001|Overall Study|Lack of Efficacy|0|||
162985581|NCT00667810|588652341|FG002|Overall Study|Lack of Efficacy|2|||
162985582|NCT00667810|588652342|FG003|Overall Study|Lack of Efficacy|0|||
162985583|NCT00667810|588652339|FG000|Overall Study|Lost to Follow-up|1|||
162985584|NCT00667810|588652340|FG001|Overall Study|Lost to Follow-up|4|||
162985585|NCT00667810|588652341|FG002|Overall Study|Lost to Follow-up|2|||
162985586|NCT00667810|588652342|FG003|Overall Study|Lost to Follow-up|0|||
162985587|NCT00667810|588652339|FG000|Overall Study|Physician Decision|1|||
162985588|NCT00667810|588652340|FG001|Overall Study|Physician Decision|1|||
162985589|NCT00667810|588652341|FG002|Overall Study|Physician Decision|2|||
162985590|NCT00667810|588652342|FG003|Overall Study|Physician Decision|0|||
162985591|NCT00667810|588652339|FG000|Overall Study|Protocol Violation|0|||
162985592|NCT00667810|588652340|FG001|Overall Study|Protocol Violation|2|||
162985593|NCT00667810|588652341|FG002|Overall Study|Protocol Violation|0|||
162985594|NCT00667810|588652342|FG003|Overall Study|Protocol Violation|0|||
162985595|NCT00667810|588652339|FG000|Overall Study|Withdrawal by Subject|14|||
162985596|NCT00667810|588652340|FG001|Overall Study|Withdrawal by Subject|20|||
162985597|NCT00667810|588652341|FG002|Overall Study|Withdrawal by Subject|29|||
162985598|NCT00667810|588652342|FG003|Overall Study|Withdrawal by Subject|1|||
162985599|NCT00667810|588652339|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
162985600|NCT00667810|588652340|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
162985601|NCT00667810|588652341|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
162985602|NCT00667810|588652342|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
162985603|NCT00667810|588652339|FG000|Overall Study|Failed to Return|0|||
162985604|NCT00667810|588652340|FG001|Overall Study|Failed to Return|0|||
162985605|NCT00667810|588652341|FG002|Overall Study|Failed to Return|2|||
162985606|NCT00667810|588652342|FG003|Overall Study|Failed to Return|0|||
162985607|NCT00667810|588652339|FG000|Overall Study|Loss of Caregiver|0|||
162985608|NCT00667810|588652340|FG001|Overall Study|Loss of Caregiver|1|||
162985609|NCT00667810|588652341|FG002|Overall Study|Loss of Caregiver|3|||
162985610|NCT00667810|588652342|FG003|Overall Study|Loss of Caregiver|0|||
162985611|NCT00667810|588652339|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
162985612|NCT00667810|588652340|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
162985613|NCT00667810|588652341|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
162985614|NCT00667810|588652342|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
162985615|NCT00667810|588652339|FG000|Overall Study|Other|6|||
162985616|NCT00667810|588652340|FG001|Overall Study|Other|6|||
162985617|NCT00667810|588652341|FG002|Overall Study|Other|5|||
162985618|NCT00667810|588652342|FG003|Overall Study|Other|0|||
162985619|NCT00754650|588652345|FG000|Overall Study|Disease Progression|2|||
162985620|NCT02227147|588652349|FG000|Controlled Treatment Period|Adverse Event|4|||
162985621|NCT02227147|588652350|FG001|Controlled Treatment Period|Adverse Event|3|||
162985622|NCT02227147|588652349|FG000|Controlled Treatment Period|Other|2|||
162985623|NCT02227147|588652350|FG001|Controlled Treatment Period|Other|0|||
162985624|NCT02227147|588652349|FG000|Follow-up Period|Other|3|||
162985625|NCT02227147|588652350|FG001|Follow-up Period|Other|5|||
162985626|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
162985627|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
162985628|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
162985629|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
162985630|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
162985631|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
162985632|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
162985633|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
162985634|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
162985635|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
162985636|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
162985637|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
162985638|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
162985639|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
162985640|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
162985641|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
162985642|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
162985643|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
162985644|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
162985645|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
162985646|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
162985647|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985648|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985649|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
162985650|NCT03514641|588652353|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985651|NCT03514641|588652354|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
162985652|NCT03514641|588652355|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985653|NCT03514641|588652356|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
162985654|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985655|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985656|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
162985657|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
162985658|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
162985659|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
162985660|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
162985661|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
162985662|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
162985663|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
162635226|NCT00267046|587378142|FG000|Overall Study|Withdrawal by Subject|1|||
162985664|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
162985665|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
162985666|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
162985667|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
162985668|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
162985669|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
162985670|NCT03514641|588652353|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
162985671|NCT03514641|588652354|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
162985672|NCT03514641|588652355|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
162985673|NCT03514641|588652356|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
162985674|NCT01345175|588652357|FG000|Overall Study|Physician Decision|0|||
162985675|NCT01345175|588652358|FG001|Overall Study|Physician Decision|1|||
162985676|NCT01345175|588652357|FG000|Overall Study|Withdrawal by Subject|1|||
162985677|NCT01345175|588652358|FG001|Overall Study|Withdrawal by Subject|1|||
162985678|NCT01345175|588652357|FG000|Overall Study|Failed to complete BFI|3|||
162985679|NCT01345175|588652358|FG001|Overall Study|Failed to complete BFI|2|||
162985680|NCT01345175|588652357|FG000|Overall Study|Stopped taking medication|2|||
162985681|NCT01345175|588652358|FG001|Overall Study|Stopped taking medication|2|||
162985682|NCT04112173|588652360|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
162985683|NCT01561430|588652361|FG000|Overall Study|Adverse Event|0|||
162985684|NCT01561430|588652362|FG001|Overall Study|Adverse Event|0|||
162985685|NCT01561430|588652363|FG002|Overall Study|Adverse Event|3|||
162985686|NCT01561430|588652364|FG003|Overall Study|Adverse Event|1|||
162635227|NCT00267046|587378143|FG001|Overall Study|Withdrawal by Subject|0|||
162635228|NCT00267046|587378142|FG000|Overall Study|Radiation|0|||
162635229|NCT00267046|587378143|FG001|Overall Study|Radiation|1|||
162635230|NCT00103142|587378144|FG000|Overall Study|Adverse Event|1|||
162635231|NCT00103142|587378145|FG001|Overall Study|Adverse Event|0|||
162635232|NCT00103142|587378144|FG000|Overall Study|Progression of disease|2|||
162635233|NCT00103142|587378145|FG001|Overall Study|Progression of disease|1|||
162635234|NCT02772081|587378146|FG000|Overall Study|Physician Decision|1|||
162635235|NCT02772081|587378147|FG001|Overall Study|Physician Decision|1|||
162635236|NCT02772081|587378146|FG000|Overall Study|Death|1|||
162635237|NCT02772081|587378147|FG001|Overall Study|Death|1|||
162635238|NCT00759954|587378153|FG000|Overall Study|Personal reason|1|||
162635239|NCT00759954|587378154|FG001|Overall Study|Personal reason|0|||
162635240|NCT00759954|587378153|FG000|Overall Study|Adverse Event|1|||
162635241|NCT00759954|587378154|FG001|Overall Study|Adverse Event|2|||
162635242|NCT00022633|587378158|FG000|Overall Study|Adverse Event|11|||
162635243|NCT00022633|587378159|FG001|Overall Study|Adverse Event|1|||
162635244|NCT00022633|587378158|FG000|Overall Study|Refusal unrelated to adverse event|1|||
162635245|NCT00022633|587378159|FG001|Overall Study|Refusal unrelated to adverse event|0|||
162635246|NCT00022633|587378158|FG000|Overall Study|Progression/relapse|9|||
162635247|NCT00022633|587378159|FG001|Overall Study|Progression/relapse|2|||
162635248|NCT00022633|587378158|FG000|Overall Study|Death|4|||
162635249|NCT00022633|587378159|FG001|Overall Study|Death|0|||
162635250|NCT00022633|587378158|FG000|Overall Study|Other - not protocol specified|3|||
162635251|NCT00022633|587378159|FG001|Overall Study|Other - not protocol specified|2|||
162635252|NCT00022633|587378158|FG000|Overall Study|Ineligible|4|||
162635253|NCT00022633|587378159|FG001|Overall Study|Ineligible|0|||
162635254|NCT01741701|587378162|FG000|Overall Study|Adverse Event|5|||
162714736|NCT00567879|587665755|FG004|Overall Study|Abnormal test procedure(s)|0|||
162635255|NCT01741701|587378163|FG001|Overall Study|Adverse Event|1|||
162985687|NCT01561430|588652361|FG000|Overall Study|Withdrawal by Subject|0|||
162985688|NCT01561430|588652362|FG001|Overall Study|Withdrawal by Subject|0|||
162985689|NCT01561430|588652363|FG002|Overall Study|Withdrawal by Subject|1|||
162985690|NCT01561430|588652364|FG003|Overall Study|Withdrawal by Subject|0|||
162985691|NCT01561430|588652361|FG000|Overall Study|Physician Decision|0|||
162985692|NCT01561430|588652362|FG001|Overall Study|Physician Decision|1|||
162985693|NCT01561430|588652363|FG002|Overall Study|Physician Decision|0|||
162985694|NCT01561430|588652364|FG003|Overall Study|Physician Decision|0|||
162985695|NCT01561430|588652361|FG000|Overall Study|Sponsor Decision|1|||
162635256|NCT01741701|587378162|FG000|Overall Study|Withdrawal by Subject|0|||
162635257|NCT01741701|587378163|FG001|Overall Study|Withdrawal by Subject|1|||
162635258|NCT00372112|587378171|FG000|Overall Study|Adverse Event|0|||
162635259|NCT00372112|587378172|FG001|Overall Study|Adverse Event|1|||
162985696|NCT01561430|588652362|FG001|Overall Study|Sponsor Decision|14|||
162985697|NCT01561430|588652363|FG002|Overall Study|Sponsor Decision|13|||
162985698|NCT01561430|588652364|FG003|Overall Study|Sponsor Decision|12|||
162985699|NCT04234984|588652372|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
162985700|NCT04234984|588652372|FG000|Follow-up at the Second Time Point|Death|1|||
162635260|NCT00372112|587378173|FG002|Overall Study|Adverse Event|1|||
162635261|NCT00372112|587378174|FG003|Overall Study|Adverse Event|1|||
162635262|NCT00372112|587378171|FG000|Overall Study|Withdrawal by Subject|0|||
162635263|NCT00372112|587378172|FG001|Overall Study|Withdrawal by Subject|0|||
162635264|NCT00372112|587378173|FG002|Overall Study|Withdrawal by Subject|2|||
162635265|NCT00372112|587378174|FG003|Overall Study|Withdrawal by Subject|1|||
162635266|NCT00372112|587378171|FG000|Overall Study|Exacerbation|0|||
162635267|NCT00372112|587378172|FG001|Overall Study|Exacerbation|0|||
162635268|NCT00372112|587378173|FG002|Overall Study|Exacerbation|0|||
162635269|NCT00372112|587378174|FG003|Overall Study|Exacerbation|1|||
162635270|NCT00372112|587378171|FG000|Overall Study|PR >240 at Visit 3|0|||
162635271|NCT00372112|587378172|FG001|Overall Study|PR >240 at Visit 3|0|||
162635272|NCT00372112|587378173|FG002|Overall Study|PR >240 at Visit 3|0|||
162635273|NCT00372112|587378174|FG003|Overall Study|PR >240 at Visit 3|1|||
162635274|NCT00372112|587378171|FG000|Overall Study|Hepatitis B|1|||
162635275|NCT00372112|587378172|FG001|Overall Study|Hepatitis B|0|||
162635276|NCT00372112|587378173|FG002|Overall Study|Hepatitis B|0|||
162635277|NCT00372112|587378174|FG003|Overall Study|Hepatitis B|0|||
162635278|NCT00372112|587378171|FG000|Overall Study|Other-protocol violation|0|||
162635279|NCT00372112|587378172|FG001|Overall Study|Other-protocol violation|0|||
162635280|NCT00372112|587378173|FG002|Overall Study|Other-protocol violation|1|||
162635281|NCT00372112|587378174|FG003|Overall Study|Other-protocol violation|0|||
162635282|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
162635283|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
162635284|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
162635285|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
162635286|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
162635287|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
162635288|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
162635289|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
162635290|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Patient Request|1|||
162635291|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Patient Request|0|||
162635292|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
162635293|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
162635294|NCT04649060|587378175|FG000|Arm A/Arm B Treatment|Other|1|||
162635295|NCT04649060|587378176|FG001|Arm A/Arm B Treatment|Other|0|||
162635296|NCT04649060|587378175|FG000|Crossover (Arm B)|Adverse Event|0|||
162635297|NCT04649060|587378176|FG001|Crossover (Arm B)|Adverse Event|1|||
162635298|NCT04649060|587378175|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
162635299|NCT04649060|587378176|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
162635300|NCT03033394|587378177|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
162635301|NCT03033394|587378177|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
162635302|NCT03033394|587378177|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
162635303|NCT03033394|587378177|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
162635304|NCT03033394|587378177|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
162635305|NCT02927431|587378178|FG000|Overall Study|Withdrawal by Subject|0|||
162635306|NCT02927431|587378179|FG001|Overall Study|Withdrawal by Subject|0|||
162635307|NCT02927431|587378180|FG002|Overall Study|Withdrawal by Subject|1|||
162635308|NCT02246660|587378181|FG000|Overall Study|Withdrawal by Subject|0|||
162635309|NCT02246660|587378182|FG001|Overall Study|Withdrawal by Subject|1|||
162635310|NCT02246660|587378183|FG002|Overall Study|Withdrawal by Subject|0|||
162635311|NCT02246660|587378181|FG000|Overall Study|Death|0|||
162635312|NCT02246660|587378182|FG001|Overall Study|Death|0|||
162635313|NCT02246660|587378183|FG002|Overall Study|Death|1|||
162635314|NCT04952402|587378184|FG000|Overall Study|Lost to Follow-up|1|||
162635315|NCT04952402|587378185|FG001|Overall Study|Lost to Follow-up|3|||
162985701|NCT04234984|588652372|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
162985702|NCT01055132|588652375|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
162985703|NCT01055132|588652376|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
162985704|NCT01055132|588652375|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
162985705|NCT01055132|588652376|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
162985706|NCT00158600|588652377|FG000|Overall Study|unable to commit time to study|0|||
162985707|NCT00158600|588652378|FG001|Overall Study|unable to commit time to study|1|||
162985708|NCT00158600|588652377|FG000|Overall Study|Adverse Event|2|||
162985709|NCT00158600|588652378|FG001|Overall Study|Adverse Event|1|||
162985710|NCT00158600|588652377|FG000|Overall Study|Death|1|||
162985711|NCT00158600|588652378|FG001|Overall Study|Death|0|||
162985712|NCT00158600|588652377|FG000|Overall Study|Withdrawal by Subject|2|||
162985713|NCT00158600|588652378|FG001|Overall Study|Withdrawal by Subject|2|||
162985714|NCT02570113|588652379|FG000|Overall Study|Withdrawal by Subject|3|||
162985715|NCT02038907|588652380|FG000|Overall Study|Protocol Violation|0|||
162985716|NCT02038907|588652381|FG001|Overall Study|Protocol Violation|0|||
162985717|NCT02038907|588652382|FG002|Overall Study|Protocol Violation|0|||
162985718|NCT02038907|588652383|FG003|Overall Study|Protocol Violation|0|||
162985719|NCT02038907|588652384|FG004|Overall Study|Protocol Violation|0|||
162985720|NCT02038907|588652385|FG005|Overall Study|Protocol Violation|0|||
162714737|NCT00567879|587665756|FG005|Overall Study|Abnormal test procedure(s)|0|||
162714738|NCT00567879|587665751|FG000|Overall Study|Withdrawal by Subject|0|||
162714739|NCT00567879|587665752|FG001|Overall Study|Withdrawal by Subject|0|||
162714740|NCT00567879|587665753|FG002|Overall Study|Withdrawal by Subject|3|||
162714741|NCT00567879|587665754|FG003|Overall Study|Withdrawal by Subject|1|||
162714742|NCT00567879|587665755|FG004|Overall Study|Withdrawal by Subject|0|||
162714743|NCT00567879|587665756|FG005|Overall Study|Withdrawal by Subject|0|||
162714744|NCT00567879|587665751|FG000|Overall Study|New cancer therapy|0|||
162714745|NCT00567879|587665752|FG001|Overall Study|New cancer therapy|0|||
162714746|NCT00567879|587665753|FG002|Overall Study|New cancer therapy|1|||
162985721|NCT02038907|588652386|FG006|Overall Study|Protocol Violation|0|||
162985722|NCT02038907|588652387|FG007|Overall Study|Protocol Violation|0|||
162985723|NCT02038907|588652388|FG008|Overall Study|Protocol Violation|0|||
162985724|NCT02038907|588652389|FG009|Overall Study|Protocol Violation|0|||
162985725|NCT02038907|588652390|FG010|Overall Study|Protocol Violation|1|||
162985726|NCT02038907|588652391|FG011|Overall Study|Protocol Violation|0|||
162985727|NCT02038907|588652392|FG012|Overall Study|Protocol Violation|0|||
162985728|NCT02038907|588652393|FG013|Overall Study|Protocol Violation|0|||
162985729|NCT02038907|588652380|FG000|Overall Study|Withdrawal by Subject|0|||
162985730|NCT02038907|588652381|FG001|Overall Study|Withdrawal by Subject|0|||
162985731|NCT02038907|588652382|FG002|Overall Study|Withdrawal by Subject|0|||
162985732|NCT02038907|588652383|FG003|Overall Study|Withdrawal by Subject|0|||
163059808|NCT01155323|588928226|FG001|First Intervention|exclusion criteria|1|||
163059809|NCT01155323|588928225|FG000|Second Intervention|Lost to Follow-up|1|||
162635316|NCT04952402|587378184|FG000|Overall Study|Lack Of Venous Access|0|||
162635317|NCT04952402|587378185|FG001|Overall Study|Lack Of Venous Access|1|||
162635318|NCT00143403|587378186|FG000|Overall Study|Adverse Event|3|||
162635319|NCT00143403|587378187|FG001|Overall Study|Adverse Event|8|||
162635320|NCT00143403|587378186|FG000|Overall Study|Death|1|||
162635321|NCT00143403|587378187|FG001|Overall Study|Death|0|||
162635322|NCT00143403|587378186|FG000|Overall Study|Withdrawal by Subject|3|||
162635323|NCT00143403|587378187|FG001|Overall Study|Withdrawal by Subject|12|||
162635324|NCT00143403|587378186|FG000|Overall Study|Relapse|15|||
162635325|NCT00143403|587378187|FG001|Overall Study|Relapse|7|||
162635326|NCT00143403|587378186|FG000|Overall Study|Protocol Violation|2|||
162635327|NCT00143403|587378187|FG001|Overall Study|Protocol Violation|2|||
162635328|NCT00143403|587378186|FG000|Overall Study|specified by site|4|||
162635329|NCT00143403|587378187|FG001|Overall Study|specified by site|9|||
162635330|NCT00143403|587378186|FG000|Overall Study|Randomized Not Treated|7|||
162635331|NCT00143403|587378187|FG001|Overall Study|Randomized Not Treated|8|||
162635332|NCT00587639|587378188|FG000|Overall Study|Withdrawal by Subject|1|||
162635333|NCT01442675|587378189|FG000|Overall Study|Protocol Violation|6|||
162985733|NCT02038907|588652384|FG004|Overall Study|Withdrawal by Subject|0|||
162985734|NCT02038907|588652385|FG005|Overall Study|Withdrawal by Subject|0|||
162985735|NCT02038907|588652386|FG006|Overall Study|Withdrawal by Subject|0|||
162985736|NCT02038907|588652387|FG007|Overall Study|Withdrawal by Subject|0|||
163059810|NCT01155323|588928226|FG001|Second Intervention|Lost to Follow-up|1|||
162635334|NCT01442675|587378189|FG000|Overall Study|Lost to Follow-up|2|||
162635335|NCT01442675|587378189|FG000|Overall Study|Withdrawal by Subject|4|||
162635336|NCT03944954|587378194|FG000|Overall Study|Withdrawal by Subject|22|||
162635337|NCT03944954|587378195|FG001|Overall Study|Withdrawal by Subject|4|||
163059811|NCT01208051|588928229|FG000|Total Enrollment|Withdrawal by Subject|0|||
162635338|NCT03944954|587378194|FG000|Overall Study|Lost to Follow-up|18|||
162714747|NCT00567879|587665754|FG003|Overall Study|New cancer therapy|0|||
162714748|NCT00567879|587665755|FG004|Overall Study|New cancer therapy|0|||
162714749|NCT00567879|587665756|FG005|Overall Study|New cancer therapy|0|||
162985737|NCT02038907|588652388|FG008|Overall Study|Withdrawal by Subject|0|||
162635339|NCT03944954|587378195|FG001|Overall Study|Lost to Follow-up|0|||
162714750|NCT00567879|587665751|FG000|Overall Study|Disease progression|5|||
162714751|NCT00567879|587665752|FG001|Overall Study|Disease progression|7|||
162714752|NCT00567879|587665753|FG002|Overall Study|Disease progression|15|||
162714753|NCT00567879|587665754|FG003|Overall Study|Disease progression|5|||
162714754|NCT00567879|587665755|FG004|Overall Study|Disease progression|11|||
162714755|NCT00567879|587665756|FG005|Overall Study|Disease progression|3|||
162714756|NCT00151996|587665759|FG000|Overall Study|Adverse Event|3|||
162714757|NCT00151996|587665760|FG001|Overall Study|Adverse Event|2|||
162714758|NCT00151996|587665759|FG000|Overall Study|Withdrawal by Subject|1|||
162714759|NCT00151996|587665760|FG001|Overall Study|Withdrawal by Subject|1|||
162714760|NCT00151996|587665759|FG000|Overall Study|Protocol Violation|1|||
162714761|NCT00151996|587665760|FG001|Overall Study|Protocol Violation|2|||
162714762|NCT00151996|587665759|FG000|Overall Study|Sponsor's decision|0|||
162714763|NCT00151996|587665760|FG001|Overall Study|Sponsor's decision|2|||
162714764|NCT01546155|587665761|FG000|Overall Study|could not tolerate long scan duration|3|||
162714765|NCT00420316|587665767|FG000|Overall Study|Withdrawal by Subject|0|||
162714766|NCT00420316|587665768|FG001|Overall Study|Withdrawal by Subject|1|||
162714767|NCT00420316|587665767|FG000|Overall Study|Lost to Follow-up|12|||
162714768|NCT00420316|587665768|FG001|Overall Study|Lost to Follow-up|8|||
162714769|NCT03546907|587665769|FG000|Overall Study|Lack of Efficacy|1|||
162714770|NCT03546907|587665770|FG001|Overall Study|Lack of Efficacy|1|||
162714771|NCT03546907|587665769|FG000|Overall Study|Withdrawal by Subject|8|||
162714772|NCT03546907|587665770|FG001|Overall Study|Withdrawal by Subject|9|||
162714773|NCT03546907|587665769|FG000|Overall Study|Adverse events (AEs)|7|||
162714774|NCT03546907|587665770|FG001|Overall Study|Adverse events (AEs)|10|||
162714775|NCT03546907|587665769|FG000|Overall Study|Other-unspecified|1|||
162714776|NCT03546907|587665770|FG001|Overall Study|Other-unspecified|1|||
162714777|NCT04033432|587665771|FG000|Overall Study|Progressive Disease|8|||
162714778|NCT04033432|587665771|FG000|Overall Study|Adverse Event|4|||
162714779|NCT04033432|587665771|FG000|Overall Study|Death|1|||
162714780|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714781|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
162714782|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714783|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714784|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714785|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714786|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714787|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714788|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714789|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714790|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714791|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714792|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162714793|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Death|0|||
162714794|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Death|0|||
162714795|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Death|0|||
162714796|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Death|1|||
162714797|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Death|0|||
162714798|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Death|0|||
162714799|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Death|0|||
162714800|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Death|0|||
162714801|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Death|0|||
162714802|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Death|0|||
162714803|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Death|0|||
162714804|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Death|0|||
162714805|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Death|0|||
162714806|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163059812|NCT01208051|588928230|FG001|Total Enrollment|Withdrawal by Subject|1|||
163059813|NCT01208051|588928231|FG002|Total Enrollment|Withdrawal by Subject|0|||
163059814|NCT01208051|588928232|FG003|Total Enrollment|Withdrawal by Subject|0|||
162714807|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
162714808|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
162714809|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
162714810|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163059815|NCT01208051|588928233|FG004|Total Enrollment|Withdrawal by Subject|2|||
162714811|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714812|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714813|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714814|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714815|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714816|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714817|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162985738|NCT02038907|588652389|FG009|Overall Study|Withdrawal by Subject|0|||
162985739|NCT02038907|588652390|FG010|Overall Study|Withdrawal by Subject|1|||
162985740|NCT02038907|588652391|FG011|Overall Study|Withdrawal by Subject|0|||
162985741|NCT02038907|588652392|FG012|Overall Study|Withdrawal by Subject|0|||
162985742|NCT02038907|588652393|FG013|Overall Study|Withdrawal by Subject|0|||
162985743|NCT02746471|588652394|FG000|Overall Study|Death|43|||
162985744|NCT02746471|588652394|FG000|Overall Study|Exited before 36 months|1119|||
162985745|NCT02564211|588652395|FG000|Overall Study|Adverse Event|4|||
162985746|NCT00910091|588652396|FG000|Pre-assignment|Withdrawal by Subject|0|||
162985747|NCT00910091|588652397|FG001|Pre-assignment|Withdrawal by Subject|2|||
162985748|NCT00910091|588652396|FG000|Treatment and Survival|Withdrawal by Subject|3|||
162985749|NCT00910091|588652397|FG001|Treatment and Survival|Withdrawal by Subject|4|||
162985750|NCT00910091|588652396|FG000|Treatment and Survival|Adverse Event|1|||
162985751|NCT00910091|588652397|FG001|Treatment and Survival|Adverse Event|0|||
162985752|NCT01908816|588652400|FG000|Overall Study|Subject's no longer requires study drug|0|||
162985753|NCT01908816|588652401|FG001|Overall Study|Subject's no longer requires study drug|0|||
162985754|NCT01908816|588652402|FG002|Overall Study|Subject's no longer requires study drug|0|||
162985755|NCT01908816|588652403|FG003|Overall Study|Subject's no longer requires study drug|1|||
162985756|NCT01908816|588652400|FG000|Overall Study|Protocol deviation|1|||
162985757|NCT01908816|588652401|FG001|Overall Study|Protocol deviation|2|||
162985758|NCT01908816|588652402|FG002|Overall Study|Protocol deviation|1|||
162985759|NCT01908816|588652403|FG003|Overall Study|Protocol deviation|1|||
162985760|NCT01908816|588652400|FG000|Overall Study|Withdrawal by Subject|0|||
162985761|NCT01908816|588652401|FG001|Overall Study|Withdrawal by Subject|4|||
162985762|NCT01908816|588652402|FG002|Overall Study|Withdrawal by Subject|2|||
162985763|NCT01908816|588652403|FG003|Overall Study|Withdrawal by Subject|2|||
162985764|NCT01908816|588652400|FG000|Overall Study|Lost to Follow-up|3|||
162985765|NCT01908816|588652401|FG001|Overall Study|Lost to Follow-up|5|||
163059816|NCT01208051|588928229|FG000|Total Enrollment|Brain metastases|0|||
163059817|NCT01208051|588928230|FG001|Total Enrollment|Brain metastases|0|||
163059818|NCT01208051|588928231|FG002|Total Enrollment|Brain metastases|1|||
163059819|NCT01208051|588928232|FG003|Total Enrollment|Brain metastases|0|||
163059820|NCT01208051|588928233|FG004|Total Enrollment|Brain metastases|0|||
163059821|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
163059822|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
163059823|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
163059824|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
163059825|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
162635340|NCT03944954|587378194|FG000|Overall Study|Failed Medical Screening|7|||
162635341|NCT03944954|587378195|FG001|Overall Study|Failed Medical Screening|0|||
162635342|NCT03235154|587378199|FG000|Overall Study|Withdrawal by Subject|1|||
162635343|NCT03235154|587378199|FG000|Overall Study|Adverse Event|1|||
162635344|NCT03235154|587378199|FG000|Overall Study|Lost to Follow-up|2|||
162635345|NCT00536198|587378200|FG000|Overall Study|Lost to Follow-up|15|||
162635346|NCT00536198|587378201|FG001|Overall Study|Lost to Follow-up|14|||
162635347|NCT00536198|587378200|FG000|Overall Study|Withdrawal by Subject|16|||
162635348|NCT00536198|587378201|FG001|Overall Study|Withdrawal by Subject|12|||
162635349|NCT00536198|587378200|FG000|Overall Study|Adverse Event|2|||
162635350|NCT00536198|587378201|FG001|Overall Study|Adverse Event|2|||
162635351|NCT00536198|587378200|FG000|Overall Study|Rescue|3|||
162635352|NCT00536198|587378201|FG001|Overall Study|Rescue|9|||
162635353|NCT00536198|587378200|FG000|Overall Study|Pregnancy|1|||
162635354|NCT00536198|587378201|FG001|Overall Study|Pregnancy|1|||
162635355|NCT00536198|587378200|FG000|Overall Study|Protocol Violation|0|||
162635356|NCT00536198|587378201|FG001|Overall Study|Protocol Violation|1|||
162635357|NCT00881712|587378202|FG000|Overall Study|Death|1|||
162635358|NCT00881712|587378203|FG001|Overall Study|Death|0|||
162635359|NCT00881712|587378204|FG002|Overall Study|Death|0|||
162635360|NCT00881712|587378202|FG000|Overall Study|Withdrawal by Subject|1|||
162714818|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162714819|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162985766|NCT01908816|588652402|FG002|Overall Study|Lost to Follow-up|4|||
162985767|NCT01908816|588652403|FG003|Overall Study|Lost to Follow-up|2|||
162985768|NCT01908816|588652400|FG000|Overall Study|Death|1|||
162985769|NCT01908816|588652401|FG001|Overall Study|Death|0|||
162985770|NCT01908816|588652402|FG002|Overall Study|Death|7|||
163059826|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
162635361|NCT00881712|587378203|FG001|Overall Study|Withdrawal by Subject|0|||
162635362|NCT00881712|587378204|FG002|Overall Study|Withdrawal by Subject|0|||
162635363|NCT00276744|587378205|FG000|PART A|Reason unknown|98|||
162635364|NCT00965718|587378224|FG000|Overall Study|Withdrawal by Subject|4|||
162635365|NCT03667924|587378225|FG000|Baseline Completed|Lost to Follow-up|0|||
162985771|NCT01908816|588652403|FG003|Overall Study|Death|1|||
162985772|NCT01908816|588652400|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162985773|NCT01908816|588652401|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162985774|NCT01908816|588652402|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163059827|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
162635366|NCT03667924|587378226|FG001|Baseline Completed|Lost to Follow-up|2|||
162635367|NCT03667924|587378227|FG002|Baseline Completed|Lost to Follow-up|0|||
162635368|NCT03667924|587378225|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
162635369|NCT03667924|587378226|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
162635370|NCT03667924|587378227|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
162635371|NCT03667924|587378225|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
162635372|NCT03667924|587378226|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
162635373|NCT03667924|587378227|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
162985775|NCT01908816|588652403|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162985776|NCT01908816|588652400|FG000|Overall Study|Early termination|87|||
162985777|NCT01908816|588652401|FG001|Overall Study|Early termination|60|||
162985778|NCT01908816|588652402|FG002|Overall Study|Early termination|43|||
162985779|NCT01908816|588652403|FG003|Overall Study|Early termination|28|||
162635374|NCT03667924|587378225|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
162635375|NCT03667924|587378226|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
162635376|NCT03667924|587378227|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
162635377|NCT03667924|587378225|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
162635378|NCT03667924|587378226|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
162635379|NCT03667924|587378227|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
162635380|NCT03667924|587378225|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
162635381|NCT03667924|587378226|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
162635382|NCT03667924|587378227|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
162635383|NCT03667924|587378225|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
162635384|NCT03667924|587378226|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
162635385|NCT03667924|587378227|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
162635386|NCT00126568|587378228|FG000|Overall Study|Death|2|||
162635387|NCT01244425|587378229|FG000|Overall Study|Withdrawal by Subject|2|||
162635388|NCT01244425|587378230|FG001|Overall Study|Withdrawal by Subject|2|||
162635389|NCT01244425|587378229|FG000|Overall Study|Adverse Event|1|||
162635390|NCT01244425|587378230|FG001|Overall Study|Adverse Event|1|||
162635391|NCT02547454|587378231|FG000|Overall Study|Due to hemodialysis|53|||
162635392|NCT02547454|587378231|FG000|Overall Study|Due to transplantation|1|||
162635393|NCT02547454|587378231|FG000|Overall Study|Due to no further need to treat|4|||
162635394|NCT02547454|587378231|FG000|Overall Study|Death|38|||
162635395|NCT02547454|587378231|FG000|Overall Study|Lost to Follow-up|26|||
162635396|NCT02547454|587378231|FG000|Overall Study|Other|39|||
162635397|NCT02547454|587378231|FG000|Overall Study|No data|11|||
162635398|NCT04232124|587379733|FG000|Overall Study|Lost to Follow-up|3|||
162635399|NCT00407563|587379738|FG000|Overall Study|Patient continues on treatment|1|||
162635400|NCT00464087|587379739|FG000|Overall Study|No PCI per inclusion criteria|0|||
162635401|NCT00464087|587379740|FG001|Overall Study|No PCI per inclusion criteria|0|||
162635402|NCT00464087|587379741|FG002|Overall Study|No PCI per inclusion criteria|29|||
162635403|NCT01164956|587379742|FG000|Overall Study|Side Effects|1|||
162635404|NCT01164956|587379743|FG001|Overall Study|Side Effects|0|||
162635405|NCT01164956|587379744|FG002|Overall Study|Side Effects|1|||
162635406|NCT00720434|587379745|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162635407|NCT00720434|587379746|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
162635408|NCT00720434|587379747|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162635409|NCT00720434|587379748|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162635410|NCT00720434|587379745|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
162635411|NCT00720434|587379746|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
162635412|NCT00720434|587379747|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
162985780|NCT02618408|588652404|FG000|Overall Study|Withdrawal by Subject|1|||
162985781|NCT02618408|588652405|FG001|Overall Study|Withdrawal by Subject|0|||
162985782|NCT02618408|588652406|FG002|Overall Study|Withdrawal by Subject|4|||
162985783|NCT02618408|588652404|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
162985784|NCT02618408|588652405|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
162985785|NCT02618408|588652406|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
162985786|NCT02618408|588652404|FG000|Overall Study|Lost to Follow-up|4|||
162985787|NCT02618408|588652405|FG001|Overall Study|Lost to Follow-up|2|||
162985788|NCT02618408|588652406|FG002|Overall Study|Lost to Follow-up|6|||
162985789|NCT02618408|588652404|FG000|Overall Study|Adverse Event|4|||
162985790|NCT02618408|588652405|FG001|Overall Study|Adverse Event|0|||
162985791|NCT02618408|588652406|FG002|Overall Study|Adverse Event|10|||
162985792|NCT02618408|588652404|FG000|Overall Study|Physician Decision|1|||
162635413|NCT00720434|587379748|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
162635414|NCT00720434|587379745|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
162635415|NCT00720434|587379746|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162985793|NCT02618408|588652405|FG001|Overall Study|Physician Decision|1|||
162985794|NCT02618408|588652406|FG002|Overall Study|Physician Decision|2|||
162985795|NCT02618408|588652404|FG000|Overall Study|Protocol Violation|1|||
162985796|NCT02618408|588652405|FG001|Overall Study|Protocol Violation|1|||
162985797|NCT02618408|588652406|FG002|Overall Study|Protocol Violation|2|||
162985798|NCT02618408|588652404|FG000|Overall Study|Other, Multiple Categories|0|||
162985799|NCT02618408|588652405|FG001|Overall Study|Other, Multiple Categories|0|||
162985800|NCT02618408|588652406|FG002|Overall Study|Other, Multiple Categories|4|||
162985801|NCT05183217|588652410|FG000|Overall Study|Withdrawal by Subject|1|||
162985802|NCT05183217|588652411|FG001|Overall Study|Withdrawal by Subject|1|||
162985803|NCT03914950|588652413|FG000|Overall Study|Physician Decision|54|||
162985804|NCT03167723|588652417|FG000|Overall Study|Protocol Violation|4|||
162985805|NCT03167723|588652418|FG001|Overall Study|Protocol Violation|6|||
162985806|NCT02524730|588652421|FG000|Overall Study|Lost to Follow-up|5|||
162985807|NCT02524730|588652421|FG000|Overall Study|Withdrawal by Subject|18|||
162985808|NCT02524730|588652421|FG000|Overall Study|Death|10|||
162985809|NCT02524730|588652421|FG000|Overall Study|Adverse Event|8|||
162985810|NCT02524730|588652421|FG000|Overall Study|Protocol Violation|1|||
162985811|NCT02524730|588652421|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
162985812|NCT00507130|588652422|FG000|Overall Study|Lost to Follow-up|0|||
162985813|NCT00507130|588652423|FG001|Overall Study|Lost to Follow-up|0|||
162985814|NCT00507130|588652424|FG002|Overall Study|Lost to Follow-up|1|||
162985815|NCT00507130|588652425|FG003|Overall Study|Lost to Follow-up|1|||
162985816|NCT00507130|588652422|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
162985817|NCT00507130|588652423|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985818|NCT00507130|588652424|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985819|NCT00507130|588652425|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
162985820|NCT03678285|588652437|FG000|Overall Study|Adverse Event|2|||
162985821|NCT03678285|588652437|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
162985822|NCT03678285|588652437|FG000|Overall Study|Dehydrated prior to start of workout|1|||
162985823|NCT02731326|588652440|FG000|Overall Study|Withdrawal by Subject|4|||
162985824|NCT02731326|588652441|FG001|Overall Study|Withdrawal by Subject|1|||
162985825|NCT02731326|588652440|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
162985826|NCT02731326|588652441|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
162985827|NCT02731326|588652440|FG000|Overall Study|Discharged without AliveCor|10|||
162985828|NCT02731326|588652441|FG001|Overall Study|Discharged without AliveCor|0|||
162985829|NCT02731326|588652440|FG000|Overall Study|Duplicate Participant|1|||
162985830|NCT02731326|588652441|FG001|Overall Study|Duplicate Participant|1|||
162985831|NCT04480710|588652444|FG000|Overall Study|Adverse Event|0|||
162985832|NCT04480710|588652445|FG001|Overall Study|Adverse Event|2|||
162985833|NCT04480710|588652446|FG002|Overall Study|Adverse Event|0|||
162985834|NCT04480710|588652447|FG003|Overall Study|Adverse Event|0|||
162985835|NCT04480710|588652444|FG000|Overall Study|Withdrawal by Subject|0|||
162985836|NCT04480710|588652445|FG001|Overall Study|Withdrawal by Subject|1|||
162985837|NCT04480710|588652446|FG002|Overall Study|Withdrawal by Subject|0|||
162985838|NCT04480710|588652447|FG003|Overall Study|Withdrawal by Subject|0|||
162985839|NCT04480710|588652444|FG000|Overall Study|Physician Decision|0|||
162985840|NCT04480710|588652445|FG001|Overall Study|Physician Decision|0|||
162985841|NCT04480710|588652446|FG002|Overall Study|Physician Decision|1|||
162985842|NCT04480710|588652447|FG003|Overall Study|Physician Decision|0|||
162985843|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
162985844|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
162985845|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
162985846|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
162985847|NCT02994940|588652448|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
162985848|NCT02994940|588652449|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
162985849|NCT01103466|588652452|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
162985850|NCT01103466|588652453|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
162985851|NCT01103466|588652454|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
162985852|NCT01103466|588652452|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
162985853|NCT01103466|588652453|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
162985854|NCT01103466|588652454|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
162985855|NCT01103466|588652452|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985856|NCT01103466|588652453|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985857|NCT01103466|588652454|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985858|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
162985859|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
162985860|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
162985861|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
162985862|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985863|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
162985864|NCT01103466|588652452|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
162985865|NCT01103466|588652453|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
162985866|NCT01103466|588652454|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
162635416|NCT00720434|587379747|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162635417|NCT00720434|587379748|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162635418|NCT00720434|587379745|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
162635419|NCT00720434|587379746|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
162635420|NCT00720434|587379747|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
162985867|NCT02331368|588652459|FG000|Overall Study|Withdrawal by Subject|3|||
162985868|NCT02987959|588652460|FG000|Overall Study|Grantor stopped supply of drugs|6|||
162985869|NCT02302859|588652461|FG000|Overall Study|Lost Phone|1|||
162985870|NCT02302859|588652462|FG001|Overall Study|Lost Phone|1|||
162985871|NCT02302859|588652461|FG000|Overall Study|Withdrawal by Subject|0|||
162985872|NCT02302859|588652462|FG001|Overall Study|Withdrawal by Subject|1|||
162985873|NCT02989168|588652475|FG000|Overall Study|Withdrawal by Subject|2|||
162985874|NCT02989168|588652476|FG001|Overall Study|Withdrawal by Subject|0|||
162985875|NCT02989168|588652475|FG000|Overall Study|Physician Decision|0|||
162985876|NCT02989168|588652476|FG001|Overall Study|Physician Decision|1|||
162985877|NCT02989168|588652475|FG000|Overall Study|Adverse Event|1|||
162985878|NCT02989168|588652476|FG001|Overall Study|Adverse Event|2|||
162985879|NCT02989168|588652475|FG000|Overall Study|Sponsor stopped study.|1|||
162985880|NCT02989168|588652476|FG001|Overall Study|Sponsor stopped study.|0|||
162985881|NCT03456960|588652477|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985882|NCT03456960|588652478|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985883|NCT03456960|588652479|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
162985884|NCT03456960|588652480|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
162985885|NCT03456960|588652481|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162635421|NCT00720434|587379748|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
162635422|NCT00720434|587379745|FG000|Open-Label Period (Week 5-72)|Other|4|||
162635423|NCT00720434|587379746|FG001|Open-Label Period (Week 5-72)|Other|3|||
162635424|NCT00720434|587379747|FG002|Open-Label Period (Week 5-72)|Other|3|||
162635425|NCT00720434|587379748|FG003|Open-Label Period (Week 5-72)|Other|2|||
162635426|NCT00418314|587379749|FG000|Overall Study|Withdrawal by Subject|1|||
162985886|NCT03456960|588652482|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162985887|NCT03456960|588652477|FG000|Period 2 (1 Day)|Adverse Event|1|||
162985888|NCT03456960|588652478|FG001|Period 2 (1 Day)|Adverse Event|0|||
162985889|NCT03456960|588652479|FG002|Period 2 (1 Day)|Adverse Event|0|||
162985890|NCT03456960|588652480|FG003|Period 2 (1 Day)|Adverse Event|1|||
162985891|NCT03456960|588652481|FG004|Period 2 (1 Day)|Adverse Event|0|||
162985892|NCT03456960|588652482|FG005|Period 2 (1 Day)|Adverse Event|0|||
162985893|NCT01940497|588652483|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
162635427|NCT00418314|587379750|FG001|Overall Study|Withdrawal by Subject|2|||
162635428|NCT00967798|587379751|FG000|Overall Study|Withdrawal by Subject|5|||
162635429|NCT00967798|587379752|FG001|Overall Study|Withdrawal by Subject|2|||
162635430|NCT00967798|587379751|FG000|Overall Study|Lost to Follow-up|4|||
162635431|NCT00967798|587379752|FG001|Overall Study|Lost to Follow-up|1|||
162635432|NCT02425046|587379753|FG000|Overall Study|Lost to Follow-up|52|||
162635433|NCT02425046|587379754|FG001|Overall Study|Lost to Follow-up|50|||
162635434|NCT02425046|587379755|FG002|Overall Study|Lost to Follow-up|56|||
162635435|NCT02425046|587379753|FG000|Overall Study|Withdrawal by Subject|16|||
162635436|NCT02425046|587379754|FG001|Overall Study|Withdrawal by Subject|12|||
162635437|NCT02425046|587379755|FG002|Overall Study|Withdrawal by Subject|0|||
162635438|NCT01409564|587379756|FG000|Overall Study|low medication compliance|4|||
162635439|NCT01409564|587379757|FG001|Overall Study|low medication compliance|3|||
162635440|NCT01409564|587379756|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
162635441|NCT01409564|587379757|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
162635442|NCT02782780|587379758|FG000|Overall Study|dropped out after randomization.|7|||
162635443|NCT02782780|587379759|FG001|Overall Study|dropped out after randomization.|5|||
162635444|NCT02782780|587379758|FG000|Overall Study|Protocol Violation|0|||
162635445|NCT02782780|587379759|FG001|Overall Study|Protocol Violation|2|||
162635446|NCT01413191|587379760|FG000|Overall Study|Lost to Follow-up|5|||
162635447|NCT01413191|587379760|FG000|Overall Study|Disease Progression|5|||
162635448|NCT01413191|587379760|FG000|Overall Study|Death|1|||
162635449|NCT05040386|587379761|FG000|Overall Study|Withdrawal by Subject|1|||
162635450|NCT05040386|587379762|FG001|Overall Study|Withdrawal by Subject|0|||
162635451|NCT05040386|587379763|FG002|Overall Study|Withdrawal by Subject|1|||
162635452|NCT05040386|587379764|FG003|Overall Study|Withdrawal by Subject|0|||
162714820|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
162985894|NCT01940497|588652484|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
162635453|NCT05040386|587379761|FG000|Overall Study|Lost to Follow-up|0|||
162635454|NCT05040386|587379762|FG001|Overall Study|Lost to Follow-up|0|||
162635455|NCT05040386|587379763|FG002|Overall Study|Lost to Follow-up|1|||
162635456|NCT05040386|587379764|FG003|Overall Study|Lost to Follow-up|0|||
162714821|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162985895|NCT01940497|588652483|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
163059828|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
162635457|NCT03654651|587379765|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162635458|NCT03654651|587379766|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162635459|NCT03045328|587379767|FG000|Overall Study|Withdrawal by Subject|2|||
162635460|NCT00589914|587379772|FG000|Overall Study|Adverse Event|19|||
162635461|NCT00589914|587379773|FG001|Overall Study|Adverse Event|10|||
162635462|NCT00589914|587379772|FG000|Overall Study|Death|2|||
162985896|NCT01940497|588652484|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
162985897|NCT01940497|588652483|FG000|Overall Study|Violation of Entry Criteria|1|||
162985898|NCT01940497|588652484|FG001|Overall Study|Violation of Entry Criteria|1|||
162985899|NCT01940497|588652483|FG000|Overall Study|Refused Treatment|1|||
162985900|NCT01940497|588652484|FG001|Overall Study|Refused Treatment|3|||
162985901|NCT01940497|588652483|FG000|Overall Study|Withdrew Consent|6|||
162985902|NCT01940497|588652484|FG001|Overall Study|Withdrew Consent|2|||
162985903|NCT01940497|588652483|FG000|Overall Study|Administrative/Other|1|||
162985904|NCT01940497|588652484|FG001|Overall Study|Administrative/Other|1|||
162985905|NCT00502801|588652485|FG000|Treatment Period|Withdrawal by Subject|3|||
162985906|NCT00502801|588652485|FG000|Treatment Period|Adverse Event|7|||
162985907|NCT00502801|588652485|FG000|Treatment Period|Death|14|||
162985908|NCT00502801|588652485|FG000|Treatment Period|OTHER|30|||
162985909|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
162985910|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
162985911|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|Death|3|||
162985912|NCT00502801|588652485|FG000|End of Therapy to Test of Cure|OTHER|2|||
162985913|NCT00446199|588652488|FG000|Overall Study|Adverse Event|7|||
162985914|NCT00446199|588652489|FG001|Overall Study|Adverse Event|4|||
162985915|NCT00446199|588652490|FG002|Overall Study|Adverse Event|6|||
162985916|NCT00446199|588652491|FG003|Overall Study|Adverse Event|4|||
162985917|NCT00446199|588652488|FG000|Overall Study|Lost to Follow-up|4|||
162985918|NCT00446199|588652489|FG001|Overall Study|Lost to Follow-up|5|||
162985919|NCT00446199|588652490|FG002|Overall Study|Lost to Follow-up|2|||
162985920|NCT00446199|588652491|FG003|Overall Study|Lost to Follow-up|6|||
162985921|NCT00446199|588652488|FG000|Overall Study|Protocol Violation|1|||
162985922|NCT00446199|588652489|FG001|Overall Study|Protocol Violation|2|||
162985923|NCT00446199|588652490|FG002|Overall Study|Protocol Violation|1|||
162985924|NCT00446199|588652491|FG003|Overall Study|Protocol Violation|3|||
162985925|NCT00446199|588652488|FG000|Overall Study|Withdrawal by Subject|2|||
162985926|NCT00446199|588652489|FG001|Overall Study|Withdrawal by Subject|5|||
162985927|NCT00446199|588652490|FG002|Overall Study|Withdrawal by Subject|9|||
162985928|NCT00446199|588652491|FG003|Overall Study|Withdrawal by Subject|10|||
162985929|NCT00446199|588652488|FG000|Overall Study|Site termination|2|||
162985930|NCT00446199|588652489|FG001|Overall Study|Site termination|0|||
162985931|NCT00446199|588652490|FG002|Overall Study|Site termination|0|||
162985932|NCT00446199|588652491|FG003|Overall Study|Site termination|1|||
162985933|NCT00446199|588652488|FG000|Overall Study|Randomization in Error|2|||
162985934|NCT00446199|588652489|FG001|Overall Study|Randomization in Error|0|||
162985935|NCT00446199|588652490|FG002|Overall Study|Randomization in Error|1|||
162985936|NCT00446199|588652491|FG003|Overall Study|Randomization in Error|1|||
162985937|NCT00446199|588652488|FG000|Overall Study|Lack of Efficacy|1|||
162985938|NCT00446199|588652489|FG001|Overall Study|Lack of Efficacy|0|||
162985939|NCT00446199|588652490|FG002|Overall Study|Lack of Efficacy|0|||
162635463|NCT00589914|587379773|FG001|Overall Study|Death|0|||
162635464|NCT00589914|587379772|FG000|Overall Study|Lack of Efficacy|40|||
162635465|NCT00589914|587379773|FG001|Overall Study|Lack of Efficacy|43|||
162635466|NCT00589914|587379772|FG000|Overall Study|Lost to Follow-up|11|||
162635467|NCT00589914|587379773|FG001|Overall Study|Lost to Follow-up|18|||
162985940|NCT00446199|588652491|FG003|Overall Study|Lack of Efficacy|1|||
162985941|NCT00446199|588652488|FG000|Overall Study|Non-compliant with study drug|1|||
162985942|NCT00446199|588652489|FG001|Overall Study|Non-compliant with study drug|0|||
162635468|NCT00589914|587379772|FG000|Overall Study|Pregnancy|1|||
162635469|NCT00589914|587379773|FG001|Overall Study|Pregnancy|0|||
162635470|NCT00589914|587379772|FG000|Overall Study|Withdrawal by Subject|55|||
162635471|NCT00589914|587379773|FG001|Overall Study|Withdrawal by Subject|49|||
162635472|NCT00589914|587379772|FG000|Overall Study|Other|22|||
162635473|NCT00589914|587379773|FG001|Overall Study|Other|17|||
162985943|NCT00446199|588652490|FG002|Overall Study|Non-compliant with study drug|5|||
162985944|NCT00446199|588652491|FG003|Overall Study|Non-compliant with study drug|0|||
162985945|NCT00446199|588652488|FG000|Overall Study|Non-compliant with visit schedule|1|||
162635474|NCT02618434|587379778|FG000|Overall Study|Withdrawal by Subject|0|||
162635475|NCT02618434|587379779|FG001|Overall Study|Withdrawal by Subject|2|||
162635476|NCT02618434|587379780|FG002|Overall Study|Withdrawal by Subject|3|||
162635477|NCT02618434|587379778|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
162635478|NCT02618434|587379779|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
162985946|NCT00446199|588652489|FG001|Overall Study|Non-compliant with visit schedule|1|||
162985947|NCT00446199|588652490|FG002|Overall Study|Non-compliant with visit schedule|1|||
162985948|NCT00446199|588652491|FG003|Overall Study|Non-compliant with visit schedule|2|||
162985949|NCT00446199|588652488|FG000|Overall Study|Hormone fear|0|||
162985950|NCT00446199|588652489|FG001|Overall Study|Hormone fear|0|||
162985951|NCT00446199|588652490|FG002|Overall Study|Hormone fear|0|||
162985952|NCT00446199|588652491|FG003|Overall Study|Hormone fear|1|||
162985953|NCT00446199|588652488|FG000|Overall Study|Lost interest in study participation|0|||
162985954|NCT00446199|588652489|FG001|Overall Study|Lost interest in study participation|1|||
162985955|NCT00446199|588652490|FG002|Overall Study|Lost interest in study participation|0|||
162985956|NCT00446199|588652491|FG003|Overall Study|Lost interest in study participation|0|||
162985957|NCT00446199|588652488|FG000|Overall Study|In-/Exclusion criterion violated|2|||
162985958|NCT00446199|588652489|FG001|Overall Study|In-/Exclusion criterion violated|1|||
162985959|NCT00446199|588652490|FG002|Overall Study|In-/Exclusion criterion violated|2|||
162985960|NCT00446199|588652491|FG003|Overall Study|In-/Exclusion criterion violated|1|||
162985961|NCT00446199|588652488|FG000|Overall Study|Move|0|||
162985962|NCT00446199|588652489|FG001|Overall Study|Move|1|||
162985963|NCT00446199|588652490|FG002|Overall Study|Move|0|||
162985964|NCT00446199|588652491|FG003|Overall Study|Move|0|||
162985965|NCT03071094|588652495|FG000|Overall Study|Death|1|||
162985966|NCT03071094|588652496|FG001|Overall Study|Death|1|||
162985967|NCT03071094|588652495|FG000|Overall Study|Adverse Event|1|||
162985968|NCT03071094|588652496|FG001|Overall Study|Adverse Event|0|||
162985969|NCT01079832|588652500|FG000|Overall Study|Withdrawal by Subject|1|||
162985970|NCT01195272|588652501|FG000|Overall Study|Adverse Event|1|||
162985971|NCT01195272|588652501|FG000|Overall Study|Lack of Efficacy|3|||
162985972|NCT01769339|588652504|FG000|Overall Study|Lost to Follow-up|42|||
162985973|NCT01769339|588652504|FG000|Overall Study|Adverse Event|1|||
162985974|NCT04969861|588652505|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
162985975|NCT04969861|588652506|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
162985976|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
163059829|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
162635479|NCT02618434|587379780|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
162635480|NCT02618434|587379778|FG000|Overall Study|Lost to Follow-up|3|||
162635481|NCT02618434|587379779|FG001|Overall Study|Lost to Follow-up|1|||
162635482|NCT02618434|587379780|FG002|Overall Study|Lost to Follow-up|3|||
162635483|NCT02618434|587379778|FG000|Overall Study|Adverse Event|1|||
162635484|NCT02618434|587379779|FG001|Overall Study|Adverse Event|0|||
162635485|NCT02618434|587379780|FG002|Overall Study|Adverse Event|12|||
162635486|NCT02618434|587379778|FG000|Overall Study|Physician Decision|0|||
162635487|NCT02618434|587379779|FG001|Overall Study|Physician Decision|1|||
162635488|NCT02618434|587379780|FG002|Overall Study|Physician Decision|0|||
162635489|NCT02618434|587379778|FG000|Overall Study|Protocol Violation|0|||
162635490|NCT02618434|587379779|FG001|Overall Study|Protocol Violation|0|||
162635491|NCT02618434|587379780|FG002|Overall Study|Protocol Violation|1|||
162635492|NCT02618434|587379778|FG000|Overall Study|Other, Multiple categories|1|||
162635493|NCT02618434|587379779|FG001|Overall Study|Other, Multiple categories|1|||
162635494|NCT02618434|587379780|FG002|Overall Study|Other, Multiple categories|1|||
162635495|NCT02289898|587379786|FG000|Overall Study|Death|5|||
162635496|NCT02289898|587379787|FG001|Overall Study|Death|4|||
162635497|NCT02289898|587379788|FG002|Overall Study|Death|3|||
162635498|NCT02289898|587379786|FG000|Overall Study|Physician Decision|2|||
162635499|NCT02289898|587379787|FG001|Overall Study|Physician Decision|5|||
162635500|NCT02289898|587379788|FG002|Overall Study|Physician Decision|2|||
162635501|NCT02289898|587379786|FG000|Overall Study|Withdrawal by Subject|0|||
162635502|NCT02289898|587379787|FG001|Overall Study|Withdrawal by Subject|4|||
162635503|NCT02289898|587379788|FG002|Overall Study|Withdrawal by Subject|1|||
162635504|NCT02289898|587379786|FG000|Overall Study|Adverse Event|3|||
162635505|NCT02289898|587379787|FG001|Overall Study|Adverse Event|5|||
162635506|NCT02289898|587379788|FG002|Overall Study|Adverse Event|5|||
162635507|NCT02289898|587379786|FG000|Overall Study|Disease progression|34|||
162635508|NCT02289898|587379787|FG001|Overall Study|Disease progression|28|||
162635509|NCT02289898|587379788|FG002|Overall Study|Disease progression|34|||
162635510|NCT02289898|587379786|FG000|Overall Study|Use of another anticancer therapy|0|||
162635511|NCT02289898|587379787|FG001|Overall Study|Use of another anticancer therapy|0|||
162635512|NCT02289898|587379788|FG002|Overall Study|Use of another anticancer therapy|1|||
162635513|NCT02289898|587379786|FG000|Overall Study|Other|8|||
162635514|NCT02289898|587379787|FG001|Overall Study|Other|7|||
163059830|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
163059831|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
163059832|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
163059833|NCT02349386|588928234|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
162635515|NCT02289898|587379788|FG002|Overall Study|Other|10|||
162635516|NCT04626297|587379789|FG000|Overall Study|Adverse Event|5|||
162635517|NCT04626297|587379790|FG001|Overall Study|Adverse Event|3|||
162635518|NCT04626297|587379789|FG000|Overall Study|Lost to Follow-up|7|||
162635519|NCT04626297|587379790|FG001|Overall Study|Lost to Follow-up|3|||
162635520|NCT04626297|587379789|FG000|Overall Study|Protocol Violation|5|||
162635521|NCT04626297|587379790|FG001|Overall Study|Protocol Violation|1|||
162635522|NCT04626297|587379789|FG000|Overall Study|Withdrawal by Subject|20|||
162635523|NCT04626297|587379790|FG001|Overall Study|Withdrawal by Subject|6|||
162635524|NCT04626297|587379789|FG000|Overall Study|Sponsor decision|2|||
162635525|NCT04626297|587379790|FG001|Overall Study|Sponsor decision|1|||
162635526|NCT00885105|587379793|FG000|Overall Study|Withdrawal by Subject|0|||
162985977|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985978|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985979|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985980|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
162985981|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
162985982|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|headache|0|||
162985983|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|headache|0|||
162985984|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|headache|0|||
162985985|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|headache|0|||
162985986|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|headache|1|||
162985987|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|headache|0|||
162985988|NCT00290251|588652507|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985989|NCT00290251|588652508|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985990|NCT00290251|588652509|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985991|NCT00290251|588652510|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
162985992|NCT00290251|588652511|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985993|NCT00290251|588652512|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
162985994|NCT03548064|588654727|FG000|Overall Study|Withdrawal by Subject|0|||
162985995|NCT03548064|588654728|FG001|Overall Study|Withdrawal by Subject|0|||
162985996|NCT03548064|588654729|FG002|Overall Study|Withdrawal by Subject|0|||
162985997|NCT03548064|588654730|FG003|Overall Study|Withdrawal by Subject|1|||
162985998|NCT03548064|588654731|FG004|Overall Study|Withdrawal by Subject|0|||
162985999|NCT03548064|588654732|FG005|Overall Study|Withdrawal by Subject|0|||
162986000|NCT03548064|588654733|FG006|Overall Study|Withdrawal by Subject|0|||
162986001|NCT03548064|588654734|FG007|Overall Study|Withdrawal by Subject|0|||
162986002|NCT03548064|588654727|FG000|Overall Study|Lost to Follow-up|0|||
162635527|NCT00885105|587379794|FG001|Overall Study|Withdrawal by Subject|8|||
162986003|NCT03548064|588654728|FG001|Overall Study|Lost to Follow-up|0|||
162986004|NCT03548064|588654729|FG002|Overall Study|Lost to Follow-up|0|||
162986005|NCT03548064|588654730|FG003|Overall Study|Lost to Follow-up|0|||
162986006|NCT03548064|588654731|FG004|Overall Study|Lost to Follow-up|2|||
162986007|NCT03548064|588654732|FG005|Overall Study|Lost to Follow-up|0|||
162986008|NCT03548064|588654733|FG006|Overall Study|Lost to Follow-up|0|||
162986009|NCT03548064|588654734|FG007|Overall Study|Lost to Follow-up|0|||
162986010|NCT03548064|588654727|FG000|Overall Study|Covid-19 Pandemic|0|||
162986011|NCT03548064|588654728|FG001|Overall Study|Covid-19 Pandemic|0|||
162986012|NCT03548064|588654729|FG002|Overall Study|Covid-19 Pandemic|0|||
162986013|NCT03548064|588654730|FG003|Overall Study|Covid-19 Pandemic|0|||
162986014|NCT03548064|588654731|FG004|Overall Study|Covid-19 Pandemic|10|||
162986015|NCT03548064|588654732|FG005|Overall Study|Covid-19 Pandemic|3|||
162986016|NCT03548064|588654733|FG006|Overall Study|Covid-19 Pandemic|0|||
162986017|NCT03548064|588654734|FG007|Overall Study|Covid-19 Pandemic|0|||
162986018|NCT06218823|588654735|FG000|Overall Study|Death|3|||
162635528|NCT00885105|587379793|FG000|Overall Study|Adverse Event|1|||
162635529|NCT00885105|587379794|FG001|Overall Study|Adverse Event|0|||
162635530|NCT00885105|587379793|FG000|Overall Study|Protocol Violation|0|||
162635531|NCT00885105|587379794|FG001|Overall Study|Protocol Violation|2|||
162635532|NCT02066233|587379795|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
162635533|NCT02066233|587379796|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
162635534|NCT02598076|587379797|FG000|Overall Study|Lost to Follow-up|2|||
162635535|NCT02598076|587379798|FG001|Overall Study|Lost to Follow-up|3|||
162635536|NCT02005445|587379799|FG000|Overall Study|Dual study enrollment|0|||
162635537|NCT02005445|587379800|FG001|Overall Study|Dual study enrollment|1|||
162635538|NCT00010374|587379801|FG000|Overall Study|False positive phrenic nerve test|1|||
162635539|NCT00533845|587379808|FG000|Overall Study|Physician Decision|1|||
162635540|NCT00533845|587379809|FG001|Overall Study|Physician Decision|0|||
162635541|NCT00667368|587379818|FG000|Overall Study|Lost to Follow-up|176|||
162635542|NCT00667368|587379819|FG001|Overall Study|Lost to Follow-up|155|||
162635543|NCT00667368|587379818|FG000|Overall Study|Discontinued early|24|||
162635544|NCT00667368|587379819|FG001|Overall Study|Discontinued early|17|||
162635545|NCT02407704|587379820|FG000|Overall Study|Lost to Follow-up|0|||
162635546|NCT02407704|587379821|FG001|Overall Study|Lost to Follow-up|0|||
162635547|NCT02407704|587379822|FG002|Overall Study|Lost to Follow-up|0|||
162986019|NCT06218823|588654736|FG001|Overall Study|Death|0|||
162986020|NCT06218823|588654735|FG000|Overall Study|Lost to Follow-up|0|||
162635548|NCT02407704|587379823|FG003|Overall Study|Lost to Follow-up|2|||
162635549|NCT02407704|587379820|FG000|Overall Study|Protocol Violation|0|||
162635550|NCT02407704|587379821|FG001|Overall Study|Protocol Violation|0|||
162714822|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162635551|NCT02407704|587379822|FG002|Overall Study|Protocol Violation|0|||
162986021|NCT06218823|588654736|FG001|Overall Study|Lost to Follow-up|2|||
162635552|NCT02407704|587379823|FG003|Overall Study|Protocol Violation|1|||
162635553|NCT02407704|587379820|FG000|Overall Study|Withdrawal by Subject|0|||
162986022|NCT04732221|588654737|FG000|Base Period|Death|2|||
162986023|NCT04732221|588654738|FG001|Base Period|Death|0|||
162986024|NCT04732221|588654739|FG002|Base Period|Death|0|||
162714823|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714824|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714825|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714826|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714827|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714828|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714829|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714830|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714831|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162714832|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714833|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714834|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
162714835|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714836|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714837|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714838|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714839|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714840|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714841|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714842|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714843|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714844|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162714845|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
162714846|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
162714847|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
162714848|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
162714849|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
162714850|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714851|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714852|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714853|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714854|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714855|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714856|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714857|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162714858|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714859|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714860|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714861|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714862|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
162714863|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714864|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714865|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714866|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714867|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714868|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714869|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714870|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162714871|NCT04936035|587665776|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
162714872|NCT04936035|587665777|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162635554|NCT02407704|587379821|FG001|Overall Study|Withdrawal by Subject|0|||
162635555|NCT02407704|587379822|FG002|Overall Study|Withdrawal by Subject|1|||
162635556|NCT02407704|587379823|FG003|Overall Study|Withdrawal by Subject|0|||
162635557|NCT01683383|587379824|FG000|Overall Study|Infant was not transported|1|||
162635558|NCT01683383|587379825|FG001|Overall Study|Infant was not transported|0|||
162635559|NCT02496611|587379826|FG000|Overall Study|Lost to Follow-up|2|||
162635560|NCT02496611|587379827|FG001|Overall Study|Lost to Follow-up|1|||
162635561|NCT02496611|587379826|FG000|Overall Study|Withdrawal by Subject|5|||
162635562|NCT02496611|587379827|FG001|Overall Study|Withdrawal by Subject|2|||
162635563|NCT02850965|587379828|FG000|Overall Study|Other than listed|3|||
162635564|NCT02850965|587379829|FG001|Overall Study|Other than listed|4|||
162635565|NCT02850965|587379828|FG000|Overall Study|Protocol Violation|0|||
162635566|NCT02850965|587379829|FG001|Overall Study|Protocol Violation|2|||
162635567|NCT02850965|587379828|FG000|Overall Study|Lost to Follow-up|5|||
162635568|NCT02850965|587379829|FG001|Overall Study|Lost to Follow-up|3|||
162714873|NCT04936035|587665778|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714874|NCT04936035|587665779|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714875|NCT04936035|587665780|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714876|NCT04936035|587665781|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714877|NCT04936035|587665782|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714878|NCT04936035|587665783|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714879|NCT04936035|587665784|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714880|NCT04936035|587665785|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714881|NCT04936035|587665786|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714882|NCT04936035|587665787|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714883|NCT04936035|587665788|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162714884|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714885|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714886|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714887|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714888|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714889|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
162714890|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
162714891|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714892|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162714893|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
162714894|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
162714895|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
162714896|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
162714897|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714898|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714899|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714900|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714901|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714902|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162714903|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162714904|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714905|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162714906|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
162714907|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162714908|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162714909|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
162714910|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714911|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714912|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714913|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714914|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714915|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714916|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714917|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714918|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714919|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
162714920|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714921|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
162714922|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
162714923|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714924|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714925|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714926|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714927|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714928|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
162714929|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714930|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
162714931|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714932|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714933|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714934|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
162714935|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
162635569|NCT02850965|587379828|FG000|Overall Study|Lack of Efficacy|4|||
162986025|NCT04732221|588654740|FG003|Base Period|Death|0|||
162986026|NCT04732221|588654741|FG004|Base Period|Death|0|||
162986027|NCT04732221|588654742|FG005|Base Period|Death|0|||
162986028|NCT04732221|588654743|FG006|Base Period|Death|0|||
162986029|NCT04732221|588654737|FG000|Base Period|Withdrawal by Subject|0|||
162986030|NCT04732221|588654738|FG001|Base Period|Withdrawal by Subject|1|||
162986031|NCT04732221|588654739|FG002|Base Period|Withdrawal by Subject|1|||
162986032|NCT04732221|588654740|FG003|Base Period|Withdrawal by Subject|0|||
162986033|NCT04732221|588654741|FG004|Base Period|Withdrawal by Subject|0|||
162986034|NCT04732221|588654742|FG005|Base Period|Withdrawal by Subject|0|||
162986035|NCT04732221|588654743|FG006|Base Period|Withdrawal by Subject|0|||
162635570|NCT02850965|587379829|FG001|Overall Study|Lack of Efficacy|8|||
162635571|NCT02850965|587379828|FG000|Overall Study|Adverse Event|3|||
162635572|NCT02850965|587379829|FG001|Overall Study|Adverse Event|2|||
162635573|NCT02850965|587379828|FG000|Overall Study|Withdrawal by Subject|3|||
162635574|NCT02850965|587379829|FG001|Overall Study|Withdrawal by Subject|4|||
162635575|NCT02850965|587379828|FG000|Overall Study|Physician Decision|0|||
162635576|NCT02850965|587379829|FG001|Overall Study|Physician Decision|1|||
162635577|NCT02850965|587379828|FG000|Overall Study|Randomized but not treated|0|||
162635578|NCT02850965|587379829|FG001|Overall Study|Randomized but not treated|1|||
162635579|NCT00230607|587379838|FG000|Overall Study|Other|3|||
162635580|NCT03672747|587379839|FG000|Overall Study|Lost to Follow-up|1|||
162635581|NCT03672747|587379840|FG001|Overall Study|Lost to Follow-up|1|||
162635582|NCT03672747|587379841|FG002|Overall Study|Lost to Follow-up|2|||
162635583|NCT03672747|587379842|FG003|Overall Study|Lost to Follow-up|2|||
162635584|NCT03672747|587379843|FG004|Overall Study|Lost to Follow-up|2|||
162635585|NCT03672747|587379844|FG005|Overall Study|Lost to Follow-up|1|||
162635586|NCT03228537|587379847|FG000|Neoadjuvant|Adverse Event|2|||
162635587|NCT03228537|587379847|FG000|Neoadjuvant|Progression/Relapse|4|||
162635588|NCT03228537|587379847|FG000|Neoadjuvant|Death|1|||
162635589|NCT03228537|587379847|FG000|Surgery|Death|1|||
162635590|NCT03228537|587379847|FG000|Surgery|Other - Not Protocol Specified|2|||
162635591|NCT03228537|587379847|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
162635592|NCT03228537|587379847|FG000|Maintenance|Progression/Relapse|10|||
162635593|NCT00580606|587379851|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
162635594|NCT00580606|587379852|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
162635595|NCT00580606|587379851|FG000|Open Label (OL)|Withdrawal by Subject|4|||
162635596|NCT00580606|587379852|FG001|Open Label (OL)|Withdrawal by Subject|6|||
162635597|NCT00580606|587379851|FG000|Open Label (OL)|Dosing Symptoms|0|||
162635598|NCT00580606|587379852|FG001|Open Label (OL)|Dosing Symptoms|1|||
162635599|NCT00580606|587379851|FG000|Open Label (OL)|Lost to Follow-up|0|||
162635600|NCT00580606|587379852|FG001|Open Label (OL)|Lost to Follow-up|1|||
162635601|NCT00580606|587379851|FG000|Open Label (OL)|Pregnancy|0|||
162635602|NCT00580606|587379852|FG001|Open Label (OL)|Pregnancy|1|||
162986036|NCT04732221|588654737|FG000|Extension Period|Adverse Event|0|||
162986037|NCT04732221|588654738|FG001|Extension Period|Adverse Event|0|||
162986038|NCT04732221|588654739|FG002|Extension Period|Adverse Event|0|||
162986039|NCT04732221|588654740|FG003|Extension Period|Adverse Event|0|||
162986040|NCT04732221|588654741|FG004|Extension Period|Adverse Event|0|||
162986041|NCT04732221|588654742|FG005|Extension Period|Adverse Event|1|||
162986042|NCT04732221|588654743|FG006|Extension Period|Adverse Event|0|||
162986043|NCT04732221|588654737|FG000|Extension Period|Death|0|||
162986044|NCT04732221|588654738|FG001|Extension Period|Death|0|||
162986045|NCT04732221|588654739|FG002|Extension Period|Death|0|||
162635603|NCT00580606|587379851|FG000|Open Label (OL)|Non-compliance|2|||
162635604|NCT00580606|587379852|FG001|Open Label (OL)|Non-compliance|0|||
162635605|NCT00580606|587379851|FG000|Open Label (OL)|Physician Decision|1|||
162635606|NCT00580606|587379852|FG001|Open Label (OL)|Physician Decision|1|||
162635607|NCT00580606|587379851|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
162635608|NCT00580606|587379852|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
162635609|NCT03358290|587379854|FG000|Overall Study|Study discontinued by Sponsor|0|||
162635610|NCT03358290|587379855|FG001|Overall Study|Study discontinued by Sponsor|1|||
162635611|NCT03358290|587379856|FG002|Overall Study|Study discontinued by Sponsor|1|||
162635612|NCT03358290|587379857|FG003|Overall Study|Study discontinued by Sponsor|0|||
162635613|NCT03358290|587379858|FG004|Overall Study|Study discontinued by Sponsor|0|||
162635614|NCT03358290|587379854|FG000|Overall Study|Adverse Event|0|||
162635615|NCT03358290|587379855|FG001|Overall Study|Adverse Event|0|||
162635616|NCT03358290|587379856|FG002|Overall Study|Adverse Event|1|||
162635617|NCT03358290|587379857|FG003|Overall Study|Adverse Event|2|||
162635618|NCT03358290|587379858|FG004|Overall Study|Adverse Event|0|||
162635619|NCT03358290|587379854|FG000|Overall Study|Withdrawal by Subject|0|||
162635620|NCT03358290|587379855|FG001|Overall Study|Withdrawal by Subject|0|||
162635621|NCT03358290|587379856|FG002|Overall Study|Withdrawal by Subject|0|||
162635622|NCT03358290|587379857|FG003|Overall Study|Withdrawal by Subject|0|||
162986046|NCT04732221|588654740|FG003|Extension Period|Death|0|||
162986047|NCT04732221|588654741|FG004|Extension Period|Death|1|||
162986048|NCT04732221|588654742|FG005|Extension Period|Death|0|||
162986049|NCT04732221|588654743|FG006|Extension Period|Death|2|||
162986050|NCT04732221|588654737|FG000|Extension Period|Pregnancy|0|||
162635623|NCT03358290|587379858|FG004|Overall Study|Withdrawal by Subject|1|||
162635624|NCT01482884|587379859|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
162635625|NCT01482884|587379860|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
162635626|NCT01482884|587379859|FG000|Overall Study|Protocol Violation|1|||
162635627|NCT01482884|587379860|FG001|Overall Study|Protocol Violation|0|||
162635628|NCT01482884|587379859|FG000|Overall Study|Lost to Follow-up|2|||
162635629|NCT01482884|587379860|FG001|Overall Study|Lost to Follow-up|2|||
162635630|NCT01482884|587379859|FG000|Overall Study|Lack of Efficacy|0|||
162635631|NCT01482884|587379860|FG001|Overall Study|Lack of Efficacy|1|||
162635632|NCT01482884|587379859|FG000|Overall Study|Adverse Event|2|||
162635633|NCT01482884|587379860|FG001|Overall Study|Adverse Event|1|||
162635634|NCT01482884|587379859|FG000|Overall Study|Withdrawal by Subject|8|||
162635635|NCT01482884|587379860|FG001|Overall Study|Withdrawal by Subject|13|||
162635636|NCT04102020|587379861|FG000|Overall Study|Adverse Event|1|||
162714936|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Death|0|||
162635637|NCT04102020|587379862|FG001|Overall Study|Adverse Event|0|||
162635638|NCT04102020|587379863|FG002|Overall Study|Adverse Event|0|||
162714937|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Death|0|||
162714938|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Death|0|||
162714939|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Death|0|||
162714940|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Death|0|||
162714941|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Death|0|||
162714942|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Death|0|||
162714943|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Death|0|||
162714944|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Death|0|||
162714945|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Death|1|||
162714946|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Death|0|||
162714947|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Death|0|||
162714948|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Death|0|||
162714949|NCT04936035|587665776|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714950|NCT04936035|587665777|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714951|NCT04936035|587665778|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714952|NCT04936035|587665779|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714953|NCT04936035|587665780|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714954|NCT04936035|587665781|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
162714955|NCT04936035|587665782|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714956|NCT04936035|587665783|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714957|NCT04936035|587665784|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714958|NCT04936035|587665785|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
162714959|NCT04936035|587665786|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
162714960|NCT04936035|587665787|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714961|NCT04936035|587665788|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162714962|NCT05827926|587665791|FG000|Overall Study|Lost to Follow-up|1|||
162714963|NCT05827926|587665792|FG001|Overall Study|Lost to Follow-up|0|||
162714964|NCT05827926|587665793|FG002|Overall Study|Lost to Follow-up|0|||
162714965|NCT05827926|587665794|FG003|Overall Study|Lost to Follow-up|0|||
162714966|NCT05827926|587665795|FG004|Overall Study|Lost to Follow-up|0|||
162714967|NCT05827926|587665796|FG005|Overall Study|Lost to Follow-up|1|||
162714968|NCT05827926|587665797|FG006|Overall Study|Lost to Follow-up|0|||
162714969|NCT05827926|587665798|FG007|Overall Study|Lost to Follow-up|0|||
162714970|NCT05827926|587665799|FG008|Overall Study|Lost to Follow-up|0|||
162714971|NCT05827926|587665800|FG009|Overall Study|Lost to Follow-up|0|||
162714972|NCT05827926|587665801|FG010|Overall Study|Lost to Follow-up|0|||
162714973|NCT05827926|587665802|FG011|Overall Study|Lost to Follow-up|0|||
162714974|NCT05827926|587665803|FG012|Overall Study|Lost to Follow-up|1|||
162714975|NCT05827926|587665804|FG013|Overall Study|Lost to Follow-up|1|||
162714976|NCT05827926|587665805|FG014|Overall Study|Lost to Follow-up|0|||
162714977|NCT05827926|587665806|FG015|Overall Study|Lost to Follow-up|1|||
162714978|NCT05827926|587665807|FG016|Overall Study|Lost to Follow-up|2|||
162714979|NCT05827926|587665808|FG017|Overall Study|Lost to Follow-up|0|||
162714980|NCT05827926|587665809|FG018|Overall Study|Lost to Follow-up|0|||
162714981|NCT05827926|587665810|FG019|Overall Study|Lost to Follow-up|0|||
162714982|NCT05827926|587665811|FG020|Overall Study|Lost to Follow-up|1|||
162714983|NCT05827926|587665812|FG021|Overall Study|Lost to Follow-up|2|||
162714984|NCT05827926|587665813|FG022|Overall Study|Lost to Follow-up|1|||
162714985|NCT05827926|587665814|FG023|Overall Study|Lost to Follow-up|1|||
162714986|NCT05827926|587665815|FG024|Overall Study|Lost to Follow-up|2|||
162714987|NCT05827926|587665816|FG025|Overall Study|Lost to Follow-up|1|||
162714988|NCT05827926|587665817|FG026|Overall Study|Lost to Follow-up|4|||
162986051|NCT04732221|588654738|FG001|Extension Period|Pregnancy|0|||
162986052|NCT04732221|588654739|FG002|Extension Period|Pregnancy|0|||
162635639|NCT04102020|587379864|FG003|Overall Study|Adverse Event|1|||
162635640|NCT04102020|587379865|FG004|Overall Study|Adverse Event|0|||
162635641|NCT04102020|587379861|FG000|Overall Study|Withdrawal by Subject|0|||
162714989|NCT05827926|587665818|FG027|Overall Study|Lost to Follow-up|1|||
162714990|NCT05827926|587665819|FG028|Overall Study|Lost to Follow-up|2|||
162714991|NCT05827926|587665820|FG029|Overall Study|Lost to Follow-up|1|||
162714992|NCT05827926|587665821|FG030|Overall Study|Lost to Follow-up|5|||
162714993|NCT05827926|587665822|FG031|Overall Study|Lost to Follow-up|0|||
162714994|NCT05827926|587665823|FG032|Overall Study|Lost to Follow-up|3|||
162714995|NCT05827926|587665824|FG033|Overall Study|Lost to Follow-up|2|||
162714996|NCT05827926|587665825|FG034|Overall Study|Lost to Follow-up|1|||
162714997|NCT05827926|587665826|FG035|Overall Study|Lost to Follow-up|3|||
162714998|NCT05827926|587665827|FG036|Overall Study|Lost to Follow-up|4|||
162714999|NCT05827926|587665791|FG000|Overall Study|Withdrawal by Subject|1|||
162715000|NCT05827926|587665792|FG001|Overall Study|Withdrawal by Subject|0|||
162715001|NCT05827926|587665793|FG002|Overall Study|Withdrawal by Subject|1|||
162715002|NCT05827926|587665794|FG003|Overall Study|Withdrawal by Subject|1|||
162715003|NCT05827926|587665795|FG004|Overall Study|Withdrawal by Subject|0|||
162715004|NCT05827926|587665796|FG005|Overall Study|Withdrawal by Subject|0|||
162715005|NCT05827926|587665797|FG006|Overall Study|Withdrawal by Subject|0|||
162715006|NCT05827926|587665798|FG007|Overall Study|Withdrawal by Subject|0|||
162715007|NCT05827926|587665799|FG008|Overall Study|Withdrawal by Subject|0|||
162715008|NCT05827926|587665800|FG009|Overall Study|Withdrawal by Subject|0|||
162715009|NCT05827926|587665801|FG010|Overall Study|Withdrawal by Subject|0|||
162715010|NCT05827926|587665802|FG011|Overall Study|Withdrawal by Subject|0|||
162715011|NCT05827926|587665803|FG012|Overall Study|Withdrawal by Subject|1|||
162715012|NCT05827926|587665804|FG013|Overall Study|Withdrawal by Subject|1|||
162715013|NCT05827926|587665805|FG014|Overall Study|Withdrawal by Subject|1|||
162715014|NCT05827926|587665806|FG015|Overall Study|Withdrawal by Subject|2|||
162715015|NCT05827926|587665807|FG016|Overall Study|Withdrawal by Subject|1|||
162715016|NCT05827926|587665808|FG017|Overall Study|Withdrawal by Subject|1|||
162715017|NCT05827926|587665809|FG018|Overall Study|Withdrawal by Subject|0|||
162715018|NCT05827926|587665810|FG019|Overall Study|Withdrawal by Subject|0|||
162715019|NCT05827926|587665811|FG020|Overall Study|Withdrawal by Subject|1|||
162715020|NCT05827926|587665812|FG021|Overall Study|Withdrawal by Subject|0|||
162986053|NCT04732221|588654740|FG003|Extension Period|Pregnancy|0|||
162986054|NCT04732221|588654741|FG004|Extension Period|Pregnancy|1|||
162635642|NCT04102020|587379862|FG001|Overall Study|Withdrawal by Subject|1|||
162635643|NCT04102020|587379863|FG002|Overall Study|Withdrawal by Subject|1|||
162635644|NCT04102020|587379864|FG003|Overall Study|Withdrawal by Subject|1|||
162635645|NCT04102020|587379865|FG004|Overall Study|Withdrawal by Subject|1|||
162635646|NCT04102020|587379861|FG000|Overall Study|Death|1|||
162635647|NCT04102020|587379862|FG001|Overall Study|Death|4|||
162635648|NCT04102020|587379863|FG002|Overall Study|Death|1|||
162635649|NCT04102020|587379864|FG003|Overall Study|Death|1|||
162635650|NCT04102020|587379865|FG004|Overall Study|Death|0|||
162635651|NCT04102020|587379861|FG000|Overall Study|Physician Decision|1|||
162635652|NCT04102020|587379862|FG001|Overall Study|Physician Decision|2|||
162635653|NCT04102020|587379863|FG002|Overall Study|Physician Decision|2|||
162635654|NCT04102020|587379864|FG003|Overall Study|Physician Decision|0|||
162635655|NCT04102020|587379865|FG004|Overall Study|Physician Decision|1|||
162635656|NCT04102020|587379861|FG000|Overall Study|COVID-19 Infection|1|||
162635657|NCT04102020|587379862|FG001|Overall Study|COVID-19 Infection|0|||
162635658|NCT04102020|587379863|FG002|Overall Study|COVID-19 Infection|0|||
162635659|NCT04102020|587379864|FG003|Overall Study|COVID-19 Infection|0|||
162635660|NCT04102020|587379865|FG004|Overall Study|COVID-19 Infection|0|||
162635661|NCT04102020|587379861|FG000|Overall Study|Not disclosed|5|||
162635662|NCT04102020|587379862|FG001|Overall Study|Not disclosed|3|||
162635663|NCT04102020|587379863|FG002|Overall Study|Not disclosed|8|||
162635664|NCT04102020|587379864|FG003|Overall Study|Not disclosed|0|||
162635665|NCT04102020|587379865|FG004|Overall Study|Not disclosed|1|||
162635666|NCT04102020|587379861|FG000|Overall Study|MIssing|1|||
162635667|NCT04102020|587379862|FG001|Overall Study|MIssing|0|||
162715021|NCT05827926|587665813|FG022|Overall Study|Withdrawal by Subject|0|||
162715022|NCT05827926|587665814|FG023|Overall Study|Withdrawal by Subject|2|||
162715023|NCT05827926|587665815|FG024|Overall Study|Withdrawal by Subject|1|||
162715024|NCT05827926|587665816|FG025|Overall Study|Withdrawal by Subject|0|||
162715025|NCT05827926|587665817|FG026|Overall Study|Withdrawal by Subject|0|||
162715026|NCT05827926|587665818|FG027|Overall Study|Withdrawal by Subject|1|||
162715027|NCT05827926|587665819|FG028|Overall Study|Withdrawal by Subject|0|||
162715028|NCT05827926|587665820|FG029|Overall Study|Withdrawal by Subject|0|||
162715029|NCT05827926|587665821|FG030|Overall Study|Withdrawal by Subject|0|||
162715030|NCT05827926|587665822|FG031|Overall Study|Withdrawal by Subject|2|||
162715031|NCT05827926|587665823|FG032|Overall Study|Withdrawal by Subject|0|||
162715032|NCT05827926|587665824|FG033|Overall Study|Withdrawal by Subject|0|||
162635668|NCT04102020|587379863|FG002|Overall Study|MIssing|1|||
162635669|NCT04102020|587379864|FG003|Overall Study|MIssing|1|||
162635670|NCT04102020|587379865|FG004|Overall Study|MIssing|1|||
162635671|NCT04102020|587379861|FG000|Overall Study|Continuing in ongoing study|13|||
162715033|NCT05827926|587665825|FG034|Overall Study|Withdrawal by Subject|0|||
162635672|NCT04102020|587379862|FG001|Overall Study|Continuing in ongoing study|13|||
162635673|NCT04102020|587379863|FG002|Overall Study|Continuing in ongoing study|7|||
162635674|NCT04102020|587379864|FG003|Overall Study|Continuing in ongoing study|26|||
162635675|NCT04102020|587379865|FG004|Overall Study|Continuing in ongoing study|12|||
162635676|NCT04853225|587379866|FG000|Overall Study|Withdrawal by Subject|81|||
162635677|NCT04853225|587379867|FG001|Overall Study|Withdrawal by Subject|4|||
162635678|NCT04853225|587379868|FG002|Overall Study|Withdrawal by Subject|1|||
162635679|NCT04853225|587379866|FG000|Overall Study|Physician Decision|12|||
162635680|NCT04853225|587379867|FG001|Overall Study|Physician Decision|4|||
162635681|NCT04853225|587379868|FG002|Overall Study|Physician Decision|1|||
162635682|NCT04853225|587379866|FG000|Overall Study|Lost to Follow-up|50|||
162635683|NCT04853225|587379867|FG001|Overall Study|Lost to Follow-up|0|||
162635684|NCT04853225|587379868|FG002|Overall Study|Lost to Follow-up|0|||
162635685|NCT04853225|587379866|FG000|Overall Study|Other|102|||
162635686|NCT04853225|587379867|FG001|Overall Study|Other|11|||
162635687|NCT04853225|587379868|FG002|Overall Study|Other|5|||
162635688|NCT04853225|587379866|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
162635689|NCT04853225|587379867|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
162635690|NCT04853225|587379868|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
162635691|NCT04853225|587379866|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
162635692|NCT04853225|587379867|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
162635693|NCT04853225|587379868|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
162635694|NCT03789318|587379869|FG000|Overall Study|Adverse Event|0|||
162635695|NCT03789318|587379870|FG001|Overall Study|Adverse Event|0|||
162635696|NCT03789318|587379871|FG002|Overall Study|Adverse Event|1|||
162635697|NCT03789318|587379872|FG003|Overall Study|Adverse Event|1|||
162635698|NCT03789318|587379873|FG004|Overall Study|Adverse Event|0|||
162635699|NCT03789318|587379869|FG000|Overall Study|Lost to Follow-up|0|||
162635700|NCT03789318|587379870|FG001|Overall Study|Lost to Follow-up|0|||
162635701|NCT03789318|587379871|FG002|Overall Study|Lost to Follow-up|1|||
162635702|NCT03789318|587379872|FG003|Overall Study|Lost to Follow-up|0|||
162635703|NCT03789318|587379873|FG004|Overall Study|Lost to Follow-up|0|||
162635704|NCT03789318|587379869|FG000|Overall Study|Withdrawal by Subject|0|||
162635705|NCT03789318|587379870|FG001|Overall Study|Withdrawal by Subject|0|||
162635706|NCT03789318|587379871|FG002|Overall Study|Withdrawal by Subject|1|||
162635707|NCT03789318|587379872|FG003|Overall Study|Withdrawal by Subject|0|||
162635708|NCT03789318|587379873|FG004|Overall Study|Withdrawal by Subject|0|||
162635709|NCT00733408|587381638|FG000|Overall Study|Adverse Event|4|||
162635710|NCT01134783|587381639|FG000|Overall Study|Pregnancy|16|||
162635711|NCT01134783|587381640|FG001|Overall Study|Pregnancy|8|||
162635712|NCT01134783|587381639|FG000|Overall Study|Withdrawal by Subject|15|||
162635713|NCT01134783|587381640|FG001|Overall Study|Withdrawal by Subject|9|||
162635714|NCT01134783|587381639|FG000|Overall Study|Lost to Follow-up|5|||
162635715|NCT01134783|587381640|FG001|Overall Study|Lost to Follow-up|20|||
162635716|NCT00531232|587381643|FG000|Overall Study|Investigator decision|0|||
162635717|NCT00531232|587381644|FG001|Overall Study|Investigator decision|0|||
162635718|NCT00531232|587381645|FG002|Overall Study|Investigator decision|4|||
162635719|NCT00531232|587381643|FG000|Overall Study|Participants refused further treatment|0|||
162635720|NCT00531232|587381644|FG001|Overall Study|Participants refused further treatment|1|||
162635721|NCT00531232|587381645|FG002|Overall Study|Participants refused further treatment|2|||
162635722|NCT00531232|587381643|FG000|Overall Study|Adverse events (AEs)|1|||
162635723|NCT00531232|587381644|FG001|Overall Study|Adverse events (AEs)|2|||
162635724|NCT00531232|587381645|FG002|Overall Study|Adverse events (AEs)|2|||
162635725|NCT00531232|587381643|FG000|Overall Study|Treatment failure|1|||
162635726|NCT00531232|587381644|FG001|Overall Study|Treatment failure|3|||
162635727|NCT00531232|587381645|FG002|Overall Study|Treatment failure|7|||
162635728|NCT00531232|587381643|FG000|Overall Study|Disease recurrence|0|||
162635729|NCT00531232|587381644|FG001|Overall Study|Disease recurrence|0|||
162635730|NCT00531232|587381645|FG002|Overall Study|Disease recurrence|1|||
162635731|NCT00531232|587381643|FG000|Overall Study|Deceased|2|||
162635732|NCT00531232|587381644|FG001|Overall Study|Deceased|2|||
162635733|NCT00531232|587381645|FG002|Overall Study|Deceased|2|||
162635734|NCT00531232|587381643|FG000|Overall Study|Withdrawal by Subject|0|||
162635735|NCT00531232|587381644|FG001|Overall Study|Withdrawal by Subject|1|||
162635736|NCT00531232|587381645|FG002|Overall Study|Withdrawal by Subject|2|||
162635737|NCT00531232|587381643|FG000|Overall Study|Other|0|||
162635738|NCT00531232|587381644|FG001|Overall Study|Other|0|||
162635739|NCT00531232|587381645|FG002|Overall Study|Other|5|||
162635740|NCT00463346|587381646|FG000|Overall Study|Withdrawal by Subject|3|||
162635741|NCT00463346|587381647|FG001|Overall Study|Withdrawal by Subject|3|||
162635742|NCT03641651|587381648|FG000|Overall Study|organizational issues at one study site|1|||
162635743|NCT01991067|587381650|FG000|Overall Study|Lost to Follow-up|6|||
162635744|NCT01991067|587381651|FG001|Overall Study|Lost to Follow-up|5|||
162635745|NCT00224055|587381653|FG000|Overall Study|Adverse Event|9|||
162635746|NCT00224055|587381654|FG001|Overall Study|Adverse Event|3|||
162635747|NCT00224055|587381653|FG000|Overall Study|Lost to Follow-up|1|||
162635748|NCT00224055|587381654|FG001|Overall Study|Lost to Follow-up|2|||
162635749|NCT00224055|587381653|FG000|Overall Study|Protocol Violation|1|||
162635750|NCT00224055|587381654|FG001|Overall Study|Protocol Violation|1|||
162635751|NCT00224055|587381653|FG000|Overall Study|Inclusion Violation|3|||
162986055|NCT04732221|588654742|FG005|Extension Period|Pregnancy|0|||
162986056|NCT04732221|588654743|FG006|Extension Period|Pregnancy|0|||
162986057|NCT04732221|588654737|FG000|Extension Period|Sponsors Decision|0|||
162986058|NCT04732221|588654738|FG001|Extension Period|Sponsors Decision|0|||
162986059|NCT04732221|588654739|FG002|Extension Period|Sponsors Decision|0|||
162986060|NCT04732221|588654740|FG003|Extension Period|Sponsors Decision|0|||
162986061|NCT04732221|588654741|FG004|Extension Period|Sponsors Decision|41|||
162986062|NCT04732221|588654742|FG005|Extension Period|Sponsors Decision|40|||
162986063|NCT04732221|588654743|FG006|Extension Period|Sponsors Decision|40|||
162986064|NCT04732221|588654737|FG000|Extension Period|Withdrawal by Subject|0|||
162986065|NCT04732221|588654738|FG001|Extension Period|Withdrawal by Subject|0|||
162986066|NCT04732221|588654739|FG002|Extension Period|Withdrawal by Subject|0|||
162986067|NCT04732221|588654740|FG003|Extension Period|Withdrawal by Subject|0|||
162986068|NCT04732221|588654741|FG004|Extension Period|Withdrawal by Subject|1|||
162986069|NCT04732221|588654742|FG005|Extension Period|Withdrawal by Subject|5|||
162986070|NCT04732221|588654743|FG006|Extension Period|Withdrawal by Subject|2|||
162986071|NCT03611543|588654744|FG000|Overall Study|Withdrawal by Subject|4|||
162986072|NCT03611543|588654745|FG001|Overall Study|Withdrawal by Subject|4|||
162986073|NCT03611543|588654744|FG000|Overall Study|Physician Decision|1|||
162986074|NCT03611543|588654745|FG001|Overall Study|Physician Decision|1|||
162986075|NCT03611543|588654744|FG000|Overall Study|Protocol Violation|2|||
162986076|NCT03611543|588654745|FG001|Overall Study|Protocol Violation|2|||
162986077|NCT03611543|588654744|FG000|Overall Study|Device failure|2|||
162986078|NCT03611543|588654745|FG001|Overall Study|Device failure|2|||
162986079|NCT03611543|588654744|FG000|Overall Study|Missing information|5|||
162986080|NCT03611543|588654745|FG001|Overall Study|Missing information|5|||
162986081|NCT06077487|588654746|FG000|Overall Study|Withdrawal by Subject|0|||
162986082|NCT06077487|588654747|FG001|Overall Study|Withdrawal by Subject|1|||
162986083|NCT05101486|588654748|FG000|Overall Study|Death|1|||
162986084|NCT05101486|588654749|FG001|Overall Study|Death|0|||
162986085|NCT05101486|588654750|FG002|Overall Study|Death|1|||
162986086|NCT05101486|588654748|FG000|Overall Study|Lost to Follow-up|12|||
162986087|NCT05101486|588654749|FG001|Overall Study|Lost to Follow-up|8|||
162986088|NCT05101486|588654750|FG002|Overall Study|Lost to Follow-up|17|||
162986089|NCT05101486|588654748|FG000|Overall Study|Physician Decision|1|||
162986090|NCT05101486|588654749|FG001|Overall Study|Physician Decision|0|||
162986091|NCT05101486|588654750|FG002|Overall Study|Physician Decision|0|||
162986092|NCT05101486|588654748|FG000|Overall Study|Protocol Violation|0|||
162986093|NCT05101486|588654749|FG001|Overall Study|Protocol Violation|0|||
162986094|NCT05101486|588654750|FG002|Overall Study|Protocol Violation|1|||
162986095|NCT05101486|588654748|FG000|Overall Study|Withdrawal by Subject|5|||
162986096|NCT05101486|588654749|FG001|Overall Study|Withdrawal by Subject|2|||
162986097|NCT05101486|588654750|FG002|Overall Study|Withdrawal by Subject|4|||
162986098|NCT05101486|588654748|FG000|Overall Study|Randomized but not vaccinated|1|||
162986099|NCT05101486|588654749|FG001|Overall Study|Randomized but not vaccinated|1|||
162986100|NCT05101486|588654750|FG002|Overall Study|Randomized but not vaccinated|1|||
162986101|NCT03047473|588654758|FG000|Overall Study|Lost to Follow-up|2|||
162986102|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Death|89|||
162986103|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Death|193|||
162986104|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Death|198|||
162986105|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
162986106|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
162986107|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
162986108|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
162986109|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
162986110|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
162986111|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
162986112|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
162986113|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
162986114|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
162986115|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
162986116|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
162986117|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
162986118|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
162986119|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
162986120|NCT02031458|588654759|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
162986121|NCT02031458|588654760|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
163154697|NCT03938259|589281381|FG001|Overall Study|unable to establish baseline for ventilation|1|||
162986122|NCT02031458|588654761|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
162986123|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Death|36|||
162986124|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Death|87|||
162986125|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Death|100|||
162986126|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
162986127|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
162986128|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
162986129|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Physician Decision|0|||
162986130|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Physician Decision|1|||
162986131|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Physician Decision|0|||
162986132|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
162986133|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
162986134|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
162986135|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
162986136|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
162986137|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
162986138|NCT02031458|588654759|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
162986139|NCT02031458|588654760|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
162986140|NCT02031458|588654761|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
162986141|NCT02031458|588654759|FG000|Baseline to May 8, 2015|On Treatment|43|||
162986142|NCT02031458|588654760|FG001|Baseline to May 8, 2015|On Treatment|81|||
162986143|NCT02031458|588654761|FG002|Baseline to May 8, 2015|On Treatment|73|||
162986144|NCT02031458|588654759|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
162986145|NCT02031458|588654760|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
162986146|NCT02031458|588654761|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
162986147|NCT04305587|588654762|FG000|Overall Study|Withdrawal by Subject|0|||
162986148|NCT04305587|588654763|FG001|Overall Study|Withdrawal by Subject|0|||
162986149|NCT04305587|588654764|FG002|Overall Study|Withdrawal by Subject|0|||
162986150|NCT04305587|588654765|FG003|Overall Study|Withdrawal by Subject|1|||
162986151|NCT04305587|588654766|FG004|Overall Study|Withdrawal by Subject|0|||
162986152|NCT04305587|588654767|FG005|Overall Study|Withdrawal by Subject|0|||
162986153|NCT04305587|588654768|FG006|Overall Study|Withdrawal by Subject|0|||
162635752|NCT00224055|587381654|FG001|Overall Study|Inclusion Violation|6|||
162635753|NCT00224055|587381653|FG000|Overall Study|Withdrawal by Subject|0|||
162635754|NCT00224055|587381654|FG001|Overall Study|Withdrawal by Subject|2|||
162635755|NCT00224055|587381653|FG000|Overall Study|Other|1|||
162635756|NCT00224055|587381654|FG001|Overall Study|Other|0|||
162635757|NCT00127712|587381655|FG000|Overall Study|Adverse Event|3|||
162635758|NCT00127712|587381656|FG001|Overall Study|Adverse Event|0|||
162635759|NCT00127712|587381655|FG000|Overall Study|Lack of GI access to continue|2|||
162635760|NCT00127712|587381656|FG001|Overall Study|Lack of GI access to continue|0|||
162635761|NCT03055260|587381657|FG000|Overall Study|Withdrawal by Subject|1|||
162635762|NCT03055260|587381658|FG001|Overall Study|Withdrawal by Subject|0|||
162635763|NCT00592839|587381659|FG000|Overall Study|Withdrawal by Subject|1|||
162635764|NCT00592839|587381660|FG001|Overall Study|Withdrawal by Subject|1|||
162635765|NCT00592839|587381661|FG002|Overall Study|Withdrawal by Subject|3|||
162635766|NCT00592839|587381659|FG000|Overall Study|Protocol Violation|1|||
162986154|NCT04305587|588654769|FG007|Overall Study|Withdrawal by Subject|0|||
162986155|NCT04305587|588654770|FG008|Overall Study|Withdrawal by Subject|0|||
162986156|NCT02492880|588654771|FG000|Overall Study|Lost to Follow-up|1|||
162635767|NCT00592839|587381660|FG001|Overall Study|Protocol Violation|1|||
162635768|NCT00592839|587381661|FG002|Overall Study|Protocol Violation|2|||
162635769|NCT00592839|587381659|FG000|Overall Study|Adverse Event|0|||
162635770|NCT00592839|587381660|FG001|Overall Study|Adverse Event|1|||
162635771|NCT00592839|587381661|FG002|Overall Study|Adverse Event|0|||
162986157|NCT02492880|588654771|FG000|Overall Study|Protocol Violation|1|||
162986158|NCT00292188|588654775|FG000|Single-Blind|Adverse Event|14|||
162986159|NCT00292188|588654776|FG001|Single-Blind|Adverse Event|0|||
162986160|NCT00292188|588654777|FG002|Single-Blind|Adverse Event|0|||
162986161|NCT00292188|588654775|FG000|Single-Blind|Lack of Efficacy|2|||
162986162|NCT00292188|588654776|FG001|Single-Blind|Lack of Efficacy|0|||
162986163|NCT00292188|588654777|FG002|Single-Blind|Lack of Efficacy|0|||
162986164|NCT00292188|588654775|FG000|Single-Blind|Laboratory Abnormality|5|||
162986165|NCT00292188|588654776|FG001|Single-Blind|Laboratory Abnormality|0|||
162986166|NCT00292188|588654777|FG002|Single-Blind|Laboratory Abnormality|0|||
162986167|NCT00292188|588654775|FG000|Single-Blind|Lost to Follow-up|3|||
162986168|NCT00292188|588654776|FG001|Single-Blind|Lost to Follow-up|0|||
162635772|NCT00592839|587381659|FG000|Overall Study|Lost to Follow-up|0|||
162635773|NCT00592839|587381660|FG001|Overall Study|Lost to Follow-up|1|||
162635774|NCT00592839|587381661|FG002|Overall Study|Lost to Follow-up|1|||
162635775|NCT00799487|587381663|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
162986169|NCT00292188|588654777|FG002|Single-Blind|Lost to Follow-up|0|||
162986170|NCT00292188|588654775|FG000|Single-Blind|Other|77|||
162986171|NCT00292188|588654776|FG001|Single-Blind|Other|0|||
162986172|NCT00292188|588654777|FG002|Single-Blind|Other|0|||
162986173|NCT00292188|588654775|FG000|Single-Blind|Withdrawal by Subject|12|||
162986174|NCT00292188|588654776|FG001|Single-Blind|Withdrawal by Subject|0|||
162986175|NCT00292188|588654777|FG002|Single-Blind|Withdrawal by Subject|0|||
162986176|NCT00292188|588654775|FG000|Single-Blind|Did not receive treatment|1|||
162986177|NCT00292188|588654776|FG001|Single-Blind|Did not receive treatment|0|||
162635776|NCT00799487|587381664|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
162635777|NCT00799487|587381665|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
162635778|NCT00799487|587381663|FG000|Dose Adjustment Period|Adverse Event|2|||
162986178|NCT00292188|588654777|FG002|Single-Blind|Did not receive treatment|0|||
162986179|NCT00292188|588654775|FG000|Double-Blind|Adverse Event|0|||
162986180|NCT00292188|588654776|FG001|Double-Blind|Adverse Event|25|||
162986181|NCT00292188|588654777|FG002|Double-Blind|Adverse Event|9|||
162986182|NCT00292188|588654775|FG000|Double-Blind|Lack of Efficacy|0|||
162986183|NCT00292188|588654776|FG001|Double-Blind|Lack of Efficacy|2|||
162986184|NCT00292188|588654777|FG002|Double-Blind|Lack of Efficacy|12|||
162986185|NCT00292188|588654775|FG000|Double-Blind|Lost to Follow-up|0|||
162986186|NCT00292188|588654776|FG001|Double-Blind|Lost to Follow-up|1|||
162986187|NCT00292188|588654777|FG002|Double-Blind|Lost to Follow-up|0|||
162986188|NCT00292188|588654775|FG000|Double-Blind|Other|0|||
162986189|NCT00292188|588654776|FG001|Double-Blind|Other|3|||
162986190|NCT00292188|588654777|FG002|Double-Blind|Other|4|||
162986191|NCT00292188|588654775|FG000|Double-Blind|Withdrawal by Subject|0|||
162986192|NCT00292188|588654776|FG001|Double-Blind|Withdrawal by Subject|0|||
162986193|NCT00292188|588654777|FG002|Double-Blind|Withdrawal by Subject|3|||
162986194|NCT00292188|588654775|FG000|Double-Blind|Laboratory Abnormality|0|||
162986195|NCT00292188|588654776|FG001|Double-Blind|Laboratory Abnormality|0|||
162986196|NCT00292188|588654777|FG002|Double-Blind|Laboratory Abnormality|1|||
162986197|NCT00824616|588654778|FG000|Overall Study|Adverse Event|2|||
162986198|NCT00824616|588654779|FG001|Overall Study|Adverse Event|1|||
162986199|NCT00824616|588654778|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
162986200|NCT00824616|588654779|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
162635779|NCT00799487|587381664|FG001|Dose Adjustment Period|Adverse Event|0|||
162635780|NCT00799487|587381665|FG002|Dose Adjustment Period|Adverse Event|0|||
162635781|NCT00799487|587381663|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
162635782|NCT00799487|587381664|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
162635783|NCT00799487|587381665|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
162986201|NCT00824616|588654778|FG000|Overall Study|Hyperglycemia|1|||
162986202|NCT00824616|588654779|FG001|Overall Study|Hyperglycemia|1|||
162986203|NCT00824616|588654778|FG000|Overall Study|Lack of Efficacy|2|||
162986204|NCT00824616|588654779|FG001|Overall Study|Lack of Efficacy|1|||
162986205|NCT00824616|588654778|FG000|Overall Study|Lost to Follow-up|0|||
162986206|NCT00824616|588654779|FG001|Overall Study|Lost to Follow-up|1|||
162986207|NCT00824616|588654778|FG000|Overall Study|Withdrawal by Subject|1|||
162986208|NCT00824616|588654779|FG001|Overall Study|Withdrawal by Subject|1|||
162986209|NCT01200992|588654780|FG000|Overall Study|Study terminated early|35|||
162986210|NCT01200992|588654781|FG001|Overall Study|Study terminated early|41|||
162635784|NCT00799487|587381663|FG000|Dose Adjustment Period|Investigator Discretion|2|||
162715034|NCT05827926|587665826|FG035|Overall Study|Withdrawal by Subject|0|||
162715035|NCT05827926|587665827|FG036|Overall Study|Withdrawal by Subject|1|||
162986211|NCT01200992|588654780|FG000|Overall Study|Randomized but not treated|2|||
162986212|NCT01200992|588654781|FG001|Overall Study|Randomized but not treated|0|||
162986213|NCT00721630|588654782|FG000|Overall Study|Participant found to be ineligible|1|||
162635785|NCT00799487|587381664|FG001|Dose Adjustment Period|Investigator Discretion|0|||
162715036|NCT05827926|587665791|FG000|Overall Study|Other Than Specified|0|||
162635786|NCT00799487|587381665|FG002|Dose Adjustment Period|Investigator Discretion|0|||
162635787|NCT00799487|587381663|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
162715037|NCT05827926|587665792|FG001|Overall Study|Other Than Specified|0|||
162635788|NCT00799487|587381664|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
162635789|NCT00799487|587381665|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
162635790|NCT00799487|587381663|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
162635791|NCT00799487|587381664|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
162635792|NCT00799487|587381665|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
162635793|NCT00799487|587381663|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
162635794|NCT00799487|587381664|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
162635795|NCT00799487|587381665|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
162635796|NCT00799487|587381663|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
162635797|NCT00799487|587381664|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
162715038|NCT05827926|587665793|FG002|Overall Study|Other Than Specified|0|||
162715039|NCT05827926|587665794|FG003|Overall Study|Other Than Specified|1|||
162715040|NCT05827926|587665795|FG004|Overall Study|Other Than Specified|0|||
162715041|NCT05827926|587665796|FG005|Overall Study|Other Than Specified|0|||
162715042|NCT05827926|587665797|FG006|Overall Study|Other Than Specified|1|||
162715043|NCT05827926|587665798|FG007|Overall Study|Other Than Specified|0|||
162715044|NCT05827926|587665799|FG008|Overall Study|Other Than Specified|0|||
162986214|NCT04711902|588654786|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986215|NCT04711902|588654787|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986216|NCT04711902|588654788|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
162635798|NCT00799487|587381665|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
162715045|NCT05827926|587665800|FG009|Overall Study|Other Than Specified|0|||
162986217|NCT04711902|588654789|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986218|NCT04711902|588654790|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986219|NCT04711902|588654791|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
162986220|NCT03786718|588654792|FG000|Overall Study|Lost to Follow-up|3|||
162715046|NCT05827926|587665801|FG010|Overall Study|Other Than Specified|0|||
162715047|NCT05827926|587665802|FG011|Overall Study|Other Than Specified|0|||
162715048|NCT05827926|587665803|FG012|Overall Study|Other Than Specified|0|||
162715049|NCT05827926|587665804|FG013|Overall Study|Other Than Specified|1|||
162715050|NCT05827926|587665805|FG014|Overall Study|Other Than Specified|0|||
162715051|NCT05827926|587665806|FG015|Overall Study|Other Than Specified|1|||
162715052|NCT05827926|587665807|FG016|Overall Study|Other Than Specified|0|||
162715053|NCT05827926|587665808|FG017|Overall Study|Other Than Specified|0|||
162715054|NCT05827926|587665809|FG018|Overall Study|Other Than Specified|0|||
162715055|NCT05827926|587665810|FG019|Overall Study|Other Than Specified|0|||
162715056|NCT05827926|587665811|FG020|Overall Study|Other Than Specified|0|||
162715057|NCT05827926|587665812|FG021|Overall Study|Other Than Specified|1|||
162986221|NCT03786718|588654792|FG000|Overall Study|Withdrawal by Subject|1|||
162986222|NCT03786718|588654792|FG000|Overall Study|Did not use the intervention|2|||
162986223|NCT03786718|588654792|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
162986224|NCT01398514|588654797|FG000|Overall Study|Adverse Event|1|||
162986225|NCT01398514|588654798|FG001|Overall Study|Adverse Event|0|||
162986226|NCT01398514|588654797|FG000|Overall Study|Non-compliance with study procedures|2|||
162715058|NCT05827926|587665813|FG022|Overall Study|Other Than Specified|1|||
162715059|NCT05827926|587665814|FG023|Overall Study|Other Than Specified|0|||
162715060|NCT05827926|587665815|FG024|Overall Study|Other Than Specified|0|||
162715061|NCT05827926|587665816|FG025|Overall Study|Other Than Specified|1|||
162715062|NCT05827926|587665817|FG026|Overall Study|Other Than Specified|0|||
162715063|NCT05827926|587665818|FG027|Overall Study|Other Than Specified|0|||
162715064|NCT05827926|587665819|FG028|Overall Study|Other Than Specified|0|||
162715065|NCT05827926|587665820|FG029|Overall Study|Other Than Specified|0|||
162715066|NCT05827926|587665821|FG030|Overall Study|Other Than Specified|0|||
162715067|NCT05827926|587665822|FG031|Overall Study|Other Than Specified|1|||
162986227|NCT01398514|588654798|FG001|Overall Study|Non-compliance with study procedures|0|||
162986228|NCT01398514|588654797|FG000|Overall Study|Physiologic non-responsiveness|1|||
162986229|NCT01398514|588654798|FG001|Overall Study|Physiologic non-responsiveness|3|||
162986230|NCT01398514|588654797|FG000|Overall Study|Failure to show a conditioned response|4|||
162986231|NCT01398514|588654798|FG001|Overall Study|Failure to show a conditioned response|3|||
162986232|NCT00123474|588654800|FG000|Randomized to Treatment|Randomized, never treated|1|||
162986233|NCT00123474|588654801|FG001|Randomized to Treatment|Randomized, never treated|4|||
162986234|NCT00123474|588654802|FG002|Randomized to Treatment|Randomized, never treated|2|||
162986235|NCT00123474|588654803|FG003|Randomized to Treatment|Randomized, never treated|1|||
162986236|NCT00123474|588654800|FG000|As Treated at Study Closure|not reported when site closed|1|||
162986237|NCT00123474|588654801|FG001|As Treated at Study Closure|not reported when site closed|0|||
162986238|NCT00123474|588654802|FG002|As Treated at Study Closure|not reported when site closed|1|||
162986239|NCT00123474|588654803|FG003|As Treated at Study Closure|not reported when site closed|0|||
162986240|NCT00123474|588654800|FG000|As Treated at Study Closure|Adverse Event|10|||
162986241|NCT00123474|588654801|FG001|As Treated at Study Closure|Adverse Event|4|||
162986242|NCT00123474|588654802|FG002|As Treated at Study Closure|Adverse Event|10|||
162986243|NCT00123474|588654803|FG003|As Treated at Study Closure|Adverse Event|8|||
162986244|NCT00123474|588654800|FG000|As Treated at Study Closure|Disease Progression|35|||
162986245|NCT00123474|588654801|FG001|As Treated at Study Closure|Disease Progression|42|||
162986246|NCT00123474|588654802|FG002|As Treated at Study Closure|Disease Progression|29|||
162986247|NCT00123474|588654803|FG003|As Treated at Study Closure|Disease Progression|27|||
162986248|NCT00123474|588654800|FG000|As Treated at Study Closure|Investigator Request|12|||
162986249|NCT00123474|588654801|FG001|As Treated at Study Closure|Investigator Request|6|||
162986250|NCT00123474|588654802|FG002|As Treated at Study Closure|Investigator Request|7|||
162986251|NCT00123474|588654803|FG003|As Treated at Study Closure|Investigator Request|5|||
162986252|NCT00123474|588654800|FG000|As Treated at Study Closure|non-specified|54|||
162986253|NCT00123474|588654801|FG001|As Treated at Study Closure|non-specified|47|||
162986254|NCT00123474|588654802|FG002|As Treated at Study Closure|non-specified|57|||
162715068|NCT05827926|587665823|FG032|Overall Study|Other Than Specified|0|||
162715069|NCT05827926|587665824|FG033|Overall Study|Other Than Specified|0|||
162715070|NCT05827926|587665825|FG034|Overall Study|Other Than Specified|0|||
162715071|NCT05827926|587665826|FG035|Overall Study|Other Than Specified|0|||
162715072|NCT05827926|587665827|FG036|Overall Study|Other Than Specified|0|||
162715073|NCT05827926|587665791|FG000|Overall Study|Physician Decision|0|||
162715074|NCT05827926|587665792|FG001|Overall Study|Physician Decision|0|||
162715075|NCT05827926|587665793|FG002|Overall Study|Physician Decision|0|||
162986255|NCT00123474|588654803|FG003|As Treated at Study Closure|non-specified|60|||
162715076|NCT05827926|587665794|FG003|Overall Study|Physician Decision|0|||
162715077|NCT05827926|587665795|FG004|Overall Study|Physician Decision|0|||
162715078|NCT05827926|587665796|FG005|Overall Study|Physician Decision|0|||
162986256|NCT00123474|588654800|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
162986257|NCT00123474|588654801|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
162986258|NCT00123474|588654802|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
162986259|NCT00123474|588654803|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
162986260|NCT00123474|588654800|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
162986261|NCT00123474|588654801|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
162986262|NCT00123474|588654802|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
162986263|NCT00123474|588654803|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
162986264|NCT01059344|588654804|FG000|Overall Study|Adverse Event|12|||
162986265|NCT01059344|588654805|FG001|Overall Study|Adverse Event|30|||
162986266|NCT01059344|588654804|FG000|Overall Study|Withdrawal by Subject|6|||
162986267|NCT01059344|588654805|FG001|Overall Study|Withdrawal by Subject|9|||
162986268|NCT01059344|588654804|FG000|Overall Study|Lost to Follow-up|1|||
162986269|NCT01059344|588654805|FG001|Overall Study|Lost to Follow-up|1|||
162986270|NCT01059344|588654804|FG000|Overall Study|Other|3|||
162986271|NCT01059344|588654805|FG001|Overall Study|Other|6|||
162986272|NCT01085201|588654810|FG000|Overall Study|Scheduling conflict|1|||
162986273|NCT01085201|588654811|FG001|Overall Study|Scheduling conflict|0|||
162986274|NCT01085201|588654812|FG002|Overall Study|Scheduling conflict|1|||
162986275|NCT01085201|588654813|FG003|Overall Study|Scheduling conflict|0|||
162986276|NCT01085201|588654814|FG004|Overall Study|Scheduling conflict|0|||
162986277|NCT01085201|588654810|FG000|Overall Study|Unknown- no study drug|2|||
162986278|NCT01085201|588654811|FG001|Overall Study|Unknown- no study drug|0|||
162986279|NCT01085201|588654812|FG002|Overall Study|Unknown- no study drug|0|||
162986280|NCT01085201|588654813|FG003|Overall Study|Unknown- no study drug|0|||
162986281|NCT01085201|588654814|FG004|Overall Study|Unknown- no study drug|0|||
162986282|NCT01085201|588654810|FG000|Overall Study|Fond ineligible after consent|0|||
162986283|NCT01085201|588654811|FG001|Overall Study|Fond ineligible after consent|1|||
162986284|NCT01085201|588654812|FG002|Overall Study|Fond ineligible after consent|1|||
162986285|NCT01085201|588654813|FG003|Overall Study|Fond ineligible after consent|0|||
162986286|NCT01085201|588654814|FG004|Overall Study|Fond ineligible after consent|0|||
162986287|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
162986288|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
162986289|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986290|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986291|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
162986292|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986293|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986294|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986295|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
162986296|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986297|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
162986298|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986299|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986300|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986301|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986302|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986303|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986304|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
162986305|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986306|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
162986307|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986308|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
162986309|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986310|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986311|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986312|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986313|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986314|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986315|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
162986316|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986317|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
162986318|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986319|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986320|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986321|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162986322|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
162635799|NCT00799487|587381663|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
162986323|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
162986324|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
162986325|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
162715079|NCT05827926|587665797|FG006|Overall Study|Physician Decision|0|||
162986326|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162635800|NCT00799487|587381664|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
162635801|NCT00799487|587381665|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
162635802|NCT00799487|587381663|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
162635803|NCT00799487|587381664|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
162986327|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
162986328|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986329|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986330|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986331|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986332|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986333|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
162986334|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986335|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986336|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986337|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986338|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986339|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986340|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
162986341|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986342|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986343|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986344|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
162986345|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986346|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986347|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986348|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986349|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986350|NCT03893565|588654815|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986351|NCT03893565|588654816|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
162986352|NCT03893565|588654817|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
162986353|NCT03893565|588654818|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
162986354|NCT03893565|588654819|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986355|NCT03893565|588654820|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986356|NCT03893565|588654821|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986357|NCT03893565|588654822|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986358|NCT03893565|588654823|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
162986359|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
162986360|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
162986361|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
162986362|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
162986363|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
162986364|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
162986365|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
162986366|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
162986367|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
162635804|NCT00799487|587381665|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
162635805|NCT00799487|587381663|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
162635806|NCT00799487|587381664|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
162635807|NCT00799487|587381665|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
162635808|NCT00799487|587381663|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
162986368|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986369|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986370|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986371|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986372|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986373|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986374|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
162986375|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986376|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
162986377|NCT03893565|588654815|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986378|NCT03893565|588654816|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986379|NCT03893565|588654817|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986380|NCT03893565|588654818|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986381|NCT03893565|588654819|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986382|NCT03893565|588654820|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
162986383|NCT03893565|588654821|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
162986384|NCT03893565|588654822|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986385|NCT03893565|588654823|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
162986386|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
162986387|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
162986388|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
162986389|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
162986390|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
162986391|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
162986392|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
162986393|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
162986394|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
162986395|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986396|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986397|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986398|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986399|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986400|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986401|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986402|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
162986403|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
162986404|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986405|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986406|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986407|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986408|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986409|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986410|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986411|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
162986412|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
162986413|NCT03893565|588654815|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986414|NCT03893565|588654816|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986415|NCT03893565|588654817|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986416|NCT03893565|588654818|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986417|NCT03893565|588654819|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986418|NCT03893565|588654820|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986419|NCT03893565|588654821|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986420|NCT03893565|588654822|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
162986421|NCT03893565|588654823|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
162986422|NCT03893565|588654815|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986423|NCT03893565|588654816|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986424|NCT03893565|588654817|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986425|NCT03893565|588654818|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162635809|NCT00799487|587381664|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
162986426|NCT03893565|588654819|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986427|NCT03893565|588654820|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986428|NCT03893565|588654821|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986429|NCT03893565|588654822|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
162986430|NCT03893565|588654823|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
162986431|NCT03870477|588654824|FG000|Overall Study|Early Study Termination|1|||
162986432|NCT02256436|588654831|FG000|Overall Study|Adverse Event|9|||
162986433|NCT02256436|588654832|FG001|Overall Study|Adverse Event|14|||
162986434|NCT02256436|588654831|FG000|Overall Study|Death|216|||
162986435|NCT02256436|588654832|FG001|Overall Study|Death|208|||
162986436|NCT02256436|588654831|FG000|Overall Study|Lost to Follow-up|1|||
162986437|NCT02256436|588654832|FG001|Overall Study|Lost to Follow-up|2|||
162986438|NCT02256436|588654831|FG000|Overall Study|Physician Decision|1|||
162986439|NCT02256436|588654832|FG001|Overall Study|Physician Decision|0|||
162986440|NCT02256436|588654831|FG000|Overall Study|Protocol Violation|0|||
162986441|NCT02256436|588654832|FG001|Overall Study|Protocol Violation|1|||
162986442|NCT02256436|588654831|FG000|Overall Study|Withdrawal by Subject|26|||
162986443|NCT02256436|588654832|FG001|Overall Study|Withdrawal by Subject|10|||
162986444|NCT02256436|588654831|FG000|Overall Study|Transferred to Extension Study|11|||
162986445|NCT02256436|588654832|FG001|Overall Study|Transferred to Extension Study|23|||
162986446|NCT02256436|588654831|FG000|Overall Study|Did Not Continue on Extension Study|8|||
162986447|NCT02256436|588654832|FG001|Overall Study|Did Not Continue on Extension Study|12|||
162986448|NCT05961215|588654833|FG000|Overall Study|Withdrawal by Subject|1|||
162986449|NCT01394952|588654834|FG000|Overall Study|Lost to Follow-up|0|||
162986450|NCT01394952|588654835|FG001|Overall Study|Lost to Follow-up|5|||
162986451|NCT01394952|588654834|FG000|Overall Study|Withdrawal by Subject|10|||
162986452|NCT01394952|588654835|FG001|Overall Study|Withdrawal by Subject|5|||
162986453|NCT01394952|588654834|FG000|Overall Study|Physician Decision|2|||
162986454|NCT01394952|588654835|FG001|Overall Study|Physician Decision|0|||
162986455|NCT01394952|588654834|FG000|Overall Study|Sponsor Decision|5|||
162986456|NCT01394952|588654835|FG001|Overall Study|Sponsor Decision|7|||
162986457|NCT01986010|588654836|FG000|Overall Study|Adverse Event|0|||
162986458|NCT01986010|588654837|FG001|Overall Study|Adverse Event|1|||
162986459|NCT01986010|588654838|FG002|Overall Study|Adverse Event|0|||
162986460|NCT01986010|588654839|FG003|Overall Study|Adverse Event|0|||
162986461|NCT01986010|588654840|FG004|Overall Study|Adverse Event|0|||
162986462|NCT01986010|588654841|FG005|Overall Study|Adverse Event|0|||
162986463|NCT01986010|588654842|FG006|Overall Study|Adverse Event|0|||
162986464|NCT01986010|588654843|FG007|Overall Study|Adverse Event|0|||
162986465|NCT01986010|588654844|FG008|Overall Study|Adverse Event|0|||
162986466|NCT01986010|588654845|FG009|Overall Study|Adverse Event|0|||
162986467|NCT01986010|588654846|FG010|Overall Study|Adverse Event|0|||
162986468|NCT01986010|588654847|FG011|Overall Study|Adverse Event|0|||
162986469|NCT01986010|588654848|FG012|Overall Study|Adverse Event|0|||
162986470|NCT01986010|588654849|FG013|Overall Study|Adverse Event|0|||
162986471|NCT01986010|588654850|FG014|Overall Study|Adverse Event|0|||
162986472|NCT01986010|588654851|FG015|Overall Study|Adverse Event|1|||
162986473|NCT01986010|588654852|FG016|Overall Study|Adverse Event|0|||
162986474|NCT01986010|588654836|FG000|Overall Study|Lost to Follow-up|2|||
162986475|NCT01986010|588654837|FG001|Overall Study|Lost to Follow-up|1|||
162635810|NCT00799487|587381665|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
162635811|NCT01463878|587381666|FG000|Overall Study|no longer met criteria for tube feed|2|||
162635812|NCT01463878|587381667|FG001|Overall Study|no longer met criteria for tube feed|2|||
162635813|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Death|3|||
162635814|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Death|3|||
162635815|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Death|0|||
162986476|NCT01986010|588654838|FG002|Overall Study|Lost to Follow-up|2|||
162986477|NCT01986010|588654839|FG003|Overall Study|Lost to Follow-up|2|||
162986478|NCT01986010|588654840|FG004|Overall Study|Lost to Follow-up|2|||
162986479|NCT01986010|588654841|FG005|Overall Study|Lost to Follow-up|2|||
162986480|NCT01986010|588654842|FG006|Overall Study|Lost to Follow-up|0|||
162986481|NCT01986010|588654843|FG007|Overall Study|Lost to Follow-up|0|||
162986482|NCT01986010|588654844|FG008|Overall Study|Lost to Follow-up|4|||
162986483|NCT01986010|588654845|FG009|Overall Study|Lost to Follow-up|2|||
162986484|NCT01986010|588654846|FG010|Overall Study|Lost to Follow-up|0|||
162986485|NCT01986010|588654847|FG011|Overall Study|Lost to Follow-up|1|||
162986486|NCT01986010|588654848|FG012|Overall Study|Lost to Follow-up|1|||
162986487|NCT01986010|588654849|FG013|Overall Study|Lost to Follow-up|1|||
162986488|NCT01986010|588654850|FG014|Overall Study|Lost to Follow-up|2|||
162986489|NCT01986010|588654851|FG015|Overall Study|Lost to Follow-up|0|||
162986490|NCT01986010|588654852|FG016|Overall Study|Lost to Follow-up|0|||
162986491|NCT01986010|588654836|FG000|Overall Study|Physician Decision|0|||
162986492|NCT01986010|588654837|FG001|Overall Study|Physician Decision|0|||
162986493|NCT01986010|588654838|FG002|Overall Study|Physician Decision|0|||
162986494|NCT01986010|588654839|FG003|Overall Study|Physician Decision|0|||
162986495|NCT01986010|588654840|FG004|Overall Study|Physician Decision|0|||
162986496|NCT01986010|588654841|FG005|Overall Study|Physician Decision|0|||
162986497|NCT01986010|588654842|FG006|Overall Study|Physician Decision|0|||
162986498|NCT01986010|588654843|FG007|Overall Study|Physician Decision|0|||
162986499|NCT01986010|588654844|FG008|Overall Study|Physician Decision|0|||
162986500|NCT01986010|588654845|FG009|Overall Study|Physician Decision|0|||
162986501|NCT01986010|588654846|FG010|Overall Study|Physician Decision|0|||
162986502|NCT01986010|588654847|FG011|Overall Study|Physician Decision|0|||
162986503|NCT01986010|588654848|FG012|Overall Study|Physician Decision|0|||
162986504|NCT01986010|588654849|FG013|Overall Study|Physician Decision|0|||
162986505|NCT01986010|588654850|FG014|Overall Study|Physician Decision|1|||
162986506|NCT01986010|588654851|FG015|Overall Study|Physician Decision|0|||
162986507|NCT01986010|588654852|FG016|Overall Study|Physician Decision|0|||
162986508|NCT01986010|588654836|FG000|Overall Study|Withdrawal by Subject|2|||
162986509|NCT01986010|588654837|FG001|Overall Study|Withdrawal by Subject|2|||
162986510|NCT01986010|588654838|FG002|Overall Study|Withdrawal by Subject|3|||
162986511|NCT01986010|588654839|FG003|Overall Study|Withdrawal by Subject|0|||
162986512|NCT01986010|588654840|FG004|Overall Study|Withdrawal by Subject|2|||
162986513|NCT01986010|588654841|FG005|Overall Study|Withdrawal by Subject|4|||
162986514|NCT01986010|588654842|FG006|Overall Study|Withdrawal by Subject|0|||
162986515|NCT01986010|588654843|FG007|Overall Study|Withdrawal by Subject|0|||
162986516|NCT01986010|588654844|FG008|Overall Study|Withdrawal by Subject|0|||
162986517|NCT01986010|588654845|FG009|Overall Study|Withdrawal by Subject|0|||
162986518|NCT01986010|588654846|FG010|Overall Study|Withdrawal by Subject|0|||
162986519|NCT01986010|588654847|FG011|Overall Study|Withdrawal by Subject|2|||
162986520|NCT01986010|588654848|FG012|Overall Study|Withdrawal by Subject|0|||
162986521|NCT01986010|588654849|FG013|Overall Study|Withdrawal by Subject|1|||
162986522|NCT01986010|588654850|FG014|Overall Study|Withdrawal by Subject|2|||
162986523|NCT01986010|588654851|FG015|Overall Study|Withdrawal by Subject|0|||
162986524|NCT01986010|588654852|FG016|Overall Study|Withdrawal by Subject|0|||
162635816|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Death|0|||
162635817|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
162635818|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
162986525|NCT01986010|588654836|FG000|Overall Study|Status Not Recorded|2|||
162986526|NCT01986010|588654837|FG001|Overall Study|Status Not Recorded|4|||
162986527|NCT01986010|588654838|FG002|Overall Study|Status Not Recorded|2|||
162986528|NCT01986010|588654839|FG003|Overall Study|Status Not Recorded|0|||
162986529|NCT01986010|588654840|FG004|Overall Study|Status Not Recorded|1|||
162986530|NCT01986010|588654841|FG005|Overall Study|Status Not Recorded|2|||
162986531|NCT01986010|588654842|FG006|Overall Study|Status Not Recorded|0|||
162986532|NCT01986010|588654843|FG007|Overall Study|Status Not Recorded|0|||
162986533|NCT01986010|588654844|FG008|Overall Study|Status Not Recorded|2|||
162986534|NCT01986010|588654845|FG009|Overall Study|Status Not Recorded|1|||
162986535|NCT01986010|588654846|FG010|Overall Study|Status Not Recorded|7|||
162986536|NCT01986010|588654847|FG011|Overall Study|Status Not Recorded|7|||
162986537|NCT01986010|588654848|FG012|Overall Study|Status Not Recorded|9|||
162986538|NCT01986010|588654849|FG013|Overall Study|Status Not Recorded|9|||
162986539|NCT01986010|588654850|FG014|Overall Study|Status Not Recorded|5|||
162635819|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
162635820|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
162986540|NCT01986010|588654851|FG015|Overall Study|Status Not Recorded|10|||
162986541|NCT01986010|588654852|FG016|Overall Study|Status Not Recorded|4|||
162986542|NCT01335997|588654855|FG000|Period I and II|Adverse Event|63|||
162986543|NCT01335997|588654856|FG001|Period I and II|Adverse Event|43|||
162986544|NCT01335997|588654855|FG000|Period I and II|Noncompliance with Study Drug|1|||
162986545|NCT01335997|588654856|FG001|Period I and II|Noncompliance with Study Drug|1|||
162986546|NCT01335997|588654855|FG000|Period I and II|Lost to Follow-up|3|||
162986547|NCT01335997|588654856|FG001|Period I and II|Lost to Follow-up|5|||
162986548|NCT01335997|588654855|FG000|Period I and II|Withdrawal by Subject|9|||
162986549|NCT01335997|588654856|FG001|Period I and II|Withdrawal by Subject|4|||
162986550|NCT01335997|588654855|FG000|Period I and II|Study Terminated by Sponsor|406|||
162986551|NCT01335997|588654856|FG001|Period I and II|Study Terminated by Sponsor|415|||
162986552|NCT01335997|588654855|FG000|Period I and II|Protocol Violation|9|||
162986553|NCT01335997|588654856|FG001|Period I and II|Protocol Violation|10|||
162986554|NCT01335997|588654855|FG000|Period I and II|Physician Decision|2|||
162986555|NCT01335997|588654856|FG001|Period I and II|Physician Decision|1|||
162986556|NCT01335997|588654855|FG000|Period III|Adverse Event|0|||
162986557|NCT01335997|588654856|FG001|Period III|Adverse Event|2|||
162986558|NCT01335997|588654855|FG000|Period III|Study Terminated by Sponsor|77|||
162986559|NCT01335997|588654856|FG001|Period III|Study Terminated by Sponsor|76|||
162986560|NCT01335997|588654855|FG000|Period III|Protocol Violation|0|||
162986561|NCT01335997|588654856|FG001|Period III|Protocol Violation|1|||
162986562|NCT01335997|588654855|FG000|Period III|Lost to Follow-up|1|||
162986563|NCT01335997|588654856|FG001|Period III|Lost to Follow-up|0|||
162986564|NCT00085423|588654857|FG000|Overall Study|Withdrawal by Subject|1|||
162986565|NCT00085423|588654857|FG000|Overall Study|screen failure|1|||
162986566|NCT04740814|588654858|FG000|Overall Study|Adverse Event|3|||
162986567|NCT04740814|588654858|FG000|Overall Study|Protocol Violation|2|||
162986568|NCT04740814|588654858|FG000|Overall Study|Lost to Follow-up|2|||
162986569|NCT04740814|588654858|FG000|Overall Study|Withdrawal by Subject|3|||
162986570|NCT04126213|588654870|FG000|Overall Study|Lost to Follow-up|9|||
162986571|NCT04126213|588654871|FG001|Overall Study|Lost to Follow-up|1|||
162986572|NCT04126213|588654872|FG002|Overall Study|Lost to Follow-up|5|||
162986573|NCT04126213|588654873|FG003|Overall Study|Lost to Follow-up|10|||
162986574|NCT04126213|588654874|FG004|Overall Study|Lost to Follow-up|4|||
162986575|NCT04126213|588654875|FG005|Overall Study|Lost to Follow-up|7|||
162986576|NCT04126213|588654870|FG000|Overall Study|Withdrawal by Subject|3|||
162986577|NCT04126213|588654871|FG001|Overall Study|Withdrawal by Subject|2|||
162986578|NCT04126213|588654872|FG002|Overall Study|Withdrawal by Subject|1|||
162986579|NCT04126213|588654873|FG003|Overall Study|Withdrawal by Subject|1|||
162986580|NCT04126213|588654874|FG004|Overall Study|Withdrawal by Subject|1|||
162986581|NCT04126213|588654875|FG005|Overall Study|Withdrawal by Subject|1|||
162986582|NCT04126213|588654870|FG000|Overall Study|Other|0|||
162986583|NCT04126213|588654871|FG001|Overall Study|Other|0|||
162986584|NCT04126213|588654872|FG002|Overall Study|Other|2|||
162986585|NCT04126213|588654873|FG003|Overall Study|Other|2|||
162986586|NCT04126213|588654874|FG004|Overall Study|Other|0|||
162986587|NCT04126213|588654875|FG005|Overall Study|Other|1|||
162635821|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
162635822|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
162635823|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
162635824|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
162635825|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
162635826|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
162635827|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
162635828|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
162635829|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
162635830|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
162635831|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
162635832|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
162635833|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
162635834|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
162635835|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
162635836|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
162635837|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
162635838|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
162635839|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
162635840|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
162635841|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Other|6|||
162635842|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Other|3|||
162635843|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Other|0|||
162635844|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Other|0|||
162635845|NCT02051608|587381670|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
162635846|NCT02051608|587381671|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
162635847|NCT02051608|587381672|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
162986588|NCT04126213|588654870|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162986589|NCT04126213|588654871|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162986590|NCT04126213|588654872|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162986591|NCT04126213|588654873|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162986592|NCT04126213|588654874|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162986593|NCT04126213|588654875|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162986594|NCT02853370|588654876|FG000|Overall Study|Physician Decision|1|||
162986595|NCT02853370|588654876|FG000|Overall Study|Lack of Efficacy|2|||
162635848|NCT02051608|587381673|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
162635849|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Adverse Event|0|||
162635850|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Adverse Event|0|||
162635851|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Adverse Event|6|||
162635852|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Adverse Event|8|||
162635853|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Death|0|||
162635854|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Death|0|||
162635855|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Death|7|||
162635856|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Death|4|||
162635857|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
162635858|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
162715080|NCT05827926|587665798|FG007|Overall Study|Physician Decision|0|||
162986596|NCT02853370|588654876|FG000|Overall Study|Death|1|||
162986597|NCT02853370|588654876|FG000|Overall Study|Adverse Event|4|||
162986598|NCT02853370|588654876|FG000|Overall Study|Withdrawal by Subject|3|||
162986599|NCT03283761|588654881|FG000|Study Treatment|Patient Non-Compliance|1|||
162715081|NCT05827926|587665799|FG008|Overall Study|Physician Decision|0|||
162715082|NCT05827926|587665800|FG009|Overall Study|Physician Decision|0|||
162715083|NCT05827926|587665801|FG010|Overall Study|Physician Decision|0|||
162715084|NCT05827926|587665802|FG011|Overall Study|Physician Decision|0|||
162715085|NCT05827926|587665803|FG012|Overall Study|Physician Decision|0|||
162715086|NCT05827926|587665804|FG013|Overall Study|Physician Decision|0|||
162715087|NCT05827926|587665805|FG014|Overall Study|Physician Decision|0|||
162715088|NCT05827926|587665806|FG015|Overall Study|Physician Decision|0|||
162715089|NCT05827926|587665807|FG016|Overall Study|Physician Decision|0|||
162715090|NCT05827926|587665808|FG017|Overall Study|Physician Decision|0|||
162715091|NCT05827926|587665809|FG018|Overall Study|Physician Decision|1|||
162715092|NCT05827926|587665810|FG019|Overall Study|Physician Decision|0|||
162715093|NCT05827926|587665811|FG020|Overall Study|Physician Decision|0|||
162715094|NCT05827926|587665812|FG021|Overall Study|Physician Decision|0|||
162715095|NCT05827926|587665813|FG022|Overall Study|Physician Decision|0|||
162715096|NCT05827926|587665814|FG023|Overall Study|Physician Decision|0|||
162715097|NCT05827926|587665815|FG024|Overall Study|Physician Decision|0|||
162715098|NCT05827926|587665816|FG025|Overall Study|Physician Decision|0|||
162715099|NCT05827926|587665817|FG026|Overall Study|Physician Decision|0|||
162715100|NCT05827926|587665818|FG027|Overall Study|Physician Decision|0|||
162715101|NCT05827926|587665819|FG028|Overall Study|Physician Decision|0|||
162715102|NCT05827926|587665820|FG029|Overall Study|Physician Decision|0|||
162715103|NCT05827926|587665821|FG030|Overall Study|Physician Decision|0|||
162715104|NCT05827926|587665822|FG031|Overall Study|Physician Decision|0|||
162715105|NCT05827926|587665823|FG032|Overall Study|Physician Decision|0|||
162715106|NCT05827926|587665824|FG033|Overall Study|Physician Decision|0|||
162715107|NCT05827926|587665825|FG034|Overall Study|Physician Decision|0|||
162715108|NCT05827926|587665826|FG035|Overall Study|Physician Decision|0|||
162986600|NCT03283761|588654881|FG000|Study Treatment|Alternative Cancer Therapy|7|||
162986601|NCT03283761|588654881|FG000|Study Treatment|Disease progression|21|||
162986602|NCT03283761|588654881|FG000|Study Treatment|Adverse Event|3|||
162986603|NCT03283761|588654881|FG000|Study Treatment|Withdrawal by Subject|4|||
162986604|NCT03283761|588654881|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
162986605|NCT03283761|588654881|FG000|Study Treatment|Symptomatic Deterioration|1|||
162986606|NCT03283761|588654881|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
162986607|NCT03283761|588654881|FG000|Follow up|Lost to Follow-up|1|||
162986608|NCT03283761|588654881|FG000|Follow up|Symptomatic Deterioration|1|||
162986609|NCT03283761|588654881|FG000|Follow up|Death|29|||
162986610|NCT03283761|588654881|FG000|Follow up|study terminated|4|||
162986611|NCT03283761|588654881|FG000|Follow up|Primary Investigator Withdrawal|1|||
162715109|NCT05827926|587665827|FG036|Overall Study|Physician Decision|0|||
162715110|NCT04588480|587665835|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
162715111|NCT04588480|587665836|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
162715112|NCT04588480|587665837|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
162635859|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
162635860|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
162715113|NCT04588480|587665835|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
162715114|NCT04588480|587665836|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
162715115|NCT04588480|587665837|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
162715116|NCT01242085|587665838|FG000|Overall Study|Withdrawal by Subject|4|||
162715117|NCT01242085|587665839|FG001|Overall Study|Withdrawal by Subject|2|||
162715118|NCT01242085|587665840|FG002|Overall Study|Withdrawal by Subject|0|||
162715119|NCT01242085|587665838|FG000|Overall Study|medically unable to have surgery|4|||
162986612|NCT03283761|588654881|FG000|Follow up|Switched to alternative therapy|1|||
162986613|NCT03283761|588654881|FG000|Follow up|Subject is now in Hospice|1|||
162986614|NCT01910389|588654882|FG000|Overall Study|Withdrawal by Subject|2|||
162986615|NCT01910389|588654883|FG001|Overall Study|Withdrawal by Subject|0|||
162986616|NCT01910389|588654882|FG000|Overall Study|Study Closed|13|||
162715120|NCT01242085|587665839|FG001|Overall Study|medically unable to have surgery|5|||
162986617|NCT01910389|588654883|FG001|Overall Study|Study Closed|8|||
162986618|NCT01898650|588654884|FG000|Overall Study|the subject would not lie still for imaging|1|||
162986619|NCT02912650|588654886|FG000|Overall Study|Withdrawal by Subject|1|||
162986620|NCT02912650|588654887|FG001|Overall Study|Withdrawal by Subject|0|||
162986621|NCT02912650|588654888|FG002|Overall Study|Withdrawal by Subject|1|||
162986622|NCT02912650|588654889|FG003|Overall Study|Withdrawal by Subject|5|||
162986623|NCT02912650|588654886|FG000|Overall Study|Adverse Event|0|||
162986624|NCT02912650|588654887|FG001|Overall Study|Adverse Event|0|||
162986625|NCT02912650|588654888|FG002|Overall Study|Adverse Event|1|||
162986626|NCT02912650|588654889|FG003|Overall Study|Adverse Event|0|||
162986627|NCT02357342|588654890|FG000|First 6 Months|Death|2|||
162986628|NCT02357342|588654891|FG001|First 6 Months|Death|0|||
162986629|NCT01674647|588654892|FG000|Treatment Period|Death|4|||
162986630|NCT01674647|588654893|FG001|Treatment Period|Death|1|||
162635861|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
162635862|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
162635863|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
162635864|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
162635865|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162635866|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162635867|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
162635868|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
162635869|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162635870|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162635871|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162635872|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
162635873|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Physician Decision|0|||
162635874|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Physician Decision|0|||
162635875|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Physician Decision|8|||
162635876|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Physician Decision|5|||
162635877|NCT02051608|587381670|FG000|Part 2: Open-label Extension|Other|0|||
162635878|NCT02051608|587381671|FG001|Part 2: Open-label Extension|Other|0|||
162635879|NCT02051608|587381672|FG002|Part 2: Open-label Extension|Other|9|||
162635880|NCT02051608|587381673|FG003|Part 2: Open-label Extension|Other|9|||
162635881|NCT00142584|587381674|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
162635882|NCT00142584|587381675|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
162635883|NCT00142584|587381674|FG000|Overall Study|Withdrawal by Subject|30|||
162635884|NCT00142584|587381675|FG001|Overall Study|Withdrawal by Subject|16|||
162635885|NCT00142584|587381674|FG000|Overall Study|Lost to Follow-up|22|||
162635886|NCT00142584|587381675|FG001|Overall Study|Lost to Follow-up|12|||
162635887|NCT00142584|587381674|FG000|Overall Study|Adverse Event|14|||
162635888|NCT00142584|587381675|FG001|Overall Study|Adverse Event|5|||
162635889|NCT00142584|587381674|FG000|Overall Study|Protocol Violation|4|||
162635890|NCT00142584|587381675|FG001|Overall Study|Protocol Violation|7|||
162635891|NCT00142584|587381674|FG000|Overall Study|Treatment Failure|2|||
162635892|NCT00142584|587381675|FG001|Overall Study|Treatment Failure|0|||
162635893|NCT01083576|587381676|FG000|Overall Study|Treatment Failure|6|||
162635894|NCT01083576|587381677|FG001|Overall Study|Treatment Failure|1|||
162635895|NCT01986985|587381678|FG000|Overall Study|Withdrawal by Subject|4|||
162635896|NCT01986985|587381678|FG000|Overall Study|Scan not completed due to malfunction|3|||
162635897|NCT00449540|587381679|FG000|Pretreatment Phase|No migraine experienced|66|||
162635898|NCT00449540|587381680|FG001|Pretreatment Phase|No migraine experienced|0|||
162635899|NCT00449540|587381681|FG002|Pretreatment Phase|No migraine experienced|0|||
162635900|NCT00449540|587381679|FG000|Treatment Phase|did not experience or treat migraine|0|||
162635901|NCT00449540|587381680|FG001|Treatment Phase|did not experience or treat migraine|20|||
162635902|NCT00449540|587381681|FG002|Treatment Phase|did not experience or treat migraine|17|||
162635903|NCT04577118|587381682|FG000|Overall Study|Withdrawal by Subject|4|||
162635904|NCT00356369|587381683|FG000|Active Phase|Withdrawal by Subject|2|||
162635905|NCT00356369|587381684|FG001|Active Phase|Withdrawal by Subject|1|||
162635906|NCT00673465|587381685|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635907|NCT00673465|587381686|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635908|NCT00673465|587381687|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635909|NCT00673465|587381688|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635910|NCT00673465|587381689|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
162635911|NCT00673465|587381690|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
162635912|NCT00673465|587381691|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635913|NCT00673465|587381692|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635914|NCT00673465|587381693|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635915|NCT00673465|587381694|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635916|NCT00673465|587381695|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
162635917|NCT00673465|587381696|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
162986631|NCT01674647|588654892|FG000|Treatment Period|Efficacy outcome reached|0|||
162986632|NCT01674647|588654893|FG001|Treatment Period|Efficacy outcome reached|1|||
162715121|NCT01242085|587665840|FG002|Overall Study|medically unable to have surgery|0|||
162715122|NCT02322216|587665841|FG000|Overall Study|Adverse Event|1|||
162715123|NCT02322216|587665842|FG001|Overall Study|Adverse Event|0|||
162715124|NCT02322216|587665841|FG000|Overall Study|Withdrawal by Subject|1|||
162715125|NCT02322216|587665842|FG001|Overall Study|Withdrawal by Subject|4|||
162715126|NCT02982213|587665844|FG000|Overall Study|Did not complete follow up questionnaire|5|||
162715127|NCT02982213|587665845|FG001|Overall Study|Did not complete follow up questionnaire|1|||
162715128|NCT01981850|587665847|FG000|Main Phase Stage 1|Death|2|||
162715129|NCT01981850|587665848|FG001|Main Phase Stage 1|Death|0|||
162715130|NCT01981850|587665849|FG002|Main Phase Stage 1|Death|0|||
162715131|NCT01981850|587665850|FG003|Main Phase Stage 1|Death|0|||
162715132|NCT01981850|587665851|FG004|Main Phase Stage 1|Death|0|||
162715133|NCT01981850|587665852|FG005|Main Phase Stage 1|Death|0|||
162715134|NCT01981850|587665853|FG006|Main Phase Stage 1|Death|0|||
162715135|NCT01981850|587665854|FG007|Main Phase Stage 1|Death|0|||
162715136|NCT01981850|587665855|FG008|Main Phase Stage 1|Death|0|||
162715137|NCT01981850|587665856|FG009|Main Phase Stage 1|Death|0|||
162715138|NCT01981850|587665847|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
163059834|NCT02349386|588928235|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
163059835|NCT02349386|588928236|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
163059836|NCT02349386|588928237|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
163059837|NCT02349386|588928234|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
163059838|NCT02349386|588928235|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
163059839|NCT02349386|588928236|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
163059840|NCT02349386|588928237|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
163059841|NCT02349386|588928234|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059842|NCT02349386|588928235|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059843|NCT02349386|588928236|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
163059844|NCT02349386|588928237|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
163059845|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
163059846|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
163059847|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
163059848|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
163059849|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
163059850|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
163059851|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
163059852|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
163059853|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
163059854|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
163059855|NCT00973973|588928238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
163059856|NCT00973973|588928239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
163059857|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
163059858|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
163059859|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
163059860|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
163059861|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
163059862|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
163059863|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
163059864|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
163059865|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
163059866|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
163059867|NCT00973973|588928238|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
163059868|NCT00973973|588928239|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
163059869|NCT02471339|588928240|FG000|Overall Study|Did not provide follow-up data|2|||
163059870|NCT02471339|588928241|FG001|Overall Study|Did not provide follow-up data|0|||
163059871|NCT06057064|588928242|FG000|Overall Study|Death|2|||
163059872|NCT06057064|588928243|FG001|Overall Study|Death|0|||
163059873|NCT06057064|588928242|FG000|Overall Study|Physician Decision|1|||
163059874|NCT06057064|588928243|FG001|Overall Study|Physician Decision|0|||
163059875|NCT06057064|588928242|FG000|Overall Study|Withdrawal by Subject|1|||
163059876|NCT06057064|588928243|FG001|Overall Study|Withdrawal by Subject|1|||
163059877|NCT00851591|588928245|FG000|Overall Study|Withdrawal by Subject|2|||
162715139|NCT01981850|587665848|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715140|NCT01981850|587665849|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715141|NCT01981850|587665850|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715142|NCT01981850|587665851|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162986633|NCT01674647|588654892|FG000|Treatment Period|Physician Decision|3|||
162986634|NCT01674647|588654893|FG001|Treatment Period|Physician Decision|1|||
162986635|NCT01674647|588654892|FG000|Treatment Period|Adverse Event|60|||
162986636|NCT01674647|588654893|FG001|Treatment Period|Adverse Event|22|||
162986637|NCT01674647|588654892|FG000|Treatment Period|Non-compliance with study drug|3|||
162986638|NCT01674647|588654893|FG001|Treatment Period|Non-compliance with study drug|0|||
162986639|NCT01674647|588654892|FG000|Treatment Period|Lost to Follow-up|1|||
162986640|NCT01674647|588654893|FG001|Treatment Period|Lost to Follow-up|1|||
162986641|NCT01674647|588654892|FG000|Treatment Period|Withdrawal by Subject|19|||
162986642|NCT01674647|588654893|FG001|Treatment Period|Withdrawal by Subject|16|||
162986643|NCT01674647|588654892|FG000|Treatment Period|Switching to other therapy|5|||
162986644|NCT01674647|588654893|FG001|Treatment Period|Switching to other therapy|2|||
162986645|NCT01674647|588654892|FG000|Treatment Period|Logistical difficulties|5|||
162986646|NCT01674647|588654893|FG001|Treatment Period|Logistical difficulties|8|||
162986647|NCT01674647|588654892|FG000|Treatment Period|Treatment failure|0|||
162986648|NCT01674647|588654893|FG001|Treatment Period|Treatment failure|14|||
162986649|NCT01674647|588654892|FG000|Treatment Period|Protocol Violation|56|||
162986650|NCT01674647|588654893|FG001|Treatment Period|Protocol Violation|36|||
162986651|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Death|3|||
162986652|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Death|2|||
162986653|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
162986654|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
162986655|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
162986656|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
162986657|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
162986658|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
162986659|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
162986660|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
162986661|NCT01674647|588654892|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
162986662|NCT01674647|588654893|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
162986663|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
162986664|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
162986665|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
162986666|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
162986667|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
162986668|NCT01490866|588654896|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
162986669|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
162986670|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
162986671|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
162986672|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
162986673|NCT01490866|588654896|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
162986674|NCT03923530|588654897|FG000|Overall Study|Withdrawal by Subject|1|||
162986675|NCT03923530|588654897|FG000|Overall Study|screen failure|3|||
162986676|NCT00741936|588654898|FG000|Overall Study|Lost to Follow-up|1|||
162986677|NCT00741936|588654899|FG001|Overall Study|Lost to Follow-up|1|||
162986678|NCT00741936|588654898|FG000|Overall Study|Adverse Event|3|||
162986679|NCT00741936|588654899|FG001|Overall Study|Adverse Event|4|||
162986680|NCT00741936|588654898|FG000|Overall Study|Pregnancy|0|||
162986681|NCT00741936|588654899|FG001|Overall Study|Pregnancy|1|||
162986682|NCT00741936|588654898|FG000|Overall Study|Protocol Violation|2|||
162986683|NCT00741936|588654899|FG001|Overall Study|Protocol Violation|0|||
162986684|NCT00741936|588654898|FG000|Overall Study|Lack of Efficacy|0|||
162986685|NCT00741936|588654899|FG001|Overall Study|Lack of Efficacy|2|||
162986686|NCT00741936|588654898|FG000|Overall Study|Low compliance|3|||
162986687|NCT00741936|588654899|FG001|Overall Study|Low compliance|0|||
162986688|NCT01941940|588654900|FG000|Overall Study|Adverse Event|11|||
162986689|NCT01941940|588654900|FG000|Overall Study|Lost to Follow-up|2|||
162986690|NCT01941940|588654900|FG000|Overall Study|Physician Decision|2|||
162986691|NCT01941940|588654900|FG000|Overall Study|Withdrawal by Subject|15|||
162635918|NCT00673465|587381685|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
162986692|NCT01941940|588654900|FG000|Overall Study|Death|1|||
162986693|NCT01941940|588654900|FG000|Overall Study|Other|1|||
162986694|NCT01941940|588654900|FG000|Overall Study|Other|1|||
162986695|NCT04135196|588654901|FG000|Overall Study|Lost to Follow-up|8|||
162635919|NCT00673465|587381686|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635920|NCT00673465|587381687|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635921|NCT00673465|587381688|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635922|NCT00673465|587381689|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
162635923|NCT00673465|587381690|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
162986696|NCT04135196|588654902|FG001|Overall Study|Lost to Follow-up|7|||
162986697|NCT04135196|588654903|FG002|Overall Study|Lost to Follow-up|8|||
162986698|NCT04135196|588654904|FG003|Overall Study|Lost to Follow-up|9|||
162986699|NCT04135196|588654905|FG004|Overall Study|Lost to Follow-up|1|||
162986700|NCT04135196|588654901|FG000|Overall Study|Pregnancy|0|||
162986701|NCT04135196|588654902|FG001|Overall Study|Pregnancy|0|||
162986702|NCT04135196|588654903|FG002|Overall Study|Pregnancy|1|||
162986703|NCT04135196|588654904|FG003|Overall Study|Pregnancy|0|||
162986704|NCT04135196|588654905|FG004|Overall Study|Pregnancy|0|||
162986705|NCT04135196|588654901|FG000|Overall Study|Withdrawal by Subject|0|||
162986706|NCT04135196|588654902|FG001|Overall Study|Withdrawal by Subject|0|||
162986707|NCT04135196|588654903|FG002|Overall Study|Withdrawal by Subject|0|||
162986708|NCT04135196|588654904|FG003|Overall Study|Withdrawal by Subject|0|||
162986709|NCT04135196|588654905|FG004|Overall Study|Withdrawal by Subject|1|||
162986710|NCT03212521|588654906|FG000|Overall Study|Adverse Event|1|||
162986711|NCT03212521|588654906|FG000|Overall Study|Lost to Follow-up|4|||
162986712|NCT03212521|588654906|FG000|Overall Study|Withdrawal by Subject|1|||
162986713|NCT03212521|588654906|FG000|Overall Study|Other|1|||
162986714|NCT00914459|588654909|FG000|Overall Study|Protocol Violation|0|||
162986715|NCT00914459|588654910|FG001|Overall Study|Protocol Violation|1|||
162986716|NCT00914459|588654909|FG000|Overall Study|Parent/Legal guardian request|1|||
162986717|NCT00914459|588654910|FG001|Overall Study|Parent/Legal guardian request|0|||
162986718|NCT01661179|588654911|FG000|Overall Study|Death|1|||
162986719|NCT01661179|588654911|FG000|Overall Study|Withdrawal by Subject|1|||
162986720|NCT01661179|588654911|FG000|Overall Study|Other Eligibility criteria|4|||
162986721|NCT01946191|588654912|FG000|Allocation|Did not complete orientation|1|||
162986722|NCT01946191|588654913|FG001|Allocation|Did not complete orientation|1|||
162986723|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
162986724|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
162986725|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
162986726|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
162986727|NCT01946191|588654912|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
162986728|NCT01946191|588654913|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
162986729|NCT01083810|588654914|FG000|Overall Study|Lost to Follow-up|23|||
162986730|NCT01083810|588654915|FG001|Overall Study|Lost to Follow-up|11|||
162986731|NCT01083810|588654916|FG002|Overall Study|Lost to Follow-up|4|||
162986732|NCT01083810|588654914|FG000|Overall Study|Adverse Event|15|||
162986733|NCT01083810|588654915|FG001|Overall Study|Adverse Event|11|||
162986734|NCT01083810|588654916|FG002|Overall Study|Adverse Event|4|||
162986735|NCT01083810|588654914|FG000|Overall Study|Withdrawal by Subject|7|||
162986736|NCT01083810|588654915|FG001|Overall Study|Withdrawal by Subject|2|||
162986737|NCT01083810|588654916|FG002|Overall Study|Withdrawal by Subject|4|||
162986738|NCT01083810|588654914|FG000|Overall Study|Reason not reported|6|||
162986739|NCT01083810|588654915|FG001|Overall Study|Reason not reported|1|||
162986740|NCT01083810|588654916|FG002|Overall Study|Reason not reported|1|||
162986741|NCT01083810|588654914|FG000|Overall Study|Non-compliance|4|||
162986742|NCT01083810|588654915|FG001|Overall Study|Non-compliance|7|||
162986743|NCT01083810|588654916|FG002|Overall Study|Non-compliance|2|||
162986744|NCT01083810|588654914|FG000|Overall Study|Simplification|4|||
162986745|NCT01083810|588654915|FG001|Overall Study|Simplification|1|||
162986746|NCT01083810|588654916|FG002|Overall Study|Simplification|0|||
162986747|NCT01083810|588654914|FG000|Overall Study|Death|2|||
162986748|NCT01083810|588654915|FG001|Overall Study|Death|2|||
162986749|NCT01083810|588654916|FG002|Overall Study|Death|3|||
162986750|NCT01083810|588654914|FG000|Overall Study|Co-morbidities|1|||
162986751|NCT01083810|588654915|FG001|Overall Study|Co-morbidities|0|||
162986752|NCT01083810|588654916|FG002|Overall Study|Co-morbidities|0|||
162986753|NCT01083810|588654914|FG000|Overall Study|Participation in study|1|||
162986754|NCT01083810|588654915|FG001|Overall Study|Participation in study|0|||
162986755|NCT01083810|588654916|FG002|Overall Study|Participation in study|0|||
162986756|NCT01083810|588654914|FG000|Overall Study|Therapy break|1|||
162986757|NCT01083810|588654915|FG001|Overall Study|Therapy break|2|||
162986758|NCT01083810|588654916|FG002|Overall Study|Therapy break|2|||
162986759|NCT01083810|588654914|FG000|Overall Study|Virologic failure|1|||
162986760|NCT01083810|588654915|FG001|Overall Study|Virologic failure|8|||
162986761|NCT01083810|588654916|FG002|Overall Study|Virologic failure|0|||
162986762|NCT04941729|588657116|FG000|Overall Study|Death|0|||
162986763|NCT04941729|588657117|FG001|Overall Study|Death|1|||
162986764|NCT04941729|588657116|FG000|Overall Study|Study terminated by sponsor|11|||
162986765|NCT04941729|588657117|FG001|Overall Study|Study terminated by sponsor|10|||
162986766|NCT00006721|588657118|FG000|Overall Study|Adverse Event|0|||
162986767|NCT00006721|588657119|FG001|Overall Study|Adverse Event|4|||
162986768|NCT00006721|588657120|FG002|Overall Study|Adverse Event|4|||
162986769|NCT00006721|588657118|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
162986770|NCT00006721|588657119|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
163059878|NCT00851591|588928246|FG001|Overall Study|Withdrawal by Subject|0|||
163059879|NCT02736617|588928247|FG000|Treatment|Adverse Event|1|||
163059880|NCT02736617|588928247|FG000|Treatment|Lack of Efficacy|1|||
163059881|NCT02736617|588928247|FG000|Treatment|Withdrawal by Subject|1|||
162986771|NCT00006721|588657120|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
162986772|NCT00006721|588657118|FG000|Overall Study|Progression/Relapse|0|||
162986773|NCT00006721|588657119|FG001|Overall Study|Progression/Relapse|1|||
162986774|NCT00006721|588657120|FG002|Overall Study|Progression/Relapse|2|||
162986775|NCT00006721|588657118|FG000|Overall Study|Death|0|||
162986776|NCT00006721|588657119|FG001|Overall Study|Death|1|||
162986777|NCT00006721|588657120|FG002|Overall Study|Death|2|||
162986778|NCT00006721|588657118|FG000|Overall Study|Other - Not Protocol Specified|0|||
162986779|NCT00006721|588657119|FG001|Overall Study|Other - Not Protocol Specified|7|||
162986780|NCT00006721|588657120|FG002|Overall Study|Other - Not Protocol Specified|7|||
162986781|NCT00006721|588657118|FG000|Overall Study|Ineligible|2|||
162986782|NCT00006721|588657119|FG001|Overall Study|Ineligible|12|||
162986783|NCT00006721|588657120|FG002|Overall Study|Ineligible|10|||
162986784|NCT00006721|588657118|FG000|Overall Study|Eligible but no Treatment Received|1|||
162986785|NCT00006721|588657119|FG001|Overall Study|Eligible but no Treatment Received|0|||
162986786|NCT00006721|588657120|FG002|Overall Study|Eligible but no Treatment Received|0|||
162986787|NCT03845296|588657121|FG000|Overall Study|On Treatment|2|||
162986788|NCT03845296|588657122|FG001|Overall Study|On Treatment|1|||
162986789|NCT03845296|588657121|FG000|Overall Study|Adverse Event|4|||
162986790|NCT03845296|588657122|FG001|Overall Study|Adverse Event|11|||
162986791|NCT03845296|588657121|FG000|Overall Study|Refusal unrelated to adverse event|0|||
162986792|NCT03845296|588657122|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162986793|NCT03845296|588657121|FG000|Overall Study|Progression/relapse|14|||
162986794|NCT03845296|588657122|FG001|Overall Study|Progression/relapse|18|||
162986795|NCT03845296|588657121|FG000|Overall Study|Death|4|||
162986796|NCT03845296|588657122|FG001|Overall Study|Death|0|||
162986797|NCT03845296|588657121|FG000|Overall Study|Other - not protocol specified|1|||
162986798|NCT03845296|588657122|FG001|Overall Study|Other - not protocol specified|3|||
162986799|NCT05424042|588657123|FG000|Overall Study|Withdrawal by Subject|2|||
162986800|NCT05424042|588657124|FG001|Overall Study|Withdrawal by Subject|0|||
162986801|NCT05424042|588657125|FG002|Overall Study|Withdrawal by Subject|4|||
162986802|NCT05424042|588657123|FG000|Overall Study|Lost to Follow-up|0|||
162986803|NCT05424042|588657124|FG001|Overall Study|Lost to Follow-up|0|||
162986804|NCT05424042|588657125|FG002|Overall Study|Lost to Follow-up|1|||
162986805|NCT05091307|588657126|FG000|Overall Study|Death|0|||
162986806|NCT05091307|588657127|FG001|Overall Study|Death|0|||
162986807|NCT05091307|588657128|FG002|Overall Study|Death|1|||
162986808|NCT05091307|588657129|FG003|Overall Study|Death|0|||
162986809|NCT05091307|588657126|FG000|Overall Study|Lost to Follow-up|33|||
162986810|NCT05091307|588657127|FG001|Overall Study|Lost to Follow-up|33|||
162986811|NCT05091307|588657128|FG002|Overall Study|Lost to Follow-up|2|||
162986812|NCT05091307|588657129|FG003|Overall Study|Lost to Follow-up|0|||
162986813|NCT05091307|588657126|FG000|Overall Study|Physician Decision|1|||
162986814|NCT05091307|588657127|FG001|Overall Study|Physician Decision|0|||
162986815|NCT05091307|588657128|FG002|Overall Study|Physician Decision|0|||
162986816|NCT05091307|588657129|FG003|Overall Study|Physician Decision|0|||
162986817|NCT05091307|588657126|FG000|Overall Study|Protocol Violation|1|||
162986818|NCT05091307|588657127|FG001|Overall Study|Protocol Violation|0|||
162986819|NCT05091307|588657128|FG002|Overall Study|Protocol Violation|0|||
163059882|NCT02736617|588928247|FG000|Maintenance|Lack of Efficacy|4|||
163059883|NCT02736617|588928247|FG000|Maintenance|Physician Decision|1|||
163059884|NCT00481676|588928250|FG000|Overall Study|Adverse Event|0|||
163059885|NCT00481676|588928251|FG001|Overall Study|Adverse Event|1|||
163059886|NCT00481676|588928250|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162986820|NCT05091307|588657129|FG003|Overall Study|Protocol Violation|0|||
162986821|NCT05091307|588657126|FG000|Overall Study|Withdrawal by Subject|16|||
162986822|NCT05091307|588657127|FG001|Overall Study|Withdrawal by Subject|16|||
163059887|NCT00481676|588928251|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163059888|NCT00481676|588928250|FG000|Overall Study|Administrative problem|1|||
163059889|NCT00481676|588928251|FG001|Overall Study|Administrative problem|0|||
162986823|NCT05091307|588657128|FG002|Overall Study|Withdrawal by Subject|0|||
162986824|NCT05091307|588657129|FG003|Overall Study|Withdrawal by Subject|1|||
162986825|NCT05091307|588657126|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
162986826|NCT05091307|588657127|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
162986827|NCT05091307|588657128|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
162986828|NCT05091307|588657129|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
162986829|NCT05091307|588657126|FG000|Overall Study|Initiated Prohibited Medication|1|||
163059890|NCT02911116|588928252|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163059891|NCT02911116|588928253|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163059892|NCT02911116|588928252|FG000|Overall Study|Lost to Follow-up|0|||
162986830|NCT05091307|588657127|FG001|Overall Study|Initiated Prohibited Medication|0|||
162986831|NCT05091307|588657128|FG002|Overall Study|Initiated Prohibited Medication|0|||
162986832|NCT05091307|588657129|FG003|Overall Study|Initiated Prohibited Medication|0|||
162986833|NCT05091307|588657126|FG000|Overall Study|Other|4|||
162986834|NCT05091307|588657127|FG001|Overall Study|Other|4|||
162986835|NCT05091307|588657128|FG002|Overall Study|Other|0|||
162986836|NCT05091307|588657129|FG003|Overall Study|Other|0|||
162986837|NCT05091307|588657126|FG000|Overall Study|Randomized but not vaccinated|0|||
162986838|NCT05091307|588657127|FG001|Overall Study|Randomized but not vaccinated|2|||
162986839|NCT05091307|588657128|FG002|Overall Study|Randomized but not vaccinated|0|||
162986840|NCT05091307|588657129|FG003|Overall Study|Randomized but not vaccinated|0|||
162986841|NCT00379340|588657132|FG000|Overall Study|Death|0|||
162986842|NCT00379340|588657133|FG001|Overall Study|Death|0|||
162986843|NCT00379340|588657134|FG002|Overall Study|Death|0|||
162986844|NCT00379340|588657135|FG003|Overall Study|Death|2|||
162986845|NCT00379340|588657136|FG004|Overall Study|Death|0|||
162986846|NCT00379340|588657132|FG000|Overall Study|Lack of Efficacy|6|||
162986847|NCT00379340|588657133|FG001|Overall Study|Lack of Efficacy|1|||
162986848|NCT00379340|588657134|FG002|Overall Study|Lack of Efficacy|0|||
162986849|NCT00379340|588657135|FG003|Overall Study|Lack of Efficacy|4|||
162986850|NCT00379340|588657136|FG004|Overall Study|Lack of Efficacy|3|||
162986851|NCT00379340|588657132|FG000|Overall Study|Physician Decision|6|||
162986852|NCT00379340|588657133|FG001|Overall Study|Physician Decision|2|||
162986853|NCT00379340|588657134|FG002|Overall Study|Physician Decision|1|||
162986854|NCT00379340|588657135|FG003|Overall Study|Physician Decision|2|||
162986855|NCT00379340|588657136|FG004|Overall Study|Physician Decision|3|||
162986856|NCT00379340|588657132|FG000|Overall Study|Withdrawal by Subject|0|||
162986857|NCT00379340|588657133|FG001|Overall Study|Withdrawal by Subject|0|||
162986858|NCT00379340|588657134|FG002|Overall Study|Withdrawal by Subject|0|||
162986859|NCT00379340|588657135|FG003|Overall Study|Withdrawal by Subject|1|||
162986860|NCT00379340|588657136|FG004|Overall Study|Withdrawal by Subject|0|||
162986861|NCT00379340|588657132|FG000|Overall Study|Refusal of further protocol therapy|1|||
162986862|NCT00379340|588657133|FG001|Overall Study|Refusal of further protocol therapy|0|||
162986863|NCT00379340|588657134|FG002|Overall Study|Refusal of further protocol therapy|1|||
162986864|NCT00379340|588657135|FG003|Overall Study|Refusal of further protocol therapy|1|||
162986865|NCT00379340|588657136|FG004|Overall Study|Refusal of further protocol therapy|7|||
162986866|NCT00379340|588657132|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
162986867|NCT00379340|588657133|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
162986868|NCT00379340|588657134|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
162986869|NCT00379340|588657135|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
162986870|NCT00379340|588657136|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
162986871|NCT00379340|588657132|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986872|NCT00379340|588657133|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986873|NCT00379340|588657134|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
162986874|NCT00379340|588657135|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
162986875|NCT00379340|588657136|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
162986876|NCT01167257|588657137|FG000|Overall Study|Lost to Follow-up|2|||
162986877|NCT01167257|588657138|FG001|Overall Study|Lost to Follow-up|2|||
162986878|NCT01167257|588657137|FG000|Overall Study|Withdrew consent|1|||
162986879|NCT01167257|588657138|FG001|Overall Study|Withdrew consent|1|||
162986880|NCT01367665|588657139|FG000|Overall Study|Death|102|||
162986881|NCT01367665|588657140|FG001|Overall Study|Death|19|||
162986882|NCT01367665|588657139|FG000|Overall Study|Lost to Follow-up|222|||
162986883|NCT01367665|588657140|FG001|Overall Study|Lost to Follow-up|22|||
162986884|NCT01367665|588657139|FG000|Overall Study|Not Done|118|||
162986885|NCT01367665|588657140|FG001|Overall Study|Not Done|14|||
162986886|NCT02752906|588657141|FG000|Overall Study|Protocol Violation|2|||
162986887|NCT02752906|588657142|FG001|Overall Study|Protocol Violation|1|||
162986888|NCT02752906|588657141|FG000|Overall Study|Withdrawal by Subject|2|||
162986889|NCT02752906|588657142|FG001|Overall Study|Withdrawal by Subject|2|||
162986890|NCT02752906|588657141|FG000|Overall Study|Lost to Follow-up|3|||
162986891|NCT02752906|588657142|FG001|Overall Study|Lost to Follow-up|2|||
162986892|NCT03283319|588657143|FG000|Overall Study|Lost to Follow-up|5|||
162986893|NCT03283319|588657144|FG001|Overall Study|Lost to Follow-up|4|||
162986894|NCT03283319|588657145|FG002|Overall Study|Lost to Follow-up|5|||
162986895|NCT03283319|588657146|FG003|Overall Study|Lost to Follow-up|5|||
162986896|NCT03283319|588657147|FG004|Overall Study|Lost to Follow-up|4|||
162986897|NCT03283319|588657148|FG005|Overall Study|Lost to Follow-up|3|||
162986898|NCT03283319|588657143|FG000|Overall Study|Withdrawal by Subject|2|||
162986899|NCT03283319|588657144|FG001|Overall Study|Withdrawal by Subject|2|||
162986900|NCT03283319|588657145|FG002|Overall Study|Withdrawal by Subject|2|||
162986901|NCT03283319|588657146|FG003|Overall Study|Withdrawal by Subject|1|||
162986902|NCT03283319|588657147|FG004|Overall Study|Withdrawal by Subject|0|||
162986903|NCT03283319|588657148|FG005|Overall Study|Withdrawal by Subject|1|||
162986904|NCT03283319|588657143|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986905|NCT03283319|588657144|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986906|NCT03283319|588657145|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986907|NCT03283319|588657146|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
162986908|NCT03283319|588657147|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986909|NCT03283319|588657148|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
162986910|NCT01007942|588657160|FG000|Overall Study|Adverse Event|29|||
162986911|NCT01007942|588657161|FG001|Overall Study|Adverse Event|14|||
162986912|NCT01007942|588657160|FG000|Overall Study|Abnormal test procedure|0|||
162986913|NCT01007942|588657161|FG001|Overall Study|Abnormal test procedure|1|||
162986914|NCT01007942|588657160|FG000|Overall Study|Disease progression|217|||
162986915|NCT01007942|588657161|FG001|Overall Study|Disease progression|242|||
162986916|NCT01007942|588657160|FG000|Overall Study|New cancer therapy|5|||
162986917|NCT01007942|588657161|FG001|Overall Study|New cancer therapy|1|||
162986918|NCT01007942|588657160|FG000|Overall Study|Protocol Violation|1|||
162986919|NCT01007942|588657161|FG001|Overall Study|Protocol Violation|1|||
162986920|NCT01007942|588657160|FG000|Overall Study|Withdrawal by Subject|19|||
162986921|NCT01007942|588657161|FG001|Overall Study|Withdrawal by Subject|14|||
162986922|NCT01007942|588657160|FG000|Overall Study|Lost to Follow-up|1|||
162986923|NCT01007942|588657161|FG001|Overall Study|Lost to Follow-up|0|||
162986924|NCT01007942|588657160|FG000|Overall Study|Administrative problems|2|||
162986925|NCT01007942|588657161|FG001|Overall Study|Administrative problems|0|||
162986926|NCT01007942|588657160|FG000|Overall Study|Death|3|||
162986927|NCT01007942|588657161|FG001|Overall Study|Death|2|||
162986928|NCT01007942|588657160|FG000|Overall Study|Patients untreated|4|||
162986929|NCT01007942|588657161|FG001|Overall Study|Patients untreated|3|||
162986930|NCT04492020|588657162|FG000|Overall Study|Adverse Event|1|||
162986931|NCT04492020|588657163|FG001|Overall Study|Adverse Event|3|||
162986932|NCT04492020|588657162|FG000|Overall Study|Withdrawal by Subject|4|||
162986933|NCT04492020|588657163|FG001|Overall Study|Withdrawal by Subject|3|||
162986934|NCT04492020|588657162|FG000|Overall Study|Lost to Follow-up|4|||
162986935|NCT04492020|588657163|FG001|Overall Study|Lost to Follow-up|3|||
162986936|NCT04492020|588657162|FG000|Overall Study|Protocol Violation|5|||
162986937|NCT04492020|588657163|FG001|Overall Study|Protocol Violation|2|||
162986938|NCT04492020|588657162|FG000|Overall Study|Lack of Qualifying Event|25|||
162986939|NCT04492020|588657163|FG001|Overall Study|Lack of Qualifying Event|27|||
162986940|NCT04492020|588657162|FG000|Overall Study|Non-compliance with Study Drug|2|||
162986941|NCT04492020|588657163|FG001|Overall Study|Non-compliance with Study Drug|1|||
162986942|NCT03412396|588657164|FG000|Overall Study|Withdrawal by Subject|2|||
162986943|NCT03412396|588657164|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
162986944|NCT03412396|588657164|FG000|Overall Study|Did not undergo RP|2|||
162986945|NCT01175811|588657165|FG000|Overall Study|Adverse Event|1|||
162986946|NCT01175811|588657166|FG001|Overall Study|Adverse Event|1|||
162986947|NCT01175811|588657165|FG000|Overall Study|Entry criteria not met|3|||
162986948|NCT01175811|588657166|FG001|Overall Study|Entry criteria not met|1|||
162986949|NCT01175811|588657165|FG000|Overall Study|Lack of Efficacy|1|||
162986950|NCT01175811|588657166|FG001|Overall Study|Lack of Efficacy|0|||
162986951|NCT01175811|588657165|FG000|Overall Study|Lost to Follow-up|3|||
162986952|NCT01175811|588657166|FG001|Overall Study|Lost to Follow-up|2|||
162986953|NCT01175811|588657165|FG000|Overall Study|Physician Decision|1|||
162986954|NCT01175811|588657166|FG001|Overall Study|Physician Decision|1|||
162986955|NCT01175811|588657165|FG000|Overall Study|Protocol Violation|1|||
162986956|NCT01175811|588657166|FG001|Overall Study|Protocol Violation|2|||
162986957|NCT01175811|588657165|FG000|Overall Study|Withdrawal by Subject|6|||
162986958|NCT01175811|588657166|FG001|Overall Study|Withdrawal by Subject|7|||
162986959|NCT04715932|588657169|FG000|Overall Study|Lost to Follow-up|1|||
162986960|NCT04715932|588657170|FG001|Overall Study|Lost to Follow-up|0|||
162986961|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
162986962|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
162986963|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162986964|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162986965|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
162986966|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
162986967|NCT03560986|588657171|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
162635924|NCT00673465|587381691|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635925|NCT00673465|587381692|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635926|NCT00673465|587381693|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635927|NCT00673465|587381694|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
162986968|NCT03560986|588657172|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
162986969|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
162986970|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
162986971|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
162986972|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
162986973|NCT03560986|588657171|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
162986974|NCT03560986|588657172|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
162986975|NCT00655876|588657173|FG000|Overall Study|Protocol Violation|9|||
162986976|NCT00655876|588657174|FG001|Overall Study|Protocol Violation|7|||
162986977|NCT00326963|588657175|FG000|Overall Study|Adverse Event|2|||
162986978|NCT00326963|588657175|FG000|Overall Study|Injection site reaction|1|||
162986979|NCT00326963|588657175|FG000|Overall Study|Death|1|||
162986980|NCT00326963|588657175|FG000|Overall Study|Failure to return|10|||
162986981|NCT00326963|588657175|FG000|Overall Study|Withdrawal by Subject|10|||
162986982|NCT00326963|588657175|FG000|Overall Study|Refused treatment / did not cooperate|5|||
162986983|NCT00326963|588657175|FG000|Overall Study|Violation of selection criteria at entry|2|||
162986984|NCT00326963|588657175|FG000|Overall Study|Other protocol violation|1|||
162986985|NCT00326963|588657175|FG000|Overall Study|Administrative / other|1|||
162986986|NCT00699374|588657178|FG000|Overall Study|Death|93|||
162986987|NCT00699374|588657179|FG001|Overall Study|Death|83|||
162986988|NCT00699374|588657178|FG000|Overall Study|Adverse Event|70|||
162986989|NCT00699374|588657179|FG001|Overall Study|Adverse Event|67|||
162986990|NCT00699374|588657178|FG000|Overall Study|Global deterioration of health status|7|||
162986991|NCT00699374|588657179|FG001|Overall Study|Global deterioration of health status|8|||
162986992|NCT00699374|588657178|FG000|Overall Study|Lost to Follow-up|3|||
162986993|NCT00699374|588657179|FG001|Overall Study|Lost to Follow-up|5|||
162986994|NCT00699374|588657178|FG000|Overall Study|Withdrawal by Subject|34|||
162986995|NCT00699374|588657179|FG001|Overall Study|Withdrawal by Subject|44|||
162986996|NCT00699374|588657178|FG000|Overall Study|Objective progression or relapse|281|||
162986997|NCT00699374|588657179|FG001|Overall Study|Objective progression or relapse|277|||
162986998|NCT00699374|588657178|FG000|Overall Study|Other|18|||
162986999|NCT00699374|588657179|FG001|Overall Study|Other|15|||
162987000|NCT00699374|588657178|FG000|Overall Study|Protocol Violation|2|||
162987001|NCT00699374|588657179|FG001|Overall Study|Protocol Violation|6|||
162987002|NCT00699374|588657178|FG000|Overall Study|Study terminated by sponsor|13|||
162987003|NCT00699374|588657179|FG001|Overall Study|Study terminated by sponsor|28|||
162987004|NCT00699374|588657178|FG000|Overall Study|Randomized but not treated|4|||
162987005|NCT00699374|588657179|FG001|Overall Study|Randomized but not treated|2|||
162987006|NCT00699374|588657178|FG000|Overall Study|Died 28 days after last dose|5|||
162987007|NCT00699374|588657179|FG001|Overall Study|Died 28 days after last dose|9|||
162987008|NCT01783548|588657183|FG000|Overall Study|Adverse Event|8|||
162987009|NCT01783548|588657184|FG001|Overall Study|Adverse Event|4|||
162987010|NCT01783548|588657183|FG000|Overall Study|Withdrawal by Subject|11|||
162987011|NCT01783548|588657184|FG001|Overall Study|Withdrawal by Subject|8|||
162987012|NCT01783548|588657183|FG000|Overall Study|Non-compliance|4|||
162987013|NCT01783548|588657184|FG001|Overall Study|Non-compliance|0|||
162987014|NCT01783548|588657183|FG000|Overall Study|Protocol Violation|2|||
162987015|NCT01783548|588657184|FG001|Overall Study|Protocol Violation|2|||
162987016|NCT01783548|588657183|FG000|Overall Study|Lost to Follow-up|8|||
162987017|NCT01783548|588657184|FG001|Overall Study|Lost to Follow-up|3|||
162987018|NCT01783548|588657183|FG000|Overall Study|Lack of Efficacy|1|||
162987019|NCT01783548|588657184|FG001|Overall Study|Lack of Efficacy|1|||
162987020|NCT04645966|588657185|FG000|Vaccination Phase|Adverse Event|1|||
162987021|NCT04645966|588657186|FG001|Vaccination Phase|Adverse Event|0|||
162987022|NCT04645966|588657187|FG002|Vaccination Phase|Adverse Event|0|||
162987023|NCT04645966|588657188|FG003|Vaccination Phase|Adverse Event|0|||
162987024|NCT04645966|588657189|FG004|Vaccination Phase|Adverse Event|0|||
162987025|NCT04645966|588657190|FG005|Vaccination Phase|Adverse Event|0|||
162987026|NCT04645966|588657191|FG006|Vaccination Phase|Adverse Event|1|||
162987027|NCT04645966|588657192|FG007|Vaccination Phase|Adverse Event|0|||
162987028|NCT04645966|588657193|FG008|Vaccination Phase|Adverse Event|0|||
162987029|NCT04645966|588657185|FG000|Vaccination Phase|Death|0|||
162987030|NCT04645966|588657186|FG001|Vaccination Phase|Death|0|||
162987031|NCT04645966|588657187|FG002|Vaccination Phase|Death|0|||
162987032|NCT04645966|588657188|FG003|Vaccination Phase|Death|0|||
162987033|NCT04645966|588657189|FG004|Vaccination Phase|Death|0|||
162987034|NCT04645966|588657190|FG005|Vaccination Phase|Death|1|||
162715143|NCT01981850|587665852|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715144|NCT01981850|587665853|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715145|NCT01981850|587665854|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162987035|NCT04645966|588657191|FG006|Vaccination Phase|Death|0|||
162987036|NCT04645966|588657192|FG007|Vaccination Phase|Death|0|||
162987037|NCT04645966|588657193|FG008|Vaccination Phase|Death|0|||
162987038|NCT04645966|588657185|FG000|Vaccination Phase|Protocol Violation|0|||
162987039|NCT04645966|588657186|FG001|Vaccination Phase|Protocol Violation|0|||
162987040|NCT04645966|588657187|FG002|Vaccination Phase|Protocol Violation|0|||
162987041|NCT04645966|588657188|FG003|Vaccination Phase|Protocol Violation|0|||
162987042|NCT04645966|588657189|FG004|Vaccination Phase|Protocol Violation|1|||
162987043|NCT04645966|588657190|FG005|Vaccination Phase|Protocol Violation|0|||
162987044|NCT04645966|588657191|FG006|Vaccination Phase|Protocol Violation|0|||
162987045|NCT04645966|588657192|FG007|Vaccination Phase|Protocol Violation|0|||
162987046|NCT04645966|588657193|FG008|Vaccination Phase|Protocol Violation|0|||
162987047|NCT04645966|588657185|FG000|Vaccination Phase|Study terminated by sponsor|0|||
162987048|NCT04645966|588657186|FG001|Vaccination Phase|Study terminated by sponsor|0|||
162987049|NCT04645966|588657187|FG002|Vaccination Phase|Study terminated by sponsor|14|||
162987050|NCT04645966|588657188|FG003|Vaccination Phase|Study terminated by sponsor|15|||
162987051|NCT04645966|588657189|FG004|Vaccination Phase|Study terminated by sponsor|47|||
162987052|NCT04645966|588657190|FG005|Vaccination Phase|Study terminated by sponsor|43|||
162987053|NCT04645966|588657191|FG006|Vaccination Phase|Study terminated by sponsor|29|||
162987054|NCT04645966|588657192|FG007|Vaccination Phase|Study terminated by sponsor|29|||
162987055|NCT04645966|588657193|FG008|Vaccination Phase|Study terminated by sponsor|12|||
162987056|NCT04645966|588657185|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987057|NCT04645966|588657186|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987058|NCT04645966|588657187|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
162987059|NCT04645966|588657188|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
162987060|NCT04645966|588657189|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
162987061|NCT04645966|588657190|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
162987062|NCT04645966|588657191|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987063|NCT04645966|588657192|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
162987064|NCT04645966|588657193|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
162987065|NCT04645966|588657185|FG000|Vaccination Phase|Other|0|||
162987066|NCT04645966|588657186|FG001|Vaccination Phase|Other|0|||
162987067|NCT04645966|588657187|FG002|Vaccination Phase|Other|0|||
162987068|NCT04645966|588657188|FG003|Vaccination Phase|Other|0|||
162987069|NCT04645966|588657189|FG004|Vaccination Phase|Other|0|||
162987070|NCT04645966|588657190|FG005|Vaccination Phase|Other|2|||
162987071|NCT04645966|588657191|FG006|Vaccination Phase|Other|0|||
162987072|NCT04645966|588657192|FG007|Vaccination Phase|Other|0|||
162987073|NCT04645966|588657193|FG008|Vaccination Phase|Other|0|||
162987074|NCT04645966|588657185|FG000|Vaccination Phase|Lost to Follow-up|0|||
162987075|NCT04645966|588657186|FG001|Vaccination Phase|Lost to Follow-up|0|||
162987076|NCT04645966|588657187|FG002|Vaccination Phase|Lost to Follow-up|0|||
162987077|NCT04645966|588657188|FG003|Vaccination Phase|Lost to Follow-up|0|||
162987078|NCT04645966|588657189|FG004|Vaccination Phase|Lost to Follow-up|0|||
162987079|NCT04645966|588657190|FG005|Vaccination Phase|Lost to Follow-up|0|||
162987080|NCT04645966|588657191|FG006|Vaccination Phase|Lost to Follow-up|0|||
162987081|NCT04645966|588657192|FG007|Vaccination Phase|Lost to Follow-up|1|||
162987082|NCT04645966|588657193|FG008|Vaccination Phase|Lost to Follow-up|0|||
162987083|NCT04645966|588657185|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
162987084|NCT04645966|588657186|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
162987085|NCT04645966|588657187|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
162987086|NCT04645966|588657188|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
162987087|NCT04645966|588657189|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
162987088|NCT04645966|588657190|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
162987089|NCT04645966|588657191|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
162987090|NCT04645966|588657192|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
162987091|NCT04645966|588657193|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
162987092|NCT04645966|588657185|FG000|Follow-up Phase|Lost to Follow-up|0|||
162987093|NCT04645966|588657186|FG001|Follow-up Phase|Lost to Follow-up|0|||
162987094|NCT04645966|588657187|FG002|Follow-up Phase|Lost to Follow-up|0|||
162987095|NCT04645966|588657188|FG003|Follow-up Phase|Lost to Follow-up|0|||
162987096|NCT04645966|588657189|FG004|Follow-up Phase|Lost to Follow-up|0|||
162987097|NCT04645966|588657190|FG005|Follow-up Phase|Lost to Follow-up|0|||
162987098|NCT04645966|588657191|FG006|Follow-up Phase|Lost to Follow-up|0|||
162987099|NCT04645966|588657192|FG007|Follow-up Phase|Lost to Follow-up|1|||
162987100|NCT04645966|588657193|FG008|Follow-up Phase|Lost to Follow-up|0|||
162987101|NCT00552578|588657197|FG000|Overall Study|Lost to Follow-up|1|||
162987102|NCT00552578|588657198|FG001|Overall Study|Lost to Follow-up|1|||
162987103|NCT04729309|588657201|FG000|Period 1|Subject unable to return for Period 2|3|||
162987104|NCT04729309|588657202|FG001|Period 1|Subject unable to return for Period 2|0|||
162987105|NCT04729309|588657201|FG000|Period 1|Lost to Follow-up|1|||
162987106|NCT04729309|588657202|FG001|Period 1|Lost to Follow-up|0|||
162987107|NCT01059539|588657203|FG000|Overall Study|Adverse Event|66|||
162987108|NCT01059539|588657203|FG000|Overall Study|Insufficient Therapeutic Response|26|||
162987109|NCT01059539|588657203|FG000|Overall Study|Protocol Violation|55|||
162987110|NCT01059539|588657203|FG000|Overall Study|Withdrawal of Consent|80|||
162987111|NCT01059539|588657203|FG000|Overall Study|Lost to Follow-up|42|||
162987112|NCT01059539|588657203|FG000|Overall Study|Reason Not Specified|2|||
162987113|NCT04091659|588657207|FG000|Overall Study|Protocol Violation|3|||
162987114|NCT04091659|588657208|FG001|Overall Study|Protocol Violation|0|||
162987115|NCT04091659|588657207|FG000|Overall Study|Lost to Follow-up|0|||
162987116|NCT04091659|588657208|FG001|Overall Study|Lost to Follow-up|1|||
162987117|NCT00895947|588657209|FG000|Overall Study|Adverse Event|3|||
162715146|NCT01981850|587665855|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162987118|NCT00895947|588657210|FG001|Overall Study|Adverse Event|4|||
162987119|NCT00895947|588657209|FG000|Overall Study|Lost to Follow-up|3|||
162987120|NCT00895947|588657210|FG001|Overall Study|Lost to Follow-up|4|||
162987121|NCT00895947|588657209|FG000|Overall Study|Protocol Violation|4|||
162987122|NCT00895947|588657210|FG001|Overall Study|Protocol Violation|2|||
162987123|NCT00895947|588657209|FG000|Overall Study|Withdrawal by Subject|2|||
162987124|NCT00895947|588657210|FG001|Overall Study|Withdrawal by Subject|0|||
162987125|NCT00616629|588657219|FG000|Overall Study|Protocol Violation|1|||
162987126|NCT00616629|588657220|FG001|Overall Study|Protocol Violation|2|||
162987127|NCT00616629|588657221|FG002|Overall Study|Protocol Violation|1|||
162987128|NCT00616629|588657222|FG003|Overall Study|Protocol Violation|0|||
162987129|NCT00616629|588657223|FG004|Overall Study|Protocol Violation|0|||
162987130|NCT00616629|588657219|FG000|Overall Study|AV-block|1|||
162987131|NCT00616629|588657220|FG001|Overall Study|AV-block|0|||
162987132|NCT00616629|588657221|FG002|Overall Study|AV-block|0|||
162987133|NCT00616629|588657222|FG003|Overall Study|AV-block|0|||
162987134|NCT00616629|588657223|FG004|Overall Study|AV-block|0|||
162987135|NCT01739348|588657224|FG000|Part I (Base Study)|Adverse Event|41|||
162987136|NCT01739348|588657225|FG001|Part I (Base Study)|Adverse Event|52|||
162987137|NCT01739348|588657226|FG002|Part I (Base Study)|Adverse Event|8|||
162987138|NCT01739348|588657227|FG003|Part I (Base Study)|Adverse Event|33|||
162987139|NCT01739348|588657224|FG000|Part I (Base Study)|Death|10|||
162987140|NCT01739348|588657225|FG001|Part I (Base Study)|Death|7|||
162987141|NCT01739348|588657226|FG002|Part I (Base Study)|Death|2|||
162987142|NCT01739348|588657227|FG003|Part I (Base Study)|Death|8|||
162987143|NCT01739348|588657224|FG000|Part I (Base Study)|Lack of Efficacy|3|||
162987144|NCT01739348|588657225|FG001|Part I (Base Study)|Lack of Efficacy|8|||
162987145|NCT01739348|588657226|FG002|Part I (Base Study)|Lack of Efficacy|0|||
162987146|NCT01739348|588657227|FG003|Part I (Base Study)|Lack of Efficacy|7|||
162987147|NCT01739348|588657224|FG000|Part I (Base Study)|Lost to Follow-up|4|||
162987148|NCT01739348|588657225|FG001|Part I (Base Study)|Lost to Follow-up|2|||
162987149|NCT01739348|588657226|FG002|Part I (Base Study)|Lost to Follow-up|4|||
162987150|NCT01739348|588657227|FG003|Part I (Base Study)|Lost to Follow-up|4|||
162987151|NCT01739348|588657224|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
162987152|NCT01739348|588657225|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
162987153|NCT01739348|588657226|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
162987154|NCT01739348|588657227|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
162987155|NCT01739348|588657224|FG000|Part I (Base Study)|Physician Decision|10|||
162987156|NCT01739348|588657225|FG001|Part I (Base Study)|Physician Decision|7|||
162987157|NCT01739348|588657226|FG002|Part I (Base Study)|Physician Decision|1|||
162987158|NCT01739348|588657227|FG003|Part I (Base Study)|Physician Decision|4|||
162987159|NCT01739348|588657224|FG000|Part I (Base Study)|Protocol Violation|2|||
162987160|NCT01739348|588657225|FG001|Part I (Base Study)|Protocol Violation|0|||
162987161|NCT01739348|588657226|FG002|Part I (Base Study)|Protocol Violation|1|||
162987162|NCT01739348|588657227|FG003|Part I (Base Study)|Protocol Violation|2|||
162987163|NCT01739348|588657224|FG000|Part I (Base Study)|Screen Failure|2|||
162987164|NCT01739348|588657225|FG001|Part I (Base Study)|Screen Failure|0|||
162987165|NCT01739348|588657226|FG002|Part I (Base Study)|Screen Failure|0|||
162987166|NCT01739348|588657227|FG003|Part I (Base Study)|Screen Failure|0|||
162987167|NCT01739348|588657224|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
162987168|NCT01739348|588657225|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
162987169|NCT01739348|588657226|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
162987170|NCT01739348|588657227|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
162987171|NCT01739348|588657224|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
162715147|NCT01981850|587665856|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162715148|NCT01981850|587665847|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
162715149|NCT01981850|587665848|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
162987172|NCT01739348|588657225|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
162987173|NCT01739348|588657226|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
162987174|NCT01739348|588657227|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
162987175|NCT01739348|588657224|FG000|Part I (Base Study)|Participant Moved|4|||
162987176|NCT01739348|588657225|FG001|Part I (Base Study)|Participant Moved|3|||
162987177|NCT01739348|588657226|FG002|Part I (Base Study)|Participant Moved|1|||
162987178|NCT01739348|588657227|FG003|Part I (Base Study)|Participant Moved|7|||
162987179|NCT01739348|588657224|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
162987180|NCT01739348|588657225|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
163059893|NCT02911116|588928253|FG001|Overall Study|Lost to Follow-up|1|||
162987181|NCT01739348|588657226|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
162987182|NCT01739348|588657227|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
162987183|NCT01739348|588657224|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
162987184|NCT01739348|588657225|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
162987185|NCT01739348|588657226|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
162987186|NCT01739348|588657227|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
162987187|NCT01739348|588657224|FG000|Part II (Extension Study)|Adverse Event|10|||
162987188|NCT01739348|588657225|FG001|Part II (Extension Study)|Adverse Event|11|||
162987189|NCT01739348|588657226|FG002|Part II (Extension Study)|Adverse Event|7|||
162987190|NCT01739348|588657227|FG003|Part II (Extension Study)|Adverse Event|26|||
162987191|NCT01739348|588657224|FG000|Part II (Extension Study)|Death|3|||
162987192|NCT01739348|588657225|FG001|Part II (Extension Study)|Death|3|||
162987193|NCT01739348|588657226|FG002|Part II (Extension Study)|Death|2|||
162987194|NCT01739348|588657227|FG003|Part II (Extension Study)|Death|6|||
162987195|NCT01739348|588657224|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
162987196|NCT01739348|588657225|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
162987197|NCT01739348|588657226|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
162987198|NCT01739348|588657227|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
162987199|NCT01739348|588657224|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
162987200|NCT01739348|588657225|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
162987201|NCT01739348|588657226|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
162987202|NCT01739348|588657227|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
162987203|NCT01739348|588657224|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987204|NCT01739348|588657225|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987205|NCT01739348|588657226|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
162987206|NCT01739348|588657227|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
162987207|NCT01739348|588657224|FG000|Part II (Extension Study)|Physician Decision|7|||
162987208|NCT01739348|588657225|FG001|Part II (Extension Study)|Physician Decision|11|||
162987209|NCT01739348|588657226|FG002|Part II (Extension Study)|Physician Decision|6|||
162987210|NCT01739348|588657227|FG003|Part II (Extension Study)|Physician Decision|12|||
162987211|NCT01739348|588657224|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
162987212|NCT01739348|588657225|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
162987213|NCT01739348|588657226|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
162987214|NCT01739348|588657227|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
162987215|NCT01739348|588657224|FG000|Part II (Extension Study)|Participant Moved|3|||
162987216|NCT01739348|588657225|FG001|Part II (Extension Study)|Participant Moved|3|||
162987217|NCT01739348|588657226|FG002|Part II (Extension Study)|Participant Moved|0|||
162987218|NCT01739348|588657227|FG003|Part II (Extension Study)|Participant Moved|3|||
162987219|NCT01739348|588657224|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
162987220|NCT01739348|588657225|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
162987221|NCT01739348|588657226|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
162987222|NCT01739348|588657227|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
162987223|NCT01739348|588657224|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
162987224|NCT01739348|588657225|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
162987225|NCT01739348|588657226|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
162987226|NCT01739348|588657227|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
162987227|NCT01447420|588657230|FG000|Overall Study|Adverse Event|2|||
162987228|NCT01447420|588657231|FG001|Overall Study|Adverse Event|4|||
162987229|NCT01447420|588657232|FG002|Overall Study|Adverse Event|2|||
162987230|NCT01447420|588657230|FG000|Overall Study|Protocol Violation|3|||
162987231|NCT01447420|588657231|FG001|Overall Study|Protocol Violation|3|||
162987232|NCT01447420|588657232|FG002|Overall Study|Protocol Violation|0|||
162987233|NCT01447420|588657230|FG000|Overall Study|Withdrawal by Subject|4|||
162987234|NCT01447420|588657231|FG001|Overall Study|Withdrawal by Subject|1|||
162987235|NCT01447420|588657232|FG002|Overall Study|Withdrawal by Subject|0|||
162987236|NCT01447420|588657230|FG000|Overall Study|Lack of Efficacy|1|||
163059894|NCT01240694|588928254|FG000|Overall Study|Adverse Event|9|||
163059895|NCT01240694|588928254|FG000|Overall Study|Lack of Efficacy|6|||
163059896|NCT01240694|588928254|FG000|Overall Study|Withdrawal by Subject|6|||
162635928|NCT00673465|587381695|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
162987237|NCT01447420|588657231|FG001|Overall Study|Lack of Efficacy|19|||
162987238|NCT01447420|588657232|FG002|Overall Study|Lack of Efficacy|8|||
162987239|NCT00528411|588657237|FG000|Overall Study|Adverse Event|4|||
162987240|NCT00528411|588657238|FG001|Overall Study|Adverse Event|0|||
162987241|NCT00528411|588657239|FG002|Overall Study|Adverse Event|1|||
162987242|NCT00528411|588657237|FG000|Overall Study|Incorrect Enrolment|1|||
162987243|NCT00528411|588657238|FG001|Overall Study|Incorrect Enrolment|1|||
162987244|NCT00528411|588657239|FG002|Overall Study|Incorrect Enrolment|0|||
162987245|NCT00528411|588657237|FG000|Overall Study|Severe non-compliance to protocol|0|||
162987246|NCT00528411|588657238|FG001|Overall Study|Severe non-compliance to protocol|1|||
163059897|NCT01240694|588928254|FG000|Overall Study|Protocol Violation|2|||
163059898|NCT01240694|588928254|FG000|Overall Study|Lost to Follow-up|2|||
162987247|NCT00528411|588657239|FG002|Overall Study|Severe non-compliance to protocol|0|||
162987248|NCT00528411|588657237|FG000|Overall Study|Prior commitment medication|0|||
162987249|NCT00528411|588657238|FG001|Overall Study|Prior commitment medication|1|||
162987250|NCT00528411|588657239|FG002|Overall Study|Prior commitment medication|0|||
162987251|NCT02695537|588657249|FG000|Overall Study|Adverse Event|3|||
162987252|NCT02695537|588657249|FG000|Overall Study|Lack of Efficacy|28|||
162987253|NCT02695537|588657249|FG000|Overall Study|Withdrawal by Subject|4|||
162987254|NCT02695537|588657249|FG000|Overall Study|Protocol Violation|3|||
162987255|NCT04015908|588657250|FG000|Overall Study|Lost to Follow-up|0|||
162987256|NCT04015908|588657251|FG001|Overall Study|Lost to Follow-up|1|||
162987257|NCT02792699|588657252|FG000|Overall Study|Adverse Event|1|||
162987258|NCT02792699|588657253|FG001|Overall Study|Adverse Event|2|||
162987259|NCT02792699|588657254|FG002|Overall Study|Adverse Event|4|||
162987260|NCT02792699|588657252|FG000|Overall Study|Withdrawal by Subject|4|||
162987261|NCT02792699|588657253|FG001|Overall Study|Withdrawal by Subject|4|||
162987262|NCT02792699|588657254|FG002|Overall Study|Withdrawal by Subject|3|||
162987263|NCT02792699|588657252|FG000|Overall Study|Lost to Follow-up|0|||
162987264|NCT02792699|588657253|FG001|Overall Study|Lost to Follow-up|1|||
162987265|NCT02792699|588657254|FG002|Overall Study|Lost to Follow-up|2|||
162987266|NCT02792699|588657252|FG000|Overall Study|Physician Decision|2|||
162987267|NCT02792699|588657253|FG001|Overall Study|Physician Decision|0|||
162987268|NCT02792699|588657254|FG002|Overall Study|Physician Decision|0|||
162987269|NCT02792699|588657252|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
162987270|NCT02792699|588657253|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
162987271|NCT02792699|588657254|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
162987272|NCT02792699|588657252|FG000|Overall Study|Other|1|||
162987273|NCT02792699|588657253|FG001|Overall Study|Other|0|||
162987274|NCT02792699|588657254|FG002|Overall Study|Other|0|||
162987275|NCT01715571|588657255|FG000|Overall Study|Lost to Follow-up|8|||
162987276|NCT06187909|588657261|FG000|Overall Study|Withdrawal by Subject|2|||
162987277|NCT06187909|588657262|FG001|Overall Study|Withdrawal by Subject|2|||
162987278|NCT03569228|588657263|FG000|Overall Study|Withdrawal by PI|0|||
162987279|NCT03569228|588657264|FG001|Overall Study|Withdrawal by PI|0|||
162987280|NCT03569228|588657265|FG002|Overall Study|Withdrawal by PI|2|||
162987281|NCT03569228|588657266|FG003|Overall Study|Withdrawal by PI|2|||
162987282|NCT03569228|588657267|FG004|Overall Study|Withdrawal by PI|1|||
162987283|NCT03569228|588657268|FG005|Overall Study|Withdrawal by PI|0|||
162987284|NCT03569228|588657269|FG006|Overall Study|Withdrawal by PI|0|||
162987285|NCT03569228|588657270|FG007|Overall Study|Withdrawal by PI|0|||
162987286|NCT03569228|588657271|FG008|Overall Study|Withdrawal by PI|0|||
162987287|NCT03569228|588657263|FG000|Overall Study|Lost to Follow-up|0|||
162987288|NCT03569228|588657264|FG001|Overall Study|Lost to Follow-up|0|||
162987289|NCT03569228|588657265|FG002|Overall Study|Lost to Follow-up|0|||
162987290|NCT03569228|588657266|FG003|Overall Study|Lost to Follow-up|0|||
162987291|NCT03569228|588657267|FG004|Overall Study|Lost to Follow-up|0|||
162987292|NCT03569228|588657268|FG005|Overall Study|Lost to Follow-up|0|||
162987293|NCT03569228|588657269|FG006|Overall Study|Lost to Follow-up|0|||
162987294|NCT03569228|588657270|FG007|Overall Study|Lost to Follow-up|0|||
162987295|NCT03569228|588657271|FG008|Overall Study|Lost to Follow-up|1|||
162987296|NCT03569228|588657263|FG000|Overall Study|Screen Fail|2|||
162987297|NCT03569228|588657264|FG001|Overall Study|Screen Fail|2|||
162635929|NCT00673465|587381696|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
162635930|NCT01195415|587381715|FG000|Overall Study|No repeat biopsy due to progression|2|||
162635931|NCT01919723|587381716|FG000|Overall Study|Blood Samples Hemolyzed|2|||
162635932|NCT01919723|587381717|FG001|Overall Study|Blood Samples Hemolyzed|2|||
162635933|NCT04294472|587381718|FG000|Overall Study|Adverse Event|0|||
162635934|NCT04294472|587381719|FG001|Overall Study|Adverse Event|1|||
162635935|NCT04294472|587381720|FG002|Overall Study|Adverse Event|1|||
162635936|NCT04294472|587381718|FG000|Overall Study|Randomized but not treated|0|||
162635937|NCT04294472|587381719|FG001|Overall Study|Randomized but not treated|1|||
162635938|NCT04294472|587381720|FG002|Overall Study|Randomized but not treated|1|||
162635939|NCT00563381|587381721|FG000|Overall Study|Adverse Event|264|||
162987298|NCT03569228|588657265|FG002|Overall Study|Screen Fail|1|||
162987299|NCT03569228|588657266|FG003|Overall Study|Screen Fail|1|||
162987300|NCT03569228|588657267|FG004|Overall Study|Screen Fail|1|||
162987301|NCT03569228|588657268|FG005|Overall Study|Screen Fail|3|||
162987302|NCT03569228|588657269|FG006|Overall Study|Screen Fail|1|||
162987303|NCT03569228|588657270|FG007|Overall Study|Screen Fail|5|||
162987304|NCT03569228|588657271|FG008|Overall Study|Screen Fail|2|||
162987305|NCT05442866|588657272|FG000|Overall Study|Death|1|||
162987306|NCT05442866|588657272|FG000|Overall Study|Lost to Follow-up|9|||
162987307|NCT05442866|588657272|FG000|Overall Study|Protocol Violation|1|||
162987308|NCT01584843|588657276|FG000|First Treatment Period|Adverse Event|0|||
162987309|NCT01584843|588657277|FG001|First Treatment Period|Adverse Event|0|||
162987310|NCT01584843|588657278|FG002|First Treatment Period|Adverse Event|1|||
162635940|NCT00563381|587381722|FG001|Overall Study|Adverse Event|292|||
162987311|NCT01584843|588657279|FG003|First Treatment Period|Adverse Event|0|||
162987312|NCT01584843|588657280|FG004|First Treatment Period|Adverse Event|0|||
162987313|NCT01584843|588657281|FG005|First Treatment Period|Adverse Event|0|||
162635941|NCT00563381|587381721|FG000|Overall Study|Protocol Violation|66|||
162635942|NCT00563381|587381722|FG001|Overall Study|Protocol Violation|74|||
162635943|NCT00563381|587381721|FG000|Overall Study|Lost to Follow-up|7|||
162635944|NCT00563381|587381722|FG001|Overall Study|Lost to Follow-up|15|||
162635945|NCT00563381|587381721|FG000|Overall Study|Withdrawal by Subject|192|||
162635946|NCT00563381|587381722|FG001|Overall Study|Withdrawal by Subject|209|||
162635947|NCT00563381|587381721|FG000|Overall Study|Lack of Efficacy|32|||
162635948|NCT00563381|587381722|FG001|Overall Study|Lack of Efficacy|24|||
162635949|NCT00563381|587381721|FG000|Overall Study|Individual different reasons|24|||
162635950|NCT00563381|587381722|FG001|Overall Study|Individual different reasons|34|||
162635951|NCT01957644|587381723|FG000|Overall Study|Adverse Event|4|||
162987314|NCT01584843|588657276|FG000|First Treatment Period|Protocol Violation|0|||
162987315|NCT01584843|588657277|FG001|First Treatment Period|Protocol Violation|0|||
162987316|NCT01584843|588657278|FG002|First Treatment Period|Protocol Violation|0|||
162987317|NCT01584843|588657279|FG003|First Treatment Period|Protocol Violation|0|||
162987318|NCT01584843|588657280|FG004|First Treatment Period|Protocol Violation|0|||
162987319|NCT01584843|588657281|FG005|First Treatment Period|Protocol Violation|1|||
162987320|NCT01584843|588657276|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987321|NCT01584843|588657277|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987322|NCT01584843|588657278|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987323|NCT01584843|588657279|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987324|NCT01584843|588657280|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
162987325|NCT01584843|588657281|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
162987326|NCT01584843|588657276|FG000|Second Treatment Period|Withdrawal by Subject|0|||
162987327|NCT01584843|588657277|FG001|Second Treatment Period|Withdrawal by Subject|0|||
162987328|NCT01584843|588657278|FG002|Second Treatment Period|Withdrawal by Subject|0|||
162987329|NCT01584843|588657279|FG003|Second Treatment Period|Withdrawal by Subject|0|||
162987330|NCT01584843|588657280|FG004|Second Treatment Period|Withdrawal by Subject|0|||
162987331|NCT01584843|588657281|FG005|Second Treatment Period|Withdrawal by Subject|1|||
162987332|NCT00643565|588657282|FG000|Overall Study|Death|12|||
162987333|NCT00643565|588657283|FG001|Overall Study|Death|11|||
162987334|NCT00643565|588657282|FG000|Overall Study|Withdrawal by Subject|4|||
162987335|NCT00643565|588657283|FG001|Overall Study|Withdrawal by Subject|1|||
162987336|NCT00643565|588657282|FG000|Overall Study|Lost to Follow-up|0|||
162987337|NCT00643565|588657283|FG001|Overall Study|Lost to Follow-up|6|||
162987338|NCT00643565|588657282|FG000|Overall Study|Other|7|||
162987339|NCT00643565|588657283|FG001|Overall Study|Other|8|||
162987340|NCT00643565|588657282|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
162987341|NCT00643565|588657283|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
162987342|NCT00643565|588657282|FG000|Overall Study|Recurrence of Disease|2|||
162987343|NCT00643565|588657283|FG001|Overall Study|Recurrence of Disease|1|||
162987344|NCT00643565|588657282|FG000|Overall Study|Progression of Disease|18|||
162987345|NCT00643565|588657283|FG001|Overall Study|Progression of Disease|14|||
162987346|NCT00643565|588657282|FG000|Overall Study|Protocol Violation|3|||
162987347|NCT00643565|588657283|FG001|Overall Study|Protocol Violation|0|||
162987348|NCT00643565|588657282|FG000|Overall Study|Did Not Cooperate|0|||
162987349|NCT00643565|588657283|FG001|Overall Study|Did Not Cooperate|1|||
162987350|NCT00643565|588657282|FG000|Overall Study|Administrative|22|||
162987351|NCT00643565|588657283|FG001|Overall Study|Administrative|16|||
162987352|NCT00643565|588657282|FG000|Overall Study|Adverse Event|5|||
162987353|NCT00643565|588657283|FG001|Overall Study|Adverse Event|8|||
162987354|NCT02317614|588657284|FG000|Overall Study|Lost to Follow-up|1|||
162987355|NCT02317614|588657285|FG001|Overall Study|Lost to Follow-up|1|||
162987356|NCT02317614|588657284|FG000|Overall Study|Withdrawal by Subject|1|||
162987357|NCT02317614|588657285|FG001|Overall Study|Withdrawal by Subject|0|||
162987358|NCT02317614|588657284|FG000|Overall Study|Death|1|||
162987359|NCT02317614|588657285|FG001|Overall Study|Death|1|||
162987360|NCT03285308|588657286|FG000|Overall Study|Adverse Event|3|||
162987361|NCT03285308|588657287|FG001|Overall Study|Adverse Event|7|||
162987362|NCT03285308|588657286|FG000|Overall Study|Withdrawal by Subject|8|||
162987363|NCT03285308|588657287|FG001|Overall Study|Withdrawal by Subject|9|||
162987364|NCT03285308|588657286|FG000|Overall Study|Lost to Follow-up|3|||
162635952|NCT01957644|587381724|FG001|Overall Study|Adverse Event|2|||
162987365|NCT03285308|588657287|FG001|Overall Study|Lost to Follow-up|1|||
162987366|NCT03285308|588657286|FG000|Overall Study|Protocol Deviation|6|||
162987367|NCT03285308|588657287|FG001|Overall Study|Protocol Deviation|5|||
162987368|NCT03285308|588657286|FG000|Overall Study|Reason not Specified|0|||
162987369|NCT03285308|588657287|FG001|Overall Study|Reason not Specified|1|||
162987370|NCT02283983|588657288|FG000|Overall Study|Inclusion criteria not met|0|||
162987371|NCT02283983|588657289|FG001|Overall Study|Inclusion criteria not met|1|||
162987372|NCT02283983|588657288|FG000|Overall Study|Withdrawal by Subject|4|||
162987373|NCT02283983|588657289|FG001|Overall Study|Withdrawal by Subject|2|||
162987374|NCT02283983|588657288|FG000|Overall Study|Protocol Violation|0|||
162987375|NCT02283983|588657289|FG001|Overall Study|Protocol Violation|4|||
162987376|NCT02283983|588657288|FG000|Overall Study|Physician Decision|2|||
162987377|NCT02283983|588657289|FG001|Overall Study|Physician Decision|4|||
162987378|NCT02283983|588657288|FG000|Overall Study|Death|1|||
162987379|NCT02283983|588657289|FG001|Overall Study|Death|0|||
162987380|NCT02283983|588657288|FG000|Overall Study|Adverse Event|1|||
162987381|NCT02283983|588657289|FG001|Overall Study|Adverse Event|0|||
162987382|NCT02283983|588657288|FG000|Overall Study|Lost to Follow-up|9|||
162987383|NCT02283983|588657289|FG001|Overall Study|Lost to Follow-up|8|||
162987384|NCT02283983|588657288|FG000|Overall Study|Relapse|1|||
162987385|NCT02283983|588657289|FG001|Overall Study|Relapse|0|||
162987386|NCT03275064|588657290|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987387|NCT03275064|588657291|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987388|NCT03275064|588657292|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987389|NCT03275064|588657293|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
162987390|NCT03275064|588657294|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
162987391|NCT03275064|588657290|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
162987392|NCT03275064|588657291|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987393|NCT03275064|588657292|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987394|NCT03275064|588657293|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987395|NCT03275064|588657294|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
162987396|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
162987397|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
162987398|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
162987399|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
162987400|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
162987401|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987402|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987403|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987404|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
162987405|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
162987406|NCT03275064|588657290|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
162987407|NCT03275064|588657291|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987408|NCT03275064|588657292|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
162987409|NCT03275064|588657293|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987410|NCT03275064|588657294|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
162987411|NCT00620555|588657297|FG000|Overall Study|Adverse Event|4|||
162987412|NCT00620555|588657297|FG000|Overall Study|Protocol Violation|2|||
162987413|NCT00620555|588657297|FG000|Overall Study|Lack of Efficacy|12|||
162987414|NCT00620555|588657297|FG000|Overall Study|Withdrawal by Subject|1|||
162987415|NCT00620555|588657297|FG000|Overall Study|Choice of other treatment|1|||
162987416|NCT00620555|588657297|FG000|Overall Study|Visit failure against planned|1|||
162987417|NCT00669071|588657299|FG000|Overall Study|Lost to Follow-up|3|||
162987418|NCT00669071|588657299|FG000|Overall Study|Final visit 40 days out of window|1|||
162987419|NCT04305496|588657300|FG000|Global Cohort|Withdrawal by Subject|13|||
162987420|NCT04305496|588657301|FG001|Global Cohort|Withdrawal by Subject|6|||
162987421|NCT04305496|588657300|FG000|Global Cohort|Physician Decision|1|||
162987422|NCT04305496|588657301|FG001|Global Cohort|Physician Decision|1|||
162987423|NCT04305496|588657300|FG000|Global Cohort|Subjective disease progression|16|||
162987424|NCT04305496|588657301|FG001|Global Cohort|Subjective disease progression|17|||
162987425|NCT04305496|588657300|FG000|Global Cohort|Condition under investigation worsened|209|||
162987426|NCT04305496|588657301|FG001|Global Cohort|Condition under investigation worsened|273|||
162987427|NCT04305496|588657300|FG000|Global Cohort|Protocol Violation|2|||
162987428|NCT04305496|588657301|FG001|Global Cohort|Protocol Violation|0|||
162987429|NCT04305496|588657300|FG000|Global Cohort|Adverse Event|44|||
162987430|NCT04305496|588657301|FG001|Global Cohort|Adverse Event|6|||
162987431|NCT04305496|588657300|FG000|Global Cohort|Death|3|||
162987432|NCT04305496|588657301|FG001|Global Cohort|Death|2|||
162987433|NCT04305496|588657300|FG000|Global Cohort|Any reason not specifically recorded|4|||
162987434|NCT04305496|588657301|FG001|Global Cohort|Any reason not specifically recorded|5|||
162715150|NCT01981850|587665849|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
162715151|NCT01981850|587665850|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
162987435|NCT04305496|588657300|FG000|China Cohort|Any reason not specifically recorded|1|||
162987436|NCT04305496|588657301|FG001|China Cohort|Any reason not specifically recorded|1|||
162987437|NCT04305496|588657300|FG000|China Cohort|Adverse Event|8|||
162987438|NCT04305496|588657301|FG001|China Cohort|Adverse Event|2|||
162987439|NCT04305496|588657300|FG000|China Cohort|Condition under investigation worsened|40|||
162987440|NCT04305496|588657301|FG001|China Cohort|Condition under investigation worsened|47|||
162987441|NCT04305496|588657300|FG000|China Cohort|Subjective disease progression|2|||
162987442|NCT04305496|588657301|FG001|China Cohort|Subjective disease progression|2|||
162987443|NCT04305496|588657300|FG000|China Cohort|Withdrawal by Subject|2|||
162987444|NCT04305496|588657301|FG001|China Cohort|Withdrawal by Subject|1|||
162987445|NCT00532935|588657303|FG000|Overall Study|Adverse Event|11|||
162987446|NCT00532935|588657304|FG001|Overall Study|Adverse Event|12|||
162987447|NCT00532935|588657303|FG000|Overall Study|Lack of Efficacy|0|||
162987448|NCT00532935|588657304|FG001|Overall Study|Lack of Efficacy|3|||
162987449|NCT00532935|588657303|FG000|Overall Study|Lost to Follow-up|10|||
162987450|NCT00532935|588657304|FG001|Overall Study|Lost to Follow-up|6|||
162987451|NCT00532935|588657303|FG000|Overall Study|Physician Decision|4|||
162987452|NCT00532935|588657304|FG001|Overall Study|Physician Decision|5|||
162987453|NCT00532935|588657303|FG000|Overall Study|Pregnancy|1|||
162987454|NCT00532935|588657304|FG001|Overall Study|Pregnancy|0|||
162987455|NCT00532935|588657303|FG000|Overall Study|Protocol Violation|4|||
162987456|NCT00532935|588657304|FG001|Overall Study|Protocol Violation|2|||
162987457|NCT00532935|588657303|FG000|Overall Study|Withdrawal by Subject|10|||
162987458|NCT00532935|588657304|FG001|Overall Study|Withdrawal by Subject|9|||
162987459|NCT00532935|588657303|FG000|Overall Study|Protocol Specific Criteria|11|||
162987460|NCT00532935|588657304|FG001|Overall Study|Protocol Specific Criteria|15|||
162987461|NCT02435836|588657308|FG000|Overall Study|Lost to Follow-up|21|||
162987462|NCT02435836|588657308|FG000|Overall Study|Lack of Efficacy|1|||
162987463|NCT02435836|588657308|FG000|Overall Study|Withdrawal by Subject|236|||
162987464|NCT02435836|588657308|FG000|Overall Study|Insufficient Clinical Response|26|||
162987465|NCT02435836|588657308|FG000|Overall Study|Adverse Event|44|||
162987466|NCT02435836|588657308|FG000|Overall Study|Sponsor discontinued trial|167|||
162987467|NCT02435836|588657308|FG000|Overall Study|Noncompliance|27|||
162987468|NCT02435836|588657308|FG000|Overall Study|Protocol Violation|6|||
162987469|NCT02435836|588657308|FG000|Overall Study|Met Withdrawal Criteria|7|||
162987470|NCT02435836|588657308|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
162987471|NCT03176459|588657309|FG000|Overall Study|Lost to Follow-up|5|||
162987472|NCT03176459|588657310|FG001|Overall Study|Lost to Follow-up|7|||
162987473|NCT01602965|588657311|FG000|Overall Study|Lost to Follow-up|4|||
162987474|NCT01602965|588657312|FG001|Overall Study|Lost to Follow-up|2|||
162987475|NCT03190330|588661155|FG000|Overall Study|Adverse Event|2|||
162987476|NCT03190330|588661155|FG000|Overall Study|Death|10|||
162987477|NCT03190330|588661155|FG000|Overall Study|Lost to Follow-up|1|||
162987478|NCT03190330|588661155|FG000|Overall Study|Withdrawal by Subject|6|||
162987479|NCT03190330|588661155|FG000|Overall Study|Progressive Disease|1|||
162987480|NCT02081209|588661156|FG000|Overall Study|Withdrawal by Subject|1|||
162987481|NCT02370329|588661157|FG000|Overall Study|Alternate treatment|1|||
162987482|NCT02370329|588661157|FG000|Overall Study|Adverse Event|1|||
162987483|NCT02370329|588661157|FG000|Overall Study|Disease progression|3|||
162987484|NCT02370329|588661157|FG000|Overall Study|Physician Decision|2|||
162987485|NCT02370329|588661157|FG000|Overall Study|Study closure|4|||
162987486|NCT02022748|588661161|FG000|Overall Study|Adverse Event|1|||
162987487|NCT02022748|588661162|FG001|Overall Study|Adverse Event|1|||
162987488|NCT02022748|588661163|FG002|Overall Study|Adverse Event|0|||
162987489|NCT02022748|588661161|FG000|Overall Study|Withdrawal by Subject|0|||
162987490|NCT02022748|588661162|FG001|Overall Study|Withdrawal by Subject|1|||
162987491|NCT02022748|588661163|FG002|Overall Study|Withdrawal by Subject|0|||
162987492|NCT04347122|588661166|FG000|Overall Study|Physician Decision|0|||
162987493|NCT04347122|588661167|FG001|Overall Study|Physician Decision|3|||
162715152|NCT01981850|587665851|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
162987494|NCT04347122|588661168|FG002|Overall Study|Physician Decision|3|||
162715153|NCT01981850|587665852|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
162715154|NCT01981850|587665853|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
162715155|NCT01981850|587665854|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
162987495|NCT04347122|588661169|FG003|Overall Study|Physician Decision|6|||
162987496|NCT03510598|588661170|FG000|Overall Study|Withdrawal by Subject|1|||
162987497|NCT05327816|588661172|FG000|Overall Study|Lost to Follow-up|1|||
162987498|NCT05327816|588661173|FG001|Overall Study|Lost to Follow-up|0|||
162987499|NCT05327816|588661174|FG002|Overall Study|Lost to Follow-up|0|||
162987500|NCT05327816|588661175|FG003|Overall Study|Lost to Follow-up|0|||
162987501|NCT05327816|588661176|FG004|Overall Study|Lost to Follow-up|0|||
162987502|NCT05327816|588661177|FG005|Overall Study|Lost to Follow-up|0|||
162987503|NCT05327816|588661178|FG006|Overall Study|Lost to Follow-up|0|||
162715156|NCT01981850|587665855|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
162987504|NCT05327816|588661179|FG007|Overall Study|Lost to Follow-up|0|||
162987505|NCT05327816|588661180|FG008|Overall Study|Lost to Follow-up|0|||
162987506|NCT05327816|588661181|FG009|Overall Study|Lost to Follow-up|1|||
162987507|NCT05327816|588661182|FG010|Overall Study|Lost to Follow-up|0|||
162987508|NCT05327816|588661172|FG000|Overall Study|Withdrawal by Subject|0|||
162987509|NCT05327816|588661173|FG001|Overall Study|Withdrawal by Subject|0|||
162987510|NCT05327816|588661174|FG002|Overall Study|Withdrawal by Subject|0|||
162987511|NCT05327816|588661175|FG003|Overall Study|Withdrawal by Subject|0|||
162987512|NCT05327816|588661176|FG004|Overall Study|Withdrawal by Subject|1|||
162987513|NCT05327816|588661177|FG005|Overall Study|Withdrawal by Subject|1|||
162987514|NCT05327816|588661178|FG006|Overall Study|Withdrawal by Subject|0|||
162987515|NCT05327816|588661179|FG007|Overall Study|Withdrawal by Subject|0|||
162987516|NCT05327816|588661180|FG008|Overall Study|Withdrawal by Subject|0|||
162987517|NCT05327816|588661181|FG009|Overall Study|Withdrawal by Subject|0|||
162987518|NCT05327816|588661182|FG010|Overall Study|Withdrawal by Subject|0|||
162987519|NCT05327816|588661172|FG000|Overall Study|Study Terminated by Sponsor|11|||
162987520|NCT05327816|588661173|FG001|Overall Study|Study Terminated by Sponsor|12|||
162987521|NCT05327816|588661174|FG002|Overall Study|Study Terminated by Sponsor|12|||
162987522|NCT05327816|588661175|FG003|Overall Study|Study Terminated by Sponsor|12|||
162987523|NCT05327816|588661176|FG004|Overall Study|Study Terminated by Sponsor|11|||
162987524|NCT05327816|588661177|FG005|Overall Study|Study Terminated by Sponsor|11|||
162987525|NCT05327816|588661178|FG006|Overall Study|Study Terminated by Sponsor|11|||
162987526|NCT05327816|588661179|FG007|Overall Study|Study Terminated by Sponsor|11|||
162987527|NCT05327816|588661180|FG008|Overall Study|Study Terminated by Sponsor|11|||
162987528|NCT05327816|588661181|FG009|Overall Study|Study Terminated by Sponsor|11|||
162987529|NCT05327816|588661182|FG010|Overall Study|Study Terminated by Sponsor|12|||
162987530|NCT05327816|588661172|FG000|Overall Study|Randomized but not treated|0|||
162987531|NCT05327816|588661173|FG001|Overall Study|Randomized but not treated|0|||
162987532|NCT05327816|588661174|FG002|Overall Study|Randomized but not treated|0|||
162987533|NCT05327816|588661175|FG003|Overall Study|Randomized but not treated|0|||
162987534|NCT05327816|588661176|FG004|Overall Study|Randomized but not treated|0|||
162987535|NCT05327816|588661177|FG005|Overall Study|Randomized but not treated|0|||
162987536|NCT05327816|588661178|FG006|Overall Study|Randomized but not treated|1|||
162987537|NCT05327816|588661179|FG007|Overall Study|Randomized but not treated|1|||
162987538|NCT05327816|588661180|FG008|Overall Study|Randomized but not treated|1|||
162987539|NCT05327816|588661181|FG009|Overall Study|Randomized but not treated|0|||
162987540|NCT05327816|588661182|FG010|Overall Study|Randomized but not treated|0|||
162987541|NCT00112866|588661184|FG000|Overall Study|Protocol Violation|1|||
162987542|NCT00112866|588661185|FG001|Overall Study|Protocol Violation|0|||
162987543|NCT00112866|588661184|FG000|Overall Study|did not start treatment post-op|1|||
162987544|NCT00112866|588661185|FG001|Overall Study|did not start treatment post-op|2|||
162987545|NCT00658658|588661189|FG000|Overall Study|Withdrawal by Subject|0|||
162987546|NCT00658658|588661190|FG001|Overall Study|Withdrawal by Subject|1|||
162987547|NCT00658658|588661191|FG002|Overall Study|Withdrawal by Subject|0|||
162987548|NCT00658658|588661192|FG003|Overall Study|Withdrawal by Subject|0|||
162987549|NCT00658658|588661193|FG004|Overall Study|Withdrawal by Subject|0|||
162987550|NCT00658658|588661189|FG000|Overall Study|Death|4|||
162987551|NCT00658658|588661190|FG001|Overall Study|Death|0|||
162987552|NCT00658658|588661191|FG002|Overall Study|Death|0|||
162987553|NCT00658658|588661192|FG003|Overall Study|Death|1|||
162987554|NCT00658658|588661193|FG004|Overall Study|Death|1|||
162987555|NCT00658658|588661189|FG000|Overall Study|Disease Progression|0|||
162987556|NCT00658658|588661190|FG001|Overall Study|Disease Progression|1|||
162987557|NCT00658658|588661191|FG002|Overall Study|Disease Progression|0|||
162987558|NCT00658658|588661192|FG003|Overall Study|Disease Progression|1|||
162987559|NCT00658658|588661193|FG004|Overall Study|Disease Progression|3|||
162987560|NCT00658658|588661189|FG000|Overall Study|Protocol-specified Criteria|1|||
162987561|NCT00658658|588661190|FG001|Overall Study|Protocol-specified Criteria|0|||
162987562|NCT00658658|588661191|FG002|Overall Study|Protocol-specified Criteria|0|||
162987563|NCT00658658|588661192|FG003|Overall Study|Protocol-specified Criteria|0|||
162987564|NCT00658658|588661193|FG004|Overall Study|Protocol-specified Criteria|0|||
162987565|NCT00658658|588661189|FG000|Overall Study|Other|0|||
162987566|NCT00658658|588661190|FG001|Overall Study|Other|0|||
162987567|NCT00658658|588661191|FG002|Overall Study|Other|0|||
162987568|NCT00658658|588661192|FG003|Overall Study|Other|0|||
162987569|NCT00658658|588661193|FG004|Overall Study|Other|1|||
162715157|NCT01981850|587665856|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
162715158|NCT01981850|587665847|FG000|Main Phase Stage 1|Various reasons|0|||
162987570|NCT01523457|588661194|FG000|Overall Study|Withdrawal by Subject|7|||
162987571|NCT01523457|588661195|FG001|Overall Study|Withdrawal by Subject|2|||
162987572|NCT04663295|588661197|FG000|Run-in Period|Withdrawal by Subject|3|||
162987573|NCT04663295|588661197|FG000|Overall Study Period|Pregnancy|1|||
162987574|NCT04663295|588661197|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
162987575|NCT00554190|588661198|FG000|Overall Study|Termination forms not completed|10|||
162987576|NCT01502410|588661199|FG000|Overall Study|Adverse Event|1|||
162987577|NCT01502410|588661200|FG001|Overall Study|Adverse Event|2|||
162987578|NCT01502410|588661201|FG002|Overall Study|Adverse Event|0|||
162987579|NCT01502410|588661202|FG003|Overall Study|Adverse Event|0|||
162987580|NCT01502410|588661199|FG000|Overall Study|Lack of Efficacy|7|||
162987581|NCT01502410|588661200|FG001|Overall Study|Lack of Efficacy|7|||
162987582|NCT01502410|588661201|FG002|Overall Study|Lack of Efficacy|0|||
162987583|NCT01502410|588661202|FG003|Overall Study|Lack of Efficacy|0|||
162987584|NCT01502410|588661199|FG000|Overall Study|Physician Decision|0|||
162987585|NCT01502410|588661200|FG001|Overall Study|Physician Decision|1|||
162987586|NCT01502410|588661201|FG002|Overall Study|Physician Decision|0|||
162987587|NCT01502410|588661202|FG003|Overall Study|Physician Decision|0|||
162987588|NCT01502410|588661199|FG000|Overall Study|Withdrawal by Subject|2|||
162987589|NCT01502410|588661200|FG001|Overall Study|Withdrawal by Subject|0|||
162987590|NCT01502410|588661201|FG002|Overall Study|Withdrawal by Subject|0|||
162987591|NCT01502410|588661202|FG003|Overall Study|Withdrawal by Subject|0|||
162987592|NCT00325195|588661204|FG000|Randomized|Not dosed|5|||
162987593|NCT00325195|588661205|FG001|Randomized|Not dosed|5|||
162987594|NCT00325195|588661206|FG002|Randomized|Not dosed|3|||
162987595|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Adverse Event|15|||
162987596|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Adverse Event|17|||
162987597|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Adverse Event|1|||
162987598|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Death|3|||
162987599|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Death|1|||
162987600|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Death|0|||
162987601|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
162987602|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
162987603|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
162987604|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
162987605|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
162987606|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
162987607|NCT00325195|588661204|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
162987608|NCT00325195|588661205|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
162987609|NCT00325195|588661206|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
162987610|NCT04594707|588661207|FG000|Overall Study|Adverse Event|0|||
162987611|NCT04594707|588661208|FG001|Overall Study|Adverse Event|0|||
162987612|NCT04594707|588661209|FG002|Overall Study|Adverse Event|1|||
162987613|NCT04594707|588661207|FG000|Overall Study|Death|0|||
162987614|NCT04594707|588661208|FG001|Overall Study|Death|2|||
162987615|NCT04594707|588661209|FG002|Overall Study|Death|2|||
162987616|NCT04594707|588661207|FG000|Overall Study|Lung Transplant|0|||
162987617|NCT04594707|588661208|FG001|Overall Study|Lung Transplant|0|||
162987618|NCT04594707|588661209|FG002|Overall Study|Lung Transplant|1|||
162987619|NCT04594707|588661207|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
162987620|NCT04594707|588661208|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
162987621|NCT04594707|588661209|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
162987622|NCT04594707|588661207|FG000|Overall Study|Study Terminated By Sponsor|19|||
162987623|NCT04594707|588661208|FG001|Overall Study|Study Terminated By Sponsor|47|||
162987624|NCT04594707|588661209|FG002|Overall Study|Study Terminated By Sponsor|41|||
162987625|NCT04594707|588661207|FG000|Overall Study|Withdrawal by Subject|1|||
162987626|NCT04594707|588661208|FG001|Overall Study|Withdrawal by Subject|0|||
162987627|NCT04594707|588661209|FG002|Overall Study|Withdrawal by Subject|2|||
162987628|NCT04585789|588661210|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
162987629|NCT04585789|588661211|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
162987630|NCT04585789|588661212|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
162987631|NCT04585789|588661210|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
162987632|NCT04585789|588661211|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
162987633|NCT04585789|588661212|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
162987634|NCT05083585|588661213|FG000|Overall Study|Death|1|||
162987635|NCT05083585|588661214|FG001|Overall Study|Death|1|||
162987636|NCT05083585|588661213|FG000|Overall Study|Lost to Follow-up|1|||
162987637|NCT05083585|588661214|FG001|Overall Study|Lost to Follow-up|1|||
162987638|NCT05083585|588661213|FG000|Overall Study|Withdrawal by Subject|2|||
162987639|NCT05083585|588661214|FG001|Overall Study|Withdrawal by Subject|0|||
162987640|NCT05083585|588661213|FG000|Overall Study|Randomized but not vaccinated|2|||
162987641|NCT05083585|588661214|FG001|Overall Study|Randomized but not vaccinated|0|||
162987642|NCT00114166|588661215|FG000|Overall Study|Wrong primary|0|||
162987643|NCT00114166|588661216|FG001|Overall Study|Wrong primary|1|||
163059899|NCT01240694|588928254|FG000|Overall Study|Other than specified|3|||
163059900|NCT01240694|588928254|FG000|Overall Study|Withdrawn due to early study termination|107|||
163059901|NCT01513590|588928255|FG000|Overall Study|Adverse Event|2|||
163059902|NCT01513590|588928256|FG001|Overall Study|Adverse Event|3|||
163059903|NCT01513590|588928255|FG000|Overall Study|Withdrawal Criteria|3|||
163059904|NCT01513590|588928256|FG001|Overall Study|Withdrawal Criteria|0|||
162987644|NCT03469336|588661217|FG000|Overall Study|Adverse Event|1|||
162987645|NCT02628743|588661219|FG000|Overall Study|Other|3|||
162987646|NCT02628743|588661219|FG000|Overall Study|Withdrawal by Subject|50|||
162635953|NCT01957644|587381725|FG002|Overall Study|Adverse Event|0|||
162987647|NCT02628743|588661219|FG000|Overall Study|Study Terminated by Sponsor|76|||
162987648|NCT02628743|588661219|FG000|Overall Study|Physician Decision|2|||
162987649|NCT02740699|588661221|FG000|Overall Study|Lost to Follow-up|5|||
162987650|NCT02740699|588661221|FG000|Overall Study|Withdrawal by Subject|14|||
162987651|NCT02740699|588661221|FG000|Overall Study|Physician Decision|5|||
162987652|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987653|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987654|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162635954|NCT01957644|587381726|FG003|Overall Study|Adverse Event|0|||
162635955|NCT01957644|587381727|FG004|Overall Study|Adverse Event|1|||
162635956|NCT01957644|587381723|FG000|Overall Study|Progressive disease / relapse|0|||
162635957|NCT01957644|587381724|FG001|Overall Study|Progressive disease / relapse|1|||
162635958|NCT01957644|587381725|FG002|Overall Study|Progressive disease / relapse|0|||
162635959|NCT01957644|587381726|FG003|Overall Study|Progressive disease / relapse|1|||
162635960|NCT01957644|587381727|FG004|Overall Study|Progressive disease / relapse|0|||
162635961|NCT01957644|587381723|FG000|Overall Study|Other reason|1|||
162635962|NCT01957644|587381724|FG001|Overall Study|Other reason|2|||
162635963|NCT01957644|587381725|FG002|Overall Study|Other reason|1|||
162635964|NCT01957644|587381726|FG003|Overall Study|Other reason|1|||
162635965|NCT01957644|587381727|FG004|Overall Study|Other reason|0|||
162635966|NCT01957644|587381723|FG000|Overall Study|Withdrawal by Subject|1|||
162635967|NCT01957644|587381724|FG001|Overall Study|Withdrawal by Subject|0|||
162635968|NCT01957644|587381725|FG002|Overall Study|Withdrawal by Subject|0|||
162635969|NCT01957644|587381726|FG003|Overall Study|Withdrawal by Subject|0|||
162635970|NCT01957644|587381727|FG004|Overall Study|Withdrawal by Subject|0|||
162635971|NCT01957644|587381723|FG000|Overall Study|Protocol Violation|0|||
162635972|NCT01957644|587381724|FG001|Overall Study|Protocol Violation|1|||
162635973|NCT01957644|587381725|FG002|Overall Study|Protocol Violation|0|||
162635974|NCT01957644|587381726|FG003|Overall Study|Protocol Violation|0|||
162635975|NCT01957644|587381727|FG004|Overall Study|Protocol Violation|0|||
162635976|NCT01957553|587381728|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
162635977|NCT01957553|587381729|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
162635978|NCT01957553|587381728|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
162635979|NCT01957553|587381729|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
162635980|NCT01957553|587381728|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
162635981|NCT01957553|587381729|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
162635982|NCT01957553|587381728|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
162635983|NCT01957553|587381729|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
162635984|NCT01957553|587381728|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
162635985|NCT01957553|587381729|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
162635986|NCT01957553|587381728|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
162635987|NCT01957553|587381729|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
162635988|NCT01957553|587381728|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
162635989|NCT01957553|587381729|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
162635990|NCT01957553|587381728|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
162635991|NCT01957553|587381729|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
162635992|NCT01957553|587381728|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
162635993|NCT01957553|587381729|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
162635994|NCT04044716|587381730|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
162635995|NCT04044716|587381731|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
162635996|NCT04044716|587381732|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
162635997|NCT04044716|587381730|FG000|Overall Study|Lost to Follow-up|2|||
162635998|NCT04044716|587381731|FG001|Overall Study|Lost to Follow-up|3|||
162635999|NCT04044716|587381732|FG002|Overall Study|Lost to Follow-up|0|||
162636000|NCT00996307|587381739|FG000|Overall Study|Adverse Event|0|||
162636001|NCT00996307|587381740|FG001|Overall Study|Adverse Event|1|||
162636002|NCT00996307|587381741|FG002|Overall Study|Adverse Event|0|||
162636003|NCT00996307|587381742|FG003|Overall Study|Adverse Event|0|||
162636004|NCT00996307|587381739|FG000|Overall Study|Withdrawal by Subject|3|||
162636005|NCT00996307|587381740|FG001|Overall Study|Withdrawal by Subject|2|||
162636006|NCT00996307|587381741|FG002|Overall Study|Withdrawal by Subject|5|||
162636007|NCT00996307|587381742|FG003|Overall Study|Withdrawal by Subject|5|||
162636008|NCT00996307|587381739|FG000|Overall Study|Lost to Follow-up|13|||
162636009|NCT00996307|587381740|FG001|Overall Study|Lost to Follow-up|13|||
162636010|NCT00996307|587381741|FG002|Overall Study|Lost to Follow-up|7|||
162636011|NCT00996307|587381742|FG003|Overall Study|Lost to Follow-up|15|||
162636012|NCT00996307|587381739|FG000|Overall Study|Administrative reason|0|||
162636013|NCT00996307|587381740|FG001|Overall Study|Administrative reason|1|||
162636014|NCT00996307|587381741|FG002|Overall Study|Administrative reason|0|||
162636015|NCT00996307|587381742|FG003|Overall Study|Administrative reason|0|||
162636016|NCT00996307|587381739|FG000|Overall Study|Unable to classify|4|||
162636017|NCT00996307|587381740|FG001|Overall Study|Unable to classify|0|||
162987655|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162636018|NCT00996307|587381741|FG002|Overall Study|Unable to classify|2|||
163059905|NCT01513590|588928255|FG000|Overall Study|Unclassified|5|||
162636019|NCT00996307|587381742|FG003|Overall Study|Unable to classify|1|||
162636020|NCT02788357|587381743|FG000|Overall Study|Lost to Follow-up|3|||
162636021|NCT02788357|587381744|FG001|Overall Study|Lost to Follow-up|0|||
162636022|NCT00640601|587381745|FG000|Overall Study|Adverse Event|43|||
162636023|NCT00640601|587381745|FG000|Overall Study|Withdrawal by Subject|20|||
162636024|NCT00640601|587381745|FG000|Overall Study|Protocol Violation|6|||
162636025|NCT00640601|587381745|FG000|Overall Study|Lack of Efficacy|16|||
162636026|NCT00640601|587381745|FG000|Overall Study|Lost to Follow-up|9|||
162636027|NCT00640601|587381745|FG000|Overall Study|Physician Decision|8|||
162636028|NCT00640601|587381745|FG000|Overall Study|treatment naive, combination therapy|10|||
162636029|NCT01835587|587381747|FG000|Overall Study|Disease Recurrence or Relapse|0|||
162636030|NCT01835587|587381748|FG001|Overall Study|Disease Recurrence or Relapse|3|||
162636031|NCT01835587|587381749|FG002|Overall Study|Disease Recurrence or Relapse|0|||
162636032|NCT01835587|587381750|FG003|Overall Study|Disease Recurrence or Relapse|3|||
162636033|NCT01835587|587381747|FG000|Overall Study|Withdrawal by Subject|2|||
162636034|NCT01835587|587381748|FG001|Overall Study|Withdrawal by Subject|0|||
162636035|NCT01835587|587381749|FG002|Overall Study|Withdrawal by Subject|0|||
162636036|NCT01835587|587381750|FG003|Overall Study|Withdrawal by Subject|3|||
162636037|NCT01835587|587381747|FG000|Overall Study|Adverse Event|0|||
162636038|NCT01835587|587381748|FG001|Overall Study|Adverse Event|0|||
162636039|NCT01835587|587381749|FG002|Overall Study|Adverse Event|2|||
162636040|NCT01835587|587381750|FG003|Overall Study|Adverse Event|2|||
162636041|NCT01835587|587381747|FG000|Overall Study|Death|0|||
162636042|NCT01835587|587381748|FG001|Overall Study|Death|0|||
162636043|NCT01835587|587381749|FG002|Overall Study|Death|0|||
162636044|NCT01835587|587381750|FG003|Overall Study|Death|1|||
162636045|NCT01835587|587381747|FG000|Overall Study|Miscellaneous|0|||
162636046|NCT01835587|587381748|FG001|Overall Study|Miscellaneous|1|||
162636047|NCT01835587|587381749|FG002|Overall Study|Miscellaneous|0|||
162636048|NCT01835587|587381750|FG003|Overall Study|Miscellaneous|0|||
162636049|NCT03310775|587381755|FG000|Overall Study|Lost to Follow-up|2|||
162636050|NCT03310775|587381756|FG001|Overall Study|Lost to Follow-up|3|||
162636051|NCT03310775|587381755|FG000|Overall Study|aggravation of depression|0|||
162636052|NCT03310775|587381756|FG001|Overall Study|aggravation of depression|1|||
162636053|NCT01648205|587381757|FG000|Placebo|Pregnancy|1|||
162636054|NCT01648205|587381757|FG000|Placebo|Withdrawal by Subject|1|||
162636055|NCT01648205|587381757|FG000|Placebo|Protocol Violation|2|||
162636056|NCT01648205|587381757|FG000|Ranolazine|Death|1|||
162636057|NCT01648205|587381757|FG000|Ranolazine|Withdrawal by Subject|1|||
162636058|NCT01648205|587381757|FG000|Ranolazine|Protocol Violation|3|||
162636059|NCT02260921|587381765|FG000|Overall Study|Adverse Event|1|||
162636060|NCT02260921|587381766|FG001|Overall Study|Adverse Event|0|||
162636061|NCT02260921|587381765|FG000|Overall Study|Lost to Follow-up|4|||
162636062|NCT02260921|587381766|FG001|Overall Study|Lost to Follow-up|3|||
162636063|NCT02260921|587381765|FG000|Overall Study|Withdraw Consent|4|||
162636064|NCT02260921|587381766|FG001|Overall Study|Withdraw Consent|1|||
162636065|NCT02260921|587381765|FG000|Overall Study|Death|1|||
162636066|NCT02260921|587381766|FG001|Overall Study|Death|0|||
162636067|NCT02260921|587381765|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
162636068|NCT02260921|587381766|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
162636069|NCT02999854|587381776|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
162636070|NCT02999854|587381777|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
162636071|NCT02999854|587381776|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
162636072|NCT02999854|587381777|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
162636073|NCT02999854|587381776|FG000|Active Study Phase (up to 18 Months)|Death|7|||
162636074|NCT02999854|587381777|FG001|Active Study Phase (up to 18 Months)|Death|5|||
162636075|NCT02999854|587381776|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
162636076|NCT02999854|587381777|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
162636077|NCT02999854|587381776|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
162636078|NCT02999854|587381777|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
162636079|NCT02999854|587381776|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
162636080|NCT02999854|587381777|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
162636081|NCT02999854|587381776|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
162636082|NCT02999854|587381777|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
162636083|NCT02999854|587381776|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
162636084|NCT02999854|587381777|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
162636085|NCT00203996|587381778|FG000|Overall Study|Lost to Follow-up|0|||
162636086|NCT00203996|587381779|FG001|Overall Study|Lost to Follow-up|0|||
162636087|NCT00203996|587381780|FG002|Overall Study|Lost to Follow-up|0|||
162636088|NCT00203996|587381781|FG003|Overall Study|Lost to Follow-up|1|||
162636089|NCT00203996|587381782|FG004|Overall Study|Lost to Follow-up|0|||
162636090|NCT00203996|587381783|FG005|Overall Study|Lost to Follow-up|0|||
162636091|NCT00203996|587381784|FG006|Overall Study|Lost to Follow-up|0|||
162636092|NCT00203996|587381785|FG007|Overall Study|Lost to Follow-up|0|||
162715159|NCT01981850|587665848|FG001|Main Phase Stage 1|Various reasons|0|||
162715160|NCT01981850|587665849|FG002|Main Phase Stage 1|Various reasons|2|||
162715161|NCT01981850|587665850|FG003|Main Phase Stage 1|Various reasons|0|||
162715162|NCT01981850|587665851|FG004|Main Phase Stage 1|Various reasons|0|||
162715163|NCT01981850|587665852|FG005|Main Phase Stage 1|Various reasons|0|||
162715164|NCT01981850|587665853|FG006|Main Phase Stage 1|Various reasons|0|||
162715165|NCT01981850|587665854|FG007|Main Phase Stage 1|Various reasons|0|||
162715166|NCT01981850|587665855|FG008|Main Phase Stage 1|Various reasons|0|||
162715167|NCT01981850|587665856|FG009|Main Phase Stage 1|Various reasons|0|||
162715168|NCT01981850|587665847|FG000|Main Phase Stage 2|Adverse Event|0|||
162715169|NCT01981850|587665848|FG001|Main Phase Stage 2|Adverse Event|0|||
162715170|NCT01981850|587665849|FG002|Main Phase Stage 2|Adverse Event|0|||
162715171|NCT01981850|587665850|FG003|Main Phase Stage 2|Adverse Event|0|||
162715172|NCT01981850|587665851|FG004|Main Phase Stage 2|Adverse Event|6|||
162715173|NCT01981850|587665852|FG005|Main Phase Stage 2|Adverse Event|5|||
162715174|NCT01981850|587665853|FG006|Main Phase Stage 2|Adverse Event|7|||
162715175|NCT01981850|587665854|FG007|Main Phase Stage 2|Adverse Event|0|||
162715176|NCT01981850|587665855|FG008|Main Phase Stage 2|Adverse Event|0|||
162715177|NCT01981850|587665856|FG009|Main Phase Stage 2|Adverse Event|0|||
162715178|NCT01981850|587665847|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715179|NCT01981850|587665848|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715180|NCT01981850|587665849|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715181|NCT01981850|587665850|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715182|NCT01981850|587665851|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
162715183|NCT01981850|587665852|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
162715184|NCT01981850|587665853|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
162715185|NCT01981850|587665854|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715186|NCT01981850|587665855|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715187|NCT01981850|587665856|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162715188|NCT01981850|587665847|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
162715189|NCT01981850|587665848|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
162715190|NCT01981850|587665849|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
162715191|NCT01981850|587665850|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
162715192|NCT01981850|587665851|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
162715193|NCT01981850|587665852|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
162715194|NCT01981850|587665853|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
162715195|NCT01981850|587665854|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
162715196|NCT01981850|587665855|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
162715197|NCT01981850|587665856|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
162715198|NCT01981850|587665847|FG000|Main Phase Stage 2|Various reasons|0|||
162715199|NCT01981850|587665848|FG001|Main Phase Stage 2|Various reasons|0|||
162715200|NCT01981850|587665849|FG002|Main Phase Stage 2|Various reasons|0|||
162715201|NCT01981850|587665850|FG003|Main Phase Stage 2|Various reasons|0|||
162715202|NCT01981850|587665851|FG004|Main Phase Stage 2|Various reasons|2|||
162715203|NCT01981850|587665852|FG005|Main Phase Stage 2|Various reasons|0|||
162715204|NCT01981850|587665853|FG006|Main Phase Stage 2|Various reasons|1|||
162715205|NCT01981850|587665854|FG007|Main Phase Stage 2|Various reasons|0|||
162715206|NCT01981850|587665855|FG008|Main Phase Stage 2|Various reasons|0|||
162715207|NCT01981850|587665856|FG009|Main Phase Stage 2|Various reasons|0|||
162715208|NCT01981850|587665847|FG000|Main Phase Stage 2|Progressive Disease|0|||
162715209|NCT01981850|587665848|FG001|Main Phase Stage 2|Progressive Disease|0|||
162715210|NCT01981850|587665849|FG002|Main Phase Stage 2|Progressive Disease|0|||
162715211|NCT01981850|587665850|FG003|Main Phase Stage 2|Progressive Disease|0|||
162715212|NCT01981850|587665851|FG004|Main Phase Stage 2|Progressive Disease|0|||
162715213|NCT01981850|587665852|FG005|Main Phase Stage 2|Progressive Disease|6|||
162715214|NCT01981850|587665853|FG006|Main Phase Stage 2|Progressive Disease|6|||
162715215|NCT01981850|587665854|FG007|Main Phase Stage 2|Progressive Disease|0|||
162715216|NCT01981850|587665855|FG008|Main Phase Stage 2|Progressive Disease|0|||
162715217|NCT01981850|587665856|FG009|Main Phase Stage 2|Progressive Disease|0|||
162715218|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Adverse Event|0|||
162715219|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Adverse Event|0|||
162715220|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Adverse Event|0|||
162715221|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Adverse Event|0|||
162715222|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Adverse Event|0|||
162715223|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Adverse Event|0|||
162715224|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Adverse Event|0|||
162715225|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Adverse Event|2|||
162715226|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Adverse Event|1|||
162715227|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Adverse Event|8|||
162715228|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
162715229|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
163059906|NCT01513590|588928256|FG001|Overall Study|Unclassified|10|||
162715230|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
162715231|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
162715232|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
162636093|NCT00203996|587381786|FG008|Overall Study|Lost to Follow-up|0|||
162636094|NCT00203996|587381787|FG009|Overall Study|Lost to Follow-up|0|||
162636095|NCT00203996|587381778|FG000|Overall Study|Protocol Violation|0|||
162636096|NCT00203996|587381779|FG001|Overall Study|Protocol Violation|0|||
162636097|NCT00203996|587381780|FG002|Overall Study|Protocol Violation|0|||
162636098|NCT00203996|587381781|FG003|Overall Study|Protocol Violation|6|||
162636099|NCT00203996|587381782|FG004|Overall Study|Protocol Violation|1|||
162636100|NCT00203996|587381783|FG005|Overall Study|Protocol Violation|0|||
162636101|NCT00203996|587381784|FG006|Overall Study|Protocol Violation|0|||
162636102|NCT00203996|587381785|FG007|Overall Study|Protocol Violation|0|||
162636103|NCT00203996|587381786|FG008|Overall Study|Protocol Violation|0|||
162636104|NCT00203996|587381787|FG009|Overall Study|Protocol Violation|0|||
162636105|NCT00203996|587381778|FG000|Overall Study|Physician Decision|0|||
162636106|NCT00203996|587381779|FG001|Overall Study|Physician Decision|0|||
162636107|NCT00203996|587381780|FG002|Overall Study|Physician Decision|0|||
162636108|NCT00203996|587381781|FG003|Overall Study|Physician Decision|2|||
162636109|NCT00203996|587381782|FG004|Overall Study|Physician Decision|0|||
162636110|NCT00203996|587381783|FG005|Overall Study|Physician Decision|0|||
162636111|NCT00203996|587381784|FG006|Overall Study|Physician Decision|0|||
162636112|NCT00203996|587381785|FG007|Overall Study|Physician Decision|0|||
162636113|NCT00203996|587381786|FG008|Overall Study|Physician Decision|0|||
162636114|NCT00203996|587381787|FG009|Overall Study|Physician Decision|1|||
162636115|NCT00203996|587381778|FG000|Overall Study|CPAP machine malfunction|0|||
162636116|NCT00203996|587381779|FG001|Overall Study|CPAP machine malfunction|0|||
162636117|NCT00203996|587381780|FG002|Overall Study|CPAP machine malfunction|0|||
162636118|NCT00203996|587381781|FG003|Overall Study|CPAP machine malfunction|1|||
162636119|NCT00203996|587381782|FG004|Overall Study|CPAP machine malfunction|0|||
162636120|NCT00203996|587381783|FG005|Overall Study|CPAP machine malfunction|0|||
162636121|NCT00203996|587381784|FG006|Overall Study|CPAP machine malfunction|0|||
162636122|NCT00203996|587381785|FG007|Overall Study|CPAP machine malfunction|0|||
162636123|NCT00203996|587381786|FG008|Overall Study|CPAP machine malfunction|0|||
162636124|NCT00203996|587381787|FG009|Overall Study|CPAP machine malfunction|0|||
162636125|NCT00203996|587381778|FG000|Overall Study|Scheduling issue|0|||
162636126|NCT00203996|587381779|FG001|Overall Study|Scheduling issue|0|||
162636127|NCT00203996|587381780|FG002|Overall Study|Scheduling issue|0|||
162636128|NCT00203996|587381781|FG003|Overall Study|Scheduling issue|0|||
162636129|NCT00203996|587381782|FG004|Overall Study|Scheduling issue|0|||
162636130|NCT00203996|587381783|FG005|Overall Study|Scheduling issue|0|||
162636131|NCT00203996|587381784|FG006|Overall Study|Scheduling issue|0|||
162636132|NCT00203996|587381785|FG007|Overall Study|Scheduling issue|2|||
162636133|NCT00203996|587381786|FG008|Overall Study|Scheduling issue|0|||
162636134|NCT00203996|587381787|FG009|Overall Study|Scheduling issue|0|||
162636135|NCT03064451|587381788|FG000|Overall Study|Lost to Follow-up|1|||
162636136|NCT03064451|587381788|FG000|Overall Study|Mapping Failure|4|||
162636137|NCT03064451|587381788|FG000|Overall Study|Exited prior to procedure|8|||
162636138|NCT03064451|587381788|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
162636139|NCT00897104|587381789|FG000|Overall Study|Lost to Follow-up|12|||
162636140|NCT00897104|587381790|FG001|Overall Study|Lost to Follow-up|17|||
162636141|NCT00897104|587381791|FG002|Overall Study|Lost to Follow-up|2|||
162636142|NCT00897104|587381789|FG000|Overall Study|Pregnancy|0|||
162636143|NCT00897104|587381790|FG001|Overall Study|Pregnancy|1|||
162636144|NCT00897104|587381791|FG002|Overall Study|Pregnancy|0|||
162636145|NCT00897104|587381789|FG000|Overall Study|Protocol Violation|0|||
162636146|NCT00897104|587381790|FG001|Overall Study|Protocol Violation|1|||
162636147|NCT00897104|587381791|FG002|Overall Study|Protocol Violation|0|||
162636148|NCT00897104|587381789|FG000|Overall Study|Withdrawal by Subject|23|||
162636149|NCT00897104|587381790|FG001|Overall Study|Withdrawal by Subject|27|||
162636150|NCT00897104|587381791|FG002|Overall Study|Withdrawal by Subject|3|||
162636151|NCT00897104|587381789|FG000|Overall Study|Abnormal Prestudy Labs|2|||
162636152|NCT00897104|587381790|FG001|Overall Study|Abnormal Prestudy Labs|0|||
162636153|NCT00897104|587381791|FG002|Overall Study|Abnormal Prestudy Labs|0|||
162636154|NCT00897104|587381789|FG000|Overall Study|Abnormal Baseline ECG|2|||
162636155|NCT00897104|587381790|FG001|Overall Study|Abnormal Baseline ECG|2|||
162636156|NCT00897104|587381791|FG002|Overall Study|Abnormal Baseline ECG|0|||
162636157|NCT00897104|587381789|FG000|Overall Study|Need for Concom. Med.|0|||
162636158|NCT00897104|587381790|FG001|Overall Study|Need for Concom. Med.|1|||
162636159|NCT00897104|587381791|FG002|Overall Study|Need for Concom. Med.|1|||
162636160|NCT00897104|587381789|FG000|Overall Study|Lack of Migraine Attack|20|||
162636161|NCT00897104|587381790|FG001|Overall Study|Lack of Migraine Attack|22|||
162636162|NCT00897104|587381791|FG002|Overall Study|Lack of Migraine Attack|1|||
162636163|NCT00897104|587381789|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162636164|NCT00897104|587381790|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162636165|NCT00897104|587381791|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162636166|NCT00897104|587381789|FG000|Overall Study|Other|3|||
162636167|NCT00897104|587381790|FG001|Overall Study|Other|0|||
162636168|NCT00897104|587381791|FG002|Overall Study|Other|0|||
162636169|NCT00897104|587381789|FG000|Overall Study|Protocol Violation|1|||
162636170|NCT00897104|587381790|FG001|Overall Study|Protocol Violation|0|||
162636171|NCT00897104|587381791|FG002|Overall Study|Protocol Violation|0|||
162715233|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
162715234|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
162715235|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
162715236|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
162715237|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
162715238|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Various reasons|0|||
162715239|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Various reasons|0|||
162715240|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Various reasons|0|||
162715241|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Various reasons|0|||
162715242|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Various reasons|0|||
162715243|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Various reasons|0|||
162715244|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Various reasons|0|||
162715245|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Various reasons|3|||
162715246|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Various reasons|1|||
162715247|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Various reasons|3|||
162715248|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
162715249|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
162715250|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
162715251|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
162636172|NCT00897104|587381789|FG000|Overall Study|Withdrawal by Subject|0|||
162636173|NCT00897104|587381790|FG001|Overall Study|Withdrawal by Subject|0|||
162636174|NCT00897104|587381791|FG002|Overall Study|Withdrawal by Subject|1|||
162636175|NCT00750204|587381792|FG000|Overall Study|study halted prematurely|1|||
162636176|NCT00750204|587381793|FG001|Overall Study|study halted prematurely|1|||
162636177|NCT00434330|587381794|FG000|Overall Study|Adverse Event|0|||
162715252|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
162715253|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
162715254|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
162715255|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
162715256|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
162715257|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
162715258|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715259|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715260|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715261|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715262|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715263|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715264|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715265|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715266|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162715267|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
162715268|NCT01981850|587665847|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715269|NCT01981850|587665848|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715270|NCT01981850|587665849|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715271|NCT01981850|587665850|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715272|NCT01981850|587665851|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715273|NCT01981850|587665852|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715274|NCT01981850|587665853|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715275|NCT01981850|587665854|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715276|NCT01981850|587665855|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
162715277|NCT01981850|587665856|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
162715278|NCT03247543|587665857|FG000|Overall Study|Adverse Event|3|||
162715279|NCT03247543|587665858|FG001|Overall Study|Adverse Event|6|||
162715280|NCT03247543|587665859|FG002|Overall Study|Adverse Event|4|||
162715281|NCT03247543|587665857|FG000|Overall Study|Lost to Follow-up|10|||
162715282|NCT03247543|587665858|FG001|Overall Study|Lost to Follow-up|7|||
162715283|NCT03247543|587665859|FG002|Overall Study|Lost to Follow-up|8|||
162715284|NCT03247543|587665857|FG000|Overall Study|Consent withdrawn by caregiver|2|||
162715285|NCT03247543|587665858|FG001|Overall Study|Consent withdrawn by caregiver|2|||
162715286|NCT03247543|587665859|FG002|Overall Study|Consent withdrawn by caregiver|9|||
162715287|NCT03247543|587665857|FG000|Overall Study|Withdrawal by Subject|0|||
162715288|NCT03247543|587665858|FG001|Overall Study|Withdrawal by Subject|0|||
162715289|NCT03247543|587665859|FG002|Overall Study|Withdrawal by Subject|1|||
162715290|NCT03247543|587665857|FG000|Overall Study|Failure to Follow study procedures|1|||
162636178|NCT00434330|587381795|FG001|Overall Study|Adverse Event|0|||
162715291|NCT03247543|587665858|FG001|Overall Study|Failure to Follow study procedures|3|||
162715292|NCT03247543|587665859|FG002|Overall Study|Failure to Follow study procedures|1|||
162715293|NCT03247543|587665857|FG000|Overall Study|Lack of Efficacy|1|||
162715294|NCT03247543|587665858|FG001|Overall Study|Lack of Efficacy|0|||
162715295|NCT03247543|587665859|FG002|Overall Study|Lack of Efficacy|0|||
162636179|NCT00434330|587381796|FG002|Overall Study|Adverse Event|1|||
162636180|NCT00434330|587381797|FG003|Overall Study|Adverse Event|0|||
162636181|NCT00434330|587381798|FG004|Overall Study|Adverse Event|0|||
162636182|NCT00434330|587381799|FG005|Overall Study|Adverse Event|0|||
162636183|NCT00434330|587381794|FG000|Overall Study|Death|1|||
162636184|NCT00434330|587381795|FG001|Overall Study|Death|0|||
162636185|NCT00434330|587381796|FG002|Overall Study|Death|0|||
162636186|NCT00434330|587381797|FG003|Overall Study|Death|0|||
162636187|NCT00434330|587381798|FG004|Overall Study|Death|1|||
162636188|NCT00434330|587381799|FG005|Overall Study|Death|1|||
162636189|NCT00434330|587381794|FG000|Overall Study|Withdrawal by Subject|0|||
162636190|NCT00434330|587381795|FG001|Overall Study|Withdrawal by Subject|0|||
162636191|NCT00434330|587381796|FG002|Overall Study|Withdrawal by Subject|1|||
162636192|NCT00434330|587381797|FG003|Overall Study|Withdrawal by Subject|1|||
162636193|NCT00434330|587381798|FG004|Overall Study|Withdrawal by Subject|0|||
162636194|NCT00434330|587381799|FG005|Overall Study|Withdrawal by Subject|0|||
162636195|NCT00434330|587381794|FG000|Overall Study|Renal transplant|0|||
162636196|NCT00434330|587381795|FG001|Overall Study|Renal transplant|0|||
162636197|NCT00434330|587381796|FG002|Overall Study|Renal transplant|0|||
162636198|NCT00434330|587381797|FG003|Overall Study|Renal transplant|1|||
162636199|NCT00434330|587381798|FG004|Overall Study|Renal transplant|0|||
162636200|NCT00434330|587381799|FG005|Overall Study|Renal transplant|0|||
162636201|NCT00434330|587381794|FG000|Overall Study|Subject Not Compliant With Study|0|||
162636202|NCT00434330|587381795|FG001|Overall Study|Subject Not Compliant With Study|0|||
162636203|NCT00434330|587381796|FG002|Overall Study|Subject Not Compliant With Study|1|||
162636204|NCT00434330|587381797|FG003|Overall Study|Subject Not Compliant With Study|0|||
162636205|NCT00434330|587381798|FG004|Overall Study|Subject Not Compliant With Study|0|||
162636206|NCT00434330|587381799|FG005|Overall Study|Subject Not Compliant With Study|0|||
162636207|NCT00850564|587381802|FG000|Overall Study|Withdrawal by Subject|2|||
162636208|NCT03032705|587381803|FG000|Overall Study|Lost to Follow-up|16|||
162636209|NCT03032705|587381804|FG001|Overall Study|Lost to Follow-up|17|||
162636210|NCT03032705|587381803|FG000|Overall Study|did not quality|6|||
162636211|NCT03032705|587381804|FG001|Overall Study|did not quality|6|||
162636212|NCT02167893|587381807|FG000|Overall Study|Investigator transferred|85|||
162636213|NCT02167893|587381807|FG000|Overall Study|Investigator health reasons|10|||
162636214|NCT02167893|587381807|FG000|Overall Study|Case report forms not collected|68|||
162636215|NCT04818840|587381808|FG000|Overall Study|Lost to Follow-up|0|||
162636216|NCT04818840|587381809|FG001|Overall Study|Lost to Follow-up|5|||
162636217|NCT04818840|587381808|FG000|Overall Study|Physician Decision|1|||
162636218|NCT04818840|587381809|FG001|Overall Study|Physician Decision|0|||
162636219|NCT04818840|587381808|FG000|Overall Study|Site Terminated by Sponsor|0|||
162636220|NCT04818840|587381809|FG001|Overall Study|Site Terminated by Sponsor|3|||
162636221|NCT04818840|587381808|FG000|Overall Study|Study Terminated by Sponsor|43|||
162636222|NCT04818840|587381809|FG001|Overall Study|Study Terminated by Sponsor|7|||
162636223|NCT04818840|587381808|FG000|Overall Study|Withdrawal by Subject|0|||
162636224|NCT04818840|587381809|FG001|Overall Study|Withdrawal by Subject|1|||
162636225|NCT04847557|587381814|FG000|Overall Study|Adverse Event|1|||
162636226|NCT04847557|587381815|FG001|Overall Study|Adverse Event|0|||
162636227|NCT04847557|587381814|FG000|Overall Study|Death|19|||
162636228|NCT04847557|587381815|FG001|Overall Study|Death|15|||
162636229|NCT04847557|587381814|FG000|Overall Study|Lost to Follow-up|3|||
162636230|NCT04847557|587381815|FG001|Overall Study|Lost to Follow-up|6|||
162636231|NCT04847557|587381814|FG000|Overall Study|Physician Decision|1|||
162636232|NCT04847557|587381815|FG001|Overall Study|Physician Decision|0|||
162636233|NCT04847557|587381814|FG000|Overall Study|Protocol Violation|0|||
162636234|NCT04847557|587381815|FG001|Overall Study|Protocol Violation|1|||
162636235|NCT04847557|587381814|FG000|Overall Study|Withdrawal by Subject|8|||
162636236|NCT04847557|587381815|FG001|Overall Study|Withdrawal by Subject|14|||
162636237|NCT01325584|587381816|FG000|Overall Study|Death|1|||
162636238|NCT00397982|587384157|FG000|Overall Study|Withdrawal by Subject|1|||
162636239|NCT00397982|587384157|FG000|Overall Study|Adverse Event|1|||
162636240|NCT00397982|587384157|FG000|Overall Study|noncompliance|1|||
162636241|NCT00397982|587384157|FG000|Overall Study|Unrelated health issues|1|||
162636242|NCT02329730|587384158|FG000|Overall Study|Protocol Violation|0|||
162636243|NCT02329730|587384159|FG001|Overall Study|Protocol Violation|0|||
162636244|NCT02329730|587384160|FG002|Overall Study|Protocol Violation|0|||
162636245|NCT02329730|587384161|FG003|Overall Study|Protocol Violation|0|||
162636246|NCT02329730|587384162|FG004|Overall Study|Protocol Violation|2|||
162636247|NCT02329730|587384163|FG005|Overall Study|Protocol Violation|2|||
162636248|NCT02329730|587384164|FG006|Overall Study|Protocol Violation|0|||
162636249|NCT02329730|587384165|FG007|Overall Study|Protocol Violation|0|||
162636250|NCT02329730|587384166|FG008|Overall Study|Protocol Violation|0|||
162636251|NCT02329730|587384167|FG009|Overall Study|Protocol Violation|0|||
162636252|NCT02329730|587384168|FG010|Overall Study|Protocol Violation|0|||
162636253|NCT02329730|587384169|FG011|Overall Study|Protocol Violation|0|||
162636254|NCT02329730|587384158|FG000|Overall Study|Withdrawal by Subject|0|||
162636255|NCT02329730|587384159|FG001|Overall Study|Withdrawal by Subject|0|||
162636256|NCT02329730|587384160|FG002|Overall Study|Withdrawal by Subject|0|||
162636257|NCT02329730|587384161|FG003|Overall Study|Withdrawal by Subject|0|||
162636258|NCT02329730|587384162|FG004|Overall Study|Withdrawal by Subject|1|||
162715296|NCT03247543|587665857|FG000|Overall Study|Non-compliance with study visits|0|||
162715297|NCT03247543|587665858|FG001|Overall Study|Non-compliance with study visits|1|||
162636259|NCT02329730|587384163|FG005|Overall Study|Withdrawal by Subject|0|||
162636260|NCT02329730|587384164|FG006|Overall Study|Withdrawal by Subject|1|||
162636261|NCT02329730|587384165|FG007|Overall Study|Withdrawal by Subject|1|||
162636262|NCT02329730|587384166|FG008|Overall Study|Withdrawal by Subject|1|||
162715298|NCT03247543|587665859|FG002|Overall Study|Non-compliance with study visits|0|||
162715299|NCT01253226|587665863|FG000|Overall Study|Adverse Event|0|||
162715300|NCT01253226|587665864|FG001|Overall Study|Adverse Event|0|||
162715301|NCT01253226|587665865|FG002|Overall Study|Adverse Event|1|||
162715302|NCT01253226|587665866|FG003|Overall Study|Adverse Event|0|||
162715303|NCT01253226|587665867|FG004|Overall Study|Adverse Event|0|||
162715304|NCT01253226|587665863|FG000|Overall Study|Death|0|||
162715305|NCT01253226|587665864|FG001|Overall Study|Death|1|||
162715306|NCT01253226|587665865|FG002|Overall Study|Death|0|||
162715307|NCT01253226|587665866|FG003|Overall Study|Death|0|||
162715308|NCT01253226|587665867|FG004|Overall Study|Death|0|||
162715309|NCT01253226|587665863|FG000|Overall Study|Physician Decision|0|||
162715310|NCT01253226|587665864|FG001|Overall Study|Physician Decision|0|||
162636263|NCT02329730|587384167|FG009|Overall Study|Withdrawal by Subject|1|||
162636264|NCT02329730|587384168|FG010|Overall Study|Withdrawal by Subject|0|||
162636265|NCT02329730|587384169|FG011|Overall Study|Withdrawal by Subject|0|||
162636266|NCT02345850|587384170|FG000|Overall Study|Not transplanted|10|||
162636267|NCT02345850|587384171|FG001|Overall Study|Not transplanted|5|||
162636268|NCT02345850|587384172|FG002|Overall Study|Not transplanted|4|||
162636269|NCT02345850|587384170|FG000|Overall Study|Lost to Follow-up|2|||
162636270|NCT02345850|587384171|FG001|Overall Study|Lost to Follow-up|3|||
162636271|NCT02345850|587384172|FG002|Overall Study|Lost to Follow-up|2|||
162636272|NCT02345850|587384170|FG000|Overall Study|Withdrawal by Subject|1|||
162636273|NCT02345850|587384171|FG001|Overall Study|Withdrawal by Subject|0|||
162636274|NCT02345850|587384172|FG002|Overall Study|Withdrawal by Subject|0|||
162636275|NCT02392247|587384173|FG000|Overall Study|Withdrawal by Subject|1|||
162636276|NCT02392247|587384173|FG000|Overall Study|Surgery cancelled; no data|1|||
162636277|NCT00951665|587384174|FG000|Phase 1b|Adverse Event|2|||
162636278|NCT00951665|587384175|FG001|Phase 1b|Adverse Event|1|||
162636279|NCT00951665|587384176|FG002|Phase 1b|Adverse Event|0|||
162636280|NCT00951665|587384177|FG003|Phase 1b|Adverse Event|1|||
162636281|NCT00951665|587384178|FG004|Phase 1b|Adverse Event|0|||
162636282|NCT00951665|587384179|FG005|Phase 1b|Adverse Event|0|||
162636283|NCT00951665|587384174|FG000|Phase 1b|Death|1|||
162636284|NCT00951665|587384175|FG001|Phase 1b|Death|0|||
162636285|NCT00951665|587384176|FG002|Phase 1b|Death|2|||
162636286|NCT00951665|587384177|FG003|Phase 1b|Death|0|||
162636287|NCT00951665|587384178|FG004|Phase 1b|Death|0|||
162636288|NCT00951665|587384179|FG005|Phase 1b|Death|0|||
162636289|NCT00951665|587384174|FG000|Phase 1b|Physician Decision|4|||
162636290|NCT00951665|587384175|FG001|Phase 1b|Physician Decision|0|||
162636291|NCT00951665|587384176|FG002|Phase 1b|Physician Decision|1|||
162636292|NCT00951665|587384177|FG003|Phase 1b|Physician Decision|0|||
162636293|NCT00951665|587384178|FG004|Phase 1b|Physician Decision|0|||
162636294|NCT00951665|587384179|FG005|Phase 1b|Physician Decision|0|||
162636295|NCT00951665|587384174|FG000|Phase 1b|Withdrawal by Subject|0|||
162636296|NCT00951665|587384175|FG001|Phase 1b|Withdrawal by Subject|1|||
162636297|NCT00951665|587384176|FG002|Phase 1b|Withdrawal by Subject|0|||
162636298|NCT00951665|587384177|FG003|Phase 1b|Withdrawal by Subject|0|||
162636299|NCT00951665|587384178|FG004|Phase 1b|Withdrawal by Subject|0|||
162636300|NCT00951665|587384179|FG005|Phase 1b|Withdrawal by Subject|0|||
162636301|NCT00951665|587384174|FG000|Phase 1b|Disease Progression|13|||
162636302|NCT00951665|587384175|FG001|Phase 1b|Disease Progression|2|||
162636303|NCT00951665|587384176|FG002|Phase 1b|Disease Progression|14|||
162636304|NCT00951665|587384177|FG003|Phase 1b|Disease Progression|0|||
162636305|NCT00951665|587384178|FG004|Phase 1b|Disease Progression|0|||
162636306|NCT00951665|587384179|FG005|Phase 1b|Disease Progression|0|||
162636307|NCT00951665|587384174|FG000|Phase 1b|Protocol Violation|2|||
162636308|NCT00951665|587384175|FG001|Phase 1b|Protocol Violation|0|||
162636309|NCT00951665|587384176|FG002|Phase 1b|Protocol Violation|0|||
162636310|NCT00951665|587384177|FG003|Phase 1b|Protocol Violation|0|||
162636311|NCT00951665|587384178|FG004|Phase 1b|Protocol Violation|0|||
162636312|NCT00951665|587384179|FG005|Phase 1b|Protocol Violation|0|||
162636313|NCT00951665|587384174|FG000|Phase 2a|Adverse Event|0|||
162636314|NCT00951665|587384175|FG001|Phase 2a|Adverse Event|0|||
162636315|NCT00951665|587384176|FG002|Phase 2a|Adverse Event|0|||
162636316|NCT00951665|587384177|FG003|Phase 2a|Adverse Event|0|||
162636317|NCT00951665|587384178|FG004|Phase 2a|Adverse Event|2|||
162636318|NCT00951665|587384179|FG005|Phase 2a|Adverse Event|0|||
162636319|NCT00951665|587384174|FG000|Phase 2a|Death|0|||
162636320|NCT00951665|587384175|FG001|Phase 2a|Death|0|||
162636321|NCT00951665|587384176|FG002|Phase 2a|Death|0|||
162636322|NCT00951665|587384177|FG003|Phase 2a|Death|0|||
162636323|NCT00951665|587384178|FG004|Phase 2a|Death|1|||
162636324|NCT00951665|587384179|FG005|Phase 2a|Death|1|||
162636325|NCT00951665|587384174|FG000|Phase 2a|Lost to Follow-up|0|||
162636326|NCT00951665|587384175|FG001|Phase 2a|Lost to Follow-up|0|||
162636327|NCT00951665|587384176|FG002|Phase 2a|Lost to Follow-up|0|||
162636328|NCT00951665|587384177|FG003|Phase 2a|Lost to Follow-up|0|||
162636329|NCT00951665|587384178|FG004|Phase 2a|Lost to Follow-up|1|||
162636330|NCT00951665|587384179|FG005|Phase 2a|Lost to Follow-up|0|||
162636331|NCT00951665|587384174|FG000|Phase 2a|Physician Decision|0|||
162636332|NCT00951665|587384175|FG001|Phase 2a|Physician Decision|0|||
162636333|NCT00951665|587384176|FG002|Phase 2a|Physician Decision|0|||
162636334|NCT00951665|587384177|FG003|Phase 2a|Physician Decision|0|||
162636335|NCT00951665|587384178|FG004|Phase 2a|Physician Decision|0|||
162636336|NCT00951665|587384179|FG005|Phase 2a|Physician Decision|1|||
162636337|NCT00951665|587384174|FG000|Phase 2a|Withdrawal by Subject|0|||
162636338|NCT00951665|587384175|FG001|Phase 2a|Withdrawal by Subject|0|||
162636339|NCT00951665|587384176|FG002|Phase 2a|Withdrawal by Subject|0|||
162636340|NCT00951665|587384177|FG003|Phase 2a|Withdrawal by Subject|0|||
162636341|NCT00951665|587384178|FG004|Phase 2a|Withdrawal by Subject|2|||
162636342|NCT00951665|587384179|FG005|Phase 2a|Withdrawal by Subject|0|||
162636343|NCT00951665|587384174|FG000|Phase 2a|Disease Progression|0|||
162636344|NCT00951665|587384175|FG001|Phase 2a|Disease Progression|0|||
162636345|NCT00951665|587384176|FG002|Phase 2a|Disease Progression|0|||
162636346|NCT00951665|587384177|FG003|Phase 2a|Disease Progression|0|||
162636347|NCT00951665|587384178|FG004|Phase 2a|Disease Progression|6|||
162636348|NCT00951665|587384179|FG005|Phase 2a|Disease Progression|5|||
162636349|NCT02450903|587384182|FG000|Overall Study|Adverse Event|3|||
162636350|NCT02450903|587384182|FG000|Overall Study|Progressive disease|15|||
162636351|NCT02450903|587384182|FG000|Overall Study|Switched to commercial drug|1|||
162636352|NCT02450903|587384182|FG000|Overall Study|Subject/guardian decision|1|||
162636353|NCT00254540|587384183|FG000|Overall Study|Adverse Event|6|||
162636354|NCT00254540|587384184|FG001|Overall Study|Adverse Event|7|||
162636355|NCT00254540|587384183|FG000|Overall Study|Lack of Efficacy|13|||
162636356|NCT00254540|587384184|FG001|Overall Study|Lack of Efficacy|13|||
162636357|NCT00254540|587384183|FG000|Overall Study|Death|0|||
162636358|NCT00254540|587384184|FG001|Overall Study|Death|1|||
162636359|NCT00254540|587384183|FG000|Overall Study|Laboratory Test Abnormality|0|||
162636360|NCT00254540|587384184|FG001|Overall Study|Laboratory Test Abnormality|1|||
162636361|NCT01313767|587384185|FG000|Overall Study|Adverse Event|1|||
162636362|NCT01313767|587384186|FG001|Overall Study|Adverse Event|0|||
162636363|NCT01313767|587384185|FG000|Overall Study|Lost to Follow-up|1|||
162636364|NCT01313767|587384186|FG001|Overall Study|Lost to Follow-up|0|||
162636365|NCT01313767|587384185|FG000|Overall Study|Withdrawal by Subject|2|||
162636366|NCT01313767|587384186|FG001|Overall Study|Withdrawal by Subject|1|||
162636367|NCT01313767|587384185|FG000|Overall Study|Protocol Violation|3|||
162636368|NCT01313767|587384186|FG001|Overall Study|Protocol Violation|1|||
162636369|NCT00249444|587384187|FG000|Overall Study|Lost to Follow-up|2|||
162636370|NCT00249444|587384188|FG001|Overall Study|Lost to Follow-up|2|||
162636371|NCT00249444|587384187|FG000|Overall Study|non-compliant|9|||
162636372|NCT00249444|587384188|FG001|Overall Study|non-compliant|11|||
162636373|NCT00249444|587384187|FG000|Overall Study|Adverse Event|1|||
162636374|NCT00249444|587384188|FG001|Overall Study|Adverse Event|1|||
162636375|NCT00249444|587384187|FG000|Overall Study|life event|0|||
162636376|NCT00249444|587384188|FG001|Overall Study|life event|1|||
162636377|NCT00232817|587384189|FG000|Overall Study|Protocol Violation|2|||
162636378|NCT00232817|587384190|FG001|Overall Study|Protocol Violation|1|||
162636379|NCT01084174|587384194|FG000|Overall Study|gastrointestinal symptoms|1|||
162636380|NCT01084174|587384195|FG001|Overall Study|gastrointestinal symptoms|1|||
162636381|NCT01084174|587384194|FG000|Overall Study|Eosinophilic esophagitis|0|||
162636382|NCT01084174|587384195|FG001|Overall Study|Eosinophilic esophagitis|1|||
162636383|NCT01084174|587384194|FG000|Overall Study|Anaphylaxis|0|||
162636384|NCT01084174|587384195|FG001|Overall Study|Anaphylaxis|1|||
162636385|NCT01084174|587384194|FG000|Overall Study|Participant noncompliance|0|||
162636386|NCT01084174|587384195|FG001|Overall Study|Participant noncompliance|1|||
162636387|NCT04273217|587384196|FG000|Overall Study|Lost to Follow-up|0|||
162636388|NCT04273217|587384197|FG001|Overall Study|Lost to Follow-up|0|||
162636389|NCT04273217|587384198|FG002|Overall Study|Lost to Follow-up|0|||
162636390|NCT04273217|587384199|FG003|Overall Study|Lost to Follow-up|0|||
162636391|NCT04273217|587384200|FG004|Overall Study|Lost to Follow-up|0|||
162636392|NCT04273217|587384201|FG005|Overall Study|Lost to Follow-up|1|||
162636393|NCT04273217|587384196|FG000|Overall Study|Participant non-compliance|0|||
162636394|NCT04273217|587384197|FG001|Overall Study|Participant non-compliance|0|||
162636395|NCT04273217|587384198|FG002|Overall Study|Participant non-compliance|0|||
162636396|NCT04273217|587384199|FG003|Overall Study|Participant non-compliance|0|||
162636397|NCT04273217|587384200|FG004|Overall Study|Participant non-compliance|1|||
162636398|NCT04273217|587384201|FG005|Overall Study|Participant non-compliance|0|||
162636399|NCT04273217|587384196|FG000|Overall Study|Positive urine drug screen|1|||
162636400|NCT04273217|587384197|FG001|Overall Study|Positive urine drug screen|0|||
162636401|NCT04273217|587384198|FG002|Overall Study|Positive urine drug screen|1|||
162636402|NCT04273217|587384199|FG003|Overall Study|Positive urine drug screen|0|||
162636403|NCT04273217|587384200|FG004|Overall Study|Positive urine drug screen|0|||
162636404|NCT04273217|587384201|FG005|Overall Study|Positive urine drug screen|1|||
163059907|NCT02110693|588928257|FG000|Overall Study|Withdrawal by Subject|6|||
162636405|NCT04532099|587384202|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
162636406|NCT04532099|587384203|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
162636407|NCT04532099|587384204|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
162636408|NCT05492942|587384205|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
162636409|NCT05492942|587384206|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
162636410|NCT05492942|587384207|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
162636411|NCT05492942|587384208|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
162636412|NCT02506153|587384209|FG000|Overall Study|Adverse Event|359|||
162636413|NCT02506153|587384210|FG001|Overall Study|Adverse Event|114|||
162636414|NCT02506153|587384209|FG000|Overall Study|Refused unrelated to adverse event|127|||
162636415|NCT02506153|587384210|FG001|Overall Study|Refused unrelated to adverse event|18|||
162636416|NCT02506153|587384209|FG000|Overall Study|Progression/relapse|91|||
162636417|NCT02506153|587384210|FG001|Overall Study|Progression/relapse|136|||
162636418|NCT02506153|587384209|FG000|Overall Study|Death|2|||
162636419|NCT02506153|587384210|FG001|Overall Study|Death|1|||
162636420|NCT02506153|587384209|FG000|Overall Study|Other - not protocol specified|23|||
162636421|NCT02506153|587384210|FG001|Overall Study|Other - not protocol specified|12|||
162636422|NCT03103919|587384211|FG000|Overall Study|Adverse Event|2|||
162636423|NCT03103919|587384212|FG001|Overall Study|Adverse Event|2|||
162636424|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
162636425|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
162636426|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
162636427|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
162636428|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
162636429|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
162636430|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
162636431|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
162636432|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
162636433|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
162636434|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
162636435|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
162636436|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
162636437|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
162636438|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
162636439|NCT01124422|587384213|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
162636440|NCT01124422|587384214|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
162636441|NCT01124422|587384215|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
162636442|NCT01124422|587384213|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
162636443|NCT01124422|587384214|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
162636444|NCT01124422|587384215|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
162636445|NCT01124422|587384213|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
162636446|NCT01124422|587384214|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
162636447|NCT01124422|587384215|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
162636448|NCT01124422|587384213|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
162636449|NCT01124422|587384214|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
162636450|NCT01124422|587384215|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
162636451|NCT01124422|587384213|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
162636452|NCT01124422|587384214|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
162636453|NCT01124422|587384215|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
162636454|NCT01828281|587384216|FG000|Overall Study|Withdrawal by Subject|1|||
162636455|NCT01828281|587384217|FG001|Overall Study|Withdrawal by Subject|0|||
162636456|NCT03454893|587384220|FG000|Overall Study|Study Terminated by the Sponsor|5|||
162636457|NCT03454893|587384220|FG000|Overall Study|Did not pass screening|4|||
162636458|NCT04876274|587384221|FG000|Overall Study|Lost to Follow-up|9|||
162636459|NCT04876274|587384222|FG001|Overall Study|Lost to Follow-up|12|||
162636460|NCT03070782|587384225|FG000|Overall Study|Adverse Event|3|||
162636461|NCT03070782|587384226|FG001|Overall Study|Adverse Event|0|||
162636462|NCT03070782|587384227|FG002|Overall Study|Adverse Event|3|||
162636463|NCT03070782|587384228|FG003|Overall Study|Adverse Event|1|||
162636464|NCT03070782|587384229|FG004|Overall Study|Adverse Event|6|||
162636465|NCT03070782|587384230|FG005|Overall Study|Adverse Event|2|||
162636466|NCT03070782|587384225|FG000|Overall Study|Withdrawal by Subject|2|||
162636467|NCT03070782|587384226|FG001|Overall Study|Withdrawal by Subject|1|||
162636468|NCT03070782|587384227|FG002|Overall Study|Withdrawal by Subject|1|||
162636469|NCT03070782|587384228|FG003|Overall Study|Withdrawal by Subject|0|||
162636470|NCT03070782|587384229|FG004|Overall Study|Withdrawal by Subject|4|||
162636471|NCT03070782|587384230|FG005|Overall Study|Withdrawal by Subject|3|||
162715311|NCT01253226|587665865|FG002|Overall Study|Physician Decision|0|||
163059908|NCT02110693|588928258|FG001|Overall Study|Withdrawal by Subject|7|||
162715312|NCT01253226|587665866|FG003|Overall Study|Physician Decision|0|||
162715313|NCT01253226|587665867|FG004|Overall Study|Physician Decision|2|||
162715314|NCT01253226|587665863|FG000|Overall Study|Withdrawal by Subject|0|||
162715315|NCT01253226|587665864|FG001|Overall Study|Withdrawal by Subject|0|||
162715316|NCT01253226|587665865|FG002|Overall Study|Withdrawal by Subject|0|||
162715317|NCT01253226|587665866|FG003|Overall Study|Withdrawal by Subject|1|||
162715318|NCT01253226|587665867|FG004|Overall Study|Withdrawal by Subject|0|||
162715319|NCT04075266|587665869|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
162715320|NCT04075266|587665870|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
162715321|NCT04075266|587665869|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
162715322|NCT04075266|587665870|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
162715323|NCT01726023|587665871|FG000|Overall Study|Death|1|||
162715324|NCT01726023|587665872|FG001|Overall Study|Death|1|||
162715325|NCT01726023|587665871|FG000|Overall Study|Lost to Follow-up|5|||
162715326|NCT01726023|587665872|FG001|Overall Study|Lost to Follow-up|10|||
162715327|NCT01726023|587665871|FG000|Overall Study|Other Eligibility criteria|7|||
162715328|NCT01726023|587665872|FG001|Overall Study|Other Eligibility criteria|7|||
162715329|NCT01726023|587665871|FG000|Overall Study|Withdrawal by Subject|16|||
162715330|NCT01726023|587665872|FG001|Overall Study|Withdrawal by Subject|8|||
162715331|NCT04858425|587665875|FG000|Overall Study|Adverse Event|2|||
162715332|NCT04858425|587665876|FG001|Overall Study|Adverse Event|2|||
162715333|NCT04858425|587665875|FG000|Overall Study|Withdrawal by Subject|3|||
162715334|NCT04858425|587665876|FG001|Overall Study|Withdrawal by Subject|1|||
162715335|NCT04858425|587665875|FG000|Overall Study|Lost to Follow-up|4|||
162715336|NCT04858425|587665876|FG001|Overall Study|Lost to Follow-up|2|||
162715337|NCT04858425|587665875|FG000|Overall Study|Lost to Follow-up|1|||
162715338|NCT04858425|587665876|FG001|Overall Study|Lost to Follow-up|0|||
162715339|NCT03473743|587665877|FG000|Overall Study|Withdrawal by Subject|0|||
162715340|NCT03473743|587665878|FG001|Overall Study|Withdrawal by Subject|0|||
162715341|NCT03473743|587665879|FG002|Overall Study|Withdrawal by Subject|0|||
162715342|NCT03473743|587665880|FG003|Overall Study|Withdrawal by Subject|0|||
162715343|NCT03473743|587665881|FG004|Overall Study|Withdrawal by Subject|0|||
162715344|NCT03473743|587665882|FG005|Overall Study|Withdrawal by Subject|0|||
162715345|NCT03473743|587665883|FG006|Overall Study|Withdrawal by Subject|0|||
162715346|NCT03473743|587665884|FG007|Overall Study|Withdrawal by Subject|3|||
162715347|NCT03473743|587665877|FG000|Overall Study|Other|0|||
162715348|NCT03473743|587665878|FG001|Overall Study|Other|0|||
162715349|NCT03473743|587665879|FG002|Overall Study|Other|0|||
162715350|NCT03473743|587665880|FG003|Overall Study|Other|1|||
162715351|NCT03473743|587665881|FG004|Overall Study|Other|0|||
162715352|NCT03473743|587665882|FG005|Overall Study|Other|0|||
162715353|NCT03473743|587665883|FG006|Overall Study|Other|0|||
162715354|NCT03473743|587665884|FG007|Overall Study|Other|0|||
162715355|NCT03473743|587665877|FG000|Overall Study|Ongoing|0|||
162715356|NCT03473743|587665878|FG001|Overall Study|Ongoing|0|||
162715357|NCT03473743|587665879|FG002|Overall Study|Ongoing|6|||
162715358|NCT03473743|587665880|FG003|Overall Study|Ongoing|8|||
162715359|NCT03473743|587665881|FG004|Overall Study|Ongoing|1|||
162715360|NCT03473743|587665882|FG005|Overall Study|Ongoing|1|||
162715361|NCT03473743|587665883|FG006|Overall Study|Ongoing|22|||
162715362|NCT03473743|587665884|FG007|Overall Study|Ongoing|24|||
162715363|NCT03473743|587665877|FG000|Overall Study|Randomized but not treated|0|||
162715364|NCT03473743|587665878|FG001|Overall Study|Randomized but not treated|0|||
162715365|NCT03473743|587665879|FG002|Overall Study|Randomized but not treated|0|||
162715366|NCT03473743|587665880|FG003|Overall Study|Randomized but not treated|0|||
162715367|NCT03473743|587665881|FG004|Overall Study|Randomized but not treated|0|||
162715368|NCT03473743|587665882|FG005|Overall Study|Randomized but not treated|0|||
162715369|NCT03473743|587665883|FG006|Overall Study|Randomized but not treated|1|||
162715370|NCT03473743|587665884|FG007|Overall Study|Randomized but not treated|1|||
162715371|NCT02864992|587665885|FG000|Overall Study|still on treatment|15|||
162715372|NCT02864992|587665886|FG001|Overall Study|still on treatment|1|||
162715373|NCT02864992|587665887|FG002|Overall Study|still on treatment|33|||
162715374|NCT04536077|587665889|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
162715375|NCT04536077|587665890|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
162715376|NCT04536077|587665889|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
162715377|NCT04536077|587665890|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
162715378|NCT04948333|587665891|FG000|Overall Study|Adverse Event|6|||
162715379|NCT04948333|587665892|FG001|Overall Study|Adverse Event|4|||
162715380|NCT04948333|587665893|FG002|Overall Study|Adverse Event|0|||
162715381|NCT04948333|587665894|FG003|Overall Study|Adverse Event|2|||
162715382|NCT04948333|587665891|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162715383|NCT04948333|587665892|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162715384|NCT04948333|587665893|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162715385|NCT04948333|587665894|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162715386|NCT04948333|587665891|FG000|Overall Study|Progressive Disease|1|||
162715387|NCT04948333|587665892|FG001|Overall Study|Progressive Disease|5|||
162715388|NCT04948333|587665893|FG002|Overall Study|Progressive Disease|0|||
162636472|NCT03070782|587384225|FG000|Overall Study|Reason Not Specified|2|||
162636473|NCT03070782|587384226|FG001|Overall Study|Reason Not Specified|0|||
162636474|NCT03070782|587384227|FG002|Overall Study|Reason Not Specified|0|||
162636475|NCT03070782|587384228|FG003|Overall Study|Reason Not Specified|1|||
162636476|NCT03070782|587384229|FG004|Overall Study|Reason Not Specified|2|||
162636477|NCT03070782|587384230|FG005|Overall Study|Reason Not Specified|1|||
162636478|NCT03070782|587384225|FG000|Overall Study|Ineligibility|0|||
162636479|NCT03070782|587384226|FG001|Overall Study|Ineligibility|0|||
162636480|NCT03070782|587384227|FG002|Overall Study|Ineligibility|0|||
162636481|NCT03070782|587384228|FG003|Overall Study|Ineligibility|1|||
162636482|NCT03070782|587384229|FG004|Overall Study|Ineligibility|0|||
162636483|NCT03070782|587384230|FG005|Overall Study|Ineligibility|1|||
162636484|NCT03070782|587384225|FG000|Overall Study|Pregnancy|0|||
162636485|NCT03070782|587384226|FG001|Overall Study|Pregnancy|0|||
162636486|NCT03070782|587384227|FG002|Overall Study|Pregnancy|0|||
162636487|NCT03070782|587384228|FG003|Overall Study|Pregnancy|1|||
162636488|NCT03070782|587384229|FG004|Overall Study|Pregnancy|0|||
162636489|NCT03070782|587384230|FG005|Overall Study|Pregnancy|0|||
162636490|NCT03070782|587384225|FG000|Overall Study|Investigator Judgement|0|||
162636491|NCT03070782|587384226|FG001|Overall Study|Investigator Judgement|0|||
162636492|NCT03070782|587384227|FG002|Overall Study|Investigator Judgement|0|||
162636493|NCT03070782|587384228|FG003|Overall Study|Investigator Judgement|1|||
162636494|NCT03070782|587384229|FG004|Overall Study|Investigator Judgement|0|||
162636495|NCT03070782|587384230|FG005|Overall Study|Investigator Judgement|0|||
162636496|NCT03527966|587384233|FG000|Overall Study|Lost to Follow-up|3|||
162636497|NCT03527966|587384234|FG001|Overall Study|Lost to Follow-up|0|||
162636498|NCT01948050|587384235|FG000|Overall Study|Withdrawal by Subject|0|||
162636499|NCT01948050|587384236|FG001|Overall Study|Withdrawal by Subject|1|||
162636500|NCT02288559|587384237|FG000|Overall Study|Adverse Event|1|||
162636501|NCT02288559|587384238|FG001|Overall Study|Adverse Event|1|||
162636502|NCT02288559|587384239|FG002|Overall Study|Adverse Event|5|||
162636503|NCT02288559|587384240|FG003|Overall Study|Adverse Event|0|||
162636504|NCT02288559|587384237|FG000|Overall Study|Death|0|||
162636505|NCT02288559|587384238|FG001|Overall Study|Death|0|||
162636506|NCT02288559|587384239|FG002|Overall Study|Death|1|||
162636507|NCT02288559|587384240|FG003|Overall Study|Death|0|||
162636508|NCT02288559|587384237|FG000|Overall Study|Lost to Follow-up|0|||
162636509|NCT02288559|587384238|FG001|Overall Study|Lost to Follow-up|0|||
162636510|NCT02288559|587384239|FG002|Overall Study|Lost to Follow-up|0|||
162636511|NCT02288559|587384240|FG003|Overall Study|Lost to Follow-up|1|||
162636512|NCT02288559|587384237|FG000|Overall Study|Withdrawal by Subject|0|||
162636513|NCT02288559|587384238|FG001|Overall Study|Withdrawal by Subject|0|||
162636514|NCT02288559|587384239|FG002|Overall Study|Withdrawal by Subject|2|||
162636515|NCT02288559|587384240|FG003|Overall Study|Withdrawal by Subject|1|||
162636516|NCT02288559|587384237|FG000|Overall Study|Reason Not Specified|0|||
162636517|NCT02288559|587384238|FG001|Overall Study|Reason Not Specified|0|||
162636518|NCT02288559|587384239|FG002|Overall Study|Reason Not Specified|3|||
162636519|NCT02288559|587384240|FG003|Overall Study|Reason Not Specified|0|||
162636520|NCT02709785|587384243|FG000|Overall Study|Withdrawal by Subject|1|||
163059909|NCT02110693|588928257|FG000|Overall Study|skipped assessment|15|||
162636521|NCT02709785|587384244|FG001|Overall Study|Withdrawal by Subject|2|||
162636522|NCT02709785|587384245|FG002|Overall Study|Withdrawal by Subject|1|||
162636523|NCT01961323|587384248|FG000|Overall Study|Withdrawal by Subject|7|||
162636524|NCT01961323|587384248|FG000|Overall Study|Lost to Follow-up|8|||
162636525|NCT01961323|587384248|FG000|Overall Study|screen failure|34|||
162715389|NCT04948333|587665894|FG003|Overall Study|Progressive Disease|0|||
162715390|NCT04948333|587665891|FG000|Overall Study|Physician Decision|2|||
162715391|NCT04948333|587665892|FG001|Overall Study|Physician Decision|2|||
162715392|NCT04948333|587665893|FG002|Overall Study|Physician Decision|0|||
162715393|NCT04948333|587665894|FG003|Overall Study|Physician Decision|0|||
162715394|NCT04948333|587665891|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
162715395|NCT04948333|587665892|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
162715396|NCT04948333|587665893|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
162715397|NCT04948333|587665894|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
162715398|NCT04948333|587665891|FG000|Overall Study|Withdrawal by Subject|2|||
162715399|NCT04948333|587665892|FG001|Overall Study|Withdrawal by Subject|0|||
162715400|NCT04948333|587665893|FG002|Overall Study|Withdrawal by Subject|0|||
162715401|NCT04948333|587665894|FG003|Overall Study|Withdrawal by Subject|1|||
162715402|NCT04948333|587665891|FG000|Overall Study|Protocol Violation|0|||
162715403|NCT04948333|587665892|FG001|Overall Study|Protocol Violation|1|||
162715404|NCT04948333|587665893|FG002|Overall Study|Protocol Violation|0|||
162715405|NCT04948333|587665894|FG003|Overall Study|Protocol Violation|0|||
162715406|NCT04948333|587665891|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
162715407|NCT04948333|587665892|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
162715408|NCT04948333|587665893|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
162715409|NCT04948333|587665894|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
162715410|NCT03805295|587665898|FG000|Overall Study|Lost to Follow-up|17|||
162715411|NCT03805295|587665899|FG001|Overall Study|Lost to Follow-up|43|||
162715412|NCT04925752|587665900|FG000|Overall Study|Still on Study|1826|||
162715413|NCT04925752|587665901|FG001|Overall Study|Still on Study|926|||
162715414|NCT04925752|587665900|FG000|Overall Study|Withdrew Consent|128|||
162715415|NCT04925752|587665901|FG001|Overall Study|Withdrew Consent|59|||
162715416|NCT04925752|587665900|FG000|Overall Study|Lost to Follow-up|73|||
162715417|NCT04925752|587665901|FG001|Overall Study|Lost to Follow-up|47|||
162715418|NCT04925752|587665900|FG000|Overall Study|Randomized but Never Treated|12|||
162715419|NCT04925752|587665901|FG001|Overall Study|Randomized but Never Treated|9|||
162715420|NCT04925752|587665900|FG000|Overall Study|Hiv-1 Infection|6|||
162715421|NCT04925752|587665901|FG001|Overall Study|Hiv-1 Infection|7|||
162715422|NCT04925752|587665900|FG000|Overall Study|Investigator's discretion|8|||
162715423|NCT04925752|587665901|FG001|Overall Study|Investigator's discretion|5|||
162715424|NCT04925752|587665900|FG000|Overall Study|Non-compliance with Study Drug|8|||
162715425|NCT04925752|587665901|FG001|Overall Study|Non-compliance with Study Drug|5|||
162715426|NCT04925752|587665900|FG000|Overall Study|Adverse Event|5|||
162715427|NCT04925752|587665901|FG001|Overall Study|Adverse Event|2|||
162715428|NCT04925752|587665900|FG000|Overall Study|Death|4|||
162715429|NCT04925752|587665901|FG001|Overall Study|Death|2|||
162715430|NCT04925752|587665900|FG000|Overall Study|Protocol Violation|1|||
162715431|NCT04925752|587665901|FG001|Overall Study|Protocol Violation|3|||
162715432|NCT04925752|587665900|FG000|Overall Study|Withdrew Assent|1|||
162715433|NCT04925752|587665901|FG001|Overall Study|Withdrew Assent|0|||
162715434|NCT04181827|587665902|FG000|Overall Study|Ongoing|124|||
162715435|NCT04181827|587665903|FG001|Overall Study|Ongoing|157|||
162715436|NCT04181827|587665902|FG000|Overall Study|Death|82|||
162715437|NCT04181827|587665903|FG001|Overall Study|Death|50|||
162924573|NCT02406742|588426050|FG001|Overall Study|Transition to other treatment|0|||
162715438|NCT04181827|587665902|FG000|Overall Study|Lost to Follow-up|0|||
162715439|NCT04181827|587665903|FG001|Overall Study|Lost to Follow-up|1|||
162715440|NCT04181827|587665902|FG000|Overall Study|Withdrawal by Subject|5|||
162715441|NCT04181827|587665903|FG001|Overall Study|Withdrawal by Subject|0|||
162715442|NCT00539591|587665904|FG000|Overall Study|Toxicity|3|||
162715443|NCT00539591|587665905|FG001|Overall Study|Toxicity|0|||
162715444|NCT00539591|587665906|FG002|Overall Study|Toxicity|0|||
162715445|NCT00539591|587665904|FG000|Overall Study|Disease progression|2|||
162715446|NCT00539591|587665905|FG001|Overall Study|Disease progression|2|||
162715447|NCT00539591|587665906|FG002|Overall Study|Disease progression|3|||
162715448|NCT06269367|587665907|FG000|Phase I|Unable to perform study procedures|0|||
162715449|NCT06269367|587665908|FG001|Phase I|Unable to perform study procedures|1|||
162715450|NCT06269367|587665907|FG000|Phase I|Could not continue study for personal reasons.|1|||
162715451|NCT06269367|587665908|FG001|Phase I|Could not continue study for personal reasons.|0|||
162715452|NCT03331250|587665909|FG000|Overall Study|Withdrawal by Subject|1|||
162715453|NCT04305912|587665910|FG000|First Intervention|COVID-19 Suspension|2|||
162715454|NCT04305912|587665911|FG001|First Intervention|COVID-19 Suspension|0|||
162715455|NCT04305912|587665910|FG000|First Intervention|Withdrawal by Subject|0|||
162715456|NCT04305912|587665911|FG001|First Intervention|Withdrawal by Subject|1|||
162715457|NCT04305912|587665910|FG000|Second Intervention|Adverse Event|0|||
162715458|NCT04305912|587665911|FG001|Second Intervention|Adverse Event|1|||
162715459|NCT01155869|587665918|FG000|Overall Study|Lost to Follow-up|3|||
162715460|NCT01155869|587665919|FG001|Overall Study|Lost to Follow-up|1|||
162715461|NCT03563053|587665923|FG000|Overall Study|Withdrawal by Subject|17|||
162715462|NCT03563053|587665923|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
162715463|NCT03563053|587665923|FG000|Overall Study|Adverse Event|3|||
162715464|NCT03563053|587665923|FG000|Overall Study|Physician Decision|1|||
162715465|NCT03563053|587665923|FG000|Overall Study|study terminated by sponsor|71|||
162715466|NCT01137292|587665924|FG000|Overall Study|Death|30|||
162715467|NCT01137292|587665924|FG000|Overall Study|Adverse Event|3|||
162715468|NCT01137292|587665924|FG000|Overall Study|Lack of Efficacy|13|||
162715469|NCT01137292|587665924|FG000|Overall Study|Lost to Follow-up|1|||
162715470|NCT01137292|587665924|FG000|Overall Study|Other|7|||
162715471|NCT04540835|587665926|FG000|Week 1|Lost to Follow-up|1|||
162715472|NCT04540835|587665926|FG000|Week 6|Pregnancy|1|||
162715473|NCT04540835|587665926|FG000|Week 6|Lack of Efficacy|1|||
162715474|NCT01838200|587665927|FG000|Overall Study|Adverse Event|0|||
162715475|NCT01838200|587665928|FG001|Overall Study|Adverse Event|2|||
162715476|NCT01838200|587665927|FG000|Overall Study|Progressive disease|3|||
162715477|NCT01838200|587665928|FG001|Overall Study|Progressive disease|0|||
162715478|NCT03105336|587665929|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
162715479|NCT03105336|587665930|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
162715480|NCT03105336|587665929|FG000|Overall Study|Death|40|||
162715481|NCT03105336|587665930|FG001|Overall Study|Death|8|||
162715482|NCT03105336|587665929|FG000|Overall Study|Lost to Follow-up|13|||
162715483|NCT03105336|587665930|FG001|Overall Study|Lost to Follow-up|2|||
162715484|NCT03105336|587665929|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
162715485|NCT03105336|587665930|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
162715486|NCT03105336|587665929|FG000|Overall Study|Reason Not Specified|3|||
162715487|NCT03105336|587665930|FG001|Overall Study|Reason Not Specified|3|||
162715488|NCT03105336|587665929|FG000|Overall Study|Investigator Decision|3|||
162715489|NCT03105336|587665930|FG001|Overall Study|Investigator Decision|0|||
162715490|NCT03451851|587665931|FG000|PCP: Week 0 -16|Adverse Event|1|||
162715491|NCT03451851|587665932|FG001|PCP: Week 0 -16|Adverse Event|0|||
162715492|NCT03451851|587665933|FG002|PCP: Week 0 -16|Adverse Event|0|||
162715493|NCT03451851|587665934|FG003|PCP: Week 0 -16|Adverse Event|0|||
162715494|NCT03451851|587665935|FG004|PCP: Week 0 -16|Adverse Event|0|||
162715495|NCT03451851|587665936|FG005|PCP: Week 0 -16|Adverse Event|0|||
162715496|NCT03451851|587665937|FG006|PCP: Week 0 -16|Adverse Event|1|||
162715497|NCT03451851|587665938|FG007|PCP: Week 0 -16|Adverse Event|0|||
162715498|NCT03451851|587665931|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715499|NCT03451851|587665932|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715500|NCT03451851|587665933|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
162715501|NCT03451851|587665934|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715502|NCT03451851|587665935|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715503|NCT03451851|587665936|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715504|NCT03451851|587665937|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715505|NCT03451851|587665938|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
162715506|NCT03451851|587665931|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715507|NCT03451851|587665932|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715508|NCT03451851|587665933|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
162715509|NCT03451851|587665934|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715510|NCT03451851|587665935|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715511|NCT03451851|587665936|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715512|NCT03451851|587665937|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715513|NCT03451851|587665938|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162715514|NCT03451851|587665931|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162715515|NCT03451851|587665932|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162715516|NCT03451851|587665933|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162715517|NCT03451851|587665934|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162715518|NCT03451851|587665935|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
162715519|NCT03451851|587665936|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
162715520|NCT03451851|587665937|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162715521|NCT03451851|587665938|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163059910|NCT02110693|588928258|FG001|Overall Study|skipped assessment|18|||
162715522|NCT03451851|587665931|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715523|NCT03451851|587665932|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715524|NCT03451851|587665933|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715525|NCT03451851|587665934|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715526|NCT03451851|587665935|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
162715527|NCT03451851|587665936|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715528|NCT03451851|587665937|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715529|NCT03451851|587665938|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162715530|NCT03451851|587665931|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715531|NCT03451851|587665932|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715532|NCT03451851|587665933|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715533|NCT03451851|587665934|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715534|NCT03451851|587665935|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
162715535|NCT03451851|587665936|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715536|NCT03451851|587665937|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715537|NCT03451851|587665938|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162715538|NCT02380742|587667009|FG000|Overall Study|Withdrawal by Subject|1|||
162715539|NCT02380742|587667010|FG001|Overall Study|Withdrawal by Subject|0|||
162715540|NCT02930343|587667011|FG000|Overall Study|Lost to Follow-up|9|||
162715541|NCT02930343|587667012|FG001|Overall Study|Lost to Follow-up|7|||
162715542|NCT01227278|587667013|FG000|Overall Study|Withdrawal by Subject|4|||
162715543|NCT01227278|587667014|FG001|Overall Study|Withdrawal by Subject|4|||
162715544|NCT01227278|587667013|FG000|Overall Study|Death|0|||
162715545|NCT01227278|587667014|FG001|Overall Study|Death|2|||
162715546|NCT01227278|587667013|FG000|Overall Study|Other|1|||
162715547|NCT01227278|587667014|FG001|Overall Study|Other|2|||
162715548|NCT03720210|587667021|FG000|Overall Study|Lost to Follow-up|1|||
162715549|NCT02274493|587667027|FG000|Overall Study|Withdrawal by Subject|1|||
162715550|NCT00868192|587667028|FG000|Overall Study|Ineligible|4|||
162715551|NCT01178762|587667030|FG000|Overall Study|Lost to Follow-up|15|||
162715552|NCT02430532|587667034|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
162715553|NCT02430532|587667035|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
162715554|NCT02430532|587667034|FG000|Overall Study|Consent Withdrawn|0|||
162715555|NCT02430532|587667035|FG001|Overall Study|Consent Withdrawn|2|||
162715556|NCT02430532|587667034|FG000|Overall Study|Adverse Event|0|||
162715557|NCT02430532|587667035|FG001|Overall Study|Adverse Event|1|||
162715558|NCT01190150|587667036|FG000|First Treatment|Withdrawal by Subject|1|||
162715559|NCT01190150|587667037|FG001|First Treatment|Withdrawal by Subject|0|||
162715560|NCT01190150|587667036|FG000|Washout|Withdrawal by Subject|0|||
162715561|NCT01190150|587667037|FG001|Washout|Withdrawal by Subject|1|||
162715562|NCT01190150|587667036|FG000|Washout|Difficulty in adherence|0|||
162715563|NCT01190150|587667037|FG001|Washout|Difficulty in adherence|1|||
162715564|NCT04511650|587667038|FG000|Overall Study|Lost to Follow-up|1|||
162987656|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987657|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987658|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
162987659|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987660|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987661|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987662|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987663|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987664|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987665|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987666|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987667|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987668|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987669|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987670|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987671|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987672|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987673|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
163059911|NCT02110693|588928257|FG000|Overall Study|technical difficulties|6|||
163059912|NCT02110693|588928258|FG001|Overall Study|technical difficulties|4|||
162715565|NCT04511650|587667039|FG001|Overall Study|Lost to Follow-up|0|||
162715566|NCT04511650|587667040|FG002|Overall Study|Lost to Follow-up|0|||
162715567|NCT04511650|587667038|FG000|Overall Study|Withdrawal by Subject|1|||
162715568|NCT04511650|587667039|FG001|Overall Study|Withdrawal by Subject|0|||
162715569|NCT04511650|587667040|FG002|Overall Study|Withdrawal by Subject|0|||
162715570|NCT04511650|587667038|FG000|Overall Study|reason not provided|0|||
162715571|NCT04511650|587667039|FG001|Overall Study|reason not provided|0|||
163059913|NCT02110693|588928257|FG000|Overall Study|Other|1|||
162987674|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987675|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987676|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
162987677|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987678|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
162987679|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987680|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987681|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987682|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987683|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987684|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987685|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987686|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987687|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987688|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987689|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987690|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987691|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987692|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987693|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987694|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987695|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987696|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987697|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987698|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987699|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987700|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987701|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
162987702|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
162987703|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
162987704|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
162987705|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
162987706|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
162987707|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
162987708|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
162987709|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
162987710|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
162987711|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
162987712|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
162987713|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
162987714|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
162987715|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
162987716|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
162987717|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
162987718|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
162987719|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
162987720|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
162987721|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
162987722|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
162987723|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
162987724|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
162987725|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
162987726|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
162987727|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
162987728|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987729|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987730|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987731|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987732|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987733|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987734|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987735|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987736|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987737|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987738|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
163059914|NCT02110693|588928258|FG001|Overall Study|Other|0|||
162636526|NCT00810407|587384249|FG000|Overall Study|Protocol Violation|3|||
162636527|NCT00810407|587384249|FG000|Overall Study|No Visit After First Day of Treatment|3|||
162636528|NCT02320149|587384253|FG000|Overall Study|Adverse Event|3|||
162636529|NCT02320149|587384254|FG001|Overall Study|Adverse Event|7|||
162636530|NCT02320149|587384253|FG000|Overall Study|Withdrawal of Consent|28|||
162636531|NCT02320149|587384254|FG001|Overall Study|Withdrawal of Consent|32|||
162636532|NCT02320149|587384253|FG000|Overall Study|Lost to Follow-up|21|||
162987739|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987740|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987741|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987742|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987743|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987744|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987745|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987746|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987747|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987748|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987749|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987750|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987751|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162987752|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987753|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987754|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987755|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987756|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987757|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
162987758|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
162987759|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987760|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987761|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
162987762|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987763|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987764|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987765|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987766|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987767|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987768|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987769|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987770|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987771|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987772|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987773|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987774|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987775|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987776|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
162987777|NCT02393248|588661222|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987778|NCT02393248|588661223|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987779|NCT02393248|588661224|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987780|NCT02393248|588661225|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987781|NCT02393248|588661226|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987782|NCT02393248|588661227|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
163059915|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
162636533|NCT02320149|587384254|FG001|Overall Study|Lost to Follow-up|34|||
162636534|NCT02320149|587384253|FG000|Overall Study|Protocol Violation|2|||
162636535|NCT02320149|587384254|FG001|Overall Study|Protocol Violation|1|||
162636536|NCT02320149|587384253|FG000|Overall Study|Noncompliance with Study Treatment|7|||
162636537|NCT02320149|587384254|FG001|Overall Study|Noncompliance with Study Treatment|2|||
162715572|NCT04511650|587667040|FG002|Overall Study|reason not provided|1|||
162715573|NCT04511650|587667038|FG000|Overall Study|Death|1|||
162715574|NCT04511650|587667039|FG001|Overall Study|Death|1|||
162715575|NCT04511650|587667040|FG002|Overall Study|Death|1|||
162715576|NCT00608907|587667041|FG000|Overall Study|Adverse Event|6|||
162715577|NCT00608907|587667042|FG001|Overall Study|Adverse Event|0|||
162715578|NCT00608907|587667043|FG002|Overall Study|Adverse Event|1|||
162715579|NCT00608907|587667041|FG000|Overall Study|Death|1|||
162715580|NCT00608907|587667042|FG001|Overall Study|Death|0|||
162715581|NCT00608907|587667043|FG002|Overall Study|Death|0|||
162715582|NCT00608907|587667041|FG000|Overall Study|Withdrawal by Subject|4|||
162715583|NCT00608907|587667042|FG001|Overall Study|Withdrawal by Subject|0|||
162715584|NCT00608907|587667043|FG002|Overall Study|Withdrawal by Subject|0|||
162987783|NCT02393248|588661228|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
162987784|NCT02393248|588661229|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987785|NCT02393248|588661230|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987786|NCT02393248|588661231|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987787|NCT02393248|588661232|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987788|NCT02393248|588661233|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987789|NCT02393248|588661234|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987790|NCT02393248|588661235|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987791|NCT02393248|588661236|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987792|NCT02393248|588661237|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987793|NCT02393248|588661238|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987794|NCT02393248|588661239|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987795|NCT02393248|588661240|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987796|NCT02393248|588661241|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987797|NCT02393248|588661242|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987798|NCT02393248|588661243|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987799|NCT02393248|588661244|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987800|NCT02393248|588661245|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987801|NCT02393248|588661246|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
162987802|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987803|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987804|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987805|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987806|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987807|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987808|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987809|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987810|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987811|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987812|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987813|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
162987814|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
162987815|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
162987816|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
162987817|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987818|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987819|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987820|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987821|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987822|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987823|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987824|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987825|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
163059916|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
163059917|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
163059918|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
163059919|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
163059920|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
162987826|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
162987827|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987828|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987829|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987830|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987831|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987832|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987833|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987834|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987835|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
163059921|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
162987836|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987837|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
162987838|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
163059922|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
163059923|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
163059924|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
163059925|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Death|3|||
163059926|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Death|1|||
163059927|NCT01056276|588928259|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
163059928|NCT01056276|588928260|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
163059929|NCT01056276|588928259|FG000|Maintenance Therapy|Toxicity|0|||
163059930|NCT01056276|588928260|FG001|Maintenance Therapy|Toxicity|2|||
163059931|NCT01056276|588928259|FG000|Maintenance Therapy|Progressive Disease|0|||
163059932|NCT01056276|588928260|FG001|Maintenance Therapy|Progressive Disease|9|||
162636538|NCT02320149|587384253|FG000|Overall Study|Lack of Efficacy|0|||
162636539|NCT02320149|587384254|FG001|Overall Study|Lack of Efficacy|1|||
162636540|NCT02320149|587384253|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162636541|NCT02320149|587384254|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162636542|NCT00276159|587384255|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
162636543|NCT00333866|587384258|FG000|Overall Study|Adverse Event|23|||
162636544|NCT00333866|587384259|FG001|Overall Study|Adverse Event|37|||
162636545|NCT00333866|587384260|FG002|Overall Study|Adverse Event|38|||
162636546|NCT00333866|587384261|FG003|Overall Study|Adverse Event|47|||
162636547|NCT00333866|587384258|FG000|Overall Study|Other|3|||
162636548|NCT00333866|587384259|FG001|Overall Study|Other|2|||
162636549|NCT00333866|587384260|FG002|Overall Study|Other|2|||
162636550|NCT00333866|587384261|FG003|Overall Study|Other|2|||
162987839|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987840|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987841|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987842|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987843|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987844|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987845|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987846|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987847|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987848|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987849|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987850|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987851|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
162987852|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
162987853|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
162987854|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
162987855|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
162987856|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
162987857|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
162987858|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
162987859|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
162987860|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
162987861|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
162987862|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
162987863|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
162987864|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
162987865|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
162987866|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
162987867|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
162987868|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
162987869|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
162987870|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
162987871|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
162987872|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
162987873|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
162987874|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
162636551|NCT00333866|587384258|FG000|Overall Study|Lack of Efficacy|8|||
162636552|NCT00333866|587384259|FG001|Overall Study|Lack of Efficacy|6|||
162987875|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
162987876|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
162987877|NCT02393248|588661222|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
163059933|NCT01056276|588928259|FG000|Maintenance Therapy|Physician Decision|0|||
163059934|NCT01056276|588928260|FG001|Maintenance Therapy|Physician Decision|1|||
163059935|NCT01056276|588928259|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
162636553|NCT00333866|587384260|FG002|Overall Study|Lack of Efficacy|3|||
162987878|NCT02393248|588661223|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162636554|NCT00333866|587384261|FG003|Overall Study|Lack of Efficacy|5|||
162636555|NCT00333866|587384258|FG000|Overall Study|Lost to Follow-up|1|||
162636556|NCT00333866|587384259|FG001|Overall Study|Lost to Follow-up|2|||
162636557|NCT00333866|587384260|FG002|Overall Study|Lost to Follow-up|2|||
162987879|NCT02393248|588661224|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987880|NCT02393248|588661225|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987881|NCT02393248|588661226|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987882|NCT02393248|588661227|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987883|NCT02393248|588661228|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987884|NCT02393248|588661229|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987885|NCT02393248|588661230|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987886|NCT02393248|588661231|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987887|NCT02393248|588661232|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987888|NCT02393248|588661233|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
162987889|NCT02393248|588661234|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987890|NCT02393248|588661235|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
162987891|NCT02393248|588661236|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987892|NCT02393248|588661237|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987893|NCT02393248|588661238|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987894|NCT02393248|588661239|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987895|NCT02393248|588661240|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987896|NCT02393248|588661241|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987897|NCT02393248|588661242|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987898|NCT02393248|588661243|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987899|NCT02393248|588661244|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987900|NCT02393248|588661245|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987901|NCT02393248|588661246|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
162987902|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987903|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987904|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987905|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987906|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987907|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987908|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987909|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987910|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987911|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987912|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987913|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987914|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987915|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987916|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987917|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987918|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987919|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987920|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987921|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987922|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
162987923|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987924|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987925|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
162987926|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162987927|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Death|0|||
162987928|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Death|0|||
162987929|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Death|0|||
162987930|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Death|0|||
162987931|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Death|0|||
162987932|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Death|0|||
162987933|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Death|0|||
162987934|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Death|0|||
162987935|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Death|0|||
162987936|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Death|0|||
162987937|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Death|0|||
162987938|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Death|0|||
162987939|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Death|0|||
162987940|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Death|0|||
162987941|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Death|0|||
162987942|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Death|1|||
162987943|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Death|7|||
162987944|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Death|5|||
162987945|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Death|5|||
162987946|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Death|3|||
162987947|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Death|7|||
162987948|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Death|5|||
162636558|NCT00333866|587384261|FG003|Overall Study|Lost to Follow-up|2|||
162636559|NCT00333866|587384258|FG000|Overall Study|Withdrawal by Subject|8|||
162636560|NCT00333866|587384259|FG001|Overall Study|Withdrawal by Subject|14|||
162636561|NCT00333866|587384260|FG002|Overall Study|Withdrawal by Subject|4|||
162636562|NCT00333866|587384261|FG003|Overall Study|Withdrawal by Subject|9|||
162636563|NCT00333866|587384258|FG000|Overall Study|Randomized but not Treated|5|||
162636564|NCT00333866|587384259|FG001|Overall Study|Randomized but not Treated|3|||
162636565|NCT00333866|587384260|FG002|Overall Study|Randomized but not Treated|2|||
162636566|NCT00333866|587384261|FG003|Overall Study|Randomized but not Treated|1|||
162636567|NCT06073119|587384262|FG000|Overall Study|Adverse Event|1|||
162636568|NCT06073119|587384263|FG001|Overall Study|Adverse Event|3|||
162636569|NCT06073119|587384264|FG002|Overall Study|Adverse Event|0|||
162636570|NCT06073119|587384265|FG003|Overall Study|Adverse Event|0|||
162636571|NCT06073119|587384266|FG004|Overall Study|Adverse Event|1|||
162636572|NCT06073119|587384267|FG005|Overall Study|Adverse Event|0|||
162636573|NCT06073119|587384262|FG000|Overall Study|Non-compliance with study schedule|1|||
162987949|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Death|6|||
162987950|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Death|3|||
162987951|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Death|0|||
162987952|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987953|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987954|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987955|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987956|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987957|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987958|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987959|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987960|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987961|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987962|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987963|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987964|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987965|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987966|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987967|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987968|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987969|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987970|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987971|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
162987972|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987973|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987974|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987975|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
162987976|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
162987977|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Disease Progression|0|||
162987978|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Disease Progression|0|||
162987979|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Disease Progression|0|||
162987980|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Disease Progression|0|||
162987981|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Disease Progression|0|||
162987982|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Disease Progression|0|||
162987983|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Disease Progression|0|||
162987984|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Disease Progression|0|||
162987985|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Disease Progression|0|||
162987986|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Disease Progression|0|||
162987987|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Disease Progression|0|||
162987988|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Disease Progression|0|||
162987989|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Disease Progression|0|||
162987990|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Disease Progression|0|||
162987991|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Disease Progression|0|||
162987992|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Disease Progression|0|||
162987993|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Disease Progression|0|||
162636574|NCT06073119|587384263|FG001|Overall Study|Non-compliance with study schedule|0|||
162636575|NCT06073119|587384264|FG002|Overall Study|Non-compliance with study schedule|0|||
162636576|NCT06073119|587384265|FG003|Overall Study|Non-compliance with study schedule|0|||
162636577|NCT06073119|587384266|FG004|Overall Study|Non-compliance with study schedule|1|||
162636578|NCT06073119|587384267|FG005|Overall Study|Non-compliance with study schedule|0|||
162636579|NCT06073119|587384262|FG000|Overall Study|Withdrawal by Subject|4|||
162636580|NCT06073119|587384263|FG001|Overall Study|Withdrawal by Subject|4|||
162636581|NCT06073119|587384264|FG002|Overall Study|Withdrawal by Subject|3|||
162987994|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Disease Progression|0|||
162987995|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Disease Progression|0|||
162987996|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Disease Progression|0|||
162987997|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Disease Progression|2|||
162987998|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Disease Progression|1|||
162987999|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Disease Progression|0|||
162988000|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Disease Progression|0|||
162988001|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Disease Progression|0|||
162988002|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988003|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988004|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988005|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988006|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988007|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988008|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988009|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988010|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988011|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988012|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988013|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988014|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988015|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988016|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988017|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988018|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988019|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988020|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988021|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988022|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
162988023|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
162988024|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988025|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988026|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
162988027|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988028|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988029|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988030|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988031|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988032|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988033|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988034|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988035|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988036|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988037|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988038|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988039|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162636582|NCT06073119|587384265|FG003|Overall Study|Withdrawal by Subject|5|||
162636583|NCT06073119|587384266|FG004|Overall Study|Withdrawal by Subject|3|||
162636584|NCT06073119|587384267|FG005|Overall Study|Withdrawal by Subject|1|||
162636585|NCT06073119|587384262|FG000|Overall Study|Other|2|||
162636586|NCT06073119|587384263|FG001|Overall Study|Other|4|||
162636587|NCT06073119|587384264|FG002|Overall Study|Other|1|||
162636588|NCT06073119|587384265|FG003|Overall Study|Other|0|||
162636589|NCT06073119|587384266|FG004|Overall Study|Other|1|||
162636590|NCT06073119|587384267|FG005|Overall Study|Other|0|||
162636591|NCT01359449|587384268|FG000|Overall Study|Lost to Follow-up|1|||
163059936|NCT01056276|588928260|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
163059937|NCT01056276|588928259|FG000|Maintenance Therapy|Intercurrent Illness|0|||
163059938|NCT01056276|588928260|FG001|Maintenance Therapy|Intercurrent Illness|1|||
162636592|NCT01359449|587384269|FG001|Overall Study|Lost to Follow-up|0|||
162636593|NCT01359449|587384268|FG000|Overall Study|Protocol Violation|0|||
162636594|NCT01359449|587384269|FG001|Overall Study|Protocol Violation|2|||
162636595|NCT01359449|587384268|FG000|Overall Study|Withdrawal by Subject|3|||
162636596|NCT01359449|587384269|FG001|Overall Study|Withdrawal by Subject|2|||
162636597|NCT02036294|587384273|FG000|Overall Study|Death|7|||
162636598|NCT02036294|587384274|FG001|Overall Study|Death|8|||
162636599|NCT02036294|587384273|FG000|Overall Study|Withdrawal by Subject|2|||
162636600|NCT02036294|587384274|FG001|Overall Study|Withdrawal by Subject|3|||
162988040|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988041|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988042|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988043|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988044|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988045|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988046|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988047|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
162988048|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988049|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988050|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988051|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
162988052|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Adverse Event|0|||
162988053|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Adverse Event|0|||
162988054|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Adverse Event|0|||
162988055|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Adverse Event|0|||
162988056|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Adverse Event|0|||
162988057|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Adverse Event|0|||
162988058|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Adverse Event|0|||
162988059|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Adverse Event|0|||
162988060|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Adverse Event|0|||
162988061|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Adverse Event|0|||
162988062|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Adverse Event|0|||
162988063|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Adverse Event|0|||
162988064|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Adverse Event|0|||
162988065|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Adverse Event|0|||
162988066|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Adverse Event|0|||
162988067|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Adverse Event|0|||
162988068|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Adverse Event|0|||
162715585|NCT00608907|587667041|FG000|Overall Study|Progressive Disease|1|||
162988069|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Adverse Event|0|||
162988070|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Adverse Event|0|||
162988071|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Adverse Event|0|||
162988072|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Adverse Event|0|||
162988073|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Adverse Event|0|||
162988074|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Adverse Event|0|||
162988075|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Adverse Event|1|||
162988076|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Adverse Event|0|||
162988077|NCT02393248|588661222|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988078|NCT02393248|588661223|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988079|NCT02393248|588661224|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988080|NCT02393248|588661225|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988081|NCT02393248|588661226|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988082|NCT02393248|588661227|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988083|NCT02393248|588661228|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988084|NCT02393248|588661229|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988085|NCT02393248|588661230|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988086|NCT02393248|588661231|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988087|NCT02393248|588661232|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988088|NCT02393248|588661233|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988089|NCT02393248|588661234|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988090|NCT02393248|588661235|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988091|NCT02393248|588661236|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988092|NCT02393248|588661237|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988093|NCT02393248|588661238|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988094|NCT02393248|588661239|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162715586|NCT00608907|587667042|FG001|Overall Study|Progressive Disease|0|||
162715587|NCT00608907|587667043|FG002|Overall Study|Progressive Disease|0|||
162715588|NCT03523962|587667051|FG000|Closed Fractures|Death|86|||
162988095|NCT02393248|588661240|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162715589|NCT03523962|587667052|FG001|Closed Fractures|Death|71|||
162715590|NCT03523962|587667053|FG002|Closed Fractures|Death|0|||
162715591|NCT03523962|587667054|FG003|Closed Fractures|Death|0|||
162715592|NCT03523962|587667051|FG000|Closed Fractures|Lost to Follow-up|62|||
162988096|NCT02393248|588661241|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988097|NCT02393248|588661242|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988098|NCT02393248|588661243|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988099|NCT02393248|588661244|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162988100|NCT02393248|588661245|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
162988101|NCT02393248|588661246|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
162715593|NCT03523962|587667052|FG001|Closed Fractures|Lost to Follow-up|36|||
162715594|NCT03523962|587667053|FG002|Closed Fractures|Lost to Follow-up|0|||
162715595|NCT03523962|587667054|FG003|Closed Fractures|Lost to Follow-up|0|||
162715596|NCT03523962|587667051|FG000|Closed Fractures|Withdrawal by Subject|19|||
162715597|NCT03523962|587667052|FG001|Closed Fractures|Withdrawal by Subject|29|||
162715598|NCT03523962|587667053|FG002|Closed Fractures|Withdrawal by Subject|0|||
162715599|NCT03523962|587667054|FG003|Closed Fractures|Withdrawal by Subject|0|||
162715600|NCT03523962|587667051|FG000|Closed Fractures|Incarceration|1|||
162715601|NCT03523962|587667052|FG001|Closed Fractures|Incarceration|4|||
162715602|NCT03523962|587667053|FG002|Closed Fractures|Incarceration|0|||
162715603|NCT03523962|587667054|FG003|Closed Fractures|Incarceration|0|||
162988102|NCT02585934|588661247|FG000|Overall Study|Lost to Follow-up|2|||
162988103|NCT02585934|588661248|FG001|Overall Study|Lost to Follow-up|2|||
162988104|NCT02585934|588661247|FG000|Overall Study|Protocol Violation|14|||
162988105|NCT02585934|588661248|FG001|Overall Study|Protocol Violation|11|||
162988106|NCT02585934|588661247|FG000|Overall Study|Adverse Event|21|||
162988107|NCT02585934|588661248|FG001|Overall Study|Adverse Event|22|||
162988108|NCT02585934|588661247|FG000|Overall Study|Physician Decision|3|||
162988109|NCT02585934|588661248|FG001|Overall Study|Physician Decision|2|||
162988110|NCT02585934|588661247|FG000|Overall Study|Withdrawal by Subject|7|||
162988111|NCT02585934|588661248|FG001|Overall Study|Withdrawal by Subject|21|||
162988112|NCT02585934|588661247|FG000|Overall Study|Lack of Efficacy|2|||
162988113|NCT02585934|588661248|FG001|Overall Study|Lack of Efficacy|1|||
162988114|NCT02585934|588661247|FG000|Overall Study|Death|2|||
162988115|NCT02585934|588661248|FG001|Overall Study|Death|0|||
162988116|NCT02585934|588661247|FG000|Overall Study|Caregiver Withdrew Consent|7|||
162988117|NCT02585934|588661248|FG001|Overall Study|Caregiver Withdrew Consent|7|||
162988118|NCT02585934|588661247|FG000|Overall Study|Sponsor Termination|1|||
162988119|NCT02585934|588661248|FG001|Overall Study|Sponsor Termination|2|||
162988120|NCT02585934|588661247|FG000|Overall Study|Another Reason|10|||
162988121|NCT02585934|588661248|FG001|Overall Study|Another Reason|5|||
162988122|NCT01359969|588661261|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
162988123|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
162988124|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
162988125|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
162988126|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
162988127|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988128|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988129|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
162988130|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
162988131|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
162636601|NCT01907815|587384279|FG000|Overall Study|Withdrawal by Subject|1|||
162636602|NCT01907815|587384280|FG001|Overall Study|Withdrawal by Subject|0|||
162636603|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
162636604|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
162636605|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
162636606|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
162636607|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
162636608|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
162636609|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
162636610|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
162988132|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
162988133|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
162988134|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
162988135|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
162636611|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
162636612|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
162636613|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
162715604|NCT03523962|587667051|FG000|Open Fractures|Death|0|||
162715605|NCT03523962|587667052|FG001|Open Fractures|Death|0|||
162715606|NCT03523962|587667053|FG002|Open Fractures|Death|11|||
162715607|NCT03523962|587667054|FG003|Open Fractures|Death|6|||
162715608|NCT03523962|587667051|FG000|Open Fractures|Lost to Follow-up|0|||
162988136|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
162988137|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
162988138|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
162988139|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988140|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988141|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
162988142|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
162988143|NCT00593736|588661265|FG000|Screening Period and Placebo Run-in|Various|0|||
162988144|NCT00593736|588661266|FG001|Screening Period and Placebo Run-in|Various|0|||
162988145|NCT00593736|588661267|FG002|Screening Period and Placebo Run-in|Various|0|||
162988146|NCT00593736|588661268|FG003|Screening Period and Placebo Run-in|Various|25|||
162988147|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
162988148|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
162988149|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
162988150|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
162988151|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
162988152|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
162988153|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
162988154|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
162988155|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
162988156|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
162988157|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
162988158|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
162988159|NCT00593736|588661265|FG000|Treatment Period and Placebo Run-out|Various|1|||
162988160|NCT00593736|588661266|FG001|Treatment Period and Placebo Run-out|Various|1|||
162988161|NCT00593736|588661267|FG002|Treatment Period and Placebo Run-out|Various|1|||
162988162|NCT00593736|588661268|FG003|Treatment Period and Placebo Run-out|Various|0|||
162988163|NCT01868893|588661269|FG000|Overall Study|Adverse Event|2|||
162988164|NCT01868893|588661269|FG000|Overall Study|Commercial availability of study drug|17|||
162988165|NCT01868893|588661269|FG000|Overall Study|Neutropenia|1|||
162988166|NCT01857271|588661270|FG000|Overall Study|Lost to Follow-up|1|||
162988167|NCT03825341|588661273|FG000|Overall Study|Withdrawal by Subject|0|||
162988168|NCT03825341|588661274|FG001|Overall Study|Withdrawal by Subject|1|||
162988169|NCT01460901|588661277|FG000|Overall Study|Withdrawal by Subject|2|||
162988170|NCT00470067|588661278|FG000|Overall Study|Death|1|||
162988171|NCT00470067|588661278|FG000|Overall Study|Disease Progression|6|||
162988172|NCT00851318|588661279|FG000|Overall Study|Withdrawal by Subject|7|||
162988173|NCT00851318|588661280|FG001|Overall Study|Withdrawal by Subject|1|||
162988174|NCT00851318|588661281|FG002|Overall Study|Withdrawal by Subject|5|||
162988175|NCT00851318|588661282|FG003|Overall Study|Withdrawal by Subject|3|||
162988176|NCT00851318|588661279|FG000|Overall Study|Adverse Event|13|||
162988177|NCT00851318|588661280|FG001|Overall Study|Adverse Event|2|||
162988178|NCT00851318|588661281|FG002|Overall Study|Adverse Event|9|||
162988179|NCT00851318|588661282|FG003|Overall Study|Adverse Event|12|||
162988180|NCT00851318|588661279|FG000|Overall Study|Pregnancy|0|||
162988181|NCT00851318|588661280|FG001|Overall Study|Pregnancy|0|||
162988182|NCT00851318|588661281|FG002|Overall Study|Pregnancy|1|||
162988183|NCT00851318|588661282|FG003|Overall Study|Pregnancy|1|||
162988184|NCT00851318|588661279|FG000|Overall Study|Lack of Efficacy|8|||
162988185|NCT00851318|588661280|FG001|Overall Study|Lack of Efficacy|2|||
162988186|NCT00851318|588661281|FG002|Overall Study|Lack of Efficacy|4|||
162988187|NCT00851318|588661282|FG003|Overall Study|Lack of Efficacy|2|||
162988188|NCT00851318|588661279|FG000|Overall Study|Non-compliance with Study Procedures|2|||
162988189|NCT00851318|588661280|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162988190|NCT00851318|588661281|FG002|Overall Study|Non-compliance with Study Procedures|1|||
162988191|NCT00851318|588661282|FG003|Overall Study|Non-compliance with Study Procedures|0|||
162988192|NCT00851318|588661279|FG000|Overall Study|Physician Decision|0|||
162988193|NCT00851318|588661280|FG001|Overall Study|Physician Decision|0|||
162988194|NCT00851318|588661281|FG002|Overall Study|Physician Decision|1|||
162988195|NCT00851318|588661282|FG003|Overall Study|Physician Decision|1|||
162988196|NCT00077857|588661287|FG000|Overall Study|Adverse Event|30|||
162988197|NCT00077857|588661288|FG001|Overall Study|Adverse Event|32|||
162988198|NCT00077857|588661287|FG000|Overall Study|Death|7|||
162988199|NCT00077857|588661288|FG001|Overall Study|Death|3|||
162636614|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162636615|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
162636616|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162988200|NCT00077857|588661287|FG000|Overall Study|Insufficient therapeutic response|112|||
162988201|NCT00077857|588661288|FG001|Overall Study|Insufficient therapeutic response|128|||
162988202|NCT00077857|588661287|FG000|Overall Study|Violation of selection criteria at entry|3|||
162988203|NCT00077857|588661288|FG001|Overall Study|Violation of selection criteria at entry|1|||
162988204|NCT00077857|588661287|FG000|Overall Study|Other protocol violation|0|||
162988205|NCT00077857|588661288|FG001|Overall Study|Other protocol violation|1|||
162988206|NCT00077857|588661287|FG000|Overall Study|Refused treatment|29|||
162988207|NCT00077857|588661288|FG001|Overall Study|Refused treatment|21|||
162988208|NCT00077857|588661287|FG000|Overall Study|Failure to return|5|||
162988209|NCT00077857|588661288|FG001|Overall Study|Failure to return|5|||
162988210|NCT00077857|588661287|FG000|Overall Study|Other|15|||
162988211|NCT00077857|588661288|FG001|Overall Study|Other|13|||
162988212|NCT05084963|588661291|FG000|Overall Study|Withdrawal by Subject|0|||
162988213|NCT05084963|588661292|FG001|Overall Study|Withdrawal by Subject|0|||
162988214|NCT05084963|588661293|FG002|Overall Study|Withdrawal by Subject|1|||
162988215|NCT06354998|588661294|FG000|Overall Study|Withdrawal by Subject|3|||
162988216|NCT06354998|588661295|FG001|Overall Study|Withdrawal by Subject|0|||
162988217|NCT03819049|588661296|FG000|Overall Study|Lost to Follow-up|1|||
162988218|NCT03819049|588661297|FG001|Overall Study|Lost to Follow-up|2|||
162988219|NCT03819049|588661298|FG002|Overall Study|Lost to Follow-up|9|||
162988220|NCT03819049|588661299|FG003|Overall Study|Lost to Follow-up|0|||
162988221|NCT03819049|588661300|FG004|Overall Study|Lost to Follow-up|3|||
162988222|NCT03819049|588661301|FG005|Overall Study|Lost to Follow-up|1|||
162988223|NCT03819049|588661302|FG006|Overall Study|Lost to Follow-up|0|||
162988224|NCT03819049|588661296|FG000|Overall Study|Withdrawal by Subject|0|||
162988225|NCT03819049|588661297|FG001|Overall Study|Withdrawal by Subject|0|||
162988226|NCT03819049|588661298|FG002|Overall Study|Withdrawal by Subject|18|||
162988227|NCT03819049|588661299|FG003|Overall Study|Withdrawal by Subject|0|||
162988228|NCT03819049|588661300|FG004|Overall Study|Withdrawal by Subject|10|||
162988229|NCT03819049|588661301|FG005|Overall Study|Withdrawal by Subject|9|||
162988230|NCT03819049|588661302|FG006|Overall Study|Withdrawal by Subject|1|||
162988231|NCT03819049|588661296|FG000|Overall Study|Ongoing|0|||
162988232|NCT03819049|588661297|FG001|Overall Study|Ongoing|0|||
162988233|NCT03819049|588661298|FG002|Overall Study|Ongoing|75|||
162988234|NCT03819049|588661299|FG003|Overall Study|Ongoing|0|||
162988235|NCT03819049|588661300|FG004|Overall Study|Ongoing|41|||
162988236|NCT03819049|588661301|FG005|Overall Study|Ongoing|0|||
162988237|NCT03819049|588661302|FG006|Overall Study|Ongoing|0|||
162988238|NCT03819049|588661296|FG000|Overall Study|Other|0|||
162988239|NCT03819049|588661297|FG001|Overall Study|Other|0|||
162988240|NCT03819049|588661298|FG002|Overall Study|Other|2|||
162988241|NCT03819049|588661299|FG003|Overall Study|Other|0|||
162988242|NCT03819049|588661300|FG004|Overall Study|Other|0|||
162988243|NCT03819049|588661301|FG005|Overall Study|Other|0|||
162988244|NCT03819049|588661302|FG006|Overall Study|Other|0|||
162988245|NCT03819049|588661296|FG000|Overall Study|Randomized but not vaccinated|0|||
162988246|NCT03819049|588661297|FG001|Overall Study|Randomized but not vaccinated|0|||
162988247|NCT03819049|588661298|FG002|Overall Study|Randomized but not vaccinated|0|||
162988248|NCT03819049|588661299|FG003|Overall Study|Randomized but not vaccinated|1|||
162988249|NCT03819049|588661300|FG004|Overall Study|Randomized but not vaccinated|0|||
162988250|NCT03819049|588661301|FG005|Overall Study|Randomized but not vaccinated|2|||
162988251|NCT03819049|588661302|FG006|Overall Study|Randomized but not vaccinated|1|||
162988252|NCT03819049|588661296|FG000|Overall Study|Physician Decision|0|||
162988253|NCT03819049|588661297|FG001|Overall Study|Physician Decision|0|||
162988254|NCT03819049|588661298|FG002|Overall Study|Physician Decision|0|||
162988255|NCT03819049|588661299|FG003|Overall Study|Physician Decision|0|||
162988256|NCT03819049|588661300|FG004|Overall Study|Physician Decision|0|||
162988257|NCT03819049|588661301|FG005|Overall Study|Physician Decision|0|||
162988258|NCT03819049|588661302|FG006|Overall Study|Physician Decision|1|||
162988259|NCT02440568|588661304|FG000|Overall Study|Death|1|||
162988260|NCT02440568|588661305|FG001|Overall Study|Death|3|||
162988261|NCT02440568|588661306|FG002|Overall Study|Death|4|||
162988262|NCT02440568|588661307|FG003|Overall Study|Death|2|||
162988263|NCT02440568|588661304|FG000|Overall Study|Lack of Efficacy|2|||
162988264|NCT02440568|588661305|FG001|Overall Study|Lack of Efficacy|0|||
162988265|NCT02440568|588661306|FG002|Overall Study|Lack of Efficacy|1|||
162988266|NCT02440568|588661307|FG003|Overall Study|Lack of Efficacy|0|||
162988267|NCT02440568|588661304|FG000|Overall Study|Lost to Follow-up|1|||
162988268|NCT02440568|588661305|FG001|Overall Study|Lost to Follow-up|0|||
162988269|NCT02440568|588661306|FG002|Overall Study|Lost to Follow-up|0|||
162988270|NCT02440568|588661307|FG003|Overall Study|Lost to Follow-up|0|||
162988271|NCT03796039|588661310|FG000|Overall Study|Death|2|||
162988272|NCT03796039|588661311|FG001|Overall Study|Death|1|||
162988273|NCT03796039|588661310|FG000|Overall Study|Withdrawal by Subject|7|||
162988274|NCT03796039|588661311|FG001|Overall Study|Withdrawal by Subject|4|||
162988275|NCT01140503|588661312|FG000|Overall Study|Withdrawal by Subject|1|||
162988276|NCT01157897|588661314|FG000|Overall Study|Lost to Follow-up|2|||
162988277|NCT01157897|588661315|FG001|Overall Study|Lost to Follow-up|0|||
162988278|NCT01157897|588661316|FG002|Overall Study|Lost to Follow-up|0|||
162988279|NCT01157897|588661317|FG003|Overall Study|Lost to Follow-up|1|||
162988280|NCT01157897|588661314|FG000|Overall Study|Relocated|0|||
162988281|NCT01157897|588661315|FG001|Overall Study|Relocated|2|||
162988282|NCT01157897|588661316|FG002|Overall Study|Relocated|0|||
162988283|NCT01157897|588661317|FG003|Overall Study|Relocated|0|||
162988284|NCT00681590|588661318|FG000|Overall Study|Withdrawal by Subject|2|||
162988285|NCT00681590|588661319|FG001|Overall Study|Withdrawal by Subject|12|||
162988286|NCT01791153|588661322|FG000|Part 1: Blinded Period|Adverse Event|7|||
162988287|NCT01791153|588661323|FG001|Part 1: Blinded Period|Adverse Event|3|||
162988288|NCT01791153|588661324|FG002|Part 1: Blinded Period|Adverse Event|2|||
162988289|NCT01791153|588661325|FG003|Part 1: Blinded Period|Adverse Event|0|||
162988290|NCT01791153|588661326|FG004|Part 1: Blinded Period|Adverse Event|0|||
162988291|NCT01791153|588661327|FG005|Part 1: Blinded Period|Adverse Event|0|||
162988292|NCT01791153|588661328|FG006|Part 1: Blinded Period|Adverse Event|0|||
163059939|NCT01056276|588928259|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
162988293|NCT01791153|588661329|FG007|Part 1: Blinded Period|Adverse Event|0|||
162988294|NCT01791153|588661322|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
162988295|NCT01791153|588661323|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
162988296|NCT01791153|588661324|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
162988297|NCT01791153|588661325|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
162988298|NCT01791153|588661326|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
162988299|NCT01791153|588661327|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
162988300|NCT01791153|588661328|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
162988301|NCT01791153|588661329|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
162988302|NCT01791153|588661322|FG000|Part 1: Blinded Period|Non-Compliance|1|||
162988303|NCT01791153|588661323|FG001|Part 1: Blinded Period|Non-Compliance|0|||
162988304|NCT01791153|588661324|FG002|Part 1: Blinded Period|Non-Compliance|0|||
162988305|NCT01791153|588661325|FG003|Part 1: Blinded Period|Non-Compliance|0|||
162988306|NCT01791153|588661326|FG004|Part 1: Blinded Period|Non-Compliance|0|||
162988307|NCT01791153|588661327|FG005|Part 1: Blinded Period|Non-Compliance|0|||
162988308|NCT01791153|588661328|FG006|Part 1: Blinded Period|Non-Compliance|0|||
162988309|NCT01791153|588661329|FG007|Part 1: Blinded Period|Non-Compliance|0|||
162988310|NCT01791153|588661322|FG000|Part 1: Blinded Period|Physician Decision|0|||
162988311|NCT01791153|588661323|FG001|Part 1: Blinded Period|Physician Decision|0|||
162988312|NCT01791153|588661324|FG002|Part 1: Blinded Period|Physician Decision|0|||
162988313|NCT01791153|588661325|FG003|Part 1: Blinded Period|Physician Decision|1|||
162988314|NCT01791153|588661326|FG004|Part 1: Blinded Period|Physician Decision|0|||
162988315|NCT01791153|588661327|FG005|Part 1: Blinded Period|Physician Decision|0|||
162988316|NCT01791153|588661328|FG006|Part 1: Blinded Period|Physician Decision|0|||
162988317|NCT01791153|588661329|FG007|Part 1: Blinded Period|Physician Decision|0|||
162988318|NCT01791153|588661322|FG000|Part 1: Blinded Period|Protocol Violation|0|||
162988319|NCT01791153|588661323|FG001|Part 1: Blinded Period|Protocol Violation|0|||
162988320|NCT01791153|588661324|FG002|Part 1: Blinded Period|Protocol Violation|0|||
162988321|NCT01791153|588661325|FG003|Part 1: Blinded Period|Protocol Violation|1|||
162988322|NCT01791153|588661326|FG004|Part 1: Blinded Period|Protocol Violation|0|||
162988323|NCT01791153|588661327|FG005|Part 1: Blinded Period|Protocol Violation|0|||
162988324|NCT01791153|588661328|FG006|Part 1: Blinded Period|Protocol Violation|0|||
162988325|NCT01791153|588661329|FG007|Part 1: Blinded Period|Protocol Violation|0|||
162988326|NCT01791153|588661322|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
162988327|NCT01791153|588661323|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
162988328|NCT01791153|588661324|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
163059940|NCT01056276|588928260|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
163059941|NCT01881425|588928261|FG000|Overall Study|Death|5|||
163059942|NCT01881425|588928262|FG001|Overall Study|Death|1|||
162715609|NCT03523962|587667052|FG001|Open Fractures|Lost to Follow-up|0|||
162988329|NCT01791153|588661325|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
162988330|NCT01791153|588661326|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988331|NCT01791153|588661327|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988332|NCT01791153|588661328|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988333|NCT01791153|588661329|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
162988334|NCT01791153|588661322|FG000|Part 2: Open-label Period|Adverse Event|0|||
162988335|NCT01791153|588661323|FG001|Part 2: Open-label Period|Adverse Event|0|||
162988336|NCT01791153|588661324|FG002|Part 2: Open-label Period|Adverse Event|0|||
163059943|NCT01881425|588928261|FG000|Overall Study|Withdrawal by Subject|8|||
162988337|NCT01791153|588661325|FG003|Part 2: Open-label Period|Adverse Event|0|||
162988338|NCT01791153|588661326|FG004|Part 2: Open-label Period|Adverse Event|0|||
162988339|NCT01791153|588661327|FG005|Part 2: Open-label Period|Adverse Event|1|||
162988340|NCT01791153|588661328|FG006|Part 2: Open-label Period|Adverse Event|1|||
162988341|NCT01791153|588661329|FG007|Part 2: Open-label Period|Adverse Event|2|||
162988342|NCT01791153|588661322|FG000|Part 2: Open-label Period|Death|0|||
162988343|NCT01791153|588661323|FG001|Part 2: Open-label Period|Death|0|||
162988344|NCT01791153|588661324|FG002|Part 2: Open-label Period|Death|0|||
162988345|NCT01791153|588661325|FG003|Part 2: Open-label Period|Death|0|||
162988346|NCT01791153|588661326|FG004|Part 2: Open-label Period|Death|0|||
162988347|NCT01791153|588661327|FG005|Part 2: Open-label Period|Death|1|||
162988348|NCT01791153|588661328|FG006|Part 2: Open-label Period|Death|1|||
162988349|NCT01791153|588661329|FG007|Part 2: Open-label Period|Death|1|||
162988350|NCT01791153|588661322|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
162988351|NCT01791153|588661323|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
162988352|NCT01791153|588661324|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
162988353|NCT01791153|588661325|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
162988354|NCT01791153|588661326|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
162988355|NCT01791153|588661327|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
162988356|NCT01791153|588661328|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
162988357|NCT01791153|588661329|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
162988358|NCT01791153|588661322|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
162988359|NCT01791153|588661323|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
162988360|NCT01791153|588661324|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
162988361|NCT01791153|588661325|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
162988362|NCT01791153|588661326|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
162988363|NCT01791153|588661327|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
162988364|NCT01791153|588661328|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
162988365|NCT01791153|588661329|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
162988366|NCT01791153|588661322|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988367|NCT01791153|588661323|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988368|NCT01791153|588661324|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988369|NCT01791153|588661325|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
162988370|NCT01791153|588661326|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
162988371|NCT01791153|588661327|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
162988372|NCT01791153|588661328|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
162988373|NCT01791153|588661329|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
162988374|NCT01791153|588661322|FG000|Part 2: Open-label Period|Physician Decision|0|||
162988375|NCT01791153|588661323|FG001|Part 2: Open-label Period|Physician Decision|0|||
162988376|NCT01791153|588661324|FG002|Part 2: Open-label Period|Physician Decision|0|||
162988377|NCT01791153|588661325|FG003|Part 2: Open-label Period|Physician Decision|0|||
162988378|NCT01791153|588661326|FG004|Part 2: Open-label Period|Physician Decision|1|||
162988379|NCT01791153|588661327|FG005|Part 2: Open-label Period|Physician Decision|1|||
162988380|NCT01791153|588661328|FG006|Part 2: Open-label Period|Physician Decision|0|||
162988381|NCT01791153|588661329|FG007|Part 2: Open-label Period|Physician Decision|0|||
162988382|NCT02562482|588661330|FG000|Overall Study|Enrolled, but did not receive product|4|||
162988383|NCT02562482|588661331|FG001|Overall Study|Enrolled, but did not receive product|0|||
162988384|NCT02562482|588661330|FG000|Overall Study|Lost to Follow-up|9|||
162988385|NCT02562482|588661331|FG001|Overall Study|Lost to Follow-up|6|||
162988386|NCT02562482|588661330|FG000|Overall Study|Moved from area|2|||
162988387|NCT02562482|588661331|FG001|Overall Study|Moved from area|3|||
162988388|NCT02562482|588661330|FG000|Overall Study|Withdrawal by Subject|5|||
162988389|NCT02562482|588661331|FG001|Overall Study|Withdrawal by Subject|3|||
162988390|NCT02562482|588661330|FG000|Overall Study|Physician Decision|1|||
162988391|NCT02562482|588661331|FG001|Overall Study|Physician Decision|3|||
162988392|NCT02562482|588661330|FG000|Overall Study|Illness/Injury unrelated to product|0|||
162988393|NCT02562482|588661331|FG001|Overall Study|Illness/Injury unrelated to product|1|||
162988394|NCT05896202|588661337|FG000|Overall Study|Lost to Follow-up|2|||
162988395|NCT05896202|588661338|FG001|Overall Study|Lost to Follow-up|2|||
162988396|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
162988397|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
162988398|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
162988399|NCT01181271|588661341|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
162988400|NCT00444457|588661342|FG000|Infant Series|Other|0|||
162988401|NCT00444457|588661343|FG001|Infant Series|Other|1|||
162988402|NCT00444457|588661344|FG002|Infant Series|Other|0|||
162988403|NCT00444457|588661345|FG003|Infant Series|Other|0|||
162988404|NCT00444457|588661342|FG000|Infant Series|Parent or legal guardian request|18|||
162988405|NCT00444457|588661343|FG001|Infant Series|Parent or legal guardian request|29|||
162988406|NCT00444457|588661344|FG002|Infant Series|Parent or legal guardian request|34|||
162988407|NCT00444457|588661345|FG003|Infant Series|Parent or legal guardian request|14|||
162988408|NCT00444457|588661342|FG000|Infant Series|Lost to Follow-up|10|||
162988409|NCT00444457|588661343|FG001|Infant Series|Lost to Follow-up|11|||
162988410|NCT00444457|588661344|FG002|Infant Series|Lost to Follow-up|7|||
162988411|NCT00444457|588661345|FG003|Infant Series|Lost to Follow-up|6|||
162988412|NCT00444457|588661342|FG000|Infant Series|Protocol Violation|16|||
162988413|NCT00444457|588661343|FG001|Infant Series|Protocol Violation|8|||
162988414|NCT00444457|588661344|FG002|Infant Series|Protocol Violation|6|||
162988415|NCT00444457|588661345|FG003|Infant Series|Protocol Violation|3|||
162988416|NCT00444457|588661342|FG000|Infant Series|Failed to return|5|||
162988417|NCT00444457|588661343|FG001|Infant Series|Failed to return|4|||
162636617|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162636618|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
162636619|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
162636620|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
162636621|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
162636622|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
162636623|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162636624|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
162636625|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
162636626|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162636627|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162636628|NCT01285310|587384283|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
162636629|NCT01285310|587384284|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162636630|NCT01285310|587384285|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
162715610|NCT03523962|587667053|FG002|Open Fractures|Lost to Follow-up|15|||
162715611|NCT03523962|587667054|FG003|Open Fractures|Lost to Follow-up|8|||
162988418|NCT00444457|588661344|FG002|Infant Series|Failed to return|4|||
162988419|NCT00444457|588661345|FG003|Infant Series|Failed to return|2|||
162988420|NCT00444457|588661342|FG000|Infant Series|Investigator request|4|||
162988421|NCT00444457|588661343|FG001|Infant Series|Investigator request|3|||
162988422|NCT00444457|588661344|FG002|Infant Series|Investigator request|3|||
162988423|NCT00444457|588661345|FG003|Infant Series|Investigator request|2|||
162988424|NCT00444457|588661342|FG000|Infant Series|Other|0|||
162988425|NCT00444457|588661343|FG001|Infant Series|Other|2|||
162988426|NCT00444457|588661344|FG002|Infant Series|Other|4|||
162988427|NCT00444457|588661345|FG003|Infant Series|Other|0|||
162988428|NCT00444457|588661342|FG000|Infant Series|Adverse Event|1|||
162988429|NCT00444457|588661343|FG001|Infant Series|Adverse Event|2|||
162988430|NCT00444457|588661344|FG002|Infant Series|Adverse Event|2|||
162988431|NCT00444457|588661345|FG003|Infant Series|Adverse Event|0|||
162988432|NCT00444457|588661342|FG000|Infant Series|Death|0|||
162988433|NCT00444457|588661343|FG001|Infant Series|Death|1|||
162988434|NCT00444457|588661344|FG002|Infant Series|Death|1|||
162988435|NCT00444457|588661345|FG003|Infant Series|Death|1|||
162988436|NCT00444457|588661342|FG000|After Infant Series|Other|0|||
162988437|NCT00444457|588661343|FG001|After Infant Series|Other|1|||
162988438|NCT00444457|588661344|FG002|After Infant Series|Other|1|||
162988439|NCT00444457|588661345|FG003|After Infant Series|Other|1|||
162988440|NCT00444457|588661342|FG000|After Infant Series|Parent or legal guardian request|4|||
162988441|NCT00444457|588661343|FG001|After Infant Series|Parent or legal guardian request|11|||
162988442|NCT00444457|588661344|FG002|After Infant Series|Parent or legal guardian request|6|||
162988443|NCT00444457|588661345|FG003|After Infant Series|Parent or legal guardian request|3|||
162988444|NCT00444457|588661342|FG000|After Infant Series|Failed to return|7|||
162988445|NCT00444457|588661343|FG001|After Infant Series|Failed to return|6|||
162988446|NCT00444457|588661344|FG002|After Infant Series|Failed to return|5|||
162988447|NCT00444457|588661345|FG003|After Infant Series|Failed to return|1|||
162988448|NCT00444457|588661342|FG000|After Infant Series|Lost to Follow-up|5|||
162988449|NCT00444457|588661343|FG001|After Infant Series|Lost to Follow-up|5|||
162988450|NCT00444457|588661344|FG002|After Infant Series|Lost to Follow-up|5|||
162988451|NCT00444457|588661345|FG003|After Infant Series|Lost to Follow-up|2|||
162988452|NCT00444457|588661342|FG000|After Infant Series|Protocol Violation|2|||
162988453|NCT00444457|588661343|FG001|After Infant Series|Protocol Violation|4|||
162988454|NCT00444457|588661344|FG002|After Infant Series|Protocol Violation|2|||
162988455|NCT00444457|588661345|FG003|After Infant Series|Protocol Violation|2|||
162988456|NCT00444457|588661342|FG000|After Infant Series|Adverse Event|2|||
162988457|NCT00444457|588661343|FG001|After Infant Series|Adverse Event|2|||
162988458|NCT00444457|588661344|FG002|After Infant Series|Adverse Event|0|||
162988459|NCT00444457|588661345|FG003|After Infant Series|Adverse Event|0|||
162988460|NCT00444457|588661342|FG000|After Infant Series|Investigator request|0|||
162988461|NCT00444457|588661343|FG001|After Infant Series|Investigator request|0|||
162988462|NCT00444457|588661344|FG002|After Infant Series|Investigator request|0|||
162988463|NCT00444457|588661345|FG003|After Infant Series|Investigator request|1|||
162988464|NCT00444457|588661342|FG000|After Infant Series|Other|0|||
162988465|NCT00444457|588661343|FG001|After Infant Series|Other|1|||
162988466|NCT00444457|588661344|FG002|After Infant Series|Other|0|||
162988467|NCT00444457|588661345|FG003|After Infant Series|Other|0|||
162988468|NCT00444457|588661342|FG000|Toddler Dose|Lost to Follow-up|4|||
162988469|NCT00444457|588661343|FG001|Toddler Dose|Lost to Follow-up|1|||
162988470|NCT00444457|588661344|FG002|Toddler Dose|Lost to Follow-up|1|||
162988471|NCT00444457|588661345|FG003|Toddler Dose|Lost to Follow-up|3|||
162988472|NCT00444457|588661342|FG000|Toddler Dose|Failed to return|2|||
162988473|NCT00444457|588661343|FG001|Toddler Dose|Failed to return|2|||
162988474|NCT00444457|588661344|FG002|Toddler Dose|Failed to return|1|||
162988475|NCT00444457|588661345|FG003|Toddler Dose|Failed to return|3|||
162988476|NCT00444457|588661342|FG000|Toddler Dose|Parent or legal guardian request|0|||
162988477|NCT00444457|588661343|FG001|Toddler Dose|Parent or legal guardian request|3|||
162988478|NCT00444457|588661344|FG002|Toddler Dose|Parent or legal guardian request|2|||
162988479|NCT00444457|588661345|FG003|Toddler Dose|Parent or legal guardian request|1|||
162988480|NCT00444457|588661342|FG000|Toddler Dose|Protocol Violation|1|||
162988481|NCT00444457|588661343|FG001|Toddler Dose|Protocol Violation|0|||
162988482|NCT00444457|588661344|FG002|Toddler Dose|Protocol Violation|0|||
162988483|NCT00444457|588661345|FG003|Toddler Dose|Protocol Violation|1|||
162988484|NCT02041091|588661346|FG000|Treatment|Adverse Event|3|||
162988485|NCT02041091|588661347|FG001|Treatment|Adverse Event|3|||
162988486|NCT02041091|588661346|FG000|Treatment|Withdrawal by Subject|2|||
162988487|NCT02041091|588661347|FG001|Treatment|Withdrawal by Subject|4|||
162988488|NCT02041091|588661346|FG000|Treatment|Physician Decision|1|||
162988489|NCT02041091|588661347|FG001|Treatment|Physician Decision|0|||
162988490|NCT02041091|588661346|FG000|Treatment|Sponsor Decision|15|||
162988491|NCT02041091|588661347|FG001|Treatment|Sponsor Decision|16|||
162988492|NCT02041091|588661346|FG000|Treatment|Lost to Follow-up|1|||
162988493|NCT02041091|588661347|FG001|Treatment|Lost to Follow-up|0|||
162988494|NCT02041091|588661346|FG000|Optional Safety Extension Period|Adverse Event|4|||
162988495|NCT02041091|588661347|FG001|Optional Safety Extension Period|Adverse Event|2|||
162988496|NCT02041091|588661346|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
162988497|NCT02041091|588661347|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
162988498|NCT02041091|588661346|FG000|Optional Safety Extension Period|Protocol Violation|2|||
162988499|NCT02041091|588661347|FG001|Optional Safety Extension Period|Protocol Violation|0|||
162988500|NCT02041091|588661346|FG000|Optional Safety Extension Period|Physician Decision|2|||
162988501|NCT02041091|588661347|FG001|Optional Safety Extension Period|Physician Decision|1|||
162988502|NCT02041091|588661346|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
162988503|NCT02041091|588661347|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
162988504|NCT02041091|588661346|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
162988505|NCT02041091|588661347|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
162988506|NCT01855074|588661348|FG000|Overall Study|Adverse Event|1|||
162988507|NCT01855074|588661348|FG000|Overall Study|Lost to Follow-up|4|||
162988508|NCT01855074|588661348|FG000|Overall Study|Withdrawal by Subject|8|||
162988509|NCT01855074|588661348|FG000|Overall Study|Started but not treated|1|||
162988510|NCT02991430|588661349|FG000|Treatment Period 1|Adverse Event|1|||
162988511|NCT02991430|588661350|FG001|Treatment Period 1|Adverse Event|0|||
162988512|NCT02991430|588661351|FG002|Treatment Period 1|Adverse Event|2|||
162988513|NCT02991430|588661349|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162988514|NCT02991430|588661350|FG001|Treatment Period 1|Withdrawal by Subject|4|||
162988515|NCT02991430|588661351|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162988516|NCT02991430|588661349|FG000|Treatment Period 2|Study Termination|6|||
162988517|NCT02991430|588661350|FG001|Treatment Period 2|Study Termination|3|||
162988518|NCT02991430|588661351|FG002|Treatment Period 2|Study Termination|3|||
162988519|NCT02991430|588661349|FG000|Treatment Period 2|Lost to Follow-up|0|||
162988520|NCT02991430|588661350|FG001|Treatment Period 2|Lost to Follow-up|0|||
162988521|NCT02991430|588661351|FG002|Treatment Period 2|Lost to Follow-up|1|||
162988522|NCT02991430|588661349|FG000|Post-treatment Observation Period|Study Termination|3|||
162988523|NCT02991430|588661350|FG001|Post-treatment Observation Period|Study Termination|6|||
162988524|NCT02991430|588661351|FG002|Post-treatment Observation Period|Study Termination|5|||
162988525|NCT03970837|588661352|FG000|Overall Study|Adverse Event|23|||
162988526|NCT03970837|588661353|FG001|Overall Study|Adverse Event|20|||
162988527|NCT03970837|588661354|FG002|Overall Study|Adverse Event|16|||
162988528|NCT03970837|588661355|FG003|Overall Study|Adverse Event|6|||
162988529|NCT03970837|588661356|FG004|Overall Study|Adverse Event|4|||
162988530|NCT03970837|588661357|FG005|Overall Study|Adverse Event|5|||
162988531|NCT03970837|588661358|FG006|Overall Study|Adverse Event|1|||
162988532|NCT03970837|588661359|FG007|Overall Study|Adverse Event|5|||
162988533|NCT03970837|588661360|FG008|Overall Study|Adverse Event|0|||
162988534|NCT03970837|588661361|FG009|Overall Study|Adverse Event|0|||
162988535|NCT03970837|588661362|FG010|Overall Study|Adverse Event|1|||
162988536|NCT03970837|588661363|FG011|Overall Study|Adverse Event|1|||
162988537|NCT03970837|588661352|FG000|Overall Study|Lack of Efficacy|14|||
162988538|NCT03970837|588661353|FG001|Overall Study|Lack of Efficacy|12|||
162988539|NCT03970837|588661354|FG002|Overall Study|Lack of Efficacy|1|||
162988540|NCT03970837|588661355|FG003|Overall Study|Lack of Efficacy|2|||
162988541|NCT03970837|588661356|FG004|Overall Study|Lack of Efficacy|3|||
162988542|NCT03970837|588661357|FG005|Overall Study|Lack of Efficacy|4|||
162988543|NCT03970837|588661358|FG006|Overall Study|Lack of Efficacy|6|||
162988544|NCT03970837|588661359|FG007|Overall Study|Lack of Efficacy|1|||
162988545|NCT03970837|588661360|FG008|Overall Study|Lack of Efficacy|1|||
162988546|NCT03970837|588661361|FG009|Overall Study|Lack of Efficacy|0|||
162988547|NCT03970837|588661362|FG010|Overall Study|Lack of Efficacy|0|||
162988548|NCT03970837|588661363|FG011|Overall Study|Lack of Efficacy|0|||
162988549|NCT03970837|588661352|FG000|Overall Study|Lost to Follow-up|6|||
162988550|NCT03970837|588661353|FG001|Overall Study|Lost to Follow-up|5|||
162988551|NCT03970837|588661354|FG002|Overall Study|Lost to Follow-up|5|||
162988552|NCT03970837|588661355|FG003|Overall Study|Lost to Follow-up|1|||
162988553|NCT03970837|588661356|FG004|Overall Study|Lost to Follow-up|0|||
162988554|NCT03970837|588661357|FG005|Overall Study|Lost to Follow-up|2|||
162988555|NCT03970837|588661358|FG006|Overall Study|Lost to Follow-up|0|||
162988556|NCT03970837|588661359|FG007|Overall Study|Lost to Follow-up|0|||
162988557|NCT03970837|588661360|FG008|Overall Study|Lost to Follow-up|0|||
162988558|NCT03970837|588661361|FG009|Overall Study|Lost to Follow-up|0|||
162988559|NCT03970837|588661362|FG010|Overall Study|Lost to Follow-up|0|||
162988560|NCT03970837|588661363|FG011|Overall Study|Lost to Follow-up|0|||
162988561|NCT03970837|588661352|FG000|Overall Study|Protocol Violation|1|||
162988562|NCT03970837|588661353|FG001|Overall Study|Protocol Violation|0|||
162988563|NCT03970837|588661354|FG002|Overall Study|Protocol Violation|0|||
162988564|NCT03970837|588661355|FG003|Overall Study|Protocol Violation|0|||
162988565|NCT03970837|588661356|FG004|Overall Study|Protocol Violation|0|||
162988566|NCT03970837|588661357|FG005|Overall Study|Protocol Violation|0|||
162988567|NCT03970837|588661358|FG006|Overall Study|Protocol Violation|0|||
162988568|NCT03970837|588661359|FG007|Overall Study|Protocol Violation|0|||
162988569|NCT03970837|588661360|FG008|Overall Study|Protocol Violation|0|||
162988570|NCT03970837|588661361|FG009|Overall Study|Protocol Violation|0|||
162988571|NCT03970837|588661362|FG010|Overall Study|Protocol Violation|0|||
162988572|NCT03970837|588661363|FG011|Overall Study|Protocol Violation|0|||
162988573|NCT03970837|588661352|FG000|Overall Study|Physician Decision|5|||
162988574|NCT03970837|588661353|FG001|Overall Study|Physician Decision|8|||
162988575|NCT03970837|588661354|FG002|Overall Study|Physician Decision|4|||
162988576|NCT03970837|588661355|FG003|Overall Study|Physician Decision|1|||
162988577|NCT03970837|588661356|FG004|Overall Study|Physician Decision|5|||
162988578|NCT03970837|588661357|FG005|Overall Study|Physician Decision|2|||
162988579|NCT03970837|588661358|FG006|Overall Study|Physician Decision|4|||
162988580|NCT03970837|588661359|FG007|Overall Study|Physician Decision|5|||
162988581|NCT03970837|588661360|FG008|Overall Study|Physician Decision|0|||
162988582|NCT03970837|588661361|FG009|Overall Study|Physician Decision|1|||
162988583|NCT03970837|588661362|FG010|Overall Study|Physician Decision|0|||
162988584|NCT03970837|588661363|FG011|Overall Study|Physician Decision|0|||
162988585|NCT03970837|588661352|FG000|Overall Study|Withdrawal by Subject|32|||
162988586|NCT03970837|588661353|FG001|Overall Study|Withdrawal by Subject|35|||
162988587|NCT03970837|588661354|FG002|Overall Study|Withdrawal by Subject|12|||
162988588|NCT03970837|588661355|FG003|Overall Study|Withdrawal by Subject|8|||
162988589|NCT03970837|588661356|FG004|Overall Study|Withdrawal by Subject|6|||
162988590|NCT03970837|588661357|FG005|Overall Study|Withdrawal by Subject|8|||
162988591|NCT03970837|588661358|FG006|Overall Study|Withdrawal by Subject|2|||
162988592|NCT03970837|588661359|FG007|Overall Study|Withdrawal by Subject|3|||
162988593|NCT03970837|588661360|FG008|Overall Study|Withdrawal by Subject|0|||
162988594|NCT03970837|588661361|FG009|Overall Study|Withdrawal by Subject|0|||
162988595|NCT03970837|588661362|FG010|Overall Study|Withdrawal by Subject|0|||
162988596|NCT03970837|588661363|FG011|Overall Study|Withdrawal by Subject|1|||
162988597|NCT03970837|588661352|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
162988598|NCT03970837|588661353|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
162988599|NCT03970837|588661354|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
162988600|NCT03970837|588661355|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988601|NCT03970837|588661356|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
162988602|NCT03970837|588661357|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988603|NCT03970837|588661358|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988604|NCT03970837|588661359|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988605|NCT03970837|588661360|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
162988606|NCT03970837|588661361|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988607|NCT03970837|588661362|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988608|NCT03970837|588661363|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
162988609|NCT03970837|588661352|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988610|NCT03970837|588661353|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988611|NCT03970837|588661354|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988612|NCT03970837|588661355|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988613|NCT03970837|588661356|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988614|NCT03970837|588661357|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
162988615|NCT03970837|588661358|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
162988616|NCT03970837|588661359|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
162988617|NCT03970837|588661360|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
162988618|NCT03970837|588661361|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
162988619|NCT03970837|588661362|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
162988620|NCT03970837|588661363|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
162988621|NCT02132754|588661364|FG000|Overall Study|Adverse Event|0|||
162988622|NCT02132754|588661365|FG001|Overall Study|Adverse Event|0|||
162988623|NCT02132754|588661366|FG002|Overall Study|Adverse Event|0|||
162988624|NCT02132754|588661367|FG003|Overall Study|Adverse Event|0|||
162988625|NCT02132754|588661368|FG004|Overall Study|Adverse Event|0|||
162988626|NCT02132754|588661369|FG005|Overall Study|Adverse Event|0|||
162988627|NCT02132754|588661370|FG006|Overall Study|Adverse Event|0|||
162988628|NCT02132754|588661371|FG007|Overall Study|Adverse Event|0|||
162988629|NCT02132754|588661372|FG008|Overall Study|Adverse Event|0|||
162988630|NCT02132754|588661373|FG009|Overall Study|Adverse Event|0|||
162636631|NCT01285310|587384286|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162636632|NCT01285310|587384287|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162636633|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
162636634|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
162636635|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
162636636|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
162636637|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
162988631|NCT02132754|588661374|FG010|Overall Study|Adverse Event|0|||
162988632|NCT02132754|588661375|FG011|Overall Study|Adverse Event|0|||
162988633|NCT02132754|588661376|FG012|Overall Study|Adverse Event|0|||
162988634|NCT02132754|588661377|FG013|Overall Study|Adverse Event|0|||
162988635|NCT02132754|588661378|FG014|Overall Study|Adverse Event|0|||
162988636|NCT02132754|588661379|FG015|Overall Study|Adverse Event|0|||
162988637|NCT02132754|588661380|FG016|Overall Study|Adverse Event|0|||
162988638|NCT02132754|588661381|FG017|Overall Study|Adverse Event|1|||
162988639|NCT02132754|588661382|FG018|Overall Study|Adverse Event|0|||
162988640|NCT02132754|588661383|FG019|Overall Study|Adverse Event|0|||
162988641|NCT02132754|588661384|FG020|Overall Study|Adverse Event|0|||
162988642|NCT02132754|588661385|FG021|Overall Study|Adverse Event|0|||
162988643|NCT02132754|588661386|FG022|Overall Study|Adverse Event|0|||
162988644|NCT02132754|588661387|FG023|Overall Study|Adverse Event|0|||
162988645|NCT02132754|588661388|FG024|Overall Study|Adverse Event|0|||
162988646|NCT02132754|588661389|FG025|Overall Study|Adverse Event|1|||
162988647|NCT02132754|588661390|FG026|Overall Study|Adverse Event|1|||
162988648|NCT02132754|588661391|FG027|Overall Study|Adverse Event|0|||
162988649|NCT02132754|588661392|FG028|Overall Study|Adverse Event|0|||
162988650|NCT02132754|588661393|FG029|Overall Study|Adverse Event|0|||
162988651|NCT02132754|588661394|FG030|Overall Study|Adverse Event|1|||
162988652|NCT02132754|588661395|FG031|Overall Study|Adverse Event|0|||
162988653|NCT02132754|588661396|FG032|Overall Study|Adverse Event|1|||
162988654|NCT02132754|588661397|FG033|Overall Study|Adverse Event|1|||
162988655|NCT02132754|588661364|FG000|Overall Study|Clinical Progression|0|||
162988656|NCT02132754|588661365|FG001|Overall Study|Clinical Progression|0|||
162988657|NCT02132754|588661366|FG002|Overall Study|Clinical Progression|0|||
162988658|NCT02132754|588661367|FG003|Overall Study|Clinical Progression|0|||
162636638|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
162988659|NCT02132754|588661368|FG004|Overall Study|Clinical Progression|0|||
162988660|NCT02132754|588661369|FG005|Overall Study|Clinical Progression|0|||
162988661|NCT02132754|588661370|FG006|Overall Study|Clinical Progression|0|||
162988662|NCT02132754|588661371|FG007|Overall Study|Clinical Progression|0|||
162988663|NCT02132754|588661372|FG008|Overall Study|Clinical Progression|0|||
162988664|NCT02132754|588661373|FG009|Overall Study|Clinical Progression|1|||
162988665|NCT02132754|588661374|FG010|Overall Study|Clinical Progression|0|||
162988666|NCT02132754|588661375|FG011|Overall Study|Clinical Progression|0|||
162988667|NCT02132754|588661376|FG012|Overall Study|Clinical Progression|0|||
162988668|NCT02132754|588661377|FG013|Overall Study|Clinical Progression|0|||
162988669|NCT02132754|588661378|FG014|Overall Study|Clinical Progression|0|||
162988670|NCT02132754|588661379|FG015|Overall Study|Clinical Progression|0|||
162988671|NCT02132754|588661380|FG016|Overall Study|Clinical Progression|1|||
162988672|NCT02132754|588661381|FG017|Overall Study|Clinical Progression|1|||
162988673|NCT02132754|588661382|FG018|Overall Study|Clinical Progression|0|||
162988674|NCT02132754|588661383|FG019|Overall Study|Clinical Progression|1|||
162988675|NCT02132754|588661384|FG020|Overall Study|Clinical Progression|0|||
162988676|NCT02132754|588661385|FG021|Overall Study|Clinical Progression|0|||
162988677|NCT02132754|588661386|FG022|Overall Study|Clinical Progression|1|||
162988678|NCT02132754|588661387|FG023|Overall Study|Clinical Progression|0|||
162988679|NCT02132754|588661388|FG024|Overall Study|Clinical Progression|1|||
163059944|NCT01881425|588928262|FG001|Overall Study|Withdrawal by Subject|3|||
163059945|NCT01881425|588928261|FG000|Overall Study|Physician Decision|2|||
163059946|NCT01881425|588928262|FG001|Overall Study|Physician Decision|1|||
162988680|NCT02132754|588661389|FG025|Overall Study|Clinical Progression|1|||
162988681|NCT02132754|588661390|FG026|Overall Study|Clinical Progression|0|||
162988682|NCT02132754|588661391|FG027|Overall Study|Clinical Progression|1|||
162988683|NCT02132754|588661392|FG028|Overall Study|Clinical Progression|1|||
162988684|NCT02132754|588661393|FG029|Overall Study|Clinical Progression|0|||
162988685|NCT02132754|588661394|FG030|Overall Study|Clinical Progression|1|||
162988686|NCT02132754|588661395|FG031|Overall Study|Clinical Progression|0|||
162988687|NCT02132754|588661396|FG032|Overall Study|Clinical Progression|0|||
162988688|NCT02132754|588661397|FG033|Overall Study|Clinical Progression|2|||
162988689|NCT02132754|588661364|FG000|Overall Study|Death|0|||
162988690|NCT02132754|588661365|FG001|Overall Study|Death|0|||
162988691|NCT02132754|588661366|FG002|Overall Study|Death|0|||
162988692|NCT02132754|588661367|FG003|Overall Study|Death|0|||
162988693|NCT02132754|588661368|FG004|Overall Study|Death|0|||
163059947|NCT01881425|588928261|FG000|Overall Study|Adverse Event|3|||
162988694|NCT02132754|588661369|FG005|Overall Study|Death|0|||
162988695|NCT02132754|588661370|FG006|Overall Study|Death|0|||
162988696|NCT02132754|588661371|FG007|Overall Study|Death|0|||
162988697|NCT02132754|588661372|FG008|Overall Study|Death|0|||
162988698|NCT02132754|588661373|FG009|Overall Study|Death|0|||
162988699|NCT02132754|588661374|FG010|Overall Study|Death|0|||
162988700|NCT02132754|588661375|FG011|Overall Study|Death|0|||
162988701|NCT02132754|588661376|FG012|Overall Study|Death|0|||
162988702|NCT02132754|588661377|FG013|Overall Study|Death|0|||
162988703|NCT02132754|588661378|FG014|Overall Study|Death|0|||
162988704|NCT02132754|588661379|FG015|Overall Study|Death|1|||
162988705|NCT02132754|588661380|FG016|Overall Study|Death|0|||
162988706|NCT02132754|588661381|FG017|Overall Study|Death|0|||
162988707|NCT02132754|588661382|FG018|Overall Study|Death|0|||
162988708|NCT02132754|588661383|FG019|Overall Study|Death|1|||
162988709|NCT02132754|588661384|FG020|Overall Study|Death|0|||
162988710|NCT02132754|588661385|FG021|Overall Study|Death|1|||
162988711|NCT02132754|588661386|FG022|Overall Study|Death|0|||
162988712|NCT02132754|588661387|FG023|Overall Study|Death|0|||
162988713|NCT02132754|588661388|FG024|Overall Study|Death|0|||
162988714|NCT02132754|588661389|FG025|Overall Study|Death|0|||
162988715|NCT02132754|588661390|FG026|Overall Study|Death|1|||
162988716|NCT02132754|588661391|FG027|Overall Study|Death|0|||
162988717|NCT02132754|588661392|FG028|Overall Study|Death|0|||
162988718|NCT02132754|588661393|FG029|Overall Study|Death|0|||
162988719|NCT02132754|588661394|FG030|Overall Study|Death|0|||
162988720|NCT02132754|588661395|FG031|Overall Study|Death|0|||
162988721|NCT02132754|588661396|FG032|Overall Study|Death|0|||
162988722|NCT02132754|588661397|FG033|Overall Study|Death|2|||
162988723|NCT02132754|588661364|FG000|Overall Study|Excluded Medication|0|||
162988724|NCT02132754|588661365|FG001|Overall Study|Excluded Medication|0|||
162988725|NCT02132754|588661366|FG002|Overall Study|Excluded Medication|0|||
162988726|NCT02132754|588661367|FG003|Overall Study|Excluded Medication|0|||
162988727|NCT02132754|588661368|FG004|Overall Study|Excluded Medication|0|||
162988728|NCT02132754|588661369|FG005|Overall Study|Excluded Medication|0|||
162988729|NCT02132754|588661370|FG006|Overall Study|Excluded Medication|0|||
162988730|NCT02132754|588661371|FG007|Overall Study|Excluded Medication|0|||
162988731|NCT02132754|588661372|FG008|Overall Study|Excluded Medication|0|||
162988732|NCT02132754|588661373|FG009|Overall Study|Excluded Medication|0|||
162988733|NCT02132754|588661374|FG010|Overall Study|Excluded Medication|0|||
162988734|NCT02132754|588661375|FG011|Overall Study|Excluded Medication|0|||
162988735|NCT02132754|588661376|FG012|Overall Study|Excluded Medication|0|||
162988736|NCT02132754|588661377|FG013|Overall Study|Excluded Medication|0|||
162988737|NCT02132754|588661378|FG014|Overall Study|Excluded Medication|0|||
162988738|NCT02132754|588661379|FG015|Overall Study|Excluded Medication|0|||
162988739|NCT02132754|588661380|FG016|Overall Study|Excluded Medication|0|||
162988740|NCT02132754|588661381|FG017|Overall Study|Excluded Medication|0|||
162988741|NCT02132754|588661382|FG018|Overall Study|Excluded Medication|0|||
162988742|NCT02132754|588661383|FG019|Overall Study|Excluded Medication|0|||
162988743|NCT02132754|588661384|FG020|Overall Study|Excluded Medication|1|||
162988744|NCT02132754|588661385|FG021|Overall Study|Excluded Medication|0|||
162988745|NCT02132754|588661386|FG022|Overall Study|Excluded Medication|0|||
162988746|NCT02132754|588661387|FG023|Overall Study|Excluded Medication|0|||
162988747|NCT02132754|588661388|FG024|Overall Study|Excluded Medication|0|||
162988748|NCT02132754|588661389|FG025|Overall Study|Excluded Medication|0|||
162988749|NCT02132754|588661390|FG026|Overall Study|Excluded Medication|0|||
162988750|NCT02132754|588661391|FG027|Overall Study|Excluded Medication|0|||
162988751|NCT02132754|588661392|FG028|Overall Study|Excluded Medication|0|||
162988752|NCT02132754|588661393|FG029|Overall Study|Excluded Medication|0|||
162988753|NCT02132754|588661394|FG030|Overall Study|Excluded Medication|0|||
162988754|NCT02132754|588661395|FG031|Overall Study|Excluded Medication|0|||
162988755|NCT02132754|588661396|FG032|Overall Study|Excluded Medication|0|||
162988756|NCT02132754|588661397|FG033|Overall Study|Excluded Medication|1|||
162988757|NCT02132754|588661364|FG000|Overall Study|Physician Decision|0|||
162988758|NCT02132754|588661365|FG001|Overall Study|Physician Decision|0|||
162988759|NCT02132754|588661366|FG002|Overall Study|Physician Decision|0|||
162988760|NCT02132754|588661367|FG003|Overall Study|Physician Decision|0|||
162988761|NCT02132754|588661368|FG004|Overall Study|Physician Decision|0|||
162988762|NCT02132754|588661369|FG005|Overall Study|Physician Decision|0|||
162988763|NCT02132754|588661370|FG006|Overall Study|Physician Decision|0|||
162988764|NCT02132754|588661371|FG007|Overall Study|Physician Decision|0|||
162988765|NCT02132754|588661372|FG008|Overall Study|Physician Decision|0|||
162988766|NCT02132754|588661373|FG009|Overall Study|Physician Decision|1|||
162988767|NCT02132754|588661374|FG010|Overall Study|Physician Decision|0|||
162988768|NCT02132754|588661375|FG011|Overall Study|Physician Decision|1|||
162988769|NCT02132754|588661376|FG012|Overall Study|Physician Decision|1|||
162988770|NCT02132754|588661377|FG013|Overall Study|Physician Decision|0|||
162988771|NCT02132754|588661378|FG014|Overall Study|Physician Decision|0|||
162988772|NCT02132754|588661379|FG015|Overall Study|Physician Decision|1|||
162988773|NCT02132754|588661380|FG016|Overall Study|Physician Decision|0|||
162988774|NCT02132754|588661381|FG017|Overall Study|Physician Decision|0|||
162988775|NCT02132754|588661382|FG018|Overall Study|Physician Decision|0|||
162988776|NCT02132754|588661383|FG019|Overall Study|Physician Decision|0|||
162988777|NCT02132754|588661384|FG020|Overall Study|Physician Decision|0|||
162988778|NCT02132754|588661385|FG021|Overall Study|Physician Decision|0|||
162988779|NCT02132754|588661386|FG022|Overall Study|Physician Decision|0|||
162988780|NCT02132754|588661387|FG023|Overall Study|Physician Decision|0|||
162988781|NCT02132754|588661388|FG024|Overall Study|Physician Decision|1|||
162988782|NCT02132754|588661389|FG025|Overall Study|Physician Decision|0|||
162988783|NCT02132754|588661390|FG026|Overall Study|Physician Decision|0|||
162988784|NCT02132754|588661391|FG027|Overall Study|Physician Decision|0|||
162988785|NCT02132754|588661392|FG028|Overall Study|Physician Decision|0|||
162988786|NCT02132754|588661393|FG029|Overall Study|Physician Decision|0|||
162988787|NCT02132754|588661394|FG030|Overall Study|Physician Decision|0|||
162988788|NCT02132754|588661395|FG031|Overall Study|Physician Decision|1|||
162988789|NCT02132754|588661396|FG032|Overall Study|Physician Decision|0|||
162988790|NCT02132754|588661397|FG033|Overall Study|Physician Decision|3|||
162988791|NCT02132754|588661364|FG000|Overall Study|Progressive Disease|1|||
162988792|NCT02132754|588661365|FG001|Overall Study|Progressive Disease|1|||
162988793|NCT02132754|588661366|FG002|Overall Study|Progressive Disease|1|||
162988794|NCT02132754|588661367|FG003|Overall Study|Progressive Disease|1|||
162988795|NCT02132754|588661368|FG004|Overall Study|Progressive Disease|1|||
162988796|NCT02132754|588661369|FG005|Overall Study|Progressive Disease|1|||
162988797|NCT02132754|588661370|FG006|Overall Study|Progressive Disease|1|||
162988798|NCT02132754|588661371|FG007|Overall Study|Progressive Disease|1|||
162988799|NCT02132754|588661372|FG008|Overall Study|Progressive Disease|1|||
162988800|NCT02132754|588661373|FG009|Overall Study|Progressive Disease|3|||
162988801|NCT02132754|588661374|FG010|Overall Study|Progressive Disease|3|||
162988802|NCT02132754|588661375|FG011|Overall Study|Progressive Disease|2|||
162988803|NCT02132754|588661376|FG012|Overall Study|Progressive Disease|2|||
162988804|NCT02132754|588661377|FG013|Overall Study|Progressive Disease|3|||
162988805|NCT02132754|588661378|FG014|Overall Study|Progressive Disease|2|||
162988806|NCT02132754|588661379|FG015|Overall Study|Progressive Disease|1|||
162988807|NCT02132754|588661380|FG016|Overall Study|Progressive Disease|2|||
162988808|NCT02132754|588661381|FG017|Overall Study|Progressive Disease|1|||
162988809|NCT02132754|588661382|FG018|Overall Study|Progressive Disease|3|||
162988810|NCT02132754|588661383|FG019|Overall Study|Progressive Disease|1|||
162988811|NCT02132754|588661384|FG020|Overall Study|Progressive Disease|1|||
162988812|NCT02132754|588661385|FG021|Overall Study|Progressive Disease|3|||
162988813|NCT02132754|588661386|FG022|Overall Study|Progressive Disease|2|||
162988814|NCT02132754|588661387|FG023|Overall Study|Progressive Disease|3|||
162988815|NCT02132754|588661388|FG024|Overall Study|Progressive Disease|0|||
162988816|NCT02132754|588661389|FG025|Overall Study|Progressive Disease|1|||
162988817|NCT02132754|588661390|FG026|Overall Study|Progressive Disease|2|||
162988818|NCT02132754|588661391|FG027|Overall Study|Progressive Disease|1|||
162988819|NCT02132754|588661392|FG028|Overall Study|Progressive Disease|2|||
162988820|NCT02132754|588661393|FG029|Overall Study|Progressive Disease|3|||
162988821|NCT02132754|588661394|FG030|Overall Study|Progressive Disease|1|||
162988822|NCT02132754|588661395|FG031|Overall Study|Progressive Disease|1|||
162988823|NCT02132754|588661396|FG032|Overall Study|Progressive Disease|3|||
162988824|NCT02132754|588661397|FG033|Overall Study|Progressive Disease|6|||
162988825|NCT02132754|588661364|FG000|Overall Study|Screen Failure|0|||
162988826|NCT02132754|588661365|FG001|Overall Study|Screen Failure|0|||
162988827|NCT02132754|588661366|FG002|Overall Study|Screen Failure|0|||
162988828|NCT02132754|588661367|FG003|Overall Study|Screen Failure|0|||
162988829|NCT02132754|588661368|FG004|Overall Study|Screen Failure|0|||
162988830|NCT02132754|588661369|FG005|Overall Study|Screen Failure|0|||
162988831|NCT02132754|588661370|FG006|Overall Study|Screen Failure|0|||
162988832|NCT02132754|588661371|FG007|Overall Study|Screen Failure|0|||
162988833|NCT02132754|588661372|FG008|Overall Study|Screen Failure|0|||
162988834|NCT02132754|588661373|FG009|Overall Study|Screen Failure|0|||
162988835|NCT02132754|588661374|FG010|Overall Study|Screen Failure|0|||
162988836|NCT02132754|588661375|FG011|Overall Study|Screen Failure|0|||
162988837|NCT02132754|588661376|FG012|Overall Study|Screen Failure|0|||
162988838|NCT02132754|588661377|FG013|Overall Study|Screen Failure|0|||
162988839|NCT02132754|588661378|FG014|Overall Study|Screen Failure|0|||
162988840|NCT02132754|588661379|FG015|Overall Study|Screen Failure|0|||
162988841|NCT02132754|588661380|FG016|Overall Study|Screen Failure|0|||
162988842|NCT02132754|588661381|FG017|Overall Study|Screen Failure|0|||
162988843|NCT02132754|588661382|FG018|Overall Study|Screen Failure|0|||
162988844|NCT02132754|588661383|FG019|Overall Study|Screen Failure|1|||
162988845|NCT02132754|588661384|FG020|Overall Study|Screen Failure|0|||
162988846|NCT02132754|588661385|FG021|Overall Study|Screen Failure|1|||
162988847|NCT02132754|588661386|FG022|Overall Study|Screen Failure|0|||
162988848|NCT02132754|588661387|FG023|Overall Study|Screen Failure|0|||
162988849|NCT02132754|588661388|FG024|Overall Study|Screen Failure|0|||
162988850|NCT02132754|588661389|FG025|Overall Study|Screen Failure|0|||
162988851|NCT02132754|588661390|FG026|Overall Study|Screen Failure|0|||
162988852|NCT02132754|588661391|FG027|Overall Study|Screen Failure|0|||
162988853|NCT02132754|588661392|FG028|Overall Study|Screen Failure|0|||
162988854|NCT02132754|588661393|FG029|Overall Study|Screen Failure|0|||
162988855|NCT02132754|588661394|FG030|Overall Study|Screen Failure|0|||
162988856|NCT02132754|588661395|FG031|Overall Study|Screen Failure|0|||
162988857|NCT02132754|588661396|FG032|Overall Study|Screen Failure|0|||
162988858|NCT02132754|588661397|FG033|Overall Study|Screen Failure|0|||
162988859|NCT02132754|588661364|FG000|Overall Study|Transferred to Extension Study|0|||
162988860|NCT02132754|588661365|FG001|Overall Study|Transferred to Extension Study|0|||
162988861|NCT02132754|588661366|FG002|Overall Study|Transferred to Extension Study|0|||
162988862|NCT02132754|588661367|FG003|Overall Study|Transferred to Extension Study|0|||
162988863|NCT02132754|588661368|FG004|Overall Study|Transferred to Extension Study|0|||
162988864|NCT02132754|588661369|FG005|Overall Study|Transferred to Extension Study|0|||
162988865|NCT02132754|588661370|FG006|Overall Study|Transferred to Extension Study|0|||
162988866|NCT02132754|588661371|FG007|Overall Study|Transferred to Extension Study|0|||
162988867|NCT02132754|588661372|FG008|Overall Study|Transferred to Extension Study|0|||
162988868|NCT02132754|588661373|FG009|Overall Study|Transferred to Extension Study|0|||
162988869|NCT02132754|588661374|FG010|Overall Study|Transferred to Extension Study|0|||
162988870|NCT02132754|588661375|FG011|Overall Study|Transferred to Extension Study|0|||
162988871|NCT02132754|588661376|FG012|Overall Study|Transferred to Extension Study|0|||
162988872|NCT02132754|588661377|FG013|Overall Study|Transferred to Extension Study|0|||
162988873|NCT02132754|588661378|FG014|Overall Study|Transferred to Extension Study|0|||
162988874|NCT02132754|588661379|FG015|Overall Study|Transferred to Extension Study|0|||
162988875|NCT02132754|588661380|FG016|Overall Study|Transferred to Extension Study|0|||
162988876|NCT02132754|588661381|FG017|Overall Study|Transferred to Extension Study|0|||
162988877|NCT02132754|588661382|FG018|Overall Study|Transferred to Extension Study|0|||
162988878|NCT02132754|588661383|FG019|Overall Study|Transferred to Extension Study|0|||
162988879|NCT02132754|588661384|FG020|Overall Study|Transferred to Extension Study|0|||
162988880|NCT02132754|588661385|FG021|Overall Study|Transferred to Extension Study|0|||
162988881|NCT02132754|588661386|FG022|Overall Study|Transferred to Extension Study|0|||
162988882|NCT02132754|588661387|FG023|Overall Study|Transferred to Extension Study|0|||
162988883|NCT02132754|588661388|FG024|Overall Study|Transferred to Extension Study|0|||
162988884|NCT02132754|588661389|FG025|Overall Study|Transferred to Extension Study|0|||
162988885|NCT02132754|588661390|FG026|Overall Study|Transferred to Extension Study|0|||
162988886|NCT02132754|588661391|FG027|Overall Study|Transferred to Extension Study|0|||
162988887|NCT02132754|588661392|FG028|Overall Study|Transferred to Extension Study|0|||
162988888|NCT02132754|588661393|FG029|Overall Study|Transferred to Extension Study|0|||
162988889|NCT02132754|588661394|FG030|Overall Study|Transferred to Extension Study|0|||
162988890|NCT02132754|588661395|FG031|Overall Study|Transferred to Extension Study|0|||
162988891|NCT02132754|588661396|FG032|Overall Study|Transferred to Extension Study|0|||
162988892|NCT02132754|588661397|FG033|Overall Study|Transferred to Extension Study|6|||
162988893|NCT02132754|588661364|FG000|Overall Study|Withdrawal by Subject|0|||
162988894|NCT02132754|588661365|FG001|Overall Study|Withdrawal by Subject|0|||
162988895|NCT02132754|588661366|FG002|Overall Study|Withdrawal by Subject|0|||
162988896|NCT02132754|588661367|FG003|Overall Study|Withdrawal by Subject|0|||
162988897|NCT02132754|588661368|FG004|Overall Study|Withdrawal by Subject|0|||
162988898|NCT02132754|588661369|FG005|Overall Study|Withdrawal by Subject|0|||
162988899|NCT02132754|588661370|FG006|Overall Study|Withdrawal by Subject|0|||
162988900|NCT02132754|588661371|FG007|Overall Study|Withdrawal by Subject|0|||
162988901|NCT02132754|588661372|FG008|Overall Study|Withdrawal by Subject|0|||
162988902|NCT02132754|588661373|FG009|Overall Study|Withdrawal by Subject|1|||
162988903|NCT02132754|588661374|FG010|Overall Study|Withdrawal by Subject|0|||
162988904|NCT02132754|588661375|FG011|Overall Study|Withdrawal by Subject|0|||
162988905|NCT02132754|588661376|FG012|Overall Study|Withdrawal by Subject|1|||
162988906|NCT02132754|588661377|FG013|Overall Study|Withdrawal by Subject|0|||
162715612|NCT03523962|587667051|FG000|Open Fractures|Withdrawal by Subject|0|||
162715613|NCT03523962|587667052|FG001|Open Fractures|Withdrawal by Subject|0|||
162715614|NCT03523962|587667053|FG002|Open Fractures|Withdrawal by Subject|6|||
162715615|NCT03523962|587667054|FG003|Open Fractures|Withdrawal by Subject|2|||
162715616|NCT03523962|587667051|FG000|Open Fractures|Incarceration|0|||
162988907|NCT02132754|588661378|FG014|Overall Study|Withdrawal by Subject|1|||
162988908|NCT02132754|588661379|FG015|Overall Study|Withdrawal by Subject|2|||
162988909|NCT02132754|588661380|FG016|Overall Study|Withdrawal by Subject|1|||
162715617|NCT03523962|587667052|FG001|Open Fractures|Incarceration|0|||
162636639|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
162636640|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
162636641|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
162636642|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
162636643|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
162636644|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
162636645|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
162636646|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
162715618|NCT03523962|587667053|FG002|Open Fractures|Incarceration|1|||
162715619|NCT03523962|587667054|FG003|Open Fractures|Incarceration|0|||
162715620|NCT00835380|587667055|FG000|Overall Study|Withdrawal by Subject|2|||
162715621|NCT01081145|587667058|FG000|Open-Label Phase|Lack of Efficacy|56|||
162715622|NCT01081145|587667059|FG001|Open-Label Phase|Lack of Efficacy|0|||
162988910|NCT02132754|588661381|FG017|Overall Study|Withdrawal by Subject|0|||
162988911|NCT02132754|588661382|FG018|Overall Study|Withdrawal by Subject|0|||
162988912|NCT02132754|588661383|FG019|Overall Study|Withdrawal by Subject|0|||
162988913|NCT02132754|588661384|FG020|Overall Study|Withdrawal by Subject|1|||
162988914|NCT02132754|588661385|FG021|Overall Study|Withdrawal by Subject|0|||
162988915|NCT02132754|588661386|FG022|Overall Study|Withdrawal by Subject|0|||
162988916|NCT02132754|588661387|FG023|Overall Study|Withdrawal by Subject|0|||
162988917|NCT02132754|588661388|FG024|Overall Study|Withdrawal by Subject|1|||
162988918|NCT02132754|588661389|FG025|Overall Study|Withdrawal by Subject|0|||
162988919|NCT02132754|588661390|FG026|Overall Study|Withdrawal by Subject|0|||
162988920|NCT02132754|588661391|FG027|Overall Study|Withdrawal by Subject|1|||
162988921|NCT02132754|588661392|FG028|Overall Study|Withdrawal by Subject|0|||
162988922|NCT02132754|588661393|FG029|Overall Study|Withdrawal by Subject|0|||
162988923|NCT02132754|588661394|FG030|Overall Study|Withdrawal by Subject|0|||
162988924|NCT02132754|588661395|FG031|Overall Study|Withdrawal by Subject|1|||
162988925|NCT02132754|588661396|FG032|Overall Study|Withdrawal by Subject|0|||
162988926|NCT02132754|588661397|FG033|Overall Study|Withdrawal by Subject|2|||
162988927|NCT01193127|588661406|FG000|Randomized|Surgery Cancelled|0|||
162988928|NCT01193127|588661407|FG001|Randomized|Surgery Cancelled|0|||
162988929|NCT01193127|588661408|FG002|Randomized|Surgery Cancelled|0|||
162988930|NCT01193127|588661409|FG003|Randomized|Surgery Cancelled|1|||
162988931|NCT01193127|588661406|FG000|Treated|Withdrawal by Subject|0|||
162988932|NCT01193127|588661407|FG001|Treated|Withdrawal by Subject|0|||
162988933|NCT01193127|588661408|FG002|Treated|Withdrawal by Subject|0|||
162988934|NCT01193127|588661409|FG003|Treated|Withdrawal by Subject|1|||
162988935|NCT00761865|588661413|FG000|Overall Study|Lost to Follow-up|8|||
162988936|NCT00761865|588661414|FG001|Overall Study|Lost to Follow-up|7|||
162988937|NCT04555720|588661417|FG000|Overall Study|Lost to Follow-up|2|||
162988938|NCT04555720|588661418|FG001|Overall Study|Lost to Follow-up|0|||
162988939|NCT04555720|588661419|FG002|Overall Study|Lost to Follow-up|0|||
162988940|NCT04555720|588661420|FG003|Overall Study|Lost to Follow-up|0|||
162988941|NCT04555720|588661417|FG000|Overall Study|Withdrawal by Subject|4|||
162988942|NCT04555720|588661418|FG001|Overall Study|Withdrawal by Subject|6|||
162988943|NCT04555720|588661419|FG002|Overall Study|Withdrawal by Subject|0|||
162988944|NCT04555720|588661420|FG003|Overall Study|Withdrawal by Subject|0|||
162988945|NCT00321737|588661421|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
162988946|NCT00321737|588661422|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
162988947|NCT00321737|588661423|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
162988948|NCT00321737|588661421|FG000|Overall Study|Adverse Event|11|||
162988949|NCT00321737|588661422|FG001|Overall Study|Adverse Event|3|||
162988950|NCT00321737|588661423|FG002|Overall Study|Adverse Event|6|||
162988951|NCT00321737|588661421|FG000|Overall Study|Lost to Follow-up|5|||
162988952|NCT00321737|588661422|FG001|Overall Study|Lost to Follow-up|5|||
162988953|NCT00321737|588661423|FG002|Overall Study|Lost to Follow-up|6|||
162988954|NCT00321737|588661421|FG000|Overall Study|Withdrawal by Subject|19|||
162988955|NCT00321737|588661422|FG001|Overall Study|Withdrawal by Subject|12|||
162636647|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
162988956|NCT00321737|588661423|FG002|Overall Study|Withdrawal by Subject|17|||
162988957|NCT00321737|588661421|FG000|Overall Study|Protocol Violation|0|||
162988958|NCT00321737|588661422|FG001|Overall Study|Protocol Violation|0|||
162988959|NCT00321737|588661423|FG002|Overall Study|Protocol Violation|1|||
162988960|NCT00321737|588661421|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
162988961|NCT00321737|588661422|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
162988962|NCT00321737|588661423|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
162636648|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
162715623|NCT01081145|587667058|FG000|Open-Label Phase|Response criteria not met|46|||
162715624|NCT01081145|587667059|FG001|Open-Label Phase|Response criteria not met|0|||
162715625|NCT01081145|587667058|FG000|Open-Label Phase|Adverse Event|42|||
162988963|NCT00321737|588661421|FG000|Overall Study|Possible Barrett's Esophagus|2|||
163059948|NCT01881425|588928262|FG001|Overall Study|Adverse Event|0|||
162988964|NCT00321737|588661422|FG001|Overall Study|Possible Barrett's Esophagus|1|||
162988965|NCT00321737|588661423|FG002|Overall Study|Possible Barrett's Esophagus|1|||
162988966|NCT00321737|588661421|FG000|Overall Study|Therapeutic Failure|6|||
162636649|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
162636650|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
162636651|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
162636652|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
162636653|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
162636654|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
162636655|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
162636656|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
162636657|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
162636658|NCT01285310|587384283|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
162636659|NCT01285310|587384284|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162636660|NCT01285310|587384285|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162636661|NCT01285310|587384286|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162636662|NCT01285310|587384287|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
162988967|NCT00321737|588661422|FG001|Overall Study|Therapeutic Failure|0|||
162988968|NCT00321737|588661423|FG002|Overall Study|Therapeutic Failure|2|||
162988969|NCT00321737|588661421|FG000|Overall Study|Pregnancy|0|||
162988970|NCT00321737|588661422|FG001|Overall Study|Pregnancy|2|||
162988971|NCT00321737|588661423|FG002|Overall Study|Pregnancy|0|||
162988972|NCT00321737|588661421|FG000|Overall Study|Noncompliance|2|||
162988973|NCT00321737|588661422|FG001|Overall Study|Noncompliance|0|||
162988974|NCT00321737|588661423|FG002|Overall Study|Noncompliance|0|||
162988975|NCT00321737|588661421|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
162988976|NCT00321737|588661422|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
162988977|NCT00321737|588661423|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
162988978|NCT02283294|588661424|FG000|Overall Study|Lost to Follow-up|1|||
162988979|NCT02283294|588661425|FG001|Overall Study|Lost to Follow-up|1|||
162988980|NCT02283294|588661424|FG000|Overall Study|Withdrawal by Subject|1|||
162988981|NCT02283294|588661425|FG001|Overall Study|Withdrawal by Subject|6|||
162988982|NCT02283294|588661424|FG000|Overall Study|Protocol Violation|1|||
162988983|NCT02283294|588661425|FG001|Overall Study|Protocol Violation|0|||
162988984|NCT02283294|588661424|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
162988985|NCT02283294|588661425|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
162988986|NCT02799095|588664355|FG000|Part A|Adverse Event|1|||
162988987|NCT02799095|588664356|FG001|Part A|Adverse Event|0|||
162988988|NCT02799095|588664357|FG002|Part A|Adverse Event|1|||
162988989|NCT02799095|588664358|FG003|Part A|Adverse Event|4|||
162988990|NCT02799095|588664359|FG004|Part A|Adverse Event|1|||
162988991|NCT02799095|588664360|FG005|Part A|Adverse Event|0|||
162988992|NCT02799095|588664361|FG006|Part A|Adverse Event|0|||
162988993|NCT02799095|588664362|FG007|Part A|Adverse Event|0|||
162988994|NCT02799095|588664363|FG008|Part A|Adverse Event|0|||
162988995|NCT02799095|588664364|FG009|Part A|Adverse Event|0|||
162988996|NCT02799095|588664365|FG010|Part A|Adverse Event|0|||
162988997|NCT02799095|588664366|FG011|Part A|Adverse Event|0|||
162988998|NCT02799095|588664367|FG012|Part A|Adverse Event|0|||
162988999|NCT02799095|588664368|FG013|Part A|Adverse Event|0|||
162989000|NCT02799095|588664369|FG014|Part A|Adverse Event|0|||
162989001|NCT02799095|588664370|FG015|Part A|Adverse Event|0|||
162989002|NCT02799095|588664371|FG016|Part A|Adverse Event|0|||
162989003|NCT02799095|588664355|FG000|Part A|Death|0|||
162989004|NCT02799095|588664356|FG001|Part A|Death|0|||
162989005|NCT02799095|588664357|FG002|Part A|Death|0|||
162989006|NCT02799095|588664358|FG003|Part A|Death|0|||
162989007|NCT02799095|588664359|FG004|Part A|Death|0|||
162989008|NCT02799095|588664360|FG005|Part A|Death|0|||
162989009|NCT02799095|588664361|FG006|Part A|Death|3|||
162989010|NCT02799095|588664362|FG007|Part A|Death|0|||
163059949|NCT01881425|588928261|FG000|Overall Study|General Anesthesia panic attack|0|||
162636663|NCT00514540|587384288|FG000|First-Line Chemo|Withdrawal by Subject|1|||
162636664|NCT00514540|587384288|FG000|First-Line Chemo|Protocol Violation|7|||
162636665|NCT00514540|587384288|FG000|Second-Line|Physician/Patient Decision|31|||
162636666|NCT01996982|587384291|FG000|Overall Study|PI/team left institution|7|||
162636667|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
162989011|NCT02799095|588664363|FG008|Part A|Death|0|||
162989012|NCT02799095|588664364|FG009|Part A|Death|0|||
162989013|NCT02799095|588664365|FG010|Part A|Death|0|||
162989014|NCT02799095|588664366|FG011|Part A|Death|0|||
162989015|NCT02799095|588664367|FG012|Part A|Death|0|||
162989016|NCT02799095|588664368|FG013|Part A|Death|0|||
162989017|NCT02799095|588664369|FG014|Part A|Death|0|||
162989018|NCT02799095|588664370|FG015|Part A|Death|0|||
162989019|NCT02799095|588664371|FG016|Part A|Death|0|||
162989020|NCT02799095|588664355|FG000|Part A|Lost to Follow-up|0|||
162989021|NCT02799095|588664356|FG001|Part A|Lost to Follow-up|1|||
162989022|NCT02799095|588664357|FG002|Part A|Lost to Follow-up|0|||
162989023|NCT02799095|588664358|FG003|Part A|Lost to Follow-up|0|||
162989024|NCT02799095|588664359|FG004|Part A|Lost to Follow-up|0|||
162989025|NCT02799095|588664360|FG005|Part A|Lost to Follow-up|0|||
162989026|NCT02799095|588664361|FG006|Part A|Lost to Follow-up|1|||
162989027|NCT02799095|588664362|FG007|Part A|Lost to Follow-up|0|||
162989028|NCT02799095|588664363|FG008|Part A|Lost to Follow-up|0|||
162989029|NCT02799095|588664364|FG009|Part A|Lost to Follow-up|0|||
162989030|NCT02799095|588664365|FG010|Part A|Lost to Follow-up|0|||
162989031|NCT02799095|588664366|FG011|Part A|Lost to Follow-up|0|||
162989032|NCT02799095|588664367|FG012|Part A|Lost to Follow-up|0|||
162989033|NCT02799095|588664368|FG013|Part A|Lost to Follow-up|0|||
162989034|NCT02799095|588664369|FG014|Part A|Lost to Follow-up|0|||
162989035|NCT02799095|588664370|FG015|Part A|Lost to Follow-up|0|||
162989036|NCT02799095|588664371|FG016|Part A|Lost to Follow-up|0|||
162989037|NCT02799095|588664355|FG000|Part A|Progressive Disease|3|||
162989038|NCT02799095|588664356|FG001|Part A|Progressive Disease|3|||
162989039|NCT02799095|588664357|FG002|Part A|Progressive Disease|3|||
162989040|NCT02799095|588664358|FG003|Part A|Progressive Disease|2|||
162989041|NCT02799095|588664359|FG004|Part A|Progressive Disease|2|||
162989042|NCT02799095|588664360|FG005|Part A|Progressive Disease|0|||
162989043|NCT02799095|588664361|FG006|Part A|Progressive Disease|0|||
162989044|NCT02799095|588664362|FG007|Part A|Progressive Disease|0|||
162989045|NCT02799095|588664363|FG008|Part A|Progressive Disease|0|||
162989046|NCT02799095|588664364|FG009|Part A|Progressive Disease|0|||
162989047|NCT02799095|588664365|FG010|Part A|Progressive Disease|0|||
162989048|NCT02799095|588664366|FG011|Part A|Progressive Disease|0|||
162989049|NCT02799095|588664367|FG012|Part A|Progressive Disease|0|||
162989050|NCT02799095|588664368|FG013|Part A|Progressive Disease|0|||
162989051|NCT02799095|588664369|FG014|Part A|Progressive Disease|0|||
162989052|NCT02799095|588664370|FG015|Part A|Progressive Disease|0|||
162989053|NCT02799095|588664371|FG016|Part A|Progressive Disease|0|||
162989054|NCT02799095|588664355|FG000|Part A|Clinical Progression|1|||
162989055|NCT02799095|588664356|FG001|Part A|Clinical Progression|0|||
162989056|NCT02799095|588664357|FG002|Part A|Clinical Progression|2|||
162989057|NCT02799095|588664358|FG003|Part A|Clinical Progression|1|||
162989058|NCT02799095|588664359|FG004|Part A|Clinical Progression|5|||
162989059|NCT02799095|588664360|FG005|Part A|Clinical Progression|0|||
162989060|NCT02799095|588664361|FG006|Part A|Clinical Progression|0|||
162989061|NCT02799095|588664362|FG007|Part A|Clinical Progression|0|||
162989062|NCT02799095|588664363|FG008|Part A|Clinical Progression|0|||
162989063|NCT02799095|588664364|FG009|Part A|Clinical Progression|0|||
162989064|NCT02799095|588664365|FG010|Part A|Clinical Progression|0|||
162989065|NCT02799095|588664366|FG011|Part A|Clinical Progression|0|||
162989066|NCT02799095|588664367|FG012|Part A|Clinical Progression|0|||
162989067|NCT02799095|588664368|FG013|Part A|Clinical Progression|0|||
162989068|NCT02799095|588664369|FG014|Part A|Clinical Progression|0|||
162636668|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
162989069|NCT02799095|588664370|FG015|Part A|Clinical Progression|0|||
162989070|NCT02799095|588664371|FG016|Part A|Clinical Progression|0|||
162989071|NCT02799095|588664355|FG000|Part A|Protocol Deviation|0|||
162989072|NCT02799095|588664356|FG001|Part A|Protocol Deviation|0|||
162989073|NCT02799095|588664357|FG002|Part A|Protocol Deviation|1|||
162636669|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
162636670|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
162636671|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
162636672|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
162636673|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162636674|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
162636675|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162636676|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162636677|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Death|2|||
162636678|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Death|1|||
162636679|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Death|4|||
162636680|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Death|0|||
162636681|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Death|0|||
162636682|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
162636683|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
162989074|NCT02799095|588664358|FG003|Part A|Protocol Deviation|0|||
162989075|NCT02799095|588664359|FG004|Part A|Protocol Deviation|0|||
162989076|NCT02799095|588664360|FG005|Part A|Protocol Deviation|0|||
162989077|NCT02799095|588664361|FG006|Part A|Protocol Deviation|0|||
162989078|NCT02799095|588664362|FG007|Part A|Protocol Deviation|0|||
162989079|NCT02799095|588664363|FG008|Part A|Protocol Deviation|0|||
162989080|NCT02799095|588664364|FG009|Part A|Protocol Deviation|0|||
162989081|NCT02799095|588664365|FG010|Part A|Protocol Deviation|0|||
162989082|NCT02799095|588664366|FG011|Part A|Protocol Deviation|0|||
162989083|NCT02799095|588664367|FG012|Part A|Protocol Deviation|0|||
162989084|NCT02799095|588664368|FG013|Part A|Protocol Deviation|0|||
162989085|NCT02799095|588664369|FG014|Part A|Protocol Deviation|0|||
162989086|NCT02799095|588664370|FG015|Part A|Protocol Deviation|0|||
162989087|NCT02799095|588664371|FG016|Part A|Protocol Deviation|0|||
162989088|NCT02799095|588664355|FG000|Part A|Withdrawal by Subject|0|||
162989089|NCT02799095|588664356|FG001|Part A|Withdrawal by Subject|0|||
162989090|NCT02799095|588664357|FG002|Part A|Withdrawal by Subject|0|||
162989091|NCT02799095|588664358|FG003|Part A|Withdrawal by Subject|1|||
162636684|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
162636685|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
162636686|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
162989092|NCT02799095|588664359|FG004|Part A|Withdrawal by Subject|3|||
162989093|NCT02799095|588664360|FG005|Part A|Withdrawal by Subject|1|||
162989094|NCT02799095|588664361|FG006|Part A|Withdrawal by Subject|1|||
162989095|NCT02799095|588664362|FG007|Part A|Withdrawal by Subject|0|||
162989096|NCT02799095|588664363|FG008|Part A|Withdrawal by Subject|0|||
162989097|NCT02799095|588664364|FG009|Part A|Withdrawal by Subject|0|||
162989098|NCT02799095|588664365|FG010|Part A|Withdrawal by Subject|0|||
162989099|NCT02799095|588664366|FG011|Part A|Withdrawal by Subject|0|||
162989100|NCT02799095|588664367|FG012|Part A|Withdrawal by Subject|0|||
162989101|NCT02799095|588664368|FG013|Part A|Withdrawal by Subject|0|||
162989102|NCT02799095|588664369|FG014|Part A|Withdrawal by Subject|0|||
162989103|NCT02799095|588664370|FG015|Part A|Withdrawal by Subject|0|||
162989104|NCT02799095|588664371|FG016|Part A|Withdrawal by Subject|0|||
162989105|NCT02799095|588664355|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
162989106|NCT02799095|588664356|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
162989107|NCT02799095|588664357|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
162989108|NCT02799095|588664358|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
162989109|NCT02799095|588664359|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
162989110|NCT02799095|588664360|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
162989111|NCT02799095|588664361|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
162989112|NCT02799095|588664362|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
162989113|NCT02799095|588664363|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
162989114|NCT02799095|588664364|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
162989115|NCT02799095|588664365|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
162989116|NCT02799095|588664366|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
162989117|NCT02799095|588664367|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
162989118|NCT02799095|588664368|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
162989119|NCT02799095|588664369|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
162989120|NCT02799095|588664370|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
162989121|NCT02799095|588664371|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
162989122|NCT02799095|588664355|FG000|Part B|Death|0|||
162989123|NCT02799095|588664356|FG001|Part B|Death|0|||
162989124|NCT02799095|588664357|FG002|Part B|Death|0|||
162989125|NCT02799095|588664358|FG003|Part B|Death|0|||
162989126|NCT02799095|588664359|FG004|Part B|Death|0|||
162989127|NCT02799095|588664360|FG005|Part B|Death|0|||
162989128|NCT02799095|588664361|FG006|Part B|Death|0|||
162989129|NCT02799095|588664362|FG007|Part B|Death|7|||
162989130|NCT02799095|588664363|FG008|Part B|Death|7|||
162989131|NCT02799095|588664364|FG009|Part B|Death|0|||
162989132|NCT02799095|588664365|FG010|Part B|Death|0|||
162989133|NCT02799095|588664366|FG011|Part B|Death|0|||
162989134|NCT02799095|588664367|FG012|Part B|Death|0|||
162989135|NCT02799095|588664368|FG013|Part B|Death|0|||
162989136|NCT02799095|588664369|FG014|Part B|Death|0|||
162989137|NCT02799095|588664370|FG015|Part B|Death|0|||
162989138|NCT02799095|588664371|FG016|Part B|Death|0|||
162989139|NCT02799095|588664355|FG000|Part B|Progressive Disease|0|||
162989140|NCT02799095|588664356|FG001|Part B|Progressive Disease|0|||
162989141|NCT02799095|588664357|FG002|Part B|Progressive Disease|0|||
162989142|NCT02799095|588664358|FG003|Part B|Progressive Disease|0|||
162989143|NCT02799095|588664359|FG004|Part B|Progressive Disease|0|||
162989144|NCT02799095|588664360|FG005|Part B|Progressive Disease|0|||
162989145|NCT02799095|588664361|FG006|Part B|Progressive Disease|0|||
162989146|NCT02799095|588664362|FG007|Part B|Progressive Disease|1|||
162636687|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Other Reason|1|||
162636688|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Other Reason|3|||
162636689|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Other Reason|2|||
162636690|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Other Reason|0|||
162989147|NCT02799095|588664363|FG008|Part B|Progressive Disease|0|||
162989148|NCT02799095|588664364|FG009|Part B|Progressive Disease|0|||
162636691|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Other Reason|0|||
162636692|NCT00555321|587384292|FG000|Treatment Phase up to 12-months|Never treated|2|||
162989149|NCT02799095|588664365|FG010|Part B|Progressive Disease|0|||
162989150|NCT02799095|588664366|FG011|Part B|Progressive Disease|0|||
162989151|NCT02799095|588664367|FG012|Part B|Progressive Disease|0|||
162989152|NCT02799095|588664368|FG013|Part B|Progressive Disease|0|||
162989153|NCT02799095|588664369|FG014|Part B|Progressive Disease|0|||
162989154|NCT02799095|588664370|FG015|Part B|Progressive Disease|0|||
162989155|NCT02799095|588664371|FG016|Part B|Progressive Disease|0|||
162989156|NCT02799095|588664355|FG000|Part B|Withdrawal by Subject|0|||
162989157|NCT02799095|588664356|FG001|Part B|Withdrawal by Subject|0|||
162989158|NCT02799095|588664357|FG002|Part B|Withdrawal by Subject|0|||
162989159|NCT02799095|588664358|FG003|Part B|Withdrawal by Subject|0|||
162989160|NCT02799095|588664359|FG004|Part B|Withdrawal by Subject|0|||
162989161|NCT02799095|588664360|FG005|Part B|Withdrawal by Subject|0|||
162989162|NCT02799095|588664361|FG006|Part B|Withdrawal by Subject|0|||
162989163|NCT02799095|588664362|FG007|Part B|Withdrawal by Subject|10|||
162636693|NCT00555321|587384293|FG001|Treatment Phase up to 12-months|Never treated|3|||
162636694|NCT00555321|587384294|FG002|Treatment Phase up to 12-months|Never treated|1|||
162636695|NCT00555321|587384295|FG003|Treatment Phase up to 12-months|Never treated|0|||
162636696|NCT00555321|587384296|FG004|Treatment Phase up to 12-months|Never treated|4|||
162636697|NCT00555321|587384292|FG000|Long-term Extension Phase|Adverse Event|2|||
162636698|NCT00555321|587384293|FG001|Long-term Extension Phase|Adverse Event|5|||
162636699|NCT00555321|587384294|FG002|Long-term Extension Phase|Adverse Event|2|||
162636700|NCT00555321|587384295|FG003|Long-term Extension Phase|Adverse Event|1|||
162636701|NCT00555321|587384296|FG004|Long-term Extension Phase|Adverse Event|0|||
162636702|NCT00555321|587384292|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
162636703|NCT00555321|587384293|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
162636704|NCT00555321|587384294|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
162636705|NCT00555321|587384295|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
162636706|NCT00555321|587384296|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
162636707|NCT00555321|587384292|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
162636708|NCT00555321|587384293|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
162636709|NCT00555321|587384294|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
162636710|NCT00555321|587384295|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
162636711|NCT00555321|587384296|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
162636712|NCT00555321|587384292|FG000|Long-term Extension Phase|Death|2|||
162636713|NCT00555321|587384293|FG001|Long-term Extension Phase|Death|0|||
162636714|NCT00555321|587384294|FG002|Long-term Extension Phase|Death|0|||
162636715|NCT00555321|587384295|FG003|Long-term Extension Phase|Death|3|||
162636716|NCT00555321|587384296|FG004|Long-term Extension Phase|Death|0|||
162636717|NCT00555321|587384292|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
162636718|NCT00555321|587384293|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
162989164|NCT02799095|588664363|FG008|Part B|Withdrawal by Subject|7|||
162989165|NCT02799095|588664364|FG009|Part B|Withdrawal by Subject|0|||
162989166|NCT02799095|588664365|FG010|Part B|Withdrawal by Subject|0|||
162989167|NCT02799095|588664366|FG011|Part B|Withdrawal by Subject|0|||
162989168|NCT02799095|588664367|FG012|Part B|Withdrawal by Subject|0|||
162989169|NCT02799095|588664368|FG013|Part B|Withdrawal by Subject|0|||
162989170|NCT02799095|588664369|FG014|Part B|Withdrawal by Subject|0|||
162989171|NCT02799095|588664370|FG015|Part B|Withdrawal by Subject|0|||
162989172|NCT02799095|588664371|FG016|Part B|Withdrawal by Subject|0|||
162989173|NCT02799095|588664355|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
162989174|NCT02799095|588664356|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
162989175|NCT02799095|588664357|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
162989176|NCT02799095|588664358|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
162989177|NCT02799095|588664359|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
162989178|NCT02799095|588664360|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
162989179|NCT02799095|588664361|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
162989180|NCT02799095|588664362|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
162989181|NCT02799095|588664363|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
162989182|NCT02799095|588664364|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
162989183|NCT02799095|588664365|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
162989184|NCT02799095|588664366|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
162989185|NCT02799095|588664367|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
162989186|NCT02799095|588664368|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
162989187|NCT02799095|588664369|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
162989188|NCT02799095|588664370|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
162989189|NCT02799095|588664371|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
162989190|NCT02799095|588664355|FG000|Part C|Adverse Event|0|||
162989191|NCT02799095|588664356|FG001|Part C|Adverse Event|0|||
162989192|NCT02799095|588664357|FG002|Part C|Adverse Event|0|||
162989193|NCT02799095|588664358|FG003|Part C|Adverse Event|0|||
162989194|NCT02799095|588664359|FG004|Part C|Adverse Event|0|||
162989195|NCT02799095|588664360|FG005|Part C|Adverse Event|0|||
162989196|NCT02799095|588664361|FG006|Part C|Adverse Event|0|||
162989197|NCT02799095|588664362|FG007|Part C|Adverse Event|0|||
162636719|NCT00555321|587384294|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
162636720|NCT00555321|587384295|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
162989198|NCT02799095|588664363|FG008|Part C|Adverse Event|0|||
162989199|NCT02799095|588664364|FG009|Part C|Adverse Event|0|||
162989200|NCT02799095|588664365|FG010|Part C|Adverse Event|3|||
162989201|NCT02799095|588664366|FG011|Part C|Adverse Event|1|||
162989202|NCT02799095|588664367|FG012|Part C|Adverse Event|0|||
162636721|NCT00555321|587384296|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
162636722|NCT00555321|587384292|FG000|Long-term Extension Phase|Other Reason|1|||
162989203|NCT02799095|588664368|FG013|Part C|Adverse Event|1|||
162636723|NCT00555321|587384293|FG001|Long-term Extension Phase|Other Reason|0|||
162636724|NCT00555321|587384294|FG002|Long-term Extension Phase|Other Reason|2|||
162989204|NCT02799095|588664369|FG014|Part C|Adverse Event|0|||
163059950|NCT01881425|588928262|FG001|Overall Study|General Anesthesia panic attack|1|||
162989205|NCT02799095|588664370|FG015|Part C|Adverse Event|0|||
162989206|NCT02799095|588664371|FG016|Part C|Adverse Event|0|||
162989207|NCT02799095|588664355|FG000|Part C|Death|0|||
162989208|NCT02799095|588664356|FG001|Part C|Death|0|||
162989209|NCT02799095|588664357|FG002|Part C|Death|0|||
162989210|NCT02799095|588664358|FG003|Part C|Death|0|||
162989211|NCT02799095|588664359|FG004|Part C|Death|0|||
162989212|NCT02799095|588664360|FG005|Part C|Death|0|||
162989213|NCT02799095|588664361|FG006|Part C|Death|0|||
162989214|NCT02799095|588664362|FG007|Part C|Death|0|||
162989215|NCT02799095|588664363|FG008|Part C|Death|0|||
162989216|NCT02799095|588664364|FG009|Part C|Death|0|||
162989217|NCT02799095|588664365|FG010|Part C|Death|7|||
162989218|NCT02799095|588664366|FG011|Part C|Death|5|||
162989219|NCT02799095|588664367|FG012|Part C|Death|6|||
162989220|NCT02799095|588664368|FG013|Part C|Death|8|||
162989221|NCT02799095|588664369|FG014|Part C|Death|1|||
162989222|NCT02799095|588664370|FG015|Part C|Death|8|||
162989223|NCT02799095|588664371|FG016|Part C|Death|1|||
162989224|NCT02799095|588664355|FG000|Part C|Lost to Follow-up|0|||
162989225|NCT02799095|588664356|FG001|Part C|Lost to Follow-up|0|||
162989226|NCT02799095|588664357|FG002|Part C|Lost to Follow-up|0|||
162989227|NCT02799095|588664358|FG003|Part C|Lost to Follow-up|0|||
162989228|NCT02799095|588664359|FG004|Part C|Lost to Follow-up|0|||
162989229|NCT02799095|588664360|FG005|Part C|Lost to Follow-up|0|||
162989230|NCT02799095|588664361|FG006|Part C|Lost to Follow-up|0|||
162989231|NCT02799095|588664362|FG007|Part C|Lost to Follow-up|0|||
162989232|NCT02799095|588664363|FG008|Part C|Lost to Follow-up|0|||
162989233|NCT02799095|588664364|FG009|Part C|Lost to Follow-up|0|||
162636725|NCT00555321|587384295|FG003|Long-term Extension Phase|Other Reason|0|||
162636726|NCT00555321|587384296|FG004|Long-term Extension Phase|Other Reason|0|||
162636727|NCT01348347|587384297|FG000|Overall Study|Withdrawal by Subject|1|||
162636728|NCT01348347|587384298|FG001|Overall Study|Withdrawal by Subject|1|||
162636729|NCT01348347|587384299|FG002|Overall Study|Withdrawal by Subject|1|||
162636730|NCT01348347|587384297|FG000|Overall Study|Progressive disease|2|||
162636731|NCT01348347|587384298|FG001|Overall Study|Progressive disease|5|||
162636732|NCT01348347|587384299|FG002|Overall Study|Progressive disease|5|||
162636733|NCT00191789|587384303|FG000|Overall Study|Adverse Event|5|||
162636734|NCT00191789|587384303|FG000|Overall Study|Patient: Satisfactory Response|5|||
162636735|NCT00191789|587384303|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
162636736|NCT00191789|587384303|FG000|Overall Study|Withdrawal by Subject|4|||
162636737|NCT00191789|587384303|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
162636738|NCT00191789|587384303|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
162636739|NCT00191789|587384303|FG000|Overall Study|Death - Not Study-Drug Related|1|||
162636740|NCT03198234|587384304|FG000|Overall Study|Relapse of primary disease|0|||
162636741|NCT03198234|587384305|FG001|Overall Study|Relapse of primary disease|1|||
162636742|NCT03198234|587384306|FG002|Overall Study|Relapse of primary disease|0|||
162636743|NCT00165776|587384307|FG000|Overall Study|Lack of Efficacy|0|||
162636744|NCT00165776|587384308|FG001|Overall Study|Lack of Efficacy|0|||
162636745|NCT00165776|587384309|FG002|Overall Study|Lack of Efficacy|0|||
162636746|NCT00165776|587384310|FG003|Overall Study|Lack of Efficacy|1|||
162636747|NCT00165776|587384307|FG000|Overall Study|Withdrawal by Subject|4|||
162636748|NCT00165776|587384308|FG001|Overall Study|Withdrawal by Subject|1|||
162989234|NCT02799095|588664365|FG010|Part C|Lost to Follow-up|1|||
162989235|NCT02799095|588664366|FG011|Part C|Lost to Follow-up|1|||
162989236|NCT02799095|588664367|FG012|Part C|Lost to Follow-up|1|||
162989237|NCT02799095|588664368|FG013|Part C|Lost to Follow-up|3|||
162989238|NCT02799095|588664369|FG014|Part C|Lost to Follow-up|0|||
162989239|NCT02799095|588664370|FG015|Part C|Lost to Follow-up|0|||
162989240|NCT02799095|588664371|FG016|Part C|Lost to Follow-up|0|||
162989241|NCT02799095|588664355|FG000|Part C|Progressive Disease|0|||
162989242|NCT02799095|588664356|FG001|Part C|Progressive Disease|0|||
162989243|NCT02799095|588664357|FG002|Part C|Progressive Disease|0|||
162989244|NCT02799095|588664358|FG003|Part C|Progressive Disease|0|||
162636749|NCT00165776|587384309|FG002|Overall Study|Withdrawal by Subject|2|||
162636750|NCT00165776|587384310|FG003|Overall Study|Withdrawal by Subject|0|||
162636751|NCT00165776|587384307|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
162636752|NCT00165776|587384308|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
162636753|NCT00165776|587384309|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
162636754|NCT00165776|587384310|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
162989245|NCT02799095|588664359|FG004|Part C|Progressive Disease|0|||
162989246|NCT02799095|588664360|FG005|Part C|Progressive Disease|0|||
162989247|NCT02799095|588664361|FG006|Part C|Progressive Disease|0|||
162989248|NCT02799095|588664362|FG007|Part C|Progressive Disease|0|||
162989249|NCT02799095|588664363|FG008|Part C|Progressive Disease|0|||
162989250|NCT02799095|588664364|FG009|Part C|Progressive Disease|2|||
162989251|NCT02799095|588664365|FG010|Part C|Progressive Disease|13|||
162989252|NCT02799095|588664366|FG011|Part C|Progressive Disease|2|||
162989253|NCT02799095|588664367|FG012|Part C|Progressive Disease|0|||
162989254|NCT02799095|588664368|FG013|Part C|Progressive Disease|1|||
162989255|NCT02799095|588664369|FG014|Part C|Progressive Disease|0|||
162989256|NCT02799095|588664370|FG015|Part C|Progressive Disease|0|||
162989257|NCT02799095|588664371|FG016|Part C|Progressive Disease|0|||
162989258|NCT02799095|588664355|FG000|Part C|Clinical Progression|0|||
162989259|NCT02799095|588664356|FG001|Part C|Clinical Progression|0|||
162989260|NCT02799095|588664357|FG002|Part C|Clinical Progression|0|||
162989261|NCT02799095|588664358|FG003|Part C|Clinical Progression|0|||
162989262|NCT02799095|588664359|FG004|Part C|Clinical Progression|0|||
162989263|NCT02799095|588664360|FG005|Part C|Clinical Progression|0|||
162989264|NCT02799095|588664361|FG006|Part C|Clinical Progression|0|||
162989265|NCT02799095|588664362|FG007|Part C|Clinical Progression|0|||
162989266|NCT02799095|588664363|FG008|Part C|Clinical Progression|0|||
162989267|NCT02799095|588664364|FG009|Part C|Clinical Progression|1|||
162989268|NCT02799095|588664365|FG010|Part C|Clinical Progression|3|||
162989269|NCT02799095|588664366|FG011|Part C|Clinical Progression|0|||
162989270|NCT02799095|588664367|FG012|Part C|Clinical Progression|0|||
162989271|NCT02799095|588664368|FG013|Part C|Clinical Progression|1|||
162989272|NCT02799095|588664369|FG014|Part C|Clinical Progression|0|||
162989273|NCT02799095|588664370|FG015|Part C|Clinical Progression|0|||
162989274|NCT02799095|588664371|FG016|Part C|Clinical Progression|0|||
162989275|NCT02799095|588664355|FG000|Part C|Withdrawal by Subject|0|||
162989276|NCT02799095|588664356|FG001|Part C|Withdrawal by Subject|0|||
162989277|NCT02799095|588664357|FG002|Part C|Withdrawal by Subject|0|||
162989278|NCT02799095|588664358|FG003|Part C|Withdrawal by Subject|0|||
162989279|NCT02799095|588664359|FG004|Part C|Withdrawal by Subject|0|||
162989280|NCT02799095|588664360|FG005|Part C|Withdrawal by Subject|0|||
162989281|NCT02799095|588664361|FG006|Part C|Withdrawal by Subject|0|||
162989282|NCT02799095|588664362|FG007|Part C|Withdrawal by Subject|0|||
162989283|NCT02799095|588664363|FG008|Part C|Withdrawal by Subject|0|||
162989284|NCT02799095|588664364|FG009|Part C|Withdrawal by Subject|0|||
162989285|NCT02799095|588664365|FG010|Part C|Withdrawal by Subject|13|||
162989286|NCT02799095|588664366|FG011|Part C|Withdrawal by Subject|15|||
162989287|NCT02799095|588664367|FG012|Part C|Withdrawal by Subject|13|||
162989288|NCT02799095|588664368|FG013|Part C|Withdrawal by Subject|21|||
162989289|NCT02799095|588664369|FG014|Part C|Withdrawal by Subject|0|||
162989290|NCT02799095|588664370|FG015|Part C|Withdrawal by Subject|12|||
162989291|NCT02799095|588664371|FG016|Part C|Withdrawal by Subject|1|||
162989292|NCT02799095|588664355|FG000|Part C|Physician Decision|0|||
162989293|NCT02799095|588664356|FG001|Part C|Physician Decision|0|||
162989294|NCT02799095|588664357|FG002|Part C|Physician Decision|0|||
162989295|NCT02799095|588664358|FG003|Part C|Physician Decision|0|||
162989296|NCT02799095|588664359|FG004|Part C|Physician Decision|0|||
162989297|NCT02799095|588664360|FG005|Part C|Physician Decision|0|||
162989298|NCT02799095|588664361|FG006|Part C|Physician Decision|0|||
162989299|NCT02799095|588664362|FG007|Part C|Physician Decision|0|||
162989300|NCT02799095|588664363|FG008|Part C|Physician Decision|0|||
162989301|NCT02799095|588664364|FG009|Part C|Physician Decision|0|||
162989302|NCT02799095|588664365|FG010|Part C|Physician Decision|1|||
162989303|NCT02799095|588664366|FG011|Part C|Physician Decision|0|||
162989304|NCT02799095|588664367|FG012|Part C|Physician Decision|0|||
162989305|NCT02799095|588664368|FG013|Part C|Physician Decision|0|||
162989306|NCT02799095|588664369|FG014|Part C|Physician Decision|0|||
162989307|NCT02799095|588664370|FG015|Part C|Physician Decision|0|||
162989308|NCT02799095|588664371|FG016|Part C|Physician Decision|0|||
162989309|NCT02799095|588664355|FG000|Part C|Other|0|||
162989310|NCT02799095|588664356|FG001|Part C|Other|0|||
162989311|NCT02799095|588664357|FG002|Part C|Other|0|||
162989312|NCT02799095|588664358|FG003|Part C|Other|0|||
162989313|NCT02799095|588664359|FG004|Part C|Other|0|||
162989314|NCT02799095|588664360|FG005|Part C|Other|0|||
162989315|NCT02799095|588664361|FG006|Part C|Other|0|||
162989316|NCT02799095|588664362|FG007|Part C|Other|0|||
162989317|NCT02799095|588664363|FG008|Part C|Other|0|||
162989318|NCT02799095|588664364|FG009|Part C|Other|0|||
162989319|NCT02799095|588664365|FG010|Part C|Other|0|||
162989320|NCT02799095|588664366|FG011|Part C|Other|2|||
162989321|NCT02799095|588664367|FG012|Part C|Other|2|||
162989322|NCT02799095|588664368|FG013|Part C|Other|0|||
162989323|NCT02799095|588664369|FG014|Part C|Other|0|||
162989324|NCT02799095|588664370|FG015|Part C|Other|0|||
162989325|NCT02799095|588664371|FG016|Part C|Other|0|||
162989326|NCT04994483|588664372|FG000|Overall Study|Adverse Event|26|||
162989327|NCT04994483|588664373|FG001|Overall Study|Adverse Event|17|||
162989328|NCT04994483|588664372|FG000|Overall Study|Lost to Follow-up|6|||
162989329|NCT04994483|588664373|FG001|Overall Study|Lost to Follow-up|10|||
162989330|NCT04994483|588664372|FG000|Overall Study|Noncompliance with study drug|8|||
162989331|NCT04994483|588664373|FG001|Overall Study|Noncompliance with study drug|5|||
162989332|NCT04994483|588664372|FG000|Overall Study|Physician Decision|5|||
162989333|NCT04994483|588664373|FG001|Overall Study|Physician Decision|0|||
162989334|NCT04994483|588664372|FG000|Overall Study|Withdrawal by Subject|41|||
162989335|NCT04994483|588664373|FG001|Overall Study|Withdrawal by Subject|38|||
162989336|NCT04994483|588664372|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
162989337|NCT04994483|588664373|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
162989338|NCT04994483|588664372|FG000|Overall Study|Met stopping criteria|1|||
162989339|NCT04994483|588664373|FG001|Overall Study|Met stopping criteria|0|||
162989340|NCT04994483|588664372|FG000|Overall Study|Randomized in error, not treated|4|||
162989341|NCT04994483|588664373|FG001|Overall Study|Randomized in error, not treated|3|||
162989342|NCT04994483|588664372|FG000|Overall Study|Lack of a reliable study partner|0|||
162989343|NCT04994483|588664373|FG001|Overall Study|Lack of a reliable study partner|1|||
162989344|NCT04994483|588664372|FG000|Overall Study|Met MRI exclusion criteria|0|||
162989345|NCT04994483|588664373|FG001|Overall Study|Met MRI exclusion criteria|1|||
162989346|NCT00759902|588664374|FG000|Overall Study|Adverse Event|0|||
162989347|NCT00759902|588664375|FG001|Overall Study|Adverse Event|1|||
162989348|NCT02213510|588664376|FG000|Overall Study|Death|0|||
162989349|NCT02213510|588664377|FG001|Overall Study|Death|1|||
162989350|NCT02213510|588664376|FG000|Overall Study|Lost to Follow-up|1|||
162989351|NCT02213510|588664377|FG001|Overall Study|Lost to Follow-up|0|||
162989352|NCT03954834|588664378|FG000|Overall Study|Adverse Event|1|||
162989353|NCT03954834|588664379|FG001|Overall Study|Adverse Event|3|||
162989354|NCT03954834|588664380|FG002|Overall Study|Adverse Event|1|||
162989355|NCT03954834|588664381|FG003|Overall Study|Adverse Event|1|||
162989356|NCT03954834|588664378|FG000|Overall Study|Death|0|||
162989357|NCT03954834|588664379|FG001|Overall Study|Death|0|||
162989358|NCT03954834|588664380|FG002|Overall Study|Death|0|||
162989359|NCT03954834|588664381|FG003|Overall Study|Death|1|||
162989360|NCT03954834|588664378|FG000|Overall Study|Physician Decision|0|||
162989361|NCT03954834|588664379|FG001|Overall Study|Physician Decision|1|||
162989362|NCT03954834|588664380|FG002|Overall Study|Physician Decision|0|||
162989363|NCT03954834|588664381|FG003|Overall Study|Physician Decision|2|||
162989364|NCT03954834|588664378|FG000|Overall Study|Protocol Violation|1|||
162989365|NCT03954834|588664379|FG001|Overall Study|Protocol Violation|0|||
162989366|NCT03954834|588664380|FG002|Overall Study|Protocol Violation|0|||
162989367|NCT03954834|588664381|FG003|Overall Study|Protocol Violation|1|||
162989368|NCT03954834|588664378|FG000|Overall Study|Withdrawal by Subject|2|||
162989369|NCT03954834|588664379|FG001|Overall Study|Withdrawal by Subject|3|||
162989370|NCT03954834|588664380|FG002|Overall Study|Withdrawal by Subject|13|||
162989371|NCT03954834|588664381|FG003|Overall Study|Withdrawal by Subject|6|||
162989372|NCT03954834|588664378|FG000|Overall Study|Participant left the country|0|||
162989373|NCT03954834|588664379|FG001|Overall Study|Participant left the country|0|||
162989374|NCT03954834|588664380|FG002|Overall Study|Participant left the country|1|||
162989375|NCT03954834|588664381|FG003|Overall Study|Participant left the country|0|||
162989376|NCT03954834|588664378|FG000|Overall Study|Lost to Follow-up|3|||
162989377|NCT03954834|588664379|FG001|Overall Study|Lost to Follow-up|2|||
162989378|NCT03954834|588664380|FG002|Overall Study|Lost to Follow-up|3|||
162989379|NCT03954834|588664381|FG003|Overall Study|Lost to Follow-up|5|||
162989380|NCT02903030|588664382|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162989381|NCT02903030|588664383|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162989382|NCT03700385|588664390|FG000|Overall Study|Lost to Follow-up|1|||
162989383|NCT00699283|588664391|FG000|Overall Study|Lack of Efficacy|15|||
162989384|NCT00699283|588664392|FG001|Overall Study|Lack of Efficacy|5|||
162989385|NCT00699283|588664391|FG000|Overall Study|Lost to Follow-up|2|||
162989386|NCT00699283|588664392|FG001|Overall Study|Lost to Follow-up|0|||
162989387|NCT00699283|588664391|FG000|Overall Study|Withdrawal by Subject|1|||
162989388|NCT00699283|588664392|FG001|Overall Study|Withdrawal by Subject|0|||
162989389|NCT00699283|588664391|FG000|Overall Study|Other Reason|5|||
162989390|NCT00699283|588664392|FG001|Overall Study|Other Reason|1|||
162989391|NCT00699283|588664391|FG000|Overall Study|SAE, non-fatal|1|||
162989392|NCT00699283|588664392|FG001|Overall Study|SAE, non-fatal|1|||
162989393|NCT00699283|588664391|FG000|Overall Study|AE, non-serious non-fatal|8|||
162989394|NCT00699283|588664392|FG001|Overall Study|AE, non-serious non-fatal|1|||
162989395|NCT00699283|588664391|FG000|Overall Study|AE of unknown type|1|||
163059951|NCT01881425|588928261|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
163059952|NCT01881425|588928262|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
163059953|NCT01881425|588928261|FG000|Overall Study|Lost to Follow-up|7|||
163059954|NCT01881425|588928262|FG001|Overall Study|Lost to Follow-up|2|||
163059955|NCT04154956|588928267|FG000|Overall Study|Death|109|||
163059956|NCT04154956|588928268|FG001|Overall Study|Death|110|||
163059957|NCT04154956|588928267|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
162636755|NCT04285879|587384311|FG000|Overall Study|Lost to Follow-up|1|||
162989396|NCT00699283|588664392|FG001|Overall Study|AE of unknown type|0|||
162989397|NCT04590040|588664398|FG000|Treatment Period|Lost to Follow-up|2|||
162989398|NCT04590040|588664399|FG001|Treatment Period|Lost to Follow-up|5|||
162989399|NCT04590040|588664400|FG002|Treatment Period|Lost to Follow-up|0|||
162989400|NCT04590040|588664398|FG000|Treatment Period|Physician Decision|0|||
162989401|NCT04590040|588664399|FG001|Treatment Period|Physician Decision|0|||
162989402|NCT04590040|588664400|FG002|Treatment Period|Physician Decision|2|||
162989403|NCT00000378|588664403|FG000|Overall Study|Lack of Efficacy|16|||
162989404|NCT00000378|588664404|FG001|Overall Study|Lack of Efficacy|14|||
162989405|NCT01284361|588664409|FG000|Overall Study|Withdrawal by Subject|1|||
162989406|NCT01284361|588664409|FG000|Overall Study|Protocol Violation|5|||
162989407|NCT01284361|588664409|FG000|Overall Study|Adverse Event|1|||
163059958|NCT04154956|588928268|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
163059959|NCT04154956|588928267|FG000|Overall Study|Withdrawal by Subject|1|||
163059960|NCT04154956|588928268|FG001|Overall Study|Withdrawal by Subject|7|||
163059961|NCT04154956|588928267|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
163059962|NCT04154956|588928268|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
163059963|NCT00147238|588928269|FG000|Overall Study|Inevaluable|8|||
163059964|NCT04424901|588928270|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
163059965|NCT04424901|588928271|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
162989408|NCT01284361|588664409|FG000|Overall Study|Lost to Follow-up|2|||
162989409|NCT00805675|588664410|FG000|Overall Study|Adverse Event|0|||
162989410|NCT00805675|588664411|FG001|Overall Study|Adverse Event|0|||
162989411|NCT00805675|588664412|FG002|Overall Study|Adverse Event|1|||
162989412|NCT02771795|588664416|FG000|Overall Study|Withdrawal by Subject|47|||
162989413|NCT02771795|588664417|FG001|Overall Study|Withdrawal by Subject|37|||
162989414|NCT02771795|588664416|FG000|Overall Study|Termination by premature discontinuation of study|168|||
162989415|NCT02771795|588664417|FG001|Overall Study|Termination by premature discontinuation of study|185|||
162989416|NCT01957397|588664419|FG000|Test Period 1|sudden leakage/small bag|1|||
162989417|NCT01957397|588664420|FG001|Test Period 1|sudden leakage/small bag|1|||
162989418|NCT01957397|588664419|FG000|Test Period 1|Withdrawal by Subject|1|||
162989419|NCT01957397|588664420|FG001|Test Period 1|Withdrawal by Subject|0|||
162989420|NCT01957397|588664419|FG000|Test Period 2|Adverse Event|0|||
162989421|NCT01957397|588664420|FG001|Test Period 2|Adverse Event|1|||
162989422|NCT01957397|588664419|FG000|Test Period 3|Adverse Event|1|||
162989423|NCT01957397|588664420|FG001|Test Period 3|Adverse Event|2|||
162636756|NCT04285879|587384312|FG001|Overall Study|Lost to Follow-up|8|||
162636757|NCT04285879|587384311|FG000|Overall Study|medical/surgical exclusion|16|||
162636758|NCT04285879|587384312|FG001|Overall Study|medical/surgical exclusion|0|||
162636759|NCT02622321|587384319|FG000|Overall Study|Withdrawal by Subject|2|||
162636760|NCT02622321|587384320|FG001|Overall Study|Withdrawal by Subject|0|||
162636761|NCT02622321|587384321|FG002|Overall Study|Withdrawal by Subject|0|||
162636762|NCT02622321|587384322|FG003|Overall Study|Withdrawal by Subject|0|||
162636763|NCT02622321|587384319|FG000|Overall Study|Death|0|||
162636764|NCT02622321|587384320|FG001|Overall Study|Death|0|||
162636765|NCT02622321|587384321|FG002|Overall Study|Death|1|||
162636766|NCT02622321|587384322|FG003|Overall Study|Death|0|||
162636767|NCT02622321|587384319|FG000|Overall Study|Physician Decision|1|||
162636768|NCT02622321|587384320|FG001|Overall Study|Physician Decision|0|||
162636769|NCT02622321|587384321|FG002|Overall Study|Physician Decision|0|||
162636770|NCT02622321|587384322|FG003|Overall Study|Physician Decision|0|||
162636771|NCT00241280|587384323|FG000|Overall Study|Adverse Event|2|||
162636772|NCT00241280|587384324|FG001|Overall Study|Adverse Event|6|||
162989424|NCT01957397|588664419|FG000|Test Period 3|the adhesive did not work|1|||
162989425|NCT01957397|588664420|FG001|Test Period 3|the adhesive did not work|0|||
162989426|NCT00505375|588664421|FG000|Overall Study|Death|1|||
162989427|NCT00505375|588664422|FG001|Overall Study|Death|0|||
162989428|NCT00505375|588664421|FG000|Overall Study|Withdrawal by Subject|2|||
162989429|NCT00505375|588664422|FG001|Overall Study|Withdrawal by Subject|2|||
162989430|NCT00505375|588664421|FG000|Overall Study|Lost to Follow-up|0|||
162989431|NCT00505375|588664422|FG001|Overall Study|Lost to Follow-up|2|||
162989432|NCT00505375|588664421|FG000|Overall Study|Pregnancy|1|||
162989433|NCT00505375|588664422|FG001|Overall Study|Pregnancy|0|||
162989434|NCT00505375|588664421|FG000|Overall Study|Travel issues|0|||
162989435|NCT00505375|588664422|FG001|Overall Study|Travel issues|1|||
162989436|NCT02906930|588664423|FG000|Overall Study|Withdrawal by Subject|0|||
162989437|NCT02906930|588664424|FG001|Overall Study|Withdrawal by Subject|5|||
162989438|NCT02906930|588664425|FG002|Overall Study|Withdrawal by Subject|5|||
163059966|NCT04810962|588928272|FG000|Overall Study|Adverse Event|0|||
163059967|NCT04810962|588928273|FG001|Overall Study|Adverse Event|1|||
163059968|NCT04810962|588928272|FG000|Overall Study|Lost to Follow-up|2|||
162636773|NCT00241280|587384323|FG000|Overall Study|Discomfort|11|||
162636774|NCT00241280|587384324|FG001|Overall Study|Discomfort|16|||
162989439|NCT02906930|588664426|FG003|Overall Study|Withdrawal by Subject|4|||
162989440|NCT02906930|588664423|FG000|Overall Study|Lost to Follow-up|5|||
162989441|NCT02906930|588664424|FG001|Overall Study|Lost to Follow-up|7|||
162989442|NCT02906930|588664425|FG002|Overall Study|Lost to Follow-up|5|||
162989443|NCT02906930|588664426|FG003|Overall Study|Lost to Follow-up|2|||
162989444|NCT02906930|588664423|FG000|Overall Study|Death|0|||
162989445|NCT02906930|588664424|FG001|Overall Study|Death|0|||
162989446|NCT02906930|588664425|FG002|Overall Study|Death|1|||
162989447|NCT02906930|588664426|FG003|Overall Study|Death|0|||
162989448|NCT02906930|588664423|FG000|Overall Study|Other|1|||
162989449|NCT02906930|588664424|FG001|Overall Study|Other|2|||
163059969|NCT04810962|588928273|FG001|Overall Study|Lost to Follow-up|1|||
163059970|NCT04810962|588928272|FG000|Overall Study|Physician Decision|1|||
162636775|NCT00241280|587384323|FG000|Overall Study|Pregnancy|1|||
162636776|NCT00241280|587384324|FG001|Overall Study|Pregnancy|5|||
162636777|NCT00241280|587384323|FG000|Overall Study|Lost to Follow-up|5|||
162989450|NCT02906930|588664425|FG002|Overall Study|Other|1|||
162989451|NCT02906930|588664426|FG003|Overall Study|Other|2|||
162989452|NCT00540293|588664427|FG000|Overall Study|Adverse event related to study drug|10|||
162989453|NCT00540293|588664427|FG000|Overall Study|Adverse event not related to study drug|7|||
162989454|NCT00540293|588664427|FG000|Overall Study|Withdrawal by Subject|6|||
162989455|NCT00540293|588664427|FG000|Overall Study|Protocol violation, & subject schedule|12|||
162989456|NCT03537599|588664428|FG000|Overall Study|Disease Progression|2|||
162989457|NCT03537599|588664429|FG001|Overall Study|Disease Progression|1|||
162989458|NCT03537599|588664428|FG000|Overall Study|Death|0|||
162989459|NCT03537599|588664429|FG001|Overall Study|Death|1|||
162989460|NCT02603393|588664431|FG000|Overall Study|Patient/guardian decision|32|||
162989461|NCT02603393|588664432|FG001|Overall Study|Patient/guardian decision|18|||
162989462|NCT02603393|588664431|FG000|Overall Study|Adverse Event|17|||
162989463|NCT02603393|588664432|FG001|Overall Study|Adverse Event|15|||
162989464|NCT02603393|588664431|FG000|Overall Study|Technical problems|4|||
162989465|NCT02603393|588664432|FG001|Overall Study|Technical problems|7|||
162989466|NCT02603393|588664431|FG000|Overall Study|Lack of Efficacy|7|||
162989467|NCT02603393|588664432|FG001|Overall Study|Lack of Efficacy|2|||
162989468|NCT02603393|588664431|FG000|Overall Study|Death|3|||
162989469|NCT02603393|588664432|FG001|Overall Study|Death|4|||
162989470|NCT02603393|588664431|FG000|Overall Study|Physician Decision|3|||
162989471|NCT02603393|588664432|FG001|Overall Study|Physician Decision|3|||
162989472|NCT02603393|588664431|FG000|Overall Study|Protocol deviation|2|||
162989473|NCT02603393|588664432|FG001|Overall Study|Protocol deviation|3|||
162989474|NCT02603393|588664431|FG000|Overall Study|Lost to Follow-up|1|||
162989475|NCT02603393|588664432|FG001|Overall Study|Lost to Follow-up|2|||
162989476|NCT02603393|588664431|FG000|Overall Study|Non-compliance with study treatment|1|||
162989477|NCT02603393|588664432|FG001|Overall Study|Non-compliance with study treatment|0|||
162989478|NCT02603393|588664431|FG000|Overall Study|Sponsor decision|1|||
162989479|NCT02603393|588664432|FG001|Overall Study|Sponsor decision|0|||
162989480|NCT04283500|588664433|FG000|Overall Study|Lost to Follow-up|8|||
162989481|NCT04283500|588664433|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
162989482|NCT04053465|588664442|FG000|Overall Study|Withdrawal by Subject|4|||
162989483|NCT04053465|588664443|FG001|Overall Study|Withdrawal by Subject|4|||
162989484|NCT02085135|588664444|FG000|Overall Study|Adverse Event|4|||
162989485|NCT02085135|588664445|FG001|Overall Study|Adverse Event|7|||
162989486|NCT02085135|588664444|FG000|Overall Study|Lost to Follow-up|2|||
162989487|NCT02085135|588664445|FG001|Overall Study|Lost to Follow-up|2|||
162989488|NCT02085135|588664444|FG000|Overall Study|Withdrawal by Subject|3|||
162989489|NCT02085135|588664445|FG001|Overall Study|Withdrawal by Subject|0|||
162989490|NCT02085135|588664444|FG000|Overall Study|Lack of Efficacy|2|||
162989491|NCT02085135|588664445|FG001|Overall Study|Lack of Efficacy|0|||
162989492|NCT00338455|588664448|FG000|Overall Study|Death|2|||
162989493|NCT00338455|588664449|FG001|Overall Study|Death|1|||
162989494|NCT00338455|588664448|FG000|Overall Study|Physician Decision|1|||
162989495|NCT00338455|588664449|FG001|Overall Study|Physician Decision|0|||
162989496|NCT01517373|588664450|FG000|Run-in Period|Death|1|||
162989497|NCT01517373|588664451|FG001|Run-in Period|Death|0|||
162989498|NCT01517373|588664452|FG002|Run-in Period|Death|0|||
162989499|NCT01517373|588664453|FG003|Run-in Period|Death|0|||
162989500|NCT01517373|588664454|FG004|Run-in Period|Death|0|||
162989501|NCT01517373|588664455|FG005|Run-in Period|Death|0|||
162989502|NCT01517373|588664450|FG000|Run-in Period|Adverse Event|5|||
162989503|NCT01517373|588664451|FG001|Run-in Period|Adverse Event|0|||
162989504|NCT01517373|588664452|FG002|Run-in Period|Adverse Event|0|||
162989505|NCT01517373|588664453|FG003|Run-in Period|Adverse Event|0|||
162989506|NCT01517373|588664454|FG004|Run-in Period|Adverse Event|0|||
162989507|NCT01517373|588664455|FG005|Run-in Period|Adverse Event|0|||
162989508|NCT01517373|588664450|FG000|Run-in Period|Did not meet eligibility criteria|34|||
162989509|NCT01517373|588664451|FG001|Run-in Period|Did not meet eligibility criteria|0|||
162989510|NCT01517373|588664452|FG002|Run-in Period|Did not meet eligibility criteria|0|||
162989511|NCT01517373|588664453|FG003|Run-in Period|Did not meet eligibility criteria|0|||
162989512|NCT01517373|588664454|FG004|Run-in Period|Did not meet eligibility criteria|0|||
163059971|NCT04810962|588928273|FG001|Overall Study|Physician Decision|0|||
163059972|NCT04810962|588928272|FG000|Overall Study|Withdrawal by Subject|1|||
162989513|NCT01517373|588664455|FG005|Run-in Period|Did not meet eligibility criteria|0|||
162989514|NCT01517373|588664450|FG000|Run-in Period|Lost to Follow-up|1|||
162989515|NCT01517373|588664451|FG001|Run-in Period|Lost to Follow-up|0|||
163059973|NCT04810962|588928273|FG001|Overall Study|Withdrawal by Subject|3|||
162989516|NCT01517373|588664452|FG002|Run-in Period|Lost to Follow-up|0|||
162989517|NCT01517373|588664453|FG003|Run-in Period|Lost to Follow-up|0|||
162989518|NCT01517373|588664454|FG004|Run-in Period|Lost to Follow-up|0|||
163059974|NCT04810962|588928272|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
162989519|NCT01517373|588664455|FG005|Run-in Period|Lost to Follow-up|0|||
162989520|NCT01517373|588664450|FG000|Run-in Period|Withdrawal by Subject|12|||
162989521|NCT01517373|588664451|FG001|Run-in Period|Withdrawal by Subject|0|||
162989522|NCT01517373|588664452|FG002|Run-in Period|Withdrawal by Subject|0|||
162989523|NCT01517373|588664453|FG003|Run-in Period|Withdrawal by Subject|0|||
163059975|NCT04810962|588928273|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
163059976|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
162989524|NCT01517373|588664454|FG004|Run-in Period|Withdrawal by Subject|0|||
162989525|NCT01517373|588664455|FG005|Run-in Period|Withdrawal by Subject|0|||
162989526|NCT01517373|588664450|FG000|Run-in Period|Sponsor Decision|3|||
162989527|NCT01517373|588664451|FG001|Run-in Period|Sponsor Decision|0|||
162989528|NCT01517373|588664452|FG002|Run-in Period|Sponsor Decision|0|||
162989529|NCT01517373|588664453|FG003|Run-in Period|Sponsor Decision|0|||
162989530|NCT01517373|588664454|FG004|Run-in Period|Sponsor Decision|0|||
162989531|NCT01517373|588664455|FG005|Run-in Period|Sponsor Decision|0|||
162989532|NCT01517373|588664450|FG000|Run-in Period|Other|1|||
162989533|NCT01517373|588664451|FG001|Run-in Period|Other|0|||
162989534|NCT01517373|588664452|FG002|Run-in Period|Other|0|||
162989535|NCT01517373|588664453|FG003|Run-in Period|Other|0|||
162989536|NCT01517373|588664454|FG004|Run-in Period|Other|0|||
162989537|NCT01517373|588664455|FG005|Run-in Period|Other|0|||
162989538|NCT01517373|588664450|FG000|Treatment Period|Adverse Event|0|||
162989539|NCT01517373|588664451|FG001|Treatment Period|Adverse Event|0|||
162989540|NCT01517373|588664452|FG002|Treatment Period|Adverse Event|0|||
162989541|NCT01517373|588664453|FG003|Treatment Period|Adverse Event|0|||
162989542|NCT01517373|588664454|FG004|Treatment Period|Adverse Event|0|||
162989543|NCT01517373|588664455|FG005|Treatment Period|Adverse Event|2|||
162989544|NCT01517373|588664450|FG000|Treatment Period|Lost to Follow-up|0|||
162989545|NCT01517373|588664451|FG001|Treatment Period|Lost to Follow-up|0|||
162989546|NCT01517373|588664452|FG002|Treatment Period|Lost to Follow-up|1|||
162989547|NCT01517373|588664453|FG003|Treatment Period|Lost to Follow-up|1|||
162989548|NCT01517373|588664454|FG004|Treatment Period|Lost to Follow-up|0|||
162989549|NCT01517373|588664455|FG005|Treatment Period|Lost to Follow-up|0|||
162989550|NCT01517373|588664450|FG000|Treatment Period|Withdrawal by Subject|0|||
162989551|NCT01517373|588664451|FG001|Treatment Period|Withdrawal by Subject|3|||
162989552|NCT01517373|588664452|FG002|Treatment Period|Withdrawal by Subject|2|||
162989553|NCT01517373|588664453|FG003|Treatment Period|Withdrawal by Subject|2|||
162989554|NCT01517373|588664454|FG004|Treatment Period|Withdrawal by Subject|2|||
162989555|NCT01517373|588664455|FG005|Treatment Period|Withdrawal by Subject|3|||
162989556|NCT01517373|588664450|FG000|Treatment Period|Other|0|||
162989557|NCT01517373|588664451|FG001|Treatment Period|Other|0|||
162989558|NCT01517373|588664452|FG002|Treatment Period|Other|0|||
162989559|NCT01517373|588664453|FG003|Treatment Period|Other|0|||
162989560|NCT01517373|588664454|FG004|Treatment Period|Other|1|||
162989561|NCT01517373|588664455|FG005|Treatment Period|Other|0|||
162989562|NCT01517373|588664450|FG000|Treatment Period|Protocol Violation|0|||
162989563|NCT01517373|588664451|FG001|Treatment Period|Protocol Violation|0|||
162989564|NCT01517373|588664452|FG002|Treatment Period|Protocol Violation|0|||
162989565|NCT01517373|588664453|FG003|Treatment Period|Protocol Violation|0|||
162989566|NCT01517373|588664454|FG004|Treatment Period|Protocol Violation|1|||
162989567|NCT01517373|588664455|FG005|Treatment Period|Protocol Violation|0|||
162989568|NCT01517373|588664450|FG000|Treatment Period|Lack of Efficacy|0|||
162989569|NCT01517373|588664451|FG001|Treatment Period|Lack of Efficacy|1|||
162989570|NCT01517373|588664452|FG002|Treatment Period|Lack of Efficacy|1|||
162989571|NCT01517373|588664453|FG003|Treatment Period|Lack of Efficacy|3|||
162989572|NCT01517373|588664454|FG004|Treatment Period|Lack of Efficacy|2|||
162989573|NCT01517373|588664455|FG005|Treatment Period|Lack of Efficacy|0|||
162989574|NCT01517373|588664450|FG000|Treatment Period|Medication error without AEs|0|||
162989575|NCT01517373|588664451|FG001|Treatment Period|Medication error without AEs|0|||
162989576|NCT01517373|588664452|FG002|Treatment Period|Medication error without AEs|2|||
162989577|NCT01517373|588664453|FG003|Treatment Period|Medication error without AEs|1|||
162989578|NCT01517373|588664454|FG004|Treatment Period|Medication error without AEs|0|||
162989579|NCT01517373|588664455|FG005|Treatment Period|Medication error without AEs|2|||
162989580|NCT05005312|588664470|FG000|Overall Study|Enrolled, but not treated|0|||
162989581|NCT05005312|588664471|FG001|Overall Study|Enrolled, but not treated|1|||
162989582|NCT06077149|588664474|FG000|Overall Study|Death|1|||
162989583|NCT06077149|588664475|FG001|Overall Study|Death|0|||
162989584|NCT06077149|588664474|FG000|Overall Study|Withdrawal by Subject|2|||
162989585|NCT06077149|588664475|FG001|Overall Study|Withdrawal by Subject|0|||
162989586|NCT06077149|588664474|FG000|Overall Study|RSV infection before vaccination|3|||
162715626|NCT01081145|587667059|FG001|Open-Label Phase|Adverse Event|0|||
162989587|NCT06077149|588664475|FG001|Overall Study|RSV infection before vaccination|0|||
162989588|NCT04658095|588664476|FG000|Overall Study|Study terminated|5|||
162989589|NCT04658095|588664477|FG001|Overall Study|Study terminated|1|||
162989590|NCT04658095|588664478|FG002|Overall Study|Study terminated|4|||
162989591|NCT01441947|588664479|FG000|Overall Study|Withdrawal by Subject|3|||
162989592|NCT01441947|588664480|FG001|Overall Study|Withdrawal by Subject|0|||
162989593|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
162989594|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
162989595|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
162989596|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
162989597|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
162989598|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
162715627|NCT01081145|587667058|FG000|Open-Label Phase|Withdrawal by Subject|41|||
162989599|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
162989600|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
162989601|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Death|41|||
162989602|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Death|33|||
162989603|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Death|0|||
162989604|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Death|0|||
162989605|NCT02970318|588664482|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989606|NCT02970318|588664483|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
162989607|NCT02970318|588664484|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989608|NCT02970318|588664485|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
162989609|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989610|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989611|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
162989612|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
162989613|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
162989614|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
162989615|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
162989616|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
162989617|NCT02970318|588664482|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
162989618|NCT02970318|588664483|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
162989619|NCT02970318|588664484|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
162989620|NCT02970318|588664485|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
162989621|NCT03384654|588664486|FG000|Overall Study|Withdrawal by Subject|0|||
162989622|NCT03384654|588664487|FG001|Overall Study|Withdrawal by Subject|0|||
162989623|NCT03384654|588664488|FG002|Overall Study|Withdrawal by Subject|1|||
162989624|NCT03384654|588664489|FG003|Overall Study|Withdrawal by Subject|0|||
162989625|NCT01616953|588664490|FG000|Overall Study|Lost to Follow-up|1|||
162989626|NCT01616953|588664491|FG001|Overall Study|Lost to Follow-up|0|||
162989627|NCT01616953|588664490|FG000|Overall Study|lack of bone and soft tissue|1|||
162989628|NCT01616953|588664491|FG001|Overall Study|lack of bone and soft tissue|0|||
162989629|NCT00816361|588664492|FG000|Overall Study|Withdrawal by Subject|0|||
162989630|NCT00816361|588664493|FG001|Overall Study|Withdrawal by Subject|0|||
162989631|NCT00816361|588664494|FG002|Overall Study|Withdrawal by Subject|0|||
162989632|NCT00816361|588664495|FG003|Overall Study|Withdrawal by Subject|0|||
162989633|NCT00816361|588664496|FG004|Overall Study|Withdrawal by Subject|1|||
162989634|NCT00816361|588664497|FG005|Overall Study|Withdrawal by Subject|2|||
162989635|NCT00816361|588664498|FG006|Overall Study|Withdrawal by Subject|0|||
162989636|NCT00816361|588664499|FG007|Overall Study|Withdrawal by Subject|2|||
162989637|NCT00816361|588664500|FG008|Overall Study|Withdrawal by Subject|1|||
162989638|NCT00816361|588664492|FG000|Overall Study|Death|4|||
162989639|NCT00816361|588664493|FG001|Overall Study|Death|3|||
162989640|NCT00816361|588664494|FG002|Overall Study|Death|3|||
162989641|NCT00816361|588664495|FG003|Overall Study|Death|3|||
162989642|NCT00816361|588664496|FG004|Overall Study|Death|1|||
162989643|NCT00816361|588664497|FG005|Overall Study|Death|1|||
162989644|NCT00816361|588664498|FG006|Overall Study|Death|3|||
162989645|NCT00816361|588664499|FG007|Overall Study|Death|7|||
162989646|NCT00816361|588664500|FG008|Overall Study|Death|8|||
162989647|NCT00816361|588664492|FG000|Overall Study|Other|0|||
162989648|NCT00816361|588664493|FG001|Overall Study|Other|0|||
162989649|NCT00816361|588664494|FG002|Overall Study|Other|0|||
162989650|NCT00816361|588664495|FG003|Overall Study|Other|0|||
162989651|NCT00816361|588664496|FG004|Overall Study|Other|0|||
162989652|NCT00816361|588664497|FG005|Overall Study|Other|0|||
162989653|NCT00816361|588664498|FG006|Overall Study|Other|0|||
162989654|NCT00816361|588664499|FG007|Overall Study|Other|0|||
162989655|NCT00816361|588664500|FG008|Overall Study|Other|1|||
162989656|NCT02500641|588664501|FG000|Overall Study|Adverse Event|0|||
162989657|NCT02500641|588664502|FG001|Overall Study|Adverse Event|2|||
162989658|NCT02500641|588664501|FG000|Overall Study|Withdrawal by Subject|4|||
162989659|NCT02500641|588664502|FG001|Overall Study|Withdrawal by Subject|5|||
162989660|NCT02500641|588664501|FG000|Overall Study|Unable to follow study procedures|3|||
162989661|NCT02500641|588664502|FG001|Overall Study|Unable to follow study procedures|2|||
163059977|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
163059978|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
163059979|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
162989662|NCT02500641|588664501|FG000|Overall Study|Protocol Violation|1|||
162989663|NCT02500641|588664502|FG001|Overall Study|Protocol Violation|2|||
162989664|NCT02500641|588664501|FG000|Overall Study|Lost to Follow-up|1|||
162989665|NCT02500641|588664502|FG001|Overall Study|Lost to Follow-up|0|||
162989666|NCT02500641|588664501|FG000|Overall Study|Sponsor decision|1|||
162636778|NCT00241280|587384324|FG001|Overall Study|Lost to Follow-up|8|||
162636779|NCT00241280|587384323|FG000|Overall Study|Withdrawal by Subject|7|||
162989667|NCT02500641|588664502|FG001|Overall Study|Sponsor decision|0|||
162989668|NCT02500641|588664501|FG000|Overall Study|Non compliance to study drug|0|||
162989669|NCT02500641|588664502|FG001|Overall Study|Non compliance to study drug|1|||
162989670|NCT01763684|588664503|FG000|Overall Study|Study terminated early due to low enrollment|126|||
162989671|NCT01763684|588664504|FG001|Overall Study|Study terminated early due to low enrollment|127|||
162989672|NCT01763684|588664503|FG000|Overall Study|Study surgery not performed|7|||
162989673|NCT01763684|588664504|FG001|Overall Study|Study surgery not performed|6|||
162989674|NCT02196701|588664505|FG000|Overall Study|Adverse Event|1|||
162989675|NCT02196701|588664505|FG000|Overall Study|Lost to Follow-up|1|||
162989676|NCT02196701|588664505|FG000|Overall Study|Non-adherence to Protocol|1|||
162989677|NCT01341782|588664506|FG000|Overall Study|Adverse Event|1|||
162989678|NCT01341782|588664507|FG001|Overall Study|Adverse Event|1|||
162989679|NCT01341782|588664506|FG000|Overall Study|Withdrawal by Subject|6|||
162989680|NCT01341782|588664507|FG001|Overall Study|Withdrawal by Subject|5|||
162989681|NCT01341782|588664506|FG000|Overall Study|Missed 3 consecutive doses|0|||
162989682|NCT01341782|588664507|FG001|Overall Study|Missed 3 consecutive doses|4|||
162989683|NCT01341782|588664506|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
162989684|NCT01341782|588664507|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
162989685|NCT01341782|588664506|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
162989686|NCT01341782|588664507|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
162989687|NCT01341782|588664506|FG000|Overall Study|Other|5|||
162989688|NCT01341782|588664507|FG001|Overall Study|Other|0|||
162989689|NCT02036775|588664508|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989690|NCT02036775|588664509|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989691|NCT02036775|588664510|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989692|NCT02036775|588664511|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989693|NCT02036775|588664512|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
162989694|NCT02036775|588664513|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
162989695|NCT03496610|588664517|FG000|Overall Study|Lost to Follow-up|3|||
162989696|NCT03496610|588664518|FG001|Overall Study|Lost to Follow-up|2|||
162989697|NCT03496610|588664517|FG000|Overall Study|Physician Decision|1|||
162989698|NCT03496610|588664518|FG001|Overall Study|Physician Decision|0|||
162989699|NCT03496610|588664517|FG000|Overall Study|Withdrawal by Subject|1|||
162989700|NCT03496610|588664518|FG001|Overall Study|Withdrawal by Subject|0|||
162989701|NCT00426361|588664519|FG000|Overall Study|Lost to Follow-up|3|||
162989702|NCT00426361|588664520|FG001|Overall Study|Lost to Follow-up|2|||
162989703|NCT00426361|588664521|FG002|Overall Study|Lost to Follow-up|5|||
162989704|NCT00426361|588664519|FG000|Overall Study|Withdrawal by Subject|1|||
162989705|NCT00426361|588664520|FG001|Overall Study|Withdrawal by Subject|3|||
162989706|NCT00426361|588664521|FG002|Overall Study|Withdrawal by Subject|0|||
162989707|NCT01408628|588664522|FG000|Consented|Withdrawal by Subject|12|||
162989708|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
162989709|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
162989710|NCT01408628|588664522|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
162989711|NCT04669691|588664523|FG000|Overall Study|Death|0|||
162989712|NCT04669691|588664524|FG001|Overall Study|Death|1|||
162989713|NCT04669691|588664525|FG002|Overall Study|Death|0|||
162989714|NCT04669691|588664526|FG003|Overall Study|Death|0|||
162989715|NCT04669691|588664527|FG004|Overall Study|Death|0|||
162989716|NCT04669691|588664528|FG005|Overall Study|Death|0|||
162989717|NCT04156620|588664529|FG000|Overall Study|Adverse event - TP 1|5|||
162989718|NCT04156620|588664530|FG001|Overall Study|Adverse event - TP 1|2|||
162989719|NCT04156620|588664529|FG000|Overall Study|Lost to follow-up TP 1|1|||
162989720|NCT04156620|588664530|FG001|Overall Study|Lost to follow-up TP 1|1|||
162989721|NCT04156620|588664529|FG000|Overall Study|Progressive disease - TP 1|0|||
162989722|NCT04156620|588664530|FG001|Overall Study|Progressive disease - TP 1|1|||
162989723|NCT04156620|588664529|FG000|Overall Study|Subject decision - TP 1|3|||
162989724|NCT04156620|588664530|FG001|Overall Study|Subject decision - TP 1|5|||
162989725|NCT04156620|588664529|FG000|Overall Study|Adverse event - TP 2|5|||
162989726|NCT04156620|588664530|FG001|Overall Study|Adverse event - TP 2|6|||
162989727|NCT04156620|588664529|FG000|Overall Study|Death - TP 2|1|||
162989728|NCT04156620|588664530|FG001|Overall Study|Death - TP 2|0|||
162989729|NCT04156620|588664529|FG000|Overall Study|Lost to follow-up - TP 2|5|||
162989730|NCT04156620|588664530|FG001|Overall Study|Lost to follow-up - TP 2|2|||
162989731|NCT04156620|588664529|FG000|Overall Study|Physician decision - TP 2|4|||
162989732|NCT04156620|588664530|FG001|Overall Study|Physician decision - TP 2|2|||
162989733|NCT04156620|588664529|FG000|Overall Study|Pregnancy - TP 2|1|||
162715628|NCT01081145|587667059|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162989734|NCT04156620|588664530|FG001|Overall Study|Pregnancy - TP 2|1|||
162989735|NCT04156620|588664529|FG000|Overall Study|Subject decision - TP 2|11|||
162989736|NCT04156620|588664530|FG001|Overall Study|Subject decision - TP 2|9|||
162989737|NCT04156620|588664529|FG000|Overall Study|New therapy for study indication - TP 2|1|||
162989738|NCT04156620|588664530|FG001|Overall Study|New therapy for study indication - TP 2|0|||
162989739|NCT01121666|588664531|FG000|Overall Study|Protocol Violation|29|||
162989740|NCT01121666|588664532|FG001|Overall Study|Protocol Violation|10|||
162989741|NCT01970865|588664535|FG000|Overall Study|Death|3|||
162989742|NCT01970865|588664536|FG001|Overall Study|Death|2|||
162989743|NCT01970865|588664537|FG002|Overall Study|Death|3|||
162989744|NCT01970865|588664538|FG003|Overall Study|Death|6|||
162989745|NCT01970865|588664539|FG004|Overall Study|Death|9|||
162989746|NCT01970865|588664540|FG005|Overall Study|Death|3|||
162989747|NCT01970865|588664541|FG006|Overall Study|Death|2|||
162989748|NCT01970865|588664542|FG007|Overall Study|Death|3|||
162989749|NCT01970865|588664543|FG008|Overall Study|Death|2|||
162989750|NCT01970865|588664544|FG009|Overall Study|Death|2|||
162989751|NCT01970865|588664545|FG010|Overall Study|Death|8|||
162989752|NCT01970865|588664546|FG011|Overall Study|Death|13|||
162989753|NCT01970865|588664547|FG012|Overall Study|Death|25|||
162989754|NCT01970865|588664548|FG013|Overall Study|Death|46|||
162989755|NCT01970865|588664549|FG014|Overall Study|Death|37|||
162989756|NCT01970865|588664550|FG015|Overall Study|Death|22|||
162989757|NCT01970865|588664551|FG016|Overall Study|Death|1|||
162989758|NCT01970865|588664552|FG017|Overall Study|Death|17|||
162989759|NCT01970865|588664535|FG000|Overall Study|Lost to Follow-up|0|||
162989760|NCT01970865|588664536|FG001|Overall Study|Lost to Follow-up|0|||
162989761|NCT01970865|588664537|FG002|Overall Study|Lost to Follow-up|0|||
162989762|NCT01970865|588664538|FG003|Overall Study|Lost to Follow-up|1|||
162989763|NCT01970865|588664539|FG004|Overall Study|Lost to Follow-up|1|||
162989764|NCT01970865|588664540|FG005|Overall Study|Lost to Follow-up|0|||
162989765|NCT01970865|588664541|FG006|Overall Study|Lost to Follow-up|0|||
162989766|NCT01970865|588664542|FG007|Overall Study|Lost to Follow-up|0|||
162989767|NCT01970865|588664543|FG008|Overall Study|Lost to Follow-up|0|||
162989768|NCT01970865|588664544|FG009|Overall Study|Lost to Follow-up|0|||
162989769|NCT01970865|588664545|FG010|Overall Study|Lost to Follow-up|1|||
162989770|NCT01970865|588664546|FG011|Overall Study|Lost to Follow-up|0|||
162989771|NCT01970865|588664547|FG012|Overall Study|Lost to Follow-up|2|||
162989772|NCT01970865|588664548|FG013|Overall Study|Lost to Follow-up|0|||
162989773|NCT01970865|588664549|FG014|Overall Study|Lost to Follow-up|1|||
162989774|NCT01970865|588664550|FG015|Overall Study|Lost to Follow-up|4|||
162989775|NCT01970865|588664551|FG016|Overall Study|Lost to Follow-up|0|||
162989776|NCT01970865|588664552|FG017|Overall Study|Lost to Follow-up|1|||
162989777|NCT01970865|588664535|FG000|Overall Study|Other|0|||
162989778|NCT01970865|588664536|FG001|Overall Study|Other|1|||
162989779|NCT01970865|588664537|FG002|Overall Study|Other|0|||
162989780|NCT01970865|588664538|FG003|Overall Study|Other|1|||
162989781|NCT01970865|588664539|FG004|Overall Study|Other|1|||
162989782|NCT01970865|588664540|FG005|Overall Study|Other|0|||
162989783|NCT01970865|588664541|FG006|Overall Study|Other|1|||
162989784|NCT01970865|588664542|FG007|Overall Study|Other|0|||
162989785|NCT01970865|588664543|FG008|Overall Study|Other|0|||
162989786|NCT01970865|588664544|FG009|Overall Study|Other|0|||
162989787|NCT01970865|588664545|FG010|Overall Study|Other|2|||
162989788|NCT01970865|588664546|FG011|Overall Study|Other|3|||
162989789|NCT01970865|588664547|FG012|Overall Study|Other|8|||
162989790|NCT01970865|588664548|FG013|Overall Study|Other|3|||
162989791|NCT01970865|588664549|FG014|Overall Study|Other|2|||
162989792|NCT01970865|588664550|FG015|Overall Study|Other|3|||
162989793|NCT01970865|588664551|FG016|Overall Study|Other|0|||
162989794|NCT01970865|588664552|FG017|Overall Study|Other|2|||
162989795|NCT01970865|588664535|FG000|Overall Study|Participant refused further follow-up|0|||
162989796|NCT01970865|588664536|FG001|Overall Study|Participant refused further follow-up|0|||
162636780|NCT00241280|587384324|FG001|Overall Study|Withdrawal by Subject|4|||
162989797|NCT01970865|588664537|FG002|Overall Study|Participant refused further follow-up|0|||
162636781|NCT00241280|587384323|FG000|Overall Study|Protocol Violation|4|||
162989798|NCT01970865|588664538|FG003|Overall Study|Participant refused further follow-up|2|||
162989799|NCT01970865|588664539|FG004|Overall Study|Participant refused further follow-up|3|||
162989800|NCT01970865|588664540|FG005|Overall Study|Participant refused further follow-up|0|||
162989801|NCT01970865|588664541|FG006|Overall Study|Participant refused further follow-up|0|||
162989802|NCT01970865|588664542|FG007|Overall Study|Participant refused further follow-up|0|||
162636782|NCT00241280|587384324|FG001|Overall Study|Protocol Violation|10|||
162989803|NCT01970865|588664543|FG008|Overall Study|Participant refused further follow-up|0|||
162636783|NCT00241280|587384323|FG000|Overall Study|Relocation|4|||
162989804|NCT01970865|588664544|FG009|Overall Study|Participant refused further follow-up|0|||
162989805|NCT01970865|588664545|FG010|Overall Study|Participant refused further follow-up|1|||
162989806|NCT01970865|588664546|FG011|Overall Study|Participant refused further follow-up|4|||
162989807|NCT01970865|588664547|FG012|Overall Study|Participant refused further follow-up|7|||
162989808|NCT01970865|588664548|FG013|Overall Study|Participant refused further follow-up|8|||
162989809|NCT01970865|588664549|FG014|Overall Study|Participant refused further follow-up|3|||
162989810|NCT01970865|588664550|FG015|Overall Study|Participant refused further follow-up|11|||
162636784|NCT00241280|587384324|FG001|Overall Study|Relocation|4|||
162636785|NCT00241280|587384323|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
162989811|NCT01970865|588664551|FG016|Overall Study|Participant refused further follow-up|0|||
162989812|NCT01970865|588664552|FG017|Overall Study|Participant refused further follow-up|6|||
162989813|NCT01629966|588664553|FG000|Overall Study|Pregnancy|0|||
162989814|NCT01629966|588664554|FG001|Overall Study|Pregnancy|1|||
162989815|NCT01629966|588664555|FG002|Overall Study|Pregnancy|0|||
162989816|NCT01629966|588664553|FG000|Overall Study|Lost to Follow-up|10|||
162989817|NCT01629966|588664554|FG001|Overall Study|Lost to Follow-up|13|||
162989818|NCT01629966|588664555|FG002|Overall Study|Lost to Follow-up|9|||
162989819|NCT01629966|588664553|FG000|Overall Study|Withdrawal by Subject|8|||
162989820|NCT01629966|588664554|FG001|Overall Study|Withdrawal by Subject|9|||
162989821|NCT01629966|588664555|FG002|Overall Study|Withdrawal by Subject|16|||
162989822|NCT01629966|588664553|FG000|Overall Study|Protocol Violation|7|||
162989823|NCT01629966|588664554|FG001|Overall Study|Protocol Violation|9|||
162989824|NCT01629966|588664555|FG002|Overall Study|Protocol Violation|7|||
162989825|NCT01629966|588664553|FG000|Overall Study|Lack of Efficacy|5|||
162989826|NCT01629966|588664554|FG001|Overall Study|Lack of Efficacy|2|||
162989827|NCT01629966|588664555|FG002|Overall Study|Lack of Efficacy|4|||
162989828|NCT01629966|588664553|FG000|Overall Study|Adverse Event|11|||
162989829|NCT01629966|588664554|FG001|Overall Study|Adverse Event|18|||
162989830|NCT01629966|588664555|FG002|Overall Study|Adverse Event|30|||
162989831|NCT01150890|588664556|FG000|Overall Study|Other|0|||
162989832|NCT01150890|588664557|FG001|Overall Study|Other|1|||
162989833|NCT01150890|588664558|FG002|Overall Study|Other|0|||
162989834|NCT01150890|588664559|FG003|Overall Study|Other|2|||
162989835|NCT01150890|588664556|FG000|Overall Study|Pregnancy|0|||
162989836|NCT01150890|588664557|FG001|Overall Study|Pregnancy|0|||
162989837|NCT01150890|588664558|FG002|Overall Study|Pregnancy|0|||
162989838|NCT01150890|588664559|FG003|Overall Study|Pregnancy|1|||
162989839|NCT01150890|588664556|FG000|Overall Study|Administrative Decision|4|||
162989840|NCT01150890|588664557|FG001|Overall Study|Administrative Decision|4|||
162989841|NCT01150890|588664558|FG002|Overall Study|Administrative Decision|5|||
162989842|NCT01150890|588664559|FG003|Overall Study|Administrative Decision|6|||
162989843|NCT01150890|588664556|FG000|Overall Study|Ineligibility determined|0|||
162989844|NCT01150890|588664557|FG001|Overall Study|Ineligibility determined|1|||
162989845|NCT01150890|588664558|FG002|Overall Study|Ineligibility determined|0|||
162989846|NCT01150890|588664559|FG003|Overall Study|Ineligibility determined|0|||
162989847|NCT01150890|588664556|FG000|Overall Study|Adverse Event|0|||
162989848|NCT01150890|588664557|FG001|Overall Study|Adverse Event|0|||
162989849|NCT01150890|588664558|FG002|Overall Study|Adverse Event|2|||
162989850|NCT01150890|588664559|FG003|Overall Study|Adverse Event|0|||
162989851|NCT01150890|588664556|FG000|Overall Study|Withdrawal by Subject|0|||
162989852|NCT01150890|588664557|FG001|Overall Study|Withdrawal by Subject|0|||
162989853|NCT01150890|588664558|FG002|Overall Study|Withdrawal by Subject|2|||
162989854|NCT01150890|588664559|FG003|Overall Study|Withdrawal by Subject|1|||
162989855|NCT01150890|588664556|FG000|Overall Study|Disease progression|0|||
162989856|NCT01150890|588664557|FG001|Overall Study|Disease progression|7|||
162989857|NCT01150890|588664558|FG002|Overall Study|Disease progression|3|||
162989858|NCT01150890|588664559|FG003|Overall Study|Disease progression|7|||
162989859|NCT03118570|588664560|FG000|Overall Study|Adverse Event|2|||
162989860|NCT03118570|588664561|FG001|Overall Study|Adverse Event|0|||
162989861|NCT03118570|588664562|FG002|Overall Study|Adverse Event|0|||
162989862|NCT03118570|588664563|FG003|Overall Study|Adverse Event|0|||
162989863|NCT03118570|588664564|FG004|Overall Study|Adverse Event|3|||
162989864|NCT03118570|588664560|FG000|Overall Study|Withdrawal by Subject|0|||
162989865|NCT03118570|588664561|FG001|Overall Study|Withdrawal by Subject|1|||
162989866|NCT03118570|588664562|FG002|Overall Study|Withdrawal by Subject|4|||
162989867|NCT03118570|588664563|FG003|Overall Study|Withdrawal by Subject|0|||
162989868|NCT03118570|588664564|FG004|Overall Study|Withdrawal by Subject|1|||
162989869|NCT03118570|588664560|FG000|Overall Study|Lost to Follow-up|2|||
162989870|NCT03118570|588664561|FG001|Overall Study|Lost to Follow-up|3|||
162989871|NCT03118570|588664562|FG002|Overall Study|Lost to Follow-up|1|||
162989872|NCT03118570|588664563|FG003|Overall Study|Lost to Follow-up|0|||
162989873|NCT03118570|588664564|FG004|Overall Study|Lost to Follow-up|1|||
162989874|NCT03118570|588664560|FG000|Overall Study|Other, Not Specified|1|||
162989875|NCT03118570|588664561|FG001|Overall Study|Other, Not Specified|3|||
162989876|NCT03118570|588664562|FG002|Overall Study|Other, Not Specified|0|||
162989877|NCT03118570|588664563|FG003|Overall Study|Other, Not Specified|0|||
162989878|NCT03118570|588664564|FG004|Overall Study|Other, Not Specified|0|||
162989879|NCT01672970|588664565|FG000|Overall Study|Lack of Efficacy|12|||
162989880|NCT01672970|588664565|FG000|Overall Study|Adverse Event|18|||
162989881|NCT01672970|588664565|FG000|Overall Study|Withdrawal by Subject|2|||
162989882|NCT01672970|588664565|FG000|Overall Study|Lost to Follow-up|5|||
162989883|NCT01672970|588664565|FG000|Overall Study|Other|9|||
162636786|NCT00241280|587384324|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
162636787|NCT00241280|587384323|FG000|Overall Study|Unsatisfactory Visual Response|1|||
162989884|NCT01672970|588664565|FG000|Overall Study|Enrolled but not treated|1|||
162989885|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
162989886|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
162989887|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
162989888|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
162989889|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
162989890|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
162989891|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
162989892|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
162989893|NCT04430855|588664566|FG000|Period 1 (Weeks 1-12)|Other|0|||
162989894|NCT04430855|588664567|FG001|Period 1 (Weeks 1-12)|Other|1|||
162989895|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
162989896|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
162989897|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
162989898|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
162989899|NCT04430855|588664566|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
162989900|NCT04430855|588664567|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
162989901|NCT00390221|588664573|FG000|Overall Study|Lost to Follow-up|0|||
162989902|NCT00390221|588664574|FG001|Overall Study|Lost to Follow-up|3|||
162989903|NCT00390221|588664575|FG002|Overall Study|Lost to Follow-up|0|||
162989904|NCT00390221|588664573|FG000|Overall Study|Adverse Event|1|||
162989905|NCT00390221|588664574|FG001|Overall Study|Adverse Event|4|||
162989906|NCT00390221|588664575|FG002|Overall Study|Adverse Event|3|||
162989907|NCT00390221|588664573|FG000|Overall Study|Investigator Decision|0|||
162989908|NCT00390221|588664574|FG001|Overall Study|Investigator Decision|0|||
162989909|NCT00390221|588664575|FG002|Overall Study|Investigator Decision|1|||
162989910|NCT00390221|588664573|FG000|Overall Study|Withdrawal by Subject|13|||
162989911|NCT00390221|588664574|FG001|Overall Study|Withdrawal by Subject|9|||
162989912|NCT00390221|588664575|FG002|Overall Study|Withdrawal by Subject|7|||
162989913|NCT00390221|588664573|FG000|Overall Study|Subject Non-compliance|1|||
162989914|NCT00390221|588664574|FG001|Overall Study|Subject Non-compliance|0|||
162989915|NCT00390221|588664575|FG002|Overall Study|Subject Non-compliance|2|||
162989916|NCT00390221|588664573|FG000|Overall Study|Other|3|||
162989917|NCT00390221|588664574|FG001|Overall Study|Other|4|||
162989918|NCT00390221|588664575|FG002|Overall Study|Other|2|||
162989919|NCT02011386|588664580|FG000|Overall Study|Non-compliance|2|||
162989920|NCT02011386|588664580|FG000|Overall Study|Lack of Efficacy|3|||
162989921|NCT00633243|588666469|FG000|Overall Study|Withdrawal by Subject|0|||
162989922|NCT00633243|588666470|FG001|Overall Study|Withdrawal by Subject|1|||
162989923|NCT00633243|588666469|FG000|Overall Study|incarceration|0|||
162989924|NCT00633243|588666470|FG001|Overall Study|incarceration|2|||
162989925|NCT00633243|588666469|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
162989926|NCT00633243|588666470|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
162989927|NCT00633243|588666469|FG000|Overall Study|Not comfortable with self-injecting|0|||
162989928|NCT00633243|588666470|FG001|Overall Study|Not comfortable with self-injecting|1|||
162989929|NCT00633243|588666469|FG000|Overall Study|Mental Health--Depression|0|||
162989930|NCT00633243|588666470|FG001|Overall Study|Mental Health--Depression|1|||
162989931|NCT00633243|588666469|FG000|Overall Study|Couldn't tolerate side-effects|1|||
162989932|NCT00633243|588666470|FG001|Overall Study|Couldn't tolerate side-effects|1|||
162989933|NCT01682863|588666471|FG000|Overall Study|Subject/guardian decision|19|||
162989934|NCT01682863|588666472|FG001|Overall Study|Subject/guardian decision|12|||
162989935|NCT01682863|588666473|FG002|Overall Study|Subject/guardian decision|10|||
162989936|NCT01682863|588666471|FG000|Overall Study|Lost to Follow-up|5|||
162989937|NCT01682863|588666472|FG001|Overall Study|Lost to Follow-up|1|||
162989938|NCT01682863|588666473|FG002|Overall Study|Lost to Follow-up|6|||
162989939|NCT01682863|588666471|FG000|Overall Study|Death|1|||
162989940|NCT01682863|588666472|FG001|Overall Study|Death|3|||
162989941|NCT01682863|588666473|FG002|Overall Study|Death|4|||
162989942|NCT01682863|588666471|FG000|Overall Study|Protocol deviation|1|||
162989943|NCT01682863|588666472|FG001|Overall Study|Protocol deviation|0|||
162989944|NCT01682863|588666473|FG002|Overall Study|Protocol deviation|1|||
162989945|NCT01682863|588666471|FG000|Overall Study|Technical problems|1|||
162989946|NCT01682863|588666472|FG001|Overall Study|Technical problems|0|||
162989947|NCT01682863|588666473|FG002|Overall Study|Technical problems|0|||
162989948|NCT01682863|588666471|FG000|Overall Study|Adverse Event|0|||
162989949|NCT01682863|588666472|FG001|Overall Study|Adverse Event|1|||
162989950|NCT01682863|588666473|FG002|Overall Study|Adverse Event|2|||
162989951|NCT01682863|588666471|FG000|Overall Study|Physician Decision|0|||
162715629|NCT01081145|587667058|FG000|Open-Label Phase|Other|12|||
162989952|NCT01682863|588666472|FG001|Overall Study|Physician Decision|0|||
162989953|NCT01682863|588666473|FG002|Overall Study|Physician Decision|1|||
162989954|NCT00977379|588666474|FG000|Overall Study|Withdrawal by Subject|1|||
162989955|NCT00977379|588666475|FG001|Overall Study|Withdrawal by Subject|1|||
162989956|NCT00977379|588666474|FG000|Overall Study|Death|7|||
162989957|NCT00977379|588666475|FG001|Overall Study|Death|9|||
162989958|NCT00977379|588666474|FG000|Overall Study|Premature Study Termination|4|||
162989959|NCT00977379|588666475|FG001|Overall Study|Premature Study Termination|0|||
162989960|NCT00977379|588666474|FG000|Overall Study|Participant Moving House|0|||
162989961|NCT00977379|588666475|FG001|Overall Study|Participant Moving House|1|||
162989962|NCT00977379|588666474|FG000|Overall Study|Randomization Error|0|||
162989963|NCT00977379|588666475|FG001|Overall Study|Randomization Error|1|||
162989964|NCT00918138|588666476|FG000|Overall Study|Subject withdrew consent|1|||
162989965|NCT00918138|588666477|FG001|Overall Study|Subject withdrew consent|1|||
162989966|NCT00918138|588666476|FG000|Overall Study|Death|1|||
162989967|NCT00918138|588666477|FG001|Overall Study|Death|0|||
162989968|NCT03972163|588666478|FG000|Overall Study|Death|0|||
162989969|NCT03972163|588666479|FG001|Overall Study|Death|1|||
162989970|NCT01212588|588666482|FG000|Overall Study|Physician Decision|0|||
162989971|NCT01212588|588666483|FG001|Overall Study|Physician Decision|1|||
162989972|NCT01212588|588666482|FG000|Overall Study|Protocol Violation|1|||
162989973|NCT01212588|588666483|FG001|Overall Study|Protocol Violation|1|||
162989974|NCT02885181|588666484|FG000|Overall Study|Investigator's Discretion|0|||
162989975|NCT02885181|588666485|FG001|Overall Study|Investigator's Discretion|1|||
162989976|NCT02885181|588666486|FG002|Overall Study|Investigator's Discretion|0|||
162989977|NCT02885181|588666487|FG003|Overall Study|Investigator's Discretion|1|||
162989978|NCT02885181|588666484|FG000|Overall Study|Adverse Event|0|||
162989979|NCT02885181|588666485|FG001|Overall Study|Adverse Event|0|||
162989980|NCT02885181|588666486|FG002|Overall Study|Adverse Event|0|||
162989981|NCT02885181|588666487|FG003|Overall Study|Adverse Event|1|||
162989982|NCT02885181|588666484|FG000|Overall Study|Withdrawal by Subject|0|||
162989983|NCT02885181|588666485|FG001|Overall Study|Withdrawal by Subject|0|||
162989984|NCT02885181|588666486|FG002|Overall Study|Withdrawal by Subject|0|||
162989985|NCT02885181|588666487|FG003|Overall Study|Withdrawal by Subject|1|||
162989986|NCT00742924|588666490|FG000|Overall Study|Adverse Event|0|||
162989987|NCT00742924|588666491|FG001|Overall Study|Adverse Event|0|||
162989988|NCT00742924|588666492|FG002|Overall Study|Adverse Event|1|||
162989989|NCT00742924|588666493|FG003|Overall Study|Adverse Event|1|||
162989990|NCT00742924|588666490|FG000|Overall Study|Lack of Efficacy|5|||
162989991|NCT00742924|588666491|FG001|Overall Study|Lack of Efficacy|1|||
162989992|NCT00742924|588666492|FG002|Overall Study|Lack of Efficacy|2|||
162989993|NCT00742924|588666493|FG003|Overall Study|Lack of Efficacy|4|||
162989994|NCT00742924|588666490|FG000|Overall Study|Physician Decision|0|||
162989995|NCT00742924|588666491|FG001|Overall Study|Physician Decision|0|||
162989996|NCT00742924|588666492|FG002|Overall Study|Physician Decision|0|||
162989997|NCT00742924|588666493|FG003|Overall Study|Physician Decision|1|||
162989998|NCT00742924|588666490|FG000|Overall Study|Withdrawal by Subject|0|||
162989999|NCT00742924|588666491|FG001|Overall Study|Withdrawal by Subject|1|||
162990000|NCT00742924|588666492|FG002|Overall Study|Withdrawal by Subject|1|||
162990001|NCT00742924|588666493|FG003|Overall Study|Withdrawal by Subject|0|||
162990002|NCT00660400|588666494|FG000|Overall Study|Lack of insurance approval|1|||
162990003|NCT00660400|588666494|FG000|Overall Study|Suboptimal organ function|1|||
162990004|NCT00660400|588666494|FG000|Overall Study|Intracranial hemorrhage|1|||
162990005|NCT00660400|588666494|FG000|Overall Study|Withdrawal by Subject|1|||
162990006|NCT01161407|588666495|FG000|Overall Study|Protocol Violation|3|||
162990007|NCT01161407|588666496|FG001|Overall Study|Protocol Violation|1|||
162990008|NCT01777620|588666497|FG000|Overall Study|Subject Withdrawal|1|||
162990009|NCT01777620|588666498|FG001|Overall Study|Subject Withdrawal|0|||
162990010|NCT04562155|588666499|FG000|Overall Study|COVID-19 pandemic|0|||
162990011|NCT04562155|588666500|FG001|Overall Study|COVID-19 pandemic|0|||
162990012|NCT04562155|588666501|FG002|Overall Study|COVID-19 pandemic|0|||
162990013|NCT04562155|588666502|FG003|Overall Study|COVID-19 pandemic|1|||
162990014|NCT04562155|588666499|FG000|Overall Study|Adverse Event|7|||
162990015|NCT04562155|588666500|FG001|Overall Study|Adverse Event|3|||
162990016|NCT04562155|588666501|FG002|Overall Study|Adverse Event|8|||
162990017|NCT04562155|588666502|FG003|Overall Study|Adverse Event|1|||
162990018|NCT04562155|588666499|FG000|Overall Study|Withdrawal by Subject|3|||
162990019|NCT04562155|588666500|FG001|Overall Study|Withdrawal by Subject|6|||
162990020|NCT04562155|588666501|FG002|Overall Study|Withdrawal by Subject|3|||
162990021|NCT04562155|588666502|FG003|Overall Study|Withdrawal by Subject|3|||
162990022|NCT04562155|588666499|FG000|Overall Study|Participant personal reason|1|||
162990023|NCT04562155|588666500|FG001|Overall Study|Participant personal reason|0|||
162990024|NCT04562155|588666501|FG002|Overall Study|Participant personal reason|2|||
162990025|NCT04562155|588666502|FG003|Overall Study|Participant personal reason|1|||
162990026|NCT04005352|588666513|FG000|Overall Study|Adverse Event|4|||
162990027|NCT04005352|588666514|FG001|Overall Study|Adverse Event|5|||
162990028|NCT04005352|588666513|FG000|Overall Study|Death|4|||
162990029|NCT04005352|588666514|FG001|Overall Study|Death|2|||
162990030|NCT04005352|588666513|FG000|Overall Study|Lost to Follow-up|6|||
162990031|NCT04005352|588666514|FG001|Overall Study|Lost to Follow-up|2|||
162990032|NCT04005352|588666513|FG000|Overall Study|Physician Decision|7|||
162990033|NCT04005352|588666514|FG001|Overall Study|Physician Decision|13|||
162990034|NCT04005352|588666513|FG000|Overall Study|Protocol Violation|0|||
162990035|NCT04005352|588666514|FG001|Overall Study|Protocol Violation|1|||
162636788|NCT00241280|587384324|FG001|Overall Study|Unsatisfactory Visual Response|1|||
162636789|NCT00241280|587384323|FG000|Overall Study|Diabetic|1|||
162990036|NCT04005352|588666513|FG000|Overall Study|Withdrawal by Subject|28|||
162990037|NCT04005352|588666514|FG001|Overall Study|Withdrawal by Subject|38|||
162990038|NCT01283035|588666517|FG000|Overall Study|Subject later found ineligible|1|||
162990039|NCT03597529|588666522|FG000|Overall Study|Lost to Follow-up|10|||
162990040|NCT03597529|588666523|FG001|Overall Study|Lost to Follow-up|12|||
162990041|NCT03597529|588666522|FG000|Overall Study|Physician Decision|3|||
162990042|NCT03597529|588666523|FG001|Overall Study|Physician Decision|1|||
162990043|NCT03597529|588666522|FG000|Overall Study|Withdrawal by Subject|6|||
162990044|NCT03597529|588666523|FG001|Overall Study|Withdrawal by Subject|3|||
162990045|NCT03597529|588666522|FG000|Overall Study|Non-compliant with study activities|1|||
162990046|NCT03597529|588666523|FG001|Overall Study|Non-compliant with study activities|2|||
162990047|NCT01755767|588666524|FG000|Overall Study|Progressive Disease|8|||
162990048|NCT01755767|588666525|FG001|Overall Study|Progressive Disease|7|||
162990049|NCT01755767|588666526|FG002|Overall Study|Progressive Disease|91|||
162990050|NCT01755767|588666527|FG003|Overall Study|Progressive Disease|43|||
162990051|NCT01755767|588666524|FG000|Overall Study|Clinical Disease Progression|4|||
162990052|NCT01755767|588666525|FG001|Overall Study|Clinical Disease Progression|2|||
162990053|NCT01755767|588666526|FG002|Overall Study|Clinical Disease Progression|29|||
162990054|NCT01755767|588666527|FG003|Overall Study|Clinical Disease Progression|20|||
162990055|NCT01755767|588666524|FG000|Overall Study|Radiographic Disease Progression|9|||
162990056|NCT01755767|588666525|FG001|Overall Study|Radiographic Disease Progression|4|||
162990057|NCT01755767|588666526|FG002|Overall Study|Radiographic Disease Progression|44|||
162990058|NCT01755767|588666527|FG003|Overall Study|Radiographic Disease Progression|27|||
162990059|NCT01755767|588666524|FG000|Overall Study|Adverse Event|6|||
162990060|NCT01755767|588666525|FG001|Overall Study|Adverse Event|0|||
162990061|NCT01755767|588666526|FG002|Overall Study|Adverse Event|28|||
162990062|NCT01755767|588666527|FG003|Overall Study|Adverse Event|11|||
162990063|NCT01755767|588666524|FG000|Overall Study|Death|1|||
162990064|NCT01755767|588666525|FG001|Overall Study|Death|2|||
162990065|NCT01755767|588666526|FG002|Overall Study|Death|15|||
162990066|NCT01755767|588666527|FG003|Overall Study|Death|4|||
162990067|NCT01755767|588666524|FG000|Overall Study|Subject Decision|0|||
162990068|NCT01755767|588666525|FG001|Overall Study|Subject Decision|0|||
162990069|NCT01755767|588666526|FG002|Overall Study|Subject Decision|10|||
162990070|NCT01755767|588666527|FG003|Overall Study|Subject Decision|3|||
162990071|NCT01755767|588666524|FG000|Overall Study|Withdrawal by Subject|0|||
162990072|NCT01755767|588666525|FG001|Overall Study|Withdrawal by Subject|0|||
162990073|NCT01755767|588666526|FG002|Overall Study|Withdrawal by Subject|2|||
162990074|NCT01755767|588666527|FG003|Overall Study|Withdrawal by Subject|1|||
162990075|NCT01755767|588666524|FG000|Overall Study|Other|0|||
162990076|NCT01755767|588666525|FG001|Overall Study|Other|0|||
162990077|NCT01755767|588666526|FG002|Overall Study|Other|2|||
162990078|NCT01755767|588666527|FG003|Overall Study|Other|3|||
162990079|NCT01755767|588666524|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
162990080|NCT01755767|588666525|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
162990081|NCT01755767|588666526|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
162990082|NCT01755767|588666527|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
162990083|NCT03196635|588666528|FG000|Overall Study|Withdrawal by Subject|1|||
162990084|NCT00998309|588666529|FG000|Overall Study|Protocol Violation|4|||
162990085|NCT02865460|588666530|FG000|Overall Study|Adverse Event|1|||
162990086|NCT02865460|588666531|FG001|Overall Study|Adverse Event|0|||
162990087|NCT02865460|588666530|FG000|Overall Study|Withdrawal by Subject|1|||
162990088|NCT02865460|588666531|FG001|Overall Study|Withdrawal by Subject|1|||
162990089|NCT02865460|588666530|FG000|Overall Study|Lost to Follow-up|7|||
162990090|NCT02865460|588666531|FG001|Overall Study|Lost to Follow-up|4|||
162990091|NCT02865460|588666530|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
162990092|NCT02865460|588666531|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
162990093|NCT00901576|588666532|FG000|Second Intervention|Withdrawal by Subject|0|||
162990094|NCT00901576|588666533|FG001|Second Intervention|Withdrawal by Subject|0|||
162990095|NCT00901576|588666534|FG002|Second Intervention|Withdrawal by Subject|0|||
162990096|NCT00901576|588666535|FG003|Second Intervention|Withdrawal by Subject|1|||
162990097|NCT00901576|588666536|FG004|Second Intervention|Withdrawal by Subject|0|||
162990098|NCT00901576|588666537|FG005|Second Intervention|Withdrawal by Subject|1|||
162990099|NCT00901576|588666532|FG000|Second Intervention|Physician Decision|1|||
162990100|NCT00901576|588666533|FG001|Second Intervention|Physician Decision|0|||
162990101|NCT00901576|588666534|FG002|Second Intervention|Physician Decision|0|||
162990102|NCT00901576|588666535|FG003|Second Intervention|Physician Decision|0|||
162990103|NCT00901576|588666536|FG004|Second Intervention|Physician Decision|0|||
162990104|NCT00901576|588666537|FG005|Second Intervention|Physician Decision|0|||
162990105|NCT01696279|588666538|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
162990106|NCT01696279|588666539|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990107|NCT01696279|588666540|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990108|NCT01696279|588666541|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
162990109|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990110|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
162990111|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990112|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
162990113|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990114|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
162990115|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990116|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
162990117|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990118|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
162990119|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990120|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
162990121|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990122|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
162990123|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990124|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
162990125|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990126|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
162990127|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990128|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
162990129|NCT01696279|588666538|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990130|NCT01696279|588666539|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
162990131|NCT01696279|588666540|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990132|NCT01696279|588666541|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
162990133|NCT01696279|588666538|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990134|NCT01696279|588666539|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990135|NCT01696279|588666540|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
162990136|NCT01696279|588666541|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
162990137|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990138|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990139|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
162990140|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
162990141|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990142|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990143|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
162990144|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
162990145|NCT01696279|588666538|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990146|NCT01696279|588666539|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990147|NCT01696279|588666540|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
162990148|NCT01696279|588666541|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
162990149|NCT00171951|588666542|FG000|Overall Study|Adverse Event|1|||
162990150|NCT00171951|588666542|FG000|Overall Study|Abnormal Laboratory Values|2|||
162990151|NCT00171951|588666542|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162990152|NCT00171951|588666542|FG000|Overall Study|Participants Withdrew Consent|3|||
162990153|NCT00171951|588666542|FG000|Overall Study|New Cancer Therapy|5|||
162990154|NCT00171951|588666542|FG000|Overall Study|Reason not Specified|2|||
162990155|NCT05788289|588666543|FG000|Overall Study|Death|3|||
162990156|NCT04154631|588666545|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
162990157|NCT04154631|588666546|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
162990158|NCT05187013|588666547|FG000|Overall Study|Withdrawal by Subject|1|||
162990159|NCT05187013|588666548|FG001|Overall Study|Withdrawal by Subject|1|||
162990160|NCT05187013|588666549|FG002|Overall Study|Withdrawal by Subject|0|||
162990161|NCT05187013|588666547|FG000|Overall Study|Death|0|||
162990162|NCT05187013|588666548|FG001|Overall Study|Death|1|||
162990163|NCT05187013|588666549|FG002|Overall Study|Death|0|||
162990164|NCT05187013|588666547|FG000|Overall Study|Lost to Follow-up|20|||
162990165|NCT05187013|588666548|FG001|Overall Study|Lost to Follow-up|17|||
162990166|NCT05187013|588666549|FG002|Overall Study|Lost to Follow-up|0|||
162990167|NCT05187013|588666547|FG000|Overall Study|Ongoing Participants|3|||
162990168|NCT05187013|588666548|FG001|Overall Study|Ongoing Participants|5|||
162990169|NCT05187013|588666549|FG002|Overall Study|Ongoing Participants|0|||
162990170|NCT01568320|588666552|FG000|Overall Study|Death|20|||
162990171|NCT01568320|588666552|FG000|Overall Study|Lost to Follow-up|9|||
162990172|NCT01568320|588666552|FG000|Overall Study|Withdrawal by Subject|10|||
162990173|NCT01568320|588666552|FG000|Overall Study|Conversion to open repair|1|||
162990174|NCT01568320|588666552|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
162990175|NCT03233230|588666553|FG000|Overall Study|Adverse Event|6|||
162990176|NCT03233230|588666554|FG001|Overall Study|Adverse Event|3|||
162990177|NCT03233230|588666555|FG002|Overall Study|Adverse Event|6|||
162990178|NCT03233230|588666556|FG003|Overall Study|Adverse Event|3|||
162990179|NCT03233230|588666553|FG000|Overall Study|Protocol Violation|1|||
162990180|NCT03233230|588666554|FG001|Overall Study|Protocol Violation|2|||
162990181|NCT03233230|588666555|FG002|Overall Study|Protocol Violation|1|||
162715630|NCT01081145|587667059|FG001|Open-Label Phase|Other|0|||
162990182|NCT03233230|588666556|FG003|Overall Study|Protocol Violation|1|||
162990183|NCT03233230|588666553|FG000|Overall Study|Lack of Efficacy|1|||
162715631|NCT01081145|587667058|FG000|Open-Label Phase|Lost to Follow-up|11|||
162990184|NCT03233230|588666554|FG001|Overall Study|Lack of Efficacy|0|||
162990185|NCT03233230|588666555|FG002|Overall Study|Lack of Efficacy|0|||
162990186|NCT03233230|588666556|FG003|Overall Study|Lack of Efficacy|0|||
162990187|NCT03233230|588666553|FG000|Overall Study|Other|5|||
162990188|NCT03233230|588666554|FG001|Overall Study|Other|5|||
162990189|NCT03233230|588666555|FG002|Overall Study|Other|5|||
162990190|NCT03233230|588666556|FG003|Overall Study|Other|3|||
162990191|NCT03233230|588666553|FG000|Overall Study|Withdrawal by Subject|2|||
162990192|NCT03233230|588666554|FG001|Overall Study|Withdrawal by Subject|2|||
162990193|NCT03233230|588666555|FG002|Overall Study|Withdrawal by Subject|0|||
162990194|NCT03233230|588666556|FG003|Overall Study|Withdrawal by Subject|1|||
162990195|NCT03233230|588666553|FG000|Overall Study|Lost to Follow-up|0|||
162990196|NCT03233230|588666554|FG001|Overall Study|Lost to Follow-up|3|||
162990197|NCT03233230|588666555|FG002|Overall Study|Lost to Follow-up|0|||
162990198|NCT03233230|588666556|FG003|Overall Study|Lost to Follow-up|0|||
162990199|NCT04159935|588666557|FG000|Overall Study|Study terminated due to COVID-19|1|||
162990200|NCT04159935|588666558|FG001|Overall Study|Study terminated due to COVID-19|3|||
162990201|NCT02927366|588666559|FG000|Overall Study|Adverse Event|1|||
162990202|NCT02927366|588666560|FG001|Overall Study|Adverse Event|0|||
162990203|NCT02927366|588666559|FG000|Overall Study|Patient schedule|1|||
162990204|NCT02927366|588666560|FG001|Overall Study|Patient schedule|0|||
162990205|NCT00587990|588666565|FG000|Overall Study|Death|0|||
162990206|NCT00587990|588666566|FG001|Overall Study|Death|0|||
162990207|NCT00587990|588666567|FG002|Overall Study|Death|1|||
162990208|NCT00206323|588666568|FG000|Overall Study|Lack of Efficacy|4|||
162990209|NCT00206323|588666569|FG001|Overall Study|Lack of Efficacy|1|||
162990210|NCT00206323|588666568|FG000|Overall Study|Adverse Event|1|||
162990211|NCT00206323|588666569|FG001|Overall Study|Adverse Event|1|||
162990212|NCT00206323|588666568|FG000|Overall Study|Lost to Follow-up|1|||
162990213|NCT00206323|588666569|FG001|Overall Study|Lost to Follow-up|1|||
162990214|NCT02910063|588666570|FG000|Phase 2|Withdrawal by Subject|3|||
162990215|NCT02910063|588666571|FG001|Phase 2|Withdrawal by Subject|0|||
162990216|NCT02910063|588666572|FG002|Phase 2|Withdrawal by Subject|0|||
162990217|NCT02910063|588666570|FG000|Phase 2|Lost to Follow-up|1|||
162990218|NCT02910063|588666571|FG001|Phase 2|Lost to Follow-up|0|||
162990219|NCT02910063|588666572|FG002|Phase 2|Lost to Follow-up|0|||
162990220|NCT02910063|588666570|FG000|Phase 2|Death|24|||
162990221|NCT02910063|588666571|FG001|Phase 2|Death|0|||
162990222|NCT02910063|588666572|FG002|Phase 2|Death|0|||
162990223|NCT03334617|588666575|FG000|Overall Study|Adverse Event|0|||
162990224|NCT03334617|588666576|FG001|Overall Study|Adverse Event|0|||
162990225|NCT03334617|588666577|FG002|Overall Study|Adverse Event|0|||
162990226|NCT03334617|588666578|FG003|Overall Study|Adverse Event|0|||
162990227|NCT03334617|588666579|FG004|Overall Study|Adverse Event|0|||
162990228|NCT03334617|588666580|FG005|Overall Study|Adverse Event|0|||
162990229|NCT03334617|588666581|FG006|Overall Study|Adverse Event|0|||
162990230|NCT03334617|588666582|FG007|Overall Study|Adverse Event|0|||
162990231|NCT03334617|588666583|FG008|Overall Study|Adverse Event|1|||
162990232|NCT03334617|588666584|FG009|Overall Study|Adverse Event|0|||
162990233|NCT03334617|588666585|FG010|Overall Study|Adverse Event|0|||
162990234|NCT03334617|588666586|FG011|Overall Study|Adverse Event|0|||
162990235|NCT03334617|588666587|FG012|Overall Study|Adverse Event|1|||
162990236|NCT03334617|588666588|FG013|Overall Study|Adverse Event|0|||
162990237|NCT03334617|588666589|FG014|Overall Study|Adverse Event|0|||
162990238|NCT03334617|588666590|FG015|Overall Study|Adverse Event|0|||
162990239|NCT03334617|588666591|FG016|Overall Study|Adverse Event|0|||
162990240|NCT03334617|588666592|FG017|Overall Study|Adverse Event|0|||
162990241|NCT03334617|588666593|FG018|Overall Study|Adverse Event|0|||
162990242|NCT03334617|588666594|FG019|Overall Study|Adverse Event|0|||
162990243|NCT03334617|588666595|FG020|Overall Study|Adverse Event|0|||
162990244|NCT03334617|588666596|FG021|Overall Study|Adverse Event|0|||
162990245|NCT03334617|588666575|FG000|Overall Study|Death|18|||
162990246|NCT03334617|588666576|FG001|Overall Study|Death|18|||
162990247|NCT03334617|588666577|FG002|Overall Study|Death|20|||
162990248|NCT03334617|588666578|FG003|Overall Study|Death|21|||
162990249|NCT03334617|588666579|FG004|Overall Study|Death|20|||
162990250|NCT03334617|588666580|FG005|Overall Study|Death|16|||
162990251|NCT03334617|588666581|FG006|Overall Study|Death|28|||
162715632|NCT01081145|587667059|FG001|Open-Label Phase|Lost to Follow-up|0|||
162990252|NCT03334617|588666582|FG007|Overall Study|Death|35|||
162715633|NCT01081145|587667058|FG000|Open-Label Phase|Protocol Violation|4|||
162990253|NCT03334617|588666583|FG008|Overall Study|Death|47|||
162990254|NCT03334617|588666584|FG009|Overall Study|Death|0|||
162990255|NCT03334617|588666585|FG010|Overall Study|Death|19|||
162715634|NCT01081145|587667059|FG001|Open-Label Phase|Protocol Violation|0|||
162990256|NCT03334617|588666586|FG011|Overall Study|Death|6|||
162990257|NCT03334617|588666587|FG012|Overall Study|Death|20|||
162990258|NCT03334617|588666588|FG013|Overall Study|Death|22|||
162990259|NCT03334617|588666589|FG014|Overall Study|Death|17|||
162990260|NCT03334617|588666590|FG015|Overall Study|Death|18|||
162990261|NCT03334617|588666591|FG016|Overall Study|Death|12|||
162990262|NCT03334617|588666592|FG017|Overall Study|Death|15|||
162990263|NCT03334617|588666593|FG018|Overall Study|Death|16|||
162990264|NCT03334617|588666594|FG019|Overall Study|Death|27|||
162990265|NCT03334617|588666595|FG020|Overall Study|Death|14|||
162990266|NCT03334617|588666596|FG021|Overall Study|Death|27|||
162990267|NCT03334617|588666575|FG000|Overall Study|Lost to Follow-up|0|||
162990268|NCT03334617|588666576|FG001|Overall Study|Lost to Follow-up|0|||
162990269|NCT03334617|588666577|FG002|Overall Study|Lost to Follow-up|0|||
162990270|NCT03334617|588666578|FG003|Overall Study|Lost to Follow-up|1|||
162990271|NCT03334617|588666579|FG004|Overall Study|Lost to Follow-up|0|||
162990272|NCT03334617|588666580|FG005|Overall Study|Lost to Follow-up|1|||
162990273|NCT03334617|588666581|FG006|Overall Study|Lost to Follow-up|0|||
162990274|NCT03334617|588666582|FG007|Overall Study|Lost to Follow-up|0|||
162990275|NCT03334617|588666583|FG008|Overall Study|Lost to Follow-up|1|||
162990276|NCT03334617|588666584|FG009|Overall Study|Lost to Follow-up|0|||
162990277|NCT03334617|588666585|FG010|Overall Study|Lost to Follow-up|0|||
162990278|NCT03334617|588666586|FG011|Overall Study|Lost to Follow-up|0|||
162990279|NCT03334617|588666587|FG012|Overall Study|Lost to Follow-up|0|||
162990280|NCT03334617|588666588|FG013|Overall Study|Lost to Follow-up|0|||
162990281|NCT03334617|588666589|FG014|Overall Study|Lost to Follow-up|0|||
162990282|NCT03334617|588666590|FG015|Overall Study|Lost to Follow-up|0|||
162990283|NCT03334617|588666591|FG016|Overall Study|Lost to Follow-up|0|||
162990284|NCT03334617|588666592|FG017|Overall Study|Lost to Follow-up|0|||
162990285|NCT03334617|588666593|FG018|Overall Study|Lost to Follow-up|0|||
162990286|NCT03334617|588666594|FG019|Overall Study|Lost to Follow-up|0|||
162990287|NCT03334617|588666595|FG020|Overall Study|Lost to Follow-up|0|||
162990288|NCT03334617|588666596|FG021|Overall Study|Lost to Follow-up|0|||
162990289|NCT03334617|588666575|FG000|Overall Study|Withdrawal by Subject|0|||
162990290|NCT03334617|588666576|FG001|Overall Study|Withdrawal by Subject|1|||
162990291|NCT03334617|588666577|FG002|Overall Study|Withdrawal by Subject|0|||
162990292|NCT03334617|588666578|FG003|Overall Study|Withdrawal by Subject|0|||
162990293|NCT03334617|588666579|FG004|Overall Study|Withdrawal by Subject|1|||
162990294|NCT03334617|588666580|FG005|Overall Study|Withdrawal by Subject|1|||
162990295|NCT03334617|588666581|FG006|Overall Study|Withdrawal by Subject|1|||
162990296|NCT03334617|588666582|FG007|Overall Study|Withdrawal by Subject|2|||
162990297|NCT03334617|588666583|FG008|Overall Study|Withdrawal by Subject|0|||
162990298|NCT03334617|588666584|FG009|Overall Study|Withdrawal by Subject|0|||
162990299|NCT03334617|588666585|FG010|Overall Study|Withdrawal by Subject|0|||
162990300|NCT03334617|588666586|FG011|Overall Study|Withdrawal by Subject|1|||
162990301|NCT03334617|588666587|FG012|Overall Study|Withdrawal by Subject|1|||
162990302|NCT03334617|588666588|FG013|Overall Study|Withdrawal by Subject|0|||
162990303|NCT03334617|588666589|FG014|Overall Study|Withdrawal by Subject|2|||
162990304|NCT03334617|588666590|FG015|Overall Study|Withdrawal by Subject|1|||
162990305|NCT03334617|588666591|FG016|Overall Study|Withdrawal by Subject|0|||
162990306|NCT03334617|588666592|FG017|Overall Study|Withdrawal by Subject|1|||
162990307|NCT03334617|588666593|FG018|Overall Study|Withdrawal by Subject|1|||
162990308|NCT03334617|588666594|FG019|Overall Study|Withdrawal by Subject|1|||
162990309|NCT03334617|588666595|FG020|Overall Study|Withdrawal by Subject|0|||
162990310|NCT03334617|588666596|FG021|Overall Study|Withdrawal by Subject|1|||
162990311|NCT03334617|588666575|FG000|Overall Study|Other|1|||
162990312|NCT03334617|588666576|FG001|Overall Study|Other|2|||
162990313|NCT03334617|588666577|FG002|Overall Study|Other|0|||
162990314|NCT03334617|588666578|FG003|Overall Study|Other|1|||
162990315|NCT03334617|588666579|FG004|Overall Study|Other|1|||
162990316|NCT03334617|588666580|FG005|Overall Study|Other|0|||
162990317|NCT03334617|588666581|FG006|Overall Study|Other|2|||
162990318|NCT03334617|588666582|FG007|Overall Study|Other|1|||
162990319|NCT03334617|588666583|FG008|Overall Study|Other|8|||
162990320|NCT03334617|588666584|FG009|Overall Study|Other|0|||
162990321|NCT03334617|588666585|FG010|Overall Study|Other|3|||
162990322|NCT03334617|588666586|FG011|Overall Study|Other|1|||
162990323|NCT03334617|588666587|FG012|Overall Study|Other|3|||
162990324|NCT03334617|588666588|FG013|Overall Study|Other|1|||
162990325|NCT03334617|588666589|FG014|Overall Study|Other|1|||
162990326|NCT03334617|588666590|FG015|Overall Study|Other|3|||
162990327|NCT03334617|588666591|FG016|Overall Study|Other|3|||
162990328|NCT03334617|588666592|FG017|Overall Study|Other|3|||
162990329|NCT03334617|588666593|FG018|Overall Study|Other|7|||
162990330|NCT03334617|588666594|FG019|Overall Study|Other|4|||
163059980|NCT01348269|588928274|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
162990331|NCT03334617|588666595|FG020|Overall Study|Other|1|||
162990332|NCT03334617|588666596|FG021|Overall Study|Other|4|||
162990333|NCT03334617|588666575|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
162990334|NCT03334617|588666576|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
162990335|NCT03334617|588666577|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
162990336|NCT03334617|588666578|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
162990337|NCT03334617|588666579|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
162990338|NCT03334617|588666580|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
162990339|NCT03334617|588666581|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
162990340|NCT03334617|588666582|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
162990341|NCT03334617|588666583|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
162990342|NCT03334617|588666584|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
162990343|NCT03334617|588666585|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
162990344|NCT03334617|588666586|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
162990345|NCT03334617|588666587|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
162990346|NCT03334617|588666588|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
162990347|NCT03334617|588666589|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
162990348|NCT03334617|588666590|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
162990349|NCT03334617|588666591|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
162990350|NCT03334617|588666592|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
162990351|NCT03334617|588666593|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
162990352|NCT03334617|588666594|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
162990353|NCT03334617|588666595|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
162990354|NCT03334617|588666596|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
162990355|NCT03657342|588666598|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
162990356|NCT03657342|588666599|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
162990357|NCT03657342|588666598|FG000|Overall Study|Withdrawal by Subject|4|||
162990358|NCT03657342|588666599|FG001|Overall Study|Withdrawal by Subject|4|||
162990359|NCT03657342|588666598|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
162990360|NCT03657342|588666599|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
162990361|NCT03657342|588666598|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
162990362|NCT03657342|588666599|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
162990363|NCT00827632|588666600|FG000|Overall Study|Lost to Follow-up|8|||
162990364|NCT00827632|588666601|FG001|Overall Study|Lost to Follow-up|12|||
162990365|NCT00827632|588666600|FG000|Overall Study|Early withdrawal|14|||
162990366|NCT00827632|588666601|FG001|Overall Study|Early withdrawal|11|||
162990367|NCT01753336|588666602|FG000|Overall Study|Patient decision|12|||
162990368|NCT01753336|588666602|FG000|Overall Study|Lost to Follow-up|3|||
162990369|NCT01753336|588666602|FG000|Overall Study|Physician Decision|2|||
162990370|NCT01753336|588666602|FG000|Overall Study|Sponsor's decision|2|||
162990371|NCT01753336|588666602|FG000|Overall Study|Withdrawal by Subject|1|||
162990372|NCT03201211|588666603|FG000|Overall Study|Adverse Event|1|||
162990373|NCT03201211|588666604|FG001|Overall Study|Adverse Event|0|||
162990374|NCT03201211|588666605|FG002|Overall Study|Adverse Event|0|||
162990375|NCT03201211|588666603|FG000|Overall Study|Protocol Violation|1|||
162990376|NCT03201211|588666604|FG001|Overall Study|Protocol Violation|0|||
162990377|NCT03201211|588666605|FG002|Overall Study|Protocol Violation|0|||
162990378|NCT03201211|588666603|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162990379|NCT03201211|588666604|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
162990380|NCT03201211|588666605|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
162990381|NCT03201211|588666603|FG000|Overall Study|OTHER unknown reasons|0|||
162990382|NCT03201211|588666604|FG001|Overall Study|OTHER unknown reasons|1|||
162990383|NCT03201211|588666605|FG002|Overall Study|OTHER unknown reasons|0|||
162990384|NCT01770392|588666606|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
162990385|NCT03401450|588666607|FG000|Overall Study|Lost to Follow-up|4|||
162990386|NCT03401450|588666608|FG001|Overall Study|Lost to Follow-up|6|||
162990387|NCT03401450|588666607|FG000|Overall Study|Anesthesia plan changed|2|||
162990388|NCT03401450|588666608|FG001|Overall Study|Anesthesia plan changed|2|||
162990389|NCT03401450|588666607|FG000|Overall Study|Did not complete medication diary|4|||
162990390|NCT03401450|588666608|FG001|Overall Study|Did not complete medication diary|2|||
162990391|NCT03401450|588666607|FG000|Overall Study|post surgery medication change|2|||
162990392|NCT03401450|588666608|FG001|Overall Study|post surgery medication change|1|||
162990393|NCT03401450|588666607|FG000|Overall Study|Cancelled surgery|0|||
162990394|NCT03401450|588666608|FG001|Overall Study|Cancelled surgery|2|||
162990395|NCT00228423|588666609|FG000|Overall Study|Adverse Event|2|||
162990396|NCT00228423|588666610|FG001|Overall Study|Adverse Event|5|||
162990397|NCT00228423|588666609|FG000|Overall Study|Withdrawal by Subject|7|||
162990398|NCT00228423|588666610|FG001|Overall Study|Withdrawal by Subject|3|||
162990399|NCT00228423|588666609|FG000|Overall Study|Protocol Violation|1|||
162990400|NCT00228423|588666610|FG001|Overall Study|Protocol Violation|3|||
162990401|NCT00228423|588666609|FG000|Overall Study|Physician Decision|0|||
162990402|NCT00228423|588666610|FG001|Overall Study|Physician Decision|1|||
162990403|NCT01709838|588666623|FG000|Overall Study|Withdrawal by Subject|21|||
162990404|NCT01709838|588666623|FG000|Overall Study|Lost to Follow-up|16|||
162990405|NCT01709838|588666623|FG000|Overall Study|Pregnancy|10|||
162990406|NCT01709838|588666623|FG000|Overall Study|Subject/guardian decision|8|||
162990407|NCT01709838|588666623|FG000|Overall Study|Adverse Event|4|||
162990408|NCT01709838|588666623|FG000|Overall Study|Physician Decision|4|||
162990409|NCT01709838|588666623|FG000|Overall Study|Death|3|||
162990410|NCT01709838|588666623|FG000|Overall Study|Protocol Violation|1|||
162990411|NCT00620659|588666624|FG000|Treatment Period 1|Adverse Event|1|||
162990412|NCT00620659|588666625|FG001|Treatment Period 1|Adverse Event|0|||
162990413|NCT00620659|588666626|FG002|Treatment Period 1|Adverse Event|0|||
162990414|NCT00620659|588666627|FG003|Treatment Period 1|Adverse Event|3|||
162990415|NCT00620659|588666628|FG004|Treatment Period 1|Adverse Event|0|||
162990416|NCT00620659|588666629|FG005|Treatment Period 1|Adverse Event|0|||
162990417|NCT00620659|588666624|FG000|Treatment Period 1|Protocol Violation|1|||
162990418|NCT00620659|588666625|FG001|Treatment Period 1|Protocol Violation|0|||
162990419|NCT00620659|588666626|FG002|Treatment Period 1|Protocol Violation|0|||
162990420|NCT00620659|588666627|FG003|Treatment Period 1|Protocol Violation|0|||
162990421|NCT00620659|588666628|FG004|Treatment Period 1|Protocol Violation|0|||
162990422|NCT00620659|588666629|FG005|Treatment Period 1|Protocol Violation|0|||
162990423|NCT00620659|588666624|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162990424|NCT00620659|588666625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162990425|NCT00620659|588666626|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162990426|NCT00620659|588666627|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162990427|NCT00620659|588666628|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162990428|NCT00620659|588666629|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162990429|NCT00620659|588666624|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990430|NCT00620659|588666625|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990431|NCT00620659|588666626|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990432|NCT00620659|588666627|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
162990433|NCT00620659|588666628|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990434|NCT00620659|588666629|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
162990435|NCT00620659|588666624|FG000|Treatment Period 2|Adverse Event|0|||
162990436|NCT00620659|588666625|FG001|Treatment Period 2|Adverse Event|3|||
162990437|NCT00620659|588666626|FG002|Treatment Period 2|Adverse Event|0|||
162990438|NCT00620659|588666627|FG003|Treatment Period 2|Adverse Event|0|||
162990439|NCT00620659|588666628|FG004|Treatment Period 2|Adverse Event|2|||
162990440|NCT00620659|588666629|FG005|Treatment Period 2|Adverse Event|0|||
162990441|NCT00620659|588666624|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162990442|NCT00620659|588666625|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162990443|NCT00620659|588666626|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162990444|NCT00620659|588666627|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162990445|NCT00620659|588666628|FG004|Treatment Period 2|Withdrawal by Subject|3|||
162990446|NCT00620659|588666629|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162990447|NCT00620659|588666624|FG000|Placebo Washout Period 2|Adverse Event|2|||
162990448|NCT00620659|588666625|FG001|Placebo Washout Period 2|Adverse Event|0|||
162990449|NCT00620659|588666626|FG002|Placebo Washout Period 2|Adverse Event|0|||
162990450|NCT00620659|588666627|FG003|Placebo Washout Period 2|Adverse Event|0|||
162990451|NCT00620659|588666628|FG004|Placebo Washout Period 2|Adverse Event|0|||
162990452|NCT00620659|588666629|FG005|Placebo Washout Period 2|Adverse Event|0|||
162990453|NCT00620659|588666624|FG000|Treatment Period 3|Adverse Event|0|||
162990454|NCT00620659|588666625|FG001|Treatment Period 3|Adverse Event|2|||
162990455|NCT00620659|588666626|FG002|Treatment Period 3|Adverse Event|0|||
162990456|NCT00620659|588666627|FG003|Treatment Period 3|Adverse Event|0|||
162990457|NCT00620659|588666628|FG004|Treatment Period 3|Adverse Event|0|||
162990458|NCT00620659|588666629|FG005|Treatment Period 3|Adverse Event|0|||
162990459|NCT00620659|588666624|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162990460|NCT00620659|588666625|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162990461|NCT00620659|588666626|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162990462|NCT00620659|588666627|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162990463|NCT00620659|588666628|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162990464|NCT00620659|588666629|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162990465|NCT02352779|588666630|FG000|Overall Study|Personal Issues|1|||
162990466|NCT02352779|588666631|FG001|Overall Study|Personal Issues|1|||
162990467|NCT02352779|588666632|FG002|Overall Study|Personal Issues|0|||
162990468|NCT02352779|588666630|FG000|Overall Study|Too Many Forms|2|||
162990469|NCT02352779|588666631|FG001|Overall Study|Too Many Forms|0|||
162990470|NCT02352779|588666632|FG002|Overall Study|Too Many Forms|0|||
162990471|NCT02352779|588666630|FG000|Overall Study|Feeling Overwhelmed|1|||
162990472|NCT02352779|588666631|FG001|Overall Study|Feeling Overwhelmed|0|||
162990473|NCT02352779|588666632|FG002|Overall Study|Feeling Overwhelmed|0|||
162990474|NCT02352779|588666630|FG000|Overall Study|Disliked Intervention|1|||
162990475|NCT02352779|588666631|FG001|Overall Study|Disliked Intervention|0|||
162990476|NCT02352779|588666632|FG002|Overall Study|Disliked Intervention|0|||
162990477|NCT02352779|588666630|FG000|Overall Study|Changed Mind|1|||
162990478|NCT02352779|588666631|FG001|Overall Study|Changed Mind|0|||
162990479|NCT02352779|588666632|FG002|Overall Study|Changed Mind|0|||
163059981|NCT01348269|588928275|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
163059982|NCT00805532|588928276|FG000|Overall Study|invalid data|0|||
162990480|NCT02352779|588666630|FG000|Overall Study|Study Related Symptoms|1|||
162990481|NCT02352779|588666631|FG001|Overall Study|Study Related Symptoms|0|||
162990482|NCT02352779|588666632|FG002|Overall Study|Study Related Symptoms|0|||
162990483|NCT02352779|588666630|FG000|Overall Study|Absence of Symptoms|1|||
162990484|NCT02352779|588666631|FG001|Overall Study|Absence of Symptoms|0|||
162990485|NCT02352779|588666632|FG002|Overall Study|Absence of Symptoms|0|||
162990486|NCT02352779|588666630|FG000|Overall Study|Other Medical Reason|0|||
162990487|NCT02352779|588666631|FG001|Overall Study|Other Medical Reason|0|||
162990488|NCT02352779|588666632|FG002|Overall Study|Other Medical Reason|1|||
162990489|NCT02352779|588666630|FG000|Overall Study|No Reason|0|||
162990490|NCT02352779|588666631|FG001|Overall Study|No Reason|0|||
162990491|NCT02352779|588666632|FG002|Overall Study|No Reason|1|||
162990492|NCT00968799|588666635|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
162990493|NCT00719849|588666638|FG000|Overall Study|Death|0|||
162990494|NCT00719849|588666639|FG001|Overall Study|Death|1|||
162990495|NCT00389831|588666643|FG000|Overall Study|Lack of Efficacy|0|||
162990496|NCT00389831|588666644|FG001|Overall Study|Lack of Efficacy|2|||
162990497|NCT00389831|588666643|FG000|Overall Study|Did not receive treatment.|0|||
162990498|NCT00389831|588666644|FG001|Overall Study|Did not receive treatment.|2|||
162990499|NCT00389831|588666643|FG000|Overall Study|Other reasons|0|||
162990500|NCT00389831|588666644|FG001|Overall Study|Other reasons|2|||
162990501|NCT00389831|588666643|FG000|Overall Study|Lost to Follow-up|0|||
162990502|NCT00389831|588666644|FG001|Overall Study|Lost to Follow-up|1|||
162990503|NCT00594646|588666649|FG000|Overall Study|Withdrawal by Subject|1|||
162990504|NCT00594646|588666649|FG000|Overall Study|Lost to Follow-up|15|||
162990505|NCT03907462|588666650|FG000|Overall Study|Physician Decision|1|||
162990506|NCT03907462|588666651|FG001|Overall Study|Physician Decision|3|||
162990507|NCT03907462|588666652|FG002|Overall Study|Physician Decision|1|||
162990508|NCT03907462|588666650|FG000|Overall Study|Withdrawal by Subject|6|||
162990509|NCT03907462|588666651|FG001|Overall Study|Withdrawal by Subject|3|||
162990510|NCT03907462|588666652|FG002|Overall Study|Withdrawal by Subject|3|||
162990511|NCT03907462|588666650|FG000|Overall Study|Pregnancy|4|||
162990512|NCT03907462|588666651|FG001|Overall Study|Pregnancy|2|||
162990513|NCT03907462|588666652|FG002|Overall Study|Pregnancy|6|||
162990514|NCT03907462|588666650|FG000|Overall Study|Lost to Follow-up|16|||
162990515|NCT03907462|588666651|FG001|Overall Study|Lost to Follow-up|18|||
162990516|NCT03907462|588666652|FG002|Overall Study|Lost to Follow-up|22|||
162990517|NCT00191113|588669080|FG000|Core Study|Withdrawal by Subject|25|||
162990518|NCT00191113|588669081|FG001|Core Study|Withdrawal by Subject|9|||
162990519|NCT00191113|588669080|FG000|Core Study|Protocol Violation|6|||
162990520|NCT00191113|588669081|FG001|Core Study|Protocol Violation|2|||
162990521|NCT00191113|588669080|FG000|Core Study|Lost to Follow-up|3|||
162990522|NCT00191113|588669081|FG001|Core Study|Lost to Follow-up|0|||
162990523|NCT00191113|588669080|FG000|Core Study|Adverse Event|0|||
162990524|NCT00191113|588669081|FG001|Core Study|Adverse Event|2|||
162990525|NCT00191113|588669080|FG000|Core Study|Lack of Efficacy|0|||
162990526|NCT00191113|588669081|FG001|Core Study|Lack of Efficacy|2|||
162990527|NCT00191113|588669080|FG000|Core Study|Death|1|||
162990528|NCT00191113|588669081|FG001|Core Study|Death|0|||
162990529|NCT01555671|588669084|FG000|Overall Study|Physician Decision|20|||
162990530|NCT01555671|588669085|FG001|Overall Study|Physician Decision|25|||
162990531|NCT00631657|588669086|FG000|6-Month Treatment Period|Adverse Event|47|||
162990532|NCT00631657|588669087|FG001|6-Month Treatment Period|Adverse Event|0|||
162990533|NCT00631657|588669088|FG002|6-Month Treatment Period|Adverse Event|7|||
162990534|NCT00631657|588669086|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
162990535|NCT00631657|588669087|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
162990536|NCT00631657|588669088|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
162990537|NCT00631657|588669086|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
162990538|NCT00631657|588669087|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
162990539|NCT00631657|588669088|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
162990540|NCT00631657|588669086|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
162990541|NCT00631657|588669087|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
162990542|NCT00631657|588669088|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
162990543|NCT00631657|588669086|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
162990544|NCT00631657|588669087|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
162990545|NCT00631657|588669088|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
162990546|NCT00631657|588669086|FG000|6-Month Treatment Period|Other|16|||
162990547|NCT00631657|588669087|FG001|6-Month Treatment Period|Other|0|||
162990548|NCT00631657|588669088|FG002|6-Month Treatment Period|Other|4|||
162990549|NCT00631657|588669086|FG000|6-Month Treatment Period|Not Treated|2|||
162990550|NCT00631657|588669087|FG001|6-Month Treatment Period|Not Treated|0|||
162990551|NCT00631657|588669088|FG002|6-Month Treatment Period|Not Treated|1|||
162990552|NCT00631657|588669086|FG000|7-Day Discontinuation Period|Not Treated|1|||
162990553|NCT00631657|588669087|FG001|7-Day Discontinuation Period|Not Treated|1|||
162990554|NCT00631657|588669088|FG002|7-Day Discontinuation Period|Not Treated|1|||
162990555|NCT00631657|588669086|FG000|7-Day Discontinuation Period|Other|1|||
162990556|NCT00631657|588669087|FG001|7-Day Discontinuation Period|Other|0|||
162990557|NCT00631657|588669088|FG002|7-Day Discontinuation Period|Other|0|||
162990558|NCT04003896|588669089|FG000|Overall Study|Withdrawal by Subject|3|||
162990559|NCT04003896|588669089|FG000|Overall Study|Physician Decision|1|||
162990560|NCT03929757|588669092|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
162990561|NCT03929757|588669093|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
162990562|NCT03929757|588669094|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
162990563|NCT03929757|588669092|FG000|Main Study: Up to Day 365|Other|1|||
162990564|NCT03929757|588669093|FG001|Main Study: Up to Day 365|Other|0|||
162990565|NCT03929757|588669094|FG002|Main Study: Up to Day 365|Other|0|||
162990566|NCT03929757|588669092|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
162990567|NCT03929757|588669093|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
162990568|NCT03929757|588669094|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
162990569|NCT01154816|588669095|FG000|Overall Study|Withdrawal by Subject|1|||
162990570|NCT01154816|588669096|FG001|Overall Study|Withdrawal by Subject|0|||
162990571|NCT01154816|588669097|FG002|Overall Study|Withdrawal by Subject|0|||
162990572|NCT01154816|588669098|FG003|Overall Study|Withdrawal by Subject|1|||
162990573|NCT01154816|588669099|FG004|Overall Study|Withdrawal by Subject|0|||
162990574|NCT01154816|588669100|FG005|Overall Study|Withdrawal by Subject|0|||
162990575|NCT01154816|588669101|FG006|Overall Study|Withdrawal by Subject|0|||
162990576|NCT01154816|588669102|FG007|Overall Study|Withdrawal by Subject|0|||
162990577|NCT01154816|588669103|FG008|Overall Study|Withdrawal by Subject|1|||
162990578|NCT01154816|588669104|FG009|Overall Study|Withdrawal by Subject|3|||
162990579|NCT01154816|588669105|FG010|Overall Study|Withdrawal by Subject|0|||
162990580|NCT01154816|588669106|FG011|Overall Study|Withdrawal by Subject|0|||
162990581|NCT01154816|588669095|FG000|Overall Study|Progressive Disease|13|||
162990582|NCT01154816|588669096|FG001|Overall Study|Progressive Disease|8|||
162990583|NCT01154816|588669097|FG002|Overall Study|Progressive Disease|9|||
162990584|NCT01154816|588669098|FG003|Overall Study|Progressive Disease|9|||
162990585|NCT01154816|588669099|FG004|Overall Study|Progressive Disease|8|||
162990586|NCT01154816|588669100|FG005|Overall Study|Progressive Disease|8|||
162990587|NCT01154816|588669101|FG006|Overall Study|Progressive Disease|5|||
162990588|NCT01154816|588669102|FG007|Overall Study|Progressive Disease|6|||
162990589|NCT01154816|588669103|FG008|Overall Study|Progressive Disease|8|||
162990590|NCT01154816|588669104|FG009|Overall Study|Progressive Disease|6|||
162990591|NCT01154816|588669105|FG010|Overall Study|Progressive Disease|10|||
162990592|NCT01154816|588669106|FG011|Overall Study|Progressive Disease|3|||
162990593|NCT01154816|588669095|FG000|Overall Study|Physician Decision|1|||
162990594|NCT01154816|588669096|FG001|Overall Study|Physician Decision|0|||
162990595|NCT01154816|588669097|FG002|Overall Study|Physician Decision|1|||
162990596|NCT01154816|588669098|FG003|Overall Study|Physician Decision|0|||
162990597|NCT01154816|588669099|FG004|Overall Study|Physician Decision|2|||
162990598|NCT01154816|588669100|FG005|Overall Study|Physician Decision|0|||
162990599|NCT01154816|588669101|FG006|Overall Study|Physician Decision|0|||
162990600|NCT01154816|588669102|FG007|Overall Study|Physician Decision|0|||
162990601|NCT01154816|588669103|FG008|Overall Study|Physician Decision|0|||
162990602|NCT01154816|588669104|FG009|Overall Study|Physician Decision|1|||
162990603|NCT01154816|588669105|FG010|Overall Study|Physician Decision|1|||
162990604|NCT01154816|588669106|FG011|Overall Study|Physician Decision|1|||
162990605|NCT01154816|588669095|FG000|Overall Study|Adverse Event|5|||
162990606|NCT01154816|588669096|FG001|Overall Study|Adverse Event|2|||
162990607|NCT01154816|588669097|FG002|Overall Study|Adverse Event|0|||
162990608|NCT01154816|588669098|FG003|Overall Study|Adverse Event|0|||
162990609|NCT01154816|588669099|FG004|Overall Study|Adverse Event|0|||
162990610|NCT01154816|588669100|FG005|Overall Study|Adverse Event|0|||
162990611|NCT01154816|588669101|FG006|Overall Study|Adverse Event|1|||
162990612|NCT01154816|588669102|FG007|Overall Study|Adverse Event|1|||
162990613|NCT01154816|588669103|FG008|Overall Study|Adverse Event|0|||
162990614|NCT01154816|588669104|FG009|Overall Study|Adverse Event|0|||
162990615|NCT01154816|588669105|FG010|Overall Study|Adverse Event|0|||
162990616|NCT01154816|588669106|FG011|Overall Study|Adverse Event|0|||
162990617|NCT00806286|588669107|FG000|Overall Study|Adverse Event|5|||
162990618|NCT00806286|588669108|FG001|Overall Study|Adverse Event|2|||
162990619|NCT00806286|588669109|FG002|Overall Study|Adverse Event|0|||
162990620|NCT00806286|588669107|FG000|Overall Study|Disease progression|31|||
162990621|NCT00806286|588669108|FG001|Overall Study|Disease progression|38|||
162990622|NCT00806286|588669109|FG002|Overall Study|Disease progression|1|||
162990623|NCT00806286|588669107|FG000|Overall Study|Death|1|||
162990624|NCT00806286|588669108|FG001|Overall Study|Death|6|||
162990625|NCT00806286|588669109|FG002|Overall Study|Death|0|||
162990626|NCT00806286|588669107|FG000|Overall Study|Lost to Follow-up|0|||
162990627|NCT00806286|588669108|FG001|Overall Study|Lost to Follow-up|1|||
162990628|NCT00806286|588669109|FG002|Overall Study|Lost to Follow-up|0|||
162990629|NCT00806286|588669107|FG000|Overall Study|Withdrawal by Subject|8|||
162990630|NCT00806286|588669108|FG001|Overall Study|Withdrawal by Subject|3|||
162990631|NCT00806286|588669109|FG002|Overall Study|Withdrawal by Subject|1|||
162990632|NCT00806286|588669107|FG000|Overall Study|Physician Decision|2|||
162990633|NCT00806286|588669108|FG001|Overall Study|Physician Decision|2|||
162990634|NCT00806286|588669109|FG002|Overall Study|Physician Decision|0|||
162990635|NCT00806286|588669107|FG000|Overall Study|Due to a variety of reasons|7|||
162990636|NCT00806286|588669108|FG001|Overall Study|Due to a variety of reasons|2|||
162990637|NCT00806286|588669109|FG002|Overall Study|Due to a variety of reasons|1|||
162990638|NCT00686075|588669110|FG000|Overall Study|Withdrawal by Subject|4|||
162990639|NCT00686075|588669111|FG001|Overall Study|Withdrawal by Subject|3|||
162990640|NCT00686075|588669112|FG002|Overall Study|Withdrawal by Subject|3|||
162990641|NCT00686075|588669113|FG003|Overall Study|Withdrawal by Subject|7|||
162990642|NCT00686075|588669114|FG004|Overall Study|Withdrawal by Subject|1|||
162990643|NCT00686075|588669115|FG005|Overall Study|Withdrawal by Subject|0|||
162990644|NCT00686075|588669116|FG006|Overall Study|Withdrawal by Subject|0|||
162990645|NCT00686075|588669117|FG007|Overall Study|Withdrawal by Subject|2|||
162990646|NCT00686075|588669118|FG008|Overall Study|Withdrawal by Subject|4|||
162990647|NCT00686075|588669119|FG009|Overall Study|Withdrawal by Subject|6|||
162990648|NCT00686075|588669110|FG000|Overall Study|Lost to Follow-up|3|||
162990649|NCT00686075|588669111|FG001|Overall Study|Lost to Follow-up|6|||
162990650|NCT00686075|588669112|FG002|Overall Study|Lost to Follow-up|3|||
162990651|NCT00686075|588669113|FG003|Overall Study|Lost to Follow-up|2|||
162990652|NCT00686075|588669114|FG004|Overall Study|Lost to Follow-up|3|||
162990653|NCT00686075|588669115|FG005|Overall Study|Lost to Follow-up|3|||
162990654|NCT00686075|588669116|FG006|Overall Study|Lost to Follow-up|0|||
162990655|NCT00686075|588669117|FG007|Overall Study|Lost to Follow-up|0|||
162990656|NCT00686075|588669118|FG008|Overall Study|Lost to Follow-up|2|||
162990657|NCT00686075|588669119|FG009|Overall Study|Lost to Follow-up|3|||
162990658|NCT00686075|588669110|FG000|Overall Study|Other|1|||
162990659|NCT00686075|588669111|FG001|Overall Study|Other|1|||
162990660|NCT00686075|588669112|FG002|Overall Study|Other|0|||
162990661|NCT00686075|588669113|FG003|Overall Study|Other|0|||
162990662|NCT00686075|588669114|FG004|Overall Study|Other|0|||
162990663|NCT00686075|588669115|FG005|Overall Study|Other|0|||
162990664|NCT00686075|588669116|FG006|Overall Study|Other|0|||
162990665|NCT00686075|588669117|FG007|Overall Study|Other|0|||
162990666|NCT00686075|588669118|FG008|Overall Study|Other|0|||
162990667|NCT00686075|588669119|FG009|Overall Study|Other|1|||
162990668|NCT04713553|588669120|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
162990669|NCT04713553|588669121|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
162990670|NCT04713553|588669122|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990671|NCT04713553|588669123|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990672|NCT04713553|588669124|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
162990673|NCT04713553|588669125|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990674|NCT04713553|588669126|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
162990675|NCT04713553|588669120|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990676|NCT04713553|588669121|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990677|NCT04713553|588669122|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990678|NCT04713553|588669123|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
162990679|NCT04713553|588669124|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990680|NCT04713553|588669125|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990681|NCT04713553|588669126|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
162990682|NCT04713553|588669120|FG000|Primary Study (2 Months)|Other|1|||
162990683|NCT04713553|588669121|FG001|Primary Study (2 Months)|Other|2|||
162990684|NCT04713553|588669122|FG002|Primary Study (2 Months)|Other|0|||
162990685|NCT04713553|588669123|FG003|Primary Study (2 Months)|Other|0|||
162990686|NCT04713553|588669124|FG004|Primary Study (2 Months)|Other|1|||
162990687|NCT04713553|588669125|FG005|Primary Study (2 Months)|Other|0|||
162990688|NCT04713553|588669126|FG006|Primary Study (2 Months)|Other|0|||
162990689|NCT04713553|588669120|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
162990690|NCT04713553|588669121|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
162990691|NCT04713553|588669122|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
162990692|NCT04713553|588669123|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
162990693|NCT04713553|588669124|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
162990694|NCT04713553|588669125|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
162990695|NCT04713553|588669126|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
162990696|NCT04713553|588669120|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990697|NCT04713553|588669121|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990698|NCT04713553|588669122|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
162990699|NCT04713553|588669123|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990700|NCT04713553|588669124|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990701|NCT04713553|588669125|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990702|NCT04713553|588669126|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
162990703|NCT01199471|588669127|FG000|Overall Study|Protocol Violation|4|||
162990704|NCT01199471|588669127|FG000|Overall Study|Withdrawal by Subject|1|||
162990705|NCT01199471|588669127|FG000|Overall Study|Physician Decision|1|||
162990706|NCT03151408|588669128|FG000|Overall Study|Adverse Event|24|||
162990707|NCT03151408|588669129|FG001|Overall Study|Adverse Event|23|||
162990708|NCT03151408|588669128|FG000|Overall Study|Death|46|||
162636790|NCT00241280|587384324|FG001|Overall Study|Diabetic|0|||
162636791|NCT00241280|587384323|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
162636792|NCT00241280|587384324|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
162636793|NCT00241280|587384323|FG000|Overall Study|Dispensed incorrect test article|1|||
162990709|NCT03151408|588669129|FG001|Overall Study|Death|26|||
162990710|NCT03151408|588669128|FG000|Overall Study|Physician Decision|13|||
162990711|NCT03151408|588669129|FG001|Overall Study|Physician Decision|19|||
162990712|NCT03151408|588669128|FG000|Overall Study|Withdrawal by Subject|16|||
162990713|NCT03151408|588669129|FG001|Overall Study|Withdrawal by Subject|20|||
162990714|NCT03151408|588669128|FG000|Overall Study|Progressive disease|45|||
162990715|NCT03151408|588669129|FG001|Overall Study|Progressive disease|61|||
162990716|NCT03151408|588669128|FG000|Overall Study|non-compliance by patient|1|||
162990717|NCT03151408|588669129|FG001|Overall Study|non-compliance by patient|0|||
162990718|NCT03151408|588669128|FG000|Overall Study|other reasons|56|||
162990719|NCT03151408|588669129|FG001|Overall Study|other reasons|52|||
162990720|NCT03151408|588669128|FG000|Overall Study|randomized and not treated|2|||
162990721|NCT03151408|588669129|FG001|Overall Study|randomized and not treated|2|||
162990722|NCT00265395|588669130|FG000|Overall Study|Adverse Event|3|||
162990723|NCT00265395|588669131|FG001|Overall Study|Adverse Event|6|||
162990724|NCT00265395|588669130|FG000|Overall Study|Lost to Follow-up|2|||
162990725|NCT00265395|588669131|FG001|Overall Study|Lost to Follow-up|1|||
162990726|NCT00265395|588669130|FG000|Overall Study|Withdrawal by Subject|1|||
162990727|NCT00265395|588669131|FG001|Overall Study|Withdrawal by Subject|6|||
162990728|NCT00265395|588669130|FG000|Overall Study|Protocol Violation|2|||
162990729|NCT00265395|588669131|FG001|Overall Study|Protocol Violation|2|||
162990730|NCT00265395|588669130|FG000|Overall Study|Lack of Efficacy|0|||
162990731|NCT00265395|588669131|FG001|Overall Study|Lack of Efficacy|1|||
162990732|NCT00265395|588669130|FG000|Overall Study|Administrative|0|||
162990733|NCT00265395|588669131|FG001|Overall Study|Administrative|1|||
162990734|NCT03400943|588669132|FG000|Treatment Period 1|Adverse Event|0|||
162990735|NCT03400943|588669133|FG001|Treatment Period 1|Adverse Event|0|||
162990736|NCT03400943|588669134|FG002|Treatment Period 1|Adverse Event|0|||
162990737|NCT03400943|588669135|FG003|Treatment Period 1|Adverse Event|1|||
162990738|NCT03400943|588669132|FG000|Treatment Period 1|Lost to Follow-up|1|||
162990739|NCT03400943|588669133|FG001|Treatment Period 1|Lost to Follow-up|0|||
162990740|NCT03400943|588669134|FG002|Treatment Period 1|Lost to Follow-up|0|||
162990741|NCT03400943|588669135|FG003|Treatment Period 1|Lost to Follow-up|0|||
162990742|NCT03400943|588669132|FG000|Treatment Period 1|Protocol Violation|0|||
162990743|NCT03400943|588669133|FG001|Treatment Period 1|Protocol Violation|1|||
162990744|NCT03400943|588669134|FG002|Treatment Period 1|Protocol Violation|1|||
162990745|NCT03400943|588669135|FG003|Treatment Period 1|Protocol Violation|0|||
162990746|NCT03400943|588669132|FG000|Treatment Period 1|Study terminated by sponsor|2|||
162990747|NCT03400943|588669133|FG001|Treatment Period 1|Study terminated by sponsor|0|||
162990748|NCT03400943|588669134|FG002|Treatment Period 1|Study terminated by sponsor|0|||
162990749|NCT03400943|588669135|FG003|Treatment Period 1|Study terminated by sponsor|1|||
162990750|NCT03400943|588669132|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162990751|NCT03400943|588669133|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162990752|NCT03400943|588669134|FG002|Treatment Period 1|Withdrawal by Subject|3|||
162990753|NCT03400943|588669135|FG003|Treatment Period 1|Withdrawal by Subject|1|||
162990754|NCT03400943|588669132|FG000|Treatment Period 1|Other|2|||
162990755|NCT03400943|588669133|FG001|Treatment Period 1|Other|1|||
162990756|NCT03400943|588669134|FG002|Treatment Period 1|Other|2|||
162990757|NCT03400943|588669135|FG003|Treatment Period 1|Other|2|||
162990758|NCT03400943|588669132|FG000|Post-treatment Period 1|Adverse Event|2|||
162990759|NCT03400943|588669133|FG001|Post-treatment Period 1|Adverse Event|0|||
162990760|NCT03400943|588669134|FG002|Post-treatment Period 1|Adverse Event|0|||
162990761|NCT03400943|588669135|FG003|Post-treatment Period 1|Adverse Event|0|||
162990762|NCT03400943|588669132|FG000|Post-treatment Period 1|Protocol Violation|1|||
162990763|NCT03400943|588669133|FG001|Post-treatment Period 1|Protocol Violation|0|||
162990764|NCT03400943|588669134|FG002|Post-treatment Period 1|Protocol Violation|0|||
162990765|NCT03400943|588669135|FG003|Post-treatment Period 1|Protocol Violation|0|||
162990766|NCT03400943|588669132|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
162990767|NCT03400943|588669133|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
162990768|NCT03400943|588669134|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
162990769|NCT03400943|588669135|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
162990770|NCT03400943|588669132|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
162990771|NCT03400943|588669133|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
162990772|NCT03400943|588669134|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
162990773|NCT03400943|588669135|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
162990774|NCT03400943|588669132|FG000|Post-treatment Period 1|Other|2|||
162990775|NCT03400943|588669133|FG001|Post-treatment Period 1|Other|0|||
162990776|NCT03400943|588669134|FG002|Post-treatment Period 1|Other|4|||
162990777|NCT03400943|588669135|FG003|Post-treatment Period 1|Other|5|||
162990778|NCT03400943|588669132|FG000|Treatment Period 2|Study terminated by sponsor|0|||
162990779|NCT03400943|588669133|FG001|Treatment Period 2|Study terminated by sponsor|1|||
162990780|NCT03400943|588669134|FG002|Treatment Period 2|Study terminated by sponsor|0|||
162990781|NCT03400943|588669135|FG003|Treatment Period 2|Study terminated by sponsor|0|||
162990782|NCT03400943|588669132|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162990783|NCT03400943|588669133|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162990784|NCT03400943|588669134|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162990785|NCT03400943|588669135|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162990786|NCT03400943|588669132|FG000|Treatment Period 2|Other|1|||
162990787|NCT03400943|588669133|FG001|Treatment Period 2|Other|6|||
162990788|NCT03400943|588669134|FG002|Treatment Period 2|Other|0|||
162990789|NCT03400943|588669135|FG003|Treatment Period 2|Other|0|||
162990790|NCT03400943|588669132|FG000|Follow-up Period|Withdrawal by Subject|1|||
162990791|NCT03400943|588669133|FG001|Follow-up Period|Withdrawal by Subject|0|||
162990792|NCT03400943|588669134|FG002|Follow-up Period|Withdrawal by Subject|0|||
162990793|NCT03400943|588669135|FG003|Follow-up Period|Withdrawal by Subject|0|||
162990794|NCT01085734|588669136|FG000|Overall Study|Adverse Event|0|||
162990795|NCT01085734|588669137|FG001|Overall Study|Adverse Event|2|||
162990796|NCT01085734|588669136|FG000|Overall Study|Death|1|||
162990797|NCT01085734|588669137|FG001|Overall Study|Death|0|||
162990798|NCT01085734|588669136|FG000|Overall Study|Lost to Follow-up|0|||
162990799|NCT01085734|588669137|FG001|Overall Study|Lost to Follow-up|1|||
162990800|NCT01085734|588669136|FG000|Overall Study|Withdrawal by Subject|0|||
162990801|NCT01085734|588669137|FG001|Overall Study|Withdrawal by Subject|1|||
162990802|NCT02045147|588669140|FG000|Overall Study|Withdrawal by Subject|2|||
162990803|NCT02045147|588669141|FG001|Overall Study|Withdrawal by Subject|0|||
162990804|NCT02045147|588669142|FG002|Overall Study|Withdrawal by Subject|0|||
162990805|NCT02045147|588669143|FG003|Overall Study|Withdrawal by Subject|0|||
162990806|NCT02045147|588669144|FG004|Overall Study|Withdrawal by Subject|0|||
162990807|NCT02045147|588669145|FG005|Overall Study|Withdrawal by Subject|0|||
162990808|NCT02045147|588669146|FG006|Overall Study|Withdrawal by Subject|0|||
162990809|NCT02045147|588669147|FG007|Overall Study|Withdrawal by Subject|1|||
162990810|NCT02045147|588669140|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
162990811|NCT02045147|588669141|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
162990812|NCT02045147|588669142|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
162990813|NCT02045147|588669143|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
162990814|NCT02045147|588669144|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
162990815|NCT02045147|588669145|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
162990816|NCT02045147|588669146|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
162990817|NCT02045147|588669147|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
162990818|NCT00049530|588669148|FG000|Overall Study|Lack of Efficacy|25|||
162990819|NCT00049530|588669148|FG000|Overall Study|Adverse Event|2|||
162990820|NCT00049530|588669148|FG000|Overall Study|Death|1|||
162990821|NCT00049530|588669148|FG000|Overall Study|symptomatic deterioration|1|||
162990822|NCT00049530|588669148|FG000|Overall Study|ineligible|3|||
162990823|NCT00849186|588669152|FG000|Overall Study|Adverse Event|2|||
162990824|NCT00849186|588669152|FG000|Overall Study|Withdrawal by Subject|1|||
162990825|NCT00849186|588669152|FG000|Overall Study|not treated|6|||
162990826|NCT00849186|588669152|FG000|Overall Study|Other|1|||
162990827|NCT00936897|588669155|FG000|Overall Study|Withdrawal by Subject|9|||
162990828|NCT00936897|588669156|FG001|Overall Study|Withdrawal by Subject|19|||
162990829|NCT00936897|588669155|FG000|Overall Study|Adverse Event|4|||
162990830|NCT00936897|588669156|FG001|Overall Study|Adverse Event|13|||
162990831|NCT00936897|588669155|FG000|Overall Study|Other|3|||
162990832|NCT00936897|588669156|FG001|Overall Study|Other|9|||
162990833|NCT00936897|588669155|FG000|Overall Study|Lost to Follow-up|1|||
162990834|NCT00936897|588669156|FG001|Overall Study|Lost to Follow-up|10|||
162990835|NCT00936897|588669155|FG000|Overall Study|Administrative Decision|1|||
162990836|NCT00936897|588669156|FG001|Overall Study|Administrative Decision|2|||
162990837|NCT00936897|588669155|FG000|Overall Study|Protocol Violation|1|||
162990838|NCT00936897|588669156|FG001|Overall Study|Protocol Violation|1|||
162990839|NCT00936897|588669155|FG000|Overall Study|Ineligibility Determined|0|||
162990840|NCT00936897|588669156|FG001|Overall Study|Ineligibility Determined|3|||
162990841|NCT00936897|588669155|FG000|Overall Study|Noncompliance|0|||
162990842|NCT00936897|588669156|FG001|Overall Study|Noncompliance|2|||
162990843|NCT00936897|588669155|FG000|Overall Study|Death|0|||
162990844|NCT00936897|588669156|FG001|Overall Study|Death|1|||
162990845|NCT00417170|588669157|FG000|Overall Study|Adverse Event|1|||
162990846|NCT00417170|588669158|FG001|Overall Study|Adverse Event|1|||
162990847|NCT00417170|588669157|FG000|Overall Study|Withdrawal by Subject|1|||
162990848|NCT00417170|588669158|FG001|Overall Study|Withdrawal by Subject|1|||
162990849|NCT00417170|588669157|FG000|Overall Study|Lost to Follow-up|0|||
162990850|NCT00417170|588669158|FG001|Overall Study|Lost to Follow-up|1|||
162990851|NCT04058067|588669159|FG000|Overall Study|Adverse Event|2|||
162990852|NCT04058067|588669160|FG001|Overall Study|Adverse Event|0|||
162990853|NCT04058067|588669159|FG000|Overall Study|Death|0|||
162990854|NCT04058067|588669160|FG001|Overall Study|Death|1|||
162990855|NCT04058067|588669159|FG000|Overall Study|Physician Decision|3|||
162990856|NCT04058067|588669160|FG001|Overall Study|Physician Decision|1|||
162990857|NCT04058067|588669159|FG000|Overall Study|Protocol Violation|0|||
162990858|NCT04058067|588669160|FG001|Overall Study|Protocol Violation|1|||
162990859|NCT04058067|588669159|FG000|Overall Study|Withdrawal by Subject|7|||
162990860|NCT04058067|588669160|FG001|Overall Study|Withdrawal by Subject|8|||
162990861|NCT01001988|588669163|FG000|Overall Study|Protocol Violation|84|||
162990862|NCT01001988|588669163|FG000|Overall Study|Withdrawal by Subject|18|||
162990863|NCT01001988|588669163|FG000|Overall Study|Lost to Follow-up|15|||
162990864|NCT04628793|588669164|FG000|Overall Study|Study terminated by sponsor|0|||
162990865|NCT04628793|588669165|FG001|Overall Study|Study terminated by sponsor|0|||
162990866|NCT04628793|588669166|FG002|Overall Study|Study terminated by sponsor|8|||
162990867|NCT04628793|588669164|FG000|Overall Study|Withdrawal by Subject|2|||
162990868|NCT04628793|588669165|FG001|Overall Study|Withdrawal by Subject|3|||
162990869|NCT04628793|588669166|FG002|Overall Study|Withdrawal by Subject|0|||
162990870|NCT04628793|588669164|FG000|Overall Study|Lost to Follow-up|0|||
162990871|NCT04628793|588669165|FG001|Overall Study|Lost to Follow-up|1|||
162990872|NCT04628793|588669166|FG002|Overall Study|Lost to Follow-up|0|||
162990873|NCT01329549|588669173|FG000|Overall Study|Withdrawal by Subject|1|||
162990874|NCT01329549|588669173|FG000|Overall Study|Adverse Event|1|||
162990875|NCT00191165|588669174|FG000|Overall Study|Adverse Event|2|||
162990876|NCT00191165|588669175|FG001|Overall Study|Adverse Event|0|||
162990877|NCT00191165|588669174|FG000|Overall Study|Protocol Violation|0|||
162990878|NCT00191165|588669175|FG001|Overall Study|Protocol Violation|1|||
162990879|NCT00191165|588669174|FG000|Overall Study|Participant Moved Away|0|||
162990880|NCT00191165|588669175|FG001|Overall Study|Participant Moved Away|1|||
162990881|NCT03200912|588669176|FG000|Overall Study|Adverse Event|3|||
162990882|NCT03200912|588669177|FG001|Overall Study|Adverse Event|0|||
162990883|NCT03200912|588669178|FG002|Overall Study|Adverse Event|0|||
162990884|NCT03200912|588669176|FG000|Overall Study|Withdrawal by Subject|1|||
162990885|NCT03200912|588669177|FG001|Overall Study|Withdrawal by Subject|2|||
162990886|NCT03200912|588669178|FG002|Overall Study|Withdrawal by Subject|4|||
162990887|NCT03200912|588669176|FG000|Overall Study|Non-compliance with study drug|0|||
162990888|NCT03200912|588669177|FG001|Overall Study|Non-compliance with study drug|1|||
162990889|NCT03200912|588669178|FG002|Overall Study|Non-compliance with study drug|0|||
162990890|NCT03421730|588669181|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990891|NCT03421730|588669182|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
162990892|NCT03421730|588669183|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990893|NCT03421730|588669184|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990894|NCT03421730|588669185|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990895|NCT03421730|588669186|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990896|NCT03421730|588669187|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990897|NCT03421730|588669188|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990898|NCT03421730|588669189|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990899|NCT03421730|588669190|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990900|NCT03421730|588669191|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990901|NCT03421730|588669192|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
162990902|NCT03421730|588669181|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990903|NCT03421730|588669182|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990904|NCT03421730|588669183|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990905|NCT03421730|588669184|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990906|NCT03421730|588669185|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
162990907|NCT03421730|588669186|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990908|NCT03421730|588669187|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990909|NCT03421730|588669188|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990910|NCT03421730|588669189|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990911|NCT03421730|588669190|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990912|NCT03421730|588669191|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990913|NCT03421730|588669192|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
162990914|NCT01661062|588669199|FG000|Overall Study|Completed Treatment Off Study|3|||
162990915|NCT01661062|588669199|FG000|Overall Study|Withdrawal by Subject|2|||
162990916|NCT02238795|588669200|FG000|Overall Study|Patient without purpura fulminans|1|||
162990917|NCT01096368|588669202|FG000|Overall Study|Death|0|||
162990918|NCT01096368|588669203|FG001|Overall Study|Death|1|||
162990919|NCT01096368|588669204|FG002|Overall Study|Death|0|||
162990920|NCT01096368|588669205|FG003|Overall Study|Death|0|||
162990921|NCT01096368|588669206|FG004|Overall Study|Death|0|||
162990922|NCT01096368|588669202|FG000|Overall Study|Physician Decision|0|||
162990923|NCT01096368|588669203|FG001|Overall Study|Physician Decision|13|||
162990924|NCT01096368|588669204|FG002|Overall Study|Physician Decision|2|||
162990925|NCT01096368|588669205|FG003|Overall Study|Physician Decision|4|||
162990926|NCT01096368|588669206|FG004|Overall Study|Physician Decision|6|||
162990927|NCT01096368|588669202|FG000|Overall Study|Withdrawal by Subject|0|||
162990928|NCT01096368|588669203|FG001|Overall Study|Withdrawal by Subject|52|||
162990929|NCT01096368|588669204|FG002|Overall Study|Withdrawal by Subject|0|||
162990930|NCT01096368|588669205|FG003|Overall Study|Withdrawal by Subject|10|||
162990931|NCT01096368|588669206|FG004|Overall Study|Withdrawal by Subject|14|||
162990932|NCT01096368|588669202|FG000|Overall Study|Ineligible|0|||
162990933|NCT01096368|588669203|FG001|Overall Study|Ineligible|3|||
162990934|NCT01096368|588669204|FG002|Overall Study|Ineligible|2|||
162990935|NCT01096368|588669205|FG003|Overall Study|Ineligible|0|||
162990936|NCT01096368|588669206|FG004|Overall Study|Ineligible|25|||
162990937|NCT01096368|588669202|FG000|Overall Study|Did not start treatment|0|||
162990938|NCT01096368|588669203|FG001|Overall Study|Did not start treatment|4|||
162990939|NCT01096368|588669204|FG002|Overall Study|Did not start treatment|4|||
162990940|NCT01096368|588669205|FG003|Overall Study|Did not start treatment|0|||
162990941|NCT01096368|588669206|FG004|Overall Study|Did not start treatment|0|||
162990942|NCT01096368|588669202|FG000|Overall Study|Progressive disease|0|||
162990943|NCT01096368|588669203|FG001|Overall Study|Progressive disease|6|||
162990944|NCT01096368|588669204|FG002|Overall Study|Progressive disease|0|||
162990945|NCT01096368|588669205|FG003|Overall Study|Progressive disease|10|||
162990946|NCT01096368|588669206|FG004|Overall Study|Progressive disease|3|||
162990947|NCT01096368|588669202|FG000|Overall Study|Other|0|||
162990948|NCT01096368|588669203|FG001|Overall Study|Other|0|||
162990949|NCT01096368|588669204|FG002|Overall Study|Other|1|||
162990950|NCT01096368|588669205|FG003|Overall Study|Other|0|||
162990951|NCT01096368|588669206|FG004|Overall Study|Other|0|||
162990952|NCT01096368|588669202|FG000|Overall Study|Treated with institutional review|0|||
162990953|NCT01096368|588669203|FG001|Overall Study|Treated with institutional review|0|||
162990954|NCT01096368|588669204|FG002|Overall Study|Treated with institutional review|0|||
162990955|NCT01096368|588669205|FG003|Overall Study|Treated with institutional review|0|||
162990956|NCT01096368|588669206|FG004|Overall Study|Treated with institutional review|1|||
162990957|NCT00407758|588669221|FG000|Overall Study|ineligible -improper prior treatment|1|||
162990958|NCT00750308|588669234|FG000|First Treatment|Adverse Event|0|||
162990959|NCT00750308|588669235|FG001|First Treatment|Adverse Event|1|||
162990960|NCT00750308|588669236|FG002|First Treatment|Adverse Event|0|||
162990961|NCT00750308|588669237|FG003|First Treatment|Adverse Event|0|||
162990962|NCT00750308|588669238|FG004|First Treatment|Adverse Event|0|||
162990963|NCT00750308|588669239|FG005|First Treatment|Adverse Event|0|||
162990964|NCT00750308|588669240|FG006|First Treatment|Adverse Event|0|||
162990965|NCT00750308|588669241|FG007|First Treatment|Adverse Event|0|||
162990966|NCT00750308|588669242|FG008|First Treatment|Adverse Event|0|||
162990967|NCT00750308|588669243|FG009|First Treatment|Adverse Event|0|||
162990968|NCT00750308|588669244|FG010|First Treatment|Adverse Event|1|||
162990969|NCT00750308|588669245|FG011|First Treatment|Adverse Event|1|||
162990970|NCT00750308|588669234|FG000|First Treatment|Withdrawal by Subject|0|||
162990971|NCT00750308|588669235|FG001|First Treatment|Withdrawal by Subject|0|||
162990972|NCT00750308|588669236|FG002|First Treatment|Withdrawal by Subject|0|||
162990973|NCT00750308|588669237|FG003|First Treatment|Withdrawal by Subject|1|||
162636794|NCT00241280|587384324|FG001|Overall Study|Dispensed incorrect test article|2|||
162636795|NCT00241280|587384323|FG000|Overall Study|Unacceptable Fit|0|||
162636796|NCT00241280|587384324|FG001|Overall Study|Unacceptable Fit|1|||
162990974|NCT00750308|588669238|FG004|First Treatment|Withdrawal by Subject|0|||
162990975|NCT00750308|588669239|FG005|First Treatment|Withdrawal by Subject|0|||
162990976|NCT00750308|588669240|FG006|First Treatment|Withdrawal by Subject|0|||
162990977|NCT00750308|588669241|FG007|First Treatment|Withdrawal by Subject|1|||
162990978|NCT00750308|588669242|FG008|First Treatment|Withdrawal by Subject|0|||
162990979|NCT00750308|588669243|FG009|First Treatment|Withdrawal by Subject|0|||
162990980|NCT00750308|588669244|FG010|First Treatment|Withdrawal by Subject|0|||
162990981|NCT00750308|588669245|FG011|First Treatment|Withdrawal by Subject|0|||
162990982|NCT00750308|588669234|FG000|Second Treatment|Adverse Event|0|||
162990983|NCT00750308|588669235|FG001|Second Treatment|Adverse Event|0|||
162990984|NCT00750308|588669236|FG002|Second Treatment|Adverse Event|0|||
162990985|NCT00750308|588669237|FG003|Second Treatment|Adverse Event|0|||
162990986|NCT00750308|588669238|FG004|Second Treatment|Adverse Event|0|||
162990987|NCT00750308|588669239|FG005|Second Treatment|Adverse Event|1|||
162990988|NCT00750308|588669240|FG006|Second Treatment|Adverse Event|0|||
162990989|NCT00750308|588669241|FG007|Second Treatment|Adverse Event|0|||
162990990|NCT00750308|588669242|FG008|Second Treatment|Adverse Event|1|||
162990991|NCT00750308|588669243|FG009|Second Treatment|Adverse Event|0|||
162990992|NCT00750308|588669244|FG010|Second Treatment|Adverse Event|0|||
162990993|NCT00750308|588669245|FG011|Second Treatment|Adverse Event|0|||
162990994|NCT00750308|588669234|FG000|Second Treatment|Withdrawal by Subject|0|||
162990995|NCT00750308|588669235|FG001|Second Treatment|Withdrawal by Subject|0|||
162990996|NCT00750308|588669236|FG002|Second Treatment|Withdrawal by Subject|0|||
162990997|NCT00750308|588669237|FG003|Second Treatment|Withdrawal by Subject|0|||
162990998|NCT00750308|588669238|FG004|Second Treatment|Withdrawal by Subject|1|||
162990999|NCT00750308|588669239|FG005|Second Treatment|Withdrawal by Subject|0|||
162991000|NCT00750308|588669240|FG006|Second Treatment|Withdrawal by Subject|0|||
162991001|NCT00750308|588669241|FG007|Second Treatment|Withdrawal by Subject|0|||
162991002|NCT00750308|588669242|FG008|Second Treatment|Withdrawal by Subject|0|||
162991003|NCT00750308|588669243|FG009|Second Treatment|Withdrawal by Subject|0|||
162991004|NCT00750308|588669244|FG010|Second Treatment|Withdrawal by Subject|0|||
162991005|NCT00750308|588669245|FG011|Second Treatment|Withdrawal by Subject|0|||
162991006|NCT00750308|588669234|FG000|Third Treatment|Withdrawal by Subject|0|||
162991007|NCT00750308|588669235|FG001|Third Treatment|Withdrawal by Subject|1|||
162991008|NCT00750308|588669236|FG002|Third Treatment|Withdrawal by Subject|0|||
162991009|NCT00750308|588669237|FG003|Third Treatment|Withdrawal by Subject|0|||
162991010|NCT00750308|588669238|FG004|Third Treatment|Withdrawal by Subject|0|||
162991011|NCT00750308|588669239|FG005|Third Treatment|Withdrawal by Subject|0|||
162991012|NCT00750308|588669240|FG006|Third Treatment|Withdrawal by Subject|0|||
162991013|NCT00750308|588669241|FG007|Third Treatment|Withdrawal by Subject|0|||
162991014|NCT00750308|588669242|FG008|Third Treatment|Withdrawal by Subject|0|||
162991015|NCT00750308|588669243|FG009|Third Treatment|Withdrawal by Subject|0|||
162991016|NCT00750308|588669244|FG010|Third Treatment|Withdrawal by Subject|0|||
162991017|NCT00750308|588669245|FG011|Third Treatment|Withdrawal by Subject|0|||
162991018|NCT02980874|588669246|FG000|Overall Study|Adverse Event|2|||
162991019|NCT02980874|588669247|FG001|Overall Study|Adverse Event|7|||
162991020|NCT02980874|588669246|FG000|Overall Study|Withdrawal by Subject|7|||
162991021|NCT02980874|588669247|FG001|Overall Study|Withdrawal by Subject|2|||
162991022|NCT02980874|588669246|FG000|Overall Study|Lost to Follow-up|5|||
162991023|NCT02980874|588669247|FG001|Overall Study|Lost to Follow-up|5|||
162991024|NCT02980874|588669246|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
162991025|NCT02980874|588669247|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
162991026|NCT02980874|588669246|FG000|Overall Study|Unknown study completion status|1|||
162991027|NCT02980874|588669247|FG001|Overall Study|Unknown study completion status|0|||
162991028|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Adverse Event|0|||
162991029|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Adverse Event|0|||
162991030|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Adverse Event|2|||
162991031|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Adverse Event|0|||
162991032|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Adverse Event|0|||
162991033|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
162991034|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
162991035|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
162991036|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
162991037|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
162991038|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
162991039|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991040|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991041|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991042|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
162991043|NCT02450526|588669248|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
162991044|NCT02450526|588669249|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
162991045|NCT02450526|588669250|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
162991046|NCT02450526|588669251|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
162991047|NCT02450526|588669252|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
162991048|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
162991049|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
162991050|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
162991051|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
162991052|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
162991053|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991054|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991055|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991056|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
162991057|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
162991058|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991059|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991060|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991061|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
162991062|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
162991063|NCT02450526|588669248|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991064|NCT02450526|588669249|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991065|NCT02450526|588669250|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
162991066|NCT02450526|588669251|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
162636797|NCT00241280|587384323|FG000|Overall Study|Scheduling Conflict|0|||
162636798|NCT00241280|587384324|FG001|Overall Study|Scheduling Conflict|2|||
162636799|NCT00241280|587384323|FG000|Overall Study|History of Ocular Surgery|0|||
162636800|NCT00241280|587384324|FG001|Overall Study|History of Ocular Surgery|1|||
162636801|NCT00241280|587384323|FG000|Overall Study|Coating on Lens|1|||
162991067|NCT02450526|588669252|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
162991068|NCT00911807|588669253|FG000|Overall Study|Adverse Event|2|||
162991069|NCT00911807|588669254|FG001|Overall Study|Adverse Event|1|||
162991070|NCT00911807|588669255|FG002|Overall Study|Adverse Event|5|||
162991071|NCT00911807|588669253|FG000|Overall Study|Death|0|||
162991072|NCT00911807|588669254|FG001|Overall Study|Death|0|||
162991073|NCT00911807|588669255|FG002|Overall Study|Death|1|||
162991074|NCT00911807|588669253|FG000|Overall Study|Protocol Violation|6|||
162991075|NCT00911807|588669254|FG001|Overall Study|Protocol Violation|4|||
162991076|NCT00911807|588669255|FG002|Overall Study|Protocol Violation|9|||
162991077|NCT00911807|588669253|FG000|Overall Study|Withdrawal by Subject|8|||
162991078|NCT00911807|588669254|FG001|Overall Study|Withdrawal by Subject|10|||
162991079|NCT00911807|588669255|FG002|Overall Study|Withdrawal by Subject|7|||
162991080|NCT00911807|588669253|FG000|Overall Study|Organizational reasons|1|||
162991081|NCT00911807|588669254|FG001|Overall Study|Organizational reasons|3|||
162991082|NCT00911807|588669255|FG002|Overall Study|Organizational reasons|1|||
162991083|NCT00855803|588669257|FG000|Overall Study|Death|2|||
162991084|NCT00855803|588669257|FG000|Overall Study|Lost to Follow-up|2|||
162991085|NCT00855803|588669257|FG000|Overall Study|Technical inability to undergo procedure|2|||
162991086|NCT00855803|588669257|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
162991087|NCT00855803|588669257|FG000|Overall Study|Withdrawal by Subject|3|||
162991088|NCT00855803|588669257|FG000|Overall Study|Physician Decision|3|||
162991089|NCT00809159|588669258|FG000|Part 1|Adverse Event|1|||
162991090|NCT00809159|588669259|FG001|Part 1|Adverse Event|1|||
162991091|NCT00809159|588669260|FG002|Part 1|Adverse Event|0|||
162991092|NCT00809159|588669261|FG003|Part 1|Adverse Event|0|||
162991093|NCT00809159|588669262|FG004|Part 1|Adverse Event|0|||
162991094|NCT00809159|588669263|FG005|Part 1|Adverse Event|0|||
162991095|NCT00809159|588669258|FG000|Part 1|Lost to Follow-up|1|||
162991096|NCT00809159|588669259|FG001|Part 1|Lost to Follow-up|0|||
162991097|NCT00809159|588669260|FG002|Part 1|Lost to Follow-up|0|||
162991098|NCT00809159|588669261|FG003|Part 1|Lost to Follow-up|0|||
162991099|NCT00809159|588669262|FG004|Part 1|Lost to Follow-up|0|||
162991100|NCT00809159|588669263|FG005|Part 1|Lost to Follow-up|0|||
162991101|NCT00809159|588669258|FG000|Part 1|Withdrawal by Subject|3|||
162991102|NCT00809159|588669259|FG001|Part 1|Withdrawal by Subject|1|||
162991103|NCT00809159|588669260|FG002|Part 1|Withdrawal by Subject|0|||
162991104|NCT00809159|588669261|FG003|Part 1|Withdrawal by Subject|0|||
162991105|NCT00809159|588669262|FG004|Part 1|Withdrawal by Subject|0|||
162991106|NCT00809159|588669263|FG005|Part 1|Withdrawal by Subject|0|||
162991107|NCT00809159|588669258|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
162991108|NCT00809159|588669259|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
162991109|NCT00809159|588669260|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
162991110|NCT00809159|588669261|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
162636802|NCT00241280|587384324|FG001|Overall Study|Coating on Lens|0|||
162636803|NCT00241280|587384323|FG000|Overall Study|Excessive Dryness|0|||
162991111|NCT00809159|588669262|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
162636804|NCT00241280|587384324|FG001|Overall Study|Excessive Dryness|1|||
162991112|NCT00809159|588669263|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
162991113|NCT00809159|588669258|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
162636805|NCT01958008|587384325|FG000|Overall Study|Worsening of disease under study|0|||
162991114|NCT00809159|588669259|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
162636806|NCT01958008|587384326|FG001|Overall Study|Worsening of disease under study|0|||
162991115|NCT00809159|588669260|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
162991116|NCT00809159|588669261|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
162991117|NCT00809159|588669262|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
162991118|NCT00809159|588669263|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
162991119|NCT00809159|588669258|FG000|Part 1 and 2|Administrative problems|0|||
162991120|NCT00809159|588669259|FG001|Part 1 and 2|Administrative problems|0|||
162991121|NCT00809159|588669260|FG002|Part 1 and 2|Administrative problems|0|||
162991122|NCT00809159|588669261|FG003|Part 1 and 2|Administrative problems|1|||
162991123|NCT00809159|588669262|FG004|Part 1 and 2|Administrative problems|0|||
162991124|NCT00809159|588669263|FG005|Part 1 and 2|Administrative problems|0|||
162991125|NCT00809159|588669258|FG000|Part 1 and 2|Adverse Event|0|||
162991126|NCT00809159|588669259|FG001|Part 1 and 2|Adverse Event|0|||
162991127|NCT00809159|588669260|FG002|Part 1 and 2|Adverse Event|1|||
162991128|NCT00809159|588669261|FG003|Part 1 and 2|Adverse Event|0|||
162991129|NCT00809159|588669262|FG004|Part 1 and 2|Adverse Event|1|||
162991130|NCT00809159|588669263|FG005|Part 1 and 2|Adverse Event|1|||
162991131|NCT00809159|588669258|FG000|Part 1 and 2|Lost to Follow-up|0|||
162991132|NCT00809159|588669259|FG001|Part 1 and 2|Lost to Follow-up|0|||
162991133|NCT00809159|588669260|FG002|Part 1 and 2|Lost to Follow-up|1|||
162991134|NCT00809159|588669261|FG003|Part 1 and 2|Lost to Follow-up|1|||
162991135|NCT00809159|588669262|FG004|Part 1 and 2|Lost to Follow-up|0|||
162991136|NCT00809159|588669263|FG005|Part 1 and 2|Lost to Follow-up|0|||
162991137|NCT00809159|588669258|FG000|Part 1 and 2|Withdrawal by Subject|0|||
162991138|NCT00809159|588669259|FG001|Part 1 and 2|Withdrawal by Subject|0|||
162991139|NCT00809159|588669260|FG002|Part 1 and 2|Withdrawal by Subject|4|||
162991140|NCT00809159|588669261|FG003|Part 1 and 2|Withdrawal by Subject|0|||
162991141|NCT00809159|588669262|FG004|Part 1 and 2|Withdrawal by Subject|0|||
162991142|NCT00809159|588669263|FG005|Part 1 and 2|Withdrawal by Subject|1|||
162991143|NCT03918109|588669268|FG000|Overall Study|Withdrawal by Subject|0|||
162991144|NCT03918109|588669269|FG001|Overall Study|Withdrawal by Subject|0|||
162991145|NCT03918109|588669270|FG002|Overall Study|Withdrawal by Subject|2|||
162991146|NCT03918109|588669271|FG003|Overall Study|Withdrawal by Subject|1|||
162636807|NCT01958008|587384327|FG002|Overall Study|Worsening of disease under study|1|||
162636808|NCT01958008|587384328|FG003|Overall Study|Worsening of disease under study|0|||
162636809|NCT01958008|587384325|FG000|Overall Study|Other adverse event|1|||
162991147|NCT03918109|588669268|FG000|Overall Study|Lost to Follow-up|0|||
162991148|NCT03918109|588669269|FG001|Overall Study|Lost to Follow-up|0|||
162991149|NCT03918109|588669270|FG002|Overall Study|Lost to Follow-up|0|||
162991150|NCT03918109|588669271|FG003|Overall Study|Lost to Follow-up|1|||
162991151|NCT03050060|588669276|FG000|Overall Study|Adverse Event|7|||
162991152|NCT03050060|588669276|FG000|Overall Study|Withdrawal by Subject|1|||
162991153|NCT03050060|588669276|FG000|Overall Study|Progression|7|||
162991154|NCT04568031|588669277|FG000|Overall Study|Lost to Follow-up|1|||
162991155|NCT04568031|588669278|FG001|Overall Study|Lost to Follow-up|0|||
162991156|NCT04568031|588669279|FG002|Overall Study|Lost to Follow-up|0|||
162991157|NCT04568031|588669280|FG003|Overall Study|Lost to Follow-up|0|||
162991158|NCT04568031|588669277|FG000|Overall Study|Physician Decision|1|||
162991159|NCT04568031|588669278|FG001|Overall Study|Physician Decision|0|||
162991160|NCT04568031|588669279|FG002|Overall Study|Physician Decision|1|||
162991161|NCT04568031|588669280|FG003|Overall Study|Physician Decision|0|||
162991162|NCT04568031|588669277|FG000|Overall Study|Withdrawal by Subject|1|||
162991163|NCT04568031|588669278|FG001|Overall Study|Withdrawal by Subject|0|||
162991164|NCT04568031|588669279|FG002|Overall Study|Withdrawal by Subject|4|||
162991165|NCT04568031|588669280|FG003|Overall Study|Withdrawal by Subject|1|||
162991166|NCT02304458|588669281|FG000|Overall Study|Adverse Event|0|||
162991167|NCT02304458|588669282|FG001|Overall Study|Adverse Event|0|||
162991168|NCT02304458|588669283|FG002|Overall Study|Adverse Event|7|||
162991169|NCT02304458|588669284|FG003|Overall Study|Adverse Event|0|||
162991170|NCT02304458|588669285|FG004|Overall Study|Adverse Event|0|||
162991171|NCT02304458|588669286|FG005|Overall Study|Adverse Event|0|||
162991172|NCT02304458|588669287|FG006|Overall Study|Adverse Event|3|||
162991173|NCT02304458|588669288|FG007|Overall Study|Adverse Event|4|||
162991174|NCT02304458|588669281|FG000|Overall Study|Death|0|||
162991175|NCT02304458|588669282|FG001|Overall Study|Death|0|||
162991176|NCT02304458|588669283|FG002|Overall Study|Death|2|||
162991177|NCT02304458|588669284|FG003|Overall Study|Death|0|||
162991178|NCT02304458|588669285|FG004|Overall Study|Death|0|||
162636810|NCT01958008|587384326|FG001|Overall Study|Other adverse event|0|||
162636811|NCT01958008|587384327|FG002|Overall Study|Other adverse event|0|||
162636812|NCT01958008|587384328|FG003|Overall Study|Other adverse event|0|||
162636813|NCT01414855|587384329|FG000|Overall Study|Death|17|||
162991179|NCT02304458|588669286|FG005|Overall Study|Death|0|||
162991180|NCT02304458|588669287|FG006|Overall Study|Death|1|||
162991181|NCT02304458|588669288|FG007|Overall Study|Death|0|||
162991182|NCT02304458|588669281|FG000|Overall Study|Lack of Efficacy|4|||
162991183|NCT02304458|588669282|FG001|Overall Study|Lack of Efficacy|6|||
162991184|NCT02304458|588669283|FG002|Overall Study|Lack of Efficacy|38|||
162991185|NCT02304458|588669284|FG003|Overall Study|Lack of Efficacy|5|||
162991186|NCT02304458|588669285|FG004|Overall Study|Lack of Efficacy|6|||
162991187|NCT02304458|588669286|FG005|Overall Study|Lack of Efficacy|6|||
162991188|NCT02304458|588669287|FG006|Overall Study|Lack of Efficacy|21|||
162991189|NCT02304458|588669288|FG007|Overall Study|Lack of Efficacy|4|||
162991190|NCT02304458|588669281|FG000|Overall Study|Physician Decision|2|||
162991191|NCT02304458|588669282|FG001|Overall Study|Physician Decision|0|||
162991192|NCT02304458|588669283|FG002|Overall Study|Physician Decision|16|||
162991193|NCT02304458|588669284|FG003|Overall Study|Physician Decision|1|||
162991194|NCT02304458|588669285|FG004|Overall Study|Physician Decision|0|||
162991195|NCT02304458|588669286|FG005|Overall Study|Physician Decision|0|||
162991196|NCT02304458|588669287|FG006|Overall Study|Physician Decision|3|||
162991197|NCT02304458|588669288|FG007|Overall Study|Physician Decision|0|||
162991198|NCT02304458|588669281|FG000|Overall Study|Protocol Violation|0|||
162991199|NCT02304458|588669282|FG001|Overall Study|Protocol Violation|0|||
162991200|NCT02304458|588669283|FG002|Overall Study|Protocol Violation|1|||
162991201|NCT02304458|588669284|FG003|Overall Study|Protocol Violation|0|||
162991202|NCT02304458|588669285|FG004|Overall Study|Protocol Violation|0|||
162991203|NCT02304458|588669286|FG005|Overall Study|Protocol Violation|0|||
162991204|NCT02304458|588669287|FG006|Overall Study|Protocol Violation|0|||
162991205|NCT02304458|588669288|FG007|Overall Study|Protocol Violation|0|||
162991206|NCT02304458|588669281|FG000|Overall Study|Withdrawal by Subject|1|||
162991207|NCT02304458|588669282|FG001|Overall Study|Withdrawal by Subject|0|||
162991208|NCT02304458|588669283|FG002|Overall Study|Withdrawal by Subject|7|||
162991209|NCT02304458|588669284|FG003|Overall Study|Withdrawal by Subject|0|||
162991210|NCT02304458|588669285|FG004|Overall Study|Withdrawal by Subject|0|||
162991211|NCT02304458|588669286|FG005|Overall Study|Withdrawal by Subject|0|||
162991212|NCT02304458|588669287|FG006|Overall Study|Withdrawal by Subject|1|||
162991213|NCT02304458|588669288|FG007|Overall Study|Withdrawal by Subject|0|||
162991214|NCT00186043|588669289|FG000|Overall Study|Lack of Efficacy|1|||
162991215|NCT00186043|588669290|FG001|Overall Study|Lack of Efficacy|3|||
162991216|NCT00186043|588669289|FG000|Overall Study|Lost to Follow-up|4|||
162991217|NCT00186043|588669290|FG001|Overall Study|Lost to Follow-up|6|||
162991218|NCT00186043|588669289|FG000|Overall Study|Withdrawal by Subject|1|||
162991219|NCT00186043|588669290|FG001|Overall Study|Withdrawal by Subject|0|||
162991220|NCT00186043|588669289|FG000|Overall Study|Adverse Event|7|||
162991221|NCT00186043|588669290|FG001|Overall Study|Adverse Event|3|||
162991222|NCT00186043|588669289|FG000|Overall Study|Protocol Violation|2|||
162991223|NCT00186043|588669290|FG001|Overall Study|Protocol Violation|1|||
162991224|NCT04874636|588669291|FG000|Overall Study|Adverse Event|17|||
162991225|NCT04874636|588669292|FG001|Overall Study|Adverse Event|7|||
162991226|NCT04874636|588669291|FG000|Overall Study|Lost to Follow-up|1|||
162991227|NCT04874636|588669292|FG001|Overall Study|Lost to Follow-up|0|||
162991228|NCT04874636|588669291|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162991229|NCT04874636|588669292|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162991230|NCT04874636|588669291|FG000|Overall Study|Physician Decision|1|||
162991231|NCT04874636|588669292|FG001|Overall Study|Physician Decision|0|||
162991232|NCT04874636|588669291|FG000|Overall Study|Withdrawal by Subject|6|||
162991233|NCT04874636|588669292|FG001|Overall Study|Withdrawal by Subject|5|||
162991234|NCT04188301|588669295|FG000|Month 3|Lost to Follow-up|0|||
162991235|NCT04188301|588669296|FG001|Month 3|Lost to Follow-up|0|||
162991236|NCT04188301|588669297|FG002|Month 3|Lost to Follow-up|1|||
162991237|NCT04188301|588669295|FG000|Month 12|Lost to Follow-up|0|||
162991238|NCT04188301|588669296|FG001|Month 12|Lost to Follow-up|0|||
162991239|NCT04188301|588669297|FG002|Month 12|Lost to Follow-up|2|||
162991240|NCT04188301|588669295|FG000|Month 12|Death|1|||
162991241|NCT04188301|588669296|FG001|Month 12|Death|1|||
162991242|NCT04188301|588669297|FG002|Month 12|Death|0|||
162991243|NCT04188301|588669295|FG000|Month 18|Lost to Follow-up|6|||
162991244|NCT04188301|588669296|FG001|Month 18|Lost to Follow-up|0|||
162991245|NCT04188301|588669297|FG002|Month 18|Lost to Follow-up|0|||
162991246|NCT02582866|588669302|FG000|Overall Study|Death|1|||
162991247|NCT02582866|588669302|FG000|Overall Study|Lack of Efficacy|2|||
162991248|NCT02582866|588669302|FG000|Overall Study|Lost to Follow-up|2|||
162991249|NCT02582866|588669302|FG000|Overall Study|Withdrawal by Subject|7|||
162991250|NCT02582866|588669302|FG000|Overall Study|Investigator decision|5|||
162991251|NCT02582866|588669302|FG000|Overall Study|Participant wants to get pregnant|1|||
162991252|NCT02582866|588669302|FG000|Overall Study|Pregnancy|2|||
162991253|NCT02582866|588669302|FG000|Overall Study|Sponsor decision|1|||
162991254|NCT02582866|588669302|FG000|Overall Study|Withdrawal due to personal reasons|1|||
162991255|NCT03567382|588669303|FG000|Overall Study|Lost to Follow-up|1|||
162991256|NCT03567382|588669304|FG001|Overall Study|Lost to Follow-up|21|||
162991257|NCT03567382|588669305|FG002|Overall Study|Lost to Follow-up|1|||
162991258|NCT03567382|588669306|FG003|Overall Study|Lost to Follow-up|21|||
162991259|NCT03567382|588669303|FG000|Overall Study|Withdrawal by Subject|2|||
162991260|NCT03567382|588669304|FG001|Overall Study|Withdrawal by Subject|14|||
162991261|NCT03567382|588669305|FG002|Overall Study|Withdrawal by Subject|1|||
162991262|NCT03567382|588669306|FG003|Overall Study|Withdrawal by Subject|12|||
162991263|NCT03246646|588669311|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
162991264|NCT03246646|588669312|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
162991265|NCT03246646|588669311|FG000|Overall Study|Withdrawal by Subject|3|||
162991266|NCT03246646|588669312|FG001|Overall Study|Withdrawal by Subject|0|||
162991267|NCT03246646|588669311|FG000|Overall Study|Lost to Follow-up|7|||
162991268|NCT03246646|588669312|FG001|Overall Study|Lost to Follow-up|0|||
162991269|NCT00319982|588669315|FG000|Overall Study|Withdrawal by Subject|1|||
162991270|NCT00319982|588669316|FG001|Overall Study|Withdrawal by Subject|0|||
162991271|NCT00758680|588669317|FG000|Overall Study|Adverse Event|0|||
162991272|NCT00758680|588669318|FG001|Overall Study|Adverse Event|0|||
162991273|NCT00758680|588669319|FG002|Overall Study|Adverse Event|0|||
162991274|NCT00758680|588669320|FG003|Overall Study|Adverse Event|0|||
162991275|NCT00758680|588669321|FG004|Overall Study|Adverse Event|0|||
162991276|NCT00758680|588669322|FG005|Overall Study|Adverse Event|0|||
162991277|NCT00758680|588669323|FG006|Overall Study|Adverse Event|0|||
162991278|NCT00758680|588669324|FG007|Overall Study|Adverse Event|1|||
162991279|NCT00758680|588669325|FG008|Overall Study|Adverse Event|0|||
162991280|NCT00758680|588669326|FG009|Overall Study|Adverse Event|1|||
162991281|NCT00758680|588669317|FG000|Overall Study|Laboratory Adverse Event|0|||
162991282|NCT00758680|588669318|FG001|Overall Study|Laboratory Adverse Event|0|||
162991283|NCT00758680|588669319|FG002|Overall Study|Laboratory Adverse Event|0|||
162991284|NCT00758680|588669320|FG003|Overall Study|Laboratory Adverse Event|0|||
162991285|NCT00758680|588669321|FG004|Overall Study|Laboratory Adverse Event|0|||
162991286|NCT00758680|588669322|FG005|Overall Study|Laboratory Adverse Event|0|||
162991287|NCT00758680|588669323|FG006|Overall Study|Laboratory Adverse Event|0|||
162991288|NCT00758680|588669324|FG007|Overall Study|Laboratory Adverse Event|0|||
162991289|NCT00758680|588669325|FG008|Overall Study|Laboratory Adverse Event|1|||
162991290|NCT00758680|588669326|FG009|Overall Study|Laboratory Adverse Event|0|||
162991291|NCT00758680|588669317|FG000|Overall Study|Withdrawal by Subject|0|||
162991292|NCT00758680|588669318|FG001|Overall Study|Withdrawal by Subject|0|||
162991293|NCT00758680|588669319|FG002|Overall Study|Withdrawal by Subject|0|||
162991294|NCT00758680|588669320|FG003|Overall Study|Withdrawal by Subject|0|||
162991295|NCT00758680|588669321|FG004|Overall Study|Withdrawal by Subject|0|||
162991296|NCT00758680|588669322|FG005|Overall Study|Withdrawal by Subject|0|||
162991297|NCT00758680|588669323|FG006|Overall Study|Withdrawal by Subject|1|||
162991298|NCT00758680|588669324|FG007|Overall Study|Withdrawal by Subject|0|||
162991299|NCT00758680|588669325|FG008|Overall Study|Withdrawal by Subject|1|||
162991300|NCT00758680|588669326|FG009|Overall Study|Withdrawal by Subject|0|||
162991301|NCT03480386|588669327|FG000|Overall Study|Did not complete measures at 3-months|17|||
162991302|NCT03480386|588669328|FG001|Overall Study|Did not complete measures at 3-months|14|||
162991303|NCT03480386|588669327|FG000|Overall Study|No baseline measures|11|||
162991304|NCT03480386|588669328|FG001|Overall Study|No baseline measures|14|||
162991305|NCT03480386|588669327|FG000|Overall Study|Death|0|||
162991306|NCT03480386|588669328|FG001|Overall Study|Death|5|||
162991307|NCT03480386|588669327|FG000|Overall Study|Withdrawal by Subject|12|||
162991308|NCT03480386|588669328|FG001|Overall Study|Withdrawal by Subject|8|||
162991309|NCT03480386|588669327|FG000|Overall Study|Lost to Follow-up|2|||
162991310|NCT03480386|588669328|FG001|Overall Study|Lost to Follow-up|1|||
162991311|NCT03480386|588669327|FG000|Overall Study|Complicating disease|0|||
162991312|NCT03480386|588669328|FG001|Overall Study|Complicating disease|1|||
162991313|NCT03480386|588669327|FG000|Overall Study|Disease progression|3|||
162991314|NCT03480386|588669328|FG001|Overall Study|Disease progression|0|||
162991315|NCT03480386|588669327|FG000|Overall Study|Became ineligible|0|||
162991316|NCT03480386|588669328|FG001|Overall Study|Became ineligible|2|||
162991317|NCT02201290|588669329|FG000|Overall Study|Withdrawal by Subject|2|||
162991318|NCT02201290|588669329|FG000|Overall Study|Lack of Efficacy|2|||
162991319|NCT02201290|588669329|FG000|Overall Study|Adverse Event|1|||
162991320|NCT04639713|588669330|FG000|Overall Study|Protocol Noncompliance|2|||
162991321|NCT04639713|588669330|FG000|Overall Study|Withdrawal by Subject|1|||
162991322|NCT03589768|588670667|FG000|Overall Study|Death|1|||
162991323|NCT03589768|588670668|FG001|Overall Study|Death|0|||
162991324|NCT03589768|588670669|FG002|Overall Study|Death|8|||
162991325|NCT03589768|588670670|FG003|Overall Study|Death|3|||
162991326|NCT03589768|588670667|FG000|Overall Study|Withdrawal by Subject|2|||
162991327|NCT03589768|588670668|FG001|Overall Study|Withdrawal by Subject|0|||
162991328|NCT03589768|588670669|FG002|Overall Study|Withdrawal by Subject|0|||
162991329|NCT03589768|588670670|FG003|Overall Study|Withdrawal by Subject|0|||
162991330|NCT03589768|588670667|FG000|Overall Study|Protocol Violation|1|||
162991331|NCT03589768|588670668|FG001|Overall Study|Protocol Violation|0|||
162991332|NCT03589768|588670669|FG002|Overall Study|Protocol Violation|0|||
162991333|NCT03589768|588670670|FG003|Overall Study|Protocol Violation|0|||
162636814|NCT01414855|587384329|FG000|Overall Study|Lost to Follow-up|5|||
162991334|NCT04241315|588670676|FG000|Overall Study|Withdrawal by Subject|0|||
162991335|NCT04241315|588670677|FG001|Overall Study|Withdrawal by Subject|1|||
162991336|NCT03047330|588670678|FG000|Sleep Block 1|Withdrawal by Subject|3|||
162991337|NCT00663026|588670685|FG000|Overall Study|Lost to Follow-up|1|||
162991338|NCT00663026|588670686|FG001|Overall Study|Lost to Follow-up|0|||
162991339|NCT00663026|588670687|FG002|Overall Study|Lost to Follow-up|0|||
162991340|NCT00663026|588670685|FG000|Overall Study|Other|1|||
162991341|NCT00663026|588670686|FG001|Overall Study|Other|2|||
162991342|NCT00663026|588670687|FG002|Overall Study|Other|0|||
162991343|NCT00663026|588670685|FG000|Overall Study|Adverse Event|0|||
162991344|NCT00663026|588670686|FG001|Overall Study|Adverse Event|2|||
162991345|NCT00663026|588670687|FG002|Overall Study|Adverse Event|3|||
162991346|NCT00663026|588670685|FG000|Overall Study|Caregiver Request|0|||
162991347|NCT00663026|588670686|FG001|Overall Study|Caregiver Request|2|||
162991348|NCT00663026|588670687|FG002|Overall Study|Caregiver Request|0|||
162991349|NCT00663026|588670685|FG000|Overall Study|Withdrawal by Subject|0|||
162991350|NCT00663026|588670686|FG001|Overall Study|Withdrawal by Subject|0|||
162991351|NCT00663026|588670687|FG002|Overall Study|Withdrawal by Subject|1|||
162991352|NCT01392963|588670691|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
162991353|NCT01392963|588670692|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
162991354|NCT01392963|588670691|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
162991355|NCT01392963|588670692|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
162991356|NCT01392963|588670691|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
162991357|NCT01392963|588670692|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
162991358|NCT03783039|588670693|FG000|Overall Study|Death|2|||
162991359|NCT03783039|588670694|FG001|Overall Study|Death|1|||
162991360|NCT02006693|588670695|FG000|Overall Study|No Reason Specified|6|||
162991361|NCT02006693|588670696|FG001|Overall Study|No Reason Specified|8|||
162991362|NCT02006693|588670695|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
162991363|NCT02006693|588670696|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
162991364|NCT02006693|588670695|FG000|Overall Study|XEN Implant Explantation|0|||
162991365|NCT02006693|588670696|FG001|Overall Study|XEN Implant Explantation|1|||
162991366|NCT02006693|588670695|FG000|Overall Study|Death|2|||
162991367|NCT02006693|588670696|FG001|Overall Study|Death|2|||
162991368|NCT02006693|588670695|FG000|Overall Study|Lost to Follow-up|4|||
162991369|NCT02006693|588670696|FG001|Overall Study|Lost to Follow-up|1|||
162991370|NCT02006693|588670695|FG000|Overall Study|Patient Decision|4|||
162991371|NCT02006693|588670696|FG001|Overall Study|Patient Decision|0|||
162991372|NCT01119508|588670697|FG000|Overall Study|Adverse Event|56|||
162991373|NCT01119508|588670697|FG000|Overall Study|Withdrawal by Subject|2|||
162991374|NCT01119508|588670697|FG000|Overall Study|Died before tumor response evaluation|1|||
162991375|NCT00837473|588670700|FG000|Overall Study|Lost to Follow-up|1|||
162991376|NCT00837473|588670700|FG000|Overall Study|Withdrawal by Subject|2|||
162991377|NCT02563106|588670701|FG000|Overall Study|Withdrawal by Subject|7|||
162991378|NCT02563106|588670702|FG001|Overall Study|Withdrawal by Subject|8|||
162991379|NCT02563106|588670701|FG000|Overall Study|Adverse Event|17|||
162991380|NCT02563106|588670702|FG001|Overall Study|Adverse Event|15|||
162991381|NCT02563106|588670701|FG000|Overall Study|Protocol Violation|1|||
162991382|NCT02563106|588670702|FG001|Overall Study|Protocol Violation|0|||
162991383|NCT02563106|588670701|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
162991384|NCT02563106|588670702|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
162991385|NCT02563106|588670701|FG000|Overall Study|Lost to Follow-up|3|||
162991386|NCT02563106|588670702|FG001|Overall Study|Lost to Follow-up|2|||
162991387|NCT02563106|588670701|FG000|Overall Study|Physician Decision|3|||
162991388|NCT02563106|588670702|FG001|Overall Study|Physician Decision|1|||
162991389|NCT02563106|588670701|FG000|Overall Study|Other reason - not specified|2|||
162991390|NCT02563106|588670702|FG001|Overall Study|Other reason - not specified|1|||
162991391|NCT02338193|588670703|FG000|Overall Study|Withdrawal by Subject|0|||
162991392|NCT02338193|588670704|FG001|Overall Study|Withdrawal by Subject|0|||
162991393|NCT02338193|588670705|FG002|Overall Study|Withdrawal by Subject|2|||
162991394|NCT02338193|588670703|FG000|Overall Study|Pregnancy|0|||
162991395|NCT02338193|588670704|FG001|Overall Study|Pregnancy|1|||
162991396|NCT02338193|588670705|FG002|Overall Study|Pregnancy|1|||
162991397|NCT02338193|588670703|FG000|Overall Study|Noncompliant with visits|2|||
162991398|NCT02338193|588670704|FG001|Overall Study|Noncompliant with visits|2|||
162991399|NCT02338193|588670705|FG002|Overall Study|Noncompliant with visits|7|||
162991400|NCT02338193|588670703|FG000|Overall Study|moved out of state|0|||
162991401|NCT02338193|588670704|FG001|Overall Study|moved out of state|1|||
162991402|NCT02338193|588670705|FG002|Overall Study|moved out of state|0|||
162991403|NCT02338193|588670703|FG000|Overall Study|intolerant of side effects|1|||
162991404|NCT02338193|588670704|FG001|Overall Study|intolerant of side effects|0|||
162991405|NCT02338193|588670705|FG002|Overall Study|intolerant of side effects|0|||
162991406|NCT01136967|588670710|FG000|Overall Study|Adverse Event|9|||
162991407|NCT01136967|588670711|FG001|Overall Study|Adverse Event|12|||
162991408|NCT01136967|588670710|FG000|Overall Study|Participant Choice|8|||
162991409|NCT01136967|588670711|FG001|Overall Study|Participant Choice|3|||
162991410|NCT01136967|588670710|FG000|Overall Study|Lost to Follow-up|0|||
162991411|NCT01136967|588670711|FG001|Overall Study|Lost to Follow-up|1|||
162991412|NCT01136967|588670710|FG000|Overall Study|Withdrawal by Subject|1|||
162991413|NCT01136967|588670711|FG001|Overall Study|Withdrawal by Subject|2|||
162636815|NCT01414855|587384329|FG000|Overall Study|Withdrawal by Subject|7|||
162991414|NCT01136967|588670710|FG000|Overall Study|Clinical Progression|3|||
162991415|NCT01136967|588670711|FG001|Overall Study|Clinical Progression|5|||
162991416|NCT01136967|588670710|FG000|Overall Study|Radiation|1|||
162991417|NCT01136967|588670711|FG001|Overall Study|Radiation|0|||
162991418|NCT01136967|588670710|FG000|Overall Study|Non-compliance|1|||
162991419|NCT01136967|588670711|FG001|Overall Study|Non-compliance|0|||
162991420|NCT01136967|588670710|FG000|Overall Study|Investigator's Choice|1|||
162991421|NCT01136967|588670711|FG001|Overall Study|Investigator's Choice|1|||
162991422|NCT01136967|588670710|FG000|Overall Study|Increase in Lesion Size|0|||
162991423|NCT01136967|588670711|FG001|Overall Study|Increase in Lesion Size|2|||
162991424|NCT01136967|588670710|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
162991425|NCT01136967|588670711|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
162991426|NCT01735955|588670712|FG000|Overall Study|Administrative problems|1|||
162991427|NCT01735955|588670712|FG000|Overall Study|Patient/guardian decision|1|||
162991428|NCT01735955|588670712|FG000|Overall Study|Patient withdrew consent|2|||
162991429|NCT01735955|588670712|FG000|Overall Study|Physician Decision|4|||
162991430|NCT01735955|588670712|FG000|Overall Study|Disease progression|24|||
162991431|NCT01735955|588670712|FG000|Overall Study|Adverse Event|5|||
162991432|NCT03317834|588670713|FG000|Overall Study|Death|2|||
162991433|NCT03317834|588670713|FG000|Overall Study|Device Revision|5|||
162991434|NCT03317834|588670713|FG000|Overall Study|Withdrawal by Subject|13|||
162991435|NCT03317834|588670713|FG000|Overall Study|Lost to Follow-up|13|||
162991436|NCT03839823|588670717|FG000|Overall Study|Adverse Event|8|||
162991437|NCT03839823|588670718|FG001|Overall Study|Adverse Event|4|||
162991438|NCT03839823|588670717|FG000|Overall Study|Death|1|||
162991439|NCT03839823|588670718|FG001|Overall Study|Death|0|||
162991440|NCT03839823|588670717|FG000|Overall Study|Physician Decision|1|||
162991441|NCT03839823|588670718|FG001|Overall Study|Physician Decision|5|||
162991442|NCT03839823|588670717|FG000|Overall Study|Progressive Disease (PD)|65|||
162991443|NCT03839823|588670718|FG001|Overall Study|Progressive Disease (PD)|65|||
162991444|NCT03839823|588670717|FG000|Overall Study|Subject Decision|2|||
162991445|NCT03839823|588670718|FG001|Overall Study|Subject Decision|9|||
162991446|NCT03839823|588670717|FG000|Overall Study|Not Treated|0|||
162991447|NCT03839823|588670718|FG001|Overall Study|Not Treated|10|||
162991448|NCT01716715|588670719|FG000|Overall Study|Never Treated|2|||
162991449|NCT01716715|588670720|FG001|Overall Study|Never Treated|4|||
162991450|NCT04228783|588670721|FG000|Overall Study|Adverse Event|1|||
162991451|NCT04228783|588670722|FG001|Overall Study|Adverse Event|0|||
162991452|NCT04228783|588670723|FG002|Overall Study|Adverse Event|2|||
162991453|NCT04228783|588670724|FG003|Overall Study|Adverse Event|0|||
162991454|NCT04228783|588670725|FG004|Overall Study|Adverse Event|0|||
162991455|NCT04228783|588670726|FG005|Overall Study|Adverse Event|1|||
162991456|NCT04228783|588670721|FG000|Overall Study|Death|0|||
162991457|NCT04228783|588670722|FG001|Overall Study|Death|0|||
162991458|NCT04228783|588670723|FG002|Overall Study|Death|0|||
162991459|NCT04228783|588670724|FG003|Overall Study|Death|0|||
162991460|NCT04228783|588670725|FG004|Overall Study|Death|1|||
162991461|NCT04228783|588670726|FG005|Overall Study|Death|0|||
162991462|NCT04228783|588670721|FG000|Overall Study|Lost to Follow-up|36|||
162991463|NCT04228783|588670722|FG001|Overall Study|Lost to Follow-up|36|||
162991464|NCT04228783|588670723|FG002|Overall Study|Lost to Follow-up|28|||
162991465|NCT04228783|588670724|FG003|Overall Study|Lost to Follow-up|6|||
162991466|NCT04228783|588670725|FG004|Overall Study|Lost to Follow-up|14|||
162991467|NCT04228783|588670726|FG005|Overall Study|Lost to Follow-up|3|||
162991468|NCT04228783|588670721|FG000|Overall Study|Physician Decision|1|||
162991469|NCT04228783|588670722|FG001|Overall Study|Physician Decision|2|||
162991470|NCT04228783|588670723|FG002|Overall Study|Physician Decision|0|||
162991471|NCT04228783|588670724|FG003|Overall Study|Physician Decision|0|||
162991472|NCT04228783|588670725|FG004|Overall Study|Physician Decision|0|||
162991473|NCT04228783|588670726|FG005|Overall Study|Physician Decision|0|||
162991474|NCT04228783|588670721|FG000|Overall Study|Protocol Violation|0|||
162991475|NCT04228783|588670722|FG001|Overall Study|Protocol Violation|0|||
162991476|NCT04228783|588670723|FG002|Overall Study|Protocol Violation|0|||
162991477|NCT04228783|588670724|FG003|Overall Study|Protocol Violation|1|||
162991478|NCT04228783|588670725|FG004|Overall Study|Protocol Violation|0|||
162991479|NCT04228783|588670726|FG005|Overall Study|Protocol Violation|0|||
162991480|NCT04228783|588670721|FG000|Overall Study|Withdrawal by Subject|6|||
162991481|NCT04228783|588670722|FG001|Overall Study|Withdrawal by Subject|10|||
162991482|NCT04228783|588670723|FG002|Overall Study|Withdrawal by Subject|19|||
162991483|NCT04228783|588670724|FG003|Overall Study|Withdrawal by Subject|1|||
162991484|NCT04228783|588670725|FG004|Overall Study|Withdrawal by Subject|2|||
162991485|NCT04228783|588670726|FG005|Overall Study|Withdrawal by Subject|0|||
162991486|NCT04228783|588670721|FG000|Overall Study|Other|4|||
162991487|NCT04228783|588670722|FG001|Overall Study|Other|3|||
162991488|NCT04228783|588670723|FG002|Overall Study|Other|2|||
162715635|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
162991489|NCT04228783|588670724|FG003|Overall Study|Other|1|||
162991490|NCT04228783|588670725|FG004|Overall Study|Other|0|||
162991491|NCT04228783|588670726|FG005|Overall Study|Other|0|||
162991492|NCT00626392|588670727|FG000|Run-in Period|Adverse Event|0|||
162991493|NCT00626392|588670728|FG001|Run-in Period|Adverse Event|0|||
162991494|NCT00626392|588670729|FG002|Run-in Period|Adverse Event|1|||
162991495|NCT00626392|588670730|FG003|Run-in Period|Adverse Event|0|||
162991496|NCT00626392|588670731|FG004|Run-in Period|Adverse Event|1|||
162991497|NCT00626392|588670732|FG005|Run-in Period|Adverse Event|0|||
162991498|NCT00626392|588670727|FG000|Run-in Period|Withdrawal by Subject|0|||
162991499|NCT00626392|588670728|FG001|Run-in Period|Withdrawal by Subject|1|||
162991500|NCT00626392|588670729|FG002|Run-in Period|Withdrawal by Subject|1|||
162991501|NCT00626392|588670730|FG003|Run-in Period|Withdrawal by Subject|1|||
162991502|NCT00626392|588670731|FG004|Run-in Period|Withdrawal by Subject|3|||
162991503|NCT00626392|588670732|FG005|Run-in Period|Withdrawal by Subject|1|||
162991504|NCT00626392|588670727|FG000|Run-in Period|Noncompliance|1|||
162991505|NCT00626392|588670728|FG001|Run-in Period|Noncompliance|0|||
162991506|NCT00626392|588670729|FG002|Run-in Period|Noncompliance|1|||
162991507|NCT00626392|588670730|FG003|Run-in Period|Noncompliance|0|||
162991508|NCT00626392|588670731|FG004|Run-in Period|Noncompliance|0|||
162991509|NCT00626392|588670732|FG005|Run-in Period|Noncompliance|0|||
162991510|NCT00626392|588670727|FG000|Coadministration Period|Adverse Event|3|||
162991511|NCT00626392|588670728|FG001|Coadministration Period|Adverse Event|1|||
162991512|NCT00626392|588670729|FG002|Coadministration Period|Adverse Event|7|||
162991513|NCT00626392|588670730|FG003|Coadministration Period|Adverse Event|4|||
162991514|NCT00626392|588670731|FG004|Coadministration Period|Adverse Event|3|||
162991515|NCT00626392|588670732|FG005|Coadministration Period|Adverse Event|4|||
162991516|NCT00626392|588670727|FG000|Coadministration Period|Withdrawal by Subject|1|||
162991517|NCT00626392|588670728|FG001|Coadministration Period|Withdrawal by Subject|1|||
162991518|NCT00626392|588670729|FG002|Coadministration Period|Withdrawal by Subject|0|||
162991519|NCT00626392|588670730|FG003|Coadministration Period|Withdrawal by Subject|1|||
162991520|NCT00626392|588670731|FG004|Coadministration Period|Withdrawal by Subject|0|||
162991521|NCT00626392|588670732|FG005|Coadministration Period|Withdrawal by Subject|1|||
162991522|NCT00626392|588670727|FG000|Coadministration Period|Protocol Violation|0|||
162991523|NCT00626392|588670728|FG001|Coadministration Period|Protocol Violation|1|||
162991524|NCT00626392|588670729|FG002|Coadministration Period|Protocol Violation|0|||
162991525|NCT00626392|588670730|FG003|Coadministration Period|Protocol Violation|1|||
162991526|NCT00626392|588670731|FG004|Coadministration Period|Protocol Violation|1|||
162991527|NCT00626392|588670732|FG005|Coadministration Period|Protocol Violation|0|||
162991528|NCT00626392|588670727|FG000|Coadministration Period|Other|0|||
162991529|NCT00626392|588670728|FG001|Coadministration Period|Other|2|||
162991530|NCT00626392|588670729|FG002|Coadministration Period|Other|3|||
162991531|NCT00626392|588670730|FG003|Coadministration Period|Other|1|||
162991532|NCT00626392|588670731|FG004|Coadministration Period|Other|1|||
162991533|NCT00626392|588670732|FG005|Coadministration Period|Other|1|||
162991534|NCT03327792|588670733|FG000|Overall Study|Adverse Event|4|||
162991535|NCT03327792|588670734|FG001|Overall Study|Adverse Event|0|||
162991536|NCT03327792|588670733|FG000|Overall Study|Family/Personal issues|3|||
162991537|NCT03327792|588670734|FG001|Overall Study|Family/Personal issues|2|||
162991538|NCT03327792|588670733|FG000|Overall Study|Lost to Follow-up|0|||
162991539|NCT03327792|588670734|FG001|Overall Study|Lost to Follow-up|1|||
162991540|NCT04576923|588670735|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
162991541|NCT03151811|588670739|FG000|Overall Study|Randomized But Not Treated|18|||
162991542|NCT03151811|588670740|FG001|Overall Study|Randomized But Not Treated|3|||
162991543|NCT03151811|588670739|FG000|Overall Study|Progressive Disease|130|||
162991544|NCT03151811|588670740|FG001|Overall Study|Progressive Disease|170|||
162991545|NCT03151811|588670739|FG000|Overall Study|Adverse Event|49|||
162991546|NCT03151811|588670740|FG001|Overall Study|Adverse Event|40|||
162991547|NCT03151811|588670739|FG000|Overall Study|Lack of Efficacy|6|||
162991548|NCT03151811|588670740|FG001|Overall Study|Lack of Efficacy|8|||
162991549|NCT03151811|588670739|FG000|Overall Study|Physician Decision|21|||
162991550|NCT03151811|588670740|FG001|Overall Study|Physician Decision|9|||
162991551|NCT03151811|588670739|FG000|Overall Study|Withdrawal by Subject|17|||
162991552|NCT03151811|588670740|FG001|Overall Study|Withdrawal by Subject|7|||
162991553|NCT03151811|588670739|FG000|Overall Study|Lost to Follow-up|0|||
162991554|NCT03151811|588670740|FG001|Overall Study|Lost to Follow-up|1|||
162991555|NCT03151811|588670739|FG000|Overall Study|Study Terminated by Sponsor|5|||
162991556|NCT03151811|588670740|FG001|Overall Study|Study Terminated by Sponsor|11|||
162991557|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
162991558|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
162991559|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
162991560|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
162991561|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
162991562|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
162991563|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
162991564|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
162991565|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
162991566|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
162991567|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Death|1|||
162991568|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Death|0|||
162991569|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Death|0|||
162991570|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Death|0|||
162991571|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Death|0|||
162991572|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
162991573|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
162991574|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
162991575|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
162991576|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
162991577|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991578|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
162991579|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991580|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
162991581|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
162991582|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
162991583|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
162991584|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
162991585|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
162991586|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
162991587|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
162991588|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
162991589|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
162991590|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
162991591|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
162991592|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
162991593|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991594|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991595|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991596|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162991597|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Other|4|||
162991598|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Other|4|||
162991599|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Other|3|||
162991600|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Other|1|||
162991601|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Other|0|||
162991602|NCT01081834|588670745|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
162991603|NCT01081834|588670746|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
162991604|NCT01081834|588670747|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991605|NCT01081834|588670748|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991606|NCT01081834|588670749|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162991607|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
162991608|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991609|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991610|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991611|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
162991612|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Death|1|||
162991613|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Death|0|||
162991614|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Death|0|||
162991615|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Death|0|||
162991616|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Death|0|||
162991617|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
162991618|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
162991619|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162715636|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
162715637|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
162715638|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
162715639|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
162715640|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
162715641|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
162715642|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
162715643|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
162715644|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
162715645|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
162715646|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
162715647|NCT01081145|587667058|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
162715648|NCT01081145|587667059|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
162715649|NCT03593070|587667060|FG000|Overall Study|administrative withdrawal|1|||
162991620|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163059983|NCT00805532|588928277|FG001|Overall Study|invalid data|1|||
162715650|NCT03593070|587667061|FG001|Overall Study|administrative withdrawal|1|||
162715651|NCT03643211|587667062|FG000|Overall Study|Contract violation/deficiency|12|||
162715652|NCT03643211|587667062|FG000|Overall Study|Invalid registration|3|||
162991621|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162991622|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991623|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
162991624|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991625|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991626|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
162991627|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
162991628|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
162991629|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991630|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991631|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162991632|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162991633|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991634|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162991635|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991636|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162991637|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
162991638|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
162991639|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991640|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991641|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
162991642|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Other|4|||
162991643|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Other|5|||
162991644|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Other|4|||
162991645|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Other|0|||
162991646|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Other|0|||
162991647|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
162991648|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
162991649|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991650|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991651|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
162991652|NCT01081834|588670745|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991653|NCT01081834|588670746|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
162991654|NCT01081834|588670747|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991655|NCT01081834|588670748|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991656|NCT01081834|588670749|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162991657|NCT01475097|588670750|FG000|Overall Study|Protocol Violation|1|||
162991658|NCT01475097|588670751|FG001|Overall Study|Protocol Violation|1|||
162991659|NCT04839692|588670752|FG000|Overall Study|Withdrawal by Subject|0|||
162991660|NCT04839692|588670753|FG001|Overall Study|Withdrawal by Subject|3|||
162991661|NCT04839692|588670752|FG000|Overall Study|Physician Decision|1|||
162991662|NCT04839692|588670753|FG001|Overall Study|Physician Decision|0|||
162991663|NCT03511326|588670754|FG000|Overall Study|Withdrawal by Subject|1|||
162991664|NCT00492024|588670755|FG000|Treatment|Adverse Event|3|||
162991665|NCT00492024|588670756|FG001|Treatment|Adverse Event|1|||
162991666|NCT00492024|588670755|FG000|Treatment|Lack of Efficacy|21|||
162991667|NCT00492024|588670756|FG001|Treatment|Lack of Efficacy|20|||
162991668|NCT00492024|588670755|FG000|Treatment|Lost to Follow-up|3|||
162991669|NCT00492024|588670756|FG001|Treatment|Lost to Follow-up|1|||
162991670|NCT00492024|588670755|FG000|Treatment|Withdrawal by Subject|2|||
162991671|NCT00492024|588670756|FG001|Treatment|Withdrawal by Subject|0|||
162991672|NCT00492024|588670755|FG000|Follow up|Lack of Efficacy|0|||
162991673|NCT00492024|588670756|FG001|Follow up|Lack of Efficacy|1|||
162991674|NCT00492024|588670755|FG000|Follow up|Lost to Follow-up|1|||
162991675|NCT00492024|588670756|FG001|Follow up|Lost to Follow-up|1|||
162991676|NCT03247816|588670757|FG000|Overall Study|Adverse Event|12|||
162991677|NCT03247816|588670757|FG000|Overall Study|Physician Decision|3|||
162991678|NCT03247816|588670757|FG000|Overall Study|Lack of Efficacy|1|||
162991679|NCT03247816|588670757|FG000|Overall Study|Lost to Follow-up|10|||
162991680|NCT03247816|588670757|FG000|Overall Study|Missing Feraccru stop date|3|||
162991681|NCT00926783|588670760|FG000|Overall Study|Incomplete CFAE Procedures|3|||
162991682|NCT00926783|588670761|FG001|Overall Study|Incomplete CFAE Procedures|3|||
162991683|NCT01439009|588670762|FG000|Overall Study|Physician Decision|5|||
162991684|NCT01439009|588670763|FG001|Overall Study|Physician Decision|3|||
162991685|NCT01439009|588670762|FG000|Overall Study|Protocol Violation|2|||
162991686|NCT01439009|588670763|FG001|Overall Study|Protocol Violation|0|||
162991687|NCT01439009|588670762|FG000|Overall Study|Deviation of exclusion criteria|1|||
162991688|NCT01439009|588670763|FG001|Overall Study|Deviation of exclusion criteria|0|||
162991689|NCT00696787|588670764|FG000|Overall Study|Adverse Event|1|||
162991690|NCT00696787|588670765|FG001|Overall Study|Adverse Event|0|||
162991691|NCT00696787|588670766|FG002|Overall Study|Adverse Event|6|||
162991692|NCT00696787|588670764|FG000|Overall Study|Discontinuation by Sponsor|9|||
162991693|NCT00696787|588670765|FG001|Overall Study|Discontinuation by Sponsor|13|||
162991694|NCT00696787|588670766|FG002|Overall Study|Discontinuation by Sponsor|14|||
162991695|NCT00696787|588670764|FG000|Overall Study|Lack of Efficacy|0|||
162991696|NCT00696787|588670765|FG001|Overall Study|Lack of Efficacy|1|||
162991697|NCT00696787|588670766|FG002|Overall Study|Lack of Efficacy|0|||
162991698|NCT00696787|588670764|FG000|Overall Study|Lost to Follow-up|4|||
162991699|NCT00696787|588670765|FG001|Overall Study|Lost to Follow-up|0|||
162991700|NCT00696787|588670766|FG002|Overall Study|Lost to Follow-up|3|||
162991701|NCT00696787|588670764|FG000|Overall Study|Withdrawal by Subject|0|||
162991702|NCT00696787|588670765|FG001|Overall Study|Withdrawal by Subject|3|||
162991703|NCT00696787|588670766|FG002|Overall Study|Withdrawal by Subject|2|||
162991704|NCT00696787|588670764|FG000|Overall Study|Failed to return|1|||
162991705|NCT00696787|588670765|FG001|Overall Study|Failed to return|3|||
162991706|NCT00696787|588670766|FG002|Overall Study|Failed to return|1|||
162991707|NCT00867503|588670768|FG000|Overall Study|Withdrawal by Subject|1|||
162991708|NCT02704403|588670769|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
162991709|NCT02704403|588670770|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
162991710|NCT02704403|588670769|FG000|Overall Study|Administrative reasons by sponsor|1251|||
162991711|NCT02704403|588670770|FG001|Overall Study|Administrative reasons by sponsor|616|||
162991712|NCT02704403|588670769|FG000|Overall Study|Death|4|||
162991713|NCT02704403|588670770|FG001|Overall Study|Death|3|||
162991714|NCT02704403|588670769|FG000|Overall Study|Endpoint event|52|||
162991715|NCT02704403|588670770|FG001|Overall Study|Endpoint event|24|||
162991716|NCT02704403|588670769|FG000|Overall Study|Lost to Follow-up|22|||
162991717|NCT02704403|588670770|FG001|Overall Study|Lost to Follow-up|11|||
162991718|NCT02704403|588670769|FG000|Overall Study|Protocol Violation|15|||
162991719|NCT02704403|588670770|FG001|Overall Study|Protocol Violation|15|||
162991720|NCT02704403|588670769|FG000|Overall Study|Adverse Event|2|||
162991721|NCT02704403|588670770|FG001|Overall Study|Adverse Event|0|||
162991722|NCT02704403|588670769|FG000|Overall Study|Withdrawal by Subject|85|||
162991723|NCT02704403|588670770|FG001|Overall Study|Withdrawal by Subject|45|||
162991724|NCT02704403|588670769|FG000|Overall Study|Investigator decision|1|||
162991725|NCT02704403|588670770|FG001|Overall Study|Investigator decision|1|||
162991726|NCT02704403|588670769|FG000|Overall Study|Follow-up not possible|1|||
162991727|NCT02704403|588670770|FG001|Overall Study|Follow-up not possible|2|||
162991728|NCT01844856|588670777|FG000|Overall Study|Lost to Follow-up|15|||
162991729|NCT01844856|588670778|FG001|Overall Study|Lost to Follow-up|3|||
162991730|NCT01844856|588670777|FG000|Overall Study|Adverse Event|3|||
162991731|NCT01844856|588670778|FG001|Overall Study|Adverse Event|6|||
162991732|NCT01844856|588670777|FG000|Overall Study|Withdrawal by Subject|3|||
162991733|NCT01844856|588670778|FG001|Overall Study|Withdrawal by Subject|2|||
162991734|NCT01844856|588670777|FG000|Overall Study|Noncompliance|2|||
162991735|NCT01844856|588670778|FG001|Overall Study|Noncompliance|3|||
162991736|NCT01844856|588670777|FG000|Overall Study|Enterococcus Resistant|0|||
162991737|NCT01844856|588670778|FG001|Overall Study|Enterococcus Resistant|1|||
162991738|NCT01844856|588670777|FG000|Overall Study|Inadvertently Not Scheduled|1|||
162991739|NCT01844856|588670778|FG001|Overall Study|Inadvertently Not Scheduled|0|||
162991740|NCT01844856|588670777|FG000|Overall Study|Randomized but was a Screen Failure|0|||
162991741|NCT01844856|588670778|FG001|Overall Study|Randomized but was a Screen Failure|1|||
162991742|NCT00927394|588670781|FG000|Overall Study|Adverse Event|14|||
162991743|NCT00927394|588670782|FG001|Overall Study|Adverse Event|9|||
162991744|NCT00927394|588670781|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
162991745|NCT00927394|588670782|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
162991746|NCT00927394|588670781|FG000|Overall Study|Withdrawal by Subject|20|||
162991747|NCT00927394|588670782|FG001|Overall Study|Withdrawal by Subject|24|||
162991748|NCT00927394|588670781|FG000|Overall Study|Lost to Follow-up|8|||
162991749|NCT00927394|588670782|FG001|Overall Study|Lost to Follow-up|14|||
162991750|NCT00927394|588670781|FG000|Overall Study|Administrative Problem|1|||
162991751|NCT00927394|588670782|FG001|Overall Study|Administrative Problem|0|||
162991752|NCT00927394|588670781|FG000|Overall Study|Death|1|||
162991753|NCT00927394|588670782|FG001|Overall Study|Death|1|||
162991754|NCT00927394|588670781|FG000|Overall Study|Protocol deviation|16|||
162991755|NCT00927394|588670782|FG001|Overall Study|Protocol deviation|13|||
162991756|NCT00927394|588670781|FG000|Overall Study|Randomized in error|0|||
162991757|NCT00927394|588670782|FG001|Overall Study|Randomized in error|1|||
162991758|NCT01221363|588670783|FG000|Overall Study|Pregnancy|1|||
162991759|NCT01221363|588670784|FG001|Overall Study|Pregnancy|0|||
162991760|NCT01221363|588670783|FG000|Overall Study|Withdrawal by Subject|11|||
162991761|NCT01221363|588670784|FG001|Overall Study|Withdrawal by Subject|5|||
162991762|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
162991763|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
162991764|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
162991765|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
162991766|NCT01756079|588670785|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
162991767|NCT02677714|588670786|FG000|Overall Study|Withdrawal by Subject|2|||
162991768|NCT02677714|588670787|FG001|Overall Study|Withdrawal by Subject|0|||
162991769|NCT01346293|588670792|FG000|Overall Study|Protocol Violation|30|||
162991770|NCT01346293|588670793|FG001|Overall Study|Protocol Violation|9|||
162991771|NCT01346293|588670792|FG000|Overall Study|Lost to Follow-up|21|||
162991772|NCT01346293|588670793|FG001|Overall Study|Lost to Follow-up|8|||
162991773|NCT01346293|588670792|FG000|Overall Study|Withdrawal by Subject|15|||
162991774|NCT01346293|588670793|FG001|Overall Study|Withdrawal by Subject|4|||
162991775|NCT01346293|588670792|FG000|Overall Study|Other|1|||
162991776|NCT01346293|588670793|FG001|Overall Study|Other|0|||
162991777|NCT02387983|588670794|FG000|Overall Study|Adverse Event|4|||
162991778|NCT02387983|588670794|FG000|Overall Study|Protocol Violation|1|||
162991779|NCT02387983|588670794|FG000|Overall Study|Withdrawal by Subject|2|||
162991780|NCT01844505|588670798|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
162991781|NCT01844505|588670799|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
162991782|NCT01844505|588670800|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
162991783|NCT01844505|588670798|FG000|Treatment Period|Other Reasons|120|||
162991784|NCT01844505|588670799|FG001|Treatment Period|Other Reasons|136|||
162991785|NCT01844505|588670800|FG002|Treatment Period|Other Reasons|58|||
162991786|NCT01844505|588670798|FG000|Treatment Period|Lost to Follow-up|9|||
162991787|NCT01844505|588670799|FG001|Treatment Period|Lost to Follow-up|11|||
162991788|NCT01844505|588670800|FG002|Treatment Period|Lost to Follow-up|6|||
162991789|NCT01844505|588670798|FG000|Treatment Period|Death|175|||
162991790|NCT01844505|588670799|FG001|Treatment Period|Death|154|||
162991791|NCT01844505|588670800|FG002|Treatment Period|Death|228|||
162991792|NCT00128830|588670801|FG000|Overall Study|Adverse Event|10|||
162991793|NCT00128830|588670801|FG000|Overall Study|Withdrawal by Subject|14|||
162991794|NCT00128830|588670801|FG000|Overall Study|Lost to Follow-up|4|||
162991795|NCT00128830|588670801|FG000|Overall Study|Reached a virologic endpoint|29|||
162991796|NCT00128830|588670801|FG000|Overall Study|Non-compliant|4|||
162991797|NCT00128830|588670801|FG000|Overall Study|Discontinued or ineligible for study|2|||
162991798|NCT00128830|588670801|FG000|Overall Study|Other|9|||
162991799|NCT02730351|588670802|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
162991800|NCT02730351|588670803|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
162991801|NCT02730351|588670802|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
162991802|NCT02730351|588670803|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
162991803|NCT02730351|588670802|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
162991804|NCT02730351|588670803|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
162991805|NCT02730351|588670802|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
162991806|NCT02730351|588670803|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
162991807|NCT02730351|588670802|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
162991808|NCT02730351|588670803|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
162991809|NCT00311402|588670804|FG000|Overall Study|Adverse Event|118|||
162991810|NCT00311402|588670805|FG001|Overall Study|Adverse Event|105|||
162991811|NCT00311402|588670804|FG000|Overall Study|Lost to Follow-up|0|||
162991812|NCT00311402|588670805|FG001|Overall Study|Lost to Follow-up|3|||
162991813|NCT00311402|588670804|FG000|Overall Study|Withdrawal by Subject|17|||
162991814|NCT00311402|588670805|FG001|Overall Study|Withdrawal by Subject|18|||
162991815|NCT00311402|588670804|FG000|Overall Study|Lack of Efficacy|58|||
163059984|NCT01859741|588928278|FG000|Overall Study|Death|3|||
163059985|NCT01859741|588928279|FG001|Overall Study|Death|2|||
162636816|NCT01937559|587384332|FG000|Overall Study|Physician Decision|3|||
162636817|NCT01937559|587384333|FG001|Overall Study|Physician Decision|3|||
162636818|NCT01937559|587384334|FG002|Overall Study|Physician Decision|0|||
162636819|NCT01937559|587384332|FG000|Overall Study|Withdrawal by Subject|6|||
162636820|NCT01937559|587384333|FG001|Overall Study|Withdrawal by Subject|4|||
162991816|NCT00311402|588670805|FG001|Overall Study|Lack of Efficacy|42|||
162991817|NCT00311402|588670804|FG000|Overall Study|Protocol Violation|7|||
162991818|NCT00311402|588670805|FG001|Overall Study|Protocol Violation|6|||
163059986|NCT01859741|588928280|FG002|Overall Study|Death|4|||
163059987|NCT01859741|588928281|FG003|Overall Study|Death|3|||
162991819|NCT00311402|588670804|FG000|Overall Study|IRB's rejection etc.|10|||
162991820|NCT00311402|588670805|FG001|Overall Study|IRB's rejection etc.|3|||
162991821|NCT02640053|588670806|FG000|Overall Study|Withdrawal by Subject|2|||
162991822|NCT02640053|588670807|FG001|Overall Study|Withdrawal by Subject|1|||
162991823|NCT02640053|588670806|FG000|Overall Study|Adverse Event|1|||
162991824|NCT02640053|588670807|FG001|Overall Study|Adverse Event|1|||
162991825|NCT02640053|588670806|FG000|Overall Study|Alternative Therapy|1|||
163059988|NCT01859741|588928282|FG004|Overall Study|Death|5|||
162991826|NCT02640053|588670807|FG001|Overall Study|Alternative Therapy|1|||
162991827|NCT02640053|588670806|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
162991828|NCT02640053|588670807|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
162991829|NCT02754856|588670809|FG000|Overall Study|Withdrawal by Subject|1|||
162991830|NCT00530218|588670810|FG000|Overall Study|CMV Not Detected|13|||
162991831|NCT00530218|588670810|FG000|Overall Study|Death|12|||
162991832|NCT03477903|588670815|FG000|Overall Study|Study Terminated by Sponsor|1|||
162991833|NCT06281171|588670818|FG000|Timepoint 2|Lost to Follow-up|6|||
162991834|NCT06281171|588670819|FG001|Timepoint 2|Lost to Follow-up|4|||
162991835|NCT06281171|588670818|FG000|Timepoint 3|Lost to Follow-up|0|||
162991836|NCT06281171|588670819|FG001|Timepoint 3|Lost to Follow-up|5|||
162991837|NCT01822275|588670820|FG000|Overall Study|Withdrawal by Subject|3|||
162991838|NCT01822275|588670820|FG000|Overall Study|Adverse Event|3|||
162991839|NCT01822275|588670820|FG000|Overall Study|Progression|14|||
162991840|NCT01822275|588670820|FG000|Overall Study|Physician Decision|2|||
162991841|NCT00513682|588670821|FG000|Washout Phase|Adverse Event|2|||
162991842|NCT03258853|588670823|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
162991843|NCT03258853|588670824|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
162991844|NCT00070499|588672500|FG000|Overall Study|Adverse Event|6|||
162991845|NCT00070499|588672501|FG001|Overall Study|Adverse Event|6|||
162991846|NCT00070499|588672502|FG002|Overall Study|Adverse Event|19|||
162991847|NCT00070499|588672503|FG003|Overall Study|Adverse Event|15|||
162991848|NCT00070499|588672500|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
162991849|NCT00070499|588672501|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
162991850|NCT00070499|588672502|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
162991851|NCT00070499|588672503|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
162991852|NCT00070499|588672500|FG000|Overall Study|Progression/relapse|4|||
162991853|NCT00070499|588672501|FG001|Overall Study|Progression/relapse|2|||
162991854|NCT00070499|588672502|FG002|Overall Study|Progression/relapse|1|||
162991855|NCT00070499|588672503|FG003|Overall Study|Progression/relapse|4|||
162991856|NCT00070499|588672500|FG000|Overall Study|Death|1|||
162991857|NCT00070499|588672501|FG001|Overall Study|Death|1|||
162991858|NCT00070499|588672502|FG002|Overall Study|Death|1|||
162991859|NCT00070499|588672503|FG003|Overall Study|Death|2|||
162991860|NCT00070499|588672500|FG000|Overall Study|Other - not protocol specified|7|||
162991861|NCT00070499|588672501|FG001|Overall Study|Other - not protocol specified|3|||
162991862|NCT00070499|588672502|FG002|Overall Study|Other - not protocol specified|12|||
162991863|NCT00070499|588672503|FG003|Overall Study|Other - not protocol specified|20|||
162991864|NCT00070499|588672500|FG000|Overall Study|Still on protocol treatment|10|||
162991865|NCT00070499|588672501|FG001|Overall Study|Still on protocol treatment|4|||
162991866|NCT00070499|588672502|FG002|Overall Study|Still on protocol treatment|79|||
162991867|NCT00070499|588672503|FG003|Overall Study|Still on protocol treatment|57|||
162991868|NCT00070499|588672500|FG000|Overall Study|Did not start treatment|1|||
162991869|NCT00070499|588672501|FG001|Overall Study|Did not start treatment|0|||
162991870|NCT00070499|588672502|FG002|Overall Study|Did not start treatment|0|||
162991871|NCT00070499|588672503|FG003|Overall Study|Did not start treatment|2|||
162991872|NCT00070499|588672500|FG000|Overall Study|Not eligible|2|||
162991873|NCT00070499|588672501|FG001|Overall Study|Not eligible|5|||
162991874|NCT00070499|588672502|FG002|Overall Study|Not eligible|3|||
162991875|NCT00070499|588672503|FG003|Overall Study|Not eligible|2|||
162991876|NCT00805467|588672504|FG000|Overall Study|Lack of Efficacy|0|||
162991877|NCT00805467|588672505|FG001|Overall Study|Lack of Efficacy|8|||
162991878|NCT00805467|588672506|FG002|Overall Study|Lack of Efficacy|13|||
162991879|NCT00805467|588672507|FG003|Overall Study|Lack of Efficacy|86|||
162991880|NCT00805467|588672504|FG000|Overall Study|Lost to Follow-up|0|||
162991881|NCT00805467|588672505|FG001|Overall Study|Lost to Follow-up|1|||
162991882|NCT00805467|588672506|FG002|Overall Study|Lost to Follow-up|7|||
162991883|NCT00805467|588672507|FG003|Overall Study|Lost to Follow-up|21|||
162991884|NCT00805467|588672504|FG000|Overall Study|Withdrawal by Subject|0|||
162991885|NCT00805467|588672505|FG001|Overall Study|Withdrawal by Subject|6|||
162636821|NCT01937559|587384334|FG002|Overall Study|Withdrawal by Subject|0|||
162636822|NCT01937559|587384332|FG000|Overall Study|screen fail|2|||
162636823|NCT01937559|587384333|FG001|Overall Study|screen fail|4|||
162991886|NCT00805467|588672506|FG002|Overall Study|Withdrawal by Subject|45|||
162991887|NCT00805467|588672507|FG003|Overall Study|Withdrawal by Subject|50|||
162991888|NCT00805467|588672504|FG000|Overall Study|Protocol Violation|0|||
162991889|NCT00805467|588672505|FG001|Overall Study|Protocol Violation|3|||
162991890|NCT00805467|588672506|FG002|Overall Study|Protocol Violation|0|||
162991891|NCT00805467|588672507|FG003|Overall Study|Protocol Violation|5|||
162991892|NCT00805467|588672504|FG000|Overall Study|Adverse Event|0|||
162991893|NCT00805467|588672505|FG001|Overall Study|Adverse Event|13|||
162991894|NCT00805467|588672506|FG002|Overall Study|Adverse Event|26|||
162991895|NCT00805467|588672507|FG003|Overall Study|Adverse Event|57|||
162991896|NCT00805467|588672504|FG000|Overall Study|Death|0|||
162991897|NCT00805467|588672505|FG001|Overall Study|Death|2|||
162991898|NCT00805467|588672506|FG002|Overall Study|Death|7|||
162991899|NCT00805467|588672507|FG003|Overall Study|Death|5|||
162991900|NCT00805467|588672504|FG000|Overall Study|Physician Decision|0|||
162991901|NCT00805467|588672505|FG001|Overall Study|Physician Decision|1|||
162991902|NCT00805467|588672506|FG002|Overall Study|Physician Decision|2|||
162991903|NCT00805467|588672507|FG003|Overall Study|Physician Decision|6|||
162991904|NCT00805467|588672504|FG000|Overall Study|Not reported|0|||
162991905|NCT00805467|588672505|FG001|Overall Study|Not reported|0|||
162991906|NCT00805467|588672506|FG002|Overall Study|Not reported|3|||
162991907|NCT00805467|588672507|FG003|Overall Study|Not reported|7|||
162991908|NCT04240392|588672509|FG000|Overall Study|Withdrawal by Subject|13|||
162991909|NCT04240392|588672510|FG001|Overall Study|Withdrawal by Subject|4|||
162991910|NCT04240392|588672509|FG000|Overall Study|Lost to Follow-up|11|||
162991911|NCT04240392|588672510|FG001|Overall Study|Lost to Follow-up|12|||
162991912|NCT04345601|588672523|FG000|Overall Study|Death|0|||
162991913|NCT04345601|588672524|FG001|Overall Study|Death|3|||
162991914|NCT04345601|588672525|FG002|Overall Study|Death|2|||
162991915|NCT04345601|588672523|FG000|Overall Study|Lost to Follow-up|0|||
162991916|NCT04345601|588672524|FG001|Overall Study|Lost to Follow-up|0|||
162991917|NCT04345601|588672525|FG002|Overall Study|Lost to Follow-up|2|||
162991918|NCT00660907|588672527|FG000|Overall Study|Incorrect Enrollment|1|||
162991919|NCT00660907|588672528|FG001|Overall Study|Incorrect Enrollment|1|||
162991920|NCT00660907|588672527|FG000|Overall Study|Adverse Event|33|||
162991921|NCT00660907|588672528|FG001|Overall Study|Adverse Event|19|||
162991922|NCT00660907|588672527|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
162991923|NCT00660907|588672528|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
162991924|NCT00660907|588672527|FG000|Overall Study|Withdrawal by Subject|23|||
162991925|NCT00660907|588672528|FG001|Overall Study|Withdrawal by Subject|32|||
162991926|NCT00660907|588672527|FG000|Overall Study|Lost to Follow-up|3|||
162991927|NCT00660907|588672528|FG001|Overall Study|Lost to Follow-up|3|||
162991928|NCT00660907|588672527|FG000|Overall Study|Poor/Non-Compliance|5|||
162991929|NCT00660907|588672528|FG001|Overall Study|Poor/Non-Compliance|1|||
162991930|NCT00660907|588672527|FG000|Overall Study|Safety|1|||
162991931|NCT00660907|588672528|FG001|Overall Study|Safety|0|||
162991932|NCT00660907|588672527|FG000|Overall Study|Death|1|||
162991933|NCT00660907|588672528|FG001|Overall Study|Death|3|||
162991934|NCT00660907|588672527|FG000|Overall Study|Various|11|||
162991935|NCT00660907|588672528|FG001|Overall Study|Various|8|||
162991936|NCT01908907|588672529|FG000|Overall Study|Physician Decision|1|||
162991937|NCT01908907|588672530|FG001|Overall Study|Physician Decision|0|||
162991938|NCT01908907|588672529|FG000|Overall Study|Protocol Violation|1|||
162991939|NCT01908907|588672530|FG001|Overall Study|Protocol Violation|0|||
162991940|NCT04975191|588672531|FG000|Overall Study|Protocol Violation|1|||
162991941|NCT04975191|588672532|FG001|Overall Study|Protocol Violation|2|||
162991942|NCT04975191|588672533|FG002|Overall Study|Protocol Violation|2|||
162991943|NCT04975191|588672534|FG003|Overall Study|Protocol Violation|2|||
162991944|NCT04975191|588672531|FG000|Overall Study|Lost to Follow-up|13|||
162991945|NCT04975191|588672532|FG001|Overall Study|Lost to Follow-up|3|||
162991946|NCT04975191|588672533|FG002|Overall Study|Lost to Follow-up|8|||
162991947|NCT04975191|588672534|FG003|Overall Study|Lost to Follow-up|8|||
162991948|NCT02152605|588672539|FG000|Overall Study|Adverse Event|6|||
162991949|NCT02152605|588672540|FG001|Overall Study|Adverse Event|8|||
162991950|NCT02152605|588672539|FG000|Overall Study|Lack of Efficacy|7|||
162991951|NCT02152605|588672540|FG001|Overall Study|Lack of Efficacy|4|||
162991952|NCT02152605|588672539|FG000|Overall Study|Protocol deviation|1|||
162991953|NCT02152605|588672540|FG001|Overall Study|Protocol deviation|4|||
162991954|NCT02152605|588672539|FG000|Overall Study|Lost to Follow-up|1|||
162991955|NCT02152605|588672540|FG001|Overall Study|Lost to Follow-up|0|||
162991956|NCT02152605|588672539|FG000|Overall Study|Withdrew consent|4|||
162991957|NCT02152605|588672540|FG001|Overall Study|Withdrew consent|2|||
162991958|NCT00537303|588672547|FG000|Overall Study|Adverse Event|1|||
162991959|NCT00537303|588672548|FG001|Overall Study|Adverse Event|4|||
162636824|NCT01937559|587384334|FG002|Overall Study|screen fail|0|||
162991960|NCT00537303|588672547|FG000|Overall Study|Lack of Efficacy|6|||
162991961|NCT00537303|588672548|FG001|Overall Study|Lack of Efficacy|7|||
162991962|NCT00537303|588672547|FG000|Overall Study|Protocol Violation|8|||
162991963|NCT00537303|588672548|FG001|Overall Study|Protocol Violation|4|||
162991964|NCT00537303|588672547|FG000|Overall Study|Withdrawal criteria|3|||
162991965|NCT00537303|588672548|FG001|Overall Study|Withdrawal criteria|3|||
162991966|NCT00537303|588672547|FG000|Overall Study|Unclassified|8|||
162991967|NCT00537303|588672548|FG001|Overall Study|Unclassified|7|||
162991968|NCT01724489|588672549|FG000|Overall Study|Adverse Event|8|||
162991969|NCT01724489|588672550|FG001|Overall Study|Adverse Event|3|||
162991970|NCT01724489|588672549|FG000|Overall Study|Surgery, medication|1|||
162991971|NCT01724489|588672550|FG001|Overall Study|Surgery, medication|1|||
162991972|NCT01724489|588672549|FG000|Overall Study|Lost to Follow-up|1|||
162991973|NCT01724489|588672550|FG001|Overall Study|Lost to Follow-up|2|||
162991974|NCT01724489|588672549|FG000|Overall Study|Withdrawal by Subject|6|||
162991975|NCT01724489|588672550|FG001|Overall Study|Withdrawal by Subject|6|||
162991976|NCT01473524|588672555|FG000|DB Phase|Adverse Event|4|||
162991977|NCT01473524|588672556|FG001|DB Phase|Adverse Event|8|||
162991978|NCT01473524|588672557|FG002|DB Phase|Adverse Event|2|||
162991979|NCT01473524|588672558|FG003|DB Phase|Adverse Event|0|||
162991980|NCT01473524|588672559|FG004|DB Phase|Adverse Event|0|||
162991981|NCT01473524|588672560|FG005|DB Phase|Adverse Event|0|||
162991982|NCT01473524|588672555|FG000|DB Phase|Death|1|||
162991983|NCT01473524|588672556|FG001|DB Phase|Death|0|||
162991984|NCT01473524|588672557|FG002|DB Phase|Death|0|||
162991985|NCT01473524|588672558|FG003|DB Phase|Death|0|||
162991986|NCT01473524|588672559|FG004|DB Phase|Death|0|||
162991987|NCT01473524|588672560|FG005|DB Phase|Death|0|||
162991988|NCT01473524|588672555|FG000|DB Phase|Withdrawal by Subject|2|||
162991989|NCT01473524|588672556|FG001|DB Phase|Withdrawal by Subject|1|||
162991990|NCT01473524|588672557|FG002|DB Phase|Withdrawal by Subject|1|||
162991991|NCT01473524|588672558|FG003|DB Phase|Withdrawal by Subject|0|||
162991992|NCT01473524|588672559|FG004|DB Phase|Withdrawal by Subject|0|||
162991993|NCT01473524|588672560|FG005|DB Phase|Withdrawal by Subject|0|||
162991994|NCT01473524|588672555|FG000|LTSE Phase|Withdrawal by Subject|0|||
162991995|NCT01473524|588672556|FG001|LTSE Phase|Withdrawal by Subject|0|||
162991996|NCT01473524|588672557|FG002|LTSE Phase|Withdrawal by Subject|0|||
162991997|NCT01473524|588672558|FG003|LTSE Phase|Withdrawal by Subject|3|||
162991998|NCT01473524|588672559|FG004|LTSE Phase|Withdrawal by Subject|3|||
162991999|NCT01473524|588672560|FG005|LTSE Phase|Withdrawal by Subject|6|||
162992000|NCT01473524|588672555|FG000|LTSE Phase|Death|0|||
162992001|NCT01473524|588672556|FG001|LTSE Phase|Death|0|||
162992002|NCT01473524|588672557|FG002|LTSE Phase|Death|0|||
162992003|NCT01473524|588672558|FG003|LTSE Phase|Death|0|||
162992004|NCT01473524|588672559|FG004|LTSE Phase|Death|1|||
162992005|NCT01473524|588672560|FG005|LTSE Phase|Death|0|||
162992006|NCT01473524|588672555|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
162992007|NCT01473524|588672556|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
162992008|NCT01473524|588672557|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
162992009|NCT01473524|588672558|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
162992010|NCT01473524|588672559|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
162992011|NCT01473524|588672560|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
162992012|NCT01473524|588672555|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
162992013|NCT01473524|588672556|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
162992014|NCT01473524|588672557|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
163059989|NCT01859741|588928283|FG005|Overall Study|Death|4|||
163059990|NCT01859741|588928284|FG006|Overall Study|Death|51|||
163059991|NCT01859741|588928285|FG007|Overall Study|Death|51|||
163059992|NCT01859741|588928278|FG000|Overall Study|Lost to Follow-up|0|||
162992015|NCT01473524|588672558|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
162992016|NCT01473524|588672559|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
162992017|NCT01473524|588672560|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
162992018|NCT01473524|588672555|FG000|LTSE Phase|Lost to Follow-up|0|||
162992019|NCT01473524|588672556|FG001|LTSE Phase|Lost to Follow-up|0|||
162992020|NCT01473524|588672557|FG002|LTSE Phase|Lost to Follow-up|0|||
162992021|NCT01473524|588672558|FG003|LTSE Phase|Lost to Follow-up|1|||
162992022|NCT01473524|588672559|FG004|LTSE Phase|Lost to Follow-up|3|||
162992023|NCT01473524|588672560|FG005|LTSE Phase|Lost to Follow-up|2|||
162992024|NCT01473524|588672555|FG000|LTSE Phase|Principal Investigator Decision|0|||
162992025|NCT01473524|588672556|FG001|LTSE Phase|Principal Investigator Decision|0|||
163059993|NCT01859741|588928279|FG001|Overall Study|Lost to Follow-up|0|||
163059994|NCT01859741|588928280|FG002|Overall Study|Lost to Follow-up|0|||
162992026|NCT01473524|588672557|FG002|LTSE Phase|Principal Investigator Decision|0|||
162992027|NCT01473524|588672558|FG003|LTSE Phase|Principal Investigator Decision|1|||
162992028|NCT01473524|588672559|FG004|LTSE Phase|Principal Investigator Decision|1|||
162992029|NCT01473524|588672560|FG005|LTSE Phase|Principal Investigator Decision|3|||
162992030|NCT01473524|588672555|FG000|LTSE Phase|Liver Transplantation|0|||
162992031|NCT01473524|588672556|FG001|LTSE Phase|Liver Transplantation|0|||
162992032|NCT01473524|588672557|FG002|LTSE Phase|Liver Transplantation|0|||
162992033|NCT01473524|588672558|FG003|LTSE Phase|Liver Transplantation|0|||
162992034|NCT01473524|588672559|FG004|LTSE Phase|Liver Transplantation|0|||
162992035|NCT01473524|588672560|FG005|LTSE Phase|Liver Transplantation|1|||
162992036|NCT01473524|588672555|FG000|LTSE Phase|Pregnancy|0|||
162992037|NCT01473524|588672556|FG001|LTSE Phase|Pregnancy|0|||
162992038|NCT01473524|588672557|FG002|LTSE Phase|Pregnancy|0|||
162992039|NCT01473524|588672558|FG003|LTSE Phase|Pregnancy|1|||
162992040|NCT01473524|588672559|FG004|LTSE Phase|Pregnancy|0|||
162992041|NCT01473524|588672560|FG005|LTSE Phase|Pregnancy|0|||
162992042|NCT01473524|588672555|FG000|LTSE Phase|Protocol Violation|0|||
162992043|NCT01473524|588672556|FG001|LTSE Phase|Protocol Violation|0|||
162992044|NCT01473524|588672557|FG002|LTSE Phase|Protocol Violation|0|||
162992045|NCT01473524|588672558|FG003|LTSE Phase|Protocol Violation|0|||
162992046|NCT01473524|588672559|FG004|LTSE Phase|Protocol Violation|0|||
162992047|NCT01473524|588672560|FG005|LTSE Phase|Protocol Violation|1|||
162992048|NCT01544179|588672561|FG000|Overall Study|Death|50|||
162992049|NCT01544179|588672562|FG001|Overall Study|Death|37|||
162992050|NCT01544179|588672561|FG000|Overall Study|Lost to Follow-up|0|||
162992051|NCT01544179|588672562|FG001|Overall Study|Lost to Follow-up|1|||
162992052|NCT01544179|588672561|FG000|Overall Study|Adverse Event|0|||
162992053|NCT01544179|588672562|FG001|Overall Study|Adverse Event|1|||
162992054|NCT01544179|588672561|FG000|Overall Study|Withdrawal by Subject|12|||
162992055|NCT01544179|588672562|FG001|Overall Study|Withdrawal by Subject|7|||
162992056|NCT01544179|588672561|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
162992057|NCT01544179|588672562|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162992058|NCT01305044|588672563|FG000|Overall Study|Withdrawal by Subject|3|||
162992059|NCT01305044|588672564|FG001|Overall Study|Withdrawal by Subject|6|||
162992060|NCT02861014|588672569|FG000|Primary Analysis|Adverse Event|7|||
162992061|NCT02861014|588672569|FG000|Primary Analysis|Death|1|||
162992062|NCT02861014|588672569|FG000|Primary Analysis|Lack of Efficacy|3|||
162992063|NCT02861014|588672569|FG000|Primary Analysis|Physician Decision|2|||
162992064|NCT02861014|588672569|FG000|Primary Analysis|Pregnancy|4|||
162992065|NCT02861014|588672569|FG000|Primary Analysis|Protocol Violation|2|||
162992066|NCT02861014|588672569|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
162992067|NCT02861014|588672569|FG000|Primary Analysis|Withdrawal by Subject|14|||
162992068|NCT02861014|588672569|FG000|Primary Analysis|Commercial ocrelizumab|3|||
162992069|NCT02861014|588672569|FG000|Safety Follow-up|Adverse Event|1|||
162992070|NCT02861014|588672569|FG000|Safety Follow-up|Pregnancy|1|||
162992071|NCT02861014|588672569|FG000|Safety Follow-up|Withdrawal by Subject|9|||
162992072|NCT02861014|588672569|FG000|Safety Follow-up|Study terminated by sponsor|1|||
162992073|NCT02861014|588672569|FG000|Safety Follow-up|Physician Decision|1|||
162992074|NCT02861014|588672569|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
162992075|NCT02861014|588672569|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
162992076|NCT04623086|588672571|FG000|Overall Study|Withdrawal by Subject|0|||
162992077|NCT04623086|588672572|FG001|Overall Study|Withdrawal by Subject|0|||
162992078|NCT04623086|588672573|FG002|Overall Study|Withdrawal by Subject|10|||
162992079|NCT03464630|588672574|FG000|Overall Study|Lost to Follow-up|62|||
162992080|NCT03464630|588672575|FG001|Overall Study|Lost to Follow-up|52|||
162992081|NCT03464630|588672574|FG000|Overall Study|Withdrawal by Subject|16|||
162992082|NCT03464630|588672575|FG001|Overall Study|Withdrawal by Subject|10|||
162992083|NCT03464630|588672574|FG000|Overall Study|Passive Disengagement|8|||
162992084|NCT03464630|588672575|FG001|Overall Study|Passive Disengagement|4|||
162992085|NCT00715624|588672576|FG000|Overall Study|Adverse Event|12|||
162992086|NCT00715624|588672577|FG001|Overall Study|Adverse Event|37|||
162992087|NCT00715624|588672576|FG000|Overall Study|Lack of Efficacy|11|||
162992088|NCT00715624|588672577|FG001|Overall Study|Lack of Efficacy|11|||
162992089|NCT00715624|588672576|FG000|Overall Study|Lost to Follow-up|1|||
162992090|NCT00715624|588672577|FG001|Overall Study|Lost to Follow-up|2|||
162992091|NCT00715624|588672576|FG000|Overall Study|Protocol Violation|1|||
162992092|NCT00715624|588672577|FG001|Overall Study|Protocol Violation|0|||
162992093|NCT00715624|588672576|FG000|Overall Study|Withdrawal by Subject|11|||
162992094|NCT00715624|588672577|FG001|Overall Study|Withdrawal by Subject|25|||
162992095|NCT00715624|588672576|FG000|Overall Study|Familial and personal reasons|10|||
162992096|NCT00715624|588672577|FG001|Overall Study|Familial and personal reasons|22|||
162992097|NCT00715624|588672576|FG000|Overall Study|Poor compliance|6|||
162992098|NCT00715624|588672577|FG001|Overall Study|Poor compliance|13|||
162992099|NCT00715624|588672576|FG000|Overall Study|Sponsor decision|0|||
162992100|NCT00715624|588672577|FG001|Overall Study|Sponsor decision|4|||
162992101|NCT00715624|588672576|FG000|Overall Study|Incorrect randomization (not treated)|0|||
162992102|NCT00715624|588672577|FG001|Overall Study|Incorrect randomization (not treated)|1|||
162992103|NCT00715624|588672576|FG000|Overall Study|Other|0|||
162992104|NCT00715624|588672577|FG001|Overall Study|Other|1|||
162992105|NCT04524364|588672580|FG000|Overall Study|Physician Decision|3|||
162992106|NCT04524364|588672581|FG001|Overall Study|Physician Decision|6|||
162992107|NCT04524364|588672580|FG000|Overall Study|Adverse Event|0|||
162992108|NCT04524364|588672581|FG001|Overall Study|Adverse Event|1|||
162992109|NCT04524364|588672580|FG000|Overall Study|Investigational device deficiency|0|||
162992110|NCT04524364|588672581|FG001|Overall Study|Investigational device deficiency|1|||
162992111|NCT04524364|588672580|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
162992112|NCT04524364|588672581|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
162992113|NCT04524364|588672580|FG000|Overall Study|Device unavailability|0|||
162992114|NCT04524364|588672581|FG001|Overall Study|Device unavailability|2|||
162992115|NCT04524364|588672580|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
162992116|NCT04524364|588672581|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
162992117|NCT04524364|588672580|FG000|Overall Study|Low International normalized ratio (INR)|1|||
162992118|NCT04524364|588672581|FG001|Overall Study|Low International normalized ratio (INR)|0|||
162992119|NCT02309138|588672582|FG000|Overall Study|Withdrawal by Subject|44|||
162992120|NCT02309138|588672583|FG001|Overall Study|Withdrawal by Subject|15|||
162992121|NCT02309138|588672582|FG000|Overall Study|Protocol Violation|4|||
162992122|NCT02309138|588672583|FG001|Overall Study|Protocol Violation|2|||
162992123|NCT02309138|588672582|FG000|Overall Study|delivered before visit 2|0|||
162992124|NCT02309138|588672583|FG001|Overall Study|delivered before visit 2|1|||
162992125|NCT00735397|588672588|FG000|Overall Study|Adverse Event|194|||
162992126|NCT00735397|588672588|FG000|Overall Study|Lost to Follow-up|33|||
162992127|NCT00735397|588672588|FG000|Overall Study|Participant choice|252|||
162992128|NCT00735397|588672588|FG000|Overall Study|Inadequate therapeutic effect|202|||
162992129|NCT00735397|588672588|FG000|Overall Study|Administrative/Other|502|||
162992130|NCT00380744|588672589|FG000|Overall Study|Death|0|||
162992131|NCT00380744|588672590|FG001|Overall Study|Death|0|||
162992132|NCT00380744|588672591|FG002|Overall Study|Death|0|||
162992133|NCT00380744|588672592|FG003|Overall Study|Death|0|||
162992134|NCT00380744|588672593|FG004|Overall Study|Death|0|||
162992135|NCT00380744|588672594|FG005|Overall Study|Death|0|||
162992136|NCT00380744|588672595|FG006|Overall Study|Death|1|||
162992137|NCT00380744|588672589|FG000|Overall Study|Withdrawal by Subject|1|||
162992138|NCT00380744|588672590|FG001|Overall Study|Withdrawal by Subject|0|||
162992139|NCT00380744|588672591|FG002|Overall Study|Withdrawal by Subject|0|||
162992140|NCT00380744|588672592|FG003|Overall Study|Withdrawal by Subject|0|||
162992141|NCT00380744|588672593|FG004|Overall Study|Withdrawal by Subject|0|||
162992142|NCT00380744|588672594|FG005|Overall Study|Withdrawal by Subject|0|||
163059995|NCT01859741|588928281|FG003|Overall Study|Lost to Follow-up|0|||
163059996|NCT01859741|588928282|FG004|Overall Study|Lost to Follow-up|0|||
163059997|NCT01859741|588928283|FG005|Overall Study|Lost to Follow-up|1|||
163059998|NCT01859741|588928284|FG006|Overall Study|Lost to Follow-up|0|||
163059999|NCT01859741|588928285|FG007|Overall Study|Lost to Follow-up|4|||
163060000|NCT01859741|588928278|FG000|Overall Study|Withdrawal by Subject|0|||
163060001|NCT01859741|588928279|FG001|Overall Study|Withdrawal by Subject|1|||
163060002|NCT01859741|588928280|FG002|Overall Study|Withdrawal by Subject|2|||
163060003|NCT01859741|588928281|FG003|Overall Study|Withdrawal by Subject|0|||
163060004|NCT01859741|588928282|FG004|Overall Study|Withdrawal by Subject|0|||
163060005|NCT01859741|588928283|FG005|Overall Study|Withdrawal by Subject|1|||
163060006|NCT01859741|588928284|FG006|Overall Study|Withdrawal by Subject|1|||
163060007|NCT01859741|588928285|FG007|Overall Study|Withdrawal by Subject|1|||
163060008|NCT01859741|588928278|FG000|Overall Study|Study Terminated by Sponsor|0|||
162992143|NCT00380744|588672595|FG006|Overall Study|Withdrawal by Subject|0|||
162992144|NCT01955083|588672603|FG000|Overall Study|Lost to Follow-up|1|||
162992145|NCT01955083|588672604|FG001|Overall Study|Lost to Follow-up|1|||
162992146|NCT01559389|588672615|FG000|Overall Study|Withdrawal by Subject|20|||
162992147|NCT01559389|588672616|FG001|Overall Study|Withdrawal by Subject|20|||
162992148|NCT02871492|588672617|FG000|Overall Study|Lost to Follow-up|6|||
162992149|NCT02871492|588672618|FG001|Overall Study|Lost to Follow-up|3|||
162992150|NCT02871492|588672619|FG002|Overall Study|Lost to Follow-up|5|||
162992151|NCT02871492|588672617|FG000|Overall Study|Withdrawal by Subject|0|||
162992152|NCT02871492|588672618|FG001|Overall Study|Withdrawal by Subject|0|||
162992153|NCT02871492|588672619|FG002|Overall Study|Withdrawal by Subject|1|||
163060009|NCT01859741|588928279|FG001|Overall Study|Study Terminated by Sponsor|0|||
162992154|NCT04546724|588672620|FG000|Overall Study|Withdrawal by Subject|145|||
162992155|NCT04546724|588672621|FG001|Overall Study|Withdrawal by Subject|41|||
162992156|NCT04546724|588672620|FG000|Overall Study|Adverse Event|1|||
162992157|NCT04546724|588672621|FG001|Overall Study|Adverse Event|1|||
162992158|NCT04546724|588672620|FG000|Overall Study|Lost to Follow-up|186|||
162992159|NCT04546724|588672621|FG001|Overall Study|Lost to Follow-up|63|||
162992160|NCT04546724|588672620|FG000|Overall Study|Physician Decision|8|||
162992161|NCT04546724|588672621|FG001|Overall Study|Physician Decision|2|||
162992162|NCT04546724|588672620|FG000|Overall Study|Death|2|||
162992163|NCT04546724|588672621|FG001|Overall Study|Death|1|||
162992164|NCT04546724|588672620|FG000|Overall Study|subject has been out of town|1|||
162992165|NCT04546724|588672621|FG001|Overall Study|subject has been out of town|0|||
162992166|NCT04546724|588672620|FG000|Overall Study|subject is incarcerated|2|||
162992167|NCT04546724|588672621|FG001|Overall Study|subject is incarcerated|0|||
162992168|NCT04546724|588672620|FG000|Overall Study|subject is relocating|12|||
162992169|NCT04546724|588672621|FG001|Overall Study|subject is relocating|4|||
162992170|NCT04546724|588672620|FG000|Overall Study|Subject in another study|1|||
162992171|NCT04546724|588672621|FG001|Overall Study|Subject in another study|1|||
162992172|NCT03583086|588672622|FG000|Overall Study|Death|2|||
162992173|NCT03583086|588672623|FG001|Overall Study|Death|6|||
162992174|NCT03583086|588672624|FG002|Overall Study|Death|12|||
162992175|NCT03583086|588672625|FG003|Overall Study|Death|10|||
162992176|NCT03583086|588672626|FG004|Overall Study|Death|14|||
162992177|NCT03583086|588672627|FG005|Overall Study|Death|14|||
162992178|NCT03583086|588672628|FG006|Overall Study|Death|4|||
162992179|NCT03583086|588672622|FG000|Overall Study|Withdrawal by Subject|0|||
162992180|NCT03583086|588672623|FG001|Overall Study|Withdrawal by Subject|0|||
162992181|NCT03583086|588672624|FG002|Overall Study|Withdrawal by Subject|1|||
162992182|NCT03583086|588672625|FG003|Overall Study|Withdrawal by Subject|0|||
162992183|NCT03583086|588672626|FG004|Overall Study|Withdrawal by Subject|0|||
162992184|NCT03583086|588672627|FG005|Overall Study|Withdrawal by Subject|0|||
162992185|NCT03583086|588672628|FG006|Overall Study|Withdrawal by Subject|1|||
162992186|NCT03583086|588672622|FG000|Overall Study|Refused follow-up|0|||
162992187|NCT03583086|588672623|FG001|Overall Study|Refused follow-up|0|||
162992188|NCT03583086|588672624|FG002|Overall Study|Refused follow-up|1|||
162992189|NCT03583086|588672625|FG003|Overall Study|Refused follow-up|0|||
162992190|NCT03583086|588672626|FG004|Overall Study|Refused follow-up|1|||
162992191|NCT03583086|588672627|FG005|Overall Study|Refused follow-up|0|||
162992192|NCT03583086|588672628|FG006|Overall Study|Refused follow-up|0|||
162992193|NCT03583086|588672622|FG000|Overall Study|Declining Performance Status|0|||
162992194|NCT03583086|588672623|FG001|Overall Study|Declining Performance Status|0|||
162992195|NCT03583086|588672624|FG002|Overall Study|Declining Performance Status|1|||
162992196|NCT03583086|588672625|FG003|Overall Study|Declining Performance Status|0|||
162992197|NCT03583086|588672626|FG004|Overall Study|Declining Performance Status|0|||
162992198|NCT03583086|588672627|FG005|Overall Study|Declining Performance Status|0|||
162992199|NCT03583086|588672628|FG006|Overall Study|Declining Performance Status|0|||
162992200|NCT03583086|588672622|FG000|Overall Study|Still on study|0|||
162992201|NCT03583086|588672623|FG001|Overall Study|Still on study|0|||
162992202|NCT03583086|588672624|FG002|Overall Study|Still on study|0|||
162992203|NCT03583086|588672625|FG003|Overall Study|Still on study|1|||
162992204|NCT03583086|588672626|FG004|Overall Study|Still on study|0|||
162636825|NCT01853826|587385974|FG000|Overall Study|Patients who switched to commercial drug|11|||
162992205|NCT03583086|588672627|FG005|Overall Study|Still on study|0|||
162992206|NCT03583086|588672628|FG006|Overall Study|Still on study|1|||
162992207|NCT03583086|588672622|FG000|Overall Study|Disease progression|0|||
162992208|NCT03583086|588672623|FG001|Overall Study|Disease progression|0|||
162992209|NCT03583086|588672624|FG002|Overall Study|Disease progression|0|||
162992210|NCT03583086|588672625|FG003|Overall Study|Disease progression|0|||
162992211|NCT03583086|588672626|FG004|Overall Study|Disease progression|0|||
162992212|NCT03583086|588672627|FG005|Overall Study|Disease progression|0|||
162992213|NCT03583086|588672628|FG006|Overall Study|Disease progression|1|||
162992214|NCT03583086|588672622|FG000|Overall Study|Undergoing radiation therapy|0|||
162992215|NCT03583086|588672623|FG001|Overall Study|Undergoing radiation therapy|0|||
162992216|NCT03583086|588672624|FG002|Overall Study|Undergoing radiation therapy|0|||
162636826|NCT01853826|587385974|FG000|Overall Study|Patient refused to continue medication|21|||
162992217|NCT03583086|588672625|FG003|Overall Study|Undergoing radiation therapy|0|||
162992218|NCT03583086|588672626|FG004|Overall Study|Undergoing radiation therapy|0|||
162636827|NCT01853826|587385974|FG000|Overall Study|Lost to Follow-up|2|||
162636828|NCT01853826|587385974|FG000|Overall Study|Non-compliant with protocol|4|||
162992219|NCT03583086|588672627|FG005|Overall Study|Undergoing radiation therapy|0|||
162992220|NCT03583086|588672628|FG006|Overall Study|Undergoing radiation therapy|1|||
162992221|NCT03583086|588672622|FG000|Overall Study|Lost to Follow-up|0|||
162992222|NCT03583086|588672623|FG001|Overall Study|Lost to Follow-up|0|||
162992223|NCT03583086|588672624|FG002|Overall Study|Lost to Follow-up|0|||
162992224|NCT03583086|588672625|FG003|Overall Study|Lost to Follow-up|0|||
162992225|NCT03583086|588672626|FG004|Overall Study|Lost to Follow-up|0|||
162992226|NCT03583086|588672627|FG005|Overall Study|Lost to Follow-up|1|||
162992227|NCT03583086|588672628|FG006|Overall Study|Lost to Follow-up|0|||
162992228|NCT03583086|588672622|FG000|Overall Study|Adverse Event|0|||
162992229|NCT03583086|588672623|FG001|Overall Study|Adverse Event|0|||
162992230|NCT03583086|588672624|FG002|Overall Study|Adverse Event|0|||
162992231|NCT03583086|588672625|FG003|Overall Study|Adverse Event|0|||
162992232|NCT03583086|588672626|FG004|Overall Study|Adverse Event|0|||
162992233|NCT03583086|588672627|FG005|Overall Study|Adverse Event|1|||
162992234|NCT03583086|588672628|FG006|Overall Study|Adverse Event|0|||
162992235|NCT00396812|588672632|FG000|Overall Study|Physician Decision|1|||
162992236|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
162992237|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
162992238|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
162992239|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
162992240|NCT03201445|588672634|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
162992241|NCT03201445|588672635|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
162992242|NCT03201445|588672634|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
162992243|NCT03201445|588672635|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
162992244|NCT03201445|588672634|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
162992245|NCT03201445|588672635|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
162992246|NCT03201445|588672634|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
162992247|NCT03201445|588672635|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
162992248|NCT03201445|588672634|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
162992249|NCT03201445|588672635|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
162992250|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
162992251|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
162992252|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
162992253|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
162992254|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
162992255|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
162992256|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
162992257|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
162992258|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
162992259|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
162992260|NCT03201445|588672634|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
162992261|NCT03201445|588672635|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
162992262|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
162992263|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
162992264|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
162992265|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
162992266|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
162992267|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
162992268|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
162992269|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
162992270|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
162992271|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
162992272|NCT03201445|588672634|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
162992273|NCT03201445|588672635|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
162992274|NCT03201445|588672634|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
162992275|NCT03201445|588672635|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
162992276|NCT03201445|588672634|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
162992277|NCT03201445|588672635|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
162992278|NCT01228019|588672636|FG000|Overall Study|Dose Violation|70|||
162992279|NCT01228019|588672636|FG000|Overall Study|Duplicate enrollment|1|||
162992280|NCT01228019|588672636|FG000|Overall Study|Missing pre-treatment data|72|||
162992281|NCT01228019|588672636|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
162992282|NCT01228019|588672636|FG000|Overall Study|Violation of Entry Criterion|9|||
162992283|NCT01268501|588672637|FG000|Overall Study|Lost to Follow-up|1|||
162992284|NCT01268501|588672637|FG000|Overall Study|Withdrawal by Subject|3|||
162992285|NCT01268501|588672637|FG000|Overall Study|Unacceptable Subjective Vision|3|||
162992286|NCT01268501|588672637|FG000|Overall Study|Handling Difficulties|2|||
162992287|NCT00724048|588672638|FG000|Overall Study|Adverse Event|1|||
162992288|NCT00724048|588672639|FG001|Overall Study|Adverse Event|1|||
163060010|NCT01859741|588928280|FG002|Overall Study|Study Terminated by Sponsor|0|||
163060011|NCT01859741|588928281|FG003|Overall Study|Study Terminated by Sponsor|0|||
162992289|NCT00724048|588672640|FG002|Overall Study|Adverse Event|1|||
162992290|NCT00724048|588672641|FG003|Overall Study|Adverse Event|0|||
162992291|NCT00724048|588672638|FG000|Overall Study|Lost to Follow-up|0|||
162992292|NCT00724048|588672639|FG001|Overall Study|Lost to Follow-up|1|||
162992293|NCT00724048|588672640|FG002|Overall Study|Lost to Follow-up|0|||
162992294|NCT00724048|588672641|FG003|Overall Study|Lost to Follow-up|0|||
162992295|NCT00724048|588672638|FG000|Overall Study|Withdrawal by Subject|1|||
162992296|NCT00724048|588672639|FG001|Overall Study|Withdrawal by Subject|2|||
162992297|NCT00724048|588672640|FG002|Overall Study|Withdrawal by Subject|1|||
162992298|NCT00724048|588672641|FG003|Overall Study|Withdrawal by Subject|2|||
162992299|NCT00724048|588672638|FG000|Overall Study|Investigator decision|0|||
162992300|NCT00724048|588672639|FG001|Overall Study|Investigator decision|0|||
162992301|NCT00724048|588672640|FG002|Overall Study|Investigator decision|1|||
162992302|NCT00724048|588672641|FG003|Overall Study|Investigator decision|0|||
162992303|NCT00724048|588672638|FG000|Overall Study|Did not tolerate study drug|0|||
162992304|NCT00724048|588672639|FG001|Overall Study|Did not tolerate study drug|0|||
162992305|NCT00724048|588672640|FG002|Overall Study|Did not tolerate study drug|0|||
162992306|NCT00724048|588672641|FG003|Overall Study|Did not tolerate study drug|1|||
162992307|NCT00724048|588672638|FG000|Overall Study|Other than specified|1|||
162992308|NCT00724048|588672639|FG001|Overall Study|Other than specified|1|||
162992309|NCT00724048|588672640|FG002|Overall Study|Other than specified|0|||
162992310|NCT00724048|588672641|FG003|Overall Study|Other than specified|0|||
162992311|NCT04874155|588672642|FG000|Overall Study|Lost to Follow-up|1|||
162992312|NCT04874155|588672643|FG001|Overall Study|Lost to Follow-up|1|||
162992313|NCT04874155|588672642|FG000|Overall Study|Withdrawal by Subject|2|||
162992314|NCT04874155|588672643|FG001|Overall Study|Withdrawal by Subject|2|||
162992315|NCT00474266|588672646|FG000|Overall Study|Withdrawal by Subject|7|||
162992316|NCT00474266|588672647|FG001|Overall Study|Withdrawal by Subject|20|||
162992317|NCT00474266|588672648|FG002|Overall Study|Withdrawal by Subject|4|||
162992318|NCT00474266|588672649|FG003|Overall Study|Withdrawal by Subject|7|||
162992319|NCT02329847|588672650|FG000|Overall Study|Death|4|||
162992320|NCT02329847|588672651|FG001|Overall Study|Death|4|||
162992321|NCT02329847|588672652|FG002|Overall Study|Death|22|||
162992322|NCT02329847|588672653|FG003|Overall Study|Death|12|||
162992323|NCT02329847|588672654|FG004|Overall Study|Death|20|||
162992324|NCT02329847|588672655|FG005|Overall Study|Death|13|||
162992325|NCT02329847|588672650|FG000|Overall Study|Lost to Follow-up|0|||
162992326|NCT02329847|588672651|FG001|Overall Study|Lost to Follow-up|0|||
162992327|NCT02329847|588672652|FG002|Overall Study|Lost to Follow-up|2|||
162992328|NCT02329847|588672653|FG003|Overall Study|Lost to Follow-up|3|||
162992329|NCT02329847|588672654|FG004|Overall Study|Lost to Follow-up|0|||
162992330|NCT02329847|588672655|FG005|Overall Study|Lost to Follow-up|1|||
162992331|NCT02329847|588672650|FG000|Overall Study|Physician Decision|0|||
162992332|NCT02329847|588672651|FG001|Overall Study|Physician Decision|0|||
162992333|NCT02329847|588672652|FG002|Overall Study|Physician Decision|0|||
162992334|NCT02329847|588672653|FG003|Overall Study|Physician Decision|0|||
162992335|NCT02329847|588672654|FG004|Overall Study|Physician Decision|1|||
162992336|NCT02329847|588672655|FG005|Overall Study|Physician Decision|0|||
162992337|NCT02329847|588672650|FG000|Overall Study|Withdrawal by Subject|2|||
162992338|NCT02329847|588672651|FG001|Overall Study|Withdrawal by Subject|1|||
162992339|NCT02329847|588672652|FG002|Overall Study|Withdrawal by Subject|5|||
162992340|NCT02329847|588672653|FG003|Overall Study|Withdrawal by Subject|7|||
162992341|NCT02329847|588672654|FG004|Overall Study|Withdrawal by Subject|8|||
162992342|NCT02329847|588672655|FG005|Overall Study|Withdrawal by Subject|3|||
162992343|NCT02329847|588672650|FG000|Overall Study|Other|1|||
162992344|NCT02329847|588672651|FG001|Overall Study|Other|2|||
162992345|NCT02329847|588672652|FG002|Overall Study|Other|6|||
162992346|NCT02329847|588672653|FG003|Overall Study|Other|13|||
162992347|NCT02329847|588672654|FG004|Overall Study|Other|10|||
162992348|NCT02329847|588672655|FG005|Overall Study|Other|3|||
162992349|NCT05330468|588672656|FG000|Overall Study|Death|6|||
162992350|NCT05330468|588672656|FG000|Overall Study|Withdrawal by Subject|4|||
162992351|NCT05330468|588672656|FG000|Overall Study|Lost to Follow-up|4|||
162992352|NCT02828241|588672659|FG000|Overall Study|Adverse Event|7|||
162992353|NCT02828241|588672660|FG001|Overall Study|Adverse Event|2|||
162992354|NCT02828241|588672659|FG000|Overall Study|Protocol Violation|1|||
162992355|NCT02828241|588672660|FG001|Overall Study|Protocol Violation|0|||
162992356|NCT04572893|588672661|FG000|Part A|Adverse Event|1|||
162992357|NCT04572893|588672662|FG001|Part A|Adverse Event|0|||
162992358|NCT04572893|588672663|FG002|Part A|Adverse Event|0|||
162992359|NCT04572893|588672664|FG003|Part A|Adverse Event|0|||
162992360|NCT04572893|588672665|FG004|Part A|Adverse Event|0|||
162992361|NCT04572893|588672666|FG005|Part A|Adverse Event|0|||
162992362|NCT04572893|588672667|FG006|Part A|Adverse Event|0|||
162992363|NCT04572893|588672661|FG000|Part B|Withdrawal by Subject|0|||
162992364|NCT04572893|588672662|FG001|Part B|Withdrawal by Subject|0|||
162992365|NCT04572893|588672663|FG002|Part B|Withdrawal by Subject|0|||
162992366|NCT04572893|588672664|FG003|Part B|Withdrawal by Subject|0|||
162992367|NCT04572893|588672665|FG004|Part B|Withdrawal by Subject|0|||
162992368|NCT04572893|588672666|FG005|Part B|Withdrawal by Subject|1|||
162992369|NCT04572893|588672667|FG006|Part B|Withdrawal by Subject|0|||
162992370|NCT04572893|588672661|FG000|Part B|Study terminated by sponsor|0|||
162992371|NCT04572893|588672662|FG001|Part B|Study terminated by sponsor|0|||
162992372|NCT04572893|588672663|FG002|Part B|Study terminated by sponsor|0|||
162992373|NCT04572893|588672664|FG003|Part B|Study terminated by sponsor|0|||
162992374|NCT04572893|588672665|FG004|Part B|Study terminated by sponsor|7|||
162992375|NCT04572893|588672666|FG005|Part B|Study terminated by sponsor|5|||
162992376|NCT04572893|588672667|FG006|Part B|Study terminated by sponsor|3|||
162992377|NCT04572893|588672661|FG000|Part B|Lost to Follow-up|0|||
162992378|NCT04572893|588672662|FG001|Part B|Lost to Follow-up|0|||
162992379|NCT04572893|588672663|FG002|Part B|Lost to Follow-up|0|||
162992380|NCT04572893|588672664|FG003|Part B|Lost to Follow-up|0|||
162992381|NCT04572893|588672665|FG004|Part B|Lost to Follow-up|0|||
162992382|NCT04572893|588672666|FG005|Part B|Lost to Follow-up|0|||
162992383|NCT04572893|588672667|FG006|Part B|Lost to Follow-up|1|||
162992384|NCT04572893|588672661|FG000|Part B|Adverse Event|0|||
162992385|NCT04572893|588672662|FG001|Part B|Adverse Event|0|||
162992386|NCT04572893|588672663|FG002|Part B|Adverse Event|0|||
162992387|NCT04572893|588672664|FG003|Part B|Adverse Event|0|||
162992388|NCT04572893|588672665|FG004|Part B|Adverse Event|1|||
162992389|NCT04572893|588672666|FG005|Part B|Adverse Event|1|||
162992390|NCT04572893|588672667|FG006|Part B|Adverse Event|0|||
162992391|NCT00477295|588672675|FG000|Overall Study|Adverse Event|31|||
162992392|NCT00477295|588672676|FG001|Overall Study|Adverse Event|35|||
162992393|NCT00477295|588672675|FG000|Overall Study|Withdrawal by Subject|35|||
162992394|NCT00477295|588672676|FG001|Overall Study|Withdrawal by Subject|24|||
162992395|NCT00477295|588672675|FG000|Overall Study|Lack of Efficacy|23|||
162992396|NCT00477295|588672676|FG001|Overall Study|Lack of Efficacy|23|||
162992397|NCT00477295|588672675|FG000|Overall Study|Protocol Violation|3|||
162992398|NCT00477295|588672676|FG001|Overall Study|Protocol Violation|8|||
162992399|NCT00477295|588672675|FG000|Overall Study|Physician Decision|4|||
162992400|NCT00477295|588672676|FG001|Overall Study|Physician Decision|5|||
162992401|NCT00477295|588672675|FG000|Overall Study|Lost to Follow-up|21|||
162992402|NCT00477295|588672676|FG001|Overall Study|Lost to Follow-up|11|||
162992403|NCT00477295|588672675|FG000|Overall Study|Other|4|||
162992404|NCT00477295|588672676|FG001|Overall Study|Other|3|||
162992405|NCT03276780|588672679|FG000|Overall Study|Withdrawal by Subject|5|||
162992406|NCT03276780|588672680|FG001|Overall Study|Withdrawal by Subject|3|||
162992407|NCT03276780|588672679|FG000|Overall Study|Lost to Follow-up|3|||
162992408|NCT03276780|588672680|FG001|Overall Study|Lost to Follow-up|5|||
162992409|NCT03276780|588672679|FG000|Overall Study|Moved out of state|1|||
162992410|NCT03276780|588672680|FG001|Overall Study|Moved out of state|1|||
162992411|NCT03276780|588672679|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
162992412|NCT03276780|588672680|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
162992413|NCT03276780|588672679|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
162992414|NCT03276780|588672680|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
162992415|NCT00510289|588672681|FG000|Overall Study|Withdrawal by Subject|7|||
162992416|NCT00510289|588672681|FG000|Overall Study|Refused bone marrow biopsy|2|||
162992417|NCT00510289|588672681|FG000|Overall Study|Lost to Follow-up|1|||
162992418|NCT00510289|588672681|FG000|Overall Study|Progressed prior to starting drug|2|||
162992419|NCT01197755|588672685|FG000|Overall Study|Adverse Event|8|||
162992420|NCT01197755|588672686|FG001|Overall Study|Adverse Event|10|||
162992421|NCT01197755|588672687|FG002|Overall Study|Adverse Event|10|||
162992422|NCT01197755|588672685|FG000|Overall Study|Study-specific discontinuation criteria|2|||
162992423|NCT01197755|588672686|FG001|Overall Study|Study-specific discontinuation criteria|1|||
162992424|NCT01197755|588672687|FG002|Overall Study|Study-specific discontinuation criteria|0|||
162992425|NCT01197755|588672685|FG000|Overall Study|Entered the long-term extension study|18|||
162992426|NCT01197755|588672686|FG001|Overall Study|Entered the long-term extension study|21|||
162992427|NCT01197755|588672687|FG002|Overall Study|Entered the long-term extension study|35|||
162992428|NCT01197755|588672685|FG000|Overall Study|Lack of therapeutic response|0|||
162992429|NCT01197755|588672686|FG001|Overall Study|Lack of therapeutic response|7|||
162992430|NCT01197755|588672687|FG002|Overall Study|Lack of therapeutic response|4|||
162992431|NCT01197755|588672685|FG000|Overall Study|Severe non-compliance to the protocol|2|||
162992432|NCT01197755|588672686|FG001|Overall Study|Severe non-compliance to the protocol|1|||
162992433|NCT01197755|588672687|FG002|Overall Study|Severe non-compliance to the protocol|2|||
162992434|NCT01197755|588672685|FG000|Overall Study|Withdrawal by Subject|1|||
162992435|NCT01197755|588672686|FG001|Overall Study|Withdrawal by Subject|0|||
162992436|NCT01197755|588672687|FG002|Overall Study|Withdrawal by Subject|0|||
162636829|NCT01853826|587385974|FG000|Overall Study|Other adverse events (AE)|62|||
162636830|NCT01853826|587385974|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
162992437|NCT01197755|588672685|FG000|Overall Study|Lost to Follow-up|0|||
162992438|NCT01197755|588672686|FG001|Overall Study|Lost to Follow-up|0|||
162992439|NCT01197755|588672687|FG002|Overall Study|Lost to Follow-up|1|||
162992440|NCT01197755|588672685|FG000|Overall Study|eg, change in circumstances|7|||
162636831|NCT01853826|587385974|FG000|Overall Study|Progressive disease|342|||
162992441|NCT01197755|588672686|FG001|Overall Study|eg, change in circumstances|3|||
162992442|NCT01197755|588672687|FG002|Overall Study|eg, change in circumstances|2|||
162992443|NCT03365011|588672688|FG000|Overall Study|Withdrawal by Subject|1|||
162992444|NCT03365011|588672689|FG001|Overall Study|Withdrawal by Subject|2|||
162992445|NCT03395405|588674435|FG000|Overall Study|Death|0|||
162992446|NCT03395405|588674436|FG001|Overall Study|Death|2|||
162992447|NCT03395405|588674435|FG000|Overall Study|Lost to Follow-up|0|||
162992448|NCT03395405|588674436|FG001|Overall Study|Lost to Follow-up|1|||
162992449|NCT03395405|588674435|FG000|Overall Study|Protocol Violation|0|||
162992450|NCT03395405|588674436|FG001|Overall Study|Protocol Violation|1|||
162992451|NCT03395405|588674435|FG000|Overall Study|Withdrawal by Subject|3|||
162992452|NCT03395405|588674436|FG001|Overall Study|Withdrawal by Subject|1|||
162992453|NCT03395405|588674435|FG000|Overall Study|COVID-19 Pandemic|1|||
162992454|NCT03395405|588674436|FG001|Overall Study|COVID-19 Pandemic|0|||
162992455|NCT01200069|588674442|FG000|Overall Study|Withdrawal by Subject|0|||
162992456|NCT01200069|588674443|FG001|Overall Study|Withdrawal by Subject|1|||
162992457|NCT05307510|588674446|FG000|Overall Study|Lost to Follow-up|3|||
162992458|NCT05307510|588674447|FG001|Overall Study|Lost to Follow-up|6|||
162992459|NCT05307510|588674446|FG000|Overall Study|Withdrawal by Subject|0|||
162992460|NCT05307510|588674447|FG001|Overall Study|Withdrawal by Subject|1|||
162992461|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
162992462|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
162992463|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
162992464|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
162992465|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
162992466|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
162992467|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
162636832|NCT01853826|587385974|FG000|Overall Study|Other than listed|13|||
162636833|NCT01853826|587385974|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
162636834|NCT04779489|587385986|FG000|Overall Study|Physician Decision|1|||
162636835|NCT05126901|587385987|FG000|Overall Study|Withdrawal by Subject|1|||
162992468|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
162992469|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
162992470|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992471|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992472|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
162992473|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
162992474|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992475|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992476|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992477|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992478|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
162992479|NCT00761657|588674450|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992480|NCT00761657|588674451|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992481|NCT00761657|588674452|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
162992482|NCT00761657|588674453|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
162992483|NCT00761657|588674454|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992484|NCT00761657|588674455|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
162992485|NCT00761657|588674456|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992486|NCT00761657|588674457|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992487|NCT00761657|588674458|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
162992488|NCT00761657|588674450|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
162992489|NCT00761657|588674451|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
162992490|NCT00761657|588674452|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
162992491|NCT00761657|588674453|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
162992492|NCT00761657|588674454|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
162992493|NCT00761657|588674455|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
162992494|NCT00761657|588674456|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
162992495|NCT00761657|588674457|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
162992496|NCT00761657|588674458|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
162992497|NCT00478244|588674467|FG000|Overall Study|Did not receive transplant|1|||
162992498|NCT01564537|588674469|FG000|Overall Study|Site Terminated by Sponsor|1|||
162992499|NCT01564537|588674470|FG001|Overall Study|Site Terminated by Sponsor|0|||
162992500|NCT01564537|588674469|FG000|Overall Study|Withdrawal by Subject|12|||
162992501|NCT01564537|588674470|FG001|Overall Study|Withdrawal by Subject|14|||
162636836|NCT05126901|587385988|FG001|Overall Study|Withdrawal by Subject|1|||
162636837|NCT05126901|587385989|FG002|Overall Study|Withdrawal by Subject|4|||
162992502|NCT01564537|588674469|FG000|Overall Study|Lost to Follow-up|7|||
162992503|NCT01564537|588674470|FG001|Overall Study|Lost to Follow-up|3|||
162992504|NCT01564537|588674469|FG000|Overall Study|Reason not specified|81|||
162992505|NCT01564537|588674470|FG001|Overall Study|Reason not specified|82|||
162992506|NCT01664130|588674488|FG000|Overall Study|competing secondary disease|2|||
162992507|NCT02679235|588674489|FG000|Overall Study|Withdrawal by Subject|3|||
162992508|NCT02679235|588674489|FG000|Overall Study|Adverse Event|1|||
162992509|NCT00923273|588674490|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992510|NCT00923273|588674491|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992511|NCT00923273|588674492|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
162992512|NCT00923273|588674493|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
162992513|NCT00923273|588674494|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
163060012|NCT01859741|588928282|FG004|Overall Study|Study Terminated by Sponsor|1|||
162992514|NCT00923273|588674490|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992515|NCT00923273|588674491|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992516|NCT00923273|588674492|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992517|NCT00923273|588674493|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
162992518|NCT00923273|588674494|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
162992519|NCT03146962|588674499|FG000|Overall Study|Lost to Follow-up|1|||
162992520|NCT03146962|588674500|FG001|Overall Study|Lost to Follow-up|1|||
162992521|NCT03146962|588674501|FG002|Overall Study|Lost to Follow-up|0|||
162992522|NCT03146962|588674502|FG003|Overall Study|Lost to Follow-up|0|||
162992523|NCT03146962|588674503|FG004|Overall Study|Lost to Follow-up|0|||
162992524|NCT03146962|588674504|FG005|Overall Study|Lost to Follow-up|0|||
162992525|NCT03146962|588674505|FG006|Overall Study|Lost to Follow-up|0|||
162992526|NCT03146962|588674506|FG007|Overall Study|Lost to Follow-up|0|||
162992527|NCT03146962|588674507|FG008|Overall Study|Lost to Follow-up|0|||
162992528|NCT03146962|588674508|FG009|Overall Study|Lost to Follow-up|0|||
162992529|NCT03146962|588674499|FG000|Overall Study|Adverse Event|0|||
162992530|NCT03146962|588674500|FG001|Overall Study|Adverse Event|3|||
162992531|NCT03146962|588674501|FG002|Overall Study|Adverse Event|0|||
162992532|NCT03146962|588674502|FG003|Overall Study|Adverse Event|0|||
162992533|NCT03146962|588674503|FG004|Overall Study|Adverse Event|0|||
162992534|NCT03146962|588674504|FG005|Overall Study|Adverse Event|0|||
162992535|NCT03146962|588674505|FG006|Overall Study|Adverse Event|0|||
162992536|NCT03146962|588674506|FG007|Overall Study|Adverse Event|1|||
162992537|NCT03146962|588674507|FG008|Overall Study|Adverse Event|0|||
162992538|NCT03146962|588674508|FG009|Overall Study|Adverse Event|0|||
162992539|NCT03146962|588674499|FG000|Overall Study|Withdrawal by Subject|0|||
162992540|NCT03146962|588674500|FG001|Overall Study|Withdrawal by Subject|0|||
162992541|NCT03146962|588674501|FG002|Overall Study|Withdrawal by Subject|0|||
162992542|NCT03146962|588674502|FG003|Overall Study|Withdrawal by Subject|0|||
162992543|NCT03146962|588674503|FG004|Overall Study|Withdrawal by Subject|1|||
162992544|NCT03146962|588674504|FG005|Overall Study|Withdrawal by Subject|0|||
162992545|NCT03146962|588674505|FG006|Overall Study|Withdrawal by Subject|0|||
162992546|NCT03146962|588674506|FG007|Overall Study|Withdrawal by Subject|0|||
162992547|NCT03146962|588674507|FG008|Overall Study|Withdrawal by Subject|0|||
162992548|NCT03146962|588674508|FG009|Overall Study|Withdrawal by Subject|0|||
162992549|NCT03146962|588674499|FG000|Overall Study|Death|0|||
162992550|NCT03146962|588674500|FG001|Overall Study|Death|1|||
162992551|NCT03146962|588674501|FG002|Overall Study|Death|0|||
162992552|NCT03146962|588674502|FG003|Overall Study|Death|0|||
162992553|NCT03146962|588674503|FG004|Overall Study|Death|0|||
162992554|NCT03146962|588674504|FG005|Overall Study|Death|0|||
162992555|NCT03146962|588674505|FG006|Overall Study|Death|0|||
162992556|NCT03146962|588674506|FG007|Overall Study|Death|0|||
162992557|NCT03146962|588674507|FG008|Overall Study|Death|0|||
162992558|NCT03146962|588674508|FG009|Overall Study|Death|0|||
162992559|NCT03146962|588674499|FG000|Overall Study|COVID Precautions|1|||
162992560|NCT03146962|588674500|FG001|Overall Study|COVID Precautions|0|||
162992561|NCT03146962|588674501|FG002|Overall Study|COVID Precautions|0|||
162992562|NCT03146962|588674502|FG003|Overall Study|COVID Precautions|0|||
162992563|NCT03146962|588674503|FG004|Overall Study|COVID Precautions|0|||
162992564|NCT03146962|588674504|FG005|Overall Study|COVID Precautions|0|||
162992565|NCT03146962|588674505|FG006|Overall Study|COVID Precautions|0|||
162992566|NCT03146962|588674506|FG007|Overall Study|COVID Precautions|0|||
162992567|NCT03146962|588674507|FG008|Overall Study|COVID Precautions|0|||
162992568|NCT03146962|588674508|FG009|Overall Study|COVID Precautions|0|||
162992569|NCT03146962|588674499|FG000|Overall Study|Physician Decision|0|||
162992570|NCT03146962|588674500|FG001|Overall Study|Physician Decision|0|||
162992571|NCT03146962|588674501|FG002|Overall Study|Physician Decision|0|||
163060013|NCT01859741|588928283|FG005|Overall Study|Study Terminated by Sponsor|0|||
162992572|NCT03146962|588674502|FG003|Overall Study|Physician Decision|0|||
162992573|NCT03146962|588674503|FG004|Overall Study|Physician Decision|0|||
162992574|NCT03146962|588674504|FG005|Overall Study|Physician Decision|0|||
162992575|NCT03146962|588674505|FG006|Overall Study|Physician Decision|0|||
162992576|NCT03146962|588674506|FG007|Overall Study|Physician Decision|0|||
163060014|NCT01859741|588928284|FG006|Overall Study|Study Terminated by Sponsor|16|||
163060015|NCT01859741|588928285|FG007|Overall Study|Study Terminated by Sponsor|14|||
163060016|NCT01859741|588928278|FG000|Overall Study|Other|0|||
163060017|NCT01859741|588928279|FG001|Overall Study|Other|0|||
162992577|NCT03146962|588674507|FG008|Overall Study|Physician Decision|0|||
162992578|NCT03146962|588674508|FG009|Overall Study|Physician Decision|1|||
162992579|NCT03146962|588674499|FG000|Overall Study|Started New Treatment|0|||
162992580|NCT03146962|588674500|FG001|Overall Study|Started New Treatment|1|||
162992581|NCT03146962|588674501|FG002|Overall Study|Started New Treatment|0|||
162992582|NCT03146962|588674502|FG003|Overall Study|Started New Treatment|0|||
162992583|NCT03146962|588674503|FG004|Overall Study|Started New Treatment|0|||
162992584|NCT03146962|588674504|FG005|Overall Study|Started New Treatment|0|||
162992585|NCT03146962|588674505|FG006|Overall Study|Started New Treatment|0|||
163060018|NCT01859741|588928280|FG002|Overall Study|Other|0|||
162992586|NCT03146962|588674506|FG007|Overall Study|Started New Treatment|0|||
162992587|NCT03146962|588674507|FG008|Overall Study|Started New Treatment|0|||
162992588|NCT03146962|588674508|FG009|Overall Study|Started New Treatment|0|||
162992589|NCT02383810|588674509|FG000|Overall Study|Physician Decision|1|||
162992590|NCT02383810|588674510|FG001|Overall Study|Physician Decision|1|||
162992591|NCT02383810|588674511|FG002|Overall Study|Physician Decision|0|||
162992592|NCT02383810|588674512|FG003|Overall Study|Physician Decision|0|||
162992593|NCT02383810|588674513|FG004|Overall Study|Physician Decision|0|||
162992594|NCT02383810|588674514|FG005|Overall Study|Physician Decision|0|||
162992595|NCT02383810|588674515|FG006|Overall Study|Physician Decision|0|||
163060019|NCT01859741|588928281|FG003|Overall Study|Other|0|||
163060020|NCT01859741|588928282|FG004|Overall Study|Other|0|||
163060021|NCT01859741|588928283|FG005|Overall Study|Other|0|||
163060022|NCT01859741|588928284|FG006|Overall Study|Other|2|||
163060023|NCT01859741|588928285|FG007|Overall Study|Other|0|||
163060024|NCT02412657|588928286|FG000|Overall Study|Lost to Follow-up|1|||
163060025|NCT02412657|588928287|FG001|Overall Study|Lost to Follow-up|0|||
163060026|NCT02412657|588928288|FG002|Overall Study|Lost to Follow-up|0|||
163060027|NCT02412657|588928286|FG000|Overall Study|Protocol Violation|0|||
163060028|NCT02412657|588928287|FG001|Overall Study|Protocol Violation|2|||
163060029|NCT02412657|588928288|FG002|Overall Study|Protocol Violation|3|||
163060030|NCT00920816|588928292|FG000|Overall Study|Death|116|||
163060031|NCT00920816|588928293|FG001|Overall Study|Death|63|||
163060032|NCT00920816|588928294|FG002|Overall Study|Death|8|||
163060033|NCT00920816|588928295|FG003|Overall Study|Death|3|||
163060034|NCT00920816|588928292|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
163060035|NCT00920816|588928293|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
163060036|NCT00920816|588928294|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
163060037|NCT00920816|588928295|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
163060038|NCT00920816|588928292|FG000|Overall Study|Global deterioration of health status|2|||
163060039|NCT00920816|588928293|FG001|Overall Study|Global deterioration of health status|0|||
163060040|NCT00920816|588928294|FG002|Overall Study|Global deterioration of health status|0|||
163060041|NCT00920816|588928295|FG003|Overall Study|Global deterioration of health status|0|||
163060042|NCT00920816|588928292|FG000|Overall Study|Objective progression or relapse|6|||
163060043|NCT00920816|588928293|FG001|Overall Study|Objective progression or relapse|2|||
163060044|NCT00920816|588928294|FG002|Overall Study|Objective progression or relapse|0|||
163060045|NCT00920816|588928295|FG003|Overall Study|Objective progression or relapse|0|||
163060046|NCT00920816|588928292|FG000|Overall Study|Other|26|||
163060047|NCT00920816|588928293|FG001|Overall Study|Other|15|||
163060048|NCT00920816|588928294|FG002|Overall Study|Other|1|||
163060049|NCT00920816|588928295|FG003|Overall Study|Other|2|||
163060050|NCT00920816|588928292|FG000|Overall Study|Lost to Follow-up|11|||
163060051|NCT00920816|588928293|FG001|Overall Study|Lost to Follow-up|2|||
163060052|NCT00920816|588928294|FG002|Overall Study|Lost to Follow-up|0|||
163060053|NCT00920816|588928295|FG003|Overall Study|Lost to Follow-up|0|||
163060054|NCT00920816|588928292|FG000|Overall Study|Adverse Event|1|||
163060055|NCT00920816|588928293|FG001|Overall Study|Adverse Event|1|||
163060056|NCT00920816|588928294|FG002|Overall Study|Adverse Event|1|||
163060057|NCT00920816|588928295|FG003|Overall Study|Adverse Event|0|||
163060058|NCT00920816|588928292|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
163060059|NCT00920816|588928293|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
163060060|NCT00920816|588928294|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
163060061|NCT00920816|588928295|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
163060062|NCT00920816|588928292|FG000|Overall Study|Randomized but not treated|3|||
163060063|NCT00920816|588928293|FG001|Overall Study|Randomized but not treated|0|||
163060064|NCT00920816|588928294|FG002|Overall Study|Randomized but not treated|0|||
163060065|NCT00920816|588928295|FG003|Overall Study|Randomized but not treated|0|||
163060066|NCT03185208|588928296|FG000|Overall Study|Did not start study medication|0|||
162636838|NCT05126901|587385987|FG000|Overall Study|Adverse Event|0|||
162636839|NCT05126901|587385988|FG001|Overall Study|Adverse Event|0|||
162636840|NCT05126901|587385989|FG002|Overall Study|Adverse Event|1|||
162636841|NCT05126901|587385987|FG000|Overall Study|Lost to Follow-up|0|||
163060067|NCT03185208|588928297|FG001|Overall Study|Did not start study medication|3|||
163060068|NCT03834350|588928298|FG000|Overall Study|Withdrawal by Subject|1|||
163060069|NCT02765165|588928303|FG000|Treatment Period|Progressive disease|3|||
163060070|NCT02765165|588928304|FG001|Treatment Period|Progressive disease|2|||
163060071|NCT02765165|588928305|FG002|Treatment Period|Progressive disease|3|||
163060072|NCT02765165|588928306|FG003|Treatment Period|Progressive disease|3|||
163060073|NCT02765165|588928307|FG004|Treatment Period|Progressive disease|4|||
162636842|NCT05126901|587385988|FG001|Overall Study|Lost to Follow-up|2|||
162636843|NCT05126901|587385989|FG002|Overall Study|Lost to Follow-up|0|||
162636844|NCT00710710|587385990|FG000|Overall Study|Consent withdrawn|2|||
162992596|NCT02383810|588674516|FG007|Overall Study|Physician Decision|0|||
162992597|NCT02383810|588674509|FG000|Overall Study|Withdrawal by Subject|2|||
162992598|NCT02383810|588674510|FG001|Overall Study|Withdrawal by Subject|3|||
162715653|NCT03643211|587667062|FG000|Overall Study|No treatment information|2|||
162715654|NCT03643211|587667062|FG000|Overall Study|No adverse event information - No revisit|4|||
162715655|NCT00881335|587667063|FG000|Overall Study|Lost to Follow-up|3|||
162992599|NCT02383810|588674511|FG002|Overall Study|Withdrawal by Subject|3|||
162992600|NCT02383810|588674512|FG003|Overall Study|Withdrawal by Subject|3|||
162992601|NCT02383810|588674513|FG004|Overall Study|Withdrawal by Subject|0|||
162992602|NCT02383810|588674514|FG005|Overall Study|Withdrawal by Subject|0|||
162992603|NCT02383810|588674515|FG006|Overall Study|Withdrawal by Subject|0|||
162992604|NCT02383810|588674516|FG007|Overall Study|Withdrawal by Subject|0|||
162992605|NCT02383810|588674509|FG000|Overall Study|Adverse Event|0|||
162992606|NCT02383810|588674510|FG001|Overall Study|Adverse Event|2|||
162992607|NCT02383810|588674511|FG002|Overall Study|Adverse Event|4|||
162992608|NCT02383810|588674512|FG003|Overall Study|Adverse Event|5|||
162992609|NCT02383810|588674513|FG004|Overall Study|Adverse Event|0|||
162992610|NCT02383810|588674514|FG005|Overall Study|Adverse Event|1|||
162992611|NCT02383810|588674515|FG006|Overall Study|Adverse Event|1|||
162992612|NCT02383810|588674516|FG007|Overall Study|Adverse Event|0|||
162992613|NCT02383810|588674509|FG000|Overall Study|Lost to Follow-up|0|||
162992614|NCT02383810|588674510|FG001|Overall Study|Lost to Follow-up|1|||
162992615|NCT02383810|588674511|FG002|Overall Study|Lost to Follow-up|0|||
162992616|NCT02383810|588674512|FG003|Overall Study|Lost to Follow-up|1|||
162992617|NCT02383810|588674513|FG004|Overall Study|Lost to Follow-up|0|||
162992618|NCT02383810|588674514|FG005|Overall Study|Lost to Follow-up|0|||
162992619|NCT02383810|588674515|FG006|Overall Study|Lost to Follow-up|0|||
162992620|NCT02383810|588674516|FG007|Overall Study|Lost to Follow-up|0|||
162992621|NCT02383810|588674509|FG000|Overall Study|other|0|||
162992622|NCT02383810|588674510|FG001|Overall Study|other|0|||
162992623|NCT02383810|588674511|FG002|Overall Study|other|0|||
162992624|NCT02383810|588674512|FG003|Overall Study|other|2|||
162992625|NCT02383810|588674513|FG004|Overall Study|other|0|||
162992626|NCT02383810|588674514|FG005|Overall Study|other|0|||
162992627|NCT02383810|588674515|FG006|Overall Study|other|0|||
162992628|NCT02383810|588674516|FG007|Overall Study|other|0|||
162992629|NCT02383810|588674509|FG000|Overall Study|subject did not receive study treatment|0|||
162992630|NCT02383810|588674510|FG001|Overall Study|subject did not receive study treatment|1|||
162992631|NCT02383810|588674511|FG002|Overall Study|subject did not receive study treatment|0|||
162992632|NCT02383810|588674512|FG003|Overall Study|subject did not receive study treatment|0|||
162992633|NCT02383810|588674513|FG004|Overall Study|subject did not receive study treatment|0|||
162992634|NCT02383810|588674514|FG005|Overall Study|subject did not receive study treatment|0|||
162992635|NCT02383810|588674515|FG006|Overall Study|subject did not receive study treatment|0|||
162992636|NCT02383810|588674516|FG007|Overall Study|subject did not receive study treatment|0|||
162992637|NCT01635283|588674519|FG000|Overall Study|Tumor Progression|3|||
162992638|NCT01635283|588674519|FG000|Overall Study|Lost to Follow-up|1|||
162992639|NCT01438996|588674522|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
162992640|NCT01438996|588674523|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
162992641|NCT01438996|588674524|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
162992642|NCT04516759|588674525|FG000|Overall Study|Withdrawal by Subject|1|||
162992643|NCT04516759|588674526|FG001|Overall Study|Withdrawal by Subject|1|||
162992644|NCT04516759|588674525|FG000|Overall Study|Other|0|||
162992645|NCT04516759|588674526|FG001|Overall Study|Other|1|||
162992646|NCT02246114|588674527|FG000|Overall Study|miscarriage|1|||
162992647|NCT02246114|588674528|FG001|Overall Study|miscarriage|0|||
162992648|NCT00229723|588674536|FG000|Concomitant Phase|Adverse Event|4|||
162992649|NCT00229723|588674537|FG001|Concomitant Phase|Adverse Event|2|||
162992650|NCT00229723|588674538|FG002|Concomitant Phase|Adverse Event|5|||
162992651|NCT00229723|588674539|FG003|Concomitant Phase|Adverse Event|2|||
162992652|NCT00229723|588674540|FG004|Concomitant Phase|Adverse Event|0|||
162992653|NCT00229723|588674541|FG005|Concomitant Phase|Adverse Event|1|||
162992654|NCT00229723|588674542|FG006|Concomitant Phase|Adverse Event|2|||
162992655|NCT00229723|588674536|FG000|Concomitant Phase|Objective disease progression|0|||
162992656|NCT00229723|588674537|FG001|Concomitant Phase|Objective disease progression|0|||
162992657|NCT00229723|588674538|FG002|Concomitant Phase|Objective disease progression|0|||
163060074|NCT02765165|588928308|FG005|Treatment Period|Progressive disease|2|||
162715656|NCT00881335|587667064|FG001|Overall Study|Lost to Follow-up|2|||
162992658|NCT00229723|588674539|FG003|Concomitant Phase|Objective disease progression|0|||
162992659|NCT00229723|588674540|FG004|Concomitant Phase|Objective disease progression|0|||
162992660|NCT00229723|588674541|FG005|Concomitant Phase|Objective disease progression|0|||
162992661|NCT00229723|588674542|FG006|Concomitant Phase|Objective disease progression|0|||
162992662|NCT00229723|588674536|FG000|Concomitant Phase|Clinical progression|0|||
162992663|NCT00229723|588674537|FG001|Concomitant Phase|Clinical progression|0|||
162715657|NCT04538664|587667065|FG000|Overall Study|Withdrawal by Subject|5|||
162992664|NCT00229723|588674538|FG002|Concomitant Phase|Clinical progression|0|||
162992665|NCT00229723|588674539|FG003|Concomitant Phase|Clinical progression|0|||
162992666|NCT00229723|588674540|FG004|Concomitant Phase|Clinical progression|0|||
162992667|NCT00229723|588674541|FG005|Concomitant Phase|Clinical progression|0|||
162992668|NCT00229723|588674542|FG006|Concomitant Phase|Clinical progression|1|||
162992669|NCT00229723|588674536|FG000|Concomitant Phase|Lost to Follow-up|0|||
162992670|NCT00229723|588674537|FG001|Concomitant Phase|Lost to Follow-up|0|||
162992671|NCT00229723|588674538|FG002|Concomitant Phase|Lost to Follow-up|0|||
162992672|NCT00229723|588674539|FG003|Concomitant Phase|Lost to Follow-up|0|||
162992673|NCT00229723|588674540|FG004|Concomitant Phase|Lost to Follow-up|1|||
162992674|NCT00229723|588674541|FG005|Concomitant Phase|Lost to Follow-up|0|||
162992675|NCT00229723|588674542|FG006|Concomitant Phase|Lost to Follow-up|0|||
162992676|NCT00229723|588674536|FG000|Concomitant Phase|Informed consent withdrawn|3|||
162992677|NCT00229723|588674537|FG001|Concomitant Phase|Informed consent withdrawn|2|||
162992678|NCT00229723|588674538|FG002|Concomitant Phase|Informed consent withdrawn|0|||
162992679|NCT00229723|588674539|FG003|Concomitant Phase|Informed consent withdrawn|2|||
162992680|NCT00229723|588674540|FG004|Concomitant Phase|Informed consent withdrawn|0|||
162992681|NCT00229723|588674541|FG005|Concomitant Phase|Informed consent withdrawn|0|||
162992682|NCT00229723|588674542|FG006|Concomitant Phase|Informed consent withdrawn|0|||
162992683|NCT00229723|588674536|FG000|Concomitant Phase|Severe non-compliance|0|||
162992684|NCT00229723|588674537|FG001|Concomitant Phase|Severe non-compliance|1|||
162992685|NCT00229723|588674538|FG002|Concomitant Phase|Severe non-compliance|0|||
162992686|NCT00229723|588674539|FG003|Concomitant Phase|Severe non-compliance|0|||
162992687|NCT00229723|588674540|FG004|Concomitant Phase|Severe non-compliance|1|||
162992688|NCT00229723|588674541|FG005|Concomitant Phase|Severe non-compliance|0|||
162992689|NCT00229723|588674542|FG006|Concomitant Phase|Severe non-compliance|0|||
162992690|NCT00229723|588674536|FG000|Concomitant Phase|Other|3|||
162992691|NCT00229723|588674537|FG001|Concomitant Phase|Other|0|||
162636845|NCT00710710|587385991|FG001|Overall Study|Consent withdrawn|2|||
162992692|NCT00229723|588674538|FG002|Concomitant Phase|Other|1|||
162992693|NCT00229723|588674539|FG003|Concomitant Phase|Other|1|||
162992694|NCT00229723|588674540|FG004|Concomitant Phase|Other|0|||
162992695|NCT00229723|588674541|FG005|Concomitant Phase|Other|2|||
162992696|NCT00229723|588674542|FG006|Concomitant Phase|Other|0|||
162992697|NCT00229723|588674536|FG000|Maintenance Phase|Adverse Event|7|||
162992698|NCT00229723|588674537|FG001|Maintenance Phase|Adverse Event|2|||
162992699|NCT00229723|588674538|FG002|Maintenance Phase|Adverse Event|1|||
162992700|NCT00229723|588674539|FG003|Maintenance Phase|Adverse Event|4|||
162992701|NCT00229723|588674540|FG004|Maintenance Phase|Adverse Event|7|||
162992702|NCT00229723|588674541|FG005|Maintenance Phase|Adverse Event|5|||
162992703|NCT00229723|588674542|FG006|Maintenance Phase|Adverse Event|2|||
162992704|NCT00229723|588674536|FG000|Maintenance Phase|Objective disease progression|5|||
162992705|NCT00229723|588674537|FG001|Maintenance Phase|Objective disease progression|5|||
162992706|NCT00229723|588674538|FG002|Maintenance Phase|Objective disease progression|3|||
162992707|NCT00229723|588674539|FG003|Maintenance Phase|Objective disease progression|6|||
162992708|NCT00229723|588674540|FG004|Maintenance Phase|Objective disease progression|2|||
162992709|NCT00229723|588674541|FG005|Maintenance Phase|Objective disease progression|9|||
162992710|NCT00229723|588674542|FG006|Maintenance Phase|Objective disease progression|5|||
162992711|NCT00229723|588674536|FG000|Maintenance Phase|Clinical progression|4|||
162992712|NCT00229723|588674537|FG001|Maintenance Phase|Clinical progression|1|||
162992713|NCT00229723|588674538|FG002|Maintenance Phase|Clinical progression|2|||
162992714|NCT00229723|588674539|FG003|Maintenance Phase|Clinical progression|2|||
162992715|NCT00229723|588674540|FG004|Maintenance Phase|Clinical progression|1|||
162992716|NCT00229723|588674541|FG005|Maintenance Phase|Clinical progression|1|||
162992717|NCT00229723|588674542|FG006|Maintenance Phase|Clinical progression|1|||
162992718|NCT00229723|588674536|FG000|Maintenance Phase|Lost to Follow-up|0|||
162992719|NCT00229723|588674537|FG001|Maintenance Phase|Lost to Follow-up|1|||
162992720|NCT00229723|588674538|FG002|Maintenance Phase|Lost to Follow-up|2|||
162992721|NCT00229723|588674539|FG003|Maintenance Phase|Lost to Follow-up|2|||
162992722|NCT00229723|588674540|FG004|Maintenance Phase|Lost to Follow-up|0|||
163060075|NCT02765165|588928309|FG006|Treatment Period|Progressive disease|2|||
163060076|NCT02765165|588928303|FG000|Treatment Period|Physician Decision|0|||
162636846|NCT00710710|587385990|FG000|Overall Study|Protocol Violation|0|||
162636847|NCT00710710|587385991|FG001|Overall Study|Protocol Violation|1|||
162636848|NCT00710710|587385990|FG000|Overall Study|Adverse Event|3|||
162636849|NCT00710710|587385991|FG001|Overall Study|Adverse Event|3|||
162636850|NCT00710710|587385990|FG000|Overall Study|Progressive disease|40|||
162992723|NCT00229723|588674541|FG005|Maintenance Phase|Lost to Follow-up|0|||
162992724|NCT00229723|588674542|FG006|Maintenance Phase|Lost to Follow-up|1|||
162992725|NCT00229723|588674536|FG000|Maintenance Phase|Informed consent withdrawn|1|||
162992726|NCT00229723|588674537|FG001|Maintenance Phase|Informed consent withdrawn|0|||
162992727|NCT00229723|588674538|FG002|Maintenance Phase|Informed consent withdrawn|0|||
162992728|NCT00229723|588674539|FG003|Maintenance Phase|Informed consent withdrawn|1|||
162992729|NCT00229723|588674540|FG004|Maintenance Phase|Informed consent withdrawn|1|||
162636851|NCT00710710|587385991|FG001|Overall Study|Progressive disease|38|||
162992730|NCT00229723|588674541|FG005|Maintenance Phase|Informed consent withdrawn|1|||
162992731|NCT00229723|588674542|FG006|Maintenance Phase|Informed consent withdrawn|0|||
162992732|NCT00229723|588674536|FG000|Maintenance Phase|Severe non-compliance|3|||
162992733|NCT00229723|588674537|FG001|Maintenance Phase|Severe non-compliance|1|||
162992734|NCT00229723|588674538|FG002|Maintenance Phase|Severe non-compliance|0|||
162992735|NCT00229723|588674539|FG003|Maintenance Phase|Severe non-compliance|0|||
162715658|NCT04538664|587667066|FG001|Overall Study|Withdrawal by Subject|9|||
162992736|NCT00229723|588674540|FG004|Maintenance Phase|Severe non-compliance|1|||
162992737|NCT00229723|588674541|FG005|Maintenance Phase|Severe non-compliance|0|||
162992738|NCT00229723|588674542|FG006|Maintenance Phase|Severe non-compliance|0|||
162992739|NCT00229723|588674536|FG000|Maintenance Phase|Other|5|||
162992740|NCT00229723|588674537|FG001|Maintenance Phase|Other|4|||
162992741|NCT00229723|588674538|FG002|Maintenance Phase|Other|1|||
162715659|NCT04538664|587667065|FG000|Overall Study|Lost to Follow-up|2|||
162992742|NCT00229723|588674539|FG003|Maintenance Phase|Other|2|||
162992743|NCT00229723|588674540|FG004|Maintenance Phase|Other|3|||
162992744|NCT00229723|588674541|FG005|Maintenance Phase|Other|3|||
162992745|NCT00229723|588674542|FG006|Maintenance Phase|Other|1|||
163060077|NCT02765165|588928304|FG001|Treatment Period|Physician Decision|1|||
163060078|NCT02765165|588928305|FG002|Treatment Period|Physician Decision|0|||
163060079|NCT02765165|588928306|FG003|Treatment Period|Physician Decision|0|||
163060080|NCT02765165|588928307|FG004|Treatment Period|Physician Decision|0|||
163060081|NCT02765165|588928308|FG005|Treatment Period|Physician Decision|0|||
163060082|NCT02765165|588928309|FG006|Treatment Period|Physician Decision|0|||
163060083|NCT02765165|588928303|FG000|Treatment Period|Adverse Event|0|||
163060084|NCT02765165|588928304|FG001|Treatment Period|Adverse Event|1|||
163060085|NCT02765165|588928305|FG002|Treatment Period|Adverse Event|0|||
163060086|NCT02765165|588928306|FG003|Treatment Period|Adverse Event|0|||
163060087|NCT02765165|588928307|FG004|Treatment Period|Adverse Event|0|||
163060088|NCT02765165|588928308|FG005|Treatment Period|Adverse Event|0|||
163060089|NCT02765165|588928309|FG006|Treatment Period|Adverse Event|0|||
163060090|NCT02765165|588928303|FG000|Treatment Period|Withdrawal by Subject|0|||
163060091|NCT02765165|588928304|FG001|Treatment Period|Withdrawal by Subject|0|||
163060092|NCT02765165|588928305|FG002|Treatment Period|Withdrawal by Subject|0|||
163060093|NCT02765165|588928306|FG003|Treatment Period|Withdrawal by Subject|0|||
163060094|NCT02765165|588928307|FG004|Treatment Period|Withdrawal by Subject|2|||
163060095|NCT02765165|588928308|FG005|Treatment Period|Withdrawal by Subject|0|||
163060096|NCT02765165|588928309|FG006|Treatment Period|Withdrawal by Subject|0|||
163060097|NCT02765165|588928303|FG000|Treatment Period|Study terminated|0|||
163060098|NCT02765165|588928304|FG001|Treatment Period|Study terminated|0|||
163060099|NCT02765165|588928305|FG002|Treatment Period|Study terminated|0|||
163060100|NCT02765165|588928306|FG003|Treatment Period|Study terminated|0|||
163060101|NCT02765165|588928307|FG004|Treatment Period|Study terminated|0|||
163060102|NCT02765165|588928308|FG005|Treatment Period|Study terminated|1|||
163060103|NCT02765165|588928309|FG006|Treatment Period|Study terminated|2|||
163060104|NCT02765165|588928303|FG000|Post-treatment Follow-up|Death|1|||
163060105|NCT02765165|588928304|FG001|Post-treatment Follow-up|Death|2|||
163060106|NCT02765165|588928305|FG002|Post-treatment Follow-up|Death|1|||
162636852|NCT00715078|587385992|FG000|Overall Study|Death|29|||
162636853|NCT00715078|587385993|FG001|Overall Study|Death|36|||
162636854|NCT00715078|587385994|FG002|Overall Study|Death|36|||
162636855|NCT00715078|587385992|FG000|Overall Study|Withdrawal by Subject|1|||
162636856|NCT00715078|587385993|FG001|Overall Study|Withdrawal by Subject|0|||
162636857|NCT00715078|587385994|FG002|Overall Study|Withdrawal by Subject|1|||
162636858|NCT00715078|587385992|FG000|Overall Study|Unable to start due to disease prog.|0|||
162636859|NCT00715078|587385993|FG001|Overall Study|Unable to start due to disease prog.|0|||
162636860|NCT00715078|587385994|FG002|Overall Study|Unable to start due to disease prog.|1|||
162992746|NCT01338870|588674544|FG000|Overall Study|Lost to Follow-up|0|||
162992747|NCT01338870|588674545|FG001|Overall Study|Lost to Follow-up|0|||
162992748|NCT01338870|588674546|FG002|Overall Study|Lost to Follow-up|1|||
162992749|NCT01338870|588674547|FG003|Overall Study|Lost to Follow-up|0|||
162992750|NCT01338870|588674548|FG004|Overall Study|Lost to Follow-up|1|||
162992751|NCT01338870|588674549|FG005|Overall Study|Lost to Follow-up|0|||
162992752|NCT01338870|588674544|FG000|Overall Study|Withdrawal by Subject|2|||
162992753|NCT01338870|588674545|FG001|Overall Study|Withdrawal by Subject|3|||
162992754|NCT01338870|588674546|FG002|Overall Study|Withdrawal by Subject|4|||
162992755|NCT01338870|588674547|FG003|Overall Study|Withdrawal by Subject|0|||
162992756|NCT01338870|588674548|FG004|Overall Study|Withdrawal by Subject|0|||
162992757|NCT01338870|588674549|FG005|Overall Study|Withdrawal by Subject|2|||
162992758|NCT01338870|588674544|FG000|Overall Study|Other|3|||
162992759|NCT01338870|588674545|FG001|Overall Study|Other|3|||
162992760|NCT01338870|588674546|FG002|Overall Study|Other|3|||
162992761|NCT01338870|588674547|FG003|Overall Study|Other|2|||
162992762|NCT01338870|588674548|FG004|Overall Study|Other|0|||
162992763|NCT01338870|588674549|FG005|Overall Study|Other|2|||
162992764|NCT01338870|588674544|FG000|Overall Study|Protocol Violation|0|||
162992765|NCT01338870|588674545|FG001|Overall Study|Protocol Violation|2|||
162992766|NCT01338870|588674546|FG002|Overall Study|Protocol Violation|2|||
162992767|NCT01338870|588674547|FG003|Overall Study|Protocol Violation|2|||
162992768|NCT01338870|588674548|FG004|Overall Study|Protocol Violation|1|||
162992769|NCT01338870|588674549|FG005|Overall Study|Protocol Violation|1|||
162992770|NCT01338870|588674544|FG000|Overall Study|Adverse Event|4|||
162992771|NCT01338870|588674545|FG001|Overall Study|Adverse Event|4|||
162992772|NCT01338870|588674546|FG002|Overall Study|Adverse Event|1|||
162992773|NCT01338870|588674547|FG003|Overall Study|Adverse Event|5|||
162992774|NCT01338870|588674548|FG004|Overall Study|Adverse Event|4|||
163060107|NCT02765165|588928306|FG003|Post-treatment Follow-up|Death|1|||
163060108|NCT02765165|588928307|FG004|Post-treatment Follow-up|Death|1|||
163060109|NCT02765165|588928308|FG005|Post-treatment Follow-up|Death|1|||
163060110|NCT02765165|588928309|FG006|Post-treatment Follow-up|Death|0|||
163060111|NCT02765165|588928303|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
162636861|NCT01529346|587385995|FG000|Overall Study|Lost to Follow-up|2|||
162636862|NCT01529346|587385996|FG001|Overall Study|Lost to Follow-up|0|||
162636863|NCT01529346|587385997|FG002|Overall Study|Lost to Follow-up|1|||
162636864|NCT01529346|587385998|FG003|Overall Study|Lost to Follow-up|0|||
162636865|NCT01529346|587385999|FG004|Overall Study|Lost to Follow-up|0|||
162636866|NCT01529346|587385995|FG000|Overall Study|Other|0|||
162636867|NCT01529346|587385996|FG001|Overall Study|Other|1|||
162715660|NCT04538664|587667066|FG001|Overall Study|Lost to Follow-up|1|||
163060112|NCT02765165|588928304|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
162636868|NCT01529346|587385997|FG002|Overall Study|Other|1|||
162636869|NCT01529346|587385998|FG003|Overall Study|Other|0|||
162715661|NCT04538664|587667065|FG000|Overall Study|Ongoing|106|||
163060113|NCT02765165|588928305|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
162992775|NCT01338870|588674549|FG005|Overall Study|Adverse Event|1|||
162992776|NCT02774642|588674550|FG000|Overall Study|Lost to Follow-up|9|||
162992777|NCT02774642|588674551|FG001|Overall Study|Lost to Follow-up|7|||
162992778|NCT03835221|588674552|FG000|Methafilcon A|Withdrawal by Subject|1|||
162992779|NCT00861198|588674553|FG000|Overall Study|SpyGlass Failed|5|||
162992780|NCT02288182|588674554|FG000|Overall Study|Adverse Event|0|||
162992781|NCT02288182|588674555|FG001|Overall Study|Adverse Event|1|||
162636870|NCT01529346|587385999|FG004|Overall Study|Other|0|||
162992782|NCT02288182|588674554|FG000|Overall Study|Lost to Follow-up|0|||
162992783|NCT02288182|588674555|FG001|Overall Study|Lost to Follow-up|1|||
162992784|NCT04619992|588674557|FG000|Overall Study|Withdrawal by Subject|1|||
162992785|NCT04619992|588674558|FG001|Overall Study|Withdrawal by Subject|0|||
162992786|NCT03582826|588674559|FG000|Overall Study|Lost to Follow-up|39|||
162992787|NCT03582826|588674560|FG001|Overall Study|Lost to Follow-up|0|||
162992788|NCT03582826|588674559|FG000|Overall Study|Withdrawal by Subject|2|||
162992789|NCT03582826|588674560|FG001|Overall Study|Withdrawal by Subject|0|||
162992790|NCT00499174|588674561|FG000|Overall Study|Physician Decision|78|||
162992791|NCT00499174|588674562|FG001|Overall Study|Physician Decision|9|||
162992792|NCT01214915|588674563|FG000|Overall Study|Adverse Event|8|||
162992793|NCT01214915|588674563|FG000|Overall Study|Lack of Efficacy|3|||
162992794|NCT00574912|588674564|FG000|Overall Study|Could not place IV lines.|3|||
162992795|NCT00574912|588674564|FG000|Overall Study|scheduling conflicts|3|||
162992796|NCT00574912|588674564|FG000|Overall Study|Physician Decision|2|||
162992797|NCT04730349|588674573|FG000|Overall Study|Participant withdrew consent|1|||
162992798|NCT04730349|588674574|FG001|Overall Study|Participant withdrew consent|0|||
162992799|NCT04730349|588674573|FG000|Overall Study|Disease progression|6|||
162992800|NCT04730349|588674574|FG001|Overall Study|Disease progression|4|||
162992801|NCT04730349|588674573|FG000|Overall Study|Study drug toxicity|0|||
162992802|NCT04730349|588674574|FG001|Overall Study|Study drug toxicity|1|||
162992803|NCT00638027|588674575|FG000|Overall Study|Adverse Event|0|||
162992804|NCT00638027|588674576|FG001|Overall Study|Adverse Event|2|||
162992805|NCT00371397|588674577|FG000|Session 1|Withdrawal by Subject|1|||
162992806|NCT00371397|588674578|FG001|Session 1|Withdrawal by Subject|0|||
162992807|NCT00371397|588674579|FG002|Session 1|Withdrawal by Subject|0|||
162992808|NCT00371397|588674580|FG003|Session 1|Withdrawal by Subject|0|||
162992809|NCT00371397|588674581|FG004|Session 1|Withdrawal by Subject|0|||
162992810|NCT00371397|588674582|FG005|Session 1|Withdrawal by Subject|0|||
162992811|NCT00371397|588674583|FG006|Session 1|Withdrawal by Subject|0|||
162992812|NCT00371397|588674584|FG007|Session 1|Withdrawal by Subject|1|||
162992813|NCT00371397|588674585|FG008|Session 1|Withdrawal by Subject|0|||
162992814|NCT00371397|588674586|FG009|Session 1|Withdrawal by Subject|0|||
162992815|NCT00371397|588674587|FG010|Session 1|Withdrawal by Subject|0|||
162992816|NCT00371397|588674588|FG011|Session 1|Withdrawal by Subject|0|||
162992817|NCT03753763|588674589|FG000|Overall Study|Adverse Event|2|||
162992818|NCT03753763|588674590|FG001|Overall Study|Adverse Event|0|||
162992819|NCT03753763|588674589|FG000|Overall Study|Withdrawal by Subject|3|||
162992820|NCT03753763|588674590|FG001|Overall Study|Withdrawal by Subject|1|||
162992821|NCT03753763|588674589|FG000|Overall Study|clinical deterioration|1|||
162992822|NCT03753763|588674590|FG001|Overall Study|clinical deterioration|0|||
162992823|NCT01104779|588674591|FG000|Overall Study|Protocol Violation|1|||
162992824|NCT01104779|588674592|FG001|Overall Study|Protocol Violation|2|||
163060114|NCT02765165|588928306|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
163060115|NCT02765165|588928307|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
162636871|NCT02282020|587386006|FG000|Overall Study|Objective Disease Progression|128|||
162636872|NCT02282020|587386007|FG001|Overall Study|Objective Disease Progression|30|||
162636873|NCT02282020|587386006|FG000|Overall Study|Adverse Event|18|||
162636874|NCT02282020|587386007|FG001|Overall Study|Adverse Event|15|||
162636875|NCT02282020|587386006|FG000|Overall Study|Withdrawal by Subject|7|||
162636876|NCT02282020|587386007|FG001|Overall Study|Withdrawal by Subject|10|||
162636877|NCT02282020|587386006|FG000|Overall Study|Miscellaneous|5|||
162636878|NCT02282020|587386007|FG001|Overall Study|Miscellaneous|19|||
162636879|NCT02282020|587386006|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
162992825|NCT01104779|588674593|FG002|Overall Study|Protocol Violation|2|||
163060116|NCT02765165|588928308|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
163060117|NCT02765165|588928309|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
163060118|NCT02765165|588928303|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060119|NCT02765165|588928304|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060120|NCT02765165|588928305|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
163060121|NCT02765165|588928306|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060122|NCT02765165|588928307|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060123|NCT02765165|588928308|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060124|NCT02765165|588928309|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
163060125|NCT02765165|588928303|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
162636880|NCT02282020|587386007|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
163060126|NCT02765165|588928304|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060127|NCT02765165|588928305|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
162636881|NCT02282020|587386006|FG000|Overall Study|Developed Discontinuation Criteria|0|||
162992826|NCT01104779|588674591|FG000|Overall Study|Lack of Efficacy|26|||
162992827|NCT01104779|588674592|FG001|Overall Study|Lack of Efficacy|12|||
162992828|NCT01104779|588674593|FG002|Overall Study|Lack of Efficacy|13|||
162992829|NCT01104779|588674591|FG000|Overall Study|Adverse Event|13|||
162715662|NCT04538664|587667066|FG001|Overall Study|Ongoing|115|||
162992830|NCT01104779|588674592|FG001|Overall Study|Adverse Event|14|||
162992831|NCT01104779|588674593|FG002|Overall Study|Adverse Event|13|||
162992832|NCT01104779|588674591|FG000|Overall Study|Did not meet inc/exc criteria|1|||
162992833|NCT01104779|588674592|FG001|Overall Study|Did not meet inc/exc criteria|1|||
162992834|NCT01104779|588674593|FG002|Overall Study|Did not meet inc/exc criteria|1|||
162992835|NCT01104779|588674591|FG000|Overall Study|Other reasons|0|||
162992836|NCT01104779|588674592|FG001|Overall Study|Other reasons|1|||
162992837|NCT01104779|588674593|FG002|Overall Study|Other reasons|0|||
162992838|NCT01104779|588674591|FG000|Overall Study|Lost to Follow-up|2|||
162992839|NCT01104779|588674592|FG001|Overall Study|Lost to Follow-up|0|||
162992840|NCT01104779|588674593|FG002|Overall Study|Lost to Follow-up|1|||
162992841|NCT01104779|588674591|FG000|Overall Study|Withdrawal by Subject|16|||
162992842|NCT01104779|588674592|FG001|Overall Study|Withdrawal by Subject|25|||
162992843|NCT01104779|588674593|FG002|Overall Study|Withdrawal by Subject|32|||
162992844|NCT02342639|588674594|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
162992845|NCT02342639|588674595|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
162992846|NCT02342639|588674594|FG000|Overall Study|Protocol Violation|0|||
162992847|NCT02342639|588674595|FG001|Overall Study|Protocol Violation|2|||
162992848|NCT01372774|588674606|FG000|Overall Study|Withdrawal prior to treatment|4|||
162992849|NCT01372774|588674607|FG001|Overall Study|Withdrawal prior to treatment|5|||
162992850|NCT00871741|588674608|FG000|Overall Study|Premature study termination|9|||
162992851|NCT00871741|588674609|FG001|Overall Study|Premature study termination|7|||
162992852|NCT01565850|588674610|FG000|Overall Study|Adverse Event|0|||
162992853|NCT01565850|588674611|FG001|Overall Study|Adverse Event|1|||
162992854|NCT01565850|588674610|FG000|Overall Study|Lost to Follow-up|12|||
162992855|NCT01565850|588674611|FG001|Overall Study|Lost to Follow-up|4|||
162992856|NCT01565850|588674610|FG000|Overall Study|Investigator's Discretion|2|||
162992857|NCT01565850|588674611|FG001|Overall Study|Investigator's Discretion|1|||
162992858|NCT01565850|588674610|FG000|Overall Study|Participant noncompliance|2|||
162992859|NCT01565850|588674611|FG001|Overall Study|Participant noncompliance|0|||
162992860|NCT01565850|588674610|FG000|Overall Study|Withdrew Consent|4|||
162992861|NCT01565850|588674611|FG001|Overall Study|Withdrew Consent|2|||
162992862|NCT04324073|588676059|FG000|Overall Study|withdrew consent|0|||
162992863|NCT04324073|588676060|FG001|Overall Study|withdrew consent|4|||
162992864|NCT04324073|588676061|FG002|Overall Study|withdrew consent|2|||
162992865|NCT04324073|588676062|FG003|Overall Study|withdrew consent|8|||
162992866|NCT03665441|588676063|FG000|Overall Study|survival follow up ongoing|23|||
162992867|NCT03665441|588676064|FG001|Overall Study|survival follow up ongoing|0|||
162992868|NCT03665441|588676063|FG000|Overall Study|Patients ongoing on treatment|9|||
162992869|NCT03665441|588676064|FG001|Overall Study|Patients ongoing on treatment|6|||
162992870|NCT03665441|588676063|FG000|Overall Study|Randomized but not treated|7|||
162992871|NCT03665441|588676064|FG001|Overall Study|Randomized but not treated|11|||
162992872|NCT03610516|588676065|FG000|Treatment Epoch|Adverse Event|3|||
162992873|NCT03610516|588676066|FG001|Treatment Epoch|Adverse Event|1|||
162992874|NCT03610516|588676065|FG000|Treatment Epoch|Death|1|||
162992875|NCT03610516|588676066|FG001|Treatment Epoch|Death|0|||
162992876|NCT03610516|588676065|FG000|Treatment Epoch|Lack of Efficacy|0|||
162992877|NCT03610516|588676066|FG001|Treatment Epoch|Lack of Efficacy|1|||
162992878|NCT03610516|588676065|FG000|Treatment Epoch|No longer requires treatment|1|||
162992879|NCT03610516|588676066|FG001|Treatment Epoch|No longer requires treatment|0|||
162992880|NCT03610516|588676065|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
162992881|NCT03610516|588676066|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
162992882|NCT03610516|588676065|FG000|Treatment Epoch|Physician Decision|8|||
162992883|NCT03610516|588676066|FG001|Treatment Epoch|Physician Decision|5|||
162992884|NCT03610516|588676065|FG000|Treatment Epoch|Protocol Deviation|1|||
162992885|NCT03610516|588676066|FG001|Treatment Epoch|Protocol Deviation|0|||
162992886|NCT03610516|588676065|FG000|Treatment Epoch|Withdrawal by Subject|3|||
162992887|NCT03610516|588676066|FG001|Treatment Epoch|Withdrawal by Subject|1|||
162992888|NCT03610516|588676065|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
162992889|NCT03610516|588676066|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
162992890|NCT03610516|588676065|FG000|Post-Treatment Follow-up|Death|1|||
162992891|NCT03610516|588676066|FG001|Post-Treatment Follow-up|Death|0|||
162992892|NCT01396512|588676069|FG000|Overall Study|Withdrawal by Subject|0|||
162992893|NCT01396512|588676070|FG001|Overall Study|Withdrawal by Subject|1|||
162992894|NCT02500043|588676075|FG000|Overall Study|Randomized, but not Treated|2|||
162992895|NCT02500043|588676076|FG001|Overall Study|Randomized, but not Treated|2|||
162992896|NCT02500043|588676075|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
162992897|NCT02500043|588676076|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
162992898|NCT02500043|588676075|FG000|Overall Study|Adverse Event|33|||
162992899|NCT02500043|588676076|FG001|Overall Study|Adverse Event|11|||
162992900|NCT02500043|588676075|FG000|Overall Study|Clinical Progression|54|||
162992901|NCT02500043|588676076|FG001|Overall Study|Clinical Progression|35|||
162992902|NCT02500043|588676075|FG000|Overall Study|Radiological Progression|192|||
162992903|NCT02500043|588676076|FG001|Overall Study|Radiological Progression|110|||
162715663|NCT03681678|587667069|FG000|Overall Study|Lost to Follow-up|20|||
162992904|NCT02500043|588676075|FG000|Overall Study|Physician's Decision|11|||
162992905|NCT02500043|588676076|FG001|Overall Study|Physician's Decision|3|||
162992906|NCT02500043|588676075|FG000|Overall Study|Withdrawal by Subject|14|||
162992907|NCT02500043|588676076|FG001|Overall Study|Withdrawal by Subject|4|||
162992908|NCT02500043|588676075|FG000|Overall Study|Death|11|||
162992909|NCT02500043|588676076|FG001|Overall Study|Death|2|||
162992910|NCT02500043|588676075|FG000|Overall Study|Protocol Deviation|1|||
162992911|NCT02500043|588676076|FG001|Overall Study|Protocol Deviation|0|||
162992912|NCT00580788|588676077|FG000|Overall Study|Adverse Event|0|||
162992913|NCT00580788|588676078|FG001|Overall Study|Adverse Event|0|||
162992914|NCT00580788|588676079|FG002|Overall Study|Adverse Event|0|||
162992915|NCT00580788|588676080|FG003|Overall Study|Adverse Event|1|||
162992916|NCT01403051|588676081|FG000|Overall Study|Protocol Violation|2|||
162992917|NCT01403051|588676082|FG001|Overall Study|Protocol Violation|0|||
162992918|NCT01403051|588676081|FG000|Overall Study|Death|1|||
162992919|NCT01403051|588676082|FG001|Overall Study|Death|0|||
162992920|NCT01403051|588676081|FG000|Overall Study|Withdrawal by Subject|2|||
162992921|NCT01403051|588676082|FG001|Overall Study|Withdrawal by Subject|1|||
162992922|NCT01403051|588676081|FG000|Overall Study|Lost to Follow-up|5|||
162992923|NCT01403051|588676082|FG001|Overall Study|Lost to Follow-up|5|||
162992924|NCT02932306|588676095|FG000|Overall Study|Withdrawal by Subject|16|||
162992925|NCT02932306|588676096|FG001|Overall Study|Withdrawal by Subject|25|||
162992926|NCT02932306|588676095|FG000|Overall Study|Adverse Event|3|||
162992927|NCT02932306|588676096|FG001|Overall Study|Adverse Event|0|||
162992928|NCT02932306|588676095|FG000|Overall Study|Pregnancy|2|||
162992929|NCT02932306|588676096|FG001|Overall Study|Pregnancy|0|||
162992930|NCT02932306|588676095|FG000|Overall Study|Protocol Violation|1|||
162992931|NCT02932306|588676096|FG001|Overall Study|Protocol Violation|1|||
162992932|NCT02932306|588676095|FG000|Overall Study|Noncompliance with Study Drug|1|||
162992933|NCT02932306|588676096|FG001|Overall Study|Noncompliance with Study Drug|1|||
162992934|NCT02932306|588676095|FG000|Overall Study|Lost to Follow-up|36|||
162992935|NCT02932306|588676096|FG001|Overall Study|Lost to Follow-up|40|||
162992936|NCT02932306|588676095|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
162992937|NCT02932306|588676096|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
162992938|NCT02932306|588676095|FG000|Overall Study|Lack of Efficacy|0|||
162992939|NCT02932306|588676096|FG001|Overall Study|Lack of Efficacy|2|||
162992940|NCT02932306|588676095|FG000|Overall Study|Worsening condition|2|||
162992941|NCT02932306|588676096|FG001|Overall Study|Worsening condition|0|||
162992942|NCT02932306|588676095|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
162992943|NCT02932306|588676096|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
162992944|NCT05776862|588676097|FG000|Overall Study|Adverse Event|0|||
162992945|NCT05776862|588676098|FG001|Overall Study|Adverse Event|1|||
162992946|NCT05776862|588676097|FG000|Overall Study|non-compliance|1|||
162992947|NCT05776862|588676098|FG001|Overall Study|non-compliance|0|||
162992948|NCT02448706|588676099|FG000|Overall Study|Withdrawal by Subject|4|||
162992949|NCT02448706|588676100|FG001|Overall Study|Withdrawal by Subject|3|||
162992950|NCT02448706|588676099|FG000|Overall Study|Protocol Violation|1|||
162992951|NCT02448706|588676100|FG001|Overall Study|Protocol Violation|1|||
162992952|NCT02065700|588676101|FG000|Overall Study|Adverse Event|165|||
162992953|NCT02065700|588676102|FG001|Overall Study|Adverse Event|101|||
162992954|NCT02065700|588676101|FG000|Overall Study|Withdrawal by Subject|90|||
162992955|NCT02065700|588676102|FG001|Overall Study|Withdrawal by Subject|29|||
162992956|NCT02065700|588676101|FG000|Overall Study|Lost to Follow-up|12|||
162992957|NCT02065700|588676102|FG001|Overall Study|Lost to Follow-up|9|||
162992958|NCT02065700|588676101|FG000|Overall Study|Physician Decision|2|||
162992959|NCT02065700|588676102|FG001|Overall Study|Physician Decision|0|||
162992960|NCT02065700|588676101|FG000|Overall Study|Sponsor Request|38|||
162992961|NCT02065700|588676102|FG001|Overall Study|Sponsor Request|15|||
162992962|NCT02065700|588676101|FG000|Overall Study|Treatment Failure|3|||
162992963|NCT02065700|588676102|FG001|Overall Study|Treatment Failure|2|||
162992964|NCT02065700|588676101|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
162992965|NCT02065700|588676102|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
162992966|NCT02065700|588676101|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
162992967|NCT02065700|588676102|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
162992968|NCT02065700|588676101|FG000|Overall Study|Non-compliance with Study Procedures|2|||
162992969|NCT02065700|588676102|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162992970|NCT02065700|588676101|FG000|Overall Study|Not Defined|21|||
162992971|NCT02065700|588676102|FG001|Overall Study|Not Defined|3|||
162992972|NCT02315196|588676103|FG000|Overall Study|Withdrew consent|9|||
162992973|NCT01635218|588676104|FG000|Overall Study|Lost to Follow-up|3|||
162992974|NCT01635218|588676105|FG001|Overall Study|Lost to Follow-up|7|||
162992975|NCT01635218|588676106|FG002|Overall Study|Lost to Follow-up|6|||
162715664|NCT00828945|587667072|FG000|Overall Study|Death|4|||
162715665|NCT00828945|587667072|FG000|Overall Study|Participant was missing|1|||
162992976|NCT03262038|588676107|FG000|Overall Study|Withdrawal by Subject|0|||
162992977|NCT03262038|588676108|FG001|Overall Study|Withdrawal by Subject|1|||
162992978|NCT04933968|588676109|FG000|Overall Study|Adverse Event|0|||
162992979|NCT04933968|588676110|FG001|Overall Study|Adverse Event|0|||
162992980|NCT04933968|588676111|FG002|Overall Study|Adverse Event|1|||
162992981|NCT04933968|588676112|FG003|Overall Study|Adverse Event|1|||
162992982|NCT04933968|588676113|FG004|Overall Study|Adverse Event|0|||
162992983|NCT04933968|588676114|FG005|Overall Study|Adverse Event|0|||
162992984|NCT04933968|588676109|FG000|Overall Study|Lost to Follow-up|1|||
163060128|NCT02765165|588928306|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
163060129|NCT02765165|588928307|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060130|NCT02765165|588928308|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060131|NCT02765165|588928309|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
163060132|NCT02765165|588928303|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060133|NCT02765165|588928304|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
163060134|NCT02765165|588928305|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060135|NCT02765165|588928306|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060136|NCT02765165|588928307|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
162992985|NCT04933968|588676110|FG001|Overall Study|Lost to Follow-up|0|||
162992986|NCT04933968|588676111|FG002|Overall Study|Lost to Follow-up|1|||
162992987|NCT04933968|588676112|FG003|Overall Study|Lost to Follow-up|0|||
162992988|NCT04933968|588676113|FG004|Overall Study|Lost to Follow-up|0|||
162992989|NCT04933968|588676114|FG005|Overall Study|Lost to Follow-up|0|||
162992990|NCT04933968|588676109|FG000|Overall Study|Randomized not treated|1|||
162992991|NCT04933968|588676110|FG001|Overall Study|Randomized not treated|0|||
162992992|NCT04933968|588676111|FG002|Overall Study|Randomized not treated|0|||
162992993|NCT04933968|588676112|FG003|Overall Study|Randomized not treated|0|||
162992994|NCT04933968|588676113|FG004|Overall Study|Randomized not treated|0|||
162992995|NCT04933968|588676114|FG005|Overall Study|Randomized not treated|0|||
162992996|NCT04933968|588676109|FG000|Overall Study|Sponsor terminated study|0|||
162992997|NCT04933968|588676110|FG001|Overall Study|Sponsor terminated study|0|||
162992998|NCT04933968|588676111|FG002|Overall Study|Sponsor terminated study|0|||
162992999|NCT04933968|588676112|FG003|Overall Study|Sponsor terminated study|1|||
162993000|NCT04933968|588676113|FG004|Overall Study|Sponsor terminated study|2|||
162993001|NCT04933968|588676114|FG005|Overall Study|Sponsor terminated study|0|||
162993002|NCT04933968|588676109|FG000|Overall Study|Other|0|||
162993003|NCT04933968|588676110|FG001|Overall Study|Other|0|||
162993004|NCT04933968|588676111|FG002|Overall Study|Other|0|||
162993005|NCT04933968|588676112|FG003|Overall Study|Other|1|||
162993006|NCT04933968|588676113|FG004|Overall Study|Other|0|||
162993007|NCT04933968|588676114|FG005|Overall Study|Other|0|||
162993008|NCT04933968|588676109|FG000|Overall Study|Missing|1|||
162993009|NCT04933968|588676110|FG001|Overall Study|Missing|3|||
162993010|NCT04933968|588676111|FG002|Overall Study|Missing|2|||
162993011|NCT04933968|588676112|FG003|Overall Study|Missing|1|||
162993012|NCT04933968|588676113|FG004|Overall Study|Missing|1|||
162993013|NCT04933968|588676114|FG005|Overall Study|Missing|0|||
162993014|NCT02278055|588676117|FG000|Overall Study|Adverse Event|1|||
162993015|NCT02278055|588676117|FG000|Overall Study|Lost to Follow-up|1|||
162993016|NCT02278055|588676117|FG000|Overall Study|Withdrawal by Subject|2|||
162993017|NCT02278055|588676117|FG000|Overall Study|Progressive Disease|4|||
162993018|NCT01934335|588676118|FG000|Overall Study|Withdrawal by Subject|1|||
162993019|NCT01934335|588676119|FG001|Overall Study|Withdrawal by Subject|1|||
162993020|NCT03016975|588676130|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
162993021|NCT03016975|588676131|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
162993022|NCT03016975|588676132|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
162993023|NCT03016975|588676130|FG000|At 6 Months Follow-up|Death|2|||
162993024|NCT03016975|588676131|FG001|At 6 Months Follow-up|Death|0|||
162993025|NCT03016975|588676132|FG002|At 6 Months Follow-up|Death|0|||
162993026|NCT03016975|588676130|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
162993027|NCT03016975|588676131|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
162993028|NCT03016975|588676132|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
162993029|NCT03016975|588676130|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
162993030|NCT03016975|588676131|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
162993031|NCT03016975|588676132|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
162993032|NCT03016975|588676130|FG000|At 6 Months Follow-up|Aborted implant|1|||
162993033|NCT03016975|588676131|FG001|At 6 Months Follow-up|Aborted implant|0|||
162993034|NCT03016975|588676132|FG002|At 6 Months Follow-up|Aborted implant|0|||
163060137|NCT02765165|588928308|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
162993035|NCT03016975|588676130|FG000|At 2 Year Follow-up|Death|1|||
162993036|NCT03016975|588676131|FG001|At 2 Year Follow-up|Death|0|||
162993037|NCT03016975|588676132|FG002|At 2 Year Follow-up|Death|0|||
163060138|NCT02765165|588928309|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
163060139|NCT02765165|588928303|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060140|NCT02765165|588928304|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060141|NCT02765165|588928305|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
162636882|NCT02282020|587386007|FG001|Overall Study|Developed Discontinuation Criteria|2|||
162636883|NCT02282020|587386006|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
162636884|NCT02282020|587386007|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
162993038|NCT03016975|588676130|FG000|At 3 Year Follow-up|Death|1|||
162993039|NCT03016975|588676131|FG001|At 3 Year Follow-up|Death|0|||
162993040|NCT03016975|588676132|FG002|At 3 Year Follow-up|Death|0|||
162993041|NCT03016975|588676130|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
162993042|NCT03016975|588676131|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
162993043|NCT03016975|588676132|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
162993044|NCT03016975|588676130|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
162993045|NCT03016975|588676131|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
162993046|NCT03016975|588676132|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
162993047|NCT00811928|588676133|FG000|Overall Study|AEs and SAEs Including Death|7|||
162993048|NCT00811928|588676134|FG001|Overall Study|AEs and SAEs Including Death|11|||
162993049|NCT00811928|588676133|FG000|Overall Study|Withdrawal by Subject|18|||
162993050|NCT00811928|588676134|FG001|Overall Study|Withdrawal by Subject|12|||
162993051|NCT00811928|588676133|FG000|Overall Study|Did Not Take Study Drug|3|||
162993052|NCT00811928|588676134|FG001|Overall Study|Did Not Take Study Drug|0|||
162993053|NCT00811928|588676133|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
162993054|NCT00811928|588676134|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
162993055|NCT00811928|588676133|FG000|Overall Study|Investigator Decision|2|||
162993056|NCT00811928|588676134|FG001|Overall Study|Investigator Decision|1|||
162993057|NCT00811928|588676133|FG000|Overall Study|Poor Compliance|2|||
162993058|NCT00811928|588676134|FG001|Overall Study|Poor Compliance|5|||
162993059|NCT01085357|588676135|FG000|Overall Study|Adverse Event|1|||
162993060|NCT01085357|588676136|FG001|Overall Study|Adverse Event|1|||
162993061|NCT01085357|588676135|FG000|Overall Study|Subject Decision|4|||
162993062|NCT01085357|588676136|FG001|Overall Study|Subject Decision|3|||
162993063|NCT01085357|588676135|FG000|Overall Study|Investigator Decision|1|||
162993064|NCT01085357|588676136|FG001|Overall Study|Investigator Decision|1|||
162993065|NCT01085357|588676135|FG000|Overall Study|Death|11|||
162993066|NCT01085357|588676136|FG001|Overall Study|Death|1|||
162993067|NCT01085357|588676135|FG000|Overall Study|Lost to Follow-up|2|||
162993068|NCT01085357|588676136|FG001|Overall Study|Lost to Follow-up|0|||
162993069|NCT02910011|588676137|FG000|Overall Study|Physician Decision|2|||
162993070|NCT00838435|588676138|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
162993071|NCT00838435|588676138|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
162993072|NCT00838435|588676138|FG000|Part 2 (7 Years)|Adverse Event|2|||
162993073|NCT00838435|588676138|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
162993074|NCT00838435|588676138|FG000|Part 2 (7 Years)|Physician Decision|1|||
162993075|NCT00838435|588676138|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
162993076|NCT00838435|588676138|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
162993077|NCT02348723|588676139|FG000|Overall Study|No ablation|21|||
162993078|NCT02348723|588676140|FG001|Overall Study|No ablation|20|||
162993079|NCT02348723|588676139|FG000|Overall Study|Non-compliant with Protocol|1|||
162993080|NCT02348723|588676140|FG001|Overall Study|Non-compliant with Protocol|0|||
162993081|NCT02348723|588676139|FG000|Overall Study|Lost to Follow-up|1|||
162993082|NCT02348723|588676140|FG001|Overall Study|Lost to Follow-up|1|||
162993083|NCT02348723|588676139|FG000|Overall Study|Consent withdrawn|1|||
162993084|NCT02348723|588676140|FG001|Overall Study|Consent withdrawn|3|||
162993085|NCT02348723|588676139|FG000|Overall Study|Reason other than specified|1|||
162993086|NCT02348723|588676140|FG001|Overall Study|Reason other than specified|1|||
162993087|NCT02348723|588676139|FG000|Overall Study|Adverse Event|3|||
162993088|NCT02348723|588676140|FG001|Overall Study|Adverse Event|1|||
162993089|NCT00678886|588676141|FG000|Overall Study|Withdrawal by Subject|0|||
162993090|NCT00678886|588676142|FG001|Overall Study|Withdrawal by Subject|0|||
162993091|NCT00678886|588676143|FG002|Overall Study|Withdrawal by Subject|4|||
162993092|NCT00678886|588676144|FG003|Overall Study|Withdrawal by Subject|6|||
162993093|NCT00678886|588676141|FG000|Overall Study|Physician Decision|0|||
162993094|NCT00678886|588676142|FG001|Overall Study|Physician Decision|0|||
162993095|NCT00678886|588676143|FG002|Overall Study|Physician Decision|1|||
163060142|NCT02765165|588928306|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
163060143|NCT02765165|588928307|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
163060144|NCT02765165|588928308|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
163060145|NCT02765165|588928309|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
163060146|NCT02382939|588928312|FG000|Overall Study|Adverse Event|1|||
163060147|NCT02382939|588928313|FG001|Overall Study|Adverse Event|1|||
163060148|NCT02382939|588928312|FG000|Overall Study|Withdrawal by Subject|2|||
163060149|NCT02382939|588928313|FG001|Overall Study|Withdrawal by Subject|2|||
163060150|NCT01189266|588928316|FG000|Overall Study|Adverse Event|1|||
163060151|NCT01189266|588928317|FG001|Overall Study|Adverse Event|0|||
162993096|NCT00678886|588676144|FG003|Overall Study|Physician Decision|1|||
162993097|NCT00678886|588676141|FG000|Overall Study|Lost to Follow-up|0|||
162636885|NCT00588848|587386008|FG000|Overall Study|Physician Decision|0|||
162636886|NCT00588848|587386009|FG001|Overall Study|Physician Decision|3|||
162636887|NCT01499667|587386010|FG000|Overall Study|administrative problems|4|||
162993098|NCT00678886|588676142|FG001|Overall Study|Lost to Follow-up|0|||
163060152|NCT01189266|588928318|FG002|Overall Study|Adverse Event|5|||
163060153|NCT01189266|588928316|FG000|Overall Study|Death|0|||
162636888|NCT01499667|587386011|FG001|Overall Study|administrative problems|5|||
162715666|NCT00828945|587667072|FG000|Overall Study|Other|36|||
163060154|NCT01189266|588928317|FG001|Overall Study|Death|0|||
162993099|NCT00678886|588676143|FG002|Overall Study|Lost to Follow-up|3|||
162993100|NCT00678886|588676144|FG003|Overall Study|Lost to Follow-up|2|||
162993101|NCT00678886|588676141|FG000|Overall Study|Other|0|||
162993102|NCT00678886|588676142|FG001|Overall Study|Other|0|||
162993103|NCT00678886|588676143|FG002|Overall Study|Other|1|||
162993104|NCT00678886|588676144|FG003|Overall Study|Other|0|||
162993105|NCT01147107|588676145|FG000|Overall Study|Lack of Efficacy|5|||
162993106|NCT01147107|588676146|FG001|Overall Study|Lack of Efficacy|0|||
162993107|NCT01147107|588676145|FG000|Overall Study|Withdrawal by Subject|1|||
162993108|NCT01147107|588676146|FG001|Overall Study|Withdrawal by Subject|1|||
162993109|NCT04435184|588676147|FG000|Overall Study|follow-up blood draws missing|3|||
162993110|NCT04435184|588676148|FG001|Overall Study|follow-up blood draws missing|5|||
162993111|NCT04693416|588676149|FG000|Overall Study|Lost to Follow-up|13|||
162993112|NCT04693416|588676150|FG001|Overall Study|Lost to Follow-up|0|||
162993113|NCT02290223|588676151|FG000|6 Months|Lost to Follow-up|9|||
162993114|NCT02290223|588676152|FG001|6 Months|Lost to Follow-up|6|||
162993115|NCT02290223|588676151|FG000|6 Months|Withdrawal by Subject|5|||
162993116|NCT02290223|588676152|FG001|6 Months|Withdrawal by Subject|0|||
162993117|NCT02290223|588676151|FG000|6 Months|deceased (not related to study)|2|||
162993118|NCT02290223|588676152|FG001|6 Months|deceased (not related to study)|0|||
162993119|NCT02290223|588676151|FG000|12 Months|Lost to Follow-up|16|||
162993120|NCT02290223|588676152|FG001|12 Months|Lost to Follow-up|10|||
162993121|NCT02290223|588676151|FG000|12 Months|Refusal|0|||
162993122|NCT02290223|588676152|FG001|12 Months|Refusal|1|||
162993123|NCT05293639|588676153|FG000|Overall Study|Withdrawal by Subject|1|||
162993124|NCT05293639|588676154|FG001|Overall Study|Withdrawal by Subject|1|||
162993125|NCT05293639|588676155|FG002|Overall Study|Withdrawal by Subject|2|||
162993126|NCT05293639|588676153|FG000|Overall Study|Death|0|||
162993127|NCT05293639|588676154|FG001|Overall Study|Death|1|||
162993128|NCT05293639|588676155|FG002|Overall Study|Death|0|||
162993129|NCT05293639|588676153|FG000|Overall Study|Lost to Follow-up|0|||
162993130|NCT05293639|588676154|FG001|Overall Study|Lost to Follow-up|0|||
162993131|NCT05293639|588676155|FG002|Overall Study|Lost to Follow-up|5|||
162993132|NCT05293639|588676153|FG000|Overall Study|Other|0|||
162993133|NCT05293639|588676154|FG001|Overall Study|Other|0|||
162993134|NCT05293639|588676155|FG002|Overall Study|Other|1|||
162993135|NCT01860677|588676162|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
162993136|NCT01860677|588676163|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
162993137|NCT01671332|588676169|FG000|Overall Study|Withdrawal by Subject|1|||
162993138|NCT01671332|588676170|FG001|Overall Study|Withdrawal by Subject|1|||
162993139|NCT02722148|588676176|FG000|Overall Study|Lost to Follow-up|2|||
162993140|NCT02722148|588676176|FG000|Overall Study|Non compliant with treatment regimen|3|||
162993141|NCT00073021|588676177|FG000|Overall Study|Protocol Violation|2|||
162993142|NCT00073021|588676178|FG001|Overall Study|Protocol Violation|1|||
162993143|NCT00073021|588676177|FG000|Overall Study|Adverse Event|4|||
162993144|NCT00073021|588676178|FG001|Overall Study|Adverse Event|4|||
162993145|NCT00073021|588676177|FG000|Overall Study|Withdrawal by Subject|6|||
162993146|NCT00073021|588676178|FG001|Overall Study|Withdrawal by Subject|5|||
162993147|NCT00073021|588676177|FG000|Overall Study|Physician Decision|3|||
162993148|NCT00073021|588676178|FG001|Overall Study|Physician Decision|1|||
162993149|NCT00073021|588676177|FG000|Overall Study|Lack of Efficacy|11|||
162993150|NCT00073021|588676178|FG001|Overall Study|Lack of Efficacy|5|||
162993151|NCT01458106|588676179|FG000|Overall Study|Withdrawal by Subject|2|||
162993152|NCT01458106|588676180|FG001|Overall Study|Withdrawal by Subject|0|||
162993153|NCT01458106|588676179|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
162993154|NCT01458106|588676180|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
162993155|NCT01458106|588676179|FG000|Overall Study|Withdrawn Per Protocol|0|||
162993156|NCT01458106|588676180|FG001|Overall Study|Withdrawn Per Protocol|1|||
162993157|NCT01425723|588676181|FG000|Overall Study|Lack of Efficacy|0|||
162993158|NCT01425723|588676182|FG001|Overall Study|Lack of Efficacy|1|||
162993159|NCT01425723|588676181|FG000|Overall Study|Withdrawal by Subject|1|||
162993160|NCT01425723|588676182|FG001|Overall Study|Withdrawal by Subject|4|||
162993161|NCT01425723|588676181|FG000|Overall Study|Lost to Follow-up|0|||
162993162|NCT01425723|588676182|FG001|Overall Study|Lost to Follow-up|3|||
162993163|NCT01425723|588676181|FG000|Overall Study|Physician Decision|2|||
162993164|NCT01425723|588676182|FG001|Overall Study|Physician Decision|0|||
162993165|NCT01425723|588676181|FG000|Overall Study|Other|1|||
162993166|NCT01425723|588676182|FG001|Overall Study|Other|10|||
162993167|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
162993168|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
162993169|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993170|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993171|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993172|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993173|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993174|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993175|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993176|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993177|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993178|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993179|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993180|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
162993181|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
162993182|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
162993183|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993184|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993185|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993186|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993187|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993188|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993189|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993190|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993191|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993192|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993193|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993194|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
162993195|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
162993196|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
162993197|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993198|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993199|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993200|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993201|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993202|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993203|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993204|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993205|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993206|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993207|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993208|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
162993209|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
162993210|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
162993211|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993212|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993213|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993214|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993215|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993216|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993217|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993218|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993219|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993220|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993221|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993222|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162993223|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
162993224|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
162993225|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993226|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993227|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993228|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993229|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993230|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993231|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993232|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993233|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993234|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993235|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993236|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
162993237|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
162993238|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
162993239|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993240|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162715667|NCT03431350|587667075|FG000|Overall Study|ONGOING|0|||
162993241|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993242|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993243|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162715668|NCT03431350|587667076|FG001|Overall Study|ONGOING|0|||
162715669|NCT03431350|587667077|FG002|Overall Study|ONGOING|2|||
162715670|NCT03431350|587667078|FG003|Overall Study|ONGOING|0|||
162993244|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993245|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993246|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993247|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993248|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993249|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993250|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
162993251|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
162993252|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
162993253|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993254|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993255|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993256|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993257|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993258|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993259|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993260|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993261|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993262|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993263|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993264|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
162993265|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
162993266|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
162993267|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993268|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993269|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993270|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993271|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993272|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993273|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993274|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993275|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993276|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993277|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993278|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
162993279|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
162993280|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
162993281|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993282|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993283|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993284|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993285|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993286|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993287|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993288|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993289|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993290|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993291|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993292|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
162993293|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
162993294|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
162993295|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993296|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993297|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993298|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993299|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993300|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993301|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993302|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993303|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
163060155|NCT01189266|588928318|FG002|Overall Study|Death|5|||
163060156|NCT01189266|588928316|FG000|Overall Study|Lack of Efficacy|4|||
163060157|NCT01189266|588928317|FG001|Overall Study|Lack of Efficacy|5|||
162715671|NCT03431350|587667079|FG004|Overall Study|ONGOING|1|||
163060158|NCT01189266|588928318|FG002|Overall Study|Lack of Efficacy|44|||
163060159|NCT01189266|588928316|FG000|Overall Study|Physician Decision|0|||
162715672|NCT03431350|587667080|FG005|Overall Study|ONGOING|3|||
162993304|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993305|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993306|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
162993307|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
162993308|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
162993309|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993310|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993311|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993312|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993313|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993314|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993315|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993316|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993317|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993318|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993319|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993320|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162993321|NCT03982199|588676185|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
162993322|NCT03982199|588676186|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
162993323|NCT03982199|588676187|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993324|NCT03982199|588676188|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993325|NCT03982199|588676189|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993326|NCT03982199|588676190|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993327|NCT03982199|588676191|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993328|NCT03982199|588676192|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993329|NCT03982199|588676193|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993330|NCT03982199|588676194|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993331|NCT03982199|588676195|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993332|NCT03982199|588676196|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993333|NCT03982199|588676197|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993334|NCT03982199|588676198|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
162993335|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993336|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993337|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993338|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
163060160|NCT01189266|588928317|FG001|Overall Study|Physician Decision|0|||
163060161|NCT01189266|588928318|FG002|Overall Study|Physician Decision|1|||
163060162|NCT01189266|588928316|FG000|Overall Study|Protocol Violation|0|||
163060163|NCT01189266|588928317|FG001|Overall Study|Protocol Violation|1|||
163060164|NCT01189266|588928318|FG002|Overall Study|Protocol Violation|1|||
163060165|NCT01189266|588928316|FG000|Overall Study|Withdrawal by Subject|0|||
163060166|NCT01189266|588928317|FG001|Overall Study|Withdrawal by Subject|0|||
163060167|NCT01189266|588928318|FG002|Overall Study|Withdrawal by Subject|1|||
163060168|NCT01189266|588928316|FG000|Overall Study|Patient refuses further therapy|1|||
163060169|NCT01189266|588928317|FG001|Overall Study|Patient refuses further therapy|0|||
163060170|NCT01189266|588928318|FG002|Overall Study|Patient refuses further therapy|7|||
163060171|NCT01189266|588928316|FG000|Overall Study|No treatment|0|||
163060172|NCT01189266|588928317|FG001|Overall Study|No treatment|0|||
163060173|NCT01189266|588928318|FG002|Overall Study|No treatment|1|||
163060174|NCT00321763|588928319|FG000|Overall Study|Adverse Event|1|||
163060175|NCT00321763|588928320|FG001|Overall Study|Adverse Event|1|||
162636889|NCT01499667|587386012|FG002|Overall Study|administrative problems|5|||
162636890|NCT01499667|587386010|FG000|Overall Study|Protocol Violation|1|||
162636891|NCT01499667|587386011|FG001|Overall Study|Protocol Violation|3|||
162636892|NCT01499667|587386012|FG002|Overall Study|Protocol Violation|2|||
162636893|NCT01499667|587386010|FG000|Overall Study|Adverse Event|0|||
163060176|NCT00321763|588928321|FG002|Overall Study|Adverse Event|0|||
163060177|NCT00321763|588928322|FG003|Overall Study|Adverse Event|1|||
163060178|NCT00321763|588928319|FG000|Overall Study|Withdrawal by Subject|2|||
163060179|NCT00321763|588928320|FG001|Overall Study|Withdrawal by Subject|0|||
163060180|NCT00321763|588928321|FG002|Overall Study|Withdrawal by Subject|1|||
163060181|NCT00321763|588928322|FG003|Overall Study|Withdrawal by Subject|0|||
163060182|NCT00321763|588928319|FG000|Overall Study|Lost to Follow-up|3|||
162636894|NCT01499667|587386011|FG001|Overall Study|Adverse Event|2|||
162636895|NCT01499667|587386012|FG002|Overall Study|Adverse Event|2|||
162636896|NCT01499667|587386010|FG000|Overall Study|Withdrawal by Subject|2|||
163060183|NCT00321763|588928320|FG001|Overall Study|Lost to Follow-up|1|||
163060184|NCT00321763|588928321|FG002|Overall Study|Lost to Follow-up|5|||
162636897|NCT01499667|587386011|FG001|Overall Study|Withdrawal by Subject|1|||
162993339|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993340|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993341|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993342|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993343|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993344|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993345|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993346|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993347|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993348|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
162993349|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993350|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993351|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
162993352|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993353|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993354|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993355|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993356|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993357|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993358|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993359|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993360|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993361|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993362|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
162993363|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993364|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993365|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
162993366|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993367|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993368|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993369|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993370|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993371|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993372|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993373|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993374|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993375|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993376|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162993377|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993378|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993379|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
162993380|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
162993381|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993382|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993383|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162636898|NCT01499667|587386012|FG002|Overall Study|Withdrawal by Subject|1|||
162636899|NCT01499667|587386010|FG000|Overall Study|Lack of Efficacy|2|||
162636900|NCT01499667|587386011|FG001|Overall Study|Lack of Efficacy|0|||
162636901|NCT01499667|587386012|FG002|Overall Study|Lack of Efficacy|0|||
162636902|NCT02673489|587386013|FG000|Treatment Period|Lost to Follow-up|3|||
162636903|NCT02673489|587386014|FG001|Treatment Period|Lost to Follow-up|0|||
162636904|NCT02673489|587386013|FG000|Treatment Period|Participant request to discontinue|1|||
162636905|NCT02673489|587386014|FG001|Treatment Period|Participant request to discontinue|1|||
162636906|NCT02673489|587386013|FG000|Treatment Period|Participant moved to another province|1|||
162636907|NCT02673489|587386014|FG001|Treatment Period|Participant moved to another province|0|||
162636908|NCT02673489|587386013|FG000|Treatment Period|Participant was incarcerated|0|||
162636909|NCT02673489|587386014|FG001|Treatment Period|Participant was incarcerated|1|||
162636910|NCT02673489|587386013|FG000|Treatment Period|Adverse Event|0|||
162636911|NCT02673489|587386014|FG001|Treatment Period|Adverse Event|1|||
162715673|NCT03431350|587667081|FG006|Overall Study|ONGOING|0|||
162715674|NCT03431350|587667082|FG007|Overall Study|ONGOING|1|||
162636912|NCT02673489|587386013|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
162636913|NCT02673489|587386014|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
162636914|NCT02673489|587386013|FG000|Follow Up Period|Unable to return for follow-up|0|||
162715675|NCT03431350|587667083|FG008|Overall Study|ONGOING|3|||
162636915|NCT02673489|587386014|FG001|Follow Up Period|Unable to return for follow-up|1|||
162715676|NCT03431350|587667084|FG009|Overall Study|ONGOING|4|||
162993384|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993385|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993386|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993387|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993388|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993389|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993390|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
162993391|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993392|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993393|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993394|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
162993395|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993396|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993397|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993398|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993399|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993400|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993401|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993402|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993403|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993404|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
162993405|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993406|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993407|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
162993408|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
162993409|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993410|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993411|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993412|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993413|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993414|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993415|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993416|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993417|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993418|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
162993419|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993420|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162636916|NCT00082355|587386015|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
162636917|NCT00082355|587386015|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
162636918|NCT00082355|587386015|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
162636919|NCT02233309|587386017|FG000|Overall Study|Physician Decision|5|||
162636920|NCT00311623|587386021|FG000|Overall Study|Physician Decision|0|||
162636921|NCT00311623|587386022|FG001|Overall Study|Physician Decision|0|||
162636922|NCT00311623|587386023|FG002|Overall Study|Physician Decision|2|||
162636923|NCT03998189|587386024|FG000|Overall Study|Lack of Efficacy|0|||
162636924|NCT03998189|587386025|FG001|Overall Study|Lack of Efficacy|1|||
162636925|NCT04983264|587386026|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
162636926|NCT04983264|587386027|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
162636927|NCT04983264|587386028|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
162636928|NCT04983264|587386026|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
162636929|NCT04983264|587386027|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
162636930|NCT04983264|587386028|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
162636931|NCT00558025|587386031|FG000|Overall Study|Adverse Event|1|||
162636932|NCT00558025|587386032|FG001|Overall Study|Adverse Event|1|||
162636933|NCT00558025|587386031|FG000|Overall Study|Withdrawal by Subject|2|||
162636934|NCT00558025|587386032|FG001|Overall Study|Withdrawal by Subject|2|||
162636935|NCT00558025|587386031|FG000|Overall Study|Protocol Violation|1|||
162636936|NCT00558025|587386032|FG001|Overall Study|Protocol Violation|0|||
162636937|NCT01506479|587386033|FG000|Overall Study|Lost to Follow-up|1|||
162636938|NCT01506479|587386034|FG001|Overall Study|Lost to Follow-up|2|||
162636939|NCT01506479|587386035|FG002|Overall Study|Lost to Follow-up|2|||
162636940|NCT01506479|587386033|FG000|Overall Study|Withdrawal by Subject|1|||
162636941|NCT01506479|587386034|FG001|Overall Study|Withdrawal by Subject|2|||
162636942|NCT01506479|587386035|FG002|Overall Study|Withdrawal by Subject|1|||
162636943|NCT01506479|587386033|FG000|Overall Study|Missing assessment|1|||
162636944|NCT01506479|587386034|FG001|Overall Study|Missing assessment|0|||
162636945|NCT01506479|587386035|FG002|Overall Study|Missing assessment|0|||
162636946|NCT01506479|587386033|FG000|Overall Study|Adverse Event|0|||
162993421|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993422|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993423|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993424|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993425|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993426|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993427|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
162993428|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993429|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993430|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993431|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993432|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
162993433|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993434|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993435|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993436|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993437|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993438|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993439|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993440|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993441|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
162993442|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993443|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993444|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993445|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993446|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162993447|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993448|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993449|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993450|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993451|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993452|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993453|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993454|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993455|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
162993456|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993457|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993458|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993459|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993460|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
162993461|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993462|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993463|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993464|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993465|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993466|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993467|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993468|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993469|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
162993470|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162636947|NCT01506479|587386034|FG001|Overall Study|Adverse Event|1|||
162636948|NCT01506479|587386035|FG002|Overall Study|Adverse Event|0|||
162636949|NCT05247866|587386037|FG000|Overall Study|Adverse Event|2|||
162636950|NCT05247866|587386037|FG000|Overall Study|Lack of Efficacy|1|||
162636951|NCT05247866|587386037|FG000|Overall Study|Protocol Violation|1|||
162993471|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993472|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993473|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993474|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
162993475|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993476|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993477|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993478|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993479|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993480|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993481|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993482|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993483|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
162993484|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993485|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993486|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993487|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993488|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
162993489|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993490|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993491|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993492|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993493|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993494|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
162993495|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993496|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
162993497|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
162993498|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993499|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993500|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993501|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993502|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
162993503|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993504|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993505|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993506|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993507|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993508|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993509|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993510|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993511|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
162993512|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993513|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993514|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993515|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993516|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
162993517|NCT03982199|588676185|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993518|NCT03982199|588676186|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993519|NCT03982199|588676187|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993520|NCT03982199|588676188|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993521|NCT03982199|588676189|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993522|NCT03982199|588676190|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
162993523|NCT03982199|588676191|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993524|NCT03982199|588676192|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
162993525|NCT03982199|588676193|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
162993526|NCT03982199|588676194|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993527|NCT03982199|588676195|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993528|NCT03982199|588676196|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993529|NCT03982199|588676197|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993530|NCT03982199|588676198|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
162993531|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993532|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993533|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993534|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993535|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993536|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993537|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993538|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993539|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
162993540|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
162993541|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
162993542|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
162993543|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
162993544|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
162993545|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993546|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993547|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993548|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993549|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993550|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993551|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993552|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993553|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993554|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
162993555|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993556|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993557|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993558|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
162993559|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993560|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993561|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993562|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993563|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993564|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993565|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993566|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162636952|NCT05247866|587386037|FG000|Overall Study|Withdrawal by Subject|3|||
162636953|NCT04463719|587386040|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
162636954|NCT04463719|587386041|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
162636955|NCT04463719|587386042|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
162636956|NCT03315208|587386043|FG000|Overall Study|Lost to Follow-up|11|||
162636957|NCT03315208|587386044|FG001|Overall Study|Lost to Follow-up|6|||
162636958|NCT03315208|587386043|FG000|Overall Study|Withdrawal by Subject|2|||
162636959|NCT03315208|587386044|FG001|Overall Study|Withdrawal by Subject|0|||
162636960|NCT02746874|587386045|FG000|Overall Study|Withdrawal by Subject|0|||
162636961|NCT02746874|587386046|FG001|Overall Study|Withdrawal by Subject|1|||
162636962|NCT02746874|587386045|FG000|Overall Study|Surgery Date Changed|0|||
162636963|NCT02746874|587386046|FG001|Overall Study|Surgery Date Changed|2|||
162636964|NCT01156311|587386050|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
162636965|NCT01156311|587386051|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
162636966|NCT01156311|587386052|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
162636967|NCT01156311|587386053|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
162636968|NCT01156311|587386050|FG000|2-Month Monotherapy Period|Physician Decision|0|||
162636969|NCT01156311|587386051|FG001|2-Month Monotherapy Period|Physician Decision|1|||
162636970|NCT01156311|587386052|FG002|2-Month Monotherapy Period|Physician Decision|0|||
162636971|NCT01156311|587386053|FG003|2-Month Monotherapy Period|Physician Decision|0|||
162636972|NCT01156311|587386050|FG000|2-Month Monotherapy Period|Other|1|||
162636973|NCT01156311|587386051|FG001|2-Month Monotherapy Period|Other|0|||
162993567|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993568|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993569|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993570|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993571|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
162993572|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
162993573|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993574|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993575|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993576|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993577|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993578|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993579|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993580|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993581|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993582|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993583|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
162993584|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
162993585|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
162993586|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
162993587|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993588|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993589|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993590|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993591|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993592|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993593|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993594|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993595|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993596|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
163060185|NCT00321763|588928322|FG003|Overall Study|Lost to Follow-up|4|||
163060186|NCT03530696|588928326|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
163060187|NCT03530696|588928327|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
163060188|NCT01129128|588928328|FG000|Overall Study|Lost to Follow-up|2|||
163060189|NCT01129128|588928329|FG001|Overall Study|Lost to Follow-up|2|||
163060190|NCT01129128|588928330|FG002|Overall Study|Lost to Follow-up|1|||
163060191|NCT01129128|588928328|FG000|Overall Study|Protocol Violation|0|||
163060192|NCT01129128|588928329|FG001|Overall Study|Protocol Violation|1|||
163060193|NCT01129128|588928330|FG002|Overall Study|Protocol Violation|0|||
163060194|NCT01129128|588928328|FG000|Overall Study|Withdrawal by Subject|0|||
163060195|NCT01129128|588928329|FG001|Overall Study|Withdrawal by Subject|1|||
163060196|NCT01129128|588928330|FG002|Overall Study|Withdrawal by Subject|3|||
163060197|NCT01129128|588928328|FG000|Overall Study|Physician Decision|1|||
163060198|NCT01129128|588928329|FG001|Overall Study|Physician Decision|0|||
163060199|NCT01129128|588928330|FG002|Overall Study|Physician Decision|0|||
163060200|NCT01311661|588928333|FG000|Overall Study|Adverse Event|2|||
163060201|NCT01311661|588928333|FG000|Overall Study|Protocol Violation|3|||
163060202|NCT01311661|588928333|FG000|Overall Study|Withdrawal by Subject|2|||
163060203|NCT01900314|588928334|FG000|Overall Study|Lost to Follow-up|1|||
163060204|NCT01900314|588928335|FG001|Overall Study|Lost to Follow-up|0|||
163060205|NCT01900314|588928334|FG000|Overall Study|Protocol Violation|0|||
163060206|NCT01900314|588928335|FG001|Overall Study|Protocol Violation|1|||
163060207|NCT01900314|588928334|FG000|Overall Study|Withdrawal by Subject|3|||
163060208|NCT01900314|588928335|FG001|Overall Study|Withdrawal by Subject|3|||
163060209|NCT04759131|588928336|FG000|Overall Study|Investigator's discretion|1|||
163060210|NCT04759131|588928337|FG001|Overall Study|Investigator's discretion|0|||
163060211|NCT04759131|588928336|FG000|Overall Study|Subject withdrawal|1|||
163060212|NCT04759131|588928337|FG001|Overall Study|Subject withdrawal|0|||
162636974|NCT01156311|587386052|FG002|2-Month Monotherapy Period|Other|0|||
162636975|NCT01156311|587386053|FG003|2-Month Monotherapy Period|Other|0|||
163060213|NCT04513366|588928341|FG000|Treatment Phase|Withdrawal by Subject|6|||
163060214|NCT04513366|588928342|FG001|Treatment Phase|Withdrawal by Subject|8|||
162636976|NCT01156311|587386050|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
163060215|NCT04513366|588928343|FG002|Treatment Phase|Withdrawal by Subject|3|||
163060216|NCT04513366|588928341|FG000|Treatment Phase|Lost to Follow-up|1|||
163060217|NCT04513366|588928342|FG001|Treatment Phase|Lost to Follow-up|2|||
163060218|NCT04513366|588928343|FG002|Treatment Phase|Lost to Follow-up|5|||
163060219|NCT04513366|588928341|FG000|Treatment Phase|Other than Specified|1|||
163060220|NCT04513366|588928342|FG001|Treatment Phase|Other than Specified|0|||
163060221|NCT04513366|588928343|FG002|Treatment Phase|Other than Specified|2|||
162636977|NCT01156311|587386051|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
162993597|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993598|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993599|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
162993600|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
162993601|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993602|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993603|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993604|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993605|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993606|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993607|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993608|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993609|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993610|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993611|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993612|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
162993613|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
162993614|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
162993615|NCT03982199|588676185|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993616|NCT03982199|588676186|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993617|NCT03982199|588676187|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993618|NCT03982199|588676188|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993619|NCT03982199|588676189|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993620|NCT03982199|588676190|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993621|NCT03982199|588676191|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993622|NCT03982199|588676192|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993623|NCT03982199|588676193|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993624|NCT03982199|588676194|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993625|NCT03982199|588676195|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993626|NCT03982199|588676196|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993627|NCT03982199|588676197|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
162993628|NCT03982199|588676198|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
162993629|NCT03433755|588676199|FG000|Overall Study|Lost to Follow-up|1|||
162993630|NCT03433755|588676200|FG001|Overall Study|Lost to Follow-up|0|||
162993631|NCT03433755|588676201|FG002|Overall Study|Lost to Follow-up|0|||
162993632|NCT03433755|588676202|FG003|Overall Study|Lost to Follow-up|0|||
162993633|NCT03433755|588676199|FG000|Overall Study|Decision by Sponsor|1|||
162993634|NCT03433755|588676200|FG001|Overall Study|Decision by Sponsor|0|||
162993635|NCT03433755|588676201|FG002|Overall Study|Decision by Sponsor|0|||
162993636|NCT03433755|588676202|FG003|Overall Study|Decision by Sponsor|0|||
162993637|NCT05065567|588676204|FG000|Overall Study|Lost to Follow-up|10|||
162993638|NCT05065567|588676205|FG001|Overall Study|Lost to Follow-up|9|||
162993639|NCT05065567|588676206|FG002|Overall Study|Lost to Follow-up|6|||
162993640|NCT05323123|588676207|FG000|Overall Study|Withdrawal by Subject|2|||
162993641|NCT05323123|588676208|FG001|Overall Study|Withdrawal by Subject|1|||
162993642|NCT05323123|588676207|FG000|Overall Study|Lost to Follow-up|4|||
162993643|NCT05323123|588676208|FG001|Overall Study|Lost to Follow-up|2|||
162993644|NCT05323123|588676207|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
162993645|NCT05323123|588676208|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
162993646|NCT05529472|588676209|FG000|Overall Study|Withdrawal by Subject|1|||
162993647|NCT05529472|588676210|FG001|Overall Study|Withdrawal by Subject|1|||
162993648|NCT02886624|588677847|FG000|12-week Post Treatment Follow-up|Death|1|||
162993649|NCT02886624|588677847|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
162993650|NCT00359801|588677852|FG000|Overall Study|Lost to Follow-up|72|||
162993651|NCT00359801|588677853|FG001|Overall Study|Lost to Follow-up|58|||
162993652|NCT00359801|588677852|FG000|Overall Study|Withdrawal by Subject|143|||
162993653|NCT00359801|588677853|FG001|Overall Study|Withdrawal by Subject|96|||
162993654|NCT00359801|588677852|FG000|Overall Study|Other|66|||
162993655|NCT00359801|588677853|FG001|Overall Study|Other|46|||
162993656|NCT00359801|588677852|FG000|Overall Study|Final Status Unknown: missing data|7|||
162993657|NCT00359801|588677853|FG001|Overall Study|Final Status Unknown: missing data|4|||
162993658|NCT00359801|588677852|FG000|Overall Study|Sponsor Decision|17|||
162993659|NCT00359801|588677853|FG001|Overall Study|Sponsor Decision|16|||
162993660|NCT02929056|588677858|FG000|Overall Study|Lost to Follow-up|0|||
162993661|NCT02929056|588677859|FG001|Overall Study|Lost to Follow-up|1|||
163060222|NCT04513366|588928341|FG000|Treatment Phase|Physician Decision|2|||
162636978|NCT01156311|587386052|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
162636979|NCT01156311|587386053|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
162993662|NCT02245412|588677865|FG000|Treatment Period|Death|1|||
162993663|NCT02245412|588677866|FG001|Treatment Period|Death|1|||
162993664|NCT02245412|588677867|FG002|Treatment Period|Death|0|||
162993665|NCT02245412|588677865|FG000|Treatment Period|Physician Decision|1|||
162993666|NCT02245412|588677866|FG001|Treatment Period|Physician Decision|1|||
162993667|NCT02245412|588677867|FG002|Treatment Period|Physician Decision|0|||
162993668|NCT02245412|588677865|FG000|Treatment Period|Withdrawal by Subject|2|||
162993669|NCT02245412|588677866|FG001|Treatment Period|Withdrawal by Subject|1|||
162993670|NCT02245412|588677867|FG002|Treatment Period|Withdrawal by Subject|0|||
162993671|NCT02245412|588677865|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
162993672|NCT02245412|588677866|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
162993673|NCT02245412|588677867|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
162993674|NCT02245412|588677865|FG000|Follow-Up Period|Death|4|||
162993675|NCT02245412|588677866|FG001|Follow-Up Period|Death|2|||
162993676|NCT02245412|588677867|FG002|Follow-Up Period|Death|1|||
162993677|NCT02245412|588677865|FG000|Follow-Up Period|Physician Decision|1|||
162993678|NCT02245412|588677866|FG001|Follow-Up Period|Physician Decision|0|||
162993679|NCT02245412|588677867|FG002|Follow-Up Period|Physician Decision|0|||
162993680|NCT02245412|588677865|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
162993681|NCT02245412|588677866|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
162993682|NCT02245412|588677867|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
162993683|NCT01056289|588677868|FG000|Open-label Phase|Adverse Event|29|||
162993684|NCT01056289|588677869|FG001|Open-label Phase|Adverse Event|0|||
162993685|NCT01056289|588677870|FG002|Open-label Phase|Adverse Event|0|||
162993686|NCT01056289|588677871|FG003|Open-label Phase|Adverse Event|0|||
162993687|NCT01056289|588677868|FG000|Open-label Phase|Lost to Follow-up|30|||
162993688|NCT01056289|588677869|FG001|Open-label Phase|Lost to Follow-up|0|||
162993689|NCT01056289|588677870|FG002|Open-label Phase|Lost to Follow-up|0|||
162993690|NCT01056289|588677871|FG003|Open-label Phase|Lost to Follow-up|0|||
162993691|NCT01056289|588677868|FG000|Open-label Phase|Other|9|||
162993692|NCT01056289|588677869|FG001|Open-label Phase|Other|0|||
162993693|NCT01056289|588677870|FG002|Open-label Phase|Other|0|||
162993694|NCT01056289|588677871|FG003|Open-label Phase|Other|0|||
162993695|NCT01056289|588677868|FG000|Open-label Phase|Protocol Violation|6|||
162993696|NCT01056289|588677869|FG001|Open-label Phase|Protocol Violation|0|||
162636980|NCT01156311|587386050|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162636981|NCT01156311|587386051|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162636982|NCT01156311|587386052|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
162636983|NCT01156311|587386053|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162636984|NCT01156311|587386050|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
162993697|NCT01056289|588677870|FG002|Open-label Phase|Protocol Violation|0|||
162993698|NCT01056289|588677871|FG003|Open-label Phase|Protocol Violation|0|||
162993699|NCT01056289|588677868|FG000|Open-label Phase|Withdrawal by Subject|26|||
162993700|NCT01056289|588677869|FG001|Open-label Phase|Withdrawal by Subject|0|||
162993701|NCT01056289|588677870|FG002|Open-label Phase|Withdrawal by Subject|0|||
162993702|NCT01056289|588677871|FG003|Open-label Phase|Withdrawal by Subject|0|||
162993703|NCT01056289|588677868|FG000|Open-label Phase|Lack of Efficacy|18|||
162993704|NCT01056289|588677869|FG001|Open-label Phase|Lack of Efficacy|0|||
162993705|NCT01056289|588677870|FG002|Open-label Phase|Lack of Efficacy|0|||
162993706|NCT01056289|588677871|FG003|Open-label Phase|Lack of Efficacy|0|||
162993707|NCT01056289|588677868|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
162993708|NCT01056289|588677869|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
162993709|NCT01056289|588677870|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
162993710|NCT01056289|588677871|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
162993711|NCT01056289|588677868|FG000|Double-blind Phase|Adverse Event|0|||
162993712|NCT01056289|588677869|FG001|Double-blind Phase|Adverse Event|1|||
162993713|NCT01056289|588677870|FG002|Double-blind Phase|Adverse Event|2|||
162993714|NCT01056289|588677871|FG003|Double-blind Phase|Adverse Event|1|||
162993715|NCT01056289|588677868|FG000|Double-blind Phase|Lost to Follow-up|0|||
162993716|NCT01056289|588677869|FG001|Double-blind Phase|Lost to Follow-up|2|||
162993717|NCT01056289|588677870|FG002|Double-blind Phase|Lost to Follow-up|2|||
162993718|NCT01056289|588677871|FG003|Double-blind Phase|Lost to Follow-up|2|||
162993719|NCT01056289|588677868|FG000|Double-blind Phase|Other|0|||
162993720|NCT01056289|588677869|FG001|Double-blind Phase|Other|0|||
162993721|NCT01056289|588677870|FG002|Double-blind Phase|Other|1|||
162993722|NCT01056289|588677871|FG003|Double-blind Phase|Other|2|||
162993723|NCT01056289|588677868|FG000|Double-blind Phase|Protocol Violation|0|||
162993724|NCT01056289|588677869|FG001|Double-blind Phase|Protocol Violation|0|||
162993725|NCT01056289|588677870|FG002|Double-blind Phase|Protocol Violation|1|||
162993726|NCT01056289|588677871|FG003|Double-blind Phase|Protocol Violation|1|||
162993727|NCT01056289|588677868|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162993728|NCT01056289|588677869|FG001|Double-blind Phase|Withdrawal by Subject|0|||
162993729|NCT01056289|588677870|FG002|Double-blind Phase|Withdrawal by Subject|4|||
162993730|NCT01056289|588677871|FG003|Double-blind Phase|Withdrawal by Subject|2|||
162993731|NCT01056289|588677868|FG000|Double-blind Phase|Discontinuation symptom|0|||
162993732|NCT01056289|588677869|FG001|Double-blind Phase|Discontinuation symptom|1|||
162993733|NCT01056289|588677870|FG002|Double-blind Phase|Discontinuation symptom|2|||
162993734|NCT01056289|588677871|FG003|Double-blind Phase|Discontinuation symptom|2|||
162993735|NCT01056289|588677868|FG000|Double-blind Phase|Physician Decision|0|||
162993736|NCT01056289|588677869|FG001|Double-blind Phase|Physician Decision|0|||
162993737|NCT01056289|588677870|FG002|Double-blind Phase|Physician Decision|1|||
162993738|NCT01056289|588677871|FG003|Double-blind Phase|Physician Decision|0|||
162993739|NCT00459043|588677878|FG000|Overall Study|Withdrawal by Subject|1|||
162993740|NCT00459043|588677879|FG001|Overall Study|Withdrawal by Subject|0|||
162993741|NCT00270855|588677880|FG000|Overall Study|Withdrawal by Subject|8|||
162993742|NCT00270855|588677881|FG001|Overall Study|Withdrawal by Subject|8|||
162993743|NCT03156504|588677889|FG000|Overall Study|Withdrawal by Subject|1|||
162993744|NCT00450801|588677890|FG000|Overall Study|Death|1|||
162993745|NCT05048329|588677891|FG000|Overall Study|Withdrawal by Subject|1|||
162993746|NCT05048329|588677891|FG000|Overall Study|Screenfail|1|||
162993747|NCT00324649|588677892|FG000|Overall Study|Adverse Event|1|||
162993748|NCT00324649|588677893|FG001|Overall Study|Adverse Event|4|||
162993749|NCT00324649|588677892|FG000|Overall Study|Withdrawal by Subject|0|||
162993750|NCT00324649|588677893|FG001|Overall Study|Withdrawal by Subject|1|||
162993751|NCT00324649|588677892|FG000|Overall Study|Noncompliance|1|||
162993752|NCT00324649|588677893|FG001|Overall Study|Noncompliance|0|||
162993753|NCT02618759|588677894|FG000|Overall Study|Lost to Follow-up|0|||
162993754|NCT02618759|588677895|FG001|Overall Study|Lost to Follow-up|1|||
162993755|NCT02618759|588677894|FG000|Overall Study|Withdrawal by Subject|1|||
162993756|NCT02618759|588677895|FG001|Overall Study|Withdrawal by Subject|0|||
162993757|NCT02618759|588677894|FG000|Overall Study|Other Reasons|1|||
162993758|NCT02618759|588677895|FG001|Overall Study|Other Reasons|4|||
162993759|NCT03301649|588677898|FG000|Overall Study|Need alternate therapy due to live lice|17|||
162993760|NCT03301649|588677899|FG001|Overall Study|Need alternate therapy due to live lice|25|||
162993761|NCT03301649|588677900|FG002|Overall Study|Need alternate therapy due to live lice|81|||
162993762|NCT03301649|588677898|FG000|Overall Study|Lost to Follow-up|11|||
162993763|NCT03301649|588677899|FG001|Overall Study|Lost to Follow-up|11|||
162993764|NCT03301649|588677900|FG002|Overall Study|Lost to Follow-up|3|||
162993765|NCT03301649|588677898|FG000|Overall Study|Protocol Violation|0|||
162993766|NCT03301649|588677899|FG001|Overall Study|Protocol Violation|1|||
162993767|NCT03301649|588677900|FG002|Overall Study|Protocol Violation|1|||
162993768|NCT03301649|588677898|FG000|Overall Study|Withdrawal by Subject|10|||
162993769|NCT03301649|588677899|FG001|Overall Study|Withdrawal by Subject|4|||
162993770|NCT03301649|588677900|FG002|Overall Study|Withdrawal by Subject|0|||
162993771|NCT03301649|588677898|FG000|Overall Study|Other than specified|5|||
162993772|NCT03301649|588677899|FG001|Overall Study|Other than specified|3|||
162993773|NCT03301649|588677900|FG002|Overall Study|Other than specified|0|||
162993774|NCT03559400|588677901|FG000|Overall Study|Lost to Follow-up|9|||
162993775|NCT03559400|588677902|FG001|Overall Study|Lost to Follow-up|7|||
162993776|NCT03559400|588677901|FG000|Overall Study|Death|0|||
162993777|NCT03559400|588677902|FG001|Overall Study|Death|2|||
162993778|NCT03323437|588677903|FG000|Overall Study|Withdrawal by Subject|0|||
162993779|NCT03323437|588677904|FG001|Overall Study|Withdrawal by Subject|4|||
162993780|NCT00282919|588677905|FG000|Overall Study|Lack of Efficacy|4|||
162993781|NCT00282919|588677905|FG000|Overall Study|Withdrawal by Subject|1|||
162993782|NCT00282919|588677905|FG000|Overall Study|Asymptomatic Parasitemia|2|||
162993783|NCT03257865|588677911|FG000|Overall Study|Adverse Event|4|||
162993784|NCT03257865|588677912|FG001|Overall Study|Adverse Event|8|||
162993785|NCT03257865|588677911|FG000|Overall Study|Lack of Efficacy|1|||
162993786|NCT03257865|588677912|FG001|Overall Study|Lack of Efficacy|2|||
162993787|NCT03257865|588677911|FG000|Overall Study|Non-compliance with Study Drug|0|||
162993788|NCT03257865|588677912|FG001|Overall Study|Non-compliance with Study Drug|2|||
162993789|NCT03257865|588677911|FG000|Overall Study|Withdrawal by Subject|23|||
162993790|NCT03257865|588677912|FG001|Overall Study|Withdrawal by Subject|17|||
162993791|NCT03257865|588677911|FG000|Overall Study|Physician Decision|3|||
162636985|NCT01156311|587386051|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
162636986|NCT01156311|587386052|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
162636987|NCT01156311|587386053|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
162636988|NCT01156311|587386050|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
162636989|NCT01156311|587386051|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
162993792|NCT03257865|588677912|FG001|Overall Study|Physician Decision|1|||
162715677|NCT03431350|587667085|FG010|Overall Study|ONGOING|2|||
162993793|NCT03257865|588677911|FG000|Overall Study|Other|0|||
162993794|NCT03257865|588677912|FG001|Overall Study|Other|1|||
162993795|NCT03257865|588677911|FG000|Overall Study|Lost to Follow-up|4|||
162993796|NCT03257865|588677912|FG001|Overall Study|Lost to Follow-up|4|||
162993797|NCT02549027|588677915|FG000|Washout After Period 4|Withdrawal by Subject|0|||
162993798|NCT02549027|588677916|FG001|Washout After Period 4|Withdrawal by Subject|1|||
162993799|NCT02549027|588677917|FG002|Washout After Period 4|Withdrawal by Subject|1|||
162993800|NCT02549027|588677918|FG003|Washout After Period 4|Withdrawal by Subject|1|||
162993801|NCT02549027|588677919|FG004|Washout After Period 4|Withdrawal by Subject|0|||
162993802|NCT02549027|588677920|FG005|Washout After Period 4|Withdrawal by Subject|0|||
162993803|NCT02549027|588677915|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993804|NCT02549027|588677916|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993805|NCT02549027|588677917|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993806|NCT02549027|588677918|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993807|NCT02549027|588677919|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
162993808|NCT02549027|588677920|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162993809|NCT01111825|588677921|FG000|Overall Study|Withdrawal by Subject|0|||
162993810|NCT01111825|588677922|FG001|Overall Study|Withdrawal by Subject|0|||
162993811|NCT01111825|588677923|FG002|Overall Study|Withdrawal by Subject|1|||
162993812|NCT01111825|588677924|FG003|Overall Study|Withdrawal by Subject|0|||
162993813|NCT01111825|588677921|FG000|Overall Study|Lost to Follow-up|0|||
162993814|NCT01111825|588677922|FG001|Overall Study|Lost to Follow-up|0|||
162993815|NCT01111825|588677923|FG002|Overall Study|Lost to Follow-up|3|||
162993816|NCT01111825|588677924|FG003|Overall Study|Lost to Follow-up|1|||
162993817|NCT01111825|588677921|FG000|Overall Study|Adverse Event|2|||
162993818|NCT01111825|588677922|FG001|Overall Study|Adverse Event|1|||
162993819|NCT01111825|588677923|FG002|Overall Study|Adverse Event|4|||
162993820|NCT01111825|588677924|FG003|Overall Study|Adverse Event|0|||
162993821|NCT01111825|588677921|FG000|Overall Study|Disease Progression|1|||
162993822|NCT01111825|588677922|FG001|Overall Study|Disease Progression|0|||
162993823|NCT01111825|588677923|FG002|Overall Study|Disease Progression|0|||
162993824|NCT01111825|588677924|FG003|Overall Study|Disease Progression|0|||
162993825|NCT01111825|588677921|FG000|Overall Study|Discontinuation by Sponsor|0|||
162993826|NCT01111825|588677922|FG001|Overall Study|Discontinuation by Sponsor|0|||
162993827|NCT01111825|588677923|FG002|Overall Study|Discontinuation by Sponsor|0|||
162993828|NCT01111825|588677924|FG003|Overall Study|Discontinuation by Sponsor|20|||
162993829|NCT01377987|588677925|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
162993830|NCT01377987|588677926|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162993831|NCT00168818|588677927|FG000|Overall Study|Adverse Event|23|||
162993832|NCT00168818|588677928|FG001|Overall Study|Adverse Event|29|||
162993833|NCT00168818|588677929|FG002|Overall Study|Adverse Event|31|||
162993834|NCT00168818|588677927|FG000|Overall Study|Protocol Violation|16|||
162993835|NCT00168818|588677928|FG001|Overall Study|Protocol Violation|11|||
162993836|NCT00168818|588677929|FG002|Overall Study|Protocol Violation|11|||
162993837|NCT00168818|588677927|FG000|Overall Study|Lost to Follow-up|13|||
162993838|NCT00168818|588677928|FG001|Overall Study|Lost to Follow-up|4|||
162993839|NCT00168818|588677929|FG002|Overall Study|Lost to Follow-up|15|||
162993840|NCT00168818|588677927|FG000|Overall Study|Withdrawal by Subject|43|||
162993841|NCT00168818|588677928|FG001|Overall Study|Withdrawal by Subject|41|||
162993842|NCT00168818|588677929|FG002|Overall Study|Withdrawal by Subject|37|||
162993843|NCT00168818|588677927|FG000|Overall Study|Other|22|||
162993844|NCT00168818|588677928|FG001|Overall Study|Other|24|||
162993845|NCT00168818|588677929|FG002|Overall Study|Other|30|||
162993846|NCT00168818|588677927|FG000|Treatment|Adverse Event|77|||
162993847|NCT00168818|588677928|FG001|Treatment|Adverse Event|89|||
162993848|NCT00168818|588677929|FG002|Treatment|Adverse Event|68|||
162993849|NCT00168818|588677927|FG000|Treatment|Protocol Violation|8|||
162993850|NCT00168818|588677928|FG001|Treatment|Protocol Violation|11|||
162993851|NCT00168818|588677929|FG002|Treatment|Protocol Violation|11|||
162993852|NCT00168818|588677927|FG000|Treatment|Lost to Follow-up|0|||
162993853|NCT00168818|588677928|FG001|Treatment|Lost to Follow-up|2|||
162993854|NCT00168818|588677929|FG002|Treatment|Lost to Follow-up|1|||
162993855|NCT00168818|588677927|FG000|Treatment|Withdrawal by Subject|25|||
162993856|NCT00168818|588677928|FG001|Treatment|Withdrawal by Subject|20|||
162993857|NCT00168818|588677929|FG002|Treatment|Withdrawal by Subject|22|||
162993858|NCT00168818|588677927|FG000|Treatment|Other|23|||
162993859|NCT00168818|588677928|FG001|Treatment|Other|29|||
162993860|NCT00168818|588677929|FG002|Treatment|Other|31|||
162993861|NCT00469144|588677930|FG000|Overall Study|Death|0|||
162993862|NCT00469144|588677931|FG001|Overall Study|Death|1|||
162993863|NCT00469144|588677930|FG000|Overall Study|No Response|5|||
162993864|NCT00469144|588677931|FG001|Overall Study|No Response|5|||
162993865|NCT00469144|588677930|FG000|Overall Study|Progressive Disease|1|||
162993866|NCT00469144|588677931|FG001|Overall Study|Progressive Disease|0|||
162993867|NCT01994291|588677932|FG000|Overall Study|Adverse Event|4|||
162993868|NCT01994291|588677933|FG001|Overall Study|Adverse Event|1|||
162993869|NCT01994291|588677934|FG002|Overall Study|Adverse Event|3|||
162993870|NCT01994291|588677932|FG000|Overall Study|Lost to Follow-up|1|||
162993871|NCT01994291|588677933|FG001|Overall Study|Lost to Follow-up|1|||
162993872|NCT01994291|588677934|FG002|Overall Study|Lost to Follow-up|0|||
162993873|NCT01994291|588677932|FG000|Overall Study|Does not meet entrance criteria|1|||
162993874|NCT01994291|588677933|FG001|Overall Study|Does not meet entrance criteria|0|||
162993875|NCT01994291|588677934|FG002|Overall Study|Does not meet entrance criteria|0|||
162993876|NCT01994291|588677932|FG000|Overall Study|Medication error without associated AE|1|||
162993877|NCT01994291|588677933|FG001|Overall Study|Medication error without associated AE|0|||
162993878|NCT01994291|588677934|FG002|Overall Study|Medication error without associated AE|1|||
162993879|NCT01994291|588677932|FG000|Overall Study|Protocol Violation|1|||
162993880|NCT01994291|588677933|FG001|Overall Study|Protocol Violation|0|||
162993881|NCT01994291|588677934|FG002|Overall Study|Protocol Violation|0|||
162993882|NCT01994291|588677932|FG000|Overall Study|Withdrawal by Subject|6|||
162993883|NCT01994291|588677933|FG001|Overall Study|Withdrawal by Subject|3|||
162993884|NCT01994291|588677934|FG002|Overall Study|Withdrawal by Subject|5|||
162993885|NCT01994291|588677932|FG000|Overall Study|Other|1|||
162993886|NCT01994291|588677933|FG001|Overall Study|Other|2|||
162993887|NCT01994291|588677934|FG002|Overall Study|Other|0|||
162993888|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993889|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
162993890|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993891|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993892|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993893|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993894|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162993895|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993896|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
162993897|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993898|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993899|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993900|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993901|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162993902|NCT01775189|588677935|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993903|NCT01775189|588677936|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
162993904|NCT01775189|588677937|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
162993905|NCT01775189|588677938|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993906|NCT01775189|588677939|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993907|NCT01775189|588677940|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993908|NCT01775189|588677941|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
162993909|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993910|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993911|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993912|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993913|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993914|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
162993915|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
162993916|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993917|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993918|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993919|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
162993920|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993921|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993922|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
162993923|NCT01775189|588677935|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993924|NCT01775189|588677936|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993925|NCT01775189|588677937|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993926|NCT01775189|588677938|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
162993927|NCT01775189|588677939|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993928|NCT01775189|588677940|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
162993929|NCT01775189|588677941|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
162993930|NCT02227446|588677942|FG000|Overall Study|not eligible post randomization|18|||
162993931|NCT02227446|588677943|FG001|Overall Study|not eligible post randomization|29|||
162993932|NCT02227446|588677942|FG000|Overall Study|Withdrawal by Subject|4|||
162993933|NCT02227446|588677943|FG001|Overall Study|Withdrawal by Subject|5|||
162993934|NCT02901548|588677950|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
162993935|NCT03336528|588677951|FG000|Overall Study|Protocol Violation|1|||
162993936|NCT03336528|588677952|FG001|Overall Study|Protocol Violation|1|||
162993937|NCT03336528|588677951|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
162993938|NCT03336528|588677952|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
162993939|NCT03336528|588677951|FG000|Overall Study|Did not receive study medication|1|||
162993940|NCT03336528|588677952|FG001|Overall Study|Did not receive study medication|2|||
162993941|NCT00920790|588677953|FG000|Overall Study|aggravation of general condition|14|||
162993942|NCT02639052|588677954|FG000|Overall Study|Lost to Follow-up|1|||
162636990|NCT01156311|587386052|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
162636991|NCT01156311|587386053|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
162636992|NCT01156311|587386050|FG000|6-month Add-on Therapy Period|Other|0|||
162636993|NCT01156311|587386051|FG001|6-month Add-on Therapy Period|Other|0|||
162993943|NCT02655666|588677956|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
162636994|NCT01156311|587386052|FG002|6-month Add-on Therapy Period|Other|1|||
162636995|NCT01156311|587386053|FG003|6-month Add-on Therapy Period|Other|2|||
162636996|NCT06133348|587386056|FG000|Overall Study|Death|3|||
162636997|NCT06133348|587386056|FG000|Overall Study|Lost to Follow-up|1|||
162636998|NCT06133348|587386056|FG000|Overall Study|Physician Decision|1|||
162636999|NCT06133348|587386056|FG000|Overall Study|Withdrawal by Subject|5|||
162993944|NCT00895414|588677957|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
162993945|NCT00895414|588677958|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
162993946|NCT00895414|588677957|FG000|First Intervention (14 Days)|Physician Decision|0|||
162993947|NCT00895414|588677958|FG001|First Intervention (14 Days)|Physician Decision|1|||
162993948|NCT00789737|588677963|FG000|Overall Study|Withdrawal by Subject|13|||
162993949|NCT00789737|588677964|FG001|Overall Study|Withdrawal by Subject|22|||
162993950|NCT00789737|588677963|FG000|Overall Study|Lost to Follow-up|10|||
162993951|NCT00789737|588677964|FG001|Overall Study|Lost to Follow-up|14|||
162993952|NCT00789737|588677963|FG000|Overall Study|Adverse Event|8|||
162993953|NCT00789737|588677964|FG001|Overall Study|Adverse Event|8|||
162993954|NCT00789737|588677963|FG000|Overall Study|Protocol Violation|3|||
162993955|NCT00789737|588677964|FG001|Overall Study|Protocol Violation|0|||
162993956|NCT00789737|588677963|FG000|Overall Study|Lack of Efficacy|3|||
162993957|NCT00789737|588677964|FG001|Overall Study|Lack of Efficacy|0|||
162993958|NCT00789737|588677963|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
162993959|NCT00789737|588677964|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
162993960|NCT00789737|588677963|FG000|Overall Study|Other|11|||
162993961|NCT00789737|588677964|FG001|Overall Study|Other|7|||
162993962|NCT02458287|588677965|FG000|Overall Study|Adverse Event|0|||
162993963|NCT02458287|588677966|FG001|Overall Study|Adverse Event|0|||
162993964|NCT02458287|588677967|FG002|Overall Study|Adverse Event|0|||
162993965|NCT02458287|588677968|FG003|Overall Study|Adverse Event|1|||
162993966|NCT02458287|588677965|FG000|Overall Study|Lost to Follow-up|0|||
162637000|NCT02393547|587386059|FG000|Overall Study|Adverse Event|2|||
162993967|NCT02458287|588677966|FG001|Overall Study|Lost to Follow-up|1|||
162637001|NCT02393547|587386059|FG000|Overall Study|Withdrawal by Subject|3|||
162993968|NCT02458287|588677967|FG002|Overall Study|Lost to Follow-up|1|||
162993969|NCT02458287|588677968|FG003|Overall Study|Lost to Follow-up|0|||
162993970|NCT02458287|588677965|FG000|Overall Study|Protocol Violation|0|||
162993971|NCT02458287|588677966|FG001|Overall Study|Protocol Violation|1|||
162993972|NCT02458287|588677967|FG002|Overall Study|Protocol Violation|0|||
162637002|NCT02393547|587386059|FG000|Overall Study|Lost to Follow-up|1|||
162993973|NCT02458287|588677968|FG003|Overall Study|Protocol Violation|0|||
162993974|NCT02458287|588677965|FG000|Overall Study|Withdrawal by Subject|0|||
162993975|NCT02458287|588677966|FG001|Overall Study|Withdrawal by Subject|2|||
162993976|NCT02458287|588677967|FG002|Overall Study|Withdrawal by Subject|2|||
162993977|NCT02458287|588677968|FG003|Overall Study|Withdrawal by Subject|1|||
162993978|NCT02458287|588677965|FG000|Overall Study|Relocated Out of State|0|||
162993979|NCT02458287|588677966|FG001|Overall Study|Relocated Out of State|0|||
162993980|NCT02458287|588677967|FG002|Overall Study|Relocated Out of State|0|||
162993981|NCT02458287|588677968|FG003|Overall Study|Relocated Out of State|1|||
162993982|NCT00369317|588677969|FG000|Overall Study|Adverse Event|3|||
162993983|NCT00369317|588677969|FG000|Overall Study|Death|1|||
162993984|NCT00369317|588677969|FG000|Overall Study|Lack of Efficacy|5|||
162993985|NCT00369317|588677969|FG000|Overall Study|Physician Decision|2|||
162993986|NCT00369317|588677969|FG000|Overall Study|Withdrawal by Subject|8|||
162993987|NCT00369317|588677969|FG000|Overall Study|Ineligible|1|||
162993988|NCT02365558|588677970|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
162993989|NCT02365558|588677971|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
162993990|NCT02365558|588677970|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
162993991|NCT02365558|588677971|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
162993992|NCT00418821|588677978|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
162993993|NCT02823652|588677979|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
162993994|NCT02823652|588677980|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
162993995|NCT02823652|588677981|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
162993996|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
162993997|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
162993998|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
162993999|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
162994000|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
162994001|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
162994002|NCT02823652|588677979|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
162994003|NCT02823652|588677980|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
162994004|NCT02823652|588677981|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
162994005|NCT04428333|588677982|FG000|Overall Study|Physician Decision|5|||
162994006|NCT04428333|588677983|FG001|Overall Study|Physician Decision|6|||
162994007|NCT04428333|588677982|FG000|Overall Study|Withdrawal by Subject|1|||
162994008|NCT04428333|588677983|FG001|Overall Study|Withdrawal by Subject|3|||
162994009|NCT04428333|588677982|FG000|Overall Study|Study Terminated By Sponsor|14|||
162994010|NCT04428333|588677983|FG001|Overall Study|Study Terminated By Sponsor|16|||
162994011|NCT04853992|588677984|FG000|Treatment Period A|Adverse Event|0|||
162994012|NCT04853992|588677985|FG001|Treatment Period A|Adverse Event|1|||
162994013|NCT04853992|588677984|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
162994014|NCT04853992|588677985|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
162994015|NCT02269163|588677986|FG000|Overall Study|Lost to Follow-up|1|||
162994016|NCT02269163|588677987|FG001|Overall Study|Lost to Follow-up|0|||
162994017|NCT02269163|588677986|FG000|Overall Study|Major protocol violation|0|||
162994018|NCT02269163|588677987|FG001|Overall Study|Major protocol violation|1|||
162994019|NCT02269163|588677986|FG000|Overall Study|Other|2|||
162994020|NCT02269163|588677987|FG001|Overall Study|Other|2|||
162994021|NCT02269163|588677986|FG000|Overall Study|Withdrawal by Subject|0|||
162994022|NCT02269163|588677987|FG001|Overall Study|Withdrawal by Subject|3|||
162994023|NCT02269163|588677986|FG000|Overall Study|Physician Decision|0|||
162994024|NCT02269163|588677987|FG001|Overall Study|Physician Decision|1|||
162994025|NCT02351960|588677990|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
162994026|NCT02351960|588677991|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
162994027|NCT02351960|588677990|FG000|Overall Study|Voluntary Withdrawal|5|||
162994028|NCT02351960|588677991|FG001|Overall Study|Voluntary Withdrawal|4|||
162994029|NCT02351960|588677990|FG000|Overall Study|Significant Protocol Deviation|0|||
162994030|NCT02351960|588677991|FG001|Overall Study|Significant Protocol Deviation|5|||
162994031|NCT00402116|588679995|FG000|Overall Study|Jaw infection after surgery-other|1|||
162994032|NCT00402116|588679996|FG001|Overall Study|Jaw infection after surgery-other|0|||
163060223|NCT04513366|588928342|FG001|Treatment Phase|Physician Decision|0|||
163060224|NCT04513366|588928343|FG002|Treatment Phase|Physician Decision|0|||
162994033|NCT00402116|588679997|FG002|Overall Study|Jaw infection after surgery-other|0|||
162994034|NCT00402116|588679995|FG000|Overall Study|Withdrawal by Subject|1|||
162994035|NCT00402116|588679996|FG001|Overall Study|Withdrawal by Subject|0|||
162994036|NCT00402116|588679997|FG002|Overall Study|Withdrawal by Subject|5|||
162994037|NCT00402116|588679995|FG000|Overall Study|Treatment completed per protocol|1|||
162994038|NCT00402116|588679996|FG001|Overall Study|Treatment completed per protocol|1|||
162994039|NCT00402116|588679997|FG002|Overall Study|Treatment completed per protocol|2|||
163060225|NCT04513366|588928341|FG000|Treatment Phase|Adverse Event|0|||
162637003|NCT00429104|587386061|FG000|Overall Study|Protocol Violation|1|||
162994040|NCT00402116|588679995|FG000|Overall Study|other complicating disease|0|||
162994041|NCT00402116|588679996|FG001|Overall Study|other complicating disease|0|||
162994042|NCT00402116|588679997|FG002|Overall Study|other complicating disease|2|||
162994043|NCT00402116|588679995|FG000|Overall Study|Disease Progression|0|||
162994044|NCT00402116|588679996|FG001|Overall Study|Disease Progression|4|||
162994045|NCT00402116|588679997|FG002|Overall Study|Disease Progression|38|||
162994046|NCT00402116|588679995|FG000|Overall Study|mistaken thrombocytopenia|0|||
162994047|NCT00402116|588679996|FG001|Overall Study|mistaken thrombocytopenia|0|||
162994048|NCT00402116|588679997|FG002|Overall Study|mistaken thrombocytopenia|1|||
162994049|NCT00402116|588679995|FG000|Overall Study|decline related hyponatremia/tumor|0|||
162994050|NCT00402116|588679996|FG001|Overall Study|decline related hyponatremia/tumor|0|||
162715678|NCT03431350|587667086|FG011|Overall Study|ONGOING|1|||
162715679|NCT03431350|587667075|FG000|Overall Study|Death|6|||
162715680|NCT03431350|587667076|FG001|Overall Study|Death|5|||
162715681|NCT03431350|587667077|FG002|Overall Study|Death|18|||
162715682|NCT03431350|587667078|FG003|Overall Study|Death|7|||
162994051|NCT00402116|588679997|FG002|Overall Study|decline related hyponatremia/tumor|1|||
162994052|NCT00402116|588679995|FG000|Overall Study|Adverse Event|0|||
162994053|NCT00402116|588679996|FG001|Overall Study|Adverse Event|1|||
162994054|NCT00402116|588679997|FG002|Overall Study|Adverse Event|6|||
162994055|NCT02135614|588679998|FG000|Overall Study|Randomized but Not Treated|2|||
162994056|NCT02135614|588679999|FG001|Overall Study|Randomized but Not Treated|1|||
162994057|NCT02135614|588679998|FG000|Overall Study|Adverse Event|0|||
162994058|NCT02135614|588679999|FG001|Overall Study|Adverse Event|1|||
162994059|NCT02135614|588679998|FG000|Overall Study|Death|1|||
162994060|NCT02135614|588679999|FG001|Overall Study|Death|0|||
162994061|NCT02135614|588679998|FG000|Overall Study|Investigator's Discretion|0|||
162994062|NCT02135614|588679999|FG001|Overall Study|Investigator's Discretion|1|||
162994063|NCT02135614|588679998|FG000|Overall Study|Withdrew Consent|2|||
162994064|NCT02135614|588679999|FG001|Overall Study|Withdrew Consent|2|||
162994065|NCT02135614|588679998|FG000|Overall Study|Lost to Follow-up|3|||
162994066|NCT02135614|588679999|FG001|Overall Study|Lost to Follow-up|0|||
162994067|NCT00554606|588680001|FG000|Overall Study|Adverse Event|3|||
162994068|NCT00554606|588680001|FG000|Overall Study|Abnormal laboratory values|1|||
162994069|NCT00554606|588680001|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
162994070|NCT00554606|588680001|FG000|Overall Study|Subject withdrew consent|2|||
162994071|NCT00554606|588680001|FG000|Overall Study|Lost to Follow-up|2|||
162994072|NCT00554606|588680001|FG000|Overall Study|Administrative problems|60|||
162994073|NCT00554606|588680001|FG000|Overall Study|Death|1|||
162994074|NCT00554606|588680001|FG000|Overall Study|Protocol deviation|2|||
162994075|NCT01421511|588680005|FG000|Overall Study|Lost to Follow-up|11|||
162994076|NCT01421511|588680006|FG001|Overall Study|Lost to Follow-up|14|||
162994077|NCT01421511|588680005|FG000|Overall Study|Randomized but didn't receive study drug|1|||
162994078|NCT01421511|588680006|FG001|Overall Study|Randomized but didn't receive study drug|7|||
162994079|NCT01421511|588680005|FG000|Overall Study|Physician Decision|0|||
162994080|NCT01421511|588680006|FG001|Overall Study|Physician Decision|1|||
162994081|NCT01421511|588680005|FG000|Overall Study|Withdrawal by Subject|6|||
162994082|NCT01421511|588680006|FG001|Overall Study|Withdrawal by Subject|5|||
162994083|NCT01421511|588680005|FG000|Overall Study|Death|1|||
162994084|NCT01421511|588680006|FG001|Overall Study|Death|1|||
162994085|NCT02242045|588680007|FG000|Overall Study|Investigator's Discretion|1|||
162994086|NCT02242045|588680007|FG000|Overall Study|Progressive Disease|2|||
162994087|NCT02242045|588680007|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
162994088|NCT02242045|588680007|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
162994089|NCT00749892|588680008|FG000|Overall Study|Withdrawal by Subject|3|||
162994090|NCT00106964|588680010|FG000|Overall Study|Lost to Follow-up|8|||
162994091|NCT00106964|588680011|FG001|Overall Study|Lost to Follow-up|6|||
162994092|NCT00106964|588680012|FG002|Overall Study|Lost to Follow-up|2|||
162994093|NCT00106964|588680010|FG000|Overall Study|Pregnancy|2|||
162994094|NCT00106964|588680011|FG001|Overall Study|Pregnancy|3|||
162994095|NCT00106964|588680012|FG002|Overall Study|Pregnancy|2|||
162994096|NCT00106964|588680010|FG000|Overall Study|Death|1|||
162994097|NCT00106964|588680011|FG001|Overall Study|Death|1|||
162994098|NCT00106964|588680012|FG002|Overall Study|Death|0|||
162994099|NCT00106964|588680010|FG000|Overall Study|Incarceration|0|||
163060226|NCT04513366|588928342|FG001|Treatment Phase|Adverse Event|1|||
162637004|NCT04997161|587386078|FG000|Overall Study|Study terminated by sponsor|3|||
162637005|NCT00752232|587386079|FG000|Overall Study|Protocol Violation|0|||
162637006|NCT00752232|587386080|FG001|Overall Study|Protocol Violation|0|||
162637007|NCT00752232|587386081|FG002|Overall Study|Protocol Violation|0|||
162637008|NCT00752232|587386082|FG003|Overall Study|Protocol Violation|0|||
162637009|NCT00752232|587386083|FG004|Overall Study|Protocol Violation|0|||
162637010|NCT00752232|587386084|FG005|Overall Study|Protocol Violation|1|||
162637011|NCT00752232|587386085|FG006|Overall Study|Protocol Violation|0|||
162637012|NCT00752232|587386079|FG000|Overall Study|Caregiver request|2|||
162637013|NCT00752232|587386080|FG001|Overall Study|Caregiver request|0|||
162637014|NCT00752232|587386081|FG002|Overall Study|Caregiver request|0|||
162637015|NCT00752232|587386082|FG003|Overall Study|Caregiver request|0|||
162637016|NCT00752232|587386083|FG004|Overall Study|Caregiver request|1|||
162637017|NCT00752232|587386084|FG005|Overall Study|Caregiver request|0|||
162994100|NCT00106964|588680011|FG001|Overall Study|Incarceration|1|||
162994101|NCT00106964|588680012|FG002|Overall Study|Incarceration|0|||
162994102|NCT00106964|588680010|FG000|Overall Study|Site Funding Terminated|0|||
162994103|NCT00106964|588680011|FG001|Overall Study|Site Funding Terminated|1|||
162994104|NCT00106964|588680012|FG002|Overall Study|Site Funding Terminated|1|||
162994105|NCT00106964|588680010|FG000|Overall Study|Failure to adhere|2|||
162994106|NCT00106964|588680011|FG001|Overall Study|Failure to adhere|0|||
162994107|NCT00106964|588680012|FG002|Overall Study|Failure to adhere|0|||
162994108|NCT00106964|588680010|FG000|Overall Study|Did not meet eligibility criteria|0|||
162994109|NCT00106964|588680011|FG001|Overall Study|Did not meet eligibility criteria|2|||
162994110|NCT00106964|588680012|FG002|Overall Study|Did not meet eligibility criteria|2|||
162994111|NCT00106964|588680010|FG000|Overall Study|Required disallowed medication|0|||
162994112|NCT00106964|588680011|FG001|Overall Study|Required disallowed medication|1|||
162994113|NCT00106964|588680012|FG002|Overall Study|Required disallowed medication|0|||
162994114|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
162994115|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
162994116|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
162994117|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
162994118|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
162994119|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
162994120|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
162994121|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
162994122|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
162994123|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
162994124|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
162994125|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
162994126|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
162994127|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
162994128|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
162994129|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
162994130|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
162994131|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
162994132|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
162994133|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
162994134|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
162994135|NCT04040192|588680013|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
162994136|NCT04040192|588680014|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
162994137|NCT04040192|588680015|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
162994138|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
162994139|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
162994140|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
162994141|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
162994142|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
162994143|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
162994144|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
162994145|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
162994146|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
162994147|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
162994148|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
162994149|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
162994150|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
162994151|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
162994152|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
162994153|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
162994154|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
162994155|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
162994156|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
162994157|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
162994158|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
162994159|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
162637018|NCT00752232|587386085|FG006|Overall Study|Caregiver request|0|||
162637019|NCT00752232|587386079|FG000|Overall Study|Investigator request|0|||
162994160|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
162994161|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
162637020|NCT00752232|587386080|FG001|Overall Study|Investigator request|0|||
162637021|NCT00752232|587386081|FG002|Overall Study|Investigator request|0|||
162994162|NCT04040192|588680013|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
162994163|NCT04040192|588680014|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
162994164|NCT04040192|588680015|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
162994165|NCT03207243|588680016|FG000|Overall Study|Adverse Event|2|||
162994166|NCT03207243|588680017|FG001|Overall Study|Adverse Event|2|||
162994167|NCT03207243|588680016|FG000|Overall Study|Loss of Asthma Control|47|||
162994168|NCT03207243|588680017|FG001|Overall Study|Loss of Asthma Control|31|||
162994169|NCT03207243|588680016|FG000|Overall Study|Withdrawal by Subject|2|||
162994170|NCT03207243|588680017|FG001|Overall Study|Withdrawal by Subject|4|||
162994171|NCT03207243|588680016|FG000|Overall Study|Physician Decision|1|||
162994172|NCT03207243|588680017|FG001|Overall Study|Physician Decision|1|||
162994173|NCT03207243|588680016|FG000|Overall Study|Lost to Follow-up|0|||
162994174|NCT03207243|588680017|FG001|Overall Study|Lost to Follow-up|1|||
162994175|NCT03207243|588680016|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
162994176|NCT03207243|588680017|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
162994177|NCT03207243|588680016|FG000|Overall Study|Protocol Violation|0|||
162994178|NCT03207243|588680017|FG001|Overall Study|Protocol Violation|3|||
162994179|NCT00603837|588680024|FG000|Overall Study|Physician Decision|3|||
162994180|NCT00603837|588680025|FG001|Overall Study|Physician Decision|0|||
162994181|NCT01352416|588680026|FG000|Overall Study|Physician Decision|1|||
162994182|NCT01352416|588680027|FG001|Overall Study|Physician Decision|2|||
162994183|NCT01352416|588680028|FG002|Overall Study|Physician Decision|2|||
162994184|NCT01352416|588680029|FG003|Overall Study|Physician Decision|1|||
162994185|NCT01199016|588680030|FG000|Overall Study|No longer meets eligibility criteria|4|||
162994186|NCT01199016|588680030|FG000|Overall Study|Entrance criteria|5|||
162994187|NCT01199016|588680030|FG000|Overall Study|Protocol Violation|9|||
162994188|NCT01199016|588680030|FG000|Overall Study|Other|13|||
162994189|NCT01199016|588680030|FG000|Overall Study|Withdrawal by Subject|21|||
162994190|NCT01199016|588680030|FG000|Overall Study|Lost to Follow-up|25|||
162994191|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
162994192|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
162994193|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994194|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994195|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994196|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994197|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994198|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994199|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994200|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
162994201|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994202|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
162994203|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994204|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994205|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994206|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994207|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994208|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994209|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994210|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
162994211|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
162994212|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
162994213|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994214|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162715683|NCT03431350|587667079|FG004|Overall Study|Death|4|||
162715684|NCT03431350|587667080|FG005|Overall Study|Death|3|||
162994215|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994216|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994217|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994218|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994219|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994220|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
162994221|NCT02960490|588680039|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
162994222|NCT02960490|588680040|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
162994223|NCT02960490|588680041|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994224|NCT02960490|588680042|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162715685|NCT03431350|587667081|FG006|Overall Study|Death|2|||
162994225|NCT02960490|588680043|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994226|NCT02960490|588680044|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994227|NCT02960490|588680045|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162715686|NCT03431350|587667082|FG007|Overall Study|Death|0|||
162994228|NCT02960490|588680046|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994229|NCT02960490|588680047|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994230|NCT02960490|588680048|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
162994231|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994232|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994233|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
162994234|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
162994235|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994236|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
162994237|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994238|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994239|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994240|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
162994241|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994242|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994243|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
162994244|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994245|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
162994246|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994247|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994248|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994249|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994250|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
162994251|NCT02960490|588680039|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
162994252|NCT02960490|588680040|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
162994253|NCT02960490|588680041|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
162994254|NCT02960490|588680042|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
162994255|NCT02960490|588680043|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
162994256|NCT02960490|588680044|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
162994257|NCT02960490|588680045|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
162994258|NCT02960490|588680046|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
162994259|NCT02960490|588680047|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
162994260|NCT02960490|588680048|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
162994261|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994262|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994263|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994264|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994265|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994266|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994267|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
162994268|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
162994269|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
162994270|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
162994271|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994272|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994273|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994274|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994275|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994276|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994277|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
163060227|NCT04513366|588928343|FG002|Treatment Phase|Adverse Event|1|||
162715687|NCT03431350|587667083|FG008|Overall Study|Death|0|||
162715688|NCT03431350|587667084|FG009|Overall Study|Death|0|||
162994278|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
162994279|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994280|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
162994281|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994282|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994283|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
163060228|NCT04513366|588928341|FG000|Extension Phase|Withdrawal by Subject|3|||
163060229|NCT04513366|588928342|FG001|Extension Phase|Withdrawal by Subject|1|||
162715689|NCT03431350|587667085|FG010|Overall Study|Death|4|||
162715690|NCT03431350|587667086|FG011|Overall Study|Death|0|||
162994284|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994285|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994286|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
162994287|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
162994288|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
162994289|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
162994290|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
162994291|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994292|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994293|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994294|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994295|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994296|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994297|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
162994298|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994299|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994300|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
162994301|NCT02960490|588680039|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994302|NCT02960490|588680040|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994303|NCT02960490|588680041|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994304|NCT02960490|588680042|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994305|NCT02960490|588680043|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994306|NCT02960490|588680044|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994307|NCT02960490|588680045|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994308|NCT02960490|588680046|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
162994309|NCT02960490|588680047|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994310|NCT02960490|588680048|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
162994311|NCT02368314|588680051|FG000|Overall Study|Withdrawal by Subject|2|||
162994312|NCT02368314|588680052|FG001|Overall Study|Withdrawal by Subject|1|||
162994313|NCT02368314|588680051|FG000|Overall Study|Adverse Event|1|||
162994314|NCT02368314|588680052|FG001|Overall Study|Adverse Event|2|||
162994315|NCT01266031|588680053|FG000|Overall Study|Not treated|0|||
162994316|NCT01266031|588680054|FG001|Overall Study|Not treated|3|||
162994317|NCT01266031|588680055|FG002|Overall Study|Not treated|2|||
162994318|NCT04893018|588680056|FG000|Overall Study|Lost to Follow-up|1|||
162994319|NCT04893018|588680057|FG001|Overall Study|Lost to Follow-up|0|||
162994320|NCT04893018|588680056|FG000|Overall Study|Withdrawal by Subject|2|||
162994321|NCT04893018|588680057|FG001|Overall Study|Withdrawal by Subject|0|||
162994322|NCT04893018|588680056|FG000|Overall Study|Study Terminated|1|||
162994323|NCT04893018|588680057|FG001|Overall Study|Study Terminated|2|||
162994324|NCT02842073|588680063|FG000|Overall Study|Withdrawal by Subject|1|||
162994325|NCT00195338|588680064|FG000|Overall Study|Lost to Follow-up|2|||
162994326|NCT00195338|588680064|FG000|Overall Study|Adverse Event|5|||
162994327|NCT00195338|588680064|FG000|Overall Study|Lack of Efficacy|1|||
162994328|NCT00195338|588680064|FG000|Overall Study|Early closure of the site|4|||
162994329|NCT02047734|588680067|FG000|Overall Study|Adverse Event|18|||
162994330|NCT02047734|588680068|FG001|Overall Study|Adverse Event|13|||
162994331|NCT02047734|588680069|FG002|Overall Study|Adverse Event|13|||
162994332|NCT02047734|588680067|FG000|Overall Study|Lack of Efficacy|4|||
162994333|NCT02047734|588680068|FG001|Overall Study|Lack of Efficacy|5|||
162994334|NCT02047734|588680069|FG002|Overall Study|Lack of Efficacy|1|||
162994335|NCT02047734|588680067|FG000|Overall Study|Protocol Violation|3|||
162994336|NCT02047734|588680068|FG001|Overall Study|Protocol Violation|1|||
162994337|NCT02047734|588680069|FG002|Overall Study|Protocol Violation|1|||
162994338|NCT02047734|588680067|FG000|Overall Study|Lost to Follow-up|1|||
162994339|NCT02047734|588680068|FG001|Overall Study|Lost to Follow-up|4|||
162994340|NCT02047734|588680069|FG002|Overall Study|Lost to Follow-up|0|||
163060230|NCT04513366|588928343|FG002|Extension Phase|Withdrawal by Subject|1|||
162994341|NCT02047734|588680067|FG000|Overall Study|Death|0|||
162994342|NCT02047734|588680068|FG001|Overall Study|Death|1|||
162994343|NCT02047734|588680069|FG002|Overall Study|Death|0|||
162994344|NCT02047734|588680067|FG000|Overall Study|Withdrawal by Subject|30|||
162994345|NCT02047734|588680068|FG001|Overall Study|Withdrawal by Subject|31|||
162994346|NCT02047734|588680069|FG002|Overall Study|Withdrawal by Subject|19|||
162994347|NCT02047734|588680067|FG000|Overall Study|Physician Decision|7|||
162994348|NCT02047734|588680068|FG001|Overall Study|Physician Decision|6|||
163060231|NCT04513366|588928341|FG000|Extension Phase|Other than Specified|4|||
162715691|NCT03431350|587667075|FG000|Overall Study|Lost to Follow-up|0|||
162994349|NCT02047734|588680069|FG002|Overall Study|Physician Decision|5|||
162994350|NCT02047734|588680067|FG000|Overall Study|Miscellaneous|2|||
162994351|NCT02047734|588680068|FG001|Overall Study|Miscellaneous|4|||
162994352|NCT02047734|588680069|FG002|Overall Study|Miscellaneous|6|||
162994353|NCT02047734|588680067|FG000|Overall Study|Did Not Receive Study Drug|2|||
162994354|NCT02047734|588680068|FG001|Overall Study|Did Not Receive Study Drug|4|||
162994355|NCT02047734|588680069|FG002|Overall Study|Did Not Receive Study Drug|1|||
162994356|NCT01333397|588680070|FG000|Overall Study|Lost to Follow-up|1|||
162994357|NCT01333397|588680071|FG001|Overall Study|Lost to Follow-up|0|||
162994358|NCT01333397|588680072|FG002|Overall Study|Lost to Follow-up|0|||
162994359|NCT01333397|588680073|FG003|Overall Study|Lost to Follow-up|1|||
162994360|NCT01333397|588680074|FG004|Overall Study|Lost to Follow-up|0|||
162994361|NCT00314951|588680077|FG000|Treatment|Didn't meet criteria for mITT population|16|||
162994362|NCT00314951|588680078|FG001|Treatment|Didn't meet criteria for mITT population|11|||
162994363|NCT00314951|588680077|FG000|Follow-up|mITT failure|44|||
162994364|NCT00314951|588680078|FG001|Follow-up|mITT failure|34|||
162994365|NCT04411914|588680079|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
162994366|NCT04411914|588680080|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
162994367|NCT04106661|588680086|FG000|Overall Study|Protocol Violation|3|||
162994368|NCT04106661|588680087|FG001|Overall Study|Protocol Violation|0|||
162994369|NCT04106661|588680086|FG000|Overall Study|Scheduling difficulties|1|||
162994370|NCT04106661|588680087|FG001|Overall Study|Scheduling difficulties|1|||
162994371|NCT00233402|588680088|FG000|Overall Study|No pathology data|12|||
162994372|NCT00233402|588680089|FG001|Overall Study|No pathology data|9|||
162994373|NCT00233402|588680088|FG000|Overall Study|No Ta/T1|89|||
162994374|NCT00233402|588680089|FG001|Overall Study|No Ta/T1|94|||
162994375|NCT00233402|588680088|FG000|Overall Study|Lost to follow up etc|3|||
162994376|NCT00233402|588680089|FG001|Overall Study|Lost to follow up etc|21|||
162994377|NCT03280381|588680090|FG000|Overall Study|Physician Decision|0|||
162994378|NCT03280381|588680091|FG001|Overall Study|Physician Decision|2|||
162994379|NCT03503864|588680092|FG000|Overall Study|Protocol Violation|6|||
162994380|NCT03503864|588680092|FG000|Overall Study|Withdrawal by Subject|7|||
162994381|NCT00423319|588680093|FG000|Overall Study|Death|2|||
162994382|NCT00423319|588680094|FG001|Overall Study|Death|0|||
162994383|NCT00423319|588680093|FG000|Overall Study|Adverse Event|93|||
162994384|NCT00423319|588680094|FG001|Overall Study|Adverse Event|112|||
162994385|NCT00423319|588680093|FG000|Overall Study|Withdrawal by Subject|86|||
162994386|NCT00423319|588680094|FG001|Overall Study|Withdrawal by Subject|99|||
162994387|NCT00423319|588680093|FG000|Overall Study|Lost to Follow-up|4|||
162994388|NCT00423319|588680094|FG001|Overall Study|Lost to Follow-up|3|||
162994389|NCT00423319|588680093|FG000|Overall Study|Poor compliance or noncompliance|1|||
162994390|NCT00423319|588680094|FG001|Overall Study|Poor compliance or noncompliance|1|||
162994391|NCT00423319|588680093|FG000|Overall Study|No longer meets study criteria|15|||
162994392|NCT00423319|588680094|FG001|Overall Study|No longer meets study criteria|15|||
162994393|NCT00423319|588680093|FG000|Overall Study|Other|23|||
162994394|NCT00423319|588680094|FG001|Overall Study|Other|22|||
162994395|NCT02087189|588680096|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
162994396|NCT00478426|588680097|FG000|Overall Study|Withdrawal by Subject|1|||
162994397|NCT01189487|588680098|FG000|Overall Study|Lack of Efficacy|2|||
162994398|NCT01189487|588680098|FG000|Overall Study|Adverse Event|1|||
162994399|NCT04630158|588680099|FG000|Overall Study|Adverse Event|1|||
162994400|NCT04630158|588680100|FG001|Overall Study|Adverse Event|1|||
162994401|NCT04630158|588680101|FG002|Overall Study|Adverse Event|1|||
162994402|NCT04630158|588680099|FG000|Overall Study|Physician Decision|0|||
162994403|NCT04630158|588680100|FG001|Overall Study|Physician Decision|2|||
162994404|NCT04630158|588680101|FG002|Overall Study|Physician Decision|0|||
162994405|NCT04630158|588680099|FG000|Overall Study|Protocol Violation|1|||
162994406|NCT04630158|588680100|FG001|Overall Study|Protocol Violation|0|||
162994407|NCT04630158|588680101|FG002|Overall Study|Protocol Violation|1|||
162994408|NCT04630158|588680099|FG000|Overall Study|Withdrawal by Subject|2|||
162994409|NCT04630158|588680100|FG001|Overall Study|Withdrawal by Subject|1|||
162994410|NCT04630158|588680101|FG002|Overall Study|Withdrawal by Subject|2|||
162994411|NCT03136965|588680105|FG000|Overall Study|Lost to Follow-up|0|||
162994412|NCT03136965|588680106|FG001|Overall Study|Lost to Follow-up|1|||
162994413|NCT03136965|588680107|FG002|Overall Study|Lost to Follow-up|0|||
162994414|NCT01210612|588680109|FG000|Overall Study|Withdrawal by Subject|0|||
162994415|NCT01210612|588680110|FG001|Overall Study|Withdrawal by Subject|2|||
162994416|NCT02752087|588680111|FG000|Washout|Physician Decision|1|||
162637022|NCT00752232|587386082|FG003|Overall Study|Investigator request|0|||
162637023|NCT00752232|587386083|FG004|Overall Study|Investigator request|1|||
162637024|NCT00752232|587386084|FG005|Overall Study|Investigator request|0|||
162637025|NCT00752232|587386085|FG006|Overall Study|Investigator request|0|||
162637026|NCT00752232|587386079|FG000|Overall Study|Subject request|0|||
162994417|NCT02752087|588680112|FG001|Washout|Physician Decision|0|||
162994418|NCT00843635|588680113|FG000|Overall Study|Adverse Event|2|||
162994419|NCT00843635|588680114|FG001|Overall Study|Adverse Event|2|||
162994420|NCT00843635|588680115|FG002|Overall Study|Adverse Event|0|||
162994421|NCT00813800|588680118|FG000|Overall Study|Screen Failure after Consent|2|||
162994422|NCT00813800|588680118|FG000|Overall Study|Adverse Event|1|||
162994423|NCT00813800|588680118|FG000|Overall Study|Worsening of depression|2|||
162994424|NCT00813800|588680118|FG000|Overall Study|Physician Decision|1|||
162994425|NCT00642278|588680119|FG000|Overall Study|Adverse Event|2|||
162994426|NCT00642278|588680120|FG001|Overall Study|Adverse Event|1|||
162994427|NCT00642278|588680121|FG002|Overall Study|Adverse Event|3|||
162994428|NCT00642278|588680122|FG003|Overall Study|Adverse Event|1|||
162994429|NCT00642278|588680123|FG004|Overall Study|Adverse Event|2|||
162994430|NCT00642278|588680124|FG005|Overall Study|Adverse Event|2|||
162994431|NCT00642278|588680125|FG006|Overall Study|Adverse Event|0|||
162994432|NCT00642278|588680119|FG000|Overall Study|Lack of Efficacy|0|||
162994433|NCT00642278|588680120|FG001|Overall Study|Lack of Efficacy|1|||
162994434|NCT00642278|588680121|FG002|Overall Study|Lack of Efficacy|0|||
162994435|NCT00642278|588680122|FG003|Overall Study|Lack of Efficacy|0|||
162994436|NCT00642278|588680123|FG004|Overall Study|Lack of Efficacy|0|||
162994437|NCT00642278|588680124|FG005|Overall Study|Lack of Efficacy|0|||
162994438|NCT00642278|588680125|FG006|Overall Study|Lack of Efficacy|0|||
162994439|NCT00642278|588680119|FG000|Overall Study|Lost to Follow-up|5|||
162994440|NCT00642278|588680120|FG001|Overall Study|Lost to Follow-up|1|||
162994441|NCT00642278|588680121|FG002|Overall Study|Lost to Follow-up|0|||
162994442|NCT00642278|588680122|FG003|Overall Study|Lost to Follow-up|1|||
162994443|NCT00642278|588680123|FG004|Overall Study|Lost to Follow-up|0|||
162994444|NCT00642278|588680124|FG005|Overall Study|Lost to Follow-up|1|||
162994445|NCT00642278|588680125|FG006|Overall Study|Lost to Follow-up|1|||
162994446|NCT00642278|588680119|FG000|Overall Study|Physician Decision|0|||
162994447|NCT00642278|588680120|FG001|Overall Study|Physician Decision|0|||
162994448|NCT00642278|588680121|FG002|Overall Study|Physician Decision|0|||
162994449|NCT00642278|588680122|FG003|Overall Study|Physician Decision|1|||
162994450|NCT00642278|588680123|FG004|Overall Study|Physician Decision|0|||
162994451|NCT00642278|588680124|FG005|Overall Study|Physician Decision|0|||
162994452|NCT00642278|588680125|FG006|Overall Study|Physician Decision|0|||
162994453|NCT00642278|588680119|FG000|Overall Study|Protocol Violation|0|||
162994454|NCT00642278|588680120|FG001|Overall Study|Protocol Violation|0|||
162994455|NCT00642278|588680121|FG002|Overall Study|Protocol Violation|1|||
162994456|NCT00642278|588680122|FG003|Overall Study|Protocol Violation|1|||
162994457|NCT00642278|588680123|FG004|Overall Study|Protocol Violation|0|||
162994458|NCT00642278|588680124|FG005|Overall Study|Protocol Violation|1|||
162994459|NCT00642278|588680125|FG006|Overall Study|Protocol Violation|2|||
162994460|NCT00642278|588680119|FG000|Overall Study|Withdrawal by Subject|1|||
162994461|NCT00642278|588680120|FG001|Overall Study|Withdrawal by Subject|1|||
162994462|NCT00642278|588680121|FG002|Overall Study|Withdrawal by Subject|1|||
162994463|NCT00642278|588680122|FG003|Overall Study|Withdrawal by Subject|3|||
162994464|NCT00642278|588680123|FG004|Overall Study|Withdrawal by Subject|6|||
162994465|NCT00642278|588680124|FG005|Overall Study|Withdrawal by Subject|2|||
162994466|NCT00642278|588680125|FG006|Overall Study|Withdrawal by Subject|2|||
162994467|NCT00642278|588680119|FG000|Overall Study|Noncompliance with study drug regimen|0|||
162994468|NCT00642278|588680120|FG001|Overall Study|Noncompliance with study drug regimen|0|||
162994469|NCT00642278|588680121|FG002|Overall Study|Noncompliance with study drug regimen|0|||
162994470|NCT00642278|588680122|FG003|Overall Study|Noncompliance with study drug regimen|1|||
162994471|NCT00642278|588680123|FG004|Overall Study|Noncompliance with study drug regimen|0|||
162994472|NCT00642278|588680124|FG005|Overall Study|Noncompliance with study drug regimen|0|||
162994473|NCT00642278|588680125|FG006|Overall Study|Noncompliance with study drug regimen|0|||
162994474|NCT00642278|588680119|FG000|Overall Study|Other|2|||
162994475|NCT00642278|588680120|FG001|Overall Study|Other|1|||
162994476|NCT00642278|588680121|FG002|Overall Study|Other|0|||
162994477|NCT00642278|588680122|FG003|Overall Study|Other|1|||
162994478|NCT00642278|588680123|FG004|Overall Study|Other|0|||
162994479|NCT00642278|588680124|FG005|Overall Study|Other|1|||
162994480|NCT00642278|588680125|FG006|Overall Study|Other|0|||
162994481|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162994482|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994483|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
162994484|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994485|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162994486|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
162994487|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
163060232|NCT04513366|588928342|FG001|Extension Phase|Other than Specified|0|||
162637027|NCT00752232|587386080|FG001|Overall Study|Subject request|0|||
162637028|NCT00752232|587386081|FG002|Overall Study|Subject request|1|||
162637029|NCT00752232|587386082|FG003|Overall Study|Subject request|0|||
162994488|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162994489|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162994490|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162994491|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994492|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994493|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
162994494|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
162994495|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
162994496|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162994497|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162637030|NCT00752232|587386083|FG004|Overall Study|Subject request|0|||
162637031|NCT00752232|587386084|FG005|Overall Study|Subject request|0|||
162637032|NCT00752232|587386085|FG006|Overall Study|Subject request|0|||
163060233|NCT04513366|588928343|FG002|Extension Phase|Other than Specified|1|||
163060234|NCT04513366|588928341|FG000|Extension Phase|Lost to Follow-up|1|||
163060235|NCT04513366|588928342|FG001|Extension Phase|Lost to Follow-up|1|||
163060236|NCT04513366|588928343|FG002|Extension Phase|Lost to Follow-up|1|||
163060237|NCT04513366|588928341|FG000|Extension Phase|Sponsor Decision|0|||
163060238|NCT04513366|588928342|FG001|Extension Phase|Sponsor Decision|1|||
163060239|NCT04513366|588928343|FG002|Extension Phase|Sponsor Decision|0|||
163060240|NCT04513366|588928341|FG000|Extension Phase|Death|0|||
163060241|NCT04513366|588928342|FG001|Extension Phase|Death|1|||
163060242|NCT04513366|588928343|FG002|Extension Phase|Death|0|||
163060243|NCT04513366|588928341|FG000|Extension Phase|Adverse Event|0|||
163060244|NCT04513366|588928342|FG001|Extension Phase|Adverse Event|0|||
163060245|NCT04513366|588928343|FG002|Extension Phase|Adverse Event|1|||
163060246|NCT03344757|588928344|FG000|Overall Study|Withdrawal by Subject|18|||
163060247|NCT03344757|588928345|FG001|Overall Study|Withdrawal by Subject|16|||
163060248|NCT03344757|588928344|FG000|Overall Study|Lost to Follow-up|0|||
163060249|NCT03344757|588928345|FG001|Overall Study|Lost to Follow-up|2|||
163060250|NCT00269152|588928346|FG000|Overall Study|Adverse Event|9|||
162715692|NCT03431350|587667076|FG001|Overall Study|Lost to Follow-up|1|||
162994498|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994499|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994500|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162994501|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
162994502|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
162994503|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
162994504|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162994505|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162994506|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994507|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994508|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
162994509|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994510|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
162994511|NCT03713619|588680126|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
162994512|NCT03713619|588680127|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
162994513|NCT03713619|588680128|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994514|NCT03713619|588680129|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994515|NCT03713619|588680130|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
162994516|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
162994517|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
162994518|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
162994519|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
162994520|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
162994521|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162994522|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994523|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994524|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162994525|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162994526|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
162994527|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
162994528|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
162994529|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
162994530|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
162994531|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
162994532|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
162994533|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
162994534|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
162994535|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
162994536|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
162994537|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
162994538|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162994539|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
163060251|NCT00269152|588928347|FG001|Overall Study|Adverse Event|3|||
163060252|NCT00269152|588928346|FG000|Overall Study|Withdrawal by Subject|7|||
163060253|NCT00269152|588928347|FG001|Overall Study|Withdrawal by Subject|3|||
163060254|NCT00269152|588928346|FG000|Overall Study|Physician Decision|2|||
162994540|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
162994541|NCT03713619|588680126|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162994542|NCT03713619|588680127|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162994543|NCT03713619|588680128|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
163060255|NCT00269152|588928347|FG001|Overall Study|Physician Decision|3|||
163060256|NCT00269152|588928346|FG000|Overall Study|Protocol Violation|0|||
163060257|NCT00269152|588928347|FG001|Overall Study|Protocol Violation|1|||
162994544|NCT03713619|588680129|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162994545|NCT03713619|588680130|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162994546|NCT03553576|588680131|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
162994547|NCT03553576|588680132|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
162994548|NCT03553576|588680131|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
162994549|NCT03553576|588680132|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
162994550|NCT03553576|588680131|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
162994551|NCT03553576|588680132|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
162994552|NCT03553576|588680131|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
162994553|NCT03553576|588680132|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
162994554|NCT03553576|588680131|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
162994555|NCT03553576|588680132|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
162994556|NCT03553576|588680131|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
162994557|NCT03553576|588680132|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
162994558|NCT03553576|588680131|FG000|Overall Study|Physician Decision|2|||
162994559|NCT03553576|588680132|FG001|Overall Study|Physician Decision|5|||
162994560|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
162994561|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
162994562|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
162994563|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
162994564|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
162994565|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
162994566|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
162994567|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
162994568|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
162994569|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
162994570|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
162994571|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
162994572|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
162994573|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
162994574|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
162994575|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
162994576|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
162994577|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
162994578|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
162994579|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
162994580|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
162994581|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
162994582|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
162994583|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
162994584|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
162994585|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
162994586|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
162994587|NCT02552212|588680133|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
162994588|NCT02552212|588680134|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
162994589|NCT02552212|588680135|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
162994590|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
162994591|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
162994592|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
162994593|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
162994594|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
162994595|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
162994596|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
162994597|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
162994598|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
162637033|NCT00752232|587386079|FG000|Overall Study|Group home admission|0|||
162637034|NCT00752232|587386080|FG001|Overall Study|Group home admission|0|||
162637035|NCT00752232|587386081|FG002|Overall Study|Group home admission|0|||
162637036|NCT00752232|587386082|FG003|Overall Study|Group home admission|1|||
162637037|NCT00752232|587386083|FG004|Overall Study|Group home admission|0|||
162637038|NCT00752232|587386084|FG005|Overall Study|Group home admission|0|||
162637039|NCT00752232|587386085|FG006|Overall Study|Group home admission|0|||
162637040|NCT00752232|587386079|FG000|Overall Study|Caregiver could not attend the subject|0|||
162637041|NCT00752232|587386080|FG001|Overall Study|Caregiver could not attend the subject|0|||
162994599|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
162994600|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
162994601|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
162994602|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
162994603|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
162994604|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
162994605|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
162994606|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
162994607|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
162994608|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
162994609|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
162994610|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
162994611|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
162994612|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
162994613|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
162994614|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
162994615|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
162994616|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
162994617|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
162994618|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
162994619|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
162994620|NCT02552212|588680133|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
162994621|NCT02552212|588680134|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
162994622|NCT02552212|588680135|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
162994623|NCT01094886|588680138|FG000|Overall Study|Adverse Event|2|||
162994624|NCT01094886|588680138|FG000|Overall Study|Withdrawal by Subject|5|||
162994625|NCT03866902|588680139|FG000|Overall Study|Lost to Follow-up|98|||
162994626|NCT03866902|588680140|FG001|Overall Study|Lost to Follow-up|82|||
162994627|NCT03866902|588680139|FG000|Overall Study|Pregnancy|18|||
162994628|NCT03866902|588680140|FG001|Overall Study|Pregnancy|24|||
162994629|NCT02092467|588680142|FG000|Overall Study|Death|49|||
162994630|NCT02092467|588680143|FG001|Overall Study|Death|66|||
162994631|NCT02092467|588680144|FG002|Overall Study|Death|38|||
162994632|NCT02092467|588680142|FG000|Overall Study|Lost to Follow-up|38|||
162994633|NCT02092467|588680143|FG001|Overall Study|Lost to Follow-up|35|||
162994634|NCT02092467|588680144|FG002|Overall Study|Lost to Follow-up|40|||
162994635|NCT02092467|588680142|FG000|Overall Study|Global Deterioration of Health Status|1|||
162994636|NCT02092467|588680143|FG001|Overall Study|Global Deterioration of Health Status|0|||
162994637|NCT02092467|588680144|FG002|Overall Study|Global Deterioration of Health Status|0|||
162994638|NCT02092467|588680142|FG000|Overall Study|Other|32|||
162994639|NCT02092467|588680143|FG001|Overall Study|Other|30|||
162994640|NCT02092467|588680144|FG002|Overall Study|Other|24|||
162994641|NCT02092467|588680142|FG000|Overall Study|Withdrawal by Subject|282|||
162994642|NCT02092467|588680143|FG001|Overall Study|Withdrawal by Subject|327|||
162994643|NCT02092467|588680144|FG002|Overall Study|Withdrawal by Subject|289|||
162994644|NCT02092467|588680142|FG000|Overall Study|Randomized but not treated|2|||
162994645|NCT02092467|588680143|FG001|Overall Study|Randomized but not treated|1|||
162994646|NCT02092467|588680144|FG002|Overall Study|Randomized but not treated|7|||
162994647|NCT01284621|588680145|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994648|NCT01284621|588680146|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994649|NCT01284621|588680147|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994650|NCT01284621|588680148|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994651|NCT01284621|588680149|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
162994652|NCT01284621|588680150|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
162994653|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Physician Decision|1|||
162994654|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Physician Decision|0|||
162994655|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Physician Decision|0|||
162994656|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Physician Decision|0|||
162994657|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Physician Decision|0|||
162994658|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
162994659|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994660|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994661|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994662|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
162994663|NCT02377427|588680153|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
162994664|NCT02377427|588680154|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994665|NCT02377427|588680155|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994666|NCT02377427|588680156|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
163060258|NCT01832766|588928350|FG000|Washout|Lost to Follow-up|0|||
162637042|NCT00752232|587386081|FG002|Overall Study|Caregiver could not attend the subject|0|||
162994667|NCT02377427|588680157|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
162994668|NCT02377427|588680153|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994669|NCT02377427|588680154|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994670|NCT02377427|588680155|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
162994671|NCT02377427|588680156|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994672|NCT02377427|588680157|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
162994673|NCT02293863|588680158|FG000|Overall Study|Death|4|||
162994674|NCT02293863|588680159|FG001|Overall Study|Death|6|||
162994675|NCT02293863|588680160|FG002|Overall Study|Death|4|||
162994676|NCT02293863|588680158|FG000|Overall Study|Lost to Follow-up|2|||
162994677|NCT02293863|588680159|FG001|Overall Study|Lost to Follow-up|2|||
162994678|NCT02293863|588680160|FG002|Overall Study|Lost to Follow-up|2|||
162994679|NCT02293863|588680158|FG000|Overall Study|Withdrawal by Subject|3|||
162994680|NCT02293863|588680159|FG001|Overall Study|Withdrawal by Subject|3|||
162994681|NCT02293863|588680160|FG002|Overall Study|Withdrawal by Subject|1|||
162994682|NCT02293863|588680158|FG000|Overall Study|Reason Not Specified|0|||
162994683|NCT02293863|588680159|FG001|Overall Study|Reason Not Specified|2|||
162994684|NCT02293863|588680160|FG002|Overall Study|Reason Not Specified|2|||
162994685|NCT03155945|588680161|FG000|Overall Study|Lost to Follow-up|0|||
162994686|NCT03155945|588680162|FG001|Overall Study|Lost to Follow-up|1|||
162994687|NCT03155945|588680161|FG000|Overall Study|Withdrawal by Subject|0|||
162994688|NCT03155945|588680162|FG001|Overall Study|Withdrawal by Subject|1|||
162994689|NCT03155945|588680161|FG000|Overall Study|Other Reason|0|||
162994690|NCT03155945|588680162|FG001|Overall Study|Other Reason|1|||
162994691|NCT02013674|588680163|FG000|Overall Study|Death|0|||
162994692|NCT02013674|588680164|FG001|Overall Study|Death|1|||
162994693|NCT02013674|588680163|FG000|Overall Study|Lost to Follow-up|1|||
162994694|NCT02013674|588680164|FG001|Overall Study|Lost to Follow-up|0|||
162994695|NCT00416884|588680165|FG000|Overall Study|Study terminated due to low accrual|1|||
162994696|NCT03408639|588682516|FG000|Overall Study|Death|5|||
162994697|NCT03408639|588682517|FG001|Overall Study|Death|5|||
162994698|NCT03408639|588682516|FG000|Overall Study|Lost to Follow-up|1|||
162994699|NCT03408639|588682517|FG001|Overall Study|Lost to Follow-up|4|||
162994700|NCT03408639|588682516|FG000|Overall Study|Withdrawal by Subject|2|||
162994701|NCT03408639|588682517|FG001|Overall Study|Withdrawal by Subject|7|||
162994702|NCT03408639|588682516|FG000|Overall Study|Physician Decision|3|||
162994703|NCT03408639|588682517|FG001|Overall Study|Physician Decision|6|||
162994704|NCT00213135|588682520|FG000|Overall Study|Adverse Event|9|||
162994705|NCT00213135|588682521|FG001|Overall Study|Adverse Event|5|||
162994706|NCT00213135|588682522|FG002|Overall Study|Adverse Event|5|||
162994707|NCT00213135|588682520|FG000|Overall Study|Lost to Follow-up|11|||
162994708|NCT00213135|588682521|FG001|Overall Study|Lost to Follow-up|8|||
162994709|NCT00213135|588682522|FG002|Overall Study|Lost to Follow-up|4|||
162994710|NCT00213135|588682520|FG000|Overall Study|Protocol Violation|4|||
162994711|NCT00213135|588682521|FG001|Overall Study|Protocol Violation|4|||
162994712|NCT00213135|588682522|FG002|Overall Study|Protocol Violation|10|||
162994713|NCT00213135|588682520|FG000|Overall Study|Death|1|||
162994714|NCT00213135|588682521|FG001|Overall Study|Death|1|||
162994715|NCT00213135|588682522|FG002|Overall Study|Death|2|||
162637043|NCT00752232|587386082|FG003|Overall Study|Caregiver could not attend the subject|0|||
162637044|NCT00752232|587386083|FG004|Overall Study|Caregiver could not attend the subject|1|||
162637045|NCT00752232|587386084|FG005|Overall Study|Caregiver could not attend the subject|0|||
162637046|NCT00752232|587386085|FG006|Overall Study|Caregiver could not attend the subject|0|||
162637047|NCT04502589|587386086|FG000|Overall Study|Physician Decision|1|||
162994716|NCT00213135|588682520|FG000|Overall Study|Disease progression|4|||
162994717|NCT00213135|588682521|FG001|Overall Study|Disease progression|5|||
162994718|NCT00213135|588682522|FG002|Overall Study|Disease progression|21|||
162994719|NCT00213135|588682520|FG000|Overall Study|Other|21|||
162994720|NCT00213135|588682521|FG001|Overall Study|Other|12|||
162994721|NCT00213135|588682522|FG002|Overall Study|Other|15|||
162637048|NCT04502589|587386087|FG001|Overall Study|Physician Decision|0|||
162637049|NCT02730455|587386089|FG000|Overall Study|Death|5|||
162994722|NCT01924754|588682526|FG000|Overall Study|Lost to Follow-up|1|||
162994723|NCT01924754|588682527|FG001|Overall Study|Lost to Follow-up|2|||
162994724|NCT01924754|588682528|FG002|Overall Study|Lost to Follow-up|1|||
162994725|NCT01924754|588682526|FG000|Overall Study|Pregnancy|0|||
162994726|NCT01924754|588682527|FG001|Overall Study|Pregnancy|1|||
162994727|NCT01924754|588682528|FG002|Overall Study|Pregnancy|2|||
162994728|NCT03132155|588682529|FG000|Overall Study|Lack of Efficacy|6|||
162994729|NCT03132155|588682529|FG000|Overall Study|Lost to Follow-up|1|||
162637050|NCT02730455|587386090|FG001|Overall Study|Death|6|||
162994730|NCT03132155|588682529|FG000|Overall Study|Withdrawal by Subject|1|||
162994731|NCT02925403|588682535|FG000|Overall Study|Lost to Follow-up|0|||
162994732|NCT02925403|588682536|FG001|Overall Study|Lost to Follow-up|1|||
162994733|NCT02899195|588682537|FG000|Concurrent Durvalumab|Adverse Event|4|||
162994734|NCT02899195|588682537|FG000|Concurrent Durvalumab|Physician Decision|1|||
162637051|NCT02730455|587386091|FG002|Overall Study|Death|4|||
162994735|NCT02899195|588682537|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
162994736|NCT02899195|588682537|FG000|Concurrent Durvalumab|Progressive Disease|5|||
162994737|NCT02899195|588682537|FG000|Maintenance Durvalumab|Adverse Event|1|||
162994738|NCT02899195|588682537|FG000|Maintenance Durvalumab|Physician Decision|1|||
162994739|NCT02899195|588682537|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
162994740|NCT02899195|588682537|FG000|Maintenance Durvalumab|Progressive Disease|31|||
162994741|NCT04778904|588682538|FG000|Overall Study|Protocol Violation|1|||
162994742|NCT04778904|588682539|FG001|Overall Study|Protocol Violation|0|||
162994743|NCT04778904|588682540|FG002|Overall Study|Protocol Violation|0|||
162994744|NCT04778904|588682541|FG003|Overall Study|Protocol Violation|0|||
162994745|NCT04778904|588682538|FG000|Overall Study|Withdrawal by Subject|0|||
162994746|NCT04778904|588682539|FG001|Overall Study|Withdrawal by Subject|0|||
162994747|NCT04778904|588682540|FG002|Overall Study|Withdrawal by Subject|1|||
162994748|NCT04778904|588682541|FG003|Overall Study|Withdrawal by Subject|0|||
162994749|NCT03452137|588682542|FG000|Overall Study|Death|67|||
162994750|NCT03452137|588682543|FG001|Overall Study|Death|70|||
162994751|NCT03452137|588682542|FG000|Overall Study|Lost to Follow-up|4|||
162994752|NCT03452137|588682543|FG001|Overall Study|Lost to Follow-up|2|||
162994753|NCT03452137|588682542|FG000|Overall Study|Physician Decision|0|||
162994754|NCT03452137|588682543|FG001|Overall Study|Physician Decision|1|||
162994755|NCT03452137|588682542|FG000|Overall Study|Study Terminated by Sponsor|120|||
162994756|NCT03452137|588682543|FG001|Overall Study|Study Terminated by Sponsor|121|||
162994757|NCT03452137|588682542|FG000|Overall Study|Withdrawal by Subject|12|||
162994758|NCT03452137|588682543|FG001|Overall Study|Withdrawal by Subject|9|||
162994759|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
162994760|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
162994761|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
162994762|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
162994763|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
162994764|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
162994765|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
162994766|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
162994767|NCT02856802|588682544|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
162994768|NCT02856802|588682545|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
162994769|NCT02856802|588682544|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
162994770|NCT02856802|588682545|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
162994771|NCT03772717|588682546|FG000|Overall Study|Withdrawal by Subject|2|||
162994772|NCT04138043|588682547|FG000|Overall Study|Withdrawal by Subject|0|||
162994773|NCT04138043|588682548|FG001|Overall Study|Withdrawal by Subject|1|||
162994774|NCT00587860|588682549|FG000|Overall Study|Lost to Follow-up|2|||
162994775|NCT00587860|588682550|FG001|Overall Study|Lost to Follow-up|2|||
162994776|NCT00587860|588682549|FG000|Overall Study|Withdrawal by Subject|3|||
162994777|NCT00587860|588682550|FG001|Overall Study|Withdrawal by Subject|3|||
162994778|NCT01659125|588682551|FG000|Overall Study|Withdrawal by Subject|2|||
162994779|NCT01659125|588682551|FG000|Overall Study|Lost to Follow-up|7|||
162994780|NCT01659125|588682551|FG000|Overall Study|Technical Problem|1|||
162994781|NCT01659125|588682551|FG000|Overall Study|Time Constraints|2|||
162994782|NCT01659125|588682551|FG000|Overall Study|Failed to Start Treatment|2|||
162994783|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
162994784|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
162994785|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
162994786|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
162994787|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
162994788|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
162994789|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
162994790|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
162994791|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
162994792|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
162994793|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
162994794|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
162994795|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
162994796|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
162994797|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
162994798|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
162994799|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
162994800|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
162994801|NCT00261443|588682552|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
162994802|NCT00261443|588682553|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
162994803|NCT00261443|588682554|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
162994804|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
162994805|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
162994806|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
163060259|NCT01832766|588928351|FG001|Washout|Lost to Follow-up|1|||
162994807|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
162994808|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
162994809|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
162994810|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
162994811|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
162994812|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
162994813|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
162994814|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
162994815|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
162994816|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
162994817|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
162994818|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
162994819|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
162994820|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
162994821|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
162994822|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
162994823|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
162994824|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
162994825|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
162994826|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
162994827|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
162994828|NCT00261443|588682552|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
162994829|NCT00261443|588682553|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
162994830|NCT00261443|588682554|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
162994831|NCT00261443|588682552|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
162994832|NCT00261443|588682553|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
162994833|NCT00261443|588682554|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
162994834|NCT00261443|588682552|FG000|3: Assessment of Relapse|Adverse Event|0|||
162994835|NCT00261443|588682553|FG001|3: Assessment of Relapse|Adverse Event|15|||
162994836|NCT00261443|588682554|FG002|3: Assessment of Relapse|Adverse Event|19|||
162994837|NCT00261443|588682552|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
162994838|NCT00261443|588682553|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
162994839|NCT00261443|588682554|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
162994840|NCT00261443|588682552|FG000|3: Assessment of Relapse|Death|0|||
162994841|NCT00261443|588682553|FG001|3: Assessment of Relapse|Death|0|||
162994842|NCT00261443|588682554|FG002|3: Assessment of Relapse|Death|1|||
162994843|NCT00261443|588682552|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
162994844|NCT00261443|588682553|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
162994845|NCT00261443|588682554|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
162994846|NCT00261443|588682552|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
162994847|NCT00261443|588682553|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
162994848|NCT00261443|588682554|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
162994849|NCT00261443|588682552|FG000|3: Assessment of Relapse|Pregnancy|0|||
162994850|NCT00261443|588682553|FG001|3: Assessment of Relapse|Pregnancy|2|||
162994851|NCT00261443|588682554|FG002|3: Assessment of Relapse|Pregnancy|1|||
162994852|NCT00261443|588682552|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
162994853|NCT00261443|588682553|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
162994854|NCT00261443|588682554|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
162994855|NCT00261443|588682552|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
162994856|NCT00261443|588682553|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
162994857|NCT00261443|588682554|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
162994858|NCT00261443|588682552|FG000|3: Assessment of Relapse|Other Reasons|0|||
162994859|NCT00261443|588682553|FG001|3: Assessment of Relapse|Other Reasons|4|||
162994860|NCT00261443|588682554|FG002|3: Assessment of Relapse|Other Reasons|3|||
162994861|NCT00261443|588682552|FG000|4: Extension Phase|Adverse Event|0|||
162994862|NCT00261443|588682553|FG001|4: Extension Phase|Adverse Event|1|||
162994863|NCT00261443|588682554|FG002|4: Extension Phase|Adverse Event|0|||
162994864|NCT00261443|588682552|FG000|4: Extension Phase|Withdrawal by Subject|0|||
162994865|NCT00261443|588682553|FG001|4: Extension Phase|Withdrawal by Subject|1|||
162994866|NCT00261443|588682554|FG002|4: Extension Phase|Withdrawal by Subject|2|||
162994867|NCT00261443|588682552|FG000|4: Extension Phase|Lost to Follow-up|0|||
162637052|NCT02730455|587386089|FG000|Overall Study|Consent withdrawn|2|||
162994868|NCT00261443|588682553|FG001|4: Extension Phase|Lost to Follow-up|1|||
162994869|NCT00261443|588682554|FG002|4: Extension Phase|Lost to Follow-up|0|||
162994870|NCT02755649|588682555|FG000|Overall Study|Transitioned into OLE study|99|||
162994871|NCT02755649|588682556|FG001|Overall Study|Transitioned into OLE study|98|||
162994872|NCT02755649|588682557|FG002|Overall Study|Transitioned into OLE study|100|||
162994873|NCT02755649|588682555|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
162994874|NCT02755649|588682556|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
162994875|NCT02755649|588682557|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
162994876|NCT02755649|588682555|FG000|Overall Study|Physician Decision|0|||
162994877|NCT02755649|588682556|FG001|Overall Study|Physician Decision|0|||
162994878|NCT02755649|588682557|FG002|Overall Study|Physician Decision|2|||
162994879|NCT02755649|588682555|FG000|Overall Study|Withdrawal by Subject|0|||
162994880|NCT02755649|588682556|FG001|Overall Study|Withdrawal by Subject|1|||
162994881|NCT02755649|588682557|FG002|Overall Study|Withdrawal by Subject|0|||
162994882|NCT02755649|588682555|FG000|Overall Study|Undecided|1|||
162994883|NCT02755649|588682556|FG001|Overall Study|Undecided|0|||
162994884|NCT02755649|588682557|FG002|Overall Study|Undecided|0|||
162994885|NCT01286753|588682558|FG000|Overall Study|Adverse Event|7|||
162994886|NCT01286753|588682559|FG001|Overall Study|Adverse Event|6|||
162994887|NCT01286753|588682558|FG000|Overall Study|Progression|11|||
162994888|NCT01286753|588682559|FG001|Overall Study|Progression|13|||
162994889|NCT01286753|588682558|FG000|Overall Study|Refused Treatment|1|||
162994890|NCT01286753|588682559|FG001|Overall Study|Refused Treatment|0|||
162994891|NCT01286753|588682558|FG000|Overall Study|Withdrawal of Consent|0|||
162994892|NCT01286753|588682559|FG001|Overall Study|Withdrawal of Consent|2|||
162994893|NCT01286753|588682558|FG000|Overall Study|Discontinued to Join Extension Study|6|||
162994894|NCT01286753|588682559|FG001|Overall Study|Discontinued to Join Extension Study|4|||
162994895|NCT01286753|588682558|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
162994896|NCT01286753|588682559|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
162994897|NCT02126826|588682563|FG000|Overall Study|Withdrawal by Subject|0|||
162994898|NCT02126826|588682564|FG001|Overall Study|Withdrawal by Subject|0|||
162994899|NCT02126826|588682565|FG002|Overall Study|Withdrawal by Subject|0|||
162994900|NCT02126826|588682566|FG003|Overall Study|Withdrawal by Subject|1|||
162994901|NCT02126826|588682567|FG004|Overall Study|Withdrawal by Subject|0|||
162994902|NCT02126826|588682568|FG005|Overall Study|Withdrawal by Subject|0|||
162994903|NCT02126826|588682569|FG006|Overall Study|Withdrawal by Subject|0|||
162994904|NCT01371747|588682570|FG000|Overall Study|Adverse Event|4|||
162994905|NCT01371747|588682571|FG001|Overall Study|Adverse Event|2|||
162994906|NCT01371747|588682572|FG002|Overall Study|Adverse Event|7|||
162994907|NCT01371747|588682573|FG003|Overall Study|Adverse Event|2|||
162994908|NCT01371747|588682574|FG004|Overall Study|Adverse Event|2|||
162994909|NCT01371747|588682575|FG005|Overall Study|Adverse Event|2|||
162994910|NCT01371747|588682570|FG000|Overall Study|Death|1|||
162994911|NCT01371747|588682571|FG001|Overall Study|Death|0|||
162994912|NCT01371747|588682572|FG002|Overall Study|Death|4|||
162994913|NCT01371747|588682573|FG003|Overall Study|Death|1|||
162994914|NCT01371747|588682574|FG004|Overall Study|Death|2|||
162994915|NCT01371747|588682575|FG005|Overall Study|Death|0|||
162994916|NCT01371747|588682570|FG000|Overall Study|Abnormal Renal Function|0|||
162994917|NCT01371747|588682571|FG001|Overall Study|Abnormal Renal Function|2|||
162994918|NCT01371747|588682572|FG002|Overall Study|Abnormal Renal Function|0|||
162994919|NCT01371747|588682573|FG003|Overall Study|Abnormal Renal Function|1|||
162994920|NCT01371747|588682574|FG004|Overall Study|Abnormal Renal Function|0|||
162994921|NCT01371747|588682575|FG005|Overall Study|Abnormal Renal Function|1|||
162994922|NCT01371747|588682570|FG000|Overall Study|High Serum Potassium Results|1|||
162994923|NCT01371747|588682571|FG001|Overall Study|High Serum Potassium Results|1|||
162994924|NCT01371747|588682572|FG002|Overall Study|High Serum Potassium Results|1|||
162994925|NCT01371747|588682573|FG003|Overall Study|High Serum Potassium Results|2|||
162994926|NCT01371747|588682574|FG004|Overall Study|High Serum Potassium Results|0|||
162994927|NCT01371747|588682575|FG005|Overall Study|High Serum Potassium Results|2|||
162994928|NCT01371747|588682570|FG000|Overall Study|Low Serum Potassium Results|1|||
162994929|NCT01371747|588682571|FG001|Overall Study|Low Serum Potassium Results|1|||
162994930|NCT01371747|588682572|FG002|Overall Study|Low Serum Potassium Results|1|||
162994931|NCT01371747|588682573|FG003|Overall Study|Low Serum Potassium Results|1|||
162994932|NCT01371747|588682574|FG004|Overall Study|Low Serum Potassium Results|0|||
162994933|NCT01371747|588682575|FG005|Overall Study|Low Serum Potassium Results|3|||
162994934|NCT01371747|588682570|FG000|Overall Study|Protocol Violation|0|||
162994935|NCT01371747|588682571|FG001|Overall Study|Protocol Violation|0|||
162994936|NCT01371747|588682572|FG002|Overall Study|Protocol Violation|1|||
162994937|NCT01371747|588682573|FG003|Overall Study|Protocol Violation|0|||
162994938|NCT01371747|588682574|FG004|Overall Study|Protocol Violation|0|||
162994939|NCT01371747|588682575|FG005|Overall Study|Protocol Violation|0|||
162994940|NCT01371747|588682570|FG000|Overall Study|Non-Compliance|3|||
162994941|NCT01371747|588682571|FG001|Overall Study|Non-Compliance|4|||
162994942|NCT01371747|588682572|FG002|Overall Study|Non-Compliance|3|||
162994943|NCT01371747|588682573|FG003|Overall Study|Non-Compliance|0|||
162994944|NCT01371747|588682574|FG004|Overall Study|Non-Compliance|0|||
162994945|NCT01371747|588682575|FG005|Overall Study|Non-Compliance|1|||
162994946|NCT01371747|588682570|FG000|Overall Study|Physician Decision|0|||
162994947|NCT01371747|588682571|FG001|Overall Study|Physician Decision|0|||
163060260|NCT03533751|588928354|FG000|Overall Study|Withdrawal by Subject|12|||
163060261|NCT03533751|588928355|FG001|Overall Study|Withdrawal by Subject|6|||
163060262|NCT03533751|588928356|FG002|Overall Study|Withdrawal by Subject|11|||
163060263|NCT03533751|588928357|FG003|Overall Study|Withdrawal by Subject|9|||
163060264|NCT03533751|588928358|FG004|Overall Study|Withdrawal by Subject|10|||
163060265|NCT03533751|588928354|FG000|Overall Study|Adverse Event|4|||
163060266|NCT03533751|588928355|FG001|Overall Study|Adverse Event|7|||
163060267|NCT03533751|588928356|FG002|Overall Study|Adverse Event|2|||
162994948|NCT01371747|588682572|FG002|Overall Study|Physician Decision|0|||
162994949|NCT01371747|588682573|FG003|Overall Study|Physician Decision|0|||
162994950|NCT01371747|588682574|FG004|Overall Study|Physician Decision|1|||
162994951|NCT01371747|588682575|FG005|Overall Study|Physician Decision|0|||
162994952|NCT01371747|588682570|FG000|Overall Study|Withdrawal by Subject|6|||
162994953|NCT01371747|588682571|FG001|Overall Study|Withdrawal by Subject|12|||
162994954|NCT01371747|588682572|FG002|Overall Study|Withdrawal by Subject|5|||
162994955|NCT01371747|588682573|FG003|Overall Study|Withdrawal by Subject|2|||
162994956|NCT01371747|588682574|FG004|Overall Study|Withdrawal by Subject|2|||
162994957|NCT01371747|588682575|FG005|Overall Study|Withdrawal by Subject|4|||
162994958|NCT01371747|588682570|FG000|Overall Study|Other Reasons|2|||
162994959|NCT01371747|588682571|FG001|Overall Study|Other Reasons|1|||
162994960|NCT01371747|588682572|FG002|Overall Study|Other Reasons|2|||
162994961|NCT01371747|588682573|FG003|Overall Study|Other Reasons|0|||
162994962|NCT01371747|588682574|FG004|Overall Study|Other Reasons|0|||
162994963|NCT01371747|588682575|FG005|Overall Study|Other Reasons|1|||
162994964|NCT03092219|588682576|FG000|Overall Study|Protocol Violation|7|||
162994965|NCT03092219|588682577|FG001|Overall Study|Protocol Violation|4|||
162994966|NCT05013008|588682584|FG000|Overall Study|Exclusion from mBFAS|5|||
162994967|NCT05013008|588682585|FG001|Overall Study|Exclusion from mBFAS|25|||
162994968|NCT02094417|588682586|FG000|Overall Study|Adverse Event|0|||
162994969|NCT02094417|588682587|FG001|Overall Study|Adverse Event|0|||
162994970|NCT02094417|588682588|FG002|Overall Study|Adverse Event|0|||
162994971|NCT02094417|588682589|FG003|Overall Study|Adverse Event|1|||
162994972|NCT02094417|588682586|FG000|Overall Study|Eligibility criteria|0|||
162994973|NCT02094417|588682587|FG001|Overall Study|Eligibility criteria|1|||
162994974|NCT02094417|588682588|FG002|Overall Study|Eligibility criteria|0|||
162994975|NCT02094417|588682589|FG003|Overall Study|Eligibility criteria|0|||
162994976|NCT02094417|588682586|FG000|Overall Study|No responder|4|||
162994977|NCT02094417|588682587|FG001|Overall Study|No responder|4|||
162994978|NCT02094417|588682588|FG002|Overall Study|No responder|4|||
162994979|NCT02094417|588682589|FG003|Overall Study|No responder|3|||
162994980|NCT02094417|588682586|FG000|Overall Study|Unable to conduct observations or assess|0|||
162994981|NCT02094417|588682587|FG001|Overall Study|Unable to conduct observations or assess|1|||
162994982|NCT02094417|588682588|FG002|Overall Study|Unable to conduct observations or assess|0|||
162994983|NCT02094417|588682589|FG003|Overall Study|Unable to conduct observations or assess|0|||
162994984|NCT02094417|588682586|FG000|Overall Study|Withdrawal by Subject|1|||
162994985|NCT02094417|588682587|FG001|Overall Study|Withdrawal by Subject|2|||
162994986|NCT02094417|588682588|FG002|Overall Study|Withdrawal by Subject|1|||
162994987|NCT02094417|588682589|FG003|Overall Study|Withdrawal by Subject|3|||
162994988|NCT01443728|588682592|FG000|Overall Study|Lost to Follow-up|2|||
162994989|NCT01443728|588682593|FG001|Overall Study|Lost to Follow-up|0|||
162994990|NCT01443728|588682592|FG000|Overall Study|Withdrawal by Subject|1|||
162994991|NCT01443728|588682593|FG001|Overall Study|Withdrawal by Subject|1|||
162994992|NCT01443728|588682592|FG000|Overall Study|Adverse Event|0|||
162994993|NCT01443728|588682593|FG001|Overall Study|Adverse Event|2|||
162994994|NCT00887289|588682594|FG000|Overall Study|Lack of Efficacy|14|||
162994995|NCT00887289|588682594|FG000|Overall Study|Adverse Event|27|||
162994996|NCT00887289|588682594|FG000|Overall Study|Withdrawal by Subject|26|||
162994997|NCT00887289|588682594|FG000|Overall Study|Lost to Follow-up|8|||
162994998|NCT00887289|588682594|FG000|Overall Study|Other|20|||
162994999|NCT00591773|588682595|FG000|Overall Study|Adverse Event|9|||
162995000|NCT00591773|588682596|FG001|Overall Study|Adverse Event|9|||
162995001|NCT00591773|588682597|FG002|Overall Study|Adverse Event|6|||
162995002|NCT00591773|588682595|FG000|Overall Study|Protocol Violation|2|||
163060268|NCT03533751|588928357|FG003|Overall Study|Adverse Event|4|||
163060269|NCT03533751|588928358|FG004|Overall Study|Adverse Event|5|||
163060270|NCT03533751|588928354|FG000|Overall Study|Physician Decision|0|||
163060271|NCT03533751|588928355|FG001|Overall Study|Physician Decision|2|||
162995003|NCT00591773|588682596|FG001|Overall Study|Protocol Violation|3|||
162995004|NCT00591773|588682597|FG002|Overall Study|Protocol Violation|0|||
162995005|NCT00591773|588682595|FG000|Overall Study|Lost to Follow-up|1|||
162995006|NCT00591773|588682596|FG001|Overall Study|Lost to Follow-up|4|||
162995007|NCT00591773|588682597|FG002|Overall Study|Lost to Follow-up|1|||
163060272|NCT03533751|588928356|FG002|Overall Study|Physician Decision|1|||
162995008|NCT00591773|588682595|FG000|Overall Study|Withdrawal by Subject|2|||
162995009|NCT00591773|588682596|FG001|Overall Study|Withdrawal by Subject|5|||
162995010|NCT00591773|588682597|FG002|Overall Study|Withdrawal by Subject|3|||
163060273|NCT03533751|588928357|FG003|Overall Study|Physician Decision|2|||
163060274|NCT03533751|588928358|FG004|Overall Study|Physician Decision|1|||
162995011|NCT00591773|588682595|FG000|Overall Study|Lack of Efficacy|1|||
162995012|NCT00591773|588682596|FG001|Overall Study|Lack of Efficacy|2|||
162995013|NCT00591773|588682597|FG002|Overall Study|Lack of Efficacy|2|||
162995014|NCT00591773|588682595|FG000|Overall Study|Other|1|||
162995015|NCT00591773|588682596|FG001|Overall Study|Other|1|||
162995016|NCT00591773|588682597|FG002|Overall Study|Other|4|||
162995017|NCT03022084|588682598|FG000|Overall Study|Lost to Follow-up|2|||
162995018|NCT03022084|588682599|FG001|Overall Study|Lost to Follow-up|3|||
162995019|NCT00605540|588682600|FG000|Overall Study|Death|15|||
162995020|NCT00605540|588682600|FG000|Overall Study|Lost to Follow-up|23|||
162995021|NCT00509366|588682601|FG000|Overall Study|Not Treated (Screen Failure)|1|||
162995022|NCT00509366|588682602|FG001|Overall Study|Not Treated (Screen Failure)|1|||
162995023|NCT00509366|588682603|FG002|Overall Study|Not Treated (Screen Failure)|1|||
162995024|NCT00509366|588682604|FG003|Overall Study|Not Treated (Screen Failure)|0|||
162995025|NCT00509366|588682605|FG004|Overall Study|Not Treated (Screen Failure)|0|||
162995026|NCT02119819|588682608|FG000|Overall Study|Adverse Event|3|||
162995027|NCT02119819|588682609|FG001|Overall Study|Adverse Event|1|||
162995028|NCT02119819|588682610|FG002|Overall Study|Adverse Event|2|||
162995029|NCT02119819|588682611|FG003|Overall Study|Adverse Event|3|||
162995030|NCT02119819|588682612|FG004|Overall Study|Adverse Event|0|||
162995031|NCT02119819|588682613|FG005|Overall Study|Adverse Event|1|||
162995032|NCT02119819|588682608|FG000|Overall Study|Lack of Efficacy|0|||
162995033|NCT02119819|588682609|FG001|Overall Study|Lack of Efficacy|0|||
162995034|NCT02119819|588682610|FG002|Overall Study|Lack of Efficacy|0|||
162995035|NCT02119819|588682611|FG003|Overall Study|Lack of Efficacy|0|||
162995036|NCT02119819|588682612|FG004|Overall Study|Lack of Efficacy|0|||
162995037|NCT02119819|588682613|FG005|Overall Study|Lack of Efficacy|1|||
162995038|NCT02119819|588682608|FG000|Overall Study|Lost to Follow-up|0|||
162995039|NCT02119819|588682609|FG001|Overall Study|Lost to Follow-up|0|||
162995040|NCT02119819|588682610|FG002|Overall Study|Lost to Follow-up|1|||
162995041|NCT02119819|588682611|FG003|Overall Study|Lost to Follow-up|2|||
162995042|NCT02119819|588682612|FG004|Overall Study|Lost to Follow-up|1|||
162995043|NCT02119819|588682613|FG005|Overall Study|Lost to Follow-up|2|||
162995044|NCT02119819|588682608|FG000|Overall Study|Physician Decision|1|||
162995045|NCT02119819|588682609|FG001|Overall Study|Physician Decision|1|||
162995046|NCT02119819|588682610|FG002|Overall Study|Physician Decision|0|||
162995047|NCT02119819|588682611|FG003|Overall Study|Physician Decision|0|||
162995048|NCT02119819|588682612|FG004|Overall Study|Physician Decision|0|||
162995049|NCT02119819|588682613|FG005|Overall Study|Physician Decision|1|||
162995050|NCT02119819|588682608|FG000|Overall Study|Withdrawal by Subject|5|||
162995051|NCT02119819|588682609|FG001|Overall Study|Withdrawal by Subject|3|||
162995052|NCT02119819|588682610|FG002|Overall Study|Withdrawal by Subject|0|||
162995053|NCT02119819|588682611|FG003|Overall Study|Withdrawal by Subject|0|||
162995054|NCT02119819|588682612|FG004|Overall Study|Withdrawal by Subject|6|||
162995055|NCT02119819|588682613|FG005|Overall Study|Withdrawal by Subject|10|||
162995056|NCT02119819|588682608|FG000|Overall Study|Jury Duty|0|||
162995057|NCT02119819|588682609|FG001|Overall Study|Jury Duty|0|||
162637053|NCT02730455|587386090|FG001|Overall Study|Consent withdrawn|4|||
162637054|NCT02730455|587386091|FG002|Overall Study|Consent withdrawn|1|||
162637055|NCT02730455|587386089|FG000|Overall Study|Lost to Follow-up|3|||
162637056|NCT02730455|587386090|FG001|Overall Study|Lost to Follow-up|1|||
162995058|NCT02119819|588682610|FG002|Overall Study|Jury Duty|1|||
162995059|NCT02119819|588682611|FG003|Overall Study|Jury Duty|0|||
162995060|NCT02119819|588682612|FG004|Overall Study|Jury Duty|0|||
162995061|NCT02119819|588682613|FG005|Overall Study|Jury Duty|0|||
162995062|NCT02119819|588682608|FG000|Overall Study|Protocol Violation|0|||
162995063|NCT02119819|588682609|FG001|Overall Study|Protocol Violation|0|||
162995064|NCT02119819|588682610|FG002|Overall Study|Protocol Violation|0|||
162995065|NCT02119819|588682611|FG003|Overall Study|Protocol Violation|1|||
162995066|NCT02119819|588682612|FG004|Overall Study|Protocol Violation|0|||
162995067|NCT02119819|588682613|FG005|Overall Study|Protocol Violation|0|||
162637057|NCT02730455|587386091|FG002|Overall Study|Lost to Follow-up|4|||
162995068|NCT02119819|588682608|FG000|Overall Study|Left the city to get a job|0|||
162995069|NCT02119819|588682609|FG001|Overall Study|Left the city to get a job|0|||
162995070|NCT02119819|588682610|FG002|Overall Study|Left the city to get a job|0|||
162995071|NCT02119819|588682611|FG003|Overall Study|Left the city to get a job|1|||
162995072|NCT02119819|588682612|FG004|Overall Study|Left the city to get a job|0|||
162995073|NCT02119819|588682613|FG005|Overall Study|Left the city to get a job|0|||
162995074|NCT04497948|588682616|FG000|Overall Study|Death|2|||
162995075|NCT05384171|588682619|FG000|Overall Study|Lost to Follow-up|9|||
162995076|NCT05384171|588682620|FG001|Overall Study|Lost to Follow-up|9|||
162995077|NCT05384171|588682619|FG000|Overall Study|Withdrawal by Subject|3|||
162995078|NCT05384171|588682620|FG001|Overall Study|Withdrawal by Subject|0|||
162995079|NCT04611529|588682623|FG000|2-day Follow up|Lost to Follow-up|5|||
162995080|NCT04611529|588682624|FG001|2-day Follow up|Lost to Follow-up|6|||
162637058|NCT02730455|587386089|FG000|Overall Study|Other|1|||
162637059|NCT02730455|587386090|FG001|Overall Study|Other|1|||
162637060|NCT02730455|587386091|FG002|Overall Study|Other|2|||
162995081|NCT04611529|588682625|FG002|2-day Follow up|Lost to Follow-up|3|||
162995082|NCT02121392|588682626|FG000|Prior to Intervention|Protocol Violation|40|||
162995083|NCT02121392|588682627|FG001|Prior to Intervention|Protocol Violation|35|||
162995084|NCT02121392|588682626|FG000|Prior to Intervention|Withdrawal by Subject|8|||
162995085|NCT02121392|588682627|FG001|Prior to Intervention|Withdrawal by Subject|6|||
162995086|NCT02121392|588682626|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
162995087|NCT02121392|588682627|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
162995088|NCT02121392|588682626|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
162995089|NCT02121392|588682627|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
162995090|NCT00253448|588682630|FG000|Overall Study|Withdrawal by Subject|1|||
162995091|NCT02564887|588682632|FG000|Overall Study|Lost to Follow-up|6|||
162995092|NCT02564887|588682633|FG001|Overall Study|Lost to Follow-up|0|||
162995093|NCT02052011|588682636|FG000|Overall Study|Lost to Follow-up|3|||
162995094|NCT02052011|588682637|FG001|Overall Study|Lost to Follow-up|0|||
162995095|NCT02052011|588682636|FG000|Overall Study|Withdrawal by Subject|1|||
162995096|NCT02052011|588682637|FG001|Overall Study|Withdrawal by Subject|2|||
162995097|NCT01851330|588682638|FG000|Overall Study|Lack of Efficacy|10|||
162995098|NCT01851330|588682639|FG001|Overall Study|Lack of Efficacy|9|||
162995099|NCT01851330|588682640|FG002|Overall Study|Lack of Efficacy|2|||
162995100|NCT01851330|588682638|FG000|Overall Study|Lost to Follow-up|1|||
162995101|NCT01851330|588682639|FG001|Overall Study|Lost to Follow-up|6|||
162995102|NCT01851330|588682640|FG002|Overall Study|Lost to Follow-up|9|||
162995103|NCT01851330|588682638|FG000|Overall Study|Withdrew Consent|2|||
162995104|NCT01851330|588682639|FG001|Overall Study|Withdrew Consent|1|||
162995105|NCT01851330|588682640|FG002|Overall Study|Withdrew Consent|0|||
162995106|NCT01851330|588682638|FG000|Overall Study|Investigator's Discretion|0|||
162995107|NCT01851330|588682639|FG001|Overall Study|Investigator's Discretion|0|||
162995108|NCT01851330|588682640|FG002|Overall Study|Investigator's Discretion|1|||
162995109|NCT02648932|588682641|FG000|Overall Study|No transplant|3|||
162995110|NCT02648932|588682642|FG001|Overall Study|No transplant|1|||
162995111|NCT01590797|588682643|FG000|Overall Study|Adverse Event|4|||
162995112|NCT01590797|588682644|FG001|Overall Study|Adverse Event|3|||
162995113|NCT01590797|588682643|FG000|Overall Study|Lack of Efficacy|0|||
162995114|NCT01590797|588682644|FG001|Overall Study|Lack of Efficacy|2|||
162995115|NCT01590797|588682643|FG000|Overall Study|Lost to Follow-up|0|||
162995116|NCT01590797|588682644|FG001|Overall Study|Lost to Follow-up|1|||
162995117|NCT01590797|588682643|FG000|Overall Study|Protocol Violation|4|||
162995118|NCT01590797|588682644|FG001|Overall Study|Protocol Violation|1|||
162995119|NCT01590797|588682643|FG000|Overall Study|Withdrawal by Subject|7|||
162995120|NCT01590797|588682644|FG001|Overall Study|Withdrawal by Subject|5|||
162995121|NCT01590797|588682643|FG000|Overall Study|Other Protocol Specified Criteria|2|||
162995122|NCT01590797|588682644|FG001|Overall Study|Other Protocol Specified Criteria|4|||
162995123|NCT03106987|588682645|FG000|Overall Study|Death|37|||
162995124|NCT03106987|588682646|FG001|Overall Study|Death|22|||
162995125|NCT03106987|588682647|FG002|Overall Study|Death|12|||
162995126|NCT03106987|588682648|FG003|Overall Study|Death|8|||
162995127|NCT03106987|588682645|FG000|Overall Study|Lost to Follow-up|2|||
162995128|NCT03106987|588682646|FG001|Overall Study|Lost to Follow-up|0|||
162995129|NCT03106987|588682647|FG002|Overall Study|Lost to Follow-up|2|||
162995130|NCT03106987|588682648|FG003|Overall Study|Lost to Follow-up|2|||
162995131|NCT03106987|588682645|FG000|Overall Study|Withdrawal by Subject|5|||
162995132|NCT03106987|588682646|FG001|Overall Study|Withdrawal by Subject|1|||
162995133|NCT03106987|588682647|FG002|Overall Study|Withdrawal by Subject|4|||
162995134|NCT03106987|588682648|FG003|Overall Study|Withdrawal by Subject|1|||
162995135|NCT01307111|588682649|FG000|IUD Insertion|Lost to Follow-up|2|||
162995136|NCT01307111|588682650|FG001|IUD Insertion|Lost to Follow-up|0|||
162995137|NCT01307111|588682649|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
162995138|NCT01307111|588682650|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
162995139|NCT02114385|588682655|FG000|Overall Study|Withdrawal by Subject|3|||
162995140|NCT02114385|588682656|FG001|Overall Study|Withdrawal by Subject|2|||
162995141|NCT02114385|588682655|FG000|Overall Study|Lost to Follow-up|0|||
162995142|NCT02114385|588682656|FG001|Overall Study|Lost to Follow-up|6|||
162995143|NCT02460679|588682661|FG000|Overall Study|Investigator Decision|1|||
162995144|NCT02460679|588682661|FG000|Overall Study|Withdrawal by Subject|4|||
162995145|NCT01994850|588682670|FG000|Overall Study|Physician Decision|1|||
162995146|NCT01994850|588682670|FG000|Overall Study|Withdrawal by Subject|1|||
162995147|NCT00339144|588682705|FG000|Overall Study|Disease progression|5|||
162995148|NCT00339144|588682706|FG001|Overall Study|Disease progression|2|||
162995149|NCT00339144|588682707|FG002|Overall Study|Disease progression|2|||
162995150|NCT00339144|588682705|FG000|Overall Study|Study drug toxicity|3|||
162995151|NCT00339144|588682706|FG001|Overall Study|Study drug toxicity|1|||
162995152|NCT00339144|588682707|FG002|Overall Study|Study drug toxicity|1|||
162995153|NCT00339144|588682705|FG000|Overall Study|Participant's request to discontinuation|1|||
162995154|NCT00339144|588682706|FG001|Overall Study|Participant's request to discontinuation|0|||
162995155|NCT00339144|588682707|FG002|Overall Study|Participant's request to discontinuation|1|||
162995156|NCT01292226|588682708|FG000|Overall Study|Adverse Event|5|||
162995157|NCT01292226|588682708|FG000|Overall Study|Death|1|||
162995158|NCT01292226|588682708|FG000|Overall Study|Graft loss|1|||
162995159|NCT01292226|588682708|FG000|Overall Study|Protocol Violation|3|||
162995160|NCT01292226|588682708|FG000|Overall Study|Withdrawal by Subject|1|||
162995161|NCT01292226|588682708|FG000|Overall Study|Other|2|||
162995162|NCT00468650|588682714|FG000|Overall Study|Lost to Follow-up|4|||
162995163|NCT00468650|588682714|FG000|Overall Study|Withdrawal by Subject|2|||
162995164|NCT00468650|588682714|FG000|Overall Study|Protocol Violation|1|||
162995165|NCT01267994|588682715|FG000|Overall Study|Adverse Event|2|||
162995166|NCT01144715|588682718|FG000|Overall Study|Lost to Follow-up|2|||
162995167|NCT01144715|588682719|FG001|Overall Study|Lost to Follow-up|1|||
162995168|NCT01144715|588682718|FG000|Overall Study|Withdrawal by Subject|2|||
162995169|NCT01144715|588682719|FG001|Overall Study|Withdrawal by Subject|1|||
162995170|NCT01144715|588682718|FG000|Overall Study|Adverse Event|0|||
162995171|NCT01144715|588682719|FG001|Overall Study|Adverse Event|1|||
162995172|NCT00857584|588682720|FG000|Overall Study|Lack of Efficacy|1|||
162995173|NCT00857584|588682721|FG001|Overall Study|Lack of Efficacy|2|||
162995174|NCT00857584|588682720|FG000|Overall Study|Adverse Event|2|||
162995175|NCT00857584|588682721|FG001|Overall Study|Adverse Event|2|||
162995176|NCT00857584|588682720|FG000|Overall Study|Physician Decision|1|||
162995177|NCT00857584|588682721|FG001|Overall Study|Physician Decision|1|||
162995178|NCT02533375|588682722|FG000|Overall Study|Lack of Efficacy|3|||
162995179|NCT02533375|588682722|FG000|Overall Study|Adverse Event|2|||
162995180|NCT00673387|588682723|FG000|Overall Study|Withdrawal by Subject|15|||
162995181|NCT00673387|588682724|FG001|Overall Study|Withdrawal by Subject|16|||
162995182|NCT00673387|588682725|FG002|Overall Study|Withdrawal by Subject|20|||
162995183|NCT00673387|588682726|FG003|Overall Study|Withdrawal by Subject|16|||
162995184|NCT00673387|588682727|FG004|Overall Study|Withdrawal by Subject|18|||
162995185|NCT00673387|588682728|FG005|Overall Study|Withdrawal by Subject|21|||
162995186|NCT00673387|588682729|FG006|Overall Study|Withdrawal by Subject|15|||
162995187|NCT00673387|588682730|FG007|Overall Study|Withdrawal by Subject|21|||
162995188|NCT00673387|588682723|FG000|Overall Study|Adverse Event|3|||
162995189|NCT00673387|588682724|FG001|Overall Study|Adverse Event|1|||
162995190|NCT00673387|588682725|FG002|Overall Study|Adverse Event|5|||
162995191|NCT00673387|588682726|FG003|Overall Study|Adverse Event|2|||
162995192|NCT00673387|588682727|FG004|Overall Study|Adverse Event|6|||
162995193|NCT00673387|588682728|FG005|Overall Study|Adverse Event|2|||
162995194|NCT00673387|588682729|FG006|Overall Study|Adverse Event|5|||
162995195|NCT00673387|588682730|FG007|Overall Study|Adverse Event|5|||
162995196|NCT00673387|588682723|FG000|Overall Study|Physician Decision|0|||
162995197|NCT00673387|588682724|FG001|Overall Study|Physician Decision|0|||
162995198|NCT00673387|588682725|FG002|Overall Study|Physician Decision|0|||
162995199|NCT00673387|588682726|FG003|Overall Study|Physician Decision|0|||
162995200|NCT00673387|588682727|FG004|Overall Study|Physician Decision|0|||
162995201|NCT00673387|588682728|FG005|Overall Study|Physician Decision|5|||
162995202|NCT00673387|588682729|FG006|Overall Study|Physician Decision|1|||
162995203|NCT00673387|588682730|FG007|Overall Study|Physician Decision|1|||
162995204|NCT00673387|588682723|FG000|Overall Study|Protocol Violation|3|||
162995205|NCT00673387|588682724|FG001|Overall Study|Protocol Violation|0|||
162995206|NCT00673387|588682725|FG002|Overall Study|Protocol Violation|1|||
162995207|NCT00673387|588682726|FG003|Overall Study|Protocol Violation|2|||
162995208|NCT00673387|588682727|FG004|Overall Study|Protocol Violation|0|||
162995209|NCT00673387|588682728|FG005|Overall Study|Protocol Violation|1|||
162995210|NCT00673387|588682729|FG006|Overall Study|Protocol Violation|1|||
162995211|NCT00673387|588682730|FG007|Overall Study|Protocol Violation|3|||
162995212|NCT00673387|588682723|FG000|Overall Study|Lost to Follow-up|8|||
162995213|NCT00673387|588682724|FG001|Overall Study|Lost to Follow-up|6|||
162995214|NCT00673387|588682725|FG002|Overall Study|Lost to Follow-up|5|||
162995215|NCT00673387|588682726|FG003|Overall Study|Lost to Follow-up|6|||
162995216|NCT00673387|588682727|FG004|Overall Study|Lost to Follow-up|6|||
162995217|NCT00673387|588682728|FG005|Overall Study|Lost to Follow-up|5|||
162995218|NCT00673387|588682729|FG006|Overall Study|Lost to Follow-up|8|||
162637061|NCT02730455|587386089|FG000|Overall Study|Other|2|||
162637062|NCT02730455|587386090|FG001|Overall Study|Other|2|||
162995219|NCT00673387|588682730|FG007|Overall Study|Lost to Follow-up|5|||
162995220|NCT00960115|588682731|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
162995221|NCT00960115|588682732|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
162995222|NCT01102374|588682733|FG000|Overall Study|Death|9|||
162995223|NCT01102374|588682734|FG001|Overall Study|Death|13|||
162995224|NCT01102374|588682733|FG000|Overall Study|Lost to Follow-up|7|||
162995225|NCT01102374|588682734|FG001|Overall Study|Lost to Follow-up|6|||
162637063|NCT02730455|587386091|FG002|Overall Study|Other|0|||
162637064|NCT02733367|587386092|FG000|Overall Study|Withdrawal by Subject|6|||
162995226|NCT03996447|588684867|FG000|First MRI Examination|Adverse Event|2|||
162995227|NCT03996447|588684868|FG001|First MRI Examination|Adverse Event|0|||
162995228|NCT03996447|588684867|FG000|First MRI Examination|Withdrawal by Subject|1|||
162995229|NCT03996447|588684868|FG001|First MRI Examination|Withdrawal by Subject|2|||
162995230|NCT03996447|588684867|FG000|First MRI Examination|Protocol Violation|0|||
162995231|NCT03996447|588684868|FG001|First MRI Examination|Protocol Violation|1|||
162995232|NCT03996447|588684867|FG000|Washout|Adverse Event|2|||
162637065|NCT01922089|587386095|FG000|Overall Study|Adverse Event|18|||
162637066|NCT01922089|587386096|FG001|Overall Study|Adverse Event|13|||
162637067|NCT01922089|587386095|FG000|Overall Study|Protocol Deviation|10|||
162995233|NCT03996447|588684868|FG001|Washout|Adverse Event|0|||
162995234|NCT03996447|588684867|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
162995235|NCT03996447|588684868|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
162995236|NCT03996447|588684867|FG000|Washout|Withdrawal by Subject|0|||
162995237|NCT03996447|588684868|FG001|Washout|Withdrawal by Subject|1|||
162995238|NCT03996447|588684867|FG000|Washout|Other reason|1|||
162995239|NCT03996447|588684868|FG001|Washout|Other reason|1|||
162995240|NCT00369486|588684870|FG000|4-Week Visit|Missed visit|2|||
162995241|NCT00369486|588684871|FG001|4-Week Visit|Missed visit|2|||
162995242|NCT00369486|588684872|FG002|4-Week Visit|Missed visit|0|||
162995243|NCT00369486|588684873|FG003|4-Week Visit|Missed visit|2|||
162995244|NCT00369486|588684874|FG004|4-Week Visit|Missed visit|1|||
162995245|NCT00369486|588684870|FG000|4-Week Visit|Dropped|0|||
162637068|NCT01922089|587386096|FG001|Overall Study|Protocol Deviation|7|||
162637069|NCT01922089|587386095|FG000|Overall Study|Withdrawal by Subject|3|||
162995246|NCT00369486|588684871|FG001|4-Week Visit|Dropped|0|||
162995247|NCT00369486|588684872|FG002|4-Week Visit|Dropped|1|||
162995248|NCT00369486|588684873|FG003|4-Week Visit|Dropped|0|||
162995249|NCT00369486|588684874|FG004|4-Week Visit|Dropped|0|||
162995250|NCT00369486|588684870|FG000|8-Week Visit|Missed visit|0|||
162995251|NCT00369486|588684871|FG001|8-Week Visit|Missed visit|1|||
162995252|NCT00369486|588684872|FG002|8-Week Visit|Missed visit|0|||
162995253|NCT00369486|588684873|FG003|8-Week Visit|Missed visit|0|||
162995254|NCT00369486|588684874|FG004|8-Week Visit|Missed visit|1|||
162995255|NCT00369486|588684870|FG000|8-Week Visit|Dropped|0|||
162995256|NCT00369486|588684871|FG001|8-Week Visit|Dropped|0|||
162995257|NCT00369486|588684872|FG002|8-Week Visit|Dropped|0|||
162995258|NCT00369486|588684873|FG003|8-Week Visit|Dropped|1|||
162995259|NCT00369486|588684874|FG004|8-Week Visit|Dropped|0|||
162995260|NCT00369486|588684870|FG000|17-Week Visit|Missed visit|0|||
162995261|NCT00369486|588684871|FG001|17-Week Visit|Missed visit|0|||
162995262|NCT00369486|588684872|FG002|17-Week Visit|Missed visit|1|||
162995263|NCT00369486|588684873|FG003|17-Week Visit|Missed visit|1|||
162995264|NCT00369486|588684874|FG004|17-Week Visit|Missed visit|1|||
162995265|NCT00369486|588684870|FG000|34-Week Visit|Dropped|0|||
162995266|NCT00369486|588684871|FG001|34-Week Visit|Dropped|1|||
162995267|NCT00369486|588684872|FG002|34-Week Visit|Dropped|1|||
162995268|NCT00369486|588684873|FG003|34-Week Visit|Dropped|3|||
162995269|NCT00369486|588684874|FG004|34-Week Visit|Dropped|3|||
162995270|NCT01810302|588684881|FG000|Overall Study|Death|1|||
162995271|NCT01810302|588684882|FG001|Overall Study|Death|0|||
162995272|NCT01810302|588684881|FG000|Overall Study|Physician Decision|0|||
162995273|NCT01810302|588684882|FG001|Overall Study|Physician Decision|1|||
162995274|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1|24|||
162995275|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1|0|||
162995276|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
162995277|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
162995278|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995279|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995280|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
162995281|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
162995282|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
162995283|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
162995284|NCT03888066|588684883|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995285|NCT03888066|588684884|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995286|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995287|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162637070|NCT01922089|587386096|FG001|Overall Study|Withdrawal by Subject|4|||
162637071|NCT01922089|587386095|FG000|Overall Study|administrative problems|4|||
162637072|NCT01922089|587386096|FG001|Overall Study|administrative problems|1|||
162637073|NCT01922089|587386095|FG000|Overall Study|Physician Decision|2|||
162995288|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
162995289|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
162995290|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995291|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995292|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
162995293|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995294|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #2|5|||
162995295|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #2|0|||
162995296|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
162995297|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
162995298|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
163060275|NCT03533751|588928354|FG000|Overall Study|Sponsor Decision|0|||
162637074|NCT01922089|587386096|FG001|Overall Study|Physician Decision|3|||
162637075|NCT01922089|587386095|FG000|Overall Study|Death|2|||
162995299|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
162995300|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
162995301|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
162995302|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3|11|||
162995303|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3|0|||
162995304|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
162995305|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
162995306|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
162995307|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995308|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995309|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995310|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4|3|||
162995311|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4|0|||
162995312|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
162995313|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
162995314|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
162995315|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
162995316|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
162995317|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162715693|NCT03431350|587667077|FG002|Overall Study|Lost to Follow-up|0|||
162995318|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
162715694|NCT03431350|587667078|FG003|Overall Study|Lost to Follow-up|0|||
162995319|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
162995320|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
162995321|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995322|NCT03888066|588684883|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
162995323|NCT03888066|588684884|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995324|NCT03888066|588684883|FG000|Run-in Phase|AE (Adverse Event)|17|||
162995325|NCT03888066|588684884|FG001|Run-in Phase|AE (Adverse Event)|0|||
162995326|NCT03888066|588684883|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
162995327|NCT03888066|588684884|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
162995328|NCT03888066|588684883|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995329|NCT03888066|588684884|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995330|NCT03888066|588684883|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162995331|NCT03888066|588684884|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995332|NCT03888066|588684883|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
162995333|NCT03888066|588684884|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995334|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal by Subject|43|||
162995335|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal by Subject|0|||
162995336|NCT03888066|588684883|FG000|Run-in Phase|AE; Physician Decision|1|||
162995337|NCT03888066|588684884|FG001|Run-in Phase|AE; Physician Decision|0|||
162995338|NCT03888066|588684883|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
162995339|NCT03888066|588684884|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162995340|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
162995341|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
162995342|NCT03888066|588684883|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
162995343|NCT03888066|588684884|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
162995344|NCT03888066|588684883|FG000|Run-in Phase|Death|1|||
162995345|NCT03888066|588684884|FG001|Run-in Phase|Death|0|||
162995346|NCT03888066|588684883|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
162995347|NCT03888066|588684884|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
162995348|NCT03888066|588684883|FG000|Run-in Phase|Physician Decision|1|||
162995349|NCT03888066|588684884|FG001|Run-in Phase|Physician Decision|0|||
162995350|NCT03888066|588684883|FG000|Run-in Phase|Protocol Violation|13|||
162995351|NCT03888066|588684884|FG001|Run-in Phase|Protocol Violation|0|||
162995352|NCT03888066|588684883|FG000|Run-in Phase|Sponsor Request|34|||
162995353|NCT03888066|588684884|FG001|Run-in Phase|Sponsor Request|0|||
162995354|NCT03888066|588684883|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
162995355|NCT03888066|588684884|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
162995356|NCT03888066|588684883|FG000|Run-in Phase|Withdrawal Of Consent|1|||
162995357|NCT03888066|588684884|FG001|Run-in Phase|Withdrawal Of Consent|0|||
162995358|NCT03888066|588684883|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
162995359|NCT03888066|588684884|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
162995360|NCT03888066|588684883|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
162995361|NCT03888066|588684884|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
162995362|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
162995363|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
162995364|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
162995365|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
162995366|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
162995367|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
162995368|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
162995369|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
162995370|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
162995371|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
162995372|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
162995373|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
162995374|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
162995375|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
162995376|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
162995377|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
162995378|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
162715695|NCT03431350|587667079|FG004|Overall Study|Lost to Follow-up|0|||
163060276|NCT03533751|588928355|FG001|Overall Study|Sponsor Decision|0|||
162715696|NCT03431350|587667080|FG005|Overall Study|Lost to Follow-up|0|||
162715697|NCT03431350|587667081|FG006|Overall Study|Lost to Follow-up|0|||
162715698|NCT03431350|587667082|FG007|Overall Study|Lost to Follow-up|0|||
162715699|NCT03431350|587667083|FG008|Overall Study|Lost to Follow-up|0|||
162995379|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
162995380|NCT03888066|588684883|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
162995381|NCT03888066|588684884|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
162995382|NCT03278626|588684885|FG000|Overall Study|Death|2|||
162995383|NCT03278626|588684885|FG000|Overall Study|Toxicity|1|||
162995384|NCT03278626|588684885|FG000|Overall Study|Disease Progression|2|||
162995385|NCT02856555|588684886|FG000|Overall Study|Adverse Event|1|||
162995386|NCT02856555|588684887|FG001|Overall Study|Adverse Event|0|||
162995387|NCT02856555|588684888|FG002|Overall Study|Adverse Event|0|||
162995388|NCT02856555|588684886|FG000|Overall Study|Lost to Follow-up|1|||
162995389|NCT02856555|588684887|FG001|Overall Study|Lost to Follow-up|3|||
162995390|NCT02856555|588684888|FG002|Overall Study|Lost to Follow-up|0|||
162995391|NCT02856555|588684886|FG000|Overall Study|Withdrawal by Subject|3|||
162995392|NCT02856555|588684887|FG001|Overall Study|Withdrawal by Subject|0|||
162995393|NCT02856555|588684888|FG002|Overall Study|Withdrawal by Subject|0|||
162995394|NCT02856555|588684886|FG000|Overall Study|Randomized but Never Treated|0|||
162995395|NCT02856555|588684887|FG001|Overall Study|Randomized but Never Treated|1|||
162995396|NCT02856555|588684888|FG002|Overall Study|Randomized but Never Treated|0|||
162995397|NCT03333941|588684889|FG000|Overall Study|Lost to Follow-up|10|||
162995398|NCT03333941|588684889|FG000|Overall Study|Death|2|||
162995399|NCT03333941|588684889|FG000|Overall Study|Adverse Event|1|||
162995400|NCT04971187|588684890|FG000|Overall Study|Screen failures|2|||
162995401|NCT04981717|588684896|FG000|Overall Study|Protocol Violation|0|||
162995402|NCT04981717|588684897|FG001|Overall Study|Protocol Violation|3|||
162995403|NCT04981717|588684896|FG000|Overall Study|Adverse Event|1|||
162995404|NCT04981717|588684897|FG001|Overall Study|Adverse Event|3|||
162995405|NCT04981717|588684896|FG000|Overall Study|Pregnancy|1|||
162995406|NCT04981717|588684897|FG001|Overall Study|Pregnancy|0|||
162995407|NCT04981717|588684896|FG000|Overall Study|Physician Decision|1|||
162995408|NCT04981717|588684897|FG001|Overall Study|Physician Decision|0|||
162995409|NCT04981717|588684896|FG000|Overall Study|Sponsor Request|157|||
162995410|NCT04981717|588684897|FG001|Overall Study|Sponsor Request|172|||
162995411|NCT04981717|588684896|FG000|Overall Study|Lost to Follow-up|4|||
162995412|NCT04981717|588684897|FG001|Overall Study|Lost to Follow-up|5|||
162995413|NCT04981717|588684896|FG000|Overall Study|Withdrawal by Subject|50|||
162995414|NCT04981717|588684897|FG001|Overall Study|Withdrawal by Subject|37|||
162995415|NCT02207634|588684898|FG000|Overall Study|Withdrawal by Subject|21|||
162995416|NCT02207634|588684899|FG001|Overall Study|Withdrawal by Subject|31|||
162995417|NCT02207634|588684898|FG000|Overall Study|Lost to Follow-up|1|||
162995418|NCT02207634|588684899|FG001|Overall Study|Lost to Follow-up|0|||
162995419|NCT02077140|588684900|FG000|Overall Study|Lost to Follow-up|4|||
162995420|NCT02077140|588684901|FG001|Overall Study|Lost to Follow-up|1|||
162995421|NCT02077140|588684902|FG002|Overall Study|Lost to Follow-up|2|||
162995422|NCT02077140|588684903|FG003|Overall Study|Lost to Follow-up|2|||
162995423|NCT02077140|588684904|FG004|Overall Study|Lost to Follow-up|3|||
162995424|NCT02077140|588684900|FG000|Overall Study|Withdrawal by Subject|0|||
162995425|NCT02077140|588684901|FG001|Overall Study|Withdrawal by Subject|1|||
162995426|NCT02077140|588684902|FG002|Overall Study|Withdrawal by Subject|0|||
162995427|NCT02077140|588684903|FG003|Overall Study|Withdrawal by Subject|2|||
162995428|NCT02077140|588684904|FG004|Overall Study|Withdrawal by Subject|2|||
162995429|NCT00974922|588684907|FG000|Overall Study|study terminated|24|||
162995430|NCT00287586|588684908|FG000|Overall Study|Withdrew Consent|19|||
162995431|NCT00287586|588684909|FG001|Overall Study|Withdrew Consent|30|||
162995432|NCT00287586|588684908|FG000|Overall Study|Lost to Follow-up|5|||
162995433|NCT00287586|588684909|FG001|Overall Study|Lost to Follow-up|4|||
162995434|NCT00287586|588684908|FG000|Overall Study|Death|2|||
162995435|NCT00287586|588684909|FG001|Overall Study|Death|3|||
162995436|NCT00287586|588684908|FG000|Overall Study|Elevated Hematocrit|3|||
162995437|NCT00287586|588684909|FG001|Overall Study|Elevated Hematocrit|0|||
162995438|NCT00287586|588684908|FG000|Overall Study|Rash|3|||
162995439|NCT00287586|588684909|FG001|Overall Study|Rash|0|||
162995440|NCT00287586|588684908|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
162995441|NCT00287586|588684909|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
162995442|NCT00287586|588684908|FG000|Overall Study|Stroke|2|||
162995443|NCT00287586|588684909|FG001|Overall Study|Stroke|0|||
162995444|NCT00287586|588684908|FG000|Overall Study|Myocardial Infarction|1|||
162995445|NCT00287586|588684909|FG001|Overall Study|Myocardial Infarction|0|||
162995446|NCT00287586|588684908|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
162995447|NCT00287586|588684909|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
162995448|NCT00287586|588684908|FG000|Overall Study|Cognitive Impairment|1|||
162995449|NCT00287586|588684909|FG001|Overall Study|Cognitive Impairment|0|||
162995450|NCT00287586|588684908|FG000|Overall Study|Pancreatic Cancer|1|||
162995451|NCT00287586|588684909|FG001|Overall Study|Pancreatic Cancer|3|||
162995452|NCT00287586|588684908|FG000|Overall Study|Sleep Apnea|1|||
162995453|NCT00287586|588684909|FG001|Overall Study|Sleep Apnea|0|||
162995454|NCT00287586|588684908|FG000|Overall Study|Shoulder Pain|1|||
162995455|NCT00287586|588684909|FG001|Overall Study|Shoulder Pain|0|||
162995456|NCT00287586|588684908|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
162995457|NCT00287586|588684909|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
162995458|NCT00287586|588684908|FG000|Overall Study|Nonadherence|1|||
162995459|NCT00287586|588684909|FG001|Overall Study|Nonadherence|1|||
162995460|NCT00287586|588684908|FG000|Overall Study|Enrolled in Another Study|1|||
162995461|NCT00287586|588684909|FG001|Overall Study|Enrolled in Another Study|0|||
162995462|NCT00287586|588684908|FG000|Overall Study|Major Depression|0|||
162995463|NCT00287586|588684909|FG001|Overall Study|Major Depression|2|||
162995464|NCT00287586|588684908|FG000|Overall Study|Lung Cancer|0|||
162995465|NCT00287586|588684909|FG001|Overall Study|Lung Cancer|2|||
162995466|NCT00287586|588684908|FG000|Overall Study|Elevated IPSS Score|0|||
162995467|NCT00287586|588684909|FG001|Overall Study|Elevated IPSS Score|1|||
162995468|NCT00287586|588684908|FG000|Overall Study|Retroperitoneal Cancer|0|||
162995469|NCT00287586|588684909|FG001|Overall Study|Retroperitoneal Cancer|1|||
162995470|NCT00287586|588684908|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
162995471|NCT00287586|588684909|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
162995472|NCT00287586|588684908|FG000|Overall Study|Mood Swings and Irritability|0|||
162995473|NCT00287586|588684909|FG001|Overall Study|Mood Swings and Irritability|1|||
162995474|NCT00287586|588684908|FG000|Overall Study|Bradycardia|0|||
162995475|NCT00287586|588684909|FG001|Overall Study|Bradycardia|1|||
162995476|NCT00287586|588684908|FG000|Overall Study|Itchy Swollen Eyes|0|||
162995477|NCT00287586|588684909|FG001|Overall Study|Itchy Swollen Eyes|1|||
162995478|NCT00287586|588684908|FG000|Overall Study|Recurrent Melanoma|0|||
162995479|NCT00287586|588684909|FG001|Overall Study|Recurrent Melanoma|1|||
162995480|NCT01762800|588684911|FG000|Overall Study|Adverse Event|8|||
162995481|NCT01762800|588684912|FG001|Overall Study|Adverse Event|13|||
162995482|NCT01762800|588684911|FG000|Overall Study|Lack of Efficacy|3|||
162995483|NCT01762800|588684912|FG001|Overall Study|Lack of Efficacy|2|||
162995484|NCT01762800|588684911|FG000|Overall Study|Study Closed/Terminated|0|||
162995485|NCT01762800|588684912|FG001|Overall Study|Study Closed/Terminated|1|||
162995486|NCT01762800|588684911|FG000|Overall Study|Physician Decision|1|||
162995487|NCT01762800|588684912|FG001|Overall Study|Physician Decision|1|||
162995488|NCT01762800|588684911|FG000|Overall Study|Withdrawal by Subject|7|||
162995489|NCT01762800|588684912|FG001|Overall Study|Withdrawal by Subject|4|||
162995490|NCT02640482|588684913|FG000|Overall Study|Lost to Follow-up|3|||
162995491|NCT02640482|588684914|FG001|Overall Study|Lost to Follow-up|0|||
162995492|NCT00517881|588684915|FG000|Overall Study|Protocol Violation|2|||
162995493|NCT00517881|588684915|FG000|Overall Study|Adverse Event|1|||
162995494|NCT00517881|588684915|FG000|Overall Study|Renal transplantation|2|||
162995495|NCT00113763|588684916|FG000|Overall Study|Adverse Event|5|||
162995496|NCT00113763|588684917|FG001|Overall Study|Adverse Event|2|||
162995497|NCT00113763|588684916|FG000|Overall Study|Disease Progression|28|||
162995498|NCT00113763|588684917|FG001|Overall Study|Disease Progression|14|||
162995499|NCT00113763|588684916|FG000|Overall Study|Lost to Follow-up|10|||
162995500|NCT00113763|588684917|FG001|Overall Study|Lost to Follow-up|0|||
162995501|NCT00113763|588684916|FG000|Overall Study|Withdrawal by Subject|1|||
162995502|NCT00113763|588684917|FG001|Overall Study|Withdrawal by Subject|4|||
162995503|NCT00113763|588684916|FG000|Overall Study|Other|27|||
162995504|NCT00113763|588684917|FG001|Overall Study|Other|6|||
162995505|NCT00113763|588684916|FG000|Overall Study|Non-compliance|1|||
162995506|NCT00113763|588684917|FG001|Overall Study|Non-compliance|0|||
162995507|NCT00113763|588684916|FG000|Overall Study|Ongoing|1|||
162995508|NCT00113763|588684917|FG001|Overall Study|Ongoing|0|||
162995509|NCT01207583|588684918|FG000|Overall Study|Withdrawal by Subject|0|||
162995510|NCT01207583|588684919|FG001|Overall Study|Withdrawal by Subject|3|||
162995511|NCT01207583|588684920|FG002|Overall Study|Withdrawal by Subject|1|||
162995512|NCT01207583|588684918|FG000|Overall Study|Participant failed to return|1|||
162995513|NCT01207583|588684919|FG001|Overall Study|Participant failed to return|0|||
162995514|NCT01207583|588684920|FG002|Overall Study|Participant failed to return|0|||
162995515|NCT01207583|588684918|FG000|Overall Study|Lost to Follow-up|0|||
162995516|NCT01207583|588684919|FG001|Overall Study|Lost to Follow-up|2|||
162995517|NCT01207583|588684920|FG002|Overall Study|Lost to Follow-up|0|||
162995518|NCT03743415|588684921|FG000|Overall Study|Death|5|||
162995519|NCT03743415|588684922|FG001|Overall Study|Death|3|||
162995520|NCT03743415|588684923|FG002|Overall Study|Death|1|||
162995521|NCT03743415|588684924|FG003|Overall Study|Death|4|||
162995522|NCT03743415|588684925|FG004|Overall Study|Death|0|||
162995523|NCT03743415|588684926|FG005|Overall Study|Death|0|||
162995524|NCT03743415|588684927|FG006|Overall Study|Death|0|||
162995525|NCT03743415|588684928|FG007|Overall Study|Death|0|||
162995526|NCT03743415|588684929|FG008|Overall Study|Death|1|||
162995527|NCT03743415|588684930|FG009|Overall Study|Death|0|||
162995528|NCT03743415|588684921|FG000|Overall Study|Withdrawal by Subject|1|||
162995529|NCT03743415|588684922|FG001|Overall Study|Withdrawal by Subject|0|||
162995530|NCT03743415|588684923|FG002|Overall Study|Withdrawal by Subject|4|||
162995531|NCT03743415|588684924|FG003|Overall Study|Withdrawal by Subject|5|||
162995532|NCT03743415|588684925|FG004|Overall Study|Withdrawal by Subject|5|||
162995533|NCT03743415|588684926|FG005|Overall Study|Withdrawal by Subject|2|||
162995534|NCT03743415|588684927|FG006|Overall Study|Withdrawal by Subject|2|||
162995535|NCT03743415|588684928|FG007|Overall Study|Withdrawal by Subject|5|||
162995536|NCT03743415|588684929|FG008|Overall Study|Withdrawal by Subject|9|||
162995537|NCT03743415|588684930|FG009|Overall Study|Withdrawal by Subject|10|||
162995538|NCT03743415|588684921|FG000|Overall Study|Lost to Follow-up|2|||
162995539|NCT03743415|588684922|FG001|Overall Study|Lost to Follow-up|0|||
162995540|NCT03743415|588684923|FG002|Overall Study|Lost to Follow-up|2|||
162995541|NCT03743415|588684924|FG003|Overall Study|Lost to Follow-up|1|||
162995542|NCT03743415|588684925|FG004|Overall Study|Lost to Follow-up|1|||
162995543|NCT03743415|588684926|FG005|Overall Study|Lost to Follow-up|0|||
162995544|NCT03743415|588684927|FG006|Overall Study|Lost to Follow-up|1|||
162995545|NCT03743415|588684928|FG007|Overall Study|Lost to Follow-up|4|||
162995546|NCT03743415|588684929|FG008|Overall Study|Lost to Follow-up|13|||
162995547|NCT03743415|588684930|FG009|Overall Study|Lost to Follow-up|13|||
162995548|NCT01433549|588684932|FG000|Phase 2: Second Study Product|Adverse Event|0|||
162995549|NCT01433549|588684933|FG001|Phase 2: Second Study Product|Adverse Event|1|||
162995550|NCT01696058|588684935|FG000|Overall Study|Adverse Event|21|||
162995551|NCT01696058|588684936|FG001|Overall Study|Adverse Event|11|||
162995552|NCT01696058|588684935|FG000|Overall Study|Lack of Efficacy|2|||
162995553|NCT01696058|588684936|FG001|Overall Study|Lack of Efficacy|3|||
162995554|NCT01696058|588684935|FG000|Overall Study|Protocol Violation|9|||
162995555|NCT01696058|588684936|FG001|Overall Study|Protocol Violation|3|||
162995556|NCT01696058|588684935|FG000|Overall Study|Lost to Follow-up|2|||
162995557|NCT01696058|588684936|FG001|Overall Study|Lost to Follow-up|5|||
162995558|NCT01696058|588684935|FG000|Overall Study|Withdrawal by Subject|4|||
162995559|NCT01696058|588684936|FG001|Overall Study|Withdrawal by Subject|6|||
162995560|NCT01696058|588684935|FG000|Overall Study|Other reason prematurely discontinued|5|||
162995561|NCT01696058|588684936|FG001|Overall Study|Other reason prematurely discontinued|3|||
162995562|NCT02186834|588684938|FG000|Dose Escalation|Death|0|||
162995563|NCT02186834|588684939|FG001|Dose Escalation|Death|0|||
162995564|NCT02186834|588684940|FG002|Dose Escalation|Death|0|||
162995565|NCT02186834|588684941|FG003|Dose Escalation|Death|1|||
162995566|NCT02186834|588684942|FG004|Dose Escalation|Death|0|||
162995567|NCT02186834|588684943|FG005|Dose Escalation|Death|0|||
162995568|NCT02186834|588684938|FG000|Treatment at RP2D|Died prior to treatment|0|||
162995569|NCT02186834|588684939|FG001|Treatment at RP2D|Died prior to treatment|0|||
162995570|NCT02186834|588684940|FG002|Treatment at RP2D|Died prior to treatment|0|||
162995571|NCT02186834|588684941|FG003|Treatment at RP2D|Died prior to treatment|0|||
162995572|NCT02186834|588684942|FG004|Treatment at RP2D|Died prior to treatment|0|||
162995573|NCT02186834|588684943|FG005|Treatment at RP2D|Died prior to treatment|1|||
162637076|NCT01922089|587386096|FG001|Overall Study|Death|1|||
162637077|NCT01922089|587386095|FG000|Overall Study|Lost to Follow-up|0|||
162995574|NCT04581369|588684944|FG000|Overall Study|Death|7|||
162995575|NCT04581369|588684945|FG001|Overall Study|Death|6|||
162995576|NCT04581369|588684946|FG002|Overall Study|Death|0|||
162995577|NCT04581369|588684944|FG000|Overall Study|Lost to Follow-up|7|||
162995578|NCT04581369|588684945|FG001|Overall Study|Lost to Follow-up|3|||
162995579|NCT04581369|588684946|FG002|Overall Study|Lost to Follow-up|0|||
162995580|NCT04581369|588684944|FG000|Overall Study|liver transplant|2|||
162995581|NCT04581369|588684945|FG001|Overall Study|liver transplant|2|||
162995582|NCT04581369|588684946|FG002|Overall Study|liver transplant|0|||
162995583|NCT04581369|588684944|FG000|Overall Study|transitioned to hospice care|0|||
162995584|NCT04581369|588684945|FG001|Overall Study|transitioned to hospice care|5|||
162995585|NCT04581369|588684946|FG002|Overall Study|transitioned to hospice care|0|||
162995586|NCT04746794|588684949|FG000|Overall Study|Did not complete any study assessment|50303|||
162995587|NCT04746794|588684950|FG001|Overall Study|Did not complete any study assessment|44997|||
162995588|NCT00856375|588685011|FG000|Overall Study|Other|0|||
162995589|NCT00856375|588685012|FG001|Overall Study|Other|1|||
162995590|NCT00856375|588685011|FG000|Overall Study|Death|32|||
162995591|NCT00856375|588685012|FG001|Overall Study|Death|30|||
162995592|NCT00856375|588685011|FG000|Overall Study|Sponsor Terminated Study|7|||
162995593|NCT00856375|588685012|FG001|Overall Study|Sponsor Terminated Study|7|||
163060277|NCT03533751|588928356|FG002|Overall Study|Sponsor Decision|1|||
163060278|NCT03533751|588928357|FG003|Overall Study|Sponsor Decision|1|||
163060279|NCT03533751|588928358|FG004|Overall Study|Sponsor Decision|0|||
163060280|NCT03533751|588928354|FG000|Overall Study|Lost to Follow-up|3|||
163060281|NCT03533751|588928355|FG001|Overall Study|Lost to Follow-up|7|||
163060282|NCT03533751|588928356|FG002|Overall Study|Lost to Follow-up|6|||
163060283|NCT03533751|588928357|FG003|Overall Study|Lost to Follow-up|4|||
163060284|NCT03533751|588928358|FG004|Overall Study|Lost to Follow-up|3|||
163060285|NCT03533751|588928354|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
163060286|NCT03533751|588928355|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
163060287|NCT03533751|588928356|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
163060288|NCT03533751|588928357|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
163060289|NCT03533751|588928358|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
163060290|NCT03533751|588928354|FG000|Overall Study|Other|0|||
163060291|NCT03533751|588928355|FG001|Overall Study|Other|2|||
163060292|NCT03533751|588928356|FG002|Overall Study|Other|1|||
163060293|NCT03533751|588928357|FG003|Overall Study|Other|0|||
163060294|NCT03533751|588928358|FG004|Overall Study|Other|3|||
163060295|NCT03454555|588929854|FG000|Overall Study|Death|6|||
163060296|NCT03454555|588929855|FG001|Overall Study|Death|6|||
163060297|NCT03454555|588929854|FG000|Overall Study|Lost to Follow-up|31|||
163060298|NCT03454555|588929855|FG001|Overall Study|Lost to Follow-up|12|||
163060299|NCT03454555|588929854|FG000|Overall Study|Physician Decision|2|||
163060300|NCT03454555|588929855|FG001|Overall Study|Physician Decision|6|||
163060301|NCT03454555|588929854|FG000|Overall Study|Withdrawal by Subject|34|||
163060302|NCT03454555|588929855|FG001|Overall Study|Withdrawal by Subject|5|||
163060303|NCT03454555|588929854|FG000|Overall Study|Ineligible|1|||
163060304|NCT03454555|588929855|FG001|Overall Study|Ineligible|5|||
163060305|NCT05493111|588929856|FG000|Overall Study|Adverse Event|3|||
163060306|NCT05493111|588929857|FG001|Overall Study|Adverse Event|4|||
162995594|NCT00856375|588685011|FG000|Overall Study|Withdrawal by Subject|2|||
162995595|NCT00856375|588685012|FG001|Overall Study|Withdrawal by Subject|1|||
162995596|NCT00856375|588685011|FG000|Overall Study|Lost to Follow-up|1|||
162995597|NCT00856375|588685012|FG001|Overall Study|Lost to Follow-up|2|||
162995598|NCT02538965|588685015|FG000|Treatment Period|Other = Death due to disease progression|1|||
162995599|NCT02538965|588685015|FG000|Treatment Period|Adverse Event|2|||
162995600|NCT02538965|588685015|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
162995601|NCT02538965|588685015|FG000|Treatment Period|Treatment Failure|9|||
162995602|NCT02538965|588685015|FG000|Treatment Period|Disease Progression|1|||
162995603|NCT02538965|588685015|FG000|Treatment Period|Physician Decision|2|||
162995604|NCT02538965|588685015|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
162995605|NCT02538965|588685015|FG000|Follow-Up Period|Withdrawal by Parent|4|||
162995606|NCT00875797|588685016|FG000|Overall Study|Protocol Violation|6|||
162995607|NCT00875797|588685017|FG001|Overall Study|Protocol Violation|3|||
162995608|NCT00000620|588685018|FG000|Overall Study|Death|86|||
162995609|NCT00000620|588685019|FG001|Overall Study|Death|67|||
162995610|NCT00000620|588685020|FG002|Overall Study|Death|112|||
162995611|NCT00000620|588685021|FG003|Overall Study|Death|126|||
162995612|NCT00000620|588685022|FG004|Overall Study|Death|64|||
162995613|NCT00000620|588685023|FG005|Overall Study|Death|77|||
162995614|NCT00000620|588685024|FG006|Overall Study|Death|91|||
162995615|NCT00000620|588685025|FG007|Overall Study|Death|95|||
162995616|NCT00000620|588685018|FG000|Overall Study|Lost to Follow-up|14|||
162995617|NCT00000620|588685019|FG001|Overall Study|Lost to Follow-up|14|||
162995618|NCT00000620|588685020|FG002|Overall Study|Lost to Follow-up|14|||
162995619|NCT00000620|588685021|FG003|Overall Study|Lost to Follow-up|14|||
163060307|NCT05493111|588929856|FG000|Overall Study|Withdrawal of Consent|19|||
163060308|NCT05493111|588929857|FG001|Overall Study|Withdrawal of Consent|10|||
162995620|NCT00000620|588685022|FG004|Overall Study|Lost to Follow-up|15|||
163060309|NCT05493111|588929856|FG000|Overall Study|Non-compliance|1|||
162995621|NCT00000620|588685023|FG005|Overall Study|Lost to Follow-up|15|||
163060310|NCT05493111|588929857|FG001|Overall Study|Non-compliance|1|||
163060311|NCT05493111|588929856|FG000|Overall Study|Lost to Follow-up|8|||
163060312|NCT05493111|588929857|FG001|Overall Study|Lost to Follow-up|1|||
162995622|NCT00000620|588685024|FG006|Overall Study|Lost to Follow-up|13|||
163060313|NCT05493111|588929856|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
163060314|NCT05493111|588929857|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
162995623|NCT00000620|588685025|FG007|Overall Study|Lost to Follow-up|14|||
162995624|NCT00000620|588685018|FG000|Overall Study|Withdrawal by Subject|40|||
162995625|NCT00000620|588685019|FG001|Overall Study|Withdrawal by Subject|27|||
162995626|NCT00000620|588685020|FG002|Overall Study|Withdrawal by Subject|28|||
162995627|NCT00000620|588685021|FG003|Overall Study|Withdrawal by Subject|27|||
162995628|NCT00000620|588685022|FG004|Overall Study|Withdrawal by Subject|30|||
162995629|NCT00000620|588685023|FG005|Overall Study|Withdrawal by Subject|32|||
162995630|NCT00000620|588685024|FG006|Overall Study|Withdrawal by Subject|32|||
162995631|NCT00000620|588685025|FG007|Overall Study|Withdrawal by Subject|21|||
162995632|NCT00000620|588685018|FG000|Overall Study|missed closeout visit|22|||
162995633|NCT00000620|588685019|FG001|Overall Study|missed closeout visit|28|||
162995634|NCT00000620|588685020|FG002|Overall Study|missed closeout visit|16|||
162995635|NCT00000620|588685021|FG003|Overall Study|missed closeout visit|11|||
162995636|NCT00000620|588685022|FG004|Overall Study|missed closeout visit|26|||
162995637|NCT00000620|588685023|FG005|Overall Study|missed closeout visit|28|||
162995638|NCT00000620|588685024|FG006|Overall Study|missed closeout visit|13|||
162995639|NCT00000620|588685025|FG007|Overall Study|missed closeout visit|16|||
162995640|NCT00182325|588685030|FG000|Overall Study|Lost to Follow-up|7|||
162995641|NCT00182325|588685031|FG001|Overall Study|Lost to Follow-up|7|||
163060315|NCT05493111|588929856|FG000|Overall Study|Withdrawal by Subject|1|||
163060316|NCT05493111|588929857|FG001|Overall Study|Withdrawal by Subject|1|||
162995642|NCT00182325|588685030|FG000|Overall Study|Miscarriage|5|||
162995643|NCT00182325|588685031|FG001|Overall Study|Miscarriage|3|||
162995644|NCT00182325|588685030|FG000|Overall Study|Did not complete survey|22|||
162995645|NCT00182325|588685031|FG001|Overall Study|Did not complete survey|43|||
162995646|NCT01420965|588685033|FG000|Overall Study|Withdrawal by Subject|1|||
162995647|NCT01420965|588685034|FG001|Overall Study|Withdrawal by Subject|0|||
162995648|NCT01420965|588685035|FG002|Overall Study|Withdrawal by Subject|0|||
162995649|NCT01420965|588685033|FG000|Overall Study|Adverse Event|0|||
162995650|NCT01420965|588685034|FG001|Overall Study|Adverse Event|1|||
162995651|NCT01420965|588685035|FG002|Overall Study|Adverse Event|0|||
162995652|NCT02015065|588685036|FG000|Overall Study|Death on study|1|||
162995653|NCT02015065|588685037|FG001|Overall Study|Death on study|2|||
162995654|NCT02015065|588685038|FG002|Overall Study|Death on study|1|||
162995655|NCT04642365|588685046|FG000|Overall Study|Death|3|||
162995656|NCT04642365|588685047|FG001|Overall Study|Death|2|||
162995657|NCT04642365|588685048|FG002|Overall Study|Death|4|||
162995658|NCT04642365|588685049|FG003|Overall Study|Death|5|||
162995659|NCT04642365|588685050|FG004|Overall Study|Death|5|||
162995660|NCT04642365|588685051|FG005|Overall Study|Death|3|||
162995661|NCT04642365|588685052|FG006|Overall Study|Death|2|||
162995662|NCT04642365|588685053|FG007|Overall Study|Death|1|||
162995663|NCT04642365|588685046|FG000|Overall Study|Physician Decision|1|||
162995664|NCT04642365|588685047|FG001|Overall Study|Physician Decision|0|||
162995665|NCT04642365|588685048|FG002|Overall Study|Physician Decision|0|||
162995666|NCT04642365|588685049|FG003|Overall Study|Physician Decision|0|||
162995667|NCT04642365|588685050|FG004|Overall Study|Physician Decision|0|||
162995668|NCT04642365|588685051|FG005|Overall Study|Physician Decision|0|||
162995669|NCT04642365|588685052|FG006|Overall Study|Physician Decision|0|||
162995670|NCT04642365|588685053|FG007|Overall Study|Physician Decision|0|||
162995671|NCT04642365|588685046|FG000|Overall Study|Progressive Disease|1|||
162995672|NCT04642365|588685047|FG001|Overall Study|Progressive Disease|1|||
162995673|NCT04642365|588685048|FG002|Overall Study|Progressive Disease|1|||
162995674|NCT04642365|588685049|FG003|Overall Study|Progressive Disease|0|||
162995675|NCT04642365|588685050|FG004|Overall Study|Progressive Disease|0|||
162995676|NCT04642365|588685051|FG005|Overall Study|Progressive Disease|0|||
162995677|NCT04642365|588685052|FG006|Overall Study|Progressive Disease|1|||
163060317|NCT00375752|588929858|FG000|Overall Study|Lack of Efficacy|4|||
163060318|NCT00375752|588929859|FG001|Overall Study|Lack of Efficacy|4|||
163060319|NCT00375752|588929858|FG000|Overall Study|Adverse Event|1|||
163060320|NCT00375752|588929859|FG001|Overall Study|Adverse Event|6|||
163060321|NCT00375752|588929858|FG000|Overall Study|Withdrawal by Subject|6|||
163060322|NCT00375752|588929859|FG001|Overall Study|Withdrawal by Subject|1|||
163060323|NCT00375752|588929858|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163060324|NCT00375752|588929859|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162995678|NCT04642365|588685053|FG007|Overall Study|Progressive Disease|0|||
162995679|NCT04642365|588685046|FG000|Overall Study|Study Terminated By Sponsor|0|||
163060325|NCT00375752|588929858|FG000|Overall Study|Protocol Violation|0|||
163060326|NCT00375752|588929859|FG001|Overall Study|Protocol Violation|2|||
162995680|NCT04642365|588685047|FG001|Overall Study|Study Terminated By Sponsor|2|||
162995681|NCT04642365|588685048|FG002|Overall Study|Study Terminated By Sponsor|1|||
162995682|NCT04642365|588685049|FG003|Overall Study|Study Terminated By Sponsor|1|||
162995683|NCT04642365|588685050|FG004|Overall Study|Study Terminated By Sponsor|1|||
162995684|NCT04642365|588685051|FG005|Overall Study|Study Terminated By Sponsor|2|||
162995685|NCT04642365|588685052|FG006|Overall Study|Study Terminated By Sponsor|2|||
162995686|NCT04642365|588685053|FG007|Overall Study|Study Terminated By Sponsor|1|||
162995687|NCT04642365|588685046|FG000|Overall Study|Symptomatic Deterioration|1|||
162995688|NCT04642365|588685047|FG001|Overall Study|Symptomatic Deterioration|1|||
162995689|NCT04642365|588685048|FG002|Overall Study|Symptomatic Deterioration|0|||
163060327|NCT00375752|588929858|FG000|Overall Study|Administrative Problems|0|||
163060328|NCT00375752|588929859|FG001|Overall Study|Administrative Problems|1|||
163060329|NCT01140906|588929864|FG000|Overall Study|Adverse Event|7|||
163060330|NCT01140906|588929865|FG001|Overall Study|Adverse Event|10|||
162995690|NCT04642365|588685049|FG003|Overall Study|Symptomatic Deterioration|0|||
162995691|NCT04642365|588685050|FG004|Overall Study|Symptomatic Deterioration|0|||
162995692|NCT04642365|588685051|FG005|Overall Study|Symptomatic Deterioration|1|||
162995693|NCT04642365|588685052|FG006|Overall Study|Symptomatic Deterioration|0|||
162995694|NCT04642365|588685053|FG007|Overall Study|Symptomatic Deterioration|0|||
162995695|NCT04642365|588685046|FG000|Overall Study|Withdrawal by Subject|0|||
162995696|NCT04642365|588685047|FG001|Overall Study|Withdrawal by Subject|0|||
162995697|NCT04642365|588685048|FG002|Overall Study|Withdrawal by Subject|1|||
162995698|NCT04642365|588685049|FG003|Overall Study|Withdrawal by Subject|1|||
162995699|NCT04642365|588685050|FG004|Overall Study|Withdrawal by Subject|0|||
162995700|NCT04642365|588685051|FG005|Overall Study|Withdrawal by Subject|0|||
162995701|NCT04642365|588685052|FG006|Overall Study|Withdrawal by Subject|2|||
162995702|NCT04642365|588685053|FG007|Overall Study|Withdrawal by Subject|0|||
162995703|NCT04642365|588685046|FG000|Overall Study|Adverse Event|0|||
162995704|NCT04642365|588685047|FG001|Overall Study|Adverse Event|0|||
162995705|NCT04642365|588685048|FG002|Overall Study|Adverse Event|0|||
162995706|NCT04642365|588685049|FG003|Overall Study|Adverse Event|0|||
162995707|NCT04642365|588685050|FG004|Overall Study|Adverse Event|0|||
162995708|NCT04642365|588685051|FG005|Overall Study|Adverse Event|0|||
162995709|NCT04642365|588685052|FG006|Overall Study|Adverse Event|0|||
162995710|NCT04642365|588685053|FG007|Overall Study|Adverse Event|1|||
162995711|NCT02728843|588685054|FG000|Overall Study|Adverse Event|0|||
162995712|NCT02728843|588685055|FG001|Overall Study|Adverse Event|2|||
162995713|NCT02728843|588685056|FG002|Overall Study|Adverse Event|3|||
162995714|NCT02728843|588685057|FG003|Overall Study|Adverse Event|1|||
162995715|NCT02728843|588685058|FG004|Overall Study|Adverse Event|2|||
162995716|NCT02728843|588685054|FG000|Overall Study|Lack of Efficacy|0|||
162995717|NCT02728843|588685055|FG001|Overall Study|Lack of Efficacy|1|||
162995718|NCT02728843|588685056|FG002|Overall Study|Lack of Efficacy|1|||
162995719|NCT02728843|588685057|FG003|Overall Study|Lack of Efficacy|0|||
162995720|NCT02728843|588685058|FG004|Overall Study|Lack of Efficacy|0|||
162995721|NCT02728843|588685054|FG000|Overall Study|Protocol Violation|2|||
162995722|NCT02728843|588685055|FG001|Overall Study|Protocol Violation|0|||
162995723|NCT02728843|588685056|FG002|Overall Study|Protocol Violation|4|||
162995724|NCT02728843|588685057|FG003|Overall Study|Protocol Violation|2|||
162995725|NCT02728843|588685058|FG004|Overall Study|Protocol Violation|2|||
162995726|NCT02728843|588685054|FG000|Overall Study|Withdrawal by Subject|1|||
162995727|NCT02728843|588685055|FG001|Overall Study|Withdrawal by Subject|0|||
162995728|NCT02728843|588685056|FG002|Overall Study|Withdrawal by Subject|0|||
162995729|NCT02728843|588685057|FG003|Overall Study|Withdrawal by Subject|1|||
162995730|NCT02728843|588685058|FG004|Overall Study|Withdrawal by Subject|0|||
162995731|NCT02728843|588685054|FG000|Overall Study|Use of rescue medication|0|||
162995732|NCT02728843|588685055|FG001|Overall Study|Use of rescue medication|2|||
162995733|NCT02728843|588685056|FG002|Overall Study|Use of rescue medication|0|||
162995734|NCT02728843|588685057|FG003|Overall Study|Use of rescue medication|2|||
162995735|NCT02728843|588685058|FG004|Overall Study|Use of rescue medication|1|||
162995736|NCT03185013|588685059|FG000|Overall Study|Withdrawal by Subject|5|||
162995737|NCT03185013|588685060|FG001|Overall Study|Withdrawal by Subject|3|||
162995738|NCT03185013|588685059|FG000|Overall Study|Adverse Event|1|||
162995739|NCT03185013|588685060|FG001|Overall Study|Adverse Event|0|||
162995740|NCT03185013|588685059|FG000|Overall Study|Progressive Disease|1|||
162995741|NCT03185013|588685060|FG001|Overall Study|Progressive Disease|0|||
162995742|NCT03185013|588685059|FG000|Overall Study|Lost to Follow-up|8|||
162995743|NCT03185013|588685060|FG001|Overall Study|Lost to Follow-up|2|||
162995744|NCT03185013|588685059|FG000|Overall Study|Physician Decision|1|||
162995745|NCT03185013|588685060|FG001|Overall Study|Physician Decision|0|||
162995746|NCT03185013|588685059|FG000|Overall Study|Protocol Deviation|2|||
162995747|NCT03185013|588685060|FG001|Overall Study|Protocol Deviation|0|||
162995748|NCT03185013|588685059|FG000|Overall Study|Reason not Specified|3|||
162995749|NCT03185013|588685060|FG001|Overall Study|Reason not Specified|2|||
162995750|NCT03185013|588685059|FG000|Overall Study|Death|1|||
162995751|NCT03185013|588685060|FG001|Overall Study|Death|0|||
162995752|NCT00197496|588685064|FG000|Baseline to Discharge|not interested|1|||
162995753|NCT00197496|588685065|FG001|Baseline to Discharge|not interested|0|||
162995754|NCT00197496|588685064|FG000|Baseline to Discharge|MRSA|1|||
162995755|NCT00197496|588685065|FG001|Baseline to Discharge|MRSA|0|||
162995756|NCT00197496|588685064|FG000|Baseline to Discharge|Physician Decision|0|||
162995757|NCT00197496|588685065|FG001|Baseline to Discharge|Physician Decision|1|||
162995758|NCT00197496|588685064|FG000|Baseline to Discharge|Protocol Violation|0|||
162995759|NCT00197496|588685065|FG001|Baseline to Discharge|Protocol Violation|1|||
162995760|NCT00197496|588685064|FG000|Follow-up|Lost to Follow-up|2|||
162995761|NCT00197496|588685065|FG001|Follow-up|Lost to Follow-up|1|||
162995762|NCT01104792|588685071|FG000|Overall Study|Adverse Event|77|||
162995763|NCT01104792|588685071|FG000|Overall Study|Insufficient Therapeutic Response|22|||
162995764|NCT01104792|588685071|FG000|Overall Study|Protocol Violation|45|||
162995765|NCT01104792|588685071|FG000|Overall Study|Withdrawal of Consent|179|||
162995766|NCT01104792|588685071|FG000|Overall Study|Lost to Follow-up|43|||
162995767|NCT01104792|588685071|FG000|Overall Study|Reasons Not Specified|27|||
162995768|NCT01104792|588685071|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
162995769|NCT02071849|588685073|FG000|6-month Primary Endpoint|Did not receive device|4|||
162995770|NCT02071849|588685073|FG000|6-month Primary Endpoint|Adverse Event|1|||
162995771|NCT02071849|588685073|FG000|2-year Extended Follow-up|Adverse Event|1|||
162995772|NCT03255655|588685074|FG000|Overall Study|Lost to Follow-up|7|||
162995773|NCT03255655|588685075|FG001|Overall Study|Lost to Follow-up|4|||
162995774|NCT02056392|588685079|FG000|Overall Study|Lost to Follow-up|0|||
162995775|NCT02056392|588685080|FG001|Overall Study|Lost to Follow-up|1|||
162995776|NCT02056392|588685081|FG002|Overall Study|Lost to Follow-up|2|||
162995777|NCT02056392|588685082|FG003|Overall Study|Lost to Follow-up|0|||
162995778|NCT02056392|588685083|FG004|Overall Study|Lost to Follow-up|0|||
162995779|NCT02056392|588685084|FG005|Overall Study|Lost to Follow-up|0|||
162995780|NCT02056392|588685079|FG000|Overall Study|Protocol Violation|1|||
162995781|NCT02056392|588685080|FG001|Overall Study|Protocol Violation|0|||
162995782|NCT02056392|588685081|FG002|Overall Study|Protocol Violation|1|||
162995783|NCT02056392|588685082|FG003|Overall Study|Protocol Violation|0|||
162995784|NCT02056392|588685083|FG004|Overall Study|Protocol Violation|0|||
162995785|NCT02056392|588685084|FG005|Overall Study|Protocol Violation|0|||
162995786|NCT02056392|588685079|FG000|Overall Study|Withdrawal by Subject|1|||
162995787|NCT02056392|588685080|FG001|Overall Study|Withdrawal by Subject|0|||
162995788|NCT02056392|588685081|FG002|Overall Study|Withdrawal by Subject|0|||
162995789|NCT02056392|588685082|FG003|Overall Study|Withdrawal by Subject|0|||
162995790|NCT02056392|588685083|FG004|Overall Study|Withdrawal by Subject|1|||
162995791|NCT02056392|588685084|FG005|Overall Study|Withdrawal by Subject|0|||
162995792|NCT00103610|588685087|FG000|Overall Study|Entered Rescue Procedure|10|||
162995793|NCT00103610|588685088|FG001|Overall Study|Entered Rescue Procedure|52|||
162995794|NCT00103610|588685087|FG000|Overall Study|Death|16|||
162995795|NCT00103610|588685088|FG001|Overall Study|Death|12|||
162995796|NCT00103610|588685087|FG000|Overall Study|Elective Withdrawal|4|||
162995797|NCT00103610|588685088|FG001|Overall Study|Elective Withdrawal|0|||
162995798|NCT00103610|588685087|FG000|Overall Study|Lost to Follow-up|3|||
162995799|NCT00103610|588685088|FG001|Overall Study|Lost to Follow-up|1|||
162995800|NCT00103610|588685087|FG000|Overall Study|Adverse Event|2|||
162995801|NCT00103610|588685088|FG001|Overall Study|Adverse Event|2|||
162995802|NCT00103610|588685087|FG000|Overall Study|Other|2|||
162995803|NCT00103610|588685088|FG001|Overall Study|Other|7|||
162995804|NCT00103610|588685087|FG000|Overall Study|Failed mobilization|1|||
162995805|NCT00103610|588685088|FG001|Overall Study|Failed mobilization|5|||
162995806|NCT00103610|588685087|FG000|Overall Study|Noncompliance|0|||
162995807|NCT00103610|588685088|FG001|Overall Study|Noncompliance|1|||
162995808|NCT00658021|588685089|FG000|28-Week Treatment Period|Adverse Event|3|||
162995809|NCT00658021|588685090|FG001|28-Week Treatment Period|Adverse Event|1|||
162995810|NCT00658021|588685091|FG002|28-Week Treatment Period|Adverse Event|0|||
162995811|NCT00658021|588685089|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
162995812|NCT00658021|588685090|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
162995813|NCT00658021|588685091|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
162995814|NCT00658021|588685089|FG000|28-Week Treatment Period|Protocol Violation|0|||
162995815|NCT00658021|588685090|FG001|28-Week Treatment Period|Protocol Violation|2|||
162995816|NCT00658021|588685091|FG002|28-Week Treatment Period|Protocol Violation|1|||
162995817|NCT00658021|588685089|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
162995818|NCT00658021|588685090|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
162995819|NCT00658021|588685091|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
162995820|NCT00658021|588685089|FG000|28-Week Treatment Period|Physician Decision|1|||
162995821|NCT00658021|588685090|FG001|28-Week Treatment Period|Physician Decision|2|||
162995822|NCT00658021|588685091|FG002|28-Week Treatment Period|Physician Decision|1|||
162995823|NCT00658021|588685089|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995824|NCT00658021|588685090|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995825|NCT00658021|588685091|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
162995826|NCT00658021|588685089|FG000|28-Week Treatment Period|Loss of glucose control|1|||
162995827|NCT00658021|588685090|FG001|28-Week Treatment Period|Loss of glucose control|1|||
162995828|NCT00658021|588685091|FG002|28-Week Treatment Period|Loss of glucose control|10|||
162995829|NCT00658021|588685089|FG000|28-Week Treatment Period|Other|2|||
162995830|NCT00658021|588685090|FG001|28-Week Treatment Period|Other|3|||
162995831|NCT00658021|588685091|FG002|28-Week Treatment Period|Other|1|||
162995832|NCT00658021|588685089|FG000|28-Week Treatment Period|Did not receive treatment|2|||
162995833|NCT00658021|588685090|FG001|28-Week Treatment Period|Did not receive treatment|0|||
162995834|NCT00658021|588685091|FG002|28-Week Treatment Period|Did not receive treatment|0|||
162995835|NCT00658021|588685089|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
162995836|NCT00658021|588685090|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
162995837|NCT00658021|588685091|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
162995838|NCT00658021|588685089|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
162995839|NCT00658021|588685090|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
162995840|NCT00658021|588685091|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
162995841|NCT01806506|588685092|FG000|Overall Study|Lost to Follow-up|2|||
162995842|NCT01806506|588685093|FG001|Overall Study|Lost to Follow-up|1|||
162995843|NCT05819203|588685098|FG000|Overall Study|Protocol Violation|1|||
162995844|NCT05819203|588685099|FG001|Overall Study|Protocol Violation|2|||
162995845|NCT05819203|588685098|FG000|Overall Study|Withdrawal by Subject|1|||
162995846|NCT05819203|588685099|FG001|Overall Study|Withdrawal by Subject|0|||
162995847|NCT02952898|588685102|FG000|Overall Study|Withdrawal by Subject|10|||
162995848|NCT02952898|588685103|FG001|Overall Study|Withdrawal by Subject|8|||
162995849|NCT02952898|588685104|FG002|Overall Study|Withdrawal by Subject|8|||
162995850|NCT02952898|588685102|FG000|Overall Study|Adverse Event|8|||
162995851|NCT02952898|588685103|FG001|Overall Study|Adverse Event|8|||
162995852|NCT02952898|588685104|FG002|Overall Study|Adverse Event|3|||
162995853|NCT02952898|588685102|FG000|Overall Study|Lost to Follow-up|3|||
162995854|NCT02952898|588685103|FG001|Overall Study|Lost to Follow-up|2|||
162995855|NCT02952898|588685104|FG002|Overall Study|Lost to Follow-up|2|||
162995856|NCT02952898|588685102|FG000|Overall Study|Non-compliance with study drug|1|||
162995857|NCT02952898|588685103|FG001|Overall Study|Non-compliance with study drug|1|||
162995858|NCT02952898|588685104|FG002|Overall Study|Non-compliance with study drug|2|||
162995859|NCT04844762|588685105|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995860|NCT04844762|588685106|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995861|NCT04844762|588685107|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
162995862|NCT04844762|588685108|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995863|NCT04844762|588685109|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995864|NCT04844762|588685110|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995865|NCT04844762|588685105|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995866|NCT04844762|588685106|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995867|NCT04844762|588685107|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995868|NCT04844762|588685108|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995869|NCT04844762|588685109|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
162995870|NCT04844762|588685110|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
162995871|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995872|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995873|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995874|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
162995875|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995876|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995877|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995878|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995879|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995880|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995881|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
162995882|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995883|NCT04844762|588685105|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
162995884|NCT04844762|588685106|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
162995885|NCT04844762|588685107|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995886|NCT04844762|588685108|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995887|NCT04844762|588685109|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995888|NCT04844762|588685110|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995889|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995890|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995891|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995892|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995893|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995894|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995895|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995896|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995897|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995898|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995899|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
162995900|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
162995901|NCT04844762|588685105|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
162995902|NCT04844762|588685106|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995903|NCT04844762|588685107|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995904|NCT04844762|588685108|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995905|NCT04844762|588685109|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
163060331|NCT01140906|588929866|FG002|Overall Study|Adverse Event|17|||
163060332|NCT01140906|588929867|FG003|Overall Study|Adverse Event|7|||
163060333|NCT01140906|588929864|FG000|Overall Study|Lack of Efficacy|6|||
163060334|NCT01140906|588929865|FG001|Overall Study|Lack of Efficacy|8|||
163060335|NCT01140906|588929866|FG002|Overall Study|Lack of Efficacy|2|||
163060336|NCT01140906|588929867|FG003|Overall Study|Lack of Efficacy|1|||
163060337|NCT01140906|588929864|FG000|Overall Study|Non-compliance|0|||
163060338|NCT01140906|588929865|FG001|Overall Study|Non-compliance|1|||
163060339|NCT01140906|588929866|FG002|Overall Study|Non-compliance|0|||
163060340|NCT01140906|588929867|FG003|Overall Study|Non-compliance|1|||
162995906|NCT04844762|588685110|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
162995907|NCT04844762|588685105|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995908|NCT04844762|588685106|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995909|NCT04844762|588685107|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995910|NCT04844762|588685108|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995911|NCT04844762|588685109|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
162995912|NCT04844762|588685110|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
162995913|NCT04844762|588685105|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995914|NCT04844762|588685106|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
162995915|NCT04844762|588685107|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995916|NCT04844762|588685108|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995917|NCT04844762|588685109|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995918|NCT04844762|588685110|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
162995919|NCT04844762|588685105|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995920|NCT04844762|588685106|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995921|NCT04844762|588685107|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995922|NCT04844762|588685108|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
162995923|NCT04844762|588685109|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995924|NCT04844762|588685110|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
162995925|NCT02099682|588685113|FG000|Overall Study|Data Not Available|51|||
162995926|NCT02099682|588685113|FG000|Overall Study|Lost to Follow-up|31|||
162995927|NCT02099682|588685113|FG000|Overall Study|Other|29|||
162995928|NCT02802631|588685114|FG000|Overall Study|Withdrawal by Subject|1|||
162995929|NCT02802631|588685115|FG001|Overall Study|Withdrawal by Subject|0|||
162995930|NCT02802631|588685116|FG002|Overall Study|Withdrawal by Subject|0|||
162995931|NCT02802631|588685117|FG003|Overall Study|Withdrawal by Subject|0|||
162995932|NCT02802631|588685118|FG004|Overall Study|Withdrawal by Subject|0|||
162995933|NCT02802631|588685119|FG005|Overall Study|Withdrawal by Subject|0|||
162995934|NCT02802631|588685120|FG006|Overall Study|Withdrawal by Subject|0|||
162995935|NCT02802631|588685121|FG007|Overall Study|Withdrawal by Subject|0|||
162995936|NCT02802631|588685114|FG000|Overall Study|Physician Decision|1|||
162995937|NCT02802631|588685115|FG001|Overall Study|Physician Decision|0|||
162995938|NCT02802631|588685116|FG002|Overall Study|Physician Decision|0|||
162995939|NCT02802631|588685117|FG003|Overall Study|Physician Decision|0|||
162995940|NCT02802631|588685118|FG004|Overall Study|Physician Decision|0|||
162995941|NCT02802631|588685119|FG005|Overall Study|Physician Decision|0|||
162995942|NCT02802631|588685120|FG006|Overall Study|Physician Decision|1|||
162995943|NCT02802631|588685121|FG007|Overall Study|Physician Decision|0|||
162995944|NCT02802631|588685114|FG000|Overall Study|Adverse Event|0|||
162995945|NCT02802631|588685115|FG001|Overall Study|Adverse Event|2|||
162995946|NCT02802631|588685116|FG002|Overall Study|Adverse Event|0|||
162995947|NCT02802631|588685117|FG003|Overall Study|Adverse Event|1|||
162995948|NCT02802631|588685118|FG004|Overall Study|Adverse Event|6|||
162995949|NCT02802631|588685119|FG005|Overall Study|Adverse Event|1|||
162995950|NCT02802631|588685120|FG006|Overall Study|Adverse Event|4|||
162995951|NCT02802631|588685121|FG007|Overall Study|Adverse Event|0|||
162995952|NCT02802631|588685114|FG000|Overall Study|Sponsor Decision|0|||
162995953|NCT02802631|588685115|FG001|Overall Study|Sponsor Decision|0|||
162995954|NCT02802631|588685116|FG002|Overall Study|Sponsor Decision|6|||
162995955|NCT02802631|588685117|FG003|Overall Study|Sponsor Decision|0|||
163060341|NCT01140906|588929864|FG000|Overall Study|Protocol Violation|5|||
162637078|NCT01922089|587386096|FG001|Overall Study|Lost to Follow-up|1|||
162637079|NCT05582889|587386098|FG000|Overall Study|Health event|3|||
162995956|NCT02802631|588685118|FG004|Overall Study|Sponsor Decision|2|||
162995957|NCT02802631|588685119|FG005|Overall Study|Sponsor Decision|0|||
162995958|NCT02802631|588685120|FG006|Overall Study|Sponsor Decision|0|||
162995959|NCT02802631|588685121|FG007|Overall Study|Sponsor Decision|4|||
162995960|NCT00477633|588685122|FG000|Overall Study|Did not receive treatment|23|||
162995961|NCT00477633|588685122|FG000|Overall Study|Adverse Event|143|||
163060342|NCT01140906|588929865|FG001|Overall Study|Protocol Violation|3|||
163060343|NCT01140906|588929866|FG002|Overall Study|Protocol Violation|2|||
162637080|NCT05582889|587386099|FG001|Overall Study|Health event|2|||
162995962|NCT00477633|588685122|FG000|Overall Study|Pregnancy|23|||
162995963|NCT00477633|588685122|FG000|Overall Study|Lost to Follow-up|271|||
163060344|NCT01140906|588929867|FG003|Overall Study|Protocol Violation|1|||
162637081|NCT05582889|587386098|FG000|Overall Study|Lost to Follow-up|2|||
162995964|NCT00477633|588685122|FG000|Overall Study|Withdrawal by Subject|149|||
162995965|NCT00477633|588685122|FG000|Overall Study|Protocol Violation|25|||
162995966|NCT00477633|588685122|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
162995967|NCT02968849|588685123|FG000|Overall Study|Death|8|||
162995968|NCT02968849|588685124|FG001|Overall Study|Death|10|||
162995969|NCT02968849|588685123|FG000|Overall Study|Lost to Follow-up|31|||
162995970|NCT02968849|588685124|FG001|Overall Study|Lost to Follow-up|29|||
162995971|NCT02968849|588685123|FG000|Overall Study|Withdrawal by Subject|73|||
162995972|NCT02968849|588685124|FG001|Overall Study|Withdrawal by Subject|64|||
162995973|NCT02968849|588685123|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
162995974|NCT02968849|588685124|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
162995975|NCT02968849|588685123|FG000|Overall Study|Physician Decision|6|||
162995976|NCT02968849|588685124|FG001|Overall Study|Physician Decision|9|||
162995977|NCT02968849|588685123|FG000|Overall Study|Other|16|||
162995978|NCT02968849|588685124|FG001|Overall Study|Other|10|||
162995979|NCT02203331|588685127|FG000|Overall Study|Pregnancy|1|||
162995980|NCT02203331|588685128|FG001|Overall Study|Pregnancy|0|||
162995981|NCT02203331|588685129|FG002|Overall Study|Pregnancy|0|||
162995982|NCT02203331|588685130|FG003|Overall Study|Pregnancy|0|||
162995983|NCT02203331|588685131|FG004|Overall Study|Pregnancy|2|||
162995984|NCT02203331|588685132|FG005|Overall Study|Pregnancy|0|||
162995985|NCT02203331|588685127|FG000|Overall Study|Withdrawal by Subject|1|||
162995986|NCT02203331|588685128|FG001|Overall Study|Withdrawal by Subject|0|||
162995987|NCT02203331|588685129|FG002|Overall Study|Withdrawal by Subject|1|||
162995988|NCT02203331|588685130|FG003|Overall Study|Withdrawal by Subject|0|||
162995989|NCT02203331|588685131|FG004|Overall Study|Withdrawal by Subject|0|||
162995990|NCT02203331|588685132|FG005|Overall Study|Withdrawal by Subject|3|||
162995991|NCT02203331|588685127|FG000|Overall Study|Adverse Event|4|||
162995992|NCT02203331|588685128|FG001|Overall Study|Adverse Event|8|||
162995993|NCT02203331|588685129|FG002|Overall Study|Adverse Event|3|||
162995994|NCT02203331|588685130|FG003|Overall Study|Adverse Event|4|||
162995995|NCT02203331|588685131|FG004|Overall Study|Adverse Event|3|||
162995996|NCT02203331|588685132|FG005|Overall Study|Adverse Event|3|||
162995997|NCT02203331|588685127|FG000|Overall Study|Other Reasons|1|||
162995998|NCT02203331|588685128|FG001|Overall Study|Other Reasons|2|||
162995999|NCT02203331|588685129|FG002|Overall Study|Other Reasons|0|||
162996000|NCT02203331|588685130|FG003|Overall Study|Other Reasons|2|||
162996001|NCT02203331|588685131|FG004|Overall Study|Other Reasons|0|||
162996002|NCT02203331|588685132|FG005|Overall Study|Other Reasons|0|||
162996003|NCT02203331|588685127|FG000|Overall Study|Lack of Efficacy|0|||
162996004|NCT02203331|588685128|FG001|Overall Study|Lack of Efficacy|2|||
162996005|NCT02203331|588685129|FG002|Overall Study|Lack of Efficacy|1|||
162996006|NCT02203331|588685130|FG003|Overall Study|Lack of Efficacy|0|||
162996007|NCT02203331|588685131|FG004|Overall Study|Lack of Efficacy|0|||
162996008|NCT02203331|588685132|FG005|Overall Study|Lack of Efficacy|1|||
162996009|NCT02203331|588685127|FG000|Overall Study|Protocol Violation|0|||
162996010|NCT02203331|588685128|FG001|Overall Study|Protocol Violation|2|||
162996011|NCT02203331|588685129|FG002|Overall Study|Protocol Violation|0|||
162996012|NCT02203331|588685130|FG003|Overall Study|Protocol Violation|1|||
162996013|NCT02203331|588685131|FG004|Overall Study|Protocol Violation|1|||
162996014|NCT02203331|588685132|FG005|Overall Study|Protocol Violation|0|||
162996015|NCT02203331|588685127|FG000|Overall Study|Lost to Follow-up|0|||
162996016|NCT02203331|588685128|FG001|Overall Study|Lost to Follow-up|0|||
162996017|NCT02203331|588685129|FG002|Overall Study|Lost to Follow-up|0|||
162996018|NCT02203331|588685130|FG003|Overall Study|Lost to Follow-up|0|||
162996019|NCT02203331|588685131|FG004|Overall Study|Lost to Follow-up|1|||
162996020|NCT02203331|588685132|FG005|Overall Study|Lost to Follow-up|0|||
162996021|NCT02542605|588685133|FG000|Part B: Challenge Phase|Sponsor decision|1|||
162996022|NCT02542605|588685134|FG001|Part B: Challenge Phase|Sponsor decision|0|||
162996023|NCT02542605|588685135|FG002|Part B: Challenge Phase|Sponsor decision|0|||
162996024|NCT02542605|588685133|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
162996025|NCT02542605|588685134|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
162996026|NCT02542605|588685135|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
162996027|NCT00278889|588685137|FG000|Overall Study|Withdrawal by Subject|0|||
162996028|NCT00278889|588685138|FG001|Overall Study|Withdrawal by Subject|5|||
162996029|NCT00278889|588685139|FG002|Overall Study|Withdrawal by Subject|3|||
162996030|NCT00278889|588685137|FG000|Overall Study|Lost to Follow-up|1|||
162996031|NCT00278889|588685138|FG001|Overall Study|Lost to Follow-up|1|||
162996032|NCT00278889|588685139|FG002|Overall Study|Lost to Follow-up|0|||
162996033|NCT00278889|588685137|FG000|Overall Study|Death|24|||
162996034|NCT00278889|588685138|FG001|Overall Study|Death|21|||
162996035|NCT00278889|588685139|FG002|Overall Study|Death|17|||
162996036|NCT00704730|588685140|FG000|Overall Study|Adverse Event|35|||
162996037|NCT00704730|588685141|FG001|Overall Study|Adverse Event|9|||
162996038|NCT00704730|588685140|FG000|Overall Study|Death|11|||
162996039|NCT00704730|588685141|FG001|Overall Study|Death|5|||
162996040|NCT00704730|588685140|FG000|Overall Study|Physician Decision|2|||
162996041|NCT00704730|588685141|FG001|Overall Study|Physician Decision|0|||
162996042|NCT00704730|588685140|FG000|Overall Study|Did not receive drug|5|||
162996043|NCT00704730|588685141|FG001|Overall Study|Did not receive drug|2|||
162996044|NCT00704730|588685140|FG000|Overall Study|Disease progression per PI|58|||
162996045|NCT00704730|588685141|FG001|Overall Study|Disease progression per PI|67|||
162996046|NCT00704730|588685140|FG000|Overall Study|data unavailable|1|||
162996047|NCT00704730|588685141|FG001|Overall Study|data unavailable|0|||
162996048|NCT00704730|588685140|FG000|Overall Study|Withdrawal by Subject|9|||
162996049|NCT00704730|588685141|FG001|Overall Study|Withdrawal by Subject|13|||
162996050|NCT05292183|588686696|FG000|Overall Study|Adverse Event|1|||
162996051|NCT05833139|588686697|FG000|Study Period 2|Adverse Event|1|||
162996052|NCT02017015|588686702|FG000|Overall Study|Adverse Event|9|||
162996053|NCT02017015|588686702|FG000|Overall Study|Withdrawal by Subject|21|||
162996054|NCT02017015|588686702|FG000|Overall Study|Death|4|||
162996055|NCT02017015|588686702|FG000|Overall Study|Progressive Disease|31|||
162996056|NCT02017015|588686702|FG000|Overall Study|Non-compliance with study drug|2|||
162996057|NCT02017015|588686702|FG000|Overall Study|Physician Decision|2|||
162996058|NCT01277601|588686703|FG000|Overall Study|Adverse Event|5|||
162996059|NCT01277601|588686704|FG001|Overall Study|Adverse Event|3|||
162996060|NCT01277601|588686705|FG002|Overall Study|Adverse Event|0|||
162996061|NCT01277601|588686706|FG003|Overall Study|Adverse Event|7|||
162996062|NCT01277601|588686703|FG000|Overall Study|Withdrawal by Subject|18|||
162996063|NCT01277601|588686704|FG001|Overall Study|Withdrawal by Subject|21|||
162996064|NCT01277601|588686705|FG002|Overall Study|Withdrawal by Subject|8|||
162996065|NCT01277601|588686706|FG003|Overall Study|Withdrawal by Subject|17|||
162996066|NCT01277601|588686703|FG000|Overall Study|Lost to Follow-up|7|||
162996067|NCT01277601|588686704|FG001|Overall Study|Lost to Follow-up|9|||
162996068|NCT01277601|588686705|FG002|Overall Study|Lost to Follow-up|4|||
162996069|NCT01277601|588686706|FG003|Overall Study|Lost to Follow-up|2|||
162996070|NCT01277601|588686703|FG000|Overall Study|Physician Decision|3|||
162996071|NCT01277601|588686704|FG001|Overall Study|Physician Decision|5|||
162996072|NCT01277601|588686705|FG002|Overall Study|Physician Decision|1|||
162996073|NCT01277601|588686706|FG003|Overall Study|Physician Decision|6|||
162996074|NCT01277601|588686703|FG000|Overall Study|Pregnancy|2|||
162996075|NCT01277601|588686704|FG001|Overall Study|Pregnancy|2|||
162996076|NCT01277601|588686705|FG002|Overall Study|Pregnancy|4|||
162996077|NCT01277601|588686706|FG003|Overall Study|Pregnancy|1|||
162996078|NCT01277601|588686703|FG000|Overall Study|Noncompliance with Study Drug|1|||
162996079|NCT01277601|588686704|FG001|Overall Study|Noncompliance with Study Drug|3|||
162996080|NCT01277601|588686705|FG002|Overall Study|Noncompliance with Study Drug|2|||
162996081|NCT01277601|588686706|FG003|Overall Study|Noncompliance with Study Drug|0|||
162996082|NCT01277601|588686703|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
162996083|NCT01277601|588686704|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
162996084|NCT01277601|588686705|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
162996085|NCT01277601|588686706|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
162996086|NCT01277601|588686703|FG000|Overall Study|Protocol Violation|0|||
162996087|NCT01277601|588686704|FG001|Overall Study|Protocol Violation|2|||
162996088|NCT01277601|588686705|FG002|Overall Study|Protocol Violation|5|||
162996089|NCT01277601|588686706|FG003|Overall Study|Protocol Violation|0|||
162996090|NCT01277601|588686703|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
162996091|NCT01277601|588686704|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
162996092|NCT01277601|588686705|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
162996093|NCT01277601|588686706|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
162996094|NCT02260570|588686708|FG000|Overall Study|Withdrawal by Subject|2|||
162996095|NCT02260570|588686709|FG001|Overall Study|Withdrawal by Subject|1|||
162996096|NCT02260570|588686708|FG000|Overall Study|Physician Decision|1|||
162996097|NCT02260570|588686709|FG001|Overall Study|Physician Decision|1|||
162996098|NCT04034927|588686710|FG000|Overall Study|Adverse Event|4|||
162996099|NCT04034927|588686711|FG001|Overall Study|Adverse Event|9|||
162996100|NCT04034927|588686710|FG000|Overall Study|Death|0|||
162996101|NCT04034927|588686711|FG001|Overall Study|Death|1|||
162996102|NCT04034927|588686710|FG000|Overall Study|Withdrawal by Subject|0|||
162996103|NCT04034927|588686711|FG001|Overall Study|Withdrawal by Subject|3|||
162996104|NCT04034927|588686710|FG000|Overall Study|Still on Treatment|2|||
162996105|NCT04034927|588686711|FG001|Overall Study|Still on Treatment|1|||
162996106|NCT04034927|588686710|FG000|Overall Study|Other|1|||
162996107|NCT04034927|588686711|FG001|Overall Study|Other|1|||
162996108|NCT00094861|588686714|FG000|Overall Study|Adverse Event|5|||
162996109|NCT00094861|588686715|FG001|Overall Study|Adverse Event|2|||
162996110|NCT00094861|588686714|FG000|Overall Study|Withdrawal by Subject|5|||
162996111|NCT00094861|588686715|FG001|Overall Study|Withdrawal by Subject|3|||
162996112|NCT00094861|588686714|FG000|Overall Study|Physician Decision|1|||
162996113|NCT00094861|588686715|FG001|Overall Study|Physician Decision|1|||
162996114|NCT00094861|588686714|FG000|Overall Study|Lost to Follow-up|0|||
162996115|NCT00094861|588686715|FG001|Overall Study|Lost to Follow-up|1|||
162996116|NCT00094861|588686714|FG000|Overall Study|Death|4|||
162996117|NCT00094861|588686715|FG001|Overall Study|Death|2|||
162996118|NCT00094861|588686714|FG000|Overall Study|Other|3|||
162996119|NCT00094861|588686715|FG001|Overall Study|Other|0|||
162996120|NCT00264550|588686716|FG000|Overall Study|Death|0|||
162996121|NCT00264550|588686717|FG001|Overall Study|Death|3|||
162996122|NCT00264550|588686718|FG002|Overall Study|Death|0|||
162996123|NCT00264550|588686719|FG003|Overall Study|Death|0|||
162996124|NCT00264550|588686716|FG000|Overall Study|Lost to Follow-up|3|||
162996125|NCT00264550|588686717|FG001|Overall Study|Lost to Follow-up|1|||
162996126|NCT00264550|588686718|FG002|Overall Study|Lost to Follow-up|1|||
162996127|NCT00264550|588686719|FG003|Overall Study|Lost to Follow-up|1|||
162996128|NCT00264550|588686716|FG000|Overall Study|Adverse Event|23|||
162996129|NCT00264550|588686717|FG001|Overall Study|Adverse Event|18|||
162996130|NCT00264550|588686718|FG002|Overall Study|Adverse Event|9|||
163060345|NCT01140906|588929864|FG000|Overall Study|Withdrawal of consent|6|||
163060346|NCT01140906|588929865|FG001|Overall Study|Withdrawal of consent|6|||
163060347|NCT01140906|588929866|FG002|Overall Study|Withdrawal of consent|2|||
163060348|NCT01140906|588929867|FG003|Overall Study|Withdrawal of consent|2|||
163060349|NCT01140906|588929864|FG000|Overall Study|Lost to Follow-up|1|||
163060350|NCT01140906|588929865|FG001|Overall Study|Lost to Follow-up|1|||
163060351|NCT01140906|588929866|FG002|Overall Study|Lost to Follow-up|0|||
163060352|NCT01140906|588929867|FG003|Overall Study|Lost to Follow-up|2|||
162996131|NCT00264550|588686719|FG003|Overall Study|Adverse Event|14|||
162996132|NCT00264550|588686716|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162996133|NCT00264550|588686717|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
162996134|NCT00264550|588686718|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
162996135|NCT00264550|588686719|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
162996136|NCT00264550|588686716|FG000|Overall Study|Discontinued oral study agent|0|||
163060353|NCT01140906|588929864|FG000|Overall Study|Administrative or other reason|0|||
162996137|NCT00264550|588686717|FG001|Overall Study|Discontinued oral study agent|1|||
162996138|NCT00264550|588686718|FG002|Overall Study|Discontinued oral study agent|0|||
162996139|NCT00264550|588686719|FG003|Overall Study|Discontinued oral study agent|0|||
162996140|NCT00264550|588686716|FG000|Overall Study|Other|13|||
162996141|NCT00264550|588686717|FG001|Overall Study|Other|7|||
162996142|NCT00264550|588686718|FG002|Overall Study|Other|3|||
162996143|NCT00264550|588686719|FG003|Overall Study|Other|9|||
162996144|NCT02129608|588686720|FG000|Overall Study|Lost to Follow-up|0|||
162996145|NCT02129608|588686721|FG001|Overall Study|Lost to Follow-up|1|||
162996146|NCT02129608|588686722|FG002|Overall Study|Lost to Follow-up|1|||
162996147|NCT02129608|588686720|FG000|Overall Study|Withdrawal by Subject|0|||
162996148|NCT02129608|588686721|FG001|Overall Study|Withdrawal by Subject|0|||
162996149|NCT02129608|588686722|FG002|Overall Study|Withdrawal by Subject|2|||
162996150|NCT00451204|588686724|FG000|Overall Study|Adverse Event|4|||
162996151|NCT00451204|588686725|FG001|Overall Study|Adverse Event|6|||
162996152|NCT00451204|588686724|FG000|Overall Study|Lack of Efficacy|4|||
162996153|NCT00451204|588686725|FG001|Overall Study|Lack of Efficacy|4|||
162996154|NCT00451204|588686724|FG000|Overall Study|Lost to Follow-up|4|||
162996155|NCT00451204|588686725|FG001|Overall Study|Lost to Follow-up|4|||
162996156|NCT00451204|588686724|FG000|Overall Study|Protocol Violation|1|||
162996157|NCT00451204|588686725|FG001|Overall Study|Protocol Violation|0|||
162996158|NCT00451204|588686724|FG000|Overall Study|Patient refusal|8|||
162996159|NCT00451204|588686725|FG001|Overall Study|Patient refusal|4|||
162996160|NCT00451204|588686724|FG000|Overall Study|Other|1|||
162996161|NCT00451204|588686725|FG001|Overall Study|Other|2|||
162996162|NCT01422187|588686728|FG000|Overall Study|Personal reason|1|||
162996163|NCT01422187|588686729|FG001|Overall Study|Personal reason|0|||
162996164|NCT01422187|588686730|FG002|Overall Study|Personal reason|0|||
162996165|NCT01422187|588686728|FG000|Overall Study|Lost to Follow-up|0|||
162996166|NCT01422187|588686729|FG001|Overall Study|Lost to Follow-up|1|||
162996167|NCT01422187|588686730|FG002|Overall Study|Lost to Follow-up|0|||
162996168|NCT00741286|588686736|FG000|Overall Study|Lost to Follow-up|15|||
162996169|NCT00741286|588686737|FG001|Overall Study|Lost to Follow-up|10|||
162996170|NCT00741286|588686736|FG000|Overall Study|Adverse Event|1|||
162996171|NCT00741286|588686737|FG001|Overall Study|Adverse Event|6|||
162996172|NCT00741286|588686736|FG000|Overall Study|Protocol Violation|3|||
162996173|NCT00741286|588686737|FG001|Overall Study|Protocol Violation|2|||
162996174|NCT00741286|588686736|FG000|Overall Study|Primary Outcome|1|||
162996175|NCT00741286|588686737|FG001|Overall Study|Primary Outcome|1|||
162996176|NCT00425373|588686746|FG000|Overall Study|Adverse Event|2|||
162996177|NCT00425373|588686747|FG001|Overall Study|Adverse Event|2|||
162996178|NCT00425373|588686748|FG002|Overall Study|Adverse Event|0|||
162996179|NCT00425373|588686749|FG003|Overall Study|Adverse Event|1|||
162996180|NCT00425373|588686750|FG004|Overall Study|Adverse Event|4|||
162996181|NCT00425373|588686751|FG005|Overall Study|Adverse Event|6|||
162996182|NCT00425373|588686752|FG006|Overall Study|Adverse Event|2|||
162996183|NCT00425373|588686753|FG007|Overall Study|Adverse Event|3|||
162996184|NCT00425373|588686754|FG008|Overall Study|Adverse Event|8|||
162996185|NCT00425373|588686746|FG000|Overall Study|Lost to Follow-up|0|||
162996186|NCT00425373|588686747|FG001|Overall Study|Lost to Follow-up|1|||
162996187|NCT00425373|588686748|FG002|Overall Study|Lost to Follow-up|0|||
162996188|NCT00425373|588686749|FG003|Overall Study|Lost to Follow-up|0|||
162996189|NCT00425373|588686750|FG004|Overall Study|Lost to Follow-up|1|||
162996190|NCT00425373|588686751|FG005|Overall Study|Lost to Follow-up|0|||
162996191|NCT00425373|588686752|FG006|Overall Study|Lost to Follow-up|0|||
162996192|NCT00425373|588686753|FG007|Overall Study|Lost to Follow-up|0|||
162996193|NCT00425373|588686754|FG008|Overall Study|Lost to Follow-up|0|||
162996194|NCT00425373|588686746|FG000|Overall Study|Protocol Violation|1|||
162996195|NCT00425373|588686747|FG001|Overall Study|Protocol Violation|0|||
162996196|NCT00425373|588686748|FG002|Overall Study|Protocol Violation|1|||
162996197|NCT00425373|588686749|FG003|Overall Study|Protocol Violation|0|||
163060354|NCT01140906|588929865|FG001|Overall Study|Administrative or other reason|5|||
163060355|NCT01140906|588929866|FG002|Overall Study|Administrative or other reason|3|||
163060356|NCT01140906|588929867|FG003|Overall Study|Administrative or other reason|2|||
163060357|NCT01649765|588929868|FG000|Overall Study|Adverse Event|5|||
163060358|NCT01649765|588929869|FG001|Overall Study|Adverse Event|3|||
162996198|NCT00425373|588686750|FG004|Overall Study|Protocol Violation|0|||
162996199|NCT00425373|588686751|FG005|Overall Study|Protocol Violation|0|||
162996200|NCT00425373|588686752|FG006|Overall Study|Protocol Violation|0|||
162996201|NCT00425373|588686753|FG007|Overall Study|Protocol Violation|5|||
162996202|NCT00425373|588686754|FG008|Overall Study|Protocol Violation|3|||
162996203|NCT00425373|588686746|FG000|Overall Study|Withdrawal by Subject|2|||
162996204|NCT00425373|588686747|FG001|Overall Study|Withdrawal by Subject|0|||
162996205|NCT00425373|588686748|FG002|Overall Study|Withdrawal by Subject|2|||
163060359|NCT01649765|588929868|FG000|Overall Study|Lack of Efficacy|1|||
162996206|NCT00425373|588686749|FG003|Overall Study|Withdrawal by Subject|1|||
162996207|NCT00425373|588686750|FG004|Overall Study|Withdrawal by Subject|4|||
162996208|NCT00425373|588686751|FG005|Overall Study|Withdrawal by Subject|0|||
162996209|NCT00425373|588686752|FG006|Overall Study|Withdrawal by Subject|2|||
162996210|NCT00425373|588686753|FG007|Overall Study|Withdrawal by Subject|2|||
162996211|NCT00425373|588686754|FG008|Overall Study|Withdrawal by Subject|2|||
162996212|NCT00425373|588686746|FG000|Overall Study|Lack of Efficacy|0|||
162996213|NCT00425373|588686747|FG001|Overall Study|Lack of Efficacy|0|||
162996214|NCT00425373|588686748|FG002|Overall Study|Lack of Efficacy|0|||
162996215|NCT00425373|588686749|FG003|Overall Study|Lack of Efficacy|0|||
162996216|NCT00425373|588686750|FG004|Overall Study|Lack of Efficacy|1|||
162996217|NCT00425373|588686751|FG005|Overall Study|Lack of Efficacy|3|||
162996218|NCT00425373|588686752|FG006|Overall Study|Lack of Efficacy|3|||
162996219|NCT00425373|588686753|FG007|Overall Study|Lack of Efficacy|0|||
162996220|NCT00425373|588686754|FG008|Overall Study|Lack of Efficacy|5|||
162996221|NCT00582010|588686762|FG000|Overall Study|Death|0|||
162996222|NCT00582010|588686763|FG001|Overall Study|Death|1|||
162996223|NCT05320887|588686769|FG000|Overall Study|Lost to Follow-up|0|||
162996224|NCT05320887|588686770|FG001|Overall Study|Lost to Follow-up|3|||
162996225|NCT05320887|588686771|FG002|Overall Study|Lost to Follow-up|0|||
162996226|NCT05320887|588686772|FG003|Overall Study|Lost to Follow-up|0|||
162996227|NCT02463357|588686773|FG000|Overall Study|Withdrawal by Subject|1|||
162996228|NCT02463357|588686774|FG001|Overall Study|Withdrawal by Subject|0|||
162996229|NCT02463357|588686775|FG002|Overall Study|Withdrawal by Subject|0|||
162996230|NCT02463357|588686776|FG003|Overall Study|Withdrawal by Subject|0|||
162996231|NCT02463357|588686777|FG004|Overall Study|Withdrawal by Subject|0|||
162996232|NCT02463357|588686773|FG000|Overall Study|Withdrawal by Subject|0|||
162996233|NCT02463357|588686774|FG001|Overall Study|Withdrawal by Subject|0|||
162996234|NCT02463357|588686775|FG002|Overall Study|Withdrawal by Subject|0|||
162996235|NCT02463357|588686776|FG003|Overall Study|Withdrawal by Subject|0|||
162996236|NCT02463357|588686777|FG004|Overall Study|Withdrawal by Subject|1|||
162996237|NCT02620579|588686778|FG000|Overall Study|Physician Decision|0|||
162996238|NCT02620579|588686779|FG001|Overall Study|Physician Decision|0|||
162996239|NCT02620579|588686780|FG002|Overall Study|Physician Decision|0|||
162996240|NCT02620579|588686781|FG003|Overall Study|Physician Decision|1|||
162996241|NCT02620579|588686778|FG000|Overall Study|Withdrawal by Subject|0|||
162996242|NCT02620579|588686779|FG001|Overall Study|Withdrawal by Subject|1|||
162996243|NCT02620579|588686780|FG002|Overall Study|Withdrawal by Subject|1|||
162996244|NCT02620579|588686781|FG003|Overall Study|Withdrawal by Subject|0|||
162996245|NCT01721317|588686782|FG000|Overall Study|Study Closed / Terminated|2|||
162996246|NCT01721317|588686783|FG001|Overall Study|Study Closed / Terminated|2|||
162996247|NCT01721317|588686782|FG000|Overall Study|Physician Decision|0|||
162996248|NCT01721317|588686783|FG001|Overall Study|Physician Decision|1|||
162996249|NCT01721317|588686782|FG000|Overall Study|Withdrawal by Subject|0|||
162996250|NCT01721317|588686783|FG001|Overall Study|Withdrawal by Subject|1|||
162996251|NCT02661217|588686789|FG000|Overall Study|Physician Decision|12|||
162996252|NCT02661217|588686790|FG001|Overall Study|Physician Decision|15|||
162996253|NCT02661217|588686789|FG000|Overall Study|Lost to Follow-up|1|||
162996254|NCT02661217|588686790|FG001|Overall Study|Lost to Follow-up|4|||
162996255|NCT02661217|588686789|FG000|Overall Study|Protocol Deviation|0|||
162996256|NCT02661217|588686790|FG001|Overall Study|Protocol Deviation|4|||
162996257|NCT02661217|588686789|FG000|Overall Study|Non-compliance with study treatment|5|||
162996258|NCT02661217|588686790|FG001|Overall Study|Non-compliance with study treatment|5|||
162996259|NCT02661217|588686789|FG000|Overall Study|Death|21|||
162996260|NCT02661217|588686790|FG001|Overall Study|Death|15|||
162996261|NCT02661217|588686789|FG000|Overall Study|Adverse Event|10|||
162996262|NCT02661217|588686790|FG001|Overall Study|Adverse Event|8|||
162996263|NCT02661217|588686789|FG000|Overall Study|Withdrawal by Subject|15|||
162996264|NCT02661217|588686790|FG001|Overall Study|Withdrawal by Subject|19|||
162996265|NCT02661217|588686789|FG000|Overall Study|Did not enter follow-up epoch|7|||
162996266|NCT02661217|588686790|FG001|Overall Study|Did not enter follow-up epoch|10|||
162996267|NCT02661217|588686789|FG000|Overall Study|Death - no study drug received|1|||
162996268|NCT02661217|588686790|FG001|Overall Study|Death - no study drug received|2|||
162996269|NCT02661217|588686789|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
162996270|NCT02661217|588686790|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
162996271|NCT00958893|588686791|FG000|Overall Study|Study prematurely terminated|4|||
162996272|NCT00378573|588686793|FG000|Treatment Period|Adverse Event|9|||
162996273|NCT00378573|588686793|FG000|Treatment Period|Physician Decision|1|||
162996274|NCT00378573|588686793|FG000|Treatment Period|Withdrawal by Subject|2|||
162996275|NCT00378573|588686793|FG000|Treatment Period|Disease Progression|4|||
162996276|NCT00378573|588686793|FG000|Treatment Period|Sponsor decision to close study|1|||
162996277|NCT00378573|588686793|FG000|Follow-up|Death|12|||
162996278|NCT00378573|588686793|FG000|Follow-up|Lost to Follow-up|1|||
162996279|NCT00378573|588686793|FG000|Follow-up|Withdrawal by Subject|1|||
162996280|NCT02892149|588686796|FG000|Overall Study|Death|262|||
162996281|NCT02892149|588686797|FG001|Overall Study|Death|278|||
162996282|NCT02892149|588686796|FG000|Overall Study|Withdrawal by Subject|53|||
162996283|NCT02892149|588686797|FG001|Overall Study|Withdrawal by Subject|47|||
162996284|NCT02892149|588686796|FG000|Overall Study|Lost to Follow-up|37|||
162996285|NCT02892149|588686797|FG001|Overall Study|Lost to Follow-up|31|||
162996286|NCT02165735|588686802|FG000|Overall Study|Lost to Follow-up|12|||
162996287|NCT02165735|588686803|FG001|Overall Study|Lost to Follow-up|10|||
162996288|NCT02165735|588686802|FG000|Overall Study|Withdrawal by Subject|3|||
162996289|NCT02165735|588686803|FG001|Overall Study|Withdrawal by Subject|0|||
162996290|NCT02165735|588686802|FG000|Overall Study|Participant indicated lack of time|1|||
162996291|NCT02165735|588686803|FG001|Overall Study|Participant indicated lack of time|3|||
162996292|NCT02165735|588686802|FG000|Overall Study|Protocol Violation|0|||
162996293|NCT02165735|588686803|FG001|Overall Study|Protocol Violation|1|||
162996294|NCT03066258|588686804|FG000|Overall Study|Death|1|||
162996295|NCT03066258|588686805|FG001|Overall Study|Death|0|||
162996296|NCT03066258|588686806|FG002|Overall Study|Death|0|||
162996297|NCT03066258|588686807|FG003|Overall Study|Death|0|||
162996298|NCT03066258|588686808|FG004|Overall Study|Death|1|||
162996299|NCT02784795|588686809|FG000|Overall Study|Progressive Disease|2|||
162996300|NCT02784795|588686810|FG001|Overall Study|Progressive Disease|1|||
162996301|NCT02784795|588686811|FG002|Overall Study|Progressive Disease|1|||
162996302|NCT02784795|588686812|FG003|Overall Study|Progressive Disease|0|||
162996303|NCT02784795|588686813|FG004|Overall Study|Progressive Disease|2|||
162996304|NCT02784795|588686814|FG005|Overall Study|Progressive Disease|0|||
162996305|NCT02784795|588686815|FG006|Overall Study|Progressive Disease|2|||
162996306|NCT02784795|588686816|FG007|Overall Study|Progressive Disease|0|||
162996307|NCT02784795|588686817|FG008|Overall Study|Progressive Disease|0|||
162996308|NCT02784795|588686818|FG009|Overall Study|Progressive Disease|0|||
162996309|NCT02784795|588686819|FG010|Overall Study|Progressive Disease|1|||
162996310|NCT02784795|588686820|FG011|Overall Study|Progressive Disease|0|||
162996311|NCT02784795|588686809|FG000|Overall Study|Adverse Event|1|||
162996312|NCT02784795|588686810|FG001|Overall Study|Adverse Event|0|||
162996313|NCT02784795|588686811|FG002|Overall Study|Adverse Event|0|||
162996314|NCT02784795|588686812|FG003|Overall Study|Adverse Event|1|||
162996315|NCT02784795|588686813|FG004|Overall Study|Adverse Event|0|||
162996316|NCT02784795|588686814|FG005|Overall Study|Adverse Event|0|||
162996317|NCT02784795|588686815|FG006|Overall Study|Adverse Event|1|||
162996318|NCT02784795|588686816|FG007|Overall Study|Adverse Event|0|||
162996319|NCT02784795|588686817|FG008|Overall Study|Adverse Event|0|||
162996320|NCT02784795|588686818|FG009|Overall Study|Adverse Event|0|||
162996321|NCT02784795|588686819|FG010|Overall Study|Adverse Event|0|||
162996322|NCT02784795|588686820|FG011|Overall Study|Adverse Event|2|||
162996323|NCT02784795|588686809|FG000|Overall Study|Withdrawal by Subject|1|||
162996324|NCT02784795|588686810|FG001|Overall Study|Withdrawal by Subject|0|||
162996325|NCT02784795|588686811|FG002|Overall Study|Withdrawal by Subject|2|||
162996326|NCT02784795|588686812|FG003|Overall Study|Withdrawal by Subject|1|||
162996327|NCT02784795|588686813|FG004|Overall Study|Withdrawal by Subject|3|||
162996328|NCT02784795|588686814|FG005|Overall Study|Withdrawal by Subject|0|||
162996329|NCT02784795|588686815|FG006|Overall Study|Withdrawal by Subject|0|||
162996330|NCT02784795|588686816|FG007|Overall Study|Withdrawal by Subject|1|||
162996331|NCT02784795|588686817|FG008|Overall Study|Withdrawal by Subject|0|||
162996332|NCT02784795|588686818|FG009|Overall Study|Withdrawal by Subject|0|||
162996333|NCT02784795|588686819|FG010|Overall Study|Withdrawal by Subject|0|||
162996334|NCT02784795|588686820|FG011|Overall Study|Withdrawal by Subject|2|||
162996335|NCT02784795|588686809|FG000|Overall Study|Death|0|||
162996336|NCT02784795|588686810|FG001|Overall Study|Death|0|||
162996337|NCT02784795|588686811|FG002|Overall Study|Death|0|||
162996338|NCT02784795|588686812|FG003|Overall Study|Death|0|||
162996339|NCT02784795|588686813|FG004|Overall Study|Death|1|||
162996340|NCT02784795|588686814|FG005|Overall Study|Death|0|||
162996341|NCT02784795|588686815|FG006|Overall Study|Death|0|||
162996342|NCT02784795|588686816|FG007|Overall Study|Death|0|||
162996343|NCT02784795|588686817|FG008|Overall Study|Death|0|||
162637082|NCT05582889|587386099|FG001|Overall Study|Lost to Follow-up|4|||
162637083|NCT00001723|587386100|FG000|Overall Study|Lack of Efficacy|6|||
162637084|NCT00001723|587386101|FG001|Overall Study|Lack of Efficacy|7|||
162637085|NCT00001723|587386100|FG000|Overall Study|Lack of family interest|4|||
162637086|NCT00001723|587386101|FG001|Overall Study|Lack of family interest|5|||
162637087|NCT00001723|587386100|FG000|Overall Study|Lost to Follow-up|2|||
162996344|NCT02784795|588686818|FG009|Overall Study|Death|0|||
162996345|NCT02784795|588686819|FG010|Overall Study|Death|0|||
162996346|NCT02784795|588686820|FG011|Overall Study|Death|0|||
162996347|NCT02784795|588686809|FG000|Overall Study|Physician Decision|0|||
162996348|NCT02784795|588686810|FG001|Overall Study|Physician Decision|0|||
162996349|NCT02784795|588686811|FG002|Overall Study|Physician Decision|0|||
162996350|NCT02784795|588686812|FG003|Overall Study|Physician Decision|0|||
162996351|NCT02784795|588686813|FG004|Overall Study|Physician Decision|0|||
162996352|NCT02784795|588686814|FG005|Overall Study|Physician Decision|0|||
162996353|NCT02784795|588686815|FG006|Overall Study|Physician Decision|1|||
162996354|NCT02784795|588686816|FG007|Overall Study|Physician Decision|0|||
162996355|NCT02784795|588686817|FG008|Overall Study|Physician Decision|0|||
162996356|NCT02784795|588686818|FG009|Overall Study|Physician Decision|0|||
162996357|NCT02784795|588686819|FG010|Overall Study|Physician Decision|0|||
162996358|NCT02784795|588686820|FG011|Overall Study|Physician Decision|0|||
162637088|NCT00001723|587386101|FG001|Overall Study|Lost to Follow-up|2|||
162637089|NCT00001723|587386100|FG000|Overall Study|medication intolerance|1|||
162637090|NCT00001723|587386101|FG001|Overall Study|medication intolerance|2|||
162996359|NCT00101283|588686821|FG000|Overall Study|Withdrawal by Subject|0|||
162996360|NCT00101283|588686822|FG001|Overall Study|Withdrawal by Subject|1|||
162996361|NCT00101283|588686821|FG000|Overall Study|Insurance Refusal|0|||
162996362|NCT00101283|588686822|FG001|Overall Study|Insurance Refusal|1|||
162996363|NCT00101283|588686821|FG000|Overall Study|Prostate Cancer Recurrence|0|||
162996364|NCT00101283|588686822|FG001|Overall Study|Prostate Cancer Recurrence|1|||
162996365|NCT00595309|588686823|FG000|Overall Study|Lost to Follow-up|1|||
162996366|NCT00595309|588686823|FG000|Overall Study|planned vaccination against yellow fever|1|||
162996367|NCT00595309|588686823|FG000|Overall Study|acute infection after V0|1|||
162996368|NCT00595309|588686823|FG000|Overall Study|personal reason|1|||
162996369|NCT00252239|588686829|FG000|Overall Study|Withdrawal by Subject|1|||
162996370|NCT00252239|588686830|FG001|Overall Study|Withdrawal by Subject|0|||
162996371|NCT00252239|588686831|FG002|Overall Study|Withdrawal by Subject|0|||
162996372|NCT00252239|588686832|FG003|Overall Study|Withdrawal by Subject|1|||
162996373|NCT00252239|588686829|FG000|Overall Study|Lost to Follow-up|0|||
162996374|NCT00252239|588686830|FG001|Overall Study|Lost to Follow-up|0|||
162996375|NCT00252239|588686831|FG002|Overall Study|Lost to Follow-up|2|||
162996376|NCT00252239|588686832|FG003|Overall Study|Lost to Follow-up|0|||
162996377|NCT02181790|588686837|FG000|Overall Study|study terminated|2|||
162996378|NCT02181790|588686838|FG001|Overall Study|study terminated|0|||
162996379|NCT03276078|588686839|FG000|Overall Study|Adverse Event|1|||
162996380|NCT02785952|588686840|FG000|Overall Study|Adverse Event|31|||
162996381|NCT02785952|588686841|FG001|Overall Study|Adverse Event|19|||
162996382|NCT02785952|588686840|FG000|Overall Study|Refusal unrelated to adverse events|10|||
162996383|NCT02785952|588686841|FG001|Overall Study|Refusal unrelated to adverse events|5|||
162996384|NCT02785952|588686840|FG000|Overall Study|Disease progression/relapse|61|||
162996385|NCT02785952|588686841|FG001|Overall Study|Disease progression/relapse|89|||
162996386|NCT02785952|588686840|FG000|Overall Study|Death|11|||
162996387|NCT02785952|588686841|FG001|Overall Study|Death|7|||
162996388|NCT02785952|588686840|FG000|Overall Study|Other- not protocol specified|6|||
162996389|NCT02785952|588686841|FG001|Overall Study|Other- not protocol specified|4|||
162996390|NCT02785952|588686840|FG000|Overall Study|On protocol treatment|6|||
162996391|NCT02785952|588686841|FG001|Overall Study|On protocol treatment|3|||
162996392|NCT00090363|588686842|FG000|Overall Study|Lost to Follow-up|1|||
162996393|NCT00090363|588686843|FG001|Overall Study|Lost to Follow-up|2|||
162996394|NCT00090363|588686844|FG002|Overall Study|Lost to Follow-up|1|||
162996395|NCT00090363|588686842|FG000|Overall Study|Withdrawal by Subject|7|||
162996396|NCT00090363|588686843|FG001|Overall Study|Withdrawal by Subject|7|||
162996397|NCT00090363|588686844|FG002|Overall Study|Withdrawal by Subject|6|||
162996398|NCT00090363|588686842|FG000|Overall Study|Study-specific discontinuation criteria|75|||
162996399|NCT00090363|588686843|FG001|Overall Study|Study-specific discontinuation criteria|74|||
162996400|NCT00090363|588686844|FG002|Overall Study|Study-specific discontinuation criteria|62|||
162996401|NCT00090363|588686842|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162996402|NCT00090363|588686843|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162996403|NCT00090363|588686844|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162996404|NCT00090363|588686842|FG000|Overall Study|Consent expired|7|||
162996405|NCT00090363|588686843|FG001|Overall Study|Consent expired|10|||
162996406|NCT00090363|588686844|FG002|Overall Study|Consent expired|9|||
162996407|NCT00090363|588686842|FG000|Overall Study|Reasons not specified|2|||
162996408|NCT00090363|588686843|FG001|Overall Study|Reasons not specified|1|||
162996409|NCT00090363|588686844|FG002|Overall Study|Reasons not specified|1|||
162996410|NCT00090363|588686842|FG000|Overall Study|Continuing on study off treatment|14|||
162996411|NCT00090363|588686843|FG001|Overall Study|Continuing on study off treatment|13|||
162996412|NCT00090363|588686844|FG002|Overall Study|Continuing on study off treatment|16|||
162996413|NCT00205803|588686848|FG000|Infant Series|Lost to Follow-up|10|||
162996414|NCT00205803|588686849|FG001|Infant Series|Lost to Follow-up|4|||
162996415|NCT00205803|588686848|FG000|Infant Series|Withdrawal by Subject|2|||
162996416|NCT00205803|588686849|FG001|Infant Series|Withdrawal by Subject|5|||
162996417|NCT00205803|588686848|FG000|Infant Series|Physician Decision|3|||
162996418|NCT00205803|588686849|FG001|Infant Series|Physician Decision|1|||
162996419|NCT00205803|588686848|FG000|Infant Series|Protocol Violation|1|||
162996420|NCT00205803|588686849|FG001|Infant Series|Protocol Violation|0|||
162996421|NCT00205803|588686848|FG000|Infant Series|Lost Kaiser coverage|0|||
162996422|NCT00205803|588686849|FG001|Infant Series|Lost Kaiser coverage|1|||
162996423|NCT00205803|588686848|FG000|Infant Series|Non-compliant|1|||
162996424|NCT00205803|588686849|FG001|Infant Series|Non-compliant|0|||
162996425|NCT00205803|588686848|FG000|Infant Series|Sponsor request|1|||
162996426|NCT00205803|588686849|FG001|Infant Series|Sponsor request|0|||
162996427|NCT00205803|588686848|FG000|After Infant Series|Adverse Event|1|||
162996428|NCT00205803|588686849|FG001|After Infant Series|Adverse Event|1|||
162996429|NCT00205803|588686848|FG000|After Infant Series|Protocol Violation|1|||
162996430|NCT00205803|588686849|FG001|After Infant Series|Protocol Violation|1|||
162996431|NCT00205803|588686848|FG000|After Infant Series|Lost to Follow-up|2|||
162996432|NCT00205803|588686849|FG001|After Infant Series|Lost to Follow-up|1|||
162996433|NCT00205803|588686848|FG000|After Infant Series|Physician Decision|3|||
163060360|NCT01649765|588929869|FG001|Overall Study|Lack of Efficacy|1|||
163060361|NCT01649765|588929868|FG000|Overall Study|Physician Decision|0|||
163060362|NCT01649765|588929869|FG001|Overall Study|Physician Decision|3|||
163060363|NCT01649765|588929868|FG000|Overall Study|Protocol Violation|1|||
163060364|NCT01649765|588929869|FG001|Overall Study|Protocol Violation|0|||
162996434|NCT00205803|588686849|FG001|After Infant Series|Physician Decision|2|||
162996435|NCT00205803|588686848|FG000|After Infant Series|Withdrawal by Subject|1|||
162996436|NCT00205803|588686849|FG001|After Infant Series|Withdrawal by Subject|4|||
162996437|NCT00205803|588686848|FG000|After Infant Series|Other|10|||
162996438|NCT00205803|588686849|FG001|After Infant Series|Other|4|||
162996439|NCT00205803|588686848|FG000|Toddler Dose|Lost to Follow-up|2|||
162996440|NCT00205803|588686849|FG001|Toddler Dose|Lost to Follow-up|3|||
162996441|NCT02478320|588686851|FG000|Overall Study|Adverse Event|2|||
162996442|NCT02478320|588686852|FG001|Overall Study|Adverse Event|0|||
162996443|NCT02478320|588686851|FG000|Overall Study|Death|1|||
162996444|NCT02478320|588686852|FG001|Overall Study|Death|0|||
162996445|NCT02478320|588686851|FG000|Overall Study|Lack of Efficacy|4|||
162996446|NCT02478320|588686852|FG001|Overall Study|Lack of Efficacy|0|||
162996447|NCT02478320|588686851|FG000|Overall Study|Withdrawal by Subject|2|||
162996448|NCT02478320|588686852|FG001|Overall Study|Withdrawal by Subject|0|||
162996449|NCT02478320|588686851|FG000|Overall Study|Screen Failure|3|||
162996450|NCT02478320|588686852|FG001|Overall Study|Screen Failure|0|||
162996451|NCT02847260|588688035|FG000|Overall Study|Adverse Event|3|||
162996452|NCT02847260|588688035|FG000|Overall Study|Withdrawal by Subject|2|||
162996453|NCT02847260|588688035|FG000|Overall Study|Clinical Deterioration|1|||
162996454|NCT02847260|588688035|FG000|Overall Study|Physician Decision|1|||
162996455|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
162996456|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
162996457|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
162996458|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
162996459|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
162996460|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996461|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996462|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996463|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996464|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
162996465|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
162996466|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
162996467|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
162996468|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
162996469|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
162996470|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996471|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996472|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996473|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996474|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
162996475|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
162996476|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
162996477|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
162996478|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
162996479|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
162996480|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996481|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996482|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996483|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
162996484|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
163060365|NCT01649765|588929868|FG000|Overall Study|Withdrawal by Subject|2|||
163060366|NCT01649765|588929869|FG001|Overall Study|Withdrawal by Subject|1|||
163060367|NCT02469233|588929870|FG000|Overall Study|Death|1|||
163060368|NCT02469233|588929871|FG001|Overall Study|Death|1|||
162996485|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
162996486|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
162996487|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
162996488|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
162996489|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
162996490|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996491|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996492|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
163060369|NCT02469233|588929870|FG000|Overall Study|Lost to post or 6 month follow up|7|||
163060370|NCT02469233|588929871|FG001|Overall Study|Lost to post or 6 month follow up|2|||
162996493|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
162996494|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
163060371|NCT04889040|588929872|FG000|Overall Study|Withdrawal by Subject|3|||
162996495|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996496|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996497|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996498|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
162996499|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996500|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996501|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996502|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996503|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996504|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
162996505|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
162996506|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
162996507|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
162996508|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
162996509|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
162996510|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996511|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996512|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996513|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996514|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
162996515|NCT03104400|588688036|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996516|NCT03104400|588688037|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996517|NCT03104400|588688038|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996518|NCT03104400|588688039|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
162996519|NCT03104400|588688040|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996520|NCT03104400|588688041|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996521|NCT03104400|588688042|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996522|NCT03104400|588688043|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996523|NCT03104400|588688044|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996524|NCT03104400|588688045|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
162996525|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
162996526|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
162996527|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
162996528|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
162996529|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
162996530|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
162996531|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
162996532|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
162996533|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
162996534|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
162996535|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996536|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996537|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996538|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996539|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
162996540|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
162996541|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
162996542|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
162996543|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
162996544|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
162637091|NCT02170051|587386102|FG000|Overall Study|Withdrawal by Subject|10|||
162637092|NCT02170051|587386103|FG001|Overall Study|Withdrawal by Subject|10|||
162996545|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996546|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996547|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996548|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996549|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
162996550|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
162996551|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
162996552|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
162996553|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
162996554|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
162996555|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996556|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996557|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996558|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996559|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
162996560|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
162996561|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
162996562|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
162637093|NCT02170051|587386102|FG000|Overall Study|Lost to Follow-up|1|||
162996563|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
162996564|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
162996565|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996566|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996567|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996568|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996569|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996570|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996571|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
162996572|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
162996573|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
162996574|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
162996575|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996576|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996577|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996578|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996579|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996580|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996581|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996582|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
162996583|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
162996584|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
162996585|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
162996586|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
162996587|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
162996588|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
162996589|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
162996590|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
162996591|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
162996592|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
162996593|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
162996594|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
162996595|NCT03104400|588688036|FG000|Period 2 Week 56 - 260)|Other|0|||
162996596|NCT03104400|588688037|FG001|Period 2 Week 56 - 260)|Other|0|||
162996597|NCT03104400|588688038|FG002|Period 2 Week 56 - 260)|Other|0|||
162996598|NCT03104400|588688039|FG003|Period 2 Week 56 - 260)|Other|0|||
162996599|NCT03104400|588688040|FG004|Period 2 Week 56 - 260)|Other|0|||
162996600|NCT03104400|588688041|FG005|Period 2 Week 56 - 260)|Other|0|||
162996601|NCT03104400|588688042|FG006|Period 2 Week 56 - 260)|Other|0|||
162996602|NCT03104400|588688043|FG007|Period 2 Week 56 - 260)|Other|0|||
162996603|NCT03104400|588688044|FG008|Period 2 Week 56 - 260)|Other|1|||
162996604|NCT03104400|588688045|FG009|Period 2 Week 56 - 260)|Other|1|||
162996605|NCT00129389|588688048|FG000|Overall Study|Adverse Event|19|||
162996606|NCT00129389|588688049|FG001|Overall Study|Adverse Event|87|||
162996607|NCT00129389|588688048|FG000|Overall Study|Death|0|||
162996608|NCT00129389|588688049|FG001|Overall Study|Death|1|||
162996609|NCT00129389|588688048|FG000|Overall Study|Lost to Follow-up|2|||
162996610|NCT00129389|588688049|FG001|Overall Study|Lost to Follow-up|1|||
162996611|NCT00129389|588688048|FG000|Overall Study|Physician Decision|0|||
162996612|NCT00129389|588688049|FG001|Overall Study|Physician Decision|4|||
162996613|NCT00129389|588688048|FG000|Overall Study|Protocol Violation|0|||
162996614|NCT00129389|588688049|FG001|Overall Study|Protocol Violation|6|||
162996615|NCT00129389|588688048|FG000|Overall Study|Withdrawal by Subject|9|||
162996616|NCT00129389|588688049|FG001|Overall Study|Withdrawal by Subject|23|||
162996617|NCT00129389|588688048|FG000|Overall Study|Relapse|1|||
162996618|NCT00129389|588688049|FG001|Overall Study|Relapse|0|||
162996619|NCT00129389|588688048|FG000|Overall Study|Not eligible|1|||
162996620|NCT00129389|588688049|FG001|Overall Study|Not eligible|2|||
162996621|NCT00129389|588688048|FG000|Overall Study|Crossed to the other arm|1|||
162996622|NCT00129389|588688049|FG001|Overall Study|Crossed to the other arm|16|||
162996623|NCT01191944|588688053|FG000|Overall Study|Adverse Event|11|||
162996624|NCT01191944|588688054|FG001|Overall Study|Adverse Event|12|||
162996625|NCT01191944|588688053|FG000|Overall Study|Protocol Violation|1|||
162996626|NCT01191944|588688054|FG001|Overall Study|Protocol Violation|2|||
162996627|NCT01191944|588688053|FG000|Overall Study|Withdrawal by Subject|4|||
162996628|NCT01191944|588688054|FG001|Overall Study|Withdrawal by Subject|2|||
162996629|NCT01191944|588688053|FG000|Overall Study|Other|1|||
162996630|NCT01191944|588688054|FG001|Overall Study|Other|3|||
162996631|NCT02794246|588688059|FG000|Overall Study|Withdrawal by Subject|2|||
162996632|NCT02794246|588688059|FG000|Overall Study|Physician Decision|4|||
162996633|NCT04602546|588688060|FG000|Overall Study|Training|2|||
162996634|NCT04602546|588688061|FG001|Overall Study|Training|2|||
162996635|NCT04602546|588688062|FG002|Overall Study|Training|1|||
162996636|NCT04602546|588688063|FG003|Overall Study|Training|2|||
162996637|NCT04602546|588688064|FG004|Overall Study|Training|0|||
162996638|NCT04602546|588688060|FG000|Overall Study|Randomized with disqualified data|2|||
162996639|NCT04602546|588688061|FG001|Overall Study|Randomized with disqualified data|0|||
162996640|NCT04602546|588688062|FG002|Overall Study|Randomized with disqualified data|2|||
162996641|NCT04602546|588688063|FG003|Overall Study|Randomized with disqualified data|5|||
162996642|NCT04602546|588688064|FG004|Overall Study|Randomized with disqualified data|3|||
162996643|NCT01831258|588688066|FG000|Overall Study|Withdrawal by Subject|2|||
162996644|NCT01831258|588688067|FG001|Overall Study|Withdrawal by Subject|1|||
162996645|NCT01831258|588688066|FG000|Overall Study|Lost to Follow-up|3|||
162996646|NCT01831258|588688067|FG001|Overall Study|Lost to Follow-up|2|||
162996647|NCT01753297|588688072|FG000|Overall Study|Lost to Follow-up|7|||
162996648|NCT01753297|588688073|FG001|Overall Study|Lost to Follow-up|2|||
162996649|NCT01753297|588688072|FG000|Overall Study|Withdrawal by Subject|26|||
162996650|NCT01753297|588688073|FG001|Overall Study|Withdrawal by Subject|23|||
162996651|NCT01753297|588688072|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
162996652|NCT01753297|588688073|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
162996653|NCT01753297|588688072|FG000|Overall Study|Death|0|||
162996654|NCT01753297|588688073|FG001|Overall Study|Death|2|||
162996655|NCT01753297|588688072|FG000|Overall Study|Did not attend end of study visit|7|||
162996656|NCT01753297|588688073|FG001|Overall Study|Did not attend end of study visit|8|||
162996657|NCT02533180|588688074|FG000|Overall Study|Death|0|||
162996658|NCT02533180|588688075|FG001|Overall Study|Death|2|||
162996659|NCT02533180|588688074|FG000|Overall Study|Lost to Follow-up|0|||
162996660|NCT02533180|588688075|FG001|Overall Study|Lost to Follow-up|1|||
162996661|NCT02533180|588688074|FG000|Overall Study|Physician Decision|0|||
162996662|NCT02533180|588688075|FG001|Overall Study|Physician Decision|1|||
162996663|NCT02533180|588688074|FG000|Overall Study|Withdrawal by Subject|2|||
162996664|NCT02533180|588688075|FG001|Overall Study|Withdrawal by Subject|5|||
162996665|NCT02533180|588688074|FG000|Overall Study|Screen Failure|37|||
162996666|NCT02533180|588688075|FG001|Overall Study|Screen Failure|0|||
162996667|NCT02533180|588688074|FG000|Overall Study|Protocol Deviation|0|||
162996668|NCT02533180|588688075|FG001|Overall Study|Protocol Deviation|1|||
162996669|NCT02533180|588688074|FG000|Overall Study|Non-compliance|0|||
162996670|NCT02533180|588688075|FG001|Overall Study|Non-compliance|1|||
162996671|NCT01174043|588688077|FG000|Overall Study|Disease progression|5|||
162996672|NCT01174043|588688077|FG000|Overall Study|Adverse Event|3|||
162996673|NCT01174043|588688077|FG000|Overall Study|Death|1|||
162996674|NCT01174043|588688077|FG000|Overall Study|Withdrawal by Subject|2|||
162996675|NCT00794339|588688082|FG000|Overall Study|Withdrawal by Subject|3|||
162996676|NCT00794339|588688082|FG000|Overall Study|Ineligible|4|||
162996677|NCT00794339|588688082|FG000|Overall Study|Tx prior to ATSM|3|||
162996678|NCT00794339|588688082|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
162996679|NCT00794339|588688082|FG000|Overall Study|Tx not per protocol|1|||
162996680|NCT01118975|588688087|FG000|Overall Study|Adverse Event|0|||
162996681|NCT01118975|588688088|FG001|Overall Study|Adverse Event|1|||
162996682|NCT01371539|588688091|FG000|Period One: One Week|Lost to Follow-up|0|||
162996683|NCT01371539|588688092|FG001|Period One: One Week|Lost to Follow-up|1|||
162996684|NCT01371539|588688091|FG000|Period Two: One Week|Lost to Follow-up|0|||
162996685|NCT01371539|588688092|FG001|Period Two: One Week|Lost to Follow-up|1|||
162996686|NCT01371539|588688091|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
162996687|NCT01371539|588688092|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
162996688|NCT01371539|588688091|FG000|Period Two: One Week|Time/job conflict|0|||
162996689|NCT01371539|588688092|FG001|Period Two: One Week|Time/job conflict|1|||
162996690|NCT01399658|588688093|FG000|Overall Study|Ineligible|1|||
162996691|NCT01399658|588688093|FG000|Overall Study|Machine Technical Issue|3|||
162996692|NCT01399658|588688093|FG000|Overall Study|Alternative therapy|1|||
162996693|NCT01399658|588688093|FG000|Overall Study|No reason given|1|||
162996694|NCT04315506|588688097|FG000|Overall Study|Lost to Follow-up|74|||
162996695|NCT04315506|588688098|FG001|Overall Study|Lost to Follow-up|82|||
162996696|NCT04315506|588688097|FG000|Overall Study|Withdrawal by Subject|8|||
162996697|NCT04315506|588688098|FG001|Overall Study|Withdrawal by Subject|8|||
162996698|NCT04315506|588688097|FG000|Overall Study|Physician Decision|0|||
162996699|NCT04315506|588688098|FG001|Overall Study|Physician Decision|1|||
162996700|NCT02756208|588688102|FG000|Overall Study|Withdrawal by Subject|1|||
162996701|NCT02756208|588688103|FG001|Overall Study|Withdrawal by Subject|0|||
162996702|NCT02756208|588688104|FG002|Overall Study|Withdrawal by Subject|1|||
162996703|NCT02756208|588688105|FG003|Overall Study|Withdrawal by Subject|3|||
162996704|NCT02756208|588688102|FG000|Overall Study|Lost to Follow-up|3|||
162996705|NCT02756208|588688103|FG001|Overall Study|Lost to Follow-up|1|||
162996706|NCT02756208|588688104|FG002|Overall Study|Lost to Follow-up|1|||
162996707|NCT02756208|588688105|FG003|Overall Study|Lost to Follow-up|1|||
162996708|NCT02756208|588688102|FG000|Overall Study|Physician Decision|1|||
162996709|NCT02756208|588688103|FG001|Overall Study|Physician Decision|0|||
162996710|NCT02756208|588688104|FG002|Overall Study|Physician Decision|0|||
162996711|NCT02756208|588688105|FG003|Overall Study|Physician Decision|0|||
162996712|NCT02756208|588688102|FG000|Overall Study|Protocol Violation|0|||
162996713|NCT02756208|588688103|FG001|Overall Study|Protocol Violation|1|||
162996714|NCT02756208|588688104|FG002|Overall Study|Protocol Violation|0|||
162996715|NCT02756208|588688105|FG003|Overall Study|Protocol Violation|0|||
162996716|NCT03485365|588688106|FG000|Overall Study|Protocol Violation|0|||
162996717|NCT03485365|588688107|FG001|Overall Study|Protocol Violation|0|||
162996718|NCT03485365|588688108|FG002|Overall Study|Protocol Violation|0|||
162996719|NCT03485365|588688109|FG003|Overall Study|Protocol Violation|1|||
162996720|NCT03485365|588688110|FG004|Overall Study|Protocol Violation|0|||
162996721|NCT03485365|588688111|FG005|Overall Study|Protocol Violation|0|||
162996722|NCT03485365|588688112|FG006|Overall Study|Protocol Violation|1|||
162996723|NCT03485365|588688113|FG007|Overall Study|Protocol Violation|0|||
162996724|NCT03485365|588688114|FG008|Overall Study|Protocol Violation|0|||
162996725|NCT01275430|588688120|FG000|Overall Study|Adverse Event|1|||
162996726|NCT01275430|588688120|FG000|Overall Study|No Contrast Injection|6|||
162996727|NCT01275430|588688120|FG000|Overall Study|Device Malfunction|1|||
162996728|NCT01275430|588688120|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
162996729|NCT04988087|588688121|FG000|Overall Study|Adverse Event|4|||
162996730|NCT04988087|588688122|FG001|Overall Study|Adverse Event|0|||
162996731|NCT04988087|588688123|FG002|Overall Study|Adverse Event|0|||
162996732|NCT04988087|588688124|FG003|Overall Study|Adverse Event|0|||
162996733|NCT04988087|588688121|FG000|Overall Study|Withdrawal by Subject|1|||
162996734|NCT04988087|588688122|FG001|Overall Study|Withdrawal by Subject|1|||
162996735|NCT04988087|588688123|FG002|Overall Study|Withdrawal by Subject|0|||
162996736|NCT04988087|588688124|FG003|Overall Study|Withdrawal by Subject|0|||
162996737|NCT04988087|588688121|FG000|Overall Study|Technical problems|7|||
162996738|NCT04988087|588688122|FG001|Overall Study|Technical problems|9|||
162996739|NCT04988087|588688123|FG002|Overall Study|Technical problems|1|||
162996740|NCT04988087|588688124|FG003|Overall Study|Technical problems|2|||
162996741|NCT02613182|588688125|FG000|Overall Study|Death|6|||
162996742|NCT02613182|588688125|FG000|Overall Study|Physician Decision|1|||
162996743|NCT02613182|588688125|FG000|Overall Study|Study Terminated by Sponsor|21|||
162996744|NCT02613182|588688125|FG000|Overall Study|Withdrawal by Subject|6|||
162996745|NCT03968978|588688126|FG000|Overall Study|Adverse Event|1|||
162996746|NCT03968978|588688127|FG001|Overall Study|Adverse Event|0|||
162996747|NCT00863772|588688128|FG000|Overall Study|Adverse Event|1|||
162996748|NCT00863772|588688129|FG001|Overall Study|Adverse Event|4|||
162996749|NCT00863772|588688130|FG002|Overall Study|Adverse Event|0|||
162996750|NCT00863772|588688128|FG000|Overall Study|Lack of Efficacy|4|||
162996751|NCT00863772|588688129|FG001|Overall Study|Lack of Efficacy|2|||
162996752|NCT00863772|588688130|FG002|Overall Study|Lack of Efficacy|4|||
162996753|NCT00863772|588688128|FG000|Overall Study|Lost to Follow-up|5|||
162996754|NCT00863772|588688129|FG001|Overall Study|Lost to Follow-up|1|||
162996755|NCT00863772|588688130|FG002|Overall Study|Lost to Follow-up|1|||
162996756|NCT00863772|588688128|FG000|Overall Study|Protocol Violation|2|||
162996757|NCT00863772|588688129|FG001|Overall Study|Protocol Violation|0|||
162996758|NCT00863772|588688130|FG002|Overall Study|Protocol Violation|2|||
162996759|NCT00863772|588688128|FG000|Overall Study|Withdrawal by Subject|4|||
162996760|NCT00863772|588688129|FG001|Overall Study|Withdrawal by Subject|7|||
162996761|NCT00863772|588688130|FG002|Overall Study|Withdrawal by Subject|5|||
162996762|NCT00863772|588688128|FG000|Overall Study|Study terminated by sponsor|44|||
162996763|NCT00863772|588688129|FG001|Overall Study|Study terminated by sponsor|45|||
162996764|NCT00863772|588688130|FG002|Overall Study|Study terminated by sponsor|36|||
162996765|NCT00863772|588688128|FG000|Overall Study|Entered extension study|6|||
162996766|NCT00863772|588688129|FG001|Overall Study|Entered extension study|4|||
162996767|NCT00863772|588688130|FG002|Overall Study|Entered extension study|9|||
162996768|NCT00863772|588688128|FG000|Overall Study|Other|1|||
162996769|NCT00863772|588688129|FG001|Overall Study|Other|2|||
162996770|NCT00863772|588688130|FG002|Overall Study|Other|4|||
163060372|NCT04889040|588929873|FG001|Overall Study|Withdrawal by Subject|3|||
162996771|NCT00863772|588688128|FG000|Overall Study|Randomized but not Treated|1|||
162996772|NCT00863772|588688129|FG001|Overall Study|Randomized but not Treated|0|||
162996773|NCT00863772|588688130|FG002|Overall Study|Randomized but not Treated|0|||
162996774|NCT05038800|588688132|FG000|Overall Study|Death|1|||
162996775|NCT05038800|588688133|FG001|Overall Study|Death|1|||
162996776|NCT05038800|588688134|FG002|Overall Study|Death|5|||
162996777|NCT05038800|588688135|FG003|Overall Study|Death|3|||
162996778|NCT05038800|588688136|FG004|Overall Study|Death|1|||
162996779|NCT05038800|588688132|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996780|NCT05038800|588688133|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996781|NCT05038800|588688134|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996782|NCT05038800|588688135|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162996783|NCT05038800|588688136|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162996784|NCT05038800|588688132|FG000|Overall Study|Lack of Efficacy|0|||
162996785|NCT05038800|588688133|FG001|Overall Study|Lack of Efficacy|0|||
162996786|NCT05038800|588688134|FG002|Overall Study|Lack of Efficacy|0|||
162996787|NCT05038800|588688135|FG003|Overall Study|Lack of Efficacy|0|||
162996788|NCT05038800|588688136|FG004|Overall Study|Lack of Efficacy|1|||
162996789|NCT00121134|588688137|FG000|Overall Study|Progression of Disease|5|||
162996790|NCT00121134|588688138|FG001|Overall Study|Progression of Disease|3|||
162996791|NCT00121134|588688139|FG002|Overall Study|Progression of Disease|4|||
162996792|NCT00121134|588688140|FG003|Overall Study|Progression of Disease|2|||
162996793|NCT00121134|588688137|FG000|Overall Study|Toxicity|4|||
163060373|NCT04889040|588929872|FG000|Overall Study|Lost to Follow-up|0|||
163060374|NCT04889040|588929873|FG001|Overall Study|Lost to Follow-up|1|||
163060375|NCT04889040|588929872|FG000|Overall Study|Adverse Event|2|||
162996794|NCT00121134|588688138|FG001|Overall Study|Toxicity|7|||
162996795|NCT00121134|588688139|FG002|Overall Study|Toxicity|13|||
162996796|NCT00121134|588688140|FG003|Overall Study|Toxicity|5|||
162996797|NCT00121134|588688137|FG000|Overall Study|Physician Decision|6|||
162996798|NCT00121134|588688138|FG001|Overall Study|Physician Decision|4|||
162996799|NCT00121134|588688139|FG002|Overall Study|Physician Decision|4|||
162996800|NCT00121134|588688140|FG003|Overall Study|Physician Decision|1|||
162996801|NCT00121134|588688137|FG000|Overall Study|Treatment Delay|1|||
162996802|NCT00121134|588688138|FG001|Overall Study|Treatment Delay|0|||
162996803|NCT00121134|588688139|FG002|Overall Study|Treatment Delay|0|||
162996804|NCT00121134|588688140|FG003|Overall Study|Treatment Delay|0|||
162996805|NCT00121134|588688137|FG000|Overall Study|Intercurrent Illness|0|||
162996806|NCT00121134|588688138|FG001|Overall Study|Intercurrent Illness|0|||
162996807|NCT00121134|588688139|FG002|Overall Study|Intercurrent Illness|0|||
163060376|NCT04889040|588929873|FG001|Overall Study|Adverse Event|1|||
162996808|NCT00121134|588688140|FG003|Overall Study|Intercurrent Illness|1|||
162996809|NCT00121134|588688137|FG000|Overall Study|Patient Personal Reasons|0|||
162996810|NCT00121134|588688138|FG001|Overall Study|Patient Personal Reasons|1|||
162996811|NCT00121134|588688139|FG002|Overall Study|Patient Personal Reasons|0|||
162996812|NCT00121134|588688140|FG003|Overall Study|Patient Personal Reasons|0|||
162996813|NCT04400682|588688148|FG000|Period 1|Withdrawal by Subject|1|||
162996814|NCT04400682|588688149|FG001|Period 1|Withdrawal by Subject|4|||
162996815|NCT02105974|588688150|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
162996816|NCT02105974|588688151|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
162996817|NCT02105974|588688152|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
162996818|NCT02105974|588688150|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
162996819|NCT02105974|588688151|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
162996820|NCT02105974|588688152|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
162996821|NCT02105974|588688150|FG000|2 Week Run-in Period|Adverse Event|6|||
162996822|NCT02105974|588688151|FG001|2 Week Run-in Period|Adverse Event|0|||
162996823|NCT02105974|588688152|FG002|2 Week Run-in Period|Adverse Event|0|||
162996824|NCT02105974|588688150|FG000|2 Week Run-in Period|Study closed/terminated|1|||
162996825|NCT02105974|588688151|FG001|2 Week Run-in Period|Study closed/terminated|0|||
162996826|NCT02105974|588688152|FG002|2 Week Run-in Period|Study closed/terminated|0|||
162996827|NCT02105974|588688150|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
162996828|NCT02105974|588688151|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
162996829|NCT02105974|588688152|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
162996830|NCT02105974|588688150|FG000|2 Week Run-in Period|Withdrew consent|23|||
162996831|NCT02105974|588688151|FG001|2 Week Run-in Period|Withdrew consent|0|||
162996832|NCT02105974|588688152|FG002|2 Week Run-in Period|Withdrew consent|0|||
162996833|NCT02105974|588688150|FG000|2 Week Run-in Period|Investigator discretion|8|||
162996834|NCT02105974|588688151|FG001|2 Week Run-in Period|Investigator discretion|0|||
162996835|NCT02105974|588688152|FG002|2 Week Run-in Period|Investigator discretion|0|||
162996836|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
162996837|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
162996838|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
162996839|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
162996840|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
162996841|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
162996842|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
162996843|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
162996844|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
162996845|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
162996846|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
162996847|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
162996848|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
162637094|NCT02170051|587386103|FG001|Overall Study|Lost to Follow-up|3|||
162637095|NCT04551092|587386104|FG000|Overall Study|Lost to Follow-up|7|||
162637096|NCT04551092|587386104|FG000|Overall Study|Withdrawal by Subject|4|||
162996849|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
162996850|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
162996851|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
162996852|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
162996853|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
162996854|NCT02105974|588688150|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
162996855|NCT02105974|588688151|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
162996856|NCT02105974|588688152|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
163060377|NCT00855582|588929878|FG000|Overall Study|Adverse Event|2|||
162637097|NCT01324999|587386105|FG000|Overall Study|Adverse Event|3|||
162996857|NCT03597464|588688153|FG000|Overall Study|Withdrawal by Subject|4|||
162996858|NCT03597464|588688154|FG001|Overall Study|Withdrawal by Subject|5|||
162996859|NCT03597464|588688153|FG000|Overall Study|Lost to Follow-up|3|||
162996860|NCT03597464|588688154|FG001|Overall Study|Lost to Follow-up|1|||
162996861|NCT03597464|588688153|FG000|Overall Study|Pregnancy|3|||
162996862|NCT03597464|588688154|FG001|Overall Study|Pregnancy|1|||
162996863|NCT03597464|588688153|FG000|Overall Study|Lack of Efficacy|2|||
162996864|NCT03597464|588688154|FG001|Overall Study|Lack of Efficacy|0|||
162996865|NCT03597464|588688153|FG000|Overall Study|Physician Decision|2|||
162996866|NCT03597464|588688154|FG001|Overall Study|Physician Decision|2|||
162996867|NCT03597464|588688153|FG000|Overall Study|Protocol Violation|1|||
162996868|NCT03597464|588688154|FG001|Overall Study|Protocol Violation|1|||
162996869|NCT03597464|588688153|FG000|Overall Study|Adverse Event|0|||
162996870|NCT03597464|588688154|FG001|Overall Study|Adverse Event|2|||
162996871|NCT03597464|588688153|FG000|Overall Study|Death|0|||
162996872|NCT03597464|588688154|FG001|Overall Study|Death|3|||
162996873|NCT03316547|588688162|FG000|Overall Study|Death|3|||
162996874|NCT03316547|588688163|FG001|Overall Study|Death|1|||
162996875|NCT03316547|588688162|FG000|Overall Study|Lost to Follow-up|6|||
162996876|NCT03316547|588688163|FG001|Overall Study|Lost to Follow-up|6|||
162996877|NCT03316547|588688162|FG000|Overall Study|Withdrawal by Subject|3|||
162996878|NCT03316547|588688163|FG001|Overall Study|Withdrawal by Subject|2|||
162996879|NCT03316547|588688162|FG000|Overall Study|Transfer to another hospital|6|||
162996880|NCT03316547|588688163|FG001|Overall Study|Transfer to another hospital|4|||
162996881|NCT00447876|588690561|FG000|Overall Study|Withdrawal by Subject|1|||
162996882|NCT00447876|588690562|FG001|Overall Study|Withdrawal by Subject|4|||
162996883|NCT00447876|588690561|FG000|Overall Study|Lost to Follow-up|1|||
162996884|NCT00447876|588690562|FG001|Overall Study|Lost to Follow-up|0|||
163060378|NCT00855582|588929879|FG001|Overall Study|Adverse Event|6|||
162996885|NCT00447876|588690561|FG000|Overall Study|Deterioration of symptomology|1|||
162996886|NCT00447876|588690562|FG001|Overall Study|Deterioration of symptomology|0|||
162996887|NCT04172597|588690563|FG000|Overall Study|Disease Progression|0|||
162996888|NCT04172597|588690564|FG001|Overall Study|Disease Progression|0|||
162996889|NCT04172597|588690565|FG002|Overall Study|Disease Progression|0|||
162996890|NCT04172597|588690566|FG003|Overall Study|Disease Progression|0|||
162996891|NCT04172597|588690567|FG004|Overall Study|Disease Progression|1|||
162996892|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Death|0|||
162996893|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Death|1|||
162996894|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
162996895|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
162996896|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
162996897|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
162996898|NCT02952586|588690571|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
162996899|NCT02952586|588690572|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
162996900|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
162996901|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
162996902|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
162996903|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
162996904|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
162996905|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
162996906|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
162996907|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
163060379|NCT00855582|588929880|FG002|Overall Study|Adverse Event|3|||
163060380|NCT00855582|588929878|FG000|Overall Study|Death|1|||
163060381|NCT00855582|588929879|FG001|Overall Study|Death|0|||
163060382|NCT00855582|588929880|FG002|Overall Study|Death|0|||
162715700|NCT03431350|587667084|FG009|Overall Study|Lost to Follow-up|0|||
162996908|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
162996909|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
162996910|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
162996911|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
162996912|NCT02952586|588690571|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
162996913|NCT02952586|588690572|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
162996914|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Death|3|||
162996915|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Death|8|||
162996916|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
162996917|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
162996918|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
162996919|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
162996920|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
162996921|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
162996922|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
162996923|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
163060383|NCT00855582|588929878|FG000|Overall Study|Lack of Efficacy|1|||
163060384|NCT00855582|588929879|FG001|Overall Study|Lack of Efficacy|3|||
162996924|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
162996925|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
162996926|NCT02952586|588690571|FG000|CRT for Cisplatin (63 Days)|Other|1|||
162996927|NCT02952586|588690572|FG001|CRT for Cisplatin (63 Days)|Other|1|||
162996928|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Death|5|||
162996929|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Death|8|||
162996930|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
162996931|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
162996932|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
162996933|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
162996934|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
162996935|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
162996936|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
162996937|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
162996938|NCT02952586|588690571|FG000|CRT for IMRT (63 Days)|Other|1|||
163060385|NCT00855582|588929880|FG002|Overall Study|Lack of Efficacy|8|||
163060386|NCT00855582|588929878|FG000|Overall Study|Lost to Follow-up|1|||
163060387|NCT00855582|588929879|FG001|Overall Study|Lost to Follow-up|3|||
162996939|NCT02952586|588690572|FG001|CRT for IMRT (63 Days)|Other|0|||
162996940|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Death|17|||
162996941|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Death|11|||
162996942|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
162996943|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
162996944|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
162996945|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
162996946|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
162996947|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
162996948|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
162996949|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
162996950|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
162996951|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
162996952|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
162996953|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
162996954|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
162996955|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
162996956|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Other|2|||
162996957|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Other|1|||
162996958|NCT02952586|588690571|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
162996959|NCT02952586|588690572|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
162996960|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Death|12|||
162996961|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Death|10|||
162996962|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
162996963|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
162996964|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
162996965|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
162996966|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Other|7|||
162996967|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Other|5|||
162996968|NCT02952586|588690571|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
162996969|NCT02952586|588690572|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
162996970|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Death|51|||
162996971|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Death|31|||
162996972|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
162996973|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
162996974|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
162996975|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
162996976|NCT02952586|588690571|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
162996977|NCT02952586|588690572|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
163060388|NCT00855582|588929880|FG002|Overall Study|Lost to Follow-up|1|||
163060389|NCT00855582|588929878|FG000|Overall Study|Physician Decision|0|||
162996978|NCT00492778|588690575|FG000|Overall Study|Ineligible by Pathology Review|8|||
162996979|NCT00492778|588690576|FG001|Overall Study|Ineligible by Pathology Review|1|||
162996980|NCT03717012|588690591|FG000|Overall Study|Due to trial termination|1|||
162996981|NCT03717012|588690592|FG001|Overall Study|Due to trial termination|2|||
162996982|NCT03717012|588690591|FG000|Overall Study|Protocol Violation|0|||
162996983|NCT03717012|588690592|FG001|Overall Study|Protocol Violation|2|||
162996984|NCT03717012|588690591|FG000|Overall Study|Adverse Event|0|||
162996985|NCT03717012|588690592|FG001|Overall Study|Adverse Event|1|||
162996986|NCT03717012|588690591|FG000|Overall Study|Lung transplant|0|||
162996987|NCT03717012|588690592|FG001|Overall Study|Lung transplant|1|||
162996988|NCT00789035|588690593|FG000|Overall Study|Adverse Event|0|||
162996989|NCT00789035|588690594|FG001|Overall Study|Adverse Event|2|||
163060390|NCT00855582|588929879|FG001|Overall Study|Physician Decision|0|||
162996990|NCT00789035|588690595|FG002|Overall Study|Adverse Event|0|||
162996991|NCT00789035|588690596|FG003|Overall Study|Adverse Event|1|||
162996992|NCT00789035|588690597|FG004|Overall Study|Adverse Event|3|||
162996993|NCT00789035|588690593|FG000|Overall Study|Lack of Efficacy|3|||
162996994|NCT00789035|588690594|FG001|Overall Study|Lack of Efficacy|0|||
162996995|NCT00789035|588690595|FG002|Overall Study|Lack of Efficacy|0|||
162996996|NCT00789035|588690596|FG003|Overall Study|Lack of Efficacy|0|||
162996997|NCT00789035|588690597|FG004|Overall Study|Lack of Efficacy|2|||
162996998|NCT00789035|588690593|FG000|Overall Study|Protocol Violation|1|||
162996999|NCT00789035|588690594|FG001|Overall Study|Protocol Violation|0|||
162997000|NCT00789035|588690595|FG002|Overall Study|Protocol Violation|0|||
162997001|NCT00789035|588690596|FG003|Overall Study|Protocol Violation|0|||
162997002|NCT00789035|588690597|FG004|Overall Study|Protocol Violation|0|||
162997003|NCT00789035|588690593|FG000|Overall Study|Withdrawal by Subject|0|||
162997004|NCT00789035|588690594|FG001|Overall Study|Withdrawal by Subject|2|||
162997005|NCT00789035|588690595|FG002|Overall Study|Withdrawal by Subject|0|||
162997006|NCT00789035|588690596|FG003|Overall Study|Withdrawal by Subject|0|||
162997007|NCT00789035|588690597|FG004|Overall Study|Withdrawal by Subject|0|||
162997008|NCT00789035|588690593|FG000|Overall Study|Other reason not defined above|2|||
162997009|NCT00789035|588690594|FG001|Overall Study|Other reason not defined above|3|||
162997010|NCT00789035|588690595|FG002|Overall Study|Other reason not defined above|1|||
162997011|NCT00789035|588690596|FG003|Overall Study|Other reason not defined above|0|||
162997012|NCT00789035|588690597|FG004|Overall Study|Other reason not defined above|1|||
162997013|NCT04414618|588690598|FG000|Overall Study|Death|3|||
162997014|NCT04414618|588690599|FG001|Overall Study|Death|3|||
162997015|NCT04414618|588690598|FG000|Overall Study|Withdrawal by Subject|2|||
162997016|NCT04414618|588690599|FG001|Overall Study|Withdrawal by Subject|1|||
162997017|NCT04414618|588690598|FG000|Overall Study|Lost to Follow-up|2|||
162997018|NCT04414618|588690599|FG001|Overall Study|Lost to Follow-up|3|||
162997019|NCT04414618|588690598|FG000|Overall Study|Physician Decision|1|||
162997020|NCT04414618|588690599|FG001|Overall Study|Physician Decision|0|||
162997021|NCT00658879|588690600|FG000|Overall Study|Protocol Violation|1|||
162997022|NCT02640690|588690601|FG000|Overall Study|Lost to Follow-up|7|||
162997023|NCT02640690|588690602|FG001|Overall Study|Lost to Follow-up|7|||
162997024|NCT02640690|588690601|FG000|Overall Study|Withdrawal by Subject|16|||
162997025|NCT02640690|588690602|FG001|Overall Study|Withdrawal by Subject|20|||
162997026|NCT02640690|588690601|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
162997027|NCT02640690|588690602|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
162997028|NCT01645787|588690603|FG000|Washout (2 Weeks)|Adverse Event|1|||
162997029|NCT01645787|588690604|FG001|Washout (2 Weeks)|Adverse Event|0|||
162997030|NCT02806024|588690606|FG000|Overall Study|Night Delivery|1|||
162997031|NCT02806024|588690607|FG001|Overall Study|Night Delivery|1|||
162997032|NCT02806024|588690606|FG000|Overall Study|DVT during antepartum admission|0|||
162997033|NCT02806024|588690607|FG001|Overall Study|DVT during antepartum admission|1|||
162997034|NCT01098474|588690608|FG000|Active Phase|Other|0|||
162997035|NCT01098474|588690609|FG001|Active Phase|Other|0|||
162997036|NCT01098474|588690610|FG002|Active Phase|Other|3|||
162997037|NCT01098474|588690611|FG003|Active Phase|Other|0|||
162997038|NCT01098474|588690612|FG004|Active Phase|Other|0|||
162997039|NCT01098474|588690613|FG005|Active Phase|Other|0|||
162997040|NCT01098474|588690608|FG000|Active Phase|Withdrawal by Subject|1|||
162997041|NCT01098474|588690609|FG001|Active Phase|Withdrawal by Subject|1|||
162997042|NCT01098474|588690610|FG002|Active Phase|Withdrawal by Subject|2|||
162997043|NCT01098474|588690611|FG003|Active Phase|Withdrawal by Subject|0|||
162997044|NCT01098474|588690612|FG004|Active Phase|Withdrawal by Subject|0|||
162997045|NCT01098474|588690613|FG005|Active Phase|Withdrawal by Subject|0|||
162997046|NCT01098474|588690608|FG000|Active Phase|Lost to Follow-up|1|||
162997047|NCT01098474|588690609|FG001|Active Phase|Lost to Follow-up|0|||
162997048|NCT01098474|588690610|FG002|Active Phase|Lost to Follow-up|0|||
162997049|NCT01098474|588690611|FG003|Active Phase|Lost to Follow-up|0|||
162997050|NCT01098474|588690612|FG004|Active Phase|Lost to Follow-up|0|||
162715701|NCT03431350|587667085|FG010|Overall Study|Lost to Follow-up|0|||
162997051|NCT01098474|588690613|FG005|Active Phase|Lost to Follow-up|0|||
162997052|NCT01098474|588690608|FG000|Follow Up Phase|Travelled out of study area|0|||
162997053|NCT01098474|588690609|FG001|Follow Up Phase|Travelled out of study area|0|||
162997054|NCT01098474|588690610|FG002|Follow Up Phase|Travelled out of study area|0|||
162997055|NCT01098474|588690611|FG003|Follow Up Phase|Travelled out of study area|0|||
162997056|NCT01098474|588690612|FG004|Follow Up Phase|Travelled out of study area|1|||
162997057|NCT01098474|588690613|FG005|Follow Up Phase|Travelled out of study area|0|||
162997058|NCT01098474|588690608|FG000|Follow Up Phase|Other|0|||
162997059|NCT01098474|588690609|FG001|Follow Up Phase|Other|0|||
162997060|NCT01098474|588690610|FG002|Follow Up Phase|Other|0|||
162997061|NCT01098474|588690611|FG003|Follow Up Phase|Other|0|||
162997062|NCT01098474|588690612|FG004|Follow Up Phase|Other|0|||
162997063|NCT01098474|588690613|FG005|Follow Up Phase|Other|4|||
162997064|NCT01098474|588690608|FG000|Follow Up Phase|Withdrawal by Subject|0|||
162997065|NCT01098474|588690609|FG001|Follow Up Phase|Withdrawal by Subject|0|||
162997066|NCT01098474|588690610|FG002|Follow Up Phase|Withdrawal by Subject|0|||
162997067|NCT01098474|588690611|FG003|Follow Up Phase|Withdrawal by Subject|2|||
162997068|NCT01098474|588690612|FG004|Follow Up Phase|Withdrawal by Subject|0|||
162997069|NCT01098474|588690613|FG005|Follow Up Phase|Withdrawal by Subject|1|||
162997070|NCT01098474|588690608|FG000|Follow Up Phase|Lost to Follow-up|0|||
162997071|NCT01098474|588690609|FG001|Follow Up Phase|Lost to Follow-up|0|||
162997072|NCT01098474|588690610|FG002|Follow Up Phase|Lost to Follow-up|0|||
162997073|NCT01098474|588690611|FG003|Follow Up Phase|Lost to Follow-up|0|||
162997074|NCT01098474|588690612|FG004|Follow Up Phase|Lost to Follow-up|1|||
162997075|NCT01098474|588690613|FG005|Follow Up Phase|Lost to Follow-up|0|||
162997076|NCT00711880|588690618|FG000|Overall Study|Adverse Event|11|||
162997077|NCT00711880|588690619|FG001|Overall Study|Adverse Event|2|||
162997078|NCT00711880|588690618|FG000|Overall Study|Patient non-compliance|1|||
162997079|NCT00711880|588690619|FG001|Overall Study|Patient non-compliance|0|||
162997080|NCT00711880|588690618|FG000|Overall Study|Lack of Efficacy|1|||
162997081|NCT00711880|588690619|FG001|Overall Study|Lack of Efficacy|5|||
162997082|NCT00704132|588690620|FG000|Overall Study|Clinical Adverse Experience|1|||
162997083|NCT00704132|588690621|FG001|Overall Study|Clinical Adverse Experience|0|||
162997084|NCT00704132|588690620|FG000|Overall Study|Lack of Efficacy|0|||
162997085|NCT00704132|588690621|FG001|Overall Study|Lack of Efficacy|1|||
162997086|NCT00704132|588690620|FG000|Overall Study|Withdrawal by Subject|0|||
162997087|NCT00704132|588690621|FG001|Overall Study|Withdrawal by Subject|1|||
162997088|NCT00442962|588690622|FG000|Overall Study|Pregnancy|1|||
162997089|NCT00442962|588690622|FG000|Overall Study|Lost to Follow-up|7|||
162997090|NCT04238650|588690623|FG000|Overall Study|Withdrawal by Subject|0|||
162997091|NCT04238650|588690624|FG001|Overall Study|Withdrawal by Subject|1|||
162997092|NCT03348163|588690625|FG000|Overall Study|Withdrawal by Subject|2|||
162997093|NCT03348163|588690626|FG001|Overall Study|Withdrawal by Subject|0|||
162997094|NCT02585778|588690627|FG000|Overall Study|Adverse Event|17|||
162997095|NCT02585778|588690628|FG001|Overall Study|Adverse Event|4|||
162997096|NCT02585778|588690627|FG000|Overall Study|Participant did not wish to continue|9|||
162997097|NCT02585778|588690628|FG001|Overall Study|Participant did not wish to continue|4|||
162997098|NCT02585778|588690627|FG000|Overall Study|Poor compliance to study protocol|0|||
162997099|NCT02585778|588690628|FG001|Overall Study|Poor compliance to study protocol|2|||
162997100|NCT02585778|588690627|FG000|Overall Study|Death|0|||
162997101|NCT02585778|588690628|FG001|Overall Study|Death|1|||
162997102|NCT02585778|588690627|FG000|Overall Study|Randomized but not treated|1|||
162997103|NCT02585778|588690628|FG001|Overall Study|Randomized but not treated|2|||
162997104|NCT02585778|588690627|FG000|Overall Study|Other than specified above|6|||
162997105|NCT02585778|588690628|FG001|Overall Study|Other than specified above|2|||
162997106|NCT05246670|588690631|FG000|Overall Study|Withdrawal by Subject|2|||
162997107|NCT05246670|588690632|FG001|Overall Study|Withdrawal by Subject|3|||
162997108|NCT05246670|588690633|FG002|Overall Study|Withdrawal by Subject|0|||
162997109|NCT05246670|588690634|FG003|Overall Study|Withdrawal by Subject|1|||
162997110|NCT05246670|588690631|FG000|Overall Study|Adverse Event|0|||
162997111|NCT05246670|588690632|FG001|Overall Study|Adverse Event|0|||
162997112|NCT05246670|588690633|FG002|Overall Study|Adverse Event|1|||
162997113|NCT05246670|588690634|FG003|Overall Study|Adverse Event|0|||
162997114|NCT05246670|588690631|FG000|Overall Study|Physician Decision|1|||
162997115|NCT05246670|588690632|FG001|Overall Study|Physician Decision|0|||
162997116|NCT05246670|588690633|FG002|Overall Study|Physician Decision|0|||
162997117|NCT05246670|588690634|FG003|Overall Study|Physician Decision|0|||
162997118|NCT05246670|588690631|FG000|Overall Study|Protocol Violation|1|||
162997119|NCT05246670|588690632|FG001|Overall Study|Protocol Violation|0|||
162637098|NCT01324999|587386105|FG000|Overall Study|Withdrawal by Subject|2|||
162637099|NCT01712490|587386106|FG000|Overall Study|Ongoing|601|||
163060391|NCT00855582|588929880|FG002|Overall Study|Physician Decision|1|||
162637100|NCT01712490|587386107|FG001|Overall Study|Ongoing|586|||
162637101|NCT01712490|587386106|FG000|Overall Study|Other|11|||
162637102|NCT01712490|587386107|FG001|Overall Study|Other|11|||
162997120|NCT05246670|588690633|FG002|Overall Study|Protocol Violation|0|||
162997121|NCT05246670|588690634|FG003|Overall Study|Protocol Violation|0|||
162997122|NCT00356525|588690640|FG000|Overall Study|Progressive Disease|8|||
162997123|NCT00356525|588690641|FG001|Overall Study|Progressive Disease|5|||
162997124|NCT00356525|588690642|FG002|Overall Study|Progressive Disease|4|||
162997125|NCT00356525|588690643|FG003|Overall Study|Progressive Disease|2|||
162997126|NCT00356525|588690640|FG000|Overall Study|Adverse Event|1|||
162997127|NCT00356525|588690641|FG001|Overall Study|Adverse Event|3|||
162997128|NCT00356525|588690642|FG002|Overall Study|Adverse Event|1|||
162997129|NCT00356525|588690643|FG003|Overall Study|Adverse Event|1|||
162637103|NCT01712490|587386106|FG000|Overall Study|Withdrawal by Subject|36|||
162997130|NCT00356525|588690640|FG000|Overall Study|Lost to Follow-up|1|||
162997131|NCT00356525|588690641|FG001|Overall Study|Lost to Follow-up|0|||
162997132|NCT00356525|588690642|FG002|Overall Study|Lost to Follow-up|0|||
162997133|NCT00356525|588690643|FG003|Overall Study|Lost to Follow-up|0|||
162997134|NCT00356525|588690640|FG000|Overall Study|Physician Decision|2|||
162997135|NCT00356525|588690641|FG001|Overall Study|Physician Decision|2|||
162997136|NCT00356525|588690642|FG002|Overall Study|Physician Decision|2|||
162997137|NCT00356525|588690643|FG003|Overall Study|Physician Decision|1|||
162997138|NCT00356525|588690640|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
162997139|NCT00356525|588690641|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
162997140|NCT00356525|588690642|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
162997141|NCT00356525|588690643|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
162997142|NCT00356525|588690640|FG000|Overall Study|Withdrawal by Subject|1|||
162997143|NCT00356525|588690641|FG001|Overall Study|Withdrawal by Subject|1|||
162997144|NCT00356525|588690642|FG002|Overall Study|Withdrawal by Subject|0|||
162997145|NCT00356525|588690643|FG003|Overall Study|Withdrawal by Subject|3|||
162997146|NCT00356525|588690640|FG000|Overall Study|Death|0|||
162997147|NCT00356525|588690641|FG001|Overall Study|Death|0|||
162997148|NCT00356525|588690642|FG002|Overall Study|Death|0|||
162997149|NCT00356525|588690643|FG003|Overall Study|Death|1|||
162997150|NCT00356525|588690640|FG000|Overall Study|Sponsor Decision|0|||
162997151|NCT00356525|588690641|FG001|Overall Study|Sponsor Decision|0|||
162997152|NCT00356525|588690642|FG002|Overall Study|Sponsor Decision|0|||
162997153|NCT00356525|588690643|FG003|Overall Study|Sponsor Decision|1|||
162997154|NCT00652340|588690644|FG000|Overall Study|Had not progressed.|4|||
162997155|NCT00652340|588690645|FG001|Overall Study|Had not progressed.|3|||
162997156|NCT03682107|588690646|FG000|Overall Study|Withdrawal by Subject|0|||
162997157|NCT03682107|588690647|FG001|Overall Study|Withdrawal by Subject|1|||
162997158|NCT03682107|588690648|FG002|Overall Study|Withdrawal by Subject|0|||
162997159|NCT03682107|588690649|FG003|Overall Study|Withdrawal by Subject|0|||
162997160|NCT03682107|588690650|FG004|Overall Study|Withdrawal by Subject|0|||
162997161|NCT00214383|588690653|FG000|Overall Study|Lost to Follow-up|16|||
162997162|NCT00214383|588690654|FG001|Overall Study|Lost to Follow-up|26|||
162997163|NCT04152291|588690655|FG000|Overall Study|Covid-19 restrictions|27|||
162997164|NCT04152291|588690655|FG000|Overall Study|Withdrawal by Subject|3|||
162997165|NCT03597295|588690656|FG000|Overall Study|Death|70|||
162997166|NCT03597295|588690656|FG000|Overall Study|Lost to Follow-up|7|||
162997167|NCT00879411|588690657|FG000|Overall Study|lost to follow-up (non-AE)|162|||
162997168|NCT05124691|588690658|FG000|Phase II|Eligibility criteria|0|||
162997169|NCT05124691|588690659|FG001|Phase II|Eligibility criteria|1|||
162997170|NCT05124691|588690660|FG002|Phase II|Eligibility criteria|0|||
162997171|NCT05124691|588690658|FG000|Phase II|Withdrawal by Subject|6|||
162997172|NCT05124691|588690659|FG001|Phase II|Withdrawal by Subject|2|||
162997173|NCT05124691|588690660|FG002|Phase II|Withdrawal by Subject|3|||
162997174|NCT05124691|588690658|FG000|Phase III|Withdrawal by Subject|6|||
162997175|NCT05124691|588690659|FG001|Phase III|Withdrawal by Subject|4|||
162997176|NCT05124691|588690660|FG002|Phase III|Withdrawal by Subject|4|||
162997177|NCT05124691|588690658|FG000|Phase III|Lost to Follow-up|1|||
162997178|NCT05124691|588690659|FG001|Phase III|Lost to Follow-up|0|||
162997179|NCT05124691|588690660|FG002|Phase III|Lost to Follow-up|0|||
162997180|NCT05211726|588690661|FG000|Overall Study|Withdrawal by Subject|2|||
162997181|NCT05211726|588690662|FG001|Overall Study|Withdrawal by Subject|3|||
162997182|NCT05211726|588690661|FG000|Overall Study|Protocol Violation|0|||
162997183|NCT05211726|588690662|FG001|Overall Study|Protocol Violation|1|||
162997184|NCT01890434|588690663|FG000|Overall Study|Adverse Event|8|||
162997185|NCT01890434|588690663|FG000|Overall Study|PCI at external hospital|1|||
162997186|NCT01890434|588690663|FG000|Overall Study|Assessment discrepancy|1|||
162997187|NCT01890434|588690663|FG000|Overall Study|CRC didn't contact participant for FU|1|||
162997188|NCT01890434|588690663|FG000|Overall Study|Could not get whole set of images|1|||
162997189|NCT01890434|588690663|FG000|Overall Study|Decline to return for GSPECT|1|||
162997190|NCT01890434|588690663|FG000|Overall Study|GSPECT at rest was not done|1|||
162997191|NCT01890434|588690663|FG000|Overall Study|Participant didn't complete MRI|1|||
162997192|NCT01890434|588690663|FG000|Overall Study|Uncontactable by phone|1|||
162997193|NCT01890434|588690663|FG000|Overall Study|Moved out of position|1|||
162997194|NCT01890434|588690663|FG000|Overall Study|Unable to contact|1|||
162997195|NCT01890434|588690663|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
162715702|NCT03431350|587667086|FG011|Overall Study|Lost to Follow-up|0|||
162997196|NCT00428116|588690664|FG000|Overall Study|Death|1|||
162997197|NCT00428116|588690665|FG001|Overall Study|Death|0|||
162997198|NCT00428116|588690664|FG000|Overall Study|Withdrawal by Subject|1|||
162997199|NCT00428116|588690665|FG001|Overall Study|Withdrawal by Subject|0|||
162997200|NCT00428116|588690664|FG000|Overall Study|Lost to Follow-up|1|||
162997201|NCT00428116|588690665|FG001|Overall Study|Lost to Follow-up|0|||
162997202|NCT01038297|588690666|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
162997203|NCT01038297|588690667|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
162997204|NCT01038297|588690668|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
162997205|NCT02257385|588690675|FG000|Overall Study|Adverse Event|12|||
162997206|NCT02257385|588690676|FG001|Overall Study|Adverse Event|8|||
162997207|NCT02257385|588690675|FG000|Overall Study|Lack of Efficacy|1|||
162997208|NCT02257385|588690676|FG001|Overall Study|Lack of Efficacy|2|||
162997209|NCT02257385|588690675|FG000|Overall Study|Protocol Violation|5|||
162997210|NCT02257385|588690676|FG001|Overall Study|Protocol Violation|7|||
162997211|NCT02257385|588690675|FG000|Overall Study|Lost to Follow-up|0|||
162997212|NCT02257385|588690676|FG001|Overall Study|Lost to Follow-up|1|||
162997213|NCT02257385|588690675|FG000|Overall Study|Withdrawal by Subject|4|||
162997214|NCT02257385|588690676|FG001|Overall Study|Withdrawal by Subject|4|||
163060392|NCT00855582|588929878|FG000|Overall Study|Protocol Violation|6|||
162997215|NCT02714426|588690684|FG000|Overall Study|Withdrawal by Subject|2|||
162997216|NCT02714426|588690685|FG001|Overall Study|Withdrawal by Subject|2|||
162997217|NCT01449370|588690689|FG000|Overall Study|Disease Progression|5|||
162997218|NCT01449370|588690690|FG001|Overall Study|Disease Progression|4|||
162997219|NCT01449370|588690691|FG002|Overall Study|Disease Progression|8|||
162997220|NCT01449370|588690692|FG003|Overall Study|Disease Progression|3|||
162997221|NCT01449370|588690693|FG004|Overall Study|Disease Progression|3|||
162997222|NCT01449370|588690694|FG005|Overall Study|Disease Progression|3|||
162997223|NCT01449370|588690695|FG006|Overall Study|Disease Progression|3|||
162715703|NCT03431350|587667075|FG000|Overall Study|Withdrawal by Subject|0|||
162715704|NCT03431350|587667076|FG001|Overall Study|Withdrawal by Subject|0|||
163060393|NCT00855582|588929879|FG001|Overall Study|Protocol Violation|2|||
163060394|NCT00855582|588929880|FG002|Overall Study|Protocol Violation|6|||
162997224|NCT01449370|588690696|FG007|Overall Study|Disease Progression|2|||
162997225|NCT01449370|588690697|FG008|Overall Study|Disease Progression|9|||
162997226|NCT01449370|588690698|FG009|Overall Study|Disease Progression|1|||
162997227|NCT01449370|588690699|FG010|Overall Study|Disease Progression|3|||
162997228|NCT01449370|588690700|FG011|Overall Study|Disease Progression|3|||
162997229|NCT01449370|588690701|FG012|Overall Study|Disease Progression|2|||
162997230|NCT01449370|588690702|FG013|Overall Study|Disease Progression|8|||
162997231|NCT01449370|588690703|FG014|Overall Study|Disease Progression|3|||
162997232|NCT01449370|588690704|FG015|Overall Study|Disease Progression|1|||
162997233|NCT01449370|588690705|FG016|Overall Study|Disease Progression|4|||
162997234|NCT01449370|588690706|FG017|Overall Study|Disease Progression|3|||
162997235|NCT01449370|588690707|FG018|Overall Study|Disease Progression|1|||
162997236|NCT01449370|588690708|FG019|Overall Study|Disease Progression|2|||
162997237|NCT01449370|588690709|FG020|Overall Study|Disease Progression|5|||
162997238|NCT01449370|588690710|FG021|Overall Study|Disease Progression|2|||
162997239|NCT01449370|588690711|FG022|Overall Study|Disease Progression|3|||
162997240|NCT01449370|588690712|FG023|Overall Study|Disease Progression|7|||
162997241|NCT01449370|588690713|FG024|Overall Study|Disease Progression|3|||
162997242|NCT01449370|588690689|FG000|Overall Study|Adverse Event|1|||
162997243|NCT01449370|588690690|FG001|Overall Study|Adverse Event|2|||
162997244|NCT01449370|588690691|FG002|Overall Study|Adverse Event|0|||
162997245|NCT01449370|588690692|FG003|Overall Study|Adverse Event|1|||
162997246|NCT01449370|588690693|FG004|Overall Study|Adverse Event|0|||
162997247|NCT01449370|588690694|FG005|Overall Study|Adverse Event|0|||
162997248|NCT01449370|588690695|FG006|Overall Study|Adverse Event|0|||
162997249|NCT01449370|588690696|FG007|Overall Study|Adverse Event|0|||
162997250|NCT01449370|588690697|FG008|Overall Study|Adverse Event|1|||
163060395|NCT00855582|588929878|FG000|Overall Study|Entry Criteria Not Met|8|||
163060396|NCT00855582|588929879|FG001|Overall Study|Entry Criteria Not Met|6|||
163060397|NCT00855582|588929880|FG002|Overall Study|Entry Criteria Not Met|3|||
163060398|NCT00855582|588929878|FG000|Overall Study|Withdrawal by Subject|7|||
163060399|NCT00855582|588929879|FG001|Overall Study|Withdrawal by Subject|4|||
163060400|NCT00855582|588929880|FG002|Overall Study|Withdrawal by Subject|8|||
163060401|NCT02832037|588929881|FG000|Overall Study|Administrative reasons|0|||
163060402|NCT02832037|588929882|FG001|Overall Study|Administrative reasons|0|||
163060403|NCT02832037|588929883|FG002|Overall Study|Administrative reasons|1|||
162997251|NCT01449370|588690698|FG009|Overall Study|Adverse Event|1|||
162997252|NCT01449370|588690699|FG010|Overall Study|Adverse Event|0|||
162997253|NCT01449370|588690700|FG011|Overall Study|Adverse Event|0|||
162997254|NCT01449370|588690701|FG012|Overall Study|Adverse Event|0|||
162997255|NCT01449370|588690702|FG013|Overall Study|Adverse Event|2|||
162997256|NCT01449370|588690703|FG014|Overall Study|Adverse Event|0|||
162997257|NCT01449370|588690704|FG015|Overall Study|Adverse Event|1|||
162997258|NCT01449370|588690705|FG016|Overall Study|Adverse Event|0|||
162997259|NCT01449370|588690706|FG017|Overall Study|Adverse Event|0|||
162997260|NCT01449370|588690707|FG018|Overall Study|Adverse Event|1|||
162997261|NCT01449370|588690708|FG019|Overall Study|Adverse Event|1|||
162997262|NCT01449370|588690709|FG020|Overall Study|Adverse Event|0|||
163060404|NCT02832037|588929884|FG003|Overall Study|Administrative reasons|0|||
162997263|NCT01449370|588690710|FG021|Overall Study|Adverse Event|1|||
163060405|NCT02832037|588929885|FG004|Overall Study|Administrative reasons|0|||
162997264|NCT01449370|588690711|FG022|Overall Study|Adverse Event|0|||
162997265|NCT01449370|588690712|FG023|Overall Study|Adverse Event|1|||
162997266|NCT01449370|588690713|FG024|Overall Study|Adverse Event|3|||
162997267|NCT01449370|588690689|FG000|Overall Study|Participant Decision|0|||
162997268|NCT01449370|588690690|FG001|Overall Study|Participant Decision|0|||
162997269|NCT01449370|588690691|FG002|Overall Study|Participant Decision|0|||
162997270|NCT01449370|588690692|FG003|Overall Study|Participant Decision|0|||
162997271|NCT01449370|588690693|FG004|Overall Study|Participant Decision|0|||
162997272|NCT01449370|588690694|FG005|Overall Study|Participant Decision|0|||
162997273|NCT01449370|588690695|FG006|Overall Study|Participant Decision|0|||
162997274|NCT01449370|588690696|FG007|Overall Study|Participant Decision|1|||
162997275|NCT01449370|588690697|FG008|Overall Study|Participant Decision|1|||
162997276|NCT01449370|588690698|FG009|Overall Study|Participant Decision|0|||
162997277|NCT01449370|588690699|FG010|Overall Study|Participant Decision|0|||
162997278|NCT01449370|588690700|FG011|Overall Study|Participant Decision|0|||
162997279|NCT01449370|588690701|FG012|Overall Study|Participant Decision|1|||
162997280|NCT01449370|588690702|FG013|Overall Study|Participant Decision|1|||
162997281|NCT01449370|588690703|FG014|Overall Study|Participant Decision|0|||
162997282|NCT01449370|588690704|FG015|Overall Study|Participant Decision|1|||
162997283|NCT01449370|588690705|FG016|Overall Study|Participant Decision|3|||
162997284|NCT01449370|588690706|FG017|Overall Study|Participant Decision|0|||
162997285|NCT01449370|588690707|FG018|Overall Study|Participant Decision|1|||
162997286|NCT01449370|588690708|FG019|Overall Study|Participant Decision|0|||
162997287|NCT01449370|588690709|FG020|Overall Study|Participant Decision|0|||
162997288|NCT01449370|588690710|FG021|Overall Study|Participant Decision|1|||
162997289|NCT01449370|588690711|FG022|Overall Study|Participant Decision|0|||
162997290|NCT01449370|588690712|FG023|Overall Study|Participant Decision|0|||
162997291|NCT01449370|588690713|FG024|Overall Study|Participant Decision|1|||
162997292|NCT01449370|588690689|FG000|Overall Study|Lost to Follow-up|0|||
162997293|NCT01449370|588690690|FG001|Overall Study|Lost to Follow-up|0|||
162997294|NCT01449370|588690691|FG002|Overall Study|Lost to Follow-up|0|||
162997295|NCT01449370|588690692|FG003|Overall Study|Lost to Follow-up|0|||
162997296|NCT01449370|588690693|FG004|Overall Study|Lost to Follow-up|0|||
162997297|NCT01449370|588690694|FG005|Overall Study|Lost to Follow-up|0|||
162997298|NCT01449370|588690695|FG006|Overall Study|Lost to Follow-up|0|||
162997299|NCT01449370|588690696|FG007|Overall Study|Lost to Follow-up|0|||
162997300|NCT01449370|588690697|FG008|Overall Study|Lost to Follow-up|0|||
162997301|NCT01449370|588690698|FG009|Overall Study|Lost to Follow-up|0|||
162997302|NCT01449370|588690699|FG010|Overall Study|Lost to Follow-up|0|||
162997303|NCT01449370|588690700|FG011|Overall Study|Lost to Follow-up|0|||
162997304|NCT01449370|588690701|FG012|Overall Study|Lost to Follow-up|0|||
162997305|NCT01449370|588690702|FG013|Overall Study|Lost to Follow-up|0|||
162997306|NCT01449370|588690703|FG014|Overall Study|Lost to Follow-up|0|||
162997307|NCT01449370|588690704|FG015|Overall Study|Lost to Follow-up|0|||
162997308|NCT01449370|588690705|FG016|Overall Study|Lost to Follow-up|0|||
162997309|NCT01449370|588690706|FG017|Overall Study|Lost to Follow-up|0|||
162997310|NCT01449370|588690707|FG018|Overall Study|Lost to Follow-up|0|||
162997311|NCT01449370|588690708|FG019|Overall Study|Lost to Follow-up|0|||
163060406|NCT02832037|588929881|FG000|Overall Study|Protocol Violation|3|||
163060407|NCT02832037|588929882|FG001|Overall Study|Protocol Violation|0|||
163060408|NCT02832037|588929883|FG002|Overall Study|Protocol Violation|4|||
162997312|NCT01449370|588690709|FG020|Overall Study|Lost to Follow-up|1|||
162997313|NCT01449370|588690710|FG021|Overall Study|Lost to Follow-up|0|||
162997314|NCT01449370|588690711|FG022|Overall Study|Lost to Follow-up|0|||
162997315|NCT01449370|588690712|FG023|Overall Study|Lost to Follow-up|0|||
162997316|NCT01449370|588690713|FG024|Overall Study|Lost to Follow-up|0|||
162997317|NCT01449370|588690689|FG000|Overall Study|Other|0|||
162997318|NCT01449370|588690690|FG001|Overall Study|Other|0|||
162997319|NCT01449370|588690691|FG002|Overall Study|Other|0|||
162997320|NCT01449370|588690692|FG003|Overall Study|Other|0|||
163060409|NCT02832037|588929884|FG003|Overall Study|Protocol Violation|1|||
162997321|NCT01449370|588690693|FG004|Overall Study|Other|0|||
162997322|NCT01449370|588690694|FG005|Overall Study|Other|0|||
162997323|NCT01449370|588690695|FG006|Overall Study|Other|0|||
162997324|NCT01449370|588690696|FG007|Overall Study|Other|0|||
162997325|NCT01449370|588690697|FG008|Overall Study|Other|1|||
162997326|NCT01449370|588690698|FG009|Overall Study|Other|1|||
162997327|NCT01449370|588690699|FG010|Overall Study|Other|0|||
162997328|NCT01449370|588690700|FG011|Overall Study|Other|0|||
162997329|NCT01449370|588690701|FG012|Overall Study|Other|0|||
162997330|NCT01449370|588690702|FG013|Overall Study|Other|0|||
162997331|NCT01449370|588690703|FG014|Overall Study|Other|0|||
162997332|NCT01449370|588690704|FG015|Overall Study|Other|0|||
162997333|NCT01449370|588690705|FG016|Overall Study|Other|0|||
163060410|NCT02832037|588929885|FG004|Overall Study|Protocol Violation|2|||
162997334|NCT01449370|588690706|FG017|Overall Study|Other|0|||
162997335|NCT01449370|588690707|FG018|Overall Study|Other|0|||
162997336|NCT01449370|588690708|FG019|Overall Study|Other|0|||
162997337|NCT01449370|588690709|FG020|Overall Study|Other|0|||
163060411|NCT02832037|588929881|FG000|Overall Study|Lost to Follow-up|2|||
162997338|NCT01449370|588690710|FG021|Overall Study|Other|0|||
162997339|NCT01449370|588690711|FG022|Overall Study|Other|1|||
162997340|NCT01449370|588690712|FG023|Overall Study|Other|1|||
162997341|NCT01449370|588690713|FG024|Overall Study|Other|0|||
162997342|NCT01449370|588690689|FG000|Overall Study|Medication Prohibited by Protocol|0|||
162997343|NCT01449370|588690690|FG001|Overall Study|Medication Prohibited by Protocol|0|||
162997344|NCT01449370|588690691|FG002|Overall Study|Medication Prohibited by Protocol|0|||
162997345|NCT01449370|588690692|FG003|Overall Study|Medication Prohibited by Protocol|0|||
162997346|NCT01449370|588690693|FG004|Overall Study|Medication Prohibited by Protocol|0|||
162997347|NCT01449370|588690694|FG005|Overall Study|Medication Prohibited by Protocol|0|||
162997348|NCT01449370|588690695|FG006|Overall Study|Medication Prohibited by Protocol|0|||
162997349|NCT01449370|588690696|FG007|Overall Study|Medication Prohibited by Protocol|0|||
162997350|NCT01449370|588690697|FG008|Overall Study|Medication Prohibited by Protocol|0|||
162997351|NCT01449370|588690698|FG009|Overall Study|Medication Prohibited by Protocol|0|||
162997352|NCT01449370|588690699|FG010|Overall Study|Medication Prohibited by Protocol|0|||
162997353|NCT01449370|588690700|FG011|Overall Study|Medication Prohibited by Protocol|0|||
162997354|NCT01449370|588690701|FG012|Overall Study|Medication Prohibited by Protocol|0|||
162997355|NCT01449370|588690702|FG013|Overall Study|Medication Prohibited by Protocol|0|||
162997356|NCT01449370|588690703|FG014|Overall Study|Medication Prohibited by Protocol|0|||
162997357|NCT01449370|588690704|FG015|Overall Study|Medication Prohibited by Protocol|0|||
162997358|NCT01449370|588690705|FG016|Overall Study|Medication Prohibited by Protocol|0|||
162997359|NCT01449370|588690706|FG017|Overall Study|Medication Prohibited by Protocol|0|||
162997360|NCT01449370|588690707|FG018|Overall Study|Medication Prohibited by Protocol|0|||
162997361|NCT01449370|588690708|FG019|Overall Study|Medication Prohibited by Protocol|0|||
162997362|NCT01449370|588690709|FG020|Overall Study|Medication Prohibited by Protocol|0|||
162997363|NCT01449370|588690710|FG021|Overall Study|Medication Prohibited by Protocol|0|||
162997364|NCT01449370|588690711|FG022|Overall Study|Medication Prohibited by Protocol|0|||
162997365|NCT01449370|588690712|FG023|Overall Study|Medication Prohibited by Protocol|1|||
162997366|NCT01449370|588690713|FG024|Overall Study|Medication Prohibited by Protocol|0|||
162997367|NCT01449370|588690689|FG000|Overall Study|Death|0|||
162997368|NCT01449370|588690690|FG001|Overall Study|Death|0|||
162997369|NCT01449370|588690691|FG002|Overall Study|Death|0|||
162997370|NCT01449370|588690692|FG003|Overall Study|Death|0|||
162997371|NCT01449370|588690693|FG004|Overall Study|Death|0|||
162997372|NCT01449370|588690694|FG005|Overall Study|Death|0|||
162997373|NCT01449370|588690695|FG006|Overall Study|Death|0|||
162997374|NCT01449370|588690696|FG007|Overall Study|Death|0|||
162997375|NCT01449370|588690697|FG008|Overall Study|Death|0|||
162997376|NCT01449370|588690698|FG009|Overall Study|Death|0|||
162997377|NCT01449370|588690699|FG010|Overall Study|Death|0|||
162997378|NCT01449370|588690700|FG011|Overall Study|Death|0|||
162997379|NCT01449370|588690701|FG012|Overall Study|Death|0|||
162997380|NCT01449370|588690702|FG013|Overall Study|Death|0|||
162997381|NCT01449370|588690703|FG014|Overall Study|Death|0|||
162997382|NCT01449370|588690704|FG015|Overall Study|Death|0|||
162997383|NCT01449370|588690705|FG016|Overall Study|Death|0|||
162997384|NCT01449370|588690706|FG017|Overall Study|Death|0|||
162997385|NCT01449370|588690707|FG018|Overall Study|Death|0|||
162997386|NCT01449370|588690708|FG019|Overall Study|Death|0|||
162997387|NCT01449370|588690709|FG020|Overall Study|Death|0|||
162997388|NCT01449370|588690710|FG021|Overall Study|Death|0|||
162997389|NCT01449370|588690711|FG022|Overall Study|Death|0|||
162997390|NCT01449370|588690712|FG023|Overall Study|Death|0|||
162997391|NCT01449370|588690713|FG024|Overall Study|Death|1|||
162997392|NCT00086281|588690714|FG000|Phase 1|Adverse Event|0|||
162997393|NCT00086281|588690715|FG001|Phase 1|Adverse Event|0|||
162997394|NCT00086281|588690716|FG002|Phase 1|Adverse Event|0|||
162997395|NCT00086281|588690717|FG003|Phase 1|Adverse Event|0|||
162997396|NCT00086281|588690718|FG004|Phase 1|Adverse Event|0|||
162997397|NCT00086281|588690719|FG005|Phase 1|Adverse Event|0|||
162997398|NCT00086281|588690720|FG006|Phase 1|Adverse Event|0|||
162997399|NCT00086281|588690721|FG007|Phase 1|Adverse Event|0|||
162997400|NCT00086281|588690722|FG008|Phase 1|Adverse Event|0|||
162997401|NCT00086281|588690723|FG009|Phase 1|Adverse Event|1|||
162997402|NCT00086281|588690724|FG010|Phase 1|Adverse Event|2|||
162997403|NCT00086281|588690725|FG011|Phase 1|Adverse Event|1|||
162997404|NCT00086281|588690726|FG012|Phase 1|Adverse Event|1|||
162997405|NCT00086281|588690727|FG013|Phase 1|Adverse Event|1|||
162997406|NCT00086281|588690728|FG014|Phase 1|Adverse Event|2|||
162997407|NCT00086281|588690714|FG000|Phase 1|Protocol Violation|0|||
162997408|NCT00086281|588690715|FG001|Phase 1|Protocol Violation|0|||
163060412|NCT02832037|588929882|FG001|Overall Study|Lost to Follow-up|0|||
162997409|NCT00086281|588690716|FG002|Phase 1|Protocol Violation|0|||
162997410|NCT00086281|588690717|FG003|Phase 1|Protocol Violation|0|||
162997411|NCT00086281|588690718|FG004|Phase 1|Protocol Violation|0|||
162997412|NCT00086281|588690719|FG005|Phase 1|Protocol Violation|0|||
162997413|NCT00086281|588690720|FG006|Phase 1|Protocol Violation|0|||
162997414|NCT00086281|588690721|FG007|Phase 1|Protocol Violation|0|||
162997415|NCT00086281|588690722|FG008|Phase 1|Protocol Violation|0|||
162997416|NCT00086281|588690723|FG009|Phase 1|Protocol Violation|0|||
162997417|NCT00086281|588690724|FG010|Phase 1|Protocol Violation|1|||
162997418|NCT00086281|588690725|FG011|Phase 1|Protocol Violation|0|||
162997419|NCT00086281|588690726|FG012|Phase 1|Protocol Violation|0|||
162997420|NCT00086281|588690727|FG013|Phase 1|Protocol Violation|0|||
162997421|NCT00086281|588690728|FG014|Phase 1|Protocol Violation|0|||
162997422|NCT00086281|588690714|FG000|Phase 1|Serious Adverse Event|0|||
162997423|NCT00086281|588690715|FG001|Phase 1|Serious Adverse Event|0|||
162997424|NCT00086281|588690716|FG002|Phase 1|Serious Adverse Event|0|||
162997425|NCT00086281|588690717|FG003|Phase 1|Serious Adverse Event|0|||
162997426|NCT00086281|588690718|FG004|Phase 1|Serious Adverse Event|0|||
162997427|NCT00086281|588690719|FG005|Phase 1|Serious Adverse Event|0|||
162997428|NCT00086281|588690720|FG006|Phase 1|Serious Adverse Event|0|||
162997429|NCT00086281|588690721|FG007|Phase 1|Serious Adverse Event|0|||
162997430|NCT00086281|588690722|FG008|Phase 1|Serious Adverse Event|0|||
162997431|NCT00086281|588690723|FG009|Phase 1|Serious Adverse Event|0|||
162997432|NCT00086281|588690724|FG010|Phase 1|Serious Adverse Event|0|||
162997433|NCT00086281|588690725|FG011|Phase 1|Serious Adverse Event|0|||
162997434|NCT00086281|588690726|FG012|Phase 1|Serious Adverse Event|0|||
162997435|NCT00086281|588690727|FG013|Phase 1|Serious Adverse Event|0|||
162997436|NCT00086281|588690728|FG014|Phase 1|Serious Adverse Event|1|||
162997437|NCT00086281|588690714|FG000|Phase 2|Adverse Event|0|||
162997438|NCT00086281|588690715|FG001|Phase 2|Adverse Event|0|||
162997439|NCT00086281|588690716|FG002|Phase 2|Adverse Event|0|||
162997440|NCT00086281|588690717|FG003|Phase 2|Adverse Event|0|||
162997441|NCT00086281|588690718|FG004|Phase 2|Adverse Event|0|||
162997442|NCT00086281|588690719|FG005|Phase 2|Adverse Event|0|||
162997443|NCT00086281|588690720|FG006|Phase 2|Adverse Event|0|||
162997444|NCT00086281|588690721|FG007|Phase 2|Adverse Event|0|||
162997445|NCT00086281|588690722|FG008|Phase 2|Adverse Event|0|||
162997446|NCT00086281|588690723|FG009|Phase 2|Adverse Event|0|||
162997447|NCT00086281|588690724|FG010|Phase 2|Adverse Event|0|||
162997448|NCT00086281|588690725|FG011|Phase 2|Adverse Event|0|||
162997449|NCT00086281|588690726|FG012|Phase 2|Adverse Event|1|||
162997450|NCT00086281|588690727|FG013|Phase 2|Adverse Event|1|||
162997451|NCT00086281|588690728|FG014|Phase 2|Adverse Event|0|||
162997452|NCT00908310|588690731|FG000|Overall Study|Death|37|||
162997453|NCT00908310|588690731|FG000|Overall Study|Withdrawal by Subject|7|||
162997454|NCT00908310|588690731|FG000|Overall Study|Lost to Follow-up|7|||
162997455|NCT00908310|588690731|FG000|Overall Study|Screening failure|5|||
162997456|NCT00908310|588690731|FG000|Overall Study|Other reasons|4|||
162997457|NCT00896480|588690734|FG000|Overall Study|Disease progression/recurrence|21|||
162997458|NCT00725205|588690737|FG000|Overall Study|Adverse Event|22|||
162997459|NCT00725205|588690737|FG000|Overall Study|Investigator Discontinued|1|||
162997460|NCT00725205|588690737|FG000|Overall Study|Non-compliance With Protocol|14|||
162997461|NCT00725205|588690737|FG000|Overall Study|Other|8|||
162997462|NCT00725205|588690737|FG000|Overall Study|Protocol Defined Clinical Event|1|||
162997463|NCT00725205|588690737|FG000|Overall Study|Treatment Failure|41|||
162997464|NCT03014180|588690740|FG000|Overall Study|Protocol Violation|2|||
162997465|NCT02212379|588690744|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
162997466|NCT02212379|588690744|FG000|From Baseline to Week 48|Adverse Event|7|||
162997467|NCT02212379|588690744|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
162637104|NCT01712490|587386107|FG001|Overall Study|Withdrawal by Subject|44|||
162637105|NCT01712490|587386106|FG000|Overall Study|Lost to Follow-up|16|||
162637106|NCT01712490|587386107|FG001|Overall Study|Lost to Follow-up|29|||
162637107|NCT01714635|587386119|FG000|Overall Study|Discontinued|1|||
162637108|NCT01714635|587386120|FG001|Overall Study|Discontinued|0|||
162637109|NCT01714635|587386121|FG002|Overall Study|Discontinued|2|||
162997468|NCT02212379|588690744|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
162997469|NCT02212379|588690744|FG000|From Week 48 to Week 96|Adverse Event|1|||
162997470|NCT02212379|588690744|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
162997471|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
162997472|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
162997473|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997474|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997475|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997476|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997477|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997478|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997479|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
163060413|NCT02832037|588929883|FG002|Overall Study|Lost to Follow-up|3|||
162997480|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
162997481|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
162997482|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
162997483|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997484|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997485|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997486|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997487|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997488|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997489|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997490|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
162997491|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997492|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
162997493|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997494|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997495|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997496|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997497|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997498|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997499|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997500|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
162997501|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
162997502|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997503|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997504|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997505|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997506|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997507|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997508|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997509|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997510|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
162997511|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
162997512|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
162997513|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997514|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997515|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997516|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
163060414|NCT02832037|588929884|FG003|Overall Study|Lost to Follow-up|0|||
163060415|NCT02832037|588929885|FG004|Overall Study|Lost to Follow-up|5|||
162997517|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997518|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997519|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997520|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
162997521|NCT04784533|588690745|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
162997522|NCT04784533|588690746|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
162997523|NCT04784533|588690747|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
163060416|NCT02832037|588929881|FG000|Overall Study|Withdrawal by Subject|9|||
163060417|NCT02832037|588929882|FG001|Overall Study|Withdrawal by Subject|8|||
163060418|NCT02832037|588929883|FG002|Overall Study|Withdrawal by Subject|0|||
163060419|NCT02832037|588929884|FG003|Overall Study|Withdrawal by Subject|4|||
163060420|NCT02832037|588929885|FG004|Overall Study|Withdrawal by Subject|8|||
162997524|NCT04784533|588690748|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997525|NCT04784533|588690749|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997526|NCT04784533|588690750|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
163060421|NCT02832037|588929881|FG000|Overall Study|Adverse Event|5|||
163060422|NCT02832037|588929882|FG001|Overall Study|Adverse Event|4|||
162997527|NCT04784533|588690751|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997528|NCT04784533|588690752|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997529|NCT04784533|588690753|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997530|NCT04784533|588690754|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
162997531|NCT04784533|588690745|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
163060423|NCT02832037|588929883|FG002|Overall Study|Adverse Event|0|||
163060424|NCT02832037|588929884|FG003|Overall Study|Adverse Event|2|||
163060425|NCT02832037|588929885|FG004|Overall Study|Adverse Event|4|||
163060426|NCT04727749|588929892|FG000|Overall Study|Lost to Follow-up|10|||
163060427|NCT04727749|588929893|FG001|Overall Study|Lost to Follow-up|3|||
162997532|NCT04784533|588690746|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997533|NCT04784533|588690747|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
162997534|NCT04784533|588690748|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997535|NCT04784533|588690749|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997536|NCT04784533|588690750|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997537|NCT04784533|588690751|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997538|NCT04784533|588690752|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997539|NCT04784533|588690753|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997540|NCT04784533|588690754|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
162997541|NCT04784533|588690745|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997542|NCT04784533|588690746|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997543|NCT04784533|588690747|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997544|NCT04784533|588690748|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997545|NCT04784533|588690749|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997546|NCT04784533|588690750|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997547|NCT04784533|588690751|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997548|NCT04784533|588690752|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997549|NCT04784533|588690753|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
162997550|NCT04784533|588690754|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
162997551|NCT04784533|588690745|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997552|NCT04784533|588690746|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997553|NCT04784533|588690747|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997554|NCT04784533|588690748|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997555|NCT04784533|588690749|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997556|NCT04784533|588690750|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162637110|NCT01714635|587386119|FG000|Overall Study|Missed 6-month exam|1|||
162637111|NCT01714635|587386120|FG001|Overall Study|Missed 6-month exam|0|||
162637112|NCT01714635|587386121|FG002|Overall Study|Missed 6-month exam|0|||
162997557|NCT04784533|588690751|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997558|NCT04784533|588690752|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
162997559|NCT04784533|588690753|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
162997560|NCT04784533|588690754|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
162997561|NCT02682927|588690770|FG000|Overall Study|Adverse Event|0|||
162997562|NCT02682927|588690771|FG001|Overall Study|Adverse Event|0|||
162997563|NCT02682927|588690772|FG002|Overall Study|Adverse Event|5|||
162997564|NCT02682927|588690773|FG003|Overall Study|Adverse Event|1|||
162997565|NCT02682927|588690774|FG004|Overall Study|Adverse Event|0|||
162997566|NCT02682927|588690775|FG005|Overall Study|Adverse Event|2|||
162997567|NCT02682927|588690770|FG000|Overall Study|Death|0|||
162997568|NCT02682927|588690771|FG001|Overall Study|Death|0|||
162997569|NCT02682927|588690772|FG002|Overall Study|Death|0|||
162997570|NCT02682927|588690773|FG003|Overall Study|Death|1|||
162997571|NCT02682927|588690774|FG004|Overall Study|Death|0|||
162997572|NCT02682927|588690775|FG005|Overall Study|Death|0|||
162997573|NCT02682927|588690770|FG000|Overall Study|Lack of Efficacy|1|||
162997574|NCT02682927|588690771|FG001|Overall Study|Lack of Efficacy|0|||
162997575|NCT02682927|588690772|FG002|Overall Study|Lack of Efficacy|0|||
162997576|NCT02682927|588690773|FG003|Overall Study|Lack of Efficacy|1|||
162997577|NCT02682927|588690774|FG004|Overall Study|Lack of Efficacy|0|||
163060428|NCT02378181|588929894|FG000|Overall Study|Lost to Follow-up|2|||
163060429|NCT02378181|588929895|FG001|Overall Study|Lost to Follow-up|5|||
163060430|NCT02378181|588929894|FG000|Overall Study|Withdrawal by Subject|1|||
163060431|NCT02378181|588929895|FG001|Overall Study|Withdrawal by Subject|1|||
162997578|NCT02682927|588690775|FG005|Overall Study|Lack of Efficacy|0|||
162997579|NCT02682927|588690770|FG000|Overall Study|Other|0|||
162997580|NCT02682927|588690771|FG001|Overall Study|Other|0|||
162997581|NCT02682927|588690772|FG002|Overall Study|Other|0|||
162997582|NCT02682927|588690773|FG003|Overall Study|Other|2|||
162997583|NCT02682927|588690774|FG004|Overall Study|Other|0|||
162997584|NCT02682927|588690775|FG005|Overall Study|Other|0|||
162997585|NCT02682927|588690770|FG000|Overall Study|Withdrawal by Subject|2|||
162997586|NCT02682927|588690771|FG001|Overall Study|Withdrawal by Subject|0|||
162997587|NCT02682927|588690772|FG002|Overall Study|Withdrawal by Subject|1|||
162997588|NCT02682927|588690773|FG003|Overall Study|Withdrawal by Subject|0|||
162997589|NCT02682927|588690774|FG004|Overall Study|Withdrawal by Subject|1|||
162997590|NCT02682927|588690775|FG005|Overall Study|Withdrawal by Subject|1|||
162997591|NCT03462459|588690776|FG000|Overall Study|Death|1|||
163060432|NCT02378181|588929894|FG000|Overall Study|Incarcerated|0|||
162997592|NCT03462459|588690777|FG001|Overall Study|Death|0|||
162997593|NCT03462459|588690776|FG000|Overall Study|Lack of Efficacy|2|||
162997594|NCT03462459|588690777|FG001|Overall Study|Lack of Efficacy|4|||
162997595|NCT03462459|588690776|FG000|Overall Study|Lost to Follow-up|1|||
162997596|NCT03462459|588690777|FG001|Overall Study|Lost to Follow-up|3|||
163060433|NCT02378181|588929895|FG001|Overall Study|Incarcerated|1|||
162637113|NCT02860169|587386123|FG000|Part A|Withdrawal by Subject|1|||
162637114|NCT02860169|587386123|FG000|Part A|Other (Screening failure)|6|||
162997597|NCT03462459|588690776|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
162997598|NCT03462459|588690777|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
162997599|NCT03462459|588690776|FG000|Overall Study|Withdrawal by Subject|3|||
162997600|NCT03462459|588690777|FG001|Overall Study|Withdrawal by Subject|2|||
162997601|NCT03462459|588690776|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
162997602|NCT03462459|588690777|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
162997603|NCT01243775|588690778|FG000|Overall Study|Withdrawal by Subject|2|||
162997604|NCT01177059|588690779|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
162997605|NCT01177059|588690779|FG000|Overall Study|Withdrew consent|2|||
162997606|NCT01177059|588690779|FG000|Overall Study|Lost to Follow-up|18|||
162997607|NCT04051619|588690780|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
162997608|NCT04051619|588690781|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
162997609|NCT04051619|588690780|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
162997610|NCT04051619|588690781|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
162997611|NCT05938621|588691961|FG000|Overall Study|Lost to Follow-up|1|||
162997612|NCT05938621|588691962|FG001|Overall Study|Lost to Follow-up|5|||
162997613|NCT05938621|588691963|FG002|Overall Study|Lost to Follow-up|2|||
162997614|NCT05938621|588691964|FG003|Overall Study|Lost to Follow-up|2|||
162997615|NCT03922529|588691969|FG000|Overall Study|Withdrawal by Subject|13|||
162997616|NCT03922529|588691970|FG001|Overall Study|Withdrawal by Subject|12|||
162997617|NCT03922529|588691969|FG000|Overall Study|Death|7|||
162997618|NCT03922529|588691970|FG001|Overall Study|Death|12|||
162997619|NCT03922529|588691969|FG000|Overall Study|Lost to Follow-up|12|||
162997620|NCT03922529|588691970|FG001|Overall Study|Lost to Follow-up|19|||
162997621|NCT03922529|588691969|FG000|Overall Study|Adverse Event|1|||
162997622|NCT03922529|588691970|FG001|Overall Study|Adverse Event|0|||
162997623|NCT03922529|588691969|FG000|Overall Study|Death after withdrawal|1|||
162997624|NCT03922529|588691970|FG001|Overall Study|Death after withdrawal|0|||
162997625|NCT03922529|588691969|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
162997626|NCT03922529|588691970|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
162997627|NCT03922529|588691969|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
162997628|NCT03922529|588691970|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
162997629|NCT02731638|588691971|FG000|Overall Study|Lost to Follow-up|6|||
162997630|NCT02731638|588691972|FG001|Overall Study|Lost to Follow-up|9|||
162997631|NCT04158245|588691973|FG000|Overall Study|Lost to Follow-up|1|||
162997632|NCT02454608|588691974|FG000|Double-Blind Period|Lack of Efficacy|0|||
162997633|NCT02454608|588691975|FG001|Double-Blind Period|Lack of Efficacy|2|||
162997634|NCT02454608|588691976|FG002|Double-Blind Period|Lack of Efficacy|0|||
162997635|NCT02454608|588691974|FG000|Open Label Period|Lost to Follow-up|0|||
162997636|NCT02454608|588691975|FG001|Open Label Period|Lost to Follow-up|0|||
162997637|NCT02454608|588691976|FG002|Open Label Period|Lost to Follow-up|11|||
162997638|NCT02454608|588691974|FG000|Open Label Period|Withdrawal by Subject|0|||
162997639|NCT02454608|588691975|FG001|Open Label Period|Withdrawal by Subject|0|||
162997640|NCT02454608|588691976|FG002|Open Label Period|Withdrawal by Subject|8|||
162997641|NCT02465398|588691977|FG000|Overall Study|Death|7|||
162997642|NCT02465398|588691977|FG000|Overall Study|Revision|7|||
162997643|NCT02465398|588691977|FG000|Overall Study|did not receive study device|1|||
162997644|NCT02465398|588691977|FG000|Overall Study|Withdrawal by Subject|1|||
162997645|NCT02465398|588691977|FG000|Overall Study|Lost to Follow-up|14|||
162997646|NCT02540850|588691978|FG000|Overall Study|Lost to Follow-up|69|||
162997647|NCT02540850|588691979|FG001|Overall Study|Lost to Follow-up|66|||
163060434|NCT01180777|588929897|FG000|Overall Study|Protocol Violation|6|||
163060435|NCT01180777|588929897|FG000|Overall Study|Poor lens fit|4|||
163060436|NCT01180777|588929897|FG000|Overall Study|Lost to Follow-up|1|||
163060437|NCT01180777|588929897|FG000|Overall Study|Adverse Event|1|||
163060438|NCT04167462|588929898|FG000|Overall Study|Other reasons|3|||
163060439|NCT04167462|588929899|FG001|Overall Study|Other reasons|2|||
162997648|NCT02540850|588691980|FG002|Overall Study|Lost to Follow-up|34|||
162997649|NCT03760185|588691991|FG000|Overall Study|Lost to Follow-up|1|||
162997650|NCT03760185|588691992|FG001|Overall Study|Lost to Follow-up|1|||
162997651|NCT02473523|588691993|FG000|Overall Study|Death|1|||
162997652|NCT02473523|588691993|FG000|Overall Study|Lost to Follow-up|1|||
162997653|NCT02111603|588691996|FG000|Overall Study|Withdrawal by Subject|1|||
162997654|NCT00976911|588691997|FG000|Overall Study|Withdrawal by Subject|4|||
162997655|NCT00976911|588691998|FG001|Overall Study|Withdrawal by Subject|6|||
162997656|NCT00976911|588691997|FG000|Overall Study|Death|138|||
162997657|NCT00976911|588691998|FG001|Overall Study|Death|126|||
162997658|NCT00976911|588691997|FG000|Overall Study|Adverse Event|0|||
162997659|NCT00976911|588691998|FG001|Overall Study|Adverse Event|1|||
162997660|NCT00976911|588691997|FG000|Overall Study|Protocol Violation|2|||
162997661|NCT00976911|588691998|FG001|Overall Study|Protocol Violation|0|||
162997662|NCT00976911|588691997|FG000|Overall Study|Other|8|||
162997663|NCT00976911|588691998|FG001|Overall Study|Other|9|||
162997664|NCT00976911|588691997|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
163060440|NCT04167462|588929898|FG000|Overall Study|Withdrawal by Subject|6|||
162997665|NCT00976911|588691998|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
162997666|NCT02954991|588691999|FG000|Overall Study|Death|92|||
162997667|NCT02954991|588692000|FG001|Overall Study|Death|11|||
162997668|NCT02954991|588692001|FG002|Overall Study|Death|2|||
162997669|NCT02954991|588691999|FG000|Overall Study|Lost to Follow-up|3|||
162997670|NCT02954991|588692000|FG001|Overall Study|Lost to Follow-up|2|||
162997671|NCT02954991|588692001|FG002|Overall Study|Lost to Follow-up|0|||
162997672|NCT02954991|588691999|FG000|Overall Study|Withdrawal by Subject|9|||
162997673|NCT02954991|588692000|FG001|Overall Study|Withdrawal by Subject|8|||
162997674|NCT02954991|588692001|FG002|Overall Study|Withdrawal by Subject|1|||
162997675|NCT02954991|588691999|FG000|Overall Study|Study Terminated by Sponsor|18|||
162997676|NCT02954991|588692000|FG001|Overall Study|Study Terminated by Sponsor|10|||
162997677|NCT02954991|588692001|FG002|Overall Study|Study Terminated by Sponsor|1|||
162997678|NCT02954991|588691999|FG000|Overall Study|Miscellaneous|2|||
162997679|NCT02954991|588692000|FG001|Overall Study|Miscellaneous|1|||
162997680|NCT02954991|588692001|FG002|Overall Study|Miscellaneous|1|||
162997681|NCT00576316|588692002|FG000|Overall Study|Adverse Event|9|||
162997682|NCT00576316|588692002|FG000|Overall Study|Withdrawal by Subject|2|||
162997683|NCT00576316|588692002|FG000|Overall Study|Protocol Violation|9|||
162997684|NCT02552303|588692005|FG000|Allocation|Withdrawal by Subject|2|||
162997685|NCT02552303|588692006|FG001|Allocation|Withdrawal by Subject|1|||
162997686|NCT02552303|588692007|FG002|Allocation|Withdrawal by Subject|1|||
162997687|NCT02552303|588692008|FG003|Allocation|Withdrawal by Subject|1|||
162997688|NCT02552303|588692005|FG000|Allocation|ineligible|1|||
162997689|NCT02552303|588692006|FG001|Allocation|ineligible|1|||
162997690|NCT02552303|588692007|FG002|Allocation|ineligible|0|||
162997691|NCT02552303|588692008|FG003|Allocation|ineligible|0|||
162997692|NCT02552303|588692005|FG000|Follow-Up|Lost to Follow-up|0|||
162997693|NCT02552303|588692006|FG001|Follow-Up|Lost to Follow-up|0|||
162997694|NCT02552303|588692007|FG002|Follow-Up|Lost to Follow-up|1|||
162997695|NCT02552303|588692008|FG003|Follow-Up|Lost to Follow-up|0|||
162997696|NCT02552303|588692005|FG000|Follow-Up|ineligible|0|||
162997697|NCT02552303|588692006|FG001|Follow-Up|ineligible|2|||
162997698|NCT02552303|588692007|FG002|Follow-Up|ineligible|0|||
162997699|NCT02552303|588692008|FG003|Follow-Up|ineligible|0|||
162997700|NCT01582152|588692009|FG000|Overall Study|Disease Progression|4|||
162997701|NCT01582152|588692010|FG001|Overall Study|Disease Progression|5|||
162997702|NCT01582152|588692009|FG000|Overall Study|Adverse Event|2|||
162997703|NCT01582152|588692010|FG001|Overall Study|Adverse Event|1|||
162997704|NCT03055624|588692011|FG000|Overall Study|Study closed|9|||
162997705|NCT02437903|588692014|FG000|Overall Study|Adverse Event|1|||
162997706|NCT02437903|588692014|FG000|Overall Study|Withdrawal by Subject|1|||
162997707|NCT02437903|588692014|FG000|Overall Study|Lost to Follow-up|3|||
162997708|NCT00230178|588692015|FG000|Overall Study|Adverse Event|1|||
162997709|NCT00230178|588692016|FG001|Overall Study|Adverse Event|5|||
162997710|NCT00230178|588692017|FG002|Overall Study|Adverse Event|2|||
162997711|NCT00230178|588692015|FG000|Overall Study|Withdrawal by Subject|0|||
162997712|NCT00230178|588692016|FG001|Overall Study|Withdrawal by Subject|0|||
162997713|NCT00230178|588692017|FG002|Overall Study|Withdrawal by Subject|1|||
162997714|NCT00230178|588692015|FG000|Overall Study|Various other reasons|3|||
162997715|NCT00230178|588692016|FG001|Overall Study|Various other reasons|2|||
163060441|NCT04167462|588929899|FG001|Overall Study|Withdrawal by Subject|7|||
162997716|NCT00230178|588692017|FG002|Overall Study|Various other reasons|4|||
162997717|NCT01275729|588692020|FG000|Overall Study|Death|3|||
162997718|NCT01275729|588692020|FG000|Overall Study|Withdrawal by Subject|1|||
162997719|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
162997720|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
163060442|NCT04167462|588929898|FG000|Overall Study|Adverse Event|4|||
162637115|NCT02860169|587386123|FG000|Part A|Other (Survey not completed)|3|||
162997721|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
162997722|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
163060443|NCT04167462|588929899|FG001|Overall Study|Adverse Event|0|||
162997723|NCT02252406|588692025|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
162997724|NCT02252406|588692026|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
162997725|NCT02252406|588692025|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
162997726|NCT02252406|588692026|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
162997727|NCT02252406|588692025|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
162997728|NCT02252406|588692026|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
162997729|NCT00005957|588692029|FG000|Overall Study|No treated|3|||
162997730|NCT00005957|588692030|FG001|Overall Study|No treated|9|||
162997731|NCT00005957|588692029|FG000|Overall Study|Crossover to the other arm|5|||
162997732|NCT00005957|588692030|FG001|Overall Study|Crossover to the other arm|19|||
162997733|NCT01609023|588692031|FG000|Overall Study|Lack of Efficacy|3|||
162997734|NCT01609023|588692031|FG000|Overall Study|Withdrawal by Subject|4|||
163060444|NCT04167462|588929898|FG000|Overall Study|Pregnancy|1|||
162997735|NCT01609023|588692031|FG000|Overall Study|Lost to Follow-up|8|||
162997736|NCT01609023|588692031|FG000|Overall Study|Toxicity|3|||
162637116|NCT02860169|587386123|FG000|Part A|Other (did not completed consent)|1|||
163060445|NCT04167462|588929899|FG001|Overall Study|Pregnancy|0|||
162997737|NCT01609023|588692031|FG000|Overall Study|Disease progression|10|||
162997738|NCT01609023|588692031|FG000|Overall Study|Physician Decision|2|||
162997739|NCT01609023|588692031|FG000|Overall Study|Death|2|||
162997740|NCT01609023|588692031|FG000|Overall Study|Personal reasons|1|||
162997741|NCT00799825|588692032|FG000|Overall Study|Adverse Event|1|||
162997742|NCT00799825|588692032|FG000|Overall Study|Withdrawal by Subject|6|||
162997743|NCT00799825|588692032|FG000|Overall Study|Lost to Follow-up|38|||
162997744|NCT00799825|588692032|FG000|Overall Study|Pregnancy|3|||
162997745|NCT00362336|588692033|FG000|Overall Study|Serious Adverse Event|1|||
162997746|NCT00362336|588692034|FG001|Overall Study|Serious Adverse Event|0|||
162997747|NCT00362336|588692035|FG002|Overall Study|Serious Adverse Event|1|||
162997748|NCT00362336|588692033|FG000|Overall Study|Protocol Violation|0|||
162997749|NCT00362336|588692034|FG001|Overall Study|Protocol Violation|0|||
162997750|NCT00362336|588692035|FG002|Overall Study|Protocol Violation|1|||
162997751|NCT00362336|588692033|FG000|Overall Study|Lost to Follow-up|6|||
162997752|NCT00362336|588692034|FG001|Overall Study|Lost to Follow-up|4|||
162997753|NCT00362336|588692035|FG002|Overall Study|Lost to Follow-up|0|||
162997754|NCT00362336|588692033|FG000|Overall Study|Withdrawal by Subject|3|||
162997755|NCT00362336|588692034|FG001|Overall Study|Withdrawal by Subject|3|||
162997756|NCT00362336|588692035|FG002|Overall Study|Withdrawal by Subject|1|||
162997757|NCT04974749|588692036|FG000|Overall Study|Withdrawal by Subject|2|||
162997758|NCT04974749|588692036|FG000|Overall Study|Gestation|1|||
162997759|NCT01520870|588692037|FG000|Overall Study|Withdrawal by Subject|2|||
162997760|NCT02289456|588692038|FG000|Induction Period|Death|2|||
162997761|NCT02289456|588692038|FG000|Induction Period|Adverse Event|11|||
162997762|NCT02289456|588692038|FG000|Induction Period|Progressive Disease (PD)|4|||
162997763|NCT02289456|588692038|FG000|Induction Period|Symptomatic Deterioration|4|||
162997764|NCT02289456|588692038|FG000|Induction Period|Withdrawal by Subject|2|||
162997765|NCT02289456|588692038|FG000|Induction Period|Miscellaneous|1|||
162997766|NCT02289456|588692038|FG000|Monotherapy Period|Death|1|||
162997767|NCT02289456|588692038|FG000|Monotherapy Period|Adverse Event|1|||
162997768|NCT02289456|588692038|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
162997769|NCT02289456|588692038|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
162997770|NCT02289456|588692038|FG000|Monotherapy Period|Withdrawal by Subject|2|||
162997771|NCT02289456|588692038|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
162997772|NCT02289456|588692038|FG000|Monotherapy Period|Miscellaneous|1|||
162997773|NCT00796107|588692044|FG000|Overall Study|Lack of Efficacy|1|||
162997774|NCT00796107|588692044|FG000|Overall Study|Progressive Disease|5|||
162997775|NCT02681510|588692049|FG000|Overall Study|Withdrawal by Subject|1|||
162997776|NCT02681510|588692049|FG000|Overall Study|Lost to Follow-up|9|||
162997777|NCT02797171|588692053|FG000|Overall Study|Lost to Follow-up|2|||
162997778|NCT02797171|588692054|FG001|Overall Study|Lost to Follow-up|0|||
162997779|NCT02797171|588692055|FG002|Overall Study|Lost to Follow-up|2|||
162997780|NCT02797171|588692056|FG003|Overall Study|Lost to Follow-up|1|||
162997781|NCT02797171|588692057|FG004|Overall Study|Lost to Follow-up|2|||
162997782|NCT02797171|588692058|FG005|Overall Study|Lost to Follow-up|0|||
162997783|NCT02797171|588692053|FG000|Overall Study|Withdrawal by Subject|1|||
162997784|NCT02797171|588692054|FG001|Overall Study|Withdrawal by Subject|1|||
162997785|NCT02797171|588692055|FG002|Overall Study|Withdrawal by Subject|0|||
162997786|NCT02797171|588692056|FG003|Overall Study|Withdrawal by Subject|0|||
162997787|NCT02797171|588692057|FG004|Overall Study|Withdrawal by Subject|0|||
162997788|NCT02797171|588692058|FG005|Overall Study|Withdrawal by Subject|0|||
162997789|NCT02797171|588692053|FG000|Overall Study|Protocol Violation|1|||
162997790|NCT02797171|588692054|FG001|Overall Study|Protocol Violation|0|||
162997791|NCT02797171|588692055|FG002|Overall Study|Protocol Violation|0|||
162997792|NCT02797171|588692056|FG003|Overall Study|Protocol Violation|0|||
162997793|NCT02797171|588692057|FG004|Overall Study|Protocol Violation|0|||
162997794|NCT02797171|588692058|FG005|Overall Study|Protocol Violation|0|||
162997795|NCT02797171|588692053|FG000|Overall Study|Participant unable to adhere|0|||
162997796|NCT02797171|588692054|FG001|Overall Study|Participant unable to adhere|1|||
162997797|NCT02797171|588692055|FG002|Overall Study|Participant unable to adhere|0|||
162997798|NCT02797171|588692056|FG003|Overall Study|Participant unable to adhere|0|||
162997799|NCT02797171|588692057|FG004|Overall Study|Participant unable to adhere|0|||
162997800|NCT02797171|588692058|FG005|Overall Study|Participant unable to adhere|0|||
162997801|NCT02797171|588692053|FG000|Overall Study|Not Randomized|0|||
162997802|NCT02797171|588692054|FG001|Overall Study|Not Randomized|0|||
162997803|NCT02797171|588692055|FG002|Overall Study|Not Randomized|0|||
162637117|NCT02860169|587386123|FG000|Part B|Other (Screening failure)|10|||
162637118|NCT02860169|587386123|FG000|Part B|Withdrawal by Subject|1|||
162637119|NCT02860169|587386123|FG000|Part C|Other (Screening failure)|1|||
162997804|NCT02797171|588692056|FG003|Overall Study|Not Randomized|0|||
162637120|NCT01782495|587386124|FG000|Overall Study|Adverse Event|0|||
162637121|NCT01782495|587386125|FG001|Overall Study|Adverse Event|0|||
162997805|NCT02797171|588692057|FG004|Overall Study|Not Randomized|0|||
162997806|NCT02797171|588692058|FG005|Overall Study|Not Randomized|1|||
162997807|NCT00626561|588692059|FG000|Overall Study|Withdrawal by Subject|2|||
162997808|NCT00626561|588692059|FG000|Overall Study|Disease Progression|2|||
162637122|NCT01782495|587386126|FG002|Overall Study|Adverse Event|0|||
162997809|NCT01372748|588692060|FG000|Overall Study|Lost to Follow-up|16|||
162997810|NCT01372748|588692061|FG001|Overall Study|Lost to Follow-up|34|||
162997811|NCT01372748|588692060|FG000|Overall Study|Withdrawal by Subject|7|||
162997812|NCT01372748|588692061|FG001|Overall Study|Withdrawal by Subject|5|||
162997813|NCT00134901|588692062|FG000|Overall Study|Lost to Follow-up|5|||
162997814|NCT00134901|588692063|FG001|Overall Study|Lost to Follow-up|5|||
162997815|NCT00134901|588692062|FG000|Overall Study|discontinued intervention|12|||
162997816|NCT00134901|588692063|FG001|Overall Study|discontinued intervention|10|||
162997817|NCT00606632|588692064|FG000|Overall Study|Withdrawal by Subject|13|||
162997818|NCT00606632|588692064|FG000|Overall Study|Miscellaneous reasons|9|||
162997819|NCT03908437|588692065|FG000|Overall Study|Death|0|||
162997820|NCT03908437|588692066|FG001|Overall Study|Death|1|||
162997821|NCT03908437|588692065|FG000|Overall Study|Lost to Follow-up|31|||
162997822|NCT03908437|588692066|FG001|Overall Study|Lost to Follow-up|24|||
162997823|NCT03633825|588692067|FG000|Enrollment|Did not post on network|5066|||
162997824|NCT03633825|588692068|FG001|Enrollment|Did not post on network|5080|||
162997825|NCT03633825|588692067|FG000|Enrollment|Post not classified as crisis|13967|||
162997826|NCT03633825|588692068|FG001|Enrollment|Post not classified as crisis|13757|||
162997827|NCT03633825|588692067|FG000|Follow up|Lost to Follow-up|478|||
162997828|NCT03633825|588692068|FG001|Follow up|Lost to Follow-up|450|||
162997829|NCT04841577|588692069|FG000|Overall Study|Adverse Event|5|||
162997830|NCT04841577|588692070|FG001|Overall Study|Adverse Event|10|||
162997831|NCT04841577|588692069|FG000|Overall Study|Lost to Follow-up|8|||
162997832|NCT04841577|588692070|FG001|Overall Study|Lost to Follow-up|7|||
162997833|NCT04841577|588692069|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
162997834|NCT04841577|588692070|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
162997835|NCT04841577|588692069|FG000|Overall Study|Other|0|||
162997836|NCT04841577|588692070|FG001|Overall Study|Other|1|||
162997837|NCT03456453|588692074|FG000|Overall Study|Withdrawal by Subject|2|||
162997838|NCT03456453|588692075|FG001|Overall Study|Withdrawal by Subject|0|||
162997839|NCT03456453|588692074|FG000|Overall Study|Not released to community|1|||
162997840|NCT03456453|588692075|FG001|Overall Study|Not released to community|5|||
162997841|NCT03456453|588692074|FG000|Overall Study|Lost to Follow-up|0|||
162997842|NCT03456453|588692075|FG001|Overall Study|Lost to Follow-up|2|||
162997843|NCT01004003|588692076|FG000|Overall Study|Progressive disease|2|||
162997844|NCT01004003|588692077|FG001|Overall Study|Progressive disease|1|||
162997845|NCT01004003|588692078|FG002|Overall Study|Progressive disease|1|||
162997846|NCT01004003|588692079|FG003|Overall Study|Progressive disease|0|||
162997847|NCT01004003|588692080|FG004|Overall Study|Progressive disease|2|||
162997848|NCT01004003|588692081|FG005|Overall Study|Progressive disease|1|||
162997849|NCT01004003|588692082|FG006|Overall Study|Progressive disease|1|||
162997850|NCT01004003|588692083|FG007|Overall Study|Progressive disease|39|||
162997851|NCT01004003|588692084|FG008|Overall Study|Progressive disease|22|||
162997852|NCT01004003|588692076|FG000|Overall Study|Adverse Event|4|||
162997853|NCT01004003|588692077|FG001|Overall Study|Adverse Event|2|||
162997854|NCT01004003|588692078|FG002|Overall Study|Adverse Event|3|||
162997855|NCT01004003|588692079|FG003|Overall Study|Adverse Event|3|||
162997856|NCT01004003|588692080|FG004|Overall Study|Adverse Event|2|||
162997857|NCT01004003|588692081|FG005|Overall Study|Adverse Event|2|||
162997858|NCT01004003|588692082|FG006|Overall Study|Adverse Event|7|||
162997859|NCT01004003|588692083|FG007|Overall Study|Adverse Event|21|||
162997860|NCT01004003|588692084|FG008|Overall Study|Adverse Event|6|||
162997861|NCT01004003|588692076|FG000|Overall Study|Refused to continue taking trial med.|0|||
162997862|NCT01004003|588692077|FG001|Overall Study|Refused to continue taking trial med.|0|||
162997863|NCT01004003|588692078|FG002|Overall Study|Refused to continue taking trial med.|0|||
162997864|NCT01004003|588692079|FG003|Overall Study|Refused to continue taking trial med.|0|||
162997865|NCT01004003|588692080|FG004|Overall Study|Refused to continue taking trial med.|0|||
162997866|NCT01004003|588692081|FG005|Overall Study|Refused to continue taking trial med.|0|||
162997867|NCT01004003|588692082|FG006|Overall Study|Refused to continue taking trial med.|0|||
162997868|NCT01004003|588692083|FG007|Overall Study|Refused to continue taking trial med.|0|||
162997869|NCT01004003|588692084|FG008|Overall Study|Refused to continue taking trial med.|2|||
162997870|NCT01004003|588692076|FG000|Overall Study|Other|0|||
162997871|NCT01004003|588692077|FG001|Overall Study|Other|0|||
162997872|NCT01004003|588692078|FG002|Overall Study|Other|0|||
162997873|NCT01004003|588692079|FG003|Overall Study|Other|0|||
162997874|NCT01004003|588692080|FG004|Overall Study|Other|0|||
162637123|NCT01782495|587386127|FG003|Overall Study|Adverse Event|0|||
162997875|NCT01004003|588692081|FG005|Overall Study|Other|1|||
162997876|NCT01004003|588692082|FG006|Overall Study|Other|0|||
162997877|NCT01004003|588692083|FG007|Overall Study|Other|0|||
162997878|NCT01004003|588692084|FG008|Overall Study|Other|0|||
162997879|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
162997880|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
162997881|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
162997882|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
162997883|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
162997884|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
162997885|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
162997886|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
162997887|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
162997888|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
162997889|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
162997890|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
162997891|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
162997892|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
162997893|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
162997894|NCT04856930|588693760|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997895|NCT04856930|588693761|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
162997896|NCT04856930|588693762|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997897|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
162997898|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
162997899|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
162997900|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
162997901|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
162997902|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
162997903|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
162997904|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
162997905|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
162997906|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
162997907|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
162997908|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
162997909|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
162997910|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997911|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
162997912|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
162997913|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
162997914|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
162997915|NCT04856930|588693760|FG000|Extension Period (16 Weeks)|Other than specified|0|||
162997916|NCT04856930|588693761|FG001|Extension Period (16 Weeks)|Other than specified|0|||
162997917|NCT04856930|588693762|FG002|Extension Period (16 Weeks)|Other than specified|1|||
162997918|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
162997919|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
162997920|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
162997921|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
162997922|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
162997923|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
162997924|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
162997925|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
162997926|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
162997927|NCT04856930|588693760|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
162997928|NCT04856930|588693761|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
162997929|NCT04856930|588693762|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
162997930|NCT00678210|588693763|FG000|Overall Study|Adverse Event|1|||
162997931|NCT00678210|588693764|FG001|Overall Study|Adverse Event|2|||
162997932|NCT00678210|588693765|FG002|Overall Study|Adverse Event|3|||
162997933|NCT00678210|588693766|FG003|Overall Study|Adverse Event|3|||
162997934|NCT00678210|588693763|FG000|Overall Study|Lack of Efficacy|2|||
162997935|NCT00678210|588693764|FG001|Overall Study|Lack of Efficacy|3|||
162997936|NCT00678210|588693765|FG002|Overall Study|Lack of Efficacy|1|||
162997937|NCT00678210|588693766|FG003|Overall Study|Lack of Efficacy|9|||
162997938|NCT00678210|588693763|FG000|Overall Study|Lost to Follow-up|4|||
162997939|NCT00678210|588693764|FG001|Overall Study|Lost to Follow-up|2|||
162997940|NCT00678210|588693765|FG002|Overall Study|Lost to Follow-up|0|||
162997941|NCT00678210|588693766|FG003|Overall Study|Lost to Follow-up|1|||
162997942|NCT00678210|588693763|FG000|Overall Study|Withdrawal by Subject|3|||
162997943|NCT00678210|588693764|FG001|Overall Study|Withdrawal by Subject|4|||
162997944|NCT00678210|588693765|FG002|Overall Study|Withdrawal by Subject|1|||
162997945|NCT00678210|588693766|FG003|Overall Study|Withdrawal by Subject|7|||
162997946|NCT00678210|588693763|FG000|Overall Study|Other|1|||
162997947|NCT00678210|588693764|FG001|Overall Study|Other|0|||
162997948|NCT00678210|588693765|FG002|Overall Study|Other|1|||
162997949|NCT00678210|588693766|FG003|Overall Study|Other|0|||
162997950|NCT01383707|588693769|FG000|Overall Study|Consent withdrawal|6|||
162997951|NCT01383707|588693769|FG000|Overall Study|Death|19|||
162997952|NCT01383707|588693769|FG000|Overall Study|Other|8|||
162997953|NCT01383707|588693769|FG000|Overall Study|Sponsor's decision|2|||
162997954|NCT01383707|588693769|FG000|Overall Study|Adverse Event|14|||
162997955|NCT01383707|588693769|FG000|Overall Study|Progressive disease|23|||
162997956|NCT01625988|588693774|FG000|Overall Study|Lost to Follow-up|5|||
162997957|NCT01625988|588693775|FG001|Overall Study|Lost to Follow-up|6|||
162997958|NCT01625988|588693774|FG000|Overall Study|Withdrawal by Subject|8|||
162997959|NCT01625988|588693775|FG001|Overall Study|Withdrawal by Subject|3|||
162997960|NCT01625988|588693774|FG000|Overall Study|Adverse Event|0|||
162997961|NCT01625988|588693775|FG001|Overall Study|Adverse Event|1|||
162997962|NCT01625988|588693774|FG000|Overall Study|Lack of Efficacy|0|||
162997963|NCT01625988|588693775|FG001|Overall Study|Lack of Efficacy|1|||
162997964|NCT01625988|588693774|FG000|Overall Study|Randomized Inappropriately|1|||
162997965|NCT01625988|588693775|FG001|Overall Study|Randomized Inappropriately|0|||
162997966|NCT01625988|588693774|FG000|Overall Study|Protocol Violation|0|||
162997967|NCT01625988|588693775|FG001|Overall Study|Protocol Violation|2|||
162997968|NCT02075515|588693778|FG000|Overall Study|Serious Adverse Event|1|||
162997969|NCT02075515|588693779|FG001|Overall Study|Serious Adverse Event|1|||
162997970|NCT02075515|588693780|FG002|Overall Study|Serious Adverse Event|1|||
162997971|NCT02075515|588693778|FG000|Overall Study|Non-Serious Adverse Event|0|||
162997972|NCT02075515|588693779|FG001|Overall Study|Non-Serious Adverse Event|1|||
162997973|NCT02075515|588693780|FG002|Overall Study|Non-Serious Adverse Event|0|||
162997974|NCT02075515|588693778|FG000|Overall Study|Withdrawal by Subject|2|||
162997975|NCT02075515|588693779|FG001|Overall Study|Withdrawal by Subject|0|||
162997976|NCT02075515|588693780|FG002|Overall Study|Withdrawal by Subject|1|||
162997977|NCT02075515|588693778|FG000|Overall Study|Lost to Follow-up|1|||
162997978|NCT02075515|588693779|FG001|Overall Study|Lost to Follow-up|3|||
162997979|NCT02075515|588693780|FG002|Overall Study|Lost to Follow-up|6|||
162997980|NCT00741338|588693791|FG000|Overall Study|Adverse Event|0|||
162997981|NCT00741338|588693792|FG001|Overall Study|Adverse Event|1|||
162997982|NCT03593395|588693793|FG000|Overall Study|Lost to Follow-up|48|||
162997983|NCT03593395|588693794|FG001|Overall Study|Lost to Follow-up|3|||
162997984|NCT03593395|588693793|FG000|Overall Study|Withdrawal by Subject|5|||
162997985|NCT03593395|588693794|FG001|Overall Study|Withdrawal by Subject|24|||
162997986|NCT03593395|588693793|FG000|Overall Study|Death|2|||
162997987|NCT03593395|588693794|FG001|Overall Study|Death|3|||
162997988|NCT03593395|588693793|FG000|Overall Study|Physician Decision|0|||
162997989|NCT03593395|588693794|FG001|Overall Study|Physician Decision|6|||
162997990|NCT03593395|588693793|FG000|Overall Study|Participant Relocated|19|||
162997991|NCT03593395|588693794|FG001|Overall Study|Participant Relocated|3|||
162997992|NCT03593395|588693793|FG000|Overall Study|No Information|1|||
162997993|NCT03593395|588693794|FG001|Overall Study|No Information|7|||
162997994|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
162997995|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
162997996|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
162997997|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162997998|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
162997999|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
162998000|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162998001|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
162998002|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162998003|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
162998004|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162998005|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162637124|NCT01782495|587386128|FG004|Overall Study|Adverse Event|0|||
162998006|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
162998007|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162998008|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
162998009|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
162998010|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998011|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
162998012|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998013|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
162998014|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162998015|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998016|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
162998017|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998018|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
162998019|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998020|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998021|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
162998022|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998023|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
162998024|NCT03713632|588693795|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
162998025|NCT03713632|588693796|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998026|NCT03713632|588693797|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998027|NCT03713632|588693798|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
163060446|NCT04167462|588929898|FG000|Overall Study|Lack of Efficacy|0|||
162998028|NCT03713632|588693799|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
162998029|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
162998030|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
162998031|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
162998032|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
162998033|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
162998034|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
162998035|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
162998036|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
162998037|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
162998038|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
162998039|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
162998040|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
162998041|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
162998042|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
162998043|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
162998044|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
162998045|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
162998046|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162998047|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
162998048|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
162998049|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
162998050|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162998051|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162998052|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
162998053|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
162998054|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
162998055|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998056|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998057|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998058|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
162998059|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Death|0|||
162998060|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Death|1|||
162998061|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Death|0|||
162998062|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Death|0|||
162998063|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Death|0|||
162998064|NCT03713632|588693795|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998065|NCT03713632|588693796|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
162998066|NCT03713632|588693797|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998067|NCT03713632|588693798|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998068|NCT03713632|588693799|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
162998069|NCT01524978|588693800|FG000|Overall Study|Other|16|||
162998070|NCT01524978|588693801|FG001|Overall Study|Other|2|||
162998071|NCT01524978|588693802|FG002|Overall Study|Other|1|||
162998072|NCT01524978|588693803|FG003|Overall Study|Other|2|||
162998073|NCT01524978|588693804|FG004|Overall Study|Other|1|||
162998074|NCT01524978|588693805|FG005|Overall Study|Other|3|||
162998075|NCT01524978|588693806|FG006|Overall Study|Other|17|||
162998076|NCT01524978|588693807|FG007|Overall Study|Other|1|||
162998077|NCT01524978|588693808|FG008|Overall Study|Other|2|||
162998078|NCT01524978|588693809|FG009|Overall Study|Other|2|||
162998079|NCT01524978|588693810|FG010|Overall Study|Other|5|||
162998080|NCT01524978|588693800|FG000|Overall Study|Withdrawal by Subject|12|||
162998081|NCT01524978|588693801|FG001|Overall Study|Withdrawal by Subject|0|||
162998082|NCT01524978|588693802|FG002|Overall Study|Withdrawal by Subject|1|||
162998083|NCT01524978|588693803|FG003|Overall Study|Withdrawal by Subject|1|||
162998084|NCT01524978|588693804|FG004|Overall Study|Withdrawal by Subject|3|||
162998085|NCT01524978|588693805|FG005|Overall Study|Withdrawal by Subject|1|||
162998086|NCT01524978|588693806|FG006|Overall Study|Withdrawal by Subject|6|||
162998087|NCT01524978|588693807|FG007|Overall Study|Withdrawal by Subject|2|||
162998088|NCT01524978|588693808|FG008|Overall Study|Withdrawal by Subject|4|||
162998089|NCT01524978|588693809|FG009|Overall Study|Withdrawal by Subject|0|||
162998090|NCT01524978|588693810|FG010|Overall Study|Withdrawal by Subject|5|||
162998091|NCT01524978|588693800|FG000|Overall Study|Lost to Follow-up|0|||
162998092|NCT01524978|588693801|FG001|Overall Study|Lost to Follow-up|0|||
162998093|NCT01524978|588693802|FG002|Overall Study|Lost to Follow-up|3|||
162998094|NCT01524978|588693803|FG003|Overall Study|Lost to Follow-up|0|||
162998095|NCT01524978|588693804|FG004|Overall Study|Lost to Follow-up|1|||
162998096|NCT01524978|588693805|FG005|Overall Study|Lost to Follow-up|1|||
162998097|NCT01524978|588693806|FG006|Overall Study|Lost to Follow-up|2|||
162998098|NCT01524978|588693807|FG007|Overall Study|Lost to Follow-up|0|||
162998099|NCT01524978|588693808|FG008|Overall Study|Lost to Follow-up|1|||
162998100|NCT01524978|588693809|FG009|Overall Study|Lost to Follow-up|1|||
162998101|NCT01524978|588693810|FG010|Overall Study|Lost to Follow-up|1|||
162998102|NCT01524978|588693800|FG000|Overall Study|Death|34|||
162998103|NCT01524978|588693801|FG001|Overall Study|Death|2|||
162998104|NCT01524978|588693802|FG002|Overall Study|Death|5|||
162998105|NCT01524978|588693803|FG003|Overall Study|Death|24|||
162998106|NCT01524978|588693804|FG004|Overall Study|Death|4|||
162998107|NCT01524978|588693805|FG005|Overall Study|Death|4|||
162998108|NCT01524978|588693806|FG006|Overall Study|Death|1|||
162998109|NCT01524978|588693807|FG007|Overall Study|Death|9|||
162998110|NCT01524978|588693808|FG008|Overall Study|Death|5|||
162998111|NCT01524978|588693809|FG009|Overall Study|Death|6|||
162998112|NCT01524978|588693810|FG010|Overall Study|Death|17|||
162998113|NCT02370238|588693817|FG000|Overall Study|Death|42|||
162998114|NCT02370238|588693818|FG001|Overall Study|Death|35|||
162998115|NCT02370238|588693817|FG000|Overall Study|Lost to Follow-up|1|||
162998116|NCT02370238|588693818|FG001|Overall Study|Lost to Follow-up|3|||
162998117|NCT02370238|588693817|FG000|Overall Study|Withdrawal by Subject|2|||
162998118|NCT02370238|588693818|FG001|Overall Study|Withdrawal by Subject|6|||
162998119|NCT02370238|588693817|FG000|Overall Study|Other|2|||
162998120|NCT02370238|588693818|FG001|Overall Study|Other|1|||
162998121|NCT01937871|588693819|FG000|Overall Study|Adverse Event|6|||
162998122|NCT01937871|588693820|FG001|Overall Study|Adverse Event|6|||
162998123|NCT01937871|588693821|FG002|Overall Study|Adverse Event|2|||
162998124|NCT01937871|588693819|FG000|Overall Study|Lost to Follow-up|8|||
162998125|NCT01937871|588693820|FG001|Overall Study|Lost to Follow-up|2|||
162998126|NCT01937871|588693821|FG002|Overall Study|Lost to Follow-up|4|||
162998127|NCT01937871|588693819|FG000|Overall Study|Withdrawal by Subject|9|||
162998128|NCT01937871|588693820|FG001|Overall Study|Withdrawal by Subject|6|||
162998129|NCT01937871|588693821|FG002|Overall Study|Withdrawal by Subject|4|||
162998130|NCT01937871|588693819|FG000|Overall Study|Physician Decision|0|||
162998131|NCT01937871|588693820|FG001|Overall Study|Physician Decision|1|||
162998132|NCT01937871|588693821|FG002|Overall Study|Physician Decision|0|||
162998133|NCT01937871|588693819|FG000|Overall Study|Entry Criteria Not Met|1|||
162998134|NCT01937871|588693820|FG001|Overall Study|Entry Criteria Not Met|2|||
162998135|NCT01937871|588693821|FG002|Overall Study|Entry Criteria Not Met|1|||
162998136|NCT02652949|588693822|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
162998137|NCT02652949|588693822|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
162998138|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
162998139|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
162998140|NCT02652949|588693822|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
162998141|NCT02652949|588693822|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
162998142|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
162998143|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
162998144|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
162998145|NCT02652949|588693822|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
162998146|NCT02652949|588693822|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
162998147|NCT02652949|588693822|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
162998148|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
162998149|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
162998150|NCT02652949|588693822|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162998151|NCT02652949|588693822|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
162998152|NCT02652949|588693822|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
162998153|NCT01973595|588693823|FG000|Washout|Withdrawal by Subject|1|||
162998154|NCT01973595|588693824|FG001|Washout|Withdrawal by Subject|0|||
162998155|NCT01973595|588693825|FG002|Washout|Withdrawal by Subject|1|||
162998156|NCT01973595|588693826|FG003|Washout|Withdrawal by Subject|0|||
162998157|NCT01141205|588693827|FG000|Overall Study|Physician Decision|1|||
162998158|NCT01141205|588693828|FG001|Overall Study|Physician Decision|1|||
162998159|NCT01141205|588693827|FG000|Overall Study|Lost to Follow-up|1|||
162998160|NCT01141205|588693828|FG001|Overall Study|Lost to Follow-up|0|||
162998161|NCT01141205|588693827|FG000|Overall Study|Withdrawal by Subject|1|||
162998162|NCT01141205|588693828|FG001|Overall Study|Withdrawal by Subject|1|||
162998163|NCT03837743|588693834|FG000|Overall Study|Adverse Event|1|||
162998164|NCT03837743|588693834|FG000|Overall Study|Withdrawal by Subject|2|||
162998165|NCT05199090|588693835|FG000|Overall Study|Adverse Event|1|||
162998166|NCT05199090|588693836|FG001|Overall Study|Adverse Event|4|||
162998167|NCT05199090|588693837|FG002|Overall Study|Adverse Event|0|||
162998168|NCT05199090|588693838|FG003|Overall Study|Adverse Event|0|||
162998169|NCT05199090|588693839|FG004|Overall Study|Adverse Event|0|||
162998170|NCT05199090|588693840|FG005|Overall Study|Adverse Event|0|||
162998171|NCT05199090|588693835|FG000|Overall Study|Lost to Follow-up|1|||
162998172|NCT05199090|588693836|FG001|Overall Study|Lost to Follow-up|0|||
162998173|NCT05199090|588693837|FG002|Overall Study|Lost to Follow-up|1|||
162998174|NCT05199090|588693838|FG003|Overall Study|Lost to Follow-up|4|||
162998175|NCT05199090|588693839|FG004|Overall Study|Lost to Follow-up|0|||
162998176|NCT05199090|588693840|FG005|Overall Study|Lost to Follow-up|5|||
162998177|NCT05199090|588693835|FG000|Overall Study|Physician Decision|0|||
162998178|NCT05199090|588693836|FG001|Overall Study|Physician Decision|0|||
162998179|NCT05199090|588693837|FG002|Overall Study|Physician Decision|0|||
162998180|NCT05199090|588693838|FG003|Overall Study|Physician Decision|0|||
162998181|NCT05199090|588693839|FG004|Overall Study|Physician Decision|0|||
162998182|NCT05199090|588693840|FG005|Overall Study|Physician Decision|1|||
162998183|NCT05199090|588693835|FG000|Overall Study|Study terminated by sponsor|0|||
162998184|NCT05199090|588693836|FG001|Overall Study|Study terminated by sponsor|6|||
162998185|NCT05199090|588693837|FG002|Overall Study|Study terminated by sponsor|0|||
162998186|NCT05199090|588693838|FG003|Overall Study|Study terminated by sponsor|0|||
162998187|NCT05199090|588693839|FG004|Overall Study|Study terminated by sponsor|0|||
162998188|NCT05199090|588693840|FG005|Overall Study|Study terminated by sponsor|5|||
162998189|NCT05199090|588693835|FG000|Overall Study|Subject decision|0|||
162998190|NCT05199090|588693836|FG001|Overall Study|Subject decision|4|||
162998191|NCT05199090|588693837|FG002|Overall Study|Subject decision|0|||
162998192|NCT05199090|588693838|FG003|Overall Study|Subject decision|2|||
162998193|NCT05199090|588693839|FG004|Overall Study|Subject decision|5|||
162998194|NCT05199090|588693840|FG005|Overall Study|Subject decision|2|||
162998195|NCT04868968|588693841|FG000|Overall Study|Lost to Follow-up|1|||
162998196|NCT00384930|588693844|FG000|Overall Study|Adverse Event|5|||
162998197|NCT00384930|588693845|FG001|Overall Study|Adverse Event|4|||
162998198|NCT00384930|588693846|FG002|Overall Study|Adverse Event|12|||
162998199|NCT00384930|588693847|FG003|Overall Study|Adverse Event|11|||
162998200|NCT00384930|588693848|FG004|Overall Study|Adverse Event|14|||
162998201|NCT00384930|588693844|FG000|Overall Study|Entry Criteria Not Met|2|||
162998202|NCT00384930|588693845|FG001|Overall Study|Entry Criteria Not Met|6|||
162998203|NCT00384930|588693846|FG002|Overall Study|Entry Criteria Not Met|7|||
162998204|NCT00384930|588693847|FG003|Overall Study|Entry Criteria Not Met|8|||
162998205|NCT00384930|588693848|FG004|Overall Study|Entry Criteria Not Met|4|||
162998206|NCT00384930|588693844|FG000|Overall Study|Lack of Efficacy|1|||
162998207|NCT00384930|588693845|FG001|Overall Study|Lack of Efficacy|1|||
162998208|NCT00384930|588693846|FG002|Overall Study|Lack of Efficacy|2|||
162998209|NCT00384930|588693847|FG003|Overall Study|Lack of Efficacy|1|||
162998210|NCT00384930|588693848|FG004|Overall Study|Lack of Efficacy|2|||
162998211|NCT00384930|588693844|FG000|Overall Study|Lost to Follow-up|5|||
162998212|NCT00384930|588693845|FG001|Overall Study|Lost to Follow-up|3|||
162998213|NCT00384930|588693846|FG002|Overall Study|Lost to Follow-up|0|||
162998214|NCT00384930|588693847|FG003|Overall Study|Lost to Follow-up|4|||
162998215|NCT00384930|588693848|FG004|Overall Study|Lost to Follow-up|6|||
162998216|NCT00384930|588693844|FG000|Overall Study|Physician Decision|0|||
162998217|NCT00384930|588693845|FG001|Overall Study|Physician Decision|1|||
162998218|NCT00384930|588693846|FG002|Overall Study|Physician Decision|1|||
162998219|NCT00384930|588693847|FG003|Overall Study|Physician Decision|0|||
162998220|NCT00384930|588693848|FG004|Overall Study|Physician Decision|1|||
162998221|NCT00384930|588693844|FG000|Overall Study|Protocol Violation|1|||
162998222|NCT00384930|588693845|FG001|Overall Study|Protocol Violation|0|||
162998223|NCT00384930|588693846|FG002|Overall Study|Protocol Violation|1|||
162998224|NCT00384930|588693847|FG003|Overall Study|Protocol Violation|6|||
162998225|NCT00384930|588693848|FG004|Overall Study|Protocol Violation|4|||
162998226|NCT00384930|588693844|FG000|Overall Study|Sponsor Decision|3|||
162998227|NCT00384930|588693845|FG001|Overall Study|Sponsor Decision|4|||
162998228|NCT00384930|588693846|FG002|Overall Study|Sponsor Decision|0|||
162998229|NCT00384930|588693847|FG003|Overall Study|Sponsor Decision|5|||
162637125|NCT01782495|587386129|FG005|Overall Study|Adverse Event|0|||
162998230|NCT00384930|588693848|FG004|Overall Study|Sponsor Decision|0|||
162998231|NCT00384930|588693844|FG000|Overall Study|Withdrawal by Subject|9|||
162998232|NCT00384930|588693845|FG001|Overall Study|Withdrawal by Subject|7|||
162998233|NCT00384930|588693846|FG002|Overall Study|Withdrawal by Subject|7|||
162998234|NCT00384930|588693847|FG003|Overall Study|Withdrawal by Subject|6|||
162998235|NCT00384930|588693848|FG004|Overall Study|Withdrawal by Subject|16|||
162998236|NCT00384930|588693844|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
162998237|NCT00384930|588693845|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
162998238|NCT00384930|588693846|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
162637126|NCT01782495|587386130|FG006|Overall Study|Adverse Event|0|||
162998239|NCT00384930|588693847|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
162998240|NCT00384930|588693848|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
162998241|NCT01547130|588693853|FG000|Overall Study|Lost to Follow-up|9|||
162998242|NCT01547130|588693854|FG001|Overall Study|Lost to Follow-up|5|||
162998243|NCT01685840|588693855|FG000|Overall Study|Death|77|||
162998244|NCT01685840|588693856|FG001|Overall Study|Death|66|||
162998245|NCT01685840|588693855|FG000|Overall Study|Lost to Follow-up|27|||
162998246|NCT01685840|588693856|FG001|Overall Study|Lost to Follow-up|25|||
163060447|NCT04167462|588929899|FG001|Overall Study|Lack of Efficacy|1|||
162998247|NCT01685840|588693855|FG000|Overall Study|Physician Decision|3|||
162998248|NCT01685840|588693856|FG001|Overall Study|Physician Decision|7|||
162998249|NCT01685840|588693855|FG000|Overall Study|Withdrawal by Subject|14|||
162998250|NCT01685840|588693856|FG001|Overall Study|Withdrawal by Subject|17|||
162998251|NCT01685840|588693855|FG000|Overall Study|Futility|197|||
162998252|NCT01685840|588693856|FG001|Overall Study|Futility|200|||
162998253|NCT01685840|588693855|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
162998254|NCT01685840|588693856|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
162998255|NCT00710866|588693857|FG000|Overall Study|Protocol Violation|5|||
162998256|NCT00710866|588693858|FG001|Overall Study|Protocol Violation|4|||
162998257|NCT00710866|588693857|FG000|Overall Study|Withdrawal by Subject|2|||
162998258|NCT00710866|588693858|FG001|Overall Study|Withdrawal by Subject|1|||
162998259|NCT00710866|588693857|FG000|Overall Study|Lost to Follow-up|1|||
162998260|NCT00710866|588693858|FG001|Overall Study|Lost to Follow-up|0|||
162998261|NCT00710866|588693857|FG000|Overall Study|Failed to meet eligibility|1|||
162998262|NCT00710866|588693858|FG001|Overall Study|Failed to meet eligibility|1|||
162998263|NCT01098487|588693864|FG000|Overall Study|Adverse Event|22|||
162998264|NCT01098487|588693864|FG000|Overall Study|Lack of Efficacy|11|||
162998265|NCT01098487|588693864|FG000|Overall Study|Withdrawal by Subject|7|||
162998266|NCT01098487|588693864|FG000|Overall Study|Lost to Follow-up|3|||
162998267|NCT01098487|588693864|FG000|Overall Study|Physician Decision|1|||
162998268|NCT00351533|588693866|FG000|Overall Study|Extubated before first BAL|1|||
162998269|NCT00351533|588693867|FG001|Overall Study|Extubated before first BAL|0|||
162998270|NCT00351533|588693866|FG000|Overall Study|Lost to Follow-up|1|||
162998271|NCT00351533|588693867|FG001|Overall Study|Lost to Follow-up|3|||
162998272|NCT00351533|588693866|FG000|Overall Study|Physician Decision|0|||
162998273|NCT00351533|588693867|FG001|Overall Study|Physician Decision|1|||
162998274|NCT00351533|588693866|FG000|Overall Study|Withdrawal by Subject|0|||
162998275|NCT00351533|588693867|FG001|Overall Study|Withdrawal by Subject|1|||
162998276|NCT01589497|588693868|FG000|Overall Study|Withdrawal by Subject|0|||
162998277|NCT01589497|588693869|FG001|Overall Study|Withdrawal by Subject|1|||
162998278|NCT01589497|588693870|FG002|Overall Study|Withdrawal by Subject|0|||
162998279|NCT01589497|588693871|FG003|Overall Study|Withdrawal by Subject|1|||
162998280|NCT01589497|588693868|FG000|Overall Study|Death|1|||
162998281|NCT01589497|588693869|FG001|Overall Study|Death|0|||
162998282|NCT01589497|588693870|FG002|Overall Study|Death|0|||
162998283|NCT01589497|588693871|FG003|Overall Study|Death|0|||
162998284|NCT01589497|588693868|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998285|NCT01589497|588693869|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998286|NCT01589497|588693870|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
162998287|NCT01589497|588693871|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
162998288|NCT01885195|588693872|FG000|Overall Study|Adverse Event|29|||
162998289|NCT01885195|588693872|FG000|Overall Study|Death|1|||
162998290|NCT01885195|588693872|FG000|Overall Study|Disease Progression|67|||
162998291|NCT01885195|588693872|FG000|Overall Study|Protocol Deviation|2|||
162998292|NCT01885195|588693872|FG000|Overall Study|Physician Decision|3|||
162998293|NCT01885195|588693872|FG000|Overall Study|Patient/guardian decision|8|||
162998294|NCT03390426|588693875|FG000|Overall Study|Protocol Violation|0|||
162998295|NCT03390426|588693876|FG001|Overall Study|Protocol Violation|1|||
162998296|NCT00259272|588693877|FG000|Overall Study|Adverse Event|2|||
162998297|NCT00259272|588693878|FG001|Overall Study|Adverse Event|1|||
162998298|NCT00259272|588693879|FG002|Overall Study|Adverse Event|0|||
162998299|NCT00259272|588693880|FG003|Overall Study|Adverse Event|3|||
162998300|NCT00259272|588693877|FG000|Overall Study|Lack of Efficacy|5|||
162998301|NCT00259272|588693878|FG001|Overall Study|Lack of Efficacy|1|||
162998302|NCT00259272|588693879|FG002|Overall Study|Lack of Efficacy|2|||
162998303|NCT00259272|588693880|FG003|Overall Study|Lack of Efficacy|6|||
162998304|NCT00259272|588693877|FG000|Overall Study|Physician Decision|1|||
162998305|NCT00259272|588693878|FG001|Overall Study|Physician Decision|2|||
162998306|NCT00259272|588693879|FG002|Overall Study|Physician Decision|1|||
162998307|NCT00259272|588693880|FG003|Overall Study|Physician Decision|3|||
162998308|NCT00259272|588693877|FG000|Overall Study|Protocol Violation|2|||
162998309|NCT00259272|588693878|FG001|Overall Study|Protocol Violation|0|||
162998310|NCT00259272|588693879|FG002|Overall Study|Protocol Violation|0|||
162998311|NCT00259272|588693880|FG003|Overall Study|Protocol Violation|1|||
162998312|NCT00259272|588693877|FG000|Overall Study|Sponsor Decision|0|||
162998313|NCT00259272|588693878|FG001|Overall Study|Sponsor Decision|1|||
162998314|NCT00259272|588693879|FG002|Overall Study|Sponsor Decision|0|||
162998315|NCT00259272|588693880|FG003|Overall Study|Sponsor Decision|0|||
162998316|NCT00259272|588693877|FG000|Overall Study|Withdrawal by Subject|4|||
163060448|NCT02320396|588929900|FG000|Overall Study|Adverse Event|2|||
162998317|NCT00259272|588693878|FG001|Overall Study|Withdrawal by Subject|2|||
162998318|NCT00259272|588693879|FG002|Overall Study|Withdrawal by Subject|2|||
162998319|NCT00259272|588693880|FG003|Overall Study|Withdrawal by Subject|7|||
162998320|NCT00259272|588693877|FG000|Overall Study|Lost to Follow-up|1|||
163060449|NCT02320396|588929901|FG001|Overall Study|Adverse Event|2|||
162998321|NCT00259272|588693878|FG001|Overall Study|Lost to Follow-up|0|||
162998322|NCT00259272|588693879|FG002|Overall Study|Lost to Follow-up|0|||
162998323|NCT00259272|588693880|FG003|Overall Study|Lost to Follow-up|1|||
163060450|NCT02320396|588929900|FG000|Overall Study|Pregnancy|0|||
163060451|NCT02320396|588929901|FG001|Overall Study|Pregnancy|1|||
163060452|NCT02320396|588929900|FG000|Overall Study|Protocol Violation|0|||
163060453|NCT02320396|588929901|FG001|Overall Study|Protocol Violation|1|||
163060454|NCT02320396|588929900|FG000|Overall Study|Withdrawal by Subject|2|||
163060455|NCT02320396|588929901|FG001|Overall Study|Withdrawal by Subject|0|||
163060456|NCT00142415|588929902|FG000|Overall Study|Physician Decision|0|||
163060457|NCT00142415|588929903|FG001|Overall Study|Physician Decision|0|||
163060458|NCT00142415|588929904|FG002|Overall Study|Physician Decision|0|||
162998324|NCT03301623|588693883|FG000|Overall Study|Death|3|||
162637127|NCT01782495|587386131|FG007|Overall Study|Adverse Event|2|||
162998325|NCT03301623|588693884|FG001|Overall Study|Death|1|||
162998326|NCT03301623|588693883|FG000|Overall Study|Withdrawal by Subject|11|||
162998327|NCT03301623|588693884|FG001|Overall Study|Withdrawal by Subject|13|||
162998328|NCT03301623|588693883|FG000|Overall Study|Lost to Follow-up|3|||
162998329|NCT03301623|588693884|FG001|Overall Study|Lost to Follow-up|1|||
162998330|NCT02516553|588693885|FG000|Overall Study|Progressive disease|2|||
162998331|NCT02516553|588693886|FG001|Overall Study|Progressive disease|2|||
162998332|NCT02516553|588693887|FG002|Overall Study|Progressive disease|3|||
162998333|NCT02516553|588693888|FG003|Overall Study|Progressive disease|5|||
162998334|NCT02516553|588693889|FG004|Overall Study|Progressive disease|3|||
162998335|NCT02516553|588693890|FG005|Overall Study|Progressive disease|0|||
162998336|NCT02516553|588693891|FG006|Overall Study|Progressive disease|5|||
162998337|NCT02516553|588693892|FG007|Overall Study|Progressive disease|5|||
162998338|NCT02516553|588693893|FG008|Overall Study|Progressive disease|11|||
162998339|NCT02516553|588693894|FG009|Overall Study|Progressive disease|3|||
162998340|NCT02516553|588693895|FG010|Overall Study|Progressive disease|10|||
162998341|NCT02516553|588693896|FG011|Overall Study|Progressive disease|8|||
162998342|NCT02516553|588693897|FG012|Overall Study|Progressive disease|8|||
162998343|NCT02516553|588693898|FG013|Overall Study|Progressive disease|2|||
162998344|NCT02516553|588693899|FG014|Overall Study|Progressive disease|2|||
162998345|NCT02516553|588693900|FG015|Overall Study|Progressive disease|2|||
162998346|NCT02516553|588693901|FG016|Overall Study|Progressive disease|1|||
162998347|NCT02516553|588693902|FG017|Overall Study|Progressive disease|9|||
162998348|NCT02516553|588693903|FG018|Overall Study|Progressive disease|12|||
162998349|NCT02516553|588693904|FG019|Overall Study|Progressive disease|7|||
162998350|NCT02516553|588693905|FG020|Overall Study|Progressive disease|16|||
162998351|NCT02516553|588693906|FG021|Overall Study|Progressive disease|18|||
162998352|NCT02516553|588693885|FG000|Overall Study|Dose limiting toxicity|0|||
162998353|NCT02516553|588693886|FG001|Overall Study|Dose limiting toxicity|0|||
162998354|NCT02516553|588693887|FG002|Overall Study|Dose limiting toxicity|0|||
162998355|NCT02516553|588693888|FG003|Overall Study|Dose limiting toxicity|0|||
162998356|NCT02516553|588693889|FG004|Overall Study|Dose limiting toxicity|3|||
162998357|NCT02516553|588693890|FG005|Overall Study|Dose limiting toxicity|1|||
162998358|NCT02516553|588693891|FG006|Overall Study|Dose limiting toxicity|1|||
162998359|NCT02516553|588693892|FG007|Overall Study|Dose limiting toxicity|0|||
162998360|NCT02516553|588693893|FG008|Overall Study|Dose limiting toxicity|1|||
162998361|NCT02516553|588693894|FG009|Overall Study|Dose limiting toxicity|0|||
162998362|NCT02516553|588693895|FG010|Overall Study|Dose limiting toxicity|0|||
162998363|NCT02516553|588693896|FG011|Overall Study|Dose limiting toxicity|1|||
163060459|NCT00142415|588929905|FG003|Overall Study|Physician Decision|0|||
163060460|NCT00142415|588929906|FG004|Overall Study|Physician Decision|1|||
163060461|NCT00142415|588929907|FG005|Overall Study|Physician Decision|2|||
162637128|NCT01782495|587386132|FG008|Overall Study|Adverse Event|0|||
162637129|NCT01782495|587386133|FG009|Overall Study|Adverse Event|0|||
162637130|NCT01782495|587386134|FG010|Overall Study|Adverse Event|0|||
162637131|NCT01782495|587386124|FG000|Overall Study|Withdrew Consent|0|||
162637132|NCT01782495|587386125|FG001|Overall Study|Withdrew Consent|1|||
162998364|NCT02516553|588693897|FG012|Overall Study|Dose limiting toxicity|0|||
162998365|NCT02516553|588693898|FG013|Overall Study|Dose limiting toxicity|1|||
162998366|NCT02516553|588693899|FG014|Overall Study|Dose limiting toxicity|0|||
162998367|NCT02516553|588693900|FG015|Overall Study|Dose limiting toxicity|0|||
162998368|NCT02516553|588693901|FG016|Overall Study|Dose limiting toxicity|1|||
162998369|NCT02516553|588693902|FG017|Overall Study|Dose limiting toxicity|1|||
162998370|NCT02516553|588693903|FG018|Overall Study|Dose limiting toxicity|0|||
163060462|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
163060463|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
163060464|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
163060465|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
162637133|NCT01782495|587386126|FG002|Overall Study|Withdrew Consent|0|||
162637134|NCT01782495|587386127|FG003|Overall Study|Withdrew Consent|0|||
162637135|NCT01782495|587386128|FG004|Overall Study|Withdrew Consent|0|||
162637136|NCT01782495|587386129|FG005|Overall Study|Withdrew Consent|0|||
162637137|NCT01782495|587386130|FG006|Overall Study|Withdrew Consent|0|||
162998371|NCT02516553|588693904|FG019|Overall Study|Dose limiting toxicity|2|||
162998372|NCT02516553|588693905|FG020|Overall Study|Dose limiting toxicity|0|||
162998373|NCT02516553|588693906|FG021|Overall Study|Dose limiting toxicity|0|||
162998374|NCT02516553|588693885|FG000|Overall Study|Other Adverse Events|0|||
162998375|NCT02516553|588693886|FG001|Overall Study|Other Adverse Events|0|||
162998376|NCT02516553|588693887|FG002|Overall Study|Other Adverse Events|0|||
162998377|NCT02516553|588693888|FG003|Overall Study|Other Adverse Events|1|||
162998378|NCT02516553|588693889|FG004|Overall Study|Other Adverse Events|0|||
162998379|NCT02516553|588693890|FG005|Overall Study|Other Adverse Events|1|||
162998380|NCT02516553|588693891|FG006|Overall Study|Other Adverse Events|0|||
162998381|NCT02516553|588693892|FG007|Overall Study|Other Adverse Events|0|||
162998382|NCT02516553|588693893|FG008|Overall Study|Other Adverse Events|0|||
162998383|NCT02516553|588693894|FG009|Overall Study|Other Adverse Events|1|||
162998384|NCT02516553|588693895|FG010|Overall Study|Other Adverse Events|3|||
162998385|NCT02516553|588693896|FG011|Overall Study|Other Adverse Events|2|||
162998386|NCT02516553|588693897|FG012|Overall Study|Other Adverse Events|0|||
162998387|NCT02516553|588693898|FG013|Overall Study|Other Adverse Events|1|||
162998388|NCT02516553|588693899|FG014|Overall Study|Other Adverse Events|0|||
162998389|NCT02516553|588693900|FG015|Overall Study|Other Adverse Events|0|||
162998390|NCT02516553|588693901|FG016|Overall Study|Other Adverse Events|0|||
162998391|NCT02516553|588693902|FG017|Overall Study|Other Adverse Events|2|||
162998392|NCT02516553|588693903|FG018|Overall Study|Other Adverse Events|1|||
162998393|NCT02516553|588693904|FG019|Overall Study|Other Adverse Events|2|||
162998394|NCT02516553|588693905|FG020|Overall Study|Other Adverse Events|2|||
162998395|NCT02516553|588693906|FG021|Overall Study|Other Adverse Events|1|||
162998396|NCT02516553|588693885|FG000|Overall Study|Refused to continue trial medication|0|||
162998397|NCT02516553|588693886|FG001|Overall Study|Refused to continue trial medication|0|||
162998398|NCT02516553|588693887|FG002|Overall Study|Refused to continue trial medication|0|||
162998399|NCT02516553|588693888|FG003|Overall Study|Refused to continue trial medication|0|||
162998400|NCT02516553|588693889|FG004|Overall Study|Refused to continue trial medication|0|||
162998401|NCT02516553|588693890|FG005|Overall Study|Refused to continue trial medication|0|||
162998402|NCT02516553|588693891|FG006|Overall Study|Refused to continue trial medication|0|||
162998403|NCT02516553|588693892|FG007|Overall Study|Refused to continue trial medication|0|||
162998404|NCT02516553|588693893|FG008|Overall Study|Refused to continue trial medication|0|||
162998405|NCT02516553|588693894|FG009|Overall Study|Refused to continue trial medication|0|||
162998406|NCT02516553|588693895|FG010|Overall Study|Refused to continue trial medication|1|||
162998407|NCT02516553|588693896|FG011|Overall Study|Refused to continue trial medication|0|||
162998408|NCT02516553|588693897|FG012|Overall Study|Refused to continue trial medication|0|||
162998409|NCT02516553|588693898|FG013|Overall Study|Refused to continue trial medication|0|||
162998410|NCT02516553|588693899|FG014|Overall Study|Refused to continue trial medication|0|||
162998411|NCT02516553|588693900|FG015|Overall Study|Refused to continue trial medication|0|||
162998412|NCT02516553|588693901|FG016|Overall Study|Refused to continue trial medication|0|||
162998413|NCT02516553|588693902|FG017|Overall Study|Refused to continue trial medication|0|||
162998414|NCT02516553|588693903|FG018|Overall Study|Refused to continue trial medication|1|||
162998415|NCT02516553|588693904|FG019|Overall Study|Refused to continue trial medication|0|||
162998416|NCT02516553|588693905|FG020|Overall Study|Refused to continue trial medication|0|||
162998417|NCT02516553|588693906|FG021|Overall Study|Refused to continue trial medication|1|||
162998418|NCT02516553|588693885|FG000|Overall Study|other reasons than listed|0|||
162998419|NCT02516553|588693886|FG001|Overall Study|other reasons than listed|0|||
162998420|NCT02516553|588693887|FG002|Overall Study|other reasons than listed|0|||
162998421|NCT02516553|588693888|FG003|Overall Study|other reasons than listed|0|||
162998422|NCT02516553|588693889|FG004|Overall Study|other reasons than listed|0|||
162998423|NCT02516553|588693890|FG005|Overall Study|other reasons than listed|0|||
162998424|NCT02516553|588693891|FG006|Overall Study|other reasons than listed|0|||
162998425|NCT02516553|588693892|FG007|Overall Study|other reasons than listed|1|||
162998426|NCT02516553|588693893|FG008|Overall Study|other reasons than listed|1|||
162998427|NCT02516553|588693894|FG009|Overall Study|other reasons than listed|0|||
162998428|NCT02516553|588693895|FG010|Overall Study|other reasons than listed|1|||
162998429|NCT02516553|588693896|FG011|Overall Study|other reasons than listed|1|||
162998430|NCT02516553|588693897|FG012|Overall Study|other reasons than listed|0|||
162998431|NCT02516553|588693898|FG013|Overall Study|other reasons than listed|0|||
162998432|NCT02516553|588693899|FG014|Overall Study|other reasons than listed|0|||
162998433|NCT02516553|588693900|FG015|Overall Study|other reasons than listed|0|||
162998434|NCT02516553|588693901|FG016|Overall Study|other reasons than listed|0|||
162998435|NCT02516553|588693902|FG017|Overall Study|other reasons than listed|0|||
162998436|NCT02516553|588693903|FG018|Overall Study|other reasons than listed|0|||
162998437|NCT02516553|588693904|FG019|Overall Study|other reasons than listed|0|||
162998438|NCT02516553|588693905|FG020|Overall Study|other reasons than listed|2|||
162998439|NCT02516553|588693906|FG021|Overall Study|other reasons than listed|2|||
162998440|NCT00315731|588693908|FG000|Overall Study|Lost to Follow-up|1|||
162998441|NCT00315731|588693908|FG000|Overall Study|Death|5|||
162998442|NCT01680497|588693910|FG000|Overall Study|Lost to Follow-up|2|||
162998443|NCT04123561|588693912|FG000|Overall Study|Lost to Follow-up|20|||
162998444|NCT04123561|588693913|FG001|Overall Study|Lost to Follow-up|12|||
162998445|NCT04123561|588693914|FG002|Overall Study|Lost to Follow-up|5|||
162998446|NCT04123561|588693912|FG000|Overall Study|Withdrawal by Subject|9|||
162998447|NCT04123561|588693913|FG001|Overall Study|Withdrawal by Subject|7|||
162998448|NCT04123561|588693914|FG002|Overall Study|Withdrawal by Subject|9|||
162998449|NCT04123561|588693912|FG000|Overall Study|Lack of Efficacy|7|||
162998450|NCT04123561|588693913|FG001|Overall Study|Lack of Efficacy|8|||
162998451|NCT04123561|588693914|FG002|Overall Study|Lack of Efficacy|6|||
162998452|NCT04123561|588693912|FG000|Overall Study|Adverse Event|5|||
162998453|NCT04123561|588693913|FG001|Overall Study|Adverse Event|2|||
162998454|NCT04123561|588693914|FG002|Overall Study|Adverse Event|3|||
162998455|NCT04123561|588693912|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
162998456|NCT04123561|588693913|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
162998457|NCT04123561|588693914|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
162998458|NCT04123561|588693912|FG000|Overall Study|Death|0|||
162998459|NCT04123561|588693913|FG001|Overall Study|Death|0|||
162998460|NCT04123561|588693914|FG002|Overall Study|Death|1|||
162998461|NCT04123561|588693912|FG000|Overall Study|Protocol Violation|0|||
162998462|NCT04123561|588693913|FG001|Overall Study|Protocol Violation|1|||
162998463|NCT04123561|588693914|FG002|Overall Study|Protocol Violation|0|||
162998464|NCT00708227|588693922|FG000|Overall Study|Physician Decision|0|||
162998465|NCT00708227|588693923|FG001|Overall Study|Physician Decision|3|||
162998466|NCT00708227|588693924|FG002|Overall Study|Physician Decision|1|||
162998467|NCT00708227|588693925|FG003|Overall Study|Physician Decision|2|||
162998468|NCT00708227|588693922|FG000|Overall Study|Withdrawal by Subject|1|||
162998469|NCT00708227|588693923|FG001|Overall Study|Withdrawal by Subject|2|||
162998470|NCT00708227|588693924|FG002|Overall Study|Withdrawal by Subject|0|||
162998471|NCT00708227|588693925|FG003|Overall Study|Withdrawal by Subject|1|||
162715705|NCT03431350|587667077|FG002|Overall Study|Withdrawal by Subject|0|||
162715706|NCT03431350|587667078|FG003|Overall Study|Withdrawal by Subject|1|||
162715707|NCT03431350|587667079|FG004|Overall Study|Withdrawal by Subject|1|||
162715708|NCT03431350|587667080|FG005|Overall Study|Withdrawal by Subject|1|||
162998472|NCT04007991|588693926|FG000|Overall Study|Withdrawal by Subject|1|||
162998473|NCT04007991|588693927|FG001|Overall Study|Withdrawal by Subject|1|||
162998474|NCT04007991|588693926|FG000|Overall Study|Physician Decision|1|||
162998475|NCT04007991|588693927|FG001|Overall Study|Physician Decision|1|||
162998476|NCT04007991|588693926|FG000|Overall Study|Non-compliance with Study Drug|0|||
162998477|NCT04007991|588693927|FG001|Overall Study|Non-compliance with Study Drug|1|||
162998478|NCT04007991|588693926|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
162998479|NCT04007991|588693927|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
162998480|NCT04007991|588693926|FG000|Overall Study|Adverse event, non-fatal|5|||
162998481|NCT04007991|588693927|FG001|Overall Study|Adverse event, non-fatal|0|||
162998482|NCT04007991|588693926|FG000|Overall Study|Lost to Follow-up|2|||
162998483|NCT04007991|588693927|FG001|Overall Study|Lost to Follow-up|1|||
162998484|NCT03654599|588693930|FG000|Overall Study|Lost to Follow-up|14|||
162998485|NCT03654599|588693931|FG001|Overall Study|Lost to Follow-up|12|||
162998486|NCT03654599|588693930|FG000|Overall Study|Death|8|||
162998487|NCT03654599|588693931|FG001|Overall Study|Death|6|||
162715709|NCT03431350|587667081|FG006|Overall Study|Withdrawal by Subject|0|||
162715710|NCT03431350|587667082|FG007|Overall Study|Withdrawal by Subject|0|||
162715711|NCT03431350|587667083|FG008|Overall Study|Withdrawal by Subject|0|||
162998488|NCT03654599|588693930|FG000|Overall Study|Withdrawal by Subject|6|||
162998489|NCT03654599|588693931|FG001|Overall Study|Withdrawal by Subject|4|||
162715712|NCT03431350|587667084|FG009|Overall Study|Withdrawal by Subject|2|||
162715713|NCT03431350|587667085|FG010|Overall Study|Withdrawal by Subject|0|||
162715714|NCT03431350|587667086|FG011|Overall Study|Withdrawal by Subject|1|||
162715715|NCT03431350|587667075|FG000|Overall Study|Other|0|||
162715716|NCT03431350|587667076|FG001|Overall Study|Other|0|||
162715717|NCT03431350|587667077|FG002|Overall Study|Other|1|||
162715718|NCT03431350|587667078|FG003|Overall Study|Other|3|||
162998490|NCT01290302|588695697|FG000|Overall Study|Adverse Event|2|||
162998491|NCT01290302|588695698|FG001|Overall Study|Adverse Event|0|||
162998492|NCT01290302|588695697|FG000|Overall Study|Withdrawal by Subject|1|||
162715719|NCT03431350|587667079|FG004|Overall Study|Other|2|||
162998493|NCT01290302|588695698|FG001|Overall Study|Withdrawal by Subject|0|||
162998494|NCT01290302|588695697|FG000|Overall Study|Physician Decision|0|||
162998495|NCT01290302|588695698|FG001|Overall Study|Physician Decision|2|||
162998496|NCT01290302|588695697|FG000|Overall Study|Expiration of time for screening window|1|||
162998497|NCT01290302|588695698|FG001|Overall Study|Expiration of time for screening window|0|||
162998498|NCT03816878|588695701|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
162998499|NCT03816878|588695702|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
162998500|NCT03816878|588695701|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
162998501|NCT03816878|588695702|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
162998502|NCT03355469|588695703|FG000|Overall Study|COVID-19|3|||
162998503|NCT03355469|588695704|FG001|Overall Study|COVID-19|2|||
162998504|NCT03355469|588695705|FG002|Overall Study|COVID-19|3|||
162998505|NCT03355469|588695706|FG003|Overall Study|COVID-19|3|||
162998506|NCT03355469|588695703|FG000|Overall Study|Lost to Follow-up|1|||
162998507|NCT03355469|588695704|FG001|Overall Study|Lost to Follow-up|0|||
162998508|NCT03355469|588695705|FG002|Overall Study|Lost to Follow-up|1|||
162998509|NCT03355469|588695706|FG003|Overall Study|Lost to Follow-up|0|||
162998510|NCT03355469|588695703|FG000|Overall Study|Withdrawal by Subject|2|||
162998511|NCT03355469|588695704|FG001|Overall Study|Withdrawal by Subject|1|||
162998512|NCT03355469|588695705|FG002|Overall Study|Withdrawal by Subject|0|||
162998513|NCT03355469|588695706|FG003|Overall Study|Withdrawal by Subject|3|||
162998514|NCT02291510|588695707|FG000|Overall Study|Adverse Event|0|||
162998515|NCT02291510|588695708|FG001|Overall Study|Adverse Event|0|||
162998516|NCT02291510|588695709|FG002|Overall Study|Adverse Event|0|||
162998517|NCT02291510|588695710|FG003|Overall Study|Adverse Event|1|||
162998518|NCT00615199|588695716|FG000|Overall Study|Adverse Event|3|||
162998519|NCT00615199|588695717|FG001|Overall Study|Adverse Event|1|||
162998520|NCT00615199|588695718|FG002|Overall Study|Adverse Event|1|||
162998521|NCT00615199|588695719|FG003|Overall Study|Adverse Event|0|||
162998522|NCT00615199|588695716|FG000|Overall Study|Lack of Efficacy|2|||
162998523|NCT00615199|588695717|FG001|Overall Study|Lack of Efficacy|0|||
162998524|NCT00615199|588695718|FG002|Overall Study|Lack of Efficacy|0|||
162998525|NCT00615199|588695719|FG003|Overall Study|Lack of Efficacy|1|||
162998526|NCT00615199|588695716|FG000|Overall Study|Lost to Follow-up|1|||
162998527|NCT00615199|588695717|FG001|Overall Study|Lost to Follow-up|0|||
162998528|NCT00615199|588695718|FG002|Overall Study|Lost to Follow-up|0|||
162998529|NCT00615199|588695719|FG003|Overall Study|Lost to Follow-up|0|||
162998530|NCT00615199|588695716|FG000|Overall Study|Other|0|||
162998531|NCT00615199|588695717|FG001|Overall Study|Other|0|||
162998532|NCT00615199|588695718|FG002|Overall Study|Other|0|||
162998533|NCT00615199|588695719|FG003|Overall Study|Other|1|||
162998534|NCT00615199|588695716|FG000|Overall Study|Withdrawal by Subject|2|||
162998535|NCT00615199|588695717|FG001|Overall Study|Withdrawal by Subject|1|||
162998536|NCT00615199|588695718|FG002|Overall Study|Withdrawal by Subject|0|||
162998537|NCT00615199|588695719|FG003|Overall Study|Withdrawal by Subject|0|||
162998538|NCT04825912|588695720|FG000|Overall Study|Death|3|||
162998539|NCT04825912|588695720|FG000|Overall Study|Withdrawal by Subject|1|||
162998540|NCT00459355|588695723|FG000|Overall Study|Subject no longer met inc criteria|20|||
162998541|NCT00459355|588695724|FG001|Overall Study|Subject no longer met inc criteria|18|||
162998542|NCT01009814|588695727|FG000|Overall Study|No longer met study criteria|1|||
162998543|NCT01009814|588695728|FG001|Overall Study|No longer met study criteria|1|||
162998544|NCT01009814|588695729|FG002|Overall Study|No longer met study criteria|0|||
162998545|NCT01009814|588695730|FG003|Overall Study|No longer met study criteria|0|||
162998546|NCT01009814|588695731|FG004|Overall Study|No longer met study criteria|0|||
162998547|NCT00618371|588695732|FG000|Overall Study|Withdrawal by Subject|2|||
162998548|NCT01173120|588695733|FG000|Overall Study|Lack of Efficacy|2|||
162998549|NCT01173120|588695733|FG000|Overall Study|Lost to Follow-up|1|||
162998550|NCT01173120|588695733|FG000|Overall Study|Participant Decision|2|||
162998551|NCT01173120|588695733|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
162998552|NCT01173120|588695733|FG000|Overall Study|Switch-Participant Decision|12|||
162998553|NCT01173120|588695733|FG000|Overall Study|Switch-Difficulty With Device|12|||
162998554|NCT01977417|588695738|FG000|Overall Study|Adverse Event|1|||
162998555|NCT01977417|588695739|FG001|Overall Study|Adverse Event|0|||
162998556|NCT01977417|588695738|FG000|Overall Study|Withdrawal by Subject|2|||
162998557|NCT01977417|588695739|FG001|Overall Study|Withdrawal by Subject|4|||
162998558|NCT01977417|588695738|FG000|Overall Study|Female enrollment goal met|0|||
163060466|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
163060467|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
163060468|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
163060469|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
163060470|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
162998559|NCT01977417|588695739|FG001|Overall Study|Female enrollment goal met|2|||
162998560|NCT02906358|588695740|FG000|Overall Study|Withdrawal by Subject|10|||
162998561|NCT02906358|588695741|FG001|Overall Study|Withdrawal by Subject|7|||
162998562|NCT02906358|588695740|FG000|Overall Study|Lost to Follow-up|12|||
162998563|NCT02906358|588695741|FG001|Overall Study|Lost to Follow-up|15|||
162998564|NCT02699684|588695742|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
162998565|NCT02699684|588695743|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
162998566|NCT00616421|588695746|FG000|Overall Study|Withdrawal by Subject|9|||
163060471|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
162998567|NCT00616421|588695747|FG001|Overall Study|Withdrawal by Subject|11|||
162998568|NCT00616421|588695748|FG002|Overall Study|Withdrawal by Subject|8|||
162998569|NCT00616421|588695746|FG000|Overall Study|Lost to Follow-up|12|||
162998570|NCT00616421|588695747|FG001|Overall Study|Lost to Follow-up|26|||
162998571|NCT00616421|588695748|FG002|Overall Study|Lost to Follow-up|30|||
162998572|NCT00616421|588695746|FG000|Overall Study|Inappropriate enrollment|3|||
162998573|NCT00616421|588695747|FG001|Overall Study|Inappropriate enrollment|0|||
162998574|NCT00616421|588695748|FG002|Overall Study|Inappropriate enrollment|1|||
162998575|NCT00616421|588695746|FG000|Overall Study|Administrative reason|1|||
162998576|NCT00616421|588695747|FG001|Overall Study|Administrative reason|0|||
162998577|NCT00616421|588695748|FG002|Overall Study|Administrative reason|0|||
162998578|NCT00616421|588695746|FG000|Overall Study|Protocol Violation|0|||
162998579|NCT00616421|588695747|FG001|Overall Study|Protocol Violation|1|||
162998580|NCT00616421|588695748|FG002|Overall Study|Protocol Violation|2|||
162998581|NCT00616421|588695746|FG000|Overall Study|Unable to classify|1|||
162998582|NCT00616421|588695747|FG001|Overall Study|Unable to classify|0|||
162998583|NCT00616421|588695748|FG002|Overall Study|Unable to classify|0|||
162998584|NCT01495702|588695749|FG000|Randomized Phase|Randomized But Not Treated|1|||
162998585|NCT01495702|588695750|FG001|Randomized Phase|Randomized But Not Treated|4|||
162998586|NCT01495702|588695749|FG000|Randomized Phase|Adverse Event|2|||
162998587|NCT01495702|588695750|FG001|Randomized Phase|Adverse Event|2|||
162998588|NCT01495702|588695749|FG000|Randomized Phase|Death|1|||
162998589|NCT01495702|588695750|FG001|Randomized Phase|Death|0|||
162998590|NCT01495702|588695749|FG000|Randomized Phase|Lack of Efficacy|2|||
162998591|NCT01495702|588695750|FG001|Randomized Phase|Lack of Efficacy|0|||
162998592|NCT01495702|588695749|FG000|Randomized Phase|Investigators Discretion|2|||
162998593|NCT01495702|588695750|FG001|Randomized Phase|Investigators Discretion|0|||
162998594|NCT01495702|588695749|FG000|Randomized Phase|Withdrew Consent|10|||
162998595|NCT01495702|588695750|FG001|Randomized Phase|Withdrew Consent|18|||
162998596|NCT01495702|588695749|FG000|Randomized Phase|Lost to Follow-up|4|||
162998597|NCT01495702|588695750|FG001|Randomized Phase|Lost to Follow-up|3|||
162998598|NCT01495702|588695749|FG000|Randomized Phase|Participant Noncompliance|1|||
162998599|NCT01495702|588695750|FG001|Randomized Phase|Participant Noncompliance|0|||
162998600|NCT01495702|588695749|FG000|Randomized Phase|Protocol Violation|3|||
162998601|NCT01495702|588695750|FG001|Randomized Phase|Protocol Violation|1|||
162998602|NCT04152863|588695751|FG000|Overall Study|Death|13|||
162998603|NCT04152863|588695752|FG001|Overall Study|Death|12|||
162998604|NCT04152863|588695753|FG002|Overall Study|Death|7|||
162998605|NCT04152863|588695751|FG000|Overall Study|Physician Decision|1|||
162998606|NCT04152863|588695752|FG001|Overall Study|Physician Decision|1|||
162998607|NCT04152863|588695753|FG002|Overall Study|Physician Decision|1|||
162998608|NCT04152863|588695751|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
162998609|NCT04152863|588695752|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
162998610|NCT04152863|588695753|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
163060472|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
163060473|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
162998611|NCT04152863|588695751|FG000|Overall Study|Withdrawal by Subject|2|||
162998612|NCT04152863|588695752|FG001|Overall Study|Withdrawal by Subject|1|||
162998613|NCT04152863|588695753|FG002|Overall Study|Withdrawal by Subject|3|||
162998614|NCT01644617|588695757|FG000|Overall Study|Withdrawal by Subject|3|||
162998615|NCT01644617|588695758|FG001|Overall Study|Withdrawal by Subject|4|||
162998616|NCT01644617|588695759|FG002|Overall Study|Withdrawal by Subject|1|||
162998617|NCT01644617|588695757|FG000|Overall Study|Lost to Follow-up|0|||
162998618|NCT01644617|588695758|FG001|Overall Study|Lost to Follow-up|1|||
162998619|NCT01644617|588695759|FG002|Overall Study|Lost to Follow-up|0|||
162998620|NCT01644617|588695757|FG000|Overall Study|Adverse Event|3|||
162998621|NCT01644617|588695758|FG001|Overall Study|Adverse Event|0|||
162998622|NCT01644617|588695759|FG002|Overall Study|Adverse Event|6|||
162998623|NCT05445492|588695768|FG000|Overall Study|Physician Decision|1|||
162998624|NCT04289363|588695770|FG000|Overall Study|Lost to Follow-up|14|||
162998625|NCT04289363|588695771|FG001|Overall Study|Lost to Follow-up|0|||
162998626|NCT03790657|588695772|FG000|Overall Study|Adverse Event|1|||
162998627|NCT03790657|588695773|FG001|Overall Study|Adverse Event|1|||
162998628|NCT03790657|588695772|FG000|Overall Study|Withdrawal by Subject|1|||
162998629|NCT03790657|588695773|FG001|Overall Study|Withdrawal by Subject|1|||
162998630|NCT03126435|588695774|FG000|Overall Study|Death|90|||
162998631|NCT03126435|588695775|FG001|Overall Study|Death|84|||
162998632|NCT03126435|588695774|FG000|Overall Study|Lost to Follow-up|4|||
162998633|NCT03126435|588695775|FG001|Overall Study|Lost to Follow-up|3|||
162998634|NCT03126435|588695774|FG000|Overall Study|Physician Decision|0|||
162998635|NCT03126435|588695775|FG001|Overall Study|Physician Decision|1|||
162998636|NCT03126435|588695774|FG000|Overall Study|Withdrawal by Subject|6|||
162998637|NCT03126435|588695775|FG001|Overall Study|Withdrawal by Subject|12|||
162998638|NCT03126435|588695774|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
162998639|NCT03126435|588695775|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
162998640|NCT03971474|588695776|FG000|Overall Study|Adverse Event|11|||
162998641|NCT03971474|588695777|FG001|Overall Study|Adverse Event|7|||
162998642|NCT03971474|588695776|FG000|Overall Study|Refusal unrelated to adverse event|5|||
162998643|NCT03971474|588695777|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162998644|NCT03971474|588695776|FG000|Overall Study|Progression/relapse|40|||
162998645|NCT03971474|588695777|FG001|Overall Study|Progression/relapse|47|||
162998646|NCT03971474|588695776|FG000|Overall Study|Death|6|||
162998647|NCT03971474|588695777|FG001|Overall Study|Death|3|||
162998648|NCT03971474|588695776|FG000|Overall Study|Other - not protocol specified|5|||
162998649|NCT03971474|588695777|FG001|Overall Study|Other - not protocol specified|4|||
162998650|NCT03971474|588695776|FG000|Overall Study|On treatment|0|||
162998651|NCT03971474|588695777|FG001|Overall Study|On treatment|7|||
162998652|NCT01023035|588695779|FG000|Treatment Period|Adverse Event|27|||
163060474|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
163060475|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
163060476|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
163060477|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
162998653|NCT01023035|588695780|FG001|Treatment Period|Adverse Event|32|||
162998654|NCT01023035|588695781|FG002|Treatment Period|Adverse Event|50|||
162998655|NCT01023035|588695779|FG000|Treatment Period|Non-Medical Reasons|19|||
162998656|NCT01023035|588695780|FG001|Treatment Period|Non-Medical Reasons|22|||
162998657|NCT01023035|588695781|FG002|Treatment Period|Non-Medical Reasons|44|||
162998658|NCT01023035|588695779|FG000|Treatment Period|Treatment Failure|26|||
162998659|NCT01023035|588695780|FG001|Treatment Period|Treatment Failure|31|||
162998660|NCT01023035|588695781|FG002|Treatment Period|Treatment Failure|24|||
162998661|NCT01023035|588695779|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
162998662|NCT01023035|588695780|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
162998663|NCT01023035|588695781|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
162998664|NCT01023035|588695779|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
162998665|NCT01023035|588695780|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
162998666|NCT01023035|588695781|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
162998667|NCT01807065|588695782|FG000|Overall Study|Receive no sip-T due to IV access|1|||
162998668|NCT01807065|588695783|FG001|Overall Study|Receive no sip-T due to IV access|1|||
162998669|NCT01482312|588695785|FG000|Period 1, 90 Minutes of Wear|Other|1|||
162998670|NCT01482312|588695786|FG001|Period 1, 90 Minutes of Wear|Other|0|||
162998671|NCT01482312|588695787|FG002|Period 1, 90 Minutes of Wear|Other|0|||
162998672|NCT01482312|588695785|FG000|Period 2, 90 Minutes of Wear|Other|1|||
162998673|NCT01482312|588695786|FG001|Period 2, 90 Minutes of Wear|Other|0|||
162998674|NCT01482312|588695787|FG002|Period 2, 90 Minutes of Wear|Other|0|||
162998675|NCT01699815|588695788|FG000|Overall Study|Protocol Violation|4|||
163060478|NCT00410163|588929910|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
162998676|NCT01699815|588695789|FG001|Overall Study|Protocol Violation|7|||
162998677|NCT01699815|588695788|FG000|Overall Study|record could not be located|1|||
163060479|NCT00410163|588929911|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
162998678|NCT01699815|588695789|FG001|Overall Study|record could not be located|0|||
162998679|NCT01699815|588695788|FG000|Overall Study|Adverse Event|0|||
162998680|NCT01699815|588695789|FG001|Overall Study|Adverse Event|1|||
162998681|NCT01295320|588695790|FG000|Overall Study|Adverse Event|2|||
162998682|NCT01295320|588695790|FG000|Overall Study|Lost to Follow-up|4|||
162998683|NCT01295320|588695790|FG000|Overall Study|Withdrawal by Subject|2|||
162998684|NCT01295320|588695790|FG000|Overall Study|Subject was bedridden|1|||
162998685|NCT01295320|588695790|FG000|Overall Study|Unable to travel|1|||
162998686|NCT00462904|588695791|FG000|Overall Study|Lost to Follow-up|1|||
162998687|NCT00699816|588695794|FG000|Overall Study|Protocol Violation|1|||
162998688|NCT00699816|588695795|FG001|Overall Study|Protocol Violation|3|||
162998689|NCT00560391|588695796|FG000|Overall Study|Still on treatment|0|||
162998690|NCT00560391|588695797|FG001|Overall Study|Still on treatment|0|||
162998691|NCT00560391|588695798|FG002|Overall Study|Still on treatment|0|||
162998692|NCT00560391|588695799|FG003|Overall Study|Still on treatment|1|||
162998693|NCT00560391|588695800|FG004|Overall Study|Still on treatment|2|||
162998694|NCT03668808|588695801|FG000|First Intervention|Withdrawal by Subject|2|||
162998695|NCT03668808|588695802|FG001|First Intervention|Withdrawal by Subject|2|||
162998696|NCT02125877|588695804|FG000|Overall Study|Physician Decision|1|||
162998697|NCT02125877|588695805|FG001|Overall Study|Physician Decision|0|||
162998698|NCT02125877|588695804|FG000|Overall Study|Death|0|||
162998699|NCT02125877|588695805|FG001|Overall Study|Death|1|||
162998700|NCT02125877|588695804|FG000|Overall Study|Administrative problems|0|||
162998701|NCT02125877|588695805|FG001|Overall Study|Administrative problems|1|||
162998702|NCT02125877|588695804|FG000|Overall Study|Participant/guardian decision|0|||
162998703|NCT02125877|588695805|FG001|Overall Study|Participant/guardian decision|2|||
162998704|NCT02125877|588695804|FG000|Overall Study|Withdrawal by Subject|2|||
162998705|NCT02125877|588695805|FG001|Overall Study|Withdrawal by Subject|1|||
162998706|NCT02125877|588695804|FG000|Overall Study|Protocol deviation|4|||
162998707|NCT02125877|588695805|FG001|Overall Study|Protocol deviation|1|||
162998708|NCT02125877|588695804|FG000|Overall Study|Adverse Event|6|||
162998709|NCT02125877|588695805|FG001|Overall Study|Adverse Event|4|||
162998710|NCT04223752|588695806|FG000|Overall Study|Participant enrolled in error|0|||
162998711|NCT04223752|588695807|FG001|Overall Study|Participant enrolled in error|0|||
162998712|NCT04223752|588695808|FG002|Overall Study|Participant enrolled in error|0|||
162998713|NCT04223752|588695809|FG003|Overall Study|Participant enrolled in error|0|||
162998714|NCT04223752|588695810|FG004|Overall Study|Participant enrolled in error|1|||
162998715|NCT04223752|588695806|FG000|Overall Study|Death|0|||
162998716|NCT04223752|588695807|FG001|Overall Study|Death|0|||
162998717|NCT04223752|588695808|FG002|Overall Study|Death|0|||
162998718|NCT04223752|588695809|FG003|Overall Study|Death|2|||
162998719|NCT04223752|588695810|FG004|Overall Study|Death|1|||
162998720|NCT01822366|588695811|FG000|Overall Study|Lost to Follow-up|5|||
162998721|NCT01822366|588695812|FG001|Overall Study|Lost to Follow-up|1|||
162998722|NCT01822366|588695813|FG002|Overall Study|Lost to Follow-up|5|||
162998723|NCT01822366|588695814|FG003|Overall Study|Lost to Follow-up|1|||
162998724|NCT01822366|588695811|FG000|Overall Study|Withdrawal by Subject|0|||
162998725|NCT01822366|588695812|FG001|Overall Study|Withdrawal by Subject|6|||
162998726|NCT01822366|588695813|FG002|Overall Study|Withdrawal by Subject|0|||
162998727|NCT01822366|588695814|FG003|Overall Study|Withdrawal by Subject|6|||
162998728|NCT01822366|588695811|FG000|Overall Study|Partial Intervention Completion|0|||
162998729|NCT01822366|588695812|FG001|Overall Study|Partial Intervention Completion|15|||
162998730|NCT01822366|588695813|FG002|Overall Study|Partial Intervention Completion|0|||
162998731|NCT01822366|588695814|FG003|Overall Study|Partial Intervention Completion|15|||
162998732|NCT03489109|588695815|FG000|Overall Study|Lost to Follow-up|1|||
162998733|NCT03489109|588695816|FG001|Overall Study|Lost to Follow-up|2|||
162998734|NCT02552732|588695817|FG000|Overall Study|Lost to Follow-up|2|||
162998735|NCT02552732|588695817|FG000|Overall Study|Physician Decision|1|||
162998736|NCT02552732|588695817|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
162998737|NCT02552732|588695817|FG000|Overall Study|Withdrawal by Subject|6|||
162998738|NCT00025259|588695819|FG000|Overall Study|Death|1|||
162998739|NCT00025259|588695820|FG001|Overall Study|Death|3|||
162998740|NCT00025259|588695821|FG002|Overall Study|Death|0|||
162998741|NCT00025259|588695822|FG003|Overall Study|Death|3|||
162998742|NCT00025259|588695823|FG004|Overall Study|Death|0|||
162998743|NCT00025259|588695824|FG005|Overall Study|Death|1|||
162998744|NCT00025259|588695825|FG006|Overall Study|Death|2|||
162998745|NCT00025259|588695819|FG000|Overall Study|Lack of Efficacy|2|||
162998746|NCT00025259|588695820|FG001|Overall Study|Lack of Efficacy|46|||
162998747|NCT00025259|588695821|FG002|Overall Study|Lack of Efficacy|60|||
162998748|NCT00025259|588695822|FG003|Overall Study|Lack of Efficacy|78|||
162998749|NCT00025259|588695823|FG004|Overall Study|Lack of Efficacy|11|||
162998750|NCT00025259|588695824|FG005|Overall Study|Lack of Efficacy|30|||
162998751|NCT00025259|588695825|FG006|Overall Study|Lack of Efficacy|38|||
162998752|NCT00025259|588695819|FG000|Overall Study|Lost to Follow-up|2|||
162998753|NCT00025259|588695820|FG001|Overall Study|Lost to Follow-up|9|||
162998754|NCT00025259|588695821|FG002|Overall Study|Lost to Follow-up|13|||
162998755|NCT00025259|588695822|FG003|Overall Study|Lost to Follow-up|13|||
162998756|NCT00025259|588695823|FG004|Overall Study|Lost to Follow-up|1|||
162998757|NCT00025259|588695824|FG005|Overall Study|Lost to Follow-up|3|||
162998758|NCT00025259|588695825|FG006|Overall Study|Lost to Follow-up|1|||
162998759|NCT00025259|588695819|FG000|Overall Study|Physician Decision|12|||
162998760|NCT00025259|588695820|FG001|Overall Study|Physician Decision|1|||
162998761|NCT00025259|588695821|FG002|Overall Study|Physician Decision|0|||
162998762|NCT00025259|588695822|FG003|Overall Study|Physician Decision|5|||
162998763|NCT00025259|588695823|FG004|Overall Study|Physician Decision|4|||
162998764|NCT00025259|588695824|FG005|Overall Study|Physician Decision|2|||
162998765|NCT00025259|588695825|FG006|Overall Study|Physician Decision|1|||
162998766|NCT00025259|588695819|FG000|Overall Study|Protocol Violation|3|||
162998767|NCT00025259|588695820|FG001|Overall Study|Protocol Violation|2|||
162998768|NCT00025259|588695821|FG002|Overall Study|Protocol Violation|2|||
162998769|NCT00025259|588695822|FG003|Overall Study|Protocol Violation|1|||
162998770|NCT00025259|588695823|FG004|Overall Study|Protocol Violation|2|||
162998771|NCT00025259|588695824|FG005|Overall Study|Protocol Violation|1|||
162998772|NCT00025259|588695825|FG006|Overall Study|Protocol Violation|3|||
162998773|NCT00025259|588695819|FG000|Overall Study|Withdrawal by Subject|9|||
162998774|NCT00025259|588695820|FG001|Overall Study|Withdrawal by Subject|27|||
162998775|NCT00025259|588695821|FG002|Overall Study|Withdrawal by Subject|6|||
162998776|NCT00025259|588695822|FG003|Overall Study|Withdrawal by Subject|14|||
162998777|NCT00025259|588695823|FG004|Overall Study|Withdrawal by Subject|11|||
162998778|NCT00025259|588695824|FG005|Overall Study|Withdrawal by Subject|8|||
162998779|NCT00025259|588695825|FG006|Overall Study|Withdrawal by Subject|3|||
162998780|NCT00025259|588695819|FG000|Overall Study|Ineligible|14|||
162998781|NCT00025259|588695820|FG001|Overall Study|Ineligible|1|||
162998782|NCT00025259|588695821|FG002|Overall Study|Ineligible|0|||
162998783|NCT00025259|588695822|FG003|Overall Study|Ineligible|0|||
162998784|NCT00025259|588695823|FG004|Overall Study|Ineligible|6|||
162998785|NCT00025259|588695824|FG005|Overall Study|Ineligible|0|||
162998786|NCT00025259|588695825|FG006|Overall Study|Ineligible|1|||
162998787|NCT00025259|588695819|FG000|Overall Study|Randomization error|1|||
162998788|NCT00025259|588695820|FG001|Overall Study|Randomization error|0|||
162998789|NCT00025259|588695821|FG002|Overall Study|Randomization error|0|||
162998790|NCT00025259|588695822|FG003|Overall Study|Randomization error|0|||
162998791|NCT00025259|588695823|FG004|Overall Study|Randomization error|1|||
162998792|NCT00025259|588695824|FG005|Overall Study|Randomization error|7|||
162998793|NCT00025259|588695825|FG006|Overall Study|Randomization error|2|||
162998794|NCT00025259|588695819|FG000|Overall Study|Adverse Event|1|||
162998795|NCT00025259|588695820|FG001|Overall Study|Adverse Event|0|||
162998796|NCT00025259|588695821|FG002|Overall Study|Adverse Event|0|||
162998797|NCT00025259|588695822|FG003|Overall Study|Adverse Event|0|||
162998798|NCT00025259|588695823|FG004|Overall Study|Adverse Event|0|||
162998799|NCT00025259|588695824|FG005|Overall Study|Adverse Event|0|||
162998800|NCT00025259|588695825|FG006|Overall Study|Adverse Event|0|||
162998801|NCT01128543|588695830|FG000|Overall Study|Withdrawal by Subject|3|||
162998802|NCT01128543|588695830|FG000|Overall Study|Protocol Violation|1|||
162998803|NCT04487067|588695836|FG000|Overall Study|Adverse Event|3|||
162998804|NCT04487067|588695836|FG000|Overall Study|Death Other Than Progressive Disease|60|||
162998805|NCT04487067|588695836|FG000|Overall Study|Death Due To Progressive Disease|40|||
162998806|NCT04487067|588695836|FG000|Overall Study|Lost to Follow-up|3|||
162998807|NCT04487067|588695836|FG000|Overall Study|Progressive Disease|1|||
162998808|NCT04487067|588695836|FG000|Overall Study|Protocol Violation|3|||
162998809|NCT04487067|588695836|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
162998810|NCT04487067|588695836|FG000|Overall Study|Withdrawal by Subject|15|||
162998811|NCT04324021|588695837|FG000|Overall Study|Adverse Event|1|||
162998812|NCT04324021|588695838|FG001|Overall Study|Adverse Event|0|||
162998813|NCT04324021|588695839|FG002|Overall Study|Adverse Event|0|||
162998814|NCT04324021|588695837|FG000|Overall Study|Lack of Efficacy|0|||
162998815|NCT04324021|588695838|FG001|Overall Study|Lack of Efficacy|0|||
162998816|NCT04324021|588695839|FG002|Overall Study|Lack of Efficacy|1|||
162998817|NCT04324021|588695837|FG000|Overall Study|Death|1|||
162998818|NCT04324021|588695838|FG001|Overall Study|Death|1|||
162998819|NCT04324021|588695839|FG002|Overall Study|Death|0|||
162998820|NCT00246324|588695840|FG000|Overall Study|Withdrawal by Subject|1|||
162998821|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
162998822|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
162998823|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
162998824|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Death|1|||
162998825|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Death|3|||
162998826|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Death|1|||
162998827|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
162998828|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
162998829|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
162998830|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
162998831|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
162998832|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
162998833|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
162998834|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
162998835|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
162998836|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
162998837|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
162998838|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
162998839|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
162998840|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
162998841|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
162998842|NCT00299130|588695841|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
162998843|NCT00299130|588695842|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
162998844|NCT00299130|588695843|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
162998845|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
162998846|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
162998847|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
162998848|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
162998849|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
162998850|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
162998851|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
162998852|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
162998853|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
162998854|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
162998855|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
162998856|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
162998857|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
162998858|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
162998859|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
162998860|NCT00299130|588695841|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
162998861|NCT00299130|588695842|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
162998862|NCT00299130|588695843|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
162998863|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
162998864|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
162998865|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
162998866|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
162998867|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
162998868|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
162998869|NCT00299130|588695841|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
162998870|NCT00299130|588695842|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
162998871|NCT00299130|588695843|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
162998872|NCT00345631|588695844|FG000|Overall Study|Withdrawal by Subject|1|||
162998873|NCT00345631|588695845|FG001|Overall Study|Withdrawal by Subject|0|||
162998874|NCT00345631|588695846|FG002|Overall Study|Withdrawal by Subject|1|||
162998875|NCT00345631|588695844|FG000|Overall Study|Adverse Event|0|||
162998876|NCT00345631|588695845|FG001|Overall Study|Adverse Event|1|||
162998877|NCT00345631|588695846|FG002|Overall Study|Adverse Event|0|||
162998878|NCT00345631|588695844|FG000|Overall Study|Lost to Follow-up|3|||
162998879|NCT00345631|588695845|FG001|Overall Study|Lost to Follow-up|7|||
162998880|NCT00345631|588695846|FG002|Overall Study|Lost to Follow-up|4|||
162998881|NCT00345631|588695844|FG000|Overall Study|Other reasons|0|||
162998882|NCT00345631|588695845|FG001|Overall Study|Other reasons|0|||
162998883|NCT00345631|588695846|FG002|Overall Study|Other reasons|1|||
162998884|NCT03371459|588695850|FG000|Washout|Lost to Follow-up|0|||
162998885|NCT03371459|588695851|FG001|Washout|Lost to Follow-up|1|||
162998886|NCT01374269|588695860|FG000|Overall Study|Withdrawal by Subject|4|||
162998887|NCT01374269|588695861|FG001|Overall Study|Withdrawal by Subject|0|||
162998888|NCT01374269|588695860|FG000|Overall Study|Lost to Follow-up|1|||
162998889|NCT01374269|588695861|FG001|Overall Study|Lost to Follow-up|3|||
162998890|NCT01374269|588695860|FG000|Overall Study|closed research|1|||
162637138|NCT01782495|587386131|FG007|Overall Study|Withdrew Consent|1|||
162998891|NCT01374269|588695861|FG001|Overall Study|closed research|2|||
162998892|NCT01653912|588695862|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162637139|NCT01782495|587386132|FG008|Overall Study|Withdrew Consent|0|||
162637140|NCT01782495|587386133|FG009|Overall Study|Withdrew Consent|0|||
162637141|NCT01782495|587386134|FG010|Overall Study|Withdrew Consent|0|||
162637142|NCT00396591|587386139|FG000|Overall Study|Disease Progression|13|||
162637143|NCT00396591|587386139|FG000|Overall Study|Adverse Event|2|||
162998893|NCT01653912|588695863|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
162998894|NCT01653912|588695864|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998895|NCT01653912|588695865|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998896|NCT01653912|588695866|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998897|NCT01653912|588695867|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
162998898|NCT01653912|588695862|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998899|NCT01653912|588695863|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998900|NCT01653912|588695864|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
162998901|NCT01653912|588695865|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998902|NCT01653912|588695866|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998903|NCT01653912|588695867|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
162998904|NCT01653912|588695862|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998905|NCT01653912|588695863|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998906|NCT01653912|588695864|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998907|NCT01653912|588695865|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
162998908|NCT01653912|588695866|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998909|NCT01653912|588695867|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
162998910|NCT01653912|588695862|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998911|NCT01653912|588695863|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998912|NCT01653912|588695864|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998913|NCT01653912|588695865|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
162998914|NCT01653912|588695866|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998915|NCT01653912|588695867|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998916|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998917|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998918|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998919|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998920|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
162998921|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
162998922|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998923|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998924|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998925|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998926|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
162998927|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
162998928|NCT01653912|588695862|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998929|NCT01653912|588695863|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998930|NCT01653912|588695864|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998931|NCT01653912|588695865|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998932|NCT01653912|588695866|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
162998933|NCT01653912|588695867|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
162998934|NCT01987479|588695868|FG000|Overall Study|Protocol Violation|1|||
162998935|NCT01987479|588695868|FG000|Overall Study|Physician Decision|2|||
162998936|NCT01987479|588695868|FG000|Overall Study|Participant/legal guardian decision|1|||
162998937|NCT01987479|588695868|FG000|Overall Study|Other|5|||
162998938|NCT01987479|588695868|FG000|Overall Study|Lost to Follow-up|1|||
162998939|NCT01987479|588695868|FG000|Overall Study|Adverse Event|7|||
162998940|NCT01954745|588695869|FG000|Overall Study|Radiological Progression|11|||
162998941|NCT01954745|588695869|FG000|Overall Study|Clinical Progression|5|||
162998942|NCT01954745|588695869|FG000|Overall Study|Adverse Event|2|||
162998943|NCT01954745|588695869|FG000|Overall Study|Death|1|||
162715720|NCT03431350|587667080|FG005|Overall Study|Other|2|||
162715721|NCT03431350|587667081|FG006|Overall Study|Other|4|||
162715722|NCT03431350|587667082|FG007|Overall Study|Other|0|||
162998944|NCT04559347|588698152|FG000|Overall Study|Death|1|||
162998945|NCT04559347|588698153|FG001|Overall Study|Death|0|||
162998946|NCT04559347|588698152|FG000|Overall Study|Thoracotomy conversion|1|||
162998947|NCT04559347|588698153|FG001|Overall Study|Thoracotomy conversion|1|||
162998948|NCT04559347|588698152|FG000|Overall Study|Provider unavailable|2|||
162998949|NCT04559347|588698153|FG001|Overall Study|Provider unavailable|1|||
162998950|NCT04559347|588698152|FG000|Overall Study|Other|2|||
162998951|NCT04559347|588698153|FG001|Overall Study|Other|1|||
162998952|NCT02653625|588698154|FG000|Overall Study|Adverse Event|1|||
162998953|NCT02653625|588698154|FG000|Overall Study|Non-compliance with Study Drug|1|||
162998954|NCT02653625|588698154|FG000|Overall Study|Protocol Violation|1|||
162998955|NCT02653625|588698154|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
162998956|NCT03965689|588698155|FG000|Overall Study|Too sick to get study intervention|2|||
162998957|NCT02969382|588698156|FG000|Overall Study|Adverse Event|8|||
162998958|NCT02969382|588698157|FG001|Overall Study|Adverse Event|10|||
163060480|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
163060481|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
163060482|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
162998959|NCT02969382|588698156|FG000|Overall Study|Lack of Efficacy|4|||
162998960|NCT02969382|588698157|FG001|Overall Study|Lack of Efficacy|5|||
162998961|NCT02969382|588698156|FG000|Overall Study|Death|0|||
162998962|NCT02969382|588698157|FG001|Overall Study|Death|1|||
162998963|NCT02969382|588698156|FG000|Overall Study|PROTOCOL DEVIATION|0|||
162998964|NCT02969382|588698157|FG001|Overall Study|PROTOCOL DEVIATION|1|||
162998965|NCT02969382|588698156|FG000|Overall Study|Withdrawal by Subject|14|||
162998966|NCT02969382|588698157|FG001|Overall Study|Withdrawal by Subject|9|||
162998967|NCT02090725|588698159|FG000|Overall Study|Withdrawal by Subject|1|||
162998968|NCT02090725|588698159|FG000|Overall Study|participants moved from area|3|||
162998969|NCT01214655|588698160|FG000|Part A|Progressive Disease|7|||
162998970|NCT01214655|588698161|FG001|Part A|Progressive Disease|0|||
162998971|NCT01214655|588698162|FG002|Part A|Progressive Disease|0|||
162998972|NCT01214655|588698160|FG000|Part A|Physician Decision|1|||
162998973|NCT01214655|588698161|FG001|Part A|Physician Decision|0|||
162998974|NCT01214655|588698162|FG002|Part A|Physician Decision|0|||
162998975|NCT01214655|588698160|FG000|Part B|Progressive disease|0|||
162998976|NCT01214655|588698161|FG001|Part B|Progressive disease|10|||
162998977|NCT01214655|588698162|FG002|Part B|Progressive disease|0|||
162998978|NCT01214655|588698160|FG000|Part B|Death|0|||
162998979|NCT01214655|588698161|FG001|Part B|Death|1|||
162998980|NCT01214655|588698162|FG002|Part B|Death|0|||
162998981|NCT01214655|588698160|FG000|Part B|Withdrawal by Subject|0|||
162998982|NCT01214655|588698161|FG001|Part B|Withdrawal by Subject|2|||
162998983|NCT01214655|588698162|FG002|Part B|Withdrawal by Subject|0|||
162998984|NCT01214655|588698160|FG000|Part C|Progressive Disease|0|||
162998985|NCT01214655|588698161|FG001|Part C|Progressive Disease|0|||
162998986|NCT01214655|588698162|FG002|Part C|Progressive Disease|5|||
162998987|NCT01214655|588698160|FG000|Part C|Death|0|||
162998988|NCT01214655|588698161|FG001|Part C|Death|0|||
162998989|NCT01214655|588698162|FG002|Part C|Death|1|||
163060483|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
163060484|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
163060485|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
163060486|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
163060487|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
162715723|NCT03431350|587667083|FG008|Overall Study|Other|14|||
162715724|NCT03431350|587667084|FG009|Overall Study|Other|11|||
162715725|NCT03431350|587667085|FG010|Overall Study|Other|11|||
162715726|NCT03431350|587667086|FG011|Overall Study|Other|15|||
162715727|NCT02141074|587667089|FG000|Pre-prophylaxis|Adverse Event|3|||
162715728|NCT02141074|587667090|FG001|Pre-prophylaxis|Adverse Event|0|||
162715729|NCT02141074|587667089|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
162715730|NCT02141074|587667090|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
162715731|NCT02141074|587667089|FG000|Prophylaxis|Adverse Event|0|||
162715732|NCT02141074|587667090|FG001|Prophylaxis|Adverse Event|4|||
162715733|NCT02141074|587667089|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
162715734|NCT02141074|587667090|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
162715735|NCT02141074|587667089|FG000|Prophylaxis|Withdrawal by Subject|0|||
162715736|NCT02141074|587667090|FG001|Prophylaxis|Withdrawal by Subject|1|||
162715737|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
162715738|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
162715739|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715740|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715741|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715742|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715743|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715744|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162998990|NCT01214655|588698160|FG000|Part C|Physician Decision|0|||
162998991|NCT01214655|588698161|FG001|Part C|Physician Decision|0|||
162998992|NCT01214655|588698162|FG002|Part C|Physician Decision|1|||
162998993|NCT00764881|588698163|FG000|Overall Study|Adverse Event|5|||
162998994|NCT00764881|588698164|FG001|Overall Study|Adverse Event|1|||
162998995|NCT00764881|588698163|FG000|Overall Study|Withdrawal by Subject|1|||
162998996|NCT00764881|588698164|FG001|Overall Study|Withdrawal by Subject|3|||
162998997|NCT00764881|588698163|FG000|Overall Study|Protocol Violation|2|||
162998998|NCT00764881|588698164|FG001|Overall Study|Protocol Violation|2|||
162998999|NCT00764881|588698163|FG000|Overall Study|Lost to Follow-up|2|||
162999000|NCT00764881|588698164|FG001|Overall Study|Lost to Follow-up|0|||
162999001|NCT00764881|588698163|FG000|Overall Study|Noncompliant|1|||
162999002|NCT00764881|588698164|FG001|Overall Study|Noncompliant|0|||
162999003|NCT00764881|588698163|FG000|Overall Study|Accidentally discontinued study drug|1|||
162999004|NCT00764881|588698164|FG001|Overall Study|Accidentally discontinued study drug|0|||
162999005|NCT00764881|588698163|FG000|Overall Study|Wished to become pregnant|1|||
162999006|NCT00764881|588698164|FG001|Overall Study|Wished to become pregnant|0|||
162999007|NCT00764881|588698163|FG000|Overall Study|Carcinoma detected|1|||
162999008|NCT00764881|588698164|FG001|Overall Study|Carcinoma detected|0|||
162999009|NCT00764881|588698163|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
162999010|NCT00764881|588698164|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
162999011|NCT00764881|588698163|FG000|Overall Study|no treatment or no observation|2|||
162999012|NCT00764881|588698164|FG001|Overall Study|no treatment or no observation|2|||
162999013|NCT05256134|588698167|FG000|Overall Study|Study Terminated by Sponsor|11|||
162999014|NCT05256134|588698168|FG001|Overall Study|Study Terminated by Sponsor|10|||
162999015|NCT05256134|588698167|FG000|Overall Study|Withdrawal by Subject|1|||
162999016|NCT05256134|588698168|FG001|Overall Study|Withdrawal by Subject|3|||
162999017|NCT02013817|588698175|FG000|Overall Study|Adverse Event|12|||
162999018|NCT02013817|588698175|FG000|Overall Study|Withdrawal by Subject|4|||
162999019|NCT02013817|588698175|FG000|Overall Study|Death|2|||
162999020|NCT02013817|588698175|FG000|Overall Study|Other|9|||
162999021|NCT00855894|588698176|FG000|Overall Study|Death|31|||
162999022|NCT00855894|588698176|FG000|Overall Study|Patient's decision|1|||
162999023|NCT00855894|588698176|FG000|Overall Study|Disease progression|1|||
162999024|NCT01145508|588698177|FG000|Overall Study|Adverse Event|1|||
162999025|NCT01145508|588698178|FG001|Overall Study|Adverse Event|0|||
162999026|NCT01145508|588698177|FG000|Overall Study|Death|1|||
162999027|NCT01145508|588698178|FG001|Overall Study|Death|0|||
162999028|NCT01145508|588698177|FG000|Overall Study|Physician Decision|2|||
162999029|NCT01145508|588698178|FG001|Overall Study|Physician Decision|1|||
162999030|NCT01145508|588698177|FG000|Overall Study|Never started treatment|1|||
162999031|NCT01145508|588698178|FG001|Overall Study|Never started treatment|1|||
162999032|NCT01611857|588698182|FG000|Overall Study|Withdrawal by Subject|0|||
162999033|NCT01611857|588698183|FG001|Overall Study|Withdrawal by Subject|2|||
162999034|NCT02439970|588698184|FG000|Overall Study|Study Terminated|2|||
162999035|NCT02439970|588698185|FG001|Overall Study|Study Terminated|3|||
162999036|NCT01121562|588698186|FG000|Overall Study|Objective progression or relapse|8|||
162999037|NCT01121562|588698186|FG000|Overall Study|Withdrawal by Subject|1|||
162999038|NCT01121562|588698186|FG000|Overall Study|Adverse Event|1|||
163060488|NCT00410163|588929910|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
163060489|NCT00410163|588929911|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
163060490|NCT01572792|588929914|FG000|Lead-in Study|Lost to Follow-up|5|||
163060491|NCT01572792|588929915|FG001|Lead-in Study|Lost to Follow-up|9|||
163060492|NCT01572792|588929916|FG002|Lead-in Study|Lost to Follow-up|4|||
163060493|NCT01572792|588929917|FG003|Lead-in Study|Lost to Follow-up|2|||
163060494|NCT01572792|588929918|FG004|Lead-in Study|Lost to Follow-up|4|||
163060495|NCT01572792|588929914|FG000|Lead-in Study|Withdrawal by Subject|22|||
163060496|NCT01572792|588929915|FG001|Lead-in Study|Withdrawal by Subject|11|||
163060497|NCT01572792|588929916|FG002|Lead-in Study|Withdrawal by Subject|12|||
163060498|NCT01572792|588929917|FG003|Lead-in Study|Withdrawal by Subject|24|||
163060499|NCT01572792|588929918|FG004|Lead-in Study|Withdrawal by Subject|11|||
163060500|NCT01572792|588929914|FG000|Lead-in Study|Protocol Violation|19|||
163060501|NCT01572792|588929915|FG001|Lead-in Study|Protocol Violation|10|||
163060502|NCT01572792|588929916|FG002|Lead-in Study|Protocol Violation|12|||
163060503|NCT01572792|588929917|FG003|Lead-in Study|Protocol Violation|13|||
163060504|NCT01572792|588929918|FG004|Lead-in Study|Protocol Violation|21|||
163060505|NCT01572792|588929914|FG000|Lead-in Study|Lack of Efficacy|20|||
163060506|NCT01572792|588929915|FG001|Lead-in Study|Lack of Efficacy|5|||
163060507|NCT01572792|588929916|FG002|Lead-in Study|Lack of Efficacy|4|||
163060508|NCT01572792|588929917|FG003|Lead-in Study|Lack of Efficacy|8|||
163060509|NCT01572792|588929918|FG004|Lead-in Study|Lack of Efficacy|10|||
163060510|NCT01572792|588929914|FG000|Lead-in Study|Adverse Event|21|||
163060511|NCT01572792|588929915|FG001|Lead-in Study|Adverse Event|21|||
162715745|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715746|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162999039|NCT01121562|588698186|FG000|Overall Study|Sponsor Decision|1|||
162999040|NCT01121562|588698186|FG000|Overall Study|Met study discontinuation criteria|1|||
162999041|NCT01569295|588698189|FG000|Overall Study|Progressive Disease|75|||
162999042|NCT01569295|588698190|FG001|Overall Study|Progressive Disease|139|||
162999043|NCT01569295|588698189|FG000|Overall Study|Adverse Event|39|||
162999044|NCT01569295|588698190|FG001|Overall Study|Adverse Event|14|||
162999045|NCT01569295|588698189|FG000|Overall Study|Withdrawal by Subject|25|||
162999046|NCT01569295|588698190|FG001|Overall Study|Withdrawal by Subject|12|||
162999047|NCT01569295|588698189|FG000|Overall Study|Death|19|||
162999048|NCT01569295|588698190|FG001|Overall Study|Death|15|||
162999049|NCT01569295|588698189|FG000|Overall Study|Physician Decision|13|||
162999050|NCT01569295|588698190|FG001|Overall Study|Physician Decision|18|||
162999051|NCT01569295|588698189|FG000|Overall Study|Study Terminated by Sponsor|24|||
162999052|NCT01569295|588698190|FG001|Overall Study|Study Terminated by Sponsor|2|||
162999053|NCT01569295|588698189|FG000|Overall Study|Other Reason not Specified|3|||
162999054|NCT01569295|588698190|FG001|Overall Study|Other Reason not Specified|5|||
162999055|NCT01569295|588698189|FG000|Overall Study|Non-Compliance with Study Drug|6|||
163060512|NCT01572792|588929916|FG002|Lead-in Study|Adverse Event|22|||
163060513|NCT01572792|588929917|FG003|Lead-in Study|Adverse Event|16|||
163060514|NCT01572792|588929918|FG004|Lead-in Study|Adverse Event|14|||
162999056|NCT01569295|588698190|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162999057|NCT01569295|588698189|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
162999058|NCT01569295|588698190|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
162999059|NCT01569295|588698189|FG000|Overall Study|Lost to Follow-up|1|||
162999060|NCT01569295|588698190|FG001|Overall Study|Lost to Follow-up|1|||
162999061|NCT00280735|588698191|FG000|Overall Study|Adverse Event|5|||
162999062|NCT00280735|588698191|FG000|Overall Study|Lack of Efficacy|3|||
162637144|NCT00396591|587386139|FG000|Overall Study|Participant request|1|||
162637145|NCT01535053|587386140|FG000|Overall Study|Ineligible|1|||
162637146|NCT01535053|587386141|FG001|Overall Study|Ineligible|2|||
162637147|NCT00512707|587386142|FG000|Overall Study|Lost to Follow-up|5|||
162637148|NCT00512707|587386143|FG001|Overall Study|Lost to Follow-up|11|||
162637149|NCT00512707|587386142|FG000|Overall Study|Developed skin irritation|2|||
162637150|NCT00512707|587386143|FG001|Overall Study|Developed skin irritation|1|||
162637151|NCT00512707|587386142|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
162637152|NCT00512707|587386143|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
162637153|NCT00512707|587386142|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
162637154|NCT00512707|587386143|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
162637155|NCT03653637|587388442|FG000|Overall Study|Death|1|||
162999063|NCT00280735|588698191|FG000|Overall Study|Withdrawal by Subject|8|||
162999064|NCT00280735|588698191|FG000|Overall Study|Intercurrent Illness|2|||
162999065|NCT01895777|588698192|FG000|Overall Study|Adverse Event|1|||
162999066|NCT01895777|588698193|FG001|Overall Study|Adverse Event|2|||
162999067|NCT01895777|588698192|FG000|Overall Study|Lost to Follow-up|2|||
162999068|NCT01895777|588698193|FG001|Overall Study|Lost to Follow-up|0|||
162999069|NCT01895777|588698192|FG000|Overall Study|Not treated|1|||
162999070|NCT01895777|588698193|FG001|Overall Study|Not treated|0|||
162999071|NCT01895777|588698192|FG000|Overall Study|Other reasons|3|||
162999072|NCT01895777|588698193|FG001|Overall Study|Other reasons|2|||
162999073|NCT01895777|588698192|FG000|Overall Study|Non-compliance with the CTP|2|||
162999074|NCT01895777|588698193|FG001|Overall Study|Non-compliance with the CTP|1|||
162999075|NCT02064296|588698197|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
162999076|NCT02064296|588698198|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
162999077|NCT02064296|588698199|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
162999078|NCT02064296|588698197|FG000|Intervention|Withdrawal by Subject|0|||
162999079|NCT02064296|588698198|FG001|Intervention|Withdrawal by Subject|1|||
162999080|NCT02064296|588698199|FG002|Intervention|Withdrawal by Subject|2|||
162999081|NCT05061420|588698210|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
162999082|NCT05061420|588698211|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162999083|NCT05061420|588698212|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162999084|NCT05061420|588698210|FG000|Overall Study|Progressive disease|11|||
162637156|NCT03653637|587388443|FG001|Overall Study|Death|3|||
162999085|NCT05061420|588698211|FG001|Overall Study|Progressive disease|15|||
162999086|NCT05061420|588698212|FG002|Overall Study|Progressive disease|14|||
162999087|NCT05061420|588698210|FG000|Overall Study|Withdrawal by Subject|2|||
162999088|NCT05061420|588698211|FG001|Overall Study|Withdrawal by Subject|0|||
163060515|NCT01572792|588929914|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
163060516|NCT01572792|588929915|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
162637157|NCT03653637|587388442|FG000|Overall Study|Lost to Follow-up|29|||
162637158|NCT03653637|587388443|FG001|Overall Study|Lost to Follow-up|30|||
162637159|NCT03653637|587388442|FG000|Overall Study|Physician Decision|1|||
163060517|NCT01572792|588929916|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
163060518|NCT01572792|588929917|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
163060519|NCT01572792|588929918|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
163060520|NCT01572792|588929914|FG000|Extension Study|Lost to Follow-up|6|||
163060521|NCT01572792|588929915|FG001|Extension Study|Lost to Follow-up|2|||
163060522|NCT01572792|588929916|FG002|Extension Study|Lost to Follow-up|0|||
163060523|NCT01572792|588929917|FG003|Extension Study|Lost to Follow-up|3|||
163060524|NCT01572792|588929918|FG004|Extension Study|Lost to Follow-up|3|||
163060525|NCT01572792|588929914|FG000|Extension Study|Withdrawal by Subject|7|||
163060526|NCT01572792|588929915|FG001|Extension Study|Withdrawal by Subject|6|||
163060527|NCT01572792|588929916|FG002|Extension Study|Withdrawal by Subject|11|||
163060528|NCT01572792|588929917|FG003|Extension Study|Withdrawal by Subject|8|||
163060529|NCT01572792|588929918|FG004|Extension Study|Withdrawal by Subject|14|||
163060530|NCT01572792|588929914|FG000|Extension Study|Protocol Violation|0|||
162637160|NCT03653637|587388443|FG001|Overall Study|Physician Decision|1|||
162637161|NCT03653637|587388442|FG000|Overall Study|Withdrawal by Subject|7|||
162999089|NCT05061420|588698212|FG002|Overall Study|Withdrawal by Subject|1|||
162999090|NCT05061420|588698210|FG000|Overall Study|Not related to COVID-19|2|||
163060531|NCT01572792|588929915|FG001|Extension Study|Protocol Violation|4|||
162637162|NCT03653637|587388443|FG001|Overall Study|Withdrawal by Subject|4|||
162999091|NCT05061420|588698211|FG001|Overall Study|Not related to COVID-19|0|||
162999092|NCT05061420|588698212|FG002|Overall Study|Not related to COVID-19|0|||
162999093|NCT01814553|588698216|FG000|Overall Study|PD per clinical progression|6|||
162999094|NCT01814553|588698217|FG001|Overall Study|PD per clinical progression|8|||
162999095|NCT01814553|588698216|FG000|Overall Study|Other Adverse Event|4|||
162999096|NCT01814553|588698217|FG001|Overall Study|Other Adverse Event|5|||
162999097|NCT01814553|588698216|FG000|Overall Study|Withdrawal by Subject|1|||
162999098|NCT01814553|588698217|FG001|Overall Study|Withdrawal by Subject|1|||
162999099|NCT01814553|588698216|FG000|Overall Study|Other than stated|7|||
162999100|NCT01814553|588698217|FG001|Overall Study|Other than stated|8|||
162999101|NCT03138655|588698218|FG000|Overall Study|Adverse Event|2|||
162999102|NCT03138655|588698219|FG001|Overall Study|Adverse Event|1|||
162999103|NCT03138655|588698220|FG002|Overall Study|Adverse Event|2|||
162999104|NCT03138655|588698221|FG003|Overall Study|Adverse Event|1|||
162999105|NCT03138655|588698222|FG004|Overall Study|Adverse Event|1|||
162999106|NCT03138655|588698223|FG005|Overall Study|Adverse Event|4|||
162999107|NCT03138655|588698224|FG006|Overall Study|Adverse Event|2|||
162999108|NCT03138655|588698225|FG007|Overall Study|Adverse Event|2|||
162999109|NCT03138655|588698218|FG000|Overall Study|Withdrawal by Subject|0|||
163060532|NCT01572792|588929916|FG002|Extension Study|Protocol Violation|3|||
163060533|NCT01572792|588929917|FG003|Extension Study|Protocol Violation|4|||
163060534|NCT01572792|588929918|FG004|Extension Study|Protocol Violation|3|||
163060535|NCT01572792|588929914|FG000|Extension Study|Lack of Efficacy|2|||
163060536|NCT01572792|588929915|FG001|Extension Study|Lack of Efficacy|3|||
163060537|NCT01572792|588929916|FG002|Extension Study|Lack of Efficacy|3|||
163060538|NCT01572792|588929917|FG003|Extension Study|Lack of Efficacy|2|||
163060539|NCT01572792|588929918|FG004|Extension Study|Lack of Efficacy|2|||
163060540|NCT01572792|588929914|FG000|Extension Study|Adverse Event|7|||
163060541|NCT01572792|588929915|FG001|Extension Study|Adverse Event|6|||
163060542|NCT01572792|588929916|FG002|Extension Study|Adverse Event|5|||
163060543|NCT01572792|588929917|FG003|Extension Study|Adverse Event|6|||
163060544|NCT01572792|588929918|FG004|Extension Study|Adverse Event|4|||
163060545|NCT01572792|588929914|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
163060546|NCT01572792|588929915|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
163060547|NCT01572792|588929916|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
163060548|NCT01572792|588929917|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
163060549|NCT01572792|588929918|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
163060550|NCT03692949|588929924|FG000|Overall Study|Lost to Follow-up|0|||
163060551|NCT03692949|588929925|FG001|Overall Study|Lost to Follow-up|0|||
163060552|NCT03692949|588929926|FG002|Overall Study|Lost to Follow-up|0|||
163060553|NCT03692949|588929927|FG003|Overall Study|Lost to Follow-up|0|||
163060554|NCT03692949|588929928|FG004|Overall Study|Lost to Follow-up|0|||
163060555|NCT03692949|588929929|FG005|Overall Study|Lost to Follow-up|0|||
163060556|NCT03692949|588929930|FG006|Overall Study|Lost to Follow-up|0|||
163060557|NCT03692949|588929931|FG007|Overall Study|Lost to Follow-up|1|||
163060558|NCT03197129|588929937|FG000|Overall Study|did not answer the VPT: shyness|4|||
163060559|NCT03197129|588929938|FG001|Overall Study|did not answer the VPT: shyness|5|||
163060560|NCT00289276|588929939|FG000|Second Part of FAST Study (Expansion)|Death|0|||
163060561|NCT00289276|588929940|FG001|Second Part of FAST Study (Expansion)|Death|2|||
163060562|NCT00289276|588929939|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
163060563|NCT00289276|588929940|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
163060564|NCT00869960|588929941|FG000|Overall Study|Lost to Follow-up|2|||
163060565|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Death|1|||
163060566|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Death|0|||
163060567|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
162999110|NCT03138655|588698219|FG001|Overall Study|Withdrawal by Subject|1|||
162999111|NCT03138655|588698220|FG002|Overall Study|Withdrawal by Subject|0|||
162999112|NCT03138655|588698221|FG003|Overall Study|Withdrawal by Subject|0|||
162999113|NCT03138655|588698222|FG004|Overall Study|Withdrawal by Subject|0|||
162999114|NCT03138655|588698223|FG005|Overall Study|Withdrawal by Subject|0|||
162999115|NCT03138655|588698224|FG006|Overall Study|Withdrawal by Subject|1|||
162999116|NCT03138655|588698225|FG007|Overall Study|Withdrawal by Subject|0|||
162999117|NCT03138655|588698218|FG000|Overall Study|Reason not Specified|1|||
162999118|NCT03138655|588698219|FG001|Overall Study|Reason not Specified|0|||
162999119|NCT03138655|588698220|FG002|Overall Study|Reason not Specified|0|||
162999120|NCT03138655|588698221|FG003|Overall Study|Reason not Specified|2|||
162999121|NCT03138655|588698222|FG004|Overall Study|Reason not Specified|1|||
162999122|NCT03138655|588698223|FG005|Overall Study|Reason not Specified|1|||
162999123|NCT03138655|588698224|FG006|Overall Study|Reason not Specified|0|||
163060568|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
162999124|NCT03138655|588698225|FG007|Overall Study|Reason not Specified|0|||
162999125|NCT04759768|588698229|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
162999126|NCT04759768|588698230|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162999127|NCT04759768|588698229|FG000|Washout (7 Days)|Physician Decision|0|||
162999128|NCT04759768|588698230|FG001|Washout (7 Days)|Physician Decision|1|||
163060569|NCT04848480|588929942|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
163060570|NCT04848480|588929943|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
163060571|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
163060572|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
162637163|NCT02068443|587388446|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162999129|NCT02996487|588698231|FG000|Overall Study|Lost to Follow-up|1|||
162999130|NCT02996487|588698232|FG001|Overall Study|Lost to Follow-up|1|||
162637164|NCT02068443|587388447|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
162637165|NCT02068443|587388448|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
162999131|NCT02996487|588698233|FG002|Overall Study|Lost to Follow-up|0|||
162999132|NCT02996487|588698231|FG000|Overall Study|Death|0|||
162999133|NCT02996487|588698232|FG001|Overall Study|Death|1|||
162999134|NCT02996487|588698233|FG002|Overall Study|Death|0|||
162999135|NCT02996487|588698231|FG000|Overall Study|Withdrawal by Subject|2|||
162999136|NCT02996487|588698232|FG001|Overall Study|Withdrawal by Subject|3|||
162999137|NCT02996487|588698233|FG002|Overall Study|Withdrawal by Subject|0|||
162999138|NCT02800642|588698234|FG000|Overall Study|Death|3|||
162999139|NCT02800642|588698234|FG000|Overall Study|Other|10|||
162999140|NCT02800642|588698234|FG000|Overall Study|Physician Decision|2|||
162999141|NCT02800642|588698234|FG000|Overall Study|Adverse Event|6|||
162999142|NCT02800642|588698234|FG000|Overall Study|Withdrawal by Subject|3|||
162999143|NCT02800642|588698234|FG000|Overall Study|Lost to Follow-up|1|||
162999144|NCT02027428|588698235|FG000|Induction|Never treated|7|||
162999145|NCT02027428|588698236|FG001|Induction|Never treated|0|||
162999146|NCT02027428|588698237|FG002|Induction|Never treated|0|||
162999147|NCT02027428|588698235|FG000|Induction|Progressive disease|77|||
162999148|NCT02027428|588698236|FG001|Induction|Progressive disease|0|||
162999149|NCT02027428|588698237|FG002|Induction|Progressive disease|0|||
162999150|NCT02027428|588698235|FG000|Induction|Adverse Event|51|||
162999151|NCT02027428|588698236|FG001|Induction|Adverse Event|0|||
162999152|NCT02027428|588698237|FG002|Induction|Adverse Event|0|||
162999153|NCT02027428|588698235|FG000|Induction|Withdrawal by Subject|22|||
162999154|NCT02027428|588698236|FG001|Induction|Withdrawal by Subject|0|||
162999155|NCT02027428|588698237|FG002|Induction|Withdrawal by Subject|0|||
162999156|NCT02027428|588698235|FG000|Induction|Death|21|||
162999157|NCT02027428|588698236|FG001|Induction|Death|0|||
162999158|NCT02027428|588698237|FG002|Induction|Death|0|||
162999159|NCT02027428|588698235|FG000|Induction|Symptomatic deterioration|16|||
162999160|NCT02027428|588698236|FG001|Induction|Symptomatic deterioration|0|||
162999161|NCT02027428|588698237|FG002|Induction|Symptomatic deterioration|0|||
162999162|NCT02027428|588698235|FG000|Induction|Study terminated by sponsor|12|||
162999163|NCT02027428|588698236|FG001|Induction|Study terminated by sponsor|0|||
162999164|NCT02027428|588698237|FG002|Induction|Study terminated by sponsor|0|||
162999165|NCT02027428|588698235|FG000|Induction|Protocol Violation|1|||
162999166|NCT02027428|588698236|FG001|Induction|Protocol Violation|0|||
162999167|NCT02027428|588698237|FG002|Induction|Protocol Violation|0|||
162999168|NCT02027428|588698235|FG000|Induction|Miscellaneous|14|||
162999169|NCT02027428|588698236|FG001|Induction|Miscellaneous|0|||
162999170|NCT02027428|588698237|FG002|Induction|Miscellaneous|0|||
162999171|NCT02027428|588698235|FG000|Induction|Induction Treatment Ongoing|4|||
162999172|NCT02027428|588698236|FG001|Induction|Induction Treatment Ongoing|0|||
162999173|NCT02027428|588698237|FG002|Induction|Induction Treatment Ongoing|0|||
162999174|NCT02027428|588698235|FG000|Maintenance|Death|0|||
162999175|NCT02027428|588698236|FG001|Maintenance|Death|3|||
162999176|NCT02027428|588698237|FG002|Maintenance|Death|2|||
162999177|NCT02027428|588698235|FG000|Maintenance|Adverse Event|0|||
162999178|NCT02027428|588698236|FG001|Maintenance|Adverse Event|21|||
162999179|NCT02027428|588698237|FG002|Maintenance|Adverse Event|1|||
162999180|NCT02027428|588698235|FG000|Maintenance|Progressive disease|0|||
162999181|NCT02027428|588698236|FG001|Maintenance|Progressive disease|84|||
162999182|NCT02027428|588698237|FG002|Maintenance|Progressive disease|47|||
162999183|NCT02027428|588698235|FG000|Maintenance|Symptomatic deterioration|0|||
162999184|NCT02027428|588698236|FG001|Maintenance|Symptomatic deterioration|4|||
163060573|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
163060574|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
162637166|NCT02068443|587388446|FG000|Overall Study|Voluntary Withdrawal|4|||
162637167|NCT02068443|587388447|FG001|Overall Study|Voluntary Withdrawal|0|||
162999185|NCT02027428|588698237|FG002|Maintenance|Symptomatic deterioration|1|||
162999186|NCT02027428|588698235|FG000|Maintenance|Withdrawal by Subject|0|||
162999187|NCT02027428|588698236|FG001|Maintenance|Withdrawal by Subject|6|||
162999188|NCT02027428|588698237|FG002|Maintenance|Withdrawal by Subject|5|||
162999189|NCT02027428|588698235|FG000|Maintenance|Protocol Violation|0|||
162999190|NCT02027428|588698236|FG001|Maintenance|Protocol Violation|0|||
162999191|NCT02027428|588698237|FG002|Maintenance|Protocol Violation|1|||
162999192|NCT02027428|588698235|FG000|Maintenance|Other|0|||
162999193|NCT02027428|588698236|FG001|Maintenance|Other|6|||
162999194|NCT02027428|588698237|FG002|Maintenance|Other|3|||
162999195|NCT02027428|588698235|FG000|Survival Follow-up|Death|0|||
162999196|NCT02027428|588698236|FG001|Survival Follow-up|Death|78|||
162999197|NCT02027428|588698237|FG002|Survival Follow-up|Death|45|||
162999198|NCT02027428|588698235|FG000|Survival Follow-up|Lost to Follow-up|0|||
162999199|NCT02027428|588698236|FG001|Survival Follow-up|Lost to Follow-up|1|||
162999200|NCT02027428|588698237|FG002|Survival Follow-up|Lost to Follow-up|1|||
162999201|NCT02859142|588698238|FG000|Overall Study|Adverse Event|1|||
162999202|NCT02859142|588698239|FG001|Overall Study|Adverse Event|2|||
162999203|NCT02859142|588698238|FG000|Overall Study|Lost to Follow-up|1|||
162999204|NCT02859142|588698239|FG001|Overall Study|Lost to Follow-up|4|||
162999205|NCT02859142|588698238|FG000|Overall Study|Withdrawal by Subject|2|||
162999206|NCT02859142|588698239|FG001|Overall Study|Withdrawal by Subject|0|||
162999207|NCT02859142|588698238|FG000|Overall Study|Scheduling difficulties|0|||
162999208|NCT02859142|588698239|FG001|Overall Study|Scheduling difficulties|3|||
162999209|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Death|8|||
162999210|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Death|5|||
162999211|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Death|5|||
162999212|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Death|7|||
162999213|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
162999214|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
162999215|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
162999216|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
162999217|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
162999218|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
162999219|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
162999220|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
162999221|NCT03340974|588698240|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
162999222|NCT03340974|588698241|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
162999223|NCT03340974|588698242|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
162999224|NCT03340974|588698243|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
162999225|NCT02374346|588698247|FG000|Overall Study|operated or discharged during weekend|48|||
162999226|NCT00396565|588698250|FG000|Overall Study|Physician Decision|3|||
162999227|NCT00396565|588698251|FG001|Overall Study|Physician Decision|1|||
162999228|NCT00396565|588698252|FG002|Overall Study|Physician Decision|2|||
162999229|NCT00396565|588698250|FG000|Overall Study|Adverse Event|5|||
162999230|NCT00396565|588698251|FG001|Overall Study|Adverse Event|13|||
162999231|NCT00396565|588698252|FG002|Overall Study|Adverse Event|3|||
162999232|NCT00396565|588698250|FG000|Overall Study|Withdrawal by Subject|8|||
162999233|NCT00396565|588698251|FG001|Overall Study|Withdrawal by Subject|13|||
162999234|NCT00396565|588698252|FG002|Overall Study|Withdrawal by Subject|1|||
162999235|NCT00396565|588698250|FG000|Overall Study|Lack of Efficacy|32|||
162999236|NCT00396565|588698251|FG001|Overall Study|Lack of Efficacy|64|||
162999237|NCT00396565|588698252|FG002|Overall Study|Lack of Efficacy|11|||
162999238|NCT05299528|588698255|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999239|NCT05299528|588698256|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
162999240|NCT05299528|588698257|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999241|NCT05299528|588698258|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999242|NCT05299528|588698259|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999243|NCT05299528|588698260|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999244|NCT05299528|588698261|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
162999245|NCT05299528|588698255|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999246|NCT05299528|588698256|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999247|NCT05299528|588698257|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999248|NCT05299528|588698258|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
163060575|NCT04848480|588929942|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
163060576|NCT04848480|588929943|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
162999249|NCT05299528|588698259|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999250|NCT05299528|588698260|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
162999251|NCT05299528|588698261|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
162999252|NCT05299528|588698255|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
162999253|NCT05299528|588698256|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
162999254|NCT05299528|588698257|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
162999255|NCT05299528|588698258|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
162999256|NCT05299528|588698259|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
162999257|NCT05299528|588698260|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
162999258|NCT05299528|588698261|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
162999259|NCT04877457|588698262|FG000|Overall Study|Early termination of study due to low enrollment|2|||
162999260|NCT04877457|588698263|FG001|Overall Study|Early termination of study due to low enrollment|1|||
162999261|NCT02211417|588698264|FG000|Overall Study|Withdrawal by Subject|11|||
162999262|NCT02211417|588698265|FG001|Overall Study|Withdrawal by Subject|8|||
162999263|NCT02211417|588698264|FG000|Overall Study|Protocol Violation|1|||
162999264|NCT02211417|588698265|FG001|Overall Study|Protocol Violation|0|||
162999265|NCT02211417|588698264|FG000|Overall Study|Pregnancy|0|||
162999266|NCT02211417|588698265|FG001|Overall Study|Pregnancy|1|||
162999267|NCT02211417|588698264|FG000|Overall Study|Lost to Follow-up|2|||
162999268|NCT02211417|588698265|FG001|Overall Study|Lost to Follow-up|3|||
162999269|NCT02211417|588698264|FG000|Overall Study|Adverse Event|1|||
162999270|NCT02211417|588698265|FG001|Overall Study|Adverse Event|4|||
162999271|NCT01198132|588698266|FG000|Overall Study|Withdrawal by Subject|4|||
162999272|NCT01198132|588698267|FG001|Overall Study|Withdrawal by Subject|5|||
162999273|NCT01198132|588698266|FG000|Overall Study|Physician Decision|5|||
162999274|NCT01198132|588698267|FG001|Overall Study|Physician Decision|4|||
162999275|NCT01198132|588698266|FG000|Overall Study|Other Unspecified|3|||
162999276|NCT01198132|588698267|FG001|Overall Study|Other Unspecified|6|||
162999277|NCT01198132|588698266|FG000|Overall Study|Lack of Efficacy|2|||
162999278|NCT01198132|588698267|FG001|Overall Study|Lack of Efficacy|3|||
162999279|NCT01198132|588698266|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
162999280|NCT01198132|588698267|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
162999281|NCT01198132|588698266|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
162999282|NCT01198132|588698267|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
162999283|NCT01198132|588698266|FG000|Overall Study|Adverse Event|0|||
162999284|NCT01198132|588698267|FG001|Overall Study|Adverse Event|1|||
162999285|NCT01198132|588698266|FG000|Overall Study|Protocol Violation|1|||
162999286|NCT01198132|588698267|FG001|Overall Study|Protocol Violation|0|||
162999287|NCT01277211|588698268|FG000|Overall Study|Adverse Event|60|||
162999288|NCT01277211|588698269|FG001|Overall Study|Adverse Event|22|||
162999289|NCT01277211|588698268|FG000|Overall Study|Pregnancy|9|||
162999290|NCT01277211|588698269|FG001|Overall Study|Pregnancy|4|||
162999291|NCT01277211|588698268|FG000|Overall Study|Lost to Follow-up|14|||
162999292|NCT01277211|588698269|FG001|Overall Study|Lost to Follow-up|9|||
162999293|NCT01277211|588698268|FG000|Overall Study|Did not wish to continue|17|||
162999294|NCT01277211|588698269|FG001|Overall Study|Did not wish to continue|0|||
162999295|NCT01277211|588698268|FG000|Overall Study|Withdrew Consent|9|||
162999296|NCT01277211|588698269|FG001|Overall Study|Withdrew Consent|9|||
162999297|NCT01277211|588698268|FG000|Overall Study|Non-compliance with protocol|13|||
162999298|NCT01277211|588698269|FG001|Overall Study|Non-compliance with protocol|4|||
162999299|NCT01277211|588698268|FG000|Overall Study|Did not meet protocol eligibility|1|||
162999300|NCT01277211|588698269|FG001|Overall Study|Did not meet protocol eligibility|0|||
162999301|NCT01277211|588698268|FG000|Overall Study|Administrative|3|||
162999302|NCT01277211|588698269|FG001|Overall Study|Administrative|0|||
162999303|NCT01277211|588698268|FG000|Overall Study|Pregnancy wish|0|||
162999304|NCT01277211|588698269|FG001|Overall Study|Pregnancy wish|2|||
162999305|NCT01277211|588698268|FG000|Overall Study|Discontinued prior to treatment|24|||
162999306|NCT01277211|588698269|FG001|Overall Study|Discontinued prior to treatment|13|||
162999307|NCT04697069|588698270|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
162999308|NCT04697069|588698271|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
162999309|NCT04697069|588698270|FG000|Overall Study|Study termination|2|||
162999310|NCT04697069|588698271|FG001|Overall Study|Study termination|1|||
162999311|NCT05180227|588698272|FG000|Overall Study|Hypertension at screening|1|||
162999312|NCT05180227|588698272|FG000|Overall Study|Lost to Follow-up|1|||
162999313|NCT02924727|588698273|FG000|Overall Study|Withdrawal by Subject|2|||
162999314|NCT02924727|588698274|FG001|Overall Study|Withdrawal by Subject|4|||
162999315|NCT02924727|588698273|FG000|Overall Study|Lost to Follow-up|2|||
162999316|NCT02924727|588698274|FG001|Overall Study|Lost to Follow-up|5|||
162999317|NCT02924727|588698273|FG000|Overall Study|Death|221|||
162999318|NCT02924727|588698274|FG001|Overall Study|Death|247|||
162999319|NCT02924727|588698273|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
162999320|NCT02924727|588698274|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
162999321|NCT04614246|588698275|FG000|Overall Study|Adverse Event|0|||
162999322|NCT04614246|588698276|FG001|Overall Study|Adverse Event|1|||
162999323|NCT04614246|588698277|FG002|Overall Study|Adverse Event|1|||
162999324|NCT04614246|588698278|FG003|Overall Study|Adverse Event|2|||
162999325|NCT04614246|588698279|FG004|Overall Study|Adverse Event|1|||
162999326|NCT04614246|588698275|FG000|Overall Study|Lost to Follow-up|0|||
162999327|NCT04614246|588698276|FG001|Overall Study|Lost to Follow-up|1|||
162999328|NCT04614246|588698277|FG002|Overall Study|Lost to Follow-up|0|||
162999329|NCT04614246|588698278|FG003|Overall Study|Lost to Follow-up|1|||
162999330|NCT04614246|588698279|FG004|Overall Study|Lost to Follow-up|3|||
162999331|NCT04614246|588698275|FG000|Overall Study|Other reason|0|||
162999332|NCT04614246|588698276|FG001|Overall Study|Other reason|1|||
162999333|NCT04614246|588698277|FG002|Overall Study|Other reason|2|||
162999334|NCT04614246|588698278|FG003|Overall Study|Other reason|0|||
162999335|NCT04614246|588698279|FG004|Overall Study|Other reason|0|||
162999336|NCT04614246|588698275|FG000|Overall Study|Withdrawal by Subject|4|||
162999337|NCT04614246|588698276|FG001|Overall Study|Withdrawal by Subject|2|||
162999338|NCT04614246|588698277|FG002|Overall Study|Withdrawal by Subject|4|||
162999339|NCT04614246|588698278|FG003|Overall Study|Withdrawal by Subject|3|||
162999340|NCT04614246|588698279|FG004|Overall Study|Withdrawal by Subject|4|||
162999341|NCT04614246|588698275|FG000|Overall Study|Physician Decision|0|||
162999342|NCT04614246|588698276|FG001|Overall Study|Physician Decision|2|||
162999343|NCT04614246|588698277|FG002|Overall Study|Physician Decision|1|||
162999344|NCT04614246|588698278|FG003|Overall Study|Physician Decision|0|||
162999345|NCT04614246|588698279|FG004|Overall Study|Physician Decision|0|||
162999346|NCT04614246|588698275|FG000|Overall Study|Study terminated by sponsor|10|||
162999347|NCT04614246|588698276|FG001|Overall Study|Study terminated by sponsor|15|||
162999348|NCT04614246|588698277|FG002|Overall Study|Study terminated by sponsor|12|||
162999349|NCT04614246|588698278|FG003|Overall Study|Study terminated by sponsor|13|||
162999350|NCT04614246|588698279|FG004|Overall Study|Study terminated by sponsor|9|||
162999351|NCT04614246|588698275|FG000|Overall Study|Pregnancy|2|||
162999352|NCT04614246|588698276|FG001|Overall Study|Pregnancy|0|||
162999353|NCT04614246|588698277|FG002|Overall Study|Pregnancy|1|||
162999354|NCT04614246|588698278|FG003|Overall Study|Pregnancy|0|||
162999355|NCT04614246|588698279|FG004|Overall Study|Pregnancy|0|||
162999356|NCT02185053|588698280|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
162999357|NCT02185053|588698281|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
162999358|NCT02185053|588698282|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
162999359|NCT02185053|588698280|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
162999360|NCT02185053|588698281|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999361|NCT02185053|588698282|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999362|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
162999363|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
162999364|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
162999365|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
162999366|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
162999367|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
162999368|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999369|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
162999370|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
162999371|NCT02185053|588698280|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
162999372|NCT02185053|588698281|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
162999373|NCT02185053|588698282|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
162999374|NCT02185053|588698280|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
162999375|NCT02185053|588698281|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
162999376|NCT02185053|588698282|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
162999377|NCT02185053|588698280|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
162999378|NCT02185053|588698281|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
162999379|NCT02185053|588698282|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
162999380|NCT02521376|588698290|FG000|Overall Study|Enrolled, But Not Treated|1|||
162999381|NCT02521376|588698291|FG001|Overall Study|Enrolled, But Not Treated|0|||
162999382|NCT02521376|588698292|FG002|Overall Study|Enrolled, But Not Treated|0|||
162999383|NCT02521376|588698293|FG003|Overall Study|Enrolled, But Not Treated|0|||
162999384|NCT00338728|588698294|FG000|Overall Study|Screen Failure|14|||
162999385|NCT00340678|588698297|FG000|Overall Study|Lost to Follow-up|1|||
162999386|NCT00340678|588698298|FG001|Overall Study|Lost to Follow-up|0|||
162999387|NCT00340678|588698299|FG002|Overall Study|Lost to Follow-up|0|||
162999388|NCT00340678|588698300|FG003|Overall Study|Lost to Follow-up|0|||
162999389|NCT01862484|588698301|FG000|Overall Study|Lack of Efficacy|1|||
162999390|NCT01862484|588698302|FG001|Overall Study|Lack of Efficacy|1|||
162999391|NCT01862484|588698301|FG000|Overall Study|Lost to Follow-up|1|||
162999392|NCT01862484|588698302|FG001|Overall Study|Lost to Follow-up|2|||
162999393|NCT01862484|588698301|FG000|Overall Study|Protocol Violation|0|||
162999394|NCT01862484|588698302|FG001|Overall Study|Protocol Violation|2|||
162999395|NCT01862484|588698301|FG000|Overall Study|Withdrawal by Subject|0|||
162999396|NCT01862484|588698302|FG001|Overall Study|Withdrawal by Subject|3|||
162999397|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
162999398|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
162999399|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
162999400|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
162999401|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
162999402|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
162999403|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
162999404|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
162999405|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
162999406|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
162999407|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
162999408|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
162999409|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
162999410|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
162999411|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
162999412|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
162999413|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
162999414|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
162999415|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
162999416|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
162999417|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Death|1|||
162999418|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Death|0|||
162999419|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Death|0|||
162999420|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Death|0|||
162999421|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Death|0|||
162999422|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Death|1|||
162999423|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Death|0|||
162999424|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Death|0|||
162999425|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Death|0|||
162999426|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Death|0|||
162999427|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Death|0|||
162999428|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Death|0|||
162999429|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Death|0|||
162999430|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Death|0|||
162999431|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Death|0|||
162999432|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Death|0|||
162999433|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Death|0|||
162999434|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Death|0|||
162999435|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Death|0|||
162999436|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Death|0|||
162999437|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
162999438|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
162999439|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
162999440|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
162999441|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
162999442|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
162999443|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
162999444|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
162999445|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
162999446|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
162999447|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
162999448|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
162999449|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
162999450|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
162999451|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
162999452|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
162999453|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
162999454|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
162999455|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
162999456|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
162999457|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999458|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999459|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999460|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
162999461|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999462|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999463|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
162999464|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999465|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999466|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999467|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999468|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999469|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999470|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999471|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999472|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999473|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999474|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999475|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999476|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
162999477|NCT00996892|588698303|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
162999478|NCT00996892|588698304|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
162999479|NCT00996892|588698305|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
162999480|NCT00996892|588698306|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
162999481|NCT00996892|588698307|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
162999482|NCT00996892|588698308|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
162999483|NCT00996892|588698309|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
162999484|NCT00996892|588698310|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
162999485|NCT00996892|588698311|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
162999486|NCT00996892|588698312|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
162999487|NCT00996892|588698313|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
162999488|NCT00996892|588698314|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
162999489|NCT00996892|588698315|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
162999490|NCT00996892|588698316|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
162999491|NCT00996892|588698317|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
162999492|NCT00996892|588698318|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
162999493|NCT00996892|588698319|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
162999494|NCT00996892|588698320|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
162999495|NCT00996892|588698321|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
162999496|NCT00996892|588698322|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
162999497|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
162999498|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
162999499|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
162999500|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
162999501|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
162999502|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
162999503|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
162999504|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
162999505|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
162999506|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
162999507|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
162999508|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
162999509|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
162999510|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
162999511|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
162999512|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
162999513|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
162999514|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
162999515|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
162999516|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
162999517|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Death|0|||
162999518|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Death|0|||
162999519|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Death|0|||
162999520|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Death|0|||
162999521|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Death|0|||
162999522|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Death|0|||
162999523|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Death|0|||
162999524|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Death|0|||
162999525|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Death|0|||
162999526|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Death|2|||
162999527|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Death|0|||
162999528|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Death|1|||
162999529|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Death|1|||
162999530|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Death|0|||
162999531|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Death|0|||
162999532|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Death|0|||
162999533|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Death|0|||
162999534|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Death|0|||
162999535|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Death|0|||
162999536|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Death|0|||
162999537|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
162999538|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
162999539|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
162999540|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
162999541|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
162999542|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
162999543|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
162999544|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
162999545|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
162999546|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
162999547|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
162999548|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
162999549|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
162999550|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
162999551|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
162999552|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
162999553|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
162999554|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
162999555|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
162999556|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
162999557|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999558|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999559|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999560|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999561|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999562|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999563|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999564|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999565|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999566|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999567|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999568|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999569|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
162999570|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999571|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999572|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999573|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999574|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999575|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999576|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
162999577|NCT00996892|588698303|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
162999578|NCT00996892|588698304|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
162999579|NCT00996892|588698305|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
162999580|NCT00996892|588698306|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
162999581|NCT00996892|588698307|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
162999582|NCT00996892|588698308|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
162999583|NCT00996892|588698309|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
162999584|NCT00996892|588698310|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
162999585|NCT00996892|588698311|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
162999586|NCT00996892|588698312|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
162999587|NCT00996892|588698313|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
162999588|NCT00996892|588698314|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
162999589|NCT00996892|588698315|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
162999590|NCT00996892|588698316|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
162999591|NCT00996892|588698317|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
162999592|NCT00996892|588698318|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
162999593|NCT00996892|588698319|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
162999594|NCT00996892|588698320|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
162999595|NCT00996892|588698321|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
162999596|NCT00996892|588698322|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
162999597|NCT00996892|588698303|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
162999598|NCT00996892|588698304|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
162999599|NCT00996892|588698305|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
162999600|NCT00996892|588698306|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
162999601|NCT00996892|588698307|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
162999602|NCT00996892|588698308|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
162999603|NCT00996892|588698309|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
162999604|NCT00996892|588698310|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
162999605|NCT00996892|588698311|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
162999606|NCT00996892|588698312|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
162999607|NCT00996892|588698313|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
162999608|NCT00996892|588698314|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
162999609|NCT00996892|588698315|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
162999610|NCT00996892|588698316|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
162999611|NCT00996892|588698317|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
162999612|NCT00996892|588698318|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
162999613|NCT00996892|588698319|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
162999614|NCT00996892|588698320|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
162999615|NCT00996892|588698321|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
162999616|NCT00996892|588698322|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
162999617|NCT00996892|588698303|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
162999618|NCT00996892|588698304|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
162999619|NCT00996892|588698305|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
162999620|NCT00996892|588698306|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
162999621|NCT00996892|588698307|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
162999622|NCT00996892|588698308|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
162999623|NCT00996892|588698309|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
162999624|NCT00996892|588698310|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
162999625|NCT00996892|588698311|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
162999626|NCT00996892|588698312|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
162999627|NCT00996892|588698313|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
162999628|NCT00996892|588698314|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
162999629|NCT00996892|588698315|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
162999630|NCT00996892|588698316|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
162999631|NCT00996892|588698317|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
162999632|NCT00996892|588698318|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
162999633|NCT00996892|588698319|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
162999634|NCT00996892|588698320|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
162999635|NCT00996892|588698321|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
162999636|NCT00996892|588698322|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
162999637|NCT00996892|588698303|FG000|Expansion Stage 2|Adverse Event|0|||
162999638|NCT00996892|588698304|FG001|Expansion Stage 2|Adverse Event|0|||
162999639|NCT00996892|588698305|FG002|Expansion Stage 2|Adverse Event|0|||
162999640|NCT00996892|588698306|FG003|Expansion Stage 2|Adverse Event|0|||
162999641|NCT00996892|588698307|FG004|Expansion Stage 2|Adverse Event|0|||
162999642|NCT00996892|588698308|FG005|Expansion Stage 2|Adverse Event|0|||
162999643|NCT00996892|588698309|FG006|Expansion Stage 2|Adverse Event|0|||
162999644|NCT00996892|588698310|FG007|Expansion Stage 2|Adverse Event|0|||
162999645|NCT00996892|588698311|FG008|Expansion Stage 2|Adverse Event|0|||
162999646|NCT00996892|588698312|FG009|Expansion Stage 2|Adverse Event|0|||
162999647|NCT00996892|588698313|FG010|Expansion Stage 2|Adverse Event|0|||
162999648|NCT00996892|588698314|FG011|Expansion Stage 2|Adverse Event|0|||
162999649|NCT00996892|588698315|FG012|Expansion Stage 2|Adverse Event|0|||
162999650|NCT00996892|588698316|FG013|Expansion Stage 2|Adverse Event|0|||
162999651|NCT00996892|588698317|FG014|Expansion Stage 2|Adverse Event|0|||
162999652|NCT00996892|588698318|FG015|Expansion Stage 2|Adverse Event|0|||
162999653|NCT00996892|588698319|FG016|Expansion Stage 2|Adverse Event|0|||
162999654|NCT00996892|588698320|FG017|Expansion Stage 2|Adverse Event|0|||
162999655|NCT00996892|588698321|FG018|Expansion Stage 2|Adverse Event|3|||
162999656|NCT00996892|588698322|FG019|Expansion Stage 2|Adverse Event|0|||
162999657|NCT00996892|588698303|FG000|Expansion Stage 2|Death|0|||
162999658|NCT00996892|588698304|FG001|Expansion Stage 2|Death|0|||
162999659|NCT00996892|588698305|FG002|Expansion Stage 2|Death|0|||
162999660|NCT00996892|588698306|FG003|Expansion Stage 2|Death|0|||
162999661|NCT00996892|588698307|FG004|Expansion Stage 2|Death|0|||
162999662|NCT00996892|588698308|FG005|Expansion Stage 2|Death|0|||
162999663|NCT00996892|588698309|FG006|Expansion Stage 2|Death|0|||
162999664|NCT00996892|588698310|FG007|Expansion Stage 2|Death|0|||
162999665|NCT00996892|588698311|FG008|Expansion Stage 2|Death|0|||
162999666|NCT00996892|588698312|FG009|Expansion Stage 2|Death|0|||
162999667|NCT00996892|588698313|FG010|Expansion Stage 2|Death|0|||
162999668|NCT00996892|588698314|FG011|Expansion Stage 2|Death|0|||
162999669|NCT00996892|588698315|FG012|Expansion Stage 2|Death|0|||
162999670|NCT00996892|588698316|FG013|Expansion Stage 2|Death|0|||
162999671|NCT00996892|588698317|FG014|Expansion Stage 2|Death|0|||
162999672|NCT00996892|588698318|FG015|Expansion Stage 2|Death|0|||
162999673|NCT00996892|588698319|FG016|Expansion Stage 2|Death|0|||
162999674|NCT00996892|588698320|FG017|Expansion Stage 2|Death|0|||
162999675|NCT00996892|588698321|FG018|Expansion Stage 2|Death|2|||
162999676|NCT00996892|588698322|FG019|Expansion Stage 2|Death|0|||
162999677|NCT00996892|588698303|FG000|Expansion Stage 2|Physician Decision|0|||
162999678|NCT00996892|588698304|FG001|Expansion Stage 2|Physician Decision|0|||
162999679|NCT00996892|588698305|FG002|Expansion Stage 2|Physician Decision|0|||
162999680|NCT00996892|588698306|FG003|Expansion Stage 2|Physician Decision|0|||
162999681|NCT00996892|588698307|FG004|Expansion Stage 2|Physician Decision|0|||
163060577|NCT05219162|588929944|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
163060578|NCT05219162|588929944|FG000|Overall Study|Withdrawal by Subject|23|||
162637168|NCT02068443|587388448|FG002|Overall Study|Voluntary Withdrawal|1|||
162999682|NCT00996892|588698308|FG005|Expansion Stage 2|Physician Decision|0|||
162999683|NCT00996892|588698309|FG006|Expansion Stage 2|Physician Decision|0|||
162999684|NCT00996892|588698310|FG007|Expansion Stage 2|Physician Decision|0|||
162999685|NCT00996892|588698311|FG008|Expansion Stage 2|Physician Decision|0|||
162999686|NCT00996892|588698312|FG009|Expansion Stage 2|Physician Decision|0|||
162999687|NCT00996892|588698313|FG010|Expansion Stage 2|Physician Decision|0|||
162999688|NCT00996892|588698314|FG011|Expansion Stage 2|Physician Decision|0|||
162999689|NCT00996892|588698315|FG012|Expansion Stage 2|Physician Decision|0|||
162999690|NCT00996892|588698316|FG013|Expansion Stage 2|Physician Decision|0|||
162999691|NCT00996892|588698317|FG014|Expansion Stage 2|Physician Decision|0|||
162999692|NCT00996892|588698318|FG015|Expansion Stage 2|Physician Decision|0|||
162999693|NCT00996892|588698319|FG016|Expansion Stage 2|Physician Decision|0|||
162999694|NCT00996892|588698320|FG017|Expansion Stage 2|Physician Decision|0|||
162999695|NCT00996892|588698321|FG018|Expansion Stage 2|Physician Decision|1|||
162999696|NCT00996892|588698322|FG019|Expansion Stage 2|Physician Decision|0|||
162999697|NCT00996892|588698303|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
162999698|NCT00996892|588698304|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
162999699|NCT00996892|588698305|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
162637169|NCT02068443|587388446|FG000|Overall Study|Lack of Efficacy|2|||
162999700|NCT00996892|588698306|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
162999701|NCT00996892|588698307|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
162999702|NCT00996892|588698308|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
162999703|NCT00996892|588698309|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
162999704|NCT00996892|588698310|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
162999705|NCT00996892|588698311|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
162999706|NCT00996892|588698312|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
162999707|NCT00996892|588698313|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
162999708|NCT00996892|588698314|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
162999709|NCT00996892|588698315|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
162999710|NCT00996892|588698316|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
162999711|NCT00996892|588698317|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
162999712|NCT00996892|588698318|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
162999713|NCT00996892|588698319|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
162999714|NCT00996892|588698320|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
162999715|NCT00996892|588698321|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
162999716|NCT00996892|588698322|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
162999717|NCT00996892|588698303|FG000|Expansion Stage 2|Disease Progression|0|||
162999718|NCT00996892|588698304|FG001|Expansion Stage 2|Disease Progression|0|||
162999719|NCT00996892|588698305|FG002|Expansion Stage 2|Disease Progression|0|||
162999720|NCT00996892|588698306|FG003|Expansion Stage 2|Disease Progression|0|||
162999721|NCT00996892|588698307|FG004|Expansion Stage 2|Disease Progression|0|||
162999722|NCT00996892|588698308|FG005|Expansion Stage 2|Disease Progression|0|||
162999723|NCT00996892|588698309|FG006|Expansion Stage 2|Disease Progression|0|||
162999724|NCT00996892|588698310|FG007|Expansion Stage 2|Disease Progression|0|||
162999725|NCT00996892|588698311|FG008|Expansion Stage 2|Disease Progression|0|||
162999726|NCT00996892|588698312|FG009|Expansion Stage 2|Disease Progression|0|||
162999727|NCT00996892|588698313|FG010|Expansion Stage 2|Disease Progression|0|||
162999728|NCT00996892|588698314|FG011|Expansion Stage 2|Disease Progression|0|||
162999729|NCT00996892|588698315|FG012|Expansion Stage 2|Disease Progression|0|||
162999730|NCT00996892|588698316|FG013|Expansion Stage 2|Disease Progression|0|||
162999731|NCT00996892|588698317|FG014|Expansion Stage 2|Disease Progression|0|||
162999732|NCT00996892|588698318|FG015|Expansion Stage 2|Disease Progression|0|||
162999733|NCT00996892|588698319|FG016|Expansion Stage 2|Disease Progression|0|||
162999734|NCT00996892|588698320|FG017|Expansion Stage 2|Disease Progression|0|||
162999735|NCT00996892|588698321|FG018|Expansion Stage 2|Disease Progression|28|||
162999736|NCT00996892|588698322|FG019|Expansion Stage 2|Disease Progression|0|||
162999737|NCT00996892|588698303|FG000|Expansion Stage 2A|Adverse Event|0|||
162999738|NCT00996892|588698304|FG001|Expansion Stage 2A|Adverse Event|0|||
162999739|NCT00996892|588698305|FG002|Expansion Stage 2A|Adverse Event|0|||
162999740|NCT00996892|588698306|FG003|Expansion Stage 2A|Adverse Event|0|||
162999741|NCT00996892|588698307|FG004|Expansion Stage 2A|Adverse Event|0|||
162999742|NCT00996892|588698308|FG005|Expansion Stage 2A|Adverse Event|0|||
162999743|NCT00996892|588698309|FG006|Expansion Stage 2A|Adverse Event|0|||
162999744|NCT00996892|588698310|FG007|Expansion Stage 2A|Adverse Event|0|||
162999745|NCT00996892|588698311|FG008|Expansion Stage 2A|Adverse Event|0|||
162999746|NCT00996892|588698312|FG009|Expansion Stage 2A|Adverse Event|0|||
162999747|NCT00996892|588698313|FG010|Expansion Stage 2A|Adverse Event|0|||
162999748|NCT00996892|588698314|FG011|Expansion Stage 2A|Adverse Event|0|||
162999749|NCT00996892|588698315|FG012|Expansion Stage 2A|Adverse Event|0|||
162999750|NCT00996892|588698316|FG013|Expansion Stage 2A|Adverse Event|0|||
162999751|NCT00996892|588698317|FG014|Expansion Stage 2A|Adverse Event|0|||
162999752|NCT00996892|588698318|FG015|Expansion Stage 2A|Adverse Event|0|||
162999753|NCT00996892|588698319|FG016|Expansion Stage 2A|Adverse Event|0|||
162999754|NCT00996892|588698320|FG017|Expansion Stage 2A|Adverse Event|0|||
162999755|NCT00996892|588698321|FG018|Expansion Stage 2A|Adverse Event|0|||
162999756|NCT00996892|588698322|FG019|Expansion Stage 2A|Adverse Event|8|||
162999757|NCT00996892|588698303|FG000|Expansion Stage 2A|Physician Decision|0|||
162999758|NCT00996892|588698304|FG001|Expansion Stage 2A|Physician Decision|0|||
162999759|NCT00996892|588698305|FG002|Expansion Stage 2A|Physician Decision|0|||
162999760|NCT00996892|588698306|FG003|Expansion Stage 2A|Physician Decision|0|||
162999761|NCT00996892|588698307|FG004|Expansion Stage 2A|Physician Decision|0|||
162999762|NCT00996892|588698308|FG005|Expansion Stage 2A|Physician Decision|0|||
162999763|NCT00996892|588698309|FG006|Expansion Stage 2A|Physician Decision|0|||
162999764|NCT00996892|588698310|FG007|Expansion Stage 2A|Physician Decision|0|||
162999765|NCT00996892|588698311|FG008|Expansion Stage 2A|Physician Decision|0|||
162999766|NCT00996892|588698312|FG009|Expansion Stage 2A|Physician Decision|0|||
162637170|NCT02068443|587388447|FG001|Overall Study|Lack of Efficacy|1|||
162637171|NCT02068443|587388448|FG002|Overall Study|Lack of Efficacy|0|||
162637172|NCT02068443|587388446|FG000|Overall Study|Other Reason Not Specified|1|||
162637173|NCT02068443|587388447|FG001|Overall Study|Other Reason Not Specified|0|||
162637174|NCT02068443|587388448|FG002|Overall Study|Other Reason Not Specified|0|||
162999767|NCT00996892|588698313|FG010|Expansion Stage 2A|Physician Decision|0|||
162999768|NCT00996892|588698314|FG011|Expansion Stage 2A|Physician Decision|0|||
162999769|NCT00996892|588698315|FG012|Expansion Stage 2A|Physician Decision|0|||
162999770|NCT00996892|588698316|FG013|Expansion Stage 2A|Physician Decision|0|||
162999771|NCT00996892|588698317|FG014|Expansion Stage 2A|Physician Decision|0|||
162999772|NCT00996892|588698318|FG015|Expansion Stage 2A|Physician Decision|0|||
162999773|NCT00996892|588698319|FG016|Expansion Stage 2A|Physician Decision|0|||
162999774|NCT00996892|588698320|FG017|Expansion Stage 2A|Physician Decision|0|||
162999775|NCT00996892|588698321|FG018|Expansion Stage 2A|Physician Decision|0|||
162999776|NCT00996892|588698322|FG019|Expansion Stage 2A|Physician Decision|2|||
162999777|NCT00996892|588698303|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
162999778|NCT00996892|588698304|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
162999779|NCT00996892|588698305|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
162999780|NCT00996892|588698306|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
162999781|NCT00996892|588698307|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
162999782|NCT00996892|588698308|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
162999783|NCT00996892|588698309|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
162999784|NCT00996892|588698310|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
162999785|NCT00996892|588698311|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
162999786|NCT00996892|588698312|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
162999787|NCT00996892|588698313|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
162999788|NCT00996892|588698314|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
162999789|NCT00996892|588698315|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
162999790|NCT00996892|588698316|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
162999791|NCT00996892|588698317|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
162999792|NCT00996892|588698318|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
162999793|NCT00996892|588698319|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
162999794|NCT00996892|588698320|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
162999795|NCT00996892|588698321|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
162999796|NCT00996892|588698322|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
162999797|NCT00996892|588698303|FG000|Expansion Stage 2A|Disease Progression|0|||
162999798|NCT00996892|588698304|FG001|Expansion Stage 2A|Disease Progression|0|||
162999799|NCT00996892|588698305|FG002|Expansion Stage 2A|Disease Progression|0|||
162999800|NCT00996892|588698306|FG003|Expansion Stage 2A|Disease Progression|0|||
162999801|NCT00996892|588698307|FG004|Expansion Stage 2A|Disease Progression|0|||
162999802|NCT00996892|588698308|FG005|Expansion Stage 2A|Disease Progression|0|||
162999803|NCT00996892|588698309|FG006|Expansion Stage 2A|Disease Progression|0|||
162999804|NCT00996892|588698310|FG007|Expansion Stage 2A|Disease Progression|0|||
162999805|NCT00996892|588698311|FG008|Expansion Stage 2A|Disease Progression|0|||
162999806|NCT00996892|588698312|FG009|Expansion Stage 2A|Disease Progression|0|||
162999807|NCT00996892|588698313|FG010|Expansion Stage 2A|Disease Progression|0|||
162999808|NCT00996892|588698314|FG011|Expansion Stage 2A|Disease Progression|0|||
162999809|NCT00996892|588698315|FG012|Expansion Stage 2A|Disease Progression|0|||
162999810|NCT00996892|588698316|FG013|Expansion Stage 2A|Disease Progression|0|||
162999811|NCT00996892|588698317|FG014|Expansion Stage 2A|Disease Progression|0|||
162999812|NCT00996892|588698318|FG015|Expansion Stage 2A|Disease Progression|0|||
162999813|NCT00996892|588698319|FG016|Expansion Stage 2A|Disease Progression|0|||
162999814|NCT00996892|588698320|FG017|Expansion Stage 2A|Disease Progression|0|||
162999815|NCT00996892|588698321|FG018|Expansion Stage 2A|Disease Progression|0|||
162999816|NCT00996892|588698322|FG019|Expansion Stage 2A|Disease Progression|31|||
162999817|NCT00993421|588698323|FG000|Overall Study|Adverse Event|2|||
162999818|NCT00993421|588698324|FG001|Overall Study|Adverse Event|7|||
162999819|NCT00993421|588698325|FG002|Overall Study|Adverse Event|6|||
162999820|NCT00993421|588698326|FG003|Overall Study|Adverse Event|9|||
162999821|NCT00993421|588698327|FG004|Overall Study|Adverse Event|5|||
162999822|NCT00993421|588698328|FG005|Overall Study|Adverse Event|7|||
162999823|NCT00993421|588698329|FG006|Overall Study|Adverse Event|1|||
162999824|NCT00993421|588698323|FG000|Overall Study|Sponsor Decision|36|||
162999825|NCT00993421|588698324|FG001|Overall Study|Sponsor Decision|31|||
162999826|NCT00993421|588698325|FG002|Overall Study|Sponsor Decision|28|||
163060579|NCT04428151|588929945|FG000|Overall Study|Death|100|||
162999827|NCT00993421|588698326|FG003|Overall Study|Sponsor Decision|30|||
162999828|NCT00993421|588698327|FG004|Overall Study|Sponsor Decision|38|||
162999829|NCT00993421|588698328|FG005|Overall Study|Sponsor Decision|30|||
162999830|NCT00993421|588698329|FG006|Overall Study|Sponsor Decision|29|||
162999831|NCT00993421|588698323|FG000|Overall Study|Lost to Follow-up|3|||
162999832|NCT00993421|588698324|FG001|Overall Study|Lost to Follow-up|5|||
162999833|NCT00993421|588698325|FG002|Overall Study|Lost to Follow-up|5|||
162999834|NCT00993421|588698326|FG003|Overall Study|Lost to Follow-up|0|||
162999835|NCT00993421|588698327|FG004|Overall Study|Lost to Follow-up|0|||
162999836|NCT00993421|588698328|FG005|Overall Study|Lost to Follow-up|0|||
162999837|NCT00993421|588698329|FG006|Overall Study|Lost to Follow-up|6|||
162637175|NCT02723084|587388450|FG000|Overall Study|Withdrawal by Subject|1|||
162637176|NCT02723084|587388451|FG001|Overall Study|Withdrawal by Subject|1|||
162637177|NCT02723084|587388450|FG000|Overall Study|Lost to Follow-up|3|||
162999838|NCT00993421|588698323|FG000|Overall Study|Withdrawal by Subject|3|||
162999839|NCT00993421|588698324|FG001|Overall Study|Withdrawal by Subject|2|||
162999840|NCT00993421|588698325|FG002|Overall Study|Withdrawal by Subject|3|||
162999841|NCT00993421|588698326|FG003|Overall Study|Withdrawal by Subject|3|||
162999842|NCT00993421|588698327|FG004|Overall Study|Withdrawal by Subject|3|||
162999843|NCT00993421|588698328|FG005|Overall Study|Withdrawal by Subject|5|||
162999844|NCT00993421|588698329|FG006|Overall Study|Withdrawal by Subject|3|||
162999845|NCT00993421|588698323|FG000|Overall Study|Death|0|||
162999846|NCT00993421|588698324|FG001|Overall Study|Death|0|||
162999847|NCT00993421|588698325|FG002|Overall Study|Death|0|||
162999848|NCT00993421|588698326|FG003|Overall Study|Death|0|||
162999849|NCT00993421|588698327|FG004|Overall Study|Death|0|||
162999850|NCT00993421|588698328|FG005|Overall Study|Death|0|||
162999851|NCT00993421|588698329|FG006|Overall Study|Death|1|||
162999852|NCT00993421|588698323|FG000|Overall Study|Entry Criteria Exclusion|0|||
162999853|NCT00993421|588698324|FG001|Overall Study|Entry Criteria Exclusion|0|||
162999854|NCT00993421|588698325|FG002|Overall Study|Entry Criteria Exclusion|1|||
162999855|NCT00993421|588698326|FG003|Overall Study|Entry Criteria Exclusion|3|||
162999856|NCT00993421|588698327|FG004|Overall Study|Entry Criteria Exclusion|0|||
162999857|NCT00993421|588698328|FG005|Overall Study|Entry Criteria Exclusion|1|||
162999858|NCT00993421|588698329|FG006|Overall Study|Entry Criteria Exclusion|0|||
162999859|NCT00993421|588698323|FG000|Overall Study|Physician Decision|0|||
162999860|NCT00993421|588698324|FG001|Overall Study|Physician Decision|0|||
162999861|NCT00993421|588698325|FG002|Overall Study|Physician Decision|0|||
162999862|NCT00993421|588698326|FG003|Overall Study|Physician Decision|0|||
162999863|NCT00993421|588698327|FG004|Overall Study|Physician Decision|0|||
162999864|NCT00993421|588698328|FG005|Overall Study|Physician Decision|1|||
162999865|NCT00993421|588698329|FG006|Overall Study|Physician Decision|1|||
162999866|NCT00993421|588698323|FG000|Overall Study|Protocol Violation|0|||
162999867|NCT00993421|588698324|FG001|Overall Study|Protocol Violation|0|||
162999868|NCT00993421|588698325|FG002|Overall Study|Protocol Violation|0|||
162999869|NCT00993421|588698326|FG003|Overall Study|Protocol Violation|0|||
162999870|NCT00993421|588698327|FG004|Overall Study|Protocol Violation|0|||
162999871|NCT00993421|588698328|FG005|Overall Study|Protocol Violation|2|||
162999872|NCT00993421|588698329|FG006|Overall Study|Protocol Violation|1|||
162999873|NCT02759692|588698330|FG000|Period 1|Test article no longer available|1|||
162999874|NCT02759692|588698331|FG001|Period 1|Test article no longer available|1|||
162999875|NCT02759692|588698330|FG000|Period 1|No longer meets eligibility criteria.|1|||
162999876|NCT02759692|588698331|FG001|Period 1|No longer meets eligibility criteria.|0|||
162999877|NCT02759692|588698330|FG000|Period 1|Miss-Randomized|1|||
162999878|NCT02759692|588698331|FG001|Period 1|Miss-Randomized|1|||
162999879|NCT02759692|588698330|FG000|Period 2|Lost to Follow-up|1|||
162999880|NCT02759692|588698331|FG001|Period 2|Lost to Follow-up|0|||
162999881|NCT02759692|588698330|FG000|Period 2|Test article no longer available|0|||
162999882|NCT02759692|588698331|FG001|Period 2|Test article no longer available|1|||
162999883|NCT05314816|588698337|FG000|Overall Study|Lost to Follow-up|5|||
162999884|NCT05314816|588698338|FG001|Overall Study|Lost to Follow-up|0|||
162999885|NCT05314816|588698339|FG002|Overall Study|Lost to Follow-up|1|||
162999886|NCT05314816|588698337|FG000|Overall Study|Protocol Violation|13|||
162999887|NCT05314816|588698338|FG001|Overall Study|Protocol Violation|8|||
162999888|NCT05314816|588698339|FG002|Overall Study|Protocol Violation|0|||
162999889|NCT04042376|588698340|FG000|Overall Study|Withdrawal by Subject|1|||
162999890|NCT04042376|588698340|FG000|Overall Study|Death|3|||
162999891|NCT02551666|588698341|FG000|Overall Study|Withdrawal by Subject|1|||
162999892|NCT02551666|588698342|FG001|Overall Study|Withdrawal by Subject|3|||
162999893|NCT05422625|588698343|FG000|Overall Study|Withdrawal by Subject|1|||
162999894|NCT05422625|588698344|FG001|Overall Study|Withdrawal by Subject|0|||
162999895|NCT01059786|588700173|FG000|Overall Study|Did not receive 6 cycles.|0|||
162999896|NCT01059786|588700174|FG001|Overall Study|Did not receive 6 cycles.|0|||
162999897|NCT01059786|588700175|FG002|Overall Study|Did not receive 6 cycles.|4|||
162999898|NCT01059786|588700176|FG003|Overall Study|Did not receive 6 cycles.|1|||
162999899|NCT01059786|588700177|FG004|Overall Study|Did not receive 6 cycles.|0|||
162999900|NCT04205812|588700178|FG000|Randomized Treatment Period|Ongoing|28|||
162999901|NCT04205812|588700179|FG001|Randomized Treatment Period|Ongoing|138|||
162999902|NCT04205812|588700178|FG000|Randomized Treatment Period|Death|94|||
162999903|NCT04205812|588700179|FG001|Randomized Treatment Period|Death|226|||
162999904|NCT04205812|588700178|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
162637178|NCT02723084|587388451|FG001|Overall Study|Lost to Follow-up|0|||
162999905|NCT04205812|588700179|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
162999906|NCT04205812|588700178|FG000|Randomized Treatment Period|Physician Decision|1|||
162999907|NCT04205812|588700179|FG001|Randomized Treatment Period|Physician Decision|4|||
162999908|NCT04205812|588700178|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
162999909|NCT04205812|588700179|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
162999910|NCT04205812|588700178|FG000|Randomized Treatment Period|Progressive Disease|0|||
162999911|NCT04205812|588700179|FG001|Randomized Treatment Period|Progressive Disease|1|||
162999912|NCT04205812|588700178|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
162999913|NCT04205812|588700179|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
163060580|NCT04428151|588929946|FG001|Overall Study|Death|86|||
162999914|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Ongoing|17|||
162999915|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Ongoing|0|||
162999916|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Death|39|||
162999917|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Death|0|||
162999918|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
162999919|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
162999920|NCT04205812|588700178|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
162999921|NCT04205812|588700179|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
162999922|NCT00371033|588700180|FG000|Overall Study|Lost to Follow-up|3|||
162999923|NCT00371033|588700181|FG001|Overall Study|Lost to Follow-up|2|||
162999924|NCT00371033|588700180|FG000|Overall Study|No longer interested|2|||
162999925|NCT00371033|588700181|FG001|Overall Study|No longer interested|0|||
162999926|NCT00371033|588700180|FG000|Overall Study|Uknown|3|||
162999927|NCT00371033|588700181|FG001|Overall Study|Uknown|1|||
162999928|NCT02514447|588700182|FG000|Overall Study|Withdrawal by Subject|3|||
162999929|NCT02514447|588700183|FG001|Overall Study|Withdrawal by Subject|1|||
162999930|NCT02514447|588700184|FG002|Overall Study|Withdrawal by Subject|1|||
162999931|NCT02514447|588700185|FG003|Overall Study|Withdrawal by Subject|0|||
162999932|NCT02514447|588700186|FG004|Overall Study|Withdrawal by Subject|0|||
162999933|NCT02514447|588700187|FG005|Overall Study|Withdrawal by Subject|0|||
162999934|NCT02514447|588700188|FG006|Overall Study|Withdrawal by Subject|0|||
162999935|NCT02514447|588700189|FG007|Overall Study|Withdrawal by Subject|1|||
162999936|NCT02514447|588700190|FG008|Overall Study|Withdrawal by Subject|1|||
162999937|NCT02514447|588700182|FG000|Overall Study|Death|24|||
162999938|NCT02514447|588700183|FG001|Overall Study|Death|28|||
162999939|NCT02514447|588700184|FG002|Overall Study|Death|29|||
162999940|NCT02514447|588700185|FG003|Overall Study|Death|0|||
162999941|NCT02514447|588700186|FG004|Overall Study|Death|3|||
162999942|NCT02514447|588700187|FG005|Overall Study|Death|4|||
162999943|NCT02514447|588700188|FG006|Overall Study|Death|8|||
162999944|NCT02514447|588700189|FG007|Overall Study|Death|6|||
162999945|NCT02514447|588700190|FG008|Overall Study|Death|5|||
162999946|NCT02514447|588700182|FG000|Overall Study|Lost to Follow-up|1|||
162999947|NCT02514447|588700183|FG001|Overall Study|Lost to Follow-up|0|||
162999948|NCT02514447|588700184|FG002|Overall Study|Lost to Follow-up|0|||
162999949|NCT02514447|588700185|FG003|Overall Study|Lost to Follow-up|0|||
162999950|NCT02514447|588700186|FG004|Overall Study|Lost to Follow-up|0|||
162999951|NCT02514447|588700187|FG005|Overall Study|Lost to Follow-up|0|||
162999952|NCT02514447|588700188|FG006|Overall Study|Lost to Follow-up|0|||
162999953|NCT02514447|588700189|FG007|Overall Study|Lost to Follow-up|0|||
162999954|NCT02514447|588700190|FG008|Overall Study|Lost to Follow-up|1|||
162999955|NCT02514447|588700182|FG000|Overall Study|Sponsor Termination of Study|0|||
162999956|NCT02514447|588700183|FG001|Overall Study|Sponsor Termination of Study|1|||
162999957|NCT02514447|588700184|FG002|Overall Study|Sponsor Termination of Study|1|||
162999958|NCT02514447|588700185|FG003|Overall Study|Sponsor Termination of Study|0|||
162999959|NCT02514447|588700186|FG004|Overall Study|Sponsor Termination of Study|0|||
162999960|NCT02514447|588700187|FG005|Overall Study|Sponsor Termination of Study|0|||
162999961|NCT02514447|588700188|FG006|Overall Study|Sponsor Termination of Study|0|||
162999962|NCT02514447|588700189|FG007|Overall Study|Sponsor Termination of Study|0|||
162999963|NCT02514447|588700190|FG008|Overall Study|Sponsor Termination of Study|0|||
162999964|NCT02514447|588700182|FG000|Overall Study|Study completion per Investigator|1|||
162999965|NCT02514447|588700183|FG001|Overall Study|Study completion per Investigator|0|||
162999966|NCT02514447|588700184|FG002|Overall Study|Study completion per Investigator|1|||
162999967|NCT02514447|588700185|FG003|Overall Study|Study completion per Investigator|2|||
162999968|NCT02514447|588700186|FG004|Overall Study|Study completion per Investigator|0|||
162999969|NCT02514447|588700187|FG005|Overall Study|Study completion per Investigator|0|||
162999970|NCT02514447|588700188|FG006|Overall Study|Study completion per Investigator|0|||
162999971|NCT02514447|588700189|FG007|Overall Study|Study completion per Investigator|0|||
162999972|NCT02514447|588700190|FG008|Overall Study|Study completion per Investigator|1|||
162999973|NCT03130777|588700195|FG000|Overall Study|Death|0|||
162999974|NCT03130777|588700196|FG001|Overall Study|Death|1|||
162999975|NCT03130777|588700195|FG000|Overall Study|Did not meet eligibility criteria|1|||
162999976|NCT03130777|588700196|FG001|Overall Study|Did not meet eligibility criteria|0|||
162999977|NCT05929651|588700200|FG000|Overall Study|Protocol Deviation|1|||
162999978|NCT05929651|588700200|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
163060581|NCT04428151|588929947|FG002|Overall Study|Death|57|||
162999979|NCT05026177|588700201|FG000|Overall Study|Adverse Event|33|||
163060582|NCT04428151|588929945|FG000|Overall Study|Lost to Follow-up|1|||
162999980|NCT05026177|588700202|FG001|Overall Study|Adverse Event|33|||
162999981|NCT05026177|588700203|FG002|Overall Study|Adverse Event|17|||
162999982|NCT05026177|588700201|FG000|Overall Study|Lost to Follow-up|7|||
162999983|NCT05026177|588700202|FG001|Overall Study|Lost to Follow-up|6|||
162999984|NCT05026177|588700203|FG002|Overall Study|Lost to Follow-up|8|||
162999985|NCT05026177|588700201|FG000|Overall Study|Noncompliance with study drug|6|||
162999986|NCT05026177|588700202|FG001|Overall Study|Noncompliance with study drug|2|||
162999987|NCT05026177|588700203|FG002|Overall Study|Noncompliance with study drug|1|||
162715747|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162999988|NCT05026177|588700201|FG000|Overall Study|Physician Decision|4|||
162999989|NCT05026177|588700202|FG001|Overall Study|Physician Decision|1|||
162999990|NCT05026177|588700203|FG002|Overall Study|Physician Decision|0|||
162999991|NCT05026177|588700201|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
162999992|NCT05026177|588700202|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
162999993|NCT05026177|588700203|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
162999994|NCT05026177|588700201|FG000|Overall Study|Withdrawal by Subject|53|||
162999995|NCT05026177|588700202|FG001|Overall Study|Withdrawal by Subject|51|||
162999996|NCT05026177|588700203|FG002|Overall Study|Withdrawal by Subject|55|||
162999997|NCT05026177|588700201|FG000|Overall Study|Protocol Violation|0|||
162999998|NCT05026177|588700202|FG001|Overall Study|Protocol Violation|1|||
162999999|NCT05026177|588700203|FG002|Overall Study|Protocol Violation|0|||
163000000|NCT05026177|588700201|FG000|Overall Study|Study terminated by sponsor|70|||
163000001|NCT05026177|588700202|FG001|Overall Study|Study terminated by sponsor|74|||
163000002|NCT05026177|588700203|FG002|Overall Study|Study terminated by sponsor|67|||
163000003|NCT05026177|588700201|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
163000004|NCT05026177|588700202|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
163000005|NCT05026177|588700203|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
163000006|NCT05026177|588700201|FG000|Overall Study|Starting alternative treatment|0|||
163000007|NCT05026177|588700202|FG001|Overall Study|Starting alternative treatment|1|||
163000008|NCT05026177|588700203|FG002|Overall Study|Starting alternative treatment|1|||
163000009|NCT05026177|588700201|FG000|Overall Study|Noncompliance with study procedures|0|||
163000010|NCT05026177|588700202|FG001|Overall Study|Noncompliance with study procedures|1|||
163000011|NCT05026177|588700203|FG002|Overall Study|Noncompliance with study procedures|1|||
163000012|NCT05026177|588700201|FG000|Overall Study|Met stopping criteria|0|||
163000013|NCT05026177|588700202|FG001|Overall Study|Met stopping criteria|0|||
163000014|NCT05026177|588700203|FG002|Overall Study|Met stopping criteria|1|||
163000015|NCT05026177|588700201|FG000|Overall Study|Health issues preventing continuation|0|||
163000016|NCT05026177|588700202|FG001|Overall Study|Health issues preventing continuation|0|||
163000017|NCT05026177|588700203|FG002|Overall Study|Health issues preventing continuation|1|||
163000018|NCT05026177|588700201|FG000|Overall Study|Randomized in error, not treated|0|||
163000019|NCT05026177|588700202|FG001|Overall Study|Randomized in error, not treated|0|||
163000020|NCT05026177|588700203|FG002|Overall Study|Randomized in error, not treated|2|||
163000021|NCT05109611|588700206|FG000|Overall Study|Adverse Event|13|||
163000022|NCT05109611|588700207|FG001|Overall Study|Adverse Event|10|||
163000023|NCT05109611|588700206|FG000|Overall Study|Withdrawal by Subject|1|||
163000024|NCT05109611|588700207|FG001|Overall Study|Withdrawal by Subject|0|||
163000025|NCT05109611|588700206|FG000|Overall Study|Lost to Follow-up|1|||
163000026|NCT05109611|588700207|FG001|Overall Study|Lost to Follow-up|2|||
163000027|NCT05109611|588700206|FG000|Overall Study|Protocol Violation|0|||
163000028|NCT05109611|588700207|FG001|Overall Study|Protocol Violation|4|||
163000029|NCT05109611|588700206|FG000|Overall Study|Information unavailable|1|||
163000030|NCT05109611|588700207|FG001|Overall Study|Information unavailable|1|||
163000031|NCT03203850|588700211|FG000|Overall Study|Subject/guardian decision|4|||
163000032|NCT03203850|588700212|FG001|Overall Study|Subject/guardian decision|3|||
163000033|NCT03203850|588700211|FG000|Overall Study|Adverse Event|3|||
163000034|NCT03203850|588700212|FG001|Overall Study|Adverse Event|0|||
163000035|NCT03203850|588700211|FG000|Overall Study|Death|1|||
163000036|NCT03203850|588700212|FG001|Overall Study|Death|0|||
163000037|NCT02717455|588700213|FG000|Overall Study|Adverse Event|1|||
163000038|NCT02717455|588700214|FG001|Overall Study|Adverse Event|0|||
163000039|NCT02717455|588700215|FG002|Overall Study|Adverse Event|0|||
163000040|NCT02717455|588700216|FG003|Overall Study|Adverse Event|2|||
163000041|NCT02717455|588700217|FG004|Overall Study|Adverse Event|2|||
163060583|NCT04428151|588929946|FG001|Overall Study|Lost to Follow-up|1|||
163060584|NCT04428151|588929947|FG002|Overall Study|Lost to Follow-up|0|||
162715748|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162715749|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162715750|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
162715751|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000042|NCT02717455|588700218|FG005|Overall Study|Adverse Event|2|||
163000043|NCT02717455|588700213|FG000|Overall Study|Withdrawal by Subject|1|||
163000044|NCT02717455|588700214|FG001|Overall Study|Withdrawal by Subject|1|||
163000045|NCT02717455|588700215|FG002|Overall Study|Withdrawal by Subject|0|||
163000046|NCT02717455|588700216|FG003|Overall Study|Withdrawal by Subject|2|||
163000047|NCT02717455|588700217|FG004|Overall Study|Withdrawal by Subject|2|||
163000048|NCT02717455|588700218|FG005|Overall Study|Withdrawal by Subject|1|||
163000049|NCT02717455|588700213|FG000|Overall Study|Death|1|||
163000050|NCT02717455|588700214|FG001|Overall Study|Death|0|||
163000051|NCT02717455|588700215|FG002|Overall Study|Death|0|||
163000052|NCT02717455|588700216|FG003|Overall Study|Death|0|||
163000053|NCT02717455|588700217|FG004|Overall Study|Death|1|||
163000054|NCT02717455|588700218|FG005|Overall Study|Death|0|||
163000055|NCT02717455|588700213|FG000|Overall Study|Did not receive study drug|0|||
163000056|NCT02717455|588700214|FG001|Overall Study|Did not receive study drug|0|||
163000057|NCT02717455|588700215|FG002|Overall Study|Did not receive study drug|0|||
163000058|NCT02717455|588700216|FG003|Overall Study|Did not receive study drug|1|||
163000059|NCT02717455|588700217|FG004|Overall Study|Did not receive study drug|0|||
163000060|NCT02717455|588700218|FG005|Overall Study|Did not receive study drug|1|||
163000061|NCT02717455|588700213|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000062|NCT02717455|588700214|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000063|NCT02717455|588700215|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000064|NCT02717455|588700216|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000065|NCT02717455|588700217|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
163000066|NCT02717455|588700218|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
163000067|NCT02717455|588700213|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
163000068|NCT02717455|588700214|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
163000069|NCT02717455|588700215|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
163000070|NCT02717455|588700216|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
163000071|NCT02717455|588700217|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
163000072|NCT02717455|588700218|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
163000073|NCT01433055|588700219|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
163000074|NCT01433055|588700220|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
163000075|NCT01433055|588700219|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
163000076|NCT01433055|588700220|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
163000077|NCT00733005|588700226|FG000|Overall Study|Adverse Event|0|||
163000078|NCT00733005|588700227|FG001|Overall Study|Adverse Event|1|||
163000079|NCT00733005|588700226|FG000|Overall Study|Treatment Failure|0|||
163000080|NCT00733005|588700227|FG001|Overall Study|Treatment Failure|1|||
163000081|NCT00733005|588700226|FG000|Overall Study|Withdrawal by Subject|0|||
163000082|NCT00733005|588700227|FG001|Overall Study|Withdrawal by Subject|1|||
163000083|NCT00733005|588700226|FG000|Overall Study|Protocol Violation|2|||
163000084|NCT00733005|588700227|FG001|Overall Study|Protocol Violation|0|||
163000085|NCT01769456|588700228|FG000|Overall Study|Lost to Follow-up|19|||
163000086|NCT01769456|588700228|FG000|Overall Study|Withdrawal by Subject|3|||
163000087|NCT01769456|588700228|FG000|Overall Study|Did not receive PCC intervention|6|||
163000088|NCT01769456|588700228|FG000|Overall Study|Moved out of the area|3|||
163000089|NCT01769456|588700228|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
163000090|NCT01769456|588700228|FG000|Overall Study|Parental request to youth to withdraw|1|||
163000091|NCT05244122|588700239|FG000|Overall Study|Withdrawal by Subject|318|||
163000092|NCT05377749|588700242|FG000|3 Weeks|Lost to Follow-up|2|||
163000093|NCT05377749|588700243|FG001|3 Weeks|Lost to Follow-up|4|||
163000094|NCT05377749|588700242|FG000|3 Weeks|Withdrawal by Subject|1|||
163000095|NCT05377749|588700243|FG001|3 Weeks|Withdrawal by Subject|1|||
163000096|NCT00886015|588700244|FG000|Overall Study|Death|0|||
163000097|NCT00886015|588700245|FG001|Overall Study|Death|2|||
163060585|NCT04428151|588929945|FG000|Overall Study|Withdrawal by Subject|2|||
163000098|NCT01692626|588700246|FG000|Overall Study|Death|0|||
163000099|NCT01692626|588700247|FG001|Overall Study|Death|1|||
163000100|NCT01692626|588700246|FG000|Overall Study|Adverse Event|2|||
163000101|NCT01692626|588700247|FG001|Overall Study|Adverse Event|3|||
163000102|NCT01692626|588700246|FG000|Overall Study|Protocol Violation|1|||
163000103|NCT01692626|588700247|FG001|Overall Study|Protocol Violation|2|||
163000104|NCT01692626|588700246|FG000|Overall Study|Withdrawal by Subject|1|||
163000105|NCT01692626|588700247|FG001|Overall Study|Withdrawal by Subject|0|||
163000106|NCT01434810|588700261|FG000|Overall Study|Did not receive treatment|11|||
163000107|NCT01434810|588700262|FG001|Overall Study|Did not receive treatment|3|||
163000108|NCT01434810|588700261|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
163000109|NCT01434810|588700262|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
163000110|NCT02794870|588700264|FG000|Overall Study|Withdrawal by Subject|2|||
163000111|NCT02794870|588700265|FG001|Overall Study|Withdrawal by Subject|0|||
163000112|NCT02540083|588700272|FG000|Overall Study|Withdrawal by Subject|16|||
163000113|NCT02301390|588700273|FG000|Overall Study|Withdrawal by Subject|3|||
163000114|NCT02301390|588700274|FG001|Overall Study|Withdrawal by Subject|5|||
163000115|NCT02301390|588700273|FG000|Overall Study|Protocol Violation|1|||
163000116|NCT02301390|588700274|FG001|Overall Study|Protocol Violation|0|||
163000117|NCT02301390|588700273|FG000|Overall Study|Physician Decision|1|||
163000118|NCT02301390|588700274|FG001|Overall Study|Physician Decision|0|||
163000119|NCT02301390|588700273|FG000|Overall Study|Lost to Follow-up|0|||
163000120|NCT02301390|588700274|FG001|Overall Study|Lost to Follow-up|1|||
163000121|NCT02301390|588700273|FG000|Overall Study|Death|2|||
163000122|NCT02301390|588700274|FG001|Overall Study|Death|2|||
163000123|NCT02301390|588700273|FG000|Overall Study|Procedure not completed|0|||
163000124|NCT02301390|588700274|FG001|Overall Study|Procedure not completed|4|||
163000125|NCT02301390|588700273|FG000|Overall Study|Missed multiple visits|1|||
163000126|NCT02301390|588700274|FG001|Overall Study|Missed multiple visits|1|||
163000127|NCT02301390|588700273|FG000|Overall Study|study terminated|2|||
163000128|NCT02301390|588700274|FG001|Overall Study|study terminated|0|||
163000129|NCT00185588|588700275|FG000|Overall Study|Adverse Event|3|||
163000130|NCT00185588|588700276|FG001|Overall Study|Adverse Event|1|||
163000131|NCT00185588|588700277|FG002|Overall Study|Adverse Event|4|||
163000132|NCT00185588|588700278|FG003|Overall Study|Adverse Event|2|||
163000133|NCT00185588|588700275|FG000|Overall Study|Lost to Follow-up|0|||
163000134|NCT00185588|588700276|FG001|Overall Study|Lost to Follow-up|0|||
163000135|NCT00185588|588700277|FG002|Overall Study|Lost to Follow-up|1|||
163000136|NCT00185588|588700278|FG003|Overall Study|Lost to Follow-up|2|||
163000137|NCT00185588|588700275|FG000|Overall Study|Withdrawal by Subject|0|||
163000138|NCT00185588|588700276|FG001|Overall Study|Withdrawal by Subject|1|||
163000139|NCT00185588|588700277|FG002|Overall Study|Withdrawal by Subject|0|||
163000140|NCT00185588|588700278|FG003|Overall Study|Withdrawal by Subject|0|||
163000141|NCT00185588|588700275|FG000|Overall Study|Physician Decision|0|||
163000142|NCT00185588|588700276|FG001|Overall Study|Physician Decision|0|||
163000143|NCT00185588|588700277|FG002|Overall Study|Physician Decision|1|||
163000144|NCT00185588|588700278|FG003|Overall Study|Physician Decision|0|||
163000145|NCT00398866|588700279|FG000|Overall Study|Adverse Event|1|||
163000146|NCT00398866|588700280|FG001|Overall Study|Adverse Event|0|||
163000147|NCT00398866|588700281|FG002|Overall Study|Adverse Event|0|||
163000148|NCT00398866|588700279|FG000|Overall Study|Lack of Efficacy|0|||
163000149|NCT00398866|588700280|FG001|Overall Study|Lack of Efficacy|0|||
163000150|NCT00398866|588700281|FG002|Overall Study|Lack of Efficacy|1|||
163060586|NCT04428151|588929946|FG001|Overall Study|Withdrawal by Subject|2|||
163060587|NCT04428151|588929947|FG002|Overall Study|Withdrawal by Subject|3|||
163060588|NCT04428151|588929945|FG000|Overall Study|Participant Ongoing in Study|41|||
162715752|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000151|NCT00398866|588700279|FG000|Overall Study|Lost to Follow-up|7|||
163000152|NCT00398866|588700280|FG001|Overall Study|Lost to Follow-up|6|||
163000153|NCT00398866|588700281|FG002|Overall Study|Lost to Follow-up|4|||
163000154|NCT00398866|588700279|FG000|Overall Study|Withdrawal by Subject|5|||
163000155|NCT00398866|588700280|FG001|Overall Study|Withdrawal by Subject|1|||
163000156|NCT00398866|588700281|FG002|Overall Study|Withdrawal by Subject|2|||
163000157|NCT00398866|588700279|FG000|Overall Study|Unable to complete requirements of study|1|||
163000158|NCT00398866|588700280|FG001|Overall Study|Unable to complete requirements of study|1|||
163000159|NCT00398866|588700281|FG002|Overall Study|Unable to complete requirements of study|1|||
163000160|NCT02481869|588700286|FG000|Overall Study|Lost to Follow-up|3|||
163000161|NCT02481869|588700287|FG001|Overall Study|Lost to Follow-up|4|||
163060589|NCT04428151|588929946|FG001|Overall Study|Participant Ongoing in Study|53|||
162715753|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000162|NCT02481869|588700286|FG000|Overall Study|Withdrawal by Subject|2|||
163000163|NCT02481869|588700287|FG001|Overall Study|Withdrawal by Subject|0|||
163000164|NCT01153425|588700293|FG000|Overall Study|Withdrawal by Subject|3|||
163000165|NCT01153425|588700294|FG001|Overall Study|Withdrawal by Subject|3|||
163000166|NCT03154125|588700295|FG000|Overall Study|Lost to Follow-up|11|||
163000167|NCT03154125|588700296|FG001|Overall Study|Lost to Follow-up|11|||
162637179|NCT04067544|587388456|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
162637180|NCT01320085|587388457|FG000|Overall Study|Disease Progression|26|||
162637181|NCT01320085|587388458|FG001|Overall Study|Disease Progression|93|||
162637182|NCT01320085|587388459|FG002|Overall Study|Disease Progression|17|||
162637183|NCT01320085|587388457|FG000|Overall Study|Adverse Event|12|||
162637184|NCT01320085|587388458|FG001|Overall Study|Adverse Event|20|||
162637185|NCT01320085|587388459|FG002|Overall Study|Adverse Event|5|||
162637186|NCT01320085|587388457|FG000|Overall Study|Withdrawal by Subject|2|||
162637187|NCT01320085|587388458|FG001|Overall Study|Withdrawal by Subject|4|||
162637188|NCT01320085|587388459|FG002|Overall Study|Withdrawal by Subject|1|||
162637189|NCT01320085|587388457|FG000|Overall Study|Protocol Deviation|1|||
162637190|NCT01320085|587388458|FG001|Overall Study|Protocol Deviation|0|||
162637191|NCT01320085|587388459|FG002|Overall Study|Protocol Deviation|1|||
162637192|NCT01320085|587388457|FG000|Overall Study|Administrative problems|0|||
162637193|NCT01320085|587388458|FG001|Overall Study|Administrative problems|0|||
162637194|NCT01320085|587388459|FG002|Overall Study|Administrative problems|1|||
162637195|NCT00225251|587388462|FG000|Overall Study|Withdrawal by Subject|1|||
162637196|NCT00225251|587388463|FG001|Overall Study|Withdrawal by Subject|1|||
162637197|NCT01702454|587388464|FG000|Overall Study|Consent withdrawal|0|||
162637198|NCT01702454|587388465|FG001|Overall Study|Consent withdrawal|1|||
162637199|NCT01702454|587388464|FG000|Overall Study|Migrated/moved from study area|0|||
162637200|NCT01702454|587388465|FG001|Overall Study|Migrated/moved from study area|1|||
162637201|NCT01702454|587388464|FG000|Overall Study|Lost to Follow-up|3|||
162637202|NCT01702454|587388465|FG001|Overall Study|Lost to Follow-up|6|||
162637203|NCT00475176|587388468|FG000|Overall Study|Adverse Event|2|||
162637204|NCT00475176|587388468|FG000|Overall Study|Withdrawal by Subject|1|||
162637205|NCT00475176|587388468|FG000|Overall Study|Protocol Violation|1|||
162637206|NCT01484873|587388469|FG000|Overall Study|Withdrawal by Subject|2|||
163000168|NCT03154125|588700297|FG002|Overall Study|Lost to Follow-up|0|||
163000169|NCT03154125|588700295|FG000|Overall Study|Withdrawal by Subject|49|||
163000170|NCT03154125|588700296|FG001|Overall Study|Withdrawal by Subject|55|||
163000171|NCT03154125|588700297|FG002|Overall Study|Withdrawal by Subject|8|||
163000172|NCT03154125|588700295|FG000|Overall Study|Physician Decision|13|||
163000173|NCT03154125|588700296|FG001|Overall Study|Physician Decision|6|||
163000174|NCT03154125|588700297|FG002|Overall Study|Physician Decision|0|||
163000175|NCT03154125|588700295|FG000|Overall Study|Protocol Violation|3|||
163000176|NCT03154125|588700296|FG001|Overall Study|Protocol Violation|5|||
163000177|NCT03154125|588700297|FG002|Overall Study|Protocol Violation|0|||
163000178|NCT00810511|588700298|FG000|Overall Study|Protocol Violation|0|||
163000179|NCT00810511|588700299|FG001|Overall Study|Protocol Violation|1|||
163000180|NCT00810511|588700298|FG000|Overall Study|Lack of Efficacy|9|||
163000181|NCT00810511|588700299|FG001|Overall Study|Lack of Efficacy|1|||
163000182|NCT00810511|588700298|FG000|Overall Study|death in the family|0|||
163000183|NCT00810511|588700299|FG001|Overall Study|death in the family|1|||
163000184|NCT00810511|588700298|FG000|Overall Study|Lost to Follow-up|1|||
163000185|NCT00810511|588700299|FG001|Overall Study|Lost to Follow-up|0|||
163000186|NCT00810511|588700298|FG000|Overall Study|deposits on contact lens|0|||
163000187|NCT00810511|588700299|FG001|Overall Study|deposits on contact lens|1|||
163000188|NCT00911300|588700301|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
162637207|NCT01549392|587388470|FG000|Overall Study|Withdrawal by Subject|1|||
162637208|NCT01549392|587388471|FG001|Overall Study|Withdrawal by Subject|0|||
162637209|NCT00227903|587388472|FG000|Overall Study|Withdrawal by Subject|2|||
162637210|NCT00227903|587388473|FG001|Overall Study|Withdrawal by Subject|5|||
162637211|NCT00227903|587388472|FG000|Overall Study|Subject moved out of area|1|||
162637212|NCT00227903|587388473|FG001|Overall Study|Subject moved out of area|2|||
162637213|NCT00227903|587388472|FG000|Overall Study|Lost to Follow-up|1|||
162637214|NCT00227903|587388473|FG001|Overall Study|Lost to Follow-up|3|||
162637215|NCT00227903|587388472|FG000|Overall Study|Miscarriage|1|||
162637216|NCT00227903|587388473|FG001|Overall Study|Miscarriage|0|||
162637217|NCT01475331|587388474|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
162715754|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000189|NCT00911300|588700302|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
163000190|NCT00911300|588700301|FG000|Overall Study|Death|1|||
163000191|NCT00911300|588700302|FG001|Overall Study|Death|0|||
163000192|NCT00911300|588700301|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
163000193|NCT00911300|588700302|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
163000194|NCT00911300|588700301|FG000|Overall Study|Adverse Event|14|||
163000195|NCT00911300|588700302|FG001|Overall Study|Adverse Event|6|||
163000196|NCT00911300|588700301|FG000|Overall Study|Protocol Violation|3|||
163000197|NCT00911300|588700302|FG001|Overall Study|Protocol Violation|2|||
163000198|NCT00911300|588700301|FG000|Overall Study|Consent Withdrawn|4|||
163000199|NCT00911300|588700302|FG001|Overall Study|Consent Withdrawn|12|||
163000200|NCT00911300|588700301|FG000|Overall Study|Coronary Angiography Performed|1|||
163000201|NCT00911300|588700302|FG001|Overall Study|Coronary Angiography Performed|0|||
163000202|NCT00911300|588700301|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
163000203|NCT00911300|588700302|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
163000204|NCT00911300|588700301|FG000|Overall Study|Received Commercial Treatment|1|||
163000205|NCT00911300|588700302|FG001|Overall Study|Received Commercial Treatment|0|||
163000206|NCT00911300|588700301|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
163000207|NCT00911300|588700302|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
163000208|NCT00911300|588700301|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
163000209|NCT00911300|588700302|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
163000210|NCT00911300|588700301|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
163000211|NCT00911300|588700302|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
163000212|NCT00911300|588700301|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
163000213|NCT00911300|588700302|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
163000214|NCT00911300|588700301|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
163000215|NCT00911300|588700302|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
163000216|NCT00911300|588700301|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
163000217|NCT00911300|588700302|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
163000218|NCT00911300|588700301|FG000|Overall Study|International Normalized Ratio Too High|0|||
163000219|NCT00911300|588700302|FG001|Overall Study|International Normalized Ratio Too High|1|||
163000220|NCT00911300|588700301|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
163000221|NCT00911300|588700302|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
163000222|NCT00911300|588700301|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
163000223|NCT00911300|588700302|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
163000224|NCT00911300|588700301|FG000|Overall Study|Physician Decision|0|||
163000225|NCT00911300|588700302|FG001|Overall Study|Physician Decision|1|||
163000226|NCT00911300|588700301|FG000|Overall Study|Treatment Stopped by Mistake|0|||
163000227|NCT00911300|588700302|FG001|Overall Study|Treatment Stopped by Mistake|1|||
163000228|NCT00911300|588700301|FG000|Overall Study|Randomized; No Study Medication Received|0|||
163000229|NCT00911300|588700302|FG001|Overall Study|Randomized; No Study Medication Received|2|||
163000230|NCT00666328|588700306|FG000|Overall Study|Death|2|||
163000231|NCT00666328|588700306|FG000|Overall Study|Lost to Follow-up|2|||
163000232|NCT00666328|588700306|FG000|Overall Study|No longer met eligibility criteria|1|||
163000233|NCT02288325|588700307|FG000|Run-in Period|Adverse Event|48|||
163000234|NCT02288325|588700308|FG001|Run-in Period|Adverse Event|0|||
163000235|NCT02288325|588700309|FG002|Run-in Period|Adverse Event|0|||
163000236|NCT02288325|588700307|FG000|Run-in Period|Lack of Efficacy|16|||
163000237|NCT02288325|588700308|FG001|Run-in Period|Lack of Efficacy|0|||
163000238|NCT02288325|588700309|FG002|Run-in Period|Lack of Efficacy|0|||
163000239|NCT02288325|588700307|FG000|Run-in Period|Withdrawal of Consent|28|||
163000240|NCT02288325|588700308|FG001|Run-in Period|Withdrawal of Consent|0|||
163000241|NCT02288325|588700309|FG002|Run-in Period|Withdrawal of Consent|0|||
163000242|NCT02288325|588700307|FG000|Run-in Period|Lost to Follow-up|25|||
163000243|NCT02288325|588700308|FG001|Run-in Period|Lost to Follow-up|0|||
163000244|NCT02288325|588700309|FG002|Run-in Period|Lost to Follow-up|0|||
163000245|NCT02288325|588700307|FG000|Run-in Period|Protocol Violation|17|||
163000246|NCT02288325|588700308|FG001|Run-in Period|Protocol Violation|0|||
163000247|NCT02288325|588700309|FG002|Run-in Period|Protocol Violation|0|||
163000248|NCT02288325|588700307|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
163000249|NCT02288325|588700308|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
163000250|NCT02288325|588700309|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
163000251|NCT02288325|588700307|FG000|Run-in Period|Reason not Specified|8|||
163000252|NCT02288325|588700308|FG001|Run-in Period|Reason not Specified|0|||
163000253|NCT02288325|588700309|FG002|Run-in Period|Reason not Specified|0|||
163000254|NCT02288325|588700307|FG000|Stabilization Period|Adverse Event|13|||
163000255|NCT02288325|588700308|FG001|Stabilization Period|Adverse Event|0|||
163000256|NCT02288325|588700309|FG002|Stabilization Period|Adverse Event|0|||
163000257|NCT02288325|588700307|FG000|Stabilization Period|Lack of Efficacy|22|||
163000258|NCT02288325|588700308|FG001|Stabilization Period|Lack of Efficacy|0|||
163000259|NCT02288325|588700309|FG002|Stabilization Period|Lack of Efficacy|0|||
163060590|NCT04428151|588929947|FG002|Overall Study|Participant Ongoing in Study|28|||
162637218|NCT01475331|587388475|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
162637219|NCT01475331|587388474|FG000|Overall Study|excessive main duct communication|1|||
162637220|NCT01475331|587388475|FG001|Overall Study|excessive main duct communication|1|||
162637221|NCT01475331|587388474|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
162637222|NCT01475331|587388475|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
163000260|NCT02288325|588700307|FG000|Stabilization Period|Withdrawal of Consent|23|||
163000261|NCT02288325|588700308|FG001|Stabilization Period|Withdrawal of Consent|0|||
163000262|NCT02288325|588700309|FG002|Stabilization Period|Withdrawal of Consent|0|||
163060591|NCT02187783|588929948|FG000|Overall Study|Adverse Event|8|||
162637223|NCT01475331|587388474|FG000|Overall Study|Sign of malignancy during the procedure|2|||
163000263|NCT02288325|588700307|FG000|Stabilization Period|Lost to Follow-up|12|||
163000264|NCT02288325|588700308|FG001|Stabilization Period|Lost to Follow-up|0|||
163000265|NCT02288325|588700309|FG002|Stabilization Period|Lost to Follow-up|0|||
163000266|NCT02288325|588700307|FG000|Stabilization Period|Protocol Violation|8|||
163000267|NCT02288325|588700308|FG001|Stabilization Period|Protocol Violation|0|||
163000268|NCT02288325|588700309|FG002|Stabilization Period|Protocol Violation|0|||
163060592|NCT02187783|588929948|FG000|Overall Study|Death|3|||
163000269|NCT02288325|588700307|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
163000270|NCT02288325|588700308|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
163000271|NCT02288325|588700309|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
163000272|NCT02288325|588700307|FG000|Stabilization Period|Reason not Specified|15|||
163000273|NCT02288325|588700308|FG001|Stabilization Period|Reason not Specified|0|||
163000274|NCT02288325|588700309|FG002|Stabilization Period|Reason not Specified|0|||
163000275|NCT02288325|588700307|FG000|Double-blind Treatment Period|Adverse Event|0|||
163000276|NCT02288325|588700308|FG001|Double-blind Treatment Period|Adverse Event|2|||
163000277|NCT02288325|588700309|FG002|Double-blind Treatment Period|Adverse Event|5|||
162637224|NCT01475331|587388475|FG001|Overall Study|Sign of malignancy during the procedure|0|||
162637225|NCT01475331|587388474|FG000|Overall Study|cyst found to be prohibitively small|0|||
162637226|NCT01475331|587388475|FG001|Overall Study|cyst found to be prohibitively small|1|||
163000278|NCT02288325|588700307|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
163000279|NCT02288325|588700308|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
163000280|NCT02288325|588700309|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
163000281|NCT02288325|588700307|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163000282|NCT02288325|588700308|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
163000283|NCT02288325|588700309|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163000284|NCT02288325|588700307|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163000285|NCT02288325|588700308|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163000286|NCT02288325|588700309|FG002|Double-blind Treatment Period|Protocol Violation|2|||
163000287|NCT02288325|588700307|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
163000288|NCT02288325|588700308|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
163000289|NCT02288325|588700309|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
163000290|NCT02288325|588700307|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
163000291|NCT02288325|588700308|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
163000292|NCT02288325|588700309|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
163000293|NCT03607487|588700313|FG000|Overall Study|Withdrawal by Subject|2|||
163000294|NCT03607487|588700314|FG001|Overall Study|Withdrawal by Subject|0|||
163000295|NCT03607487|588700315|FG002|Overall Study|Withdrawal by Subject|0|||
163000296|NCT03607487|588700316|FG003|Overall Study|Withdrawal by Subject|1|||
163000297|NCT04759703|588700317|FG000|Overall Study|Withdrawal by Subject|4|||
163000298|NCT04759703|588700318|FG001|Overall Study|Withdrawal by Subject|9|||
163000299|NCT04759703|588700317|FG000|Overall Study|Adverse Event|1|||
163000300|NCT04759703|588700318|FG001|Overall Study|Adverse Event|0|||
163000301|NCT04759703|588700317|FG000|Overall Study|Lost to Follow-up|2|||
163000302|NCT04759703|588700318|FG001|Overall Study|Lost to Follow-up|0|||
163000303|NCT04186845|588700326|FG000|Overall Study|Death|2|||
163000304|NCT04186845|588700326|FG000|Overall Study|Lost to Follow-up|1|||
163000305|NCT04186845|588700326|FG000|Overall Study|Physician Decision|1|||
163000306|NCT04186845|588700326|FG000|Overall Study|Protocol Violation|1|||
163000307|NCT04186845|588700326|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
163000308|NCT04186845|588700326|FG000|Overall Study|Biopsy ordered but not done|1|||
163000309|NCT04186845|588700326|FG000|Overall Study|It was previously confirmed|1|||
163000310|NCT04186845|588700326|FG000|Overall Study|Patient cancelled scheduled scans|2|||
163000311|NCT04186845|588700326|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
163000312|NCT04186845|588700326|FG000|Overall Study|Subject refused confirmatory imaging|1|||
163000313|NCT04186845|588700326|FG000|Overall Study|Too small to biopsy|1|||
163000314|NCT03151304|588700327|FG000|Overall Study|Termination of study by Sponsor|23|||
163000315|NCT03151304|588700327|FG000|Overall Study|missing|3|||
163000316|NCT03151304|588700327|FG000|Overall Study|Withdrawal by Subject|8|||
163000317|NCT03151304|588700327|FG000|Overall Study|multiple reasons|30|||
163000318|NCT04036110|588700330|FG000|Overall Study|Lost to Follow-up|3|||
163000319|NCT04036110|588700331|FG001|Overall Study|Lost to Follow-up|2|||
162637227|NCT00462761|587388476|FG000|Overall Study|Adverse Event|6|||
162637228|NCT00462761|587388476|FG000|Overall Study|Withdrawal by Subject|9|||
162637229|NCT00462761|587388476|FG000|Overall Study|Physician Decision|5|||
162637230|NCT00462761|587388476|FG000|Overall Study|Disease progression|43|||
162637231|NCT00462761|587388476|FG000|Overall Study|Death|12|||
163000320|NCT04036110|588700332|FG002|Overall Study|Lost to Follow-up|1|||
163000321|NCT04036110|588700330|FG000|Overall Study|Study Suspended|4|||
163000322|NCT04036110|588700331|FG001|Overall Study|Study Suspended|5|||
163000323|NCT04036110|588700332|FG002|Overall Study|Study Suspended|1|||
163000324|NCT00534404|588700335|FG000|Overall Study|Death|0|||
163000325|NCT00534404|588700336|FG001|Overall Study|Death|0|||
162637232|NCT00462761|587388476|FG000|Overall Study|Other|1|||
162637233|NCT02877082|587388477|FG000|Overall Study|Trial was closed early|5|||
162637234|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
162637235|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
163000326|NCT00534404|588700337|FG002|Overall Study|Death|2|||
163000327|NCT00534404|588700335|FG000|Overall Study|Withdrawal by Subject|8|||
163000328|NCT00534404|588700336|FG001|Overall Study|Withdrawal by Subject|2|||
163000329|NCT00534404|588700337|FG002|Overall Study|Withdrawal by Subject|38|||
163000330|NCT00534404|588700335|FG000|Overall Study|Removed by study staff|2|||
163000331|NCT00534404|588700336|FG001|Overall Study|Removed by study staff|3|||
163000332|NCT00534404|588700337|FG002|Overall Study|Removed by study staff|1|||
163000333|NCT00534404|588700335|FG000|Overall Study|Lost to Follow-up|170|||
163000334|NCT00534404|588700336|FG001|Overall Study|Lost to Follow-up|138|||
163000335|NCT00534404|588700337|FG002|Overall Study|Lost to Follow-up|201|||
163000336|NCT02676765|588700338|FG000|Overall Study|Lost to Follow-up|0|||
163000337|NCT02676765|588700339|FG001|Overall Study|Lost to Follow-up|1|||
163000338|NCT00490841|588700340|FG000|Overall Study|Death|5|||
163000339|NCT00490841|588700340|FG000|Overall Study|Withdrawal by Subject|4|||
163000340|NCT00490841|588700340|FG000|Overall Study|Lost to Follow-up|1|||
163000341|NCT00490841|588700340|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
163000342|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
163000343|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
163000344|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
163000345|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
163000346|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
163000347|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
163000348|NCT03452943|588700341|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
163000349|NCT03452943|588700342|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
163000350|NCT03452943|588700341|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
163000351|NCT03452943|588700342|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
163000352|NCT03452943|588700341|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
163000353|NCT03452943|588700342|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
163000354|NCT01107197|588700345|FG000|Overall Study|Death|12|||
163000355|NCT01107197|588700346|FG001|Overall Study|Death|10|||
163000356|NCT01107197|588700345|FG000|Overall Study|Lost to Follow-up|5|||
163000357|NCT01107197|588700346|FG001|Overall Study|Lost to Follow-up|8|||
163000358|NCT01107197|588700345|FG000|Overall Study|Withdrawal by Subject|3|||
163000359|NCT01107197|588700346|FG001|Overall Study|Withdrawal by Subject|5|||
163000360|NCT01301729|588700348|FG000|Overall Study|Withdrawal by Subject|2|||
163000361|NCT01301729|588700348|FG000|Overall Study|Participant did not Return for Treatment|1|||
163000362|NCT01301729|588700348|FG000|Overall Study|Violated Selection Criteria|1|||
163000363|NCT00447993|588700349|FG000|Overall Study|Lost to Follow-up|0|||
163000364|NCT00447993|588700350|FG001|Overall Study|Lost to Follow-up|0|||
163000365|NCT00447993|588700351|FG002|Overall Study|Lost to Follow-up|2|||
163000366|NCT00447993|588700352|FG003|Overall Study|Lost to Follow-up|2|||
163060593|NCT02187783|588929948|FG000|Overall Study|Progressive disease|80|||
163060594|NCT02187783|588929948|FG000|Overall Study|Protocol Violation|3|||
163060595|NCT02187783|588929948|FG000|Overall Study|Physician Decision|2|||
163060596|NCT02187783|588929948|FG000|Overall Study|Withdrawal by Subject|9|||
163060597|NCT02187783|588929948|FG000|Overall Study|Study terminated by sponsor|1|||
163060598|NCT00392223|588929949|FG000|Overall Study|Adverse Event|5|||
163060599|NCT00392223|588929950|FG001|Overall Study|Adverse Event|4|||
163060600|NCT00392223|588929949|FG000|Overall Study|Lost to Follow-up|1|||
163060601|NCT00392223|588929950|FG001|Overall Study|Lost to Follow-up|4|||
163060602|NCT00392223|588929949|FG000|Overall Study|Protocol Violation|0|||
163060603|NCT00392223|588929950|FG001|Overall Study|Protocol Violation|3|||
163060604|NCT00392223|588929949|FG000|Overall Study|Withdrawal by Subject|3|||
163060605|NCT00392223|588929950|FG001|Overall Study|Withdrawal by Subject|2|||
163060606|NCT02908347|588929951|FG000|Overall Study|Adverse Event|0|||
163060607|NCT02908347|588929952|FG001|Overall Study|Adverse Event|1|||
163060608|NCT02908347|588929951|FG000|Overall Study|Lost to Follow-up|1|||
163000367|NCT00447993|588700349|FG000|Overall Study|Withdrawal by Subject|0|||
163000368|NCT00447993|588700350|FG001|Overall Study|Withdrawal by Subject|0|||
163000369|NCT00447993|588700351|FG002|Overall Study|Withdrawal by Subject|2|||
163000370|NCT00447993|588700352|FG003|Overall Study|Withdrawal by Subject|2|||
163000371|NCT04380961|588700355|FG000|Overall Study|Lost to Follow-up|17|||
163000372|NCT04380961|588700356|FG001|Overall Study|Lost to Follow-up|11|||
163000373|NCT04380961|588700355|FG000|Overall Study|Withdrawal by Subject|3|||
163000374|NCT04380961|588700356|FG001|Overall Study|Withdrawal by Subject|0|||
163060609|NCT02908347|588929952|FG001|Overall Study|Lost to Follow-up|0|||
163060610|NCT05516758|588929958|FG000|Overall Study|Adverse Event|5|||
163060611|NCT05516758|588929959|FG001|Overall Study|Adverse Event|1|||
163000375|NCT04380961|588700355|FG000|Overall Study|Death|22|||
163000376|NCT04380961|588700356|FG001|Overall Study|Death|16|||
163000377|NCT04380961|588700355|FG000|Overall Study|Other|1|||
163000378|NCT04380961|588700356|FG001|Overall Study|Other|0|||
163000379|NCT04380961|588700355|FG000|Overall Study|Randomized but Not Treated|1|||
163000380|NCT04380961|588700356|FG001|Overall Study|Randomized but Not Treated|2|||
163060612|NCT05516758|588929960|FG002|Overall Study|Adverse Event|3|||
163060613|NCT05516758|588929961|FG003|Overall Study|Adverse Event|0|||
163060614|NCT05516758|588929962|FG004|Overall Study|Adverse Event|1|||
163000381|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
163000382|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
163000383|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
163060615|NCT05516758|588929963|FG005|Overall Study|Adverse Event|3|||
163060616|NCT05516758|588929964|FG006|Overall Study|Adverse Event|5|||
163000384|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
163000385|NCT04803305|588700357|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
163000386|NCT04803305|588700358|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
163000387|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
163000388|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
163000389|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
163000390|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
163000391|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
163000392|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
163000393|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
163000394|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
163000395|NCT04803305|588700357|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
163000396|NCT04803305|588700358|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
163000397|NCT02121652|588701804|FG000|Overall Study|Lost to Follow-up|2|||
163000398|NCT02121652|588701805|FG001|Overall Study|Lost to Follow-up|1|||
163000399|NCT02121652|588701804|FG000|Overall Study|Death|1|||
163000400|NCT02121652|588701805|FG001|Overall Study|Death|0|||
163000401|NCT02121652|588701804|FG000|Overall Study|Withdrawal by Subject|3|||
163000402|NCT02121652|588701805|FG001|Overall Study|Withdrawal by Subject|3|||
163000403|NCT01090414|588701806|FG000|Study 101-99|Progressive Disease|28|||
163000404|NCT01090414|588701807|FG001|Study 101-99|Progressive Disease|48|||
163000405|NCT01090414|588701808|FG002|Study 101-99|Progressive Disease|10|||
163000406|NCT01090414|588701809|FG003|Study 101-99|Progressive Disease|4|||
163000407|NCT01090414|588701806|FG000|Study 101-99|Adverse Event|10|||
163000408|NCT01090414|588701807|FG001|Study 101-99|Adverse Event|28|||
163000409|NCT01090414|588701808|FG002|Study 101-99|Adverse Event|18|||
163000410|NCT01090414|588701809|FG003|Study 101-99|Adverse Event|0|||
163000411|NCT01090414|588701806|FG000|Study 101-99|Investigator Request|1|||
163000412|NCT01090414|588701807|FG001|Study 101-99|Investigator Request|11|||
163000413|NCT01090414|588701808|FG002|Study 101-99|Investigator Request|4|||
163000414|NCT01090414|588701809|FG003|Study 101-99|Investigator Request|0|||
163000415|NCT01090414|588701806|FG000|Study 101-99|Death|3|||
163000416|NCT01090414|588701807|FG001|Study 101-99|Death|8|||
163000417|NCT01090414|588701808|FG002|Study 101-99|Death|1|||
163000418|NCT01090414|588701809|FG003|Study 101-99|Death|0|||
163000419|NCT01090414|588701806|FG000|Study 101-99|Sponsor Discontinued Study|0|||
163000420|NCT01090414|588701807|FG001|Study 101-99|Sponsor Discontinued Study|7|||
163000421|NCT01090414|588701808|FG002|Study 101-99|Sponsor Discontinued Study|5|||
163000422|NCT01090414|588701809|FG003|Study 101-99|Sponsor Discontinued Study|0|||
163000423|NCT01090414|588701806|FG000|Study 101-99|Other (Unknown Reasons)|3|||
163000424|NCT01090414|588701807|FG001|Study 101-99|Other (Unknown Reasons)|3|||
163000425|NCT01090414|588701808|FG002|Study 101-99|Other (Unknown Reasons)|0|||
163000426|NCT01090414|588701809|FG003|Study 101-99|Other (Unknown Reasons)|0|||
163000427|NCT01090414|588701806|FG000|Study 101-99|Withdrew Consent|0|||
163000428|NCT01090414|588701807|FG001|Study 101-99|Withdrew Consent|2|||
163000429|NCT01090414|588701808|FG002|Study 101-99|Withdrew Consent|3|||
163000430|NCT01090414|588701809|FG003|Study 101-99|Withdrew Consent|1|||
163000431|NCT01090414|588701806|FG000|Study 101-99|Participant Request|3|||
163000432|NCT01090414|588701807|FG001|Study 101-99|Participant Request|1|||
163000433|NCT01090414|588701808|FG002|Study 101-99|Participant Request|0|||
163000434|NCT01090414|588701809|FG003|Study 101-99|Participant Request|0|||
163000435|NCT04342819|588701810|FG000|Overall Study|Declined|4|||
163000436|NCT04342819|588701810|FG000|Overall Study|Not meeeting selection criteria|1|||
163000437|NCT01965860|588701811|FG000|Overall Study|Pregnancy|1|||
163000438|NCT01965860|588701812|FG001|Overall Study|Pregnancy|0|||
163000439|NCT01965860|588701813|FG002|Overall Study|Pregnancy|1|||
163000440|NCT01965860|588701811|FG000|Overall Study|Logistics|1|||
163000441|NCT01965860|588701812|FG001|Overall Study|Logistics|0|||
163000442|NCT01965860|588701813|FG002|Overall Study|Logistics|0|||
163000443|NCT00769379|588701814|FG000|Overall Study|No follow up data mapped to Other.|3|||
163000444|NCT00769379|588701815|FG001|Overall Study|No follow up data mapped to Other.|13|||
163000445|NCT04138823|588701824|FG000|Overall Study|Clinical disease progression|0|||
163000446|NCT04138823|588701825|FG001|Overall Study|Clinical disease progression|0|||
163000447|NCT04138823|588701826|FG002|Overall Study|Clinical disease progression|1|||
163000448|NCT04138823|588701824|FG000|Overall Study|Objective disease progression|3|||
163000449|NCT04138823|588701825|FG001|Overall Study|Objective disease progression|2|||
163000450|NCT04138823|588701826|FG002|Overall Study|Objective disease progression|5|||
163000451|NCT04868500|588701827|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
163000452|NCT04868500|588701828|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
163000453|NCT04868500|588701827|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
163000454|NCT04868500|588701828|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
163000455|NCT02466685|588701830|FG000|Overall Study|Adverse Event|5|||
163000456|NCT02466685|588701831|FG001|Overall Study|Adverse Event|2|||
163000457|NCT02466685|588701830|FG000|Overall Study|Lost to Follow-up|1|||
163000458|NCT02466685|588701831|FG001|Overall Study|Lost to Follow-up|1|||
163000459|NCT02466685|588701830|FG000|Overall Study|Withdrawal by Subject|1|||
163000460|NCT02466685|588701831|FG001|Overall Study|Withdrawal by Subject|0|||
163000461|NCT02466685|588701830|FG000|Overall Study|Physician Decision|1|||
163000462|NCT02466685|588701831|FG001|Overall Study|Physician Decision|1|||
163000463|NCT02565511|588701832|FG000|Overall Study|Study terminated by Sponsor|35|||
163000464|NCT02565511|588701833|FG001|Overall Study|Study terminated by Sponsor|22|||
163000465|NCT02565511|588701834|FG002|Overall Study|Study terminated by Sponsor|235|||
163000466|NCT02565511|588701835|FG003|Overall Study|Study terminated by Sponsor|156|||
163000467|NCT02565511|588701832|FG000|Overall Study|Withdrawal by Subject|3|||
163000468|NCT02565511|588701833|FG001|Overall Study|Withdrawal by Subject|0|||
163000469|NCT02565511|588701834|FG002|Overall Study|Withdrawal by Subject|12|||
163000470|NCT02565511|588701835|FG003|Overall Study|Withdrawal by Subject|5|||
163000471|NCT02565511|588701832|FG000|Overall Study|Adverse Event|0|||
163000472|NCT02565511|588701833|FG001|Overall Study|Adverse Event|0|||
163000473|NCT02565511|588701834|FG002|Overall Study|Adverse Event|1|||
163000474|NCT02565511|588701835|FG003|Overall Study|Adverse Event|1|||
163000475|NCT02565511|588701832|FG000|Overall Study|Lost to Follow-up|4|||
163000476|NCT02565511|588701833|FG001|Overall Study|Lost to Follow-up|1|||
163000477|NCT02565511|588701834|FG002|Overall Study|Lost to Follow-up|0|||
163000478|NCT02565511|588701835|FG003|Overall Study|Lost to Follow-up|1|||
163000479|NCT02565511|588701832|FG000|Overall Study|Physician Decision|0|||
163000480|NCT02565511|588701833|FG001|Overall Study|Physician Decision|0|||
163000481|NCT02565511|588701834|FG002|Overall Study|Physician Decision|0|||
163000482|NCT02565511|588701835|FG003|Overall Study|Physician Decision|1|||
163000483|NCT02565511|588701832|FG000|Overall Study|Protocol deviation|0|||
163000484|NCT02565511|588701833|FG001|Overall Study|Protocol deviation|0|||
163000485|NCT02565511|588701834|FG002|Overall Study|Protocol deviation|3|||
163000486|NCT02565511|588701835|FG003|Overall Study|Protocol deviation|0|||
163000487|NCT01941498|588701836|FG000|Overall Study|Relocated out of state|1|||
163000488|NCT00104572|588701838|FG000|Overall Study|Withdrawal by Subject|3|||
163000489|NCT00104572|588701839|FG001|Overall Study|Withdrawal by Subject|3|||
163000490|NCT00104572|588701840|FG002|Overall Study|Withdrawal by Subject|0|||
163000491|NCT00098774|588701841|FG000|Overall Study|Adverse Event|2|||
163000492|NCT00098774|588701841|FG000|Overall Study|Disease Progression|9|||
163000493|NCT00098774|588701841|FG000|Overall Study|Withdrawal by Subject|1|||
163000494|NCT00098774|588701841|FG000|Overall Study|Failed (to respond) during induction|4|||
163000495|NCT00098774|588701841|FG000|Overall Study|Physician Decision|2|||
163000496|NCT03097991|588701842|FG000|Overall Study|Didn't meet study criteria|8|||
163000497|NCT03097991|588701843|FG001|Overall Study|Didn't meet study criteria|0|||
163000498|NCT03097991|588701842|FG000|Overall Study|Withdrawal by Subject|12|||
163000499|NCT03097991|588701843|FG001|Overall Study|Withdrawal by Subject|6|||
163000500|NCT03097991|588701842|FG000|Overall Study|Death of Baby|3|||
163000501|NCT03097991|588701843|FG001|Overall Study|Death of Baby|1|||
163000502|NCT03097991|588701842|FG000|Overall Study|Lost to Follow-up|24|||
163000503|NCT03097991|588701843|FG001|Overall Study|Lost to Follow-up|38|||
163000504|NCT03097991|588701842|FG000|Overall Study|Adverse Event|3|||
163000505|NCT03097991|588701843|FG001|Overall Study|Adverse Event|5|||
163000506|NCT01755091|588701844|FG000|Overall Study|Withdrawal by Subject|6|||
163000507|NCT01755091|588701845|FG001|Overall Study|Withdrawal by Subject|1|||
163000508|NCT01755091|588701846|FG002|Overall Study|Withdrawal by Subject|3|||
163000509|NCT01755091|588701844|FG000|Overall Study|Adverse Event|1|||
163000510|NCT01755091|588701845|FG001|Overall Study|Adverse Event|1|||
163000511|NCT01755091|588701846|FG002|Overall Study|Adverse Event|1|||
163000512|NCT01755091|588701844|FG000|Overall Study|Lost to Follow-up|1|||
163000513|NCT01755091|588701845|FG001|Overall Study|Lost to Follow-up|0|||
163000514|NCT01755091|588701846|FG002|Overall Study|Lost to Follow-up|1|||
163000515|NCT01755091|588701844|FG000|Overall Study|Physician Decision|1|||
163000516|NCT01755091|588701845|FG001|Overall Study|Physician Decision|1|||
163000517|NCT01755091|588701846|FG002|Overall Study|Physician Decision|2|||
163000518|NCT01330303|588701851|FG000|Period 1|Adverse Event|1|||
163000519|NCT01330303|588701852|FG001|Period 1|Adverse Event|0|||
163000520|NCT01330303|588701851|FG000|Period 1|Protocol Violation|0|||
163000521|NCT01330303|588701852|FG001|Period 1|Protocol Violation|1|||
163000522|NCT01330303|588701851|FG000|Period 1|Withdrawal by Subject|0|||
163000523|NCT01330303|588701852|FG001|Period 1|Withdrawal by Subject|1|||
163000524|NCT00796757|588701853|FG000|Overall Study|Withdrawal by Subject|14|||
163060617|NCT05516758|588929958|FG000|Overall Study|Assigned treatment by mistake|1|||
163060618|NCT05516758|588929959|FG001|Overall Study|Assigned treatment by mistake|0|||
163060619|NCT05516758|588929960|FG002|Overall Study|Assigned treatment by mistake|0|||
163000525|NCT00796757|588701853|FG000|Overall Study|Death|61|||
163060620|NCT05516758|588929961|FG003|Overall Study|Assigned treatment by mistake|0|||
163060621|NCT05516758|588929962|FG004|Overall Study|Assigned treatment by mistake|1|||
163000526|NCT00796757|588701853|FG000|Overall Study|Protocol Violation|1|||
163000527|NCT00796757|588701853|FG000|Overall Study|Participant noncompliance|1|||
163000528|NCT00796757|588701853|FG000|Overall Study|Investigator's decision|2|||
163000529|NCT00796757|588701853|FG000|Overall Study|Other|7|||
163000530|NCT03516513|588701854|FG000|Overall Study|Withdrawal by Subject|2|||
163000531|NCT03516513|588701855|FG001|Overall Study|Withdrawal by Subject|2|||
163000532|NCT03516513|588701856|FG002|Overall Study|Withdrawal by Subject|0|||
162637236|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
163000533|NCT03516513|588701857|FG003|Overall Study|Withdrawal by Subject|0|||
163000534|NCT02593110|588701858|FG000|Overall Study|Withdrawal by Subject|0|||
163000535|NCT02593110|588701859|FG001|Overall Study|Withdrawal by Subject|3|||
163000536|NCT02593110|588701860|FG002|Overall Study|Withdrawal by Subject|3|||
163000537|NCT02593110|588701861|FG003|Overall Study|Withdrawal by Subject|2|||
163000538|NCT02593110|588701858|FG000|Overall Study|Death|0|||
163000539|NCT02593110|588701859|FG001|Overall Study|Death|0|||
163000540|NCT02593110|588701860|FG002|Overall Study|Death|1|||
163000541|NCT02593110|588701861|FG003|Overall Study|Death|0|||
163000542|NCT01130597|588701862|FG000|Overall Study|Protocol-specified (High K+)|1|||
163000543|NCT01130597|588701862|FG000|Overall Study|Adverse Event|4|||
163000544|NCT01130597|588701862|FG000|Overall Study|Death|1|||
163000545|NCT01130597|588701862|FG000|Overall Study|Protocol Violation|1|||
163000546|NCT03071276|588701863|FG000|Overall Study|Adverse Event|1|||
163000547|NCT03071276|588701863|FG000|Overall Study|Lack of Efficacy|14|||
163000548|NCT05794503|588701868|FG000|Overall Study|Operation Cancelled|2|||
163000549|NCT05794503|588701869|FG001|Overall Study|Operation Cancelled|0|||
163000550|NCT05794503|588701868|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
163000551|NCT05794503|588701869|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
163000552|NCT05794503|588701868|FG000|Overall Study|Protocol Violation|1|||
163000553|NCT05794503|588701869|FG001|Overall Study|Protocol Violation|0|||
163000554|NCT03052127|588701870|FG000|Overall Study|Withdrawal by Subject|0|||
163000555|NCT03052127|588701871|FG001|Overall Study|Withdrawal by Subject|0|||
163000556|NCT03052127|588701872|FG002|Overall Study|Withdrawal by Subject|0|||
163000557|NCT03052127|588701873|FG003|Overall Study|Withdrawal by Subject|0|||
163000558|NCT03052127|588701874|FG004|Overall Study|Withdrawal by Subject|0|||
162637237|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
162637238|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
162637239|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
162637240|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
162637241|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163000559|NCT03052127|588701875|FG005|Overall Study|Withdrawal by Subject|0|||
163000560|NCT03052127|588701876|FG006|Overall Study|Withdrawal by Subject|0|||
163000561|NCT03052127|588701877|FG007|Overall Study|Withdrawal by Subject|1|||
163000562|NCT03052127|588701878|FG008|Overall Study|Withdrawal by Subject|1|||
163000563|NCT03052127|588701879|FG009|Overall Study|Withdrawal by Subject|1|||
163000564|NCT03052127|588701880|FG010|Overall Study|Withdrawal by Subject|0|||
163000565|NCT03052127|588701881|FG011|Overall Study|Withdrawal by Subject|0|||
163000566|NCT03052127|588701870|FG000|Overall Study|Discontinuation by Sponsor|0|||
163000567|NCT03052127|588701871|FG001|Overall Study|Discontinuation by Sponsor|0|||
163000568|NCT03052127|588701872|FG002|Overall Study|Discontinuation by Sponsor|0|||
163000569|NCT03052127|588701873|FG003|Overall Study|Discontinuation by Sponsor|0|||
163000570|NCT03052127|588701874|FG004|Overall Study|Discontinuation by Sponsor|0|||
163000571|NCT03052127|588701875|FG005|Overall Study|Discontinuation by Sponsor|0|||
163000572|NCT03052127|588701876|FG006|Overall Study|Discontinuation by Sponsor|0|||
163000573|NCT03052127|588701877|FG007|Overall Study|Discontinuation by Sponsor|0|||
163000574|NCT03052127|588701878|FG008|Overall Study|Discontinuation by Sponsor|4|||
163000575|NCT03052127|588701879|FG009|Overall Study|Discontinuation by Sponsor|2|||
163000576|NCT03052127|588701880|FG010|Overall Study|Discontinuation by Sponsor|5|||
163000577|NCT03052127|588701881|FG011|Overall Study|Discontinuation by Sponsor|13|||
163000578|NCT03052127|588701870|FG000|Overall Study|Inability to comply with trial requirements|0|||
163000579|NCT03052127|588701871|FG001|Overall Study|Inability to comply with trial requirements|0|||
163000580|NCT03052127|588701872|FG002|Overall Study|Inability to comply with trial requirements|1|||
163000581|NCT03052127|588701873|FG003|Overall Study|Inability to comply with trial requirements|0|||
163000582|NCT03052127|588701874|FG004|Overall Study|Inability to comply with trial requirements|0|||
163000583|NCT03052127|588701875|FG005|Overall Study|Inability to comply with trial requirements|0|||
163000584|NCT03052127|588701876|FG006|Overall Study|Inability to comply with trial requirements|0|||
163000585|NCT03052127|588701877|FG007|Overall Study|Inability to comply with trial requirements|0|||
163000586|NCT03052127|588701878|FG008|Overall Study|Inability to comply with trial requirements|0|||
163000587|NCT03052127|588701879|FG009|Overall Study|Inability to comply with trial requirements|0|||
163000588|NCT03052127|588701880|FG010|Overall Study|Inability to comply with trial requirements|0|||
163000589|NCT03052127|588701881|FG011|Overall Study|Inability to comply with trial requirements|0|||
163000590|NCT03052127|588701870|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000591|NCT03052127|588701871|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000592|NCT03052127|588701872|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000593|NCT03052127|588701873|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000594|NCT03052127|588701874|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000595|NCT03052127|588701875|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000596|NCT03052127|588701876|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
163000597|NCT03052127|588701877|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000598|NCT03052127|588701878|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000599|NCT03052127|588701879|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000600|NCT03052127|588701880|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000601|NCT03052127|588701881|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
163000602|NCT03694327|588701882|FG000|Overall Study|Lost to Follow-up|13|||
163000603|NCT03694327|588701883|FG001|Overall Study|Lost to Follow-up|23|||
163000604|NCT01464931|588701884|FG000|Overall Study|Withdrawal by Subject|1|||
163000605|NCT01464931|588701885|FG001|Overall Study|Withdrawal by Subject|0|||
163000606|NCT01982812|588701888|FG000|Overall Study|Death|1|||
163000607|NCT01982812|588701889|FG001|Overall Study|Death|5|||
163000608|NCT01982812|588701888|FG000|Overall Study|Adverse Event|0|||
163000609|NCT01982812|588701889|FG001|Overall Study|Adverse Event|5|||
163000610|NCT00307437|588701893|FG000|Controlled Period|Adverse Event|7|||
163000611|NCT00307437|588701894|FG001|Controlled Period|Adverse Event|2|||
163000612|NCT00307437|588701895|FG002|Controlled Period|Adverse Event|5|||
163000613|NCT00307437|588701896|FG003|Controlled Period|Adverse Event|0|||
163000614|NCT00307437|588701897|FG004|Controlled Period|Adverse Event|0|||
163000615|NCT00307437|588701898|FG005|Controlled Period|Adverse Event|0|||
163000616|NCT00307437|588701899|FG006|Controlled Period|Adverse Event|0|||
163000617|NCT00307437|588701893|FG000|Controlled Period|Death|0|||
163000618|NCT00307437|588701894|FG001|Controlled Period|Death|0|||
163000619|NCT00307437|588701895|FG002|Controlled Period|Death|1|||
163000620|NCT00307437|588701896|FG003|Controlled Period|Death|0|||
163000621|NCT00307437|588701897|FG004|Controlled Period|Death|0|||
163000622|NCT00307437|588701898|FG005|Controlled Period|Death|0|||
163000623|NCT00307437|588701899|FG006|Controlled Period|Death|0|||
163000624|NCT00307437|588701893|FG000|Controlled Period|Lack of Efficacy|2|||
163000625|NCT00307437|588701894|FG001|Controlled Period|Lack of Efficacy|0|||
163000626|NCT00307437|588701895|FG002|Controlled Period|Lack of Efficacy|0|||
163000627|NCT00307437|588701896|FG003|Controlled Period|Lack of Efficacy|0|||
163000628|NCT00307437|588701897|FG004|Controlled Period|Lack of Efficacy|0|||
163000629|NCT00307437|588701898|FG005|Controlled Period|Lack of Efficacy|0|||
163000630|NCT00307437|588701899|FG006|Controlled Period|Lack of Efficacy|0|||
163000631|NCT00307437|588701893|FG000|Controlled Period|Lost to Follow-up|2|||
163000632|NCT00307437|588701894|FG001|Controlled Period|Lost to Follow-up|3|||
163000633|NCT00307437|588701895|FG002|Controlled Period|Lost to Follow-up|0|||
163000634|NCT00307437|588701896|FG003|Controlled Period|Lost to Follow-up|0|||
163000635|NCT00307437|588701897|FG004|Controlled Period|Lost to Follow-up|0|||
163000636|NCT00307437|588701898|FG005|Controlled Period|Lost to Follow-up|0|||
163000637|NCT00307437|588701899|FG006|Controlled Period|Lost to Follow-up|0|||
163000638|NCT00307437|588701893|FG000|Controlled Period|Other|5|||
163000639|NCT00307437|588701894|FG001|Controlled Period|Other|1|||
163000640|NCT00307437|588701895|FG002|Controlled Period|Other|3|||
163000641|NCT00307437|588701896|FG003|Controlled Period|Other|0|||
163000642|NCT00307437|588701897|FG004|Controlled Period|Other|0|||
163000643|NCT00307437|588701898|FG005|Controlled Period|Other|0|||
163000644|NCT00307437|588701899|FG006|Controlled Period|Other|0|||
163000645|NCT00307437|588701893|FG000|After Controlled Period|Adverse Event|0|||
163000646|NCT00307437|588701894|FG001|After Controlled Period|Adverse Event|0|||
163000647|NCT00307437|588701895|FG002|After Controlled Period|Adverse Event|0|||
163000648|NCT00307437|588701896|FG003|After Controlled Period|Adverse Event|18|||
163000649|NCT00307437|588701897|FG004|After Controlled Period|Adverse Event|16|||
163000650|NCT00307437|588701898|FG005|After Controlled Period|Adverse Event|31|||
163000651|NCT00307437|588701899|FG006|After Controlled Period|Adverse Event|40|||
163000652|NCT00307437|588701893|FG000|After Controlled Period|Death|0|||
163000653|NCT00307437|588701894|FG001|After Controlled Period|Death|0|||
163000654|NCT00307437|588701895|FG002|After Controlled Period|Death|0|||
163000655|NCT00307437|588701896|FG003|After Controlled Period|Death|3|||
163000656|NCT00307437|588701897|FG004|After Controlled Period|Death|1|||
163000657|NCT00307437|588701898|FG005|After Controlled Period|Death|1|||
162637242|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163000658|NCT00307437|588701899|FG006|After Controlled Period|Death|3|||
163000659|NCT00307437|588701893|FG000|After Controlled Period|Lack of Efficacy|0|||
163000660|NCT00307437|588701894|FG001|After Controlled Period|Lack of Efficacy|0|||
163000661|NCT00307437|588701895|FG002|After Controlled Period|Lack of Efficacy|0|||
163000662|NCT00307437|588701896|FG003|After Controlled Period|Lack of Efficacy|15|||
163000663|NCT00307437|588701897|FG004|After Controlled Period|Lack of Efficacy|17|||
163000664|NCT00307437|588701898|FG005|After Controlled Period|Lack of Efficacy|37|||
163000665|NCT00307437|588701899|FG006|After Controlled Period|Lack of Efficacy|24|||
163000666|NCT00307437|588701893|FG000|After Controlled Period|Lost to Follow-up|0|||
163000667|NCT00307437|588701894|FG001|After Controlled Period|Lost to Follow-up|0|||
163000668|NCT00307437|588701895|FG002|After Controlled Period|Lost to Follow-up|0|||
162637243|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
163000669|NCT00307437|588701896|FG003|After Controlled Period|Lost to Follow-up|7|||
163000670|NCT00307437|588701897|FG004|After Controlled Period|Lost to Follow-up|12|||
162637244|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
163000671|NCT00307437|588701898|FG005|After Controlled Period|Lost to Follow-up|13|||
163000672|NCT00307437|588701899|FG006|After Controlled Period|Lost to Follow-up|18|||
163000673|NCT00307437|588701893|FG000|After Controlled Period|Other|0|||
163000674|NCT00307437|588701894|FG001|After Controlled Period|Other|0|||
163000675|NCT00307437|588701895|FG002|After Controlled Period|Other|0|||
163000676|NCT00307437|588701896|FG003|After Controlled Period|Other|15|||
163000677|NCT00307437|588701897|FG004|After Controlled Period|Other|9|||
163000678|NCT00307437|588701898|FG005|After Controlled Period|Other|40|||
163000679|NCT00307437|588701899|FG006|After Controlled Period|Other|28|||
163000680|NCT03017612|588701902|FG000|Overall Study|Adverse Event|2|||
163000681|NCT00985491|588701904|FG000|Overall Study|Adverse Event|8|||
163000682|NCT00985491|588701904|FG000|Overall Study|device migration|7|||
163000683|NCT00985491|588701904|FG000|Overall Study|Withdrawal by Subject|1|||
163000684|NCT00985491|588701904|FG000|Overall Study|implant failure|3|||
163000685|NCT01893346|588701905|FG000|Overall Study|Lost to Follow-up|0|||
163000686|NCT01893346|588701906|FG001|Overall Study|Lost to Follow-up|1|||
163000687|NCT01893346|588701907|FG002|Overall Study|Lost to Follow-up|0|||
163000688|NCT01893346|588701908|FG003|Overall Study|Lost to Follow-up|0|||
163000689|NCT01893346|588701905|FG000|Overall Study|Protocol Violation|1|||
163000690|NCT01893346|588701906|FG001|Overall Study|Protocol Violation|0|||
163000691|NCT01893346|588701907|FG002|Overall Study|Protocol Violation|0|||
163000692|NCT01893346|588701908|FG003|Overall Study|Protocol Violation|0|||
163000693|NCT01893346|588701905|FG000|Overall Study|Withdrawal by Subject|2|||
163000694|NCT01893346|588701906|FG001|Overall Study|Withdrawal by Subject|0|||
163000695|NCT01893346|588701907|FG002|Overall Study|Withdrawal by Subject|0|||
163000696|NCT01893346|588701908|FG003|Overall Study|Withdrawal by Subject|0|||
163000697|NCT00352417|588701911|FG000|Overall Study|Adverse Event|1|||
163000698|NCT00352417|588701912|FG001|Overall Study|Adverse Event|0|||
163000699|NCT00352417|588701911|FG000|Overall Study|Protocol Violation|0|||
163000700|NCT00352417|588701912|FG001|Overall Study|Protocol Violation|2|||
163000701|NCT00352417|588701911|FG000|Overall Study|Withdrawal by Subject|1|||
163000702|NCT00352417|588701912|FG001|Overall Study|Withdrawal by Subject|2|||
163000703|NCT00352417|588701911|FG000|Overall Study|Lost to Follow-up|1|||
163000704|NCT00352417|588701912|FG001|Overall Study|Lost to Follow-up|0|||
163000705|NCT00352417|588701911|FG000|Overall Study|Schedule Change|2|||
163000706|NCT00352417|588701912|FG001|Overall Study|Schedule Change|1|||
163000707|NCT00912912|588701913|FG000|Overall Study|Withdrawal by Subject|1|||
163000708|NCT00912912|588701913|FG000|Overall Study|Disease Progression|3|||
163000709|NCT02447744|588701914|FG000|Overall Study|Withdrawal by Subject|3|||
163000710|NCT02447744|588701915|FG001|Overall Study|Withdrawal by Subject|1|||
163000711|NCT02447744|588701914|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
163000712|NCT02447744|588701915|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
163000713|NCT00306995|588701916|FG000|Study Part I|Withdrawal by Subject|0|||
163000714|NCT00306995|588701917|FG001|Study Part I|Withdrawal by Subject|0|||
163000715|NCT00306995|588701918|FG002|Study Part I|Withdrawal by Subject|0|||
162637245|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
163000716|NCT00306995|588701919|FG003|Study Part I|Withdrawal by Subject|0|||
163000717|NCT00306995|588701920|FG004|Study Part I|Withdrawal by Subject|0|||
163000718|NCT00306995|588701921|FG005|Study Part I|Withdrawal by Subject|0|||
163000719|NCT00306995|588701922|FG006|Study Part I|Withdrawal by Subject|1|||
163000720|NCT00306995|588701916|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
163000721|NCT00306995|588701917|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
163000722|NCT00306995|588701918|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
163000723|NCT00306995|588701919|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
163000724|NCT00306995|588701920|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
163000725|NCT00306995|588701921|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
163000726|NCT00306995|588701922|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
163000727|NCT06419907|588703646|FG000|Overall Study|Protocol Violation|0|||
163000728|NCT06419907|588703647|FG001|Overall Study|Protocol Violation|3|||
163000729|NCT06419907|588703648|FG002|Overall Study|Protocol Violation|0|||
163000730|NCT06419907|588703649|FG003|Overall Study|Protocol Violation|1|||
163000731|NCT06419907|588703646|FG000|Overall Study|Lost to Follow-up|0|||
163000732|NCT06419907|588703647|FG001|Overall Study|Lost to Follow-up|0|||
163000733|NCT06419907|588703648|FG002|Overall Study|Lost to Follow-up|2|||
163000734|NCT06419907|588703649|FG003|Overall Study|Lost to Follow-up|1|||
163000735|NCT03573830|588703650|FG000|Overall Study|Dropped without completing treatment|0|||
163000736|NCT03573830|588703651|FG001|Overall Study|Dropped without completing treatment|7|||
163000737|NCT03573830|588703650|FG000|Overall Study|Lost to Follow-up|4|||
163000738|NCT03573830|588703651|FG001|Overall Study|Lost to Follow-up|0|||
163000739|NCT00266630|588703652|FG000|Overall Study|Adverse Event|8|||
163000740|NCT00266630|588703653|FG001|Overall Study|Adverse Event|6|||
163000741|NCT00266630|588703652|FG000|Overall Study|Lack of Efficacy|1|||
163000742|NCT00266630|588703653|FG001|Overall Study|Lack of Efficacy|4|||
163000743|NCT00266630|588703652|FG000|Overall Study|Entry Criteria not met|1|||
163000744|NCT00266630|588703653|FG001|Overall Study|Entry Criteria not met|0|||
163000745|NCT00266630|588703652|FG000|Overall Study|Protocol Violation|1|||
163000746|NCT00266630|588703653|FG001|Overall Study|Protocol Violation|3|||
163000747|NCT00266630|588703652|FG000|Overall Study|Physician Decision|1|||
163000748|NCT00266630|588703653|FG001|Overall Study|Physician Decision|2|||
163000749|NCT00266630|588703652|FG000|Overall Study|Withdrawal by Subject|10|||
163000750|NCT00266630|588703653|FG001|Overall Study|Withdrawal by Subject|2|||
163000751|NCT00266630|588703652|FG000|Overall Study|Lost to Follow-up|1|||
163000752|NCT00266630|588703653|FG001|Overall Study|Lost to Follow-up|0|||
163000753|NCT00266630|588703652|FG000|Overall Study|Other|19|||
163000754|NCT00266630|588703653|FG001|Overall Study|Other|11|||
163000755|NCT03284723|588703658|FG000|Overall Study|Death|0|||
163000756|NCT03284723|588703659|FG001|Overall Study|Death|0|||
163000757|NCT03284723|588703660|FG002|Overall Study|Death|0|||
163000758|NCT03284723|588703661|FG003|Overall Study|Death|1|||
163000759|NCT03284723|588703662|FG004|Overall Study|Death|0|||
163000760|NCT03284723|588703663|FG005|Overall Study|Death|0|||
163000761|NCT03284723|588703664|FG006|Overall Study|Death|1|||
163000762|NCT03284723|588703665|FG007|Overall Study|Death|0|||
163000763|NCT03284723|588703666|FG008|Overall Study|Death|0|||
163000764|NCT03284723|588703667|FG009|Overall Study|Death|2|||
163000765|NCT03284723|588703668|FG010|Overall Study|Death|1|||
163000766|NCT03284723|588703669|FG011|Overall Study|Death|0|||
163000767|NCT03284723|588703658|FG000|Overall Study|Lost to Follow-up|0|||
163000768|NCT03284723|588703659|FG001|Overall Study|Lost to Follow-up|0|||
163000769|NCT03284723|588703660|FG002|Overall Study|Lost to Follow-up|0|||
163000770|NCT03284723|588703661|FG003|Overall Study|Lost to Follow-up|0|||
163000771|NCT03284723|588703662|FG004|Overall Study|Lost to Follow-up|0|||
163000772|NCT03284723|588703663|FG005|Overall Study|Lost to Follow-up|2|||
163000773|NCT03284723|588703664|FG006|Overall Study|Lost to Follow-up|1|||
163000774|NCT03284723|588703665|FG007|Overall Study|Lost to Follow-up|0|||
163000775|NCT03284723|588703666|FG008|Overall Study|Lost to Follow-up|0|||
163000776|NCT03284723|588703667|FG009|Overall Study|Lost to Follow-up|2|||
163000777|NCT03284723|588703668|FG010|Overall Study|Lost to Follow-up|0|||
163000778|NCT03284723|588703669|FG011|Overall Study|Lost to Follow-up|0|||
163000779|NCT03284723|588703658|FG000|Overall Study|Study Terminated By Sponsor|0|||
163000780|NCT03284723|588703659|FG001|Overall Study|Study Terminated By Sponsor|0|||
163000781|NCT03284723|588703660|FG002|Overall Study|Study Terminated By Sponsor|0|||
163000782|NCT03284723|588703661|FG003|Overall Study|Study Terminated By Sponsor|0|||
163000783|NCT03284723|588703662|FG004|Overall Study|Study Terminated By Sponsor|1|||
163000784|NCT03284723|588703663|FG005|Overall Study|Study Terminated By Sponsor|0|||
163000785|NCT03284723|588703664|FG006|Overall Study|Study Terminated By Sponsor|0|||
163000786|NCT03284723|588703665|FG007|Overall Study|Study Terminated By Sponsor|0|||
163000787|NCT03284723|588703666|FG008|Overall Study|Study Terminated By Sponsor|1|||
163000788|NCT03284723|588703667|FG009|Overall Study|Study Terminated By Sponsor|1|||
163000789|NCT03284723|588703668|FG010|Overall Study|Study Terminated By Sponsor|1|||
163000790|NCT03284723|588703669|FG011|Overall Study|Study Terminated By Sponsor|1|||
163000791|NCT03284723|588703658|FG000|Overall Study|Withdrawal by Subject|0|||
163000792|NCT03284723|588703659|FG001|Overall Study|Withdrawal by Subject|0|||
163000793|NCT03284723|588703660|FG002|Overall Study|Withdrawal by Subject|0|||
163000794|NCT03284723|588703661|FG003|Overall Study|Withdrawal by Subject|0|||
163000795|NCT03284723|588703662|FG004|Overall Study|Withdrawal by Subject|5|||
163000796|NCT03284723|588703663|FG005|Overall Study|Withdrawal by Subject|3|||
163000797|NCT03284723|588703664|FG006|Overall Study|Withdrawal by Subject|1|||
163000798|NCT03284723|588703665|FG007|Overall Study|Withdrawal by Subject|0|||
163000799|NCT03284723|588703666|FG008|Overall Study|Withdrawal by Subject|6|||
163000800|NCT03284723|588703667|FG009|Overall Study|Withdrawal by Subject|0|||
163000801|NCT03284723|588703668|FG010|Overall Study|Withdrawal by Subject|3|||
163000802|NCT03284723|588703669|FG011|Overall Study|Withdrawal by Subject|1|||
163000803|NCT03284723|588703658|FG000|Overall Study|Other|1|||
163000804|NCT03284723|588703659|FG001|Overall Study|Other|0|||
163000805|NCT03284723|588703660|FG002|Overall Study|Other|1|||
163000806|NCT03284723|588703661|FG003|Overall Study|Other|0|||
163000807|NCT03284723|588703662|FG004|Overall Study|Other|1|||
163000808|NCT03284723|588703663|FG005|Overall Study|Other|0|||
163000809|NCT03284723|588703664|FG006|Overall Study|Other|0|||
163000810|NCT03284723|588703665|FG007|Overall Study|Other|0|||
163000811|NCT03284723|588703666|FG008|Overall Study|Other|0|||
163000812|NCT03284723|588703667|FG009|Overall Study|Other|0|||
163000813|NCT03284723|588703668|FG010|Overall Study|Other|1|||
163000814|NCT03284723|588703669|FG011|Overall Study|Other|0|||
163000815|NCT03284723|588703658|FG000|Overall Study|Adverse Event|0|||
163000816|NCT03284723|588703659|FG001|Overall Study|Adverse Event|0|||
163000817|NCT03284723|588703660|FG002|Overall Study|Adverse Event|0|||
163000818|NCT03284723|588703661|FG003|Overall Study|Adverse Event|0|||
163000819|NCT03284723|588703662|FG004|Overall Study|Adverse Event|0|||
163000820|NCT03284723|588703663|FG005|Overall Study|Adverse Event|0|||
163000821|NCT03284723|588703664|FG006|Overall Study|Adverse Event|0|||
163000822|NCT03284723|588703665|FG007|Overall Study|Adverse Event|0|||
163000823|NCT03284723|588703666|FG008|Overall Study|Adverse Event|1|||
163000824|NCT03284723|588703667|FG009|Overall Study|Adverse Event|0|||
163000825|NCT03284723|588703668|FG010|Overall Study|Adverse Event|0|||
163000826|NCT03284723|588703669|FG011|Overall Study|Adverse Event|0|||
163000827|NCT00064987|588703674|FG000|Overall Study|Physician Decision|3|||
163000828|NCT00064987|588703675|FG001|Overall Study|Physician Decision|0|||
163000829|NCT01499095|588703676|FG000|Overall Study|Randomized But Not Treated|1|||
163000830|NCT01499095|588703677|FG001|Overall Study|Randomized But Not Treated|1|||
163000831|NCT01499095|588703676|FG000|Overall Study|Adverse Event|12|||
163000832|NCT01499095|588703677|FG001|Overall Study|Adverse Event|7|||
163000833|NCT01499095|588703676|FG000|Overall Study|Lack of Efficacy|2|||
163000834|NCT01499095|588703677|FG001|Overall Study|Lack of Efficacy|1|||
162637246|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
162637247|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
162637248|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
163000835|NCT01499095|588703676|FG000|Overall Study|Protocol Violation|6|||
163000836|NCT01499095|588703677|FG001|Overall Study|Protocol Violation|7|||
162637249|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
163000837|NCT01499095|588703676|FG000|Overall Study|Received Rescue Therapy|32|||
163000838|NCT01499095|588703677|FG001|Overall Study|Received Rescue Therapy|40|||
163000839|NCT01499095|588703676|FG000|Overall Study|Diverse Reasons|22|||
163000840|NCT01499095|588703677|FG001|Overall Study|Diverse Reasons|25|||
163000841|NCT01499095|588703676|FG000|Overall Study|Lost to Follow-up|6|||
163000842|NCT01499095|588703677|FG001|Overall Study|Lost to Follow-up|4|||
163000843|NCT01499095|588703676|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
163000844|NCT01499095|588703677|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
163000845|NCT01499095|588703676|FG000|Overall Study|Hypoglycemia|3|||
163000846|NCT01499095|588703677|FG001|Overall Study|Hypoglycemia|1|||
163000847|NCT01499095|588703676|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
163000848|NCT01499095|588703677|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
163000849|NCT01499095|588703676|FG000|Overall Study|Change in Injection Schedule|2|||
163000850|NCT01499095|588703677|FG001|Overall Study|Change in Injection Schedule|0|||
163000851|NCT01499095|588703676|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163000852|NCT01499095|588703677|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163000853|NCT01368497|588703678|FG000|Overall Study|Lost to Follow-up|2|||
163000854|NCT00443729|588703682|FG000|Overall Study|Never Treated|0|||
163000855|NCT00443729|588703683|FG001|Overall Study|Never Treated|1|||
163000856|NCT00443729|588703682|FG000|Overall Study|Lack of Efficacy|4|||
163000857|NCT00443729|588703683|FG001|Overall Study|Lack of Efficacy|2|||
163000858|NCT00443729|588703682|FG000|Overall Study|Lost to Follow-up|0|||
163000859|NCT00443729|588703683|FG001|Overall Study|Lost to Follow-up|1|||
163000860|NCT00443729|588703682|FG000|Overall Study|Physician Decision|2|||
163000861|NCT00443729|588703683|FG001|Overall Study|Physician Decision|1|||
163000862|NCT00443729|588703682|FG000|Overall Study|Protocol Violation|1|||
163000863|NCT00443729|588703683|FG001|Overall Study|Protocol Violation|1|||
163000864|NCT00443729|588703682|FG000|Overall Study|Withdrawal by Subject|3|||
163000865|NCT00443729|588703683|FG001|Overall Study|Withdrawal by Subject|1|||
163000866|NCT00782626|588703687|FG000|Overall Study|Adverse Event|1|||
163000867|NCT00782626|588703687|FG000|Overall Study|Progressive Disease|5|||
163000868|NCT00782626|588703687|FG000|Overall Study|Other Complicating Disease|1|||
163000869|NCT00077207|588703690|FG000|Overall Study|Adverse Event|5|||
163000870|NCT00077207|588703690|FG000|Overall Study|Lack of Efficacy|12|||
163000871|NCT00077207|588703690|FG000|Overall Study|Physician Decision|6|||
163000872|NCT00077207|588703690|FG000|Overall Study|Withdrawal by Subject|6|||
163000873|NCT00077207|588703690|FG000|Overall Study|Ineligible|1|||
163000874|NCT03052751|588703693|FG000|Dosing Period 1|Adverse Event|0|||
163000875|NCT03052751|588703694|FG001|Dosing Period 1|Adverse Event|1|||
163000876|NCT03052751|588703695|FG002|Dosing Period 1|Adverse Event|0|||
163000877|NCT03052751|588703696|FG003|Dosing Period 1|Adverse Event|0|||
163000878|NCT03052751|588703697|FG004|Dosing Period 1|Adverse Event|0|||
163000879|NCT03052751|588703698|FG005|Dosing Period 1|Adverse Event|0|||
163000880|NCT03052751|588703693|FG000|Dosing Period 2|Adverse Event|0|||
163000881|NCT03052751|588703694|FG001|Dosing Period 2|Adverse Event|0|||
163000882|NCT03052751|588703695|FG002|Dosing Period 2|Adverse Event|3|||
163000883|NCT03052751|588703696|FG003|Dosing Period 2|Adverse Event|0|||
163000884|NCT03052751|588703697|FG004|Dosing Period 2|Adverse Event|0|||
163000885|NCT03052751|588703698|FG005|Dosing Period 2|Adverse Event|0|||
163000886|NCT03052751|588703693|FG000|Observation Period|Adverse Event|0|||
163000887|NCT03052751|588703694|FG001|Observation Period|Adverse Event|0|||
163000888|NCT03052751|588703695|FG002|Observation Period|Adverse Event|0|||
163000889|NCT03052751|588703696|FG003|Observation Period|Adverse Event|0|||
163000890|NCT03052751|588703697|FG004|Observation Period|Adverse Event|1|||
163000891|NCT03052751|588703698|FG005|Observation Period|Adverse Event|0|||
163000892|NCT01427608|588703703|FG000|Overall Study|Death|1|||
163000893|NCT01427608|588703704|FG001|Overall Study|Death|0|||
163000894|NCT01427608|588703703|FG000|Overall Study|Withdrawal by Subject|7|||
163000895|NCT01427608|588703704|FG001|Overall Study|Withdrawal by Subject|3|||
163000896|NCT01427608|588703703|FG000|Overall Study|Relapsed-all cause|13|||
163000897|NCT01427608|588703704|FG001|Overall Study|Relapsed-all cause|34|||
163000898|NCT01427608|588703703|FG000|Overall Study|Events not attributed to study meds|0|||
163000899|NCT01427608|588703704|FG001|Overall Study|Events not attributed to study meds|1|||
163000900|NCT01027702|588703707|FG000|Overall Study|Received subsequent therapy|1|||
163000901|NCT01027702|588703708|FG001|Overall Study|Received subsequent therapy|2|||
163000902|NCT01027702|588703709|FG002|Overall Study|Received subsequent therapy|0|||
163000903|NCT01027702|588703710|FG003|Overall Study|Received subsequent therapy|4|||
163000904|NCT01027702|588703711|FG004|Overall Study|Received subsequent therapy|1|||
163000905|NCT01027702|588703712|FG005|Overall Study|Received subsequent therapy|0|||
163000906|NCT01027702|588703713|FG006|Overall Study|Received subsequent therapy|1|||
163000907|NCT01027702|588703707|FG000|Overall Study|Death|0|||
163000908|NCT01027702|588703708|FG001|Overall Study|Death|0|||
163000909|NCT01027702|588703709|FG002|Overall Study|Death|1|||
163000910|NCT01027702|588703710|FG003|Overall Study|Death|0|||
163000911|NCT01027702|588703711|FG004|Overall Study|Death|0|||
163000912|NCT01027702|588703712|FG005|Overall Study|Death|0|||
163000913|NCT01027702|588703713|FG006|Overall Study|Death|0|||
163000914|NCT00403585|588703714|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
163000915|NCT00403585|588703714|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
163000916|NCT00403585|588703714|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
163000917|NCT02862730|588703717|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000918|NCT02862730|588703718|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
162637250|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
162637251|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
162637252|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162637253|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162637254|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162637255|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162637256|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
162637257|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
162637258|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
162637259|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
162637260|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
163000919|NCT02862730|588703719|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
163000920|NCT02862730|588703720|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000921|NCT02862730|588703721|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000922|NCT02862730|588703722|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000923|NCT02862730|588703723|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
163000924|NCT02862730|588703717|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
163000925|NCT02862730|588703718|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000926|NCT02862730|588703719|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000927|NCT02862730|588703720|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000928|NCT02862730|588703721|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000929|NCT02862730|588703722|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000930|NCT02862730|588703723|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
163000931|NCT02862730|588703717|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000932|NCT02862730|588703718|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000933|NCT02862730|588703719|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
163000934|NCT02862730|588703720|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000935|NCT02862730|588703721|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
162637261|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
163000936|NCT02862730|588703722|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
163000937|NCT02862730|588703723|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
162715755|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000938|NCT02862730|588703717|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000939|NCT02862730|588703718|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000940|NCT02862730|588703719|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000941|NCT02862730|588703720|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
163000942|NCT02862730|588703721|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000943|NCT02862730|588703722|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000944|NCT02862730|588703723|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
163000945|NCT03022370|588703724|FG000|Overall Study|Death|6|||
163000946|NCT03022370|588703725|FG001|Overall Study|Death|12|||
163000947|NCT03022370|588703724|FG000|Overall Study|Lost to Follow-up|174|||
163000948|NCT03022370|588703725|FG001|Overall Study|Lost to Follow-up|109|||
163000949|NCT00668317|588703726|FG000|Overall Study|Adverse Event|2|||
163000950|NCT01526655|588703727|FG000|Overall Study|Withdrawal by Subject|0|||
163000951|NCT01526655|588703728|FG001|Overall Study|Withdrawal by Subject|1|||
163000952|NCT04753216|588703729|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
163000953|NCT04753216|588703729|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
163000954|NCT04753216|588703729|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
163000955|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
163000956|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Death|1|||
163000957|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
163000958|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
163000959|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
163000960|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
163000961|NCT02001987|588703731|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
163000962|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
163000963|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
163000964|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
163000965|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
163000966|NCT02001987|588703731|FG000|LTE Period (52 Weeks)|Other|3|||
163000967|NCT03571828|588703738|FG000|Overall Study|Withdrawal by Subject|1|||
163000968|NCT03571828|588703739|FG001|Overall Study|Withdrawal by Subject|0|||
163000969|NCT03571828|588703738|FG000|Overall Study|Decision by sponsor|5|||
163000970|NCT03571828|588703739|FG001|Overall Study|Decision by sponsor|1|||
163000971|NCT03571828|588703738|FG000|Overall Study|Death|2|||
163000972|NCT03571828|588703739|FG001|Overall Study|Death|0|||
163000973|NCT02232984|588703742|FG000|Overall Study|Withdrawal by Subject|5|||
163000974|NCT02232984|588703742|FG000|Overall Study|Death|1|||
163000975|NCT02232984|588703742|FG000|Overall Study|Investigator withdrawal|10|||
163000976|NCT02232984|588703742|FG000|Overall Study|Device implant unsuccessful|53|||
163000977|NCT02232984|588703742|FG000|Overall Study|not disclosed by site|7|||
163000978|NCT02232984|588703742|FG000|Overall Study|Protocol Violation|1|||
163000979|NCT01884337|588703745|FG000|Treatment|Adverse Event|2|||
163000980|NCT01884337|588703746|FG001|Treatment|Adverse Event|2|||
163000981|NCT01884337|588703745|FG000|Treatment|Subj. request to discont. treatment|2|||
163000982|NCT01884337|588703746|FG001|Treatment|Subj. request to discont. treatment|0|||
163000983|NCT01884337|588703745|FG000|Follow-up Period|Lost to Follow-up|1|||
163000984|NCT01884337|588703746|FG001|Follow-up Period|Lost to Follow-up|1|||
163000985|NCT02455518|588703747|FG000|Overall Study|Protocol Violation|0|||
163000986|NCT02455518|588703748|FG001|Overall Study|Protocol Violation|1|||
163000987|NCT02455518|588703749|FG002|Overall Study|Protocol Violation|1|||
163000988|NCT02455518|588703750|FG003|Overall Study|Protocol Violation|3|||
162715756|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000989|NCT02508935|588703751|FG000|Overall Study|Withdrawal by Subject|1|||
162715757|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162715758|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162715759|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163000990|NCT02508935|588703751|FG000|Overall Study|Withdrawal by Caregiver|8|||
163000991|NCT02508935|588703751|FG000|Overall Study|Pain Score <4|1|||
163000992|NCT02508935|588703751|FG000|Overall Study|Emesis|3|||
163000993|NCT02508935|588703751|FG000|Overall Study|Adverse Event|3|||
163000994|NCT02508935|588703751|FG000|Overall Study|Protocol Violation|1|||
163000995|NCT02508935|588703751|FG000|Overall Study|Physician Decision|1|||
163000996|NCT02508935|588703751|FG000|Overall Study|Trial terminated by sponsor|5|||
163000997|NCT01332292|588703759|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163000998|NCT01332292|588703760|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163000999|NCT01332292|588703759|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163001000|NCT01332292|588703760|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
163001001|NCT01332292|588703759|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
163001002|NCT01332292|588703760|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
163001003|NCT02006732|588703761|FG000|Overall Study|Adverse Event|10|||
162715760|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162715761|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
163001004|NCT02006732|588703762|FG001|Overall Study|Adverse Event|7|||
163001005|NCT02006732|588703763|FG002|Overall Study|Adverse Event|4|||
163001006|NCT02006732|588703764|FG003|Overall Study|Adverse Event|2|||
163001007|NCT02006732|588703761|FG000|Overall Study|Lack of Efficacy|6|||
163001008|NCT02006732|588703762|FG001|Overall Study|Lack of Efficacy|3|||
163001009|NCT02006732|588703763|FG002|Overall Study|Lack of Efficacy|1|||
163001010|NCT02006732|588703764|FG003|Overall Study|Lack of Efficacy|1|||
163001011|NCT02006732|588703761|FG000|Overall Study|Protocol Violation|1|||
163001012|NCT02006732|588703762|FG001|Overall Study|Protocol Violation|1|||
163001013|NCT02006732|588703763|FG002|Overall Study|Protocol Violation|0|||
163001014|NCT02006732|588703764|FG003|Overall Study|Protocol Violation|0|||
163001015|NCT02006732|588703761|FG000|Overall Study|Lost to Follow-up|0|||
163001016|NCT02006732|588703762|FG001|Overall Study|Lost to Follow-up|1|||
163001017|NCT02006732|588703763|FG002|Overall Study|Lost to Follow-up|0|||
163001018|NCT02006732|588703764|FG003|Overall Study|Lost to Follow-up|0|||
163001019|NCT02006732|588703761|FG000|Overall Study|Withdrawal by Subject|3|||
163001020|NCT02006732|588703762|FG001|Overall Study|Withdrawal by Subject|0|||
163001021|NCT02006732|588703763|FG002|Overall Study|Withdrawal by Subject|4|||
163001022|NCT02006732|588703764|FG003|Overall Study|Withdrawal by Subject|1|||
163001023|NCT02969044|588703767|FG000|Overall Study|Withdrawal by Subject|2|||
163001024|NCT02969044|588703768|FG001|Overall Study|Withdrawal by Subject|6|||
163001025|NCT02969044|588703767|FG000|Overall Study|Adverse Event|3|||
163001026|NCT02969044|588703768|FG001|Overall Study|Adverse Event|0|||
163001027|NCT03548337|588703770|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
163001028|NCT03548337|588703771|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
163001029|NCT03548337|588703770|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
163001030|NCT03548337|588703771|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
163001031|NCT03548337|588703770|FG000|Infant Series|Lost to Follow-up|2|||
163001032|NCT03548337|588703771|FG001|Infant Series|Lost to Follow-up|1|||
163001033|NCT03548337|588703770|FG000|Infant Series|Adverse Event|0|||
163001034|NCT03548337|588703771|FG001|Infant Series|Adverse Event|2|||
163001035|NCT03548337|588703770|FG000|Infant Series|Randomized but Not Vaccinated|1|||
163001036|NCT03548337|588703771|FG001|Infant Series|Randomized but Not Vaccinated|0|||
163001037|NCT03548337|588703770|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
163001038|NCT03548337|588703771|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
163001039|NCT04502212|588703772|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
163001040|NCT04502212|588703772|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
163001041|NCT02359994|588703774|FG000|Overall Population Study|Adverse Event|1|||
163001042|NCT02359994|588703775|FG001|Overall Population Study|Adverse Event|1|||
163001043|NCT02359994|588703774|FG000|Overall Population Study|Death|1|||
163001044|NCT02359994|588703775|FG001|Overall Population Study|Death|5|||
163001045|NCT02359994|588703774|FG000|Overall Population Study|Lost to Follow-up|1|||
163001046|NCT02359994|588703775|FG001|Overall Population Study|Lost to Follow-up|1|||
163001047|NCT02359994|588703774|FG000|Overall Population Study|Withdrawal by Subject|1|||
163001048|NCT02359994|588703775|FG001|Overall Population Study|Withdrawal by Subject|0|||
163001049|NCT02359994|588703774|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
163001050|NCT02359994|588703775|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
163001051|NCT02359994|588703774|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
163001052|NCT02359994|588703775|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
163001053|NCT02359994|588703774|FG000|Extended Oncology 24-Month Survival|Death|19|||
163001054|NCT02359994|588703775|FG001|Extended Oncology 24-Month Survival|Death|21|||
163001055|NCT02359994|588703774|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
163001056|NCT02359994|588703775|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
163001057|NCT01320150|588703776|FG000|Overall Study|Protocol Violation|15|||
163001058|NCT01320150|588703776|FG000|Overall Study|Withdrawal by Subject|5|||
163001059|NCT01320150|588703776|FG000|Overall Study|Death|2|||
163001060|NCT01320150|588703776|FG000|Overall Study|Lost to Follow-up|44|||
163001061|NCT00489827|588703780|FG000|Overall Study|Intraoperative exclusion criteria|1|||
163001062|NCT00489827|588703781|FG001|Overall Study|Intraoperative exclusion criteria|1|||
163001063|NCT00489827|588703780|FG000|Overall Study|Intraoperative exclusion criteria|1|||
163001064|NCT00489827|588703781|FG001|Overall Study|Intraoperative exclusion criteria|1|||
163001065|NCT02766283|588703782|FG000|Overall Study|Lost to Follow-up|27|||
163001066|NCT00721227|588703783|FG000|Overall Study|Lost to Follow-up|3|||
163001067|NCT00721227|588703784|FG001|Overall Study|Lost to Follow-up|0|||
163001068|NCT00721227|588703783|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
163001069|NCT00721227|588703784|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
163001070|NCT01632280|588703798|FG000|Overall Study|Withdrawal by Subject|1|||
162637262|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
162637263|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
162637264|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
162637265|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
162637266|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
162637267|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
163001071|NCT01632280|588703799|FG001|Overall Study|Withdrawal by Subject|0|||
163001072|NCT03086551|588703800|FG000|First Intervention|Failure to meet inclusion criterion|1|||
163001073|NCT03086551|588703801|FG001|First Intervention|Failure to meet inclusion criterion|0|||
163001074|NCT03086551|588703800|FG000|First Intervention|Lost to Follow-up|0|||
163001075|NCT03086551|588703801|FG001|First Intervention|Lost to Follow-up|1|||
163001076|NCT03086551|588703800|FG000|Washout|Lost to Follow-up|1|||
163001077|NCT03086551|588703801|FG001|Washout|Lost to Follow-up|2|||
163001078|NCT03086551|588703800|FG000|Washout|Withdrawal by Subject|2|||
163001079|NCT03086551|588703801|FG001|Washout|Withdrawal by Subject|1|||
163001080|NCT03736031|588703805|FG000|Overall Study|Death|2|||
163001081|NCT03736031|588703806|FG001|Overall Study|Death|4|||
163001082|NCT03736031|588703805|FG000|Overall Study|Lost to Follow-up|21|||
163001083|NCT03736031|588703806|FG001|Overall Study|Lost to Follow-up|2|||
163001084|NCT03736031|588703805|FG000|Overall Study|Withdrawal by Subject|9|||
163001085|NCT03736031|588703806|FG001|Overall Study|Withdrawal by Subject|0|||
163001086|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
163001087|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
163001088|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
163001089|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
163001090|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
163001091|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
163001092|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
163001093|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
163001094|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
163001095|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
163001096|NCT00451178|588703807|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
163001097|NCT00451178|588703808|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
163001098|NCT00451178|588703807|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
163001099|NCT00451178|588703808|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
163001100|NCT00451178|588703807|FG000|Prior to Maintenance Therapy|PD|2|||
163001101|NCT00451178|588703808|FG001|Prior to Maintenance Therapy|PD|0|||
163001102|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
163001103|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
163001104|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
163001105|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
163001106|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
163060622|NCT05516758|588929963|FG005|Overall Study|Assigned treatment by mistake|0|||
163060623|NCT05516758|588929964|FG006|Overall Study|Assigned treatment by mistake|0|||
163060624|NCT05516758|588929958|FG000|Overall Study|Lack of Efficacy|6|||
163060625|NCT05516758|588929959|FG001|Overall Study|Lack of Efficacy|0|||
163060626|NCT05516758|588929960|FG002|Overall Study|Lack of Efficacy|2|||
163060627|NCT05516758|588929961|FG003|Overall Study|Lack of Efficacy|0|||
163060628|NCT05516758|588929962|FG004|Overall Study|Lack of Efficacy|3|||
163060629|NCT05516758|588929963|FG005|Overall Study|Lack of Efficacy|6|||
163060630|NCT05516758|588929964|FG006|Overall Study|Lack of Efficacy|3|||
163060631|NCT05516758|588929958|FG000|Overall Study|Lost to Follow-up|2|||
163060632|NCT05516758|588929959|FG001|Overall Study|Lost to Follow-up|0|||
163060633|NCT05516758|588929960|FG002|Overall Study|Lost to Follow-up|2|||
163060634|NCT05516758|588929961|FG003|Overall Study|Lost to Follow-up|0|||
163060635|NCT05516758|588929962|FG004|Overall Study|Lost to Follow-up|3|||
163060636|NCT05516758|588929963|FG005|Overall Study|Lost to Follow-up|2|||
163060637|NCT05516758|588929964|FG006|Overall Study|Lost to Follow-up|1|||
163060638|NCT05516758|588929958|FG000|Overall Study|Other- As reported by the site|2|||
163060639|NCT05516758|588929959|FG001|Overall Study|Other- As reported by the site|1|||
163060640|NCT05516758|588929960|FG002|Overall Study|Other- As reported by the site|8|||
162637268|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
163001107|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
163001108|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
163001109|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
163001110|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
163060641|NCT05516758|588929961|FG003|Overall Study|Other- As reported by the site|1|||
163060642|NCT05516758|588929962|FG004|Overall Study|Other- As reported by the site|2|||
163060643|NCT05516758|588929963|FG005|Overall Study|Other- As reported by the site|3|||
163060644|NCT05516758|588929964|FG006|Overall Study|Other- As reported by the site|8|||
163060645|NCT05516758|588929958|FG000|Overall Study|Physician Decision|1|||
162637269|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
163001111|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
163001112|NCT00451178|588703807|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
163001113|NCT00451178|588703808|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
163001114|NCT00451178|588703807|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
163001115|NCT00451178|588703808|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
163001116|NCT02586688|588706213|FG000|Overall Study|Lost to Follow-up|2|||
163001117|NCT02586688|588706214|FG001|Overall Study|Lost to Follow-up|1|||
163001118|NCT02586688|588706213|FG000|Overall Study|Withdrawal by Subject|1|||
163001119|NCT02586688|588706214|FG001|Overall Study|Withdrawal by Subject|1|||
163001120|NCT02586688|588706213|FG000|Overall Study|Adverse Event|3|||
163001121|NCT02586688|588706214|FG001|Overall Study|Adverse Event|1|||
163001122|NCT04856917|588706215|FG000|Overall Study|Withdrawal by Subject|4|||
163001123|NCT04856917|588706216|FG001|Overall Study|Withdrawal by Subject|3|||
163001124|NCT04856917|588706217|FG002|Overall Study|Withdrawal by Subject|1|||
163001125|NCT04856917|588706215|FG000|Overall Study|Lost to Follow-up|3|||
163001126|NCT04856917|588706216|FG001|Overall Study|Lost to Follow-up|1|||
163001127|NCT04856917|588706217|FG002|Overall Study|Lost to Follow-up|1|||
163001128|NCT04856917|588706215|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
163001129|NCT04856917|588706216|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
163001130|NCT04856917|588706217|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
163001131|NCT04856917|588706215|FG000|Overall Study|Other|1|||
163001132|NCT04856917|588706216|FG001|Overall Study|Other|1|||
163001133|NCT04856917|588706217|FG002|Overall Study|Other|0|||
163001134|NCT05168202|588706218|FG000|Overall Study|Progressive Disease|4|||
163001135|NCT05168202|588706219|FG001|Overall Study|Progressive Disease|4|||
163001136|NCT05168202|588706220|FG002|Overall Study|Progressive Disease|2|||
163001137|NCT05168202|588706221|FG003|Overall Study|Progressive Disease|3|||
163001138|NCT05168202|588706222|FG004|Overall Study|Progressive Disease|2|||
163001139|NCT05168202|588706223|FG005|Overall Study|Progressive Disease|3|||
163001140|NCT05168202|588706224|FG006|Overall Study|Progressive Disease|2|||
163001141|NCT05168202|588706218|FG000|Overall Study|Adverse Event|2|||
163001142|NCT05168202|588706219|FG001|Overall Study|Adverse Event|1|||
163001143|NCT05168202|588706220|FG002|Overall Study|Adverse Event|4|||
163001144|NCT05168202|588706221|FG003|Overall Study|Adverse Event|4|||
163001145|NCT05168202|588706222|FG004|Overall Study|Adverse Event|3|||
163001146|NCT05168202|588706223|FG005|Overall Study|Adverse Event|2|||
163001147|NCT05168202|588706224|FG006|Overall Study|Adverse Event|0|||
163001148|NCT05168202|588706218|FG000|Overall Study|Lack of Efficacy|0|||
163001149|NCT05168202|588706219|FG001|Overall Study|Lack of Efficacy|1|||
163001150|NCT05168202|588706220|FG002|Overall Study|Lack of Efficacy|1|||
163001151|NCT05168202|588706221|FG003|Overall Study|Lack of Efficacy|0|||
163001152|NCT05168202|588706222|FG004|Overall Study|Lack of Efficacy|1|||
163001153|NCT05168202|588706223|FG005|Overall Study|Lack of Efficacy|2|||
163001154|NCT05168202|588706224|FG006|Overall Study|Lack of Efficacy|2|||
163001155|NCT05168202|588706218|FG000|Overall Study|Withdrawal by Subject|0|||
163001156|NCT05168202|588706219|FG001|Overall Study|Withdrawal by Subject|0|||
163001157|NCT05168202|588706220|FG002|Overall Study|Withdrawal by Subject|1|||
163001158|NCT05168202|588706221|FG003|Overall Study|Withdrawal by Subject|1|||
163001159|NCT05168202|588706222|FG004|Overall Study|Withdrawal by Subject|1|||
163001160|NCT05168202|588706223|FG005|Overall Study|Withdrawal by Subject|1|||
163001161|NCT05168202|588706224|FG006|Overall Study|Withdrawal by Subject|0|||
163001162|NCT05168202|588706218|FG000|Overall Study|Disease Relapse|0|||
163001163|NCT05168202|588706219|FG001|Overall Study|Disease Relapse|1|||
163001164|NCT05168202|588706220|FG002|Overall Study|Disease Relapse|0|||
163001165|NCT05168202|588706221|FG003|Overall Study|Disease Relapse|1|||
163001166|NCT05168202|588706222|FG004|Overall Study|Disease Relapse|1|||
163001167|NCT05168202|588706223|FG005|Overall Study|Disease Relapse|0|||
163001168|NCT05168202|588706224|FG006|Overall Study|Disease Relapse|0|||
163001169|NCT05168202|588706218|FG000|Overall Study|Other Reasons|0|||
163001170|NCT05168202|588706219|FG001|Overall Study|Other Reasons|0|||
163001171|NCT05168202|588706220|FG002|Overall Study|Other Reasons|0|||
163001172|NCT05168202|588706221|FG003|Overall Study|Other Reasons|0|||
163001173|NCT05168202|588706222|FG004|Overall Study|Other Reasons|0|||
163001174|NCT05168202|588706223|FG005|Overall Study|Other Reasons|2|||
163001175|NCT05168202|588706224|FG006|Overall Study|Other Reasons|1|||
163001176|NCT05168202|588706218|FG000|Overall Study|Physician Decision|0|||
163001177|NCT05168202|588706219|FG001|Overall Study|Physician Decision|1|||
163001178|NCT05168202|588706220|FG002|Overall Study|Physician Decision|1|||
163001179|NCT05168202|588706221|FG003|Overall Study|Physician Decision|0|||
163001180|NCT05168202|588706222|FG004|Overall Study|Physician Decision|0|||
163001181|NCT05168202|588706223|FG005|Overall Study|Physician Decision|0|||
163001182|NCT05168202|588706224|FG006|Overall Study|Physician Decision|0|||
163001183|NCT05168202|588706218|FG000|Overall Study|Study Terminated by Sponsor|0|||
163001184|NCT05168202|588706219|FG001|Overall Study|Study Terminated by Sponsor|0|||
163001185|NCT05168202|588706220|FG002|Overall Study|Study Terminated by Sponsor|0|||
163001186|NCT05168202|588706221|FG003|Overall Study|Study Terminated by Sponsor|1|||
163001187|NCT05168202|588706222|FG004|Overall Study|Study Terminated by Sponsor|0|||
163001188|NCT05168202|588706223|FG005|Overall Study|Study Terminated by Sponsor|0|||
163001189|NCT05168202|588706224|FG006|Overall Study|Study Terminated by Sponsor|0|||
163001190|NCT04011722|588706228|FG000|30 Days|Death|5|||
163001191|NCT04011722|588706229|FG001|30 Days|Death|1|||
163001192|NCT04011722|588706228|FG000|1 Year|Death|13|||
163001193|NCT04011722|588706229|FG001|1 Year|Death|5|||
163001194|NCT04011722|588706228|FG000|1 Year|Withdrawal by Subject|8|||
163001195|NCT04011722|588706229|FG001|1 Year|Withdrawal by Subject|2|||
163001196|NCT04011722|588706228|FG000|1 Year|Missed Visit|6|||
163001197|NCT04011722|588706229|FG001|1 Year|Missed Visit|1|||
163001198|NCT04011722|588706228|FG000|1 Year|Pending Visit|0|||
163001199|NCT04011722|588706229|FG001|1 Year|Pending Visit|11|||
163001200|NCT04011722|588706228|FG000|1 Year|Not Yet Due|0|||
163001201|NCT04011722|588706229|FG001|1 Year|Not Yet Due|9|||
163001202|NCT04011722|588706228|FG000|2 Year|Death|16|||
163001203|NCT04011722|588706229|FG001|2 Year|Death|1|||
163001204|NCT04011722|588706228|FG000|2 Year|Withdrawal by Subject|10|||
163001205|NCT04011722|588706229|FG001|2 Year|Withdrawal by Subject|1|||
163001206|NCT04011722|588706228|FG000|2 Year|Missed Visit|9|||
163001207|NCT04011722|588706229|FG001|2 Year|Missed Visit|0|||
163001208|NCT04011722|588706228|FG000|2 Year|Visit Pending|1|||
163001209|NCT04011722|588706229|FG001|2 Year|Visit Pending|3|||
163001210|NCT04011722|588706228|FG000|2 Year|Not Yet Due|43|||
163001211|NCT04011722|588706229|FG001|2 Year|Not Yet Due|54|||
163001212|NCT04011722|588706228|FG000|3 Year|Death|10|||
163001213|NCT04011722|588706229|FG001|3 Year|Death|0|||
163001214|NCT04011722|588706228|FG000|3 Year|Withdrawal by Subject|2|||
163001215|NCT04011722|588706229|FG001|3 Year|Withdrawal by Subject|0|||
163001216|NCT04011722|588706228|FG000|3 Year|Missed Visit|2|||
163001217|NCT04011722|588706229|FG001|3 Year|Missed Visit|0|||
163001218|NCT04011722|588706228|FG000|3 Year|Pending Visit|34|||
162637270|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162637271|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162637272|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162637273|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
162637274|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
162637275|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
163001219|NCT04011722|588706229|FG001|3 Year|Pending Visit|0|||
163001220|NCT04011722|588706228|FG000|3 Year|Not Yet Due|99|||
163001221|NCT04011722|588706229|FG001|3 Year|Not Yet Due|0|||
163001222|NCT05626231|588706232|FG000|Provider Enrollment|Worked part-time|4|||
163001223|NCT05626231|588706232|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
163001224|NCT05626231|588706232|FG000|Provider Enrollment|Non-clinical employee|1|||
163001225|NCT05626231|588706232|FG000|Provider Enrollment|Provider does not see clients|3|||
163001226|NCT05626231|588706232|FG000|Provider Enrollment|Other|5|||
163001227|NCT06195930|588706233|FG000|Overall Study|Adverse Event|4|||
163001228|NCT00233948|588706242|FG000|Overall Study|Adverse Event|1|||
163001229|NCT00233948|588706243|FG001|Overall Study|Adverse Event|0|||
163001230|NCT00233948|588706244|FG002|Overall Study|Adverse Event|0|||
163001231|NCT00233948|588706245|FG003|Overall Study|Adverse Event|0|||
163001232|NCT00233948|588706246|FG004|Overall Study|Adverse Event|0|||
163060646|NCT05516758|588929959|FG001|Overall Study|Physician Decision|0|||
163060647|NCT05516758|588929960|FG002|Overall Study|Physician Decision|7|||
163060648|NCT05516758|588929961|FG003|Overall Study|Physician Decision|0|||
163060649|NCT05516758|588929962|FG004|Overall Study|Physician Decision|1|||
162637276|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
162637277|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
162715762|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
162715763|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715764|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715765|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163001233|NCT00233948|588706247|FG005|Overall Study|Adverse Event|0|||
163001234|NCT01567462|588706248|FG000|Overall Study|Withdrawal by Subject|4|||
163001235|NCT01567462|588706249|FG001|Overall Study|Withdrawal by Subject|7|||
163001236|NCT02548156|588706250|FG000|Washout Period 1|Lost to Follow-up|0|||
163001237|NCT02548156|588706251|FG001|Washout Period 1|Lost to Follow-up|0|||
163001238|NCT02548156|588706252|FG002|Washout Period 1|Lost to Follow-up|0|||
163001239|NCT02548156|588706253|FG003|Washout Period 1|Lost to Follow-up|0|||
163001240|NCT02548156|588706254|FG004|Washout Period 1|Lost to Follow-up|1|||
163001241|NCT02548156|588706255|FG005|Washout Period 1|Lost to Follow-up|0|||
163001242|NCT00444587|588706262|FG000|Overall Study|Death|2|||
163001243|NCT00444587|588706263|FG001|Overall Study|Death|1|||
163001244|NCT00444587|588706262|FG000|Overall Study|Progression of the disease|73|||
163001245|NCT00444587|588706263|FG001|Overall Study|Progression of the disease|8|||
163001246|NCT00444587|588706262|FG000|Overall Study|Refused treatment/did not cooperate|4|||
163001247|NCT00444587|588706263|FG001|Overall Study|Refused treatment/did not cooperate|1|||
163001248|NCT00444587|588706262|FG000|Overall Study|Investigator decision|3|||
163001249|NCT00444587|588706263|FG001|Overall Study|Investigator decision|0|||
163001250|NCT00444587|588706262|FG000|Overall Study|Protocol Violation|1|||
163001251|NCT00444587|588706263|FG001|Overall Study|Protocol Violation|0|||
163001252|NCT00444587|588706262|FG000|Overall Study|Missing|0|||
163001253|NCT00444587|588706263|FG001|Overall Study|Missing|5|||
163001254|NCT00196326|588706264|FG000|Overall Study|Did not meet protocol requirements|64|||
163001255|NCT00196326|588706264|FG000|Overall Study|Non-compliance with the protocol|81|||
163001256|NCT00196326|588706264|FG000|Overall Study|Physician Decision|3|||
163001257|NCT00196326|588706264|FG000|Overall Study|Withdrawal by Subject|225|||
163001258|NCT00196326|588706264|FG000|Overall Study|Adverse Event|253|||
163001259|NCT00196326|588706264|FG000|Overall Study|Pregnancy|34|||
163001260|NCT00196326|588706264|FG000|Overall Study|Lost to Follow-up|304|||
163001261|NCT00196326|588706264|FG000|Overall Study|Other|22|||
163001262|NCT01473407|588706273|FG000|Overall Study|Physician Decision|1|||
163001263|NCT01473407|588706274|FG001|Overall Study|Physician Decision|4|||
163001264|NCT01473407|588706273|FG000|Overall Study|Lost to Follow-up|10|||
163001265|NCT01473407|588706274|FG001|Overall Study|Lost to Follow-up|4|||
163001266|NCT01473407|588706273|FG000|Overall Study|Adverse Event|8|||
163001267|NCT01473407|588706274|FG001|Overall Study|Adverse Event|8|||
163001268|NCT01473407|588706273|FG000|Overall Study|Randomization Error|3|||
163001269|NCT01473407|588706274|FG001|Overall Study|Randomization Error|1|||
163001270|NCT01473407|588706273|FG000|Overall Study|Withdrawal by Subject|4|||
163001271|NCT01473407|588706274|FG001|Overall Study|Withdrawal by Subject|7|||
163001272|NCT01473407|588706273|FG000|Overall Study|Kidney Transplant|7|||
163001273|NCT01473407|588706274|FG001|Overall Study|Kidney Transplant|6|||
163001274|NCT01473407|588706273|FG000|Overall Study|Vacation/Travel|1|||
163001275|NCT01473407|588706274|FG001|Overall Study|Vacation/Travel|1|||
163001276|NCT01473407|588706273|FG000|Overall Study|Elevated Hemoglobin|1|||
163001277|NCT01473407|588706274|FG001|Overall Study|Elevated Hemoglobin|0|||
163001278|NCT01473407|588706273|FG000|Overall Study|Patient Received Aranesp|1|||
163001279|NCT01473407|588706274|FG001|Overall Study|Patient Received Aranesp|0|||
163001280|NCT01473407|588706273|FG000|Overall Study|Patient Lost Green Card Status|1|||
163001281|NCT01473407|588706274|FG001|Overall Study|Patient Lost Green Card Status|0|||
163001282|NCT01473407|588706273|FG000|Overall Study|Temperature Excursion|2|||
163001283|NCT01473407|588706274|FG001|Overall Study|Temperature Excursion|3|||
163001284|NCT01473407|588706273|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
163001285|NCT01473407|588706274|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
163001286|NCT01473407|588706273|FG000|Overall Study|Sponsor's Decision|10|||
163001287|NCT01473407|588706274|FG001|Overall Study|Sponsor's Decision|10|||
163001288|NCT01473407|588706273|FG000|Overall Study|Site Closure|1|||
163001289|NCT01473407|588706274|FG001|Overall Study|Site Closure|0|||
163001290|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
163001291|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
163001292|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
163001293|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
163001294|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
163001295|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
163001296|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163001297|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163001298|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
163001299|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
163001300|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
163001301|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
163001302|NCT02422797|588706275|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
163001303|NCT02422797|588706276|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
163001304|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
163001305|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
163001306|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
163001307|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
163001308|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
163001309|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
163001310|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
163001311|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
163001312|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
163001313|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
163001314|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
163001315|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
163001316|NCT02422797|588706275|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163001317|NCT02422797|588706276|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
163001318|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
163001319|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
163001320|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
163001321|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
163001322|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
163001323|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
163001324|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
163001325|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
163001326|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
163001327|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
163001328|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
163001329|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
163001330|NCT02422797|588706275|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
163001331|NCT02422797|588706276|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
163001332|NCT05223920|588706277|FG000|Overall Study|Adverse Event|6|||
163001333|NCT05223920|588706278|FG001|Overall Study|Adverse Event|3|||
163001334|NCT05223920|588706277|FG000|Overall Study|Death|2|||
163001335|NCT05223920|588706278|FG001|Overall Study|Death|0|||
163001336|NCT05223920|588706277|FG000|Overall Study|Disease Progression|1|||
163001337|NCT05223920|588706278|FG001|Overall Study|Disease Progression|2|||
163001338|NCT05223920|588706277|FG000|Overall Study|Physician Decision|1|||
163001339|NCT05223920|588706278|FG001|Overall Study|Physician Decision|2|||
163001340|NCT05223920|588706277|FG000|Overall Study|Sponsor decision|11|||
163001341|NCT05223920|588706278|FG001|Overall Study|Sponsor decision|9|||
163001342|NCT05223920|588706277|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
163001343|NCT05223920|588706278|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
163001344|NCT05223920|588706277|FG000|Overall Study|Subject decision|1|||
163001345|NCT05223920|588706278|FG001|Overall Study|Subject decision|0|||
163001346|NCT05223920|588706277|FG000|Overall Study|Withdrawal by Subject|1|||
163001347|NCT05223920|588706278|FG001|Overall Study|Withdrawal by Subject|6|||
163001348|NCT04071405|588706279|FG000|Overall Study|Protocol Violation|3|||
163001349|NCT00369941|588706282|FG000|Overall Study|Never Treated|1|||
163001350|NCT00369941|588706283|FG001|Overall Study|Never Treated|2|||
163001351|NCT00369941|588706282|FG000|Overall Study|Adverse Event|14|||
163001352|NCT00369941|588706283|FG001|Overall Study|Adverse Event|28|||
163001353|NCT00369941|588706282|FG000|Overall Study|Lack of Efficacy|6|||
163001354|NCT00369941|588706283|FG001|Overall Study|Lack of Efficacy|10|||
163001355|NCT00369941|588706282|FG000|Overall Study|Lost to Follow-up|12|||
163001356|NCT00369941|588706283|FG001|Overall Study|Lost to Follow-up|22|||
163001357|NCT00369941|588706282|FG000|Overall Study|Protocol Violation|5|||
163001358|NCT00369941|588706283|FG001|Overall Study|Protocol Violation|3|||
163001359|NCT00369941|588706282|FG000|Overall Study|Withdrawal by Subject|5|||
163001360|NCT00369941|588706283|FG001|Overall Study|Withdrawal by Subject|18|||
163001361|NCT00369941|588706282|FG000|Overall Study|Pregnancy|4|||
163001362|NCT00369941|588706283|FG001|Overall Study|Pregnancy|2|||
163001363|NCT00369941|588706282|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
163001364|NCT00369941|588706283|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
163001365|NCT00369941|588706282|FG000|Overall Study|Moved|11|||
163001366|NCT00369941|588706283|FG001|Overall Study|Moved|5|||
163001367|NCT00369941|588706282|FG000|Overall Study|Treatment with Prohibited Medication|3|||
163001368|NCT00369941|588706283|FG001|Overall Study|Treatment with Prohibited Medication|1|||
163001369|NCT00369941|588706282|FG000|Overall Study|Employment Interfered with Study Visits|1|||
163001370|NCT00369941|588706283|FG001|Overall Study|Employment Interfered with Study Visits|0|||
163001371|NCT00369941|588706282|FG000|Overall Study|Study Site Terminated|2|||
163001372|NCT00369941|588706283|FG001|Overall Study|Study Site Terminated|0|||
163001373|NCT00369941|588706282|FG000|Overall Study|Miscellaneous|3|||
163001374|NCT00369941|588706283|FG001|Overall Study|Miscellaneous|3|||
163001375|NCT03685344|588706284|FG000|Overall Study|Withdrawal by Subject|1|||
163001376|NCT03685344|588706285|FG001|Overall Study|Withdrawal by Subject|1|||
163001377|NCT03685344|588706286|FG002|Overall Study|Withdrawal by Subject|2|||
163001378|NCT03685344|588706287|FG003|Overall Study|Withdrawal by Subject|0|||
163001379|NCT03685344|588706284|FG000|Overall Study|Physician Decision|1|||
163001380|NCT03685344|588706285|FG001|Overall Study|Physician Decision|1|||
163001381|NCT03685344|588706286|FG002|Overall Study|Physician Decision|5|||
163001382|NCT03685344|588706287|FG003|Overall Study|Physician Decision|0|||
163001383|NCT03685344|588706284|FG000|Overall Study|Death|1|||
163001384|NCT03685344|588706285|FG001|Overall Study|Death|1|||
163001385|NCT03685344|588706286|FG002|Overall Study|Death|0|||
163001386|NCT03685344|588706287|FG003|Overall Study|Death|0|||
163001387|NCT02276807|588706288|FG000|Overall Study|Withdrawal by Subject|8|||
163001388|NCT02276807|588706289|FG001|Overall Study|Withdrawal by Subject|7|||
163001389|NCT02276807|588706288|FG000|Overall Study|Lost to Follow-up|10|||
163001390|NCT02276807|588706289|FG001|Overall Study|Lost to Follow-up|10|||
163001391|NCT00261950|588706290|FG000|Overall Study|Lost to Follow-up|2|||
163001392|NCT00261950|588706290|FG000|Overall Study|Death|6|||
163001393|NCT00261950|588706290|FG000|Overall Study|Withdrawal by Subject|5|||
163001394|NCT00261950|588706290|FG000|Overall Study|Other|1|||
163001395|NCT00261950|588706290|FG000|Overall Study|Physician Decision|1|||
163001396|NCT00261950|588706290|FG000|Overall Study|Protocol specified Criteria|11|||
163001397|NCT03288714|588706291|FG000|Overall Study|Lost to Follow-up|2|||
163001398|NCT03288714|588706292|FG001|Overall Study|Lost to Follow-up|1|||
163001399|NCT03288714|588706291|FG000|Overall Study|Non-compliance with study schedule|2|||
163001400|NCT03288714|588706292|FG001|Overall Study|Non-compliance with study schedule|0|||
163001401|NCT03288714|588706291|FG000|Overall Study|Withdrawal by Subject|3|||
163001402|NCT03288714|588706292|FG001|Overall Study|Withdrawal by Subject|1|||
163001403|NCT03288714|588706291|FG000|Overall Study|Clinical Worsening|2|||
163001404|NCT03288714|588706292|FG001|Overall Study|Clinical Worsening|1|||
163001405|NCT03288714|588706291|FG000|Overall Study|Adverse Event|1|||
163001406|NCT03288714|588706292|FG001|Overall Study|Adverse Event|0|||
163001407|NCT02789137|588706298|FG000|Overall Study|Dropped out/Died|58|||
163001408|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
163001409|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
163001410|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
163001411|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
163001412|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001413|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001414|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
163001415|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
163001416|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
163001417|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
163001418|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
163001419|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
163001420|NCT00445432|588706299|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
163001421|NCT00445432|588706300|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
163001422|NCT00445432|588706301|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
163001423|NCT00445432|588706302|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
163001424|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001425|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001426|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
163001427|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
163001428|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001429|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001430|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
163001431|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
163001432|NCT00445432|588706299|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
163001433|NCT00445432|588706300|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
163001434|NCT00445432|588706301|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
163001435|NCT00445432|588706302|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
163001436|NCT00799058|588706309|FG000|Overall Study|Withdrawal by Subject|2|||
163001437|NCT00799058|588706310|FG001|Overall Study|Withdrawal by Subject|2|||
163001438|NCT00799058|588706311|FG002|Overall Study|Withdrawal by Subject|2|||
163001439|NCT00799058|588706309|FG000|Overall Study|Lost to Follow-up|1|||
162715766|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163001440|NCT00799058|588706310|FG001|Overall Study|Lost to Follow-up|2|||
163001441|NCT00799058|588706311|FG002|Overall Study|Lost to Follow-up|1|||
163001442|NCT00799058|588706309|FG000|Overall Study|Adverse Event|0|||
163001443|NCT00799058|588706310|FG001|Overall Study|Adverse Event|2|||
163001444|NCT00799058|588706311|FG002|Overall Study|Adverse Event|0|||
163001445|NCT00799058|588706309|FG000|Overall Study|Pregnancy|1|||
163001446|NCT00799058|588706310|FG001|Overall Study|Pregnancy|0|||
163001447|NCT00799058|588706311|FG002|Overall Study|Pregnancy|0|||
163001448|NCT00799058|588706309|FG000|Overall Study|Not adherent|3|||
163001449|NCT00799058|588706310|FG001|Overall Study|Not adherent|2|||
163001450|NCT00799058|588706311|FG002|Overall Study|Not adherent|1|||
163001451|NCT00799058|588706309|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
163001452|NCT00799058|588706310|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
163001453|NCT00799058|588706311|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
163001454|NCT00799058|588706309|FG000|Overall Study|IP dispensing error|1|||
163001455|NCT00799058|588706310|FG001|Overall Study|IP dispensing error|0|||
163001456|NCT00799058|588706311|FG002|Overall Study|IP dispensing error|0|||
163001457|NCT00799058|588706309|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
163001458|NCT00799058|588706310|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
163001459|NCT00799058|588706311|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
163001460|NCT00799058|588706309|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
163001461|NCT00799058|588706310|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
163001462|NCT00799058|588706311|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
163001463|NCT00799058|588706309|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
163001464|NCT00799058|588706310|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
163001465|NCT00799058|588706311|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
163001466|NCT00799058|588706309|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
163001467|NCT00799058|588706310|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
163001468|NCT00799058|588706311|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
163001469|NCT02088697|588706316|FG000|Period I|Physician Decision|1|||
163001470|NCT02088697|588706317|FG001|Period I|Physician Decision|4|||
163001471|NCT02088697|588706316|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
163001472|NCT02088697|588706317|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
163001473|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Other|34|||
163001474|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Other|0|||
163001475|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Other|0|||
163001476|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Other|0|||
163001477|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Death|14|||
163001478|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Death|0|||
163001479|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Death|0|||
163001480|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Death|0|||
163001481|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
163001482|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
163001483|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
163001484|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
163001485|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
163001486|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001487|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001488|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
163001489|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
163001490|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
163001491|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
163001492|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
163001493|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
163001494|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001495|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001496|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
163001497|NCT01995513|588706320|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
163001498|NCT01995513|588706321|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001499|NCT01995513|588706322|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001500|NCT01995513|588706323|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
163001501|NCT01995513|588706320|FG000|Period 1: Second Open Label Treatment|Other|0|||
163001502|NCT01995513|588706321|FG001|Period 1: Second Open Label Treatment|Other|2|||
163001503|NCT01995513|588706322|FG002|Period 1: Second Open Label Treatment|Other|0|||
163001504|NCT01995513|588706323|FG003|Period 1: Second Open Label Treatment|Other|0|||
163001505|NCT01995513|588706320|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
163001506|NCT01995513|588706321|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
163001507|NCT01995513|588706322|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
163001508|NCT01995513|588706323|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
162637278|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
162637279|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
163001509|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Death|0|||
163001510|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Death|0|||
163001511|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Death|0|||
162637280|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
162637281|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
162637282|NCT03720470|587388482|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162637283|NCT03720470|587388483|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162637284|NCT03720470|587388484|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162637285|NCT03720470|587388485|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162637286|NCT03720470|587388486|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162637287|NCT03720470|587388487|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
162637288|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162637289|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162637290|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162637291|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
162637292|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
162637293|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
162637294|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162637295|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162637296|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
162637297|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162637298|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162637299|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162637300|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162637301|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162637302|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162637303|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
162637304|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162637305|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
162637306|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162637307|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162637308|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162637309|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
163001512|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Death|1|||
163001513|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Other|0|||
163001514|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Other|0|||
163001515|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Other|3|||
163001516|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Other|3|||
163001517|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
163001518|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
163001519|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
163001520|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
163001521|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
163001522|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
163001523|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
163001524|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
163001525|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
163001526|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
163001527|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
163001528|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
163001529|NCT01995513|588706320|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
163001530|NCT01995513|588706321|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
163001531|NCT01995513|588706322|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
162637310|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162637311|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
162637312|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162637313|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162637314|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
162637315|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162637316|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162637317|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162637318|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
162637319|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
162637320|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
162637321|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162637322|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162637323|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162637324|NCT03720470|587388482|FG000|Treatment Period: Final 4 Weeks|Other|0|||
162637325|NCT03720470|587388483|FG001|Treatment Period: Final 4 Weeks|Other|1|||
162637326|NCT03720470|587388484|FG002|Treatment Period: Final 4 Weeks|Other|0|||
162637327|NCT03720470|587388485|FG003|Treatment Period: Final 4 Weeks|Other|2|||
162637328|NCT03720470|587388486|FG004|Treatment Period: Final 4 Weeks|Other|1|||
163001532|NCT01995513|588706323|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
163001533|NCT01232452|588706324|FG000|Overall Study|Adverse Event|17|||
163001534|NCT01232452|588706325|FG001|Overall Study|Adverse Event|15|||
163001535|NCT01232452|588706324|FG000|Overall Study|Withdrawal by Subject|11|||
163001536|NCT01232452|588706325|FG001|Overall Study|Withdrawal by Subject|8|||
163001537|NCT01232452|588706324|FG000|Overall Study|Physician Decision|8|||
163001538|NCT01232452|588706325|FG001|Overall Study|Physician Decision|12|||
163001539|NCT01232452|588706324|FG000|Overall Study|Protocol entry criterion not met|0|||
163001540|NCT01232452|588706325|FG001|Overall Study|Protocol entry criterion not met|2|||
163001541|NCT01232452|588706324|FG000|Overall Study|Sponsor Decision|3|||
163001542|NCT01232452|588706325|FG001|Overall Study|Sponsor Decision|1|||
163001543|NCT01232452|588706324|FG000|Overall Study|Protocol Violation|0|||
163001544|NCT01232452|588706325|FG001|Overall Study|Protocol Violation|1|||
163001545|NCT00247676|588706330|FG000|Overall Study|Death|5|||
163001546|NCT00247676|588706330|FG000|Overall Study|Adverse Event|11|||
163001547|NCT00247676|588706330|FG000|Overall Study|Lack of Efficacy|15|||
163001548|NCT00247676|588706330|FG000|Overall Study|Other|3|||
163001549|NCT00247676|588706330|FG000|Overall Study|Withdrawal by Subject|2|||
163001550|NCT03594071|588706331|FG000|Overall Study|Re-operation|3|||
163001551|NCT03594071|588706331|FG000|Overall Study|Missed visit|2|||
163001552|NCT05219448|588706332|FG000|Overall Study|Lost to Follow-up|9|||
163001553|NCT05219448|588706333|FG001|Overall Study|Lost to Follow-up|0|||
163001554|NCT01750190|588706334|FG000|Overall Study|Adverse Event|47|||
163001555|NCT01750190|588706335|FG001|Overall Study|Adverse Event|19|||
163001556|NCT01750190|588706334|FG000|Overall Study|Death|38|||
163001557|NCT01750190|588706335|FG001|Overall Study|Death|11|||
163001558|NCT01750190|588706334|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
163001559|NCT01750190|588706335|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
163001560|NCT01750190|588706334|FG000|Overall Study|Lost to Follow-up|28|||
163001561|NCT01750190|588706335|FG001|Overall Study|Lost to Follow-up|7|||
163001562|NCT01750190|588706334|FG000|Overall Study|Physician Decision|16|||
163001563|NCT01750190|588706335|FG001|Overall Study|Physician Decision|17|||
163001564|NCT01750190|588706334|FG000|Overall Study|Protocol Violation|6|||
163001565|NCT01750190|588706335|FG001|Overall Study|Protocol Violation|5|||
162637329|NCT03720470|587388487|FG005|Treatment Period: Final 4 Weeks|Other|0|||
162637330|NCT01988103|587388488|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
162637331|NCT01988103|587388489|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
162637332|NCT01988103|587388490|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
163001566|NCT01750190|588706334|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
163001567|NCT01750190|588706335|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
163001568|NCT01750190|588706334|FG000|Overall Study|Withdrawal by Subject|83|||
163001569|NCT01750190|588706335|FG001|Overall Study|Withdrawal by Subject|89|||
163001570|NCT01750190|588706334|FG000|Overall Study|Kidney Transplant|8|||
163001571|NCT01750190|588706335|FG001|Overall Study|Kidney Transplant|4|||
163001572|NCT01750190|588706334|FG000|Overall Study|Dialysis|22|||
163001573|NCT01750190|588706335|FG001|Overall Study|Dialysis|8|||
163001574|NCT01750190|588706334|FG000|Overall Study|Other than Specified|13|||
163001575|NCT01750190|588706335|FG001|Overall Study|Other than Specified|4|||
163001576|NCT02287922|588706336|FG000|Overall Study|Adverse Event|1|||
163001577|NCT02287922|588706337|FG001|Overall Study|Adverse Event|1|||
163001578|NCT02287922|588706338|FG002|Overall Study|Adverse Event|3|||
163001579|NCT02287922|588706339|FG003|Overall Study|Adverse Event|4|||
163001580|NCT02287922|588706336|FG000|Overall Study|Withdrawal by Subject|1|||
163001581|NCT02287922|588706337|FG001|Overall Study|Withdrawal by Subject|1|||
163001582|NCT02287922|588706338|FG002|Overall Study|Withdrawal by Subject|1|||
163001583|NCT02287922|588706339|FG003|Overall Study|Withdrawal by Subject|2|||
163001584|NCT02287922|588706336|FG000|Overall Study|Lost to Follow-up|0|||
163001585|NCT02287922|588706337|FG001|Overall Study|Lost to Follow-up|0|||
163001586|NCT02287922|588706338|FG002|Overall Study|Lost to Follow-up|1|||
162637333|NCT01988103|587388491|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
162637334|NCT01988103|587388492|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
163001587|NCT02287922|588706339|FG003|Overall Study|Lost to Follow-up|0|||
163001588|NCT02287922|588706336|FG000|Overall Study|Sponsor's decision|0|||
163001589|NCT02287922|588706337|FG001|Overall Study|Sponsor's decision|0|||
163001590|NCT02287922|588706338|FG002|Overall Study|Sponsor's decision|0|||
163001591|NCT02287922|588706339|FG003|Overall Study|Sponsor's decision|1|||
163001592|NCT02287922|588706336|FG000|Overall Study|Other|1|||
163001593|NCT02287922|588706337|FG001|Overall Study|Other|0|||
163001594|NCT02287922|588706338|FG002|Overall Study|Other|2|||
163001595|NCT02287922|588706339|FG003|Overall Study|Other|0|||
163001596|NCT03762239|588706344|FG000|Overall Study|Appointment to the doctor|1|||
163001597|NCT03762239|588706345|FG001|Overall Study|Appointment to the doctor|1|||
163001598|NCT00535405|588706346|FG000|Overall Study|Adverse Event|6|||
163001599|NCT00535405|588706347|FG001|Overall Study|Adverse Event|8|||
163001600|NCT00535405|588706348|FG002|Overall Study|Adverse Event|3|||
163001601|NCT00535405|588706349|FG003|Overall Study|Adverse Event|8|||
163001602|NCT00535405|588706350|FG004|Overall Study|Adverse Event|6|||
163001603|NCT00535405|588706346|FG000|Overall Study|Lost to Follow-up|1|||
163001604|NCT00535405|588706347|FG001|Overall Study|Lost to Follow-up|3|||
163001605|NCT00535405|588706348|FG002|Overall Study|Lost to Follow-up|3|||
163001606|NCT00535405|588706349|FG003|Overall Study|Lost to Follow-up|2|||
163001607|NCT00535405|588706350|FG004|Overall Study|Lost to Follow-up|1|||
163001608|NCT00535405|588706346|FG000|Overall Study|Physician Decision|3|||
163001609|NCT00535405|588706347|FG001|Overall Study|Physician Decision|2|||
163001610|NCT00535405|588706348|FG002|Overall Study|Physician Decision|0|||
163001611|NCT00535405|588706349|FG003|Overall Study|Physician Decision|1|||
163001612|NCT00535405|588706350|FG004|Overall Study|Physician Decision|1|||
163001613|NCT00535405|588706346|FG000|Overall Study|Protocol Violation|2|||
163001614|NCT00535405|588706347|FG001|Overall Study|Protocol Violation|2|||
163001615|NCT00535405|588706348|FG002|Overall Study|Protocol Violation|2|||
163001616|NCT00535405|588706349|FG003|Overall Study|Protocol Violation|1|||
163001617|NCT00535405|588706350|FG004|Overall Study|Protocol Violation|0|||
163001618|NCT00535405|588706346|FG000|Overall Study|Withdrawal by Subject|5|||
163001619|NCT00535405|588706347|FG001|Overall Study|Withdrawal by Subject|11|||
163001620|NCT00535405|588706348|FG002|Overall Study|Withdrawal by Subject|10|||
163001621|NCT00535405|588706349|FG003|Overall Study|Withdrawal by Subject|10|||
163001622|NCT00535405|588706350|FG004|Overall Study|Withdrawal by Subject|8|||
163001623|NCT03910673|588706354|FG000|Overall Study|Adverse Event|0|||
163001624|NCT03910673|588706355|FG001|Overall Study|Adverse Event|0|||
163001625|NCT03910673|588706356|FG002|Overall Study|Adverse Event|0|||
163001626|NCT03910673|588706357|FG003|Overall Study|Adverse Event|2|||
163001627|NCT03910673|588706358|FG004|Overall Study|Adverse Event|0|||
163001628|NCT04650204|588706374|FG000|Overall Study|Study was Terminated|2|||
163001629|NCT04650204|588706375|FG001|Overall Study|Study was Terminated|1|||
163001630|NCT03164616|588706376|FG000|Overall Study|Death|250|||
163001631|NCT03164616|588706377|FG001|Overall Study|Death|264|||
163001632|NCT03164616|588706378|FG002|Overall Study|Death|279|||
163001633|NCT03164616|588706376|FG000|Overall Study|Lost to Follow-up|2|||
163001634|NCT03164616|588706377|FG001|Overall Study|Lost to Follow-up|2|||
163001635|NCT03164616|588706378|FG002|Overall Study|Lost to Follow-up|2|||
163001636|NCT03164616|588706376|FG000|Overall Study|Withdrawal by Subject|6|||
163001637|NCT03164616|588706377|FG001|Overall Study|Withdrawal by Subject|7|||
163001638|NCT03164616|588706378|FG002|Overall Study|Withdrawal by Subject|16|||
163001639|NCT01911273|588706381|FG000|Overall Study|Progression of Disease|1|||
163001640|NCT01911273|588706382|FG001|Overall Study|Progression of Disease|0|||
163001641|NCT01911273|588706381|FG000|Overall Study|Withdrawal by Subject|0|||
163001642|NCT01911273|588706382|FG001|Overall Study|Withdrawal by Subject|2|||
163001643|NCT02503787|588706387|FG000|Enrollment|Withdrawal by Subject|6|||
163001644|NCT02503787|588706387|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
163001645|NCT02503787|588706387|FG000|Enrollment|Physician Decision|2|||
163001646|NCT02503787|588706387|FG000|Enrollment|Insurance issue|2|||
163001647|NCT02503787|588706387|FG000|Enrollment|Lost to Follow-up|1|||
163001648|NCT02503787|588706387|FG000|Enrollment|Study closure|1|||
163001649|NCT02503787|588706387|FG000|Enrollment|Adverse Event|1|||
163001650|NCT02503787|588706387|FG000|Enrollment|Protocol Violation|1|||
163001651|NCT02503787|588706387|FG000|Enrollment|Inability to implant system|1|||
163001652|NCT02503787|588706387|FG000|Enrollment|Unable to be programmed|1|||
163001653|NCT02503787|588706387|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
163001654|NCT02503787|588706387|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
163001655|NCT02503787|588706387|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
163001656|NCT02503787|588706387|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
163001657|NCT02503787|588706387|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
163001658|NCT02503787|588706387|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
163001659|NCT04787627|588706388|FG000|Overall Study|Withdrawal by Subject|3|||
163001660|NCT04787627|588706389|FG001|Overall Study|Withdrawal by Subject|0|||
163001661|NCT04787627|588706388|FG000|Overall Study|Physician Decision|2|||
163001662|NCT04787627|588706389|FG001|Overall Study|Physician Decision|0|||
163001663|NCT04787627|588706388|FG000|Overall Study|Excluded|0|||
163001664|NCT04787627|588706389|FG001|Overall Study|Excluded|1|||
163001665|NCT00548093|588706390|FG000|Overall Study|Death|33|||
163001666|NCT00548093|588706391|FG001|Overall Study|Death|13|||
163001667|NCT00548093|588706390|FG000|Overall Study|Lost to Follow-up|3|||
163001668|NCT00548093|588706391|FG001|Overall Study|Lost to Follow-up|1|||
163001669|NCT00548093|588706390|FG000|Overall Study|Objective progression or relapse|1|||
163001670|NCT00548093|588706391|FG001|Overall Study|Objective progression or relapse|1|||
163001671|NCT00548093|588706390|FG000|Overall Study|Other|11|||
163001672|NCT00548093|588706391|FG001|Overall Study|Other|1|||
163001673|NCT00548093|588706390|FG000|Overall Study|Withdrawal by Subject|1|||
163001674|NCT00548093|588706391|FG001|Overall Study|Withdrawal by Subject|0|||
163001675|NCT00548093|588706390|FG000|Overall Study|Completed post-treatment follow-up|1|||
163001676|NCT00548093|588706391|FG001|Overall Study|Completed post-treatment follow-up|0|||
163001677|NCT00919854|588706394|FG000|Overall Study|Adverse Event|1|||
163001678|NCT00143247|588706402|FG000|Overall Study|Death|8|||
163001679|NCT00143247|588706402|FG000|Overall Study|Adverse Event|19|||
163001680|NCT00143247|588706402|FG000|Overall Study|Lack of Efficacy|3|||
163001681|NCT00143247|588706402|FG000|Overall Study|Withdrawal by Subject|55|||
163001682|NCT00143247|588706402|FG000|Overall Study|Study terminated by sponsor|31|||
163001683|NCT00143247|588706402|FG000|Overall Study|Protocol Violation|15|||
163001684|NCT00143247|588706402|FG000|Overall Study|Lost to Follow-up|12|||
163001685|NCT00143247|588706402|FG000|Overall Study|following inaccurate lab adverse event|1|||
163001686|NCT00143247|588706402|FG000|Overall Study|Other|12|||
163001687|NCT02933255|588706403|FG000|Overall Study|Discontinued due to study closure.|1|||
163001688|NCT02933255|588706404|FG001|Overall Study|Discontinued due to study closure.|0|||
163001689|NCT02215967|588706409|FG000|Overall Study|Patient became ineligible for treatment|0|||
163001690|NCT02215967|588706410|FG001|Overall Study|Patient became ineligible for treatment|0|||
163001691|NCT02215967|588706411|FG002|Overall Study|Patient became ineligible for treatment|0|||
163001692|NCT02215967|588706412|FG003|Overall Study|Patient became ineligible for treatment|3|||
163001693|NCT02215967|588706409|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
163001694|NCT02215967|588706410|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
163001695|NCT02215967|588706411|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
163001696|NCT02215967|588706412|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
163001697|NCT03207867|588706413|FG000|Overall Study|Adverse Event|1|||
163001698|NCT03207867|588706414|FG001|Overall Study|Adverse Event|0|||
163001699|NCT03207867|588706415|FG002|Overall Study|Adverse Event|1|||
163001700|NCT03207867|588706416|FG003|Overall Study|Adverse Event|0|||
163001701|NCT03207867|588706417|FG004|Overall Study|Adverse Event|0|||
163001702|NCT03207867|588706418|FG005|Overall Study|Adverse Event|2|||
163001703|NCT03207867|588706419|FG006|Overall Study|Adverse Event|1|||
163001704|NCT03207867|588706420|FG007|Overall Study|Adverse Event|1|||
163001705|NCT03207867|588706421|FG008|Overall Study|Adverse Event|2|||
163001706|NCT03207867|588706422|FG009|Overall Study|Adverse Event|2|||
162637335|NCT01988103|587388488|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
162637336|NCT01988103|587388489|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
163001707|NCT03207867|588706423|FG010|Overall Study|Adverse Event|0|||
163001708|NCT03207867|588706424|FG011|Overall Study|Adverse Event|0|||
163001709|NCT03207867|588706425|FG012|Overall Study|Adverse Event|0|||
163001710|NCT03207867|588706426|FG013|Overall Study|Adverse Event|0|||
163001711|NCT03207867|588706427|FG014|Overall Study|Adverse Event|0|||
163001712|NCT03207867|588706428|FG015|Overall Study|Adverse Event|0|||
163001713|NCT03207867|588706429|FG016|Overall Study|Adverse Event|3|||
163001714|NCT03207867|588706430|FG017|Overall Study|Adverse Event|1|||
163001715|NCT03207867|588706431|FG018|Overall Study|Adverse Event|2|||
163001716|NCT03207867|588706432|FG019|Overall Study|Adverse Event|1|||
163001717|NCT03207867|588706433|FG020|Overall Study|Adverse Event|0|||
163001718|NCT03207867|588706434|FG021|Overall Study|Adverse Event|0|||
163001719|NCT03207867|588706435|FG022|Overall Study|Adverse Event|0|||
163001720|NCT03207867|588706436|FG023|Overall Study|Adverse Event|0|||
163001721|NCT03207867|588706413|FG000|Overall Study|Death|0|||
163001722|NCT03207867|588706414|FG001|Overall Study|Death|0|||
163001723|NCT03207867|588706415|FG002|Overall Study|Death|0|||
163001724|NCT03207867|588706416|FG003|Overall Study|Death|0|||
163001725|NCT03207867|588706417|FG004|Overall Study|Death|0|||
163001726|NCT03207867|588706418|FG005|Overall Study|Death|1|||
163001727|NCT03207867|588706419|FG006|Overall Study|Death|0|||
163001728|NCT03207867|588706420|FG007|Overall Study|Death|3|||
163001729|NCT03207867|588706421|FG008|Overall Study|Death|1|||
163001730|NCT03207867|588706422|FG009|Overall Study|Death|2|||
163001731|NCT03207867|588706423|FG010|Overall Study|Death|0|||
163001732|NCT03207867|588706424|FG011|Overall Study|Death|1|||
163001733|NCT03207867|588706425|FG012|Overall Study|Death|0|||
163001734|NCT03207867|588706426|FG013|Overall Study|Death|1|||
163001735|NCT03207867|588706427|FG014|Overall Study|Death|0|||
163001736|NCT03207867|588706428|FG015|Overall Study|Death|0|||
163001737|NCT03207867|588706429|FG016|Overall Study|Death|0|||
163001738|NCT03207867|588706430|FG017|Overall Study|Death|2|||
163001739|NCT03207867|588706431|FG018|Overall Study|Death|0|||
163001740|NCT03207867|588706432|FG019|Overall Study|Death|1|||
163001741|NCT03207867|588706433|FG020|Overall Study|Death|0|||
163001742|NCT03207867|588706434|FG021|Overall Study|Death|0|||
163001743|NCT03207867|588706435|FG022|Overall Study|Death|0|||
163001744|NCT03207867|588706436|FG023|Overall Study|Death|0|||
163001745|NCT03207867|588706413|FG000|Overall Study|Physician Decision|3|||
163001746|NCT03207867|588706414|FG001|Overall Study|Physician Decision|5|||
163001747|NCT03207867|588706415|FG002|Overall Study|Physician Decision|0|||
163001748|NCT03207867|588706416|FG003|Overall Study|Physician Decision|3|||
163001749|NCT03207867|588706417|FG004|Overall Study|Physician Decision|2|||
163001750|NCT03207867|588706418|FG005|Overall Study|Physician Decision|0|||
163001751|NCT03207867|588706419|FG006|Overall Study|Physician Decision|0|||
163001752|NCT03207867|588706420|FG007|Overall Study|Physician Decision|0|||
163001753|NCT03207867|588706421|FG008|Overall Study|Physician Decision|4|||
163001754|NCT03207867|588706422|FG009|Overall Study|Physician Decision|2|||
163001755|NCT03207867|588706423|FG010|Overall Study|Physician Decision|0|||
163001756|NCT03207867|588706424|FG011|Overall Study|Physician Decision|4|||
163001757|NCT03207867|588706425|FG012|Overall Study|Physician Decision|0|||
163001758|NCT03207867|588706426|FG013|Overall Study|Physician Decision|0|||
163001759|NCT03207867|588706427|FG014|Overall Study|Physician Decision|2|||
163001760|NCT03207867|588706428|FG015|Overall Study|Physician Decision|1|||
163001761|NCT03207867|588706429|FG016|Overall Study|Physician Decision|1|||
163001762|NCT03207867|588706430|FG017|Overall Study|Physician Decision|2|||
163001763|NCT03207867|588706431|FG018|Overall Study|Physician Decision|1|||
163001764|NCT03207867|588706432|FG019|Overall Study|Physician Decision|3|||
163001765|NCT03207867|588706433|FG020|Overall Study|Physician Decision|0|||
163001766|NCT03207867|588706434|FG021|Overall Study|Physician Decision|0|||
163001767|NCT03207867|588706435|FG022|Overall Study|Physician Decision|0|||
163001768|NCT03207867|588706436|FG023|Overall Study|Physician Decision|0|||
163001769|NCT03207867|588706413|FG000|Overall Study|Progressive Disease|7|||
163001770|NCT03207867|588706414|FG001|Overall Study|Progressive Disease|7|||
163001771|NCT03207867|588706415|FG002|Overall Study|Progressive Disease|9|||
163001772|NCT03207867|588706416|FG003|Overall Study|Progressive Disease|10|||
163001773|NCT03207867|588706417|FG004|Overall Study|Progressive Disease|11|||
163001774|NCT03207867|588706418|FG005|Overall Study|Progressive Disease|10|||
163001775|NCT03207867|588706419|FG006|Overall Study|Progressive Disease|9|||
163001776|NCT03207867|588706420|FG007|Overall Study|Progressive Disease|8|||
163001777|NCT03207867|588706421|FG008|Overall Study|Progressive Disease|19|||
163001778|NCT03207867|588706422|FG009|Overall Study|Progressive Disease|23|||
163001779|NCT03207867|588706423|FG010|Overall Study|Progressive Disease|2|||
163001780|NCT03207867|588706424|FG011|Overall Study|Progressive Disease|24|||
163001781|NCT03207867|588706425|FG012|Overall Study|Progressive Disease|3|||
163001782|NCT03207867|588706426|FG013|Overall Study|Progressive Disease|11|||
163001783|NCT03207867|588706427|FG014|Overall Study|Progressive Disease|9|||
163001784|NCT03207867|588706428|FG015|Overall Study|Progressive Disease|5|||
163001785|NCT03207867|588706429|FG016|Overall Study|Progressive Disease|10|||
163001786|NCT03207867|588706430|FG017|Overall Study|Progressive Disease|14|||
163001787|NCT03207867|588706431|FG018|Overall Study|Progressive Disease|13|||
163001788|NCT03207867|588706432|FG019|Overall Study|Progressive Disease|14|||
163001789|NCT03207867|588706433|FG020|Overall Study|Progressive Disease|6|||
163001790|NCT03207867|588706434|FG021|Overall Study|Progressive Disease|3|||
163001791|NCT03207867|588706435|FG022|Overall Study|Progressive Disease|3|||
163001792|NCT03207867|588706436|FG023|Overall Study|Progressive Disease|3|||
163001793|NCT03207867|588706413|FG000|Overall Study|Patient/guardian Decision|0|||
163001794|NCT03207867|588706414|FG001|Overall Study|Patient/guardian Decision|0|||
163001795|NCT03207867|588706415|FG002|Overall Study|Patient/guardian Decision|1|||
163001796|NCT03207867|588706416|FG003|Overall Study|Patient/guardian Decision|1|||
162637337|NCT01988103|587388490|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
163001797|NCT03207867|588706417|FG004|Overall Study|Patient/guardian Decision|1|||
163001798|NCT03207867|588706418|FG005|Overall Study|Patient/guardian Decision|2|||
163001799|NCT03207867|588706419|FG006|Overall Study|Patient/guardian Decision|1|||
163001800|NCT03207867|588706420|FG007|Overall Study|Patient/guardian Decision|0|||
163001801|NCT03207867|588706421|FG008|Overall Study|Patient/guardian Decision|1|||
163001802|NCT03207867|588706422|FG009|Overall Study|Patient/guardian Decision|0|||
163001803|NCT03207867|588706423|FG010|Overall Study|Patient/guardian Decision|0|||
163001804|NCT03207867|588706424|FG011|Overall Study|Patient/guardian Decision|1|||
163001805|NCT03207867|588706425|FG012|Overall Study|Patient/guardian Decision|0|||
163001806|NCT03207867|588706426|FG013|Overall Study|Patient/guardian Decision|1|||
162637338|NCT01988103|587388491|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
162637339|NCT01988103|587388492|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
162637340|NCT01988103|587388488|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
162637341|NCT01988103|587388489|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
163001807|NCT03207867|588706427|FG014|Overall Study|Patient/guardian Decision|2|||
162637342|NCT01988103|587388490|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
162637343|NCT01988103|587388491|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162637344|NCT01988103|587388492|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162637345|NCT01988103|587388488|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
162637346|NCT01988103|587388489|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
162637347|NCT01988103|587388490|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
162637348|NCT01988103|587388491|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
162637349|NCT01988103|587388492|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
162637350|NCT01988103|587388488|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162637351|NCT01988103|587388489|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
162637352|NCT01988103|587388490|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
162637353|NCT01988103|587388491|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162637354|NCT01988103|587388492|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162637355|NCT01988103|587388488|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
162637356|NCT01988103|587388489|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
162637357|NCT01988103|587388490|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
162637358|NCT01988103|587388491|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
162637359|NCT01988103|587388492|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
162637360|NCT01988103|587388488|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
162637361|NCT01988103|587388489|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
162637362|NCT01988103|587388490|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
162637363|NCT01988103|587388491|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
162637364|NCT01988103|587388492|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
162637365|NCT05682326|587388497|FG000|Overall Study|Withdrawal by Subject|1|||
162637366|NCT05682326|587388498|FG001|Overall Study|Withdrawal by Subject|0|||
162637367|NCT01402544|587388499|FG000|Overall Study|Withdrawal by Subject|6|||
162637368|NCT01113801|587388500|FG000|Overall Study|Adverse Event|4|||
162637369|NCT01113801|587388501|FG001|Overall Study|Adverse Event|0|||
162637370|NCT01113801|587388502|FG002|Overall Study|Adverse Event|2|||
162637371|NCT01113801|587388503|FG003|Overall Study|Adverse Event|6|||
162637372|NCT01113801|587388500|FG000|Overall Study|Death|4|||
162637373|NCT01113801|587388501|FG001|Overall Study|Death|5|||
162637374|NCT01113801|587388502|FG002|Overall Study|Death|3|||
163001808|NCT03207867|588706428|FG015|Overall Study|Patient/guardian Decision|0|||
163001809|NCT03207867|588706429|FG016|Overall Study|Patient/guardian Decision|1|||
163001810|NCT03207867|588706430|FG017|Overall Study|Patient/guardian Decision|3|||
163001811|NCT03207867|588706431|FG018|Overall Study|Patient/guardian Decision|4|||
163001812|NCT03207867|588706432|FG019|Overall Study|Patient/guardian Decision|1|||
163001813|NCT03207867|588706433|FG020|Overall Study|Patient/guardian Decision|0|||
163001814|NCT03207867|588706434|FG021|Overall Study|Patient/guardian Decision|0|||
163001815|NCT03207867|588706435|FG022|Overall Study|Patient/guardian Decision|0|||
163001816|NCT03207867|588706436|FG023|Overall Study|Patient/guardian Decision|0|||
163001817|NCT02603146|588708875|FG000|Overall Study|Lost to Follow-up|5|||
163001818|NCT02603146|588708876|FG001|Overall Study|Lost to Follow-up|6|||
163001819|NCT02603146|588708875|FG000|Overall Study|Withdrawal by Subject|8|||
163001820|NCT02603146|588708876|FG001|Overall Study|Withdrawal by Subject|10|||
163001821|NCT02603146|588708875|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
162637375|NCT01113801|587388503|FG003|Overall Study|Death|4|||
162637376|NCT01113801|587388500|FG000|Overall Study|Protocol Violation|0|||
162637377|NCT01113801|587388501|FG001|Overall Study|Protocol Violation|1|||
163001822|NCT02603146|588708876|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
163001823|NCT02603146|588708875|FG000|Overall Study|Participant moved|2|||
163001824|NCT02603146|588708876|FG001|Overall Study|Participant moved|0|||
163001825|NCT02603146|588708875|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
163001826|NCT02603146|588708876|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
163001827|NCT05221320|588708877|FG000|Overall Study|Lack of Efficacy|3|||
163001828|NCT05221320|588708878|FG001|Overall Study|Lack of Efficacy|7|||
163001829|NCT05221320|588708879|FG002|Overall Study|Lack of Efficacy|10|||
163001830|NCT05221320|588708880|FG003|Overall Study|Lack of Efficacy|1|||
163001831|NCT05221320|588708881|FG004|Overall Study|Lack of Efficacy|0|||
163001832|NCT05221320|588708882|FG005|Overall Study|Lack of Efficacy|0|||
163001833|NCT05221320|588708877|FG000|Overall Study|Physician Decision|1|||
163001834|NCT05221320|588708878|FG001|Overall Study|Physician Decision|0|||
163001835|NCT05221320|588708879|FG002|Overall Study|Physician Decision|3|||
163001836|NCT05221320|588708880|FG003|Overall Study|Physician Decision|1|||
163001837|NCT05221320|588708881|FG004|Overall Study|Physician Decision|0|||
163001838|NCT05221320|588708882|FG005|Overall Study|Physician Decision|0|||
163001839|NCT05221320|588708877|FG000|Overall Study|Withdrawal by Subject|0|||
163001840|NCT05221320|588708878|FG001|Overall Study|Withdrawal by Subject|3|||
163001841|NCT05221320|588708879|FG002|Overall Study|Withdrawal by Subject|1|||
163001842|NCT05221320|588708880|FG003|Overall Study|Withdrawal by Subject|0|||
163001843|NCT05221320|588708881|FG004|Overall Study|Withdrawal by Subject|0|||
163001844|NCT05221320|588708882|FG005|Overall Study|Withdrawal by Subject|0|||
163001845|NCT05221320|588708877|FG000|Overall Study|Death|0|||
163001846|NCT05221320|588708878|FG001|Overall Study|Death|5|||
163001847|NCT05221320|588708879|FG002|Overall Study|Death|6|||
163001848|NCT05221320|588708880|FG003|Overall Study|Death|0|||
163001849|NCT05221320|588708881|FG004|Overall Study|Death|1|||
163001850|NCT05221320|588708882|FG005|Overall Study|Death|0|||
163001851|NCT06473519|588708883|FG000|Overall Study|Lost to Follow-up|2|||
163001852|NCT06473519|588708884|FG001|Overall Study|Lost to Follow-up|5|||
163001853|NCT06473519|588708883|FG000|Overall Study|Withdrawal by Subject|1|||
163001854|NCT06473519|588708884|FG001|Overall Study|Withdrawal by Subject|4|||
163001855|NCT06473519|588708883|FG000|Overall Study|Randomized but not vaccinated|1|||
163001856|NCT06473519|588708884|FG001|Overall Study|Randomized but not vaccinated|2|||
163001857|NCT05016960|588708885|FG000|Overall Study|Withdrawal by Subject|1|||
163001858|NCT05016960|588708886|FG001|Overall Study|Withdrawal by Subject|9|||
163001859|NCT03729596|588708888|FG000|Overall Study|Death|3|||
163001860|NCT03729596|588708889|FG001|Overall Study|Death|5|||
163001861|NCT03729596|588708890|FG002|Overall Study|Death|4|||
163001862|NCT03729596|588708891|FG003|Overall Study|Death|1|||
163001863|NCT03729596|588708892|FG004|Overall Study|Death|0|||
163001864|NCT03729596|588708893|FG005|Overall Study|Death|34|||
163001865|NCT03729596|588708894|FG006|Overall Study|Death|18|||
163001866|NCT03729596|588708895|FG007|Overall Study|Death|14|||
163001867|NCT03729596|588708896|FG008|Overall Study|Death|19|||
163001868|NCT03729596|588708897|FG009|Overall Study|Death|9|||
163001869|NCT03729596|588708888|FG000|Overall Study|Lost to Follow-up|0|||
163001870|NCT03729596|588708889|FG001|Overall Study|Lost to Follow-up|0|||
163001871|NCT03729596|588708890|FG002|Overall Study|Lost to Follow-up|0|||
163001872|NCT03729596|588708891|FG003|Overall Study|Lost to Follow-up|0|||
163001873|NCT03729596|588708892|FG004|Overall Study|Lost to Follow-up|0|||
163001874|NCT03729596|588708893|FG005|Overall Study|Lost to Follow-up|0|||
163001875|NCT03729596|588708894|FG006|Overall Study|Lost to Follow-up|1|||
163001876|NCT03729596|588708895|FG007|Overall Study|Lost to Follow-up|0|||
163001877|NCT03729596|588708896|FG008|Overall Study|Lost to Follow-up|0|||
163001878|NCT03729596|588708897|FG009|Overall Study|Lost to Follow-up|1|||
163001879|NCT03729596|588708888|FG000|Overall Study|protocol amendment|0|||
163001880|NCT03729596|588708889|FG001|Overall Study|protocol amendment|1|||
163001881|NCT03729596|588708890|FG002|Overall Study|protocol amendment|3|||
163001882|NCT03729596|588708891|FG003|Overall Study|protocol amendment|6|||
163001883|NCT03729596|588708892|FG004|Overall Study|protocol amendment|5|||
163001884|NCT03729596|588708893|FG005|Overall Study|protocol amendment|0|||
163001885|NCT03729596|588708894|FG006|Overall Study|protocol amendment|0|||
163001886|NCT03729596|588708895|FG007|Overall Study|protocol amendment|0|||
163001887|NCT03729596|588708896|FG008|Overall Study|protocol amendment|0|||
163001888|NCT03729596|588708897|FG009|Overall Study|protocol amendment|0|||
163001889|NCT03729596|588708888|FG000|Overall Study|Withdrawal by Subject|0|||
163001890|NCT03729596|588708889|FG001|Overall Study|Withdrawal by Subject|0|||
163001891|NCT03729596|588708890|FG002|Overall Study|Withdrawal by Subject|0|||
163001892|NCT03729596|588708891|FG003|Overall Study|Withdrawal by Subject|0|||
163001893|NCT03729596|588708892|FG004|Overall Study|Withdrawal by Subject|0|||
163001894|NCT03729596|588708893|FG005|Overall Study|Withdrawal by Subject|4|||
163001895|NCT03729596|588708894|FG006|Overall Study|Withdrawal by Subject|2|||
163001896|NCT03729596|588708895|FG007|Overall Study|Withdrawal by Subject|3|||
163001897|NCT03729596|588708896|FG008|Overall Study|Withdrawal by Subject|2|||
163001898|NCT03729596|588708897|FG009|Overall Study|Withdrawal by Subject|3|||
163001899|NCT03729596|588708888|FG000|Overall Study|study terminated by sponsor|0|||
163001900|NCT03729596|588708889|FG001|Overall Study|study terminated by sponsor|0|||
163001901|NCT03729596|588708890|FG002|Overall Study|study terminated by sponsor|0|||
163001902|NCT03729596|588708891|FG003|Overall Study|study terminated by sponsor|0|||
163001903|NCT03729596|588708892|FG004|Overall Study|study terminated by sponsor|1|||
163001904|NCT03729596|588708893|FG005|Overall Study|study terminated by sponsor|3|||
163001905|NCT03729596|588708894|FG006|Overall Study|study terminated by sponsor|0|||
163001906|NCT03729596|588708895|FG007|Overall Study|study terminated by sponsor|1|||
163001907|NCT03729596|588708896|FG008|Overall Study|study terminated by sponsor|0|||
163001908|NCT03729596|588708897|FG009|Overall Study|study terminated by sponsor|0|||
163001909|NCT03713593|588708898|FG000|Overall Study|Sponsor Decision|73|||
163001910|NCT03713593|588708899|FG001|Overall Study|Sponsor Decision|41|||
163001911|NCT03713593|588708898|FG000|Overall Study|Lost to Follow-up|2|||
163001912|NCT03713593|588708899|FG001|Overall Study|Lost to Follow-up|1|||
163001913|NCT03713593|588708898|FG000|Overall Study|Death|314|||
163001914|NCT03713593|588708899|FG001|Overall Study|Death|349|||
163001915|NCT03713593|588708898|FG000|Overall Study|Withdrawal by Subject|6|||
163001916|NCT03713593|588708899|FG001|Overall Study|Withdrawal by Subject|8|||
163001917|NCT03560037|588708901|FG000|Overall Study|Protocol Violation|1|||
163001918|NCT03560037|588708902|FG001|Overall Study|Protocol Violation|0|||
163001919|NCT03560037|588708901|FG000|Overall Study|Physician Decision|0|||
163001920|NCT03560037|588708902|FG001|Overall Study|Physician Decision|1|||
163001921|NCT03620708|588708903|FG000|Overall Study|Lost to Follow-up|1|||
163001922|NCT03620708|588708904|FG001|Overall Study|Lost to Follow-up|1|||
163001923|NCT03620708|588708905|FG002|Overall Study|Lost to Follow-up|2|||
163001924|NCT03620708|588708903|FG000|Overall Study|Withdrawal by Subject|0|||
163001925|NCT03620708|588708904|FG001|Overall Study|Withdrawal by Subject|0|||
163001926|NCT03620708|588708905|FG002|Overall Study|Withdrawal by Subject|1|||
163001927|NCT02498613|588708906|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
163001928|NCT02498613|588708907|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
163001929|NCT02498613|588708908|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
163001930|NCT02498613|588708909|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
163001931|NCT02498613|588708906|FG000|Overall Study|Withdrawal by Subject|3|||
163001932|NCT02498613|588708907|FG001|Overall Study|Withdrawal by Subject|1|||
163001933|NCT02498613|588708908|FG002|Overall Study|Withdrawal by Subject|0|||
163001934|NCT02498613|588708909|FG003|Overall Study|Withdrawal by Subject|0|||
163001935|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
163001936|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
163001937|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
163001938|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
163001939|NCT05126693|588708910|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
163001940|NCT05126693|588708911|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
163001941|NCT03631199|588708916|FG000|Overall Study|Progressive disease|9|||
163001942|NCT03631199|588708917|FG001|Overall Study|Progressive disease|5|||
163001943|NCT03631199|588708918|FG002|Overall Study|Progressive disease|5|||
163001944|NCT03631199|588708919|FG003|Overall Study|Progressive disease|149|||
163001945|NCT03631199|588708920|FG004|Overall Study|Progressive disease|148|||
163001946|NCT03631199|588708916|FG000|Overall Study|Physician Decision|0|||
163001947|NCT03631199|588708917|FG001|Overall Study|Physician Decision|2|||
163001948|NCT03631199|588708918|FG002|Overall Study|Physician Decision|3|||
163001949|NCT03631199|588708919|FG003|Overall Study|Physician Decision|19|||
163001950|NCT03631199|588708920|FG004|Overall Study|Physician Decision|13|||
163001951|NCT03631199|588708916|FG000|Overall Study|Adverse Event|1|||
163001952|NCT03631199|588708917|FG001|Overall Study|Adverse Event|1|||
163001953|NCT03631199|588708918|FG002|Overall Study|Adverse Event|0|||
163001954|NCT03631199|588708919|FG003|Overall Study|Adverse Event|28|||
163001955|NCT03631199|588708920|FG004|Overall Study|Adverse Event|29|||
163001956|NCT03631199|588708916|FG000|Overall Study|Death|0|||
163001957|NCT03631199|588708917|FG001|Overall Study|Death|1|||
163001958|NCT03631199|588708918|FG002|Overall Study|Death|0|||
163001959|NCT03631199|588708919|FG003|Overall Study|Death|35|||
163001960|NCT03631199|588708920|FG004|Overall Study|Death|48|||
163001961|NCT03631199|588708916|FG000|Overall Study|Subject decision|0|||
163001962|NCT03631199|588708917|FG001|Overall Study|Subject decision|1|||
163001963|NCT03631199|588708918|FG002|Overall Study|Subject decision|0|||
163001964|NCT03631199|588708919|FG003|Overall Study|Subject decision|12|||
163001965|NCT03631199|588708920|FG004|Overall Study|Subject decision|12|||
163001966|NCT03631199|588708916|FG000|Overall Study|No treated|0|||
163001967|NCT03631199|588708917|FG001|Overall Study|No treated|0|||
163001968|NCT03631199|588708918|FG002|Overall Study|No treated|0|||
163001969|NCT03631199|588708919|FG003|Overall Study|No treated|0|||
163001970|NCT03631199|588708920|FG004|Overall Study|No treated|1|||
163001971|NCT03631199|588708916|FG000|Overall Study|Treatment ongoing|0|||
163001972|NCT03631199|588708917|FG001|Overall Study|Treatment ongoing|1|||
163001973|NCT03631199|588708918|FG002|Overall Study|Treatment ongoing|1|||
163001974|NCT03631199|588708919|FG003|Overall Study|Treatment ongoing|76|||
163001975|NCT03631199|588708920|FG004|Overall Study|Treatment ongoing|71|||
163001976|NCT03631199|588708916|FG000|Overall Study|Guardian decision|0|||
163001977|NCT03631199|588708917|FG001|Overall Study|Guardian decision|0|||
163001978|NCT03631199|588708918|FG002|Overall Study|Guardian decision|0|||
163001979|NCT03631199|588708919|FG003|Overall Study|Guardian decision|1|||
163001980|NCT03631199|588708920|FG004|Overall Study|Guardian decision|1|||
163001981|NCT03690388|588708921|FG000|Overall Study|Adverse Event|8|||
162637378|NCT01113801|587388502|FG002|Overall Study|Protocol Violation|0|||
163001982|NCT03690388|588708922|FG001|Overall Study|Adverse Event|1|||
163001983|NCT03690388|588708921|FG000|Overall Study|Radiographic Progression|14|||
163001984|NCT03690388|588708922|FG001|Overall Study|Radiographic Progression|29|||
163001985|NCT03690388|588708921|FG000|Overall Study|Clinical deterioration|10|||
163001986|NCT03690388|588708922|FG001|Overall Study|Clinical deterioration|6|||
163001987|NCT03690388|588708921|FG000|Overall Study|Withdrawal by Subject|2|||
163001988|NCT03690388|588708922|FG001|Overall Study|Withdrawal by Subject|0|||
163001989|NCT03690388|588708921|FG000|Overall Study|Lack of Efficacy|1|||
163001990|NCT03690388|588708922|FG001|Overall Study|Lack of Efficacy|0|||
163001991|NCT03690388|588708921|FG000|Overall Study|Lost to Follow-up|1|||
163001992|NCT03690388|588708922|FG001|Overall Study|Lost to Follow-up|0|||
163001993|NCT03041311|588708923|FG000|Overall Study|Death|39|||
163001994|NCT03041311|588708924|FG001|Overall Study|Death|42|||
163001995|NCT03041311|588708923|FG000|Overall Study|Lost to Follow-up|0|||
163001996|NCT03041311|588708924|FG001|Overall Study|Lost to Follow-up|1|||
163001997|NCT03041311|588708923|FG000|Overall Study|Withdrawal by Subject|8|||
163001998|NCT03041311|588708924|FG001|Overall Study|Withdrawal by Subject|5|||
163001999|NCT03041311|588708923|FG000|Overall Study|Sponsor Terminated Study|2|||
163002000|NCT03041311|588708924|FG001|Overall Study|Sponsor Terminated Study|4|||
163002001|NCT03041311|588708923|FG000|Overall Study|Disease Progression|3|||
163002002|NCT03041311|588708924|FG001|Overall Study|Disease Progression|1|||
163002003|NCT03041311|588708923|FG000|Overall Study|Randomized in error, did not receive drug|2|||
163002004|NCT03041311|588708924|FG001|Overall Study|Randomized in error, did not receive drug|0|||
163002005|NCT01720225|588708926|FG000|Overall Study|Withdrawal by Subject|0|||
163002006|NCT01720225|588708927|FG001|Overall Study|Withdrawal by Subject|1|||
163002007|NCT01720225|588708926|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
163002008|NCT01720225|588708927|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
163002009|NCT02604407|588708928|FG000|Overall Study|Adverse Event|0|||
163002010|NCT02604407|588708929|FG001|Overall Study|Adverse Event|7|||
163002011|NCT02604407|588708930|FG002|Overall Study|Adverse Event|5|||
163002012|NCT02604407|588708928|FG000|Overall Study|Protocol Violation|2|||
163002013|NCT02604407|588708929|FG001|Overall Study|Protocol Violation|0|||
163002014|NCT02604407|588708930|FG002|Overall Study|Protocol Violation|0|||
163002015|NCT02604407|588708928|FG000|Overall Study|Withdrawal by Subject|3|||
163002016|NCT02604407|588708929|FG001|Overall Study|Withdrawal by Subject|3|||
163002017|NCT02604407|588708930|FG002|Overall Study|Withdrawal by Subject|5|||
163002018|NCT02604407|588708928|FG000|Overall Study|Lost to Follow-up|2|||
163002019|NCT02604407|588708929|FG001|Overall Study|Lost to Follow-up|1|||
163002020|NCT02604407|588708930|FG002|Overall Study|Lost to Follow-up|2|||
163002021|NCT02604407|588708928|FG000|Overall Study|Lack of Efficacy|1|||
163002022|NCT02604407|588708929|FG001|Overall Study|Lack of Efficacy|0|||
163002023|NCT02604407|588708930|FG002|Overall Study|Lack of Efficacy|0|||
163002024|NCT02604407|588708928|FG000|Overall Study|Other|3|||
163002025|NCT02604407|588708929|FG001|Overall Study|Other|1|||
163002026|NCT02604407|588708930|FG002|Overall Study|Other|4|||
163002027|NCT00661193|588708931|FG000|Overall Study|Adverse Event|2|||
163002028|NCT00661193|588708932|FG001|Overall Study|Adverse Event|1|||
163002029|NCT00661193|588708931|FG000|Overall Study|Withdrawal by Subject|3|||
163002030|NCT00661193|588708932|FG001|Overall Study|Withdrawal by Subject|1|||
163002031|NCT00661193|588708931|FG000|Overall Study|Progression|27|||
163002032|NCT00661193|588708932|FG001|Overall Study|Progression|24|||
163002033|NCT00661193|588708931|FG000|Overall Study|Not protocol specified|1|||
163002034|NCT00661193|588708932|FG001|Overall Study|Not protocol specified|0|||
163002035|NCT02964312|588708939|FG000|Overall Study|Lost to Follow-up|28|||
163002036|NCT02964312|588708939|FG000|Overall Study|Withdrawal by Subject|11|||
163002037|NCT02964312|588708939|FG000|Overall Study|Lack of Efficacy|10|||
163002038|NCT02964312|588708939|FG000|Overall Study|Did not consent to long-term FU|14|||
162637379|NCT01113801|587388503|FG003|Overall Study|Protocol Violation|0|||
163002039|NCT02964312|588708939|FG000|Overall Study|Death|1|||
163002040|NCT00191191|588708942|FG000|Overall Study|Entry Criteria Exclusion|2|||
163002041|NCT00191191|588708943|FG001|Overall Study|Entry Criteria Exclusion|0|||
163002042|NCT00191191|588708942|FG000|Overall Study|Treated with Another Systemic Agent|1|||
163002043|NCT00191191|588708943|FG001|Overall Study|Treated with Another Systemic Agent|1|||
163002044|NCT00191191|588708942|FG000|Overall Study|Adverse Event|11|||
163002045|NCT00191191|588708943|FG001|Overall Study|Adverse Event|21|||
163002046|NCT00191191|588708942|FG000|Overall Study|Progressive Disease|84|||
163002047|NCT00191191|588708943|FG001|Overall Study|Progressive Disease|72|||
163002048|NCT00191191|588708942|FG000|Overall Study|Toxicity After Dose Reduction|7|||
163002049|NCT00191191|588708943|FG001|Overall Study|Toxicity After Dose Reduction|8|||
163002050|NCT00191191|588708942|FG000|Overall Study|Family/Caregiver Decision|5|||
163002051|NCT00191191|588708943|FG001|Overall Study|Family/Caregiver Decision|7|||
163002052|NCT00191191|588708942|FG000|Overall Study|Lost to Follow-up|1|||
163002053|NCT00191191|588708943|FG001|Overall Study|Lost to Follow-up|0|||
163002054|NCT00191191|588708942|FG000|Overall Study|Physician Decision|3|||
163002055|NCT00191191|588708943|FG001|Overall Study|Physician Decision|2|||
163002056|NCT00191191|588708942|FG000|Overall Study|Good Clinical Practice Violation|0|||
163002057|NCT00191191|588708943|FG001|Overall Study|Good Clinical Practice Violation|1|||
163002058|NCT03280264|588708949|FG000|Overall Study|Adverse Event|1|||
163002059|NCT03280264|588708949|FG000|Overall Study|Physician Decision|1|||
163002060|NCT03280264|588708949|FG000|Overall Study|Withdrawal by Subject|1|||
163002061|NCT00524420|588708956|FG000|Overall Study|Lack of Efficacy|1|||
163002062|NCT00524420|588708957|FG001|Overall Study|Lack of Efficacy|0|||
163002063|NCT00577863|588708958|FG000|Overall Study|Adverse Event|4|||
163002064|NCT00577863|588708959|FG001|Overall Study|Adverse Event|2|||
163002065|NCT00577863|588708958|FG000|Overall Study|Death|1|||
163002066|NCT00577863|588708959|FG001|Overall Study|Death|0|||
163002067|NCT00577863|588708958|FG000|Overall Study|Lost to Follow-up|2|||
163002068|NCT00577863|588708959|FG001|Overall Study|Lost to Follow-up|2|||
163002069|NCT00577863|588708958|FG000|Overall Study|Entry Criteria Exclusion|1|||
163002070|NCT00577863|588708959|FG001|Overall Study|Entry Criteria Exclusion|0|||
163002071|NCT00577863|588708958|FG000|Overall Study|Withdrawal by Subject|0|||
163002072|NCT00577863|588708959|FG001|Overall Study|Withdrawal by Subject|2|||
163002073|NCT00577863|588708958|FG000|Overall Study|Sponsor Decision|2|||
163002074|NCT00577863|588708959|FG001|Overall Study|Sponsor Decision|7|||
163002075|NCT00577863|588708958|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
163002076|NCT00577863|588708959|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
163002077|NCT02738138|588708961|FG000|Overall Study|Adverse Event|0|||
163002078|NCT02738138|588708962|FG001|Overall Study|Adverse Event|1|||
163002079|NCT02738138|588708961|FG000|Overall Study|Lost to Follow-up|2|||
162637380|NCT01113801|587388500|FG000|Overall Study|Withdrawal by Subject|9|||
162637381|NCT01113801|587388501|FG001|Overall Study|Withdrawal by Subject|7|||
163002080|NCT02738138|588708962|FG001|Overall Study|Lost to Follow-up|0|||
163002081|NCT02738138|588708961|FG000|Overall Study|Other - not further specified|1|||
163002082|NCT02738138|588708962|FG001|Overall Study|Other - not further specified|0|||
163002083|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
163002084|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
163002085|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
163002086|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
162637382|NCT01113801|587388502|FG002|Overall Study|Withdrawal by Subject|7|||
162637383|NCT01113801|587388503|FG003|Overall Study|Withdrawal by Subject|8|||
162637384|NCT01113801|587388500|FG000|Overall Study|Physician Decision|2|||
163002087|NCT05024747|588708973|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
163002088|NCT05024747|588708974|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
162637385|NCT01113801|587388501|FG001|Overall Study|Physician Decision|2|||
163002089|NCT00662649|588708976|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
163002090|NCT00662649|588708977|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
163002091|NCT00662649|588708978|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
162637386|NCT01113801|587388502|FG002|Overall Study|Physician Decision|3|||
162637387|NCT01113801|587388503|FG003|Overall Study|Physician Decision|3|||
162637388|NCT01113801|587388500|FG000|Overall Study|Sponsor Decision|15|||
162637389|NCT01113801|587388501|FG001|Overall Study|Sponsor Decision|21|||
162637390|NCT01113801|587388502|FG002|Overall Study|Sponsor Decision|20|||
162637391|NCT01113801|587388503|FG003|Overall Study|Sponsor Decision|15|||
162637392|NCT01113801|587388500|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
162637393|NCT01113801|587388501|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
162637394|NCT01113801|587388502|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
162637395|NCT01113801|587388503|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
162637396|NCT01949051|587388507|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
162637397|NCT01949051|587388508|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162637398|NCT01949051|587388509|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
163002092|NCT00662649|588708979|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
163002093|NCT00662649|588708980|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
163002094|NCT00662649|588708976|FG000|Core Study (24 Months)|Adverse Event|22|||
163002095|NCT00662649|588708977|FG001|Core Study (24 Months)|Adverse Event|13|||
163002096|NCT00662649|588708978|FG002|Core Study (24 Months)|Adverse Event|18|||
163002097|NCT00662649|588708979|FG003|Core Study (24 Months)|Adverse Event|0|||
163002098|NCT00662649|588708980|FG004|Core Study (24 Months)|Adverse Event|0|||
163002099|NCT00662649|588708976|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
163002100|NCT00662649|588708977|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
163002101|NCT00662649|588708978|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
163002102|NCT00662649|588708979|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
163002103|NCT00662649|588708980|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
163002104|NCT00662649|588708976|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
163002105|NCT00662649|588708977|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
163002106|NCT00662649|588708978|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
163002107|NCT00662649|588708979|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
163002108|NCT00662649|588708980|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
163002109|NCT00662649|588708976|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
163002110|NCT00662649|588708977|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
163002111|NCT00662649|588708978|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
163002112|NCT00662649|588708979|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
163002113|NCT00662649|588708980|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
163002114|NCT00662649|588708976|FG000|Core Study (24 Months)|Protocol Violation|5|||
163002115|NCT00662649|588708977|FG001|Core Study (24 Months)|Protocol Violation|5|||
163002116|NCT00662649|588708978|FG002|Core Study (24 Months)|Protocol Violation|4|||
163002117|NCT00662649|588708979|FG003|Core Study (24 Months)|Protocol Violation|0|||
163002118|NCT00662649|588708980|FG004|Core Study (24 Months)|Protocol Violation|0|||
163002119|NCT00662649|588708976|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
163002120|NCT00662649|588708977|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
163002121|NCT00662649|588708978|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
163002122|NCT00662649|588708979|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
163002123|NCT00662649|588708980|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
163002124|NCT00662649|588708976|FG000|Core Study (24 Months)|Death|1|||
163002125|NCT00662649|588708977|FG001|Core Study (24 Months)|Death|0|||
163002126|NCT00662649|588708978|FG002|Core Study (24 Months)|Death|2|||
162637399|NCT01949051|587388510|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
162637400|NCT01949051|587388511|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162637401|NCT01949051|587388512|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162637402|NCT01949051|587388507|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
162637403|NCT01949051|587388508|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162637404|NCT01949051|587388509|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162637405|NCT01949051|587388510|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162637406|NCT01949051|587388511|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162637407|NCT01949051|587388512|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162637408|NCT01949051|587388507|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163002127|NCT00662649|588708979|FG003|Core Study (24 Months)|Death|0|||
163002128|NCT00662649|588708980|FG004|Core Study (24 Months)|Death|0|||
163002129|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
163002130|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
163002131|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
163002132|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
163002133|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
163002134|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
163002135|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
162637409|NCT01949051|587388508|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162637410|NCT01949051|587388509|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162637411|NCT01949051|587388510|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162637412|NCT01949051|587388511|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
163002136|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
163002137|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
163002138|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
163060650|NCT05516758|588929963|FG005|Overall Study|Physician Decision|1|||
163060651|NCT05516758|588929964|FG006|Overall Study|Physician Decision|2|||
163060652|NCT05516758|588929958|FG000|Overall Study|Protocol Deviation|1|||
163060653|NCT05516758|588929959|FG001|Overall Study|Protocol Deviation|0|||
163060654|NCT05516758|588929960|FG002|Overall Study|Protocol Deviation|0|||
163060655|NCT05516758|588929961|FG003|Overall Study|Protocol Deviation|0|||
163060656|NCT05516758|588929962|FG004|Overall Study|Protocol Deviation|0|||
163060657|NCT05516758|588929963|FG005|Overall Study|Protocol Deviation|1|||
163060658|NCT05516758|588929964|FG006|Overall Study|Protocol Deviation|5|||
163060659|NCT05516758|588929958|FG000|Overall Study|Withdrawal by Subject|11|||
163060660|NCT05516758|588929959|FG001|Overall Study|Withdrawal by Subject|1|||
163060661|NCT05516758|588929960|FG002|Overall Study|Withdrawal by Subject|15|||
163060662|NCT05516758|588929961|FG003|Overall Study|Withdrawal by Subject|2|||
163060663|NCT05516758|588929962|FG004|Overall Study|Withdrawal by Subject|7|||
163060664|NCT05516758|588929963|FG005|Overall Study|Withdrawal by Subject|7|||
163060665|NCT05516758|588929964|FG006|Overall Study|Withdrawal by Subject|6|||
163060666|NCT05516758|588929958|FG000|Overall Study|Death|1|||
163060667|NCT05516758|588929959|FG001|Overall Study|Death|0|||
163060668|NCT05516758|588929960|FG002|Overall Study|Death|0|||
163060669|NCT05516758|588929961|FG003|Overall Study|Death|0|||
163060670|NCT05516758|588929962|FG004|Overall Study|Death|0|||
163060671|NCT05516758|588929963|FG005|Overall Study|Death|0|||
163060672|NCT05516758|588929964|FG006|Overall Study|Death|0|||
163060673|NCT05516758|588929958|FG000|Overall Study|Non-compliance With Study Drug|0|||
163060674|NCT05516758|588929959|FG001|Overall Study|Non-compliance With Study Drug|0|||
163060675|NCT05516758|588929960|FG002|Overall Study|Non-compliance With Study Drug|1|||
163060676|NCT05516758|588929961|FG003|Overall Study|Non-compliance With Study Drug|0|||
163060677|NCT05516758|588929962|FG004|Overall Study|Non-compliance With Study Drug|0|||
163060678|NCT05516758|588929963|FG005|Overall Study|Non-compliance With Study Drug|0|||
163060679|NCT05516758|588929964|FG006|Overall Study|Non-compliance With Study Drug|0|||
163060680|NCT05516758|588929958|FG000|Overall Study|Site Terminated by Sponsor|2|||
163060681|NCT05516758|588929959|FG001|Overall Study|Site Terminated by Sponsor|0|||
163060682|NCT05516758|588929960|FG002|Overall Study|Site Terminated by Sponsor|0|||
163060683|NCT05516758|588929961|FG003|Overall Study|Site Terminated by Sponsor|0|||
163060684|NCT05516758|588929962|FG004|Overall Study|Site Terminated by Sponsor|0|||
163060685|NCT05516758|588929963|FG005|Overall Study|Site Terminated by Sponsor|0|||
163060686|NCT05516758|588929964|FG006|Overall Study|Site Terminated by Sponsor|0|||
163060687|NCT05516758|588929958|FG000|Overall Study|Study Terminated by Sponsor|4|||
163002139|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002140|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002141|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002142|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
163002143|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
163002144|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
163002145|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
163002146|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
163002147|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
163002148|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
163002149|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
163002150|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
163002151|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
163060688|NCT05516758|588929959|FG001|Overall Study|Study Terminated by Sponsor|0|||
163060689|NCT05516758|588929960|FG002|Overall Study|Study Terminated by Sponsor|3|||
163060690|NCT05516758|588929961|FG003|Overall Study|Study Terminated by Sponsor|0|||
163060691|NCT05516758|588929962|FG004|Overall Study|Study Terminated by Sponsor|2|||
163060692|NCT05516758|588929963|FG005|Overall Study|Study Terminated by Sponsor|3|||
163060693|NCT05516758|588929964|FG006|Overall Study|Study Terminated by Sponsor|0|||
163060694|NCT05516758|588929958|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
163002152|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
163002153|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
163002154|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
163002155|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
163002156|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002157|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002158|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
163002159|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
163002160|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
163002161|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
163002162|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
163002163|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
163002164|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002165|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
163002166|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002167|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002168|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
163002169|NCT00662649|588708976|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
163002170|NCT00662649|588708977|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
163002171|NCT00662649|588708978|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
163002172|NCT00662649|588708979|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
163002173|NCT00662649|588708980|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
163002174|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
163002175|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
163002176|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
163002177|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
163002178|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
163002179|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
163002180|NCT01960257|588708981|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
163002181|NCT01960257|588708982|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
163002182|NCT01960257|588708983|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
163002183|NCT01942993|588708984|FG000|Overall Study|Lost to Follow-up|1|||
163002184|NCT01942993|588708984|FG000|Overall Study|Physician Decision|1|||
163002185|NCT02906670|588708988|FG000|Cohort 1, QW|Radiological Progression|1|||
163002186|NCT02906670|588708989|FG001|Cohort 1, QW|Radiological Progression|0|||
163002187|NCT02906670|588708990|FG002|Cohort 1, QW|Radiological Progression|0|||
163002188|NCT02906670|588708991|FG003|Cohort 1, QW|Radiological Progression|0|||
163002189|NCT02906670|588708992|FG004|Cohort 1, QW|Radiological Progression|0|||
163002190|NCT02906670|588708993|FG005|Cohort 1, QW|Radiological Progression|0|||
163002191|NCT02906670|588708994|FG006|Cohort 1, QW|Radiological Progression|0|||
163002192|NCT02906670|588708995|FG007|Cohort 1, QW|Radiological Progression|0|||
163002193|NCT02906670|588708996|FG008|Cohort 1, QW|Radiological Progression|0|||
163002194|NCT02906670|588708997|FG009|Cohort 1, QW|Radiological Progression|0|||
163002195|NCT02906670|588708988|FG000|Cohort 2, QW|Radiological Progression|0|||
162715767|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715768|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715769|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715770|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715771|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715772|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162715773|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715774|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
162715775|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715776|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163060695|NCT05516758|588929959|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
162715777|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715778|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715779|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715780|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715781|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163002196|NCT02906670|588708989|FG001|Cohort 2, QW|Radiological Progression|1|||
163002197|NCT02906670|588708990|FG002|Cohort 2, QW|Radiological Progression|0|||
163002198|NCT02906670|588708991|FG003|Cohort 2, QW|Radiological Progression|0|||
163002199|NCT02906670|588708992|FG004|Cohort 2, QW|Radiological Progression|0|||
163002200|NCT02906670|588708993|FG005|Cohort 2, QW|Radiological Progression|0|||
163002201|NCT02906670|588708994|FG006|Cohort 2, QW|Radiological Progression|0|||
163002202|NCT02906670|588708995|FG007|Cohort 2, QW|Radiological Progression|0|||
163002203|NCT02906670|588708996|FG008|Cohort 2, QW|Radiological Progression|0|||
163002204|NCT02906670|588708997|FG009|Cohort 2, QW|Radiological Progression|0|||
163002205|NCT02906670|588708988|FG000|Cohort 3, QW|Radiological Progression|0|||
163002206|NCT02906670|588708989|FG001|Cohort 3, QW|Radiological Progression|0|||
163002207|NCT02906670|588708990|FG002|Cohort 3, QW|Radiological Progression|2|||
163002208|NCT02906670|588708991|FG003|Cohort 3, QW|Radiological Progression|0|||
163002209|NCT02906670|588708992|FG004|Cohort 3, QW|Radiological Progression|0|||
163002210|NCT02906670|588708993|FG005|Cohort 3, QW|Radiological Progression|0|||
163002211|NCT02906670|588708994|FG006|Cohort 3, QW|Radiological Progression|0|||
163002212|NCT02906670|588708995|FG007|Cohort 3, QW|Radiological Progression|0|||
163002213|NCT02906670|588708996|FG008|Cohort 3, QW|Radiological Progression|0|||
163002214|NCT02906670|588708997|FG009|Cohort 3, QW|Radiological Progression|0|||
163002215|NCT02906670|588708988|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002216|NCT02906670|588708989|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002217|NCT02906670|588708990|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
163002218|NCT02906670|588708991|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002219|NCT02906670|588708992|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002220|NCT02906670|588708993|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002221|NCT02906670|588708994|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002222|NCT02906670|588708995|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002223|NCT02906670|588708996|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002224|NCT02906670|588708997|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
163002225|NCT02906670|588708988|FG000|Cohort 4, Q2W|Radiological Progression|0|||
163002226|NCT02906670|588708989|FG001|Cohort 4, Q2W|Radiological Progression|0|||
163002227|NCT02906670|588708990|FG002|Cohort 4, Q2W|Radiological Progression|0|||
163002228|NCT02906670|588708991|FG003|Cohort 4, Q2W|Radiological Progression|0|||
163002229|NCT02906670|588708992|FG004|Cohort 4, Q2W|Radiological Progression|0|||
163002230|NCT02906670|588708993|FG005|Cohort 4, Q2W|Radiological Progression|1|||
163002231|NCT02906670|588708994|FG006|Cohort 4, Q2W|Radiological Progression|0|||
163002232|NCT02906670|588708995|FG007|Cohort 4, Q2W|Radiological Progression|0|||
163002233|NCT02906670|588708996|FG008|Cohort 4, Q2W|Radiological Progression|0|||
163002234|NCT02906670|588708997|FG009|Cohort 4, Q2W|Radiological Progression|0|||
163002235|NCT02906670|588708988|FG000|Cohort 4, Q2W|Clinical Progression|0|||
163002236|NCT02906670|588708989|FG001|Cohort 4, Q2W|Clinical Progression|0|||
163002237|NCT02906670|588708990|FG002|Cohort 4, Q2W|Clinical Progression|0|||
163002238|NCT02906670|588708991|FG003|Cohort 4, Q2W|Clinical Progression|0|||
163002239|NCT02906670|588708992|FG004|Cohort 4, Q2W|Clinical Progression|0|||
163002240|NCT02906670|588708993|FG005|Cohort 4, Q2W|Clinical Progression|2|||
163002241|NCT02906670|588708994|FG006|Cohort 4, Q2W|Clinical Progression|0|||
163002242|NCT02906670|588708995|FG007|Cohort 4, Q2W|Clinical Progression|0|||
163002243|NCT02906670|588708996|FG008|Cohort 4, Q2W|Clinical Progression|0|||
163002244|NCT02906670|588708997|FG009|Cohort 4, Q2W|Clinical Progression|0|||
163002245|NCT02906670|588708988|FG000|Cohort 5, Q2W|Radiological Progression|0|||
163002246|NCT02906670|588708989|FG001|Cohort 5, Q2W|Radiological Progression|0|||
163002247|NCT02906670|588708990|FG002|Cohort 5, Q2W|Radiological Progression|0|||
163002248|NCT02906670|588708991|FG003|Cohort 5, Q2W|Radiological Progression|0|||
163002249|NCT02906670|588708992|FG004|Cohort 5, Q2W|Radiological Progression|0|||
163002250|NCT02906670|588708993|FG005|Cohort 5, Q2W|Radiological Progression|0|||
163002251|NCT02906670|588708994|FG006|Cohort 5, Q2W|Radiological Progression|4|||
163002252|NCT02906670|588708995|FG007|Cohort 5, Q2W|Radiological Progression|0|||
163002253|NCT02906670|588708996|FG008|Cohort 5, Q2W|Radiological Progression|0|||
163002254|NCT02906670|588708997|FG009|Cohort 5, Q2W|Radiological Progression|0|||
163002255|NCT02906670|588708988|FG000|Cohort 5, Q2W|Clinical Progression|0|||
163002256|NCT02906670|588708989|FG001|Cohort 5, Q2W|Clinical Progression|0|||
163002257|NCT02906670|588708990|FG002|Cohort 5, Q2W|Clinical Progression|0|||
163002258|NCT02906670|588708991|FG003|Cohort 5, Q2W|Clinical Progression|0|||
163060696|NCT05516758|588929960|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
163060697|NCT05516758|588929961|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
163002259|NCT02906670|588708992|FG004|Cohort 5, Q2W|Clinical Progression|0|||
163002260|NCT02906670|588708993|FG005|Cohort 5, Q2W|Clinical Progression|0|||
163002261|NCT02906670|588708994|FG006|Cohort 5, Q2W|Clinical Progression|1|||
163002262|NCT02906670|588708995|FG007|Cohort 5, Q2W|Clinical Progression|0|||
163002263|NCT02906670|588708996|FG008|Cohort 5, Q2W|Clinical Progression|0|||
163002264|NCT02906670|588708997|FG009|Cohort 5, Q2W|Clinical Progression|0|||
163002265|NCT02906670|588708988|FG000|Cohort 5, Q2W|Adverse Event|0|||
163002266|NCT02906670|588708989|FG001|Cohort 5, Q2W|Adverse Event|0|||
163002267|NCT02906670|588708990|FG002|Cohort 5, Q2W|Adverse Event|0|||
163002268|NCT02906670|588708991|FG003|Cohort 5, Q2W|Adverse Event|0|||
163002269|NCT02906670|588708992|FG004|Cohort 5, Q2W|Adverse Event|0|||
163002270|NCT02906670|588708993|FG005|Cohort 5, Q2W|Adverse Event|0|||
163002271|NCT02906670|588708994|FG006|Cohort 5, Q2W|Adverse Event|1|||
163002272|NCT02906670|588708995|FG007|Cohort 5, Q2W|Adverse Event|0|||
163002273|NCT02906670|588708996|FG008|Cohort 5, Q2W|Adverse Event|0|||
163002274|NCT02906670|588708997|FG009|Cohort 5, Q2W|Adverse Event|0|||
163002275|NCT02906670|588708988|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002276|NCT02906670|588708989|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002277|NCT02906670|588708990|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002278|NCT02906670|588708991|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002279|NCT02906670|588708992|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002280|NCT02906670|588708993|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002281|NCT02906670|588708994|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
163002282|NCT02906670|588708995|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002283|NCT02906670|588708996|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002284|NCT02906670|588708997|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
163002285|NCT02906670|588708988|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
163002286|NCT02906670|588708989|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
163002287|NCT02906670|588708990|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
163002288|NCT02906670|588708991|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
163002289|NCT02906670|588708992|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
163002290|NCT02906670|588708993|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
163002291|NCT02906670|588708994|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
163002292|NCT02906670|588708995|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
163060698|NCT05516758|588929962|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
163060699|NCT05516758|588929963|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
163060700|NCT05516758|588929964|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
163060701|NCT05516758|588929958|FG000|Overall Study|Other|0|||
163060702|NCT05516758|588929959|FG001|Overall Study|Other|0|||
163060703|NCT05516758|588929960|FG002|Overall Study|Other|0|||
163060704|NCT05516758|588929961|FG003|Overall Study|Other|0|||
163060705|NCT05516758|588929962|FG004|Overall Study|Other|0|||
163060706|NCT05516758|588929963|FG005|Overall Study|Other|0|||
163060707|NCT05516758|588929964|FG006|Overall Study|Other|1|||
163060708|NCT01316575|588929965|FG000|Overall Study|Withdrawal by Subject|2|||
163060709|NCT01316575|588929966|FG001|Overall Study|Withdrawal by Subject|0|||
163060710|NCT01316575|588929965|FG000|Overall Study|Required alternate treatment|0|||
163060711|NCT01316575|588929966|FG001|Overall Study|Required alternate treatment|1|||
163060712|NCT00402831|588929967|FG000|Overall Study|Lost to Follow-up|1|||
163060713|NCT00402831|588929968|FG001|Overall Study|Lost to Follow-up|2|||
163060714|NCT00402831|588929967|FG000|Overall Study|Non-compliance with protocol|0|||
163060715|NCT00402831|588929968|FG001|Overall Study|Non-compliance with protocol|1|||
163060716|NCT02792504|588929969|FG000|Overall Study|Lost to Follow-up|24|||
163060717|NCT02792504|588929969|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
163060718|NCT02814526|588929976|FG000|Overall Study|Adverse Event|4|||
163060719|NCT02814526|588929977|FG001|Overall Study|Adverse Event|3|||
163060720|NCT02814526|588929976|FG000|Overall Study|Death|1|||
163060721|NCT02814526|588929977|FG001|Overall Study|Death|1|||
163060722|NCT02814526|588929976|FG000|Overall Study|Lost to Follow-up|3|||
163060723|NCT02814526|588929977|FG001|Overall Study|Lost to Follow-up|4|||
163060724|NCT02814526|588929976|FG000|Overall Study|non site physician decision|1|||
163060725|NCT02814526|588929977|FG001|Overall Study|non site physician decision|0|||
163060726|NCT02814526|588929976|FG000|Overall Study|participant noncompliance|1|||
163060727|NCT02814526|588929977|FG001|Overall Study|participant noncompliance|1|||
163060728|NCT02814526|588929976|FG000|Overall Study|Withdrawal by Subject|20|||
163060729|NCT02814526|588929977|FG001|Overall Study|Withdrawal by Subject|14|||
163060730|NCT02814526|588929976|FG000|Overall Study|safety risk|2|||
163060731|NCT02814526|588929977|FG001|Overall Study|safety risk|1|||
163060732|NCT02814526|588929976|FG000|Overall Study|early termination-study terminated|1|||
163060733|NCT02814526|588929977|FG001|Overall Study|early termination-study terminated|2|||
163060734|NCT02814526|588929976|FG000|Overall Study|Other|0|||
163060735|NCT02814526|588929977|FG001|Overall Study|Other|4|||
163060736|NCT02485860|588929978|FG000|Overall Study|Lost to Follow-up|4|||
162715782|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163002293|NCT02906670|588708996|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
163002294|NCT02906670|588708997|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
163060737|NCT02485860|588929979|FG001|Overall Study|Lost to Follow-up|1|||
163060738|NCT02485860|588929978|FG000|Overall Study|Physician Decision|1|||
163060739|NCT02485860|588929979|FG001|Overall Study|Physician Decision|2|||
163060740|NCT02485860|588929978|FG000|Overall Study|Health context (COVID-19)|1|||
163060741|NCT02485860|588929979|FG001|Overall Study|Health context (COVID-19)|0|||
163060742|NCT03836053|588931281|FG000|Overall Study|Protocol-specified criteria|0|||
163060743|NCT03836053|588931282|FG001|Overall Study|Protocol-specified criteria|2|||
163002295|NCT02906670|588708988|FG000|Cohort 5P, Q2W|Adverse Event|0|||
163002296|NCT02906670|588708989|FG001|Cohort 5P, Q2W|Adverse Event|0|||
163002297|NCT02906670|588708990|FG002|Cohort 5P, Q2W|Adverse Event|0|||
163060744|NCT03836053|588931283|FG002|Overall Study|Protocol-specified criteria|1|||
163060745|NCT03836053|588931281|FG000|Overall Study|Death|1|||
163060746|NCT03836053|588931282|FG001|Overall Study|Death|6|||
163060747|NCT03836053|588931283|FG002|Overall Study|Death|4|||
163060748|NCT03836053|588931281|FG000|Overall Study|Withdrawal of consent from study|0|||
163060749|NCT03836053|588931282|FG001|Overall Study|Withdrawal of consent from study|0|||
163060750|NCT03836053|588931283|FG002|Overall Study|Withdrawal of consent from study|1|||
163002298|NCT02906670|588708991|FG003|Cohort 5P, Q2W|Adverse Event|0|||
163002299|NCT02906670|588708992|FG004|Cohort 5P, Q2W|Adverse Event|0|||
163002300|NCT02906670|588708993|FG005|Cohort 5P, Q2W|Adverse Event|0|||
163002301|NCT02906670|588708994|FG006|Cohort 5P, Q2W|Adverse Event|0|||
163002302|NCT02906670|588708995|FG007|Cohort 5P, Q2W|Adverse Event|1|||
163002303|NCT02906670|588708996|FG008|Cohort 5P, Q2W|Adverse Event|0|||
163002304|NCT02906670|588708997|FG009|Cohort 5P, Q2W|Adverse Event|0|||
163002305|NCT02906670|588708988|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
163002306|NCT02906670|588708989|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
163002307|NCT02906670|588708990|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
163002308|NCT02906670|588708991|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
163002309|NCT02906670|588708992|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
163002310|NCT02906670|588708993|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
163002311|NCT02906670|588708994|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
163002312|NCT02906670|588708995|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
163002313|NCT02906670|588708996|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
163002314|NCT02906670|588708997|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
163002315|NCT02906670|588708988|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
163002316|NCT02906670|588708989|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
163002317|NCT02906670|588708990|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
163002318|NCT02906670|588708991|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
163002319|NCT02906670|588708992|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
163002320|NCT02906670|588708993|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
163002321|NCT02906670|588708994|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
163002322|NCT02906670|588708995|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
163002323|NCT02906670|588708996|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
163002324|NCT02906670|588708997|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
163002325|NCT02906670|588708988|FG000|Cohort 4P, QW|Radiological Progression|0|||
163002326|NCT02906670|588708989|FG001|Cohort 4P, QW|Radiological Progression|0|||
163002327|NCT02906670|588708990|FG002|Cohort 4P, QW|Radiological Progression|0|||
163002328|NCT02906670|588708991|FG003|Cohort 4P, QW|Radiological Progression|3|||
163002329|NCT02906670|588708992|FG004|Cohort 4P, QW|Radiological Progression|0|||
163002330|NCT02906670|588708993|FG005|Cohort 4P, QW|Radiological Progression|0|||
163002331|NCT02906670|588708994|FG006|Cohort 4P, QW|Radiological Progression|0|||
163002332|NCT02906670|588708995|FG007|Cohort 4P, QW|Radiological Progression|0|||
163002333|NCT02906670|588708996|FG008|Cohort 4P, QW|Radiological Progression|0|||
163002334|NCT02906670|588708997|FG009|Cohort 4P, QW|Radiological Progression|0|||
163002335|NCT02906670|588708988|FG000|Cohort 7P, Q2W|Adverse Event|0|||
163002336|NCT02906670|588708989|FG001|Cohort 7P, Q2W|Adverse Event|0|||
163002337|NCT02906670|588708990|FG002|Cohort 7P, Q2W|Adverse Event|0|||
163002338|NCT02906670|588708991|FG003|Cohort 7P, Q2W|Adverse Event|0|||
163002339|NCT02906670|588708992|FG004|Cohort 7P, Q2W|Adverse Event|0|||
163002340|NCT02906670|588708993|FG005|Cohort 7P, Q2W|Adverse Event|0|||
163002341|NCT02906670|588708994|FG006|Cohort 7P, Q2W|Adverse Event|0|||
163002342|NCT02906670|588708995|FG007|Cohort 7P, Q2W|Adverse Event|0|||
163002343|NCT02906670|588708996|FG008|Cohort 7P, Q2W|Adverse Event|0|||
163002344|NCT02906670|588708997|FG009|Cohort 7P, Q2W|Adverse Event|1|||
163002345|NCT02906670|588708988|FG000|Cohort 7P, Q2W|Physician Decision|0|||
163002346|NCT02906670|588708989|FG001|Cohort 7P, Q2W|Physician Decision|0|||
163002347|NCT02906670|588708990|FG002|Cohort 7P, Q2W|Physician Decision|0|||
163002348|NCT02906670|588708991|FG003|Cohort 7P, Q2W|Physician Decision|0|||
163002349|NCT02906670|588708992|FG004|Cohort 7P, Q2W|Physician Decision|0|||
163002350|NCT02906670|588708993|FG005|Cohort 7P, Q2W|Physician Decision|0|||
163002351|NCT02906670|588708994|FG006|Cohort 7P, Q2W|Physician Decision|0|||
163002352|NCT02906670|588708995|FG007|Cohort 7P, Q2W|Physician Decision|0|||
163002353|NCT02906670|588708996|FG008|Cohort 7P, Q2W|Physician Decision|0|||
163002354|NCT02906670|588708997|FG009|Cohort 7P, Q2W|Physician Decision|1|||
163002355|NCT02906670|588708988|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002356|NCT02906670|588708989|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002357|NCT02906670|588708990|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002358|NCT02906670|588708991|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002359|NCT02906670|588708992|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002360|NCT02906670|588708993|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002361|NCT02906670|588708994|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002362|NCT02906670|588708995|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002363|NCT02906670|588708996|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
163002364|NCT02906670|588708997|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
163002365|NCT02906670|588708988|FG000|Cohort 5P, QW|Radiological Progression|0|||
163002366|NCT02906670|588708989|FG001|Cohort 5P, QW|Radiological Progression|0|||
163002367|NCT02906670|588708990|FG002|Cohort 5P, QW|Radiological Progression|0|||
163002368|NCT02906670|588708991|FG003|Cohort 5P, QW|Radiological Progression|0|||
163002369|NCT02906670|588708992|FG004|Cohort 5P, QW|Radiological Progression|3|||
163002370|NCT02906670|588708993|FG005|Cohort 5P, QW|Radiological Progression|0|||
163002371|NCT02906670|588708994|FG006|Cohort 5P, QW|Radiological Progression|0|||
163002372|NCT02906670|588708995|FG007|Cohort 5P, QW|Radiological Progression|0|||
163002373|NCT02906670|588708996|FG008|Cohort 5P, QW|Radiological Progression|0|||
162637413|NCT01949051|587388512|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
162637414|NCT01949051|587388507|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162637415|NCT01949051|587388508|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
162637416|NCT01949051|587388509|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162637417|NCT01949051|587388510|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162637418|NCT01949051|587388511|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162637419|NCT01949051|587388512|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162637420|NCT01949051|587388507|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162637421|NCT01949051|587388508|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162637422|NCT01949051|587388509|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
162637423|NCT01949051|587388510|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162637424|NCT01949051|587388511|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162637425|NCT01949051|587388512|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162637426|NCT04545866|587388514|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
162637427|NCT04545866|587388515|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
162637428|NCT04545866|587388514|FG000|Overall Study|Withdrawal by Physician|1|||
162637429|NCT04545866|587388515|FG001|Overall Study|Withdrawal by Physician|0|||
162637430|NCT02436356|587388518|FG000|Overall Study|Excluded by MRI Screening|0|||
162637431|NCT02436356|587388519|FG001|Overall Study|Excluded by MRI Screening|0|||
162637432|NCT02436356|587388520|FG002|Overall Study|Excluded by MRI Screening|2|||
162637433|NCT02436356|587388518|FG000|Overall Study|Lost to Follow-up|0|||
162637434|NCT02436356|587388519|FG001|Overall Study|Lost to Follow-up|1|||
162637435|NCT02436356|587388520|FG002|Overall Study|Lost to Follow-up|0|||
162637436|NCT02436356|587388518|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
162637437|NCT02436356|587388519|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
162637438|NCT02436356|587388520|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
163002374|NCT02906670|588708997|FG009|Cohort 5P, QW|Radiological Progression|0|||
163002375|NCT01349192|588708998|FG000|Overall Study|Protocol Violation|0|||
163002376|NCT01349192|588708999|FG001|Overall Study|Protocol Violation|1|||
163002377|NCT01349192|588708998|FG000|Overall Study|Withdrawal by Subject|0|||
163002378|NCT01349192|588708999|FG001|Overall Study|Withdrawal by Subject|2|||
162637439|NCT02436356|587388518|FG000|Overall Study|Excluded due to other medical conditions|3|||
162637440|NCT02436356|587388519|FG001|Overall Study|Excluded due to other medical conditions|0|||
162637441|NCT02436356|587388520|FG002|Overall Study|Excluded due to other medical conditions|0|||
162637442|NCT02436356|587388518|FG000|Overall Study|Withdrawal by Subject|1|||
162637443|NCT02436356|587388519|FG001|Overall Study|Withdrawal by Subject|0|||
162637444|NCT02436356|587388520|FG002|Overall Study|Withdrawal by Subject|0|||
162637445|NCT02875860|587388521|FG000|Overall Study|Withdrawal by Subject|0|||
162637446|NCT02875860|587388522|FG001|Overall Study|Withdrawal by Subject|1|||
162637447|NCT03287804|587388523|FG000|Overall Study|Death|1|||
162637448|NCT03287804|587388523|FG000|Overall Study|Physician Decision|2|||
162637449|NCT03287804|587388523|FG000|Overall Study|Progressive disease|8|||
162637450|NCT01881776|587388524|FG000|Overall Study|Lost to Follow-up|1|||
162637451|NCT01881776|587388525|FG001|Overall Study|Lost to Follow-up|2|||
162637452|NCT01881776|587388526|FG002|Overall Study|Lost to Follow-up|1|||
162637453|NCT01881776|587388524|FG000|Overall Study|Protocol Violation|0|||
162637454|NCT01881776|587388525|FG001|Overall Study|Protocol Violation|2|||
162637455|NCT01881776|587388526|FG002|Overall Study|Protocol Violation|1|||
163002379|NCT01349192|588708998|FG000|Overall Study|Lost to Follow-up|1|||
162637456|NCT00487747|587388527|FG000|Overall Study|Adverse Event|1|||
162637457|NCT00487747|587388527|FG000|Overall Study|Lost to Follow-up|9|||
162715783|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715784|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162715785|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715786|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
163002380|NCT01349192|588708999|FG001|Overall Study|Lost to Follow-up|3|||
163002381|NCT01349192|588708998|FG000|Overall Study|Failure to adhere to Protocol|2|||
163002382|NCT01349192|588708999|FG001|Overall Study|Failure to adhere to Protocol|0|||
163002383|NCT03749330|588709000|FG000|Overall Study|Clinicians left work in the CICU|0|||
163002384|NCT03749330|588709001|FG001|Overall Study|Clinicians left work in the CICU|2|||
163002385|NCT03749330|588709002|FG002|Overall Study|Clinicians left work in the CICU|0|||
163002386|NCT03749330|588709003|FG003|Overall Study|Clinicians left work in the CICU|0|||
163002387|NCT03749330|588709004|FG004|Overall Study|Clinicians left work in the CICU|0|||
163002388|NCT03749330|588709005|FG005|Overall Study|Clinicians left work in the CICU|0|||
163002389|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163060751|NCT03836053|588931281|FG000|Overall Study|Decision by sponsor|0|||
162637458|NCT00487747|587388527|FG000|Overall Study|Lack of Efficacy|1|||
162637459|NCT04483011|587388528|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
162637460|NCT04483011|587388529|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162637461|NCT02979522|587388552|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
162637462|NCT02979522|587388553|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
162637463|NCT02979522|587388552|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
163002390|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
163002391|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163002392|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
163002393|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
163002394|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002395|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002396|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
163002397|NCT02038010|588709006|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002398|NCT02038010|588709007|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
163002399|NCT02038010|588709008|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002400|NCT02038010|588709009|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
163002401|NCT02038010|588709006|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
163002402|NCT02038010|588709007|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
163002403|NCT02038010|588709008|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
163002404|NCT02038010|588709009|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
163002405|NCT02038010|588709006|FG000|Follow Up|Death|4|||
163002406|NCT02038010|588709007|FG001|Follow Up|Death|3|||
163002407|NCT02038010|588709008|FG002|Follow Up|Death|0|||
163002408|NCT02038010|588709009|FG003|Follow Up|Death|0|||
163002409|NCT02038010|588709006|FG000|Follow Up|Other|3|||
163002410|NCT02038010|588709007|FG001|Follow Up|Other|0|||
163002411|NCT02038010|588709008|FG002|Follow Up|Other|0|||
163002412|NCT02038010|588709009|FG003|Follow Up|Other|0|||
163002413|NCT02105467|588709016|FG000|Period 1|Lost to Follow-up|1|||
163002414|NCT02105467|588709017|FG001|Period 1|Lost to Follow-up|0|||
163002415|NCT02105467|588709016|FG000|Period 1|Death|1|||
163002416|NCT02105467|588709017|FG001|Period 1|Death|0|||
163002417|NCT02105467|588709016|FG000|Period 2|Lost to Follow-up|1|||
163002418|NCT02105467|588709017|FG001|Period 2|Lost to Follow-up|0|||
163002419|NCT02105467|588709016|FG000|Period 2|Death|1|||
163002420|NCT02105467|588709017|FG001|Period 2|Death|0|||
163002421|NCT02105467|588709016|FG000|Period 2|Withdrawal by Subject|0|||
163002422|NCT02105467|588709017|FG001|Period 2|Withdrawal by Subject|2|||
163002423|NCT02105467|588709016|FG000|Period 3|Lost to Follow-up|0|||
163002424|NCT02105467|588709017|FG001|Period 3|Lost to Follow-up|1|||
163002425|NCT03908125|588709018|FG000|Overall Study|Withdrawal by Subject|92|||
163002426|NCT03908125|588709018|FG000|Overall Study|Lost to Follow-up|8|||
163002427|NCT02262325|588709019|FG000|Overall Study|Death|16|||
163002428|NCT02262325|588709019|FG000|Overall Study|Lost to Follow-up|1|||
163002429|NCT02815995|588709020|FG000|Overall Study|Disease Progression|3|||
163002430|NCT02815995|588709021|FG001|Overall Study|Disease Progression|7|||
163002431|NCT02815995|588709022|FG002|Overall Study|Disease Progression|2|||
163002432|NCT02815995|588709023|FG003|Overall Study|Disease Progression|4|||
163002433|NCT02815995|588709024|FG004|Overall Study|Disease Progression|3|||
163002434|NCT02815995|588709025|FG005|Overall Study|Disease Progression|9|||
163002435|NCT02815995|588709026|FG006|Overall Study|Disease Progression|3|||
163002436|NCT02815995|588709027|FG007|Overall Study|Disease Progression|1|||
163002437|NCT02815995|588709020|FG000|Overall Study|Adverse Event|1|||
163002438|NCT02815995|588709021|FG001|Overall Study|Adverse Event|2|||
163002439|NCT02815995|588709022|FG002|Overall Study|Adverse Event|2|||
163002440|NCT02815995|588709023|FG003|Overall Study|Adverse Event|0|||
163002441|NCT02815995|588709024|FG004|Overall Study|Adverse Event|0|||
163002442|NCT02815995|588709025|FG005|Overall Study|Adverse Event|1|||
163002443|NCT02815995|588709026|FG006|Overall Study|Adverse Event|0|||
163002444|NCT02815995|588709027|FG007|Overall Study|Adverse Event|0|||
163002445|NCT02815995|588709020|FG000|Overall Study|Pregnancy|0|||
163002446|NCT02815995|588709021|FG001|Overall Study|Pregnancy|0|||
163002447|NCT02815995|588709022|FG002|Overall Study|Pregnancy|0|||
163002448|NCT02815995|588709023|FG003|Overall Study|Pregnancy|0|||
163002449|NCT02815995|588709024|FG004|Overall Study|Pregnancy|0|||
162637464|NCT02979522|587388553|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
162637465|NCT01896531|587388556|FG000|Overall Study|Death|57|||
162637466|NCT01896531|587388557|FG001|Overall Study|Death|59|||
162637467|NCT01896531|587388556|FG000|Overall Study|Lost to Follow-up|3|||
162637468|NCT01896531|587388557|FG001|Overall Study|Lost to Follow-up|0|||
163002450|NCT02815995|588709025|FG005|Overall Study|Pregnancy|0|||
163002451|NCT02815995|588709026|FG006|Overall Study|Pregnancy|1|||
163002452|NCT02815995|588709027|FG007|Overall Study|Pregnancy|0|||
163002453|NCT01071915|588709032|FG000|Overall Study|Adverse Event|3|||
163002454|NCT01071915|588709032|FG000|Overall Study|Physician Decision|2|||
163002455|NCT01071915|588709032|FG000|Overall Study|Withdrawal by Subject|2|||
163002456|NCT01071915|588709032|FG000|Overall Study|Miscellaneous Reasons|2|||
163002457|NCT00958828|588709033|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
163002458|NCT00958828|588709034|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
163002459|NCT00958828|588709033|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
163002460|NCT00958828|588709034|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
163002461|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
163002462|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
163002463|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
163002464|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
162637469|NCT01896531|587388556|FG000|Overall Study|Non-compliance|0|||
162637470|NCT01896531|587388557|FG001|Overall Study|Non-compliance|1|||
162637471|NCT01896531|587388556|FG000|Overall Study|Study Ended by Sponsor|7|||
163002465|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
163002466|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
163002467|NCT02673775|588709045|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
163002468|NCT02673775|588709046|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
163002469|NCT02016183|588709047|FG000|Overall Study|Case Report Forms Uncollected|13|||
163002470|NCT02016183|588709047|FG000|Overall Study|Protocol Violation|52|||
163002471|NCT00770328|588709048|FG000|Overall Study|Adverse Event|11|||
163002472|NCT00770328|588709049|FG001|Overall Study|Adverse Event|2|||
163002473|NCT00770328|588709048|FG000|Overall Study|Lost to Follow-up|2|||
163002474|NCT00770328|588709049|FG001|Overall Study|Lost to Follow-up|2|||
163002475|NCT02286843|588709052|FG000|Overall Study|Not Treated|4|||
163002476|NCT02286843|588709052|FG000|Overall Study|Protocol Violation|1|||
163002477|NCT02286843|588709052|FG000|Overall Study|Withdrawal by Subject|1|||
163002478|NCT02536846|588709053|FG000|Overall Study|Withdrawal by Subject|1|||
163002479|NCT04388553|588709054|FG000|Overall Study|Protocol Violation|1|||
163002480|NCT04388553|588709055|FG001|Overall Study|Protocol Violation|0|||
163002481|NCT04604795|588709056|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
163002482|NCT04604795|588709057|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
163002483|NCT04604795|588709058|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002484|NCT04604795|588709059|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002485|NCT04604795|588709060|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002486|NCT04604795|588709061|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002487|NCT04604795|588709062|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002488|NCT04604795|588709063|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002489|NCT04604795|588709064|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002490|NCT04604795|588709065|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
163002491|NCT04604795|588709056|FG000|Part B: Up to Day 14|Adverse Event|0|||
163002492|NCT04604795|588709057|FG001|Part B: Up to Day 14|Adverse Event|0|||
163002493|NCT04604795|588709058|FG002|Part B: Up to Day 14|Adverse Event|0|||
163002494|NCT04604795|588709059|FG003|Part B: Up to Day 14|Adverse Event|0|||
163002495|NCT04604795|588709060|FG004|Part B: Up to Day 14|Adverse Event|2|||
163002496|NCT04604795|588709061|FG005|Part B: Up to Day 14|Adverse Event|1|||
163002497|NCT04604795|588709062|FG006|Part B: Up to Day 14|Adverse Event|0|||
163002498|NCT04604795|588709063|FG007|Part B: Up to Day 14|Adverse Event|0|||
163002499|NCT04604795|588709064|FG008|Part B: Up to Day 14|Adverse Event|0|||
163002500|NCT04604795|588709065|FG009|Part B: Up to Day 14|Adverse Event|0|||
163002501|NCT04604795|588709056|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002502|NCT04604795|588709057|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002503|NCT04604795|588709058|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002504|NCT04604795|588709059|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002505|NCT04604795|588709060|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002506|NCT04604795|588709061|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002507|NCT04604795|588709062|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002508|NCT04604795|588709063|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002509|NCT04604795|588709064|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
163002510|NCT04604795|588709065|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
163002511|NCT04604795|588709056|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002512|NCT04604795|588709057|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002513|NCT04604795|588709058|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002514|NCT04604795|588709059|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002515|NCT04604795|588709060|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002516|NCT04604795|588709061|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002517|NCT04604795|588709062|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
162637472|NCT01896531|587388557|FG001|Overall Study|Study Ended by Sponsor|20|||
162637473|NCT01896531|587388556|FG000|Overall Study|Withdrawal by Subject|3|||
162637474|NCT01896531|587388557|FG001|Overall Study|Withdrawal by Subject|2|||
162637475|NCT01896531|587388556|FG000|Overall Study|Death Prior to Treatment|1|||
162637476|NCT01896531|587388557|FG001|Overall Study|Death Prior to Treatment|0|||
162637477|NCT05185089|587388558|FG000|First Intervention (4 weeks)|Adverse Event|0|||
162637478|NCT05185089|587388559|FG001|First Intervention (4 weeks)|Adverse Event|0|||
163002518|NCT04604795|588709063|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002519|NCT04604795|588709064|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
163002520|NCT04604795|588709065|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
163002521|NCT04604795|588709056|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002522|NCT04604795|588709057|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002523|NCT04604795|588709058|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002524|NCT04604795|588709059|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002525|NCT04604795|588709060|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002526|NCT04604795|588709061|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002527|NCT04604795|588709062|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002528|NCT04604795|588709063|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002529|NCT04604795|588709064|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
163002530|NCT04604795|588709065|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
163002531|NCT04604795|588709056|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002532|NCT04604795|588709057|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002533|NCT04604795|588709058|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002534|NCT04604795|588709059|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002535|NCT04604795|588709060|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002536|NCT04604795|588709061|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002537|NCT04604795|588709062|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002538|NCT04604795|588709063|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002539|NCT04604795|588709064|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
163002540|NCT04604795|588709065|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
163002541|NCT00174954|588709070|FG000|Overall Study|Adverse Event|2|||
163002542|NCT00174954|588709070|FG000|Overall Study|No tophi found in MRI|1|||
163002543|NCT00174954|588709070|FG000|Overall Study|Physician Decision|1|||
163002544|NCT00839254|588709071|FG000|Overall Study|Protocol Violation|0|||
163002545|NCT00839254|588709072|FG001|Overall Study|Protocol Violation|1|||
163002546|NCT00839254|588709073|FG002|Overall Study|Protocol Violation|1|||
163002547|NCT00839254|588709074|FG003|Overall Study|Protocol Violation|1|||
163002548|NCT00839254|588709075|FG004|Overall Study|Protocol Violation|0|||
163002549|NCT00839254|588709076|FG005|Overall Study|Protocol Violation|0|||
163002550|NCT00839254|588709077|FG006|Overall Study|Protocol Violation|1|||
163002551|NCT00839254|588709078|FG007|Overall Study|Protocol Violation|2|||
163002552|NCT00839254|588709071|FG000|Overall Study|Physician Decision|0|||
163002553|NCT00839254|588709072|FG001|Overall Study|Physician Decision|1|||
163002554|NCT00839254|588709073|FG002|Overall Study|Physician Decision|0|||
163002555|NCT00839254|588709074|FG003|Overall Study|Physician Decision|0|||
163002556|NCT00839254|588709075|FG004|Overall Study|Physician Decision|0|||
163002557|NCT00839254|588709076|FG005|Overall Study|Physician Decision|0|||
163002558|NCT00839254|588709077|FG006|Overall Study|Physician Decision|0|||
163002559|NCT00839254|588709078|FG007|Overall Study|Physician Decision|1|||
163002560|NCT00839254|588709071|FG000|Overall Study|Wrong treatment number allocation|0|||
163002561|NCT00839254|588709072|FG001|Overall Study|Wrong treatment number allocation|1|||
163002562|NCT00839254|588709073|FG002|Overall Study|Wrong treatment number allocation|0|||
163002563|NCT00839254|588709074|FG003|Overall Study|Wrong treatment number allocation|0|||
163002564|NCT00839254|588709075|FG004|Overall Study|Wrong treatment number allocation|0|||
163002565|NCT00839254|588709076|FG005|Overall Study|Wrong treatment number allocation|1|||
163002566|NCT00839254|588709077|FG006|Overall Study|Wrong treatment number allocation|0|||
163002567|NCT00839254|588709078|FG007|Overall Study|Wrong treatment number allocation|0|||
163002568|NCT00839254|588709071|FG000|Overall Study|Adverse Event|12|||
163002569|NCT00839254|588709072|FG001|Overall Study|Adverse Event|6|||
163002570|NCT00839254|588709073|FG002|Overall Study|Adverse Event|3|||
163002571|NCT00839254|588709074|FG003|Overall Study|Adverse Event|5|||
163002572|NCT00839254|588709075|FG004|Overall Study|Adverse Event|2|||
163002573|NCT00839254|588709076|FG005|Overall Study|Adverse Event|1|||
163002574|NCT00839254|588709077|FG006|Overall Study|Adverse Event|0|||
163002575|NCT00839254|588709078|FG007|Overall Study|Adverse Event|1|||
163002576|NCT00839254|588709071|FG000|Overall Study|Withdrawal by Subject|87|||
163002577|NCT00839254|588709072|FG001|Overall Study|Withdrawal by Subject|53|||
163002578|NCT00839254|588709073|FG002|Overall Study|Withdrawal by Subject|54|||
163002579|NCT00839254|588709074|FG003|Overall Study|Withdrawal by Subject|32|||
163002580|NCT00839254|588709075|FG004|Overall Study|Withdrawal by Subject|27|||
163002581|NCT00839254|588709076|FG005|Overall Study|Withdrawal by Subject|15|||
163002582|NCT00839254|588709077|FG006|Overall Study|Withdrawal by Subject|22|||
163002583|NCT00839254|588709078|FG007|Overall Study|Withdrawal by Subject|9|||
163002584|NCT00839254|588709071|FG000|Overall Study|Wrong group allocation|0|||
163002585|NCT00839254|588709072|FG001|Overall Study|Wrong group allocation|0|||
163002586|NCT00839254|588709073|FG002|Overall Study|Wrong group allocation|0|||
163002587|NCT00839254|588709074|FG003|Overall Study|Wrong group allocation|0|||
163002588|NCT00839254|588709075|FG004|Overall Study|Wrong group allocation|0|||
163002589|NCT00839254|588709076|FG005|Overall Study|Wrong group allocation|0|||
163002590|NCT00839254|588709077|FG006|Overall Study|Wrong group allocation|1|||
163002591|NCT00839254|588709078|FG007|Overall Study|Wrong group allocation|0|||
163060752|NCT03836053|588931282|FG001|Overall Study|Decision by sponsor|2|||
163002592|NCT00839254|588709071|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
163002593|NCT00839254|588709072|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002594|NCT00839254|588709073|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002595|NCT00839254|588709074|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002596|NCT00839254|588709075|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002597|NCT00839254|588709076|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
163002598|NCT00839254|588709077|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002599|NCT00839254|588709078|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
163002600|NCT00839254|588709071|FG000|Overall Study|Withdrawn due to non-compliance|2|||
163002601|NCT00839254|588709072|FG001|Overall Study|Withdrawn due to non-compliance|0|||
163002602|NCT00839254|588709073|FG002|Overall Study|Withdrawn due to non-compliance|0|||
163002603|NCT00839254|588709074|FG003|Overall Study|Withdrawn due to non-compliance|0|||
163002604|NCT00839254|588709075|FG004|Overall Study|Withdrawn due to non-compliance|0|||
163002605|NCT00839254|588709076|FG005|Overall Study|Withdrawn due to non-compliance|0|||
163002606|NCT00839254|588709077|FG006|Overall Study|Withdrawn due to non-compliance|0|||
163002607|NCT00839254|588709078|FG007|Overall Study|Withdrawn due to non-compliance|0|||
163002608|NCT00839254|588709071|FG000|Overall Study|Lost to Follow-up|51|||
163002609|NCT00839254|588709072|FG001|Overall Study|Lost to Follow-up|30|||
163002610|NCT00839254|588709073|FG002|Overall Study|Lost to Follow-up|32|||
163002611|NCT00839254|588709074|FG003|Overall Study|Lost to Follow-up|24|||
163002612|NCT00839254|588709075|FG004|Overall Study|Lost to Follow-up|8|||
163002613|NCT00839254|588709076|FG005|Overall Study|Lost to Follow-up|8|||
163002614|NCT00839254|588709077|FG006|Overall Study|Lost to Follow-up|4|||
163002615|NCT00839254|588709078|FG007|Overall Study|Lost to Follow-up|2|||
163002616|NCT04597632|588709079|FG000|Overall Study|Withdrawal by Subject|10|||
163002617|NCT04597632|588709079|FG000|Overall Study|Lost to Follow-up|1|||
163002618|NCT04597632|588709079|FG000|Overall Study|Death|1|||
163002619|NCT04597632|588709079|FG000|Overall Study|Adverse Event|5|||
163002620|NCT01823835|588709080|FG000|Overall Study|Adverse Event|0|||
163002621|NCT01823835|588709081|FG001|Overall Study|Adverse Event|0|||
163002622|NCT01823835|588709082|FG002|Overall Study|Adverse Event|0|||
163002623|NCT01823835|588709083|FG003|Overall Study|Adverse Event|0|||
163002624|NCT01823835|588709084|FG004|Overall Study|Adverse Event|1|||
163002625|NCT01823835|588709085|FG005|Overall Study|Adverse Event|0|||
163002626|NCT01823835|588709086|FG006|Overall Study|Adverse Event|1|||
163002627|NCT01823835|588709087|FG007|Overall Study|Adverse Event|0|||
163002628|NCT01823835|588709088|FG008|Overall Study|Adverse Event|0|||
163002629|NCT01823835|588709089|FG009|Overall Study|Adverse Event|0|||
163002630|NCT01823835|588709090|FG010|Overall Study|Adverse Event|1|||
163002631|NCT01823835|588709091|FG011|Overall Study|Adverse Event|2|||
163002632|NCT01823835|588709092|FG012|Overall Study|Adverse Event|0|||
163002633|NCT01823835|588709093|FG013|Overall Study|Adverse Event|0|||
163002634|NCT01823835|588709094|FG014|Overall Study|Adverse Event|0|||
163002635|NCT01823835|588709080|FG000|Overall Study|Physician Decision|0|||
163002636|NCT01823835|588709081|FG001|Overall Study|Physician Decision|0|||
163002637|NCT01823835|588709082|FG002|Overall Study|Physician Decision|0|||
163002638|NCT01823835|588709083|FG003|Overall Study|Physician Decision|0|||
163002639|NCT01823835|588709084|FG004|Overall Study|Physician Decision|0|||
163002640|NCT01823835|588709085|FG005|Overall Study|Physician Decision|0|||
163002641|NCT01823835|588709086|FG006|Overall Study|Physician Decision|0|||
163002642|NCT01823835|588709087|FG007|Overall Study|Physician Decision|0|||
163002643|NCT01823835|588709088|FG008|Overall Study|Physician Decision|0|||
163002644|NCT01823835|588709089|FG009|Overall Study|Physician Decision|0|||
163002645|NCT01823835|588709090|FG010|Overall Study|Physician Decision|0|||
163002646|NCT01823835|588709091|FG011|Overall Study|Physician Decision|2|||
163002647|NCT01823835|588709092|FG012|Overall Study|Physician Decision|0|||
163002648|NCT01823835|588709093|FG013|Overall Study|Physician Decision|0|||
163002649|NCT01823835|588709094|FG014|Overall Study|Physician Decision|0|||
163002650|NCT01823835|588709080|FG000|Overall Study|Progressive Disease|3|||
163002651|NCT01823835|588709081|FG001|Overall Study|Progressive Disease|4|||
163002652|NCT01823835|588709082|FG002|Overall Study|Progressive Disease|3|||
163002653|NCT01823835|588709083|FG003|Overall Study|Progressive Disease|6|||
163002654|NCT01823835|588709084|FG004|Overall Study|Progressive Disease|4|||
162715787|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163002655|NCT01823835|588709085|FG005|Overall Study|Progressive Disease|6|||
163002656|NCT01823835|588709086|FG006|Overall Study|Progressive Disease|5|||
163002657|NCT01823835|588709087|FG007|Overall Study|Progressive Disease|3|||
163002658|NCT01823835|588709088|FG008|Overall Study|Progressive Disease|3|||
163002659|NCT01823835|588709089|FG009|Overall Study|Progressive Disease|18|||
163002660|NCT01823835|588709090|FG010|Overall Study|Progressive Disease|8|||
163002661|NCT01823835|588709091|FG011|Overall Study|Progressive Disease|46|||
163002662|NCT01823835|588709092|FG012|Overall Study|Progressive Disease|18|||
163002663|NCT01823835|588709093|FG013|Overall Study|Progressive Disease|4|||
163002664|NCT01823835|588709094|FG014|Overall Study|Progressive Disease|6|||
163002665|NCT01823835|588709080|FG000|Overall Study|Study Termination|0|||
163002666|NCT01823835|588709081|FG001|Overall Study|Study Termination|0|||
163002667|NCT01823835|588709082|FG002|Overall Study|Study Termination|0|||
163002668|NCT01823835|588709083|FG003|Overall Study|Study Termination|0|||
163002669|NCT01823835|588709084|FG004|Overall Study|Study Termination|1|||
163002670|NCT01823835|588709085|FG005|Overall Study|Study Termination|0|||
163002671|NCT01823835|588709086|FG006|Overall Study|Study Termination|0|||
163002672|NCT01823835|588709087|FG007|Overall Study|Study Termination|0|||
163002673|NCT01823835|588709088|FG008|Overall Study|Study Termination|0|||
163002674|NCT01823835|588709089|FG009|Overall Study|Study Termination|0|||
163002675|NCT01823835|588709090|FG010|Overall Study|Study Termination|0|||
163002676|NCT01823835|588709091|FG011|Overall Study|Study Termination|1|||
163002677|NCT01823835|588709092|FG012|Overall Study|Study Termination|0|||
163002678|NCT01823835|588709093|FG013|Overall Study|Study Termination|0|||
163002679|NCT01823835|588709094|FG014|Overall Study|Study Termination|0|||
163002680|NCT01823835|588709080|FG000|Overall Study|Withdrawal by Subject|0|||
163002681|NCT01823835|588709081|FG001|Overall Study|Withdrawal by Subject|0|||
163002682|NCT01823835|588709082|FG002|Overall Study|Withdrawal by Subject|1|||
163002683|NCT01823835|588709083|FG003|Overall Study|Withdrawal by Subject|0|||
163002684|NCT01823835|588709084|FG004|Overall Study|Withdrawal by Subject|0|||
163002685|NCT01823835|588709085|FG005|Overall Study|Withdrawal by Subject|0|||
163002686|NCT01823835|588709086|FG006|Overall Study|Withdrawal by Subject|0|||
163002687|NCT01823835|588709087|FG007|Overall Study|Withdrawal by Subject|0|||
163002688|NCT01823835|588709088|FG008|Overall Study|Withdrawal by Subject|0|||
163002689|NCT01823835|588709089|FG009|Overall Study|Withdrawal by Subject|1|||
163002690|NCT01823835|588709090|FG010|Overall Study|Withdrawal by Subject|1|||
163002691|NCT01823835|588709091|FG011|Overall Study|Withdrawal by Subject|2|||
163002692|NCT01823835|588709092|FG012|Overall Study|Withdrawal by Subject|1|||
163002693|NCT01823835|588709093|FG013|Overall Study|Withdrawal by Subject|0|||
163002694|NCT01823835|588709094|FG014|Overall Study|Withdrawal by Subject|0|||
163002695|NCT00509795|588709095|FG000|Overall Study|Adverse Event|4|||
163002696|NCT00509795|588709096|FG001|Overall Study|Adverse Event|3|||
163002697|NCT00509795|588709097|FG002|Overall Study|Adverse Event|5|||
163002698|NCT00509795|588709098|FG003|Overall Study|Adverse Event|4|||
163002699|NCT00509795|588709095|FG000|Overall Study|Death|3|||
163002700|NCT00509795|588709096|FG001|Overall Study|Death|1|||
163002701|NCT00509795|588709097|FG002|Overall Study|Death|2|||
163002702|NCT00509795|588709098|FG003|Overall Study|Death|7|||
163002703|NCT00509795|588709095|FG000|Overall Study|Lack of Efficacy|0|||
163002704|NCT00509795|588709096|FG001|Overall Study|Lack of Efficacy|0|||
163002705|NCT00509795|588709097|FG002|Overall Study|Lack of Efficacy|2|||
163002706|NCT00509795|588709098|FG003|Overall Study|Lack of Efficacy|2|||
163002707|NCT00509795|588709095|FG000|Overall Study|Lost to Follow-up|1|||
163002708|NCT00509795|588709096|FG001|Overall Study|Lost to Follow-up|2|||
163002709|NCT00509795|588709097|FG002|Overall Study|Lost to Follow-up|4|||
163002710|NCT00509795|588709098|FG003|Overall Study|Lost to Follow-up|4|||
163002711|NCT00509795|588709095|FG000|Overall Study|OTHER|1|||
163002712|NCT00509795|588709096|FG001|Overall Study|OTHER|0|||
163002713|NCT00509795|588709097|FG002|Overall Study|OTHER|4|||
163002714|NCT00509795|588709098|FG003|Overall Study|OTHER|1|||
163002715|NCT00509795|588709095|FG000|Overall Study|Protocol Violation|3|||
163002716|NCT00509795|588709096|FG001|Overall Study|Protocol Violation|0|||
163002717|NCT00509795|588709097|FG002|Overall Study|Protocol Violation|3|||
163002718|NCT00509795|588709098|FG003|Overall Study|Protocol Violation|1|||
163002719|NCT00509795|588709095|FG000|Overall Study|Withdrawal by Subject|10|||
163002720|NCT00509795|588709096|FG001|Overall Study|Withdrawal by Subject|5|||
163002721|NCT00509795|588709097|FG002|Overall Study|Withdrawal by Subject|7|||
163002722|NCT00509795|588709098|FG003|Overall Study|Withdrawal by Subject|8|||
163002723|NCT04895982|588709099|FG000|Overall Study|Withdrawal by Subject|0|||
163002724|NCT04895982|588709100|FG001|Overall Study|Withdrawal by Subject|0|||
163002725|NCT04895982|588709101|FG002|Overall Study|Withdrawal by Subject|0|||
163002726|NCT04895982|588709102|FG003|Overall Study|Withdrawal by Subject|0|||
163002727|NCT04895982|588709103|FG004|Overall Study|Withdrawal by Subject|0|||
163002728|NCT04895982|588709104|FG005|Overall Study|Withdrawal by Subject|1|||
163002729|NCT04895982|588709105|FG006|Overall Study|Withdrawal by Subject|1|||
163002730|NCT04895982|588709106|FG007|Overall Study|Withdrawal by Subject|0|||
163002731|NCT04895982|588709107|FG008|Overall Study|Withdrawal by Subject|0|||
163002732|NCT04895982|588709108|FG009|Overall Study|Withdrawal by Subject|1|||
163002733|NCT04895982|588709109|FG010|Overall Study|Withdrawal by Subject|0|||
163002734|NCT04895982|588709110|FG011|Overall Study|Withdrawal by Subject|1|||
163002735|NCT04895982|588709099|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163002736|NCT04895982|588709100|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163002737|NCT04895982|588709101|FG002|Overall Study|Withdrawal by parent/guardian|3|||
163002738|NCT04895982|588709102|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163002739|NCT04895982|588709103|FG004|Overall Study|Withdrawal by parent/guardian|3|||
163002740|NCT04895982|588709104|FG005|Overall Study|Withdrawal by parent/guardian|2|||
163002741|NCT04895982|588709105|FG006|Overall Study|Withdrawal by parent/guardian|1|||
163002742|NCT04895982|588709106|FG007|Overall Study|Withdrawal by parent/guardian|0|||
163002743|NCT04895982|588709107|FG008|Overall Study|Withdrawal by parent/guardian|3|||
163002744|NCT04895982|588709108|FG009|Overall Study|Withdrawal by parent/guardian|0|||
163002745|NCT04895982|588709109|FG010|Overall Study|Withdrawal by parent/guardian|0|||
163002746|NCT04895982|588709110|FG011|Overall Study|Withdrawal by parent/guardian|0|||
163002747|NCT04895982|588709099|FG000|Overall Study|Other|0|||
163002748|NCT04895982|588709100|FG001|Overall Study|Other|0|||
163002749|NCT04895982|588709101|FG002|Overall Study|Other|1|||
163002750|NCT04895982|588709102|FG003|Overall Study|Other|1|||
163002751|NCT04895982|588709103|FG004|Overall Study|Other|0|||
163002752|NCT04895982|588709104|FG005|Overall Study|Other|0|||
163002753|NCT04895982|588709105|FG006|Overall Study|Other|0|||
163002754|NCT04895982|588709106|FG007|Overall Study|Other|0|||
163002755|NCT04895982|588709107|FG008|Overall Study|Other|0|||
163002756|NCT04895982|588709108|FG009|Overall Study|Other|1|||
163002757|NCT04895982|588709109|FG010|Overall Study|Other|0|||
163002758|NCT04895982|588709110|FG011|Overall Study|Other|0|||
163002759|NCT04895982|588709099|FG000|Overall Study|Protocol Violation|0|||
163002760|NCT04895982|588709100|FG001|Overall Study|Protocol Violation|0|||
163002761|NCT04895982|588709101|FG002|Overall Study|Protocol Violation|1|||
163002762|NCT04895982|588709102|FG003|Overall Study|Protocol Violation|1|||
163002763|NCT04895982|588709103|FG004|Overall Study|Protocol Violation|1|||
163002764|NCT04895982|588709104|FG005|Overall Study|Protocol Violation|0|||
163002765|NCT04895982|588709105|FG006|Overall Study|Protocol Violation|0|||
163002766|NCT04895982|588709106|FG007|Overall Study|Protocol Violation|1|||
163002767|NCT04895982|588709107|FG008|Overall Study|Protocol Violation|0|||
163002768|NCT04895982|588709108|FG009|Overall Study|Protocol Violation|0|||
163002769|NCT04895982|588709109|FG010|Overall Study|Protocol Violation|0|||
163002770|NCT04895982|588709110|FG011|Overall Study|Protocol Violation|0|||
163002771|NCT04895982|588709099|FG000|Overall Study|Lost to Follow-up|0|||
163002772|NCT04895982|588709100|FG001|Overall Study|Lost to Follow-up|0|||
163002773|NCT04895982|588709101|FG002|Overall Study|Lost to Follow-up|1|||
163002774|NCT04895982|588709102|FG003|Overall Study|Lost to Follow-up|0|||
163002775|NCT04895982|588709103|FG004|Overall Study|Lost to Follow-up|0|||
163002776|NCT04895982|588709104|FG005|Overall Study|Lost to Follow-up|1|||
163002777|NCT04895982|588709105|FG006|Overall Study|Lost to Follow-up|0|||
163002778|NCT04895982|588709106|FG007|Overall Study|Lost to Follow-up|0|||
163002779|NCT04895982|588709107|FG008|Overall Study|Lost to Follow-up|1|||
163002780|NCT04895982|588709108|FG009|Overall Study|Lost to Follow-up|0|||
163002781|NCT04895982|588709109|FG010|Overall Study|Lost to Follow-up|0|||
163002782|NCT04895982|588709110|FG011|Overall Study|Lost to Follow-up|0|||
163002783|NCT04895982|588709099|FG000|Overall Study|Refused further study procedures|0|||
163002784|NCT04895982|588709100|FG001|Overall Study|Refused further study procedures|0|||
163002785|NCT04895982|588709101|FG002|Overall Study|Refused further study procedures|1|||
163002786|NCT04895982|588709102|FG003|Overall Study|Refused further study procedures|0|||
163002787|NCT04895982|588709103|FG004|Overall Study|Refused further study procedures|0|||
163002788|NCT04895982|588709104|FG005|Overall Study|Refused further study procedures|0|||
163002789|NCT04895982|588709105|FG006|Overall Study|Refused further study procedures|0|||
163002790|NCT04895982|588709106|FG007|Overall Study|Refused further study procedures|0|||
163002791|NCT04895982|588709107|FG008|Overall Study|Refused further study procedures|0|||
163002792|NCT04895982|588709108|FG009|Overall Study|Refused further study procedures|0|||
163002793|NCT04895982|588709109|FG010|Overall Study|Refused further study procedures|0|||
163002794|NCT04895982|588709110|FG011|Overall Study|Refused further study procedures|0|||
163002795|NCT03300817|588711375|FG000|Overall Study|Withdrawal by Subject|1|||
163002796|NCT03300817|588711375|FG000|Overall Study|Adverse Event|1|||
163002797|NCT03300817|588711375|FG000|Overall Study|Subject Found to be Ineligible|2|||
163002798|NCT05061134|588711377|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
163002799|NCT05061134|588711378|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
163002800|NCT05061134|588711379|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
163002801|NCT05061134|588711377|FG000|Overall Study|Subject not treated|0|||
163002802|NCT05061134|588711378|FG001|Overall Study|Subject not treated|0|||
163002803|NCT05061134|588711379|FG002|Overall Study|Subject not treated|2|||
163002804|NCT05061134|588711377|FG000|Overall Study|Other|0|||
163002805|NCT05061134|588711378|FG001|Overall Study|Other|0|||
163002806|NCT05061134|588711379|FG002|Overall Study|Other|9|||
163002807|NCT05061134|588711377|FG000|Overall Study|Withdrawal by Subject|9|||
163002808|NCT05061134|588711378|FG001|Overall Study|Withdrawal by Subject|8|||
163002809|NCT05061134|588711379|FG002|Overall Study|Withdrawal by Subject|5|||
163002810|NCT05061134|588711377|FG000|Overall Study|Study Terminated by Sponsor|22|||
163002811|NCT05061134|588711378|FG001|Overall Study|Study Terminated by Sponsor|14|||
163002812|NCT05061134|588711379|FG002|Overall Study|Study Terminated by Sponsor|7|||
163002813|NCT05061134|588711377|FG000|Overall Study|Progressive Disease|1|||
163002814|NCT05061134|588711378|FG001|Overall Study|Progressive Disease|2|||
163002815|NCT05061134|588711379|FG002|Overall Study|Progressive Disease|0|||
163002816|NCT05061134|588711377|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
163002817|NCT05061134|588711378|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
163002818|NCT05061134|588711379|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
163002819|NCT05061134|588711377|FG000|Overall Study|Lost to Follow-up|1|||
163002820|NCT05061134|588711378|FG001|Overall Study|Lost to Follow-up|0|||
163002821|NCT05061134|588711379|FG002|Overall Study|Lost to Follow-up|0|||
163002822|NCT05061134|588711377|FG000|Overall Study|Physician Decision|1|||
163002823|NCT05061134|588711378|FG001|Overall Study|Physician Decision|1|||
163002824|NCT05061134|588711379|FG002|Overall Study|Physician Decision|0|||
163002825|NCT05061134|588711377|FG000|Overall Study|Disease progression|1|||
163002826|NCT05061134|588711378|FG001|Overall Study|Disease progression|0|||
163002827|NCT05061134|588711379|FG002|Overall Study|Disease progression|0|||
163002828|NCT05061134|588711377|FG000|Overall Study|Death|43|||
163002829|NCT05061134|588711378|FG001|Overall Study|Death|23|||
163002830|NCT05061134|588711379|FG002|Overall Study|Death|14|||
163002831|NCT05061134|588711377|FG000|Overall Study|Database lock|2|||
163002832|NCT05061134|588711378|FG001|Overall Study|Database lock|0|||
163002833|NCT05061134|588711379|FG002|Overall Study|Database lock|0|||
163002834|NCT03999996|588711380|FG000|Prior to Booster|Adverse Event|2|||
163002835|NCT03999996|588711381|FG001|Prior to Booster|Adverse Event|0|||
163002836|NCT03999996|588711382|FG002|Prior to Booster|Adverse Event|0|||
163002837|NCT03999996|588711383|FG003|Prior to Booster|Adverse Event|0|||
163002838|NCT03999996|588711380|FG000|Prior to Booster|Lost to Follow-up|17|||
163002839|NCT03999996|588711381|FG001|Prior to Booster|Lost to Follow-up|22|||
163002840|NCT03999996|588711382|FG002|Prior to Booster|Lost to Follow-up|0|||
163002841|NCT03999996|588711383|FG003|Prior to Booster|Lost to Follow-up|0|||
163002842|NCT03999996|588711380|FG000|Prior to Booster|Withdrawal of Consent|51|||
163002843|NCT03999996|588711381|FG001|Prior to Booster|Withdrawal of Consent|8|||
163002844|NCT03999996|588711382|FG002|Prior to Booster|Withdrawal of Consent|0|||
163002845|NCT03999996|588711383|FG003|Prior to Booster|Withdrawal of Consent|0|||
163002846|NCT03999996|588711380|FG000|Prior to Booster|Death|0|||
163002847|NCT03999996|588711381|FG001|Prior to Booster|Death|1|||
163002848|NCT03999996|588711382|FG002|Prior to Booster|Death|0|||
163002849|NCT03999996|588711383|FG003|Prior to Booster|Death|0|||
163002850|NCT03999996|588711380|FG000|Prior to Booster|Reason Not Specified|27|||
163002851|NCT03999996|588711381|FG001|Prior to Booster|Reason Not Specified|4|||
163002852|NCT03999996|588711382|FG002|Prior to Booster|Reason Not Specified|0|||
163002853|NCT03999996|588711383|FG003|Prior to Booster|Reason Not Specified|0|||
163002854|NCT03999996|588711380|FG000|Booster Phase|Lost to Follow-up|0|||
163002855|NCT03999996|588711381|FG001|Booster Phase|Lost to Follow-up|0|||
163002856|NCT03999996|588711382|FG002|Booster Phase|Lost to Follow-up|3|||
163002857|NCT03999996|588711383|FG003|Booster Phase|Lost to Follow-up|3|||
163002858|NCT03999996|588711380|FG000|Booster Phase|Withdrawal of Consent|0|||
163002859|NCT03999996|588711381|FG001|Booster Phase|Withdrawal of Consent|0|||
163002860|NCT03999996|588711382|FG002|Booster Phase|Withdrawal of Consent|0|||
163002861|NCT03999996|588711383|FG003|Booster Phase|Withdrawal of Consent|1|||
163002862|NCT03999996|588711380|FG000|Booster Phase|Reason Not Specified|0|||
163002863|NCT03999996|588711381|FG001|Booster Phase|Reason Not Specified|0|||
163002864|NCT03999996|588711382|FG002|Booster Phase|Reason Not Specified|0|||
163002865|NCT03999996|588711383|FG003|Booster Phase|Reason Not Specified|1|||
163002866|NCT03765788|588711384|FG000|Overall Study|Subject decision|2|||
163002867|NCT03765788|588711385|FG001|Overall Study|Subject decision|3|||
163002868|NCT03765788|588711384|FG000|Overall Study|Physician Decision|2|||
163002869|NCT03765788|588711385|FG001|Overall Study|Physician Decision|4|||
163060753|NCT03836053|588931283|FG002|Overall Study|Decision by sponsor|4|||
163060754|NCT03846479|588931284|FG000|Overall Study|Death|8|||
163060755|NCT03846479|588931284|FG000|Overall Study|Lost to Follow-up|1|||
163060756|NCT02332707|588931285|FG000|Overall Study|Adverse Event|0|||
163060757|NCT02332707|588931286|FG001|Overall Study|Adverse Event|0|||
163002870|NCT03765788|588711384|FG000|Overall Study|Death|0|||
163002871|NCT03765788|588711385|FG001|Overall Study|Death|1|||
163002872|NCT03765788|588711384|FG000|Overall Study|Lost to Follow-up|1|||
163060758|NCT02332707|588931287|FG002|Overall Study|Adverse Event|0|||
163002873|NCT03765788|588711385|FG001|Overall Study|Lost to Follow-up|0|||
163002874|NCT00001521|588711386|FG000|Overall Study|Withdrawal by Subject|3|||
163002875|NCT00001521|588711387|FG001|Overall Study|Withdrawal by Subject|3|||
163002876|NCT00001521|588711386|FG000|Overall Study|Physician Decision|1|||
163060759|NCT02332707|588931288|FG003|Overall Study|Adverse Event|0|||
163002877|NCT00001521|588711387|FG001|Overall Study|Physician Decision|1|||
163002878|NCT00001521|588711386|FG000|Overall Study|Noncompliant|6|||
163002879|NCT00001521|588711387|FG001|Overall Study|Noncompliant|3|||
163002880|NCT03176134|588711388|FG000|Overall Study|Lost to Follow-up|0|||
163002881|NCT03176134|588711389|FG001|Overall Study|Lost to Follow-up|2|||
163002882|NCT03176134|588711390|FG002|Overall Study|Lost to Follow-up|0|||
163002883|NCT03176134|588711391|FG003|Overall Study|Lost to Follow-up|0|||
163002884|NCT03176134|588711392|FG004|Overall Study|Lost to Follow-up|0|||
163060760|NCT02332707|588931289|FG004|Overall Study|Adverse Event|0|||
163060761|NCT02332707|588931290|FG005|Overall Study|Adverse Event|0|||
163002885|NCT03176134|588711393|FG005|Overall Study|Lost to Follow-up|0|||
163002886|NCT03176134|588711394|FG006|Overall Study|Lost to Follow-up|0|||
163002887|NCT03176134|588711395|FG007|Overall Study|Lost to Follow-up|0|||
163002888|NCT03176134|588711388|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163002889|NCT03176134|588711389|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163002890|NCT03176134|588711390|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163002891|NCT03176134|588711391|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163002892|NCT03176134|588711392|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163002893|NCT03176134|588711393|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163002894|NCT03176134|588711394|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
163002895|NCT03176134|588711395|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
163002896|NCT03410056|588711400|FG000|Overall Study|Decision by Sponsor|0|||
163002897|NCT03410056|588711401|FG001|Overall Study|Decision by Sponsor|0|||
163002898|NCT03410056|588711402|FG002|Overall Study|Decision by Sponsor|3|||
163002899|NCT03410056|588711403|FG003|Overall Study|Decision by Sponsor|0|||
163002900|NCT03410056|588711404|FG004|Overall Study|Decision by Sponsor|0|||
163002901|NCT03410056|588711405|FG005|Overall Study|Decision by Sponsor|0|||
163002902|NCT03410056|588711406|FG006|Overall Study|Decision by Sponsor|0|||
163002903|NCT03410056|588711400|FG000|Overall Study|Withdrawal by Subject|0|||
163002904|NCT03410056|588711401|FG001|Overall Study|Withdrawal by Subject|2|||
163002905|NCT03410056|588711402|FG002|Overall Study|Withdrawal by Subject|5|||
163002906|NCT03410056|588711403|FG003|Overall Study|Withdrawal by Subject|5|||
163002907|NCT03410056|588711404|FG004|Overall Study|Withdrawal by Subject|0|||
163002908|NCT03410056|588711405|FG005|Overall Study|Withdrawal by Subject|0|||
163002909|NCT03410056|588711406|FG006|Overall Study|Withdrawal by Subject|0|||
163002910|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
163002911|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
163060762|NCT02332707|588931291|FG006|Overall Study|Adverse Event|0|||
163060763|NCT02332707|588931292|FG007|Overall Study|Adverse Event|0|||
163060764|NCT02332707|588931293|FG008|Overall Study|Adverse Event|0|||
163060765|NCT02332707|588931294|FG009|Overall Study|Adverse Event|0|||
163060766|NCT02332707|588931295|FG010|Overall Study|Adverse Event|0|||
163060767|NCT02332707|588931296|FG011|Overall Study|Adverse Event|0|||
163060768|NCT02332707|588931297|FG012|Overall Study|Adverse Event|1|||
163060769|NCT02332707|588931298|FG013|Overall Study|Adverse Event|0|||
163060770|NCT02332707|588931299|FG014|Overall Study|Adverse Event|0|||
162637479|NCT05185089|587388560|FG002|First Intervention (4 weeks)|Adverse Event|0|||
162637480|NCT05185089|587388561|FG003|First Intervention (4 weeks)|Adverse Event|1|||
162637481|NCT05185089|587388558|FG000|Second Intervention (4 weeks)|Death|0|||
162637482|NCT05185089|587388559|FG001|Second Intervention (4 weeks)|Death|1|||
162637483|NCT05185089|587388560|FG002|Second Intervention (4 weeks)|Death|0|||
162637484|NCT05185089|587388561|FG003|Second Intervention (4 weeks)|Death|0|||
162637485|NCT05185089|587388558|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
162637486|NCT05185089|587388559|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
162637487|NCT05185089|587388560|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
162637488|NCT05185089|587388561|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
162637489|NCT00770289|587388562|FG000|Overall Study|Other|6|||
162637490|NCT02733991|587388563|FG000|Overall Study|Adverse Event|1|||
162637491|NCT02733991|587388564|FG001|Overall Study|Adverse Event|0|||
162637492|NCT02733991|587388563|FG000|Overall Study|Withdrawal by Subject|0|||
162637493|NCT02733991|587388564|FG001|Overall Study|Withdrawal by Subject|5|||
162637494|NCT02956486|587388567|FG000|Core Phase|Adverse Event|51|||
162637495|NCT02956486|587388568|FG001|Core Phase|Adverse Event|88|||
162637496|NCT02956486|587388569|FG002|Core Phase|Adverse Event|0|||
162637497|NCT02956486|587388567|FG000|Core Phase|Lost to Follow-up|8|||
162637498|NCT02956486|587388568|FG001|Core Phase|Lost to Follow-up|6|||
162637499|NCT02956486|587388569|FG002|Core Phase|Lost to Follow-up|0|||
162637500|NCT02956486|587388567|FG000|Core Phase|Inadequate therapeutic effect|4|||
162637501|NCT02956486|587388568|FG001|Core Phase|Inadequate therapeutic effect|5|||
162637502|NCT02956486|587388569|FG002|Core Phase|Inadequate therapeutic effect|0|||
162637503|NCT02956486|587388567|FG000|Core Phase|Withdrawal by Subject|101|||
162637504|NCT02956486|587388568|FG001|Core Phase|Withdrawal by Subject|104|||
162637505|NCT02956486|587388569|FG002|Core Phase|Withdrawal by Subject|0|||
162637506|NCT02956486|587388567|FG000|Core Phase|Study terminated by sponsor|888|||
162637507|NCT02956486|587388568|FG001|Core Phase|Study terminated by sponsor|848|||
162637508|NCT02956486|587388569|FG002|Core Phase|Study terminated by sponsor|0|||
162637509|NCT02956486|587388567|FG000|Core Phase|Other|27|||
162637510|NCT02956486|587388568|FG001|Core Phase|Other|18|||
162637511|NCT02956486|587388569|FG002|Core Phase|Other|0|||
162637512|NCT02956486|587388567|FG000|Core Phase|Not treated|0|||
162637513|NCT02956486|587388568|FG001|Core Phase|Not treated|3|||
162637514|NCT02956486|587388569|FG002|Core Phase|Not treated|0|||
162637515|NCT02956486|587388567|FG000|Extension Phase|Adverse Event|0|||
162637516|NCT02956486|587388568|FG001|Extension Phase|Adverse Event|0|||
162637517|NCT02956486|587388569|FG002|Extension Phase|Adverse Event|2|||
162637518|NCT02956486|587388567|FG000|Extension Phase|Study terminated by sponsor|0|||
162637519|NCT02956486|587388568|FG001|Extension Phase|Study terminated by sponsor|0|||
162637520|NCT02956486|587388569|FG002|Extension Phase|Study terminated by sponsor|16|||
162637521|NCT02956486|587388567|FG000|Extension Phase|Not Treated|0|||
162637522|NCT02956486|587388568|FG001|Extension Phase|Not Treated|0|||
162637523|NCT02956486|587388569|FG002|Extension Phase|Not Treated|1|||
162637524|NCT02485574|587388576|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
162637525|NCT00255047|587388578|FG000|Overall Study|Serious Adverse Events|2|||
162637526|NCT00255047|587388579|FG001|Overall Study|Serious Adverse Events|1|||
163002912|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
163002913|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
163002914|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
163002915|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
163002916|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
163002917|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
163002918|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
163002919|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
162637527|NCT00255047|587388580|FG002|Overall Study|Serious Adverse Events|2|||
162637528|NCT00255047|587388581|FG003|Overall Study|Serious Adverse Events|1|||
162637529|NCT00255047|587388578|FG000|Overall Study|Adverse Event|0|||
162637530|NCT00255047|587388579|FG001|Overall Study|Adverse Event|3|||
162637531|NCT00255047|587388580|FG002|Overall Study|Adverse Event|2|||
162637532|NCT00255047|587388581|FG003|Overall Study|Adverse Event|1|||
162637533|NCT00255047|587388578|FG000|Overall Study|Protocol Violation|13|||
162637534|NCT00255047|587388579|FG001|Overall Study|Protocol Violation|13|||
162637535|NCT00255047|587388580|FG002|Overall Study|Protocol Violation|16|||
162637536|NCT00255047|587388581|FG003|Overall Study|Protocol Violation|20|||
162637537|NCT00255047|587388578|FG000|Overall Study|Lost to Follow-up|9|||
162637538|NCT00255047|587388579|FG001|Overall Study|Lost to Follow-up|8|||
162637539|NCT00255047|587388580|FG002|Overall Study|Lost to Follow-up|5|||
162637540|NCT00255047|587388581|FG003|Overall Study|Lost to Follow-up|6|||
162637541|NCT00255047|587388578|FG000|Overall Study|Withdrawal by Subject|24|||
162637542|NCT00255047|587388579|FG001|Overall Study|Withdrawal by Subject|23|||
163002920|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
163060771|NCT02332707|588931300|FG015|Overall Study|Adverse Event|0|||
163060772|NCT02332707|588931301|FG016|Overall Study|Adverse Event|0|||
163060773|NCT02332707|588931302|FG017|Overall Study|Adverse Event|0|||
163060774|NCT02332707|588931285|FG000|Overall Study|Lost to Follow-up|0|||
163060775|NCT02332707|588931286|FG001|Overall Study|Lost to Follow-up|0|||
163060776|NCT02332707|588931287|FG002|Overall Study|Lost to Follow-up|0|||
163060777|NCT02332707|588931288|FG003|Overall Study|Lost to Follow-up|0|||
163060778|NCT02332707|588931289|FG004|Overall Study|Lost to Follow-up|0|||
163060779|NCT02332707|588931290|FG005|Overall Study|Lost to Follow-up|1|||
163060780|NCT02332707|588931291|FG006|Overall Study|Lost to Follow-up|0|||
163060781|NCT02332707|588931292|FG007|Overall Study|Lost to Follow-up|0|||
163060782|NCT02332707|588931293|FG008|Overall Study|Lost to Follow-up|0|||
163060783|NCT02332707|588931294|FG009|Overall Study|Lost to Follow-up|0|||
163060784|NCT02332707|588931295|FG010|Overall Study|Lost to Follow-up|2|||
163060785|NCT02332707|588931296|FG011|Overall Study|Lost to Follow-up|0|||
163060786|NCT02332707|588931297|FG012|Overall Study|Lost to Follow-up|3|||
163060787|NCT02332707|588931298|FG013|Overall Study|Lost to Follow-up|0|||
162637543|NCT00255047|587388580|FG002|Overall Study|Withdrawal by Subject|25|||
162637544|NCT00255047|587388581|FG003|Overall Study|Withdrawal by Subject|18|||
162637545|NCT00003492|587388588|FG000|Overall Study|Not evaluable|6|||
162637546|NCT03049280|587388594|FG000|Overall Study|Physician Decision|1|||
162637547|NCT01867021|587388595|FG000|Overall Study|Adverse Event|0|||
163060788|NCT02332707|588931299|FG014|Overall Study|Lost to Follow-up|0|||
163060789|NCT02332707|588931300|FG015|Overall Study|Lost to Follow-up|0|||
163060790|NCT02332707|588931301|FG016|Overall Study|Lost to Follow-up|0|||
162637548|NCT01867021|587388596|FG001|Overall Study|Adverse Event|1|||
162637549|NCT01867021|587388595|FG000|Overall Study|Not Eligible|0|||
162637550|NCT01867021|587388596|FG001|Overall Study|Not Eligible|1|||
162637551|NCT01867021|587388595|FG000|Overall Study|Death|1|||
162637552|NCT01867021|587388596|FG001|Overall Study|Death|0|||
163002921|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
163060791|NCT02332707|588931302|FG017|Overall Study|Lost to Follow-up|0|||
163060792|NCT02332707|588931285|FG000|Overall Study|Physician Decision|0|||
163002922|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
163002923|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
163002924|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
163002925|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
163002926|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
163002927|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
163002928|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
163002929|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
163002930|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
163002931|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
163002932|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
163002933|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
163002934|NCT01130532|588711410|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
163002935|NCT01130532|588711411|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
163002936|NCT01130532|588711412|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
163002937|NCT01130532|588711413|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
163002938|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
163002939|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
163002940|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
163002941|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
163002942|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002943|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002944|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
163002945|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
163002946|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002947|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002948|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
163002949|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
163002950|NCT01130532|588711410|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002951|NCT01130532|588711411|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002952|NCT01130532|588711412|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
163002953|NCT01130532|588711413|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
163002954|NCT02762929|588711414|FG000|Overall Study|Adverse Event|0|||
163002955|NCT02762929|588711415|FG001|Overall Study|Adverse Event|0|||
162637553|NCT01867021|587388595|FG000|Overall Study|Lost to Follow-up|0|||
162637554|NCT01867021|587388596|FG001|Overall Study|Lost to Follow-up|2|||
162637555|NCT01867021|587388595|FG000|Overall Study|Withdrawal by Subject|1|||
162637556|NCT01867021|587388596|FG001|Overall Study|Withdrawal by Subject|6|||
162637557|NCT01129960|587388600|FG000|Overall Study|Withdrawal by Subject|3|||
162637558|NCT01129960|587388601|FG001|Overall Study|Withdrawal by Subject|0|||
162637559|NCT01129960|587388602|FG002|Overall Study|Withdrawal by Subject|3|||
162637560|NCT01129960|587388603|FG003|Overall Study|Withdrawal by Subject|2|||
162637561|NCT01129960|587388600|FG000|Overall Study|Lack of Efficacy|1|||
162637562|NCT01129960|587388601|FG001|Overall Study|Lack of Efficacy|1|||
162637563|NCT01129960|587388602|FG002|Overall Study|Lack of Efficacy|1|||
162637564|NCT01129960|587388603|FG003|Overall Study|Lack of Efficacy|1|||
162637565|NCT01129960|587388600|FG000|Overall Study|Adverse Event|23|||
162637566|NCT01129960|587388601|FG001|Overall Study|Adverse Event|16|||
162637567|NCT01129960|587388602|FG002|Overall Study|Adverse Event|16|||
162637568|NCT01129960|587388603|FG003|Overall Study|Adverse Event|7|||
162637569|NCT01129960|587388600|FG000|Overall Study|Protocol Violation|1|||
162637570|NCT01129960|587388601|FG001|Overall Study|Protocol Violation|2|||
162637571|NCT01129960|587388602|FG002|Overall Study|Protocol Violation|3|||
162637572|NCT01129960|587388603|FG003|Overall Study|Protocol Violation|0|||
162637573|NCT01129960|587388600|FG000|Overall Study|Lost to Follow-up|0|||
162637574|NCT01129960|587388601|FG001|Overall Study|Lost to Follow-up|2|||
162637575|NCT01129960|587388602|FG002|Overall Study|Lost to Follow-up|3|||
162637576|NCT01129960|587388603|FG003|Overall Study|Lost to Follow-up|3|||
162637577|NCT01129960|587388600|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
162637578|NCT01129960|587388601|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
162637579|NCT01129960|587388602|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
163002956|NCT02762929|588711416|FG002|Overall Study|Adverse Event|0|||
163002957|NCT02762929|588711417|FG003|Overall Study|Adverse Event|1|||
163002958|NCT02762929|588711418|FG004|Overall Study|Adverse Event|0|||
163002959|NCT02762929|588711419|FG005|Overall Study|Adverse Event|0|||
163002960|NCT02762929|588711414|FG000|Overall Study|Lost to Follow-up|1|||
163002961|NCT02762929|588711415|FG001|Overall Study|Lost to Follow-up|2|||
163002962|NCT02762929|588711416|FG002|Overall Study|Lost to Follow-up|0|||
162637580|NCT01129960|587388603|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
162637581|NCT01129960|587388600|FG000|Overall Study|Physician Decision|1|||
162637582|NCT01129960|587388601|FG001|Overall Study|Physician Decision|0|||
162637583|NCT01129960|587388602|FG002|Overall Study|Physician Decision|0|||
162637584|NCT01129960|587388603|FG003|Overall Study|Physician Decision|0|||
162637585|NCT01129960|587388600|FG000|Overall Study|Pregnancy|1|||
163002963|NCT02762929|588711417|FG003|Overall Study|Lost to Follow-up|1|||
163002964|NCT02762929|588711418|FG004|Overall Study|Lost to Follow-up|0|||
163002965|NCT02762929|588711419|FG005|Overall Study|Lost to Follow-up|0|||
162637586|NCT01129960|587388601|FG001|Overall Study|Pregnancy|0|||
162637587|NCT01129960|587388602|FG002|Overall Study|Pregnancy|0|||
162637588|NCT01129960|587388603|FG003|Overall Study|Pregnancy|0|||
162637589|NCT01927367|587388606|FG000|Overall Study|Withdrawal by Subject|7|||
162637590|NCT01927367|587388607|FG001|Overall Study|Withdrawal by Subject|4|||
162637591|NCT01927367|587388606|FG000|Overall Study|No baseline data|0|||
162637592|NCT01927367|587388607|FG001|Overall Study|No baseline data|1|||
162637593|NCT00071513|587388608|FG000|Intervention Component|Withdrawal by Subject|2|||
162637594|NCT00071513|587388609|FG001|Intervention Component|Withdrawal by Subject|3|||
162637595|NCT00071513|587388608|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
162637596|NCT00071513|587388609|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
162637597|NCT01634360|587388610|FG000|Overall Study|Adverse Event|10|||
162637598|NCT01634360|587388611|FG001|Overall Study|Adverse Event|34|||
162637599|NCT01634360|587388610|FG000|Overall Study|subject withdrew consent|13|||
162637600|NCT01634360|587388611|FG001|Overall Study|subject withdrew consent|23|||
162637601|NCT01634360|587388610|FG000|Overall Study|Protocol Violation|1|||
162637602|NCT01634360|587388611|FG001|Overall Study|Protocol Violation|1|||
162637603|NCT01634360|587388610|FG000|Overall Study|Lack of Efficacy|4|||
162637604|NCT01634360|587388611|FG001|Overall Study|Lack of Efficacy|14|||
162637605|NCT01634360|587388610|FG000|Overall Study|Other|3|||
162637606|NCT01634360|587388611|FG001|Overall Study|Other|20|||
162637607|NCT01634360|587388610|FG000|Overall Study|Study termination by sponsor|18|||
162637608|NCT01634360|587388611|FG001|Overall Study|Study termination by sponsor|44|||
162637609|NCT02743871|587388612|FG000|Overall Study|Lost to Follow-up|0|||
162637610|NCT02743871|587388613|FG001|Overall Study|Lost to Follow-up|0|||
162637611|NCT02743871|587388614|FG002|Overall Study|Lost to Follow-up|0|||
162637612|NCT02743871|587388615|FG003|Overall Study|Lost to Follow-up|1|||
162637613|NCT02743871|587388616|FG004|Overall Study|Lost to Follow-up|0|||
162637614|NCT02743871|587388617|FG005|Overall Study|Lost to Follow-up|0|||
162637615|NCT02743871|587388618|FG006|Overall Study|Lost to Follow-up|1|||
162637616|NCT02743871|587388619|FG007|Overall Study|Lost to Follow-up|0|||
162637617|NCT02743871|587388620|FG008|Overall Study|Lost to Follow-up|0|||
162637618|NCT02743871|587388621|FG009|Overall Study|Lost to Follow-up|0|||
162637619|NCT02743871|587388622|FG010|Overall Study|Lost to Follow-up|0|||
162637620|NCT02743871|587388623|FG011|Overall Study|Lost to Follow-up|2|||
162637621|NCT02743871|587388624|FG012|Overall Study|Lost to Follow-up|0|||
163002966|NCT02762929|588711414|FG000|Overall Study|Withdrawal by Subject|0|||
163002967|NCT02762929|588711415|FG001|Overall Study|Withdrawal by Subject|1|||
163002968|NCT02762929|588711416|FG002|Overall Study|Withdrawal by Subject|0|||
163002969|NCT02762929|588711417|FG003|Overall Study|Withdrawal by Subject|0|||
163002970|NCT02762929|588711418|FG004|Overall Study|Withdrawal by Subject|0|||
163002971|NCT02762929|588711419|FG005|Overall Study|Withdrawal by Subject|0|||
163002972|NCT02762929|588711414|FG000|Overall Study|exclusionary medication disclosed late|0|||
163002973|NCT02762929|588711415|FG001|Overall Study|exclusionary medication disclosed late|0|||
163002974|NCT02762929|588711416|FG002|Overall Study|exclusionary medication disclosed late|0|||
163002975|NCT02762929|588711417|FG003|Overall Study|exclusionary medication disclosed late|1|||
163002976|NCT02762929|588711418|FG004|Overall Study|exclusionary medication disclosed late|0|||
163002977|NCT02762929|588711419|FG005|Overall Study|exclusionary medication disclosed late|0|||
163002978|NCT02656303|588711420|FG000|Overall Study|Adverse Event|3|||
163002979|NCT02656303|588711421|FG001|Overall Study|Adverse Event|2|||
163002980|NCT02656303|588711422|FG002|Overall Study|Adverse Event|0|||
163002981|NCT02656303|588711420|FG000|Overall Study|Death|12|||
163002982|NCT02656303|588711421|FG001|Overall Study|Death|4|||
163002983|NCT02656303|588711422|FG002|Overall Study|Death|1|||
163002984|NCT02656303|588711420|FG000|Overall Study|Lack of Efficacy|1|||
163002985|NCT02656303|588711421|FG001|Overall Study|Lack of Efficacy|0|||
163002986|NCT02656303|588711422|FG002|Overall Study|Lack of Efficacy|0|||
163002987|NCT02656303|588711420|FG000|Overall Study|Non-Compliance with Study|1|||
163002988|NCT02656303|588711421|FG001|Overall Study|Non-Compliance with Study|1|||
163002989|NCT02656303|588711422|FG002|Overall Study|Non-Compliance with Study|0|||
163002990|NCT02656303|588711420|FG000|Overall Study|Investigator Decision|2|||
162637622|NCT02743871|587388625|FG013|Overall Study|Lost to Follow-up|0|||
162637623|NCT02743871|587388612|FG000|Overall Study|Withdrawal by Subject|0|||
162637624|NCT02743871|587388613|FG001|Overall Study|Withdrawal by Subject|0|||
162637625|NCT02743871|587388614|FG002|Overall Study|Withdrawal by Subject|0|||
162637626|NCT02743871|587388615|FG003|Overall Study|Withdrawal by Subject|0|||
163002991|NCT02656303|588711421|FG001|Overall Study|Investigator Decision|1|||
163002992|NCT02656303|588711422|FG002|Overall Study|Investigator Decision|0|||
163002993|NCT02656303|588711420|FG000|Overall Study|Progressive Disease|25|||
163002994|NCT02656303|588711421|FG001|Overall Study|Progressive Disease|14|||
163002995|NCT02656303|588711422|FG002|Overall Study|Progressive Disease|10|||
163002996|NCT02656303|588711420|FG000|Overall Study|Study Terminated by Sponsor|20|||
162637627|NCT02743871|587388616|FG004|Overall Study|Withdrawal by Subject|0|||
162637628|NCT02743871|587388617|FG005|Overall Study|Withdrawal by Subject|0|||
162637629|NCT02743871|587388618|FG006|Overall Study|Withdrawal by Subject|0|||
163002997|NCT02656303|588711421|FG001|Overall Study|Study Terminated by Sponsor|7|||
162637630|NCT02743871|587388619|FG007|Overall Study|Withdrawal by Subject|0|||
162637631|NCT02743871|587388620|FG008|Overall Study|Withdrawal by Subject|0|||
162637632|NCT02743871|587388621|FG009|Overall Study|Withdrawal by Subject|0|||
162637633|NCT02743871|587388622|FG010|Overall Study|Withdrawal by Subject|1|||
162637634|NCT02743871|587388623|FG011|Overall Study|Withdrawal by Subject|0|||
162637635|NCT02743871|587388624|FG012|Overall Study|Withdrawal by Subject|12|||
162637636|NCT02743871|587388625|FG013|Overall Study|Withdrawal by Subject|6|||
162637637|NCT02743871|587388612|FG000|Overall Study|Adverse Event|1|||
162637638|NCT02743871|587388613|FG001|Overall Study|Adverse Event|0|||
162637639|NCT02743871|587388614|FG002|Overall Study|Adverse Event|0|||
162637640|NCT02743871|587388615|FG003|Overall Study|Adverse Event|0|||
162637641|NCT02743871|587388616|FG004|Overall Study|Adverse Event|0|||
162637642|NCT02743871|587388617|FG005|Overall Study|Adverse Event|0|||
162637643|NCT02743871|587388618|FG006|Overall Study|Adverse Event|0|||
162637644|NCT02743871|587388619|FG007|Overall Study|Adverse Event|0|||
162637645|NCT02743871|587388620|FG008|Overall Study|Adverse Event|0|||
162637646|NCT02743871|587388621|FG009|Overall Study|Adverse Event|0|||
162637647|NCT02743871|587388622|FG010|Overall Study|Adverse Event|0|||
162637648|NCT02743871|587388623|FG011|Overall Study|Adverse Event|0|||
162637649|NCT02743871|587388624|FG012|Overall Study|Adverse Event|0|||
162637650|NCT02743871|587388625|FG013|Overall Study|Adverse Event|0|||
162637651|NCT02743871|587388612|FG000|Overall Study|Other|0|||
162637652|NCT02743871|587388613|FG001|Overall Study|Other|0|||
162637653|NCT02743871|587388614|FG002|Overall Study|Other|0|||
162637654|NCT02743871|587388615|FG003|Overall Study|Other|0|||
162637655|NCT02743871|587388616|FG004|Overall Study|Other|0|||
162637656|NCT02743871|587388617|FG005|Overall Study|Other|0|||
162637657|NCT02743871|587388618|FG006|Overall Study|Other|0|||
162637658|NCT02743871|587388619|FG007|Overall Study|Other|0|||
162637659|NCT02743871|587388620|FG008|Overall Study|Other|0|||
162637660|NCT02743871|587388621|FG009|Overall Study|Other|0|||
162637661|NCT02743871|587388622|FG010|Overall Study|Other|0|||
162637662|NCT02743871|587388623|FG011|Overall Study|Other|1|||
162637663|NCT02743871|587388624|FG012|Overall Study|Other|1|||
163002998|NCT02656303|588711422|FG002|Overall Study|Study Terminated by Sponsor|5|||
163002999|NCT02656303|588711420|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
163003000|NCT02656303|588711421|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
163003001|NCT02656303|588711422|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
163003002|NCT02656303|588711420|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
163003003|NCT02656303|588711421|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
163003004|NCT02656303|588711422|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
163003005|NCT02656303|588711420|FG000|Overall Study|Reason not Specified|1|||
163003006|NCT02656303|588711421|FG001|Overall Study|Reason not Specified|1|||
163003007|NCT02656303|588711422|FG002|Overall Study|Reason not Specified|2|||
163003008|NCT01842438|588711425|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
163003009|NCT01842438|588711426|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
163003010|NCT01842438|588711425|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
163003011|NCT01842438|588711426|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
163003012|NCT01842438|588711425|FG000|T2: 6month Follow-up|Death|0|||
163003013|NCT01842438|588711426|FG001|T2: 6month Follow-up|Death|1|||
163003014|NCT04909853|588711427|FG000|Part 1|Assigned but not treated|0|||
163003015|NCT04909853|588711428|FG001|Part 1|Assigned but not treated|0|||
163003016|NCT04909853|588711429|FG002|Part 1|Assigned but not treated|1|||
163003017|NCT04909853|588711430|FG003|Part 1|Assigned but not treated|0|||
163003018|NCT04909853|588711427|FG000|Part 2|Adverse Event|0|||
163003019|NCT04909853|588711428|FG001|Part 2|Adverse Event|0|||
163003020|NCT04909853|588711429|FG002|Part 2|Adverse Event|0|||
163003021|NCT04909853|588711430|FG003|Part 2|Adverse Event|1|||
163003022|NCT02366689|588711439|FG000|Overall Study|Withdrawal by Subject|1|||
163003023|NCT02366689|588711440|FG001|Overall Study|Withdrawal by Subject|0|||
163003024|NCT02366689|588711441|FG002|Overall Study|Withdrawal by Subject|1|||
163003025|NCT02366689|588711439|FG000|Overall Study|Lost to Follow-up|3|||
163003026|NCT02366689|588711440|FG001|Overall Study|Lost to Follow-up|2|||
163003027|NCT02366689|588711441|FG002|Overall Study|Lost to Follow-up|0|||
163003028|NCT02366689|588711439|FG000|Overall Study|Pregnancy|0|||
163003029|NCT02366689|588711440|FG001|Overall Study|Pregnancy|1|||
163003030|NCT02366689|588711441|FG002|Overall Study|Pregnancy|1|||
163003031|NCT03718832|588711442|FG000|Analysis Sample|Withdrawal by Subject|18|||
163003032|NCT03718832|588711443|FG001|Analysis Sample|Withdrawal by Subject|15|||
163003033|NCT03718832|588711442|FG000|Analysis Sample|Legal hold on data|1|||
163003034|NCT03718832|588711443|FG001|Analysis Sample|Legal hold on data|0|||
163003035|NCT03718832|588711442|FG000|Analysis Sample|Participant from treated household|0|||
162637664|NCT02743871|587388625|FG013|Overall Study|Other|1|||
162637665|NCT02743871|587388612|FG000|Overall Study|Protocol Violation|0|||
162637666|NCT02743871|587388613|FG001|Overall Study|Protocol Violation|0|||
162637667|NCT02743871|587388614|FG002|Overall Study|Protocol Violation|0|||
162637668|NCT02743871|587388615|FG003|Overall Study|Protocol Violation|0|||
162637669|NCT02743871|587388616|FG004|Overall Study|Protocol Violation|0|||
162637670|NCT02743871|587388617|FG005|Overall Study|Protocol Violation|0|||
162637671|NCT02743871|587388618|FG006|Overall Study|Protocol Violation|0|||
162637672|NCT02743871|587388619|FG007|Overall Study|Protocol Violation|0|||
162637673|NCT02743871|587388620|FG008|Overall Study|Protocol Violation|0|||
162637674|NCT02743871|587388621|FG009|Overall Study|Protocol Violation|0|||
162637675|NCT02743871|587388622|FG010|Overall Study|Protocol Violation|0|||
162637676|NCT02743871|587388623|FG011|Overall Study|Protocol Violation|0|||
162637677|NCT02743871|587388624|FG012|Overall Study|Protocol Violation|2|||
162637678|NCT02743871|587388625|FG013|Overall Study|Protocol Violation|0|||
162637679|NCT03171415|587388627|FG000|Overall Study|Lost to Follow-up|0|||
162637680|NCT03171415|587388628|FG001|Overall Study|Lost to Follow-up|0|||
162637681|NCT03171415|587388629|FG002|Overall Study|Lost to Follow-up|0|||
162637682|NCT03171415|587388630|FG003|Overall Study|Lost to Follow-up|0|||
162637683|NCT03171415|587388631|FG004|Overall Study|Lost to Follow-up|2|||
162637684|NCT02848651|587388632|FG000|Overall Study|Death|85|||
162637685|NCT02848651|587388632|FG000|Overall Study|Lost to Follow-up|1|||
162637686|NCT02848651|587388632|FG000|Overall Study|Non-Compliance|1|||
162637687|NCT02848651|587388632|FG000|Overall Study|Symptomatic Deterioration|1|||
162637688|NCT02848651|587388632|FG000|Overall Study|Physician Decision|4|||
162637689|NCT02848651|587388632|FG000|Overall Study|Withdrawal by Subject|14|||
162637690|NCT04140292|587388633|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
162637691|NCT04140292|587388634|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
162637692|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
162637693|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
162637694|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
162637695|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
162637696|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
162637697|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
162637698|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
162637699|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
162637700|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
162637701|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
162637702|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
162637703|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
162637704|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
162637705|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
162637706|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
163003036|NCT03718832|588711443|FG001|Analysis Sample|Participant from treated household|1|||
163003037|NCT03718832|588711442|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
163060793|NCT02332707|588931286|FG001|Overall Study|Physician Decision|0|||
163060794|NCT02332707|588931287|FG002|Overall Study|Physician Decision|0|||
163060795|NCT02332707|588931288|FG003|Overall Study|Physician Decision|1|||
163060796|NCT02332707|588931289|FG004|Overall Study|Physician Decision|0|||
163060797|NCT02332707|588931290|FG005|Overall Study|Physician Decision|0|||
163060798|NCT02332707|588931291|FG006|Overall Study|Physician Decision|0|||
163060799|NCT02332707|588931292|FG007|Overall Study|Physician Decision|0|||
163060800|NCT02332707|588931293|FG008|Overall Study|Physician Decision|0|||
163060801|NCT02332707|588931294|FG009|Overall Study|Physician Decision|0|||
162637707|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
162637708|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
162637709|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
162637710|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
162637711|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
163003038|NCT03718832|588711443|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
163003039|NCT01996241|588711445|FG000|Overall Study|Lost to Follow-up|252|||
163003040|NCT01996241|588711446|FG001|Overall Study|Lost to Follow-up|235|||
163003041|NCT04882241|588711451|FG000|Overall Study|Ongoing in study|46|||
163003042|NCT04882241|588711452|FG001|Overall Study|Ongoing in study|48|||
163003043|NCT04882241|588711453|FG002|Overall Study|Ongoing in study|0|||
163003044|NCT04882241|588711454|FG003|Overall Study|Ongoing in study|0|||
163003045|NCT04882241|588711451|FG000|Overall Study|Death|13|||
163003046|NCT04882241|588711452|FG001|Overall Study|Death|13|||
163003047|NCT04882241|588711453|FG002|Overall Study|Death|0|||
163003048|NCT04882241|588711454|FG003|Overall Study|Death|0|||
163003049|NCT03639779|588711457|FG000|Overall Study|Lost to Follow-up|1|||
163003050|NCT02932462|588711458|FG000|Overall Study|Adverse Event|1|||
163003051|NCT02932462|588711459|FG001|Overall Study|Adverse Event|2|||
163060802|NCT02332707|588931295|FG010|Overall Study|Physician Decision|0|||
163060803|NCT02332707|588931296|FG011|Overall Study|Physician Decision|0|||
163060804|NCT02332707|588931297|FG012|Overall Study|Physician Decision|1|||
162637712|NCT01962207|587388638|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
162637713|NCT01962207|587388639|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
162637714|NCT01962207|587388640|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
163003052|NCT02932462|588711458|FG000|Overall Study|Lost to Follow-up|4|||
163003053|NCT02932462|588711459|FG001|Overall Study|Lost to Follow-up|1|||
163060805|NCT02332707|588931298|FG013|Overall Study|Physician Decision|0|||
163003054|NCT02932462|588711458|FG000|Overall Study|Protocol Violation|0|||
163003055|NCT02932462|588711459|FG001|Overall Study|Protocol Violation|5|||
163003056|NCT02932462|588711458|FG000|Overall Study|Withdrawal by Subject|1|||
163003057|NCT02932462|588711459|FG001|Overall Study|Withdrawal by Subject|4|||
163003058|NCT02932462|588711458|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163003059|NCT02932462|588711459|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163003060|NCT02932462|588711458|FG000|Overall Study|Progressive Disease|1|||
163003061|NCT02932462|588711459|FG001|Overall Study|Progressive Disease|0|||
163003062|NCT02413229|588711460|FG000|Overall Study|Adverse Event|0|||
163003063|NCT02413229|588711461|FG001|Overall Study|Adverse Event|0|||
163003064|NCT02413229|588711462|FG002|Overall Study|Adverse Event|0|||
163003065|NCT02413229|588711463|FG003|Overall Study|Adverse Event|1|||
163003066|NCT02413229|588711464|FG004|Overall Study|Adverse Event|0|||
163003067|NCT02413229|588711465|FG005|Overall Study|Adverse Event|0|||
162637715|NCT01962207|587388641|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
162637716|NCT00680043|587388642|FG000|Overall Study|Withdrawal by Subject|1|||
162637717|NCT00680043|587388643|FG001|Overall Study|Withdrawal by Subject|0|||
162637718|NCT00680043|587388644|FG002|Overall Study|Withdrawal by Subject|0|||
162637719|NCT00680043|587388642|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
162637720|NCT00680043|587388643|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
162637721|NCT00680043|587388644|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
162637722|NCT00680043|587388642|FG000|Overall Study|Renal Transplant|1|||
162637723|NCT00680043|587388643|FG001|Overall Study|Renal Transplant|0|||
162637724|NCT00680043|587388644|FG002|Overall Study|Renal Transplant|4|||
162637725|NCT02480114|587388645|FG000|Overall Study|Not completing surveys|3|||
162637726|NCT02480114|587388646|FG001|Overall Study|Not completing surveys|2|||
162637727|NCT02480114|587388645|FG000|Overall Study|Withdrawal by Subject|2|||
162637728|NCT02480114|587388646|FG001|Overall Study|Withdrawal by Subject|4|||
162637729|NCT02480114|587388645|FG000|Overall Study|Disease progression|3|||
162637730|NCT02480114|587388646|FG001|Overall Study|Disease progression|0|||
162637731|NCT02480114|587388645|FG000|Overall Study|Improper completion of survey|1|||
162637732|NCT02480114|587388646|FG001|Overall Study|Improper completion of survey|1|||
162637733|NCT02480114|587388645|FG000|Overall Study|Not eligible|0|||
162637734|NCT02480114|587388646|FG001|Overall Study|Not eligible|1|||
162637735|NCT02081690|587390717|FG000|Overall Study|Death|3|||
162637736|NCT02081690|587390717|FG000|Overall Study|Physician Decision|3|||
162637737|NCT02081690|587390717|FG000|Overall Study|Withdrawal by Subject|1|||
162637738|NCT00982488|587390720|FG000|Overall Study|Administrative reason by sponsor|81|||
162637739|NCT00982488|587390721|FG001|Overall Study|Administrative reason by sponsor|3|||
162637740|NCT00982488|587390722|FG002|Overall Study|Administrative reason by sponsor|11|||
162637741|NCT00982488|587390723|FG003|Overall Study|Administrative reason by sponsor|0|||
162637742|NCT00982488|587390724|FG004|Overall Study|Administrative reason by sponsor|0|||
162637743|NCT00982488|587390720|FG000|Overall Study|Adverse event unrelated to study drug|5|||
162637744|NCT00982488|587390721|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162637745|NCT00982488|587390722|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162637746|NCT00982488|587390723|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163003068|NCT02413229|588711466|FG006|Overall Study|Adverse Event|0|||
163003069|NCT02413229|588711467|FG007|Overall Study|Adverse Event|1|||
163003070|NCT02413229|588711460|FG000|Overall Study|Lost to Follow-up|0|||
163003071|NCT02413229|588711461|FG001|Overall Study|Lost to Follow-up|0|||
163003072|NCT02413229|588711462|FG002|Overall Study|Lost to Follow-up|1|||
163003073|NCT02413229|588711463|FG003|Overall Study|Lost to Follow-up|0|||
163003074|NCT02413229|588711464|FG004|Overall Study|Lost to Follow-up|2|||
163003075|NCT02413229|588711465|FG005|Overall Study|Lost to Follow-up|0|||
163003076|NCT02413229|588711466|FG006|Overall Study|Lost to Follow-up|0|||
163003077|NCT02413229|588711467|FG007|Overall Study|Lost to Follow-up|0|||
163003078|NCT02413229|588711460|FG000|Overall Study|Withdrawal by Subject|1|||
163003079|NCT02413229|588711461|FG001|Overall Study|Withdrawal by Subject|1|||
163003080|NCT02413229|588711462|FG002|Overall Study|Withdrawal by Subject|0|||
163003081|NCT02413229|588711463|FG003|Overall Study|Withdrawal by Subject|0|||
163003082|NCT02413229|588711464|FG004|Overall Study|Withdrawal by Subject|1|||
163003083|NCT02413229|588711465|FG005|Overall Study|Withdrawal by Subject|0|||
163003084|NCT02413229|588711466|FG006|Overall Study|Withdrawal by Subject|0|||
163003085|NCT02413229|588711467|FG007|Overall Study|Withdrawal by Subject|2|||
163003086|NCT02413229|588711460|FG000|Overall Study|Progressive Disease|0|||
163003087|NCT02413229|588711461|FG001|Overall Study|Progressive Disease|0|||
163003088|NCT02413229|588711462|FG002|Overall Study|Progressive Disease|0|||
163003089|NCT02413229|588711463|FG003|Overall Study|Progressive Disease|0|||
163003090|NCT02413229|588711464|FG004|Overall Study|Progressive Disease|0|||
163003091|NCT02413229|588711465|FG005|Overall Study|Progressive Disease|0|||
163003092|NCT02413229|588711466|FG006|Overall Study|Progressive Disease|0|||
163003093|NCT02413229|588711467|FG007|Overall Study|Progressive Disease|1|||
163003094|NCT02009722|588711477|FG000|Overall Study|Protocol Violation|1|||
163003095|NCT02009722|588711478|FG001|Overall Study|Protocol Violation|2|||
163003096|NCT02009722|588711477|FG000|Overall Study|Did not receive intervention|0|||
163003097|NCT02009722|588711478|FG001|Overall Study|Did not receive intervention|1|||
163003098|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
163003099|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
163003100|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
163003101|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
163003102|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
163003103|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
163003104|NCT02955212|588711479|FG000|Period 1: Double-blind Treatment Period|Other|3|||
163003105|NCT02955212|588711480|FG001|Period 1: Double-blind Treatment Period|Other|2|||
163060806|NCT02332707|588931299|FG014|Overall Study|Physician Decision|0|||
163060807|NCT02332707|588931300|FG015|Overall Study|Physician Decision|0|||
163060808|NCT02332707|588931301|FG016|Overall Study|Physician Decision|0|||
163060809|NCT02332707|588931302|FG017|Overall Study|Physician Decision|0|||
163060810|NCT02332707|588931285|FG000|Overall Study|Withdrawal by Subject|0|||
163060811|NCT02332707|588931286|FG001|Overall Study|Withdrawal by Subject|0|||
163060812|NCT02332707|588931287|FG002|Overall Study|Withdrawal by Subject|1|||
162637747|NCT00982488|587390724|FG004|Overall Study|Adverse event unrelated to study drug|0|||
162637748|NCT00982488|587390720|FG000|Overall Study|Death|11|||
162637749|NCT00982488|587390721|FG001|Overall Study|Death|0|||
162637750|NCT00982488|587390722|FG002|Overall Study|Death|2|||
162637751|NCT00982488|587390723|FG003|Overall Study|Death|0|||
162637752|NCT00982488|587390724|FG004|Overall Study|Death|0|||
162637753|NCT00982488|587390720|FG000|Overall Study|Disease progression|30|||
162637754|NCT00982488|587390721|FG001|Overall Study|Disease progression|5|||
162637755|NCT00982488|587390722|FG002|Overall Study|Disease progression|10|||
162637756|NCT00982488|587390723|FG003|Overall Study|Disease progression|1|||
162637757|NCT00982488|587390724|FG004|Overall Study|Disease progression|1|||
162637758|NCT00982488|587390720|FG000|Overall Study|Lost to Follow-up|1|||
162637759|NCT00982488|587390721|FG001|Overall Study|Lost to Follow-up|0|||
162637760|NCT00982488|587390722|FG002|Overall Study|Lost to Follow-up|0|||
162637761|NCT00982488|587390723|FG003|Overall Study|Lost to Follow-up|0|||
162637762|NCT00982488|587390724|FG004|Overall Study|Lost to Follow-up|0|||
162637763|NCT00982488|587390720|FG000|Overall Study|Maximum clinical benefit|1|||
162637764|NCT00982488|587390721|FG001|Overall Study|Maximum clinical benefit|1|||
162637765|NCT00982488|587390722|FG002|Overall Study|Maximum clinical benefit|1|||
162637766|NCT00982488|587390723|FG003|Overall Study|Maximum clinical benefit|0|||
162637767|NCT00982488|587390724|FG004|Overall Study|Maximum clinical benefit|0|||
162637768|NCT00982488|587390720|FG000|Overall Study|Other|15|||
162637769|NCT00982488|587390721|FG001|Overall Study|Other|1|||
162637770|NCT00982488|587390722|FG002|Overall Study|Other|3|||
162637771|NCT00982488|587390723|FG003|Overall Study|Other|1|||
162637772|NCT00982488|587390724|FG004|Overall Study|Other|0|||
162637773|NCT00982488|587390720|FG000|Overall Study|Poor compliance/noncompliance|0|||
162637774|NCT00982488|587390721|FG001|Overall Study|Poor compliance/noncompliance|1|||
162637775|NCT00982488|587390722|FG002|Overall Study|Poor compliance/noncompliance|0|||
163003106|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Adverse Event|11|||
163003107|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Adverse Event|7|||
163003108|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
163003109|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
163003110|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
163003111|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
163003112|NCT02955212|588711479|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
163003113|NCT02955212|588711480|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
163003114|NCT02955212|588711479|FG000|Period 2: Open-label Extension|Other|2|||
163003115|NCT02955212|588711480|FG001|Period 2: Open-label Extension|Other|4|||
163060813|NCT02332707|588931288|FG003|Overall Study|Withdrawal by Subject|0|||
163060814|NCT02332707|588931289|FG004|Overall Study|Withdrawal by Subject|0|||
163060815|NCT02332707|588931290|FG005|Overall Study|Withdrawal by Subject|0|||
163060816|NCT02332707|588931291|FG006|Overall Study|Withdrawal by Subject|0|||
163060817|NCT02332707|588931292|FG007|Overall Study|Withdrawal by Subject|0|||
163060818|NCT02332707|588931293|FG008|Overall Study|Withdrawal by Subject|0|||
163060819|NCT02332707|588931294|FG009|Overall Study|Withdrawal by Subject|3|||
163060820|NCT02332707|588931295|FG010|Overall Study|Withdrawal by Subject|0|||
163060821|NCT02332707|588931296|FG011|Overall Study|Withdrawal by Subject|0|||
163060822|NCT02332707|588931297|FG012|Overall Study|Withdrawal by Subject|0|||
163060823|NCT02332707|588931298|FG013|Overall Study|Withdrawal by Subject|0|||
162637776|NCT00982488|587390723|FG003|Overall Study|Poor compliance/noncompliance|0|||
163060824|NCT02332707|588931299|FG014|Overall Study|Withdrawal by Subject|0|||
163060825|NCT02332707|588931300|FG015|Overall Study|Withdrawal by Subject|0|||
162637777|NCT00982488|587390724|FG004|Overall Study|Poor compliance/noncompliance|0|||
162637778|NCT00982488|587390720|FG000|Overall Study|Stem cell transplant|2|||
162637779|NCT00982488|587390721|FG001|Overall Study|Stem cell transplant|0|||
162637780|NCT00982488|587390722|FG002|Overall Study|Stem cell transplant|0|||
162637781|NCT00982488|587390723|FG003|Overall Study|Stem cell transplant|1|||
162637782|NCT00982488|587390724|FG004|Overall Study|Stem cell transplant|0|||
163003116|NCT02454933|588711485|FG000|Overall Study|Progressive disease|10|||
163003117|NCT02454933|588711486|FG001|Overall Study|Progressive disease|7|||
163003118|NCT02454933|588711485|FG000|Overall Study|Adverse Event|1|||
163003119|NCT02454933|588711486|FG001|Overall Study|Adverse Event|1|||
163003120|NCT02454933|588711485|FG000|Overall Study|Withdrawal by Subject|0|||
163003121|NCT02454933|588711486|FG001|Overall Study|Withdrawal by Subject|3|||
163003122|NCT02454933|588711485|FG000|Overall Study|Lost to Follow-up|1|||
163003123|NCT02454933|588711486|FG001|Overall Study|Lost to Follow-up|0|||
163003124|NCT02071225|588711494|FG000|Overall Study|Withdrawal of Consent|2|||
163003125|NCT02071225|588711494|FG000|Overall Study|Protocol Deviation|1|||
163003126|NCT02071225|588711494|FG000|Overall Study|Lost to Follow-up|2|||
163003127|NCT02071225|588711494|FG000|Overall Study|Death|25|||
163003128|NCT01342081|588711497|FG000|Overall Study|Did not receive allocated intervention|0|||
163003129|NCT01342081|588711498|FG001|Overall Study|Did not receive allocated intervention|0|||
163003130|NCT01342081|588711499|FG002|Overall Study|Did not receive allocated intervention|1|||
163003131|NCT01342081|588711497|FG000|Overall Study|Adverse Event|1|||
163003132|NCT01342081|588711498|FG001|Overall Study|Adverse Event|0|||
163003133|NCT01342081|588711499|FG002|Overall Study|Adverse Event|0|||
163003134|NCT01342081|588711497|FG000|Overall Study|Physician Decision|0|||
163003135|NCT01342081|588711498|FG001|Overall Study|Physician Decision|1|||
163003136|NCT01342081|588711499|FG002|Overall Study|Physician Decision|0|||
163003137|NCT01342081|588711497|FG000|Overall Study|Withdrawal by Subject|1|||
163003138|NCT01342081|588711498|FG001|Overall Study|Withdrawal by Subject|1|||
163003139|NCT01342081|588711499|FG002|Overall Study|Withdrawal by Subject|0|||
163003140|NCT04720053|588711504|FG000|Overall Study|Lost to Follow-up|12|||
163003141|NCT03519087|588711505|FG000|Clinic Evaluation|Physician Decision|15|||
163003142|NCT03519087|588711506|FG001|Clinic Evaluation|Physician Decision|18|||
163003143|NCT03519087|588711507|FG002|Clinic Evaluation|Physician Decision|0|||
163003144|NCT03519087|588711508|FG003|Clinic Evaluation|Physician Decision|0|||
163003145|NCT03519087|588711509|FG004|Clinic Evaluation|Physician Decision|0|||
163003146|NCT03519087|588711505|FG000|Clinic Evaluation|Protocol Violation|1|||
163003147|NCT03519087|588711506|FG001|Clinic Evaluation|Protocol Violation|0|||
163003148|NCT03519087|588711507|FG002|Clinic Evaluation|Protocol Violation|0|||
163003149|NCT03519087|588711508|FG003|Clinic Evaluation|Protocol Violation|0|||
163003150|NCT03519087|588711509|FG004|Clinic Evaluation|Protocol Violation|0|||
163003151|NCT03519087|588711505|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
163003152|NCT03519087|588711506|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
163003153|NCT03519087|588711507|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003154|NCT03519087|588711508|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003155|NCT03519087|588711509|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
163003156|NCT03519087|588711505|FG000|Re-randomization for Treatment|Not appropriate|2|||
163003157|NCT03519087|588711506|FG001|Re-randomization for Treatment|Not appropriate|3|||
163003158|NCT03519087|588711507|FG002|Re-randomization for Treatment|Not appropriate|0|||
163003159|NCT03519087|588711508|FG003|Re-randomization for Treatment|Not appropriate|0|||
163003160|NCT03519087|588711509|FG004|Re-randomization for Treatment|Not appropriate|0|||
163003161|NCT03519087|588711505|FG000|Laboratory Testing|Lost to Follow-up|0|||
163003162|NCT03519087|588711506|FG001|Laboratory Testing|Lost to Follow-up|0|||
163003163|NCT03519087|588711507|FG002|Laboratory Testing|Lost to Follow-up|2|||
163003164|NCT03519087|588711508|FG003|Laboratory Testing|Lost to Follow-up|3|||
163003165|NCT03519087|588711509|FG004|Laboratory Testing|Lost to Follow-up|6|||
163003166|NCT03519087|588711505|FG000|Laboratory Testing|Protocol Violation|0|||
163003167|NCT03519087|588711506|FG001|Laboratory Testing|Protocol Violation|0|||
163003168|NCT03519087|588711507|FG002|Laboratory Testing|Protocol Violation|0|||
163003169|NCT03519087|588711508|FG003|Laboratory Testing|Protocol Violation|1|||
163003170|NCT03519087|588711509|FG004|Laboratory Testing|Protocol Violation|0|||
163003171|NCT01137071|588711510|FG000|Overall Study|Disease Progression|11|||
163003172|NCT01137071|588711510|FG000|Overall Study|Withdrawal by Subject|2|||
163003173|NCT01137071|588711510|FG000|Overall Study|Wrongly Included|1|||
163060826|NCT02332707|588931301|FG016|Overall Study|Withdrawal by Subject|0|||
163060827|NCT02332707|588931302|FG017|Overall Study|Withdrawal by Subject|0|||
162637783|NCT00982488|587390720|FG000|Overall Study|Study drug toxicity|34|||
163003174|NCT04807400|588711513|FG000|Overall Study|Adverse Event|2|||
163003175|NCT04807400|588711514|FG001|Overall Study|Adverse Event|3|||
163003176|NCT04807400|588711515|FG002|Overall Study|Adverse Event|3|||
163003177|NCT04807400|588711513|FG000|Overall Study|Death|2|||
163003178|NCT04807400|588711514|FG001|Overall Study|Death|0|||
163003179|NCT04807400|588711515|FG002|Overall Study|Death|0|||
163003180|NCT04807400|588711513|FG000|Overall Study|Lost to Follow-up|8|||
163003181|NCT04807400|588711514|FG001|Overall Study|Lost to Follow-up|6|||
163003182|NCT04807400|588711515|FG002|Overall Study|Lost to Follow-up|6|||
163003183|NCT04807400|588711513|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163060828|NCT01473134|588931303|FG000|Overall Study|Lost to Follow-up|21|||
163003184|NCT04807400|588711514|FG001|Overall Study|Non-Compliance With Study Drug|4|||
163003185|NCT04807400|588711515|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163003186|NCT04807400|588711513|FG000|Overall Study|Participant Decision|20|||
163003187|NCT04807400|588711514|FG001|Overall Study|Participant Decision|19|||
163003188|NCT04807400|588711515|FG002|Overall Study|Participant Decision|26|||
163060829|NCT01473134|588931304|FG001|Overall Study|Lost to Follow-up|13|||
163060830|NCT01473134|588931303|FG000|Overall Study|Protocol Violation|32|||
163060831|NCT01473134|588931304|FG001|Overall Study|Protocol Violation|19|||
163060832|NCT01473134|588931303|FG000|Overall Study|Withdrawal by Subject|1|||
163060833|NCT01473134|588931304|FG001|Overall Study|Withdrawal by Subject|2|||
163060834|NCT01473134|588931303|FG000|Overall Study|Death|0|||
163060835|NCT01473134|588931304|FG001|Overall Study|Death|1|||
163060836|NCT01473134|588931303|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
163060837|NCT01473134|588931304|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
163060838|NCT04761822|588931307|FG000|Overall Study|Adverse Event|3|||
163060839|NCT04761822|588931308|FG001|Overall Study|Adverse Event|1|||
163060840|NCT04761822|588931309|FG002|Overall Study|Adverse Event|1|||
163060841|NCT04761822|588931310|FG003|Overall Study|Adverse Event|3|||
163060842|NCT04761822|588931307|FG000|Overall Study|Lost to Follow-up|1|||
163060843|NCT04761822|588931308|FG001|Overall Study|Lost to Follow-up|0|||
163060844|NCT04761822|588931309|FG002|Overall Study|Lost to Follow-up|2|||
163060845|NCT04761822|588931310|FG003|Overall Study|Lost to Follow-up|3|||
163060846|NCT04761822|588931307|FG000|Overall Study|Physician Decision|0|||
163060847|NCT04761822|588931308|FG001|Overall Study|Physician Decision|1|||
163060848|NCT04761822|588931309|FG002|Overall Study|Physician Decision|0|||
163060849|NCT04761822|588931310|FG003|Overall Study|Physician Decision|0|||
163060850|NCT04761822|588931307|FG000|Overall Study|Withdrawal by Subject|3|||
163060851|NCT04761822|588931308|FG001|Overall Study|Withdrawal by Subject|8|||
163060852|NCT04761822|588931309|FG002|Overall Study|Withdrawal by Subject|1|||
162637784|NCT00982488|587390721|FG001|Overall Study|Study drug toxicity|1|||
162637785|NCT00982488|587390722|FG002|Overall Study|Study drug toxicity|6|||
162637786|NCT00982488|587390723|FG003|Overall Study|Study drug toxicity|0|||
162637787|NCT00982488|587390724|FG004|Overall Study|Study drug toxicity|0|||
162637788|NCT00982488|587390720|FG000|Overall Study|Withdrawal by Subject|5|||
162637789|NCT00982488|587390721|FG001|Overall Study|Withdrawal by Subject|1|||
162637790|NCT00982488|587390722|FG002|Overall Study|Withdrawal by Subject|1|||
162637791|NCT00982488|587390723|FG003|Overall Study|Withdrawal by Subject|0|||
162637792|NCT00982488|587390724|FG004|Overall Study|Withdrawal by Subject|0|||
162637793|NCT03204981|587390725|FG000|Overall Study|Physician Decision|2|||
162637794|NCT03204981|587390725|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
162637795|NCT04203238|587390726|FG000|Overall Study|Withdrawal by Subject|1|||
162637796|NCT04203238|587390727|FG001|Overall Study|Withdrawal by Subject|1|||
162637797|NCT04203238|587390726|FG000|Overall Study|Covid-19|3|||
162637798|NCT04203238|587390727|FG001|Overall Study|Covid-19|0|||
162637799|NCT04244786|587390730|FG000|Overall Study|Adverse Event|0|||
162637800|NCT04244786|587390731|FG001|Overall Study|Adverse Event|0|||
162637801|NCT04244786|587390732|FG002|Overall Study|Adverse Event|2|||
162637802|NCT04244786|587390730|FG000|Overall Study|Withdrawal by Subject|0|||
162637803|NCT04244786|587390731|FG001|Overall Study|Withdrawal by Subject|0|||
162637804|NCT04244786|587390732|FG002|Overall Study|Withdrawal by Subject|5|||
162637805|NCT00415909|587390733|FG000|Overall Study|Withdrawal by Subject|2|||
162637806|NCT00415909|587390733|FG000|Overall Study|Death|1|||
162637807|NCT05024058|587390734|FG000|Treatment|Study terminated by sponsor|5|||
162637808|NCT05024058|587390735|FG001|Treatment|Study terminated by sponsor|6|||
162637809|NCT05024058|587390736|FG002|Treatment|Study terminated by sponsor|4|||
162637810|NCT05024058|587390737|FG003|Treatment|Study terminated by sponsor|2|||
162637811|NCT05024058|587390738|FG004|Treatment|Study terminated by sponsor|3|||
163060853|NCT04761822|588931310|FG003|Overall Study|Withdrawal by Subject|11|||
162637812|NCT05024058|587390739|FG005|Treatment|Study terminated by sponsor|3|||
162637813|NCT05024058|587390740|FG006|Treatment|Study terminated by sponsor|1|||
162637814|NCT05024058|587390741|FG007|Treatment|Study terminated by sponsor|3|||
163060854|NCT04761822|588931307|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
163060855|NCT04761822|588931308|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163060856|NCT04761822|588931309|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163060857|NCT04761822|588931310|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
163060858|NCT04761822|588931307|FG000|Overall Study|Participant requested unblinding|0|||
163060859|NCT04761822|588931308|FG001|Overall Study|Participant requested unblinding|0|||
162637815|NCT05024058|587390742|FG008|Treatment|Study terminated by sponsor|6|||
163003189|NCT04807400|588711513|FG000|Overall Study|Physician Decision|0|||
163003190|NCT04807400|588711514|FG001|Overall Study|Physician Decision|1|||
163003191|NCT04807400|588711515|FG002|Overall Study|Physician Decision|0|||
163003192|NCT04807400|588711513|FG000|Overall Study|Protocol Violation|4|||
163003193|NCT04807400|588711514|FG001|Overall Study|Protocol Violation|3|||
163003194|NCT04807400|588711515|FG002|Overall Study|Protocol Violation|7|||
163003195|NCT04807400|588711513|FG000|Overall Study|Withdrawal by Subject|13|||
163003196|NCT04807400|588711514|FG001|Overall Study|Withdrawal by Subject|9|||
163060860|NCT04761822|588931309|FG002|Overall Study|Participant requested unblinding|0|||
163060861|NCT04761822|588931310|FG003|Overall Study|Participant requested unblinding|1|||
163060862|NCT06217380|588931313|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
163060863|NCT06217380|588931313|FG000|Overall Study|Physician Decision|1|||
163060864|NCT06217380|588931313|FG000|Overall Study|Withdrawal by Subject|2|||
163060865|NCT03286504|588931322|FG000|Overall Study|Lost to Follow-up|19|||
163060866|NCT03286504|588931323|FG001|Overall Study|Lost to Follow-up|16|||
163060867|NCT00141921|588931326|FG000|Overall Study|Remain on Study|28|||
163060868|NCT00141921|588931326|FG000|Overall Study|Withdrawal by Subject|42|||
163060869|NCT00141921|588931326|FG000|Overall Study|Lost to Follow-up|19|||
163060870|NCT00141921|588931326|FG000|Overall Study|Noncompliance|17|||
163060871|NCT00141921|588931326|FG000|Overall Study|Disease Progression|7|||
163060872|NCT00141921|588931326|FG000|Overall Study|Protocol Deviation|7|||
163060873|NCT00141921|588931326|FG000|Overall Study|Adverse Event|5|||
163060874|NCT00141921|588931326|FG000|Overall Study|Administrative Decision|2|||
163060875|NCT00141921|588931326|FG000|Overall Study|Pregnancy|4|||
163060876|NCT00141921|588931326|FG000|Overall Study|Ineligibility Determined|2|||
163060877|NCT00141921|588931326|FG000|Overall Study|Other|8|||
163060878|NCT03320369|588931327|FG000|Overall Study|Adverse Event|1|||
163060879|NCT03320369|588931327|FG000|Overall Study|Withdrawal by Subject|2|||
163060880|NCT03813654|588931328|FG000|Overall Study|Protocol Violation|0|||
163060881|NCT03813654|588931329|FG001|Overall Study|Protocol Violation|1|||
163060882|NCT03813654|588931330|FG002|Overall Study|Protocol Violation|2|||
163060883|NCT03813654|588931328|FG000|Overall Study|Withdrawal by Subject|1|||
163060884|NCT03813654|588931329|FG001|Overall Study|Withdrawal by Subject|0|||
163060885|NCT03813654|588931330|FG002|Overall Study|Withdrawal by Subject|0|||
163060886|NCT00297167|588931343|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
163060887|NCT00297167|588931344|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
163060888|NCT00297167|588931345|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
163060889|NCT00297167|588931343|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
163060890|NCT00297167|588931344|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
163060891|NCT00297167|588931345|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
163060892|NCT00171249|588931348|FG000|Overall Study|Withdrawal by Subject|2|||
163060893|NCT00171249|588931349|FG001|Overall Study|Withdrawal by Subject|0|||
163060894|NCT00171249|588931350|FG002|Overall Study|Withdrawal by Subject|0|||
163060895|NCT00171249|588931351|FG003|Overall Study|Withdrawal by Subject|6|||
163060896|NCT00171249|588931352|FG004|Overall Study|Withdrawal by Subject|0|||
163060897|NCT00171249|588931353|FG005|Overall Study|Withdrawal by Subject|0|||
163060898|NCT00171249|588931354|FG006|Overall Study|Withdrawal by Subject|0|||
163060899|NCT00171249|588931348|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
163060900|NCT00171249|588931349|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163060901|NCT00171249|588931350|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
163060902|NCT00171249|588931351|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
163060903|NCT00171249|588931352|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163060904|NCT00171249|588931353|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
163060905|NCT00171249|588931354|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163060906|NCT00171249|588931348|FG000|Overall Study|Death|7|||
163060907|NCT00171249|588931349|FG001|Overall Study|Death|1|||
163060908|NCT00171249|588931350|FG002|Overall Study|Death|0|||
163060909|NCT00171249|588931351|FG003|Overall Study|Death|4|||
163060910|NCT00171249|588931352|FG004|Overall Study|Death|0|||
163003197|NCT04807400|588711515|FG002|Overall Study|Withdrawal by Subject|20|||
163060911|NCT00171249|588931353|FG005|Overall Study|Death|3|||
163060912|NCT00171249|588931354|FG006|Overall Study|Death|1|||
163060913|NCT00171249|588931348|FG000|Overall Study|Other|10|||
163060914|NCT00171249|588931349|FG001|Overall Study|Other|0|||
163060915|NCT00171249|588931350|FG002|Overall Study|Other|0|||
163060916|NCT00171249|588931351|FG003|Overall Study|Other|43|||
163060917|NCT00171249|588931352|FG004|Overall Study|Other|0|||
163060918|NCT00171249|588931353|FG005|Overall Study|Other|2|||
163060919|NCT00171249|588931354|FG006|Overall Study|Other|0|||
163060920|NCT00171249|588931348|FG000|Overall Study|No Longer Requires Study Drug|4|||
163060921|NCT00171249|588931349|FG001|Overall Study|No Longer Requires Study Drug|0|||
163003198|NCT04807400|588711513|FG000|Overall Study|Mis-randomized|1|||
163003199|NCT04807400|588711514|FG001|Overall Study|Mis-randomized|0|||
163003200|NCT04807400|588711515|FG002|Overall Study|Mis-randomized|0|||
163003201|NCT04194645|588711516|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003202|NCT04194645|588711517|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003203|NCT04194645|588711518|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003204|NCT04194645|588711519|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003205|NCT04194645|588711520|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003206|NCT04194645|588711521|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003207|NCT04194645|588711522|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003208|NCT04194645|588711523|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003209|NCT04194645|588711524|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003210|NCT04194645|588711525|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
163003211|NCT04194645|588711526|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003212|NCT04194645|588711527|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003213|NCT04194645|588711528|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003214|NCT04194645|588711529|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003215|NCT04194645|588711530|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
163003216|NCT03656744|588711531|FG000|Overall Study|Adverse Event|1|||
162637816|NCT05024058|587390743|FG009|Treatment|Study terminated by sponsor|6|||
162637817|NCT05024058|587390734|FG000|Follow-up|Withdrawal by Subject|1|||
162637818|NCT05024058|587390735|FG001|Follow-up|Withdrawal by Subject|0|||
162637819|NCT05024058|587390736|FG002|Follow-up|Withdrawal by Subject|1|||
162637820|NCT05024058|587390737|FG003|Follow-up|Withdrawal by Subject|0|||
162637821|NCT05024058|587390738|FG004|Follow-up|Withdrawal by Subject|0|||
162637822|NCT05024058|587390739|FG005|Follow-up|Withdrawal by Subject|0|||
162637823|NCT05024058|587390740|FG006|Follow-up|Withdrawal by Subject|0|||
162637824|NCT05024058|587390741|FG007|Follow-up|Withdrawal by Subject|1|||
162637825|NCT05024058|587390742|FG008|Follow-up|Withdrawal by Subject|0|||
162637826|NCT05024058|587390743|FG009|Follow-up|Withdrawal by Subject|1|||
162637827|NCT02734810|587390744|FG000|Overall Study|Adverse Event|1|||
162637828|NCT02734810|587390745|FG001|Overall Study|Adverse Event|0|||
162637829|NCT02734810|587390744|FG000|Overall Study|Lack of Efficacy|1|||
162637830|NCT02734810|587390745|FG001|Overall Study|Lack of Efficacy|0|||
162637831|NCT02507505|587390746|FG000|Overall Study|Withdrawal by Subject|13|||
162637832|NCT02507505|587390747|FG001|Overall Study|Withdrawal by Subject|11|||
162637833|NCT02507505|587390746|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
162637834|NCT02507505|587390747|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
162637835|NCT02507505|587390746|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
162637836|NCT02507505|587390747|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
162637837|NCT02507505|587390746|FG000|Overall Study|Death before receipt of anesthesia|0|||
162637838|NCT02507505|587390747|FG001|Overall Study|Death before receipt of anesthesia|1|||
162637839|NCT00931762|587390748|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
162637840|NCT00931762|587390748|FG000|Overall Study|Administrative Problems|5|||
162637841|NCT00931762|587390748|FG000|Overall Study|Death|1|||
162637842|NCT00931762|587390748|FG000|Overall Study|Disease Progression|3|||
162637843|NCT00931762|587390748|FG000|Overall Study|Adverse Event (s)|11|||
162637844|NCT00931762|587390748|FG000|Overall Study|Subject withdrew consent|13|||
162637845|NCT03510884|587390749|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
162637846|NCT03510884|587390750|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
162637847|NCT03510884|587390751|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
162637848|NCT03510884|587390752|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
162637849|NCT03510884|587390749|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
162637850|NCT03510884|587390750|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
162637851|NCT03510884|587390751|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
162637852|NCT03510884|587390752|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
162637853|NCT03510884|587390749|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
162637854|NCT03510884|587390750|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
162637855|NCT03510884|587390751|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
162637856|NCT03510884|587390752|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
163003217|NCT03656744|588711532|FG001|Overall Study|Adverse Event|4|||
163003218|NCT03656744|588711533|FG002|Overall Study|Adverse Event|1|||
162637857|NCT03510884|587390749|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162637858|NCT03510884|587390750|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
162637859|NCT03510884|587390751|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162715788|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163003219|NCT03656744|588711531|FG000|Overall Study|Protocol Violation|1|||
163003220|NCT03656744|588711532|FG001|Overall Study|Protocol Violation|0|||
163060922|NCT00171249|588931350|FG002|Overall Study|No Longer Requires Study Drug|0|||
163060923|NCT00171249|588931351|FG003|Overall Study|No Longer Requires Study Drug|3|||
162715789|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715790|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715791|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715792|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715793|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715794|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715795|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162637860|NCT03510884|587390752|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162637861|NCT03510884|587390749|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
162637862|NCT03510884|587390750|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
162637863|NCT03510884|587390751|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
162637864|NCT03510884|587390752|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
162637865|NCT03510884|587390749|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
162637866|NCT03510884|587390750|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
162637867|NCT03510884|587390751|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
162637868|NCT03510884|587390752|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
162637869|NCT03510884|587390749|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162637870|NCT03510884|587390750|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
162637871|NCT03510884|587390751|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162637872|NCT03510884|587390752|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162637873|NCT03510884|587390749|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
162637874|NCT03510884|587390750|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
162637875|NCT03510884|587390751|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
162637876|NCT03510884|587390752|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
162637877|NCT03510884|587390749|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162637878|NCT03510884|587390750|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
162637879|NCT03510884|587390751|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162637880|NCT03510884|587390752|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162637881|NCT03510884|587390749|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
162637882|NCT03510884|587390750|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
162637883|NCT03510884|587390751|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
162637884|NCT03510884|587390752|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
162637885|NCT00157950|587390753|FG000|Overall Study|Death|1|||
162637886|NCT00157950|587390754|FG001|Overall Study|Death|0|||
162637887|NCT01287897|587390758|FG000|Overall Study|Adverse Event|5|||
162637888|NCT01287897|587390759|FG001|Overall Study|Adverse Event|3|||
162637889|NCT01287897|587390760|FG002|Overall Study|Adverse Event|6|||
162637890|NCT01287897|587390761|FG003|Overall Study|Adverse Event|4|||
162637891|NCT01287897|587390758|FG000|Overall Study|Lack of Efficacy|2|||
163003221|NCT03656744|588711533|FG002|Overall Study|Protocol Violation|0|||
163003222|NCT03656744|588711531|FG000|Overall Study|Lost to Follow-up|2|||
163003223|NCT03656744|588711532|FG001|Overall Study|Lost to Follow-up|2|||
162637892|NCT01287897|587390759|FG001|Overall Study|Lack of Efficacy|0|||
162637893|NCT01287897|587390760|FG002|Overall Study|Lack of Efficacy|0|||
162637894|NCT01287897|587390761|FG003|Overall Study|Lack of Efficacy|0|||
162637895|NCT01287897|587390758|FG000|Overall Study|Protocol Violation|1|||
162637896|NCT01287897|587390759|FG001|Overall Study|Protocol Violation|1|||
162637897|NCT01287897|587390760|FG002|Overall Study|Protocol Violation|0|||
162637898|NCT01287897|587390761|FG003|Overall Study|Protocol Violation|1|||
163003224|NCT03656744|588711533|FG002|Overall Study|Lost to Follow-up|0|||
163003225|NCT03656744|588711531|FG000|Overall Study|Withdrawal by Subject|0|||
163003226|NCT03656744|588711532|FG001|Overall Study|Withdrawal by Subject|1|||
163003227|NCT03656744|588711533|FG002|Overall Study|Withdrawal by Subject|0|||
163003228|NCT03656744|588711531|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
163003229|NCT03656744|588711532|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
163003230|NCT03656744|588711533|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
163003231|NCT03076775|588711534|FG000|Overall Study|Lost to Follow-up|1|||
163003232|NCT03076775|588711535|FG001|Overall Study|Lost to Follow-up|0|||
163003233|NCT01783886|588711536|FG000|Overall Study|Lost to Follow-up|0|||
163003234|NCT01783886|588711537|FG001|Overall Study|Lost to Follow-up|3|||
163003235|NCT01783886|588711538|FG002|Overall Study|Lost to Follow-up|0|||
163003236|NCT01783886|588711536|FG000|Overall Study|Protocol deviation|0|||
163003237|NCT01783886|588711537|FG001|Overall Study|Protocol deviation|0|||
163003238|NCT01783886|588711538|FG002|Overall Study|Protocol deviation|2|||
163003239|NCT01783886|588711536|FG000|Overall Study|Withdrawal of consent by participant|1|||
163003240|NCT01783886|588711537|FG001|Overall Study|Withdrawal of consent by participant|3|||
163003241|NCT01783886|588711538|FG002|Overall Study|Withdrawal of consent by participant|4|||
163003242|NCT01783886|588711536|FG000|Overall Study|Adverse Event|4|||
163003243|NCT01783886|588711537|FG001|Overall Study|Adverse Event|5|||
163003244|NCT01783886|588711538|FG002|Overall Study|Adverse Event|4|||
163003245|NCT00940316|588711539|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
163003246|NCT00940316|588711540|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
163003247|NCT00940316|588711541|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
163003248|NCT00940316|588711539|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
163003249|NCT00940316|588711540|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
163003250|NCT00940316|588711541|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
163003251|NCT00940316|588711539|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
163003252|NCT00940316|588711540|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
163003253|NCT00940316|588711541|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
163003254|NCT00940316|588711539|FG000|Treated After Cycle 5|Adverse Event|0|||
163003255|NCT00940316|588711540|FG001|Treated After Cycle 5|Adverse Event|0|||
163003256|NCT00940316|588711541|FG002|Treated After Cycle 5|Adverse Event|1|||
163003257|NCT00940316|588711539|FG000|Treated After Cycle 5|Progressive disease|0|||
163003258|NCT00940316|588711540|FG001|Treated After Cycle 5|Progressive disease|1|||
163003259|NCT00940316|588711541|FG002|Treated After Cycle 5|Progressive disease|0|||
163003260|NCT02290405|588711542|FG000|Overall Study|Withdrawal by Subject|1|||
163003261|NCT02290405|588711543|FG001|Overall Study|Withdrawal by Subject|0|||
163003262|NCT00996489|588711544|FG000|Overall Study|Device failure|45|||
163003263|NCT00996489|588711544|FG000|Overall Study|Discontinued|116|||
163003264|NCT03142191|588711545|FG000|Placebo Controlled Period|Death|0|||
163003265|NCT03142191|588711546|FG001|Placebo Controlled Period|Death|1|||
163003266|NCT03142191|588711547|FG002|Placebo Controlled Period|Death|1|||
163003267|NCT03142191|588711548|FG003|Placebo Controlled Period|Death|0|||
163003268|NCT03142191|588711549|FG004|Placebo Controlled Period|Death|0|||
163003269|NCT03142191|588711545|FG000|Placebo Controlled Period|Adverse Event|4|||
163003270|NCT03142191|588711546|FG001|Placebo Controlled Period|Adverse Event|5|||
163003271|NCT03142191|588711547|FG002|Placebo Controlled Period|Adverse Event|1|||
163003272|NCT03142191|588711548|FG003|Placebo Controlled Period|Adverse Event|0|||
163003273|NCT03142191|588711549|FG004|Placebo Controlled Period|Adverse Event|0|||
163003274|NCT03142191|588711545|FG000|Placebo Controlled Period|Progressive Disease|1|||
163003275|NCT03142191|588711546|FG001|Placebo Controlled Period|Progressive Disease|0|||
163003276|NCT03142191|588711547|FG002|Placebo Controlled Period|Progressive Disease|1|||
163003277|NCT03142191|588711548|FG003|Placebo Controlled Period|Progressive Disease|0|||
163003278|NCT03142191|588711549|FG004|Placebo Controlled Period|Progressive Disease|0|||
163003279|NCT03142191|588711545|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
163003280|NCT03142191|588711546|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
163003281|NCT03142191|588711547|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
163003282|NCT03142191|588711548|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
163003283|NCT03142191|588711549|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
163003284|NCT03142191|588711545|FG000|Placebo Controlled Period|Other Reasons|1|||
163003285|NCT03142191|588711546|FG001|Placebo Controlled Period|Other Reasons|0|||
163003286|NCT03142191|588711547|FG002|Placebo Controlled Period|Other Reasons|0|||
163003287|NCT03142191|588711548|FG003|Placebo Controlled Period|Other Reasons|0|||
163003288|NCT03142191|588711549|FG004|Placebo Controlled Period|Other Reasons|0|||
163003289|NCT03142191|588711545|FG000|Active Treatment Extension Period|Death|2|||
163003290|NCT03142191|588711546|FG001|Active Treatment Extension Period|Death|1|||
163003291|NCT03142191|588711547|FG002|Active Treatment Extension Period|Death|1|||
163003292|NCT03142191|588711548|FG003|Active Treatment Extension Period|Death|1|||
163003293|NCT03142191|588711549|FG004|Active Treatment Extension Period|Death|0|||
163003294|NCT03142191|588711545|FG000|Active Treatment Extension Period|Adverse Event|6|||
163003295|NCT03142191|588711546|FG001|Active Treatment Extension Period|Adverse Event|5|||
163003296|NCT03142191|588711547|FG002|Active Treatment Extension Period|Adverse Event|4|||
163003297|NCT03142191|588711548|FG003|Active Treatment Extension Period|Adverse Event|1|||
163003298|NCT03142191|588711549|FG004|Active Treatment Extension Period|Adverse Event|0|||
163003299|NCT03142191|588711545|FG000|Active Treatment Extension Period|Progressive Disease|10|||
163003300|NCT03142191|588711546|FG001|Active Treatment Extension Period|Progressive Disease|5|||
163003301|NCT03142191|588711547|FG002|Active Treatment Extension Period|Progressive Disease|4|||
163003302|NCT03142191|588711548|FG003|Active Treatment Extension Period|Progressive Disease|1|||
163003303|NCT03142191|588711549|FG004|Active Treatment Extension Period|Progressive Disease|2|||
163003304|NCT03142191|588711545|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
163003305|NCT03142191|588711546|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
163003306|NCT03142191|588711547|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
163003307|NCT03142191|588711548|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
163003308|NCT03142191|588711549|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
163003309|NCT03142191|588711545|FG000|Active Treatment Extension Period|Physician Decision|2|||
163003310|NCT03142191|588711546|FG001|Active Treatment Extension Period|Physician Decision|0|||
163003311|NCT03142191|588711547|FG002|Active Treatment Extension Period|Physician Decision|0|||
163003312|NCT03142191|588711548|FG003|Active Treatment Extension Period|Physician Decision|0|||
163003313|NCT03142191|588711549|FG004|Active Treatment Extension Period|Physician Decision|0|||
163003314|NCT03142191|588711545|FG000|Active Treatment Extension Period|Other Reasons|3|||
163003315|NCT03142191|588711546|FG001|Active Treatment Extension Period|Other Reasons|3|||
163003316|NCT03142191|588711547|FG002|Active Treatment Extension Period|Other Reasons|3|||
163003317|NCT03142191|588711548|FG003|Active Treatment Extension Period|Other Reasons|8|||
163003318|NCT03142191|588711549|FG004|Active Treatment Extension Period|Other Reasons|3|||
163003319|NCT03142191|588711545|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
163003320|NCT03142191|588711546|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
163003321|NCT03142191|588711547|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
163003322|NCT03142191|588711548|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
163003323|NCT03142191|588711549|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
163003324|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
163003325|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
163003326|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
163003327|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
163003328|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
163003329|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
163003330|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
163003331|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
163003332|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
163003333|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
163003334|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
163003335|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
163003336|NCT01130493|588711554|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
163003337|NCT01130493|588711555|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
163003338|NCT01130493|588711556|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
163003339|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
163003340|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
163003341|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
163003342|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
162715796|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162715797|NCT03536884|587667091|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163003343|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
163003344|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
163003345|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
163003346|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
163003347|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
163003348|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
163003349|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
163003350|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
163003351|NCT01130493|588711554|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
163003352|NCT01130493|588711555|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
163003353|NCT01130493|588711556|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
163003354|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
163003355|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
163003356|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163003357|NCT01130493|588711554|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
163003358|NCT01130493|588711555|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
163003359|NCT01130493|588711556|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
163003360|NCT01130493|588711554|FG000|Part 2: OLE|Adverse Event|0|||
163003361|NCT01130493|588711555|FG001|Part 2: OLE|Adverse Event|2|||
163003362|NCT01130493|588711556|FG002|Part 2: OLE|Adverse Event|1|||
163003363|NCT01130493|588711554|FG000|Part 2: OLE|Withdrawal by Subject|0|||
163003364|NCT01130493|588711555|FG001|Part 2: OLE|Withdrawal by Subject|1|||
163003365|NCT01130493|588711556|FG002|Part 2: OLE|Withdrawal by Subject|4|||
163060924|NCT00171249|588931352|FG004|Overall Study|No Longer Requires Study Drug|0|||
162715798|NCT03536884|587667092|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
162715799|NCT03536884|587667093|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715800|NCT03536884|587667094|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163003366|NCT03541317|588711559|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
163003367|NCT03541317|588711560|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003368|NCT03541317|588711561|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003369|NCT03541317|588711562|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003370|NCT03541317|588711563|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003371|NCT03541317|588711564|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
163003372|NCT00879086|588711565|FG000|Overall Study|Adverse Event|3|||
163003373|NCT00879086|588711566|FG001|Overall Study|Adverse Event|15|||
163003374|NCT00879086|588711565|FG000|Overall Study|Participant choice|2|||
163003375|NCT00879086|588711566|FG001|Overall Study|Participant choice|2|||
163003376|NCT00879086|588711565|FG000|Overall Study|Progression of disease|40|||
163003377|NCT00879086|588711566|FG001|Overall Study|Progression of disease|26|||
163003378|NCT00879086|588711565|FG000|Overall Study|Withdrawal of consent|2|||
163003379|NCT00879086|588711566|FG001|Overall Study|Withdrawal of consent|1|||
163003380|NCT00879086|588711565|FG000|Overall Study|Other|4|||
163003381|NCT00879086|588711566|FG001|Overall Study|Other|6|||
163003382|NCT00879086|588711565|FG000|Overall Study|Death|1|||
163003383|NCT00879086|588711566|FG001|Overall Study|Death|2|||
163003384|NCT04728802|588711567|FG000|Overall Study|Withdrawal by Subject|4|||
163003385|NCT04728802|588711568|FG001|Overall Study|Withdrawal by Subject|20|||
163003386|NCT04728802|588711567|FG000|Overall Study|Physician Decision|7|||
163003387|NCT04728802|588711568|FG001|Overall Study|Physician Decision|7|||
163003388|NCT04728802|588711567|FG000|Overall Study|Protocol Violation|10|||
163003389|NCT04728802|588711568|FG001|Overall Study|Protocol Violation|4|||
163003390|NCT04728802|588711567|FG000|Overall Study|Transfer|1|||
163003391|NCT04728802|588711568|FG001|Overall Study|Transfer|0|||
163003392|NCT04728802|588711567|FG000|Overall Study|Death|4|||
163003393|NCT04728802|588711568|FG001|Overall Study|Death|5|||
163003394|NCT04728802|588711567|FG000|Overall Study|Other|3|||
163003395|NCT04728802|588711568|FG001|Overall Study|Other|0|||
163003396|NCT02517463|588711569|FG000|Overall Study|Lost to Follow-up|5|||
163003397|NCT02517463|588711570|FG001|Overall Study|Lost to Follow-up|2|||
163003398|NCT02296931|588711573|FG000|Overall Study|Protocol Violation|0|||
163003399|NCT02296931|588711574|FG001|Overall Study|Protocol Violation|2|||
163003400|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|3|||
163003401|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|2|||
163003402|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|1|||
163003403|NCT01590277|588711575|FG000|Overall Study|Withdrawal by Subject|1|||
163003404|NCT04386616|588711576|FG000|Overall Study|Death|22|||
163003405|NCT04386616|588711577|FG001|Overall Study|Death|22|||
163003406|NCT04386616|588711578|FG002|Overall Study|Death|21|||
163003407|NCT04386616|588711576|FG000|Overall Study|Lost to Follow-up|5|||
163003408|NCT04386616|588711577|FG001|Overall Study|Lost to Follow-up|8|||
163003409|NCT04386616|588711578|FG002|Overall Study|Lost to Follow-up|6|||
163003410|NCT04386616|588711576|FG000|Overall Study|Withdrawal by Subject|2|||
163003411|NCT04386616|588711577|FG001|Overall Study|Withdrawal by Subject|4|||
163003412|NCT04386616|588711578|FG002|Overall Study|Withdrawal by Subject|1|||
163003413|NCT04386616|588711576|FG000|Overall Study|Adverse Event|1|||
163003414|NCT04386616|588711577|FG001|Overall Study|Adverse Event|1|||
163003415|NCT04386616|588711578|FG002|Overall Study|Adverse Event|0|||
163003416|NCT01377012|588711579|FG000|Core Study|Study terminated by Sponsor|47|||
163003417|NCT01377012|588711580|FG001|Core Study|Study terminated by Sponsor|54|||
163003418|NCT01377012|588711581|FG002|Core Study|Study terminated by Sponsor|46|||
163003419|NCT01377012|588711579|FG000|Core Study|Technical problems|1|||
163003420|NCT01377012|588711580|FG001|Core Study|Technical problems|0|||
163003421|NCT01377012|588711581|FG002|Core Study|Technical problems|0|||
163003422|NCT01377012|588711579|FG000|Core Study|Withdrawal by Subject|15|||
163003423|NCT01377012|588711580|FG001|Core Study|Withdrawal by Subject|23|||
163003424|NCT01377012|588711581|FG002|Core Study|Withdrawal by Subject|18|||
163003425|NCT01377012|588711579|FG000|Core Study|Protocol Violation|7|||
163003426|NCT01377012|588711580|FG001|Core Study|Protocol Violation|3|||
163003427|NCT01377012|588711581|FG002|Core Study|Protocol Violation|2|||
163003428|NCT01377012|588711579|FG000|Core Study|Pregnancy|0|||
163003429|NCT01377012|588711580|FG001|Core Study|Pregnancy|0|||
163003430|NCT01377012|588711581|FG002|Core Study|Pregnancy|1|||
163003431|NCT01377012|588711579|FG000|Core Study|Physician Decision|5|||
163003432|NCT01377012|588711580|FG001|Core Study|Physician Decision|4|||
163003433|NCT01377012|588711581|FG002|Core Study|Physician Decision|10|||
163003434|NCT01377012|588711579|FG000|Core Study|Non-Compliant with study treatment|0|||
163003435|NCT01377012|588711580|FG001|Core Study|Non-Compliant with study treatment|0|||
163003436|NCT01377012|588711581|FG002|Core Study|Non-Compliant with study treatment|1|||
163003437|NCT01377012|588711579|FG000|Core Study|No Longer require treatment|0|||
163003438|NCT01377012|588711580|FG001|Core Study|No Longer require treatment|0|||
163003439|NCT01377012|588711581|FG002|Core Study|No Longer require treatment|1|||
163003440|NCT01377012|588711579|FG000|Core Study|Lost to Follow-up|7|||
163003441|NCT01377012|588711580|FG001|Core Study|Lost to Follow-up|5|||
163003442|NCT01377012|588711581|FG002|Core Study|Lost to Follow-up|4|||
163003443|NCT01377012|588711579|FG000|Core Study|Lack of Efficacy|41|||
163003444|NCT01377012|588711580|FG001|Core Study|Lack of Efficacy|28|||
163003445|NCT01377012|588711581|FG002|Core Study|Lack of Efficacy|37|||
163003446|NCT01377012|588711579|FG000|Core Study|Death|1|||
163003447|NCT01377012|588711580|FG001|Core Study|Death|1|||
163003448|NCT01377012|588711581|FG002|Core Study|Death|1|||
163003449|NCT01377012|588711579|FG000|Core Study|Adverse Event|10|||
163003450|NCT01377012|588711580|FG001|Core Study|Adverse Event|14|||
163003451|NCT01377012|588711581|FG002|Core Study|Adverse Event|13|||
163003452|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
163003453|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
163003454|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
163003455|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
163003456|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
163003457|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
163003458|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
163003459|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
163003460|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
163003461|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
163003462|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
163003463|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
163003464|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
163003465|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
163003466|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
163003467|NCT01377012|588711579|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
163003468|NCT01377012|588711580|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
163003469|NCT01377012|588711581|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
163003470|NCT00805961|588711582|FG000|Modality Therapy|Withdrawal by Subject|1|||
163003471|NCT00805961|588711582|FG000|Modality Therapy|Adverse Event|1|||
163003472|NCT00805961|588711582|FG000|Modality Therapy|Disease Progression|2|||
163003473|NCT00805961|588711582|FG000|Treatment-Free Interval|Adverse Event|3|||
163003474|NCT00805961|588711582|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
163003475|NCT00805961|588711582|FG000|Treatment-Free Interval|Physician Decision|1|||
163003476|NCT00805961|588711582|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
163003477|NCT00805961|588711582|FG000|Maintenance Treatment|Lack of Efficacy|13|||
163003478|NCT00805961|588711582|FG000|Maintenance Treatment|Intercurrent Illness|7|||
163003479|NCT00805961|588711582|FG000|Maintenance Treatment|Adverse Event|6|||
163003480|NCT00805961|588711582|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
163003481|NCT00805961|588711582|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
163003482|NCT00805961|588711582|FG000|Maintenance Treatment|Withdrawn Consent|1|||
163003483|NCT05022212|588711590|FG000|Overall Study|Lost to Follow-up|0|||
163003484|NCT05022212|588711591|FG001|Overall Study|Lost to Follow-up|2|||
163003485|NCT02905032|588711592|FG000|Overall Study|Withdrawal by Subject|2|||
163003486|NCT02905032|588711593|FG001|Overall Study|Withdrawal by Subject|0|||
163003487|NCT02905032|588711594|FG002|Overall Study|Withdrawal by Subject|0|||
163003488|NCT02905032|588711592|FG000|Overall Study|Protocol Violation|6|||
163003489|NCT02905032|588711593|FG001|Overall Study|Protocol Violation|12|||
163003490|NCT02905032|588711594|FG002|Overall Study|Protocol Violation|0|||
163003491|NCT00739063|588711595|FG000|Overall Study|Screen failures|8|||
163003492|NCT01068262|588713289|FG000|Overall Study|Adverse Event|2|||
163003493|NCT01068262|588713290|FG001|Overall Study|Adverse Event|0|||
163003494|NCT01068262|588713291|FG002|Overall Study|Adverse Event|1|||
163003495|NCT01068262|588713292|FG003|Overall Study|Adverse Event|0|||
163003496|NCT01068262|588713289|FG000|Overall Study|Protocol Violation|1|||
163003497|NCT01068262|588713290|FG001|Overall Study|Protocol Violation|0|||
163003498|NCT01068262|588713291|FG002|Overall Study|Protocol Violation|0|||
163003499|NCT01068262|588713292|FG003|Overall Study|Protocol Violation|0|||
163003500|NCT01068262|588713289|FG000|Overall Study|Withdrawal by Subject|0|||
163003501|NCT01068262|588713290|FG001|Overall Study|Withdrawal by Subject|1|||
163003502|NCT01068262|588713291|FG002|Overall Study|Withdrawal by Subject|0|||
163003503|NCT01068262|588713292|FG003|Overall Study|Withdrawal by Subject|0|||
163003504|NCT04182490|588713293|FG000|Overall Study|Withdrawal by Subject|3|||
163003505|NCT04182490|588713294|FG001|Overall Study|Withdrawal by Subject|3|||
163003506|NCT04182490|588713293|FG000|Overall Study|Lost to Follow-up|0|||
163003507|NCT04182490|588713294|FG001|Overall Study|Lost to Follow-up|1|||
163003508|NCT04182490|588713293|FG000|Overall Study|Physician Decision|0|||
163003509|NCT04182490|588713294|FG001|Overall Study|Physician Decision|1|||
163003510|NCT01811472|588713300|FG000|Overall Study|Adverse Event|1|||
163003511|NCT01811472|588713301|FG001|Overall Study|Adverse Event|0|||
163003512|NCT01811472|588713302|FG002|Overall Study|Adverse Event|4|||
163003513|NCT01811472|588713300|FG000|Overall Study|Lost to Follow-up|0|||
163003514|NCT01811472|588713301|FG001|Overall Study|Lost to Follow-up|0|||
163003515|NCT01811472|588713302|FG002|Overall Study|Lost to Follow-up|1|||
163003516|NCT01811472|588713300|FG000|Overall Study|Subject/guardian decision|1|||
163003517|NCT01811472|588713301|FG001|Overall Study|Subject/guardian decision|0|||
163003518|NCT01811472|588713302|FG002|Overall Study|Subject/guardian decision|0|||
163003519|NCT04108299|588713311|FG000|Overall Study|Not interested in participating|2|||
163003520|NCT04108299|588713312|FG001|Overall Study|Not interested in participating|1|||
163003521|NCT04108299|588713313|FG002|Overall Study|Not interested in participating|2|||
163003522|NCT04108299|588713314|FG003|Overall Study|Not interested in participating|1|||
163003523|NCT02515331|588713323|FG000|Overall Study|Withdrawal by Subject|0|||
163003524|NCT02515331|588713324|FG001|Overall Study|Withdrawal by Subject|0|||
163003525|NCT02515331|588713325|FG002|Overall Study|Withdrawal by Subject|1|||
163003526|NCT02515331|588713323|FG000|Overall Study|Protocol deviation|0|||
163003527|NCT02515331|588713324|FG001|Overall Study|Protocol deviation|0|||
163003528|NCT02515331|588713325|FG002|Overall Study|Protocol deviation|3|||
163003529|NCT02515331|588713323|FG000|Overall Study|Adverse Event|2|||
163003530|NCT02515331|588713324|FG001|Overall Study|Adverse Event|0|||
162637899|NCT01287897|587390758|FG000|Overall Study|Lost to Follow-up|0|||
162637900|NCT01287897|587390759|FG001|Overall Study|Lost to Follow-up|0|||
162637901|NCT01287897|587390760|FG002|Overall Study|Lost to Follow-up|2|||
162637902|NCT01287897|587390761|FG003|Overall Study|Lost to Follow-up|0|||
162637903|NCT01287897|587390758|FG000|Overall Study|Withdrawal by Subject|1|||
162637904|NCT01287897|587390759|FG001|Overall Study|Withdrawal by Subject|5|||
162637905|NCT01287897|587390760|FG002|Overall Study|Withdrawal by Subject|3|||
162637906|NCT01287897|587390761|FG003|Overall Study|Withdrawal by Subject|2|||
162637907|NCT01287897|587390758|FG000|Overall Study|Not consented properly|0|||
162637908|NCT01287897|587390759|FG001|Overall Study|Not consented properly|1|||
162637909|NCT01287897|587390760|FG002|Overall Study|Not consented properly|0|||
162637910|NCT01287897|587390761|FG003|Overall Study|Not consented properly|0|||
162637911|NCT01287897|587390758|FG000|Overall Study|Not meeting entrance criteria|1|||
162637912|NCT01287897|587390759|FG001|Overall Study|Not meeting entrance criteria|1|||
162637913|NCT01287897|587390760|FG002|Overall Study|Not meeting entrance criteria|0|||
162637914|NCT01287897|587390761|FG003|Overall Study|Not meeting entrance criteria|0|||
162637915|NCT01287897|587390758|FG000|Overall Study|Other|1|||
162637916|NCT01287897|587390759|FG001|Overall Study|Other|0|||
162637917|NCT01287897|587390760|FG002|Overall Study|Other|1|||
162637918|NCT01287897|587390761|FG003|Overall Study|Other|0|||
162637919|NCT02892760|587390762|FG000|Overall Study|Withdrawal by Subject|3|||
162637920|NCT00386776|587390763|FG000|Overall Study|Withdrawal by Subject|8|||
162637921|NCT01500629|587390768|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
162637922|NCT01500629|587390769|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
162637923|NCT02902965|587390770|FG000|Overall Study|Withdrawal by Subject|10|||
162637924|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
162637925|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
162637926|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
162637927|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162637928|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
162637929|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
162637930|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162637931|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162637932|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
162637933|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162637934|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
162637935|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162637936|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
162637937|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
162637938|NCT00293254|587390771|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
162637939|NCT00293254|587390772|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
162637940|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
162637941|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
162637942|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Death|4|||
162637943|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Death|1|||
162637944|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
162637945|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
162637946|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
162637947|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
162637948|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
162637949|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
163003531|NCT02515331|588713325|FG002|Overall Study|Adverse Event|0|||
163003532|NCT00124748|588713326|FG000|Overall Study|Adverse Event|8|||
163003533|NCT00124748|588713327|FG001|Overall Study|Adverse Event|39|||
162637950|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
162637951|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
162637952|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
162637953|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
162637954|NCT00293254|587390771|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
162637955|NCT00293254|587390772|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
163003534|NCT00124748|588713326|FG000|Overall Study|Abnormal laboratory Value|2|||
163003535|NCT00124748|588713327|FG001|Overall Study|Abnormal laboratory Value|2|||
162637956|NCT00293254|587390771|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
162637957|NCT00293254|587390772|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
162637958|NCT00293254|587390771|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
162637959|NCT00293254|587390772|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
162637960|NCT00293254|587390771|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
162637961|NCT00293254|587390772|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
162637962|NCT00293254|587390771|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
162637963|NCT00293254|587390772|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
162637964|NCT00293254|587390771|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
162637965|NCT00293254|587390772|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
162637966|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
162637967|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
162637968|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
162637969|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
162637970|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
162637971|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
162637972|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
162637973|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
162637974|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
162637975|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
162637976|NCT00293254|587390771|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
162637977|NCT00293254|587390772|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
162637978|NCT02259582|587390773|FG000|Overall Study|Physician Decision|0|||
162637979|NCT02259582|587390774|FG001|Overall Study|Physician Decision|1|||
162637980|NCT02259582|587390775|FG002|Overall Study|Physician Decision|0|||
162637981|NCT02259582|587390773|FG000|Overall Study|Death|0|||
162637982|NCT02259582|587390774|FG001|Overall Study|Death|0|||
162637983|NCT02259582|587390775|FG002|Overall Study|Death|1|||
162637984|NCT02259582|587390773|FG000|Overall Study|Adverse Event|1|||
162637985|NCT02259582|587390774|FG001|Overall Study|Adverse Event|0|||
162637986|NCT02259582|587390775|FG002|Overall Study|Adverse Event|1|||
162637987|NCT02259582|587390773|FG000|Overall Study|Withdrawal by Subject|0|||
162637988|NCT02259582|587390774|FG001|Overall Study|Withdrawal by Subject|0|||
162637989|NCT02259582|587390775|FG002|Overall Study|Withdrawal by Subject|1|||
162637990|NCT02259582|587390773|FG000|Overall Study|Disease progression|14|||
163003536|NCT00124748|588713326|FG000|Overall Study|Abnormal Procedure|0|||
163003537|NCT00124748|588713327|FG001|Overall Study|Abnormal Procedure|1|||
163003538|NCT00124748|588713326|FG000|Overall Study|Lack of Efficacy|20|||
163003539|NCT00124748|588713327|FG001|Overall Study|Lack of Efficacy|41|||
163003540|NCT00124748|588713326|FG000|Overall Study|No longer requires study drug|1|||
163003541|NCT00124748|588713327|FG001|Overall Study|No longer requires study drug|1|||
163003542|NCT00124748|588713326|FG000|Overall Study|Protocol Violation|3|||
163003543|NCT00124748|588713327|FG001|Overall Study|Protocol Violation|1|||
163003544|NCT00124748|588713326|FG000|Overall Study|Withdrawal by Subject|5|||
163003545|NCT00124748|588713327|FG001|Overall Study|Withdrawal by Subject|15|||
163003546|NCT00124748|588713326|FG000|Overall Study|Lost to Follow-up|2|||
163003547|NCT00124748|588713327|FG001|Overall Study|Lost to Follow-up|7|||
163003548|NCT00124748|588713326|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
163003549|NCT00124748|588713327|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
163003550|NCT00124748|588713326|FG000|Overall Study|Death|1|||
163003551|NCT00124748|588713327|FG001|Overall Study|Death|3|||
163003552|NCT00322712|588713328|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
163003553|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
163003554|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
163003555|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
163003556|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003557|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
163003558|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
163003559|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060925|NCT00171249|588931353|FG005|Overall Study|No Longer Requires Study Drug|5|||
163003560|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003561|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060926|NCT00171249|588931354|FG006|Overall Study|No Longer Requires Study Drug|0|||
163003562|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003563|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060927|NCT00171249|588931348|FG000|Overall Study|Administrative Problems|1|||
163060928|NCT00171249|588931349|FG001|Overall Study|Administrative Problems|0|||
162637991|NCT02259582|587390774|FG001|Overall Study|Disease progression|15|||
162637992|NCT02259582|587390775|FG002|Overall Study|Disease progression|17|||
163003564|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163060929|NCT00171249|588931350|FG002|Overall Study|Administrative Problems|0|||
162637993|NCT02259582|587390773|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
163003565|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003566|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003567|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003568|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003569|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
163003570|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003571|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003572|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
163003573|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003574|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
163003575|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
163003576|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003577|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003578|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003579|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003580|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003581|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003582|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003583|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003584|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003585|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003586|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
163003587|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
163003588|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003589|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003590|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
163003591|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
163003592|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
163003593|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003594|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003595|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003596|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003597|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003598|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003599|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003600|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003601|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003602|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003603|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
163003604|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003605|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
163003606|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
163003607|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003608|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
163060930|NCT00171249|588931351|FG003|Overall Study|Administrative Problems|2|||
163060931|NCT00171249|588931352|FG004|Overall Study|Administrative Problems|0|||
163060932|NCT00171249|588931353|FG005|Overall Study|Administrative Problems|0|||
163060933|NCT00171249|588931354|FG006|Overall Study|Administrative Problems|0|||
163003609|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
163060934|NCT00171249|588931348|FG000|Overall Study|Adverse Event|3|||
163060935|NCT00171249|588931349|FG001|Overall Study|Adverse Event|1|||
163003610|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163060936|NCT00171249|588931350|FG002|Overall Study|Adverse Event|0|||
163003611|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003612|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003613|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003614|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003615|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003616|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003617|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003618|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003619|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
162637994|NCT02259582|587390774|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
162637995|NCT02259582|587390775|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
162637996|NCT02335489|587390776|FG000|Overall Study|Sponsor terminated study|4|||
162637997|NCT02335489|587390776|FG000|Overall Study|Lost to Follow-up|1|||
162637998|NCT02335489|587390776|FG000|Overall Study|Withdrawal by Subject|2|||
162637999|NCT02335489|587390776|FG000|Overall Study|Physician Decision|2|||
163003620|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
163003621|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
162638000|NCT02335489|587390776|FG000|Overall Study|Lack of Efficacy|1|||
162638001|NCT00759863|587390779|FG000|Overall Study|Death, moved, or lost contact|20|||
162638002|NCT00759863|587390780|FG001|Overall Study|Death, moved, or lost contact|18|||
162638003|NCT00412854|587390784|FG000|Overall Study|Withdrawn due to adverse events|1|||
162638004|NCT00412854|587390785|FG001|Overall Study|Withdrawn due to adverse events|5|||
162638005|NCT00412854|587390784|FG000|Overall Study|Withdrawn for other reasons|13|||
162638006|NCT00412854|587390785|FG001|Overall Study|Withdrawn for other reasons|11|||
162638007|NCT00503308|587390786|FG000|Overall Study|Protocol Violation|2|||
162638008|NCT00503308|587390787|FG001|Overall Study|Protocol Violation|1|||
162638009|NCT00531050|587390789|FG000|Part 1: Period 1|Adverse Event|0|||
162638010|NCT00531050|587390790|FG001|Part 1: Period 1|Adverse Event|1|||
162638011|NCT00531050|587390791|FG002|Part 1: Period 1|Adverse Event|0|||
162638012|NCT00531050|587390792|FG003|Part 1: Period 1|Adverse Event|0|||
162638013|NCT00531050|587390793|FG004|Part 1: Period 1|Adverse Event|0|||
162638014|NCT00531050|587390794|FG005|Part 1: Period 1|Adverse Event|0|||
162638015|NCT00531050|587390789|FG000|Part 1: Period 1|Protocol Deviation|0|||
162638016|NCT00531050|587390790|FG001|Part 1: Period 1|Protocol Deviation|0|||
162638017|NCT00531050|587390791|FG002|Part 1: Period 1|Protocol Deviation|0|||
162638018|NCT00531050|587390792|FG003|Part 1: Period 1|Protocol Deviation|1|||
162638019|NCT00531050|587390793|FG004|Part 1: Period 1|Protocol Deviation|0|||
162638020|NCT00531050|587390794|FG005|Part 1: Period 1|Protocol Deviation|0|||
162638021|NCT00531050|587390789|FG000|Part 1: Period 3|Adverse Event|1|||
162638022|NCT00531050|587390790|FG001|Part 1: Period 3|Adverse Event|0|||
162638023|NCT00531050|587390791|FG002|Part 1: Period 3|Adverse Event|0|||
162638024|NCT00531050|587390792|FG003|Part 1: Period 3|Adverse Event|0|||
162638025|NCT00531050|587390793|FG004|Part 1: Period 3|Adverse Event|0|||
162638026|NCT00531050|587390794|FG005|Part 1: Period 3|Adverse Event|0|||
162638027|NCT00531050|587390789|FG000|Part 2: Period 1|Adverse Event|0|||
162638028|NCT00531050|587390790|FG001|Part 2: Period 1|Adverse Event|0|||
162638029|NCT00531050|587390791|FG002|Part 2: Period 1|Adverse Event|0|||
162638030|NCT00531050|587390792|FG003|Part 2: Period 1|Adverse Event|0|||
162638031|NCT00531050|587390793|FG004|Part 2: Period 1|Adverse Event|0|||
162638032|NCT00531050|587390794|FG005|Part 2: Period 1|Adverse Event|1|||
162638033|NCT00531050|587390789|FG000|Part 2: Period 3|Abnormal test procedure|1|||
162638034|NCT00531050|587390790|FG001|Part 2: Period 3|Abnormal test procedure|0|||
162638035|NCT00531050|587390791|FG002|Part 2: Period 3|Abnormal test procedure|0|||
162638036|NCT00531050|587390792|FG003|Part 2: Period 3|Abnormal test procedure|0|||
162638037|NCT00531050|587390793|FG004|Part 2: Period 3|Abnormal test procedure|0|||
162638038|NCT00531050|587390794|FG005|Part 2: Period 3|Abnormal test procedure|1|||
162638039|NCT03263442|587390795|FG000|Inpatient Phase|Death|1|||
162638040|NCT03263442|587390796|FG001|Inpatient Phase|Death|0|||
162638041|NCT03263442|587390795|FG000|Inpatient Phase|Withdrawal by Subject|1|||
162638042|NCT03263442|587390796|FG001|Inpatient Phase|Withdrawal by Subject|0|||
162638043|NCT03263442|587390795|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
162638044|NCT03263442|587390796|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
162638045|NCT03263442|587390795|FG000|1-month Follow-Up|Lost to Follow-up|1|||
162638046|NCT03263442|587390796|FG001|1-month Follow-Up|Lost to Follow-up|0|||
162638047|NCT03263442|587390795|FG000|3-month Follow-Up|Lost to Follow-up|1|||
162638048|NCT03263442|587390796|FG001|3-month Follow-Up|Lost to Follow-up|3|||
162638049|NCT03263442|587390795|FG000|6-month Follow-Up|Lost to Follow-up|2|||
162638050|NCT03263442|587390796|FG001|6-month Follow-Up|Lost to Follow-up|2|||
162638051|NCT01594125|587390797|FG000|Overall Study|Withdrawal by Subject|1|||
162638052|NCT01594125|587390798|FG001|Overall Study|Withdrawal by Subject|0|||
162638053|NCT01594125|587390799|FG002|Overall Study|Withdrawal by Subject|0|||
162638054|NCT01594125|587390800|FG003|Overall Study|Withdrawal by Subject|1|||
162638055|NCT01594125|587390801|FG004|Overall Study|Withdrawal by Subject|0|||
162638056|NCT01594125|587390797|FG000|Overall Study|Progressive Disease|3|||
162638057|NCT01594125|587390798|FG001|Overall Study|Progressive Disease|12|||
163003622|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003623|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
163003624|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
163003625|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003626|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
162638058|NCT01594125|587390799|FG002|Overall Study|Progressive Disease|3|||
162638059|NCT01594125|587390800|FG003|Overall Study|Progressive Disease|3|||
162638060|NCT01594125|587390801|FG004|Overall Study|Progressive Disease|7|||
162638061|NCT00708643|587390802|FG000|Overall Study|Adverse Event|0|||
162638062|NCT00708643|587390803|FG001|Overall Study|Adverse Event|1|||
162638063|NCT03635957|587390806|FG000|Run-In Period|Lost to Follow-up|1|||
162638064|NCT03635957|587390806|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
162715801|NCT03536884|587667095|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163003627|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
162638065|NCT01710033|587390807|FG000|Stage 2|Adverse Event|0|||
162638066|NCT01710033|587390808|FG001|Stage 2|Adverse Event|0|||
162638067|NCT01710033|587390809|FG002|Stage 2|Adverse Event|0|||
162638068|NCT01710033|587390810|FG003|Stage 2|Adverse Event|0|||
163003628|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003629|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003630|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003631|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003632|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003633|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003634|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003635|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003636|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003637|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
163003638|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003639|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003640|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003641|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003642|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
163003643|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003644|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003645|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003646|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003647|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003648|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003649|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003650|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003651|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003652|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003653|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163060937|NCT00171249|588931351|FG003|Overall Study|Adverse Event|15|||
163060938|NCT00171249|588931352|FG004|Overall Study|Adverse Event|0|||
163060939|NCT00171249|588931353|FG005|Overall Study|Adverse Event|2|||
163060940|NCT00171249|588931354|FG006|Overall Study|Adverse Event|0|||
163060941|NCT00171249|588931348|FG000|Overall Study|Lost to Follow-up|5|||
163060942|NCT00171249|588931349|FG001|Overall Study|Lost to Follow-up|0|||
163060943|NCT00171249|588931350|FG002|Overall Study|Lost to Follow-up|0|||
162638069|NCT01710033|587390811|FG004|Stage 2|Adverse Event|1|||
162638070|NCT01525550|587390813|FG000|Overall Study|Lost to Follow-up|8|||
162638071|NCT01525550|587390814|FG001|Overall Study|Lost to Follow-up|2|||
162638072|NCT01525550|587390813|FG000|Overall Study|Death|19|||
162638073|NCT01525550|587390814|FG001|Overall Study|Death|28|||
162638074|NCT01525550|587390813|FG000|Overall Study|Other|0|||
162638075|NCT01525550|587390814|FG001|Overall Study|Other|4|||
162638076|NCT01525550|587390813|FG000|Overall Study|Sponsor's Decision|30|||
162638077|NCT01525550|587390814|FG001|Overall Study|Sponsor's Decision|11|||
162638078|NCT01525550|587390813|FG000|Overall Study|Withdrawal by Subject|4|||
162638079|NCT01525550|587390814|FG001|Overall Study|Withdrawal by Subject|0|||
162638080|NCT00460031|587390817|FG000|Overall Study|Adverse Event|5|||
162638081|NCT00460031|587390817|FG000|Overall Study|Withdrawal by Subject|5|||
162638082|NCT00460031|587390817|FG000|Overall Study|Death|1|||
162638083|NCT01946425|587390824|FG000|Overall Study|Protocol Violation|1|||
162638084|NCT01946425|587390825|FG001|Overall Study|Protocol Violation|0|||
162638085|NCT01946425|587390824|FG000|Overall Study|Withdrawal by Subject|1|||
162638086|NCT01946425|587390825|FG001|Overall Study|Withdrawal by Subject|0|||
163003654|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
163003655|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003656|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
163003657|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003658|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003659|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003660|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003661|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003662|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003663|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003664|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003665|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003666|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003667|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003668|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003669|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003670|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003671|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
163003672|NCT00758524|588713331|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003673|NCT00758524|588713332|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
163003674|NCT00758524|588713333|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003675|NCT00758524|588713334|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003676|NCT00758524|588713335|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003677|NCT00758524|588713336|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003678|NCT00758524|588713337|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003679|NCT00758524|588713338|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003680|NCT00758524|588713339|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003681|NCT00758524|588713340|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003682|NCT00758524|588713341|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003683|NCT00758524|588713342|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003684|NCT00758524|588713343|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003685|NCT00758524|588713344|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003686|NCT00758524|588713345|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003687|NCT00758524|588713346|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003688|NCT00758524|588713347|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
163003689|NCT00758524|588713331|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003690|NCT00758524|588713332|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003691|NCT00758524|588713333|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003692|NCT00758524|588713334|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003693|NCT00758524|588713335|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003694|NCT00758524|588713336|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163060944|NCT00171249|588931351|FG003|Overall Study|Lost to Follow-up|9|||
162638087|NCT03045887|587390828|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
162638088|NCT03045887|587390829|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638089|NCT03045887|587390830|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
163003695|NCT00758524|588713337|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003696|NCT00758524|588713338|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003697|NCT00758524|588713339|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
163003698|NCT00758524|588713340|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003699|NCT00758524|588713341|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003700|NCT00758524|588713342|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003701|NCT00758524|588713343|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003702|NCT00758524|588713344|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003703|NCT00758524|588713345|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003704|NCT00758524|588713346|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003705|NCT00758524|588713347|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
163003706|NCT00758524|588713331|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003707|NCT00758524|588713332|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003708|NCT00758524|588713333|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003709|NCT00758524|588713334|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003710|NCT00758524|588713335|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163060945|NCT00171249|588931352|FG004|Overall Study|Lost to Follow-up|0|||
163060946|NCT00171249|588931353|FG005|Overall Study|Lost to Follow-up|0|||
163060947|NCT00171249|588931354|FG006|Overall Study|Lost to Follow-up|0|||
163060948|NCT02783690|588931357|FG000|Overall Study|Withdrawal by Subject|3|||
163060949|NCT02783690|588931358|FG001|Overall Study|Withdrawal by Subject|3|||
163060950|NCT01114724|588931359|FG000|Overall Study|Death|8|||
163060951|NCT01114724|588931359|FG000|Overall Study|Lost to Follow-up|1|||
163060952|NCT01114724|588931359|FG000|Overall Study|Withdrawal by Subject|1|||
163060953|NCT04585893|588931360|FG000|Overall Study|Death|1|||
163060954|NCT04585893|588931361|FG001|Overall Study|Death|0|||
163060955|NCT06178991|588931364|FG000|Overall Study|Withdrawal by Subject|2|||
163060956|NCT06178991|588931365|FG001|Overall Study|Withdrawal by Subject|6|||
163060957|NCT06178991|588931366|FG002|Overall Study|Withdrawal by Subject|44|||
163060958|NCT06178991|588931367|FG003|Overall Study|Withdrawal by Subject|23|||
163060959|NCT06178991|588931368|FG004|Overall Study|Withdrawal by Subject|7|||
163060960|NCT06178991|588931369|FG005|Overall Study|Withdrawal by Subject|7|||
163060961|NCT06178991|588931370|FG006|Overall Study|Withdrawal by Subject|7|||
163060962|NCT06178991|588931371|FG007|Overall Study|Withdrawal by Subject|5|||
163060963|NCT06178991|588931364|FG000|Overall Study|Lost to Follow-up|2|||
163060964|NCT06178991|588931365|FG001|Overall Study|Lost to Follow-up|4|||
163060965|NCT06178991|588931366|FG002|Overall Study|Lost to Follow-up|133|||
162638090|NCT03045887|587390831|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638091|NCT03045887|587390832|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638092|NCT03045887|587390833|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638093|NCT03045887|587390834|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638094|NCT03045887|587390835|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638095|NCT03045887|587390836|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638096|NCT03045887|587390837|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162638097|NCT03045887|587390828|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638098|NCT03045887|587390829|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638099|NCT03045887|587390830|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638100|NCT03045887|587390831|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
162638101|NCT03045887|587390832|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638102|NCT03045887|587390833|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638103|NCT03045887|587390834|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638104|NCT03045887|587390835|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638105|NCT03045887|587390836|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638106|NCT03045887|587390837|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162638107|NCT03045887|587390828|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
162638108|NCT03045887|587390829|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638109|NCT03045887|587390830|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638110|NCT03045887|587390831|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638111|NCT03045887|587390832|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638112|NCT03045887|587390833|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
163060966|NCT06178991|588931367|FG003|Overall Study|Lost to Follow-up|65|||
163060967|NCT06178991|588931368|FG004|Overall Study|Lost to Follow-up|68|||
162638113|NCT03045887|587390834|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638114|NCT03045887|587390835|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638115|NCT03045887|587390836|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638116|NCT03045887|587390837|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
162638117|NCT03045887|587390828|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638118|NCT03045887|587390829|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
163060968|NCT06178991|588931369|FG005|Overall Study|Lost to Follow-up|57|||
163060969|NCT06178991|588931370|FG006|Overall Study|Lost to Follow-up|25|||
163003711|NCT00758524|588713336|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003712|NCT00758524|588713337|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
163003713|NCT00758524|588713338|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003714|NCT00758524|588713339|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003715|NCT00758524|588713340|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003716|NCT00758524|588713341|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003717|NCT00758524|588713342|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003718|NCT00758524|588713343|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003719|NCT00758524|588713344|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003720|NCT00758524|588713345|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003721|NCT00758524|588713346|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003722|NCT00758524|588713347|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
163003723|NCT04176250|588713348|FG000|Overall Study|Adverse Event|0|||
163003724|NCT04176250|588713349|FG001|Overall Study|Adverse Event|1|||
163003725|NCT04176250|588713350|FG002|Overall Study|Adverse Event|0|||
163003726|NCT04176250|588713351|FG003|Overall Study|Adverse Event|1|||
163003727|NCT04176250|588713352|FG004|Overall Study|Adverse Event|0|||
163003728|NCT04176250|588713353|FG005|Overall Study|Adverse Event|1|||
163003729|NCT04176250|588713348|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003730|NCT04176250|588713349|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003731|NCT04176250|588713350|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
163003732|NCT04176250|588713351|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
163003733|NCT04176250|588713352|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003734|NCT04176250|588713353|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
163003735|NCT04176250|588713348|FG000|Overall Study|Withdrawal by Subject|0|||
163003736|NCT04176250|588713349|FG001|Overall Study|Withdrawal by Subject|0|||
163003737|NCT04176250|588713350|FG002|Overall Study|Withdrawal by Subject|0|||
163003738|NCT04176250|588713351|FG003|Overall Study|Withdrawal by Subject|0|||
163003739|NCT04176250|588713352|FG004|Overall Study|Withdrawal by Subject|0|||
163003740|NCT04176250|588713353|FG005|Overall Study|Withdrawal by Subject|1|||
163003741|NCT04176250|588713348|FG000|Overall Study|Randomized in error|0|||
163003742|NCT04176250|588713349|FG001|Overall Study|Randomized in error|0|||
163003743|NCT04176250|588713350|FG002|Overall Study|Randomized in error|0|||
163003744|NCT04176250|588713351|FG003|Overall Study|Randomized in error|0|||
163003745|NCT04176250|588713352|FG004|Overall Study|Randomized in error|1|||
163003746|NCT04176250|588713353|FG005|Overall Study|Randomized in error|0|||
163003747|NCT04688671|588713354|FG000|Overall Study|Adverse Event|3|||
163003748|NCT04688671|588713355|FG001|Overall Study|Adverse Event|1|||
163003749|NCT04688671|588713354|FG000|Overall Study|Withdrawal by Subject|3|||
163003750|NCT04688671|588713355|FG001|Overall Study|Withdrawal by Subject|1|||
163003751|NCT04688671|588713354|FG000|Overall Study|Lack of Efficacy|1|||
163003752|NCT04688671|588713355|FG001|Overall Study|Lack of Efficacy|1|||
163003753|NCT04688671|588713354|FG000|Overall Study|Protocol Violation|1|||
163003754|NCT04688671|588713355|FG001|Overall Study|Protocol Violation|0|||
163003755|NCT04688671|588713354|FG000|Overall Study|Lost to Follow-up|0|||
163003756|NCT04688671|588713355|FG001|Overall Study|Lost to Follow-up|1|||
163003757|NCT01350271|588713356|FG000|Overall Study|Lost to Follow-up|21|||
163003758|NCT01350271|588713357|FG001|Overall Study|Lost to Follow-up|17|||
163003759|NCT01350271|588713358|FG002|Overall Study|Lost to Follow-up|26|||
163003760|NCT01973439|588713359|FG000|Overall Study|Lost samples from one PK Day|2|||
163003761|NCT01973439|588713359|FG000|Overall Study|Vomiting after commencing once daily|1|||
163003762|NCT01973439|588713359|FG000|Overall Study|PK curve incomplete|2|||
163003763|NCT00344448|588713360|FG000|Screening|Withdrawal by Subject|0|||
163003764|NCT00344448|588713361|FG001|Screening|Withdrawal by Subject|1|||
163003765|NCT00344448|588713360|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
163003766|NCT00344448|588713361|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
163003767|NCT00344448|588713360|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
163003768|NCT00344448|588713361|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
163003769|NCT00344448|588713360|FG000|Open Label|Withdrawal by Subject|1|||
163003770|NCT00344448|588713361|FG001|Open Label|Withdrawal by Subject|1|||
163003771|NCT00344448|588713360|FG000|Open Label|Study terminated|1|||
163003772|NCT00344448|588713361|FG001|Open Label|Study terminated|0|||
163003773|NCT02096744|588713384|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
162638119|NCT03045887|587390830|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
162638120|NCT03045887|587390831|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
162638121|NCT03045887|587390832|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638122|NCT03045887|587390833|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638123|NCT03045887|587390834|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638124|NCT03045887|587390835|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638125|NCT03045887|587390836|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638126|NCT03045887|587390837|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162638127|NCT03045887|587390828|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638128|NCT03045887|587390829|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638129|NCT03045887|587390830|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638130|NCT03045887|587390831|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
162638131|NCT03045887|587390832|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638132|NCT03045887|587390833|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638133|NCT03045887|587390834|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638134|NCT03045887|587390835|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638135|NCT03045887|587390836|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638136|NCT03045887|587390837|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162638137|NCT03414424|587390838|FG000|Overall Study|Screened out after consent|0|||
162638138|NCT03414424|587390839|FG001|Overall Study|Screened out after consent|2|||
162638139|NCT03414424|587390838|FG000|Overall Study|Lost to Follow-up|0|||
162638140|NCT03414424|587390839|FG001|Overall Study|Lost to Follow-up|1|||
162638141|NCT01846507|587390840|FG000|Overall Study|Lost to Follow-up|4|||
162638142|NCT01846507|587390840|FG000|Overall Study|Protocol Violation|1|||
162638143|NCT01846507|587390840|FG000|Overall Study|Missing data|2|||
162638144|NCT01314443|587390841|FG000|Overall Study|Withdrawal by Subject|2|||
162638145|NCT01314443|587390842|FG001|Overall Study|Withdrawal by Subject|1|||
163003774|NCT02096744|588713385|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
163003775|NCT02096744|588713384|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
163003776|NCT02096744|588713385|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
163003777|NCT02096744|588713384|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
163003778|NCT02096744|588713385|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
163003779|NCT05724589|588713391|FG000|Overall Study|Lost to Follow-up|1|||
163003780|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
163003781|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Off-label use|283|||
163003782|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
163003783|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
163003784|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
163003785|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
163003786|NCT01070953|588713394|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
163003787|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
163003788|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
163003789|NCT01070953|588713394|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
163003790|NCT04700137|588713395|FG000|Overall Study|Lost to Follow-up|1|||
163003791|NCT04700137|588713396|FG001|Overall Study|Lost to Follow-up|6|||
163003792|NCT04700137|588713397|FG002|Overall Study|Lost to Follow-up|1|||
163003793|NCT04700137|588713398|FG003|Overall Study|Lost to Follow-up|1|||
163003794|NCT04700137|588713395|FG000|Overall Study|Withdrawal by Subject|0|||
163003795|NCT04700137|588713396|FG001|Overall Study|Withdrawal by Subject|0|||
163003796|NCT04700137|588713397|FG002|Overall Study|Withdrawal by Subject|1|||
163003797|NCT04700137|588713398|FG003|Overall Study|Withdrawal by Subject|0|||
163003798|NCT04700137|588713395|FG000|Overall Study|Death|0|||
163003799|NCT04700137|588713396|FG001|Overall Study|Death|0|||
163003800|NCT04700137|588713397|FG002|Overall Study|Death|1|||
163003801|NCT04700137|588713398|FG003|Overall Study|Death|0|||
163003802|NCT03449446|588713404|FG000|Overall Study|Randomized but Never Treated|0|||
163003803|NCT03449446|588713405|FG001|Overall Study|Randomized but Never Treated|0|||
163003804|NCT03449446|588713406|FG002|Overall Study|Randomized but Never Treated|1|||
163003805|NCT03449446|588713407|FG003|Overall Study|Randomized but Never Treated|1|||
163003806|NCT03449446|588713408|FG004|Overall Study|Randomized but Never Treated|1|||
163003807|NCT03449446|588713409|FG005|Overall Study|Randomized but Never Treated|0|||
163003808|NCT03449446|588713410|FG006|Overall Study|Randomized but Never Treated|0|||
163003809|NCT03449446|588713404|FG000|Overall Study|Unknown Reason|33|||
163003810|NCT03449446|588713405|FG001|Overall Study|Unknown Reason|1|||
163003811|NCT03449446|588713406|FG002|Overall Study|Unknown Reason|1|||
163003812|NCT03449446|588713407|FG003|Overall Study|Unknown Reason|1|||
162638146|NCT01314443|587390843|FG002|Overall Study|Withdrawal by Subject|1|||
163003813|NCT03449446|588713408|FG004|Overall Study|Unknown Reason|2|||
163003814|NCT03449446|588713409|FG005|Overall Study|Unknown Reason|2|||
163003815|NCT03449446|588713410|FG006|Overall Study|Unknown Reason|0|||
163003816|NCT03449446|588713404|FG000|Overall Study|Withdrew Consent|1|||
163003817|NCT03449446|588713405|FG001|Overall Study|Withdrew Consent|3|||
163003818|NCT03449446|588713406|FG002|Overall Study|Withdrew Consent|1|||
163003819|NCT03449446|588713407|FG003|Overall Study|Withdrew Consent|4|||
163003820|NCT03449446|588713408|FG004|Overall Study|Withdrew Consent|4|||
163003821|NCT03449446|588713409|FG005|Overall Study|Withdrew Consent|4|||
163003822|NCT03449446|588713410|FG006|Overall Study|Withdrew Consent|1|||
163003823|NCT03449446|588713404|FG000|Overall Study|Adverse Event|1|||
163003824|NCT03449446|588713405|FG001|Overall Study|Adverse Event|2|||
163003825|NCT03449446|588713406|FG002|Overall Study|Adverse Event|1|||
163003826|NCT03449446|588713407|FG003|Overall Study|Adverse Event|0|||
163003827|NCT03449446|588713408|FG004|Overall Study|Adverse Event|0|||
163003828|NCT03449446|588713409|FG005|Overall Study|Adverse Event|2|||
163003829|NCT03449446|588713410|FG006|Overall Study|Adverse Event|0|||
163003830|NCT03449446|588713404|FG000|Overall Study|Lost to Follow-up|0|||
163003831|NCT03449446|588713405|FG001|Overall Study|Lost to Follow-up|0|||
163003832|NCT03449446|588713406|FG002|Overall Study|Lost to Follow-up|2|||
163003833|NCT03449446|588713407|FG003|Overall Study|Lost to Follow-up|1|||
163003834|NCT03449446|588713408|FG004|Overall Study|Lost to Follow-up|3|||
163003835|NCT03449446|588713409|FG005|Overall Study|Lost to Follow-up|0|||
163003836|NCT03449446|588713410|FG006|Overall Study|Lost to Follow-up|0|||
163003837|NCT03449446|588713404|FG000|Overall Study|Investigator's Discretion|0|||
163003838|NCT03449446|588713405|FG001|Overall Study|Investigator's Discretion|1|||
163003839|NCT03449446|588713406|FG002|Overall Study|Investigator's Discretion|1|||
163003840|NCT03449446|588713407|FG003|Overall Study|Investigator's Discretion|2|||
163003841|NCT03449446|588713408|FG004|Overall Study|Investigator's Discretion|0|||
163003842|NCT03449446|588713409|FG005|Overall Study|Investigator's Discretion|0|||
163003843|NCT03449446|588713410|FG006|Overall Study|Investigator's Discretion|0|||
163003844|NCT03449446|588713404|FG000|Overall Study|Non Compliance with Study Drug|1|||
163003845|NCT03449446|588713405|FG001|Overall Study|Non Compliance with Study Drug|0|||
163003846|NCT03449446|588713406|FG002|Overall Study|Non Compliance with Study Drug|0|||
163003847|NCT03449446|588713407|FG003|Overall Study|Non Compliance with Study Drug|0|||
163003848|NCT03449446|588713408|FG004|Overall Study|Non Compliance with Study Drug|0|||
163003849|NCT03449446|588713409|FG005|Overall Study|Non Compliance with Study Drug|0|||
163003850|NCT03449446|588713410|FG006|Overall Study|Non Compliance with Study Drug|0|||
163003851|NCT03449446|588713404|FG000|Overall Study|Protocol Violation|0|||
163003852|NCT03449446|588713405|FG001|Overall Study|Protocol Violation|0|||
163003853|NCT03449446|588713406|FG002|Overall Study|Protocol Violation|0|||
163003854|NCT03449446|588713407|FG003|Overall Study|Protocol Violation|0|||
163003855|NCT03449446|588713408|FG004|Overall Study|Protocol Violation|1|||
163003856|NCT03449446|588713409|FG005|Overall Study|Protocol Violation|1|||
163003857|NCT03449446|588713410|FG006|Overall Study|Protocol Violation|0|||
163003858|NCT03449446|588713404|FG000|Overall Study|Death|0|||
163003859|NCT03449446|588713405|FG001|Overall Study|Death|0|||
163003860|NCT03449446|588713406|FG002|Overall Study|Death|0|||
163003861|NCT03449446|588713407|FG003|Overall Study|Death|0|||
163003862|NCT03449446|588713408|FG004|Overall Study|Death|1|||
163003863|NCT03449446|588713409|FG005|Overall Study|Death|0|||
163003864|NCT03449446|588713410|FG006|Overall Study|Death|0|||
163003865|NCT03180645|588713423|FG000|Overall Study|Adverse Event|0|||
163003866|NCT03180645|588713424|FG001|Overall Study|Adverse Event|1|||
163003867|NCT03180645|588713425|FG002|Overall Study|Adverse Event|2|||
163003868|NCT04208750|588713426|FG000|Overall Study|Lost to Follow-up|16|||
163003869|NCT04208750|588713427|FG001|Overall Study|Lost to Follow-up|15|||
163003870|NCT02201277|588713428|FG000|Overall Study|Death|3|||
163003871|NCT02201277|588713429|FG001|Overall Study|Death|4|||
163003872|NCT02201277|588713428|FG000|Overall Study|Lost to Follow-up|2|||
163003873|NCT02201277|588713429|FG001|Overall Study|Lost to Follow-up|1|||
163003874|NCT02201277|588713428|FG000|Overall Study|Failed retrieval|1|||
163003875|NCT02201277|588713429|FG001|Overall Study|Failed retrieval|0|||
163003876|NCT02201277|588713428|FG000|Overall Study|Physician Decision|1|||
163003877|NCT02201277|588713429|FG001|Overall Study|Physician Decision|0|||
163003878|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
163003879|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
163003880|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
163003881|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
163003882|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
163003883|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003884|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003885|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
163003886|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
163003887|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003888|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003889|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
163003890|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
163003891|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
163003892|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
163060970|NCT06178991|588931371|FG007|Overall Study|Lost to Follow-up|18|||
163003893|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
163003894|NCT00866359|588713431|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
163003895|NCT00866359|588713432|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
163003896|NCT00866359|588713433|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
163003897|NCT00866359|588713434|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
163003898|NCT00866359|588713431|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
163003899|NCT00866359|588713432|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
163003900|NCT00866359|588713433|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
163003901|NCT00866359|588713434|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
163003902|NCT01625091|588713435|FG000|Intervention|Death|1|||
163003903|NCT01625091|588713436|FG001|Intervention|Death|1|||
163003904|NCT01625091|588713435|FG000|Intervention|Withdrawal by Subject|4|||
163003905|NCT01625091|588713436|FG001|Intervention|Withdrawal by Subject|1|||
163003906|NCT01625091|588713435|FG000|Intervention|Adverse Event|0|||
163003907|NCT01625091|588713436|FG001|Intervention|Adverse Event|2|||
163003908|NCT01625091|588713435|FG000|Intervention|Lost to Follow-up|4|||
163003909|NCT01625091|588713436|FG001|Intervention|Lost to Follow-up|4|||
163003910|NCT01625091|588713435|FG000|Intervention|Study termination|2|||
163003911|NCT01625091|588713436|FG001|Intervention|Study termination|3|||
163003912|NCT01625091|588713435|FG000|Post-intervention|Death|0|||
163003913|NCT01625091|588713436|FG001|Post-intervention|Death|1|||
163003914|NCT01625091|588713435|FG000|Post-intervention|Lost to Follow-up|2|||
163003915|NCT01625091|588713436|FG001|Post-intervention|Lost to Follow-up|0|||
163003916|NCT01625091|588713435|FG000|Post-intervention|Study termination|2|||
163003917|NCT01625091|588713436|FG001|Post-intervention|Study termination|1|||
163003918|NCT02163057|588713437|FG000|Overall Study|Participant Refusal to Continue|2|||
163003919|NCT02163057|588713438|FG001|Overall Study|Participant Refusal to Continue|2|||
163003920|NCT02163057|588713437|FG000|Overall Study|Participant Significant Noncompliance|0|||
163003921|NCT02163057|588713438|FG001|Overall Study|Participant Significant Noncompliance|1|||
163003922|NCT02163057|588713437|FG000|Overall Study|Progression of Disease|1|||
163003923|NCT02163057|588713438|FG001|Overall Study|Progression of Disease|2|||
163003924|NCT01547390|588713445|FG000|Overall Study|Withdrawal by Subject|10|||
163003925|NCT01547390|588713446|FG001|Overall Study|Withdrawal by Subject|7|||
163003926|NCT01547390|588713445|FG000|Overall Study|termination of pregnancy|0|||
163003927|NCT01547390|588713446|FG001|Overall Study|termination of pregnancy|1|||
163003928|NCT01547390|588713445|FG000|Overall Study|Lost to Follow-up|0|||
163003929|NCT01547390|588713446|FG001|Overall Study|Lost to Follow-up|2|||
163003930|NCT01547390|588713445|FG000|Overall Study|Adverse Event|3|||
163060971|NCT06178991|588931364|FG000|Overall Study|Death|1|||
163060972|NCT06178991|588931365|FG001|Overall Study|Death|0|||
163060973|NCT06178991|588931366|FG002|Overall Study|Death|2|||
163060974|NCT06178991|588931367|FG003|Overall Study|Death|1|||
163060975|NCT06178991|588931368|FG004|Overall Study|Death|1|||
163060976|NCT06178991|588931369|FG005|Overall Study|Death|0|||
163060977|NCT06178991|588931370|FG006|Overall Study|Death|1|||
163060978|NCT06178991|588931371|FG007|Overall Study|Death|1|||
163060979|NCT06178991|588931364|FG000|Overall Study|Randomized but not Vaccinated|4|||
163060980|NCT06178991|588931365|FG001|Overall Study|Randomized but not Vaccinated|1|||
163060981|NCT06178991|588931366|FG002|Overall Study|Randomized but not Vaccinated|15|||
163060982|NCT06178991|588931367|FG003|Overall Study|Randomized but not Vaccinated|9|||
163060983|NCT06178991|588931368|FG004|Overall Study|Randomized but not Vaccinated|8|||
163060984|NCT06178991|588931369|FG005|Overall Study|Randomized but not Vaccinated|4|||
163060985|NCT06178991|588931370|FG006|Overall Study|Randomized but not Vaccinated|2|||
163060986|NCT06178991|588931371|FG007|Overall Study|Randomized but not Vaccinated|2|||
163060987|NCT06178991|588931364|FG000|Overall Study|Other: Unspecified|0|||
163003931|NCT01547390|588713446|FG001|Overall Study|Adverse Event|0|||
163003932|NCT04917861|588713451|FG000|Main Study (196 Days)|Adverse Event|0|||
163003933|NCT04917861|588713452|FG001|Main Study (196 Days)|Adverse Event|1|||
163003934|NCT04917861|588713453|FG002|Main Study (196 Days)|Adverse Event|0|||
163003935|NCT04917861|588713454|FG003|Main Study (196 Days)|Adverse Event|0|||
163003936|NCT04917861|588713451|FG000|Main Study (196 Days)|Death|0|||
163003937|NCT04917861|588713452|FG001|Main Study (196 Days)|Death|0|||
163060988|NCT06178991|588931365|FG001|Overall Study|Other: Unspecified|1|||
163060989|NCT06178991|588931366|FG002|Overall Study|Other: Unspecified|7|||
163060990|NCT06178991|588931367|FG003|Overall Study|Other: Unspecified|6|||
163060991|NCT06178991|588931368|FG004|Overall Study|Other: Unspecified|1|||
163060992|NCT06178991|588931369|FG005|Overall Study|Other: Unspecified|1|||
163003938|NCT04917861|588713453|FG002|Main Study (196 Days)|Death|0|||
163003939|NCT04917861|588713454|FG003|Main Study (196 Days)|Death|1|||
163003940|NCT04917861|588713451|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
163003941|NCT04917861|588713452|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
163003942|NCT04917861|588713453|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
163003943|NCT04917861|588713454|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
163003944|NCT04917861|588713451|FG000|Main Study (196 Days)|Physician Decision|0|||
163003945|NCT04917861|588713452|FG001|Main Study (196 Days)|Physician Decision|0|||
163003946|NCT04917861|588713453|FG002|Main Study (196 Days)|Physician Decision|0|||
163003947|NCT04917861|588713454|FG003|Main Study (196 Days)|Physician Decision|1|||
163003948|NCT04917861|588713451|FG000|Main Study (196 Days)|Pregnancy|1|||
163003949|NCT04917861|588713452|FG001|Main Study (196 Days)|Pregnancy|1|||
163003950|NCT04917861|588713453|FG002|Main Study (196 Days)|Pregnancy|0|||
163003951|NCT04917861|588713454|FG003|Main Study (196 Days)|Pregnancy|0|||
163003952|NCT04917861|588713451|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
163003953|NCT04917861|588713452|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
163003954|NCT04917861|588713453|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
163003955|NCT04917861|588713454|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
163003956|NCT04917861|588713451|FG000|Main Study (196 Days)|Other Than Specified|1|||
163003957|NCT04917861|588713452|FG001|Main Study (196 Days)|Other Than Specified|0|||
163003958|NCT04917861|588713453|FG002|Main Study (196 Days)|Other Than Specified|1|||
163003959|NCT04917861|588713454|FG003|Main Study (196 Days)|Other Than Specified|2|||
163003960|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
163003961|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
163003962|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
163003963|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
163003964|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003965|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
163003966|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003967|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
163003968|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003969|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
163003970|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003971|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
163003972|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
163003973|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
163003974|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
163003975|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
163003976|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003977|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
163003978|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003979|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
163003980|NCT04917861|588713451|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
163003981|NCT04917861|588713452|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
163003982|NCT04917861|588713453|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
163003983|NCT04917861|588713454|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
163003984|NCT01260701|588713455|FG000|Overall Study|Adverse Event|9|||
163003985|NCT01260701|588713455|FG000|Overall Study|Withdrawal by Subject|2|||
163003986|NCT01260701|588713455|FG000|Overall Study|Progression|53|||
163003987|NCT01260701|588713455|FG000|Overall Study|Death|2|||
163003988|NCT01260701|588713455|FG000|Overall Study|Not protocol specified|3|||
163003989|NCT01260701|588713455|FG000|Overall Study|Under review|1|||
163003990|NCT01260701|588713455|FG000|Overall Study|Ineligible|4|||
163003991|NCT01260701|588713455|FG000|Overall Study|Did not begin protocol therapy|1|||
163003992|NCT00720382|588713457|FG000|Overall Study|Adverse Event|54|||
163003993|NCT00720382|588713458|FG001|Overall Study|Adverse Event|17|||
163003994|NCT00720382|588713457|FG000|Overall Study|Lack of Efficacy|18|||
163003995|NCT00720382|588713458|FG001|Overall Study|Lack of Efficacy|7|||
163003996|NCT00720382|588713457|FG000|Overall Study|Non-Compliance|15|||
163003997|NCT00720382|588713458|FG001|Overall Study|Non-Compliance|5|||
163003998|NCT00720382|588713457|FG000|Overall Study|Withdrawal by Subject|47|||
163003999|NCT00720382|588713458|FG001|Overall Study|Withdrawal by Subject|11|||
163004000|NCT00720382|588713457|FG000|Overall Study|Lost to Follow-up|28|||
163004001|NCT00720382|588713458|FG001|Overall Study|Lost to Follow-up|14|||
163004002|NCT00720382|588713457|FG000|Overall Study|administrative|14|||
163004003|NCT00720382|588713458|FG001|Overall Study|administrative|5|||
163004004|NCT05192889|588713459|FG000|Block 1: All Eligible Patients|Death|2|||
163004005|NCT05192889|588713460|FG001|Block 1: All Eligible Patients|Death|0|||
163004006|NCT05192889|588713461|FG002|Block 1: All Eligible Patients|Death|0|||
163004007|NCT05192889|588713459|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
163004008|NCT05192889|588713460|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
163004009|NCT05192889|588713461|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
163004010|NCT05192889|588713459|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
163004011|NCT05192889|588713460|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
163004012|NCT05192889|588713461|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
163004013|NCT04467840|588714497|FG000|Overall Study|Death|35|||
163004014|NCT04467840|588714498|FG001|Overall Study|Death|39|||
163004015|NCT04467840|588714497|FG000|Overall Study|Withdrawal by Subject|8|||
163004016|NCT04467840|588714498|FG001|Overall Study|Withdrawal by Subject|4|||
163004017|NCT04467840|588714497|FG000|Overall Study|Adverse Event|2|||
163004018|NCT04467840|588714498|FG001|Overall Study|Adverse Event|0|||
163004019|NCT04467840|588714497|FG000|Overall Study|Lost to Follow-up|1|||
163004020|NCT04467840|588714498|FG001|Overall Study|Lost to Follow-up|3|||
163004021|NCT04467840|588714497|FG000|Overall Study|Physician Decision|1|||
163004022|NCT04467840|588714498|FG001|Overall Study|Physician Decision|0|||
163004023|NCT04467840|588714497|FG000|Overall Study|Other|1|||
163004024|NCT04467840|588714498|FG001|Overall Study|Other|5|||
163004025|NCT04467840|588714497|FG000|Overall Study|Missing study completion status|3|||
163004026|NCT04467840|588714498|FG001|Overall Study|Missing study completion status|1|||
163004027|NCT06082843|588714505|FG000|Overall Study|Withdrawal by Subject|0|||
163004028|NCT06082843|588714506|FG001|Overall Study|Withdrawal by Subject|2|||
163004029|NCT06082843|588714505|FG000|Overall Study|Study terminated by sponsor|12|||
163004030|NCT06082843|588714506|FG001|Overall Study|Study terminated by sponsor|8|||
163004031|NCT00696423|588714509|FG000|Overall Study|Lost to Follow-up|0|||
163004032|NCT00696423|588714510|FG001|Overall Study|Lost to Follow-up|5|||
163004033|NCT03989102|588714511|FG000|Year 1|Withdrawal by Subject|6|||
163004034|NCT03989102|588714512|FG001|Year 1|Withdrawal by Subject|2|||
163004035|NCT03989102|588714513|FG002|Year 1|Withdrawal by Subject|7|||
163004036|NCT03989102|588714511|FG000|Year 1|Lost to Follow-up|5|||
163004037|NCT03989102|588714512|FG001|Year 1|Lost to Follow-up|2|||
163004038|NCT03989102|588714513|FG002|Year 1|Lost to Follow-up|5|||
163004039|NCT03989102|588714511|FG000|Year 1|Subject met withdrawal criteria|1|||
163004040|NCT03989102|588714512|FG001|Year 1|Subject met withdrawal criteria|0|||
163004041|NCT03989102|588714513|FG002|Year 1|Subject met withdrawal criteria|1|||
163004042|NCT03989102|588714511|FG000|Year 2|Lost to Follow-up|7|||
163004043|NCT03989102|588714512|FG001|Year 2|Lost to Follow-up|3|||
163004044|NCT03989102|588714513|FG002|Year 2|Lost to Follow-up|4|||
163004045|NCT03989102|588714511|FG000|Year 2|Withdrawal by Subject|3|||
163004046|NCT03989102|588714512|FG001|Year 2|Withdrawal by Subject|1|||
163004047|NCT03989102|588714513|FG002|Year 2|Withdrawal by Subject|2|||
163004048|NCT03989102|588714511|FG000|Year 2|Subject non-compliant|3|||
163004049|NCT03989102|588714512|FG001|Year 2|Subject non-compliant|2|||
163004050|NCT03989102|588714513|FG002|Year 2|Subject non-compliant|0|||
163004051|NCT03989102|588714511|FG000|Year 2|Travel|1|||
163004052|NCT03989102|588714512|FG001|Year 2|Travel|0|||
163004053|NCT03989102|588714513|FG002|Year 2|Travel|1|||
163004054|NCT03989102|588714511|FG000|Year 2|P16 missing|4|||
163004055|NCT03989102|588714512|FG001|Year 2|P16 missing|2|||
163004056|NCT03989102|588714513|FG002|Year 2|P16 missing|1|||
163004057|NCT03989102|588714511|FG000|Year 2|P11 missing|1|||
163004058|NCT03989102|588714512|FG001|Year 2|P11 missing|3|||
163004059|NCT03989102|588714513|FG002|Year 2|P11 missing|7|||
163004060|NCT03989102|588714511|FG000|Year 2|Definitive displacement outside the study site|0|||
163004061|NCT03989102|588714512|FG001|Year 2|Definitive displacement outside the study site|1|||
163004062|NCT03989102|588714513|FG002|Year 2|Definitive displacement outside the study site|0|||
163004063|NCT03989102|588714511|FG000|Year 2|Subject missed last study visit|0|||
163004064|NCT03989102|588714512|FG001|Year 2|Subject missed last study visit|1|||
163004065|NCT03989102|588714513|FG002|Year 2|Subject missed last study visit|0|||
163004066|NCT03989102|588714511|FG000|Year 2|Death|0|||
163004067|NCT03989102|588714512|FG001|Year 2|Death|1|||
163004068|NCT03989102|588714513|FG002|Year 2|Death|0|||
163004069|NCT03989102|588714511|FG000|Year 2|Subject not reachable|0|||
163004070|NCT03989102|588714512|FG001|Year 2|Subject not reachable|0|||
163004071|NCT03989102|588714513|FG002|Year 2|Subject not reachable|1|||
163004072|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
163004073|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
163004074|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
163004075|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004076|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004077|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
163004078|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
163004079|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
163004080|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
163004081|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
163004082|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
163004083|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
163004084|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
163004085|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
163004086|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
163004087|NCT03989102|588714511|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
163004088|NCT03989102|588714512|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
163004089|NCT03989102|588714513|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
163004090|NCT04054765|588714514|FG000|Baseline|Withdrawal by Subject|5|||
163004091|NCT04054765|588714515|FG001|Baseline|Withdrawal by Subject|3|||
163004092|NCT04054765|588714514|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
163004093|NCT04054765|588714515|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
163004094|NCT04054765|588714514|FG000|3-month Follow up|Withdrawal by Subject|0|||
163004095|NCT04054765|588714515|FG001|3-month Follow up|Withdrawal by Subject|3|||
163004096|NCT04054765|588714514|FG000|6-month Follow up|Lost to Follow-up|32|||
163004097|NCT04054765|588714515|FG001|6-month Follow up|Lost to Follow-up|32|||
163004098|NCT01290068|588714516|FG000|Overall Study|Adverse Event|1|||
163004099|NCT01290068|588714517|FG001|Overall Study|Adverse Event|3|||
163004100|NCT01290068|588714516|FG000|Overall Study|Lost to Follow-up|3|||
163004101|NCT01290068|588714517|FG001|Overall Study|Lost to Follow-up|0|||
163004102|NCT01290068|588714516|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
163004103|NCT01290068|588714517|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
163004104|NCT01290068|588714516|FG000|Overall Study|Other|3|||
163004105|NCT01290068|588714517|FG001|Overall Study|Other|1|||
163004106|NCT02719184|588714520|FG000|Overall Study|Other than listed|1|||
163004107|NCT02719184|588714521|FG001|Overall Study|Other than listed|12|||
163004108|NCT02719184|588714522|FG002|Overall Study|Other than listed|13|||
163004109|NCT02719184|588714523|FG003|Overall Study|Other than listed|22|||
163004110|NCT02719184|588714524|FG004|Overall Study|Other than listed|9|||
163004111|NCT02719184|588714520|FG000|Overall Study|Withdrawal by Subject|5|||
163004112|NCT02719184|588714521|FG001|Overall Study|Withdrawal by Subject|3|||
163004113|NCT02719184|588714522|FG002|Overall Study|Withdrawal by Subject|6|||
163004114|NCT02719184|588714523|FG003|Overall Study|Withdrawal by Subject|6|||
163004115|NCT02719184|588714524|FG004|Overall Study|Withdrawal by Subject|0|||
163004116|NCT02719184|588714520|FG000|Overall Study|Lost to Follow-up|0|||
163004117|NCT02719184|588714521|FG001|Overall Study|Lost to Follow-up|4|||
163004118|NCT02719184|588714522|FG002|Overall Study|Lost to Follow-up|1|||
163004119|NCT02719184|588714523|FG003|Overall Study|Lost to Follow-up|3|||
163004120|NCT02719184|588714524|FG004|Overall Study|Lost to Follow-up|0|||
163004121|NCT02719184|588714520|FG000|Overall Study|Protocol Violation|0|||
163004122|NCT02719184|588714521|FG001|Overall Study|Protocol Violation|3|||
163004123|NCT02719184|588714522|FG002|Overall Study|Protocol Violation|0|||
163004124|NCT02719184|588714523|FG003|Overall Study|Protocol Violation|2|||
163004125|NCT02719184|588714524|FG004|Overall Study|Protocol Violation|0|||
163004126|NCT02719184|588714520|FG000|Overall Study|Adverse Event|0|||
163004127|NCT02719184|588714521|FG001|Overall Study|Adverse Event|0|||
163004128|NCT02719184|588714522|FG002|Overall Study|Adverse Event|0|||
163004129|NCT02719184|588714523|FG003|Overall Study|Adverse Event|3|||
163004130|NCT02719184|588714524|FG004|Overall Study|Adverse Event|0|||
163004131|NCT04428034|588714527|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
163004132|NCT02556801|588714530|FG000|Overall Study|Lost to Follow-up|1|||
163004133|NCT02556801|588714531|FG001|Overall Study|Lost to Follow-up|0|||
163004134|NCT02556801|588714532|FG002|Overall Study|Lost to Follow-up|2|||
163004135|NCT02556801|588714533|FG003|Overall Study|Lost to Follow-up|0|||
163060993|NCT06178991|588931370|FG006|Overall Study|Other: Unspecified|1|||
163060994|NCT06178991|588931371|FG007|Overall Study|Other: Unspecified|0|||
163060995|NCT06178991|588931364|FG000|Overall Study|Physician Decision|0|||
163060996|NCT06178991|588931365|FG001|Overall Study|Physician Decision|0|||
163060997|NCT06178991|588931366|FG002|Overall Study|Physician Decision|2|||
163004136|NCT02556801|588714530|FG000|Overall Study|Withdrawal by Subject|1|||
163060998|NCT06178991|588931367|FG003|Overall Study|Physician Decision|0|||
163060999|NCT06178991|588931368|FG004|Overall Study|Physician Decision|2|||
163061000|NCT06178991|588931369|FG005|Overall Study|Physician Decision|1|||
163061001|NCT06178991|588931370|FG006|Overall Study|Physician Decision|0|||
163061002|NCT06178991|588931371|FG007|Overall Study|Physician Decision|0|||
163061003|NCT06178991|588931364|FG000|Overall Study|Protocol Violation|0|||
163004137|NCT02556801|588714531|FG001|Overall Study|Withdrawal by Subject|1|||
163004138|NCT02556801|588714532|FG002|Overall Study|Withdrawal by Subject|1|||
163004139|NCT02556801|588714533|FG003|Overall Study|Withdrawal by Subject|0|||
163004140|NCT02556801|588714530|FG000|Overall Study|Protocol Violation|0|||
163004141|NCT02556801|588714531|FG001|Overall Study|Protocol Violation|3|||
163004142|NCT02556801|588714532|FG002|Overall Study|Protocol Violation|1|||
163004143|NCT02556801|588714533|FG003|Overall Study|Protocol Violation|1|||
163061004|NCT06178991|588931365|FG001|Overall Study|Protocol Violation|0|||
163061005|NCT06178991|588931366|FG002|Overall Study|Protocol Violation|1|||
163061006|NCT06178991|588931367|FG003|Overall Study|Protocol Violation|0|||
163004144|NCT02556801|588714530|FG000|Overall Study|Adverse Event|0|||
163004145|NCT02556801|588714531|FG001|Overall Study|Adverse Event|2|||
163004146|NCT02556801|588714532|FG002|Overall Study|Adverse Event|0|||
163004147|NCT02556801|588714533|FG003|Overall Study|Adverse Event|3|||
163004148|NCT02556801|588714530|FG000|Overall Study|Pregnancy|0|||
163004149|NCT02556801|588714531|FG001|Overall Study|Pregnancy|1|||
163004150|NCT02556801|588714532|FG002|Overall Study|Pregnancy|0|||
163004151|NCT02556801|588714533|FG003|Overall Study|Pregnancy|0|||
163004152|NCT02556801|588714530|FG000|Overall Study|Personal reasons patient|0|||
163004153|NCT02556801|588714531|FG001|Overall Study|Personal reasons patient|0|||
163004154|NCT02556801|588714532|FG002|Overall Study|Personal reasons patient|0|||
163004155|NCT02556801|588714533|FG003|Overall Study|Personal reasons patient|1|||
163004156|NCT02676882|588714545|FG000|Overall Study|Adverse Event|1|||
163004157|NCT02676882|588714546|FG001|Overall Study|Adverse Event|0|||
163004158|NCT02676882|588714545|FG000|Overall Study|Lost to Follow-up|1|||
163004159|NCT02676882|588714546|FG001|Overall Study|Lost to Follow-up|0|||
163004160|NCT02676882|588714545|FG000|Overall Study|Withdrawal by Subject|1|||
163004161|NCT02676882|588714546|FG001|Overall Study|Withdrawal by Subject|2|||
163004162|NCT00114140|588714547|FG000|Overall Study|Protocol Violation|7|||
163004163|NCT00110396|588714552|FG000|Overall Study|Adverse Event|15|||
163004164|NCT00110396|588714552|FG000|Overall Study|Lost to Follow-up|1|||
163004165|NCT00110396|588714552|FG000|Overall Study|Administration of plasmapheresis|1|||
163004166|NCT00110396|588714552|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
163004167|NCT00110396|588714552|FG000|Overall Study|Lack of Efficacy|1|||
163004168|NCT00110396|588714552|FG000|Overall Study|Decided not to continue treatment|1|||
163061007|NCT06178991|588931368|FG004|Overall Study|Protocol Violation|0|||
163061008|NCT06178991|588931369|FG005|Overall Study|Protocol Violation|0|||
163061009|NCT06178991|588931370|FG006|Overall Study|Protocol Violation|0|||
163061010|NCT06178991|588931371|FG007|Overall Study|Protocol Violation|0|||
163061011|NCT01366092|588931377|FG000|Overall Study|Progressive cGVHD|2|||
163061012|NCT01366092|588931377|FG000|Overall Study|Physician Decision|1|||
163061013|NCT01366092|588931377|FG000|Overall Study|Withdrawal by Subject|1|||
163061014|NCT02273167|588931378|FG000|Overall Study|Adverse Event|1|||
163061015|NCT02273167|588931379|FG001|Overall Study|Adverse Event|0|||
163061016|NCT02273167|588931380|FG002|Overall Study|Adverse Event|0|||
163061017|NCT02273167|588931378|FG000|Overall Study|Protocol Violation|3|||
163061018|NCT02273167|588931379|FG001|Overall Study|Protocol Violation|1|||
163061019|NCT02273167|588931380|FG002|Overall Study|Protocol Violation|1|||
163061020|NCT02273167|588931378|FG000|Overall Study|Lost to Follow-up|0|||
163061021|NCT02273167|588931379|FG001|Overall Study|Lost to Follow-up|1|||
163061022|NCT02273167|588931380|FG002|Overall Study|Lost to Follow-up|1|||
163061023|NCT02273167|588931378|FG000|Overall Study|Withdrawal by Subject|10|||
163061024|NCT02273167|588931379|FG001|Overall Study|Withdrawal by Subject|12|||
163061025|NCT02273167|588931380|FG002|Overall Study|Withdrawal by Subject|11|||
163061026|NCT02273167|588931378|FG000|Overall Study|Various|10|||
163061027|NCT02273167|588931379|FG001|Overall Study|Various|9|||
163061028|NCT02273167|588931380|FG002|Overall Study|Various|8|||
163061029|NCT03082729|588931384|FG000|Overall Study|Lost to Follow-up|7|||
163061030|NCT03082729|588931384|FG000|Overall Study|Physician Decision|2|||
163061031|NCT03082729|588931384|FG000|Overall Study|Withdrawal by Subject|1|||
163061032|NCT03082729|588931384|FG000|Overall Study|Lack of Efficacy|9|||
163061033|NCT03082729|588931384|FG000|Overall Study|Adverse Event|4|||
163061034|NCT03082729|588931384|FG000|Overall Study|Protocol Violation|6|||
163061035|NCT03082729|588931384|FG000|Overall Study|Fear of study procedure|1|||
163061036|NCT03082729|588931384|FG000|Overall Study|Scheduling conflict|1|||
163061037|NCT01416571|588931389|FG000|Overall Study|Lost to Follow-up|2|||
163061038|NCT03608163|588931390|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
163061039|NCT03608163|588931391|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
163061040|NCT03353220|588931397|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
163061041|NCT03353220|588931398|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
163061042|NCT03586479|588931399|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
163061043|NCT03586479|588931400|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
163061044|NCT03586479|588931401|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
163061045|NCT03586479|588931399|FG000|Overall Study|Protocol Violation|2|||
163061046|NCT03586479|588931400|FG001|Overall Study|Protocol Violation|0|||
163061047|NCT03586479|588931401|FG002|Overall Study|Protocol Violation|0|||
163061048|NCT03586479|588931399|FG000|Overall Study|Lost to Follow-up|1|||
163061049|NCT03586479|588931400|FG001|Overall Study|Lost to Follow-up|1|||
163061050|NCT03586479|588931401|FG002|Overall Study|Lost to Follow-up|2|||
162638147|NCT01314443|587390844|FG003|Overall Study|Withdrawal by Subject|1|||
163004169|NCT00110396|588714552|FG000|Overall Study|Patient non-compliance|1|||
163004170|NCT00110396|588714552|FG000|Overall Study|Patient refused to continue|1|||
163061051|NCT03586479|588931399|FG000|Overall Study|Behavioral Issues|1|||
163061052|NCT03586479|588931400|FG001|Overall Study|Behavioral Issues|0|||
163061053|NCT03586479|588931401|FG002|Overall Study|Behavioral Issues|0|||
163061054|NCT00661388|588931410|FG000|Overall Study|Adverse Event|14|||
163061055|NCT00661388|588931410|FG000|Overall Study|Protocol Violation|7|||
163061056|NCT00661388|588931410|FG000|Overall Study|Renal transplantation|1|||
162638148|NCT01314443|587390841|FG000|Overall Study|Protocol Violation|2|||
163004171|NCT00110396|588714552|FG000|Overall Study|Patient refused to participate|1|||
163061057|NCT00661388|588931410|FG000|Overall Study|Dialysis initiation|1|||
163004172|NCT00110396|588714552|FG000|Overall Study|Patient will|1|||
163004173|NCT00110396|588714552|FG000|Overall Study|Patient's decision|1|||
163004174|NCT00110396|588714552|FG000|Overall Study|Participation in MS vaccine study|1|||
163004175|NCT00110396|588714552|FG000|Overall Study|Pregnancy|1|||
163004176|NCT00110396|588714552|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
163004177|NCT00110396|588714552|FG000|Overall Study|Protocol Violation|2|||
163004178|NCT00110396|588714552|FG000|Overall Study|Patient refused to come back|1|||
163004179|NCT00110396|588714552|FG000|Overall Study|The patient has refused|2|||
163004180|NCT00110396|588714552|FG000|Overall Study|The patient has refused to visit site|1|||
163004181|NCT00110396|588714552|FG000|Overall Study|Patient is to be administered copaxone|1|||
163004182|NCT00811733|588714554|FG000|Overall Study|Investigator Discretion|10|||
163004183|NCT00811733|588714555|FG001|Overall Study|Investigator Discretion|8|||
163004184|NCT00811733|588714554|FG000|Overall Study|Withdrawal by Subject|1|||
163004185|NCT00811733|588714555|FG001|Overall Study|Withdrawal by Subject|2|||
163004186|NCT00793871|588714556|FG000|Overall Study|Death|50|||
163004187|NCT00793871|588714556|FG000|Overall Study|Lost to Follow-up|3|||
163004188|NCT00793871|588714556|FG000|Overall Study|Study terminated by the Sponsor|7|||
163004189|NCT02500589|588714557|FG000|Overall Study|Withdrawal by Subject|11|||
163004190|NCT02500589|588714558|FG001|Overall Study|Withdrawal by Subject|14|||
163004191|NCT02500589|588714557|FG000|Overall Study|Lost to Follow-up|10|||
163004192|NCT02500589|588714558|FG001|Overall Study|Lost to Follow-up|12|||
163004193|NCT02500589|588714557|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
163004194|NCT02500589|588714558|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
163004195|NCT02500589|588714557|FG000|Overall Study|Death|7|||
163004196|NCT02500589|588714558|FG001|Overall Study|Death|5|||
163004197|NCT00245466|588714559|FG000|Overall Study|Adverse Event|2|||
163004198|NCT00245466|588714560|FG001|Overall Study|Adverse Event|8|||
163004199|NCT00245466|588714561|FG002|Overall Study|Adverse Event|4|||
163004200|NCT00245466|588714559|FG000|Overall Study|Low prostate specific antigen suppr|16|||
163004201|NCT00245466|588714560|FG001|Overall Study|Low prostate specific antigen suppr|14|||
163004202|NCT00245466|588714561|FG002|Overall Study|Low prostate specific antigen suppr|5|||
163004203|NCT00245466|588714559|FG000|Overall Study|Insufficient testosterone suppr|12|||
163004204|NCT00245466|588714560|FG001|Overall Study|Insufficient testosterone suppr|12|||
163004205|NCT00245466|588714561|FG002|Overall Study|Insufficient testosterone suppr|21|||
163004206|NCT00245466|588714559|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
163004207|NCT00245466|588714560|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
163004208|NCT00245466|588714561|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
163004209|NCT00245466|588714559|FG000|Overall Study|Withdrawal by Subject|2|||
163004210|NCT00245466|588714560|FG001|Overall Study|Withdrawal by Subject|2|||
163004211|NCT00245466|588714561|FG002|Overall Study|Withdrawal by Subject|1|||
163004212|NCT00245466|588714559|FG000|Overall Study|Lost to Follow-up|3|||
163004213|NCT00245466|588714560|FG001|Overall Study|Lost to Follow-up|0|||
163004214|NCT00245466|588714561|FG002|Overall Study|Lost to Follow-up|0|||
163004215|NCT00245466|588714559|FG000|Overall Study|Disease progression|0|||
163004216|NCT00245466|588714560|FG001|Overall Study|Disease progression|3|||
163004217|NCT00245466|588714561|FG002|Overall Study|Disease progression|1|||
163004218|NCT00245466|588714559|FG000|Overall Study|Protocol Violation|1|||
163004219|NCT00245466|588714560|FG001|Overall Study|Protocol Violation|2|||
163004220|NCT00245466|588714561|FG002|Overall Study|Protocol Violation|2|||
163004221|NCT00245466|588714559|FG000|Overall Study|Death|0|||
163004222|NCT00245466|588714560|FG001|Overall Study|Death|2|||
163004223|NCT00245466|588714561|FG002|Overall Study|Death|0|||
163004224|NCT00245466|588714559|FG000|Overall Study|Administrative reasons|0|||
163004225|NCT00245466|588714560|FG001|Overall Study|Administrative reasons|1|||
163004226|NCT00245466|588714561|FG002|Overall Study|Administrative reasons|0|||
163004227|NCT00856193|588714562|FG000|Period 2|Abnormal test procedure results|0|||
163004228|NCT00856193|588714563|FG001|Period 2|Abnormal test procedure results|1|||
163004229|NCT00856193|588714562|FG000|Period 2|Lost to Follow-up|0|||
163004230|NCT00856193|588714563|FG001|Period 2|Lost to Follow-up|1|||
163004231|NCT03885661|588714564|FG000|Overall Study|Withdrawal by Subject|0|||
163004232|NCT03885661|588714565|FG001|Overall Study|Withdrawal by Subject|1|||
163004233|NCT03885661|588714564|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
163004234|NCT03885661|588714565|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
163004235|NCT05064397|588714566|FG000|Overall Study|Adverse Event|4|||
163004236|NCT05064397|588714566|FG000|Overall Study|Lack of Efficacy|12|||
163004237|NCT05064397|588714566|FG000|Overall Study|Withdrawal by Subject|3|||
163004238|NCT05064397|588714566|FG000|Overall Study|Lost to Follow-up|1|||
163004239|NCT05064397|588714566|FG000|Overall Study|Other reasons|3|||
163004240|NCT02324582|588714569|FG000|Overall Study|Screen Failures|0|||
163004241|NCT02324582|588714570|FG001|Overall Study|Screen Failures|5|||
163004242|NCT00129545|588714574|FG000|Overall Study|Death|5|||
163004243|NCT00129545|588714575|FG001|Overall Study|Death|60|||
163004244|NCT00129545|588714576|FG002|Overall Study|Death|44|||
163004245|NCT00129545|588714574|FG000|Overall Study|Withdrawal by Subject|3|||
163004246|NCT00129545|588714575|FG001|Overall Study|Withdrawal by Subject|18|||
163004247|NCT00129545|588714576|FG002|Overall Study|Withdrawal by Subject|44|||
162715802|NCT03536884|587667096|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715803|NCT03536884|587667097|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715804|NCT03536884|587667098|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715805|NCT03536884|587667099|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715806|NCT03536884|587667100|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715807|NCT03536884|587667101|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715808|NCT03536884|587667102|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162715809|NCT03536884|587667091|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715810|NCT03536884|587667092|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715811|NCT03536884|587667093|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
162715812|NCT03536884|587667094|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715813|NCT03536884|587667095|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
162715814|NCT03536884|587667096|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715815|NCT03536884|587667097|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715816|NCT03536884|587667098|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715817|NCT03536884|587667099|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715818|NCT03536884|587667100|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715819|NCT03536884|587667101|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715820|NCT03536884|587667102|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
162715821|NCT03536884|587667091|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162715822|NCT03536884|587667092|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163004248|NCT00129545|588714574|FG000|Overall Study|Lost to Follow-up|2|||
163004249|NCT00129545|588714575|FG001|Overall Study|Lost to Follow-up|22|||
163004250|NCT00129545|588714576|FG002|Overall Study|Lost to Follow-up|13|||
163004251|NCT00129545|588714574|FG000|Overall Study|Physician Decision|0|||
163004252|NCT00129545|588714575|FG001|Overall Study|Physician Decision|3|||
163004253|NCT00129545|588714576|FG002|Overall Study|Physician Decision|10|||
163004254|NCT00129545|588714574|FG000|Overall Study|Device not implanted|16|||
163004255|NCT00129545|588714575|FG001|Overall Study|Device not implanted|61|||
163004256|NCT00129545|588714576|FG002|Overall Study|Device not implanted|0|||
163004257|NCT04660331|588714577|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
163004258|NCT04660331|588714578|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
163004259|NCT04660331|588714579|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
163004260|NCT00111241|588714581|FG000|Overall Study|Lost to Follow-up|1|||
163004261|NCT00111241|588714582|FG001|Overall Study|Lost to Follow-up|0|||
163004262|NCT00111241|588714581|FG000|Overall Study|Withdrawal by Subject|4|||
163004263|NCT00111241|588714582|FG001|Overall Study|Withdrawal by Subject|0|||
163004264|NCT00111241|588714581|FG000|Overall Study|Protocol Violation|9|||
163004265|NCT00111241|588714582|FG001|Overall Study|Protocol Violation|8|||
163004266|NCT00111241|588714581|FG000|Overall Study|Adverse Event|1|||
163004267|NCT00111241|588714582|FG001|Overall Study|Adverse Event|0|||
163004268|NCT01449812|588714583|FG000|Overall Study|Migrated/moved from study area|1|||
163004269|NCT01449812|588714584|FG001|Overall Study|Migrated/moved from study area|0|||
163004270|NCT01449812|588714585|FG002|Overall Study|Migrated/moved from study area|0|||
163004271|NCT01449812|588714583|FG000|Overall Study|Withdrawal by Subject|0|||
163004272|NCT01449812|588714584|FG001|Overall Study|Withdrawal by Subject|0|||
163004273|NCT01449812|588714585|FG002|Overall Study|Withdrawal by Subject|1|||
163004274|NCT01449812|588714583|FG000|Overall Study|Lost to Follow-up|1|||
163004275|NCT01449812|588714584|FG001|Overall Study|Lost to Follow-up|0|||
163004276|NCT01449812|588714585|FG002|Overall Study|Lost to Follow-up|0|||
163004277|NCT00265759|588717050|FG000|Overall Study|Withdrawal by Subject|0|||
163004278|NCT00265759|588717051|FG001|Overall Study|Withdrawal by Subject|1|||
163004279|NCT00265759|588717052|FG002|Overall Study|Withdrawal by Subject|2|||
163061058|NCT00661388|588931410|FG000|Overall Study|Administrative reasons|1|||
163061059|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
163061060|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
163061061|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Death|1|||
163061062|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Death|3|||
163061063|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
163061064|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
163061065|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
162715823|NCT03536884|587667093|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
162715824|NCT03536884|587667094|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
162715825|NCT03536884|587667095|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
162715826|NCT03536884|587667096|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162715827|NCT03536884|587667097|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162715828|NCT03536884|587667098|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162715829|NCT03536884|587667099|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163004280|NCT00265759|588717053|FG003|Overall Study|Withdrawal by Subject|2|||
163004281|NCT00265759|588717050|FG000|Overall Study|Cancel|0|||
163004282|NCT00265759|588717051|FG001|Overall Study|Cancel|0|||
163004283|NCT00265759|588717052|FG002|Overall Study|Cancel|0|||
163004284|NCT00265759|588717053|FG003|Overall Study|Cancel|3|||
163061066|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
163004285|NCT00265759|588717050|FG000|Overall Study|Ineligible|0|||
163004286|NCT00265759|588717051|FG001|Overall Study|Ineligible|0|||
163004287|NCT00265759|588717052|FG002|Overall Study|Ineligible|0|||
163004288|NCT00265759|588717053|FG003|Overall Study|Ineligible|1|||
163004289|NCT00265759|588717050|FG000|Overall Study|Bilateral disease|0|||
163004290|NCT00265759|588717051|FG001|Overall Study|Bilateral disease|0|||
163004291|NCT00265759|588717052|FG002|Overall Study|Bilateral disease|0|||
163004292|NCT00265759|588717053|FG003|Overall Study|Bilateral disease|2|||
163004293|NCT00265759|588717050|FG000|Overall Study|Discontinued due to intolerability|0|||
163004294|NCT00265759|588717051|FG001|Overall Study|Discontinued due to intolerability|0|||
163004295|NCT00265759|588717052|FG002|Overall Study|Discontinued due to intolerability|0|||
163004296|NCT00265759|588717053|FG003|Overall Study|Discontinued due to intolerability|1|||
163004297|NCT04515147|588717054|FG000|Overall Study|Withdrawal by Subject|1|||
163004298|NCT04515147|588717055|FG001|Overall Study|Withdrawal by Subject|0|||
163004299|NCT04515147|588717056|FG002|Overall Study|Withdrawal by Subject|10|||
163004300|NCT04515147|588717057|FG003|Overall Study|Withdrawal by Subject|18|||
163004301|NCT04515147|588717058|FG004|Overall Study|Withdrawal by Subject|1|||
163004302|NCT04515147|588717059|FG005|Overall Study|Withdrawal by Subject|8|||
163004303|NCT04515147|588717054|FG000|Overall Study|Lost to Follow-up|0|||
163004304|NCT04515147|588717055|FG001|Overall Study|Lost to Follow-up|1|||
163004305|NCT04515147|588717056|FG002|Overall Study|Lost to Follow-up|5|||
163004306|NCT04515147|588717057|FG003|Overall Study|Lost to Follow-up|6|||
163004307|NCT04515147|588717058|FG004|Overall Study|Lost to Follow-up|2|||
163004308|NCT04515147|588717059|FG005|Overall Study|Lost to Follow-up|1|||
163004309|NCT04515147|588717054|FG000|Overall Study|Adverse Event|0|||
163004310|NCT04515147|588717055|FG001|Overall Study|Adverse Event|0|||
163004311|NCT04515147|588717056|FG002|Overall Study|Adverse Event|0|||
163004312|NCT04515147|588717057|FG003|Overall Study|Adverse Event|2|||
163004313|NCT04515147|588717058|FG004|Overall Study|Adverse Event|0|||
163004314|NCT04515147|588717059|FG005|Overall Study|Adverse Event|0|||
163004315|NCT04515147|588717054|FG000|Overall Study|Miscellaneous|0|||
163004316|NCT04515147|588717055|FG001|Overall Study|Miscellaneous|0|||
163004317|NCT04515147|588717056|FG002|Overall Study|Miscellaneous|0|||
163004318|NCT04515147|588717057|FG003|Overall Study|Miscellaneous|1|||
163004319|NCT04515147|588717058|FG004|Overall Study|Miscellaneous|0|||
163004320|NCT04515147|588717059|FG005|Overall Study|Miscellaneous|1|||
163004321|NCT04123405|588717060|FG000|Overall Study|Adverse Event|1|||
163004322|NCT04123405|588717061|FG001|Overall Study|Adverse Event|2|||
163004323|NCT04123405|588717062|FG002|Overall Study|Adverse Event|3|||
163004324|NCT04123405|588717063|FG003|Overall Study|Adverse Event|3|||
163004325|NCT04123405|588717060|FG000|Overall Study|Exclusion criteria met|1|||
163004326|NCT04123405|588717061|FG001|Overall Study|Exclusion criteria met|2|||
163004327|NCT04123405|588717062|FG002|Overall Study|Exclusion criteria met|0|||
163004328|NCT04123405|588717063|FG003|Overall Study|Exclusion criteria met|2|||
163004329|NCT04123405|588717060|FG000|Overall Study|Withdrawal by Subject|1|||
163004330|NCT04123405|588717061|FG001|Overall Study|Withdrawal by Subject|3|||
163004331|NCT04123405|588717062|FG002|Overall Study|Withdrawal by Subject|0|||
163004332|NCT04123405|588717063|FG003|Overall Study|Withdrawal by Subject|2|||
163004333|NCT04123405|588717060|FG000|Overall Study|Contact to subject lost|0|||
163004334|NCT04123405|588717061|FG001|Overall Study|Contact to subject lost|0|||
163004335|NCT04123405|588717062|FG002|Overall Study|Contact to subject lost|0|||
163004336|NCT04123405|588717063|FG003|Overall Study|Contact to subject lost|1|||
163004337|NCT04123405|588717060|FG000|Overall Study|screening failure|1|||
163004338|NCT04123405|588717061|FG001|Overall Study|screening failure|0|||
163004339|NCT04123405|588717062|FG002|Overall Study|screening failure|0|||
163004340|NCT04123405|588717063|FG003|Overall Study|screening failure|0|||
163004341|NCT01050530|588717064|FG000|Overall Study|Adverse Event|6|||
163004342|NCT01050530|588717065|FG001|Overall Study|Adverse Event|3|||
163004343|NCT01050530|588717064|FG000|Overall Study|Lack of Efficacy|1|||
163004344|NCT01050530|588717065|FG001|Overall Study|Lack of Efficacy|4|||
163004345|NCT01050530|588717064|FG000|Overall Study|Withdrawal by Subject|0|||
163061067|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
163061068|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
163061069|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
163061070|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
163061071|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
163004346|NCT01050530|588717065|FG001|Overall Study|Withdrawal by Subject|3|||
163004347|NCT01050530|588717064|FG000|Overall Study|Protocol Violation|1|||
163004348|NCT01050530|588717065|FG001|Overall Study|Protocol Violation|0|||
163004349|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Physician Decision|3|||
163004350|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
163004351|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Disease Progression|1|||
163004352|NCT00545714|588717066|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
163004353|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
163004354|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
163004355|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
163004356|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
162924574|NCT02406742|588426051|FG002|Overall Study|Transition to other treatment|1|||
162924575|NCT02406742|588426049|FG000|Overall Study|Other Reasons|1|||
162924576|NCT02406742|588426050|FG001|Overall Study|Other Reasons|11|||
162924577|NCT02406742|588426051|FG002|Overall Study|Other Reasons|5|||
162924578|NCT02367729|588426052|FG000|Overall Study|Organic disorder diagnosed|2|||
162924579|NCT02367729|588426053|FG001|Overall Study|Organic disorder diagnosed|1|||
162924580|NCT02367729|588426052|FG000|Overall Study|Adverse Event|1|||
162924581|NCT02367729|588426053|FG001|Overall Study|Adverse Event|2|||
162924582|NCT02367729|588426052|FG000|Overall Study|Withdrawal by Subject|0|||
162924583|NCT02367729|588426053|FG001|Overall Study|Withdrawal by Subject|5|||
162924584|NCT00759174|588426054|FG000|Overall Study|Other|0|||
162924585|NCT00759174|588426055|FG001|Overall Study|Other|2|||
162924586|NCT01890109|588426056|FG000|Overall Study|Withdrawal by Subject|0|||
162924587|NCT01890109|588426057|FG001|Overall Study|Withdrawal by Subject|3|||
162924588|NCT01890109|588426056|FG000|Overall Study|Lost to Follow-up|1|||
162924589|NCT01890109|588426057|FG001|Overall Study|Lost to Follow-up|2|||
162924590|NCT01643928|588426058|FG000|Overall Study|Lost to Follow-up|1|||
162924591|NCT01643928|588426059|FG001|Overall Study|Lost to Follow-up|0|||
162924592|NCT01643928|588426060|FG002|Overall Study|Lost to Follow-up|2|||
162924593|NCT01643928|588426061|FG003|Overall Study|Lost to Follow-up|0|||
162924594|NCT01643928|588426062|FG004|Overall Study|Lost to Follow-up|0|||
162924595|NCT01643928|588426058|FG000|Overall Study|Withdrawal by Subject|2|||
162924596|NCT01643928|588426059|FG001|Overall Study|Withdrawal by Subject|0|||
162924597|NCT01643928|588426060|FG002|Overall Study|Withdrawal by Subject|0|||
162924598|NCT01643928|588426061|FG003|Overall Study|Withdrawal by Subject|1|||
162924599|NCT01643928|588426062|FG004|Overall Study|Withdrawal by Subject|0|||
162924600|NCT01643928|588426058|FG000|Overall Study|Pregnancy|0|||
162924601|NCT01643928|588426059|FG001|Overall Study|Pregnancy|0|||
162924602|NCT01643928|588426060|FG002|Overall Study|Pregnancy|0|||
162924603|NCT01643928|588426061|FG003|Overall Study|Pregnancy|1|||
162924604|NCT01643928|588426062|FG004|Overall Study|Pregnancy|0|||
162924605|NCT01643928|588426058|FG000|Overall Study|Other|5|||
162924606|NCT01643928|588426059|FG001|Overall Study|Other|1|||
162924607|NCT01643928|588426060|FG002|Overall Study|Other|1|||
162924608|NCT01643928|588426061|FG003|Overall Study|Other|0|||
162924609|NCT01643928|588426062|FG004|Overall Study|Other|0|||
162924610|NCT01643928|588426058|FG000|Overall Study|Adverse Event|2|||
162924611|NCT01643928|588426059|FG001|Overall Study|Adverse Event|1|||
162924612|NCT01643928|588426060|FG002|Overall Study|Adverse Event|0|||
162924613|NCT01643928|588426061|FG003|Overall Study|Adverse Event|1|||
162924614|NCT01643928|588426062|FG004|Overall Study|Adverse Event|2|||
162924615|NCT00916617|588426069|FG000|Overall Study|Adverse Event|3|||
162924616|NCT00916617|588426070|FG001|Overall Study|Adverse Event|2|||
162924617|NCT00916617|588426071|FG002|Overall Study|Adverse Event|6|||
162924618|NCT00916617|588426072|FG003|Overall Study|Adverse Event|3|||
162924619|NCT00916617|588426069|FG000|Overall Study|Withdrawal by Subject|3|||
162924620|NCT00916617|588426070|FG001|Overall Study|Withdrawal by Subject|2|||
162924621|NCT00916617|588426071|FG002|Overall Study|Withdrawal by Subject|0|||
162924622|NCT00916617|588426072|FG003|Overall Study|Withdrawal by Subject|1|||
162924623|NCT00916617|588426069|FG000|Overall Study|Caregiver Request|3|||
162924624|NCT00916617|588426070|FG001|Overall Study|Caregiver Request|2|||
162924625|NCT00916617|588426071|FG002|Overall Study|Caregiver Request|1|||
162924626|NCT00916617|588426072|FG003|Overall Study|Caregiver Request|0|||
162924627|NCT00916617|588426069|FG000|Overall Study|Physician Decision|1|||
162924628|NCT00916617|588426070|FG001|Overall Study|Physician Decision|1|||
162924629|NCT00916617|588426071|FG002|Overall Study|Physician Decision|0|||
162924630|NCT00916617|588426072|FG003|Overall Study|Physician Decision|0|||
162924631|NCT00916617|588426069|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
162924632|NCT00916617|588426070|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
162924633|NCT00916617|588426071|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
162924634|NCT00916617|588426072|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
162924635|NCT00916617|588426069|FG000|Overall Study|Lost to Follow-up|2|||
162924636|NCT00916617|588426070|FG001|Overall Study|Lost to Follow-up|1|||
162924637|NCT00916617|588426071|FG002|Overall Study|Lost to Follow-up|0|||
162924638|NCT00916617|588426072|FG003|Overall Study|Lost to Follow-up|0|||
162924639|NCT00916617|588426069|FG000|Overall Study|Lack of Efficacy|1|||
162924640|NCT00916617|588426070|FG001|Overall Study|Lack of Efficacy|0|||
162924641|NCT00916617|588426071|FG002|Overall Study|Lack of Efficacy|0|||
162924642|NCT00916617|588426072|FG003|Overall Study|Lack of Efficacy|0|||
162924643|NCT00916617|588426069|FG000|Overall Study|Other|2|||
162924644|NCT00916617|588426070|FG001|Overall Study|Other|0|||
162924645|NCT00916617|588426071|FG002|Overall Study|Other|0|||
162924646|NCT00916617|588426072|FG003|Overall Study|Other|2|||
162924647|NCT00499252|588426074|FG000|Overall Study|Adverse Event|3|||
162924648|NCT00499252|588426074|FG000|Overall Study|Refused further treatment|2|||
162924649|NCT00499252|588426074|FG000|Overall Study|Ineligible|4|||
162924650|NCT00499252|588426074|FG000|Overall Study|<no further label>|3|||
163061072|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
162924651|NCT02230332|588426075|FG000|Overall Study|Adverse Event|2|||
162924652|NCT02230332|588426076|FG001|Overall Study|Adverse Event|1|||
163004357|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
163004358|NCT00545714|588717066|FG000|Maintenance Phase (36 Months)|Death|2|||
163004359|NCT01431079|588717069|FG000|Overall Study|Lost to Follow-up|35|||
163004360|NCT01431079|588717070|FG001|Overall Study|Lost to Follow-up|39|||
163004361|NCT01202175|588717071|FG000|Overall Study|Lost to Follow-up|2|||
163004362|NCT01202175|588717071|FG000|Overall Study|Withdrawal by Subject|1|||
163004363|NCT01202175|588717071|FG000|Overall Study|Adverse Event|2|||
163004364|NCT04747470|588717072|FG000|Overall Study|Death|0|||
163004365|NCT04747470|588717073|FG001|Overall Study|Death|3|||
163004366|NCT04747470|588717074|FG002|Overall Study|Death|2|||
163004367|NCT04747470|588717075|FG003|Overall Study|Death|2|||
163004368|NCT04747470|588717076|FG004|Overall Study|Death|2|||
163004369|NCT04747470|588717077|FG005|Overall Study|Death|0|||
163004370|NCT04747470|588717078|FG006|Overall Study|Death|0|||
163004371|NCT04747470|588717079|FG007|Overall Study|Death|0|||
163004372|NCT04747470|588717080|FG008|Overall Study|Death|0|||
163004373|NCT04747470|588717081|FG009|Overall Study|Death|0|||
163004374|NCT04747470|588717082|FG010|Overall Study|Death|0|||
163004375|NCT04747470|588717072|FG000|Overall Study|Withdrew Consent|0|||
163004376|NCT04747470|588717073|FG001|Overall Study|Withdrew Consent|0|||
163004377|NCT04747470|588717074|FG002|Overall Study|Withdrew Consent|0|||
163004378|NCT04747470|588717075|FG003|Overall Study|Withdrew Consent|1|||
163004379|NCT04747470|588717076|FG004|Overall Study|Withdrew Consent|0|||
163004380|NCT04747470|588717077|FG005|Overall Study|Withdrew Consent|0|||
163004381|NCT04747470|588717078|FG006|Overall Study|Withdrew Consent|0|||
163004382|NCT04747470|588717079|FG007|Overall Study|Withdrew Consent|0|||
163004383|NCT04747470|588717080|FG008|Overall Study|Withdrew Consent|0|||
163004384|NCT04747470|588717081|FG009|Overall Study|Withdrew Consent|0|||
163004385|NCT04747470|588717082|FG010|Overall Study|Withdrew Consent|0|||
163004386|NCT04747470|588717072|FG000|Overall Study|Study Terminated by Sponsor|0|||
163004387|NCT04747470|588717073|FG001|Overall Study|Study Terminated by Sponsor|0|||
163004388|NCT04747470|588717074|FG002|Overall Study|Study Terminated by Sponsor|1|||
163004389|NCT04747470|588717075|FG003|Overall Study|Study Terminated by Sponsor|0|||
163004390|NCT04747470|588717076|FG004|Overall Study|Study Terminated by Sponsor|2|||
163004391|NCT04747470|588717077|FG005|Overall Study|Study Terminated by Sponsor|0|||
163004392|NCT04747470|588717078|FG006|Overall Study|Study Terminated by Sponsor|0|||
163004393|NCT04747470|588717079|FG007|Overall Study|Study Terminated by Sponsor|0|||
163004394|NCT04747470|588717080|FG008|Overall Study|Study Terminated by Sponsor|0|||
163004395|NCT04747470|588717081|FG009|Overall Study|Study Terminated by Sponsor|0|||
163004396|NCT04747470|588717082|FG010|Overall Study|Study Terminated by Sponsor|0|||
163004397|NCT02790437|588717083|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
163004398|NCT02790437|588717084|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
163004399|NCT02790437|588717083|FG000|Overall Study|Adverse Event|1|||
163004400|NCT02790437|588717084|FG001|Overall Study|Adverse Event|0|||
163004401|NCT02790437|588717083|FG000|Overall Study|Withdrawal by Subject|1|||
163004402|NCT02790437|588717084|FG001|Overall Study|Withdrawal by Subject|0|||
163004403|NCT01626690|588717087|FG000|Overall Study|Protocol Violation|1|||
163004404|NCT01626690|588717088|FG001|Overall Study|Protocol Violation|0|||
163004405|NCT01626690|588717087|FG000|Overall Study|Adverse Event|1|||
163004406|NCT01626690|588717088|FG001|Overall Study|Adverse Event|0|||
163004407|NCT01125189|588717089|FG000|Treatment Period|Lack of Efficacy|15|||
163004408|NCT01125189|588717090|FG001|Treatment Period|Lack of Efficacy|18|||
163004409|NCT01125189|588717091|FG002|Treatment Period|Lack of Efficacy|25|||
163004410|NCT01125189|588717089|FG000|Treatment Period|Adverse Event|7|||
163004411|NCT01125189|588717090|FG001|Treatment Period|Adverse Event|8|||
163004412|NCT01125189|588717091|FG002|Treatment Period|Adverse Event|8|||
163004413|NCT01125189|588717089|FG000|Treatment Period|Withdrawal by Subject|3|||
163004414|NCT01125189|588717090|FG001|Treatment Period|Withdrawal by Subject|1|||
163004415|NCT01125189|588717091|FG002|Treatment Period|Withdrawal by Subject|1|||
163004416|NCT01125189|588717089|FG000|Treatment Period|Death|1|||
163004417|NCT01125189|588717090|FG001|Treatment Period|Death|0|||
163004418|NCT01125189|588717091|FG002|Treatment Period|Death|0|||
163004419|NCT01125189|588717089|FG000|Treatment Period|Lost to Follow-up|1|||
163004420|NCT01125189|588717090|FG001|Treatment Period|Lost to Follow-up|2|||
163004421|NCT01125189|588717091|FG002|Treatment Period|Lost to Follow-up|1|||
163004422|NCT01125189|588717089|FG000|Treatment Period|Poor compliance/noncompliance|0|||
163004423|NCT01125189|588717090|FG001|Treatment Period|Poor compliance/noncompliance|1|||
163004424|NCT01125189|588717091|FG002|Treatment Period|Poor compliance/noncompliance|0|||
163004425|NCT01125189|588717089|FG000|Treatment Period|Participants requested to discontinue|1|||
163004426|NCT01125189|588717090|FG001|Treatment Period|Participants requested to discontinue|3|||
163004427|NCT01125189|588717091|FG002|Treatment Period|Participants requested to discontinue|4|||
163004428|NCT01125189|588717089|FG000|Treatment Period|Other reasons|1|||
163004429|NCT01125189|588717090|FG001|Treatment Period|Other reasons|1|||
163004430|NCT01125189|588717091|FG002|Treatment Period|Other reasons|0|||
163004431|NCT01125189|588717089|FG000|Treatment Period|Completed 24 week treatment period only|2|||
163004432|NCT01125189|588717090|FG001|Treatment Period|Completed 24 week treatment period only|1|||
163004433|NCT01125189|588717091|FG002|Treatment Period|Completed 24 week treatment period only|2|||
163004434|NCT01125189|588717089|FG000|Follow up Period|Withdrawal by Subject|3|||
163061073|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
163061074|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
162638149|NCT01314443|587390842|FG001|Overall Study|Protocol Violation|2|||
162638150|NCT01314443|587390843|FG002|Overall Study|Protocol Violation|1|||
162638151|NCT01314443|587390844|FG003|Overall Study|Protocol Violation|1|||
162638152|NCT01782859|587390845|FG000|Overall Study|Protocol Violation|6|||
162638153|NCT01782859|587390846|FG001|Overall Study|Protocol Violation|6|||
162638154|NCT01782859|587390845|FG000|Overall Study|Withdrawal by Subject|0|||
162638155|NCT01782859|587390846|FG001|Overall Study|Withdrawal by Subject|1|||
163004435|NCT01125189|588717090|FG001|Follow up Period|Withdrawal by Subject|2|||
163004436|NCT01125189|588717091|FG002|Follow up Period|Withdrawal by Subject|5|||
163004437|NCT01125189|588717089|FG000|Follow up Period|Death|1|||
163004438|NCT01125189|588717090|FG001|Follow up Period|Death|0|||
163004439|NCT01125189|588717091|FG002|Follow up Period|Death|0|||
163004440|NCT01125189|588717089|FG000|Follow up Period|Lost to Follow-up|12|||
163004441|NCT01125189|588717090|FG001|Follow up Period|Lost to Follow-up|9|||
163004442|NCT01125189|588717091|FG002|Follow up Period|Lost to Follow-up|6|||
163004443|NCT01125189|588717089|FG000|Follow up Period|Other reasons|4|||
163004444|NCT01125189|588717090|FG001|Follow up Period|Other reasons|4|||
163004445|NCT01125189|588717091|FG002|Follow up Period|Other reasons|5|||
163004446|NCT02414958|588717092|FG000|Overall Study|Adverse Event|6|||
163004447|NCT02414958|588717093|FG001|Overall Study|Adverse Event|6|||
163004448|NCT02414958|588717094|FG002|Overall Study|Adverse Event|3|||
163004449|NCT02414958|588717092|FG000|Overall Study|Protocol Violation|10|||
163004450|NCT02414958|588717093|FG001|Overall Study|Protocol Violation|3|||
163004451|NCT02414958|588717094|FG002|Overall Study|Protocol Violation|1|||
163004452|NCT02414958|588717092|FG000|Overall Study|Lost to Follow-up|7|||
163004453|NCT02414958|588717093|FG001|Overall Study|Lost to Follow-up|4|||
163004454|NCT02414958|588717094|FG002|Overall Study|Lost to Follow-up|0|||
163004455|NCT02414958|588717092|FG000|Overall Study|Withdrawal by Subject|5|||
163004456|NCT02414958|588717093|FG001|Overall Study|Withdrawal by Subject|3|||
163004457|NCT02414958|588717094|FG002|Overall Study|Withdrawal by Subject|5|||
163004458|NCT02414958|588717092|FG000|Overall Study|Other than specified|4|||
163004459|NCT02414958|588717093|FG001|Overall Study|Other than specified|4|||
163004460|NCT02414958|588717094|FG002|Overall Study|Other than specified|5|||
163004461|NCT01269918|588717095|FG000|Overall Study|Did not receive study drug|0|||
163004462|NCT01269918|588717096|FG001|Overall Study|Did not receive study drug|3|||
163004463|NCT04542057|588717097|FG000|Overall Study|Death|3|||
163004464|NCT04542057|588717098|FG001|Overall Study|Death|1|||
163004465|NCT04542057|588717097|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
163004466|NCT04542057|588717098|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
163004467|NCT04542057|588717097|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
163004468|NCT04542057|588717098|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
163004469|NCT04542057|588717097|FG000|Overall Study|Adverse Event|15|||
163004470|NCT04542057|588717098|FG001|Overall Study|Adverse Event|6|||
163004471|NCT04542057|588717097|FG000|Overall Study|COVID-19 adverse event|6|||
163004472|NCT04542057|588717098|FG001|Overall Study|COVID-19 adverse event|4|||
163004473|NCT04542057|588717097|FG000|Overall Study|Lack of Efficacy|2|||
163004474|NCT04542057|588717098|FG001|Overall Study|Lack of Efficacy|5|||
163004475|NCT04542057|588717097|FG000|Overall Study|Study terminated by sponsor|1|||
163004476|NCT04542057|588717098|FG001|Overall Study|Study terminated by sponsor|0|||
163004477|NCT04542057|588717097|FG000|Overall Study|Investigator discretion|2|||
163004478|NCT04542057|588717098|FG001|Overall Study|Investigator discretion|1|||
163004479|NCT04542057|588717097|FG000|Overall Study|Withdrawal by Subject|52|||
163004480|NCT04542057|588717098|FG001|Overall Study|Withdrawal by Subject|30|||
162638156|NCT00680745|587390850|FG000|Overall Study|Withdrawal by Subject|8|||
162638157|NCT00680745|587390851|FG001|Overall Study|Withdrawal by Subject|3|||
162638158|NCT00680745|587390852|FG002|Overall Study|Withdrawal by Subject|2|||
162638159|NCT00680745|587390853|FG003|Overall Study|Withdrawal by Subject|8|||
162638160|NCT00680745|587390850|FG000|Overall Study|Lost to Follow-up|0|||
162638161|NCT00680745|587390851|FG001|Overall Study|Lost to Follow-up|1|||
162638162|NCT00680745|587390852|FG002|Overall Study|Lost to Follow-up|1|||
163004481|NCT04542057|588717097|FG000|Overall Study|Lost to Follow-up|8|||
163004482|NCT04542057|588717098|FG001|Overall Study|Lost to Follow-up|11|||
162638163|NCT00680745|587390853|FG003|Overall Study|Lost to Follow-up|0|||
163004483|NCT04542057|588717097|FG000|Overall Study|Other|2|||
163004484|NCT04542057|588717098|FG001|Overall Study|Other|2|||
163004485|NCT03624192|588717099|FG000|Overall Study|Lost to Follow-up|1|||
163004486|NCT03624192|588717100|FG001|Overall Study|Lost to Follow-up|1|||
163004487|NCT01640249|588717101|FG000|Period 1|Withdrawal by Subject|1|||
163004488|NCT01640249|588717102|FG001|Period 1|Withdrawal by Subject|0|||
163004489|NCT01640249|588717103|FG002|Period 1|Withdrawal by Subject|0|||
163004490|NCT01640249|588717104|FG003|Period 1|Withdrawal by Subject|0|||
163004491|NCT01640249|588717105|FG004|Period 1|Withdrawal by Subject|0|||
163004492|NCT01640249|588717106|FG005|Period 1|Withdrawal by Subject|1|||
163004493|NCT01640249|588717107|FG006|Period 1|Withdrawal by Subject|0|||
163004494|NCT00065156|588717108|FG000|Overall Study|Adverse Event|37|||
163004495|NCT00065156|588717108|FG000|Overall Study|Lack of Efficacy|52|||
163004496|NCT00065156|588717108|FG000|Overall Study|Withdrawal by Subject|8|||
163004497|NCT00065156|588717108|FG000|Overall Study|Lost to Follow-up|1|||
163004498|NCT00065156|588717108|FG000|Overall Study|Death|11|||
163004499|NCT00065156|588717108|FG000|Overall Study|Study Closed by Sponsor|2|||
163004500|NCT00065156|588717108|FG000|Overall Study|Disease Progression|7|||
163004501|NCT00065156|588717108|FG000|Overall Study|Investigator Decision|2|||
163004502|NCT00065156|588717108|FG000|Overall Study|Non-Compliance|2|||
163004503|NCT00065156|588717108|FG000|Overall Study|Loss of Response|1|||
163004504|NCT00065156|588717108|FG000|Overall Study|Secondary Malign Disease|1|||
163004505|NCT00312338|588717109|FG000|Overall Study|Adverse Event|7|||
163004506|NCT00312338|588717110|FG001|Overall Study|Adverse Event|2|||
163004507|NCT00312338|588717109|FG000|Overall Study|Lost to Follow-up|9|||
163004508|NCT00312338|588717110|FG001|Overall Study|Lost to Follow-up|1|||
163004509|NCT00312338|588717109|FG000|Overall Study|Withdrawal by Subject|4|||
163004510|NCT00312338|588717110|FG001|Overall Study|Withdrawal by Subject|0|||
163004511|NCT00312338|588717109|FG000|Overall Study|Subsequent infection|2|||
163004512|NCT00312338|588717110|FG001|Overall Study|Subsequent infection|0|||
163004513|NCT00100828|588717111|FG000|Overall Study|Physician Decision|6|||
163004514|NCT04583735|588717112|FG000|Double-masked Treatment Period|Adverse Event|0|||
163004515|NCT04583735|588717113|FG001|Double-masked Treatment Period|Adverse Event|1|||
163004516|NCT04583735|588717112|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
163004517|NCT04583735|588717113|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
163061075|NCT00362232|588933015|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
163061076|NCT00362232|588933016|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
163061077|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
163061078|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
163061079|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
163061080|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
163004518|NCT04583735|588717112|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
163004519|NCT04583735|588717113|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
163061081|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
163061082|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
163061083|NCT00362232|588933015|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
163061084|NCT00362232|588933016|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
163061085|NCT02233413|588933019|FG000|Overall Study|Lost to Follow-up|7|||
163061086|NCT02233413|588933020|FG001|Overall Study|Lost to Follow-up|9|||
162638164|NCT00680745|587390850|FG000|Overall Study|Death|1|||
162638165|NCT00680745|587390851|FG001|Overall Study|Death|0|||
162638166|NCT00680745|587390852|FG002|Overall Study|Death|1|||
162638167|NCT00680745|587390853|FG003|Overall Study|Death|0|||
162638168|NCT00680745|587390850|FG000|Overall Study|Adverse Event|5|||
162638169|NCT00680745|587390851|FG001|Overall Study|Adverse Event|3|||
162638170|NCT00680745|587390852|FG002|Overall Study|Adverse Event|3|||
162638171|NCT00680745|587390853|FG003|Overall Study|Adverse Event|3|||
162638172|NCT00680745|587390850|FG000|Overall Study|Poor/Non-compliance|0|||
162638173|NCT00680745|587390851|FG001|Overall Study|Poor/Non-compliance|3|||
163061087|NCT02233413|588933019|FG000|Overall Study|Withdrawal by Subject|4|||
163061088|NCT02233413|588933020|FG001|Overall Study|Withdrawal by Subject|5|||
163061089|NCT01799889|588933021|FG000|Overall Study|Adverse Event|4|||
163061090|NCT01799889|588933022|FG001|Overall Study|Adverse Event|4|||
163061091|NCT01799889|588933023|FG002|Overall Study|Adverse Event|5|||
163061092|NCT01799889|588933024|FG003|Overall Study|Adverse Event|1|||
163061093|NCT01799889|588933025|FG004|Overall Study|Adverse Event|11|||
163061094|NCT01799889|588933026|FG005|Overall Study|Adverse Event|1|||
163061095|NCT01799889|588933027|FG006|Overall Study|Adverse Event|5|||
162638174|NCT00680745|587390852|FG002|Overall Study|Poor/Non-compliance|0|||
162638175|NCT00680745|587390853|FG003|Overall Study|Poor/Non-compliance|0|||
162638176|NCT00680745|587390850|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
162638177|NCT00680745|587390851|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
162638178|NCT00680745|587390852|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
162638179|NCT00680745|587390853|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
163004520|NCT04583735|588717112|FG000|Open-label Treatment Period|Adverse Event|1|||
163004521|NCT04583735|588717113|FG001|Open-label Treatment Period|Adverse Event|1|||
163004522|NCT04583735|588717112|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
163004523|NCT04583735|588717113|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163004524|NCT04583735|588717112|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163004525|NCT04583735|588717113|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
163004526|NCT01176513|588717114|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
163004527|NCT01215136|588717115|FG000|Overall Study|Adverse Event|2|||
163004528|NCT01215136|588717116|FG001|Overall Study|Adverse Event|9|||
163004529|NCT01215136|588717115|FG000|Overall Study|Disease Progression|3|||
163061096|NCT01799889|588933028|FG007|Overall Study|Adverse Event|2|||
163061097|NCT01799889|588933029|FG008|Overall Study|Adverse Event|3|||
163061098|NCT01799889|588933030|FG009|Overall Study|Adverse Event|1|||
163061099|NCT01799889|588933031|FG010|Overall Study|Adverse Event|1|||
163061100|NCT01799889|588933032|FG011|Overall Study|Adverse Event|0|||
163061101|NCT01799889|588933021|FG000|Overall Study|Death|1|||
163004530|NCT01215136|588717116|FG001|Overall Study|Disease Progression|14|||
163004531|NCT01215136|588717115|FG000|Overall Study|Symptomatic Deterioration|1|||
163004532|NCT01215136|588717116|FG001|Overall Study|Symptomatic Deterioration|1|||
163004533|NCT01215136|588717115|FG000|Overall Study|Death|0|||
163004534|NCT01215136|588717116|FG001|Overall Study|Death|2|||
163004535|NCT01215136|588717115|FG000|Overall Study|Withdrawal by Subject|0|||
163004536|NCT01215136|588717116|FG001|Overall Study|Withdrawal by Subject|1|||
163004537|NCT01125917|588717121|FG000|Overall Study|Adverse Event|43|||
163004538|NCT01125917|588717121|FG000|Overall Study|Lost to Follow-up|23|||
163004539|NCT01125917|588717121|FG000|Overall Study|Withdrawal by Subject|31|||
163004540|NCT01125917|588717121|FG000|Overall Study|Administrative|223|||
163004541|NCT01125917|588717121|FG000|Overall Study|Lack of Efficacy|19|||
163004542|NCT04421131|588717123|FG000|Overall Study|Lost to Follow-up|1|||
163004543|NCT04421131|588717123|FG000|Overall Study|Protocol Violation|2|||
163004544|NCT04421131|588717123|FG000|Overall Study|App crashed|5|||
163004545|NCT02308124|588717124|FG000|Overall Study|Lost to Follow-up|6|||
163004546|NCT02308124|588717125|FG001|Overall Study|Lost to Follow-up|6|||
163004547|NCT02308124|588717126|FG002|Overall Study|Lost to Follow-up|6|||
163004548|NCT02308124|588717124|FG000|Overall Study|Adverse Event|0|||
163004549|NCT02308124|588717125|FG001|Overall Study|Adverse Event|2|||
163004550|NCT02308124|588717126|FG002|Overall Study|Adverse Event|2|||
163004551|NCT00838526|588717131|FG000|Overall Study|Adverse Event|3|||
163004552|NCT00838526|588717132|FG001|Overall Study|Adverse Event|12|||
163004553|NCT00838526|588717131|FG000|Overall Study|Lost to Follow-up|4|||
163004554|NCT00838526|588717132|FG001|Overall Study|Lost to Follow-up|12|||
163004555|NCT00838526|588717131|FG000|Overall Study|Withdrawal by Subject|4|||
163004556|NCT00838526|588717132|FG001|Overall Study|Withdrawal by Subject|5|||
163004557|NCT00838526|588717131|FG000|Overall Study|Lack of Efficacy|2|||
163004558|NCT00838526|588717132|FG001|Overall Study|Lack of Efficacy|3|||
163004559|NCT00838526|588717131|FG000|Overall Study|Other|11|||
163004560|NCT00838526|588717132|FG001|Overall Study|Other|7|||
163004561|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
163004562|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
163004563|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
163004564|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
163004565|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
163004566|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
163004567|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
163004568|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
163004569|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
163004570|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
163004571|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
163004572|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
163004573|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
163004574|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
163004575|NCT04338022|588717134|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
163004576|NCT04338022|588717135|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
163004577|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
163004578|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
163004579|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
163004580|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
163004581|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
163004582|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
163004583|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
163004584|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
163004585|NCT04338022|588717134|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
163004586|NCT04338022|588717135|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
163004587|NCT04338022|588717134|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
163004588|NCT04338022|588717135|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
163004589|NCT00786409|588717136|FG000|Overall Study|Withdrawal by Subject|2|||
163004590|NCT00786409|588717136|FG000|Overall Study|Adverse Event|2|||
163004591|NCT00786409|588717136|FG000|Overall Study|Pregnancy|2|||
163004592|NCT00786409|588717136|FG000|Overall Study|Lost to Follow-up|1|||
163004593|NCT00610129|588717137|FG000|Overall Study|Not treated since patients ineligible|3|||
163061102|NCT01799889|588933022|FG001|Overall Study|Death|0|||
163004594|NCT02273388|588717141|FG000|Overall Study|Adverse Event|0|||
163004595|NCT02273388|588717142|FG001|Overall Study|Adverse Event|0|||
163004596|NCT02273388|588717143|FG002|Overall Study|Adverse Event|0|||
163004597|NCT02273388|588717144|FG003|Overall Study|Adverse Event|0|||
163004598|NCT02273388|588717145|FG004|Overall Study|Adverse Event|0|||
163004599|NCT02273388|588717146|FG005|Overall Study|Adverse Event|0|||
163004600|NCT02273388|588717147|FG006|Overall Study|Adverse Event|1|||
163004601|NCT02273388|588717148|FG007|Overall Study|Adverse Event|2|||
163061103|NCT01799889|588933023|FG002|Overall Study|Death|5|||
163004602|NCT02273388|588717149|FG008|Overall Study|Adverse Event|0|||
163004603|NCT02273388|588717150|FG009|Overall Study|Adverse Event|0|||
163004604|NCT02273388|588717151|FG010|Overall Study|Adverse Event|0|||
163004605|NCT02273388|588717152|FG011|Overall Study|Adverse Event|0|||
163004606|NCT02273388|588717141|FG000|Overall Study|Adverse Event study disease worse|4|||
163004607|NCT02273388|588717142|FG001|Overall Study|Adverse Event study disease worse|3|||
163004608|NCT02273388|588717143|FG002|Overall Study|Adverse Event study disease worse|3|||
163004609|NCT02273388|588717144|FG003|Overall Study|Adverse Event study disease worse|2|||
163004610|NCT02273388|588717145|FG004|Overall Study|Adverse Event study disease worse|4|||
163004611|NCT02273388|588717146|FG005|Overall Study|Adverse Event study disease worse|3|||
163004612|NCT02273388|588717147|FG006|Overall Study|Adverse Event study disease worse|14|||
163004613|NCT02273388|588717148|FG007|Overall Study|Adverse Event study disease worse|6|||
163004614|NCT02273388|588717149|FG008|Overall Study|Adverse Event study disease worse|6|||
163004615|NCT02273388|588717150|FG009|Overall Study|Adverse Event study disease worse|5|||
163004616|NCT02273388|588717151|FG010|Overall Study|Adverse Event study disease worse|10|||
163004617|NCT02273388|588717152|FG011|Overall Study|Adverse Event study disease worse|1|||
163004618|NCT02273388|588717141|FG000|Overall Study|Sponsor decision|0|||
163004619|NCT02273388|588717142|FG001|Overall Study|Sponsor decision|0|||
163004620|NCT02273388|588717143|FG002|Overall Study|Sponsor decision|0|||
163004621|NCT02273388|588717144|FG003|Overall Study|Sponsor decision|0|||
163004622|NCT02273388|588717145|FG004|Overall Study|Sponsor decision|0|||
163004623|NCT02273388|588717146|FG005|Overall Study|Sponsor decision|0|||
163004624|NCT02273388|588717147|FG006|Overall Study|Sponsor decision|0|||
163004625|NCT02273388|588717148|FG007|Overall Study|Sponsor decision|0|||
163004626|NCT02273388|588717149|FG008|Overall Study|Sponsor decision|0|||
163004627|NCT02273388|588717150|FG009|Overall Study|Sponsor decision|0|||
163004628|NCT02273388|588717151|FG010|Overall Study|Sponsor decision|0|||
163004629|NCT02273388|588717152|FG011|Overall Study|Sponsor decision|1|||
163004630|NCT04331808|588717153|FG000|Overall Study|Withdrew consent|1|||
163061104|NCT01799889|588933024|FG003|Overall Study|Death|3|||
163061105|NCT01799889|588933025|FG004|Overall Study|Death|1|||
163061106|NCT01799889|588933026|FG005|Overall Study|Death|0|||
163061107|NCT01799889|588933027|FG006|Overall Study|Death|0|||
163061108|NCT01799889|588933028|FG007|Overall Study|Death|0|||
163061109|NCT01799889|588933029|FG008|Overall Study|Death|1|||
163061110|NCT01799889|588933030|FG009|Overall Study|Death|0|||
163061111|NCT01799889|588933031|FG010|Overall Study|Death|1|||
163061112|NCT01799889|588933032|FG011|Overall Study|Death|0|||
163061113|NCT01799889|588933021|FG000|Overall Study|Lack of Efficacy|1|||
163061114|NCT01799889|588933022|FG001|Overall Study|Lack of Efficacy|1|||
163061115|NCT01799889|588933023|FG002|Overall Study|Lack of Efficacy|0|||
163061116|NCT01799889|588933024|FG003|Overall Study|Lack of Efficacy|1|||
163061117|NCT01799889|588933025|FG004|Overall Study|Lack of Efficacy|2|||
163061118|NCT01799889|588933026|FG005|Overall Study|Lack of Efficacy|2|||
163061119|NCT01799889|588933027|FG006|Overall Study|Lack of Efficacy|0|||
163061120|NCT01799889|588933028|FG007|Overall Study|Lack of Efficacy|0|||
163061121|NCT01799889|588933029|FG008|Overall Study|Lack of Efficacy|2|||
163061122|NCT01799889|588933030|FG009|Overall Study|Lack of Efficacy|0|||
163061123|NCT01799889|588933031|FG010|Overall Study|Lack of Efficacy|1|||
163061124|NCT01799889|588933032|FG011|Overall Study|Lack of Efficacy|0|||
163061125|NCT01799889|588933021|FG000|Overall Study|Lost to Follow-up|0|||
163061126|NCT01799889|588933022|FG001|Overall Study|Lost to Follow-up|1|||
163061127|NCT01799889|588933023|FG002|Overall Study|Lost to Follow-up|0|||
163061128|NCT01799889|588933024|FG003|Overall Study|Lost to Follow-up|0|||
163061129|NCT01799889|588933025|FG004|Overall Study|Lost to Follow-up|0|||
163061130|NCT01799889|588933026|FG005|Overall Study|Lost to Follow-up|0|||
163061131|NCT01799889|588933027|FG006|Overall Study|Lost to Follow-up|0|||
163061132|NCT01799889|588933028|FG007|Overall Study|Lost to Follow-up|0|||
163061133|NCT01799889|588933029|FG008|Overall Study|Lost to Follow-up|0|||
163061134|NCT01799889|588933030|FG009|Overall Study|Lost to Follow-up|0|||
163061135|NCT01799889|588933031|FG010|Overall Study|Lost to Follow-up|0|||
163061136|NCT01799889|588933032|FG011|Overall Study|Lost to Follow-up|0|||
163061137|NCT01799889|588933021|FG000|Overall Study|Physician Decision|3|||
163061138|NCT01799889|588933022|FG001|Overall Study|Physician Decision|2|||
163061139|NCT01799889|588933023|FG002|Overall Study|Physician Decision|4|||
163004631|NCT04331808|588717154|FG001|Overall Study|Withdrew consent|0|||
163004632|NCT04331808|588717155|FG002|Overall Study|Withdrew consent|2|||
163004633|NCT04331808|588717156|FG003|Overall Study|Withdrew consent|3|||
163004634|NCT02445963|588717157|FG000|Overall Study|Lost to Follow-up|1|||
163004635|NCT02445963|588717158|FG001|Overall Study|Lost to Follow-up|0|||
163004636|NCT02445963|588717159|FG002|Overall Study|Lost to Follow-up|0|||
163061140|NCT01799889|588933024|FG003|Overall Study|Physician Decision|4|||
163004637|NCT02445963|588717160|FG003|Overall Study|Lost to Follow-up|0|||
163004638|NCT02445963|588717157|FG000|Overall Study|Change in employment|1|||
163061141|NCT01799889|588933025|FG004|Overall Study|Physician Decision|5|||
163061142|NCT01799889|588933026|FG005|Overall Study|Physician Decision|5|||
163061143|NCT01799889|588933027|FG006|Overall Study|Physician Decision|5|||
163061144|NCT01799889|588933028|FG007|Overall Study|Physician Decision|2|||
163061145|NCT01799889|588933029|FG008|Overall Study|Physician Decision|6|||
163061146|NCT01799889|588933030|FG009|Overall Study|Physician Decision|0|||
163004639|NCT02445963|588717158|FG001|Overall Study|Change in employment|0|||
163004640|NCT02445963|588717159|FG002|Overall Study|Change in employment|0|||
163004641|NCT02445963|588717160|FG003|Overall Study|Change in employment|0|||
163004642|NCT02445963|588717157|FG000|Overall Study|Symptoms post-vaccination|0|||
163004643|NCT02445963|588717158|FG001|Overall Study|Symptoms post-vaccination|0|||
163004644|NCT02445963|588717159|FG002|Overall Study|Symptoms post-vaccination|1|||
163004645|NCT02445963|588717160|FG003|Overall Study|Symptoms post-vaccination|0|||
163004646|NCT01957176|588717164|FG000|Overall Study|Adverse Event|2|||
163004647|NCT01957176|588717165|FG001|Overall Study|Adverse Event|0|||
163004648|NCT01957176|588717164|FG000|Overall Study|Physician Decision|2|||
163004649|NCT01957176|588717165|FG001|Overall Study|Physician Decision|1|||
163004650|NCT01957176|588717164|FG000|Overall Study|Withdrawal by Subject|1|||
163004651|NCT01957176|588717165|FG001|Overall Study|Withdrawal by Subject|0|||
163004652|NCT00952731|588717166|FG000|Overall Study|Drug supply expired|1|||
163004653|NCT00952731|588717167|FG001|Overall Study|Drug supply expired|0|||
163004654|NCT03172494|588717168|FG000|Overall Study|Adverse Event|5|||
163004655|NCT03172494|588717169|FG001|Overall Study|Adverse Event|1|||
163004656|NCT03172494|588717170|FG002|Overall Study|Adverse Event|15|||
163004657|NCT03172494|588717168|FG000|Overall Study|Protocol Violation|3|||
163004658|NCT03172494|588717169|FG001|Overall Study|Protocol Violation|2|||
163004659|NCT03172494|588717170|FG002|Overall Study|Protocol Violation|1|||
163004660|NCT03172494|588717168|FG000|Overall Study|Lack of Efficacy|0|||
163004661|NCT03172494|588717169|FG001|Overall Study|Lack of Efficacy|0|||
163004662|NCT03172494|588717170|FG002|Overall Study|Lack of Efficacy|4|||
163004663|NCT03172494|588717168|FG000|Overall Study|Pregnancy|0|||
163004664|NCT03172494|588717169|FG001|Overall Study|Pregnancy|1|||
163004665|NCT03172494|588717170|FG002|Overall Study|Pregnancy|0|||
163004666|NCT03172494|588717168|FG000|Overall Study|Withdrawal by Subject|10|||
163004667|NCT03172494|588717169|FG001|Overall Study|Withdrawal by Subject|8|||
163004668|NCT03172494|588717170|FG002|Overall Study|Withdrawal by Subject|8|||
163004669|NCT03172494|588717168|FG000|Overall Study|Severe hypoglycaemic episode|0|||
163004670|NCT03172494|588717169|FG001|Overall Study|Severe hypoglycaemic episode|0|||
163004671|NCT03172494|588717170|FG002|Overall Study|Severe hypoglycaemic episode|1|||
163004672|NCT03172494|588717168|FG000|Overall Study|Non-compliance towards treatment|2|||
163004673|NCT03172494|588717169|FG001|Overall Study|Non-compliance towards treatment|0|||
163004674|NCT03172494|588717170|FG002|Overall Study|Non-compliance towards treatment|0|||
162638180|NCT00680745|587390850|FG000|Overall Study|False Treatment|0|||
162638181|NCT00680745|587390851|FG001|Overall Study|False Treatment|1|||
162638182|NCT00680745|587390852|FG002|Overall Study|False Treatment|3|||
162638183|NCT00680745|587390853|FG003|Overall Study|False Treatment|0|||
162638184|NCT01408914|587390854|FG000|Overall Study|Could not complete tx in protocol period|5|||
162638185|NCT01408914|587390855|FG001|Overall Study|Could not complete tx in protocol period|5|||
162638186|NCT01408914|587390856|FG002|Overall Study|Could not complete tx in protocol period|6|||
162638187|NCT01408914|587390854|FG000|Overall Study|Lost to Follow-up|4|||
162638188|NCT01408914|587390855|FG001|Overall Study|Lost to Follow-up|1|||
162638189|NCT01408914|587390856|FG002|Overall Study|Lost to Follow-up|2|||
162638190|NCT01408914|587390854|FG000|Overall Study|Physician Decision|1|||
162638191|NCT01408914|587390855|FG001|Overall Study|Physician Decision|1|||
163004675|NCT04233073|588717171|FG000|Overall Study|Death|5|||
163004676|NCT00143390|588717172|FG000|Overall Study|Death|2|||
163004677|NCT00143390|588717173|FG001|Overall Study|Death|0|||
163004678|NCT00143390|588717172|FG000|Overall Study|Not meeting entry criteria|2|||
163004679|NCT00143390|588717173|FG001|Overall Study|Not meeting entry criteria|5|||
163004680|NCT00143390|588717172|FG000|Overall Study|Withdrawal by Subject|4|||
163004681|NCT00143390|588717173|FG001|Overall Study|Withdrawal by Subject|4|||
163004682|NCT00143390|588717172|FG000|Overall Study|Progressive disease|119|||
163004683|NCT00143390|588717173|FG001|Overall Study|Progressive disease|115|||
163004684|NCT00143390|588717172|FG000|Overall Study|Protocol Violation|2|||
163004685|NCT00143390|588717173|FG001|Overall Study|Protocol Violation|0|||
163004686|NCT00143390|588717172|FG000|Overall Study|Study termination|10|||
163004687|NCT00143390|588717173|FG001|Overall Study|Study termination|15|||
163004688|NCT00143390|588717172|FG000|Overall Study|Adverse Event|9|||
163004689|NCT00143390|588717173|FG001|Overall Study|Adverse Event|8|||
163004690|NCT00143390|588717172|FG000|Overall Study|Other|1|||
163004691|NCT00143390|588717173|FG001|Overall Study|Other|2|||
162638192|NCT01408914|587390856|FG002|Overall Study|Physician Decision|0|||
163004692|NCT00243412|588717174|FG000|Overall Study|Death|0|||
163004693|NCT00243412|588717175|FG001|Overall Study|Death|1|||
163004694|NCT00243412|588717174|FG000|Overall Study|Adverse Event|4|||
163004695|NCT00243412|588717175|FG001|Overall Study|Adverse Event|2|||
163061147|NCT01799889|588933031|FG010|Overall Study|Physician Decision|0|||
162638193|NCT01408914|587390854|FG000|Overall Study|Withdrawal by Subject|1|||
162638194|NCT01408914|587390855|FG001|Overall Study|Withdrawal by Subject|0|||
162638195|NCT01408914|587390856|FG002|Overall Study|Withdrawal by Subject|1|||
163004696|NCT00243412|588717174|FG000|Overall Study|Lost to Follow-up|0|||
163004697|NCT00243412|588717175|FG001|Overall Study|Lost to Follow-up|1|||
163004698|NCT00243412|588717174|FG000|Overall Study|Physician Decision|1|||
163004699|NCT00243412|588717175|FG001|Overall Study|Physician Decision|1|||
163004700|NCT00243412|588717174|FG000|Overall Study|Withdrawal by Subject|4|||
162638196|NCT01408914|587390854|FG000|Overall Study|Moved out of study jurisdiction|1|||
162638197|NCT01408914|587390855|FG001|Overall Study|Moved out of study jurisdiction|1|||
162638198|NCT01408914|587390856|FG002|Overall Study|Moved out of study jurisdiction|0|||
163004701|NCT00243412|588717175|FG001|Overall Study|Withdrawal by Subject|5|||
163004702|NCT00243412|588717174|FG000|Overall Study|Other|1|||
163004703|NCT00243412|588717175|FG001|Overall Study|Other|1|||
163004704|NCT00041132|588717177|FG000|Overall Study|Adverse Event|19|||
163004705|NCT00041132|588717177|FG000|Overall Study|Death|1|||
163004706|NCT00041132|588717177|FG000|Overall Study|Not Eligible|7|||
163004707|NCT00041132|588717177|FG000|Overall Study|Withdrawal by Subject|1|||
163004708|NCT00041132|588717177|FG000|Overall Study|Physician Decision|2|||
163004709|NCT02764151|588717178|FG000|Overall Study|Subject refused further follow-up|0|||
163004710|NCT02764151|588717179|FG001|Overall Study|Subject refused further follow-up|0|||
163004711|NCT02764151|588717180|FG002|Overall Study|Subject refused further follow-up|0|||
163004712|NCT02764151|588717181|FG003|Overall Study|Subject refused further follow-up|1|||
163004713|NCT02764151|588717178|FG000|Overall Study|Other|0|||
163004714|NCT02764151|588717179|FG001|Overall Study|Other|0|||
163004715|NCT02764151|588717180|FG002|Overall Study|Other|0|||
163004716|NCT02764151|588717181|FG003|Overall Study|Other|2|||
163004717|NCT01450683|588717185|FG000|Overall Study|Adverse Event|2|||
163004718|NCT00625872|588717187|FG000|Overall Study|Withdrawal by Subject|1|||
163004719|NCT00625872|588717188|FG001|Overall Study|Withdrawal by Subject|0|||
163004720|NCT00625872|588717187|FG000|Overall Study|Does not meet inclusion criteria|1|||
163004721|NCT00625872|588717188|FG001|Overall Study|Does not meet inclusion criteria|0|||
163004722|NCT00625872|588717187|FG000|Overall Study|Terminated by sponsor|2|||
163004723|NCT00625872|588717188|FG001|Overall Study|Terminated by sponsor|5|||
163004724|NCT00625872|588717187|FG000|Overall Study|Randomized but not treated|0|||
163004725|NCT00625872|588717188|FG001|Overall Study|Randomized but not treated|1|||
163004726|NCT01512160|588717189|FG000|Overall Study|Lost to Follow-up|1|||
163004727|NCT01512160|588717190|FG001|Overall Study|Lost to Follow-up|0|||
163004728|NCT01512160|588717191|FG002|Overall Study|Lost to Follow-up|0|||
163004729|NCT01512160|588717192|FG003|Overall Study|Lost to Follow-up|0|||
163004730|NCT01512160|588717189|FG000|Overall Study|Withdrawal by Subject|1|||
163004731|NCT01512160|588717190|FG001|Overall Study|Withdrawal by Subject|0|||
163004732|NCT01512160|588717191|FG002|Overall Study|Withdrawal by Subject|0|||
163004733|NCT01512160|588717192|FG003|Overall Study|Withdrawal by Subject|1|||
163004734|NCT02729909|588717193|FG000|Overall Study|Lost to Follow-up|0|||
163004735|NCT02729909|588717194|FG001|Overall Study|Lost to Follow-up|1|||
163004736|NCT02729909|588717193|FG000|Overall Study|Lack of Efficacy|0|||
163004737|NCT02729909|588717194|FG001|Overall Study|Lack of Efficacy|2|||
163004738|NCT02729909|588717193|FG000|Overall Study|Significant Protocol Deviation|0|||
163004739|NCT02729909|588717194|FG001|Overall Study|Significant Protocol Deviation|2|||
163004740|NCT02729909|588717193|FG000|Overall Study|Voluntary Withdrawal|1|||
163004741|NCT02729909|588717194|FG001|Overall Study|Voluntary Withdrawal|0|||
163004742|NCT04779879|588717198|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004743|NCT04779879|588717199|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004744|NCT04779879|588717200|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004745|NCT04779879|588717201|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
163004746|NCT04779879|588717202|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004747|NCT04779879|588717203|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
163004748|NCT04779879|588717198|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004749|NCT04779879|588717199|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004750|NCT04779879|588717200|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004751|NCT04779879|588717201|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
163004752|NCT04779879|588717202|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004753|NCT04779879|588717203|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
163004754|NCT04779879|588717198|FG000|Part C: Up to Week 36|Death|0|||
163004755|NCT04779879|588717199|FG001|Part C: Up to Week 36|Death|0|||
163004756|NCT04779879|588717200|FG002|Part C: Up to Week 36|Death|0|||
163004757|NCT04779879|588717201|FG003|Part C: Up to Week 36|Death|0|||
162638199|NCT01408914|587390854|FG000|Overall Study|Late exclusion|0|||
162638200|NCT01408914|587390855|FG001|Overall Study|Late exclusion|3|||
163004758|NCT04779879|588717202|FG004|Part C: Up to Week 36|Death|0|||
163004759|NCT04779879|588717203|FG005|Part C: Up to Week 36|Death|1|||
163004760|NCT04779879|588717198|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004761|NCT04779879|588717199|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004762|NCT04779879|588717200|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
162638201|NCT01408914|587390856|FG002|Overall Study|Late exclusion|3|||
163004763|NCT04779879|588717201|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
163004764|NCT04779879|588717202|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
163004765|NCT04779879|588717203|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
163004766|NCT05101343|588717204|FG000|Overall Study|Withdrawal by Subject|2|||
163004767|NCT05101343|588717205|FG001|Overall Study|Withdrawal by Subject|1|||
162638202|NCT01408914|587390854|FG000|Overall Study|Change in local TB/HIV norms|0|||
163004768|NCT02854527|588717206|FG000|Overall Study|Adverse Event|0|||
163004769|NCT02854527|588717207|FG001|Overall Study|Adverse Event|0|||
163004770|NCT02854527|588717208|FG002|Overall Study|Adverse Event|0|||
163061148|NCT01799889|588933032|FG011|Overall Study|Physician Decision|1|||
163061149|NCT01799889|588933021|FG000|Overall Study|Progressive Disease|30|||
163061150|NCT01799889|588933022|FG001|Overall Study|Progressive Disease|26|||
163061151|NCT01799889|588933023|FG002|Overall Study|Progressive Disease|25|||
163061152|NCT01799889|588933024|FG003|Overall Study|Progressive Disease|30|||
163061153|NCT01799889|588933025|FG004|Overall Study|Progressive Disease|23|||
163061154|NCT01799889|588933026|FG005|Overall Study|Progressive Disease|9|||
163061155|NCT01799889|588933027|FG006|Overall Study|Progressive Disease|8|||
163061156|NCT01799889|588933028|FG007|Overall Study|Progressive Disease|13|||
163061157|NCT01799889|588933029|FG008|Overall Study|Progressive Disease|18|||
163061158|NCT01799889|588933030|FG009|Overall Study|Progressive Disease|5|||
163061159|NCT01799889|588933031|FG010|Overall Study|Progressive Disease|3|||
163061160|NCT01799889|588933032|FG011|Overall Study|Progressive Disease|1|||
163061161|NCT01799889|588933021|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
163061162|NCT01799889|588933022|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
163061163|NCT01799889|588933023|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
163061164|NCT01799889|588933024|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
163061165|NCT01799889|588933025|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
163061166|NCT01799889|588933026|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
163061167|NCT01799889|588933027|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
163061168|NCT01799889|588933028|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
163061169|NCT01799889|588933029|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
163061170|NCT01799889|588933030|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
163061171|NCT01799889|588933031|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
163061172|NCT01799889|588933032|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
163061173|NCT01799889|588933021|FG000|Overall Study|Study Terminated By Sponsor|1|||
163061174|NCT01799889|588933022|FG001|Overall Study|Study Terminated By Sponsor|0|||
163061175|NCT01799889|588933023|FG002|Overall Study|Study Terminated By Sponsor|0|||
163004771|NCT02854527|588717209|FG003|Overall Study|Adverse Event|0|||
163004772|NCT02854527|588717210|FG004|Overall Study|Adverse Event|1|||
163004773|NCT02854527|588717211|FG005|Overall Study|Adverse Event|0|||
163004774|NCT02854527|588717212|FG006|Overall Study|Adverse Event|0|||
163004775|NCT02854527|588717213|FG007|Overall Study|Adverse Event|0|||
163004776|NCT02854527|588717214|FG008|Overall Study|Adverse Event|0|||
163004777|NCT02854527|588717215|FG009|Overall Study|Adverse Event|0|||
163004778|NCT02854527|588717206|FG000|Overall Study|Lost to Follow-up|0|||
163004779|NCT02854527|588717207|FG001|Overall Study|Lost to Follow-up|0|||
163004780|NCT02854527|588717208|FG002|Overall Study|Lost to Follow-up|0|||
163004781|NCT02854527|588717209|FG003|Overall Study|Lost to Follow-up|1|||
163004782|NCT02854527|588717210|FG004|Overall Study|Lost to Follow-up|0|||
163004783|NCT02854527|588717211|FG005|Overall Study|Lost to Follow-up|0|||
163004784|NCT02854527|588717212|FG006|Overall Study|Lost to Follow-up|0|||
163004785|NCT02854527|588717213|FG007|Overall Study|Lost to Follow-up|0|||
163004786|NCT02854527|588717214|FG008|Overall Study|Lost to Follow-up|0|||
163004787|NCT02854527|588717215|FG009|Overall Study|Lost to Follow-up|0|||
163004788|NCT01959295|588717216|FG000|Overall Study|Adverse Event|2|||
163004789|NCT01959295|588717217|FG001|Overall Study|Adverse Event|0|||
163004790|NCT01959295|588717216|FG000|Overall Study|Lost to Follow-up|0|||
163004791|NCT01959295|588717217|FG001|Overall Study|Lost to Follow-up|2|||
163004792|NCT01959295|588717216|FG000|Overall Study|Physician Decision|2|||
163004793|NCT01959295|588717217|FG001|Overall Study|Physician Decision|3|||
163004794|NCT01959295|588717216|FG000|Overall Study|Protocol Violation|16|||
163004795|NCT01959295|588717217|FG001|Overall Study|Protocol Violation|5|||
163004796|NCT01959295|588717216|FG000|Overall Study|Withdrawal by Subject|3|||
163004797|NCT01959295|588717217|FG001|Overall Study|Withdrawal by Subject|1|||
163004798|NCT01959295|588717216|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
163004799|NCT01959295|588717217|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
163004800|NCT01128179|588717219|FG000|Overall Study|Death|1|||
163061176|NCT01799889|588933024|FG003|Overall Study|Study Terminated By Sponsor|0|||
163061177|NCT01799889|588933025|FG004|Overall Study|Study Terminated By Sponsor|2|||
163061178|NCT01799889|588933026|FG005|Overall Study|Study Terminated By Sponsor|1|||
163004801|NCT01128179|588717220|FG001|Overall Study|Death|0|||
163004802|NCT01128179|588717219|FG000|Overall Study|Protocol Violation|1|||
163061179|NCT01799889|588933027|FG006|Overall Study|Study Terminated By Sponsor|0|||
163061180|NCT01799889|588933028|FG007|Overall Study|Study Terminated By Sponsor|2|||
163061181|NCT01799889|588933029|FG008|Overall Study|Study Terminated By Sponsor|1|||
162638203|NCT01408914|587390855|FG001|Overall Study|Change in local TB/HIV norms|1|||
163004803|NCT01128179|588717220|FG001|Overall Study|Protocol Violation|0|||
163004804|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163061182|NCT01799889|588933030|FG009|Overall Study|Study Terminated By Sponsor|1|||
163061183|NCT01799889|588933031|FG010|Overall Study|Study Terminated By Sponsor|0|||
163061184|NCT01799889|588933032|FG011|Overall Study|Study Terminated By Sponsor|0|||
163061185|NCT01799889|588933021|FG000|Overall Study|Withdrawal by Subject|1|||
163004805|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004806|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004807|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004808|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
163004809|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004810|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
163004811|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
163004812|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
163004813|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
163004814|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
163004815|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
163004816|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
163004817|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
163004818|NCT01682811|588717221|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004819|NCT01682811|588717222|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004820|NCT01682811|588717223|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004821|NCT01682811|588717224|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004822|NCT01682811|588717225|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
163004823|NCT01682811|588717226|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004824|NCT01682811|588717227|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
163004825|NCT01682811|588717221|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004826|NCT01682811|588717222|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004827|NCT01682811|588717223|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004828|NCT01682811|588717224|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004829|NCT01682811|588717225|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004830|NCT01682811|588717226|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
163004831|NCT01682811|588717227|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
163004832|NCT02694328|588717232|FG000|Overall Study|Adverse Event|27|||
163004833|NCT02694328|588717233|FG001|Overall Study|Adverse Event|33|||
163004834|NCT02694328|588717232|FG000|Overall Study|Withdrawal by Subject|27|||
163004835|NCT02694328|588717233|FG001|Overall Study|Withdrawal by Subject|23|||
163004836|NCT02694328|588717232|FG000|Overall Study|Lost to Follow-up|26|||
163004837|NCT02694328|588717233|FG001|Overall Study|Lost to Follow-up|22|||
163004838|NCT02694328|588717232|FG000|Overall Study|Noncompliant with study drug|11|||
163004839|NCT02694328|588717233|FG001|Overall Study|Noncompliant with study drug|8|||
163004840|NCT02694328|588717232|FG000|Overall Study|Incarceration|1|||
163004841|NCT02694328|588717233|FG001|Overall Study|Incarceration|1|||
163004842|NCT02694328|588717232|FG000|Overall Study|Lack of Efficacy|1|||
163004843|NCT02694328|588717233|FG001|Overall Study|Lack of Efficacy|2|||
163004844|NCT02694328|588717232|FG000|Overall Study|Pregnancy|1|||
163004845|NCT02694328|588717233|FG001|Overall Study|Pregnancy|1|||
163004846|NCT02694328|588717232|FG000|Overall Study|Protocol Violation|6|||
163004847|NCT02694328|588717233|FG001|Overall Study|Protocol Violation|5|||
163004848|NCT02694328|588717232|FG000|Overall Study|Abnormal Laboratory Value|0|||
163004849|NCT02694328|588717233|FG001|Overall Study|Abnormal Laboratory Value|3|||
163004850|NCT04075487|588719675|FG000|Overall Study|Withdrawal by Subject|1|||
163004851|NCT04653454|588719678|FG000|Overall Study|Withdrawal by Subject|1|||
163004852|NCT04653454|588719678|FG000|Overall Study|Physician Decision|40|||
163004853|NCT05525520|588719680|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
163004854|NCT05525520|588719681|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
163004855|NCT05525520|588719680|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
163004856|NCT05525520|588719681|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
163004857|NCT05878093|588719682|FG000|Overall Study|Withdrawal by Subject|3|||
163004858|NCT05878093|588719683|FG001|Overall Study|Withdrawal by Subject|1|||
163004859|NCT02721732|588719684|FG000|Overall Study|Adverse Event|2|||
163004860|NCT02721732|588719685|FG001|Overall Study|Adverse Event|0|||
163004861|NCT02721732|588719686|FG002|Overall Study|Adverse Event|2|||
163004862|NCT02721732|588719687|FG003|Overall Study|Adverse Event|0|||
163004863|NCT02721732|588719688|FG004|Overall Study|Adverse Event|1|||
163004864|NCT02721732|588719689|FG005|Overall Study|Adverse Event|0|||
163004865|NCT02721732|588719690|FG006|Overall Study|Adverse Event|1|||
163004866|NCT02721732|588719691|FG007|Overall Study|Adverse Event|0|||
163004867|NCT02721732|588719692|FG008|Overall Study|Adverse Event|1|||
162638204|NCT01408914|587390856|FG002|Overall Study|Change in local TB/HIV norms|1|||
162638205|NCT01585194|587390857|FG000|Overall Study|Withdrawal by Subject|1|||
163004868|NCT02721732|588719693|FG009|Overall Study|Adverse Event|1|||
163004869|NCT02721732|588719684|FG000|Overall Study|Death|0|||
163004870|NCT02721732|588719685|FG001|Overall Study|Death|0|||
163004871|NCT02721732|588719686|FG002|Overall Study|Death|0|||
163004872|NCT02721732|588719687|FG003|Overall Study|Death|0|||
163004873|NCT02721732|588719688|FG004|Overall Study|Death|1|||
163004874|NCT02721732|588719689|FG005|Overall Study|Death|0|||
163004875|NCT02721732|588719690|FG006|Overall Study|Death|1|||
162638206|NCT01585194|587390857|FG000|Overall Study|Physician Decision|2|||
163004876|NCT02721732|588719691|FG007|Overall Study|Death|0|||
163004877|NCT02721732|588719692|FG008|Overall Study|Death|0|||
163004878|NCT02721732|588719693|FG009|Overall Study|Death|1|||
163004879|NCT02721732|588719684|FG000|Overall Study|Lack of Efficacy|12|||
163004880|NCT02721732|588719685|FG001|Overall Study|Lack of Efficacy|11|||
163004881|NCT02721732|588719686|FG002|Overall Study|Lack of Efficacy|18|||
162638207|NCT01585194|587390857|FG000|Overall Study|Lack of insurance|1|||
162638208|NCT00993291|587390858|FG000|Overall Study|Withdrawal by Subject|1|||
162638209|NCT04446377|587390860|FG000|Overall Study|Withdrawal by Subject|6|||
162638210|NCT04446377|587390861|FG001|Overall Study|Withdrawal by Subject|1|||
162638211|NCT04446377|587390860|FG000|Overall Study|Physician Decision|1|||
162638212|NCT04446377|587390861|FG001|Overall Study|Physician Decision|1|||
163004882|NCT02721732|588719687|FG003|Overall Study|Lack of Efficacy|5|||
163004883|NCT02721732|588719688|FG004|Overall Study|Lack of Efficacy|21|||
163004884|NCT02721732|588719689|FG005|Overall Study|Lack of Efficacy|2|||
163004885|NCT02721732|588719690|FG006|Overall Study|Lack of Efficacy|8|||
163004886|NCT02721732|588719691|FG007|Overall Study|Lack of Efficacy|11|||
163004887|NCT02721732|588719692|FG008|Overall Study|Lack of Efficacy|10|||
163004888|NCT02721732|588719693|FG009|Overall Study|Lack of Efficacy|20|||
163004889|NCT02721732|588719684|FG000|Overall Study|Physician Decision|0|||
163004890|NCT02721732|588719685|FG001|Overall Study|Physician Decision|0|||
163004891|NCT02721732|588719686|FG002|Overall Study|Physician Decision|1|||
163004892|NCT02721732|588719687|FG003|Overall Study|Physician Decision|0|||
163004893|NCT02721732|588719688|FG004|Overall Study|Physician Decision|0|||
163004894|NCT02721732|588719689|FG005|Overall Study|Physician Decision|0|||
163004895|NCT02721732|588719690|FG006|Overall Study|Physician Decision|0|||
163004896|NCT02721732|588719691|FG007|Overall Study|Physician Decision|0|||
163004897|NCT02721732|588719692|FG008|Overall Study|Physician Decision|0|||
163004898|NCT02721732|588719693|FG009|Overall Study|Physician Decision|0|||
163004899|NCT02721732|588719684|FG000|Overall Study|Withdrawal by Subject|1|||
163004900|NCT02721732|588719685|FG001|Overall Study|Withdrawal by Subject|0|||
163004901|NCT02721732|588719686|FG002|Overall Study|Withdrawal by Subject|0|||
163004902|NCT02721732|588719687|FG003|Overall Study|Withdrawal by Subject|0|||
163004903|NCT02721732|588719688|FG004|Overall Study|Withdrawal by Subject|3|||
163004904|NCT02721732|588719689|FG005|Overall Study|Withdrawal by Subject|0|||
163004905|NCT02721732|588719690|FG006|Overall Study|Withdrawal by Subject|1|||
163004906|NCT02721732|588719691|FG007|Overall Study|Withdrawal by Subject|1|||
163004907|NCT02721732|588719692|FG008|Overall Study|Withdrawal by Subject|0|||
163004908|NCT02721732|588719693|FG009|Overall Study|Withdrawal by Subject|1|||
163004909|NCT02721732|588719684|FG000|Overall Study|Participant Choice|1|||
163004910|NCT02721732|588719685|FG001|Overall Study|Participant Choice|0|||
163004911|NCT02721732|588719686|FG002|Overall Study|Participant Choice|0|||
163004912|NCT02721732|588719687|FG003|Overall Study|Participant Choice|0|||
163004913|NCT02721732|588719688|FG004|Overall Study|Participant Choice|0|||
163004914|NCT02721732|588719689|FG005|Overall Study|Participant Choice|0|||
163004915|NCT02721732|588719690|FG006|Overall Study|Participant Choice|0|||
163004916|NCT02721732|588719691|FG007|Overall Study|Participant Choice|0|||
163004917|NCT02721732|588719692|FG008|Overall Study|Participant Choice|0|||
163004918|NCT02721732|588719693|FG009|Overall Study|Participant Choice|1|||
163004919|NCT02721732|588719684|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004920|NCT02721732|588719685|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004921|NCT02721732|588719686|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
163004922|NCT02721732|588719687|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004923|NCT02721732|588719688|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004924|NCT02721732|588719689|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004925|NCT02721732|588719690|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004926|NCT02721732|588719691|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004927|NCT02721732|588719692|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004928|NCT02721732|588719693|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
163004929|NCT02721732|588719684|FG000|Overall Study|Progression and withdrew consent|1|||
163004930|NCT02721732|588719685|FG001|Overall Study|Progression and withdrew consent|1|||
163004931|NCT02721732|588719686|FG002|Overall Study|Progression and withdrew consent|0|||
163061186|NCT01799889|588933022|FG001|Overall Study|Withdrawal by Subject|6|||
163061187|NCT01799889|588933023|FG002|Overall Study|Withdrawal by Subject|4|||
163061188|NCT01799889|588933024|FG003|Overall Study|Withdrawal by Subject|0|||
162638213|NCT04446377|587390860|FG000|Overall Study|Lost to Follow-up|0|||
162638214|NCT04446377|587390861|FG001|Overall Study|Lost to Follow-up|2|||
162638215|NCT04446377|587390860|FG000|Overall Study|Not eligible|0|||
162715830|NCT03536884|587667100|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162715831|NCT03536884|587667101|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163004932|NCT02721732|588719687|FG003|Overall Study|Progression and withdrew consent|0|||
163004933|NCT02721732|588719688|FG004|Overall Study|Progression and withdrew consent|0|||
163004934|NCT02721732|588719689|FG005|Overall Study|Progression and withdrew consent|0|||
163004935|NCT02721732|588719690|FG006|Overall Study|Progression and withdrew consent|0|||
163004936|NCT02721732|588719691|FG007|Overall Study|Progression and withdrew consent|0|||
163004937|NCT02721732|588719692|FG008|Overall Study|Progression and withdrew consent|0|||
163004938|NCT02721732|588719693|FG009|Overall Study|Progression and withdrew consent|1|||
162638216|NCT04446377|587390861|FG001|Overall Study|Not eligible|1|||
162638217|NCT04903626|587390864|FG000|Overall Study|Lost to Follow-up|6|||
163004939|NCT02721732|588719684|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
163004940|NCT02721732|588719685|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
163004941|NCT02721732|588719686|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
163004942|NCT02721732|588719687|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
163004943|NCT02721732|588719688|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
163004944|NCT02721732|588719689|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
163004945|NCT02721732|588719690|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
163004946|NCT02721732|588719691|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
163004947|NCT02721732|588719692|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
163004948|NCT02721732|588719693|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
163004949|NCT04100018|588719699|FG000|Pre-Treatment Period|Not Reported|0|||
163004950|NCT04100018|588719700|FG001|Pre-Treatment Period|Not Reported|4|||
163004951|NCT04100018|588719699|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
163004952|NCT04100018|588719700|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
163004953|NCT04100018|588719699|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
163004954|NCT04100018|588719700|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
163004955|NCT04100018|588719699|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
163004956|NCT04100018|588719700|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163004957|NCT04100018|588719699|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163004958|NCT04100018|588719700|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
163004959|NCT04100018|588719699|FG000|Treatment Period|Ongoing Treatment|1|||
163004960|NCT04100018|588719700|FG001|Treatment Period|Ongoing Treatment|0|||
163004961|NCT04100018|588719699|FG000|Treatment Period|Other Reason|26|||
163004962|NCT04100018|588719700|FG001|Treatment Period|Other Reason|37|||
163004963|NCT04100018|588719699|FG000|Treatment Period|Completed treatment as per protocol|1|||
163004964|NCT04100018|588719700|FG001|Treatment Period|Completed treatment as per protocol|2|||
163004965|NCT04100018|588719699|FG000|Treatment Period|Maximum clinical benefit|3|||
163004966|NCT04100018|588719700|FG001|Treatment Period|Maximum clinical benefit|0|||
163004967|NCT04100018|588719699|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
163004968|NCT04100018|588719700|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
163004969|NCT04100018|588719699|FG000|Treatment Period|Study drug toxicity|67|||
163004970|NCT04100018|588719700|FG001|Treatment Period|Study drug toxicity|28|||
163004971|NCT04100018|588719699|FG000|Treatment Period|Disease Progression|284|||
163004972|NCT04100018|588719700|FG001|Treatment Period|Disease Progression|327|||
163004973|NCT04100018|588719699|FG000|Treatment Period|Administrative reasons by sponsor|16|||
163004974|NCT04100018|588719700|FG001|Treatment Period|Administrative reasons by sponsor|30|||
163004975|NCT04100018|588719699|FG000|Treatment Period|Poor/Non-Compliance|1|||
163004976|NCT04100018|588719700|FG001|Treatment Period|Poor/Non-Compliance|0|||
163004977|NCT04100018|588719699|FG000|Treatment Period|Lost to Follow-up|2|||
163004978|NCT04100018|588719700|FG001|Treatment Period|Lost to Follow-up|2|||
163004979|NCT04100018|588719699|FG000|Treatment Period|Death|16|||
163004980|NCT04100018|588719700|FG001|Treatment Period|Death|11|||
163004981|NCT04100018|588719699|FG000|Treatment Period|Participant withdrew consent|10|||
163004982|NCT04100018|588719700|FG001|Treatment Period|Participant withdrew consent|10|||
163004983|NCT04100018|588719699|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
163004984|NCT04100018|588719700|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
163004985|NCT04100018|588719699|FG000|Treatment Period|Adverse Event|14|||
163004986|NCT04100018|588719700|FG001|Treatment Period|Adverse Event|6|||
163004987|NCT04100018|588719699|FG000|Treatment Period|Lack of Efficacy|4|||
163004988|NCT04100018|588719700|FG001|Treatment Period|Lack of Efficacy|2|||
163004989|NCT02848001|588719701|FG000|Overall Study|other reasons|0|||
163004990|NCT02848001|588719702|FG001|Overall Study|other reasons|0|||
163004991|NCT02848001|588719703|FG002|Overall Study|other reasons|1|||
163004992|NCT02848001|588719704|FG003|Overall Study|other reasons|0|||
163004993|NCT02848001|588719705|FG004|Overall Study|other reasons|4|||
163004994|NCT02848001|588719706|FG005|Overall Study|other reasons|1|||
163004995|NCT02848001|588719707|FG006|Overall Study|other reasons|0|||
163004996|NCT02848001|588719708|FG007|Overall Study|other reasons|2|||
163004997|NCT02848001|588719709|FG008|Overall Study|other reasons|2|||
163004998|NCT02848001|588719710|FG009|Overall Study|other reasons|3|||
163004999|NCT02848001|588719711|FG010|Overall Study|other reasons|0|||
162638218|NCT04903626|587390864|FG000|Overall Study|Withdrawal by Subject|1|||
163005000|NCT02848001|588719712|FG011|Overall Study|other reasons|1|||
163005001|NCT02848001|588719713|FG012|Overall Study|other reasons|1|||
163005002|NCT02848001|588719714|FG013|Overall Study|other reasons|0|||
163005003|NCT02848001|588719715|FG014|Overall Study|other reasons|0|||
163005004|NCT02848001|588719716|FG015|Overall Study|other reasons|2|||
163005005|NCT02848001|588719717|FG016|Overall Study|other reasons|1|||
163005006|NCT02848001|588719701|FG000|Overall Study|Lack of Efficacy|0|||
163005007|NCT02848001|588719702|FG001|Overall Study|Lack of Efficacy|1|||
163005008|NCT02848001|588719703|FG002|Overall Study|Lack of Efficacy|1|||
163005009|NCT02848001|588719704|FG003|Overall Study|Lack of Efficacy|2|||
163005010|NCT02848001|588719705|FG004|Overall Study|Lack of Efficacy|3|||
163005011|NCT02848001|588719706|FG005|Overall Study|Lack of Efficacy|0|||
163005012|NCT02848001|588719707|FG006|Overall Study|Lack of Efficacy|1|||
163005013|NCT02848001|588719708|FG007|Overall Study|Lack of Efficacy|0|||
163005014|NCT02848001|588719709|FG008|Overall Study|Lack of Efficacy|0|||
163005015|NCT02848001|588719710|FG009|Overall Study|Lack of Efficacy|1|||
163005016|NCT02848001|588719711|FG010|Overall Study|Lack of Efficacy|0|||
163005017|NCT02848001|588719712|FG011|Overall Study|Lack of Efficacy|2|||
163005018|NCT02848001|588719713|FG012|Overall Study|Lack of Efficacy|0|||
163005019|NCT02848001|588719714|FG013|Overall Study|Lack of Efficacy|2|||
163005020|NCT02848001|588719715|FG014|Overall Study|Lack of Efficacy|2|||
163005021|NCT02848001|588719716|FG015|Overall Study|Lack of Efficacy|0|||
163005022|NCT02848001|588719717|FG016|Overall Study|Lack of Efficacy|0|||
163005023|NCT02848001|588719701|FG000|Overall Study|Progressive Disease|2|||
163005024|NCT02848001|588719702|FG001|Overall Study|Progressive Disease|1|||
163005025|NCT02848001|588719703|FG002|Overall Study|Progressive Disease|0|||
163005026|NCT02848001|588719704|FG003|Overall Study|Progressive Disease|4|||
163005027|NCT02848001|588719705|FG004|Overall Study|Progressive Disease|3|||
163005028|NCT02848001|588719706|FG005|Overall Study|Progressive Disease|0|||
163005029|NCT02848001|588719707|FG006|Overall Study|Progressive Disease|4|||
163005030|NCT02848001|588719708|FG007|Overall Study|Progressive Disease|1|||
163005031|NCT02848001|588719709|FG008|Overall Study|Progressive Disease|0|||
163005032|NCT02848001|588719710|FG009|Overall Study|Progressive Disease|2|||
163005033|NCT02848001|588719711|FG010|Overall Study|Progressive Disease|3|||
163005034|NCT02848001|588719712|FG011|Overall Study|Progressive Disease|2|||
163005035|NCT02848001|588719713|FG012|Overall Study|Progressive Disease|1|||
163005036|NCT02848001|588719714|FG013|Overall Study|Progressive Disease|0|||
163005037|NCT02848001|588719715|FG014|Overall Study|Progressive Disease|2|||
163005038|NCT02848001|588719716|FG015|Overall Study|Progressive Disease|4|||
163005039|NCT02848001|588719717|FG016|Overall Study|Progressive Disease|0|||
163005040|NCT02848001|588719701|FG000|Overall Study|Adverse Event|0|||
163005041|NCT02848001|588719702|FG001|Overall Study|Adverse Event|0|||
163005042|NCT02848001|588719703|FG002|Overall Study|Adverse Event|0|||
163005043|NCT02848001|588719704|FG003|Overall Study|Adverse Event|0|||
163005044|NCT02848001|588719705|FG004|Overall Study|Adverse Event|2|||
163005045|NCT02848001|588719706|FG005|Overall Study|Adverse Event|0|||
163005046|NCT02848001|588719707|FG006|Overall Study|Adverse Event|0|||
163005047|NCT02848001|588719708|FG007|Overall Study|Adverse Event|0|||
163005048|NCT02848001|588719709|FG008|Overall Study|Adverse Event|0|||
163005049|NCT02848001|588719710|FG009|Overall Study|Adverse Event|1|||
163005050|NCT02848001|588719711|FG010|Overall Study|Adverse Event|0|||
163005051|NCT02848001|588719712|FG011|Overall Study|Adverse Event|1|||
163005052|NCT02848001|588719713|FG012|Overall Study|Adverse Event|1|||
163005053|NCT02848001|588719714|FG013|Overall Study|Adverse Event|0|||
163005054|NCT02848001|588719715|FG014|Overall Study|Adverse Event|2|||
163005055|NCT02848001|588719716|FG015|Overall Study|Adverse Event|0|||
163005056|NCT02848001|588719717|FG016|Overall Study|Adverse Event|0|||
163005057|NCT02848001|588719701|FG000|Overall Study|Death|0|||
163005058|NCT02848001|588719702|FG001|Overall Study|Death|0|||
163005059|NCT02848001|588719703|FG002|Overall Study|Death|0|||
163005060|NCT02848001|588719704|FG003|Overall Study|Death|1|||
163005061|NCT02848001|588719705|FG004|Overall Study|Death|3|||
162638219|NCT04903626|587390864|FG000|Overall Study|Other, Not Specified|1|||
162638220|NCT06112756|587390867|FG000|Overall Study|Withdrawal by Subject|0|||
163005062|NCT02848001|588719706|FG005|Overall Study|Death|1|||
163005063|NCT02848001|588719707|FG006|Overall Study|Death|2|||
163005064|NCT02848001|588719708|FG007|Overall Study|Death|3|||
163005065|NCT02848001|588719709|FG008|Overall Study|Death|4|||
163005066|NCT02848001|588719710|FG009|Overall Study|Death|1|||
163005067|NCT02848001|588719711|FG010|Overall Study|Death|0|||
162638221|NCT06112756|587390868|FG001|Overall Study|Withdrawal by Subject|2|||
162638222|NCT06112756|587390867|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
162638223|NCT06112756|587390868|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
162638224|NCT06112756|587390867|FG000|Overall Study|Adverse Event|2|||
163005068|NCT02848001|588719712|FG011|Overall Study|Death|1|||
163005069|NCT02848001|588719713|FG012|Overall Study|Death|3|||
163005070|NCT02848001|588719714|FG013|Overall Study|Death|0|||
163005071|NCT02848001|588719715|FG014|Overall Study|Death|2|||
163005072|NCT02848001|588719716|FG015|Overall Study|Death|3|||
162638225|NCT06112756|587390868|FG001|Overall Study|Adverse Event|2|||
162638226|NCT03060629|587390869|FG000|Overall Study|Death|4|||
163005073|NCT02848001|588719717|FG016|Overall Study|Death|0|||
163005074|NCT02848001|588719701|FG000|Overall Study|Physician Decision|0|||
163005075|NCT02848001|588719702|FG001|Overall Study|Physician Decision|0|||
163005076|NCT02848001|588719703|FG002|Overall Study|Physician Decision|0|||
163005077|NCT02848001|588719704|FG003|Overall Study|Physician Decision|0|||
163005078|NCT02848001|588719705|FG004|Overall Study|Physician Decision|0|||
163005079|NCT02848001|588719706|FG005|Overall Study|Physician Decision|0|||
163005080|NCT02848001|588719707|FG006|Overall Study|Physician Decision|0|||
163005081|NCT02848001|588719708|FG007|Overall Study|Physician Decision|0|||
163005082|NCT02848001|588719709|FG008|Overall Study|Physician Decision|1|||
163005083|NCT02848001|588719710|FG009|Overall Study|Physician Decision|1|||
163005084|NCT02848001|588719711|FG010|Overall Study|Physician Decision|0|||
163005085|NCT02848001|588719712|FG011|Overall Study|Physician Decision|0|||
163005086|NCT02848001|588719713|FG012|Overall Study|Physician Decision|2|||
163005087|NCT02848001|588719714|FG013|Overall Study|Physician Decision|0|||
163005088|NCT02848001|588719715|FG014|Overall Study|Physician Decision|0|||
163005089|NCT02848001|588719716|FG015|Overall Study|Physician Decision|0|||
163005090|NCT02848001|588719717|FG016|Overall Study|Physician Decision|0|||
163005091|NCT02848001|588719701|FG000|Overall Study|Withdrawal by Subject|0|||
163005092|NCT02848001|588719702|FG001|Overall Study|Withdrawal by Subject|0|||
163005093|NCT02848001|588719703|FG002|Overall Study|Withdrawal by Subject|0|||
163005094|NCT02848001|588719704|FG003|Overall Study|Withdrawal by Subject|0|||
163005095|NCT02848001|588719705|FG004|Overall Study|Withdrawal by Subject|0|||
163005096|NCT02848001|588719706|FG005|Overall Study|Withdrawal by Subject|1|||
163005097|NCT02848001|588719707|FG006|Overall Study|Withdrawal by Subject|1|||
163005098|NCT02848001|588719708|FG007|Overall Study|Withdrawal by Subject|1|||
163005099|NCT02848001|588719709|FG008|Overall Study|Withdrawal by Subject|0|||
163005100|NCT02848001|588719710|FG009|Overall Study|Withdrawal by Subject|0|||
163005101|NCT02848001|588719711|FG010|Overall Study|Withdrawal by Subject|0|||
163005102|NCT02848001|588719712|FG011|Overall Study|Withdrawal by Subject|0|||
163005103|NCT02848001|588719713|FG012|Overall Study|Withdrawal by Subject|0|||
163005104|NCT02848001|588719714|FG013|Overall Study|Withdrawal by Subject|0|||
163005105|NCT02848001|588719715|FG014|Overall Study|Withdrawal by Subject|0|||
163005106|NCT02848001|588719716|FG015|Overall Study|Withdrawal by Subject|0|||
163005107|NCT02848001|588719717|FG016|Overall Study|Withdrawal by Subject|0|||
163005108|NCT04358081|588719718|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
163005109|NCT04358081|588719719|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
163005110|NCT04358081|588719720|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
163005111|NCT04358081|588719718|FG000|Treatment Phase of Study|Adverse Event|1|||
163005112|NCT04358081|588719719|FG001|Treatment Phase of Study|Adverse Event|0|||
163005113|NCT04358081|588719720|FG002|Treatment Phase of Study|Adverse Event|1|||
163005114|NCT04358081|588719718|FG000|Treatment Phase of Study|Physician Decision|2|||
163005115|NCT04358081|588719719|FG001|Treatment Phase of Study|Physician Decision|0|||
163005116|NCT04358081|588719720|FG002|Treatment Phase of Study|Physician Decision|1|||
163005117|NCT04358081|588719718|FG000|Treatment Phase of Study|Protocol Violation|1|||
163005118|NCT04358081|588719719|FG001|Treatment Phase of Study|Protocol Violation|0|||
163005119|NCT04358081|588719720|FG002|Treatment Phase of Study|Protocol Violation|0|||
163005120|NCT04358081|588719718|FG000|Study Completion Phase|Death|0|||
163005121|NCT04358081|588719719|FG001|Study Completion Phase|Death|0|||
163005122|NCT04358081|588719720|FG002|Study Completion Phase|Death|1|||
163005123|NCT04358081|588719718|FG000|Study Completion Phase|Lost to Follow-up|1|||
163005124|NCT04358081|588719719|FG001|Study Completion Phase|Lost to Follow-up|0|||
163005125|NCT04358081|588719720|FG002|Study Completion Phase|Lost to Follow-up|1|||
163005126|NCT00725283|588719724|FG000|Overall Study|Missing Code|3|||
163005127|NCT00725283|588719724|FG000|Overall Study|Death|5|||
163005128|NCT00725283|588719724|FG000|Overall Study|Other|6|||
163005129|NCT00725283|588719724|FG000|Overall Study|Withdrawal by Subject|10|||
163005130|NCT03103087|588719725|FG000|Overall Study|Did not receive any study drug|1|||
163005131|NCT03103087|588719726|FG001|Overall Study|Did not receive any study drug|0|||
163005132|NCT03103087|588719727|FG002|Overall Study|Did not receive any study drug|0|||
163005133|NCT03103087|588719725|FG000|Overall Study|Protocol Violation|1|||
163005134|NCT03103087|588719726|FG001|Overall Study|Protocol Violation|2|||
163005135|NCT03103087|588719727|FG002|Overall Study|Protocol Violation|1|||
163005136|NCT03103087|588719725|FG000|Overall Study|Lack of Efficacy|2|||
163005137|NCT03103087|588719726|FG001|Overall Study|Lack of Efficacy|1|||
163005138|NCT03103087|588719727|FG002|Overall Study|Lack of Efficacy|1|||
163005139|NCT03103087|588719725|FG000|Overall Study|Pregnancy|0|||
163005140|NCT03103087|588719726|FG001|Overall Study|Pregnancy|0|||
163005141|NCT03103087|588719727|FG002|Overall Study|Pregnancy|1|||
163005142|NCT03103087|588719725|FG000|Overall Study|Adverse Event|2|||
163005143|NCT03103087|588719726|FG001|Overall Study|Adverse Event|15|||
163005144|NCT03103087|588719727|FG002|Overall Study|Adverse Event|6|||
163005145|NCT03103087|588719725|FG000|Overall Study|Withdrawal by Subject|13|||
163005146|NCT03103087|588719726|FG001|Overall Study|Withdrawal by Subject|6|||
163005147|NCT03103087|588719727|FG002|Overall Study|Withdrawal by Subject|6|||
163005148|NCT03103087|588719725|FG000|Overall Study|Lost to Follow-up|4|||
163061189|NCT01799889|588933025|FG004|Overall Study|Withdrawal by Subject|5|||
163005149|NCT03103087|588719726|FG001|Overall Study|Lost to Follow-up|2|||
163005150|NCT03103087|588719727|FG002|Overall Study|Lost to Follow-up|7|||
163005151|NCT03103087|588719725|FG000|Overall Study|Other reason not reported|1|||
163005152|NCT03103087|588719726|FG001|Overall Study|Other reason not reported|3|||
163005153|NCT03103087|588719727|FG002|Overall Study|Other reason not reported|5|||
163005154|NCT00118157|588719728|FG000|Overall Study|Adverse Event|2|||
163061190|NCT01799889|588933026|FG005|Overall Study|Withdrawal by Subject|1|||
163005155|NCT00118157|588719728|FG000|Overall Study|Death|8|||
163005156|NCT00118157|588719728|FG000|Overall Study|Withdrawal by Subject|2|||
163005157|NCT03283566|588719729|FG000|Overall Study|Lost to Follow-up|1|||
163005158|NCT03283566|588719730|FG001|Overall Study|Lost to Follow-up|2|||
163005159|NCT02760004|588719731|FG000|Overall Study|Lost to Follow-up|13|||
162638227|NCT03060629|587390870|FG001|Overall Study|Death|5|||
162638228|NCT03060629|587390869|FG000|Overall Study|Withdrawal by Subject|50|||
163005160|NCT02760004|588719732|FG001|Overall Study|Lost to Follow-up|22|||
163005161|NCT01495000|588719733|FG000|Overall Study|Lost to Follow-up|2|||
163005162|NCT01495000|588719734|FG001|Overall Study|Lost to Follow-up|2|||
163005163|NCT01495000|588719733|FG000|Overall Study|Protocol Violation|1|||
163005164|NCT01495000|588719734|FG001|Overall Study|Protocol Violation|0|||
163005165|NCT01495000|588719733|FG000|Overall Study|Withdrawal by Subject|10|||
163005166|NCT01495000|588719734|FG001|Overall Study|Withdrawal by Subject|10|||
163005167|NCT02070965|588719735|FG000|Overall Study|Lost to Follow-up|0|||
163005168|NCT02070965|588719736|FG001|Overall Study|Lost to Follow-up|1|||
163005169|NCT02070965|588719737|FG002|Overall Study|Lost to Follow-up|0|||
163005170|NCT02070965|588719735|FG000|Overall Study|Withdrawal by Subject|1|||
163005171|NCT02070965|588719736|FG001|Overall Study|Withdrawal by Subject|1|||
163005172|NCT02070965|588719737|FG002|Overall Study|Withdrawal by Subject|1|||
163005173|NCT02070965|588719735|FG000|Overall Study|Subject moved|1|||
163005174|NCT02070965|588719736|FG001|Overall Study|Subject moved|0|||
163005175|NCT02070965|588719737|FG002|Overall Study|Subject moved|0|||
163005176|NCT03889886|588719739|FG000|Overall Study|Other|0|||
163005177|NCT03889886|588719740|FG001|Overall Study|Other|1|||
163005178|NCT03889886|588719741|FG002|Overall Study|Other|0|||
163005179|NCT03889886|588719742|FG003|Overall Study|Other|1|||
163005180|NCT03889886|588719739|FG000|Overall Study|Withdrawal by Subject|0|||
163005181|NCT03889886|588719740|FG001|Overall Study|Withdrawal by Subject|0|||
163005182|NCT03889886|588719741|FG002|Overall Study|Withdrawal by Subject|1|||
163005183|NCT03889886|588719742|FG003|Overall Study|Withdrawal by Subject|0|||
163005184|NCT03889886|588719739|FG000|Overall Study|Adverse Event|0|||
163005185|NCT03889886|588719740|FG001|Overall Study|Adverse Event|0|||
163005186|NCT03889886|588719741|FG002|Overall Study|Adverse Event|0|||
163005187|NCT03889886|588719742|FG003|Overall Study|Adverse Event|6|||
163005188|NCT00276484|588719743|FG000|Overall Study|Adverse Event|4|||
163005189|NCT00276484|588719744|FG001|Overall Study|Adverse Event|7|||
163005190|NCT00276484|588719743|FG000|Overall Study|Lost to Follow-up|1|||
163005191|NCT00276484|588719744|FG001|Overall Study|Lost to Follow-up|1|||
163005192|NCT00276484|588719743|FG000|Overall Study|Protocol Violation|0|||
163005193|NCT00276484|588719744|FG001|Overall Study|Protocol Violation|1|||
163005194|NCT00276484|588719743|FG000|Overall Study|Withdrawal by Subject|4|||
163005195|NCT00276484|588719744|FG001|Overall Study|Withdrawal by Subject|3|||
163005196|NCT00276484|588719743|FG000|Overall Study|Could not take time off work|0|||
163005197|NCT00276484|588719744|FG001|Overall Study|Could not take time off work|1|||
163005198|NCT00116779|588719756|FG000|Overall Study|Adverse Event|4|||
163005199|NCT00116779|588719757|FG001|Overall Study|Adverse Event|2|||
163005200|NCT00116779|588719756|FG000|Overall Study|Protocol Violation|1|||
163005201|NCT00116779|588719757|FG001|Overall Study|Protocol Violation|4|||
163005202|NCT00116779|588719756|FG000|Overall Study|Withdrawal by Subject|4|||
163005203|NCT00116779|588719757|FG001|Overall Study|Withdrawal by Subject|1|||
163005204|NCT00116779|588719756|FG000|Overall Study|Inadequate testosterone suppression|7|||
163005205|NCT00116779|588719757|FG001|Overall Study|Inadequate testosterone suppression|9|||
163005206|NCT00116779|588719756|FG000|Overall Study|Physician Decision|3|||
163005207|NCT00116779|588719757|FG001|Overall Study|Physician Decision|1|||
163005208|NCT00116779|588719756|FG000|Overall Study|Elevated PSA levels|2|||
163005209|NCT00116779|588719757|FG001|Overall Study|Elevated PSA levels|2|||
163005210|NCT03934541|588719772|FG000|Overall Study|Study Terminated by Sponsor|0|||
163005211|NCT03934541|588719773|FG001|Overall Study|Study Terminated by Sponsor|1|||
163005212|NCT03934541|588719774|FG002|Overall Study|Study Terminated by Sponsor|0|||
163005213|NCT03934541|588719775|FG003|Overall Study|Study Terminated by Sponsor|0|||
163005214|NCT01928472|588719778|FG000|Overall Study|Death|0|||
163005215|NCT01928472|588719779|FG001|Overall Study|Death|0|||
163005216|NCT01928472|588719780|FG002|Overall Study|Death|1|||
163005217|NCT01928472|588719781|FG003|Overall Study|Death|0|||
163005218|NCT01928472|588719778|FG000|Overall Study|Withdrawal by Subject|4|||
163005219|NCT01928472|588719779|FG001|Overall Study|Withdrawal by Subject|4|||
163005220|NCT01928472|588719780|FG002|Overall Study|Withdrawal by Subject|1|||
163005221|NCT01928472|588719781|FG003|Overall Study|Withdrawal by Subject|2|||
163005222|NCT01928472|588719778|FG000|Overall Study|Lost to Follow-up|2|||
163005223|NCT01928472|588719779|FG001|Overall Study|Lost to Follow-up|3|||
163005224|NCT01928472|588719780|FG002|Overall Study|Lost to Follow-up|4|||
163005225|NCT01928472|588719781|FG003|Overall Study|Lost to Follow-up|0|||
163005226|NCT01928472|588719778|FG000|Overall Study|Administrative Reason|2|||
163005227|NCT01928472|588719779|FG001|Overall Study|Administrative Reason|1|||
163005228|NCT01928472|588719780|FG002|Overall Study|Administrative Reason|0|||
163005229|NCT01928472|588719781|FG003|Overall Study|Administrative Reason|0|||
163005230|NCT01928472|588719778|FG000|Overall Study|Unclassified|0|||
163005231|NCT01928472|588719779|FG001|Overall Study|Unclassified|0|||
163005232|NCT01928472|588719780|FG002|Overall Study|Unclassified|1|||
163005233|NCT01928472|588719781|FG003|Overall Study|Unclassified|0|||
162638229|NCT03060629|587390870|FG001|Overall Study|Withdrawal by Subject|35|||
163005234|NCT04620746|588719782|FG000|Overall Study|Adverse Event|2|||
163005235|NCT04620746|588719783|FG001|Overall Study|Adverse Event|0|||
163005236|NCT04620746|588719782|FG000|Overall Study|Uniterpretable skin test|1|||
163005237|NCT04620746|588719783|FG001|Overall Study|Uniterpretable skin test|0|||
163005238|NCT04620746|588719782|FG000|Overall Study|Withdrawal by Subject|0|||
163005239|NCT04620746|588719783|FG001|Overall Study|Withdrawal by Subject|1|||
163005240|NCT05767905|588719788|FG000|Overall Study|Adverse Event|0|||
163005241|NCT05767905|588719789|FG001|Overall Study|Adverse Event|0|||
163005242|NCT05767905|588719790|FG002|Overall Study|Adverse Event|1|||
163005243|NCT03404674|588719796|FG000|Overall Study|Inability to Attend Future Visits|0|||
163005244|NCT03404674|588719797|FG001|Overall Study|Inability to Attend Future Visits|1|||
163005245|NCT03404674|588719798|FG002|Overall Study|Inability to Attend Future Visits|1|||
163005246|NCT03404674|588719799|FG003|Overall Study|Inability to Attend Future Visits|0|||
163005247|NCT03404674|588719800|FG004|Overall Study|Inability to Attend Future Visits|0|||
163005248|NCT03404674|588719801|FG005|Overall Study|Inability to Attend Future Visits|0|||
163005249|NCT03404674|588719796|FG000|Overall Study|Behavioral Problems|0|||
163005250|NCT03404674|588719797|FG001|Overall Study|Behavioral Problems|0|||
163005251|NCT03404674|588719798|FG002|Overall Study|Behavioral Problems|1|||
163005252|NCT03404674|588719799|FG003|Overall Study|Behavioral Problems|0|||
163005253|NCT03404674|588719800|FG004|Overall Study|Behavioral Problems|0|||
163005254|NCT03404674|588719801|FG005|Overall Study|Behavioral Problems|0|||
163005255|NCT03404674|588719796|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005256|NCT03404674|588719797|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005257|NCT03404674|588719798|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005258|NCT03404674|588719799|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
163005259|NCT03404674|588719800|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
163005260|NCT03404674|588719801|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
163005261|NCT01841593|588719807|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
163005262|NCT01841593|588719808|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
163005263|NCT01841593|588719807|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
163005264|NCT01841593|588719808|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
163005265|NCT02635984|588719809|FG000|Overall Study|Lost to Follow-up|2|||
163005266|NCT02635984|588719810|FG001|Overall Study|Lost to Follow-up|4|||
163005267|NCT02635984|588719809|FG000|Overall Study|Study Arm Closed|1|||
163005268|NCT02635984|588719810|FG001|Overall Study|Study Arm Closed|0|||
163005269|NCT00307086|588719813|FG000|Overall Study|ineligible|5|||
163005270|NCT01487525|588719814|FG000|Overall Study|Withdrawal by Subject|0|||
163005271|NCT01487525|588719815|FG001|Overall Study|Withdrawal by Subject|1|||
163005272|NCT03518008|588719816|FG000|Period 2, Second Week of Wear|Family emergency|0|||
163005273|NCT03518008|588719817|FG001|Period 2, Second Week of Wear|Family emergency|1|||
163005274|NCT02501928|588719818|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163005275|NCT02501928|588719819|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
163005276|NCT02501928|588719820|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
163005277|NCT02501928|588719821|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
163005278|NCT02501928|588719822|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
163005279|NCT02501928|588719823|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
163005280|NCT01197911|588719824|FG000|Overall Study|Adverse Event|0|||
163005281|NCT01197911|588719825|FG001|Overall Study|Adverse Event|0|||
163005282|NCT01197911|588719826|FG002|Overall Study|Adverse Event|1|||
163005283|NCT01526057|588719830|FG000|Overall Study|Withdrawal by Subject|3|||
163005284|NCT01526057|588719831|FG001|Overall Study|Withdrawal by Subject|2|||
163005285|NCT01526057|588719832|FG002|Overall Study|Withdrawal by Subject|2|||
163005286|NCT01526057|588719830|FG000|Overall Study|Adverse Event|3|||
163005287|NCT01526057|588719831|FG001|Overall Study|Adverse Event|1|||
163005288|NCT01526057|588719832|FG002|Overall Study|Adverse Event|1|||
163005289|NCT01526057|588719830|FG000|Overall Study|Death|1|||
163005290|NCT01526057|588719831|FG001|Overall Study|Death|0|||
163005291|NCT01526057|588719832|FG002|Overall Study|Death|0|||
163005292|NCT01526057|588719830|FG000|Overall Study|Lost to Follow-up|1|||
163005293|NCT01526057|588719831|FG001|Overall Study|Lost to Follow-up|0|||
163005294|NCT01526057|588719832|FG002|Overall Study|Lost to Follow-up|1|||
163005295|NCT01526057|588719830|FG000|Overall Study|Other|1|||
163005296|NCT01526057|588719831|FG001|Overall Study|Other|0|||
163005297|NCT01526057|588719832|FG002|Overall Study|Other|1|||
163005298|NCT01526057|588719830|FG000|Overall Study|Protocol Violation|0|||
163005299|NCT01526057|588719831|FG001|Overall Study|Protocol Violation|0|||
163005300|NCT01526057|588719832|FG002|Overall Study|Protocol Violation|1|||
163005301|NCT02123446|588719833|FG000|Washout Period (1 Day)|Physician Decision|1|||
163005302|NCT02123446|588719834|FG001|Washout Period (1 Day)|Physician Decision|0|||
163005303|NCT02553772|588719836|FG000|Overall Study|Adverse Event|2|||
163005304|NCT02553772|588719837|FG001|Overall Study|Adverse Event|3|||
163005305|NCT02553772|588719836|FG000|Overall Study|Lost to Follow-up|2|||
163005306|NCT02553772|588719837|FG001|Overall Study|Lost to Follow-up|1|||
163005307|NCT02553772|588719836|FG000|Overall Study|Withdrawal of Consent|1|||
163005308|NCT02553772|588719837|FG001|Overall Study|Withdrawal of Consent|1|||
163005309|NCT02553772|588719836|FG000|Overall Study|Lack of Efficacy|1|||
163005310|NCT02553772|588719837|FG001|Overall Study|Lack of Efficacy|0|||
163061191|NCT01799889|588933027|FG006|Overall Study|Withdrawal by Subject|3|||
163061192|NCT01799889|588933028|FG007|Overall Study|Withdrawal by Subject|1|||
163061193|NCT01799889|588933029|FG008|Overall Study|Withdrawal by Subject|2|||
163061194|NCT01799889|588933030|FG009|Overall Study|Withdrawal by Subject|1|||
163061195|NCT01799889|588933031|FG010|Overall Study|Withdrawal by Subject|1|||
163061196|NCT01799889|588933032|FG011|Overall Study|Withdrawal by Subject|1|||
163061197|NCT01799889|588933021|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163061198|NCT01799889|588933022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163061199|NCT01799889|588933023|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163061200|NCT01799889|588933024|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163061201|NCT01799889|588933025|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163061202|NCT01799889|588933026|FG005|Overall Study|Non-Compliance With Study Drug|1|||
163061203|NCT01799889|588933027|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163061204|NCT01799889|588933028|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163061205|NCT01799889|588933029|FG008|Overall Study|Non-Compliance With Study Drug|0|||
163061206|NCT01799889|588933030|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163061207|NCT01799889|588933031|FG010|Overall Study|Non-Compliance With Study Drug|0|||
163061208|NCT01799889|588933032|FG011|Overall Study|Non-Compliance With Study Drug|0|||
163061209|NCT06633965|588933033|FG000|Overall Study|Withdrawal by Subject|0|||
163061210|NCT06633965|588933034|FG001|Overall Study|Withdrawal by Subject|1|||
162638230|NCT03060629|587390869|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
162638231|NCT03060629|587390870|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
163061211|NCT00300053|588933040|FG000|Overall Study|Patient/Caregiver Preference|2|||
163061212|NCT00300053|588933041|FG001|Overall Study|Patient/Caregiver Preference|2|||
163061213|NCT00300053|588933042|FG002|Overall Study|Patient/Caregiver Preference|3|||
163061214|NCT00300053|588933040|FG000|Overall Study|Death|0|||
163061215|NCT00300053|588933041|FG001|Overall Study|Death|0|||
163061216|NCT00300053|588933042|FG002|Overall Study|Death|3|||
163061217|NCT00300053|588933040|FG000|Overall Study|Lost to Follow-up|0|||
163061218|NCT00300053|588933041|FG001|Overall Study|Lost to Follow-up|1|||
163061219|NCT00300053|588933042|FG002|Overall Study|Lost to Follow-up|0|||
163061220|NCT02472405|588933043|FG000|Overall Study|Lost to Follow-up|9|||
163061221|NCT02472405|588933043|FG000|Overall Study|Adverse Event|1|||
163061222|NCT03095287|588933044|FG000|Overall Study|Treatment Failure|1|||
163061223|NCT03095287|588933044|FG000|Overall Study|Adverse Event|1|||
162638232|NCT03060629|587390869|FG000|Overall Study|Participant Relocate|15|||
162638233|NCT03060629|587390870|FG001|Overall Study|Participant Relocate|15|||
162638234|NCT03060629|587390869|FG000|Overall Study|Unable to Contact Participant|34|||
162924653|NCT02230332|588426075|FG000|Overall Study|Lost to Follow-up|1|||
162924654|NCT02230332|588426076|FG001|Overall Study|Lost to Follow-up|0|||
162924655|NCT02230332|588426075|FG000|Overall Study|Protocol Violation|1|||
162924656|NCT02230332|588426076|FG001|Overall Study|Protocol Violation|0|||
162924657|NCT01260194|588426079|FG000|Overall Study|Withdrawal of Consent|1|||
162924658|NCT02086968|588426080|FG000|Overall Study|Adverse Event|1|||
162924659|NCT02086968|588426081|FG001|Overall Study|Adverse Event|5|||
162924660|NCT02086968|588426080|FG000|Overall Study|Lost to Follow-up|2|||
162924661|NCT02086968|588426081|FG001|Overall Study|Lost to Follow-up|3|||
162924662|NCT02086968|588426080|FG000|Overall Study|Study drug received outside protocol|0|||
162924663|NCT02086968|588426081|FG001|Overall Study|Study drug received outside protocol|1|||
162924664|NCT02086968|588426080|FG000|Overall Study|Physician Decision|4|||
162924665|NCT02086968|588426081|FG001|Overall Study|Physician Decision|0|||
162924666|NCT02086968|588426080|FG000|Overall Study|Withdrawal by Subject|1|||
162924667|NCT02086968|588426081|FG001|Overall Study|Withdrawal by Subject|4|||
162924668|NCT00556166|588426087|FG000|Overall Study|Withdrawal by Subject|1|||
162924669|NCT03359473|588426088|FG000|Overall Study|Adverse Event|0|||
162924670|NCT03359473|588426089|FG001|Overall Study|Adverse Event|2|||
162924671|NCT03359473|588426090|FG002|Overall Study|Adverse Event|5|||
162924672|NCT03359473|588426091|FG003|Overall Study|Adverse Event|3|||
162924673|NCT03359473|588426088|FG000|Overall Study|Lost to Follow-up|0|||
162924674|NCT03359473|588426089|FG001|Overall Study|Lost to Follow-up|1|||
162924675|NCT03359473|588426090|FG002|Overall Study|Lost to Follow-up|0|||
162924676|NCT03359473|588426091|FG003|Overall Study|Lost to Follow-up|0|||
162924677|NCT03359473|588426088|FG000|Overall Study|Physician Decision|0|||
162924678|NCT03359473|588426089|FG001|Overall Study|Physician Decision|1|||
162924679|NCT03359473|588426090|FG002|Overall Study|Physician Decision|0|||
162924680|NCT03359473|588426091|FG003|Overall Study|Physician Decision|1|||
162924681|NCT03359473|588426088|FG000|Overall Study|Withdrawal by Subject|1|||
162924682|NCT03359473|588426089|FG001|Overall Study|Withdrawal by Subject|2|||
162924683|NCT03359473|588426090|FG002|Overall Study|Withdrawal by Subject|1|||
162924684|NCT03359473|588426091|FG003|Overall Study|Withdrawal by Subject|0|||
162924685|NCT03359473|588426088|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162924686|NCT03359473|588426089|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162924687|NCT03359473|588426090|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162924688|NCT03359473|588426091|FG003|Overall Study|Protocol-defined stopping criteria|1|||
163005311|NCT02553772|588719836|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163005312|NCT02553772|588719837|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163005313|NCT02860546|588719838|FG000|Overall Study|Clinical Progression|6|||
163005314|NCT02860546|588719838|FG000|Overall Study|Radiological Progression|12|||
163005315|NCT02466321|588719839|FG000|Overall Study|Death|26|||
163005316|NCT02466321|588719839|FG000|Overall Study|Revision|6|||
163005317|NCT02466321|588719839|FG000|Overall Study|Lost to Follow-up|60|||
163005318|NCT02466321|588719839|FG000|Overall Study|Did not receive study device|1|||
163005319|NCT01855828|588719840|FG000|Overall Study|Adverse Event|1|||
163005320|NCT01855828|588719840|FG000|Overall Study|Withdrawal by Subject|1|||
163005321|NCT05655546|588721773|FG000|Overall Study|Withdrawal by Subject|2|||
163005322|NCT05655546|588721774|FG001|Overall Study|Withdrawal by Subject|4|||
163005323|NCT03493685|588721775|FG000|Overall Study|Death|4|||
163005324|NCT03493685|588721776|FG001|Overall Study|Death|3|||
163005325|NCT03493685|588721775|FG000|Overall Study|Lost to Follow-up|3|||
163005326|NCT03493685|588721776|FG001|Overall Study|Lost to Follow-up|2|||
163005327|NCT03493685|588721775|FG000|Overall Study|Physician Decision|2|||
163005328|NCT03493685|588721776|FG001|Overall Study|Physician Decision|0|||
163005329|NCT03493685|588721775|FG000|Overall Study|Withdrawal by Subject|7|||
163005330|NCT03493685|588721776|FG001|Overall Study|Withdrawal by Subject|11|||
163005331|NCT04452669|588721777|FG000|Overall Study|Death|1|||
163005332|NCT04452669|588721778|FG001|Overall Study|Death|4|||
163005333|NCT04576507|588721782|FG000|Overall Study|Adverse Event|4|||
163005334|NCT04576507|588721782|FG000|Overall Study|Withdrawal by Subject|1|||
163005335|NCT00413699|588721783|FG000|Initial Period|Death|25|||
163005336|NCT00413699|588721784|FG001|Initial Period|Death|30|||
163005337|NCT00413699|588721785|FG002|Initial Period|Death|0|||
163005338|NCT00413699|588721783|FG000|Initial Period|Lack of Efficacy|59|||
163005339|NCT00413699|588721784|FG001|Initial Period|Lack of Efficacy|115|||
163005340|NCT00413699|588721785|FG002|Initial Period|Lack of Efficacy|0|||
163005341|NCT00413699|588721783|FG000|Initial Period|Lost to Follow-up|31|||
163005342|NCT00413699|588721784|FG001|Initial Period|Lost to Follow-up|101|||
163005343|NCT00413699|588721785|FG002|Initial Period|Lost to Follow-up|0|||
163005344|NCT00413699|588721783|FG000|Initial Period|Protocol Violation|38|||
163005345|NCT00413699|588721784|FG001|Initial Period|Protocol Violation|89|||
163005346|NCT00413699|588721785|FG002|Initial Period|Protocol Violation|0|||
163005347|NCT00413699|588721783|FG000|Initial Period|Pregnancy|10|||
163005348|NCT00413699|588721784|FG001|Initial Period|Pregnancy|8|||
163005349|NCT00413699|588721785|FG002|Initial Period|Pregnancy|0|||
163005350|NCT00413699|588721783|FG000|Initial Period|Did not meet entrance criteria|2|||
163005351|NCT00413699|588721784|FG001|Initial Period|Did not meet entrance criteria|2|||
163005352|NCT00413699|588721785|FG002|Initial Period|Did not meet entrance criteria|0|||
163005353|NCT00413699|588721783|FG000|Initial Period|Medication error without adverse event|0|||
163005354|NCT00413699|588721784|FG001|Initial Period|Medication error without adverse event|1|||
163005355|NCT00413699|588721785|FG002|Initial Period|Medication error without adverse event|0|||
163005356|NCT00413699|588721783|FG000|Initial Period|Study terminated by Sponsor|0|||
163005357|NCT00413699|588721784|FG001|Initial Period|Study terminated by Sponsor|1|||
163005358|NCT00413699|588721785|FG002|Initial Period|Study terminated by Sponsor|0|||
163005359|NCT00413699|588721783|FG000|Initial Period|Other|67|||
163005360|NCT00413699|588721784|FG001|Initial Period|Other|211|||
163005361|NCT00413699|588721785|FG002|Initial Period|Other|0|||
163005362|NCT00413699|588721783|FG000|Initial Period|Adverse event related to study drug|178|||
163005363|NCT00413699|588721784|FG001|Initial Period|Adverse event related to study drug|527|||
163005364|NCT00413699|588721785|FG002|Initial Period|Adverse event related to study drug|0|||
163005365|NCT00413699|588721783|FG000|Initial Period|Adverse event not related to study drug|113|||
163005366|NCT00413699|588721784|FG001|Initial Period|Adverse event not related to study drug|248|||
163005367|NCT00413699|588721785|FG002|Initial Period|Adverse event not related to study drug|0|||
163005368|NCT00413699|588721783|FG000|Initial Period|Missing end of study page|0|||
163005369|NCT00413699|588721784|FG001|Initial Period|Missing end of study page|4|||
163005370|NCT00413699|588721785|FG002|Initial Period|Missing end of study page|0|||
163005371|NCT00413699|588721783|FG000|Initial Period|No longer willing to participate|116|||
163005372|NCT00413699|588721784|FG001|Initial Period|No longer willing to participate|368|||
163005373|NCT00413699|588721785|FG002|Initial Period|No longer willing to participate|0|||
163005374|NCT00413699|588721783|FG000|Extension Period|No Longer Willing to Participate|0|||
163005375|NCT00413699|588721784|FG001|Extension Period|No Longer Willing to Participate|0|||
163005376|NCT00413699|588721785|FG002|Extension Period|No Longer Willing to Participate|2|||
163005377|NCT00413699|588721783|FG000|Extension Period|Protocol Violation|0|||
163005378|NCT00413699|588721784|FG001|Extension Period|Protocol Violation|0|||
163005379|NCT00413699|588721785|FG002|Extension Period|Protocol Violation|1|||
163005380|NCT00413699|588721783|FG000|Extension Period|Adverse Event|0|||
163005381|NCT00413699|588721784|FG001|Extension Period|Adverse Event|0|||
163005382|NCT00413699|588721785|FG002|Extension Period|Adverse Event|2|||
163005383|NCT02115269|588721786|FG000|Overall Study|Lost to Follow-up|43|||
163005384|NCT02115269|588721786|FG000|Overall Study|Did not complete patient diary|3|||
163005385|NCT02115269|588721786|FG000|Overall Study|Moved to another city|7|||
163005386|NCT02115269|588721786|FG000|Overall Study|Withdrawal by Subject|2|||
163005387|NCT02115269|588721786|FG000|Overall Study|Didn't take study drug|2|||
163005388|NCT05989672|588721788|FG000|Overall Study|Adverse Event|3|||
163005389|NCT05989672|588721789|FG001|Overall Study|Adverse Event|0|||
163005390|NCT05989672|588721790|FG002|Overall Study|Adverse Event|0|||
163005391|NCT03511105|588721791|FG000|Overall Study|Adverse Event|1|||
163005392|NCT03511105|588721792|FG001|Overall Study|Adverse Event|0|||
163005393|NCT03511105|588721791|FG000|Overall Study|Withdrew consent|1|||
163005394|NCT03511105|588721792|FG001|Overall Study|Withdrew consent|0|||
163005395|NCT02810457|588721793|FG000|Overall Study|Randomised but no treatment received|2|||
163005396|NCT02810457|588721794|FG001|Overall Study|Randomised but no treatment received|1|||
163005397|NCT02810457|588721793|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
163005398|NCT02810457|588721794|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
163005399|NCT02810457|588721793|FG000|Overall Study|Adverse Event|37|||
163005400|NCT02810457|588721794|FG001|Overall Study|Adverse Event|43|||
163005401|NCT02810457|588721793|FG000|Overall Study|Patient decision|31|||
163005402|NCT02810457|588721794|FG001|Overall Study|Patient decision|35|||
163005403|NCT02810457|588721793|FG000|Overall Study|Patient lost to follow-up|2|||
163005404|NCT02810457|588721794|FG001|Overall Study|Patient lost to follow-up|2|||
163005405|NCT02810457|588721793|FG000|Overall Study|Death|39|||
163005406|NCT02810457|588721794|FG001|Overall Study|Death|28|||
163005407|NCT02810457|588721793|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
163005408|NCT02810457|588721794|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
163005409|NCT02810457|588721793|FG000|Overall Study|Clinical progression|15|||
163005410|NCT02810457|588721794|FG001|Overall Study|Clinical progression|16|||
163005411|NCT02810457|588721793|FG000|Overall Study|Investigator decision|3|||
163005412|NCT02810457|588721794|FG001|Overall Study|Investigator decision|2|||
163005413|NCT02810457|588721793|FG000|Overall Study|Patient ineligibility|3|||
163005414|NCT02810457|588721794|FG001|Overall Study|Patient ineligibility|0|||
163005415|NCT02810457|588721793|FG000|Overall Study|Miscalculated PD|1|||
163005416|NCT02810457|588721794|FG001|Overall Study|Miscalculated PD|0|||
163005417|NCT02810457|588721793|FG000|Overall Study|Physician Decision|0|||
163005418|NCT02810457|588721794|FG001|Overall Study|Physician Decision|1|||
163005419|NCT01962103|588721795|FG000|Phase 1|Adverse Event|4|||
163005420|NCT01962103|588721796|FG001|Phase 1|Adverse Event|0|||
163005421|NCT01962103|588721797|FG002|Phase 1|Adverse Event|2|||
163005422|NCT01962103|588721798|FG003|Phase 1|Adverse Event|1|||
163005423|NCT01962103|588721799|FG004|Phase 1|Adverse Event|2|||
163005424|NCT01962103|588721800|FG005|Phase 1|Adverse Event|2|||
163005425|NCT01962103|588721801|FG006|Phase 1|Adverse Event|0|||
163005426|NCT01962103|588721802|FG007|Phase 1|Adverse Event|0|||
163005427|NCT01962103|588721803|FG008|Phase 1|Adverse Event|0|||
163005428|NCT01962103|588721795|FG000|Phase 1|Progressive Disease|8|||
163005429|NCT01962103|588721796|FG001|Phase 1|Progressive Disease|6|||
163005430|NCT01962103|588721797|FG002|Phase 1|Progressive Disease|8|||
163005431|NCT01962103|588721798|FG003|Phase 1|Progressive Disease|4|||
163005432|NCT01962103|588721799|FG004|Phase 1|Progressive Disease|5|||
163005433|NCT01962103|588721800|FG005|Phase 1|Progressive Disease|4|||
163005434|NCT01962103|588721801|FG006|Phase 1|Progressive Disease|0|||
163005435|NCT01962103|588721802|FG007|Phase 1|Progressive Disease|0|||
163005436|NCT01962103|588721803|FG008|Phase 1|Progressive Disease|0|||
163005437|NCT01962103|588721795|FG000|Phase 1|Withdrawal by Subject|0|||
163005438|NCT01962103|588721796|FG001|Phase 1|Withdrawal by Subject|0|||
163005439|NCT01962103|588721797|FG002|Phase 1|Withdrawal by Subject|0|||
163005440|NCT01962103|588721798|FG003|Phase 1|Withdrawal by Subject|2|||
163005441|NCT01962103|588721799|FG004|Phase 1|Withdrawal by Subject|0|||
163005442|NCT01962103|588721800|FG005|Phase 1|Withdrawal by Subject|0|||
163005443|NCT01962103|588721801|FG006|Phase 1|Withdrawal by Subject|0|||
163005444|NCT01962103|588721802|FG007|Phase 1|Withdrawal by Subject|0|||
163005445|NCT01962103|588721803|FG008|Phase 1|Withdrawal by Subject|0|||
163005446|NCT01962103|588721795|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
163005447|NCT01962103|588721796|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
163005448|NCT01962103|588721797|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
163005449|NCT01962103|588721798|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
163005450|NCT01962103|588721799|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
163005451|NCT01962103|588721800|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
163005452|NCT01962103|588721801|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
163005453|NCT01962103|588721802|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
163005454|NCT01962103|588721803|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
163005455|NCT01962103|588721795|FG000|Phase 1|Physician Decision|0|||
163005456|NCT01962103|588721796|FG001|Phase 1|Physician Decision|0|||
163005457|NCT01962103|588721797|FG002|Phase 1|Physician Decision|0|||
163005458|NCT01962103|588721798|FG003|Phase 1|Physician Decision|1|||
163005459|NCT01962103|588721799|FG004|Phase 1|Physician Decision|0|||
163005460|NCT01962103|588721800|FG005|Phase 1|Physician Decision|0|||
163005461|NCT01962103|588721801|FG006|Phase 1|Physician Decision|0|||
163005462|NCT01962103|588721802|FG007|Phase 1|Physician Decision|0|||
163005463|NCT01962103|588721803|FG008|Phase 1|Physician Decision|0|||
163005464|NCT01962103|588721795|FG000|Phase 1|Symptomatic Deterioration|3|||
163005465|NCT01962103|588721796|FG001|Phase 1|Symptomatic Deterioration|2|||
163005466|NCT01962103|588721797|FG002|Phase 1|Symptomatic Deterioration|2|||
163005467|NCT01962103|588721798|FG003|Phase 1|Symptomatic Deterioration|2|||
163005468|NCT01962103|588721799|FG004|Phase 1|Symptomatic Deterioration|1|||
163005469|NCT01962103|588721800|FG005|Phase 1|Symptomatic Deterioration|1|||
163005470|NCT01962103|588721801|FG006|Phase 1|Symptomatic Deterioration|0|||
163005471|NCT01962103|588721802|FG007|Phase 1|Symptomatic Deterioration|0|||
163005472|NCT01962103|588721803|FG008|Phase 1|Symptomatic Deterioration|0|||
163005473|NCT01962103|588721795|FG000|Phase 1|Miscellaneous|1|||
163005474|NCT01962103|588721796|FG001|Phase 1|Miscellaneous|0|||
163005475|NCT01962103|588721797|FG002|Phase 1|Miscellaneous|0|||
163005476|NCT01962103|588721798|FG003|Phase 1|Miscellaneous|0|||
163005477|NCT01962103|588721799|FG004|Phase 1|Miscellaneous|0|||
163005478|NCT01962103|588721800|FG005|Phase 1|Miscellaneous|0|||
163005479|NCT01962103|588721801|FG006|Phase 1|Miscellaneous|0|||
163005480|NCT01962103|588721802|FG007|Phase 1|Miscellaneous|0|||
163005481|NCT01962103|588721803|FG008|Phase 1|Miscellaneous|0|||
163005482|NCT01962103|588721795|FG000|Phase 2|Adverse Event|0|||
163005483|NCT01962103|588721796|FG001|Phase 2|Adverse Event|0|||
163005484|NCT01962103|588721797|FG002|Phase 2|Adverse Event|0|||
163005485|NCT01962103|588721798|FG003|Phase 2|Adverse Event|0|||
163005486|NCT01962103|588721799|FG004|Phase 2|Adverse Event|0|||
163005487|NCT01962103|588721800|FG005|Phase 2|Adverse Event|0|||
163005488|NCT01962103|588721801|FG006|Phase 2|Adverse Event|1|||
163005489|NCT01962103|588721802|FG007|Phase 2|Adverse Event|0|||
163005490|NCT01962103|588721803|FG008|Phase 2|Adverse Event|3|||
163005491|NCT01962103|588721795|FG000|Phase 2|Progressive Disease|0|||
163005492|NCT01962103|588721796|FG001|Phase 2|Progressive Disease|0|||
163005493|NCT01962103|588721797|FG002|Phase 2|Progressive Disease|0|||
163005494|NCT01962103|588721798|FG003|Phase 2|Progressive Disease|0|||
163005495|NCT01962103|588721799|FG004|Phase 2|Progressive Disease|0|||
163005496|NCT01962103|588721800|FG005|Phase 2|Progressive Disease|0|||
163005497|NCT01962103|588721801|FG006|Phase 2|Progressive Disease|11|||
163005498|NCT01962103|588721802|FG007|Phase 2|Progressive Disease|12|||
163005499|NCT01962103|588721803|FG008|Phase 2|Progressive Disease|11|||
163005500|NCT01962103|588721795|FG000|Phase 2|Symptomatic Deterioration|0|||
163005501|NCT01962103|588721796|FG001|Phase 2|Symptomatic Deterioration|0|||
163005502|NCT01962103|588721797|FG002|Phase 2|Symptomatic Deterioration|0|||
163005503|NCT01962103|588721798|FG003|Phase 2|Symptomatic Deterioration|0|||
163005504|NCT01962103|588721799|FG004|Phase 2|Symptomatic Deterioration|0|||
163005505|NCT01962103|588721800|FG005|Phase 2|Symptomatic Deterioration|0|||
163005506|NCT01962103|588721801|FG006|Phase 2|Symptomatic Deterioration|2|||
163005507|NCT01962103|588721802|FG007|Phase 2|Symptomatic Deterioration|2|||
163005508|NCT01962103|588721803|FG008|Phase 2|Symptomatic Deterioration|0|||
163005509|NCT02750618|588721804|FG000|Overall Study|Withdrawal by Subject|1|||
163005510|NCT02094300|588721811|FG000|Overall Study|Death|7|||
163005511|NCT02094300|588721811|FG000|Overall Study|Lost to Follow-up|10|||
163005512|NCT02094300|588721811|FG000|Overall Study|Still be eligible for follow-up|3|||
163005513|NCT03347110|588721814|FG000|Overall Study|Other (Participant is incarcerated)|1|||
163005514|NCT03347110|588721814|FG000|Overall Study|Withdrawal by Subject|9|||
163005515|NCT03347110|588721814|FG000|Overall Study|Lost to Follow-up|1|||
163005516|NCT03347110|588721814|FG000|Overall Study|Lack of Efficacy|2|||
163005517|NCT03347110|588721814|FG000|Overall Study|Adverse Event, non-fatal|9|||
163005518|NCT01321879|588721815|FG000|Overall Study|Lack of Efficacy|5|||
163005519|NCT01321879|588721815|FG000|Overall Study|Adverse Event|5|||
163005520|NCT01321879|588721815|FG000|Overall Study|Death|3|||
163005521|NCT01321879|588721815|FG000|Overall Study|Withdrawal by Subject|1|||
163005522|NCT02687451|588721816|FG000|Overall Study|Withdrawal by Subject|1|||
163005523|NCT02687451|588721817|FG001|Overall Study|Withdrawal by Subject|0|||
163005524|NCT02687451|588721818|FG002|Overall Study|Withdrawal by Subject|0|||
163005525|NCT02687451|588721819|FG003|Overall Study|Withdrawal by Subject|0|||
163005526|NCT02687451|588721820|FG004|Overall Study|Withdrawal by Subject|0|||
163005527|NCT02687451|588721821|FG005|Overall Study|Withdrawal by Subject|1|||
163005528|NCT01518322|588721822|FG000|Overall Study|FeNO measurement was missing|13|||
163005529|NCT00707239|588721823|FG000|Overall Study|Adverse Event|5|||
163005530|NCT00707239|588721824|FG001|Overall Study|Adverse Event|3|||
163005531|NCT00707239|588721825|FG002|Overall Study|Adverse Event|2|||
163005532|NCT00707239|588721823|FG000|Overall Study|Death|3|||
163005533|NCT00707239|588721824|FG001|Overall Study|Death|1|||
163005534|NCT00707239|588721825|FG002|Overall Study|Death|3|||
163005535|NCT00707239|588721823|FG000|Overall Study|Physician Decision|1|||
163005536|NCT00707239|588721824|FG001|Overall Study|Physician Decision|1|||
163005537|NCT00707239|588721825|FG002|Overall Study|Physician Decision|2|||
163005538|NCT00707239|588721823|FG000|Overall Study|Protocol Violation|0|||
163005539|NCT00707239|588721824|FG001|Overall Study|Protocol Violation|0|||
163005540|NCT00707239|588721825|FG002|Overall Study|Protocol Violation|1|||
163005541|NCT00707239|588721823|FG000|Overall Study|Lack of Efficacy|1|||
163005542|NCT00707239|588721824|FG001|Overall Study|Lack of Efficacy|2|||
163005543|NCT00707239|588721825|FG002|Overall Study|Lack of Efficacy|0|||
163005544|NCT00707239|588721823|FG000|Overall Study|Randomized, but not treated|1|||
163005545|NCT00707239|588721824|FG001|Overall Study|Randomized, but not treated|1|||
163005546|NCT00707239|588721825|FG002|Overall Study|Randomized, but not treated|1|||
163005547|NCT00707239|588721823|FG000|Overall Study|Other|8|||
163005548|NCT00707239|588721824|FG001|Overall Study|Other|3|||
163005549|NCT00707239|588721825|FG002|Overall Study|Other|5|||
163005550|NCT03472014|588721826|FG000|Overall Study|Lost to Follow-up|4|||
163005551|NCT03652051|588721827|FG000|Stage 1|Adverse Event|0|||
163005552|NCT03652051|588721828|FG001|Stage 1|Adverse Event|5|||
163005553|NCT03652051|588721829|FG002|Stage 1|Adverse Event|7|||
163005554|NCT03652051|588721830|FG003|Stage 1|Adverse Event|1|||
163005555|NCT03652051|588721827|FG000|Stage 1|Withdrawal by Subject|0|||
163005556|NCT03652051|588721828|FG001|Stage 1|Withdrawal by Subject|0|||
163005557|NCT03652051|588721829|FG002|Stage 1|Withdrawal by Subject|1|||
163005558|NCT03652051|588721830|FG003|Stage 1|Withdrawal by Subject|0|||
163005559|NCT03652051|588721827|FG000|Stage 2|Adverse Event|0|||
163005560|NCT03652051|588721828|FG001|Stage 2|Adverse Event|2|||
163005561|NCT03652051|588721829|FG002|Stage 2|Adverse Event|1|||
163005562|NCT03652051|588721830|FG003|Stage 2|Adverse Event|0|||
163005563|NCT03652051|588721827|FG000|Stage 2|Protocol Violation|0|||
163005564|NCT03652051|588721828|FG001|Stage 2|Protocol Violation|1|||
163005565|NCT03652051|588721829|FG002|Stage 2|Protocol Violation|6|||
163005566|NCT03652051|588721830|FG003|Stage 2|Protocol Violation|0|||
163005567|NCT03652051|588721827|FG000|Stage 2|Lost to Follow-up|0|||
163005568|NCT03652051|588721828|FG001|Stage 2|Lost to Follow-up|2|||
163005569|NCT03652051|588721829|FG002|Stage 2|Lost to Follow-up|0|||
163005570|NCT03652051|588721830|FG003|Stage 2|Lost to Follow-up|3|||
163005571|NCT03652051|588721827|FG000|Stage 2|Withdrawal by Subject|0|||
163005572|NCT03652051|588721828|FG001|Stage 2|Withdrawal by Subject|11|||
163005573|NCT03652051|588721829|FG002|Stage 2|Withdrawal by Subject|9|||
163005574|NCT03652051|588721830|FG003|Stage 2|Withdrawal by Subject|3|||
163005575|NCT01930162|588721831|FG000|Overall Study|Abnormal test procedure result(s)|4|||
163005576|NCT01930162|588721831|FG000|Overall Study|Death|1|||
163005577|NCT02394600|588721834|FG000|Overall Study|Adverse Event|3|||
163005578|NCT02394600|588721835|FG001|Overall Study|Adverse Event|0|||
163005579|NCT02394600|588721834|FG000|Overall Study|Lost to Follow-up|0|||
163005580|NCT02394600|588721835|FG001|Overall Study|Lost to Follow-up|1|||
163005581|NCT02394600|588721834|FG000|Overall Study|Withdrawal by Subject|0|||
163005582|NCT02394600|588721835|FG001|Overall Study|Withdrawal by Subject|1|||
163005583|NCT02394600|588721834|FG000|Overall Study|Protocol Violation|1|||
163005584|NCT02394600|588721835|FG001|Overall Study|Protocol Violation|0|||
163005585|NCT02569801|588721836|FG000|Overall Study|Withdrawal by Subject|9|||
163005586|NCT02569801|588721837|FG001|Overall Study|Withdrawal by Subject|9|||
163005587|NCT02569801|588721836|FG000|Overall Study|Sponsor Decision|13|||
163005588|NCT02569801|588721837|FG001|Overall Study|Sponsor Decision|14|||
163005589|NCT02569801|588721836|FG000|Overall Study|Progressive Disease|2|||
163005590|NCT02569801|588721837|FG001|Overall Study|Progressive Disease|7|||
163005591|NCT02569801|588721836|FG000|Overall Study|Lost to Follow-up|0|||
163005592|NCT02569801|588721837|FG001|Overall Study|Lost to Follow-up|1|||
163005593|NCT02569801|588721836|FG000|Overall Study|Death|12|||
163005594|NCT02569801|588721837|FG001|Overall Study|Death|4|||
163005595|NCT03442751|588721840|FG000|Overall Study|Withdrawal by Subject|3|||
163005596|NCT03442751|588721841|FG001|Overall Study|Withdrawal by Subject|1|||
163005597|NCT03442751|588721840|FG000|Overall Study|Lost to Follow-up|3|||
163005598|NCT03442751|588721841|FG001|Overall Study|Lost to Follow-up|0|||
163005599|NCT01308424|588721842|FG000|Baseline Eligibility|Screen Failures|71|||
163005600|NCT01308424|588721843|FG001|Baseline Eligibility|Screen Failures|0|||
163005601|NCT01308424|588721844|FG002|Baseline Eligibility|Screen Failures|0|||
163005602|NCT01308424|588721842|FG000|Randomization|Adverse Event|0|||
163005603|NCT01308424|588721843|FG001|Randomization|Adverse Event|1|||
163005604|NCT01308424|588721844|FG002|Randomization|Adverse Event|1|||
163005605|NCT01308424|588721842|FG000|Randomization|Lost to Follow-up|0|||
163005606|NCT01308424|588721843|FG001|Randomization|Lost to Follow-up|1|||
163005607|NCT01308424|588721844|FG002|Randomization|Lost to Follow-up|0|||
163005608|NCT01308424|588721842|FG000|Randomization|Physician Decision|0|||
163061224|NCT01431976|588933047|FG000|Overall Study|Adverse Event|6|||
162715832|NCT03536884|587667102|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163005609|NCT01308424|588721843|FG001|Randomization|Physician Decision|1|||
163005610|NCT01308424|588721844|FG002|Randomization|Physician Decision|1|||
163005611|NCT00948155|588721845|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
163005612|NCT00948155|588721846|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
163005613|NCT00948155|588721845|FG000|Washout 14 Days|Lost to Follow-up|1|||
163005614|NCT00948155|588721846|FG001|Washout 14 Days|Lost to Follow-up|2|||
163005615|NCT01870778|588721848|FG000|Overall Study|Withdrawal by Subject|8|||
163005616|NCT01870778|588721849|FG001|Overall Study|Withdrawal by Subject|7|||
163005617|NCT01870778|588721848|FG000|Overall Study|Lost to Follow-up|0|||
163005618|NCT01870778|588721849|FG001|Overall Study|Lost to Follow-up|2|||
163005619|NCT01169350|588721852|FG000|Overall Study|Physician Decision|3|||
163005620|NCT01169350|588721852|FG000|Overall Study|Lost to Follow-up|2|||
163005621|NCT04870710|588721856|FG000|Overall Study|Lost to Follow-up|3|||
163005622|NCT01329900|588721857|FG000|Overall Study|Elevated creatinine/renal function|1|||
163005623|NCT01866098|588721858|FG000|Overall Study|Lost to Follow-up|11|||
163005624|NCT01866098|588721859|FG001|Overall Study|Lost to Follow-up|18|||
163005625|NCT01866098|588721860|FG002|Overall Study|Lost to Follow-up|13|||
163005626|NCT01866098|588721858|FG000|Overall Study|Physician Decision|0|||
163005627|NCT01866098|588721859|FG001|Overall Study|Physician Decision|1|||
163005628|NCT01866098|588721860|FG002|Overall Study|Physician Decision|2|||
163005629|NCT01866098|588721858|FG000|Overall Study|Adverse Event|1|||
163005630|NCT01866098|588721859|FG001|Overall Study|Adverse Event|5|||
163005631|NCT01866098|588721860|FG002|Overall Study|Adverse Event|4|||
163005632|NCT01866098|588721858|FG000|Overall Study|Protocol Violation|1|||
163005633|NCT01866098|588721859|FG001|Overall Study|Protocol Violation|0|||
163005634|NCT01866098|588721860|FG002|Overall Study|Protocol Violation|0|||
163005635|NCT01866098|588721858|FG000|Overall Study|Withdrawal by Subject|1|||
163005636|NCT01866098|588721859|FG001|Overall Study|Withdrawal by Subject|2|||
163005637|NCT01866098|588721860|FG002|Overall Study|Withdrawal by Subject|0|||
163005638|NCT01866098|588721858|FG000|Overall Study|Unrelated Hospitalization|2|||
163005639|NCT01866098|588721859|FG001|Overall Study|Unrelated Hospitalization|0|||
163005640|NCT01866098|588721860|FG002|Overall Study|Unrelated Hospitalization|1|||
163005641|NCT01866098|588721858|FG000|Overall Study|Non-compliance|1|||
163005642|NCT01866098|588721859|FG001|Overall Study|Non-compliance|0|||
163005643|NCT01866098|588721860|FG002|Overall Study|Non-compliance|1|||
163005644|NCT01866098|588721858|FG000|Overall Study|Pregnancy|2|||
163005645|NCT01866098|588721859|FG001|Overall Study|Pregnancy|0|||
163005646|NCT01866098|588721860|FG002|Overall Study|Pregnancy|0|||
163005647|NCT01866098|588721858|FG000|Overall Study|Death|0|||
163005648|NCT01866098|588721859|FG001|Overall Study|Death|1|||
163005649|NCT01866098|588721860|FG002|Overall Study|Death|0|||
163005650|NCT04239027|588721861|FG000|Overall Study|Adverse Event|4|||
163005651|NCT04239027|588721861|FG000|Overall Study|Withdrawal by Subject|9|||
163005652|NCT04239027|588721861|FG000|Overall Study|Death|1|||
163061225|NCT01431976|588933047|FG000|Overall Study|Lack of Efficacy|2|||
163061226|NCT01431976|588933047|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
163061227|NCT01431976|588933047|FG000|Overall Study|Physician Decision|1|||
163061228|NCT01431976|588933047|FG000|Overall Study|Withdrawal by Subject|1|||
163061229|NCT01294514|588933048|FG000|Overall Study|Excluded due to Arrhythmia|1|||
163061230|NCT01963611|588933049|FG000|Overall Study|Adverse Event|1|||
163061231|NCT01963611|588933050|FG001|Overall Study|Adverse Event|1|||
163061232|NCT01963611|588933051|FG002|Overall Study|Adverse Event|3|||
163061233|NCT01963611|588933052|FG003|Overall Study|Adverse Event|4|||
163061234|NCT01963611|588933053|FG004|Overall Study|Adverse Event|3|||
163061235|NCT01963611|588933049|FG000|Overall Study|Protocol Violation|0|||
163061236|NCT01963611|588933050|FG001|Overall Study|Protocol Violation|0|||
163061237|NCT01963611|588933051|FG002|Overall Study|Protocol Violation|0|||
163061238|NCT01963611|588933052|FG003|Overall Study|Protocol Violation|1|||
163061239|NCT01963611|588933053|FG004|Overall Study|Protocol Violation|0|||
163061240|NCT01963611|588933049|FG000|Overall Study|Lack of Efficacy|0|||
163061241|NCT01963611|588933050|FG001|Overall Study|Lack of Efficacy|0|||
163061242|NCT01963611|588933051|FG002|Overall Study|Lack of Efficacy|0|||
163061243|NCT01963611|588933052|FG003|Overall Study|Lack of Efficacy|1|||
163061244|NCT01963611|588933053|FG004|Overall Study|Lack of Efficacy|0|||
163061245|NCT01963611|588933049|FG000|Overall Study|Withdrawal by Subject|3|||
163061246|NCT01963611|588933050|FG001|Overall Study|Withdrawal by Subject|2|||
163061247|NCT01963611|588933051|FG002|Overall Study|Withdrawal by Subject|1|||
163061248|NCT01963611|588933052|FG003|Overall Study|Withdrawal by Subject|1|||
163061249|NCT01963611|588933053|FG004|Overall Study|Withdrawal by Subject|3|||
163061250|NCT01963611|588933049|FG000|Overall Study|Other|47|||
163061251|NCT01963611|588933050|FG001|Overall Study|Other|46|||
163061252|NCT01963611|588933051|FG002|Overall Study|Other|48|||
163061253|NCT01963611|588933052|FG003|Overall Study|Other|45|||
163061254|NCT01963611|588933053|FG004|Overall Study|Other|45|||
163061255|NCT01126424|588933059|FG000|Overall Study|Adverse Event|0|||
163061256|NCT01126424|588933060|FG001|Overall Study|Adverse Event|0|||
163061257|NCT01126424|588933061|FG002|Overall Study|Adverse Event|0|||
163005653|NCT04239027|588721861|FG000|Overall Study|Physician Decision|9|||
163005654|NCT04239027|588721861|FG000|Overall Study|Lost to Follow-up|2|||
163005655|NCT04239027|588721861|FG000|Overall Study|Lack of Efficacy|1|||
163005656|NCT01184079|588721868|FG000|Overall Study|Lost to Follow-up|14|||
163005657|NCT01184079|588721869|FG001|Overall Study|Lost to Follow-up|2|||
163005658|NCT01876446|588721872|FG000|Overall Study|Death|0|||
163005659|NCT01876446|588721873|FG001|Overall Study|Death|1|||
163061258|NCT01126424|588933062|FG003|Overall Study|Adverse Event|0|||
163061259|NCT01126424|588933063|FG004|Overall Study|Adverse Event|1|||
163061260|NCT01126424|588933064|FG005|Overall Study|Adverse Event|0|||
163061261|NCT01126424|588933059|FG000|Overall Study|Withdrawal by Subject|0|||
163061262|NCT01126424|588933060|FG001|Overall Study|Withdrawal by Subject|0|||
163005660|NCT01876446|588721872|FG000|Overall Study|Withdrawal by Subject|1|||
163005661|NCT01876446|588721873|FG001|Overall Study|Withdrawal by Subject|2|||
163005662|NCT01876446|588721872|FG000|Overall Study|Physician Decision|1|||
163005663|NCT01876446|588721873|FG001|Overall Study|Physician Decision|3|||
163005664|NCT02108912|588721874|FG000|Overall Study|Lost to Follow-up|1|||
163061263|NCT01126424|588933061|FG002|Overall Study|Withdrawal by Subject|1|||
163005665|NCT02108912|588721875|FG001|Overall Study|Lost to Follow-up|1|||
163005666|NCT02108912|588721874|FG000|Overall Study|lack of transportation|1|||
163005667|NCT02108912|588721875|FG001|Overall Study|lack of transportation|0|||
163005668|NCT02108912|588721874|FG000|Overall Study|high blood pressure|1|||
163005669|NCT02108912|588721875|FG001|Overall Study|high blood pressure|0|||
163005670|NCT01808573|588721881|FG000|Overall Study|Death|212|||
163005671|NCT01808573|588721882|FG001|Overall Study|Death|240|||
163005672|NCT01808573|588721881|FG000|Overall Study|Withdrawal by Subject|12|||
163005673|NCT01808573|588721882|FG001|Overall Study|Withdrawal by Subject|10|||
163005674|NCT01808573|588721881|FG000|Overall Study|Lost to Follow-up|3|||
163005675|NCT01808573|588721882|FG001|Overall Study|Lost to Follow-up|0|||
163005676|NCT01808573|588721881|FG000|Overall Study|Discontinuation of study by sponsor|79|||
163005677|NCT01808573|588721882|FG001|Overall Study|Discontinuation of study by sponsor|64|||
163005678|NCT01808573|588721881|FG000|Overall Study|Randomized in Error|1|||
162638235|NCT03060629|587390870|FG001|Overall Study|Unable to Contact Participant|23|||
163005679|NCT01808573|588721882|FG001|Overall Study|Randomized in Error|0|||
163005680|NCT01523002|588721885|FG000|Period 1|Withdrawal by Subject|1|||
163005681|NCT01523002|588721886|FG001|Period 1|Withdrawal by Subject|3|||
163005682|NCT01523002|588721885|FG000|Period 1|Lost to Follow-up|1|||
163005683|NCT01523002|588721886|FG001|Period 1|Lost to Follow-up|0|||
163005684|NCT01523002|588721885|FG000|Period 1|Adverse Event|0|||
163005685|NCT01523002|588721886|FG001|Period 1|Adverse Event|8|||
163005686|NCT01523002|588721885|FG000|Period 2|Withdrawal by Subject|4|||
163005687|NCT01523002|588721886|FG001|Period 2|Withdrawal by Subject|1|||
163005688|NCT01523002|588721885|FG000|Period 2|Adverse Event|2|||
163005689|NCT01523002|588721886|FG001|Period 2|Adverse Event|5|||
163005690|NCT01523002|588721885|FG000|Period 3|Withdrawal by Subject|1|||
163005691|NCT01523002|588721886|FG001|Period 3|Withdrawal by Subject|0|||
163005692|NCT01523002|588721885|FG000|Period 3|Adverse Event|3|||
163005693|NCT01523002|588721886|FG001|Period 3|Adverse Event|0|||
163005694|NCT01256502|588721887|FG000|Overall Study|Had scaffold removed|4|||
163005695|NCT01256502|588721887|FG000|Overall Study|Personal reasons|5|||
163005696|NCT01256502|588721887|FG000|Overall Study|Protocol deviation|1|||
163005697|NCT00489255|588721888|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
162638236|NCT03060629|587390869|FG000|Overall Study|Investigator Decision|7|||
162638237|NCT03060629|587390870|FG001|Overall Study|Investigator Decision|7|||
162638238|NCT03060629|587390869|FG000|Overall Study|Study Terminated by Sponsor|1100|||
162638239|NCT03060629|587390870|FG001|Overall Study|Study Terminated by Sponsor|1123|||
163005698|NCT00489255|588721889|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
163005699|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
163005700|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
163005701|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
163005702|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
163005703|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
163005704|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
163005705|NCT00489255|588721888|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
163005706|NCT00489255|588721889|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
163005707|NCT00489255|588721888|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
163005708|NCT00489255|588721889|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
163005709|NCT00489255|588721888|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
163005710|NCT00489255|588721889|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
163005711|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
163005712|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
163005713|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
163005714|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
163005715|NCT00489255|588721888|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
163005716|NCT00489255|588721889|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
163005717|NCT03953612|588721890|FG000|Overall Study|Randomized but did not start|1|||
163005718|NCT03953612|588721891|FG001|Overall Study|Randomized but did not start|1|||
163005719|NCT03953612|588721892|FG002|Overall Study|Randomized but did not start|1|||
163005720|NCT03953612|588721890|FG000|Overall Study|Withdrawal by Subject|2|||
163005721|NCT03953612|588721891|FG001|Overall Study|Withdrawal by Subject|1|||
163005722|NCT03953612|588721892|FG002|Overall Study|Withdrawal by Subject|0|||
163005723|NCT03485352|588721893|FG000|Overall Study|Lost to Follow-up|9|||
163005724|NCT00852202|588721904|FG000|Overall Study|Adverse Event|2|||
163005725|NCT00852202|588721905|FG001|Overall Study|Adverse Event|3|||
163005726|NCT00852202|588721906|FG002|Overall Study|Adverse Event|7|||
163005727|NCT00852202|588721904|FG000|Overall Study|Lack of Efficacy|4|||
163005728|NCT00852202|588721905|FG001|Overall Study|Lack of Efficacy|1|||
163005729|NCT00852202|588721906|FG002|Overall Study|Lack of Efficacy|2|||
163005730|NCT00852202|588721904|FG000|Overall Study|Protocol Violation|2|||
163005731|NCT00852202|588721905|FG001|Overall Study|Protocol Violation|2|||
163005732|NCT00852202|588721906|FG002|Overall Study|Protocol Violation|7|||
163005733|NCT00852202|588721904|FG000|Overall Study|Withdrawal by Subject|3|||
163005734|NCT00852202|588721905|FG001|Overall Study|Withdrawal by Subject|1|||
163005735|NCT00852202|588721906|FG002|Overall Study|Withdrawal by Subject|2|||
162638240|NCT03060629|587390869|FG000|Overall Study|Other|4|||
163005736|NCT00852202|588721904|FG000|Overall Study|Lost to Follow-up|5|||
163005737|NCT00852202|588721905|FG001|Overall Study|Lost to Follow-up|5|||
163005738|NCT00852202|588721906|FG002|Overall Study|Lost to Follow-up|6|||
163005739|NCT00852202|588721904|FG000|Overall Study|pregnancy,moving away and surgery|1|||
163005740|NCT00852202|588721905|FG001|Overall Study|pregnancy,moving away and surgery|0|||
163005741|NCT00852202|588721906|FG002|Overall Study|pregnancy,moving away and surgery|2|||
163005742|NCT02552121|588721909|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
163005743|NCT02552121|588721910|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005744|NCT02552121|588721911|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005745|NCT02552121|588721912|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005746|NCT02552121|588721913|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005747|NCT02552121|588721914|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005748|NCT02552121|588721915|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005749|NCT02552121|588721916|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
163005750|NCT02552121|588721909|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
163005751|NCT02552121|588721910|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005752|NCT02552121|588721911|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005753|NCT02552121|588721912|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005754|NCT02552121|588721913|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005755|NCT02552121|588721914|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005756|NCT02552121|588721915|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005757|NCT02552121|588721916|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
163005758|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005759|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
163005760|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005761|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005762|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005763|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005764|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005765|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
163005766|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005767|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
163061264|NCT01126424|588933062|FG003|Overall Study|Withdrawal by Subject|3|||
163061265|NCT01126424|588933063|FG004|Overall Study|Withdrawal by Subject|1|||
163061266|NCT01126424|588933064|FG005|Overall Study|Withdrawal by Subject|0|||
163061267|NCT02127671|588933065|FG000|Overall Study|Death|2|||
163061268|NCT02127671|588933066|FG001|Overall Study|Death|2|||
163061269|NCT02127671|588933065|FG000|Overall Study|Lost to Follow-up|4|||
163061270|NCT02127671|588933066|FG001|Overall Study|Lost to Follow-up|2|||
163061271|NCT02127671|588933065|FG000|Overall Study|Physician Decision|1|||
163061272|NCT02127671|588933066|FG001|Overall Study|Physician Decision|0|||
163061273|NCT02127671|588933065|FG000|Overall Study|incarceration|0|||
163061274|NCT02127671|588933066|FG001|Overall Study|incarceration|1|||
163061275|NCT02127671|588933065|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
163061276|NCT02127671|588933066|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
163061277|NCT02394275|588933067|FG000|Overall Study|Adverse Event|22|||
163061278|NCT02394275|588933067|FG000|Overall Study|Lost to Follow-up|7|||
163061279|NCT00782067|588933068|FG000|Overall Study|Adverse Event|35|||
163061280|NCT00782067|588933068|FG000|Overall Study|Subject withdrew consent|11|||
163061281|NCT00782067|588933068|FG000|Overall Study|Lost to Follow-up|2|||
163061282|NCT00782067|588933068|FG000|Overall Study|Administrative problems|14|||
163061283|NCT00782067|588933068|FG000|Overall Study|Death|9|||
163061284|NCT00782067|588933068|FG000|Overall Study|Disease progression|43|||
163061285|NCT00782067|588933068|FG000|Overall Study|Protocol deviation|2|||
163061286|NCT02471183|588933069|FG000|Main Treatment Period|Adverse Event|1|||
163061287|NCT02471183|588933069|FG000|Main Treatment Period|Withdrawal by Subject|1|||
163061288|NCT02471183|588933069|FG000|Extended Treatment Period|Lack of Efficacy|1|||
163061289|NCT00614393|588933071|FG000|Overall Study|Adverse Event|20|||
163061290|NCT00614393|588933072|FG001|Overall Study|Adverse Event|2|||
163061291|NCT00614393|588933073|FG002|Overall Study|Adverse Event|3|||
163061292|NCT00614393|588933074|FG003|Overall Study|Adverse Event|13|||
163061293|NCT00614393|588933075|FG004|Overall Study|Adverse Event|21|||
163061294|NCT00614393|588933071|FG000|Overall Study|Lost to Follow-up|0|||
163061295|NCT00614393|588933072|FG001|Overall Study|Lost to Follow-up|0|||
162715833|NCT03536884|587667091|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163005768|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005769|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005770|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005771|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005772|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163061296|NCT00614393|588933073|FG002|Overall Study|Lost to Follow-up|0|||
163061297|NCT00614393|588933074|FG003|Overall Study|Lost to Follow-up|1|||
163061298|NCT00614393|588933075|FG004|Overall Study|Lost to Follow-up|2|||
162638241|NCT03060629|587390870|FG001|Overall Study|Other|4|||
162638242|NCT01862874|587390871|FG000|Overall Study|Randomized not treated|1|||
162638243|NCT01862874|587390872|FG001|Overall Study|Randomized not treated|0|||
162638244|NCT01862874|587390871|FG000|Overall Study|Adverse Event|0|||
162638245|NCT01862874|587390872|FG001|Overall Study|Adverse Event|3|||
162638246|NCT01862874|587390871|FG000|Overall Study|Lost to Follow-up|26|||
162638247|NCT01862874|587390872|FG001|Overall Study|Lost to Follow-up|29|||
162638248|NCT01862874|587390871|FG000|Overall Study|Physician Decision|5|||
162638249|NCT01862874|587390872|FG001|Overall Study|Physician Decision|3|||
162638250|NCT01862874|587390871|FG000|Overall Study|Withdrawn by parent/guardian|1|||
162638251|NCT01862874|587390872|FG001|Overall Study|Withdrawn by parent/guardian|1|||
162638252|NCT01862874|587390871|FG000|Overall Study|Withdrawal by Subject|46|||
162638253|NCT01862874|587390872|FG001|Overall Study|Withdrawal by Subject|40|||
162638254|NCT01862874|587390871|FG000|Overall Study|Death|0|||
162638255|NCT01862874|587390872|FG001|Overall Study|Death|1|||
162638256|NCT03681405|587390873|FG000|Overall Study|Found to be ineligible after randomized|1|||
162638257|NCT03681405|587390874|FG001|Overall Study|Found to be ineligible after randomized|0|||
162638258|NCT02056340|587390875|FG000|Overall Study|Lost to Follow-up|5|||
162638259|NCT02056340|587390876|FG001|Overall Study|Lost to Follow-up|5|||
162638260|NCT02056340|587390875|FG000|Overall Study|Withdrawal by Subject|2|||
162638261|NCT02056340|587390876|FG001|Overall Study|Withdrawal by Subject|6|||
162638262|NCT00883116|587390878|FG000|Overall Study|Adverse event unrelated to study drug|5|||
162638263|NCT00883116|587390879|FG001|Overall Study|Adverse event unrelated to study drug|10|||
162638264|NCT00883116|587390878|FG000|Overall Study|Death|6|||
162638265|NCT00883116|587390879|FG001|Overall Study|Death|2|||
162638266|NCT00883116|587390878|FG000|Overall Study|Disease progression|130|||
162638267|NCT00883116|587390879|FG001|Overall Study|Disease progression|128|||
162638268|NCT00883116|587390878|FG000|Overall Study|Lost to Follow-up|0|||
162638269|NCT00883116|587390879|FG001|Overall Study|Lost to Follow-up|1|||
162638270|NCT00883116|587390878|FG000|Overall Study|Maximum clinical benefit|13|||
162638271|NCT00883116|587390879|FG001|Overall Study|Maximum clinical benefit|46|||
162638272|NCT00883116|587390878|FG000|Overall Study|Not identified|3|||
162638273|NCT00883116|587390879|FG001|Overall Study|Not identified|6|||
162638274|NCT00883116|587390878|FG000|Overall Study|Study drug toxicity|36|||
162638275|NCT00883116|587390879|FG001|Overall Study|Study drug toxicity|16|||
162638276|NCT00883116|587390878|FG000|Overall Study|Withdrawal by Subject|14|||
162638277|NCT00883116|587390879|FG001|Overall Study|Withdrawal by Subject|8|||
162638278|NCT00883116|587390878|FG000|Overall Study|No longer meets study criteria|2|||
162638279|NCT00883116|587390879|FG001|Overall Study|No longer meets study criteria|2|||
162638280|NCT02484729|587390880|FG000|Overall Study|Failure of IntelliCap Error|0|||
162638281|NCT02484729|587390881|FG001|Overall Study|Failure of IntelliCap Error|0|||
163005773|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
163005774|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005775|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
163005776|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005777|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005778|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005779|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005780|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005781|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
163005782|NCT02552121|588721909|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005783|NCT02552121|588721910|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
163005784|NCT02552121|588721911|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005785|NCT02552121|588721912|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005786|NCT02552121|588721913|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005787|NCT02552121|588721914|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
162638282|NCT02484729|587390882|FG002|Overall Study|Failure of IntelliCap Error|0|||
163005788|NCT02552121|588721915|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005789|NCT02552121|588721916|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
163005790|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
163005791|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
163005792|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
162638283|NCT02484729|587390883|FG003|Overall Study|Failure of IntelliCap Error|0|||
162638284|NCT02484729|587390884|FG004|Overall Study|Failure of IntelliCap Error|0|||
162638285|NCT02484729|587390885|FG005|Overall Study|Failure of IntelliCap Error|0|||
162638286|NCT02484729|587390886|FG006|Overall Study|Failure of IntelliCap Error|0|||
162638287|NCT02484729|587390887|FG007|Overall Study|Failure of IntelliCap Error|0|||
162638288|NCT02484729|587390888|FG008|Overall Study|Failure of IntelliCap Error|0|||
162638289|NCT02484729|587390889|FG009|Overall Study|Failure of IntelliCap Error|1|||
162638290|NCT01031069|587390890|FG000|Overall Study|Serious Adverse Event|0|||
163005793|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
162638291|NCT01031069|587390891|FG001|Overall Study|Serious Adverse Event|1|||
162638292|NCT01031069|587390892|FG002|Overall Study|Serious Adverse Event|0|||
162638293|NCT01031069|587390893|FG003|Overall Study|Serious Adverse Event|0|||
163005794|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
163005795|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
162638294|NCT01031069|587390890|FG000|Overall Study|Withdrawal by Subject|2|||
162638295|NCT01031069|587390891|FG001|Overall Study|Withdrawal by Subject|3|||
162638296|NCT01031069|587390892|FG002|Overall Study|Withdrawal by Subject|18|||
163005796|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
163005797|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
163005798|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
163005799|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
163005800|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
163005801|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
163005802|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
163005803|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
163005804|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
163005805|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
163005806|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
163005807|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
163005808|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
163005809|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
163005810|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
163005811|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
163005812|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
163005813|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
163005814|NCT02552121|588721909|FG000|Part 2: Cohort Expansion|Death|0|||
163005815|NCT02552121|588721910|FG001|Part 2: Cohort Expansion|Death|0|||
163005816|NCT02552121|588721911|FG002|Part 2: Cohort Expansion|Death|1|||
163005817|NCT02552121|588721912|FG003|Part 2: Cohort Expansion|Death|0|||
163005818|NCT02552121|588721913|FG004|Part 2: Cohort Expansion|Death|0|||
163005819|NCT02552121|588721914|FG005|Part 2: Cohort Expansion|Death|0|||
162638297|NCT01031069|587390893|FG003|Overall Study|Withdrawal by Subject|18|||
162638298|NCT01031069|587390890|FG000|Overall Study|Migrated/moved from study area|1|||
162638299|NCT01031069|587390891|FG001|Overall Study|Migrated/moved from study area|2|||
162638300|NCT01031069|587390892|FG002|Overall Study|Migrated/moved from study area|1|||
162638301|NCT01031069|587390893|FG003|Overall Study|Migrated/moved from study area|1|||
163005820|NCT02552121|588721915|FG006|Part 2: Cohort Expansion|Death|0|||
163005821|NCT02552121|588721916|FG007|Part 2: Cohort Expansion|Death|0|||
163005822|NCT03629184|588721917|FG000|Overall Study|Withdrawal by Subject|2|||
163005823|NCT03629184|588721918|FG001|Overall Study|Withdrawal by Subject|1|||
163005824|NCT03629184|588721917|FG000|Overall Study|Physician Decision|1|||
163005825|NCT03629184|588721918|FG001|Overall Study|Physician Decision|0|||
163005826|NCT01982955|588721920|FG000|Overall Study|Randomized but not treated|0|||
163005827|NCT01982955|588721921|FG001|Overall Study|Randomized but not treated|0|||
163005828|NCT01982955|588721922|FG002|Overall Study|Randomized but not treated|0|||
163005829|NCT01982955|588721923|FG003|Overall Study|Randomized but not treated|1|||
163005830|NCT01982955|588721924|FG004|Overall Study|Randomized but not treated|0|||
163005831|NCT02548143|588721926|FG000|Overall Study|Adverse Event|1|||
163005832|NCT02548143|588721927|FG001|Overall Study|Adverse Event|0|||
163005833|NCT02548143|588721926|FG000|Overall Study|Withdrawal by Subject|0|||
163005834|NCT02548143|588721927|FG001|Overall Study|Withdrawal by Subject|1|||
163005835|NCT04179838|588723172|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163005836|NCT04179838|588723173|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
163005837|NCT04179838|588723172|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
163061299|NCT00614393|588933071|FG000|Overall Study|Physician Decision|17|||
162638302|NCT01031069|587390890|FG000|Overall Study|Lost to Follow-up|9|||
162638303|NCT01031069|587390891|FG001|Overall Study|Lost to Follow-up|5|||
162638304|NCT01031069|587390892|FG002|Overall Study|Lost to Follow-up|21|||
162638305|NCT01031069|587390893|FG003|Overall Study|Lost to Follow-up|15|||
162638306|NCT01031069|587390890|FG000|Overall Study|Other|0|||
163005838|NCT04179838|588723173|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
163005839|NCT02763046|588723174|FG000|Overall Study|Adverse Event|5|||
163005840|NCT02763046|588723175|FG001|Overall Study|Adverse Event|4|||
163005841|NCT02763046|588723176|FG002|Overall Study|Adverse Event|0|||
163005842|NCT02763046|588723174|FG000|Overall Study|Lack of Efficacy|1|||
162638307|NCT01031069|587390891|FG001|Overall Study|Other|0|||
162638308|NCT01031069|587390892|FG002|Overall Study|Other|1|||
162638309|NCT01031069|587390893|FG003|Overall Study|Other|0|||
162638310|NCT01317160|587390894|FG000|Overall Study|Incorrect inclusion|1|||
163005843|NCT02763046|588723175|FG001|Overall Study|Lack of Efficacy|1|||
163005844|NCT02763046|588723176|FG002|Overall Study|Lack of Efficacy|3|||
163005845|NCT02763046|588723174|FG000|Overall Study|Physician Decision|1|||
163005846|NCT02763046|588723175|FG001|Overall Study|Physician Decision|0|||
163005847|NCT02763046|588723176|FG002|Overall Study|Physician Decision|1|||
163005848|NCT02763046|588723174|FG000|Overall Study|Subject/guardian decision|2|||
163005849|NCT02763046|588723175|FG001|Overall Study|Subject/guardian decision|0|||
163005850|NCT02763046|588723176|FG002|Overall Study|Subject/guardian decision|4|||
163005851|NCT00818766|588723181|FG000|Overall Study|Could not be Contacted on Day 28|11|||
163061300|NCT00614393|588933072|FG001|Overall Study|Physician Decision|0|||
163005852|NCT00818766|588723182|FG001|Overall Study|Could not be Contacted on Day 28|10|||
163005853|NCT00818766|588723181|FG000|Overall Study|Death|1|||
163005854|NCT00818766|588723182|FG001|Overall Study|Death|0|||
163005855|NCT00818766|588723181|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
163005856|NCT00818766|588723182|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
163005857|NCT00086684|588723183|FG000|Overall Study|Adverse Event|12|||
163005858|NCT00086684|588723184|FG001|Overall Study|Adverse Event|17|||
163005859|NCT00086684|588723185|FG002|Overall Study|Adverse Event|14|||
163005860|NCT00086684|588723183|FG000|Overall Study|Lack of Efficacy|6|||
163005861|NCT00086684|588723184|FG001|Overall Study|Lack of Efficacy|6|||
163005862|NCT00086684|588723185|FG002|Overall Study|Lack of Efficacy|5|||
163005863|NCT00086684|588723183|FG000|Overall Study|Lost to Follow-up|15|||
163005864|NCT00086684|588723184|FG001|Overall Study|Lost to Follow-up|8|||
163005865|NCT00086684|588723185|FG002|Overall Study|Lost to Follow-up|10|||
163005866|NCT00086684|588723183|FG000|Overall Study|Protocol Violation|8|||
163005867|NCT00086684|588723184|FG001|Overall Study|Protocol Violation|3|||
163005868|NCT00086684|588723185|FG002|Overall Study|Protocol Violation|0|||
163005869|NCT00086684|588723183|FG000|Overall Study|Withdrawal by Subject|0|||
163005870|NCT00086684|588723184|FG001|Overall Study|Withdrawal by Subject|4|||
163005871|NCT00086684|588723185|FG002|Overall Study|Withdrawal by Subject|10|||
163005872|NCT00086684|588723183|FG000|Overall Study|NONCOMPLIANCE|5|||
163005873|NCT00086684|588723184|FG001|Overall Study|NONCOMPLIANCE|7|||
163005874|NCT00086684|588723185|FG002|Overall Study|NONCOMPLIANCE|6|||
163005875|NCT00086684|588723183|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
163005876|NCT00086684|588723184|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
163005877|NCT00086684|588723185|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
163005878|NCT00086684|588723183|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
163005879|NCT00086684|588723184|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
163005880|NCT00086684|588723185|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
163005881|NCT00086684|588723183|FG000|Overall Study|Other|4|||
163005882|NCT00086684|588723184|FG001|Overall Study|Other|2|||
163005883|NCT00086684|588723185|FG002|Overall Study|Other|3|||
163005884|NCT01103180|588723188|FG000|Overall Study|Withdrawal by Subject|8|||
163005885|NCT01103180|588723189|FG001|Overall Study|Withdrawal by Subject|13|||
163005886|NCT01103180|588723188|FG000|Overall Study|Lost to Follow-up|13|||
163005887|NCT01103180|588723189|FG001|Overall Study|Lost to Follow-up|7|||
163005888|NCT01103180|588723188|FG000|Overall Study|Physician Decision|1|||
163005889|NCT01103180|588723189|FG001|Overall Study|Physician Decision|0|||
163005890|NCT01103180|588723188|FG000|Overall Study|Protocol Violation|0|||
163005891|NCT01103180|588723189|FG001|Overall Study|Protocol Violation|1|||
163005892|NCT01173523|588723190|FG000|Overall Study|Clinical Progression|1|||
163005893|NCT01173523|588723191|FG001|Overall Study|Clinical Progression|1|||
163005894|NCT01173523|588723190|FG000|Overall Study|Progressive Disease|10|||
163005895|NCT01173523|588723191|FG001|Overall Study|Progressive Disease|8|||
163005896|NCT01173523|588723190|FG000|Overall Study|Other|2|||
163005897|NCT01173523|588723191|FG001|Overall Study|Other|3|||
163005898|NCT01067105|588723192|FG000|Overall Study|Adverse Event|14|||
163005899|NCT01067105|588723192|FG000|Overall Study|Protocol Violation|48|||
163005900|NCT01067105|588723192|FG000|Overall Study|Withdrawal by Subject|36|||
163005901|NCT01067105|588723192|FG000|Overall Study|Lost to Follow-up|6|||
163005902|NCT01067105|588723192|FG000|Overall Study|Physician Decision|6|||
163005903|NCT01067105|588723192|FG000|Overall Study|Other|31|||
163005904|NCT00853099|588723193|FG000|Double-blind Period|Adverse Event|7|||
163005905|NCT00853099|588723194|FG001|Double-blind Period|Adverse Event|9|||
163005906|NCT00853099|588723195|FG002|Double-blind Period|Adverse Event|13|||
163005907|NCT00853099|588723196|FG003|Double-blind Period|Adverse Event|0|||
163005908|NCT00853099|588723193|FG000|Double-blind Period|Withdrawal by Subject|2|||
163005909|NCT00853099|588723194|FG001|Double-blind Period|Withdrawal by Subject|3|||
163005910|NCT00853099|588723195|FG002|Double-blind Period|Withdrawal by Subject|0|||
163005911|NCT00853099|588723196|FG003|Double-blind Period|Withdrawal by Subject|0|||
163005912|NCT00853099|588723193|FG000|Double-blind Period|Lack of Efficacy|14|||
163005913|NCT00853099|588723194|FG001|Double-blind Period|Lack of Efficacy|17|||
163005914|NCT00853099|588723195|FG002|Double-blind Period|Lack of Efficacy|16|||
163005915|NCT00853099|588723196|FG003|Double-blind Period|Lack of Efficacy|0|||
163005916|NCT00853099|588723193|FG000|Double-blind Period|Other|0|||
163005917|NCT00853099|588723194|FG001|Double-blind Period|Other|0|||
163005918|NCT00853099|588723195|FG002|Double-blind Period|Other|1|||
163005919|NCT00853099|588723196|FG003|Double-blind Period|Other|0|||
163005920|NCT00853099|588723193|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
163005921|NCT00853099|588723194|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
163061301|NCT00614393|588933073|FG002|Overall Study|Physician Decision|1|||
163005922|NCT00853099|588723195|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
163005923|NCT00853099|588723196|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
163005924|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005925|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005926|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
163005927|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
163005928|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
163005929|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
163005930|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
163005931|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
163005932|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005933|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005934|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
163005935|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
163005936|NCT00853099|588723193|FG000|Double-blind + Open-label Periods|Other|0|||
163005937|NCT00853099|588723194|FG001|Double-blind + Open-label Periods|Other|0|||
163005938|NCT00853099|588723195|FG002|Double-blind + Open-label Periods|Other|0|||
163005939|NCT00853099|588723196|FG003|Double-blind + Open-label Periods|Other|6|||
163005940|NCT02439216|588723200|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
163005941|NCT02439216|588723201|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005942|NCT02439216|588723202|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005943|NCT02439216|588723203|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005944|NCT02439216|588723204|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005945|NCT02439216|588723205|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005946|NCT02439216|588723206|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005947|NCT02439216|588723207|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005948|NCT02439216|588723208|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
163005949|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005950|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005951|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005952|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005953|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005954|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005955|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005956|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
163005957|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
163005958|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005959|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005960|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005961|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005962|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005963|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005964|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
163005965|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
163005966|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
163005967|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005968|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005969|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005970|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005971|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005972|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005973|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005974|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
163005975|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
163005976|NCT02439216|588723200|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005977|NCT02439216|588723201|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005978|NCT02439216|588723202|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005979|NCT02439216|588723203|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005980|NCT02439216|588723204|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163061302|NCT00614393|588933074|FG003|Overall Study|Physician Decision|8|||
163061303|NCT00614393|588933075|FG004|Overall Study|Physician Decision|9|||
163061304|NCT00614393|588933071|FG000|Overall Study|Progressive Disease|118|||
163061305|NCT00614393|588933072|FG001|Overall Study|Progressive Disease|5|||
163005981|NCT02439216|588723205|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005982|NCT02439216|588723206|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
163005983|NCT02439216|588723207|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
163005984|NCT02439216|588723208|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
163005985|NCT00470535|588723212|FG000|Overall Study|Disease Progression|13|||
163005986|NCT00470535|588723212|FG000|Overall Study|Withdrawal by Subject|1|||
163005987|NCT00470535|588723212|FG000|Overall Study|Adverse Event|1|||
163005988|NCT00470535|588723212|FG000|Overall Study|Death|1|||
163005989|NCT00470535|588723212|FG000|Overall Study|Other|2|||
163005990|NCT00725491|588723219|FG000|Overall Study|Adverse Event|3|||
163005991|NCT00725491|588723220|FG001|Overall Study|Adverse Event|2|||
163005992|NCT00725491|588723219|FG000|Overall Study|Pregnancy|0|||
163005993|NCT00725491|588723220|FG001|Overall Study|Pregnancy|3|||
163005994|NCT00725491|588723219|FG000|Overall Study|Risk for hyperstimulation|2|||
163005995|NCT00725491|588723220|FG001|Overall Study|Risk for hyperstimulation|9|||
163005996|NCT00725491|588723219|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
163005997|NCT00725491|588723220|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
163005998|NCT00725491|588723219|FG000|Overall Study|Fertilization failure|0|||
163005999|NCT00725491|588723220|FG001|Overall Study|Fertilization failure|1|||
163006000|NCT00725491|588723219|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
163006001|NCT00725491|588723220|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
163006002|NCT00942357|588723223|FG000|Overall Study|Ineligible|37|||
163006003|NCT00942357|588723224|FG001|Overall Study|Ineligible|40|||
163006004|NCT01998919|588723225|FG000|Overall Study|Death|2|||
163006005|NCT01998919|588723226|FG001|Overall Study|Death|2|||
163006006|NCT01998919|588723225|FG000|Overall Study|Adverse Event|0|||
163006007|NCT01998919|588723226|FG001|Overall Study|Adverse Event|5|||
163006008|NCT01998919|588723225|FG000|Overall Study|Disease progression|31|||
163006009|NCT01998919|588723226|FG001|Overall Study|Disease progression|22|||
163006010|NCT01998919|588723225|FG000|Overall Study|Withdrawal by Subject|2|||
163006011|NCT01998919|588723226|FG001|Overall Study|Withdrawal by Subject|4|||
163006012|NCT01998919|588723225|FG000|Overall Study|Lost to Follow-up|2|||
163006013|NCT01998919|588723226|FG001|Overall Study|Lost to Follow-up|0|||
163006014|NCT01998919|588723225|FG000|Overall Study|Other|5|||
163006015|NCT01998919|588723226|FG001|Overall Study|Other|2|||
163006016|NCT00897715|588723227|FG000|Overall Study|Lost to Follow-up|0|||
163006017|NCT00897715|588723228|FG001|Overall Study|Lost to Follow-up|1|||
163006018|NCT00897715|588723227|FG000|Overall Study|Physician Decision|1|||
163006019|NCT00897715|588723228|FG001|Overall Study|Physician Decision|0|||
163006020|NCT00897715|588723227|FG000|Overall Study|increased risk of infection|1|||
163006021|NCT00897715|588723228|FG001|Overall Study|increased risk of infection|0|||
163006022|NCT00927589|588723230|FG000|Overall Study|Death|1|||
163006023|NCT00927589|588723230|FG000|Overall Study|Physician Decision|1|||
163006024|NCT00927589|588723230|FG000|Overall Study|Withdrawal by Subject|3|||
163006025|NCT00927589|588723230|FG000|Overall Study|Adverse Event|2|||
163006026|NCT00927589|588723230|FG000|Overall Study|Disease Progression|8|||
163006027|NCT00927589|588723230|FG000|Overall Study|Non-compliance|1|||
163006028|NCT01641640|588723231|FG000|Overall Study|Enrolled but not treated|1|||
163006029|NCT01641640|588723231|FG000|Overall Study|Efficacy failure|29|||
163006030|NCT01641640|588723231|FG000|Overall Study|Lost to Follow-up|3|||
163006031|NCT01641640|588723231|FG000|Overall Study|Withdrawal by Subject|2|||
163006032|NCT01641640|588723231|FG000|Overall Study|Adverse Event|1|||
163006033|NCT01778530|588723233|FG000|Overall Study|Progression on study|1|||
163006034|NCT01778530|588723233|FG000|Overall Study|Adverse event/side effect|1|||
162638311|NCT01317160|587390895|FG001|Overall Study|Incorrect inclusion|1|||
162638312|NCT01317160|587390894|FG000|Overall Study|Lost to Follow-up|3|||
162638313|NCT01317160|587390895|FG001|Overall Study|Lost to Follow-up|3|||
162638314|NCT01317160|587390894|FG000|Overall Study|Withdrawal by Subject|0|||
162638315|NCT01317160|587390895|FG001|Overall Study|Withdrawal by Subject|2|||
162638316|NCT03578367|587390897|FG000|Overall Study|Adverse Event|0|||
162638317|NCT03578367|587390898|FG001|Overall Study|Adverse Event|3|||
162638318|NCT03578367|587390899|FG002|Overall Study|Adverse Event|0|||
162638319|NCT03578367|587390900|FG003|Overall Study|Adverse Event|5|||
162638320|NCT03578367|587390897|FG000|Overall Study|Withdrawal by Subject|2|||
162638321|NCT03578367|587390898|FG001|Overall Study|Withdrawal by Subject|2|||
162638322|NCT03578367|587390899|FG002|Overall Study|Withdrawal by Subject|1|||
163006035|NCT01199939|588723236|FG000|Overall Study|Adverse Event|4|||
163006036|NCT01199939|588723236|FG000|Overall Study|Protocol Violation|3|||
163006037|NCT01199939|588723236|FG000|Overall Study|Lost to Follow-up|2|||
163006038|NCT01199939|588723236|FG000|Overall Study|Reached a virologic endpoint|4|||
163006039|NCT02792517|588723244|FG000|Overall Study|Withdrawal by Subject|10|||
163006040|NCT02792517|588723244|FG000|Overall Study|Decision by Sponsor|7|||
163006041|NCT02792517|588723244|FG000|Overall Study|Lost to Follow-up|3|||
163006042|NCT00882518|588723245|FG000|Overall Study|Adverse Event|9|||
163061306|NCT00614393|588933073|FG002|Overall Study|Progressive Disease|5|||
163006043|NCT00882518|588723246|FG001|Overall Study|Adverse Event|18|||
163006044|NCT00882518|588723245|FG000|Overall Study|Withdrawal by Subject|9|||
163006045|NCT00882518|588723246|FG001|Overall Study|Withdrawal by Subject|13|||
163006046|NCT00882518|588723245|FG000|Overall Study|Lack of Efficacy|12|||
163006047|NCT00882518|588723246|FG001|Overall Study|Lack of Efficacy|9|||
163006048|NCT00882518|588723245|FG000|Overall Study|Severe non-compliance to protocol|3|||
163006049|NCT00882518|588723246|FG001|Overall Study|Severe non-compliance to protocol|1|||
163006050|NCT00882518|588723245|FG000|Overall Study|Incorrect enrolment|4|||
163006051|NCT00882518|588723246|FG001|Overall Study|Incorrect enrolment|2|||
163006052|NCT00882518|588723245|FG000|Overall Study|Central lab closure for National day|1|||
163006053|NCT00882518|588723246|FG001|Overall Study|Central lab closure for National day|0|||
163006054|NCT00882518|588723245|FG000|Overall Study|Allocating random number by mistake|0|||
163006055|NCT00882518|588723246|FG001|Overall Study|Allocating random number by mistake|1|||
163006056|NCT03238651|588723247|FG000|Overall Study|Other|0|||
163006057|NCT03238651|588723248|FG001|Overall Study|Other|0|||
163006058|NCT03238651|588723249|FG002|Overall Study|Other|0|||
163006059|NCT03238651|588723250|FG003|Overall Study|Other|0|||
163006060|NCT03238651|588723251|FG004|Overall Study|Other|1|||
163006061|NCT03238651|588723247|FG000|Overall Study|Progressive Disease|2|||
163006062|NCT03238651|588723248|FG001|Overall Study|Progressive Disease|2|||
163006063|NCT03238651|588723249|FG002|Overall Study|Progressive Disease|2|||
163006064|NCT03238651|588723250|FG003|Overall Study|Progressive Disease|2|||
163006065|NCT03238651|588723251|FG004|Overall Study|Progressive Disease|0|||
163006066|NCT03238651|588723247|FG000|Overall Study|Withdrawal by Subject|0|||
163006067|NCT03238651|588723248|FG001|Overall Study|Withdrawal by Subject|1|||
163006068|NCT03238651|588723249|FG002|Overall Study|Withdrawal by Subject|0|||
163006069|NCT03238651|588723250|FG003|Overall Study|Withdrawal by Subject|1|||
163006070|NCT03238651|588723251|FG004|Overall Study|Withdrawal by Subject|0|||
163006071|NCT03238651|588723247|FG000|Overall Study|Adverse Event|1|||
163006072|NCT03238651|588723248|FG001|Overall Study|Adverse Event|3|||
163006073|NCT03238651|588723249|FG002|Overall Study|Adverse Event|2|||
163006074|NCT03238651|588723250|FG003|Overall Study|Adverse Event|0|||
163006075|NCT03238651|588723251|FG004|Overall Study|Adverse Event|0|||
163006076|NCT03875508|588723252|FG000|Overall Study|Adverse Event|1|||
162715834|NCT03536884|587667092|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163006077|NCT03875508|588723252|FG000|Overall Study|Lost to Follow-up|8|||
163006078|NCT03875508|588723252|FG000|Overall Study|Lack of Efficacy|1|||
163006079|NCT03875508|588723252|FG000|Overall Study|Other, not specified|2|||
163006080|NCT00711087|588723253|FG000|Overall Study|Lost to Follow-up|1|||
163006081|NCT00711087|588723254|FG001|Overall Study|Lost to Follow-up|0|||
163006082|NCT02137252|588723255|FG000|Overall Study|trial terminated early|2|||
163006083|NCT02137252|588723256|FG001|Overall Study|trial terminated early|1|||
163006084|NCT01958437|588723258|FG000|Overall Study|Incidental MRI findings|0|||
163006085|NCT01958437|588723259|FG001|Overall Study|Incidental MRI findings|0|||
163006086|NCT01958437|588723260|FG002|Overall Study|Incidental MRI findings|1|||
163006087|NCT01958437|588723261|FG003|Overall Study|Incidental MRI findings|1|||
163006088|NCT00428246|588723262|FG000|Overall Study|Withdrawal by Subject|0|||
163006089|NCT00428246|588723263|FG001|Overall Study|Withdrawal by Subject|0|||
163006090|NCT00428246|588723264|FG002|Overall Study|Withdrawal by Subject|1|||
163006091|NCT00428246|588723262|FG000|Overall Study|Adverse Event|1|||
163006092|NCT00428246|588723263|FG001|Overall Study|Adverse Event|0|||
163006093|NCT00428246|588723264|FG002|Overall Study|Adverse Event|0|||
163006094|NCT02603887|588723268|FG000|Stage 1|Adverse Event|4|||
163006095|NCT02603887|588723268|FG000|Stage 1|Disease progression|1|||
163006096|NCT02603887|588723268|FG000|Stage 2|FDA guidance|1|||
163006097|NCT03535740|588723271|FG000|Overall Study|Death|44|||
163006098|NCT03535740|588723271|FG000|Overall Study|Lost to Follow-up|1|||
163006099|NCT03535740|588723271|FG000|Overall Study|Withdrawal by Subject|13|||
163006100|NCT03535740|588723271|FG000|Overall Study|Site terminated by Sponsor|45|||
163006101|NCT05198518|588723274|FG000|Screening Visit|Deemed unable to participate|58|||
163006102|NCT05198518|588723275|FG001|Screening Visit|Deemed unable to participate|0|||
163006103|NCT05198518|588723276|FG002|Screening Visit|Deemed unable to participate|0|||
163006104|NCT05317312|588723282|FG000|Overall Study|Withdrawal by Subject|0|||
163006105|NCT05317312|588723283|FG001|Overall Study|Withdrawal by Subject|1|||
163006106|NCT05317312|588723284|FG002|Overall Study|Withdrawal by Subject|0|||
163006107|NCT05317312|588723285|FG003|Overall Study|Withdrawal by Subject|0|||
163006108|NCT05317312|588723282|FG000|Overall Study|Lost to Follow-up|0|||
163006109|NCT05317312|588723283|FG001|Overall Study|Lost to Follow-up|0|||
163006110|NCT05317312|588723284|FG002|Overall Study|Lost to Follow-up|0|||
163006111|NCT05317312|588723285|FG003|Overall Study|Lost to Follow-up|1|||
163006112|NCT05317312|588723282|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
163006113|NCT05317312|588723283|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
163006114|NCT05317312|588723284|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
163006115|NCT05317312|588723285|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
163006116|NCT00124917|588723286|FG000|Overall Study|Physician Decision|3|||
163006117|NCT00613171|588723289|FG000|Overall Study|Adverse Event|7|||
163006118|NCT00613171|588723289|FG000|Overall Study|Withdrawal by Subject|3|||
163006119|NCT00613171|588723289|FG000|Overall Study|Reason not Specified|4|||
163006120|NCT00951496|588723294|FG000|Overall Study|Did not initiate study treatment|10|||
163006121|NCT00951496|588723295|FG001|Overall Study|Did not initiate study treatment|8|||
163006122|NCT00951496|588723296|FG002|Overall Study|Did not initiate study treatment|13|||
163006123|NCT01042093|588723297|FG000|Overall Study|Protocol Violation|2|||
163006124|NCT01042093|588723298|FG001|Overall Study|Protocol Violation|2|||
163006125|NCT01042093|588723299|FG002|Overall Study|Protocol Violation|2|||
163006126|NCT01042093|588723300|FG003|Overall Study|Protocol Violation|3|||
163006127|NCT01042093|588723297|FG000|Overall Study|Withdrawal by Subject|0|||
163006128|NCT01042093|588723298|FG001|Overall Study|Withdrawal by Subject|0|||
163006129|NCT01042093|588723299|FG002|Overall Study|Withdrawal by Subject|0|||
163006130|NCT01042093|588723300|FG003|Overall Study|Withdrawal by Subject|1|||
163006131|NCT03447743|588723307|FG000|Overall Study|Withdrawal by Subject|2|||
163006132|NCT03447743|588723307|FG000|Overall Study|Lost to Follow-up|3|||
163006133|NCT03447743|588723307|FG000|Overall Study|Adverse Event|1|||
163006134|NCT03447743|588723307|FG000|Overall Study|Did not meet criteria to continue|1|||
163006135|NCT01610492|588723312|FG000|Overall Study|Adverse Event|1|||
163006136|NCT01610492|588723312|FG000|Overall Study|Lack of Efficacy|3|||
163006137|NCT01610492|588723312|FG000|Overall Study|Other: Reached stopping criteria|1|||
163006138|NCT01610492|588723312|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
163006139|NCT02575833|588723313|FG000|Overall Study|Withdrawal by Subject|0|||
163006140|NCT02575833|588723314|FG001|Overall Study|Withdrawal by Subject|1|||
163006141|NCT02575833|588723313|FG000|Overall Study|Lost to Follow-up|1|||
163006142|NCT02575833|588723314|FG001|Overall Study|Lost to Follow-up|0|||
163006143|NCT01757275|588723315|FG000|Overall Study|Lost to Follow-up|1|||
163006144|NCT01757275|588723316|FG001|Overall Study|Lost to Follow-up|2|||
163006145|NCT01757275|588723315|FG000|Overall Study|Adverse Event|3|||
163006146|NCT01757275|588723316|FG001|Overall Study|Adverse Event|3|||
163006147|NCT01757275|588723315|FG000|Overall Study|Withdrawal by Subject|2|||
163006148|NCT01757275|588723316|FG001|Overall Study|Withdrawal by Subject|4|||
163006149|NCT01757275|588723315|FG000|Overall Study|Not treated|3|||
163006150|NCT01757275|588723316|FG001|Overall Study|Not treated|4|||
163006151|NCT01821807|588723317|FG000|Overall Study|Lost to Follow-up|3|||
163006152|NCT01821807|588723318|FG001|Overall Study|Lost to Follow-up|1|||
163006153|NCT00768248|588723319|FG000|Overall Study|Research coordinator didn't collect data|1|||
163006154|NCT00768248|588723320|FG001|Overall Study|Research coordinator didn't collect data|1|||
163006155|NCT04211831|588723321|FG000|Overall Study|Withdrawal by Subject|4|||
163061307|NCT00614393|588933074|FG003|Overall Study|Progressive Disease|138|||
162638323|NCT03578367|587390900|FG003|Overall Study|Withdrawal by Subject|3|||
162638324|NCT03578367|587390897|FG000|Overall Study|Physician Decision|0|||
162638325|NCT03578367|587390898|FG001|Overall Study|Physician Decision|0|||
162638326|NCT03578367|587390899|FG002|Overall Study|Physician Decision|14|||
162638327|NCT03578367|587390900|FG003|Overall Study|Physician Decision|0|||
162638328|NCT03578367|587390897|FG000|Overall Study|Death|1|||
163006156|NCT04211831|588723322|FG001|Overall Study|Withdrawal by Subject|1|||
163006157|NCT04211831|588723323|FG002|Overall Study|Withdrawal by Subject|1|||
163006158|NCT04211831|588723321|FG000|Overall Study|Protocol Violation|0|||
163061308|NCT00614393|588933075|FG004|Overall Study|Progressive Disease|130|||
162638329|NCT03578367|587390898|FG001|Overall Study|Death|0|||
163061309|NCT00614393|588933071|FG000|Overall Study|Protocol Violation|1|||
162638330|NCT03578367|587390899|FG002|Overall Study|Death|0|||
163006159|NCT04211831|588723322|FG001|Overall Study|Protocol Violation|0|||
163006160|NCT04211831|588723323|FG002|Overall Study|Protocol Violation|1|||
163006161|NCT04211831|588723321|FG000|Overall Study|Adverse Event|0|||
163006162|NCT04211831|588723322|FG001|Overall Study|Adverse Event|1|||
163006163|NCT04211831|588723323|FG002|Overall Study|Adverse Event|0|||
163061310|NCT00614393|588933072|FG001|Overall Study|Protocol Violation|0|||
162638331|NCT03578367|587390900|FG003|Overall Study|Death|0|||
163006164|NCT04211831|588723321|FG000|Overall Study|Lack of Efficacy|0|||
163006165|NCT04211831|588723322|FG001|Overall Study|Lack of Efficacy|0|||
163006166|NCT04211831|588723323|FG002|Overall Study|Lack of Efficacy|1|||
163006167|NCT04211831|588723321|FG000|Overall Study|Lost to Follow-up|0|||
163006168|NCT04211831|588723322|FG001|Overall Study|Lost to Follow-up|0|||
163006169|NCT04211831|588723323|FG002|Overall Study|Lost to Follow-up|2|||
163006170|NCT04211831|588723321|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
163006171|NCT04211831|588723322|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
163006172|NCT04211831|588723323|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
163006173|NCT04211831|588723321|FG000|Overall Study|Other|0|||
163006174|NCT04211831|588723322|FG001|Overall Study|Other|1|||
163006175|NCT04211831|588723323|FG002|Overall Study|Other|0|||
163006176|NCT00967330|588723324|FG000|Overall Study|Protocol Violation|3|||
163006177|NCT00967330|588723325|FG001|Overall Study|Protocol Violation|4|||
163006178|NCT00967330|588723324|FG000|Overall Study|Regular|10|||
163006179|NCT00967330|588723325|FG001|Overall Study|Regular|3|||
163006180|NCT00967330|588723324|FG000|Overall Study|Withdrawal by Subject|6|||
163006181|NCT00967330|588723325|FG001|Overall Study|Withdrawal by Subject|0|||
163006182|NCT00967330|588723324|FG000|Overall Study|Lost to Follow-up|1|||
163006183|NCT00967330|588723325|FG001|Overall Study|Lost to Follow-up|1|||
163006184|NCT00967330|588723324|FG000|Overall Study|Death|102|||
163006185|NCT00967330|588723325|FG001|Overall Study|Death|51|||
163006186|NCT00967330|588723324|FG000|Overall Study|Severe protocol deviation|0|||
163006187|NCT00967330|588723325|FG001|Overall Study|Severe protocol deviation|1|||
163006188|NCT04796961|588725292|FG000|Overall Study|Lost to Follow-up|10|||
163006189|NCT04796961|588725292|FG000|Overall Study|Withdrawal by Subject|3|||
163006190|NCT04796961|588725292|FG000|Overall Study|Left Organization|10|||
163006191|NCT05825404|588725295|FG000|First Intervention (Weeks 2-5)|Death|0|||
163006192|NCT05825404|588725296|FG001|First Intervention (Weeks 2-5)|Death|1|||
163006193|NCT05825404|588725295|FG000|Second Intervention (Weeks 8-11)|Death|0|||
163006194|NCT05825404|588725296|FG001|Second Intervention (Weeks 8-11)|Death|1|||
163006195|NCT01922037|588725297|FG000|Overall Study|Withdrawal by Subject|2|||
163006196|NCT01922037|588725298|FG001|Overall Study|Withdrawal by Subject|44|||
163006197|NCT01922037|588725297|FG000|Overall Study|Adverse Event|1|||
163006198|NCT01922037|588725298|FG001|Overall Study|Adverse Event|7|||
163006199|NCT01922037|588725297|FG000|Overall Study|Death|0|||
163006200|NCT01922037|588725298|FG001|Overall Study|Death|5|||
163006201|NCT01922037|588725297|FG000|Overall Study|Pregnancy|0|||
163006202|NCT01922037|588725298|FG001|Overall Study|Pregnancy|2|||
163006203|NCT01922037|588725297|FG000|Overall Study|Participant non-compliance|4|||
163006204|NCT01922037|588725298|FG001|Overall Study|Participant non-compliance|46|||
163006205|NCT01922037|588725297|FG000|Overall Study|Investigator/Sponsor decision|1|||
163006206|NCT01922037|588725298|FG001|Overall Study|Investigator/Sponsor decision|4|||
163006207|NCT01922037|588725297|FG000|Overall Study|Other unspecified|2|||
163006208|NCT01922037|588725298|FG001|Overall Study|Other unspecified|66|||
163006209|NCT00679211|588725299|FG000|Overall Study|Progressive disease|82|||
163006210|NCT00679211|588725299|FG000|Overall Study|Adverse Event|7|||
163006211|NCT00679211|588725299|FG000|Overall Study|Withdrawal by Subject|2|||
163006212|NCT00679211|588725299|FG000|Overall Study|Physician Decision|5|||
163006213|NCT00679211|588725299|FG000|Overall Study|Refused to undergo protocol procedures|1|||
163006214|NCT00679211|588725299|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
163006215|NCT00679211|588725299|FG000|Overall Study|Other|1|||
163006216|NCT00931528|588725300|FG000|Overall Study|Protocol Violation|9|||
163006217|NCT00931528|588725301|FG001|Overall Study|Protocol Violation|12|||
163006218|NCT00931528|588725300|FG000|Overall Study|Withdrawal by Subject|4|||
163006219|NCT00931528|588725301|FG001|Overall Study|Withdrawal by Subject|12|||
163006220|NCT00931528|588725300|FG000|Overall Study|Lost to Follow-up|6|||
163006221|NCT00931528|588725301|FG001|Overall Study|Lost to Follow-up|13|||
163006222|NCT00931528|588725300|FG000|Overall Study|Assessment outside of Time Frame|22|||
163006223|NCT00931528|588725301|FG001|Overall Study|Assessment outside of Time Frame|23|||
163006224|NCT01470248|588725302|FG000|Overall Study|Withdrawal by Subject|1|||
163006225|NCT02243605|588725305|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
163006226|NCT02243605|588725306|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
163006227|NCT02243605|588725305|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
163006228|NCT02243605|588725306|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
163006229|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
163006230|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
163006231|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
163006232|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
163006233|NCT02243605|588725305|FG000|Stage 2 - Final Analysis Population|Progression|0|||
163006234|NCT02243605|588725306|FG001|Stage 2 - Final Analysis Population|Progression|1|||
163006235|NCT05842967|588725307|FG000|Period 1: SSA|Adverse Event|1|||
163006236|NCT05842967|588725308|FG001|Period 1: SSA|Adverse Event|1|||
163006237|NCT05842967|588725309|FG002|Period 1: SSA|Adverse Event|0|||
163006238|NCT05842967|588725310|FG003|Period 1: SSA|Adverse Event|0|||
163006239|NCT05842967|588725307|FG000|Period 1: SSA|Death|1|||
163006240|NCT05842967|588725308|FG001|Period 1: SSA|Death|0|||
163006241|NCT05842967|588725309|FG002|Period 1: SSA|Death|0|||
163006242|NCT05842967|588725310|FG003|Period 1: SSA|Death|0|||
163006243|NCT05842967|588725307|FG000|Period 1: SSA|Lost to Follow-up|16|||
163006244|NCT05842967|588725308|FG001|Period 1: SSA|Lost to Follow-up|4|||
163006245|NCT05842967|588725309|FG002|Period 1: SSA|Lost to Follow-up|0|||
163006246|NCT05842967|588725310|FG003|Period 1: SSA|Lost to Follow-up|0|||
163006247|NCT05842967|588725307|FG000|Period 1: SSA|Physician Decision|1|||
163006248|NCT05842967|588725308|FG001|Period 1: SSA|Physician Decision|0|||
163006249|NCT05842967|588725309|FG002|Period 1: SSA|Physician Decision|0|||
163006250|NCT05842967|588725310|FG003|Period 1: SSA|Physician Decision|0|||
163006251|NCT05842967|588725307|FG000|Period 1: SSA|Withdrawal by Subject|2|||
163006252|NCT05842967|588725308|FG001|Period 1: SSA|Withdrawal by Subject|2|||
163006253|NCT05842967|588725309|FG002|Period 1: SSA|Withdrawal by Subject|0|||
163006254|NCT05842967|588725310|FG003|Period 1: SSA|Withdrawal by Subject|0|||
163006255|NCT05842967|588725307|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
163006256|NCT05842967|588725308|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
163006257|NCT05842967|588725309|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
163006258|NCT05842967|588725310|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
163006259|NCT05842967|588725307|FG000|Period 2: SSB|Adverse Event|0|||
163006260|NCT05842967|588725308|FG001|Period 2: SSB|Adverse Event|0|||
163006261|NCT05842967|588725309|FG002|Period 2: SSB|Adverse Event|2|||
163006262|NCT05842967|588725310|FG003|Period 2: SSB|Adverse Event|0|||
163006263|NCT05842967|588725307|FG000|Period 2: SSB|Lost to Follow-up|0|||
163006264|NCT05842967|588725308|FG001|Period 2: SSB|Lost to Follow-up|0|||
163006265|NCT05842967|588725309|FG002|Period 2: SSB|Lost to Follow-up|4|||
163006266|NCT05842967|588725310|FG003|Period 2: SSB|Lost to Follow-up|3|||
163006267|NCT05842967|588725307|FG000|Period 2: SSB|Withdrawal by Subject|0|||
163006268|NCT05842967|588725308|FG001|Period 2: SSB|Withdrawal by Subject|0|||
163006269|NCT05842967|588725309|FG002|Period 2: SSB|Withdrawal by Subject|1|||
163006270|NCT05842967|588725310|FG003|Period 2: SSB|Withdrawal by Subject|0|||
163006271|NCT05842967|588725307|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
163006272|NCT05842967|588725308|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
163006273|NCT05842967|588725309|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
163006274|NCT05842967|588725310|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
163006275|NCT05842967|588725307|FG000|Period 2: SSB|Protocol Violation|0|||
163006276|NCT05842967|588725308|FG001|Period 2: SSB|Protocol Violation|0|||
163006277|NCT05842967|588725309|FG002|Period 2: SSB|Protocol Violation|0|||
163006278|NCT05842967|588725310|FG003|Period 2: SSB|Protocol Violation|1|||
163006279|NCT01557504|588725318|FG000|Overall Study|Physician Decision|1|||
163006280|NCT01557504|588725319|FG001|Overall Study|Physician Decision|0|||
163006281|NCT01321749|588725325|FG000|Overall Study|Lost to Follow-up|4|||
163006282|NCT01321749|588725326|FG001|Overall Study|Lost to Follow-up|11|||
163006283|NCT01321749|588725325|FG000|Overall Study|Protocol Violation|4|||
163006284|NCT01321749|588725326|FG001|Overall Study|Protocol Violation|7|||
163006285|NCT01321749|588725325|FG000|Overall Study|Withdrawal by Subject|5|||
163006286|NCT01321749|588725326|FG001|Overall Study|Withdrawal by Subject|4|||
163006287|NCT00970593|588725327|FG000|Overall Study|Adverse Event|1|||
163006288|NCT00970593|588725328|FG001|Overall Study|Adverse Event|1|||
163006289|NCT00970593|588725329|FG002|Overall Study|Adverse Event|0|||
163006290|NCT00970593|588725330|FG003|Overall Study|Adverse Event|0|||
163006291|NCT00970593|588725331|FG004|Overall Study|Adverse Event|0|||
163006292|NCT00970593|588725332|FG005|Overall Study|Adverse Event|0|||
163006293|NCT00970593|588725333|FG006|Overall Study|Adverse Event|0|||
163006294|NCT00970593|588725327|FG000|Overall Study|Discontinuation of study by sponsor|0|||
163006295|NCT00970593|588725328|FG001|Overall Study|Discontinuation of study by sponsor|0|||
163006296|NCT00970593|588725329|FG002|Overall Study|Discontinuation of study by sponsor|5|||
162638332|NCT03578367|587390897|FG000|Overall Study|Not treated|0|||
162638333|NCT03578367|587390898|FG001|Overall Study|Not treated|0|||
162638334|NCT03578367|587390899|FG002|Overall Study|Not treated|1|||
163006297|NCT00970593|588725330|FG003|Overall Study|Discontinuation of study by sponsor|0|||
163006298|NCT00970593|588725331|FG004|Overall Study|Discontinuation of study by sponsor|0|||
163006299|NCT00970593|588725332|FG005|Overall Study|Discontinuation of study by sponsor|0|||
163006300|NCT00970593|588725333|FG006|Overall Study|Discontinuation of study by sponsor|2|||
163006301|NCT00970593|588725327|FG000|Overall Study|Withdrawal by Subject|0|||
163006302|NCT00970593|588725328|FG001|Overall Study|Withdrawal by Subject|0|||
163006303|NCT00970593|588725329|FG002|Overall Study|Withdrawal by Subject|1|||
163006304|NCT00970593|588725330|FG003|Overall Study|Withdrawal by Subject|0|||
163006305|NCT00970593|588725331|FG004|Overall Study|Withdrawal by Subject|0|||
163006306|NCT00970593|588725332|FG005|Overall Study|Withdrawal by Subject|0|||
163006307|NCT00970593|588725333|FG006|Overall Study|Withdrawal by Subject|0|||
163006308|NCT02203357|588725334|FG000|Overall Study|Lost to Follow-up|58|||
163006309|NCT02203357|588725335|FG001|Overall Study|Lost to Follow-up|66|||
163006310|NCT02203357|588725336|FG002|Overall Study|Lost to Follow-up|70|||
163006311|NCT01866826|588725343|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
163006312|NCT01866826|588725344|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
163006313|NCT01866826|588725343|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
163006314|NCT01866826|588725344|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
163006315|NCT01866826|588725343|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
163006316|NCT01866826|588725344|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
163006317|NCT02288312|588725345|FG000|Overall Study|Pregnancy|1|||
163006318|NCT02288312|588725346|FG001|Overall Study|Pregnancy|0|||
163006319|NCT02288312|588725347|FG002|Overall Study|Pregnancy|0|||
163006320|NCT01276041|588725348|FG000|Overall Study|Adverse Event|2|||
163006321|NCT01276041|588725348|FG000|Overall Study|Protocol Violation|1|||
163006322|NCT02968576|588725349|FG000|Overall Study|Pregnancy|0|||
163006323|NCT02968576|588725350|FG001|Overall Study|Pregnancy|1|||
163006324|NCT02058069|588725353|FG000|Overall Study|Exclusion due to implant size|5|||
163006325|NCT02058069|588725353|FG000|Overall Study|Withdrawal by Subject|6|||
163006326|NCT02222922|588725354|FG000|Overall Study|Death|0|||
163006327|NCT02222922|588725355|FG001|Overall Study|Death|0|||
163006328|NCT02222922|588725356|FG002|Overall Study|Death|0|||
163006329|NCT02222922|588725357|FG003|Overall Study|Death|0|||
163006330|NCT02222922|588725358|FG004|Overall Study|Death|13|||
163006331|NCT02222922|588725359|FG005|Overall Study|Death|0|||
163006332|NCT02222922|588725360|FG006|Overall Study|Death|0|||
163006333|NCT02222922|588725361|FG007|Overall Study|Death|0|||
163006334|NCT02222922|588725362|FG008|Overall Study|Death|2|||
163006335|NCT02222922|588725354|FG000|Overall Study|Lost to Follow-up|0|||
163006336|NCT02222922|588725355|FG001|Overall Study|Lost to Follow-up|0|||
163006337|NCT02222922|588725356|FG002|Overall Study|Lost to Follow-up|1|||
163006338|NCT02222922|588725357|FG003|Overall Study|Lost to Follow-up|0|||
163006339|NCT02222922|588725358|FG004|Overall Study|Lost to Follow-up|9|||
162638335|NCT03578367|587390900|FG003|Overall Study|Not treated|0|||
162638336|NCT00670800|587392462|FG000|Overall Study|2 controls were insulin resistant|0|||
162638337|NCT00670800|587392463|FG001|Overall Study|2 controls were insulin resistant|2|||
162638338|NCT00587561|587392464|FG000|Overall Study|Lost to Follow-up|6|||
163006340|NCT02222922|588725359|FG005|Overall Study|Lost to Follow-up|1|||
163006341|NCT02222922|588725360|FG006|Overall Study|Lost to Follow-up|0|||
163006342|NCT02222922|588725361|FG007|Overall Study|Lost to Follow-up|0|||
163006343|NCT02222922|588725362|FG008|Overall Study|Lost to Follow-up|0|||
163006344|NCT02222922|588725354|FG000|Overall Study|Other|0|||
163006345|NCT02222922|588725355|FG001|Overall Study|Other|0|||
163006346|NCT02222922|588725356|FG002|Overall Study|Other|0|||
163006347|NCT02222922|588725357|FG003|Overall Study|Other|2|||
163006348|NCT02222922|588725358|FG004|Overall Study|Other|10|||
163006349|NCT02222922|588725359|FG005|Overall Study|Other|2|||
163006350|NCT02222922|588725360|FG006|Overall Study|Other|2|||
163006351|NCT02222922|588725361|FG007|Overall Study|Other|4|||
163006352|NCT02222922|588725362|FG008|Overall Study|Other|1|||
163006353|NCT02222922|588725354|FG000|Overall Study|Participant refused further follow-up|1|||
163006354|NCT02222922|588725355|FG001|Overall Study|Participant refused further follow-up|0|||
163006355|NCT02222922|588725356|FG002|Overall Study|Participant refused further follow-up|0|||
163006356|NCT02222922|588725357|FG003|Overall Study|Participant refused further follow-up|1|||
163006357|NCT02222922|588725358|FG004|Overall Study|Participant refused further follow-up|6|||
163006358|NCT02222922|588725359|FG005|Overall Study|Participant refused further follow-up|0|||
163006359|NCT02222922|588725360|FG006|Overall Study|Participant refused further follow-up|0|||
163006360|NCT02222922|588725361|FG007|Overall Study|Participant refused further follow-up|0|||
163006361|NCT02222922|588725362|FG008|Overall Study|Participant refused further follow-up|3|||
163006362|NCT02002221|588725363|FG000|Overall Study|Adverse Event|2|||
163006363|NCT02002221|588725364|FG001|Overall Study|Adverse Event|1|||
163006364|NCT02002221|588725363|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163006365|NCT02002221|588725364|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163006366|NCT02002221|588725363|FG000|Overall Study|Patient withdrew consent|0|||
163006367|NCT02002221|588725364|FG001|Overall Study|Patient withdrew consent|1|||
163006368|NCT01068860|588725365|FG000|Overall Study|Withdrawal by Subject|0|||
162638339|NCT00587561|587392465|FG001|Overall Study|Lost to Follow-up|4|||
162638340|NCT05661942|587392466|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
162638341|NCT05661942|587392467|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
163006369|NCT01068860|588725366|FG001|Overall Study|Withdrawal by Subject|0|||
163006370|NCT01068860|588725367|FG002|Overall Study|Withdrawal by Subject|0|||
163006371|NCT01068860|588725368|FG003|Overall Study|Withdrawal by Subject|0|||
162638342|NCT03274687|587392470|FG000|Overall Study|Protocol Violation|1|||
163006372|NCT01068860|588725369|FG004|Overall Study|Withdrawal by Subject|0|||
163006373|NCT01068860|588725370|FG005|Overall Study|Withdrawal by Subject|2|||
162638343|NCT03274687|587392471|FG001|Overall Study|Protocol Violation|1|||
163006374|NCT01068860|588725371|FG006|Overall Study|Withdrawal by Subject|0|||
163006375|NCT01068860|588725372|FG007|Overall Study|Withdrawal by Subject|0|||
163006376|NCT01068860|588725373|FG008|Overall Study|Withdrawal by Subject|0|||
163006377|NCT01068860|588725374|FG009|Overall Study|Withdrawal by Subject|3|||
163006378|NCT01068860|588725365|FG000|Overall Study|Administrative problems; misrandomized|0|||
162638344|NCT01572909|587392474|FG000|Overall Study|Adverse Event|7|||
162638345|NCT01572909|587392475|FG001|Overall Study|Adverse Event|2|||
162638346|NCT01572909|587392474|FG000|Overall Study|Death|3|||
162638347|NCT01572909|587392475|FG001|Overall Study|Death|1|||
162638348|NCT01572909|587392474|FG000|Overall Study|Lost to Follow-up|8|||
162638349|NCT01572909|587392475|FG001|Overall Study|Lost to Follow-up|7|||
162638350|NCT01572909|587392474|FG000|Overall Study|Physician Decision|1|||
162638351|NCT01572909|587392475|FG001|Overall Study|Physician Decision|1|||
162638352|NCT01572909|587392474|FG000|Overall Study|Technical Issues|1|||
163006379|NCT01068860|588725366|FG001|Overall Study|Administrative problems; misrandomized|0|||
163006380|NCT01068860|588725367|FG002|Overall Study|Administrative problems; misrandomized|0|||
163006381|NCT01068860|588725368|FG003|Overall Study|Administrative problems; misrandomized|1|||
163006382|NCT01068860|588725369|FG004|Overall Study|Administrative problems; misrandomized|0|||
163006383|NCT01068860|588725370|FG005|Overall Study|Administrative problems; misrandomized|0|||
163006384|NCT01068860|588725371|FG006|Overall Study|Administrative problems; misrandomized|0|||
163006385|NCT01068860|588725372|FG007|Overall Study|Administrative problems; misrandomized|0|||
163006386|NCT01068860|588725373|FG008|Overall Study|Administrative problems; misrandomized|0|||
163006387|NCT01068860|588725374|FG009|Overall Study|Administrative problems; misrandomized|1|||
163006388|NCT01068860|588725365|FG000|Overall Study|Lost to Follow-up|0|||
163006389|NCT01068860|588725366|FG001|Overall Study|Lost to Follow-up|1|||
163006390|NCT01068860|588725367|FG002|Overall Study|Lost to Follow-up|0|||
163006391|NCT01068860|588725368|FG003|Overall Study|Lost to Follow-up|0|||
163006392|NCT01068860|588725369|FG004|Overall Study|Lost to Follow-up|0|||
163006393|NCT01068860|588725370|FG005|Overall Study|Lost to Follow-up|0|||
163006394|NCT01068860|588725371|FG006|Overall Study|Lost to Follow-up|0|||
163006395|NCT01068860|588725372|FG007|Overall Study|Lost to Follow-up|0|||
163006396|NCT01068860|588725373|FG008|Overall Study|Lost to Follow-up|0|||
163006397|NCT01068860|588725374|FG009|Overall Study|Lost to Follow-up|0|||
163006398|NCT03743051|588725378|FG000|Overall Study|Adverse Event|5|||
163006399|NCT03743051|588725379|FG001|Overall Study|Adverse Event|9|||
163006400|NCT03743051|588725378|FG000|Overall Study|Death|27|||
163006401|NCT03743051|588725379|FG001|Overall Study|Death|26|||
163006402|NCT03743051|588725378|FG000|Overall Study|Lost to Follow-up|4|||
163006403|NCT03743051|588725379|FG001|Overall Study|Lost to Follow-up|8|||
163006404|NCT03743051|588725378|FG000|Overall Study|Withdrawal by Subject|32|||
163006405|NCT03743051|588725379|FG001|Overall Study|Withdrawal by Subject|19|||
163006406|NCT03743051|588725378|FG000|Overall Study|Physician Decision|10|||
163006407|NCT03743051|588725379|FG001|Overall Study|Physician Decision|15|||
163006408|NCT03743051|588725378|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
163006409|NCT03743051|588725379|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
163006410|NCT02550561|588725380|FG000|Overall Study|Lost to Follow-up|5|||
163006411|NCT02550561|588725380|FG000|Overall Study|Withdrawal by Subject|1|||
163006412|NCT03411863|588725381|FG000|Overall Study|Withdrawal by Subject|3|||
163006413|NCT03411863|588725382|FG001|Overall Study|Withdrawal by Subject|1|||
163006414|NCT03411863|588725381|FG000|Overall Study|Physician Decision|0|||
163006415|NCT03411863|588725382|FG001|Overall Study|Physician Decision|1|||
163006416|NCT02766335|588725383|FG000|Initial Registration|Adverse Event|6|||
163006417|NCT02766335|588725384|FG001|Initial Registration|Adverse Event|3|||
163006418|NCT02766335|588725385|FG002|Initial Registration|Adverse Event|0|||
163006419|NCT02766335|588725383|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
163006420|NCT02766335|588725384|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
163006421|NCT02766335|588725385|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
163006422|NCT02766335|588725383|FG000|Initial Registration|Progression/relapse|49|||
163006423|NCT02766335|588725384|FG001|Initial Registration|Progression/relapse|15|||
163006424|NCT02766335|588725385|FG002|Initial Registration|Progression/relapse|0|||
163006425|NCT02766335|588725383|FG000|Initial Registration|Death|1|||
163006426|NCT02766335|588725384|FG001|Initial Registration|Death|3|||
163006427|NCT02766335|588725385|FG002|Initial Registration|Death|0|||
163006428|NCT02766335|588725383|FG000|Initial Registration|not protocol specified|1|||
163006429|NCT02766335|588725384|FG001|Initial Registration|not protocol specified|9|||
163006430|NCT02766335|588725385|FG002|Initial Registration|not protocol specified|0|||
163006431|NCT02766335|588725383|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
163006432|NCT02766335|588725384|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
163006433|NCT02766335|588725385|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
163006434|NCT02766335|588725383|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
162638353|NCT01572909|587392475|FG001|Overall Study|Technical Issues|0|||
162638354|NCT01572909|587392474|FG000|Overall Study|Withdrawal by Subject|12|||
162638355|NCT01572909|587392475|FG001|Overall Study|Withdrawal by Subject|11|||
163006435|NCT02766335|588725384|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
163006436|NCT02766335|588725385|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
162638356|NCT01572909|587392474|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
163006437|NCT00262028|588725390|FG000|Overall Study|Withdrawal by Subject|6|||
162638357|NCT01572909|587392475|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
163006438|NCT00262028|588725391|FG001|Overall Study|Withdrawal by Subject|3|||
163006439|NCT00262028|588725392|FG002|Overall Study|Withdrawal by Subject|6|||
162638358|NCT01199289|587392476|FG000|Overall Study|Ineligibility determined|2|||
162638359|NCT01199289|587392477|FG001|Overall Study|Ineligibility determined|1|||
162638360|NCT01199289|587392478|FG002|Overall Study|Ineligibility determined|0|||
162638361|NCT01199289|587392479|FG003|Overall Study|Ineligibility determined|0|||
162638362|NCT01199289|587392476|FG000|Overall Study|Protocol Violation|1|||
162638363|NCT01199289|587392477|FG001|Overall Study|Protocol Violation|0|||
162638364|NCT01199289|587392478|FG002|Overall Study|Protocol Violation|0|||
162638365|NCT01199289|587392479|FG003|Overall Study|Protocol Violation|1|||
162638366|NCT01199289|587392476|FG000|Overall Study|Noncompliance|1|||
162638367|NCT01199289|587392477|FG001|Overall Study|Noncompliance|0|||
162638368|NCT01199289|587392478|FG002|Overall Study|Noncompliance|2|||
162638369|NCT01199289|587392479|FG003|Overall Study|Noncompliance|0|||
162638370|NCT01199289|587392476|FG000|Overall Study|Adverse Event|0|||
162638371|NCT01199289|587392477|FG001|Overall Study|Adverse Event|3|||
162638372|NCT01199289|587392478|FG002|Overall Study|Adverse Event|1|||
162638373|NCT01199289|587392479|FG003|Overall Study|Adverse Event|4|||
162638374|NCT01199289|587392476|FG000|Overall Study|Full consent withdrawn|2|||
162638375|NCT01199289|587392477|FG001|Overall Study|Full consent withdrawn|2|||
162638376|NCT01199289|587392478|FG002|Overall Study|Full consent withdrawn|2|||
162638377|NCT01199289|587392479|FG003|Overall Study|Full consent withdrawn|3|||
162638378|NCT01199289|587392476|FG000|Overall Study|Administrative decision|0|||
162638379|NCT01199289|587392477|FG001|Overall Study|Administrative decision|0|||
162638380|NCT01199289|587392478|FG002|Overall Study|Administrative decision|0|||
162638381|NCT01199289|587392479|FG003|Overall Study|Administrative decision|1|||
162638382|NCT01199289|587392476|FG000|Overall Study|Lost to Follow-up|0|||
162638383|NCT01199289|587392477|FG001|Overall Study|Lost to Follow-up|0|||
162638384|NCT01199289|587392478|FG002|Overall Study|Lost to Follow-up|0|||
162638385|NCT01199289|587392479|FG003|Overall Study|Lost to Follow-up|1|||
162638386|NCT01199289|587392476|FG000|Overall Study|Protocol-specified criteria|3|||
162638387|NCT01199289|587392477|FG001|Overall Study|Protocol-specified criteria|0|||
162638388|NCT01199289|587392478|FG002|Overall Study|Protocol-specified criteria|0|||
162638389|NCT01199289|587392479|FG003|Overall Study|Protocol-specified criteria|1|||
162638390|NCT01199289|587392476|FG000|Overall Study|Pregnancy|0|||
162638391|NCT01199289|587392477|FG001|Overall Study|Pregnancy|1|||
162638392|NCT01199289|587392478|FG002|Overall Study|Pregnancy|0|||
162638393|NCT01199289|587392479|FG003|Overall Study|Pregnancy|1|||
162638394|NCT02636868|587392480|FG000|Overall Study|Death|0|||
162638395|NCT02636868|587392481|FG001|Overall Study|Death|1|||
162638396|NCT02636868|587392482|FG002|Overall Study|Death|2|||
162638397|NCT03182829|587392488|FG000|Overall Study|Protocol Violation|12|||
162638398|NCT03182829|587392489|FG001|Overall Study|Protocol Violation|12|||
162638399|NCT03182829|587392488|FG000|Overall Study|Other|4|||
162638400|NCT03182829|587392489|FG001|Overall Study|Other|3|||
162638401|NCT03316131|587392490|FG000|Treatment Period 2|Protocol deviation|1|||
162638402|NCT03316131|587392491|FG001|Treatment Period 2|Protocol deviation|0|||
162638403|NCT02664441|587392492|FG000|Randomization|Withdrawal by Subject|0|||
162638404|NCT02664441|587392493|FG001|Randomization|Withdrawal by Subject|1|||
162638405|NCT02664441|587392492|FG000|36-week Randomized Trial|Adverse Event|2|||
162638406|NCT02664441|587392493|FG001|36-week Randomized Trial|Adverse Event|0|||
162638407|NCT02664441|587392492|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
162638408|NCT02664441|587392493|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
162638409|NCT02664441|587392492|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
162638410|NCT02664441|587392493|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
162638411|NCT02664441|587392492|FG000|18-week Open Label Extension|Adverse Event|1|||
162638412|NCT02664441|587392493|FG001|18-week Open Label Extension|Adverse Event|0|||
162638413|NCT02664441|587392492|FG000|18-week Open Label Extension|Physician Decision|1|||
162638414|NCT02664441|587392493|FG001|18-week Open Label Extension|Physician Decision|0|||
162638415|NCT02664441|587392492|FG000|18-week Open Label Extension|Death|1|||
162638416|NCT02664441|587392493|FG001|18-week Open Label Extension|Death|0|||
162638417|NCT02664441|587392492|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
162638418|NCT02664441|587392493|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
162638419|NCT05608005|587392495|FG000|Overall Study|Adverse Event|2|||
162638420|NCT05608005|587392496|FG001|Overall Study|Adverse Event|1|||
162638421|NCT05608005|587392497|FG002|Overall Study|Adverse Event|3|||
162638422|NCT05608005|587392495|FG000|Overall Study|Protocol Violation|2|||
162638423|NCT05608005|587392496|FG001|Overall Study|Protocol Violation|3|||
162638424|NCT05608005|587392497|FG002|Overall Study|Protocol Violation|0|||
162638425|NCT05608005|587392495|FG000|Overall Study|Withdrawal by Subject|10|||
162638426|NCT05608005|587392496|FG001|Overall Study|Withdrawal by Subject|12|||
162638427|NCT05608005|587392497|FG002|Overall Study|Withdrawal by Subject|4|||
162638428|NCT05608005|587392495|FG000|Overall Study|Lost to Follow-up|25|||
162638429|NCT05608005|587392496|FG001|Overall Study|Lost to Follow-up|27|||
162638430|NCT05608005|587392497|FG002|Overall Study|Lost to Follow-up|15|||
162638431|NCT05608005|587392495|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
162638432|NCT05608005|587392496|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
162638433|NCT05608005|587392497|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
162638434|NCT03518073|587392498|FG000|Overall Study|Adverse Event|2|||
162638435|NCT03518073|587392499|FG001|Overall Study|Adverse Event|4|||
162638436|NCT03518073|587392500|FG002|Overall Study|Adverse Event|2|||
162638437|NCT03518073|587392498|FG000|Overall Study|Death|2|||
163006440|NCT00262028|588725393|FG003|Overall Study|Withdrawal by Subject|5|||
163006441|NCT00262028|588725394|FG004|Overall Study|Withdrawal by Subject|2|||
163006442|NCT00262028|588725395|FG005|Overall Study|Withdrawal by Subject|3|||
163006443|NCT00262028|588725396|FG006|Overall Study|Withdrawal by Subject|5|||
163006444|NCT00262028|588725397|FG007|Overall Study|Withdrawal by Subject|7|||
163006445|NCT00262028|588725398|FG008|Overall Study|Withdrawal by Subject|2|||
163006446|NCT00262028|588725390|FG000|Overall Study|Lost to Follow-up|7|||
163006447|NCT00262028|588725391|FG001|Overall Study|Lost to Follow-up|7|||
163006448|NCT00262028|588725392|FG002|Overall Study|Lost to Follow-up|5|||
163006449|NCT00262028|588725393|FG003|Overall Study|Lost to Follow-up|5|||
163006450|NCT00262028|588725394|FG004|Overall Study|Lost to Follow-up|4|||
163006451|NCT00262028|588725395|FG005|Overall Study|Lost to Follow-up|3|||
163006452|NCT00262028|588725396|FG006|Overall Study|Lost to Follow-up|3|||
163006453|NCT00262028|588725397|FG007|Overall Study|Lost to Follow-up|5|||
163006454|NCT00262028|588725398|FG008|Overall Study|Lost to Follow-up|6|||
163006455|NCT00262028|588725390|FG000|Overall Study|Administrative Reason|11|||
163006456|NCT00262028|588725391|FG001|Overall Study|Administrative Reason|14|||
163006457|NCT00262028|588725392|FG002|Overall Study|Administrative Reason|9|||
163006458|NCT00262028|588725393|FG003|Overall Study|Administrative Reason|12|||
163006459|NCT00262028|588725394|FG004|Overall Study|Administrative Reason|6|||
163006460|NCT00262028|588725395|FG005|Overall Study|Administrative Reason|7|||
163006461|NCT00262028|588725396|FG006|Overall Study|Administrative Reason|4|||
163006462|NCT00262028|588725397|FG007|Overall Study|Administrative Reason|6|||
163006463|NCT00262028|588725398|FG008|Overall Study|Administrative Reason|10|||
163006464|NCT00262028|588725390|FG000|Overall Study|Protocol Violation|0|||
163006465|NCT00262028|588725391|FG001|Overall Study|Protocol Violation|0|||
163006466|NCT00262028|588725392|FG002|Overall Study|Protocol Violation|0|||
163006467|NCT00262028|588725393|FG003|Overall Study|Protocol Violation|1|||
163061311|NCT00614393|588933073|FG002|Overall Study|Protocol Violation|0|||
163061312|NCT00614393|588933074|FG003|Overall Study|Protocol Violation|0|||
163061313|NCT00614393|588933075|FG004|Overall Study|Protocol Violation|0|||
163061314|NCT00614393|588933071|FG000|Overall Study|Terminated by Sponsor|0|||
163061315|NCT00614393|588933072|FG001|Overall Study|Terminated by Sponsor|0|||
163061316|NCT00614393|588933073|FG002|Overall Study|Terminated by Sponsor|0|||
163061317|NCT00614393|588933074|FG003|Overall Study|Terminated by Sponsor|0|||
163061318|NCT00614393|588933075|FG004|Overall Study|Terminated by Sponsor|1|||
163061319|NCT00614393|588933071|FG000|Overall Study|Withdrawal by Subject|20|||
162638438|NCT03518073|587392499|FG001|Overall Study|Death|1|||
162638439|NCT03518073|587392500|FG002|Overall Study|Death|3|||
163061320|NCT00614393|588933072|FG001|Overall Study|Withdrawal by Subject|1|||
162638440|NCT03518073|587392498|FG000|Overall Study|Lost to Follow-up|1|||
163006468|NCT00262028|588725394|FG004|Overall Study|Protocol Violation|0|||
163006469|NCT00262028|588725395|FG005|Overall Study|Protocol Violation|0|||
163006470|NCT00262028|588725396|FG006|Overall Study|Protocol Violation|0|||
163061321|NCT00614393|588933073|FG002|Overall Study|Withdrawal by Subject|1|||
162638441|NCT03518073|587392499|FG001|Overall Study|Lost to Follow-up|0|||
162638442|NCT03518073|587392500|FG002|Overall Study|Lost to Follow-up|1|||
163006471|NCT00262028|588725397|FG007|Overall Study|Protocol Violation|0|||
163006472|NCT00262028|588725398|FG008|Overall Study|Protocol Violation|0|||
163006473|NCT00262028|588725390|FG000|Overall Study|Unable to classify|0|||
163006474|NCT00262028|588725391|FG001|Overall Study|Unable to classify|3|||
163006475|NCT00262028|588725392|FG002|Overall Study|Unable to classify|0|||
163006476|NCT00262028|588725393|FG003|Overall Study|Unable to classify|0|||
163006477|NCT00262028|588725394|FG004|Overall Study|Unable to classify|0|||
163006478|NCT00262028|588725395|FG005|Overall Study|Unable to classify|0|||
163006479|NCT00262028|588725396|FG006|Overall Study|Unable to classify|0|||
163006480|NCT00262028|588725397|FG007|Overall Study|Unable to classify|0|||
163061322|NCT00614393|588933074|FG003|Overall Study|Withdrawal by Subject|16|||
163061323|NCT00614393|588933075|FG004|Overall Study|Withdrawal by Subject|13|||
163061324|NCT00614393|588933071|FG000|Overall Study|Other|4|||
163061325|NCT00614393|588933072|FG001|Overall Study|Other|0|||
163061326|NCT00614393|588933073|FG002|Overall Study|Other|0|||
163061327|NCT00614393|588933074|FG003|Overall Study|Other|4|||
163061328|NCT00614393|588933075|FG004|Overall Study|Other|2|||
163061329|NCT00614393|588933071|FG000|Overall Study|Not Treated|0|||
163061330|NCT00614393|588933072|FG001|Overall Study|Not Treated|0|||
163061331|NCT00614393|588933073|FG002|Overall Study|Not Treated|0|||
163061332|NCT00614393|588933074|FG003|Overall Study|Not Treated|0|||
163061333|NCT00614393|588933075|FG004|Overall Study|Not Treated|2|||
163061334|NCT02328105|588933076|FG000|Overall Study|Death|6|||
163061335|NCT02328105|588933076|FG000|Overall Study|Withdrawal by Subject|1|||
163061336|NCT02328105|588933076|FG000|Overall Study|Still On Study in Follow-Up|4|||
163061337|NCT01013753|588933081|FG000|Overall Study|Adverse Event|8|||
163061338|NCT01013753|588933081|FG000|Overall Study|Protocol Violation|3|||
163061339|NCT01013753|588933081|FG000|Overall Study|Lost to Follow-up|1|||
163061340|NCT01013753|588933081|FG000|Overall Study|Withdrawal by Subject|2|||
163061341|NCT01013753|588933081|FG000|Overall Study|Other|2|||
163061342|NCT05350423|588933082|FG000|Overall Study|Lost to Follow-up|3|||
163061343|NCT05350423|588933083|FG001|Overall Study|Lost to Follow-up|3|||
163061344|NCT05350423|588933082|FG000|Overall Study|screen failure|5|||
163061345|NCT05350423|588933083|FG001|Overall Study|screen failure|6|||
163061346|NCT02097277|588933084|FG000|Overall Study|Subject no longer meets study criteria|0|||
163061347|NCT02097277|588933085|FG001|Overall Study|Subject no longer meets study criteria|1|||
163061348|NCT02097277|588933086|FG002|Overall Study|Subject no longer meets study criteria|0|||
163061349|NCT02097277|588933087|FG003|Overall Study|Subject no longer meets study criteria|1|||
163061350|NCT02097277|588933088|FG004|Overall Study|Subject no longer meets study criteria|0|||
163006481|NCT00262028|588725398|FG008|Overall Study|Unable to classify|1|||
163006482|NCT03164551|588725399|FG000|Overall Study|Imaging discontinued prior completion|8|||
163006483|NCT03164551|588725400|FG001|Overall Study|Imaging discontinued prior completion|0|||
163061351|NCT02097277|588933084|FG000|Overall Study|Subject request to discontinue treatment|0|||
163061352|NCT02097277|588933085|FG001|Overall Study|Subject request to discontinue treatment|0|||
163061353|NCT02097277|588933086|FG002|Overall Study|Subject request to discontinue treatment|0|||
163061354|NCT02097277|588933087|FG003|Overall Study|Subject request to discontinue treatment|0|||
163061355|NCT02097277|588933088|FG004|Overall Study|Subject request to discontinue treatment|1|||
163061356|NCT02097277|588933084|FG000|Overall Study|Lost to Follow-up|0|||
163061357|NCT02097277|588933085|FG001|Overall Study|Lost to Follow-up|1|||
163061358|NCT02097277|588933086|FG002|Overall Study|Lost to Follow-up|1|||
163061359|NCT02097277|588933087|FG003|Overall Study|Lost to Follow-up|0|||
163061360|NCT02097277|588933088|FG004|Overall Study|Lost to Follow-up|0|||
163061361|NCT02097277|588933084|FG000|Overall Study|Withdrawal by Subject|2|||
163061362|NCT02097277|588933085|FG001|Overall Study|Withdrawal by Subject|1|||
163061363|NCT02097277|588933086|FG002|Overall Study|Withdrawal by Subject|0|||
163061364|NCT02097277|588933087|FG003|Overall Study|Withdrawal by Subject|1|||
163061365|NCT02097277|588933088|FG004|Overall Study|Withdrawal by Subject|0|||
163061366|NCT02097277|588933084|FG000|Overall Study|Adverse Event|0|||
163061367|NCT02097277|588933085|FG001|Overall Study|Adverse Event|0|||
163061368|NCT02097277|588933086|FG002|Overall Study|Adverse Event|1|||
163061369|NCT02097277|588933087|FG003|Overall Study|Adverse Event|2|||
163061370|NCT02097277|588933088|FG004|Overall Study|Adverse Event|0|||
163061371|NCT01461551|588933100|FG000|Overall Study|Physician Decision|2|||
163061372|NCT01461551|588933101|FG001|Overall Study|Physician Decision|1|||
163061373|NCT01461551|588933102|FG002|Overall Study|Physician Decision|2|||
163061374|NCT00303186|588933103|FG000|Overall Study|Other|52|||
163061375|NCT02326883|588933104|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
163061376|NCT02326883|588933105|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
163061377|NCT02326883|588933106|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
163061378|NCT01385176|588933107|FG000|Randomization Phase|Death|1|||
163061379|NCT01385176|588933108|FG001|Randomization Phase|Death|2|||
163061380|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Death|1|||
163061381|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Death|2|||
163061382|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Physician Decision|0|||
163061383|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Physician Decision|1|||
163061384|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
163006484|NCT03164551|588725399|FG000|Overall Study|Participant was non-compliant|1|||
163061385|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
163006485|NCT03164551|588725400|FG001|Overall Study|Participant was non-compliant|0|||
163006486|NCT03164551|588725399|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
163006487|NCT03164551|588725400|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
163006488|NCT03164551|588725399|FG000|Overall Study|Other|8|||
163006489|NCT03164551|588725400|FG001|Overall Study|Other|2|||
163006490|NCT01515423|588725401|FG000|Open Label Phase|Adverse Event|57|||
163006491|NCT01515423|588725402|FG001|Open Label Phase|Adverse Event|0|||
163006492|NCT01515423|588725403|FG002|Open Label Phase|Adverse Event|0|||
163006493|NCT01515423|588725401|FG000|Open Label Phase|Death|2|||
163006494|NCT01515423|588725402|FG001|Open Label Phase|Death|0|||
163006495|NCT01515423|588725403|FG002|Open Label Phase|Death|0|||
163006496|NCT01515423|588725401|FG000|Open Label Phase|Lack of Efficacy|117|||
163006497|NCT01515423|588725402|FG001|Open Label Phase|Lack of Efficacy|0|||
163006498|NCT01515423|588725403|FG002|Open Label Phase|Lack of Efficacy|0|||
163006499|NCT01515423|588725401|FG000|Open Label Phase|Lost to Follow-up|21|||
163006500|NCT01515423|588725402|FG001|Open Label Phase|Lost to Follow-up|0|||
163006501|NCT01515423|588725403|FG002|Open Label Phase|Lost to Follow-up|0|||
163006502|NCT01515423|588725401|FG000|Open Label Phase|Withdrawal by Subject|118|||
163006503|NCT01515423|588725402|FG001|Open Label Phase|Withdrawal by Subject|0|||
163006504|NCT01515423|588725403|FG002|Open Label Phase|Withdrawal by Subject|0|||
163006505|NCT01515423|588725401|FG000|Open Label Phase|excluded from DB Phase|70|||
163006506|NCT01515423|588725402|FG001|Open Label Phase|excluded from DB Phase|0|||
163006507|NCT01515423|588725403|FG002|Open Label Phase|excluded from DB Phase|0|||
163006508|NCT01515423|588725401|FG000|Open Label Phase|Other|28|||
162638443|NCT03518073|587392498|FG000|Overall Study|Physician Decision|5|||
162638444|NCT03518073|587392499|FG001|Overall Study|Physician Decision|0|||
162638445|NCT03518073|587392500|FG002|Overall Study|Physician Decision|2|||
162638446|NCT03518073|587392498|FG000|Overall Study|Progressive disease|1|||
162638447|NCT03518073|587392499|FG001|Overall Study|Progressive disease|1|||
162638448|NCT03518073|587392500|FG002|Overall Study|Progressive disease|1|||
162638449|NCT03518073|587392498|FG000|Overall Study|Protocol Violation|1|||
162638450|NCT03518073|587392499|FG001|Overall Study|Protocol Violation|0|||
162638451|NCT03518073|587392500|FG002|Overall Study|Protocol Violation|0|||
162638452|NCT03518073|587392498|FG000|Overall Study|Withdrawal by Subject|30|||
162638453|NCT03518073|587392499|FG001|Overall Study|Withdrawal by Subject|34|||
162638454|NCT03518073|587392500|FG002|Overall Study|Withdrawal by Subject|29|||
162638455|NCT03518073|587392498|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
162638456|NCT03518073|587392499|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
162638457|NCT03518073|587392500|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
162638458|NCT03518073|587392498|FG000|Overall Study|Covid-19|1|||
162638459|NCT03518073|587392499|FG001|Overall Study|Covid-19|2|||
162638460|NCT03518073|587392500|FG002|Overall Study|Covid-19|1|||
162638461|NCT03045081|587392501|FG000|Overall Study|Withdrawal by Subject|6|||
162638462|NCT03045081|587392502|FG001|Overall Study|Withdrawal by Subject|11|||
162638463|NCT03804879|587392503|FG000|Overall Study|Adverse Event|3|||
162638464|NCT03804879|587392504|FG001|Overall Study|Adverse Event|0|||
162638465|NCT03804879|587392503|FG000|Overall Study|Study Terminated By Sponsor|10|||
162638466|NCT03804879|587392504|FG001|Overall Study|Study Terminated By Sponsor|12|||
162638467|NCT03804879|587392503|FG000|Overall Study|Withdrawal by Subject|3|||
163006509|NCT01515423|588725402|FG001|Open Label Phase|Other|0|||
163006510|NCT01515423|588725403|FG002|Open Label Phase|Other|0|||
163006511|NCT01515423|588725401|FG000|DOUBLE BLIND|Adverse Event|0|||
163006512|NCT01515423|588725402|FG001|DOUBLE BLIND|Adverse Event|15|||
163006513|NCT01515423|588725403|FG002|DOUBLE BLIND|Adverse Event|13|||
163006514|NCT01515423|588725401|FG000|DOUBLE BLIND|Death|0|||
163006515|NCT01515423|588725402|FG001|DOUBLE BLIND|Death|1|||
163006516|NCT01515423|588725403|FG002|DOUBLE BLIND|Death|2|||
163006517|NCT01515423|588725401|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
163006518|NCT01515423|588725402|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
163006519|NCT01515423|588725403|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
163006520|NCT01515423|588725401|FG000|DOUBLE BLIND|Pregnancy|0|||
163006521|NCT01515423|588725402|FG001|DOUBLE BLIND|Pregnancy|2|||
163006522|NCT01515423|588725403|FG002|DOUBLE BLIND|Pregnancy|0|||
162638468|NCT03804879|587392504|FG001|Overall Study|Withdrawal by Subject|1|||
162638469|NCT02436889|587392505|FG000|Overall Study|No improvement in symptoms|1|||
163006523|NCT01515423|588725401|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
162638470|NCT02436889|587392506|FG001|Overall Study|No improvement in symptoms|0|||
162638471|NCT02436889|587392505|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
163006524|NCT01515423|588725402|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
163006525|NCT01515423|588725403|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
163006526|NCT01515423|588725401|FG000|DOUBLE BLIND|Other|0|||
163006527|NCT01515423|588725402|FG001|DOUBLE BLIND|Other|6|||
163006528|NCT01515423|588725403|FG002|DOUBLE BLIND|Other|12|||
163006529|NCT01515423|588725401|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
163006530|NCT01515423|588725402|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
163006531|NCT01515423|588725403|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
163006532|NCT00995774|588725414|FG000|Training Period 2|Withdrawal by Subject|2|||
163006533|NCT00995774|588725415|FG001|Training Period 2|Withdrawal by Subject|0|||
163006534|NCT01998841|588725420|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
163006535|NCT01998841|588725421|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
163006536|NCT01998841|588725422|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
163006537|NCT01998841|588725423|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006538|NCT01998841|588725424|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006539|NCT01998841|588725420|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006540|NCT01998841|588725421|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006541|NCT01998841|588725422|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
163006542|NCT01998841|588725423|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
163006543|NCT01998841|588725424|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
163006544|NCT00972595|588725425|FG000|Period 1|Adverse Event|1|||
163006545|NCT00972595|588725426|FG001|Period 1|Adverse Event|0|||
163006546|NCT01461538|588725427|FG000|Overall Study|Death|15|||
163006547|NCT01461538|588725428|FG001|Overall Study|Death|6|||
163006548|NCT01461538|588725429|FG002|Overall Study|Death|2|||
163006549|NCT01461538|588725427|FG000|Overall Study|Study Stopped by Sponsor|2|||
163006550|NCT01461538|588725428|FG001|Overall Study|Study Stopped by Sponsor|1|||
163006551|NCT01461538|588725429|FG002|Overall Study|Study Stopped by Sponsor|0|||
163006552|NCT01461538|588725427|FG000|Overall Study|Withdrawal by Subject|1|||
163006553|NCT01461538|588725428|FG001|Overall Study|Withdrawal by Subject|1|||
163006554|NCT01461538|588725429|FG002|Overall Study|Withdrawal by Subject|0|||
163006555|NCT00141778|588725430|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
163006556|NCT00141778|588725431|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
163006557|NCT00141778|588725432|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
163006558|NCT00141778|588725430|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
163006559|NCT00141778|588725431|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
163006560|NCT00141778|588725432|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
163006561|NCT00141778|588725430|FG000|Started Study Medication|Withdrawal by Subject|0|||
163006562|NCT00141778|588725431|FG001|Started Study Medication|Withdrawal by Subject|2|||
163006563|NCT00141778|588725432|FG002|Started Study Medication|Withdrawal by Subject|0|||
163006564|NCT00141778|588725430|FG000|Started Study Medication|Difficulty Swallowing|0|||
163006565|NCT00141778|588725431|FG001|Started Study Medication|Difficulty Swallowing|1|||
163006566|NCT00141778|588725432|FG002|Started Study Medication|Difficulty Swallowing|0|||
163006567|NCT00141778|588725430|FG000|Started Study Medication|Chest Discomfort|0|||
163006568|NCT00141778|588725431|FG001|Started Study Medication|Chest Discomfort|0|||
163006569|NCT00141778|588725432|FG002|Started Study Medication|Chest Discomfort|1|||
163006570|NCT01406574|588725434|FG000|Overall Study|Adverse Event|0|||
163006571|NCT01406574|588725435|FG001|Overall Study|Adverse Event|0|||
163006572|NCT01406574|588725436|FG002|Overall Study|Adverse Event|1|||
163006573|NCT01406574|588725437|FG003|Overall Study|Adverse Event|3|||
163006574|NCT01406574|588725434|FG000|Overall Study|Physician Decision|0|||
163006575|NCT01406574|588725435|FG001|Overall Study|Physician Decision|0|||
163006576|NCT01406574|588725436|FG002|Overall Study|Physician Decision|0|||
163006577|NCT01406574|588725437|FG003|Overall Study|Physician Decision|1|||
163006578|NCT01406574|588725434|FG000|Overall Study|Withdrawal by Subject|0|||
163006579|NCT01406574|588725435|FG001|Overall Study|Withdrawal by Subject|1|||
163006580|NCT01406574|588725436|FG002|Overall Study|Withdrawal by Subject|0|||
163006581|NCT01406574|588725437|FG003|Overall Study|Withdrawal by Subject|0|||
163006582|NCT01406574|588725434|FG000|Overall Study|Definite progression of primary disease|1|||
163006583|NCT01406574|588725435|FG001|Overall Study|Definite progression of primary disease|0|||
163006584|NCT01406574|588725436|FG002|Overall Study|Definite progression of primary disease|0|||
163006585|NCT01406574|588725437|FG003|Overall Study|Definite progression of primary disease|0|||
163006586|NCT04052620|588725438|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
163006587|NCT04052620|588725439|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
163006588|NCT04052620|588725438|FG000|Overall Study|Withdrawal by Subject|1|||
163006589|NCT04052620|588725439|FG001|Overall Study|Withdrawal by Subject|0|||
163006590|NCT04052620|588725438|FG000|Overall Study|Lost to Follow-up|1|||
163006591|NCT04052620|588725439|FG001|Overall Study|Lost to Follow-up|1|||
163006592|NCT04052620|588725438|FG000|Overall Study|Adverse Event|1|||
163006593|NCT04052620|588725439|FG001|Overall Study|Adverse Event|0|||
163006594|NCT04052620|588725438|FG000|Overall Study|Subject did not meet study Criteria|0|||
163006595|NCT04052620|588725439|FG001|Overall Study|Subject did not meet study Criteria|1|||
163006596|NCT04052620|588725438|FG000|Overall Study|Screened failure, randomized by mistake|0|||
163006597|NCT04052620|588725439|FG001|Overall Study|Screened failure, randomized by mistake|1|||
163006598|NCT04052620|588725438|FG000|Overall Study|Personal reasons|2|||
163006599|NCT04052620|588725439|FG001|Overall Study|Personal reasons|4|||
163006600|NCT04052620|588725438|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
163006601|NCT04052620|588725439|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
163006602|NCT03552380|588725441|FG000|Study Treatment|Disease Progression|3|||
163006603|NCT03552380|588725442|FG001|Study Treatment|Disease Progression|4|||
163006604|NCT03552380|588725441|FG000|Study Treatment|Adverse Event|2|||
163006605|NCT03552380|588725442|FG001|Study Treatment|Adverse Event|2|||
163006606|NCT03552380|588725441|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
163006607|NCT03552380|588725442|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
163006608|NCT03552380|588725441|FG000|Follow up|Death|3|||
163006609|NCT03552380|588725442|FG001|Follow up|Death|4|||
163006610|NCT03552380|588725441|FG000|Follow up|Site IRB terminated|0|||
163006611|NCT03552380|588725442|FG001|Follow up|Site IRB terminated|1|||
163006612|NCT01112059|588725443|FG000|Overall Study|Withdrawal by Subject|1|||
163006613|NCT01112059|588725444|FG001|Overall Study|Withdrawal by Subject|0|||
163006614|NCT01245283|588725445|FG000|Overall Study|Lost to Follow-up|14|||
163006615|NCT01245283|588725446|FG001|Overall Study|Lost to Follow-up|11|||
163006616|NCT01245283|588725447|FG002|Overall Study|Lost to Follow-up|11|||
163006617|NCT03567980|588725454|FG000|Overall Study|Adverse Event|1|||
163006618|NCT03093259|588725458|FG000|Overall Study|Adverse Event|1|||
163006619|NCT03093259|588725459|FG001|Overall Study|Adverse Event|0|||
163006620|NCT03093259|588725458|FG000|Overall Study|Withdrawal by Subject|1|||
163006621|NCT03093259|588725459|FG001|Overall Study|Withdrawal by Subject|0|||
163061386|NCT01385176|588933107|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
163061387|NCT01385176|588933108|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
163061388|NCT01056536|588933109|FG000|Overall Study|Lost to Follow-up|202|||
163006622|NCT00550459|588725462|FG000|Overall Study|Adverse Event|0|||
163006623|NCT00550459|588725463|FG001|Overall Study|Adverse Event|2|||
163006624|NCT00550459|588725462|FG000|Overall Study|Withdrawal by Subject|1|||
163006625|NCT00550459|588725463|FG001|Overall Study|Withdrawal by Subject|1|||
163006626|NCT01401452|588725464|FG000|Overall Study|Adverse reaction|9|||
163006627|NCT01401452|588725464|FG000|Overall Study|Lost to Follow-up|12|||
163006628|NCT01401452|588725464|FG000|Overall Study|Lack of Efficacy|30|||
163006629|NCT01401452|588725464|FG000|Overall Study|Participant developed breast cancer|1|||
163006630|NCT01401452|588725464|FG000|Overall Study|Tx stopped due to financial reasons|1|||
163006631|NCT01401452|588725464|FG000|Overall Study|Tx stopped by psychiatrist|1|||
163006632|NCT01401452|588725464|FG000|Overall Study|No more visits within the 36 wk followup|4|||
163006633|NCT01401452|588725464|FG000|Overall Study|Subject did not come to follow up visits|2|||
163006634|NCT01401452|588725464|FG000|Overall Study|Subject didn't return for routine visits|1|||
163061389|NCT01056536|588933110|FG001|Overall Study|Lost to Follow-up|116|||
162638472|NCT02436889|587392506|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
163006635|NCT01401452|588725464|FG000|Overall Study|Subject moved to another city|1|||
163006636|NCT01401452|588725464|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
163006637|NCT01401452|588725464|FG000|Overall Study|Psoriatic arthritis|1|||
163006638|NCT01401452|588725464|FG000|Overall Study|Participant stopped Tx|2|||
163006639|NCT01401452|588725464|FG000|Overall Study|Discontinuation for personal reasons|1|||
163006640|NCT01401452|588725464|FG000|Overall Study|Treatment failure|1|||
163061390|NCT01056536|588933111|FG002|Overall Study|Lost to Follow-up|248|||
163006641|NCT01401452|588725464|FG000|Overall Study|Unsatisfactory output|1|||
163006642|NCT01401452|588725464|FG000|Overall Study|Subject withdrew because of Tx success|1|||
163006643|NCT01401452|588725464|FG000|Overall Study|Subject chose to discontinue treatment|1|||
163006644|NCT01401452|588725464|FG000|Overall Study|Participant withdrew consent|1|||
163006645|NCT02633787|588725465|FG000|Overall Study|Withdrawal by Subject|1|||
163006646|NCT00584454|588725466|FG000|Overall Study|Adverse Event|1|||
163006647|NCT00584454|588725466|FG000|Overall Study|Relocation|1|||
163006648|NCT00584454|588725466|FG000|Overall Study|Clinical Hold|2|||
163006649|NCT01742897|588725467|FG000|Overall Study|Adverse Event|3|||
163006650|NCT01742897|588725467|FG000|Overall Study|Withdrawal by Subject|1|||
163006651|NCT01742897|588725467|FG000|Overall Study|Other|1|||
163006652|NCT02404805|588725468|FG000|Overall Study|Withdrawal by Subject|1|||
163006653|NCT02404805|588725469|FG001|Overall Study|Withdrawal by Subject|0|||
163006654|NCT02404805|588725470|FG002|Overall Study|Withdrawal by Subject|0|||
163006655|NCT02404805|588725471|FG003|Overall Study|Withdrawal by Subject|0|||
163006656|NCT02404805|588725472|FG004|Overall Study|Withdrawal by Subject|0|||
163006657|NCT02404805|588725473|FG005|Overall Study|Withdrawal by Subject|0|||
163006658|NCT01459783|588725477|FG000|Baseline to 6 Months|Death|1|||
163006659|NCT01459783|588725478|FG001|Baseline to 6 Months|Death|0|||
163006660|NCT01459783|588725477|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
163006661|NCT01459783|588725478|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
163006662|NCT01459783|588725477|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
163006663|NCT01459783|588725478|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
163006664|NCT01459783|588725477|FG000|6 Months to 12 Months|Death|0|||
163006665|NCT01459783|588725478|FG001|6 Months to 12 Months|Death|1|||
163006666|NCT01459783|588725477|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
163006667|NCT01459783|588725478|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
163006668|NCT01459783|588725477|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
163006669|NCT01459783|588725478|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
163006670|NCT01459783|588725477|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
163006671|NCT01459783|588725478|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
163006672|NCT04199104|588727633|FG000|Overall Study|Death|148|||
163006673|NCT04199104|588727634|FG001|Overall Study|Death|134|||
163006674|NCT04199104|588727633|FG000|Overall Study|Lost to Follow-up|1|||
163006675|NCT04199104|588727634|FG001|Overall Study|Lost to Follow-up|1|||
163006676|NCT04199104|588727633|FG000|Overall Study|Withdrawal by Subject|4|||
163006677|NCT04199104|588727634|FG001|Overall Study|Withdrawal by Subject|4|||
163006678|NCT04199104|588727633|FG000|Overall Study|Participants Ongoing|103|||
163006679|NCT04199104|588727634|FG001|Overall Study|Participants Ongoing|116|||
163006680|NCT04563754|588727636|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
163006681|NCT04563754|588727637|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
163006682|NCT04563754|588727638|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
163006683|NCT04563754|588727636|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
163006684|NCT04563754|588727637|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
163006685|NCT04563754|588727638|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
163006686|NCT04563754|588727636|FG000|Follow up|Lost to Follow-up|61|||
163006687|NCT04563754|588727637|FG001|Follow up|Lost to Follow-up|23|||
163006688|NCT04563754|588727638|FG002|Follow up|Lost to Follow-up|5|||
163006689|NCT04563754|588727636|FG000|Follow up|Death|0|||
163006690|NCT04563754|588727637|FG001|Follow up|Death|2|||
163006691|NCT04563754|588727638|FG002|Follow up|Death|0|||
163006692|NCT04563754|588727636|FG000|Follow up|Ongoing|0|||
163006693|NCT04563754|588727637|FG001|Follow up|Ongoing|28|||
163006694|NCT04563754|588727638|FG002|Follow up|Ongoing|0|||
163006695|NCT00070564|588727639|FG000|Overall Study|Progression|2|||
163006696|NCT00070564|588727640|FG001|Overall Study|Progression|4|||
163006697|NCT00070564|588727641|FG002|Overall Study|Progression|7|||
163006698|NCT00070564|588727642|FG003|Overall Study|Progression|7|||
163006699|NCT00070564|588727643|FG004|Overall Study|Progression|1|||
163006700|NCT00070564|588727644|FG005|Overall Study|Progression|0|||
163006701|NCT00070564|588727639|FG000|Overall Study|Delinquent|1|||
163006702|NCT00070564|588727640|FG001|Overall Study|Delinquent|4|||
163006703|NCT00070564|588727641|FG002|Overall Study|Delinquent|2|||
163006704|NCT00070564|588727642|FG003|Overall Study|Delinquent|0|||
163006705|NCT00070564|588727643|FG004|Overall Study|Delinquent|0|||
163006706|NCT00070564|588727644|FG005|Overall Study|Delinquent|0|||
162638473|NCT01034462|587392507|FG000|Overall Study|Adverse Event|7|||
162638474|NCT01034462|587392508|FG001|Overall Study|Adverse Event|17|||
163006707|NCT00070564|588727639|FG000|Overall Study|Adverse Event|150|||
163006708|NCT00070564|588727640|FG001|Overall Study|Adverse Event|142|||
163006709|NCT00070564|588727641|FG002|Overall Study|Adverse Event|120|||
163006710|NCT00070564|588727642|FG003|Overall Study|Adverse Event|108|||
163006711|NCT00070564|588727643|FG004|Overall Study|Adverse Event|63|||
163006712|NCT00070564|588727644|FG005|Overall Study|Adverse Event|36|||
163006713|NCT00070564|588727639|FG000|Overall Study|Death|4|||
163006714|NCT00070564|588727640|FG001|Overall Study|Death|1|||
163006715|NCT00070564|588727641|FG002|Overall Study|Death|5|||
163006716|NCT00070564|588727642|FG003|Overall Study|Death|3|||
163006717|NCT00070564|588727643|FG004|Overall Study|Death|0|||
163006718|NCT00070564|588727644|FG005|Overall Study|Death|1|||
163006719|NCT00070564|588727639|FG000|Overall Study|Other, not protocol specified|17|||
163006720|NCT00070564|588727640|FG001|Overall Study|Other, not protocol specified|15|||
163006721|NCT00070564|588727641|FG002|Overall Study|Other, not protocol specified|14|||
163006722|NCT00070564|588727642|FG003|Overall Study|Other, not protocol specified|19|||
163006723|NCT00070564|588727643|FG004|Overall Study|Other, not protocol specified|6|||
163006724|NCT00070564|588727644|FG005|Overall Study|Other, not protocol specified|7|||
163006725|NCT00070564|588727639|FG000|Overall Study|Withdrawal by Subject|26|||
163006726|NCT00070564|588727640|FG001|Overall Study|Withdrawal by Subject|37|||
163006727|NCT00070564|588727641|FG002|Overall Study|Withdrawal by Subject|23|||
163006728|NCT00070564|588727642|FG003|Overall Study|Withdrawal by Subject|30|||
163006729|NCT00070564|588727643|FG004|Overall Study|Withdrawal by Subject|8|||
163006730|NCT00070564|588727644|FG005|Overall Study|Withdrawal by Subject|8|||
163006731|NCT00070564|588727639|FG000|Overall Study|Not reported|0|||
163006732|NCT00070564|588727640|FG001|Overall Study|Not reported|0|||
163006733|NCT00070564|588727641|FG002|Overall Study|Not reported|0|||
163006734|NCT00070564|588727642|FG003|Overall Study|Not reported|0|||
163006735|NCT00070564|588727643|FG004|Overall Study|Not reported|1|||
163006736|NCT00070564|588727644|FG005|Overall Study|Not reported|0|||
163006737|NCT04023396|588727645|FG000|Overall Study|Adverse Event|16|||
163006738|NCT04023396|588727645|FG000|Overall Study|Death|1|||
163006739|NCT04023396|588727645|FG000|Overall Study|Lost to Follow-up|1|||
163006740|NCT04023396|588727645|FG000|Overall Study|Withdrawal by Subject|14|||
163006741|NCT04023396|588727645|FG000|Overall Study|Pregnancy|4|||
163006742|NCT04023396|588727645|FG000|Overall Study|Lack of Efficacy|3|||
163006743|NCT04023396|588727645|FG000|Overall Study|Physician Decision|4|||
163006744|NCT04023396|588727645|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
163006745|NCT02325973|588727648|FG000|Overall Study|Death|5|||
163006746|NCT02325973|588727648|FG000|Overall Study|Withdrawal by subject or investigator|16|||
163006747|NCT04075825|588727649|FG000|Overall Study|Withdrawal by Subject|6|||
163006748|NCT04075825|588727650|FG001|Overall Study|Withdrawal by Subject|8|||
163006749|NCT04075825|588727649|FG000|Overall Study|Physician Decision|3|||
163006750|NCT04075825|588727650|FG001|Overall Study|Physician Decision|1|||
163006751|NCT04075825|588727649|FG000|Overall Study|Lost to Follow-up|5|||
163006752|NCT04075825|588727650|FG001|Overall Study|Lost to Follow-up|1|||
163006753|NCT04075825|588727649|FG000|Overall Study|Participation in New Clinical Trial|1|||
163006754|NCT04075825|588727650|FG001|Overall Study|Participation in New Clinical Trial|1|||
163006755|NCT04075825|588727649|FG000|Overall Study|Reason Not Specified|2|||
163006756|NCT04075825|588727650|FG001|Overall Study|Reason Not Specified|2|||
163006757|NCT01168232|588727651|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
163006758|NCT01168232|588727651|FG000|Overall Study|Ineligible- Wrong cell type|6|||
163006759|NCT01168232|588727651|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
163006760|NCT03879135|588727658|FG000|Overall Study|Physician Decision|0|||
163006761|NCT03879135|588727659|FG001|Overall Study|Physician Decision|0|||
163006762|NCT03879135|588727660|FG002|Overall Study|Physician Decision|0|||
163006763|NCT03879135|588727661|FG003|Overall Study|Physician Decision|1|||
163006764|NCT03879135|588727662|FG004|Overall Study|Physician Decision|0|||
163006765|NCT03879135|588727663|FG005|Overall Study|Physician Decision|0|||
163006766|NCT03879135|588727658|FG000|Overall Study|Withdrawal by Subject|0|||
163006767|NCT03879135|588727659|FG001|Overall Study|Withdrawal by Subject|0|||
163006768|NCT03879135|588727660|FG002|Overall Study|Withdrawal by Subject|0|||
163006769|NCT03879135|588727661|FG003|Overall Study|Withdrawal by Subject|0|||
163006770|NCT03879135|588727662|FG004|Overall Study|Withdrawal by Subject|0|||
163006771|NCT03879135|588727663|FG005|Overall Study|Withdrawal by Subject|1|||
163006772|NCT03879135|588727658|FG000|Overall Study|Site Closed by Sponsor|0|||
163006773|NCT03879135|588727659|FG001|Overall Study|Site Closed by Sponsor|0|||
163006774|NCT03879135|588727660|FG002|Overall Study|Site Closed by Sponsor|0|||
163061391|NCT00284856|588933112|FG000|Overall Study|Adverse Event|3|||
163061392|NCT00284856|588933113|FG001|Overall Study|Adverse Event|3|||
163061393|NCT00284856|588933114|FG002|Overall Study|Adverse Event|3|||
162638475|NCT01034462|587392507|FG000|Overall Study|Lack of Efficacy|4|||
162638476|NCT01034462|587392508|FG001|Overall Study|Lack of Efficacy|4|||
163006775|NCT03879135|588727661|FG003|Overall Study|Site Closed by Sponsor|1|||
163006776|NCT03879135|588727662|FG004|Overall Study|Site Closed by Sponsor|1|||
162638477|NCT01034462|587392507|FG000|Overall Study|Protocol Violation|10|||
163006777|NCT03879135|588727663|FG005|Overall Study|Site Closed by Sponsor|0|||
163006778|NCT05201794|588727664|FG000|Overall Study|Withdrawal by Subject|13|||
163006779|NCT05201794|588727665|FG001|Overall Study|Withdrawal by Subject|12|||
163006780|NCT05201794|588727666|FG002|Overall Study|Withdrawal by Subject|14|||
163006781|NCT05201794|588727667|FG003|Overall Study|Withdrawal by Subject|0|||
163006782|NCT05201794|588727664|FG000|Overall Study|Adverse Event|5|||
163006783|NCT05201794|588727665|FG001|Overall Study|Adverse Event|5|||
163006784|NCT05201794|588727666|FG002|Overall Study|Adverse Event|4|||
163006785|NCT05201794|588727667|FG003|Overall Study|Adverse Event|0|||
163061394|NCT00284856|588933112|FG000|Overall Study|Lack of Efficacy|2|||
163006786|NCT05201794|588727664|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
163006787|NCT05201794|588727665|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163006788|NCT05201794|588727666|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
163006789|NCT05201794|588727667|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163006790|NCT05201794|588727664|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163006791|NCT05201794|588727665|FG001|Overall Study|Non-Compliance With Study Drug|3|||
163006792|NCT05201794|588727666|FG002|Overall Study|Non-Compliance With Study Drug|3|||
163006793|NCT05201794|588727667|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163006794|NCT05201794|588727664|FG000|Overall Study|Physician Decision|1|||
163006795|NCT05201794|588727665|FG001|Overall Study|Physician Decision|3|||
163006796|NCT05201794|588727666|FG002|Overall Study|Physician Decision|2|||
163006797|NCT05201794|588727667|FG003|Overall Study|Physician Decision|0|||
163006798|NCT05201794|588727664|FG000|Overall Study|Lost to Follow-up|2|||
163006799|NCT05201794|588727665|FG001|Overall Study|Lost to Follow-up|2|||
163006800|NCT05201794|588727666|FG002|Overall Study|Lost to Follow-up|0|||
163006801|NCT05201794|588727667|FG003|Overall Study|Lost to Follow-up|0|||
163006802|NCT05201794|588727664|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
163006803|NCT05201794|588727665|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
163006804|NCT05201794|588727666|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
163006805|NCT05201794|588727667|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
163006806|NCT05201794|588727664|FG000|Overall Study|Protocol Violation|2|||
163006807|NCT05201794|588727665|FG001|Overall Study|Protocol Violation|0|||
163006808|NCT05201794|588727666|FG002|Overall Study|Protocol Violation|1|||
163006809|NCT05201794|588727667|FG003|Overall Study|Protocol Violation|0|||
163006810|NCT05201794|588727664|FG000|Overall Study|Death|1|||
163006811|NCT05201794|588727665|FG001|Overall Study|Death|0|||
163006812|NCT05201794|588727666|FG002|Overall Study|Death|0|||
163006813|NCT05201794|588727667|FG003|Overall Study|Death|0|||
163006814|NCT05201794|588727664|FG000|Overall Study|Site Terminated By Sponsor|0|||
163006815|NCT05201794|588727665|FG001|Overall Study|Site Terminated By Sponsor|1|||
163006816|NCT05201794|588727666|FG002|Overall Study|Site Terminated By Sponsor|0|||
163006817|NCT05201794|588727667|FG003|Overall Study|Site Terminated By Sponsor|0|||
163006818|NCT05201794|588727664|FG000|Overall Study|Other|3|||
163006819|NCT05201794|588727665|FG001|Overall Study|Other|3|||
163006820|NCT05201794|588727666|FG002|Overall Study|Other|3|||
163006821|NCT05201794|588727667|FG003|Overall Study|Other|0|||
163006822|NCT05201794|588727664|FG000|Overall Study|Randomized But Not Treated|1|||
163006823|NCT05201794|588727665|FG001|Overall Study|Randomized But Not Treated|2|||
163006824|NCT05201794|588727666|FG002|Overall Study|Randomized But Not Treated|1|||
163006825|NCT05201794|588727667|FG003|Overall Study|Randomized But Not Treated|0|||
163006826|NCT03428958|588727668|FG000|Overall Study|Adverse Event|0|||
163006827|NCT03428958|588727669|FG001|Overall Study|Adverse Event|0|||
163006828|NCT03428958|588727670|FG002|Overall Study|Adverse Event|0|||
163006829|NCT03428958|588727671|FG003|Overall Study|Adverse Event|1|||
163006830|NCT03428958|588727672|FG004|Overall Study|Adverse Event|0|||
162638478|NCT01034462|587392508|FG001|Overall Study|Protocol Violation|7|||
163006831|NCT03428958|588727673|FG005|Overall Study|Adverse Event|2|||
163006832|NCT03428958|588727674|FG006|Overall Study|Adverse Event|1|||
163006833|NCT03428958|588727675|FG007|Overall Study|Adverse Event|0|||
163006834|NCT03428958|588727676|FG008|Overall Study|Adverse Event|0|||
163006835|NCT03428958|588727677|FG009|Overall Study|Adverse Event|0|||
163006836|NCT03428958|588727678|FG010|Overall Study|Adverse Event|0|||
163006837|NCT03428958|588727679|FG011|Overall Study|Adverse Event|0|||
163006838|NCT03428958|588727680|FG012|Overall Study|Adverse Event|0|||
163006839|NCT03428958|588727681|FG013|Overall Study|Adverse Event|0|||
163006840|NCT03428958|588727682|FG014|Overall Study|Adverse Event|0|||
163061395|NCT00284856|588933113|FG001|Overall Study|Lack of Efficacy|1|||
163061396|NCT00284856|588933114|FG002|Overall Study|Lack of Efficacy|8|||
162638479|NCT01034462|587392507|FG000|Overall Study|Withdrawal by Subject|9|||
162638480|NCT01034462|587392508|FG001|Overall Study|Withdrawal by Subject|8|||
163006841|NCT03428958|588727683|FG015|Overall Study|Adverse Event|0|||
163006842|NCT03428958|588727684|FG016|Overall Study|Adverse Event|0|||
163006843|NCT03428958|588727668|FG000|Overall Study|Clinical Progression|2|||
163006844|NCT03428958|588727669|FG001|Overall Study|Clinical Progression|3|||
163006845|NCT03428958|588727670|FG002|Overall Study|Clinical Progression|2|||
163006846|NCT03428958|588727671|FG003|Overall Study|Clinical Progression|1|||
163006847|NCT03428958|588727672|FG004|Overall Study|Clinical Progression|0|||
163006848|NCT03428958|588727673|FG005|Overall Study|Clinical Progression|2|||
163006849|NCT03428958|588727674|FG006|Overall Study|Clinical Progression|0|||
163006850|NCT03428958|588727675|FG007|Overall Study|Clinical Progression|0|||
163006851|NCT03428958|588727676|FG008|Overall Study|Clinical Progression|0|||
163006852|NCT03428958|588727677|FG009|Overall Study|Clinical Progression|0|||
162638481|NCT01034462|587392507|FG000|Overall Study|Lost to Follow-up|14|||
163006853|NCT03428958|588727678|FG010|Overall Study|Clinical Progression|0|||
163006854|NCT03428958|588727679|FG011|Overall Study|Clinical Progression|0|||
162638482|NCT01034462|587392508|FG001|Overall Study|Lost to Follow-up|16|||
163006855|NCT03428958|588727680|FG012|Overall Study|Clinical Progression|0|||
163061397|NCT00284856|588933112|FG000|Overall Study|Lost to Follow-up|25|||
163006856|NCT03428958|588727681|FG013|Overall Study|Clinical Progression|0|||
163006857|NCT03428958|588727682|FG014|Overall Study|Clinical Progression|0|||
163006858|NCT03428958|588727683|FG015|Overall Study|Clinical Progression|0|||
163006859|NCT03428958|588727684|FG016|Overall Study|Clinical Progression|0|||
163006860|NCT03428958|588727668|FG000|Overall Study|Progression per RECIST|6|||
163006861|NCT03428958|588727669|FG001|Overall Study|Progression per RECIST|6|||
163006862|NCT03428958|588727670|FG002|Overall Study|Progression per RECIST|7|||
163006863|NCT03428958|588727671|FG003|Overall Study|Progression per RECIST|4|||
163006864|NCT03428958|588727672|FG004|Overall Study|Progression per RECIST|0|||
163006865|NCT03428958|588727673|FG005|Overall Study|Progression per RECIST|7|||
163006866|NCT03428958|588727674|FG006|Overall Study|Progression per RECIST|8|||
163006867|NCT03428958|588727675|FG007|Overall Study|Progression per RECIST|0|||
163006868|NCT03428958|588727676|FG008|Overall Study|Progression per RECIST|0|||
163006869|NCT03428958|588727677|FG009|Overall Study|Progression per RECIST|0|||
163006870|NCT03428958|588727678|FG010|Overall Study|Progression per RECIST|0|||
163006871|NCT03428958|588727679|FG011|Overall Study|Progression per RECIST|0|||
163006872|NCT03428958|588727680|FG012|Overall Study|Progression per RECIST|1|||
163006873|NCT03428958|588727681|FG013|Overall Study|Progression per RECIST|0|||
163006874|NCT03428958|588727682|FG014|Overall Study|Progression per RECIST|0|||
163006875|NCT03428958|588727683|FG015|Overall Study|Progression per RECIST|0|||
163006876|NCT03428958|588727684|FG016|Overall Study|Progression per RECIST|0|||
163006877|NCT03428958|588727668|FG000|Overall Study|Death|2|||
163006878|NCT03428958|588727669|FG001|Overall Study|Death|2|||
163006879|NCT03428958|588727670|FG002|Overall Study|Death|0|||
163006880|NCT03428958|588727671|FG003|Overall Study|Death|0|||
163006881|NCT03428958|588727672|FG004|Overall Study|Death|0|||
163006882|NCT03428958|588727673|FG005|Overall Study|Death|7|||
163006883|NCT03428958|588727674|FG006|Overall Study|Death|9|||
163006884|NCT03428958|588727675|FG007|Overall Study|Death|6|||
163006885|NCT03428958|588727676|FG008|Overall Study|Death|0|||
163006886|NCT03428958|588727677|FG009|Overall Study|Death|0|||
163006887|NCT03428958|588727678|FG010|Overall Study|Death|3|||
163006888|NCT03428958|588727679|FG011|Overall Study|Death|0|||
163006889|NCT03428958|588727680|FG012|Overall Study|Death|4|||
163006890|NCT03428958|588727681|FG013|Overall Study|Death|0|||
163006891|NCT03428958|588727682|FG014|Overall Study|Death|0|||
163006892|NCT03428958|588727683|FG015|Overall Study|Death|0|||
163006893|NCT03428958|588727684|FG016|Overall Study|Death|0|||
163006894|NCT03428958|588727668|FG000|Overall Study|Lost to Follow-up|0|||
163006895|NCT03428958|588727669|FG001|Overall Study|Lost to Follow-up|0|||
163006896|NCT03428958|588727670|FG002|Overall Study|Lost to Follow-up|0|||
163006897|NCT03428958|588727671|FG003|Overall Study|Lost to Follow-up|0|||
163006898|NCT03428958|588727672|FG004|Overall Study|Lost to Follow-up|0|||
163006899|NCT03428958|588727673|FG005|Overall Study|Lost to Follow-up|1|||
163006900|NCT03428958|588727674|FG006|Overall Study|Lost to Follow-up|1|||
163006901|NCT03428958|588727675|FG007|Overall Study|Lost to Follow-up|0|||
163006902|NCT03428958|588727676|FG008|Overall Study|Lost to Follow-up|0|||
163006903|NCT03428958|588727677|FG009|Overall Study|Lost to Follow-up|0|||
163006904|NCT03428958|588727678|FG010|Overall Study|Lost to Follow-up|0|||
163006905|NCT03428958|588727679|FG011|Overall Study|Lost to Follow-up|0|||
163006906|NCT03428958|588727680|FG012|Overall Study|Lost to Follow-up|0|||
163006907|NCT03428958|588727681|FG013|Overall Study|Lost to Follow-up|0|||
163006908|NCT03428958|588727682|FG014|Overall Study|Lost to Follow-up|0|||
163006909|NCT03428958|588727683|FG015|Overall Study|Lost to Follow-up|0|||
163006910|NCT03428958|588727684|FG016|Overall Study|Lost to Follow-up|0|||
163006911|NCT03428958|588727668|FG000|Overall Study|Physician/Sponsor Decision|1|||
163006912|NCT03428958|588727669|FG001|Overall Study|Physician/Sponsor Decision|0|||
163006913|NCT03428958|588727670|FG002|Overall Study|Physician/Sponsor Decision|1|||
163006914|NCT03428958|588727671|FG003|Overall Study|Physician/Sponsor Decision|0|||
163006915|NCT03428958|588727672|FG004|Overall Study|Physician/Sponsor Decision|0|||
163006916|NCT03428958|588727673|FG005|Overall Study|Physician/Sponsor Decision|2|||
163006917|NCT03428958|588727674|FG006|Overall Study|Physician/Sponsor Decision|2|||
163006918|NCT03428958|588727675|FG007|Overall Study|Physician/Sponsor Decision|2|||
163006919|NCT03428958|588727676|FG008|Overall Study|Physician/Sponsor Decision|0|||
163006920|NCT03428958|588727677|FG009|Overall Study|Physician/Sponsor Decision|0|||
163006921|NCT03428958|588727678|FG010|Overall Study|Physician/Sponsor Decision|2|||
163006922|NCT03428958|588727679|FG011|Overall Study|Physician/Sponsor Decision|0|||
163006923|NCT03428958|588727680|FG012|Overall Study|Physician/Sponsor Decision|4|||
163006924|NCT03428958|588727681|FG013|Overall Study|Physician/Sponsor Decision|0|||
163006925|NCT03428958|588727682|FG014|Overall Study|Physician/Sponsor Decision|0|||
163006926|NCT03428958|588727683|FG015|Overall Study|Physician/Sponsor Decision|0|||
163006927|NCT03428958|588727684|FG016|Overall Study|Physician/Sponsor Decision|0|||
163006928|NCT03428958|588727668|FG000|Overall Study|Withdrawal by Subject|0|||
163006929|NCT03428958|588727669|FG001|Overall Study|Withdrawal by Subject|0|||
163006930|NCT03428958|588727670|FG002|Overall Study|Withdrawal by Subject|2|||
163006931|NCT03428958|588727671|FG003|Overall Study|Withdrawal by Subject|0|||
163006932|NCT03428958|588727672|FG004|Overall Study|Withdrawal by Subject|0|||
163006933|NCT03428958|588727673|FG005|Overall Study|Withdrawal by Subject|2|||
163006934|NCT03428958|588727674|FG006|Overall Study|Withdrawal by Subject|4|||
162638483|NCT01034462|587392507|FG000|Overall Study|Other reasons|1|||
163006935|NCT03428958|588727675|FG007|Overall Study|Withdrawal by Subject|1|||
163006936|NCT03428958|588727676|FG008|Overall Study|Withdrawal by Subject|0|||
163006937|NCT03428958|588727677|FG009|Overall Study|Withdrawal by Subject|0|||
163006938|NCT03428958|588727678|FG010|Overall Study|Withdrawal by Subject|0|||
163006939|NCT03428958|588727679|FG011|Overall Study|Withdrawal by Subject|0|||
163006940|NCT03428958|588727680|FG012|Overall Study|Withdrawal by Subject|0|||
163006941|NCT03428958|588727681|FG013|Overall Study|Withdrawal by Subject|0|||
163006942|NCT03428958|588727682|FG014|Overall Study|Withdrawal by Subject|0|||
163006943|NCT03428958|588727683|FG015|Overall Study|Withdrawal by Subject|0|||
163006944|NCT03428958|588727684|FG016|Overall Study|Withdrawal by Subject|0|||
163006945|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
163006946|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
163006947|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
163006948|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
163006949|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163006950|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163006951|NCT03874117|588727685|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
163006952|NCT03874117|588727686|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
163006953|NCT03874117|588727685|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163006954|NCT03874117|588727686|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163006955|NCT01490086|588727688|FG000|Overall Study|Consent withdrawn|4|||
163006956|NCT01490086|588727689|FG001|Overall Study|Consent withdrawn|4|||
163006957|NCT01490086|588727690|FG002|Overall Study|Consent withdrawn|3|||
163006958|NCT01490086|588727691|FG003|Overall Study|Consent withdrawn|0|||
163006959|NCT01490086|588727692|FG004|Overall Study|Consent withdrawn|1|||
163006960|NCT01490086|588727688|FG000|Overall Study|Non-compliance|0|||
163006961|NCT01490086|588727689|FG001|Overall Study|Non-compliance|1|||
163006962|NCT01490086|588727690|FG002|Overall Study|Non-compliance|0|||
163006963|NCT01490086|588727691|FG003|Overall Study|Non-compliance|0|||
163006964|NCT01490086|588727692|FG004|Overall Study|Non-compliance|0|||
163006965|NCT01490086|588727688|FG000|Overall Study|Abnormal laboratory findings|1|||
163006966|NCT01490086|588727689|FG001|Overall Study|Abnormal laboratory findings|0|||
163006967|NCT01490086|588727690|FG002|Overall Study|Abnormal laboratory findings|0|||
163006968|NCT01490086|588727691|FG003|Overall Study|Abnormal laboratory findings|0|||
163006969|NCT01490086|588727692|FG004|Overall Study|Abnormal laboratory findings|0|||
163006970|NCT01490086|588727688|FG000|Overall Study|Lost to Follow-up|0|||
163006971|NCT01490086|588727689|FG001|Overall Study|Lost to Follow-up|0|||
163006972|NCT01490086|588727690|FG002|Overall Study|Lost to Follow-up|0|||
163006973|NCT01490086|588727691|FG003|Overall Study|Lost to Follow-up|0|||
163006974|NCT01490086|588727692|FG004|Overall Study|Lost to Follow-up|1|||
163006975|NCT01490086|588727688|FG000|Overall Study|Physician Decision|3|||
163006976|NCT01490086|588727689|FG001|Overall Study|Physician Decision|4|||
163006977|NCT01490086|588727690|FG002|Overall Study|Physician Decision|2|||
163006978|NCT01490086|588727691|FG003|Overall Study|Physician Decision|3|||
163006979|NCT01490086|588727692|FG004|Overall Study|Physician Decision|1|||
163006980|NCT01490086|588727688|FG000|Overall Study|Adverse Event|0|||
163006981|NCT01490086|588727689|FG001|Overall Study|Adverse Event|0|||
163006982|NCT01490086|588727690|FG002|Overall Study|Adverse Event|1|||
163006983|NCT01490086|588727691|FG003|Overall Study|Adverse Event|2|||
163006984|NCT01490086|588727692|FG004|Overall Study|Adverse Event|0|||
163006985|NCT01490086|588727688|FG000|Overall Study|Lack of Efficacy|0|||
163006986|NCT01490086|588727689|FG001|Overall Study|Lack of Efficacy|3|||
163006987|NCT01490086|588727690|FG002|Overall Study|Lack of Efficacy|1|||
163006988|NCT01490086|588727691|FG003|Overall Study|Lack of Efficacy|0|||
163006989|NCT01490086|588727692|FG004|Overall Study|Lack of Efficacy|8|||
163006990|NCT01490086|588727688|FG000|Overall Study|Worsening of symptoms|0|||
163006991|NCT01490086|588727689|FG001|Overall Study|Worsening of symptoms|1|||
163006992|NCT01490086|588727690|FG002|Overall Study|Worsening of symptoms|0|||
163006993|NCT01490086|588727691|FG003|Overall Study|Worsening of symptoms|1|||
163006994|NCT01490086|588727692|FG004|Overall Study|Worsening of symptoms|0|||
163006995|NCT01490086|588727688|FG000|Overall Study|Subject uncontrollable and abusive|0|||
163061398|NCT00284856|588933113|FG001|Overall Study|Lost to Follow-up|21|||
163061399|NCT00284856|588933114|FG002|Overall Study|Lost to Follow-up|22|||
162638484|NCT01034462|587392508|FG001|Overall Study|Other reasons|2|||
162638485|NCT02169739|587392510|FG000|Overall Study|Lost to Follow-up|0|||
163006996|NCT01490086|588727689|FG001|Overall Study|Subject uncontrollable and abusive|1|||
163006997|NCT01490086|588727690|FG002|Overall Study|Subject uncontrollable and abusive|0|||
163006998|NCT01490086|588727691|FG003|Overall Study|Subject uncontrollable and abusive|0|||
163006999|NCT01490086|588727692|FG004|Overall Study|Subject uncontrollable and abusive|0|||
163007000|NCT01490086|588727688|FG000|Overall Study|Subject left hospital|0|||
163007001|NCT01490086|588727689|FG001|Overall Study|Subject left hospital|1|||
163007002|NCT01490086|588727690|FG002|Overall Study|Subject left hospital|0|||
163007003|NCT01490086|588727691|FG003|Overall Study|Subject left hospital|1|||
163007004|NCT01490086|588727692|FG004|Overall Study|Subject left hospital|0|||
163007005|NCT04510090|588727695|FG000|FE-HS|Withdrawal by Subject|0|||
163007006|NCT04510090|588727696|FG001|FE-HS|Withdrawal by Subject|0|||
163007007|NCT04510090|588727697|FG002|FE-HS|Withdrawal by Subject|0|||
163007008|NCT04510090|588727698|FG003|FE-HS|Withdrawal by Subject|0|||
163007009|NCT04510090|588727699|FG004|FE-HS|Withdrawal by Subject|1|||
163007010|NCT04510090|588727700|FG005|FE-HS|Withdrawal by Subject|0|||
163007011|NCT04510090|588727701|FG006|FE-HS|Withdrawal by Subject|0|||
163007012|NCT04510090|588727702|FG007|FE-HS|Withdrawal by Subject|0|||
163007013|NCT01127256|588727703|FG000|Overall Study|Adverse Event|13|||
163007014|NCT01127256|588727704|FG001|Overall Study|Adverse Event|13|||
163007015|NCT01127256|588727703|FG000|Overall Study|Lack of Efficacy|4|||
163007016|NCT01127256|588727704|FG001|Overall Study|Lack of Efficacy|0|||
163007017|NCT01127256|588727703|FG000|Overall Study|Lost to Follow-up|16|||
163007018|NCT01127256|588727704|FG001|Overall Study|Lost to Follow-up|17|||
163007019|NCT01127256|588727703|FG000|Overall Study|Withdrawal by Subject|5|||
163007020|NCT01127256|588727704|FG001|Overall Study|Withdrawal by Subject|9|||
163007021|NCT01127256|588727703|FG000|Overall Study|Protocol Violation|1|||
163007022|NCT01127256|588727704|FG001|Overall Study|Protocol Violation|0|||
163007023|NCT03657797|588727720|FG000|Overall Study|Lost to Follow-up|0|||
163007024|NCT03657797|588727721|FG001|Overall Study|Lost to Follow-up|1|||
163007025|NCT03657797|588727722|FG002|Overall Study|Lost to Follow-up|1|||
163007026|NCT03657797|588727723|FG003|Overall Study|Lost to Follow-up|0|||
163007027|NCT03657797|588727720|FG000|Overall Study|Physician Decision|0|||
163007028|NCT03657797|588727721|FG001|Overall Study|Physician Decision|1|||
163007029|NCT03657797|588727722|FG002|Overall Study|Physician Decision|0|||
163007030|NCT03657797|588727723|FG003|Overall Study|Physician Decision|0|||
163007031|NCT03657797|588727720|FG000|Overall Study|Withdrawal by Subject|0|||
163007032|NCT03657797|588727721|FG001|Overall Study|Withdrawal by Subject|1|||
163007033|NCT03657797|588727722|FG002|Overall Study|Withdrawal by Subject|2|||
163007034|NCT03657797|588727723|FG003|Overall Study|Withdrawal by Subject|0|||
163007035|NCT03657797|588727720|FG000|Overall Study|Adverse Event|0|||
163007036|NCT03657797|588727721|FG001|Overall Study|Adverse Event|0|||
163007037|NCT03657797|588727722|FG002|Overall Study|Adverse Event|2|||
163007038|NCT03657797|588727723|FG003|Overall Study|Adverse Event|0|||
163007039|NCT00711243|588727724|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
163007040|NCT00711243|588727725|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
163007041|NCT00711243|588727726|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
163007042|NCT00711243|588727727|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
163007043|NCT00711243|588727728|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
163007044|NCT00711243|588727729|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
163007045|NCT00711243|588727724|FG000|Reached First Response/4 Cycles|Death|0|||
163007046|NCT00711243|588727725|FG001|Reached First Response/4 Cycles|Death|0|||
163007047|NCT00711243|588727726|FG002|Reached First Response/4 Cycles|Death|0|||
163007048|NCT00711243|588727727|FG003|Reached First Response/4 Cycles|Death|0|||
163007049|NCT00711243|588727728|FG004|Reached First Response/4 Cycles|Death|0|||
163007050|NCT00711243|588727729|FG005|Reached First Response/4 Cycles|Death|2|||
163007051|NCT00711243|588727724|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
163007052|NCT00711243|588727725|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
163007053|NCT00711243|588727726|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
163007054|NCT00711243|588727727|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
163007055|NCT00711243|588727728|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
163007056|NCT00711243|588727729|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
163007057|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
163007058|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
163007059|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
163007060|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
163007061|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
163007062|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
163007063|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Death|0|||
163007064|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Death|0|||
163007065|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Death|0|||
163007066|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Death|0|||
163007067|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Death|0|||
163007068|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Death|2|||
163007069|NCT00711243|588727724|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007070|NCT00711243|588727725|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007071|NCT00711243|588727726|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007072|NCT00711243|588727727|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007073|NCT00711243|588727728|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
163007074|NCT00711243|588727729|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
163007075|NCT00711243|588727724|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007076|NCT00711243|588727725|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007077|NCT00711243|588727726|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007078|NCT00711243|588727727|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007079|NCT00711243|588727728|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
163007080|NCT00711243|588727729|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
163007081|NCT01402570|588727730|FG000|Overall Study|Adverse Event|1|||
163007082|NCT03642262|588727733|FG000|Period 1|Withdrawal by Subject|1|||
163007083|NCT03642262|588727734|FG001|Period 1|Withdrawal by Subject|1|||
163007084|NCT03642262|588727733|FG000|Period 1|Adverse Event|0|||
163007085|NCT03642262|588727734|FG001|Period 1|Adverse Event|1|||
163007086|NCT02572570|588727735|FG000|Overall Study|Study Terminated|27|||
163007087|NCT02019472|588727736|FG000|Overall Study|Adverse Event|14|||
163007088|NCT02019472|588727737|FG001|Overall Study|Adverse Event|23|||
163007089|NCT02019472|588727738|FG002|Overall Study|Adverse Event|17|||
163007090|NCT02019472|588727736|FG000|Overall Study|Death|0|||
163007091|NCT02019472|588727737|FG001|Overall Study|Death|1|||
163007092|NCT02019472|588727738|FG002|Overall Study|Death|1|||
163007093|NCT02019472|588727736|FG000|Overall Study|Lack of Efficacy|7|||
163007094|NCT02019472|588727737|FG001|Overall Study|Lack of Efficacy|4|||
163007095|NCT02019472|588727738|FG002|Overall Study|Lack of Efficacy|4|||
163007096|NCT02019472|588727736|FG000|Overall Study|Lost to Follow-up|0|||
163007097|NCT02019472|588727737|FG001|Overall Study|Lost to Follow-up|2|||
163007098|NCT02019472|588727738|FG002|Overall Study|Lost to Follow-up|1|||
163007099|NCT02019472|588727736|FG000|Overall Study|Physician Decision|1|||
163007100|NCT02019472|588727737|FG001|Overall Study|Physician Decision|2|||
163007101|NCT02019472|588727738|FG002|Overall Study|Physician Decision|0|||
163007102|NCT02019472|588727736|FG000|Overall Study|Pregnancy|1|||
163007103|NCT02019472|588727737|FG001|Overall Study|Pregnancy|2|||
163007104|NCT02019472|588727738|FG002|Overall Study|Pregnancy|2|||
163007105|NCT02019472|588727736|FG000|Overall Study|Withdrawal by Subject|11|||
163007106|NCT02019472|588727737|FG001|Overall Study|Withdrawal by Subject|10|||
163007107|NCT02019472|588727738|FG002|Overall Study|Withdrawal by Subject|11|||
163007108|NCT02019472|588727736|FG000|Overall Study|Other|3|||
163007109|NCT02019472|588727737|FG001|Overall Study|Other|8|||
163007110|NCT02019472|588727738|FG002|Overall Study|Other|6|||
163007111|NCT00513695|588727739|FG000|Overall Study|Discontinued therapy|2|||
163007112|NCT00513695|588727739|FG000|Overall Study|Progression prior to surgery|3|||
163007113|NCT02157935|588727742|FG000|Overall Study|Withdrawal by Subject|25|||
163007114|NCT02157935|588727743|FG001|Overall Study|Withdrawal by Subject|39|||
163007115|NCT02157935|588727742|FG000|Overall Study|Screen failure|1|||
163007116|NCT02157935|588727743|FG001|Overall Study|Screen failure|2|||
163007117|NCT02157935|588727742|FG000|Overall Study|Protocol Violation|1|||
163007118|NCT02157935|588727743|FG001|Overall Study|Protocol Violation|0|||
163007119|NCT02157935|588727742|FG000|Overall Study|Progressive disease|0|||
163007120|NCT02157935|588727743|FG001|Overall Study|Progressive disease|2|||
163007121|NCT02157935|588727742|FG000|Overall Study|Other|5|||
163007122|NCT02157935|588727743|FG001|Overall Study|Other|12|||
163007123|NCT02157935|588727742|FG000|Overall Study|Lack of Efficacy|0|||
163007124|NCT02157935|588727743|FG001|Overall Study|Lack of Efficacy|1|||
163007125|NCT02157935|588727742|FG000|Overall Study|Death|4|||
163007126|NCT02157935|588727743|FG001|Overall Study|Death|4|||
163007127|NCT02157935|588727742|FG000|Overall Study|Adverse Event|3|||
163007128|NCT02157935|588727743|FG001|Overall Study|Adverse Event|5|||
163007129|NCT01417156|588727744|FG000|Overall Study|Adverse Event|12|||
163007130|NCT01417156|588727744|FG000|Overall Study|Protocol Violation|2|||
163007131|NCT03192488|588727745|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
163007132|NCT03192488|588727746|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
163007133|NCT03192488|588727747|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
163007134|NCT03192488|588727748|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
163007135|NCT03192488|588727749|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
163007136|NCT03192488|588727750|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
163007137|NCT03192488|588727745|FG000|Third Intervention (d1)|Adverse Event|0|||
163007138|NCT03192488|588727746|FG001|Third Intervention (d1)|Adverse Event|0|||
163007139|NCT03192488|588727747|FG002|Third Intervention (d1)|Adverse Event|0|||
163007140|NCT03192488|588727748|FG003|Third Intervention (d1)|Adverse Event|0|||
163007141|NCT03192488|588727749|FG004|Third Intervention (d1)|Adverse Event|1|||
163007142|NCT03192488|588727750|FG005|Third Intervention (d1)|Adverse Event|0|||
163007143|NCT00611923|588727752|FG000|Overall Study|Withdrawal by Subject|2|||
163007144|NCT00611923|588727753|FG001|Overall Study|Withdrawal by Subject|2|||
163007145|NCT02302833|588727767|FG000|Overall Study|Lost to Follow-up|3|||
163007146|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
163007147|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
163007148|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007149|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007150|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007151|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
163007152|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
163007153|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
163007154|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
163007155|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
163007156|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
163007157|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
163007158|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
163007159|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
163007160|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
163007161|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007162|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007163|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
163007164|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
163007165|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
163007166|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
163007167|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007168|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007169|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
163007170|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
163007171|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
163007172|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
163007173|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007174|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007175|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
163007176|NCT04429503|588727768|FG000|Main Study (Up to Wk 96)|Death|9|||
163007177|NCT04429503|588727769|FG001|Main Study (Up to Wk 96)|Death|18|||
163007178|NCT04429503|588727770|FG002|Main Study (Up to Wk 96)|Death|5|||
163007179|NCT04429503|588727771|FG003|Main Study (Up to Wk 96)|Death|0|||
163007180|NCT04429503|588727772|FG004|Main Study (Up to Wk 96)|Death|0|||
163007181|NCT04429503|588727773|FG005|Main Study (Up to Wk 96)|Death|0|||
163007182|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007183|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007184|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007185|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
163007186|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163061400|NCT00284856|588933112|FG000|Overall Study|Protocol Violation|5|||
163007187|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
163007188|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007189|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007190|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
163007191|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163061401|NCT00284856|588933113|FG001|Overall Study|Protocol Violation|4|||
163007192|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163007193|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
163007194|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007195|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007196|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007197|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
163007198|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
163007199|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
163007200|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007201|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007202|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
163007203|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
163007204|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
163007205|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
163007206|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007207|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007208|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
163007209|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
163007210|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
163007211|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
163007212|NCT04429503|588727768|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007213|NCT04429503|588727769|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007214|NCT04429503|588727770|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
163007215|NCT04429503|588727771|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
163007216|NCT04429503|588727772|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
163007217|NCT04429503|588727773|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
163007218|NCT05516108|588727774|FG000|Overall Study|Time Commitment|3|||
163007219|NCT05516108|588727775|FG001|Overall Study|Time Commitment|1|||
163007220|NCT05516108|588727774|FG000|Overall Study|Reason Unknown|2|||
163007221|NCT05516108|588727775|FG001|Overall Study|Reason Unknown|4|||
163007222|NCT03664232|588727776|FG000|Overall Study|Withdrawal by Subject|0|||
163007223|NCT03664232|588727777|FG001|Overall Study|Withdrawal by Subject|1|||
163007224|NCT03664232|588727778|FG002|Overall Study|Withdrawal by Subject|0|||
163007225|NCT03664232|588727779|FG003|Overall Study|Withdrawal by Subject|1|||
163007226|NCT03664232|588727776|FG000|Overall Study|Adverse Event|0|||
163007227|NCT03664232|588727777|FG001|Overall Study|Adverse Event|0|||
163007228|NCT03664232|588727778|FG002|Overall Study|Adverse Event|1|||
163007229|NCT03664232|588727779|FG003|Overall Study|Adverse Event|0|||
163007230|NCT03664232|588727776|FG000|Overall Study|Other-Non-compliance with study drug|0|||
163007231|NCT03664232|588727777|FG001|Overall Study|Other-Non-compliance with study drug|1|||
163007232|NCT03664232|588727778|FG002|Overall Study|Other-Non-compliance with study drug|0|||
163007233|NCT03664232|588727779|FG003|Overall Study|Other-Non-compliance with study drug|2|||
163007234|NCT03664232|588727776|FG000|Overall Study|Other-Unspecified|0|||
163007235|NCT03664232|588727777|FG001|Overall Study|Other-Unspecified|3|||
163007236|NCT03664232|588727778|FG002|Overall Study|Other-Unspecified|0|||
163007237|NCT03664232|588727779|FG003|Overall Study|Other-Unspecified|1|||
163007238|NCT03664232|588727776|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007239|NCT03664232|588727777|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007240|NCT03664232|588727778|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
163007241|NCT03664232|588727779|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
163007242|NCT02717507|588727780|FG000|Overall Study|Lost to Follow-up|5|||
163007243|NCT02717507|588727781|FG001|Overall Study|Lost to Follow-up|8|||
163007244|NCT02717507|588727780|FG000|Overall Study|Pregnancy|1|||
163007245|NCT02717507|588727781|FG001|Overall Study|Pregnancy|1|||
163007246|NCT02717507|588727780|FG000|Overall Study|Protocol Violation|2|||
163007247|NCT02717507|588727781|FG001|Overall Study|Protocol Violation|2|||
163007248|NCT02717507|588727780|FG000|Overall Study|Withdrawal by Subject|20|||
163007249|NCT02717507|588727781|FG001|Overall Study|Withdrawal by Subject|20|||
163007250|NCT02717507|588727780|FG000|Overall Study|Relapse|1|||
163007251|NCT02717507|588727781|FG001|Overall Study|Relapse|1|||
163007252|NCT02717507|588727780|FG000|Overall Study|Cardiac Event|2|||
163007253|NCT02717507|588727781|FG001|Overall Study|Cardiac Event|6|||
163007254|NCT05017246|588727782|FG000|Overall Study|Withdrawal by Subject|5|||
163007255|NCT05017246|588727783|FG001|Overall Study|Withdrawal by Subject|3|||
163007256|NCT05017246|588727782|FG000|Overall Study|Determined to be ineligible|0|||
163061402|NCT00284856|588933114|FG002|Overall Study|Protocol Violation|5|||
163007257|NCT05017246|588727783|FG001|Overall Study|Determined to be ineligible|1|||
163007258|NCT05017246|588727782|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
163007259|NCT05017246|588727783|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
163007260|NCT05017246|588727782|FG000|Overall Study|Technical failure|1|||
163007261|NCT05017246|588727783|FG001|Overall Study|Technical failure|3|||
162638486|NCT02169739|587392511|FG001|Overall Study|Lost to Follow-up|4|||
162638487|NCT00723892|587392514|FG000|Overall Study|Participant not tracked|33|||
162638488|NCT00723892|587392515|FG001|Overall Study|Participant not tracked|35|||
162638489|NCT00723892|587392514|FG000|Overall Study|Virological criterion|24|||
162638490|NCT00723892|587392515|FG001|Overall Study|Virological criterion|9|||
162638491|NCT00723892|587392514|FG000|Overall Study|Withdrawal by Subject|6|||
162638492|NCT00723892|587392515|FG001|Overall Study|Withdrawal by Subject|9|||
162638493|NCT00723892|587392514|FG000|Overall Study|End planned|11|||
162638494|NCT00723892|587392515|FG001|Overall Study|End planned|7|||
162638495|NCT00723892|587392514|FG000|Overall Study|Bad tolerance|5|||
162638496|NCT00723892|587392515|FG001|Overall Study|Bad tolerance|5|||
162638497|NCT00723892|587392514|FG000|Overall Study|Multiple reasons|17|||
162638498|NCT00723892|587392515|FG001|Overall Study|Multiple reasons|12|||
162638499|NCT00723892|587392514|FG000|Overall Study|Other|6|||
162638500|NCT00723892|587392515|FG001|Overall Study|Other|3|||
162638501|NCT00723892|587392514|FG000|Overall Study|Study end|1|||
162638502|NCT00723892|587392515|FG001|Overall Study|Study end|3|||
163007262|NCT02493660|588727784|FG000|Overall Study|Physician Decision|0|||
163007263|NCT02493660|588727785|FG001|Overall Study|Physician Decision|1|||
163007264|NCT02493660|588727784|FG000|Overall Study|Adverse Event|4|||
163007265|NCT02493660|588727785|FG001|Overall Study|Adverse Event|2|||
163007266|NCT02493660|588727784|FG000|Overall Study|Withdrawal by Subject|2|||
163007267|NCT02493660|588727785|FG001|Overall Study|Withdrawal by Subject|3|||
163007268|NCT02493660|588727784|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
163007269|NCT02493660|588727785|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
163007270|NCT02493660|588727784|FG000|Overall Study|Protocol Violation|0|||
163007271|NCT02493660|588727785|FG001|Overall Study|Protocol Violation|1|||
163007272|NCT02493660|588727784|FG000|Overall Study|Death|0|||
163007273|NCT02493660|588727785|FG001|Overall Study|Death|1|||
163007274|NCT02493660|588727784|FG000|Overall Study|Lost to Follow-up|2|||
163007275|NCT02493660|588727785|FG001|Overall Study|Lost to Follow-up|4|||
163007276|NCT00709995|588727788|FG000|Overall Study|Adverse Event|4|||
163007277|NCT00709995|588727789|FG001|Overall Study|Adverse Event|2|||
163007278|NCT00709995|588727788|FG000|Overall Study|Withdrawal by Subject|1|||
163007279|NCT00709995|588727789|FG001|Overall Study|Withdrawal by Subject|3|||
163007280|NCT00638508|588727790|FG000|Overall Study|Physician Decision|5|||
163007281|NCT00638508|588727791|FG001|Overall Study|Physician Decision|2|||
163007282|NCT03500198|588727792|FG000|Overall Study|Lost to Follow-up|0|||
163007283|NCT03500198|588727793|FG001|Overall Study|Lost to Follow-up|1|||
163007284|NCT00654095|588727794|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
163007285|NCT00654095|588727794|FG000|Overall Study|Elevated triglyceride level (2)|1|||
163007286|NCT00654095|588727794|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
163007287|NCT00654095|588727794|FG000|Overall Study|Adverse Event|11|||
163007288|NCT00654095|588727794|FG000|Overall Study|Withdrawal by Subject|5|||
163007289|NCT00654095|588727794|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
163007290|NCT00654095|588727794|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
163007291|NCT00654095|588727794|FG000|Overall Study|Did not meet inclusion criteria|1|||
163007292|NCT00595621|588727800|FG000|Open Label Run in|Adverse Event|1|||
163007293|NCT00595621|588727801|FG001|Open Label Run in|Adverse Event|0|||
163007294|NCT00595621|588727800|FG000|Open Label Run in|Physician Decision|1|||
163007295|NCT00595621|588727801|FG001|Open Label Run in|Physician Decision|0|||
163007296|NCT00595621|588727800|FG000|Open Label Run in|Withdrawal by Subject|1|||
163007297|NCT00595621|588727801|FG001|Open Label Run in|Withdrawal by Subject|0|||
163007298|NCT00595621|588727800|FG000|Randomization and Study|Adverse Event|2|||
163007299|NCT00595621|588727801|FG001|Randomization and Study|Adverse Event|0|||
163007300|NCT00595621|588727800|FG000|Randomization and Study|Withdrawal by Subject|0|||
163007301|NCT00595621|588727801|FG001|Randomization and Study|Withdrawal by Subject|1|||
163007302|NCT02440464|588727802|FG000|Overall Study|Withdrawal by Subject|3|||
163007303|NCT02440464|588727803|FG001|Overall Study|Withdrawal by Subject|2|||
163007304|NCT00324987|588727804|FG000|Overall Study|Adverse Event|2|||
163007305|NCT00324987|588727805|FG001|Overall Study|Adverse Event|1|||
163007306|NCT00324987|588727804|FG000|Overall Study|Withdrawal by Subject|1|||
163007307|NCT00324987|588727805|FG001|Overall Study|Withdrawal by Subject|1|||
162638503|NCT00723892|587392514|FG000|Overall Study|Weight loss|1|||
162638504|NCT00723892|587392515|FG001|Overall Study|Weight loss|3|||
162638505|NCT00723892|587392514|FG000|Overall Study|Alcohol abuse|0|||
162638506|NCT00723892|587392515|FG001|Overall Study|Alcohol abuse|1|||
163007308|NCT00324987|588727804|FG000|Overall Study|Progression|1|||
163007309|NCT00324987|588727805|FG001|Overall Study|Progression|1|||
163007310|NCT00324987|588727804|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
163007311|NCT00324987|588727805|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
162638507|NCT00723892|587392514|FG000|Overall Study|Intercurrent infection|2|||
162638508|NCT00723892|587392515|FG001|Overall Study|Intercurrent infection|0|||
162638509|NCT00723892|587392514|FG000|Overall Study|Drug addiction|1|||
163007312|NCT02568072|588727807|FG000|Overall Study|Unavailable for appointment|23|||
162638510|NCT00723892|587392515|FG001|Overall Study|Drug addiction|0|||
162638511|NCT03683758|587392516|FG000|Overall Study|Non-study commitment conflict|1|||
163061403|NCT00284856|588933112|FG000|Overall Study|Withdrawal by Subject|12|||
163061404|NCT00284856|588933113|FG001|Overall Study|Withdrawal by Subject|16|||
163061405|NCT00284856|588933114|FG002|Overall Study|Withdrawal by Subject|18|||
163061406|NCT00284856|588933112|FG000|Overall Study|Other|4|||
163061407|NCT00284856|588933113|FG001|Overall Study|Other|5|||
163061408|NCT00284856|588933114|FG002|Overall Study|Other|4|||
163061409|NCT05853120|588933115|FG000|Overall Study|Lost to Follow-up|4|||
163061410|NCT05853120|588933116|FG001|Overall Study|Lost to Follow-up|4|||
163061411|NCT05853120|588933115|FG000|Overall Study|Physician Decision|3|||
162638512|NCT03683758|587392517|FG001|Overall Study|Non-study commitment conflict|3|||
162638513|NCT03683758|587392516|FG000|Overall Study|Illness preventing participation|1|||
162638514|NCT03683758|587392517|FG001|Overall Study|Illness preventing participation|0|||
163007313|NCT02568072|588727807|FG000|Overall Study|Unable to contact|3|||
163007314|NCT02568072|588727807|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
163007315|NCT02568072|588727807|FG000|Overall Study|Withdrawal by Subject|1|||
163007316|NCT02568072|588727807|FG000|Overall Study|Sustained injury, marathon not run|24|||
163007317|NCT05263908|588727808|FG000|Overall Study|No informed consent for publication of study results|397|||
163007318|NCT05263908|588727808|FG000|Overall Study|CRF not collected|1|||
163007319|NCT02714218|588727809|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163007320|NCT02714218|588727810|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163007321|NCT02714218|588727811|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163007322|NCT02714218|588727809|FG000|Pre-Treatment Period|Other reasons|0|||
163007323|NCT02714218|588727810|FG001|Pre-Treatment Period|Other reasons|1|||
163007324|NCT02714218|588727811|FG002|Pre-Treatment Period|Other reasons|0|||
163007325|NCT02714218|588727809|FG000|Treatment Period|Disease Progression|55|||
163007326|NCT02714218|588727810|FG001|Treatment Period|Disease Progression|52|||
163007327|NCT02714218|588727811|FG002|Treatment Period|Disease Progression|14|||
163007328|NCT02714218|588727809|FG000|Treatment Period|Study drug toxicity|46|||
163007329|NCT02714218|588727810|FG001|Treatment Period|Study drug toxicity|70|||
163007330|NCT02714218|588727811|FG002|Treatment Period|Study drug toxicity|6|||
163007331|NCT02714218|588727809|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
163007332|NCT02714218|588727810|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
163007333|NCT02714218|588727811|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
163007334|NCT02714218|588727809|FG000|Treatment Period|Request to discontinue treatment|1|||
163007335|NCT02714218|588727810|FG001|Treatment Period|Request to discontinue treatment|4|||
163007336|NCT02714218|588727811|FG002|Treatment Period|Request to discontinue treatment|1|||
163007337|NCT02714218|588727809|FG000|Treatment Period|Participant withdrew consent|2|||
163007338|NCT02714218|588727810|FG001|Treatment Period|Participant withdrew consent|2|||
163007339|NCT02714218|588727811|FG002|Treatment Period|Participant withdrew consent|0|||
163007340|NCT02714218|588727809|FG000|Treatment Period|Maximum clinical benefit|4|||
163007341|NCT02714218|588727810|FG001|Treatment Period|Maximum clinical benefit|2|||
163007342|NCT02714218|588727811|FG002|Treatment Period|Maximum clinical benefit|0|||
163007343|NCT02714218|588727809|FG000|Treatment Period|Administrative reason by sponsor|2|||
163007344|NCT02714218|588727810|FG001|Treatment Period|Administrative reason by sponsor|1|||
163007345|NCT02714218|588727811|FG002|Treatment Period|Administrative reason by sponsor|0|||
163007346|NCT02714218|588727809|FG000|Treatment Period|Other reasons|6|||
163007347|NCT02714218|588727810|FG001|Treatment Period|Other reasons|6|||
163007348|NCT02714218|588727811|FG002|Treatment Period|Other reasons|0|||
163007349|NCT02714218|588727809|FG000|Treatment Period|Completed treatment as per protocol|36|||
163007350|NCT02714218|588727810|FG001|Treatment Period|Completed treatment as per protocol|27|||
163007351|NCT02714218|588727811|FG002|Treatment Period|Completed treatment as per protocol|3|||
163007352|NCT02714218|588727809|FG000|Treatment Period|Not reported|9|||
163007353|NCT02714218|588727810|FG001|Treatment Period|Not reported|6|||
163007354|NCT02714218|588727811|FG002|Treatment Period|Not reported|0|||
163007355|NCT00840749|588727814|FG000|Overall Study|Death|1|||
162638515|NCT03683758|587392516|FG000|Overall Study|Adverse Event|1|||
162638516|NCT03683758|587392517|FG001|Overall Study|Adverse Event|0|||
163007356|NCT00840749|588727815|FG001|Overall Study|Death|2|||
163007357|NCT00840749|588727814|FG000|Overall Study|not treated on study arm|11|||
162638517|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
162638518|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
162638519|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
163007358|NCT00840749|588727815|FG001|Overall Study|not treated on study arm|11|||
163007359|NCT00840749|588727814|FG000|Overall Study|study closed|19|||
163007360|NCT00840749|588727815|FG001|Overall Study|study closed|14|||
163007361|NCT01113892|588727820|FG000|Overall Study|Lost to Follow-up|2|||
163007362|NCT01113892|588727821|FG001|Overall Study|Lost to Follow-up|2|||
163007363|NCT01113892|588727820|FG000|Overall Study|Withdrawal by Subject|1|||
163007364|NCT01113892|588727821|FG001|Overall Study|Withdrawal by Subject|1|||
163061412|NCT05853120|588933116|FG001|Overall Study|Physician Decision|0|||
163061413|NCT05853120|588933115|FG000|Overall Study|Withdrawal by Subject|5|||
163061414|NCT05853120|588933116|FG001|Overall Study|Withdrawal by Subject|2|||
163007365|NCT01113892|588727820|FG000|Overall Study|Death|2|||
163007366|NCT01113892|588727821|FG001|Overall Study|Death|4|||
163061415|NCT00790036|588933117|FG000|Overall Study|Abnormal lab values|3|||
163007367|NCT01113892|588727820|FG000|Overall Study|Graft no longer evaluable|9|||
163007368|NCT01113892|588727821|FG001|Overall Study|Graft no longer evaluable|9|||
163007369|NCT00789854|588727824|FG000|Overall Study|Adverse Event|28|||
163007370|NCT00789854|588727825|FG001|Overall Study|Adverse Event|23|||
163007371|NCT00789854|588727826|FG002|Overall Study|Adverse Event|18|||
163007372|NCT00789854|588727824|FG000|Overall Study|Lost to Follow-up|1|||
163007373|NCT00789854|588727825|FG001|Overall Study|Lost to Follow-up|1|||
163007374|NCT00789854|588727826|FG002|Overall Study|Lost to Follow-up|4|||
163007375|NCT00789854|588727824|FG000|Overall Study|Withdrawal by Subject|9|||
163007376|NCT00789854|588727825|FG001|Overall Study|Withdrawal by Subject|6|||
163007377|NCT00789854|588727826|FG002|Overall Study|Withdrawal by Subject|17|||
163007378|NCT00789854|588727824|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163007379|NCT00789854|588727825|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
163007380|NCT00789854|588727826|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
163007381|NCT00789854|588727824|FG000|Overall Study|Severe non-compliance to the protocol|3|||
163007382|NCT00789854|588727825|FG001|Overall Study|Severe non-compliance to the protocol|0|||
163007383|NCT00789854|588727826|FG002|Overall Study|Severe non-compliance to the protocol|0|||
163007384|NCT00789854|588727824|FG000|Overall Study|Safety reasons|0|||
163007385|NCT00789854|588727825|FG001|Overall Study|Safety reasons|0|||
163007386|NCT00789854|588727826|FG002|Overall Study|Safety reasons|2|||
163007387|NCT00789854|588727824|FG000|Overall Study|Other|6|||
163007388|NCT00789854|588727825|FG001|Overall Study|Other|0|||
163007389|NCT00789854|588727826|FG002|Overall Study|Other|5|||
163007390|NCT03473925|588727827|FG000|Overall Study|Death|48|||
163007391|NCT03473925|588727828|FG001|Overall Study|Death|44|||
163007392|NCT03473925|588727827|FG000|Overall Study|Sponsor Decision|2|||
163007393|NCT03473925|588727828|FG001|Overall Study|Sponsor Decision|7|||
163007394|NCT03473925|588727827|FG000|Overall Study|Withdrawal by Subject|1|||
163007395|NCT03473925|588727828|FG001|Overall Study|Withdrawal by Subject|3|||
163007396|NCT03473925|588727827|FG000|Overall Study|Not Treated|1|||
163007397|NCT03473925|588727828|FG001|Overall Study|Not Treated|1|||
163007398|NCT02756611|588727830|FG000|Overall Study|Death|70|||
163007399|NCT02756611|588727830|FG000|Overall Study|Withdrawal by Subject|2|||
163007400|NCT02756611|588727830|FG000|Overall Study|Lost to Follow-up|3|||
163007401|NCT02756611|588727830|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
163007402|NCT02756611|588727830|FG000|Overall Study|Other|10|||
163007403|NCT03125798|588727831|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
163007404|NCT03125798|588727832|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
163007405|NCT03125798|588727831|FG000|Overall Study|Conversion to thoracotomy|7|||
163007406|NCT03125798|588727832|FG001|Overall Study|Conversion to thoracotomy|7|||
163007407|NCT01422213|588727839|FG000|Overall Study|Adverse Event|8|||
163007408|NCT01422213|588727840|FG001|Overall Study|Adverse Event|7|||
163007409|NCT01422213|588727841|FG002|Overall Study|Adverse Event|11|||
163007410|NCT01422213|588727839|FG000|Overall Study|Lack of Efficacy|10|||
163007411|NCT01422213|588727840|FG001|Overall Study|Lack of Efficacy|2|||
163007412|NCT01422213|588727841|FG002|Overall Study|Lack of Efficacy|2|||
163007413|NCT01422213|588727839|FG000|Overall Study|Non-compliance with study drug|0|||
163007414|NCT01422213|588727840|FG001|Overall Study|Non-compliance with study drug|1|||
163007415|NCT01422213|588727841|FG002|Overall Study|Non-compliance with study drug|0|||
163007416|NCT01422213|588727839|FG000|Overall Study|Protocol Violation|0|||
163007417|NCT01422213|588727840|FG001|Overall Study|Protocol Violation|2|||
163007418|NCT01422213|588727841|FG002|Overall Study|Protocol Violation|4|||
163007419|NCT01422213|588727839|FG000|Overall Study|Withdrawal of Consent|7|||
163007420|NCT01422213|588727840|FG001|Overall Study|Withdrawal of Consent|3|||
163007421|NCT01422213|588727841|FG002|Overall Study|Withdrawal of Consent|5|||
163007422|NCT01422213|588727839|FG000|Overall Study|Lost to Follow-up|3|||
163007423|NCT01422213|588727840|FG001|Overall Study|Lost to Follow-up|3|||
163007424|NCT01422213|588727841|FG002|Overall Study|Lost to Follow-up|5|||
163007425|NCT01422213|588727839|FG000|Overall Study|Administrative or Other Reason(s)|5|||
163007426|NCT01422213|588727840|FG001|Overall Study|Administrative or Other Reason(s)|4|||
163007427|NCT01422213|588727841|FG002|Overall Study|Administrative or Other Reason(s)|2|||
163007428|NCT00476190|588727845|FG000|Overall Study|Ineligible|1|||
163007429|NCT00476190|588727846|FG001|Overall Study|Ineligible|1|||
163007430|NCT00476190|588727845|FG000|Overall Study|Induction Death|2|||
163007431|NCT00476190|588727846|FG001|Overall Study|Induction Death|0|||
163007432|NCT00476190|588727845|FG000|Overall Study|Induction Failure|2|||
163007433|NCT00476190|588727846|FG001|Overall Study|Induction Failure|4|||
163007434|NCT00476190|588727845|FG000|Overall Study|Lost to Follow-up|1|||
163007435|NCT00476190|588727846|FG001|Overall Study|Lost to Follow-up|0|||
163007436|NCT00476190|588727845|FG000|Overall Study|Relapse/Progression|5|||
163007437|NCT00476190|588727846|FG001|Overall Study|Relapse/Progression|2|||
163007438|NCT00476190|588727845|FG000|Overall Study|Remission Death|0|||
163007439|NCT00476190|588727846|FG001|Overall Study|Remission Death|1|||
163007440|NCT00476190|588727845|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
163007441|NCT00476190|588727846|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
162638520|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
162638521|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
162638522|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
162638523|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
162638524|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
162638525|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Other|4|||
162638526|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Other|1|||
162638527|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
162638528|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
163007442|NCT00476190|588727845|FG000|Overall Study|Withdrawal by Subject|6|||
163007443|NCT00476190|588727846|FG001|Overall Study|Withdrawal by Subject|2|||
163007444|NCT00476190|588727845|FG000|Overall Study|Other|9|||
163007445|NCT00476190|588727846|FG001|Overall Study|Other|10|||
163007446|NCT04782076|588727847|FG000|Overall Study|Family Emergency|1|||
163007447|NCT04565145|588729988|FG000|Overall Study|Withdrawal by Subject|1|||
163007448|NCT04565145|588729989|FG001|Overall Study|Withdrawal by Subject|1|||
163007449|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
163007450|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
163007451|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
163007452|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
163007453|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
163007454|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
163007455|NCT02547428|588729990|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
163007456|NCT02547428|588729991|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
163007457|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
163007458|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
163007459|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
163007460|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
163007461|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
163007462|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
163007463|NCT02547428|588729990|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
163007464|NCT02547428|588729991|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
163007465|NCT00742209|588730004|FG000|Overall Study|Adverse Event|11|||
163007466|NCT00742209|588730005|FG001|Overall Study|Adverse Event|4|||
163007467|NCT00742209|588730006|FG002|Overall Study|Adverse Event|17|||
163007468|NCT00742209|588730007|FG003|Overall Study|Adverse Event|16|||
163007469|NCT00742209|588730008|FG004|Overall Study|Adverse Event|13|||
163007470|NCT00742209|588730004|FG000|Overall Study|Participant Withdrew Consent|8|||
163007471|NCT00742209|588730005|FG001|Overall Study|Participant Withdrew Consent|4|||
163007472|NCT00742209|588730006|FG002|Overall Study|Participant Withdrew Consent|14|||
163007473|NCT00742209|588730007|FG003|Overall Study|Participant Withdrew Consent|7|||
163007474|NCT00742209|588730008|FG004|Overall Study|Participant Withdrew Consent|4|||
163007475|NCT00742209|588730004|FG000|Overall Study|Protocol Violation|6|||
163061416|NCT00790036|588933118|FG001|Overall Study|Abnormal lab values|2|||
163061417|NCT00790036|588933117|FG000|Overall Study|Administrative problems|5|||
163061418|NCT00790036|588933118|FG001|Overall Study|Administrative problems|9|||
163061419|NCT00790036|588933117|FG000|Overall Study|Adverse Event|113|||
163061420|NCT00790036|588933118|FG001|Overall Study|Adverse Event|44|||
163061421|NCT00790036|588933117|FG000|Overall Study|Death|1|||
163061422|NCT00790036|588933118|FG001|Overall Study|Death|0|||
163061423|NCT00790036|588933117|FG000|Overall Study|Disease progression|24|||
163061424|NCT00790036|588933118|FG001|Overall Study|Disease progression|48|||
163061425|NCT00790036|588933117|FG000|Overall Study|Lost to Follow-up|1|||
162638529|NCT00303498|587392518|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
162638530|NCT00303498|587392519|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
162638531|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
162638532|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
163007476|NCT00742209|588730005|FG001|Overall Study|Protocol Violation|5|||
163007477|NCT00742209|588730006|FG002|Overall Study|Protocol Violation|4|||
163007478|NCT00742209|588730007|FG003|Overall Study|Protocol Violation|5|||
163007479|NCT00742209|588730008|FG004|Overall Study|Protocol Violation|3|||
163007480|NCT00742209|588730004|FG000|Overall Study|Lost to Follow-up|3|||
163007481|NCT00742209|588730005|FG001|Overall Study|Lost to Follow-up|4|||
163007482|NCT00742209|588730006|FG002|Overall Study|Lost to Follow-up|5|||
163007483|NCT00742209|588730007|FG003|Overall Study|Lost to Follow-up|5|||
163007484|NCT00742209|588730008|FG004|Overall Study|Lost to Follow-up|3|||
163061426|NCT00790036|588933118|FG001|Overall Study|Lost to Follow-up|2|||
163061427|NCT00790036|588933117|FG000|Overall Study|Protocol Violation|10|||
163007485|NCT00742209|588730004|FG000|Overall Study|Lack of Efficacy|6|||
163007486|NCT00742209|588730005|FG001|Overall Study|Lack of Efficacy|1|||
163061428|NCT00790036|588933118|FG001|Overall Study|Protocol Violation|2|||
163061429|NCT00790036|588933117|FG000|Overall Study|Withdrawal by Subject|18|||
162638533|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Death|1|||
163007487|NCT00742209|588730006|FG002|Overall Study|Lack of Efficacy|1|||
163007488|NCT00742209|588730007|FG003|Overall Study|Lack of Efficacy|3|||
163007489|NCT00742209|588730008|FG004|Overall Study|Lack of Efficacy|1|||
163007490|NCT00742209|588730004|FG000|Overall Study|Investigator Discretion|0|||
163007491|NCT00742209|588730005|FG001|Overall Study|Investigator Discretion|0|||
163007492|NCT00742209|588730006|FG002|Overall Study|Investigator Discretion|5|||
163007493|NCT00742209|588730007|FG003|Overall Study|Investigator Discretion|1|||
163007494|NCT00742209|588730008|FG004|Overall Study|Investigator Discretion|1|||
163007495|NCT02003209|588730009|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
163007496|NCT02003209|588730010|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
163007497|NCT00485264|588730013|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
163007498|NCT00485264|588730014|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
163007499|NCT00485264|588730015|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
163007500|NCT00485264|588730016|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
163007501|NCT00485264|588730017|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
163007502|NCT00485264|588730018|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
163007503|NCT00485264|588730013|FG000|Overall Study|Death|1|||
163007504|NCT00485264|588730014|FG001|Overall Study|Death|0|||
163007505|NCT00485264|588730015|FG002|Overall Study|Death|0|||
163007506|NCT00485264|588730016|FG003|Overall Study|Death|0|||
163007507|NCT00485264|588730017|FG004|Overall Study|Death|1|||
163007508|NCT00485264|588730018|FG005|Overall Study|Death|0|||
163007509|NCT00485264|588730013|FG000|Overall Study|Adverse Event|1|||
163007510|NCT00485264|588730014|FG001|Overall Study|Adverse Event|0|||
163007511|NCT00485264|588730015|FG002|Overall Study|Adverse Event|2|||
163007512|NCT00485264|588730016|FG003|Overall Study|Adverse Event|3|||
163007513|NCT00485264|588730017|FG004|Overall Study|Adverse Event|1|||
163007514|NCT00485264|588730018|FG005|Overall Study|Adverse Event|3|||
163007515|NCT00485264|588730013|FG000|Overall Study|Pregnancy|4|||
163007516|NCT00485264|588730014|FG001|Overall Study|Pregnancy|0|||
163007517|NCT00485264|588730015|FG002|Overall Study|Pregnancy|0|||
163007518|NCT00485264|588730016|FG003|Overall Study|Pregnancy|0|||
163007519|NCT00485264|588730017|FG004|Overall Study|Pregnancy|0|||
163007520|NCT00485264|588730018|FG005|Overall Study|Pregnancy|0|||
163007521|NCT00485264|588730013|FG000|Overall Study|Disallowed Medication|0|||
163007522|NCT00485264|588730014|FG001|Overall Study|Disallowed Medication|0|||
163007523|NCT00485264|588730015|FG002|Overall Study|Disallowed Medication|0|||
163007524|NCT00485264|588730016|FG003|Overall Study|Disallowed Medication|0|||
163007525|NCT00485264|588730017|FG004|Overall Study|Disallowed Medication|0|||
163007526|NCT00485264|588730018|FG005|Overall Study|Disallowed Medication|1|||
163007527|NCT00485264|588730013|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
163007528|NCT00485264|588730014|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
163007529|NCT00485264|588730015|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
163007530|NCT00485264|588730016|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007531|NCT00485264|588730017|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007532|NCT00485264|588730018|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
163007533|NCT00485264|588730013|FG000|Overall Study|Lack of Efficacy|0|||
163007534|NCT00485264|588730014|FG001|Overall Study|Lack of Efficacy|1|||
163007535|NCT00485264|588730015|FG002|Overall Study|Lack of Efficacy|0|||
163007536|NCT00485264|588730016|FG003|Overall Study|Lack of Efficacy|0|||
163007537|NCT00485264|588730017|FG004|Overall Study|Lack of Efficacy|0|||
163007538|NCT00485264|588730018|FG005|Overall Study|Lack of Efficacy|0|||
163007539|NCT00485264|588730013|FG000|Overall Study|Guardian Consent Withdrawn|1|||
163007540|NCT00485264|588730014|FG001|Overall Study|Guardian Consent Withdrawn|0|||
163007541|NCT00485264|588730015|FG002|Overall Study|Guardian Consent Withdrawn|0|||
163007542|NCT00485264|588730016|FG003|Overall Study|Guardian Consent Withdrawn|0|||
163007543|NCT00485264|588730017|FG004|Overall Study|Guardian Consent Withdrawn|1|||
163007544|NCT00485264|588730018|FG005|Overall Study|Guardian Consent Withdrawn|0|||
163007545|NCT00485264|588730013|FG000|Overall Study|Physician Decision|0|||
163007546|NCT00485264|588730014|FG001|Overall Study|Physician Decision|2|||
163007547|NCT00485264|588730015|FG002|Overall Study|Physician Decision|0|||
163007548|NCT00485264|588730016|FG003|Overall Study|Physician Decision|0|||
163007549|NCT00485264|588730017|FG004|Overall Study|Physician Decision|0|||
163007550|NCT00485264|588730018|FG005|Overall Study|Physician Decision|0|||
163007551|NCT00485264|588730013|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007552|NCT00485264|588730014|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007553|NCT00485264|588730015|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
163007554|NCT00485264|588730016|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007555|NCT00485264|588730017|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007556|NCT00485264|588730018|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
163007557|NCT00485264|588730013|FG000|Overall Study|Not Able to Attend Clinic|5|||
163007558|NCT00485264|588730014|FG001|Overall Study|Not Able to Attend Clinic|0|||
163007559|NCT00485264|588730015|FG002|Overall Study|Not Able to Attend Clinic|0|||
163007560|NCT00485264|588730016|FG003|Overall Study|Not Able to Attend Clinic|1|||
163007561|NCT00485264|588730017|FG004|Overall Study|Not Able to Attend Clinic|1|||
163007562|NCT00485264|588730018|FG005|Overall Study|Not Able to Attend Clinic|2|||
163007563|NCT00485264|588730013|FG000|Overall Study|Non-Compliant|17|||
162638534|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Death|0|||
162638535|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
162638536|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
162638537|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
162638538|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
162638539|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
162638540|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
162638541|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
162638542|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
162638543|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Other|1|||
162638544|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Other|0|||
162638545|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
162638546|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
162638547|NCT00303498|587392518|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
162638548|NCT00303498|587392519|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
162638549|NCT00546637|587392520|FG000|Overall Study|Adverse Event|46|||
162638550|NCT00546637|587392521|FG001|Overall Study|Adverse Event|20|||
162638551|NCT00546637|587392520|FG000|Overall Study|Lack of Efficacy|5|||
162638552|NCT00546637|587392521|FG001|Overall Study|Lack of Efficacy|5|||
162638553|NCT00546637|587392520|FG000|Overall Study|Lost to Follow-up|2|||
162638554|NCT00546637|587392521|FG001|Overall Study|Lost to Follow-up|2|||
162638555|NCT00546637|587392520|FG000|Overall Study|Other|10|||
162638556|NCT00546637|587392521|FG001|Overall Study|Other|12|||
162638557|NCT00546637|587392520|FG000|Overall Study|Withdrawal by Subject|7|||
162638558|NCT00546637|587392521|FG001|Overall Study|Withdrawal by Subject|9|||
162638559|NCT00546637|587392520|FG000|Overall Study|Randomized, but not treated|3|||
162638560|NCT00546637|587392521|FG001|Overall Study|Randomized, but not treated|1|||
162638561|NCT04984993|587392525|FG000|Overall Study|Withdrawal by Subject|8|||
162638562|NCT04984993|587392526|FG001|Overall Study|Withdrawal by Subject|2|||
162638563|NCT04984993|587392525|FG000|Overall Study|Lost to Follow-up|2|||
162638564|NCT04984993|587392526|FG001|Overall Study|Lost to Follow-up|2|||
162638565|NCT04984993|587392525|FG000|Overall Study|Both patients moved to another country|4|||
162638566|NCT04984993|587392526|FG001|Overall Study|Both patients moved to another country|0|||
162638567|NCT01110707|587392527|FG000|Overall Study|Protocol Violation|0|||
162638568|NCT01110707|587392528|FG001|Overall Study|Protocol Violation|3|||
162638569|NCT03108027|587392533|FG000|Period 1|Subject/Guardian Decision|0|||
162638570|NCT03108027|587392534|FG001|Period 1|Subject/Guardian Decision|0|||
162638571|NCT03108027|587392535|FG002|Period 1|Subject/Guardian Decision|0|||
162638572|NCT03108027|587392536|FG003|Period 1|Subject/Guardian Decision|2|||
162638573|NCT03108027|587392537|FG004|Period 1|Subject/Guardian Decision|0|||
162638574|NCT03108027|587392538|FG005|Period 1|Subject/Guardian Decision|0|||
162638575|NCT03108027|587392533|FG000|Period 3|Adverse Event|0|||
162638576|NCT03108027|587392534|FG001|Period 3|Adverse Event|1|||
162638577|NCT03108027|587392535|FG002|Period 3|Adverse Event|0|||
162638578|NCT03108027|587392536|FG003|Period 3|Adverse Event|0|||
162638579|NCT03108027|587392537|FG004|Period 3|Adverse Event|0|||
162638580|NCT03108027|587392538|FG005|Period 3|Adverse Event|0|||
162638581|NCT02426892|587392539|FG000|Overall Study|Adverse Event|2|||
162638582|NCT02426892|587392539|FG000|Overall Study|Lack of Efficacy|17|||
162638583|NCT02426892|587392539|FG000|Overall Study|Withdrawal by Subject|1|||
162638584|NCT03178773|587392540|FG000|Overall Study|Death|0|||
162638585|NCT03178773|587392541|FG001|Overall Study|Death|1|||
162638586|NCT03178773|587392540|FG000|Overall Study|Lost to Follow-up|29|||
162638587|NCT03178773|587392541|FG001|Overall Study|Lost to Follow-up|25|||
162638588|NCT03178773|587392540|FG000|Overall Study|Withdrawal by Subject|10|||
162638589|NCT03178773|587392541|FG001|Overall Study|Withdrawal by Subject|14|||
162638590|NCT01382446|587392542|FG000|Overall Study|Withdrawal by Subject|0|||
162638591|NCT01382446|587392543|FG001|Overall Study|Withdrawal by Subject|1|||
162638592|NCT01382446|587392542|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
162638593|NCT01382446|587392543|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
162638594|NCT00003901|587392544|FG000|Overall Study|Adverse Event|1|||
162638595|NCT00003901|587392544|FG000|Overall Study|Withdrawal by Subject|1|||
162638596|NCT00003901|587392544|FG000|Overall Study|Ineligible|6|||
162638597|NCT00003901|587392544|FG000|Overall Study|CT Scan not within protocol requirement|2|||
162638598|NCT00003901|587392544|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
162638599|NCT00003901|587392544|FG000|Overall Study|Medical problems|6|||
162638600|NCT00268996|587392547|FG000|Overall Study|Adverse Event|11|||
162638601|NCT00268996|587392548|FG001|Overall Study|Adverse Event|7|||
162638602|NCT00268996|587392547|FG000|Overall Study|Lost to Follow-up|3|||
162638603|NCT00268996|587392548|FG001|Overall Study|Lost to Follow-up|1|||
162638604|NCT00268996|587392547|FG000|Overall Study|Withdrawal by Subject|5|||
162638605|NCT00268996|587392548|FG001|Overall Study|Withdrawal by Subject|11|||
162638606|NCT00268996|587392547|FG000|Overall Study|Non-compliance|1|||
162638607|NCT00268996|587392548|FG001|Overall Study|Non-compliance|0|||
162638608|NCT00268996|587392547|FG000|Overall Study|Other|1|||
162638609|NCT00268996|587392548|FG001|Overall Study|Other|1|||
163007564|NCT00485264|588730014|FG001|Overall Study|Non-Compliant|2|||
163007565|NCT00485264|588730015|FG002|Overall Study|Non-Compliant|1|||
163007566|NCT00485264|588730016|FG003|Overall Study|Non-Compliant|0|||
163007567|NCT00485264|588730017|FG004|Overall Study|Non-Compliant|1|||
163007568|NCT00485264|588730018|FG005|Overall Study|Non-Compliant|0|||
163007569|NCT00485264|588730013|FG000|Overall Study|Lost to Follow-up|2|||
163007570|NCT00485264|588730014|FG001|Overall Study|Lost to Follow-up|1|||
163007571|NCT00485264|588730015|FG002|Overall Study|Lost to Follow-up|1|||
163007572|NCT00485264|588730016|FG003|Overall Study|Lost to Follow-up|0|||
163007573|NCT00485264|588730017|FG004|Overall Study|Lost to Follow-up|0|||
163007574|NCT00485264|588730018|FG005|Overall Study|Lost to Follow-up|1|||
163007575|NCT00485264|588730013|FG000|Overall Study|Other Reason|3|||
163007576|NCT00485264|588730014|FG001|Overall Study|Other Reason|0|||
163007577|NCT00485264|588730015|FG002|Overall Study|Other Reason|0|||
163007578|NCT00485264|588730016|FG003|Overall Study|Other Reason|0|||
163007579|NCT00485264|588730017|FG004|Overall Study|Other Reason|0|||
163007580|NCT00485264|588730018|FG005|Overall Study|Other Reason|0|||
163007581|NCT01514461|588730019|FG000|Overall Study|Adverse Event|2|||
163007582|NCT01514461|588730020|FG001|Overall Study|Adverse Event|1|||
163007583|NCT01514461|588730021|FG002|Overall Study|Adverse Event|3|||
163007584|NCT01514461|588730019|FG000|Overall Study|Physician Decision|1|||
163007585|NCT01514461|588730020|FG001|Overall Study|Physician Decision|1|||
163007586|NCT01514461|588730021|FG002|Overall Study|Physician Decision|0|||
163007587|NCT01514461|588730019|FG000|Overall Study|Patient/guardian decision|1|||
163007588|NCT01514461|588730020|FG001|Overall Study|Patient/guardian decision|1|||
163007589|NCT01514461|588730021|FG002|Overall Study|Patient/guardian decision|1|||
163007590|NCT01514461|588730019|FG000|Overall Study|Death|1|||
163007591|NCT01514461|588730020|FG001|Overall Study|Death|0|||
163007592|NCT01514461|588730021|FG002|Overall Study|Death|0|||
163007593|NCT02548832|588730022|FG000|Overall Study|Lost to Follow-up|2|||
163007594|NCT02548832|588730023|FG001|Overall Study|Lost to Follow-up|2|||
163007595|NCT02548832|588730024|FG002|Overall Study|Lost to Follow-up|2|||
163061430|NCT00790036|588933118|FG001|Overall Study|Withdrawal by Subject|7|||
163061431|NCT00790036|588933117|FG000|Overall Study|Subject/guardian decision|20|||
163061432|NCT00790036|588933118|FG001|Overall Study|Subject/guardian decision|7|||
163061433|NCT01285518|588933119|FG000|Overall Study|Lost to Follow-up|0|||
163061434|NCT01285518|588933120|FG001|Overall Study|Lost to Follow-up|0|||
163061435|NCT01285518|588933121|FG002|Overall Study|Lost to Follow-up|0|||
163061436|NCT01285518|588933122|FG003|Overall Study|Lost to Follow-up|0|||
163061437|NCT01285518|588933123|FG004|Overall Study|Lost to Follow-up|0|||
163061438|NCT01285518|588933124|FG005|Overall Study|Lost to Follow-up|1|||
163061439|NCT01285518|588933125|FG006|Overall Study|Lost to Follow-up|0|||
163061440|NCT01285518|588933126|FG007|Overall Study|Lost to Follow-up|0|||
163061441|NCT00639509|588933133|FG000|Overall Study|Death|1|||
163061442|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Adverse Event|6|||
162638610|NCT03325075|587392551|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
162638611|NCT03325075|587392552|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162638612|NCT03325075|587392553|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162638613|NCT03325075|587392554|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162638614|NCT03325075|587392551|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162638615|NCT03325075|587392552|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
162638616|NCT03325075|587392553|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162638617|NCT03325075|587392554|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162638618|NCT03325075|587392551|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
162638619|NCT03325075|587392552|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
162638620|NCT03325075|587392553|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
162638621|NCT03325075|587392554|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
162638622|NCT00422591|587392555|FG000|Overall Study|Physician Decision|4|||
162638623|NCT00422591|587392555|FG000|Overall Study|Withdrawal by Subject|2|||
162638624|NCT01414075|587392560|FG000|Overall Study|Adverse Event|1|||
162638625|NCT01414075|587392561|FG001|Overall Study|Adverse Event|0|||
162638626|NCT01414075|587392562|FG002|Overall Study|Adverse Event|1|||
162638627|NCT01414075|587392563|FG003|Overall Study|Adverse Event|0|||
163007596|NCT03565900|588730025|FG000|Overall Study|Disposition Unknown|4|||
163007597|NCT03565900|588730026|FG001|Overall Study|Disposition Unknown|1|||
163007598|NCT03565900|588730025|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163007599|NCT03565900|588730026|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
163007600|NCT03565900|588730025|FG000|Overall Study|Withdrawal by Subject|4|||
163007601|NCT03565900|588730026|FG001|Overall Study|Withdrawal by Subject|5|||
163007602|NCT03565900|588730025|FG000|Overall Study|Randomized By Mistake|0|||
163007603|NCT03565900|588730026|FG001|Overall Study|Randomized By Mistake|2|||
163007604|NCT03565900|588730025|FG000|Overall Study|Physician Decision|7|||
163007605|NCT03565900|588730026|FG001|Overall Study|Physician Decision|11|||
163007606|NCT03565900|588730025|FG000|Overall Study|Death|9|||
163007607|NCT03565900|588730026|FG001|Overall Study|Death|7|||
163007608|NCT01254643|588730027|FG000|Overall Study|Withdrawal by Subject|1|||
163007609|NCT03359850|588730033|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
162638628|NCT01414075|587392560|FG000|Overall Study|Death|1|||
162638629|NCT01414075|587392561|FG001|Overall Study|Death|0|||
162638630|NCT01414075|587392562|FG002|Overall Study|Death|0|||
162638631|NCT01414075|587392563|FG003|Overall Study|Death|1|||
162638632|NCT01414075|587392560|FG000|Overall Study|Withdrawal by Subject|0|||
162638633|NCT01414075|587392561|FG001|Overall Study|Withdrawal by Subject|0|||
162638634|NCT01414075|587392562|FG002|Overall Study|Withdrawal by Subject|0|||
162638635|NCT01414075|587392563|FG003|Overall Study|Withdrawal by Subject|1|||
163007610|NCT03359850|588730034|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
163007611|NCT03359850|588730033|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
163007612|NCT03359850|588730034|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
163007613|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Death|2|||
163007614|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Death|4|||
163007615|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
163007616|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
163007617|NCT03359850|588730033|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
163007618|NCT03359850|588730034|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
163007619|NCT03817125|588730052|FG000|Overall Study|Adverse Event|1|||
163007620|NCT03817125|588730053|FG001|Overall Study|Adverse Event|0|||
163007621|NCT03817125|588730052|FG000|Overall Study|Physician Decision|0|||
163007622|NCT03817125|588730053|FG001|Overall Study|Physician Decision|1|||
163007623|NCT03817125|588730052|FG000|Overall Study|Lack of Efficacy|1|||
163007624|NCT03817125|588730053|FG001|Overall Study|Lack of Efficacy|5|||
163007625|NCT00942084|588730054|FG000|Overall Study|Death|2|||
163007626|NCT01062425|588730055|FG000|Overall Study|Protocol Violation|3|||
163007627|NCT01062425|588730056|FG001|Overall Study|Protocol Violation|6|||
163007628|NCT01037218|588730057|FG000|Overall Study|Adverse Event|4|||
163007629|NCT01037218|588730058|FG001|Overall Study|Adverse Event|2|||
163007630|NCT01037218|588730059|FG002|Overall Study|Adverse Event|2|||
163007631|NCT01037218|588730060|FG003|Overall Study|Adverse Event|1|||
163007632|NCT01037218|588730057|FG000|Overall Study|Lack of Efficacy|0|||
163007633|NCT01037218|588730058|FG001|Overall Study|Lack of Efficacy|2|||
163007634|NCT01037218|588730059|FG002|Overall Study|Lack of Efficacy|1|||
163007635|NCT01037218|588730060|FG003|Overall Study|Lack of Efficacy|5|||
163007636|NCT01037218|588730057|FG000|Overall Study|Lost to Follow-up|3|||
163007637|NCT01037218|588730058|FG001|Overall Study|Lost to Follow-up|5|||
163007638|NCT01037218|588730059|FG002|Overall Study|Lost to Follow-up|4|||
163007639|NCT01037218|588730060|FG003|Overall Study|Lost to Follow-up|2|||
163007640|NCT01037218|588730057|FG000|Overall Study|Withdrawal by Subject|6|||
163007641|NCT01037218|588730058|FG001|Overall Study|Withdrawal by Subject|7|||
163007642|NCT01037218|588730059|FG002|Overall Study|Withdrawal by Subject|7|||
163007643|NCT01037218|588730060|FG003|Overall Study|Withdrawal by Subject|4|||
163007644|NCT01037218|588730057|FG000|Overall Study|Partner Withdrew Consent|0|||
163007645|NCT01037218|588730058|FG001|Overall Study|Partner Withdrew Consent|3|||
163007646|NCT01037218|588730059|FG002|Overall Study|Partner Withdrew Consent|2|||
163007647|NCT01037218|588730060|FG003|Overall Study|Partner Withdrew Consent|1|||
163007648|NCT01037218|588730057|FG000|Overall Study|Protocol Violation|0|||
163007649|NCT01037218|588730058|FG001|Overall Study|Protocol Violation|0|||
163007650|NCT01037218|588730059|FG002|Overall Study|Protocol Violation|2|||
163007651|NCT01037218|588730060|FG003|Overall Study|Protocol Violation|2|||
163007652|NCT01037218|588730057|FG000|Overall Study|Various|3|||
163007653|NCT01037218|588730058|FG001|Overall Study|Various|2|||
163007654|NCT01037218|588730059|FG002|Overall Study|Various|3|||
163007655|NCT01037218|588730060|FG003|Overall Study|Various|1|||
163007656|NCT00513240|588730062|FG000|Overall Study|Did not have intended surgery|3|||
163007657|NCT00513240|588730063|FG001|Overall Study|Did not have intended surgery|0|||
163007658|NCT00513240|588730062|FG000|Overall Study|Death|3|||
162638636|NCT01414075|587392560|FG000|Overall Study|Other than specified|1|||
162638637|NCT01414075|587392561|FG001|Overall Study|Other than specified|0|||
162638638|NCT01414075|587392562|FG002|Overall Study|Other than specified|1|||
162638639|NCT01414075|587392563|FG003|Overall Study|Other than specified|0|||
163007659|NCT00513240|588730063|FG001|Overall Study|Death|3|||
163007660|NCT00513240|588730062|FG000|Overall Study|Withdrawal by Subject|7|||
163007661|NCT00513240|588730063|FG001|Overall Study|Withdrawal by Subject|4|||
163007662|NCT01949662|588730066|FG000|Overall Study|Death|9|||
163007663|NCT01949662|588730067|FG001|Overall Study|Death|7|||
163007664|NCT01949662|588730066|FG000|Overall Study|Discharged before an agitation event|8|||
163007665|NCT01949662|588730067|FG001|Overall Study|Discharged before an agitation event|3|||
163007666|NCT01949662|588730066|FG000|Overall Study|Dropped out|1|||
163007667|NCT01949662|588730067|FG001|Overall Study|Dropped out|3|||
163007668|NCT01949662|588730066|FG000|Overall Study|Ineligible|0|||
163007669|NCT01949662|588730067|FG001|Overall Study|Ineligible|1|||
163007670|NCT02291237|588730068|FG000|Overall Study|Study Terminated by Sponsor|72|||
163007671|NCT02291237|588730069|FG001|Overall Study|Study Terminated by Sponsor|67|||
163007672|NCT02291237|588730068|FG000|Overall Study|Adverse Event|1|||
163007673|NCT02291237|588730069|FG001|Overall Study|Adverse Event|3|||
162638640|NCT04851314|587392569|FG000|Overall Study|Unable to complete research set-up procedures|0|||
163007674|NCT02291237|588730068|FG000|Overall Study|Investigator's Discretion|0|||
163007675|NCT02291237|588730069|FG001|Overall Study|Investigator's Discretion|3|||
163007676|NCT02291237|588730068|FG000|Overall Study|Withdrew Consent|11|||
163007677|NCT02291237|588730069|FG001|Overall Study|Withdrew Consent|11|||
163007678|NCT02291237|588730068|FG000|Overall Study|Lost to Follow-up|0|||
163007679|NCT02291237|588730069|FG001|Overall Study|Lost to Follow-up|2|||
163007680|NCT02291237|588730068|FG000|Overall Study|Subject Required Prohibited Medication|2|||
163007681|NCT02291237|588730069|FG001|Overall Study|Subject Required Prohibited Medication|0|||
163007682|NCT02189837|588730072|FG000|Overall Study|Withdrawal by Subject|2|||
163007683|NCT02189837|588730073|FG001|Overall Study|Withdrawal by Subject|1|||
163007684|NCT02189837|588730074|FG002|Overall Study|Withdrawal by Subject|3|||
163007685|NCT02189837|588730075|FG003|Overall Study|Withdrawal by Subject|1|||
163007686|NCT02189837|588730072|FG000|Overall Study|Sponsor Decision|0|||
163007687|NCT02189837|588730073|FG001|Overall Study|Sponsor Decision|0|||
163007688|NCT02189837|588730074|FG002|Overall Study|Sponsor Decision|0|||
163061443|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Adverse Event|15|||
163061444|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Adverse Event|0|||
163061445|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Death|0|||
163061446|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Death|2|||
163061447|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Death|0|||
163061448|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
163061449|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
163061450|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
163061451|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
163061452|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
163061453|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
163061454|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Physician Decision|1|||
163061455|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Physician Decision|1|||
163061456|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Physician Decision|0|||
163061457|NCT02921256|588933134|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
163061458|NCT02921256|588933135|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
163061459|NCT02921256|588933136|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
163061460|NCT02921256|588933134|FG000|Arm Ib v Arm III|Adverse Event|9|||
163061461|NCT02921256|588933135|FG001|Arm Ib v Arm III|Adverse Event|0|||
163061462|NCT02921256|588933136|FG002|Arm Ib v Arm III|Adverse Event|4|||
163061463|NCT02921256|588933134|FG000|Arm Ib v Arm III|Death|1|||
163061464|NCT02921256|588933135|FG001|Arm Ib v Arm III|Death|0|||
163061465|NCT02921256|588933136|FG002|Arm Ib v Arm III|Death|1|||
163061466|NCT02921256|588933134|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
163061467|NCT02921256|588933135|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
163061468|NCT02921256|588933136|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
163061469|NCT02921256|588933134|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
163061470|NCT02921256|588933135|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
163061471|NCT02921256|588933136|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
163061472|NCT02921256|588933134|FG000|Arm Ib v Arm III|Physician Decision|4|||
163061473|NCT02921256|588933135|FG001|Arm Ib v Arm III|Physician Decision|0|||
163061474|NCT02921256|588933136|FG002|Arm Ib v Arm III|Physician Decision|1|||
163061475|NCT02921256|588933134|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
163061476|NCT02921256|588933135|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
163061477|NCT02921256|588933136|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
163061478|NCT03507790|588933137|FG000|Overall Study|Adverse Event|0|||
163061479|NCT03507790|588933138|FG001|Overall Study|Adverse Event|11|||
163061480|NCT03507790|588933139|FG002|Overall Study|Adverse Event|3|||
163061481|NCT03507790|588933137|FG000|Overall Study|Withdrawal by Subject|2|||
163061482|NCT03507790|588933138|FG001|Overall Study|Withdrawal by Subject|0|||
163061483|NCT03507790|588933139|FG002|Overall Study|Withdrawal by Subject|0|||
163061484|NCT03507790|588933137|FG000|Overall Study|Subject moved to another location|1|||
163061485|NCT03507790|588933138|FG001|Overall Study|Subject moved to another location|2|||
163061486|NCT03507790|588933139|FG002|Overall Study|Subject moved to another location|0|||
163061487|NCT03507790|588933137|FG000|Overall Study|Non-compliance with study drug|0|||
163061488|NCT03507790|588933138|FG001|Overall Study|Non-compliance with study drug|0|||
163061489|NCT03507790|588933139|FG002|Overall Study|Non-compliance with study drug|1|||
163061490|NCT03507790|588933137|FG000|Overall Study|COVID 19 Pandemic|0|||
163061491|NCT03507790|588933138|FG001|Overall Study|COVID 19 Pandemic|1|||
163061492|NCT03507790|588933139|FG002|Overall Study|COVID 19 Pandemic|0|||
163007689|NCT02189837|588730075|FG003|Overall Study|Sponsor Decision|1|||
163007690|NCT00729937|588730076|FG000|Overall Study|Lost to Follow-up|49|||
163007691|NCT00729937|588730077|FG001|Overall Study|Lost to Follow-up|58|||
163007692|NCT00729937|588730078|FG002|Overall Study|Lost to Follow-up|18|||
163007693|NCT00729937|588730079|FG003|Overall Study|Lost to Follow-up|33|||
163061493|NCT03507790|588933137|FG000|Overall Study|Lost to Follow-up|0|||
163061494|NCT03507790|588933138|FG001|Overall Study|Lost to Follow-up|1|||
163061495|NCT03507790|588933139|FG002|Overall Study|Lost to Follow-up|0|||
163061496|NCT03507790|588933137|FG000|Overall Study|Discontinuation of the trial at the site|1|||
163007694|NCT00729937|588730080|FG004|Overall Study|Lost to Follow-up|18|||
163007695|NCT00729937|588730081|FG005|Overall Study|Lost to Follow-up|23|||
163007696|NCT00729937|588730076|FG000|Overall Study|Physician Decision|7|||
163061497|NCT03507790|588933138|FG001|Overall Study|Discontinuation of the trial at the site|1|||
162638641|NCT04851314|587392570|FG001|Overall Study|Unable to complete research set-up procedures|2|||
162638642|NCT04851314|587392569|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
163007697|NCT00729937|588730077|FG001|Overall Study|Physician Decision|16|||
163007698|NCT00729937|588730078|FG002|Overall Study|Physician Decision|2|||
163007699|NCT00729937|588730079|FG003|Overall Study|Physician Decision|0|||
163007700|NCT00729937|588730080|FG004|Overall Study|Physician Decision|5|||
163007701|NCT00729937|588730081|FG005|Overall Study|Physician Decision|8|||
163007702|NCT00729937|588730076|FG000|Overall Study|Death|1|||
163007703|NCT00729937|588730077|FG001|Overall Study|Death|0|||
163007704|NCT00729937|588730078|FG002|Overall Study|Death|1|||
163007705|NCT00729937|588730079|FG003|Overall Study|Death|0|||
162638643|NCT04851314|587392570|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
162638644|NCT00867009|587392571|FG000|Induction Period|Nonserious Adverse Event|5|||
162638645|NCT00867009|587392571|FG000|Induction Period|Serious Adverse Event|10|||
162638646|NCT00867009|587392571|FG000|Induction Period|Death due to serious adverse event|6|||
162638647|NCT00867009|587392571|FG000|Induction Period|Death due to Study Disease|4|||
162638648|NCT00867009|587392571|FG000|Induction Period|Protocol Violation|1|||
162638649|NCT00867009|587392571|FG000|Induction Period|Withdrawal by Subject|8|||
162638650|NCT00867009|587392571|FG000|Induction Period|Physician Decision|3|||
162638651|NCT00867009|587392571|FG000|Induction Period|Progressive Disease (PD)|25|||
162638652|NCT00867009|587392571|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
162638653|NCT03266094|587392574|FG000|Overall Study|Lost to Follow-up|1|||
162638654|NCT03266094|587392574|FG000|Overall Study|Withdrawal by Subject|1|||
162638655|NCT03241342|587392579|FG000|Overall Study|Adverse Event|5|||
162638656|NCT03241342|587392580|FG001|Overall Study|Adverse Event|8|||
162638657|NCT03241342|587392581|FG002|Overall Study|Adverse Event|4|||
162638658|NCT03241342|587392579|FG000|Overall Study|Lack of Efficacy|0|||
162638659|NCT03241342|587392580|FG001|Overall Study|Lack of Efficacy|0|||
162638660|NCT03241342|587392581|FG002|Overall Study|Lack of Efficacy|1|||
162638661|NCT03241342|587392579|FG000|Overall Study|noncompliance with study drug|2|||
162638662|NCT03241342|587392580|FG001|Overall Study|noncompliance with study drug|1|||
162638663|NCT03241342|587392581|FG002|Overall Study|noncompliance with study drug|1|||
162638664|NCT03241342|587392579|FG000|Overall Study|sponsor decision|0|||
162638665|NCT03241342|587392580|FG001|Overall Study|sponsor decision|1|||
162638666|NCT03241342|587392581|FG002|Overall Study|sponsor decision|2|||
162638667|NCT03241342|587392579|FG000|Overall Study|not reported|15|||
162638668|NCT03241342|587392580|FG001|Overall Study|not reported|21|||
162638669|NCT03241342|587392581|FG002|Overall Study|not reported|19|||
162638670|NCT03036072|587392585|FG000|Overall Study|Death|0|||
162638671|NCT03036072|587392586|FG001|Overall Study|Death|1|||
162638672|NCT03036072|587392585|FG000|Overall Study|Withdrawal by Subject|0|||
163007706|NCT00729937|588730080|FG004|Overall Study|Death|0|||
163007707|NCT00729937|588730081|FG005|Overall Study|Death|1|||
163007708|NCT00729937|588730076|FG000|Overall Study|Withdrawal by Subject|3|||
163007709|NCT00729937|588730077|FG001|Overall Study|Withdrawal by Subject|5|||
163007710|NCT00729937|588730078|FG002|Overall Study|Withdrawal by Subject|6|||
163007711|NCT00729937|588730079|FG003|Overall Study|Withdrawal by Subject|0|||
163007712|NCT00729937|588730080|FG004|Overall Study|Withdrawal by Subject|4|||
163007713|NCT00729937|588730081|FG005|Overall Study|Withdrawal by Subject|2|||
163007714|NCT00729937|588730076|FG000|Overall Study|Randomized but not treated|12|||
163007715|NCT00729937|588730077|FG001|Overall Study|Randomized but not treated|6|||
163007716|NCT00729937|588730078|FG002|Overall Study|Randomized but not treated|1|||
163007717|NCT00729937|588730079|FG003|Overall Study|Randomized but not treated|0|||
163007718|NCT00729937|588730080|FG004|Overall Study|Randomized but not treated|1|||
163007719|NCT00729937|588730081|FG005|Overall Study|Randomized but not treated|3|||
163007720|NCT00729937|588730076|FG000|Overall Study|Did not meet eligibility criteria|2|||
163007721|NCT00729937|588730077|FG001|Overall Study|Did not meet eligibility criteria|1|||
163007722|NCT00729937|588730078|FG002|Overall Study|Did not meet eligibility criteria|0|||
163007723|NCT00729937|588730079|FG003|Overall Study|Did not meet eligibility criteria|0|||
163007724|NCT00729937|588730080|FG004|Overall Study|Did not meet eligibility criteria|0|||
163007725|NCT00729937|588730081|FG005|Overall Study|Did not meet eligibility criteria|0|||
163007726|NCT00729937|588730076|FG000|Overall Study|Incarcerated|0|||
163007727|NCT00729937|588730077|FG001|Overall Study|Incarcerated|2|||
163007728|NCT00729937|588730078|FG002|Overall Study|Incarcerated|1|||
163007729|NCT00729937|588730079|FG003|Overall Study|Incarcerated|1|||
163007730|NCT00729937|588730080|FG004|Overall Study|Incarcerated|0|||
163007731|NCT00729937|588730081|FG005|Overall Study|Incarcerated|0|||
163007732|NCT02198963|588730085|FG000|Overall Study|Adverse Event|1|||
163007733|NCT02198963|588730085|FG000|Overall Study|Withdrawal by Subject|6|||
163007734|NCT00281957|588730086|FG000|Overall Study|Adverse Event|7|||
162638673|NCT03036072|587392586|FG001|Overall Study|Withdrawal by Subject|1|||
163007735|NCT00281957|588730087|FG001|Overall Study|Adverse Event|2|||
163007736|NCT00281957|588730086|FG000|Overall Study|Death|1|||
163007737|NCT00281957|588730087|FG001|Overall Study|Death|0|||
163007738|NCT00281957|588730086|FG000|Overall Study|Progression/relapse|47|||
163007739|NCT00281957|588730087|FG001|Overall Study|Progression/relapse|35|||
163007740|NCT00281957|588730086|FG000|Overall Study|Not protocol specified|8|||
163007741|NCT00281957|588730087|FG001|Overall Study|Not protocol specified|1|||
163007742|NCT00281957|588730086|FG000|Overall Study|Not eligible|1|||
163007743|NCT00281957|588730087|FG001|Overall Study|Not eligible|2|||
163007744|NCT00281957|588730086|FG000|Overall Study|Did not start treatment|3|||
163007745|NCT00281957|588730087|FG001|Overall Study|Did not start treatment|1|||
163007746|NCT00281957|588730086|FG000|Overall Study|Refusal unrelated to adverse events|0|||
163007747|NCT00281957|588730087|FG001|Overall Study|Refusal unrelated to adverse events|1|||
163007748|NCT03281876|588730095|FG000|Overall Study|Adverse Event|4|||
163007749|NCT03281876|588730096|FG001|Overall Study|Adverse Event|15|||
163007750|NCT03281876|588730095|FG000|Overall Study|Lost to Follow-up|1|||
163007751|NCT03281876|588730096|FG001|Overall Study|Lost to Follow-up|4|||
163007752|NCT03281876|588730095|FG000|Overall Study|Withdrawal by Subject|11|||
163007753|NCT03281876|588730096|FG001|Overall Study|Withdrawal by Subject|15|||
163007754|NCT03281876|588730095|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163007755|NCT03281876|588730096|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163007756|NCT03281876|588730095|FG000|Overall Study|OTHER|5|||
163007757|NCT03281876|588730096|FG001|Overall Study|OTHER|5|||
163007758|NCT02208089|588730097|FG000|Overall Study|Withdrawal by Subject|1|||
163007759|NCT02208089|588730098|FG001|Overall Study|Withdrawal by Subject|0|||
163007760|NCT02208089|588730097|FG000|Overall Study|Lost to Follow-up|6|||
163007761|NCT02208089|588730098|FG001|Overall Study|Lost to Follow-up|0|||
163007762|NCT00456300|588730099|FG000|Overall Study|Adverse Event|1|||
163007763|NCT00456300|588730100|FG001|Overall Study|Adverse Event|0|||
163007764|NCT01478373|588730101|FG000|Treatment Phase|Protocol Violation|1|||
163007765|NCT01478373|588730101|FG000|Survival Phase|Adverse Event|8|||
163007766|NCT01478373|588730101|FG000|Survival Phase|Protocol Violation|1|||
163007767|NCT01478373|588730101|FG000|Survival Phase|crossover to another study|2|||
163007768|NCT01478373|588730101|FG000|Survival Phase|Progressive Disease|27|||
163007769|NCT00683657|588730106|FG000|Overall Study|Adverse Event|0|||
163007770|NCT00683657|588730107|FG001|Overall Study|Adverse Event|1|||
163007771|NCT00683657|588730106|FG000|Overall Study|Subject Withdrew Consent|1|||
163007772|NCT00683657|588730107|FG001|Overall Study|Subject Withdrew Consent|0|||
163007773|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
163007774|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007775|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007776|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007777|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
163007778|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
163007779|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007780|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007781|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007782|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
163007783|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
163007784|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007785|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007786|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007787|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
163007788|NCT01074944|588730113|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
163007789|NCT01074944|588730114|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007790|NCT01074944|588730115|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007791|NCT01074944|588730116|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007792|NCT01074944|588730117|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
163007793|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163007794|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
163007795|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
163007796|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163061498|NCT03507790|588933139|FG002|Overall Study|Discontinuation of the trial at the site|0|||
163007797|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
163007798|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007799|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
163007800|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
163007801|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007802|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
163007803|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007804|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
163007805|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
163007806|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007807|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
163007808|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007809|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
163007810|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007811|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007812|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
163007813|NCT01074944|588730113|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007814|NCT01074944|588730114|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
163007815|NCT01074944|588730115|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
163007816|NCT01074944|588730116|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007817|NCT01074944|588730117|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
163007818|NCT01074944|588730113|FG000|Long Term Treatment|Adverse Event|0|||
163007819|NCT01074944|588730114|FG001|Long Term Treatment|Adverse Event|0|||
163007820|NCT01074944|588730115|FG002|Long Term Treatment|Adverse Event|0|||
163007821|NCT01074944|588730116|FG003|Long Term Treatment|Adverse Event|3|||
163007822|NCT01074944|588730117|FG004|Long Term Treatment|Adverse Event|0|||
163007823|NCT01074944|588730113|FG000|Long Term Treatment|Lost to Follow-up|0|||
163007824|NCT01074944|588730114|FG001|Long Term Treatment|Lost to Follow-up|0|||
163007825|NCT01074944|588730115|FG002|Long Term Treatment|Lost to Follow-up|0|||
163007826|NCT01074944|588730116|FG003|Long Term Treatment|Lost to Follow-up|2|||
163007827|NCT01074944|588730117|FG004|Long Term Treatment|Lost to Follow-up|0|||
163007828|NCT01074944|588730113|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007829|NCT01074944|588730114|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007830|NCT01074944|588730115|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007831|NCT01074944|588730116|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
163007832|NCT01074944|588730117|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
163007833|NCT01074944|588730113|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007834|NCT01074944|588730114|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007835|NCT01074944|588730115|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007836|NCT01074944|588730116|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
163007837|NCT01074944|588730117|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
163007838|NCT01074944|588730113|FG000|Long Term Treatment|Withdrawal by Subject|0|||
163007839|NCT01074944|588730114|FG001|Long Term Treatment|Withdrawal by Subject|0|||
163007840|NCT01074944|588730115|FG002|Long Term Treatment|Withdrawal by Subject|0|||
163007841|NCT01074944|588730116|FG003|Long Term Treatment|Withdrawal by Subject|2|||
163007842|NCT01074944|588730117|FG004|Long Term Treatment|Withdrawal by Subject|0|||
163007843|NCT01074944|588730113|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007844|NCT01074944|588730114|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007845|NCT01074944|588730115|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007846|NCT01074944|588730116|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
163007847|NCT01074944|588730117|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
163007848|NCT01074944|588730113|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007849|NCT01074944|588730114|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007850|NCT01074944|588730115|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007851|NCT01074944|588730116|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
163007852|NCT01074944|588730117|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
163007853|NCT03200717|588730126|FG000|Overall Study|Progressive disease|24|||
163007854|NCT03200717|588730127|FG001|Overall Study|Progressive disease|5|||
163007855|NCT03200717|588730126|FG000|Overall Study|Adverse Event|11|||
163007856|NCT03200717|588730127|FG001|Overall Study|Adverse Event|8|||
163007857|NCT03200717|588730126|FG000|Overall Study|Physician Decision|3|||
163007858|NCT03200717|588730127|FG001|Overall Study|Physician Decision|2|||
163007859|NCT03200717|588730126|FG000|Overall Study|Death|2|||
163007860|NCT03200717|588730127|FG001|Overall Study|Death|0|||
163007861|NCT03200717|588730126|FG000|Overall Study|Subject/Guardian Decision|1|||
163007862|NCT03200717|588730127|FG001|Overall Study|Subject/Guardian Decision|0|||
163007863|NCT02586155|588730128|FG000|Overall Study|Adverse Event|2|||
163007864|NCT02586155|588730129|FG001|Overall Study|Adverse Event|3|||
163007865|NCT02586155|588730128|FG000|Overall Study|Withdrawal by Subject|31|||
163007866|NCT02586155|588730129|FG001|Overall Study|Withdrawal by Subject|24|||
163007867|NCT02586155|588730128|FG000|Overall Study|Lost to Follow-up|7|||
163007868|NCT02586155|588730129|FG001|Overall Study|Lost to Follow-up|13|||
163007869|NCT02586155|588730128|FG000|Overall Study|Death|61|||
163007870|NCT02586155|588730129|FG001|Overall Study|Death|72|||
163007871|NCT02586155|588730128|FG000|Overall Study|Other reasons|26|||
163061499|NCT03507790|588933137|FG000|Overall Study|Randomized in error|0|||
163061500|NCT03507790|588933138|FG001|Overall Study|Randomized in error|0|||
163007872|NCT02586155|588730129|FG001|Overall Study|Other reasons|15|||
163007873|NCT01522456|588730130|FG000|Overall Study|Adverse Event|2|||
163007874|NCT01522456|588730130|FG000|Overall Study|Lost to Follow-up|2|||
163007875|NCT01522456|588730130|FG000|Overall Study|Withdrawal by Subject|2|||
163007876|NCT01522456|588730130|FG000|Overall Study|Pregnancy|1|||
163007877|NCT01522456|588730130|FG000|Overall Study|Tolerability Assessment|1|||
163007878|NCT02201784|588730131|FG000|Overall Study|Failure to achieve adequate block|2|||
163007879|NCT02201784|588730132|FG001|Overall Study|Failure to achieve adequate block|0|||
163007880|NCT02072980|588730133|FG000|Period 2, Second Wear|Adverse Event|0|||
163007881|NCT02072980|588730134|FG001|Period 2, Second Wear|Adverse Event|1|||
163007882|NCT00916383|588730135|FG000|Overall Study|Adverse Event|1|||
163007883|NCT00916383|588730135|FG000|Overall Study|Death|1|||
163007884|NCT00916383|588730135|FG000|Overall Study|Protocol Violation|1|||
163007885|NCT02899962|588730136|FG000|Open-label Phase|Adverse Event|2|||
163007886|NCT02899962|588730137|FG001|Open-label Phase|Adverse Event|0|||
163007887|NCT02899962|588730138|FG002|Open-label Phase|Adverse Event|0|||
163007888|NCT02899962|588730136|FG000|Open-label Phase|Lost to Follow-up|9|||
163007889|NCT02899962|588730137|FG001|Open-label Phase|Lost to Follow-up|0|||
163007890|NCT02899962|588730138|FG002|Open-label Phase|Lost to Follow-up|0|||
163007891|NCT02899962|588730136|FG000|Open-label Phase|Other reasons|9|||
163007892|NCT02899962|588730137|FG001|Open-label Phase|Other reasons|0|||
163007893|NCT02899962|588730138|FG002|Open-label Phase|Other reasons|0|||
163007894|NCT02899962|588730136|FG000|Open-label Phase|Withdrawal by Subject|7|||
163007895|NCT02899962|588730137|FG001|Open-label Phase|Withdrawal by Subject|0|||
163007896|NCT02899962|588730138|FG002|Open-label Phase|Withdrawal by Subject|0|||
163007897|NCT02899962|588730136|FG000|Maintenance Phase|Adverse Event|0|||
163007898|NCT02899962|588730137|FG001|Maintenance Phase|Adverse Event|2|||
163007899|NCT02899962|588730138|FG002|Maintenance Phase|Adverse Event|1|||
163007900|NCT02899962|588730136|FG000|Maintenance Phase|Death|0|||
163007901|NCT02899962|588730137|FG001|Maintenance Phase|Death|0|||
163007902|NCT02899962|588730138|FG002|Maintenance Phase|Death|1|||
163007903|NCT02899962|588730136|FG000|Maintenance Phase|Lack of Efficacy|0|||
163007904|NCT02899962|588730137|FG001|Maintenance Phase|Lack of Efficacy|20|||
163007905|NCT02899962|588730138|FG002|Maintenance Phase|Lack of Efficacy|16|||
163007906|NCT02899962|588730136|FG000|Maintenance Phase|Lost to Follow-up|0|||
163007907|NCT02899962|588730137|FG001|Maintenance Phase|Lost to Follow-up|12|||
163007908|NCT02899962|588730138|FG002|Maintenance Phase|Lost to Follow-up|14|||
163007909|NCT02899962|588730136|FG000|Maintenance Phase|Other reasons|0|||
163007910|NCT02899962|588730137|FG001|Maintenance Phase|Other reasons|9|||
163007911|NCT02899962|588730138|FG002|Maintenance Phase|Other reasons|13|||
163007912|NCT02899962|588730136|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
163007913|NCT02899962|588730137|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
163007914|NCT02899962|588730138|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
163007915|NCT02899962|588730136|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
163007916|NCT02899962|588730137|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
163007917|NCT02899962|588730138|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
163007918|NCT02899962|588730136|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163007919|NCT02899962|588730137|FG001|Maintenance Phase|Withdrawal by Subject|30|||
163007920|NCT02899962|588730138|FG002|Maintenance Phase|Withdrawal by Subject|36|||
163007921|NCT00258960|588730139|FG000|Overall Study|Death|2|||
163007922|NCT00258960|588730139|FG000|Overall Study|Disease Progression|7|||
163007923|NCT00258960|588730139|FG000|Overall Study|Adverse Event|4|||
163007924|NCT00258960|588730139|FG000|Overall Study|Physician Decision|1|||
163061501|NCT03507790|588933139|FG002|Overall Study|Randomized in error|1|||
163061502|NCT00671788|588933140|FG000|Overall Study|Adverse Event|8|||
163061503|NCT00671788|588933140|FG000|Overall Study|Refused further treatment|3|||
163061504|NCT00671788|588933140|FG000|Overall Study|Ineligible|1|||
163061505|NCT00671788|588933140|FG000|Overall Study|MD Decision|1|||
163061506|NCT00671788|588933140|FG000|Overall Study|Other|1|||
163061507|NCT03415178|588933141|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
163061508|NCT03415178|588933142|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
163007925|NCT00258960|588730139|FG000|Overall Study|Withdrawal by Subject|1|||
163007926|NCT00258960|588730139|FG000|Overall Study|Mistake|2|||
163007927|NCT00473590|588730140|FG000|Overall Study|Adverse Event|3|||
163007928|NCT00473590|588730141|FG001|Overall Study|Adverse Event|3|||
163061509|NCT03415178|588933141|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
163007929|NCT00473590|588730140|FG000|Overall Study|Death|4|||
163007930|NCT00473590|588730141|FG001|Overall Study|Death|2|||
163007931|NCT00473590|588730140|FG000|Overall Study|Progression not resulting in death|24|||
163061510|NCT03415178|588933142|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
163007932|NCT00473590|588730141|FG001|Overall Study|Progression not resulting in death|20|||
163007933|NCT00473590|588730140|FG000|Overall Study|Non-protocol-specified therapy|7|||
163007934|NCT00473590|588730141|FG001|Overall Study|Non-protocol-specified therapy|5|||
163007935|NCT00473590|588730140|FG000|Overall Study|Physician Decision|2|||
163007936|NCT00473590|588730141|FG001|Overall Study|Physician Decision|4|||
163061511|NCT01093846|588933143|FG000|Overall Study|Adverse Event|0|||
163061512|NCT01093846|588933144|FG001|Overall Study|Adverse Event|0|||
162638674|NCT03036072|587392585|FG000|Overall Study|Physician Decision|0|||
162638675|NCT03036072|587392586|FG001|Overall Study|Physician Decision|1|||
162638676|NCT03334903|587392587|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
162638677|NCT03334903|587392588|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
162638678|NCT03334903|587392587|FG000|Overall Study|Protocol Violation|1|||
162638679|NCT03334903|587392588|FG001|Overall Study|Protocol Violation|3|||
162638680|NCT03334903|587392587|FG000|Overall Study|Surgery postponed|1|||
162638681|NCT03334903|587392588|FG001|Overall Study|Surgery postponed|0|||
162638682|NCT03334903|587392587|FG000|Overall Study|Adverse Event|1|||
162638683|NCT03334903|587392588|FG001|Overall Study|Adverse Event|1|||
163007937|NCT00473590|588730140|FG000|Overall Study|Withdrawal by Subject|5|||
162638684|NCT03334903|587392587|FG000|Overall Study|Withdrawal by Subject|0|||
162638685|NCT03334903|587392588|FG001|Overall Study|Withdrawal by Subject|1|||
162638686|NCT00001596|587394291|FG000|Overall Study|Death|1|||
162638687|NCT00001596|587394292|FG001|Overall Study|Death|0|||
162638688|NCT00001596|587394291|FG000|Overall Study|Withdrawal by Subject|3|||
162638689|NCT00001596|587394292|FG001|Overall Study|Withdrawal by Subject|1|||
162638690|NCT00001596|587394291|FG000|Overall Study|Study Termination|12|||
162638691|NCT00001596|587394292|FG001|Overall Study|Study Termination|9|||
162638692|NCT00001596|587394291|FG000|Overall Study|Adverse Event|1|||
162638693|NCT00001596|587394292|FG001|Overall Study|Adverse Event|0|||
162638694|NCT00903617|587394293|FG000|Overall Study|Adverse Event|0|||
162638695|NCT00903617|587394294|FG001|Overall Study|Adverse Event|1|||
162638696|NCT00903617|587394295|FG002|Overall Study|Adverse Event|1|||
162638697|NCT00903617|587394296|FG003|Overall Study|Adverse Event|0|||
162638698|NCT00903617|587394293|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162638699|NCT00903617|587394294|FG001|Overall Study|Protocol-defined stopping criteria|2|||
162638700|NCT00903617|587394295|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162638701|NCT00903617|587394296|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162638702|NCT00903617|587394293|FG000|Overall Study|Lost to Follow-up|2|||
162638703|NCT00903617|587394294|FG001|Overall Study|Lost to Follow-up|0|||
162638704|NCT00903617|587394295|FG002|Overall Study|Lost to Follow-up|1|||
162638705|NCT00903617|587394296|FG003|Overall Study|Lost to Follow-up|1|||
162638706|NCT00903617|587394293|FG000|Overall Study|Withdrawal by Subject|1|||
162638707|NCT00903617|587394294|FG001|Overall Study|Withdrawal by Subject|2|||
162638708|NCT00903617|587394295|FG002|Overall Study|Withdrawal by Subject|3|||
162638709|NCT00903617|587394296|FG003|Overall Study|Withdrawal by Subject|0|||
162638710|NCT01104636|587394297|FG000|Overall Study|Lack of Efficacy|43|||
162638711|NCT01104636|587394297|FG000|Overall Study|Lost to Follow-up|24|||
162638712|NCT01104636|587394297|FG000|Overall Study|Withdrawal by Subject|4|||
162638713|NCT01104636|587394297|FG000|Overall Study|Other|43|||
162638714|NCT01104636|587394297|FG000|Overall Study|Study terminated by sponsor|1|||
162638715|NCT01104636|587394297|FG000|Overall Study|Pregnancy|2|||
162638716|NCT01104636|587394297|FG000|Overall Study|Adverse Event|40|||
162638717|NCT01104636|587394297|FG000|Overall Study|Ongoing|21|||
163007938|NCT00473590|588730141|FG001|Overall Study|Withdrawal by Subject|3|||
163007939|NCT00473590|588730140|FG000|Overall Study|Other|0|||
163007940|NCT00473590|588730141|FG001|Overall Study|Other|1|||
163007941|NCT02601014|588730145|FG000|Overall Study|Adverse Event|3|||
163007942|NCT02601014|588730146|FG001|Overall Study|Adverse Event|3|||
163007943|NCT02601014|588730145|FG000|Overall Study|Death|3|||
163007944|NCT02601014|588730146|FG001|Overall Study|Death|1|||
163007945|NCT02601014|588730145|FG000|Overall Study|Disease progression|4|||
163007946|NCT02601014|588730146|FG001|Overall Study|Disease progression|8|||
163007947|NCT02623725|588730148|FG000|Overall Study|Non compliance with protocol|9|||
163007948|NCT02623725|588730149|FG001|Overall Study|Non compliance with protocol|3|||
163007949|NCT02623725|588730148|FG000|Overall Study|Serious adverse event|0|||
162638718|NCT01706003|587394298|FG000|Overall Study|Withdrawal by Subject|2|||
162638719|NCT01706003|587394299|FG001|Overall Study|Withdrawal by Subject|0|||
162638720|NCT01706003|587394298|FG000|Overall Study|Not scheduled|3|||
162638721|NCT01706003|587394299|FG001|Overall Study|Not scheduled|0|||
162638722|NCT01706003|587394298|FG000|Overall Study|Lost to Follow-up|6|||
162638723|NCT01706003|587394299|FG001|Overall Study|Lost to Follow-up|4|||
163007950|NCT02623725|588730149|FG001|Overall Study|Serious adverse event|2|||
163007951|NCT02623725|588730148|FG000|Overall Study|Withdrawal by Subject|7|||
163007952|NCT02623725|588730149|FG001|Overall Study|Withdrawal by Subject|1|||
163007953|NCT03918629|588730150|FG000|Overall Study|Adverse Event|19|||
163007954|NCT03918629|588730151|FG001|Overall Study|Adverse Event|20|||
163007955|NCT03918629|588730150|FG000|Overall Study|Death|14|||
163007956|NCT03918629|588730151|FG001|Overall Study|Death|7|||
163007957|NCT03918629|588730150|FG000|Overall Study|Lost to Follow-up|36|||
163007958|NCT03918629|588730151|FG001|Overall Study|Lost to Follow-up|28|||
163007959|NCT03918629|588730150|FG000|Overall Study|Physician Decision|1|||
163007960|NCT03918629|588730151|FG001|Overall Study|Physician Decision|0|||
163007961|NCT03918629|588730150|FG000|Overall Study|Protocol Violation|7|||
163007962|NCT03918629|588730151|FG001|Overall Study|Protocol Violation|4|||
162638724|NCT01244906|587394301|FG000|Overall Study|Death|2|||
162638725|NCT01244906|587394301|FG000|Overall Study|Progression of disease post treatment|6|||
163061513|NCT01093846|588933145|FG002|Overall Study|Adverse Event|1|||
163007963|NCT03918629|588730150|FG000|Overall Study|Withdrawal by Subject|47|||
163007964|NCT03918629|588730151|FG001|Overall Study|Withdrawal by Subject|47|||
163007965|NCT03918629|588730150|FG000|Overall Study|Other|7|||
163007966|NCT03918629|588730151|FG001|Overall Study|Other|11|||
163007967|NCT03918629|588730150|FG000|Overall Study|Randomized but not vaccinated|2|||
163007968|NCT03918629|588730151|FG001|Overall Study|Randomized but not vaccinated|1|||
163007969|NCT01891864|588730153|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
163007970|NCT01891864|588730154|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
163007971|NCT01891864|588730155|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007972|NCT01891864|588730156|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007973|NCT01891864|588730157|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007974|NCT01891864|588730158|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
163007975|NCT01891864|588730153|FG000|Treatment Period 1|Physician Decision|0|||
163007976|NCT01891864|588730154|FG001|Treatment Period 1|Physician Decision|1|||
162638726|NCT03480750|587394302|FG000|Overall Study|Withdrawal by Subject|0|||
162638727|NCT03480750|587394303|FG001|Overall Study|Withdrawal by Subject|1|||
162638728|NCT03480750|587394304|FG002|Overall Study|Withdrawal by Subject|0|||
162638729|NCT03480750|587394305|FG003|Overall Study|Withdrawal by Subject|0|||
162638730|NCT03480750|587394306|FG004|Overall Study|Withdrawal by Subject|0|||
162638731|NCT03480750|587394307|FG005|Overall Study|Withdrawal by Subject|0|||
163007977|NCT01891864|588730155|FG002|Treatment Period 1|Physician Decision|0|||
163007978|NCT01891864|588730156|FG003|Treatment Period 1|Physician Decision|0|||
163007979|NCT01891864|588730157|FG004|Treatment Period 1|Physician Decision|0|||
163007980|NCT01891864|588730158|FG005|Treatment Period 1|Physician Decision|0|||
163007981|NCT01891864|588730153|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007982|NCT01891864|588730154|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
163007983|NCT01891864|588730155|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007984|NCT01891864|588730156|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007985|NCT01891864|588730157|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007986|NCT01891864|588730158|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
163007987|NCT01891864|588730153|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
163007988|NCT01891864|588730154|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
163007989|NCT01891864|588730155|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007990|NCT01891864|588730156|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163061514|NCT01093846|588933143|FG000|Overall Study|Lack of Efficacy|0|||
163061515|NCT01093846|588933144|FG001|Overall Study|Lack of Efficacy|0|||
163061516|NCT01093846|588933145|FG002|Overall Study|Lack of Efficacy|4|||
163007991|NCT01891864|588730157|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007992|NCT01891864|588730158|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
163007993|NCT01891864|588730153|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163007994|NCT01891864|588730154|FG001|Treatment Period 1|Withdrawal by Subject|5|||
163007995|NCT01891864|588730155|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163007996|NCT01891864|588730156|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163007997|NCT01891864|588730157|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163007998|NCT01891864|588730158|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163007999|NCT01891864|588730153|FG000|Treatment Period 1|Lost to Follow-up|1|||
163008000|NCT01891864|588730154|FG001|Treatment Period 1|Lost to Follow-up|0|||
163008001|NCT01891864|588730155|FG002|Treatment Period 1|Lost to Follow-up|0|||
163008002|NCT01891864|588730156|FG003|Treatment Period 1|Lost to Follow-up|0|||
163008003|NCT01891864|588730157|FG004|Treatment Period 1|Lost to Follow-up|0|||
163008004|NCT01891864|588730158|FG005|Treatment Period 1|Lost to Follow-up|0|||
163008005|NCT01891864|588730153|FG000|Treatment Period 2|Protocol Violation|0|||
163008006|NCT01891864|588730154|FG001|Treatment Period 2|Protocol Violation|0|||
163008007|NCT01891864|588730155|FG002|Treatment Period 2|Protocol Violation|0|||
162638732|NCT03480750|587394302|FG000|Overall Study|The interruption in Trientine shippment|0|||
163008008|NCT01891864|588730156|FG003|Treatment Period 2|Protocol Violation|1|||
163008009|NCT01891864|588730157|FG004|Treatment Period 2|Protocol Violation|0|||
163008010|NCT01891864|588730158|FG005|Treatment Period 2|Protocol Violation|0|||
163061517|NCT01093846|588933143|FG000|Overall Study|Condition no longer required study drug|1|||
162638733|NCT03480750|587394303|FG001|Overall Study|The interruption in Trientine shippment|0|||
163008011|NCT01891864|588730153|FG000|Treatment Period 2|Physician Decision|0|||
163008012|NCT01891864|588730154|FG001|Treatment Period 2|Physician Decision|0|||
163008013|NCT01891864|588730155|FG002|Treatment Period 2|Physician Decision|1|||
163008014|NCT01891864|588730156|FG003|Treatment Period 2|Physician Decision|0|||
163008015|NCT01891864|588730157|FG004|Treatment Period 2|Physician Decision|0|||
163008016|NCT01891864|588730158|FG005|Treatment Period 2|Physician Decision|0|||
163008017|NCT01891864|588730153|FG000|Treatment Period 2|Site Termination|0|||
163008018|NCT01891864|588730154|FG001|Treatment Period 2|Site Termination|0|||
163008019|NCT01891864|588730155|FG002|Treatment Period 2|Site Termination|1|||
163008020|NCT01891864|588730156|FG003|Treatment Period 2|Site Termination|2|||
163008021|NCT01891864|588730157|FG004|Treatment Period 2|Site Termination|0|||
163008022|NCT01891864|588730158|FG005|Treatment Period 2|Site Termination|0|||
162638734|NCT03480750|587394304|FG002|Overall Study|The interruption in Trientine shippment|0|||
162638735|NCT03480750|587394305|FG003|Overall Study|The interruption in Trientine shippment|0|||
162638736|NCT03480750|587394306|FG004|Overall Study|The interruption in Trientine shippment|0|||
162638737|NCT03480750|587394307|FG005|Overall Study|The interruption in Trientine shippment|1|||
162638738|NCT02411292|587394312|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
162638739|NCT02411292|587394312|FG000|Overall Study|Death|2|||
162638740|NCT02411292|587394312|FG000|Overall Study|Lost to Follow-up|3|||
162638741|NCT00453921|587394313|FG000|Overall Study|Withdrawal by Subject|1|||
162638742|NCT00453921|587394314|FG001|Overall Study|Withdrawal by Subject|1|||
162638743|NCT00453921|587394315|FG002|Overall Study|Withdrawal by Subject|1|||
162638744|NCT00453921|587394316|FG003|Overall Study|Withdrawal by Subject|1|||
162638745|NCT00453921|587394313|FG000|Overall Study|Lost to Follow-up|0|||
163008023|NCT01891864|588730153|FG000|Treatment Period 2|Lack of Efficacy|0|||
163008024|NCT01891864|588730154|FG001|Treatment Period 2|Lack of Efficacy|0|||
163008025|NCT01891864|588730155|FG002|Treatment Period 2|Lack of Efficacy|1|||
163008026|NCT01891864|588730156|FG003|Treatment Period 2|Lack of Efficacy|0|||
163008027|NCT01891864|588730157|FG004|Treatment Period 2|Lack of Efficacy|1|||
163008028|NCT01891864|588730158|FG005|Treatment Period 2|Lack of Efficacy|0|||
163008029|NCT01891864|588730153|FG000|Treatment Period 2|Adverse Event|0|||
163008030|NCT01891864|588730154|FG001|Treatment Period 2|Adverse Event|0|||
163008031|NCT01891864|588730155|FG002|Treatment Period 2|Adverse Event|1|||
163008032|NCT01891864|588730156|FG003|Treatment Period 2|Adverse Event|2|||
163008033|NCT01891864|588730157|FG004|Treatment Period 2|Adverse Event|0|||
163008034|NCT01891864|588730158|FG005|Treatment Period 2|Adverse Event|4|||
163008035|NCT01891864|588730153|FG000|Treatment Period 2|Termination of Site|0|||
163008036|NCT01891864|588730154|FG001|Treatment Period 2|Termination of Site|0|||
163008037|NCT01891864|588730155|FG002|Treatment Period 2|Termination of Site|0|||
163008038|NCT01891864|588730156|FG003|Treatment Period 2|Termination of Site|0|||
163008039|NCT01891864|588730157|FG004|Treatment Period 2|Termination of Site|2|||
163008040|NCT01891864|588730158|FG005|Treatment Period 2|Termination of Site|0|||
163008041|NCT01891864|588730153|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163008042|NCT01891864|588730154|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163008043|NCT01891864|588730155|FG002|Treatment Period 2|Withdrawal by Subject|3|||
163008044|NCT01891864|588730156|FG003|Treatment Period 2|Withdrawal by Subject|4|||
163008045|NCT01891864|588730157|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163008046|NCT01891864|588730158|FG005|Treatment Period 2|Withdrawal by Subject|1|||
163008047|NCT01891864|588730153|FG000|Extension Period|Lack of Efficacy|0|||
163008048|NCT01891864|588730154|FG001|Extension Period|Lack of Efficacy|0|||
163008049|NCT01891864|588730155|FG002|Extension Period|Lack of Efficacy|0|||
163008050|NCT01891864|588730156|FG003|Extension Period|Lack of Efficacy|1|||
163008051|NCT01891864|588730157|FG004|Extension Period|Lack of Efficacy|1|||
163008052|NCT01891864|588730158|FG005|Extension Period|Lack of Efficacy|0|||
163008053|NCT01891864|588730153|FG000|Extension Period|Pregnancy|0|||
163008054|NCT01891864|588730154|FG001|Extension Period|Pregnancy|0|||
163008055|NCT01891864|588730155|FG002|Extension Period|Pregnancy|1|||
163008056|NCT01891864|588730156|FG003|Extension Period|Pregnancy|0|||
163008057|NCT01891864|588730157|FG004|Extension Period|Pregnancy|0|||
163008058|NCT01891864|588730158|FG005|Extension Period|Pregnancy|0|||
162638746|NCT00453921|587394314|FG001|Overall Study|Lost to Follow-up|0|||
162638747|NCT00453921|587394315|FG002|Overall Study|Lost to Follow-up|1|||
163008059|NCT01891864|588730153|FG000|Extension Period|Adverse Event|0|||
163008060|NCT01891864|588730154|FG001|Extension Period|Adverse Event|0|||
163008061|NCT01891864|588730155|FG002|Extension Period|Adverse Event|4|||
163008062|NCT01891864|588730156|FG003|Extension Period|Adverse Event|2|||
162638748|NCT00453921|587394316|FG003|Overall Study|Lost to Follow-up|0|||
162638749|NCT00174915|587394317|FG000|Overall Study|Lost to Follow-up|19|||
163008063|NCT01891864|588730157|FG004|Extension Period|Adverse Event|2|||
163008064|NCT01891864|588730158|FG005|Extension Period|Adverse Event|0|||
163008065|NCT01891864|588730153|FG000|Extension Period|Withdrawal by Subject|0|||
163008066|NCT01891864|588730154|FG001|Extension Period|Withdrawal by Subject|0|||
163008067|NCT01891864|588730155|FG002|Extension Period|Withdrawal by Subject|1|||
163008068|NCT01891864|588730156|FG003|Extension Period|Withdrawal by Subject|2|||
163008069|NCT01891864|588730157|FG004|Extension Period|Withdrawal by Subject|4|||
163008070|NCT01891864|588730158|FG005|Extension Period|Withdrawal by Subject|0|||
163008071|NCT01891864|588730153|FG000|Extension Period|Lost to Follow-up|0|||
162638750|NCT00174915|587394318|FG001|Overall Study|Lost to Follow-up|17|||
162638751|NCT00174915|587394319|FG002|Overall Study|Lost to Follow-up|9|||
162638752|NCT00174915|587394320|FG003|Overall Study|Lost to Follow-up|17|||
162638753|NCT00174915|587394321|FG004|Overall Study|Lost to Follow-up|10|||
162638754|NCT00174915|587394317|FG000|Overall Study|Adverse Event|18|||
162638755|NCT00174915|587394318|FG001|Overall Study|Adverse Event|16|||
162638756|NCT00174915|587394319|FG002|Overall Study|Adverse Event|11|||
162638757|NCT00174915|587394320|FG003|Overall Study|Adverse Event|18|||
162638758|NCT00174915|587394321|FG004|Overall Study|Adverse Event|5|||
162638759|NCT00174915|587394317|FG000|Overall Study|Personal Reason(s)|16|||
162638760|NCT00174915|587394318|FG001|Overall Study|Personal Reason(s)|16|||
162638761|NCT00174915|587394319|FG002|Overall Study|Personal Reason(s)|9|||
162638762|NCT00174915|587394320|FG003|Overall Study|Personal Reason(s)|9|||
162638763|NCT00174915|587394321|FG004|Overall Study|Personal Reason(s)|9|||
162638764|NCT00174915|587394317|FG000|Overall Study|Other|15|||
162638765|NCT00174915|587394318|FG001|Overall Study|Other|8|||
162638766|NCT00174915|587394319|FG002|Overall Study|Other|6|||
162638767|NCT00174915|587394320|FG003|Overall Study|Other|5|||
162638768|NCT00174915|587394321|FG004|Overall Study|Other|3|||
162638769|NCT00174915|587394317|FG000|Overall Study|Gout Flare|13|||
162638770|NCT00174915|587394318|FG001|Overall Study|Gout Flare|6|||
162638771|NCT00174915|587394319|FG002|Overall Study|Gout Flare|8|||
162638772|NCT00174915|587394320|FG003|Overall Study|Gout Flare|1|||
162638773|NCT00174915|587394321|FG004|Overall Study|Gout Flare|0|||
162638774|NCT00174915|587394317|FG000|Overall Study|Protocol Violation|6|||
162638775|NCT00174915|587394318|FG001|Overall Study|Protocol Violation|3|||
162638776|NCT00174915|587394319|FG002|Overall Study|Protocol Violation|3|||
162638777|NCT00174915|587394320|FG003|Overall Study|Protocol Violation|6|||
162638778|NCT00174915|587394321|FG004|Overall Study|Protocol Violation|3|||
162638779|NCT00174915|587394317|FG000|Overall Study|Therapeutic Failure|6|||
162638780|NCT00174915|587394318|FG001|Overall Study|Therapeutic Failure|3|||
162638781|NCT00174915|587394319|FG002|Overall Study|Therapeutic Failure|2|||
162638782|NCT00174915|587394320|FG003|Overall Study|Therapeutic Failure|1|||
162638783|NCT00174915|587394321|FG004|Overall Study|Therapeutic Failure|3|||
162638784|NCT03060447|587394322|FG000|Overall Study|Withdrawal by Subject|2|||
162638785|NCT03060447|587394323|FG001|Overall Study|Withdrawal by Subject|0|||
162638786|NCT02232425|587394324|FG000|Overall Study|Lost to Follow-up|6|||
162638787|NCT02232425|587394325|FG001|Overall Study|Lost to Follow-up|2|||
162638788|NCT02232425|587394324|FG000|Overall Study|Adverse Event|2|||
162638789|NCT02232425|587394325|FG001|Overall Study|Adverse Event|0|||
162638790|NCT02232425|587394324|FG000|Overall Study|Withdrawal by Subject|5|||
162638791|NCT02232425|587394325|FG001|Overall Study|Withdrawal by Subject|6|||
162638792|NCT02232425|587394324|FG000|Overall Study|Lack of Efficacy|1|||
162638793|NCT02232425|587394325|FG001|Overall Study|Lack of Efficacy|0|||
162638794|NCT01601626|587394328|FG000|Overall Study|Death|1|||
162638795|NCT01601626|587394329|FG001|Overall Study|Death|1|||
162638796|NCT01601626|587394330|FG002|Overall Study|Death|1|||
162638797|NCT01601626|587394328|FG000|Overall Study|Lost to Follow-up|1|||
162638798|NCT01601626|587394329|FG001|Overall Study|Lost to Follow-up|2|||
162638799|NCT01601626|587394330|FG002|Overall Study|Lost to Follow-up|0|||
162638800|NCT01601626|587394328|FG000|Overall Study|Unable to Get to Clinic|0|||
162638801|NCT01601626|587394329|FG001|Overall Study|Unable to Get to Clinic|1|||
162638802|NCT01601626|587394330|FG002|Overall Study|Unable to Get to Clinic|0|||
162638803|NCT01601626|587394328|FG000|Overall Study|Withdrawal by Subject|0|||
162638804|NCT01601626|587394329|FG001|Overall Study|Withdrawal by Subject|1|||
162638805|NCT01601626|587394330|FG002|Overall Study|Withdrawal by Subject|1|||
163008072|NCT01891864|588730154|FG001|Extension Period|Lost to Follow-up|0|||
163008073|NCT01891864|588730155|FG002|Extension Period|Lost to Follow-up|2|||
163008074|NCT01891864|588730156|FG003|Extension Period|Lost to Follow-up|0|||
163008075|NCT01891864|588730157|FG004|Extension Period|Lost to Follow-up|0|||
162638806|NCT01601626|587394328|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
162638807|NCT01601626|587394329|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
162638808|NCT01601626|587394330|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
163008076|NCT01891864|588730158|FG005|Extension Period|Lost to Follow-up|0|||
163008077|NCT02698163|588730159|FG000|Overall Study|Lost to Follow-up|0|||
163008078|NCT02698163|588730160|FG001|Overall Study|Lost to Follow-up|1|||
162638809|NCT00498602|587394331|FG000|Overall Study|Death|0|||
162638810|NCT00498602|587394332|FG001|Overall Study|Death|0|||
162638811|NCT00498602|587394333|FG002|Overall Study|Death|0|||
162638812|NCT00498602|587394334|FG003|Overall Study|Death|0|||
162638813|NCT00498602|587394335|FG004|Overall Study|Death|0|||
162638814|NCT00498602|587394336|FG005|Overall Study|Death|1|||
162638815|NCT00498602|587394337|FG006|Overall Study|Death|0|||
162638816|NCT00498602|587394331|FG000|Overall Study|Lack of Efficacy|1|||
162638817|NCT00498602|587394332|FG001|Overall Study|Lack of Efficacy|0|||
162638818|NCT00498602|587394333|FG002|Overall Study|Lack of Efficacy|0|||
162638819|NCT00498602|587394334|FG003|Overall Study|Lack of Efficacy|0|||
162638820|NCT00498602|587394335|FG004|Overall Study|Lack of Efficacy|0|||
162638821|NCT00498602|587394336|FG005|Overall Study|Lack of Efficacy|0|||
163008079|NCT01133067|588730161|FG000|Overall Study|Death|136|||
163008080|NCT01133067|588730161|FG000|Overall Study|Lost to Follow-up|3|||
163008081|NCT00752128|588730162|FG000|Overall Study|Withdrawal by Subject|4|||
163008082|NCT00349973|588730163|FG000|Overall Study|Adverse Event|3|||
163008083|NCT00349973|588730164|FG001|Overall Study|Adverse Event|3|||
163008084|NCT00349973|588730163|FG000|Overall Study|Withdrawal by Subject|1|||
163008085|NCT00349973|588730164|FG001|Overall Study|Withdrawal by Subject|0|||
163008086|NCT04135937|588730165|FG000|Overall Study|Lost to Follow-up|2|||
163008087|NCT04135937|588730165|FG000|Overall Study|Withdrawal by Subject|1|||
163008088|NCT05620082|588730166|FG000|Overall Study|Discharged before study end|1|||
163008089|NCT05620082|588730167|FG001|Overall Study|Discharged before study end|4|||
163008090|NCT05620082|588730168|FG002|Overall Study|Discharged before study end|0|||
163008091|NCT05620082|588730166|FG000|Overall Study|Moved to a different ward|1|||
163008092|NCT05620082|588730167|FG001|Overall Study|Moved to a different ward|0|||
163008093|NCT05620082|588730168|FG002|Overall Study|Moved to a different ward|0|||
163008094|NCT05620082|588730166|FG000|Overall Study|Feeling too unwell|1|||
163008095|NCT05620082|588730167|FG001|Overall Study|Feeling too unwell|0|||
163008096|NCT05620082|588730168|FG002|Overall Study|Feeling too unwell|0|||
163008097|NCT02141438|588732249|FG000|Overall Study|Death|1308|||
163008098|NCT02141438|588732249|FG000|Overall Study|Lost to Follow-up|84|||
163008099|NCT02141438|588732249|FG000|Overall Study|Withdrawal by Subject|52|||
163008100|NCT02141438|588732249|FG000|Overall Study|Physician Decision|1|||
163008101|NCT02141438|588732249|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
163008102|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
163008103|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008104|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008105|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
163008106|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
163008107|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008108|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008109|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
163008110|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
163008111|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008112|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008113|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
163008114|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
163008115|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008116|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008117|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
163008118|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
163008119|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008120|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008121|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
163008122|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
163008123|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008124|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008125|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
163008126|NCT02513160|588732252|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
163008127|NCT02513160|588732253|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008128|NCT02513160|588732254|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008129|NCT02513160|588732255|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
163008130|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
163008131|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
163008132|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
163008133|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
163008134|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
163008135|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008136|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008137|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
163008138|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
163008139|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008140|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008141|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
163008142|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
163008143|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163008144|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163008145|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
163008146|NCT02513160|588732252|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
162638822|NCT00498602|587394337|FG006|Overall Study|Lack of Efficacy|0|||
162638823|NCT00498602|587394331|FG000|Overall Study|Lost to Follow-up|0|||
162638824|NCT00498602|587394332|FG001|Overall Study|Lost to Follow-up|2|||
162638825|NCT00498602|587394333|FG002|Overall Study|Lost to Follow-up|0|||
162638826|NCT00498602|587394334|FG003|Overall Study|Lost to Follow-up|2|||
162638827|NCT00498602|587394335|FG004|Overall Study|Lost to Follow-up|0|||
162638828|NCT00498602|587394336|FG005|Overall Study|Lost to Follow-up|0|||
162638829|NCT00498602|587394337|FG006|Overall Study|Lost to Follow-up|0|||
162638830|NCT00498602|587394331|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162638831|NCT00498602|587394332|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162638832|NCT00498602|587394333|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
162638833|NCT00498602|587394334|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
162638834|NCT00498602|587394335|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162638835|NCT00498602|587394336|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162638836|NCT00498602|587394337|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162638837|NCT00498602|587394331|FG000|Overall Study|AE not related to Study Drug|1|||
162638838|NCT00498602|587394332|FG001|Overall Study|AE not related to Study Drug|3|||
162638839|NCT00498602|587394333|FG002|Overall Study|AE not related to Study Drug|0|||
162638840|NCT00498602|587394334|FG003|Overall Study|AE not related to Study Drug|0|||
162638841|NCT00498602|587394335|FG004|Overall Study|AE not related to Study Drug|2|||
162638842|NCT00498602|587394336|FG005|Overall Study|AE not related to Study Drug|2|||
162638843|NCT00498602|587394337|FG006|Overall Study|AE not related to Study Drug|1|||
162638844|NCT00498602|587394331|FG000|Overall Study|Caregiver Request|2|||
162638845|NCT00498602|587394332|FG001|Overall Study|Caregiver Request|2|||
162638846|NCT00498602|587394333|FG002|Overall Study|Caregiver Request|2|||
162638847|NCT00498602|587394334|FG003|Overall Study|Caregiver Request|0|||
162638848|NCT00498602|587394335|FG004|Overall Study|Caregiver Request|1|||
162638849|NCT00498602|587394336|FG005|Overall Study|Caregiver Request|2|||
162638850|NCT00498602|587394337|FG006|Overall Study|Caregiver Request|0|||
162638851|NCT00498602|587394331|FG000|Overall Study|Investigator Request|0|||
162638852|NCT00498602|587394332|FG001|Overall Study|Investigator Request|0|||
162638853|NCT00498602|587394333|FG002|Overall Study|Investigator Request|1|||
162638854|NCT00498602|587394334|FG003|Overall Study|Investigator Request|0|||
162638855|NCT00498602|587394335|FG004|Overall Study|Investigator Request|0|||
162638856|NCT00498602|587394336|FG005|Overall Study|Investigator Request|0|||
162638857|NCT00498602|587394337|FG006|Overall Study|Investigator Request|0|||
162638858|NCT00498602|587394331|FG000|Overall Study|Subject Request|3|||
163008147|NCT02513160|588732253|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
163008148|NCT02513160|588732254|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
163008149|NCT02513160|588732255|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
163008150|NCT04021914|588732258|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
163008151|NCT00803790|588732262|FG000|Period 1|Adverse Event|0|||
163008152|NCT00803790|588732263|FG001|Period 1|Adverse Event|1|||
163008153|NCT00803790|588732264|FG002|Period 1|Adverse Event|0|||
163008154|NCT00803790|588732265|FG003|Period 1|Adverse Event|0|||
163008155|NCT00803790|588732262|FG000|Period 1|Lost to Follow-up|1|||
163008156|NCT00803790|588732263|FG001|Period 1|Lost to Follow-up|2|||
163008157|NCT00803790|588732264|FG002|Period 1|Lost to Follow-up|0|||
163008158|NCT00803790|588732265|FG003|Period 1|Lost to Follow-up|0|||
163008159|NCT00803790|588732262|FG000|Period 1|Withdrawal by Subject|8|||
163008160|NCT00803790|588732263|FG001|Period 1|Withdrawal by Subject|6|||
163008161|NCT00803790|588732264|FG002|Period 1|Withdrawal by Subject|0|||
163008162|NCT00803790|588732265|FG003|Period 1|Withdrawal by Subject|0|||
163008163|NCT00803790|588732262|FG000|Period 1|positive drug screen or personal reasons|0|||
163008164|NCT00803790|588732263|FG001|Period 1|positive drug screen or personal reasons|3|||
163008165|NCT00803790|588732264|FG002|Period 1|positive drug screen or personal reasons|0|||
163008166|NCT00803790|588732265|FG003|Period 1|positive drug screen or personal reasons|4|||
163008167|NCT00803790|588732262|FG000|Period 1|Protocol Violation|0|||
163008168|NCT00803790|588732263|FG001|Period 1|Protocol Violation|0|||
163008169|NCT00803790|588732264|FG002|Period 1|Protocol Violation|1|||
163008170|NCT00803790|588732265|FG003|Period 1|Protocol Violation|0|||
162638859|NCT00498602|587394332|FG001|Overall Study|Subject Request|0|||
162638860|NCT00498602|587394333|FG002|Overall Study|Subject Request|1|||
162638861|NCT00498602|587394334|FG003|Overall Study|Subject Request|1|||
163008171|NCT00803790|588732262|FG000|Period 2|Adverse Event|0|||
163061518|NCT01093846|588933144|FG001|Overall Study|Condition no longer required study drug|1|||
163061519|NCT01093846|588933145|FG002|Overall Study|Condition no longer required study drug|1|||
163061520|NCT01093846|588933143|FG000|Overall Study|Administrative Problems|18|||
162638862|NCT00498602|587394335|FG004|Overall Study|Subject Request|1|||
163008172|NCT00803790|588732263|FG001|Period 2|Adverse Event|0|||
163061521|NCT01093846|588933144|FG001|Overall Study|Administrative Problems|17|||
162638863|NCT00498602|587394336|FG005|Overall Study|Subject Request|4|||
162638864|NCT00498602|587394337|FG006|Overall Study|Subject Request|1|||
162638865|NCT00498602|587394331|FG000|Overall Study|Other|2|||
162638866|NCT00498602|587394332|FG001|Overall Study|Other|3|||
163008173|NCT00803790|588732264|FG002|Period 2|Adverse Event|1|||
163008174|NCT00803790|588732265|FG003|Period 2|Adverse Event|1|||
163008175|NCT00803790|588732262|FG000|Period 2|Withdrawal by Subject|1|||
163008176|NCT00803790|588732263|FG001|Period 2|Withdrawal by Subject|0|||
163008177|NCT00803790|588732264|FG002|Period 2|Withdrawal by Subject|0|||
163008178|NCT00803790|588732265|FG003|Period 2|Withdrawal by Subject|0|||
163008179|NCT00803790|588732262|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
163008180|NCT00803790|588732263|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008181|NCT00803790|588732264|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008182|NCT00803790|588732265|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
163008183|NCT04581824|588732267|FG000|Overall Study|Lost to Follow-up|1|||
163008184|NCT04581824|588732268|FG001|Overall Study|Lost to Follow-up|0|||
163008185|NCT04581824|588732267|FG000|Overall Study|Withdrawal by Subject|2|||
163008186|NCT04581824|588732268|FG001|Overall Study|Withdrawal by Subject|7|||
163008187|NCT04581824|588732267|FG000|Overall Study|Study terminated by sponsor|37|||
163008188|NCT04581824|588732268|FG001|Overall Study|Study terminated by sponsor|23|||
163008189|NCT05012098|588732269|FG000|Overall Study|Disease progression|5|||
163008190|NCT05012098|588732270|FG001|Overall Study|Disease progression|2|||
163008191|NCT05012098|588732269|FG000|Overall Study|Adverse Event|1|||
163008192|NCT05012098|588732270|FG001|Overall Study|Adverse Event|0|||
163008193|NCT05012098|588732269|FG000|Overall Study|Withdrawal by Subject|1|||
163008194|NCT05012098|588732270|FG001|Overall Study|Withdrawal by Subject|0|||
163008195|NCT05012098|588732269|FG000|Overall Study|Discontinuation per protocol|1|||
163008196|NCT05012098|588732270|FG001|Overall Study|Discontinuation per protocol|0|||
163008197|NCT01749826|588732273|FG000|Overall Study|Study Terminated|20|||
163008198|NCT01749826|588732274|FG001|Overall Study|Study Terminated|0|||
163008199|NCT00813150|588732275|FG000|Treatment Period|Adverse Event|16|||
163008200|NCT00813150|588732276|FG001|Treatment Period|Adverse Event|15|||
163008201|NCT00813150|588732275|FG000|Treatment Period|Death|2|||
163008202|NCT00813150|588732276|FG001|Treatment Period|Death|0|||
163008203|NCT00813150|588732275|FG000|Treatment Period|Progressive disease|1|||
163008204|NCT00813150|588732276|FG001|Treatment Period|Progressive disease|0|||
163008205|NCT00813150|588732275|FG000|Treatment Period|Complete response|0|||
163008206|NCT00813150|588732276|FG001|Treatment Period|Complete response|1|||
163008207|NCT00813150|588732275|FG000|Treatment Period|Stable disease|1|||
163008208|NCT00813150|588732276|FG001|Treatment Period|Stable disease|2|||
163008209|NCT00813150|588732275|FG000|Treatment Period|Protocol Violation|3|||
163008210|NCT00813150|588732276|FG001|Treatment Period|Protocol Violation|4|||
163008211|NCT00813150|588732275|FG000|Treatment Period|Withdrawal by Subject|5|||
163008212|NCT00813150|588732276|FG001|Treatment Period|Withdrawal by Subject|3|||
163008213|NCT00813150|588732275|FG000|Treatment Period|Non compliance|0|||
163008214|NCT00813150|588732276|FG001|Treatment Period|Non compliance|1|||
163008215|NCT00813150|588732275|FG000|Treatment Period|Reason not specified|3|||
163008216|NCT00813150|588732276|FG001|Treatment Period|Reason not specified|4|||
163008217|NCT00813150|588732275|FG000|Treatment Period|Data not available|1|||
163008218|NCT00813150|588732276|FG001|Treatment Period|Data not available|2|||
163008219|NCT00813150|588732275|FG000|Long Term Follow-up|Death|0|||
163008220|NCT00813150|588732276|FG001|Long Term Follow-up|Death|4|||
163008221|NCT00813150|588732275|FG000|Long Term Follow-up|Other|0|||
163008222|NCT00813150|588732276|FG001|Long Term Follow-up|Other|3|||
163061522|NCT01093846|588933145|FG002|Overall Study|Administrative Problems|15|||
163061523|NCT02781324|588933146|FG000|Overall Study|Withdrawal by Subject|1|||
163061524|NCT02781324|588933147|FG001|Overall Study|Withdrawal by Subject|0|||
163061525|NCT02781324|588933146|FG000|Overall Study|Physician Decision|1|||
163061526|NCT02781324|588933147|FG001|Overall Study|Physician Decision|2|||
163061527|NCT05020015|588934978|FG000|Overall Study|Ongoing on study|1|||
163061528|NCT05020015|588934979|FG001|Overall Study|Ongoing on study|3|||
163061529|NCT05020015|588934980|FG002|Overall Study|Ongoing on study|4|||
163061530|NCT05020015|588934981|FG003|Overall Study|Ongoing on study|7|||
163061531|NCT05020015|588934978|FG000|Overall Study|Death|2|||
163061532|NCT05020015|588934979|FG001|Overall Study|Death|3|||
163061533|NCT05020015|588934980|FG002|Overall Study|Death|4|||
163061534|NCT05020015|588934981|FG003|Overall Study|Death|0|||
163061535|NCT05020015|588934978|FG000|Overall Study|Withdrawal by Subject|0|||
163061536|NCT05020015|588934979|FG001|Overall Study|Withdrawal by Subject|0|||
163061537|NCT05020015|588934980|FG002|Overall Study|Withdrawal by Subject|1|||
163061538|NCT05020015|588934981|FG003|Overall Study|Withdrawal by Subject|0|||
163061539|NCT05020015|588934978|FG000|Overall Study|Reason Not Specified|0|||
163061540|NCT05020015|588934979|FG001|Overall Study|Reason Not Specified|0|||
163061541|NCT05020015|588934980|FG002|Overall Study|Reason Not Specified|2|||
163061542|NCT05020015|588934981|FG003|Overall Study|Reason Not Specified|0|||
163061543|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
163061544|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
163061545|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
163061546|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
163061547|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
163061548|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
163061549|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
163061550|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
163061551|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
163061552|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
163061553|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
163061554|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
163061555|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
163061556|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
163061557|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
163008223|NCT00813150|588732275|FG000|Long Term Follow-up|Lost to Follow-up|2|||
163008224|NCT00813150|588732276|FG001|Long Term Follow-up|Lost to Follow-up|0|||
163008225|NCT00813150|588732275|FG000|Long Term Follow-up|Progression/Relapse|22|||
163008226|NCT00813150|588732276|FG001|Long Term Follow-up|Progression/Relapse|24|||
163008227|NCT05085834|588732277|FG000|Overall Study|Lost to Follow-up|9|||
163008228|NCT05085834|588732278|FG001|Overall Study|Lost to Follow-up|2|||
163008229|NCT05085834|588732277|FG000|Overall Study|Adverse Event|6|||
163008230|NCT05085834|588732278|FG001|Overall Study|Adverse Event|0|||
163008231|NCT05085834|588732277|FG000|Overall Study|Death|1|||
163008232|NCT05085834|588732278|FG001|Overall Study|Death|0|||
163008233|NCT05085834|588732277|FG000|Overall Study|Inability to swallow the pill|0|||
163061558|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
163061559|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
163061560|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
163061561|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
163061562|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
163008234|NCT05085834|588732278|FG001|Overall Study|Inability to swallow the pill|1|||
163008235|NCT01823328|588732283|FG000|Overall Study|Withdrawal by Subject|8|||
163008236|NCT01823328|588732284|FG001|Overall Study|Withdrawal by Subject|6|||
163008237|NCT01662635|588732285|FG000|Overall Study|scarce samples for evaluation|30|||
163008238|NCT01217112|588732286|FG000|Overall Study|Adverse Event|0|||
163061563|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
163008239|NCT01217112|588732287|FG001|Overall Study|Adverse Event|2|||
163008240|NCT01217112|588732288|FG002|Overall Study|Adverse Event|0|||
163008241|NCT01217112|588732289|FG003|Overall Study|Adverse Event|2|||
163008242|NCT01217112|588732290|FG004|Overall Study|Adverse Event|0|||
163008243|NCT01217112|588732286|FG000|Overall Study|Withdrawal by Subject|0|||
163008244|NCT01217112|588732287|FG001|Overall Study|Withdrawal by Subject|0|||
163008245|NCT01217112|588732288|FG002|Overall Study|Withdrawal by Subject|1|||
163008246|NCT01217112|588732289|FG003|Overall Study|Withdrawal by Subject|0|||
163008247|NCT01217112|588732290|FG004|Overall Study|Withdrawal by Subject|0|||
163008248|NCT01217112|588732286|FG000|Overall Study|Physician Decision|0|||
163008249|NCT01217112|588732287|FG001|Overall Study|Physician Decision|0|||
163008250|NCT01217112|588732288|FG002|Overall Study|Physician Decision|0|||
163008251|NCT01217112|588732289|FG003|Overall Study|Physician Decision|0|||
163008252|NCT01217112|588732290|FG004|Overall Study|Physician Decision|1|||
163008253|NCT01401361|588732291|FG000|Overall Study|Withdrawal by Subject|16|||
163008254|NCT01401361|588732291|FG000|Overall Study|Lack of Efficacy|6|||
163008255|NCT01401361|588732291|FG000|Overall Study|Physician Decision|1|||
163008256|NCT01401361|588732291|FG000|Overall Study|Lost to Follow-up|3|||
163008257|NCT01401361|588732291|FG000|Overall Study|Subject/family decision post procedure|2|||
163008258|NCT00595920|588732294|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
163008259|NCT00351468|588732295|FG000|Overall Study|Adverse Event|42|||
163008260|NCT00351468|588732295|FG000|Overall Study|Withdrawal by Subject|39|||
163008261|NCT00351468|588732295|FG000|Overall Study|Various -follow up w clinical team|39|||
163008262|NCT00351468|588732295|FG000|Overall Study|Lack of Efficacy|32|||
163008263|NCT00351468|588732295|FG000|Overall Study|Non-compliance|8|||
163008264|NCT00351468|588732295|FG000|Overall Study|Lost to Follow-up|4|||
163008265|NCT00351468|588732295|FG000|Overall Study|Protocol Violation|3|||
163008266|NCT03588910|588732296|FG000|Overall Study|Withdrawal by Subject|1|||
163008267|NCT03588910|588732297|FG001|Overall Study|Withdrawal by Subject|0|||
163008268|NCT03588910|588732296|FG000|Overall Study|Allergy|2|||
163008269|NCT03588910|588732297|FG001|Overall Study|Allergy|0|||
163008270|NCT03588910|588732296|FG000|Overall Study|Protocol Violation|0|||
163008271|NCT03588910|588732297|FG001|Overall Study|Protocol Violation|3|||
163008272|NCT03588910|588732296|FG000|Overall Study|Did not complete Day 1 Survey|5|||
163008273|NCT03588910|588732297|FG001|Overall Study|Did not complete Day 1 Survey|10|||
163008274|NCT03588910|588732296|FG000|Overall Study|Did not complete Day 7 Survey|5|||
163008275|NCT03588910|588732297|FG001|Overall Study|Did not complete Day 7 Survey|2|||
163008276|NCT03096314|588732298|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
163008277|NCT03096314|588732299|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
163008278|NCT00471822|588732300|FG000|Overall Study|Protocol Violation|2|||
163008279|NCT03318861|588732301|FG000|Overall Study|Death|2|||
163008280|NCT03318861|588732302|FG001|Overall Study|Death|3|||
163008281|NCT03318861|588732303|FG002|Overall Study|Death|3|||
163008282|NCT03318861|588732304|FG003|Overall Study|Death|2|||
163008283|NCT03318861|588732305|FG004|Overall Study|Death|2|||
163008284|NCT03318861|588732301|FG000|Overall Study|Enrolled But Never Treated|0|||
163008285|NCT03318861|588732302|FG001|Overall Study|Enrolled But Never Treated|1|||
163008286|NCT03318861|588732303|FG002|Overall Study|Enrolled But Never Treated|0|||
163008287|NCT03318861|588732304|FG003|Overall Study|Enrolled But Never Treated|1|||
163008288|NCT03318861|588732305|FG004|Overall Study|Enrolled But Never Treated|1|||
163008289|NCT03318861|588732301|FG000|Overall Study|Informed Consent Withdraw|0|||
163008290|NCT03318861|588732302|FG001|Overall Study|Informed Consent Withdraw|0|||
163008291|NCT03318861|588732303|FG002|Overall Study|Informed Consent Withdraw|0|||
163008292|NCT03318861|588732304|FG003|Overall Study|Informed Consent Withdraw|1|||
163008293|NCT03318861|588732305|FG004|Overall Study|Informed Consent Withdraw|0|||
163008294|NCT03318861|588732301|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
163008295|NCT03318861|588732302|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008296|NCT03318861|588732303|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008297|NCT03318861|588732304|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008298|NCT03318861|588732305|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
163008299|NCT02844933|588732306|FG000|Overall Study|Discontinued due to premature termination of study|3|||
163008300|NCT02844933|588732307|FG001|Overall Study|Discontinued due to premature termination of study|2|||
163008301|NCT01479465|588732308|FG000|Overall Study|Disease Progression|9|||
163008302|NCT01479465|588732309|FG001|Overall Study|Disease Progression|61|||
163008303|NCT01479465|588732310|FG002|Overall Study|Disease Progression|65|||
163008304|NCT01479465|588732311|FG003|Overall Study|Disease Progression|70|||
163008305|NCT01479465|588732308|FG000|Overall Study|Study Discontinued by Sponsor|0|||
163008306|NCT01479465|588732309|FG001|Overall Study|Study Discontinued by Sponsor|7|||
163008307|NCT01479465|588732310|FG002|Overall Study|Study Discontinued by Sponsor|5|||
163008308|NCT01479465|588732311|FG003|Overall Study|Study Discontinued by Sponsor|3|||
163008309|NCT01479465|588732308|FG000|Overall Study|Adverse Event|0|||
163008310|NCT01479465|588732309|FG001|Overall Study|Adverse Event|3|||
163061564|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
162638867|NCT00498602|587394333|FG002|Overall Study|Other|1|||
162638868|NCT00498602|587394334|FG003|Overall Study|Other|0|||
163008311|NCT01479465|588732310|FG002|Overall Study|Adverse Event|6|||
163008312|NCT01479465|588732311|FG003|Overall Study|Adverse Event|4|||
163008313|NCT01479465|588732308|FG000|Overall Study|Investigator Discretion|1|||
163008314|NCT01479465|588732309|FG001|Overall Study|Investigator Discretion|4|||
163008315|NCT01479465|588732310|FG002|Overall Study|Investigator Discretion|2|||
163008316|NCT01479465|588732311|FG003|Overall Study|Investigator Discretion|4|||
163008317|NCT01479465|588732308|FG000|Overall Study|Subject Request|1|||
163008318|NCT01479465|588732309|FG001|Overall Study|Subject Request|3|||
163008319|NCT01479465|588732310|FG002|Overall Study|Subject Request|4|||
163008320|NCT01479465|588732311|FG003|Overall Study|Subject Request|2|||
163008321|NCT01479465|588732308|FG000|Overall Study|Subject Withdrew Consent|0|||
163008322|NCT01479465|588732309|FG001|Overall Study|Subject Withdrew Consent|5|||
163008323|NCT01479465|588732310|FG002|Overall Study|Subject Withdrew Consent|2|||
163008324|NCT01479465|588732311|FG003|Overall Study|Subject Withdrew Consent|1|||
163008325|NCT01479465|588732308|FG000|Overall Study|Protocol Violation|0|||
163008326|NCT01479465|588732309|FG001|Overall Study|Protocol Violation|1|||
163008327|NCT01479465|588732310|FG002|Overall Study|Protocol Violation|1|||
163008328|NCT01479465|588732311|FG003|Overall Study|Protocol Violation|0|||
163008329|NCT01479465|588732308|FG000|Overall Study|Death|0|||
163008330|NCT01479465|588732309|FG001|Overall Study|Death|0|||
163008331|NCT01479465|588732310|FG002|Overall Study|Death|0|||
163008332|NCT01479465|588732311|FG003|Overall Study|Death|1|||
163008333|NCT01479465|588732308|FG000|Overall Study|Lost to Follow-up|0|||
163008334|NCT01479465|588732309|FG001|Overall Study|Lost to Follow-up|0|||
163008335|NCT01479465|588732310|FG002|Overall Study|Lost to Follow-up|1|||
163008336|NCT01479465|588732311|FG003|Overall Study|Lost to Follow-up|0|||
163008337|NCT01892501|588732312|FG000|Overall Study|Protocol Violation|2|||
163008338|NCT01892501|588732312|FG000|Overall Study|Puncture not carried out|9|||
163008339|NCT01892501|588732312|FG000|Overall Study|Radiological monitoring not carried out|5|||
163008340|NCT01892501|588732312|FG000|Overall Study|Non-contributory histological result|12|||
163008341|NCT04335123|588732316|FG000|Overall Study|Withdrawal by Subject|2|||
163008342|NCT04335123|588732317|FG001|Overall Study|Withdrawal by Subject|0|||
163008343|NCT04335123|588732316|FG000|Overall Study|Physician Decision|2|||
163008344|NCT04335123|588732317|FG001|Overall Study|Physician Decision|0|||
163008345|NCT01439802|588732318|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
163008346|NCT01439802|588732318|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
163008347|NCT02088177|588732324|FG000|Overall Study|Lost to Follow-up|3|||
163008348|NCT01234350|588732325|FG000|Overall Study|Adverse Event|277|||
163008349|NCT01234350|588732326|FG001|Overall Study|Adverse Event|92|||
163008350|NCT01234350|588732325|FG000|Overall Study|Withdrawal by Subject|61|||
163008351|NCT01234350|588732326|FG001|Overall Study|Withdrawal by Subject|36|||
163008352|NCT01234350|588732325|FG000|Overall Study|Lost to Follow-up|115|||
163008353|NCT01234350|588732326|FG001|Overall Study|Lost to Follow-up|47|||
163008354|NCT01234350|588732325|FG000|Overall Study|Covers a diverse set of reasons|234|||
163008355|NCT01234350|588732326|FG001|Overall Study|Covers a diverse set of reasons|92|||
163008356|NCT00289848|588732327|FG000|Overall Study|Adverse Event|6|||
163008357|NCT00289848|588732328|FG001|Overall Study|Adverse Event|4|||
163008358|NCT00289848|588732327|FG000|Overall Study|Death|1|||
163008359|NCT00289848|588732328|FG001|Overall Study|Death|0|||
163008360|NCT00289848|588732327|FG000|Overall Study|Lack of Efficacy|20|||
163061565|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
163061566|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
163061567|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
163061568|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
162638869|NCT00498602|587394335|FG004|Overall Study|Other|0|||
162638870|NCT00498602|587394336|FG005|Overall Study|Other|3|||
162638871|NCT00498602|587394337|FG006|Overall Study|Other|0|||
162638872|NCT03318315|587394341|FG000|Overall Study|Lost to Follow-up|3|||
162638873|NCT03318315|587394342|FG001|Overall Study|Lost to Follow-up|2|||
162638874|NCT03318315|587394343|FG002|Overall Study|Lost to Follow-up|1|||
162638875|NCT03318315|587394341|FG000|Overall Study|Protocol Violation|1|||
162638876|NCT03318315|587394342|FG001|Overall Study|Protocol Violation|1|||
163008361|NCT00289848|588732328|FG001|Overall Study|Lack of Efficacy|24|||
163008362|NCT00289848|588732327|FG000|Overall Study|Lost to Follow-up|3|||
163008363|NCT00289848|588732328|FG001|Overall Study|Lost to Follow-up|1|||
163008364|NCT00289848|588732327|FG000|Overall Study|Protocol Violation|5|||
163008365|NCT00289848|588732328|FG001|Overall Study|Protocol Violation|2|||
163008366|NCT00289848|588732327|FG000|Overall Study|Withdrawal by Subject|5|||
162638877|NCT03318315|587394343|FG002|Overall Study|Protocol Violation|1|||
163008367|NCT00289848|588732328|FG001|Overall Study|Withdrawal by Subject|11|||
163008368|NCT00289848|588732327|FG000|Overall Study|Patient Moved|6|||
163008369|NCT00289848|588732328|FG001|Overall Study|Patient Moved|2|||
163008370|NCT00289848|588732327|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
162638878|NCT03318315|587394341|FG000|Overall Study|Withdrawal by Subject|0|||
162638879|NCT03318315|587394342|FG001|Overall Study|Withdrawal by Subject|0|||
163008371|NCT00289848|588732328|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
163008372|NCT01433471|588732331|FG000|Overall Study|Withdrawal by Subject|0|||
163008373|NCT01433471|588732332|FG001|Overall Study|Withdrawal by Subject|1|||
163008374|NCT03428152|588732337|FG000|Overall Study|Physician Decision|4|||
163008375|NCT03428152|588732338|FG001|Overall Study|Physician Decision|2|||
163008376|NCT03428152|588732337|FG000|Overall Study|Protocol Violation|3|||
163008377|NCT03428152|588732338|FG001|Overall Study|Protocol Violation|5|||
163008378|NCT03428152|588732337|FG000|Overall Study|Lack of Efficacy|0|||
163008379|NCT03428152|588732338|FG001|Overall Study|Lack of Efficacy|4|||
163008380|NCT00395629|588732339|FG000|Core Study|Adverse Event|0|||
163008381|NCT00395629|588732340|FG001|Core Study|Adverse Event|3|||
163008382|NCT00395629|588732341|FG002|Core Study|Adverse Event|4|||
163008383|NCT00395629|588732339|FG000|Core Study|Abnormal laboratory value(s)|0|||
163008384|NCT00395629|588732340|FG001|Core Study|Abnormal laboratory value(s)|0|||
163008385|NCT00395629|588732341|FG002|Core Study|Abnormal laboratory value(s)|1|||
163008386|NCT00395629|588732339|FG000|Core Study|Protocol Violation|1|||
163008387|NCT00395629|588732340|FG001|Core Study|Protocol Violation|0|||
163008388|NCT00395629|588732341|FG002|Core Study|Protocol Violation|0|||
163008389|NCT00395629|588732339|FG000|Core Study|Withdrawal by Subject|0|||
163008390|NCT00395629|588732340|FG001|Core Study|Withdrawal by Subject|1|||
163008391|NCT00395629|588732341|FG002|Core Study|Withdrawal by Subject|1|||
163008392|NCT00395629|588732339|FG000|Core Study|Lost to Follow-up|0|||
163008393|NCT00395629|588732340|FG001|Core Study|Lost to Follow-up|0|||
163008394|NCT00395629|588732341|FG002|Core Study|Lost to Follow-up|1|||
163008395|NCT00395629|588732339|FG000|Extension Study|Adverse Event|0|||
163008396|NCT00395629|588732340|FG001|Extension Study|Adverse Event|0|||
163008397|NCT00395629|588732341|FG002|Extension Study|Adverse Event|2|||
163008398|NCT00395629|588732339|FG000|Extension Study|Administrative problems|0|||
163008399|NCT00395629|588732340|FG001|Extension Study|Administrative problems|0|||
163008400|NCT00395629|588732341|FG002|Extension Study|Administrative problems|1|||
163008401|NCT01686373|588732342|FG000|Overall Study|Lost to Follow-up|3|||
163008402|NCT01686373|588732343|FG001|Overall Study|Lost to Follow-up|0|||
163008403|NCT01686373|588732342|FG000|Overall Study|Withdrawal by Subject|0|||
163008404|NCT01686373|588732343|FG001|Overall Study|Withdrawal by Subject|1|||
163008405|NCT01686373|588732342|FG000|Overall Study|Adverse Event|0|||
163008406|NCT01686373|588732343|FG001|Overall Study|Adverse Event|1|||
163008407|NCT02285361|588732353|FG000|Overall Study|Protocol Violation|43|||
163008408|NCT02285361|588732353|FG000|Overall Study|Lost to Follow-up|5|||
163008409|NCT02285361|588732353|FG000|Overall Study|Not taken GIOTRIF|2|||
163008410|NCT02285361|588732353|FG000|Overall Study|Consented prior to the contract date|1|||
163008411|NCT00191477|588732354|FG000|Overall Study|Tumor Recurrence|49|||
163008412|NCT00191477|588732355|FG001|Overall Study|Tumor Recurrence|48|||
163008413|NCT00191477|588732354|FG000|Overall Study|Death, Study Disease|1|||
163008414|NCT00191477|588732355|FG001|Overall Study|Death, Study Disease|1|||
163008415|NCT00191477|588732354|FG000|Overall Study|Death, Other Cause|3|||
163008416|NCT00191477|588732355|FG001|Overall Study|Death, Other Cause|6|||
163008417|NCT00191477|588732354|FG000|Overall Study|Lost to Follow-up|23|||
163008418|NCT00191477|588732355|FG001|Overall Study|Lost to Follow-up|21|||
163008419|NCT00191477|588732354|FG000|Overall Study|Protocol Violation|1|||
163008420|NCT00191477|588732355|FG001|Overall Study|Protocol Violation|1|||
163008421|NCT00191477|588732354|FG000|Overall Study|Treatment Change|2|||
163008422|NCT00191477|588732355|FG001|Overall Study|Treatment Change|0|||
163008423|NCT00191477|588732354|FG000|Overall Study|Withdrawal by Subject|2|||
163008424|NCT00191477|588732355|FG001|Overall Study|Withdrawal by Subject|0|||
163008425|NCT00191477|588732354|FG000|Overall Study|Other|2|||
163008426|NCT00191477|588732355|FG001|Overall Study|Other|0|||
163008427|NCT00191477|588732354|FG000|Overall Study|Not Eligible|41|||
163008428|NCT00191477|588732355|FG001|Overall Study|Not Eligible|38|||
163008429|NCT00191477|588732354|FG000|Overall Study|Pathological Specimen Lost|1|||
163008430|NCT00191477|588732355|FG001|Overall Study|Pathological Specimen Lost|0|||
163008431|NCT00191477|588732354|FG000|Overall Study|Discontinued Prior to Instillation|13|||
163008432|NCT00191477|588732355|FG001|Overall Study|Discontinued Prior to Instillation|14|||
163008433|NCT02411656|588732356|FG000|Overall Study|Adverse Event|4|||
163008434|NCT02411656|588732356|FG000|Overall Study|Clinical Progression|33|||
163008435|NCT06481709|588732357|FG000|Overall Study|Withdrawal by Subject|0|||
163008436|NCT06481709|588732358|FG001|Overall Study|Withdrawal by Subject|0|||
163008437|NCT06481709|588732359|FG002|Overall Study|Withdrawal by Subject|2|||
163008438|NCT06481709|588732360|FG003|Overall Study|Withdrawal by Subject|0|||
163008439|NCT05366010|588732362|FG000|Overall Study|Withdrawal by Subject|1|||
163008440|NCT05366010|588732362|FG000|Overall Study|Protocol Violation|1|||
163008441|NCT05366010|588732362|FG000|Overall Study|Lost to Follow-up|2|||
163008442|NCT05366010|588732362|FG000|Overall Study|Screen Failure|2|||
163008443|NCT02224157|588732363|FG000|Overall Study|Severe non-compliance to protocol|2|||
163008444|NCT02224157|588732364|FG001|Overall Study|Severe non-compliance to protocol|2|||
163008445|NCT02224157|588732363|FG000|Overall Study|Other|13|||
163008446|NCT02224157|588732364|FG001|Overall Study|Other|10|||
163008447|NCT02224157|588732363|FG000|Overall Study|Subject decision|58|||
163008448|NCT02224157|588732364|FG001|Overall Study|Subject decision|50|||
163008449|NCT02224157|588732363|FG000|Overall Study|Prematurely closed site|4|||
163008450|NCT02224157|588732364|FG001|Overall Study|Prematurely closed site|2|||
163008451|NCT02224157|588732363|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
163008452|NCT02224157|588732364|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
163008453|NCT02224157|588732363|FG000|Overall Study|Lost to Follow-up|27|||
163008454|NCT02224157|588732364|FG001|Overall Study|Lost to Follow-up|35|||
163008455|NCT02224157|588732363|FG000|Overall Study|Death|1|||
163008456|NCT02224157|588732364|FG001|Overall Study|Death|1|||
163008457|NCT02224157|588732363|FG000|Overall Study|Adverse Event|1|||
163008458|NCT02224157|588732364|FG001|Overall Study|Adverse Event|3|||
163008459|NCT05906628|588732365|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
163008460|NCT05906628|588732366|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
163008461|NCT05906628|588732365|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
163008462|NCT05906628|588732366|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
162638880|NCT03318315|587394343|FG002|Overall Study|Withdrawal by Subject|2|||
162638881|NCT02617511|587394354|FG000|Overall Study|Withdrawal by Subject|1|||
162638882|NCT02617511|587394355|FG001|Overall Study|Withdrawal by Subject|0|||
162638883|NCT00811473|587394356|FG000|Overall Study|Adverse Event|3|||
162638884|NCT00811473|587394357|FG001|Overall Study|Adverse Event|12|||
162638885|NCT00811473|587394356|FG000|Overall Study|Lost to Follow-up|5|||
162638886|NCT00811473|587394357|FG001|Overall Study|Lost to Follow-up|1|||
162638887|NCT00811473|587394356|FG000|Overall Study|Withdrawal by Subject|2|||
162638888|NCT00811473|587394357|FG001|Overall Study|Withdrawal by Subject|4|||
162638889|NCT00811473|587394356|FG000|Overall Study|Severe non-compliance to protocol|2|||
162638890|NCT00811473|587394357|FG001|Overall Study|Severe non-compliance to protocol|4|||
162638891|NCT00811473|587394356|FG000|Overall Study|Lack of therapeutic response|4|||
162638892|NCT00811473|587394357|FG001|Overall Study|Lack of therapeutic response|1|||
162638893|NCT00811473|587394356|FG000|Overall Study|Condition under investigation worsened|1|||
162638894|NCT00811473|587394357|FG001|Overall Study|Condition under investigation worsened|3|||
162638895|NCT00811473|587394356|FG000|Overall Study|Other 2|4|||
162638896|NCT00811473|587394357|FG001|Overall Study|Other 2|1|||
162638897|NCT00811473|587394356|FG000|Overall Study|Incorrect Enrollment|1|||
162638898|NCT00811473|587394357|FG001|Overall Study|Incorrect Enrollment|0|||
162638899|NCT00811473|587394356|FG000|Overall Study|Safety Reasons|1|||
162638900|NCT00811473|587394357|FG001|Overall Study|Safety Reasons|0|||
162638901|NCT01119131|587394361|FG000|Overall Study|Adverse Event|1|||
162638902|NCT01119131|587394362|FG001|Overall Study|Adverse Event|1|||
162638903|NCT01119131|587394363|FG002|Overall Study|Adverse Event|1|||
162638904|NCT01119131|587394361|FG000|Overall Study|Non-Compliance|1|||
162638905|NCT01119131|587394362|FG001|Overall Study|Non-Compliance|0|||
162638906|NCT01119131|587394363|FG002|Overall Study|Non-Compliance|4|||
162638907|NCT01119131|587394361|FG000|Overall Study|Physician Decision|0|||
162638908|NCT01119131|587394362|FG001|Overall Study|Physician Decision|0|||
162638909|NCT01119131|587394363|FG002|Overall Study|Physician Decision|1|||
162638910|NCT00573534|587394364|FG000|Overall Study|oppositional behavior|3|||
162638911|NCT02457910|587394365|FG000|Overall Study|Withdrawal by Subject|0|||
162638912|NCT02457910|587394366|FG001|Overall Study|Withdrawal by Subject|0|||
162638913|NCT02457910|587394367|FG002|Overall Study|Withdrawal by Subject|0|||
162638914|NCT02457910|587394368|FG003|Overall Study|Withdrawal by Subject|0|||
162638915|NCT02457910|587394369|FG004|Overall Study|Withdrawal by Subject|0|||
162638916|NCT02457910|587394370|FG005|Overall Study|Withdrawal by Subject|1|||
162638917|NCT02457910|587394365|FG000|Overall Study|Adverse Event|0|||
162638918|NCT02457910|587394366|FG001|Overall Study|Adverse Event|2|||
162638919|NCT02457910|587394367|FG002|Overall Study|Adverse Event|1|||
162638920|NCT02457910|587394368|FG003|Overall Study|Adverse Event|1|||
162638921|NCT02457910|587394369|FG004|Overall Study|Adverse Event|1|||
162638922|NCT02457910|587394370|FG005|Overall Study|Adverse Event|3|||
162638923|NCT02457910|587394365|FG000|Overall Study|Disease progression|3|||
162638924|NCT02457910|587394366|FG001|Overall Study|Disease progression|3|||
162638925|NCT02457910|587394367|FG002|Overall Study|Disease progression|1|||
162638926|NCT02457910|587394368|FG003|Overall Study|Disease progression|1|||
162638927|NCT02457910|587394369|FG004|Overall Study|Disease progression|4|||
162638928|NCT02457910|587394370|FG005|Overall Study|Disease progression|6|||
162638929|NCT02457910|587394365|FG000|Overall Study|Other complicating illness|0|||
162638930|NCT02457910|587394366|FG001|Overall Study|Other complicating illness|0|||
162638931|NCT02457910|587394367|FG002|Overall Study|Other complicating illness|0|||
162638932|NCT02457910|587394368|FG003|Overall Study|Other complicating illness|0|||
162638933|NCT02457910|587394369|FG004|Overall Study|Other complicating illness|0|||
162638934|NCT02457910|587394370|FG005|Overall Study|Other complicating illness|1|||
162638935|NCT02457910|587394365|FG000|Overall Study|Death|0|||
163008463|NCT05906628|588732365|FG000|16-Week DBVC Period|Protocol Violation|4|||
163008464|NCT05906628|588732366|FG001|16-Week DBVC Period|Protocol Violation|2|||
162638936|NCT02457910|587394366|FG001|Overall Study|Death|0|||
162638937|NCT02457910|587394367|FG002|Overall Study|Death|1|||
163008465|NCT05906628|588732365|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
163008466|NCT05906628|588732366|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
162638938|NCT02457910|587394368|FG003|Overall Study|Death|0|||
162638939|NCT02457910|587394369|FG004|Overall Study|Death|0|||
162638940|NCT02457910|587394370|FG005|Overall Study|Death|0|||
162638941|NCT01339429|587394371|FG000|Overall Study|Withdrawal by Subject|1|||
162638942|NCT01339429|587394371|FG000|Overall Study|Physician Decision|3|||
162638943|NCT00459667|587394374|FG000|Overall Study|Adverse Event|9|||
162638944|NCT00459667|587394375|FG001|Overall Study|Adverse Event|12|||
162638945|NCT00459667|587394376|FG002|Overall Study|Adverse Event|8|||
162638946|NCT00459667|587394374|FG000|Overall Study|Lost to Follow-up|5|||
162638947|NCT00459667|587394375|FG001|Overall Study|Lost to Follow-up|9|||
162638948|NCT00459667|587394376|FG002|Overall Study|Lost to Follow-up|3|||
162638949|NCT00459667|587394374|FG000|Overall Study|Pregnancy|1|||
162638950|NCT00459667|587394375|FG001|Overall Study|Pregnancy|1|||
162638951|NCT00459667|587394376|FG002|Overall Study|Pregnancy|1|||
162638952|NCT00459667|587394374|FG000|Overall Study|Protocol Violation|1|||
162638953|NCT00459667|587394375|FG001|Overall Study|Protocol Violation|0|||
162638954|NCT00459667|587394376|FG002|Overall Study|Protocol Violation|0|||
162638955|NCT00459667|587394374|FG000|Overall Study|Withdrawal by Subject|3|||
162638956|NCT00459667|587394375|FG001|Overall Study|Withdrawal by Subject|5|||
162638957|NCT00459667|587394376|FG002|Overall Study|Withdrawal by Subject|5|||
162638958|NCT00459667|587394374|FG000|Overall Study|Other disease modifying treatment|1|||
162638959|NCT00459667|587394375|FG001|Overall Study|Other disease modifying treatment|2|||
162638960|NCT00459667|587394376|FG002|Overall Study|Other disease modifying treatment|1|||
162638961|NCT00459667|587394374|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
162638962|NCT00459667|587394375|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
162638963|NCT00459667|587394376|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
162638964|NCT00459667|587394374|FG000|Overall Study|No treatment administered|6|||
162638965|NCT00459667|587394375|FG001|Overall Study|No treatment administered|3|||
162638966|NCT00459667|587394376|FG002|Overall Study|No treatment administered|1|||
162638967|NCT01013701|587394377|FG000|Overall Study|study prematurely terminated|7|||
162638968|NCT00556712|587394381|FG000|Overall Study|Adverse Event|7|||
162638969|NCT00556712|587394382|FG001|Overall Study|Adverse Event|19|||
162638970|NCT00556712|587394381|FG000|Overall Study|Death|5|||
162638971|NCT00556712|587394382|FG001|Overall Study|Death|10|||
162638972|NCT00556712|587394381|FG000|Overall Study|Progressive Disease|383|||
162638973|NCT00556712|587394382|FG001|Overall Study|Progressive Disease|320|||
162638974|NCT00556712|587394381|FG000|Overall Study|Protocol Violation|3|||
162638975|NCT00556712|587394382|FG001|Overall Study|Protocol Violation|2|||
162638976|NCT00556712|587394381|FG000|Overall Study|Refused Treatment|17|||
162638977|NCT00556712|587394382|FG001|Overall Study|Refused Treatment|16|||
162638978|NCT00556712|587394381|FG000|Overall Study|Failure to Return|2|||
162638979|NCT00556712|587394382|FG001|Overall Study|Failure to Return|3|||
162638980|NCT00556712|587394381|FG000|Overall Study|Other|2|||
162638981|NCT00556712|587394382|FG001|Overall Study|Other|2|||
162638982|NCT00556712|587394381|FG000|Overall Study|Ongoing at Data Cutoff|32|||
162638983|NCT00556712|587394382|FG001|Overall Study|Ongoing at Data Cutoff|66|||
162638984|NCT01059799|587394383|FG000|Overall Study|Adverse Event|2|||
162638985|NCT01059799|587394384|FG001|Overall Study|Adverse Event|3|||
162638986|NCT01059799|587394383|FG000|Overall Study|Lack of Efficacy|1|||
162638987|NCT01059799|587394384|FG001|Overall Study|Lack of Efficacy|0|||
162638988|NCT01059799|587394383|FG000|Overall Study|Protocol Violation|3|||
162638989|NCT01059799|587394384|FG001|Overall Study|Protocol Violation|2|||
162638990|NCT01059799|587394383|FG000|Overall Study|Withdrawal criteria|13|||
162638991|NCT01059799|587394384|FG001|Overall Study|Withdrawal criteria|2|||
163008467|NCT05906628|588732365|FG000|16-Week OLE Period|Death|1|||
163008468|NCT05906628|588732366|FG001|16-Week OLE Period|Death|0|||
163008469|NCT05906628|588732365|FG000|16-Week OLE Period|Lost to Follow-up|1|||
163008470|NCT05906628|588732366|FG001|16-Week OLE Period|Lost to Follow-up|1|||
163008471|NCT05906628|588732365|FG000|16-Week OLE Period|Protocol Violation|0|||
163008472|NCT05906628|588732366|FG001|16-Week OLE Period|Protocol Violation|1|||
163008473|NCT05906628|588732365|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
163008474|NCT05906628|588732366|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
163008475|NCT01108718|588732367|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
163008476|NCT01108718|588732368|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
163008477|NCT02857816|588732371|FG000|Overall Study|Screen Failure|33|||
163008478|NCT02857816|588732371|FG000|Overall Study|Withdrawal by Subject|4|||
162638992|NCT01059799|587394383|FG000|Overall Study|Other|12|||
162638993|NCT01059799|587394384|FG001|Overall Study|Other|3|||
162638994|NCT01361464|587394385|FG000|Overall Study|Death|1|||
162638995|NCT01361464|587394385|FG000|Overall Study|Withdrawal by Subject|2|||
162638996|NCT00818662|587394390|FG000|Overall Study|Adverse Event|5|||
162638997|NCT00818662|587394391|FG001|Overall Study|Adverse Event|14|||
162638998|NCT00818662|587394392|FG002|Overall Study|Adverse Event|4|||
162638999|NCT00818662|587394393|FG003|Overall Study|Adverse Event|3|||
163008479|NCT02857816|588732371|FG000|Overall Study|Lost to Follow-up|1|||
162639000|NCT00818662|587394390|FG000|Overall Study|Withdrawal by Subject|5|||
162639001|NCT00818662|587394391|FG001|Overall Study|Withdrawal by Subject|4|||
162639002|NCT00818662|587394392|FG002|Overall Study|Withdrawal by Subject|2|||
162639003|NCT00818662|587394393|FG003|Overall Study|Withdrawal by Subject|2|||
163008480|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008481|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008482|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008483|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008484|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008485|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
163008486|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008487|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008488|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008489|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008490|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
163008491|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
163008492|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
162639004|NCT00818662|587394390|FG000|Overall Study|Death|1|||
162639005|NCT00818662|587394391|FG001|Overall Study|Death|3|||
162639006|NCT00818662|587394392|FG002|Overall Study|Death|0|||
162639007|NCT00818662|587394393|FG003|Overall Study|Death|0|||
162639008|NCT00818662|587394390|FG000|Overall Study|Physician Decision|1|||
163008493|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008494|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008495|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008496|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008497|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
163008498|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008499|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008500|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008501|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
163008502|NCT02443740|588732372|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008503|NCT02443740|588732373|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008504|NCT02443740|588732374|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008505|NCT02443740|588732375|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008506|NCT02443740|588732376|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008507|NCT02443740|588732377|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
163008508|NCT02443740|588732378|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008509|NCT02443740|588732379|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008510|NCT02443740|588732380|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008511|NCT02443740|588732381|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008512|NCT02443740|588732382|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
163008513|NCT02046603|588732383|FG000|Overall Study|Other|11|||
163008514|NCT02046603|588732384|FG001|Overall Study|Other|66|||
163008515|NCT02046603|588732383|FG000|Overall Study|Protocol Violation|0|||
163008516|NCT02046603|588732384|FG001|Overall Study|Protocol Violation|1|||
163008517|NCT02046603|588732383|FG000|Overall Study|Participant/legal guardian decision|1|||
163008518|NCT02046603|588732384|FG001|Overall Study|Participant/legal guardian decision|3|||
163008519|NCT02046603|588732383|FG000|Overall Study|Physician Decision|2|||
163008520|NCT02046603|588732384|FG001|Overall Study|Physician Decision|1|||
163008521|NCT02046603|588732383|FG000|Overall Study|Lost to Follow-up|1|||
163008522|NCT02046603|588732384|FG001|Overall Study|Lost to Follow-up|2|||
163008523|NCT02046603|588732383|FG000|Overall Study|Death|0|||
163008524|NCT02046603|588732384|FG001|Overall Study|Death|1|||
163008525|NCT02046603|588732383|FG000|Overall Study|Adverse Event|0|||
163008526|NCT02046603|588732384|FG001|Overall Study|Adverse Event|1|||
163008527|NCT02461160|588732385|FG000|Overall Study|Lost to Follow-up|0|||
163008528|NCT02461160|588732386|FG001|Overall Study|Lost to Follow-up|0|||
163008529|NCT02461160|588732387|FG002|Overall Study|Lost to Follow-up|0|||
163008530|NCT02461160|588732388|FG003|Overall Study|Lost to Follow-up|0|||
163008531|NCT02461160|588732389|FG004|Overall Study|Lost to Follow-up|0|||
163008532|NCT02461160|588732390|FG005|Overall Study|Lost to Follow-up|0|||
163008533|NCT02461160|588732391|FG006|Overall Study|Lost to Follow-up|0|||
163008534|NCT02461160|588732392|FG007|Overall Study|Lost to Follow-up|1|||
162639009|NCT00818662|587394391|FG001|Overall Study|Physician Decision|0|||
162639010|NCT00818662|587394392|FG002|Overall Study|Physician Decision|0|||
162639011|NCT00818662|587394393|FG003|Overall Study|Physician Decision|0|||
162639012|NCT00818662|587394390|FG000|Overall Study|Lost to Follow-up|0|||
163008535|NCT02461160|588732393|FG008|Overall Study|Lost to Follow-up|0|||
163008536|NCT02461160|588732394|FG009|Overall Study|Lost to Follow-up|0|||
163008537|NCT02461160|588732395|FG010|Overall Study|Lost to Follow-up|0|||
163008538|NCT02461160|588732396|FG011|Overall Study|Lost to Follow-up|0|||
163008539|NCT02461160|588732397|FG012|Overall Study|Lost to Follow-up|0|||
162639013|NCT00818662|587394391|FG001|Overall Study|Lost to Follow-up|0|||
162639014|NCT00818662|587394392|FG002|Overall Study|Lost to Follow-up|0|||
162639015|NCT00818662|587394393|FG003|Overall Study|Lost to Follow-up|1|||
162639016|NCT00818662|587394390|FG000|Overall Study|Unwilling or Unable to Participate|4|||
163008540|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
163008541|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
162639017|NCT00818662|587394391|FG001|Overall Study|Unwilling or Unable to Participate|6|||
162639018|NCT00818662|587394392|FG002|Overall Study|Unwilling or Unable to Participate|2|||
162639019|NCT00818662|587394393|FG003|Overall Study|Unwilling or Unable to Participate|4|||
162639020|NCT00818662|587394390|FG000|Overall Study|Protocol Violation|1|||
162639021|NCT00818662|587394391|FG001|Overall Study|Protocol Violation|1|||
162639022|NCT00818662|587394392|FG002|Overall Study|Protocol Violation|0|||
162639023|NCT00818662|587394393|FG003|Overall Study|Protocol Violation|0|||
162639024|NCT00818662|587394390|FG000|Overall Study|Requires a Prohibited Medication|1|||
162639025|NCT00818662|587394391|FG001|Overall Study|Requires a Prohibited Medication|0|||
162639026|NCT00818662|587394392|FG002|Overall Study|Requires a Prohibited Medication|0|||
162639027|NCT00818662|587394393|FG003|Overall Study|Requires a Prohibited Medication|0|||
162639028|NCT00818662|587394390|FG000|Overall Study|Safety Risk|1|||
162639029|NCT00818662|587394391|FG001|Overall Study|Safety Risk|1|||
162639030|NCT00818662|587394392|FG002|Overall Study|Safety Risk|0|||
162639031|NCT00818662|587394393|FG003|Overall Study|Safety Risk|1|||
162639032|NCT00818662|587394390|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
162639033|NCT00818662|587394391|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
162639034|NCT00818662|587394392|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
162639035|NCT00818662|587394393|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
162639036|NCT00818662|587394390|FG000|Overall Study|Participant's health declined|0|||
162639037|NCT00818662|587394391|FG001|Overall Study|Participant's health declined|0|||
162639038|NCT00818662|587394392|FG002|Overall Study|Participant's health declined|0|||
162639039|NCT00818662|587394393|FG003|Overall Study|Participant's health declined|1|||
162639040|NCT00818662|587394390|FG000|Overall Study|Caregiver to pursue other treatment|0|||
162639041|NCT00818662|587394391|FG001|Overall Study|Caregiver to pursue other treatment|1|||
162639042|NCT00818662|587394392|FG002|Overall Study|Caregiver to pursue other treatment|0|||
163008542|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Physician Decision|2|||
163008543|NCT00193050|588732398|FG000|Neoadjuvant Treatment|Adverse Event|2|||
163008544|NCT00193050|588732398|FG000|Adjuvant|Physician Decision|5|||
163008545|NCT00193050|588732398|FG000|Adjuvant|Intercurrent Hospitalization|3|||
163008546|NCT00193050|588732398|FG000|Adjuvant|Lack of Efficacy|2|||
163008547|NCT02431364|588732399|FG000|Overall Study|Adverse Event|0|||
163008548|NCT02431364|588732400|FG001|Overall Study|Adverse Event|1|||
163008549|NCT02431364|588732401|FG002|Overall Study|Adverse Event|0|||
163008550|NCT02431364|588732402|FG003|Overall Study|Adverse Event|0|||
163008551|NCT02431364|588732403|FG004|Overall Study|Adverse Event|0|||
163008552|NCT02431364|588732399|FG000|Overall Study|Randomized but never treated|0|||
163008553|NCT02431364|588732400|FG001|Overall Study|Randomized but never treated|0|||
163008554|NCT02431364|588732401|FG002|Overall Study|Randomized but never treated|0|||
162639043|NCT00818662|587394393|FG003|Overall Study|Caregiver to pursue other treatment|0|||
162639044|NCT00818662|587394390|FG000|Overall Study|Moving out of state|0|||
162639045|NCT00818662|587394391|FG001|Overall Study|Moving out of state|0|||
162639046|NCT00818662|587394392|FG002|Overall Study|Moving out of state|0|||
162639047|NCT00818662|587394393|FG003|Overall Study|Moving out of state|1|||
162639048|NCT00818662|587394390|FG000|Overall Study|Declined move to another study site|1|||
162639049|NCT00818662|587394391|FG001|Overall Study|Declined move to another study site|0|||
162639050|NCT00818662|587394392|FG002|Overall Study|Declined move to another study site|0|||
163008555|NCT02431364|588732402|FG003|Overall Study|Randomized but never treated|1|||
163008556|NCT02431364|588732403|FG004|Overall Study|Randomized but never treated|0|||
163008557|NCT00061932|588732404|FG000|Overall Study|Withdrawal by Subject|13|||
163008558|NCT00061932|588732405|FG001|Overall Study|Withdrawal by Subject|4|||
163008559|NCT03367819|588732406|FG000|Overall Study|Adverse Event|4|||
163008560|NCT03367819|588732407|FG001|Overall Study|Adverse Event|4|||
162639051|NCT00818662|587394393|FG003|Overall Study|Declined move to another study site|0|||
162639052|NCT00818662|587394390|FG000|Overall Study|Change in living situation|0|||
162639053|NCT00818662|587394391|FG001|Overall Study|Change in living situation|0|||
162639054|NCT00818662|587394392|FG002|Overall Study|Change in living situation|0|||
163008561|NCT03367819|588732406|FG000|Overall Study|Progressive Disease|15|||
163008562|NCT03367819|588732407|FG001|Overall Study|Progressive Disease|13|||
162639055|NCT00818662|587394393|FG003|Overall Study|Change in living situation|1|||
163008563|NCT03367819|588732406|FG000|Overall Study|Withdrawal by Subject|1|||
163008564|NCT03367819|588732407|FG001|Overall Study|Withdrawal by Subject|0|||
163008565|NCT03367819|588732406|FG000|Overall Study|Other|4|||
162639056|NCT00818662|587394390|FG000|Overall Study|Study partner decision|0|||
163008566|NCT03367819|588732407|FG001|Overall Study|Other|2|||
163008567|NCT00445146|588732410|FG000|Overall Study|Withdrew Consent|29|||
163008568|NCT00445146|588732410|FG000|Overall Study|Lack of Efficacy|28|||
163008569|NCT00445146|588732410|FG000|Overall Study|Investigator's Discretion|22|||
163008570|NCT00445146|588732410|FG000|Overall Study|Adverse Event|13|||
163008571|NCT00445146|588732410|FG000|Overall Study|Lost to Follow-up|13|||
163008572|NCT00445146|588732410|FG000|Overall Study|Death|9|||
163008573|NCT00445146|588732410|FG000|Overall Study|Protocol Violation|4|||
163008574|NCT00445146|588732410|FG000|Overall Study|Pregnancy|1|||
163008575|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008576|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008577|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
163008578|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008579|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008580|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008581|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008582|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008583|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
163008584|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
163008585|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
163008586|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
163008587|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008588|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008589|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008590|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008591|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008592|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
163008593|NCT02456740|588732411|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
163008594|NCT02456740|588732412|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
163008595|NCT02456740|588732413|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
163008596|NCT02456740|588732414|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008597|NCT02456740|588732415|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008598|NCT02456740|588732416|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008599|NCT02456740|588732417|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008600|NCT02456740|588732418|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008601|NCT02456740|588732419|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
163008602|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008603|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008604|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008605|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
163008606|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
163008607|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008608|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
162639057|NCT00818662|587394391|FG001|Overall Study|Study partner decision|0|||
162639058|NCT00818662|587394392|FG002|Overall Study|Study partner decision|0|||
163008609|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
163008610|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
163008611|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008612|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008613|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163008614|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
163008615|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
163008616|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
163008617|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
163008618|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
163008619|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
163008620|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008621|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008622|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008623|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
162639059|NCT00818662|587394393|FG003|Overall Study|Study partner decision|1|||
162639060|NCT00818662|587394390|FG000|Overall Study|Admitted to long term nursing care|0|||
163008624|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
162639061|NCT00818662|587394391|FG001|Overall Study|Admitted to long term nursing care|1|||
163008625|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008626|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008627|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
163008628|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
163008629|NCT02456740|588732411|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008630|NCT02456740|588732412|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008631|NCT02456740|588732413|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163008632|NCT02456740|588732414|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
163008633|NCT02456740|588732415|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
163008634|NCT02456740|588732416|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
163008635|NCT02456740|588732417|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163008636|NCT02456740|588732418|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
163008637|NCT02456740|588732419|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
163008638|NCT04720105|588732423|FG000|Overall Study|Lack of Efficacy|1|||
163008639|NCT04720105|588732423|FG000|Overall Study|Lost to Follow-up|1|||
163008640|NCT04720105|588732423|FG000|Overall Study|Withdrawal by Subject|3|||
163008641|NCT00625820|588732428|FG000|Overall Study|Withdrawal by Subject|1|||
163008642|NCT02546986|588734198|FG000|Treatment Period|Progressive Disease|20|||
163008643|NCT02546986|588734199|FG001|Treatment Period|Progressive Disease|22|||
163008644|NCT02546986|588734198|FG000|Treatment Period|Adverse Event|14|||
163008645|NCT02546986|588734199|FG001|Treatment Period|Adverse Event|6|||
163008646|NCT02546986|588734198|FG000|Treatment Period|Symptomatic Deterioration|4|||
163008647|NCT02546986|588734199|FG001|Treatment Period|Symptomatic Deterioration|3|||
163008648|NCT02546986|588734198|FG000|Treatment Period|Death|3|||
163008649|NCT02546986|588734199|FG001|Treatment Period|Death|4|||
163008650|NCT02546986|588734198|FG000|Treatment Period|Physician Decision|1|||
163008651|NCT02546986|588734199|FG001|Treatment Period|Physician Decision|2|||
163008652|NCT02546986|588734198|FG000|Treatment Period|Protocol Violation|1|||
163008653|NCT02546986|588734199|FG001|Treatment Period|Protocol Violation|0|||
163008654|NCT02546986|588734198|FG000|Treatment Period|Withdrawal by Subject|1|||
163008655|NCT02546986|588734199|FG001|Treatment Period|Withdrawal by Subject|1|||
163008656|NCT02546986|588734198|FG000|Treatment Period|Non-compliance with Study Drug|0|||
163008657|NCT02546986|588734199|FG001|Treatment Period|Non-compliance with Study Drug|1|||
163008658|NCT02546986|588734198|FG000|Treatment Period|Study Terminated by Sponsor|0|||
163008659|NCT02546986|588734199|FG001|Treatment Period|Study Terminated by Sponsor|1|||
163008660|NCT02546986|588734198|FG000|Treatment Period|Miscellaneous|7|||
163008661|NCT02546986|588734199|FG001|Treatment Period|Miscellaneous|9|||
163008662|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Missing Status|3|||
163008663|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Missing Status|5|||
163008664|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Death|18|||
163008665|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Death|12|||
163008666|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Alive|13|||
163008667|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Alive|16|||
163008668|NCT02546986|588734198|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
163008669|NCT02546986|588734199|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
163008670|NCT02844543|588734200|FG000|Overall Study|Withdrawal by Subject|4|||
163008671|NCT02844543|588734200|FG000|Overall Study|Did not meet eligibility criteria|1|||
163008672|NCT03349060|588734201|FG000|Overall Study|Adverse Event|9|||
163008673|NCT03349060|588734202|FG001|Overall Study|Adverse Event|9|||
163008674|NCT03349060|588734203|FG002|Overall Study|Adverse Event|7|||
163008675|NCT03349060|588734201|FG000|Overall Study|Lack of Efficacy|1|||
163008676|NCT03349060|588734202|FG001|Overall Study|Lack of Efficacy|0|||
163008677|NCT03349060|588734203|FG002|Overall Study|Lack of Efficacy|2|||
163008678|NCT03349060|588734201|FG000|Overall Study|Lost to Follow-up|2|||
163008679|NCT03349060|588734202|FG001|Overall Study|Lost to Follow-up|1|||
163008680|NCT03349060|588734203|FG002|Overall Study|Lost to Follow-up|1|||
163008681|NCT03349060|588734201|FG000|Overall Study|Protocol Violation|2|||
163008682|NCT03349060|588734202|FG001|Overall Study|Protocol Violation|2|||
163008683|NCT03349060|588734203|FG002|Overall Study|Protocol Violation|1|||
163008684|NCT03349060|588734201|FG000|Overall Study|Withdrawal by Subject|5|||
163008685|NCT03349060|588734202|FG001|Overall Study|Withdrawal by Subject|3|||
162639062|NCT00818662|587394392|FG002|Overall Study|Admitted to long term nursing care|0|||
162639063|NCT00818662|587394393|FG003|Overall Study|Admitted to long term nursing care|0|||
163008686|NCT03349060|588734203|FG002|Overall Study|Withdrawal by Subject|4|||
163008687|NCT03349060|588734201|FG000|Overall Study|Medication error,no linked adverse event|0|||
163008688|NCT03349060|588734202|FG001|Overall Study|Medication error,no linked adverse event|0|||
163008689|NCT03349060|588734203|FG002|Overall Study|Medication error,no linked adverse event|1|||
163008690|NCT03349060|588734201|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163008691|NCT03349060|588734202|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
163008692|NCT03349060|588734203|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
163008693|NCT03349060|588734201|FG000|Overall Study|Other|2|||
163008694|NCT03349060|588734202|FG001|Overall Study|Other|1|||
163008695|NCT03349060|588734203|FG002|Overall Study|Other|0|||
163008696|NCT02861586|588734204|FG000|Overall Study|Withdrawal by Subject|1|||
163008697|NCT02861586|588734205|FG001|Overall Study|Withdrawal by Subject|2|||
163008698|NCT02861586|588734206|FG002|Overall Study|Withdrawal by Subject|0|||
163008699|NCT02861586|588734207|FG003|Overall Study|Withdrawal by Subject|0|||
163008700|NCT02861586|588734208|FG004|Overall Study|Withdrawal by Subject|0|||
163008701|NCT02861586|588734209|FG005|Overall Study|Withdrawal by Subject|1|||
163008702|NCT02861586|588734210|FG006|Overall Study|Withdrawal by Subject|1|||
163008703|NCT02861586|588734211|FG007|Overall Study|Withdrawal by Subject|0|||
163008704|NCT02861586|588734204|FG000|Overall Study|Lost to Follow-up|3|||
163008705|NCT02861586|588734205|FG001|Overall Study|Lost to Follow-up|1|||
163008706|NCT02861586|588734206|FG002|Overall Study|Lost to Follow-up|1|||
163008707|NCT02861586|588734207|FG003|Overall Study|Lost to Follow-up|0|||
163008708|NCT02861586|588734208|FG004|Overall Study|Lost to Follow-up|0|||
163008709|NCT02861586|588734209|FG005|Overall Study|Lost to Follow-up|3|||
163008710|NCT02861586|588734210|FG006|Overall Study|Lost to Follow-up|0|||
163008711|NCT02861586|588734211|FG007|Overall Study|Lost to Follow-up|0|||
163008712|NCT02861586|588734204|FG000|Overall Study|Adverse Event|0|||
163008713|NCT02861586|588734205|FG001|Overall Study|Adverse Event|0|||
163008714|NCT02861586|588734206|FG002|Overall Study|Adverse Event|0|||
163008715|NCT02861586|588734207|FG003|Overall Study|Adverse Event|0|||
163008716|NCT02861586|588734208|FG004|Overall Study|Adverse Event|0|||
163008717|NCT02861586|588734209|FG005|Overall Study|Adverse Event|1|||
163008718|NCT02861586|588734210|FG006|Overall Study|Adverse Event|0|||
163008719|NCT02861586|588734211|FG007|Overall Study|Adverse Event|0|||
163008720|NCT04710576|588734212|FG000|Overall Study|Participants still in the study|73|||
163008721|NCT04710576|588734213|FG001|Overall Study|Participants still in the study|70|||
163008722|NCT04710576|588734214|FG002|Overall Study|Participants still in the study|60|||
163008723|NCT04710576|588734212|FG000|Overall Study|Death|2|||
163008724|NCT04710576|588734213|FG001|Overall Study|Death|7|||
163008725|NCT04710576|588734214|FG002|Overall Study|Death|12|||
163008726|NCT04710576|588734212|FG000|Overall Study|Withdrawal by Subject|4|||
163008727|NCT04710576|588734213|FG001|Overall Study|Withdrawal by Subject|3|||
163008728|NCT04710576|588734214|FG002|Overall Study|Withdrawal by Subject|7|||
163008729|NCT04710576|588734212|FG000|Overall Study|Sponsor decision|1|||
163008730|NCT04710576|588734213|FG001|Overall Study|Sponsor decision|0|||
163008731|NCT04710576|588734214|FG002|Overall Study|Sponsor decision|0|||
162639064|NCT03021265|587394394|FG000|Overall Study|Adverse Event|29|||
162639065|NCT03021265|587394394|FG000|Overall Study|Lack of Efficacy|3|||
162639066|NCT03021265|587394394|FG000|Overall Study|Improved|17|||
162639067|NCT03021265|587394394|FG000|Overall Study|Lost to Follow-up|67|||
162639068|NCT03021265|587394394|FG000|Overall Study|No reason given|2|||
162639069|NCT03021265|587394394|FG000|Overall Study|No visit since the first visit|4|||
162639070|NCT01722071|587394395|FG000|Overall Study|Protocol Violation|1|||
162639071|NCT01722071|587394396|FG001|Overall Study|Protocol Violation|0|||
162639072|NCT01106898|587394397|FG000|Overall Study|Adverse Event|6|||
162639073|NCT01338493|587394398|FG000|Enrolled|Withdrawal by Subject|1|||
162639074|NCT01338493|587394398|FG000|Enrolled|Patient not implanted|4|||
162639075|NCT01338493|587394398|FG000|Discharge|Death|1|||
163008732|NCT04796909|588734215|FG000|Overall Study|Withdrawal by Subject|1|||
162639076|NCT01338493|587394398|FG000|Discharge|Missed visit|1|||
162639077|NCT01338493|587394398|FG000|6 Months Follow up|Lost to Follow-up|11|||
162639078|NCT01338493|587394398|FG000|6 Months Follow up|Missed visit|8|||
162639079|NCT01338493|587394398|FG000|12 Months Follow up|Lost to Follow-up|9|||
162639080|NCT01846611|587394399|FG000|Overall Study|Lost to Follow-up|4|||
163008733|NCT04796909|588734216|FG001|Overall Study|Withdrawal by Subject|1|||
163008734|NCT00437021|588734217|FG000|Overall Study|Adverse Event|0|||
163008735|NCT00437021|588734218|FG001|Overall Study|Adverse Event|0|||
163008736|NCT00437021|588734219|FG002|Overall Study|Adverse Event|0|||
163008737|NCT00437021|588734220|FG003|Overall Study|Adverse Event|0|||
163008738|NCT00437021|588734221|FG004|Overall Study|Adverse Event|0|||
163008739|NCT00437021|588734222|FG005|Overall Study|Adverse Event|0|||
163008740|NCT00437021|588734223|FG006|Overall Study|Adverse Event|1|||
163008741|NCT00437021|588734224|FG007|Overall Study|Adverse Event|0|||
163008742|NCT00437021|588734225|FG008|Overall Study|Adverse Event|0|||
163008743|NCT00437021|588734226|FG009|Overall Study|Adverse Event|0|||
163008744|NCT00437021|588734227|FG010|Overall Study|Adverse Event|0|||
162639081|NCT01846611|587394400|FG001|Overall Study|Lost to Follow-up|6|||
162639082|NCT01846611|587394399|FG000|Overall Study|Withdrawal by Subject|15|||
162639083|NCT01846611|587394400|FG001|Overall Study|Withdrawal by Subject|19|||
162639084|NCT01846611|587394399|FG000|Overall Study|Other|19|||
162639085|NCT01846611|587394400|FG001|Overall Study|Other|18|||
162639086|NCT00541034|587394401|FG000|Overall Study|Non-Compliance|3|||
162639087|NCT00847704|587394402|FG000|Overall Study|Withdrawal by Subject|1|||
162639088|NCT01614067|587394403|FG000|Overall Study|Pregnancy|1|||
162639089|NCT01614067|587394404|FG001|Overall Study|Pregnancy|0|||
162639090|NCT01614067|587394403|FG000|Overall Study|Physician Decision|6|||
162639091|NCT01614067|587394404|FG001|Overall Study|Physician Decision|5|||
162639092|NCT01614067|587394403|FG000|Overall Study|Withdrawal by Subject|0|||
162639093|NCT01614067|587394404|FG001|Overall Study|Withdrawal by Subject|1|||
162639094|NCT01614067|587394403|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
162639095|NCT01614067|587394404|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
162639096|NCT02289079|587394410|FG000|Overall Study|Physician Decision|2|||
162639097|NCT02289079|587394411|FG001|Overall Study|Physician Decision|0|||
162639098|NCT02289079|587394410|FG000|Overall Study|Lost to Follow-up|0|||
162639099|NCT02289079|587394411|FG001|Overall Study|Lost to Follow-up|1|||
163008745|NCT00437021|588734228|FG011|Overall Study|Adverse Event|0|||
163008746|NCT00437021|588734217|FG000|Overall Study|Lost to Follow-up|0|||
162639100|NCT02671422|587394412|FG000|Overall Study|Lost to Follow-up|1|||
162639101|NCT02671422|587394412|FG000|Overall Study|Adverse Event|68|||
162639102|NCT02671422|587394412|FG000|Overall Study|Lack of Efficacy|1|||
163008747|NCT00437021|588734218|FG001|Overall Study|Lost to Follow-up|3|||
162639103|NCT02671422|587394412|FG000|Overall Study|Lost to Follow-up|4|||
162639104|NCT02671422|587394412|FG000|Overall Study|Withdrawal by Subject|7|||
162639105|NCT02671422|587394412|FG000|Overall Study|Progressive Disease|156|||
162639106|NCT02671422|587394412|FG000|Overall Study|Worsening of Disease|4|||
162639107|NCT02671422|587394412|FG000|Overall Study|Sponsor decision|5|||
162639108|NCT02671422|587394412|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
162639109|NCT02671422|587394412|FG000|Overall Study|Not treated with Vargatef®|3|||
162639110|NCT02671422|587394412|FG000|Overall Study|Other not defined above|3|||
162639111|NCT02111850|587394413|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639112|NCT02111850|587394414|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639113|NCT02111850|587394415|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639114|NCT02111850|587394416|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639115|NCT02111850|587394417|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
162639116|NCT02111850|587394418|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639117|NCT02111850|587394419|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639118|NCT02111850|587394420|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639119|NCT02111850|587394421|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639120|NCT02111850|587394422|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639121|NCT02111850|587394423|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162639122|NCT03061331|587394424|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
162639123|NCT03061331|587394425|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
162639124|NCT02625259|587394426|FG000|First Intervention (Day 1)|Other|0|||
162639125|NCT02625259|587394427|FG001|First Intervention (Day 1)|Other|0|||
162639126|NCT02625259|587394428|FG002|First Intervention (Day 1)|Other|1|||
162639127|NCT02625259|587394429|FG003|First Intervention (Day 1)|Other|0|||
162639128|NCT02625259|587394430|FG004|First Intervention (Day 1)|Other|0|||
162639129|NCT02625259|587394426|FG000|First Intervention (Day 1)|Adverse Event|2|||
162639130|NCT02625259|587394427|FG001|First Intervention (Day 1)|Adverse Event|1|||
162639131|NCT02625259|587394428|FG002|First Intervention (Day 1)|Adverse Event|0|||
162639132|NCT02625259|587394429|FG003|First Intervention (Day 1)|Adverse Event|0|||
162639133|NCT02625259|587394430|FG004|First Intervention (Day 1)|Adverse Event|0|||
162639134|NCT02625259|587394426|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
163061569|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
163061570|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
163061571|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
163061572|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
163061573|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
163061574|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
163061575|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
163061576|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
163061577|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
163061578|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
163061579|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
163061580|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
163061581|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
163061582|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
163061583|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
163061584|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
163061585|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
163061586|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
163061587|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
163061588|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
163061589|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
163061590|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
163061591|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
163061592|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
163061593|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
163061594|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
163061595|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
163061596|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
162639135|NCT02625259|587394427|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
162639136|NCT02625259|587394428|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162639137|NCT02625259|587394429|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
162639138|NCT02625259|587394430|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
163061597|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
163061598|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
163061599|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
163061600|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
163061601|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
163061602|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
163061603|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
163061604|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
163061605|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
163061606|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
163061607|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
163061608|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
162639139|NCT00513474|587394431|FG000|Overall Study|Death|6|||
162639140|NCT00513474|587394432|FG001|Overall Study|Death|9|||
162639141|NCT00513474|587394431|FG000|Overall Study|Participant Withdrew Consent|1|||
162639142|NCT00513474|587394432|FG001|Overall Study|Participant Withdrew Consent|0|||
162639143|NCT04772755|587394433|FG000|Overall Study|Withdrawal by Subject|1|||
162639144|NCT04772755|587394434|FG001|Overall Study|Withdrawal by Subject|0|||
162639145|NCT04772755|587394433|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
162639146|NCT04772755|587394434|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
162639147|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Adverse Event|82|||
162639148|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Death|6|||
162639149|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
162639150|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
162639151|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
162639152|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
162639153|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
162639154|NCT00195676|587394436|FG000|Period O - Open-label Treatment|Other reasons|68|||
162639155|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
162639156|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
162639157|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
162639158|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
162639159|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
162639160|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
163008748|NCT00437021|588734219|FG002|Overall Study|Lost to Follow-up|0|||
163008749|NCT00437021|588734220|FG003|Overall Study|Lost to Follow-up|0|||
163008750|NCT00437021|588734221|FG004|Overall Study|Lost to Follow-up|0|||
163008751|NCT00437021|588734222|FG005|Overall Study|Lost to Follow-up|2|||
163008752|NCT00437021|588734223|FG006|Overall Study|Lost to Follow-up|0|||
163008753|NCT00437021|588734224|FG007|Overall Study|Lost to Follow-up|1|||
163008754|NCT00437021|588734225|FG008|Overall Study|Lost to Follow-up|0|||
163008755|NCT00437021|588734226|FG009|Overall Study|Lost to Follow-up|0|||
163008756|NCT00437021|588734227|FG010|Overall Study|Lost to Follow-up|0|||
163008757|NCT00437021|588734228|FG011|Overall Study|Lost to Follow-up|0|||
163008758|NCT00437021|588734217|FG000|Overall Study|Withdrawal by Subject|2|||
163008759|NCT00437021|588734218|FG001|Overall Study|Withdrawal by Subject|1|||
163008760|NCT00437021|588734219|FG002|Overall Study|Withdrawal by Subject|0|||
163008761|NCT00437021|588734220|FG003|Overall Study|Withdrawal by Subject|0|||
163008762|NCT00437021|588734221|FG004|Overall Study|Withdrawal by Subject|0|||
163008763|NCT00437021|588734222|FG005|Overall Study|Withdrawal by Subject|0|||
163008764|NCT00437021|588734223|FG006|Overall Study|Withdrawal by Subject|0|||
163008765|NCT00437021|588734224|FG007|Overall Study|Withdrawal by Subject|0|||
163008766|NCT00437021|588734225|FG008|Overall Study|Withdrawal by Subject|0|||
163008767|NCT00437021|588734226|FG009|Overall Study|Withdrawal by Subject|0|||
163008768|NCT00437021|588734227|FG010|Overall Study|Withdrawal by Subject|0|||
163008769|NCT00437021|588734228|FG011|Overall Study|Withdrawal by Subject|0|||
163008770|NCT04162847|588734229|FG000|Overall Study|Withdrawal by Subject|7|||
163008771|NCT04162847|588734230|FG001|Overall Study|Withdrawal by Subject|1|||
163008772|NCT03985800|588734231|FG000|Overall Study|Death|1|||
163008773|NCT03985800|588734232|FG001|Overall Study|Death|2|||
163008774|NCT03985800|588734231|FG000|Overall Study|Withdrawal by Subject|3|||
163008775|NCT03985800|588734232|FG001|Overall Study|Withdrawal by Subject|6|||
163008776|NCT03985800|588734231|FG000|Overall Study|Protocol Violation|2|||
163008777|NCT03985800|588734232|FG001|Overall Study|Protocol Violation|0|||
163008778|NCT05258773|588734233|FG000|Overall Study|Screen Failure|1|||
163008779|NCT05258773|588734234|FG001|Overall Study|Screen Failure|1|||
163008780|NCT05258773|588734233|FG000|Overall Study|Adverse Event|1|||
163008781|NCT05258773|588734234|FG001|Overall Study|Adverse Event|0|||
163008782|NCT05258773|588734233|FG000|Overall Study|Withdrawal by Subject|0|||
163008783|NCT05258773|588734234|FG001|Overall Study|Withdrawal by Subject|1|||
163008784|NCT03018288|588734237|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
162639161|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
163008785|NCT03018288|588734238|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
163008786|NCT03018288|588734239|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
163008787|NCT03018288|588734240|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
163008788|NCT03018288|588734237|FG000|Overall Study|Participant withdrew consent.|0|||
163008789|NCT03018288|588734238|FG001|Overall Study|Participant withdrew consent.|0|||
163008790|NCT03018288|588734239|FG002|Overall Study|Participant withdrew consent.|1|||
163008791|NCT03018288|588734240|FG003|Overall Study|Participant withdrew consent.|0|||
163008792|NCT03018288|588734237|FG000|Overall Study|Switched to alternative treatment.|0|||
163008793|NCT03018288|588734238|FG001|Overall Study|Switched to alternative treatment.|0|||
163008794|NCT03018288|588734239|FG002|Overall Study|Switched to alternative treatment.|1|||
162639162|NCT00195676|587394436|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
162639163|NCT00195676|587394436|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
162639164|NCT00195676|587394436|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
162639165|NCT00195676|587394436|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
162639166|NCT00195676|587394436|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
162639167|NCT00195676|587394436|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
162639168|NCT01189812|587394437|FG000|Overall Study|Withdrawal by Subject|2|||
162639169|NCT01189812|587394438|FG001|Overall Study|Withdrawal by Subject|3|||
162639170|NCT01189812|587394437|FG000|Overall Study|Adverse Event|1|||
162639171|NCT01189812|587394438|FG001|Overall Study|Adverse Event|0|||
162639172|NCT01189812|587394437|FG000|Overall Study|Out of Window|4|||
162639173|NCT01189812|587394438|FG001|Overall Study|Out of Window|3|||
162639174|NCT01189812|587394437|FG000|Overall Study|Moved out of State|1|||
162639175|NCT01189812|587394438|FG001|Overall Study|Moved out of State|2|||
162639176|NCT03761147|587394439|FG000|Overall Study|Withdrawal by Subject|6|||
163008795|NCT03018288|588734240|FG003|Overall Study|Switched to alternative treatment.|0|||
163008796|NCT03018288|588734237|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008797|NCT03018288|588734238|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008798|NCT03018288|588734239|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
163008799|NCT03018288|588734240|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
163008800|NCT03018288|588734237|FG000|Overall Study|Screen failures|0|||
163008801|NCT03018288|588734238|FG001|Overall Study|Screen failures|0|||
163008802|NCT03018288|588734239|FG002|Overall Study|Screen failures|0|||
163008803|NCT03018288|588734240|FG003|Overall Study|Screen failures|51|||
163008804|NCT03018288|588734237|FG000|Overall Study|Chose treatment outside of UNC|0|||
162639177|NCT03761147|587394440|FG001|Overall Study|Withdrawal by Subject|1|||
162639178|NCT03761147|587394439|FG000|Overall Study|Adverse Event|1|||
162639179|NCT03761147|587394440|FG001|Overall Study|Adverse Event|3|||
162639180|NCT04080297|587394441|FG000|Overall Study|Adverse Event|1|||
162639181|NCT04080297|587394442|FG001|Overall Study|Adverse Event|3|||
162639182|NCT04080297|587394441|FG000|Overall Study|concurrent illness|1|||
162639183|NCT04080297|587394442|FG001|Overall Study|concurrent illness|0|||
162639184|NCT02744391|587394443|FG000|Overall Study|Lost to Follow-up|9|||
162639185|NCT02744391|587394443|FG000|Overall Study|Physician Decision|2|||
162639186|NCT02744391|587394443|FG000|Overall Study|Withdrawal by Subject|3|||
162639187|NCT05838742|587394444|FG000|Overall Study|Adverse Event|2|||
162639188|NCT05838742|587394445|FG001|Overall Study|Adverse Event|0|||
162639189|NCT05838742|587394446|FG002|Overall Study|Adverse Event|1|||
162639190|NCT05838742|587394447|FG003|Overall Study|Adverse Event|0|||
162639191|NCT05838742|587394448|FG004|Overall Study|Adverse Event|1|||
162639192|NCT05838742|587394444|FG000|Overall Study|Lost to Follow-up|1|||
162639193|NCT05838742|587394445|FG001|Overall Study|Lost to Follow-up|1|||
162639194|NCT05838742|587394446|FG002|Overall Study|Lost to Follow-up|1|||
162639195|NCT05838742|587394447|FG003|Overall Study|Lost to Follow-up|0|||
162639196|NCT05838742|587394448|FG004|Overall Study|Lost to Follow-up|0|||
162639197|NCT05838742|587394444|FG000|Overall Study|Physician Decision|0|||
162639198|NCT05838742|587394445|FG001|Overall Study|Physician Decision|0|||
162639199|NCT05838742|587394446|FG002|Overall Study|Physician Decision|0|||
162639200|NCT05838742|587394447|FG003|Overall Study|Physician Decision|0|||
162639201|NCT05838742|587394448|FG004|Overall Study|Physician Decision|1|||
162639202|NCT05838742|587394444|FG000|Overall Study|Withdrawal by Subject|8|||
162639203|NCT05838742|587394445|FG001|Overall Study|Withdrawal by Subject|3|||
162639204|NCT05838742|587394446|FG002|Overall Study|Withdrawal by Subject|3|||
162639205|NCT05838742|587394447|FG003|Overall Study|Withdrawal by Subject|1|||
162639206|NCT05838742|587394448|FG004|Overall Study|Withdrawal by Subject|4|||
163008805|NCT03018288|588734238|FG001|Overall Study|Chose treatment outside of UNC|0|||
163008806|NCT03018288|588734239|FG002|Overall Study|Chose treatment outside of UNC|0|||
163008807|NCT03018288|588734240|FG003|Overall Study|Chose treatment outside of UNC|1|||
163008808|NCT03018288|588734237|FG000|Overall Study|Unable to comply with protocol requirements|1|||
162639207|NCT05838742|587394444|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
162639208|NCT05838742|587394445|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
162639209|NCT05838742|587394446|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
162639210|NCT05838742|587394447|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
162639211|NCT05838742|587394448|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
163008809|NCT03018288|588734238|FG001|Overall Study|Unable to comply with protocol requirements|1|||
163008810|NCT03018288|588734239|FG002|Overall Study|Unable to comply with protocol requirements|0|||
163008811|NCT03018288|588734240|FG003|Overall Study|Unable to comply with protocol requirements|1|||
163008812|NCT03018288|588734237|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163008813|NCT03018288|588734238|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
163008814|NCT03018288|588734239|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
163008815|NCT03018288|588734240|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
163008816|NCT03018288|588734237|FG000|Overall Study|Physician Decision|0|||
163008817|NCT03018288|588734238|FG001|Overall Study|Physician Decision|0|||
163008818|NCT03018288|588734239|FG002|Overall Study|Physician Decision|0|||
163008819|NCT03018288|588734240|FG003|Overall Study|Physician Decision|1|||
163008820|NCT05573464|588734241|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
163008821|NCT05573464|588734242|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
163008822|NCT05573464|588734241|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
163008823|NCT05573464|588734242|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
163008824|NCT05573464|588734241|FG000|12-week Treatment Period|Protocol Violation|3|||
163008825|NCT05573464|588734242|FG001|12-week Treatment Period|Protocol Violation|1|||
163008826|NCT05573464|588734241|FG000|12-week Treatment Period|Physician Decision|1|||
163008827|NCT05573464|588734242|FG001|12-week Treatment Period|Physician Decision|2|||
163008828|NCT05573464|588734241|FG000|12-week Treatment Period|Lost to Follow-up|2|||
163008829|NCT05573464|588734242|FG001|12-week Treatment Period|Lost to Follow-up|0|||
163008830|NCT05573464|588734241|FG000|12-week Treatment Period|Adverse Event|20|||
163008831|NCT05573464|588734242|FG001|12-week Treatment Period|Adverse Event|9|||
163008832|NCT05573464|588734241|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
163008833|NCT05573464|588734242|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
163008834|NCT05573464|588734241|FG000|12-week Treatment Period|Randomised, not treated|0|||
163008835|NCT05573464|588734242|FG001|12-week Treatment Period|Randomised, not treated|1|||
163008836|NCT05573464|588734241|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
163008837|NCT05573464|588734242|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
163008838|NCT05573464|588734241|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
163008839|NCT05573464|588734242|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
163008840|NCT05573464|588734241|FG000|52-week Treatment Period|Protocol Violation|1|||
163008841|NCT05573464|588734242|FG001|52-week Treatment Period|Protocol Violation|1|||
163008842|NCT05573464|588734241|FG000|52-week Treatment Period|Physician Decision|2|||
163008843|NCT05573464|588734242|FG001|52-week Treatment Period|Physician Decision|2|||
163008844|NCT05573464|588734241|FG000|52-week Treatment Period|Lost to Follow-up|1|||
163008845|NCT05573464|588734242|FG001|52-week Treatment Period|Lost to Follow-up|1|||
163008846|NCT05573464|588734241|FG000|52-week Treatment Period|Adverse Event|11|||
163008847|NCT05573464|588734242|FG001|52-week Treatment Period|Adverse Event|8|||
163008848|NCT05573464|588734241|FG000|52-week Treatment Period|Death|1|||
163008849|NCT05573464|588734242|FG001|52-week Treatment Period|Death|1|||
163008850|NCT05734157|588734243|FG000|Overall Study|Death|3|||
163008851|NCT05734157|588734243|FG000|Overall Study|Withdrawal by Subject|2|||
163008852|NCT05734157|588734243|FG000|Overall Study|Lost to Follow-up|1|||
163008853|NCT05734157|588734243|FG000|Overall Study|Telephone call|3|||
163008854|NCT04815083|588734244|FG000|Overall Study|Physician Decision|1|||
163008855|NCT04815083|588734244|FG000|Overall Study|Study pause|2|||
163008856|NCT04815083|588734244|FG000|Overall Study|Screening failure|4|||
163008857|NCT06025721|588734245|FG000|Overall Study|Physician Decision|1|||
163008858|NCT06025721|588734245|FG000|Overall Study|Protocol Violation|1|||
163008859|NCT06025721|588734245|FG000|Overall Study|Incarceration|1|||
163008860|NCT01730053|588734248|FG000|Overall Study|Participant moved|0|||
163008861|NCT01730053|588734249|FG001|Overall Study|Participant moved|0|||
163008862|NCT01730053|588734250|FG002|Overall Study|Participant moved|1|||
163008863|NCT01730053|588734251|FG003|Overall Study|Participant moved|0|||
163008864|NCT01730053|588734252|FG004|Overall Study|Participant moved|0|||
163008865|NCT01730053|588734253|FG005|Overall Study|Participant moved|0|||
163008866|NCT01730053|588734248|FG000|Overall Study|Physician Decision|0|||
163008867|NCT01730053|588734249|FG001|Overall Study|Physician Decision|0|||
163008868|NCT01730053|588734250|FG002|Overall Study|Physician Decision|0|||
163008869|NCT01730053|588734251|FG003|Overall Study|Physician Decision|1|||
163008870|NCT01730053|588734252|FG004|Overall Study|Physician Decision|0|||
163008871|NCT01730053|588734253|FG005|Overall Study|Physician Decision|0|||
163008872|NCT01730053|588734248|FG000|Overall Study|Adverse Event|2|||
163008873|NCT01730053|588734249|FG001|Overall Study|Adverse Event|6|||
163008874|NCT01730053|588734250|FG002|Overall Study|Adverse Event|3|||
163008875|NCT01730053|588734251|FG003|Overall Study|Adverse Event|3|||
163008876|NCT01730053|588734252|FG004|Overall Study|Adverse Event|2|||
163008877|NCT01730053|588734253|FG005|Overall Study|Adverse Event|2|||
163008878|NCT01730053|588734248|FG000|Overall Study|Poor compliance to protocol|1|||
163008879|NCT01730053|588734249|FG001|Overall Study|Poor compliance to protocol|2|||
163008880|NCT01730053|588734250|FG002|Overall Study|Poor compliance to protocol|2|||
163008881|NCT01730053|588734251|FG003|Overall Study|Poor compliance to protocol|0|||
163008882|NCT01730053|588734252|FG004|Overall Study|Poor compliance to protocol|0|||
163008883|NCT01730053|588734253|FG005|Overall Study|Poor compliance to protocol|2|||
162639212|NCT05838742|587394444|FG000|Overall Study|Lack of Efficacy|0|||
162639213|NCT05838742|587394445|FG001|Overall Study|Lack of Efficacy|0|||
162639214|NCT05838742|587394446|FG002|Overall Study|Lack of Efficacy|0|||
162639215|NCT05838742|587394447|FG003|Overall Study|Lack of Efficacy|1|||
162639216|NCT05838742|587394448|FG004|Overall Study|Lack of Efficacy|0|||
162639217|NCT05838742|587394444|FG000|Overall Study|Randomized, not treated|2|||
162639218|NCT05838742|587394445|FG001|Overall Study|Randomized, not treated|1|||
162639219|NCT05838742|587394446|FG002|Overall Study|Randomized, not treated|0|||
162639220|NCT05838742|587394447|FG003|Overall Study|Randomized, not treated|1|||
162639221|NCT05838742|587394448|FG004|Overall Study|Randomized, not treated|0|||
162639222|NCT02045797|587394449|FG000|Overall Study|Adverse Event|3|||
162639223|NCT02045797|587394450|FG001|Overall Study|Adverse Event|1|||
162639224|NCT02045797|587394451|FG002|Overall Study|Adverse Event|0|||
162639225|NCT02045797|587394449|FG000|Overall Study|Lack of Efficacy|1|||
162639226|NCT02045797|587394450|FG001|Overall Study|Lack of Efficacy|0|||
162639227|NCT02045797|587394451|FG002|Overall Study|Lack of Efficacy|0|||
162639228|NCT02045797|587394449|FG000|Overall Study|Lost to Follow-up|2|||
162639229|NCT02045797|587394450|FG001|Overall Study|Lost to Follow-up|3|||
162639230|NCT02045797|587394451|FG002|Overall Study|Lost to Follow-up|1|||
162639231|NCT02045797|587394449|FG000|Overall Study|Physician Decision|0|||
162639232|NCT02045797|587394450|FG001|Overall Study|Physician Decision|1|||
162639233|NCT02045797|587394451|FG002|Overall Study|Physician Decision|0|||
162639234|NCT02045797|587394449|FG000|Overall Study|Withdrawal by Subject|1|||
162639235|NCT02045797|587394450|FG001|Overall Study|Withdrawal by Subject|2|||
162639236|NCT02045797|587394451|FG002|Overall Study|Withdrawal by Subject|0|||
162639237|NCT03851302|587394452|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
162639238|NCT03851302|587394453|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
162639239|NCT03851302|587394454|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
162639240|NCT03851302|587394455|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
162639241|NCT03851302|587394456|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
162639242|NCT03851302|587394457|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
162639243|NCT03851302|587394452|FG000|Screening (1 Day)|Screened out|0|||
162639244|NCT03851302|587394453|FG001|Screening (1 Day)|Screened out|0|||
162639245|NCT03851302|587394454|FG002|Screening (1 Day)|Screened out|1|||
162639246|NCT03851302|587394455|FG003|Screening (1 Day)|Screened out|1|||
162639247|NCT03851302|587394456|FG004|Screening (1 Day)|Screened out|0|||
162639248|NCT03851302|587394457|FG005|Screening (1 Day)|Screened out|0|||
162639249|NCT03851302|587394452|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
162639250|NCT03851302|587394453|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
162639251|NCT03851302|587394454|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
162639252|NCT03851302|587394455|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
162639253|NCT03851302|587394456|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
162639254|NCT03851302|587394457|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
163008884|NCT01730053|588734248|FG000|Overall Study|Other than specified|2|||
163008885|NCT01730053|588734249|FG001|Overall Study|Other than specified|6|||
163008886|NCT01730053|588734250|FG002|Overall Study|Other than specified|5|||
163008887|NCT01730053|588734251|FG003|Overall Study|Other than specified|4|||
163008888|NCT01730053|588734252|FG004|Overall Study|Other than specified|7|||
163008889|NCT01730053|588734253|FG005|Overall Study|Other than specified|9|||
162639255|NCT03220217|587396113|FG000|Overall Study|Withdrawal by Subject|0|||
162639256|NCT03220217|587396114|FG001|Overall Study|Withdrawal by Subject|1|||
162639257|NCT03220217|587396115|FG002|Overall Study|Withdrawal by Subject|0|||
162639258|NCT03220217|587396113|FG000|Overall Study|Subject Missed Procedure|0|||
162639259|NCT03220217|587396114|FG001|Overall Study|Subject Missed Procedure|0|||
162639260|NCT03220217|587396115|FG002|Overall Study|Subject Missed Procedure|1|||
162639261|NCT00501293|587396116|FG000|Optimization Period|Enrolled in error|1|||
162639262|NCT00501293|587396117|FG001|Optimization Period|Enrolled in error|0|||
162639263|NCT00501293|587396116|FG000|Maintenance Period|Withdrawal by Subject|14|||
162639264|NCT00501293|587396117|FG001|Maintenance Period|Withdrawal by Subject|13|||
162639265|NCT00501293|587396116|FG000|Maintenance Period|Lost to Follow-up|12|||
162639266|NCT00501293|587396117|FG001|Maintenance Period|Lost to Follow-up|7|||
162639267|NCT00501293|587396116|FG000|Maintenance Period|Adverse Event|6|||
162639268|NCT00501293|587396117|FG001|Maintenance Period|Adverse Event|6|||
162639269|NCT00501293|587396116|FG000|Maintenance Period|Protocol Violation|2|||
162639270|NCT00501293|587396117|FG001|Maintenance Period|Protocol Violation|1|||
162639271|NCT00501293|587396116|FG000|Maintenance Period|Lack of Efficacy|4|||
162639272|NCT00501293|587396117|FG001|Maintenance Period|Lack of Efficacy|1|||
162639273|NCT00501293|587396116|FG000|Maintenance Period|Noncompliant with study medication|5|||
162639274|NCT00501293|587396117|FG001|Maintenance Period|Noncompliant with study medication|0|||
163008890|NCT02068508|588734254|FG000|Overall Study|Case report forms uncollected|27|||
163008891|NCT02068508|588734254|FG000|Overall Study|Patient did not visit the study site|1|||
163008892|NCT02068508|588734254|FG000|Overall Study|Protocol Violation|4|||
163008893|NCT00075816|588734262|FG000|Overall Study|Did not undergo transplantation|14|||
163008894|NCT00075816|588734263|FG001|Overall Study|Did not undergo transplantation|11|||
163008895|NCT04173507|588734264|FG000|Overall Study|On Treatment|3|||
163008896|NCT04173507|588734264|FG000|Overall Study|Adverse Event|3|||
163008897|NCT04173507|588734264|FG000|Overall Study|Progression/Relapse|34|||
163008898|NCT04173507|588734264|FG000|Overall Study|Death|2|||
163008899|NCT02832687|588734265|FG000|Overall Study|Adverse Event|0|||
163008900|NCT02832687|588734266|FG001|Overall Study|Adverse Event|2|||
163008901|NCT04231825|588734267|FG000|Overall Study|Protocol Violation|3|||
163008902|NCT04231825|588734268|FG001|Overall Study|Protocol Violation|3|||
163008903|NCT04231825|588734267|FG000|Overall Study|Lost to Follow-up|0|||
163008904|NCT04231825|588734268|FG001|Overall Study|Lost to Follow-up|1|||
163008905|NCT02392481|588734269|FG000|Overall Study|Adverse Event|0|||
163008906|NCT02392481|588734270|FG001|Overall Study|Adverse Event|0|||
163008907|NCT02392481|588734271|FG002|Overall Study|Adverse Event|1|||
163008908|NCT02392481|588734272|FG003|Overall Study|Adverse Event|2|||
163008909|NCT02392481|588734269|FG000|Overall Study|Withdrawal by Subject|0|||
163008910|NCT02392481|588734270|FG001|Overall Study|Withdrawal by Subject|0|||
163008911|NCT02392481|588734271|FG002|Overall Study|Withdrawal by Subject|1|||
162639275|NCT00501293|587396116|FG000|Maintenance Period|Went into rehabilitation|1|||
163008912|NCT02392481|588734272|FG003|Overall Study|Withdrawal by Subject|0|||
163008913|NCT04341363|588734275|FG000|Overall Study|Adverse Event|1|||
163008914|NCT04341363|588734275|FG000|Overall Study|Withdrawal by Subject|1|||
163008915|NCT00063934|588734276|FG000|Overall Study|Ineligible|1|||
163008916|NCT01836471|588734277|FG000|Overall Study|Pregnancy|1|||
163008917|NCT01836471|588734278|FG001|Overall Study|Pregnancy|0|||
163008918|NCT01836471|588734279|FG002|Overall Study|Pregnancy|0|||
163008919|NCT01836471|588734280|FG003|Overall Study|Pregnancy|0|||
162639276|NCT00501293|587396117|FG001|Maintenance Period|Went into rehabilitation|0|||
163008920|NCT01836471|588734281|FG004|Overall Study|Pregnancy|0|||
163008921|NCT01836471|588734277|FG000|Overall Study|Withdrawal by Subject|3|||
163008922|NCT01836471|588734278|FG001|Overall Study|Withdrawal by Subject|4|||
163008923|NCT01836471|588734279|FG002|Overall Study|Withdrawal by Subject|1|||
163008924|NCT01836471|588734280|FG003|Overall Study|Withdrawal by Subject|0|||
163008925|NCT01836471|588734281|FG004|Overall Study|Withdrawal by Subject|2|||
163008926|NCT01836471|588734277|FG000|Overall Study|Physician Decision|0|||
162639277|NCT00501293|587396116|FG000|Maintenance Period|Would not wear patch|1|||
162639278|NCT00501293|587396117|FG001|Maintenance Period|Would not wear patch|0|||
162639279|NCT00501293|587396116|FG000|Maintenance Period|Application site reaction|1|||
162639280|NCT00501293|587396117|FG001|Maintenance Period|Application site reaction|0|||
162639281|NCT02355691|587396122|FG000|Overall Study|Loss of Research Personnel|7|||
162639282|NCT02355691|587396123|FG001|Overall Study|Loss of Research Personnel|9|||
162639283|NCT01042236|587396127|FG000|Treatment Period 1|Adverse Event|0|||
162639284|NCT01042236|587396128|FG001|Treatment Period 1|Adverse Event|1|||
162639285|NCT01042236|587396129|FG002|Treatment Period 1|Adverse Event|0|||
162639286|NCT01042236|587396130|FG003|Treatment Period 1|Adverse Event|0|||
162639287|NCT01042236|587396131|FG004|Treatment Period 1|Adverse Event|1|||
162639288|NCT01042236|587396132|FG005|Treatment Period 1|Adverse Event|0|||
162639289|NCT01042236|587396127|FG000|Treatment Period 3|Adverse Event|0|||
162639290|NCT01042236|587396128|FG001|Treatment Period 3|Adverse Event|0|||
162639291|NCT01042236|587396129|FG002|Treatment Period 3|Adverse Event|0|||
162639292|NCT01042236|587396130|FG003|Treatment Period 3|Adverse Event|1|||
162639293|NCT01042236|587396131|FG004|Treatment Period 3|Adverse Event|0|||
162639294|NCT01042236|587396132|FG005|Treatment Period 3|Adverse Event|0|||
162639295|NCT01042236|587396127|FG000|Treatment Period 3|Protocol Violation|0|||
162639296|NCT01042236|587396128|FG001|Treatment Period 3|Protocol Violation|0|||
163008927|NCT01836471|588734278|FG001|Overall Study|Physician Decision|1|||
163008928|NCT01836471|588734279|FG002|Overall Study|Physician Decision|0|||
163008929|NCT01836471|588734280|FG003|Overall Study|Physician Decision|0|||
163008930|NCT01836471|588734281|FG004|Overall Study|Physician Decision|0|||
163008931|NCT01836471|588734277|FG000|Overall Study|Lost to Follow-up|0|||
163008932|NCT01836471|588734278|FG001|Overall Study|Lost to Follow-up|0|||
163008933|NCT01836471|588734279|FG002|Overall Study|Lost to Follow-up|0|||
163008934|NCT01836471|588734280|FG003|Overall Study|Lost to Follow-up|1|||
163008935|NCT01836471|588734281|FG004|Overall Study|Lost to Follow-up|1|||
163008936|NCT01836471|588734277|FG000|Overall Study|Adverse Event|6|||
163008937|NCT01836471|588734278|FG001|Overall Study|Adverse Event|3|||
163008938|NCT01836471|588734279|FG002|Overall Study|Adverse Event|1|||
163008939|NCT01836471|588734280|FG003|Overall Study|Adverse Event|1|||
162639297|NCT01042236|587396129|FG002|Treatment Period 3|Protocol Violation|0|||
162639298|NCT01042236|587396130|FG003|Treatment Period 3|Protocol Violation|1|||
162639299|NCT01042236|587396131|FG004|Treatment Period 3|Protocol Violation|0|||
162639300|NCT01042236|587396132|FG005|Treatment Period 3|Protocol Violation|0|||
162639301|NCT01172847|587396135|FG000|Overall Study|Withdrawal by Subject|3|||
162639302|NCT02132767|587396140|FG000|Overall Study|Death|3|||
163008940|NCT01836471|588734281|FG004|Overall Study|Adverse Event|2|||
162639303|NCT02132767|587396141|FG001|Overall Study|Death|2|||
162639304|NCT02132767|587396140|FG000|Overall Study|Withdrawal by Subject|10|||
162639305|NCT02132767|587396141|FG001|Overall Study|Withdrawal by Subject|9|||
162639306|NCT02132767|587396140|FG000|Overall Study|Lost to Follow-up|4|||
162639307|NCT02132767|587396141|FG001|Overall Study|Lost to Follow-up|4|||
162639308|NCT00390858|587396142|FG000|Overall Study|Adverse Event|6|||
162639309|NCT00390858|587396143|FG001|Overall Study|Adverse Event|2|||
162639310|NCT00390858|587396142|FG000|Overall Study|Lack of Efficacy|0|||
162639311|NCT00390858|587396143|FG001|Overall Study|Lack of Efficacy|1|||
162639312|NCT00390858|587396142|FG000|Overall Study|Withdrawal by Subject|3|||
162639313|NCT00390858|587396143|FG001|Overall Study|Withdrawal by Subject|4|||
162639314|NCT00937157|587396144|FG000|Overall Study|Pregnancy|1|||
162639315|NCT00937157|587396144|FG000|Overall Study|Lost to Follow-up|3|||
162639316|NCT02865187|587396145|FG000|Overall Study|Lost to Follow-up|12|||
162639317|NCT02865187|587396146|FG001|Overall Study|Lost to Follow-up|7|||
162639318|NCT02865187|587396145|FG000|Overall Study|Adverse Event|1|||
162639319|NCT02865187|587396146|FG001|Overall Study|Adverse Event|0|||
162639320|NCT04267133|587396147|FG000|Overall Study|Withdrawal by Subject|1|||
162639321|NCT04267133|587396147|FG000|Overall Study|Adverse Event|4|||
162639322|NCT02968563|587396148|FG000|Overall Study|Adverse Event|0|||
162639323|NCT02968563|587396149|FG001|Overall Study|Adverse Event|6|||
162639324|NCT02968563|587396148|FG000|Overall Study|Death|1|||
162639325|NCT02968563|587396149|FG001|Overall Study|Death|1|||
162639326|NCT02968563|587396148|FG000|Overall Study|Lost to Follow-up|0|||
162924689|NCT04101721|588426095|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
162639327|NCT02968563|587396149|FG001|Overall Study|Lost to Follow-up|1|||
162639328|NCT00674661|587396150|FG000|Overall Study|Other|5|||
162639329|NCT00674661|587396151|FG001|Overall Study|Other|7|||
162639330|NCT00674661|587396150|FG000|Overall Study|Lost to Follow-up|6|||
162639331|NCT00674661|587396151|FG001|Overall Study|Lost to Follow-up|3|||
162639332|NCT00674661|587396150|FG000|Overall Study|Withdrawal by Subject|0|||
162639333|NCT00674661|587396151|FG001|Overall Study|Withdrawal by Subject|5|||
162639334|NCT03566823|587396154|FG000|Overall Study|Lack of Efficacy|0|||
162715835|NCT03536884|587667093|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162715836|NCT03536884|587667094|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
162924690|NCT04101721|588426096|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
162924691|NCT04101721|588426095|FG000|Overall Study|Death|0|||
162924692|NCT04101721|588426096|FG001|Overall Study|Death|1|||
162924693|NCT04101721|588426095|FG000|Overall Study|Lost to Follow-up|0|||
162924694|NCT04101721|588426096|FG001|Overall Study|Lost to Follow-up|3|||
162924695|NCT01215955|588426097|FG000|Overall Study|Adverse Event|1|||
162924696|NCT01215955|588426098|FG001|Overall Study|Adverse Event|4|||
162924697|NCT01215955|588426099|FG002|Overall Study|Adverse Event|2|||
162924698|NCT01215955|588426100|FG003|Overall Study|Adverse Event|3|||
162924699|NCT01215955|588426097|FG000|Overall Study|Death|2|||
162924700|NCT01215955|588426098|FG001|Overall Study|Death|0|||
162924701|NCT01215955|588426099|FG002|Overall Study|Death|1|||
162924702|NCT01215955|588426100|FG003|Overall Study|Death|3|||
162924703|NCT01215955|588426097|FG000|Overall Study|Entry Criteria Not Met|1|||
162924704|NCT01215955|588426098|FG001|Overall Study|Entry Criteria Not Met|3|||
162924705|NCT01215955|588426099|FG002|Overall Study|Entry Criteria Not Met|4|||
162924706|NCT01215955|588426100|FG003|Overall Study|Entry Criteria Not Met|7|||
162924707|NCT01215955|588426097|FG000|Overall Study|Lack of Efficacy|1|||
162924708|NCT01215955|588426098|FG001|Overall Study|Lack of Efficacy|2|||
162924709|NCT01215955|588426099|FG002|Overall Study|Lack of Efficacy|1|||
162924710|NCT01215955|588426100|FG003|Overall Study|Lack of Efficacy|0|||
162924711|NCT01215955|588426097|FG000|Overall Study|Lost to Follow-up|4|||
162924712|NCT01215955|588426098|FG001|Overall Study|Lost to Follow-up|4|||
162924713|NCT01215955|588426099|FG002|Overall Study|Lost to Follow-up|8|||
162924714|NCT01215955|588426100|FG003|Overall Study|Lost to Follow-up|9|||
162924715|NCT01215955|588426097|FG000|Overall Study|Physician Decision|4|||
162924716|NCT01215955|588426098|FG001|Overall Study|Physician Decision|10|||
162924717|NCT01215955|588426099|FG002|Overall Study|Physician Decision|8|||
162924718|NCT01215955|588426100|FG003|Overall Study|Physician Decision|11|||
162924719|NCT01215955|588426097|FG000|Overall Study|Protocol Violation|17|||
162924720|NCT01215955|588426098|FG001|Overall Study|Protocol Violation|13|||
162639335|NCT03566823|587396155|FG001|Overall Study|Lack of Efficacy|1|||
162639336|NCT03566823|587396156|FG002|Overall Study|Lack of Efficacy|0|||
162639337|NCT03566823|587396154|FG000|Overall Study|Withdrawal by Subject|1|||
162639338|NCT03566823|587396155|FG001|Overall Study|Withdrawal by Subject|2|||
162924721|NCT01215955|588426099|FG002|Overall Study|Protocol Violation|8|||
162924722|NCT01215955|588426100|FG003|Overall Study|Protocol Violation|8|||
162924723|NCT01215955|588426097|FG000|Overall Study|Sponsor Decision|1|||
162639339|NCT03566823|587396156|FG002|Overall Study|Withdrawal by Subject|0|||
162639340|NCT03566823|587396154|FG000|Overall Study|Adverse Event|1|||
162639341|NCT03566823|587396155|FG001|Overall Study|Adverse Event|0|||
162639342|NCT03566823|587396156|FG002|Overall Study|Adverse Event|2|||
162924724|NCT01215955|588426098|FG001|Overall Study|Sponsor Decision|2|||
162924725|NCT01215955|588426099|FG002|Overall Study|Sponsor Decision|0|||
162924726|NCT01215955|588426100|FG003|Overall Study|Sponsor Decision|1|||
162639343|NCT01909479|587396157|FG000|From Baseline to Week 26|Adverse Event|3|||
162639344|NCT01909479|587396158|FG001|From Baseline to Week 26|Adverse Event|2|||
162639345|NCT01909479|587396157|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
162639346|NCT01909479|587396158|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
162639347|NCT01909479|587396157|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
162639348|NCT01909479|587396158|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
162639349|NCT01909479|587396157|FG000|26 - 52 Weeks|Adverse Event|0|||
162639350|NCT01909479|587396158|FG001|26 - 52 Weeks|Adverse Event|1|||
162639351|NCT01909479|587396157|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
162639352|NCT01909479|587396158|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
162639353|NCT01909479|587396157|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
162639354|NCT01909479|587396158|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
162639355|NCT01909479|587396157|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
162639356|NCT01909479|587396158|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
162639357|NCT01909479|587396157|FG000|52 Weeks to End of Study|Adverse Event|2|||
162639358|NCT01909479|587396158|FG001|52 Weeks to End of Study|Adverse Event|1|||
162639359|NCT01909479|587396157|FG000|52 Weeks to End of Study|Death|0|||
162639360|NCT01909479|587396158|FG001|52 Weeks to End of Study|Death|1|||
162639361|NCT01909479|587396157|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
162639362|NCT01909479|587396158|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
162639363|NCT01909479|587396157|FG000|52 Weeks to End of Study|Protocol Violation|1|||
162639364|NCT01909479|587396158|FG001|52 Weeks to End of Study|Protocol Violation|0|||
162639365|NCT01909479|587396157|FG000|52 Weeks to End of Study|Progressive disease|1|||
162639366|NCT01909479|587396158|FG001|52 Weeks to End of Study|Progressive disease|1|||
162639367|NCT01909479|587396157|FG000|52 Weeks to End of Study|Personal reasons|2|||
162639368|NCT01909479|587396158|FG001|52 Weeks to End of Study|Personal reasons|1|||
162639369|NCT01909479|587396157|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
162639370|NCT01909479|587396158|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
162639371|NCT01909479|587396157|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
162639372|NCT01909479|587396158|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
162639373|NCT01909479|587396157|FG000|52 Weeks to End of Study|Lack of contact|1|||
162639374|NCT01909479|587396158|FG001|52 Weeks to End of Study|Lack of contact|0|||
162639375|NCT01909479|587396157|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
162639376|NCT01909479|587396158|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
162639377|NCT01909479|587396157|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
162639378|NCT01909479|587396158|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
162639379|NCT03557151|587396160|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
162639380|NCT03557151|587396161|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
162639381|NCT03557151|587396160|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
162639382|NCT03557151|587396161|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
162639383|NCT03557151|587396160|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
162639384|NCT03557151|587396161|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
162639385|NCT02810392|587396162|FG000|Overall Study|Subject too ill to continue|1|||
162639386|NCT02810392|587396163|FG001|Overall Study|Subject too ill to continue|0|||
162639387|NCT02810392|587396162|FG000|Overall Study|COVID 19 research restrictions|0|||
162639388|NCT02810392|587396163|FG001|Overall Study|COVID 19 research restrictions|1|||
162639389|NCT01187043|587396165|FG000|Overall Study|Adverse Event|0|||
162639390|NCT01187043|587396166|FG001|Overall Study|Adverse Event|0|||
162639391|NCT01187043|587396167|FG002|Overall Study|Adverse Event|0|||
162639392|NCT01187043|587396168|FG003|Overall Study|Adverse Event|0|||
162639393|NCT01187043|587396169|FG004|Overall Study|Adverse Event|1|||
162639394|NCT01187043|587396165|FG000|Overall Study|Unable to make scheduled visits|1|||
162639395|NCT01187043|587396166|FG001|Overall Study|Unable to make scheduled visits|0|||
162639396|NCT01187043|587396167|FG002|Overall Study|Unable to make scheduled visits|4|||
162639397|NCT01187043|587396168|FG003|Overall Study|Unable to make scheduled visits|0|||
162639398|NCT01187043|587396169|FG004|Overall Study|Unable to make scheduled visits|1|||
162639399|NCT03035409|587396170|FG000|Overall Study|Adverse Event|5|||
162639400|NCT03035409|587396170|FG000|Overall Study|Death|2|||
162639401|NCT03035409|587396170|FG000|Overall Study|Withdrawal by Subject|2|||
162639402|NCT03035409|587396170|FG000|Overall Study|Non compliance|4|||
162639403|NCT03035409|587396170|FG000|Overall Study|Patient was jittery|1|||
162639404|NCT03035409|587396170|FG000|Overall Study|Did not like Questionnaire|1|||
162639405|NCT03035409|587396170|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
162639406|NCT03035409|587396170|FG000|Overall Study|Did not like taking drugs|1|||
163061609|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
163061610|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
163061611|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
162639407|NCT00927784|587396175|FG000|Overall Study|Death|1|||
162639408|NCT00927784|587396176|FG001|Overall Study|Death|0|||
162639409|NCT00927784|587396175|FG000|Overall Study|Withdrawal by Subject|1|||
162639410|NCT00927784|587396176|FG001|Overall Study|Withdrawal by Subject|0|||
162639411|NCT00467259|587396177|FG000|Overall Study|Adverse Event|24|||
163008941|NCT01836471|588734277|FG000|Overall Study|Non compliance with tx|1|||
163008942|NCT01836471|588734278|FG001|Overall Study|Non compliance with tx|1|||
163008943|NCT01836471|588734279|FG002|Overall Study|Non compliance with tx|0|||
163008944|NCT01836471|588734280|FG003|Overall Study|Non compliance with tx|0|||
163008945|NCT01836471|588734281|FG004|Overall Study|Non compliance with tx|0|||
163008946|NCT02570308|588734284|FG000|Overall Study|Death|1|||
163008947|NCT02570308|588734285|FG001|Overall Study|Death|5|||
163008948|NCT02570308|588734286|FG002|Overall Study|Death|4|||
163008949|NCT02570308|588734287|FG003|Overall Study|Death|4|||
163008950|NCT02570308|588734288|FG004|Overall Study|Death|69|||
163008951|NCT02570308|588734284|FG000|Overall Study|Lost to Follow-up|0|||
163008952|NCT02570308|588734285|FG001|Overall Study|Lost to Follow-up|0|||
163008953|NCT02570308|588734286|FG002|Overall Study|Lost to Follow-up|0|||
163008954|NCT02570308|588734287|FG003|Overall Study|Lost to Follow-up|0|||
163008955|NCT02570308|588734288|FG004|Overall Study|Lost to Follow-up|2|||
163008956|NCT02570308|588734284|FG000|Overall Study|Withdrawal by Subject|0|||
163008957|NCT02570308|588734285|FG001|Overall Study|Withdrawal by Subject|0|||
163008958|NCT02570308|588734286|FG002|Overall Study|Withdrawal by Subject|0|||
163008959|NCT02570308|588734287|FG003|Overall Study|Withdrawal by Subject|0|||
163008960|NCT02570308|588734288|FG004|Overall Study|Withdrawal by Subject|1|||
163008961|NCT02570308|588734284|FG000|Overall Study|Other|0|||
163008962|NCT02570308|588734285|FG001|Overall Study|Other|0|||
163008963|NCT02570308|588734286|FG002|Overall Study|Other|0|||
163008964|NCT02570308|588734287|FG003|Overall Study|Other|0|||
163008965|NCT02570308|588734288|FG004|Overall Study|Other|2|||
163008966|NCT01960413|588734289|FG000|Overall Study|Withdrawal by Subject|1|||
163008967|NCT01960413|588734290|FG001|Overall Study|Withdrawal by Subject|1|||
163008968|NCT01960413|588734289|FG000|Overall Study|Physician Decision|1|||
163008969|NCT01960413|588734290|FG001|Overall Study|Physician Decision|0|||
163008970|NCT01960413|588734289|FG000|Overall Study|Lost to Follow-up|2|||
163008971|NCT01960413|588734290|FG001|Overall Study|Lost to Follow-up|0|||
163008972|NCT02069015|588734291|FG000|Overall Study|Lost to Follow-up|39|||
163008973|NCT02069015|588734292|FG001|Overall Study|Lost to Follow-up|32|||
163008974|NCT02069015|588734291|FG000|Overall Study|Withdrawal by Subject|1|||
163008975|NCT02069015|588734292|FG001|Overall Study|Withdrawal by Subject|1|||
163008976|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
163008977|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
163008978|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
163008979|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
163008980|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
163008981|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
163008982|NCT02059135|588734293|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
163008983|NCT02059135|588734294|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
163008984|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
163008985|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
163008986|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
163008987|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
163008988|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
163008989|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
163008990|NCT02059135|588734293|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
163008991|NCT02059135|588734294|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
163008992|NCT05921903|588734299|FG000|Overall Study|Unsolicited non-SAE|0|||
163008993|NCT05921903|588734300|FG001|Overall Study|Unsolicited non-SAE|1|||
163008994|NCT05921903|588734301|FG002|Overall Study|Unsolicited non-SAE|0|||
163008995|NCT05921903|588734299|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
163008996|NCT05921903|588734300|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
163008997|NCT05921903|588734301|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
163008998|NCT05921903|588734299|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
163008999|NCT05921903|588734300|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
163009000|NCT05921903|588734301|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
163009001|NCT03305848|588734302|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
163009002|NCT03305848|588734302|FG000|Overall Study|Physician Decision|2|||
163009003|NCT02301169|588734304|FG000|Overall Study|Adverse Event|1|||
163009004|NCT02301169|588734305|FG001|Overall Study|Adverse Event|0|||
163009005|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
163009006|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
163009007|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
163009008|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
163009009|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
163009010|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
163009011|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
163009012|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
163009013|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
163009014|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
163009015|NCT03762265|588734306|FG000|BT Period: Weeks 1 to 37|Other|0|||
163009016|NCT03762265|588734307|FG001|BT Period: Weeks 1 to 37|Other|1|||
163009017|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
163009018|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
163009019|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
163009020|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
163009021|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
163009022|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
163009023|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
163009024|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
163009025|NCT03762265|588734306|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
163009026|NCT03762265|588734307|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
163009027|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
163009028|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
163009029|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
163009030|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
162639412|NCT00467259|587396178|FG001|Overall Study|Adverse Event|90|||
162639413|NCT00467259|587396177|FG000|Overall Study|Protocol Violation|1|||
162639414|NCT00467259|587396178|FG001|Overall Study|Protocol Violation|7|||
162639415|NCT00467259|587396177|FG000|Overall Study|Withdrawal by Subject|34|||
162639416|NCT00467259|587396178|FG001|Overall Study|Withdrawal by Subject|108|||
162639417|NCT00467259|587396177|FG000|Overall Study|Physician Decision|0|||
162639418|NCT00467259|587396178|FG001|Overall Study|Physician Decision|2|||
162639419|NCT00467259|587396177|FG000|Overall Study|Lost to Follow-up|14|||
162639420|NCT00467259|587396178|FG001|Overall Study|Lost to Follow-up|34|||
162639421|NCT00467259|587396177|FG000|Overall Study|Site Closed|2|||
162639422|NCT00467259|587396178|FG001|Overall Study|Site Closed|1|||
162639423|NCT06079320|587396179|FG000|Follow up Phase|Lost to Follow-up|1|||
162639424|NCT06079320|587396180|FG001|Follow up Phase|Lost to Follow-up|0|||
162639425|NCT02196558|587396181|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
162639426|NCT02196558|587396182|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
162639427|NCT02196558|587396183|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
162639428|NCT02196558|587396181|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
162639429|NCT02196558|587396182|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
162639430|NCT02196558|587396183|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
162639431|NCT02196558|587396181|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
162639432|NCT02196558|587396182|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
162639433|NCT02196558|587396183|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
162639434|NCT02196558|587396181|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
162639435|NCT02196558|587396182|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
162639436|NCT02196558|587396183|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
162639437|NCT02196558|587396181|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162639438|NCT02196558|587396182|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162639439|NCT02196558|587396183|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162639440|NCT02107482|587396188|FG000|Overall Study|inconveinence|2|||
162639441|NCT02107482|587396188|FG000|Overall Study|Lost to Follow-up|1|||
162639442|NCT02107482|587396188|FG000|Overall Study|Lack of Efficacy|1|||
162639443|NCT03128892|587396189|FG000|Overall Study|Withdrawal by Subject|2|||
162639444|NCT03128892|587396189|FG000|Overall Study|Physician Decision|1|||
162639445|NCT00368355|587396191|FG000|Overall Study|Adverse Event|1|||
162639446|NCT00368355|587396192|FG001|Overall Study|Adverse Event|0|||
162639447|NCT00368355|587396191|FG000|Overall Study|Death|2|||
162639448|NCT00368355|587396192|FG001|Overall Study|Death|4|||
162639449|NCT00368355|587396191|FG000|Overall Study|Relapse|6|||
162639450|NCT00368355|587396192|FG001|Overall Study|Relapse|10|||
162639451|NCT00368355|587396191|FG000|Overall Study|Subsequent transplant|0|||
162639452|NCT00368355|587396192|FG001|Overall Study|Subsequent transplant|3|||
162639453|NCT00368355|587396191|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
162639454|NCT00368355|587396192|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
162639455|NCT03473808|587396201|FG000|Overall Study|Withdrawal by Subject|1|||
162639456|NCT01085591|587396204|FG000|Overall Study|Adverse Event|0|||
162639457|NCT01085591|587396205|FG001|Overall Study|Adverse Event|1|||
162639458|NCT01085591|587396206|FG002|Overall Study|Adverse Event|3|||
162639459|NCT01085591|587396204|FG000|Overall Study|Physician Decision|1|||
162639460|NCT01085591|587396205|FG001|Overall Study|Physician Decision|0|||
162639461|NCT01085591|587396206|FG002|Overall Study|Physician Decision|1|||
163009031|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
163009032|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
163009033|NCT03762265|588734306|FG000|LTE Period: Weeks 61 to 109|Other|1|||
163009034|NCT03762265|588734307|FG001|LTE Period: Weeks 61 to 109|Other|0|||
162639462|NCT01085591|587396204|FG000|Overall Study|Withdrawal by Subject|0|||
162639463|NCT01085591|587396205|FG001|Overall Study|Withdrawal by Subject|2|||
162639464|NCT01085591|587396206|FG002|Overall Study|Withdrawal by Subject|1|||
162639465|NCT01085591|587396204|FG000|Overall Study|Lost to Follow-up|0|||
162639466|NCT01085591|587396205|FG001|Overall Study|Lost to Follow-up|1|||
162639467|NCT01085591|587396206|FG002|Overall Study|Lost to Follow-up|1|||
162639468|NCT01085591|587396204|FG000|Overall Study|Protocol Violation|1|||
162639469|NCT01085591|587396205|FG001|Overall Study|Protocol Violation|1|||
162639470|NCT01085591|587396206|FG002|Overall Study|Protocol Violation|1|||
162639471|NCT01085591|587396204|FG000|Overall Study|Other|0|||
162639472|NCT01085591|587396205|FG001|Overall Study|Other|1|||
162639473|NCT01085591|587396206|FG002|Overall Study|Other|0|||
162639474|NCT01085591|587396204|FG000|Overall Study|Not Properly Consented|1|||
162639475|NCT01085591|587396205|FG001|Overall Study|Not Properly Consented|0|||
162639476|NCT01085591|587396206|FG002|Overall Study|Not Properly Consented|0|||
162639477|NCT03715764|587396207|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
162639478|NCT03715764|587396208|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
162639479|NCT03715764|587396207|FG000|3 Month Follow-up|Lost to Follow-up|2|||
162639480|NCT03715764|587396208|FG001|3 Month Follow-up|Lost to Follow-up|2|||
162639481|NCT03715764|587396207|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
162639482|NCT03715764|587396208|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
162639483|NCT03715764|587396207|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162639484|NCT03715764|587396208|FG001|6 Month Follow-up|Lost to Follow-up|0|||
162639485|NCT03715764|587396207|FG000|12 Month Follow-up|Lost to Follow-up|2|||
162639486|NCT03715764|587396208|FG001|12 Month Follow-up|Lost to Follow-up|3|||
162639487|NCT03715764|587396207|FG000|12 Month Follow-up|Pregnancy|0|||
162639488|NCT03715764|587396208|FG001|12 Month Follow-up|Pregnancy|1|||
162639489|NCT03715764|587396207|FG000|12 Month Follow-up|Surgery|2|||
162639490|NCT03715764|587396208|FG001|12 Month Follow-up|Surgery|0|||
162639491|NCT03715764|587396207|FG000|12 Month Follow-up|Wrong address|1|||
162639492|NCT03715764|587396208|FG001|12 Month Follow-up|Wrong address|0|||
162639493|NCT03715764|587396207|FG000|12 Month Follow-up|No symptoms|1|||
162639494|NCT03715764|587396208|FG001|12 Month Follow-up|No symptoms|0|||
162639495|NCT03715764|587396207|FG000|12 Month Follow-up|Changed primary care centre|0|||
162639496|NCT03715764|587396208|FG001|12 Month Follow-up|Changed primary care centre|1|||
162639497|NCT01980875|587396210|FG000|Overall Study|Withdrew Consent|1|||
162639498|NCT01980875|587396211|FG001|Overall Study|Withdrew Consent|1|||
162639499|NCT01980875|587396212|FG002|Overall Study|Withdrew Consent|1|||
162639500|NCT01980875|587396210|FG000|Overall Study|Study Terminated by Sponsor|7|||
162639501|NCT01980875|587396211|FG001|Overall Study|Study Terminated by Sponsor|24|||
162639502|NCT01980875|587396212|FG002|Overall Study|Study Terminated by Sponsor|22|||
162639503|NCT01980875|587396210|FG000|Overall Study|Lost to Follow-up|0|||
162639504|NCT01980875|587396211|FG001|Overall Study|Lost to Follow-up|0|||
162639505|NCT01980875|587396212|FG002|Overall Study|Lost to Follow-up|1|||
162639506|NCT00662363|587396213|FG000|Overall Study|Withdrawal by Subject|6|||
162639507|NCT00662363|587396214|FG001|Overall Study|Withdrawal by Subject|5|||
162639508|NCT00662363|587396213|FG000|Overall Study|Adverse Event|0|||
162639509|NCT00662363|587396214|FG001|Overall Study|Adverse Event|3|||
162639510|NCT00662363|587396213|FG000|Overall Study|Discharged early from rehab|4|||
162639511|NCT00662363|587396214|FG001|Overall Study|Discharged early from rehab|1|||
162715837|NCT03536884|587667095|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
162715838|NCT03536884|587667096|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162715839|NCT03536884|587667097|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162639512|NCT00662363|587396213|FG000|Overall Study|Protocol Violation|1|||
162715840|NCT03536884|587667098|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162715841|NCT03536884|587667099|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162715842|NCT03536884|587667100|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162639513|NCT00662363|587396214|FG001|Overall Study|Protocol Violation|1|||
162639514|NCT01905657|587396215|FG000|Overall Study|Adverse Event|23|||
162639515|NCT01905657|587396216|FG001|Overall Study|Adverse Event|17|||
162639516|NCT01905657|587396217|FG002|Overall Study|Adverse Event|18|||
162639517|NCT01905657|587396215|FG000|Overall Study|Clinical Progression|103|||
163009035|NCT00765102|588734308|FG000|Overall Study|Progressive disease|18|||
163009036|NCT00765102|588734308|FG000|Overall Study|Adverse Event|6|||
163009037|NCT00765102|588734308|FG000|Overall Study|Physician Decision|4|||
163009038|NCT00765102|588734308|FG000|Overall Study|Withdrawal by Subject|2|||
163009039|NCT00765102|588734308|FG000|Overall Study|Protocol Violation|1|||
163009040|NCT02289729|588734311|FG000|Overall Study|Lack of Efficacy|3|||
163009041|NCT02289729|588734311|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
163009042|NCT02289729|588734311|FG000|Overall Study|Withdrawal by Subject|1|||
163009043|NCT02289729|588734311|FG000|Overall Study|Death|1|||
163009044|NCT00470470|588734312|FG000|Overall Study|Adverse Event|2|||
163009045|NCT00470470|588734312|FG000|Overall Study|Death|2|||
163009046|NCT00470470|588734312|FG000|Overall Study|Not treated|1|||
163009047|NCT01149863|588734316|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
163009048|NCT02452476|588734321|FG000|Overall Study|Death|4|||
163009049|NCT02452476|588734322|FG001|Overall Study|Death|7|||
163009050|NCT02452476|588734321|FG000|Overall Study|Lost to Follow-up|1|||
163009051|NCT02452476|588734322|FG001|Overall Study|Lost to Follow-up|1|||
163009052|NCT02452476|588734321|FG000|Overall Study|Physician Decision|1|||
163009053|NCT02452476|588734322|FG001|Overall Study|Physician Decision|1|||
163061612|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
163061613|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
163061614|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
163061615|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
163061616|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
163061617|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
163061618|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
163061619|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
163061620|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
163061621|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
163061622|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
163061623|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
163061624|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
163061625|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
163061626|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
163061627|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
163061628|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
163061629|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
163061630|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
163061631|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
163061632|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
163061633|NCT00090103|588934982|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
163061634|NCT00090103|588934983|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
163061635|NCT00090103|588934984|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
163061636|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
163061637|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
163061638|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
163061639|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
163061640|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
163061641|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
163061642|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
163061643|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
163061644|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
163061645|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
163061646|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
163061647|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
163061648|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
163061649|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
163061650|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
163061651|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
163061652|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
163061653|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
163061654|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
163061655|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
163061656|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
163061657|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
163061658|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
163061659|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
163061660|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
162924727|NCT01215955|588426097|FG000|Overall Study|Withdrawal by Subject|14|||
162639518|NCT01905657|587396216|FG001|Overall Study|Clinical Progression|78|||
162639519|NCT01905657|587396217|FG002|Overall Study|Clinical Progression|59|||
162639520|NCT01905657|587396215|FG000|Overall Study|Death|40|||
162639521|NCT01905657|587396216|FG001|Overall Study|Death|43|||
162639522|NCT01905657|587396217|FG002|Overall Study|Death|47|||
162639523|NCT01905657|587396215|FG000|Overall Study|Excluded Medication|13|||
162639524|NCT01905657|587396216|FG001|Overall Study|Excluded Medication|16|||
162639525|NCT01905657|587396217|FG002|Overall Study|Excluded Medication|9|||
162639526|NCT01905657|587396215|FG000|Overall Study|Lost to Follow-up|1|||
162639527|NCT01905657|587396216|FG001|Overall Study|Lost to Follow-up|2|||
162639528|NCT01905657|587396217|FG002|Overall Study|Lost to Follow-up|1|||
162639529|NCT01905657|587396215|FG000|Overall Study|Physician Decision|5|||
162639530|NCT01905657|587396216|FG001|Overall Study|Physician Decision|8|||
162639531|NCT01905657|587396217|FG002|Overall Study|Physician Decision|12|||
162639532|NCT01905657|587396215|FG000|Overall Study|Protocol Violation|2|||
162639533|NCT01905657|587396216|FG001|Overall Study|Protocol Violation|1|||
162639534|NCT01905657|587396217|FG002|Overall Study|Protocol Violation|1|||
162639535|NCT01905657|587396215|FG000|Overall Study|Screen Failure|0|||
162639536|NCT01905657|587396216|FG001|Overall Study|Screen Failure|1|||
162639537|NCT01905657|587396217|FG002|Overall Study|Screen Failure|0|||
162639538|NCT01905657|587396215|FG000|Overall Study|Withdrawal by Subject|15|||
162639539|NCT01905657|587396216|FG001|Overall Study|Withdrawal by Subject|21|||
162639540|NCT01905657|587396217|FG002|Overall Study|Withdrawal by Subject|53|||
162639541|NCT01905657|587396215|FG000|Overall Study|Sponsor Decision|1|||
162639542|NCT01905657|587396216|FG001|Overall Study|Sponsor Decision|0|||
162639543|NCT01905657|587396217|FG002|Overall Study|Sponsor Decision|0|||
162639544|NCT05119569|587396222|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
162639545|NCT05119569|587396223|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
162639546|NCT05119569|587396224|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162639547|NCT05119569|587396225|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162639548|NCT05119569|587396222|FG000|Double Blind Treatment Phase|Adverse Event|6|||
162639549|NCT05119569|587396223|FG001|Double Blind Treatment Phase|Adverse Event|0|||
162639550|NCT05119569|587396224|FG002|Double Blind Treatment Phase|Adverse Event|0|||
162639551|NCT05119569|587396225|FG003|Double Blind Treatment Phase|Adverse Event|0|||
162639552|NCT05119569|587396222|FG000|Open Label Extension Phase|Ongoing in the study|0|||
162639553|NCT05119569|587396223|FG001|Open Label Extension Phase|Ongoing in the study|0|||
162639554|NCT05119569|587396224|FG002|Open Label Extension Phase|Ongoing in the study|65|||
162639555|NCT05119569|587396225|FG003|Open Label Extension Phase|Ongoing in the study|34|||
162639556|NCT02623439|587396228|FG000|Overall Study|Withdrawal by Subject|1|||
162639557|NCT02623439|587396228|FG000|Overall Study|Screen Failure|1|||
162639558|NCT02200445|587396232|FG000|Overall Study|Lack of Efficacy|1|||
162639559|NCT02200445|587396233|FG001|Overall Study|Lack of Efficacy|2|||
162639560|NCT02200445|587396234|FG002|Overall Study|Lack of Efficacy|2|||
162639561|NCT02200445|587396232|FG000|Overall Study|Adverse Event|0|||
162639562|NCT02200445|587396233|FG001|Overall Study|Adverse Event|2|||
162639563|NCT02200445|587396234|FG002|Overall Study|Adverse Event|0|||
162639564|NCT04484142|587396235|FG000|Overall Study|Adverse Event|13|||
162639565|NCT04484142|587396235|FG000|Overall Study|Progressive Disease|87|||
162639566|NCT04484142|587396235|FG000|Overall Study|Clinical Progression|10|||
162639567|NCT04484142|587396235|FG000|Overall Study|Withdrawal by Subject|6|||
162639568|NCT04484142|587396235|FG000|Overall Study|Physician Decision|1|||
162639569|NCT03700671|587396236|FG000|Overall Study|Lack of Efficacy|1|||
162639570|NCT03700671|587396237|FG001|Overall Study|Lack of Efficacy|2|||
162639571|NCT05371509|587396238|FG000|Overall Study|Physician Decision|1|||
162639572|NCT05371509|587396239|FG001|Overall Study|Physician Decision|0|||
162639573|NCT04405037|587396246|FG000|Overall Study|Withdrawal by Subject|1|||
162639574|NCT04405037|587396247|FG001|Overall Study|Withdrawal by Subject|0|||
162639575|NCT04405037|587396246|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
163009054|NCT02452476|588734321|FG000|Overall Study|Not treated|5|||
163009055|NCT02452476|588734322|FG001|Overall Study|Not treated|1|||
162639576|NCT04405037|587396247|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
162639577|NCT04434092|587396248|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
162639578|NCT04434092|587396249|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
163009056|NCT01408043|588734323|FG000|Overall Study|unable to collect cells|1|||
163009057|NCT00946920|588734324|FG000|Overall Study|Withdrawal by Subject|28|||
163009058|NCT00946920|588734325|FG001|Overall Study|Withdrawal by Subject|15|||
162639579|NCT04434092|587396250|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
162639580|NCT04434092|587396248|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
162639581|NCT04434092|587396249|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
162639582|NCT04434092|587396250|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
162639583|NCT04434092|587396248|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
162639584|NCT04434092|587396249|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
163009059|NCT00946920|588734324|FG000|Overall Study|Lost to Follow-up|2|||
163009060|NCT00946920|588734325|FG001|Overall Study|Lost to Follow-up|2|||
163009061|NCT00946920|588734324|FG000|Overall Study|Physician Decision|5|||
163061661|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
163061662|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
163061663|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
163061664|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
163061665|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
163061666|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
163061667|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
163061668|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
163061669|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
163061670|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
162639585|NCT04434092|587396250|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
162639586|NCT04434092|587396248|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
162639587|NCT04434092|587396249|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
162639588|NCT04434092|587396250|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
162639589|NCT04434092|587396248|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
162639590|NCT04434092|587396249|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
162639591|NCT04434092|587396250|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
162639592|NCT04434092|587396248|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
162639593|NCT04434092|587396249|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
162639594|NCT04434092|587396250|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
162639595|NCT04434092|587396248|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
162639596|NCT04434092|587396249|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
162639597|NCT04434092|587396250|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
162639598|NCT02554812|587396251|FG000|Overall Study|Adverse Event|2|||
162639599|NCT02554812|587396252|FG001|Overall Study|Adverse Event|5|||
162639600|NCT02554812|587396253|FG002|Overall Study|Adverse Event|3|||
162639601|NCT02554812|587396254|FG003|Overall Study|Adverse Event|0|||
162639602|NCT02554812|587396255|FG004|Overall Study|Adverse Event|5|||
162639603|NCT02554812|587396256|FG005|Overall Study|Adverse Event|0|||
162639604|NCT02554812|587396257|FG006|Overall Study|Adverse Event|1|||
162639605|NCT02554812|587396258|FG007|Overall Study|Adverse Event|6|||
162639606|NCT02554812|587396259|FG008|Overall Study|Adverse Event|2|||
162639607|NCT02554812|587396260|FG009|Overall Study|Adverse Event|2|||
162639608|NCT02554812|587396261|FG010|Overall Study|Adverse Event|1|||
162639609|NCT02554812|587396262|FG011|Overall Study|Adverse Event|2|||
162639610|NCT02554812|587396263|FG012|Overall Study|Adverse Event|0|||
162639611|NCT02554812|587396264|FG013|Overall Study|Adverse Event|3|||
162639612|NCT02554812|587396265|FG014|Overall Study|Adverse Event|2|||
162639613|NCT02554812|587396266|FG015|Overall Study|Adverse Event|1|||
162639614|NCT02554812|587396267|FG016|Overall Study|Adverse Event|0|||
162639615|NCT02554812|587396268|FG017|Overall Study|Adverse Event|1|||
162639616|NCT02554812|587396269|FG018|Overall Study|Adverse Event|0|||
162639617|NCT02554812|587396270|FG019|Overall Study|Adverse Event|0|||
162639618|NCT02554812|587396271|FG020|Overall Study|Adverse Event|0|||
162639619|NCT02554812|587396272|FG021|Overall Study|Adverse Event|2|||
162639620|NCT02554812|587396273|FG022|Overall Study|Adverse Event|1|||
162639621|NCT02554812|587396274|FG023|Overall Study|Adverse Event|1|||
162639622|NCT02554812|587396275|FG024|Overall Study|Adverse Event|1|||
162639623|NCT02554812|587396276|FG025|Overall Study|Adverse Event|2|||
162639624|NCT02554812|587396277|FG026|Overall Study|Adverse Event|1|||
162639625|NCT02554812|587396251|FG000|Overall Study|Death|1|||
162639626|NCT02554812|587396252|FG001|Overall Study|Death|2|||
162639627|NCT02554812|587396253|FG002|Overall Study|Death|2|||
162639628|NCT02554812|587396254|FG003|Overall Study|Death|2|||
162639629|NCT02554812|587396255|FG004|Overall Study|Death|0|||
162639630|NCT02554812|587396256|FG005|Overall Study|Death|1|||
163061671|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
162639631|NCT02554812|587396257|FG006|Overall Study|Death|1|||
162639632|NCT02554812|587396258|FG007|Overall Study|Death|1|||
162639633|NCT02554812|587396259|FG008|Overall Study|Death|0|||
162639634|NCT02554812|587396260|FG009|Overall Study|Death|0|||
162639635|NCT02554812|587396261|FG010|Overall Study|Death|0|||
162639636|NCT02554812|587396262|FG011|Overall Study|Death|0|||
163061672|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
163061673|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
163061674|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
162639637|NCT02554812|587396263|FG012|Overall Study|Death|0|||
162639638|NCT02554812|587396264|FG013|Overall Study|Death|0|||
162639639|NCT02554812|587396265|FG014|Overall Study|Death|1|||
162639640|NCT02554812|587396266|FG015|Overall Study|Death|1|||
162715843|NCT03536884|587667101|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162715844|NCT03536884|587667102|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162639641|NCT02554812|587396267|FG016|Overall Study|Death|1|||
162639642|NCT02554812|587396268|FG017|Overall Study|Death|0|||
162639643|NCT02554812|587396269|FG018|Overall Study|Death|1|||
163009062|NCT00946920|588734325|FG001|Overall Study|Physician Decision|2|||
163009063|NCT00946920|588734324|FG000|Overall Study|Adverse Event|41|||
163009064|NCT00946920|588734325|FG001|Overall Study|Adverse Event|14|||
163009065|NCT00946920|588734324|FG000|Overall Study|Protocol Violation|16|||
163009066|NCT00946920|588734325|FG001|Overall Study|Protocol Violation|8|||
163009067|NCT00946920|588734324|FG000|Overall Study|Miscellaneous reasons|18|||
163009068|NCT00946920|588734325|FG001|Overall Study|Miscellaneous reasons|3|||
163009069|NCT00397514|588734326|FG000|Overall Study|Withdrawal by Subject|1|||
163009070|NCT00397514|588734326|FG000|Overall Study|Pacing wire malfunction|1|||
163009071|NCT00397514|588734326|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
163009072|NCT00397514|588734326|FG000|Overall Study|early extubation|2|||
163009073|NCT00397514|588734326|FG000|Overall Study|poor echocardiographic windows|1|||
163009074|NCT05373108|588734327|FG000|Overall Study|Withdrawal by Subject|2|||
163009075|NCT02892331|588734329|FG000|Overall Study|Withdrawal by Subject|0|||
163009076|NCT02892331|588734330|FG001|Overall Study|Withdrawal by Subject|1|||
163009077|NCT02892331|588734331|FG002|Overall Study|Withdrawal by Subject|1|||
163009078|NCT02892331|588734329|FG000|Overall Study|Sick family member|0|||
163009079|NCT02892331|588734330|FG001|Overall Study|Sick family member|0|||
163009080|NCT02892331|588734331|FG002|Overall Study|Sick family member|1|||
163009081|NCT02892331|588734329|FG000|Overall Study|Corona virus pandemic|1|||
163009082|NCT02892331|588734330|FG001|Overall Study|Corona virus pandemic|0|||
163009083|NCT02892331|588734331|FG002|Overall Study|Corona virus pandemic|1|||
163009084|NCT02892331|588734329|FG000|Overall Study|Lost to Follow-up|1|||
163009085|NCT02892331|588734330|FG001|Overall Study|Lost to Follow-up|0|||
163009086|NCT02892331|588734331|FG002|Overall Study|Lost to Follow-up|1|||
163009087|NCT02892331|588734329|FG000|Overall Study|Blood pressure was too elevated|0|||
163009088|NCT02892331|588734330|FG001|Overall Study|Blood pressure was too elevated|1|||
163009089|NCT02892331|588734331|FG002|Overall Study|Blood pressure was too elevated|0|||
163009090|NCT02892331|588734329|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
163009091|NCT02892331|588734330|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
163009092|NCT02892331|588734331|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
163009093|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
163009094|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
163009095|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
163009096|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163009097|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
163009098|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
163009099|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009100|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009101|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
163009102|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Other|1|||
163009103|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Other|0|||
162639644|NCT02554812|587396270|FG019|Overall Study|Death|2|||
162639645|NCT02554812|587396271|FG020|Overall Study|Death|0|||
163009104|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Other|4|||
163009105|NCT02654054|588734336|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163009106|NCT02654054|588734337|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163009107|NCT02654054|588734338|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
163061675|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
162639646|NCT02554812|587396272|FG021|Overall Study|Death|1|||
162639647|NCT02554812|587396273|FG022|Overall Study|Death|1|||
163009108|NCT04871776|588734339|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
163009109|NCT04871776|588734340|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
163009110|NCT04871776|588734341|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
163009111|NCT04871776|588734339|FG000|Overall Study|Did not meet eligibility criteria|1|||
163009112|NCT04871776|588734340|FG001|Overall Study|Did not meet eligibility criteria|1|||
163009113|NCT04871776|588734341|FG002|Overall Study|Did not meet eligibility criteria|1|||
163009114|NCT06389487|588734346|FG000|Overall Study|Lost to Follow-up|9|||
163009115|NCT06389487|588734347|FG001|Overall Study|Lost to Follow-up|5|||
163009116|NCT06389487|588734348|FG002|Overall Study|Lost to Follow-up|13|||
163009117|NCT06389487|588734346|FG000|Overall Study|Protocol Violation|0|||
163009118|NCT06389487|588734347|FG001|Overall Study|Protocol Violation|0|||
163009119|NCT06389487|588734348|FG002|Overall Study|Protocol Violation|2|||
163009120|NCT06389487|588734346|FG000|Overall Study|Withdrawal by Subject|2|||
163009121|NCT06389487|588734347|FG001|Overall Study|Withdrawal by Subject|2|||
163009122|NCT06389487|588734348|FG002|Overall Study|Withdrawal by Subject|1|||
163009123|NCT06389487|588734346|FG000|Overall Study|Other|1|||
163009124|NCT06389487|588734347|FG001|Overall Study|Other|0|||
163009125|NCT06389487|588734348|FG002|Overall Study|Other|1|||
163009126|NCT05423093|588736219|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
163009127|NCT05423093|588736219|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
163009128|NCT05423093|588736219|FG000|Attended Intervention Session|Lost to Follow-up|3|||
163009129|NCT05423093|588736219|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
163009130|NCT05423093|588736219|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
163009131|NCT03593525|588736220|FG000|Overall Study|Withdrawal by Subject|1|||
163009132|NCT03593525|588736221|FG001|Overall Study|Withdrawal by Subject|0|||
163009133|NCT03593525|588736220|FG000|Overall Study|Lost to Follow-up|7|||
163009134|NCT03593525|588736221|FG001|Overall Study|Lost to Follow-up|5|||
163009135|NCT00210210|588736229|FG000|Overall Study|Withdrawal by Subject|3|||
163009136|NCT00210210|588736230|FG001|Overall Study|Withdrawal by Subject|2|||
163009137|NCT00210210|588736229|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
163009138|NCT00210210|588736230|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
163009139|NCT02502149|588736235|FG000|Intermediate|Discontinued prematurely|1|||
163009140|NCT02502149|588736236|FG001|Intermediate|Discontinued prematurely|0|||
163009141|NCT02502149|588736237|FG002|Intermediate|Discontinued prematurely|0|||
163009142|NCT02502149|588736238|FG003|Intermediate|Discontinued prematurely|0|||
163009143|NCT02502149|588736239|FG004|Intermediate|Discontinued prematurely|0|||
163009144|NCT04067050|588736247|FG000|One Month|Lost to Follow-up|4|||
163009145|NCT04067050|588736248|FG001|One Month|Lost to Follow-up|0|||
163009146|NCT04067050|588736247|FG000|Two Month|Lost to Follow-up|1|||
163009147|NCT04067050|588736248|FG001|Two Month|Lost to Follow-up|0|||
163009148|NCT04067050|588736247|FG000|Two Month|Adverse Event|1|||
163009149|NCT04067050|588736248|FG001|Two Month|Adverse Event|0|||
163009150|NCT02383017|588736256|FG000|Overall Study|Injury Sustained Outside Study|1|||
163009151|NCT02383017|588736257|FG001|Overall Study|Injury Sustained Outside Study|0|||
163009152|NCT02383017|588736256|FG000|Overall Study|Compliance|3|||
163009153|NCT02383017|588736257|FG001|Overall Study|Compliance|2|||
163009154|NCT02383017|588736256|FG000|Overall Study|Found to be Hypogonadal|1|||
163009155|NCT02383017|588736257|FG001|Overall Study|Found to be Hypogonadal|0|||
163009156|NCT03871543|588736265|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
163009157|NCT03871543|588736265|FG000|Period 1|Investigator Error|1|||
162715845|NCT03536884|587667091|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163009158|NCT03871543|588736265|FG000|Period 1|Protocol Violation|2|||
163009159|NCT03871543|588736265|FG000|Period 1|COVID-19 Related|1|||
163009160|NCT03871543|588736265|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
163009161|NCT03871543|588736265|FG000|Period 1|Withdrawal by Subject|10|||
163009162|NCT03871543|588736265|FG000|Period 2|Adverse Event|1|||
163009163|NCT03871543|588736265|FG000|Period 2|Withdrawal by Subject|1|||
163009164|NCT01894919|588736266|FG000|Overall Study|Withdrawal by Subject|1|||
163009165|NCT01894919|588736267|FG001|Overall Study|Withdrawal by Subject|0|||
163009166|NCT01894919|588736268|FG002|Overall Study|Withdrawal by Subject|0|||
163009167|NCT01894919|588736269|FG003|Overall Study|Withdrawal by Subject|0|||
163009168|NCT01894919|588736270|FG004|Overall Study|Withdrawal by Subject|1|||
163009169|NCT01894919|588736271|FG005|Overall Study|Withdrawal by Subject|0|||
163009170|NCT01894919|588736272|FG006|Overall Study|Withdrawal by Subject|0|||
163009171|NCT01894919|588736273|FG007|Overall Study|Withdrawal by Subject|0|||
163009172|NCT01894919|588736274|FG008|Overall Study|Withdrawal by Subject|0|||
163009173|NCT01894919|588736275|FG009|Overall Study|Withdrawal by Subject|1|||
163009174|NCT01894919|588736276|FG010|Overall Study|Withdrawal by Subject|1|||
163009175|NCT01894919|588736277|FG011|Overall Study|Withdrawal by Subject|0|||
163009176|NCT01894919|588736278|FG012|Overall Study|Withdrawal by Subject|0|||
163009177|NCT01894919|588736266|FG000|Overall Study|Adverse Event|0|||
163009178|NCT01894919|588736267|FG001|Overall Study|Adverse Event|0|||
163009179|NCT01894919|588736268|FG002|Overall Study|Adverse Event|0|||
163009180|NCT01894919|588736269|FG003|Overall Study|Adverse Event|0|||
163009181|NCT01894919|588736270|FG004|Overall Study|Adverse Event|0|||
163009182|NCT01894919|588736271|FG005|Overall Study|Adverse Event|0|||
163009183|NCT01894919|588736272|FG006|Overall Study|Adverse Event|0|||
163009184|NCT01894919|588736273|FG007|Overall Study|Adverse Event|0|||
163009185|NCT01894919|588736274|FG008|Overall Study|Adverse Event|0|||
163009186|NCT01894919|588736275|FG009|Overall Study|Adverse Event|0|||
163009187|NCT01894919|588736276|FG010|Overall Study|Adverse Event|1|||
163009188|NCT01894919|588736277|FG011|Overall Study|Adverse Event|0|||
163009189|NCT01894919|588736278|FG012|Overall Study|Adverse Event|0|||
163009190|NCT01894919|588736266|FG000|Overall Study|Other-Unspecified|1|||
163009191|NCT01894919|588736267|FG001|Overall Study|Other-Unspecified|0|||
163009192|NCT01894919|588736268|FG002|Overall Study|Other-Unspecified|0|||
163009193|NCT01894919|588736269|FG003|Overall Study|Other-Unspecified|0|||
163009194|NCT01894919|588736270|FG004|Overall Study|Other-Unspecified|0|||
163009195|NCT01894919|588736271|FG005|Overall Study|Other-Unspecified|0|||
163009196|NCT01894919|588736272|FG006|Overall Study|Other-Unspecified|0|||
163009197|NCT01894919|588736273|FG007|Overall Study|Other-Unspecified|0|||
163009198|NCT01894919|588736274|FG008|Overall Study|Other-Unspecified|0|||
163009199|NCT01894919|588736275|FG009|Overall Study|Other-Unspecified|0|||
163009200|NCT01894919|588736276|FG010|Overall Study|Other-Unspecified|0|||
163009201|NCT01894919|588736277|FG011|Overall Study|Other-Unspecified|0|||
163009202|NCT01894919|588736278|FG012|Overall Study|Other-Unspecified|0|||
163009203|NCT01894919|588736266|FG000|Overall Study|Lost to Follow-up|0|||
163009204|NCT01894919|588736267|FG001|Overall Study|Lost to Follow-up|0|||
163009205|NCT01894919|588736268|FG002|Overall Study|Lost to Follow-up|0|||
163009206|NCT01894919|588736269|FG003|Overall Study|Lost to Follow-up|0|||
163009207|NCT01894919|588736270|FG004|Overall Study|Lost to Follow-up|2|||
163009208|NCT01894919|588736271|FG005|Overall Study|Lost to Follow-up|0|||
163009209|NCT01894919|588736272|FG006|Overall Study|Lost to Follow-up|0|||
163009210|NCT01894919|588736273|FG007|Overall Study|Lost to Follow-up|0|||
163009211|NCT01894919|588736274|FG008|Overall Study|Lost to Follow-up|0|||
163009212|NCT01894919|588736275|FG009|Overall Study|Lost to Follow-up|0|||
163009213|NCT01894919|588736276|FG010|Overall Study|Lost to Follow-up|0|||
163009214|NCT01894919|588736277|FG011|Overall Study|Lost to Follow-up|0|||
163009215|NCT01894919|588736278|FG012|Overall Study|Lost to Follow-up|0|||
163009216|NCT03711188|588736279|FG000|Overall Study|Disease progression|11|||
163009217|NCT03711188|588736279|FG000|Overall Study|Adverse Event|1|||
163009218|NCT03534687|588736282|FG000|Overall Study|Lost to Follow-up|7|||
163009219|NCT03534687|588736283|FG001|Overall Study|Lost to Follow-up|2|||
163009220|NCT00314340|588736285|FG000|Overall Study|lost interest|1|||
163009221|NCT00957801|588736286|FG000|Overall Study|Withdrawal by Subject|0|||
163009222|NCT00957801|588736287|FG001|Overall Study|Withdrawal by Subject|0|||
163009223|NCT00957801|588736288|FG002|Overall Study|Withdrawal by Subject|0|||
163009224|NCT00957801|588736289|FG003|Overall Study|Withdrawal by Subject|1|||
163009225|NCT01283464|588736290|FG000|Overall Study|Lost to Follow-up|0|||
163009226|NCT01283464|588736291|FG001|Overall Study|Lost to Follow-up|1|||
163009227|NCT01283464|588736290|FG000|Overall Study|Withdrawal by Subject|1|||
163009228|NCT01283464|588736291|FG001|Overall Study|Withdrawal by Subject|0|||
163009229|NCT01283464|588736290|FG000|Overall Study|Physician Decision|1|||
163009230|NCT01283464|588736291|FG001|Overall Study|Physician Decision|0|||
163009231|NCT03051100|588736293|FG000|Overall Study|Withdrawal by Subject|1|||
163009232|NCT03051100|588736294|FG001|Overall Study|Withdrawal by Subject|0|||
163009233|NCT02626026|588736295|FG000|Overall Study|Randomized but Never Treated|0|||
163009234|NCT02626026|588736296|FG001|Overall Study|Randomized but Never Treated|0|||
163009235|NCT02626026|588736297|FG002|Overall Study|Randomized but Never Treated|0|||
163009236|NCT02626026|588736298|FG003|Overall Study|Randomized but Never Treated|0|||
163009237|NCT02626026|588736299|FG004|Overall Study|Randomized but Never Treated|1|||
163009238|NCT02626026|588736300|FG005|Overall Study|Randomized but Never Treated|0|||
163009239|NCT01778855|588736301|FG000|Overall Study|Death|0|||
163009240|NCT01778855|588736302|FG001|Overall Study|Death|1|||
163009241|NCT01286467|588736305|FG000|Overall Study|Death|1|||
163009242|NCT01286467|588736306|FG001|Overall Study|Death|1|||
163009243|NCT01286467|588736307|FG002|Overall Study|Death|1|||
163009244|NCT01286467|588736308|FG003|Overall Study|Death|0|||
163009245|NCT01286467|588736305|FG000|Overall Study|Lost to Follow-up|0|||
163009246|NCT01286467|588736306|FG001|Overall Study|Lost to Follow-up|0|||
163009247|NCT01286467|588736307|FG002|Overall Study|Lost to Follow-up|0|||
163009248|NCT01286467|588736308|FG003|Overall Study|Lost to Follow-up|1|||
163009249|NCT01286467|588736305|FG000|Overall Study|Withdrawal by Subject|0|||
163009250|NCT01286467|588736306|FG001|Overall Study|Withdrawal by Subject|0|||
163009251|NCT01286467|588736307|FG002|Overall Study|Withdrawal by Subject|1|||
163009252|NCT01286467|588736308|FG003|Overall Study|Withdrawal by Subject|0|||
163009253|NCT01286467|588736305|FG000|Overall Study|Physician Decision|0|||
163009254|NCT01286467|588736306|FG001|Overall Study|Physician Decision|0|||
163009255|NCT01286467|588736307|FG002|Overall Study|Physician Decision|0|||
163009256|NCT01286467|588736308|FG003|Overall Study|Physician Decision|1|||
163009257|NCT01286467|588736305|FG000|Overall Study|Disease progression|3|||
163009258|NCT01286467|588736306|FG001|Overall Study|Disease progression|2|||
163009259|NCT01286467|588736307|FG002|Overall Study|Disease progression|2|||
163009260|NCT01286467|588736308|FG003|Overall Study|Disease progression|3|||
163009261|NCT01286467|588736305|FG000|Overall Study|Adverse Event|0|||
163009262|NCT01286467|588736306|FG001|Overall Study|Adverse Event|1|||
163009263|NCT01286467|588736307|FG002|Overall Study|Adverse Event|2|||
163009264|NCT01286467|588736308|FG003|Overall Study|Adverse Event|3|||
163009265|NCT01286467|588736305|FG000|Overall Study|Study drug stop longer than 14 days|0|||
163061676|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
163009266|NCT01286467|588736306|FG001|Overall Study|Study drug stop longer than 14 days|0|||
163009267|NCT01286467|588736307|FG002|Overall Study|Study drug stop longer than 14 days|1|||
163009268|NCT01286467|588736308|FG003|Overall Study|Study drug stop longer than 14 days|0|||
163009269|NCT03335475|588736309|FG000|Overall Study|Did not wear accelerometer|4|||
163009270|NCT03335475|588736310|FG001|Overall Study|Did not wear accelerometer|0|||
163009271|NCT03335475|588736309|FG000|Overall Study|Withdrawal by Subject|0|||
163009272|NCT03335475|588736310|FG001|Overall Study|Withdrawal by Subject|1|||
163009273|NCT04886596|588736311|FG000|Overall Study|Adverse Event|442|||
163009274|NCT04886596|588736312|FG001|Overall Study|Adverse Event|441|||
163009275|NCT04886596|588736311|FG000|Overall Study|Lost to Follow-up|448|||
163009276|NCT04886596|588736312|FG001|Overall Study|Lost to Follow-up|465|||
163009277|NCT04886596|588736311|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
163009278|NCT04886596|588736312|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
163009279|NCT04886596|588736311|FG000|Overall Study|Migrated/moved from the study area|201|||
163009280|NCT04886596|588736312|FG001|Overall Study|Migrated/moved from the study area|184|||
163009281|NCT04886596|588736311|FG000|Overall Study|Other|298|||
163009282|NCT04886596|588736312|FG001|Overall Study|Other|326|||
163009283|NCT03751098|588736315|FG000|Overall Study|Withdrawal by Subject|0|||
163009284|NCT03751098|588736316|FG001|Overall Study|Withdrawal by Subject|1|||
163009285|NCT00923013|588736317|FG000|Overall Study|Refused further treatment|0|||
163009286|NCT00923013|588736318|FG001|Overall Study|Refused further treatment|1|||
163009287|NCT00923013|588736319|FG002|Overall Study|Refused further treatment|2|||
163009288|NCT00923013|588736320|FG003|Overall Study|Refused further treatment|0|||
163061677|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
162639648|NCT02554812|587396274|FG023|Overall Study|Death|0|||
162639649|NCT02554812|587396275|FG024|Overall Study|Death|0|||
162639650|NCT02554812|587396276|FG025|Overall Study|Death|0|||
162639651|NCT02554812|587396277|FG026|Overall Study|Death|0|||
162639652|NCT02554812|587396251|FG000|Overall Study|Lost to Follow-up|0|||
162639653|NCT02554812|587396252|FG001|Overall Study|Lost to Follow-up|1|||
162639654|NCT02554812|587396253|FG002|Overall Study|Lost to Follow-up|0|||
162639655|NCT02554812|587396254|FG003|Overall Study|Lost to Follow-up|0|||
162639656|NCT02554812|587396255|FG004|Overall Study|Lost to Follow-up|0|||
162639657|NCT02554812|587396256|FG005|Overall Study|Lost to Follow-up|0|||
162639658|NCT02554812|587396257|FG006|Overall Study|Lost to Follow-up|0|||
162639659|NCT02554812|587396258|FG007|Overall Study|Lost to Follow-up|0|||
162639660|NCT02554812|587396259|FG008|Overall Study|Lost to Follow-up|0|||
162639661|NCT02554812|587396260|FG009|Overall Study|Lost to Follow-up|0|||
162639662|NCT02554812|587396261|FG010|Overall Study|Lost to Follow-up|0|||
162639663|NCT02554812|587396262|FG011|Overall Study|Lost to Follow-up|0|||
162639664|NCT02554812|587396263|FG012|Overall Study|Lost to Follow-up|0|||
162639665|NCT02554812|587396264|FG013|Overall Study|Lost to Follow-up|0|||
162639666|NCT02554812|587396265|FG014|Overall Study|Lost to Follow-up|0|||
162639667|NCT02554812|587396266|FG015|Overall Study|Lost to Follow-up|0|||
162639668|NCT02554812|587396267|FG016|Overall Study|Lost to Follow-up|0|||
162639669|NCT02554812|587396268|FG017|Overall Study|Lost to Follow-up|0|||
162639670|NCT02554812|587396269|FG018|Overall Study|Lost to Follow-up|0|||
162639671|NCT02554812|587396270|FG019|Overall Study|Lost to Follow-up|0|||
162639672|NCT02554812|587396271|FG020|Overall Study|Lost to Follow-up|0|||
162639673|NCT02554812|587396272|FG021|Overall Study|Lost to Follow-up|0|||
162639674|NCT02554812|587396273|FG022|Overall Study|Lost to Follow-up|0|||
162639675|NCT02554812|587396274|FG023|Overall Study|Lost to Follow-up|0|||
162639676|NCT02554812|587396275|FG024|Overall Study|Lost to Follow-up|0|||
162639677|NCT02554812|587396276|FG025|Overall Study|Lost to Follow-up|0|||
162639678|NCT02554812|587396277|FG026|Overall Study|Lost to Follow-up|0|||
162639679|NCT02554812|587396251|FG000|Overall Study|Global deterioration of health status|4|||
162639680|NCT02554812|587396252|FG001|Overall Study|Global deterioration of health status|3|||
162639681|NCT02554812|587396253|FG002|Overall Study|Global deterioration of health status|3|||
162639682|NCT02554812|587396254|FG003|Overall Study|Global deterioration of health status|2|||
162639683|NCT02554812|587396255|FG004|Overall Study|Global deterioration of health status|5|||
162639684|NCT02554812|587396256|FG005|Overall Study|Global deterioration of health status|0|||
162639685|NCT02554812|587396257|FG006|Overall Study|Global deterioration of health status|2|||
162639686|NCT02554812|587396258|FG007|Overall Study|Global deterioration of health status|1|||
162639687|NCT02554812|587396259|FG008|Overall Study|Global deterioration of health status|1|||
162639688|NCT02554812|587396260|FG009|Overall Study|Global deterioration of health status|1|||
162639689|NCT02554812|587396261|FG010|Overall Study|Global deterioration of health status|2|||
162639690|NCT02554812|587396262|FG011|Overall Study|Global deterioration of health status|1|||
162639691|NCT02554812|587396263|FG012|Overall Study|Global deterioration of health status|0|||
162639692|NCT02554812|587396264|FG013|Overall Study|Global deterioration of health status|0|||
162639693|NCT02554812|587396265|FG014|Overall Study|Global deterioration of health status|0|||
162639694|NCT02554812|587396266|FG015|Overall Study|Global deterioration of health status|1|||
162639695|NCT02554812|587396267|FG016|Overall Study|Global deterioration of health status|0|||
162639696|NCT02554812|587396268|FG017|Overall Study|Global deterioration of health status|0|||
163009289|NCT00923013|588736321|FG004|Overall Study|Refused further treatment|0|||
163009290|NCT00923013|588736322|FG005|Overall Study|Refused further treatment|0|||
163009291|NCT00923013|588736317|FG000|Overall Study|Switched to alternative treatment|0|||
163009292|NCT00923013|588736318|FG001|Overall Study|Switched to alternative treatment|1|||
163009293|NCT00923013|588736319|FG002|Overall Study|Switched to alternative treatment|0|||
163009294|NCT00923013|588736320|FG003|Overall Study|Switched to alternative treatment|0|||
163009295|NCT00923013|588736321|FG004|Overall Study|Switched to alternative treatment|0|||
162639697|NCT02554812|587396269|FG018|Overall Study|Global deterioration of health status|0|||
162639698|NCT02554812|587396270|FG019|Overall Study|Global deterioration of health status|0|||
162715846|NCT03536884|587667092|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162639699|NCT02554812|587396271|FG020|Overall Study|Global deterioration of health status|0|||
162639700|NCT02554812|587396272|FG021|Overall Study|Global deterioration of health status|0|||
162639701|NCT02554812|587396273|FG022|Overall Study|Global deterioration of health status|0|||
163009296|NCT00923013|588736322|FG005|Overall Study|Switched to alternative treatment|0|||
163009297|NCT00923013|588736317|FG000|Overall Study|Death on study|2|||
163009298|NCT00923013|588736318|FG001|Overall Study|Death on study|2|||
163009299|NCT00923013|588736319|FG002|Overall Study|Death on study|0|||
163009300|NCT00923013|588736320|FG003|Overall Study|Death on study|1|||
163009301|NCT00923013|588736321|FG004|Overall Study|Death on study|0|||
163009302|NCT00923013|588736322|FG005|Overall Study|Death on study|0|||
163009303|NCT01060072|588736325|FG000|Overall Study|Adverse Event|1|||
163009304|NCT01060072|588736326|FG001|Overall Study|Adverse Event|1|||
163009305|NCT01060072|588736325|FG000|Overall Study|Physician Decision|0|||
163009306|NCT01060072|588736326|FG001|Overall Study|Physician Decision|2|||
163009307|NCT01060072|588736325|FG000|Overall Study|Protocol Violation|0|||
163009308|NCT01060072|588736326|FG001|Overall Study|Protocol Violation|1|||
163009309|NCT01060072|588736325|FG000|Overall Study|Acute cholecystitis|1|||
163009310|NCT01060072|588736326|FG001|Overall Study|Acute cholecystitis|0|||
163009311|NCT01060072|588736325|FG000|Overall Study|Excluded Medications|0|||
163009312|NCT01060072|588736326|FG001|Overall Study|Excluded Medications|1|||
163009313|NCT03326193|588736336|FG000|Overall Study|Sponsor decision|35|||
163009314|NCT00822692|588736337|FG000|Overall Study|Lost to Follow-up|17|||
163009315|NCT00822692|588736338|FG001|Overall Study|Lost to Follow-up|25|||
163009316|NCT02348112|588736339|FG000|Overall Study|Withdrawal by Subject|32|||
163009317|NCT02348112|588736340|FG001|Overall Study|Withdrawal by Subject|29|||
163009318|NCT02348112|588736339|FG000|Overall Study|Lost to Follow-up|24|||
163009319|NCT02348112|588736340|FG001|Overall Study|Lost to Follow-up|20|||
163009320|NCT02348112|588736339|FG000|Overall Study|Physician Decision|17|||
163009321|NCT02348112|588736340|FG001|Overall Study|Physician Decision|15|||
163009322|NCT02348112|588736339|FG000|Overall Study|Site closed due to PI leaving|0|||
163009323|NCT02348112|588736340|FG001|Overall Study|Site closed due to PI leaving|30|||
163009324|NCT02348112|588736339|FG000|Overall Study|Sponsor withdrawal|0|||
163009325|NCT02348112|588736340|FG001|Overall Study|Sponsor withdrawal|7|||
163009326|NCT02348112|588736339|FG000|Overall Study|Death|0|||
163009327|NCT02348112|588736340|FG001|Overall Study|Death|1|||
163009328|NCT01168427|588736342|FG000|Overall Study|Patient exited prior to implant|1|||
163009329|NCT00640315|588736343|FG000|Overall Study|Withdrawal by Subject|0|||
163009330|NCT00640315|588736344|FG001|Overall Study|Withdrawal by Subject|1|||
163009331|NCT01530464|588736345|FG000|Washout (24h)|Withdrawal by Subject|1|||
163009332|NCT01530464|588736346|FG001|Washout (24h)|Withdrawal by Subject|0|||
163009333|NCT01530464|588736345|FG000|Washout (24h)|Withdrawal by Subject|0|||
163009334|NCT01530464|588736346|FG001|Washout (24h)|Withdrawal by Subject|1|||
163009335|NCT01709500|588736347|FG000|Overall Study|Randomized but not treated|0|||
163009336|NCT01709500|588736348|FG001|Overall Study|Randomized but not treated|1|||
163009337|NCT01709500|588736347|FG000|Overall Study|Adverse Event|5|||
163009338|NCT01709500|588736348|FG001|Overall Study|Adverse Event|1|||
163009339|NCT01709500|588736347|FG000|Overall Study|Poor compliance to protocol|2|||
163009340|NCT01709500|588736348|FG001|Overall Study|Poor compliance to protocol|1|||
163009341|NCT01709500|588736347|FG000|Overall Study|Other|3|||
163009342|NCT01709500|588736348|FG001|Overall Study|Other|1|||
163009343|NCT01709500|588736347|FG000|Overall Study|Related to IMP administration|1|||
163009344|NCT01709500|588736348|FG001|Overall Study|Related to IMP administration|0|||
163009345|NCT01709500|588736347|FG000|Overall Study|Treatment ongoing|156|||
163009346|NCT01709500|588736348|FG001|Overall Study|Treatment ongoing|78|||
163009347|NCT02107131|588736349|FG000|Overall Study|Lost to Follow-up|4|||
163009348|NCT02107131|588736350|FG001|Overall Study|Lost to Follow-up|4|||
163009349|NCT02107131|588736349|FG000|Overall Study|Physician Decision|1|||
163009350|NCT02107131|588736350|FG001|Overall Study|Physician Decision|0|||
163009351|NCT02107131|588736349|FG000|Overall Study|Withdrawal by Subject|2|||
163009352|NCT02107131|588736350|FG001|Overall Study|Withdrawal by Subject|0|||
163009353|NCT02107131|588736349|FG000|Overall Study|mental instability|1|||
163009354|NCT02107131|588736350|FG001|Overall Study|mental instability|0|||
163009355|NCT02107131|588736349|FG000|Overall Study|Death|0|||
163009356|NCT02107131|588736350|FG001|Overall Study|Death|1|||
163009357|NCT02107131|588736349|FG000|Overall Study|Protocol Violation|0|||
163061678|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
163009358|NCT02107131|588736350|FG001|Overall Study|Protocol Violation|4|||
163009359|NCT02286713|588736351|FG000|One Week Follow-Up|Death|1|||
163009360|NCT02286713|588736352|FG001|One Week Follow-Up|Death|0|||
163009361|NCT02286713|588736351|FG000|One Week Follow-Up|Lost to Follow-up|17|||
163009362|NCT02286713|588736352|FG001|One Week Follow-Up|Lost to Follow-up|21|||
163009363|NCT02286713|588736351|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
163009364|NCT02286713|588736352|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
163009365|NCT02286713|588736351|FG000|Three Month Follow-Up|Death|1|||
163009366|NCT02286713|588736352|FG001|Three Month Follow-Up|Death|1|||
163009367|NCT02286713|588736351|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
163009368|NCT02286713|588736352|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
163009369|NCT02286713|588736351|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
163061679|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
163009370|NCT02286713|588736352|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
163009371|NCT02286713|588736351|FG000|Six Month Follow-Up|Death|2|||
163009372|NCT02286713|588736352|FG001|Six Month Follow-Up|Death|0|||
163009373|NCT02286713|588736351|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
163009374|NCT02286713|588736352|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
163009375|NCT04314037|588736353|FG000|Treatment Period 2|Adverse Event|1|||
163009376|NCT04314037|588736354|FG001|Treatment Period 2|Adverse Event|0|||
163009377|NCT04314037|588736353|FG000|Treatment Period 3|Protocol Violation|1|||
163009378|NCT04314037|588736354|FG001|Treatment Period 3|Protocol Violation|0|||
163009379|NCT04314037|588736353|FG000|Treatment Period 3|Adverse Event|0|||
163009380|NCT04314037|588736354|FG001|Treatment Period 3|Adverse Event|1|||
163009381|NCT00856492|588736357|FG000|Overall Study|Ineligible or withdrew consent|1|||
163009382|NCT00856492|588736358|FG001|Overall Study|Ineligible or withdrew consent|1|||
163009383|NCT00856492|588736359|FG002|Overall Study|Ineligible or withdrew consent|2|||
163009384|NCT00955409|588737936|FG000|Overall Study|Lack of Efficacy|1|||
163009385|NCT00955409|588737937|FG001|Overall Study|Lack of Efficacy|0|||
163009386|NCT00955409|588737938|FG002|Overall Study|Lack of Efficacy|0|||
163009387|NCT00955409|588737939|FG003|Overall Study|Lack of Efficacy|0|||
163009388|NCT00955409|588737940|FG004|Overall Study|Lack of Efficacy|0|||
163009389|NCT00955409|588737941|FG005|Overall Study|Lack of Efficacy|0|||
163009390|NCT00955409|588737942|FG006|Overall Study|Lack of Efficacy|0|||
163009391|NCT00955409|588737943|FG007|Overall Study|Lack of Efficacy|0|||
163009392|NCT00955409|588737944|FG008|Overall Study|Lack of Efficacy|0|||
163009393|NCT00955409|588737945|FG009|Overall Study|Lack of Efficacy|0|||
163009394|NCT00955409|588737936|FG000|Overall Study|Withdrawal by Subject|1|||
163009395|NCT00955409|588737937|FG001|Overall Study|Withdrawal by Subject|0|||
163009396|NCT00955409|588737938|FG002|Overall Study|Withdrawal by Subject|5|||
163009397|NCT00955409|588737939|FG003|Overall Study|Withdrawal by Subject|2|||
163009398|NCT00955409|588737940|FG004|Overall Study|Withdrawal by Subject|0|||
163009399|NCT00955409|588737941|FG005|Overall Study|Withdrawal by Subject|0|||
163009400|NCT00955409|588737942|FG006|Overall Study|Withdrawal by Subject|2|||
163009401|NCT00955409|588737943|FG007|Overall Study|Withdrawal by Subject|0|||
163009402|NCT00955409|588737944|FG008|Overall Study|Withdrawal by Subject|1|||
163009403|NCT00955409|588737945|FG009|Overall Study|Withdrawal by Subject|0|||
163009404|NCT00955409|588737936|FG000|Overall Study|Caregiver Request|2|||
163009405|NCT00955409|588737937|FG001|Overall Study|Caregiver Request|0|||
163009406|NCT00955409|588737938|FG002|Overall Study|Caregiver Request|6|||
163009407|NCT00955409|588737939|FG003|Overall Study|Caregiver Request|5|||
163009408|NCT00955409|588737940|FG004|Overall Study|Caregiver Request|0|||
163009409|NCT00955409|588737941|FG005|Overall Study|Caregiver Request|2|||
163009410|NCT00955409|588737942|FG006|Overall Study|Caregiver Request|3|||
163009411|NCT00955409|588737943|FG007|Overall Study|Caregiver Request|1|||
163009412|NCT00955409|588737944|FG008|Overall Study|Caregiver Request|3|||
163009413|NCT00955409|588737945|FG009|Overall Study|Caregiver Request|0|||
163009414|NCT00955409|588737936|FG000|Overall Study|Investigator Request|0|||
163009415|NCT00955409|588737937|FG001|Overall Study|Investigator Request|0|||
163009416|NCT00955409|588737938|FG002|Overall Study|Investigator Request|1|||
163009417|NCT00955409|588737939|FG003|Overall Study|Investigator Request|0|||
163009418|NCT00955409|588737940|FG004|Overall Study|Investigator Request|0|||
163009419|NCT00955409|588737941|FG005|Overall Study|Investigator Request|0|||
163009420|NCT00955409|588737942|FG006|Overall Study|Investigator Request|0|||
163009421|NCT00955409|588737943|FG007|Overall Study|Investigator Request|0|||
163009422|NCT00955409|588737944|FG008|Overall Study|Investigator Request|0|||
163009423|NCT00955409|588737945|FG009|Overall Study|Investigator Request|0|||
163009424|NCT00955409|588737936|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163009425|NCT00955409|588737937|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163009426|NCT00955409|588737938|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163009427|NCT00955409|588737939|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163009428|NCT00955409|588737940|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163061680|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
163061681|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
163061682|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
163009429|NCT00955409|588737941|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163009430|NCT00955409|588737942|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
163009431|NCT00955409|588737943|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
163009432|NCT00955409|588737944|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
163009433|NCT00955409|588737945|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
163009434|NCT00955409|588737936|FG000|Overall Study|Lost to Follow-up|0|||
163009435|NCT00955409|588737937|FG001|Overall Study|Lost to Follow-up|0|||
163009436|NCT00955409|588737938|FG002|Overall Study|Lost to Follow-up|1|||
163009437|NCT00955409|588737939|FG003|Overall Study|Lost to Follow-up|0|||
163009438|NCT00955409|588737940|FG004|Overall Study|Lost to Follow-up|0|||
163009439|NCT00955409|588737941|FG005|Overall Study|Lost to Follow-up|0|||
163009440|NCT00955409|588737942|FG006|Overall Study|Lost to Follow-up|1|||
163009441|NCT00955409|588737943|FG007|Overall Study|Lost to Follow-up|0|||
163009442|NCT00955409|588737944|FG008|Overall Study|Lost to Follow-up|0|||
163009443|NCT00955409|588737945|FG009|Overall Study|Lost to Follow-up|0|||
163009444|NCT00955409|588737936|FG000|Overall Study|Failed to Return|2|||
163009445|NCT00955409|588737937|FG001|Overall Study|Failed to Return|0|||
163009446|NCT00955409|588737938|FG002|Overall Study|Failed to Return|0|||
163009447|NCT00955409|588737939|FG003|Overall Study|Failed to Return|0|||
163009448|NCT00955409|588737940|FG004|Overall Study|Failed to Return|0|||
163009449|NCT00955409|588737941|FG005|Overall Study|Failed to Return|0|||
163009450|NCT00955409|588737942|FG006|Overall Study|Failed to Return|0|||
163009451|NCT00955409|588737943|FG007|Overall Study|Failed to Return|2|||
163009452|NCT00955409|588737944|FG008|Overall Study|Failed to Return|0|||
163009453|NCT00955409|588737945|FG009|Overall Study|Failed to Return|0|||
163009454|NCT00955409|588737936|FG000|Overall Study|Adverse Event (AE)|2|||
163009455|NCT00955409|588737937|FG001|Overall Study|Adverse Event (AE)|0|||
163009456|NCT00955409|588737938|FG002|Overall Study|Adverse Event (AE)|0|||
163009457|NCT00955409|588737939|FG003|Overall Study|Adverse Event (AE)|0|||
163009458|NCT00955409|588737940|FG004|Overall Study|Adverse Event (AE)|0|||
163009459|NCT00955409|588737941|FG005|Overall Study|Adverse Event (AE)|1|||
163009460|NCT00955409|588737942|FG006|Overall Study|Adverse Event (AE)|2|||
163009461|NCT00955409|588737943|FG007|Overall Study|Adverse Event (AE)|0|||
163009462|NCT00955409|588737944|FG008|Overall Study|Adverse Event (AE)|2|||
163009463|NCT00955409|588737945|FG009|Overall Study|Adverse Event (AE)|0|||
163009464|NCT00955409|588737936|FG000|Overall Study|Reason not Specified|2|||
163009465|NCT00955409|588737937|FG001|Overall Study|Reason not Specified|1|||
163009466|NCT00955409|588737938|FG002|Overall Study|Reason not Specified|13|||
163009467|NCT00955409|588737939|FG003|Overall Study|Reason not Specified|1|||
163009468|NCT00955409|588737940|FG004|Overall Study|Reason not Specified|2|||
163009469|NCT00955409|588737941|FG005|Overall Study|Reason not Specified|0|||
163009470|NCT00955409|588737942|FG006|Overall Study|Reason not Specified|16|||
163009471|NCT00955409|588737943|FG007|Overall Study|Reason not Specified|0|||
163009472|NCT00955409|588737944|FG008|Overall Study|Reason not Specified|8|||
163009473|NCT00955409|588737945|FG009|Overall Study|Reason not Specified|1|||
163009474|NCT00485732|588737946|FG000|Overall Study|Protocol Violation|1|||
163009475|NCT00485732|588737947|FG001|Overall Study|Protocol Violation|3|||
163009476|NCT00485732|588737946|FG000|Overall Study|Withdrawal by Subject|5|||
163009477|NCT00485732|588737947|FG001|Overall Study|Withdrawal by Subject|4|||
163061683|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
163061684|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Death|1|||
163061685|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Death|0|||
162639702|NCT02554812|587396274|FG023|Overall Study|Global deterioration of health status|0|||
162639703|NCT02554812|587396275|FG024|Overall Study|Global deterioration of health status|0|||
162639704|NCT02554812|587396276|FG025|Overall Study|Global deterioration of health status|0|||
162639705|NCT02554812|587396277|FG026|Overall Study|Global deterioration of health status|0|||
162639706|NCT02554812|587396251|FG000|Overall Study|Progressive disease|20|||
162715847|NCT03536884|587667093|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
162715848|NCT03536884|587667094|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
162715849|NCT03536884|587667095|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
162639707|NCT02554812|587396252|FG001|Overall Study|Progressive disease|16|||
162639708|NCT02554812|587396253|FG002|Overall Study|Progressive disease|19|||
162639709|NCT02554812|587396254|FG003|Overall Study|Progressive disease|18|||
162639710|NCT02554812|587396255|FG004|Overall Study|Progressive disease|21|||
162639711|NCT02554812|587396256|FG005|Overall Study|Progressive disease|15|||
162639712|NCT02554812|587396257|FG006|Overall Study|Progressive disease|6|||
162639713|NCT02554812|587396258|FG007|Overall Study|Progressive disease|13|||
162639714|NCT02554812|587396259|FG008|Overall Study|Progressive disease|6|||
162639715|NCT02554812|587396260|FG009|Overall Study|Progressive disease|6|||
162639716|NCT02554812|587396261|FG010|Overall Study|Progressive disease|8|||
162639717|NCT02554812|587396262|FG011|Overall Study|Progressive disease|8|||
162639718|NCT02554812|587396263|FG012|Overall Study|Progressive disease|6|||
162639719|NCT02554812|587396264|FG013|Overall Study|Progressive disease|10|||
162639720|NCT02554812|587396265|FG014|Overall Study|Progressive disease|20|||
162715850|NCT03536884|587667096|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162715851|NCT03536884|587667097|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162715852|NCT03536884|587667098|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163009478|NCT00485732|588737946|FG000|Overall Study|Lost to Follow-up|2|||
163009479|NCT00485732|588737947|FG001|Overall Study|Lost to Follow-up|2|||
162639721|NCT02554812|587396266|FG015|Overall Study|Progressive disease|6|||
163009480|NCT02445248|588737949|FG000|Overall Study|Death|45|||
163009481|NCT02445248|588737950|FG001|Overall Study|Death|12|||
163009482|NCT02445248|588737949|FG000|Overall Study|Progressive disease|13|||
163009483|NCT02445248|588737950|FG001|Overall Study|Progressive disease|1|||
163009484|NCT02445248|588737949|FG000|Overall Study|Subject decision|8|||
163009485|NCT02445248|588737950|FG001|Overall Study|Subject decision|0|||
163009486|NCT02445248|588737949|FG000|Overall Study|Physician Decision|5|||
163009487|NCT02445248|588737950|FG001|Overall Study|Physician Decision|0|||
163009488|NCT02445248|588737949|FG000|Overall Study|Adverse Event|1|||
163009489|NCT02445248|588737950|FG001|Overall Study|Adverse Event|0|||
163009490|NCT02445248|588737949|FG000|Overall Study|Lost to Follow-up|1|||
162639722|NCT02554812|587396267|FG016|Overall Study|Progressive disease|3|||
163009491|NCT02445248|588737950|FG001|Overall Study|Lost to Follow-up|0|||
163009492|NCT01120184|588737951|FG000|Overall Study|Adverse Event|0|||
163009493|NCT01120184|588737952|FG001|Overall Study|Adverse Event|1|||
163009494|NCT01120184|588737953|FG002|Overall Study|Adverse Event|0|||
163009495|NCT01120184|588737951|FG000|Overall Study|Lost to Follow-up|13|||
163009496|NCT01120184|588737952|FG001|Overall Study|Lost to Follow-up|13|||
163009497|NCT01120184|588737953|FG002|Overall Study|Lost to Follow-up|11|||
163009498|NCT01120184|588737951|FG000|Overall Study|Physician Decision|9|||
163009499|NCT01120184|588737952|FG001|Overall Study|Physician Decision|1|||
163009500|NCT01120184|588737953|FG002|Overall Study|Physician Decision|3|||
163009501|NCT01120184|588737951|FG000|Overall Study|Reason not Specified|8|||
163009502|NCT01120184|588737952|FG001|Overall Study|Reason not Specified|3|||
163009503|NCT01120184|588737953|FG002|Overall Study|Reason not Specified|12|||
163009504|NCT01120184|588737951|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
163009505|NCT01120184|588737952|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
163009506|NCT01120184|588737953|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
163009507|NCT01120184|588737951|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
163009508|NCT01120184|588737952|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
163009509|NCT01120184|588737953|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
163009510|NCT01120184|588737951|FG000|Overall Study|Death|170|||
163009511|NCT01120184|588737952|FG001|Overall Study|Death|176|||
163009512|NCT01120184|588737953|FG002|Overall Study|Death|169|||
163009513|NCT02596971|588737954|FG000|Overall Study|Death|5|||
163009514|NCT02596971|588737955|FG001|Overall Study|Death|1|||
163009515|NCT02596971|588737956|FG002|Overall Study|Death|5|||
163009516|NCT02596971|588737954|FG000|Overall Study|Withdrawal by Subject|5|||
163009517|NCT02596971|588737955|FG001|Overall Study|Withdrawal by Subject|1|||
163009518|NCT02596971|588737956|FG002|Overall Study|Withdrawal by Subject|4|||
163009519|NCT00824772|588737959|FG000|Overall Study|Withdrawal by Subject|8|||
163009520|NCT00683618|588737960|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
163009521|NCT00683618|588737961|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
162639723|NCT02554812|587396268|FG017|Overall Study|Progressive disease|3|||
162639724|NCT02554812|587396269|FG018|Overall Study|Progressive disease|11|||
162639725|NCT02554812|587396270|FG019|Overall Study|Progressive disease|7|||
162639726|NCT02554812|587396271|FG020|Overall Study|Progressive disease|11|||
162639727|NCT02554812|587396272|FG021|Overall Study|Progressive disease|6|||
162639728|NCT02554812|587396273|FG022|Overall Study|Progressive disease|9|||
162639729|NCT02554812|587396274|FG023|Overall Study|Progressive disease|9|||
162639730|NCT02554812|587396275|FG024|Overall Study|Progressive disease|4|||
162639731|NCT02554812|587396276|FG025|Overall Study|Progressive disease|5|||
162639732|NCT02554812|587396277|FG026|Overall Study|Progressive disease|5|||
162639733|NCT02554812|587396251|FG000|Overall Study|Other|0|||
162639734|NCT02554812|587396252|FG001|Overall Study|Other|0|||
162639735|NCT02554812|587396253|FG002|Overall Study|Other|2|||
162639736|NCT02554812|587396254|FG003|Overall Study|Other|3|||
162639737|NCT02554812|587396255|FG004|Overall Study|Other|2|||
162639738|NCT02554812|587396256|FG005|Overall Study|Other|1|||
162639739|NCT02554812|587396257|FG006|Overall Study|Other|0|||
162639740|NCT02554812|587396258|FG007|Overall Study|Other|0|||
162639741|NCT02554812|587396259|FG008|Overall Study|Other|1|||
162639742|NCT02554812|587396260|FG009|Overall Study|Other|1|||
162639743|NCT02554812|587396261|FG010|Overall Study|Other|0|||
162639744|NCT02554812|587396262|FG011|Overall Study|Other|0|||
162639745|NCT02554812|587396263|FG012|Overall Study|Other|1|||
162639746|NCT02554812|587396264|FG013|Overall Study|Other|0|||
162639747|NCT02554812|587396265|FG014|Overall Study|Other|1|||
162639748|NCT02554812|587396266|FG015|Overall Study|Other|0|||
162639749|NCT02554812|587396267|FG016|Overall Study|Other|0|||
162639750|NCT02554812|587396268|FG017|Overall Study|Other|0|||
162639751|NCT02554812|587396269|FG018|Overall Study|Other|0|||
162639752|NCT02554812|587396270|FG019|Overall Study|Other|0|||
162715853|NCT03536884|587667099|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163009522|NCT00683618|588737962|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
163009523|NCT00683618|588737960|FG000|Randomised Treatment Period|Protocol Violation|0|||
162639753|NCT02554812|587396271|FG020|Overall Study|Other|0|||
162639754|NCT02554812|587396272|FG021|Overall Study|Other|2|||
162639755|NCT02554812|587396273|FG022|Overall Study|Other|0|||
162639756|NCT02554812|587396274|FG023|Overall Study|Other|0|||
162639757|NCT02554812|587396275|FG024|Overall Study|Other|0|||
163009524|NCT00683618|588737961|FG001|Randomised Treatment Period|Protocol Violation|1|||
163009525|NCT00683618|588737962|FG002|Randomised Treatment Period|Protocol Violation|0|||
163009526|NCT00683618|588737960|FG000|Randomised Treatment Period|Adverse Event|2|||
163009527|NCT00683618|588737961|FG001|Randomised Treatment Period|Adverse Event|0|||
163009528|NCT00683618|588737962|FG002|Randomised Treatment Period|Adverse Event|2|||
163009529|NCT00683618|588737960|FG000|Randomised Treatment Period|Reason not provided|0|||
162639758|NCT02554812|587396276|FG025|Overall Study|Other|0|||
162639759|NCT02554812|587396277|FG026|Overall Study|Other|0|||
162639760|NCT02554812|587396251|FG000|Overall Study|Withdrawal by Subject|1|||
162639761|NCT02554812|587396252|FG001|Overall Study|Withdrawal by Subject|0|||
162639762|NCT02554812|587396253|FG002|Overall Study|Withdrawal by Subject|0|||
163009530|NCT00683618|588737961|FG001|Randomised Treatment Period|Reason not provided|0|||
163009531|NCT00683618|588737962|FG002|Randomised Treatment Period|Reason not provided|2|||
163009532|NCT00683618|588737960|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163009533|NCT00683618|588737961|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163009534|NCT00683618|588737962|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163009535|NCT00683618|588737960|FG000|Extension Treatment Period|Adverse Event|1|||
162639763|NCT02554812|587396254|FG003|Overall Study|Withdrawal by Subject|2|||
162924728|NCT01215955|588426098|FG001|Overall Study|Withdrawal by Subject|15|||
162924729|NCT01215955|588426099|FG002|Overall Study|Withdrawal by Subject|13|||
162924730|NCT01215955|588426100|FG003|Overall Study|Withdrawal by Subject|9|||
162924731|NCT01215955|588426097|FG000|Overall Study|Quality Issues|0|||
162924732|NCT01215955|588426098|FG001|Overall Study|Quality Issues|0|||
162924733|NCT01215955|588426099|FG002|Overall Study|Quality Issues|3|||
162924734|NCT01215955|588426100|FG003|Overall Study|Quality Issues|2|||
162924735|NCT05013749|588426101|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
162924736|NCT05013749|588426102|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
162924737|NCT05013749|588426101|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
162924738|NCT05013749|588426102|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
162924739|NCT02858076|588426103|FG000|Overall Study|Death|6|||
162924740|NCT02858076|588426104|FG001|Overall Study|Death|3|||
162924741|NCT02858076|588426103|FG000|Overall Study|Withdrawal by Subject|1|||
162924742|NCT02858076|588426104|FG001|Overall Study|Withdrawal by Subject|5|||
162924743|NCT02858076|588426103|FG000|Overall Study|Lost to Follow-up|2|||
162924744|NCT02858076|588426104|FG001|Overall Study|Lost to Follow-up|7|||
162924745|NCT02858076|588426103|FG000|Overall Study|Completed Out of Window|1|||
162924746|NCT02858076|588426104|FG001|Overall Study|Completed Out of Window|3|||
162924747|NCT02643394|588426105|FG000|Overall Study|Protocol Violation|4|||
162924748|NCT02643394|588426106|FG001|Overall Study|Protocol Violation|5|||
162924749|NCT00943384|588426107|FG000|Overall Study|Dispositioned prior to treatment|23|||
162924750|NCT00943384|588426107|FG000|Overall Study|Treated off protocol-protocol violation|5|||
162924751|NCT00943384|588426107|FG000|Overall Study|Lost to Follow-up|16|||
162924752|NCT00943384|588426107|FG000|Overall Study|Withdrawal by Subject|5|||
162924753|NCT00096200|588426108|FG000|Overall Study|Adverse Event|0|||
162924754|NCT00096200|588426109|FG001|Overall Study|Adverse Event|4|||
163009536|NCT00683618|588737961|FG001|Extension Treatment Period|Adverse Event|0|||
162639764|NCT02554812|587396255|FG004|Overall Study|Withdrawal by Subject|2|||
162639765|NCT02554812|587396256|FG005|Overall Study|Withdrawal by Subject|3|||
162639766|NCT02554812|587396257|FG006|Overall Study|Withdrawal by Subject|0|||
162639767|NCT02554812|587396258|FG007|Overall Study|Withdrawal by Subject|0|||
162639768|NCT02554812|587396259|FG008|Overall Study|Withdrawal by Subject|1|||
162639769|NCT02554812|587396260|FG009|Overall Study|Withdrawal by Subject|1|||
162639770|NCT02554812|587396261|FG010|Overall Study|Withdrawal by Subject|0|||
162639771|NCT02554812|587396262|FG011|Overall Study|Withdrawal by Subject|1|||
162639772|NCT02554812|587396263|FG012|Overall Study|Withdrawal by Subject|1|||
162639773|NCT02554812|587396264|FG013|Overall Study|Withdrawal by Subject|1|||
162639774|NCT02554812|587396265|FG014|Overall Study|Withdrawal by Subject|1|||
162639775|NCT02554812|587396266|FG015|Overall Study|Withdrawal by Subject|1|||
162639776|NCT02554812|587396267|FG016|Overall Study|Withdrawal by Subject|3|||
162639777|NCT02554812|587396268|FG017|Overall Study|Withdrawal by Subject|1|||
162639778|NCT02554812|587396269|FG018|Overall Study|Withdrawal by Subject|0|||
162639779|NCT02554812|587396270|FG019|Overall Study|Withdrawal by Subject|2|||
162639780|NCT02554812|587396271|FG020|Overall Study|Withdrawal by Subject|0|||
163009537|NCT00683618|588737962|FG002|Extension Treatment Period|Adverse Event|0|||
163009538|NCT00683618|588737960|FG000|Extension Treatment Period|Protocol Violation|1|||
163009539|NCT00683618|588737961|FG001|Extension Treatment Period|Protocol Violation|0|||
163009540|NCT00683618|588737962|FG002|Extension Treatment Period|Protocol Violation|0|||
163009541|NCT04570670|588737963|FG000|Overall Study|Withdrawal by Subject|1|||
162639781|NCT02554812|587396272|FG021|Overall Study|Withdrawal by Subject|1|||
162639782|NCT02554812|587396273|FG022|Overall Study|Withdrawal by Subject|0|||
162639783|NCT02554812|587396274|FG023|Overall Study|Withdrawal by Subject|1|||
162639784|NCT02554812|587396275|FG024|Overall Study|Withdrawal by Subject|0|||
162639785|NCT02554812|587396276|FG025|Overall Study|Withdrawal by Subject|0|||
162639786|NCT02554812|587396277|FG026|Overall Study|Withdrawal by Subject|1|||
162639787|NCT02554812|587396251|FG000|Overall Study|Physician Decision|1|||
162715854|NCT03536884|587667100|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162715855|NCT03536884|587667101|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163009542|NCT04570670|588737964|FG001|Overall Study|Withdrawal by Subject|0|||
163009543|NCT02764762|588737968|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163009544|NCT02764762|588737968|FG000|Overall Study|Lost to Follow-up|4|||
163009545|NCT02764762|588737968|FG000|Overall Study|Voluntary Withdrawal|8|||
163009546|NCT02764762|588737968|FG000|Overall Study|Site Termination|1|||
163009547|NCT02764762|588737968|FG000|Overall Study|Lack of Efficacy|16|||
163009548|NCT02764762|588737968|FG000|Overall Study|Reason not Specified|1|||
163009549|NCT01002989|588737969|FG000|Overall Study|exclusion criteria, no consent|5|||
163009550|NCT02954601|588737970|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009551|NCT02954601|588737971|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009552|NCT02954601|588737972|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
163009553|NCT02954601|588737973|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
163009554|NCT00318474|588737974|FG000|Overall Study|Adverse Event|1|||
163009555|NCT00318474|588737975|FG001|Overall Study|Adverse Event|1|||
163009556|NCT00318474|588737974|FG000|Overall Study|Lost to Follow-up|0|||
163009557|NCT00318474|588737975|FG001|Overall Study|Lost to Follow-up|1|||
163061686|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Death|1|||
163061687|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
163061688|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
163061689|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
163061690|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
163061691|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
163061692|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
163061693|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
163009558|NCT00318474|588737974|FG000|Overall Study|Pregnancy|0|||
163009559|NCT00318474|588737975|FG001|Overall Study|Pregnancy|2|||
163009560|NCT00318474|588737974|FG000|Overall Study|Protocol Violation|1|||
163009561|NCT00318474|588737975|FG001|Overall Study|Protocol Violation|0|||
163009562|NCT00318474|588737974|FG000|Overall Study|Withdrawal by Subject|3|||
163009563|NCT00318474|588737975|FG001|Overall Study|Withdrawal by Subject|2|||
163009564|NCT00318474|588737974|FG000|Overall Study|Fall in GFR|3|||
163009565|NCT00318474|588737975|FG001|Overall Study|Fall in GFR|3|||
163009566|NCT00318474|588737974|FG000|Overall Study|Post-therapy hyperflycemia|0|||
162715856|NCT03536884|587667102|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162639788|NCT02554812|587396252|FG001|Overall Study|Physician Decision|0|||
162639789|NCT02554812|587396253|FG002|Overall Study|Physician Decision|0|||
162639790|NCT02554812|587396254|FG003|Overall Study|Physician Decision|1|||
162639791|NCT02554812|587396255|FG004|Overall Study|Physician Decision|0|||
162639792|NCT02554812|587396256|FG005|Overall Study|Physician Decision|1|||
163009567|NCT00318474|588737975|FG001|Overall Study|Post-therapy hyperflycemia|1|||
163009568|NCT00318474|588737974|FG000|Overall Study|Trial terminated|10|||
163009569|NCT00318474|588737975|FG001|Overall Study|Trial terminated|7|||
163009570|NCT00917852|588737979|FG000|Overall Study|Death|6|||
162639793|NCT02554812|587396257|FG006|Overall Study|Physician Decision|0|||
162639794|NCT02554812|587396258|FG007|Overall Study|Physician Decision|0|||
162639795|NCT02554812|587396259|FG008|Overall Study|Physician Decision|0|||
162639796|NCT02554812|587396260|FG009|Overall Study|Physician Decision|0|||
162639797|NCT02554812|587396261|FG010|Overall Study|Physician Decision|1|||
162639798|NCT02554812|587396262|FG011|Overall Study|Physician Decision|0|||
162639799|NCT02554812|587396263|FG012|Overall Study|Physician Decision|0|||
162639800|NCT02554812|587396264|FG013|Overall Study|Physician Decision|0|||
162639801|NCT02554812|587396265|FG014|Overall Study|Physician Decision|0|||
162639802|NCT02554812|587396266|FG015|Overall Study|Physician Decision|0|||
162639803|NCT02554812|587396267|FG016|Overall Study|Physician Decision|1|||
162639804|NCT02554812|587396268|FG017|Overall Study|Physician Decision|1|||
162639805|NCT02554812|587396269|FG018|Overall Study|Physician Decision|0|||
162639806|NCT02554812|587396270|FG019|Overall Study|Physician Decision|1|||
162639807|NCT02554812|587396271|FG020|Overall Study|Physician Decision|1|||
162639808|NCT02554812|587396272|FG021|Overall Study|Physician Decision|0|||
162639809|NCT02554812|587396273|FG022|Overall Study|Physician Decision|1|||
162639810|NCT02554812|587396274|FG023|Overall Study|Physician Decision|0|||
162639811|NCT02554812|587396275|FG024|Overall Study|Physician Decision|0|||
162639812|NCT02554812|587396276|FG025|Overall Study|Physician Decision|0|||
162639813|NCT02554812|587396277|FG026|Overall Study|Physician Decision|0|||
162639814|NCT02554812|587396251|FG000|Overall Study|Study terminated by sponsor|0|||
162639815|NCT02554812|587396252|FG001|Overall Study|Study terminated by sponsor|0|||
162639816|NCT02554812|587396253|FG002|Overall Study|Study terminated by sponsor|0|||
162639817|NCT02554812|587396254|FG003|Overall Study|Study terminated by sponsor|0|||
162639818|NCT02554812|587396255|FG004|Overall Study|Study terminated by sponsor|0|||
162639819|NCT02554812|587396256|FG005|Overall Study|Study terminated by sponsor|0|||
162639820|NCT02554812|587396257|FG006|Overall Study|Study terminated by sponsor|0|||
162639821|NCT02554812|587396258|FG007|Overall Study|Study terminated by sponsor|0|||
162639822|NCT02554812|587396259|FG008|Overall Study|Study terminated by sponsor|0|||
162639823|NCT02554812|587396260|FG009|Overall Study|Study terminated by sponsor|0|||
162639824|NCT02554812|587396261|FG010|Overall Study|Study terminated by sponsor|0|||
162639825|NCT02554812|587396262|FG011|Overall Study|Study terminated by sponsor|0|||
163009571|NCT00471081|588737980|FG000|Active Phase|Protocol Violation|1|||
163009572|NCT00471081|588737981|FG001|Active Phase|Protocol Violation|1|||
163009573|NCT00471081|588737980|FG000|Active Phase|Withdrawal by Subject|0|||
163009574|NCT00471081|588737981|FG001|Active Phase|Withdrawal by Subject|3|||
163009575|NCT00471081|588737980|FG000|Active Phase|Lost to Follow-up|0|||
163009576|NCT00471081|588737981|FG001|Active Phase|Lost to Follow-up|1|||
163009577|NCT00471081|588737980|FG000|Active Phase|Lost health plan/insurance|1|||
163009578|NCT00471081|588737981|FG001|Active Phase|Lost health plan/insurance|8|||
163009579|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
163009580|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
163009581|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
163009582|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
163009583|NCT00471081|588737980|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
163009584|NCT00471081|588737981|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
163009585|NCT02393950|588737986|FG000|Overall Study|Adverse Event|1|||
163009586|NCT02393950|588737987|FG001|Overall Study|Adverse Event|0|||
163009587|NCT02393950|588737986|FG000|Overall Study|Withdrawal by Subject|0|||
163009588|NCT02393950|588737987|FG001|Overall Study|Withdrawal by Subject|1|||
163009589|NCT05486091|588737988|FG000|Overall Study|Withdrawal by Subject|1|||
163009590|NCT05486091|588737988|FG000|Overall Study|Lost to Follow-up|2|||
163009591|NCT00370552|588737989|FG000|Overall Study|Adverse Event|2|||
163009592|NCT00370552|588737990|FG001|Overall Study|Adverse Event|2|||
163009593|NCT00370552|588737991|FG002|Overall Study|Adverse Event|2|||
163009594|NCT00370552|588737989|FG000|Overall Study|Disease progression|23|||
163009595|NCT00370552|588737990|FG001|Overall Study|Disease progression|23|||
163009596|NCT00370552|588737991|FG002|Overall Study|Disease progression|15|||
163009597|NCT00370552|588737989|FG000|Overall Study|Maximum clinical benefit|3|||
163009598|NCT00370552|588737990|FG001|Overall Study|Maximum clinical benefit|5|||
163009599|NCT00370552|588737991|FG002|Overall Study|Maximum clinical benefit|5|||
163009600|NCT00370552|588737989|FG000|Overall Study|Poor or noncompliance|0|||
163009601|NCT00370552|588737990|FG001|Overall Study|Poor or noncompliance|0|||
163009602|NCT00370552|588737991|FG002|Overall Study|Poor or noncompliance|1|||
163009603|NCT00370552|588737989|FG000|Overall Study|Study drug toxicity|11|||
163009604|NCT00370552|588737990|FG001|Overall Study|Study drug toxicity|8|||
163009605|NCT00370552|588737991|FG002|Overall Study|Study drug toxicity|6|||
163009606|NCT00370552|588737989|FG000|Overall Study|Withdrawal by Subject|2|||
162639826|NCT02554812|587396263|FG012|Overall Study|Study terminated by sponsor|0|||
162639827|NCT02554812|587396264|FG013|Overall Study|Study terminated by sponsor|0|||
163009607|NCT00370552|588737990|FG001|Overall Study|Withdrawal by Subject|0|||
163009608|NCT00370552|588737991|FG002|Overall Study|Withdrawal by Subject|1|||
163009609|NCT00370552|588737989|FG000|Overall Study|Still on treatment|1|||
162639828|NCT02554812|587396265|FG014|Overall Study|Study terminated by sponsor|0|||
162639829|NCT02554812|587396266|FG015|Overall Study|Study terminated by sponsor|0|||
162639830|NCT02554812|587396267|FG016|Overall Study|Study terminated by sponsor|0|||
162639831|NCT02554812|587396268|FG017|Overall Study|Study terminated by sponsor|0|||
162639832|NCT02554812|587396269|FG018|Overall Study|Study terminated by sponsor|0|||
162639833|NCT02554812|587396270|FG019|Overall Study|Study terminated by sponsor|0|||
162715857|NCT03536884|587667091|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715858|NCT03536884|587667092|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715859|NCT03536884|587667093|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
162715860|NCT03536884|587667094|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
162715861|NCT03536884|587667095|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
162715862|NCT03536884|587667096|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715863|NCT03536884|587667097|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715864|NCT03536884|587667098|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715865|NCT03536884|587667099|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715866|NCT03536884|587667100|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715867|NCT03536884|587667101|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715868|NCT03536884|587667102|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162715869|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715870|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715871|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715872|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715873|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715874|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
162715875|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
162715876|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
162715877|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
162639834|NCT02554812|587396271|FG020|Overall Study|Study terminated by sponsor|0|||
162639835|NCT02554812|587396272|FG021|Overall Study|Study terminated by sponsor|0|||
162639836|NCT02554812|587396273|FG022|Overall Study|Study terminated by sponsor|0|||
162639837|NCT02554812|587396274|FG023|Overall Study|Study terminated by sponsor|0|||
162639838|NCT02554812|587396275|FG024|Overall Study|Study terminated by sponsor|1|||
162639839|NCT02554812|587396276|FG025|Overall Study|Study terminated by sponsor|0|||
162639840|NCT02554812|587396277|FG026|Overall Study|Study terminated by sponsor|0|||
162639841|NCT02554812|587396251|FG000|Overall Study|No longer meets eligibility criteria|0|||
162639842|NCT02554812|587396252|FG001|Overall Study|No longer meets eligibility criteria|1|||
162639843|NCT02554812|587396253|FG002|Overall Study|No longer meets eligibility criteria|0|||
162639844|NCT02554812|587396254|FG003|Overall Study|No longer meets eligibility criteria|0|||
162639845|NCT02554812|587396255|FG004|Overall Study|No longer meets eligibility criteria|0|||
162639846|NCT02554812|587396256|FG005|Overall Study|No longer meets eligibility criteria|0|||
162639847|NCT02554812|587396257|FG006|Overall Study|No longer meets eligibility criteria|0|||
162639848|NCT02554812|587396258|FG007|Overall Study|No longer meets eligibility criteria|0|||
162639849|NCT02554812|587396259|FG008|Overall Study|No longer meets eligibility criteria|0|||
162639850|NCT02554812|587396260|FG009|Overall Study|No longer meets eligibility criteria|0|||
162639851|NCT02554812|587396261|FG010|Overall Study|No longer meets eligibility criteria|0|||
162639852|NCT02554812|587396262|FG011|Overall Study|No longer meets eligibility criteria|0|||
162639853|NCT02554812|587396263|FG012|Overall Study|No longer meets eligibility criteria|0|||
162639854|NCT02554812|587396264|FG013|Overall Study|No longer meets eligibility criteria|0|||
162639855|NCT02554812|587396265|FG014|Overall Study|No longer meets eligibility criteria|0|||
162639856|NCT02554812|587396266|FG015|Overall Study|No longer meets eligibility criteria|0|||
162639857|NCT02554812|587396267|FG016|Overall Study|No longer meets eligibility criteria|0|||
162639858|NCT02554812|587396268|FG017|Overall Study|No longer meets eligibility criteria|0|||
162639859|NCT02554812|587396269|FG018|Overall Study|No longer meets eligibility criteria|0|||
162639860|NCT02554812|587396270|FG019|Overall Study|No longer meets eligibility criteria|0|||
162639861|NCT02554812|587396271|FG020|Overall Study|No longer meets eligibility criteria|0|||
162639862|NCT02554812|587396272|FG021|Overall Study|No longer meets eligibility criteria|0|||
162639863|NCT02554812|587396273|FG022|Overall Study|No longer meets eligibility criteria|0|||
162639864|NCT02554812|587396274|FG023|Overall Study|No longer meets eligibility criteria|0|||
162639865|NCT02554812|587396275|FG024|Overall Study|No longer meets eligibility criteria|0|||
162639866|NCT02554812|587396276|FG025|Overall Study|No longer meets eligibility criteria|0|||
162639867|NCT02554812|587396277|FG026|Overall Study|No longer meets eligibility criteria|0|||
162639868|NCT02879305|587396278|FG000|Overall Study|Investigator Site Closed|55|||
162715878|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715879|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715880|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
162715881|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715882|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162639869|NCT02879305|587396279|FG001|Overall Study|Investigator Site Closed|57|||
162715883|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715884|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715885|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162924755|NCT00096200|588426110|FG002|Overall Study|Adverse Event|0|||
162639870|NCT02879305|587396278|FG000|Overall Study|Withdrawal by Subject|44|||
162639871|NCT02879305|587396279|FG001|Overall Study|Withdrawal by Subject|42|||
162639872|NCT02879305|587396278|FG000|Overall Study|Lost to Follow-up|17|||
162639873|NCT02879305|587396279|FG001|Overall Study|Lost to Follow-up|12|||
162639874|NCT02879305|587396278|FG000|Overall Study|Other|1|||
162639875|NCT02879305|587396279|FG001|Overall Study|Other|0|||
163009610|NCT00370552|588737990|FG001|Overall Study|Still on treatment|3|||
163009611|NCT00370552|588737991|FG002|Overall Study|Still on treatment|2|||
163009612|NCT00370552|588737989|FG000|Overall Study|Never treated|1|||
163009613|NCT00370552|588737990|FG001|Overall Study|Never treated|0|||
163009614|NCT00370552|588737991|FG002|Overall Study|Never treated|0|||
162715886|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162715887|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162715888|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162715889|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
162715890|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715891|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715892|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162715893|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715894|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715895|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715896|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715897|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715898|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
162715899|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715900|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
162715901|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715902|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715903|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715904|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162715905|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715906|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715907|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715908|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715909|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715910|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
162715911|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715912|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
162715913|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
162715914|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715915|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715916|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162715917|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715918|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715919|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715920|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715921|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715922|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
162715923|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
162715924|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
162715925|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
162715926|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715927|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715928|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162715929|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715930|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715931|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715932|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715933|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715934|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
162715935|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715936|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163009615|NCT00370552|588737989|FG000|Overall Study|Physician Decision|1|||
163009616|NCT00370552|588737990|FG001|Overall Study|Physician Decision|1|||
163009617|NCT00370552|588737991|FG002|Overall Study|Physician Decision|0|||
163009618|NCT00370552|588737989|FG000|Overall Study|Investigator decision|2|||
162715937|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715938|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715939|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162715940|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163009619|NCT00370552|588737990|FG001|Overall Study|Investigator decision|1|||
163009620|NCT00370552|588737991|FG002|Overall Study|Investigator decision|0|||
162639876|NCT00613938|587398002|FG000|Overall Study|Withdrawal by Subject|2|||
162639877|NCT00613938|587398003|FG001|Overall Study|Withdrawal by Subject|4|||
162639878|NCT00613938|587398004|FG002|Overall Study|Withdrawal by Subject|9|||
162639879|NCT00613938|587398005|FG003|Overall Study|Withdrawal by Subject|9|||
162639880|NCT00613938|587398002|FG000|Overall Study|Adverse Event|1|||
162639881|NCT00613938|587398003|FG001|Overall Study|Adverse Event|4|||
162639882|NCT00613938|587398004|FG002|Overall Study|Adverse Event|8|||
162639883|NCT00613938|587398005|FG003|Overall Study|Adverse Event|5|||
162639884|NCT00613938|587398002|FG000|Overall Study|Lack of Efficacy|16|||
162639885|NCT00613938|587398003|FG001|Overall Study|Lack of Efficacy|18|||
162639886|NCT00613938|587398004|FG002|Overall Study|Lack of Efficacy|5|||
162639887|NCT00613938|587398005|FG003|Overall Study|Lack of Efficacy|9|||
162639888|NCT00613938|587398002|FG000|Overall Study|Other|1|||
162639889|NCT00613938|587398003|FG001|Overall Study|Other|2|||
162639890|NCT00613938|587398004|FG002|Overall Study|Other|1|||
162639891|NCT00613938|587398005|FG003|Overall Study|Other|3|||
162639892|NCT03025542|587398006|FG000|Overall Study|Adverse Event|0|||
162639893|NCT03025542|587398007|FG001|Overall Study|Adverse Event|2|||
162639894|NCT03025542|587398006|FG000|Overall Study|Lost to Follow-up|1|||
162639895|NCT03025542|587398007|FG001|Overall Study|Lost to Follow-up|0|||
162639896|NCT03025542|587398006|FG000|Overall Study|Withdrawal by Subject|1|||
162639897|NCT03025542|587398007|FG001|Overall Study|Withdrawal by Subject|0|||
162639898|NCT00312494|587398008|FG000|Overall Study|Randomized; not treated with study drug|9|||
162639899|NCT00312494|587398009|FG001|Overall Study|Randomized; not treated with study drug|10|||
162639900|NCT00312494|587398010|FG002|Overall Study|Randomized; not treated with study drug|5|||
162639901|NCT00312494|587398008|FG000|Overall Study|Adverse Event|33|||
162639902|NCT00312494|587398009|FG001|Overall Study|Adverse Event|15|||
162639903|NCT00312494|587398010|FG002|Overall Study|Adverse Event|11|||
162639904|NCT00312494|587398008|FG000|Overall Study|Lack of Efficacy|4|||
162924756|NCT00096200|588426108|FG000|Overall Study|Withdrawal by Subject|1|||
162924757|NCT00096200|588426109|FG001|Overall Study|Withdrawal by Subject|2|||
162924758|NCT00096200|588426110|FG002|Overall Study|Withdrawal by Subject|0|||
162924759|NCT00096200|588426108|FG000|Overall Study|Ineligible pathology|0|||
162924760|NCT00096200|588426109|FG001|Overall Study|Ineligible pathology|1|||
162924761|NCT00096200|588426110|FG002|Overall Study|Ineligible pathology|0|||
162924762|NCT03014570|588426118|FG000|Overall Study|COVID-19 Restrictions|38|||
162924763|NCT03014570|588426119|FG001|Overall Study|COVID-19 Restrictions|24|||
162924764|NCT03014570|588426118|FG000|Overall Study|Death|70|||
162924765|NCT03014570|588426119|FG001|Overall Study|Death|79|||
162924766|NCT03014570|588426118|FG000|Overall Study|Transfer from facility|11|||
162924767|NCT03014570|588426119|FG001|Overall Study|Transfer from facility|14|||
162924768|NCT03014570|588426118|FG000|Overall Study|Hospitalized|5|||
163009621|NCT00370552|588737989|FG000|Overall Study|High risk of allergic reaction|0|||
163009622|NCT00370552|588737990|FG001|Overall Study|High risk of allergic reaction|1|||
163009623|NCT00370552|588737991|FG002|Overall Study|High risk of allergic reaction|0|||
163009624|NCT00370552|588737989|FG000|Overall Study|Planned radiation for palliation|0|||
163009625|NCT00370552|588737990|FG001|Overall Study|Planned radiation for palliation|1|||
163009626|NCT00370552|588737991|FG002|Overall Study|Planned radiation for palliation|0|||
163009627|NCT03499067|588737992|FG000|First Intervention|Physician Decision|2|||
163009628|NCT03499067|588737993|FG001|First Intervention|Physician Decision|1|||
163009629|NCT03499067|588737992|FG000|First Intervention|Withdrawal by Subject|3|||
163009630|NCT03499067|588737993|FG001|First Intervention|Withdrawal by Subject|6|||
163009631|NCT03776357|588737996|FG000|Overall Study|Lost to Follow-up|3|||
163009632|NCT02211209|588737998|FG000|Overall Study|Investigator judgment|0|||
163009633|NCT02211209|588737999|FG001|Overall Study|Investigator judgment|1|||
163009634|NCT02211209|588737998|FG000|Overall Study|Voluntary withdrawal|1|||
163009635|NCT02211209|588737999|FG001|Overall Study|Voluntary withdrawal|4|||
163009636|NCT02211209|588737998|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163009637|NCT02211209|588737999|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
163009638|NCT02211209|588737998|FG000|Overall Study|Reason Not Specified|1|||
163009639|NCT02211209|588737999|FG001|Overall Study|Reason Not Specified|0|||
162639905|NCT00312494|587398009|FG001|Overall Study|Lack of Efficacy|6|||
162639906|NCT00312494|587398010|FG002|Overall Study|Lack of Efficacy|8|||
162639907|NCT00312494|587398008|FG000|Overall Study|Laboratory abnormality|1|||
162639908|NCT00312494|587398009|FG001|Overall Study|Laboratory abnormality|0|||
162639909|NCT00312494|587398010|FG002|Overall Study|Laboratory abnormality|0|||
162639910|NCT00312494|587398008|FG000|Overall Study|Lost to Follow-up|8|||
162639911|NCT00312494|587398009|FG001|Overall Study|Lost to Follow-up|8|||
162639912|NCT00312494|587398010|FG002|Overall Study|Lost to Follow-up|8|||
163009640|NCT03889418|588738003|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
163009641|NCT03889418|588738004|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009642|NCT03889418|588738005|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009643|NCT03889418|588738006|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009644|NCT03889418|588738007|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009645|NCT03889418|588738008|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009646|NCT03889418|588738009|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009647|NCT03889418|588738010|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009648|NCT03889418|588738011|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009649|NCT03889418|588738012|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
163009650|NCT03889418|588738003|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009651|NCT03889418|588738004|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
163009652|NCT03889418|588738005|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
162639913|NCT00312494|587398008|FG000|Overall Study|Withdrawal by Subject|6|||
162639914|NCT00312494|587398009|FG001|Overall Study|Withdrawal by Subject|9|||
162639915|NCT00312494|587398010|FG002|Overall Study|Withdrawal by Subject|10|||
162639916|NCT00312494|587398008|FG000|Overall Study|Other|10|||
162639917|NCT00312494|587398009|FG001|Overall Study|Other|10|||
162639918|NCT00312494|587398010|FG002|Overall Study|Other|1|||
162639919|NCT00488345|587398011|FG000|Overall Study|Adverse Event|0|||
162639920|NCT00488345|587398012|FG001|Overall Study|Adverse Event|1|||
162639921|NCT00488345|587398013|FG002|Overall Study|Adverse Event|1|||
162639922|NCT00488345|587398011|FG000|Overall Study|Unable to administer antibiotics at home|0|||
162639923|NCT00488345|587398012|FG001|Overall Study|Unable to administer antibiotics at home|1|||
162639924|NCT00488345|587398013|FG002|Overall Study|Unable to administer antibiotics at home|0|||
162639925|NCT00488345|587398011|FG000|Overall Study|Institutional Review Board review|0|||
162639926|NCT00488345|587398012|FG001|Overall Study|Institutional Review Board review|0|||
162639927|NCT00488345|587398013|FG002|Overall Study|Institutional Review Board review|1|||
162639928|NCT00488345|587398011|FG000|Overall Study|Surgical team recommendation|0|||
162639929|NCT00488345|587398012|FG001|Overall Study|Surgical team recommendation|1|||
162639930|NCT00488345|587398013|FG002|Overall Study|Surgical team recommendation|0|||
162639931|NCT00488345|587398011|FG000|Overall Study|Parent/legal guardian request|0|||
162639932|NCT00488345|587398012|FG001|Overall Study|Parent/legal guardian request|1|||
162639933|NCT00488345|587398013|FG002|Overall Study|Parent/legal guardian request|1|||
162639934|NCT01585428|587398016|FG000|Overall Study|Death during treatment|1|||
162639935|NCT01585428|587398017|FG001|Overall Study|Death during treatment|0|||
162639936|NCT02057198|587398020|FG000|Overall Study|Death|0|||
162639937|NCT02057198|587398021|FG001|Overall Study|Death|0|||
162639938|NCT02057198|587398022|FG002|Overall Study|Death|1|||
162639939|NCT02057198|587398020|FG000|Overall Study|Discharged early; lost to followup|0|||
162639940|NCT02057198|587398021|FG001|Overall Study|Discharged early; lost to followup|1|||
162639941|NCT02057198|587398022|FG002|Overall Study|Discharged early; lost to followup|0|||
162736236|NCT03699709|587744923|FG001|Overall Study|Withdrawal by Subject|0|||
163009653|NCT03889418|588738006|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009654|NCT03889418|588738007|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009655|NCT03889418|588738008|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009656|NCT03889418|588738009|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009657|NCT03889418|588738010|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009658|NCT03889418|588738011|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009659|NCT03889418|588738012|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
163009660|NCT03889418|588738003|FG000|October-December 2019 (Month 7-9)|Death|0|||
163009661|NCT03889418|588738004|FG001|October-December 2019 (Month 7-9)|Death|0|||
163009662|NCT03889418|588738005|FG002|October-December 2019 (Month 7-9)|Death|0|||
163009663|NCT03889418|588738006|FG003|October-December 2019 (Month 7-9)|Death|0|||
163009664|NCT03889418|588738007|FG004|October-December 2019 (Month 7-9)|Death|0|||
163009665|NCT03889418|588738008|FG005|October-December 2019 (Month 7-9)|Death|0|||
163009666|NCT03889418|588738009|FG006|October-December 2019 (Month 7-9)|Death|0|||
163009667|NCT03889418|588738010|FG007|October-December 2019 (Month 7-9)|Death|0|||
163009668|NCT03889418|588738011|FG008|October-December 2019 (Month 7-9)|Death|1|||
163009669|NCT03889418|588738012|FG009|October-December 2019 (Month 7-9)|Death|0|||
163009670|NCT03889418|588738003|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009671|NCT03889418|588738004|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009672|NCT03889418|588738005|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009673|NCT03889418|588738006|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
163009674|NCT03889418|588738007|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009675|NCT03889418|588738008|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009676|NCT03889418|588738009|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009677|NCT03889418|588738010|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
163009678|NCT03889418|588738011|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009679|NCT03889418|588738012|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
163009680|NCT03889418|588738003|FG000|April - June 2020 (Month 13-15)|Death|0|||
162639942|NCT00065507|587398024|FG000|Overall Study|Death|16|||
162639943|NCT00065507|587398025|FG001|Overall Study|Death|17|||
162639944|NCT00065507|587398024|FG000|Overall Study|Adverse Event|4|||
162639945|NCT00065507|587398025|FG001|Overall Study|Adverse Event|3|||
162639946|NCT00065507|587398024|FG000|Overall Study|Lack of Efficacy|0|||
163009681|NCT03889418|588738004|FG001|April - June 2020 (Month 13-15)|Death|1|||
163009682|NCT03889418|588738005|FG002|April - June 2020 (Month 13-15)|Death|0|||
163009683|NCT03889418|588738006|FG003|April - June 2020 (Month 13-15)|Death|0|||
163009684|NCT03889418|588738007|FG004|April - June 2020 (Month 13-15)|Death|0|||
163009685|NCT03889418|588738008|FG005|April - June 2020 (Month 13-15)|Death|0|||
163009686|NCT03889418|588738009|FG006|April - June 2020 (Month 13-15)|Death|0|||
163009687|NCT03889418|588738010|FG007|April - June 2020 (Month 13-15)|Death|0|||
163009688|NCT03889418|588738011|FG008|April - June 2020 (Month 13-15)|Death|0|||
163009689|NCT03889418|588738012|FG009|April - June 2020 (Month 13-15)|Death|0|||
163009690|NCT03889418|588738003|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009691|NCT03889418|588738004|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009692|NCT03889418|588738005|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009693|NCT03889418|588738006|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
163009694|NCT03889418|588738007|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009695|NCT03889418|588738008|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009696|NCT03889418|588738009|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009697|NCT03889418|588738010|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009698|NCT03889418|588738011|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009699|NCT03889418|588738012|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
163009700|NCT03889418|588738003|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009701|NCT03889418|588738004|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009702|NCT03889418|588738005|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
163009703|NCT03889418|588738006|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009704|NCT03889418|588738007|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009705|NCT03889418|588738008|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009706|NCT03889418|588738009|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009707|NCT03889418|588738010|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
163009708|NCT03889418|588738011|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009709|NCT03889418|588738012|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
163009710|NCT03889418|588738003|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009711|NCT03889418|588738004|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
163009712|NCT03889418|588738005|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
163009713|NCT03889418|588738006|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
163009714|NCT03889418|588738007|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009715|NCT03889418|588738008|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009716|NCT03889418|588738009|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009717|NCT03889418|588738010|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
163009718|NCT03889418|588738011|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
163009719|NCT03889418|588738012|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
162639947|NCT00065507|587398025|FG001|Overall Study|Lack of Efficacy|6|||
162639948|NCT00065507|587398024|FG000|Overall Study|Poor/Non-compliance|3|||
162639949|NCT00065507|587398025|FG001|Overall Study|Poor/Non-compliance|2|||
162639950|NCT00065507|587398024|FG000|Overall Study|Lost to Follow-up|3|||
162639951|NCT00065507|587398025|FG001|Overall Study|Lost to Follow-up|0|||
162639952|NCT00065507|587398024|FG000|Overall Study|Subject Withdrew Consent|2|||
162639953|NCT00065507|587398025|FG001|Overall Study|Subject Withdrew Consent|1|||
162639954|NCT00065507|587398024|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
162639955|NCT00065507|587398025|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
162639956|NCT00350636|587398026|FG000|Overall Study|Adverse Event|19|||
162639957|NCT00350636|587398027|FG001|Overall Study|Adverse Event|13|||
162639958|NCT00350636|587398026|FG000|Overall Study|Protocol Violation|1|||
162639959|NCT00350636|587398027|FG001|Overall Study|Protocol Violation|3|||
162639960|NCT00350636|587398026|FG000|Overall Study|Withdrawal by Subject|13|||
162639961|NCT00350636|587398027|FG001|Overall Study|Withdrawal by Subject|17|||
162639962|NCT00350636|587398026|FG000|Overall Study|Lost to Follow-up|9|||
162639963|NCT00350636|587398027|FG001|Overall Study|Lost to Follow-up|8|||
162639964|NCT00350636|587398026|FG000|Overall Study|Physician Decision|0|||
162639965|NCT00350636|587398027|FG001|Overall Study|Physician Decision|2|||
163009720|NCT00837148|588738016|FG000|Overall Study|Adverse Event|1|||
163009721|NCT00837148|588738016|FG000|Overall Study|Death|1|||
163009722|NCT01827111|588738017|FG000|Overall Study|Disease Progression|1|||
163009723|NCT03181633|588738018|FG000|Overall Study|Withdrawal by Subject|1|||
163009724|NCT03181633|588738018|FG000|Overall Study|Missing follow-up visit|1|||
163009725|NCT04383327|588738025|FG000|Overall Study|Lost to Follow-up|112|||
162639966|NCT00350636|587398026|FG000|Overall Study|Other|1|||
162639967|NCT00350636|587398027|FG001|Overall Study|Other|2|||
162639968|NCT00100815|587398028|FG000|Overall Study|Progression|24|||
162639969|NCT00100815|587398028|FG000|Overall Study|Adverse Event|18|||
162639970|NCT00100815|587398028|FG000|Overall Study|Death|4|||
163009726|NCT04383327|588738026|FG001|Overall Study|Lost to Follow-up|14|||
163009727|NCT04383327|588738027|FG002|Overall Study|Lost to Follow-up|78|||
163009728|NCT04383327|588738028|FG003|Overall Study|Lost to Follow-up|13|||
162639971|NCT00100815|587398028|FG000|Overall Study|Other|3|||
162639972|NCT01647282|587398031|FG000|Overall Study|Physician Decision|7|||
162639973|NCT01647282|587398032|FG001|Overall Study|Physician Decision|5|||
162639974|NCT00665353|587398033|FG000|Study Step 1|Adverse Event|1|||
162639975|NCT00665353|587398033|FG000|Study Step 1|Withdrawal by Subject|2|||
162639976|NCT00665353|587398033|FG000|Study Step 2|Lost to Follow-up|2|||
162639977|NCT00665353|587398033|FG000|Study Step 2|Lack of Efficacy|12|||
162639978|NCT01851720|587398034|FG000|Overall Study|Lost to Follow-up|0|||
162639979|NCT01851720|587398035|FG001|Overall Study|Lost to Follow-up|1|||
162639980|NCT02632552|587398040|FG000|Overall Study|Lost to Follow-up|14|||
162639981|NCT02632552|587398041|FG001|Overall Study|Lost to Follow-up|8|||
162639982|NCT02632552|587398040|FG000|Overall Study|Withdrawal by Subject|2|||
162639983|NCT02632552|587398041|FG001|Overall Study|Withdrawal by Subject|0|||
162639984|NCT02632552|587398040|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
162639985|NCT02632552|587398041|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
162639986|NCT02377466|587398052|FG000|Overall Study|Other: Randomized and not treated|0|||
162639987|NCT02377466|587398053|FG001|Overall Study|Other: Randomized and not treated|2|||
163061694|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
162639988|NCT00495170|587398054|FG000|Overall Study|Lost to Follow-up|9|||
162639989|NCT00495170|587398054|FG000|Overall Study|Withdrawal by Subject|3|||
162639990|NCT00495170|587398054|FG000|Overall Study|Inappropriate staging|8|||
162639991|NCT04210310|587398055|FG000|Overall Study|Lost to Follow-up|32|||
162639992|NCT04210310|587398056|FG001|Overall Study|Lost to Follow-up|1|||
162639993|NCT00330616|587398057|FG000|Overall Study|Adverse Event|13|||
162924769|NCT03014570|588426119|FG001|Overall Study|Hospitalized|3|||
162924770|NCT03014570|588426118|FG000|Overall Study|Transfer within facility|1|||
162924771|NCT03014570|588426119|FG001|Overall Study|Transfer within facility|0|||
162924772|NCT03014570|588426118|FG000|Overall Study|Site refusal|0|||
162924773|NCT03014570|588426119|FG001|Overall Study|Site refusal|11|||
162924774|NCT01154673|588426120|FG000|Overall Study|Lost to Follow-up|1|||
162924775|NCT01154673|588426121|FG001|Overall Study|Lost to Follow-up|0|||
162924776|NCT01154673|588426120|FG000|Overall Study|moved out of province|1|||
162924777|NCT01154673|588426121|FG001|Overall Study|moved out of province|0|||
162924778|NCT01216319|588426125|FG000|Overall Study|Lost to Follow-up|2|||
162924779|NCT01216319|588426125|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
162924780|NCT02666768|588426128|FG000|Overall Study|Withdrawal by Subject|4|||
162924781|NCT03728257|588426129|FG000|Overall Study|Death|3|||
162924782|NCT03728257|588426130|FG001|Overall Study|Death|0|||
162924783|NCT00621309|588426131|FG000|Overall Study|Withdrawal by Subject|2|||
162924784|NCT00621309|588426132|FG001|Overall Study|Withdrawal by Subject|0|||
162924785|NCT00621309|588426133|FG002|Overall Study|Withdrawal by Subject|1|||
162924786|NCT00621309|588426134|FG003|Overall Study|Withdrawal by Subject|1|||
162924787|NCT00621309|588426135|FG004|Overall Study|Withdrawal by Subject|1|||
162924788|NCT00621309|588426136|FG005|Overall Study|Withdrawal by Subject|1|||
162924789|NCT04993339|588426137|FG000|Overall Study|Lost to Follow-up|0|||
162924790|NCT04993339|588426138|FG001|Overall Study|Lost to Follow-up|1|||
162924791|NCT04993339|588426137|FG000|Overall Study|no MRI scan|3|||
162924792|NCT04993339|588426138|FG001|Overall Study|no MRI scan|1|||
162924793|NCT00797316|588426139|FG000|Overall Study|Administrative problems|1|||
162924794|NCT00797316|588426140|FG001|Overall Study|Administrative problems|0|||
162924795|NCT00797316|588426139|FG000|Overall Study|Adverse Event|5|||
162924796|NCT00797316|588426140|FG001|Overall Study|Adverse Event|3|||
162924797|NCT00797316|588426139|FG000|Overall Study|Lost to Follow-up|4|||
162924798|NCT00797316|588426140|FG001|Overall Study|Lost to Follow-up|8|||
162924799|NCT00797316|588426139|FG000|Overall Study|Protocol Deviation|1|||
162924800|NCT00797316|588426140|FG001|Overall Study|Protocol Deviation|2|||
162924801|NCT00797316|588426139|FG000|Overall Study|Patient withdrew consent|12|||
162924802|NCT00797316|588426140|FG001|Overall Study|Patient withdrew consent|6|||
162924803|NCT00797316|588426139|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162924804|NCT00797316|588426140|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162924805|NCT00402779|588426143|FG000|Overall Study|Screen Failure|77|||
162924806|NCT00402779|588426144|FG001|Overall Study|Screen Failure|76|||
162924807|NCT03075215|588426145|FG000|12-Month Primary Endpoint|Death|152|||
162924808|NCT03075215|588426145|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
162924809|NCT03075215|588426145|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
162924810|NCT03075215|588426145|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
162924811|NCT00690573|588426154|FG000|Overall Study|Lack of Efficacy|8|||
162924812|NCT00690573|588426154|FG000|Overall Study|Withdrawal by Subject|1|||
162924813|NCT00777920|588426155|FG000|Overall Study|Adverse Event|39|||
162924814|NCT00777920|588426155|FG000|Overall Study|Withdrawal of Consent|4|||
162924815|NCT00777920|588426155|FG000|Overall Study|Lost to Follow-up|1|||
162924816|NCT00777920|588426155|FG000|Overall Study|Investigator's discretion|1|||
162924817|NCT00777920|588426155|FG000|Overall Study|Clinical status did not improve|1|||
162924818|NCT00777920|588426155|FG000|Overall Study|Other, not specified|4|||
162924819|NCT02146365|588426156|FG000|Overall Study|Lost to Follow-up|2|||
162924820|NCT02146365|588426157|FG001|Overall Study|Lost to Follow-up|1|||
162924821|NCT02146365|588426158|FG002|Overall Study|Lost to Follow-up|3|||
162639994|NCT00330616|587398057|FG000|Overall Study|Lack of Efficacy|1|||
162639995|NCT00330616|587398057|FG000|Overall Study|Lost to Follow-up|2|||
162639996|NCT00330616|587398057|FG000|Overall Study|Withdrawal by Subject|4|||
162639997|NCT00330616|587398057|FG000|Overall Study|Other|1|||
162639998|NCT02141997|587398062|FG000|Overall Study|Adverse Event|0|||
162639999|NCT02141997|587398063|FG001|Overall Study|Adverse Event|2|||
162640000|NCT02141997|587398064|FG002|Overall Study|Adverse Event|0|||
162640001|NCT02141997|587398065|FG003|Overall Study|Adverse Event|1|||
162640002|NCT02141997|587398062|FG000|Overall Study|Participant noncompliance|1|||
162640003|NCT02141997|587398063|FG001|Overall Study|Participant noncompliance|0|||
163009729|NCT04383327|588738029|FG004|Overall Study|Lost to Follow-up|110|||
163009730|NCT04383327|588738030|FG005|Overall Study|Lost to Follow-up|13|||
163009731|NCT04383327|588738031|FG006|Overall Study|Lost to Follow-up|74|||
163009732|NCT04383327|588738032|FG007|Overall Study|Lost to Follow-up|13|||
163009733|NCT04383327|588738033|FG008|Overall Study|Lost to Follow-up|78|||
163009734|NCT04383327|588738034|FG009|Overall Study|Lost to Follow-up|10|||
163009735|NCT04383327|588738035|FG010|Overall Study|Lost to Follow-up|160|||
163009736|NCT04383327|588738036|FG011|Overall Study|Lost to Follow-up|13|||
163009737|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009738|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
163009739|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009740|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
163009741|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
163009742|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009743|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
163009744|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
163009745|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009746|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
163009747|NCT04837196|588738037|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009748|NCT04837196|588738038|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
163009749|NCT04837196|588738039|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009750|NCT04837196|588738040|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009751|NCT04837196|588738041|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
163009752|NCT04837196|588738037|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009753|NCT04837196|588738038|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009754|NCT04837196|588738039|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
163009755|NCT04837196|588738040|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009756|NCT04837196|588738041|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
163009757|NCT04837196|588738037|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009758|NCT04837196|588738038|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009759|NCT04837196|588738039|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
163009760|NCT04837196|588738040|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009761|NCT04837196|588738041|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
163009762|NCT00991887|588738042|FG000|Overall Study|Lost to Follow-up|2|||
163009763|NCT00991887|588738043|FG001|Overall Study|Lost to Follow-up|1|||
163009764|NCT01306305|588738044|FG000|Overall Study|Lost to Follow-up|1|||
163009765|NCT01306305|588738045|FG001|Overall Study|Lost to Follow-up|0|||
163009766|NCT01306305|588738044|FG000|Overall Study|Withdrew consent|1|||
163009767|NCT01306305|588738045|FG001|Overall Study|Withdrew consent|0|||
163009768|NCT01964976|588738046|FG000|Overall Study|Protocol Violation|31|||
163009769|NCT01256879|588738047|FG000|Overall Study|Withdrawal by Subject|1|||
163009770|NCT02964247|588738049|FG000|Overall Study|Lost to Follow-up|2|||
163009771|NCT02964247|588738050|FG001|Overall Study|Lost to Follow-up|0|||
163009772|NCT02964247|588738049|FG000|Overall Study|Withdrawal by Subject|1|||
163009773|NCT02964247|588738050|FG001|Overall Study|Withdrawal by Subject|2|||
163009774|NCT00725920|588738051|FG000|Overall Study|Lack of Efficacy|3|||
163009775|NCT00725920|588738052|FG001|Overall Study|Lack of Efficacy|6|||
163009776|NCT00359424|588738053|FG000|Overall Study|Death|99|||
163009777|NCT00359424|588738054|FG001|Overall Study|Death|58|||
163009778|NCT00359424|588738053|FG000|Overall Study|Lost to Follow-up|19|||
163009779|NCT00359424|588738054|FG001|Overall Study|Lost to Follow-up|7|||
162640004|NCT02141997|587398064|FG002|Overall Study|Participant noncompliance|0|||
162640005|NCT02141997|587398065|FG003|Overall Study|Participant noncompliance|0|||
162640006|NCT02141997|587398062|FG000|Overall Study|Withdrew consent|1|||
162640007|NCT02141997|587398063|FG001|Overall Study|Withdrew consent|0|||
162640008|NCT02141997|587398064|FG002|Overall Study|Withdrew consent|3|||
162640009|NCT02141997|587398065|FG003|Overall Study|Withdrew consent|0|||
162640010|NCT02141997|587398062|FG000|Overall Study|Other|1|||
162640011|NCT02141997|587398063|FG001|Overall Study|Other|4|||
162640012|NCT02141997|587398064|FG002|Overall Study|Other|0|||
162640013|NCT02141997|587398065|FG003|Overall Study|Other|0|||
162640014|NCT00451321|587398067|FG000|Overall Study|Lost to Follow-up|3|||
162640015|NCT00451321|587398068|FG001|Overall Study|Lost to Follow-up|3|||
162640016|NCT00451321|587398069|FG002|Overall Study|Lost to Follow-up|1|||
162640017|NCT00451321|587398070|FG003|Overall Study|Lost to Follow-up|3|||
162640018|NCT00451321|587398071|FG004|Overall Study|Lost to Follow-up|0|||
162640019|NCT00451321|587398072|FG005|Overall Study|Lost to Follow-up|1|||
162640020|NCT00451321|587398073|FG006|Overall Study|Lost to Follow-up|0|||
162640021|NCT00451321|587398074|FG007|Overall Study|Lost to Follow-up|0|||
162640022|NCT00451321|587398067|FG000|Overall Study|Withdrawal by Subject|3|||
162640023|NCT00451321|587398068|FG001|Overall Study|Withdrawal by Subject|1|||
162640024|NCT00451321|587398069|FG002|Overall Study|Withdrawal by Subject|0|||
162640025|NCT00451321|587398070|FG003|Overall Study|Withdrawal by Subject|4|||
162640026|NCT00451321|587398071|FG004|Overall Study|Withdrawal by Subject|0|||
162640027|NCT00451321|587398072|FG005|Overall Study|Withdrawal by Subject|0|||
162640028|NCT00451321|587398073|FG006|Overall Study|Withdrawal by Subject|0|||
162640029|NCT00451321|587398074|FG007|Overall Study|Withdrawal by Subject|0|||
162640030|NCT00451321|587398067|FG000|Overall Study|Study closed/terminated|1|||
162640031|NCT00451321|587398068|FG001|Overall Study|Study closed/terminated|1|||
162640032|NCT00451321|587398069|FG002|Overall Study|Study closed/terminated|17|||
162640033|NCT00451321|587398070|FG003|Overall Study|Study closed/terminated|5|||
162640034|NCT00451321|587398071|FG004|Overall Study|Study closed/terminated|7|||
162640035|NCT00451321|587398072|FG005|Overall Study|Study closed/terminated|7|||
162640036|NCT00451321|587398073|FG006|Overall Study|Study closed/terminated|5|||
162924822|NCT02146365|588426159|FG003|Overall Study|Lost to Follow-up|3|||
162924823|NCT02146365|588426160|FG004|Overall Study|Lost to Follow-up|1|||
162924824|NCT02146365|588426161|FG005|Overall Study|Lost to Follow-up|1|||
162924825|NCT02146365|588426162|FG006|Overall Study|Lost to Follow-up|0|||
162924826|NCT02146365|588426163|FG007|Overall Study|Lost to Follow-up|1|||
162924827|NCT02146365|588426156|FG000|Overall Study|Withdrawal by Subject|1|||
162924828|NCT02146365|588426157|FG001|Overall Study|Withdrawal by Subject|2|||
162924829|NCT02146365|588426158|FG002|Overall Study|Withdrawal by Subject|1|||
162924830|NCT02146365|588426159|FG003|Overall Study|Withdrawal by Subject|5|||
162924831|NCT02146365|588426160|FG004|Overall Study|Withdrawal by Subject|1|||
162924832|NCT02146365|588426161|FG005|Overall Study|Withdrawal by Subject|0|||
162924833|NCT02146365|588426162|FG006|Overall Study|Withdrawal by Subject|0|||
162924834|NCT02146365|588426163|FG007|Overall Study|Withdrawal by Subject|0|||
162924835|NCT02146365|588426156|FG000|Overall Study|Unable to Comply with Protocol|0|||
162924836|NCT02146365|588426157|FG001|Overall Study|Unable to Comply with Protocol|1|||
162924837|NCT02146365|588426158|FG002|Overall Study|Unable to Comply with Protocol|1|||
162924838|NCT02146365|588426159|FG003|Overall Study|Unable to Comply with Protocol|0|||
162924839|NCT02146365|588426160|FG004|Overall Study|Unable to Comply with Protocol|0|||
162924840|NCT02146365|588426161|FG005|Overall Study|Unable to Comply with Protocol|0|||
162924841|NCT02146365|588426162|FG006|Overall Study|Unable to Comply with Protocol|0|||
162924842|NCT02146365|588426163|FG007|Overall Study|Unable to Comply with Protocol|0|||
162924843|NCT02146365|588426156|FG000|Overall Study|Other|1|||
162924844|NCT02146365|588426157|FG001|Overall Study|Other|0|||
162924845|NCT02146365|588426158|FG002|Overall Study|Other|2|||
162924846|NCT02146365|588426159|FG003|Overall Study|Other|1|||
162924847|NCT02146365|588426160|FG004|Overall Study|Other|0|||
162924848|NCT02146365|588426161|FG005|Overall Study|Other|0|||
162924849|NCT02146365|588426162|FG006|Overall Study|Other|0|||
162924850|NCT02146365|588426163|FG007|Overall Study|Other|0|||
162924851|NCT02332655|588426164|FG000|Overall Study|Lack of Efficacy|1|||
162924852|NCT01977482|588426165|FG000|Overall Study|Adverse Event|0|||
162924853|NCT01977482|588426166|FG001|Overall Study|Adverse Event|1|||
162924854|NCT01977482|588426167|FG002|Overall Study|Adverse Event|1|||
162924855|NCT01977482|588426168|FG003|Overall Study|Adverse Event|0|||
162924856|NCT01977482|588426169|FG004|Overall Study|Adverse Event|2|||
162924857|NCT01977482|588426170|FG005|Overall Study|Adverse Event|0|||
162924858|NCT01977482|588426165|FG000|Overall Study|Lost to Follow-up|1|||
162924859|NCT01977482|588426166|FG001|Overall Study|Lost to Follow-up|0|||
162924860|NCT01977482|588426167|FG002|Overall Study|Lost to Follow-up|0|||
162640037|NCT00451321|587398074|FG007|Overall Study|Study closed/terminated|3|||
162640038|NCT00451321|587398067|FG000|Overall Study|Sponsor decision to amend protocol|0|||
162640039|NCT00451321|587398068|FG001|Overall Study|Sponsor decision to amend protocol|0|||
162640040|NCT00451321|587398069|FG002|Overall Study|Sponsor decision to amend protocol|0|||
162640041|NCT00451321|587398070|FG003|Overall Study|Sponsor decision to amend protocol|0|||
162924861|NCT01977482|588426168|FG003|Overall Study|Lost to Follow-up|0|||
162640042|NCT00451321|587398071|FG004|Overall Study|Sponsor decision to amend protocol|0|||
162640043|NCT00451321|587398072|FG005|Overall Study|Sponsor decision to amend protocol|1|||
162640044|NCT00451321|587398073|FG006|Overall Study|Sponsor decision to amend protocol|1|||
162640045|NCT00451321|587398074|FG007|Overall Study|Sponsor decision to amend protocol|3|||
162640046|NCT00732615|587398077|FG000|Overall Study|Withdrawal by Subject|3|||
162640047|NCT00732615|587398078|FG001|Overall Study|Withdrawal by Subject|1|||
162640048|NCT00732615|587398077|FG000|Overall Study|Lost to Follow-up|0|||
162640049|NCT00732615|587398078|FG001|Overall Study|Lost to Follow-up|1|||
162640050|NCT00732615|587398077|FG000|Overall Study|Adverse Event|0|||
162640051|NCT00732615|587398078|FG001|Overall Study|Adverse Event|2|||
162640052|NCT00732615|587398077|FG000|Overall Study|Physician Decision|3|||
162640053|NCT00732615|587398078|FG001|Overall Study|Physician Decision|0|||
162640054|NCT00732615|587398077|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
162640055|NCT00732615|587398078|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
162640056|NCT00909389|587398082|FG000|Overall Study|Adverse Event|6|||
162640057|NCT00909389|587398082|FG000|Overall Study|Death|4|||
162640058|NCT00909389|587398082|FG000|Overall Study|Poor Compliance|16|||
162640059|NCT00909389|587398082|FG000|Overall Study|Lost to Follow-up|4|||
162640060|NCT00909389|587398082|FG000|Overall Study|No Information|103|||
162640061|NCT00597766|587398085|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
162640062|NCT00597766|587398086|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
162640063|NCT00597766|587398087|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
162640064|NCT00597766|587398085|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
162640065|NCT00597766|587398086|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
162640066|NCT00597766|587398087|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
162640067|NCT01333059|587398088|FG000|Overall Study|Physician Decision|3|||
162640068|NCT01333059|587398089|FG001|Overall Study|Physician Decision|3|||
162640069|NCT01333059|587398088|FG000|Overall Study|Protocol Violation|3|||
162640070|NCT01333059|587398089|FG001|Overall Study|Protocol Violation|0|||
162640071|NCT01166763|587398091|FG000|Overall Study|Withdrawal by Subject|3|||
162640072|NCT00737282|587398092|FG000|Overall Study|Study prematurely terminated|175|||
162640073|NCT02763189|587398093|FG000|Overall Study|Device failure|0|||
162640074|NCT02763189|587398094|FG001|Overall Study|Device failure|2|||
162640075|NCT02049957|587398099|FG000|Overall Study|Progressive Disease|5|||
162640076|NCT02049957|587398100|FG001|Overall Study|Progressive Disease|4|||
162640077|NCT02049957|587398101|FG002|Overall Study|Progressive Disease|2|||
162640078|NCT02049957|587398102|FG003|Overall Study|Progressive Disease|2|||
162640079|NCT02049957|587398103|FG004|Overall Study|Progressive Disease|6|||
162640080|NCT02049957|587398104|FG005|Overall Study|Progressive Disease|35|||
162640081|NCT02049957|587398105|FG006|Overall Study|Progressive Disease|7|||
162640082|NCT02049957|587398106|FG007|Overall Study|Progressive Disease|26|||
162640083|NCT02049957|587398107|FG008|Overall Study|Progressive Disease|6|||
162640084|NCT02049957|587398099|FG000|Overall Study|Adverse Event|1|||
162640085|NCT02049957|587398100|FG001|Overall Study|Adverse Event|1|||
162640086|NCT02049957|587398101|FG002|Overall Study|Adverse Event|1|||
162640087|NCT02049957|587398102|FG003|Overall Study|Adverse Event|0|||
162640088|NCT02049957|587398103|FG004|Overall Study|Adverse Event|0|||
162640089|NCT02049957|587398104|FG005|Overall Study|Adverse Event|5|||
162640090|NCT02049957|587398105|FG006|Overall Study|Adverse Event|0|||
162640091|NCT02049957|587398106|FG007|Overall Study|Adverse Event|6|||
162640092|NCT02049957|587398107|FG008|Overall Study|Adverse Event|1|||
162640093|NCT02049957|587398099|FG000|Overall Study|Study Terminated by Sponsor|0|||
162640094|NCT02049957|587398100|FG001|Overall Study|Study Terminated by Sponsor|1|||
162640095|NCT02049957|587398101|FG002|Overall Study|Study Terminated by Sponsor|0|||
162640096|NCT02049957|587398102|FG003|Overall Study|Study Terminated by Sponsor|0|||
163009780|NCT00359424|588738053|FG000|Overall Study|Withdrawal by Subject|10|||
163009781|NCT00359424|588738054|FG001|Overall Study|Withdrawal by Subject|2|||
163009782|NCT00359424|588738053|FG000|Overall Study|follow up not conducted|2|||
163009783|NCT00359424|588738054|FG001|Overall Study|follow up not conducted|0|||
163009784|NCT06018129|588738055|FG000|Overall Study|Death|1|||
162640097|NCT02049957|587398103|FG004|Overall Study|Study Terminated by Sponsor|0|||
162640098|NCT02049957|587398104|FG005|Overall Study|Study Terminated by Sponsor|0|||
162640099|NCT02049957|587398105|FG006|Overall Study|Study Terminated by Sponsor|1|||
162640100|NCT02049957|587398106|FG007|Overall Study|Study Terminated by Sponsor|0|||
162640101|NCT02049957|587398107|FG008|Overall Study|Study Terminated by Sponsor|0|||
163009785|NCT06018129|588738056|FG001|Overall Study|Death|1|||
163009786|NCT06018129|588738057|FG002|Overall Study|Death|2|||
163009787|NCT06018129|588738055|FG000|Overall Study|Sponsor Decision|2|||
163009788|NCT06018129|588738056|FG001|Overall Study|Sponsor Decision|2|||
163009789|NCT06018129|588738057|FG002|Overall Study|Sponsor Decision|1|||
162640102|NCT02049957|587398099|FG000|Overall Study|Withdrawal by Subject|0|||
162640103|NCT02049957|587398100|FG001|Overall Study|Withdrawal by Subject|0|||
162640104|NCT02049957|587398101|FG002|Overall Study|Withdrawal by Subject|0|||
162640105|NCT02049957|587398102|FG003|Overall Study|Withdrawal by Subject|1|||
162640106|NCT02049957|587398103|FG004|Overall Study|Withdrawal by Subject|0|||
162640107|NCT02049957|587398104|FG005|Overall Study|Withdrawal by Subject|2|||
162640108|NCT02049957|587398105|FG006|Overall Study|Withdrawal by Subject|0|||
162640109|NCT02049957|587398106|FG007|Overall Study|Withdrawal by Subject|3|||
163009790|NCT03832686|588738058|FG000|Overall Study|Lost to Follow-up|6|||
163009791|NCT03832686|588738059|FG001|Overall Study|Lost to Follow-up|9|||
163009792|NCT03832686|588738058|FG000|Overall Study|Discontinued Intervention|5|||
163009793|NCT03832686|588738059|FG001|Overall Study|Discontinued Intervention|4|||
163009794|NCT02235454|588738062|FG000|Overall Study|Withdrawal by Subject|2|||
163009795|NCT03323398|588738063|FG000|Overall Study|Other than Specified|0|||
163009796|NCT03323398|588738064|FG001|Overall Study|Other than Specified|1|||
163009797|NCT03323398|588738065|FG002|Overall Study|Other than Specified|2|||
163009798|NCT03323398|588738066|FG003|Overall Study|Other than Specified|0|||
163009799|NCT03323398|588738067|FG004|Overall Study|Other than Specified|0|||
163009800|NCT03323398|588738068|FG005|Overall Study|Other than Specified|0|||
163009801|NCT03323398|588738069|FG006|Overall Study|Other than Specified|1|||
163009802|NCT03323398|588738070|FG007|Overall Study|Other than Specified|0|||
163009803|NCT03323398|588738071|FG008|Overall Study|Other than Specified|2|||
163009804|NCT03323398|588738063|FG000|Overall Study|Lost to Follow-up|1|||
163009805|NCT03323398|588738064|FG001|Overall Study|Lost to Follow-up|2|||
163009806|NCT03323398|588738065|FG002|Overall Study|Lost to Follow-up|1|||
163009807|NCT03323398|588738066|FG003|Overall Study|Lost to Follow-up|0|||
163009808|NCT03323398|588738067|FG004|Overall Study|Lost to Follow-up|0|||
163009809|NCT03323398|588738068|FG005|Overall Study|Lost to Follow-up|0|||
163009810|NCT03323398|588738069|FG006|Overall Study|Lost to Follow-up|0|||
163009811|NCT03323398|588738070|FG007|Overall Study|Lost to Follow-up|0|||
163009812|NCT03323398|588738071|FG008|Overall Study|Lost to Follow-up|0|||
163009813|NCT03323398|588738063|FG000|Overall Study|Death|4|||
163009814|NCT03323398|588738064|FG001|Overall Study|Death|6|||
163009815|NCT03323398|588738065|FG002|Overall Study|Death|2|||
163009816|NCT03323398|588738066|FG003|Overall Study|Death|2|||
163009817|NCT03323398|588738067|FG004|Overall Study|Death|1|||
163009818|NCT03323398|588738068|FG005|Overall Study|Death|2|||
163061695|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
163061696|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
163061697|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
163061698|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
163061699|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
163061700|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
163061701|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
163061702|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
163061703|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
163061704|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
163061705|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
163061706|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
163061707|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
163061708|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Depression|0|||
163061709|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Depression|1|||
163061710|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Depression|0|||
163061711|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
163061712|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
163061713|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
163061714|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Jailed|0|||
163061715|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Jailed|1|||
163061716|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Jailed|0|||
163061717|NCT00090103|588934982|FG000|16-Week Safety Follow-up Period|Other|0|||
162640110|NCT02049957|587398107|FG008|Overall Study|Withdrawal by Subject|1|||
162640111|NCT02049957|587398099|FG000|Overall Study|Physician Decision|0|||
162640112|NCT02049957|587398100|FG001|Overall Study|Physician Decision|0|||
162640113|NCT02049957|587398101|FG002|Overall Study|Physician Decision|0|||
162640114|NCT02049957|587398102|FG003|Overall Study|Physician Decision|0|||
162640115|NCT02049957|587398103|FG004|Overall Study|Physician Decision|0|||
162640116|NCT02049957|587398104|FG005|Overall Study|Physician Decision|1|||
162640117|NCT02049957|587398105|FG006|Overall Study|Physician Decision|0|||
162640118|NCT02049957|587398106|FG007|Overall Study|Physician Decision|0|||
162640119|NCT02049957|587398107|FG008|Overall Study|Physician Decision|0|||
162640120|NCT04447755|587398108|FG000|Overall Study|Death|9|||
162640121|NCT04447755|587398109|FG001|Overall Study|Death|16|||
162640122|NCT04447755|587398110|FG002|Overall Study|Death|8|||
162640123|NCT04447755|587398111|FG003|Overall Study|Death|9|||
162640124|NCT04447755|587398112|FG004|Overall Study|Death|8|||
162640125|NCT04447755|587398113|FG005|Overall Study|Death|9|||
162640126|NCT04447755|587398114|FG006|Overall Study|Death|55|||
162640127|NCT04447755|587398108|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162640128|NCT04447755|587398109|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162640129|NCT04447755|587398110|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163009819|NCT03323398|588738069|FG006|Overall Study|Death|0|||
163009820|NCT03323398|588738070|FG007|Overall Study|Death|0|||
163009821|NCT03323398|588738071|FG008|Overall Study|Death|6|||
162640130|NCT04447755|587398111|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162640131|NCT04447755|587398112|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162640132|NCT04447755|587398113|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162640133|NCT04447755|587398114|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
162640134|NCT04447755|587398108|FG000|Overall Study|Sponsor Decision|0|||
162640135|NCT04447755|587398109|FG001|Overall Study|Sponsor Decision|0|||
162640136|NCT04447755|587398110|FG002|Overall Study|Sponsor Decision|0|||
162640137|NCT04447755|587398111|FG003|Overall Study|Sponsor Decision|0|||
162640138|NCT04447755|587398112|FG004|Overall Study|Sponsor Decision|1|||
162640139|NCT04447755|587398113|FG005|Overall Study|Sponsor Decision|0|||
162640140|NCT04447755|587398114|FG006|Overall Study|Sponsor Decision|10|||
162640141|NCT04447755|587398108|FG000|Overall Study|Lost to Follow-up|0|||
162640142|NCT04447755|587398109|FG001|Overall Study|Lost to Follow-up|0|||
162640143|NCT04447755|587398110|FG002|Overall Study|Lost to Follow-up|0|||
162924862|NCT01977482|588426169|FG004|Overall Study|Lost to Follow-up|0|||
162924863|NCT01977482|588426170|FG005|Overall Study|Lost to Follow-up|0|||
162924864|NCT01977482|588426165|FG000|Overall Study|Physician Decision|0|||
162924865|NCT01977482|588426166|FG001|Overall Study|Physician Decision|1|||
162924866|NCT01977482|588426167|FG002|Overall Study|Physician Decision|0|||
162924867|NCT01977482|588426168|FG003|Overall Study|Physician Decision|0|||
162924868|NCT01977482|588426169|FG004|Overall Study|Physician Decision|0|||
162924869|NCT01977482|588426170|FG005|Overall Study|Physician Decision|0|||
162924870|NCT01977482|588426165|FG000|Overall Study|Protocol Violation|0|||
162924871|NCT01977482|588426166|FG001|Overall Study|Protocol Violation|0|||
162924872|NCT01977482|588426167|FG002|Overall Study|Protocol Violation|1|||
162924873|NCT01977482|588426168|FG003|Overall Study|Protocol Violation|0|||
162924874|NCT01977482|588426169|FG004|Overall Study|Protocol Violation|0|||
162924875|NCT01977482|588426170|FG005|Overall Study|Protocol Violation|0|||
162924876|NCT01977482|588426165|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924877|NCT01977482|588426166|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
162924878|NCT01977482|588426167|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
162924879|NCT01977482|588426168|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
162924880|NCT01977482|588426169|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924881|NCT01977482|588426170|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
162924882|NCT01977482|588426165|FG000|Overall Study|Withdrawal by Subject|2|||
162924883|NCT01977482|588426166|FG001|Overall Study|Withdrawal by Subject|4|||
162924884|NCT01977482|588426167|FG002|Overall Study|Withdrawal by Subject|1|||
162924885|NCT01977482|588426168|FG003|Overall Study|Withdrawal by Subject|3|||
162924886|NCT01977482|588426169|FG004|Overall Study|Withdrawal by Subject|1|||
162924887|NCT01977482|588426170|FG005|Overall Study|Withdrawal by Subject|5|||
162924888|NCT01964898|588427299|FG000|Overall Study|ineligible post-randomization|1|||
162924889|NCT01964898|588427300|FG001|Overall Study|ineligible post-randomization|1|||
162924890|NCT01964898|588427299|FG000|Overall Study|did not receive the allocated interventi|2|||
162924891|NCT01964898|588427300|FG001|Overall Study|did not receive the allocated interventi|1|||
162924892|NCT01964898|588427299|FG000|Overall Study|Lost to Follow-up|3|||
162924893|NCT01964898|588427300|FG001|Overall Study|Lost to Follow-up|5|||
162924894|NCT01964898|588427299|FG000|Overall Study|Withdrawal by Subject|1|||
162924895|NCT01964898|588427300|FG001|Overall Study|Withdrawal by Subject|0|||
162924896|NCT02428231|588427303|FG000|Overall Study|Other|10|||
162924897|NCT02428231|588427304|FG001|Overall Study|Other|16|||
162924898|NCT02428231|588427303|FG000|Overall Study|Required Symptomatic Therapy|0|||
162924899|NCT02428231|588427304|FG001|Overall Study|Required Symptomatic Therapy|1|||
162924900|NCT02428231|588427303|FG000|Overall Study|Adverse Event|3|||
162924901|NCT02428231|588427304|FG001|Overall Study|Adverse Event|0|||
162924902|NCT02957682|588427307|FG000|Overall Study|Adverse Event|64|||
162924903|NCT02957682|588427308|FG001|Overall Study|Adverse Event|67|||
162924904|NCT02957682|588427307|FG000|Overall Study|Poor Compliance to Protocol|30|||
162924905|NCT02957682|588427308|FG001|Overall Study|Poor Compliance to Protocol|26|||
162924906|NCT02957682|588427307|FG000|Overall Study|Physician Decision|4|||
162924907|NCT02957682|588427308|FG001|Overall Study|Physician Decision|4|||
162924908|NCT02957682|588427307|FG000|Overall Study|Study Terminated by Sponsor|4|||
162924909|NCT02957682|588427308|FG001|Overall Study|Study Terminated by Sponsor|3|||
162924910|NCT02957682|588427307|FG000|Overall Study|Subject Moved|10|||
162924911|NCT02957682|588427308|FG001|Overall Study|Subject Moved|16|||
162924912|NCT02957682|588427307|FG000|Overall Study|Withdrawal by Subject|64|||
162924913|NCT02957682|588427308|FG001|Overall Study|Withdrawal by Subject|33|||
162924914|NCT02957682|588427307|FG000|Overall Study|Related to IMP Administration|3|||
162924915|NCT02957682|588427308|FG001|Overall Study|Related to IMP Administration|6|||
162924916|NCT02957682|588427307|FG000|Overall Study|Non-disclosed|16|||
162924917|NCT02957682|588427308|FG001|Overall Study|Non-disclosed|12|||
162924918|NCT02957682|588427307|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
162924919|NCT02957682|588427308|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
162924920|NCT02953262|588427309|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
162924921|NCT02953262|588427310|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
162924922|NCT02953262|588427311|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
162640144|NCT04447755|587398111|FG003|Overall Study|Lost to Follow-up|0|||
162640145|NCT04447755|587398112|FG004|Overall Study|Lost to Follow-up|0|||
162640146|NCT04447755|587398113|FG005|Overall Study|Lost to Follow-up|0|||
162640147|NCT04447755|587398114|FG006|Overall Study|Lost to Follow-up|1|||
162640148|NCT00840294|587398115|FG000|Overall Study|Withdrawal by Subject|2|||
162640149|NCT00840294|587398116|FG001|Overall Study|Withdrawal by Subject|1|||
162640150|NCT00840294|587398115|FG000|Overall Study|Protocol Violation|1|||
162640151|NCT00840294|587398116|FG001|Overall Study|Protocol Violation|3|||
162640152|NCT00840294|587398115|FG000|Overall Study|Illness|0|||
162640153|NCT00840294|587398116|FG001|Overall Study|Illness|1|||
162640154|NCT03721276|587398118|FG000|Overall Study|Lost to Follow-up|5|||
162640155|NCT03721276|587398119|FG001|Overall Study|Lost to Follow-up|3|||
163009822|NCT03323398|588738063|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
163009823|NCT03323398|588738064|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
163009824|NCT03323398|588738065|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
163009825|NCT03323398|588738066|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
163009826|NCT03323398|588738067|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
163009827|NCT03323398|588738068|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
163009828|NCT03323398|588738069|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
163009829|NCT03323398|588738070|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
163009830|NCT03323398|588738071|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
163009831|NCT03323398|588738063|FG000|Overall Study|Withdrawal by Subject|2|||
163009832|NCT03323398|588738064|FG001|Overall Study|Withdrawal by Subject|1|||
163009833|NCT03323398|588738065|FG002|Overall Study|Withdrawal by Subject|3|||
163009834|NCT03323398|588738066|FG003|Overall Study|Withdrawal by Subject|0|||
163009835|NCT03323398|588738067|FG004|Overall Study|Withdrawal by Subject|0|||
163009836|NCT03323398|588738068|FG005|Overall Study|Withdrawal by Subject|1|||
163009837|NCT03323398|588738069|FG006|Overall Study|Withdrawal by Subject|0|||
163009838|NCT03323398|588738070|FG007|Overall Study|Withdrawal by Subject|0|||
163009839|NCT03323398|588738071|FG008|Overall Study|Withdrawal by Subject|0|||
163009840|NCT03323398|588738063|FG000|Overall Study|Participant was Put on Hospice|0|||
163009841|NCT03323398|588738064|FG001|Overall Study|Participant was Put on Hospice|0|||
163009842|NCT03323398|588738065|FG002|Overall Study|Participant was Put on Hospice|0|||
163009843|NCT03323398|588738066|FG003|Overall Study|Participant was Put on Hospice|0|||
163009844|NCT03323398|588738067|FG004|Overall Study|Participant was Put on Hospice|0|||
163009845|NCT03323398|588738068|FG005|Overall Study|Participant was Put on Hospice|0|||
163009846|NCT03323398|588738069|FG006|Overall Study|Participant was Put on Hospice|1|||
163009847|NCT03323398|588738070|FG007|Overall Study|Participant was Put on Hospice|0|||
163009848|NCT03323398|588738071|FG008|Overall Study|Participant was Put on Hospice|0|||
163009849|NCT03323398|588738063|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
163009850|NCT03323398|588738064|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
162640156|NCT03721276|587398118|FG000|Overall Study|Adverse Event|0|||
162640157|NCT03721276|587398119|FG001|Overall Study|Adverse Event|1|||
162640158|NCT01405742|587398122|FG000|Overall Study|Lost to Follow-up|1|||
162640159|NCT01405742|587398123|FG001|Overall Study|Lost to Follow-up|0|||
162640160|NCT01340898|587398124|FG000|Primary Phase|Serious Adverse Events|0|||
162640161|NCT01340898|587398125|FG001|Primary Phase|Serious Adverse Events|0|||
162640162|NCT01340898|587398126|FG002|Primary Phase|Serious Adverse Events|1|||
162640163|NCT01340898|587398124|FG000|Primary Phase|Withdrawal by Subject|8|||
162640164|NCT01340898|587398125|FG001|Primary Phase|Withdrawal by Subject|7|||
163061718|NCT00090103|588934983|FG001|16-Week Safety Follow-up Period|Other|1|||
163061719|NCT00090103|588934984|FG002|16-Week Safety Follow-up Period|Other|0|||
163009851|NCT03323398|588738065|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
163009852|NCT03323398|588738066|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
163009853|NCT03323398|588738067|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
163061720|NCT00947544|588934989|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
163061721|NCT00947544|588934990|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
163009854|NCT03323398|588738068|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
163009855|NCT03323398|588738069|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
163009856|NCT03323398|588738070|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
163009857|NCT03323398|588738071|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
163009858|NCT03641469|588738072|FG000|Overall Study|Ineligible|2|||
162640165|NCT01340898|587398126|FG002|Primary Phase|Withdrawal by Subject|5|||
162640166|NCT01340898|587398124|FG000|Primary Phase|Migrated/moved from study area|4|||
162640167|NCT01340898|587398125|FG001|Primary Phase|Migrated/moved from study area|1|||
162640168|NCT01340898|587398126|FG002|Primary Phase|Migrated/moved from study area|0|||
162640169|NCT01340898|587398124|FG000|Primary Phase|Lost to Follow-up|4|||
162640170|NCT01340898|587398125|FG001|Primary Phase|Lost to Follow-up|1|||
162640171|NCT01340898|587398126|FG002|Primary Phase|Lost to Follow-up|0|||
163009859|NCT03641469|588738072|FG000|Overall Study|Withdrawal by Subject|5|||
163009860|NCT03641469|588738072|FG000|Overall Study|Physician Decision|1|||
163009861|NCT03641469|588738072|FG000|Overall Study|Protocol Violation|1|||
163009862|NCT03641469|588738072|FG000|Overall Study|Lost to Follow-up|2|||
163009863|NCT05479435|588738073|FG000|Overall Study|Withdrawal by Subject|1|||
163009864|NCT05479435|588738074|FG001|Overall Study|Withdrawal by Subject|0|||
163009865|NCT05479435|588738075|FG002|Overall Study|Withdrawal by Subject|0|||
163009866|NCT05479435|588738073|FG000|Overall Study|Covid 19|0|||
163009867|NCT05479435|588738074|FG001|Overall Study|Covid 19|0|||
163009868|NCT05479435|588738075|FG002|Overall Study|Covid 19|2|||
163009869|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
163009870|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
163009871|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
163009872|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
163009873|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
163009874|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
163009875|NCT00955617|588738076|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
163009876|NCT00955617|588738077|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
163009877|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Adverse Event|7|||
163009878|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
163009879|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Non-compliance|3|||
163009880|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Other|17|||
163009881|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Physician Decision|2|||
163009882|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Pregnancy|1|||
163009883|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
163009884|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
163009885|NCT05207865|588740077|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
163009886|NCT05207865|588740077|FG000|Follow-up Phase|Lost to Follow-up|1|||
163009887|NCT05207865|588740077|FG000|Follow-up Phase|Non-compliance|1|||
163009888|NCT05207865|588740077|FG000|Follow-up Phase|Not reported|2|||
163009889|NCT05207865|588740077|FG000|Follow-up Phase|Not collected|11|||
163009890|NCT00739882|588740078|FG000|Double-blind Period|Adverse Event|1|||
163009891|NCT00739882|588740079|FG001|Double-blind Period|Adverse Event|2|||
163009892|NCT00739882|588740078|FG000|Double-blind Period|Protocol Violation|1|||
163009893|NCT00739882|588740079|FG001|Double-blind Period|Protocol Violation|0|||
163009894|NCT00739882|588740078|FG000|Double-blind Period|Lack of Efficacy|1|||
163009895|NCT00739882|588740079|FG001|Double-blind Period|Lack of Efficacy|1|||
163009896|NCT00739882|588740078|FG000|Double-blind Period|Other|16|||
163009897|NCT00739882|588740079|FG001|Double-blind Period|Other|8|||
163009898|NCT00739882|588740078|FG000|Open-label Period|Adverse Event|1|||
163009899|NCT00739882|588740079|FG001|Open-label Period|Adverse Event|0|||
163009900|NCT00739882|588740078|FG000|Open-label Period|Other|9|||
163009901|NCT00739882|588740079|FG001|Open-label Period|Other|5|||
163009902|NCT03055338|588740082|FG000|Overall Study|Lost to Follow-up|9|||
163009903|NCT03055338|588740083|FG001|Overall Study|Lost to Follow-up|2|||
163009904|NCT03055338|588740084|FG002|Overall Study|Lost to Follow-up|3|||
163009905|NCT03055338|588740082|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
163009906|NCT03055338|588740083|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
163009907|NCT03055338|588740084|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
163009908|NCT03055338|588740082|FG000|Overall Study|Physician Decision|0|||
163061722|NCT02566005|588934992|FG000|Overall Study|vaginal bleeding|0|||
163061723|NCT02566005|588934993|FG001|Overall Study|vaginal bleeding|1|||
163061724|NCT02566005|588934992|FG000|Overall Study|received foley|8|||
163061725|NCT02566005|588934993|FG001|Overall Study|received foley|0|||
163061726|NCT02566005|588934992|FG000|Overall Study|did not receive foley|0|||
163061727|NCT02566005|588934993|FG001|Overall Study|did not receive foley|1|||
163061728|NCT02566005|588934992|FG000|Overall Study|labor after randomization|0|||
163061729|NCT02566005|588934993|FG001|Overall Study|labor after randomization|4|||
163061730|NCT01134042|588934996|FG000|Overall Study|Adverse Event|3|||
162640172|NCT01340898|587398124|FG000|Booster Phase|Withdrawal by Subject|3|||
162640173|NCT01340898|587398125|FG001|Booster Phase|Withdrawal by Subject|0|||
163061731|NCT01134042|588934997|FG001|Overall Study|Adverse Event|7|||
162736237|NCT03699709|587744922|FG000|Overall Study|incarcerated|1|||
163061732|NCT01134042|588934998|FG002|Overall Study|Adverse Event|2|||
163009909|NCT03055338|588740083|FG001|Overall Study|Physician Decision|0|||
163009910|NCT03055338|588740084|FG002|Overall Study|Physician Decision|2|||
163009911|NCT03055338|588740082|FG000|Overall Study|Withdrawal by Subject|9|||
163009912|NCT03055338|588740083|FG001|Overall Study|Withdrawal by Subject|8|||
163009913|NCT03055338|588740084|FG002|Overall Study|Withdrawal by Subject|7|||
163009914|NCT00975611|588740085|FG000|Overall Study|Screen Fail|16|||
163009915|NCT00975611|588740085|FG000|Overall Study|Physician Decision|1|||
163009916|NCT03058705|588740086|FG000|Overall Study|Withdrawal by Subject|2|||
162715941|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163009917|NCT03058705|588740086|FG000|Overall Study|Physician Decision|2|||
163009918|NCT01880554|588740087|FG000|Overall Study|Protocol Violation|14|||
163009919|NCT01880554|588740087|FG000|Overall Study|Simon's design requirements|2|||
163009920|NCT01415518|588740088|FG000|Overall Study|Withdrawal by Subject|2|||
163009921|NCT01415518|588740089|FG001|Overall Study|Withdrawal by Subject|12|||
163009922|NCT01415518|588740088|FG000|Overall Study|Protocol Violation|6|||
163009923|NCT01415518|588740089|FG001|Overall Study|Protocol Violation|8|||
163009924|NCT01415518|588740088|FG000|Overall Study|Lost to Follow-up|3|||
163009925|NCT01415518|588740089|FG001|Overall Study|Lost to Follow-up|5|||
163009926|NCT01415518|588740088|FG000|Overall Study|Adverse Event|3|||
163009927|NCT01415518|588740089|FG001|Overall Study|Adverse Event|4|||
163009928|NCT01415518|588740088|FG000|Overall Study|Death|1|||
163009929|NCT01415518|588740089|FG001|Overall Study|Death|1|||
163009930|NCT01415518|588740088|FG000|Overall Study|Condition under Investigation Worsened|1|||
163009931|NCT01415518|588740089|FG001|Overall Study|Condition under Investigation Worsened|1|||
163009932|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
163009933|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
163009934|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
163009935|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
163009936|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
163009937|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
163009938|NCT03752970|588740097|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
163009939|NCT03752970|588740098|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
163009940|NCT03752970|588740099|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
163009941|NCT03752970|588740097|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
163009942|NCT03752970|588740098|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
163009943|NCT03752970|588740099|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
163009944|NCT03752970|588740097|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
163009945|NCT03752970|588740098|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
163009946|NCT03752970|588740099|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
163009947|NCT03976362|588740100|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
163009948|NCT03976362|588740101|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163009949|NCT03976362|588740102|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163009950|NCT03976362|588740100|FG000|Induction Phase|Death|62|||
163009951|NCT03976362|588740101|FG001|Induction Phase|Death|0|||
163009952|NCT03976362|588740102|FG002|Induction Phase|Death|0|||
163009953|NCT03976362|588740100|FG000|Maintenance Phase|Participants Ongoing|0|||
163009954|NCT03976362|588740101|FG001|Maintenance Phase|Participants Ongoing|106|||
163009955|NCT03976362|588740102|FG002|Maintenance Phase|Participants Ongoing|103|||
163009956|NCT03976362|588740100|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163009957|NCT03976362|588740101|FG001|Maintenance Phase|Withdrawal by Subject|4|||
163009958|NCT03976362|588740102|FG002|Maintenance Phase|Withdrawal by Subject|4|||
163009959|NCT03976362|588740100|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
163009960|NCT03976362|588740101|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
163009961|NCT03976362|588740102|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
163009962|NCT03976362|588740100|FG000|Maintenance Phase|Death|0|||
163009963|NCT03976362|588740101|FG001|Maintenance Phase|Death|186|||
163009964|NCT03976362|588740102|FG002|Maintenance Phase|Death|187|||
163009965|NCT04767282|588740103|FG000|Overall Study|Refused or did not begin surveys|6|||
163009966|NCT04767282|588740104|FG001|Overall Study|Refused or did not begin surveys|2|||
163009967|NCT04767282|588740105|FG002|Overall Study|Refused or did not begin surveys|2|||
163009968|NCT04767282|588740103|FG000|Overall Study|Duplicate household previously enrolled|2|||
163009969|NCT04767282|588740104|FG001|Overall Study|Duplicate household previously enrolled|0|||
163009970|NCT04767282|588740105|FG002|Overall Study|Duplicate household previously enrolled|8|||
163009971|NCT04767282|588740103|FG000|Overall Study|Unable to confirm legal guardian|0|||
163009972|NCT04767282|588740104|FG001|Overall Study|Unable to confirm legal guardian|2|||
163009973|NCT04767282|588740105|FG002|Overall Study|Unable to confirm legal guardian|8|||
163009974|NCT04767282|588740103|FG000|Overall Study|Withdrawal by Subject|0|||
163009975|NCT04767282|588740104|FG001|Overall Study|Withdrawal by Subject|0|||
162715942|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163009976|NCT04767282|588740105|FG002|Overall Study|Withdrawal by Subject|6|||
163009977|NCT04767282|588740103|FG000|Overall Study|Survey comprehension challenges|4|||
163009978|NCT04767282|588740104|FG001|Overall Study|Survey comprehension challenges|0|||
163009979|NCT04767282|588740105|FG002|Overall Study|Survey comprehension challenges|0|||
163009980|NCT01467713|588740107|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
163009981|NCT01467713|588740108|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
163009982|NCT01467713|588740109|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
163009983|NCT01467713|588740110|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
163061733|NCT01134042|588934996|FG000|Overall Study|Lack of Efficacy|21|||
163009984|NCT01467713|588740107|FG000|Overall Study|Major Protocol Deviation|2|||
163009985|NCT01467713|588740108|FG001|Overall Study|Major Protocol Deviation|4|||
163009986|NCT01467713|588740109|FG002|Overall Study|Major Protocol Deviation|4|||
163009987|NCT01467713|588740110|FG003|Overall Study|Major Protocol Deviation|1|||
163009988|NCT01467713|588740107|FG000|Overall Study|Lost to Follow-up|9|||
163009989|NCT01467713|588740108|FG001|Overall Study|Lost to Follow-up|12|||
163009990|NCT01467713|588740109|FG002|Overall Study|Lost to Follow-up|6|||
163061734|NCT01134042|588934997|FG001|Overall Study|Lack of Efficacy|6|||
163061735|NCT01134042|588934998|FG002|Overall Study|Lack of Efficacy|18|||
163061736|NCT01134042|588934996|FG000|Overall Study|Protocol Violation|5|||
163061737|NCT01134042|588934997|FG001|Overall Study|Protocol Violation|3|||
163061738|NCT01134042|588934998|FG002|Overall Study|Protocol Violation|5|||
163061739|NCT01134042|588934996|FG000|Overall Study|Lost to Follow-up|2|||
163061740|NCT01134042|588934997|FG001|Overall Study|Lost to Follow-up|0|||
163061741|NCT01134042|588934998|FG002|Overall Study|Lost to Follow-up|1|||
163061742|NCT01134042|588934996|FG000|Overall Study|Physician Decision|4|||
163061743|NCT01134042|588934997|FG001|Overall Study|Physician Decision|8|||
163061744|NCT01134042|588934998|FG002|Overall Study|Physician Decision|1|||
163061745|NCT01134042|588934996|FG000|Overall Study|Withdrawal by Subject|13|||
163061746|NCT01134042|588934997|FG001|Overall Study|Withdrawal by Subject|4|||
163061747|NCT01134042|588934998|FG002|Overall Study|Withdrawal by Subject|7|||
163061748|NCT03345004|588934999|FG000|Overall Study|Physician Decision|1|||
163061749|NCT03345004|588935000|FG001|Overall Study|Physician Decision|0|||
163061750|NCT03345004|588934999|FG000|Overall Study|Withdrawal by Subject|0|||
163061751|NCT03345004|588935000|FG001|Overall Study|Withdrawal by Subject|1|||
163061752|NCT01091259|588935005|FG000|Overall Study|Adverse Event|3|||
163061753|NCT01091259|588935005|FG000|Overall Study|Lack of Efficacy|2|||
163061754|NCT00984867|588935006|FG000|Overall Study|Adverse Event|3|||
163061755|NCT00984867|588935007|FG001|Overall Study|Adverse Event|7|||
163061756|NCT00984867|588935006|FG000|Overall Study|Death|1|||
163061757|NCT00984867|588935007|FG001|Overall Study|Death|0|||
163061758|NCT00984867|588935006|FG000|Overall Study|Withdrawal by Subject|13|||
163061759|NCT00984867|588935007|FG001|Overall Study|Withdrawal by Subject|4|||
163061760|NCT00984867|588935006|FG000|Overall Study|Lost to Follow-up|3|||
163061761|NCT00984867|588935007|FG001|Overall Study|Lost to Follow-up|4|||
163061762|NCT00984867|588935006|FG000|Overall Study|Poor/non-compliance|0|||
163061763|NCT00984867|588935007|FG001|Overall Study|Poor/non-compliance|1|||
163061764|NCT00984867|588935006|FG000|Overall Study|Subject no longer meets study criteria|1|||
163061765|NCT00984867|588935007|FG001|Overall Study|Subject no longer meets study criteria|1|||
163061766|NCT00984867|588935006|FG000|Overall Study|site closing|1|||
163061767|NCT00984867|588935007|FG001|Overall Study|site closing|0|||
163061768|NCT00984867|588935006|FG000|Overall Study|lack of efficacy and subject compliance|1|||
163061769|NCT00984867|588935007|FG001|Overall Study|lack of efficacy and subject compliance|0|||
163061770|NCT00671060|588935008|FG000|Overall Study|Protocol Violation|1|||
163061771|NCT00671060|588935009|FG001|Overall Study|Protocol Violation|0|||
163061772|NCT00671060|588935008|FG000|Overall Study|Physician Decision|0|||
163061773|NCT00671060|588935009|FG001|Overall Study|Physician Decision|1|||
163061774|NCT01541748|588935010|FG000|Overall Study|Lost to Follow-up|17|||
163009991|NCT01467713|588740110|FG003|Overall Study|Lost to Follow-up|9|||
163061775|NCT01541748|588935010|FG000|Overall Study|Moved out of state|1|||
163061776|NCT01541748|588935010|FG000|Overall Study|Withdrawal by Subject|7|||
163061777|NCT01541748|588935010|FG000|Overall Study|Screen failure|5|||
163061778|NCT01541748|588935010|FG000|Overall Study|Did not receive study device|1|||
163061779|NCT00626639|588935018|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
163061780|NCT00626639|588935019|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
163061781|NCT01155141|588935020|FG000|Overall Study|Withdrawal by Subject|1|||
163061782|NCT01155141|588935020|FG000|Overall Study|Screen Failure|1|||
163061783|NCT03473197|588935021|FG000|Overall Study|Adverse Event|4|||
163061784|NCT03473197|588935021|FG000|Overall Study|Lost to Follow-up|1|||
163061785|NCT03473197|588935021|FG000|Overall Study|Withdrawal by Subject|5|||
163061786|NCT00785629|588935022|FG000|Overall Study|Adverse Event|2|||
163061787|NCT00785629|588935023|FG001|Overall Study|Adverse Event|1|||
163061788|NCT00785629|588935024|FG002|Overall Study|Adverse Event|1|||
163061789|NCT00785629|588935025|FG003|Overall Study|Adverse Event|5|||
163061790|NCT00785629|588935022|FG000|Overall Study|Protocol Violation|1|||
163061791|NCT00785629|588935023|FG001|Overall Study|Protocol Violation|2|||
162640174|NCT01340898|587398126|FG002|Booster Phase|Withdrawal by Subject|4|||
163009992|NCT01467713|588740107|FG000|Overall Study|Voluntary Withdrawal|18|||
163061792|NCT00785629|588935024|FG002|Overall Study|Protocol Violation|4|||
163061793|NCT00785629|588935025|FG003|Overall Study|Protocol Violation|5|||
163061794|NCT00785629|588935022|FG000|Overall Study|administrative decision|5|||
163061795|NCT00785629|588935023|FG001|Overall Study|administrative decision|1|||
163061796|NCT00785629|588935024|FG002|Overall Study|administrative decision|3|||
163061797|NCT00785629|588935025|FG003|Overall Study|administrative decision|4|||
163061798|NCT00785629|588935022|FG000|Overall Study|Withdrawal by Subject|0|||
163061799|NCT00785629|588935023|FG001|Overall Study|Withdrawal by Subject|1|||
163061800|NCT00785629|588935024|FG002|Overall Study|Withdrawal by Subject|2|||
163009993|NCT01467713|588740108|FG001|Overall Study|Voluntary Withdrawal|14|||
163009994|NCT01467713|588740109|FG002|Overall Study|Voluntary Withdrawal|21|||
163009995|NCT01467713|588740110|FG003|Overall Study|Voluntary Withdrawal|20|||
163009996|NCT01467713|588740107|FG000|Overall Study|Study Termination|23|||
163009997|NCT01467713|588740108|FG001|Overall Study|Study Termination|33|||
163009998|NCT01467713|588740109|FG002|Overall Study|Study Termination|28|||
163009999|NCT01467713|588740110|FG003|Overall Study|Study Termination|29|||
163010000|NCT01467713|588740107|FG000|Overall Study|Pregnancy|0|||
163010001|NCT01467713|588740108|FG001|Overall Study|Pregnancy|1|||
163010002|NCT01467713|588740109|FG002|Overall Study|Pregnancy|1|||
163010003|NCT01467713|588740110|FG003|Overall Study|Pregnancy|3|||
163010004|NCT01467713|588740107|FG000|Overall Study|Relapse|35|||
163010005|NCT01467713|588740108|FG001|Overall Study|Relapse|25|||
163010006|NCT01467713|588740109|FG002|Overall Study|Relapse|28|||
163010007|NCT01467713|588740110|FG003|Overall Study|Relapse|35|||
163010008|NCT01467713|588740107|FG000|Overall Study|Reason not Specified|6|||
163010009|NCT01467713|588740108|FG001|Overall Study|Reason not Specified|11|||
163010010|NCT01467713|588740109|FG002|Overall Study|Reason not Specified|8|||
163010011|NCT01467713|588740110|FG003|Overall Study|Reason not Specified|7|||
163010012|NCT04846569|588740111|FG000|Overall Study|Withdrawal by Subject|3|||
163010013|NCT04846569|588740112|FG001|Overall Study|Withdrawal by Subject|1|||
163010014|NCT02525783|588740113|FG000|Overall Study|Lost to Follow-up|10|||
163010015|NCT02512302|588740114|FG000|Period 1|Adverse Event|0|||
163010016|NCT02512302|588740115|FG001|Period 1|Adverse Event|1|||
163010017|NCT02512302|588740116|FG002|Period 1|Adverse Event|0|||
163010018|NCT02512302|588740117|FG003|Period 1|Adverse Event|0|||
163010019|NCT02512302|588740118|FG004|Period 1|Adverse Event|0|||
163010020|NCT02512302|588740119|FG005|Period 1|Adverse Event|0|||
163010021|NCT02512302|588740120|FG006|Period 1|Adverse Event|0|||
163010022|NCT02512302|588740121|FG007|Period 1|Adverse Event|0|||
163010023|NCT02512302|588740122|FG008|Period 1|Adverse Event|0|||
163010024|NCT02512302|588740123|FG009|Period 1|Adverse Event|0|||
163010025|NCT02512302|588740114|FG000|Period 2|Adverse Event|0|||
163010026|NCT02512302|588740115|FG001|Period 2|Adverse Event|0|||
163010027|NCT02512302|588740116|FG002|Period 2|Adverse Event|0|||
163010028|NCT02512302|588740117|FG003|Period 2|Adverse Event|0|||
163010029|NCT02512302|588740118|FG004|Period 2|Adverse Event|0|||
163010030|NCT02512302|588740119|FG005|Period 2|Adverse Event|0|||
163010031|NCT02512302|588740120|FG006|Period 2|Adverse Event|0|||
163010032|NCT02512302|588740121|FG007|Period 2|Adverse Event|0|||
163010033|NCT02512302|588740122|FG008|Period 2|Adverse Event|0|||
163010034|NCT02512302|588740123|FG009|Period 2|Adverse Event|1|||
163010035|NCT02512302|588740114|FG000|Period 3|Lost to Follow-up|0|||
163010036|NCT02512302|588740115|FG001|Period 3|Lost to Follow-up|0|||
163010037|NCT02512302|588740116|FG002|Period 3|Lost to Follow-up|1|||
163010038|NCT02512302|588740117|FG003|Period 3|Lost to Follow-up|0|||
163010039|NCT02512302|588740118|FG004|Period 3|Lost to Follow-up|0|||
163010040|NCT02512302|588740119|FG005|Period 3|Lost to Follow-up|0|||
163010041|NCT02512302|588740120|FG006|Period 3|Lost to Follow-up|0|||
163010042|NCT02512302|588740121|FG007|Period 3|Lost to Follow-up|0|||
163010043|NCT02512302|588740122|FG008|Period 3|Lost to Follow-up|0|||
163010044|NCT02512302|588740123|FG009|Period 3|Lost to Follow-up|0|||
163010045|NCT02512302|588740114|FG000|Period 4|Adverse Event|0|||
163010046|NCT02512302|588740115|FG001|Period 4|Adverse Event|0|||
163010047|NCT02512302|588740116|FG002|Period 4|Adverse Event|0|||
163010048|NCT02512302|588740117|FG003|Period 4|Adverse Event|0|||
163010049|NCT02512302|588740118|FG004|Period 4|Adverse Event|0|||
163010050|NCT02512302|588740119|FG005|Period 4|Adverse Event|0|||
163010051|NCT02512302|588740120|FG006|Period 4|Adverse Event|1|||
163010052|NCT02512302|588740121|FG007|Period 4|Adverse Event|0|||
163010053|NCT02512302|588740122|FG008|Period 4|Adverse Event|0|||
163010054|NCT02512302|588740123|FG009|Period 4|Adverse Event|0|||
163010055|NCT01735916|588740134|FG000|Overall Study|Subject not eligible to be randomized|11|||
162640175|NCT01340898|587398124|FG000|Booster Phase|Migrated/moved from study area|3|||
162640176|NCT01340898|587398125|FG001|Booster Phase|Migrated/moved from study area|0|||
162640177|NCT01340898|587398126|FG002|Booster Phase|Migrated/moved from study area|0|||
162640178|NCT01340898|587398124|FG000|Booster Phase|Lost to Follow-up|4|||
162640179|NCT01340898|587398125|FG001|Booster Phase|Lost to Follow-up|2|||
162640180|NCT01340898|587398126|FG002|Booster Phase|Lost to Follow-up|3|||
162640181|NCT04900220|587398127|FG000|Overall Study|Lost to Follow-up|1|||
162640182|NCT04900220|587398128|FG001|Overall Study|Lost to Follow-up|1|||
162640183|NCT03428360|587398129|FG000|Overall Study|Informed consent withdrawn|5|||
162640184|NCT03428360|587398129|FG000|Overall Study|Withdrawal by Subject|4|||
162640185|NCT03428360|587398129|FG000|Overall Study|Lost to Follow-up|5|||
162640186|NCT03428360|587398129|FG000|Overall Study|Physician Decision|2|||
162640187|NCT03428360|587398129|FG000|Overall Study|Informed consent withdrawn|5|||
162640188|NCT03428360|587398129|FG000|Overall Study|Study terminated by sponsor|10|||
162640189|NCT03428360|587398129|FG000|Overall Study|Non-compliant with study|1|||
162640190|NCT03428360|587398129|FG000|Overall Study|Non-compliant with study drug|3|||
162640191|NCT03428360|587398129|FG000|Overall Study|Death|3|||
162640192|NCT03428360|587398129|FG000|Overall Study|Adverse Event|1|||
162640193|NCT03428360|587398129|FG000|Overall Study|Not on antiepileptic drug|1|||
162640194|NCT02028065|587398130|FG000|Randomization Through Start Treatment|Not treated|1|||
162640195|NCT02028065|587398131|FG001|Randomization Through Start Treatment|Not treated|3|||
162640196|NCT02028065|587398132|FG002|Randomization Through Start Treatment|Not treated|3|||
162640197|NCT02028065|587398130|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
162640198|NCT02028065|587398131|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
162640199|NCT02028065|587398132|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
162640200|NCT02028065|587398130|FG000|Treatment Through Study Completion|Physician Decision|1|||
162640201|NCT02028065|587398131|FG001|Treatment Through Study Completion|Physician Decision|0|||
162640202|NCT02028065|587398132|FG002|Treatment Through Study Completion|Physician Decision|0|||
162640203|NCT02028065|587398130|FG000|Treatment Through Study Completion|Protocol Violation|1|||
162640204|NCT02028065|587398131|FG001|Treatment Through Study Completion|Protocol Violation|4|||
162640205|NCT02028065|587398132|FG002|Treatment Through Study Completion|Protocol Violation|0|||
162640206|NCT02028065|587398130|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
162640207|NCT02028065|587398131|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
162640208|NCT02028065|587398132|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
162640209|NCT02028065|587398130|FG000|Treatment Through Study Completion|Adverse Event|3|||
162640210|NCT02028065|587398131|FG001|Treatment Through Study Completion|Adverse Event|3|||
162640211|NCT02028065|587398132|FG002|Treatment Through Study Completion|Adverse Event|5|||
162640212|NCT04868890|587398135|FG000|Overall Study|Death|2|||
162640213|NCT04868890|587398136|FG001|Overall Study|Death|1|||
162640214|NCT04868890|587398135|FG000|Overall Study|Withdrawal by Subject|1|||
162640215|NCT04868890|587398136|FG001|Overall Study|Withdrawal by Subject|5|||
162640216|NCT02669433|587398139|FG000|Overall Study|Protocol Violation|0|||
162640217|NCT02669433|587398140|FG001|Overall Study|Protocol Violation|4|||
162640218|NCT02669433|587398141|FG002|Overall Study|Protocol Violation|1|||
162640219|NCT02669433|587398139|FG000|Overall Study|Disease Progression|1|||
162640220|NCT02669433|587398140|FG001|Overall Study|Disease Progression|0|||
162640221|NCT02669433|587398141|FG002|Overall Study|Disease Progression|0|||
162640222|NCT02669433|587398139|FG000|Overall Study|Physician Decision|1|||
162640223|NCT02669433|587398140|FG001|Overall Study|Physician Decision|1|||
162640224|NCT02669433|587398141|FG002|Overall Study|Physician Decision|0|||
162640225|NCT02669433|587398139|FG000|Overall Study|Adverse Event|6|||
162640226|NCT02669433|587398140|FG001|Overall Study|Adverse Event|7|||
162640227|NCT02669433|587398141|FG002|Overall Study|Adverse Event|10|||
162640228|NCT02669433|587398139|FG000|Overall Study|Sponsor Termination|1|||
162640229|NCT02669433|587398140|FG001|Overall Study|Sponsor Termination|0|||
162640230|NCT02669433|587398141|FG002|Overall Study|Sponsor Termination|1|||
162924923|NCT02953262|588427312|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
162924924|NCT03284424|588427313|FG000|Overall Study|Death|70|||
162924925|NCT03284424|588427314|FG001|Overall Study|Death|24|||
162924926|NCT03284424|588427313|FG000|Overall Study|Lost to Follow-up|3|||
162924927|NCT03284424|588427314|FG001|Overall Study|Lost to Follow-up|1|||
162924928|NCT03284424|588427313|FG000|Overall Study|Physician Decision|1|||
162924929|NCT03284424|588427314|FG001|Overall Study|Physician Decision|2|||
162924930|NCT03284424|588427313|FG000|Overall Study|Withdrawal by Subject|4|||
162924931|NCT03284424|588427314|FG001|Overall Study|Withdrawal by Subject|5|||
162924932|NCT03284424|588427313|FG000|Overall Study|Sponsor's decision|27|||
162924933|NCT03284424|588427314|FG001|Overall Study|Sponsor's decision|22|||
162924934|NCT00765999|588427315|FG000|Overall Study|Adverse Event|203|||
162924935|NCT00765999|588427315|FG000|Overall Study|Insufficient Therapeutic Response|100|||
162924936|NCT00765999|588427315|FG000|Overall Study|Protocol Violation|95|||
162924937|NCT00765999|588427315|FG000|Overall Study|Consent Withdrawn|202|||
162924938|NCT00765999|588427315|FG000|Overall Study|Lost to Follow-up|131|||
162924939|NCT00765999|588427315|FG000|Overall Study|Study Terminated by Sponsor|2|||
162924940|NCT00765999|588427315|FG000|Overall Study|Other Miscellaneous Reasons|51|||
162924941|NCT00203892|588427319|FG000|Overall Study|Physician Decision|1|||
162924942|NCT00203892|588427320|FG001|Overall Study|Physician Decision|2|||
163010056|NCT01735916|588740135|FG001|Overall Study|Subject not eligible to be randomized|0|||
163010057|NCT01735916|588740136|FG002|Overall Study|Subject not eligible to be randomized|0|||
163010058|NCT01735916|588740134|FG000|Overall Study|Early termination of study by sponsor|4|||
163010059|NCT01735916|588740135|FG001|Overall Study|Early termination of study by sponsor|19|||
163010060|NCT01735916|588740136|FG002|Overall Study|Early termination of study by sponsor|7|||
163010061|NCT01735916|588740134|FG000|Overall Study|Withdrawal by Subject|3|||
163010062|NCT01735916|588740135|FG001|Overall Study|Withdrawal by Subject|0|||
163010063|NCT01735916|588740136|FG002|Overall Study|Withdrawal by Subject|0|||
163010064|NCT05177484|588740142|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
163010065|NCT05177484|588740143|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
163010066|NCT05177484|588740142|FG000|Overall Study|Inadvertently withdrawn|3|||
163010067|NCT05177484|588740143|FG001|Overall Study|Inadvertently withdrawn|1|||
163010068|NCT05177484|588740142|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
163010069|NCT05177484|588740143|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
163010070|NCT01379768|588740144|FG000|Overall Study|Adverse Event|1|||
163010071|NCT01379768|588740145|FG001|Overall Study|Adverse Event|1|||
163010072|NCT01379768|588740146|FG002|Overall Study|Adverse Event|0|||
163010073|NCT01379768|588740144|FG000|Overall Study|Lost to Follow-up|2|||
163010074|NCT01379768|588740145|FG001|Overall Study|Lost to Follow-up|0|||
163010075|NCT01379768|588740146|FG002|Overall Study|Lost to Follow-up|0|||
163010076|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
163010077|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
163010078|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
163010079|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
163010080|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
163010081|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010082|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010083|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010084|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010085|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010086|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010087|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010088|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010089|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163061801|NCT00785629|588935025|FG003|Overall Study|Withdrawal by Subject|2|||
162640231|NCT02669433|587398139|FG000|Overall Study|Withdrawal by Subject|5|||
162640232|NCT02669433|587398140|FG001|Overall Study|Withdrawal by Subject|1|||
162640233|NCT02669433|587398141|FG002|Overall Study|Withdrawal by Subject|0|||
162640234|NCT02669433|587398139|FG000|Overall Study|Withdrawal by Caregiver|1|||
162640235|NCT02669433|587398140|FG001|Overall Study|Withdrawal by Caregiver|0|||
162640236|NCT02669433|587398141|FG002|Overall Study|Withdrawal by Caregiver|2|||
162640237|NCT02669433|587398139|FG000|Overall Study|Death|0|||
162640238|NCT02669433|587398140|FG001|Overall Study|Death|1|||
162640239|NCT02669433|587398141|FG002|Overall Study|Death|1|||
162640240|NCT00576927|587398142|FG000|Clinical Assessment|Lack of Efficacy|24|||
162640241|NCT00576927|587398142|FG000|Clinical Assessment|Death|1|||
162640242|NCT00576927|587398142|FG000|Clinical Assessment|Withdrawal by Subject|10|||
162640243|NCT00576927|587398142|FG000|Clinical Assessment|Physician Decision|1|||
162640244|NCT00576927|587398142|FG000|Baseline|Physician Decision|9|||
162640245|NCT00576927|587398142|FG000|Baseline|Medication Change by PCP of subject|1|||
162640246|NCT00576927|587398142|FG000|Baseline|Withdrawal by Subject|3|||
162640247|NCT00576927|587398142|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
162640248|NCT00576927|587398142|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
162640249|NCT00576927|587398142|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
162640250|NCT00576927|587398142|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
162640251|NCT00576927|587398142|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
162640252|NCT01850524|587398146|FG000|Overall Study|Lost to Follow-up|5|||
162640253|NCT01850524|587398147|FG001|Overall Study|Lost to Follow-up|10|||
162715943|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162640254|NCT01850524|587398146|FG000|Overall Study|Withdrawal by Subject|24|||
162640255|NCT01850524|587398147|FG001|Overall Study|Withdrawal by Subject|22|||
162640256|NCT01850524|587398146|FG000|Overall Study|Reason not Specified|142|||
162640257|NCT01850524|587398147|FG001|Overall Study|Reason not Specified|141|||
162640258|NCT02157298|587398148|FG000|Overall Study|Adverse Event|1|||
162640259|NCT02157298|587398149|FG001|Overall Study|Adverse Event|0|||
162640260|NCT02157298|587398148|FG000|Overall Study|Subject no longer meets study criteria|1|||
162640261|NCT02157298|587398149|FG001|Overall Study|Subject no longer meets study criteria|2|||
162640262|NCT02157298|587398148|FG000|Overall Study|Poor/Non-compliance|1|||
162640263|NCT02157298|587398149|FG001|Overall Study|Poor/Non-compliance|0|||
162640264|NCT02157298|587398148|FG000|Overall Study|Withdrawal by Subject|1|||
162640265|NCT02157298|587398149|FG001|Overall Study|Withdrawal by Subject|0|||
162640266|NCT04059094|587398150|FG000|Overall Study|Adverse Event|0|||
162640267|NCT04059094|587398151|FG001|Overall Study|Adverse Event|0|||
162640268|NCT04059094|587398152|FG002|Overall Study|Adverse Event|0|||
162640269|NCT04059094|587398153|FG003|Overall Study|Adverse Event|0|||
162640270|NCT04059094|587398154|FG004|Overall Study|Adverse Event|1|||
162640271|NCT04059094|587398150|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162640272|NCT04059094|587398151|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
162640273|NCT04059094|587398152|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162640274|NCT04059094|587398153|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162640275|NCT04059094|587398154|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162640276|NCT01698801|587398159|FG000|Treatment Phase|Adverse Event|4|||
162640277|NCT01698801|587398159|FG000|Treatment Phase|Protocol Violation|1|||
162640278|NCT01698801|587398159|FG000|Treatment Phase|Other|4|||
162640279|NCT01698801|587398159|FG000|Treatment Phase|Withdrawal by Subject|1|||
162640280|NCT01698801|587398159|FG000|Treatment Phase|Disease progression|1|||
162640281|NCT01698801|587398159|FG000|Follow Up Phase|Withdrawal by Subject|1|||
162640282|NCT01698801|587398159|FG000|Follow Up Phase|Death|4|||
162640283|NCT00656474|587398160|FG000|Overall Study|Other Reason|1|||
162640284|NCT02062879|587398161|FG000|Overall Study|Withdrawal by Subject|4|||
162640285|NCT02062879|587398162|FG001|Overall Study|Withdrawal by Subject|1|||
163010090|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
163010091|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
163010092|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
163010093|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
163010094|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
163010095|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
163010096|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010097|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010098|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010099|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010100|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010101|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010102|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010103|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010104|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010105|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
163010106|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
163010107|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
163010108|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
163010109|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
163061802|NCT02020941|588935028|FG000|Overall Study|Adverse Event|1|||
162640286|NCT00665847|587398166|FG000|Overall Study|Adverse Event|8|||
162640287|NCT00665847|587398166|FG000|Overall Study|Withdrawal by Subject|2|||
162640288|NCT00665847|587398166|FG000|Overall Study|Subject non-compliant|8|||
162640289|NCT00665847|587398166|FG000|Overall Study|Subject reached a virologic endpoint|4|||
162640290|NCT00665847|587398166|FG000|Overall Study|Resistance to TMC125|1|||
162640291|NCT00665847|587398166|FG000|Overall Study|Subject ineligible to continue the trial|1|||
162640292|NCT00665847|587398166|FG000|Overall Study|Switch to Commercial Medication|1|||
162640293|NCT01786629|587399836|FG000|Overall Study|Lack of Efficacy|0|||
162640294|NCT01786629|587399837|FG001|Overall Study|Lack of Efficacy|4|||
162640295|NCT01786629|587399836|FG000|Overall Study|Adverse Event|0|||
162640296|NCT01786629|587399837|FG001|Overall Study|Adverse Event|1|||
162640297|NCT00180414|587399838|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
162640298|NCT00180414|587399839|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
162640299|NCT00623727|587399840|FG000|Double Blind (DB)|Adverse Event|1|||
162640300|NCT00623727|587399841|FG001|Double Blind (DB)|Adverse Event|3|||
162640301|NCT00623727|587399840|FG000|Double Blind (DB)|Physician Decision|0|||
162640302|NCT00623727|587399841|FG001|Double Blind (DB)|Physician Decision|1|||
162640303|NCT00623727|587399840|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
162640304|NCT00623727|587399841|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
162640305|NCT00623727|587399840|FG000|Double Blind (DB)|Lack of Efficacy|2|||
162640306|NCT00623727|587399841|FG001|Double Blind (DB)|Lack of Efficacy|2|||
162640307|NCT00623727|587399840|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
162640308|NCT00623727|587399841|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
162640309|NCT00623727|587399840|FG000|Double Blind (DB)|Lost to Follow-up|1|||
162640310|NCT00623727|587399841|FG001|Double Blind (DB)|Lost to Follow-up|1|||
162640311|NCT00623727|587399840|FG000|Double Blind (DB)|Protocol Violation|2|||
162640312|NCT00623727|587399841|FG001|Double Blind (DB)|Protocol Violation|2|||
162924943|NCT00203892|588427321|FG002|Overall Study|Physician Decision|0|||
162924944|NCT00203892|588427319|FG000|Overall Study|Death|1|||
162924945|NCT00203892|588427320|FG001|Overall Study|Death|0|||
162924946|NCT00203892|588427321|FG002|Overall Study|Death|0|||
162924947|NCT03829462|588427325|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
162924948|NCT03829462|588427326|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
162924949|NCT03829462|588427325|FG000|Overall Study|No treatment due to progression disease|0|||
162924950|NCT03829462|588427326|FG001|Overall Study|No treatment due to progression disease|1|||
162924951|NCT02341482|588427327|FG000|Overall Study|Adverse Event|1|||
162924952|NCT03000075|588427331|FG000|Part A|Adverse Event|4|||
162924953|NCT03000075|588427332|FG001|Part A|Adverse Event|0|||
162924954|NCT03000075|588427333|FG002|Part A|Adverse Event|0|||
162924955|NCT03000075|588427334|FG003|Part A|Adverse Event|0|||
162924956|NCT03000075|588427335|FG004|Part A|Adverse Event|0|||
162924957|NCT03000075|588427336|FG005|Part A|Adverse Event|0|||
162924958|NCT03000075|588427337|FG006|Part A|Adverse Event|0|||
162924959|NCT03000075|588427331|FG000|Part B|Not dosed due to AE|0|||
162924960|NCT03000075|588427332|FG001|Part B|Not dosed due to AE|0|||
162924961|NCT03000075|588427333|FG002|Part B|Not dosed due to AE|0|||
162924962|NCT03000075|588427334|FG003|Part B|Not dosed due to AE|0|||
162924963|NCT03000075|588427335|FG004|Part B|Not dosed due to AE|0|||
162924964|NCT03000075|588427336|FG005|Part B|Not dosed due to AE|2|||
162924965|NCT03000075|588427337|FG006|Part B|Not dosed due to AE|1|||
162924966|NCT03000075|588427331|FG000|Part B|Adverse Event|0|||
162924967|NCT03000075|588427332|FG001|Part B|Adverse Event|0|||
162924968|NCT03000075|588427333|FG002|Part B|Adverse Event|0|||
162924969|NCT03000075|588427334|FG003|Part B|Adverse Event|0|||
162924970|NCT03000075|588427335|FG004|Part B|Adverse Event|1|||
162924971|NCT03000075|588427336|FG005|Part B|Adverse Event|0|||
162924972|NCT03000075|588427337|FG006|Part B|Adverse Event|0|||
162924973|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
162924974|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
162924975|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Death|5|||
162924976|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Death|2|||
162924977|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
162924978|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
162924979|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
162924980|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
162924981|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
162924982|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
162924983|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Relapse|1|||
162924984|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Relapse|0|||
162924985|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
162924986|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
162924987|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
162924988|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
162924989|NCT00111007|588427338|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
162924990|NCT00111007|588427339|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
162924991|NCT00111007|588427338|FG000|Active Follow-up|Adverse Event|1|||
162924992|NCT00111007|588427339|FG001|Active Follow-up|Adverse Event|0|||
162924993|NCT00111007|588427338|FG000|Active Follow-up|Death|2|||
162924994|NCT00111007|588427339|FG001|Active Follow-up|Death|0|||
162924995|NCT00111007|588427338|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
162924996|NCT00111007|588427339|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
162924997|NCT00111007|588427338|FG000|Long Term Follow-up|Death|34|||
162924998|NCT00111007|588427339|FG001|Long Term Follow-up|Death|39|||
162924999|NCT00111007|588427338|FG000|Long Term Follow-up|Lost to Follow-up|1|||
162925000|NCT00111007|588427339|FG001|Long Term Follow-up|Lost to Follow-up|1|||
162925001|NCT00111007|588427338|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
162925002|NCT00111007|588427339|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
162925003|NCT00111007|588427338|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
162925004|NCT00111007|588427339|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
162925005|NCT00111007|588427338|FG000|Long Term Follow-up|Missing|10|||
162925006|NCT00111007|588427339|FG001|Long Term Follow-up|Missing|3|||
162925007|NCT01495793|588427340|FG000|Overall Study|Lost to Follow-up|1|||
162925008|NCT01495793|588427340|FG000|Overall Study|Violation of inclusion criteria|1|||
162925009|NCT03332212|588427341|FG000|Overall Study|Not treated|0|||
163061803|NCT02020941|588935028|FG000|Overall Study|Physician Decision|2|||
162925010|NCT03332212|588427342|FG001|Overall Study|Not treated|1|||
163010110|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
163010111|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010112|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010113|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010114|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010115|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010116|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010117|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010118|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010119|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010120|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
163010121|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
163010122|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
163010123|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
163010124|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
163010125|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
163010126|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010127|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010128|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010129|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010130|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010131|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010132|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010133|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010134|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010135|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
163010136|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
163010137|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010138|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
163010139|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
163010140|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
163010141|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010142|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010143|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010144|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010145|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010146|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010147|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010148|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010149|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010150|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
163010151|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010152|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010153|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010154|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
163010155|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010156|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010157|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010158|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010159|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010160|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010161|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010162|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010163|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010164|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010165|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
163010166|NCT03334435|588740151|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010167|NCT03334435|588740152|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
163010168|NCT03334435|588740153|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
163010169|NCT03334435|588740154|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
163010170|NCT03334435|588740155|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
163010171|NCT03334435|588740156|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010172|NCT03334435|588740157|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010173|NCT03334435|588740158|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010174|NCT03334435|588740159|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010175|NCT03334435|588740160|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010176|NCT03334435|588740161|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010177|NCT03334435|588740162|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010178|NCT03334435|588740163|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010179|NCT03334435|588740164|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010180|NCT03334435|588740165|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
163010181|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010182|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010183|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010184|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010185|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
163010186|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010187|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
163010188|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010189|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
163010190|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
163010191|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
163010192|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
163010193|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
163010194|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
163010195|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
163010196|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010197|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010198|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010199|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010200|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
163010201|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
163010202|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
163010203|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
163010204|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
163010205|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
163010206|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
163010207|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
163010208|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
163010209|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
163010210|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
163010211|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010212|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010213|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010214|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010215|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
163010216|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
163010217|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
163010218|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
163010219|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
163010220|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
163010221|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
163010222|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
163010223|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
162640313|NCT00623727|587399840|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
162640314|NCT00623727|587399841|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
162640315|NCT00623727|587399840|FG000|Open Label Follow-up|Study termination|0|||
162640316|NCT00623727|587399841|FG001|Open Label Follow-up|Study termination|6|||
162640317|NCT00623727|587399840|FG000|Open Label Follow-up|Participant convenience|0|||
163010224|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
163010225|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
163010226|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010227|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
162640318|NCT00623727|587399841|FG001|Open Label Follow-up|Participant convenience|1|||
163010228|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010229|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010230|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
163010231|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
163010232|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
163010233|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010234|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010235|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
163010236|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
163010237|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
163010238|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
163010239|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
163010240|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
163010241|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010242|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010243|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010244|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010245|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010246|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010247|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
163010248|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
163010249|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
163010250|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010251|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010252|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
163010253|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
163010254|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
163010255|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
163010256|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010257|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010258|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010259|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010260|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010261|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010262|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010263|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010264|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010265|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010266|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010267|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
163010268|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010269|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
163010270|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
163010271|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010272|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010273|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
162640319|NCT01852942|587399842|FG000|Overall Study|Physician Decision|1|||
163010274|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010275|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010276|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
163010277|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010278|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
162640320|NCT01852942|587399843|FG001|Overall Study|Physician Decision|0|||
162640321|NCT01852942|587399842|FG000|Overall Study|Death|1|||
162640322|NCT01852942|587399843|FG001|Overall Study|Death|1|||
162640323|NCT01852942|587399842|FG000|Overall Study|Withdrawal by Subject|2|||
163010279|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010280|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
162640324|NCT01852942|587399843|FG001|Overall Study|Withdrawal by Subject|3|||
162640325|NCT01852942|587399842|FG000|Overall Study|Lost to Follow-up|1|||
163010281|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
163061804|NCT02020941|588935028|FG000|Overall Study|Withdrawal by Subject|1|||
163061805|NCT02020941|588935028|FG000|Overall Study|Disease Progression|4|||
163061806|NCT02107898|588935031|FG000|Overall Study|Adverse Event|4|||
162640326|NCT01852942|587399843|FG001|Overall Study|Lost to Follow-up|2|||
163010282|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010283|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010284|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
163010285|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
163010286|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010287|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010288|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010289|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010290|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010291|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010292|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010293|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010294|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010295|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
163010296|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010297|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
163010298|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010299|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010300|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
163010301|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010302|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010303|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010304|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010305|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010306|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010307|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010308|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010309|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010310|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010311|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
163010312|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010313|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
163010314|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
163010315|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
163010316|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010317|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010318|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010319|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010320|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010321|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010322|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010323|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010324|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010325|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010326|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010327|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010328|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010329|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
163010330|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
163010331|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010332|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010333|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010334|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010335|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010336|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010337|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010338|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010339|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163061807|NCT02107898|588935032|FG001|Overall Study|Adverse Event|7|||
162640327|NCT00696696|587399847|FG000|Overall Study|Adverse Event|5|||
162640328|NCT00696696|587399847|FG000|Overall Study|Withdrawal by Subject|8|||
162640329|NCT00696696|587399847|FG000|Overall Study|Physician Decision|2|||
162640330|NCT00696696|587399847|FG000|Overall Study|Death|3|||
162640331|NCT02642614|587399848|FG000|Overall Study|Adverse Event|1|||
162925011|NCT03332212|588427343|FG002|Overall Study|Not treated|0|||
162925012|NCT03332212|588427344|FG003|Overall Study|Not treated|0|||
162925013|NCT03332212|588427341|FG000|Overall Study|Adverse Event|0|||
162925014|NCT03332212|588427342|FG001|Overall Study|Adverse Event|0|||
162925015|NCT03332212|588427343|FG002|Overall Study|Adverse Event|0|||
162925016|NCT03332212|588427344|FG003|Overall Study|Adverse Event|1|||
162925017|NCT03332212|588427341|FG000|Overall Study|worsening of disease under study|1|||
162925018|NCT03332212|588427342|FG001|Overall Study|worsening of disease under study|1|||
162925019|NCT03332212|588427343|FG002|Overall Study|worsening of disease under study|0|||
162925020|NCT03332212|588427344|FG003|Overall Study|worsening of disease under study|0|||
162925021|NCT02362646|588427345|FG000|Overall Study|Death|15|||
162925022|NCT02362646|588427346|FG001|Overall Study|Death|8|||
162925023|NCT02362646|588427345|FG000|Overall Study|Withdrawal by Subject|2|||
162925024|NCT02362646|588427346|FG001|Overall Study|Withdrawal by Subject|2|||
162925025|NCT02362646|588427345|FG000|Overall Study|received transplant|21|||
162925026|NCT02362646|588427346|FG001|Overall Study|received transplant|14|||
162925027|NCT00929864|588427350|FG000|Overall Study|Death|1|||
162925028|NCT00929864|588427351|FG001|Overall Study|Death|1|||
162925029|NCT00929864|588427350|FG000|Overall Study|Adverse Event|11|||
162925030|NCT00929864|588427351|FG001|Overall Study|Adverse Event|30|||
162925031|NCT00929864|588427350|FG000|Overall Study|Lack of Efficacy|19|||
162925032|NCT00929864|588427351|FG001|Overall Study|Lack of Efficacy|16|||
162925033|NCT00929864|588427350|FG000|Overall Study|Lost to Follow-up|7|||
162925034|NCT00929864|588427351|FG001|Overall Study|Lost to Follow-up|12|||
162925035|NCT00929864|588427350|FG000|Overall Study|Withdrawal by Subject|20|||
162925036|NCT00929864|588427351|FG001|Overall Study|Withdrawal by Subject|9|||
162925037|NCT00929864|588427350|FG000|Overall Study|No longer met criteria|2|||
162925038|NCT00929864|588427351|FG001|Overall Study|No longer met criteria|1|||
162925039|NCT00929864|588427350|FG000|Overall Study|Poor or non-compliance|3|||
162925040|NCT00929864|588427351|FG001|Overall Study|Poor or non-compliance|3|||
162925041|NCT00929864|588427350|FG000|Overall Study|Pregnancy|0|||
162925042|NCT00929864|588427351|FG001|Overall Study|Pregnancy|3|||
162925043|NCT00929864|588427350|FG000|Overall Study|Administrative reason by Sponsor|1|||
162925044|NCT00929864|588427351|FG001|Overall Study|Administrative reason by Sponsor|1|||
162925045|NCT00929864|588427350|FG000|Overall Study|Non-specified|2|||
162925046|NCT00929864|588427351|FG001|Overall Study|Non-specified|7|||
162925047|NCT03940742|588427352|FG000|Overall Study|Lost to Follow-up|0|||
162925048|NCT03940742|588427353|FG001|Overall Study|Lost to Follow-up|0|||
162925049|NCT03940742|588427354|FG002|Overall Study|Lost to Follow-up|0|||
162925050|NCT03940742|588427355|FG003|Overall Study|Lost to Follow-up|1|||
162925051|NCT03428217|588427357|FG000|Overall Study|Death|89|||
162925052|NCT03428217|588427358|FG001|Overall Study|Death|93|||
162925053|NCT03428217|588427357|FG000|Overall Study|Withdrawal by Subject|8|||
162925054|NCT03428217|588427358|FG001|Overall Study|Withdrawal by Subject|7|||
162925055|NCT03428217|588427357|FG000|Overall Study|Lost to Follow-up|1|||
162925056|NCT03428217|588427358|FG001|Overall Study|Lost to Follow-up|3|||
162925057|NCT03428217|588427357|FG000|Overall Study|Study terminated by sponsor|124|||
162925058|NCT03428217|588427358|FG001|Overall Study|Study terminated by sponsor|118|||
162925059|NCT03428217|588427357|FG000|Overall Study|Other, Not Specified|1|||
162925060|NCT03428217|588427358|FG001|Overall Study|Other, Not Specified|0|||
162925061|NCT00905437|588427359|FG000|Overall Study|Adverse Event|3|||
162925062|NCT00905437|588427360|FG001|Overall Study|Adverse Event|2|||
162925063|NCT00905437|588427359|FG000|Overall Study|Lost to Follow-up|0|||
162925064|NCT00905437|588427360|FG001|Overall Study|Lost to Follow-up|1|||
162925065|NCT00905437|588427359|FG000|Overall Study|Withdrawal by Subject|0|||
162925066|NCT00905437|588427360|FG001|Overall Study|Withdrawal by Subject|1|||
162925067|NCT00905437|588427359|FG000|Overall Study|Other|5|||
162925068|NCT00905437|588427360|FG001|Overall Study|Other|6|||
162925069|NCT05246111|588427361|FG000|Period 01|NOT ELIGIBLE IC5|1|||
162925070|NCT05246111|588427362|FG001|Period 01|NOT ELIGIBLE IC5|0|||
162925071|NCT01306968|588427365|FG000|Overall Study|Lost to Follow-up|1|||
162925072|NCT01306968|588427366|FG001|Overall Study|Lost to Follow-up|1|||
162925073|NCT01306968|588427367|FG002|Overall Study|Lost to Follow-up|0|||
162925074|NCT01306968|588427368|FG003|Overall Study|Lost to Follow-up|0|||
162925075|NCT01306968|588427365|FG000|Overall Study|Physician Decision|0|||
162925076|NCT01306968|588427366|FG001|Overall Study|Physician Decision|1|||
162925077|NCT01306968|588427367|FG002|Overall Study|Physician Decision|0|||
162925078|NCT01306968|588427368|FG003|Overall Study|Physician Decision|0|||
162925079|NCT01306968|588427365|FG000|Overall Study|Relocated and left active duty|0|||
162925080|NCT01306968|588427366|FG001|Overall Study|Relocated and left active duty|1|||
162925081|NCT01306968|588427367|FG002|Overall Study|Relocated and left active duty|1|||
162925082|NCT01306968|588427368|FG003|Overall Study|Relocated and left active duty|1|||
162925083|NCT01306968|588427365|FG000|Overall Study|Withdrew - time commitment|0|||
162925084|NCT01306968|588427366|FG001|Overall Study|Withdrew - time commitment|0|||
162925085|NCT01306968|588427367|FG002|Overall Study|Withdrew - time commitment|0|||
162925086|NCT01306968|588427368|FG003|Overall Study|Withdrew - time commitment|2|||
162925087|NCT01306968|588427365|FG000|Overall Study|Withdrew over privacy concerns|0|||
163010340|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010341|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010342|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
163010343|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
163010344|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010345|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
163010346|NCT03334435|588740151|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010347|NCT03334435|588740152|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010348|NCT03334435|588740153|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010349|NCT03334435|588740154|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010350|NCT03334435|588740155|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010351|NCT03334435|588740156|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010352|NCT03334435|588740157|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010353|NCT03334435|588740158|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010354|NCT03334435|588740159|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010355|NCT03334435|588740160|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010356|NCT03334435|588740161|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010357|NCT03334435|588740162|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010358|NCT03334435|588740163|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
163010359|NCT03334435|588740164|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010360|NCT03334435|588740165|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
163010361|NCT03922321|588740166|FG000|Overall Study|Participant Moved|1|||
163010362|NCT03922321|588740166|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
163010363|NCT02342678|588740170|FG000|Overall Study|Lost to Follow-up|0|||
163010364|NCT02342678|588740171|FG001|Overall Study|Lost to Follow-up|1|||
163010365|NCT02342678|588740170|FG000|Overall Study|Too busy to complete study|0|||
163010366|NCT02342678|588740171|FG001|Overall Study|Too busy to complete study|2|||
163010367|NCT02342678|588740170|FG000|Overall Study|Family illness/emergency|0|||
163010368|NCT02342678|588740171|FG001|Overall Study|Family illness/emergency|1|||
163010369|NCT02342678|588740170|FG000|Overall Study|Illness/medical reason|1|||
163061808|NCT02107898|588935031|FG000|Overall Study|Poor compliance to protocol|0|||
163061809|NCT02107898|588935032|FG001|Overall Study|Poor compliance to protocol|1|||
163061810|NCT02107898|588935031|FG000|Overall Study|Participant moved|0|||
163061811|NCT02107898|588935032|FG001|Overall Study|Participant moved|2|||
163061812|NCT02107898|588935031|FG000|Overall Study|Consent withdrawn by participant|2|||
163061813|NCT02107898|588935032|FG001|Overall Study|Consent withdrawn by participant|1|||
163061814|NCT02107898|588935031|FG000|Overall Study|Randomized but not treated|0|||
163061815|NCT02107898|588935032|FG001|Overall Study|Randomized but not treated|1|||
163061816|NCT03329989|588935033|FG000|Overall Study|Withdrawal by Subject|9|||
163061817|NCT03329989|588935033|FG000|Overall Study|Lost to Follow-up|8|||
163061818|NCT03329989|588935033|FG000|Overall Study|Adverse Event|5|||
163061819|NCT03329989|588935033|FG000|Overall Study|Protocol Violation|1|||
163061820|NCT01283386|588935034|FG000|Overall Study|Death|2|||
163061821|NCT01283386|588935035|FG001|Overall Study|Death|0|||
163061822|NCT01283386|588935034|FG000|Overall Study|Withdrawal by Subject|2|||
163061823|NCT01283386|588935035|FG001|Overall Study|Withdrawal by Subject|1|||
163061824|NCT01283386|588935034|FG000|Overall Study|Relapse of underlying disease|1|||
163061825|NCT01283386|588935035|FG001|Overall Study|Relapse of underlying disease|3|||
163061826|NCT01283386|588935034|FG000|Overall Study|Progression of underlying disease|2|||
163061827|NCT01283386|588935035|FG001|Overall Study|Progression of underlying disease|7|||
163061828|NCT01283386|588935034|FG000|Overall Study|Reason not specified|1|||
163061829|NCT01283386|588935035|FG001|Overall Study|Reason not specified|0|||
163061830|NCT01283386|588935034|FG000|Overall Study|Protocol Violation|0|||
163061831|NCT01283386|588935035|FG001|Overall Study|Protocol Violation|1|||
163061832|NCT02469857|588935036|FG000|Overall Study|Death|24|||
163061833|NCT02469857|588935037|FG001|Overall Study|Death|29|||
163061834|NCT02469857|588935036|FG000|Overall Study|Discontinuation|1|||
163061835|NCT02469857|588935037|FG001|Overall Study|Discontinuation|3|||
163061836|NCT01137786|588935038|FG000|Overall Study|Lost to Follow-up|0|||
163061837|NCT01137786|588935039|FG001|Overall Study|Lost to Follow-up|2|||
163061838|NCT01137786|588935038|FG000|Overall Study|Withdrawal by Subject|1|||
163010370|NCT02342678|588740171|FG001|Overall Study|Illness/medical reason|1|||
163010371|NCT00460603|588740172|FG000|Phase 1|Death|1|||
163010372|NCT00460603|588740173|FG001|Phase 1|Death|0|||
163061839|NCT01137786|588935039|FG001|Overall Study|Withdrawal by Subject|1|||
163061840|NCT01531153|588935040|FG000|Overall Study|Withdrawal by Subject|10|||
163061841|NCT01531153|588935041|FG001|Overall Study|Withdrawal by Subject|9|||
163061842|NCT01531153|588935042|FG002|Overall Study|Withdrawal by Subject|15|||
163061843|NCT03416179|588935043|FG000|Overall Study|Death|90|||
163061844|NCT03416179|588935044|FG001|Overall Study|Death|87|||
163061845|NCT03416179|588935045|FG002|Overall Study|Death|117|||
163061846|NCT03416179|588935046|FG003|Overall Study|Death|113|||
163061847|NCT03416179|588935043|FG000|Overall Study|Withdrawal by Subject|15|||
163061848|NCT03416179|588935044|FG001|Overall Study|Withdrawal by Subject|20|||
163061849|NCT03416179|588935045|FG002|Overall Study|Withdrawal by Subject|6|||
163061850|NCT03416179|588935046|FG003|Overall Study|Withdrawal by Subject|9|||
163061851|NCT03416179|588935043|FG000|Overall Study|Lost to Follow-up|1|||
163061852|NCT03416179|588935044|FG001|Overall Study|Lost to Follow-up|1|||
163061853|NCT03416179|588935045|FG002|Overall Study|Lost to Follow-up|0|||
163061854|NCT03416179|588935046|FG003|Overall Study|Lost to Follow-up|3|||
163061855|NCT03416179|588935043|FG000|Overall Study|Study participation terminated by Sponsor|93|||
163061856|NCT03416179|588935044|FG001|Overall Study|Study participation terminated by Sponsor|91|||
163061857|NCT03416179|588935045|FG002|Overall Study|Study participation terminated by Sponsor|26|||
163061858|NCT03416179|588935046|FG003|Overall Study|Study participation terminated by Sponsor|31|||
163061859|NCT03416179|588935043|FG000|Overall Study|Other|2|||
163061860|NCT03416179|588935044|FG001|Overall Study|Other|3|||
163061861|NCT03416179|588935045|FG002|Overall Study|Other|1|||
163061862|NCT03416179|588935046|FG003|Overall Study|Other|0|||
163061863|NCT00879658|588935047|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163061864|NCT00879658|588935048|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163061865|NCT00879658|588935049|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163061866|NCT00879658|588935050|FG003|Overall Study|Abnormal laboratory value(s)|1|||
163061867|NCT00879658|588935051|FG004|Overall Study|Abnormal laboratory value(s)|0|||
163061868|NCT00879658|588935052|FG005|Overall Study|Abnormal laboratory value(s)|0|||
163061869|NCT00879658|588935053|FG006|Overall Study|Abnormal laboratory value(s)|0|||
163061870|NCT00879658|588935047|FG000|Overall Study|Administrative problems|2|||
163061871|NCT00879658|588935048|FG001|Overall Study|Administrative problems|1|||
163061872|NCT00879658|588935049|FG002|Overall Study|Administrative problems|0|||
163061873|NCT00879658|588935050|FG003|Overall Study|Administrative problems|1|||
163061874|NCT00879658|588935051|FG004|Overall Study|Administrative problems|0|||
163061875|NCT00879658|588935052|FG005|Overall Study|Administrative problems|0|||
163061876|NCT00879658|588935053|FG006|Overall Study|Administrative problems|0|||
163061877|NCT00879658|588935047|FG000|Overall Study|Adverse Event|6|||
163061878|NCT00879658|588935048|FG001|Overall Study|Adverse Event|4|||
163061879|NCT00879658|588935049|FG002|Overall Study|Adverse Event|3|||
163061880|NCT00879658|588935050|FG003|Overall Study|Adverse Event|1|||
163061881|NCT00879658|588935051|FG004|Overall Study|Adverse Event|2|||
163061882|NCT00879658|588935052|FG005|Overall Study|Adverse Event|0|||
163061883|NCT00879658|588935053|FG006|Overall Study|Adverse Event|0|||
163061884|NCT00879658|588935047|FG000|Overall Study|Protocol Violation|1|||
163061885|NCT00879658|588935048|FG001|Overall Study|Protocol Violation|0|||
163061886|NCT00879658|588935049|FG002|Overall Study|Protocol Violation|0|||
163061887|NCT00879658|588935050|FG003|Overall Study|Protocol Violation|0|||
163061888|NCT00879658|588935051|FG004|Overall Study|Protocol Violation|0|||
163061889|NCT00879658|588935052|FG005|Overall Study|Protocol Violation|0|||
163061890|NCT00879658|588935053|FG006|Overall Study|Protocol Violation|0|||
163061891|NCT00879658|588935047|FG000|Overall Study|Withdrawal by Subject|3|||
163061892|NCT00879658|588935048|FG001|Overall Study|Withdrawal by Subject|0|||
163061893|NCT00879658|588935049|FG002|Overall Study|Withdrawal by Subject|2|||
163061894|NCT00879658|588935050|FG003|Overall Study|Withdrawal by Subject|0|||
163061895|NCT00879658|588935051|FG004|Overall Study|Withdrawal by Subject|0|||
163061896|NCT00879658|588935052|FG005|Overall Study|Withdrawal by Subject|1|||
163061897|NCT00879658|588935053|FG006|Overall Study|Withdrawal by Subject|0|||
163061898|NCT00879658|588935047|FG000|Overall Study|Lack of Efficacy|0|||
163061899|NCT00879658|588935048|FG001|Overall Study|Lack of Efficacy|0|||
163061900|NCT00879658|588935049|FG002|Overall Study|Lack of Efficacy|2|||
163061901|NCT00879658|588935050|FG003|Overall Study|Lack of Efficacy|0|||
163061902|NCT00879658|588935051|FG004|Overall Study|Lack of Efficacy|0|||
163061903|NCT00879658|588935052|FG005|Overall Study|Lack of Efficacy|0|||
163061904|NCT00879658|588935053|FG006|Overall Study|Lack of Efficacy|0|||
162640332|NCT02642614|587399849|FG001|Overall Study|Adverse Event|1|||
162640333|NCT02642614|587399850|FG002|Overall Study|Adverse Event|2|||
163061905|NCT00879658|588935047|FG000|Overall Study|misrandomized (never received study med)|0|||
163061906|NCT00879658|588935048|FG001|Overall Study|misrandomized (never received study med)|0|||
163061907|NCT00879658|588935049|FG002|Overall Study|misrandomized (never received study med)|0|||
163061908|NCT00879658|588935050|FG003|Overall Study|misrandomized (never received study med)|1|||
163061909|NCT00879658|588935051|FG004|Overall Study|misrandomized (never received study med)|0|||
163061910|NCT00879658|588935052|FG005|Overall Study|misrandomized (never received study med)|0|||
163061911|NCT00879658|588935053|FG006|Overall Study|misrandomized (never received study med)|0|||
163061912|NCT00157755|588935055|FG000|Overall Study|Death|2|||
163061913|NCT00157755|588935056|FG001|Overall Study|Death|3|||
163061914|NCT00157755|588935057|FG002|Overall Study|Death|3|||
163061915|NCT00157755|588935058|FG003|Overall Study|Death|2|||
163061916|NCT00157755|588935059|FG004|Overall Study|Death|0|||
163061917|NCT00157755|588935060|FG005|Overall Study|Death|0|||
163061918|NCT00157755|588935055|FG000|Overall Study|Lost to Follow-up|0|||
162640334|NCT02642614|587399851|FG003|Overall Study|Adverse Event|2|||
163061919|NCT00157755|588935056|FG001|Overall Study|Lost to Follow-up|0|||
163061920|NCT00157755|588935057|FG002|Overall Study|Lost to Follow-up|1|||
162640335|NCT02642614|587399848|FG000|Overall Study|Lost to Follow-up|1|||
162640336|NCT02642614|587399849|FG001|Overall Study|Lost to Follow-up|0|||
162640337|NCT02642614|587399850|FG002|Overall Study|Lost to Follow-up|0|||
162640338|NCT02642614|587399851|FG003|Overall Study|Lost to Follow-up|0|||
162640339|NCT02642614|587399848|FG000|Overall Study|Withdrawal by Subject|1|||
162640340|NCT02642614|587399849|FG001|Overall Study|Withdrawal by Subject|1|||
162640341|NCT02642614|587399850|FG002|Overall Study|Withdrawal by Subject|0|||
162640342|NCT02642614|587399851|FG003|Overall Study|Withdrawal by Subject|0|||
162640343|NCT04708886|587399857|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
162640344|NCT04708886|587399857|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
162640345|NCT00936910|587399858|FG000|Overall Study|Lack of Efficacy|3|||
162640346|NCT01729754|587399859|FG000|Part 1|Adverse Event|2|||
162640347|NCT01729754|587399860|FG001|Part 1|Adverse Event|0|||
162640348|NCT01729754|587399861|FG002|Part 1|Adverse Event|0|||
162640349|NCT01729754|587399862|FG003|Part 1|Adverse Event|1|||
162715944|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162715945|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162925088|NCT01306968|588427366|FG001|Overall Study|Withdrew over privacy concerns|0|||
162925089|NCT01306968|588427367|FG002|Overall Study|Withdrew over privacy concerns|0|||
162925090|NCT01306968|588427368|FG003|Overall Study|Withdrew over privacy concerns|1|||
162925091|NCT02736695|588427369|FG000|Overall Study|Ineligible|6|||
162925092|NCT02736695|588427370|FG001|Overall Study|Ineligible|0|||
162925093|NCT01329562|588427373|FG000|Overall Study|Protocol Violation|5|||
162925094|NCT01329562|588427374|FG001|Overall Study|Protocol Violation|3|||
162925095|NCT01329562|588427373|FG000|Overall Study|Lost to Follow-up|1|||
162925096|NCT01329562|588427374|FG001|Overall Study|Lost to Follow-up|1|||
162925097|NCT01329562|588427373|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
162925098|NCT01329562|588427374|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
162925099|NCT01329562|588427373|FG000|Overall Study|Physician Decision|0|||
162925100|NCT01329562|588427374|FG001|Overall Study|Physician Decision|1|||
162925101|NCT03252015|588427375|FG000|Overall Study|Withdrawal by Subject|0|||
162925102|NCT03252015|588427376|FG001|Overall Study|Withdrawal by Subject|1|||
162925103|NCT03252015|588427377|FG002|Overall Study|Withdrawal by Subject|1|||
162925104|NCT03252015|588427378|FG003|Overall Study|Withdrawal by Subject|0|||
162925105|NCT03252015|588427375|FG000|Overall Study|Adverse Event|1|||
162925106|NCT03252015|588427376|FG001|Overall Study|Adverse Event|0|||
162925107|NCT03252015|588427377|FG002|Overall Study|Adverse Event|0|||
162925108|NCT03252015|588427378|FG003|Overall Study|Adverse Event|1|||
162925109|NCT00061568|588427379|FG000|Overall Study|Lost to Follow-up|12|||
162925110|NCT00061568|588427380|FG001|Overall Study|Lost to Follow-up|0|||
162925111|NCT00061568|588427379|FG000|Overall Study|Death|6|||
162925112|NCT00061568|588427380|FG001|Overall Study|Death|0|||
162925113|NCT00061568|588427379|FG000|Overall Study|Withdrawal by Subject|1|||
162925114|NCT00061568|588427380|FG001|Overall Study|Withdrawal by Subject|0|||
162925115|NCT01381068|588427381|FG000|Overall Study|Death|1|||
162925116|NCT01381068|588427382|FG001|Overall Study|Death|0|||
162925117|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
162925118|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
162925119|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
162925120|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
162925121|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
162925122|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
162925123|NCT01907516|588427387|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
162925124|NCT01907516|588427388|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
162925125|NCT00975000|588427392|FG000|Overall Study|Other|1|||
162925126|NCT00975000|588427393|FG001|Overall Study|Other|0|||
162925127|NCT00975000|588427392|FG000|Overall Study|Adverse Event|1|||
162925128|NCT00975000|588427393|FG001|Overall Study|Adverse Event|1|||
162925129|NCT00975000|588427392|FG000|Overall Study|Withdrawal by Subject|2|||
162925130|NCT00975000|588427393|FG001|Overall Study|Withdrawal by Subject|2|||
162925131|NCT00975000|588427392|FG000|Overall Study|Lost to Follow-up|0|||
162925132|NCT00975000|588427393|FG001|Overall Study|Lost to Follow-up|1|||
162925133|NCT00975000|588427392|FG000|Overall Study|Protocol-specified Criteria|1|||
162925134|NCT00975000|588427393|FG001|Overall Study|Protocol-specified Criteria|0|||
162925135|NCT00975000|588427392|FG000|Overall Study|Non-compliance|0|||
162925136|NCT00975000|588427393|FG001|Overall Study|Non-compliance|1|||
162925137|NCT01126359|588427396|FG000|First Intervention (20-minutes)|Physician Decision|0|||
162640350|NCT01729754|587399863|FG004|Part 1|Adverse Event|0|||
162925138|NCT01126359|588427397|FG001|First Intervention (20-minutes)|Physician Decision|1|||
162925139|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
162925140|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
162925141|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
162925142|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
162925143|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
163010373|NCT00460603|588740174|FG002|Phase 1|Death|0|||
163010374|NCT00460603|588740175|FG003|Phase 1|Death|2|||
163010375|NCT00460603|588740176|FG004|Phase 1|Death|0|||
163010376|NCT00460603|588740177|FG005|Phase 1|Death|0|||
163010377|NCT00460603|588740178|FG006|Phase 1|Death|0|||
163010378|NCT00460603|588740179|FG007|Phase 1|Death|0|||
162640351|NCT01729754|587399864|FG005|Part 1|Adverse Event|0|||
162640352|NCT01729754|587399865|FG006|Part 1|Adverse Event|2|||
162640353|NCT01729754|587399866|FG007|Part 1|Adverse Event|0|||
162640354|NCT01729754|587399867|FG008|Part 1|Adverse Event|0|||
163010379|NCT00460603|588740180|FG008|Phase 1|Death|1|||
163010380|NCT00460603|588740181|FG009|Phase 1|Death|0|||
163010381|NCT00460603|588740182|FG010|Phase 1|Death|0|||
163010382|NCT00460603|588740183|FG011|Phase 1|Death|0|||
163010383|NCT00460603|588740172|FG000|Phase 1|Adverse Event|3|||
163010384|NCT00460603|588740173|FG001|Phase 1|Adverse Event|1|||
163010385|NCT00460603|588740174|FG002|Phase 1|Adverse Event|1|||
163010386|NCT00460603|588740175|FG003|Phase 1|Adverse Event|2|||
163010387|NCT00460603|588740176|FG004|Phase 1|Adverse Event|0|||
163010388|NCT00460603|588740177|FG005|Phase 1|Adverse Event|0|||
163010389|NCT00460603|588740178|FG006|Phase 1|Adverse Event|3|||
163010390|NCT00460603|588740179|FG007|Phase 1|Adverse Event|0|||
163010391|NCT00460603|588740180|FG008|Phase 1|Adverse Event|4|||
163010392|NCT00460603|588740181|FG009|Phase 1|Adverse Event|0|||
163010393|NCT00460603|588740182|FG010|Phase 1|Adverse Event|0|||
163010394|NCT00460603|588740183|FG011|Phase 1|Adverse Event|0|||
163061921|NCT00157755|588935058|FG003|Overall Study|Lost to Follow-up|0|||
162640355|NCT01729754|587399868|FG009|Part 1|Adverse Event|5|||
163010395|NCT00460603|588740172|FG000|Phase 1|Lack of Efficacy|1|||
163061922|NCT00157755|588935059|FG004|Overall Study|Lost to Follow-up|0|||
162640356|NCT01729754|587399859|FG000|Part 1|Lack of Efficacy|1|||
162640357|NCT01729754|587399860|FG001|Part 1|Lack of Efficacy|0|||
162640358|NCT01729754|587399861|FG002|Part 1|Lack of Efficacy|0|||
162640359|NCT01729754|587399862|FG003|Part 1|Lack of Efficacy|0|||
163010396|NCT00460603|588740173|FG001|Phase 1|Lack of Efficacy|0|||
163010397|NCT00460603|588740174|FG002|Phase 1|Lack of Efficacy|1|||
163010398|NCT00460603|588740175|FG003|Phase 1|Lack of Efficacy|2|||
163010399|NCT00460603|588740176|FG004|Phase 1|Lack of Efficacy|2|||
163010400|NCT00460603|588740177|FG005|Phase 1|Lack of Efficacy|2|||
163010401|NCT00460603|588740178|FG006|Phase 1|Lack of Efficacy|2|||
162640360|NCT01729754|587399863|FG004|Part 1|Lack of Efficacy|0|||
162640361|NCT01729754|587399864|FG005|Part 1|Lack of Efficacy|0|||
162640362|NCT01729754|587399865|FG006|Part 1|Lack of Efficacy|2|||
162640363|NCT01729754|587399866|FG007|Part 1|Lack of Efficacy|0|||
162640364|NCT01729754|587399867|FG008|Part 1|Lack of Efficacy|0|||
162640365|NCT01729754|587399868|FG009|Part 1|Lack of Efficacy|0|||
162640366|NCT01729754|587399859|FG000|Part 1|Lost to Follow-up|1|||
162640367|NCT01729754|587399860|FG001|Part 1|Lost to Follow-up|0|||
162640368|NCT01729754|587399861|FG002|Part 1|Lost to Follow-up|0|||
162640369|NCT01729754|587399862|FG003|Part 1|Lost to Follow-up|2|||
162640370|NCT01729754|587399863|FG004|Part 1|Lost to Follow-up|0|||
162640371|NCT01729754|587399864|FG005|Part 1|Lost to Follow-up|0|||
162640372|NCT01729754|587399865|FG006|Part 1|Lost to Follow-up|3|||
162640373|NCT01729754|587399866|FG007|Part 1|Lost to Follow-up|0|||
162640374|NCT01729754|587399867|FG008|Part 1|Lost to Follow-up|0|||
162640375|NCT01729754|587399868|FG009|Part 1|Lost to Follow-up|3|||
162640376|NCT01729754|587399859|FG000|Part 1|Non-compliance with Study Drug|1|||
162640377|NCT01729754|587399860|FG001|Part 1|Non-compliance with Study Drug|0|||
162640378|NCT01729754|587399861|FG002|Part 1|Non-compliance with Study Drug|0|||
162640379|NCT01729754|587399862|FG003|Part 1|Non-compliance with Study Drug|0|||
162640380|NCT01729754|587399863|FG004|Part 1|Non-compliance with Study Drug|0|||
162640381|NCT01729754|587399864|FG005|Part 1|Non-compliance with Study Drug|0|||
162640382|NCT01729754|587399865|FG006|Part 1|Non-compliance with Study Drug|0|||
162640383|NCT01729754|587399866|FG007|Part 1|Non-compliance with Study Drug|0|||
162640384|NCT01729754|587399867|FG008|Part 1|Non-compliance with Study Drug|0|||
162640385|NCT01729754|587399868|FG009|Part 1|Non-compliance with Study Drug|0|||
162640386|NCT01729754|587399859|FG000|Part 1|Physician Decision|0|||
162640387|NCT01729754|587399860|FG001|Part 1|Physician Decision|0|||
162640388|NCT01729754|587399861|FG002|Part 1|Physician Decision|0|||
162640389|NCT01729754|587399862|FG003|Part 1|Physician Decision|0|||
162640390|NCT01729754|587399863|FG004|Part 1|Physician Decision|0|||
162640391|NCT01729754|587399864|FG005|Part 1|Physician Decision|0|||
162640392|NCT01729754|587399865|FG006|Part 1|Physician Decision|0|||
162640393|NCT01729754|587399866|FG007|Part 1|Physician Decision|0|||
162640394|NCT01729754|587399867|FG008|Part 1|Physician Decision|0|||
162640395|NCT01729754|587399868|FG009|Part 1|Physician Decision|4|||
162640396|NCT01729754|587399859|FG000|Part 1|Pregnancy|0|||
162640397|NCT01729754|587399860|FG001|Part 1|Pregnancy|0|||
162640398|NCT01729754|587399861|FG002|Part 1|Pregnancy|0|||
162640399|NCT01729754|587399862|FG003|Part 1|Pregnancy|1|||
162640400|NCT01729754|587399863|FG004|Part 1|Pregnancy|0|||
162640401|NCT01729754|587399864|FG005|Part 1|Pregnancy|0|||
162640402|NCT01729754|587399865|FG006|Part 1|Pregnancy|0|||
162640403|NCT01729754|587399866|FG007|Part 1|Pregnancy|0|||
162640404|NCT01729754|587399867|FG008|Part 1|Pregnancy|0|||
162640405|NCT01729754|587399868|FG009|Part 1|Pregnancy|1|||
162640406|NCT01729754|587399859|FG000|Part 1|Progressive Disease|0|||
162640407|NCT01729754|587399860|FG001|Part 1|Progressive Disease|0|||
162640408|NCT01729754|587399861|FG002|Part 1|Progressive Disease|0|||
162640409|NCT01729754|587399862|FG003|Part 1|Progressive Disease|0|||
162640410|NCT01729754|587399863|FG004|Part 1|Progressive Disease|0|||
162640411|NCT01729754|587399864|FG005|Part 1|Progressive Disease|0|||
162640412|NCT01729754|587399865|FG006|Part 1|Progressive Disease|0|||
162640413|NCT01729754|587399866|FG007|Part 1|Progressive Disease|0|||
162640414|NCT01729754|587399867|FG008|Part 1|Progressive Disease|0|||
162640415|NCT01729754|587399868|FG009|Part 1|Progressive Disease|1|||
162640416|NCT01729754|587399859|FG000|Part 1|Protocol Violation|2|||
162640417|NCT01729754|587399860|FG001|Part 1|Protocol Violation|0|||
162640418|NCT01729754|587399861|FG002|Part 1|Protocol Violation|0|||
162640419|NCT01729754|587399862|FG003|Part 1|Protocol Violation|1|||
162640420|NCT01729754|587399863|FG004|Part 1|Protocol Violation|0|||
162640421|NCT01729754|587399864|FG005|Part 1|Protocol Violation|0|||
162640422|NCT01729754|587399865|FG006|Part 1|Protocol Violation|1|||
162640423|NCT01729754|587399866|FG007|Part 1|Protocol Violation|0|||
162640424|NCT01729754|587399867|FG008|Part 1|Protocol Violation|0|||
162640425|NCT01729754|587399868|FG009|Part 1|Protocol Violation|0|||
162640426|NCT01729754|587399859|FG000|Part 1|Withdrawal by Subject|5|||
162640427|NCT01729754|587399860|FG001|Part 1|Withdrawal by Subject|0|||
162640428|NCT01729754|587399861|FG002|Part 1|Withdrawal by Subject|0|||
162640429|NCT01729754|587399862|FG003|Part 1|Withdrawal by Subject|7|||
162640430|NCT01729754|587399863|FG004|Part 1|Withdrawal by Subject|0|||
162640431|NCT01729754|587399864|FG005|Part 1|Withdrawal by Subject|0|||
162640432|NCT01729754|587399865|FG006|Part 1|Withdrawal by Subject|5|||
162640433|NCT01729754|587399866|FG007|Part 1|Withdrawal by Subject|0|||
162640434|NCT01729754|587399867|FG008|Part 1|Withdrawal by Subject|0|||
162640435|NCT01729754|587399868|FG009|Part 1|Withdrawal by Subject|6|||
162640436|NCT01729754|587399859|FG000|Part 1|Other Protocol Specified Criteria|2|||
162640437|NCT01729754|587399860|FG001|Part 1|Other Protocol Specified Criteria|0|||
162640438|NCT01729754|587399861|FG002|Part 1|Other Protocol Specified Criteria|0|||
162640439|NCT01729754|587399862|FG003|Part 1|Other Protocol Specified Criteria|0|||
162640440|NCT01729754|587399863|FG004|Part 1|Other Protocol Specified Criteria|0|||
162640441|NCT01729754|587399864|FG005|Part 1|Other Protocol Specified Criteria|0|||
162640442|NCT01729754|587399865|FG006|Part 1|Other Protocol Specified Criteria|1|||
162640443|NCT01729754|587399866|FG007|Part 1|Other Protocol Specified Criteria|0|||
162640444|NCT01729754|587399867|FG008|Part 1|Other Protocol Specified Criteria|0|||
162640445|NCT01729754|587399868|FG009|Part 1|Other Protocol Specified Criteria|4|||
162640446|NCT01729754|587399859|FG000|Part 2|Adverse Event|2|||
162640447|NCT01729754|587399860|FG001|Part 2|Adverse Event|0|||
162640448|NCT01729754|587399861|FG002|Part 2|Adverse Event|0|||
162640449|NCT01729754|587399862|FG003|Part 2|Adverse Event|0|||
162640450|NCT01729754|587399863|FG004|Part 2|Adverse Event|0|||
162640451|NCT01729754|587399864|FG005|Part 2|Adverse Event|0|||
163061923|NCT00157755|588935060|FG005|Overall Study|Lost to Follow-up|0|||
163061924|NCT00157755|588935055|FG000|Overall Study|Withdrawal by Subject|0|||
163061925|NCT00157755|588935056|FG001|Overall Study|Withdrawal by Subject|0|||
163061926|NCT00157755|588935057|FG002|Overall Study|Withdrawal by Subject|1|||
163061927|NCT00157755|588935058|FG003|Overall Study|Withdrawal by Subject|1|||
163061928|NCT00157755|588935059|FG004|Overall Study|Withdrawal by Subject|1|||
163061929|NCT00157755|588935060|FG005|Overall Study|Withdrawal by Subject|2|||
163061930|NCT00157755|588935055|FG000|Overall Study|Explant due to infection|0|||
163061931|NCT00157755|588935056|FG001|Overall Study|Explant due to infection|0|||
162640452|NCT01729754|587399865|FG006|Part 2|Adverse Event|0|||
162640453|NCT01729754|587399866|FG007|Part 2|Adverse Event|0|||
162640454|NCT01729754|587399867|FG008|Part 2|Adverse Event|1|||
162640455|NCT01729754|587399868|FG009|Part 2|Adverse Event|2|||
162640456|NCT01729754|587399859|FG000|Part 2|Lack of Efficacy|0|||
162640457|NCT01729754|587399860|FG001|Part 2|Lack of Efficacy|0|||
162640458|NCT01729754|587399861|FG002|Part 2|Lack of Efficacy|0|||
162640459|NCT01729754|587399862|FG003|Part 2|Lack of Efficacy|0|||
162640460|NCT01729754|587399863|FG004|Part 2|Lack of Efficacy|0|||
162640461|NCT01729754|587399864|FG005|Part 2|Lack of Efficacy|0|||
162640462|NCT01729754|587399865|FG006|Part 2|Lack of Efficacy|0|||
162640463|NCT01729754|587399866|FG007|Part 2|Lack of Efficacy|0|||
162640464|NCT01729754|587399867|FG008|Part 2|Lack of Efficacy|2|||
162640465|NCT01729754|587399868|FG009|Part 2|Lack of Efficacy|2|||
162640466|NCT01729754|587399859|FG000|Part 2|Lost to Follow-up|0|||
162640467|NCT01729754|587399860|FG001|Part 2|Lost to Follow-up|0|||
162640468|NCT01729754|587399861|FG002|Part 2|Lost to Follow-up|0|||
162640469|NCT01729754|587399862|FG003|Part 2|Lost to Follow-up|2|||
162640470|NCT01729754|587399863|FG004|Part 2|Lost to Follow-up|0|||
162640471|NCT01729754|587399864|FG005|Part 2|Lost to Follow-up|0|||
162640472|NCT01729754|587399865|FG006|Part 2|Lost to Follow-up|0|||
162640473|NCT01729754|587399866|FG007|Part 2|Lost to Follow-up|1|||
162640474|NCT01729754|587399867|FG008|Part 2|Lost to Follow-up|0|||
162640475|NCT01729754|587399868|FG009|Part 2|Lost to Follow-up|2|||
162640476|NCT01729754|587399859|FG000|Part 2|Non-Compliance with Study Drug|0|||
162640477|NCT01729754|587399860|FG001|Part 2|Non-Compliance with Study Drug|0|||
162640478|NCT01729754|587399861|FG002|Part 2|Non-Compliance with Study Drug|0|||
162640479|NCT01729754|587399862|FG003|Part 2|Non-Compliance with Study Drug|0|||
162640480|NCT01729754|587399863|FG004|Part 2|Non-Compliance with Study Drug|0|||
162640481|NCT01729754|587399864|FG005|Part 2|Non-Compliance with Study Drug|0|||
162925144|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
162925145|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
162925146|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925147|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925148|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925149|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
162925150|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
162925151|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925152|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925153|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925154|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
162925155|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
162925156|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
162925157|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925158|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925159|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925160|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
162925161|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925162|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
162925163|NCT00902486|588427398|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925164|NCT00902486|588427399|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925165|NCT00902486|588427400|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925166|NCT00902486|588427401|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
163061932|NCT00157755|588935057|FG002|Overall Study|Explant due to infection|1|||
162640482|NCT01729754|587399865|FG006|Part 2|Non-Compliance with Study Drug|0|||
162640483|NCT01729754|587399866|FG007|Part 2|Non-Compliance with Study Drug|0|||
162640484|NCT01729754|587399867|FG008|Part 2|Non-Compliance with Study Drug|0|||
162640485|NCT01729754|587399868|FG009|Part 2|Non-Compliance with Study Drug|1|||
163010402|NCT00460603|588740179|FG007|Phase 1|Lack of Efficacy|2|||
163010403|NCT00460603|588740180|FG008|Phase 1|Lack of Efficacy|11|||
163010404|NCT00460603|588740181|FG009|Phase 1|Lack of Efficacy|0|||
163010405|NCT00460603|588740182|FG010|Phase 1|Lack of Efficacy|0|||
163010406|NCT00460603|588740183|FG011|Phase 1|Lack of Efficacy|0|||
163010407|NCT00460603|588740172|FG000|Phase 1|Withdrawal by Subject|1|||
163010408|NCT00460603|588740173|FG001|Phase 1|Withdrawal by Subject|2|||
163010409|NCT00460603|588740174|FG002|Phase 1|Withdrawal by Subject|1|||
163010410|NCT00460603|588740175|FG003|Phase 1|Withdrawal by Subject|1|||
163010411|NCT00460603|588740176|FG004|Phase 1|Withdrawal by Subject|3|||
163010412|NCT00460603|588740177|FG005|Phase 1|Withdrawal by Subject|0|||
163010413|NCT00460603|588740178|FG006|Phase 1|Withdrawal by Subject|1|||
163010414|NCT00460603|588740179|FG007|Phase 1|Withdrawal by Subject|0|||
163010415|NCT00460603|588740180|FG008|Phase 1|Withdrawal by Subject|2|||
163010416|NCT00460603|588740181|FG009|Phase 1|Withdrawal by Subject|0|||
163010417|NCT00460603|588740182|FG010|Phase 1|Withdrawal by Subject|0|||
163010418|NCT00460603|588740183|FG011|Phase 1|Withdrawal by Subject|0|||
163010419|NCT00460603|588740172|FG000|Phase 1|Other|0|||
163010420|NCT00460603|588740173|FG001|Phase 1|Other|3|||
163010421|NCT00460603|588740174|FG002|Phase 1|Other|1|||
163010422|NCT00460603|588740175|FG003|Phase 1|Other|1|||
163010423|NCT00460603|588740176|FG004|Phase 1|Other|1|||
163010424|NCT00460603|588740177|FG005|Phase 1|Other|2|||
163010425|NCT00460603|588740178|FG006|Phase 1|Other|0|||
163010426|NCT00460603|588740179|FG007|Phase 1|Other|1|||
163010427|NCT00460603|588740180|FG008|Phase 1|Other|0|||
163010428|NCT00460603|588740181|FG009|Phase 1|Other|0|||
163010429|NCT00460603|588740182|FG010|Phase 1|Other|0|||
163010430|NCT00460603|588740183|FG011|Phase 1|Other|0|||
163010431|NCT00460603|588740172|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010432|NCT00460603|588740173|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010433|NCT00460603|588740174|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163061933|NCT00157755|588935058|FG003|Overall Study|Explant due to infection|0|||
163061934|NCT00157755|588935059|FG004|Overall Study|Explant due to infection|0|||
163061935|NCT00157755|588935060|FG005|Overall Study|Explant due to infection|0|||
163061936|NCT00157755|588935055|FG000|Overall Study|Medical reason|0|||
163061937|NCT00157755|588935056|FG001|Overall Study|Medical reason|0|||
163061938|NCT00157755|588935057|FG002|Overall Study|Medical reason|1|||
163061939|NCT00157755|588935058|FG003|Overall Study|Medical reason|1|||
163061940|NCT00157755|588935059|FG004|Overall Study|Medical reason|0|||
163061941|NCT00157755|588935060|FG005|Overall Study|Medical reason|0|||
163061942|NCT00157755|588935055|FG000|Overall Study|Study site closure|0|||
163061943|NCT00157755|588935056|FG001|Overall Study|Study site closure|1|||
163061944|NCT00157755|588935057|FG002|Overall Study|Study site closure|0|||
163061945|NCT00157755|588935058|FG003|Overall Study|Study site closure|0|||
163061946|NCT00157755|588935059|FG004|Overall Study|Study site closure|0|||
163061947|NCT00157755|588935060|FG005|Overall Study|Study site closure|0|||
163061948|NCT00157755|588935055|FG000|Overall Study|Subject non-compliance|0|||
163061949|NCT00157755|588935056|FG001|Overall Study|Subject non-compliance|0|||
163061950|NCT00157755|588935057|FG002|Overall Study|Subject non-compliance|0|||
163061951|NCT00157755|588935058|FG003|Overall Study|Subject non-compliance|0|||
163061952|NCT00157755|588935059|FG004|Overall Study|Subject non-compliance|0|||
163061953|NCT00157755|588935060|FG005|Overall Study|Subject non-compliance|1|||
163061954|NCT00157755|588935055|FG000|Overall Study|Study completion|0|||
163061955|NCT00157755|588935056|FG001|Overall Study|Study completion|0|||
163061956|NCT00157755|588935057|FG002|Overall Study|Study completion|0|||
163061957|NCT00157755|588935058|FG003|Overall Study|Study completion|0|||
163061958|NCT00157755|588935059|FG004|Overall Study|Study completion|1|||
163061959|NCT00157755|588935060|FG005|Overall Study|Study completion|2|||
163061960|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
162640486|NCT01729754|587399859|FG000|Part 2|Pregnancy|0|||
162640487|NCT01729754|587399860|FG001|Part 2|Pregnancy|0|||
162640488|NCT01729754|587399861|FG002|Part 2|Pregnancy|0|||
162640489|NCT01729754|587399862|FG003|Part 2|Pregnancy|1|||
162640490|NCT01729754|587399863|FG004|Part 2|Pregnancy|0|||
162640491|NCT01729754|587399864|FG005|Part 2|Pregnancy|0|||
162640492|NCT01729754|587399865|FG006|Part 2|Pregnancy|0|||
162640493|NCT01729754|587399866|FG007|Part 2|Pregnancy|0|||
162640494|NCT01729754|587399867|FG008|Part 2|Pregnancy|0|||
162640495|NCT01729754|587399868|FG009|Part 2|Pregnancy|1|||
163061961|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
163061962|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
163061963|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
162640496|NCT01729754|587399859|FG000|Part 2|Withdrawal by Subject|3|||
162640497|NCT01729754|587399860|FG001|Part 2|Withdrawal by Subject|0|||
163061964|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Death|38|||
162640498|NCT01729754|587399861|FG002|Part 2|Withdrawal by Subject|0|||
163010434|NCT00460603|588740175|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010435|NCT00460603|588740176|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010436|NCT00460603|588740177|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010437|NCT00460603|588740178|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010438|NCT00460603|588740179|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163061965|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Death|10|||
163061966|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
163061967|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
163061968|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
163061969|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
162640499|NCT01729754|587399862|FG003|Part 2|Withdrawal by Subject|2|||
162640500|NCT01729754|587399863|FG004|Part 2|Withdrawal by Subject|0|||
162640501|NCT01729754|587399864|FG005|Part 2|Withdrawal by Subject|0|||
162640502|NCT01729754|587399865|FG006|Part 2|Withdrawal by Subject|0|||
162640503|NCT01729754|587399866|FG007|Part 2|Withdrawal by Subject|1|||
162640504|NCT01729754|587399867|FG008|Part 2|Withdrawal by Subject|1|||
162640505|NCT01729754|587399868|FG009|Part 2|Withdrawal by Subject|4|||
162640506|NCT01729754|587399859|FG000|Part 2|Other Protocol Specified Criteria|1|||
162640507|NCT01729754|587399860|FG001|Part 2|Other Protocol Specified Criteria|0|||
162640508|NCT01729754|587399861|FG002|Part 2|Other Protocol Specified Criteria|0|||
162640509|NCT01729754|587399862|FG003|Part 2|Other Protocol Specified Criteria|0|||
162640510|NCT01729754|587399863|FG004|Part 2|Other Protocol Specified Criteria|0|||
162640511|NCT01729754|587399864|FG005|Part 2|Other Protocol Specified Criteria|0|||
162640512|NCT01729754|587399865|FG006|Part 2|Other Protocol Specified Criteria|0|||
162640513|NCT01729754|587399866|FG007|Part 2|Other Protocol Specified Criteria|1|||
162640514|NCT01729754|587399867|FG008|Part 2|Other Protocol Specified Criteria|0|||
162640515|NCT01729754|587399868|FG009|Part 2|Other Protocol Specified Criteria|0|||
162640516|NCT01729754|587399859|FG000|Part 3|Adverse Event|0|||
162640517|NCT01729754|587399860|FG001|Part 3|Adverse Event|0|||
162640518|NCT01729754|587399861|FG002|Part 3|Adverse Event|1|||
162640519|NCT01729754|587399862|FG003|Part 3|Adverse Event|0|||
162715946|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162715947|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
162715948|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162640520|NCT01729754|587399863|FG004|Part 3|Adverse Event|0|||
162640521|NCT01729754|587399864|FG005|Part 3|Adverse Event|5|||
162640522|NCT01729754|587399865|FG006|Part 3|Adverse Event|0|||
162640523|NCT01729754|587399866|FG007|Part 3|Adverse Event|0|||
162640524|NCT01729754|587399867|FG008|Part 3|Adverse Event|0|||
162640525|NCT01729754|587399868|FG009|Part 3|Adverse Event|3|||
162640526|NCT01729754|587399859|FG000|Part 3|Death|0|||
162925167|NCT00902486|588427402|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925168|NCT00902486|588427403|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
162925169|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925170|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925171|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925172|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
162925173|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
162925174|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
162925175|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925176|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925177|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
162925178|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
162925179|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925180|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
162925181|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925182|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925183|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925184|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925185|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
162925186|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
162925187|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925188|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925189|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925190|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
162925191|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925192|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
162925193|NCT00902486|588427398|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925194|NCT00902486|588427399|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925195|NCT00902486|588427400|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
162925196|NCT00902486|588427401|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925197|NCT00902486|588427402|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925198|NCT00902486|588427403|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
162925199|NCT00902486|588427398|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
162640527|NCT01729754|587399860|FG001|Part 3|Death|0|||
162640528|NCT01729754|587399861|FG002|Part 3|Death|0|||
162640529|NCT01729754|587399862|FG003|Part 3|Death|0|||
162640530|NCT01729754|587399863|FG004|Part 3|Death|0|||
162640531|NCT01729754|587399864|FG005|Part 3|Death|2|||
162640532|NCT01729754|587399865|FG006|Part 3|Death|0|||
162640533|NCT01729754|587399866|FG007|Part 3|Death|0|||
162640534|NCT01729754|587399867|FG008|Part 3|Death|0|||
162640535|NCT01729754|587399868|FG009|Part 3|Death|0|||
162640536|NCT01729754|587399859|FG000|Part 3|Lack of Efficacy|0|||
162640537|NCT01729754|587399860|FG001|Part 3|Lack of Efficacy|0|||
162640538|NCT01729754|587399861|FG002|Part 3|Lack of Efficacy|0|||
162640539|NCT01729754|587399862|FG003|Part 3|Lack of Efficacy|0|||
162640540|NCT01729754|587399863|FG004|Part 3|Lack of Efficacy|2|||
162640541|NCT01729754|587399864|FG005|Part 3|Lack of Efficacy|0|||
162640542|NCT01729754|587399865|FG006|Part 3|Lack of Efficacy|0|||
162640543|NCT01729754|587399866|FG007|Part 3|Lack of Efficacy|0|||
162640544|NCT01729754|587399867|FG008|Part 3|Lack of Efficacy|0|||
162640545|NCT01729754|587399868|FG009|Part 3|Lack of Efficacy|4|||
162640546|NCT01729754|587399859|FG000|Part 3|Lost to Follow-up|0|||
162640547|NCT01729754|587399860|FG001|Part 3|Lost to Follow-up|1|||
162640548|NCT01729754|587399861|FG002|Part 3|Lost to Follow-up|2|||
162640549|NCT01729754|587399862|FG003|Part 3|Lost to Follow-up|0|||
162640550|NCT01729754|587399863|FG004|Part 3|Lost to Follow-up|0|||
162640551|NCT01729754|587399864|FG005|Part 3|Lost to Follow-up|3|||
162640552|NCT01729754|587399865|FG006|Part 3|Lost to Follow-up|0|||
162640553|NCT01729754|587399866|FG007|Part 3|Lost to Follow-up|0|||
162640554|NCT01729754|587399867|FG008|Part 3|Lost to Follow-up|1|||
162640555|NCT01729754|587399868|FG009|Part 3|Lost to Follow-up|0|||
162640556|NCT01729754|587399859|FG000|Part 3|Physician Decision|0|||
162640557|NCT01729754|587399860|FG001|Part 3|Physician Decision|0|||
162640558|NCT01729754|587399861|FG002|Part 3|Physician Decision|1|||
162640559|NCT01729754|587399862|FG003|Part 3|Physician Decision|0|||
162640560|NCT01729754|587399863|FG004|Part 3|Physician Decision|0|||
162640561|NCT01729754|587399864|FG005|Part 3|Physician Decision|0|||
162640562|NCT01729754|587399865|FG006|Part 3|Physician Decision|0|||
162640563|NCT01729754|587399866|FG007|Part 3|Physician Decision|0|||
162640564|NCT01729754|587399867|FG008|Part 3|Physician Decision|0|||
162640565|NCT01729754|587399868|FG009|Part 3|Physician Decision|0|||
162640566|NCT01729754|587399859|FG000|Part 3|Withdrawal by Subject|0|||
162640567|NCT01729754|587399860|FG001|Part 3|Withdrawal by Subject|4|||
162640568|NCT01729754|587399861|FG002|Part 3|Withdrawal by Subject|1|||
162640569|NCT01729754|587399862|FG003|Part 3|Withdrawal by Subject|0|||
162640570|NCT01729754|587399863|FG004|Part 3|Withdrawal by Subject|2|||
162640571|NCT01729754|587399864|FG005|Part 3|Withdrawal by Subject|1|||
162640572|NCT01729754|587399865|FG006|Part 3|Withdrawal by Subject|0|||
162640573|NCT01729754|587399866|FG007|Part 3|Withdrawal by Subject|2|||
162640574|NCT01729754|587399867|FG008|Part 3|Withdrawal by Subject|0|||
162640575|NCT01729754|587399868|FG009|Part 3|Withdrawal by Subject|0|||
162640576|NCT01729754|587399859|FG000|Part 3|Other Protocol Specified Criteria|0|||
162640577|NCT01729754|587399860|FG001|Part 3|Other Protocol Specified Criteria|0|||
162640578|NCT01729754|587399861|FG002|Part 3|Other Protocol Specified Criteria|0|||
162640579|NCT01729754|587399862|FG003|Part 3|Other Protocol Specified Criteria|0|||
162640580|NCT01729754|587399863|FG004|Part 3|Other Protocol Specified Criteria|0|||
162640581|NCT01729754|587399864|FG005|Part 3|Other Protocol Specified Criteria|2|||
162640582|NCT01729754|587399865|FG006|Part 3|Other Protocol Specified Criteria|0|||
162640583|NCT01729754|587399866|FG007|Part 3|Other Protocol Specified Criteria|1|||
162640584|NCT01729754|587399867|FG008|Part 3|Other Protocol Specified Criteria|0|||
162640585|NCT01729754|587399868|FG009|Part 3|Other Protocol Specified Criteria|0|||
162640586|NCT01853046|587399869|FG000|Overall Study|Withdrawal by Subject|1|||
162640587|NCT01853046|587399870|FG001|Overall Study|Withdrawal by Subject|1|||
162640588|NCT01853046|587399869|FG000|Overall Study|Adverse Event|4|||
162715949|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162715950|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162715951|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162640589|NCT01853046|587399870|FG001|Overall Study|Adverse Event|2|||
162640590|NCT01853046|587399869|FG000|Overall Study|Disease progression|13|||
162640591|NCT01853046|587399870|FG001|Overall Study|Disease progression|3|||
162640592|NCT03020407|587399872|FG000|Overall Study|Withdrawal by Subject|2|||
162640593|NCT03020407|587399873|FG001|Overall Study|Withdrawal by Subject|1|||
162640594|NCT03020407|587399872|FG000|Overall Study|Lost to Follow-up|2|||
162640595|NCT03020407|587399873|FG001|Overall Study|Lost to Follow-up|3|||
162640596|NCT03020407|587399872|FG000|Overall Study|Protocol Violation|0|||
162640597|NCT03020407|587399873|FG001|Overall Study|Protocol Violation|1|||
163010439|NCT00460603|588740180|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010440|NCT00460603|588740181|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
163010441|NCT00460603|588740182|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
163010442|NCT00460603|588740183|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
162640598|NCT02699554|587399874|FG000|Overall Study|Lost to Follow-up|9|||
162640599|NCT00788151|587399875|FG000|Overall Study|Other adverse event|0|||
162640600|NCT00788151|587399876|FG001|Overall Study|Other adverse event|2|||
162640601|NCT00788151|587399875|FG000|Overall Study|Protocol Violation|0|||
162640602|NCT00788151|587399876|FG001|Overall Study|Protocol Violation|1|||
163010443|NCT00460603|588740172|FG000|Phase 2|Adverse Event|0|||
163010444|NCT00460603|588740173|FG001|Phase 2|Adverse Event|0|||
163010445|NCT00460603|588740174|FG002|Phase 2|Adverse Event|0|||
163010446|NCT00460603|588740175|FG003|Phase 2|Adverse Event|0|||
163010447|NCT00460603|588740176|FG004|Phase 2|Adverse Event|0|||
163010448|NCT00460603|588740177|FG005|Phase 2|Adverse Event|0|||
163010449|NCT00460603|588740178|FG006|Phase 2|Adverse Event|0|||
163010450|NCT00460603|588740179|FG007|Phase 2|Adverse Event|0|||
163010451|NCT00460603|588740180|FG008|Phase 2|Adverse Event|0|||
163010452|NCT00460603|588740181|FG009|Phase 2|Adverse Event|12|||
163010453|NCT00460603|588740182|FG010|Phase 2|Adverse Event|9|||
163010454|NCT00460603|588740183|FG011|Phase 2|Adverse Event|10|||
163010455|NCT00460603|588740172|FG000|Phase 2|Death|0|||
163010456|NCT00460603|588740173|FG001|Phase 2|Death|0|||
163010457|NCT00460603|588740174|FG002|Phase 2|Death|0|||
163010458|NCT00460603|588740175|FG003|Phase 2|Death|0|||
162640603|NCT00788151|587399875|FG000|Overall Study|Withdrawal by Subject|13|||
163010459|NCT00460603|588740176|FG004|Phase 2|Death|0|||
163010460|NCT00460603|588740177|FG005|Phase 2|Death|0|||
163010461|NCT00460603|588740178|FG006|Phase 2|Death|0|||
163010462|NCT00460603|588740179|FG007|Phase 2|Death|0|||
163010463|NCT00460603|588740180|FG008|Phase 2|Death|0|||
163010464|NCT00460603|588740181|FG009|Phase 2|Death|4|||
163010465|NCT00460603|588740182|FG010|Phase 2|Death|2|||
163010466|NCT00460603|588740183|FG011|Phase 2|Death|2|||
163010467|NCT00460603|588740172|FG000|Phase 2|Protocol Violation|0|||
163010468|NCT00460603|588740173|FG001|Phase 2|Protocol Violation|0|||
163010469|NCT00460603|588740174|FG002|Phase 2|Protocol Violation|0|||
163010470|NCT00460603|588740175|FG003|Phase 2|Protocol Violation|0|||
163010471|NCT00460603|588740176|FG004|Phase 2|Protocol Violation|0|||
163010472|NCT00460603|588740177|FG005|Phase 2|Protocol Violation|0|||
163010473|NCT00460603|588740178|FG006|Phase 2|Protocol Violation|0|||
163010474|NCT00460603|588740179|FG007|Phase 2|Protocol Violation|0|||
163010475|NCT00460603|588740180|FG008|Phase 2|Protocol Violation|0|||
163010476|NCT00460603|588740181|FG009|Phase 2|Protocol Violation|1|||
163010477|NCT00460603|588740182|FG010|Phase 2|Protocol Violation|1|||
163010478|NCT00460603|588740183|FG011|Phase 2|Protocol Violation|0|||
163010479|NCT00460603|588740172|FG000|Phase 2|Lost to Follow-up|0|||
163010480|NCT00460603|588740173|FG001|Phase 2|Lost to Follow-up|0|||
163010481|NCT00460603|588740174|FG002|Phase 2|Lost to Follow-up|0|||
163010482|NCT00460603|588740175|FG003|Phase 2|Lost to Follow-up|0|||
163010483|NCT00460603|588740176|FG004|Phase 2|Lost to Follow-up|0|||
163010484|NCT00460603|588740177|FG005|Phase 2|Lost to Follow-up|0|||
163010485|NCT00460603|588740178|FG006|Phase 2|Lost to Follow-up|0|||
163010486|NCT00460603|588740179|FG007|Phase 2|Lost to Follow-up|0|||
163010487|NCT00460603|588740180|FG008|Phase 2|Lost to Follow-up|0|||
163010488|NCT00460603|588740181|FG009|Phase 2|Lost to Follow-up|1|||
163010489|NCT00460603|588740182|FG010|Phase 2|Lost to Follow-up|0|||
163010490|NCT00460603|588740183|FG011|Phase 2|Lost to Follow-up|0|||
163010491|NCT00460603|588740172|FG000|Phase 2|Other|0|||
163010492|NCT00460603|588740173|FG001|Phase 2|Other|0|||
163010493|NCT00460603|588740174|FG002|Phase 2|Other|0|||
163010494|NCT00460603|588740175|FG003|Phase 2|Other|0|||
163010495|NCT00460603|588740176|FG004|Phase 2|Other|0|||
163010496|NCT00460603|588740177|FG005|Phase 2|Other|0|||
163010497|NCT00460603|588740178|FG006|Phase 2|Other|0|||
163010498|NCT00460603|588740179|FG007|Phase 2|Other|0|||
163010499|NCT00460603|588740180|FG008|Phase 2|Other|0|||
163010500|NCT00460603|588740181|FG009|Phase 2|Other|6|||
163010501|NCT00460603|588740182|FG010|Phase 2|Other|16|||
163010502|NCT00460603|588740183|FG011|Phase 2|Other|7|||
163010503|NCT00460603|588740172|FG000|Phase 2|Objective Progression or Relapse|0|||
163010504|NCT00460603|588740173|FG001|Phase 2|Objective Progression or Relapse|0|||
163010505|NCT00460603|588740174|FG002|Phase 2|Objective Progression or Relapse|0|||
163010506|NCT00460603|588740175|FG003|Phase 2|Objective Progression or Relapse|0|||
163010507|NCT00460603|588740176|FG004|Phase 2|Objective Progression or Relapse|0|||
163010508|NCT00460603|588740177|FG005|Phase 2|Objective Progression or Relapse|0|||
162640604|NCT00788151|587399876|FG001|Overall Study|Withdrawal by Subject|6|||
163010509|NCT00460603|588740178|FG006|Phase 2|Objective Progression or Relapse|0|||
163010510|NCT00460603|588740179|FG007|Phase 2|Objective Progression or Relapse|0|||
163010511|NCT00460603|588740180|FG008|Phase 2|Objective Progression or Relapse|0|||
163010512|NCT00460603|588740181|FG009|Phase 2|Objective Progression or Relapse|9|||
163010513|NCT00460603|588740182|FG010|Phase 2|Objective Progression or Relapse|10|||
163010514|NCT00460603|588740183|FG011|Phase 2|Objective Progression or Relapse|17|||
163010515|NCT00460603|588740172|FG000|Phase 2|Global Deterioration of Health Status|0|||
163010516|NCT00460603|588740173|FG001|Phase 2|Global Deterioration of Health Status|0|||
163010517|NCT00460603|588740174|FG002|Phase 2|Global Deterioration of Health Status|0|||
163010518|NCT00460603|588740175|FG003|Phase 2|Global Deterioration of Health Status|0|||
163010519|NCT00460603|588740176|FG004|Phase 2|Global Deterioration of Health Status|0|||
163010520|NCT00460603|588740177|FG005|Phase 2|Global Deterioration of Health Status|0|||
163010521|NCT00460603|588740178|FG006|Phase 2|Global Deterioration of Health Status|0|||
163010522|NCT00460603|588740179|FG007|Phase 2|Global Deterioration of Health Status|0|||
163010523|NCT00460603|588740180|FG008|Phase 2|Global Deterioration of Health Status|0|||
163010524|NCT00460603|588740181|FG009|Phase 2|Global Deterioration of Health Status|0|||
163010525|NCT00460603|588740182|FG010|Phase 2|Global Deterioration of Health Status|1|||
163010526|NCT00460603|588740183|FG011|Phase 2|Global Deterioration of Health Status|0|||
163061970|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
163061971|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
163061972|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
163061973|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
163061974|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
163061975|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
163061976|NCT02421939|588935066|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
163061977|NCT02421939|588935067|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
163061978|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
162640605|NCT00788151|587399875|FG000|Overall Study|Enrolled but not treated|1|||
162640606|NCT00788151|587399876|FG001|Overall Study|Enrolled but not treated|1|||
162640607|NCT00503009|587399877|FG000|Overall Study|Protocol Violation|1|||
162640608|NCT00503009|587399878|FG001|Overall Study|Protocol Violation|0|||
162640609|NCT00503009|587399879|FG002|Overall Study|Protocol Violation|1|||
162640610|NCT00503009|587399877|FG000|Overall Study|Withdrawal by Subject|0|||
162640611|NCT00503009|587399878|FG001|Overall Study|Withdrawal by Subject|1|||
162640612|NCT00503009|587399879|FG002|Overall Study|Withdrawal by Subject|1|||
162640613|NCT00503009|587399877|FG000|Overall Study|Physician Decision|0|||
162640614|NCT00503009|587399878|FG001|Overall Study|Physician Decision|1|||
163061979|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
162640615|NCT00503009|587399879|FG002|Overall Study|Physician Decision|1|||
163010527|NCT00460603|588740172|FG000|Phase 2|Withdrawal by Subject|0|||
163010528|NCT00460603|588740173|FG001|Phase 2|Withdrawal by Subject|0|||
163010529|NCT00460603|588740174|FG002|Phase 2|Withdrawal by Subject|0|||
163010530|NCT00460603|588740175|FG003|Phase 2|Withdrawal by Subject|0|||
163010531|NCT00460603|588740176|FG004|Phase 2|Withdrawal by Subject|0|||
163010532|NCT00460603|588740177|FG005|Phase 2|Withdrawal by Subject|0|||
163010533|NCT00460603|588740178|FG006|Phase 2|Withdrawal by Subject|0|||
163010534|NCT00460603|588740179|FG007|Phase 2|Withdrawal by Subject|0|||
163010535|NCT00460603|588740180|FG008|Phase 2|Withdrawal by Subject|0|||
163010536|NCT00460603|588740181|FG009|Phase 2|Withdrawal by Subject|5|||
163010537|NCT00460603|588740182|FG010|Phase 2|Withdrawal by Subject|4|||
163010538|NCT00460603|588740183|FG011|Phase 2|Withdrawal by Subject|5|||
163010539|NCT00460603|588740172|FG000|Phase 2|Randomized, but not treated|0|||
163010540|NCT00460603|588740173|FG001|Phase 2|Randomized, but not treated|0|||
163010541|NCT00460603|588740174|FG002|Phase 2|Randomized, but not treated|0|||
163010542|NCT00460603|588740175|FG003|Phase 2|Randomized, but not treated|0|||
163010543|NCT00460603|588740176|FG004|Phase 2|Randomized, but not treated|0|||
163010544|NCT00460603|588740177|FG005|Phase 2|Randomized, but not treated|0|||
163010545|NCT00460603|588740178|FG006|Phase 2|Randomized, but not treated|0|||
163010546|NCT00460603|588740179|FG007|Phase 2|Randomized, but not treated|0|||
163010547|NCT00460603|588740180|FG008|Phase 2|Randomized, but not treated|0|||
163010548|NCT00460603|588740181|FG009|Phase 2|Randomized, but not treated|3|||
163010549|NCT00460603|588740182|FG010|Phase 2|Randomized, but not treated|0|||
163010550|NCT00460603|588740183|FG011|Phase 2|Randomized, but not treated|0|||
163010551|NCT01651117|588740187|FG000|Overall Study|Death|2|||
163010552|NCT01651117|588740188|FG001|Overall Study|Death|3|||
163010553|NCT01651117|588740189|FG002|Overall Study|Death|2|||
163010554|NCT01651117|588740190|FG003|Overall Study|Death|2|||
163010555|NCT02075203|588740192|FG000|Overall Study|Withdrawal by Subject|1|||
163010556|NCT02075203|588740193|FG001|Overall Study|Withdrawal by Subject|0|||
163010557|NCT02075203|588740194|FG002|Overall Study|Withdrawal by Subject|1|||
163010558|NCT02075203|588740192|FG000|Overall Study|Adverse Event|1|||
163010559|NCT02075203|588740193|FG001|Overall Study|Adverse Event|0|||
163010560|NCT02075203|588740194|FG002|Overall Study|Adverse Event|0|||
163010561|NCT02075203|588740192|FG000|Overall Study|participant refused to use contraception|1|||
163010562|NCT02075203|588740193|FG001|Overall Study|participant refused to use contraception|0|||
163010563|NCT02075203|588740194|FG002|Overall Study|participant refused to use contraception|0|||
162640616|NCT01870583|587399880|FG000|Overall Study|Protocol Violation|0|||
162640617|NCT01870583|587399881|FG001|Overall Study|Protocol Violation|5|||
162640618|NCT01870583|587399882|FG002|Overall Study|Protocol Violation|3|||
162640619|NCT01870583|587399880|FG000|Overall Study|Lost to Follow-up|11|||
162640620|NCT01870583|587399881|FG001|Overall Study|Lost to Follow-up|13|||
163010564|NCT00350207|588740195|FG000|Overall Study|Adverse Event|5|||
163010565|NCT00350207|588740196|FG001|Overall Study|Adverse Event|2|||
163010566|NCT00350207|588740197|FG002|Overall Study|Adverse Event|2|||
163010567|NCT00350207|588740195|FG000|Overall Study|Lack of Efficacy|1|||
163010568|NCT00350207|588740196|FG001|Overall Study|Lack of Efficacy|0|||
163010569|NCT00350207|588740197|FG002|Overall Study|Lack of Efficacy|2|||
163010570|NCT00350207|588740195|FG000|Overall Study|Lost to Follow-up|1|||
163010571|NCT00350207|588740196|FG001|Overall Study|Lost to Follow-up|0|||
163010572|NCT00350207|588740197|FG002|Overall Study|Lost to Follow-up|1|||
163010573|NCT00350207|588740195|FG000|Overall Study|Withdrawal by Subject|0|||
163010574|NCT00350207|588740196|FG001|Overall Study|Withdrawal by Subject|1|||
162640621|NCT01870583|587399882|FG002|Overall Study|Lost to Follow-up|5|||
162640622|NCT01394523|587399883|FG000|Overall Study|Unable to place block|1|||
162640623|NCT01394523|587399884|FG001|Overall Study|Unable to place block|0|||
162640624|NCT01394523|587399885|FG002|Overall Study|Unable to place block|0|||
162640625|NCT02389998|587399889|FG000|Overall Study|car accident|1|||
162640626|NCT02389998|587399890|FG001|Overall Study|car accident|0|||
162640627|NCT04741074|587399893|FG000|Overall Study|Withdrawal by Subject|1|||
162736238|NCT03699709|587744923|FG001|Overall Study|incarcerated|0|||
163061980|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
163061981|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
163061982|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Death|118|||
163061983|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Death|65|||
163061984|NCT02421939|588935066|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
163061985|NCT02421939|588935067|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
163061986|NCT01035138|588935071|FG000|Overall Study|Adverse Event|4|||
163061987|NCT01035138|588935072|FG001|Overall Study|Adverse Event|0|||
163061988|NCT01035138|588935073|FG002|Overall Study|Adverse Event|2|||
163061989|NCT01035138|588935071|FG000|Overall Study|Caregiver Decision|2|||
163061990|NCT01035138|588935072|FG001|Overall Study|Caregiver Decision|0|||
163061991|NCT01035138|588935073|FG002|Overall Study|Caregiver Decision|1|||
163061992|NCT01035138|588935071|FG000|Overall Study|Withdrawal by Subject|1|||
163061993|NCT01035138|588935072|FG001|Overall Study|Withdrawal by Subject|0|||
163061994|NCT01035138|588935073|FG002|Overall Study|Withdrawal by Subject|0|||
163061995|NCT01035138|588935071|FG000|Overall Study|Physician Decision|0|||
163061996|NCT01035138|588935072|FG001|Overall Study|Physician Decision|0|||
163061997|NCT01035138|588935073|FG002|Overall Study|Physician Decision|1|||
163061998|NCT01035138|588935071|FG000|Overall Study|Sponsor Decision|66|||
163061999|NCT01035138|588935072|FG001|Overall Study|Sponsor Decision|60|||
163062000|NCT01035138|588935073|FG002|Overall Study|Sponsor Decision|42|||
163062001|NCT01035138|588935071|FG000|Overall Study|Lost to Follow-up|0|||
163062002|NCT01035138|588935072|FG001|Overall Study|Lost to Follow-up|0|||
163062003|NCT01035138|588935073|FG002|Overall Study|Lost to Follow-up|1|||
163062004|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062005|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062006|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062007|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062008|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
163062009|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
163062010|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
163062011|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062012|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062013|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062014|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062015|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163062016|NCT02966834|588935074|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062017|NCT02966834|588935075|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062018|NCT02966834|588935076|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
163062019|NCT02966834|588935077|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
163062020|NCT02966834|588935078|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163062021|NCT02966834|588935079|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
163010575|NCT00350207|588740197|FG002|Overall Study|Withdrawal by Subject|1|||
163010576|NCT00350207|588740195|FG000|Overall Study|Other|1|||
163010577|NCT00350207|588740196|FG001|Overall Study|Other|3|||
163010578|NCT00350207|588740197|FG002|Overall Study|Other|1|||
163010579|NCT03802825|588740198|FG000|Overall Study|Lost to follow-up for intervention|12|||
163010580|NCT03802825|588740199|FG001|Overall Study|Lost to follow-up for intervention|3|||
163010581|NCT03802825|588740198|FG000|Overall Study|Received only 1 component of intervention|0|||
163010582|NCT03802825|588740199|FG001|Overall Study|Received only 1 component of intervention|13|||
163010583|NCT00568451|588740203|FG000|Overall Study|Disease Progression|0|||
163010584|NCT00568451|588740204|FG001|Overall Study|Disease Progression|0|||
163010585|NCT00568451|588740205|FG002|Overall Study|Disease Progression|2|||
163010586|NCT00568451|588740206|FG003|Overall Study|Disease Progression|7|||
163010587|NCT00777296|588740207|FG000|Overall Study|Adverse Event|0|||
163010588|NCT00777296|588740208|FG001|Overall Study|Adverse Event|1|||
163010589|NCT00777296|588740209|FG002|Overall Study|Adverse Event|0|||
163010590|NCT00777296|588740210|FG003|Overall Study|Adverse Event|1|||
163010591|NCT00777296|588740207|FG000|Overall Study|Withdrawal by Subject|1|||
163010592|NCT00777296|588740208|FG001|Overall Study|Withdrawal by Subject|0|||
163010593|NCT00777296|588740209|FG002|Overall Study|Withdrawal by Subject|0|||
163010594|NCT00777296|588740210|FG003|Overall Study|Withdrawal by Subject|0|||
163010595|NCT00777296|588740207|FG000|Overall Study|CRF form not completed|0|||
163010596|NCT00777296|588740208|FG001|Overall Study|CRF form not completed|0|||
163010597|NCT00777296|588740209|FG002|Overall Study|CRF form not completed|2|||
163010598|NCT00777296|588740210|FG003|Overall Study|CRF form not completed|0|||
163010599|NCT00658723|588740211|FG000|Overall Study|Lost to Follow-up|0|||
163010600|NCT00658723|588740212|FG001|Overall Study|Lost to Follow-up|2|||
163010601|NCT00658723|588740213|FG002|Overall Study|Lost to Follow-up|2|||
163062022|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062023|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062024|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
163062025|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
163062026|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
163062027|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
163062028|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062029|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062030|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062031|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
163062032|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062033|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163062034|NCT02966834|588935074|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062035|NCT02966834|588935075|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062036|NCT02966834|588935076|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062037|NCT02966834|588935077|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
163062038|NCT02966834|588935078|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062039|NCT02966834|588935079|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
163062040|NCT01925417|588935092|FG000|Overall Study|Withdrawal by Subject|2|||
163062041|NCT01925417|588935092|FG000|Overall Study|Death|1|||
163062042|NCT00655889|588935093|FG000|Overall Study|Inadequate cell growth|1|||
163062043|NCT00655889|588935093|FG000|Overall Study|Protocol Violation|1|||
163062044|NCT04739800|588935095|FG000|Overall Study|Adverse Event|2|||
163062045|NCT04739800|588935096|FG001|Overall Study|Adverse Event|1|||
163062046|NCT04739800|588935097|FG002|Overall Study|Adverse Event|4|||
163062047|NCT04739800|588935098|FG003|Overall Study|Adverse Event|5|||
163062048|NCT04739800|588935095|FG000|Overall Study|Never Treated|2|||
163062049|NCT04739800|588935096|FG001|Overall Study|Never Treated|0|||
163062050|NCT04739800|588935097|FG002|Overall Study|Never Treated|1|||
163062051|NCT04739800|588935098|FG003|Overall Study|Never Treated|1|||
163062052|NCT04739800|588935095|FG000|Overall Study|On Treatment|5|||
163062053|NCT04739800|588935096|FG001|Overall Study|On Treatment|9|||
163062054|NCT04739800|588935097|FG002|Overall Study|On Treatment|9|||
163062055|NCT04739800|588935098|FG003|Overall Study|On Treatment|9|||
163062056|NCT04739800|588935095|FG000|Overall Study|Symptomatic Deterioration|1|||
163062057|NCT04739800|588935096|FG001|Overall Study|Symptomatic Deterioration|1|||
163062058|NCT04739800|588935097|FG002|Overall Study|Symptomatic Deterioration|3|||
163062059|NCT04739800|588935098|FG003|Overall Study|Symptomatic Deterioration|0|||
163062060|NCT04739800|588935095|FG000|Overall Study|Withdrawal by Subject|1|||
163062061|NCT04739800|588935096|FG001|Overall Study|Withdrawal by Subject|2|||
163062062|NCT04739800|588935097|FG002|Overall Study|Withdrawal by Subject|1|||
163062063|NCT04739800|588935098|FG003|Overall Study|Withdrawal by Subject|3|||
163062064|NCT04739800|588935095|FG000|Overall Study|Other Reason|1|||
163062065|NCT04739800|588935096|FG001|Overall Study|Other Reason|3|||
163062066|NCT04739800|588935097|FG002|Overall Study|Other Reason|5|||
163062067|NCT04739800|588935098|FG003|Overall Study|Other Reason|4|||
163062068|NCT03573297|588935101|FG000|Open Label Treatment Period|Adverse Event|67|||
163062069|NCT03573297|588935102|FG001|Open Label Treatment Period|Adverse Event|0|||
163062070|NCT03573297|588935103|FG002|Open Label Treatment Period|Adverse Event|0|||
163062071|NCT03573297|588935104|FG003|Open Label Treatment Period|Adverse Event|0|||
163062072|NCT03573297|588935101|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
163062073|NCT03573297|588935102|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
163062074|NCT03573297|588935103|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
163062075|NCT03573297|588935104|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
162640628|NCT04741074|587399894|FG001|Overall Study|Withdrawal by Subject|1|||
162640629|NCT04741074|587399893|FG000|Overall Study|Study terminated prematurely|1|||
162640630|NCT04741074|587399894|FG001|Overall Study|Study terminated prematurely|0|||
162640631|NCT01770379|587399896|FG000|Overall Study|Technical issues|1|||
162640632|NCT01770379|587399897|FG001|Overall Study|Technical issues|0|||
163062076|NCT03573297|588935101|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
163062077|NCT03573297|588935102|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
163062078|NCT03573297|588935103|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
162640633|NCT01770379|587399898|FG002|Overall Study|Technical issues|0|||
162640634|NCT01770379|587399896|FG000|Overall Study|Withdrawal by Subject|7|||
162640635|NCT01770379|587399897|FG001|Overall Study|Withdrawal by Subject|10|||
162640636|NCT01770379|587399898|FG002|Overall Study|Withdrawal by Subject|7|||
163062079|NCT03573297|588935104|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
163062080|NCT03573297|588935101|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
162640637|NCT01770379|587399896|FG000|Overall Study|study terminated by sponsor|22|||
162640638|NCT01770379|587399897|FG001|Overall Study|study terminated by sponsor|23|||
163062081|NCT03573297|588935102|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
163062082|NCT03573297|588935103|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
163062083|NCT03573297|588935104|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
163062084|NCT03573297|588935101|FG000|Open Label Treatment Period|Pregnancy|1|||
163062085|NCT03573297|588935102|FG001|Open Label Treatment Period|Pregnancy|0|||
163062086|NCT03573297|588935103|FG002|Open Label Treatment Period|Pregnancy|0|||
163062087|NCT03573297|588935104|FG003|Open Label Treatment Period|Pregnancy|0|||
163062088|NCT03573297|588935101|FG000|Open Label Treatment Period|Protocol Violation|17|||
163062089|NCT03573297|588935102|FG001|Open Label Treatment Period|Protocol Violation|0|||
163062090|NCT03573297|588935103|FG002|Open Label Treatment Period|Protocol Violation|0|||
163062091|NCT03573297|588935104|FG003|Open Label Treatment Period|Protocol Violation|0|||
163062092|NCT03573297|588935101|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
163062093|NCT03573297|588935102|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163062094|NCT03573297|588935103|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163062095|NCT03573297|588935104|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
163010602|NCT00658723|588740211|FG000|Overall Study|Death|2|||
163010603|NCT00658723|588740212|FG001|Overall Study|Death|1|||
163010604|NCT00658723|588740213|FG002|Overall Study|Death|4|||
163010605|NCT00658723|588740211|FG000|Overall Study|Scheduling Issue|1|||
163010606|NCT00658723|588740212|FG001|Overall Study|Scheduling Issue|1|||
163010607|NCT00658723|588740213|FG002|Overall Study|Scheduling Issue|0|||
163010608|NCT00658723|588740211|FG000|Overall Study|Withdrawal by Subject|1|||
163010609|NCT00658723|588740212|FG001|Overall Study|Withdrawal by Subject|0|||
163062096|NCT03573297|588935101|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
163062097|NCT03573297|588935102|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062098|NCT03573297|588935103|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062099|NCT03573297|588935104|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
163062100|NCT03573297|588935101|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
163062101|NCT03573297|588935102|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062102|NCT03573297|588935103|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062103|NCT03573297|588935104|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
163062104|NCT03573297|588935101|FG000|Open Label Treatment Period|Other, Not Specified|7|||
163062105|NCT03573297|588935102|FG001|Open Label Treatment Period|Other, Not Specified|0|||
163062106|NCT03573297|588935103|FG002|Open Label Treatment Period|Other, Not Specified|0|||
163062107|NCT03573297|588935104|FG003|Open Label Treatment Period|Other, Not Specified|0|||
163062108|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
163062109|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
163062110|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
163062111|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
163062112|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163062113|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163062114|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Adverse Event|5|||
163062115|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Adverse Event|1|||
163062116|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062117|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
163062118|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062119|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
163062120|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163062121|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
163062122|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
163062123|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
163062124|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163062125|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
163062126|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
163062127|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
163062128|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163062129|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
163062130|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
163062131|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
163062132|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
163062133|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
163062134|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
163062135|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
163062136|NCT03573297|588935101|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
163062137|NCT03573297|588935102|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
163062138|NCT03573297|588935103|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
163062139|NCT03573297|588935104|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
163062140|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
163062141|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
163062142|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
163062143|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Death|0|||
163062144|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Death|0|||
163062145|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Death|1|||
162640639|NCT01770379|587399898|FG002|Overall Study|study terminated by sponsor|22|||
163010610|NCT00658723|588740213|FG002|Overall Study|Withdrawal by Subject|1|||
162640640|NCT01770379|587399896|FG000|Overall Study|Protocol Violation|0|||
163010611|NCT03876743|588740214|FG000|Overall Study|Lost to Follow-up|6|||
163010612|NCT03876743|588740215|FG001|Overall Study|Lost to Follow-up|4|||
163010613|NCT03876743|588740216|FG002|Overall Study|Lost to Follow-up|4|||
163010614|NCT03876743|588740217|FG003|Overall Study|Lost to Follow-up|7|||
163010615|NCT00092118|588740219|FG000|Overall Study|Adverse Event|35|||
163010616|NCT00092118|588740220|FG001|Overall Study|Adverse Event|32|||
163010617|NCT00092118|588740219|FG000|Overall Study|Lack of Efficacy|12|||
163010618|NCT00092118|588740220|FG001|Overall Study|Lack of Efficacy|14|||
163010619|NCT00092118|588740219|FG000|Overall Study|Lost to Follow-up|4|||
163010620|NCT00092118|588740220|FG001|Overall Study|Lost to Follow-up|3|||
163010621|NCT00092118|588740219|FG000|Overall Study|Protocol Violation|23|||
163062146|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
163062147|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
163062148|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
163062149|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
163062150|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
163062151|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
163062152|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
163062153|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
163062154|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
163062155|NCT02696798|588935107|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
163062156|NCT02696798|588935108|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
163062157|NCT02696798|588935109|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
163062158|NCT02696798|588935107|FG000|Extended Treatment Period|Adverse Event|1|||
163062159|NCT02696798|588935108|FG001|Extended Treatment Period|Adverse Event|4|||
163062160|NCT02696798|588935109|FG002|Extended Treatment Period|Adverse Event|5|||
163062161|NCT02696798|588935107|FG000|Extended Treatment Period|Lack of Efficacy|7|||
163062162|NCT02696798|588935108|FG001|Extended Treatment Period|Lack of Efficacy|2|||
163062163|NCT02696798|588935109|FG002|Extended Treatment Period|Lack of Efficacy|2|||
163062164|NCT02696798|588935107|FG000|Extended Treatment Period|Lost to Follow-up|1|||
163062165|NCT02696798|588935108|FG001|Extended Treatment Period|Lost to Follow-up|0|||
163062166|NCT02696798|588935109|FG002|Extended Treatment Period|Lost to Follow-up|0|||
163062167|NCT02696798|588935107|FG000|Extended Treatment Period|Physician Decision|0|||
163062168|NCT02696798|588935108|FG001|Extended Treatment Period|Physician Decision|1|||
163062169|NCT02696798|588935109|FG002|Extended Treatment Period|Physician Decision|0|||
163062170|NCT02696798|588935107|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
163062171|NCT02696798|588935108|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
163062172|NCT02696798|588935109|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
163062173|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
163062174|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
163062175|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
163062176|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
163062177|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
163062178|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
163062179|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
163062180|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
163062181|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
163062182|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
163062183|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
162925200|NCT00902486|588427399|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925201|NCT00902486|588427400|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925202|NCT00902486|588427401|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
162925203|NCT00902486|588427402|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925204|NCT00902486|588427403|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
162925205|NCT01843660|588427404|FG000|Overall Study|Other|30|||
162925206|NCT00209560|588427405|FG000|Overall Study|Lack of Efficacy|1|||
162925207|NCT00209560|588427406|FG001|Overall Study|Lack of Efficacy|0|||
162925208|NCT04439110|588427407|FG000|Overall Study|Ineligible|2|||
162925209|NCT04439110|588427407|FG000|Overall Study|Adverse Event|4|||
162925210|NCT04439110|588427407|FG000|Overall Study|Death|2|||
162925211|NCT04439110|588427407|FG000|Overall Study|Disease proression|25|||
162925212|NCT04439110|588427407|FG000|Overall Study|Withdrawal by Subject|1|||
162925213|NCT04439110|588427407|FG000|Overall Study|Alternative therapy|1|||
162925214|NCT04439110|588427407|FG000|Overall Study|Other complicating disease|1|||
162925215|NCT04439110|588427407|FG000|Overall Study|Personal reasons|1|||
162925216|NCT04439110|588427407|FG000|Overall Study|Still on treatment|1|||
163010622|NCT00092118|588740220|FG001|Overall Study|Protocol Violation|25|||
163010623|NCT00092118|588740219|FG000|Overall Study|Withdrawal by Subject|4|||
163010624|NCT00092118|588740220|FG001|Overall Study|Withdrawal by Subject|10|||
163010625|NCT00092118|588740219|FG000|Overall Study|Other|6|||
163010626|NCT00092118|588740220|FG001|Overall Study|Other|5|||
162925217|NCT00526227|588427414|FG000|Overall Study|Device not implanted|1|||
162925218|NCT00526227|588427414|FG000|Overall Study|Death|1|||
162925219|NCT01525407|588427415|FG000|Overall Study|Change in recipient treatment plan|2|||
162925220|NCT01525407|588427416|FG001|Overall Study|Change in recipient treatment plan|2|||
162925221|NCT01525407|588427415|FG000|Overall Study|Withdrawal by Subject|0|||
162925222|NCT01525407|588427416|FG001|Overall Study|Withdrawal by Subject|1|||
162925223|NCT01525407|588427415|FG000|Overall Study|Transplant was delayed|0|||
162925224|NCT01525407|588427416|FG001|Overall Study|Transplant was delayed|1|||
162925225|NCT01525407|588427415|FG000|Overall Study|Delay in Transplant|1|||
162925226|NCT01525407|588427416|FG001|Overall Study|Delay in Transplant|0|||
162925227|NCT05257109|588427417|FG000|Overall Study|Withdrawal by Subject|1|||
162925228|NCT05257109|588427418|FG001|Overall Study|Withdrawal by Subject|0|||
162925229|NCT05257109|588427419|FG002|Overall Study|Withdrawal by Subject|0|||
162925230|NCT05257109|588427420|FG003|Overall Study|Withdrawal by Subject|0|||
162925231|NCT00858234|588428885|FG000|Overall Study|Adverse Event|6|||
162925232|NCT00858234|588428885|FG000|Overall Study|Progressive disease|2|||
162925233|NCT00858234|588428885|FG000|Overall Study|Status unknown|1|||
162925234|NCT01678924|588428886|FG000|Overall Study|Adverse Event|1|||
162925235|NCT01678924|588428887|FG001|Overall Study|Adverse Event|1|||
162925236|NCT01678924|588428888|FG002|Overall Study|Adverse Event|0|||
162925237|NCT01678924|588428889|FG003|Overall Study|Adverse Event|1|||
162925238|NCT01678924|588428886|FG000|Overall Study|Lack of Efficacy|7|||
163062184|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
163062185|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
163062186|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
163062187|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
163062188|NCT02696798|588935107|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
163062189|NCT02696798|588935108|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
163062190|NCT02696798|588935109|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
163062191|NCT04880850|588935110|FG000|Overall Study|Death|2|||
163062192|NCT04880850|588935111|FG001|Overall Study|Death|1|||
163062193|NCT04880850|588935110|FG000|Overall Study|Lost to Follow-up|3|||
163062194|NCT04880850|588935111|FG001|Overall Study|Lost to Follow-up|6|||
163062195|NCT04880850|588935110|FG000|Overall Study|Physician Decision|2|||
163062196|NCT04880850|588935111|FG001|Overall Study|Physician Decision|1|||
163062197|NCT04880850|588935110|FG000|Overall Study|Withdrawal by Subject|9|||
163062198|NCT04880850|588935111|FG001|Overall Study|Withdrawal by Subject|10|||
163062199|NCT04091451|588935112|FG000|Overall Study|Adverse Event|15|||
163062200|NCT04091451|588935113|FG001|Overall Study|Adverse Event|10|||
163062201|NCT04091451|588935112|FG000|Overall Study|Lost to Follow-up|8|||
163062202|NCT04091451|588935113|FG001|Overall Study|Lost to Follow-up|8|||
163062203|NCT04091451|588935112|FG000|Overall Study|Protocol Violation|5|||
163062204|NCT04091451|588935113|FG001|Overall Study|Protocol Violation|4|||
163062205|NCT04091451|588935112|FG000|Overall Study|Withdrawal by Subject|21|||
163062206|NCT04091451|588935113|FG001|Overall Study|Withdrawal by Subject|27|||
163062207|NCT04091451|588935112|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
163062208|NCT04091451|588935113|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
162925239|NCT01678924|588428887|FG001|Overall Study|Lack of Efficacy|2|||
162925240|NCT01678924|588428888|FG002|Overall Study|Lack of Efficacy|0|||
162925241|NCT01678924|588428889|FG003|Overall Study|Lack of Efficacy|5|||
162925242|NCT01678924|588428886|FG000|Overall Study|Lost to Follow-up|0|||
162925243|NCT01678924|588428887|FG001|Overall Study|Lost to Follow-up|4|||
162925244|NCT01678924|588428888|FG002|Overall Study|Lost to Follow-up|0|||
162925245|NCT01678924|588428889|FG003|Overall Study|Lost to Follow-up|2|||
162925246|NCT01678924|588428886|FG000|Overall Study|Personal Reasons|2|||
162925247|NCT01678924|588428887|FG001|Overall Study|Personal Reasons|2|||
162925248|NCT01678924|588428888|FG002|Overall Study|Personal Reasons|2|||
162925249|NCT01678924|588428889|FG003|Overall Study|Personal Reasons|7|||
162925250|NCT01678924|588428886|FG000|Overall Study|Withdrawal by Subject|0|||
162925251|NCT01678924|588428887|FG001|Overall Study|Withdrawal by Subject|3|||
162925252|NCT01678924|588428888|FG002|Overall Study|Withdrawal by Subject|0|||
162925253|NCT01678924|588428889|FG003|Overall Study|Withdrawal by Subject|2|||
162925254|NCT01678924|588428886|FG000|Overall Study|Unable to attend scheduled visits|0|||
162925255|NCT01678924|588428887|FG001|Overall Study|Unable to attend scheduled visits|0|||
162925256|NCT01678924|588428888|FG002|Overall Study|Unable to attend scheduled visits|0|||
162925257|NCT01678924|588428889|FG003|Overall Study|Unable to attend scheduled visits|1|||
162925258|NCT02253654|588428890|FG000|Overall Study|Withdrawal by Subject|12|||
162925259|NCT02253654|588428891|FG001|Overall Study|Withdrawal by Subject|4|||
162925260|NCT02253654|588428890|FG000|Overall Study|Decision by Sponsor|1|||
162925261|NCT02253654|588428891|FG001|Overall Study|Decision by Sponsor|1|||
162925262|NCT02253654|588428890|FG000|Overall Study|Lost to Follow-up|2|||
162925263|NCT02253654|588428891|FG001|Overall Study|Lost to Follow-up|5|||
162925264|NCT02253654|588428890|FG000|Overall Study|Death|4|||
162925265|NCT02253654|588428891|FG001|Overall Study|Death|7|||
162925266|NCT02253654|588428890|FG000|Overall Study|Did Not Receive Study Treatment|4|||
163010627|NCT01139125|588740221|FG000|Overall Study|Withdrawal by Subject|1|||
163010628|NCT00931411|588740224|FG000|First Intervention - 42 Days|Adverse Event|2|||
163010629|NCT00931411|588740225|FG001|First Intervention - 42 Days|Adverse Event|3|||
163010630|NCT00931411|588740224|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
163010631|NCT00931411|588740225|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
163010632|NCT00931411|588740224|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
163010633|NCT00931411|588740225|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
163010634|NCT04030299|588740228|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
163010635|NCT04030299|588740228|FG000|Overall Study|Withdrawal by Subject|3|||
163010636|NCT00699998|588740229|FG000|Overall Study|Withdrawal by Subject|194|||
163010637|NCT00699998|588740230|FG001|Overall Study|Withdrawal by Subject|83|||
163010638|NCT00699998|588740231|FG002|Overall Study|Withdrawal by Subject|202|||
163010639|NCT00699998|588740232|FG003|Overall Study|Withdrawal by Subject|80|||
163010640|NCT00699998|588740229|FG000|Overall Study|Physician Decision|3|||
163010641|NCT00699998|588740230|FG001|Overall Study|Physician Decision|2|||
163010642|NCT00699998|588740231|FG002|Overall Study|Physician Decision|1|||
163010643|NCT00699998|588740232|FG003|Overall Study|Physician Decision|1|||
163010644|NCT00699998|588740229|FG000|Overall Study|Lost to Follow-up|2|||
163010645|NCT00699998|588740230|FG001|Overall Study|Lost to Follow-up|1|||
163010646|NCT00699998|588740231|FG002|Overall Study|Lost to Follow-up|3|||
163010647|NCT00699998|588740232|FG003|Overall Study|Lost to Follow-up|1|||
163010648|NCT04616612|588740239|FG000|Overall Study|Lost to Follow-up|6|||
163010649|NCT04616612|588740240|FG001|Overall Study|Lost to Follow-up|3|||
163010650|NCT04740918|588740242|FG000|Overall Study|Study Terminated by Sponsor|41|||
163010651|NCT04740918|588740243|FG001|Overall Study|Study Terminated by Sponsor|32|||
163010652|NCT04740918|588740242|FG000|Overall Study|Death|3|||
163010653|NCT04740918|588740243|FG001|Overall Study|Death|6|||
163010654|NCT04740918|588740242|FG000|Overall Study|Withdrawal by Subject|5|||
163010655|NCT04740918|588740243|FG001|Overall Study|Withdrawal by Subject|4|||
163010656|NCT04740918|588740242|FG000|Overall Study|Lost to Follow-up|1|||
163010657|NCT04740918|588740243|FG001|Overall Study|Lost to Follow-up|3|||
163010658|NCT04740918|588740242|FG000|Overall Study|Progressive disease|0|||
163010659|NCT04740918|588740243|FG001|Overall Study|Progressive disease|1|||
163010660|NCT02208362|588740246|FG000|Overall Study|Participant did not complete treatment|0|||
163010661|NCT02208362|588740247|FG001|Overall Study|Participant did not complete treatment|1|||
163010662|NCT02208362|588740248|FG002|Overall Study|Participant did not complete treatment|0|||
163010663|NCT02208362|588740249|FG003|Overall Study|Participant did not complete treatment|0|||
163010664|NCT02208362|588740250|FG004|Overall Study|Participant did not complete treatment|0|||
163010665|NCT02208362|588740251|FG005|Overall Study|Participant did not complete treatment|0|||
163010666|NCT02208362|588740252|FG006|Overall Study|Participant did not complete treatment|1|||
163010667|NCT02208362|588740253|FG007|Overall Study|Participant did not complete treatment|1|||
163010668|NCT02208362|588740254|FG008|Overall Study|Participant did not complete treatment|2|||
163010669|NCT02208362|588740255|FG009|Overall Study|Participant did not complete treatment|0|||
163010670|NCT02208362|588740256|FG010|Overall Study|Participant did not complete treatment|1|||
163010671|NCT02208362|588740257|FG011|Overall Study|Participant did not complete treatment|0|||
163010672|NCT02208362|588740246|FG000|Overall Study|Participant received disallowed treatment|0|||
163010673|NCT02208362|588740247|FG001|Overall Study|Participant received disallowed treatment|0|||
163010674|NCT02208362|588740248|FG002|Overall Study|Participant received disallowed treatment|0|||
163010675|NCT02208362|588740249|FG003|Overall Study|Participant received disallowed treatment|0|||
163010676|NCT02208362|588740250|FG004|Overall Study|Participant received disallowed treatment|0|||
163010677|NCT02208362|588740251|FG005|Overall Study|Participant received disallowed treatment|0|||
163010678|NCT02208362|588740252|FG006|Overall Study|Participant received disallowed treatment|0|||
163010679|NCT02208362|588740253|FG007|Overall Study|Participant received disallowed treatment|0|||
163010680|NCT02208362|588740254|FG008|Overall Study|Participant received disallowed treatment|1|||
163010681|NCT02208362|588740255|FG009|Overall Study|Participant received disallowed treatment|0|||
163010682|NCT02208362|588740256|FG010|Overall Study|Participant received disallowed treatment|0|||
163010683|NCT02208362|588740257|FG011|Overall Study|Participant received disallowed treatment|0|||
163010684|NCT01609790|588740262|FG000|Overall Study|Protocol Violation|1|||
163010685|NCT01609790|588740263|FG001|Overall Study|Protocol Violation|7|||
163010686|NCT01609790|588740264|FG002|Overall Study|Protocol Violation|8|||
163010687|NCT00858273|588740265|FG000|Overall Study|Protocol Violation|3|||
163010688|NCT00858273|588740266|FG001|Overall Study|Protocol Violation|5|||
163010689|NCT00982657|588740267|FG000|Overall Study|Death|1|||
163010690|NCT00982657|588740268|FG001|Overall Study|Death|0|||
163010691|NCT00982657|588740269|FG002|Overall Study|Death|1|||
163010692|NCT00982657|588740270|FG003|Overall Study|Death|1|||
163010693|NCT00982657|588740267|FG000|Overall Study|Withdrawal by Subject|0|||
163010694|NCT00982657|588740268|FG001|Overall Study|Withdrawal by Subject|0|||
163010695|NCT00982657|588740269|FG002|Overall Study|Withdrawal by Subject|1|||
163010696|NCT00982657|588740270|FG003|Overall Study|Withdrawal by Subject|3|||
163010697|NCT00982657|588740267|FG000|Overall Study|Other|0|||
163010698|NCT00982657|588740268|FG001|Overall Study|Other|0|||
163010699|NCT00982657|588740269|FG002|Overall Study|Other|0|||
163010700|NCT00982657|588740270|FG003|Overall Study|Other|4|||
162640641|NCT01770379|587399897|FG001|Overall Study|Protocol Violation|1|||
162640642|NCT01770379|587399898|FG002|Overall Study|Protocol Violation|1|||
162640643|NCT01770379|587399896|FG000|Overall Study|Physician Decision|0|||
162640644|NCT01770379|587399897|FG001|Overall Study|Physician Decision|1|||
163010701|NCT00982657|588740267|FG000|Overall Study|On going at date of cut-off|0|||
163010702|NCT00982657|588740268|FG001|Overall Study|On going at date of cut-off|0|||
163010703|NCT00982657|588740269|FG002|Overall Study|On going at date of cut-off|0|||
163010704|NCT00982657|588740270|FG003|Overall Study|On going at date of cut-off|1|||
163010705|NCT03760744|588741532|FG000|Overall Study|Lost to Follow-up|3|||
163010706|NCT03760744|588741533|FG001|Overall Study|Lost to Follow-up|0|||
163010707|NCT01102257|588741538|FG000|Overall Study|Adverse Event|1|||
163010708|NCT01102257|588741539|FG001|Overall Study|Adverse Event|0|||
163010709|NCT01102257|588741538|FG000|Overall Study|Adverse Event|1|||
163010710|NCT01102257|588741539|FG001|Overall Study|Adverse Event|0|||
163010711|NCT05364931|588741540|FG000|Overall Study|Adverse Event|0|||
163010712|NCT05364931|588741541|FG001|Overall Study|Adverse Event|2|||
163010713|NCT05364931|588741542|FG002|Overall Study|Adverse Event|1|||
163010714|NCT05364931|588741543|FG003|Overall Study|Adverse Event|0|||
163010715|NCT05364931|588741540|FG000|Overall Study|Lost to Follow-up|1|||
163010716|NCT05364931|588741541|FG001|Overall Study|Lost to Follow-up|0|||
163010717|NCT05364931|588741542|FG002|Overall Study|Lost to Follow-up|0|||
163010718|NCT05364931|588741543|FG003|Overall Study|Lost to Follow-up|0|||
163010719|NCT05364931|588741540|FG000|Overall Study|Withdrawal by Subject|1|||
163010720|NCT05364931|588741541|FG001|Overall Study|Withdrawal by Subject|1|||
163010721|NCT05364931|588741542|FG002|Overall Study|Withdrawal by Subject|3|||
163010722|NCT05364931|588741543|FG003|Overall Study|Withdrawal by Subject|2|||
163010723|NCT05364931|588741540|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010724|NCT05364931|588741541|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
163010725|NCT05364931|588741542|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010726|NCT05364931|588741543|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
163010727|NCT05364931|588741540|FG000|Overall Study|Discontinued|1|||
163010728|NCT05364931|588741541|FG001|Overall Study|Discontinued|0|||
163010729|NCT05364931|588741542|FG002|Overall Study|Discontinued|0|||
163010730|NCT05364931|588741543|FG003|Overall Study|Discontinued|0|||
163010731|NCT05266053|588741546|FG000|Overall Study|Withdrawal by Subject|8|||
163010732|NCT05266053|588741547|FG001|Overall Study|Withdrawal by Subject|4|||
163010733|NCT05344560|588741548|FG000|Period 1|Subject out of visit window|1|||
163010734|NCT05344560|588741549|FG001|Period 1|Subject out of visit window|1|||
163010735|NCT05344560|588741548|FG000|Period 2|Covid-19 Related|1|||
163010736|NCT05344560|588741549|FG001|Period 2|Covid-19 Related|0|||
163010737|NCT05344560|588741548|FG000|Period 2|Adverse Event|1|||
163010738|NCT05344560|588741549|FG001|Period 2|Adverse Event|0|||
163010739|NCT05344560|588741548|FG000|Period 2|Subject out of visit window|1|||
163010740|NCT05344560|588741549|FG001|Period 2|Subject out of visit window|1|||
163010741|NCT05344560|588741548|FG000|Period 3|Subject out of visit window|1|||
163010742|NCT05344560|588741549|FG001|Period 3|Subject out of visit window|0|||
163010743|NCT01051960|588741554|FG000|Overall Study|Adverse Event|1|||
163010744|NCT02996968|588741555|FG000|Overall Study|Withdrawal by Subject|1|||
163010745|NCT02996968|588741556|FG001|Overall Study|Withdrawal by Subject|0|||
163010746|NCT01293695|588741560|FG000|Overall Study|Withdrawal by Subject|7|||
163010747|NCT01293695|588741561|FG001|Overall Study|Withdrawal by Subject|1|||
163010748|NCT01293695|588741560|FG000|Overall Study|Lost to Follow-up|8|||
163010749|NCT01293695|588741561|FG001|Overall Study|Lost to Follow-up|6|||
163010750|NCT00791778|588741565|FG000|Double-blind Treatment|Adverse Event|49|||
163010751|NCT00791778|588741566|FG001|Double-blind Treatment|Adverse Event|9|||
163010752|NCT00791778|588741565|FG000|Double-blind Treatment|Physician Decision|6|||
163010753|NCT00791778|588741566|FG001|Double-blind Treatment|Physician Decision|26|||
163010754|NCT00791778|588741565|FG000|Double-blind Treatment|Protocol Violation|0|||
163010755|NCT00791778|588741566|FG001|Double-blind Treatment|Protocol Violation|4|||
163010756|NCT00791778|588741565|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
163062209|NCT04091451|588935112|FG000|Overall Study|Migrated/moved from the study area|3|||
163062210|NCT04091451|588935113|FG001|Overall Study|Migrated/moved from the study area|5|||
163062211|NCT04091451|588935112|FG000|Overall Study|Suspected HZ episode|1|||
163010757|NCT00791778|588741566|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
163010758|NCT00791778|588741565|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
163010759|NCT00791778|588741566|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
163010760|NCT00791778|588741565|FG000|Follow-up|Withdrawal by Subject|3|||
163010761|NCT00791778|588741566|FG001|Follow-up|Withdrawal by Subject|0|||
163010762|NCT00791778|588741565|FG000|Follow-up|Lost to Follow-up|2|||
163010763|NCT00791778|588741566|FG001|Follow-up|Lost to Follow-up|1|||
163010764|NCT01082328|588741567|FG000|Overall Study|Adverse Event|1|||
163010765|NCT00031590|588741568|FG000|Overall Study|Adverse Event|1|||
163062212|NCT04091451|588935113|FG001|Overall Study|Suspected HZ episode|0|||
163010766|NCT00031590|588741568|FG000|Overall Study|Withdrawal by parents|2|||
163010767|NCT05506046|588741571|FG000|Overall Study|Lost to Follow-up|89|||
163010768|NCT05506046|588741572|FG001|Overall Study|Lost to Follow-up|101|||
163010769|NCT05506046|588741573|FG002|Overall Study|Lost to Follow-up|102|||
163010770|NCT05506046|588741574|FG003|Overall Study|Lost to Follow-up|99|||
163010771|NCT03313180|588741578|FG000|Overall Study|Adverse Event|120|||
163010772|NCT03313180|588741578|FG000|Overall Study|Lost to Follow-up|3|||
163010773|NCT03313180|588741578|FG000|Overall Study|Withdrawal by Subject|39|||
163010774|NCT03313180|588741578|FG000|Overall Study|Other than listed above|15|||
163010775|NCT03313180|588741578|FG000|Overall Study|Covid-19 related|2|||
163010776|NCT01058642|588741580|FG000|Treatment Period 1|Adverse Event|0|||
163010777|NCT01058642|588741581|FG001|Treatment Period 1|Adverse Event|1|||
163010778|NCT01058642|588741582|FG002|Treatment Period 1|Adverse Event|1|||
163010779|NCT01058642|588741583|FG003|Treatment Period 1|Adverse Event|0|||
163010780|NCT01058642|588741580|FG000|Treatment Period 1|Physician Decision|0|||
163010781|NCT01058642|588741581|FG001|Treatment Period 1|Physician Decision|0|||
163010782|NCT01058642|588741582|FG002|Treatment Period 1|Physician Decision|1|||
163010783|NCT01058642|588741583|FG003|Treatment Period 1|Physician Decision|0|||
163010784|NCT01058642|588741580|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163010785|NCT01058642|588741581|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163010786|NCT01058642|588741582|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163010787|NCT01058642|588741583|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163010788|NCT01058642|588741580|FG000|Treatment Period 1|Lack of Efficacy|0|||
163010789|NCT01058642|588741581|FG001|Treatment Period 1|Lack of Efficacy|0|||
163010790|NCT01058642|588741582|FG002|Treatment Period 1|Lack of Efficacy|0|||
163010791|NCT01058642|588741583|FG003|Treatment Period 1|Lack of Efficacy|1|||
163010792|NCT01058642|588741580|FG000|Treatment Period 1|Protocol Violation|0|||
163010793|NCT01058642|588741581|FG001|Treatment Period 1|Protocol Violation|0|||
163010794|NCT01058642|588741582|FG002|Treatment Period 1|Protocol Violation|0|||
163010795|NCT01058642|588741583|FG003|Treatment Period 1|Protocol Violation|1|||
163010796|NCT01058642|588741580|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
163010797|NCT01058642|588741581|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010798|NCT01058642|588741582|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010799|NCT01058642|588741583|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
163010800|NCT04177095|588741594|FG000|Overall Study|Withdrawal by Subject|3|||
163010801|NCT04177095|588741594|FG000|Overall Study|Screen Failure|3|||
163010802|NCT04177095|588741594|FG000|Overall Study|Problems with the Trugraf assay|1|||
163010803|NCT03810092|588741595|FG000|Overall Study|no ground support|17|||
163010804|NCT03810092|588741595|FG000|Overall Study|ADL not done at J0|16|||
163010805|NCT03810092|588741595|FG000|Overall Study|No hemoglobin measure at J5|27|||
163010806|NCT00235755|588741597|FG000|4-Week Titration Phase|Adverse Event|6|||
163010807|NCT00235755|588741598|FG001|4-Week Titration Phase|Adverse Event|14|||
163010808|NCT00235755|588741599|FG002|4-Week Titration Phase|Adverse Event|20|||
163010809|NCT00235755|588741597|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
163010810|NCT00235755|588741598|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
163010811|NCT00235755|588741599|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
163010812|NCT00235755|588741597|FG000|4-Week Titration Phase|Protocol Violation|2|||
163010813|NCT00235755|588741598|FG001|4-Week Titration Phase|Protocol Violation|2|||
163010814|NCT00235755|588741599|FG002|4-Week Titration Phase|Protocol Violation|1|||
163010815|NCT00235755|588741597|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
163010816|NCT00235755|588741598|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
163010817|NCT00235755|588741599|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
163010818|NCT00235755|588741597|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163010819|NCT00235755|588741598|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163010820|NCT00235755|588741599|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
163010821|NCT00235755|588741597|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
163010822|NCT00235755|588741598|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
163010823|NCT00235755|588741599|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
163010824|NCT00235755|588741597|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
163010825|NCT00235755|588741598|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
163010826|NCT00235755|588741599|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
163010827|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Adverse Event|8|||
163010828|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Adverse Event|12|||
163010829|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Adverse Event|26|||
163010830|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
163062213|NCT03074500|588935114|FG000|Overall Study|Lost to Follow-up|1|||
163062214|NCT03074500|588935115|FG001|Overall Study|Lost to Follow-up|0|||
163062215|NCT03074500|588935116|FG002|Overall Study|Lost to Follow-up|0|||
163062216|NCT03074500|588935114|FG000|Overall Study|Lack of Efficacy|0|||
163062217|NCT03074500|588935115|FG001|Overall Study|Lack of Efficacy|1|||
163062218|NCT03074500|588935116|FG002|Overall Study|Lack of Efficacy|0|||
163010831|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
163010832|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
163010833|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
163010834|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
163010835|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
163010836|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
163010837|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
163010838|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
163010839|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
163010840|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
163010841|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
163010842|NCT00235755|588741597|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
163010843|NCT00235755|588741598|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
163010844|NCT00235755|588741599|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
163010845|NCT00806403|588741604|FG000|Overall Study|Death|4|||
163062219|NCT03074500|588935114|FG000|Overall Study|Adverse Event|0|||
163010846|NCT00806403|588741605|FG001|Overall Study|Death|3|||
163010847|NCT01320293|588741606|FG000|Overall Study|Lack of Efficacy|1|||
163010848|NCT01320293|588741606|FG000|Overall Study|Adverse Event|1|||
162715952|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162715953|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162715954|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163010849|NCT01532934|588741609|FG000|Overall Study|Lost to Follow-up|11|||
163010850|NCT01532934|588741610|FG001|Overall Study|Lost to Follow-up|11|||
163010851|NCT01532934|588741609|FG000|Overall Study|In controlled environment|3|||
163010852|NCT01532934|588741610|FG001|Overall Study|In controlled environment|2|||
163010853|NCT00468819|588741612|FG000|Overall Study|Withdrawal by Subject|4|||
163062220|NCT03074500|588935115|FG001|Overall Study|Adverse Event|0|||
163062221|NCT03074500|588935116|FG002|Overall Study|Adverse Event|1|||
163062222|NCT00634504|588936830|FG000|Overall Study|Protocol Violation|1|||
163062223|NCT00634504|588936831|FG001|Overall Study|Protocol Violation|0|||
163062224|NCT00937950|588936832|FG000|Overall Study|Withdrawal by Subject|23|||
163062225|NCT00937950|588936832|FG000|Overall Study|Migrated/moved from study area|27|||
162715955|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163062226|NCT00937950|588936832|FG000|Overall Study|Lost to Follow-up|144|||
162715956|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163010854|NCT00468819|588741613|FG001|Overall Study|Withdrawal by Subject|0|||
163010855|NCT00468819|588741614|FG002|Overall Study|Withdrawal by Subject|1|||
163010856|NCT00468819|588741612|FG000|Overall Study|Lost to Follow-up|0|||
163010857|NCT00468819|588741613|FG001|Overall Study|Lost to Follow-up|0|||
163010858|NCT00468819|588741614|FG002|Overall Study|Lost to Follow-up|1|||
163062227|NCT00937950|588936832|FG000|Overall Study|Missing confirmed|4|||
163062228|NCT00937950|588936832|FG000|Overall Study|Other|18|||
163062229|NCT03483103|588936837|FG000|Pre-Treatment Phase|Other reasons|1|||
163062230|NCT03483103|588936837|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
163062231|NCT03483103|588936837|FG000|Pre-Treatment Phase|Disease-related complications|1|||
163062232|NCT03483103|588936837|FG000|Pre-Treatment Phase|Death|5|||
163062233|NCT03483103|588936837|FG000|Treatment Phase|Withdrawal by Subject|7|||
163062234|NCT03483103|588936837|FG000|Treatment Phase|Other reasons|1|||
163062235|NCT03483103|588936837|FG000|Treatment Phase|Death|23|||
163062236|NCT03483103|588936837|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
163062237|NCT03483103|588936837|FG000|Treatment Phase|Received nonconforming product|1|||
163062238|NCT02475213|588936838|FG000|Overall Study|Adverse Event|2|||
163062239|NCT02475213|588936839|FG001|Overall Study|Adverse Event|0|||
163062240|NCT02475213|588936840|FG002|Overall Study|Adverse Event|0|||
163062241|NCT02475213|588936841|FG003|Overall Study|Adverse Event|1|||
163062242|NCT02475213|588936842|FG004|Overall Study|Adverse Event|1|||
163062243|NCT02475213|588936843|FG005|Overall Study|Adverse Event|4|||
163062244|NCT02475213|588936844|FG006|Overall Study|Adverse Event|6|||
163062245|NCT02475213|588936845|FG007|Overall Study|Adverse Event|2|||
163062246|NCT02475213|588936838|FG000|Overall Study|Physician Decision|1|||
163062247|NCT02475213|588936839|FG001|Overall Study|Physician Decision|1|||
163062248|NCT02475213|588936840|FG002|Overall Study|Physician Decision|1|||
163062249|NCT02475213|588936841|FG003|Overall Study|Physician Decision|0|||
163062250|NCT02475213|588936842|FG004|Overall Study|Physician Decision|0|||
163062251|NCT02475213|588936843|FG005|Overall Study|Physician Decision|1|||
163062252|NCT02475213|588936844|FG006|Overall Study|Physician Decision|4|||
163062253|NCT02475213|588936845|FG007|Overall Study|Physician Decision|0|||
163062254|NCT02475213|588936838|FG000|Overall Study|Progressive Disease|3|||
163062255|NCT02475213|588936839|FG001|Overall Study|Progressive Disease|2|||
163062256|NCT02475213|588936840|FG002|Overall Study|Progressive Disease|2|||
163062257|NCT02475213|588936841|FG003|Overall Study|Progressive Disease|13|||
163062258|NCT02475213|588936842|FG004|Overall Study|Progressive Disease|15|||
163062259|NCT02475213|588936843|FG005|Overall Study|Progressive Disease|25|||
163062260|NCT02475213|588936844|FG006|Overall Study|Progressive Disease|30|||
163010859|NCT00468819|588741612|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
163010860|NCT00468819|588741613|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
163010861|NCT00468819|588741614|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
163010862|NCT03759392|588741617|FG000|Overall Study|Adverse Event|12|||
163010863|NCT03759392|588741618|FG001|Overall Study|Adverse Event|4|||
163010864|NCT03759392|588741617|FG000|Overall Study|Death|2|||
163010865|NCT03759392|588741618|FG001|Overall Study|Death|1|||
163010866|NCT03759392|588741617|FG000|Overall Study|Withdrawal by Subject|2|||
163010867|NCT03759392|588741618|FG001|Overall Study|Withdrawal by Subject|0|||
163010868|NCT03759392|588741617|FG000|Overall Study|Protocol Violation|2|||
163010869|NCT03759392|588741618|FG001|Overall Study|Protocol Violation|0|||
163010870|NCT03759392|588741617|FG000|Overall Study|Physician Decision|0|||
163010871|NCT03759392|588741618|FG001|Overall Study|Physician Decision|1|||
163010872|NCT03759392|588741617|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
163010873|NCT03759392|588741618|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
163010874|NCT03759392|588741617|FG000|Overall Study|No longer able to take medicines|1|||
163010875|NCT03759392|588741618|FG001|Overall Study|No longer able to take medicines|0|||
163010876|NCT03759392|588741617|FG000|Overall Study|Stopped taking study drug|1|||
163010877|NCT03759392|588741618|FG001|Overall Study|Stopped taking study drug|0|||
163010878|NCT01288079|588741619|FG000|Overall Study|Withdrawal by Subject|2|||
163010879|NCT01288079|588741620|FG001|Overall Study|Withdrawal by Subject|4|||
163010880|NCT01288079|588741621|FG002|Overall Study|Withdrawal by Subject|1|||
163010881|NCT01288079|588741622|FG003|Overall Study|Withdrawal by Subject|0|||
163010882|NCT01288079|588741619|FG000|Overall Study|Adverse Event|2|||
163010883|NCT01288079|588741620|FG001|Overall Study|Adverse Event|1|||
163010884|NCT01288079|588741621|FG002|Overall Study|Adverse Event|2|||
163010885|NCT01288079|588741622|FG003|Overall Study|Adverse Event|3|||
163010886|NCT01288079|588741619|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
163010887|NCT01288079|588741620|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
163010888|NCT01288079|588741621|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
163010889|NCT01288079|588741622|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
163010890|NCT01288079|588741619|FG000|Overall Study|Condition under Investigation Worsened|0|||
163010891|NCT01288079|588741620|FG001|Overall Study|Condition under Investigation Worsened|0|||
163010892|NCT01288079|588741621|FG002|Overall Study|Condition under Investigation Worsened|0|||
163010893|NCT01288079|588741622|FG003|Overall Study|Condition under Investigation Worsened|1|||
163010894|NCT01288079|588741619|FG000|Overall Study|Lack of Efficacy|2|||
163010895|NCT01288079|588741620|FG001|Overall Study|Lack of Efficacy|2|||
163010896|NCT01288079|588741621|FG002|Overall Study|Lack of Efficacy|0|||
163010897|NCT01288079|588741622|FG003|Overall Study|Lack of Efficacy|2|||
163010898|NCT01288079|588741619|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
163010899|NCT01288079|588741620|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163010900|NCT01288079|588741621|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
163010901|NCT01288079|588741622|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
163010902|NCT01288079|588741619|FG000|Overall Study|Lost to Follow-up|1|||
163010903|NCT01288079|588741620|FG001|Overall Study|Lost to Follow-up|1|||
163010904|NCT01288079|588741621|FG002|Overall Study|Lost to Follow-up|1|||
163010905|NCT01288079|588741622|FG003|Overall Study|Lost to Follow-up|0|||
163010906|NCT01288079|588741619|FG000|Overall Study|Other or Study Termination|11|||
163010907|NCT01288079|588741620|FG001|Overall Study|Other or Study Termination|15|||
163010908|NCT01288079|588741621|FG002|Overall Study|Other or Study Termination|14|||
163010909|NCT01288079|588741622|FG003|Overall Study|Other or Study Termination|8|||
163010910|NCT03170544|588741623|FG000|Part 1|Lost to Follow-up|1|||
163010911|NCT03170544|588741624|FG001|Part 1|Lost to Follow-up|0|||
163010912|NCT03170544|588741625|FG002|Part 1|Lost to Follow-up|0|||
163010913|NCT03170544|588741626|FG003|Part 1|Lost to Follow-up|0|||
163010914|NCT03170544|588741627|FG004|Part 1|Lost to Follow-up|0|||
163010915|NCT03170544|588741628|FG005|Part 1|Lost to Follow-up|0|||
163010916|NCT03170544|588741629|FG006|Part 1|Lost to Follow-up|0|||
163062261|NCT02475213|588936845|FG007|Overall Study|Progressive Disease|10|||
163010917|NCT03170544|588741630|FG007|Part 1|Lost to Follow-up|0|||
163062262|NCT02475213|588936838|FG000|Overall Study|Death|0|||
163062263|NCT02475213|588936839|FG001|Overall Study|Death|0|||
163062264|NCT02475213|588936840|FG002|Overall Study|Death|0|||
163010918|NCT03170544|588741631|FG008|Part 1|Lost to Follow-up|0|||
163010919|NCT03170544|588741632|FG009|Part 1|Lost to Follow-up|0|||
163010920|NCT03170544|588741633|FG010|Part 1|Lost to Follow-up|0|||
163010921|NCT03170544|588741634|FG011|Part 1|Lost to Follow-up|0|||
163010922|NCT03170544|588741623|FG000|Part 1|Not treated|0|||
163010923|NCT03170544|588741624|FG001|Part 1|Not treated|0|||
163010924|NCT03170544|588741625|FG002|Part 1|Not treated|0|||
163010925|NCT03170544|588741626|FG003|Part 1|Not treated|1|||
163010926|NCT03170544|588741627|FG004|Part 1|Not treated|0|||
163010927|NCT03170544|588741628|FG005|Part 1|Not treated|0|||
163010928|NCT03170544|588741629|FG006|Part 1|Not treated|0|||
163062265|NCT02475213|588936841|FG003|Overall Study|Death|0|||
163010929|NCT03170544|588741630|FG007|Part 1|Not treated|0|||
163010930|NCT03170544|588741631|FG008|Part 1|Not treated|0|||
163010931|NCT03170544|588741632|FG009|Part 1|Not treated|0|||
163010932|NCT03170544|588741633|FG010|Part 1|Not treated|0|||
163010933|NCT03170544|588741634|FG011|Part 1|Not treated|0|||
163010934|NCT02387840|588741635|FG000|Overall Study|Death|0|||
163010935|NCT02387840|588741636|FG001|Overall Study|Death|0|||
163010936|NCT02387840|588741637|FG002|Overall Study|Death|0|||
163010937|NCT02387840|588741638|FG003|Overall Study|Death|0|||
163010938|NCT02387840|588741639|FG004|Overall Study|Death|0|||
162715957|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163010939|NCT02387840|588741640|FG005|Overall Study|Death|1|||
163010940|NCT01213966|588741641|FG000|Overall Study|Protocol Violation|1|||
163010941|NCT01213966|588741642|FG001|Overall Study|Protocol Violation|0|||
163010942|NCT01213966|588741643|FG002|Overall Study|Protocol Violation|3|||
163010943|NCT01213966|588741644|FG003|Overall Study|Protocol Violation|1|||
163010944|NCT00420420|588741659|FG000|Overall Study|Adverse Event|5|||
163010945|NCT00420420|588741660|FG001|Overall Study|Adverse Event|3|||
163010946|NCT00420420|588741659|FG000|Overall Study|Protocol Violation|1|||
163010947|NCT00420420|588741660|FG001|Overall Study|Protocol Violation|1|||
163010948|NCT00420420|588741659|FG000|Overall Study|Withdrawal by Subject|1|||
163010949|NCT00420420|588741660|FG001|Overall Study|Withdrawal by Subject|0|||
163010950|NCT00420420|588741659|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
163010951|NCT00420420|588741660|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
162715958|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163010952|NCT00273182|588741661|FG000|Overall Study|Death|450|||
163010953|NCT00273182|588741661|FG000|Overall Study|Lost to Follow-up|88|||
163010954|NCT00273182|588741661|FG000|Overall Study|Withdrawal by Subject|257|||
163010955|NCT00273182|588741661|FG000|Overall Study|Device/System Explant|154|||
163062266|NCT02475213|588936842|FG004|Overall Study|Death|0|||
163010956|NCT00273182|588741661|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
163010957|NCT04762160|588741662|FG000|Overall Study|Study terminated early due to business reasons|5|||
163010958|NCT00536939|588743696|FG000|Overall Study|Withdrawal by Subject|1|||
163010959|NCT00536939|588743697|FG001|Overall Study|Withdrawal by Subject|0|||
163010960|NCT00536939|588743696|FG000|Overall Study|Other Complicating Disease|1|||
163010961|NCT00536939|588743697|FG001|Overall Study|Other Complicating Disease|0|||
163010962|NCT01100086|588743698|FG000|Period 1|Withdrawal by Subject|1|||
163010963|NCT01100086|588743699|FG001|Period 1|Withdrawal by Subject|0|||
163010964|NCT01611935|588743702|FG000|Overall Study|Family Declined Participation|1|||
163010965|NCT01611935|588743703|FG001|Overall Study|Family Declined Participation|0|||
163010966|NCT04227197|588743704|FG000|Randomization|Protocol Violation|1|||
163010967|NCT04227197|588743705|FG001|Randomization|Protocol Violation|0|||
163010968|NCT04227197|588743704|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
163010969|NCT04227197|588743705|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
163010970|NCT04227197|588743704|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
163010971|NCT04227197|588743705|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
163010972|NCT04227197|588743704|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
163010973|NCT04227197|588743705|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
163010974|NCT04227197|588743704|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
163010975|NCT04227197|588743705|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
163010976|NCT04227197|588743704|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
163010977|NCT04227197|588743705|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
163010978|NCT04227197|588743704|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
163010979|NCT04227197|588743705|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
163010980|NCT02549859|588743710|FG000|Long-term 60 Hz DBS|Study Closed|1|||
163010981|NCT01209949|588743718|FG000|Overall Study|Lost to Follow-up|3|||
163010982|NCT00729612|588743719|FG000|Overall Study|Non evaluable for response|10|||
163010983|NCT00708552|588743720|FG000|Overall Study|Adverse Event|10|||
163010984|NCT00708552|588743721|FG001|Overall Study|Adverse Event|3|||
163062267|NCT02475213|588936843|FG005|Overall Study|Death|4|||
163062268|NCT02475213|588936844|FG006|Overall Study|Death|1|||
163062269|NCT02475213|588936845|FG007|Overall Study|Death|0|||
163062270|NCT02475213|588936838|FG000|Overall Study|Protocol Violation|0|||
163062271|NCT02475213|588936839|FG001|Overall Study|Protocol Violation|0|||
163062272|NCT02475213|588936840|FG002|Overall Study|Protocol Violation|0|||
163062273|NCT02475213|588936841|FG003|Overall Study|Protocol Violation|0|||
163062274|NCT02475213|588936842|FG004|Overall Study|Protocol Violation|1|||
163062275|NCT02475213|588936843|FG005|Overall Study|Protocol Violation|0|||
163062276|NCT02475213|588936844|FG006|Overall Study|Protocol Violation|0|||
163062277|NCT02475213|588936845|FG007|Overall Study|Protocol Violation|0|||
163062278|NCT02475213|588936838|FG000|Overall Study|Withdrawal by Subject|0|||
163062279|NCT02475213|588936839|FG001|Overall Study|Withdrawal by Subject|0|||
163062280|NCT02475213|588936840|FG002|Overall Study|Withdrawal by Subject|0|||
163062281|NCT02475213|588936841|FG003|Overall Study|Withdrawal by Subject|1|||
163062282|NCT02475213|588936842|FG004|Overall Study|Withdrawal by Subject|0|||
163062283|NCT02475213|588936843|FG005|Overall Study|Withdrawal by Subject|2|||
163062284|NCT02475213|588936844|FG006|Overall Study|Withdrawal by Subject|2|||
163062285|NCT02475213|588936845|FG007|Overall Study|Withdrawal by Subject|0|||
163062286|NCT02475213|588936838|FG000|Overall Study|Other|0|||
163062287|NCT02475213|588936839|FG001|Overall Study|Other|0|||
163062288|NCT02475213|588936840|FG002|Overall Study|Other|0|||
163062289|NCT02475213|588936841|FG003|Overall Study|Other|1|||
163062290|NCT02475213|588936842|FG004|Overall Study|Other|3|||
163062291|NCT02475213|588936843|FG005|Overall Study|Other|1|||
163062292|NCT02475213|588936844|FG006|Overall Study|Other|0|||
163062293|NCT02475213|588936845|FG007|Overall Study|Other|0|||
163062294|NCT00505921|588936846|FG000|Overall Study|Ineligible|1|||
163062295|NCT00505921|588936846|FG000|Overall Study|Failed to Mobilize|8|||
163062296|NCT00630292|588936847|FG000|Overall Study|Withdrawal by Subject|1|||
163062297|NCT00717886|588936849|FG000|Overall Study|Withdrawal by Subject|3|||
163010985|NCT00708552|588743722|FG002|Overall Study|Adverse Event|4|||
163010986|NCT00708552|588743723|FG003|Overall Study|Adverse Event|6|||
163010987|NCT00708552|588743720|FG000|Overall Study|Lack of Efficacy|0|||
163010988|NCT00708552|588743721|FG001|Overall Study|Lack of Efficacy|4|||
163010989|NCT00708552|588743722|FG002|Overall Study|Lack of Efficacy|1|||
163010990|NCT00708552|588743723|FG003|Overall Study|Lack of Efficacy|0|||
163010991|NCT00708552|588743720|FG000|Overall Study|Protocol Violation|0|||
163062298|NCT00717886|588936849|FG000|Overall Study|Treatment Failure|1|||
163062299|NCT01553851|588936850|FG000|Overall Study|Adverse Event|2|||
163062300|NCT01553851|588936850|FG000|Overall Study|constipation|1|||
163062301|NCT00797563|588936851|FG000|Overall Study|Adverse Event|1|||
162640645|NCT01770379|587399898|FG002|Overall Study|Physician Decision|2|||
162640646|NCT01770379|587399896|FG000|Overall Study|Lost to Follow-up|0|||
162640647|NCT01770379|587399897|FG001|Overall Study|Lost to Follow-up|0|||
162640648|NCT01770379|587399898|FG002|Overall Study|Lost to Follow-up|2|||
162640649|NCT01770379|587399896|FG000|Overall Study|Lack of Efficacy|8|||
162640650|NCT01770379|587399897|FG001|Overall Study|Lack of Efficacy|6|||
162640651|NCT01770379|587399898|FG002|Overall Study|Lack of Efficacy|6|||
162640652|NCT01770379|587399896|FG000|Overall Study|Adverse Event|1|||
162640653|NCT01770379|587399897|FG001|Overall Study|Adverse Event|3|||
162640654|NCT01770379|587399898|FG002|Overall Study|Adverse Event|2|||
162640655|NCT00778700|587399899|FG000|Overall Study|Adverse Event|6|||
162640656|NCT00778700|587399900|FG001|Overall Study|Adverse Event|1|||
162640657|NCT00778700|587399901|FG002|Overall Study|Adverse Event|3|||
163010992|NCT00708552|588743721|FG001|Overall Study|Protocol Violation|0|||
163010993|NCT00708552|588743722|FG002|Overall Study|Protocol Violation|2|||
163010994|NCT00708552|588743723|FG003|Overall Study|Protocol Violation|4|||
163010995|NCT00708552|588743720|FG000|Overall Study|Lost to Follow-up|4|||
163010996|NCT00708552|588743721|FG001|Overall Study|Lost to Follow-up|2|||
163010997|NCT00708552|588743722|FG002|Overall Study|Lost to Follow-up|0|||
163010998|NCT00708552|588743723|FG003|Overall Study|Lost to Follow-up|1|||
163010999|NCT00708552|588743720|FG000|Overall Study|Physician Decision|1|||
163011000|NCT00708552|588743721|FG001|Overall Study|Physician Decision|2|||
163011001|NCT00708552|588743722|FG002|Overall Study|Physician Decision|0|||
163011002|NCT00708552|588743723|FG003|Overall Study|Physician Decision|0|||
163011003|NCT00708552|588743720|FG000|Overall Study|Withdrawal by Subject|12|||
163011004|NCT00708552|588743721|FG001|Overall Study|Withdrawal by Subject|7|||
163011005|NCT00708552|588743722|FG002|Overall Study|Withdrawal by Subject|8|||
163011006|NCT00708552|588743723|FG003|Overall Study|Withdrawal by Subject|10|||
163011007|NCT02309411|588743724|FG000|Overall Study|Physician Decision|1|||
163011008|NCT02309411|588743725|FG001|Overall Study|Physician Decision|0|||
163011009|NCT02309411|588743726|FG002|Overall Study|Physician Decision|0|||
163062302|NCT03822416|588936857|FG000|Overall Study|Lost to Follow-up|1|||
163062303|NCT03822416|588936858|FG001|Overall Study|Lost to Follow-up|0|||
163062304|NCT03822416|588936857|FG000|Overall Study|Withdrawal by Subject|0|||
163062305|NCT03822416|588936858|FG001|Overall Study|Withdrawal by Subject|1|||
163062306|NCT04666298|588936859|FG000|Overall Study|Subject decision|1|||
163062307|NCT04666298|588936860|FG001|Overall Study|Subject decision|0|||
163062308|NCT04666298|588936861|FG002|Overall Study|Subject decision|0|||
163062309|NCT04666298|588936862|FG003|Overall Study|Subject decision|2|||
163062310|NCT04666298|588936859|FG000|Overall Study|Death|1|||
163062311|NCT04666298|588936860|FG001|Overall Study|Death|0|||
163062312|NCT04666298|588936861|FG002|Overall Study|Death|0|||
163062313|NCT04666298|588936862|FG003|Overall Study|Death|0|||
163062314|NCT04666298|588936859|FG000|Overall Study|Lost to Follow-up|0|||
163062315|NCT04666298|588936860|FG001|Overall Study|Lost to Follow-up|0|||
163062316|NCT04666298|588936861|FG002|Overall Study|Lost to Follow-up|0|||
163062317|NCT04666298|588936862|FG003|Overall Study|Lost to Follow-up|1|||
163062318|NCT04666298|588936859|FG000|Overall Study|Physician Decision|0|||
163062319|NCT04666298|588936860|FG001|Overall Study|Physician Decision|0|||
163062320|NCT04666298|588936861|FG002|Overall Study|Physician Decision|0|||
163062321|NCT04666298|588936862|FG003|Overall Study|Physician Decision|1|||
163062322|NCT04666298|588936859|FG000|Overall Study|Protocol deviation|0|||
163062323|NCT04666298|588936860|FG001|Overall Study|Protocol deviation|0|||
163062324|NCT04666298|588936861|FG002|Overall Study|Protocol deviation|1|||
163062325|NCT04666298|588936862|FG003|Overall Study|Protocol deviation|0|||
163062326|NCT00844519|588936863|FG000|Overall Study|Withdrawal by Subject|1|||
163062327|NCT00844519|588936864|FG001|Overall Study|Withdrawal by Subject|1|||
163062328|NCT00844519|588936863|FG000|Overall Study|Adverse Event|1|||
163062329|NCT00844519|588936864|FG001|Overall Study|Adverse Event|0|||
163062330|NCT01303419|588936865|FG000|Overall Study|Discontinuation of study|60|||
163062331|NCT01303419|588936865|FG000|Overall Study|Did not complete both imaging methods|5|||
163062332|NCT01303419|588936865|FG000|Overall Study|Did not meet all I/E after screening|31|||
163062333|NCT06438601|588936866|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
163062334|NCT06438601|588936867|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
163062335|NCT06438601|588936866|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
163062336|NCT06438601|588936867|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
163062337|NCT03329001|588936868|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062338|NCT03329001|588936869|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062339|NCT03329001|588936870|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
163062340|NCT03329001|588936871|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
163062341|NCT03329001|588936872|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062342|NCT03329001|588936873|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062343|NCT03329001|588936874|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163062344|NCT03329001|588936875|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
163011010|NCT02309411|588743724|FG000|Overall Study|Withdrawal by Subject|1|||
163011011|NCT02309411|588743725|FG001|Overall Study|Withdrawal by Subject|1|||
163062345|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062346|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062347|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062348|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
163062349|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062350|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163011012|NCT02309411|588743726|FG002|Overall Study|Withdrawal by Subject|0|||
163011013|NCT04878432|588743728|FG000|Overall Study|Adverse Event|1|||
163011014|NCT04878432|588743728|FG000|Overall Study|Death|2|||
163062351|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062352|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
163062353|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
162715959|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
162715960|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163011015|NCT04878432|588743728|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163011016|NCT04878432|588743728|FG000|Overall Study|Withdrawal by Subject|6|||
163011017|NCT04878432|588743728|FG000|Overall Study|Progressive Disease|7|||
163011018|NCT04878432|588743728|FG000|Overall Study|New Therapy for Study Indication|7|||
163011019|NCT04878432|588743728|FG000|Overall Study|Physician Decision|11|||
163011020|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011021|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
163011022|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011023|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011024|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
163011025|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
163062354|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062355|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062356|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
163062357|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062358|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062359|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062360|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
163062361|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062362|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062363|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062364|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
163062365|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062366|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062367|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062368|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
163062369|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062370|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163011026|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
163011027|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
163011028|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163062371|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
163062372|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062373|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062374|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062375|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062376|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
163062377|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062378|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
162715961|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162715962|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162715963|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162715964|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162715965|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715966|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715967|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715968|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715969|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715970|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
162715971|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715972|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715973|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715974|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715975|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715976|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
162715977|NCT03536884|587667091|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162715978|NCT03536884|587667092|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162715979|NCT03536884|587667093|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162715980|NCT03536884|587667094|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163011029|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163011030|NCT03971071|588743729|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
163011031|NCT03971071|588743730|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
163011032|NCT03971071|588743731|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
163011033|NCT03971071|588743732|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
163011034|NCT03971071|588743733|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
163011035|NCT03971071|588743729|FG000|Open-label Treatment Period|Sponsor decision|0|||
163011036|NCT03971071|588743730|FG001|Open-label Treatment Period|Sponsor decision|0|||
163011037|NCT03971071|588743731|FG002|Open-label Treatment Period|Sponsor decision|0|||
163011038|NCT03971071|588743732|FG003|Open-label Treatment Period|Sponsor decision|0|||
163011039|NCT03971071|588743733|FG004|Open-label Treatment Period|Sponsor decision|1|||
163011040|NCT03971071|588743729|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
163011041|NCT03971071|588743730|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163011042|NCT03971071|588743731|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163011043|NCT03971071|588743732|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
163011044|NCT03971071|588743733|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
163011045|NCT03971071|588743729|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163011046|NCT03971071|588743730|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163011047|NCT03971071|588743731|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163011048|NCT03971071|588743732|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163011049|NCT03971071|588743733|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
163011050|NCT00495391|588743734|FG000|Overall Study|Lack of Efficacy|34|||
163011051|NCT00495391|588743735|FG001|Overall Study|Lack of Efficacy|18|||
163011052|NCT00495391|588743734|FG000|Overall Study|Withdrawal by Subject|2|||
163011053|NCT00495391|588743735|FG001|Overall Study|Withdrawal by Subject|3|||
163011054|NCT03214224|588743736|FG000|Overall Study|Protocol Violation|1|||
163011055|NCT03214224|588743736|FG000|Overall Study|Withdrawal by Subject|2|||
163011056|NCT03214224|588743736|FG000|Overall Study|Practice controls or therapists|6|||
163011057|NCT02712320|588743745|FG000|Overall Study|Lost to Follow-up|1|||
163011058|NCT02712320|588743745|FG000|Overall Study|Withdrawal by Subject|1|||
163011059|NCT02712320|588743745|FG000|Overall Study|Transferred to another facility|1|||
163011060|NCT02712320|588743745|FG000|Overall Study|Treating with the prohibited medications|2|||
163011061|NCT00360282|588743746|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011062|NCT00360282|588743747|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011063|NCT00360282|588743748|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
163011064|NCT00360282|588743749|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
163011065|NCT00360282|588743746|FG000|Second Intervention|Adverse Event|0|||
163011066|NCT00360282|588743747|FG001|Second Intervention|Adverse Event|1|||
163011067|NCT00360282|588743748|FG002|Second Intervention|Adverse Event|0|||
163011068|NCT00360282|588743749|FG003|Second Intervention|Adverse Event|0|||
163011069|NCT04537078|588743750|FG000|Overall Study|Protocol Violation|3|||
163011070|NCT04537078|588743751|FG001|Overall Study|Protocol Violation|2|||
163011071|NCT04537078|588743750|FG000|Overall Study|Lost to Follow-up|1|||
163011072|NCT04537078|588743751|FG001|Overall Study|Lost to Follow-up|0|||
163011073|NCT04537078|588743750|FG000|Overall Study|Withdrawal by Subject|0|||
163011074|NCT04537078|588743751|FG001|Overall Study|Withdrawal by Subject|1|||
163011075|NCT03207815|588743752|FG000|Overall Study|Protocol Violation|3|||
163011076|NCT03207815|588743753|FG001|Overall Study|Protocol Violation|1|||
163011077|NCT03207815|588743752|FG000|Overall Study|Adverse Event|1|||
163011078|NCT03207815|588743753|FG001|Overall Study|Adverse Event|2|||
163011079|NCT03207815|588743752|FG000|Overall Study|Lost to Follow-up|1|||
163011080|NCT03207815|588743753|FG001|Overall Study|Lost to Follow-up|2|||
163011081|NCT03207815|588743752|FG000|Overall Study|Investigator's Discretion|1|||
163011082|NCT03207815|588743753|FG001|Overall Study|Investigator's Discretion|1|||
163011083|NCT03207815|588743752|FG000|Overall Study|Lack of Efficacy|0|||
163011084|NCT03207815|588743753|FG001|Overall Study|Lack of Efficacy|1|||
163011085|NCT03207815|588743752|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
163011086|NCT03207815|588743753|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
163011087|NCT03207815|588743752|FG000|Overall Study|Withdrew Consent|1|||
163011088|NCT03207815|588743753|FG001|Overall Study|Withdrew Consent|0|||
163011089|NCT00391768|588743754|FG000|Overall Study|Withdrawal by Subject|0|||
163011090|NCT00391768|588743755|FG001|Overall Study|Withdrawal by Subject|0|||
163011091|NCT00391768|588743756|FG002|Overall Study|Withdrawal by Subject|1|||
163011092|NCT00391768|588743757|FG003|Overall Study|Withdrawal by Subject|0|||
163011093|NCT00391768|588743758|FG004|Overall Study|Withdrawal by Subject|0|||
163011094|NCT00391768|588743759|FG005|Overall Study|Withdrawal by Subject|1|||
163011095|NCT00391768|588743760|FG006|Overall Study|Withdrawal by Subject|1|||
163011096|NCT00391768|588743754|FG000|Overall Study|Lost to Follow-up|0|||
163011097|NCT00391768|588743755|FG001|Overall Study|Lost to Follow-up|0|||
163154698|NCT01213472|589281382|FG000|Overall Study|Recurrence/Progressive disease|25|||
162640658|NCT00778700|587399902|FG003|Overall Study|Adverse Event|5|||
163011098|NCT00391768|588743756|FG002|Overall Study|Lost to Follow-up|0|||
163011099|NCT00391768|588743757|FG003|Overall Study|Lost to Follow-up|1|||
163011100|NCT00391768|588743758|FG004|Overall Study|Lost to Follow-up|2|||
163011101|NCT00391768|588743759|FG005|Overall Study|Lost to Follow-up|2|||
162640659|NCT00778700|587399899|FG000|Overall Study|Protocol Violation|1|||
162640660|NCT00778700|587399900|FG001|Overall Study|Protocol Violation|1|||
163011102|NCT00391768|588743760|FG006|Overall Study|Lost to Follow-up|3|||
163011103|NCT01620138|588743761|FG000|Overall Study|Withdrawal by Subject|3|||
163011104|NCT01620138|588743762|FG001|Overall Study|Withdrawal by Subject|0|||
163011105|NCT01620138|588743761|FG000|Overall Study|Lack of Efficacy|1|||
163011106|NCT01620138|588743762|FG001|Overall Study|Lack of Efficacy|0|||
163011107|NCT01620138|588743761|FG000|Overall Study|Adverse Event|2|||
163011108|NCT01620138|588743762|FG001|Overall Study|Adverse Event|0|||
163011109|NCT00444535|588743765|FG000|Overall Study|Withdrawal by Subject|5|||
163011110|NCT00444535|588743765|FG000|Overall Study|Physician Decision|5|||
163011111|NCT00444535|588743765|FG000|Overall Study|progressive disease|1|||
163011112|NCT00444535|588743765|FG000|Overall Study|Adverse Event|2|||
163011113|NCT01568892|588743766|FG000|Open-label Phase|Adverse Event|2|||
163011114|NCT01568892|588743767|FG001|Open-label Phase|Adverse Event|0|||
163011115|NCT01568892|588743766|FG000|Open-label Phase|Lack of Efficacy|4|||
163011116|NCT01568892|588743767|FG001|Open-label Phase|Lack of Efficacy|2|||
163011117|NCT01568892|588743766|FG000|Open-label Phase|Lost to Follow-up|0|||
163011118|NCT01568892|588743767|FG001|Open-label Phase|Lost to Follow-up|1|||
163011119|NCT01697748|588743777|FG000|Overall Study|ineligible skin incision|1|||
163011120|NCT01697748|588743778|FG001|Overall Study|ineligible skin incision|2|||
163011121|NCT01697748|588743777|FG000|Overall Study|ineligible uterine incision|4|||
163011122|NCT01697748|588743778|FG001|Overall Study|ineligible uterine incision|1|||
163011123|NCT01697748|588743777|FG000|Overall Study|Lost to Follow-up|53|||
163011124|NCT01697748|588743778|FG001|Overall Study|Lost to Follow-up|65|||
163011125|NCT01704495|588743779|FG000|Subjects Randomized|Other Reason|3|||
163011126|NCT01704495|588743780|FG001|Subjects Randomized|Other Reason|2|||
163011127|NCT01704495|588743781|FG002|Subjects Randomized|Other Reason|3|||
163011128|NCT01704495|588743782|FG003|Subjects Randomized|Other Reason|2|||
163011129|NCT01704495|588743779|FG000|Subjects Randomized|Discontinuation criteria met|4|||
163011130|NCT01704495|588743780|FG001|Subjects Randomized|Discontinuation criteria met|2|||
163011131|NCT01704495|588743781|FG002|Subjects Randomized|Discontinuation criteria met|2|||
163011132|NCT01704495|588743782|FG003|Subjects Randomized|Discontinuation criteria met|0|||
163011133|NCT01704495|588743779|FG000|Subjects Randomized|Adverse Event|8|||
163011134|NCT01704495|588743780|FG001|Subjects Randomized|Adverse Event|2|||
163011135|NCT01704495|588743781|FG002|Subjects Randomized|Adverse Event|0|||
163011136|NCT01704495|588743782|FG003|Subjects Randomized|Adverse Event|7|||
163011137|NCT01704495|588743779|FG000|Subjects Randomized|Withdrawal by Subject|5|||
163011138|NCT01704495|588743780|FG001|Subjects Randomized|Withdrawal by Subject|5|||
162640661|NCT00778700|587399901|FG002|Overall Study|Protocol Violation|0|||
162640662|NCT00778700|587399902|FG003|Overall Study|Protocol Violation|0|||
162640663|NCT00778700|587399899|FG000|Overall Study|Subject Withdrew Consent|6|||
162640664|NCT00778700|587399900|FG001|Overall Study|Subject Withdrew Consent|4|||
163011139|NCT01704495|588743781|FG002|Subjects Randomized|Withdrawal by Subject|5|||
163011140|NCT01704495|588743782|FG003|Subjects Randomized|Withdrawal by Subject|5|||
163011141|NCT01704495|588743779|FG000|Subjects Randomized|Protocol Violation|1|||
163011142|NCT01704495|588743780|FG001|Subjects Randomized|Protocol Violation|1|||
163011143|NCT01704495|588743781|FG002|Subjects Randomized|Protocol Violation|2|||
163011144|NCT01704495|588743782|FG003|Subjects Randomized|Protocol Violation|0|||
163011145|NCT01704495|588743779|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
163011146|NCT01704495|588743780|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
163011147|NCT01704495|588743781|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
163011148|NCT01704495|588743782|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
163011149|NCT01704495|588743779|FG000|Optional Safety Extension|Adverse Event|0|||
163011150|NCT01704495|588743780|FG001|Optional Safety Extension|Adverse Event|4|||
163011151|NCT01704495|588743781|FG002|Optional Safety Extension|Adverse Event|0|||
163011152|NCT01704495|588743782|FG003|Optional Safety Extension|Adverse Event|1|||
163011153|NCT01704495|588743779|FG000|Optional Safety Extension|Other reason|27|||
163011154|NCT01704495|588743780|FG001|Optional Safety Extension|Other reason|29|||
163011155|NCT01704495|588743781|FG002|Optional Safety Extension|Other reason|30|||
163011156|NCT01704495|588743782|FG003|Optional Safety Extension|Other reason|28|||
163011157|NCT01704495|588743779|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
163011158|NCT01704495|588743780|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
163011159|NCT01704495|588743781|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
163011160|NCT01704495|588743782|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
163011161|NCT01256450|588743783|FG000|Open-label Titration|Adverse Event|39|||
163011162|NCT01256450|588743784|FG001|Open-label Titration|Adverse Event|0|||
163011163|NCT01256450|588743785|FG002|Open-label Titration|Adverse Event|0|||
163011164|NCT01256450|588743783|FG000|Open-label Titration|Lost to Follow-up|7|||
162640665|NCT00778700|587399901|FG002|Overall Study|Subject Withdrew Consent|1|||
163011165|NCT01256450|588743784|FG001|Open-label Titration|Lost to Follow-up|0|||
163011166|NCT01256450|588743785|FG002|Open-label Titration|Lost to Follow-up|0|||
163011167|NCT01256450|588743783|FG000|Open-label Titration|Lack of analgesic effect|30|||
163011168|NCT01256450|588743784|FG001|Open-label Titration|Lack of analgesic effect|0|||
163011169|NCT01256450|588743785|FG002|Open-label Titration|Lack of analgesic effect|0|||
163011170|NCT01256450|588743783|FG000|Open-label Titration|Non-compliance|9|||
163011171|NCT01256450|588743784|FG001|Open-label Titration|Non-compliance|0|||
163011172|NCT01256450|588743785|FG002|Open-label Titration|Non-compliance|0|||
163011173|NCT01256450|588743783|FG000|Open-label Titration|Screen failure|1|||
163011174|NCT01256450|588743784|FG001|Open-label Titration|Screen failure|0|||
163011175|NCT01256450|588743785|FG002|Open-label Titration|Screen failure|0|||
163011176|NCT01256450|588743783|FG000|Open-label Titration|Other|13|||
163011177|NCT01256450|588743784|FG001|Open-label Titration|Other|0|||
163011178|NCT01256450|588743785|FG002|Open-label Titration|Other|0|||
163011179|NCT01256450|588743783|FG000|Double-blind Treatment|Adverse Event|0|||
163011180|NCT01256450|588743784|FG001|Double-blind Treatment|Adverse Event|8|||
163011181|NCT01256450|588743785|FG002|Double-blind Treatment|Adverse Event|6|||
163011182|NCT01256450|588743783|FG000|Double-blind Treatment|Lost to Follow-up|0|||
163011183|NCT01256450|588743784|FG001|Double-blind Treatment|Lost to Follow-up|1|||
163011184|NCT01256450|588743785|FG002|Double-blind Treatment|Lost to Follow-up|7|||
163011185|NCT01256450|588743783|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
163011186|NCT01256450|588743784|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
163011187|NCT01256450|588743785|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
163011188|NCT01256450|588743783|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
163011189|NCT01256450|588743784|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
163011190|NCT01256450|588743785|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
163011191|NCT01256450|588743783|FG000|Double-blind Treatment|Non-compliance|0|||
163011192|NCT01256450|588743784|FG001|Double-blind Treatment|Non-compliance|5|||
163011193|NCT01256450|588743785|FG002|Double-blind Treatment|Non-compliance|4|||
163011194|NCT01256450|588743783|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
163011195|NCT01256450|588743784|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
163011196|NCT01256450|588743785|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
163011197|NCT01256450|588743783|FG000|Double-blind Treatment|Other|0|||
163011198|NCT01256450|588743784|FG001|Double-blind Treatment|Other|9|||
163011199|NCT01256450|588743785|FG002|Double-blind Treatment|Other|12|||
163011200|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
163011201|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
163062379|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
163062380|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062381|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062382|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062383|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062384|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
163062385|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062386|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062387|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
163062388|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062389|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062390|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062391|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062392|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
163062393|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062394|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062395|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
163011202|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
163011203|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011204|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011205|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
163011206|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
162640666|NCT00778700|587399902|FG003|Overall Study|Subject Withdrew Consent|4|||
162640667|NCT00778700|587399899|FG000|Overall Study|Lost to Follow-up|3|||
163011207|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
163011208|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
163011209|NCT02375971|588743787|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
163011210|NCT02375971|588743788|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
163011211|NCT02375971|588743789|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
163011212|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
163011213|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
163011214|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
163011215|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
163011216|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
163011217|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
163011218|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
163011219|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
163011220|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
163011221|NCT02375971|588743787|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
163011222|NCT02375971|588743788|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
163011223|NCT02375971|588743789|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
163011224|NCT00891020|588743790|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
163011225|NCT00891020|588743791|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
163011226|NCT00891020|588743792|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
163011227|NCT00891020|588743790|FG000|24 Week Treatment Period|Death|0|||
163011228|NCT00891020|588743791|FG001|24 Week Treatment Period|Death|2|||
163011229|NCT00891020|588743792|FG002|24 Week Treatment Period|Death|0|||
163011230|NCT00891020|588743790|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
163011231|NCT00891020|588743791|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
163011232|NCT00891020|588743792|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
163011233|NCT00891020|588743790|FG000|24 Week Treatment Period|Failure to return|4|||
163011234|NCT00891020|588743791|FG001|24 Week Treatment Period|Failure to return|5|||
163011235|NCT00891020|588743792|FG002|24 Week Treatment Period|Failure to return|5|||
163011236|NCT00891020|588743790|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
163011237|NCT00891020|588743791|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
163011238|NCT00891020|588743792|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
163011239|NCT00891020|588743790|FG000|24 Week Treatment Period|Other protocol violation|1|||
163011240|NCT00891020|588743791|FG001|24 Week Treatment Period|Other protocol violation|1|||
163011241|NCT00891020|588743792|FG002|24 Week Treatment Period|Other protocol violation|2|||
163011242|NCT00891020|588743790|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
163011243|NCT00891020|588743791|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
163011244|NCT00891020|588743792|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
163011245|NCT00891020|588743790|FG000|24 Week Treatment Period|Withdrew consent|6|||
163011246|NCT00891020|588743791|FG001|24 Week Treatment Period|Withdrew consent|3|||
163011247|NCT00891020|588743792|FG002|24 Week Treatment Period|Withdrew consent|15|||
163011248|NCT00891020|588743790|FG000|24 Week Treatment Period|Administrative/Other|5|||
162640668|NCT00778700|587399900|FG001|Overall Study|Lost to Follow-up|1|||
162640669|NCT00778700|587399901|FG002|Overall Study|Lost to Follow-up|0|||
162640670|NCT00778700|587399902|FG003|Overall Study|Lost to Follow-up|1|||
162640671|NCT00778700|587399899|FG000|Overall Study|Reason not Specified|2|||
163011249|NCT00891020|588743791|FG001|24 Week Treatment Period|Administrative/Other|6|||
163011250|NCT00891020|588743792|FG002|24 Week Treatment Period|Administrative/Other|1|||
163011251|NCT00891020|588743790|FG000|Long-term Extension Period|Adverse Event|1|||
163011252|NCT00891020|588743791|FG001|Long-term Extension Period|Adverse Event|11|||
163011253|NCT00891020|588743792|FG002|Long-term Extension Period|Adverse Event|10|||
162640672|NCT00778700|587399900|FG001|Overall Study|Reason not Specified|0|||
163011254|NCT00891020|588743790|FG000|Long-term Extension Period|Death|0|||
163011255|NCT00891020|588743791|FG001|Long-term Extension Period|Death|0|||
163011256|NCT00891020|588743792|FG002|Long-term Extension Period|Death|1|||
163011257|NCT00891020|588743790|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
163011258|NCT00891020|588743791|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
163011259|NCT00891020|588743792|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
163011260|NCT00891020|588743790|FG000|Long-term Extension Period|Protocol Violation|0|||
163011261|NCT00891020|588743791|FG001|Long-term Extension Period|Protocol Violation|1|||
163011262|NCT00891020|588743792|FG002|Long-term Extension Period|Protocol Violation|1|||
163011263|NCT00891020|588743790|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
163011264|NCT00891020|588743791|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
163011265|NCT00891020|588743792|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
163011266|NCT00891020|588743790|FG000|Long-term Extension Period|Failure to return|0|||
163011267|NCT00891020|588743791|FG001|Long-term Extension Period|Failure to return|2|||
163011268|NCT00891020|588743792|FG002|Long-term Extension Period|Failure to return|3|||
163011269|NCT00891020|588743790|FG000|Long-term Extension Period|Administrative|1|||
163011270|NCT00891020|588743791|FG001|Long-term Extension Period|Administrative|2|||
163011271|NCT00891020|588743792|FG002|Long-term Extension Period|Administrative|2|||
163011272|NCT02275819|588743793|FG000|Overall Study|Adverse Event|0|||
163011273|NCT02275819|588743794|FG001|Overall Study|Adverse Event|1|||
163011274|NCT01346059|588743795|FG000|Overall Study|Withdrawal by Subject|1|||
163011275|NCT01346059|588743796|FG001|Overall Study|Withdrawal by Subject|0|||
163011276|NCT02556775|588743797|FG000|Overall Study|Withdrawal by Subject|1|||
163011277|NCT02556775|588743798|FG001|Overall Study|Withdrawal by Subject|0|||
163011278|NCT02556775|588743799|FG002|Overall Study|Withdrawal by Subject|1|||
163011279|NCT02556775|588743800|FG003|Overall Study|Withdrawal by Subject|0|||
163011280|NCT02556775|588743797|FG000|Overall Study|Lost to Follow-up|1|||
163011281|NCT02556775|588743798|FG001|Overall Study|Lost to Follow-up|0|||
163011282|NCT02556775|588743799|FG002|Overall Study|Lost to Follow-up|0|||
163011283|NCT02556775|588743800|FG003|Overall Study|Lost to Follow-up|0|||
163011284|NCT01592786|588743801|FG000|Overall Study|Adverse Event|60|||
163011285|NCT01592786|588743801|FG000|Overall Study|Lack of Efficacy|19|||
163011286|NCT01592786|588743801|FG000|Overall Study|Protocol Violation|14|||
163011287|NCT01592786|588743801|FG000|Overall Study|Withdrawal by Subject|23|||
163011288|NCT01592786|588743801|FG000|Overall Study|Lost to Follow-up|19|||
163011289|NCT01592786|588743801|FG000|Overall Study|Other|3|||
163011290|NCT02025725|588743802|FG000|Overall Study|Adverse Event|5|||
163011291|NCT02025725|588743803|FG001|Overall Study|Adverse Event|0|||
163011292|NCT02025725|588743802|FG000|Overall Study|Lost to Follow-up|2|||
163011293|NCT02025725|588743803|FG001|Overall Study|Lost to Follow-up|0|||
163011294|NCT02025725|588743802|FG000|Overall Study|Protocol Violation|1|||
163011295|NCT02025725|588743803|FG001|Overall Study|Protocol Violation|1|||
163011296|NCT02025725|588743802|FG000|Overall Study|Withdrawal by Subject|3|||
163011297|NCT02025725|588743803|FG001|Overall Study|Withdrawal by Subject|2|||
163011298|NCT02025725|588743802|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
163011299|NCT02025725|588743803|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
163011300|NCT02172664|588743809|FG000|Overall Study|Lost to Follow-up|4|||
163011301|NCT02172664|588743810|FG001|Overall Study|Lost to Follow-up|4|||
163011302|NCT02172664|588743809|FG000|Overall Study|Death|1|||
163011303|NCT02172664|588743810|FG001|Overall Study|Death|1|||
163011304|NCT02172664|588743809|FG000|Overall Study|Moved out of area|1|||
163011305|NCT02172664|588743810|FG001|Overall Study|Moved out of area|1|||
163011306|NCT01909934|588743811|FG000|Overall Study|Withdrawal by Subject|3|||
163011307|NCT01909934|588743811|FG000|Overall Study|Lost to Follow-up|1|||
163011308|NCT01909934|588743811|FG000|Overall Study|Death|25|||
163011309|NCT01909934|588743811|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163011310|NCT01909934|588743811|FG000|Overall Study|Reason Not Specified|1|||
163011311|NCT01787292|588743814|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
163011312|NCT01787292|588743815|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
163011313|NCT01787292|588743814|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
163011314|NCT01787292|588743815|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
163011315|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
163011316|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011317|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011318|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011319|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011320|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
163011321|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
163011322|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
163011323|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
163011324|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
163011325|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
163062396|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062397|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062398|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062399|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062400|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
163062401|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062402|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062403|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
163062404|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
163062405|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062406|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062407|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062408|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163062409|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062410|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062411|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
163062412|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062413|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062414|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062415|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062416|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
163062417|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062418|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062419|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
163062420|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
163062421|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062422|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062423|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062424|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
163062425|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062426|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062427|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
163062428|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
163062429|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062430|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062431|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062432|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
163062433|NCT03329001|588936868|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062434|NCT03329001|588936869|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062435|NCT03329001|588936870|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
163062436|NCT03329001|588936871|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
163062437|NCT03329001|588936872|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062438|NCT03329001|588936873|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062439|NCT03329001|588936874|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062440|NCT03329001|588936875|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
163062441|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062442|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062443|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062444|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
163062445|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062446|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062447|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062448|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
163062449|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062450|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062451|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062452|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
163062453|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062454|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062455|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163062456|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
163011326|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
163011327|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
163011328|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
163011329|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011330|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
163011331|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011332|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011333|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011334|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
163011335|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
163011336|NCT01147068|588743816|FG000|Subjects That Received 2nd Dose|Other|0|||
163011337|NCT01147068|588743817|FG001|Subjects That Received 2nd Dose|Other|3|||
163011338|NCT01147068|588743818|FG002|Subjects That Received 2nd Dose|Other|3|||
163011339|NCT01147068|588743819|FG003|Subjects That Received 2nd Dose|Other|0|||
163011340|NCT01147068|588743820|FG004|Subjects That Received 2nd Dose|Other|1|||
163011341|NCT01147068|588743821|FG005|Subjects That Received 2nd Dose|Other|0|||
163011342|NCT01147068|588743822|FG006|Subjects That Received 2nd Dose|Other|0|||
163011343|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011344|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011345|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011346|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011347|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
163011348|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011349|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
163011350|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011351|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011352|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011353|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
163011354|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011355|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011356|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
163011357|NCT01147068|588743816|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011358|NCT01147068|588743817|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
163011359|NCT01147068|588743818|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011360|NCT01147068|588743819|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011361|NCT01147068|588743820|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011362|NCT01147068|588743821|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
163011363|NCT01147068|588743822|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
162640673|NCT00778700|587399901|FG002|Overall Study|Reason not Specified|1|||
163011364|NCT02962648|588743823|FG000|Overall Study|Withdrawal by Subject|3|||
163011365|NCT02962648|588743823|FG000|Overall Study|Lost to Follow-up|3|||
163011366|NCT02962648|588743823|FG000|Overall Study|Physician Decision|1|||
163011367|NCT02962648|588743823|FG000|Overall Study|Subject had problems with transportation|2|||
163011368|NCT01597778|588743825|FG000|Overall Study|Death|7|||
163011369|NCT01597778|588743826|FG001|Overall Study|Death|10|||
163011370|NCT01597778|588743825|FG000|Overall Study|Withdrawal by Subject|3|||
163011371|NCT01597778|588743826|FG001|Overall Study|Withdrawal by Subject|4|||
163011372|NCT01597778|588743825|FG000|Overall Study|Adverse Event|1|||
163011373|NCT01597778|588743826|FG001|Overall Study|Adverse Event|1|||
163011374|NCT01597778|588743825|FG000|Overall Study|Protocol Violation|1|||
163011375|NCT01597778|588743826|FG001|Overall Study|Protocol Violation|11|||
163011376|NCT01597778|588743825|FG000|Overall Study|Transplanted off protocol|2|||
163011377|NCT01597778|588743826|FG001|Overall Study|Transplanted off protocol|3|||
163011378|NCT03267212|588743827|FG000|First Intervention|Lost to Follow-up|0|||
163011379|NCT03267212|588743828|FG001|First Intervention|Lost to Follow-up|2|||
163011380|NCT03267212|588743827|FG000|First Intervention|Withdrawal by Subject|1|||
163011381|NCT03267212|588743828|FG001|First Intervention|Withdrawal by Subject|1|||
163011382|NCT03267212|588743827|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
163062457|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062458|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062459|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
163154699|NCT01213472|589281382|FG000|Overall Study|Withdrawal by Subject|1|||
162640674|NCT00778700|587399902|FG003|Overall Study|Reason not Specified|3|||
162640675|NCT00778700|587399899|FG000|Overall Study|Other|0|||
163011383|NCT03267212|588743828|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
163011384|NCT05691712|588743829|FG000|Overall Study|Adverse Event|0|||
163011385|NCT05691712|588743830|FG001|Overall Study|Adverse Event|1|||
163011386|NCT05691712|588743831|FG002|Overall Study|Adverse Event|2|||
163011387|NCT05691712|588743832|FG003|Overall Study|Adverse Event|1|||
163011388|NCT05691712|588743829|FG000|Overall Study|Withdrawal by Subject|2|||
163011389|NCT05691712|588743830|FG001|Overall Study|Withdrawal by Subject|3|||
163011390|NCT05691712|588743831|FG002|Overall Study|Withdrawal by Subject|3|||
163011391|NCT05691712|588743832|FG003|Overall Study|Withdrawal by Subject|1|||
163011392|NCT05691712|588743829|FG000|Overall Study|Death|1|||
163011393|NCT05691712|588743830|FG001|Overall Study|Death|0|||
163011394|NCT05691712|588743831|FG002|Overall Study|Death|0|||
163011395|NCT05691712|588743832|FG003|Overall Study|Death|0|||
163011396|NCT05691712|588743829|FG000|Overall Study|Pregnancy|0|||
163011397|NCT05691712|588743830|FG001|Overall Study|Pregnancy|1|||
163011398|NCT05691712|588743831|FG002|Overall Study|Pregnancy|0|||
163011399|NCT05691712|588743832|FG003|Overall Study|Pregnancy|0|||
163011400|NCT05691712|588743829|FG000|Overall Study|Assigned Treatment by Mistake|1|||
163011401|NCT05691712|588743830|FG001|Overall Study|Assigned Treatment by Mistake|0|||
163011402|NCT05691712|588743831|FG002|Overall Study|Assigned Treatment by Mistake|0|||
163011403|NCT05691712|588743832|FG003|Overall Study|Assigned Treatment by Mistake|1|||
163011404|NCT05303194|588743833|FG000|Overall Study|Lost to Follow-up|1|||
163011405|NCT05303194|588743834|FG001|Overall Study|Lost to Follow-up|1|||
163011406|NCT05303194|588743833|FG000|Overall Study|Withdrawal by Subject|0|||
163011407|NCT05303194|588743834|FG001|Overall Study|Withdrawal by Subject|1|||
163011408|NCT01289678|588743844|FG000|Overall Study|Physician Decision|6|||
163011409|NCT00226499|588743845|FG000|Overall Study|Adverse Event|10|||
163011410|NCT00226499|588743846|FG001|Overall Study|Adverse Event|6|||
163011411|NCT00226499|588743847|FG002|Overall Study|Adverse Event|3|||
163011412|NCT00226499|588743845|FG000|Overall Study|Others|1064|||
163011413|NCT00226499|588743846|FG001|Overall Study|Others|1066|||
163011414|NCT00226499|588743847|FG002|Overall Study|Others|356|||
163011415|NCT02723344|588743848|FG000|Overall Study|Lost to Follow-up|0|||
163011416|NCT02723344|588743849|FG001|Overall Study|Lost to Follow-up|4|||
163011417|NCT02524847|588743851|FG000|Overall Study|Adverse Event|4|||
163011418|NCT02524847|588743851|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163011419|NCT02524847|588743851|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
163011420|NCT02524847|588743851|FG000|Overall Study|Death|1|||
163011421|NCT02524847|588743851|FG000|Overall Study|Reason not Specified|1|||
163011422|NCT04352101|588743852|FG000|Overall Study|Physician Decision|2|||
163011423|NCT04352101|588743853|FG001|Overall Study|Physician Decision|1|||
163011424|NCT03539302|588743862|FG000|Overall Study|Spontaneous cardio version|0|||
163011425|NCT03539302|588743863|FG001|Overall Study|Spontaneous cardio version|0|||
163011426|NCT03539302|588743864|FG002|Overall Study|Spontaneous cardio version|0|||
163011427|NCT03539302|588743865|FG003|Overall Study|Spontaneous cardio version|0|||
163011428|NCT03539302|588743866|FG004|Overall Study|Spontaneous cardio version|0|||
163011429|NCT03539302|588743867|FG005|Overall Study|Spontaneous cardio version|1|||
163011430|NCT03539302|588743868|FG006|Overall Study|Spontaneous cardio version|1|||
163011431|NCT04564092|588743870|FG000|Overall Study|Withdrawal by Subject|1|||
163011432|NCT02362360|588743876|FG000|Period 1|Lack of Efficacy|1|||
163011433|NCT02362360|588743877|FG001|Period 1|Lack of Efficacy|0|||
163011434|NCT02362360|588743876|FG000|Period 1|Withdrawal by Subject|2|||
163011435|NCT02362360|588743877|FG001|Period 1|Withdrawal by Subject|1|||
163011436|NCT03817190|588743878|FG000|Overall Study|Early Termination|13|||
163011437|NCT03817190|588743879|FG001|Overall Study|Early Termination|20|||
163011438|NCT03817190|588743878|FG000|Overall Study|Adverse Event|10|||
163011439|NCT03817190|588743879|FG001|Overall Study|Adverse Event|17|||
163011440|NCT03817190|588743878|FG000|Overall Study|Withdrawal by Subject|12|||
163011441|NCT03817190|588743879|FG001|Overall Study|Withdrawal by Subject|8|||
163011442|NCT03817190|588743878|FG000|Overall Study|Lost to Follow-up|11|||
163011443|NCT03817190|588743879|FG001|Overall Study|Lost to Follow-up|7|||
163011444|NCT03817190|588743878|FG000|Overall Study|Lack of Efficacy|7|||
163011445|NCT03817190|588743879|FG001|Overall Study|Lack of Efficacy|5|||
163011446|NCT03817190|588743878|FG000|Overall Study|Investigator Decision|5|||
163011447|NCT03817190|588743879|FG001|Overall Study|Investigator Decision|1|||
163011448|NCT03817190|588743878|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
163011449|NCT03817190|588743879|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
163011450|NCT03817190|588743878|FG000|Overall Study|Lack of Contact|1|||
163011451|NCT03817190|588743879|FG001|Overall Study|Lack of Contact|0|||
163011452|NCT03817190|588743878|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
163011453|NCT03817190|588743879|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
163011454|NCT04146012|588743880|FG000|Overall Study|Study Terminated|30|||
163011455|NCT04146012|588743881|FG001|Overall Study|Study Terminated|15|||
163011456|NCT01546025|588743882|FG000|Overall Study|Lost to Follow-up|0|||
163011457|NCT01546025|588743883|FG001|Overall Study|Lost to Follow-up|1|||
163011458|NCT00868530|588743884|FG000|Overall Study|Adverse Event|3|||
163011459|NCT00868530|588743884|FG000|Overall Study|Lost to Follow-up|1|||
163011460|NCT05795153|588745687|FG000|Overall Study|Adverse Event|2|||
163011461|NCT05795153|588745687|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163011462|NCT05795153|588745687|FG000|Overall Study|Lost to Follow-up|1|||
163011463|NCT05795153|588745687|FG000|Overall Study|Subject decision|2|||
163011464|NCT03668119|588745688|FG000|Pre-treatment|Disease Progression|1|||
163011465|NCT03668119|588745689|FG001|Pre-treatment|Disease Progression|0|||
163011466|NCT03668119|588745688|FG000|Treatment|Disease Progression|76|||
163011467|NCT03668119|588745689|FG001|Treatment|Disease Progression|57|||
163011468|NCT03668119|588745688|FG000|Treatment|Study drug toxicity|19|||
163011469|NCT03668119|588745689|FG001|Treatment|Study drug toxicity|1|||
163011470|NCT03668119|588745688|FG000|Treatment|Death|3|||
163011471|NCT03668119|588745689|FG001|Treatment|Death|0|||
163011472|NCT03668119|588745688|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
163011473|NCT03668119|588745689|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
163011474|NCT03668119|588745688|FG000|Treatment|Withdrawal by Subject|1|||
163011475|NCT03668119|588745689|FG001|Treatment|Withdrawal by Subject|1|||
163011476|NCT03668119|588745688|FG000|Treatment|Participant request to discontinue study treatment|3|||
163011477|NCT03668119|588745689|FG001|Treatment|Participant request to discontinue study treatment|1|||
163011478|NCT03668119|588745688|FG000|Treatment|Maximum Clinical Benefit|0|||
163011479|NCT03668119|588745689|FG001|Treatment|Maximum Clinical Benefit|1|||
163011480|NCT03668119|588745688|FG000|Treatment|Participants completed treatment|27|||
163011481|NCT03668119|588745689|FG001|Treatment|Participants completed treatment|11|||
163011482|NCT03668119|588745688|FG000|Treatment|Other reasons|2|||
163011483|NCT03668119|588745689|FG001|Treatment|Other reasons|1|||
163011484|NCT03769168|588745690|FG000|Overall Study|Adverse Event|0|||
163011485|NCT03769168|588745691|FG001|Overall Study|Adverse Event|1|||
163011486|NCT03769168|588745690|FG000|Overall Study|Lack of Efficacy|2|||
163011487|NCT03769168|588745691|FG001|Overall Study|Lack of Efficacy|4|||
163011488|NCT03769168|588745690|FG000|Overall Study|Post study access to treatment|3|||
163011489|NCT03769168|588745691|FG001|Overall Study|Post study access to treatment|11|||
163011490|NCT03769168|588745690|FG000|Overall Study|Physician Decision|1|||
163011491|NCT03769168|588745691|FG001|Overall Study|Physician Decision|4|||
163011492|NCT03769168|588745690|FG000|Overall Study|Subject Decision|2|||
163011493|NCT03769168|588745691|FG001|Overall Study|Subject Decision|4|||
163011494|NCT03769168|588745690|FG000|Overall Study|Guardian decision|1|||
163011495|NCT03769168|588745691|FG001|Overall Study|Guardian decision|0|||
163011496|NCT05142722|588745692|FG000|Overall Study|Lost to Follow-up|16|||
163011497|NCT05142722|588745693|FG001|Overall Study|Lost to Follow-up|38|||
163011498|NCT05142722|588745692|FG000|Overall Study|Withdrawal by Subject|20|||
163011499|NCT05142722|588745693|FG001|Overall Study|Withdrawal by Subject|27|||
163011500|NCT05142722|588745692|FG000|Overall Study|Death|11|||
163011501|NCT05142722|588745693|FG001|Overall Study|Death|17|||
163011502|NCT05142722|588745692|FG000|Overall Study|Physician Decision|0|||
163011503|NCT05142722|588745693|FG001|Overall Study|Physician Decision|1|||
163011504|NCT05142722|588745692|FG000|Overall Study|Participant Moved Away|0|||
163011505|NCT05142722|588745693|FG001|Overall Study|Participant Moved Away|2|||
163011506|NCT05142722|588745692|FG000|Overall Study|Adverse Event|2|||
163011507|NCT05142722|588745693|FG001|Overall Study|Adverse Event|1|||
163011508|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011509|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011510|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011511|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011512|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
163011513|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011514|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011515|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
163011516|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011517|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011518|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
163011519|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011520|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011521|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
163011522|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011523|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
163011524|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011525|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011526|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011527|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011528|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011529|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011530|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
163011531|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
163011532|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011533|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011534|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011535|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011536|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011537|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
163011538|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011539|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
163011540|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011541|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011542|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
163011543|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011544|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011545|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011546|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
163011547|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011548|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011549|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011550|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
163011551|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011552|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011553|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
163011554|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
163011555|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
163011556|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
163011557|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
163011558|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011559|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011560|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011561|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
162640676|NCT00778700|587399900|FG001|Overall Study|Other|0|||
162640677|NCT00778700|587399901|FG002|Overall Study|Other|1|||
162640678|NCT00778700|587399902|FG003|Overall Study|Other|0|||
162640679|NCT03274440|587399905|FG000|Overall Study|Time commitment too great|1|||
162640680|NCT03274440|587399906|FG001|Overall Study|Time commitment too great|0|||
162640681|NCT03274440|587399907|FG002|Overall Study|Time commitment too great|0|||
163062460|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062461|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062462|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062463|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163062464|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
163011562|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163011563|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
163062465|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062466|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062467|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
163062468|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
163062469|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062470|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163011564|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011565|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
163011566|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011567|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011568|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011569|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011570|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011571|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
163011572|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011573|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011574|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011575|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011576|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
163011577|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011578|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011579|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
163011580|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011581|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011582|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011583|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011584|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011585|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
163011586|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011587|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
163011588|NCT03896503|588745696|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011589|NCT03896503|588745697|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011590|NCT03896503|588745698|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011591|NCT03896503|588745699|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011592|NCT03896503|588745700|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011593|NCT03896503|588745701|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
163011594|NCT03896503|588745702|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
163011595|NCT03896503|588745703|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
163011596|NCT05400655|588745704|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
163011597|NCT05400655|588745705|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
163011598|NCT05400655|588745706|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
163011599|NCT05400655|588745707|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
163011600|NCT05400655|588745708|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
163011601|NCT05400655|588745709|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
163062471|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062472|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
163062473|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062474|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163154700|NCT01213472|589281382|FG000|Overall Study|Physician Decision|1|||
163154701|NCT02435992|589281385|FG000|Overall Study|non compliance with protocol|2|||
163154702|NCT02435992|589281386|FG001|Overall Study|non compliance with protocol|0|||
163154703|NCT02435992|589281387|FG002|Overall Study|non compliance with protocol|1|||
163154704|NCT02435992|589281388|FG003|Overall Study|non compliance with protocol|0|||
163011602|NCT05400655|588745710|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
163011603|NCT05400655|588745711|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
163011604|NCT05400655|588745712|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
163011605|NCT05400655|588745713|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
163011606|NCT05400655|588745714|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
163011607|NCT05400655|588745715|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
163011608|NCT05400655|588745716|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
163011609|NCT05400655|588745717|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
163011610|NCT05400655|588745718|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
163011611|NCT05400655|588745719|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
163011612|NCT05400655|588745720|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
163011613|NCT05400655|588745721|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
163011614|NCT05400655|588745722|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
163011615|NCT05400655|588745723|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
163011616|NCT05400655|588745724|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
163011617|NCT05400655|588745725|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
163011618|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011619|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011620|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011621|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011622|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011623|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011624|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011625|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011626|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011627|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011628|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011629|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011630|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011631|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011632|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011633|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011634|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011635|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011636|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
163011637|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
163011638|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011639|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
163011640|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011641|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011642|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011643|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011644|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011645|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011646|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011647|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011648|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011649|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011650|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011651|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011652|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011653|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
163011654|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011655|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011656|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
163011657|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011658|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
163011659|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011660|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011661|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
163011662|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011663|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011664|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011665|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011666|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011667|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011668|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011669|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011670|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011671|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011672|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011673|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011674|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011675|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011676|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011677|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011678|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011679|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011680|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
163011681|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
163011682|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
163011683|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
163011684|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011685|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011686|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011687|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011688|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011689|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011690|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011691|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011692|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011693|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011694|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011695|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011696|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011697|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011698|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011699|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011700|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011701|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
163011702|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
163011703|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011704|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011705|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
163011706|NCT05400655|588745704|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011707|NCT05400655|588745705|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011708|NCT05400655|588745706|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011709|NCT05400655|588745707|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011710|NCT05400655|588745708|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011711|NCT05400655|588745709|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011712|NCT05400655|588745710|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011713|NCT05400655|588745711|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011714|NCT05400655|588745712|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011715|NCT05400655|588745713|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011716|NCT05400655|588745714|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011717|NCT05400655|588745715|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011718|NCT05400655|588745716|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011719|NCT05400655|588745717|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011720|NCT05400655|588745718|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011721|NCT05400655|588745719|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163062475|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
163062476|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
162715981|NCT03536884|587667095|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162925267|NCT02253654|588428891|FG001|Overall Study|Did Not Receive Study Treatment|1|||
162925268|NCT01614925|588428892|FG000|Overall Study|Withdrawal by Subject|1|||
162925269|NCT01614925|588428893|FG001|Overall Study|Withdrawal by Subject|0|||
162925270|NCT01614925|588428892|FG000|Overall Study|Protocol Violation|3|||
162925271|NCT01614925|588428893|FG001|Overall Study|Protocol Violation|2|||
162925272|NCT01652573|588428904|FG000|Overall Study|Adverse Event|0|||
162925273|NCT01652573|588428905|FG001|Overall Study|Adverse Event|1|||
162925274|NCT00934622|588428906|FG000|Overall Study|Lost to Follow-up|7|||
162925275|NCT00934622|588428906|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
162925276|NCT00468312|588428909|FG000|Overall Study|Adverse Event|2|||
162925277|NCT00468312|588428910|FG001|Overall Study|Adverse Event|1|||
162925278|NCT00468312|588428909|FG000|Overall Study|Lack of Efficacy|0|||
162925279|NCT00468312|588428910|FG001|Overall Study|Lack of Efficacy|1|||
162925280|NCT00468312|588428909|FG000|Overall Study|Withdrawal by Subject|0|||
162925281|NCT00468312|588428910|FG001|Overall Study|Withdrawal by Subject|1|||
162925282|NCT00468312|588428909|FG000|Overall Study|Protocol Violation|2|||
162925283|NCT00468312|588428910|FG001|Overall Study|Protocol Violation|1|||
162925284|NCT00468312|588428909|FG000|Overall Study|Did not meet protocol eligibility|0|||
162925285|NCT00468312|588428910|FG001|Overall Study|Did not meet protocol eligibility|1|||
162925286|NCT01052038|588428911|FG000|Overall Study|Lost to Follow-up|2|||
162925287|NCT01052038|588428912|FG001|Overall Study|Lost to Follow-up|3|||
162925288|NCT01052038|588428913|FG002|Overall Study|Lost to Follow-up|1|||
162925289|NCT01052038|588428911|FG000|Overall Study|Protocol Violation|2|||
162925290|NCT01052038|588428912|FG001|Overall Study|Protocol Violation|3|||
162925291|NCT01052038|588428913|FG002|Overall Study|Protocol Violation|3|||
162925292|NCT03349437|588428914|FG000|Screening|Screen Fail|4|||
162925293|NCT03349437|588428915|FG001|Screening|Screen Fail|0|||
162925294|NCT03349437|588428916|FG002|Screening|Screen Fail|0|||
162925295|NCT03349437|588428914|FG000|Screening|Withdrawn|1|||
162925296|NCT03349437|588428915|FG001|Screening|Withdrawn|0|||
162925297|NCT03349437|588428916|FG002|Screening|Withdrawn|0|||
162925298|NCT03343054|588428919|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
162925299|NCT03343054|588428920|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
162925300|NCT03343054|588428921|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
162925301|NCT03343054|588428919|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
162925302|NCT03343054|588428920|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
162925303|NCT03343054|588428921|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
162925304|NCT03343054|588428919|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
162925305|NCT03343054|588428920|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
162925306|NCT03343054|588428921|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
162925307|NCT03343054|588428919|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
162925308|NCT03343054|588428920|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
162925309|NCT03343054|588428921|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
162925310|NCT05723835|588428927|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
162925311|NCT05723835|588428928|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
162925312|NCT05723835|588428929|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
163011722|NCT05400655|588745720|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011723|NCT05400655|588745721|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
163011724|NCT05400655|588745722|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011725|NCT05400655|588745723|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
163011726|NCT05400655|588745724|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
163011727|NCT05400655|588745725|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
163011728|NCT01068678|588745734|FG000|Overall Study|Lack of Efficacy|3|||
163011729|NCT01068678|588745735|FG001|Overall Study|Lack of Efficacy|2|||
163011730|NCT01068678|588745734|FG000|Overall Study|Protocol Violation|5|||
163011731|NCT01068678|588745735|FG001|Overall Study|Protocol Violation|1|||
163011732|NCT01068678|588745734|FG000|Overall Study|Withdrawal criteria|12|||
163011733|NCT01068678|588745735|FG001|Overall Study|Withdrawal criteria|6|||
163011734|NCT01068678|588745734|FG000|Overall Study|Unclassified|18|||
163011735|NCT01068678|588745735|FG001|Overall Study|Unclassified|15|||
163011736|NCT05161481|588745736|FG000|Overall Study|Withdrawal of consent|0|||
163011737|NCT05161481|588745737|FG001|Overall Study|Withdrawal of consent|1|||
163011738|NCT05161481|588745738|FG002|Overall Study|Withdrawal of consent|1|||
163011739|NCT05161481|588745736|FG000|Overall Study|Study terminated by sponsor|3|||
163011740|NCT05161481|588745737|FG001|Overall Study|Study terminated by sponsor|3|||
163011741|NCT05161481|588745738|FG002|Overall Study|Study terminated by sponsor|2|||
163011742|NCT05161481|588745736|FG000|Overall Study|Adverse Event|3|||
163011743|NCT05161481|588745737|FG001|Overall Study|Adverse Event|0|||
163011744|NCT05161481|588745738|FG002|Overall Study|Adverse Event|6|||
163011745|NCT05161481|588745736|FG000|Overall Study|Randomised in error and was not treated|1|||
163011746|NCT05161481|588745737|FG001|Overall Study|Randomised in error and was not treated|0|||
163011747|NCT05161481|588745738|FG002|Overall Study|Randomised in error and was not treated|0|||
163011748|NCT05161481|588745736|FG000|Overall Study|Subject decision|0|||
163011749|NCT05161481|588745737|FG001|Overall Study|Subject decision|0|||
163011750|NCT05161481|588745738|FG002|Overall Study|Subject decision|1|||
163011751|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
163011752|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
163011753|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
163011754|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
163011755|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
163011756|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
163011757|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
163011758|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
163011759|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
163011760|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
163011761|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
163011762|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
163011763|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011764|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011765|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
163011766|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163011767|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
163011768|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
163011769|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
163011770|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
163011771|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
163011772|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
163011773|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
163011774|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
163011775|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
163011776|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
163011777|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
163011778|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
163011779|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
163011780|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
163011781|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
163011782|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
163011783|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011784|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
163011785|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011786|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
163011787|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011788|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011789|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
163011790|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
163011791|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
163011792|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011793|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011794|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
163011795|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
163011796|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
163011797|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
163011798|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
163011799|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011800|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011801|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
163011802|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
163011803|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Site closed|0|||
163011804|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Site closed|0|||
163011805|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Site closed|1|||
163011806|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Site closed|0|||
163011807|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
163011808|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163011809|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163154705|NCT02435992|589281389|FG004|Overall Study|non compliance with protocol|0|||
162640682|NCT03274440|587399908|FG003|Overall Study|Time commitment too great|1|||
163011810|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
163011811|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
163011812|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
163011813|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
163011814|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
163011815|NCT00838903|588745739|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
163011816|NCT00838903|588745740|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011817|NCT00838903|588745741|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011818|NCT00838903|588745742|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
163011819|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
163011820|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
163011821|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
163011822|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
163011823|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163011824|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
163011825|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
163011826|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
163011827|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
163011828|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
163011829|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
162640683|NCT03274440|587399909|FG004|Overall Study|Time commitment too great|0|||
162640684|NCT03274440|587399910|FG005|Overall Study|Time commitment too great|0|||
162640685|NCT00450450|587399911|FG000|Overall Study|Death|1|||
163011830|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
163011831|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
163011832|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
163011833|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
163011834|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
163011835|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
163011836|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
163011837|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
163011838|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
163011839|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011840|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011841|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011842|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
163011843|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
163011844|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163011845|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
163011846|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163011847|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011848|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
163011849|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011850|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
163011851|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011852|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
163011853|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011854|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
163011855|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011856|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011857|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
163011858|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
163011859|NCT00838903|588745739|FG000|Follow-up Period (8 Weeks)|Missing|1|||
163011860|NCT00838903|588745740|FG001|Follow-up Period (8 Weeks)|Missing|2|||
163011861|NCT00838903|588745741|FG002|Follow-up Period (8 Weeks)|Missing|1|||
163011862|NCT00838903|588745742|FG003|Follow-up Period (8 Weeks)|Missing|1|||
163011863|NCT04225715|588745743|FG000|Overall Study|Reason not Specified|1|||
163011864|NCT04225715|588745744|FG001|Overall Study|Reason not Specified|0|||
163011865|NCT04225715|588745745|FG002|Overall Study|Reason not Specified|0|||
163011866|NCT04225715|588745746|FG003|Overall Study|Reason not Specified|0|||
163011867|NCT04225715|588745747|FG004|Overall Study|Reason not Specified|0|||
163011868|NCT04225715|588745748|FG005|Overall Study|Reason not Specified|0|||
163011869|NCT04225715|588745749|FG006|Overall Study|Reason not Specified|0|||
163011870|NCT04225715|588745750|FG007|Overall Study|Reason not Specified|0|||
163011871|NCT04225715|588745751|FG008|Overall Study|Reason not Specified|0|||
163011872|NCT04225715|588745743|FG000|Overall Study|Protocol Violation|1|||
163011873|NCT04225715|588745744|FG001|Overall Study|Protocol Violation|0|||
163011874|NCT04225715|588745745|FG002|Overall Study|Protocol Violation|0|||
163011875|NCT04225715|588745746|FG003|Overall Study|Protocol Violation|0|||
163011876|NCT04225715|588745747|FG004|Overall Study|Protocol Violation|0|||
163011877|NCT04225715|588745748|FG005|Overall Study|Protocol Violation|9|||
163011878|NCT04225715|588745749|FG006|Overall Study|Protocol Violation|0|||
163011879|NCT04225715|588745750|FG007|Overall Study|Protocol Violation|0|||
163011880|NCT04225715|588745751|FG008|Overall Study|Protocol Violation|0|||
163011881|NCT04225715|588745743|FG000|Overall Study|Withdrawal by Subject|4|||
163011882|NCT04225715|588745744|FG001|Overall Study|Withdrawal by Subject|1|||
163011883|NCT04225715|588745745|FG002|Overall Study|Withdrawal by Subject|1|||
163011884|NCT04225715|588745746|FG003|Overall Study|Withdrawal by Subject|0|||
163011885|NCT04225715|588745747|FG004|Overall Study|Withdrawal by Subject|3|||
163011886|NCT04225715|588745748|FG005|Overall Study|Withdrawal by Subject|1|||
163011887|NCT04225715|588745749|FG006|Overall Study|Withdrawal by Subject|1|||
163011888|NCT04225715|588745750|FG007|Overall Study|Withdrawal by Subject|1|||
163011889|NCT04225715|588745751|FG008|Overall Study|Withdrawal by Subject|0|||
163011890|NCT04225715|588745743|FG000|Overall Study|Adverse Event|0|||
163011891|NCT04225715|588745744|FG001|Overall Study|Adverse Event|0|||
163011892|NCT04225715|588745745|FG002|Overall Study|Adverse Event|0|||
163011893|NCT04225715|588745746|FG003|Overall Study|Adverse Event|0|||
163011894|NCT04225715|588745747|FG004|Overall Study|Adverse Event|0|||
163011895|NCT04225715|588745748|FG005|Overall Study|Adverse Event|0|||
163011896|NCT04225715|588745749|FG006|Overall Study|Adverse Event|0|||
163011897|NCT04225715|588745750|FG007|Overall Study|Adverse Event|0|||
163011898|NCT04225715|588745751|FG008|Overall Study|Adverse Event|1|||
163011899|NCT04225715|588745743|FG000|Overall Study|Arm Terminated By Sponsor|0|||
163011900|NCT04225715|588745744|FG001|Overall Study|Arm Terminated By Sponsor|0|||
163011901|NCT04225715|588745745|FG002|Overall Study|Arm Terminated By Sponsor|0|||
163011902|NCT04225715|588745746|FG003|Overall Study|Arm Terminated By Sponsor|0|||
163011903|NCT04225715|588745747|FG004|Overall Study|Arm Terminated By Sponsor|0|||
163011904|NCT04225715|588745748|FG005|Overall Study|Arm Terminated By Sponsor|0|||
163062477|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062478|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062479|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062480|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
163062481|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062482|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062483|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
163062484|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062485|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062486|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062487|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062488|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
163062489|NCT03329001|588936868|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062490|NCT03329001|588936869|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062491|NCT03329001|588936870|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062492|NCT03329001|588936871|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
163062493|NCT03329001|588936872|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062494|NCT03329001|588936873|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062495|NCT03329001|588936874|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062496|NCT03329001|588936875|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
163062497|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062498|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062499|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062500|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062501|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062502|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
163062503|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062504|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
163062505|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062506|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062507|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062508|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062509|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
163062510|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163062511|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
162640686|NCT00450450|587399912|FG001|Overall Study|Death|3|||
163062512|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
163011905|NCT04225715|588745749|FG006|Overall Study|Arm Terminated By Sponsor|0|||
163062513|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062514|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062515|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062516|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062517|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
163062518|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
163062519|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062520|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
163062521|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062522|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
162640687|NCT00450450|587399911|FG000|Overall Study|Relapse|2|||
162640688|NCT00450450|587399912|FG001|Overall Study|Relapse|0|||
162640689|NCT00450450|587399911|FG000|Overall Study|Missing Data|2|||
162640690|NCT00450450|587399912|FG001|Overall Study|Missing Data|0|||
162640691|NCT02150954|587399915|FG000|Overall Study|Protocol Violation|1|||
162640692|NCT02150954|587399916|FG001|Overall Study|Protocol Violation|0|||
162640693|NCT02611778|587399922|FG000|Overall Study|Withdrawal by Subject|2|||
162640694|NCT02611778|587399923|FG001|Overall Study|Withdrawal by Subject|8|||
162640695|NCT02611778|587399922|FG000|Overall Study|Adverse Event|1|||
162640696|NCT02611778|587399923|FG001|Overall Study|Adverse Event|2|||
162640697|NCT02611778|587399922|FG000|Overall Study|Death|2|||
162715982|NCT03536884|587667096|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162715983|NCT03536884|587667097|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162640698|NCT02611778|587399923|FG001|Overall Study|Death|1|||
162640699|NCT02611778|587399922|FG000|Overall Study|Protocol Violation|1|||
162640700|NCT02611778|587399923|FG001|Overall Study|Protocol Violation|0|||
162640701|NCT02611778|587399922|FG000|Overall Study|Lost to Follow-up|3|||
162640702|NCT02611778|587399923|FG001|Overall Study|Lost to Follow-up|1|||
162640703|NCT02611778|587399922|FG000|Overall Study|Need for alternative treatment|1|||
162640704|NCT02611778|587399923|FG001|Overall Study|Need for alternative treatment|0|||
162640705|NCT02611778|587399922|FG000|Overall Study|Other Reason|2|||
162640706|NCT02611778|587399923|FG001|Overall Study|Other Reason|1|||
162640707|NCT04008030|587399925|FG000|Pre-Treatment|Withdrawal by Subject|0|||
162640708|NCT04008030|587399926|FG001|Pre-Treatment|Withdrawal by Subject|0|||
162715984|NCT03536884|587667098|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162715985|NCT03536884|587667099|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
162715986|NCT03536884|587667100|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162640709|NCT04008030|587399927|FG002|Pre-Treatment|Withdrawal by Subject|9|||
162715987|NCT03536884|587667101|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163062523|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
162640710|NCT04008030|587399925|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
162640711|NCT04008030|587399926|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
162640712|NCT04008030|587399927|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
162640713|NCT04008030|587399925|FG000|Pre-Treatment|Other reasons|0|||
162640714|NCT04008030|587399926|FG001|Pre-Treatment|Other reasons|1|||
162640715|NCT04008030|587399927|FG002|Pre-Treatment|Other reasons|6|||
162640716|NCT04008030|587399925|FG000|Treatment|Withdrawal by Subject|1|||
162640717|NCT04008030|587399926|FG001|Treatment|Withdrawal by Subject|1|||
162640718|NCT04008030|587399927|FG002|Treatment|Withdrawal by Subject|1|||
162640719|NCT04008030|587399925|FG000|Treatment|Death|2|||
162640720|NCT04008030|587399926|FG001|Treatment|Death|4|||
162640721|NCT04008030|587399927|FG002|Treatment|Death|0|||
162640722|NCT04008030|587399925|FG000|Treatment|Pregnancy|0|||
163011906|NCT04225715|588745750|FG007|Overall Study|Arm Terminated By Sponsor|17|||
163011907|NCT04225715|588745751|FG008|Overall Study|Arm Terminated By Sponsor|18|||
163011908|NCT01894841|588745752|FG000|Overall Study|Withdrawal by Subject|9|||
162640723|NCT04008030|587399926|FG001|Treatment|Pregnancy|1|||
162640724|NCT04008030|587399927|FG002|Treatment|Pregnancy|0|||
162640725|NCT04008030|587399925|FG000|Treatment|Participant no longer meets study criteria|0|||
163011909|NCT01894841|588745753|FG001|Overall Study|Withdrawal by Subject|4|||
163011910|NCT01894841|588745752|FG000|Overall Study|Withdrawn by investigator|2|||
163011911|NCT01894841|588745753|FG001|Overall Study|Withdrawn by investigator|2|||
163011912|NCT01894841|588745752|FG000|Overall Study|Lost to Follow-up|7|||
163011913|NCT01894841|588745753|FG001|Overall Study|Lost to Follow-up|3|||
163011914|NCT04168112|588745754|FG000|Overall Study|Lost to Follow-up|1|||
163011915|NCT04168112|588745755|FG001|Overall Study|Lost to Follow-up|0|||
163011916|NCT04168112|588745754|FG000|Overall Study|Withdrawal by Subject|1|||
163011917|NCT04168112|588745755|FG001|Overall Study|Withdrawal by Subject|0|||
163011918|NCT02275546|588745758|FG000|Treatment Period 2|Withdrawal by Subject|2|||
163011919|NCT02275546|588745759|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163011920|NCT02275546|588745758|FG000|Treatment Period 2|Protocol Violation|0|||
163011921|NCT02275546|588745759|FG001|Treatment Period 2|Protocol Violation|1|||
163011922|NCT00570141|588745769|FG000|Overall Study|Adverse Event|1|||
163011923|NCT00570141|588745769|FG000|Overall Study|Missed visits|1|||
163011924|NCT00570141|588745769|FG000|Overall Study|Lost to Follow-up|1|||
163011925|NCT00925704|588745770|FG000|First Intervention|Withdrew consent|0|||
163011926|NCT00925704|588745771|FG001|First Intervention|Withdrew consent|0|||
163011927|NCT00925704|588745772|FG002|First Intervention|Withdrew consent|0|||
163011928|NCT00925704|588745773|FG003|First Intervention|Withdrew consent|1|||
163011929|NCT00925704|588745774|FG004|First Intervention|Withdrew consent|1|||
163011930|NCT00925704|588745775|FG005|First Intervention|Withdrew consent|0|||
163011931|NCT00925704|588745770|FG000|Second Intervention|Withdrawal by Subject|1|||
163011932|NCT00925704|588745771|FG001|Second Intervention|Withdrawal by Subject|0|||
163011933|NCT00925704|588745772|FG002|Second Intervention|Withdrawal by Subject|0|||
163011934|NCT00925704|588745773|FG003|Second Intervention|Withdrawal by Subject|0|||
163011935|NCT00925704|588745774|FG004|Second Intervention|Withdrawal by Subject|1|||
163011936|NCT00925704|588745775|FG005|Second Intervention|Withdrawal by Subject|0|||
163011937|NCT00925704|588745770|FG000|Third Intervention|Withdrew consent|0|||
163011938|NCT00925704|588745771|FG001|Third Intervention|Withdrew consent|0|||
163011939|NCT00925704|588745772|FG002|Third Intervention|Withdrew consent|0|||
163011940|NCT00925704|588745773|FG003|Third Intervention|Withdrew consent|0|||
163011941|NCT00925704|588745774|FG004|Third Intervention|Withdrew consent|0|||
163011942|NCT00925704|588745775|FG005|Third Intervention|Withdrew consent|1|||
163011943|NCT03817853|588745778|FG000|Induction Phase|Adverse Event|5|||
163011944|NCT03817853|588745779|FG001|Induction Phase|Adverse Event|0|||
163011945|NCT03817853|588745780|FG002|Induction Phase|Adverse Event|0|||
163011946|NCT03817853|588745778|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
163011947|NCT03817853|588745779|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
163011948|NCT03817853|588745780|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
163011949|NCT03817853|588745778|FG000|Induction Phase|Physician Decision|2|||
163011950|NCT03817853|588745779|FG001|Induction Phase|Physician Decision|0|||
163011951|NCT03817853|588745780|FG002|Induction Phase|Physician Decision|0|||
163011952|NCT03817853|588745778|FG000|Induction Phase|Progressive Disease|6|||
163011953|NCT03817853|588745779|FG001|Induction Phase|Progressive Disease|0|||
163011954|NCT03817853|588745780|FG002|Induction Phase|Progressive Disease|0|||
163011955|NCT03817853|588745778|FG000|Induction Phase|Withdrawal by Subject|4|||
163011956|NCT03817853|588745779|FG001|Induction Phase|Withdrawal by Subject|0|||
163011957|NCT03817853|588745780|FG002|Induction Phase|Withdrawal by Subject|0|||
163011958|NCT03817853|588745778|FG000|Maintenance Phase|Adverse Event|0|||
163011959|NCT03817853|588745779|FG001|Maintenance Phase|Adverse Event|8|||
163011960|NCT03817853|588745780|FG002|Maintenance Phase|Adverse Event|0|||
163011961|NCT03817853|588745778|FG000|Maintenance Phase|Death|0|||
163011962|NCT03817853|588745779|FG001|Maintenance Phase|Death|5|||
163011963|NCT03817853|588745780|FG002|Maintenance Phase|Death|0|||
163011964|NCT03817853|588745778|FG000|Maintenance Phase|Progressive Disease|0|||
163011965|NCT03817853|588745779|FG001|Maintenance Phase|Progressive Disease|7|||
163011966|NCT03817853|588745780|FG002|Maintenance Phase|Progressive Disease|0|||
163011967|NCT03817853|588745778|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163011968|NCT03817853|588745779|FG001|Maintenance Phase|Withdrawal by Subject|2|||
163011969|NCT03817853|588745780|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163011970|NCT03817853|588745778|FG000|Maintenance Phase|Physician Decision|0|||
163011971|NCT03817853|588745779|FG001|Maintenance Phase|Physician Decision|1|||
163011972|NCT03817853|588745780|FG002|Maintenance Phase|Physician Decision|0|||
163011973|NCT03817853|588745778|FG000|Maintenance Phase|Various reasons|0|||
163011974|NCT03817853|588745779|FG001|Maintenance Phase|Various reasons|4|||
163011975|NCT03817853|588745780|FG002|Maintenance Phase|Various reasons|0|||
163011976|NCT03817853|588745778|FG000|Maintenance Phase|Protocol Deviation|0|||
163011977|NCT03817853|588745779|FG001|Maintenance Phase|Protocol Deviation|1|||
163011978|NCT03817853|588745780|FG002|Maintenance Phase|Protocol Deviation|0|||
163011979|NCT03817853|588745778|FG000|Follow-up Phase|Adverse Event|0|||
163011980|NCT03817853|588745779|FG001|Follow-up Phase|Adverse Event|0|||
163011981|NCT03817853|588745780|FG002|Follow-up Phase|Adverse Event|2|||
163011982|NCT03817853|588745778|FG000|Follow-up Phase|Death|0|||
163011983|NCT03817853|588745779|FG001|Follow-up Phase|Death|0|||
163011984|NCT03817853|588745780|FG002|Follow-up Phase|Death|1|||
163062524|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062525|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
163062526|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062527|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062528|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
163062529|NCT03329001|588936868|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062530|NCT03329001|588936869|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062531|NCT03329001|588936870|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062532|NCT03329001|588936871|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062533|NCT03329001|588936872|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
163062534|NCT03329001|588936873|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
163062535|NCT03329001|588936874|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163062536|NCT03329001|588936875|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163011985|NCT03817853|588745778|FG000|Follow-up Phase|Progressive Disease|0|||
163011986|NCT03817853|588745779|FG001|Follow-up Phase|Progressive Disease|0|||
163011987|NCT03817853|588745780|FG002|Follow-up Phase|Progressive Disease|3|||
163011988|NCT03817853|588745778|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163011989|NCT03817853|588745779|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163011990|NCT03817853|588745780|FG002|Follow-up Phase|Withdrawal by Subject|1|||
163011991|NCT05005507|588745781|FG000|Overall Study|Premature termination of study|1|||
163011992|NCT03866512|588745783|FG000|Overall Study|Lost to Follow-up|1|||
163011993|NCT03866512|588745784|FG001|Overall Study|Lost to Follow-up|2|||
163011994|NCT03866512|588745785|FG002|Overall Study|Lost to Follow-up|1|||
163011995|NCT03866512|588745783|FG000|Overall Study|Cannulation issues|0|||
163011996|NCT03866512|588745784|FG001|Overall Study|Cannulation issues|1|||
163011997|NCT03866512|588745785|FG002|Overall Study|Cannulation issues|2|||
163011998|NCT00320710|588745786|FG000|Overall Study|Disease progression|24|||
163062537|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062538|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062539|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062540|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062541|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062542|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
163062543|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
163062544|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
163062545|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062546|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062547|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062548|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062549|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062550|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062551|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
163062552|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
163062553|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062554|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062555|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062556|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062557|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062558|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
163062559|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
163062560|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
163062561|NCT03329001|588936868|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062562|NCT03329001|588936869|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062563|NCT03329001|588936870|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062564|NCT03329001|588936871|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
162640726|NCT04008030|587399926|FG001|Treatment|Participant no longer meets study criteria|1|||
162640727|NCT04008030|587399927|FG002|Treatment|Participant no longer meets study criteria|0|||
163011999|NCT00320710|588745787|FG001|Overall Study|Disease progression|19|||
163012000|NCT00320710|588745788|FG002|Overall Study|Disease progression|2|||
163012001|NCT00320710|588745786|FG000|Overall Study|Death|10|||
162640728|NCT04008030|587399925|FG000|Treatment|Other reasons|5|||
162640729|NCT04008030|587399926|FG001|Treatment|Other reasons|13|||
162640730|NCT04008030|587399927|FG002|Treatment|Other reasons|6|||
163012002|NCT00320710|588745787|FG001|Overall Study|Death|7|||
162640731|NCT04008030|587399925|FG000|Treatment|Disease Progression|137|||
163012003|NCT00320710|588745788|FG002|Overall Study|Death|1|||
163012004|NCT00320710|588745786|FG000|Overall Study|Administrative problems|1|||
163012005|NCT00320710|588745787|FG001|Overall Study|Administrative problems|2|||
163012006|NCT00320710|588745788|FG002|Overall Study|Administrative problems|0|||
163012007|NCT00320710|588745786|FG000|Overall Study|Withdrawal by Subject|20|||
163012008|NCT00320710|588745787|FG001|Overall Study|Withdrawal by Subject|26|||
163012009|NCT00320710|588745788|FG002|Overall Study|Withdrawal by Subject|1|||
163012010|NCT00320710|588745786|FG000|Overall Study|Protocol Violation|6|||
163012011|NCT00320710|588745787|FG001|Overall Study|Protocol Violation|5|||
163012012|NCT00320710|588745788|FG002|Overall Study|Protocol Violation|0|||
163012013|NCT00320710|588745786|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163012014|NCT00320710|588745787|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163012015|NCT00320710|588745788|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163012016|NCT00320710|588745786|FG000|Overall Study|Abnormal laboratory value(s)|12|||
163012017|NCT00320710|588745787|FG001|Overall Study|Abnormal laboratory value(s)|3|||
163012018|NCT00320710|588745788|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163012019|NCT00320710|588745786|FG000|Overall Study|Adverse Event|18|||
163012020|NCT00320710|588745787|FG001|Overall Study|Adverse Event|14|||
163012021|NCT00320710|588745788|FG002|Overall Study|Adverse Event|1|||
163012022|NCT00320710|588745786|FG000|Overall Study|Lost to Follow-up|1|||
163012023|NCT00320710|588745787|FG001|Overall Study|Lost to Follow-up|0|||
163012024|NCT00320710|588745788|FG002|Overall Study|Lost to Follow-up|0|||
163012025|NCT00997373|588745794|FG000|Overall Study|Withdrawal by Subject|5|||
163012026|NCT00997373|588745795|FG001|Overall Study|Withdrawal by Subject|0|||
163012027|NCT00997373|588745794|FG000|Overall Study|wrong tumor type|4|||
163012028|NCT00997373|588745795|FG001|Overall Study|wrong tumor type|0|||
163012029|NCT00997373|588745794|FG000|Overall Study|could not have hysterectomy|6|||
163012030|NCT00997373|588745795|FG001|Overall Study|could not have hysterectomy|0|||
163012031|NCT04578457|588745796|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
163012032|NCT04578457|588745796|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
163012033|NCT04578457|588745796|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
163012034|NCT04578457|588745796|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
163012035|NCT00832455|588745797|FG000|Overall Study|Adverse Event|13|||
163012036|NCT00832455|588745797|FG000|Overall Study|Lost to Follow-up|26|||
163012037|NCT00832455|588745797|FG000|Overall Study|Protocol Violation|4|||
163012038|NCT00832455|588745797|FG000|Overall Study|Withdrawal by Subject|17|||
163012039|NCT00832455|588745797|FG000|Overall Study|Screening Failure|2|||
163012040|NCT00832455|588745797|FG000|Overall Study|Stopped Medication|4|||
163012041|NCT00832455|588745797|FG000|Overall Study|Parent misunderstood study|1|||
163012042|NCT00832455|588745797|FG000|Overall Study|Parent dissatisfied|1|||
163012043|NCT00832455|588745797|FG000|Overall Study|No improvement|3|||
163012044|NCT00832455|588745797|FG000|Overall Study|Patient moved|1|||
163012045|NCT02841995|588745805|FG000|Overall Study|Disease progression|5|||
163012046|NCT02841995|588745806|FG001|Overall Study|Disease progression|11|||
163012047|NCT02841995|588745807|FG002|Overall Study|Disease progression|8|||
163012048|NCT02841995|588745805|FG000|Overall Study|Withdrawal by Subject|2|||
163012049|NCT02841995|588745806|FG001|Overall Study|Withdrawal by Subject|4|||
163012050|NCT02841995|588745807|FG002|Overall Study|Withdrawal by Subject|4|||
163012051|NCT02841995|588745805|FG000|Overall Study|Adverse Event|2|||
163012052|NCT02841995|588745806|FG001|Overall Study|Adverse Event|0|||
163012053|NCT02841995|588745807|FG002|Overall Study|Adverse Event|1|||
163012054|NCT02841995|588745805|FG000|Overall Study|Investigator decision|2|||
163012055|NCT02841995|588745806|FG001|Overall Study|Investigator decision|0|||
163012056|NCT02841995|588745807|FG002|Overall Study|Investigator decision|1|||
163012057|NCT02841995|588745805|FG000|Overall Study|Death|0|||
163012058|NCT02841995|588745806|FG001|Overall Study|Death|0|||
163012059|NCT02841995|588745807|FG002|Overall Study|Death|2|||
163012060|NCT02841995|588745805|FG000|Overall Study|Noncompliance to protocol|1|||
163012061|NCT02841995|588745806|FG001|Overall Study|Noncompliance to protocol|0|||
163012062|NCT02841995|588745807|FG002|Overall Study|Noncompliance to protocol|0|||
163012063|NCT02841995|588745805|FG000|Overall Study|Sponsor decision|1|||
163012064|NCT02841995|588745806|FG001|Overall Study|Sponsor decision|0|||
163012065|NCT02841995|588745807|FG002|Overall Study|Sponsor decision|0|||
163012066|NCT02841995|588745805|FG000|Overall Study|Other|4|||
163012067|NCT02841995|588745806|FG001|Overall Study|Other|1|||
163012068|NCT02841995|588745807|FG002|Overall Study|Other|5|||
163012069|NCT02755103|588745809|FG000|Overall Study|Lost to Follow-up|17|||
163012070|NCT02755103|588745810|FG001|Overall Study|Lost to Follow-up|15|||
163012071|NCT02755103|588745809|FG000|Overall Study|Death|0|||
163012072|NCT02755103|588745810|FG001|Overall Study|Death|1|||
163012073|NCT02755103|588745809|FG000|Overall Study|Physician Decision|0|||
163012074|NCT02755103|588745810|FG001|Overall Study|Physician Decision|1|||
163012075|NCT02755103|588745809|FG000|Overall Study|Pregnancy|0|||
163012076|NCT02755103|588745810|FG001|Overall Study|Pregnancy|1|||
163012077|NCT02755103|588745809|FG000|Overall Study|Withdrawal by Subject|3|||
163012078|NCT02755103|588745810|FG001|Overall Study|Withdrawal by Subject|0|||
163012079|NCT00739661|588745818|FG000|Overall Study|Adverse Event|2|||
163012080|NCT00739661|588745819|FG001|Overall Study|Adverse Event|0|||
163012081|NCT00739661|588745818|FG000|Overall Study|Physician decision to withdraw patient|1|||
163012082|NCT00739661|588745819|FG001|Overall Study|Physician decision to withdraw patient|0|||
163012083|NCT00739661|588745818|FG000|Overall Study|Patient decision to withdraw|9|||
163012084|NCT00739661|588745819|FG001|Overall Study|Patient decision to withdraw|4|||
162640732|NCT04008030|587399926|FG001|Treatment|Disease Progression|82|||
162640733|NCT04008030|587399927|FG002|Treatment|Disease Progression|85|||
163012085|NCT00739661|588745818|FG000|Overall Study|Disease progression, radiographic|33|||
163012086|NCT00739661|588745819|FG001|Overall Study|Disease progression, radiographic|37|||
163012087|NCT00739661|588745818|FG000|Overall Study|Reason for discontinuation not available|1|||
163012088|NCT00739661|588745819|FG001|Overall Study|Reason for discontinuation not available|1|||
162640734|NCT04008030|587399925|FG000|Treatment|Study drug toxicity|28|||
162640735|NCT04008030|587399926|FG001|Treatment|Study drug toxicity|48|||
163012089|NCT02883062|588745822|FG000|Overall Study|Withdrawal by Subject|6|||
163012090|NCT02883062|588745823|FG001|Overall Study|Withdrawal by Subject|0|||
163012091|NCT04578535|588745824|FG000|Overall Study|Lost to Follow-up|1|||
163012092|NCT04578535|588745825|FG001|Overall Study|Lost to Follow-up|0|||
163012093|NCT04578535|588745826|FG002|Overall Study|Lost to Follow-up|0|||
163012094|NCT04578535|588745827|FG003|Overall Study|Lost to Follow-up|1|||
163012095|NCT04578535|588745828|FG004|Overall Study|Lost to Follow-up|0|||
163012096|NCT04578535|588745829|FG005|Overall Study|Lost to Follow-up|2|||
163012097|NCT04578535|588745824|FG000|Overall Study|Pregnancy|1|||
163012098|NCT04578535|588745825|FG001|Overall Study|Pregnancy|0|||
163012099|NCT04578535|588745826|FG002|Overall Study|Pregnancy|0|||
163012100|NCT04578535|588745827|FG003|Overall Study|Pregnancy|0|||
163012101|NCT04578535|588745828|FG004|Overall Study|Pregnancy|0|||
163012102|NCT04578535|588745829|FG005|Overall Study|Pregnancy|0|||
163012103|NCT04578535|588745824|FG000|Overall Study|Withdrawal by Subject|0|||
163012104|NCT04578535|588745825|FG001|Overall Study|Withdrawal by Subject|0|||
163012105|NCT04578535|588745826|FG002|Overall Study|Withdrawal by Subject|0|||
163012106|NCT04578535|588745827|FG003|Overall Study|Withdrawal by Subject|1|||
163012107|NCT04578535|588745828|FG004|Overall Study|Withdrawal by Subject|1|||
163012108|NCT04578535|588745829|FG005|Overall Study|Withdrawal by Subject|5|||
163012109|NCT04578535|588745824|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
163012110|NCT04578535|588745825|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
163012111|NCT04578535|588745826|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
163012112|NCT04578535|588745827|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
163012113|NCT04578535|588745828|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
163012114|NCT04578535|588745829|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
163012115|NCT03839628|588745830|FG000|Overall Study|Withdrawal by Subject|1|||
163012116|NCT00380874|588745831|FG000|Overall Study|Adverse Event|7|||
163012117|NCT00380874|588745832|FG001|Overall Study|Adverse Event|7|||
163012118|NCT00380874|588745831|FG000|Overall Study|Death|1|||
163012119|NCT00380874|588745832|FG001|Overall Study|Death|0|||
163012120|NCT00380874|588745831|FG000|Overall Study|Withdrawal by Subject|2|||
163012121|NCT00380874|588745832|FG001|Overall Study|Withdrawal by Subject|1|||
163012122|NCT00380874|588745831|FG000|Overall Study|Not related to study drug|3|||
163012123|NCT00380874|588745832|FG001|Overall Study|Not related to study drug|2|||
163012124|NCT03380429|588745833|FG000|Overall Study|Physician Decision|0|||
163012125|NCT03380429|588745834|FG001|Overall Study|Physician Decision|1|||
163012126|NCT03380429|588745835|FG002|Overall Study|Physician Decision|0|||
163012127|NCT03380429|588745836|FG003|Overall Study|Physician Decision|1|||
163012128|NCT03380429|588745837|FG004|Overall Study|Physician Decision|1|||
163012129|NCT03380429|588745833|FG000|Overall Study|Withdrawal by Subject|3|||
163012130|NCT03380429|588745834|FG001|Overall Study|Withdrawal by Subject|3|||
163012131|NCT03380429|588745835|FG002|Overall Study|Withdrawal by Subject|5|||
163012132|NCT03380429|588745836|FG003|Overall Study|Withdrawal by Subject|2|||
163012133|NCT03380429|588745837|FG004|Overall Study|Withdrawal by Subject|1|||
163012134|NCT03380429|588745833|FG000|Overall Study|Lost to Follow-up|0|||
163012135|NCT03380429|588745834|FG001|Overall Study|Lost to Follow-up|2|||
163012136|NCT03380429|588745835|FG002|Overall Study|Lost to Follow-up|4|||
163012137|NCT03380429|588745836|FG003|Overall Study|Lost to Follow-up|3|||
163012138|NCT03380429|588745837|FG004|Overall Study|Lost to Follow-up|1|||
163012139|NCT03380429|588745833|FG000|Overall Study|Protocol Violation|1|||
163012140|NCT03380429|588745834|FG001|Overall Study|Protocol Violation|0|||
163012141|NCT03380429|588745835|FG002|Overall Study|Protocol Violation|1|||
163012142|NCT03380429|588745836|FG003|Overall Study|Protocol Violation|0|||
163012143|NCT03380429|588745837|FG004|Overall Study|Protocol Violation|1|||
163012144|NCT03380429|588745833|FG000|Overall Study|Lack of Efficacy|0|||
163012145|NCT03380429|588745834|FG001|Overall Study|Lack of Efficacy|0|||
163012146|NCT03380429|588745835|FG002|Overall Study|Lack of Efficacy|0|||
163012147|NCT03380429|588745836|FG003|Overall Study|Lack of Efficacy|2|||
163012148|NCT03380429|588745837|FG004|Overall Study|Lack of Efficacy|1|||
163012149|NCT03380429|588745833|FG000|Overall Study|Adverse Event|1|||
163012150|NCT03380429|588745834|FG001|Overall Study|Adverse Event|1|||
163012151|NCT03380429|588745835|FG002|Overall Study|Adverse Event|1|||
163012152|NCT03380429|588745836|FG003|Overall Study|Adverse Event|2|||
163012153|NCT03380429|588745837|FG004|Overall Study|Adverse Event|0|||
163012154|NCT01707290|588745842|FG000|Overall Study|Adverse event (AE)|1|||
163012155|NCT01707290|588745843|FG001|Overall Study|Adverse event (AE)|0|||
163012156|NCT01707290|588745842|FG000|Overall Study|Physician Decision|1|||
163012157|NCT01707290|588745843|FG001|Overall Study|Physician Decision|0|||
163012158|NCT01707290|588745842|FG000|Overall Study|Lost to Follow-up|3|||
163012159|NCT01707290|588745843|FG001|Overall Study|Lost to Follow-up|0|||
163012160|NCT01707290|588745842|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
163012161|NCT01707290|588745843|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
163012162|NCT01707290|588745842|FG000|Overall Study|Commercial drug available|60|||
163012163|NCT01707290|588745843|FG001|Overall Study|Commercial drug available|1|||
163012164|NCT01707290|588745842|FG000|Overall Study|Other unspecified|17|||
163012165|NCT01707290|588745843|FG001|Overall Study|Other unspecified|0|||
163012166|NCT02314026|588745844|FG000|Overall Study|Protocol Violation|28|||
163012167|NCT01139775|588745845|FG000|Overall Study|Adverse Event|0|||
163012168|NCT01139775|588745846|FG001|Overall Study|Adverse Event|6|||
163012169|NCT01139775|588745847|FG002|Overall Study|Adverse Event|2|||
163012170|NCT01139775|588745845|FG000|Overall Study|Protocol Violation|0|||
163012171|NCT01139775|588745846|FG001|Overall Study|Protocol Violation|5|||
163012172|NCT01139775|588745847|FG002|Overall Study|Protocol Violation|0|||
163012173|NCT01139775|588745845|FG000|Overall Study|Withdrawal by Subject|1|||
163012174|NCT01139775|588745846|FG001|Overall Study|Withdrawal by Subject|0|||
163012175|NCT01139775|588745847|FG002|Overall Study|Withdrawal by Subject|2|||
163012176|NCT01139775|588745845|FG000|Overall Study|Physician Decision|0|||
163012177|NCT01139775|588745846|FG001|Overall Study|Physician Decision|2|||
163012178|NCT01139775|588745847|FG002|Overall Study|Physician Decision|2|||
163012179|NCT01882985|588745850|FG000|Overall Study|Lost to Follow-up|1|||
163012180|NCT01882985|588745850|FG000|Overall Study|Withdrawal by Subject|1|||
163012181|NCT03193853|588745857|FG000|Overall Study|Death|6|||
163012182|NCT04129125|588745858|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
163012183|NCT04129125|588745858|FG000|Overall Study|Study device was not used|3|||
163012184|NCT00740636|588745866|FG000|Overall Study|Adverse Event|0|||
163012185|NCT00740636|588745867|FG001|Overall Study|Adverse Event|2|||
163012186|NCT00740636|588745866|FG000|Overall Study|Patient Ineligible|0|||
163012187|NCT00740636|588745867|FG001|Overall Study|Patient Ineligible|1|||
163012188|NCT00740636|588745866|FG000|Overall Study|Patient Not Treated|0|||
163012189|NCT00740636|588745867|FG001|Overall Study|Patient Not Treated|1|||
163012190|NCT00740636|588745866|FG000|Overall Study|Progressive Disease|1|||
163012191|NCT00740636|588745867|FG001|Overall Study|Progressive Disease|0|||
163012192|NCT00740636|588745866|FG000|Overall Study|Death|1|||
163012193|NCT00740636|588745867|FG001|Overall Study|Death|0|||
163012194|NCT02174627|588745870|FG000|Overall Study|Missing|0|||
163012195|NCT02174627|588745871|FG001|Overall Study|Missing|1|||
163012196|NCT02174627|588745870|FG000|Overall Study|Incorrect enrolment before randomization|0|||
163012197|NCT02174627|588745871|FG001|Overall Study|Incorrect enrolment before randomization|1|||
163012198|NCT02174627|588745870|FG000|Overall Study|Participant decision|84|||
163012199|NCT02174627|588745871|FG001|Overall Study|Participant decision|128|||
163012200|NCT02166333|588745872|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
163012201|NCT02166333|588745873|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012202|NCT02166333|588745874|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012203|NCT02166333|588745875|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
163012204|NCT02166333|588745876|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
163012205|NCT02166333|588745877|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
163012206|NCT02166333|588745872|FG000|Stage 1|Death|4|||
163012207|NCT02166333|588745873|FG001|Stage 1|Death|0|||
163012208|NCT02166333|588745874|FG002|Stage 1|Death|2|||
163012209|NCT02166333|588745875|FG003|Stage 1|Death|0|||
163012210|NCT02166333|588745876|FG004|Stage 1|Death|3|||
163012211|NCT02166333|588745877|FG005|Stage 1|Death|2|||
163012212|NCT02166333|588745872|FG000|Stage 1|Lost to Follow-up|12|||
163012213|NCT02166333|588745873|FG001|Stage 1|Lost to Follow-up|0|||
163012214|NCT02166333|588745874|FG002|Stage 1|Lost to Follow-up|6|||
163012215|NCT02166333|588745875|FG003|Stage 1|Lost to Follow-up|0|||
163012216|NCT02166333|588745876|FG004|Stage 1|Lost to Follow-up|3|||
163012217|NCT02166333|588745877|FG005|Stage 1|Lost to Follow-up|3|||
163012218|NCT02166333|588745872|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
163012219|NCT02166333|588745873|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
163012220|NCT02166333|588745874|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
163012221|NCT02166333|588745875|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
163012222|NCT02166333|588745876|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
163012223|NCT02166333|588745877|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
163012224|NCT02166333|588745872|FG000|Stage 2|Death|4|||
163012225|NCT02166333|588745873|FG001|Stage 2|Death|2|||
163012226|NCT02166333|588745874|FG002|Stage 2|Death|1|||
163012227|NCT02166333|588745875|FG003|Stage 2|Death|0|||
163012228|NCT02166333|588745876|FG004|Stage 2|Death|0|||
163012229|NCT02166333|588745877|FG005|Stage 2|Death|1|||
163012230|NCT02166333|588745872|FG000|Stage 2|Lost to Follow-up|23|||
163012231|NCT02166333|588745873|FG001|Stage 2|Lost to Follow-up|4|||
163012232|NCT02166333|588745874|FG002|Stage 2|Lost to Follow-up|11|||
163012233|NCT02166333|588745875|FG003|Stage 2|Lost to Follow-up|9|||
163012234|NCT02166333|588745876|FG004|Stage 2|Lost to Follow-up|3|||
163012235|NCT02166333|588745877|FG005|Stage 2|Lost to Follow-up|6|||
163012236|NCT00503698|588745878|FG000|Overall Study|Protocol Violation|5|||
163012237|NCT00503698|588745879|FG001|Overall Study|Protocol Violation|6|||
163012238|NCT00503698|588745878|FG000|Overall Study|Adverse Event|52|||
163012239|NCT00503698|588745879|FG001|Overall Study|Adverse Event|41|||
163012240|NCT00503698|588745878|FG000|Overall Study|Death|1|||
163012241|NCT00503698|588745879|FG001|Overall Study|Death|0|||
163012242|NCT00503698|588745878|FG000|Overall Study|Lack of Efficacy|3|||
163062565|NCT03329001|588936872|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163062566|NCT03329001|588936873|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
163012243|NCT00503698|588745879|FG001|Overall Study|Lack of Efficacy|4|||
163062567|NCT03329001|588936874|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
163062568|NCT03329001|588936875|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
163012244|NCT00503698|588745878|FG000|Overall Study|Trial terminated|216|||
163012245|NCT00503698|588745879|FG001|Overall Study|Trial terminated|253|||
163012246|NCT00503698|588745878|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
163012247|NCT00503698|588745879|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
163012248|NCT00503698|588745878|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
163012249|NCT00503698|588745879|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
163012250|NCT00503698|588745878|FG000|Overall Study|Any condition in exclusion criteria|4|||
163012251|NCT00503698|588745879|FG001|Overall Study|Any condition in exclusion criteria|6|||
163012252|NCT00503698|588745878|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
163012253|NCT00503698|588745879|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
163012254|NCT00503698|588745878|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
163012255|NCT00503698|588745879|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
163012256|NCT00503698|588745878|FG000|Overall Study|Critically ill|2|||
162715988|NCT03536884|587667102|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163012257|NCT00503698|588745879|FG001|Overall Study|Critically ill|0|||
163012258|NCT00503698|588745878|FG000|Overall Study|Unclassified|48|||
163012259|NCT00503698|588745879|FG001|Overall Study|Unclassified|32|||
163062569|NCT02178956|588936878|FG000|Overall Study|Lost to Follow-up|4|||
163062570|NCT02178956|588936879|FG001|Overall Study|Lost to Follow-up|4|||
163062571|NCT02178956|588936878|FG000|Overall Study|Sponsor terminated study|49|||
163062572|NCT02178956|588936879|FG001|Overall Study|Sponsor terminated study|58|||
163062573|NCT02178956|588936878|FG000|Overall Study|Withdrawal by Subject|15|||
163062574|NCT02178956|588936879|FG001|Overall Study|Withdrawal by Subject|11|||
163062575|NCT02178956|588936878|FG000|Overall Study|Various Reasons|3|||
163062576|NCT02178956|588936879|FG001|Overall Study|Various Reasons|5|||
163062577|NCT02709369|588936881|FG000|Overall Study|Lost to Follow-up|15|||
163062578|NCT02709369|588936881|FG000|Overall Study|Withdrawal by Subject|10|||
163062579|NCT02709369|588936881|FG000|Overall Study|Did not received intervention|2|||
163062580|NCT01341470|588936882|FG000|Overall Study|Sponsor decision|0|||
163062581|NCT01341470|588936883|FG001|Overall Study|Sponsor decision|0|||
163062582|NCT01341470|588936884|FG002|Overall Study|Sponsor decision|1|||
163062583|NCT01341470|588936885|FG003|Overall Study|Sponsor decision|1|||
163062584|NCT01341470|588936886|FG004|Overall Study|Sponsor decision|0|||
163062585|NCT01341470|588936887|FG005|Overall Study|Sponsor decision|1|||
163062586|NCT03282097|588936888|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
163062587|NCT03282097|588936889|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
163062588|NCT03282097|588936888|FG000|Intervention Visit Complete|Patient Death|13|||
163062589|NCT03282097|588936889|FG001|Intervention Visit Complete|Patient Death|15|||
163062590|NCT03282097|588936888|FG000|Intervention Visit Complete|Caregiver Death|0|||
163062591|NCT03282097|588936889|FG001|Intervention Visit Complete|Caregiver Death|3|||
163062592|NCT03282097|588936888|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
163062593|NCT03282097|588936889|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
163062594|NCT03282097|588936888|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
163062595|NCT03282097|588936889|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
163062596|NCT03282097|588936888|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
163062597|NCT03282097|588936889|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
163062598|NCT03282097|588936888|FG000|Primary Outcome Data Collection Complete|Missing|2|||
163062599|NCT03282097|588936889|FG001|Primary Outcome Data Collection Complete|Missing|3|||
163062600|NCT03282097|588936888|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
163062601|NCT03282097|588936889|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
163062602|NCT03282097|588936888|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
163062603|NCT03282097|588936889|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
163062604|NCT03282097|588936888|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
163062605|NCT03282097|588936889|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
163062606|NCT02755090|588936891|FG000|Overall Study|equipment malfunction|1|||
163062607|NCT02755090|588936892|FG001|Overall Study|equipment malfunction|0|||
163062608|NCT03034967|588936895|FG000|Overall Study|Withdrawal by Subject|9|||
163062609|NCT03034967|588936896|FG001|Overall Study|Withdrawal by Subject|2|||
163062610|NCT03034967|588936897|FG002|Overall Study|Withdrawal by Subject|6|||
163062611|NCT03034967|588936898|FG003|Overall Study|Withdrawal by Subject|6|||
163062612|NCT03034967|588936899|FG004|Overall Study|Withdrawal by Subject|9|||
163062613|NCT03034967|588936900|FG005|Overall Study|Withdrawal by Subject|2|||
163062614|NCT03034967|588936895|FG000|Overall Study|Physician Decision|1|||
163062615|NCT03034967|588936896|FG001|Overall Study|Physician Decision|0|||
163062616|NCT03034967|588936897|FG002|Overall Study|Physician Decision|1|||
162640736|NCT04008030|587399927|FG002|Treatment|Study drug toxicity|8|||
162640737|NCT04008030|587399925|FG000|Treatment|Adverse Event unrelated to study drug|28|||
162640738|NCT04008030|587399926|FG001|Treatment|Adverse Event unrelated to study drug|22|||
162640739|NCT04008030|587399927|FG002|Treatment|Adverse Event unrelated to study drug|6|||
162640740|NCT04008030|587399925|FG000|Treatment|Maximum Clinical Benefit|0|||
163012260|NCT00503698|588745878|FG000|Overall Study|Not exposed to trial drug|11|||
163012261|NCT00503698|588745879|FG001|Overall Study|Not exposed to trial drug|6|||
163012262|NCT02269098|588745880|FG000|Overall Study|Lost to Follow-up|14|||
163012263|NCT02269098|588745881|FG001|Overall Study|Lost to Follow-up|9|||
163012264|NCT00682786|588745886|FG000|Overall Study|Withdrawal by Subject|2|||
163012265|NCT00682786|588745887|FG001|Overall Study|Withdrawal by Subject|2|||
163012266|NCT00682786|588745886|FG000|Overall Study|Did not receive irinotecan|0|||
163012267|NCT00682786|588745887|FG001|Overall Study|Did not receive irinotecan|1|||
163012268|NCT03644342|588745888|FG000|Overall Study|Adverse Event|2|||
163012269|NCT03644342|588745889|FG001|Overall Study|Adverse Event|0|||
163012270|NCT03644342|588745888|FG000|Overall Study|Protocol Violation|0|||
163012271|NCT03644342|588745889|FG001|Overall Study|Protocol Violation|1|||
163012272|NCT02462603|588745892|FG000|Overall Study|Investigator Decision|1|||
163012273|NCT02462603|588745892|FG000|Overall Study|Non-Compliance|1|||
163012274|NCT02462603|588745892|FG000|Overall Study|Withdrawal by Subject|2|||
163012275|NCT01831635|588745893|FG000|Overall Study|Withdrawal by Subject|0|||
163012276|NCT01831635|588745894|FG001|Overall Study|Withdrawal by Subject|2|||
162640741|NCT04008030|587399926|FG001|Treatment|Maximum Clinical Benefit|1|||
162640742|NCT04008030|587399927|FG002|Treatment|Maximum Clinical Benefit|9|||
162640743|NCT04008030|587399925|FG000|Treatment|On-going treatment|13|||
163012277|NCT01831635|588745895|FG002|Overall Study|Withdrawal by Subject|0|||
163012278|NCT01991743|588745898|FG000|Overall Study|external cephalic version not performed|0|||
163012279|NCT01991743|588745899|FG001|Overall Study|external cephalic version not performed|0|||
163012280|NCT01991743|588745900|FG002|Overall Study|external cephalic version not performed|1|||
163012281|NCT01991743|588745901|FG003|Overall Study|external cephalic version not performed|0|||
163062617|NCT03034967|588936898|FG003|Overall Study|Physician Decision|1|||
163062618|NCT03034967|588936899|FG004|Overall Study|Physician Decision|1|||
163062619|NCT03034967|588936900|FG005|Overall Study|Physician Decision|0|||
163062620|NCT03034967|588936895|FG000|Overall Study|Lost to Follow-up|0|||
163062621|NCT03034967|588936896|FG001|Overall Study|Lost to Follow-up|0|||
163062622|NCT03034967|588936897|FG002|Overall Study|Lost to Follow-up|0|||
163062623|NCT03034967|588936898|FG003|Overall Study|Lost to Follow-up|1|||
163062624|NCT03034967|588936899|FG004|Overall Study|Lost to Follow-up|0|||
163062625|NCT03034967|588936900|FG005|Overall Study|Lost to Follow-up|2|||
163062626|NCT03034967|588936895|FG000|Overall Study|Liver function test abnormality|0|||
163062627|NCT03034967|588936896|FG001|Overall Study|Liver function test abnormality|0|||
163062628|NCT03034967|588936897|FG002|Overall Study|Liver function test abnormality|1|||
163062629|NCT03034967|588936898|FG003|Overall Study|Liver function test abnormality|0|||
163062630|NCT03034967|588936899|FG004|Overall Study|Liver function test abnormality|0|||
163062631|NCT03034967|588936900|FG005|Overall Study|Liver function test abnormality|0|||
163062632|NCT03034967|588936895|FG000|Overall Study|Protocol Violation|1|||
163062633|NCT03034967|588936896|FG001|Overall Study|Protocol Violation|0|||
163062634|NCT03034967|588936897|FG002|Overall Study|Protocol Violation|0|||
163062635|NCT03034967|588936898|FG003|Overall Study|Protocol Violation|0|||
163062636|NCT03034967|588936899|FG004|Overall Study|Protocol Violation|0|||
163062637|NCT03034967|588936900|FG005|Overall Study|Protocol Violation|2|||
163062638|NCT03034967|588936895|FG000|Overall Study|Lack of Efficacy|0|||
163062639|NCT03034967|588936896|FG001|Overall Study|Lack of Efficacy|1|||
163062640|NCT03034967|588936897|FG002|Overall Study|Lack of Efficacy|2|||
163062641|NCT03034967|588936898|FG003|Overall Study|Lack of Efficacy|1|||
163062642|NCT03034967|588936899|FG004|Overall Study|Lack of Efficacy|1|||
163062643|NCT03034967|588936900|FG005|Overall Study|Lack of Efficacy|0|||
163062644|NCT03034967|588936895|FG000|Overall Study|Adverse Event, non-fatal|3|||
163062645|NCT03034967|588936896|FG001|Overall Study|Adverse Event, non-fatal|1|||
163062646|NCT03034967|588936897|FG002|Overall Study|Adverse Event, non-fatal|2|||
163062647|NCT03034967|588936898|FG003|Overall Study|Adverse Event, non-fatal|0|||
163062648|NCT03034967|588936899|FG004|Overall Study|Adverse Event, non-fatal|2|||
163062649|NCT03034967|588936900|FG005|Overall Study|Adverse Event, non-fatal|8|||
163062650|NCT03034967|588936895|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
163062651|NCT03034967|588936896|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
163062652|NCT03034967|588936897|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
162640744|NCT04008030|587399926|FG001|Treatment|On-going treatment|20|||
163062653|NCT03034967|588936898|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
163062654|NCT03034967|588936899|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
163062655|NCT03034967|588936900|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
163062656|NCT05291689|588936907|FG000|Overall Study|Adverse Event|3|||
163062657|NCT05291689|588936907|FG000|Overall Study|Lack of Efficacy|10|||
163062658|NCT05291689|588936907|FG000|Overall Study|Withdrawal by Subject|4|||
162640745|NCT04008030|587399927|FG002|Treatment|On-going treatment|0|||
163062659|NCT01931098|588936908|FG000|Overall Study|Withdrawal by Subject|0|||
163062660|NCT01931098|588936909|FG001|Overall Study|Withdrawal by Subject|1|||
163012282|NCT04955691|588747982|FG000|Period 2|Discontinued intervention|1|||
163012283|NCT04955691|588747983|FG001|Period 2|Discontinued intervention|2|||
163012284|NCT05336227|588747984|FG000|Overall Study|Adverse Event|1|||
163012285|NCT05336227|588747985|FG001|Overall Study|Adverse Event|0|||
163012286|NCT05336227|588747984|FG000|Overall Study|Lost to Follow-up|2|||
163012287|NCT05336227|588747985|FG001|Overall Study|Lost to Follow-up|0|||
163012288|NCT05336227|588747984|FG000|Overall Study|Withdrawal by Subject|1|||
163012289|NCT05336227|588747985|FG001|Overall Study|Withdrawal by Subject|0|||
163012290|NCT05086744|588747986|FG000|Part A|Adverse Event|0|||
163012291|NCT05086744|588747987|FG001|Part A|Adverse Event|1|||
163012292|NCT05086744|588747986|FG000|Part A|Lack of Efficacy|3|||
163012293|NCT05086744|588747987|FG001|Part A|Lack of Efficacy|0|||
163012294|NCT05086744|588747986|FG000|Part A|Protocol deviation|1|||
163012295|NCT05086744|588747987|FG001|Part A|Protocol deviation|0|||
163012296|NCT05086744|588747986|FG000|Part A|Subject decision|1|||
163012297|NCT05086744|588747987|FG001|Part A|Subject decision|0|||
163012298|NCT05086744|588747986|FG000|Part B|Adverse Event|0|||
163012299|NCT05086744|588747987|FG001|Part B|Adverse Event|1|||
163012300|NCT05086744|588747986|FG000|Part B|Lack of Efficacy|0|||
163012301|NCT05086744|588747987|FG001|Part B|Lack of Efficacy|1|||
163012302|NCT05086744|588747986|FG000|Part B|Study terminated by sponsor|1|||
163012303|NCT05086744|588747987|FG001|Part B|Study terminated by sponsor|6|||
163012304|NCT04050462|588747988|FG000|Overall Study|Withdrawal by Subject|1|||
163012305|NCT04050462|588747989|FG001|Overall Study|Withdrawal by Subject|0|||
163012306|NCT04050462|588747990|FG002|Overall Study|Withdrawal by Subject|0|||
163012307|NCT05151744|588747993|FG000|Overall Study|Adverse Event|6|||
163012308|NCT05151744|588747994|FG001|Overall Study|Adverse Event|2|||
163012309|NCT05151744|588747993|FG000|Overall Study|Death|1|||
163012310|NCT05151744|588747994|FG001|Overall Study|Death|2|||
163012311|NCT05151744|588747993|FG000|Overall Study|Lack of Efficacy|1|||
163012312|NCT05151744|588747994|FG001|Overall Study|Lack of Efficacy|1|||
163012313|NCT05151744|588747993|FG000|Overall Study|Lost to Follow-up|2|||
163012314|NCT05151744|588747994|FG001|Overall Study|Lost to Follow-up|2|||
163012315|NCT05151744|588747993|FG000|Overall Study|Need for Rescue Treatment|0|||
163012316|NCT05151744|588747994|FG001|Overall Study|Need for Rescue Treatment|1|||
163012317|NCT05151744|588747993|FG000|Overall Study|Non-compliance with Study Drug|0|||
163012318|NCT05151744|588747994|FG001|Overall Study|Non-compliance with Study Drug|1|||
163012319|NCT05151744|588747993|FG000|Overall Study|Reason not Specified|10|||
163012320|NCT05151744|588747994|FG001|Overall Study|Reason not Specified|0|||
163012321|NCT05151744|588747993|FG000|Overall Study|Physician Decision|2|||
163012322|NCT05151744|588747994|FG001|Overall Study|Physician Decision|1|||
163012323|NCT05151744|588747993|FG000|Overall Study|Protocol Violation|1|||
163012324|NCT05151744|588747994|FG001|Overall Study|Protocol Violation|0|||
163012325|NCT05151744|588747993|FG000|Overall Study|Withdrawal by Subject|6|||
163012326|NCT05151744|588747994|FG001|Overall Study|Withdrawal by Subject|3|||
163012327|NCT04053868|588747995|FG000|Overall Study|Withdrawal by Subject|1|||
163012328|NCT04053868|588747996|FG001|Overall Study|Withdrawal by Subject|0|||
163012329|NCT05731700|588747997|FG000|Overall Study|Death|1|||
163012330|NCT01682226|588748000|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
163012331|NCT01682226|588748000|FG000|Overall Study|Participants did not receive treatment|2|||
163012332|NCT01682226|588748000|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
163012333|NCT03771898|588748009|FG000|Overall Study|Adverse Event|1|||
163012334|NCT03771898|588748010|FG001|Overall Study|Adverse Event|0|||
163012335|NCT03771898|588748011|FG002|Overall Study|Adverse Event|0|||
163012336|NCT03771898|588748012|FG003|Overall Study|Adverse Event|0|||
163012337|NCT03771898|588748013|FG004|Overall Study|Adverse Event|0|||
163012338|NCT03771898|588748009|FG000|Overall Study|Lost to Follow-up|1|||
163012339|NCT03771898|588748010|FG001|Overall Study|Lost to Follow-up|1|||
163012340|NCT03771898|588748011|FG002|Overall Study|Lost to Follow-up|1|||
163012341|NCT03771898|588748012|FG003|Overall Study|Lost to Follow-up|0|||
163012342|NCT03771898|588748013|FG004|Overall Study|Lost to Follow-up|0|||
163012343|NCT03771898|588748009|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163012344|NCT03771898|588748010|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163012345|NCT03771898|588748011|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163012346|NCT03771898|588748012|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163012347|NCT03771898|588748013|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163012348|NCT03771898|588748009|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012349|NCT03771898|588748010|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012350|NCT03771898|588748011|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012351|NCT03771898|588748012|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
163012352|NCT03771898|588748013|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
163012353|NCT03123120|588748014|FG000|Overall Study|Lost to Follow-up|0|||
163012354|NCT03123120|588748015|FG001|Overall Study|Lost to Follow-up|1|||
163012355|NCT03123120|588748014|FG000|Overall Study|Withdrawal by Subject|0|||
163012356|NCT03123120|588748015|FG001|Overall Study|Withdrawal by Subject|1|||
163012357|NCT03135548|588748019|FG000|Overall Study|Lost to Follow-up|3|||
163012358|NCT03135548|588748020|FG001|Overall Study|Lost to Follow-up|0|||
163012359|NCT03135548|588748021|FG002|Overall Study|Lost to Follow-up|0|||
163012360|NCT03135548|588748019|FG000|Overall Study|Withdrawal by Subject|2|||
163012361|NCT03135548|588748020|FG001|Overall Study|Withdrawal by Subject|2|||
163012362|NCT03135548|588748021|FG002|Overall Study|Withdrawal by Subject|1|||
163012363|NCT03135548|588748019|FG000|Overall Study|Other than listed|0|||
163012364|NCT03135548|588748020|FG001|Overall Study|Other than listed|2|||
163012365|NCT03135548|588748021|FG002|Overall Study|Other than listed|2|||
163012366|NCT02632175|588748022|FG000|Overall Study|Withdrawal by Subject|6|||
163012367|NCT02632175|588748022|FG000|Overall Study|Lost to Follow-up|1|||
163012368|NCT02632175|588748022|FG000|Overall Study|Lack of Efficacy|18|||
163012369|NCT02632175|588748022|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
163012370|NCT02632175|588748022|FG000|Overall Study|Subject noncompliance|3|||
163012371|NCT02632175|588748022|FG000|Overall Study|other|2|||
163012372|NCT02088554|588748023|FG000|Overall Study|Exited before procedure|130|||
163012373|NCT02088554|588748023|FG000|Overall Study|Attempted but not implanted|31|||
163012374|NCT02088554|588748023|FG000|Overall Study|Implant not attempted|19|||
163012375|NCT02088554|588748023|FG000|Overall Study|Pending next visit|532|||
163012376|NCT02088554|588748023|FG000|Overall Study|Death|170|||
163012377|NCT02088554|588748023|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
163012378|NCT02088554|588748023|FG000|Overall Study|Lost to Follow-up|23|||
163012379|NCT02088554|588748023|FG000|Overall Study|Explanted|32|||
163012380|NCT02088554|588748023|FG000|Overall Study|Any other reason not covered by previous categories|11|||
163012381|NCT04623216|588748024|FG000|Overall Study|Death|5|||
163012382|NCT04623216|588748025|FG001|Overall Study|Death|2|||
163012383|NCT04623216|588748026|FG002|Overall Study|Death|0|||
163012384|NCT04623216|588748027|FG003|Overall Study|Death|0|||
163012385|NCT04623216|588748024|FG000|Overall Study|Terminated by Sponsor|3|||
163012386|NCT04623216|588748025|FG001|Overall Study|Terminated by Sponsor|2|||
163012387|NCT04623216|588748026|FG002|Overall Study|Terminated by Sponsor|2|||
163012388|NCT04623216|588748027|FG003|Overall Study|Terminated by Sponsor|0|||
163012389|NCT04623216|588748024|FG000|Overall Study|Physician Decision|1|||
163012390|NCT04623216|588748025|FG001|Overall Study|Physician Decision|0|||
163012391|NCT04623216|588748026|FG002|Overall Study|Physician Decision|0|||
163012392|NCT04623216|588748027|FG003|Overall Study|Physician Decision|0|||
163012393|NCT03521154|588748030|FG000|Overall Study|Ongoing study at data cut-off|111|||
163012394|NCT03521154|588748031|FG001|Overall Study|Ongoing study at data cut-off|52|||
163012395|NCT05468164|588748032|FG000|Treatment Period 4|Adverse Event|0|||
163012396|NCT05468164|588748033|FG001|Treatment Period 4|Adverse Event|0|||
163012397|NCT05468164|588748034|FG002|Treatment Period 4|Adverse Event|0|||
163012398|NCT05468164|588748035|FG003|Treatment Period 4|Adverse Event|1|||
163012399|NCT04632927|588748036|FG000|Overall Study|Adverse Event|0|||
163012400|NCT04632927|588748037|FG001|Overall Study|Adverse Event|1|||
163012401|NCT04632927|588748036|FG000|Overall Study|Lack of Efficacy|0|||
162925313|NCT05723835|588428930|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
162925314|NCT05723835|588428931|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
162925315|NCT05723835|588428932|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
162925316|NCT05723835|588428933|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
162925317|NCT05723835|588428934|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
162925318|NCT05226286|588428935|FG000|Overall Study|Screen failures prior to implant|62|||
162925319|NCT05226286|588428935|FG000|Overall Study|Withdrawal by Subject|13|||
162925320|NCT05226286|588428935|FG000|Overall Study|Lost to Follow-up|3|||
162925321|NCT05226286|588428935|FG000|Overall Study|Physician Decision|1|||
162925322|NCT05226286|588428935|FG000|Overall Study|Adverse Event|1|||
162925323|NCT05226286|588428935|FG000|Overall Study|Death|1|||
162925324|NCT05226286|588428935|FG000|Overall Study|Device explant with no planned replacement|1|||
162925325|NCT05226286|588428935|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
162925326|NCT05226286|588428935|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
162925327|NCT00602641|588428936|FG000|Overall Study|Never started protocol therapy|6|||
162925328|NCT00602641|588428937|FG001|Overall Study|Never started protocol therapy|2|||
162925329|NCT00602641|588428936|FG000|Overall Study|Still on treatment at time of analysis|8|||
162925330|NCT00602641|588428937|FG001|Overall Study|Still on treatment at time of analysis|15|||
162925331|NCT00602641|588428936|FG000|Overall Study|Adverse Event|62|||
162925332|NCT00602641|588428937|FG001|Overall Study|Adverse Event|53|||
163012402|NCT04632927|588748037|FG001|Overall Study|Lack of Efficacy|4|||
163012403|NCT04632927|588748036|FG000|Overall Study|Loss of efficacy|0|||
163012404|NCT04632927|588748037|FG001|Overall Study|Loss of efficacy|1|||
163012405|NCT04632927|588748036|FG000|Overall Study|Non-compliance with study drug|0|||
163012406|NCT04632927|588748037|FG001|Overall Study|Non-compliance with study drug|1|||
163012407|NCT04632927|588748036|FG000|Overall Study|Physician Decision|0|||
163012408|NCT04632927|588748037|FG001|Overall Study|Physician Decision|1|||
163012409|NCT04632927|588748036|FG000|Overall Study|Subject decision|0|||
163012410|NCT04632927|588748037|FG001|Overall Study|Subject decision|1|||
162925333|NCT00602641|588428936|FG000|Overall Study|Disease progression|38|||
162925334|NCT00602641|588428937|FG001|Overall Study|Disease progression|55|||
162925335|NCT00602641|588428936|FG000|Overall Study|Death|6|||
162925336|NCT00602641|588428937|FG001|Overall Study|Death|5|||
162925337|NCT00602641|588428936|FG000|Overall Study|Withdrawal by Subject|15|||
162925338|NCT00602641|588428937|FG001|Overall Study|Withdrawal by Subject|12|||
162925339|NCT00602641|588428936|FG000|Overall Study|Alternative therapy|5|||
162925340|NCT00602641|588428937|FG001|Overall Study|Alternative therapy|2|||
163012411|NCT04632927|588748036|FG000|Overall Study|Withdrawal by Subject|0|||
163012412|NCT04632927|588748037|FG001|Overall Study|Withdrawal by Subject|1|||
163012413|NCT03827291|588748038|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
163012414|NCT03827291|588748039|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
163012415|NCT04795466|588748040|FG000|Overall Study|Adverse Event|3|||
163012416|NCT04795466|588748041|FG001|Overall Study|Adverse Event|1|||
163012417|NCT04795466|588748040|FG000|Overall Study|Physician Decision|1|||
163012418|NCT04795466|588748041|FG001|Overall Study|Physician Decision|0|||
163012419|NCT04795466|588748040|FG000|Overall Study|Withdrawal by Subject|2|||
163012420|NCT04795466|588748041|FG001|Overall Study|Withdrawal by Subject|1|||
163012421|NCT02955355|588748049|FG000|Overall Study|Adverse Event|4|||
163012422|NCT02955355|588748049|FG000|Overall Study|Death|1|||
163012423|NCT02955355|588748049|FG000|Overall Study|Physician Decision|21|||
163012424|NCT02955355|588748049|FG000|Overall Study|Site Terminated by Sponsor|35|||
163012425|NCT02955355|588748049|FG000|Overall Study|Withdrawal by Subject|19|||
163012426|NCT02955355|588748049|FG000|Overall Study|Reason Not Specified|5|||
163012427|NCT02612623|588748050|FG000|Overall Study|Withdrawal by Subject|0|||
163012428|NCT02612623|588748051|FG001|Overall Study|Withdrawal by Subject|1|||
163012429|NCT02612623|588748052|FG002|Overall Study|Withdrawal by Subject|0|||
163012430|NCT02612623|588748053|FG003|Overall Study|Withdrawal by Subject|0|||
163012431|NCT02612623|588748050|FG000|Overall Study|Adverse Event|1|||
163012432|NCT02612623|588748051|FG001|Overall Study|Adverse Event|0|||
163012433|NCT02612623|588748052|FG002|Overall Study|Adverse Event|1|||
163012434|NCT02612623|588748053|FG003|Overall Study|Adverse Event|0|||
163012435|NCT03168711|588748055|FG000|Overall Study|Adverse Event|2|||
163012436|NCT03168711|588748056|FG001|Overall Study|Adverse Event|0|||
163012437|NCT03168711|588748055|FG000|Overall Study|Withdrawal by Subject|0|||
163012438|NCT03168711|588748056|FG001|Overall Study|Withdrawal by Subject|1|||
163012439|NCT03168711|588748055|FG000|Overall Study|Death|0|||
163012440|NCT03168711|588748056|FG001|Overall Study|Death|1|||
163012441|NCT01671007|588748061|FG000|Overall Study|Other reasons than listed|166|||
163012442|NCT01671007|588748062|FG001|Overall Study|Other reasons than listed|373|||
163012443|NCT01671007|588748063|FG002|Overall Study|Other reasons than listed|197|||
163012444|NCT01671007|588748064|FG003|Overall Study|Other reasons than listed|228|||
163012445|NCT01671007|588748065|FG004|Overall Study|Other reasons than listed|14|||
163012446|NCT01671007|588748066|FG005|Overall Study|Other reasons than listed|71|||
163012447|NCT01671007|588748067|FG006|Overall Study|Other reasons than listed|17|||
163012448|NCT01671007|588748068|FG007|Overall Study|Other reasons than listed|66|||
163012449|NCT01671007|588748069|FG008|Overall Study|Other reasons than listed|0|||
163012450|NCT01671007|588748061|FG000|Overall Study|Withdrawal by Subject|36|||
163012451|NCT01671007|588748062|FG001|Overall Study|Withdrawal by Subject|59|||
163012452|NCT01671007|588748063|FG002|Overall Study|Withdrawal by Subject|53|||
163012453|NCT01671007|588748064|FG003|Overall Study|Withdrawal by Subject|58|||
163012454|NCT01671007|588748065|FG004|Overall Study|Withdrawal by Subject|4|||
163012455|NCT01671007|588748066|FG005|Overall Study|Withdrawal by Subject|15|||
163012456|NCT01671007|588748067|FG006|Overall Study|Withdrawal by Subject|1|||
163012457|NCT01671007|588748068|FG007|Overall Study|Withdrawal by Subject|19|||
163012458|NCT01671007|588748069|FG008|Overall Study|Withdrawal by Subject|0|||
163012459|NCT01671007|588748061|FG000|Overall Study|Lost to Follow-up|93|||
163012460|NCT01671007|588748062|FG001|Overall Study|Lost to Follow-up|142|||
163012461|NCT01671007|588748063|FG002|Overall Study|Lost to Follow-up|91|||
163012462|NCT01671007|588748064|FG003|Overall Study|Lost to Follow-up|63|||
163012463|NCT01671007|588748065|FG004|Overall Study|Lost to Follow-up|7|||
163012464|NCT01671007|588748066|FG005|Overall Study|Lost to Follow-up|20|||
163012465|NCT01671007|588748067|FG006|Overall Study|Lost to Follow-up|2|||
163012466|NCT01671007|588748068|FG007|Overall Study|Lost to Follow-up|28|||
163012467|NCT01671007|588748069|FG008|Overall Study|Lost to Follow-up|0|||
162925341|NCT00602641|588428936|FG000|Overall Study|Other Complicating Disease|5|||
163012468|NCT01671007|588748061|FG000|Overall Study|No end of study case report form|3|||
163012469|NCT01671007|588748062|FG001|Overall Study|No end of study case report form|1|||
163012470|NCT01671007|588748063|FG002|Overall Study|No end of study case report form|0|||
163012471|NCT01671007|588748064|FG003|Overall Study|No end of study case report form|2|||
163012472|NCT01671007|588748065|FG004|Overall Study|No end of study case report form|0|||
163012473|NCT01671007|588748066|FG005|Overall Study|No end of study case report form|0|||
163012474|NCT01671007|588748067|FG006|Overall Study|No end of study case report form|0|||
163012475|NCT01671007|588748068|FG007|Overall Study|No end of study case report form|0|||
163012476|NCT01671007|588748069|FG008|Overall Study|No end of study case report form|0|||
163012477|NCT01671007|588748061|FG000|Overall Study|Not eligible|23|||
163012478|NCT01671007|588748062|FG001|Overall Study|Not eligible|76|||
163012479|NCT01671007|588748063|FG002|Overall Study|Not eligible|25|||
163012480|NCT01671007|588748064|FG003|Overall Study|Not eligible|17|||
163012481|NCT01671007|588748065|FG004|Overall Study|Not eligible|0|||
163012482|NCT01671007|588748066|FG005|Overall Study|Not eligible|6|||
163012483|NCT01671007|588748067|FG006|Overall Study|Not eligible|1|||
163012484|NCT01671007|588748068|FG007|Overall Study|Not eligible|19|||
163012485|NCT01671007|588748069|FG008|Overall Study|Not eligible|0|||
163012486|NCT03877068|588748070|FG000|Overall Study|Physician Decision|9|||
163012487|NCT03877068|588748071|FG001|Overall Study|Physician Decision|3|||
163012488|NCT00449865|588748072|FG000|Overall Study|Withdrawal by Subject|110|||
163012489|NCT00449865|588748073|FG001|Overall Study|Withdrawal by Subject|110|||
163012490|NCT00449865|588748072|FG000|Overall Study|Lost to Follow-up|36|||
163012491|NCT00449865|588748073|FG001|Overall Study|Lost to Follow-up|37|||
163012492|NCT00449865|588748072|FG000|Overall Study|Physician Decision|13|||
163012493|NCT00449865|588748073|FG001|Overall Study|Physician Decision|12|||
163012494|NCT00449865|588748072|FG000|Overall Study|Death|31|||
163012495|NCT00449865|588748073|FG001|Overall Study|Death|40|||
163012496|NCT00449865|588748072|FG000|Overall Study|Protocol Violation|8|||
163012497|NCT00449865|588748073|FG001|Overall Study|Protocol Violation|7|||
163012498|NCT00449865|588748072|FG000|Overall Study|Study was stopped|324|||
163012499|NCT00449865|588748073|FG001|Overall Study|Study was stopped|328|||
163012500|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
163012501|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163012502|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
163012503|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
163012504|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
163012505|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
163012506|NCT00406367|588748074|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
163012507|NCT00406367|588748075|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
163012508|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
163012509|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
163012510|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
163012511|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
163012512|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
163012513|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
163012514|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
163012515|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
163012516|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
163012517|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
163012518|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
163012519|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
163012520|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
163012521|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
163012522|NCT00406367|588748074|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
163012523|NCT00406367|588748075|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
163012524|NCT03252535|588748076|FG000|Overall Study|Withdrawal by Subject|1|||
163012525|NCT03252535|588748077|FG001|Overall Study|Withdrawal by Subject|0|||
163012526|NCT03252535|588748078|FG002|Overall Study|Withdrawal by Subject|0|||
163012527|NCT03252535|588748076|FG000|Overall Study|Physician Decision|0|||
163062661|NCT01931098|588936908|FG000|Overall Study|Enrolled in different protocol|0|||
163062662|NCT01931098|588936909|FG001|Overall Study|Enrolled in different protocol|1|||
163062663|NCT01931098|588936908|FG000|Overall Study|Unable to begin trmt:active infection|0|||
163012528|NCT03252535|588748077|FG001|Overall Study|Physician Decision|1|||
163012529|NCT03252535|588748078|FG002|Overall Study|Physician Decision|0|||
163012530|NCT03252535|588748076|FG000|Overall Study|Met discontinuation criteria|0|||
163012531|NCT03252535|588748077|FG001|Overall Study|Met discontinuation criteria|1|||
163012532|NCT03252535|588748078|FG002|Overall Study|Met discontinuation criteria|0|||
163012533|NCT03922308|588748079|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
163012534|NCT03922308|588748080|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
163012535|NCT03922308|588748081|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
163012536|NCT03922308|588748079|FG000|Overall Study|Lost to Follow-up|1|||
163012537|NCT03922308|588748080|FG001|Overall Study|Lost to Follow-up|0|||
163012538|NCT03922308|588748081|FG002|Overall Study|Lost to Follow-up|0|||
163012539|NCT03922308|588748079|FG000|Overall Study|Reason not Specified|0|||
163012540|NCT03922308|588748080|FG001|Overall Study|Reason not Specified|2|||
163012541|NCT03922308|588748081|FG002|Overall Study|Reason not Specified|1|||
163012542|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
163012543|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012544|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163062664|NCT01931098|588936909|FG001|Overall Study|Unable to begin trmt:active infection|1|||
163012545|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012546|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
163012547|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012548|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012549|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
163012550|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
163012551|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012552|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012553|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
163012554|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
163012555|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012556|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012557|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012558|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
163012559|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012560|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012561|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012562|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
163012563|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012564|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012565|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012566|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
163012567|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012568|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012569|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
163012570|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
163012571|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012572|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012573|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
163012574|NCT00506415|588748082|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
163012575|NCT00506415|588748083|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012576|NCT00506415|588748084|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012577|NCT00506415|588748085|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012578|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
163012579|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
163012580|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
163012581|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
163012582|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
163012583|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
163012584|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
163012585|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
163012586|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
162640746|NCT02574247|587399934|FG000|Overall Study|Withdrawal by Subject|1|||
162640747|NCT02574247|587399935|FG001|Overall Study|Withdrawal by Subject|0|||
163012587|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
163012588|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
163012589|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
163012590|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
163012591|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
163012592|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
163012593|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
163012594|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
163012595|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
163012596|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
163012597|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
163012598|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
163012599|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
163012600|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
163012601|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
163012602|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
162640748|NCT02574247|587399936|FG002|Overall Study|Withdrawal by Subject|0|||
162640749|NCT02574247|587399934|FG000|Overall Study|Did not meet inclusion criteria|4|||
163012603|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
163012604|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
163012605|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
163012606|NCT00506415|588748082|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012607|NCT00506415|588748083|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012608|NCT00506415|588748084|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
163012609|NCT00506415|588748085|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
163012610|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012611|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012612|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
163012613|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
163012614|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012615|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012616|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
163012617|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
163012618|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012619|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012620|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
163012621|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
163012622|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012623|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012624|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
163012625|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
163012626|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012627|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012628|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
163012629|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
163012630|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012631|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012632|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
163012633|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
163012634|NCT00506415|588748082|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012635|NCT00506415|588748083|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012636|NCT00506415|588748084|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
163012637|NCT00506415|588748085|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
163012638|NCT02198664|588748086|FG000|Overall Study|Adverse Event|2|||
163012639|NCT02198664|588748087|FG001|Overall Study|Adverse Event|0|||
163012640|NCT02198664|588748086|FG000|Overall Study|Withdrawal by Subject|11|||
163012641|NCT02198664|588748087|FG001|Overall Study|Withdrawal by Subject|8|||
163012642|NCT02198664|588748086|FG000|Overall Study|Failure to tolerate|2|||
163012643|NCT02198664|588748087|FG001|Overall Study|Failure to tolerate|0|||
163012644|NCT02198664|588748086|FG000|Overall Study|Not stated|1|||
163012645|NCT02198664|588748087|FG001|Overall Study|Not stated|0|||
163012646|NCT02632409|588748088|FG000|Randomized|AE unrelated to study Drug|0|||
163012647|NCT02632409|588748089|FG001|Randomized|AE unrelated to study Drug|1|||
163012648|NCT02632409|588748088|FG000|Randomized|Participant withdrew consent|2|||
163012649|NCT02632409|588748089|FG001|Randomized|Participant withdrew consent|1|||
163012650|NCT02632409|588748088|FG000|Randomized|No Longer meets study criteria|5|||
163012651|NCT02632409|588748089|FG001|Randomized|No Longer meets study criteria|0|||
163012652|NCT02632409|588748088|FG000|Randomized|other reasons|1|||
163012653|NCT02632409|588748089|FG001|Randomized|other reasons|0|||
163012654|NCT02632409|588748088|FG000|Treatment Period|Ongoing Treatment|20|||
163012655|NCT02632409|588748089|FG001|Treatment Period|Ongoing Treatment|21|||
163012656|NCT02632409|588748088|FG000|Treatment Period|Disease Recurrence|147|||
163012657|NCT02632409|588748089|FG001|Treatment Period|Disease Recurrence|90|||
163012658|NCT02632409|588748088|FG000|Treatment Period|Study Drug Toxicity|8|||
163012659|NCT02632409|588748089|FG001|Treatment Period|Study Drug Toxicity|49|||
163012660|NCT02632409|588748088|FG000|Treatment Period|Death|1|||
163012661|NCT02632409|588748089|FG001|Treatment Period|Death|0|||
163012662|NCT02632409|588748088|FG000|Treatment Period|AE unrelated to study drug|15|||
163012663|NCT02632409|588748089|FG001|Treatment Period|AE unrelated to study drug|16|||
163012664|NCT02632409|588748088|FG000|Treatment Period|Request to discontinue treatment|4|||
163012665|NCT02632409|588748089|FG001|Treatment Period|Request to discontinue treatment|19|||
163012666|NCT02632409|588748088|FG000|Treatment Period|Participant withdrew consent|7|||
163012667|NCT02632409|588748089|FG001|Treatment Period|Participant withdrew consent|5|||
163062665|NCT01931098|588936908|FG000|Overall Study|Refused further treatment|0|||
163062666|NCT01931098|588936909|FG001|Overall Study|Refused further treatment|1|||
163062667|NCT02612155|588936910|FG000|Overall Study|Death|1|||
163012668|NCT02632409|588748088|FG000|Treatment Period|Lost to Follow-up|0|||
163012669|NCT02632409|588748089|FG001|Treatment Period|Lost to Follow-up|1|||
163012670|NCT02632409|588748088|FG000|Treatment Period|Maximum clinical benefit|1|||
163012671|NCT02632409|588748089|FG001|Treatment Period|Maximum clinical benefit|0|||
163062668|NCT02612155|588936911|FG001|Overall Study|Death|1|||
163062669|NCT02612155|588936910|FG000|Overall Study|Lost to Follow-up|2|||
163062670|NCT02612155|588936911|FG001|Overall Study|Lost to Follow-up|2|||
163062671|NCT04235374|588936912|FG000|Overall Study|Death|91|||
163062672|NCT04235374|588936913|FG001|Overall Study|Death|91|||
163062673|NCT04235374|588936912|FG000|Overall Study|Refused|2|||
163062674|NCT04235374|588936913|FG001|Overall Study|Refused|2|||
163062675|NCT04235374|588936912|FG000|Overall Study|Unavailable|12|||
163062676|NCT04235374|588936913|FG001|Overall Study|Unavailable|3|||
163062677|NCT04235374|588936912|FG000|Overall Study|Withdrawal by Subject|0|||
163062678|NCT04235374|588936913|FG001|Overall Study|Withdrawal by Subject|1|||
163062679|NCT04235374|588936912|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
163012672|NCT02632409|588748088|FG000|Treatment Period|No longer meets study criteria|3|||
163012673|NCT02632409|588748089|FG001|Treatment Period|No longer meets study criteria|0|||
163012674|NCT02632409|588748088|FG000|Treatment Period|Administrative Reason by sponsor|0|||
163012675|NCT02632409|588748089|FG001|Treatment Period|Administrative Reason by sponsor|1|||
163012676|NCT02632409|588748088|FG000|Treatment Period|Other Reasons|10|||
163012677|NCT02632409|588748089|FG001|Treatment Period|Other Reasons|6|||
163012678|NCT04426006|588748090|FG000|Inclusion|Protocol Violation|1|||
163012679|NCT04426006|588748090|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
163012680|NCT04426006|588748090|FG000|Inclusion|Blood sample at inclusion not done|1|||
163012681|NCT04426006|588748090|FG000|3 Months|Lost to Follow-up|17|||
163012682|NCT04426006|588748090|FG000|12 Months|Lost to Follow-up|38|||
163012683|NCT01262872|588748093|FG000|Step 2|Death|0|||
163012684|NCT01262872|588748094|FG001|Step 2|Death|0|||
163012685|NCT01262872|588748095|FG002|Step 2|Death|0|||
163012686|NCT01262872|588748096|FG003|Step 2|Death|1|||
163012687|NCT01262872|588748097|FG004|Step 2|Death|0|||
163012688|NCT01262872|588748098|FG005|Step 2|Death|2|||
163012689|NCT01262872|588748099|FG006|Step 2|Death|2|||
163012690|NCT01262872|588748100|FG007|Step 2|Death|1|||
163012691|NCT01262872|588748093|FG000|Step 2|Protocol Violation|0|||
163012692|NCT01262872|588748094|FG001|Step 2|Protocol Violation|0|||
163012693|NCT01262872|588748095|FG002|Step 2|Protocol Violation|1|||
163012694|NCT01262872|588748096|FG003|Step 2|Protocol Violation|0|||
163012695|NCT01262872|588748097|FG004|Step 2|Protocol Violation|0|||
163012696|NCT01262872|588748098|FG005|Step 2|Protocol Violation|0|||
163012697|NCT01262872|588748099|FG006|Step 2|Protocol Violation|3|||
163012698|NCT01262872|588748100|FG007|Step 2|Protocol Violation|1|||
163012699|NCT01262872|588748093|FG000|Step 2|Withdrawal by Subject|0|||
163062680|NCT04235374|588936913|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
163062681|NCT01551173|588936914|FG000|Overall Study|Withdrawal by Subject|11|||
163062682|NCT01551173|588936915|FG001|Overall Study|Withdrawal by Subject|16|||
163062683|NCT01551173|588936914|FG000|Overall Study|Adverse Event|7|||
163062684|NCT01551173|588936915|FG001|Overall Study|Adverse Event|6|||
162640750|NCT02574247|587399935|FG001|Overall Study|Did not meet inclusion criteria|3|||
162640751|NCT02574247|587399936|FG002|Overall Study|Did not meet inclusion criteria|5|||
162640752|NCT02268864|587399937|FG000|Overall Study|Withdrawal by Subject|2|||
162640753|NCT02268864|587399938|FG001|Overall Study|Withdrawal by Subject|0|||
163062685|NCT01551173|588936914|FG000|Overall Study|Lost to Follow-up|5|||
163062686|NCT01551173|588936915|FG001|Overall Study|Lost to Follow-up|7|||
163062687|NCT01551173|588936914|FG000|Overall Study|Other|5|||
163062688|NCT01551173|588936915|FG001|Overall Study|Other|3|||
162640754|NCT02268864|587399939|FG002|Overall Study|Withdrawal by Subject|0|||
162640755|NCT02268864|587399937|FG000|Overall Study|Death|0|||
163062689|NCT01394276|588936916|FG000|Overall Study|Related Adverse event (AEs)|15|||
162640756|NCT02268864|587399938|FG001|Overall Study|Death|1|||
163012700|NCT01262872|588748094|FG001|Step 2|Withdrawal by Subject|0|||
163012701|NCT01262872|588748095|FG002|Step 2|Withdrawal by Subject|4|||
163012702|NCT01262872|588748096|FG003|Step 2|Withdrawal by Subject|6|||
163012703|NCT01262872|588748097|FG004|Step 2|Withdrawal by Subject|3|||
163012704|NCT01262872|588748098|FG005|Step 2|Withdrawal by Subject|1|||
163012705|NCT01262872|588748099|FG006|Step 2|Withdrawal by Subject|2|||
163012706|NCT01262872|588748100|FG007|Step 2|Withdrawal by Subject|1|||
163012707|NCT01262872|588748093|FG000|Step 2|Migrated/moved from study area|0|||
163012708|NCT01262872|588748094|FG001|Step 2|Migrated/moved from study area|0|||
163062690|NCT01394276|588936916|FG000|Overall Study|Not related AEs|9|||
163012709|NCT01262872|588748095|FG002|Step 2|Migrated/moved from study area|4|||
163012710|NCT01262872|588748096|FG003|Step 2|Migrated/moved from study area|3|||
163012711|NCT01262872|588748097|FG004|Step 2|Migrated/moved from study area|2|||
163012712|NCT01262872|588748098|FG005|Step 2|Migrated/moved from study area|6|||
163012713|NCT01262872|588748099|FG006|Step 2|Migrated/moved from study area|2|||
163012714|NCT01262872|588748100|FG007|Step 2|Migrated/moved from study area|3|||
163012715|NCT01000155|588748103|FG000|Overall Study|Withdrawal by Subject|1|||
163012716|NCT01000155|588748103|FG000|Overall Study|Adverse Event|1|||
163012717|NCT01198470|588748106|FG000|Overall Study|Adverse Event|2|||
163012718|NCT00720213|588748107|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
163012719|NCT00720213|588748108|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
163012720|NCT00720213|588748109|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
163012721|NCT01924689|588748113|FG000|Overall Study|Death|0|||
163012722|NCT01924689|588748114|FG001|Overall Study|Death|1|||
163012723|NCT01924689|588748115|FG002|Overall Study|Death|0|||
163012724|NCT01924689|588748116|FG003|Overall Study|Death|1|||
163012725|NCT01924689|588748117|FG004|Overall Study|Death|0|||
163012726|NCT01924689|588748118|FG005|Overall Study|Death|0|||
163012727|NCT01924689|588748113|FG000|Overall Study|Disease progression|0|||
163012728|NCT01924689|588748114|FG001|Overall Study|Disease progression|0|||
163012729|NCT01924689|588748115|FG002|Overall Study|Disease progression|2|||
163012730|NCT01924689|588748116|FG003|Overall Study|Disease progression|0|||
163012731|NCT01924689|588748117|FG004|Overall Study|Disease progression|3|||
163012732|NCT01924689|588748118|FG005|Overall Study|Disease progression|2|||
163012733|NCT01924689|588748113|FG000|Overall Study|New therapy or study|3|||
163012734|NCT01924689|588748114|FG001|Overall Study|New therapy or study|2|||
163012735|NCT01924689|588748115|FG002|Overall Study|New therapy or study|1|||
163012736|NCT01924689|588748116|FG003|Overall Study|New therapy or study|4|||
163012737|NCT01924689|588748117|FG004|Overall Study|New therapy or study|2|||
163012738|NCT01924689|588748118|FG005|Overall Study|New therapy or study|0|||
163012739|NCT01924689|588748113|FG000|Overall Study|Withdrawal of consent|0|||
163012740|NCT01924689|588748114|FG001|Overall Study|Withdrawal of consent|0|||
163012741|NCT01924689|588748115|FG002|Overall Study|Withdrawal of consent|1|||
163012742|NCT01924689|588748116|FG003|Overall Study|Withdrawal of consent|1|||
163012743|NCT01924689|588748117|FG004|Overall Study|Withdrawal of consent|0|||
163012744|NCT01924689|588748118|FG005|Overall Study|Withdrawal of consent|0|||
163012745|NCT01924689|588748113|FG000|Overall Study|Other|0|||
163012746|NCT01924689|588748114|FG001|Overall Study|Other|0|||
163012747|NCT01924689|588748115|FG002|Overall Study|Other|0|||
163012748|NCT01924689|588748116|FG003|Overall Study|Other|0|||
163012749|NCT01924689|588748117|FG004|Overall Study|Other|1|||
163012750|NCT01924689|588748118|FG005|Overall Study|Other|0|||
163012751|NCT05271175|588748120|FG000|One Week Follow up|Lost to Follow-up|10|||
163012752|NCT05271175|588748121|FG001|One Week Follow up|Lost to Follow-up|7|||
163012753|NCT05271175|588748122|FG002|One Week Follow up|Lost to Follow-up|5|||
163012754|NCT05271175|588748120|FG000|One Month Follow up|Lost to Follow-up|12|||
163012755|NCT05271175|588748121|FG001|One Month Follow up|Lost to Follow-up|7|||
163012756|NCT05271175|588748122|FG002|One Month Follow up|Lost to Follow-up|9|||
163012757|NCT05271175|588748120|FG000|Six Months Follow up|Lost to Follow-up|8|||
163012758|NCT05271175|588748121|FG001|Six Months Follow up|Lost to Follow-up|2|||
163012759|NCT05271175|588748122|FG002|Six Months Follow up|Lost to Follow-up|2|||
163012760|NCT02492867|588748123|FG000|Overall Study|Alternate therapy|1|||
163012761|NCT02492867|588748123|FG000|Overall Study|Withdrawal by Subject|2|||
163012762|NCT02492867|588748123|FG000|Overall Study|Disease progression after treatment started|1|||
163012763|NCT02492867|588748123|FG000|Overall Study|Death|1|||
163012764|NCT03296527|588748124|FG000|Overall Study|Adverse Event|15|||
163012765|NCT03296527|588748125|FG001|Overall Study|Adverse Event|33|||
163012766|NCT03296527|588748124|FG000|Overall Study|Protocol Deviation|4|||
163012767|NCT03296527|588748125|FG001|Overall Study|Protocol Deviation|0|||
163012768|NCT03296527|588748124|FG000|Overall Study|Participant withdrew consent|3|||
163012769|NCT03296527|588748125|FG001|Overall Study|Participant withdrew consent|1|||
163012770|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
163012771|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
163012772|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
163012773|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
162640757|NCT02268864|587399939|FG002|Overall Study|Death|0|||
163012774|NCT03296527|588748124|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
163012775|NCT03296527|588748125|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
163012776|NCT03296527|588748124|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
163012777|NCT03296527|588748125|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
163012778|NCT03296527|588748124|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
163012779|NCT03296527|588748125|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
163012780|NCT01597973|588748126|FG000|Overall Study|Found ineligible before study medication started|4|||
163012781|NCT01597973|588748127|FG001|Overall Study|Found ineligible before study medication started|2|||
163012782|NCT01597973|588748126|FG000|Overall Study|Eligible pathogen not confirmed|14|||
163012783|NCT01597973|588748127|FG001|Overall Study|Eligible pathogen not confirmed|15|||
163012784|NCT01597973|588748126|FG000|Overall Study|LAR not authorized to consent|0|||
163012785|NCT01597973|588748127|FG001|Overall Study|LAR not authorized to consent|1|||
163012786|NCT01597973|588748126|FG000|Overall Study|Ineligible due to early seizures|1|||
163012787|NCT01597973|588748127|FG001|Overall Study|Ineligible due to early seizures|0|||
163012788|NCT01597973|588748126|FG000|Overall Study|Ineligible due to non-target infection|1|||
163012789|NCT01597973|588748127|FG001|Overall Study|Ineligible due to non-target infection|1|||
163012790|NCT01326845|588748128|FG000|Overall Study|Administrative Problems|5|||
163012791|NCT01326845|588748129|FG001|Overall Study|Administrative Problems|2|||
163012792|NCT01326845|588748128|FG000|Overall Study|Adverse Event|1|||
163012793|NCT01326845|588748129|FG001|Overall Study|Adverse Event|0|||
163012794|NCT01326845|588748128|FG000|Overall Study|Misisng|1|||
163012795|NCT01326845|588748129|FG001|Overall Study|Misisng|3|||
163012796|NCT01662492|588748134|FG000|Overall Study|Other miscellaneous reasons.|1|||
163012797|NCT01662492|588748135|FG001|Overall Study|Other miscellaneous reasons.|0|||
163012798|NCT01662492|588748136|FG002|Overall Study|Other miscellaneous reasons.|1|||
163012799|NCT01662492|588748134|FG000|Overall Study|Withdrawal by Subject|0|||
163012800|NCT01662492|588748135|FG001|Overall Study|Withdrawal by Subject|0|||
163012801|NCT01662492|588748136|FG002|Overall Study|Withdrawal by Subject|1|||
163012802|NCT01662492|588748134|FG000|Overall Study|Protocol Violation|1|||
163012803|NCT01662492|588748135|FG001|Overall Study|Protocol Violation|0|||
163012804|NCT01662492|588748136|FG002|Overall Study|Protocol Violation|0|||
163012805|NCT01662492|588748134|FG000|Overall Study|Lost to Follow-up|0|||
163012806|NCT01662492|588748135|FG001|Overall Study|Lost to Follow-up|0|||
163012807|NCT01662492|588748136|FG002|Overall Study|Lost to Follow-up|2|||
163012808|NCT01662492|588748134|FG000|Overall Study|Lack of Efficacy|1|||
163012809|NCT01662492|588748135|FG001|Overall Study|Lack of Efficacy|1|||
163012810|NCT01662492|588748136|FG002|Overall Study|Lack of Efficacy|2|||
163012811|NCT01591096|588748137|FG000|Overall Study|Adverse Event|1|||
163012812|NCT03655405|588748138|FG000|Overall Study|Death after initial data collection|4|||
163012813|NCT03655405|588748139|FG001|Overall Study|Death after initial data collection|2|||
163012814|NCT03655405|588748138|FG000|Overall Study|Died before initial data collection|1|||
163012815|NCT03655405|588748139|FG001|Overall Study|Died before initial data collection|2|||
163012816|NCT03655405|588748138|FG000|Overall Study|Protocol Violation|0|||
163012817|NCT03655405|588748139|FG001|Overall Study|Protocol Violation|1|||
163012818|NCT05271370|588749844|FG000|Overall Study|Study early termination|8|||
163012819|NCT05271370|588749845|FG001|Overall Study|Study early termination|16|||
163012820|NCT05271370|588749846|FG002|Overall Study|Study early termination|29|||
163012821|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
163012822|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
163012823|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
163012824|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
163012825|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
163012826|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
163012827|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Death|0|||
163012828|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Death|0|||
163012829|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Death|0|||
163012830|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Death|0|||
163012831|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Death|0|||
163012832|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Death|2|||
163012833|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012834|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012835|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012836|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012837|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
163012838|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
163012839|NCT04066244|588749860|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012840|NCT04066244|588749861|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012841|NCT04066244|588749862|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163154706|NCT02435992|589281385|FG000|Overall Study|Adverse Event|11|||
163154707|NCT02435992|589281386|FG001|Overall Study|Adverse Event|6|||
163154708|NCT02435992|589281387|FG002|Overall Study|Adverse Event|12|||
163154709|NCT02435992|589281388|FG003|Overall Study|Adverse Event|0|||
163154710|NCT02435992|589281389|FG004|Overall Study|Adverse Event|0|||
163012842|NCT04066244|588749863|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012843|NCT04066244|588749864|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
163012844|NCT04066244|588749865|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
163012845|NCT00866281|588749866|FG000|Overall Study|Adverse Event|1|||
163012846|NCT00866281|588749867|FG001|Overall Study|Adverse Event|0|||
163012847|NCT00866281|588749866|FG000|Overall Study|Withdrawal by participants|3|||
163012848|NCT00866281|588749867|FG001|Overall Study|Withdrawal by participants|0|||
163012849|NCT00866281|588749866|FG000|Overall Study|Disease progression|3|||
163012850|NCT00866281|588749867|FG001|Overall Study|Disease progression|11|||
163012851|NCT00866281|588749866|FG000|Overall Study|New cancer therapy|0|||
163012852|NCT00866281|588749867|FG001|Overall Study|New cancer therapy|4|||
163012853|NCT00529087|588749870|FG000|Overall Study|Adverse Event|10|||
163012854|NCT00529087|588749871|FG001|Overall Study|Adverse Event|13|||
163012855|NCT00529087|588749872|FG002|Overall Study|Adverse Event|4|||
163012856|NCT00529087|588749870|FG000|Overall Study|Lost to Follow-up|6|||
163012857|NCT00529087|588749871|FG001|Overall Study|Lost to Follow-up|4|||
163012858|NCT00529087|588749872|FG002|Overall Study|Lost to Follow-up|1|||
163012859|NCT00529087|588749870|FG000|Overall Study|Protocol Violation|8|||
163012860|NCT00529087|588749871|FG001|Overall Study|Protocol Violation|7|||
163012861|NCT00529087|588749872|FG002|Overall Study|Protocol Violation|6|||
163012862|NCT00529087|588749870|FG000|Overall Study|Withdrawal by Subject|3|||
163012863|NCT00529087|588749871|FG001|Overall Study|Withdrawal by Subject|3|||
163012864|NCT00529087|588749872|FG002|Overall Study|Withdrawal by Subject|3|||
163012865|NCT00529087|588749870|FG000|Overall Study|Protocol deviation|1|||
163012866|NCT00529087|588749871|FG001|Overall Study|Protocol deviation|1|||
163012867|NCT00529087|588749872|FG002|Overall Study|Protocol deviation|2|||
163012868|NCT02283268|588749875|FG000|Overall Study|Withdrawal by Subject|1|||
163012869|NCT00333983|588749876|FG000|Overall Study|Lost to Follow-up|2|||
163012870|NCT00333983|588749877|FG001|Overall Study|Lost to Follow-up|1|||
163012871|NCT00333983|588749878|FG002|Overall Study|Lost to Follow-up|0|||
163012872|NCT00333983|588749876|FG000|Overall Study|Adverse Event|1|||
163012873|NCT00333983|588749877|FG001|Overall Study|Adverse Event|1|||
163012874|NCT00333983|588749878|FG002|Overall Study|Adverse Event|1|||
163012875|NCT00333983|588749876|FG000|Overall Study|Withdrawal by Subject|0|||
163012876|NCT00333983|588749877|FG001|Overall Study|Withdrawal by Subject|3|||
163012877|NCT00333983|588749878|FG002|Overall Study|Withdrawal by Subject|1|||
163012878|NCT03656068|588749879|FG000|Overall Study|Withdrawal by Subject|4|||
163012879|NCT03656068|588749879|FG000|Overall Study|Adverse Event|1|||
163012880|NCT01436370|588749880|FG000|Overall Study|Lost to Follow-up|0|||
163012881|NCT01436370|588749881|FG001|Overall Study|Lost to Follow-up|0|||
163012882|NCT01436370|588749882|FG002|Overall Study|Lost to Follow-up|0|||
163012883|NCT01436370|588749883|FG003|Overall Study|Lost to Follow-up|0|||
163012884|NCT01436370|588749884|FG004|Overall Study|Lost to Follow-up|1|||
163012885|NCT01436370|588749885|FG005|Overall Study|Lost to Follow-up|0|||
163012886|NCT01436370|588749886|FG006|Overall Study|Lost to Follow-up|0|||
163012887|NCT01436370|588749887|FG007|Overall Study|Lost to Follow-up|0|||
163012888|NCT02770170|588749888|FG000|Overall Study|Withdrawal by Subject|0|||
163012889|NCT02770170|588749889|FG001|Overall Study|Withdrawal by Subject|0|||
163012890|NCT02770170|588749890|FG002|Overall Study|Withdrawal by Subject|0|||
163012891|NCT02770170|588749891|FG003|Overall Study|Withdrawal by Subject|2|||
163012892|NCT02770170|588749888|FG000|Overall Study|due to pregnancy|1|||
163012893|NCT02770170|588749889|FG001|Overall Study|due to pregnancy|0|||
163012894|NCT02770170|588749890|FG002|Overall Study|due to pregnancy|0|||
163012895|NCT02770170|588749891|FG003|Overall Study|due to pregnancy|0|||
163012896|NCT02770170|588749888|FG000|Overall Study|Lack of Efficacy|2|||
163012897|NCT02770170|588749889|FG001|Overall Study|Lack of Efficacy|0|||
163012898|NCT02770170|588749890|FG002|Overall Study|Lack of Efficacy|0|||
163012899|NCT02770170|588749891|FG003|Overall Study|Lack of Efficacy|1|||
163012900|NCT02770170|588749888|FG000|Overall Study|Adverse Event|4|||
163012901|NCT02770170|588749889|FG001|Overall Study|Adverse Event|3|||
163012902|NCT02770170|588749890|FG002|Overall Study|Adverse Event|5|||
163012903|NCT02770170|588749891|FG003|Overall Study|Adverse Event|3|||
163012904|NCT02770170|588749888|FG000|Overall Study|due to disease worsening|0|||
163012905|NCT02770170|588749889|FG001|Overall Study|due to disease worsening|0|||
163012906|NCT02770170|588749890|FG002|Overall Study|due to disease worsening|0|||
163012907|NCT02770170|588749891|FG003|Overall Study|due to disease worsening|1|||
163012908|NCT03270657|588749892|FG000|Overall Study|Withdrawal by Subject|1|||
163012909|NCT00162981|588749893|FG000|Overall Study|Adverse Event|2|||
163012910|NCT00162981|588749894|FG001|Overall Study|Adverse Event|5|||
163012911|NCT00162981|588749893|FG000|Overall Study|Withdrawal by Subject|1|||
163012912|NCT00162981|588749894|FG001|Overall Study|Withdrawal by Subject|1|||
163012913|NCT00162981|588749893|FG000|Overall Study|Physician Decision|1|||
163012914|NCT00162981|588749894|FG001|Overall Study|Physician Decision|0|||
163012915|NCT03187301|588749897|FG000|Titration Period|Adverse Event|0|||
163012916|NCT03187301|588749898|FG001|Titration Period|Adverse Event|0|||
163012917|NCT03187301|588749899|FG002|Titration Period|Adverse Event|0|||
163012918|NCT03187301|588749900|FG003|Titration Period|Adverse Event|0|||
163012919|NCT03187301|588749901|FG004|Titration Period|Adverse Event|0|||
163012920|NCT03187301|588749902|FG005|Titration Period|Adverse Event|0|||
163012921|NCT03187301|588749903|FG006|Titration Period|Adverse Event|5|||
163012922|NCT03187301|588749897|FG000|Titration Period|Withdrawal by Subject|0|||
163012923|NCT03187301|588749898|FG001|Titration Period|Withdrawal by Subject|0|||
163012924|NCT03187301|588749899|FG002|Titration Period|Withdrawal by Subject|0|||
163012925|NCT03187301|588749900|FG003|Titration Period|Withdrawal by Subject|0|||
163012926|NCT03187301|588749901|FG004|Titration Period|Withdrawal by Subject|0|||
163012927|NCT03187301|588749902|FG005|Titration Period|Withdrawal by Subject|0|||
163012928|NCT03187301|588749903|FG006|Titration Period|Withdrawal by Subject|1|||
163012929|NCT03187301|588749897|FG000|Titration Period|Exclusion Criteria Met|0|||
163012930|NCT03187301|588749898|FG001|Titration Period|Exclusion Criteria Met|0|||
163012931|NCT03187301|588749899|FG002|Titration Period|Exclusion Criteria Met|0|||
163012932|NCT03187301|588749900|FG003|Titration Period|Exclusion Criteria Met|0|||
163012933|NCT03187301|588749901|FG004|Titration Period|Exclusion Criteria Met|0|||
163012934|NCT03187301|588749902|FG005|Titration Period|Exclusion Criteria Met|0|||
163012935|NCT03187301|588749903|FG006|Titration Period|Exclusion Criteria Met|1|||
163012936|NCT03187301|588749897|FG000|Pre-Intervention|Withdrawal by Subject|1|||
163012937|NCT03187301|588749898|FG001|Pre-Intervention|Withdrawal by Subject|0|||
163012938|NCT03187301|588749899|FG002|Pre-Intervention|Withdrawal by Subject|0|||
163012939|NCT03187301|588749900|FG003|Pre-Intervention|Withdrawal by Subject|0|||
163012940|NCT03187301|588749901|FG004|Pre-Intervention|Withdrawal by Subject|0|||
163012941|NCT03187301|588749902|FG005|Pre-Intervention|Withdrawal by Subject|0|||
163012942|NCT03187301|588749903|FG006|Pre-Intervention|Withdrawal by Subject|0|||
163012943|NCT01966120|588749909|FG000|Overall Study|Withdrawal by Subject|0|||
163012944|NCT01966120|588749910|FG001|Overall Study|Withdrawal by Subject|5|||
163012945|NCT01966120|588749909|FG000|Overall Study|Lost to Follow-up|1|||
163012946|NCT01966120|588749910|FG001|Overall Study|Lost to Follow-up|1|||
163012947|NCT00461630|588749911|FG000|Overall Study|Death|798|||
163012948|NCT00461630|588749912|FG001|Overall Study|Death|732|||
163012949|NCT00461630|588749911|FG000|Overall Study|Lost to Follow-up|108|||
163012950|NCT00461630|588749912|FG001|Overall Study|Lost to Follow-up|95|||
163012951|NCT02588612|588749916|FG000|Overall Study|Physician Decision|1|||
163012952|NCT02588612|588749916|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
163012953|NCT02588612|588749916|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
163012954|NCT02588612|588749916|FG000|Overall Study|Death prior to T-cell infusion|1|||
163012955|NCT03809663|588749917|FG000|Overall Study|Decision by sponsor|24|||
163012956|NCT03809663|588749918|FG001|Overall Study|Decision by sponsor|18|||
163012957|NCT03809663|588749919|FG002|Overall Study|Decision by sponsor|20|||
163012958|NCT03809663|588749920|FG003|Overall Study|Decision by sponsor|20|||
163012959|NCT03809663|588749921|FG004|Overall Study|Decision by sponsor|0|||
163012960|NCT03809663|588749922|FG005|Overall Study|Decision by sponsor|0|||
163012961|NCT03809663|588749917|FG000|Overall Study|Withdrawal by Subject|26|||
163012962|NCT03809663|588749918|FG001|Overall Study|Withdrawal by Subject|22|||
163012963|NCT03809663|588749919|FG002|Overall Study|Withdrawal by Subject|27|||
163012964|NCT03809663|588749920|FG003|Overall Study|Withdrawal by Subject|26|||
163012965|NCT03809663|588749921|FG004|Overall Study|Withdrawal by Subject|0|||
163012966|NCT03809663|588749922|FG005|Overall Study|Withdrawal by Subject|0|||
163012967|NCT03809663|588749917|FG000|Overall Study|Lost to Follow-up|1|||
163012968|NCT03809663|588749918|FG001|Overall Study|Lost to Follow-up|4|||
163012969|NCT03809663|588749919|FG002|Overall Study|Lost to Follow-up|1|||
163012970|NCT03809663|588749920|FG003|Overall Study|Lost to Follow-up|1|||
163012971|NCT03809663|588749921|FG004|Overall Study|Lost to Follow-up|0|||
163012972|NCT03809663|588749922|FG005|Overall Study|Lost to Follow-up|0|||
163012973|NCT03376789|588749923|FG000|Overall Study|Withdrawal by Subject|3|||
163012974|NCT03376789|588749924|FG001|Overall Study|Withdrawal by Subject|5|||
163012975|NCT03376789|588749923|FG000|Overall Study|Protocol Violation|0|||
163012976|NCT03376789|588749924|FG001|Overall Study|Protocol Violation|1|||
163012977|NCT03376789|588749923|FG000|Overall Study|Adverse Event|0|||
163012978|NCT03376789|588749924|FG001|Overall Study|Adverse Event|1|||
163012979|NCT03376789|588749923|FG000|Overall Study|Lost to Follow-up|1|||
163012980|NCT03376789|588749924|FG001|Overall Study|Lost to Follow-up|1|||
163012981|NCT03376789|588749923|FG000|Overall Study|Per sponsor due to noncompliance|1|||
163012982|NCT03376789|588749924|FG001|Overall Study|Per sponsor due to noncompliance|0|||
163012983|NCT03376789|588749923|FG000|Overall Study|Subject off study medication|0|||
163012984|NCT03376789|588749924|FG001|Overall Study|Subject off study medication|1|||
163012985|NCT01703260|588749925|FG000|Overall Study|Adverse Event|1|||
163012986|NCT01703260|588749926|FG001|Overall Study|Adverse Event|2|||
163012987|NCT01703260|588749927|FG002|Overall Study|Adverse Event|2|||
163012988|NCT01703260|588749925|FG000|Overall Study|Lost to Follow-up|1|||
163012989|NCT01703260|588749926|FG001|Overall Study|Lost to Follow-up|0|||
163012990|NCT01703260|588749927|FG002|Overall Study|Lost to Follow-up|0|||
163012991|NCT01703260|588749925|FG000|Overall Study|Withdrawal by Subject|0|||
163012992|NCT01703260|588749926|FG001|Overall Study|Withdrawal by Subject|0|||
163012993|NCT01703260|588749927|FG002|Overall Study|Withdrawal by Subject|1|||
163012994|NCT01703260|588749925|FG000|Overall Study|Study Termination|1|||
163012995|NCT01703260|588749926|FG001|Overall Study|Study Termination|2|||
163012996|NCT01703260|588749927|FG002|Overall Study|Study Termination|0|||
163012997|NCT02042014|588749928|FG000|Overall Study|Adverse Event|1|||
163012998|NCT02042014|588749928|FG000|Overall Study|Physician Decision|7|||
163012999|NCT02792062|588749932|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
163013000|NCT02792062|588749933|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013001|NCT02792062|588749934|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013002|NCT02792062|588749935|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013003|NCT02792062|588749936|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013004|NCT02792062|588749937|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
163013005|NCT03309943|588749940|FG000|Overall Study|Withdrawal by Subject|0|||
163013006|NCT03309943|588749941|FG001|Overall Study|Withdrawal by Subject|1|||
163013007|NCT03309943|588749940|FG000|Overall Study|Inappropriate behavior towards staff|0|||
163013008|NCT03309943|588749941|FG001|Overall Study|Inappropriate behavior towards staff|1|||
163013009|NCT03123393|588749942|FG000|Overall Study|Study Terminated by Sponsor|6|||
163013010|NCT03123393|588749943|FG001|Overall Study|Study Terminated by Sponsor|9|||
163013011|NCT03123393|588749942|FG000|Overall Study|Withdrawal by Subject|2|||
163013012|NCT03123393|588749943|FG001|Overall Study|Withdrawal by Subject|1|||
163013013|NCT03123393|588749942|FG000|Overall Study|Reason not Specified|13|||
163013014|NCT03123393|588749943|FG001|Overall Study|Reason not Specified|13|||
163013015|NCT02230904|588749945|FG000|Overall Study|Safety follow up could not take place|0|||
163013016|NCT02230904|588749946|FG001|Overall Study|Safety follow up could not take place|1|||
163013017|NCT01464424|588749947|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
163013018|NCT01464424|588749948|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
163013019|NCT05047211|588749952|FG000|Overall Study|Lost to Follow-up|8|||
163013020|NCT05047211|588749953|FG001|Overall Study|Lost to Follow-up|5|||
163013021|NCT00561392|588749954|FG000|Overall Study|Adverse Event|38|||
163013022|NCT00561392|588749954|FG000|Overall Study|Lack of Efficacy|2|||
163013023|NCT00561392|588749954|FG000|Overall Study|Protocol Violation|1|||
163013024|NCT00561392|588749954|FG000|Overall Study|Withdrawal by Subject|8|||
163013025|NCT00561392|588749954|FG000|Overall Study|Administrative problems|4|||
163013026|NCT03822468|588749955|FG000|Treatment Period|Progressive disease|98|||
163013027|NCT03822468|588749956|FG001|Treatment Period|Progressive disease|94|||
163013028|NCT03822468|588749955|FG000|Treatment Period|Adverse Event|21|||
163013029|NCT03822468|588749956|FG001|Treatment Period|Adverse Event|24|||
163013030|NCT03822468|588749955|FG000|Treatment Period|Withdrawal by Subject|9|||
163013031|NCT03822468|588749956|FG001|Treatment Period|Withdrawal by Subject|5|||
163013032|NCT03822468|588749955|FG000|Treatment Period|Physician Decision|9|||
163013033|NCT03822468|588749956|FG001|Treatment Period|Physician Decision|7|||
163013034|NCT03822468|588749955|FG000|Treatment Period|Protocol Violation|2|||
163013035|NCT03822468|588749956|FG001|Treatment Period|Protocol Violation|1|||
163013036|NCT03822468|588749955|FG000|Treatment Period|Death|2|||
163013037|NCT03822468|588749956|FG001|Treatment Period|Death|3|||
163013038|NCT03822468|588749955|FG000|Treatment Period|Lost to Follow-up|1|||
163013039|NCT03822468|588749956|FG001|Treatment Period|Lost to Follow-up|1|||
163013040|NCT03822468|588749955|FG000|Treatment Period|Sponsor decision|46|||
163013041|NCT03822468|588749956|FG001|Treatment Period|Sponsor decision|53|||
163013042|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
163013043|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
163013044|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
163013045|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
163013046|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Death|1|||
163013047|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163013048|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163013049|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163013050|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163013051|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163013052|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
163013053|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163013054|NCT03822468|588749955|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
162640758|NCT01528254|587399944|FG000|Overall Study|Administrative problems|96|||
162640759|NCT01528254|587399945|FG001|Overall Study|Administrative problems|94|||
162640760|NCT01528254|587399944|FG000|Overall Study|Adverse Event|28|||
163013055|NCT03822468|588749956|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
163013056|NCT01808066|588749957|FG000|Overall Study|Withdrawal by Subject|15|||
163013057|NCT02949973|588749962|FG000|Overall Study|Physician Decision|1|||
162640761|NCT01528254|587399945|FG001|Overall Study|Adverse Event|44|||
163013058|NCT01420068|588749963|FG000|Overall Study|Administrative problems|1|||
163013059|NCT01420068|588749964|FG001|Overall Study|Administrative problems|3|||
163013060|NCT01420068|588749963|FG000|Overall Study|Withdrawal by Subject|1|||
163013061|NCT01420068|588749964|FG001|Overall Study|Withdrawal by Subject|2|||
163013062|NCT01252095|588749965|FG000|Overall Study|Disease progression|1|||
163013063|NCT01252095|588749966|FG001|Overall Study|Disease progression|0|||
163154711|NCT02435992|589281385|FG000|Overall Study|Lack of Efficacy|4|||
162640762|NCT01528254|587399944|FG000|Overall Study|Lost to Follow-up|17|||
163013064|NCT00365794|588749967|FG000|Overall Study|Withdrawal by Subject|2|||
163013065|NCT00586703|588749968|FG000|Overall Study|Death|12|||
163013066|NCT04760626|588749969|FG000|Overall Study|Withdrawal by Subject|24|||
163013067|NCT04760626|588749970|FG001|Overall Study|Withdrawal by Subject|20|||
163013068|NCT04760626|588749969|FG000|Overall Study|Lost to Follow-up|14|||
163013069|NCT04760626|588749970|FG001|Overall Study|Lost to Follow-up|19|||
163013070|NCT04760626|588749969|FG000|Overall Study|Physician Decision|3|||
163013071|NCT04760626|588749970|FG001|Overall Study|Physician Decision|5|||
163013072|NCT04760626|588749969|FG000|Overall Study|Death|3|||
163013073|NCT04760626|588749970|FG001|Overall Study|Death|6|||
163013074|NCT04760626|588749969|FG000|Overall Study|Site closure|1|||
163013075|NCT04760626|588749970|FG001|Overall Study|Site closure|0|||
163013076|NCT02554682|588749973|FG000|Overall Study|Lost to Follow-up|11|||
163013077|NCT02554682|588749974|FG001|Overall Study|Lost to Follow-up|9|||
163013078|NCT02554682|588749975|FG002|Overall Study|Lost to Follow-up|4|||
163013079|NCT02554682|588749976|FG003|Overall Study|Lost to Follow-up|3|||
163013080|NCT02554682|588749977|FG004|Overall Study|Lost to Follow-up|2|||
163013081|NCT02554682|588749978|FG005|Overall Study|Lost to Follow-up|1|||
163013082|NCT02554682|588749979|FG006|Overall Study|Lost to Follow-up|6|||
163013083|NCT02554682|588749980|FG007|Overall Study|Lost to Follow-up|6|||
163013084|NCT02554682|588749981|FG008|Overall Study|Lost to Follow-up|2|||
163013085|NCT02554682|588749982|FG009|Overall Study|Lost to Follow-up|2|||
163013086|NCT02554682|588749973|FG000|Overall Study|Withdrawal by Subject|2|||
163013087|NCT02554682|588749974|FG001|Overall Study|Withdrawal by Subject|1|||
163013088|NCT02554682|588749975|FG002|Overall Study|Withdrawal by Subject|0|||
163013089|NCT02554682|588749976|FG003|Overall Study|Withdrawal by Subject|0|||
163013090|NCT02554682|588749977|FG004|Overall Study|Withdrawal by Subject|0|||
163013091|NCT02554682|588749978|FG005|Overall Study|Withdrawal by Subject|0|||
163013092|NCT02554682|588749979|FG006|Overall Study|Withdrawal by Subject|0|||
163013093|NCT02554682|588749980|FG007|Overall Study|Withdrawal by Subject|0|||
163013094|NCT02554682|588749981|FG008|Overall Study|Withdrawal by Subject|0|||
163013095|NCT02554682|588749982|FG009|Overall Study|Withdrawal by Subject|0|||
163013096|NCT02554682|588749973|FG000|Overall Study|Physician Decision|2|||
163013097|NCT02554682|588749974|FG001|Overall Study|Physician Decision|2|||
163013098|NCT02554682|588749975|FG002|Overall Study|Physician Decision|0|||
163013099|NCT02554682|588749976|FG003|Overall Study|Physician Decision|0|||
163013100|NCT02554682|588749977|FG004|Overall Study|Physician Decision|0|||
163013101|NCT02554682|588749978|FG005|Overall Study|Physician Decision|0|||
163013102|NCT02554682|588749979|FG006|Overall Study|Physician Decision|0|||
163013103|NCT02554682|588749980|FG007|Overall Study|Physician Decision|0|||
163013104|NCT02554682|588749981|FG008|Overall Study|Physician Decision|0|||
163013105|NCT02554682|588749982|FG009|Overall Study|Physician Decision|0|||
163013106|NCT00884117|588749985|FG000|Overall Study|Adverse Event|2|||
163013107|NCT00884117|588749985|FG000|Overall Study|Withdrawal by Subject|89|||
163013108|NCT00884117|588749985|FG000|Overall Study|Death|3|||
163013109|NCT00884117|588749985|FG000|Overall Study|Lost to Follow-up|143|||
163013110|NCT00884117|588749985|FG000|Overall Study|Other|12|||
163013111|NCT02946463|588749986|FG000|Primary Evaluation Period|Physician Decision|0|||
163013112|NCT02946463|588749987|FG001|Primary Evaluation Period|Physician Decision|1|||
163013113|NCT02946463|588749988|FG002|Primary Evaluation Period|Physician Decision|0|||
163013114|NCT02946463|588749989|FG003|Primary Evaluation Period|Physician Decision|0|||
163013115|NCT02946463|588749986|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
163062691|NCT01394276|588936916|FG000|Overall Study|Remission of disease|2|||
163062692|NCT01394276|588936916|FG000|Overall Study|Insufficient therapeutic effect|17|||
163062693|NCT01394276|588936916|FG000|Overall Study|Insufficient compliance|9|||
163062694|NCT01394276|588936916|FG000|Overall Study|Lost to Follow-up|5|||
163062695|NCT01394276|588936916|FG000|Overall Study|Participant moved to another site|1|||
163062696|NCT01394276|588936916|FG000|Overall Study|Pregnancy|1|||
163062697|NCT01394276|588936916|FG000|Overall Study|unavailability of drug at the Hospital|2|||
163062698|NCT01394276|588936916|FG000|Overall Study|Symptoms of concurrent diseases|1|||
163062699|NCT04530344|588936917|FG000|Overall Study|Lost to Follow-up|3|||
163013116|NCT02946463|588749987|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
163062700|NCT04530344|588936918|FG001|Overall Study|Lost to Follow-up|3|||
163013117|NCT02946463|588749988|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
163062701|NCT04530344|588936919|FG002|Overall Study|Lost to Follow-up|3|||
163013118|NCT02946463|588749989|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
163013119|NCT02946463|588749986|FG000|Extension Period|Death|4|||
163062702|NCT04530344|588936920|FG003|Overall Study|Lost to Follow-up|10|||
163013120|NCT02946463|588749987|FG001|Extension Period|Death|4|||
163013121|NCT02946463|588749988|FG002|Extension Period|Death|0|||
163013122|NCT02946463|588749989|FG003|Extension Period|Death|0|||
163013123|NCT02946463|588749986|FG000|Extension Period|Withdrawal by Subject|4|||
163013124|NCT02946463|588749987|FG001|Extension Period|Withdrawal by Subject|3|||
163013125|NCT02946463|588749988|FG002|Extension Period|Withdrawal by Subject|0|||
163062703|NCT04530344|588936917|FG000|Overall Study|Withdrawal by Subject|14|||
163013126|NCT02946463|588749989|FG003|Extension Period|Withdrawal by Subject|0|||
163013127|NCT02946463|588749986|FG000|Extension Period|Other than specified|2|||
163013128|NCT02946463|588749987|FG001|Extension Period|Other than specified|3|||
163013129|NCT02946463|588749988|FG002|Extension Period|Other than specified|2|||
163013130|NCT02946463|588749989|FG003|Extension Period|Other than specified|0|||
163013131|NCT02946463|588749986|FG000|Extension Period|Physician Decision|1|||
163013132|NCT02946463|588749987|FG001|Extension Period|Physician Decision|4|||
163013133|NCT02946463|588749988|FG002|Extension Period|Physician Decision|0|||
163013134|NCT02946463|588749989|FG003|Extension Period|Physician Decision|0|||
163013135|NCT02946463|588749986|FG000|Extension Period|Pregnancy|3|||
163013136|NCT02946463|588749987|FG001|Extension Period|Pregnancy|1|||
163013137|NCT02946463|588749988|FG002|Extension Period|Pregnancy|0|||
163013138|NCT02946463|588749989|FG003|Extension Period|Pregnancy|0|||
163013139|NCT02946463|588749986|FG000|Extension Period|Adverse Event|1|||
163013140|NCT02946463|588749987|FG001|Extension Period|Adverse Event|2|||
163013141|NCT02946463|588749988|FG002|Extension Period|Adverse Event|0|||
163013142|NCT02946463|588749989|FG003|Extension Period|Adverse Event|0|||
163013143|NCT02946463|588749986|FG000|Extension Period|Lost to Follow-up|1|||
163013144|NCT02946463|588749987|FG001|Extension Period|Lost to Follow-up|0|||
163013145|NCT02946463|588749988|FG002|Extension Period|Lost to Follow-up|0|||
163013146|NCT02946463|588749989|FG003|Extension Period|Lost to Follow-up|0|||
163013147|NCT02022202|588749990|FG000|Overall Study|Withdrawal by Subject|2|||
163013148|NCT02022202|588749990|FG000|Overall Study|Disease Progression|3|||
163013149|NCT02022202|588749990|FG000|Overall Study|Desire go to immediately to surgery|3|||
163013150|NCT00122382|588749992|FG000|Double-Blind Study|Adverse Event|9|||
163013151|NCT00122382|588749993|FG001|Double-Blind Study|Adverse Event|11|||
163013152|NCT00122382|588749994|FG002|Double-Blind Study|Adverse Event|0|||
163013153|NCT00122382|588749992|FG000|Double-Blind Study|Death|2|||
163013154|NCT00122382|588749993|FG001|Double-Blind Study|Death|2|||
163013155|NCT00122382|588749994|FG002|Double-Blind Study|Death|0|||
163013156|NCT00122382|588749992|FG000|Double-Blind Study|Lack of Efficacy|0|||
163013157|NCT00122382|588749993|FG001|Double-Blind Study|Lack of Efficacy|8|||
163013158|NCT00122382|588749994|FG002|Double-Blind Study|Lack of Efficacy|0|||
163013159|NCT00122382|588749992|FG000|Double-Blind Study|Lost to Follow-up|2|||
163013160|NCT00122382|588749993|FG001|Double-Blind Study|Lost to Follow-up|1|||
163062704|NCT04530344|588936918|FG001|Overall Study|Withdrawal by Subject|5|||
163062705|NCT04530344|588936919|FG002|Overall Study|Withdrawal by Subject|18|||
163013161|NCT00122382|588749994|FG002|Double-Blind Study|Lost to Follow-up|0|||
163013162|NCT00122382|588749992|FG000|Double-Blind Study|Pregnancy|2|||
163013163|NCT00122382|588749993|FG001|Double-Blind Study|Pregnancy|0|||
163013164|NCT00122382|588749994|FG002|Double-Blind Study|Pregnancy|0|||
163013165|NCT00122382|588749992|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
163013166|NCT00122382|588749993|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
163013167|NCT00122382|588749994|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
163013168|NCT00122382|588749992|FG000|Double-Blind Study|Withdrawal of Consent|7|||
163013169|NCT00122382|588749993|FG001|Double-Blind Study|Withdrawal of Consent|3|||
163013170|NCT00122382|588749994|FG002|Double-Blind Study|Withdrawal of Consent|0|||
163013171|NCT00122382|588749992|FG000|Double-Blind Study|Protocol Violation|1|||
163013172|NCT00122382|588749993|FG001|Double-Blind Study|Protocol Violation|0|||
163013173|NCT00122382|588749994|FG002|Double-Blind Study|Protocol Violation|0|||
163013174|NCT00122382|588749992|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
163013175|NCT00122382|588749993|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
163062706|NCT04530344|588936920|FG003|Overall Study|Withdrawal by Subject|33|||
163062707|NCT04530344|588936917|FG000|Overall Study|Adverse Event|0|||
163062708|NCT04530344|588936918|FG001|Overall Study|Adverse Event|0|||
163062709|NCT04530344|588936919|FG002|Overall Study|Adverse Event|0|||
163062710|NCT04530344|588936920|FG003|Overall Study|Adverse Event|1|||
163062711|NCT04530344|588936917|FG000|Overall Study|Lack of Efficacy|0|||
163062712|NCT04530344|588936918|FG001|Overall Study|Lack of Efficacy|0|||
163062713|NCT04530344|588936919|FG002|Overall Study|Lack of Efficacy|0|||
163062714|NCT04530344|588936920|FG003|Overall Study|Lack of Efficacy|1|||
163062715|NCT04530344|588936917|FG000|Overall Study|Physician Decision|0|||
163062716|NCT04530344|588936918|FG001|Overall Study|Physician Decision|0|||
163062717|NCT04530344|588936919|FG002|Overall Study|Physician Decision|1|||
163013176|NCT00122382|588749994|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
163013177|NCT00122382|588749992|FG000|Double-Blind Study|Randomized but not treated|0|||
163013178|NCT00122382|588749993|FG001|Double-Blind Study|Randomized but not treated|2|||
163013179|NCT00122382|588749994|FG002|Double-Blind Study|Randomized but not treated|0|||
163013180|NCT00122382|588749992|FG000|Open-Label Study|Adverse Event|0|||
163013181|NCT00122382|588749993|FG001|Open-Label Study|Adverse Event|0|||
163062718|NCT04530344|588936920|FG003|Overall Study|Physician Decision|1|||
163013182|NCT00122382|588749994|FG002|Open-Label Study|Adverse Event|11|||
163013183|NCT00122382|588749992|FG000|Open-Label Study|Death|0|||
163013184|NCT00122382|588749993|FG001|Open-Label Study|Death|0|||
163013185|NCT00122382|588749994|FG002|Open-Label Study|Death|2|||
163013186|NCT00122382|588749992|FG000|Open-Label Study|Lack of Efficacy|0|||
163013187|NCT00122382|588749993|FG001|Open-Label Study|Lack of Efficacy|0|||
163062719|NCT04530344|588936917|FG000|Overall Study|Pregnancy|0|||
163013188|NCT00122382|588749994|FG002|Open-Label Study|Lack of Efficacy|3|||
163013189|NCT00122382|588749992|FG000|Open-Label Study|Lost to Follow-up|0|||
163013190|NCT00122382|588749993|FG001|Open-Label Study|Lost to Follow-up|0|||
163013191|NCT00122382|588749994|FG002|Open-Label Study|Lost to Follow-up|3|||
163013192|NCT00122382|588749992|FG000|Open-Label Study|Pregnancy|0|||
163013193|NCT00122382|588749993|FG001|Open-Label Study|Pregnancy|0|||
163013194|NCT00122382|588749994|FG002|Open-Label Study|Pregnancy|2|||
163013195|NCT00122382|588749992|FG000|Open-Label Study|Poor/Non-Compliance|0|||
163013196|NCT00122382|588749993|FG001|Open-Label Study|Poor/Non-Compliance|0|||
163013197|NCT00122382|588749994|FG002|Open-Label Study|Poor/Non-Compliance|1|||
163013198|NCT00122382|588749992|FG000|Open-Label Study|Withdrawal of Consent|0|||
163013199|NCT00122382|588749993|FG001|Open-Label Study|Withdrawal of Consent|0|||
163013200|NCT00122382|588749994|FG002|Open-Label Study|Withdrawal of Consent|4|||
163013201|NCT02040805|588749995|FG000|Overall Study|Lost to Follow-up|14|||
163013202|NCT02040805|588749996|FG001|Overall Study|Lost to Follow-up|9|||
163013203|NCT02040805|588749995|FG000|Overall Study|Withdrawal by Subject|28|||
163013204|NCT02040805|588749996|FG001|Overall Study|Withdrawal by Subject|41|||
163013205|NCT00908544|588749997|FG000|Overall Study|Withdrawal by Subject|2|||
163013206|NCT00908544|588749998|FG001|Overall Study|Withdrawal by Subject|4|||
163013207|NCT00908544|588749997|FG000|Overall Study|Lack of Efficacy|0|||
163013208|NCT00908544|588749998|FG001|Overall Study|Lack of Efficacy|1|||
163013209|NCT00908544|588749997|FG000|Overall Study|Pregnancy|1|||
163013210|NCT00908544|588749998|FG001|Overall Study|Pregnancy|0|||
163013211|NCT00908544|588749997|FG000|Overall Study|Relocation abroad|1|||
163013212|NCT00908544|588749998|FG001|Overall Study|Relocation abroad|1|||
163013213|NCT00908544|588749997|FG000|Overall Study|Unable to visit sutdy center|1|||
163013214|NCT00908544|588749998|FG001|Overall Study|Unable to visit sutdy center|0|||
163013215|NCT02859337|588750004|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
163013216|NCT02859337|588750005|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
163013217|NCT02859337|588750006|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
163013218|NCT02859337|588750004|FG000|Overall Study|Withdrawal by Subject|3|||
163013219|NCT02859337|588750005|FG001|Overall Study|Withdrawal by Subject|1|||
163013220|NCT02859337|588750006|FG002|Overall Study|Withdrawal by Subject|0|||
163013221|NCT02859337|588750004|FG000|Overall Study|Lost to Follow-up|1|||
163013222|NCT02859337|588750005|FG001|Overall Study|Lost to Follow-up|0|||
163013223|NCT02859337|588750006|FG002|Overall Study|Lost to Follow-up|0|||
163013224|NCT00848718|588750007|FG000|Overall Study|Adverse Event|2|||
163013225|NCT00848718|588750008|FG001|Overall Study|Adverse Event|2|||
163013226|NCT00848718|588750009|FG002|Overall Study|Adverse Event|1|||
163013227|NCT00848718|588750010|FG003|Overall Study|Adverse Event|1|||
163013228|NCT00848718|588750011|FG004|Overall Study|Adverse Event|1|||
163013229|NCT00848718|588750012|FG005|Overall Study|Adverse Event|0|||
163013230|NCT00848718|588750013|FG006|Overall Study|Adverse Event|0|||
163013231|NCT00848718|588750014|FG007|Overall Study|Adverse Event|1|||
163013232|NCT00848718|588750015|FG008|Overall Study|Adverse Event|1|||
163013233|NCT00848718|588750016|FG009|Overall Study|Adverse Event|0|||
163013234|NCT00848718|588750017|FG010|Overall Study|Adverse Event|0|||
163013235|NCT00848718|588750018|FG011|Overall Study|Adverse Event|0|||
163013236|NCT00848718|588750019|FG012|Overall Study|Adverse Event|2|||
163013237|NCT00848718|588750007|FG000|Overall Study|Lack of Efficacy|0|||
163013238|NCT00848718|588750008|FG001|Overall Study|Lack of Efficacy|0|||
163013239|NCT00848718|588750009|FG002|Overall Study|Lack of Efficacy|1|||
163013240|NCT00848718|588750010|FG003|Overall Study|Lack of Efficacy|0|||
163013241|NCT00848718|588750011|FG004|Overall Study|Lack of Efficacy|0|||
163013242|NCT00848718|588750012|FG005|Overall Study|Lack of Efficacy|0|||
163013243|NCT00848718|588750013|FG006|Overall Study|Lack of Efficacy|1|||
163013244|NCT00848718|588750014|FG007|Overall Study|Lack of Efficacy|0|||
163013245|NCT00848718|588750015|FG008|Overall Study|Lack of Efficacy|0|||
163013246|NCT00848718|588750016|FG009|Overall Study|Lack of Efficacy|0|||
163013247|NCT00848718|588750017|FG010|Overall Study|Lack of Efficacy|0|||
163013248|NCT00848718|588750018|FG011|Overall Study|Lack of Efficacy|0|||
163013249|NCT00848718|588750019|FG012|Overall Study|Lack of Efficacy|0|||
163013250|NCT00848718|588750007|FG000|Overall Study|Physician Decision|0|||
163013251|NCT00848718|588750008|FG001|Overall Study|Physician Decision|1|||
163013252|NCT00848718|588750009|FG002|Overall Study|Physician Decision|0|||
163013253|NCT00848718|588750010|FG003|Overall Study|Physician Decision|0|||
163013254|NCT00848718|588750011|FG004|Overall Study|Physician Decision|1|||
163013255|NCT00848718|588750012|FG005|Overall Study|Physician Decision|1|||
163013256|NCT00848718|588750013|FG006|Overall Study|Physician Decision|0|||
163013257|NCT00848718|588750014|FG007|Overall Study|Physician Decision|0|||
163013258|NCT00848718|588750015|FG008|Overall Study|Physician Decision|1|||
163062720|NCT04530344|588936918|FG001|Overall Study|Pregnancy|0|||
163062721|NCT04530344|588936919|FG002|Overall Study|Pregnancy|2|||
163062722|NCT04530344|588936920|FG003|Overall Study|Pregnancy|1|||
163062723|NCT04530344|588936917|FG000|Overall Study|Protocol Violation|0|||
163062724|NCT04530344|588936918|FG001|Overall Study|Protocol Violation|0|||
163062725|NCT04530344|588936919|FG002|Overall Study|Protocol Violation|0|||
163062726|NCT04530344|588936920|FG003|Overall Study|Protocol Violation|1|||
163062727|NCT04530344|588936917|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
163062728|NCT04530344|588936918|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
163013259|NCT00848718|588750016|FG009|Overall Study|Physician Decision|2|||
163013260|NCT00848718|588750017|FG010|Overall Study|Physician Decision|0|||
163013261|NCT00848718|588750018|FG011|Overall Study|Physician Decision|0|||
163013262|NCT00848718|588750019|FG012|Overall Study|Physician Decision|1|||
163013263|NCT00848718|588750007|FG000|Overall Study|Progressive disease before treatment|1|||
163013264|NCT00848718|588750008|FG001|Overall Study|Progressive disease before treatment|5|||
163013265|NCT00848718|588750009|FG002|Overall Study|Progressive disease before treatment|1|||
163013266|NCT00848718|588750010|FG003|Overall Study|Progressive disease before treatment|3|||
163013267|NCT00848718|588750011|FG004|Overall Study|Progressive disease before treatment|4|||
163013268|NCT00848718|588750012|FG005|Overall Study|Progressive disease before treatment|4|||
163013269|NCT00848718|588750013|FG006|Overall Study|Progressive disease before treatment|2|||
163013270|NCT00848718|588750014|FG007|Overall Study|Progressive disease before treatment|1|||
163013271|NCT00848718|588750015|FG008|Overall Study|Progressive disease before treatment|2|||
163013272|NCT00848718|588750016|FG009|Overall Study|Progressive disease before treatment|7|||
163013273|NCT00848718|588750017|FG010|Overall Study|Progressive disease before treatment|3|||
163013274|NCT00848718|588750018|FG011|Overall Study|Progressive disease before treatment|6|||
163013275|NCT00848718|588750019|FG012|Overall Study|Progressive disease before treatment|2|||
163013276|NCT00848718|588750007|FG000|Overall Study|Protocol Violation|0|||
163013277|NCT00848718|588750008|FG001|Overall Study|Protocol Violation|1|||
163013278|NCT00848718|588750009|FG002|Overall Study|Protocol Violation|0|||
163013279|NCT00848718|588750010|FG003|Overall Study|Protocol Violation|0|||
163013280|NCT00848718|588750011|FG004|Overall Study|Protocol Violation|0|||
163013281|NCT00848718|588750012|FG005|Overall Study|Protocol Violation|0|||
163013282|NCT00848718|588750013|FG006|Overall Study|Protocol Violation|0|||
163013283|NCT00848718|588750014|FG007|Overall Study|Protocol Violation|1|||
163013284|NCT00848718|588750015|FG008|Overall Study|Protocol Violation|0|||
163013285|NCT00848718|588750016|FG009|Overall Study|Protocol Violation|0|||
163013286|NCT00848718|588750017|FG010|Overall Study|Protocol Violation|0|||
163013287|NCT00848718|588750018|FG011|Overall Study|Protocol Violation|0|||
163013288|NCT00848718|588750019|FG012|Overall Study|Protocol Violation|1|||
163013289|NCT00848718|588750007|FG000|Overall Study|Withdrawal by Subject|1|||
163013290|NCT00848718|588750008|FG001|Overall Study|Withdrawal by Subject|0|||
163013291|NCT00848718|588750009|FG002|Overall Study|Withdrawal by Subject|0|||
163013292|NCT00848718|588750010|FG003|Overall Study|Withdrawal by Subject|1|||
163013293|NCT00848718|588750011|FG004|Overall Study|Withdrawal by Subject|0|||
163013294|NCT00848718|588750012|FG005|Overall Study|Withdrawal by Subject|0|||
163013295|NCT00848718|588750013|FG006|Overall Study|Withdrawal by Subject|0|||
163013296|NCT00848718|588750014|FG007|Overall Study|Withdrawal by Subject|0|||
163013297|NCT00848718|588750015|FG008|Overall Study|Withdrawal by Subject|0|||
163013298|NCT00848718|588750016|FG009|Overall Study|Withdrawal by Subject|0|||
162640763|NCT01528254|587399945|FG001|Overall Study|Lost to Follow-up|24|||
162640764|NCT01528254|587399944|FG000|Overall Study|Death|13|||
162640765|NCT01528254|587399945|FG001|Overall Study|Death|9|||
162640766|NCT01528254|587399944|FG000|Overall Study|Protocol deviation|9|||
162640767|NCT01528254|587399945|FG001|Overall Study|Protocol deviation|19|||
162640768|NCT01528254|587399944|FG000|Overall Study|New therapy for study indication|8|||
162640769|NCT01528254|587399945|FG001|Overall Study|New therapy for study indication|6|||
162640770|NCT01528254|587399944|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162640771|NCT01528254|587399945|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163013299|NCT00848718|588750017|FG010|Overall Study|Withdrawal by Subject|1|||
163062729|NCT04530344|588936919|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
163062730|NCT04530344|588936920|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
163062731|NCT04530344|588936917|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
162640772|NCT01528254|587399944|FG000|Overall Study|Withdrawal by Subject|5|||
162640773|NCT01528254|587399945|FG001|Overall Study|Withdrawal by Subject|4|||
162640774|NCT01528254|587399944|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163013300|NCT00848718|588750018|FG011|Overall Study|Withdrawal by Subject|0|||
163013301|NCT00848718|588750019|FG012|Overall Study|Withdrawal by Subject|0|||
163013302|NCT00848718|588750007|FG000|Overall Study|Progressive disease during treatment|3|||
163013303|NCT00848718|588750008|FG001|Overall Study|Progressive disease during treatment|0|||
163013304|NCT00848718|588750009|FG002|Overall Study|Progressive disease during treatment|3|||
163013305|NCT00848718|588750010|FG003|Overall Study|Progressive disease during treatment|0|||
163013306|NCT00848718|588750011|FG004|Overall Study|Progressive disease during treatment|0|||
163013307|NCT00848718|588750012|FG005|Overall Study|Progressive disease during treatment|0|||
163062732|NCT04530344|588936918|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
162640775|NCT01528254|587399945|FG001|Overall Study|Abnormal laboratory value(s)|7|||
162640776|NCT01528254|587399944|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162640777|NCT01528254|587399945|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162640778|NCT01528254|587399944|FG000|Overall Study|No longer requires study drug|1|||
162640779|NCT01528254|587399945|FG001|Overall Study|No longer requires study drug|1|||
162640780|NCT00383149|587399946|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
162640781|NCT00383149|587399946|FG000|Overall Study|Death|2|||
162640782|NCT00383149|587399946|FG000|Overall Study|Disease Progression|38|||
162640783|NCT00383149|587399946|FG000|Overall Study|Lost to Follow-up|1|||
163013308|NCT00848718|588750013|FG006|Overall Study|Progressive disease during treatment|0|||
163013309|NCT00848718|588750014|FG007|Overall Study|Progressive disease during treatment|2|||
163013310|NCT00848718|588750015|FG008|Overall Study|Progressive disease during treatment|0|||
163013311|NCT00848718|588750016|FG009|Overall Study|Progressive disease during treatment|0|||
163013312|NCT00848718|588750017|FG010|Overall Study|Progressive disease during treatment|0|||
163013313|NCT00848718|588750018|FG011|Overall Study|Progressive disease during treatment|0|||
163013314|NCT00848718|588750019|FG012|Overall Study|Progressive disease during treatment|2|||
163013315|NCT02389829|588750020|FG000|Overall Study|Lost to Follow-up|0|||
163013316|NCT02389829|588750021|FG001|Overall Study|Lost to Follow-up|1|||
163013317|NCT00833105|588751446|FG000|Overall Study|Withdrawal by Subject|1|||
163013318|NCT00833105|588751446|FG000|Overall Study|Adverse Event|2|||
163013319|NCT02898597|588751447|FG000|Overall Study|Protocol Violation|4|||
163013320|NCT02898597|588751448|FG001|Overall Study|Protocol Violation|2|||
163013321|NCT02898597|588751447|FG000|Overall Study|Lost to Follow-up|0|||
163013322|NCT02898597|588751448|FG001|Overall Study|Lost to Follow-up|9|||
163013323|NCT02898597|588751447|FG000|Overall Study|Death|0|||
163013324|NCT02898597|588751448|FG001|Overall Study|Death|1|||
163013325|NCT00171210|588751452|FG000|Overall Study|Adverse Event|16|||
163013326|NCT00171210|588751453|FG001|Overall Study|Adverse Event|27|||
163013327|NCT00171210|588751452|FG000|Overall Study|Abnormal laboratory value(s)|6|||
163013328|NCT00171210|588751453|FG001|Overall Study|Abnormal laboratory value(s)|3|||
163013329|NCT00171210|588751452|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163013330|NCT00171210|588751453|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163013331|NCT00171210|588751452|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
163013332|NCT00171210|588751453|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
163013333|NCT00171210|588751452|FG000|Overall Study|Protocol Violation|0|||
163013334|NCT00171210|588751453|FG001|Overall Study|Protocol Violation|2|||
163013335|NCT00171210|588751452|FG000|Overall Study|Withdrawal by Subject|32|||
163013336|NCT00171210|588751453|FG001|Overall Study|Withdrawal by Subject|30|||
163013337|NCT00171210|588751452|FG000|Overall Study|Lost to Follow-up|1|||
163013338|NCT00171210|588751453|FG001|Overall Study|Lost to Follow-up|0|||
163013339|NCT00171210|588751452|FG000|Overall Study|Administrative problems|1|||
163013340|NCT00171210|588751453|FG001|Overall Study|Administrative problems|1|||
163013341|NCT00171210|588751452|FG000|Overall Study|Death|2|||
163013342|NCT00171210|588751453|FG001|Overall Study|Death|3|||
163013343|NCT00171210|588751452|FG000|Overall Study|Stopped at end of core|0|||
163013344|NCT00171210|588751453|FG001|Overall Study|Stopped at end of core|32|||
163013345|NCT00171210|588751452|FG000|Overall Study|Stopped at end of extension 1|0|||
163013346|NCT00171210|588751453|FG001|Overall Study|Stopped at end of extension 1|1|||
163013347|NCT01609296|588751454|FG000|Overall Study|Death|253|||
163013348|NCT01609296|588751454|FG000|Overall Study|Withdrawal by Subject|151|||
163013349|NCT01609296|588751454|FG000|Overall Study|Lost to Follow-up|21|||
163013350|NCT01609296|588751454|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
163013351|NCT01609296|588751454|FG000|Overall Study|missed visit but known to be alive|28|||
163013352|NCT01681212|588751457|FG000|Overall Study|No longer met study criteria|5|||
163013353|NCT01681212|588751457|FG000|Overall Study|Administrative reason by sponsor|1|||
163013354|NCT01464333|588751458|FG000|Overall Study|Adverse Event|34|||
163013355|NCT01464333|588751458|FG000|Overall Study|Lack of Efficacy|72|||
163013356|NCT01464333|588751458|FG000|Overall Study|Withdrawal by Subject|11|||
163013357|NCT01464333|588751458|FG000|Overall Study|Other|4|||
163013358|NCT01464333|588751458|FG000|Overall Study|No Hospital Visit|42|||
163013359|NCT03321968|588751462|FG000|Overall Study|Withdrawal by Subject|1|||
163013360|NCT03321968|588751463|FG001|Overall Study|Withdrawal by Subject|2|||
163013361|NCT03321968|588751464|FG002|Overall Study|Withdrawal by Subject|1|||
163013362|NCT03321968|588751462|FG000|Overall Study|Lost to Follow-up|2|||
163013363|NCT03321968|588751463|FG001|Overall Study|Lost to Follow-up|0|||
163062733|NCT04530344|588936919|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
162640784|NCT00383149|587399946|FG000|Overall Study|Other|1|||
163062734|NCT04530344|588936920|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
163062735|NCT04530344|588936917|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
162640785|NCT00383149|587399946|FG000|Overall Study|Study Drug Toxicity|4|||
162640786|NCT00383149|587399946|FG000|Overall Study|Request to Discontinue Treatment|4|||
163013364|NCT03321968|588751464|FG002|Overall Study|Lost to Follow-up|1|||
163013365|NCT03321968|588751462|FG000|Overall Study|Other than specified|0|||
163013366|NCT03321968|588751463|FG001|Overall Study|Other than specified|0|||
163013367|NCT03321968|588751464|FG002|Overall Study|Other than specified|1|||
163013368|NCT02282813|588751467|FG000|Overall Study|Withdrawal by Subject|4|||
163013369|NCT02282813|588751468|FG001|Overall Study|Withdrawal by Subject|5|||
163013370|NCT02282813|588751469|FG002|Overall Study|Withdrawal by Subject|0|||
163013371|NCT02282813|588751467|FG000|Overall Study|Adverse Event|3|||
163013372|NCT02282813|588751468|FG001|Overall Study|Adverse Event|10|||
163013373|NCT02282813|588751469|FG002|Overall Study|Adverse Event|1|||
163013374|NCT02282813|588751467|FG000|Overall Study|Subject non-compliance|1|||
163013375|NCT02282813|588751468|FG001|Overall Study|Subject non-compliance|4|||
163013376|NCT02282813|588751469|FG002|Overall Study|Subject non-compliance|0|||
163013377|NCT02282813|588751467|FG000|Overall Study|Physician Decision|0|||
163013378|NCT02282813|588751468|FG001|Overall Study|Physician Decision|3|||
163013379|NCT02282813|588751469|FG002|Overall Study|Physician Decision|1|||
163013380|NCT02282813|588751467|FG000|Overall Study|Lost to Follow-up|2|||
163013381|NCT02282813|588751468|FG001|Overall Study|Lost to Follow-up|0|||
163013382|NCT02282813|588751469|FG002|Overall Study|Lost to Follow-up|1|||
163013383|NCT02282813|588751467|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
163013384|NCT02282813|588751468|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
163013385|NCT02282813|588751469|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
163013386|NCT02282813|588751467|FG000|Overall Study|Lack of Efficacy|1|||
163013387|NCT02282813|588751468|FG001|Overall Study|Lack of Efficacy|0|||
163013388|NCT02282813|588751469|FG002|Overall Study|Lack of Efficacy|0|||
163013389|NCT02282813|588751467|FG000|Overall Study|Administrative reasons|0|||
163013390|NCT02282813|588751468|FG001|Overall Study|Administrative reasons|1|||
163013391|NCT02282813|588751469|FG002|Overall Study|Administrative reasons|0|||
163013392|NCT00529308|588751470|FG000|Overall Study|Withdrawal by Subject|1|||
163013393|NCT00529308|588751471|FG001|Overall Study|Withdrawal by Subject|1|||
163013394|NCT06509438|588751472|FG000|Overall Study|Adverse Event|1|||
163013395|NCT06509438|588751472|FG000|Overall Study|Lost to Follow-up|3|||
163013396|NCT03331796|588751473|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
163013397|NCT03331796|588751474|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
163013398|NCT03331796|588751475|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
163013399|NCT03331796|588751473|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
163013400|NCT03331796|588751474|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
163013401|NCT03331796|588751475|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
163013402|NCT03331796|588751473|FG000|Extended Follow-up|Adverse Event|1|||
163013403|NCT03331796|588751474|FG001|Extended Follow-up|Adverse Event|0|||
163013404|NCT03331796|588751475|FG002|Extended Follow-up|Adverse Event|1|||
163013405|NCT03331796|588751473|FG000|Extended Follow-up|Lost to Follow-up|0|||
163013406|NCT03331796|588751474|FG001|Extended Follow-up|Lost to Follow-up|0|||
163013407|NCT03331796|588751475|FG002|Extended Follow-up|Lost to Follow-up|1|||
163013408|NCT03331796|588751473|FG000|Extended Follow-up|Withdrawal by Subject|1|||
163013409|NCT03331796|588751474|FG001|Extended Follow-up|Withdrawal by Subject|0|||
163013410|NCT03331796|588751475|FG002|Extended Follow-up|Withdrawal by Subject|0|||
163013411|NCT03331796|588751473|FG000|Extended Follow-up|Termination of Funding|0|||
163013412|NCT03331796|588751474|FG001|Extended Follow-up|Termination of Funding|1|||
163013413|NCT03331796|588751475|FG002|Extended Follow-up|Termination of Funding|0|||
163013414|NCT00745901|588751478|FG000|Overall Study|Adverse Event|3|||
163013415|NCT00745901|588751479|FG001|Overall Study|Adverse Event|4|||
163013416|NCT00745901|588751478|FG000|Overall Study|Protocol Violation|0|||
163013417|NCT00745901|588751479|FG001|Overall Study|Protocol Violation|1|||
163013418|NCT00745901|588751478|FG000|Overall Study|Withdrawal by Subject|1|||
163013419|NCT00745901|588751479|FG001|Overall Study|Withdrawal by Subject|0|||
163013420|NCT00745901|588751478|FG000|Overall Study|Lost to Follow-up|7|||
163013421|NCT00745901|588751479|FG001|Overall Study|Lost to Follow-up|4|||
163013422|NCT00745901|588751478|FG000|Overall Study|Pregnancy|2|||
163013423|NCT00745901|588751479|FG001|Overall Study|Pregnancy|4|||
163013424|NCT00745901|588751478|FG000|Overall Study|Lack of compliance|2|||
163013425|NCT00745901|588751479|FG001|Overall Study|Lack of compliance|2|||
163013426|NCT00745901|588751478|FG000|Overall Study|Patient's next menses did not start with|1|||
163013427|NCT00745901|588751479|FG001|Overall Study|Patient's next menses did not start with|0|||
163013428|NCT00745901|588751478|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
163013429|NCT00745901|588751479|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
163013430|NCT00745901|588751478|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
163013431|NCT00745901|588751479|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
162640787|NCT00383149|587399946|FG000|Overall Study|Participant Withdrew Consent|1|||
163013432|NCT00745901|588751478|FG000|Overall Study|Patient didn't take any study medication|7|||
163013433|NCT00745901|588751479|FG001|Overall Study|Patient didn't take any study medication|3|||
163013434|NCT01753310|588751481|FG000|Overall Study|Entered into open label extension study|25|||
163013435|NCT01753310|588751482|FG001|Overall Study|Entered into open label extension study|22|||
163013436|NCT01753310|588751481|FG000|Overall Study|Adverse Event|1|||
163013437|NCT01753310|588751482|FG001|Overall Study|Adverse Event|0|||
163013438|NCT01753310|588751481|FG000|Overall Study|Lost to Follow-up|2|||
163013439|NCT01753310|588751482|FG001|Overall Study|Lost to Follow-up|0|||
163013440|NCT01753310|588751481|FG000|Overall Study|Subject decision|2|||
163013441|NCT01753310|588751482|FG001|Overall Study|Subject decision|2|||
163013442|NCT01753310|588751481|FG000|Overall Study|Sponsor decision|1|||
163013443|NCT01753310|588751482|FG001|Overall Study|Sponsor decision|0|||
163013444|NCT01753310|588751481|FG000|Overall Study|Withdrawal by Subject|1|||
163013445|NCT01753310|588751482|FG001|Overall Study|Withdrawal by Subject|0|||
163013446|NCT05581641|588751483|FG000|Overall Study|Withdrawal by Subject|0|||
163013447|NCT05581641|588751484|FG001|Overall Study|Withdrawal by Subject|1|||
163013448|NCT05581641|588751485|FG002|Overall Study|Withdrawal by Subject|3|||
163013449|NCT05581641|588751486|FG003|Overall Study|Withdrawal by Subject|1|||
163013450|NCT05581641|588751483|FG000|Overall Study|Lost to Follow-up|0|||
163013451|NCT05581641|588751484|FG001|Overall Study|Lost to Follow-up|1|||
163013452|NCT05581641|588751485|FG002|Overall Study|Lost to Follow-up|0|||
163013453|NCT05581641|588751486|FG003|Overall Study|Lost to Follow-up|1|||
163013454|NCT05581641|588751483|FG000|Overall Study|Protocol Violation|1|||
163013455|NCT05581641|588751484|FG001|Overall Study|Protocol Violation|0|||
163013456|NCT05581641|588751485|FG002|Overall Study|Protocol Violation|0|||
163013457|NCT05581641|588751486|FG003|Overall Study|Protocol Violation|0|||
163013458|NCT05581641|588751483|FG000|Overall Study|Other|1|||
163013459|NCT05581641|588751484|FG001|Overall Study|Other|0|||
163013460|NCT05581641|588751485|FG002|Overall Study|Other|2|||
163013461|NCT05581641|588751486|FG003|Overall Study|Other|1|||
163013462|NCT04390763|588751487|FG000|Safety run-in Part|Adverse Event|4|||
163013463|NCT04390763|588751488|FG001|Safety run-in Part|Adverse Event|0|||
163013464|NCT04390763|588751489|FG002|Safety run-in Part|Adverse Event|0|||
163013465|NCT04390763|588751490|FG003|Safety run-in Part|Adverse Event|0|||
163013466|NCT04390763|588751487|FG000|Safety run-in Part|Physician Decision|1|||
163013467|NCT04390763|588751488|FG001|Safety run-in Part|Physician Decision|0|||
163013468|NCT04390763|588751489|FG002|Safety run-in Part|Physician Decision|0|||
163013469|NCT04390763|588751490|FG003|Safety run-in Part|Physician Decision|0|||
163013470|NCT04390763|588751487|FG000|Safety run-in Part|Progressive Disease|6|||
163013471|NCT04390763|588751488|FG001|Safety run-in Part|Progressive Disease|0|||
163013472|NCT04390763|588751489|FG002|Safety run-in Part|Progressive Disease|0|||
163013473|NCT04390763|588751490|FG003|Safety run-in Part|Progressive Disease|0|||
163013474|NCT04390763|588751487|FG000|Randomized Part|Adverse Event|0|||
163013475|NCT04390763|588751488|FG001|Randomized Part|Adverse Event|11|||
163013476|NCT04390763|588751489|FG002|Randomized Part|Adverse Event|5|||
163013477|NCT04390763|588751490|FG003|Randomized Part|Adverse Event|5|||
163013478|NCT04390763|588751487|FG000|Randomized Part|Death|0|||
163013479|NCT04390763|588751488|FG001|Randomized Part|Death|3|||
163013480|NCT04390763|588751489|FG002|Randomized Part|Death|4|||
163013481|NCT04390763|588751490|FG003|Randomized Part|Death|2|||
163013482|NCT04390763|588751487|FG000|Randomized Part|Physician Decision|0|||
163013483|NCT04390763|588751488|FG001|Randomized Part|Physician Decision|2|||
163013484|NCT04390763|588751489|FG002|Randomized Part|Physician Decision|2|||
163013485|NCT04390763|588751490|FG003|Randomized Part|Physician Decision|9|||
163013486|NCT04390763|588751487|FG000|Randomized Part|Progressive Disease|0|||
163013487|NCT04390763|588751488|FG001|Randomized Part|Progressive Disease|24|||
163013488|NCT04390763|588751489|FG002|Randomized Part|Progressive Disease|31|||
163013489|NCT04390763|588751490|FG003|Randomized Part|Progressive Disease|23|||
163013490|NCT04390763|588751487|FG000|Randomized Part|Study terminated by sponsor|0|||
163013491|NCT04390763|588751488|FG001|Randomized Part|Study terminated by sponsor|1|||
163013492|NCT04390763|588751489|FG002|Randomized Part|Study terminated by sponsor|0|||
163013493|NCT04390763|588751490|FG003|Randomized Part|Study terminated by sponsor|0|||
163013494|NCT04390763|588751487|FG000|Randomized Part|Participant Decision|0|||
163013495|NCT04390763|588751488|FG001|Randomized Part|Participant Decision|5|||
163013496|NCT04390763|588751489|FG002|Randomized Part|Participant Decision|7|||
163013497|NCT04390763|588751490|FG003|Randomized Part|Participant Decision|6|||
163013498|NCT04390763|588751487|FG000|Randomized Part|Not treated|0|||
163013499|NCT04390763|588751488|FG001|Randomized Part|Not treated|4|||
163013500|NCT04390763|588751489|FG002|Randomized Part|Not treated|2|||
163013501|NCT04390763|588751490|FG003|Randomized Part|Not treated|7|||
163013502|NCT01786993|588751491|FG000|Overall Study|Death|6|||
163013503|NCT01786993|588751492|FG001|Overall Study|Death|7|||
163013504|NCT01786993|588751491|FG000|Overall Study|Withdrawal by Subject|3|||
163013505|NCT01786993|588751492|FG001|Overall Study|Withdrawal by Subject|2|||
163013506|NCT01786993|588751491|FG000|Overall Study|Lost to Follow-up|0|||
163013507|NCT01786993|588751492|FG001|Overall Study|Lost to Follow-up|1|||
163013508|NCT01786993|588751491|FG000|Overall Study|Subject Non-Compliance|1|||
163013509|NCT01786993|588751492|FG001|Overall Study|Subject Non-Compliance|0|||
163013510|NCT01786993|588751491|FG000|Overall Study|System Explant|1|||
163013511|NCT01786993|588751492|FG001|Overall Study|System Explant|0|||
163013512|NCT01786993|588751491|FG000|Overall Study|Hospice Admission|1|||
163013513|NCT01786993|588751492|FG001|Overall Study|Hospice Admission|0|||
163013514|NCT00450437|588751493|FG000|Overall Study|Withdrawal by Subject|10|||
163013515|NCT00450437|588751494|FG001|Overall Study|Withdrawal by Subject|2|||
163013516|NCT00450437|588751495|FG002|Overall Study|Withdrawal by Subject|0|||
163013517|NCT00450437|588751496|FG003|Overall Study|Withdrawal by Subject|1|||
163013518|NCT00450437|588751493|FG000|Overall Study|Lost to Follow-up|31|||
163013519|NCT00450437|588751494|FG001|Overall Study|Lost to Follow-up|12|||
163013520|NCT00450437|588751495|FG002|Overall Study|Lost to Follow-up|19|||
163013521|NCT00450437|588751496|FG003|Overall Study|Lost to Follow-up|9|||
163013522|NCT00450437|588751493|FG000|Overall Study|Protocol Violation|0|||
163013523|NCT00450437|588751494|FG001|Overall Study|Protocol Violation|1|||
163013524|NCT00450437|588751495|FG002|Overall Study|Protocol Violation|0|||
163013525|NCT00450437|588751496|FG003|Overall Study|Protocol Violation|1|||
163013526|NCT00450437|588751493|FG000|Overall Study|Inappropriate enrollment|4|||
163013527|NCT00450437|588751494|FG001|Overall Study|Inappropriate enrollment|1|||
163013528|NCT00450437|588751495|FG002|Overall Study|Inappropriate enrollment|3|||
163013529|NCT00450437|588751496|FG003|Overall Study|Inappropriate enrollment|0|||
163013530|NCT00450437|588751493|FG000|Overall Study|Administrative reason|0|||
163013531|NCT00450437|588751494|FG001|Overall Study|Administrative reason|0|||
163013532|NCT00450437|588751495|FG002|Overall Study|Administrative reason|1|||
163013533|NCT00450437|588751496|FG003|Overall Study|Administrative reason|0|||
163013534|NCT00450437|588751493|FG000|Overall Study|Unable to Classify|1|||
163013535|NCT00450437|588751494|FG001|Overall Study|Unable to Classify|0|||
163013536|NCT00450437|588751495|FG002|Overall Study|Unable to Classify|1|||
163013537|NCT00450437|588751496|FG003|Overall Study|Unable to Classify|0|||
163013538|NCT01890122|588751497|FG000|Overall Study|Adverse Event|1|||
163013539|NCT01890122|588751498|FG001|Overall Study|Adverse Event|1|||
163013540|NCT01890122|588751499|FG002|Overall Study|Adverse Event|1|||
163013541|NCT01890122|588751500|FG003|Overall Study|Adverse Event|2|||
163013542|NCT01890122|588751497|FG000|Overall Study|Major Protocol Deviation|3|||
163013543|NCT01890122|588751498|FG001|Overall Study|Major Protocol Deviation|1|||
162715989|NCT03536884|587667091|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715990|NCT03536884|587667092|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715991|NCT03536884|587667093|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715992|NCT03536884|587667094|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715993|NCT03536884|587667095|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715994|NCT03536884|587667096|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715995|NCT03536884|587667097|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715996|NCT03536884|587667098|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715997|NCT03536884|587667099|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162715998|NCT03536884|587667100|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162715999|NCT03536884|587667101|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162716000|NCT03536884|587667102|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162716001|NCT03536884|587667091|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716002|NCT03536884|587667092|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716003|NCT03536884|587667093|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716004|NCT03536884|587667094|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716005|NCT03536884|587667095|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716006|NCT03536884|587667096|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716007|NCT03536884|587667097|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716008|NCT03536884|587667098|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716009|NCT03536884|587667099|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162716010|NCT03536884|587667100|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162716011|NCT03536884|587667101|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162716012|NCT03536884|587667102|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162716013|NCT03536884|587667091|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716014|NCT03536884|587667092|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716015|NCT03536884|587667093|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716016|NCT03536884|587667094|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716017|NCT03536884|587667095|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716018|NCT03536884|587667096|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716019|NCT03536884|587667097|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716020|NCT03536884|587667098|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716021|NCT03536884|587667099|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716022|NCT03536884|587667100|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716023|NCT03536884|587667101|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
162716024|NCT03536884|587667102|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162716025|NCT03536884|587667091|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716026|NCT03536884|587667092|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163013544|NCT01890122|588751499|FG002|Overall Study|Major Protocol Deviation|0|||
163013545|NCT01890122|588751500|FG003|Overall Study|Major Protocol Deviation|1|||
163013546|NCT01890122|588751497|FG000|Overall Study|Lost to Follow-up|0|||
163013547|NCT01890122|588751498|FG001|Overall Study|Lost to Follow-up|1|||
163013548|NCT01890122|588751499|FG002|Overall Study|Lost to Follow-up|2|||
163013549|NCT01890122|588751500|FG003|Overall Study|Lost to Follow-up|2|||
163013550|NCT01890122|588751497|FG000|Overall Study|Voluntary Withdrawal|8|||
163013551|NCT01890122|588751498|FG001|Overall Study|Voluntary Withdrawal|8|||
163013552|NCT01890122|588751499|FG002|Overall Study|Voluntary Withdrawal|2|||
163013553|NCT01890122|588751500|FG003|Overall Study|Voluntary Withdrawal|11|||
163013554|NCT01890122|588751497|FG000|Overall Study|Lack of Efficacy|14|||
163013555|NCT01890122|588751498|FG001|Overall Study|Lack of Efficacy|24|||
163013556|NCT01890122|588751499|FG002|Overall Study|Lack of Efficacy|7|||
163013557|NCT01890122|588751500|FG003|Overall Study|Lack of Efficacy|41|||
163013558|NCT01890122|588751497|FG000|Overall Study|Reason not Specified|0|||
163013559|NCT01890122|588751498|FG001|Overall Study|Reason not Specified|1|||
163013560|NCT01890122|588751499|FG002|Overall Study|Reason not Specified|1|||
163013561|NCT01890122|588751500|FG003|Overall Study|Reason not Specified|2|||
163013562|NCT01890122|588751497|FG000|Overall Study|Randomized but not Treated|1|||
163013563|NCT01890122|588751498|FG001|Overall Study|Randomized but not Treated|1|||
163013564|NCT01890122|588751499|FG002|Overall Study|Randomized but not Treated|0|||
163013565|NCT01890122|588751500|FG003|Overall Study|Randomized but not Treated|0|||
163013566|NCT04025879|588751501|FG000|Randomization|Participant withdrew consent|0|||
163013567|NCT04025879|588751502|FG001|Randomization|Participant withdrew consent|1|||
163013568|NCT04025879|588751501|FG000|Randomization|Participant no longer met study criteria|1|||
163013569|NCT04025879|588751502|FG001|Randomization|Participant no longer met study criteria|1|||
163013570|NCT04025879|588751501|FG000|Treatment|Ongoing treatment|10|||
163013571|NCT04025879|588751502|FG001|Treatment|Ongoing treatment|8|||
163013572|NCT04025879|588751501|FG000|Treatment|Disease progression/recurrence|36|||
163013573|NCT04025879|588751502|FG001|Treatment|Disease progression/recurrence|72|||
163013574|NCT04025879|588751501|FG000|Treatment|Study drug toxicity|36|||
163062736|NCT04530344|588936918|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
163062737|NCT04530344|588936919|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
163062738|NCT04530344|588936920|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
163062739|NCT04530344|588936917|FG000|Overall Study|Personal Reasons|0|||
163062740|NCT04530344|588936918|FG001|Overall Study|Personal Reasons|0|||
163062741|NCT04530344|588936919|FG002|Overall Study|Personal Reasons|0|||
163062742|NCT04530344|588936920|FG003|Overall Study|Personal Reasons|1|||
163062743|NCT04530344|588936917|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163062744|NCT04530344|588936918|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163062745|NCT04530344|588936919|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
163013575|NCT04025879|588751502|FG001|Treatment|Study drug toxicity|13|||
163013576|NCT04025879|588751501|FG000|Treatment|Death|2|||
163062746|NCT04530344|588936920|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
163062747|NCT01402700|588936921|FG000|Overall Study|Death|3|||
163062748|NCT01402700|588936921|FG000|Overall Study|Withdrawal by Subject|3|||
163062749|NCT01402700|588936921|FG000|Overall Study|Missed Visit|1|||
163062750|NCT01933594|588936922|FG000|Overall Study|Lost to Follow-up|1|||
163062751|NCT01933594|588936923|FG001|Overall Study|Lost to Follow-up|0|||
163062752|NCT01933594|588936924|FG002|Overall Study|Lost to Follow-up|0|||
163062753|NCT01933594|588936925|FG003|Overall Study|Lost to Follow-up|0|||
163062754|NCT01933594|588936926|FG004|Overall Study|Lost to Follow-up|1|||
163062755|NCT01933594|588936927|FG005|Overall Study|Lost to Follow-up|0|||
163062756|NCT01933594|588936922|FG000|Overall Study|Ineligible for subsequent study step|0|||
163062757|NCT01933594|588936923|FG001|Overall Study|Ineligible for subsequent study step|0|||
163062758|NCT01933594|588936924|FG002|Overall Study|Ineligible for subsequent study step|0|||
163062759|NCT01933594|588936925|FG003|Overall Study|Ineligible for subsequent study step|0|||
163062760|NCT01933594|588936926|FG004|Overall Study|Ineligible for subsequent study step|1|||
163062761|NCT01933594|588936927|FG005|Overall Study|Ineligible for subsequent study step|0|||
163062762|NCT05352399|588936941|FG000|Overall Study|Discontinued intervention|6|||
163013577|NCT04025879|588751502|FG001|Treatment|Death|0|||
163013578|NCT04025879|588751501|FG000|Treatment|Adverse event unrelated to study drug|21|||
163013579|NCT04025879|588751502|FG001|Treatment|Adverse event unrelated to study drug|14|||
163013580|NCT04025879|588751501|FG000|Treatment|Participant request to discontinue study treatment|16|||
163013581|NCT04025879|588751502|FG001|Treatment|Participant request to discontinue study treatment|8|||
163013582|NCT04025879|588751501|FG000|Treatment|Participant withdrew consent|1|||
163013583|NCT04025879|588751502|FG001|Treatment|Participant withdrew consent|3|||
163013584|NCT04025879|588751501|FG000|Treatment|Participant no longer meets study criteria|3|||
163013585|NCT04025879|588751502|FG001|Treatment|Participant no longer meets study criteria|2|||
163013586|NCT04025879|588751501|FG000|Treatment|Lost to Follow-up|1|||
163013587|NCT04025879|588751502|FG001|Treatment|Lost to Follow-up|0|||
163013588|NCT04025879|588751501|FG000|Treatment|Other reasons|15|||
163013589|NCT04025879|588751502|FG001|Treatment|Other reasons|17|||
163013590|NCT04025879|588751501|FG000|Treatment|Administrative reason by sponsor|0|||
163013591|NCT04025879|588751502|FG001|Treatment|Administrative reason by sponsor|1|||
163013592|NCT04025879|588751501|FG000|Treatment|Not reported|2|||
163013593|NCT04025879|588751502|FG001|Treatment|Not reported|0|||
163013594|NCT01565889|588751507|FG000|Part A|Withdrawal by Subject|1|||
163013595|NCT01565889|588751508|FG001|Part A|Withdrawal by Subject|0|||
163013596|NCT01565889|588751509|FG002|Part A|Withdrawal by Subject|0|||
163013597|NCT01565889|588751510|FG003|Part A|Withdrawal by Subject|0|||
163013598|NCT01565889|588751511|FG004|Part A|Withdrawal by Subject|0|||
163013599|NCT01565889|588751512|FG005|Part A|Withdrawal by Subject|0|||
163013600|NCT01565889|588751507|FG000|Part B|Withdrawal by Subject|0|||
163013601|NCT01565889|588751508|FG001|Part B|Withdrawal by Subject|0|||
163013602|NCT01565889|588751509|FG002|Part B|Withdrawal by Subject|0|||
163013603|NCT01565889|588751510|FG003|Part B|Withdrawal by Subject|0|||
163013604|NCT01565889|588751511|FG004|Part B|Withdrawal by Subject|0|||
163013605|NCT01565889|588751512|FG005|Part B|Withdrawal by Subject|1|||
163013606|NCT01565889|588751507|FG000|Part B|Lack of Efficacy|0|||
163013607|NCT01565889|588751508|FG001|Part B|Lack of Efficacy|0|||
163013608|NCT01565889|588751509|FG002|Part B|Lack of Efficacy|0|||
163013609|NCT01565889|588751510|FG003|Part B|Lack of Efficacy|0|||
163013610|NCT01565889|588751511|FG004|Part B|Lack of Efficacy|0|||
163013611|NCT01565889|588751512|FG005|Part B|Lack of Efficacy|2|||
163013612|NCT01565889|588751507|FG000|Part B|Lost to Follow-up|0|||
163013613|NCT01565889|588751508|FG001|Part B|Lost to Follow-up|0|||
163013614|NCT01565889|588751509|FG002|Part B|Lost to Follow-up|0|||
163013615|NCT01565889|588751510|FG003|Part B|Lost to Follow-up|0|||
163013616|NCT01565889|588751511|FG004|Part B|Lost to Follow-up|0|||
163013617|NCT01565889|588751512|FG005|Part B|Lost to Follow-up|1|||
163013618|NCT00071110|588751513|FG000|Overall Study|Protocol Violation|0|||
163013619|NCT00071110|588751514|FG001|Overall Study|Protocol Violation|4|||
163013620|NCT02259010|588751519|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
163013621|NCT03194542|588751520|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
163013622|NCT03194542|588751521|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013623|NCT03194542|588751522|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013624|NCT03194542|588751523|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
163013625|NCT03194542|588751520|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
163013626|NCT03194542|588751521|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
163013627|NCT03194542|588751522|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
163013628|NCT03194542|588751523|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
163013629|NCT03194542|588751520|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
163013630|NCT03194542|588751521|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
163013631|NCT03194542|588751522|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
163013632|NCT03194542|588751523|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
163013633|NCT03194542|588751520|FG000|Overall Study|Loss of Response|4|||
163013634|NCT03194542|588751521|FG001|Overall Study|Loss of Response|2|||
163013635|NCT03194542|588751522|FG002|Overall Study|Loss of Response|3|||
163013636|NCT03194542|588751523|FG003|Overall Study|Loss of Response|4|||
163013637|NCT03194542|588751520|FG000|Overall Study|Physician Decision|0|||
163013638|NCT03194542|588751521|FG001|Overall Study|Physician Decision|1|||
163013639|NCT03194542|588751522|FG002|Overall Study|Physician Decision|0|||
163013640|NCT03194542|588751523|FG003|Overall Study|Physician Decision|0|||
163013641|NCT03194542|588751520|FG000|Overall Study|Lack of Efficacy|2|||
163013642|NCT03194542|588751521|FG001|Overall Study|Lack of Efficacy|2|||
163013643|NCT03194542|588751522|FG002|Overall Study|Lack of Efficacy|2|||
163013644|NCT03194542|588751523|FG003|Overall Study|Lack of Efficacy|6|||
163013645|NCT03194542|588751520|FG000|Overall Study|Withdrawal by Subject|2|||
163013646|NCT03194542|588751521|FG001|Overall Study|Withdrawal by Subject|1|||
163013647|NCT03194542|588751522|FG002|Overall Study|Withdrawal by Subject|5|||
163013648|NCT03194542|588751523|FG003|Overall Study|Withdrawal by Subject|4|||
163013649|NCT03194542|588751520|FG000|Overall Study|Progressive Disease|1|||
163013650|NCT03194542|588751521|FG001|Overall Study|Progressive Disease|0|||
163013651|NCT03194542|588751522|FG002|Overall Study|Progressive Disease|1|||
163013652|NCT03194542|588751523|FG003|Overall Study|Progressive Disease|1|||
163013653|NCT03194542|588751520|FG000|Overall Study|Adverse Event|1|||
163013654|NCT03194542|588751521|FG001|Overall Study|Adverse Event|2|||
163013655|NCT03194542|588751522|FG002|Overall Study|Adverse Event|0|||
163013656|NCT03194542|588751523|FG003|Overall Study|Adverse Event|5|||
163013657|NCT03194542|588751520|FG000|Overall Study|Death|1|||
163013658|NCT03194542|588751521|FG001|Overall Study|Death|2|||
163013659|NCT03194542|588751522|FG002|Overall Study|Death|0|||
163013660|NCT03194542|588751523|FG003|Overall Study|Death|5|||
163013661|NCT03194542|588751520|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
163013662|NCT03194542|588751521|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
163013663|NCT03194542|588751522|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
163013664|NCT03194542|588751523|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
163013665|NCT02640664|588751527|FG000|Epoch 1|Withdrawal of informed consent|1|||
163013666|NCT02640664|588751528|FG001|Epoch 1|Withdrawal of informed consent|0|||
163013667|NCT02640664|588751529|FG002|Epoch 1|Withdrawal of informed consent|0|||
163013668|NCT02640664|588751527|FG000|Epoch 1|Death|0|||
163013669|NCT02640664|588751528|FG001|Epoch 1|Death|0|||
163013670|NCT02640664|588751529|FG002|Epoch 1|Death|1|||
163013671|NCT02640664|588751527|FG000|Epoch 2|Withdrawal of informed consent|3|||
163013672|NCT02640664|588751528|FG001|Epoch 2|Withdrawal of informed consent|4|||
163013673|NCT02640664|588751529|FG002|Epoch 2|Withdrawal of informed consent|2|||
163013674|NCT02640664|588751527|FG000|Epoch 2|Subject/guardian decision|0|||
163013675|NCT02640664|588751528|FG001|Epoch 2|Subject/guardian decision|2|||
163013676|NCT02640664|588751529|FG002|Epoch 2|Subject/guardian decision|2|||
163013677|NCT02640664|588751527|FG000|Epoch 2|Lost to Follow-up|3|||
163013678|NCT02640664|588751528|FG001|Epoch 2|Lost to Follow-up|4|||
163013679|NCT02640664|588751529|FG002|Epoch 2|Lost to Follow-up|1|||
163013680|NCT02640664|588751527|FG000|Epoch 2|Death|0|||
163013681|NCT02640664|588751528|FG001|Epoch 2|Death|0|||
163013682|NCT02640664|588751529|FG002|Epoch 2|Death|1|||
163013683|NCT00722137|588751532|FG000|Overall Study|Overt Disease Progression|5|||
163013684|NCT00722137|588751533|FG001|Overall Study|Overt Disease Progression|4|||
163013685|NCT00722137|588751532|FG000|Overall Study|Adverse Event|17|||
163013686|NCT00722137|588751533|FG001|Overall Study|Adverse Event|21|||
163013687|NCT00722137|588751532|FG000|Overall Study|Death|12|||
163013688|NCT00722137|588751533|FG001|Overall Study|Death|7|||
163013689|NCT00722137|588751532|FG000|Overall Study|Withdrawal by Subject|6|||
163013690|NCT00722137|588751533|FG001|Overall Study|Withdrawal by Subject|9|||
163013691|NCT00722137|588751532|FG000|Overall Study|Other Reason Unknown|3|||
163013692|NCT00722137|588751533|FG001|Overall Study|Other Reason Unknown|4|||
163013693|NCT00722137|588751532|FG000|Overall Study|Randomized But Not Treated|2|||
163013694|NCT00722137|588751533|FG001|Overall Study|Randomized But Not Treated|3|||
163013695|NCT05514873|588751536|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
163013696|NCT05514873|588751536|FG000|Main Treatment Period|Adverse Event|2|||
163013697|NCT05514873|588751536|FG000|Extension Treatment Period|Lost to Follow-up|3|||
163013698|NCT02729025|588751537|FG000|Overall Study|Sponsor Decision|0|||
163013699|NCT02729025|588751538|FG001|Overall Study|Sponsor Decision|1|||
163013700|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
163013701|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
163013702|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
163013703|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
163013704|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
163013705|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
163013706|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
163013707|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013708|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013709|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
163013710|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
163013711|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
163013712|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
163013713|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
163013714|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
163013715|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
163013716|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
163013717|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
163013718|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
163013719|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
163013720|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
163013721|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
163013722|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
163013723|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
163013724|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
163013725|NCT03525678|588751542|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
163013726|NCT03525678|588751543|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
163013727|NCT03525678|588751544|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013728|NCT03525678|588751545|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013729|NCT03525678|588751546|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
163013730|NCT05343000|588753050|FG000|Overall Study|Physician Decision|2|||
163013731|NCT04432831|588753051|FG000|Overall Study|Withdrawal by Subject|24|||
163013732|NCT04432831|588753052|FG001|Overall Study|Withdrawal by Subject|28|||
163013733|NCT04432831|588753053|FG002|Overall Study|Withdrawal by Subject|21|||
162640788|NCT00416078|587399953|FG000|Overall Study|Death|3|||
163013734|NCT04432831|588753051|FG000|Overall Study|Death|23|||
163013735|NCT04432831|588753052|FG001|Overall Study|Death|23|||
163013736|NCT04432831|588753053|FG002|Overall Study|Death|17|||
163013737|NCT04432831|588753051|FG000|Overall Study|Lost to Follow-up|15|||
163013738|NCT04432831|588753052|FG001|Overall Study|Lost to Follow-up|15|||
163013739|NCT04432831|588753053|FG002|Overall Study|Lost to Follow-up|12|||
163013740|NCT04432831|588753051|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
162640789|NCT00416078|587399954|FG001|Overall Study|Death|4|||
163013741|NCT04432831|588753052|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
163013742|NCT04432831|588753053|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
163013743|NCT04432831|588753051|FG000|Overall Study|Reason Not Specified|7|||
163013744|NCT04432831|588753052|FG001|Overall Study|Reason Not Specified|11|||
163013745|NCT04432831|588753053|FG002|Overall Study|Reason Not Specified|9|||
163013746|NCT04432831|588753051|FG000|Overall Study|Adverse Event|7|||
163013747|NCT04432831|588753052|FG001|Overall Study|Adverse Event|7|||
163013748|NCT04432831|588753053|FG002|Overall Study|Adverse Event|7|||
163013749|NCT04432831|588753051|FG000|Overall Study|Physician Decision|1|||
163013750|NCT04432831|588753052|FG001|Overall Study|Physician Decision|3|||
163013751|NCT04432831|588753053|FG002|Overall Study|Physician Decision|6|||
163013752|NCT04432831|588753051|FG000|Overall Study|Protocol Violation|1|||
163013753|NCT04432831|588753052|FG001|Overall Study|Protocol Violation|0|||
163013754|NCT04432831|588753053|FG002|Overall Study|Protocol Violation|2|||
163013755|NCT04432831|588753051|FG000|Overall Study|Pregnancy|0|||
163013756|NCT04432831|588753052|FG001|Overall Study|Pregnancy|1|||
163013757|NCT04432831|588753053|FG002|Overall Study|Pregnancy|0|||
163013758|NCT04432831|588753051|FG000|Overall Study|Lack of Efficacy|0|||
163013759|NCT04432831|588753052|FG001|Overall Study|Lack of Efficacy|0|||
163013760|NCT04432831|588753053|FG002|Overall Study|Lack of Efficacy|2|||
163013761|NCT03782792|588753054|FG000|Overall Study|Patient left the country|0|||
163013762|NCT03782792|588753055|FG001|Overall Study|Patient left the country|1|||
163013763|NCT03782792|588753054|FG000|Overall Study|Withdrawal by Subject|1|||
163013764|NCT03782792|588753055|FG001|Overall Study|Withdrawal by Subject|2|||
163013765|NCT00617890|588753056|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
163013766|NCT00617890|588753057|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
163013767|NCT00617890|588753058|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
163013768|NCT00617890|588753059|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
163013769|NCT00617890|588753056|FG000|Overall Study|Lack of Efficacy|23|||
163013770|NCT00617890|588753057|FG001|Overall Study|Lack of Efficacy|26|||
163013771|NCT00617890|588753058|FG002|Overall Study|Lack of Efficacy|30|||
163013772|NCT00617890|588753059|FG003|Overall Study|Lack of Efficacy|97|||
163013773|NCT00617890|588753056|FG000|Overall Study|Lost to Follow-up|0|||
163013774|NCT00617890|588753057|FG001|Overall Study|Lost to Follow-up|0|||
163013775|NCT00617890|588753058|FG002|Overall Study|Lost to Follow-up|1|||
163013776|NCT00617890|588753059|FG003|Overall Study|Lost to Follow-up|2|||
163013777|NCT00617890|588753056|FG000|Overall Study|Withdrawal by Subject|4|||
163013778|NCT00617890|588753057|FG001|Overall Study|Withdrawal by Subject|1|||
163013779|NCT00617890|588753058|FG002|Overall Study|Withdrawal by Subject|0|||
163013780|NCT00617890|588753059|FG003|Overall Study|Withdrawal by Subject|2|||
163013781|NCT00617890|588753056|FG000|Overall Study|Protocol Violation|2|||
163013782|NCT00617890|588753057|FG001|Overall Study|Protocol Violation|1|||
163013783|NCT00617890|588753058|FG002|Overall Study|Protocol Violation|0|||
163013784|NCT00617890|588753059|FG003|Overall Study|Protocol Violation|0|||
163013785|NCT00617890|588753056|FG000|Overall Study|Adverse Event|1|||
163013786|NCT00617890|588753057|FG001|Overall Study|Adverse Event|0|||
163013787|NCT00617890|588753058|FG002|Overall Study|Adverse Event|3|||
163013788|NCT00617890|588753059|FG003|Overall Study|Adverse Event|8|||
163013789|NCT00617890|588753056|FG000|Overall Study|Not treated|1|||
163013790|NCT00617890|588753057|FG001|Overall Study|Not treated|0|||
163013791|NCT00617890|588753058|FG002|Overall Study|Not treated|1|||
163013792|NCT00617890|588753059|FG003|Overall Study|Not treated|1|||
163013793|NCT00154284|588753063|FG000|Overall Study|Adverse Event|6|||
163013794|NCT00154284|588753064|FG001|Overall Study|Adverse Event|9|||
163013795|NCT00154284|588753063|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162640790|NCT00416078|587399953|FG000|Overall Study|Withdrawal by Subject|3|||
162640791|NCT00416078|587399954|FG001|Overall Study|Withdrawal by Subject|2|||
162640792|NCT00416078|587399953|FG000|Overall Study|Physician Decision|1|||
162640793|NCT00416078|587399954|FG001|Overall Study|Physician Decision|0|||
162640794|NCT00416078|587399953|FG000|Overall Study|Lost to Follow-up|4|||
163013796|NCT00154284|588753064|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163013797|NCT00154284|588753063|FG000|Overall Study|Lack of Efficacy|1|||
163013798|NCT00154284|588753064|FG001|Overall Study|Lack of Efficacy|2|||
163013799|NCT00154284|588753063|FG000|Overall Study|Protocol Violation|0|||
163013800|NCT00154284|588753064|FG001|Overall Study|Protocol Violation|1|||
163013801|NCT01295671|588753075|FG000|Overall Study|Lost to Follow-up|4|||
163013802|NCT01295671|588753076|FG001|Overall Study|Lost to Follow-up|6|||
163013803|NCT01295671|588753077|FG002|Overall Study|Lost to Follow-up|3|||
163013804|NCT01295671|588753075|FG000|Overall Study|Withdrawal by Subject|3|||
163013805|NCT01295671|588753076|FG001|Overall Study|Withdrawal by Subject|1|||
163013806|NCT01295671|588753077|FG002|Overall Study|Withdrawal by Subject|0|||
163013807|NCT02395848|588753078|FG000|Overall Study|Lost to Follow-up|2|||
163013808|NCT02276560|588753079|FG000|Overall Study|Adverse Event|1|||
163013809|NCT02276560|588753080|FG001|Overall Study|Adverse Event|0|||
163013810|NCT02276560|588753081|FG002|Overall Study|Adverse Event|0|||
163013811|NCT01609010|588753085|FG000|Overall Study|Stable disease (SD)|22|||
163013812|NCT01609010|588753086|FG001|Overall Study|Stable disease (SD)|16|||
163013813|NCT01609010|588753085|FG000|Overall Study|Progressive disease (PD)|8|||
163013814|NCT01609010|588753086|FG001|Overall Study|Progressive disease (PD)|10|||
163013815|NCT01609010|588753085|FG000|Overall Study|Adverse Event|3|||
163013816|NCT01609010|588753086|FG001|Overall Study|Adverse Event|6|||
163013817|NCT01609010|588753085|FG000|Overall Study|Withdrawal by Subject|2|||
163013818|NCT01609010|588753086|FG001|Overall Study|Withdrawal by Subject|2|||
163013819|NCT01609010|588753085|FG000|Overall Study|Other|2|||
163013820|NCT01609010|588753086|FG001|Overall Study|Other|0|||
163013821|NCT01609010|588753085|FG000|Overall Study|Other malignancy|1|||
163013822|NCT01609010|588753086|FG001|Overall Study|Other malignancy|0|||
163013823|NCT01609010|588753085|FG000|Overall Study|Pathology review|2|||
163013824|NCT01609010|588753086|FG001|Overall Study|Pathology review|1|||
163013825|NCT01609010|588753085|FG000|Overall Study|Protocol Violation|1|||
163013826|NCT01609010|588753086|FG001|Overall Study|Protocol Violation|1|||
163013827|NCT01609010|588753085|FG000|Overall Study|New cancer|1|||
163013828|NCT01609010|588753086|FG001|Overall Study|New cancer|0|||
163013829|NCT01609010|588753085|FG000|Overall Study|Lost to Follow-up|1|||
163013830|NCT01609010|588753086|FG001|Overall Study|Lost to Follow-up|1|||
163013831|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
163013832|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
163013833|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
163013834|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
163013835|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
163013836|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
163013837|NCT01134107|588753088|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
163013838|NCT01134107|588753089|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
163013839|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
163013840|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
163013841|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
163013842|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
163013843|NCT01134107|588753088|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
163013844|NCT01134107|588753089|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
163013845|NCT04541589|588753095|FG000|Treatment Period|Adverse Event|8|||
163013846|NCT04541589|588753096|FG001|Treatment Period|Adverse Event|2|||
163013847|NCT04541589|588753095|FG000|Treatment Period|Physician Decision|3|||
163013848|NCT04541589|588753096|FG001|Treatment Period|Physician Decision|1|||
163013849|NCT04541589|588753095|FG000|Treatment Period|Subject decision|7|||
163013850|NCT04541589|588753096|FG001|Treatment Period|Subject decision|4|||
163013851|NCT04541589|588753095|FG000|Treatment Period|Withdrawal by Subject|1|||
163013852|NCT04541589|588753096|FG001|Treatment Period|Withdrawal by Subject|0|||
163013853|NCT04541589|588753095|FG000|Safety Follow-up Period|Adverse Event|2|||
163013854|NCT04541589|588753096|FG001|Safety Follow-up Period|Adverse Event|1|||
163013855|NCT04541589|588753095|FG000|Safety Follow-up Period|Physician Decision|1|||
163013856|NCT04541589|588753096|FG001|Safety Follow-up Period|Physician Decision|0|||
163013857|NCT04541589|588753095|FG000|Safety Follow-up Period|Subject decision|5|||
163013858|NCT04541589|588753096|FG001|Safety Follow-up Period|Subject decision|3|||
163013859|NCT04541589|588753095|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
163013860|NCT04541589|588753096|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
163013861|NCT03581123|588753099|FG000|2-month Follow-up|Withdrawal by Subject|5|||
163013862|NCT03581123|588753100|FG001|2-month Follow-up|Withdrawal by Subject|4|||
163013863|NCT03581123|588753101|FG002|2-month Follow-up|Withdrawal by Subject|6|||
163013864|NCT03581123|588753102|FG003|2-month Follow-up|Withdrawal by Subject|4|||
163013865|NCT03581123|588753099|FG000|2-month Follow-up|Lost to Follow-up|8|||
163013866|NCT03581123|588753100|FG001|2-month Follow-up|Lost to Follow-up|1|||
163013867|NCT03581123|588753101|FG002|2-month Follow-up|Lost to Follow-up|2|||
163013868|NCT03581123|588753102|FG003|2-month Follow-up|Lost to Follow-up|2|||
163013869|NCT03581123|588753099|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
163013870|NCT03581123|588753100|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
163013871|NCT03581123|588753101|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
163013872|NCT03581123|588753102|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
163013873|NCT03581123|588753099|FG000|6-Month Follow-up|Lost to Follow-up|3|||
163013874|NCT03581123|588753100|FG001|6-Month Follow-up|Lost to Follow-up|3|||
163013875|NCT03581123|588753101|FG002|6-Month Follow-up|Lost to Follow-up|1|||
163013876|NCT03581123|588753102|FG003|6-Month Follow-up|Lost to Follow-up|1|||
163013877|NCT03581123|588753099|FG000|12-Month Follow-up|Lost to Follow-up|4|||
163013878|NCT03581123|588753100|FG001|12-Month Follow-up|Lost to Follow-up|3|||
163013879|NCT03581123|588753101|FG002|12-Month Follow-up|Lost to Follow-up|4|||
163013880|NCT03581123|588753102|FG003|12-Month Follow-up|Lost to Follow-up|5|||
163013881|NCT04195685|588753103|FG000|Overall Study|Withdrawal by Subject|6|||
163013882|NCT04195685|588753104|FG001|Overall Study|Withdrawal by Subject|2|||
163013883|NCT04195685|588753103|FG000|Overall Study|Lost to Follow-up|1|||
163013884|NCT04195685|588753104|FG001|Overall Study|Lost to Follow-up|4|||
163013885|NCT03448419|588753108|FG000|Overall Study|Adverse Event|10|||
163013886|NCT03448419|588753109|FG001|Overall Study|Adverse Event|9|||
163013887|NCT03448419|588753108|FG000|Overall Study|Lost to Follow-up|0|||
163013888|NCT03448419|588753109|FG001|Overall Study|Lost to Follow-up|2|||
163013889|NCT03448419|588753108|FG000|Overall Study|Withdrawal by Subject|3|||
163013890|NCT03448419|588753109|FG001|Overall Study|Withdrawal by Subject|1|||
163013891|NCT03448419|588753108|FG000|Overall Study|Not treated|0|||
163013892|NCT03448419|588753109|FG001|Overall Study|Not treated|1|||
163013893|NCT03448419|588753108|FG000|Overall Study|Patient did not attend all visits|0|||
163013894|NCT03448419|588753109|FG001|Overall Study|Patient did not attend all visits|2|||
163013895|NCT03448419|588753108|FG000|Overall Study|Withdrawn by Sponsor|0|||
163013896|NCT03448419|588753109|FG001|Overall Study|Withdrawn by Sponsor|1|||
163013897|NCT04548193|588753120|FG000|Overall Study|Lost to Follow-up|0|||
163013898|NCT04548193|588753121|FG001|Overall Study|Lost to Follow-up|1|||
163013899|NCT04548193|588753120|FG000|Overall Study|Death|0|||
163013900|NCT04548193|588753121|FG001|Overall Study|Death|1|||
163013901|NCT04548193|588753120|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
163013902|NCT04548193|588753121|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
163013903|NCT04548193|588753120|FG000|Overall Study|Withdrawal by Subject|2|||
163013904|NCT04548193|588753121|FG001|Overall Study|Withdrawal by Subject|2|||
163013905|NCT00630825|588753122|FG000|Overall Study|Adverse Event|4|||
163013906|NCT00630825|588753123|FG001|Overall Study|Adverse Event|4|||
163013907|NCT00630825|588753124|FG002|Overall Study|Adverse Event|3|||
163013908|NCT00630825|588753125|FG003|Overall Study|Adverse Event|1|||
163013909|NCT00630825|588753122|FG000|Overall Study|Entry Criteria Not Met|1|||
163013910|NCT00630825|588753123|FG001|Overall Study|Entry Criteria Not Met|0|||
163013911|NCT00630825|588753124|FG002|Overall Study|Entry Criteria Not Met|2|||
163013912|NCT00630825|588753125|FG003|Overall Study|Entry Criteria Not Met|1|||
163013913|NCT00630825|588753122|FG000|Overall Study|Lost to Follow-up|1|||
163013914|NCT00630825|588753123|FG001|Overall Study|Lost to Follow-up|1|||
163013915|NCT00630825|588753124|FG002|Overall Study|Lost to Follow-up|1|||
163013916|NCT00630825|588753125|FG003|Overall Study|Lost to Follow-up|1|||
162716027|NCT03536884|587667093|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716028|NCT03536884|587667094|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716029|NCT03536884|587667095|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716030|NCT03536884|587667096|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716031|NCT03536884|587667097|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716032|NCT03536884|587667098|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716033|NCT03536884|587667099|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716034|NCT03536884|587667100|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716035|NCT03536884|587667101|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162716036|NCT03536884|587667102|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
162716037|NCT03536884|587667091|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716038|NCT03536884|587667092|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716039|NCT03536884|587667093|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716040|NCT03536884|587667094|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716041|NCT03536884|587667095|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716042|NCT03536884|587667096|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716043|NCT03536884|587667097|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716044|NCT03536884|587667098|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716045|NCT03536884|587667099|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716046|NCT03536884|587667100|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716047|NCT03536884|587667101|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162716048|NCT03536884|587667102|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
162716049|NCT03722446|587667103|FG000|Overall Study|Protocol Violation|15|||
162716050|NCT03722446|587667104|FG001|Overall Study|Protocol Violation|2|||
162716051|NCT04487080|587667111|FG000|Overall Study|Withdrawal by Subject|19|||
162716052|NCT04487080|587667112|FG001|Overall Study|Withdrawal by Subject|18|||
162716053|NCT04487080|587667113|FG002|Overall Study|Withdrawal by Subject|13|||
162716054|NCT04487080|587667111|FG000|Overall Study|Lost to Follow-up|3|||
162716055|NCT04487080|587667112|FG001|Overall Study|Lost to Follow-up|1|||
162716056|NCT04487080|587667113|FG002|Overall Study|Lost to Follow-up|0|||
163013917|NCT00630825|588753122|FG000|Overall Study|Physician Decision|1|||
163013918|NCT00630825|588753123|FG001|Overall Study|Physician Decision|0|||
163013919|NCT00630825|588753124|FG002|Overall Study|Physician Decision|0|||
163013920|NCT00630825|588753125|FG003|Overall Study|Physician Decision|0|||
163013921|NCT00630825|588753122|FG000|Overall Study|Withdrawal by Subject|2|||
163013922|NCT00630825|588753123|FG001|Overall Study|Withdrawal by Subject|2|||
163013923|NCT00630825|588753124|FG002|Overall Study|Withdrawal by Subject|2|||
163013924|NCT00630825|588753125|FG003|Overall Study|Withdrawal by Subject|3|||
163013925|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
163013926|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
163013927|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
163013928|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
163013929|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
163013930|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
163013931|NCT01081769|588753128|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
163013932|NCT01081769|588753129|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
163013933|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Adverse Event|14|||
163013934|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Adverse Event|11|||
163013935|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Death|1|||
163013936|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Death|1|||
163013937|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
163013938|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
163013939|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
163013940|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
163013941|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Pregnancy|1|||
163013942|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Pregnancy|0|||
163013943|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
163013944|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
163013945|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
163013946|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
163013947|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Other|0|||
163013948|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Other|1|||
163013949|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Ineligibility|3|||
163013950|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Ineligibility|4|||
163013951|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
163013952|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
163013953|NCT01081769|588753128|FG000|CORE Intent-To-Treat|Patient Moved|2|||
163013954|NCT01081769|588753129|FG001|CORE Intent-To-Treat|Patient Moved|2|||
163013955|NCT00558701|588753133|FG000|Overall Study|Protocol Deviations|1|||
163013956|NCT00558701|588753134|FG001|Overall Study|Protocol Deviations|4|||
163013957|NCT00427648|588753135|FG000|Overall Study|Protocol Violation|1|||
163013958|NCT00427648|588753136|FG001|Overall Study|Protocol Violation|2|||
163013959|NCT00427648|588753135|FG000|Overall Study|Adverse Event|0|||
163013960|NCT00427648|588753136|FG001|Overall Study|Adverse Event|1|||
163013961|NCT02187198|588753137|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
163013962|NCT02187198|588753138|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
163013963|NCT02187198|588753137|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
163013964|NCT02187198|588753138|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
163013965|NCT00546377|588753139|FG000|Overall Study|Deemed ineligible|1|||
163013966|NCT00546377|588753139|FG000|Overall Study|Adverse Event|6|||
163013967|NCT01532518|588753140|FG000|Overall Study|Withdrawal by Subject|0|||
163013968|NCT01532518|588753141|FG001|Overall Study|Withdrawal by Subject|0|||
163013969|NCT01532518|588753142|FG002|Overall Study|Withdrawal by Subject|1|||
163013970|NCT01575834|588753143|FG000|Overall Study|Withdrawal by Subject|352|||
163013971|NCT01575834|588753144|FG001|Overall Study|Withdrawal by Subject|390|||
163013972|NCT01575834|588753143|FG000|Overall Study|Death|81|||
163013973|NCT01575834|588753144|FG001|Overall Study|Death|74|||
163013974|NCT01575834|588753143|FG000|Overall Study|Other|70|||
163013975|NCT01575834|588753144|FG001|Overall Study|Other|70|||
163013976|NCT01575834|588753143|FG000|Overall Study|Adverse Event|63|||
163013977|NCT01575834|588753144|FG001|Overall Study|Adverse Event|61|||
163013978|NCT01575834|588753143|FG000|Overall Study|Lost to Follow-up|55|||
163013979|NCT01575834|588753144|FG001|Overall Study|Lost to Follow-up|68|||
163013980|NCT01575834|588753143|FG000|Overall Study|Noncompliance|52|||
163013981|NCT01575834|588753144|FG001|Overall Study|Noncompliance|27|||
163013982|NCT01575834|588753143|FG000|Overall Study|Administrative decision|15|||
163013983|NCT01575834|588753144|FG001|Overall Study|Administrative decision|33|||
163013984|NCT01575834|588753143|FG000|Overall Study|Ineligibility Determined|5|||
163013985|NCT01575834|588753144|FG001|Overall Study|Ineligibility Determined|8|||
163013986|NCT01575834|588753143|FG000|Overall Study|Protocol Deviation|4|||
163013987|NCT01575834|588753144|FG001|Overall Study|Protocol Deviation|3|||
163013988|NCT01575834|588753143|FG000|Overall Study|Requirement for Alternative Therapy|2|||
163013989|NCT01575834|588753144|FG001|Overall Study|Requirement for Alternative Therapy|4|||
162640795|NCT00416078|587399954|FG001|Overall Study|Lost to Follow-up|2|||
163013990|NCT00488644|588753145|FG000|Overall Study|Not Eligible|1|||
163013991|NCT00488644|588753145|FG000|Overall Study|Not Evaluable|1|||
163013992|NCT01956773|588753150|FG000|Overall Study|Lost to Follow-up|628|||
163013993|NCT01956773|588753151|FG001|Overall Study|Lost to Follow-up|1|||
163013994|NCT01383174|588753154|FG000|3 Month Assessment|Death|0|||
163013995|NCT01383174|588753155|FG001|3 Month Assessment|Death|1|||
163013996|NCT01383174|588753154|FG000|3 Month Assessment|Lost to Follow-up|2|||
163013997|NCT01383174|588753155|FG001|3 Month Assessment|Lost to Follow-up|0|||
163013998|NCT01383174|588753154|FG000|3 Month Assessment|Refused to complete|4|||
163013999|NCT01383174|588753155|FG001|3 Month Assessment|Refused to complete|0|||
163014000|NCT01383174|588753154|FG000|6 Month Assessment|Lost to Follow-up|1|||
163014001|NCT01383174|588753155|FG001|6 Month Assessment|Lost to Follow-up|1|||
163014002|NCT01383174|588753154|FG000|6 Month Assessment|Refused to complete|4|||
163014003|NCT01383174|588753155|FG001|6 Month Assessment|Refused to complete|0|||
163014004|NCT01153815|588753156|FG000|Overall Study|Adverse Event|3|||
163014005|NCT01153815|588753157|FG001|Overall Study|Adverse Event|1|||
163014006|NCT01153815|588753156|FG000|Overall Study|Withdrawal by Subject|6|||
163014007|NCT01153815|588753157|FG001|Overall Study|Withdrawal by Subject|4|||
163014008|NCT02169271|588753160|FG000|Overall Study|Protocol Violation|1|||
163014009|NCT02169271|588753161|FG001|Overall Study|Protocol Violation|2|||
163014010|NCT03591874|588753166|FG000|Overall Study|Adverse Event|4|||
163014011|NCT03591874|588753167|FG001|Overall Study|Adverse Event|0|||
163014012|NCT03591874|588753166|FG000|Overall Study|Withdrawal by Subject|2|||
163014013|NCT03591874|588753167|FG001|Overall Study|Withdrawal by Subject|1|||
163014014|NCT03591874|588753166|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
163014015|NCT03591874|588753167|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
163014016|NCT03591874|588753166|FG000|Overall Study|On Study at Time of Study Termination|12|||
163014017|NCT03591874|588753167|FG001|Overall Study|On Study at Time of Study Termination|6|||
163014018|NCT03859427|588753168|FG000|Overall Study|Withdrawal by Subject|4|||
163014019|NCT03859427|588753169|FG001|Overall Study|Withdrawal by Subject|7|||
163014020|NCT03859427|588753168|FG000|Overall Study|Decision by sponsor|0|||
163014021|NCT03859427|588753169|FG001|Overall Study|Decision by sponsor|3|||
163014022|NCT03859427|588753168|FG000|Overall Study|Lost to Follow-up|3|||
163014023|NCT03859427|588753169|FG001|Overall Study|Lost to Follow-up|2|||
163014024|NCT03859427|588753168|FG000|Overall Study|Death|22|||
163014025|NCT03859427|588753169|FG001|Overall Study|Death|25|||
163014026|NCT04031846|588753170|FG000|Overall Study|Lost to Follow-up|4|||
163014027|NCT04031846|588753171|FG001|Overall Study|Lost to Follow-up|4|||
163014028|NCT04031846|588753170|FG000|Overall Study|Physician Decision|0|||
163014029|NCT04031846|588753171|FG001|Overall Study|Physician Decision|1|||
163014030|NCT04031846|588753170|FG000|Overall Study|Protocol Violation|1|||
163014031|NCT04031846|588753171|FG001|Overall Study|Protocol Violation|1|||
163014032|NCT04031846|588753170|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
163014033|NCT04031846|588753171|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
163014034|NCT02431676|588753172|FG000|Overall Study|no lab obtained|0|||
163014035|NCT02431676|588753173|FG001|Overall Study|no lab obtained|1|||
163014036|NCT02431676|588753174|FG002|Overall Study|no lab obtained|2|||
163014037|NCT00571727|588753175|FG000|Overall Study|Did not enter in this study|1|||
163014038|NCT00571727|588753175|FG000|Overall Study|Non-compliance|4|||
163014039|NCT00571727|588753175|FG000|Overall Study|Lost to Follow-up|30|||
163014040|NCT00571727|588753175|FG000|Overall Study|Poor growth|1|||
163014041|NCT00571727|588753175|FG000|Overall Study|Parent/patient decision|2|||
163014042|NCT00571727|588753175|FG000|Overall Study|Participant transferred to commercial drug|14|||
163014043|NCT00571727|588753175|FG000|Overall Study|Unable to provide study drug|6|||
163014044|NCT00571727|588753175|FG000|Overall Study|On-treatment at end of study|8|||
163014045|NCT01622673|588753176|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163014046|NCT01622673|588753177|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163014047|NCT01622673|588753178|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163014048|NCT01622673|588753179|FG003|Treatment Period 1|Withdrawal by Subject|1|||
163014049|NCT01622673|588753180|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163014050|NCT01622673|588753181|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163014051|NCT01622673|588753176|FG000|Treatment Period 1|Protocol Violation|0|||
162640796|NCT02998840|587399963|FG000|Overall Study|Lost to Follow-up|1|||
162640797|NCT02998840|587399964|FG001|Overall Study|Lost to Follow-up|1|||
163014052|NCT01622673|588753177|FG001|Treatment Period 1|Protocol Violation|1|||
163014053|NCT01622673|588753178|FG002|Treatment Period 1|Protocol Violation|0|||
163014054|NCT01622673|588753179|FG003|Treatment Period 1|Protocol Violation|0|||
163014055|NCT01622673|588753180|FG004|Treatment Period 1|Protocol Violation|0|||
163014056|NCT01622673|588753181|FG005|Treatment Period 1|Protocol Violation|0|||
163014057|NCT01622673|588753176|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162640798|NCT02998840|587399965|FG002|Overall Study|Lost to Follow-up|2|||
163014058|NCT01622673|588753177|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163014059|NCT01622673|588753178|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163014060|NCT01622673|588753179|FG003|Treatment Period 2|Withdrawal by Subject|1|||
163014061|NCT01622673|588753180|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163014062|NCT01622673|588753181|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163014063|NCT01622673|588753176|FG000|Treatment Period 3|Protocol Violation|0|||
163014064|NCT01622673|588753177|FG001|Treatment Period 3|Protocol Violation|1|||
163014065|NCT01622673|588753178|FG002|Treatment Period 3|Protocol Violation|0|||
163014066|NCT01622673|588753179|FG003|Treatment Period 3|Protocol Violation|0|||
163014067|NCT01622673|588753180|FG004|Treatment Period 3|Protocol Violation|0|||
163014068|NCT01622673|588753181|FG005|Treatment Period 3|Protocol Violation|0|||
163014069|NCT02058537|588755000|FG000|Overall Study|Withdrawal by Subject|1|||
163014070|NCT02126579|588755001|FG000|Overall Study|disease progression|0|||
163014071|NCT02126579|588755002|FG001|Overall Study|disease progression|0|||
163014072|NCT02126579|588755003|FG002|Overall Study|disease progression|0|||
163014073|NCT02126579|588755004|FG003|Overall Study|disease progression|1|||
163014074|NCT02126579|588755005|FG004|Overall Study|disease progression|0|||
163014075|NCT02126579|588755006|FG005|Overall Study|disease progression|0|||
163014076|NCT02126579|588755007|FG006|Overall Study|disease progression|1|||
163014077|NCT01780038|588755010|FG000|Overall Study|Lost to Follow-up|4|||
163014078|NCT01780038|588755011|FG001|Overall Study|Lost to Follow-up|1|||
163014079|NCT02366637|588755012|FG000|First Intervention Period|Adverse Event|0|||
163014080|NCT02366637|588755013|FG001|First Intervention Period|Adverse Event|1|||
163014081|NCT02366637|588755012|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
163014082|NCT02366637|588755013|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
163014083|NCT02366637|588755012|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
163014084|NCT02366637|588755013|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
163014085|NCT00455403|588755024|FG000|Overall Study|Lost to Follow-up|2|||
163014086|NCT00455403|588755025|FG001|Overall Study|Lost to Follow-up|1|||
163014087|NCT00455403|588755024|FG000|Overall Study|Withdrawal by Subject|1|||
163014088|NCT00455403|588755025|FG001|Overall Study|Withdrawal by Subject|3|||
163014089|NCT00455403|588755024|FG000|Overall Study|Protocol Violation|0|||
163014090|NCT00455403|588755025|FG001|Overall Study|Protocol Violation|2|||
163014091|NCT04509076|588755026|FG000|Overall Study|Withdrawal by Subject|1|||
163014092|NCT04509076|588755027|FG001|Overall Study|Withdrawal by Subject|2|||
163014093|NCT04509076|588755026|FG000|Overall Study|Lost to Follow-up|1|||
163014094|NCT04509076|588755027|FG001|Overall Study|Lost to Follow-up|2|||
163014095|NCT03351608|588755028|FG000|Overall Study|Lost to Follow-up|0|||
163014096|NCT03351608|588755029|FG001|Overall Study|Lost to Follow-up|1|||
163014097|NCT03351608|588755030|FG002|Overall Study|Lost to Follow-up|1|||
163014098|NCT03351608|588755031|FG003|Overall Study|Lost to Follow-up|1|||
163014099|NCT03351608|588755032|FG004|Overall Study|Lost to Follow-up|1|||
163014100|NCT03351608|588755028|FG000|Overall Study|Physician Decision|1|||
163014101|NCT03351608|588755029|FG001|Overall Study|Physician Decision|0|||
163014102|NCT03351608|588755030|FG002|Overall Study|Physician Decision|0|||
163014103|NCT03351608|588755031|FG003|Overall Study|Physician Decision|2|||
163014104|NCT03351608|588755032|FG004|Overall Study|Physician Decision|1|||
163014105|NCT03351608|588755028|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
163014106|NCT03351608|588755029|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
163014107|NCT03351608|588755030|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
163014108|NCT03351608|588755031|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
163014109|NCT03351608|588755032|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
163014110|NCT03351608|588755028|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163014111|NCT03351608|588755029|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163014112|NCT03351608|588755030|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163014113|NCT03351608|588755031|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163014114|NCT03351608|588755032|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163062763|NCT04478266|588936942|FG000|Overall Study|Adverse Event|20|||
163062764|NCT04478266|588936943|FG001|Overall Study|Adverse Event|21|||
163062765|NCT04478266|588936942|FG000|Overall Study|Progressive disease|146|||
163062766|NCT04478266|588936943|FG001|Overall Study|Progressive disease|168|||
163062767|NCT04478266|588936942|FG000|Overall Study|Poor compliance to protocol|1|||
163062768|NCT04478266|588936943|FG001|Overall Study|Poor compliance to protocol|0|||
162716057|NCT04487080|587667111|FG000|Overall Study|Ongoing|313|||
163014115|NCT03351608|588755028|FG000|Overall Study|Other|0|||
163014116|NCT03351608|588755029|FG001|Overall Study|Other|1|||
163014117|NCT03351608|588755030|FG002|Overall Study|Other|1|||
163014118|NCT03351608|588755031|FG003|Overall Study|Other|3|||
163014119|NCT03351608|588755032|FG004|Overall Study|Other|0|||
163014120|NCT02877004|588755033|FG000|Overall Study|Pregnancy|0|||
163014121|NCT02877004|588755034|FG001|Overall Study|Pregnancy|0|||
163014122|NCT02877004|588755035|FG002|Overall Study|Pregnancy|1|||
163014123|NCT02727478|588755036|FG000|Overall Study|Withdrawal by Subject|8|||
163014124|NCT02727478|588755037|FG001|Overall Study|Withdrawal by Subject|10|||
163014125|NCT00502242|588755040|FG000|Overall Study|Lack of Efficacy|1|||
163014126|NCT00502242|588755041|FG001|Overall Study|Lack of Efficacy|11|||
163062769|NCT04478266|588936942|FG000|Overall Study|Withdrawal by Subject|19|||
163062770|NCT04478266|588936943|FG001|Overall Study|Withdrawal by Subject|16|||
163014127|NCT00502242|588755040|FG000|Overall Study|Adverse Event|31|||
163014128|NCT00502242|588755041|FG001|Overall Study|Adverse Event|20|||
163014129|NCT00502242|588755040|FG000|Overall Study|Physician Decision|2|||
163014130|NCT00502242|588755041|FG001|Overall Study|Physician Decision|3|||
163014131|NCT00502242|588755040|FG000|Overall Study|Other - Unspecified|8|||
163014132|NCT00502242|588755041|FG001|Overall Study|Other - Unspecified|14|||
163014133|NCT00502242|588755040|FG000|Overall Study|Protocol Violation|3|||
163014134|NCT00502242|588755041|FG001|Overall Study|Protocol Violation|1|||
163014135|NCT00502242|588755040|FG000|Overall Study|Withdrawal by Subject|6|||
163014136|NCT00502242|588755041|FG001|Overall Study|Withdrawal by Subject|7|||
163014137|NCT00778817|588755042|FG000|Overall Study|Adverse Event|2|||
163014138|NCT00778817|588755042|FG000|Overall Study|Withdrawal by Subject|2|||
163014139|NCT02509507|588755043|FG000|Overall Study|Death|21|||
163014140|NCT02509507|588755044|FG001|Overall Study|Death|3|||
163014141|NCT02509507|588755045|FG002|Overall Study|Death|22|||
163014142|NCT02509507|588755046|FG003|Overall Study|Death|14|||
163014143|NCT02509507|588755047|FG004|Overall Study|Death|8|||
163014144|NCT02509507|588755048|FG005|Overall Study|Death|12|||
163014145|NCT02509507|588755049|FG006|Overall Study|Death|5|||
163014146|NCT02509507|588755050|FG007|Overall Study|Death|4|||
163014147|NCT02509507|588755051|FG008|Overall Study|Death|8|||
163014148|NCT02509507|588755043|FG000|Overall Study|Lost to Follow-up|0|||
163014149|NCT02509507|588755044|FG001|Overall Study|Lost to Follow-up|1|||
163014150|NCT02509507|588755045|FG002|Overall Study|Lost to Follow-up|0|||
163014151|NCT02509507|588755046|FG003|Overall Study|Lost to Follow-up|0|||
163014152|NCT02509507|588755047|FG004|Overall Study|Lost to Follow-up|0|||
163014153|NCT02509507|588755048|FG005|Overall Study|Lost to Follow-up|2|||
163014154|NCT02509507|588755049|FG006|Overall Study|Lost to Follow-up|0|||
163014155|NCT02509507|588755050|FG007|Overall Study|Lost to Follow-up|0|||
163014156|NCT02509507|588755051|FG008|Overall Study|Lost to Follow-up|0|||
163014157|NCT02509507|588755043|FG000|Overall Study|Withdrawal by Subject|2|||
163014158|NCT02509507|588755044|FG001|Overall Study|Withdrawal by Subject|0|||
163014159|NCT02509507|588755045|FG002|Overall Study|Withdrawal by Subject|1|||
163014160|NCT02509507|588755046|FG003|Overall Study|Withdrawal by Subject|4|||
163014161|NCT02509507|588755047|FG004|Overall Study|Withdrawal by Subject|1|||
163014162|NCT02509507|588755048|FG005|Overall Study|Withdrawal by Subject|3|||
163014163|NCT02509507|588755049|FG006|Overall Study|Withdrawal by Subject|4|||
163014164|NCT02509507|588755050|FG007|Overall Study|Withdrawal by Subject|0|||
163014165|NCT02509507|588755051|FG008|Overall Study|Withdrawal by Subject|1|||
163014166|NCT02356588|588755052|FG000|Overall Study|Lack of Efficacy|4|||
163014167|NCT02356588|588755053|FG001|Overall Study|Lack of Efficacy|10|||
163014168|NCT02356588|588755052|FG000|Overall Study|Adverse Event|0|||
163014169|NCT02356588|588755053|FG001|Overall Study|Adverse Event|2|||
163014170|NCT02356588|588755052|FG000|Overall Study|Withdrawal by Subject|1|||
163014171|NCT02356588|588755053|FG001|Overall Study|Withdrawal by Subject|0|||
163014172|NCT02356588|588755052|FG000|Overall Study|Protocol Violation|0|||
163014173|NCT02356588|588755053|FG001|Overall Study|Protocol Violation|1|||
163014174|NCT01418378|588755054|FG000|Overall Study|Death|1|||
163014175|NCT01418378|588755055|FG001|Overall Study|Death|2|||
163014176|NCT01418378|588755054|FG000|Overall Study|Physician Decision|0|||
163014177|NCT01418378|588755055|FG001|Overall Study|Physician Decision|1|||
163014178|NCT01418378|588755054|FG000|Overall Study|ligament imbalance|0|||
163014179|NCT01418378|588755055|FG001|Overall Study|ligament imbalance|1|||
163014180|NCT01418378|588755054|FG000|Overall Study|developed chronic myopathy|0|||
163014181|NCT01418378|588755055|FG001|Overall Study|developed chronic myopathy|1|||
163014182|NCT01812109|588755058|FG000|Overall Study|research personnel delay|16|||
162640799|NCT02998840|587399966|FG003|Overall Study|Lost to Follow-up|3|||
163014183|NCT01812109|588755058|FG000|Overall Study|NIRS Unattainable|17|||
163014184|NCT04630002|588755059|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
163014185|NCT04630002|588755060|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014186|NCT04630002|588755061|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014187|NCT04630002|588755059|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
163014188|NCT04630002|588755060|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014189|NCT04630002|588755061|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
162640800|NCT02998840|587399963|FG000|Overall Study|Withdrawal by Subject|1|||
162640801|NCT02998840|587399964|FG001|Overall Study|Withdrawal by Subject|1|||
162640802|NCT02998840|587399965|FG002|Overall Study|Withdrawal by Subject|0|||
163014190|NCT04630002|588755059|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
163014191|NCT04630002|588755060|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
162640803|NCT02998840|587399966|FG003|Overall Study|Withdrawal by Subject|1|||
163014192|NCT04630002|588755061|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014193|NCT04630002|588755059|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014194|NCT04630002|588755060|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
163014195|NCT04630002|588755061|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
163014196|NCT04630002|588755059|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014197|NCT04630002|588755060|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
162640804|NCT02998840|587399963|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
163014198|NCT04630002|588755061|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
163014199|NCT04630002|588755059|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014200|NCT04630002|588755060|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
163014201|NCT04630002|588755061|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
163014202|NCT04630002|588755059|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
163014203|NCT04630002|588755060|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
163014204|NCT04630002|588755061|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
163014205|NCT04630002|588755059|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
163014206|NCT04630002|588755060|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
163014207|NCT04630002|588755061|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
163014208|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
163014209|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
163014210|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Death|0|||
163014211|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Death|1|||
163014212|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
163014213|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
163014214|NCT00442897|588755063|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
163014215|NCT00442897|588755064|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
163014216|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
163014217|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
163014218|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
163014219|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
163014220|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
163014221|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
163014222|NCT00442897|588755063|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
163014223|NCT00442897|588755064|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
163014224|NCT04498182|588755065|FG000|Overall Study|Adverse Event|2|||
163014225|NCT04498182|588755066|FG001|Overall Study|Adverse Event|3|||
163014226|NCT04498182|588755067|FG002|Overall Study|Adverse Event|2|||
163014227|NCT04498182|588755065|FG000|Overall Study|Withdrawal of Consent|3|||
163014228|NCT04498182|588755066|FG001|Overall Study|Withdrawal of Consent|4|||
163014229|NCT04498182|588755067|FG002|Overall Study|Withdrawal of Consent|3|||
163014230|NCT04498182|588755065|FG000|Overall Study|Non-Compliant|1|||
163014231|NCT04498182|588755066|FG001|Overall Study|Non-Compliant|0|||
163014232|NCT04498182|588755067|FG002|Overall Study|Non-Compliant|1|||
163014233|NCT04498182|588755065|FG000|Overall Study|Lost to Follow-up|0|||
163014234|NCT04498182|588755066|FG001|Overall Study|Lost to Follow-up|0|||
163014235|NCT04498182|588755067|FG002|Overall Study|Lost to Follow-up|1|||
163014236|NCT04498182|588755065|FG000|Overall Study|Investigator Decision|0|||
163014237|NCT04498182|588755066|FG001|Overall Study|Investigator Decision|0|||
163014238|NCT04498182|588755067|FG002|Overall Study|Investigator Decision|1|||
163014239|NCT04498182|588755065|FG000|Overall Study|Protocol Violation|1|||
163014240|NCT04498182|588755066|FG001|Overall Study|Protocol Violation|0|||
163014241|NCT04498182|588755067|FG002|Overall Study|Protocol Violation|2|||
163014242|NCT01372618|588755077|FG000|Overall Study|PI Died. Study Terminated|9|||
163014243|NCT04610346|588755078|FG000|Overall Study|Withdrawal by Subject|1|||
163014244|NCT04610346|588755079|FG001|Overall Study|Withdrawal by Subject|1|||
163014245|NCT04610346|588755078|FG000|Overall Study|did not complete shelter onboarding|2|||
163014246|NCT04610346|588755079|FG001|Overall Study|did not complete shelter onboarding|1|||
163014247|NCT00558467|588755080|FG000|Overall Study|Adverse Event|1|||
163014248|NCT00558467|588755081|FG001|Overall Study|Adverse Event|2|||
163014249|NCT00558467|588755080|FG000|Overall Study|Lack of Efficacy|0|||
163014250|NCT00558467|588755081|FG001|Overall Study|Lack of Efficacy|1|||
163014251|NCT00558467|588755080|FG000|Overall Study|Patient moving out of state|0|||
163014252|NCT00558467|588755081|FG001|Overall Study|Patient moving out of state|1|||
163014253|NCT00931255|588755082|FG000|Overall Study|Follow up biopsy not done|2|||
163014254|NCT00931255|588755083|FG001|Overall Study|Follow up biopsy not done|3|||
163014255|NCT02019264|588755084|FG000|Overall Study|Not treated|6|||
163014256|NCT02019264|588755085|FG001|Overall Study|Not treated|4|||
163014257|NCT02019264|588755084|FG000|Overall Study|Lost to Follow-up|50|||
163062771|NCT04478266|588936942|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
163062772|NCT04478266|588936943|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
162716058|NCT04487080|587667112|FG001|Overall Study|Ongoing|297|||
163014258|NCT02019264|588755085|FG001|Overall Study|Lost to Follow-up|47|||
163014259|NCT02019264|588755084|FG000|Overall Study|Withdrawal by Subject|142|||
163014260|NCT02019264|588755085|FG001|Overall Study|Withdrawal by Subject|117|||
163014261|NCT02019264|588755084|FG000|Overall Study|Administrative reason|36|||
163014262|NCT02019264|588755085|FG001|Overall Study|Administrative reason|28|||
163014263|NCT02019264|588755084|FG000|Overall Study|Missing|14|||
163014264|NCT02019264|588755085|FG001|Overall Study|Missing|11|||
163014265|NCT02220764|588755095|FG000|Overall Study|Lost to Follow-up|3|||
163014266|NCT02220764|588755096|FG001|Overall Study|Lost to Follow-up|1|||
163014267|NCT02220764|588755095|FG000|Overall Study|Death|1|||
163014268|NCT02220764|588755096|FG001|Overall Study|Death|0|||
163014269|NCT04526288|588755100|FG000|Overall Study|Disease Progression|1|||
163014270|NCT04526288|588755101|FG001|Overall Study|Disease Progression|0|||
163014271|NCT00952068|588755103|FG000|Overall Study|Adverse Event|3|||
163014272|NCT00952068|588755103|FG000|Overall Study|Withdrawal by Subject|4|||
163014273|NCT04926831|588755104|FG000|Overall Study|Withdrawal by Subject|2|||
163014274|NCT04926831|588755104|FG000|Overall Study|Adverse Event|2|||
163014275|NCT00564850|588755105|FG000|Overall Study|Protocol Violation|2|||
163014276|NCT01804946|588755106|FG000|Overall Study|Protocol Violation|1|||
163014277|NCT01804946|588755107|FG001|Overall Study|Protocol Violation|0|||
163014278|NCT01804946|588755106|FG000|Overall Study|Adverse Event|0|||
163014279|NCT01804946|588755107|FG001|Overall Study|Adverse Event|1|||
163014280|NCT01804946|588755106|FG000|Overall Study|Insufficient data available|0|||
163014281|NCT01804946|588755107|FG001|Overall Study|Insufficient data available|1|||
163014282|NCT01804946|588755106|FG000|Overall Study|Do not meet inclusion criteria|1|||
163014283|NCT01804946|588755107|FG001|Overall Study|Do not meet inclusion criteria|2|||
163014284|NCT01129557|588755109|FG000|Overall Study|Adverse Event|1|||
163014285|NCT01129557|588755110|FG001|Overall Study|Adverse Event|2|||
163014286|NCT01129557|588755111|FG002|Overall Study|Adverse Event|2|||
163014287|NCT01129557|588755109|FG000|Overall Study|Novartis terminated study early|3|||
163014288|NCT01129557|588755110|FG001|Overall Study|Novartis terminated study early|3|||
163014289|NCT01129557|588755111|FG002|Overall Study|Novartis terminated study early|2|||
163014290|NCT01486446|588755112|FG000|Overall Study|Adverse Event|1|||
163014291|NCT01486446|588755113|FG001|Overall Study|Adverse Event|0|||
163014292|NCT00669669|588755114|FG000|Overall Study|To late to start treatment|1|||
163014293|NCT04390113|588755115|FG000|Overall Study|Not Treated|0|||
163014294|NCT04390113|588755116|FG001|Overall Study|Not Treated|1|||
163014295|NCT04390113|588755115|FG000|Overall Study|Adverse Event|1|||
163014296|NCT04390113|588755116|FG001|Overall Study|Adverse Event|0|||
163014297|NCT04390113|588755115|FG000|Overall Study|Death|2|||
163014298|NCT04390113|588755116|FG001|Overall Study|Death|1|||
163014299|NCT04390113|588755115|FG000|Overall Study|Physician Decision|1|||
163014300|NCT04390113|588755116|FG001|Overall Study|Physician Decision|3|||
163014301|NCT04390113|588755115|FG000|Overall Study|Study Terminated by Sponsor|5|||
163014302|NCT04390113|588755116|FG001|Overall Study|Study Terminated by Sponsor|3|||
163014303|NCT04390113|588755115|FG000|Overall Study|Withdrawal by Subject|10|||
163014304|NCT04390113|588755116|FG001|Overall Study|Withdrawal by Subject|5|||
163014305|NCT04390113|588755115|FG000|Overall Study|Other|1|||
163014306|NCT04390113|588755116|FG001|Overall Study|Other|0|||
163014307|NCT04390113|588755115|FG000|Overall Study|Missing|0|||
163014308|NCT04390113|588755116|FG001|Overall Study|Missing|1|||
163014309|NCT01611883|588755117|FG000|Overall Study|Adverse Event|1|||
163014310|NCT01611883|588755118|FG001|Overall Study|Adverse Event|1|||
163014311|NCT03379727|588755120|FG000|Overall Study|Lack of Efficacy|73|||
163014312|NCT03379727|588755120|FG000|Overall Study|Adverse Event|32|||
163014313|NCT03379727|588755120|FG000|Overall Study|Death|18|||
163014314|NCT03379727|588755120|FG000|Overall Study|Patient/guardian decision|17|||
163014315|NCT03379727|588755120|FG000|Overall Study|Physician Decision|104|||
163014316|NCT03379727|588755120|FG000|Overall Study|Protocol Violation|4|||
163014317|NCT03379727|588755120|FG000|Overall Study|Lost to Follow-up|1|||
163014318|NCT00030901|588755124|FG000|Initial Registration|Ineligible|167|||
163014319|NCT00030901|588755125|FG001|Initial Registration|Ineligible|0|||
163014320|NCT00030901|588755126|FG002|Initial Registration|Ineligible|0|||
163014321|NCT00030901|588755124|FG000|Randomization|Adverse Event|0|||
163014322|NCT00030901|588755125|FG001|Randomization|Adverse Event|11|||
163014323|NCT00030901|588755126|FG002|Randomization|Adverse Event|7|||
163014324|NCT00030901|588755124|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
163014325|NCT00030901|588755125|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
163014326|NCT00030901|588755126|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
163014327|NCT00030901|588755124|FG000|Randomization|Progression/Relapse|0|||
163014328|NCT00030901|588755125|FG001|Randomization|Progression/Relapse|22|||
162716059|NCT04487080|587667113|FG002|Overall Study|Ongoing|149|||
163014329|NCT00030901|588755126|FG002|Randomization|Progression/Relapse|21|||
163014330|NCT00030901|588755124|FG000|Randomization|Death|0|||
163014331|NCT00030901|588755125|FG001|Randomization|Death|1|||
163014332|NCT00030901|588755126|FG002|Randomization|Death|3|||
163014333|NCT00030901|588755124|FG000|Randomization|Other|0|||
163014334|NCT00030901|588755125|FG001|Randomization|Other|36|||
163014335|NCT00030901|588755126|FG002|Randomization|Other|33|||
163014336|NCT00030901|588755124|FG000|Randomization|Ineligible|0|||
163014337|NCT00030901|588755125|FG001|Randomization|Ineligible|15|||
163014338|NCT00030901|588755126|FG002|Randomization|Ineligible|14|||
163014339|NCT02576847|588755129|FG000|Overall Study|Adverse Event|27|||
163014340|NCT02576847|588755129|FG000|Overall Study|Lost to Follow-up|22|||
163014341|NCT02576847|588755129|FG000|Overall Study|Physician Decision|1|||
163014342|NCT02576847|588755129|FG000|Overall Study|Pregnancy|1|||
163014343|NCT02576847|588755129|FG000|Overall Study|Protocol Violation|3|||
163014344|NCT02576847|588755129|FG000|Overall Study|Withdrawal by Subject|78|||
163014345|NCT02576847|588755129|FG000|Overall Study|Other|5|||
163014346|NCT01806051|588755130|FG000|Overall Study|Withdrawal by Subject|6|||
163014347|NCT02418182|588755133|FG000|Overall Study|Unable to re-consent|18|||
163014348|NCT02418182|588755134|FG001|Overall Study|Unable to re-consent|15|||
163014349|NCT02418182|588755133|FG000|Overall Study|Lost to Follow-up|0|||
163014350|NCT02418182|588755134|FG001|Overall Study|Lost to Follow-up|2|||
163014351|NCT01205776|588755135|FG000|Overall Study|Lost to Follow-up|53|||
163014352|NCT01205776|588755136|FG001|Overall Study|Lost to Follow-up|61|||
163014353|NCT01205776|588755135|FG000|Overall Study|Withdrawal by Subject|11|||
163014354|NCT01205776|588755136|FG001|Overall Study|Withdrawal by Subject|34|||
163014355|NCT01540487|588757117|FG000|Overall Study|Protocol Violation|1|||
163014356|NCT01540487|588757118|FG001|Overall Study|Protocol Violation|0|||
163014357|NCT03503370|588757119|FG000|Overall Study|Death|3|||
163014358|NCT03503370|588757120|FG001|Overall Study|Death|1|||
163014359|NCT03483961|588757121|FG000|Overall Study|Lost to Follow-up|7|||
163014360|NCT03483961|588757122|FG001|Overall Study|Lost to Follow-up|6|||
163014361|NCT03483961|588757123|FG002|Overall Study|Lost to Follow-up|6|||
163014362|NCT03483961|588757124|FG003|Overall Study|Lost to Follow-up|6|||
163014363|NCT03483961|588757125|FG004|Overall Study|Lost to Follow-up|6|||
163014364|NCT03483961|588757126|FG005|Overall Study|Lost to Follow-up|4|||
163014365|NCT03483961|588757127|FG006|Overall Study|Lost to Follow-up|4|||
163014366|NCT03483961|588757128|FG007|Overall Study|Lost to Follow-up|11|||
163014367|NCT03483961|588757129|FG008|Overall Study|Lost to Follow-up|1|||
163014368|NCT03483961|588757130|FG009|Overall Study|Lost to Follow-up|0|||
163014369|NCT03483961|588757121|FG000|Overall Study|Withdrawal by Subject|3|||
163014370|NCT03483961|588757122|FG001|Overall Study|Withdrawal by Subject|4|||
163014371|NCT03483961|588757123|FG002|Overall Study|Withdrawal by Subject|5|||
163014372|NCT03483961|588757124|FG003|Overall Study|Withdrawal by Subject|3|||
163014373|NCT03483961|588757125|FG004|Overall Study|Withdrawal by Subject|4|||
163014374|NCT03483961|588757126|FG005|Overall Study|Withdrawal by Subject|2|||
163014375|NCT03483961|588757127|FG006|Overall Study|Withdrawal by Subject|1|||
163014376|NCT03483961|588757128|FG007|Overall Study|Withdrawal by Subject|2|||
163014377|NCT03483961|588757129|FG008|Overall Study|Withdrawal by Subject|1|||
163014378|NCT03483961|588757130|FG009|Overall Study|Withdrawal by Subject|0|||
163014379|NCT03483961|588757121|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
163014380|NCT03483961|588757122|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014381|NCT03483961|588757123|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014382|NCT03483961|588757124|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014383|NCT03483961|588757125|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014384|NCT03483961|588757126|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014385|NCT03483961|588757127|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014386|NCT03483961|588757128|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014387|NCT03483961|588757129|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014388|NCT03483961|588757130|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
163014389|NCT03483961|588757121|FG000|Overall Study|Adverse Event|0|||
163014390|NCT03483961|588757122|FG001|Overall Study|Adverse Event|0|||
163014391|NCT03483961|588757123|FG002|Overall Study|Adverse Event|1|||
163014392|NCT03483961|588757124|FG003|Overall Study|Adverse Event|0|||
163014393|NCT03483961|588757125|FG004|Overall Study|Adverse Event|0|||
163014394|NCT03483961|588757126|FG005|Overall Study|Adverse Event|0|||
163014395|NCT03483961|588757127|FG006|Overall Study|Adverse Event|0|||
163014396|NCT03483961|588757128|FG007|Overall Study|Adverse Event|0|||
163014397|NCT03483961|588757129|FG008|Overall Study|Adverse Event|0|||
163014398|NCT03483961|588757130|FG009|Overall Study|Adverse Event|0|||
163014399|NCT00298272|588757131|FG000|Double-blind Phase|Adverse Event|2|||
163014400|NCT00298272|588757132|FG001|Double-blind Phase|Adverse Event|0|||
163014401|NCT00298272|588757131|FG000|Double-blind Phase|Failure to Return|2|||
163014402|NCT00298272|588757132|FG001|Double-blind Phase|Failure to Return|0|||
163014403|NCT00298272|588757131|FG000|Double-blind Phase|Protocol Violation|2|||
163014404|NCT00298272|588757132|FG001|Double-blind Phase|Protocol Violation|0|||
163014405|NCT00298272|588757131|FG000|Double-blind Phase|Withdrawal by Subject|2|||
163014406|NCT00298272|588757132|FG001|Double-blind Phase|Withdrawal by Subject|0|||
163014407|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Adverse Event|1|||
163014408|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Adverse Event|2|||
163014409|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
163014410|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
163014411|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Failure to Return|1|||
163014412|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Failure to Return|0|||
163014413|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
163014414|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
163014415|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
163014416|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
163154712|NCT02435992|589281386|FG001|Overall Study|Lack of Efficacy|10|||
163014417|NCT00298272|588757131|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
163014418|NCT00298272|588757132|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
163014419|NCT00298272|588757131|FG000|Safety Follow-up Phase|Failure to Return|1|||
163014420|NCT00298272|588757132|FG001|Safety Follow-up Phase|Failure to Return|1|||
163014421|NCT00298272|588757131|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
163014422|NCT00298272|588757132|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
163014423|NCT00298272|588757131|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
163014424|NCT00298272|588757132|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
163014425|NCT00326716|588757133|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
163014426|NCT00326716|588757134|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
163014427|NCT00326716|588757135|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
163014428|NCT00326716|588757136|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
163014429|NCT00684411|588757137|FG000|Overall Study|New Primary Cancer|1|||
163014430|NCT00684411|588757137|FG000|Overall Study|Disease Progression|10|||
163014431|NCT00684411|588757137|FG000|Overall Study|Adverse Event|1|||
163014432|NCT00734162|588757138|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
163014433|NCT00734162|588757139|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
163014434|NCT00734162|588757140|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
163014435|NCT00734162|588757141|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
163014436|NCT00734162|588757138|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014437|NCT00734162|588757139|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014438|NCT00734162|588757140|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
163014439|NCT00734162|588757141|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
163014440|NCT00734162|588757138|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
163014441|NCT00734162|588757139|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014442|NCT00734162|588757140|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014443|NCT00734162|588757141|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
163014444|NCT00734162|588757138|FG000|Open-Label Phase|Withdrew Consent|1|||
163014445|NCT00734162|588757139|FG001|Open-Label Phase|Withdrew Consent|0|||
163014446|NCT00734162|588757140|FG002|Open-Label Phase|Withdrew Consent|1|||
163014447|NCT00734162|588757141|FG003|Open-Label Phase|Withdrew Consent|1|||
163014448|NCT00734162|588757138|FG000|Open-Label Phase|Lost to Follow-up|1|||
163014449|NCT00734162|588757139|FG001|Open-Label Phase|Lost to Follow-up|2|||
163014450|NCT00734162|588757140|FG002|Open-Label Phase|Lost to Follow-up|0|||
163014451|NCT00734162|588757141|FG003|Open-Label Phase|Lost to Follow-up|1|||
163014452|NCT00734162|588757138|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014453|NCT00734162|588757139|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014454|NCT00734162|588757140|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
163014455|NCT00734162|588757141|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
163014456|NCT05253573|588757142|FG000|Overall Study|Death|1|||
163014457|NCT05253573|588757143|FG001|Overall Study|Death|0|||
163014458|NCT01344824|588757144|FG000|Overall Study|Adverse Event|15|||
163014459|NCT01344824|588757144|FG000|Overall Study|Withdrawal by Subject|6|||
163014460|NCT01344824|588757144|FG000|Overall Study|Other complicating disease|1|||
163014461|NCT01344824|588757144|FG000|Overall Study|Progression|15|||
163014462|NCT00566020|588757145|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
163014463|NCT00566020|588757146|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
163014464|NCT00566020|588757145|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
163014465|NCT00566020|588757146|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
163014466|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
163062773|NCT04478266|588936942|FG000|Overall Study|Study terminated by sponsor|33|||
163062774|NCT04478266|588936943|FG001|Overall Study|Study terminated by sponsor|35|||
163062775|NCT04478266|588936942|FG000|Overall Study|Other: unspecified|5|||
163062776|NCT04478266|588936943|FG001|Overall Study|Other: unspecified|7|||
163062777|NCT04478266|588936942|FG000|Overall Study|Randomized but not treated|1|||
163062778|NCT04478266|588936943|FG001|Overall Study|Randomized but not treated|1|||
163014467|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
163014468|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
163014469|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
163014470|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
163014471|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
163014472|NCT00566020|588757145|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
163062779|NCT04058717|588936944|FG000|Randomization Period|Lost to Follow-up|2|||
163154713|NCT02435992|589281387|FG002|Overall Study|Lack of Efficacy|9|||
163154714|NCT02435992|589281388|FG003|Overall Study|Lack of Efficacy|0|||
163154715|NCT02435992|589281389|FG004|Overall Study|Lack of Efficacy|0|||
163154716|NCT02435992|589281385|FG000|Overall Study|Withdrawal by Subject|10|||
163154717|NCT02435992|589281386|FG001|Overall Study|Withdrawal by Subject|8|||
163154718|NCT02435992|589281387|FG002|Overall Study|Withdrawal by Subject|20|||
163154719|NCT02435992|589281388|FG003|Overall Study|Withdrawal by Subject|0|||
163154720|NCT02435992|589281389|FG004|Overall Study|Withdrawal by Subject|0|||
162640805|NCT02998840|587399964|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
163014473|NCT00566020|588757146|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
163014474|NCT01754129|588757147|FG000|Overall Study|Death|13|||
163014475|NCT01754129|588757147|FG000|Overall Study|Duodopa discontinuation|9|||
163014476|NCT01754129|588757147|FG000|Overall Study|Lost to Follow-up|7|||
163014477|NCT01754129|588757147|FG000|Overall Study|Withdrew consent|1|||
163014478|NCT01754129|588757147|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
163014479|NCT01085630|588757148|FG000|Overall Study|Insufficient data|1|||
163014480|NCT01085630|588757149|FG001|Overall Study|Insufficient data|0|||
163014481|NCT01085630|588757148|FG000|Overall Study|Ineligible|3|||
163014482|NCT01085630|588757149|FG001|Overall Study|Ineligible|0|||
163014483|NCT02609607|588757160|FG000|Overall Study|Lost to Follow-up|0|||
163014484|NCT02609607|588757161|FG001|Overall Study|Lost to Follow-up|1|||
163014485|NCT03691207|588757162|FG000|Overall Study|Death|41|||
163014486|NCT03691207|588757163|FG001|Overall Study|Death|26|||
163014487|NCT03691207|588757162|FG000|Overall Study|Lost to Follow-up|1|||
163014488|NCT03691207|588757163|FG001|Overall Study|Lost to Follow-up|1|||
163014489|NCT03691207|588757162|FG000|Overall Study|Withdrawal by Subject|2|||
163014490|NCT03691207|588757163|FG001|Overall Study|Withdrawal by Subject|8|||
163014491|NCT03691207|588757162|FG000|Overall Study|Sponsor decision|1|||
163014492|NCT03691207|588757163|FG001|Overall Study|Sponsor decision|7|||
163014493|NCT00651261|588757164|FG000|Overall Study|Adverse Event|32|||
163014494|NCT00651261|588757165|FG001|Overall Study|Adverse Event|22|||
163014495|NCT00651261|588757164|FG000|Overall Study|Death|18|||
163014496|NCT00651261|588757165|FG001|Overall Study|Death|18|||
163014497|NCT00651261|588757164|FG000|Overall Study|Withdrawal by Subject|22|||
163014498|NCT00651261|588757165|FG001|Overall Study|Withdrawal by Subject|40|||
163014499|NCT00651261|588757164|FG000|Overall Study|Induction failure|24|||
163014500|NCT00651261|588757165|FG001|Overall Study|Induction failure|35|||
163014501|NCT00651261|588757164|FG000|Overall Study|Disease progression|58|||
163014502|NCT00651261|588757165|FG001|Overall Study|Disease progression|58|||
163014503|NCT00651261|588757164|FG000|Overall Study|Alternative therapy|109|||
163014504|NCT00651261|588757165|FG001|Overall Study|Alternative therapy|107|||
163014505|NCT00651261|588757164|FG000|Overall Study|Other disease or participant decisions|23|||
163014506|NCT00651261|588757165|FG001|Overall Study|Other disease or participant decisions|23|||
163014507|NCT00651261|588757164|FG000|Overall Study|Never treated|5|||
163014508|NCT00651261|588757165|FG001|Overall Study|Never treated|3|||
163014509|NCT02027545|588757166|FG000|Overall Study|Failed to sign HIPAA|0|||
163014510|NCT02027545|588757167|FG001|Overall Study|Failed to sign HIPAA|2|||
163014511|NCT02027545|588757166|FG000|Overall Study|Failed to attend study visit|2|||
163014512|NCT02027545|588757167|FG001|Overall Study|Failed to attend study visit|0|||
163014513|NCT02027545|588757166|FG000|Overall Study|Protocol Violation|1|||
163014514|NCT02027545|588757167|FG001|Overall Study|Protocol Violation|0|||
163014515|NCT02633293|588757168|FG000|Overall Study|Death|56|||
163014516|NCT02633293|588757168|FG000|Overall Study|Progressive Disease|12|||
163014517|NCT02633293|588757168|FG000|Overall Study|Adverse Event|29|||
163014518|NCT02633293|588757168|FG000|Overall Study|Withdrawal by Subject|41|||
163014519|NCT02633293|588757168|FG000|Overall Study|Protocol Violation|1|||
163014520|NCT02633293|588757168|FG000|Overall Study|Lost to Follow-up|1|||
163014521|NCT02633293|588757168|FG000|Overall Study|Study Terminated by Sponsor|24|||
163014522|NCT02633293|588757168|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
163014523|NCT02633293|588757168|FG000|Overall Study|Lung Transplant|5|||
163014524|NCT02633293|588757168|FG000|Overall Study|Lack of Efficacy|2|||
163014525|NCT02633293|588757168|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
163014526|NCT01343043|588757169|FG000|Overall Study|Disease progression before treatment|1|||
163014527|NCT01343043|588757170|FG001|Overall Study|Disease progression before treatment|0|||
163014528|NCT01343043|588757171|FG002|Overall Study|Disease progression before treatment|0|||
163014529|NCT01343043|588757172|FG003|Overall Study|Disease progression before treatment|0|||
163014530|NCT01343043|588757169|FG000|Overall Study|Withdrawal by Subject|1|||
163014531|NCT01343043|588757170|FG001|Overall Study|Withdrawal by Subject|0|||
163014532|NCT01343043|588757171|FG002|Overall Study|Withdrawal by Subject|0|||
163014533|NCT01343043|588757172|FG003|Overall Study|Withdrawal by Subject|0|||
163014534|NCT01343043|588757169|FG000|Overall Study|Death|1|||
163014535|NCT01343043|588757170|FG001|Overall Study|Death|1|||
162640806|NCT02998840|587399965|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
163014536|NCT01343043|588757171|FG002|Overall Study|Death|0|||
163014537|NCT01343043|588757172|FG003|Overall Study|Death|1|||
163014538|NCT01017874|588757173|FG000|Overall Study|Withdrawal by Subject|23|||
163014539|NCT01017874|588757174|FG001|Overall Study|Withdrawal by Subject|20|||
163014540|NCT01017874|588757173|FG000|Overall Study|Sponsor decision|3|||
163014541|NCT01017874|588757174|FG001|Overall Study|Sponsor decision|1|||
163014542|NCT01017874|588757173|FG000|Overall Study|Lost to Follow-up|3|||
163014543|NCT01017874|588757174|FG001|Overall Study|Lost to Follow-up|2|||
163014544|NCT01017874|588757173|FG000|Overall Study|Physician Decision|1|||
163014545|NCT01017874|588757174|FG001|Overall Study|Physician Decision|3|||
163014546|NCT01790984|588757179|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
163154721|NCT02435992|589281385|FG000|Overall Study|Other Reason|1|||
163014547|NCT01790984|588757180|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
163014548|NCT01790984|588757181|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
163014549|NCT01790984|588757182|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
163014550|NCT01346696|588757185|FG000|Overall Study|Death|1|||
163014551|NCT02182843|588757186|FG000|Overall Study|Withdrawal by Subject|7|||
163014552|NCT02182843|588757186|FG000|Overall Study|Lost to Follow-up|2|||
163014553|NCT02182843|588757186|FG000|Overall Study|Adverse Event|1|||
163014554|NCT01051791|588757190|FG000|Overall Study|Failed screening|3|||
163014555|NCT01051791|588757190|FG000|Overall Study|Withdrawal by Subject|1|||
163014556|NCT00288626|588757197|FG000|Overall Study|Death|3|||
163014557|NCT00288626|588757197|FG000|Overall Study|Withdrawal by Subject|4|||
163014558|NCT01684423|588757198|FG000|Overall Study|Withdrawal by Subject|0|||
163014559|NCT01684423|588757199|FG001|Overall Study|Withdrawal by Subject|0|||
163014560|NCT01684423|588757200|FG002|Overall Study|Withdrawal by Subject|1|||
163014561|NCT01684423|588757201|FG003|Overall Study|Withdrawal by Subject|0|||
163014562|NCT01684423|588757202|FG004|Overall Study|Withdrawal by Subject|0|||
163014563|NCT02155283|588757203|FG000|Overall Study|Lost to Follow-up|3|||
163014564|NCT02155283|588757203|FG000|Overall Study|Withdrawal by Subject|1|||
163014565|NCT02155283|588757203|FG000|Overall Study|Protocol Violation|3|||
163014566|NCT01741688|588757207|FG000|Overall Study|Lack of insurance coverage|2|||
163014567|NCT01741688|588757207|FG000|Overall Study|Withdrawal by Subject|1|||
163014568|NCT03850496|588757212|FG000|Overall Study|Withdrawal by Subject|1|||
163014569|NCT03850496|588757213|FG001|Overall Study|Withdrawal by Subject|0|||
163014570|NCT03850496|588757214|FG002|Overall Study|Withdrawal by Subject|0|||
163014571|NCT03850496|588757212|FG000|Overall Study|Lost to Follow-up|0|||
163014572|NCT03850496|588757213|FG001|Overall Study|Lost to Follow-up|1|||
163014573|NCT03850496|588757214|FG002|Overall Study|Lost to Follow-up|4|||
163014574|NCT00869999|588757219|FG000|Overall Study|Withdrawal by Subject|1|||
163014575|NCT00869999|588757219|FG000|Overall Study|removed prior to starting therapy|1|||
163014576|NCT03674112|588757221|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
163014577|NCT03674112|588757222|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
163014578|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
163014579|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
163014580|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
163014581|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
163014582|NCT03674112|588757221|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
163014583|NCT03674112|588757222|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
163014584|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
163014585|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
163014586|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
163014587|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
163014588|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Death|2|||
163014589|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Death|0|||
163014590|NCT03674112|588757221|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
163014591|NCT03674112|588757222|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
163014592|NCT04157348|588757223|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
163014593|NCT04157348|588757224|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
162716060|NCT03354390|587667117|FG000|Level 1|Death|2|||
163014594|NCT04157348|588757223|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163014595|NCT04157348|588757224|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163014596|NCT04157348|588757223|FG000|Double-blind Treatment Period|Adverse Event|0|||
163014597|NCT04157348|588757224|FG001|Double-blind Treatment Period|Adverse Event|1|||
163014598|NCT04157348|588757223|FG000|Open-label Extension Period|Adverse Event|1|||
163014599|NCT04157348|588757224|FG001|Open-label Extension Period|Adverse Event|1|||
163014600|NCT04157348|588757223|FG000|Open-label Extension Period|Death|0|||
163014601|NCT04157348|588757224|FG001|Open-label Extension Period|Death|1|||
163014602|NCT04157348|588757223|FG000|Open-label Extension Period|Lack of Efficacy|2|||
163014603|NCT04157348|588757224|FG001|Open-label Extension Period|Lack of Efficacy|2|||
163014604|NCT04157348|588757223|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
163014605|NCT04157348|588757224|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
163014606|NCT04157348|588757223|FG000|Open-label Extension Period|Ongoing|60|||
163014607|NCT04157348|588757224|FG001|Open-label Extension Period|Ongoing|57|||
163014608|NCT04157348|588757223|FG000|Open-label Extension Period|other reasons|1|||
163014609|NCT04157348|588757224|FG001|Open-label Extension Period|other reasons|1|||
162716061|NCT03354390|587667118|FG001|Level 1|Death|0|||
162716062|NCT03354390|587667119|FG002|Level 1|Death|0|||
162716063|NCT03354390|587667120|FG003|Level 1|Death|0|||
163014610|NCT03020992|588757227|FG000|Overall Study|Adverse Event|5|||
163014611|NCT03020992|588757227|FG000|Overall Study|Withdrawal by Subject|1|||
163014612|NCT05000164|588757228|FG000|Overall Study|Adverse Event|1|||
163014613|NCT05000164|588757228|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163014614|NCT05000164|588757228|FG000|Overall Study|Lens Discomfort|3|||
163014615|NCT05000164|588757228|FG000|Overall Study|Withdrew Consent during Study|2|||
163014616|NCT05000164|588757228|FG000|Overall Study|Subject Withdrawn by PI|2|||
163014617|NCT05000164|588757228|FG000|Overall Study|Other Fractured Test Article|1|||
163014618|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
163014619|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
163014620|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
163014621|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
163014622|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Pregnancy|0|||
163014623|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Pregnancy|1|||
163014624|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
163014625|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
163014626|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
163014627|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
163014628|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
163014629|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
163014630|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Other|3|||
163014631|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Other|0|||
163014632|NCT01006122|588757229|FG000|First Double-blind Intervention Period|Adverse Event|0|||
163014633|NCT01006122|588757230|FG001|First Double-blind Intervention Period|Adverse Event|4|||
163014634|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
163014635|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
163014636|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
163014637|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
163014638|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163014639|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
163014640|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163014641|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
163014642|NCT01006122|588757229|FG000|Second Double-blind Intervention Period|Death|0|||
163014643|NCT01006122|588757230|FG001|Second Double-blind Intervention Period|Death|1|||
163014644|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
163014645|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
163014646|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
163014647|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
163014648|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
163014649|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
163014650|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
163014651|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
163014652|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
163014653|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
163014654|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
163014655|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
163014656|NCT03493854|588757231|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
163014657|NCT03493854|588757232|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
163014658|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
163014659|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
163014660|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
163014661|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
163014662|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
163014663|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
163014664|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
163014665|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
163014666|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
163014667|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
163014668|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
163014669|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
163014670|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
163014671|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
163014672|NCT03493854|588757231|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
163014673|NCT03493854|588757232|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
163014674|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
163014675|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
163014676|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
163014677|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
162716064|NCT03354390|587667117|FG000|Level 1|Physician Decision|1|||
162716065|NCT03354390|587667118|FG001|Level 1|Physician Decision|0|||
162716066|NCT03354390|587667119|FG002|Level 1|Physician Decision|0|||
162716067|NCT03354390|587667120|FG003|Level 1|Physician Decision|0|||
163014678|NCT03493854|588757231|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
163014679|NCT03493854|588757232|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
163014680|NCT00410813|588757235|FG000|Overall Study|Adverse Event|6|||
163014681|NCT00410813|588757236|FG001|Overall Study|Adverse Event|11|||
163014682|NCT00410813|588757235|FG000|Overall Study|Progression|32|||
163014683|NCT00410813|588757236|FG001|Overall Study|Progression|21|||
163014684|NCT00410813|588757235|FG000|Overall Study|Not protocol specified|3|||
163014685|NCT00410813|588757236|FG001|Overall Study|Not protocol specified|4|||
163014686|NCT00410813|588757235|FG000|Overall Study|Ineligible|2|||
163014687|NCT00410813|588757236|FG001|Overall Study|Ineligible|4|||
163014688|NCT00410813|588757235|FG000|Overall Study|Death|0|||
163014689|NCT00410813|588757236|FG001|Overall Study|Death|2|||
163014690|NCT02712554|588757240|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
163014691|NCT02712554|588757241|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
163014692|NCT02712554|588757240|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
163014693|NCT02712554|588757241|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
163014694|NCT02712554|588757240|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
163014695|NCT02712554|588757241|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
163014696|NCT02712554|588757240|FG000|Part B: Qualification Phase|Adverse Event|0|||
163014697|NCT02712554|588757241|FG001|Part B: Qualification Phase|Adverse Event|1|||
163014698|NCT02712554|588757240|FG000|Part B: Treatment Phase|Adverse Event|0|||
163014699|NCT02712554|588757241|FG001|Part B: Treatment Phase|Adverse Event|1|||
163014700|NCT02712554|588757240|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
163014701|NCT02712554|588757241|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
163014702|NCT02712554|588757240|FG000|Part B: Treatment Phase|Other|0|||
163014703|NCT02712554|588757241|FG001|Part B: Treatment Phase|Other|1|||
163014704|NCT02503540|588757242|FG000|Overall Study|Death|2|||
163014705|NCT02503540|588757242|FG000|Overall Study|Withdrawal by Subject|1|||
163014706|NCT00979654|588757243|FG000|Overall Study|Lost to Follow-up|1|||
163014707|NCT00979654|588757243|FG000|Overall Study|Withdrawal by Subject|22|||
163014708|NCT00979654|588757243|FG000|Overall Study|Death|1|||
163014709|NCT00979654|588757243|FG000|Overall Study|Lack of Efficacy|6|||
163014710|NCT00979654|588757243|FG000|Overall Study|Adverse Event|1|||
163014711|NCT00979654|588757243|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
163014712|NCT00979654|588757243|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
163014713|NCT00979654|588757243|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
163014714|NCT00979654|588757243|FG000|Overall Study|Serious Adverse Event|1|||
163014715|NCT00979654|588757243|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
163014716|NCT03830333|588757247|FG000|Overall Study|Death|0|||
163014717|NCT03830333|588757248|FG001|Overall Study|Death|1|||
163014718|NCT03830333|588757247|FG000|Overall Study|Withdrawal by Subject|5|||
163014719|NCT03830333|588757248|FG001|Overall Study|Withdrawal by Subject|1|||
163014720|NCT03830333|588757247|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
163014721|NCT03830333|588757248|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
163014722|NCT01445730|588757249|FG000|Overall Study|Adverse Event|1|||
163014723|NCT01445730|588757249|FG000|Overall Study|For the advice of a dentist|1|||
163014724|NCT01445730|588757249|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
163014725|NCT01367886|588757250|FG000|Overall Study|Lost to Follow-up|4|||
163014726|NCT01367886|588757250|FG000|Overall Study|Lack of Efficacy|2|||
163014727|NCT01367886|588757250|FG000|Overall Study|Death|1|||
163014728|NCT00985504|588757255|FG000|Acute Treatment Period|Adverse Event|3|||
163014729|NCT00985504|588757256|FG001|Acute Treatment Period|Adverse Event|4|||
163014730|NCT00985504|588757255|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
163014731|NCT00985504|588757256|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
163014732|NCT00985504|588757255|FG000|Acute Treatment Period|Protocol Violation|2|||
163014733|NCT00985504|588757256|FG001|Acute Treatment Period|Protocol Violation|0|||
163014734|NCT00985504|588757255|FG000|Acute Treatment Period|Sponsor Decision|0|||
163014735|NCT00985504|588757256|FG001|Acute Treatment Period|Sponsor Decision|1|||
163062780|NCT04058717|588936945|FG001|Randomization Period|Lost to Follow-up|3|||
163062781|NCT04058717|588936946|FG002|Randomization Period|Lost to Follow-up|4|||
163062782|NCT04058717|588936947|FG003|Randomization Period|Lost to Follow-up|4|||
163062783|NCT04058717|588936944|FG000|Randomization Period|Withdrawal by Subject|1|||
163062784|NCT04058717|588936945|FG001|Randomization Period|Withdrawal by Subject|3|||
163062785|NCT04058717|588936946|FG002|Randomization Period|Withdrawal by Subject|3|||
162640807|NCT02998840|587399966|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
162640808|NCT01686633|587399967|FG000|Overall Study|Lack of Efficacy|33|||
162640809|NCT01686633|587399968|FG001|Overall Study|Lack of Efficacy|13|||
162640810|NCT01686633|587399969|FG002|Overall Study|Lack of Efficacy|11|||
162640811|NCT01686633|587399967|FG000|Overall Study|Withdrawal by Subject|8|||
163014736|NCT00985504|588757255|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
163014737|NCT00985504|588757256|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
163014738|NCT00985504|588757255|FG000|Optimization Period|Adverse Event|7|||
163014739|NCT00985504|588757256|FG001|Optimization Period|Adverse Event|9|||
163014740|NCT00985504|588757255|FG000|Optimization Period|Death|0|||
163014741|NCT00985504|588757256|FG001|Optimization Period|Death|1|||
163014742|NCT00985504|588757255|FG000|Optimization Period|Lack of Efficacy|5|||
163014743|NCT00985504|588757256|FG001|Optimization Period|Lack of Efficacy|3|||
163014744|NCT00985504|588757255|FG000|Optimization Period|Lost to Follow-up|0|||
163014745|NCT00985504|588757256|FG001|Optimization Period|Lost to Follow-up|1|||
163014746|NCT00985504|588757255|FG000|Optimization Period|Physician Decision|1|||
163014747|NCT00985504|588757256|FG001|Optimization Period|Physician Decision|0|||
163014748|NCT00985504|588757255|FG000|Optimization Period|Protocol Violation|3|||
163014749|NCT00985504|588757256|FG001|Optimization Period|Protocol Violation|1|||
163014750|NCT00985504|588757255|FG000|Optimization Period|Withdrawal by Subject|10|||
163014751|NCT00985504|588757256|FG001|Optimization Period|Withdrawal by Subject|8|||
163014752|NCT01167140|588757257|FG000|Overall Study|Withdrawal by Subject|1|||
163014753|NCT03805412|588757268|FG000|Overall Study|Lost to Follow-up|0|||
163014754|NCT03805412|588757269|FG001|Overall Study|Lost to Follow-up|1|||
163014755|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
163014756|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
163014757|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
163014758|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
163014759|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
163014760|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
163014761|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
163014762|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
163014763|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
163014764|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
163014765|NCT03711786|588757270|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
163014766|NCT03711786|588757271|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
163014767|NCT00734994|588757276|FG000|Overall Study|Withdrawal by Subject|1|||
163014768|NCT02747108|588757278|FG000|Overall Study|Death|2|||
163014769|NCT02747108|588757279|FG001|Overall Study|Death|2|||
163014770|NCT02747108|588757278|FG000|Overall Study|Withdrawal by Subject|1|||
163014771|NCT02747108|588757279|FG001|Overall Study|Withdrawal by Subject|0|||
163014772|NCT02747108|588757278|FG000|Overall Study|Protocol Violation|2|||
163014773|NCT02747108|588757279|FG001|Overall Study|Protocol Violation|0|||
163014774|NCT03103152|588757280|FG000|Overall Study|Physician Decision|5|||
163014775|NCT03103152|588757281|FG001|Overall Study|Physician Decision|2|||
163014776|NCT03103152|588757282|FG002|Overall Study|Physician Decision|6|||
163014777|NCT03103152|588757283|FG003|Overall Study|Physician Decision|3|||
163014778|NCT03103152|588757284|FG004|Overall Study|Physician Decision|3|||
163014779|NCT03103152|588757285|FG005|Overall Study|Physician Decision|1|||
163014780|NCT03103152|588757280|FG000|Overall Study|Protocol Violation|2|||
163014781|NCT03103152|588757281|FG001|Overall Study|Protocol Violation|2|||
163014782|NCT03103152|588757282|FG002|Overall Study|Protocol Violation|1|||
163014783|NCT03103152|588757283|FG003|Overall Study|Protocol Violation|2|||
163014784|NCT03103152|588757284|FG004|Overall Study|Protocol Violation|1|||
163014785|NCT03103152|588757285|FG005|Overall Study|Protocol Violation|1|||
163014786|NCT03103152|588757280|FG000|Overall Study|Inter-current illness|0|||
163014787|NCT03103152|588757281|FG001|Overall Study|Inter-current illness|0|||
163014788|NCT03103152|588757282|FG002|Overall Study|Inter-current illness|1|||
163014789|NCT03103152|588757283|FG003|Overall Study|Inter-current illness|0|||
163014790|NCT03103152|588757284|FG004|Overall Study|Inter-current illness|0|||
163014791|NCT03103152|588757285|FG005|Overall Study|Inter-current illness|0|||
163014792|NCT03103152|588757280|FG000|Overall Study|Death|0|||
163014793|NCT03103152|588757281|FG001|Overall Study|Death|1|||
163014794|NCT03103152|588757282|FG002|Overall Study|Death|0|||
163014795|NCT03103152|588757283|FG003|Overall Study|Death|0|||
163014796|NCT03103152|588757284|FG004|Overall Study|Death|0|||
163014797|NCT03103152|588757285|FG005|Overall Study|Death|0|||
163014798|NCT03103152|588757280|FG000|Overall Study|Adverse Event|0|||
163014799|NCT03103152|588757281|FG001|Overall Study|Adverse Event|0|||
163014800|NCT03103152|588757282|FG002|Overall Study|Adverse Event|1|||
163014801|NCT03103152|588757283|FG003|Overall Study|Adverse Event|0|||
163014802|NCT03103152|588757284|FG004|Overall Study|Adverse Event|0|||
163014803|NCT03103152|588757285|FG005|Overall Study|Adverse Event|1|||
163014804|NCT03103152|588757280|FG000|Overall Study|Withdrawal by Subject|1|||
163014805|NCT03103152|588757281|FG001|Overall Study|Withdrawal by Subject|0|||
163014806|NCT03103152|588757282|FG002|Overall Study|Withdrawal by Subject|1|||
163014807|NCT03103152|588757283|FG003|Overall Study|Withdrawal by Subject|1|||
163014808|NCT03103152|588757284|FG004|Overall Study|Withdrawal by Subject|1|||
163014809|NCT03103152|588757285|FG005|Overall Study|Withdrawal by Subject|1|||
163014810|NCT03103152|588757280|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
163014811|NCT03103152|588757281|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
163014812|NCT03103152|588757282|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
163014813|NCT03103152|588757283|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
163014814|NCT03103152|588757284|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
163014815|NCT03103152|588757285|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
163014816|NCT03103152|588757280|FG000|Overall Study|Unacceptable side effects|0|||
163014817|NCT03103152|588757281|FG001|Overall Study|Unacceptable side effects|0|||
163014818|NCT03103152|588757282|FG002|Overall Study|Unacceptable side effects|0|||
163014819|NCT03103152|588757283|FG003|Overall Study|Unacceptable side effects|0|||
163014820|NCT03103152|588757284|FG004|Overall Study|Unacceptable side effects|0|||
163014821|NCT03103152|588757285|FG005|Overall Study|Unacceptable side effects|1|||
163014822|NCT03103152|588757280|FG000|Overall Study|Lost to Follow-up|0|||
163014823|NCT03103152|588757281|FG001|Overall Study|Lost to Follow-up|1|||
163014824|NCT03103152|588757282|FG002|Overall Study|Lost to Follow-up|0|||
163014825|NCT03103152|588757283|FG003|Overall Study|Lost to Follow-up|1|||
163014826|NCT03103152|588757284|FG004|Overall Study|Lost to Follow-up|0|||
163014827|NCT03103152|588757285|FG005|Overall Study|Lost to Follow-up|1|||
163014828|NCT03103152|588757280|FG000|Overall Study|Testicular pain|0|||
163014829|NCT03103152|588757281|FG001|Overall Study|Testicular pain|0|||
163014830|NCT03103152|588757282|FG002|Overall Study|Testicular pain|0|||
163014831|NCT03103152|588757283|FG003|Overall Study|Testicular pain|1|||
163014832|NCT03103152|588757284|FG004|Overall Study|Testicular pain|0|||
163014833|NCT03103152|588757285|FG005|Overall Study|Testicular pain|0|||
163014834|NCT05966584|588757286|FG000|Overall Study|Lost to Follow-up|1|||
163014835|NCT03100903|588758902|FG000|Overall Study|Withdrawal by Subject|0|||
163014836|NCT03100903|588758903|FG001|Overall Study|Withdrawal by Subject|0|||
163014837|NCT03100903|588758904|FG002|Overall Study|Withdrawal by Subject|1|||
163014838|NCT04659993|588758905|FG000|Overall Study|Withdrawal by Subject|2|||
163014839|NCT04659993|588758905|FG000|Overall Study|Lost to Follow-up|2|||
163014840|NCT06360588|588758908|FG000|Overall Study|Adverse Event|3|||
163014841|NCT06360588|588758908|FG000|Overall Study|Death|2|||
163014842|NCT06360588|588758908|FG000|Overall Study|Disease Progression|14|||
163014843|NCT06360588|588758908|FG000|Overall Study|Withdrawal by Subject|1|||
163014844|NCT06360588|588758908|FG000|Overall Study|Lack of Efficacy|1|||
163014845|NCT06360588|588758908|FG000|Overall Study|Ineligible|1|||
163014846|NCT04010240|588758909|FG000|Overall Study|IHC not performed|2299|||
163014847|NCT01481766|588758910|FG000|4 months|Lost to Follow-up|3|||
163014848|NCT01481766|588758911|FG001|4 months|Lost to Follow-up|2|||
163014849|NCT01481766|588758912|FG002|4 months|Lost to Follow-up|1|||
163014850|NCT01481766|588758913|FG003|4 months|Lost to Follow-up|5|||
163014851|NCT01481766|588758910|FG000|12 months|Lost to Follow-up|7|||
163014852|NCT01481766|588758911|FG001|12 months|Lost to Follow-up|8|||
163014853|NCT01481766|588758912|FG002|12 months|Lost to Follow-up|5|||
162640812|NCT01686633|587399968|FG001|Overall Study|Withdrawal by Subject|8|||
162640813|NCT01686633|587399969|FG002|Overall Study|Withdrawal by Subject|5|||
162640814|NCT01686633|587399967|FG000|Overall Study|Physician Decision|3|||
162640815|NCT01686633|587399968|FG001|Overall Study|Physician Decision|4|||
162640816|NCT01686633|587399969|FG002|Overall Study|Physician Decision|4|||
162640817|NCT01686633|587399967|FG000|Overall Study|Adverse Event|4|||
162640818|NCT01686633|587399968|FG001|Overall Study|Adverse Event|3|||
162640819|NCT01686633|587399969|FG002|Overall Study|Adverse Event|3|||
163014854|NCT01481766|588758913|FG003|12 months|Lost to Follow-up|3|||
163014855|NCT00347958|588758914|FG000|Overall Study|Adverse Event|1|||
163014856|NCT00347958|588758914|FG000|Overall Study|Protocol Violation|2|||
163014857|NCT00347958|588758914|FG000|Overall Study|Withdrawal by Subject|1|||
163014858|NCT00754234|588758915|FG000|Overall Study|Withdrawal by Subject|3|||
163014859|NCT00570687|588758916|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014860|NCT00570687|588758917|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014861|NCT00570687|588758918|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
162640820|NCT01686633|587399967|FG000|Overall Study|Protocol Violation|2|||
162640821|NCT01686633|587399968|FG001|Overall Study|Protocol Violation|3|||
162640822|NCT01686633|587399969|FG002|Overall Study|Protocol Violation|0|||
162640823|NCT01686633|587399967|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
162716068|NCT03354390|587667117|FG000|Level 2|Physician Decision|0|||
162716069|NCT03354390|587667118|FG001|Level 2|Physician Decision|2|||
163014862|NCT00570687|588758919|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014863|NCT00570687|588758920|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014864|NCT00570687|588758921|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014865|NCT00570687|588758922|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
163014866|NCT00570687|588758923|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014867|NCT00570687|588758924|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
163014868|NCT00570687|588758925|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
163014869|NCT00570687|588758916|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014870|NCT00570687|588758917|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
162640824|NCT01686633|587399968|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
162640825|NCT01686633|587399969|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
162640826|NCT01686633|587399967|FG000|Overall Study|Lost to Follow-up|0|||
162640827|NCT01686633|587399968|FG001|Overall Study|Lost to Follow-up|1|||
162640828|NCT01686633|587399969|FG002|Overall Study|Lost to Follow-up|1|||
162640829|NCT00511667|587399974|FG000|Overall Study|Adverse Event|1|||
162640830|NCT00511667|587399975|FG001|Overall Study|Adverse Event|0|||
162640831|NCT00511667|587399974|FG000|Overall Study|Protocol Violation|1|||
162640832|NCT00511667|587399975|FG001|Overall Study|Protocol Violation|1|||
162640833|NCT00511667|587399974|FG000|Overall Study|Withdrawal by Subject|2|||
162640834|NCT00511667|587399975|FG001|Overall Study|Withdrawal by Subject|0|||
162640835|NCT00511667|587399974|FG000|Overall Study|Site terminated|6|||
162640836|NCT00511667|587399975|FG001|Overall Study|Site terminated|1|||
162640837|NCT00511667|587399974|FG000|Overall Study|Other|2|||
162640838|NCT00511667|587399975|FG001|Overall Study|Other|1|||
162640839|NCT03564145|587399976|FG000|Overall Study|Adverse Event|4|||
163014871|NCT00570687|588758918|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014872|NCT00570687|588758919|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014873|NCT00570687|588758920|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014874|NCT00570687|588758921|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014875|NCT00570687|588758922|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014876|NCT00570687|588758923|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014877|NCT00570687|588758924|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
163014878|NCT00570687|588758925|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014879|NCT00570687|588758916|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014880|NCT00570687|588758917|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014881|NCT00570687|588758918|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014882|NCT00570687|588758919|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014883|NCT00570687|588758920|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014884|NCT00570687|588758921|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014885|NCT00570687|588758922|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
163014886|NCT00570687|588758923|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014887|NCT00570687|588758924|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014888|NCT00570687|588758925|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
163014889|NCT03263936|588758926|FG000|Overall Study|Adverse Event|0|||
163014890|NCT03263936|588758927|FG001|Overall Study|Adverse Event|1|||
163014891|NCT03263936|588758928|FG002|Overall Study|Adverse Event|0|||
163014892|NCT03263936|588758926|FG000|Overall Study|Death|0|||
163014893|NCT03263936|588758927|FG001|Overall Study|Death|1|||
163014894|NCT03263936|588758928|FG002|Overall Study|Death|0|||
163014895|NCT00457002|588758930|FG000|Overall Study|Death|40|||
163014896|NCT00457002|588758931|FG001|Overall Study|Death|47|||
163014897|NCT00457002|588758930|FG000|Overall Study|Adverse Event|284|||
163014898|NCT00457002|588758931|FG001|Overall Study|Adverse Event|260|||
163014899|NCT00457002|588758930|FG000|Overall Study|Withdrawal by Subject|299|||
163014900|NCT00457002|588758931|FG001|Overall Study|Withdrawal by Subject|271|||
163014901|NCT00457002|588758930|FG000|Overall Study|Lost to Follow-up|72|||
163014902|NCT00457002|588758931|FG001|Overall Study|Lost to Follow-up|71|||
163014903|NCT00457002|588758930|FG000|Overall Study|Poor/Non-compliance|46|||
163014904|NCT00457002|588758931|FG001|Overall Study|Poor/Non-compliance|33|||
163014905|NCT00457002|588758930|FG000|Overall Study|No longer met criteria|41|||
163014906|NCT00457002|588758931|FG001|Overall Study|No longer met criteria|37|||
163014907|NCT00457002|588758930|FG000|Overall Study|Administrative reason by Sponsor|1|||
163014908|NCT00457002|588758931|FG001|Overall Study|Administrative reason by Sponsor|0|||
163062786|NCT04058717|588936947|FG003|Randomization Period|Withdrawal by Subject|3|||
163062787|NCT04058717|588936944|FG000|Randomization Period|PI decision|0|||
163062788|NCT04058717|588936945|FG001|Randomization Period|PI decision|1|||
163062789|NCT04058717|588936946|FG002|Randomization Period|PI decision|0|||
163062790|NCT04058717|588936947|FG003|Randomization Period|PI decision|0|||
163014909|NCT00457002|588758930|FG000|Overall Study|non-specified|29|||
163062791|NCT02799602|588936949|FG000|Overall Study|Protocol Violation|1|||
163014910|NCT00457002|588758931|FG001|Overall Study|non-specified|38|||
163062792|NCT02799602|588936950|FG001|Overall Study|Protocol Violation|0|||
163062793|NCT02799602|588936949|FG000|Overall Study|Physician Decision|5|||
162640840|NCT03564145|587399976|FG000|Overall Study|Lost to Follow-up|21|||
162640841|NCT03564145|587399976|FG000|Overall Study|Protocol Violation|2|||
163062794|NCT02799602|588936950|FG001|Overall Study|Physician Decision|6|||
163062795|NCT02799602|588936949|FG000|Overall Study|Lost to Follow-up|4|||
163062796|NCT02799602|588936950|FG001|Overall Study|Lost to Follow-up|2|||
162640842|NCT03564145|587399976|FG000|Overall Study|Withdrawal by Subject|48|||
162640843|NCT03564145|587399976|FG000|Overall Study|Study Terminated by Sponsor|146|||
162640844|NCT03564145|587399976|FG000|Overall Study|Physician Decision|1|||
163014911|NCT00457002|588758930|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
163014912|NCT00457002|588758931|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
163014913|NCT01623310|588758932|FG000|Overall Study|Adverse Event|21|||
163154722|NCT02435992|589281386|FG001|Overall Study|Other Reason|0|||
163014914|NCT01623310|588758932|FG000|Overall Study|Lost to Follow-up|18|||
163014915|NCT01623310|588758932|FG000|Overall Study|Lack of Efficacy|6|||
163014916|NCT01623310|588758932|FG000|Overall Study|Protocol Violation|6|||
163014917|NCT01623310|588758932|FG000|Overall Study|Withdrawal by Subject|25|||
163014918|NCT01623310|588758932|FG000|Overall Study|Became potentially child-bearing|1|||
163014919|NCT01623310|588758932|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
163014920|NCT01623310|588758932|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
163014921|NCT00454246|588758933|FG000|Overall Study|Adverse Event|2|||
163014922|NCT00454246|588758934|FG001|Overall Study|Adverse Event|2|||
163014923|NCT00454246|588758935|FG002|Overall Study|Adverse Event|0|||
163014924|NCT00454246|588758933|FG000|Overall Study|Violation of selection criteria at entry|6|||
163014925|NCT00454246|588758934|FG001|Overall Study|Violation of selection criteria at entry|0|||
163014926|NCT00454246|588758935|FG002|Overall Study|Violation of selection criteria at entry|0|||
163014927|NCT00454246|588758933|FG000|Overall Study|Protocol Violation|1|||
163014928|NCT00454246|588758934|FG001|Overall Study|Protocol Violation|0|||
163014929|NCT00454246|588758935|FG002|Overall Study|Protocol Violation|0|||
163014930|NCT00454246|588758933|FG000|Overall Study|Refused Treatment|1|||
163014931|NCT00454246|588758934|FG001|Overall Study|Refused Treatment|1|||
163014932|NCT00454246|588758935|FG002|Overall Study|Refused Treatment|0|||
163014933|NCT00454246|588758933|FG000|Overall Study|Failure to return|1|||
163014934|NCT00454246|588758934|FG001|Overall Study|Failure to return|0|||
163014935|NCT00454246|588758935|FG002|Overall Study|Failure to return|0|||
163014936|NCT00454246|588758933|FG000|Overall Study|Early termination of study|62|||
163014937|NCT00454246|588758934|FG001|Overall Study|Early termination of study|26|||
163014938|NCT00454246|588758935|FG002|Overall Study|Early termination of study|9|||
163014939|NCT00356603|588758936|FG000|Overall Study|Other|6|||
163014940|NCT00356603|588758937|FG001|Overall Study|Other|3|||
163014941|NCT05326529|588758938|FG000|Overall Study|Lack of Efficacy|0|||
163014942|NCT05326529|588758939|FG001|Overall Study|Lack of Efficacy|1|||
163014943|NCT05326529|588758940|FG002|Overall Study|Lack of Efficacy|0|||
163014944|NCT05326529|588758938|FG000|Overall Study|Physician Decision|0|||
163014945|NCT05326529|588758939|FG001|Overall Study|Physician Decision|0|||
163014946|NCT05326529|588758940|FG002|Overall Study|Physician Decision|2|||
163014947|NCT01262287|588758942|FG000|Overall Study|Lost to Follow-up|2|||
163014948|NCT01262287|588758943|FG001|Overall Study|Lost to Follow-up|1|||
163014949|NCT00932373|588758944|FG000|Overall Study|Progressive disease|3|||
163014950|NCT00932373|588758945|FG001|Overall Study|Progressive disease|1|||
163014951|NCT00932373|588758946|FG002|Overall Study|Progressive disease|0|||
163014952|NCT00932373|588758947|FG003|Overall Study|Progressive disease|0|||
163014953|NCT00932373|588758948|FG004|Overall Study|Progressive disease|10|||
163062797|NCT02799602|588936949|FG000|Overall Study|Additional primary malignancy|11|||
162640845|NCT03564145|587399976|FG000|Overall Study|Other Than Specified|1|||
162640846|NCT03564145|587399976|FG000|Overall Study|Pregnancy|1|||
162640847|NCT04219891|587399979|FG000|Overall Study|Lost to Follow-up|3|||
162640848|NCT04219891|587399979|FG000|Overall Study|Withdrawal by Subject|2|||
162640849|NCT00410761|587401477|FG000|Randomized Treatment Period|Adverse Event|34|||
162640850|NCT00410761|587401478|FG001|Randomized Treatment Period|Adverse Event|3|||
162640851|NCT00410761|587401477|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
162640852|NCT00410761|587401478|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
162640853|NCT00410761|587401477|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
162640854|NCT00410761|587401478|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
162640855|NCT00410761|587401477|FG000|Randomized Treatment Period|Other|69|||
162640856|NCT00410761|587401478|FG001|Randomized Treatment Period|Other|21|||
162640857|NCT00410761|587401477|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
162716070|NCT03354390|587667119|FG002|Level 2|Physician Decision|0|||
163014954|NCT00932373|588758949|FG005|Overall Study|Progressive disease|1|||
163014955|NCT00932373|588758950|FG006|Overall Study|Progressive disease|0|||
163014956|NCT00932373|588758951|FG007|Overall Study|Progressive disease|2|||
163014957|NCT00932373|588758952|FG008|Overall Study|Progressive disease|1|||
163014958|NCT00932373|588758953|FG009|Overall Study|Progressive disease|9|||
163014959|NCT00932373|588758954|FG010|Overall Study|Progressive disease|2|||
163014960|NCT00932373|588758944|FG000|Overall Study|Adverse Event|0|||
163014961|NCT00932373|588758945|FG001|Overall Study|Adverse Event|0|||
163014962|NCT00932373|588758946|FG002|Overall Study|Adverse Event|0|||
163014963|NCT00932373|588758947|FG003|Overall Study|Adverse Event|0|||
163014964|NCT00932373|588758948|FG004|Overall Study|Adverse Event|2|||
163014965|NCT00932373|588758949|FG005|Overall Study|Adverse Event|1|||
162716071|NCT03354390|587667120|FG003|Level 2|Physician Decision|0|||
162716072|NCT03354390|587667117|FG000|Level 2|Lack of Efficacy|0|||
163014966|NCT00932373|588758950|FG006|Overall Study|Adverse Event|0|||
163014967|NCT00932373|588758951|FG007|Overall Study|Adverse Event|1|||
163014968|NCT00932373|588758952|FG008|Overall Study|Adverse Event|0|||
163014969|NCT00932373|588758953|FG009|Overall Study|Adverse Event|2|||
163014970|NCT00932373|588758954|FG010|Overall Study|Adverse Event|1|||
163014971|NCT00932373|588758944|FG000|Overall Study|Physician Decision|0|||
163014972|NCT00932373|588758945|FG001|Overall Study|Physician Decision|0|||
163014973|NCT00932373|588758946|FG002|Overall Study|Physician Decision|1|||
163014974|NCT00932373|588758947|FG003|Overall Study|Physician Decision|0|||
163014975|NCT00932373|588758948|FG004|Overall Study|Physician Decision|2|||
163014976|NCT00932373|588758949|FG005|Overall Study|Physician Decision|0|||
163014977|NCT00932373|588758950|FG006|Overall Study|Physician Decision|0|||
163014978|NCT00932373|588758951|FG007|Overall Study|Physician Decision|0|||
163014979|NCT00932373|588758952|FG008|Overall Study|Physician Decision|0|||
163014980|NCT00932373|588758953|FG009|Overall Study|Physician Decision|1|||
163014981|NCT00932373|588758954|FG010|Overall Study|Physician Decision|0|||
163014982|NCT00932373|588758944|FG000|Overall Study|Dose limiting toxicity|0|||
163014983|NCT00932373|588758945|FG001|Overall Study|Dose limiting toxicity|0|||
163014984|NCT00932373|588758946|FG002|Overall Study|Dose limiting toxicity|0|||
163014985|NCT00932373|588758947|FG003|Overall Study|Dose limiting toxicity|0|||
163014986|NCT00932373|588758948|FG004|Overall Study|Dose limiting toxicity|0|||
163014987|NCT00932373|588758949|FG005|Overall Study|Dose limiting toxicity|1|||
163014988|NCT00932373|588758950|FG006|Overall Study|Dose limiting toxicity|0|||
163014989|NCT00932373|588758951|FG007|Overall Study|Dose limiting toxicity|0|||
163014990|NCT00932373|588758952|FG008|Overall Study|Dose limiting toxicity|0|||
163014991|NCT00932373|588758953|FG009|Overall Study|Dose limiting toxicity|0|||
163014992|NCT00932373|588758954|FG010|Overall Study|Dose limiting toxicity|0|||
163014993|NCT00932373|588758944|FG000|Overall Study|Withdrawal by Subject|0|||
163014994|NCT00932373|588758945|FG001|Overall Study|Withdrawal by Subject|0|||
163014995|NCT00932373|588758946|FG002|Overall Study|Withdrawal by Subject|0|||
163014996|NCT00932373|588758947|FG003|Overall Study|Withdrawal by Subject|0|||
163014997|NCT00932373|588758948|FG004|Overall Study|Withdrawal by Subject|0|||
163014998|NCT00932373|588758949|FG005|Overall Study|Withdrawal by Subject|0|||
163014999|NCT00932373|588758950|FG006|Overall Study|Withdrawal by Subject|0|||
163015000|NCT00932373|588758951|FG007|Overall Study|Withdrawal by Subject|0|||
163015001|NCT00932373|588758952|FG008|Overall Study|Withdrawal by Subject|1|||
163015002|NCT00932373|588758953|FG009|Overall Study|Withdrawal by Subject|0|||
163015003|NCT00932373|588758954|FG010|Overall Study|Withdrawal by Subject|0|||
163015004|NCT00932373|588758944|FG000|Overall Study|Clinical progression|0|||
163015005|NCT00932373|588758945|FG001|Overall Study|Clinical progression|0|||
163015006|NCT00932373|588758946|FG002|Overall Study|Clinical progression|0|||
163015007|NCT00932373|588758947|FG003|Overall Study|Clinical progression|0|||
163015008|NCT00932373|588758948|FG004|Overall Study|Clinical progression|0|||
163015009|NCT00932373|588758949|FG005|Overall Study|Clinical progression|0|||
163015010|NCT00932373|588758950|FG006|Overall Study|Clinical progression|1|||
163015011|NCT00932373|588758951|FG007|Overall Study|Clinical progression|0|||
163015012|NCT00932373|588758952|FG008|Overall Study|Clinical progression|0|||
163015013|NCT00932373|588758953|FG009|Overall Study|Clinical progression|0|||
163015014|NCT00932373|588758954|FG010|Overall Study|Clinical progression|0|||
163015015|NCT00932373|588758944|FG000|Overall Study|Lack of Efficacy|0|||
163015016|NCT00932373|588758945|FG001|Overall Study|Lack of Efficacy|0|||
163015017|NCT00932373|588758946|FG002|Overall Study|Lack of Efficacy|0|||
163015018|NCT00932373|588758947|FG003|Overall Study|Lack of Efficacy|0|||
163015019|NCT00932373|588758948|FG004|Overall Study|Lack of Efficacy|0|||
163015020|NCT00932373|588758949|FG005|Overall Study|Lack of Efficacy|0|||
163015021|NCT00932373|588758950|FG006|Overall Study|Lack of Efficacy|0|||
163015022|NCT00932373|588758951|FG007|Overall Study|Lack of Efficacy|0|||
163015023|NCT00932373|588758952|FG008|Overall Study|Lack of Efficacy|0|||
163015024|NCT00932373|588758953|FG009|Overall Study|Lack of Efficacy|1|||
163015025|NCT00932373|588758954|FG010|Overall Study|Lack of Efficacy|0|||
163015026|NCT04134767|588758957|FG000|Overall Study|Death|0|||
163015027|NCT04134767|588758958|FG001|Overall Study|Death|1|||
163015028|NCT04134767|588758957|FG000|Overall Study|Removed for harassing staff|0|||
163015029|NCT04134767|588758958|FG001|Overall Study|Removed for harassing staff|1|||
163015030|NCT04134767|588758957|FG000|Overall Study|Lost to Follow-up|44|||
162640858|NCT00410761|587401478|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
162640859|NCT00410761|587401477|FG000|Open-Label Treatment Period|Adverse Event|13|||
162640860|NCT00410761|587401478|FG001|Open-Label Treatment Period|Adverse Event|15|||
162640861|NCT00410761|587401477|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
163015031|NCT04134767|588758958|FG001|Overall Study|Lost to Follow-up|40|||
163015032|NCT01163851|588758966|FG000|Overall Study|Site Closure|0|||
163015033|NCT01163851|588758967|FG001|Overall Study|Site Closure|1|||
163015034|NCT01163851|588758966|FG000|Overall Study|Enrolled but not treated|1|||
162640862|NCT00410761|587401478|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
162716073|NCT03354390|587667118|FG001|Level 2|Lack of Efficacy|1|||
163015035|NCT01163851|588758967|FG001|Overall Study|Enrolled but not treated|0|||
163015036|NCT00789373|588758971|FG000|Induction|Adverse Event|64|||
163015037|NCT00789373|588758972|FG001|Induction|Adverse Event|0|||
163015038|NCT00789373|588758973|FG002|Induction|Adverse Event|0|||
163015039|NCT00789373|588758971|FG000|Induction|Death Due to study disease|24|||
163015040|NCT00789373|588758972|FG001|Induction|Death Due to study disease|0|||
163015041|NCT00789373|588758973|FG002|Induction|Death Due to study disease|0|||
163015042|NCT00789373|588758971|FG000|Induction|Death due to adverse event|19|||
163015043|NCT00789373|588758972|FG001|Induction|Death due to adverse event|0|||
163015044|NCT00789373|588758973|FG002|Induction|Death due to adverse event|0|||
163015045|NCT00789373|588758971|FG000|Induction|Death due to toxicity|11|||
162640863|NCT00410761|587401477|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
163015046|NCT00789373|588758972|FG001|Induction|Death due to toxicity|0|||
163015047|NCT00789373|588758973|FG002|Induction|Death due to toxicity|0|||
163015048|NCT00789373|588758971|FG000|Induction|Death due to procedure|1|||
163015049|NCT00789373|588758972|FG001|Induction|Death due to procedure|0|||
163015050|NCT00789373|588758973|FG002|Induction|Death due to procedure|0|||
163015051|NCT00789373|588758971|FG000|Induction|Investigator decision|7|||
163015052|NCT00789373|588758972|FG001|Induction|Investigator decision|0|||
163015053|NCT00789373|588758973|FG002|Induction|Investigator decision|0|||
163015054|NCT00789373|588758971|FG000|Induction|Protocol entry criteria not met|9|||
163015055|NCT00789373|588758972|FG001|Induction|Protocol entry criteria not met|0|||
163015056|NCT00789373|588758973|FG002|Induction|Protocol entry criteria not met|0|||
163015057|NCT00789373|588758971|FG000|Induction|Lost to Follow-up|6|||
163015058|NCT00789373|588758972|FG001|Induction|Lost to Follow-up|0|||
163015059|NCT00789373|588758973|FG002|Induction|Lost to Follow-up|0|||
163015060|NCT00789373|588758971|FG000|Induction|Protocol Violation|1|||
163015061|NCT00789373|588758972|FG001|Induction|Protocol Violation|0|||
163015062|NCT00789373|588758973|FG002|Induction|Protocol Violation|0|||
163015063|NCT00789373|588758971|FG000|Induction|Progressive Disease|220|||
163015064|NCT00789373|588758972|FG001|Induction|Progressive Disease|0|||
163015065|NCT00789373|588758973|FG002|Induction|Progressive Disease|0|||
163015066|NCT00789373|588758971|FG000|Induction|Withdrawal by Subject|37|||
163015067|NCT00789373|588758972|FG001|Induction|Withdrawal by Subject|0|||
163015068|NCT00789373|588758973|FG002|Induction|Withdrawal by Subject|0|||
163015069|NCT00789373|588758971|FG000|Maintenance|Adverse Event|0|||
163015070|NCT00789373|588758972|FG001|Maintenance|Adverse Event|65|||
163015071|NCT00789373|588758973|FG002|Maintenance|Adverse Event|12|||
163015072|NCT00789373|588758971|FG000|Maintenance|Death due to study disease|0|||
163015073|NCT00789373|588758972|FG001|Maintenance|Death due to study disease|3|||
163015074|NCT00789373|588758973|FG002|Maintenance|Death due to study disease|1|||
163015075|NCT00789373|588758971|FG000|Maintenance|Death due to adverse event|0|||
163015076|NCT00789373|588758972|FG001|Maintenance|Death due to adverse event|4|||
163015077|NCT00789373|588758973|FG002|Maintenance|Death due to adverse event|1|||
163015078|NCT00789373|588758971|FG000|Maintenance|Death due to toxicity|0|||
163015079|NCT00789373|588758972|FG001|Maintenance|Death due to toxicity|1|||
163015080|NCT00789373|588758973|FG002|Maintenance|Death due to toxicity|2|||
163015081|NCT00789373|588758971|FG000|Maintenance|Investigator Decision|0|||
163062798|NCT02799602|588936950|FG001|Overall Study|Additional primary malignancy|6|||
162640864|NCT00410761|587401478|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
162640865|NCT00410761|587401477|FG000|Open-Label Treatment Period|Other|18|||
162640866|NCT00410761|587401478|FG001|Open-Label Treatment Period|Other|9|||
163015082|NCT00789373|588758972|FG001|Maintenance|Investigator Decision|4|||
163015083|NCT00789373|588758973|FG002|Maintenance|Investigator Decision|2|||
163015084|NCT00789373|588758971|FG000|Maintenance|Protocol entry criteria not met|0|||
163015085|NCT00789373|588758972|FG001|Maintenance|Protocol entry criteria not met|2|||
163015086|NCT00789373|588758973|FG002|Maintenance|Protocol entry criteria not met|0|||
163015087|NCT00789373|588758971|FG000|Maintenance|Lost to Follow-up|0|||
163015088|NCT00789373|588758972|FG001|Maintenance|Lost to Follow-up|2|||
163015089|NCT00789373|588758973|FG002|Maintenance|Lost to Follow-up|0|||
163015090|NCT00789373|588758971|FG000|Maintenance|Progressive Disease|0|||
163015091|NCT00789373|588758972|FG001|Maintenance|Progressive Disease|253|||
163015092|NCT00789373|588758973|FG002|Maintenance|Progressive Disease|152|||
163015093|NCT00789373|588758971|FG000|Maintenance|Withdrawal by Subject|0|||
163015094|NCT00789373|588758972|FG001|Maintenance|Withdrawal by Subject|21|||
163015095|NCT00789373|588758973|FG002|Maintenance|Withdrawal by Subject|8|||
163015096|NCT00789373|588758971|FG000|Maintenance|Sponsor Decision|0|||
163015097|NCT00789373|588758972|FG001|Maintenance|Sponsor Decision|0|||
163015098|NCT00789373|588758973|FG002|Maintenance|Sponsor Decision|2|||
163015099|NCT00789373|588758971|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
163015100|NCT00789373|588758972|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
163015101|NCT00789373|588758973|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
163015102|NCT02268916|588758996|FG000|Overall Study|Lost to Follow-up|1|||
163015103|NCT02268916|588758997|FG001|Overall Study|Lost to Follow-up|1|||
163015104|NCT02268916|588758996|FG000|Overall Study|Withdrawal by Subject|6|||
163015105|NCT02268916|588758997|FG001|Overall Study|Withdrawal by Subject|5|||
163015106|NCT02268916|588758996|FG000|Overall Study|Participant did not have diabetes|1|||
163015107|NCT02268916|588758997|FG001|Overall Study|Participant did not have diabetes|0|||
163015108|NCT02268916|588758996|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
163015109|NCT02268916|588758997|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
163015110|NCT00594165|588759002|FG000|Overall Study|Major protocol violation|1|||
163015111|NCT00594165|588759002|FG000|Overall Study|Lack of Efficacy|12|||
163015112|NCT00594165|588759002|FG000|Overall Study|Adverse Event|52|||
163015113|NCT00594165|588759002|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
163015114|NCT00594165|588759002|FG000|Overall Study|Subject withdrew consent|27|||
163015115|NCT00594165|588759002|FG000|Overall Study|Study ended per sponsor|102|||
163015116|NCT00594165|588759002|FG000|Overall Study|Lost to Follow-up|4|||
163015117|NCT00594165|588759002|FG000|Overall Study|Other: PI discretion|5|||
163015118|NCT00594165|588759002|FG000|Overall Study|Other: Subject moving|3|||
163015119|NCT00594165|588759002|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
163015120|NCT00594165|588759002|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
163015121|NCT00594165|588759002|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
163015122|NCT00594165|588759002|FG000|Overall Study|Other: Site terminated participation|2|||
163015123|NCT04830969|588759003|FG000|Overall Study|Withdrawal by Subject|6|||
163015124|NCT04830969|588759004|FG001|Overall Study|Withdrawal by Subject|2|||
163015125|NCT04830969|588759003|FG000|Overall Study|Protocol Violation|3|||
163015126|NCT04830969|588759004|FG001|Overall Study|Protocol Violation|9|||
163015127|NCT04830969|588759003|FG000|Overall Study|Lost to Follow-up|4|||
163015128|NCT04830969|588759004|FG001|Overall Study|Lost to Follow-up|4|||
163015129|NCT02097745|588759007|FG000|Overall Study|Adverse Event|25|||
163015130|NCT02097745|588759007|FG000|Overall Study|Death|16|||
163015131|NCT02097745|588759007|FG000|Overall Study|Failure to Return|14|||
163015132|NCT02097745|588759007|FG000|Overall Study|Administrative/Other|27|||
163015133|NCT02097745|588759007|FG000|Overall Study|Reason Not Specified|96|||
163015134|NCT02748356|588759008|FG000|Overall Study|Withdrawal by Subject|1|||
163015135|NCT00425750|588759009|FG000|Overall Study|Death|1|||
163015136|NCT00425750|588759009|FG000|Overall Study|Withdrawal by Subject|3|||
163015137|NCT00425750|588759009|FG000|Overall Study|Adverse Event|3|||
163015138|NCT00425750|588759009|FG000|Overall Study|Progression of disease|18|||
163015139|NCT00996125|588759010|FG000|Overall Study|Adverse Event|0|||
163015140|NCT00996125|588759011|FG001|Overall Study|Adverse Event|2|||
163015141|NCT00996125|588759010|FG000|Overall Study|Lost to Follow-up|1|||
163015142|NCT00996125|588759011|FG001|Overall Study|Lost to Follow-up|6|||
162640867|NCT00773292|587401482|FG000|Treatment 48 Weeks|Adverse Event|1|||
162640868|NCT00773292|587401482|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
162640869|NCT00708162|587401483|FG000|Randomized Phase|Randomized but Not Treated|7|||
162640870|NCT00708162|587401484|FG001|Randomized Phase|Randomized but Not Treated|5|||
162640871|NCT00708162|587401483|FG000|Randomized Phase|Participant Noncompliance|40|||
162640872|NCT00708162|587401484|FG001|Randomized Phase|Participant Noncompliance|32|||
162640873|NCT00708162|587401483|FG000|Randomized Phase|Lost to Follow-up|34|||
163015143|NCT00996125|588759010|FG000|Overall Study|Withdrawal by Subject|4|||
163015144|NCT00996125|588759011|FG001|Overall Study|Withdrawal by Subject|3|||
163015145|NCT04331067|588759012|FG000|Overall Study|Adverse Event|1|||
163062799|NCT02799602|588936949|FG000|Overall Study|Non-compliance with study drug|14|||
163062800|NCT02799602|588936950|FG001|Overall Study|Non-compliance with study drug|12|||
162640874|NCT00708162|587401484|FG001|Randomized Phase|Lost to Follow-up|34|||
163015146|NCT04331067|588759013|FG001|Overall Study|Adverse Event|3|||
163015147|NCT04331067|588759014|FG002|Overall Study|Adverse Event|1|||
163015148|NCT04331067|588759012|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
163015149|NCT04331067|588759013|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
163015150|NCT04331067|588759014|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
163015151|NCT05236764|588759015|FG000|Overall Study|In follow up (ongoing)|1|||
163015152|NCT05236764|588759015|FG000|Overall Study|Taken off study - secondary graft failure|1|||
163015153|NCT05236764|588759015|FG000|Overall Study|Death|1|||
162640875|NCT00708162|587401483|FG000|Randomized Phase|Withdrew Consent|31|||
162640876|NCT00708162|587401484|FG001|Randomized Phase|Withdrew Consent|22|||
163015154|NCT02062450|588759021|FG000|Overall Study|No follow-up visit|124|||
162640877|NCT00708162|587401483|FG000|Randomized Phase|Lack of Efficacy|14|||
162640878|NCT00708162|587401484|FG001|Randomized Phase|Lack of Efficacy|19|||
162640879|NCT00708162|587401483|FG000|Randomized Phase|Protocol Violation|10|||
162640880|NCT00708162|587401484|FG001|Randomized Phase|Protocol Violation|11|||
163015155|NCT01796392|588759022|FG000|Overall Study|Withdrawal by Subject|2|||
163015156|NCT01796392|588759023|FG001|Overall Study|Withdrawal by Subject|0|||
163015157|NCT01796392|588759022|FG000|Overall Study|Death|5|||
163015158|NCT01796392|588759023|FG001|Overall Study|Death|1|||
163015159|NCT01796392|588759022|FG000|Overall Study|Excluded for medical reasons|1|||
163015160|NCT01796392|588759023|FG001|Overall Study|Excluded for medical reasons|2|||
163015161|NCT01796392|588759022|FG000|Overall Study|Lost to Follow-up|1|||
163015162|NCT01796392|588759023|FG001|Overall Study|Lost to Follow-up|0|||
163015163|NCT03482635|588759024|FG000|Overall Study|Lack of Efficacy|0|||
163015164|NCT03482635|588759025|FG001|Overall Study|Lack of Efficacy|0|||
163015165|NCT03482635|588759026|FG002|Overall Study|Lack of Efficacy|1|||
163015166|NCT03482635|588759027|FG003|Overall Study|Lack of Efficacy|3|||
163015167|NCT03482635|588759024|FG000|Overall Study|Adverse Event|2|||
163015168|NCT03482635|588759025|FG001|Overall Study|Adverse Event|2|||
163015169|NCT03482635|588759026|FG002|Overall Study|Adverse Event|0|||
163015170|NCT03482635|588759027|FG003|Overall Study|Adverse Event|3|||
163015171|NCT03482635|588759024|FG000|Overall Study|Withdrawal by Subject|2|||
163015172|NCT03482635|588759025|FG001|Overall Study|Withdrawal by Subject|1|||
163015173|NCT03482635|588759026|FG002|Overall Study|Withdrawal by Subject|0|||
163015174|NCT03482635|588759027|FG003|Overall Study|Withdrawal by Subject|1|||
163015175|NCT03482635|588759024|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
163015176|NCT03482635|588759025|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
163015177|NCT03482635|588759026|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
163015178|NCT03482635|588759027|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
163015179|NCT03482635|588759024|FG000|Overall Study|Not treated|0|||
163015180|NCT03482635|588759025|FG001|Overall Study|Not treated|0|||
163015181|NCT03482635|588759026|FG002|Overall Study|Not treated|0|||
163015182|NCT03482635|588759027|FG003|Overall Study|Not treated|1|||
163154723|NCT02435992|589281387|FG002|Overall Study|Other Reason|0|||
163154724|NCT02435992|589281388|FG003|Overall Study|Other Reason|0|||
163154725|NCT02435992|589281389|FG004|Overall Study|Other Reason|0|||
163154726|NCT02435992|589281385|FG000|Overall Study|Physician Decision|0|||
163154727|NCT02435992|589281386|FG001|Overall Study|Physician Decision|0|||
163154728|NCT02435992|589281387|FG002|Overall Study|Physician Decision|1|||
163154729|NCT02435992|589281388|FG003|Overall Study|Physician Decision|0|||
163154730|NCT02435992|589281389|FG004|Overall Study|Physician Decision|0|||
163154731|NCT01210313|589281406|FG000|Overall Study|Withdrawal by Subject|3|||
163154732|NCT01210313|589281406|FG000|Overall Study|Adverse Event|2|||
163154733|NCT01210313|589281406|FG000|Overall Study|Distant recurrence|4|||
163154734|NCT01210313|589281406|FG000|Overall Study|Non-compliance|7|||
163154735|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
163154736|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
163154737|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
163154738|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
163154739|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
163154740|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
163154741|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
163154742|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
163154743|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
163154744|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
163154745|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
163154746|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
163154747|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
163154748|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
163154749|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
163154750|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
163154751|NCT03773978|589281411|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
163154752|NCT03773978|589281412|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
163154753|NCT03773978|589281411|FG000|DBW Period|Adverse Event|2|||
163154754|NCT03773978|589281412|FG001|DBW Period|Adverse Event|2|||
163154755|NCT03773978|589281411|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
163154756|NCT03773978|589281412|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
163154757|NCT03773978|589281411|FG000|DBW Period|Withdrawal by Subject|2|||
163154758|NCT03773978|589281412|FG001|DBW Period|Withdrawal by Subject|1|||
163154759|NCT03773978|589281411|FG000|DBW Period|Due to epidemic or pandemic|5|||
163154760|NCT03773978|589281412|FG001|DBW Period|Due to epidemic or pandemic|6|||
163154761|NCT03773978|589281411|FG000|DBW Period|Study team decision|1|||
163154762|NCT03773978|589281412|FG001|DBW Period|Study team decision|0|||
163015183|NCT04639219|588759028|FG000|Overall Study|Withdrawal by Subject|8|||
163015184|NCT04639219|588759028|FG000|Overall Study|Lost to Follow-up|6|||
163015185|NCT04639219|588759028|FG000|Overall Study|Death|55|||
163015186|NCT04681066|588759029|FG000|Overall Study|Lost to Follow-up|3|||
163015187|NCT04681066|588759030|FG001|Overall Study|Lost to Follow-up|1|||
163015188|NCT04681066|588759031|FG002|Overall Study|Lost to Follow-up|2|||
163015189|NCT04681066|588759032|FG003|Overall Study|Lost to Follow-up|1|||
163015190|NCT04681066|588759029|FG000|Overall Study|Withdrawal by Subject|2|||
163015191|NCT04681066|588759030|FG001|Overall Study|Withdrawal by Subject|1|||
163015192|NCT04681066|588759031|FG002|Overall Study|Withdrawal by Subject|0|||
163015193|NCT04681066|588759032|FG003|Overall Study|Withdrawal by Subject|3|||
163015194|NCT04681066|588759029|FG000|Overall Study|Death|0|||
163015195|NCT04681066|588759030|FG001|Overall Study|Death|1|||
163015196|NCT04681066|588759031|FG002|Overall Study|Death|0|||
163015197|NCT04681066|588759032|FG003|Overall Study|Death|0|||
163015198|NCT04495829|588759033|FG000|Overall Study|Lost to Follow-up|2|||
163015199|NCT04495829|588759033|FG000|Overall Study|Inclusion criterion not met|3|||
163015200|NCT01205269|588759042|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015201|NCT01205269|588759043|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015202|NCT01205269|588759044|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
162640881|NCT00708162|587401483|FG000|Randomized Phase|Adverse Event|8|||
162640882|NCT00708162|587401484|FG001|Randomized Phase|Adverse Event|12|||
162640883|NCT00708162|587401483|FG000|Randomized Phase|Investigator's Discretion|7|||
162640884|NCT00708162|587401484|FG001|Randomized Phase|Investigator's Discretion|10|||
162640885|NCT00708162|587401483|FG000|Randomized Phase|Death|2|||
162640886|NCT00708162|587401484|FG001|Randomized Phase|Death|9|||
162640887|NCT00708162|587401483|FG000|Randomized Phase|Pregnancy|3|||
162640888|NCT00708162|587401484|FG001|Randomized Phase|Pregnancy|0|||
162640889|NCT00708162|587401483|FG000|Open-Label Phase|Lost to Follow-up|10|||
162640890|NCT00708162|587401484|FG001|Open-Label Phase|Lost to Follow-up|8|||
162640891|NCT00708162|587401483|FG000|Open-Label Phase|Withdrew Consent|12|||
162640892|NCT00708162|587401484|FG001|Open-Label Phase|Withdrew Consent|6|||
162640893|NCT00708162|587401483|FG000|Open-Label Phase|Participant Noncompliance|7|||
162640894|NCT00708162|587401484|FG001|Open-Label Phase|Participant Noncompliance|7|||
162640895|NCT00708162|587401483|FG000|Open-Label Phase|Lack of Efficacy|7|||
162640896|NCT00708162|587401484|FG001|Open-Label Phase|Lack of Efficacy|4|||
162640897|NCT00708162|587401483|FG000|Open-Label Phase|Investigator's Discretion|3|||
162640898|NCT00708162|587401484|FG001|Open-Label Phase|Investigator's Discretion|2|||
162640899|NCT00708162|587401483|FG000|Open-Label Phase|Death|3|||
162640900|NCT00708162|587401484|FG001|Open-Label Phase|Death|1|||
162640901|NCT00708162|587401483|FG000|Open-Label Phase|Adverse Event|1|||
162640902|NCT00708162|587401484|FG001|Open-Label Phase|Adverse Event|2|||
162640903|NCT00708162|587401483|FG000|Open-Label Phase|Other|1|||
162640904|NCT00708162|587401484|FG001|Open-Label Phase|Other|0|||
162640905|NCT01349803|587401486|FG000|Overall Study|Adverse Event|0|||
162640906|NCT01349803|587401487|FG001|Overall Study|Adverse Event|0|||
162640907|NCT01349803|587401488|FG002|Overall Study|Adverse Event|0|||
162640908|NCT01349803|587401489|FG003|Overall Study|Adverse Event|2|||
162640909|NCT01349803|587401486|FG000|Overall Study|Withdrawal by Subject|1|||
162640910|NCT01349803|587401487|FG001|Overall Study|Withdrawal by Subject|0|||
162640911|NCT01349803|587401488|FG002|Overall Study|Withdrawal by Subject|0|||
162640912|NCT01349803|587401489|FG003|Overall Study|Withdrawal by Subject|0|||
162640913|NCT01349803|587401486|FG000|Overall Study|Protocol-specified criteria|0|||
162640914|NCT01349803|587401487|FG001|Overall Study|Protocol-specified criteria|1|||
163015203|NCT01205269|588759045|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
162640915|NCT01349803|587401488|FG002|Overall Study|Protocol-specified criteria|3|||
162640916|NCT01349803|587401489|FG003|Overall Study|Protocol-specified criteria|0|||
163015204|NCT01205269|588759046|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015205|NCT01205269|588759047|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
163015206|NCT00987337|588759048|FG000|Overall Study|Adverse Event|10|||
163015207|NCT00987337|588759049|FG001|Overall Study|Adverse Event|9|||
162640917|NCT02345811|587401490|FG000|First Intervention|Withdrawal by Subject|1|||
163015208|NCT00987337|588759050|FG002|Overall Study|Adverse Event|8|||
163015209|NCT00987337|588759048|FG000|Overall Study|Insufficient Virologic Response|10|||
162640918|NCT02345811|587401491|FG001|First Intervention|Withdrawal by Subject|1|||
162640919|NCT02522286|587401492|FG000|Overall Study|Withdrawal by Subject|3|||
162640920|NCT02522286|587401493|FG001|Overall Study|Withdrawal by Subject|0|||
163015210|NCT00987337|588759049|FG001|Overall Study|Insufficient Virologic Response|7|||
163015211|NCT00987337|588759050|FG002|Overall Study|Insufficient Virologic Response|12|||
163015212|NCT00987337|588759048|FG000|Overall Study|Virologic Breakthrough|2|||
163015213|NCT00987337|588759049|FG001|Overall Study|Virologic Breakthrough|2|||
163015214|NCT00987337|588759050|FG002|Overall Study|Virologic Breakthrough|8|||
163015215|NCT00987337|588759048|FG000|Overall Study|Lost to Follow-up|10|||
163015216|NCT00987337|588759049|FG001|Overall Study|Lost to Follow-up|6|||
163015217|NCT00987337|588759050|FG002|Overall Study|Lost to Follow-up|2|||
163015218|NCT00987337|588759048|FG000|Overall Study|Withdrawal by Subject|6|||
163015219|NCT00987337|588759049|FG001|Overall Study|Withdrawal by Subject|9|||
163015220|NCT00987337|588759050|FG002|Overall Study|Withdrawal by Subject|9|||
163015221|NCT00987337|588759048|FG000|Overall Study|Other|0|||
163015222|NCT00987337|588759049|FG001|Overall Study|Other|2|||
163015223|NCT00987337|588759050|FG002|Overall Study|Other|5|||
163015224|NCT00987337|588759048|FG000|Overall Study|Protocol Violation|1|||
163015225|NCT00987337|588759049|FG001|Overall Study|Protocol Violation|0|||
163015226|NCT00987337|588759050|FG002|Overall Study|Protocol Violation|2|||
163015227|NCT00987337|588759048|FG000|Overall Study|Participant Relapsed|18|||
163015228|NCT00987337|588759049|FG001|Overall Study|Participant Relapsed|20|||
163015229|NCT00987337|588759050|FG002|Overall Study|Participant Relapsed|5|||
163015230|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
163015231|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
163015232|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
163015233|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
163015234|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
163015235|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
163015236|NCT03868930|588760746|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
163062801|NCT02799602|588936949|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
163062802|NCT02799602|588936950|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
163062803|NCT02799602|588936949|FG000|Overall Study|Withdrawal by Subject|26|||
163062804|NCT02799602|588936950|FG001|Overall Study|Withdrawal by Subject|40|||
163062805|NCT02799602|588936949|FG000|Overall Study|Progressive disease - clinical progression|131|||
163062806|NCT02799602|588936950|FG001|Overall Study|Progressive disease - clinical progression|276|||
163062807|NCT02799602|588936949|FG000|Overall Study|Progressive disease - radiological progression|90|||
163062808|NCT02799602|588936950|FG001|Overall Study|Progressive disease - radiological progression|133|||
163062809|NCT02799602|588936949|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
163062810|NCT02799602|588936950|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
163062811|NCT02799602|588936949|FG000|Overall Study|Death|9|||
163062812|NCT02799602|588936950|FG001|Overall Study|Death|5|||
163062813|NCT02799602|588936949|FG000|Overall Study|Other|287|||
163062814|NCT02799602|588936950|FG001|Overall Study|Other|118|||
163062815|NCT02799602|588936949|FG000|Overall Study|Study drug never administered|0|||
163062816|NCT02799602|588936950|FG001|Overall Study|Study drug never administered|3|||
163062817|NCT01101178|588936955|FG000|Period 1|Withdrawal by Subject|1|||
163062818|NCT01101178|588936956|FG001|Period 1|Withdrawal by Subject|2|||
163062819|NCT01101178|588936955|FG000|Period 1|Positive drug screen|1|||
163062820|NCT01101178|588936956|FG001|Period 1|Positive drug screen|1|||
163062821|NCT01101178|588936955|FG000|Period 1|Adverse Event|2|||
163062822|NCT01101178|588936956|FG001|Period 1|Adverse Event|1|||
163062823|NCT01101178|588936955|FG000|Period 2|Withdrawal by Subject|0|||
163062824|NCT01101178|588936956|FG001|Period 2|Withdrawal by Subject|1|||
163062825|NCT01850641|588936957|FG000|Overall Study|Physician Decision|1|||
163062826|NCT01850641|588936957|FG000|Overall Study|Decrease in serum phosphorus|1|||
163062827|NCT01850641|588936957|FG000|Overall Study|Decrease in serum calcium|2|||
163062828|NCT01850641|588936957|FG000|Overall Study|Increase in serum ferritin|1|||
163062829|NCT00141817|588936958|FG000|Overall Study|Protocol Violation|0|||
163062830|NCT00141817|588936959|FG001|Overall Study|Protocol Violation|0|||
163062831|NCT00141817|588936960|FG002|Overall Study|Protocol Violation|1|||
163015237|NCT03868930|588760747|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
162640921|NCT02522286|587401494|FG002|Overall Study|Withdrawal by Subject|0|||
163015238|NCT03868930|588760746|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
163015239|NCT03868930|588760747|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
163015240|NCT02151851|588760750|FG000|Overall Study|Lack of Efficacy|67|||
163015241|NCT02151851|588760751|FG001|Overall Study|Lack of Efficacy|94|||
163015242|NCT02151851|588760750|FG000|Overall Study|Protocol Violation|0|||
163015243|NCT02151851|588760751|FG001|Overall Study|Protocol Violation|1|||
163062832|NCT00141817|588936961|FG003|Overall Study|Protocol Violation|0|||
163062833|NCT00141817|588936958|FG000|Overall Study|Parent request|1|||
163062834|NCT00141817|588936959|FG001|Overall Study|Parent request|0|||
163062835|NCT00141817|588936960|FG002|Overall Study|Parent request|0|||
162716074|NCT03354390|587667119|FG002|Level 2|Lack of Efficacy|0|||
163015244|NCT02151851|588760750|FG000|Overall Study|Withdrawal by Subject|2|||
163015245|NCT02151851|588760751|FG001|Overall Study|Withdrawal by Subject|5|||
163015246|NCT02151851|588760750|FG000|Overall Study|Medical impairment|1|||
163015247|NCT02151851|588760751|FG001|Overall Study|Medical impairment|0|||
163015248|NCT02151851|588760750|FG000|Overall Study|Low compliance to study visits|0|||
163015249|NCT02151851|588760751|FG001|Overall Study|Low compliance to study visits|1|||
163015250|NCT02151851|588760750|FG000|Overall Study|Subject entered into study in error|0|||
163015251|NCT02151851|588760751|FG001|Overall Study|Subject entered into study in error|1|||
163015252|NCT02151851|588760750|FG000|Overall Study|Adverse Event|6|||
163015253|NCT02151851|588760751|FG001|Overall Study|Adverse Event|28|||
163015254|NCT02159053|588760752|FG000|Overall Study|Death|2|||
163015255|NCT02159053|588760753|FG001|Overall Study|Death|0|||
163015256|NCT02159053|588760754|FG002|Overall Study|Death|1|||
163015257|NCT02159053|588760752|FG000|Overall Study|Physician Decision|0|||
163015258|NCT02159053|588760753|FG001|Overall Study|Physician Decision|1|||
163015259|NCT02159053|588760754|FG002|Overall Study|Physician Decision|1|||
163015260|NCT02159053|588760752|FG000|Overall Study|Lack of Efficacy|3|||
163015261|NCT02159053|588760753|FG001|Overall Study|Lack of Efficacy|4|||
163015262|NCT02159053|588760754|FG002|Overall Study|Lack of Efficacy|7|||
163015263|NCT02159053|588760752|FG000|Overall Study|Adverse Event|7|||
163015264|NCT02159053|588760753|FG001|Overall Study|Adverse Event|6|||
163015265|NCT02159053|588760754|FG002|Overall Study|Adverse Event|5|||
163015266|NCT02159053|588760752|FG000|Overall Study|Participants/guardian decision|8|||
163015267|NCT02159053|588760753|FG001|Overall Study|Participants/guardian decision|10|||
163015268|NCT02159053|588760754|FG002|Overall Study|Participants/guardian decision|6|||
163015269|NCT02640950|588760755|FG000|Overall Study|Adverse Event|1|||
163015270|NCT02640950|588760755|FG000|Overall Study|Withdrawal by Subject|1|||
163015271|NCT04545489|588760756|FG000|Overall Study|Withdrawal by Subject|12|||
163015272|NCT04545489|588760757|FG001|Overall Study|Withdrawal by Subject|4|||
163015273|NCT04545489|588760756|FG000|Overall Study|Lost to Follow-up|17|||
163015274|NCT04545489|588760757|FG001|Overall Study|Lost to Follow-up|18|||
163015275|NCT04545489|588760756|FG000|Overall Study|12month BP not collected|4|||
163015276|NCT04545489|588760757|FG001|Overall Study|12month BP not collected|4|||
163015277|NCT00652626|588760758|FG000|Initial Treatment Phase|Adverse Event|0|||
163015278|NCT00652626|588760759|FG001|Initial Treatment Phase|Adverse Event|0|||
163015279|NCT00652626|588760760|FG002|Initial Treatment Phase|Adverse Event|0|||
163015280|NCT00652626|588760761|FG003|Initial Treatment Phase|Adverse Event|0|||
163015281|NCT00652626|588760762|FG004|Initial Treatment Phase|Adverse Event|1|||
163015282|NCT00652626|588760763|FG005|Initial Treatment Phase|Adverse Event|0|||
163015283|NCT00652626|588760764|FG006|Initial Treatment Phase|Adverse Event|0|||
163015284|NCT00652626|588760758|FG000|Initial Treatment Phase|Protocol Violation|0|||
163015285|NCT00652626|588760759|FG001|Initial Treatment Phase|Protocol Violation|0|||
163015286|NCT00652626|588760760|FG002|Initial Treatment Phase|Protocol Violation|0|||
163015287|NCT00652626|588760761|FG003|Initial Treatment Phase|Protocol Violation|1|||
163015288|NCT00652626|588760762|FG004|Initial Treatment Phase|Protocol Violation|0|||
163015289|NCT00652626|588760763|FG005|Initial Treatment Phase|Protocol Violation|0|||
163015290|NCT00652626|588760764|FG006|Initial Treatment Phase|Protocol Violation|0|||
163015291|NCT00652626|588760758|FG000|Initial Treatment Phase|Physician Decision|0|||
163015292|NCT00652626|588760759|FG001|Initial Treatment Phase|Physician Decision|0|||
163015293|NCT00652626|588760760|FG002|Initial Treatment Phase|Physician Decision|0|||
163015294|NCT00652626|588760761|FG003|Initial Treatment Phase|Physician Decision|0|||
163015295|NCT00652626|588760762|FG004|Initial Treatment Phase|Physician Decision|1|||
163015296|NCT00652626|588760763|FG005|Initial Treatment Phase|Physician Decision|0|||
163015297|NCT00652626|588760764|FG006|Initial Treatment Phase|Physician Decision|0|||
163015298|NCT00652626|588760758|FG000|Initial Treatment Phase|Sponsor Request|0|||
163015299|NCT00652626|588760759|FG001|Initial Treatment Phase|Sponsor Request|0|||
163015300|NCT00652626|588760760|FG002|Initial Treatment Phase|Sponsor Request|1|||
163015301|NCT00652626|588760761|FG003|Initial Treatment Phase|Sponsor Request|0|||
163015302|NCT00652626|588760762|FG004|Initial Treatment Phase|Sponsor Request|0|||
163015303|NCT00652626|588760763|FG005|Initial Treatment Phase|Sponsor Request|0|||
163015304|NCT00652626|588760764|FG006|Initial Treatment Phase|Sponsor Request|0|||
163015305|NCT00652626|588760758|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
163015306|NCT00652626|588760759|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
163015307|NCT00652626|588760760|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
163015308|NCT00652626|588760761|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
163015309|NCT00652626|588760762|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
163015310|NCT00652626|588760763|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
163015311|NCT00652626|588760764|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
162716075|NCT03354390|587667120|FG003|Level 2|Lack of Efficacy|0|||
163015312|NCT00652626|588760758|FG000|Extension Phase|Withdrawal by Subject|0|||
163015313|NCT00652626|588760759|FG001|Extension Phase|Withdrawal by Subject|0|||
163015314|NCT00652626|588760760|FG002|Extension Phase|Withdrawal by Subject|0|||
163015315|NCT00652626|588760761|FG003|Extension Phase|Withdrawal by Subject|0|||
163015316|NCT00652626|588760762|FG004|Extension Phase|Withdrawal by Subject|0|||
163015317|NCT00652626|588760763|FG005|Extension Phase|Withdrawal by Subject|2|||
163015318|NCT00652626|588760764|FG006|Extension Phase|Withdrawal by Subject|0|||
163015319|NCT00652626|588760758|FG000|Extension Phase|Adverse Event|0|||
163015320|NCT00652626|588760759|FG001|Extension Phase|Adverse Event|0|||
163015321|NCT00652626|588760760|FG002|Extension Phase|Adverse Event|0|||
163015322|NCT00652626|588760761|FG003|Extension Phase|Adverse Event|0|||
163015323|NCT00652626|588760762|FG004|Extension Phase|Adverse Event|0|||
163015324|NCT00652626|588760763|FG005|Extension Phase|Adverse Event|2|||
163015325|NCT00652626|588760764|FG006|Extension Phase|Adverse Event|1|||
163015326|NCT00652626|588760758|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015327|NCT00652626|588760759|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015328|NCT00652626|588760760|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015329|NCT00652626|588760761|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015330|NCT00652626|588760762|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015331|NCT00652626|588760763|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
163015332|NCT00652626|588760764|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
163015333|NCT00652626|588760758|FG000|Extension Phase|Physician Decision|0|||
163015334|NCT00652626|588760759|FG001|Extension Phase|Physician Decision|0|||
163015335|NCT00652626|588760760|FG002|Extension Phase|Physician Decision|0|||
163015336|NCT00652626|588760761|FG003|Extension Phase|Physician Decision|0|||
163015337|NCT00652626|588760762|FG004|Extension Phase|Physician Decision|0|||
163015338|NCT00652626|588760763|FG005|Extension Phase|Physician Decision|1|||
163015339|NCT00652626|588760764|FG006|Extension Phase|Physician Decision|1|||
163015340|NCT00652626|588760758|FG000|Extension Phase|Death|0|||
163015341|NCT00652626|588760759|FG001|Extension Phase|Death|0|||
163015342|NCT00652626|588760760|FG002|Extension Phase|Death|0|||
163015343|NCT00652626|588760761|FG003|Extension Phase|Death|0|||
163015344|NCT00652626|588760762|FG004|Extension Phase|Death|0|||
163015345|NCT00652626|588760763|FG005|Extension Phase|Death|1|||
163015346|NCT00652626|588760764|FG006|Extension Phase|Death|1|||
163015347|NCT04003636|588760765|FG000|Overall Study|Death|409|||
163015348|NCT04003636|588760766|FG001|Overall Study|Death|443|||
163015349|NCT04003636|588760765|FG000|Overall Study|Lost to Follow-up|0|||
163015350|NCT04003636|588760766|FG001|Overall Study|Lost to Follow-up|1|||
163015351|NCT04003636|588760765|FG000|Overall Study|Withdrawal by Subject|5|||
163015352|NCT04003636|588760766|FG001|Overall Study|Withdrawal by Subject|2|||
163015353|NCT04003636|588760765|FG000|Overall Study|Participant On-going|119|||
163015354|NCT04003636|588760766|FG001|Overall Study|Participant On-going|90|||
163015355|NCT03048747|588760767|FG000|Overall Study|Adverse Event|2|||
163015356|NCT03048747|588760767|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
163015357|NCT03048747|588760767|FG000|Overall Study|Physician Decision|1|||
163015358|NCT00915018|588760770|FG000|Overall Study|Death|75|||
163015359|NCT00915018|588760771|FG001|Overall Study|Death|70|||
163015360|NCT00915018|588760770|FG000|Overall Study|Lost to Follow-up|10|||
163015361|NCT00915018|588760771|FG001|Overall Study|Lost to Follow-up|5|||
163015362|NCT00915018|588760770|FG000|Overall Study|Withdrawal by Subject|38|||
163015363|NCT00915018|588760771|FG001|Overall Study|Withdrawal by Subject|27|||
163015364|NCT00915018|588760770|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
163015365|NCT00915018|588760771|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
163015366|NCT00300885|588760772|FG000|Treatment|Adverse Event|134|||
163015367|NCT00300885|588760773|FG001|Treatment|Adverse Event|82|||
163015368|NCT00300885|588760772|FG000|Treatment|Death|20|||
163015369|NCT00300885|588760773|FG001|Treatment|Death|7|||
163015370|NCT00300885|588760772|FG000|Treatment|Lack of Efficacy|1|||
163015371|NCT00300885|588760773|FG001|Treatment|Lack of Efficacy|1|||
163015372|NCT00300885|588760772|FG000|Treatment|Lost to Follow-up|3|||
163015373|NCT00300885|588760773|FG001|Treatment|Lost to Follow-up|2|||
163015374|NCT00300885|588760772|FG000|Treatment|Physician Decision|4|||
163015375|NCT00300885|588760773|FG001|Treatment|Physician Decision|5|||
163015376|NCT00300885|588760772|FG000|Treatment|Protocol Violation|11|||
163015377|NCT00300885|588760773|FG001|Treatment|Protocol Violation|11|||
163015378|NCT00300885|588760772|FG000|Treatment|Withdrawal by Subject|26|||
163015379|NCT00300885|588760773|FG001|Treatment|Withdrawal by Subject|23|||
163062836|NCT00141817|588936961|FG003|Overall Study|Parent request|0|||
163015380|NCT00300885|588760772|FG000|Treatment|Disease progression|171|||
163015381|NCT00300885|588760773|FG001|Treatment|Disease progression|238|||
163015382|NCT00300885|588760772|FG000|Treatment|Random code broken (subject died)|0|||
163015383|NCT00300885|588760773|FG001|Treatment|Random code broken (subject died)|1|||
163015384|NCT00300885|588760772|FG000|Treatment|Non-compliant with study medication|3|||
163015385|NCT00300885|588760773|FG001|Treatment|Non-compliant with study medication|4|||
163015386|NCT00300885|588760772|FG000|Follow-up|Death|141|||
163015387|NCT00300885|588760773|FG001|Follow-up|Death|163|||
163015388|NCT00300885|588760772|FG000|Follow-up|Lost to Follow-up|11|||
163015389|NCT00300885|588760773|FG001|Follow-up|Lost to Follow-up|7|||
163015390|NCT00300885|588760772|FG000|Follow-up|Withdrawal by Subject|26|||
163015391|NCT00300885|588760773|FG001|Follow-up|Withdrawal by Subject|25|||
163015392|NCT02582242|588760774|FG000|Overall Study|Adverse Event|4|||
163015393|NCT02582242|588760775|FG001|Overall Study|Adverse Event|3|||
163015394|NCT02582242|588760774|FG000|Overall Study|Protocol Violation|3|||
163015395|NCT02582242|588760775|FG001|Overall Study|Protocol Violation|1|||
163015396|NCT02582242|588760774|FG000|Overall Study|Lost to Follow-up|0|||
163015397|NCT02582242|588760775|FG001|Overall Study|Lost to Follow-up|1|||
163015398|NCT02582242|588760774|FG000|Overall Study|Withdrawal by Subject|11|||
163015399|NCT02582242|588760775|FG001|Overall Study|Withdrawal by Subject|11|||
163015400|NCT02582242|588760774|FG000|Overall Study|Unclassified|2|||
163015401|NCT02582242|588760775|FG001|Overall Study|Unclassified|1|||
163015402|NCT02492984|588760776|FG000|Overall Study|Adverse Event|1|||
163015403|NCT02492984|588760777|FG001|Overall Study|Adverse Event|0|||
163015404|NCT02492984|588760776|FG000|Overall Study|Protocol Violation|1|||
163015405|NCT02492984|588760777|FG001|Overall Study|Protocol Violation|0|||
163015406|NCT02492984|588760776|FG000|Overall Study|Withdrawal by Subject|1|||
163015407|NCT02492984|588760777|FG001|Overall Study|Withdrawal by Subject|0|||
163015408|NCT02101736|588760781|FG000|Overall Study|Protocol Violation|3|||
163015409|NCT02101736|588760782|FG001|Overall Study|Protocol Violation|0|||
163015410|NCT02101736|588760781|FG000|Overall Study|Withdrawal by Subject|1|||
163015411|NCT02101736|588760782|FG001|Overall Study|Withdrawal by Subject|1|||
163015412|NCT02282631|588760783|FG000|Overall Study|Lost to Follow-up|2|||
163015413|NCT02282631|588760784|FG001|Overall Study|Lost to Follow-up|0|||
163015414|NCT02453334|588760785|FG000|Overall Study|Death|15|||
163015415|NCT02453334|588760786|FG001|Overall Study|Death|13|||
163015416|NCT02453334|588760785|FG000|Overall Study|Adverse Event|2|||
163015417|NCT02453334|588760786|FG001|Overall Study|Adverse Event|1|||
163015418|NCT02453334|588760785|FG000|Overall Study|Lost to Follow-up|5|||
163015419|NCT02453334|588760786|FG001|Overall Study|Lost to Follow-up|9|||
163015420|NCT02453334|588760785|FG000|Overall Study|Physician Decision|1|||
163015421|NCT02453334|588760786|FG001|Overall Study|Physician Decision|0|||
163015422|NCT02453334|588760785|FG000|Overall Study|Withdrawal by Subject|17|||
163015423|NCT02453334|588760786|FG001|Overall Study|Withdrawal by Subject|13|||
163015424|NCT02453334|588760785|FG000|Overall Study|Other reason|1|||
163015425|NCT02453334|588760786|FG001|Overall Study|Other reason|4|||
163015426|NCT01841762|588760787|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
163015427|NCT01841762|588760787|FG000|Treatment Period|Adverse Event|16|||
163015428|NCT01841762|588760787|FG000|Treatment Period|Death|1|||
163015429|NCT01841762|588760787|FG000|Treatment Period|Withdrawal by Subject|7|||
163015430|NCT01841762|588760787|FG000|Treatment Period|Lost to Follow-up|1|||
163015431|NCT01841762|588760787|FG000|Treatment Period|Physician Decision|2|||
163015432|NCT01841762|588760787|FG000|Treatment Period|Other, including non-compliance|5|||
163015433|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
163015434|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
163015435|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
163015436|NCT01841762|588760787|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
163015437|NCT05483686|588760793|FG000|Overall Study|Lost to Follow-up|5|||
163015438|NCT05483686|588760794|FG001|Overall Study|Lost to Follow-up|7|||
163015439|NCT03981900|588760795|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
163015440|NCT03981900|588760795|FG000|Overall Study|Adverse Event|5|||
163015441|NCT03981900|588760795|FG000|Overall Study|Protocol Violation|1|||
163015442|NCT03981900|588760795|FG000|Overall Study|Withdrawal by Subject|7|||
163015443|NCT03981900|588760795|FG000|Overall Study|Lost to Follow-up|46|||
163015444|NCT03981900|588760795|FG000|Overall Study|Decision of the researcher|3|||
163015445|NCT03981900|588760795|FG000|Overall Study|Death|3|||
163015446|NCT03981900|588760795|FG000|Overall Study|Other|5|||
163015447|NCT02693106|588760796|FG000|Overall Study|No time|3|||
163015448|NCT06152224|588760806|FG000|Overall Study|Withdrawal by Subject|1|||
163015449|NCT06152224|588760807|FG001|Overall Study|Withdrawal by Subject|0|||
163015450|NCT06152224|588760806|FG000|Overall Study|Lost to Follow-up|0|||
163015451|NCT06152224|588760807|FG001|Overall Study|Lost to Follow-up|1|||
163015452|NCT06152224|588760806|FG000|Overall Study|On Follow Up|18|||
163015453|NCT06152224|588760807|FG001|Overall Study|On Follow Up|18|||
163015454|NCT05780983|588760808|FG000|Overall Study|Withdrawal by Subject|1|||
163015455|NCT06028438|588760812|FG000|Overall Study|Adverse Event|3|||
163015456|NCT06028438|588760813|FG001|Overall Study|Adverse Event|9|||
163015457|NCT06028438|588760812|FG000|Overall Study|Lack of Efficacy|1|||
163015458|NCT06028438|588760813|FG001|Overall Study|Lack of Efficacy|1|||
163015459|NCT06028438|588760812|FG000|Overall Study|Lost to Follow-up|1|||
163015460|NCT06028438|588760813|FG001|Overall Study|Lost to Follow-up|0|||
163015461|NCT06028438|588760812|FG000|Overall Study|Withdrawal by Subject|1|||
163062837|NCT00127803|588936964|FG000|Overall Study|Adverse Event|2|||
163015462|NCT06028438|588760813|FG001|Overall Study|Withdrawal by Subject|0|||
163015463|NCT06028438|588760812|FG000|Overall Study|Other|3|||
163015464|NCT06028438|588760813|FG001|Overall Study|Other|3|||
163015465|NCT05625802|588760814|FG000|Overall Study|Lost to Follow-up|1|||
163015466|NCT05625802|588760815|FG001|Overall Study|Lost to Follow-up|0|||
163015467|NCT00808210|588760817|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
163015468|NCT00808210|588760818|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
163015469|NCT00808210|588760817|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
163015470|NCT00808210|588760818|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
163015471|NCT00808210|588760817|FG000|Double-Blind TX Period|Adverse Event|0|||
163015472|NCT00808210|588760818|FG001|Double-Blind TX Period|Adverse Event|1|||
163015473|NCT00808210|588760817|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
163015474|NCT00808210|588760818|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
163015475|NCT00808210|588760817|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
163015476|NCT00808210|588760818|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
163015477|NCT00808210|588760817|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
163015478|NCT00808210|588760818|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
163015479|NCT02044302|588760819|FG000|Overall Study|study terminated|2|||
163015480|NCT02044302|588760820|FG001|Overall Study|study terminated|0|||
163015481|NCT03150719|588760821|FG000|Overall Study|Adverse Event|0|||
163015482|NCT03150719|588760822|FG001|Overall Study|Adverse Event|1|||
163015483|NCT03150719|588760821|FG000|Overall Study|Death|0|||
163015484|NCT03150719|588760822|FG001|Overall Study|Death|1|||
163015485|NCT03150719|588760821|FG000|Overall Study|Other|1|||
163015486|NCT03150719|588760822|FG001|Overall Study|Other|0|||
163015487|NCT01954056|588760824|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
163015488|NCT01954056|588760825|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
163015489|NCT04938180|588760829|FG000|Overall Study|Adverse Event|1|||
163015490|NCT01964222|588760832|FG000|Overall Study|Lost to Follow-up|7|||
163015491|NCT01964222|588760833|FG001|Overall Study|Lost to Follow-up|5|||
163015492|NCT01964222|588760832|FG000|Overall Study|Withdrawal by Subject|6|||
163015493|NCT01964222|588760833|FG001|Overall Study|Withdrawal by Subject|6|||
163015494|NCT01964222|588760832|FG000|Overall Study|Screening Failure|2|||
163015495|NCT01964222|588760833|FG001|Overall Study|Screening Failure|0|||
163015496|NCT01019694|588760836|FG000|Overall Study|Adverse Event|12|||
163015497|NCT01019694|588760837|FG001|Overall Study|Adverse Event|16|||
163015498|NCT01019694|588760838|FG002|Overall Study|Adverse Event|19|||
163015499|NCT01019694|588760836|FG000|Overall Study|Protocol Violation|2|||
163015500|NCT01019694|588760837|FG001|Overall Study|Protocol Violation|6|||
163015501|NCT01019694|588760838|FG002|Overall Study|Protocol Violation|4|||
163015502|NCT01019694|588760836|FG000|Overall Study|Lost to Follow-up|5|||
163015503|NCT01019694|588760837|FG001|Overall Study|Lost to Follow-up|3|||
163015504|NCT01019694|588760838|FG002|Overall Study|Lost to Follow-up|3|||
163015505|NCT01019694|588760836|FG000|Overall Study|Withdrawal by Subject|4|||
163015506|NCT01019694|588760837|FG001|Overall Study|Withdrawal by Subject|6|||
163015507|NCT01019694|588760838|FG002|Overall Study|Withdrawal by Subject|12|||
163015508|NCT01019694|588760836|FG000|Overall Study|Not treated|0|||
163015509|NCT01019694|588760837|FG001|Overall Study|Not treated|2|||
163015510|NCT01019694|588760838|FG002|Overall Study|Not treated|3|||
163015511|NCT01019694|588760836|FG000|Overall Study|Other reason (not specified)|1|||
163015512|NCT01019694|588760837|FG001|Overall Study|Other reason (not specified)|5|||
163015513|NCT01019694|588760838|FG002|Overall Study|Other reason (not specified)|6|||
163015514|NCT00441129|588760841|FG000|Overall Study|Withdrawal by Subject|6|||
163015515|NCT00441129|588760842|FG001|Overall Study|Withdrawal by Subject|14|||
163015516|NCT00463047|588760843|FG000|Titration Period 1|Adverse Event|10|||
163015517|NCT00463047|588760844|FG001|Titration Period 1|Adverse Event|8|||
163015518|NCT00463047|588760843|FG000|Titration Period 1|Lack of Efficacy|10|||
163015519|NCT00463047|588760844|FG001|Titration Period 1|Lack of Efficacy|4|||
163015520|NCT00463047|588760843|FG000|Titration Period 1|Lost to Follow-up|2|||
163015521|NCT00463047|588760844|FG001|Titration Period 1|Lost to Follow-up|0|||
163015522|NCT00463047|588760843|FG000|Titration Period 1|Non-compliance with study medication|3|||
163015523|NCT00463047|588760844|FG001|Titration Period 1|Non-compliance with study medication|5|||
163015524|NCT00463047|588760843|FG000|Titration Period 1|Protocol Violation|5|||
163062838|NCT00127803|588936965|FG001|Overall Study|Adverse Event|0|||
163062839|NCT00127803|588936966|FG002|Overall Study|Adverse Event|0|||
163015525|NCT00463047|588760844|FG001|Titration Period 1|Protocol Violation|5|||
163015526|NCT00463047|588760843|FG000|Titration Period 1|Withdrawal by Subject|3|||
163015527|NCT00463047|588760844|FG001|Titration Period 1|Withdrawal by Subject|5|||
163015528|NCT00463047|588760843|FG000|Titration Period 1|Non-compliance procedures|4|||
163015529|NCT00463047|588760844|FG001|Titration Period 1|Non-compliance procedures|10|||
163062840|NCT00127803|588936967|FG003|Overall Study|Adverse Event|0|||
163015530|NCT00463047|588760843|FG000|Titration Period 1|Other|0|||
163015531|NCT00463047|588760844|FG001|Titration Period 1|Other|2|||
163015532|NCT00463047|588760843|FG000|Titration Period 2|Adverse Event|9|||
163062841|NCT00127803|588936964|FG000|Overall Study|Withdrawal by Subject|1|||
163015533|NCT00463047|588760844|FG001|Titration Period 2|Adverse Event|9|||
163015534|NCT00463047|588760843|FG000|Titration Period 2|Lack of Efficacy|6|||
163015535|NCT00463047|588760844|FG001|Titration Period 2|Lack of Efficacy|4|||
163015536|NCT00463047|588760843|FG000|Titration Period 2|Withdrawal by Subject|1|||
163015537|NCT00463047|588760844|FG001|Titration Period 2|Withdrawal by Subject|0|||
163015538|NCT00463047|588760843|FG000|Titration Period 2|Protocol Violation|2|||
163015539|NCT00463047|588760844|FG001|Titration Period 2|Protocol Violation|3|||
163015540|NCT00463047|588760843|FG000|Titration Period 2|Lost to Follow-up|1|||
163015541|NCT00463047|588760844|FG001|Titration Period 2|Lost to Follow-up|2|||
163015542|NCT00463047|588760843|FG000|Titration Period 2|Non-compliance study medication|4|||
163015543|NCT00463047|588760844|FG001|Titration Period 2|Non-compliance study medication|2|||
163015544|NCT00463047|588760843|FG000|Titration Period 2|Non-compliance procedures|4|||
163015545|NCT00463047|588760844|FG001|Titration Period 2|Non-compliance procedures|1|||
163015546|NCT00463047|588760843|FG000|Titration Period 2|Other|3|||
163015547|NCT00463047|588760844|FG001|Titration Period 2|Other|2|||
163015548|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
163015549|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
163015550|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
163015551|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
163015552|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
163015553|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
163015554|NCT00463047|588760843|FG000|Double-Blind Treatment Period 1|Other|1|||
163015555|NCT00463047|588760844|FG001|Double-Blind Treatment Period 1|Other|0|||
163015556|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
163015557|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
163015558|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
163015559|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
163015560|NCT00463047|588760843|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
163015561|NCT00463047|588760844|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
163015562|NCT04278417|588760857|FG000|Overall Study|Withdrawal by Subject|20|||
163015563|NCT04278417|588760858|FG001|Overall Study|Withdrawal by Subject|20|||
163015564|NCT04278417|588760857|FG000|Overall Study|Progressive disease|0|||
163015565|NCT04278417|588760858|FG001|Overall Study|Progressive disease|2|||
163015566|NCT04278417|588760857|FG000|Overall Study|Physician Decision|4|||
163015567|NCT04278417|588760858|FG001|Overall Study|Physician Decision|6|||
163015568|NCT04278417|588760857|FG000|Overall Study|Lost to Follow-up|11|||
163015569|NCT04278417|588760858|FG001|Overall Study|Lost to Follow-up|13|||
163015570|NCT04278417|588760857|FG000|Overall Study|Death|8|||
163015571|NCT04278417|588760858|FG001|Overall Study|Death|9|||
163015572|NCT04278417|588760857|FG000|Overall Study|Adverse Event|3|||
163015573|NCT04278417|588760858|FG001|Overall Study|Adverse Event|5|||
163015574|NCT01732458|588760860|FG000|Overall Study|Lost to Follow-up|0|||
163015575|NCT01732458|588760861|FG001|Overall Study|Lost to Follow-up|2|||
163015576|NCT01732458|588760862|FG002|Overall Study|Lost to Follow-up|0|||
163015577|NCT01732458|588760863|FG003|Overall Study|Lost to Follow-up|0|||
163015578|NCT01732458|588760860|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163015579|NCT01732458|588760861|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163015580|NCT01732458|588760862|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163015581|NCT01732458|588760863|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163015582|NCT01732458|588760860|FG000|Overall Study|Physician Decision|1|||
163015583|NCT01732458|588760861|FG001|Overall Study|Physician Decision|2|||
163015584|NCT01732458|588760862|FG002|Overall Study|Physician Decision|2|||
163015585|NCT01732458|588760863|FG003|Overall Study|Physician Decision|0|||
163015586|NCT01732458|588760860|FG000|Overall Study|Protocol Violation|2|||
163015587|NCT01732458|588760861|FG001|Overall Study|Protocol Violation|0|||
163015588|NCT01732458|588760862|FG002|Overall Study|Protocol Violation|0|||
163015589|NCT01732458|588760863|FG003|Overall Study|Protocol Violation|2|||
163015590|NCT01732458|588760860|FG000|Overall Study|Screen Failure|0|||
163015591|NCT01732458|588760861|FG001|Overall Study|Screen Failure|1|||
163015592|NCT01732458|588760862|FG002|Overall Study|Screen Failure|0|||
163015593|NCT01732458|588760863|FG003|Overall Study|Screen Failure|0|||
163015594|NCT05870371|588760864|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
163015595|NCT05870371|588760865|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
163015596|NCT02203721|588760866|FG000|Overall Study|Lost to Follow-up|1|||
163015597|NCT02203721|588760867|FG001|Overall Study|Lost to Follow-up|0|||
163015598|NCT02203721|588760866|FG000|Overall Study|Death|0|||
163015599|NCT02203721|588760867|FG001|Overall Study|Death|2|||
163015600|NCT02203721|588760866|FG000|Overall Study|Illness|0|||
163015601|NCT02203721|588760867|FG001|Overall Study|Illness|1|||
163015602|NCT00703157|588760868|FG000|Overall Study|Lost to Follow-up|0|||
163015603|NCT00703157|588760869|FG001|Overall Study|Lost to Follow-up|1|||
163015604|NCT00703157|588760868|FG000|Overall Study|source data permanently lost/ other|4|||
163015605|NCT00703157|588760869|FG001|Overall Study|source data permanently lost/ other|1|||
163015606|NCT00347009|588760870|FG000|Overall Study|Death|1|||
163015607|NCT00347009|588760870|FG000|Overall Study|Adverse Event|6|||
163015608|NCT00347009|588760870|FG000|Overall Study|Withdrawal by Subject|3|||
163015609|NCT00347009|588760870|FG000|Overall Study|Physician Decision|5|||
163015610|NCT00347009|588760870|FG000|Overall Study|Lost to Follow-up|4|||
163015611|NCT00347009|588760870|FG000|Overall Study|Protocol Violation|2|||
163015612|NCT00347009|588760870|FG000|Overall Study|Adverse Laboratory Experience|1|||
163015613|NCT00347009|588760870|FG000|Overall Study|Insufficient Viral Suppression|3|||
163015614|NCT00347009|588760870|FG000|Overall Study|Increased ALT/HBV DNA|1|||
163015615|NCT00347009|588760870|FG000|Overall Study|Serious Adverse Event|1|||
163015616|NCT02522884|588760873|FG000|Overall Study|Withdrawal by Subject|6|||
163015617|NCT02522884|588760873|FG000|Overall Study|Death|3|||
163015618|NCT02522884|588760873|FG000|Overall Study|Missed 12-month Follow-up|9|||
163015619|NCT04495751|588760874|FG000|Overall Study|Withdrawal by Subject|1|||
163015620|NCT04495751|588760875|FG001|Overall Study|Withdrawal by Subject|0|||
163015621|NCT04495751|588760874|FG000|Overall Study|Lost to Follow-up|1|||
163015622|NCT04495751|588760875|FG001|Overall Study|Lost to Follow-up|0|||
163015623|NCT00708461|588760876|FG000|Overall Study|Lost to Follow-up|18|||
163015624|NCT00708461|588760877|FG001|Overall Study|Lost to Follow-up|11|||
163015625|NCT00708461|588760876|FG000|Overall Study|Withdrawal by Subject|8|||
163015626|NCT00708461|588760877|FG001|Overall Study|Withdrawal by Subject|9|||
163015627|NCT00708461|588760876|FG000|Overall Study|left workforce|115|||
163015628|NCT00708461|588760877|FG001|Overall Study|left workforce|180|||
163015629|NCT02907177|588760878|FG000|Overall Study|Death|0|||
163015630|NCT02907177|588760879|FG001|Overall Study|Death|1|||
163015631|NCT02907177|588760878|FG000|Overall Study|Physician Decision|3|||
163015632|NCT02907177|588760879|FG001|Overall Study|Physician Decision|3|||
163015633|NCT02907177|588760878|FG000|Overall Study|Withdrawal by Subject|15|||
163015634|NCT02907177|588760879|FG001|Overall Study|Withdrawal by Subject|7|||
163015635|NCT02907177|588760878|FG000|Overall Study|Sponsor's Decision|50|||
163015636|NCT02907177|588760879|FG001|Overall Study|Sponsor's Decision|57|||
163015637|NCT02968173|588760880|FG000|Overall Study|Withdrawal by Subject|1|||
163015638|NCT00314327|588760884|FG000|Overall Study|Withdrawal by Subject|1|||
163015639|NCT01207687|588760885|FG000|Overall Study|Adverse Event|1|||
163015640|NCT01207687|588760885|FG000|Overall Study|Withdrawal by Subject|1|||
163015641|NCT03474965|588760886|FG000|Overall Study|Pregnancy|1|||
163015642|NCT03474965|588760887|FG001|Overall Study|Pregnancy|0|||
163015643|NCT03474965|588760888|FG002|Overall Study|Pregnancy|0|||
163015644|NCT03474965|588760889|FG003|Overall Study|Pregnancy|0|||
163015645|NCT03474965|588760886|FG000|Overall Study|Lost to Follow-up|0|||
163015646|NCT03474965|588760887|FG001|Overall Study|Lost to Follow-up|0|||
163015647|NCT03474965|588760888|FG002|Overall Study|Lost to Follow-up|1|||
163015648|NCT03474965|588760889|FG003|Overall Study|Lost to Follow-up|0|||
163015649|NCT03474965|588760886|FG000|Overall Study|Death|1|||
163015650|NCT03474965|588760887|FG001|Overall Study|Death|0|||
163015651|NCT03474965|588760888|FG002|Overall Study|Death|0|||
163015652|NCT03474965|588760889|FG003|Overall Study|Death|0|||
163015653|NCT03474965|588760886|FG000|Overall Study|Adverse Event|1|||
163015654|NCT03474965|588760887|FG001|Overall Study|Adverse Event|0|||
163015655|NCT03474965|588760888|FG002|Overall Study|Adverse Event|0|||
163015656|NCT03474965|588760889|FG003|Overall Study|Adverse Event|1|||
163015657|NCT03474965|588760886|FG000|Overall Study|Physician Decision|3|||
163015658|NCT03474965|588760887|FG001|Overall Study|Physician Decision|1|||
163015659|NCT03474965|588760888|FG002|Overall Study|Physician Decision|2|||
163015660|NCT03474965|588760889|FG003|Overall Study|Physician Decision|0|||
163015661|NCT03474965|588760886|FG000|Overall Study|Participant Decision|7|||
163015662|NCT03474965|588760887|FG001|Overall Study|Participant Decision|0|||
163015663|NCT03474965|588760888|FG002|Overall Study|Participant Decision|1|||
163015664|NCT03474965|588760889|FG003|Overall Study|Participant Decision|0|||
163015665|NCT03474965|588760886|FG000|Overall Study|Guardian Decision|4|||
163015666|NCT03474965|588760887|FG001|Overall Study|Guardian Decision|2|||
163015667|NCT03474965|588760888|FG002|Overall Study|Guardian Decision|7|||
163015668|NCT03474965|588760889|FG003|Overall Study|Guardian Decision|2|||
163015669|NCT01637922|588762415|FG000|Overall Study|Adverse Event|0|||
163015670|NCT01637922|588762416|FG001|Overall Study|Adverse Event|1|||
163015671|NCT01637922|588762415|FG000|Overall Study|Protocol Violation|0|||
163015672|NCT01637922|588762416|FG001|Overall Study|Protocol Violation|1|||
163015673|NCT01637922|588762415|FG000|Overall Study|Withdrawal by Subject|0|||
163015674|NCT01637922|588762416|FG001|Overall Study|Withdrawal by Subject|3|||
163015675|NCT01637922|588762415|FG000|Overall Study|Lost to Follow-up|2|||
163015676|NCT01637922|588762416|FG001|Overall Study|Lost to Follow-up|0|||
163015677|NCT00638404|588762417|FG000|Overall Study|Physician Decision|8|||
163015678|NCT00638404|588762418|FG001|Overall Study|Physician Decision|0|||
163015679|NCT00459290|588762419|FG000|Overall Study|Adverse Event|3|||
163015680|NCT00459290|588762419|FG000|Overall Study|Ineligible|2|||
163015681|NCT00687271|588762420|FG000|Overall Study|Adverse Event|1|||
163015682|NCT00687271|588762421|FG001|Overall Study|Adverse Event|3|||
163015683|NCT00687271|588762422|FG002|Overall Study|Adverse Event|1|||
163015684|NCT00687271|588762423|FG003|Overall Study|Adverse Event|0|||
163015685|NCT00687271|588762420|FG000|Overall Study|Lost to Follow-up|0|||
163015686|NCT00687271|588762421|FG001|Overall Study|Lost to Follow-up|1|||
163015687|NCT00687271|588762422|FG002|Overall Study|Lost to Follow-up|0|||
163015688|NCT00687271|588762423|FG003|Overall Study|Lost to Follow-up|0|||
163015689|NCT00687271|588762420|FG000|Overall Study|Protocol Violation|2|||
163015690|NCT00687271|588762421|FG001|Overall Study|Protocol Violation|1|||
163015691|NCT00687271|588762422|FG002|Overall Study|Protocol Violation|1|||
163015692|NCT00687271|588762423|FG003|Overall Study|Protocol Violation|0|||
163015693|NCT00687271|588762420|FG000|Overall Study|Withdrawal by Subject|0|||
163015694|NCT00687271|588762421|FG001|Overall Study|Withdrawal by Subject|1|||
163015695|NCT00687271|588762422|FG002|Overall Study|Withdrawal by Subject|3|||
163015696|NCT00687271|588762423|FG003|Overall Study|Withdrawal by Subject|0|||
163015697|NCT04090060|588762430|FG000|Overall Study|Lost to Follow-up|76|||
163015698|NCT04090060|588762431|FG001|Overall Study|Lost to Follow-up|77|||
163015699|NCT03337113|588762438|FG000|Overall Study|Adverse Event|1|||
163015700|NCT03337113|588762439|FG001|Overall Study|Adverse Event|1|||
163015701|NCT03337113|588762440|FG002|Overall Study|Adverse Event|0|||
163015702|NCT03337113|588762441|FG003|Overall Study|Adverse Event|1|||
163015703|NCT03337113|588762438|FG000|Overall Study|Physician Decision|0|||
163015704|NCT03337113|588762439|FG001|Overall Study|Physician Decision|2|||
163015705|NCT03337113|588762440|FG002|Overall Study|Physician Decision|0|||
163015706|NCT03337113|588762441|FG003|Overall Study|Physician Decision|1|||
163015707|NCT03337113|588762438|FG000|Overall Study|Withdrawal by Subject|0|||
163015708|NCT03337113|588762439|FG001|Overall Study|Withdrawal by Subject|0|||
163015709|NCT03337113|588762440|FG002|Overall Study|Withdrawal by Subject|1|||
163015710|NCT03337113|588762441|FG003|Overall Study|Withdrawal by Subject|0|||
163015711|NCT01164579|588762442|FG000|Overall Study|Lack of Efficacy|0|||
163015712|NCT01164579|588762443|FG001|Overall Study|Lack of Efficacy|0|||
163015713|NCT01164579|588762444|FG002|Overall Study|Lack of Efficacy|6|||
163015714|NCT01164579|588762442|FG000|Overall Study|Lost to Follow-up|1|||
163015715|NCT01164579|588762443|FG001|Overall Study|Lost to Follow-up|1|||
163015716|NCT01164579|588762444|FG002|Overall Study|Lost to Follow-up|0|||
163015717|NCT01164579|588762442|FG000|Overall Study|Withdrawal by Subject|2|||
163015718|NCT01164579|588762443|FG001|Overall Study|Withdrawal by Subject|5|||
163015719|NCT01164579|588762444|FG002|Overall Study|Withdrawal by Subject|3|||
163015720|NCT01164579|588762442|FG000|Overall Study|Protocol Violation|0|||
163015721|NCT01164579|588762443|FG001|Overall Study|Protocol Violation|1|||
163015722|NCT01164579|588762444|FG002|Overall Study|Protocol Violation|2|||
163015723|NCT01164579|588762442|FG000|Overall Study|Adverse Event|4|||
163015724|NCT01164579|588762443|FG001|Overall Study|Adverse Event|2|||
163015725|NCT01164579|588762444|FG002|Overall Study|Adverse Event|5|||
163015726|NCT01164579|588762442|FG000|Overall Study|Reason not specified|1|||
163015727|NCT01164579|588762443|FG001|Overall Study|Reason not specified|0|||
163015728|NCT01164579|588762444|FG002|Overall Study|Reason not specified|0|||
163015729|NCT02176655|588762453|FG000|Overall Study|Subjects did not treat|6|||
163015730|NCT00507455|588762454|FG000|Overall Study|Adverse Event|3|||
163015731|NCT00507455|588762455|FG001|Overall Study|Adverse Event|3|||
163015732|NCT00507455|588762456|FG002|Overall Study|Adverse Event|6|||
163015733|NCT00507455|588762454|FG000|Overall Study|Withdrawal by Subject|2|||
163015734|NCT00507455|588762455|FG001|Overall Study|Withdrawal by Subject|1|||
163015735|NCT00507455|588762456|FG002|Overall Study|Withdrawal by Subject|2|||
163015736|NCT00507455|588762454|FG000|Overall Study|Protocol Violation|4|||
163015737|NCT00507455|588762455|FG001|Overall Study|Protocol Violation|1|||
163015738|NCT00507455|588762456|FG002|Overall Study|Protocol Violation|1|||
163015739|NCT00507455|588762454|FG000|Overall Study|Lost to Follow-up|2|||
163015740|NCT00507455|588762455|FG001|Overall Study|Lost to Follow-up|0|||
163015741|NCT00507455|588762456|FG002|Overall Study|Lost to Follow-up|2|||
163015742|NCT00507455|588762454|FG000|Overall Study|Lack of Efficacy|0|||
163015743|NCT00507455|588762455|FG001|Overall Study|Lack of Efficacy|1|||
163015744|NCT00507455|588762456|FG002|Overall Study|Lack of Efficacy|0|||
163015745|NCT00507455|588762454|FG000|Overall Study|Other - miscellaneous reason|1|||
163015746|NCT00507455|588762455|FG001|Overall Study|Other - miscellaneous reason|0|||
163015747|NCT00507455|588762456|FG002|Overall Study|Other - miscellaneous reason|1|||
163015748|NCT01372995|588762457|FG000|Overall Study|Spouse withdrew participant from study|0|||
163015749|NCT01372995|588762458|FG001|Overall Study|Spouse withdrew participant from study|1|||
163015750|NCT01372995|588762459|FG002|Overall Study|Spouse withdrew participant from study|0|||
163015751|NCT01372995|588762457|FG000|Overall Study|Physician Decision|0|||
163015752|NCT01372995|588762458|FG001|Overall Study|Physician Decision|0|||
163015753|NCT01372995|588762459|FG002|Overall Study|Physician Decision|1|||
163015754|NCT06110494|588762465|FG000|Overall Study|Protocol Violation|2|||
163015755|NCT06110494|588762466|FG001|Overall Study|Protocol Violation|0|||
163015756|NCT06110494|588762467|FG002|Overall Study|Protocol Violation|1|||
163015757|NCT06110494|588762465|FG000|Overall Study|Dixon's test for outlier analysis|1|||
163015758|NCT06110494|588762466|FG001|Overall Study|Dixon's test for outlier analysis|1|||
163015759|NCT06110494|588762467|FG002|Overall Study|Dixon's test for outlier analysis|0|||
163015760|NCT00105079|588762468|FG000|Overall Study|Adverse Event|5|||
163015761|NCT00105079|588762469|FG001|Overall Study|Adverse Event|12|||
163015762|NCT00105079|588762468|FG000|Overall Study|Death|3|||
163015763|NCT00105079|588762469|FG001|Overall Study|Death|1|||
163015764|NCT00105079|588762468|FG000|Overall Study|Lost to Follow-up|12|||
163015765|NCT00105079|588762469|FG001|Overall Study|Lost to Follow-up|12|||
163015766|NCT00105079|588762468|FG000|Overall Study|Lack of Efficacy|9|||
163062842|NCT00127803|588936965|FG001|Overall Study|Withdrawal by Subject|0|||
163062843|NCT00127803|588936966|FG002|Overall Study|Withdrawal by Subject|0|||
163062844|NCT00127803|588936967|FG003|Overall Study|Withdrawal by Subject|0|||
163062845|NCT00127803|588936964|FG000|Overall Study|Lost to Follow-up|0|||
163015767|NCT00105079|588762469|FG001|Overall Study|Lack of Efficacy|3|||
163015768|NCT00105079|588762468|FG000|Overall Study|Refused treatment|6|||
163015769|NCT00105079|588762469|FG001|Overall Study|Refused treatment|4|||
163015770|NCT00105079|588762468|FG000|Overall Study|Violation of selection criteria at entry|0|||
163015771|NCT00105079|588762469|FG001|Overall Study|Violation of selection criteria at entry|2|||
163015772|NCT00105079|588762468|FG000|Overall Study|Protocol Violation|1|||
163015773|NCT00105079|588762469|FG001|Overall Study|Protocol Violation|0|||
163015774|NCT00105079|588762468|FG000|Overall Study|Other|3|||
163015775|NCT00105079|588762469|FG001|Overall Study|Other|1|||
163015776|NCT01464593|588762470|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
163015777|NCT01297517|588762477|FG000|Overall Study|Adverse Event|21|||
163015778|NCT01297517|588762478|FG001|Overall Study|Adverse Event|7|||
163015779|NCT01297517|588762479|FG002|Overall Study|Adverse Event|16|||
163015780|NCT01297517|588762477|FG000|Overall Study|Lost to Follow-up|1|||
163015781|NCT01297517|588762478|FG001|Overall Study|Lost to Follow-up|0|||
163015782|NCT01297517|588762479|FG002|Overall Study|Lost to Follow-up|1|||
163015783|NCT01297517|588762477|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
163015784|NCT01297517|588762478|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
163015785|NCT01297517|588762479|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
163015786|NCT01297517|588762477|FG000|Overall Study|Noncompliance|1|||
163015787|NCT01297517|588762478|FG001|Overall Study|Noncompliance|0|||
163015788|NCT01297517|588762479|FG002|Overall Study|Noncompliance|0|||
163015789|NCT01297517|588762477|FG000|Overall Study|Protocol Violation|1|||
163015790|NCT01297517|588762478|FG001|Overall Study|Protocol Violation|1|||
163015791|NCT01297517|588762479|FG002|Overall Study|Protocol Violation|1|||
163015792|NCT01297517|588762477|FG000|Overall Study|Inadequate Control of IOP|1|||
163015793|NCT01297517|588762478|FG001|Overall Study|Inadequate Control of IOP|1|||
163015794|NCT01297517|588762479|FG002|Overall Study|Inadequate Control of IOP|2|||
163015795|NCT02914613|588762480|FG000|Overall Study|Withdrawal by Subject|1|||
163015796|NCT02914613|588762481|FG001|Overall Study|Withdrawal by Subject|2|||
163015797|NCT02914613|588762480|FG000|Overall Study|Adverse Event|1|||
163015798|NCT02914613|588762481|FG001|Overall Study|Adverse Event|0|||
163015799|NCT01737710|588762484|FG000|Overall Study|Lost to Follow-up|0|||
163015800|NCT01737710|588762485|FG001|Overall Study|Lost to Follow-up|2|||
163015801|NCT01737710|588762486|FG002|Overall Study|Lost to Follow-up|2|||
163015802|NCT01737710|588762487|FG003|Overall Study|Lost to Follow-up|0|||
163015803|NCT01737710|588762488|FG004|Overall Study|Lost to Follow-up|0|||
163015804|NCT01737710|588762484|FG000|Overall Study|Withdrawal by Subject|1|||
163015805|NCT01737710|588762485|FG001|Overall Study|Withdrawal by Subject|1|||
163015806|NCT01737710|588762486|FG002|Overall Study|Withdrawal by Subject|1|||
163015807|NCT01737710|588762487|FG003|Overall Study|Withdrawal by Subject|0|||
163015808|NCT01737710|588762488|FG004|Overall Study|Withdrawal by Subject|0|||
163015809|NCT01737710|588762484|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
163015810|NCT01737710|588762485|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
163015811|NCT01737710|588762486|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
163062846|NCT00127803|588936965|FG001|Overall Study|Lost to Follow-up|0|||
163015812|NCT01737710|588762487|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
163015813|NCT01737710|588762488|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
163015814|NCT00921557|588762494|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
163015815|NCT00921557|588762495|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
163015816|NCT00921557|588762496|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
163015817|NCT00921557|588762494|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
163015818|NCT00921557|588762495|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
163015819|NCT00921557|588762496|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
163015820|NCT00921557|588762494|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
163015821|NCT00921557|588762495|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
163015822|NCT00921557|588762496|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
163015823|NCT00921557|588762494|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
163015824|NCT00921557|588762495|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
163015825|NCT00921557|588762496|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
163015826|NCT00921557|588762494|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
163015827|NCT00921557|588762495|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
163015828|NCT00921557|588762496|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
163015829|NCT02993250|588762500|FG000|Overall Study|Lost to Follow-up|0|||
163015830|NCT02993250|588762501|FG001|Overall Study|Lost to Follow-up|1|||
163015831|NCT02527434|588762503|FG000|Overall Study|Lost to Follow-up|2|||
163015832|NCT02527434|588762504|FG001|Overall Study|Lost to Follow-up|2|||
163062847|NCT00127803|588936966|FG002|Overall Study|Lost to Follow-up|0|||
163015833|NCT02527434|588762505|FG002|Overall Study|Lost to Follow-up|0|||
163015834|NCT02527434|588762503|FG000|Overall Study|Death|19|||
163015835|NCT02527434|588762504|FG001|Overall Study|Death|6|||
163015836|NCT02527434|588762505|FG002|Overall Study|Death|17|||
163015837|NCT02527434|588762503|FG000|Overall Study|Withdrawal by Subject|5|||
163015838|NCT02527434|588762504|FG001|Overall Study|Withdrawal by Subject|3|||
163015839|NCT02527434|588762505|FG002|Overall Study|Withdrawal by Subject|3|||
163015840|NCT02527434|588762503|FG000|Overall Study|Reason Not Specified|1|||
163015841|NCT02527434|588762504|FG001|Overall Study|Reason Not Specified|0|||
163015842|NCT02527434|588762505|FG002|Overall Study|Reason Not Specified|0|||
163015843|NCT02527434|588762503|FG000|Overall Study|Site closure|1|||
163015844|NCT02527434|588762504|FG001|Overall Study|Site closure|0|||
163015845|NCT02527434|588762505|FG002|Overall Study|Site closure|0|||
163015846|NCT02861807|588762506|FG000|Overall Study|Lost to Follow-up|7|||
163015847|NCT02861807|588762507|FG001|Overall Study|Lost to Follow-up|6|||
163015848|NCT02861807|588762506|FG000|Overall Study|Withdrawal by Subject|5|||
163015849|NCT02861807|588762507|FG001|Overall Study|Withdrawal by Subject|8|||
163015850|NCT00568061|588762512|FG000|Overall Study|Inclusion / exclusion criteria|5|||
163015851|NCT00568061|588762513|FG001|Overall Study|Inclusion / exclusion criteria|1|||
163015852|NCT00568061|588762512|FG000|Overall Study|Adverse Event|0|||
163015853|NCT00568061|588762513|FG001|Overall Study|Adverse Event|1|||
163015854|NCT00356148|588762514|FG000|Overall Study|Reoperation within 30 days|2|||
163015855|NCT00356148|588762515|FG001|Overall Study|Reoperation within 30 days|1|||
163015856|NCT02693002|588762516|FG000|Overall Study|Withdrawal by Subject|1|||
163015857|NCT02693002|588762517|FG001|Overall Study|Withdrawal by Subject|0|||
163015858|NCT04666259|588762519|FG000|Treatment Phase|Physician Decision|9|||
163015859|NCT04666259|588762520|FG001|Treatment Phase|Physician Decision|3|||
163015860|NCT04666259|588762521|FG002|Treatment Phase|Physician Decision|3|||
163015861|NCT04666259|588762519|FG000|Treatment Phase|Adverse Event|3|||
163015862|NCT04666259|588762520|FG001|Treatment Phase|Adverse Event|1|||
163015863|NCT04666259|588762521|FG002|Treatment Phase|Adverse Event|0|||
163015864|NCT04666259|588762519|FG000|Treatment Phase|Subject decision|1|||
163015865|NCT04666259|588762520|FG001|Treatment Phase|Subject decision|2|||
163015866|NCT04666259|588762521|FG002|Treatment Phase|Subject decision|0|||
163015867|NCT04666259|588762519|FG000|Treatment Phase|Progressive disease|0|||
163015868|NCT04666259|588762520|FG001|Treatment Phase|Progressive disease|1|||
163015869|NCT04666259|588762521|FG002|Treatment Phase|Progressive disease|0|||
163015870|NCT04666259|588762519|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
163015871|NCT04666259|588762520|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
163015872|NCT04666259|588762521|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
163015873|NCT04666259|588762519|FG000|Safety Follow-up Phase|Physician Decision|2|||
163015874|NCT04666259|588762520|FG001|Safety Follow-up Phase|Physician Decision|0|||
163015875|NCT04666259|588762521|FG002|Safety Follow-up Phase|Physician Decision|0|||
163015876|NCT04666259|588762519|FG000|Safety Follow-up Phase|Subject decision|1|||
163015877|NCT04666259|588762520|FG001|Safety Follow-up Phase|Subject decision|0|||
163015878|NCT04666259|588762521|FG002|Safety Follow-up Phase|Subject decision|0|||
163015879|NCT04666259|588762519|FG000|Safety Follow-up Phase|Death|0|||
163015880|NCT04666259|588762520|FG001|Safety Follow-up Phase|Death|1|||
163015881|NCT04666259|588762521|FG002|Safety Follow-up Phase|Death|0|||
163015882|NCT01791894|588762526|FG000|Overall Study|Adverse Event|1|||
163015883|NCT01422889|588762527|FG000|Overall Study|No Data Entered for Study Stent|9|||
163015884|NCT03289754|588762538|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
163015885|NCT04873934|588762539|FG000|Overall Study|Adverse Event|0|||
163015886|NCT04873934|588762540|FG001|Overall Study|Adverse Event|1|||
163015887|NCT04873934|588762539|FG000|Overall Study|Death|0|||
163015888|NCT04873934|588762540|FG001|Overall Study|Death|2|||
163015889|NCT04873934|588762539|FG000|Overall Study|Lost to Follow-up|13|||
163015890|NCT04873934|588762540|FG001|Overall Study|Lost to Follow-up|9|||
162640922|NCT02522286|587401495|FG003|Overall Study|Withdrawal by Subject|3|||
162640923|NCT00605813|587401497|FG000|Overall Study|Protocol Violation|25|||
162640924|NCT01163279|587401499|FG000|Overall Study|Withdrawal by Subject|2|||
162640925|NCT01163279|587401500|FG001|Overall Study|Withdrawal by Subject|0|||
162640926|NCT03525574|587401504|FG000|Overall Study|Adverse Event|15|||
162640927|NCT03525574|587401505|FG001|Overall Study|Adverse Event|0|||
162640928|NCT03525574|587401504|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
162640929|NCT03525574|587401505|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
162640930|NCT03525574|587401504|FG000|Overall Study|Lost to Follow-up|4|||
163015891|NCT04873934|588762539|FG000|Overall Study|Physician Decision|1|||
163015892|NCT04873934|588762540|FG001|Overall Study|Physician Decision|1|||
163015893|NCT04873934|588762539|FG000|Overall Study|Protocol deviation|2|||
163015894|NCT04873934|588762540|FG001|Overall Study|Protocol deviation|1|||
163015895|NCT04873934|588762539|FG000|Overall Study|Subject decision|1|||
163015896|NCT04873934|588762540|FG001|Overall Study|Subject decision|8|||
163015897|NCT04873934|588762539|FG000|Overall Study|Withdrew consent|0|||
163015898|NCT04873934|588762540|FG001|Overall Study|Withdrew consent|4|||
163015899|NCT04873934|588762539|FG000|Overall Study|Missing|1|||
163015900|NCT04873934|588762540|FG001|Overall Study|Missing|0|||
163015901|NCT03584854|588762541|FG000|Overall Study|Primary outcome not measured|1|||
163015902|NCT03584854|588762542|FG001|Overall Study|Primary outcome not measured|2|||
163015903|NCT00153179|588762548|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
163015904|NCT00153179|588762549|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
163015905|NCT00153179|588762550|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
163015906|NCT00153179|588762551|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
163015907|NCT01801865|588762552|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
163015908|NCT01801865|588762552|FG000|Overall Study|Physician Decision|7|||
163015909|NCT01500382|588762555|FG000|Washout Period|Study site went out of business|0|||
163015910|NCT01500382|588762556|FG001|Washout Period|Study site went out of business|0|||
163015911|NCT01500382|588762557|FG002|Washout Period|Study site went out of business|1|||
163015912|NCT01500382|588762558|FG003|Washout Period|Study site went out of business|0|||
163015913|NCT02134015|588762559|FG000|Overall Study|Protocol Violation|0|||
163015914|NCT02134015|588762560|FG001|Overall Study|Protocol Violation|1|||
163015915|NCT02134015|588762559|FG000|Overall Study|Death|2|||
163015916|NCT02134015|588762560|FG001|Overall Study|Death|1|||
163015917|NCT02134015|588762559|FG000|Overall Study|Reason not provided|1|||
163015918|NCT02134015|588762560|FG001|Overall Study|Reason not provided|2|||
163015919|NCT02134015|588762559|FG000|Overall Study|Clinical progression|14|||
163015920|NCT02134015|588762560|FG001|Overall Study|Clinical progression|7|||
163015921|NCT02134015|588762559|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
163015922|NCT02134015|588762560|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
163015923|NCT02134015|588762559|FG000|Overall Study|Study terminated by sponsor|2|||
163015924|NCT02134015|588762560|FG001|Overall Study|Study terminated by sponsor|3|||
163015925|NCT02134015|588762559|FG000|Overall Study|Adverse Event|9|||
163015926|NCT02134015|588762560|FG001|Overall Study|Adverse Event|10|||
163015927|NCT02134015|588762559|FG000|Overall Study|Withdrawal by Subject|3|||
163015928|NCT02134015|588762560|FG001|Overall Study|Withdrawal by Subject|7|||
163015929|NCT02186873|588764112|FG000|Overall Study|Adverse Event|1|||
163015930|NCT02186873|588764113|FG001|Overall Study|Adverse Event|3|||
163015931|NCT02186873|588764112|FG000|Overall Study|Lack of Efficacy|0|||
163015932|NCT02186873|588764113|FG001|Overall Study|Lack of Efficacy|1|||
163015933|NCT02186873|588764112|FG000|Overall Study|Lost to Follow-up|1|||
163015934|NCT02186873|588764113|FG001|Overall Study|Lost to Follow-up|2|||
163015935|NCT02186873|588764112|FG000|Overall Study|Withdrawal by Subject|7|||
163015936|NCT02186873|588764113|FG001|Overall Study|Withdrawal by Subject|2|||
163015937|NCT03694002|588764114|FG000|Overall Study|Progression|4|||
163015938|NCT03694002|588764115|FG001|Overall Study|Progression|2|||
163015939|NCT03694002|588764114|FG000|Overall Study|Adverse Event|2|||
163015940|NCT03694002|588764115|FG001|Overall Study|Adverse Event|0|||
163015941|NCT03694002|588764114|FG000|Overall Study|Other not protocol specified|1|||
163015942|NCT03694002|588764115|FG001|Overall Study|Other not protocol specified|0|||
163015943|NCT03694002|588764114|FG000|Overall Study|Ineligible|0|||
163015944|NCT03694002|588764115|FG001|Overall Study|Ineligible|1|||
163015945|NCT03694002|588764114|FG000|Overall Study|Withdrew consent before starting treatment|0|||
163015946|NCT03694002|588764115|FG001|Overall Study|Withdrew consent before starting treatment|3|||
163015947|NCT01760655|588764116|FG000|Overall Study|Death|18|||
163015948|NCT01760655|588764116|FG000|Overall Study|Physician Decision|1|||
163015949|NCT00068393|588764121|FG000|Overall Study|Adverse Event|2|||
163015950|NCT00068393|588764121|FG000|Overall Study|Death|3|||
163015951|NCT00068393|588764121|FG000|Overall Study|Withdrawal by Subject|3|||
163015952|NCT00068393|588764121|FG000|Overall Study|Alternative treatment|1|||
163015953|NCT00068393|588764121|FG000|Overall Study|Quality of life worsening|1|||
163015954|NCT01399047|588764122|FG000|Overall Study|Withdrawal by Subject|0|||
163015955|NCT01399047|588764123|FG001|Overall Study|Withdrawal by Subject|1|||
163015956|NCT03300505|588764129|FG000|Overall Study|Death|0|||
163015957|NCT03300505|588764130|FG001|Overall Study|Death|1|||
163015958|NCT03300505|588764131|FG002|Overall Study|Death|0|||
163015959|NCT03300505|588764129|FG000|Overall Study|Withdrawal by Subject|0|||
163015960|NCT03300505|588764130|FG001|Overall Study|Withdrawal by Subject|1|||
163015961|NCT03300505|588764131|FG002|Overall Study|Withdrawal by Subject|1|||
163015962|NCT03300505|588764129|FG000|Overall Study|Sponsor Termination|0|||
163015963|NCT03300505|588764130|FG001|Overall Study|Sponsor Termination|1|||
163015964|NCT03300505|588764131|FG002|Overall Study|Sponsor Termination|0|||
163015965|NCT03300505|588764129|FG000|Overall Study|Adverse Event|0|||
162716076|NCT03354390|587667117|FG000|Level 2|Lost to Follow-up|0|||
162716077|NCT03354390|587667118|FG001|Level 2|Lost to Follow-up|1|||
163015966|NCT03300505|588764130|FG001|Overall Study|Adverse Event|0|||
163015967|NCT03300505|588764131|FG002|Overall Study|Adverse Event|2|||
163015968|NCT01108341|588764134|FG000|Overall Study|Death|2|||
163015969|NCT01108341|588764134|FG000|Overall Study|Withdrawal by Subject|1|||
163015970|NCT01108341|588764134|FG000|Overall Study|Lost to Follow-up|1|||
163015971|NCT01108341|588764134|FG000|Overall Study|Other|1|||
163015972|NCT01515865|588764137|FG000|Part A (Open-label)|Other|3|||
163015973|NCT01515865|588764138|FG001|Part A (Open-label)|Other|0|||
163015974|NCT01515865|588764139|FG002|Part A (Open-label)|Other|0|||
163015975|NCT01515865|588764137|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
163015976|NCT01515865|588764138|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
163015977|NCT01515865|588764139|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
163015978|NCT01515865|588764137|FG000|Part B (Open-label)|Other|1|||
163015979|NCT01515865|588764138|FG001|Part B (Open-label)|Other|0|||
163015980|NCT01515865|588764139|FG002|Part B (Open-label)|Other|0|||
163015981|NCT02510664|588764144|FG000|Overall Study|Transferred Care|9|||
163015982|NCT02510664|588764145|FG001|Overall Study|Transferred Care|9|||
163015983|NCT02510664|588764146|FG002|Overall Study|Transferred Care|0|||
163015984|NCT02510664|588764144|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
163015985|NCT02510664|588764145|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
163015986|NCT02510664|588764146|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
163015987|NCT02510664|588764144|FG000|Overall Study|Time Constraints|1|||
163015988|NCT02510664|588764145|FG001|Overall Study|Time Constraints|1|||
163015989|NCT02510664|588764146|FG002|Overall Study|Time Constraints|0|||
163015990|NCT00386360|588764147|FG000|Overall Study|Adverse Event|4|||
163015991|NCT00386360|588764148|FG001|Overall Study|Adverse Event|2|||
163015992|NCT00386360|588764147|FG000|Overall Study|Physician Decision|2|||
163015993|NCT00386360|588764148|FG001|Overall Study|Physician Decision|2|||
163015994|NCT00386360|588764147|FG000|Overall Study|Lost to Follow-up|0|||
163015995|NCT00386360|588764148|FG001|Overall Study|Lost to Follow-up|2|||
163015996|NCT00386360|588764147|FG000|Overall Study|Protocol Violation|0|||
163015997|NCT00386360|588764148|FG001|Overall Study|Protocol Violation|3|||
163015998|NCT00386360|588764147|FG000|Overall Study|Withdrawal by Subject|3|||
163015999|NCT00386360|588764148|FG001|Overall Study|Withdrawal by Subject|6|||
163016000|NCT00386360|588764147|FG000|Overall Study|Did not take any study medication|0|||
163016001|NCT00386360|588764148|FG001|Overall Study|Did not take any study medication|2|||
163016002|NCT02490371|588764151|FG000|Overall Study|Lost to Follow-up|1|||
163016003|NCT02490371|588764152|FG001|Overall Study|Lost to Follow-up|1|||
163016004|NCT03018080|588764153|FG000|Overall Study|Death|12|||
163016005|NCT03018080|588764154|FG001|Overall Study|Death|19|||
163016006|NCT00026494|588764157|FG000|Overall Study|Withdrawal by Subject|1|||
163016007|NCT00026494|588764158|FG001|Overall Study|Withdrawal by Subject|0|||
163016008|NCT00026494|588764159|FG002|Overall Study|Withdrawal by Subject|1|||
163016009|NCT00026494|588764160|FG003|Overall Study|Withdrawal by Subject|0|||
163016010|NCT00026494|588764157|FG000|Overall Study|Patient non-compliance|1|||
163016011|NCT00026494|588764158|FG001|Overall Study|Patient non-compliance|0|||
163016012|NCT00026494|588764159|FG002|Overall Study|Patient non-compliance|0|||
163016013|NCT00026494|588764160|FG003|Overall Study|Patient non-compliance|0|||
163016014|NCT00026494|588764157|FG000|Overall Study|Patient not treated|0|||
163016015|NCT00026494|588764158|FG001|Overall Study|Patient not treated|0|||
163016016|NCT00026494|588764159|FG002|Overall Study|Patient not treated|2|||
163016017|NCT00026494|588764160|FG003|Overall Study|Patient not treated|0|||
163016018|NCT00026494|588764157|FG000|Overall Study|Clinical progression|0|||
163016019|NCT00026494|588764158|FG001|Overall Study|Clinical progression|0|||
163016020|NCT00026494|588764159|FG002|Overall Study|Clinical progression|3|||
163016021|NCT00026494|588764160|FG003|Overall Study|Clinical progression|0|||
163016022|NCT01455597|588764161|FG000|Overall Study|Adverse Event|7|||
163016023|NCT01455597|588764162|FG001|Overall Study|Adverse Event|0|||
163016024|NCT01455597|588764163|FG002|Overall Study|Adverse Event|5|||
163016025|NCT01455597|588764164|FG003|Overall Study|Adverse Event|1|||
163016026|NCT01455597|588764161|FG000|Overall Study|Lack of Efficacy|0|||
163016027|NCT01455597|588764162|FG001|Overall Study|Lack of Efficacy|1|||
163016028|NCT01455597|588764163|FG002|Overall Study|Lack of Efficacy|2|||
163016029|NCT01455597|588764164|FG003|Overall Study|Lack of Efficacy|0|||
163016030|NCT01455597|588764161|FG000|Overall Study|Lost to Follow-up|3|||
163016031|NCT01455597|588764162|FG001|Overall Study|Lost to Follow-up|0|||
163016032|NCT01455597|588764163|FG002|Overall Study|Lost to Follow-up|2|||
163016033|NCT01455597|588764164|FG003|Overall Study|Lost to Follow-up|1|||
163016034|NCT01455597|588764161|FG000|Overall Study|Withdrew Consent|6|||
163016035|NCT01455597|588764162|FG001|Overall Study|Withdrew Consent|5|||
163016036|NCT01455597|588764163|FG002|Overall Study|Withdrew Consent|8|||
163016037|NCT01455597|588764164|FG003|Overall Study|Withdrew Consent|5|||
163016038|NCT01455597|588764161|FG000|Overall Study|Reason not Specified|1|||
163016039|NCT01455597|588764162|FG001|Overall Study|Reason not Specified|2|||
163016040|NCT01455597|588764163|FG002|Overall Study|Reason not Specified|3|||
162716078|NCT03354390|587667119|FG002|Level 2|Lost to Follow-up|0|||
163016041|NCT01455597|588764164|FG003|Overall Study|Reason not Specified|3|||
163016042|NCT03412734|588764168|FG000|Overall Study|Incorrect labeling of samples|2|||
163016043|NCT03412734|588764169|FG001|Overall Study|Incorrect labeling of samples|0|||
163016044|NCT03412734|588764168|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
163016045|NCT03412734|588764169|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
163016046|NCT00423332|588764170|FG000|Overall Study|Adverse Event|6|||
163016047|NCT00423332|588764171|FG001|Overall Study|Adverse Event|2|||
163016048|NCT00423332|588764170|FG000|Overall Study|Withdrawal by Subject|1|||
163016049|NCT00423332|588764171|FG001|Overall Study|Withdrawal by Subject|0|||
163016050|NCT00423332|588764170|FG000|Overall Study|Condition under investigation worsened|1|||
163016051|NCT00423332|588764171|FG001|Overall Study|Condition under investigation worsened|1|||
163016052|NCT00423332|588764170|FG000|Overall Study|Progressive at Week 6|0|||
163016053|NCT00423332|588764171|FG001|Overall Study|Progressive at Week 6|1|||
163016054|NCT00423332|588764170|FG000|Overall Study|Unblinded before 12 weeks|1|||
163016055|NCT00423332|588764171|FG001|Overall Study|Unblinded before 12 weeks|3|||
163016056|NCT03777436|588764172|FG000|Placebo-controlled Phase|Adverse Event|8|||
163016057|NCT03777436|588764173|FG001|Placebo-controlled Phase|Adverse Event|10|||
163016058|NCT03777436|588764174|FG002|Placebo-controlled Phase|Adverse Event|0|||
163016059|NCT03777436|588764172|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
163016060|NCT03777436|588764173|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
163016061|NCT03777436|588764174|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163016062|NCT03777436|588764172|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
163016063|NCT03777436|588764173|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
163016064|NCT03777436|588764174|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163016065|NCT03777436|588764172|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
163016066|NCT03777436|588764173|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
163016067|NCT03777436|588764174|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
163016068|NCT03777436|588764172|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
163016069|NCT03777436|588764173|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
163016070|NCT03777436|588764174|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163016071|NCT03777436|588764172|FG000|Placebo-controlled Phase|Physician Decision|0|||
163016072|NCT03777436|588764173|FG001|Placebo-controlled Phase|Physician Decision|1|||
163016073|NCT03777436|588764174|FG002|Placebo-controlled Phase|Physician Decision|0|||
163016074|NCT03777436|588764172|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
163016075|NCT03777436|588764173|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
163016076|NCT03777436|588764174|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
163016077|NCT03777436|588764172|FG000|Apremilast Extension Phase|Adverse Event|0|||
163016078|NCT03777436|588764173|FG001|Apremilast Extension Phase|Adverse Event|0|||
163016079|NCT03777436|588764174|FG002|Apremilast Extension Phase|Adverse Event|6|||
163016080|NCT03777436|588764172|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163016081|NCT03777436|588764173|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163016082|NCT03777436|588764174|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
163016083|NCT03777436|588764172|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163016084|NCT03777436|588764173|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163016085|NCT03777436|588764174|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
163016086|NCT03777436|588764172|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163016087|NCT03777436|588764173|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
163016088|NCT03777436|588764174|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
163016089|NCT03777436|588764172|FG000|Apremilast Extension Phase|Miscellaneous|0|||
163016090|NCT03777436|588764173|FG001|Apremilast Extension Phase|Miscellaneous|0|||
163016091|NCT03777436|588764174|FG002|Apremilast Extension Phase|Miscellaneous|1|||
163016092|NCT02035202|588764175|FG000|Overall Study|Lost to Follow-up|8|||
163016093|NCT02035202|588764176|FG001|Overall Study|Lost to Follow-up|16|||
163016094|NCT02035202|588764177|FG002|Overall Study|Lost to Follow-up|2|||
163016095|NCT00685399|588764178|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163016096|NCT00685399|588764179|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163016097|NCT00685399|588764180|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163016098|NCT00685399|588764181|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163016099|NCT00685399|588764182|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163016100|NCT00685399|588764183|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163016101|NCT00685399|588764184|FG006|Treatment Period 1|Withdrawal by Subject|0|||
163016102|NCT00685399|588764185|FG007|Treatment Period 1|Withdrawal by Subject|0|||
163016103|NCT00685399|588764178|FG000|Treatment Period 1|Protocol Violation|1|||
163016104|NCT00685399|588764179|FG001|Treatment Period 1|Protocol Violation|0|||
163016105|NCT00685399|588764180|FG002|Treatment Period 1|Protocol Violation|0|||
163016106|NCT00685399|588764181|FG003|Treatment Period 1|Protocol Violation|0|||
163016107|NCT00685399|588764182|FG004|Treatment Period 1|Protocol Violation|0|||
163016108|NCT00685399|588764183|FG005|Treatment Period 1|Protocol Violation|0|||
163062848|NCT00127803|588936967|FG003|Overall Study|Lost to Follow-up|1|||
163062849|NCT03907488|588936968|FG000|Overall Study|Adverse Event|20|||
163062850|NCT03907488|588936969|FG001|Overall Study|Adverse Event|20|||
163062851|NCT03907488|588936968|FG000|Overall Study|Withdrawal by Subject|9|||
163016109|NCT00685399|588764184|FG006|Treatment Period 1|Protocol Violation|0|||
163016110|NCT00685399|588764185|FG007|Treatment Period 1|Protocol Violation|0|||
162716079|NCT03354390|587667120|FG003|Level 2|Lost to Follow-up|0|||
163016111|NCT00685399|588764178|FG000|Treatment Period 1|Administrative|2|||
163016112|NCT00685399|588764179|FG001|Treatment Period 1|Administrative|0|||
163016113|NCT00685399|588764180|FG002|Treatment Period 1|Administrative|0|||
163016114|NCT00685399|588764181|FG003|Treatment Period 1|Administrative|0|||
163016115|NCT00685399|588764182|FG004|Treatment Period 1|Administrative|0|||
163016116|NCT00685399|588764183|FG005|Treatment Period 1|Administrative|0|||
163016117|NCT00685399|588764184|FG006|Treatment Period 1|Administrative|0|||
163016118|NCT00685399|588764185|FG007|Treatment Period 1|Administrative|0|||
163016119|NCT00685399|588764178|FG000|Treatment Period 1|Lack of Efficacy|1|||
163016120|NCT00685399|588764179|FG001|Treatment Period 1|Lack of Efficacy|0|||
163016121|NCT00685399|588764180|FG002|Treatment Period 1|Lack of Efficacy|0|||
163016122|NCT00685399|588764181|FG003|Treatment Period 1|Lack of Efficacy|0|||
163016123|NCT00685399|588764182|FG004|Treatment Period 1|Lack of Efficacy|0|||
163016124|NCT00685399|588764183|FG005|Treatment Period 1|Lack of Efficacy|0|||
163016125|NCT00685399|588764184|FG006|Treatment Period 1|Lack of Efficacy|0|||
163016126|NCT00685399|588764185|FG007|Treatment Period 1|Lack of Efficacy|0|||
163016127|NCT00685399|588764178|FG000|Treatment Period 2|Administrative Problems|0|||
163016128|NCT00685399|588764179|FG001|Treatment Period 2|Administrative Problems|2|||
163016129|NCT00685399|588764180|FG002|Treatment Period 2|Administrative Problems|1|||
163016130|NCT00685399|588764181|FG003|Treatment Period 2|Administrative Problems|0|||
163016131|NCT00685399|588764182|FG004|Treatment Period 2|Administrative Problems|0|||
163016132|NCT00685399|588764183|FG005|Treatment Period 2|Administrative Problems|0|||
163016133|NCT00685399|588764184|FG006|Treatment Period 2|Administrative Problems|0|||
163016134|NCT00685399|588764185|FG007|Treatment Period 2|Administrative Problems|0|||
163016135|NCT00685399|588764178|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163016136|NCT00685399|588764179|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163016137|NCT00685399|588764180|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163016138|NCT00685399|588764181|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163016139|NCT00685399|588764182|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163016140|NCT00685399|588764183|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163016141|NCT00685399|588764184|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163016142|NCT00685399|588764185|FG007|Treatment Period 2|Withdrawal by Subject|2|||
163016143|NCT00685399|588764178|FG000|Treatment Period 2|Adverse Event|0|||
163016144|NCT00685399|588764179|FG001|Treatment Period 2|Adverse Event|0|||
163016145|NCT00685399|588764180|FG002|Treatment Period 2|Adverse Event|0|||
163016146|NCT00685399|588764181|FG003|Treatment Period 2|Adverse Event|0|||
163016147|NCT00685399|588764182|FG004|Treatment Period 2|Adverse Event|0|||
163062852|NCT03907488|588936969|FG001|Overall Study|Withdrawal by Subject|13|||
163062853|NCT03907488|588936968|FG000|Overall Study|Lack of Efficacy|0|||
163062854|NCT03907488|588936969|FG001|Overall Study|Lack of Efficacy|9|||
163062855|NCT03907488|588936968|FG000|Overall Study|Death|3|||
163062856|NCT03907488|588936969|FG001|Overall Study|Death|8|||
163062857|NCT03907488|588936968|FG000|Overall Study|not protocol specified|5|||
163062858|NCT03907488|588936969|FG001|Overall Study|not protocol specified|8|||
163062859|NCT03907488|588936968|FG000|Overall Study|Ineligible|9|||
163062860|NCT03907488|588936969|FG001|Overall Study|Ineligible|15|||
163062861|NCT03321721|588936971|FG000|Overall Study|Lost to Follow-up|4|||
163062862|NCT03321721|588936972|FG001|Overall Study|Lost to Follow-up|8|||
163062863|NCT03321721|588936973|FG002|Overall Study|Lost to Follow-up|11|||
163062864|NCT04809974|588938511|FG000|Lead-in Phase|Withdrawal by Subject|3|||
163062865|NCT04809974|588938512|FG001|Lead-in Phase|Withdrawal by Subject|0|||
163062866|NCT04809974|588938513|FG002|Lead-in Phase|Withdrawal by Subject|0|||
163062867|NCT04809974|588938511|FG000|Lead-in Phase|No longer eligible|11|||
163062868|NCT04809974|588938512|FG001|Lead-in Phase|No longer eligible|0|||
163062869|NCT04809974|588938513|FG002|Lead-in Phase|No longer eligible|0|||
163062870|NCT04809974|588938511|FG000|Randomized Phase|Lost to Follow-up|0|||
163062871|NCT04809974|588938512|FG001|Randomized Phase|Lost to Follow-up|1|||
163062872|NCT04809974|588938513|FG002|Randomized Phase|Lost to Follow-up|5|||
163062873|NCT04809974|588938511|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
163062874|NCT04809974|588938512|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
163062875|NCT04809974|588938513|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
163062876|NCT04809974|588938511|FG000|Randomized Phase|Adverse Event|0|||
163062877|NCT04809974|588938512|FG001|Randomized Phase|Adverse Event|1|||
163062878|NCT04809974|588938513|FG002|Randomized Phase|Adverse Event|4|||
163062879|NCT04809974|588938511|FG000|Randomized Phase|Withdrawal by Subject|0|||
162640931|NCT03525574|587401505|FG001|Overall Study|Lost to Follow-up|0|||
162640932|NCT03525574|587401504|FG000|Overall Study|Commercial drug is Available for participant|48|||
162640933|NCT03525574|587401505|FG001|Overall Study|Commercial drug is Available for participant|0|||
162640934|NCT03525574|587401504|FG000|Overall Study|Death|1|||
163062880|NCT04809974|588938512|FG001|Randomized Phase|Withdrawal by Subject|0|||
163016148|NCT00685399|588764183|FG005|Treatment Period 2|Adverse Event|1|||
163016149|NCT00685399|588764184|FG006|Treatment Period 2|Adverse Event|0|||
163062881|NCT04809974|588938513|FG002|Randomized Phase|Withdrawal by Subject|5|||
163062882|NCT04338581|588938514|FG000|Overall Study|Lack of Efficacy|1|||
163062883|NCT04338581|588938515|FG001|Overall Study|Lack of Efficacy|0|||
163062884|NCT04338581|588938514|FG000|Overall Study|Withdrawal by Subject|4|||
162640935|NCT03525574|587401505|FG001|Overall Study|Death|0|||
163016150|NCT00685399|588764185|FG007|Treatment Period 2|Adverse Event|0|||
163016151|NCT00685399|588764178|FG000|Treatment Period 2|Lack of Efficacy|0|||
163016152|NCT00685399|588764179|FG001|Treatment Period 2|Lack of Efficacy|10|||
163016153|NCT00685399|588764180|FG002|Treatment Period 2|Lack of Efficacy|2|||
162640936|NCT03525574|587401504|FG000|Overall Study|Other non-compliance|2|||
163016154|NCT00685399|588764181|FG003|Treatment Period 2|Lack of Efficacy|0|||
163016155|NCT00685399|588764182|FG004|Treatment Period 2|Lack of Efficacy|0|||
163016156|NCT00685399|588764183|FG005|Treatment Period 2|Lack of Efficacy|1|||
163016157|NCT00685399|588764184|FG006|Treatment Period 2|Lack of Efficacy|0|||
163016158|NCT00685399|588764185|FG007|Treatment Period 2|Lack of Efficacy|0|||
163016159|NCT00685399|588764178|FG000|Extension|Administrative Issues|0|||
163016160|NCT00685399|588764179|FG001|Extension|Administrative Issues|0|||
163016161|NCT00685399|588764180|FG002|Extension|Administrative Issues|0|||
163016162|NCT00685399|588764181|FG003|Extension|Administrative Issues|1|||
163016163|NCT00685399|588764182|FG004|Extension|Administrative Issues|0|||
163016164|NCT00685399|588764183|FG005|Extension|Administrative Issues|0|||
163016165|NCT00685399|588764184|FG006|Extension|Administrative Issues|0|||
163016166|NCT00685399|588764185|FG007|Extension|Administrative Issues|0|||
163016167|NCT00685399|588764178|FG000|Extension|Withdrawal by Subject|0|||
163016168|NCT00685399|588764179|FG001|Extension|Withdrawal by Subject|0|||
163016169|NCT00685399|588764180|FG002|Extension|Withdrawal by Subject|0|||
163016170|NCT00685399|588764181|FG003|Extension|Withdrawal by Subject|1|||
163016171|NCT00685399|588764182|FG004|Extension|Withdrawal by Subject|0|||
163016172|NCT00685399|588764183|FG005|Extension|Withdrawal by Subject|0|||
163016173|NCT00685399|588764184|FG006|Extension|Withdrawal by Subject|0|||
163016174|NCT00685399|588764185|FG007|Extension|Withdrawal by Subject|0|||
163016175|NCT00685399|588764178|FG000|Extension|Protocol Violation|0|||
163016176|NCT00685399|588764179|FG001|Extension|Protocol Violation|0|||
163016177|NCT00685399|588764180|FG002|Extension|Protocol Violation|0|||
163016178|NCT00685399|588764181|FG003|Extension|Protocol Violation|1|||
163016179|NCT00685399|588764182|FG004|Extension|Protocol Violation|0|||
163016180|NCT00685399|588764183|FG005|Extension|Protocol Violation|0|||
163016181|NCT00685399|588764184|FG006|Extension|Protocol Violation|0|||
163016182|NCT00685399|588764185|FG007|Extension|Protocol Violation|0|||
163016183|NCT00685399|588764178|FG000|Extension|Lack of Efficacy|0|||
163016184|NCT00685399|588764179|FG001|Extension|Lack of Efficacy|0|||
163016185|NCT00685399|588764180|FG002|Extension|Lack of Efficacy|0|||
163016186|NCT00685399|588764181|FG003|Extension|Lack of Efficacy|2|||
163016187|NCT00685399|588764182|FG004|Extension|Lack of Efficacy|0|||
163016188|NCT00685399|588764183|FG005|Extension|Lack of Efficacy|0|||
163016189|NCT00685399|588764184|FG006|Extension|Lack of Efficacy|0|||
163016190|NCT00685399|588764185|FG007|Extension|Lack of Efficacy|0|||
163016191|NCT00685399|588764178|FG000|Extension|Adverse Event|0|||
163016192|NCT00685399|588764179|FG001|Extension|Adverse Event|0|||
163016193|NCT00685399|588764180|FG002|Extension|Adverse Event|0|||
163016194|NCT00685399|588764181|FG003|Extension|Adverse Event|2|||
163016195|NCT00685399|588764182|FG004|Extension|Adverse Event|0|||
163016196|NCT00685399|588764183|FG005|Extension|Adverse Event|0|||
163016197|NCT00685399|588764184|FG006|Extension|Adverse Event|0|||
163016198|NCT00685399|588764185|FG007|Extension|Adverse Event|0|||
163016199|NCT00758485|588764187|FG000|Overall Study|Lost to Follow-up|0|||
163016200|NCT00758485|588764188|FG001|Overall Study|Lost to Follow-up|1|||
163016201|NCT00758485|588764187|FG000|Overall Study|Not Treated|1|||
163016202|NCT00758485|588764188|FG001|Overall Study|Not Treated|2|||
163016203|NCT00656292|588764189|FG000|Overall Study|Withdrawal by Subject|2|||
163016204|NCT00656292|588764190|FG001|Overall Study|Withdrawal by Subject|3|||
163016205|NCT00656292|588764189|FG000|Overall Study|Screen failure|1|||
162640937|NCT03525574|587401505|FG001|Overall Study|Other non-compliance|0|||
163016206|NCT00656292|588764190|FG001|Overall Study|Screen failure|2|||
163016207|NCT03259425|588764191|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
163016208|NCT03363776|588764196|FG000|Overall Study|Progressive disease|2|||
163016209|NCT03363776|588764197|FG001|Overall Study|Progressive disease|3|||
163016210|NCT03363776|588764198|FG002|Overall Study|Progressive disease|1|||
163016211|NCT03363776|588764196|FG000|Overall Study|Study drug toxicity|0|||
163016212|NCT03363776|588764197|FG001|Overall Study|Study drug toxicity|0|||
163016213|NCT03363776|588764198|FG002|Overall Study|Study drug toxicity|1|||
163016214|NCT03363776|588764196|FG000|Overall Study|Death|1|||
162640938|NCT03525574|587401504|FG000|Overall Study|Physician Decision|6|||
163016215|NCT03363776|588764197|FG001|Overall Study|Death|0|||
163016216|NCT03363776|588764198|FG002|Overall Study|Death|0|||
163016217|NCT01562782|588764199|FG000|Overall Study|Withdrawal by Subject|3|||
163016218|NCT01562782|588764200|FG001|Overall Study|Withdrawal by Subject|3|||
163016219|NCT01562782|588764199|FG000|Overall Study|screen failure|1|||
163016220|NCT01562782|588764200|FG001|Overall Study|screen failure|2|||
163062885|NCT04338581|588938515|FG001|Overall Study|Withdrawal by Subject|4|||
163016221|NCT02649439|588764205|FG000|Overall Study|Switched to alternative treatment|6|||
163016222|NCT02649439|588764206|FG001|Overall Study|Switched to alternative treatment|4|||
162640939|NCT03525574|587401505|FG001|Overall Study|Physician Decision|0|||
163016223|NCT02649439|588764205|FG000|Overall Study|Patient decision|1|||
163016224|NCT02649439|588764206|FG001|Overall Study|Patient decision|0|||
163016225|NCT02649439|588764205|FG000|Overall Study|Patient going out of country|1|||
163016226|NCT02649439|588764206|FG001|Overall Study|Patient going out of country|0|||
163016227|NCT02649439|588764205|FG000|Overall Study|To start finasteride|1|||
163016228|NCT02649439|588764206|FG001|Overall Study|To start finasteride|0|||
163016229|NCT02649439|588764205|FG000|Overall Study|Physician Decision|1|||
163016230|NCT02649439|588764206|FG001|Overall Study|Physician Decision|0|||
163016231|NCT02649439|588764205|FG000|Overall Study|Disease progression on study|12|||
163016232|NCT02649439|588764206|FG001|Overall Study|Disease progression on study|13|||
163016233|NCT02649439|588764205|FG000|Overall Study|Refused further treatment|1|||
163016234|NCT02649439|588764206|FG001|Overall Study|Refused further treatment|0|||
163016235|NCT02649439|588764205|FG000|Overall Study|Refused further follow up|2|||
163016236|NCT02649439|588764206|FG001|Overall Study|Refused further follow up|7|||
163016237|NCT02649439|588764205|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
163016238|NCT02649439|588764206|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
163016239|NCT02649439|588764205|FG000|Overall Study|No treatment, per protocol|1|||
163016240|NCT02649439|588764206|FG001|Overall Study|No treatment, per protocol|0|||
163016241|NCT02649439|588764205|FG000|Overall Study|PSA DT makes ineligible|0|||
163016242|NCT02649439|588764206|FG001|Overall Study|PSA DT makes ineligible|1|||
163016243|NCT02649439|588764205|FG000|Overall Study|Rising PSA No Mets|0|||
163016244|NCT02649439|588764206|FG001|Overall Study|Rising PSA No Mets|1|||
163016245|NCT02649439|588764205|FG000|Overall Study|Rising PSA|0|||
163016246|NCT02649439|588764206|FG001|Overall Study|Rising PSA|1|||
163016247|NCT02649439|588764205|FG000|Overall Study|Signed follow up protocol|0|||
163016248|NCT02649439|588764206|FG001|Overall Study|Signed follow up protocol|1|||
163016249|NCT02097238|588764207|FG000|Overall Study|Death|1|||
163016250|NCT02097238|588764207|FG000|Overall Study|Physician Decision|1|||
163016251|NCT02097238|588764207|FG000|Overall Study|Progressive Disease|17|||
163016252|NCT01282372|588764218|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
163016253|NCT01282372|588764218|FG000|Overall Study|Lost to Follow-up|23|||
163016254|NCT01282372|588764218|FG000|Overall Study|Withdrawal by Subject|11|||
163016255|NCT01282372|588764218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
163016256|NCT01282372|588764218|FG000|Overall Study|Death|1|||
163016257|NCT01282372|588764218|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
163016258|NCT01282372|588764218|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
163016259|NCT01282372|588764218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
163016260|NCT01282372|588764218|FG000|Overall Study|Adverse Event|12|||
163016261|NCT05027451|588764219|FG000|Overall Study|Lost to Follow-up|1|||
163016262|NCT05027451|588764220|FG001|Overall Study|Lost to Follow-up|1|||
163016263|NCT00812981|588764222|FG000|Overall Study|Other|0|||
163016264|NCT00812981|588764223|FG001|Overall Study|Other|1|||
163016265|NCT02737930|588764224|FG000|Overall Study|Withdrawal by Subject|0|||
163016266|NCT02737930|588764225|FG001|Overall Study|Withdrawal by Subject|1|||
163016267|NCT04178122|588764226|FG000|Overall Study|Withdrawal by Subject|1|||
163016268|NCT04178122|588764227|FG001|Overall Study|Withdrawal by Subject|1|||
163016269|NCT04178122|588764226|FG000|Overall Study|Death|2|||
163016270|NCT04178122|588764227|FG001|Overall Study|Death|0|||
163016271|NCT04178122|588764226|FG000|Overall Study|Did not complete testing|3|||
163016272|NCT04178122|588764227|FG001|Overall Study|Did not complete testing|13|||
163016273|NCT03124407|588764228|FG000|Overall Study|Lost to Follow-up|1|||
163016274|NCT03124407|588764229|FG001|Overall Study|Lost to Follow-up|0|||
163016275|NCT03124407|588764230|FG002|Overall Study|Lost to Follow-up|0|||
163016276|NCT03124407|588764231|FG003|Overall Study|Lost to Follow-up|0|||
163016277|NCT03124407|588764228|FG000|Overall Study|Adverse Event|0|||
163016278|NCT03124407|588764229|FG001|Overall Study|Adverse Event|0|||
163016279|NCT03124407|588764230|FG002|Overall Study|Adverse Event|1|||
163016280|NCT03124407|588764231|FG003|Overall Study|Adverse Event|0|||
163016281|NCT05343364|588764232|FG000|Overall Study|Miscellaneous|0|||
163016282|NCT05343364|588764233|FG001|Overall Study|Miscellaneous|1|||
163016283|NCT00984542|588764236|FG000|Overall Study|disease progression|19|||
163016284|NCT00984542|588764236|FG000|Overall Study|toxicity|7|||
163016285|NCT00984542|588764236|FG000|Overall Study|Death|7|||
163016286|NCT00984542|588764236|FG000|Overall Study|complicating disease|3|||
163016287|NCT00984542|588764236|FG000|Overall Study|Withdrawal by Subject|3|||
163062886|NCT04338581|588938514|FG000|Overall Study|Prohibited Medication|1|||
163062887|NCT04338581|588938515|FG001|Overall Study|Prohibited Medication|0|||
163062888|NCT00549055|588938516|FG000|Overall Study|Adverse Event|4|||
163062889|NCT00549055|588938516|FG000|Overall Study|Lack of Efficacy|18|||
163016288|NCT00984542|588764236|FG000|Overall Study|clinical deterioration|2|||
163016289|NCT01276756|588764238|FG000|Overall Study|Lost to Follow-up|2|||
162640940|NCT03525574|587401504|FG000|Overall Study|Other|58|||
163016290|NCT01276756|588764239|FG001|Overall Study|Lost to Follow-up|0|||
163016291|NCT01276756|588764238|FG000|Overall Study|Adverse Event|3|||
162640941|NCT03525574|587401505|FG001|Overall Study|Other|0|||
163016292|NCT01276756|588764239|FG001|Overall Study|Adverse Event|2|||
163016293|NCT02589639|588764240|FG000|Overall Study|Lost to Follow-up|1|||
163016294|NCT02589639|588764241|FG001|Overall Study|Lost to Follow-up|0|||
163016295|NCT02589639|588764242|FG002|Overall Study|Lost to Follow-up|0|||
163062890|NCT00549055|588938516|FG000|Overall Study|Stabilization|5|||
163062891|NCT00549055|588938516|FG000|Overall Study|Progression to fibrosis|2|||
162640942|NCT03525574|587401504|FG000|Overall Study|Enrolled but never dosed|1|||
162640943|NCT03525574|587401505|FG001|Overall Study|Enrolled but never dosed|0|||
163062892|NCT00549055|588938516|FG000|Overall Study|Decrease of size|1|||
163016296|NCT02589639|588764240|FG000|Overall Study|Protocol Violation|1|||
163016297|NCT02589639|588764241|FG001|Overall Study|Protocol Violation|0|||
163016298|NCT02589639|588764242|FG002|Overall Study|Protocol Violation|0|||
163016299|NCT02589639|588764240|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
163016300|NCT02589639|588764241|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
163016301|NCT02589639|588764242|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
163016302|NCT02589639|588764240|FG000|Overall Study|Adverse Event|4|||
163016303|NCT02589639|588764241|FG001|Overall Study|Adverse Event|5|||
163016304|NCT02589639|588764242|FG002|Overall Study|Adverse Event|3|||
163016305|NCT02589639|588764240|FG000|Overall Study|Other reason than specified above|1|||
163016306|NCT02589639|588764241|FG001|Overall Study|Other reason than specified above|2|||
163016307|NCT02589639|588764242|FG002|Overall Study|Other reason than specified above|1|||
163016308|NCT02589639|588764240|FG000|Overall Study|Not Treated|0|||
163016309|NCT02589639|588764241|FG001|Overall Study|Not Treated|3|||
163016310|NCT02589639|588764242|FG002|Overall Study|Not Treated|0|||
163016311|NCT05868577|588764243|FG000|Overall Study|Lost to Follow-up|5|||
163016312|NCT05868577|588764244|FG001|Overall Study|Lost to Follow-up|5|||
163016313|NCT02630251|588764246|FG000|Overall Study|Physician Decision|0|||
163016314|NCT02630251|588764247|FG001|Overall Study|Physician Decision|0|||
163016315|NCT02630251|588764248|FG002|Overall Study|Physician Decision|1|||
163016316|NCT02630251|588764249|FG003|Overall Study|Physician Decision|0|||
163016317|NCT02505217|588764250|FG000|Overall Study|Withdrawal by Subject|1|||
163016318|NCT02505217|588764251|FG001|Overall Study|Withdrawal by Subject|2|||
163016319|NCT03517540|588764252|FG000|Overall Study|Protocol Violation|2|||
163016320|NCT03517540|588764253|FG001|Overall Study|Protocol Violation|0|||
163016321|NCT03517540|588764254|FG002|Overall Study|Protocol Violation|0|||
163016322|NCT03517540|588764255|FG003|Overall Study|Protocol Violation|1|||
163016323|NCT03517540|588764252|FG000|Overall Study|Adverse Event|9|||
163016324|NCT03517540|588764253|FG001|Overall Study|Adverse Event|3|||
163016325|NCT03517540|588764254|FG002|Overall Study|Adverse Event|8|||
163016326|NCT03517540|588764255|FG003|Overall Study|Adverse Event|1|||
163016327|NCT03517540|588764252|FG000|Overall Study|Withdrawal by Subject|3|||
163016328|NCT03517540|588764253|FG001|Overall Study|Withdrawal by Subject|4|||
163016329|NCT03517540|588764254|FG002|Overall Study|Withdrawal by Subject|1|||
163016330|NCT03517540|588764255|FG003|Overall Study|Withdrawal by Subject|3|||
163016331|NCT00615550|588764260|FG000|Overall Study|Lost to Follow-up|6|||
163016332|NCT00615550|588764261|FG001|Overall Study|Lost to Follow-up|1|||
163016333|NCT01408303|588764262|FG000|Overall Study|Adverse Event|3|||
163016334|NCT01408303|588764263|FG001|Overall Study|Adverse Event|7|||
163016335|NCT01408303|588764264|FG002|Overall Study|Adverse Event|2|||
163016336|NCT01408303|588764262|FG000|Overall Study|Lost to Follow-up|0|||
163016337|NCT01408303|588764263|FG001|Overall Study|Lost to Follow-up|1|||
163016338|NCT01408303|588764264|FG002|Overall Study|Lost to Follow-up|2|||
163016339|NCT01408303|588764262|FG000|Overall Study|Withdrawal by Subject|2|||
163062893|NCT00549055|588938516|FG000|Overall Study|Active choroidal neovascula increased|1|||
163062894|NCT00549055|588938516|FG000|Overall Study|Vitreous hemorrhage|1|||
163062895|NCT00549055|588938516|FG000|Overall Study|Growth choroidal neovascularisation|1|||
162640944|NCT03525574|587401504|FG000|Overall Study|Not enrolled in 105 study|0|||
162640945|NCT03525574|587401505|FG001|Overall Study|Not enrolled in 105 study|3|||
162640946|NCT03227029|587401511|FG000|Overall Study|Child Wheezed (no treatment)|0|||
162640947|NCT03227029|587401512|FG001|Overall Study|Child Wheezed (no treatment)|1|||
162640948|NCT03227029|587401513|FG002|Overall Study|Child Wheezed (no treatment)|0|||
162640949|NCT03227029|587401511|FG000|Overall Study|No post RSV season visit due to COVID|3|||
162640950|NCT03227029|587401512|FG001|Overall Study|No post RSV season visit due to COVID|3|||
162640951|NCT03227029|587401513|FG002|Overall Study|No post RSV season visit due to COVID|2|||
162640952|NCT03227029|587401511|FG000|Overall Study|Not able to get to clinic|0|||
162640953|NCT03227029|587401512|FG001|Overall Study|Not able to get to clinic|0|||
162640954|NCT03227029|587401513|FG002|Overall Study|Not able to get to clinic|1|||
162640955|NCT03227029|587401511|FG000|Overall Study|Withdrawal by Subject|1|||
162640956|NCT03227029|587401512|FG001|Overall Study|Withdrawal by Subject|0|||
162640957|NCT03227029|587401513|FG002|Overall Study|Withdrawal by Subject|0|||
162640958|NCT03227029|587401511|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
162640959|NCT03227029|587401512|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
162640960|NCT03227029|587401513|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
162640961|NCT01291173|587401514|FG000|Overall Study|Adverse Event|0|||
162640962|NCT01291173|587401515|FG001|Overall Study|Adverse Event|3|||
163016340|NCT01408303|588764263|FG001|Overall Study|Withdrawal by Subject|3|||
163016341|NCT01408303|588764264|FG002|Overall Study|Withdrawal by Subject|1|||
163062896|NCT00549055|588938516|FG000|Overall Study|Choroidal neovascularization|1|||
163062897|NCT00549055|588938516|FG000|Overall Study|Very low visual acuity (VA)|1|||
162640963|NCT01291173|587401516|FG002|Overall Study|Adverse Event|1|||
162640964|NCT01291173|587401517|FG003|Overall Study|Adverse Event|3|||
163016342|NCT01408303|588764262|FG000|Overall Study|Protocol Violation|0|||
163016343|NCT01408303|588764263|FG001|Overall Study|Protocol Violation|1|||
163016344|NCT01408303|588764264|FG002|Overall Study|Protocol Violation|0|||
163016345|NCT01408303|588764262|FG000|Overall Study|Noncompliance|1|||
163016346|NCT01408303|588764263|FG001|Overall Study|Noncompliance|0|||
163016347|NCT01408303|588764264|FG002|Overall Study|Noncompliance|1|||
163016348|NCT02644668|588764265|FG000|Overall Study|Adverse Event|2|||
163016349|NCT02644668|588764266|FG001|Overall Study|Adverse Event|0|||
163016350|NCT02644668|588764267|FG002|Overall Study|Adverse Event|1|||
163016351|NCT02644668|588764265|FG000|Overall Study|Protocol Violation|0|||
163016352|NCT02644668|588764266|FG001|Overall Study|Protocol Violation|0|||
163016353|NCT02644668|588764267|FG002|Overall Study|Protocol Violation|1|||
163016354|NCT02644668|588764265|FG000|Overall Study|Withdrawal by Subject|0|||
163016355|NCT02644668|588764266|FG001|Overall Study|Withdrawal by Subject|0|||
163062898|NCT00770809|588938517|FG000|Overall Study|Adverse Event|9|||
163016356|NCT02644668|588764267|FG002|Overall Study|Withdrawal by Subject|1|||
163016357|NCT05763875|588764272|FG000|Overall Study|Subject decision|5|||
163016358|NCT05763875|588764273|FG001|Overall Study|Subject decision|2|||
163016359|NCT05763875|588764274|FG002|Overall Study|Subject decision|1|||
163016360|NCT05763875|588764272|FG000|Overall Study|Lost to Follow-up|4|||
163016361|NCT05763875|588764273|FG001|Overall Study|Lost to Follow-up|1|||
163016362|NCT05763875|588764274|FG002|Overall Study|Lost to Follow-up|2|||
163016363|NCT05763875|588764272|FG000|Overall Study|Adverse Event|1|||
163016364|NCT05763875|588764273|FG001|Overall Study|Adverse Event|0|||
163016365|NCT05763875|588764274|FG002|Overall Study|Adverse Event|0|||
163016366|NCT01777282|588764275|FG000|Overall Study|Persistent Hyperglycemia|0|||
163016367|NCT01777282|588764276|FG001|Overall Study|Persistent Hyperglycemia|0|||
163016368|NCT01777282|588764277|FG002|Overall Study|Persistent Hyperglycemia|1|||
163016369|NCT01777282|588764278|FG003|Overall Study|Persistent Hyperglycemia|0|||
163016370|NCT01777282|588764279|FG004|Overall Study|Persistent Hyperglycemia|0|||
163016371|NCT01777282|588764275|FG000|Overall Study|New Antidiabetic Medication|0|||
163016372|NCT01777282|588764276|FG001|Overall Study|New Antidiabetic Medication|0|||
163016373|NCT01777282|588764277|FG002|Overall Study|New Antidiabetic Medication|1|||
163016374|NCT01777282|588764278|FG003|Overall Study|New Antidiabetic Medication|0|||
163016375|NCT01777282|588764279|FG004|Overall Study|New Antidiabetic Medication|0|||
163016376|NCT01777282|588764275|FG000|Overall Study|Adverse Event|4|||
163016377|NCT01777282|588764276|FG001|Overall Study|Adverse Event|4|||
163016378|NCT01777282|588764277|FG002|Overall Study|Adverse Event|2|||
163016379|NCT01777282|588764278|FG003|Overall Study|Adverse Event|1|||
163016380|NCT01777282|588764279|FG004|Overall Study|Adverse Event|3|||
163016381|NCT01777282|588764275|FG000|Overall Study|Withdrawal by Subject|4|||
163016382|NCT01777282|588764276|FG001|Overall Study|Withdrawal by Subject|0|||
163016383|NCT01777282|588764277|FG002|Overall Study|Withdrawal by Subject|0|||
163016384|NCT01777282|588764278|FG003|Overall Study|Withdrawal by Subject|1|||
163016385|NCT01777282|588764279|FG004|Overall Study|Withdrawal by Subject|2|||
163016386|NCT01777282|588764275|FG000|Overall Study|Protocol Violation|2|||
163016387|NCT01777282|588764276|FG001|Overall Study|Protocol Violation|0|||
163016388|NCT01777282|588764277|FG002|Overall Study|Protocol Violation|1|||
163016389|NCT01777282|588764278|FG003|Overall Study|Protocol Violation|0|||
163016390|NCT01777282|588764279|FG004|Overall Study|Protocol Violation|2|||
163016391|NCT01777282|588764275|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
163016392|NCT01777282|588764276|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163016393|NCT01777282|588764277|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
163016394|NCT01777282|588764278|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163016395|NCT01777282|588764279|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
163016396|NCT04015518|588764280|FG000|Overall Study|Adverse Event|6|||
163016397|NCT04015518|588764281|FG001|Overall Study|Adverse Event|1|||
163016398|NCT04015518|588764282|FG002|Overall Study|Adverse Event|1|||
163016399|NCT04015518|588764283|FG003|Overall Study|Adverse Event|3|||
163016400|NCT04015518|588764284|FG004|Overall Study|Adverse Event|3|||
163016401|NCT04015518|588764280|FG000|Overall Study|Lack of Efficacy|1|||
163016402|NCT04015518|588764281|FG001|Overall Study|Lack of Efficacy|0|||
163016403|NCT04015518|588764282|FG002|Overall Study|Lack of Efficacy|1|||
162640965|NCT01291173|587401514|FG000|Overall Study|Protocol Violation|7|||
162640966|NCT01291173|587401515|FG001|Overall Study|Protocol Violation|2|||
163016404|NCT04015518|588764283|FG003|Overall Study|Lack of Efficacy|0|||
163016405|NCT04015518|588764284|FG004|Overall Study|Lack of Efficacy|4|||
163016406|NCT04015518|588764280|FG000|Overall Study|Lost to Follow-up|0|||
163016407|NCT04015518|588764281|FG001|Overall Study|Lost to Follow-up|0|||
163016408|NCT04015518|588764282|FG002|Overall Study|Lost to Follow-up|0|||
163016409|NCT04015518|588764283|FG003|Overall Study|Lost to Follow-up|0|||
163016410|NCT04015518|588764284|FG004|Overall Study|Lost to Follow-up|1|||
163016411|NCT04015518|588764280|FG000|Overall Study|Withdrawal by Subject|0|||
163016412|NCT04015518|588764281|FG001|Overall Study|Withdrawal by Subject|1|||
163016413|NCT04015518|588764282|FG002|Overall Study|Withdrawal by Subject|0|||
163016414|NCT04015518|588764283|FG003|Overall Study|Withdrawal by Subject|1|||
163016415|NCT04015518|588764284|FG004|Overall Study|Withdrawal by Subject|1|||
163016416|NCT04015518|588764280|FG000|Overall Study|Patient did not come for consecutive visits|0|||
163016417|NCT04015518|588764281|FG001|Overall Study|Patient did not come for consecutive visits|1|||
163016418|NCT04015518|588764282|FG002|Overall Study|Patient did not come for consecutive visits|0|||
163016419|NCT04015518|588764283|FG003|Overall Study|Patient did not come for consecutive visits|0|||
163016420|NCT04015518|588764284|FG004|Overall Study|Patient did not come for consecutive visits|0|||
163016421|NCT04015518|588764280|FG000|Overall Study|not willing to travel due to Covid-19|0|||
163016422|NCT04015518|588764281|FG001|Overall Study|not willing to travel due to Covid-19|0|||
163016423|NCT04015518|588764282|FG002|Overall Study|not willing to travel due to Covid-19|1|||
163016424|NCT04015518|588764283|FG003|Overall Study|not willing to travel due to Covid-19|0|||
163016425|NCT04015518|588764284|FG004|Overall Study|not willing to travel due to Covid-19|0|||
163016426|NCT04015518|588764280|FG000|Overall Study|Patient wants to discontinue treatment|0|||
163016427|NCT04015518|588764281|FG001|Overall Study|Patient wants to discontinue treatment|0|||
163016428|NCT04015518|588764282|FG002|Overall Study|Patient wants to discontinue treatment|0|||
163016429|NCT04015518|588764283|FG003|Overall Study|Patient wants to discontinue treatment|1|||
163016430|NCT04015518|588764284|FG004|Overall Study|Patient wants to discontinue treatment|0|||
163016431|NCT04015518|588764280|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
163016432|NCT04015518|588764281|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
163016433|NCT04015518|588764282|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
163016434|NCT04015518|588764283|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
163016435|NCT04015518|588764284|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
163016436|NCT04015518|588764280|FG000|Overall Study|Pregnancy|0|||
163016437|NCT04015518|588764281|FG001|Overall Study|Pregnancy|0|||
163016438|NCT04015518|588764282|FG002|Overall Study|Pregnancy|0|||
163016439|NCT04015518|588764283|FG003|Overall Study|Pregnancy|0|||
163016440|NCT04015518|588764284|FG004|Overall Study|Pregnancy|1|||
163016441|NCT04015518|588764280|FG000|Overall Study|Personal reasons|1|||
163016442|NCT04015518|588764281|FG001|Overall Study|Personal reasons|0|||
163016443|NCT04015518|588764282|FG002|Overall Study|Personal reasons|0|||
163016444|NCT04015518|588764283|FG003|Overall Study|Personal reasons|0|||
163016445|NCT04015518|588764284|FG004|Overall Study|Personal reasons|1|||
163016446|NCT04015518|588764280|FG000|Overall Study|Withdrew consent|1|||
163016447|NCT04015518|588764281|FG001|Overall Study|Withdrew consent|0|||
163016448|NCT04015518|588764282|FG002|Overall Study|Withdrew consent|0|||
163016449|NCT04015518|588764283|FG003|Overall Study|Withdrew consent|0|||
163016450|NCT04015518|588764284|FG004|Overall Study|Withdrew consent|0|||
163016451|NCT04015518|588764280|FG000|Overall Study|Prostate carcinoma|1|||
163016452|NCT04015518|588764281|FG001|Overall Study|Prostate carcinoma|0|||
163016453|NCT04015518|588764282|FG002|Overall Study|Prostate carcinoma|0|||
163016454|NCT04015518|588764283|FG003|Overall Study|Prostate carcinoma|0|||
163016455|NCT04015518|588764284|FG004|Overall Study|Prostate carcinoma|0|||
163016456|NCT04015518|588764280|FG000|Overall Study|Could not keep appointments due to work|1|||
163016457|NCT04015518|588764281|FG001|Overall Study|Could not keep appointments due to work|0|||
163016458|NCT04015518|588764282|FG002|Overall Study|Could not keep appointments due to work|0|||
163016459|NCT04015518|588764283|FG003|Overall Study|Could not keep appointments due to work|0|||
163016460|NCT04015518|588764284|FG004|Overall Study|Could not keep appointments due to work|0|||
163016461|NCT05119595|588766076|FG000|Overall Study|Death|1|||
163016462|NCT05119595|588766076|FG000|Overall Study|Lost to Follow-up|7|||
163016463|NCT01806961|588766077|FG000|Overall Study|sponsor decision|16|||
163016464|NCT03056638|588766084|FG000|Overall Study|Death|1|||
163016465|NCT03056638|588766085|FG001|Overall Study|Death|0|||
163016466|NCT02530125|588766086|FG000|Completed Treatment|Early termination of study|1|||
163016467|NCT02530125|588766086|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
163016468|NCT00468481|588766087|FG000|Overall Study|Adverse Event|13|||
163016469|NCT00468481|588766088|FG001|Overall Study|Adverse Event|3|||
163016470|NCT00468481|588766087|FG000|Overall Study|Lost to Follow-up|25|||
163016471|NCT00468481|588766088|FG001|Overall Study|Lost to Follow-up|8|||
163016472|NCT00468481|588766087|FG000|Overall Study|Pregnancy|2|||
163016473|NCT00468481|588766088|FG001|Overall Study|Pregnancy|0|||
163016474|NCT00468481|588766087|FG000|Overall Study|Protocol Violation|18|||
163016475|NCT00468481|588766088|FG001|Overall Study|Protocol Violation|8|||
163016476|NCT00468481|588766087|FG000|Overall Study|Withdrawal by Subject|12|||
163016477|NCT00468481|588766088|FG001|Overall Study|Withdrawal by Subject|3|||
163016478|NCT00468481|588766087|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
163016479|NCT00468481|588766088|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
163016480|NCT00468481|588766087|FG000|Overall Study|Prohibited Medication|1|||
163016481|NCT00468481|588766088|FG001|Overall Study|Prohibited Medication|1|||
163016482|NCT00468481|588766087|FG000|Overall Study|Egg Donor|1|||
163016483|NCT00468481|588766088|FG001|Overall Study|Egg Donor|0|||
163016484|NCT00468481|588766087|FG000|Overall Study|Moved out of area|4|||
163016485|NCT00468481|588766088|FG001|Overall Study|Moved out of area|1|||
163016486|NCT00468481|588766087|FG000|Overall Study|Non-Compliance|5|||
163016487|NCT00468481|588766088|FG001|Overall Study|Non-Compliance|0|||
163016488|NCT00468481|588766087|FG000|Overall Study|Other|6|||
163016489|NCT00468481|588766088|FG001|Overall Study|Other|0|||
163016490|NCT00728468|588766089|FG000|Overall Study|Enrolled but not treated|1|||
163016491|NCT00728468|588766089|FG000|Overall Study|Death|1|||
163016492|NCT00728468|588766089|FG000|Overall Study|Protocol Violation|4|||
163016493|NCT00728468|588766089|FG000|Overall Study|Objective progression or relapse|9|||
163016494|NCT00728468|588766089|FG000|Overall Study|Study terminated by sponsor|1|||
163016495|NCT01568034|588766090|FG000|Overall Study|Withdrawal by Subject|1|||
163016496|NCT01568034|588766091|FG001|Overall Study|Withdrawal by Subject|0|||
163016497|NCT01568034|588766092|FG002|Overall Study|Withdrawal by Subject|0|||
163016498|NCT01568034|588766093|FG003|Overall Study|Withdrawal by Subject|0|||
163016499|NCT00596687|588766094|FG000|Overall Study|< 24 hours of insulin treatment|8|||
163016500|NCT00596687|588766095|FG001|Overall Study|< 24 hours of insulin treatment|6|||
163016501|NCT00596687|588766094|FG000|Overall Study|continuous insulin infusion during TPN|2|||
163016502|NCT00596687|588766095|FG001|Overall Study|continuous insulin infusion during TPN|1|||
163016503|NCT00596687|588766094|FG000|Overall Study|Withdrawal by Subject|3|||
163016504|NCT00596687|588766095|FG001|Overall Study|Withdrawal by Subject|1|||
163016505|NCT00596687|588766094|FG000|Overall Study|cancelled surgery|1|||
163016506|NCT00596687|588766095|FG001|Overall Study|cancelled surgery|1|||
163016507|NCT03831113|588766096|FG000|Overall Study|Withdrawal by Subject|0|||
163016508|NCT03831113|588766097|FG001|Overall Study|Withdrawal by Subject|2|||
163016509|NCT03831113|588766096|FG000|Overall Study|Protocol Violation|0|||
163016510|NCT03831113|588766097|FG001|Overall Study|Protocol Violation|9|||
163016511|NCT03508726|588766098|FG000|Overall Study|Withdrawal by Subject|0|||
163016512|NCT03508726|588766099|FG001|Overall Study|Withdrawal by Subject|1|||
163016513|NCT01068730|588766100|FG000|Period 3|Personal reason|1|||
163016514|NCT01068730|588766101|FG001|Period 3|Personal reason|0|||
163016515|NCT01068730|588766102|FG002|Period 3|Personal reason|0|||
163016516|NCT01068730|588766103|FG003|Period 3|Personal reason|0|||
163016517|NCT01068730|588766100|FG000|Period 4|Family emergency|0|||
163016518|NCT01068730|588766101|FG001|Period 4|Family emergency|1|||
163016519|NCT01068730|588766102|FG002|Period 4|Family emergency|0|||
163016520|NCT01068730|588766103|FG003|Period 4|Family emergency|0|||
163016521|NCT02498444|588766107|FG000|Overall Study|Withdrawal by Subject|3|||
163016522|NCT02498444|588766108|FG001|Overall Study|Withdrawal by Subject|0|||
163016523|NCT02498444|588766107|FG000|Overall Study|Physician Decision|1|||
163016524|NCT02498444|588766108|FG001|Overall Study|Physician Decision|0|||
163016525|NCT01073605|588766122|FG000|Overall Study|Ongoing at Cutoff Date|1|||
163016526|NCT01073605|588766123|FG001|Overall Study|Ongoing at Cutoff Date|1|||
163016527|NCT01073605|588766124|FG002|Overall Study|Ongoing at Cutoff Date|0|||
163016528|NCT01073605|588766122|FG000|Overall Study|Adverse Event|2|||
163016529|NCT01073605|588766123|FG001|Overall Study|Adverse Event|1|||
163016530|NCT01073605|588766124|FG002|Overall Study|Adverse Event|0|||
163016531|NCT01073605|588766122|FG000|Overall Study|Lost to Follow-up|3|||
163016532|NCT01073605|588766123|FG001|Overall Study|Lost to Follow-up|4|||
163016533|NCT01073605|588766124|FG002|Overall Study|Lost to Follow-up|9|||
163016534|NCT01073605|588766122|FG000|Overall Study|Other|25|||
163016535|NCT01073605|588766123|FG001|Overall Study|Other|21|||
163016536|NCT01073605|588766124|FG002|Overall Study|Other|29|||
163016537|NCT01073605|588766122|FG000|Overall Study|Withdrawal by Subject|31|||
163016538|NCT01073605|588766123|FG001|Overall Study|Withdrawal by Subject|39|||
163016539|NCT01073605|588766124|FG002|Overall Study|Withdrawal by Subject|22|||
163016540|NCT01073605|588766122|FG000|Overall Study|Randomized But Not Treated|0|||
163016541|NCT01073605|588766123|FG001|Overall Study|Randomized But Not Treated|1|||
163016542|NCT01073605|588766124|FG002|Overall Study|Randomized But Not Treated|1|||
163016543|NCT03491462|588766125|FG000|Overall Study|Lost to Follow-up|2|||
163016544|NCT03491462|588766126|FG001|Overall Study|Lost to Follow-up|0|||
163016545|NCT03491462|588766125|FG000|Overall Study|Adverse Event|11|||
163016546|NCT03491462|588766126|FG001|Overall Study|Adverse Event|1|||
163016547|NCT03491462|588766125|FG000|Overall Study|Physician Decision|3|||
163016548|NCT03491462|588766126|FG001|Overall Study|Physician Decision|0|||
163016549|NCT03491462|588766125|FG000|Overall Study|Withdrawal by Subject|22|||
163016550|NCT03491462|588766126|FG001|Overall Study|Withdrawal by Subject|15|||
163062899|NCT00770809|588938518|FG001|Overall Study|Adverse Event|1|||
162716080|NCT03354390|587667117|FG000|Level 3|Death|0|||
163016551|NCT00740792|588766127|FG000|Overall Study|Adverse Event|3|||
163016552|NCT00740792|588766128|FG001|Overall Study|Adverse Event|1|||
163016553|NCT00740792|588766129|FG002|Overall Study|Adverse Event|1|||
163016554|NCT00740792|588766130|FG003|Overall Study|Adverse Event|3|||
163016555|NCT00740792|588766127|FG000|Overall Study|Lack of Efficacy|1|||
163016556|NCT00740792|588766128|FG001|Overall Study|Lack of Efficacy|1|||
163016557|NCT00740792|588766129|FG002|Overall Study|Lack of Efficacy|0|||
163016558|NCT00740792|588766130|FG003|Overall Study|Lack of Efficacy|3|||
163016559|NCT00740792|588766127|FG000|Overall Study|Lost to Follow-up|2|||
162716081|NCT03354390|587667118|FG001|Level 3|Death|0|||
163016560|NCT00740792|588766128|FG001|Overall Study|Lost to Follow-up|1|||
163016561|NCT00740792|588766129|FG002|Overall Study|Lost to Follow-up|0|||
163016562|NCT00740792|588766130|FG003|Overall Study|Lost to Follow-up|0|||
163016563|NCT00740792|588766127|FG000|Overall Study|Protocol Violation|0|||
163016564|NCT00740792|588766128|FG001|Overall Study|Protocol Violation|1|||
163016565|NCT00740792|588766129|FG002|Overall Study|Protocol Violation|0|||
163016566|NCT00740792|588766130|FG003|Overall Study|Protocol Violation|2|||
163016567|NCT00740792|588766127|FG000|Overall Study|Withdrawal by Subject|1|||
163016568|NCT00740792|588766128|FG001|Overall Study|Withdrawal by Subject|1|||
163016569|NCT00740792|588766129|FG002|Overall Study|Withdrawal by Subject|0|||
163016570|NCT00740792|588766130|FG003|Overall Study|Withdrawal by Subject|0|||
163016571|NCT00740792|588766127|FG000|Overall Study|administrative|3|||
163016572|NCT00740792|588766128|FG001|Overall Study|administrative|3|||
163016573|NCT00740792|588766129|FG002|Overall Study|administrative|8|||
163016574|NCT00740792|588766130|FG003|Overall Study|administrative|2|||
163016575|NCT00179660|588766139|FG000|Overall Study|Adverse Event|7|||
163062900|NCT00770809|588938519|FG002|Overall Study|Adverse Event|12|||
163062901|NCT00770809|588938517|FG000|Overall Study|Death|1|||
163062902|NCT00770809|588938518|FG001|Overall Study|Death|0|||
163062903|NCT00770809|588938519|FG002|Overall Study|Death|0|||
163016576|NCT00179660|588766139|FG000|Overall Study|Lack of therapeutic effect|28|||
163016577|NCT00179660|588766139|FG000|Overall Study|Withdrawal by Subject|2|||
163016578|NCT00179660|588766139|FG000|Overall Study|Lost to Follow-up|1|||
163016579|NCT00179660|588766139|FG000|Overall Study|Death|3|||
163016580|NCT00179660|588766139|FG000|Overall Study|Other - Unspecified|9|||
163016581|NCT04478695|588766140|FG000|Overall Study|Death|1|||
163016582|NCT04478695|588766141|FG001|Overall Study|Death|0|||
163016583|NCT00644917|588766142|FG000|Overall Study|Withdrawal by Subject|2|||
163016584|NCT01136356|588766143|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
163062904|NCT00770809|588938517|FG000|Overall Study|Withdrawal by Subject|3|||
163062905|NCT00770809|588938518|FG001|Overall Study|Withdrawal by Subject|3|||
163062906|NCT00770809|588938519|FG002|Overall Study|Withdrawal by Subject|7|||
163062907|NCT00770809|588938517|FG000|Overall Study|Progression|2|||
163062908|NCT00770809|588938518|FG001|Overall Study|Progression|2|||
163062909|NCT00770809|588938519|FG002|Overall Study|Progression|0|||
163062910|NCT00770809|588938517|FG000|Overall Study|Complicating illness|0|||
163062911|NCT00770809|588938518|FG001|Overall Study|Complicating illness|0|||
163062912|NCT00770809|588938519|FG002|Overall Study|Complicating illness|1|||
163062913|NCT00770809|588938517|FG000|Overall Study|Other Medical Reasons|2|||
163062914|NCT00770809|588938518|FG001|Overall Study|Other Medical Reasons|4|||
163062915|NCT00770809|588938519|FG002|Overall Study|Other Medical Reasons|3|||
163062916|NCT00770367|588938522|FG000|First Intervention|Withdrawal by Subject|0|||
163062917|NCT00770367|588938523|FG001|First Intervention|Withdrawal by Subject|2|||
163062918|NCT00770367|588938522|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
163062919|NCT00770367|588938523|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
163062920|NCT00770367|588938522|FG000|Second Intervention|Lost to Follow-up|2|||
163062921|NCT00770367|588938523|FG001|Second Intervention|Lost to Follow-up|0|||
163062922|NCT00435942|588938524|FG000|Overall Study|Death|17|||
163062923|NCT00435942|588938525|FG001|Overall Study|Death|10|||
163062924|NCT00435942|588938524|FG000|Overall Study|Withdrawal by Subject|2|||
163062925|NCT00435942|588938525|FG001|Overall Study|Withdrawal by Subject|0|||
163062926|NCT00435942|588938524|FG000|Overall Study|Lost to Follow-up|0|||
163062927|NCT00435942|588938525|FG001|Overall Study|Lost to Follow-up|16|||
163062928|NCT00435942|588938524|FG000|Overall Study|Conversion to Open Repair|1|||
163062929|NCT00435942|588938525|FG001|Overall Study|Conversion to Open Repair|0|||
163062930|NCT00435942|588938524|FG000|Overall Study|Technical Failure|3|||
163062931|NCT00435942|588938525|FG001|Overall Study|Technical Failure|0|||
163062932|NCT00435942|588938524|FG000|Overall Study|Other|0|||
163062933|NCT00435942|588938525|FG001|Overall Study|Other|1|||
163062934|NCT01898130|588938526|FG000|Treatment|Withdrawal by Subject|2|||
163062935|NCT01898130|588938526|FG000|Treatment|Progressive Disease|4|||
163062936|NCT01898130|588938526|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
163062937|NCT04115059|588938527|FG000|Overall Study|Withdrawal by Subject|1|||
163062938|NCT04115059|588938527|FG000|Overall Study|Lack of Efficacy|2|||
163016585|NCT01136356|588766144|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
163016586|NCT01136356|588766143|FG000|First 18-day Withdrawal|Physician Decision|1|||
163016587|NCT01136356|588766144|FG001|First 18-day Withdrawal|Physician Decision|0|||
163016588|NCT01136356|588766143|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
163016589|NCT01136356|588766144|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
163016590|NCT00402688|588766145|FG000|Overall Study|Adverse Event|12|||
163016591|NCT00402688|588766146|FG001|Overall Study|Adverse Event|9|||
163016592|NCT00402688|588766147|FG002|Overall Study|Adverse Event|3|||
163016593|NCT00402688|588766145|FG000|Overall Study|Withdrawal by Subject|3|||
163016594|NCT00402688|588766146|FG001|Overall Study|Withdrawal by Subject|1|||
163016595|NCT00402688|588766147|FG002|Overall Study|Withdrawal by Subject|1|||
163016596|NCT00402688|588766145|FG000|Overall Study|Physician Decision|0|||
163016597|NCT00402688|588766146|FG001|Overall Study|Physician Decision|0|||
163016598|NCT00402688|588766147|FG002|Overall Study|Physician Decision|1|||
163016599|NCT00402688|588766145|FG000|Overall Study|Lack of Efficacy|4|||
163016600|NCT00402688|588766146|FG001|Overall Study|Lack of Efficacy|4|||
163016601|NCT00402688|588766147|FG002|Overall Study|Lack of Efficacy|5|||
163016602|NCT00402688|588766145|FG000|Overall Study|Protocol Violation|1|||
163016603|NCT00402688|588766146|FG001|Overall Study|Protocol Violation|1|||
163016604|NCT00402688|588766147|FG002|Overall Study|Protocol Violation|1|||
163016605|NCT00402688|588766145|FG000|Overall Study|Lost to Follow-up|1|||
163016606|NCT00402688|588766146|FG001|Overall Study|Lost to Follow-up|0|||
163016607|NCT00402688|588766147|FG002|Overall Study|Lost to Follow-up|2|||
163016608|NCT00402688|588766145|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
163016609|NCT00402688|588766146|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
163016610|NCT00402688|588766147|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
163016611|NCT00402688|588766145|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
163016612|NCT00402688|588766146|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
163016613|NCT00402688|588766147|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
163016614|NCT00402688|588766145|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
163016615|NCT00402688|588766146|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
163016616|NCT00402688|588766147|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
163016617|NCT00178685|588766148|FG000|Overall Study|Death|3|||
163016618|NCT00178685|588766149|FG001|Overall Study|Death|3|||
163016619|NCT00178685|588766150|FG002|Overall Study|Death|6|||
163016620|NCT00178685|588766148|FG000|Overall Study|Lost to Follow-up|100|||
163016621|NCT00178685|588766149|FG001|Overall Study|Lost to Follow-up|187|||
163016622|NCT00178685|588766150|FG002|Overall Study|Lost to Follow-up|183|||
163016623|NCT00178685|588766148|FG000|Overall Study|Withdrawal by Subject|8|||
163016624|NCT00178685|588766149|FG001|Overall Study|Withdrawal by Subject|14|||
163016625|NCT00178685|588766150|FG002|Overall Study|Withdrawal by Subject|7|||
163016626|NCT00927862|588766151|FG000|Overall Study|Missing data needed for endpt analyses|27|||
163016627|NCT00927862|588766152|FG001|Overall Study|Missing data needed for endpt analyses|45|||
163016628|NCT00820248|588766153|FG000|Overall Study|No treated|4|||
163016629|NCT00820248|588766154|FG001|Overall Study|No treated|1|||
163016630|NCT04157296|588766164|FG000|Overall Study|Withdrawal by Subject|0|||
163016631|NCT04157296|588766165|FG001|Overall Study|Withdrawal by Subject|1|||
163016632|NCT04157296|588766164|FG000|Overall Study|Did not obtain second fMRI.|0|||
163016633|NCT04157296|588766165|FG001|Overall Study|Did not obtain second fMRI.|1|||
163016634|NCT04157296|588766164|FG000|Overall Study|MRI failed/no second fMRI|0|||
163016635|NCT04157296|588766165|FG001|Overall Study|MRI failed/no second fMRI|1|||
163016636|NCT02088905|588766170|FG000|Overall Study|Withdrawal by Subject|5|||
163016637|NCT02088905|588766171|FG001|Overall Study|Withdrawal by Subject|1|||
163016638|NCT05708976|588766186|FG000|Overall Study|Withdrawal by Subject|0|||
163016639|NCT05708976|588766187|FG001|Overall Study|Withdrawal by Subject|1|||
163016640|NCT02343939|588766198|FG000|Overall Study|Death|0|||
163016641|NCT02343939|588766199|FG001|Overall Study|Death|15|||
163016642|NCT02343939|588766200|FG002|Overall Study|Death|4|||
163016643|NCT02343939|588766201|FG003|Overall Study|Death|2|||
163016644|NCT02343939|588766202|FG004|Overall Study|Death|5|||
163016645|NCT02343939|588766203|FG005|Overall Study|Death|11|||
163016646|NCT02343939|588766204|FG006|Overall Study|Death|8|||
163016647|NCT02343939|588766205|FG007|Overall Study|Death|22|||
163016648|NCT02343939|588766206|FG008|Overall Study|Death|1|||
163016649|NCT02343939|588766198|FG000|Overall Study|Study terminated by sponsor|0|||
163016650|NCT02343939|588766199|FG001|Overall Study|Study terminated by sponsor|27|||
163016651|NCT02343939|588766200|FG002|Overall Study|Study terminated by sponsor|0|||
163016652|NCT02343939|588766201|FG003|Overall Study|Study terminated by sponsor|1|||
163016653|NCT02343939|588766202|FG004|Overall Study|Study terminated by sponsor|1|||
163016654|NCT02343939|588766203|FG005|Overall Study|Study terminated by sponsor|5|||
163016655|NCT02343939|588766204|FG006|Overall Study|Study terminated by sponsor|3|||
163016656|NCT02343939|588766205|FG007|Overall Study|Study terminated by sponsor|4|||
163016657|NCT02343939|588766206|FG008|Overall Study|Study terminated by sponsor|0|||
163016658|NCT02343939|588766198|FG000|Overall Study|Withdrew consent|3|||
163016659|NCT02343939|588766199|FG001|Overall Study|Withdrew consent|6|||
163016660|NCT02343939|588766200|FG002|Overall Study|Withdrew consent|1|||
163016661|NCT02343939|588766201|FG003|Overall Study|Withdrew consent|2|||
163016662|NCT02343939|588766202|FG004|Overall Study|Withdrew consent|2|||
163016663|NCT02343939|588766203|FG005|Overall Study|Withdrew consent|0|||
163016664|NCT02343939|588766204|FG006|Overall Study|Withdrew consent|0|||
163016665|NCT02343939|588766205|FG007|Overall Study|Withdrew consent|8|||
163016666|NCT02343939|588766206|FG008|Overall Study|Withdrew consent|6|||
163016667|NCT02343939|588766198|FG000|Overall Study|Treatment failure|0|||
163016668|NCT02343939|588766199|FG001|Overall Study|Treatment failure|0|||
163016669|NCT02343939|588766200|FG002|Overall Study|Treatment failure|0|||
163016670|NCT02343939|588766201|FG003|Overall Study|Treatment failure|0|||
163016671|NCT02343939|588766202|FG004|Overall Study|Treatment failure|0|||
163016672|NCT02343939|588766203|FG005|Overall Study|Treatment failure|0|||
163016673|NCT02343939|588766204|FG006|Overall Study|Treatment failure|2|||
163016674|NCT02343939|588766205|FG007|Overall Study|Treatment failure|1|||
163016675|NCT02343939|588766206|FG008|Overall Study|Treatment failure|0|||
163016676|NCT02343939|588766198|FG000|Overall Study|Investigator's discretion|0|||
163016677|NCT02343939|588766199|FG001|Overall Study|Investigator's discretion|0|||
163016678|NCT02343939|588766200|FG002|Overall Study|Investigator's discretion|0|||
163016679|NCT02343939|588766201|FG003|Overall Study|Investigator's discretion|1|||
163016680|NCT02343939|588766202|FG004|Overall Study|Investigator's discretion|0|||
163016681|NCT02343939|588766203|FG005|Overall Study|Investigator's discretion|0|||
163016682|NCT02343939|588766204|FG006|Overall Study|Investigator's discretion|1|||
163016683|NCT02343939|588766205|FG007|Overall Study|Investigator's discretion|0|||
163016684|NCT02343939|588766206|FG008|Overall Study|Investigator's discretion|0|||
163016685|NCT02343939|588766198|FG000|Overall Study|Adverse Event|0|||
163016686|NCT02343939|588766199|FG001|Overall Study|Adverse Event|0|||
163016687|NCT02343939|588766200|FG002|Overall Study|Adverse Event|0|||
163016688|NCT02343939|588766201|FG003|Overall Study|Adverse Event|0|||
163016689|NCT02343939|588766202|FG004|Overall Study|Adverse Event|0|||
163016690|NCT02343939|588766203|FG005|Overall Study|Adverse Event|1|||
163016691|NCT02343939|588766204|FG006|Overall Study|Adverse Event|0|||
163016692|NCT02343939|588766205|FG007|Overall Study|Adverse Event|0|||
163016693|NCT02343939|588766206|FG008|Overall Study|Adverse Event|0|||
163016694|NCT02343939|588766198|FG000|Overall Study|Never Treated With ENTO|0|||
163016695|NCT02343939|588766199|FG001|Overall Study|Never Treated With ENTO|0|||
163016696|NCT02343939|588766200|FG002|Overall Study|Never Treated With ENTO|0|||
163016697|NCT02343939|588766201|FG003|Overall Study|Never Treated With ENTO|0|||
163016698|NCT02343939|588766202|FG004|Overall Study|Never Treated With ENTO|0|||
163016699|NCT02343939|588766203|FG005|Overall Study|Never Treated With ENTO|0|||
163016700|NCT02343939|588766204|FG006|Overall Study|Never Treated With ENTO|1|||
163016701|NCT02343939|588766205|FG007|Overall Study|Never Treated With ENTO|2|||
163016702|NCT02343939|588766206|FG008|Overall Study|Never Treated With ENTO|0|||
163016703|NCT02684097|588766207|FG000|Overall Study|Lack of Efficacy|13|||
163016704|NCT02684097|588766208|FG001|Overall Study|Lack of Efficacy|6|||
163016705|NCT02064816|588766209|FG000|Overall Study|Adverse Event|3|||
163016706|NCT02064816|588766210|FG001|Overall Study|Adverse Event|2|||
162640967|NCT01291173|587401516|FG002|Overall Study|Protocol Violation|2|||
163016707|NCT02064816|588766209|FG000|Overall Study|Withdrawal by Subject|2|||
163016708|NCT02064816|588766210|FG001|Overall Study|Withdrawal by Subject|1|||
163016709|NCT02064816|588766209|FG000|Overall Study|Lost to Follow-up|2|||
163016710|NCT02064816|588766210|FG001|Overall Study|Lost to Follow-up|1|||
163016711|NCT02064816|588766209|FG000|Overall Study|Therapeutic failure|0|||
163016712|NCT02064816|588766210|FG001|Overall Study|Therapeutic failure|1|||
163016713|NCT02064816|588766209|FG000|Overall Study|Other|1|||
163016714|NCT02064816|588766210|FG001|Overall Study|Other|3|||
163016715|NCT01757184|588766211|FG000|Double-blind Period|Adverse Event|1|||
163016716|NCT01757184|588766212|FG001|Double-blind Period|Adverse Event|0|||
163016717|NCT01757184|588766213|FG002|Double-blind Period|Adverse Event|0|||
163016718|NCT01757184|588766214|FG003|Double-blind Period|Adverse Event|0|||
163016719|NCT01757184|588766211|FG000|Open-label Period|Lost to Follow-up|0|||
163016720|NCT01757184|588766212|FG001|Open-label Period|Lost to Follow-up|0|||
163016721|NCT01757184|588766213|FG002|Open-label Period|Lost to Follow-up|2|||
163016722|NCT01757184|588766214|FG003|Open-label Period|Lost to Follow-up|0|||
163016723|NCT01757184|588766211|FG000|Open-label Period|Withdrawal by Subject|0|||
163016724|NCT01757184|588766212|FG001|Open-label Period|Withdrawal by Subject|0|||
163016725|NCT01757184|588766213|FG002|Open-label Period|Withdrawal by Subject|1|||
163016726|NCT01757184|588766214|FG003|Open-label Period|Withdrawal by Subject|1|||
163016727|NCT01757184|588766211|FG000|Open-label Period|Discontinued by Sponsor|0|||
163016728|NCT01757184|588766212|FG001|Open-label Period|Discontinued by Sponsor|0|||
163016729|NCT01757184|588766213|FG002|Open-label Period|Discontinued by Sponsor|1|||
163016730|NCT01757184|588766214|FG003|Open-label Period|Discontinued by Sponsor|2|||
163016731|NCT04468347|588766217|FG000|Overall Study|Withdrawal by Subject|0|||
163016732|NCT04468347|588766218|FG001|Overall Study|Withdrawal by Subject|1|||
163016733|NCT04468347|588766219|FG002|Overall Study|Withdrawal by Subject|3|||
163016734|NCT04468347|588766220|FG003|Overall Study|Withdrawal by Subject|3|||
163016735|NCT04468347|588766217|FG000|Overall Study|Lost to Follow-up|0|||
163016736|NCT04468347|588766218|FG001|Overall Study|Lost to Follow-up|0|||
163016737|NCT04468347|588766219|FG002|Overall Study|Lost to Follow-up|1|||
163016738|NCT04468347|588766220|FG003|Overall Study|Lost to Follow-up|1|||
163016739|NCT04468347|588766217|FG000|Overall Study|Physician Decision|1|||
163016740|NCT04468347|588766218|FG001|Overall Study|Physician Decision|0|||
163016741|NCT04468347|588766219|FG002|Overall Study|Physician Decision|2|||
163016742|NCT04468347|588766220|FG003|Overall Study|Physician Decision|0|||
163016743|NCT04468347|588766217|FG000|Overall Study|Protocol Violation|1|||
163016744|NCT04468347|588766218|FG001|Overall Study|Protocol Violation|0|||
163016745|NCT04468347|588766219|FG002|Overall Study|Protocol Violation|0|||
163016746|NCT04468347|588766220|FG003|Overall Study|Protocol Violation|0|||
163016747|NCT00994461|588766221|FG000|Overall Study|Adverse Event|2|||
163016748|NCT00994461|588766222|FG001|Overall Study|Adverse Event|1|||
163016749|NCT00994461|588766223|FG002|Overall Study|Adverse Event|0|||
163016750|NCT04339062|588766224|FG000|Overall Study|Death|0|||
163016751|NCT04339062|588766225|FG001|Overall Study|Death|1|||
163016752|NCT04586244|588766226|FG000|Overall Study|Lost to Follow-up|1|||
163016753|NCT04586244|588766227|FG001|Overall Study|Lost to Follow-up|0|||
163016754|NCT04586244|588766228|FG002|Overall Study|Lost to Follow-up|0|||
163016755|NCT04586244|588766229|FG003|Overall Study|Lost to Follow-up|1|||
163016756|NCT04586244|588766230|FG004|Overall Study|Lost to Follow-up|0|||
163016757|NCT04586244|588766226|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016758|NCT04586244|588766227|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
163016759|NCT04586244|588766228|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016760|NCT04586244|588766229|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016761|NCT04586244|588766230|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
163016762|NCT03564119|588766231|FG000|Overall Study|Adverse Event|4|||
163016763|NCT03564119|588766232|FG001|Overall Study|Adverse Event|0|||
163016764|NCT03564119|588766231|FG000|Overall Study|Lost to Follow-up|1|||
163016765|NCT03564119|588766232|FG001|Overall Study|Lost to Follow-up|4|||
163016766|NCT03564119|588766231|FG000|Overall Study|Protocol Violation|1|||
163016767|NCT03564119|588766232|FG001|Overall Study|Protocol Violation|0|||
163016768|NCT03564119|588766231|FG000|Overall Study|Withdrawal by Subject|9|||
163016769|NCT03564119|588766232|FG001|Overall Study|Withdrawal by Subject|4|||
163016770|NCT03564119|588766231|FG000|Overall Study|Other Than Specified|0|||
163016771|NCT03564119|588766232|FG001|Overall Study|Other Than Specified|1|||
163016772|NCT03896022|588766233|FG000|Overall Study|Withdrawal by Subject|1|||
163016773|NCT03896022|588766234|FG001|Overall Study|Withdrawal by Subject|0|||
163016774|NCT03896022|588766235|FG002|Overall Study|Withdrawal by Subject|0|||
163016775|NCT03896022|588766233|FG000|Overall Study|Did not have procedure|3|||
163016776|NCT03896022|588766234|FG001|Overall Study|Did not have procedure|0|||
163016777|NCT03896022|588766235|FG002|Overall Study|Did not have procedure|0|||
163016778|NCT02741076|588766236|FG000|Overall Study|Adverse Event|0|||
163016779|NCT02741076|588766237|FG001|Overall Study|Adverse Event|1|||
163016780|NCT02741076|588766238|FG002|Overall Study|Adverse Event|1|||
163016781|NCT02741076|588766239|FG003|Overall Study|Adverse Event|0|||
163016782|NCT02741076|588766236|FG000|Overall Study|Lack of Efficacy|1|||
163016783|NCT02741076|588766237|FG001|Overall Study|Lack of Efficacy|0|||
163016784|NCT02741076|588766238|FG002|Overall Study|Lack of Efficacy|0|||
163016785|NCT02741076|588766239|FG003|Overall Study|Lack of Efficacy|0|||
163016786|NCT02741076|588766236|FG000|Overall Study|Withdrawal by Subject|0|||
163016787|NCT02741076|588766237|FG001|Overall Study|Withdrawal by Subject|1|||
163016788|NCT02741076|588766238|FG002|Overall Study|Withdrawal by Subject|0|||
163016789|NCT02741076|588766239|FG003|Overall Study|Withdrawal by Subject|0|||
163016790|NCT02741076|588766236|FG000|Overall Study|Sponsor Request|2|||
163016791|NCT02741076|588766237|FG001|Overall Study|Sponsor Request|3|||
163016792|NCT02741076|588766238|FG002|Overall Study|Sponsor Request|0|||
163016793|NCT02741076|588766239|FG003|Overall Study|Sponsor Request|1|||
163016794|NCT02741076|588766236|FG000|Overall Study|No additional information available|0|||
163016795|NCT02741076|588766237|FG001|Overall Study|No additional information available|0|||
163016796|NCT02741076|588766238|FG002|Overall Study|No additional information available|1|||
163016797|NCT02741076|588766239|FG003|Overall Study|No additional information available|1|||
163016798|NCT01779440|588766240|FG000|Overall Study|Withdrawal by Subject|3|||
163016799|NCT01779440|588766241|FG001|Overall Study|Withdrawal by Subject|5|||
163016800|NCT00550745|588766242|FG000|Overall Study|Death|20|||
163016801|NCT00550745|588766243|FG001|Overall Study|Death|16|||
163016802|NCT00550745|588766242|FG000|Overall Study|Lost to Follow-up|45|||
163016803|NCT00550745|588766243|FG001|Overall Study|Lost to Follow-up|30|||
163016804|NCT00550745|588766242|FG000|Overall Study|Physician Decision|0|||
163016805|NCT00550745|588766243|FG001|Overall Study|Physician Decision|2|||
163016806|NCT00550745|588766242|FG000|Overall Study|Protocol Violation|4|||
163016807|NCT00550745|588766243|FG001|Overall Study|Protocol Violation|2|||
163016808|NCT00550745|588766242|FG000|Overall Study|Withdrawal by Subject|17|||
163016809|NCT00550745|588766243|FG001|Overall Study|Withdrawal by Subject|10|||
163016810|NCT00550745|588766242|FG000|Overall Study|Screen failure|1|||
163016811|NCT00550745|588766243|FG001|Overall Study|Screen failure|0|||
163016812|NCT01131455|588766244|FG000|Overall Study|Death of PI|6|||
163016813|NCT01131455|588766245|FG001|Overall Study|Death of PI|4|||
163016814|NCT01131455|588766246|FG002|Overall Study|Death of PI|0|||
163016815|NCT00764660|588766247|FG000|Overall Study|Adverse Event|6|||
163016816|NCT00764660|588766248|FG001|Overall Study|Adverse Event|3|||
163016817|NCT00764660|588766247|FG000|Overall Study|Lost to Follow-up|3|||
163016818|NCT00764660|588766248|FG001|Overall Study|Lost to Follow-up|4|||
163016819|NCT00764660|588766247|FG000|Overall Study|Withdrawal by Subject|7|||
163016820|NCT00764660|588766248|FG001|Overall Study|Withdrawal by Subject|3|||
163016821|NCT00764660|588766247|FG000|Overall Study|Noncompliance With Protocol|5|||
163016822|NCT00764660|588766248|FG001|Overall Study|Noncompliance With Protocol|1|||
163016823|NCT00764660|588766247|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163016824|NCT00764660|588766248|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
163016825|NCT01190410|588767405|FG000|Overall Study|Adverse Event|0|||
163016826|NCT01190410|588767406|FG001|Overall Study|Adverse Event|3|||
163016827|NCT01190410|588767405|FG000|Overall Study|Lack of Efficacy|0|||
163016828|NCT01190410|588767406|FG001|Overall Study|Lack of Efficacy|2|||
163016829|NCT01190410|588767405|FG000|Overall Study|Withdrawal by Subject|0|||
163016830|NCT01190410|588767406|FG001|Overall Study|Withdrawal by Subject|2|||
163016831|NCT01190410|588767405|FG000|Overall Study|Administrative decision|1|||
163016832|NCT01190410|588767406|FG001|Overall Study|Administrative decision|0|||
163016833|NCT01190410|588767405|FG000|Overall Study|PI discretion|0|||
163016834|NCT01190410|588767406|FG001|Overall Study|PI discretion|2|||
163016835|NCT00769067|588767407|FG000|Overall Study|Death|89|||
163016836|NCT00769067|588767408|FG001|Overall Study|Death|86|||
163016837|NCT00769067|588767407|FG000|Overall Study|Lost to Follow-up|3|||
163016838|NCT00769067|588767408|FG001|Overall Study|Lost to Follow-up|1|||
163016839|NCT00769067|588767407|FG000|Overall Study|Study terminated by sponsor|1|||
163016840|NCT00769067|588767408|FG001|Overall Study|Study terminated by sponsor|3|||
163016841|NCT00769067|588767407|FG000|Overall Study|Other|1|||
163016842|NCT00769067|588767408|FG001|Overall Study|Other|3|||
163016843|NCT00769067|588767407|FG000|Overall Study|Withdrawal by Subject|0|||
163016844|NCT00769067|588767408|FG001|Overall Study|Withdrawal by Subject|1|||
163016845|NCT04981470|588767411|FG000|Overall Study|Device failure in all 4 patients|4|||
163016846|NCT04402138|588767412|FG000|Overall Study|Progressive Disease|2|||
163016847|NCT04402138|588767412|FG000|Overall Study|Adverse Event|1|||
163016848|NCT00784238|588767413|FG000|Overall Study|Adverse Event|14|||
163016849|NCT00784238|588767413|FG000|Overall Study|Death|2|||
163016850|NCT00784238|588767413|FG000|Overall Study|Lack of Efficacy|33|||
163016851|NCT00784238|588767413|FG000|Overall Study|Lost to Follow-up|29|||
163016852|NCT00784238|588767413|FG000|Overall Study|Pregnancy|1|||
163016853|NCT00784238|588767413|FG000|Overall Study|Withdrawal by Subject|26|||
163016854|NCT00784238|588767413|FG000|Overall Study|Other|14|||
163016855|NCT00078767|588767415|FG000|Overall Study|Withdrawal by Subject|1|||
163016856|NCT00078767|588767416|FG001|Overall Study|Withdrawal by Subject|1|||
163016857|NCT06098339|588767417|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
163016858|NCT06098339|588767418|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
163016859|NCT06098339|588767417|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
163016860|NCT06098339|588767418|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
163016861|NCT03656692|588767421|FG000|Overall Study|Worsening of disease activity|2|||
163016862|NCT03656692|588767421|FG000|Overall Study|Physician Decision|1|||
163016863|NCT00594100|588767422|FG000|Procedure|Technical Failure|9|||
163016864|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
163016865|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
163016866|NCT00594100|588767422|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
163016867|NCT02448537|588767423|FG000|Overall Study|Withdrawal by Subject|1|||
163016868|NCT02448537|588767424|FG001|Overall Study|Withdrawal by Subject|1|||
163016869|NCT02448537|588767425|FG002|Overall Study|Withdrawal by Subject|1|||
163016870|NCT03528369|588767426|FG000|Overall Study|Withdrawal by Subject|2|||
163016871|NCT03528369|588767427|FG001|Overall Study|Withdrawal by Subject|0|||
163016872|NCT03528369|588767428|FG002|Overall Study|Withdrawal by Subject|0|||
163016873|NCT03528369|588767426|FG000|Overall Study|Lost to Follow-up|1|||
163016874|NCT03528369|588767427|FG001|Overall Study|Lost to Follow-up|0|||
163016875|NCT03528369|588767428|FG002|Overall Study|Lost to Follow-up|0|||
163016876|NCT03528369|588767426|FG000|Overall Study|Adverse Event|0|||
163016877|NCT03528369|588767427|FG001|Overall Study|Adverse Event|1|||
163016878|NCT03528369|588767428|FG002|Overall Study|Adverse Event|0|||
163016879|NCT05656534|588767430|FG000|Overall Study|Withdrawal by Subject|1|||
163016880|NCT05656534|588767431|FG001|Overall Study|Withdrawal by Subject|1|||
163016881|NCT05656534|588767432|FG002|Overall Study|Withdrawal by Subject|0|||
163016882|NCT05656534|588767433|FG003|Overall Study|Withdrawal by Subject|0|||
163016883|NCT05656534|588767430|FG000|Overall Study|Physician Decision|1|||
163016884|NCT05656534|588767431|FG001|Overall Study|Physician Decision|1|||
163016885|NCT05656534|588767432|FG002|Overall Study|Physician Decision|0|||
163016886|NCT05656534|588767433|FG003|Overall Study|Physician Decision|0|||
163016887|NCT02801617|588767438|FG000|Overall Study|Protocol Violation|2|||
163016888|NCT02801617|588767439|FG001|Overall Study|Protocol Violation|6|||
163016889|NCT00302328|588767440|FG000|Overall Study|Physician Decision|0|||
163016890|NCT00302328|588767441|FG001|Overall Study|Physician Decision|1|||
163016891|NCT00302328|588767442|FG002|Overall Study|Physician Decision|0|||
163016892|NCT01718535|588767443|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
163016893|NCT01718535|588767444|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
163016894|NCT01718535|588767445|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
163016895|NCT01718535|588767446|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
163016896|NCT01718535|588767447|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
163016897|NCT01718535|588767448|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
163016898|NCT01718535|588767449|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
163016899|NCT01718535|588767450|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
163016900|NCT01718535|588767451|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
163016901|NCT01718535|588767452|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
163016902|NCT02476578|588767453|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
163016903|NCT02476578|588767454|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
163016904|NCT02476578|588767453|FG000|Overall Study|Lost to Follow-up|6|||
163016905|NCT02476578|588767454|FG001|Overall Study|Lost to Follow-up|13|||
163016906|NCT01057810|588767456|FG000|Overall Study|Disease progression|156|||
163016907|NCT01057810|588767457|FG001|Overall Study|Disease progression|197|||
163016908|NCT01057810|588767456|FG000|Overall Study|Study drug toxicity|5|||
163016909|NCT01057810|588767457|FG001|Overall Study|Study drug toxicity|114|||
163016910|NCT01057810|588767456|FG000|Overall Study|Adverse event unrelated to study drug|13|||
163016911|NCT01057810|588767457|FG001|Overall Study|Adverse event unrelated to study drug|29|||
163016912|NCT01057810|588767456|FG000|Overall Study|Withdrawal by Subject|10|||
163016913|NCT01057810|588767457|FG001|Overall Study|Withdrawal by Subject|25|||
163016914|NCT01057810|588767456|FG000|Overall Study|Death|2|||
163016915|NCT01057810|588767457|FG001|Overall Study|Death|12|||
163016916|NCT01057810|588767456|FG000|Overall Study|Maximum clinical benefit|5|||
163016917|NCT01057810|588767457|FG001|Overall Study|Maximum clinical benefit|5|||
163016918|NCT01057810|588767456|FG000|Overall Study|Poor/non-compliance|0|||
163016919|NCT01057810|588767457|FG001|Overall Study|Poor/non-compliance|1|||
163016920|NCT01057810|588767456|FG000|Overall Study|No longer met study criteria|0|||
163016921|NCT01057810|588767457|FG001|Overall Study|No longer met study criteria|1|||
163016922|NCT01057810|588767456|FG000|Overall Study|Other|7|||
163016923|NCT01057810|588767457|FG001|Overall Study|Other|14|||
163016924|NCT00267969|588767458|FG000|Controlled Period|Adverse Event|6|||
163016925|NCT00267969|588767459|FG001|Controlled Period|Adverse Event|0|||
163016926|NCT00267969|588767460|FG002|Controlled Period|Adverse Event|2|||
163016927|NCT00267969|588767461|FG003|Controlled Period|Adverse Event|0|||
163016928|NCT00267969|588767462|FG004|Controlled Period|Adverse Event|0|||
163016929|NCT00267969|588767463|FG005|Controlled Period|Adverse Event|0|||
163016930|NCT00267969|588767464|FG006|Controlled Period|Adverse Event|0|||
163016931|NCT00267969|588767458|FG000|Controlled Period|Lack of Efficacy|3|||
163016932|NCT00267969|588767459|FG001|Controlled Period|Lack of Efficacy|0|||
163016933|NCT00267969|588767460|FG002|Controlled Period|Lack of Efficacy|1|||
163016934|NCT00267969|588767461|FG003|Controlled Period|Lack of Efficacy|0|||
163016935|NCT00267969|588767462|FG004|Controlled Period|Lack of Efficacy|0|||
163016936|NCT00267969|588767463|FG005|Controlled Period|Lack of Efficacy|0|||
163016937|NCT00267969|588767464|FG006|Controlled Period|Lack of Efficacy|0|||
163016938|NCT00267969|588767458|FG000|Controlled Period|Lost to Follow-up|1|||
163016939|NCT00267969|588767459|FG001|Controlled Period|Lost to Follow-up|0|||
163016940|NCT00267969|588767460|FG002|Controlled Period|Lost to Follow-up|1|||
163016941|NCT00267969|588767461|FG003|Controlled Period|Lost to Follow-up|0|||
163016942|NCT00267969|588767462|FG004|Controlled Period|Lost to Follow-up|0|||
163016943|NCT00267969|588767463|FG005|Controlled Period|Lost to Follow-up|0|||
163016944|NCT00267969|588767464|FG006|Controlled Period|Lost to Follow-up|0|||
163016945|NCT00267969|588767458|FG000|Controlled Period|Randomized but not treated|0|||
163016946|NCT00267969|588767459|FG001|Controlled Period|Randomized but not treated|0|||
163016947|NCT00267969|588767460|FG002|Controlled Period|Randomized but not treated|1|||
163016948|NCT00267969|588767461|FG003|Controlled Period|Randomized but not treated|0|||
163016949|NCT00267969|588767462|FG004|Controlled Period|Randomized but not treated|0|||
163016950|NCT00267969|588767463|FG005|Controlled Period|Randomized but not treated|0|||
163016951|NCT00267969|588767464|FG006|Controlled Period|Randomized but not treated|0|||
163016952|NCT00267969|588767458|FG000|Controlled Period|Other|2|||
163016953|NCT00267969|588767459|FG001|Controlled Period|Other|1|||
163016954|NCT00267969|588767460|FG002|Controlled Period|Other|6|||
163016955|NCT00267969|588767461|FG003|Controlled Period|Other|0|||
163016956|NCT00267969|588767462|FG004|Controlled Period|Other|0|||
163016957|NCT00267969|588767463|FG005|Controlled Period|Other|0|||
163016958|NCT00267969|588767464|FG006|Controlled Period|Other|0|||
163016959|NCT00267969|588767458|FG000|After Controlled Period|Adverse Event|0|||
163016960|NCT00267969|588767459|FG001|After Controlled Period|Adverse Event|0|||
163016961|NCT00267969|588767460|FG002|After Controlled Period|Adverse Event|0|||
163016962|NCT00267969|588767461|FG003|After Controlled Period|Adverse Event|7|||
163016963|NCT00267969|588767462|FG004|After Controlled Period|Adverse Event|8|||
163016964|NCT00267969|588767463|FG005|After Controlled Period|Adverse Event|23|||
163016965|NCT00267969|588767464|FG006|After Controlled Period|Adverse Event|21|||
163016966|NCT00267969|588767458|FG000|After Controlled Period|Death|0|||
163016967|NCT00267969|588767459|FG001|After Controlled Period|Death|0|||
163016968|NCT00267969|588767460|FG002|After Controlled Period|Death|0|||
163016969|NCT00267969|588767461|FG003|After Controlled Period|Death|1|||
163016970|NCT00267969|588767462|FG004|After Controlled Period|Death|2|||
163016971|NCT00267969|588767463|FG005|After Controlled Period|Death|0|||
163016972|NCT00267969|588767464|FG006|After Controlled Period|Death|1|||
163016973|NCT00267969|588767458|FG000|After Controlled Period|Lack of Efficacy|0|||
163016974|NCT00267969|588767459|FG001|After Controlled Period|Lack of Efficacy|0|||
163016975|NCT00267969|588767460|FG002|After Controlled Period|Lack of Efficacy|0|||
163016976|NCT00267969|588767461|FG003|After Controlled Period|Lack of Efficacy|10|||
163016977|NCT00267969|588767462|FG004|After Controlled Period|Lack of Efficacy|6|||
163016978|NCT00267969|588767463|FG005|After Controlled Period|Lack of Efficacy|28|||
163016979|NCT00267969|588767464|FG006|After Controlled Period|Lack of Efficacy|15|||
163016980|NCT00267969|588767458|FG000|After Controlled Period|Lost to Follow-up|0|||
163016981|NCT00267969|588767459|FG001|After Controlled Period|Lost to Follow-up|0|||
163016982|NCT00267969|588767460|FG002|After Controlled Period|Lost to Follow-up|0|||
163016983|NCT00267969|588767461|FG003|After Controlled Period|Lost to Follow-up|5|||
163016984|NCT00267969|588767462|FG004|After Controlled Period|Lost to Follow-up|8|||
163016985|NCT00267969|588767463|FG005|After Controlled Period|Lost to Follow-up|9|||
163016986|NCT00267969|588767464|FG006|After Controlled Period|Lost to Follow-up|10|||
163016987|NCT00267969|588767458|FG000|After Controlled Period|Other|0|||
163016988|NCT00267969|588767459|FG001|After Controlled Period|Other|0|||
163016989|NCT00267969|588767460|FG002|After Controlled Period|Other|0|||
163016990|NCT00267969|588767461|FG003|After Controlled Period|Other|13|||
163016991|NCT00267969|588767462|FG004|After Controlled Period|Other|11|||
163016992|NCT00267969|588767463|FG005|After Controlled Period|Other|22|||
163016993|NCT00267969|588767464|FG006|After Controlled Period|Other|25|||
163016994|NCT00862823|588767465|FG000|First Intervention|Withdrawal by Subject|1|||
162640968|NCT01291173|587401517|FG003|Overall Study|Protocol Violation|5|||
162640969|NCT01291173|587401514|FG000|Overall Study|Withdrawal by Subject|6|||
162640970|NCT01291173|587401515|FG001|Overall Study|Withdrawal by Subject|4|||
163016995|NCT00862823|588767466|FG001|First Intervention|Withdrawal by Subject|1|||
163016996|NCT00887315|588767467|FG000|Overall Study|Study termination|7|||
163016997|NCT00887315|588767468|FG001|Overall Study|Study termination|4|||
163016998|NCT00857896|588767475|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
163016999|NCT02308540|588767476|FG000|Overall Study|Lost to Follow-up|0|||
163017000|NCT02308540|588767477|FG001|Overall Study|Lost to Follow-up|0|||
163017001|NCT02308540|588767478|FG002|Overall Study|Lost to Follow-up|0|||
163017002|NCT02308540|588767479|FG003|Overall Study|Lost to Follow-up|0|||
163017003|NCT02308540|588767480|FG004|Overall Study|Lost to Follow-up|0|||
163017004|NCT02308540|588767481|FG005|Overall Study|Lost to Follow-up|1|||
163017005|NCT01091662|588767482|FG000|Overall Study|Adverse Event|1|||
163017006|NCT01091662|588767483|FG001|Overall Study|Adverse Event|9|||
163017007|NCT01091662|588767482|FG000|Overall Study|Physician Decision|1|||
163017008|NCT01091662|588767483|FG001|Overall Study|Physician Decision|1|||
163017009|NCT01091662|588767482|FG000|Overall Study|Withdrawal by Subject|7|||
163017010|NCT01091662|588767483|FG001|Overall Study|Withdrawal by Subject|6|||
163017011|NCT01091662|588767482|FG000|Overall Study|met exit criteria|7|||
163017012|NCT01091662|588767483|FG001|Overall Study|met exit criteria|13|||
163017013|NCT01091662|588767482|FG000|Overall Study|met exclusion criteria|1|||
163017014|NCT01091662|588767483|FG001|Overall Study|met exclusion criteria|0|||
163017015|NCT01091662|588767482|FG000|Overall Study|Lost to Follow-up|0|||
163017016|NCT01091662|588767483|FG001|Overall Study|Lost to Follow-up|1|||
163017017|NCT01091662|588767482|FG000|Overall Study|Pregnancy|0|||
163017018|NCT01091662|588767483|FG001|Overall Study|Pregnancy|1|||
163017019|NCT01091662|588767482|FG000|Overall Study|Protocol Violation|0|||
163017020|NCT01091662|588767483|FG001|Overall Study|Protocol Violation|2|||
163017021|NCT01091662|588767482|FG000|Overall Study|unable to swallow capsule|0|||
163017022|NCT01091662|588767483|FG001|Overall Study|unable to swallow capsule|1|||
163017023|NCT04109391|588767484|FG000|Overall Study|Adverse Event|2|||
163017024|NCT04109391|588767485|FG001|Overall Study|Adverse Event|2|||
163017025|NCT04109391|588767486|FG002|Overall Study|Adverse Event|0|||
163017026|NCT04109391|588767484|FG000|Overall Study|Withdrawal by Subject|2|||
163017027|NCT04109391|588767485|FG001|Overall Study|Withdrawal by Subject|0|||
163017028|NCT04109391|588767486|FG002|Overall Study|Withdrawal by Subject|0|||
163017029|NCT04109391|588767484|FG000|Overall Study|Pregnancy|1|||
163017030|NCT04109391|588767485|FG001|Overall Study|Pregnancy|0|||
163017031|NCT04109391|588767486|FG002|Overall Study|Pregnancy|0|||
163017032|NCT04109391|588767484|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
163017033|NCT04109391|588767485|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
163017034|NCT04109391|588767486|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
163017035|NCT04109391|588767484|FG000|Overall Study|Lost to Follow-up|0|||
163017036|NCT04109391|588767485|FG001|Overall Study|Lost to Follow-up|0|||
163017037|NCT04109391|588767486|FG002|Overall Study|Lost to Follow-up|1|||
163017038|NCT04109391|588767484|FG000|Overall Study|Lack of Efficacy|2|||
163017039|NCT04109391|588767485|FG001|Overall Study|Lack of Efficacy|2|||
163017040|NCT04109391|588767486|FG002|Overall Study|Lack of Efficacy|3|||
163017041|NCT02285166|588767487|FG000|Overall Study|Case Report Forms Uncollected|564|||
163017042|NCT02285166|588767487|FG000|Overall Study|Protocol Deviation|402|||
163017043|NCT00443079|588767488|FG000|Overall Study|Lost to Follow-up|0|||
163017044|NCT00443079|588767489|FG001|Overall Study|Lost to Follow-up|1|||
163017045|NCT01421225|588767490|FG000|Overall Study|Withdrawal by Subject|0|||
163017046|NCT01421225|588767491|FG001|Overall Study|Withdrawal by Subject|1|||
163017047|NCT01106911|588767492|FG000|Overall Study|Physician Decision|2|||
163017048|NCT01106911|588767492|FG000|Overall Study|deemed ineligible after screening|3|||
163017049|NCT01814696|588767494|FG000|Overall Study|Withdrawal by Subject|1|||
163017050|NCT01814696|588767495|FG001|Overall Study|Withdrawal by Subject|0|||
163017051|NCT01814696|588767494|FG000|Overall Study|Randomized to wrong group|1|||
163017052|NCT01814696|588767495|FG001|Overall Study|Randomized to wrong group|0|||
163017053|NCT05310071|588767497|FG000|Overall Study|Death|0|||
163017054|NCT05310071|588767498|FG001|Overall Study|Death|3|||
163017055|NCT05310071|588767497|FG000|Overall Study|Adverse Event|4|||
163017056|NCT05310071|588767498|FG001|Overall Study|Adverse Event|31|||
163017057|NCT05310071|588767497|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
163017058|NCT05310071|588767498|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
163017059|NCT05310071|588767497|FG000|Overall Study|Protocol Deviation|2|||
163017060|NCT05310071|588767498|FG001|Overall Study|Protocol Deviation|0|||
163017061|NCT05310071|588767497|FG000|Overall Study|Randomized by Mistake|0|||
163017062|NCT05310071|588767498|FG001|Overall Study|Randomized by Mistake|1|||
163017063|NCT05310071|588767497|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
163017064|NCT05310071|588767498|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163017065|NCT05310071|588767497|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
163017066|NCT05310071|588767498|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163017067|NCT05310071|588767497|FG000|Overall Study|Site Terminated by Sponsor|0|||
163017068|NCT05310071|588767498|FG001|Overall Study|Site Terminated by Sponsor|2|||
163017069|NCT05310071|588767497|FG000|Overall Study|Study Terminated by Sponsor|282|||
163017070|NCT05310071|588767498|FG001|Overall Study|Study Terminated by Sponsor|559|||
163017071|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
163017072|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
163017073|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
163017074|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
163017075|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
163017076|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
163017077|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
163017078|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
163017079|NCT05310071|588767497|FG000|Overall Study|Withdrawal by Participant - Other|25|||
163017080|NCT05310071|588767498|FG001|Overall Study|Withdrawal by Participant - Other|30|||
163017081|NCT05310071|588767497|FG000|Overall Study|Lost to Follow-up|2|||
163017082|NCT05310071|588767498|FG001|Overall Study|Lost to Follow-up|4|||
163017083|NCT05310071|588767497|FG000|Overall Study|Reason Not Specified|1|||
163017084|NCT05310071|588767498|FG001|Overall Study|Reason Not Specified|3|||
163017085|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
163017086|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017087|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017088|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017089|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017090|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
163017091|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
163017092|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
163017093|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017094|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017095|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017096|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
163017097|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
163017098|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
163017099|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017100|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017101|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017102|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017103|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017104|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017105|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017106|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017107|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017108|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017109|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
163017110|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
163017111|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017112|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017113|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017114|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
163017115|NCT02105987|588767499|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017116|NCT02105987|588767500|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
163017117|NCT02105987|588767501|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017118|NCT02105987|588767502|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017119|NCT02105987|588767503|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017120|NCT02105987|588767504|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
163017121|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017122|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017123|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
163017124|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
163017125|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017126|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
163017127|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017128|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017129|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
163017130|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
163017131|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017132|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
163017133|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017134|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017135|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
163017136|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
163017137|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017138|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
163017139|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163062939|NCT04491994|588938528|FG000|Overall Study|Withdrawal by Subject|10|||
163062940|NCT04491994|588938529|FG001|Overall Study|Withdrawal by Subject|5|||
163062941|NCT04491994|588938528|FG000|Overall Study|developed fever > 3 days|4|||
163062942|NCT04491994|588938529|FG001|Overall Study|developed fever > 3 days|1|||
163062943|NCT04491994|588938528|FG000|Overall Study|Protocol Violation|11|||
163062944|NCT04491994|588938529|FG001|Overall Study|Protocol Violation|2|||
163062945|NCT04491994|588938528|FG000|Overall Study|Lost to Follow-up|4|||
163062946|NCT04491994|588938529|FG001|Overall Study|Lost to Follow-up|3|||
163017140|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017141|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
163017142|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
163017143|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017144|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
163017145|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017146|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017147|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
163017148|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017149|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017150|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
163017151|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017152|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017153|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017154|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
163017155|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017156|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
163017157|NCT02105987|588767499|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017158|NCT02105987|588767500|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017159|NCT02105987|588767501|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
163017160|NCT02105987|588767502|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017161|NCT02105987|588767503|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017162|NCT02105987|588767504|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
163017163|NCT02105987|588767499|FG000|Continuation Phase|Protocol Violation|0|||
163017164|NCT02105987|588767500|FG001|Continuation Phase|Protocol Violation|0|||
163017165|NCT02105987|588767501|FG002|Continuation Phase|Protocol Violation|0|||
163017166|NCT02105987|588767502|FG003|Continuation Phase|Protocol Violation|0|||
163017167|NCT02105987|588767503|FG004|Continuation Phase|Protocol Violation|1|||
163017168|NCT02105987|588767504|FG005|Continuation Phase|Protocol Violation|0|||
163017169|NCT02418949|588767505|FG000|Overall Study|Withdrawal by Subject|1|||
163017170|NCT02418949|588767506|FG001|Overall Study|Withdrawal by Subject|0|||
163017171|NCT02418949|588767507|FG002|Overall Study|Withdrawal by Subject|1|||
163017172|NCT02418949|588767508|FG003|Overall Study|Withdrawal by Subject|1|||
163017173|NCT02418949|588767505|FG000|Overall Study|Lost to Follow-up|1|||
163017174|NCT02418949|588767506|FG001|Overall Study|Lost to Follow-up|0|||
163017175|NCT02418949|588767507|FG002|Overall Study|Lost to Follow-up|1|||
163017176|NCT02418949|588767508|FG003|Overall Study|Lost to Follow-up|0|||
163017177|NCT02418949|588767505|FG000|Overall Study|Physician Decision|1|||
163017178|NCT02418949|588767506|FG001|Overall Study|Physician Decision|1|||
163017179|NCT02418949|588767507|FG002|Overall Study|Physician Decision|1|||
163017180|NCT02418949|588767508|FG003|Overall Study|Physician Decision|0|||
163017181|NCT00396656|588767510|FG000|First Treatment Period|Withdrawal by Subject|0|||
163017182|NCT00396656|588767511|FG001|First Treatment Period|Withdrawal by Subject|2|||
163017183|NCT00396656|588767510|FG000|Second Treatment Period|Adverse Event|0|||
163017184|NCT00396656|588767511|FG001|Second Treatment Period|Adverse Event|1|||
163017185|NCT01303172|588767512|FG000|Overall Study|Physician Decision|9|||
163017186|NCT01303172|588767513|FG001|Overall Study|Physician Decision|6|||
163017187|NCT01303172|588767512|FG000|Overall Study|Adverse Event|5|||
163017188|NCT01303172|588767513|FG001|Overall Study|Adverse Event|2|||
163017189|NCT01303172|588767512|FG000|Overall Study|Withdrawal by Subject|4|||
163017190|NCT01303172|588767513|FG001|Overall Study|Withdrawal by Subject|2|||
163017191|NCT01303172|588767512|FG000|Overall Study|Death|20|||
163017192|NCT01303172|588767513|FG001|Overall Study|Death|7|||
163017193|NCT01303172|588767512|FG000|Overall Study|Lack of Efficacy|25|||
163017194|NCT01303172|588767513|FG001|Overall Study|Lack of Efficacy|17|||
163017195|NCT00462709|588767514|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
163017196|NCT00462709|588767514|FG000|Overall Study|Lost to Follow-up|10|||
163017197|NCT00462709|588767514|FG000|Overall Study|Withdrawal by Subject|8|||
163017198|NCT00462709|588767514|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
163062947|NCT03575364|588938535|FG000|Overall Study|Death|45|||
163062948|NCT03575364|588938535|FG000|Overall Study|Lost to Follow-up|114|||
163062949|NCT03575364|588938535|FG000|Overall Study|Withdrawal by Subject|21|||
162716082|NCT03354390|587667119|FG002|Level 3|Death|1|||
163062950|NCT03575364|588938535|FG000|Overall Study|Physician Decision|11|||
163017199|NCT00462709|588767514|FG000|Overall Study|Death|2|||
163017200|NCT00462709|588767514|FG000|Overall Study|Logistical reasons|2|||
163017201|NCT00462709|588767514|FG000|Overall Study|Physician Decision|1|||
163017202|NCT00462709|588767514|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
163017203|NCT02099110|588767519|FG000|Overall Study|Protocol Violation|2|||
163017204|NCT02099110|588767520|FG001|Overall Study|Protocol Violation|1|||
163017205|NCT02099110|588767521|FG002|Overall Study|Protocol Violation|0|||
163017206|NCT02099110|588767522|FG003|Overall Study|Protocol Violation|3|||
163017207|NCT02099110|588767523|FG004|Overall Study|Protocol Violation|1|||
163017208|NCT02099110|588767519|FG000|Overall Study|Participant moved|1|||
163017209|NCT02099110|588767520|FG001|Overall Study|Participant moved|1|||
163017210|NCT02099110|588767521|FG002|Overall Study|Participant moved|1|||
163017211|NCT02099110|588767522|FG003|Overall Study|Participant moved|0|||
163017212|NCT02099110|588767523|FG004|Overall Study|Participant moved|2|||
163017213|NCT02099110|588767519|FG000|Overall Study|Withdrawal by Subject|7|||
163017214|NCT02099110|588767520|FG001|Overall Study|Withdrawal by Subject|11|||
163017215|NCT02099110|588767521|FG002|Overall Study|Withdrawal by Subject|13|||
163017216|NCT02099110|588767522|FG003|Overall Study|Withdrawal by Subject|9|||
163017217|NCT02099110|588767523|FG004|Overall Study|Withdrawal by Subject|13|||
163017218|NCT02099110|588767519|FG000|Overall Study|Adverse Event|3|||
163017219|NCT02099110|588767520|FG001|Overall Study|Adverse Event|5|||
163017220|NCT02099110|588767521|FG002|Overall Study|Adverse Event|2|||
163017221|NCT02099110|588767522|FG003|Overall Study|Adverse Event|3|||
163017222|NCT02099110|588767523|FG004|Overall Study|Adverse Event|2|||
163062951|NCT03575364|588938535|FG000|Overall Study|Subject Refused Follow-up|13|||
163062952|NCT03575364|588938535|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
163062953|NCT03575364|588938535|FG000|Overall Study|Patient moved out of the state|1|||
163062954|NCT03575364|588938535|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
163062955|NCT03575364|588938535|FG000|Overall Study|Patient is lost to follow up|1|||
163062956|NCT03575364|588938535|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
163062957|NCT02567188|588938536|FG000|Overall Study|Death|10|||
163062958|NCT02567188|588938536|FG000|Overall Study|Terminated Mircera Treatment|9|||
163062959|NCT02567188|588938536|FG000|Overall Study|Lost to Follow-up|5|||
163062960|NCT02567188|588938536|FG000|Overall Study|Adverse Event|1|||
163062961|NCT02567188|588938536|FG000|Overall Study|Withdrawal by Subject|1|||
163062962|NCT02567188|588938536|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
163062963|NCT02567188|588938536|FG000|Overall Study|Moved and Changed Clinic|1|||
163062964|NCT02567188|588938536|FG000|Overall Study|Started Hemodialysis|2|||
163062965|NCT02567188|588938536|FG000|Overall Study|Protocol Violation|5|||
163062966|NCT01033136|588938537|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
163062967|NCT01033136|588938538|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
163062968|NCT05383209|588938539|FG000|Overall Study|Adverse Event: Non-ocular|0|||
163062969|NCT05383209|588938540|FG001|Overall Study|Adverse Event: Non-ocular|1|||
163062970|NCT05383209|588938541|FG002|Overall Study|Adverse Event: Non-ocular|0|||
163062971|NCT05383209|588938539|FG000|Overall Study|Lost to Follow-up|2|||
163062972|NCT05383209|588938540|FG001|Overall Study|Lost to Follow-up|1|||
163062973|NCT05383209|588938541|FG002|Overall Study|Lost to Follow-up|4|||
163062974|NCT05383209|588938539|FG000|Overall Study|Withdrawal by Subject|2|||
163062975|NCT05383209|588938540|FG001|Overall Study|Withdrawal by Subject|0|||
163062976|NCT05383209|588938541|FG002|Overall Study|Withdrawal by Subject|1|||
163062977|NCT05383209|588938539|FG000|Overall Study|Death|1|||
163062978|NCT05383209|588938540|FG001|Overall Study|Death|0|||
163062979|NCT05383209|588938541|FG002|Overall Study|Death|0|||
163062980|NCT05383209|588938539|FG000|Overall Study|Other|0|||
163017223|NCT02099110|588767519|FG000|Overall Study|Lost to Follow-up|6|||
163017224|NCT02099110|588767520|FG001|Overall Study|Lost to Follow-up|12|||
163017225|NCT02099110|588767521|FG002|Overall Study|Lost to Follow-up|11|||
163017226|NCT02099110|588767522|FG003|Overall Study|Lost to Follow-up|5|||
163062981|NCT05383209|588938540|FG001|Overall Study|Other|1|||
163062982|NCT05383209|588938541|FG002|Overall Study|Other|0|||
163062983|NCT01369433|588938542|FG000|Overall Study|Adverse Event|31|||
163062984|NCT01369433|588938543|FG001|Overall Study|Adverse Event|1|||
163062985|NCT01369433|588938542|FG000|Overall Study|Required significant surgical procedure|1|||
163062986|NCT01369433|588938543|FG001|Overall Study|Required significant surgical procedure|0|||
163017227|NCT02099110|588767523|FG004|Overall Study|Lost to Follow-up|6|||
163017228|NCT02099110|588767519|FG000|Overall Study|Death|0|||
163017229|NCT02099110|588767520|FG001|Overall Study|Death|1|||
163017230|NCT02099110|588767521|FG002|Overall Study|Death|0|||
163017231|NCT02099110|588767522|FG003|Overall Study|Death|0|||
163017232|NCT02099110|588767523|FG004|Overall Study|Death|0|||
163062987|NCT01369433|588938542|FG000|Overall Study|Non-compliance|1|||
163062988|NCT01369433|588938543|FG001|Overall Study|Non-compliance|0|||
163062989|NCT01369433|588938542|FG000|Overall Study|Withdrawal by Subject|5|||
163062990|NCT01369433|588938543|FG001|Overall Study|Withdrawal by Subject|2|||
163017233|NCT02099110|588767519|FG000|Overall Study|Screen failure|0|||
163017234|NCT02099110|588767520|FG001|Overall Study|Screen failure|0|||
163017235|NCT02099110|588767521|FG002|Overall Study|Screen failure|0|||
163017236|NCT02099110|588767522|FG003|Overall Study|Screen failure|0|||
163017237|NCT02099110|588767523|FG004|Overall Study|Screen failure|1|||
163017238|NCT02099110|588767519|FG000|Overall Study|Non-compliance with study drug|2|||
163017239|NCT02099110|588767520|FG001|Overall Study|Non-compliance with study drug|0|||
163017240|NCT02099110|588767521|FG002|Overall Study|Non-compliance with study drug|0|||
163017241|NCT02099110|588767522|FG003|Overall Study|Non-compliance with study drug|0|||
163017242|NCT02099110|588767523|FG004|Overall Study|Non-compliance with study drug|1|||
163017243|NCT02099110|588767519|FG000|Overall Study|Physician Decision|3|||
163017244|NCT02099110|588767520|FG001|Overall Study|Physician Decision|0|||
163017245|NCT02099110|588767521|FG002|Overall Study|Physician Decision|1|||
163017246|NCT02099110|588767522|FG003|Overall Study|Physician Decision|2|||
163017247|NCT02099110|588767523|FG004|Overall Study|Physician Decision|1|||
163017248|NCT00237458|588767530|FG000|Overall Study|Lack of Efficacy|1|||
163017249|NCT00237458|588767530|FG000|Overall Study|Adverse Event|1|||
163017250|NCT00237458|588767530|FG000|Overall Study|Withdrawal by Subject|1|||
163017251|NCT05107492|588767531|FG000|Overall Study|Lost to Follow-up|1|||
163017252|NCT05107492|588767532|FG001|Overall Study|Lost to Follow-up|0|||
163017253|NCT03218826|588767533|FG000|Overall Study|Non-compliance with protocol|1|||
163017254|NCT03218826|588767534|FG001|Overall Study|Non-compliance with protocol|0|||
163017255|NCT03218826|588767535|FG002|Overall Study|Non-compliance with protocol|2|||
163017256|NCT03218826|588767536|FG003|Overall Study|Non-compliance with protocol|1|||
163017257|NCT03218826|588767537|FG004|Overall Study|Non-compliance with protocol|1|||
163017258|NCT02858583|588767540|FG000|Overall Study|Declined consent|1|||
163017259|NCT02858583|588767541|FG001|Overall Study|Declined consent|1|||
163017260|NCT00634036|588767548|FG000|Overall Study|Lost to Follow-up|1|||
163017261|NCT00634036|588767549|FG001|Overall Study|Lost to Follow-up|1|||
163017262|NCT00634036|588767548|FG000|Overall Study|Withdrawal by Subject|1|||
163017263|NCT00634036|588767549|FG001|Overall Study|Withdrawal by Subject|1|||
163017264|NCT00961350|588767550|FG000|Overall Study|Adverse Event|18|||
163017265|NCT00961350|588767551|FG001|Overall Study|Adverse Event|33|||
163062991|NCT01369433|588938542|FG000|Overall Study|Study terminated by Sponsor|67|||
163062992|NCT01369433|588938543|FG001|Overall Study|Study terminated by Sponsor|0|||
163062993|NCT01369433|588938542|FG000|Overall Study|Lost to Follow-up|1|||
163062994|NCT01369433|588938543|FG001|Overall Study|Lost to Follow-up|0|||
163062995|NCT01369433|588938542|FG000|Overall Study|Death|5|||
163062996|NCT01369433|588938543|FG001|Overall Study|Death|0|||
163062997|NCT01369433|588938542|FG000|Overall Study|Investigator discretion|6|||
163062998|NCT01369433|588938543|FG001|Overall Study|Investigator discretion|1|||
163062999|NCT01369433|588938542|FG000|Overall Study|Progressive Disease|92|||
163063000|NCT01369433|588938543|FG001|Overall Study|Progressive Disease|12|||
163063001|NCT02313155|588938544|FG000|Overall Study|Lost to Follow-up|0|||
163063002|NCT02313155|588938545|FG001|Overall Study|Lost to Follow-up|1|||
163063003|NCT00933933|588938551|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
163063004|NCT00933933|588938552|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
163063005|NCT00933933|588938553|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
163063006|NCT00933933|588938551|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
163063007|NCT00933933|588938552|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
163063008|NCT00933933|588938553|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
163063009|NCT01138046|588938556|FG000|Overall Study|Withdrawal due to death|6|||
163063010|NCT01104766|588938560|FG000|Overall Study|Did not meet inc/exc criteria|1|||
163063011|NCT01104766|588938561|FG001|Overall Study|Did not meet inc/exc criteria|0|||
163063012|NCT01104766|588938562|FG002|Overall Study|Did not meet inc/exc criteria|0|||
163063013|NCT01104766|588938563|FG003|Overall Study|Did not meet inc/exc criteria|0|||
163063014|NCT01104766|588938560|FG000|Overall Study|Adverse Event|17|||
163063015|NCT01104766|588938561|FG001|Overall Study|Adverse Event|15|||
163063016|NCT01104766|588938562|FG002|Overall Study|Adverse Event|20|||
163017266|NCT00961350|588767550|FG000|Overall Study|Withdrawal by Subject|10|||
163017267|NCT00961350|588767551|FG001|Overall Study|Withdrawal by Subject|10|||
163017268|NCT00961350|588767550|FG000|Overall Study|Lost to Follow-up|3|||
163017269|NCT00961350|588767551|FG001|Overall Study|Lost to Follow-up|3|||
163063017|NCT01104766|588938563|FG003|Overall Study|Adverse Event|14|||
163017270|NCT00961350|588767550|FG000|Overall Study|Misc|16|||
163017271|NCT00961350|588767551|FG001|Overall Study|Misc|21|||
163017272|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
163017273|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
163017274|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
163017275|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
163017276|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
163017277|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
163017278|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
163017279|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
163017280|NCT03867201|588767552|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
163017281|NCT03867201|588767553|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
163017282|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Adverse Event|5|||
163017283|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Adverse Event|11|||
163017284|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
163017285|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
163017286|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Physician Decision|6|||
163017287|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Physician Decision|3|||
163017288|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Pregnancy|2|||
163017289|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Pregnancy|2|||
163017290|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
163017291|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
163017292|NCT03867201|588767552|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
163017293|NCT03867201|588767553|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
163017294|NCT03867201|588767552|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
163017295|NCT03867201|588767553|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
163017296|NCT03867201|588767552|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
163017297|NCT03867201|588767553|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
163017298|NCT01283334|588769029|FG000|Overall Study|Withdrawal by Subject|1|||
163017299|NCT01283334|588769029|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
163017300|NCT01283334|588769029|FG000|Overall Study|Adverse Event|4|||
163017301|NCT01283334|588769029|FG000|Overall Study|Physician Decision|1|||
163017302|NCT03467217|588769030|FG000|Overall Study|Trial stopped early|5|||
163017303|NCT03467217|588769031|FG001|Overall Study|Trial stopped early|2|||
163017304|NCT03467217|588769030|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
163017305|NCT03467217|588769031|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
163017306|NCT03467217|588769030|FG000|Overall Study|Lost to Follow-up|0|||
163017307|NCT03467217|588769031|FG001|Overall Study|Lost to Follow-up|2|||
163017308|NCT04390503|588769032|FG000|Overall Study|Physician Decision|2|||
163017309|NCT04390503|588769033|FG001|Overall Study|Physician Decision|1|||
163017310|NCT04390503|588769032|FG000|Overall Study|Adverse Event|1|||
163017311|NCT04390503|588769033|FG001|Overall Study|Adverse Event|0|||
163017312|NCT03233529|588769035|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
163017313|NCT03233529|588769035|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
163017314|NCT03260244|588769036|FG000|Overall Study|Death|19|||
163017315|NCT03260244|588769036|FG000|Overall Study|Lost to Follow-up|60|||
163017316|NCT03260244|588769036|FG000|Overall Study|Withdrawal by Subject|48|||
163017317|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed|21|||
163017318|NCT03260244|588769036|FG000|Overall Study|Enrollment Criteria Not Met|31|||
163017319|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
163017320|NCT03260244|588769036|FG000|Overall Study|Subject Noncompliance|6|||
163017321|NCT03260244|588769036|FG000|Overall Study|No inducible Arrhythmia|2|||
163017322|NCT03260244|588769036|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
163017323|NCT03260244|588769036|FG000|Overall Study|Screen Failure|2|||
163017324|NCT03260244|588769036|FG000|Overall Study|Treated Off Label|69|||
163017325|NCT03260244|588769036|FG000|Overall Study|No Radiofrequency Ablation|14|||
163017326|NCT01177293|588769040|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
163017327|NCT01177293|588769041|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
163017328|NCT04725812|588769042|FG000|Overall Study|Withdrawal by Subject|1|||
163017329|NCT00839800|588769044|FG000|Overall Study|Adverse Event|8|||
163017330|NCT00839800|588769045|FG001|Overall Study|Adverse Event|12|||
163017331|NCT00839800|588769044|FG000|Overall Study|Lost to Follow-up|31|||
163017332|NCT00839800|588769045|FG001|Overall Study|Lost to Follow-up|26|||
163017333|NCT00839800|588769044|FG000|Overall Study|Withdrawal by Subject|28|||
162716083|NCT03354390|587667120|FG003|Level 3|Death|0|||
163017334|NCT00839800|588769045|FG001|Overall Study|Withdrawal by Subject|34|||
163017335|NCT00839800|588769044|FG000|Overall Study|Incorrect Enrolment|3|||
163063018|NCT01104766|588938560|FG000|Overall Study|Lack of Efficacy|20|||
162716084|NCT03354390|587667117|FG000|Level 3|Physician Decision|0|||
162716085|NCT03354390|587667118|FG001|Level 3|Physician Decision|0|||
162716086|NCT03354390|587667119|FG002|Level 3|Physician Decision|2|||
162716087|NCT03354390|587667120|FG003|Level 3|Physician Decision|0|||
163017336|NCT00839800|588769045|FG001|Overall Study|Incorrect Enrolment|3|||
163017337|NCT00839800|588769044|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
163017338|NCT00839800|588769045|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
163017339|NCT00839800|588769044|FG000|Overall Study|Safety Reasons|2|||
163017340|NCT00839800|588769045|FG001|Overall Study|Safety Reasons|1|||
163017341|NCT00839800|588769044|FG000|Overall Study|Other|8|||
163017342|NCT00839800|588769045|FG001|Overall Study|Other|14|||
163017343|NCT00839800|588769044|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
163017344|NCT00839800|588769045|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
163017345|NCT00912743|588769053|FG000|Overall Study|Adverse Event|3|||
163017346|NCT00912743|588769054|FG001|Overall Study|Adverse Event|1|||
163017347|NCT00912743|588769053|FG000|Overall Study|Lack of Efficacy|9|||
163017348|NCT00912743|588769054|FG001|Overall Study|Lack of Efficacy|18|||
163017349|NCT00912743|588769053|FG000|Overall Study|Toxicity|0|||
162716088|NCT03354390|587667117|FG000|Level 4|Death|0|||
162716089|NCT03354390|587667118|FG001|Level 4|Death|0|||
162716090|NCT03354390|587667119|FG002|Level 4|Death|0|||
162716091|NCT03354390|587667120|FG003|Level 4|Death|3|||
162716092|NCT03944512|587667122|FG000|Overall Study|Death|0|||
162716093|NCT03944512|587667123|FG001|Overall Study|Death|0|||
162716094|NCT03944512|587667124|FG002|Overall Study|Death|1|||
162716095|NCT03944512|587667125|FG003|Overall Study|Death|2|||
162716096|NCT03944512|587667122|FG000|Overall Study|Lost to Follow-up|0|||
162716097|NCT03944512|587667123|FG001|Overall Study|Lost to Follow-up|0|||
162716098|NCT03944512|587667124|FG002|Overall Study|Lost to Follow-up|4|||
163017350|NCT00912743|588769054|FG001|Overall Study|Toxicity|1|||
163017351|NCT00912743|588769053|FG000|Overall Study|End of treatment form was not collected|1|||
163017352|NCT00912743|588769054|FG001|Overall Study|End of treatment form was not collected|0|||
163017353|NCT04747886|588769055|FG000|Overall Study|Withdrawal by Subject|1|||
163017354|NCT04747886|588769056|FG001|Overall Study|Withdrawal by Subject|4|||
163017355|NCT02237196|588769058|FG000|Overall Study|Adverse Event|0|||
163017356|NCT02237196|588769059|FG001|Overall Study|Adverse Event|1|||
163017357|NCT02237196|588769060|FG002|Overall Study|Adverse Event|1|||
163017358|NCT02237196|588769061|FG003|Overall Study|Adverse Event|0|||
163017359|NCT02237196|588769058|FG000|Overall Study|Lost to Follow-up|4|||
163017360|NCT02237196|588769059|FG001|Overall Study|Lost to Follow-up|2|||
163017361|NCT02237196|588769060|FG002|Overall Study|Lost to Follow-up|4|||
163017362|NCT02237196|588769061|FG003|Overall Study|Lost to Follow-up|6|||
163017363|NCT02237196|588769058|FG000|Overall Study|Physician Decision|2|||
163017364|NCT02237196|588769059|FG001|Overall Study|Physician Decision|0|||
163017365|NCT02237196|588769060|FG002|Overall Study|Physician Decision|0|||
163017366|NCT02237196|588769061|FG003|Overall Study|Physician Decision|1|||
163017367|NCT02237196|588769058|FG000|Overall Study|Pregnancy|0|||
163017368|NCT02237196|588769059|FG001|Overall Study|Pregnancy|0|||
163017369|NCT02237196|588769060|FG002|Overall Study|Pregnancy|1|||
163017370|NCT02237196|588769061|FG003|Overall Study|Pregnancy|1|||
163017371|NCT02237196|588769058|FG000|Overall Study|Withdrawal by Subject|1|||
163017372|NCT02237196|588769059|FG001|Overall Study|Withdrawal by Subject|1|||
163017373|NCT02237196|588769060|FG002|Overall Study|Withdrawal by Subject|4|||
163017374|NCT02237196|588769061|FG003|Overall Study|Withdrawal by Subject|1|||
163017375|NCT02237196|588769058|FG000|Overall Study|Site Error|1|||
162640971|NCT01291173|587401516|FG002|Overall Study|Withdrawal by Subject|4|||
162640972|NCT01291173|587401517|FG003|Overall Study|Withdrawal by Subject|2|||
162640973|NCT01291173|587401514|FG000|Overall Study|Lost to Follow-up|4|||
162640974|NCT01291173|587401515|FG001|Overall Study|Lost to Follow-up|6|||
162640975|NCT01291173|587401516|FG002|Overall Study|Lost to Follow-up|3|||
162640976|NCT01291173|587401517|FG003|Overall Study|Lost to Follow-up|2|||
162640977|NCT01291173|587401514|FG000|Overall Study|Unable to meet visit schedule|0|||
162640978|NCT01291173|587401515|FG001|Overall Study|Unable to meet visit schedule|0|||
162640979|NCT01291173|587401516|FG002|Overall Study|Unable to meet visit schedule|1|||
162640980|NCT01291173|587401517|FG003|Overall Study|Unable to meet visit schedule|0|||
162640981|NCT01291173|587401514|FG000|Overall Study|Lack of compliance|0|||
162640982|NCT01291173|587401515|FG001|Overall Study|Lack of compliance|0|||
162640983|NCT01291173|587401516|FG002|Overall Study|Lack of compliance|0|||
162640984|NCT01291173|587401517|FG003|Overall Study|Lack of compliance|1|||
162640985|NCT01291173|587401514|FG000|Overall Study|Subject was unblinded|0|||
162640986|NCT01291173|587401515|FG001|Overall Study|Subject was unblinded|0|||
162640987|NCT01291173|587401516|FG002|Overall Study|Subject was unblinded|1|||
162640988|NCT01291173|587401517|FG003|Overall Study|Subject was unblinded|0|||
162640989|NCT01291173|587401514|FG000|Overall Study|Excluded therapy|0|||
162640990|NCT01291173|587401515|FG001|Overall Study|Excluded therapy|0|||
162640991|NCT01291173|587401516|FG002|Overall Study|Excluded therapy|1|||
162640992|NCT01291173|587401517|FG003|Overall Study|Excluded therapy|0|||
162640993|NCT01074450|587401523|FG000|First Intervention|Emesis in Dosing Interval|0|||
162640994|NCT01074450|587401524|FG001|First Intervention|Emesis in Dosing Interval|2|||
162640995|NCT01074450|587401523|FG000|Second Intervention|Protocol Violation|1|||
162640996|NCT01074450|587401524|FG001|Second Intervention|Protocol Violation|0|||
162640997|NCT01074450|587401523|FG000|Second Intervention|Physician Decision|0|||
163017376|NCT02237196|588769059|FG001|Overall Study|Site Error|2|||
163017377|NCT02237196|588769060|FG002|Overall Study|Site Error|0|||
163017378|NCT02237196|588769061|FG003|Overall Study|Site Error|2|||
163017379|NCT00619892|588769062|FG000|Overall Study|Adverse Event|3|||
163017380|NCT00619892|588769063|FG001|Overall Study|Adverse Event|0|||
163017381|NCT00619892|588769062|FG000|Overall Study|Lost to Follow-up|0|||
163017382|NCT00619892|588769063|FG001|Overall Study|Lost to Follow-up|1|||
163017383|NCT00619892|588769062|FG000|Overall Study|Intercurrent illness|0|||
163017384|NCT00619892|588769063|FG001|Overall Study|Intercurrent illness|1|||
163017385|NCT02049814|588769072|FG000|Overall Study|Reason not Specified|4|||
163017386|NCT02049814|588769073|FG001|Overall Study|Reason not Specified|3|||
163017387|NCT02049814|588769072|FG000|Overall Study|Pregnancy|1|||
163017388|NCT02049814|588769073|FG001|Overall Study|Pregnancy|0|||
163017389|NCT02049814|588769072|FG000|Overall Study|Lost to Follow-up|2|||
163017390|NCT02049814|588769073|FG001|Overall Study|Lost to Follow-up|3|||
163017391|NCT02049814|588769072|FG000|Overall Study|Serious Protocol Violation|5|||
163017392|NCT02049814|588769073|FG001|Overall Study|Serious Protocol Violation|7|||
163017393|NCT02049814|588769072|FG000|Overall Study|Study Termination|0|||
163017394|NCT02049814|588769073|FG001|Overall Study|Study Termination|1|||
163017395|NCT02049814|588769072|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
163017396|NCT02049814|588769073|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
163017397|NCT02049814|588769072|FG000|Overall Study|Voluntary withdrawal|9|||
163017398|NCT02049814|588769073|FG001|Overall Study|Voluntary withdrawal|8|||
163017399|NCT02714595|588769074|FG000|Overall Study|Lost to Follow-up|1|||
163017400|NCT02714595|588769075|FG001|Overall Study|Lost to Follow-up|0|||
163017401|NCT02714595|588769074|FG000|Overall Study|Withdrawal by Subject|1|||
162716099|NCT03944512|587667125|FG003|Overall Study|Lost to Follow-up|4|||
162716100|NCT03944512|587667122|FG000|Overall Study|refused follow-up|0|||
162716101|NCT03944512|587667123|FG001|Overall Study|refused follow-up|0|||
162716102|NCT03944512|587667124|FG002|Overall Study|refused follow-up|2|||
162716103|NCT03944512|587667125|FG003|Overall Study|refused follow-up|2|||
162716104|NCT01090024|587668382|FG000|Period 1|Met exclusion criteria|0|||
162716105|NCT01090024|587668383|FG001|Period 1|Met exclusion criteria|0|||
162716106|NCT01090024|587668384|FG002|Period 1|Met exclusion criteria|0|||
162716107|NCT01090024|587668385|FG003|Period 1|Met exclusion criteria|0|||
162716108|NCT01090024|587668386|FG004|Period 1|Met exclusion criteria|0|||
162716109|NCT01090024|587668387|FG005|Period 1|Met exclusion criteria|0|||
162716110|NCT01090024|587668388|FG006|Period 1|Met exclusion criteria|0|||
162716111|NCT01090024|587668389|FG007|Period 1|Met exclusion criteria|0|||
162716112|NCT01090024|587668390|FG008|Period 1|Met exclusion criteria|0|||
162716113|NCT01090024|587668391|FG009|Period 1|Met exclusion criteria|0|||
162716114|NCT01090024|587668392|FG010|Period 1|Met exclusion criteria|0|||
162716115|NCT01090024|587668393|FG011|Period 1|Met exclusion criteria|0|||
162716116|NCT01090024|587668394|FG012|Period 1|Met exclusion criteria|0|||
162716117|NCT01090024|587668395|FG013|Period 1|Met exclusion criteria|0|||
162716118|NCT01090024|587668396|FG014|Period 1|Met exclusion criteria|1|||
162716119|NCT01090024|587668397|FG015|Period 1|Met exclusion criteria|0|||
162716120|NCT01090024|587668398|FG016|Period 1|Met exclusion criteria|0|||
162716121|NCT01090024|587668399|FG017|Period 1|Met exclusion criteria|0|||
162716122|NCT01090024|587668382|FG000|Period 1|Adverse Event|0|||
162716123|NCT01090024|587668383|FG001|Period 1|Adverse Event|0|||
162716124|NCT01090024|587668384|FG002|Period 1|Adverse Event|0|||
162716125|NCT01090024|587668385|FG003|Period 1|Adverse Event|0|||
162716126|NCT01090024|587668386|FG004|Period 1|Adverse Event|0|||
162716127|NCT01090024|587668387|FG005|Period 1|Adverse Event|0|||
162716128|NCT01090024|587668388|FG006|Period 1|Adverse Event|0|||
162716129|NCT01090024|587668389|FG007|Period 1|Adverse Event|0|||
162716130|NCT01090024|587668390|FG008|Period 1|Adverse Event|0|||
163017402|NCT02714595|588769075|FG001|Overall Study|Withdrawal by Subject|2|||
163017403|NCT02714595|588769074|FG000|Overall Study|Lack of Efficacy|0|||
163017404|NCT02714595|588769075|FG001|Overall Study|Lack of Efficacy|1|||
163017405|NCT02714595|588769074|FG000|Overall Study|Death|30|||
163017406|NCT02714595|588769075|FG001|Overall Study|Death|9|||
162716131|NCT01090024|587668391|FG009|Period 1|Adverse Event|1|||
162716132|NCT01090024|587668392|FG010|Period 1|Adverse Event|0|||
162716133|NCT01090024|587668393|FG011|Period 1|Adverse Event|1|||
162716134|NCT01090024|587668394|FG012|Period 1|Adverse Event|0|||
162716135|NCT01090024|587668395|FG013|Period 1|Adverse Event|0|||
162716136|NCT01090024|587668396|FG014|Period 1|Adverse Event|0|||
162716137|NCT01090024|587668397|FG015|Period 1|Adverse Event|0|||
162716138|NCT01090024|587668398|FG016|Period 1|Adverse Event|0|||
162716139|NCT01090024|587668399|FG017|Period 1|Adverse Event|1|||
162716140|NCT01090024|587668382|FG000|Period 1|Withdrawal by Subject|0|||
163017407|NCT02714595|588769074|FG000|Overall Study|Other-Miscellaneous|0|||
163017408|NCT02714595|588769075|FG001|Overall Study|Other-Miscellaneous|1|||
163017409|NCT00713258|588769076|FG000|Overall Study|Adverse Event|2|||
163017410|NCT00713258|588769077|FG001|Overall Study|Adverse Event|4|||
163017411|NCT00713258|588769076|FG000|Overall Study|Non-Compliance|2|||
162716141|NCT01090024|587668383|FG001|Period 1|Withdrawal by Subject|0|||
162716142|NCT01090024|587668384|FG002|Period 1|Withdrawal by Subject|0|||
162716143|NCT01090024|587668385|FG003|Period 1|Withdrawal by Subject|1|||
163017412|NCT00713258|588769077|FG001|Overall Study|Non-Compliance|1|||
163017413|NCT00713258|588769076|FG000|Overall Study|Other|1|||
163017414|NCT00713258|588769077|FG001|Overall Study|Other|1|||
163017415|NCT01431716|588769078|FG000|Overall Study|Withdrawal of consent|1|||
163017416|NCT02199795|588769081|FG000|Overall Study|no longer met inclusion criteria|1|||
163017417|NCT02199795|588769082|FG001|Overall Study|no longer met inclusion criteria|0|||
163017418|NCT02199795|588769081|FG000|Overall Study|withdrew due to shoulder pain|1|||
163017419|NCT02199795|588769082|FG001|Overall Study|withdrew due to shoulder pain|0|||
163017420|NCT01339923|588769086|FG000|Overall Study|Adverse Event|1|||
163017421|NCT01339923|588769087|FG001|Overall Study|Adverse Event|1|||
163017422|NCT01339923|588769088|FG002|Overall Study|Adverse Event|1|||
163017423|NCT01339923|588769089|FG003|Overall Study|Adverse Event|0|||
163017424|NCT01339923|588769090|FG004|Overall Study|Adverse Event|0|||
163017425|NCT01339923|588769091|FG005|Overall Study|Adverse Event|0|||
163017426|NCT01339923|588769092|FG006|Overall Study|Adverse Event|1|||
163017427|NCT01339923|588769086|FG000|Overall Study|Inappropriate Enrollment|1|||
163017428|NCT01339923|588769087|FG001|Overall Study|Inappropriate Enrollment|0|||
163017429|NCT01339923|588769088|FG002|Overall Study|Inappropriate Enrollment|0|||
163017430|NCT01339923|588769089|FG003|Overall Study|Inappropriate Enrollment|0|||
163017431|NCT01339923|588769090|FG004|Overall Study|Inappropriate Enrollment|0|||
163017432|NCT01339923|588769091|FG005|Overall Study|Inappropriate Enrollment|1|||
163017433|NCT01339923|588769092|FG006|Overall Study|Inappropriate Enrollment|0|||
163017434|NCT01339923|588769086|FG000|Overall Study|Lost to Follow-up|4|||
163017435|NCT01339923|588769087|FG001|Overall Study|Lost to Follow-up|4|||
163017436|NCT01339923|588769088|FG002|Overall Study|Lost to Follow-up|0|||
163017437|NCT01339923|588769089|FG003|Overall Study|Lost to Follow-up|3|||
163017438|NCT01339923|588769090|FG004|Overall Study|Lost to Follow-up|1|||
163017439|NCT01339923|588769091|FG005|Overall Study|Lost to Follow-up|1|||
163017440|NCT01339923|588769092|FG006|Overall Study|Lost to Follow-up|5|||
163017441|NCT01339923|588769086|FG000|Overall Study|Protocol Violation|0|||
163017442|NCT01339923|588769087|FG001|Overall Study|Protocol Violation|0|||
163017443|NCT01339923|588769088|FG002|Overall Study|Protocol Violation|0|||
163017444|NCT01339923|588769089|FG003|Overall Study|Protocol Violation|0|||
163017445|NCT01339923|588769090|FG004|Overall Study|Protocol Violation|0|||
163017446|NCT01339923|588769091|FG005|Overall Study|Protocol Violation|3|||
163017447|NCT01339923|588769092|FG006|Overall Study|Protocol Violation|1|||
163017448|NCT01339923|588769086|FG000|Overall Study|Unable to Classify|1|||
163017449|NCT01339923|588769087|FG001|Overall Study|Unable to Classify|0|||
163017450|NCT01339923|588769088|FG002|Overall Study|Unable to Classify|1|||
163017451|NCT01339923|588769089|FG003|Overall Study|Unable to Classify|0|||
163017452|NCT01339923|588769090|FG004|Overall Study|Unable to Classify|0|||
163017453|NCT01339923|588769091|FG005|Overall Study|Unable to Classify|1|||
163017454|NCT01339923|588769092|FG006|Overall Study|Unable to Classify|5|||
163017455|NCT01339923|588769086|FG000|Overall Study|Withdrawal by Subject|7|||
163017456|NCT01339923|588769087|FG001|Overall Study|Withdrawal by Subject|11|||
163017457|NCT01339923|588769088|FG002|Overall Study|Withdrawal by Subject|6|||
163017458|NCT01339923|588769089|FG003|Overall Study|Withdrawal by Subject|1|||
163017459|NCT01339923|588769090|FG004|Overall Study|Withdrawal by Subject|4|||
163017460|NCT01339923|588769091|FG005|Overall Study|Withdrawal by Subject|3|||
163017461|NCT01339923|588769092|FG006|Overall Study|Withdrawal by Subject|2|||
163017462|NCT00828568|588769104|FG000|Randomized|Withdrawal by Subject|1|||
163017463|NCT00828568|588769105|FG001|Randomized|Withdrawal by Subject|0|||
163017464|NCT00828568|588769106|FG002|Randomized|Withdrawal by Subject|2|||
163017465|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
163017466|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
163017467|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
163017468|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
163017469|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
163017470|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
163017471|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
163017472|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
163017473|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
163017474|NCT00828568|588769104|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
163017475|NCT00828568|588769105|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
163017476|NCT00828568|588769106|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
163017477|NCT00460811|588769108|FG000|Overall Study|Adverse Event|4|||
163017478|NCT00460811|588769109|FG001|Overall Study|Adverse Event|6|||
163017479|NCT00460811|588769110|FG002|Overall Study|Adverse Event|3|||
162716144|NCT01090024|587668386|FG004|Period 1|Withdrawal by Subject|0|||
163017480|NCT00460811|588769111|FG003|Overall Study|Adverse Event|10|||
163017481|NCT00460811|588769112|FG004|Overall Study|Adverse Event|2|||
163017482|NCT00460811|588769108|FG000|Overall Study|Noncompliance|1|||
163017483|NCT00460811|588769109|FG001|Overall Study|Noncompliance|0|||
163017484|NCT00460811|588769110|FG002|Overall Study|Noncompliance|0|||
163017485|NCT00460811|588769111|FG003|Overall Study|Noncompliance|2|||
163017486|NCT00460811|588769112|FG004|Overall Study|Noncompliance|1|||
163017487|NCT00460811|588769108|FG000|Overall Study|Withdrawal by Subject|7|||
163017488|NCT00460811|588769109|FG001|Overall Study|Withdrawal by Subject|7|||
163017489|NCT00460811|588769110|FG002|Overall Study|Withdrawal by Subject|6|||
163017490|NCT00460811|588769111|FG003|Overall Study|Withdrawal by Subject|3|||
163017491|NCT00460811|588769112|FG004|Overall Study|Withdrawal by Subject|11|||
163017492|NCT00460811|588769108|FG000|Overall Study|Physician Decision|1|||
163017493|NCT00460811|588769109|FG001|Overall Study|Physician Decision|0|||
163017494|NCT00460811|588769110|FG002|Overall Study|Physician Decision|0|||
163017495|NCT00460811|588769111|FG003|Overall Study|Physician Decision|0|||
163017496|NCT00460811|588769112|FG004|Overall Study|Physician Decision|0|||
163017497|NCT00460811|588769108|FG000|Overall Study|Lost to Follow-up|3|||
163017498|NCT00460811|588769109|FG001|Overall Study|Lost to Follow-up|2|||
163017499|NCT00460811|588769110|FG002|Overall Study|Lost to Follow-up|5|||
163017500|NCT00460811|588769111|FG003|Overall Study|Lost to Follow-up|3|||
163017501|NCT00460811|588769112|FG004|Overall Study|Lost to Follow-up|6|||
163017502|NCT02821754|588769113|FG000|Overall Study|Procedure not required prior to amendment change|13|||
163017503|NCT02821754|588769114|FG001|Overall Study|Procedure not required prior to amendment change|11|||
163017504|NCT02821754|588769115|FG002|Overall Study|Procedure not required prior to amendment change|0|||
163017505|NCT02821754|588769113|FG000|Overall Study|Participant's Clinical status|2|||
163017506|NCT02821754|588769114|FG001|Overall Study|Participant's Clinical status|0|||
163017507|NCT02821754|588769115|FG002|Overall Study|Participant's Clinical status|0|||
163017508|NCT02821754|588769113|FG000|Overall Study|Participant removed for noncompliance|1|||
163017509|NCT02821754|588769114|FG001|Overall Study|Participant removed for noncompliance|0|||
162716145|NCT01090024|587668387|FG005|Period 1|Withdrawal by Subject|0|||
162716146|NCT01090024|587668388|FG006|Period 1|Withdrawal by Subject|0|||
162716147|NCT01090024|587668389|FG007|Period 1|Withdrawal by Subject|0|||
162716148|NCT01090024|587668390|FG008|Period 1|Withdrawal by Subject|0|||
162716149|NCT01090024|587668391|FG009|Period 1|Withdrawal by Subject|0|||
162716150|NCT01090024|587668392|FG010|Period 1|Withdrawal by Subject|0|||
162716151|NCT01090024|587668393|FG011|Period 1|Withdrawal by Subject|0|||
162716152|NCT01090024|587668394|FG012|Period 1|Withdrawal by Subject|0|||
162716153|NCT01090024|587668395|FG013|Period 1|Withdrawal by Subject|0|||
162716154|NCT01090024|587668396|FG014|Period 1|Withdrawal by Subject|0|||
162716155|NCT01090024|587668397|FG015|Period 1|Withdrawal by Subject|0|||
162716156|NCT01090024|587668398|FG016|Period 1|Withdrawal by Subject|0|||
162716157|NCT01090024|587668399|FG017|Period 1|Withdrawal by Subject|0|||
162716158|NCT01090024|587668382|FG000|Period 1|Lost to Follow-up|0|||
162716159|NCT01090024|587668383|FG001|Period 1|Lost to Follow-up|1|||
162716160|NCT01090024|587668384|FG002|Period 1|Lost to Follow-up|0|||
162716161|NCT01090024|587668385|FG003|Period 1|Lost to Follow-up|0|||
162716162|NCT01090024|587668386|FG004|Period 1|Lost to Follow-up|0|||
162716163|NCT01090024|587668387|FG005|Period 1|Lost to Follow-up|0|||
162716164|NCT01090024|587668388|FG006|Period 1|Lost to Follow-up|0|||
162716165|NCT01090024|587668389|FG007|Period 1|Lost to Follow-up|0|||
162716166|NCT01090024|587668390|FG008|Period 1|Lost to Follow-up|0|||
162716167|NCT01090024|587668391|FG009|Period 1|Lost to Follow-up|0|||
162716168|NCT01090024|587668392|FG010|Period 1|Lost to Follow-up|0|||
162716169|NCT01090024|587668393|FG011|Period 1|Lost to Follow-up|0|||
162716170|NCT01090024|587668394|FG012|Period 1|Lost to Follow-up|0|||
162716171|NCT01090024|587668395|FG013|Period 1|Lost to Follow-up|0|||
162716172|NCT01090024|587668396|FG014|Period 1|Lost to Follow-up|0|||
162716173|NCT01090024|587668397|FG015|Period 1|Lost to Follow-up|0|||
162716174|NCT01090024|587668398|FG016|Period 1|Lost to Follow-up|0|||
162716175|NCT01090024|587668399|FG017|Period 1|Lost to Follow-up|0|||
162716176|NCT01090024|587668382|FG000|Period 2|Lost to Follow-up|0|||
162716177|NCT01090024|587668383|FG001|Period 2|Lost to Follow-up|0|||
162716178|NCT01090024|587668384|FG002|Period 2|Lost to Follow-up|0|||
162716179|NCT01090024|587668385|FG003|Period 2|Lost to Follow-up|1|||
162716180|NCT01090024|587668386|FG004|Period 2|Lost to Follow-up|0|||
162716181|NCT01090024|587668387|FG005|Period 2|Lost to Follow-up|0|||
162716182|NCT01090024|587668388|FG006|Period 2|Lost to Follow-up|0|||
162716183|NCT01090024|587668389|FG007|Period 2|Lost to Follow-up|0|||
162716184|NCT01090024|587668390|FG008|Period 2|Lost to Follow-up|0|||
163017510|NCT02821754|588769115|FG002|Overall Study|Participant removed for noncompliance|0|||
163063019|NCT01104766|588938561|FG001|Overall Study|Lack of Efficacy|15|||
162716185|NCT01090024|587668391|FG009|Period 2|Lost to Follow-up|0|||
162716186|NCT01090024|587668392|FG010|Period 2|Lost to Follow-up|0|||
162716187|NCT01090024|587668393|FG011|Period 2|Lost to Follow-up|0|||
163017511|NCT02821754|588769113|FG000|Overall Study|Drug not available.|0|||
163017512|NCT02821754|588769114|FG001|Overall Study|Drug not available.|0|||
163017513|NCT02821754|588769115|FG002|Overall Study|Drug not available.|1|||
163063020|NCT01104766|588938562|FG002|Overall Study|Lack of Efficacy|14|||
162716188|NCT01090024|587668394|FG012|Period 2|Lost to Follow-up|0|||
162716189|NCT01090024|587668395|FG013|Period 2|Lost to Follow-up|0|||
162716190|NCT01090024|587668396|FG014|Period 2|Lost to Follow-up|0|||
162716191|NCT01090024|587668397|FG015|Period 2|Lost to Follow-up|0|||
162716192|NCT01090024|587668398|FG016|Period 2|Lost to Follow-up|0|||
162716193|NCT01090024|587668399|FG017|Period 2|Lost to Follow-up|0|||
162716194|NCT01090024|587668382|FG000|Period 2|Adverse Event|1|||
162716195|NCT01090024|587668383|FG001|Period 2|Adverse Event|0|||
163017514|NCT02821754|588769113|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
163017515|NCT02821754|588769114|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
163017516|NCT02821754|588769115|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
163017517|NCT03515811|588769117|FG000|Overall Study|Lost to Follow-up|2|||
163017518|NCT03515811|588769118|FG001|Overall Study|Lost to Follow-up|1|||
163017519|NCT03515811|588769117|FG000|Overall Study|Protocol Violation|1|||
163017520|NCT03515811|588769118|FG001|Overall Study|Protocol Violation|1|||
163017521|NCT03515811|588769117|FG000|Overall Study|Death|1|||
163017522|NCT03515811|588769118|FG001|Overall Study|Death|1|||
163017523|NCT03515811|588769117|FG000|Overall Study|Withdrawal by Subject|0|||
163017524|NCT03515811|588769118|FG001|Overall Study|Withdrawal by Subject|2|||
163017525|NCT03515811|588769117|FG000|Overall Study|Technical Problems|1|||
163017526|NCT03515811|588769118|FG001|Overall Study|Technical Problems|0|||
163017527|NCT03515811|588769117|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
163017528|NCT03515811|588769118|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
163017529|NCT03515811|588769117|FG000|Overall Study|COVID-19|0|||
163017530|NCT03515811|588769118|FG001|Overall Study|COVID-19|1|||
163017531|NCT01355575|588769119|FG000|Overall Study|Withdrawal by Subject|2|||
163017532|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
163017533|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
163017534|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
163017535|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
163017536|NCT01166438|588769120|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
163017537|NCT01166438|588769121|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
163017538|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
163017539|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
163017540|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
162640998|NCT01074450|587401524|FG001|Second Intervention|Physician Decision|1|||
162640999|NCT02728895|587401525|FG000|Overall Study|Other|1|||
162641000|NCT02728895|587401526|FG001|Overall Study|Other|2|||
162641001|NCT02728895|587401525|FG000|Overall Study|Withdrawal by Subject|0|||
162641002|NCT02728895|587401526|FG001|Overall Study|Withdrawal by Subject|3|||
162641003|NCT02769247|587401527|FG000|Overall Study|Withdrawal by Subject|1|||
162641004|NCT02769247|587401528|FG001|Overall Study|Withdrawal by Subject|0|||
162641005|NCT02769247|587401529|FG002|Overall Study|Withdrawal by Subject|0|||
162641006|NCT02769247|587401530|FG003|Overall Study|Withdrawal by Subject|1|||
162641007|NCT02769247|587401527|FG000|Overall Study|Protocol Violation|0|||
162641008|NCT02769247|587401528|FG001|Overall Study|Protocol Violation|0|||
162641009|NCT02769247|587401529|FG002|Overall Study|Protocol Violation|1|||
162641010|NCT02769247|587401530|FG003|Overall Study|Protocol Violation|0|||
162641011|NCT02769247|587401527|FG000|Overall Study|Physician Decision|1|||
162641012|NCT02769247|587401528|FG001|Overall Study|Physician Decision|0|||
162641013|NCT02769247|587401529|FG002|Overall Study|Physician Decision|0|||
162641014|NCT02769247|587401530|FG003|Overall Study|Physician Decision|0|||
162641015|NCT04788953|587401531|FG000|Overall Study|Adverse Event|1|||
162641016|NCT04788953|587401532|FG001|Overall Study|Adverse Event|1|||
162641017|NCT04788953|587401531|FG000|Overall Study|Withdrawal by Subject|1|||
162641018|NCT04788953|587401532|FG001|Overall Study|Withdrawal by Subject|0|||
162641019|NCT04788953|587401531|FG000|Overall Study|Protocol Violation|0|||
162641020|NCT04788953|587401532|FG001|Overall Study|Protocol Violation|1|||
162641021|NCT00469092|587401533|FG000|Overall Study|Adverse Event|5|||
162641022|NCT00469092|587401534|FG001|Overall Study|Adverse Event|4|||
162641023|NCT00469092|587401533|FG000|Overall Study|Lack of Efficacy|1|||
162641024|NCT00469092|587401534|FG001|Overall Study|Lack of Efficacy|0|||
162641025|NCT00469092|587401533|FG000|Overall Study|Lost to Follow-up|1|||
162641026|NCT00469092|587401534|FG001|Overall Study|Lost to Follow-up|2|||
162641027|NCT00469092|587401533|FG000|Overall Study|Protocol Violation|3|||
162641028|NCT00469092|587401534|FG001|Overall Study|Protocol Violation|3|||
162641029|NCT00469092|587401533|FG000|Overall Study|Withdrawal by Subject|4|||
162641030|NCT00469092|587401534|FG001|Overall Study|Withdrawal by Subject|4|||
162641031|NCT00469092|587401533|FG000|Overall Study|Withdrawal Criteria|3|||
162641032|NCT00469092|587401534|FG001|Overall Study|Withdrawal Criteria|4|||
162641033|NCT00469092|587401533|FG000|Overall Study|Incorrectly Randomised|4|||
162641034|NCT00469092|587401534|FG001|Overall Study|Incorrectly Randomised|3|||
162641035|NCT00469092|587401533|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
162641036|NCT00469092|587401534|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
162641037|NCT00469092|587401533|FG000|Overall Study|Use of lipid lowering drug|1|||
162641038|NCT00469092|587401534|FG001|Overall Study|Use of lipid lowering drug|0|||
162641039|NCT00469092|587401533|FG000|Overall Study|Hypoglycaemic Episodes|1|||
162641040|NCT00469092|587401534|FG001|Overall Study|Hypoglycaemic Episodes|1|||
162641041|NCT00469092|587401533|FG000|Overall Study|Abnormal lab value|1|||
162641042|NCT00469092|587401534|FG001|Overall Study|Abnormal lab value|0|||
163017541|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
163017542|NCT01166438|588769120|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
163017543|NCT01166438|588769121|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
163017544|NCT01197534|588769126|FG000|Overall Study|Not reported|16|||
163017545|NCT01197534|588769127|FG001|Overall Study|Not reported|10|||
163017546|NCT01197534|588769128|FG002|Overall Study|Not reported|16|||
163017547|NCT01197534|588769126|FG000|Overall Study|Enrolment in long term extension|57|||
163017548|NCT01197534|588769127|FG001|Overall Study|Enrolment in long term extension|66|||
163017549|NCT01197534|588769128|FG002|Overall Study|Enrolment in long term extension|119|||
163017550|NCT01197534|588769126|FG000|Overall Study|Severe non-compliance to protocol|3|||
163017551|NCT01197534|588769127|FG001|Overall Study|Severe non-compliance to protocol|4|||
163017552|NCT01197534|588769128|FG002|Overall Study|Severe non-compliance to protocol|1|||
163017553|NCT01197534|588769126|FG000|Overall Study|Lack of therapeutic response|9|||
163017554|NCT01197534|588769127|FG001|Overall Study|Lack of therapeutic response|4|||
163017555|NCT01197534|588769128|FG002|Overall Study|Lack of therapeutic response|9|||
163017556|NCT01197534|588769126|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
163017557|NCT01197534|588769127|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
163017558|NCT01197534|588769128|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
163017559|NCT01197534|588769126|FG000|Overall Study|Lost to Follow-up|1|||
163017560|NCT01197534|588769127|FG001|Overall Study|Lost to Follow-up|4|||
163017561|NCT01197534|588769128|FG002|Overall Study|Lost to Follow-up|2|||
163017562|NCT01197534|588769126|FG000|Overall Study|Adverse Event|35|||
163017563|NCT01197534|588769127|FG001|Overall Study|Adverse Event|36|||
163017564|NCT01197534|588769128|FG002|Overall Study|Adverse Event|24|||
163017565|NCT02593097|588769135|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
163017566|NCT02593097|588769136|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
163017567|NCT02593097|588769135|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163017568|NCT02593097|588769136|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
163017569|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
163017570|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
162641043|NCT00469092|587401533|FG000|Overall Study|Use of Corticosteroid|1|||
162641044|NCT00469092|587401534|FG001|Overall Study|Use of Corticosteroid|0|||
163017571|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
163017572|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
163017573|NCT02593097|588769135|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
163017574|NCT02593097|588769136|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
163017575|NCT03759587|588769137|FG000|Overall Study|Adverse Event|5|||
163017576|NCT03759587|588769137|FG000|Overall Study|Progressive Disease|10|||
163017577|NCT03759587|588769137|FG000|Overall Study|Site Terminated by Sponsor|3|||
163017578|NCT03759587|588769137|FG000|Overall Study|Withdrawal by Subject|1|||
163017579|NCT00591565|588769140|FG000|Overall Study|lost follow up, withdrawn|5|||
163017580|NCT00454363|588769141|FG000|Overall Study|Adverse Event|1|||
163017581|NCT00454363|588769142|FG001|Overall Study|Adverse Event|2|||
163017582|NCT00454363|588769141|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
163017583|NCT00454363|588769142|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
163017584|NCT01554527|588769144|FG000|Overall Study|Withdrawal by Subject|1|||
163017585|NCT01554527|588769145|FG001|Overall Study|Withdrawal by Subject|0|||
163017586|NCT01554527|588769146|FG002|Overall Study|Withdrawal by Subject|3|||
163017587|NCT01554527|588769144|FG000|Overall Study|Lost to Follow-up|0|||
163017588|NCT01554527|588769145|FG001|Overall Study|Lost to Follow-up|0|||
162641045|NCT01086540|587401536|FG000|Overall Study|Death|3|||
162641046|NCT01086540|587401537|FG001|Overall Study|Death|1|||
162641047|NCT01086540|587401536|FG000|Overall Study|Physician Decision|2|||
162641048|NCT01086540|587401537|FG001|Overall Study|Physician Decision|1|||
162641049|NCT01086540|587401536|FG000|Overall Study|Addition of new therapy for PAH|1|||
162641050|NCT01086540|587401537|FG001|Overall Study|Addition of new therapy for PAH|0|||
162641051|NCT02707991|587401538|FG000|Overall Study|Protocol Violation|1|||
162641052|NCT02707991|587401539|FG001|Overall Study|Protocol Violation|0|||
163017589|NCT01554527|588769146|FG002|Overall Study|Lost to Follow-up|4|||
163017590|NCT01554527|588769144|FG000|Overall Study|Physician Decision|0|||
163017591|NCT01554527|588769145|FG001|Overall Study|Physician Decision|0|||
163017592|NCT01554527|588769146|FG002|Overall Study|Physician Decision|1|||
163017593|NCT01863667|588769153|FG000|Overall Study|Adverse Event|1|||
163017594|NCT01863667|588769154|FG001|Overall Study|Adverse Event|0|||
163017595|NCT01863667|588769153|FG000|Overall Study|Study terminated by Sponsor|30|||
162716196|NCT01090024|587668384|FG002|Period 2|Adverse Event|0|||
162716197|NCT01090024|587668385|FG003|Period 2|Adverse Event|0|||
162716198|NCT01090024|587668386|FG004|Period 2|Adverse Event|0|||
162716199|NCT01090024|587668387|FG005|Period 2|Adverse Event|0|||
162716200|NCT01090024|587668388|FG006|Period 2|Adverse Event|0|||
162716201|NCT01090024|587668389|FG007|Period 2|Adverse Event|0|||
162716202|NCT01090024|587668390|FG008|Period 2|Adverse Event|0|||
162716203|NCT01090024|587668391|FG009|Period 2|Adverse Event|0|||
162716204|NCT01090024|587668392|FG010|Period 2|Adverse Event|0|||
162716205|NCT01090024|587668393|FG011|Period 2|Adverse Event|0|||
162716206|NCT01090024|587668394|FG012|Period 2|Adverse Event|0|||
162716207|NCT01090024|587668395|FG013|Period 2|Adverse Event|0|||
162716208|NCT01090024|587668396|FG014|Period 2|Adverse Event|0|||
162716209|NCT01090024|587668397|FG015|Period 2|Adverse Event|0|||
163063021|NCT01104766|588938563|FG003|Overall Study|Lack of Efficacy|8|||
162716210|NCT01090024|587668398|FG016|Period 2|Adverse Event|0|||
162716211|NCT01090024|587668399|FG017|Period 2|Adverse Event|0|||
162716212|NCT01090024|587668382|FG000|Period 3|Withdrawal by Subject|0|||
162716213|NCT01090024|587668383|FG001|Period 3|Withdrawal by Subject|0|||
162716214|NCT01090024|587668384|FG002|Period 3|Withdrawal by Subject|0|||
162716215|NCT01090024|587668385|FG003|Period 3|Withdrawal by Subject|0|||
162716216|NCT01090024|587668386|FG004|Period 3|Withdrawal by Subject|0|||
162716217|NCT01090024|587668387|FG005|Period 3|Withdrawal by Subject|0|||
162716218|NCT01090024|587668388|FG006|Period 3|Withdrawal by Subject|0|||
162716219|NCT01090024|587668389|FG007|Period 3|Withdrawal by Subject|0|||
162716220|NCT01090024|587668390|FG008|Period 3|Withdrawal by Subject|0|||
162716221|NCT01090024|587668391|FG009|Period 3|Withdrawal by Subject|0|||
162716222|NCT01090024|587668392|FG010|Period 3|Withdrawal by Subject|0|||
162716223|NCT01090024|587668393|FG011|Period 3|Withdrawal by Subject|0|||
162716224|NCT01090024|587668394|FG012|Period 3|Withdrawal by Subject|0|||
162716225|NCT01090024|587668395|FG013|Period 3|Withdrawal by Subject|0|||
162716226|NCT01090024|587668396|FG014|Period 3|Withdrawal by Subject|0|||
162716227|NCT01090024|587668397|FG015|Period 3|Withdrawal by Subject|1|||
162716228|NCT01090024|587668398|FG016|Period 3|Withdrawal by Subject|0|||
162716229|NCT01090024|587668399|FG017|Period 3|Withdrawal by Subject|0|||
162716230|NCT01090024|587668382|FG000|Period 3|Protocol Violation|0|||
162716231|NCT01090024|587668383|FG001|Period 3|Protocol Violation|0|||
162716232|NCT01090024|587668384|FG002|Period 3|Protocol Violation|0|||
162716233|NCT01090024|587668385|FG003|Period 3|Protocol Violation|0|||
162716234|NCT01090024|587668386|FG004|Period 3|Protocol Violation|0|||
162716235|NCT01090024|587668387|FG005|Period 3|Protocol Violation|0|||
162716236|NCT01090024|587668388|FG006|Period 3|Protocol Violation|0|||
163017596|NCT01863667|588769154|FG001|Overall Study|Study terminated by Sponsor|30|||
163017597|NCT01863667|588769153|FG000|Overall Study|Withdrawal by Subject|2|||
163017598|NCT01863667|588769154|FG001|Overall Study|Withdrawal by Subject|2|||
163017599|NCT03627546|588769155|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
163017600|NCT03627546|588769156|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
163017601|NCT03627546|588769157|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
163017602|NCT03627546|588769155|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
163017603|NCT03627546|588769156|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
163063022|NCT01104766|588938560|FG000|Overall Study|Protocol Violation|2|||
163063023|NCT01104766|588938561|FG001|Overall Study|Protocol Violation|0|||
163063024|NCT01104766|588938562|FG002|Overall Study|Protocol Violation|0|||
163063025|NCT01104766|588938563|FG003|Overall Study|Protocol Violation|0|||
163063026|NCT01104766|588938560|FG000|Overall Study|Withdrawal by Subject|17|||
163063027|NCT01104766|588938561|FG001|Overall Study|Withdrawal by Subject|19|||
163063028|NCT01104766|588938562|FG002|Overall Study|Withdrawal by Subject|25|||
163063029|NCT01104766|588938563|FG003|Overall Study|Withdrawal by Subject|15|||
163063030|NCT01104766|588938560|FG000|Overall Study|Lost to Follow-up|1|||
163063031|NCT01104766|588938561|FG001|Overall Study|Lost to Follow-up|2|||
162716237|NCT01090024|587668389|FG007|Period 3|Protocol Violation|0|||
162716238|NCT01090024|587668390|FG008|Period 3|Protocol Violation|1|||
162716239|NCT01090024|587668391|FG009|Period 3|Protocol Violation|0|||
162716240|NCT01090024|587668392|FG010|Period 3|Protocol Violation|0|||
162716241|NCT01090024|587668393|FG011|Period 3|Protocol Violation|0|||
162716242|NCT01090024|587668394|FG012|Period 3|Protocol Violation|0|||
162716243|NCT01090024|587668395|FG013|Period 3|Protocol Violation|0|||
162716244|NCT01090024|587668396|FG014|Period 3|Protocol Violation|0|||
162716245|NCT01090024|587668397|FG015|Period 3|Protocol Violation|0|||
162716246|NCT01090024|587668398|FG016|Period 3|Protocol Violation|0|||
162716247|NCT01090024|587668399|FG017|Period 3|Protocol Violation|0|||
162716248|NCT01090024|587668382|FG000|Period 3|Adverse Event|0|||
163017604|NCT03627546|588769157|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
163063032|NCT01104766|588938562|FG002|Overall Study|Lost to Follow-up|1|||
162716249|NCT01090024|587668383|FG001|Period 3|Adverse Event|0|||
162716250|NCT01090024|587668384|FG002|Period 3|Adverse Event|0|||
163017605|NCT01537042|588769161|FG000|Overall Study|Adverse Event|0|||
163017606|NCT01537042|588769162|FG001|Overall Study|Adverse Event|2|||
163017607|NCT01537042|588769161|FG000|Overall Study|Lack of Efficacy|0|||
163017608|NCT01537042|588769162|FG001|Overall Study|Lack of Efficacy|1|||
163017609|NCT01537042|588769161|FG000|Overall Study|Protocol Violation|0|||
163017610|NCT01537042|588769162|FG001|Overall Study|Protocol Violation|1|||
163017611|NCT01537042|588769161|FG000|Overall Study|Other|0|||
163017612|NCT01537042|588769162|FG001|Overall Study|Other|1|||
163017613|NCT02837731|588769163|FG000|Allocation|Admitted to General Floor|3|||
163017614|NCT02837731|588769164|FG001|Allocation|Admitted to General Floor|4|||
163017615|NCT02837731|588769163|FG000|Allocation|Immediate surgery/withdrew|2|||
163017616|NCT02837731|588769164|FG001|Allocation|Immediate surgery/withdrew|0|||
163017617|NCT02837731|588769163|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
163017618|NCT02837731|588769164|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
163017619|NCT02837731|588769163|FG000|Allocation|Withdrawal by Subject|2|||
163017620|NCT02837731|588769164|FG001|Allocation|Withdrawal by Subject|0|||
163017621|NCT02837731|588769163|FG000|Allocation|Device not available|1|||
163017622|NCT02837731|588769164|FG001|Allocation|Device not available|0|||
163017623|NCT02837731|588769163|FG000|Allocation|Protocol not implemented|7|||
163017624|NCT02837731|588769164|FG001|Allocation|Protocol not implemented|0|||
163017625|NCT02837731|588769163|FG000|Allocation|Moribund/Do not resuscitate|2|||
163017626|NCT02837731|588769164|FG001|Allocation|Moribund/Do not resuscitate|0|||
163017627|NCT02837731|588769163|FG000|Allocation|Did not meet sepsis criteria|1|||
163017628|NCT02837731|588769164|FG001|Allocation|Did not meet sepsis criteria|2|||
163017629|NCT02837731|588769163|FG000|Allocation|Known aortic abnormalities|0|||
163017630|NCT02837731|588769164|FG001|Allocation|Known aortic abnormalities|1|||
163017631|NCT02965573|588769165|FG000|Overall Study|Lack of Efficacy|1|||
163017632|NCT02965573|588769166|FG001|Overall Study|Lack of Efficacy|0|||
163017633|NCT00315458|588769170|FG000|Overall Study|Administrative|0|||
163017634|NCT00315458|588769171|FG001|Overall Study|Administrative|3|||
163017635|NCT00315458|588769172|FG002|Overall Study|Administrative|8|||
163017636|NCT00315458|588769173|FG003|Overall Study|Administrative|21|||
163017637|NCT00315458|588769170|FG000|Overall Study|Adverse Event|2|||
163017638|NCT00315458|588769171|FG001|Overall Study|Adverse Event|4|||
163017639|NCT00315458|588769172|FG002|Overall Study|Adverse Event|23|||
163017640|NCT00315458|588769173|FG003|Overall Study|Adverse Event|3|||
163017641|NCT00315458|588769170|FG000|Overall Study|Lost to Follow-up|1|||
163017642|NCT00315458|588769171|FG001|Overall Study|Lost to Follow-up|2|||
162641053|NCT02707991|587401538|FG000|Overall Study|Became ineligible|0|||
162641054|NCT02707991|587401539|FG001|Overall Study|Became ineligible|1|||
162641055|NCT02659631|587401542|FG000|Overall Study|Lost to Follow-up|0|||
162641056|NCT02659631|587401543|FG001|Overall Study|Lost to Follow-up|0|||
162641057|NCT02659631|587401544|FG002|Overall Study|Lost to Follow-up|2|||
162641058|NCT02659631|587401545|FG003|Overall Study|Lost to Follow-up|0|||
162641059|NCT02659631|587401546|FG004|Overall Study|Lost to Follow-up|0|||
162641060|NCT02659631|587401547|FG005|Overall Study|Lost to Follow-up|1|||
162641061|NCT02659631|587401548|FG006|Overall Study|Lost to Follow-up|0|||
162641062|NCT02659631|587401549|FG007|Overall Study|Lost to Follow-up|0|||
162641063|NCT02659631|587401550|FG008|Overall Study|Lost to Follow-up|0|||
162641064|NCT02659631|587401551|FG009|Overall Study|Lost to Follow-up|0|||
162641065|NCT02659631|587401542|FG000|Overall Study|Withdrawal prior to treatment|0|||
162641066|NCT02659631|587401543|FG001|Overall Study|Withdrawal prior to treatment|0|||
162641067|NCT02659631|587401544|FG002|Overall Study|Withdrawal prior to treatment|0|||
162641068|NCT02659631|587401545|FG003|Overall Study|Withdrawal prior to treatment|0|||
162641069|NCT02659631|587401546|FG004|Overall Study|Withdrawal prior to treatment|1|||
162641070|NCT02659631|587401547|FG005|Overall Study|Withdrawal prior to treatment|0|||
162641071|NCT02659631|587401548|FG006|Overall Study|Withdrawal prior to treatment|0|||
162641072|NCT02659631|587401549|FG007|Overall Study|Withdrawal prior to treatment|0|||
162641073|NCT02659631|587401550|FG008|Overall Study|Withdrawal prior to treatment|0|||
162641074|NCT02659631|587401551|FG009|Overall Study|Withdrawal prior to treatment|0|||
162641075|NCT02659631|587401542|FG000|Overall Study|Participant refused further follow-up|0|||
162641076|NCT02659631|587401543|FG001|Overall Study|Participant refused further follow-up|0|||
162641077|NCT02659631|587401544|FG002|Overall Study|Participant refused further follow-up|0|||
162641078|NCT02659631|587401545|FG003|Overall Study|Participant refused further follow-up|1|||
162641079|NCT02659631|587401546|FG004|Overall Study|Participant refused further follow-up|0|||
162641080|NCT02659631|587401547|FG005|Overall Study|Participant refused further follow-up|0|||
162641081|NCT02659631|587401548|FG006|Overall Study|Participant refused further follow-up|0|||
162641082|NCT02659631|587401549|FG007|Overall Study|Participant refused further follow-up|0|||
162641083|NCT02659631|587401550|FG008|Overall Study|Participant refused further follow-up|1|||
162641084|NCT02659631|587401551|FG009|Overall Study|Participant refused further follow-up|0|||
162641085|NCT02659631|587401542|FG000|Overall Study|Death (follow-up phase)|1|||
162641086|NCT02659631|587401543|FG001|Overall Study|Death (follow-up phase)|2|||
162641087|NCT02659631|587401544|FG002|Overall Study|Death (follow-up phase)|1|||
162641088|NCT02659631|587401545|FG003|Overall Study|Death (follow-up phase)|1|||
162641089|NCT02659631|587401546|FG004|Overall Study|Death (follow-up phase)|3|||
162641090|NCT02659631|587401547|FG005|Overall Study|Death (follow-up phase)|2|||
163017643|NCT00315458|588769172|FG002|Overall Study|Lost to Follow-up|0|||
163017644|NCT00315458|588769173|FG003|Overall Study|Lost to Follow-up|2|||
163017645|NCT00315458|588769170|FG000|Overall Study|Withdrawal by Subject|0|||
163017646|NCT00315458|588769171|FG001|Overall Study|Withdrawal by Subject|3|||
163017647|NCT00315458|588769172|FG002|Overall Study|Withdrawal by Subject|0|||
163017648|NCT00315458|588769173|FG003|Overall Study|Withdrawal by Subject|2|||
163017649|NCT00315458|588769170|FG000|Overall Study|Lack of Efficacy|0|||
163017650|NCT00315458|588769171|FG001|Overall Study|Lack of Efficacy|0|||
163017651|NCT00315458|588769172|FG002|Overall Study|Lack of Efficacy|20|||
163017652|NCT00315458|588769173|FG003|Overall Study|Lack of Efficacy|1|||
163017653|NCT00315458|588769170|FG000|Overall Study|Did not qualify|0|||
163017654|NCT00315458|588769171|FG001|Overall Study|Did not qualify|0|||
163017655|NCT00315458|588769172|FG002|Overall Study|Did not qualify|1|||
163017656|NCT00315458|588769173|FG003|Overall Study|Did not qualify|0|||
163017657|NCT06868654|588769175|FG000|Overall Study|Death|4|||
163017658|NCT06868654|588769176|FG001|Overall Study|Death|14|||
163017659|NCT06868654|588769175|FG000|Overall Study|Lost to Follow-up|0|||
163017660|NCT06868654|588769176|FG001|Overall Study|Lost to Follow-up|1|||
163017661|NCT06868654|588769175|FG000|Overall Study|Withdrawal by Subject|5|||
163017662|NCT06868654|588769176|FG001|Overall Study|Withdrawal by Subject|3|||
163017663|NCT06868654|588769175|FG000|Overall Study|Physician Decision|0|||
163017664|NCT06868654|588769176|FG001|Overall Study|Physician Decision|1|||
163017665|NCT06868654|588769175|FG000|Overall Study|Ongoing|23|||
163017666|NCT06868654|588769176|FG001|Overall Study|Ongoing|21|||
163017667|NCT03232931|588770668|FG000|Overall Study|Physician Decision|1|||
162641091|NCT02659631|587401548|FG006|Overall Study|Death (follow-up phase)|0|||
162641092|NCT02659631|587401549|FG007|Overall Study|Death (follow-up phase)|3|||
162641093|NCT02659631|587401550|FG008|Overall Study|Death (follow-up phase)|1|||
162641094|NCT02659631|587401551|FG009|Overall Study|Death (follow-up phase)|0|||
162641095|NCT02659631|587401542|FG000|Overall Study|Death (treatment phase)|0|||
162641096|NCT02659631|587401543|FG001|Overall Study|Death (treatment phase)|0|||
162641097|NCT02659631|587401544|FG002|Overall Study|Death (treatment phase)|0|||
162641098|NCT02659631|587401545|FG003|Overall Study|Death (treatment phase)|0|||
162641099|NCT02659631|587401546|FG004|Overall Study|Death (treatment phase)|1|||
162641100|NCT02659631|587401547|FG005|Overall Study|Death (treatment phase)|0|||
162641101|NCT02659631|587401548|FG006|Overall Study|Death (treatment phase)|1|||
162641102|NCT02659631|587401549|FG007|Overall Study|Death (treatment phase)|0|||
162641103|NCT02659631|587401550|FG008|Overall Study|Death (treatment phase)|0|||
162641104|NCT02659631|587401551|FG009|Overall Study|Death (treatment phase)|0|||
162641105|NCT05407675|587401552|FG000|Overall Study|Withdrawal by Subject|0|||
162641106|NCT05407675|587401553|FG001|Overall Study|Withdrawal by Subject|2|||
163017668|NCT03232931|588770669|FG001|Overall Study|Physician Decision|1|||
163017669|NCT03232931|588770668|FG000|Overall Study|Withdrawal by Subject|6|||
163017670|NCT03232931|588770669|FG001|Overall Study|Withdrawal by Subject|0|||
163017671|NCT03232931|588770668|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
163017672|NCT03232931|588770669|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
163017673|NCT03232931|588770668|FG000|Overall Study|Parent did not record voice|1|||
163017674|NCT03232931|588770669|FG001|Overall Study|Parent did not record voice|2|||
163017675|NCT03232931|588770668|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
163017676|NCT03232931|588770669|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
163017677|NCT04925557|588770670|FG000|Overall Study|Study closed|5|||
163017678|NCT04925557|588770671|FG001|Overall Study|Study closed|3|||
163017679|NCT01270464|588770675|FG000|Overall Study|Protocol Violation|4|||
163017680|NCT01270464|588770676|FG001|Overall Study|Protocol Violation|3|||
163017681|NCT01270464|588770677|FG002|Overall Study|Protocol Violation|2|||
163017682|NCT01270464|588770675|FG000|Overall Study|Lack of Efficacy|2|||
163017683|NCT01270464|588770676|FG001|Overall Study|Lack of Efficacy|3|||
163017684|NCT01270464|588770677|FG002|Overall Study|Lack of Efficacy|1|||
163017685|NCT01270464|588770675|FG000|Overall Study|Adverse Event|9|||
163017686|NCT01270464|588770676|FG001|Overall Study|Adverse Event|1|||
163017687|NCT01270464|588770677|FG002|Overall Study|Adverse Event|7|||
163017688|NCT01270464|588770675|FG000|Overall Study|Withdrawal by Subject|2|||
163017689|NCT01270464|588770676|FG001|Overall Study|Withdrawal by Subject|1|||
163017690|NCT01270464|588770677|FG002|Overall Study|Withdrawal by Subject|4|||
163017691|NCT01270464|588770675|FG000|Overall Study|Lost to Follow-up|2|||
163017692|NCT01270464|588770676|FG001|Overall Study|Lost to Follow-up|3|||
163017693|NCT01270464|588770677|FG002|Overall Study|Lost to Follow-up|1|||
163017694|NCT01270464|588770675|FG000|Overall Study|Other|1|||
163017695|NCT01270464|588770676|FG001|Overall Study|Other|1|||
163017696|NCT01270464|588770677|FG002|Overall Study|Other|3|||
163017697|NCT01750697|588770679|FG000|Overall Study|Transferred Back to Local Hospital|1|||
163017698|NCT01750697|588770679|FG000|Overall Study|Physician and Family Decision|1|||
163017699|NCT01750697|588770679|FG000|Overall Study|Transferred to Adult Services|5|||
163017700|NCT01750697|588770679|FG000|Overall Study|Physician Decision|1|||
163017701|NCT01750697|588770679|FG000|Overall Study|Withdrawal by Subject|1|||
163017702|NCT00384839|588770682|FG000|Overall Study|Adverse Event|4|||
163017703|NCT00384839|588770682|FG000|Overall Study|Investigator Request|1|||
163017704|NCT00384839|588770682|FG000|Overall Study|Patient Request|1|||
163017705|NCT00384839|588770682|FG000|Overall Study|Ineligible|2|||
162716251|NCT01090024|587668385|FG003|Period 3|Adverse Event|0|||
162716252|NCT01090024|587668386|FG004|Period 3|Adverse Event|0|||
162716253|NCT01090024|587668387|FG005|Period 3|Adverse Event|1|||
162716254|NCT01090024|587668388|FG006|Period 3|Adverse Event|0|||
162716255|NCT01090024|587668389|FG007|Period 3|Adverse Event|0|||
162716256|NCT01090024|587668390|FG008|Period 3|Adverse Event|0|||
162716257|NCT01090024|587668391|FG009|Period 3|Adverse Event|0|||
162716258|NCT01090024|587668392|FG010|Period 3|Adverse Event|0|||
163017706|NCT01322490|588770685|FG000|Treatment Period|Adverse Event|12|||
163017707|NCT01322490|588770686|FG001|Treatment Period|Adverse Event|18|||
163017708|NCT01322490|588770687|FG002|Treatment Period|Adverse Event|15|||
163017709|NCT01322490|588770685|FG000|Treatment Period|Death|5|||
163017710|NCT01322490|588770686|FG001|Treatment Period|Death|7|||
163017711|NCT01322490|588770687|FG002|Treatment Period|Death|3|||
163017712|NCT01322490|588770685|FG000|Treatment Period|Lack of Efficacy|89|||
163017713|NCT01322490|588770686|FG001|Treatment Period|Lack of Efficacy|100|||
163017714|NCT01322490|588770687|FG002|Treatment Period|Lack of Efficacy|112|||
163017715|NCT01322490|588770685|FG000|Treatment Period|Physician Decision|0|||
163017716|NCT01322490|588770686|FG001|Treatment Period|Physician Decision|2|||
163017717|NCT01322490|588770687|FG002|Treatment Period|Physician Decision|1|||
163017718|NCT01322490|588770685|FG000|Treatment Period|Protocol Violation|7|||
163017719|NCT01322490|588770686|FG001|Treatment Period|Protocol Violation|5|||
163017720|NCT01322490|588770687|FG002|Treatment Period|Protocol Violation|4|||
163017721|NCT01322490|588770685|FG000|Treatment Period|Withdrawal by Subject|14|||
163017722|NCT01322490|588770686|FG001|Treatment Period|Withdrawal by Subject|16|||
163017723|NCT01322490|588770687|FG002|Treatment Period|Withdrawal by Subject|11|||
163017724|NCT01322490|588770685|FG000|Treatment Period|Non-compliance with study drug|0|||
163017725|NCT01322490|588770686|FG001|Treatment Period|Non-compliance with study drug|0|||
163017726|NCT01322490|588770687|FG002|Treatment Period|Non-compliance with study drug|1|||
163017727|NCT01322490|588770685|FG000|Treatment Period|Other per report|2|||
163017728|NCT01322490|588770686|FG001|Treatment Period|Other per report|2|||
163017729|NCT01322490|588770687|FG002|Treatment Period|Other per report|1|||
163017730|NCT01322490|588770685|FG000|Treatment Period|Randomized but Not Treated|3|||
163017731|NCT01322490|588770686|FG001|Treatment Period|Randomized but Not Treated|3|||
163017732|NCT01322490|588770687|FG002|Treatment Period|Randomized but Not Treated|5|||
163017733|NCT01322490|588770685|FG000|Long Term Follow-up Period|Death|235|||
163017734|NCT01322490|588770686|FG001|Long Term Follow-up Period|Death|239|||
163017735|NCT01322490|588770687|FG002|Long Term Follow-up Period|Death|236|||
163017736|NCT01322490|588770685|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
163017737|NCT01322490|588770686|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
163017738|NCT01322490|588770687|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
163017739|NCT01322490|588770685|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
163017740|NCT01322490|588770686|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
163017741|NCT01322490|588770687|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
163017742|NCT01322490|588770685|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
163017743|NCT01322490|588770686|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
163017744|NCT01322490|588770687|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
163017745|NCT01322490|588770685|FG000|Long Term Follow-up Period|Other per report|3|||
163017746|NCT01322490|588770686|FG001|Long Term Follow-up Period|Other per report|2|||
163017747|NCT01322490|588770687|FG002|Long Term Follow-up Period|Other per report|2|||
163017748|NCT01322490|588770685|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
163017749|NCT01322490|588770686|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
163017750|NCT01322490|588770687|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
163017751|NCT02484456|588770688|FG000|Washout Period|Withdrawal by Subject|0|||
163017752|NCT02484456|588770689|FG001|Washout Period|Withdrawal by Subject|1|||
162716259|NCT01090024|587668393|FG011|Period 3|Adverse Event|0|||
162716260|NCT01090024|587668394|FG012|Period 3|Adverse Event|0|||
163017753|NCT02484456|588770688|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
162716261|NCT01090024|587668395|FG013|Period 3|Adverse Event|0|||
162716262|NCT01090024|587668396|FG014|Period 3|Adverse Event|0|||
162716263|NCT01090024|587668397|FG015|Period 3|Adverse Event|0|||
162716264|NCT01090024|587668398|FG016|Period 3|Adverse Event|0|||
162716265|NCT01090024|587668399|FG017|Period 3|Adverse Event|0|||
163017754|NCT02484456|588770689|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
163017755|NCT02484456|588770688|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
163017756|NCT02484456|588770689|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
163063033|NCT01104766|588938563|FG003|Overall Study|Lost to Follow-up|1|||
163063034|NCT01136915|588938565|FG000|Overall Study|Lost to Follow-up|2|||
163063035|NCT01136915|588938566|FG001|Overall Study|Lost to Follow-up|0|||
163063036|NCT01136915|588938565|FG000|Overall Study|Exclusion criterion met|0|||
163063037|NCT01136915|588938566|FG001|Overall Study|Exclusion criterion met|1|||
163063038|NCT05452239|588938569|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
163017757|NCT02484456|588770688|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
163017758|NCT02484456|588770689|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
163017759|NCT00708214|588770690|FG000|Overall Study|Other Adverse Event|3|||
163017760|NCT00708214|588770691|FG001|Overall Study|Other Adverse Event|6|||
163017761|NCT00708214|588770692|FG002|Overall Study|Other Adverse Event|2|||
163017762|NCT00708214|588770690|FG000|Overall Study|Other|0|||
163017763|NCT00708214|588770691|FG001|Overall Study|Other|1|||
163017764|NCT00708214|588770692|FG002|Overall Study|Other|1|||
163017765|NCT00708214|588770690|FG000|Overall Study|Progressive Disease|4|||
163017766|NCT00708214|588770691|FG001|Overall Study|Progressive Disease|6|||
163017767|NCT00708214|588770692|FG002|Overall Study|Progressive Disease|5|||
163017768|NCT01908829|588770693|FG000|Overall Study|Adverse Event|13|||
163017769|NCT01908829|588770694|FG001|Overall Study|Adverse Event|11|||
163017770|NCT01908829|588770695|FG002|Overall Study|Adverse Event|13|||
163017771|NCT01908829|588770693|FG000|Overall Study|Lost to Follow-up|4|||
163017772|NCT01908829|588770694|FG001|Overall Study|Lost to Follow-up|2|||
163017773|NCT01908829|588770695|FG002|Overall Study|Lost to Follow-up|1|||
163017774|NCT01908829|588770693|FG000|Overall Study|Randomized no double-blind drug received|1|||
163017775|NCT01908829|588770694|FG001|Overall Study|Randomized no double-blind drug received|0|||
163063039|NCT05452239|588938570|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
163063040|NCT05452239|588938569|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
163063041|NCT05452239|588938570|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
163063042|NCT05452239|588938569|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
163063043|NCT05452239|588938570|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
163063044|NCT05452239|588938569|FG000|Placebo-controlled Period|Randomized but not treated|2|||
163063045|NCT05452239|588938570|FG001|Placebo-controlled Period|Randomized but not treated|2|||
163063046|NCT05452239|588938569|FG000|Placebo-controlled Period|Other than specified|1|||
163063047|NCT05452239|588938570|FG001|Placebo-controlled Period|Other than specified|1|||
163063048|NCT05452239|588938569|FG000|Open-label Period|Withdrawal by Subject|2|||
163063049|NCT05452239|588938570|FG001|Open-label Period|Withdrawal by Subject|1|||
163063050|NCT05452239|588938569|FG000|Open-label Period|Lost to Follow-up|3|||
163063051|NCT05452239|588938570|FG001|Open-label Period|Lost to Follow-up|0|||
163063052|NCT05452239|588938569|FG000|Open-label Period|Other than specified|1|||
163063053|NCT05452239|588938570|FG001|Open-label Period|Other than specified|2|||
163063054|NCT03965923|588938571|FG000|Overall Study|Withdrawal by Subject|1|||
163063055|NCT03965923|588938572|FG001|Overall Study|Withdrawal by Subject|2|||
163063056|NCT03965923|588938573|FG002|Overall Study|Withdrawal by Subject|3|||
163063057|NCT03965923|588938574|FG003|Overall Study|Withdrawal by Subject|1|||
163063058|NCT03965923|588938575|FG004|Overall Study|Withdrawal by Subject|2|||
163063059|NCT03965923|588938576|FG005|Overall Study|Withdrawal by Subject|0|||
163063060|NCT03965923|588938577|FG006|Overall Study|Withdrawal by Subject|4|||
163063061|NCT03965923|588938578|FG007|Overall Study|Withdrawal by Subject|3|||
163063062|NCT03965923|588938579|FG008|Overall Study|Withdrawal by Subject|4|||
163063063|NCT03965923|588938580|FG009|Overall Study|Withdrawal by Subject|0|||
163063064|NCT03965923|588938581|FG010|Overall Study|Withdrawal by Subject|2|||
163063065|NCT03965923|588938582|FG011|Overall Study|Withdrawal by Subject|0|||
163063066|NCT03965923|588938571|FG000|Overall Study|Lost to Follow-up|2|||
163063067|NCT03965923|588938572|FG001|Overall Study|Lost to Follow-up|1|||
163063068|NCT03965923|588938573|FG002|Overall Study|Lost to Follow-up|1|||
163063069|NCT03965923|588938574|FG003|Overall Study|Lost to Follow-up|0|||
163063070|NCT03965923|588938575|FG004|Overall Study|Lost to Follow-up|2|||
163063071|NCT03965923|588938576|FG005|Overall Study|Lost to Follow-up|1|||
163063072|NCT03965923|588938577|FG006|Overall Study|Lost to Follow-up|2|||
163063073|NCT03965923|588938578|FG007|Overall Study|Lost to Follow-up|1|||
163063074|NCT03965923|588938579|FG008|Overall Study|Lost to Follow-up|0|||
163063075|NCT03965923|588938580|FG009|Overall Study|Lost to Follow-up|2|||
163063076|NCT03965923|588938581|FG010|Overall Study|Lost to Follow-up|0|||
163063077|NCT03965923|588938582|FG011|Overall Study|Lost to Follow-up|0|||
162641107|NCT05407675|587401554|FG002|Overall Study|Withdrawal by Subject|3|||
162641108|NCT05407675|587401555|FG003|Overall Study|Withdrawal by Subject|5|||
163017776|NCT01908829|588770695|FG002|Overall Study|Randomized no double-blind drug received|1|||
163017777|NCT01908829|588770693|FG000|Overall Study|Discontinued (no EoT page)|2|||
163017778|NCT01908829|588770694|FG001|Overall Study|Discontinued (no EoT page)|0|||
163017779|NCT01908829|588770695|FG002|Overall Study|Discontinued (no EoT page)|0|||
163063078|NCT03965923|588938571|FG000|Overall Study|Death|0|||
163063079|NCT03965923|588938572|FG001|Overall Study|Death|0|||
163063080|NCT03965923|588938573|FG002|Overall Study|Death|0|||
163063081|NCT03965923|588938574|FG003|Overall Study|Death|0|||
163017780|NCT01908829|588770693|FG000|Overall Study|Miscellaneous|0|||
163017781|NCT01908829|588770694|FG001|Overall Study|Miscellaneous|2|||
163017782|NCT01908829|588770695|FG002|Overall Study|Miscellaneous|0|||
163017783|NCT01908829|588770693|FG000|Overall Study|Protocol Violation|2|||
163017784|NCT01908829|588770694|FG001|Overall Study|Protocol Violation|2|||
163017785|NCT01908829|588770695|FG002|Overall Study|Protocol Violation|0|||
163017786|NCT01908829|588770693|FG000|Overall Study|Lack of Efficacy|1|||
163017787|NCT01908829|588770694|FG001|Overall Study|Lack of Efficacy|3|||
163017788|NCT01908829|588770695|FG002|Overall Study|Lack of Efficacy|2|||
163017789|NCT01908829|588770693|FG000|Overall Study|Withdrawal by Subject|26|||
162716266|NCT00470626|587668401|FG000|Overall Study|Lost to Follow-up|10|||
162716267|NCT00470626|587668401|FG000|Overall Study|Withdrawal by Subject|7|||
162716268|NCT00777556|587668402|FG000|Overall Study|Inappropriate self-selection|34|||
162716269|NCT00777556|587668402|FG000|Overall Study|Dispensed but did not use product|12|||
163017790|NCT01908829|588770694|FG001|Overall Study|Withdrawal by Subject|29|||
163017791|NCT01908829|588770695|FG002|Overall Study|Withdrawal by Subject|22|||
163017792|NCT02792192|588770696|FG000|Overall Study|Death|1|||
163017793|NCT02792192|588770697|FG001|Overall Study|Death|0|||
163017794|NCT02792192|588770698|FG002|Overall Study|Death|0|||
163017795|NCT02792192|588770699|FG003|Overall Study|Death|0|||
163017796|NCT02792192|588770696|FG000|Overall Study|Informed Consent Withdrawn|4|||
163017797|NCT02792192|588770697|FG001|Overall Study|Informed Consent Withdrawn|0|||
163017798|NCT02792192|588770698|FG002|Overall Study|Informed Consent Withdrawn|0|||
163017799|NCT02792192|588770699|FG003|Overall Study|Informed Consent Withdrawn|0|||
163063082|NCT03965923|588938575|FG004|Overall Study|Death|0|||
163063083|NCT03965923|588938576|FG005|Overall Study|Death|0|||
162641109|NCT05407675|587401556|FG004|Overall Study|Withdrawal by Subject|0|||
162641110|NCT05407675|587401557|FG005|Overall Study|Withdrawal by Subject|2|||
162641111|NCT05407675|587401558|FG006|Overall Study|Withdrawal by Subject|0|||
162641112|NCT05407675|587401559|FG007|Overall Study|Withdrawal by Subject|0|||
162641113|NCT05407675|587401560|FG008|Overall Study|Withdrawal by Subject|2|||
162641114|NCT05407675|587401561|FG009|Overall Study|Withdrawal by Subject|0|||
162641115|NCT05407675|587401562|FG010|Overall Study|Withdrawal by Subject|1|||
162641116|NCT05407675|587401563|FG011|Overall Study|Withdrawal by Subject|0|||
162641117|NCT05407675|587401564|FG012|Overall Study|Withdrawal by Subject|0|||
162641118|NCT05407675|587401552|FG000|Overall Study|Site terminated by sponsor|0|||
162641119|NCT05407675|587401553|FG001|Overall Study|Site terminated by sponsor|0|||
162641120|NCT05407675|587401554|FG002|Overall Study|Site terminated by sponsor|1|||
162641121|NCT05407675|587401555|FG003|Overall Study|Site terminated by sponsor|0|||
162641122|NCT05407675|587401556|FG004|Overall Study|Site terminated by sponsor|2|||
162641123|NCT05407675|587401557|FG005|Overall Study|Site terminated by sponsor|0|||
162641124|NCT05407675|587401558|FG006|Overall Study|Site terminated by sponsor|1|||
162641125|NCT05407675|587401559|FG007|Overall Study|Site terminated by sponsor|0|||
162641126|NCT05407675|587401560|FG008|Overall Study|Site terminated by sponsor|0|||
162641127|NCT05407675|587401561|FG009|Overall Study|Site terminated by sponsor|2|||
162641128|NCT05407675|587401562|FG010|Overall Study|Site terminated by sponsor|2|||
163017800|NCT02792192|588770696|FG000|Overall Study|Physician Decision|1|||
163017801|NCT02792192|588770697|FG001|Overall Study|Physician Decision|0|||
162641129|NCT05407675|587401563|FG011|Overall Study|Site terminated by sponsor|2|||
162641130|NCT05407675|587401564|FG012|Overall Study|Site terminated by sponsor|1|||
162641131|NCT05407675|587401552|FG000|Overall Study|Disease Progression|0|||
162641132|NCT05407675|587401553|FG001|Overall Study|Disease Progression|0|||
162641133|NCT05407675|587401554|FG002|Overall Study|Disease Progression|0|||
162641134|NCT05407675|587401555|FG003|Overall Study|Disease Progression|0|||
162641135|NCT05407675|587401556|FG004|Overall Study|Disease Progression|0|||
163017802|NCT02792192|588770698|FG002|Overall Study|Physician Decision|0|||
163063084|NCT03965923|588938577|FG006|Overall Study|Death|0|||
163063085|NCT03965923|588938578|FG007|Overall Study|Death|1|||
162716270|NCT00777556|587668402|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
162716271|NCT02689349|587668403|FG000|Overall Study|Not implanted|4|||
162716272|NCT02689349|587668404|FG001|Overall Study|Not implanted|0|||
162716273|NCT02689349|587668403|FG000|Overall Study|Withdrawal by Subject|9|||
162716274|NCT02689349|587668404|FG001|Overall Study|Withdrawal by Subject|0|||
162716275|NCT01185522|587668405|FG000|Overall Study|Lack of Efficacy|28|||
162716276|NCT01185522|587668405|FG000|Overall Study|Lost to Follow-up|19|||
162716277|NCT01185522|587668405|FG000|Overall Study|Withdrawal by Subject|10|||
162716278|NCT01185522|587668405|FG000|Overall Study|Poor tolerance|39|||
162716279|NCT01185522|587668405|FG000|Overall Study|Other reasons|12|||
162716280|NCT01729819|587668406|FG000|Overall Study|Adverse Event|2|||
162716281|NCT01729819|587668407|FG001|Overall Study|Adverse Event|4|||
162716282|NCT01729819|587668406|FG000|Overall Study|Lack of Efficacy|1|||
162716283|NCT01729819|587668407|FG001|Overall Study|Lack of Efficacy|0|||
162716284|NCT01729819|587668406|FG000|Overall Study|Lost to Follow-up|2|||
162716285|NCT01729819|587668407|FG001|Overall Study|Lost to Follow-up|0|||
162716286|NCT01729819|587668406|FG000|Overall Study|Other reason|1|||
162716287|NCT01729819|587668407|FG001|Overall Study|Other reason|0|||
162716288|NCT01729819|587668406|FG000|Overall Study|Protocol Violation|0|||
162716289|NCT01729819|587668407|FG001|Overall Study|Protocol Violation|1|||
162716290|NCT01729819|587668406|FG000|Overall Study|Withdrawal by Subject|0|||
162716291|NCT01729819|587668407|FG001|Overall Study|Withdrawal by Subject|2|||
162716292|NCT01025843|587668408|FG000|Washout 4|Withdrawal by Subject|0|||
162716293|NCT01025843|587668409|FG001|Washout 4|Withdrawal by Subject|0|||
162716294|NCT01025843|587668410|FG002|Washout 4|Withdrawal by Subject|1|||
162716295|NCT01025843|587668411|FG003|Washout 4|Withdrawal by Subject|1|||
162716296|NCT01025843|587668412|FG004|Washout 4|Withdrawal by Subject|0|||
162716297|NCT01025843|587668413|FG005|Washout 4|Withdrawal by Subject|0|||
162716298|NCT01025843|587668414|FG006|Washout 4|Withdrawal by Subject|0|||
162716299|NCT01025843|587668415|FG007|Washout 4|Withdrawal by Subject|0|||
162716300|NCT01025843|587668416|FG008|Washout 4|Withdrawal by Subject|0|||
162716301|NCT01025843|587668417|FG009|Washout 4|Withdrawal by Subject|0|||
162716302|NCT01649791|587668418|FG000|Overall Study|Disease Progression|2|||
162716303|NCT01649791|587668418|FG000|Overall Study|Adverse Event|1|||
162716304|NCT02987543|587668419|FG000|Overall Study|Ongoing study at data cut off|49|||
162716305|NCT02987543|587668420|FG001|Overall Study|Ongoing study at data cut off|21|||
162716306|NCT02987543|587668421|FG002|Overall Study|Ongoing study at data cut off|19|||
162716307|NCT02987543|587668422|FG003|Overall Study|Ongoing study at data cut off|12|||
162716308|NCT02987543|587668419|FG000|Overall Study|Death|88|||
162716309|NCT02987543|587668420|FG001|Overall Study|Death|54|||
162716310|NCT02987543|587668421|FG002|Overall Study|Death|67|||
162716311|NCT02987543|587668422|FG003|Overall Study|Death|28|||
162716312|NCT02987543|587668419|FG000|Overall Study|Lost to Follow-up|3|||
162716313|NCT02987543|587668420|FG001|Overall Study|Lost to Follow-up|0|||
162716314|NCT02987543|587668421|FG002|Overall Study|Lost to Follow-up|1|||
162716315|NCT02987543|587668422|FG003|Overall Study|Lost to Follow-up|0|||
162716316|NCT02987543|587668419|FG000|Overall Study|Screen failure|0|||
162716317|NCT02987543|587668420|FG001|Overall Study|Screen failure|0|||
162716318|NCT02987543|587668421|FG002|Overall Study|Screen failure|0|||
162716319|NCT02987543|587668422|FG003|Overall Study|Screen failure|1|||
162716320|NCT02987543|587668419|FG000|Overall Study|Withdrawal by Subject|21|||
162716321|NCT02987543|587668420|FG001|Overall Study|Withdrawal by Subject|7|||
162716322|NCT02987543|587668421|FG002|Overall Study|Withdrawal by Subject|7|||
162716323|NCT02987543|587668422|FG003|Overall Study|Withdrawal by Subject|6|||
162716324|NCT02987543|587668419|FG000|Overall Study|Study terminated by sponsor|1|||
162716325|NCT02987543|587668420|FG001|Overall Study|Study terminated by sponsor|0|||
162716326|NCT02987543|587668421|FG002|Overall Study|Study terminated by sponsor|0|||
162716327|NCT02987543|587668422|FG003|Overall Study|Study terminated by sponsor|0|||
162716328|NCT02987543|587668419|FG000|Overall Study|Investigator decision|0|||
162716329|NCT02987543|587668420|FG001|Overall Study|Investigator decision|1|||
162716330|NCT02987543|587668421|FG002|Overall Study|Investigator decision|0|||
162716331|NCT02987543|587668422|FG003|Overall Study|Investigator decision|0|||
162716332|NCT02987543|587668419|FG000|Overall Study|Disease progression|0|||
162716333|NCT02987543|587668420|FG001|Overall Study|Disease progression|0|||
162716334|NCT02987543|587668421|FG002|Overall Study|Disease progression|0|||
162716335|NCT02987543|587668422|FG003|Overall Study|Disease progression|1|||
162716336|NCT03646669|587668425|FG000|Overall Study|Withdrawal by Subject|5|||
162716337|NCT03646669|587668426|FG001|Overall Study|Withdrawal by Subject|0|||
162716338|NCT00309452|587668427|FG000|Overall Study|Withdrawal by Subject|3|||
162716339|NCT00309452|587668428|FG001|Overall Study|Withdrawal by Subject|0|||
162716340|NCT02962674|587668430|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
162716341|NCT00771667|587668431|FG000|Induction Phase|Adverse Event|5|||
162716342|NCT00771667|587668432|FG001|Induction Phase|Adverse Event|2|||
162716343|NCT00771667|587668433|FG002|Induction Phase|Adverse Event|4|||
162716344|NCT00771667|587668434|FG003|Induction Phase|Adverse Event|1|||
162716345|NCT00771667|587668435|FG004|Induction Phase|Adverse Event|0|||
162716346|NCT00771667|587668436|FG005|Induction Phase|Adverse Event|0|||
162716347|NCT00771667|587668437|FG006|Induction Phase|Adverse Event|0|||
163017803|NCT02792192|588770699|FG003|Overall Study|Physician Decision|0|||
163017804|NCT02792192|588770696|FG000|Overall Study|Progressive Disease|0|||
163017805|NCT02792192|588770697|FG001|Overall Study|Progressive Disease|1|||
163017806|NCT02792192|588770698|FG002|Overall Study|Progressive Disease|0|||
163017807|NCT02792192|588770699|FG003|Overall Study|Progressive Disease|0|||
163017808|NCT02792192|588770696|FG000|Overall Study|Study Terminated By Sponsor|6|||
163017809|NCT02792192|588770697|FG001|Overall Study|Study Terminated By Sponsor|10|||
163017810|NCT02792192|588770698|FG002|Overall Study|Study Terminated By Sponsor|0|||
163017811|NCT02792192|588770699|FG003|Overall Study|Study Terminated By Sponsor|0|||
163017812|NCT01430403|588770700|FG000|Overall Study|Lost to Follow-up|5|||
162641136|NCT05407675|587401557|FG005|Overall Study|Disease Progression|0|||
162641137|NCT05407675|587401558|FG006|Overall Study|Disease Progression|0|||
162716348|NCT00771667|587668438|FG007|Induction Phase|Adverse Event|0|||
162716349|NCT00771667|587668439|FG008|Induction Phase|Adverse Event|0|||
162716350|NCT00771667|587668440|FG009|Induction Phase|Adverse Event|0|||
162716351|NCT00771667|587668431|FG000|Induction Phase|Lack of Efficacy|9|||
162716352|NCT00771667|587668432|FG001|Induction Phase|Lack of Efficacy|2|||
162716353|NCT00771667|587668433|FG002|Induction Phase|Lack of Efficacy|4|||
162716354|NCT00771667|587668434|FG003|Induction Phase|Lack of Efficacy|3|||
162716355|NCT00771667|587668435|FG004|Induction Phase|Lack of Efficacy|0|||
162716356|NCT00771667|587668436|FG005|Induction Phase|Lack of Efficacy|0|||
162716357|NCT00771667|587668437|FG006|Induction Phase|Lack of Efficacy|0|||
162716358|NCT00771667|587668438|FG007|Induction Phase|Lack of Efficacy|0|||
162716359|NCT00771667|587668439|FG008|Induction Phase|Lack of Efficacy|0|||
162716360|NCT00771667|587668440|FG009|Induction Phase|Lack of Efficacy|0|||
162716361|NCT00771667|587668431|FG000|Induction Phase|Lost to Follow-up|1|||
162716362|NCT00771667|587668432|FG001|Induction Phase|Lost to Follow-up|0|||
162716363|NCT00771667|587668433|FG002|Induction Phase|Lost to Follow-up|1|||
162716364|NCT00771667|587668434|FG003|Induction Phase|Lost to Follow-up|0|||
162716365|NCT00771667|587668435|FG004|Induction Phase|Lost to Follow-up|0|||
162716366|NCT00771667|587668436|FG005|Induction Phase|Lost to Follow-up|0|||
162716367|NCT00771667|587668437|FG006|Induction Phase|Lost to Follow-up|0|||
162716368|NCT00771667|587668438|FG007|Induction Phase|Lost to Follow-up|0|||
162716369|NCT00771667|587668439|FG008|Induction Phase|Lost to Follow-up|0|||
162716370|NCT00771667|587668440|FG009|Induction Phase|Lost to Follow-up|0|||
162716371|NCT00771667|587668431|FG000|Induction Phase|Other|4|||
162716372|NCT00771667|587668432|FG001|Induction Phase|Other|6|||
162716373|NCT00771667|587668433|FG002|Induction Phase|Other|3|||
162716374|NCT00771667|587668434|FG003|Induction Phase|Other|4|||
162716375|NCT00771667|587668435|FG004|Induction Phase|Other|0|||
162716376|NCT00771667|587668436|FG005|Induction Phase|Other|0|||
162716377|NCT00771667|587668437|FG006|Induction Phase|Other|0|||
162716378|NCT00771667|587668438|FG007|Induction Phase|Other|0|||
162716379|NCT00771667|587668439|FG008|Induction Phase|Other|0|||
162716380|NCT00771667|587668440|FG009|Induction Phase|Other|0|||
162716381|NCT00771667|587668431|FG000|Maintenance Phase|Adverse Event|0|||
162716382|NCT00771667|587668432|FG001|Maintenance Phase|Adverse Event|0|||
162641138|NCT05407675|587401559|FG007|Overall Study|Disease Progression|0|||
162641139|NCT05407675|587401560|FG008|Overall Study|Disease Progression|0|||
162641140|NCT05407675|587401561|FG009|Overall Study|Disease Progression|0|||
162641141|NCT05407675|587401562|FG010|Overall Study|Disease Progression|1|||
162641142|NCT05407675|587401563|FG011|Overall Study|Disease Progression|0|||
162641143|NCT05407675|587401564|FG012|Overall Study|Disease Progression|0|||
162641144|NCT05407675|587401552|FG000|Overall Study|Physician Decision|0|||
162641145|NCT05407675|587401553|FG001|Overall Study|Physician Decision|0|||
162641146|NCT05407675|587401554|FG002|Overall Study|Physician Decision|0|||
162641147|NCT05407675|587401555|FG003|Overall Study|Physician Decision|0|||
162641148|NCT05407675|587401556|FG004|Overall Study|Physician Decision|0|||
162716383|NCT00771667|587668433|FG002|Maintenance Phase|Adverse Event|0|||
162716384|NCT00771667|587668434|FG003|Maintenance Phase|Adverse Event|0|||
162716385|NCT00771667|587668435|FG004|Maintenance Phase|Adverse Event|1|||
163017813|NCT01430403|588770701|FG001|Overall Study|Lost to Follow-up|5|||
163017814|NCT01430403|588770702|FG002|Overall Study|Lost to Follow-up|3|||
163017815|NCT01430403|588770700|FG000|Overall Study|Physician Decision|1|||
163017816|NCT01430403|588770701|FG001|Overall Study|Physician Decision|0|||
163017817|NCT01430403|588770702|FG002|Overall Study|Physician Decision|0|||
163017818|NCT01430403|588770700|FG000|Overall Study|Protocol Violation|2|||
163017819|NCT01430403|588770701|FG001|Overall Study|Protocol Violation|3|||
162641149|NCT05407675|587401557|FG005|Overall Study|Physician Decision|0|||
162716386|NCT00771667|587668436|FG005|Maintenance Phase|Adverse Event|3|||
162716387|NCT00771667|587668437|FG006|Maintenance Phase|Adverse Event|5|||
162716388|NCT00771667|587668438|FG007|Maintenance Phase|Adverse Event|1|||
162716389|NCT00771667|587668439|FG008|Maintenance Phase|Adverse Event|8|||
162716390|NCT00771667|587668440|FG009|Maintenance Phase|Adverse Event|7|||
162641150|NCT05407675|587401558|FG006|Overall Study|Physician Decision|0|||
162641151|NCT05407675|587401559|FG007|Overall Study|Physician Decision|0|||
162641152|NCT05407675|587401560|FG008|Overall Study|Physician Decision|0|||
162641153|NCT05407675|587401561|FG009|Overall Study|Physician Decision|0|||
163017820|NCT01430403|588770702|FG002|Overall Study|Protocol Violation|2|||
162716391|NCT00771667|587668431|FG000|Maintenance Phase|Lack of Efficacy|0|||
162716392|NCT00771667|587668432|FG001|Maintenance Phase|Lack of Efficacy|0|||
163017821|NCT01430403|588770700|FG000|Overall Study|Withdrawal by Subject|9|||
163017822|NCT01430403|588770701|FG001|Overall Study|Withdrawal by Subject|1|||
163017823|NCT01430403|588770702|FG002|Overall Study|Withdrawal by Subject|3|||
163017824|NCT02677922|588770705|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
163017825|NCT02677922|588770706|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
163017826|NCT02677922|588770707|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
163017827|NCT02677922|588770708|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
163017828|NCT02677922|588770709|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
163017829|NCT02677922|588770710|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
163017830|NCT02677922|588770705|FG000|Treatment Period|Adverse Event|0|||
163017831|NCT02677922|588770706|FG001|Treatment Period|Adverse Event|0|||
163017832|NCT02677922|588770707|FG002|Treatment Period|Adverse Event|1|||
163017833|NCT02677922|588770708|FG003|Treatment Period|Adverse Event|3|||
163017834|NCT02677922|588770709|FG004|Treatment Period|Adverse Event|5|||
163017835|NCT02677922|588770710|FG005|Treatment Period|Adverse Event|2|||
163017836|NCT02677922|588770705|FG000|Treatment Period|Progressive Disease|1|||
163017837|NCT02677922|588770706|FG001|Treatment Period|Progressive Disease|1|||
163017838|NCT02677922|588770707|FG002|Treatment Period|Progressive Disease|0|||
163017839|NCT02677922|588770708|FG003|Treatment Period|Progressive Disease|0|||
163017840|NCT02677922|588770709|FG004|Treatment Period|Progressive Disease|8|||
163017841|NCT02677922|588770710|FG005|Treatment Period|Progressive Disease|7|||
163017842|NCT02677922|588770705|FG000|Treatment Period|Lack of Efficacy|0|||
163017843|NCT02677922|588770706|FG001|Treatment Period|Lack of Efficacy|0|||
163017844|NCT02677922|588770707|FG002|Treatment Period|Lack of Efficacy|0|||
163017845|NCT02677922|588770708|FG003|Treatment Period|Lack of Efficacy|1|||
163017846|NCT02677922|588770709|FG004|Treatment Period|Lack of Efficacy|1|||
163017847|NCT02677922|588770710|FG005|Treatment Period|Lack of Efficacy|6|||
163017848|NCT02677922|588770705|FG000|Treatment Period|Withdrawal by Subject|0|||
163017849|NCT02677922|588770706|FG001|Treatment Period|Withdrawal by Subject|0|||
163017850|NCT02677922|588770707|FG002|Treatment Period|Withdrawal by Subject|1|||
163017851|NCT02677922|588770708|FG003|Treatment Period|Withdrawal by Subject|3|||
163017852|NCT02677922|588770709|FG004|Treatment Period|Withdrawal by Subject|5|||
163017853|NCT02677922|588770710|FG005|Treatment Period|Withdrawal by Subject|5|||
163017854|NCT02677922|588770705|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
163017855|NCT02677922|588770706|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
163017856|NCT02677922|588770707|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
163017857|NCT02677922|588770708|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
163017858|NCT02677922|588770709|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
163017859|NCT02677922|588770710|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
163017860|NCT02677922|588770705|FG000|Treatment Period|Disease Relapse|0|||
163017861|NCT02677922|588770706|FG001|Treatment Period|Disease Relapse|0|||
163017862|NCT02677922|588770707|FG002|Treatment Period|Disease Relapse|0|||
163017863|NCT02677922|588770708|FG003|Treatment Period|Disease Relapse|3|||
163017864|NCT02677922|588770709|FG004|Treatment Period|Disease Relapse|6|||
163017865|NCT02677922|588770710|FG005|Treatment Period|Disease Relapse|1|||
163017866|NCT02677922|588770705|FG000|Treatment Period|Allogeneic HSCT|1|||
163017867|NCT02677922|588770706|FG001|Treatment Period|Allogeneic HSCT|0|||
163017868|NCT02677922|588770707|FG002|Treatment Period|Allogeneic HSCT|0|||
163017869|NCT02677922|588770708|FG003|Treatment Period|Allogeneic HSCT|1|||
163017870|NCT02677922|588770709|FG004|Treatment Period|Allogeneic HSCT|4|||
163017871|NCT02677922|588770710|FG005|Treatment Period|Allogeneic HSCT|1|||
163017872|NCT02677922|588770705|FG000|Treatment Period|Other Reasons|0|||
163017873|NCT02677922|588770706|FG001|Treatment Period|Other Reasons|0|||
163017874|NCT02677922|588770707|FG002|Treatment Period|Other Reasons|0|||
163017875|NCT02677922|588770708|FG003|Treatment Period|Other Reasons|1|||
163017876|NCT02677922|588770709|FG004|Treatment Period|Other Reasons|3|||
163017877|NCT02677922|588770710|FG005|Treatment Period|Other Reasons|5|||
163017878|NCT02677922|588770705|FG000|Treatment Period|Death|0|||
163017879|NCT02677922|588770706|FG001|Treatment Period|Death|0|||
163017880|NCT02677922|588770707|FG002|Treatment Period|Death|0|||
163017881|NCT02677922|588770708|FG003|Treatment Period|Death|0|||
163017882|NCT02677922|588770709|FG004|Treatment Period|Death|12|||
163017883|NCT02677922|588770710|FG005|Treatment Period|Death|1|||
163017884|NCT02677922|588770705|FG000|Treatment Period|Non-compliance with Study Drug|0|||
163017885|NCT02677922|588770706|FG001|Treatment Period|Non-compliance with Study Drug|0|||
163017886|NCT02677922|588770707|FG002|Treatment Period|Non-compliance with Study Drug|0|||
163017887|NCT02677922|588770708|FG003|Treatment Period|Non-compliance with Study Drug|0|||
163017888|NCT02677922|588770709|FG004|Treatment Period|Non-compliance with Study Drug|1|||
163017889|NCT02677922|588770710|FG005|Treatment Period|Non-compliance with Study Drug|0|||
163017890|NCT02677922|588770705|FG000|Treatment Period|Physician Decision|0|||
163017891|NCT02677922|588770706|FG001|Treatment Period|Physician Decision|0|||
163017892|NCT02677922|588770707|FG002|Treatment Period|Physician Decision|0|||
163017893|NCT02677922|588770708|FG003|Treatment Period|Physician Decision|0|||
163017894|NCT02677922|588770709|FG004|Treatment Period|Physician Decision|0|||
163017895|NCT02677922|588770710|FG005|Treatment Period|Physician Decision|1|||
163017896|NCT02677922|588770705|FG000|Treatment Period|Symptomatic Deterioration|0|||
163017897|NCT02677922|588770706|FG001|Treatment Period|Symptomatic Deterioration|0|||
163017898|NCT02677922|588770707|FG002|Treatment Period|Symptomatic Deterioration|0|||
163017899|NCT02677922|588770708|FG003|Treatment Period|Symptomatic Deterioration|0|||
163017900|NCT02677922|588770709|FG004|Treatment Period|Symptomatic Deterioration|1|||
163017901|NCT02677922|588770710|FG005|Treatment Period|Symptomatic Deterioration|0|||
163017902|NCT00637000|588770711|FG000|Overall Study|Withdrawal by Subject|4|||
163017903|NCT00637000|588770712|FG001|Overall Study|Withdrawal by Subject|3|||
163017904|NCT00183885|588770735|FG000|Overall Study|Adverse Event|11|||
163017905|NCT00183885|588770735|FG000|Overall Study|Death|1|||
163017906|NCT00183885|588770735|FG000|Overall Study|Lost to Follow-up|3|||
163017907|NCT00183885|588770735|FG000|Overall Study|Physician Decision|6|||
163017908|NCT00183885|588770735|FG000|Overall Study|Withdrawal by Subject|5|||
163017909|NCT00183885|588770735|FG000|Overall Study|Switched to alternative treatment|8|||
163017910|NCT00183885|588770735|FG000|Overall Study|Treatment delayed too long|4|||
163017911|NCT00183885|588770735|FG000|Overall Study|Developed second malignancy|1|||
163017912|NCT00014495|588770738|FG000|Overall Study|Death|0|||
163017913|NCT00014495|588770739|FG001|Overall Study|Death|0|||
163017914|NCT00014495|588770740|FG002|Overall Study|Death|1|||
163017915|NCT00014495|588770741|FG003|Overall Study|Death|0|||
163017916|NCT00014495|588770738|FG000|Overall Study|Clinical deterioration|0|||
163017917|NCT00014495|588770739|FG001|Overall Study|Clinical deterioration|0|||
163017918|NCT00014495|588770740|FG002|Overall Study|Clinical deterioration|0|||
163017919|NCT00014495|588770741|FG003|Overall Study|Clinical deterioration|1|||
163017920|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
163017921|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
163017922|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
163017923|NCT00403481|588770743|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
163017924|NCT00403481|588770743|FG000|Olm 40 mg|Adverse Event|2|||
163017925|NCT00403481|588770743|FG000|Olm 40 mg|Protocol Violation|1|||
163017926|NCT00403481|588770743|FG000|Olm 40 mg|Withdrawal by Subject|1|||
163017927|NCT00403481|588770743|FG000|Olm 40 mg|Other|1|||
163017928|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
163017929|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
163017930|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
163017931|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
163017932|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
163017933|NCT00403481|588770743|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
163017934|NCT02091089|588770744|FG000|Overall Study|Lost to Follow-up|2|||
163017935|NCT02929589|588770745|FG000|Overall Study|Withdrawal by Subject|1|||
163017936|NCT02929589|588770746|FG001|Overall Study|Withdrawal by Subject|0|||
163017937|NCT02929589|588770747|FG002|Overall Study|Withdrawal by Subject|0|||
163017938|NCT02929589|588770748|FG003|Overall Study|Withdrawal by Subject|0|||
163017939|NCT02929589|588770745|FG000|Overall Study|Physician Decision|2|||
162641154|NCT05407675|587401562|FG010|Overall Study|Physician Decision|1|||
162641155|NCT05407675|587401563|FG011|Overall Study|Physician Decision|0|||
162641156|NCT05407675|587401564|FG012|Overall Study|Physician Decision|0|||
163017940|NCT02929589|588770746|FG001|Overall Study|Physician Decision|0|||
163017941|NCT02929589|588770747|FG002|Overall Study|Physician Decision|0|||
163063086|NCT03965923|588938579|FG008|Overall Study|Death|4|||
162641157|NCT05407675|587401552|FG000|Overall Study|Other reasons|0|||
162641158|NCT05407675|587401553|FG001|Overall Study|Other reasons|0|||
162641159|NCT05407675|587401554|FG002|Overall Study|Other reasons|0|||
162641160|NCT05407675|587401555|FG003|Overall Study|Other reasons|0|||
162641161|NCT05407675|587401556|FG004|Overall Study|Other reasons|0|||
162641162|NCT05407675|587401557|FG005|Overall Study|Other reasons|0|||
162641163|NCT05407675|587401558|FG006|Overall Study|Other reasons|0|||
162641164|NCT05407675|587401559|FG007|Overall Study|Other reasons|0|||
162641165|NCT05407675|587401560|FG008|Overall Study|Other reasons|1|||
162641166|NCT05407675|587401561|FG009|Overall Study|Other reasons|1|||
162641167|NCT05407675|587401562|FG010|Overall Study|Other reasons|1|||
162641168|NCT05407675|587401563|FG011|Overall Study|Other reasons|1|||
162641169|NCT05407675|587401564|FG012|Overall Study|Other reasons|0|||
162641170|NCT05407675|587401552|FG000|Overall Study|Death|3|||
162641171|NCT05407675|587401553|FG001|Overall Study|Death|4|||
162641172|NCT05407675|587401554|FG002|Overall Study|Death|3|||
162641173|NCT05407675|587401555|FG003|Overall Study|Death|6|||
162641174|NCT05407675|587401556|FG004|Overall Study|Death|0|||
162641175|NCT05407675|587401557|FG005|Overall Study|Death|2|||
162641176|NCT05407675|587401558|FG006|Overall Study|Death|4|||
162641177|NCT05407675|587401559|FG007|Overall Study|Death|2|||
162641178|NCT05407675|587401560|FG008|Overall Study|Death|2|||
162641179|NCT05407675|587401561|FG009|Overall Study|Death|4|||
162641180|NCT05407675|587401562|FG010|Overall Study|Death|2|||
162641181|NCT05407675|587401563|FG011|Overall Study|Death|1|||
162641182|NCT05407675|587401564|FG012|Overall Study|Death|0|||
162641183|NCT05407675|587401552|FG000|Overall Study|Adverse Event|0|||
162641184|NCT05407675|587401553|FG001|Overall Study|Adverse Event|0|||
162641185|NCT05407675|587401554|FG002|Overall Study|Adverse Event|0|||
162641186|NCT05407675|587401555|FG003|Overall Study|Adverse Event|0|||
162641187|NCT05407675|587401556|FG004|Overall Study|Adverse Event|1|||
162641188|NCT05407675|587401557|FG005|Overall Study|Adverse Event|0|||
162641189|NCT05407675|587401558|FG006|Overall Study|Adverse Event|0|||
162641190|NCT05407675|587401559|FG007|Overall Study|Adverse Event|0|||
162641191|NCT05407675|587401560|FG008|Overall Study|Adverse Event|0|||
162641192|NCT05407675|587401561|FG009|Overall Study|Adverse Event|0|||
162641193|NCT05407675|587401562|FG010|Overall Study|Adverse Event|0|||
162641194|NCT05407675|587401563|FG011|Overall Study|Adverse Event|1|||
162641195|NCT05407675|587401564|FG012|Overall Study|Adverse Event|0|||
162641196|NCT05407675|587401552|FG000|Overall Study|Ongoing Treatment|0|||
162641197|NCT05407675|587401553|FG001|Overall Study|Ongoing Treatment|0|||
162641198|NCT05407675|587401554|FG002|Overall Study|Ongoing Treatment|0|||
162641199|NCT05407675|587401555|FG003|Overall Study|Ongoing Treatment|0|||
163017942|NCT02929589|588770748|FG003|Overall Study|Physician Decision|0|||
163017943|NCT00766636|588770759|FG000|Overall Study|Withdrawal by Subject|1|||
163063087|NCT03965923|588938580|FG009|Overall Study|Death|0|||
162641200|NCT05407675|587401556|FG004|Overall Study|Ongoing Treatment|0|||
162641201|NCT05407675|587401557|FG005|Overall Study|Ongoing Treatment|0|||
162716393|NCT00771667|587668433|FG002|Maintenance Phase|Lack of Efficacy|0|||
163063088|NCT03965923|588938581|FG010|Overall Study|Death|4|||
162641202|NCT05407675|587401558|FG006|Overall Study|Ongoing Treatment|0|||
162641203|NCT05407675|587401559|FG007|Overall Study|Ongoing Treatment|0|||
162641204|NCT05407675|587401560|FG008|Overall Study|Ongoing Treatment|1|||
162641205|NCT05407675|587401561|FG009|Overall Study|Ongoing Treatment|0|||
162641206|NCT05407675|587401562|FG010|Overall Study|Ongoing Treatment|0|||
162641207|NCT05407675|587401563|FG011|Overall Study|Ongoing Treatment|0|||
162641208|NCT05407675|587401564|FG012|Overall Study|Ongoing Treatment|0|||
162641209|NCT02612428|587401565|FG000|VTL-308|Death|14|||
162641210|NCT02612428|587401566|FG001|VTL-308|Death|16|||
162641211|NCT02612428|587401565|FG000|VTL-308|Withdrawal by Subject|0|||
162641212|NCT02612428|587401566|FG001|VTL-308|Withdrawal by Subject|1|||
162716394|NCT00771667|587668434|FG003|Maintenance Phase|Lack of Efficacy|0|||
162716395|NCT00771667|587668435|FG004|Maintenance Phase|Lack of Efficacy|1|||
162716396|NCT00771667|587668436|FG005|Maintenance Phase|Lack of Efficacy|3|||
162716397|NCT00771667|587668437|FG006|Maintenance Phase|Lack of Efficacy|3|||
162716398|NCT00771667|587668438|FG007|Maintenance Phase|Lack of Efficacy|2|||
162716399|NCT00771667|587668439|FG008|Maintenance Phase|Lack of Efficacy|11|||
162716400|NCT00771667|587668440|FG009|Maintenance Phase|Lack of Efficacy|7|||
162716401|NCT00771667|587668431|FG000|Maintenance Phase|Other|0|||
162716402|NCT00771667|587668432|FG001|Maintenance Phase|Other|0|||
162716403|NCT00771667|587668433|FG002|Maintenance Phase|Other|0|||
162716404|NCT00771667|587668434|FG003|Maintenance Phase|Other|0|||
162716405|NCT00771667|587668435|FG004|Maintenance Phase|Other|0|||
162716406|NCT00771667|587668436|FG005|Maintenance Phase|Other|1|||
162716407|NCT00771667|587668437|FG006|Maintenance Phase|Other|2|||
163017944|NCT00766636|588770760|FG001|Overall Study|Withdrawal by Subject|1|||
163017945|NCT00766636|588770759|FG000|Overall Study|Incomplete Treatment|0|||
163017946|NCT00766636|588770760|FG001|Overall Study|Incomplete Treatment|1|||
163017947|NCT00766636|588770759|FG000|Overall Study|Adverse Event|1|||
163017948|NCT00766636|588770760|FG001|Overall Study|Adverse Event|0|||
163017949|NCT00766636|588770759|FG000|Overall Study|Disease Progression|1|||
163017950|NCT00766636|588770760|FG001|Overall Study|Disease Progression|0|||
162641213|NCT02612428|587401565|FG000|VTL-308E|Death|9|||
162641214|NCT02612428|587401566|FG001|VTL-308E|Death|7|||
162641215|NCT02612428|587401565|FG000|VTL-308E|Lost to Follow-up|2|||
162641216|NCT02612428|587401566|FG001|VTL-308E|Lost to Follow-up|0|||
162641217|NCT00742001|587401569|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
162641218|NCT00742001|587401570|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
162641219|NCT00742001|587401571|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
162641220|NCT01928329|587401572|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
162641221|NCT01928329|587401573|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
162641222|NCT01928329|587401572|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
162641223|NCT01928329|587401573|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
162641224|NCT01928329|587401572|FG000|Overall Study|Adverse Event|5|||
162641225|NCT01928329|587401573|FG001|Overall Study|Adverse Event|3|||
162641226|NCT01928329|587401572|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
162641227|NCT01928329|587401573|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
162641228|NCT01928329|587401572|FG000|Overall Study|Withdrawal by Subject|1|||
162641229|NCT01928329|587401573|FG001|Overall Study|Withdrawal by Subject|5|||
162641230|NCT01928329|587401572|FG000|Overall Study|Physician Decision|1|||
162641231|NCT01928329|587401573|FG001|Overall Study|Physician Decision|1|||
162716408|NCT00771667|587668438|FG007|Maintenance Phase|Other|2|||
163017951|NCT02477332|588770763|FG000|Overall Study|Adverse Event|0|||
163017952|NCT02477332|588770764|FG001|Overall Study|Adverse Event|1|||
163017953|NCT02477332|588770765|FG002|Overall Study|Adverse Event|1|||
163017954|NCT02477332|588770766|FG003|Overall Study|Adverse Event|2|||
163017955|NCT02477332|588770767|FG004|Overall Study|Adverse Event|1|||
163017956|NCT02477332|588770768|FG005|Overall Study|Adverse Event|2|||
163017957|NCT02477332|588770763|FG000|Overall Study|Lack of Efficacy|1|||
163017958|NCT02477332|588770764|FG001|Overall Study|Lack of Efficacy|2|||
163017959|NCT02477332|588770765|FG002|Overall Study|Lack of Efficacy|1|||
163017960|NCT02477332|588770766|FG003|Overall Study|Lack of Efficacy|2|||
163017961|NCT02477332|588770767|FG004|Overall Study|Lack of Efficacy|1|||
163017962|NCT02477332|588770768|FG005|Overall Study|Lack of Efficacy|1|||
163017963|NCT02477332|588770763|FG000|Overall Study|Non-compliance with study treatment|0|||
163017964|NCT02477332|588770764|FG001|Overall Study|Non-compliance with study treatment|1|||
163017965|NCT02477332|588770765|FG002|Overall Study|Non-compliance with study treatment|2|||
163017966|NCT02477332|588770766|FG003|Overall Study|Non-compliance with study treatment|0|||
163017967|NCT02477332|588770767|FG004|Overall Study|Non-compliance with study treatment|0|||
163017968|NCT02477332|588770768|FG005|Overall Study|Non-compliance with study treatment|0|||
163017969|NCT02477332|588770763|FG000|Overall Study|Pregnancy|0|||
163017970|NCT02477332|588770764|FG001|Overall Study|Pregnancy|0|||
163017971|NCT02477332|588770765|FG002|Overall Study|Pregnancy|0|||
163017972|NCT02477332|588770766|FG003|Overall Study|Pregnancy|1|||
163017973|NCT02477332|588770767|FG004|Overall Study|Pregnancy|0|||
163017974|NCT02477332|588770768|FG005|Overall Study|Pregnancy|0|||
163017975|NCT02477332|588770763|FG000|Overall Study|Protocol Violation|2|||
163017976|NCT02477332|588770764|FG001|Overall Study|Protocol Violation|0|||
162641232|NCT01496313|587401574|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
162641233|NCT01496313|587401575|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
162716409|NCT00771667|587668439|FG008|Maintenance Phase|Other|3|||
162716410|NCT00771667|587668440|FG009|Maintenance Phase|Other|3|||
163017977|NCT02477332|588770765|FG002|Overall Study|Protocol Violation|3|||
163017978|NCT02477332|588770766|FG003|Overall Study|Protocol Violation|3|||
163017979|NCT02477332|588770767|FG004|Overall Study|Protocol Violation|1|||
163017980|NCT02477332|588770768|FG005|Overall Study|Protocol Violation|1|||
163017981|NCT02477332|588770763|FG000|Overall Study|Technical problems|0|||
163017982|NCT02477332|588770764|FG001|Overall Study|Technical problems|0|||
163017983|NCT02477332|588770765|FG002|Overall Study|Technical problems|1|||
163017984|NCT02477332|588770766|FG003|Overall Study|Technical problems|0|||
163017985|NCT02477332|588770767|FG004|Overall Study|Technical problems|0|||
163017986|NCT02477332|588770768|FG005|Overall Study|Technical problems|0|||
162641234|NCT01496313|587401576|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
162641235|NCT01496313|587401577|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
162641236|NCT01496313|587401578|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
162641237|NCT01496313|587401579|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
162641238|NCT01496313|587401574|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
162641239|NCT01496313|587401575|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
162641240|NCT01496313|587401576|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162641241|NCT01496313|587401577|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162641242|NCT01496313|587401578|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162641243|NCT01496313|587401579|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162641244|NCT01496313|587401574|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162641245|NCT01496313|587401575|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
162641246|NCT01496313|587401576|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162641247|NCT01496313|587401577|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162641248|NCT01496313|587401578|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162641249|NCT01496313|587401579|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162641250|NCT01496313|587401574|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
162641251|NCT01496313|587401575|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
162641252|NCT01496313|587401576|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
162641253|NCT01496313|587401577|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
162641254|NCT01496313|587401578|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
162641255|NCT01496313|587401579|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
162641256|NCT01496313|587401574|FG000|Randomized Period (up to 14 Months)|Other|1|||
162641257|NCT01496313|587401575|FG001|Randomized Period (up to 14 Months)|Other|2|||
162641258|NCT01496313|587401576|FG002|Randomized Period (up to 14 Months)|Other|0|||
162641259|NCT01496313|587401577|FG003|Randomized Period (up to 14 Months)|Other|0|||
162641260|NCT01496313|587401578|FG004|Randomized Period (up to 14 Months)|Other|0|||
162641261|NCT01496313|587401579|FG005|Randomized Period (up to 14 Months)|Other|0|||
162641262|NCT01496313|587401574|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162641263|NCT01496313|587401575|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162641264|NCT01496313|587401576|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162641265|NCT01496313|587401577|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162641266|NCT01496313|587401578|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162641267|NCT01496313|587401579|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
162641268|NCT01496313|587401574|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162641269|NCT01496313|587401575|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162641270|NCT01496313|587401576|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162641271|NCT01496313|587401577|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162641272|NCT01496313|587401578|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162641273|NCT01496313|587401579|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
162641274|NCT01496313|587401574|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
162641275|NCT01496313|587401575|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
162641276|NCT01496313|587401576|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
162641277|NCT01496313|587401577|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
162641278|NCT01496313|587401578|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
162641279|NCT01496313|587401579|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
162641280|NCT01050257|587401587|FG000|Overall Study|Adverse Event|4|||
162641281|NCT01050257|587401588|FG001|Overall Study|Adverse Event|4|||
162641282|NCT01050257|587401589|FG002|Overall Study|Adverse Event|2|||
162641283|NCT01050257|587401587|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
162641284|NCT01050257|587401588|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
162641285|NCT01050257|587401589|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
162641286|NCT01050257|587401587|FG000|Overall Study|Withdrawal by Subject|0|||
162641287|NCT01050257|587401588|FG001|Overall Study|Withdrawal by Subject|3|||
162641288|NCT01050257|587401589|FG002|Overall Study|Withdrawal by Subject|0|||
162641289|NCT01050257|587401587|FG000|Overall Study|No reason specified|0|||
162641290|NCT01050257|587401588|FG001|Overall Study|No reason specified|0|||
162716413|NCT01897233|587668442|FG000|Part B (24 Weeks)|Adverse Event|1|||
162716414|NCT01897233|587668442|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
163017987|NCT02477332|588770763|FG000|Overall Study|Lost to Follow-up|0|||
163017988|NCT02477332|588770764|FG001|Overall Study|Lost to Follow-up|0|||
163017989|NCT02477332|588770765|FG002|Overall Study|Lost to Follow-up|2|||
163017990|NCT02477332|588770766|FG003|Overall Study|Lost to Follow-up|0|||
163017991|NCT02477332|588770767|FG004|Overall Study|Lost to Follow-up|0|||
163017992|NCT02477332|588770768|FG005|Overall Study|Lost to Follow-up|0|||
163017993|NCT02477332|588770763|FG000|Overall Study|Physician Decision|0|||
163017994|NCT02477332|588770764|FG001|Overall Study|Physician Decision|0|||
163017995|NCT02477332|588770765|FG002|Overall Study|Physician Decision|1|||
163017996|NCT02477332|588770766|FG003|Overall Study|Physician Decision|3|||
163017997|NCT02477332|588770767|FG004|Overall Study|Physician Decision|0|||
163017998|NCT02477332|588770768|FG005|Overall Study|Physician Decision|1|||
163017999|NCT02477332|588770763|FG000|Overall Study|Withdrawal by Subject|0|||
163018000|NCT02477332|588770764|FG001|Overall Study|Withdrawal by Subject|3|||
163018001|NCT02477332|588770765|FG002|Overall Study|Withdrawal by Subject|1|||
163018002|NCT02477332|588770766|FG003|Overall Study|Withdrawal by Subject|2|||
163018003|NCT02477332|588770767|FG004|Overall Study|Withdrawal by Subject|1|||
163018004|NCT02477332|588770768|FG005|Overall Study|Withdrawal by Subject|0|||
163018005|NCT04657198|588770769|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
163018006|NCT04657198|588770770|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
163018007|NCT04657198|588770771|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
163018008|NCT02977572|588770774|FG000|Overall Study|Exclusion criterion|2|||
163018009|NCT02977572|588770775|FG001|Overall Study|Exclusion criterion|2|||
163018010|NCT01075256|588770778|FG000|Overall Study|Withdrawal by Subject|1|||
163018011|NCT01075256|588770779|FG001|Overall Study|Withdrawal by Subject|0|||
163018012|NCT01075256|588770780|FG002|Overall Study|Withdrawal by Subject|0|||
163018013|NCT03502070|588770781|FG000|Overall Study|Withdrawal by Subject|1|||
163018014|NCT03502070|588770781|FG000|Overall Study|Screen Failure|1|||
163018015|NCT00523848|588770785|FG000|Overall Study|Adverse Event|11|||
163018016|NCT00523848|588770785|FG000|Overall Study|Withdrawal by Subject|2|||
163018017|NCT00523848|588770785|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
163018018|NCT00523848|588770785|FG000|Overall Study|Disease Progression|5|||
163018019|NCT00523848|588770785|FG000|Overall Study|Other, unspecified|4|||
163018020|NCT00086619|588770787|FG000|Overall Study|Withdrawal by Subject|6|||
163018021|NCT00086619|588770788|FG001|Overall Study|Withdrawal by Subject|6|||
163018022|NCT00086619|588770787|FG000|Overall Study|Adverse Event|8|||
163018023|NCT00086619|588770788|FG001|Overall Study|Adverse Event|10|||
163018024|NCT00086619|588770787|FG000|Overall Study|Protocol Violation|1|||
163018025|NCT00086619|588770788|FG001|Overall Study|Protocol Violation|1|||
163018026|NCT00489918|588770789|FG000|Overall Study|Withdrawal by Subject|2|||
163018027|NCT00489918|588770790|FG001|Overall Study|Withdrawal by Subject|1|||
163018028|NCT00489918|588770791|FG002|Overall Study|Withdrawal by Subject|1|||
163018029|NCT00489918|588770792|FG003|Overall Study|Withdrawal by Subject|0|||
163018030|NCT00489918|588770793|FG004|Overall Study|Withdrawal by Subject|1|||
163018031|NCT00489918|588770789|FG000|Overall Study|Adverse Event|0|||
163018032|NCT00489918|588770790|FG001|Overall Study|Adverse Event|1|||
163018033|NCT00489918|588770791|FG002|Overall Study|Adverse Event|1|||
163018034|NCT00489918|588770792|FG003|Overall Study|Adverse Event|0|||
163018035|NCT00489918|588770793|FG004|Overall Study|Adverse Event|0|||
163018036|NCT00489918|588770789|FG000|Overall Study|Lost to Follow-up|0|||
162641291|NCT01050257|587401589|FG002|Overall Study|No reason specified|2|||
162641292|NCT01050257|587401587|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
163018037|NCT00489918|588770790|FG001|Overall Study|Lost to Follow-up|0|||
163018038|NCT00489918|588770791|FG002|Overall Study|Lost to Follow-up|1|||
163018039|NCT00489918|588770792|FG003|Overall Study|Lost to Follow-up|1|||
163018040|NCT00489918|588770793|FG004|Overall Study|Lost to Follow-up|0|||
163018041|NCT00489918|588770789|FG000|Overall Study|Physician Decision|0|||
163018042|NCT00489918|588770790|FG001|Overall Study|Physician Decision|0|||
163018043|NCT00489918|588770791|FG002|Overall Study|Physician Decision|1|||
163018044|NCT00489918|588770792|FG003|Overall Study|Physician Decision|0|||
163018045|NCT00489918|588770793|FG004|Overall Study|Physician Decision|0|||
163018046|NCT02748213|588770794|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
163018047|NCT02748213|588770795|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
163018048|NCT02748213|588770794|FG000|Overall Study|Abnormal Laboratory Test|1|||
163018049|NCT02748213|588770795|FG001|Overall Study|Abnormal Laboratory Test|0|||
163018050|NCT02748213|588770794|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
163018051|NCT02748213|588770795|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
163018052|NCT02748213|588770794|FG000|Overall Study|Death|5|||
163018053|NCT02748213|588770795|FG001|Overall Study|Death|3|||
163018054|NCT02748213|588770794|FG000|Overall Study|Insufficient Therapeutic Response|56|||
163018055|NCT02748213|588770795|FG001|Overall Study|Insufficient Therapeutic Response|57|||
163018056|NCT02748213|588770794|FG000|Overall Study|Violation of Selection Criteria|2|||
163018057|NCT02748213|588770795|FG001|Overall Study|Violation of Selection Criteria|0|||
163018058|NCT02748213|588770794|FG000|Overall Study|Protocol Violation|6|||
163018059|NCT02748213|588770795|FG001|Overall Study|Protocol Violation|4|||
163018060|NCT02748213|588770794|FG000|Overall Study|Refused Treatment*|6|||
163018061|NCT02748213|588770795|FG001|Overall Study|Refused Treatment*|6|||
163018062|NCT02748213|588770794|FG000|Overall Study|Failure to Return|1|||
163018063|NCT02748213|588770795|FG001|Overall Study|Failure to Return|0|||
163018064|NCT02748213|588770794|FG000|Overall Study|Other|30|||
163018065|NCT02748213|588770795|FG001|Overall Study|Other|29|||
163018066|NCT01209520|588770799|FG000|Overall Study|Withdrawal by Subject|3|||
163018067|NCT03291431|588770800|FG000|Overall Study|Protocol Violation|2|||
163018068|NCT03291431|588770801|FG001|Overall Study|Protocol Violation|1|||
163018069|NCT03291431|588770800|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
163018070|NCT03291431|588770801|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
163018071|NCT03291431|588770800|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
163063089|NCT03965923|588938582|FG011|Overall Study|Death|0|||
163063090|NCT03965923|588938571|FG000|Overall Study|Other reason|0|||
163063091|NCT03965923|588938572|FG001|Overall Study|Other reason|0|||
162716415|NCT01897233|587668442|FG000|Part B (24 Weeks)|Physician Decision|1|||
162716416|NCT00628862|587668447|FG000|Overall Study|Adverse Event|6|||
162716417|NCT00628862|587668448|FG001|Overall Study|Adverse Event|8|||
162716418|NCT00628862|587668449|FG002|Overall Study|Adverse Event|10|||
162716419|NCT00628862|587668447|FG000|Overall Study|Withdrawal by Subject|4|||
162716420|NCT00628862|587668448|FG001|Overall Study|Withdrawal by Subject|6|||
162716421|NCT00628862|587668449|FG002|Overall Study|Withdrawal by Subject|11|||
162716422|NCT00628862|587668447|FG000|Overall Study|Lost to Follow-up|0|||
162716423|NCT00628862|587668448|FG001|Overall Study|Lost to Follow-up|2|||
162716424|NCT00628862|587668449|FG002|Overall Study|Lost to Follow-up|1|||
162716425|NCT00628862|587668447|FG000|Overall Study|Protocol Violation|1|||
162716426|NCT00628862|587668448|FG001|Overall Study|Protocol Violation|0|||
162716427|NCT00628862|587668449|FG002|Overall Study|Protocol Violation|0|||
162716428|NCT00628862|587668447|FG000|Overall Study|COPD Exacerbation|0|||
162716429|NCT00628862|587668448|FG001|Overall Study|COPD Exacerbation|1|||
162716430|NCT00628862|587668449|FG002|Overall Study|COPD Exacerbation|0|||
162716431|NCT02814643|587668450|FG000|Overall Study|Lost to Follow-up|0|||
162716432|NCT02814643|587668451|FG001|Overall Study|Lost to Follow-up|1|||
162716433|NCT02814643|587668450|FG000|Overall Study|Withdrawal by Subject|1|||
162716434|NCT02814643|587668451|FG001|Overall Study|Withdrawal by Subject|2|||
162716435|NCT01281813|587668463|FG000|Overall Study|Adverse Event|0|||
162716436|NCT01281813|587668464|FG001|Overall Study|Adverse Event|0|||
162716437|NCT01281813|587668465|FG002|Overall Study|Adverse Event|10|||
162716438|NCT01281813|587668463|FG000|Overall Study|Lost to Follow-up|0|||
162716439|NCT01281813|587668464|FG001|Overall Study|Lost to Follow-up|0|||
162716440|NCT01281813|587668465|FG002|Overall Study|Lost to Follow-up|31|||
163063092|NCT03965923|588938573|FG002|Overall Study|Other reason|0|||
163063093|NCT03965923|588938574|FG003|Overall Study|Other reason|1|||
162716441|NCT01281813|587668463|FG000|Overall Study|Withdrawal by Subject|0|||
162716442|NCT01281813|587668464|FG001|Overall Study|Withdrawal by Subject|0|||
162716443|NCT01281813|587668465|FG002|Overall Study|Withdrawal by Subject|13|||
162716444|NCT01281813|587668463|FG000|Overall Study|Subject Non-Compliant|0|||
162716445|NCT01281813|587668464|FG001|Overall Study|Subject Non-Compliant|0|||
162716446|NCT01281813|587668465|FG002|Overall Study|Subject Non-Compliant|6|||
162716447|NCT01281813|587668463|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
162716448|NCT01281813|587668464|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
163018072|NCT03291431|588770801|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
163018073|NCT03850483|588770802|FG000|Treatment for Stage 1|Adverse Event|1|||
163018074|NCT03850483|588770803|FG001|Treatment for Stage 1|Adverse Event|1|||
163063094|NCT03965923|588938575|FG004|Overall Study|Other reason|0|||
163063095|NCT03965923|588938576|FG005|Overall Study|Other reason|0|||
163063096|NCT03965923|588938577|FG006|Overall Study|Other reason|0|||
163063097|NCT03965923|588938578|FG007|Overall Study|Other reason|0|||
163063098|NCT03965923|588938579|FG008|Overall Study|Other reason|0|||
163063099|NCT03965923|588938580|FG009|Overall Study|Other reason|0|||
163063100|NCT03965923|588938581|FG010|Overall Study|Other reason|2|||
163063101|NCT03965923|588938582|FG011|Overall Study|Other reason|0|||
163063102|NCT00207740|588938583|FG000|Overall Study|Adverse Event|4|||
163063103|NCT00207740|588938584|FG001|Overall Study|Adverse Event|14|||
163063104|NCT00207740|588938585|FG002|Overall Study|Adverse Event|14|||
163063105|NCT00207740|588938586|FG003|Overall Study|Adverse Event|11|||
163063106|NCT00207740|588938583|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163063107|NCT00207740|588938584|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163063108|NCT00207740|588938585|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162641293|NCT01050257|587401588|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
162641294|NCT01050257|587401589|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
162641295|NCT01050257|587401587|FG000|Overall Study|Violation criteria|0|||
162641296|NCT01050257|587401588|FG001|Overall Study|Violation criteria|1|||
162641297|NCT01050257|587401589|FG002|Overall Study|Violation criteria|0|||
162641298|NCT01050257|587401587|FG000|Overall Study|Failure to return|0|||
162641299|NCT01050257|587401588|FG001|Overall Study|Failure to return|2|||
162641300|NCT01050257|587401589|FG002|Overall Study|Failure to return|0|||
162641301|NCT01050257|587401587|FG000|Overall Study|Death|0|||
162641302|NCT01050257|587401588|FG001|Overall Study|Death|0|||
162641303|NCT01050257|587401589|FG002|Overall Study|Death|1|||
162641304|NCT00171223|587401590|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
162641305|NCT00171223|587401591|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
162641306|NCT00171223|587401592|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
162641307|NCT00171223|587401590|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
162641308|NCT00171223|587401591|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
162641309|NCT00171223|587401592|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
162641310|NCT00171223|587401590|FG000|Overall Study|Abnormal Procedure|1|||
162641311|NCT00171223|587401591|FG001|Overall Study|Abnormal Procedure|0|||
162641312|NCT00171223|587401592|FG002|Overall Study|Abnormal Procedure|0|||
162641313|NCT00171223|587401590|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
162641314|NCT00171223|587401591|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
162641315|NCT00171223|587401592|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
162641316|NCT00171223|587401590|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
162641317|NCT00171223|587401591|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
162641318|NCT00171223|587401592|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
162641319|NCT00171223|587401590|FG000|Overall Study|Protocol Violation|2|||
162641320|NCT00171223|587401591|FG001|Overall Study|Protocol Violation|2|||
162641321|NCT00171223|587401592|FG002|Overall Study|Protocol Violation|3|||
162641322|NCT00171223|587401590|FG000|Overall Study|Participant Withdrew Consent|12|||
162641323|NCT00171223|587401591|FG001|Overall Study|Participant Withdrew Consent|21|||
162641324|NCT00171223|587401592|FG002|Overall Study|Participant Withdrew Consent|15|||
162641325|NCT00171223|587401590|FG000|Overall Study|Lost to Follow-up|5|||
162641326|NCT00171223|587401591|FG001|Overall Study|Lost to Follow-up|2|||
162641327|NCT00171223|587401592|FG002|Overall Study|Lost to Follow-up|3|||
162641328|NCT00171223|587401590|FG000|Overall Study|Administrative Problems|4|||
162641329|NCT00171223|587401591|FG001|Overall Study|Administrative Problems|7|||
162641330|NCT00171223|587401592|FG002|Overall Study|Administrative Problems|6|||
162641331|NCT00171223|587401590|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
162641332|NCT00171223|587401591|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
162641333|NCT00171223|587401592|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
162641334|NCT00171223|587401590|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
162641335|NCT00171223|587401591|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
162641336|NCT00171223|587401592|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
162641337|NCT02064166|587401593|FG000|Overall Study|Adverse Event|1|||
162641338|NCT02064166|587401594|FG001|Overall Study|Adverse Event|0|||
162641339|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641340|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
162641341|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641342|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641343|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641344|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641345|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162641346|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
162641347|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
162641348|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
162641349|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
162641350|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
163063109|NCT00207740|588938586|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
162641351|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
163063110|NCT00207740|588938583|FG000|Overall Study|Lost to Follow-up|0|||
163063111|NCT00207740|588938584|FG001|Overall Study|Lost to Follow-up|2|||
163063112|NCT00207740|588938585|FG002|Overall Study|Lost to Follow-up|1|||
163063113|NCT00207740|588938586|FG003|Overall Study|Lost to Follow-up|1|||
162641352|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
162641353|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
162641354|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
162641355|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
162641356|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
162641357|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
162641358|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
162641359|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
162641360|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162641361|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
162641362|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162641363|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162641364|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162641365|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
162641366|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162641367|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
162641368|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
162641369|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
162641370|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
162641371|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
162641372|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
162641373|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
162641374|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641375|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641376|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641377|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641378|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641379|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
162641380|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162641381|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162641382|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162641383|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162641384|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162641385|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162641386|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162641387|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
162641388|NCT03742037|587401596|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641389|NCT03742037|587401597|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641390|NCT03742037|587401598|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641391|NCT03742037|587401599|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641392|NCT03742037|587401600|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641393|NCT03742037|587401601|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162641394|NCT03742037|587401602|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
162641395|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
162641396|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
162641397|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
162641398|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
162641399|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
162641400|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
162641401|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
162641402|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162641403|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162641404|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
162641405|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
162641406|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162641407|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162641408|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
162716449|NCT01281813|587668465|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
162716450|NCT01281813|587668463|FG000|Overall Study|Sponsor's Decision|4|||
162716451|NCT01281813|587668464|FG001|Overall Study|Sponsor's Decision|3|||
162716452|NCT01281813|587668465|FG002|Overall Study|Sponsor's Decision|7|||
162716453|NCT01281813|587668463|FG000|Overall Study|Switched to Commercially Available Medication|0|||
162716454|NCT01281813|587668464|FG001|Overall Study|Switched to Commercially Available Medication|0|||
162716455|NCT01281813|587668465|FG002|Overall Study|Switched to Commercially Available Medication|26|||
162716456|NCT01281813|587668463|FG000|Overall Study|Other|0|||
162716457|NCT01281813|587668464|FG001|Overall Study|Other|1|||
162716458|NCT01281813|587668465|FG002|Overall Study|Other|39|||
162716459|NCT00558363|587668466|FG000|Overall Study|Physician Decision|18|||
162716460|NCT00558363|587668467|FG001|Overall Study|Physician Decision|4|||
162716461|NCT00558363|587668466|FG000|Overall Study|Withdrawal by Subject|11|||
162716462|NCT00558363|587668467|FG001|Overall Study|Withdrawal by Subject|4|||
162716463|NCT00558363|587668466|FG000|Overall Study|Adverse Event|5|||
162716464|NCT00558363|587668467|FG001|Overall Study|Adverse Event|5|||
162716465|NCT00558363|587668466|FG000|Overall Study|Lack of Efficacy|2|||
162716466|NCT00558363|587668467|FG001|Overall Study|Lack of Efficacy|2|||
162716467|NCT00558363|587668466|FG000|Overall Study|Protocol Violation|2|||
162716468|NCT00558363|587668467|FG001|Overall Study|Protocol Violation|1|||
162716469|NCT00558363|587668466|FG000|Overall Study|Lost to Follow-up|0|||
162716470|NCT00558363|587668467|FG001|Overall Study|Lost to Follow-up|1|||
162716471|NCT00558363|587668466|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
162716472|NCT00558363|587668467|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
162716473|NCT00558363|587668466|FG000|Overall Study|Randomized in Error|1|||
162716474|NCT00558363|587668467|FG001|Overall Study|Randomized in Error|2|||
162716475|NCT00558363|587668466|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
162716476|NCT00558363|587668467|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
162716477|NCT03673124|587668468|FG000|Overall Study|Eligible with no protocol therapy|2|||
162716478|NCT02174562|587668469|FG000|Overall Study|Withdrawal by Subject|7|||
162716479|NCT02174562|587668470|FG001|Overall Study|Withdrawal by Subject|2|||
162716480|NCT02174562|587668469|FG000|Overall Study|Death|2|||
162716481|NCT02174562|587668470|FG001|Overall Study|Death|0|||
162716482|NCT02174562|587668469|FG000|Overall Study|Lost to Follow-up|0|||
162716483|NCT02174562|587668470|FG001|Overall Study|Lost to Follow-up|3|||
162716484|NCT00798096|587668472|FG000|Overall Study|Ongoing|2|||
162716485|NCT01651949|587668474|FG000|Overall Study|Unknown status|4|||
162716486|NCT01651949|587668475|FG001|Overall Study|Unknown status|4|||
162716487|NCT01651949|587668476|FG002|Overall Study|Unknown status|0|||
162716488|NCT01651949|587668474|FG000|Overall Study|Lost to Follow-up|30|||
162716489|NCT01651949|587668475|FG001|Overall Study|Lost to Follow-up|56|||
162716490|NCT01651949|587668476|FG002|Overall Study|Lost to Follow-up|20|||
162716491|NCT01651949|587668474|FG000|Overall Study|Protocol Violation|0|||
162716492|NCT01651949|587668475|FG001|Overall Study|Protocol Violation|2|||
162716493|NCT01651949|587668476|FG002|Overall Study|Protocol Violation|1|||
162716494|NCT01651949|587668474|FG000|Overall Study|Physician Decision|0|||
162716495|NCT01651949|587668475|FG001|Overall Study|Physician Decision|2|||
162716496|NCT01651949|587668476|FG002|Overall Study|Physician Decision|0|||
162716497|NCT01651949|587668474|FG000|Overall Study|Adverse Event|0|||
162716498|NCT01651949|587668475|FG001|Overall Study|Adverse Event|2|||
163063114|NCT00207740|588938583|FG000|Overall Study|Death|0|||
163063115|NCT00207740|588938584|FG001|Overall Study|Death|0|||
163063116|NCT00207740|588938585|FG002|Overall Study|Death|0|||
163063117|NCT00207740|588938586|FG003|Overall Study|Death|1|||
163063118|NCT00207740|588938583|FG000|Overall Study|Sponsor Directive|22|||
163063119|NCT00207740|588938584|FG001|Overall Study|Sponsor Directive|15|||
163063120|NCT00207740|588938585|FG002|Overall Study|Sponsor Directive|16|||
163063121|NCT00207740|588938586|FG003|Overall Study|Sponsor Directive|21|||
162716499|NCT01651949|587668476|FG002|Overall Study|Adverse Event|1|||
163018075|NCT03850483|588770804|FG002|Treatment for Stage 1|Adverse Event|3|||
163018076|NCT03850483|588770805|FG003|Treatment for Stage 1|Adverse Event|0|||
163018077|NCT03850483|588770806|FG004|Treatment for Stage 1|Adverse Event|2|||
163018078|NCT03850483|588770807|FG005|Treatment for Stage 1|Adverse Event|0|||
162716500|NCT01651949|587668474|FG000|Overall Study|Screen failure|2|||
162716501|NCT01651949|587668475|FG001|Overall Study|Screen failure|2|||
162716502|NCT01651949|587668476|FG002|Overall Study|Screen failure|0|||
162716503|NCT01651949|587668474|FG000|Overall Study|Withdrawal by Subject|17|||
162716504|NCT01651949|587668475|FG001|Overall Study|Withdrawal by Subject|18|||
162716505|NCT01651949|587668476|FG002|Overall Study|Withdrawal by Subject|9|||
162716506|NCT02155829|587668479|FG000|Overall Study|Adverse Event|1|||
162716507|NCT02155829|587668480|FG001|Overall Study|Adverse Event|0|||
162716508|NCT02155829|587668479|FG000|Overall Study|Withdrawal by Subject|3|||
163018079|NCT03850483|588770808|FG006|Treatment for Stage 1|Adverse Event|2|||
163018080|NCT03850483|588770809|FG007|Treatment for Stage 1|Adverse Event|2|||
163018081|NCT03850483|588770810|FG008|Treatment for Stage 1|Adverse Event|0|||
163018082|NCT03850483|588770811|FG009|Treatment for Stage 1|Adverse Event|0|||
163018083|NCT03850483|588770802|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
163018084|NCT03850483|588770803|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
163018085|NCT03850483|588770804|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
163063122|NCT00207740|588938583|FG000|Overall Study|Other|2|||
162716509|NCT02155829|587668480|FG001|Overall Study|Withdrawal by Subject|3|||
162716510|NCT02155829|587668479|FG000|Overall Study|Protocol Violation|2|||
162716511|NCT02155829|587668480|FG001|Overall Study|Protocol Violation|0|||
162716512|NCT01585038|587668481|FG000|Overall Study|Adverse Event|2|||
163018086|NCT03850483|588770805|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
163018087|NCT03850483|588770806|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
163018088|NCT03850483|588770807|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
163018089|NCT03850483|588770808|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
163018090|NCT03850483|588770809|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
163018091|NCT03850483|588770810|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
163018092|NCT03850483|588770811|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
163018093|NCT03850483|588770802|FG000|Treatment for Stage 1|Protocol Violation|1|||
163018094|NCT03850483|588770803|FG001|Treatment for Stage 1|Protocol Violation|0|||
163018095|NCT03850483|588770804|FG002|Treatment for Stage 1|Protocol Violation|0|||
163018096|NCT03850483|588770805|FG003|Treatment for Stage 1|Protocol Violation|0|||
163018097|NCT03850483|588770806|FG004|Treatment for Stage 1|Protocol Violation|0|||
163018098|NCT03850483|588770807|FG005|Treatment for Stage 1|Protocol Violation|0|||
163018099|NCT03850483|588770808|FG006|Treatment for Stage 1|Protocol Violation|1|||
163018100|NCT03850483|588770809|FG007|Treatment for Stage 1|Protocol Violation|0|||
163018101|NCT03850483|588770810|FG008|Treatment for Stage 1|Protocol Violation|0|||
163018102|NCT03850483|588770811|FG009|Treatment for Stage 1|Protocol Violation|0|||
163018103|NCT03850483|588770802|FG000|Treatment for Stage 1|Physician Decision|0|||
163018104|NCT03850483|588770803|FG001|Treatment for Stage 1|Physician Decision|0|||
163018105|NCT03850483|588770804|FG002|Treatment for Stage 1|Physician Decision|0|||
163018106|NCT03850483|588770805|FG003|Treatment for Stage 1|Physician Decision|0|||
163018107|NCT03850483|588770806|FG004|Treatment for Stage 1|Physician Decision|0|||
162716513|NCT01585038|587668482|FG001|Overall Study|Adverse Event|2|||
162716514|NCT00678795|587668483|FG000|Overall Study|Adverse Event|7|||
162716515|NCT00678795|587668484|FG001|Overall Study|Adverse Event|3|||
162716516|NCT00678795|587668483|FG000|Overall Study|Withdrawal by Subject|3|||
162716517|NCT00678795|587668484|FG001|Overall Study|Withdrawal by Subject|0|||
162716518|NCT00678795|587668483|FG000|Overall Study|Protocol Violation|0|||
162716519|NCT00678795|587668484|FG001|Overall Study|Protocol Violation|1|||
162716520|NCT00678795|587668483|FG000|Overall Study|Lost to Follow-up|0|||
162716521|NCT00678795|587668484|FG001|Overall Study|Lost to Follow-up|1|||
162716522|NCT00678795|587668483|FG000|Overall Study|Lack of Efficacy|1|||
162716523|NCT00678795|587668484|FG001|Overall Study|Lack of Efficacy|1|||
162716524|NCT02750709|587668485|FG000|Treatment Period 1|Adverse Event|0|||
162716525|NCT02750709|587668486|FG001|Treatment Period 1|Adverse Event|0|||
162716526|NCT02750709|587668487|FG002|Treatment Period 1|Adverse Event|0|||
162716527|NCT02750709|587668488|FG003|Treatment Period 1|Adverse Event|0|||
162716528|NCT02750709|587668489|FG004|Treatment Period 1|Adverse Event|0|||
162716529|NCT02750709|587668490|FG005|Treatment Period 1|Adverse Event|1|||
162716530|NCT00771849|587668492|FG000|Overall Study|Lost to Follow-up|1|||
162716531|NCT00771849|587668493|FG001|Overall Study|Lost to Follow-up|2|||
162716532|NCT00771849|587668492|FG000|Overall Study|Withdrawal by Subject|1|||
162716533|NCT00771849|587668493|FG001|Overall Study|Withdrawal by Subject|1|||
162716534|NCT00771849|587668492|FG000|Overall Study|Not vaccinated|0|||
162716535|NCT00771849|587668493|FG001|Overall Study|Not vaccinated|1|||
162716536|NCT00290732|587668494|FG000|Overall Study|Inability to instill drug intraductally.|0|||
162716537|NCT00290732|587668495|FG001|Overall Study|Inability to instill drug intraductally.|1|||
162716538|NCT00290732|587668496|FG002|Overall Study|Inability to instill drug intraductally.|1|||
162716539|NCT00290732|587668497|FG003|Overall Study|Inability to instill drug intraductally.|0|||
162716540|NCT00290732|587668498|FG004|Overall Study|Inability to instill drug intraductally.|0|||
162716541|NCT02736799|587668502|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162716542|NCT02736799|587668503|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162716543|NCT02736799|587668504|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162716544|NCT02736799|587668505|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
162716545|NCT00843193|587668506|FG000|Overall Study|Adverse Event|2|||
162716546|NCT00843193|587668507|FG001|Overall Study|Adverse Event|4|||
162716547|NCT00843193|587668506|FG000|Overall Study|Lack of Efficacy|1|||
162716548|NCT00843193|587668507|FG001|Overall Study|Lack of Efficacy|1|||
162716549|NCT00843193|587668506|FG000|Overall Study|Protocol Violation|1|||
162716550|NCT00843193|587668507|FG001|Overall Study|Protocol Violation|2|||
162716551|NCT00843193|587668506|FG000|Overall Study|Lost to Follow-up|1|||
162716552|NCT00843193|587668507|FG001|Overall Study|Lost to Follow-up|0|||
163018108|NCT03850483|588770807|FG005|Treatment for Stage 1|Physician Decision|1|||
162716553|NCT00843193|587668506|FG000|Overall Study|Physician Decision|0|||
162716554|NCT00843193|587668507|FG001|Overall Study|Physician Decision|1|||
162716555|NCT00843193|587668506|FG000|Overall Study|Withdrawal by Subject|3|||
162716556|NCT00843193|587668507|FG001|Overall Study|Withdrawal by Subject|3|||
162716557|NCT00197015|587668508|FG000|Overall Study|Adverse Event|3|||
163018109|NCT03850483|588770808|FG006|Treatment for Stage 1|Physician Decision|0|||
163018110|NCT03850483|588770809|FG007|Treatment for Stage 1|Physician Decision|0|||
163018111|NCT03850483|588770810|FG008|Treatment for Stage 1|Physician Decision|0|||
163018112|NCT03850483|588770811|FG009|Treatment for Stage 1|Physician Decision|0|||
163018113|NCT03850483|588770802|FG000|Treatment for Stage 1|Other|0|||
163018114|NCT03850483|588770803|FG001|Treatment for Stage 1|Other|0|||
163018115|NCT03850483|588770804|FG002|Treatment for Stage 1|Other|0|||
163018116|NCT03850483|588770805|FG003|Treatment for Stage 1|Other|0|||
162641409|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162641410|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
162641411|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
162641412|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162641413|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162641414|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162641415|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162641416|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
162641417|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162641418|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162641419|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162641420|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162641421|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162641422|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
162641423|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162641424|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
162641425|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
162641426|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
162641427|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162641428|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162641429|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
162641430|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
162641431|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162641432|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
162641433|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162641434|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162641435|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162641436|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
162716558|NCT00197015|587668509|FG001|Overall Study|Adverse Event|0|||
163018117|NCT03850483|588770806|FG004|Treatment for Stage 1|Other|2|||
163018118|NCT03850483|588770807|FG005|Treatment for Stage 1|Other|1|||
163018119|NCT03850483|588770808|FG006|Treatment for Stage 1|Other|0|||
163018120|NCT03850483|588770809|FG007|Treatment for Stage 1|Other|0|||
163018121|NCT03850483|588770810|FG008|Treatment for Stage 1|Other|0|||
163018122|NCT03850483|588770811|FG009|Treatment for Stage 1|Other|0|||
163018123|NCT03850483|588770802|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
162716559|NCT00197015|587668510|FG002|Overall Study|Adverse Event|1|||
162716560|NCT00197015|587668508|FG000|Overall Study|Protocol Violation|0|||
162716561|NCT00197015|587668509|FG001|Overall Study|Protocol Violation|3|||
162716562|NCT00197015|587668510|FG002|Overall Study|Protocol Violation|3|||
162716563|NCT00197015|587668508|FG000|Overall Study|Withdrawal by Subject|17|||
162716564|NCT00197015|587668509|FG001|Overall Study|Withdrawal by Subject|37|||
162716565|NCT00197015|587668510|FG002|Overall Study|Withdrawal by Subject|34|||
162716566|NCT00197015|587668508|FG000|Overall Study|Lost to Follow-up|28|||
162716567|NCT00197015|587668509|FG001|Overall Study|Lost to Follow-up|46|||
162716568|NCT00197015|587668510|FG002|Overall Study|Lost to Follow-up|37|||
162716569|NCT00197015|587668508|FG000|Overall Study|Other|2|||
162716570|NCT00197015|587668509|FG001|Overall Study|Other|3|||
162716571|NCT00197015|587668510|FG002|Overall Study|Other|2|||
162716572|NCT02596035|587668511|FG000|Overall Study|Disease Progression|64|||
162716573|NCT02596035|587668512|FG001|Overall Study|Disease Progression|32|||
162716574|NCT02596035|587668513|FG002|Overall Study|Disease Progression|1|||
162716575|NCT02596035|587668511|FG000|Overall Study|study drug toxicity|12|||
162716576|NCT02596035|587668512|FG001|Overall Study|study drug toxicity|3|||
162716577|NCT02596035|587668513|FG002|Overall Study|study drug toxicity|0|||
162716578|NCT02596035|587668511|FG000|Overall Study|AE unrelated to study drug|5|||
162716579|NCT02596035|587668512|FG001|Overall Study|AE unrelated to study drug|2|||
162716580|NCT02596035|587668513|FG002|Overall Study|AE unrelated to study drug|0|||
162716581|NCT02596035|587668511|FG000|Overall Study|participant request to discontinue study treatment|2|||
162716582|NCT02596035|587668512|FG001|Overall Study|participant request to discontinue study treatment|0|||
162716583|NCT02596035|587668513|FG002|Overall Study|participant request to discontinue study treatment|0|||
162716584|NCT02596035|587668511|FG000|Overall Study|participant withdrew consent|2|||
162716585|NCT02596035|587668512|FG001|Overall Study|participant withdrew consent|2|||
162716586|NCT02596035|587668513|FG002|Overall Study|participant withdrew consent|0|||
162716587|NCT02596035|587668511|FG000|Overall Study|Poor/Non Comlpiance|0|||
162716588|NCT02596035|587668512|FG001|Overall Study|Poor/Non Comlpiance|1|||
162716589|NCT02596035|587668513|FG002|Overall Study|Poor/Non Comlpiance|0|||
162716590|NCT02596035|587668511|FG000|Overall Study|participant no longer meets study criteria|1|||
162716591|NCT02596035|587668512|FG001|Overall Study|participant no longer meets study criteria|0|||
162716592|NCT02596035|587668513|FG002|Overall Study|participant no longer meets study criteria|0|||
162716593|NCT02596035|587668511|FG000|Overall Study|other reasons|11|||
162716594|NCT02596035|587668512|FG001|Overall Study|other reasons|4|||
162716595|NCT02596035|587668513|FG002|Overall Study|other reasons|0|||
163018124|NCT03850483|588770803|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018125|NCT03850483|588770804|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
163018126|NCT03850483|588770805|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018127|NCT03850483|588770806|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018128|NCT03850483|588770807|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018129|NCT03850483|588770808|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018130|NCT03850483|588770809|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018131|NCT03850483|588770810|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018132|NCT03850483|588770811|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
163018133|NCT03850483|588770802|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018134|NCT03850483|588770803|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018135|NCT03850483|588770804|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018136|NCT03850483|588770805|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018137|NCT03850483|588770806|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018138|NCT03850483|588770807|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
163018139|NCT03850483|588770808|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018140|NCT03850483|588770809|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018141|NCT03850483|588770810|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018142|NCT03850483|588770811|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
163018143|NCT03850483|588770802|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
163018144|NCT03850483|588770803|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
163018145|NCT03850483|588770804|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
162716596|NCT03395353|587668515|FG000|Overall Study|Adverse Event|20|||
162716597|NCT03395353|587668515|FG000|Overall Study|Protocol Violation|1|||
163018146|NCT03850483|588770805|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
163018147|NCT03850483|588770806|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
162716598|NCT03395353|587668515|FG000|Overall Study|Lack of Efficacy|3|||
162716599|NCT03395353|587668515|FG000|Overall Study|Withdrawal by Subject|24|||
162716600|NCT03395353|587668515|FG000|Overall Study|Discontinued visit|1|||
162716601|NCT03395353|587668515|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
162716602|NCT03395353|587668515|FG000|Overall Study|Physician Decision|4|||
162716603|NCT03395353|587668515|FG000|Overall Study|Early termination of overall study|33|||
162716604|NCT03301220|587668516|FG000|Overall Study|Death|26|||
162641437|NCT03742037|587401596|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162641438|NCT03742037|587401597|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162641439|NCT03742037|587401598|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
162641440|NCT03742037|587401599|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163018148|NCT03850483|588770807|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
163018149|NCT03850483|588770808|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
163018150|NCT03850483|588770809|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
163018151|NCT03850483|588770810|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
163018152|NCT03850483|588770811|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
163018153|NCT03850483|588770802|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
163018154|NCT03850483|588770803|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
163018155|NCT03850483|588770804|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
163018156|NCT03850483|588770805|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
163018157|NCT03850483|588770806|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
163018158|NCT03850483|588770807|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
163018159|NCT03850483|588770808|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
163018160|NCT03850483|588770809|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
163018161|NCT03850483|588770810|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
163018162|NCT03850483|588770811|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
163018163|NCT03850483|588770802|FG000|Treatment for Stage 1|Death|0|||
162641441|NCT03742037|587401600|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162641442|NCT03742037|587401601|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163018164|NCT03850483|588770803|FG001|Treatment for Stage 1|Death|0|||
163018165|NCT03850483|588770804|FG002|Treatment for Stage 1|Death|0|||
163018166|NCT03850483|588770805|FG003|Treatment for Stage 1|Death|0|||
163018167|NCT03850483|588770806|FG004|Treatment for Stage 1|Death|0|||
163018168|NCT03850483|588770807|FG005|Treatment for Stage 1|Death|1|||
163018169|NCT03850483|588770808|FG006|Treatment for Stage 1|Death|0|||
163018170|NCT03850483|588770809|FG007|Treatment for Stage 1|Death|0|||
163018171|NCT03850483|588770810|FG008|Treatment for Stage 1|Death|0|||
163018172|NCT03850483|588770811|FG009|Treatment for Stage 1|Death|0|||
163018173|NCT03850483|588770802|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
163018174|NCT03850483|588770803|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
163018175|NCT03850483|588770804|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
163018176|NCT03850483|588770805|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
163018177|NCT03850483|588770806|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
163018178|NCT03850483|588770807|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
163018179|NCT03850483|588770808|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
163018180|NCT03850483|588770809|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
163018181|NCT03850483|588770810|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
163018182|NCT03850483|588770811|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
163018183|NCT03850483|588770802|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
163018184|NCT03850483|588770803|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
163018185|NCT03850483|588770804|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
163018186|NCT03850483|588770805|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
163018187|NCT03850483|588770806|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
163018188|NCT03850483|588770807|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
163018189|NCT03850483|588770808|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
163018190|NCT03850483|588770809|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
163018191|NCT03850483|588770810|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
163018192|NCT03850483|588770811|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
163018193|NCT03850483|588770802|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018194|NCT03850483|588770803|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018195|NCT03850483|588770804|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018196|NCT03850483|588770805|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018197|NCT03850483|588770806|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018198|NCT03850483|588770807|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018199|NCT03850483|588770808|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
163063123|NCT00207740|588938584|FG001|Overall Study|Other|10|||
163018200|NCT03850483|588770809|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
163018201|NCT03850483|588770810|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018202|NCT03850483|588770811|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
163018203|NCT03850483|588770802|FG000|Follow-up for Stage 1|Physician Decision|0|||
163018204|NCT03850483|588770803|FG001|Follow-up for Stage 1|Physician Decision|0|||
163018205|NCT03850483|588770804|FG002|Follow-up for Stage 1|Physician Decision|0|||
163018206|NCT03850483|588770805|FG003|Follow-up for Stage 1|Physician Decision|0|||
163018207|NCT03850483|588770806|FG004|Follow-up for Stage 1|Physician Decision|1|||
163018208|NCT03850483|588770807|FG005|Follow-up for Stage 1|Physician Decision|0|||
163018209|NCT03850483|588770808|FG006|Follow-up for Stage 1|Physician Decision|1|||
163018210|NCT03850483|588770809|FG007|Follow-up for Stage 1|Physician Decision|0|||
163018211|NCT03850483|588770810|FG008|Follow-up for Stage 1|Physician Decision|0|||
163018212|NCT03850483|588770811|FG009|Follow-up for Stage 1|Physician Decision|0|||
163018213|NCT03850483|588770802|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
163018214|NCT03850483|588770803|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
163018215|NCT03850483|588770804|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
163018216|NCT03850483|588770805|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
163018217|NCT03850483|588770806|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
163018218|NCT03850483|588770807|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
163018219|NCT03850483|588770808|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
163018220|NCT03850483|588770809|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
163018221|NCT03850483|588770810|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
163018222|NCT03850483|588770811|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
163018223|NCT03850483|588770802|FG000|Follow-up for Stage 1|Adverse Event|0|||
163018224|NCT03850483|588770803|FG001|Follow-up for Stage 1|Adverse Event|0|||
163018225|NCT03850483|588770804|FG002|Follow-up for Stage 1|Adverse Event|1|||
163018226|NCT03850483|588770805|FG003|Follow-up for Stage 1|Adverse Event|0|||
163018227|NCT03850483|588770806|FG004|Follow-up for Stage 1|Adverse Event|0|||
163018228|NCT03850483|588770807|FG005|Follow-up for Stage 1|Adverse Event|1|||
163018229|NCT03850483|588770808|FG006|Follow-up for Stage 1|Adverse Event|0|||
163018230|NCT03850483|588770809|FG007|Follow-up for Stage 1|Adverse Event|0|||
163018231|NCT03850483|588770810|FG008|Follow-up for Stage 1|Adverse Event|0|||
163018232|NCT03850483|588770811|FG009|Follow-up for Stage 1|Adverse Event|0|||
163018233|NCT03850483|588770802|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018234|NCT03850483|588770803|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
163018235|NCT03850483|588770804|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018236|NCT03850483|588770805|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018237|NCT03850483|588770806|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
163018238|NCT03850483|588770807|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
163018239|NCT03850483|588770808|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018240|NCT03850483|588770809|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018241|NCT03850483|588770810|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018242|NCT03850483|588770811|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
163018243|NCT03850483|588770802|FG000|Follow-up for Stage 1|Other|0|||
163018244|NCT03850483|588770803|FG001|Follow-up for Stage 1|Other|2|||
163018245|NCT03850483|588770804|FG002|Follow-up for Stage 1|Other|0|||
163018246|NCT03850483|588770805|FG003|Follow-up for Stage 1|Other|2|||
163018247|NCT03850483|588770806|FG004|Follow-up for Stage 1|Other|0|||
163018248|NCT03850483|588770807|FG005|Follow-up for Stage 1|Other|1|||
163018249|NCT03850483|588770808|FG006|Follow-up for Stage 1|Other|0|||
163018250|NCT03850483|588770809|FG007|Follow-up for Stage 1|Other|0|||
163018251|NCT03850483|588770810|FG008|Follow-up for Stage 1|Other|0|||
163018252|NCT03850483|588770811|FG009|Follow-up for Stage 1|Other|0|||
163018253|NCT03850483|588770802|FG000|Treatment for Stage 2|Adverse Event|0|||
163018254|NCT03850483|588770803|FG001|Treatment for Stage 2|Adverse Event|0|||
163018255|NCT03850483|588770804|FG002|Treatment for Stage 2|Adverse Event|0|||
163018256|NCT03850483|588770805|FG003|Treatment for Stage 2|Adverse Event|0|||
163018257|NCT03850483|588770806|FG004|Treatment for Stage 2|Adverse Event|0|||
163018258|NCT03850483|588770807|FG005|Treatment for Stage 2|Adverse Event|0|||
163018259|NCT03850483|588770808|FG006|Treatment for Stage 2|Adverse Event|0|||
163018260|NCT03850483|588770809|FG007|Treatment for Stage 2|Adverse Event|0|||
163018261|NCT03850483|588770810|FG008|Treatment for Stage 2|Adverse Event|0|||
163018262|NCT03850483|588770811|FG009|Treatment for Stage 2|Adverse Event|1|||
163018263|NCT03850483|588770802|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
163018264|NCT03850483|588770803|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
163018265|NCT03850483|588770804|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
163018266|NCT03850483|588770805|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
163018267|NCT03850483|588770806|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
163018268|NCT03850483|588770807|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
163018269|NCT03850483|588770808|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
163063124|NCT00207740|588938585|FG002|Overall Study|Other|7|||
163063125|NCT00207740|588938586|FG003|Overall Study|Other|5|||
163063126|NCT03916926|588938587|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
163063127|NCT03916926|588938588|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
163063128|NCT03916926|588938587|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
163063129|NCT03916926|588938588|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
163063130|NCT03916926|588938587|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
163063131|NCT03916926|588938588|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
163063132|NCT03916926|588938587|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
163063133|NCT03916926|588938588|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
163063134|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
163063135|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
163063136|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
163063137|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
163063138|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
163063139|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
163063140|NCT03806296|588938594|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
163063141|NCT03806296|588938595|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
163063142|NCT03806296|588938596|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
163063143|NCT02763566|588938605|FG000|Overall Study|Lost to Follow-up|1|||
163063144|NCT02763566|588938606|FG001|Overall Study|Lost to Follow-up|4|||
163063145|NCT02763566|588938607|FG002|Overall Study|Lost to Follow-up|0|||
163063146|NCT02763566|588938608|FG003|Overall Study|Lost to Follow-up|1|||
163063147|NCT02763566|588938605|FG000|Overall Study|On study treatment at study conclusion|114|||
163063148|NCT02763566|588938606|FG001|Overall Study|On study treatment at study conclusion|34|||
163063149|NCT02763566|588938607|FG002|Overall Study|On study treatment at study conclusion|54|||
163063150|NCT02763566|588938608|FG003|Overall Study|On study treatment at study conclusion|13|||
163063151|NCT02763566|588938605|FG000|Overall Study|Withdrawal by Subject|3|||
163063152|NCT02763566|588938606|FG001|Overall Study|Withdrawal by Subject|1|||
163063153|NCT02763566|588938607|FG002|Overall Study|Withdrawal by Subject|0|||
163063154|NCT02763566|588938608|FG003|Overall Study|Withdrawal by Subject|0|||
163063155|NCT04896385|588938609|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
163063156|NCT04896385|588938610|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
163063157|NCT04896385|588938611|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
163063158|NCT04896385|588938612|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163063159|NCT04896385|588938609|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
163063160|NCT04896385|588938610|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
163063161|NCT04896385|588938611|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163063162|NCT04896385|588938612|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163063163|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163063164|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163063165|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
163063166|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
163063167|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163063168|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163063169|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
163063170|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
163063171|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
163063172|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
163018270|NCT03850483|588770809|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
163018271|NCT03850483|588770810|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
163018272|NCT03850483|588770811|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
163018273|NCT03850483|588770802|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
163018274|NCT03850483|588770803|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
163018275|NCT03850483|588770804|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
163018276|NCT03850483|588770805|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
163018277|NCT03850483|588770806|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
163018278|NCT03850483|588770807|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
163018279|NCT03850483|588770808|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
163018280|NCT03850483|588770809|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
163018281|NCT03850483|588770810|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
163018282|NCT03850483|588770811|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
163018283|NCT03850483|588770802|FG000|Treatment for Stage 2|Physician Decision|0|||
163018284|NCT03850483|588770803|FG001|Treatment for Stage 2|Physician Decision|0|||
163018285|NCT03850483|588770804|FG002|Treatment for Stage 2|Physician Decision|0|||
163018286|NCT03850483|588770805|FG003|Treatment for Stage 2|Physician Decision|0|||
163018287|NCT03850483|588770806|FG004|Treatment for Stage 2|Physician Decision|0|||
163018288|NCT03850483|588770807|FG005|Treatment for Stage 2|Physician Decision|0|||
163018289|NCT03850483|588770808|FG006|Treatment for Stage 2|Physician Decision|0|||
163018290|NCT03850483|588770809|FG007|Treatment for Stage 2|Physician Decision|0|||
163018291|NCT03850483|588770810|FG008|Treatment for Stage 2|Physician Decision|0|||
163018292|NCT03850483|588770811|FG009|Treatment for Stage 2|Physician Decision|1|||
163018293|NCT03850483|588770802|FG000|Treatment for Stage 2|Protocol Violation|0|||
163018294|NCT03850483|588770803|FG001|Treatment for Stage 2|Protocol Violation|0|||
163018295|NCT03850483|588770804|FG002|Treatment for Stage 2|Protocol Violation|0|||
163018296|NCT03850483|588770805|FG003|Treatment for Stage 2|Protocol Violation|0|||
163018297|NCT03850483|588770806|FG004|Treatment for Stage 2|Protocol Violation|0|||
163018298|NCT03850483|588770807|FG005|Treatment for Stage 2|Protocol Violation|0|||
163018299|NCT03850483|588770808|FG006|Treatment for Stage 2|Protocol Violation|0|||
163018300|NCT03850483|588770809|FG007|Treatment for Stage 2|Protocol Violation|0|||
163018301|NCT03850483|588770810|FG008|Treatment for Stage 2|Protocol Violation|1|||
163018302|NCT03850483|588770811|FG009|Treatment for Stage 2|Protocol Violation|0|||
163018303|NCT03850483|588770802|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
163018304|NCT03850483|588770803|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
163018305|NCT03850483|588770804|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
163018306|NCT03850483|588770805|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
163018307|NCT03850483|588770806|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
163018308|NCT03850483|588770807|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
163018309|NCT03850483|588770808|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
163018310|NCT03850483|588770809|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
163018311|NCT03850483|588770810|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
163018312|NCT03850483|588770811|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
163018313|NCT03850483|588770802|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018314|NCT03850483|588770803|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018315|NCT03850483|588770804|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018316|NCT03850483|588770805|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018317|NCT03850483|588770806|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018318|NCT03850483|588770807|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018319|NCT03850483|588770808|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018320|NCT03850483|588770809|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018321|NCT03850483|588770810|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
163018322|NCT03850483|588770811|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
163018323|NCT03850483|588770802|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
163018324|NCT03850483|588770803|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
163018325|NCT03850483|588770804|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
163018326|NCT03850483|588770805|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
163018327|NCT03850483|588770806|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
163018328|NCT03850483|588770807|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
163018329|NCT03850483|588770808|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
163018330|NCT03850483|588770809|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
163018331|NCT03850483|588770810|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
163018332|NCT03850483|588770811|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
163018333|NCT03850483|588770802|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
163018334|NCT03850483|588770803|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
163018335|NCT03850483|588770804|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
163018336|NCT03850483|588770805|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
163018337|NCT03850483|588770806|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
163018338|NCT03850483|588770807|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
163018339|NCT03850483|588770808|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
163018340|NCT03850483|588770809|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
163018341|NCT03850483|588770810|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
163018342|NCT03850483|588770811|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
163018343|NCT03850483|588770802|FG000|Follow-up For Stage 2|Other|0|||
163018344|NCT03850483|588770803|FG001|Follow-up For Stage 2|Other|0|||
163018345|NCT03850483|588770804|FG002|Follow-up For Stage 2|Other|0|||
163018346|NCT03850483|588770805|FG003|Follow-up For Stage 2|Other|0|||
163018347|NCT03850483|588770806|FG004|Follow-up For Stage 2|Other|0|||
163018348|NCT03850483|588770807|FG005|Follow-up For Stage 2|Other|0|||
163018349|NCT03850483|588770808|FG006|Follow-up For Stage 2|Other|0|||
163018350|NCT03850483|588770809|FG007|Follow-up For Stage 2|Other|0|||
163018351|NCT03850483|588770810|FG008|Follow-up For Stage 2|Other|0|||
163018352|NCT03850483|588770811|FG009|Follow-up For Stage 2|Other|1|||
163018353|NCT00076752|588772579|FG000|Overall Study|Death|2|||
163018354|NCT00076752|588772579|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
163018355|NCT01288937|588772580|FG000|Overall Study|Adverse Event|1|||
163018356|NCT01288937|588772581|FG001|Overall Study|Adverse Event|0|||
163018357|NCT02875613|588772585|FG000|Overall Study|Withdrawal by Subject|1|||
163018358|NCT02875613|588772585|FG000|Overall Study|Screen Failure|1|||
163018359|NCT00892151|588772586|FG000|Overall Study|Protocol Violation|1|||
163018360|NCT01222520|588772589|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
163018361|NCT01222520|588772590|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
163018362|NCT01222520|588772589|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
163018363|NCT01222520|588772590|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
163018364|NCT01222520|588772589|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
163018365|NCT01222520|588772590|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
163018366|NCT01222520|588772589|FG000|Double-blind Period|Adverse Event|0|||
163018367|NCT01222520|588772590|FG001|Double-blind Period|Adverse Event|1|||
163018368|NCT01222520|588772589|FG000|Double-blind Period|Lack of Efficacy|0|||
163018369|NCT01222520|588772590|FG001|Double-blind Period|Lack of Efficacy|1|||
163018370|NCT01222520|588772589|FG000|Double-blind Period|Study medication stolen|1|||
163018371|NCT01222520|588772590|FG001|Double-blind Period|Study medication stolen|0|||
163018372|NCT02257489|588772597|FG000|Overall Study|Withdrawal by Subject|0|||
163018373|NCT02257489|588772598|FG001|Overall Study|Withdrawal by Subject|0|||
163018374|NCT02257489|588772599|FG002|Overall Study|Withdrawal by Subject|0|||
163018375|NCT02257489|588772600|FG003|Overall Study|Withdrawal by Subject|1|||
163018376|NCT02257489|588772601|FG004|Overall Study|Withdrawal by Subject|0|||
163018377|NCT02257489|588772602|FG005|Overall Study|Withdrawal by Subject|0|||
163018378|NCT02257489|588772603|FG006|Overall Study|Withdrawal by Subject|0|||
163018379|NCT02257489|588772604|FG007|Overall Study|Withdrawal by Subject|0|||
163018380|NCT02257489|588772605|FG008|Overall Study|Withdrawal by Subject|0|||
163018381|NCT04606394|588772608|FG000|Overall Study|Withdrawal by Subject|3|||
163018382|NCT04606394|588772608|FG000|Overall Study|Exclusion criteria screen failure|12|||
163018383|NCT01896128|588772609|FG000|Overall Study|Withdrawal by Subject|3|||
163018384|NCT01896128|588772610|FG001|Overall Study|Withdrawal by Subject|3|||
163018385|NCT01996254|588772611|FG000|Overall Study|Change in Eligibility|0|||
163018386|NCT01996254|588772612|FG001|Overall Study|Change in Eligibility|2|||
163018387|NCT01996254|588772613|FG002|Overall Study|Change in Eligibility|0|||
163018388|NCT01996254|588772611|FG000|Overall Study|Withdrawal by Subject|0|||
163018389|NCT01996254|588772612|FG001|Overall Study|Withdrawal by Subject|3|||
163018390|NCT01996254|588772613|FG002|Overall Study|Withdrawal by Subject|4|||
163018391|NCT01996254|588772611|FG000|Overall Study|Lost to Follow-up|1|||
163018392|NCT01996254|588772612|FG001|Overall Study|Lost to Follow-up|0|||
163018393|NCT01996254|588772613|FG002|Overall Study|Lost to Follow-up|4|||
163018394|NCT01053663|588772614|FG000|Overall Study|Death|2|||
163018395|NCT01053663|588772614|FG000|Overall Study|Lost to Follow-up|1|||
163018396|NCT01053663|588772614|FG000|Overall Study|Poor IV Access|1|||
163018397|NCT01053663|588772614|FG000|Overall Study|Transferred to Another Hospital|1|||
163018398|NCT01053663|588772614|FG000|Overall Study|Negative Influenza Diagnosis|1|||
163063173|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
163063174|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
163018399|NCT02920008|588772615|FG000|Overall Study|Death|117|||
163018400|NCT02920008|588772616|FG001|Overall Study|Death|127|||
163018401|NCT02920008|588772615|FG000|Overall Study|Withdrawal by Subject|3|||
163063175|NCT04896385|588938609|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
163063176|NCT04896385|588938610|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
163018402|NCT02920008|588772616|FG001|Overall Study|Withdrawal by Subject|6|||
163018403|NCT02920008|588772615|FG000|Overall Study|Lost to Follow-up|0|||
163018404|NCT02920008|588772616|FG001|Overall Study|Lost to Follow-up|1|||
163018405|NCT03533114|588772619|FG000|Overall|Adverse Event|16|||
163018406|NCT03533114|588772620|FG001|Overall|Adverse Event|11|||
163018407|NCT03533114|588772619|FG000|Overall|Consent Withdrawal by Participant|7|||
163018408|NCT03533114|588772620|FG001|Overall|Consent Withdrawal by Participant|6|||
163018409|NCT03533114|588772619|FG000|Overall|Lack of Efficacy|5|||
163018410|NCT03533114|588772620|FG001|Overall|Lack of Efficacy|3|||
163018411|NCT03533114|588772619|FG000|Overall|Lost to Follow-up|1|||
163018412|NCT03533114|588772620|FG001|Overall|Lost to Follow-up|1|||
163063177|NCT04896385|588938611|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
163063178|NCT04896385|588938612|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
163063179|NCT05233761|588938613|FG000|Treatment Period A|Withdrawal by Subject|12|||
163063180|NCT05233761|588938614|FG001|Treatment Period A|Withdrawal by Subject|10|||
163063181|NCT05233761|588938613|FG000|Treatment Period A|Lost to Follow-up|6|||
163063182|NCT05233761|588938614|FG001|Treatment Period A|Lost to Follow-up|12|||
163063183|NCT05233761|588938613|FG000|Treatment Period A|Protocol Violation|8|||
163063184|NCT05233761|588938614|FG001|Treatment Period A|Protocol Violation|15|||
163063185|NCT03314935|588938617|FG000|Phase 1|Death|4|||
163063186|NCT03314935|588938618|FG001|Phase 1|Death|2|||
163063187|NCT03314935|588938619|FG002|Phase 1|Death|5|||
163063188|NCT03314935|588938620|FG003|Phase 1|Death|4|||
163063189|NCT03314935|588938621|FG004|Phase 1|Death|3|||
163063190|NCT03314935|588938622|FG005|Phase 1|Death|4|||
163063191|NCT03314935|588938623|FG006|Phase 1|Death|5|||
163063192|NCT03314935|588938624|FG007|Phase 1|Death|4|||
163063193|NCT03314935|588938625|FG008|Phase 1|Death|3|||
163063194|NCT03314935|588938626|FG009|Phase 1|Death|0|||
163063195|NCT03314935|588938627|FG010|Phase 1|Death|0|||
163063196|NCT03314935|588938628|FG011|Phase 1|Death|0|||
163063197|NCT03314935|588938629|FG012|Phase 1|Death|0|||
163063198|NCT03314935|588938630|FG013|Phase 1|Death|0|||
163063199|NCT03314935|588938631|FG014|Phase 1|Death|0|||
163063200|NCT03314935|588938617|FG000|Phase 1|Withdrawal by Subject|2|||
163063201|NCT03314935|588938618|FG001|Phase 1|Withdrawal by Subject|1|||
163063202|NCT03314935|588938619|FG002|Phase 1|Withdrawal by Subject|1|||
163063203|NCT03314935|588938620|FG003|Phase 1|Withdrawal by Subject|2|||
163063204|NCT03314935|588938621|FG004|Phase 1|Withdrawal by Subject|1|||
163063205|NCT03314935|588938622|FG005|Phase 1|Withdrawal by Subject|0|||
163063206|NCT03314935|588938623|FG006|Phase 1|Withdrawal by Subject|1|||
163063207|NCT03314935|588938624|FG007|Phase 1|Withdrawal by Subject|0|||
163063208|NCT03314935|588938625|FG008|Phase 1|Withdrawal by Subject|1|||
163063209|NCT03314935|588938626|FG009|Phase 1|Withdrawal by Subject|0|||
163063210|NCT03314935|588938627|FG010|Phase 1|Withdrawal by Subject|0|||
163063211|NCT03314935|588938628|FG011|Phase 1|Withdrawal by Subject|0|||
163063212|NCT03314935|588938629|FG012|Phase 1|Withdrawal by Subject|0|||
163018413|NCT03533114|588772619|FG000|Overall|Physician Decision|0|||
163018414|NCT03533114|588772620|FG001|Overall|Physician Decision|2|||
163018415|NCT03533114|588772619|FG000|Overall|Protocol deviation|1|||
163018416|NCT03533114|588772620|FG001|Overall|Protocol deviation|1|||
163018417|NCT03533114|588772619|FG000|Overall|Failure to meet randomization criteria|1|||
163018418|NCT03533114|588772620|FG001|Overall|Failure to meet randomization criteria|2|||
163018419|NCT03533114|588772619|FG000|Overall|Non-Compliance with study drug|0|||
163018420|NCT03533114|588772620|FG001|Overall|Non-Compliance with study drug|1|||
163018421|NCT03533114|588772619|FG000|Overall|Other|0|||
163063213|NCT03314935|588938630|FG013|Phase 1|Withdrawal by Subject|0|||
163063214|NCT03314935|588938631|FG014|Phase 1|Withdrawal by Subject|0|||
163063215|NCT03314935|588938617|FG000|Phase 1|Progressive Disease|2|||
163063216|NCT03314935|588938618|FG001|Phase 1|Progressive Disease|0|||
163063217|NCT03314935|588938619|FG002|Phase 1|Progressive Disease|0|||
163063218|NCT03314935|588938620|FG003|Phase 1|Progressive Disease|1|||
163063219|NCT03314935|588938621|FG004|Phase 1|Progressive Disease|0|||
163063220|NCT03314935|588938622|FG005|Phase 1|Progressive Disease|0|||
163018422|NCT03533114|588772620|FG001|Overall|Other|1|||
163018423|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Adverse Event|11|||
163063221|NCT03314935|588938623|FG006|Phase 1|Progressive Disease|0|||
163063222|NCT03314935|588938624|FG007|Phase 1|Progressive Disease|0|||
163018424|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Adverse Event|8|||
163063223|NCT03314935|588938625|FG008|Phase 1|Progressive Disease|0|||
163063224|NCT03314935|588938626|FG009|Phase 1|Progressive Disease|0|||
163063225|NCT03314935|588938627|FG010|Phase 1|Progressive Disease|0|||
163018425|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
163018426|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
163018427|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
163018428|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
163018429|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
163018430|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
163018431|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
163018432|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
163018433|NCT03533114|588772619|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
163018434|NCT03533114|588772620|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
163018435|NCT03533114|588772619|FG000|Stable Dose|Adverse Event|0|||
163018436|NCT03533114|588772620|FG001|Stable Dose|Adverse Event|2|||
163018437|NCT03533114|588772619|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
163018438|NCT03533114|588772620|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
163018439|NCT03533114|588772619|FG000|Stable Dose|Lack of Efficacy|1|||
163018440|NCT03533114|588772620|FG001|Stable Dose|Lack of Efficacy|0|||
163018441|NCT03533114|588772619|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
163018442|NCT03533114|588772620|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
163018443|NCT03533114|588772619|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
163018444|NCT03533114|588772620|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
163018445|NCT03533114|588772619|FG000|Open-Label Safety Extension|Adverse Event|3|||
163018446|NCT03533114|588772620|FG001|Open-Label Safety Extension|Adverse Event|0|||
163018447|NCT03533114|588772619|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
163018448|NCT03533114|588772620|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
163018449|NCT03533114|588772619|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
163018450|NCT03533114|588772620|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
163018451|NCT03533114|588772619|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
163018452|NCT03533114|588772620|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
163018453|NCT03533114|588772619|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
163018454|NCT03533114|588772620|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
163018455|NCT01862250|588772621|FG000|Overall Study|Adverse Event|4|||
163018456|NCT03852264|588772622|FG000|Third Research Visit|Lost to Follow-up|1|||
163018457|NCT03852264|588772623|FG001|Third Research Visit|Lost to Follow-up|0|||
163018458|NCT02411396|588772627|FG000|Overall Study|Lost to Follow-up|31|||
163018459|NCT02411396|588772627|FG000|Overall Study|Death|10|||
163018464|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
163018465|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
163018466|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
163018467|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
163018468|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
163018469|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
163018470|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
163018471|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
163018472|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
163018473|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
163018474|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
163018475|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
163018476|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
163018477|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
163018478|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018479|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018480|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018481|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
163018482|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
163018483|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
163018484|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
163018485|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
163018486|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
163018487|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
163018488|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
163018489|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
163018490|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
163018491|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
163018492|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
163018493|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
163018494|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
163018495|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
163018496|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018497|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018498|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018499|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
163018500|NCT02016105|588772638|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
163018501|NCT02016105|588772639|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
163018502|NCT02016105|588772640|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018503|NCT02016105|588772641|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018504|NCT02016105|588772642|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018505|NCT02016105|588772643|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
163018506|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018507|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018508|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018509|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018510|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
163018511|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
163018512|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
163018513|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
163018514|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
163018515|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
163018516|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
163018517|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
163018518|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
163018519|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
163018520|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
163018521|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
163018522|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
163018523|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
163018524|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Death|0|||
163018525|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Death|0|||
163018526|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Death|0|||
163018527|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Death|0|||
163018528|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Death|0|||
163018529|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Death|1|||
163018530|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
163018531|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
163018532|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
163018533|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
163018534|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
163018535|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
163018536|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
163018537|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
163018538|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
163018539|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
163018540|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
163018541|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
163018542|NCT02016105|588772638|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018543|NCT02016105|588772639|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018544|NCT02016105|588772640|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
163018545|NCT02016105|588772641|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018546|NCT02016105|588772642|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
163018547|NCT02016105|588772643|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
163018548|NCT02016105|588772638|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
163018549|NCT02016105|588772639|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
163018550|NCT02016105|588772640|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
163018551|NCT02016105|588772641|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
163018552|NCT02016105|588772642|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
163018553|NCT02016105|588772643|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
163018554|NCT02016105|588772638|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
163018555|NCT02016105|588772639|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
163018556|NCT02016105|588772640|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
163018557|NCT02016105|588772641|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
163018558|NCT02016105|588772642|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
162716605|NCT03301220|587668517|FG001|Overall Study|Death|15|||
162716606|NCT03301220|587668516|FG000|Overall Study|Withdrawal by Subject|23|||
162716607|NCT03301220|587668517|FG001|Overall Study|Withdrawal by Subject|12|||
163018559|NCT02016105|588772643|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
163018560|NCT02016105|588772638|FG000|EXTENSION PERIOD|Adverse Event|0|||
163018561|NCT02016105|588772639|FG001|EXTENSION PERIOD|Adverse Event|0|||
163018562|NCT02016105|588772640|FG002|EXTENSION PERIOD|Adverse Event|2|||
163018563|NCT02016105|588772641|FG003|EXTENSION PERIOD|Adverse Event|0|||
162716608|NCT03301220|587668516|FG000|Overall Study|Lost to Follow-up|1|||
163018564|NCT02016105|588772642|FG004|EXTENSION PERIOD|Adverse Event|1|||
163018565|NCT02016105|588772643|FG005|EXTENSION PERIOD|Adverse Event|0|||
163018566|NCT02016105|588772638|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
163018567|NCT02016105|588772639|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
163018568|NCT02016105|588772640|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018569|NCT02016105|588772641|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018570|NCT02016105|588772642|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018571|NCT02016105|588772643|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
163018572|NCT02016105|588772638|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018573|NCT02016105|588772639|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018574|NCT02016105|588772640|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018575|NCT02016105|588772641|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018576|NCT02016105|588772642|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
163018577|NCT02016105|588772643|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
163018578|NCT02016105|588772638|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
163018579|NCT02016105|588772639|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
163018580|NCT02016105|588772640|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
163018581|NCT02016105|588772641|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
163018582|NCT02016105|588772642|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
163018583|NCT02016105|588772643|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
163018584|NCT00090493|588772644|FG000|Overall Study|Physician Decision|2|||
163018585|NCT02865499|588772647|FG000|Baseline|Adverse Event|1|||
163018586|NCT02865499|588772647|FG000|Baseline|Withdrawal by Subject|1|||
163018587|NCT02320058|588772648|FG000|Overall Study|Death|25|||
163018588|NCT02320058|588772649|FG001|Overall Study|Death|10|||
163018589|NCT02320058|588772648|FG000|Overall Study|Lost to Follow-up|4|||
163018590|NCT02320058|588772649|FG001|Overall Study|Lost to Follow-up|0|||
163018591|NCT02320058|588772648|FG000|Overall Study|Other reasons|4|||
163018592|NCT02320058|588772649|FG001|Overall Study|Other reasons|1|||
163018593|NCT02320058|588772648|FG000|Overall Study|Withdrawal by Subject|8|||
163018594|NCT02320058|588772649|FG001|Overall Study|Withdrawal by Subject|2|||
163018595|NCT02320058|588772648|FG000|Overall Study|Not reported|1|||
163018596|NCT02320058|588772649|FG001|Overall Study|Not reported|0|||
163018597|NCT00661609|588772650|FG000|Overall Study|Adverse Event|4|||
163018598|NCT00661609|588772650|FG000|Overall Study|Death|20|||
163018599|NCT00661609|588772650|FG000|Overall Study|Withdrawal by Subject|2|||
163018600|NCT00661609|588772650|FG000|Overall Study|PI Decision|1|||
163018601|NCT00661609|588772650|FG000|Overall Study|Survival follow up stage discontinued|11|||
163018602|NCT00661609|588772650|FG000|Overall Study|Disease progression|3|||
163018603|NCT03521115|588772651|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
163018604|NCT03521115|588772652|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
163018605|NCT03521115|588772651|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
163018606|NCT03521115|588772652|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
163018607|NCT01769508|588772656|FG000|Overall Study|Death|3|||
163018608|NCT01769508|588772656|FG000|Overall Study|Withdrawal by Subject|1|||
163018609|NCT01769508|588772656|FG000|Overall Study|Adverse Event|1|||
163018610|NCT01769508|588772656|FG000|Overall Study|Lost to Follow-up|1|||
163018611|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
163018612|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
163018613|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
163018614|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
163018615|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
163018616|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
163018617|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
163018618|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
163018619|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
163018620|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
163018621|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
163018622|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
163018623|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
163018624|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
163018625|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
163018626|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
163018627|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
163018628|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
163018629|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
163018630|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
163018631|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
163018632|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
163018633|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
162716609|NCT03301220|587668517|FG001|Overall Study|Lost to Follow-up|1|||
162716610|NCT03301220|587668516|FG000|Overall Study|Randomized in error|1|||
163018634|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
163018635|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
163018636|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
163018637|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
163018638|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
163018639|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163018640|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
163018641|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
163018642|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
163018643|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
163018644|NCT00839527|588772663|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
163018645|NCT00839527|588772664|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
163018646|NCT00839527|588772665|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
163018647|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163018648|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
163018649|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
163018650|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
163018651|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
163018652|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
163018653|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
163018654|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
163018655|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
163018656|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
163018657|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
163018658|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
163018659|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
163018660|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
163018661|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
163018662|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
163018663|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
163018664|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
163018665|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
163018666|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
163018667|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
163018668|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
163018669|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
163018670|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
163018671|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
163018672|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
163018673|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
163018674|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
163018675|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
163018676|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
163018677|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
163018678|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
163018679|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
163018680|NCT00839527|588772663|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
163018681|NCT00839527|588772664|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
163018682|NCT00839527|588772665|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
163018683|NCT02295020|588772666|FG000|Overall Study|Adverse Event|0|||
163018684|NCT02295020|588772667|FG001|Overall Study|Adverse Event|1|||
163018685|NCT02295020|588772666|FG000|Overall Study|Withdrawal by Subject|3|||
163018686|NCT02295020|588772667|FG001|Overall Study|Withdrawal by Subject|2|||
163018687|NCT02751450|588772668|FG000|Overall Study|Adverse Event|1|||
163018688|NCT02751450|588772669|FG001|Overall Study|Adverse Event|0|||
163018689|NCT00562302|588772670|FG000|Overall Study|Lost to Follow-up|3|||
163018690|NCT00562302|588772671|FG001|Overall Study|Lost to Follow-up|3|||
163018691|NCT00562302|588772670|FG000|Overall Study|Adverse Event|0|||
163018692|NCT00562302|588772671|FG001|Overall Study|Adverse Event|6|||
163018693|NCT00562302|588772670|FG000|Overall Study|Non-compliance|1|||
163018694|NCT00562302|588772671|FG001|Overall Study|Non-compliance|2|||
163018695|NCT00562302|588772670|FG000|Overall Study|Withdrawal by Subject|7|||
163018696|NCT00562302|588772671|FG001|Overall Study|Withdrawal by Subject|8|||
163018697|NCT00562302|588772670|FG000|Overall Study|Death|1|||
163018698|NCT00562302|588772671|FG001|Overall Study|Death|2|||
163063226|NCT03314935|588938628|FG011|Phase 1|Progressive Disease|0|||
163063227|NCT03314935|588938629|FG012|Phase 1|Progressive Disease|0|||
163063228|NCT03314935|588938630|FG013|Phase 1|Progressive Disease|0|||
163063229|NCT03314935|588938631|FG014|Phase 1|Progressive Disease|0|||
163063230|NCT03314935|588938617|FG000|Phase 1|Study Terminated by Sponsor|0|||
162716611|NCT03301220|587668517|FG001|Overall Study|Randomized in error|1|||
163018699|NCT00562302|588772670|FG000|Overall Study|Lung resection prior to study completion|7|||
163018700|NCT00562302|588772671|FG001|Overall Study|Lung resection prior to study completion|7|||
163018701|NCT00562302|588772670|FG000|Overall Study|Not stated|1|||
163063231|NCT03314935|588938618|FG001|Phase 1|Study Terminated by Sponsor|1|||
163018702|NCT00562302|588772671|FG001|Overall Study|Not stated|4|||
163018703|NCT01855243|588772672|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
163018704|NCT01855243|588772673|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
163018705|NCT01855243|588772674|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
163018706|NCT03615144|588772675|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
163018707|NCT03615144|588772676|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
163018708|NCT02587598|588772679|FG000|Overall Study|Death|4|||
163018709|NCT02587598|588772680|FG001|Overall Study|Death|8|||
163018710|NCT02587598|588772681|FG002|Overall Study|Death|4|||
163018711|NCT02587598|588772682|FG003|Overall Study|Death|16|||
163018712|NCT02587598|588772683|FG004|Overall Study|Death|9|||
163018713|NCT02587598|588772684|FG005|Overall Study|Death|4|||
163018714|NCT02587598|588772685|FG006|Overall Study|Death|6|||
163018715|NCT02587598|588772686|FG007|Overall Study|Death|7|||
163018716|NCT02587598|588772687|FG008|Overall Study|Death|9|||
163018717|NCT02587598|588772688|FG009|Overall Study|Death|1|||
163018718|NCT02587598|588772689|FG010|Overall Study|Death|3|||
163018719|NCT02587598|588772679|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163018720|NCT02587598|588772680|FG001|Overall Study|Study Terminated by the Sponsor|1|||
163018721|NCT02587598|588772681|FG002|Overall Study|Study Terminated by the Sponsor|0|||
163018722|NCT02587598|588772682|FG003|Overall Study|Study Terminated by the Sponsor|3|||
163018723|NCT02587598|588772683|FG004|Overall Study|Study Terminated by the Sponsor|0|||
163018724|NCT02587598|588772684|FG005|Overall Study|Study Terminated by the Sponsor|1|||
163018725|NCT02587598|588772685|FG006|Overall Study|Study Terminated by the Sponsor|0|||
163018726|NCT02587598|588772686|FG007|Overall Study|Study Terminated by the Sponsor|0|||
163018727|NCT02587598|588772687|FG008|Overall Study|Study Terminated by the Sponsor|0|||
163018728|NCT02587598|588772688|FG009|Overall Study|Study Terminated by the Sponsor|1|||
163018729|NCT02587598|588772689|FG010|Overall Study|Study Terminated by the Sponsor|6|||
163018730|NCT02587598|588772679|FG000|Overall Study|Reason for study withdrawal not specified|0|||
163018731|NCT02587598|588772680|FG001|Overall Study|Reason for study withdrawal not specified|1|||
163018732|NCT02587598|588772681|FG002|Overall Study|Reason for study withdrawal not specified|0|||
163018733|NCT02587598|588772682|FG003|Overall Study|Reason for study withdrawal not specified|0|||
163018734|NCT02587598|588772683|FG004|Overall Study|Reason for study withdrawal not specified|0|||
163018735|NCT02587598|588772684|FG005|Overall Study|Reason for study withdrawal not specified|0|||
163018736|NCT02587598|588772685|FG006|Overall Study|Reason for study withdrawal not specified|0|||
163018737|NCT02587598|588772686|FG007|Overall Study|Reason for study withdrawal not specified|0|||
163018738|NCT02587598|588772687|FG008|Overall Study|Reason for study withdrawal not specified|0|||
163018739|NCT02587598|588772688|FG009|Overall Study|Reason for study withdrawal not specified|0|||
163018740|NCT02587598|588772689|FG010|Overall Study|Reason for study withdrawal not specified|0|||
163018741|NCT02587598|588772679|FG000|Overall Study|Withdrawal by Subject|0|||
163018742|NCT02587598|588772680|FG001|Overall Study|Withdrawal by Subject|1|||
163018743|NCT02587598|588772681|FG002|Overall Study|Withdrawal by Subject|0|||
163018744|NCT02587598|588772682|FG003|Overall Study|Withdrawal by Subject|2|||
163018745|NCT02587598|588772683|FG004|Overall Study|Withdrawal by Subject|3|||
163018746|NCT02587598|588772684|FG005|Overall Study|Withdrawal by Subject|1|||
163018747|NCT02587598|588772685|FG006|Overall Study|Withdrawal by Subject|0|||
163018748|NCT02587598|588772686|FG007|Overall Study|Withdrawal by Subject|0|||
163018749|NCT02587598|588772687|FG008|Overall Study|Withdrawal by Subject|0|||
163018750|NCT02587598|588772688|FG009|Overall Study|Withdrawal by Subject|1|||
163018751|NCT02587598|588772689|FG010|Overall Study|Withdrawal by Subject|2|||
163018752|NCT02587598|588772679|FG000|Overall Study|Physician Decision|0|||
163018753|NCT02587598|588772680|FG001|Overall Study|Physician Decision|0|||
163018754|NCT02587598|588772681|FG002|Overall Study|Physician Decision|0|||
163018755|NCT02587598|588772682|FG003|Overall Study|Physician Decision|0|||
163018756|NCT02587598|588772683|FG004|Overall Study|Physician Decision|0|||
163018757|NCT02587598|588772684|FG005|Overall Study|Physician Decision|0|||
163018758|NCT02587598|588772685|FG006|Overall Study|Physician Decision|0|||
163018759|NCT02587598|588772686|FG007|Overall Study|Physician Decision|0|||
163018760|NCT02587598|588772687|FG008|Overall Study|Physician Decision|0|||
163018761|NCT02587598|588772688|FG009|Overall Study|Physician Decision|0|||
163018762|NCT02587598|588772689|FG010|Overall Study|Physician Decision|3|||
163018763|NCT01860040|588772690|FG000|Overall Study|Withdrawal by Subject|1|||
163018764|NCT01860040|588772691|FG001|Overall Study|Withdrawal by Subject|0|||
163018765|NCT00679289|588772692|FG000|Overall Study|Progressive disease|4|||
163018766|NCT00679289|588772693|FG001|Overall Study|Progressive disease|5|||
163018767|NCT00679289|588772694|FG002|Overall Study|Progressive disease|18|||
163063232|NCT03314935|588938619|FG002|Phase 1|Study Terminated by Sponsor|0|||
163063233|NCT03314935|588938620|FG003|Phase 1|Study Terminated by Sponsor|0|||
163018768|NCT00679289|588772692|FG000|Overall Study|Withdrawal by Subject|0|||
163018769|NCT00679289|588772693|FG001|Overall Study|Withdrawal by Subject|1|||
163018770|NCT00679289|588772694|FG002|Overall Study|Withdrawal by Subject|1|||
163063234|NCT03314935|588938621|FG004|Phase 1|Study Terminated by Sponsor|0|||
163018771|NCT00679289|588772692|FG000|Overall Study|Adverse Event|0|||
163018772|NCT00679289|588772693|FG001|Overall Study|Adverse Event|0|||
163018773|NCT00679289|588772694|FG002|Overall Study|Adverse Event|3|||
163018774|NCT00679289|588772692|FG000|Overall Study|Physician Decision|1|||
163018775|NCT00679289|588772693|FG001|Overall Study|Physician Decision|0|||
163018776|NCT00679289|588772694|FG002|Overall Study|Physician Decision|1|||
163018777|NCT00937040|588772695|FG000|Overall Study|Adverse Event|5|||
163018778|NCT00937040|588772696|FG001|Overall Study|Adverse Event|8|||
163018779|NCT00937040|588772695|FG000|Overall Study|Lost to Follow-up|12|||
163018780|NCT00937040|588772696|FG001|Overall Study|Lost to Follow-up|12|||
163018781|NCT00937040|588772695|FG000|Overall Study|Protocol Violation|3|||
163018782|NCT00937040|588772696|FG001|Overall Study|Protocol Violation|0|||
163018783|NCT00937040|588772695|FG000|Overall Study|Withdrawal by Subject|13|||
163018784|NCT00937040|588772696|FG001|Overall Study|Withdrawal by Subject|7|||
163018785|NCT00937040|588772695|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
163018786|NCT00937040|588772696|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
163018787|NCT00937040|588772695|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
163018788|NCT00937040|588772696|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
163018789|NCT02477826|588772697|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018790|NCT02477826|588772698|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018791|NCT02477826|588772699|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
163018792|NCT02477826|588772700|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018793|NCT02477826|588772701|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018794|NCT02477826|588772702|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018795|NCT02477826|588772703|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
163018796|NCT02477826|588772704|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
163018797|NCT02477826|588772705|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018798|NCT02477826|588772706|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
163018799|NCT02477826|588772697|FG000|Pre-Treatment|Other reasons|4|||
163018800|NCT02477826|588772698|FG001|Pre-Treatment|Other reasons|1|||
163018801|NCT02477826|588772699|FG002|Pre-Treatment|Other reasons|4|||
163018802|NCT02477826|588772700|FG003|Pre-Treatment|Other reasons|1|||
163018803|NCT02477826|588772701|FG004|Pre-Treatment|Other reasons|4|||
163018804|NCT02477826|588772702|FG005|Pre-Treatment|Other reasons|2|||
163018805|NCT02477826|588772703|FG006|Pre-Treatment|Other reasons|0|||
163018806|NCT02477826|588772704|FG007|Pre-Treatment|Other reasons|0|||
163018807|NCT02477826|588772705|FG008|Pre-Treatment|Other reasons|0|||
163018808|NCT02477826|588772706|FG009|Pre-Treatment|Other reasons|0|||
163018809|NCT02477826|588772697|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
163018810|NCT02477826|588772698|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
163018811|NCT02477826|588772699|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
163018812|NCT02477826|588772700|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
163018813|NCT02477826|588772701|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
163018814|NCT02477826|588772702|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
163018815|NCT02477826|588772703|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
163018816|NCT02477826|588772704|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
163018817|NCT02477826|588772705|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
163018818|NCT02477826|588772706|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
163018819|NCT02477826|588772697|FG000|Pre-Treatment|Subject withdrew consent|0|||
163018820|NCT02477826|588772698|FG001|Pre-Treatment|Subject withdrew consent|0|||
163018821|NCT02477826|588772699|FG002|Pre-Treatment|Subject withdrew consent|3|||
163018822|NCT02477826|588772700|FG003|Pre-Treatment|Subject withdrew consent|0|||
163018823|NCT02477826|588772701|FG004|Pre-Treatment|Subject withdrew consent|0|||
163018824|NCT02477826|588772702|FG005|Pre-Treatment|Subject withdrew consent|1|||
163018825|NCT02477826|588772703|FG006|Pre-Treatment|Subject withdrew consent|0|||
163018826|NCT02477826|588772704|FG007|Pre-Treatment|Subject withdrew consent|1|||
163018827|NCT02477826|588772705|FG008|Pre-Treatment|Subject withdrew consent|0|||
163018828|NCT02477826|588772706|FG009|Pre-Treatment|Subject withdrew consent|3|||
163018829|NCT02477826|588772697|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018830|NCT02477826|588772698|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
163018831|NCT02477826|588772699|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018832|NCT02477826|588772700|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018833|NCT02477826|588772701|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
163063235|NCT03314935|588938622|FG005|Phase 1|Study Terminated by Sponsor|0|||
163063236|NCT03314935|588938623|FG006|Phase 1|Study Terminated by Sponsor|0|||
163018834|NCT02477826|588772702|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018835|NCT02477826|588772703|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018836|NCT02477826|588772704|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018837|NCT02477826|588772705|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
163018838|NCT02477826|588772706|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
163018839|NCT02477826|588772697|FG000|Pre-Treatment|Death|0|||
163063237|NCT03314935|588938624|FG007|Phase 1|Study Terminated by Sponsor|0|||
163063238|NCT03314935|588938625|FG008|Phase 1|Study Terminated by Sponsor|1|||
163018840|NCT02477826|588772698|FG001|Pre-Treatment|Death|0|||
163018841|NCT02477826|588772699|FG002|Pre-Treatment|Death|0|||
163018842|NCT02477826|588772700|FG003|Pre-Treatment|Death|0|||
163018843|NCT02477826|588772701|FG004|Pre-Treatment|Death|0|||
163018844|NCT02477826|588772702|FG005|Pre-Treatment|Death|0|||
163018845|NCT02477826|588772703|FG006|Pre-Treatment|Death|1|||
163018846|NCT02477826|588772704|FG007|Pre-Treatment|Death|0|||
163018847|NCT02477826|588772705|FG008|Pre-Treatment|Death|0|||
163018848|NCT02477826|588772706|FG009|Pre-Treatment|Death|0|||
163018849|NCT02477826|588772697|FG000|Treatment Period|Not reported|8|||
163018850|NCT02477826|588772698|FG001|Treatment Period|Not reported|6|||
163018851|NCT02477826|588772699|FG002|Treatment Period|Not reported|4|||
163018852|NCT02477826|588772700|FG003|Treatment Period|Not reported|4|||
163018853|NCT02477826|588772701|FG004|Treatment Period|Not reported|2|||
163018854|NCT02477826|588772702|FG005|Treatment Period|Not reported|1|||
163018855|NCT02477826|588772703|FG006|Treatment Period|Not reported|14|||
163018856|NCT02477826|588772704|FG007|Treatment Period|Not reported|8|||
163018857|NCT02477826|588772705|FG008|Treatment Period|Not reported|5|||
163018858|NCT02477826|588772706|FG009|Treatment Period|Not reported|2|||
163018859|NCT02477826|588772697|FG000|Treatment Period|Other reasons|5|||
163018860|NCT02477826|588772698|FG001|Treatment Period|Other reasons|6|||
163018861|NCT02477826|588772699|FG002|Treatment Period|Other reasons|12|||
163018862|NCT02477826|588772700|FG003|Treatment Period|Other reasons|7|||
163018863|NCT02477826|588772701|FG004|Treatment Period|Other reasons|5|||
163018864|NCT02477826|588772702|FG005|Treatment Period|Other reasons|1|||
163018865|NCT02477826|588772703|FG006|Treatment Period|Other reasons|8|||
162641443|NCT03742037|587401602|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
163018866|NCT02477826|588772704|FG007|Treatment Period|Other reasons|8|||
163018867|NCT02477826|588772705|FG008|Treatment Period|Other reasons|21|||
163018868|NCT02477826|588772706|FG009|Treatment Period|Other reasons|1|||
163018869|NCT02477826|588772697|FG000|Treatment Period|Administrative reason by sponsor|0|||
163018870|NCT02477826|588772698|FG001|Treatment Period|Administrative reason by sponsor|3|||
163018871|NCT02477826|588772699|FG002|Treatment Period|Administrative reason by sponsor|0|||
163018872|NCT02477826|588772700|FG003|Treatment Period|Administrative reason by sponsor|0|||
163018873|NCT02477826|588772701|FG004|Treatment Period|Administrative reason by sponsor|0|||
163018874|NCT02477826|588772702|FG005|Treatment Period|Administrative reason by sponsor|0|||
163018875|NCT02477826|588772703|FG006|Treatment Period|Administrative reason by sponsor|0|||
163018876|NCT02477826|588772704|FG007|Treatment Period|Administrative reason by sponsor|0|||
163018877|NCT02477826|588772705|FG008|Treatment Period|Administrative reason by sponsor|0|||
163018878|NCT02477826|588772706|FG009|Treatment Period|Administrative reason by sponsor|0|||
163018879|NCT02477826|588772697|FG000|Treatment Period|Participant meet no longer study criteria|1|||
163018880|NCT02477826|588772698|FG001|Treatment Period|Participant meet no longer study criteria|1|||
163018881|NCT02477826|588772699|FG002|Treatment Period|Participant meet no longer study criteria|0|||
163018882|NCT02477826|588772700|FG003|Treatment Period|Participant meet no longer study criteria|0|||
163063239|NCT03314935|588938626|FG009|Phase 1|Study Terminated by Sponsor|0|||
163063240|NCT03314935|588938627|FG010|Phase 1|Study Terminated by Sponsor|0|||
163063241|NCT03314935|588938628|FG011|Phase 1|Study Terminated by Sponsor|0|||
163063242|NCT03314935|588938629|FG012|Phase 1|Study Terminated by Sponsor|0|||
163063243|NCT03314935|588938630|FG013|Phase 1|Study Terminated by Sponsor|0|||
163063244|NCT03314935|588938631|FG014|Phase 1|Study Terminated by Sponsor|0|||
163063245|NCT03314935|588938617|FG000|Phase 1|"Captured as Other in Database"|0|||
163063246|NCT03314935|588938618|FG001|Phase 1|"Captured as Other in Database"|2|||
163063247|NCT03314935|588938619|FG002|Phase 1|"Captured as Other in Database"|0|||
162641444|NCT04128267|587401605|FG000|Overall Study|Withdrawal by Subject|6|||
162641445|NCT04128267|587401605|FG000|Overall Study|Death|2|||
163018883|NCT02477826|588772701|FG004|Treatment Period|Participant meet no longer study criteria|1|||
163018884|NCT02477826|588772702|FG005|Treatment Period|Participant meet no longer study criteria|1|||
163018885|NCT02477826|588772703|FG006|Treatment Period|Participant meet no longer study criteria|0|||
163018886|NCT02477826|588772704|FG007|Treatment Period|Participant meet no longer study criteria|1|||
163018887|NCT02477826|588772705|FG008|Treatment Period|Participant meet no longer study criteria|0|||
163018888|NCT02477826|588772706|FG009|Treatment Period|Participant meet no longer study criteria|0|||
163018889|NCT02477826|588772697|FG000|Treatment Period|Poor/Non Compliance|1|||
163018890|NCT02477826|588772698|FG001|Treatment Period|Poor/Non Compliance|0|||
163018891|NCT02477826|588772699|FG002|Treatment Period|Poor/Non Compliance|2|||
163018892|NCT02477826|588772700|FG003|Treatment Period|Poor/Non Compliance|0|||
163018893|NCT02477826|588772701|FG004|Treatment Period|Poor/Non Compliance|0|||
163018894|NCT02477826|588772702|FG005|Treatment Period|Poor/Non Compliance|1|||
163018895|NCT02477826|588772703|FG006|Treatment Period|Poor/Non Compliance|1|||
163018896|NCT02477826|588772704|FG007|Treatment Period|Poor/Non Compliance|0|||
163018897|NCT02477826|588772705|FG008|Treatment Period|Poor/Non Compliance|0|||
163018898|NCT02477826|588772706|FG009|Treatment Period|Poor/Non Compliance|1|||
163018899|NCT02477826|588772697|FG000|Treatment Period|Maximum Clinical Benefit|3|||
163063248|NCT03314935|588938620|FG003|Phase 1|"Captured as Other in Database"|0|||
163018900|NCT02477826|588772698|FG001|Treatment Period|Maximum Clinical Benefit|3|||
163018901|NCT02477826|588772699|FG002|Treatment Period|Maximum Clinical Benefit|1|||
163018902|NCT02477826|588772700|FG003|Treatment Period|Maximum Clinical Benefit|1|||
163018903|NCT02477826|588772701|FG004|Treatment Period|Maximum Clinical Benefit|3|||
163018904|NCT02477826|588772702|FG005|Treatment Period|Maximum Clinical Benefit|0|||
163018905|NCT02477826|588772703|FG006|Treatment Period|Maximum Clinical Benefit|3|||
163018906|NCT02477826|588772704|FG007|Treatment Period|Maximum Clinical Benefit|2|||
163018907|NCT02477826|588772705|FG008|Treatment Period|Maximum Clinical Benefit|2|||
163018908|NCT02477826|588772706|FG009|Treatment Period|Maximum Clinical Benefit|2|||
163018909|NCT02477826|588772697|FG000|Treatment Period|Lost to Follow-up|0|||
163018910|NCT02477826|588772698|FG001|Treatment Period|Lost to Follow-up|0|||
163018911|NCT02477826|588772699|FG002|Treatment Period|Lost to Follow-up|1|||
163018912|NCT02477826|588772700|FG003|Treatment Period|Lost to Follow-up|1|||
163018913|NCT02477826|588772701|FG004|Treatment Period|Lost to Follow-up|0|||
163018914|NCT02477826|588772702|FG005|Treatment Period|Lost to Follow-up|0|||
163018915|NCT02477826|588772703|FG006|Treatment Period|Lost to Follow-up|2|||
163018916|NCT02477826|588772704|FG007|Treatment Period|Lost to Follow-up|2|||
163018917|NCT02477826|588772705|FG008|Treatment Period|Lost to Follow-up|0|||
163018918|NCT02477826|588772706|FG009|Treatment Period|Lost to Follow-up|0|||
163018919|NCT02477826|588772697|FG000|Treatment Period|Participant withdrew Consent|5|||
163018920|NCT02477826|588772698|FG001|Treatment Period|Participant withdrew Consent|5|||
163018921|NCT02477826|588772699|FG002|Treatment Period|Participant withdrew Consent|3|||
163018922|NCT02477826|588772700|FG003|Treatment Period|Participant withdrew Consent|3|||
163018923|NCT02477826|588772701|FG004|Treatment Period|Participant withdrew Consent|1|||
163018924|NCT02477826|588772702|FG005|Treatment Period|Participant withdrew Consent|3|||
163018925|NCT02477826|588772703|FG006|Treatment Period|Participant withdrew Consent|3|||
163018926|NCT02477826|588772704|FG007|Treatment Period|Participant withdrew Consent|3|||
163018927|NCT02477826|588772705|FG008|Treatment Period|Participant withdrew Consent|2|||
163018928|NCT02477826|588772706|FG009|Treatment Period|Participant withdrew Consent|3|||
163018929|NCT02477826|588772697|FG000|Treatment Period|Participant request to discontinue treatment|5|||
163018930|NCT02477826|588772698|FG001|Treatment Period|Participant request to discontinue treatment|3|||
163018931|NCT02477826|588772699|FG002|Treatment Period|Participant request to discontinue treatment|15|||
163018932|NCT02477826|588772700|FG003|Treatment Period|Participant request to discontinue treatment|5|||
163018933|NCT02477826|588772701|FG004|Treatment Period|Participant request to discontinue treatment|3|||
163018934|NCT02477826|588772702|FG005|Treatment Period|Participant request to discontinue treatment|6|||
163018935|NCT02477826|588772703|FG006|Treatment Period|Participant request to discontinue treatment|13|||
163018936|NCT02477826|588772704|FG007|Treatment Period|Participant request to discontinue treatment|15|||
163018937|NCT02477826|588772705|FG008|Treatment Period|Participant request to discontinue treatment|4|||
163018938|NCT02477826|588772706|FG009|Treatment Period|Participant request to discontinue treatment|18|||
163018939|NCT02477826|588772697|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
163018940|NCT02477826|588772698|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
163018941|NCT02477826|588772699|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
163018942|NCT02477826|588772700|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
163018943|NCT02477826|588772701|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
163018944|NCT02477826|588772702|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
163018945|NCT02477826|588772703|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
163018946|NCT02477826|588772704|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
163018947|NCT02477826|588772705|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
163018948|NCT02477826|588772706|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
163018949|NCT02477826|588772697|FG000|Treatment Period|Death|4|||
163018950|NCT02477826|588772698|FG001|Treatment Period|Death|7|||
163018951|NCT02477826|588772699|FG002|Treatment Period|Death|0|||
163018952|NCT02477826|588772700|FG003|Treatment Period|Death|0|||
163018953|NCT02477826|588772701|FG004|Treatment Period|Death|1|||
163018954|NCT02477826|588772702|FG005|Treatment Period|Death|2|||
163018955|NCT02477826|588772703|FG006|Treatment Period|Death|6|||
163063249|NCT03314935|588938621|FG004|Phase 1|"Captured as Other in Database"|0|||
163063250|NCT03314935|588938622|FG005|Phase 1|"Captured as Other in Database"|0|||
163063251|NCT03314935|588938623|FG006|Phase 1|"Captured as Other in Database"|1|||
163063252|NCT03314935|588938624|FG007|Phase 1|"Captured as Other in Database"|1|||
163063253|NCT03314935|588938625|FG008|Phase 1|"Captured as Other in Database"|1|||
163063254|NCT03314935|588938626|FG009|Phase 1|"Captured as Other in Database"|0|||
163063255|NCT03314935|588938627|FG010|Phase 1|"Captured as Other in Database"|0|||
163063256|NCT03314935|588938628|FG011|Phase 1|"Captured as Other in Database"|0|||
163018956|NCT02477826|588772704|FG007|Treatment Period|Death|5|||
163018957|NCT02477826|588772705|FG008|Treatment Period|Death|9|||
163018958|NCT02477826|588772706|FG009|Treatment Period|Death|0|||
163018959|NCT02477826|588772697|FG000|Treatment Period|Study Drug Toxicity|79|||
163018960|NCT02477826|588772698|FG001|Treatment Period|Study Drug Toxicity|51|||
163018961|NCT02477826|588772699|FG002|Treatment Period|Study Drug Toxicity|31|||
163018962|NCT02477826|588772700|FG003|Treatment Period|Study Drug Toxicity|39|||
163018963|NCT02477826|588772701|FG004|Treatment Period|Study Drug Toxicity|12|||
163063257|NCT03314935|588938629|FG012|Phase 1|"Captured as Other in Database"|0|||
163018964|NCT02477826|588772702|FG005|Treatment Period|Study Drug Toxicity|25|||
163018965|NCT02477826|588772703|FG006|Treatment Period|Study Drug Toxicity|52|||
163018966|NCT02477826|588772704|FG007|Treatment Period|Study Drug Toxicity|30|||
163018967|NCT02477826|588772705|FG008|Treatment Period|Study Drug Toxicity|20|||
163018968|NCT02477826|588772706|FG009|Treatment Period|Study Drug Toxicity|9|||
163018969|NCT02477826|588772697|FG000|Treatment Period|Disease progression|212|||
163018970|NCT02477826|588772698|FG001|Treatment Period|Disease progression|240|||
163018971|NCT02477826|588772699|FG002|Treatment Period|Disease progression|202|||
163018972|NCT02477826|588772700|FG003|Treatment Period|Disease progression|93|||
163018973|NCT02477826|588772701|FG004|Treatment Period|Disease progression|113|||
163018974|NCT02477826|588772702|FG005|Treatment Period|Disease progression|96|||
163018975|NCT02477826|588772703|FG006|Treatment Period|Disease progression|208|||
163018976|NCT02477826|588772704|FG007|Treatment Period|Disease progression|195|||
163018977|NCT02477826|588772705|FG008|Treatment Period|Disease progression|59|||
163018978|NCT02477826|588772706|FG009|Treatment Period|Disease progression|46|||
163018979|NCT02477826|588772697|FG000|Treatment Period|Pregnancy|0|||
163018980|NCT02477826|588772698|FG001|Treatment Period|Pregnancy|0|||
163018981|NCT02477826|588772699|FG002|Treatment Period|Pregnancy|0|||
163018982|NCT02477826|588772700|FG003|Treatment Period|Pregnancy|0|||
163018983|NCT02477826|588772701|FG004|Treatment Period|Pregnancy|0|||
163018984|NCT02477826|588772702|FG005|Treatment Period|Pregnancy|0|||
163018985|NCT02477826|588772703|FG006|Treatment Period|Pregnancy|0|||
163018986|NCT02477826|588772704|FG007|Treatment Period|Pregnancy|0|||
163018987|NCT02477826|588772705|FG008|Treatment Period|Pregnancy|0|||
163018988|NCT02477826|588772706|FG009|Treatment Period|Pregnancy|1|||
163018989|NCT02477826|588772697|FG000|Treatment Period|Other|0|||
163018990|NCT02477826|588772698|FG001|Treatment Period|Other|0|||
163018991|NCT02477826|588772699|FG002|Treatment Period|Other|0|||
163018992|NCT02477826|588772700|FG003|Treatment Period|Other|0|||
163018993|NCT02477826|588772701|FG004|Treatment Period|Other|0|||
163018994|NCT02477826|588772702|FG005|Treatment Period|Other|0|||
163018995|NCT02477826|588772703|FG006|Treatment Period|Other|0|||
163018996|NCT02477826|588772704|FG007|Treatment Period|Other|0|||
163018997|NCT02477826|588772705|FG008|Treatment Period|Other|0|||
163018998|NCT02477826|588772706|FG009|Treatment Period|Other|1|||
163018999|NCT00364923|588772740|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
163019000|NCT00364923|588772740|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
163019001|NCT01218087|588772755|FG000|Overall Study|Death|2|||
163019002|NCT01218087|588772756|FG001|Overall Study|Death|1|||
163019003|NCT01218087|588772755|FG000|Overall Study|Withdrawal by Subject|5|||
163019004|NCT01218087|588772756|FG001|Overall Study|Withdrawal by Subject|0|||
163019005|NCT01218087|588772755|FG000|Overall Study|Transferred|8|||
163019006|NCT01218087|588772756|FG001|Overall Study|Transferred|5|||
163019007|NCT03170362|588772757|FG000|Overall Study|Death|2|||
163019008|NCT03170362|588772758|FG001|Overall Study|Death|2|||
163019009|NCT03170362|588772757|FG000|Overall Study|Withdrawal by Subject|23|||
163019010|NCT03170362|588772758|FG001|Overall Study|Withdrawal by Subject|22|||
163019011|NCT03170362|588772757|FG000|Overall Study|Lost to Follow-up|187|||
163019012|NCT03170362|588772758|FG001|Overall Study|Lost to Follow-up|167|||
163019013|NCT00552396|588772759|FG000|Overall Study|protocol withdrawal criteria|3|||
163019014|NCT00552396|588772760|FG001|Overall Study|protocol withdrawal criteria|3|||
163019015|NCT00552396|588772761|FG002|Overall Study|protocol withdrawal criteria|3|||
163019016|NCT00552396|588772762|FG003|Overall Study|protocol withdrawal criteria|6|||
163019017|NCT00552396|588772763|FG004|Overall Study|protocol withdrawal criteria|3|||
163019018|NCT00552396|588772764|FG005|Overall Study|protocol withdrawal criteria|3|||
163019019|NCT00552396|588772765|FG006|Overall Study|protocol withdrawal criteria|9|||
163019020|NCT03340454|588772766|FG000|Overall Study|Lost to Follow-up|0|||
163019021|NCT03340454|588772767|FG001|Overall Study|Lost to Follow-up|4|||
163019022|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Death|1|||
163019023|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Death|0|||
163019024|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
163019025|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
163019026|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
163019027|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
163019028|NCT01972438|588772768|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
163019029|NCT01972438|588772769|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
163019030|NCT01972438|588772768|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
163019031|NCT01972438|588772769|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
163019032|NCT01972438|588772768|FG000|Months 6-12 Study Period|Death|1|||
163019033|NCT01972438|588772769|FG001|Months 6-12 Study Period|Death|0|||
163019034|NCT01972438|588772768|FG000|Months 6-12 Study Period|Early Study Closure|2|||
163019035|NCT01972438|588772769|FG001|Months 6-12 Study Period|Early Study Closure|2|||
163019036|NCT01972438|588772768|FG000|Post Month 12 Study Period|Early Study Closure|3|||
163019037|NCT01972438|588772769|FG001|Post Month 12 Study Period|Early Study Closure|4|||
163019038|NCT00697463|588772775|FG000|Overall Study|Withdrawal by Subject|1|||
163019039|NCT02568189|588772776|FG000|Overall Study|Protocol Violation|0|||
163019040|NCT02568189|588772777|FG001|Overall Study|Protocol Violation|0|||
163019041|NCT02568189|588772778|FG002|Overall Study|Protocol Violation|19|||
163019042|NCT02568189|588772779|FG003|Overall Study|Protocol Violation|18|||
163019043|NCT00529373|588772780|FG000|Base Study|Adverse Event|525|||
163019044|NCT00529373|588772781|FG001|Base Study|Adverse Event|470|||
163019045|NCT00529373|588772780|FG000|Base Study|Lack of Efficacy|16|||
163019046|NCT00529373|588772781|FG001|Base Study|Lack of Efficacy|75|||
163019047|NCT00529373|588772780|FG000|Base Study|Lost to Follow-up|221|||
163019048|NCT00529373|588772781|FG001|Base Study|Lost to Follow-up|208|||
163019049|NCT00529373|588772780|FG000|Base Study|Other Protocol Specified Criteria|19|||
163019050|NCT00529373|588772781|FG001|Base Study|Other Protocol Specified Criteria|20|||
163019051|NCT00529373|588772780|FG000|Base Study|Physician Decision|60|||
163019052|NCT00529373|588772781|FG001|Base Study|Physician Decision|52|||
163019053|NCT00529373|588772780|FG000|Base Study|Protocol Violation|48|||
163019054|NCT00529373|588772781|FG001|Base Study|Protocol Violation|38|||
163019055|NCT00529373|588772780|FG000|Base Study|Withdrawal by Subject|1062|||
163019056|NCT00529373|588772781|FG001|Base Study|Withdrawal by Subject|967|||
163019057|NCT00529373|588772780|FG000|Base Study|Did not continue into Extension|1795|||
163019058|NCT00529373|588772781|FG001|Base Study|Did not continue into Extension|2238|||
163019059|NCT00529373|588772780|FG000|First Extension Study|Adverse Event|162|||
163019060|NCT00529373|588772781|FG001|First Extension Study|Adverse Event|142|||
163019061|NCT00529373|588772780|FG000|First Extension Study|Lack of Efficacy|65|||
163019062|NCT00529373|588772781|FG001|First Extension Study|Lack of Efficacy|427|||
163019063|NCT00529373|588772780|FG000|First Extension Study|Lost to Follow-up|41|||
163019064|NCT00529373|588772781|FG001|First Extension Study|Lost to Follow-up|37|||
163019065|NCT00529373|588772780|FG000|First Extension Study|Other|27|||
163019066|NCT00529373|588772781|FG001|First Extension Study|Other|47|||
163019067|NCT00529373|588772780|FG000|First Extension Study|Physician Decision|50|||
163019068|NCT00529373|588772781|FG001|First Extension Study|Physician Decision|45|||
163019069|NCT00529373|588772780|FG000|First Extension Study|Protocol Violation|16|||
163019070|NCT00529373|588772781|FG001|First Extension Study|Protocol Violation|13|||
163019071|NCT00529373|588772780|FG000|First Extension Study|Withdrawal by Subject|296|||
163019072|NCT00529373|588772781|FG001|First Extension Study|Withdrawal by Subject|287|||
163019073|NCT00529373|588772780|FG000|First Extension Study|Disposition record non-existing|0|||
163019074|NCT00529373|588772781|FG001|First Extension Study|Disposition record non-existing|1|||
163019075|NCT00529373|588772780|FG000|First Extension Study|Discontinued after 5 years completion|208|||
163019076|NCT00529373|588772781|FG001|First Extension Study|Discontinued after 5 years completion|346|||
163019077|NCT00529373|588772780|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
163019078|NCT00529373|588772781|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
163019079|NCT00529373|588772780|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
163019080|NCT00529373|588772781|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
163019081|NCT00529373|588772780|FG000|Second Extension Study|Adverse Event|101|||
163019082|NCT00529373|588772781|FG001|Second Extension Study|Adverse Event|51|||
163019083|NCT00529373|588772780|FG000|Second Extension Study|Lack of Efficacy|7|||
163019084|NCT00529373|588772781|FG001|Second Extension Study|Lack of Efficacy|15|||
163019085|NCT00529373|588772780|FG000|Second Extension Study|Lost to Follow-up|18|||
163019086|NCT00529373|588772781|FG001|Second Extension Study|Lost to Follow-up|12|||
163019087|NCT00529373|588772780|FG000|Second Extension Study|Other|7|||
163019088|NCT00529373|588772781|FG001|Second Extension Study|Other|12|||
163019089|NCT00529373|588772780|FG000|Second Extension Study|Physician Decision|63|||
163019090|NCT00529373|588772781|FG001|Second Extension Study|Physician Decision|26|||
163019091|NCT00529373|588772780|FG000|Second Extension Study|Protocol Violation|2|||
163019092|NCT00529373|588772781|FG001|Second Extension Study|Protocol Violation|1|||
163019093|NCT00529373|588772780|FG000|Second Extension Study|Withdrawal by Subject|97|||
163019094|NCT00529373|588772781|FG001|Second Extension Study|Withdrawal by Subject|75|||
163019095|NCT00529373|588772780|FG000|Second Extension Study|Status Missing|5|||
163019096|NCT00529373|588772781|FG001|Second Extension Study|Status Missing|5|||
163019097|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
163019098|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
163019099|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
163019100|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
163019101|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
163019102|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
163019103|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
163019104|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
163019105|NCT01074268|588772784|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
163019106|NCT01074268|588772785|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
163019107|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
163019108|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
163019109|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
163019110|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
163019111|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
163019112|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
163019113|NCT01074268|588772784|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
163019114|NCT01074268|588772785|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
163019115|NCT00603473|588772790|FG000|Overall Study|Adverse Event|4|||
163019116|NCT00603473|588772790|FG000|Overall Study|Lack of Efficacy|4|||
163019117|NCT00603473|588772790|FG000|Overall Study|Protocol Violation|1|||
163019118|NCT01134939|588772794|FG000|Overall Study|Adverse Event|9|||
163019119|NCT01134939|588772795|FG001|Overall Study|Adverse Event|3|||
163019120|NCT01134939|588772796|FG002|Overall Study|Adverse Event|4|||
163063258|NCT03314935|588938630|FG013|Phase 1|"Captured as Other in Database"|0|||
163063259|NCT03314935|588938631|FG014|Phase 1|"Captured as Other in Database"|0|||
163019121|NCT01134939|588772797|FG003|Overall Study|Adverse Event|5|||
163019122|NCT01134939|588772798|FG004|Overall Study|Adverse Event|5|||
163019123|NCT01134939|588772799|FG005|Overall Study|Adverse Event|5|||
163019124|NCT01134939|588772800|FG006|Overall Study|Adverse Event|1|||
163019125|NCT01134939|588772801|FG007|Overall Study|Adverse Event|0|||
163019126|NCT01134939|588772794|FG000|Overall Study|Lack of Efficacy|2|||
163019127|NCT01134939|588772795|FG001|Overall Study|Lack of Efficacy|5|||
163019128|NCT01134939|588772796|FG002|Overall Study|Lack of Efficacy|1|||
163019129|NCT01134939|588772797|FG003|Overall Study|Lack of Efficacy|0|||
163019130|NCT01134939|588772798|FG004|Overall Study|Lack of Efficacy|3|||
163019131|NCT01134939|588772799|FG005|Overall Study|Lack of Efficacy|0|||
163019132|NCT01134939|588772800|FG006|Overall Study|Lack of Efficacy|1|||
163019133|NCT01134939|588772801|FG007|Overall Study|Lack of Efficacy|0|||
163019134|NCT01134939|588772794|FG000|Overall Study|Lost to Follow-up|2|||
163019135|NCT01134939|588772795|FG001|Overall Study|Lost to Follow-up|3|||
163019136|NCT01134939|588772796|FG002|Overall Study|Lost to Follow-up|0|||
163019137|NCT01134939|588772797|FG003|Overall Study|Lost to Follow-up|1|||
163019138|NCT01134939|588772798|FG004|Overall Study|Lost to Follow-up|2|||
163019139|NCT01134939|588772799|FG005|Overall Study|Lost to Follow-up|1|||
163019140|NCT01134939|588772800|FG006|Overall Study|Lost to Follow-up|0|||
163019141|NCT01134939|588772801|FG007|Overall Study|Lost to Follow-up|0|||
163019142|NCT01134939|588772794|FG000|Overall Study|Death|0|||
163019143|NCT01134939|588772795|FG001|Overall Study|Death|1|||
163019144|NCT01134939|588772796|FG002|Overall Study|Death|0|||
163019145|NCT01134939|588772797|FG003|Overall Study|Death|0|||
163019146|NCT01134939|588772798|FG004|Overall Study|Death|0|||
163019147|NCT01134939|588772799|FG005|Overall Study|Death|0|||
163019148|NCT01134939|588772800|FG006|Overall Study|Death|0|||
163019149|NCT01134939|588772801|FG007|Overall Study|Death|0|||
163019150|NCT01134939|588772794|FG000|Overall Study|Termination page not available|4|||
163019151|NCT01134939|588772795|FG001|Overall Study|Termination page not available|6|||
163019152|NCT01134939|588772796|FG002|Overall Study|Termination page not available|5|||
163019153|NCT01134939|588772797|FG003|Overall Study|Termination page not available|8|||
163019154|NCT01134939|588772798|FG004|Overall Study|Termination page not available|0|||
163019155|NCT01134939|588772799|FG005|Overall Study|Termination page not available|3|||
163019156|NCT01134939|588772800|FG006|Overall Study|Termination page not available|7|||
163019157|NCT01134939|588772801|FG007|Overall Study|Termination page not available|0|||
163019158|NCT03225105|588772802|FG000|Overall Study|Withdrawal by Subject|1|||
163019159|NCT03225105|588772803|FG001|Overall Study|Withdrawal by Subject|0|||
163019160|NCT03225105|588772804|FG002|Overall Study|Withdrawal by Subject|0|||
163019161|NCT03225105|588772805|FG003|Overall Study|Withdrawal by Subject|0|||
163019162|NCT03225105|588772802|FG000|Overall Study|Death|0|||
163019163|NCT03225105|588772803|FG001|Overall Study|Death|4|||
163019164|NCT03225105|588772804|FG002|Overall Study|Death|2|||
163019165|NCT03225105|588772805|FG003|Overall Study|Death|0|||
163019166|NCT03225105|588772802|FG000|Overall Study|Study termination per Sponsor Decision|2|||
163019167|NCT03225105|588772803|FG001|Overall Study|Study termination per Sponsor Decision|0|||
163019168|NCT03225105|588772804|FG002|Overall Study|Study termination per Sponsor Decision|3|||
163019169|NCT03225105|588772805|FG003|Overall Study|Study termination per Sponsor Decision|3|||
163019170|NCT05488470|588774356|FG000|Overall Study|Physician Decision|2|||
163019171|NCT05488470|588774356|FG000|Overall Study|Withdrawal by Subject|1|||
163019172|NCT05488470|588774356|FG000|Overall Study|Death|1|||
163019173|NCT01736397|588774357|FG000|Overall Study|Lack of Efficacy|1|||
163019174|NCT01736397|588774358|FG001|Overall Study|Lack of Efficacy|11|||
163019175|NCT01736397|588774357|FG000|Overall Study|Withdrawal by Subject|6|||
163019176|NCT01736397|588774358|FG001|Overall Study|Withdrawal by Subject|5|||
163019177|NCT01736397|588774357|FG000|Overall Study|Lost to Follow-up|0|||
163019178|NCT01736397|588774358|FG001|Overall Study|Lost to Follow-up|1|||
163019179|NCT01736397|588774357|FG000|Overall Study|Adverse Event|6|||
163019180|NCT01736397|588774358|FG001|Overall Study|Adverse Event|3|||
163019181|NCT01736397|588774357|FG000|Overall Study|Not stated|1|||
163019182|NCT01736397|588774358|FG001|Overall Study|Not stated|4|||
163019183|NCT01868438|588774359|FG000|First Intervention|Withdrawal by Subject|5|||
163019184|NCT01868438|588774360|FG001|First Intervention|Withdrawal by Subject|1|||
163019185|NCT01868438|588774359|FG000|First Intervention|Lost to Follow-up|2|||
163019186|NCT01868438|588774360|FG001|First Intervention|Lost to Follow-up|3|||
163019187|NCT01868438|588774359|FG000|First Intervention|Meeting the non-redosing criteria|0|||
163019188|NCT01868438|588774360|FG001|First Intervention|Meeting the non-redosing criteria|1|||
163019189|NCT01868438|588774359|FG000|Second Intervention|Adverse Event|3|||
163019190|NCT01868438|588774360|FG001|Second Intervention|Adverse Event|3|||
163019191|NCT01284348|588774361|FG000|Overall Study|Death|1|||
163019192|NCT01284348|588774362|FG001|Overall Study|Death|1|||
163019193|NCT01284348|588774361|FG000|Overall Study|Withdrew consent|0|||
163019194|NCT01284348|588774362|FG001|Overall Study|Withdrew consent|1|||
163019195|NCT01284348|588774361|FG000|Overall Study|Status not recorded|9|||
163019196|NCT01284348|588774362|FG001|Overall Study|Status not recorded|10|||
163019197|NCT02347774|588774363|FG000|Study Participation|Lost to Follow-up|3|||
163019198|NCT02347774|588774364|FG001|Study Participation|Lost to Follow-up|6|||
163019199|NCT02347774|588774365|FG002|Study Participation|Lost to Follow-up|2|||
163019200|NCT02347774|588774363|FG000|Study Participation|Withdrawal by Subject|8|||
163019201|NCT02347774|588774364|FG001|Study Participation|Withdrawal by Subject|9|||
163019202|NCT02347774|588774365|FG002|Study Participation|Withdrawal by Subject|15|||
163019203|NCT02347774|588774363|FG000|Study Participation|Adverse Event|1|||
163019204|NCT02347774|588774364|FG001|Study Participation|Adverse Event|4|||
163019205|NCT02347774|588774365|FG002|Study Participation|Adverse Event|6|||
163019206|NCT02347774|588774363|FG000|Study Participation|withdrew consent|1|||
163019207|NCT02347774|588774364|FG001|Study Participation|withdrew consent|1|||
163019208|NCT02347774|588774365|FG002|Study Participation|withdrew consent|1|||
163019209|NCT02347774|588774363|FG000|Study Participation|Met Prolonged QT criteria|1|||
163019210|NCT02347774|588774364|FG001|Study Participation|Met Prolonged QT criteria|0|||
163019211|NCT02347774|588774365|FG002|Study Participation|Met Prolonged QT criteria|0|||
163019212|NCT02347774|588774363|FG000|Study Participation|non-compliance with study drug|0|||
163019213|NCT02347774|588774364|FG001|Study Participation|non-compliance with study drug|1|||
163019214|NCT02347774|588774365|FG002|Study Participation|non-compliance with study drug|0|||
163019215|NCT02347774|588774363|FG000|Study Participation|incarceration|1|||
163019216|NCT02347774|588774364|FG001|Study Participation|incarceration|0|||
163019217|NCT02347774|588774365|FG002|Study Participation|incarceration|0|||
163019218|NCT02347774|588774363|FG000|Study Participation|randomized in error|0|||
163019219|NCT02347774|588774364|FG001|Study Participation|randomized in error|0|||
163019220|NCT02347774|588774365|FG002|Study Participation|randomized in error|1|||
163019221|NCT02347774|588774363|FG000|On Study Treatment|Adverse Event|9|||
163019222|NCT02347774|588774364|FG001|On Study Treatment|Adverse Event|15|||
163019223|NCT02347774|588774365|FG002|On Study Treatment|Adverse Event|19|||
163019224|NCT02347774|588774363|FG000|On Study Treatment|Lack of Efficacy|3|||
163019225|NCT02347774|588774364|FG001|On Study Treatment|Lack of Efficacy|0|||
163019226|NCT02347774|588774365|FG002|On Study Treatment|Lack of Efficacy|2|||
163019227|NCT02347774|588774363|FG000|On Study Treatment|non-complicance with study medication|0|||
163019228|NCT02347774|588774364|FG001|On Study Treatment|non-complicance with study medication|2|||
163019229|NCT02347774|588774365|FG002|On Study Treatment|non-complicance with study medication|0|||
163019230|NCT02347774|588774363|FG000|On Study Treatment|Protocol Violation|0|||
163019231|NCT02347774|588774364|FG001|On Study Treatment|Protocol Violation|0|||
163019232|NCT02347774|588774365|FG002|On Study Treatment|Protocol Violation|1|||
163019233|NCT02347774|588774363|FG000|On Study Treatment|withdrew consent|9|||
163019234|NCT02347774|588774364|FG001|On Study Treatment|withdrew consent|8|||
163019235|NCT02347774|588774365|FG002|On Study Treatment|withdrew consent|12|||
163019236|NCT02347774|588774363|FG000|On Study Treatment|Lost to Follow-up|2|||
163019237|NCT02347774|588774364|FG001|On Study Treatment|Lost to Follow-up|6|||
163019238|NCT02347774|588774365|FG002|On Study Treatment|Lost to Follow-up|1|||
163019239|NCT02347774|588774363|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
163019240|NCT02347774|588774364|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
163019241|NCT02347774|588774365|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
163019242|NCT02347774|588774363|FG000|On Study Treatment|ranomized in error|0|||
163019243|NCT02347774|588774364|FG001|On Study Treatment|ranomized in error|0|||
163019244|NCT02347774|588774365|FG002|On Study Treatment|ranomized in error|1|||
163019245|NCT04075682|588774368|FG000|Overall Study|Lost to Follow-up|5|||
163019246|NCT04075682|588774369|FG001|Overall Study|Lost to Follow-up|5|||
163019247|NCT04075682|588774370|FG002|Overall Study|Lost to Follow-up|2|||
163019248|NCT04075682|588774371|FG003|Overall Study|Lost to Follow-up|2|||
163019249|NCT04075682|588774368|FG000|Overall Study|Withdrawal by Subject|1|||
163019250|NCT04075682|588774369|FG001|Overall Study|Withdrawal by Subject|0|||
163019251|NCT04075682|588774370|FG002|Overall Study|Withdrawal by Subject|1|||
163019252|NCT04075682|588774371|FG003|Overall Study|Withdrawal by Subject|0|||
163019253|NCT04075682|588774368|FG000|Overall Study|Protocol Violation|0|||
163019254|NCT04075682|588774369|FG001|Overall Study|Protocol Violation|1|||
163019255|NCT04075682|588774370|FG002|Overall Study|Protocol Violation|1|||
163019256|NCT04075682|588774371|FG003|Overall Study|Protocol Violation|0|||
163019257|NCT04075682|588774368|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
163019258|NCT04075682|588774369|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
163019259|NCT04075682|588774370|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
163019260|NCT04075682|588774371|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
163019261|NCT04075682|588774368|FG000|Overall Study|Lost study phone the first day of study participation|0|||
163019262|NCT04075682|588774369|FG001|Overall Study|Lost study phone the first day of study participation|1|||
163019263|NCT04075682|588774370|FG002|Overall Study|Lost study phone the first day of study participation|0|||
163063260|NCT03314935|588938617|FG000|Phase 1|Lost to Follow-up|0|||
163019264|NCT04075682|588774371|FG003|Overall Study|Lost study phone the first day of study participation|0|||
163063261|NCT03314935|588938618|FG001|Phase 1|Lost to Follow-up|0|||
163019265|NCT00954941|588774372|FG000|Overall Study|Received treatment at home|1|||
163019266|NCT00954941|588774373|FG001|Overall Study|Received treatment at home|0|||
163019267|NCT00954941|588774372|FG000|Overall Study|Withdrawal by Subject|1|||
163019268|NCT00954941|588774373|FG001|Overall Study|Withdrawal by Subject|0|||
163019269|NCT00954941|588774372|FG000|Overall Study|Insurance Denial|2|||
163019270|NCT00954941|588774373|FG001|Overall Study|Insurance Denial|2|||
163019271|NCT00954941|588774372|FG000|Overall Study|Physician Decision|2|||
163019272|NCT00954941|588774373|FG001|Overall Study|Physician Decision|2|||
163019273|NCT00954941|588774372|FG000|Overall Study|Ineligible|2|||
163019274|NCT00954941|588774373|FG001|Overall Study|Ineligible|2|||
163019275|NCT00954941|588774372|FG000|Overall Study|Adverse Event|0|||
163019276|NCT00954941|588774373|FG001|Overall Study|Adverse Event|1|||
163019277|NCT00955955|588774374|FG000|Overall Study|Lost to Follow-up|2|||
163019278|NCT00955955|588774375|FG001|Overall Study|Lost to Follow-up|0|||
163019279|NCT00955955|588774376|FG002|Overall Study|Lost to Follow-up|0|||
163019280|NCT03423173|588774380|FG000|Overall Study|Randomized but not vaccinated|1|||
163019281|NCT03423173|588774381|FG001|Overall Study|Randomized but not vaccinated|0|||
163019282|NCT03423173|588774382|FG002|Overall Study|Randomized but not vaccinated|2|||
163019283|NCT03423173|588774383|FG003|Overall Study|Randomized but not vaccinated|1|||
163019284|NCT03423173|588774380|FG000|Overall Study|Adverse Event|1|||
163019285|NCT03423173|588774381|FG001|Overall Study|Adverse Event|1|||
163019286|NCT03423173|588774382|FG002|Overall Study|Adverse Event|1|||
163019287|NCT03423173|588774383|FG003|Overall Study|Adverse Event|1|||
163019288|NCT03423173|588774380|FG000|Overall Study|Lost to Follow-up|10|||
163019289|NCT03423173|588774381|FG001|Overall Study|Lost to Follow-up|19|||
163019290|NCT03423173|588774382|FG002|Overall Study|Lost to Follow-up|17|||
163019291|NCT03423173|588774383|FG003|Overall Study|Lost to Follow-up|22|||
163019292|NCT03423173|588774380|FG000|Overall Study|Withdrawal of consent|4|||
163019293|NCT03423173|588774381|FG001|Overall Study|Withdrawal of consent|10|||
163019294|NCT03423173|588774382|FG002|Overall Study|Withdrawal of consent|4|||
163019295|NCT03423173|588774383|FG003|Overall Study|Withdrawal of consent|5|||
163019296|NCT03423173|588774380|FG000|Overall Study|Death|1|||
163019297|NCT03423173|588774381|FG001|Overall Study|Death|0|||
163019298|NCT03423173|588774382|FG002|Overall Study|Death|0|||
163019299|NCT03423173|588774383|FG003|Overall Study|Death|0|||
163019300|NCT03423173|588774380|FG000|Overall Study|Reason not Specified|2|||
163019301|NCT03423173|588774381|FG001|Overall Study|Reason not Specified|5|||
163019302|NCT03423173|588774382|FG002|Overall Study|Reason not Specified|3|||
163019303|NCT03423173|588774383|FG003|Overall Study|Reason not Specified|1|||
163019304|NCT02071706|588774384|FG000|Overall Study|Adverse Event|1|||
163019305|NCT02071706|588774384|FG000|Overall Study|Withdrawal by Subject|2|||
163019306|NCT02247440|588774385|FG000|Overall Study|Withdrawal by Subject|1|||
163019307|NCT02247440|588774385|FG000|Overall Study|Lack of Efficacy|3|||
163019308|NCT00729157|588774386|FG000|Overall Study|Withdrawal by Subject|1|||
163019309|NCT01062113|588774387|FG000|Overall Study|Adverse Event|1|||
163019310|NCT01062113|588774388|FG001|Overall Study|Adverse Event|0|||
163019311|NCT01062113|588774389|FG002|Overall Study|Adverse Event|0|||
163019312|NCT01062113|588774387|FG000|Overall Study|Lack of Efficacy|38|||
163019313|NCT01062113|588774388|FG001|Overall Study|Lack of Efficacy|22|||
163019314|NCT01062113|588774389|FG002|Overall Study|Lack of Efficacy|31|||
163019315|NCT01062113|588774387|FG000|Overall Study|Withdrawal by Subject|1|||
163019316|NCT01062113|588774388|FG001|Overall Study|Withdrawal by Subject|0|||
163019317|NCT01062113|588774389|FG002|Overall Study|Withdrawal by Subject|0|||
163019318|NCT03499899|588774390|FG000|Overall Study|Adverse Event|2|||
163019319|NCT03499899|588774391|FG001|Overall Study|Adverse Event|3|||
163019320|NCT03499899|588774392|FG002|Overall Study|Adverse Event|3|||
163019321|NCT03499899|588774390|FG000|Overall Study|Death|0|||
163019322|NCT03499899|588774391|FG001|Overall Study|Death|0|||
163019323|NCT03499899|588774392|FG002|Overall Study|Death|1|||
163019324|NCT03499899|588774390|FG000|Overall Study|Physician Decision|3|||
163019325|NCT03499899|588774391|FG001|Overall Study|Physician Decision|6|||
162641446|NCT04128267|587401605|FG000|Overall Study|Disease progression|1|||
163019326|NCT03499899|588774392|FG002|Overall Study|Physician Decision|6|||
163019327|NCT03499899|588774390|FG000|Overall Study|Progressive disease|15|||
163019328|NCT03499899|588774391|FG001|Overall Study|Progressive disease|23|||
163019329|NCT03499899|588774392|FG002|Overall Study|Progressive disease|23|||
163019330|NCT03499899|588774390|FG000|Overall Study|Patient decision|0|||
163019331|NCT03499899|588774391|FG001|Overall Study|Patient decision|1|||
163019332|NCT03499899|588774392|FG002|Overall Study|Patient decision|1|||
163019333|NCT03499899|588774390|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
163019334|NCT03499899|588774391|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
163019335|NCT03499899|588774392|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
163019336|NCT03655470|588774393|FG000|Overall Study|Lost to Follow-up|6|||
163019337|NCT03655470|588774394|FG001|Overall Study|Lost to Follow-up|7|||
163019338|NCT03063086|588774395|FG000|Overall Study|technical problems|1|||
163019339|NCT03063086|588774396|FG001|Overall Study|technical problems|0|||
163019340|NCT03063086|588774397|FG002|Overall Study|technical problems|0|||
163019341|NCT03063086|588774398|FG003|Overall Study|technical problems|0|||
163019342|NCT03063086|588774399|FG004|Overall Study|technical problems|0|||
163019343|NCT03063086|588774400|FG005|Overall Study|technical problems|0|||
163019344|NCT03063086|588774395|FG000|Overall Study|Adverse Event|1|||
163019345|NCT03063086|588774396|FG001|Overall Study|Adverse Event|1|||
163019346|NCT03063086|588774397|FG002|Overall Study|Adverse Event|1|||
163019347|NCT03063086|588774398|FG003|Overall Study|Adverse Event|1|||
163019348|NCT03063086|588774399|FG004|Overall Study|Adverse Event|0|||
163019349|NCT03063086|588774400|FG005|Overall Study|Adverse Event|0|||
163019350|NCT03063086|588774395|FG000|Overall Study|subject/guardian decision|1|||
163019351|NCT03063086|588774396|FG001|Overall Study|subject/guardian decision|0|||
163019352|NCT03063086|588774397|FG002|Overall Study|subject/guardian decision|0|||
163019353|NCT03063086|588774398|FG003|Overall Study|subject/guardian decision|0|||
163019354|NCT03063086|588774399|FG004|Overall Study|subject/guardian decision|0|||
163019355|NCT03063086|588774400|FG005|Overall Study|subject/guardian decision|0|||
163019356|NCT03063086|588774395|FG000|Overall Study|Non-compliance with study treatment|0|||
163019357|NCT03063086|588774396|FG001|Overall Study|Non-compliance with study treatment|0|||
163019358|NCT03063086|588774397|FG002|Overall Study|Non-compliance with study treatment|0|||
163019359|NCT03063086|588774398|FG003|Overall Study|Non-compliance with study treatment|1|||
163019360|NCT03063086|588774399|FG004|Overall Study|Non-compliance with study treatment|0|||
163019361|NCT03063086|588774400|FG005|Overall Study|Non-compliance with study treatment|1|||
163019362|NCT03063086|588774395|FG000|Overall Study|Physician Decision|0|||
163019363|NCT03063086|588774396|FG001|Overall Study|Physician Decision|0|||
163019364|NCT03063086|588774397|FG002|Overall Study|Physician Decision|0|||
163019365|NCT03063086|588774398|FG003|Overall Study|Physician Decision|1|||
163019366|NCT03063086|588774399|FG004|Overall Study|Physician Decision|0|||
163019367|NCT03063086|588774400|FG005|Overall Study|Physician Decision|0|||
163019368|NCT02244463|588774405|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
163019369|NCT02244463|588774406|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019370|NCT02244463|588774407|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019371|NCT02244463|588774408|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019372|NCT02244463|588774409|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019373|NCT02244463|588774410|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
163019374|NCT02244463|588774405|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
163019375|NCT02244463|588774406|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
163019376|NCT02244463|588774407|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
163019377|NCT02244463|588774408|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
163019378|NCT02244463|588774409|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
163019379|NCT02244463|588774410|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
163019380|NCT02244463|588774405|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019381|NCT02244463|588774406|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
163019382|NCT02244463|588774407|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019383|NCT02244463|588774408|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019384|NCT02244463|588774409|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019385|NCT02244463|588774410|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
163019386|NCT02244463|588774405|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019387|NCT02244463|588774406|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019388|NCT02244463|588774407|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
163019389|NCT02244463|588774408|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019390|NCT02244463|588774409|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019391|NCT02244463|588774410|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
163019392|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019393|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019394|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019395|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
163019396|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019397|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
163019398|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019399|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019400|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019401|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
163019402|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019403|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
163019404|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163063262|NCT03314935|588938619|FG002|Phase 1|Lost to Follow-up|0|||
163063263|NCT03314935|588938620|FG003|Phase 1|Lost to Follow-up|0|||
163019405|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019406|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019407|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
163019408|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019409|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
163019410|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019411|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019412|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019413|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
163019414|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019415|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
163019416|NCT02244463|588774405|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019417|NCT02244463|588774406|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019418|NCT02244463|588774407|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019419|NCT02244463|588774408|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
163019420|NCT02244463|588774409|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019421|NCT02244463|588774410|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
163019422|NCT02244463|588774405|FG000|Period 5: Phase II|Disease Progression|0|||
163019423|NCT02244463|588774406|FG001|Period 5: Phase II|Disease Progression|0|||
163019424|NCT02244463|588774407|FG002|Period 5: Phase II|Disease Progression|0|||
163019425|NCT02244463|588774408|FG003|Period 5: Phase II|Disease Progression|0|||
163019426|NCT02244463|588774409|FG004|Period 5: Phase II|Disease Progression|10|||
163019427|NCT02244463|588774410|FG005|Period 5: Phase II|Disease Progression|11|||
163019428|NCT02244463|588774405|FG000|Period 5: Phase II|Physician Decision|0|||
163019429|NCT02244463|588774406|FG001|Period 5: Phase II|Physician Decision|0|||
163063264|NCT03314935|588938621|FG004|Phase 1|Lost to Follow-up|0|||
163063265|NCT03314935|588938622|FG005|Phase 1|Lost to Follow-up|0|||
163063266|NCT03314935|588938623|FG006|Phase 1|Lost to Follow-up|0|||
163063267|NCT03314935|588938624|FG007|Phase 1|Lost to Follow-up|0|||
163063268|NCT03314935|588938625|FG008|Phase 1|Lost to Follow-up|1|||
163063269|NCT03314935|588938626|FG009|Phase 1|Lost to Follow-up|0|||
163063270|NCT03314935|588938627|FG010|Phase 1|Lost to Follow-up|0|||
163063271|NCT03314935|588938628|FG011|Phase 1|Lost to Follow-up|0|||
163063272|NCT03314935|588938629|FG012|Phase 1|Lost to Follow-up|0|||
163063273|NCT03314935|588938630|FG013|Phase 1|Lost to Follow-up|0|||
163063274|NCT03314935|588938631|FG014|Phase 1|Lost to Follow-up|0|||
163063275|NCT03314935|588938617|FG000|Phase 2|Death|0|||
163063276|NCT03314935|588938618|FG001|Phase 2|Death|0|||
163063277|NCT03314935|588938619|FG002|Phase 2|Death|0|||
163063278|NCT03314935|588938620|FG003|Phase 2|Death|0|||
163063279|NCT03314935|588938621|FG004|Phase 2|Death|0|||
163063280|NCT03314935|588938622|FG005|Phase 2|Death|0|||
163063281|NCT03314935|588938623|FG006|Phase 2|Death|0|||
163063282|NCT03314935|588938624|FG007|Phase 2|Death|0|||
163063283|NCT03314935|588938625|FG008|Phase 2|Death|0|||
163063284|NCT03314935|588938626|FG009|Phase 2|Death|5|||
163063285|NCT03314935|588938627|FG010|Phase 2|Death|20|||
163063286|NCT03314935|588938628|FG011|Phase 2|Death|6|||
163063287|NCT03314935|588938629|FG012|Phase 2|Death|7|||
163063288|NCT03314935|588938630|FG013|Phase 2|Death|6|||
163063289|NCT03314935|588938631|FG014|Phase 2|Death|17|||
163063290|NCT03314935|588938617|FG000|Phase 2|Withdrawal by Subject|0|||
163063291|NCT03314935|588938618|FG001|Phase 2|Withdrawal by Subject|0|||
163063292|NCT03314935|588938619|FG002|Phase 2|Withdrawal by Subject|0|||
163063293|NCT03314935|588938620|FG003|Phase 2|Withdrawal by Subject|0|||
163063294|NCT03314935|588938621|FG004|Phase 2|Withdrawal by Subject|0|||
163063295|NCT03314935|588938622|FG005|Phase 2|Withdrawal by Subject|0|||
163063296|NCT03314935|588938623|FG006|Phase 2|Withdrawal by Subject|0|||
163063297|NCT03314935|588938624|FG007|Phase 2|Withdrawal by Subject|0|||
163063298|NCT03314935|588938625|FG008|Phase 2|Withdrawal by Subject|0|||
163063299|NCT03314935|588938626|FG009|Phase 2|Withdrawal by Subject|1|||
163063300|NCT03314935|588938627|FG010|Phase 2|Withdrawal by Subject|4|||
163063301|NCT03314935|588938628|FG011|Phase 2|Withdrawal by Subject|0|||
163063302|NCT03314935|588938629|FG012|Phase 2|Withdrawal by Subject|1|||
163063303|NCT03314935|588938630|FG013|Phase 2|Withdrawal by Subject|0|||
163063304|NCT03314935|588938631|FG014|Phase 2|Withdrawal by Subject|1|||
163063305|NCT03314935|588938617|FG000|Phase 2|Progressive Disease|0|||
163063306|NCT03314935|588938618|FG001|Phase 2|Progressive Disease|0|||
163063307|NCT03314935|588938619|FG002|Phase 2|Progressive Disease|0|||
163063308|NCT03314935|588938620|FG003|Phase 2|Progressive Disease|0|||
163063309|NCT03314935|588938621|FG004|Phase 2|Progressive Disease|0|||
163063310|NCT03314935|588938622|FG005|Phase 2|Progressive Disease|0|||
163063311|NCT03314935|588938623|FG006|Phase 2|Progressive Disease|0|||
163063312|NCT03314935|588938624|FG007|Phase 2|Progressive Disease|0|||
163019430|NCT02244463|588774407|FG002|Period 5: Phase II|Physician Decision|0|||
163019431|NCT02244463|588774408|FG003|Period 5: Phase II|Physician Decision|0|||
163019432|NCT02244463|588774409|FG004|Period 5: Phase II|Physician Decision|3|||
163019433|NCT02244463|588774410|FG005|Period 5: Phase II|Physician Decision|2|||
163019434|NCT02244463|588774405|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
163019435|NCT02244463|588774406|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
163019436|NCT02244463|588774407|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
163019437|NCT02244463|588774408|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
163019438|NCT02244463|588774409|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
163019439|NCT02244463|588774410|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
163019440|NCT02244463|588774405|FG000|Period 5: Phase II|Intercurrent Illness|0|||
163019441|NCT02244463|588774406|FG001|Period 5: Phase II|Intercurrent Illness|0|||
163019442|NCT02244463|588774407|FG002|Period 5: Phase II|Intercurrent Illness|0|||
163019443|NCT02244463|588774408|FG003|Period 5: Phase II|Intercurrent Illness|0|||
163019444|NCT02244463|588774409|FG004|Period 5: Phase II|Intercurrent Illness|2|||
163019445|NCT02244463|588774410|FG005|Period 5: Phase II|Intercurrent Illness|0|||
163019446|NCT02244463|588774405|FG000|Period 5: Phase II|Adverse Event|0|||
163019447|NCT02244463|588774406|FG001|Period 5: Phase II|Adverse Event|0|||
163019448|NCT02244463|588774407|FG002|Period 5: Phase II|Adverse Event|0|||
163019449|NCT02244463|588774408|FG003|Period 5: Phase II|Adverse Event|0|||
163019450|NCT02244463|588774409|FG004|Period 5: Phase II|Adverse Event|0|||
163019451|NCT02244463|588774410|FG005|Period 5: Phase II|Adverse Event|2|||
163019452|NCT02244463|588774405|FG000|Period 5: Phase II|Still On treatment|0|||
163019453|NCT02244463|588774406|FG001|Period 5: Phase II|Still On treatment|0|||
163019454|NCT02244463|588774407|FG002|Period 5: Phase II|Still On treatment|0|||
163019455|NCT02244463|588774408|FG003|Period 5: Phase II|Still On treatment|0|||
163019456|NCT02244463|588774409|FG004|Period 5: Phase II|Still On treatment|0|||
163019457|NCT02244463|588774410|FG005|Period 5: Phase II|Still On treatment|3|||
163019458|NCT05481125|588774411|FG000|Overall Study|Adverse Event|1|||
163019459|NCT05481125|588774412|FG001|Overall Study|Adverse Event|0|||
163019460|NCT05481125|588774411|FG000|Overall Study|Lost to Follow-up|0|||
163019461|NCT05481125|588774412|FG001|Overall Study|Lost to Follow-up|1|||
163019462|NCT05481125|588774411|FG000|Overall Study|Withdrawal by Subject|0|||
163019463|NCT05481125|588774412|FG001|Overall Study|Withdrawal by Subject|1|||
163019464|NCT03702010|588774415|FG000|Follow-up (30days)|Lack of Efficacy|2|||
163019465|NCT03702010|588774416|FG001|Follow-up (30days)|Lack of Efficacy|2|||
163019466|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
163019467|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
163019468|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
163019469|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
163019470|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019471|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019472|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019473|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019474|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019475|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019476|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
163019477|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
163019478|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019479|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
163019480|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
163019481|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019482|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019483|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019484|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019485|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019486|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019487|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
163019488|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
163019489|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
163019490|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
163019491|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
163019492|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163063313|NCT03314935|588938625|FG008|Phase 2|Progressive Disease|0|||
163019493|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019494|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019495|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019496|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019497|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019498|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
163019499|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
163019500|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
163019501|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
163019502|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
163019503|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019504|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019505|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019506|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019507|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019508|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019509|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
163019510|NCT04791319|588774419|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019511|NCT04791319|588774420|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019512|NCT04791319|588774421|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019513|NCT04791319|588774422|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
163019514|NCT04791319|588774423|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019515|NCT04791319|588774424|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019516|NCT04791319|588774425|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019517|NCT04791319|588774426|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019518|NCT04791319|588774427|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019519|NCT04791319|588774428|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019520|NCT04791319|588774429|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
163019521|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019522|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019523|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019524|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019525|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
163019526|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
163019527|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
163019528|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019529|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019530|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
163019531|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
163019532|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019533|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019534|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019535|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019536|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019537|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019538|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019539|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019540|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019541|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
163019542|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
163019543|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019544|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019545|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019546|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163019547|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
163019548|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
163019549|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
163019550|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
163063314|NCT03314935|588938626|FG009|Phase 2|Progressive Disease|1|||
163063315|NCT03314935|588938627|FG010|Phase 2|Progressive Disease|1|||
163019551|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
163019552|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
163019553|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
163019554|NCT04791319|588774419|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019555|NCT04791319|588774420|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019556|NCT04791319|588774421|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019557|NCT04791319|588774422|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
163019558|NCT04791319|588774423|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
163019559|NCT04791319|588774424|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
163019560|NCT04791319|588774425|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
163019561|NCT04791319|588774426|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
163019562|NCT04791319|588774427|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
163019563|NCT04791319|588774428|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
163019564|NCT04791319|588774429|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
163019565|NCT01704651|588774434|FG000|Overall Study|Pre-op withdrawal by subject|1|||
163019566|NCT01704651|588774435|FG001|Overall Study|Pre-op withdrawal by subject|1|||
163019567|NCT01704651|588774434|FG000|Overall Study|Pre-op change in treatment plan|1|||
163019568|NCT01704651|588774435|FG001|Overall Study|Pre-op change in treatment plan|4|||
163019569|NCT01704651|588774434|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
163019570|NCT01704651|588774435|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
163019571|NCT01704651|588774434|FG000|Overall Study|Post-op did not have laparotomy|2|||
163019572|NCT01704651|588774435|FG001|Overall Study|Post-op did not have laparotomy|1|||
163019573|NCT01931995|588774436|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
163019574|NCT01931995|588774437|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
163019575|NCT01931995|588774436|FG000|First Intervention (1 Day)|Physician Decision|1|||
163019576|NCT01931995|588774437|FG001|First Intervention (1 Day)|Physician Decision|1|||
163019577|NCT01931995|588774436|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
163019578|NCT01931995|588774437|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
163019579|NCT00791661|588774438|FG000|7 Day Wash-out|Adverse Event|0|||
163019580|NCT00791661|588774439|FG001|7 Day Wash-out|Adverse Event|0|||
163019581|NCT00791661|588774440|FG002|7 Day Wash-out|Adverse Event|1|||
163019582|NCT00791661|588774438|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
163019583|NCT00791661|588774439|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
163019584|NCT00791661|588774440|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
163019585|NCT00427921|588774448|FG000|Overall Study|Adverse Event|26|||
163019586|NCT00427921|588774448|FG000|Overall Study|Withdrawal by Subject|4|||
163019587|NCT00427921|588774448|FG000|Overall Study|Lost to Follow-up|2|||
163019588|NCT00427921|588774448|FG000|Overall Study|Other reason not specified|10|||
163019589|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Hospitalization|1|||
163019590|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
163019591|NCT00427921|588774448|FG000|Overall Study|Adverse Event + No Response|1|||
163019592|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
163019593|NCT00427921|588774448|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
163019594|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Lost Response|1|||
163019595|NCT00427921|588774448|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
163019596|NCT00427921|588774448|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
163019597|NCT00520533|588774451|FG000|Overall Study|Death|1|||
163019598|NCT00520533|588774451|FG000|Overall Study|Suspension of the study for safety reasons|1|||
163019599|NCT00520533|588774451|FG000|Overall Study|Withdrawal by Subject|1|||
163019600|NCT00520533|588774451|FG000|Overall Study|Physician Decision|1|||
163019601|NCT01464164|588774455|FG000|Overall Study|Screen failure|0|||
163019602|NCT01464164|588774456|FG001|Overall Study|Screen failure|1|||
163019603|NCT01464164|588774457|FG002|Overall Study|Screen failure|2|||
163019604|NCT01464164|588774458|FG003|Overall Study|Screen failure|0|||
163019605|NCT01464164|588774459|FG004|Overall Study|Screen failure|0|||
163063316|NCT03314935|588938628|FG011|Phase 2|Progressive Disease|1|||
163063317|NCT03314935|588938629|FG012|Phase 2|Progressive Disease|2|||
163019606|NCT01464164|588774460|FG005|Overall Study|Screen failure|0|||
163063318|NCT03314935|588938630|FG013|Phase 2|Progressive Disease|0|||
163019607|NCT01464164|588774461|FG006|Overall Study|Screen failure|0|||
163019608|NCT01464164|588774455|FG000|Overall Study|Physician Decision|0|||
163019609|NCT01464164|588774456|FG001|Overall Study|Physician Decision|1|||
163019610|NCT01464164|588774457|FG002|Overall Study|Physician Decision|0|||
163019611|NCT01464164|588774458|FG003|Overall Study|Physician Decision|0|||
163019612|NCT01464164|588774459|FG004|Overall Study|Physician Decision|0|||
163019613|NCT01464164|588774460|FG005|Overall Study|Physician Decision|0|||
163019614|NCT01464164|588774461|FG006|Overall Study|Physician Decision|2|||
163019615|NCT03307252|588774462|FG000|Part 2, Period 1|Treatment not received|0|||
163019616|NCT03307252|588774463|FG001|Part 2, Period 1|Treatment not received|0|||
163019617|NCT03307252|588774464|FG002|Part 2, Period 1|Treatment not received|0|||
163019618|NCT03307252|588774465|FG003|Part 2, Period 1|Treatment not received|0|||
163019619|NCT03307252|588774466|FG004|Part 2, Period 1|Treatment not received|0|||
163019620|NCT03307252|588774467|FG005|Part 2, Period 1|Treatment not received|1|||
163019621|NCT03307252|588774468|FG006|Part 2, Period 1|Treatment not received|0|||
163019622|NCT03307252|588774469|FG007|Part 2, Period 1|Treatment not received|0|||
163019623|NCT03307252|588774470|FG008|Part 2, Period 1|Treatment not received|0|||
163019624|NCT03307252|588774471|FG009|Part 2, Period 1|Treatment not received|0|||
163019625|NCT03307252|588774472|FG010|Part 2, Period 1|Treatment not received|0|||
163019626|NCT03307252|588774462|FG000|Part 2, Period 3|Other than listed|0|||
163019627|NCT03307252|588774463|FG001|Part 2, Period 3|Other than listed|0|||
163019628|NCT03307252|588774464|FG002|Part 2, Period 3|Other than listed|0|||
163019629|NCT03307252|588774465|FG003|Part 2, Period 3|Other than listed|0|||
163019630|NCT03307252|588774466|FG004|Part 2, Period 3|Other than listed|1|||
163019631|NCT03307252|588774467|FG005|Part 2, Period 3|Other than listed|0|||
163019632|NCT03307252|588774468|FG006|Part 2, Period 3|Other than listed|0|||
163019633|NCT03307252|588774469|FG007|Part 2, Period 3|Other than listed|0|||
163019634|NCT03307252|588774470|FG008|Part 2, Period 3|Other than listed|0|||
163019635|NCT03307252|588774471|FG009|Part 2, Period 3|Other than listed|0|||
163019636|NCT03307252|588774472|FG010|Part 2, Period 3|Other than listed|0|||
163019637|NCT03307252|588774462|FG000|Part 2, Period 4|Other than listed|0|||
163019638|NCT03307252|588774463|FG001|Part 2, Period 4|Other than listed|0|||
163019639|NCT03307252|588774464|FG002|Part 2, Period 4|Other than listed|0|||
163019640|NCT03307252|588774465|FG003|Part 2, Period 4|Other than listed|0|||
163019641|NCT03307252|588774466|FG004|Part 2, Period 4|Other than listed|0|||
163019642|NCT03307252|588774467|FG005|Part 2, Period 4|Other than listed|0|||
163019643|NCT03307252|588774468|FG006|Part 2, Period 4|Other than listed|1|||
163019644|NCT03307252|588774469|FG007|Part 2, Period 4|Other than listed|0|||
163019645|NCT03307252|588774470|FG008|Part 2, Period 4|Other than listed|0|||
163019646|NCT03307252|588774471|FG009|Part 2, Period 4|Other than listed|0|||
163019647|NCT03307252|588774472|FG010|Part 2, Period 4|Other than listed|0|||
163019648|NCT03307252|588774462|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019649|NCT03307252|588774463|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019650|NCT03307252|588774464|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019651|NCT03307252|588774465|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019652|NCT03307252|588774466|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019653|NCT03307252|588774467|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019654|NCT03307252|588774468|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019655|NCT03307252|588774469|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019656|NCT03307252|588774470|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019657|NCT03307252|588774471|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
163019658|NCT03307252|588774472|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
163019659|NCT01052480|588774473|FG000|Overall Study|Lost to Follow-up|3|||
163019660|NCT01052480|588774474|FG001|Overall Study|Lost to Follow-up|3|||
163019661|NCT01052480|588774473|FG000|Overall Study|Protocol Violation|1|||
163019662|NCT01052480|588774474|FG001|Overall Study|Protocol Violation|0|||
163019663|NCT01052480|588774473|FG000|Overall Study|Withdrawal by Subject|3|||
163019664|NCT01052480|588774474|FG001|Overall Study|Withdrawal by Subject|7|||
163019665|NCT01052480|588774473|FG000|Overall Study|Physician Decision|0|||
163019666|NCT01052480|588774474|FG001|Overall Study|Physician Decision|2|||
163019667|NCT01052480|588774473|FG000|Overall Study|Death|1|||
163019668|NCT01052480|588774474|FG001|Overall Study|Death|5|||
163019669|NCT01578239|588774475|FG000|Treatment Period|Progressive Disease|19|||
163019670|NCT01578239|588774476|FG001|Treatment Period|Progressive Disease|64|||
162716612|NCT03301220|587668516|FG000|Overall Study|Randomized but not treated|0|||
163019671|NCT01578239|588774475|FG000|Treatment Period|Physician Decision|17|||
163019672|NCT01578239|588774476|FG001|Treatment Period|Physician Decision|17|||
163019673|NCT01578239|588774475|FG000|Treatment Period|Adverse Event|13|||
163019674|NCT01578239|588774476|FG001|Treatment Period|Adverse Event|10|||
163019675|NCT01578239|588774475|FG000|Treatment Period|Non-compliance|2|||
163019676|NCT01578239|588774476|FG001|Treatment Period|Non-compliance|0|||
163019677|NCT01578239|588774475|FG000|Treatment Period|Withdrawal by Subject|10|||
163019678|NCT01578239|588774476|FG001|Treatment Period|Withdrawal by Subject|9|||
163019679|NCT01578239|588774475|FG000|Treatment Period|Other|6|||
163019680|NCT01578239|588774476|FG001|Treatment Period|Other|1|||
163019681|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Death|69|||
163019682|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Death|64|||
163019683|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
163019684|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
163019685|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
163019686|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
163019687|NCT01578239|588774475|FG000|Long-term Follow-Up Period|Other|2|||
163019688|NCT01578239|588774476|FG001|Long-term Follow-Up Period|Other|2|||
163019689|NCT02347813|588774479|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
163019690|NCT02347813|588774480|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
163019691|NCT02347813|588774479|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
163019692|NCT02347813|588774480|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
163019693|NCT01119859|588774481|FG000|Overall Study|Adverse Event|9|||
163019694|NCT01119859|588774482|FG001|Overall Study|Adverse Event|10|||
163019695|NCT01119859|588774481|FG000|Overall Study|Death|2|||
163019696|NCT01119859|588774482|FG001|Overall Study|Death|0|||
163019697|NCT01119859|588774481|FG000|Overall Study|Insufficient therapeutic response|7|||
163019698|NCT01119859|588774482|FG001|Overall Study|Insufficient therapeutic response|14|||
163019699|NCT01119859|588774481|FG000|Overall Study|Refused treatment|3|||
163019700|NCT01119859|588774482|FG001|Overall Study|Refused treatment|6|||
163019701|NCT01119859|588774481|FG000|Overall Study|Failure to return|3|||
163019702|NCT01119859|588774482|FG001|Overall Study|Failure to return|0|||
163019703|NCT00733421|588774483|FG000|Overall Study|Withdrawal by Subject|1|||
163019704|NCT00733421|588774484|FG001|Overall Study|Withdrawal by Subject|1|||
163019705|NCT04185220|588774488|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
163019706|NCT04185220|588774489|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
163019707|NCT04185220|588774488|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
163019708|NCT04185220|588774489|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
163019709|NCT01029782|588774490|FG000|Overall Study|Lost to Follow-up|2|||
163019710|NCT01029782|588774491|FG001|Overall Study|Lost to Follow-up|2|||
163063319|NCT03314935|588938631|FG014|Phase 2|Progressive Disease|1|||
163063320|NCT03314935|588938617|FG000|Phase 2|Study Terminated by Sponsor|0|||
163063321|NCT03314935|588938618|FG001|Phase 2|Study Terminated by Sponsor|0|||
163063322|NCT03314935|588938619|FG002|Phase 2|Study Terminated by Sponsor|0|||
163063323|NCT03314935|588938620|FG003|Phase 2|Study Terminated by Sponsor|0|||
163063324|NCT03314935|588938621|FG004|Phase 2|Study Terminated by Sponsor|0|||
163063325|NCT03314935|588938622|FG005|Phase 2|Study Terminated by Sponsor|0|||
163063326|NCT03314935|588938623|FG006|Phase 2|Study Terminated by Sponsor|0|||
163063327|NCT03314935|588938624|FG007|Phase 2|Study Terminated by Sponsor|0|||
163063328|NCT03314935|588938625|FG008|Phase 2|Study Terminated by Sponsor|0|||
163063329|NCT03314935|588938626|FG009|Phase 2|Study Terminated by Sponsor|0|||
163063330|NCT03314935|588938627|FG010|Phase 2|Study Terminated by Sponsor|7|||
163019711|NCT01029782|588774490|FG000|Overall Study|Diagnosis changed|1|||
163019712|NCT01029782|588774491|FG001|Overall Study|Diagnosis changed|1|||
163019713|NCT01029782|588774490|FG000|Overall Study|Adverse Event|0|||
163019714|NCT01029782|588774491|FG001|Overall Study|Adverse Event|1|||
163019715|NCT01029782|588774490|FG000|Overall Study|Physician Decision|0|||
163063331|NCT03314935|588938628|FG011|Phase 2|Study Terminated by Sponsor|2|||
163019716|NCT01029782|588774491|FG001|Overall Study|Physician Decision|1|||
163019717|NCT01029782|588774490|FG000|Overall Study|Protocol Violation|0|||
163019718|NCT01029782|588774491|FG001|Overall Study|Protocol Violation|2|||
163019719|NCT01029782|588774490|FG000|Overall Study|Withdrawal by Subject|0|||
163019720|NCT01029782|588774491|FG001|Overall Study|Withdrawal by Subject|1|||
163019721|NCT02195869|588774495|FG000|Overall Study|cGVHD Progression|5|||
163019722|NCT02195869|588774495|FG000|Overall Study|Malignancy Progression/relapse|2|||
163019723|NCT02195869|588774495|FG000|Overall Study|Adverse Event|15|||
163019724|NCT02195869|588774495|FG000|Overall Study|Withdrawal by Subject|7|||
163019725|NCT02195869|588774495|FG000|Overall Study|Physician Decision|4|||
163019726|NCT02195869|588774495|FG000|Overall Study|Study Terminated by Sponsor|7|||
163019727|NCT02195869|588774495|FG000|Overall Study|Noncompliance with study drug|2|||
163019728|NCT02981082|588774499|FG000|Overall Study|Withdrawal by Subject|2|||
163019729|NCT02981082|588774500|FG001|Overall Study|Withdrawal by Subject|0|||
163019730|NCT02981082|588774499|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
163019731|NCT02981082|588774500|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
163019732|NCT02981082|588774499|FG000|Overall Study|Adverse Event|0|||
163019733|NCT02981082|588774500|FG001|Overall Study|Adverse Event|1|||
163019734|NCT03652636|588776258|FG000|Overall Study|Withdrawal by Subject|7|||
163019735|NCT00679029|588776261|FG000|Overall Study|Adverse Event|3|||
163019736|NCT00679029|588776261|FG000|Overall Study|Withdrawal by Subject|1|||
163019737|NCT00679029|588776261|FG000|Overall Study|Lost to Follow-up|1|||
163019738|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
163019739|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
163019740|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
163019741|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
163019742|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Death|0|||
163019743|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Death|0|||
163019744|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Death|1|||
163019745|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Death|0|||
163019746|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
163019747|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019748|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019749|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
163019750|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
163019751|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
163019752|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
163019753|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
163019754|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
163019755|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
163019756|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
163019757|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
163019758|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
163019759|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
163019760|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
163019761|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
163019762|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
163019763|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
163019764|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
163019765|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
163019766|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
163019767|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
163019768|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
163019769|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
163019770|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
163019771|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
163019772|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163019773|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163019774|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
162641447|NCT04128267|587401605|FG000|Overall Study|Participant had other medical issues|4|||
163019775|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
163019776|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
163019777|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
163019778|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
163019779|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
163019780|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
163019781|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
163019782|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Other|8|||
163019783|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Other|14|||
163019784|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Other|8|||
163019785|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Other|23|||
163019786|NCT01106677|588776263|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
163019787|NCT01106677|588776264|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
163019788|NCT01106677|588776265|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
163019789|NCT01106677|588776266|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
163019790|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163019791|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
163019792|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
163019793|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
163019794|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Death|0|||
163019795|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Death|0|||
163019796|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Death|0|||
163019797|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Death|1|||
163019798|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
163019799|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
163019800|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
163019801|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
163019802|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
163019803|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019804|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019805|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
163019806|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163019807|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
163019808|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
163019809|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
163019810|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
163019811|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019812|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019813|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
163019814|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163019815|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
163019816|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
163019817|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163019818|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
163019819|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
163019820|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
163019821|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
162641448|NCT04128267|587401605|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
162641449|NCT01705652|587401606|FG000|Overall Study|Adverse Event|1|||
162641450|NCT01705652|587401607|FG001|Overall Study|Adverse Event|0|||
162641451|NCT01705652|587401606|FG000|Overall Study|Withdrawal by Subject|1|||
162641452|NCT01705652|587401607|FG001|Overall Study|Withdrawal by Subject|2|||
162641453|NCT01705652|587401606|FG000|Overall Study|non-compliance|1|||
162641454|NCT01705652|587401607|FG001|Overall Study|non-compliance|1|||
162641455|NCT00056407|587401610|FG000|Overall Study|Adverse Event|282|||
163019822|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019823|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019824|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
163019825|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163019826|NCT01106677|588776263|FG000|Extension Period: Week 26 to Week 52|Other|6|||
163019827|NCT01106677|588776264|FG001|Extension Period: Week 26 to Week 52|Other|5|||
163019828|NCT01106677|588776265|FG002|Extension Period: Week 26 to Week 52|Other|8|||
163019829|NCT01106677|588776266|FG003|Extension Period: Week 26 to Week 52|Other|5|||
163019830|NCT00972816|588776267|FG000|Overall Study|Adverse Event|0|||
163019831|NCT00972816|588776268|FG001|Overall Study|Adverse Event|0|||
163019832|NCT00972816|588776269|FG002|Overall Study|Adverse Event|1|||
163019833|NCT00972816|588776270|FG003|Overall Study|Adverse Event|0|||
163019834|NCT00972816|588776271|FG004|Overall Study|Adverse Event|0|||
163019835|NCT00972816|588776272|FG005|Overall Study|Adverse Event|0|||
163019836|NCT00972816|588776273|FG006|Overall Study|Adverse Event|0|||
163019837|NCT00972816|588776274|FG007|Overall Study|Adverse Event|0|||
163019838|NCT00972816|588776267|FG000|Overall Study|Withdrawal by Subject|4|||
163019839|NCT00972816|588776268|FG001|Overall Study|Withdrawal by Subject|2|||
163019840|NCT00972816|588776269|FG002|Overall Study|Withdrawal by Subject|1|||
163019841|NCT00972816|588776270|FG003|Overall Study|Withdrawal by Subject|3|||
163019842|NCT00972816|588776271|FG004|Overall Study|Withdrawal by Subject|0|||
163019843|NCT00972816|588776272|FG005|Overall Study|Withdrawal by Subject|1|||
163019844|NCT00972816|588776273|FG006|Overall Study|Withdrawal by Subject|1|||
163019845|NCT00972816|588776274|FG007|Overall Study|Withdrawal by Subject|2|||
163019846|NCT00972816|588776267|FG000|Overall Study|Lost to Follow-up|11|||
163019847|NCT00972816|588776268|FG001|Overall Study|Lost to Follow-up|9|||
163019848|NCT00972816|588776269|FG002|Overall Study|Lost to Follow-up|7|||
163019849|NCT00972816|588776270|FG003|Overall Study|Lost to Follow-up|5|||
163019850|NCT00972816|588776271|FG004|Overall Study|Lost to Follow-up|11|||
163019851|NCT00972816|588776272|FG005|Overall Study|Lost to Follow-up|10|||
163019852|NCT00972816|588776273|FG006|Overall Study|Lost to Follow-up|7|||
163019853|NCT00972816|588776274|FG007|Overall Study|Lost to Follow-up|7|||
163019854|NCT00972816|588776267|FG000|Overall Study|Inappropriate enrolment|0|||
163019855|NCT00972816|588776268|FG001|Overall Study|Inappropriate enrolment|0|||
163019856|NCT00972816|588776269|FG002|Overall Study|Inappropriate enrolment|0|||
162641456|NCT00056407|587401611|FG001|Overall Study|Adverse Event|364|||
162641457|NCT00056407|587401610|FG000|Overall Study|Withdrawal by Subject|377|||
162641458|NCT00056407|587401611|FG001|Overall Study|Withdrawal by Subject|361|||
162641459|NCT00056407|587401610|FG000|Overall Study|Lost to Follow-up|123|||
162641460|NCT00056407|587401611|FG001|Overall Study|Lost to Follow-up|113|||
162641461|NCT00056407|587401610|FG000|Overall Study|Protocol Violation|104|||
162641462|NCT00056407|587401611|FG001|Overall Study|Protocol Violation|95|||
162641463|NCT00056407|587401610|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
162641464|NCT00056407|587401611|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
162641465|NCT00056407|587401610|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
162641466|NCT00056407|587401611|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
162641467|NCT00056407|587401610|FG000|Overall Study|Missing|25|||
162641468|NCT00056407|587401611|FG001|Overall Study|Missing|34|||
162641469|NCT00616655|587401612|FG000|Overall Study|Adverse Event|10|||
162641470|NCT00616655|587401613|FG001|Overall Study|Adverse Event|7|||
162641471|NCT00616655|587401614|FG002|Overall Study|Adverse Event|12|||
162641472|NCT00616655|587401612|FG000|Overall Study|Lack of Efficacy|5|||
162641473|NCT00616655|587401613|FG001|Overall Study|Lack of Efficacy|5|||
162641474|NCT00616655|587401614|FG002|Overall Study|Lack of Efficacy|5|||
162641475|NCT00616655|587401612|FG000|Overall Study|Lost to Follow-up|3|||
162641476|NCT00616655|587401613|FG001|Overall Study|Lost to Follow-up|12|||
162641477|NCT00616655|587401614|FG002|Overall Study|Lost to Follow-up|10|||
162641478|NCT00616655|587401612|FG000|Overall Study|Protocol Violation|2|||
162641479|NCT00616655|587401613|FG001|Overall Study|Protocol Violation|4|||
162641480|NCT00616655|587401614|FG002|Overall Study|Protocol Violation|3|||
162641481|NCT00616655|587401612|FG000|Overall Study|Withdrawal by Subject|9|||
162641482|NCT00616655|587401613|FG001|Overall Study|Withdrawal by Subject|7|||
162641483|NCT00616655|587401614|FG002|Overall Study|Withdrawal by Subject|11|||
162641484|NCT00616655|587401612|FG000|Overall Study|Does not meet in/ex criteria|0|||
162641485|NCT00616655|587401613|FG001|Overall Study|Does not meet in/ex criteria|0|||
162641486|NCT00616655|587401614|FG002|Overall Study|Does not meet in/ex criteria|2|||
162641487|NCT00616655|587401612|FG000|Overall Study|Other|6|||
162641488|NCT00616655|587401613|FG001|Overall Study|Other|6|||
162641489|NCT00616655|587401614|FG002|Overall Study|Other|5|||
162641490|NCT00309842|587401615|FG000|Overall Study|Lost to Follow-up|1|||
162641491|NCT01026792|587401616|FG000|Overall Study|Protocol Violation|1|||
162641492|NCT02335099|587401619|FG000|Treatment|Withdrawal by Subject|1|||
162641493|NCT02335099|587401620|FG001|Treatment|Withdrawal by Subject|3|||
162641494|NCT02335099|587401619|FG000|Treatment|Lost to Follow-up|2|||
162641495|NCT02335099|587401620|FG001|Treatment|Lost to Follow-up|0|||
162641496|NCT02335099|587401619|FG000|Treatment|Death|1|||
162641497|NCT02335099|587401620|FG001|Treatment|Death|0|||
162641498|NCT02335099|587401619|FG000|Treatment|Adverse Event|1|||
162641499|NCT02335099|587401620|FG001|Treatment|Adverse Event|2|||
162641500|NCT02335099|587401619|FG000|Follow-up|Death|0|||
162641501|NCT02335099|587401620|FG001|Follow-up|Death|1|||
162641502|NCT01472081|587401621|FG000|Overall Study|Continuing treatment at time of analysis|1|||
162641503|NCT01472081|587401622|FG001|Overall Study|Continuing treatment at time of analysis|4|||
162641504|NCT01472081|587401623|FG002|Overall Study|Continuing treatment at time of analysis|1|||
162641505|NCT01472081|587401624|FG003|Overall Study|Continuing treatment at time of analysis|8|||
162716613|NCT03301220|587668517|FG001|Overall Study|Randomized but not treated|1|||
162716614|NCT03301220|587668516|FG000|Overall Study|Ongoing followup|145|||
163019857|NCT00972816|588776270|FG003|Overall Study|Inappropriate enrolment|0|||
163019858|NCT00972816|588776271|FG004|Overall Study|Inappropriate enrolment|0|||
163019859|NCT00972816|588776272|FG005|Overall Study|Inappropriate enrolment|0|||
163019860|NCT00972816|588776273|FG006|Overall Study|Inappropriate enrolment|2|||
163019861|NCT00972816|588776274|FG007|Overall Study|Inappropriate enrolment|0|||
163019862|NCT00972816|588776267|FG000|Overall Study|Unable to classify|2|||
163019863|NCT00972816|588776268|FG001|Overall Study|Unable to classify|0|||
163019864|NCT00972816|588776269|FG002|Overall Study|Unable to classify|0|||
163019865|NCT00972816|588776270|FG003|Overall Study|Unable to classify|0|||
163019866|NCT00972816|588776271|FG004|Overall Study|Unable to classify|1|||
163019867|NCT00972816|588776272|FG005|Overall Study|Unable to classify|0|||
162641506|NCT01472081|587401625|FG004|Overall Study|Continuing treatment at time of analysis|9|||
162641507|NCT01472081|587401626|FG005|Overall Study|Continuing treatment at time of analysis|0|||
162641508|NCT01472081|587401621|FG000|Overall Study|Disease Progression|4|||
162641509|NCT01472081|587401622|FG001|Overall Study|Disease Progression|10|||
162641510|NCT01472081|587401623|FG002|Overall Study|Disease Progression|12|||
162641511|NCT01472081|587401624|FG003|Overall Study|Disease Progression|31|||
162641512|NCT01472081|587401625|FG004|Overall Study|Disease Progression|22|||
162641513|NCT01472081|587401626|FG005|Overall Study|Disease Progression|3|||
163019868|NCT00972816|588776273|FG006|Overall Study|Unable to classify|0|||
163019869|NCT00972816|588776274|FG007|Overall Study|Unable to classify|0|||
163019870|NCT03806933|588776275|FG000|Main Period|Physician Decision|0|||
163019871|NCT03806933|588776276|FG001|Main Period|Physician Decision|0|||
163019872|NCT03806933|588776277|FG002|Main Period|Physician Decision|0|||
163019873|NCT03806933|588776278|FG003|Main Period|Physician Decision|1|||
163019874|NCT03806933|588776275|FG000|Main Period|Pregnancy|0|||
163019875|NCT03806933|588776276|FG001|Main Period|Pregnancy|0|||
163019876|NCT03806933|588776277|FG002|Main Period|Pregnancy|1|||
163019877|NCT03806933|588776278|FG003|Main Period|Pregnancy|0|||
163019878|NCT03806933|588776275|FG000|Main Period|Withdrawal by Subject|2|||
163019879|NCT03806933|588776276|FG001|Main Period|Withdrawal by Subject|1|||
163019880|NCT03806933|588776277|FG002|Main Period|Withdrawal by Subject|1|||
163019881|NCT03806933|588776278|FG003|Main Period|Withdrawal by Subject|2|||
163019882|NCT03806933|588776275|FG000|Main Period|Lost to Follow-up|2|||
163019883|NCT03806933|588776276|FG001|Main Period|Lost to Follow-up|2|||
163019884|NCT03806933|588776277|FG002|Main Period|Lost to Follow-up|0|||
163019885|NCT03806933|588776278|FG003|Main Period|Lost to Follow-up|0|||
163019886|NCT03806933|588776275|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019887|NCT03806933|588776276|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019888|NCT03806933|588776277|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
163019889|NCT03806933|588776278|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
163019890|NCT05088603|588776279|FG000|Overall Study|Protocol Violation|6|||
163019891|NCT05088603|588776280|FG001|Overall Study|Protocol Violation|1|||
163019892|NCT00956592|588776285|FG000|Overall Study|Protocol Violation|1|||
163019893|NCT00956592|588776286|FG001|Overall Study|Protocol Violation|3|||
163019894|NCT02162719|588776287|FG000|Overall Study|Death|41|||
163019895|NCT02162719|588776288|FG001|Overall Study|Death|46|||
163019896|NCT02162719|588776287|FG000|Overall Study|Lost to Follow-up|1|||
163019897|NCT02162719|588776288|FG001|Overall Study|Lost to Follow-up|3|||
163019898|NCT02162719|588776287|FG000|Overall Study|Disease Progression|2|||
163019899|NCT02162719|588776288|FG001|Overall Study|Disease Progression|1|||
163019900|NCT02162719|588776287|FG000|Overall Study|Withdrawal by Subject|8|||
163019901|NCT02162719|588776288|FG001|Overall Study|Withdrawal by Subject|2|||
163019902|NCT02162719|588776287|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
163019903|NCT02162719|588776288|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
163019904|NCT03555565|588776290|FG000|Overall Study|Case Report Forms Uncollected|2|||
163019905|NCT03555565|588776290|FG000|Overall Study|Protocol Deviation|13|||
163019906|NCT03854370|588776295|FG000|Overall Study|samples not collected|1|||
163019907|NCT03854370|588776296|FG001|Overall Study|samples not collected|1|||
163019908|NCT03854370|588776297|FG002|Overall Study|samples not collected|1|||
163019909|NCT03854370|588776298|FG003|Overall Study|samples not collected|1|||
163019910|NCT02656290|588776299|FG000|Overall Study|Lost to Follow-up|1|||
162641514|NCT01472081|587401621|FG000|Overall Study|Study drug toxicity|2|||
162641515|NCT01472081|587401622|FG001|Overall Study|Study drug toxicity|9|||
162641516|NCT01472081|587401623|FG002|Overall Study|Study drug toxicity|4|||
162641517|NCT01472081|587401624|FG003|Overall Study|Study drug toxicity|6|||
162641518|NCT01472081|587401625|FG004|Overall Study|Study drug toxicity|13|||
162641519|NCT01472081|587401626|FG005|Overall Study|Study drug toxicity|2|||
163019911|NCT02656290|588776299|FG000|Overall Study|Reintervention|3|||
163019912|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
163019913|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
163019914|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
163019915|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
163019916|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
163019917|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
163019918|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
163019919|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
163019920|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Death|0|||
163019921|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Death|1|||
163019922|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
163019923|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
163019924|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
163019925|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
163019926|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
163019927|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
163019928|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
163019929|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
163019930|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
163019931|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
163019932|NCT00394836|588776300|FG000|Teatment or Follow-up Phase|Non compliance|0|||
163019933|NCT00394836|588776301|FG001|Teatment or Follow-up Phase|Non compliance|1|||
163019934|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
163019935|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
163019936|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
163019937|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
163019938|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
163019939|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
163019940|NCT00394836|588776300|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
163019941|NCT00394836|588776301|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
163019942|NCT03692325|588776302|FG000|Overall Study|Adverse Event|2|||
163019943|NCT03692325|588776302|FG000|Overall Study|Progression/Recurrence|2|||
163019944|NCT02817516|588776303|FG000|Overall Study|Other|0|||
162641520|NCT01472081|587401621|FG000|Overall Study|Death|0|||
162641521|NCT01472081|587401622|FG001|Overall Study|Death|0|||
162641522|NCT01472081|587401623|FG002|Overall Study|Death|0|||
162641523|NCT01472081|587401624|FG003|Overall Study|Death|0|||
162641524|NCT01472081|587401625|FG004|Overall Study|Death|1|||
162641525|NCT01472081|587401626|FG005|Overall Study|Death|0|||
162641526|NCT01472081|587401621|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
162641527|NCT01472081|587401622|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162641528|NCT01472081|587401623|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162641529|NCT01472081|587401624|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
162641530|NCT01472081|587401625|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
162641531|NCT01472081|587401626|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
162641532|NCT01472081|587401621|FG000|Overall Study|Withdrawal by Subject|0|||
162641533|NCT01472081|587401622|FG001|Overall Study|Withdrawal by Subject|0|||
162641534|NCT01472081|587401623|FG002|Overall Study|Withdrawal by Subject|0|||
162641535|NCT01472081|587401624|FG003|Overall Study|Withdrawal by Subject|0|||
162641536|NCT01472081|587401625|FG004|Overall Study|Withdrawal by Subject|0|||
162641537|NCT01472081|587401626|FG005|Overall Study|Withdrawal by Subject|1|||
162641538|NCT01472081|587401621|FG000|Overall Study|Poor/non-compliance|0|||
162641539|NCT01472081|587401622|FG001|Overall Study|Poor/non-compliance|0|||
163019945|NCT02817516|588776304|FG001|Overall Study|Other|0|||
162641540|NCT01472081|587401623|FG002|Overall Study|Poor/non-compliance|1|||
162641541|NCT01472081|587401624|FG003|Overall Study|Poor/non-compliance|0|||
162641542|NCT01472081|587401625|FG004|Overall Study|Poor/non-compliance|1|||
162641543|NCT01472081|587401626|FG005|Overall Study|Poor/non-compliance|0|||
162641544|NCT01472081|587401621|FG000|Overall Study|No longer meets study criteria|0|||
162716615|NCT03301220|587668517|FG001|Overall Study|Ongoing followup|163|||
162716616|NCT03301220|587668516|FG000|Overall Study|Principal Investigator and participant decision|0|||
162716617|NCT03301220|587668517|FG001|Overall Study|Principal Investigator and participant decision|1|||
162716618|NCT04845620|587668522|FG000|Overall Study|Withdrawal by Subject|11|||
162641545|NCT01472081|587401622|FG001|Overall Study|No longer meets study criteria|0|||
162641546|NCT01472081|587401623|FG002|Overall Study|No longer meets study criteria|1|||
162641547|NCT01472081|587401624|FG003|Overall Study|No longer meets study criteria|0|||
162641548|NCT01472081|587401625|FG004|Overall Study|No longer meets study criteria|0|||
162641549|NCT01472081|587401626|FG005|Overall Study|No longer meets study criteria|0|||
162641550|NCT01472081|587401621|FG000|Overall Study|Subject request to discontinue treatment|0|||
162641551|NCT01472081|587401622|FG001|Overall Study|Subject request to discontinue treatment|3|||
162641552|NCT01472081|587401623|FG002|Overall Study|Subject request to discontinue treatment|1|||
162641553|NCT01472081|587401624|FG003|Overall Study|Subject request to discontinue treatment|1|||
162641554|NCT01472081|587401625|FG004|Overall Study|Subject request to discontinue treatment|0|||
162641555|NCT01472081|587401626|FG005|Overall Study|Subject request to discontinue treatment|0|||
162641556|NCT04702997|587401627|FG000|Overall Study|Withdrawal by Subject|1|||
162641557|NCT04702997|587401628|FG001|Overall Study|Withdrawal by Subject|1|||
162641558|NCT03915496|587401629|FG000|Overall Study|Adverse Event|2|||
162641559|NCT03915496|587401630|FG001|Overall Study|Adverse Event|1|||
162641560|NCT03915496|587401631|FG002|Overall Study|Adverse Event|2|||
162641561|NCT02759471|587401632|FG000|Overall Study|discomfort|2|||
162641562|NCT01103284|587401633|FG000|Overall Study|Death|2|||
162641563|NCT01103284|587401634|FG001|Overall Study|Death|0|||
162641564|NCT01103284|587401633|FG000|Overall Study|Lost to Follow-up|9|||
162641565|NCT01103284|587401634|FG001|Overall Study|Lost to Follow-up|10|||
162641566|NCT01103284|587401633|FG000|Overall Study|Pregnancy|3|||
162641567|NCT01103284|587401634|FG001|Overall Study|Pregnancy|1|||
162641568|NCT01103284|587401633|FG000|Overall Study|Protocol Violation|12|||
162641569|NCT01103284|587401634|FG001|Overall Study|Protocol Violation|5|||
162641570|NCT01103284|587401633|FG000|Overall Study|Adverse Event|0|||
162641571|NCT01103284|587401634|FG001|Overall Study|Adverse Event|5|||
162641572|NCT01103284|587401633|FG000|Overall Study|Withdrawal by Subject|14|||
162641573|NCT01103284|587401634|FG001|Overall Study|Withdrawal by Subject|18|||
162641574|NCT01103284|587401633|FG000|Overall Study|Dermal Hypersensitivity|0|||
162641575|NCT01103284|587401634|FG001|Overall Study|Dermal Hypersensitivity|1|||
162641576|NCT01103284|587401633|FG000|Overall Study|Termination by the Sponsor|0|||
162641577|NCT01103284|587401634|FG001|Overall Study|Termination by the Sponsor|1|||
162641578|NCT01103284|587401633|FG000|Overall Study|Not described|2|||
162641579|NCT01103284|587401634|FG001|Overall Study|Not described|1|||
162641580|NCT01103284|587401633|FG000|Overall Study|Missing CRF entries for study completion|0|||
162641581|NCT01103284|587401634|FG001|Overall Study|Missing CRF entries for study completion|2|||
162641582|NCT03712904|587403169|FG000|Overall Study|Death|0|||
162641583|NCT03712904|587403170|FG001|Overall Study|Death|1|||
162641584|NCT03712904|587403169|FG000|Overall Study|Withdrawal by Subject|0|||
162641585|NCT03712904|587403170|FG001|Overall Study|Withdrawal by Subject|1|||
162641586|NCT03712904|587403169|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
162641587|NCT03712904|587403170|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
162641588|NCT03745937|587403171|FG000|Overall Study|Withdrawal by Subject|0|||
162641589|NCT03745937|587403172|FG001|Overall Study|Withdrawal by Subject|0|||
162641590|NCT03745937|587403173|FG002|Overall Study|Withdrawal by Subject|0|||
162641591|NCT03745937|587403174|FG003|Overall Study|Withdrawal by Subject|1|||
162641592|NCT03745937|587403171|FG000|Overall Study|Not-specifed|0|||
162641593|NCT03745937|587403172|FG001|Overall Study|Not-specifed|1|||
162641594|NCT03745937|587403173|FG002|Overall Study|Not-specifed|0|||
162641595|NCT03745937|587403174|FG003|Overall Study|Not-specifed|1|||
162641596|NCT01190254|587403177|FG000|Overall Study|Adverse Event|3|||
162641597|NCT01190254|587403178|FG001|Overall Study|Adverse Event|6|||
162641598|NCT01190254|587403179|FG002|Overall Study|Adverse Event|8|||
162641599|NCT01190254|587403177|FG000|Overall Study|Lack of Efficacy|7|||
162641600|NCT01190254|587403178|FG001|Overall Study|Lack of Efficacy|4|||
162641601|NCT01190254|587403179|FG002|Overall Study|Lack of Efficacy|5|||
163063332|NCT03314935|588938629|FG012|Phase 2|Study Terminated by Sponsor|1|||
163063333|NCT03314935|588938630|FG013|Phase 2|Study Terminated by Sponsor|4|||
162641602|NCT01190254|587403177|FG000|Overall Study|Lost to Follow-up|4|||
162641603|NCT01190254|587403178|FG001|Overall Study|Lost to Follow-up|2|||
162641604|NCT01190254|587403179|FG002|Overall Study|Lost to Follow-up|0|||
162641605|NCT01190254|587403177|FG000|Overall Study|Withdrawal by Subject|4|||
162641606|NCT01190254|587403178|FG001|Overall Study|Withdrawal by Subject|5|||
162641607|NCT01190254|587403179|FG002|Overall Study|Withdrawal by Subject|7|||
163063334|NCT03314935|588938631|FG014|Phase 2|Study Terminated by Sponsor|4|||
163063335|NCT03314935|588938617|FG000|Phase 2|Lost to Follow-up|0|||
162641608|NCT01190254|587403177|FG000|Overall Study|Protocol Violation|2|||
162641609|NCT01190254|587403178|FG001|Overall Study|Protocol Violation|0|||
162641610|NCT01190254|587403179|FG002|Overall Study|Protocol Violation|2|||
162641611|NCT01190254|587403177|FG000|Overall Study|Did not meet protocol eligibility|1|||
162641612|NCT01190254|587403178|FG001|Overall Study|Did not meet protocol eligibility|0|||
162641613|NCT01190254|587403179|FG002|Overall Study|Did not meet protocol eligibility|0|||
162641614|NCT02356783|587403180|FG000|Overall Study|Lost to Follow-up|1|||
162641615|NCT02356783|587403181|FG001|Overall Study|Lost to Follow-up|3|||
162641616|NCT01485640|587403182|FG000|Overall Study|Adverse Event|10|||
162641617|NCT01485640|587403182|FG000|Overall Study|Lack of Efficacy|2|||
162641618|NCT01485640|587403182|FG000|Overall Study|Protocol Violation|1|||
162641619|NCT01485640|587403182|FG000|Overall Study|Withdrawal by Subject|14|||
162641620|NCT01485640|587403182|FG000|Overall Study|Terminated by Sponsor|95|||
162641621|NCT00202644|587403185|FG000|Overall Study|Adverse Event|12|||
162641622|NCT00202644|587403186|FG001|Overall Study|Adverse Event|13|||
162641623|NCT00202644|587403185|FG000|Overall Study|Withdrawal by Subject|8|||
162641624|NCT00202644|587403186|FG001|Overall Study|Withdrawal by Subject|6|||
162641625|NCT00202644|587403185|FG000|Overall Study|Lack of Efficacy|6|||
162641626|NCT00202644|587403186|FG001|Overall Study|Lack of Efficacy|6|||
162641627|NCT00202644|587403185|FG000|Overall Study|Lost to Follow-up|0|||
162641628|NCT00202644|587403186|FG001|Overall Study|Lost to Follow-up|1|||
162641629|NCT00202644|587403185|FG000|Overall Study|Other|9|||
162641630|NCT00202644|587403186|FG001|Overall Study|Other|1|||
162641631|NCT03232281|587403192|FG000|Overall Study|Adverse Event|1|||
162641632|NCT03232281|587403193|FG001|Overall Study|Adverse Event|1|||
162641633|NCT03232281|587403192|FG000|Overall Study|Withdrawal by Subject|5|||
162641634|NCT03232281|587403193|FG001|Overall Study|Withdrawal by Subject|4|||
162641635|NCT03232281|587403192|FG000|Overall Study|Protocol Deviation|1|||
162641636|NCT03232281|587403193|FG001|Overall Study|Protocol Deviation|1|||
162641637|NCT01372501|587403197|FG000|Overall Study|Adverse Event|4|||
162641638|NCT01372501|587403197|FG000|Overall Study|Device migration|1|||
162641639|NCT05333900|587403198|FG000|Overall Study|Protocol Violation|0|||
162641640|NCT05333900|587403199|FG001|Overall Study|Protocol Violation|1|||
162641641|NCT05333900|587403198|FG000|Overall Study|Withdrawal by Subject|0|||
162641642|NCT05333900|587403199|FG001|Overall Study|Withdrawal by Subject|1|||
162641643|NCT05333900|587403198|FG000|Overall Study|COVID-19 Pandemic|1|||
162641644|NCT05333900|587403199|FG001|Overall Study|COVID-19 Pandemic|1|||
162641645|NCT00573755|587403200|FG000|Overall Study|Still receiving treatment|1|||
162641646|NCT00573755|587403201|FG001|Overall Study|Still receiving treatment|0|||
162641647|NCT03724812|587403202|FG000|Overall Study|Missed Visit|1|||
162716619|NCT04845620|587668523|FG001|Overall Study|Withdrawal by Subject|10|||
162641648|NCT03724812|587403202|FG000|Overall Study|Death|2|||
162641649|NCT03724812|587403202|FG000|Overall Study|Withdrawal by Subject|1|||
162641650|NCT02024867|587403203|FG000|Overall Study|Protocol Violation|3|||
162641651|NCT02024867|587403204|FG001|Overall Study|Protocol Violation|3|||
162641652|NCT02024867|587403203|FG000|Overall Study|Lost to Follow-up|6|||
162641653|NCT02024867|587403204|FG001|Overall Study|Lost to Follow-up|4|||
162641654|NCT01462084|587403206|FG000|Overall Study|Withdrawal by Subject|1|||
162641655|NCT01462084|587403207|FG001|Overall Study|Withdrawal by Subject|0|||
162641656|NCT01462084|587403206|FG000|Overall Study|Protocol Violation|1|||
163019946|NCT02817516|588776305|FG002|Overall Study|Other|1|||
163019947|NCT02817516|588776306|FG003|Overall Study|Other|0|||
163019948|NCT00610155|588776310|FG000|Period 1|Withdrawal by Subject|0|||
163019949|NCT00610155|588776311|FG001|Period 1|Withdrawal by Subject|0|||
163019950|NCT00610155|588776312|FG002|Period 1|Withdrawal by Subject|1|||
163019951|NCT00610155|588776313|FG003|Period 1|Withdrawal by Subject|0|||
163019952|NCT00610155|588776314|FG004|Period 1|Withdrawal by Subject|0|||
163019953|NCT00610155|588776315|FG005|Period 1|Withdrawal by Subject|0|||
163019954|NCT00610155|588776310|FG000|Period 3|Adverse Event|1|||
163019955|NCT00610155|588776311|FG001|Period 3|Adverse Event|0|||
163019956|NCT00610155|588776312|FG002|Period 3|Adverse Event|0|||
163019957|NCT00610155|588776313|FG003|Period 3|Adverse Event|0|||
163019958|NCT00610155|588776314|FG004|Period 3|Adverse Event|0|||
163019959|NCT00610155|588776315|FG005|Period 3|Adverse Event|0|||
163019960|NCT01560234|588776316|FG000|Overall Study|Lost to Follow-up|3|||
163019961|NCT01560234|588776317|FG001|Overall Study|Lost to Follow-up|0|||
163019962|NCT01560234|588776318|FG002|Overall Study|Lost to Follow-up|1|||
163019963|NCT01560234|588776319|FG003|Overall Study|Lost to Follow-up|0|||
163019964|NCT01560234|588776320|FG004|Overall Study|Lost to Follow-up|0|||
163019965|NCT01560234|588776321|FG005|Overall Study|Lost to Follow-up|2|||
163019966|NCT01560234|588776322|FG006|Overall Study|Lost to Follow-up|0|||
163019967|NCT01560234|588776323|FG007|Overall Study|Lost to Follow-up|2|||
163019968|NCT02028767|588776324|FG000|Treatment Period 2|Non compliant with protocol|1|||
163019969|NCT02028767|588776325|FG001|Treatment Period 2|Non compliant with protocol|0|||
163019970|NCT02028767|588776324|FG000|Treatment Period 2|Reason other than those specified above|1|||
163019971|NCT02028767|588776325|FG001|Treatment Period 2|Reason other than those specified above|0|||
163019972|NCT00083759|588776331|FG000|Overall Study|Adverse Event|5|||
163019973|NCT00083759|588776332|FG001|Overall Study|Adverse Event|3|||
163019974|NCT00083759|588776331|FG000|Overall Study|Lost to Follow-up|1|||
163019975|NCT00083759|588776332|FG001|Overall Study|Lost to Follow-up|0|||
163019976|NCT00083759|588776331|FG000|Overall Study|Death|1|||
163019977|NCT00083759|588776332|FG001|Overall Study|Death|1|||
163019978|NCT00083759|588776331|FG000|Overall Study|Inadequate Therapeutic Response|32|||
163019979|NCT00083759|588776332|FG001|Overall Study|Inadequate Therapeutic Response|35|||
163019980|NCT00083759|588776331|FG000|Overall Study|Subject Withdrew Consent|2|||
163019981|NCT00083759|588776332|FG001|Overall Study|Subject Withdrew Consent|2|||
163019982|NCT00083759|588776331|FG000|Overall Study|Non-Compliance|1|||
163019983|NCT00083759|588776332|FG001|Overall Study|Non-Compliance|0|||
163019984|NCT00083759|588776331|FG000|Overall Study|Sponsor's Discretion|28|||
163019985|NCT00083759|588776332|FG001|Overall Study|Sponsor's Discretion|29|||
163019986|NCT00083759|588776331|FG000|Overall Study|Other|14|||
163019987|NCT00083759|588776332|FG001|Overall Study|Other|13|||
163019988|NCT04112043|588776334|FG000|Overall Study|Withdrawal by Subject|1|||
163019989|NCT04112043|588776335|FG001|Overall Study|Withdrawal by Subject|1|||
163019990|NCT04112043|588776336|FG002|Overall Study|Withdrawal by Subject|1|||
163019991|NCT04112043|588776334|FG000|Overall Study|Taking NR supplement|1|||
163019992|NCT04112043|588776335|FG001|Overall Study|Taking NR supplement|0|||
163019993|NCT04112043|588776336|FG002|Overall Study|Taking NR supplement|0|||
163019994|NCT04112043|588776334|FG000|Overall Study|Adverse Event|0|||
163019995|NCT04112043|588776335|FG001|Overall Study|Adverse Event|1|||
163019996|NCT04112043|588776336|FG002|Overall Study|Adverse Event|0|||
163019997|NCT04292912|588776341|FG000|Overall Study|Physician Decision|1|||
163019998|NCT04292912|588776341|FG000|Overall Study|Protocol Violation|6|||
163019999|NCT03348930|588776342|FG000|Washout (1 Week)|Lost to Follow-up|1|||
163020000|NCT03348930|588776343|FG001|Washout (1 Week)|Lost to Follow-up|1|||
163020001|NCT05338502|588776344|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
163020002|NCT05338502|588776345|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
163020003|NCT05338502|588776346|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
163020004|NCT05338502|588776344|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
163020005|NCT05338502|588776345|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
163020006|NCT05338502|588776346|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
162641657|NCT01462084|587403207|FG001|Overall Study|Protocol Violation|1|||
162641658|NCT02369341|587403208|FG000|Overall Study|Migrated/moved from study area|1|||
162641659|NCT02369341|587403209|FG001|Overall Study|Migrated/moved from study area|0|||
163020007|NCT01290679|588776354|FG000|Overall Study|Adverse Event|2|||
163020008|NCT01290679|588776355|FG001|Overall Study|Adverse Event|0|||
163020009|NCT01290679|588776354|FG000|Overall Study|Lost to Follow-up|8|||
163020010|NCT01290679|588776355|FG001|Overall Study|Lost to Follow-up|10|||
163020011|NCT01290679|588776354|FG000|Overall Study|Protocol Violation|0|||
163020012|NCT01290679|588776355|FG001|Overall Study|Protocol Violation|1|||
163020013|NCT01290679|588776354|FG000|Overall Study|Withdrawal by Subject|6|||
163020014|NCT01290679|588776355|FG001|Overall Study|Withdrawal by Subject|5|||
163020015|NCT01290679|588776354|FG000|Overall Study|Subject Entered Another Trial|0|||
163020016|NCT01290679|588776355|FG001|Overall Study|Subject Entered Another Trial|5|||
162641660|NCT02278263|587403212|FG000|Overall Study|Protocol Violation|7|||
162641661|NCT02278263|587403213|FG001|Overall Study|Protocol Violation|0|||
162641662|NCT02278263|587403214|FG002|Overall Study|Protocol Violation|9|||
163063336|NCT03314935|588938618|FG001|Phase 2|Lost to Follow-up|0|||
163063337|NCT03314935|588938619|FG002|Phase 2|Lost to Follow-up|0|||
163063338|NCT03314935|588938620|FG003|Phase 2|Lost to Follow-up|0|||
163063339|NCT03314935|588938621|FG004|Phase 2|Lost to Follow-up|0|||
163063340|NCT03314935|588938622|FG005|Phase 2|Lost to Follow-up|0|||
163063341|NCT03314935|588938623|FG006|Phase 2|Lost to Follow-up|0|||
163063342|NCT03314935|588938624|FG007|Phase 2|Lost to Follow-up|0|||
163063343|NCT03314935|588938625|FG008|Phase 2|Lost to Follow-up|0|||
163063344|NCT03314935|588938626|FG009|Phase 2|Lost to Follow-up|1|||
163063345|NCT03314935|588938627|FG010|Phase 2|Lost to Follow-up|0|||
163063346|NCT03314935|588938628|FG011|Phase 2|Lost to Follow-up|0|||
163063347|NCT03314935|588938629|FG012|Phase 2|Lost to Follow-up|0|||
163063348|NCT03314935|588938630|FG013|Phase 2|Lost to Follow-up|0|||
163063349|NCT03314935|588938631|FG014|Phase 2|Lost to Follow-up|1|||
163063350|NCT03314935|588938617|FG000|Phase 2|Physician Decision|0|||
163063351|NCT03314935|588938618|FG001|Phase 2|Physician Decision|0|||
163063352|NCT03314935|588938619|FG002|Phase 2|Physician Decision|0|||
163063353|NCT03314935|588938620|FG003|Phase 2|Physician Decision|0|||
163063354|NCT03314935|588938621|FG004|Phase 2|Physician Decision|0|||
163063355|NCT03314935|588938622|FG005|Phase 2|Physician Decision|0|||
163063356|NCT03314935|588938623|FG006|Phase 2|Physician Decision|0|||
163063357|NCT03314935|588938624|FG007|Phase 2|Physician Decision|0|||
163063358|NCT03314935|588938625|FG008|Phase 2|Physician Decision|0|||
163063359|NCT03314935|588938626|FG009|Phase 2|Physician Decision|0|||
163063360|NCT03314935|588938627|FG010|Phase 2|Physician Decision|1|||
163063361|NCT03314935|588938628|FG011|Phase 2|Physician Decision|0|||
163063362|NCT03314935|588938629|FG012|Phase 2|Physician Decision|0|||
163063363|NCT03314935|588938630|FG013|Phase 2|Physician Decision|0|||
163063364|NCT03314935|588938631|FG014|Phase 2|Physician Decision|0|||
163063365|NCT05252702|588938632|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
163063366|NCT05252702|588938632|FG000|Overall Study|Death|16|||
163063367|NCT05252702|588938632|FG000|Overall Study|System explant|5|||
163063368|NCT05252702|588938632|FG000|Overall Study|Lost to Follow-up|1|||
163063369|NCT05252702|588938632|FG000|Overall Study|Withdrawn by investigator|1|||
163063370|NCT05252702|588938632|FG000|Overall Study|Visit not due|306|||
163063371|NCT05252702|588938632|FG000|Overall Study|Visit within window but not completed|92|||
163063372|NCT05252702|588938632|FG000|Overall Study|Unsuccessful implant|1|||
163063373|NCT02657551|588938633|FG000|Overall Study|Adverse Event|2|||
163063374|NCT02657551|588938633|FG000|Overall Study|Withdrawal by Subject|1|||
163063375|NCT02657551|588938633|FG000|Overall Study|Non-Compliance|1|||
163063376|NCT02657551|588938633|FG000|Overall Study|Progression / Relapse|4|||
163063377|NCT01192178|588938635|FG000|Overall Study|Withdrawal by Subject|6|||
163063378|NCT01192178|588938636|FG001|Overall Study|Withdrawal by Subject|10|||
163063379|NCT01192178|588938635|FG000|Overall Study|Protocol Violation|10|||
163063380|NCT01192178|588938636|FG001|Overall Study|Protocol Violation|3|||
163063381|NCT01192178|588938635|FG000|Overall Study|Physician Decision|2|||
163063382|NCT01192178|588938636|FG001|Overall Study|Physician Decision|4|||
163063383|NCT01192178|588938635|FG000|Overall Study|Lost to Follow-up|3|||
163063384|NCT01192178|588938636|FG001|Overall Study|Lost to Follow-up|3|||
163063385|NCT01192178|588938635|FG000|Overall Study|Adverse Event|2|||
163063386|NCT01192178|588938636|FG001|Overall Study|Adverse Event|1|||
163063387|NCT01192178|588938635|FG000|Overall Study|Lack of Efficacy|1|||
163063388|NCT01192178|588938636|FG001|Overall Study|Lack of Efficacy|2|||
163063389|NCT02164916|588938637|FG000|Overall Study|Adverse Event|3|||
163063390|NCT02164916|588938638|FG001|Overall Study|Adverse Event|8|||
163063391|NCT02164916|588938637|FG000|Overall Study|Death|1|||
163063392|NCT02164916|588938638|FG001|Overall Study|Death|1|||
163063393|NCT02164916|588938637|FG000|Overall Study|Refusal unrelated to adverse event|3|||
163063394|NCT02164916|588938638|FG001|Overall Study|Refusal unrelated to adverse event|7|||
163063395|NCT02164916|588938637|FG000|Overall Study|Progression|37|||
163063396|NCT02164916|588938638|FG001|Overall Study|Progression|26|||
163063397|NCT02164916|588938637|FG000|Overall Study|Not protocol specified|5|||
163063398|NCT02164916|588938638|FG001|Overall Study|Not protocol specified|1|||
163063399|NCT02164916|588938637|FG000|Overall Study|Reason under review|1|||
163063400|NCT02164916|588938638|FG001|Overall Study|Reason under review|6|||
163063401|NCT02164916|588938637|FG000|Overall Study|Not eligible|2|||
163063402|NCT02164916|588938638|FG001|Overall Study|Not eligible|5|||
163063403|NCT00296517|588938639|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
163063404|NCT00296517|588938640|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
163063405|NCT00296517|588938639|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
163063406|NCT00296517|588938640|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
162716620|NCT04845620|587668522|FG000|Overall Study|Adverse Event|5|||
163063407|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
163063408|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
163063409|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
163063410|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
163063411|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
163063412|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
163063413|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
163063414|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
162641663|NCT01998737|587403215|FG000|Overall Study|Corrupted database|23|||
162641664|NCT01998737|587403216|FG001|Overall Study|Corrupted database|0|||
162641665|NCT02092662|587403218|FG000|Overall Study|Lost to Follow-up|13|||
162641666|NCT02092662|587403219|FG001|Overall Study|Lost to Follow-up|0|||
162641667|NCT00772707|587403220|FG000|Overall Study|Withdrawn|3|||
162641668|NCT01266460|587403222|FG000|Overall Study|Adverse Event|3|||
162641669|NCT01266460|587403222|FG000|Overall Study|Withdrawal by Subject|5|||
162641670|NCT01266460|587403222|FG000|Overall Study|Disease Progression|18|||
162641671|NCT01266460|587403222|FG000|Overall Study|Not otherwise specified|8|||
162641672|NCT01132547|587403223|FG000|Overall Study|Withdrawal by Subject|3|||
162641673|NCT01132547|587403224|FG001|Overall Study|Withdrawal by Subject|1|||
162641674|NCT01132547|587403223|FG000|Overall Study|Death|1|||
162641675|NCT01132547|587403224|FG001|Overall Study|Death|0|||
162641676|NCT05811234|587403225|FG000|Overall Study|Loss of Effectiveness|2|||
162641677|NCT05811234|587403225|FG000|Overall Study|Adverse Event|4|||
162641678|NCT05811234|587403225|FG000|Overall Study|Pregnancy|1|||
162641679|NCT05811234|587403225|FG000|Overall Study|Disease progression|1|||
162641680|NCT05811234|587403225|FG000|Overall Study|Withdrawal by Subject|4|||
162641681|NCT05811234|587403225|FG000|Overall Study|Lost to Follow-up|13|||
163020017|NCT03474731|588776365|FG000|Overall Study|Withdrawal by Subject|36|||
163020018|NCT03474731|588776366|FG001|Overall Study|Withdrawal by Subject|29|||
163020019|NCT03474731|588776367|FG002|Overall Study|Withdrawal by Subject|11|||
163020020|NCT03474731|588776368|FG003|Overall Study|Withdrawal by Subject|27|||
163020021|NCT03474731|588776365|FG000|Overall Study|COVID|0|||
163020022|NCT03474731|588776366|FG001|Overall Study|COVID|23|||
163020023|NCT03474731|588776367|FG002|Overall Study|COVID|0|||
162641682|NCT05811234|587403225|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
162641683|NCT02710045|587403226|FG000|Overall Study|Death|1|||
162641684|NCT02710045|587403227|FG001|Overall Study|Death|2|||
162641685|NCT02710045|587403228|FG002|Overall Study|Death|0|||
162641686|NCT02710045|587403226|FG000|Overall Study|Withdrawal by Subject|6|||
162641687|NCT02710045|587403227|FG001|Overall Study|Withdrawal by Subject|6|||
162641688|NCT02710045|587403228|FG002|Overall Study|Withdrawal by Subject|2|||
162641689|NCT02710045|587403226|FG000|Overall Study|Protocol Violation|1|||
162641690|NCT02710045|587403227|FG001|Overall Study|Protocol Violation|2|||
162641691|NCT02710045|587403228|FG002|Overall Study|Protocol Violation|3|||
162641692|NCT02710045|587403226|FG000|Overall Study|Lost to Follow-up|3|||
162641693|NCT02710045|587403227|FG001|Overall Study|Lost to Follow-up|6|||
162641694|NCT02710045|587403228|FG002|Overall Study|Lost to Follow-up|7|||
162641695|NCT02710045|587403226|FG000|Overall Study|Physician Decision|0|||
162641696|NCT02710045|587403227|FG001|Overall Study|Physician Decision|0|||
162641697|NCT02710045|587403228|FG002|Overall Study|Physician Decision|1|||
162641698|NCT02710045|587403226|FG000|Overall Study|Poor Attendance|0|||
162641699|NCT02710045|587403227|FG001|Overall Study|Poor Attendance|1|||
162641700|NCT02710045|587403228|FG002|Overall Study|Poor Attendance|0|||
162641701|NCT00227305|587403229|FG000|Overall Study|Adverse Event|40|||
162641702|NCT00227305|587403229|FG000|Overall Study|Withdrawal by Subject|42|||
162641703|NCT00227305|587403229|FG000|Overall Study|Lost to Follow-up|33|||
162641704|NCT00227305|587403229|FG000|Overall Study|Study specific discontinuation|13|||
162641705|NCT00227305|587403229|FG000|Overall Study|MOVED OUT OF AREA|3|||
162641706|NCT00227305|587403229|FG000|Overall Study|Lack of Efficacy|7|||
162641707|NCT00227305|587403229|FG000|Overall Study|Physician Decision|3|||
162641708|NCT00227305|587403229|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
162641709|NCT00227305|587403229|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
162641710|NCT00227305|587403229|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
162641711|NCT00857220|587403233|FG000|Overall Study|Adverse Event|35|||
162641712|NCT00857220|587403233|FG000|Overall Study|Death|1|||
163020024|NCT03474731|588776368|FG003|Overall Study|COVID|0|||
163020025|NCT03474731|588776365|FG000|Overall Study|Participant moved from area|1|||
163020026|NCT03474731|588776366|FG001|Overall Study|Participant moved from area|0|||
163020027|NCT03474731|588776367|FG002|Overall Study|Participant moved from area|0|||
163020028|NCT03474731|588776368|FG003|Overall Study|Participant moved from area|0|||
162641713|NCT00857220|587403233|FG000|Overall Study|Lack of Efficacy|11|||
162641714|NCT00857220|587403233|FG000|Overall Study|Lost to Follow-up|30|||
162641715|NCT00857220|587403233|FG000|Overall Study|Physician Decision|4|||
162641716|NCT00857220|587403233|FG000|Overall Study|Protocol Violation|16|||
162641717|NCT00857220|587403233|FG000|Overall Study|Withdrawal by Subject|67|||
162641718|NCT00857220|587403233|FG000|Overall Study|Clinical Hold|6|||
162641719|NCT00857220|587403233|FG000|Overall Study|Site Closed|5|||
163020029|NCT03474731|588776365|FG000|Overall Study|Lost to Follow-up|11|||
163020030|NCT03474731|588776366|FG001|Overall Study|Lost to Follow-up|3|||
163063415|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
162641720|NCT00857220|587403233|FG000|Overall Study|Miscellaneous|8|||
162641721|NCT00137423|587403234|FG000|Overall Study|Adverse Event|7|||
162641722|NCT00137423|587403235|FG001|Overall Study|Adverse Event|9|||
162641723|NCT00137423|587403234|FG000|Overall Study|consent withdrawn|1|||
162641724|NCT00137423|587403235|FG001|Overall Study|consent withdrawn|1|||
163020031|NCT03474731|588776367|FG002|Overall Study|Lost to Follow-up|18|||
163020032|NCT03474731|588776368|FG003|Overall Study|Lost to Follow-up|17|||
163020033|NCT03474731|588776365|FG000|Overall Study|Death|0|||
163020034|NCT03474731|588776366|FG001|Overall Study|Death|1|||
163020035|NCT03474731|588776367|FG002|Overall Study|Death|0|||
163020036|NCT03474731|588776368|FG003|Overall Study|Death|0|||
163020037|NCT03474731|588776365|FG000|Overall Study|Participant Removed|0|||
163020038|NCT03474731|588776366|FG001|Overall Study|Participant Removed|0|||
163020039|NCT03474731|588776367|FG002|Overall Study|Participant Removed|0|||
163020040|NCT03474731|588776368|FG003|Overall Study|Participant Removed|1|||
163020041|NCT00554515|588776369|FG000|Overall Study|Withdrawal by Subject|3|||
163020042|NCT00554515|588776369|FG000|Overall Study|Disease progression|52|||
163020043|NCT00554515|588776369|FG000|Overall Study|Physician Decision|18|||
163020044|NCT00554515|588776369|FG000|Overall Study|Withdrawal by Subject|11|||
163020045|NCT00554515|588776369|FG000|Overall Study|Adverse Event|9|||
163020046|NCT00554515|588776369|FG000|Overall Study|Death|2|||
163020047|NCT00554515|588776369|FG000|Overall Study|Achieved Stable Disease|7|||
163020048|NCT00554515|588776369|FG000|Overall Study|Other|1|||
163020049|NCT00554515|588776369|FG000|Overall Study|Misc|15|||
163020050|NCT03793842|588776377|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
163020051|NCT03793842|588776378|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
163020052|NCT03793842|588776377|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
163020053|NCT03793842|588776378|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
163020054|NCT02549287|588776379|FG000|Overall Study|Lost to Follow-up|65|||
163020055|NCT02549287|588776380|FG001|Overall Study|Lost to Follow-up|26|||
163020056|NCT02549287|588776379|FG000|Overall Study|Withdrawal by Subject|15|||
163020057|NCT02549287|588776380|FG001|Overall Study|Withdrawal by Subject|6|||
163020058|NCT04087720|588776381|FG000|Overall Study|Withdrawal by Subject|2|||
163020059|NCT04087720|588776381|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
163020060|NCT00900159|588776384|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
163020061|NCT00900159|588776385|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
163020062|NCT00765336|588776386|FG000|Overall Study|Protocol Violation|4|||
163020063|NCT00765336|588776387|FG001|Overall Study|Protocol Violation|2|||
163020064|NCT00765336|588776386|FG000|Overall Study|Withdrawal by Subject|6|||
163020065|NCT00765336|588776387|FG001|Overall Study|Withdrawal by Subject|4|||
163020066|NCT00765336|588776386|FG000|Overall Study|Lost to Follow-up|7|||
163020067|NCT00765336|588776387|FG001|Overall Study|Lost to Follow-up|9|||
163020068|NCT00765336|588776386|FG000|Overall Study|Adverse Event|2|||
163020069|NCT00765336|588776387|FG001|Overall Study|Adverse Event|1|||
163020070|NCT01377922|588776388|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
163020071|NCT01377922|588776389|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
163020072|NCT04615403|588776390|FG000|Overall Study|Death|1|||
163020073|NCT00665431|588776391|FG000|Overall Study|Adverse Event|16|||
163020074|NCT00665431|588776392|FG001|Overall Study|Adverse Event|22|||
163020075|NCT00665431|588776393|FG002|Overall Study|Adverse Event|6|||
163020076|NCT00665431|588776391|FG000|Overall Study|Withdrawal by Subject|17|||
163020077|NCT00665431|588776392|FG001|Overall Study|Withdrawal by Subject|25|||
163020078|NCT00665431|588776393|FG002|Overall Study|Withdrawal by Subject|15|||
163020079|NCT00665431|588776391|FG000|Overall Study|Lost to Follow-up|3|||
163020080|NCT00665431|588776392|FG001|Overall Study|Lost to Follow-up|3|||
163020081|NCT00665431|588776393|FG002|Overall Study|Lost to Follow-up|1|||
163020082|NCT00665431|588776391|FG000|Overall Study|Other|4|||
163020083|NCT00665431|588776392|FG001|Overall Study|Other|7|||
163020084|NCT00665431|588776393|FG002|Overall Study|Other|2|||
163020085|NCT02547220|588776394|FG000|Overall Study|Withdrawal by Subject|1|||
163020086|NCT02547220|588776395|FG001|Overall Study|Withdrawal by Subject|0|||
163020087|NCT02547220|588776394|FG000|Overall Study|Study terminated by sponsor|18|||
163020088|NCT02547220|588776395|FG001|Overall Study|Study terminated by sponsor|20|||
163020089|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
163020090|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
163020091|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
163020092|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
163020093|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020094|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
163020095|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020096|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
163020097|NCT03817229|588776396|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
163020098|NCT03817229|588776397|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
163020099|NCT03817229|588776398|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
163020100|NCT03817229|588776399|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
163020101|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
163020102|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
163020103|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
163020104|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
163020105|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
163020106|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
162716621|NCT04845620|587668523|FG001|Overall Study|Adverse Event|4|||
163063416|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
163063417|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
163063418|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
163063419|NCT00296517|588938639|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
163063420|NCT00296517|588938640|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
163063421|NCT00596635|588938645|FG000|Overall Study|Lost to Follow-up|0|||
163063422|NCT00596635|588938646|FG001|Overall Study|Lost to Follow-up|2|||
163063423|NCT00596635|588938647|FG002|Overall Study|Lost to Follow-up|0|||
163063424|NCT00596635|588938645|FG000|Overall Study|Treatment for symptomatic UTI|4|||
163063425|NCT00596635|588938646|FG001|Overall Study|Treatment for symptomatic UTI|6|||
163063426|NCT00596635|588938647|FG002|Overall Study|Treatment for symptomatic UTI|3|||
163063427|NCT00596635|588938645|FG000|Overall Study|Hip fracture|2|||
163063428|NCT00596635|588938646|FG001|Overall Study|Hip fracture|3|||
163063429|NCT00596635|588938647|FG002|Overall Study|Hip fracture|3|||
163063430|NCT00596635|588938645|FG000|Overall Study|Could not provide urine specimen|1|||
163063431|NCT00596635|588938646|FG001|Overall Study|Could not provide urine specimen|2|||
163063432|NCT00596635|588938647|FG002|Overall Study|Could not provide urine specimen|2|||
163063433|NCT01143324|588938650|FG000|Overall Study|Lost to Follow-up|11|||
163063434|NCT01143324|588938650|FG000|Overall Study|Withdrawal by Subject|4|||
163063435|NCT01143324|588938650|FG000|Overall Study|Explant of the device|4|||
163063436|NCT00858988|588938655|FG000|Analysis|Lactulose unable to be detected in urine|2|||
163063437|NCT00858988|588938656|FG001|Analysis|Lactulose unable to be detected in urine|1|||
163063438|NCT00846365|588938659|FG000|Overall Study|Adverse Event|20|||
163063439|NCT00846365|588938660|FG001|Overall Study|Adverse Event|30|||
163063440|NCT00846365|588938661|FG002|Overall Study|Adverse Event|11|||
163063441|NCT00846365|588938659|FG000|Overall Study|Protocol Violation|5|||
163063442|NCT00846365|588938660|FG001|Overall Study|Protocol Violation|4|||
163063443|NCT00846365|588938661|FG002|Overall Study|Protocol Violation|0|||
163063444|NCT00846365|588938659|FG000|Overall Study|Lost to Follow-up|8|||
163063445|NCT00846365|588938660|FG001|Overall Study|Lost to Follow-up|2|||
163063446|NCT00846365|588938661|FG002|Overall Study|Lost to Follow-up|5|||
163063447|NCT00846365|588938659|FG000|Overall Study|Withdrawal by Subject|11|||
163063448|NCT00846365|588938660|FG001|Overall Study|Withdrawal by Subject|11|||
163063449|NCT00846365|588938661|FG002|Overall Study|Withdrawal by Subject|9|||
163063450|NCT00846365|588938659|FG000|Overall Study|Pregnancy|1|||
163063451|NCT00846365|588938660|FG001|Overall Study|Pregnancy|0|||
163063452|NCT00846365|588938661|FG002|Overall Study|Pregnancy|0|||
163063453|NCT00846365|588938659|FG000|Overall Study|Lack of Efficacy|1|||
163063454|NCT00846365|588938660|FG001|Overall Study|Lack of Efficacy|1|||
163063455|NCT00846365|588938661|FG002|Overall Study|Lack of Efficacy|2|||
163063456|NCT00846365|588938659|FG000|Overall Study|Other|9|||
163063457|NCT00846365|588938660|FG001|Overall Study|Other|1|||
163063458|NCT00846365|588938661|FG002|Overall Study|Other|6|||
163063459|NCT01277861|588938669|FG000|Overall Study|Physician Decision|2|||
163063460|NCT01277861|588938670|FG001|Overall Study|Physician Decision|2|||
163063461|NCT05032196|588938671|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063462|NCT05032196|588938672|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
163063463|NCT05032196|588938673|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063464|NCT05032196|588938674|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063465|NCT05032196|588938675|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063466|NCT05032196|588938676|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
163063467|NCT05032196|588938671|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063468|NCT05032196|588938672|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063469|NCT05032196|588938673|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063470|NCT05032196|588938674|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
163063471|NCT05032196|588938675|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063472|NCT05032196|588938676|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
163063473|NCT05032196|588938671|FG000|Period 2 (Multidose)|Physician Decision|0|||
163063474|NCT05032196|588938672|FG001|Period 2 (Multidose)|Physician Decision|0|||
163020107|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
163020108|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
163020109|NCT03817229|588776396|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
163020110|NCT03817229|588776397|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
163020111|NCT03817229|588776398|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
163020112|NCT03817229|588776399|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
163020113|NCT03817229|588776396|FG000|Post-Intervention|Withdrawal by Subject|6|||
163020114|NCT03817229|588776397|FG001|Post-Intervention|Withdrawal by Subject|0|||
163063475|NCT05032196|588938673|FG002|Period 2 (Multidose)|Physician Decision|0|||
163063476|NCT05032196|588938674|FG003|Period 2 (Multidose)|Physician Decision|0|||
163063477|NCT05032196|588938675|FG004|Period 2 (Multidose)|Physician Decision|1|||
163063478|NCT05032196|588938676|FG005|Period 2 (Multidose)|Physician Decision|0|||
163063479|NCT00857389|588938677|FG000|Overall Study|Did not proceed to transplant|2|||
162641725|NCT00137423|587403234|FG000|Overall Study|Lack of Efficacy|31|||
162641726|NCT00137423|587403235|FG001|Overall Study|Lack of Efficacy|33|||
162641727|NCT00137423|587403234|FG000|Overall Study|Death|0|||
162641728|NCT00137423|587403235|FG001|Overall Study|Death|1|||
162641729|NCT03187262|587403236|FG000|Induction|Lack of Efficacy|2|||
162641730|NCT03187262|587403236|FG000|Induction|Progressive Disease|4|||
162641731|NCT03187262|587403236|FG000|Consolidation|Progressive Disease|5|||
162641732|NCT00278109|587403238|FG000|Overall Study|Adverse Event|3|||
162641733|NCT00278109|587403238|FG000|Overall Study|social circumstances|1|||
162641734|NCT02580357|587403239|FG000|Overall Study|Lost to Follow-up|2|||
162641735|NCT02580357|587403240|FG001|Overall Study|Lost to Follow-up|0|||
162641736|NCT02580357|587403241|FG002|Overall Study|Lost to Follow-up|0|||
162641737|NCT02580357|587403239|FG000|Overall Study|Protocol Violation|1|||
162641738|NCT02580357|587403240|FG001|Overall Study|Protocol Violation|0|||
162641739|NCT02580357|587403241|FG002|Overall Study|Protocol Violation|0|||
162641740|NCT04339296|587403245|FG000|Overall Study|Refuse to participate after allocation|1|||
162641741|NCT04339296|587403246|FG001|Overall Study|Refuse to participate after allocation|1|||
162641742|NCT04339296|587403245|FG000|Overall Study|Withdrew after completion of baseline|2|||
162641743|NCT04339296|587403246|FG001|Overall Study|Withdrew after completion of baseline|1|||
162641744|NCT04339296|587403245|FG000|Overall Study|Lost to Follow-up|0|||
162641745|NCT04339296|587403246|FG001|Overall Study|Lost to Follow-up|4|||
162641746|NCT04339296|587403245|FG000|Overall Study|Discontinued intervention|5|||
162641747|NCT04339296|587403246|FG001|Overall Study|Discontinued intervention|3|||
162641748|NCT03424265|587403247|FG000|Overall Study|screening failure|1|||
162641749|NCT03424265|587403248|FG001|Overall Study|screening failure|0|||
162641750|NCT03424265|587403247|FG000|Overall Study|Withdrawal by Subject|0|||
162641751|NCT03424265|587403248|FG001|Overall Study|Withdrawal by Subject|2|||
162641752|NCT00453544|587403249|FG000|Overall Study|Withdrawal by Subject|1|||
162641753|NCT00453544|587403250|FG001|Overall Study|Withdrawal by Subject|0|||
162641754|NCT00453544|587403251|FG002|Overall Study|Withdrawal by Subject|0|||
162641755|NCT00453544|587403252|FG003|Overall Study|Withdrawal by Subject|0|||
162641756|NCT00453544|587403249|FG000|Overall Study|Primary outcome measure not completed|1|||
162641757|NCT00453544|587403250|FG001|Overall Study|Primary outcome measure not completed|1|||
162641758|NCT00453544|587403251|FG002|Overall Study|Primary outcome measure not completed|0|||
162641759|NCT00453544|587403252|FG003|Overall Study|Primary outcome measure not completed|1|||
162641760|NCT01558752|587403253|FG000|Overall Study|Physician Decision|2|||
162641761|NCT01558752|587403254|FG001|Overall Study|Physician Decision|0|||
162641762|NCT01829230|587403255|FG000|Overall Study|Protocol Violation|0|||
162641763|NCT01829230|587403256|FG001|Overall Study|Protocol Violation|2|||
162641764|NCT01829230|587403255|FG000|Overall Study|Withdrawal by Subject|0|||
162641765|NCT01829230|587403256|FG001|Overall Study|Withdrawal by Subject|1|||
162641766|NCT01829230|587403255|FG000|Overall Study|Lost to Follow-up|1|||
162641767|NCT01829230|587403256|FG001|Overall Study|Lost to Follow-up|1|||
162641768|NCT00969150|587403257|FG000|Overall Study|Adverse Event|4|||
162641769|NCT00969150|587403258|FG001|Overall Study|Adverse Event|14|||
162641770|NCT00969150|587403257|FG000|Overall Study|Lack of Efficacy|1|||
162641771|NCT00969150|587403258|FG001|Overall Study|Lack of Efficacy|1|||
162641772|NCT00969150|587403257|FG000|Overall Study|Protocol Violation|9|||
163020115|NCT03817229|588776398|FG002|Post-Intervention|Withdrawal by Subject|2|||
163063480|NCT00764517|588939884|FG000|Overall Study|Adverse Event|9|||
163063481|NCT00764517|588939885|FG001|Overall Study|Adverse Event|3|||
162641773|NCT00969150|587403258|FG001|Overall Study|Protocol Violation|12|||
162641774|NCT00969150|587403257|FG000|Overall Study|Withdrawal by Subject|13|||
162641775|NCT00969150|587403258|FG001|Overall Study|Withdrawal by Subject|9|||
162641776|NCT00969150|587403257|FG000|Overall Study|Lost to Follow-up|5|||
162641777|NCT00969150|587403258|FG001|Overall Study|Lost to Follow-up|4|||
162641778|NCT00969150|587403257|FG000|Overall Study|Other reasons|1|||
162641779|NCT00969150|587403258|FG001|Overall Study|Other reasons|0|||
162641780|NCT00461682|587403259|FG000|Overall Study|Protocol Violation|1|||
163063482|NCT00764517|588939884|FG000|Overall Study|Death|3|||
163063483|NCT00764517|588939885|FG001|Overall Study|Death|11|||
163063484|NCT00764517|588939884|FG000|Overall Study|Physician Decision|3|||
162641781|NCT01367158|587403260|FG000|Overall Study|Withdrew consent|0|||
162641782|NCT01367158|587403261|FG001|Overall Study|Withdrew consent|2|||
162641783|NCT01367158|587403262|FG002|Overall Study|Withdrew consent|1|||
162641784|NCT01367158|587403263|FG003|Overall Study|Withdrew consent|0|||
162641785|NCT01367158|587403264|FG004|Overall Study|Withdrew consent|2|||
162641786|NCT01367158|587403265|FG005|Overall Study|Withdrew consent|0|||
163063485|NCT00764517|588939885|FG001|Overall Study|Physician Decision|0|||
163063486|NCT00460798|588939886|FG000|Overall Study|Death|59|||
163063487|NCT00460798|588939886|FG000|Overall Study|Adverse Event|27|||
163063488|NCT00460798|588939886|FG000|Overall Study|Lost to Follow-up|19|||
163063489|NCT00460798|588939886|FG000|Overall Study|Progressive Disease|99|||
163063490|NCT00460798|588939886|FG000|Overall Study|Other|27|||
163063491|NCT00460798|588939886|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
163063492|NCT00460798|588939886|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
163063493|NCT03517137|588939892|FG000|Overall Study|Lack of Efficacy|1|||
163063494|NCT03517137|588939892|FG000|Overall Study|Adverse Event|2|||
163063495|NCT03517137|588939892|FG000|Overall Study|Withdrawal by Subject|2|||
163063496|NCT03517137|588939892|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
163063497|NCT01186770|588939893|FG000|Overall Study|Ineligibility|0|||
163063498|NCT01186770|588939894|FG001|Overall Study|Ineligibility|0|||
163063499|NCT01186770|588939895|FG002|Overall Study|Ineligibility|2|||
163063500|NCT01186770|588939896|FG003|Overall Study|Ineligibility|0|||
163063501|NCT01186770|588939893|FG000|Overall Study|Protocol Violation|7|||
163063502|NCT01186770|588939894|FG001|Overall Study|Protocol Violation|9|||
163063503|NCT01186770|588939895|FG002|Overall Study|Protocol Violation|12|||
163063504|NCT01186770|588939896|FG003|Overall Study|Protocol Violation|14|||
163063505|NCT01186770|588939893|FG000|Overall Study|Adverse Event|2|||
163063506|NCT01186770|588939894|FG001|Overall Study|Adverse Event|9|||
163063507|NCT01186770|588939895|FG002|Overall Study|Adverse Event|7|||
163063508|NCT01186770|588939896|FG003|Overall Study|Adverse Event|9|||
163063509|NCT01186770|588939893|FG000|Overall Study|Withdrawal by Subject|15|||
163063510|NCT01186770|588939894|FG001|Overall Study|Withdrawal by Subject|13|||
163063511|NCT01186770|588939895|FG002|Overall Study|Withdrawal by Subject|11|||
163063512|NCT01186770|588939896|FG003|Overall Study|Withdrawal by Subject|17|||
163063513|NCT01186770|588939893|FG000|Overall Study|Lost to Follow-up|10|||
163063514|NCT01186770|588939894|FG001|Overall Study|Lost to Follow-up|6|||
163063515|NCT01186770|588939895|FG002|Overall Study|Lost to Follow-up|14|||
163063516|NCT01186770|588939896|FG003|Overall Study|Lost to Follow-up|9|||
163063517|NCT01186770|588939893|FG000|Overall Study|Insufficient response to treatment|7|||
163063518|NCT01186770|588939894|FG001|Overall Study|Insufficient response to treatment|8|||
163063519|NCT01186770|588939895|FG002|Overall Study|Insufficient response to treatment|5|||
163063520|NCT01186770|588939896|FG003|Overall Study|Insufficient response to treatment|7|||
163063521|NCT01186770|588939893|FG000|Overall Study|Other than specified|0|||
163063522|NCT01186770|588939894|FG001|Overall Study|Other than specified|1|||
163063523|NCT01186770|588939895|FG002|Overall Study|Other than specified|1|||
163063524|NCT01186770|588939896|FG003|Overall Study|Other than specified|2|||
163063525|NCT02441283|588939897|FG000|Overall Study|Withdrew consent|15|||
163063526|NCT02441283|588939897|FG000|Overall Study|Lost to Follow-up|42|||
163063527|NCT02441283|588939897|FG000|Overall Study|Death|1|||
163063528|NCT02441283|588939897|FG000|Overall Study|Other, not specified|32|||
163063529|NCT02472353|588939899|FG000|Overall Study|Lost to Follow-up|1|||
163063530|NCT02472353|588939900|FG001|Overall Study|Lost to Follow-up|1|||
162641787|NCT01367158|587403266|FG006|Overall Study|Withdrew consent|0|||
162641788|NCT01367158|587403267|FG007|Overall Study|Withdrew consent|1|||
162641789|NCT01367158|587403268|FG008|Overall Study|Withdrew consent|0|||
162641790|NCT01367158|587403269|FG009|Overall Study|Withdrew consent|0|||
162641791|NCT01367158|587403270|FG010|Overall Study|Withdrew consent|0|||
162716622|NCT04845620|587668522|FG000|Overall Study|Lost to Follow-up|5|||
163063531|NCT02472353|588939899|FG000|Overall Study|Withdrawal by Subject|2|||
163063532|NCT02472353|588939900|FG001|Overall Study|Withdrawal by Subject|1|||
163063533|NCT02472353|588939899|FG000|Overall Study|Study Termination|1|||
163063534|NCT02472353|588939900|FG001|Overall Study|Study Termination|4|||
163063535|NCT00688597|588939901|FG000|Overall Study|Adverse Event|2|||
163063536|NCT00688597|588939902|FG001|Overall Study|Adverse Event|0|||
163063537|NCT00688597|588939903|FG002|Overall Study|Adverse Event|0|||
163063538|NCT00688597|588939901|FG000|Overall Study|Physician Decision|1|||
163063539|NCT00688597|588939902|FG001|Overall Study|Physician Decision|0|||
163063540|NCT00688597|588939903|FG002|Overall Study|Physician Decision|0|||
163063541|NCT01995201|588939904|FG000|From Baseline Until Week 24|Adverse Event|4|||
163063542|NCT01995201|588939905|FG001|From Baseline Until Week 24|Adverse Event|15|||
162641792|NCT01367158|587403260|FG000|Overall Study|Lost to Follow-up|0|||
163063543|NCT01995201|588939906|FG002|From Baseline Until Week 24|Adverse Event|0|||
163063544|NCT01995201|588939907|FG003|From Baseline Until Week 24|Adverse Event|0|||
163063545|NCT01995201|588939908|FG004|From Baseline Until Week 24|Adverse Event|0|||
163063546|NCT01995201|588939909|FG005|From Baseline Until Week 24|Adverse Event|0|||
163063547|NCT01995201|588939910|FG006|From Baseline Until Week 24|Adverse Event|0|||
163063548|NCT01995201|588939904|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063549|NCT01995201|588939905|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
162641793|NCT01367158|587403261|FG001|Overall Study|Lost to Follow-up|0|||
162641794|NCT01367158|587403262|FG002|Overall Study|Lost to Follow-up|0|||
162641795|NCT01367158|587403263|FG003|Overall Study|Lost to Follow-up|1|||
162641796|NCT01367158|587403264|FG004|Overall Study|Lost to Follow-up|0|||
162641797|NCT01367158|587403265|FG005|Overall Study|Lost to Follow-up|2|||
162641798|NCT01367158|587403266|FG006|Overall Study|Lost to Follow-up|0|||
162641799|NCT01367158|587403267|FG007|Overall Study|Lost to Follow-up|1|||
162641800|NCT01367158|587403268|FG008|Overall Study|Lost to Follow-up|0|||
162641801|NCT01367158|587403269|FG009|Overall Study|Lost to Follow-up|0|||
162641802|NCT01367158|587403270|FG010|Overall Study|Lost to Follow-up|1|||
162641803|NCT01367158|587403260|FG000|Overall Study|Protocol Violation|0|||
162641804|NCT01367158|587403261|FG001|Overall Study|Protocol Violation|1|||
162641805|NCT01367158|587403262|FG002|Overall Study|Protocol Violation|0|||
162641806|NCT01367158|587403263|FG003|Overall Study|Protocol Violation|0|||
162641807|NCT01367158|587403264|FG004|Overall Study|Protocol Violation|0|||
162641808|NCT01367158|587403265|FG005|Overall Study|Protocol Violation|0|||
162641809|NCT01367158|587403266|FG006|Overall Study|Protocol Violation|0|||
162641810|NCT01367158|587403267|FG007|Overall Study|Protocol Violation|0|||
163020116|NCT03817229|588776399|FG003|Post-Intervention|Withdrawal by Subject|2|||
162641811|NCT01367158|587403268|FG008|Overall Study|Protocol Violation|0|||
162641812|NCT01367158|587403269|FG009|Overall Study|Protocol Violation|0|||
162641813|NCT01367158|587403270|FG010|Overall Study|Protocol Violation|0|||
162641814|NCT01765153|587403271|FG000|Training Phase 1|Format of intervention differed|1|||
162641815|NCT01765153|587403272|FG001|Training Phase 1|Format of intervention differed|0|||
162641816|NCT01765153|587403271|FG000|Training Phase 1|Poor participation in intervention|0|||
162641817|NCT01765153|587403272|FG001|Training Phase 1|Poor participation in intervention|1|||
162641818|NCT01765153|587403271|FG000|Rest Phase 1|Withdrawal by Subject|0|||
162641819|NCT01765153|587403272|FG001|Rest Phase 1|Withdrawal by Subject|1|||
162641820|NCT01765153|587403271|FG000|Training Phase 2|Withdrawal by Subject|0|||
162641821|NCT01765153|587403272|FG001|Training Phase 2|Withdrawal by Subject|1|||
162641822|NCT01765153|587403271|FG000|Rest Phase 2|Lost to Follow-up|2|||
162641823|NCT01765153|587403272|FG001|Rest Phase 2|Lost to Follow-up|1|||
162641824|NCT02663674|587403273|FG000|Overall Study|Lost to Follow-up|5|||
162641825|NCT02663674|587403274|FG001|Overall Study|Lost to Follow-up|4|||
162641826|NCT02663674|587403273|FG000|Overall Study|Withdrawal by Subject|1|||
162641827|NCT02663674|587403274|FG001|Overall Study|Withdrawal by Subject|4|||
162641828|NCT02663674|587403273|FG000|Overall Study|Physician Decision|1|||
162641829|NCT02663674|587403274|FG001|Overall Study|Physician Decision|1|||
162641830|NCT02663674|587403273|FG000|Overall Study|Other Event (Health Related)|0|||
162641831|NCT02663674|587403274|FG001|Overall Study|Other Event (Health Related)|1|||
162641832|NCT01386554|587403277|FG000|Overall Study|Lost to Follow-up|0|||
162641833|NCT01386554|587403278|FG001|Overall Study|Lost to Follow-up|0|||
162641834|NCT01386554|587403279|FG002|Overall Study|Lost to Follow-up|1|||
162641835|NCT01386554|587403277|FG000|Overall Study|Adverse Event|2|||
162641836|NCT01386554|587403278|FG001|Overall Study|Adverse Event|5|||
162641837|NCT01386554|587403279|FG002|Overall Study|Adverse Event|2|||
162641838|NCT01386554|587403277|FG000|Overall Study|Progressive disease|1|||
162641839|NCT01386554|587403278|FG001|Overall Study|Progressive disease|2|||
162641840|NCT01386554|587403279|FG002|Overall Study|Progressive disease|2|||
162641841|NCT01386554|587403277|FG000|Overall Study|Administration of live vaccines|0|||
162641842|NCT01386554|587403278|FG001|Overall Study|Administration of live vaccines|1|||
162641843|NCT01386554|587403279|FG002|Overall Study|Administration of live vaccines|0|||
162641844|NCT01386554|587403277|FG000|Overall Study|Investigator discretion|0|||
162641845|NCT01386554|587403278|FG001|Overall Study|Investigator discretion|0|||
162641846|NCT01386554|587403279|FG002|Overall Study|Investigator discretion|1|||
162641847|NCT01386554|587403277|FG000|Overall Study|Reason not collected|0|||
162641848|NCT01386554|587403278|FG001|Overall Study|Reason not collected|1|||
162641849|NCT01386554|587403279|FG002|Overall Study|Reason not collected|0|||
162641850|NCT00353262|587403280|FG000|Overall Study|Adverse Event|8|||
162641851|NCT00353262|587403280|FG000|Overall Study|Withdrawal by Subject|2|||
162641852|NCT00353262|587403280|FG000|Overall Study|Insufficient Therapeutic Response|13|||
162641853|NCT00353262|587403280|FG000|Overall Study|Progression|1|||
162641854|NCT00353262|587403280|FG000|Overall Study|Surgery|4|||
163020117|NCT03817229|588776396|FG000|Post-Intervention|Withdrawal by Study Team|3|||
162716623|NCT04845620|587668523|FG001|Overall Study|Lost to Follow-up|4|||
162641855|NCT00353262|587403280|FG000|Overall Study|Break from Chemotherapy|1|||
162641856|NCT04166513|587403281|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
162641857|NCT04166513|587403282|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
162641858|NCT04166513|587403283|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
162641859|NCT04166513|587403284|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
162641860|NCT04166513|587403281|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
162641861|NCT04166513|587403282|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
162641862|NCT04166513|587403283|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
162641863|NCT04166513|587403284|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
162641864|NCT04166513|587403281|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
162641865|NCT04166513|587403282|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
162716624|NCT04845620|587668522|FG000|Overall Study|Lack of Efficacy|4|||
162716625|NCT04845620|587668523|FG001|Overall Study|Lack of Efficacy|4|||
163020118|NCT03817229|588776397|FG001|Post-Intervention|Withdrawal by Study Team|1|||
163020119|NCT03817229|588776398|FG002|Post-Intervention|Withdrawal by Study Team|1|||
163020120|NCT03817229|588776399|FG003|Post-Intervention|Withdrawal by Study Team|4|||
163020121|NCT03817229|588776396|FG000|Post-Intervention|Weaned from medication|3|||
163020122|NCT03817229|588776397|FG001|Post-Intervention|Weaned from medication|0|||
163020123|NCT03817229|588776398|FG002|Post-Intervention|Weaned from medication|2|||
163020124|NCT03817229|588776399|FG003|Post-Intervention|Weaned from medication|1|||
163020125|NCT03817229|588776396|FG000|Post-Intervention|Transferred care to another institution|1|||
163020126|NCT03817229|588776397|FG001|Post-Intervention|Transferred care to another institution|0|||
163020127|NCT03817229|588776398|FG002|Post-Intervention|Transferred care to another institution|0|||
162716626|NCT04845620|587668522|FG000|Overall Study|Physician Decision|2|||
163020128|NCT03817229|588776399|FG003|Post-Intervention|Transferred care to another institution|0|||
163020129|NCT03817229|588776396|FG000|Post-Intervention|Change in parental guardianship|0|||
163020130|NCT03817229|588776397|FG001|Post-Intervention|Change in parental guardianship|0|||
163020131|NCT03817229|588776398|FG002|Post-Intervention|Change in parental guardianship|1|||
163020132|NCT03817229|588776399|FG003|Post-Intervention|Change in parental guardianship|0|||
163020133|NCT03817229|588776396|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
163020134|NCT03817229|588776397|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
163020135|NCT03817229|588776398|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
163020136|NCT03817229|588776399|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
163020137|NCT03817229|588776396|FG000|Follow-up 1|Withdrawal by Subject|1|||
163020138|NCT03817229|588776397|FG001|Follow-up 1|Withdrawal by Subject|2|||
163020139|NCT03817229|588776398|FG002|Follow-up 1|Withdrawal by Subject|0|||
163020140|NCT03817229|588776399|FG003|Follow-up 1|Withdrawal by Subject|0|||
163020141|NCT03817229|588776396|FG000|Follow-up 1|Withdrawal by Study Team|3|||
163020142|NCT03817229|588776397|FG001|Follow-up 1|Withdrawal by Study Team|1|||
163020143|NCT03817229|588776398|FG002|Follow-up 1|Withdrawal by Study Team|0|||
163020144|NCT03817229|588776399|FG003|Follow-up 1|Withdrawal by Study Team|0|||
163020145|NCT03817229|588776396|FG000|Follow-up 1|Wean from medication|3|||
163020146|NCT03817229|588776397|FG001|Follow-up 1|Wean from medication|4|||
163020147|NCT03817229|588776398|FG002|Follow-up 1|Wean from medication|0|||
163020148|NCT03817229|588776399|FG003|Follow-up 1|Wean from medication|1|||
163020149|NCT03817229|588776396|FG000|Follow-up 1|Transferred care to another hospital|1|||
163020150|NCT03817229|588776397|FG001|Follow-up 1|Transferred care to another hospital|0|||
163020151|NCT03817229|588776398|FG002|Follow-up 1|Transferred care to another hospital|0|||
163020152|NCT03817229|588776399|FG003|Follow-up 1|Transferred care to another hospital|0|||
163020153|NCT03817229|588776396|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
163020154|NCT03817229|588776397|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
163020155|NCT03817229|588776398|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
163020156|NCT03817229|588776399|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
163020157|NCT03817229|588776396|FG000|Follow-up 2|Withdrawal by Subject|2|||
163020158|NCT03817229|588776397|FG001|Follow-up 2|Withdrawal by Subject|0|||
163020159|NCT03817229|588776398|FG002|Follow-up 2|Withdrawal by Subject|1|||
163020160|NCT03817229|588776399|FG003|Follow-up 2|Withdrawal by Subject|1|||
163020161|NCT03817229|588776396|FG000|Follow-up 2|Withdrawal by Study Team|2|||
163020162|NCT03817229|588776397|FG001|Follow-up 2|Withdrawal by Study Team|0|||
163020163|NCT03817229|588776398|FG002|Follow-up 2|Withdrawal by Study Team|1|||
163020164|NCT03817229|588776399|FG003|Follow-up 2|Withdrawal by Study Team|0|||
163020165|NCT03817229|588776396|FG000|Follow-up 2|Wean from medication|1|||
163020166|NCT03817229|588776397|FG001|Follow-up 2|Wean from medication|0|||
163020167|NCT03817229|588776398|FG002|Follow-up 2|Wean from medication|0|||
163020168|NCT03817229|588776399|FG003|Follow-up 2|Wean from medication|0|||
162641866|NCT04166513|587403283|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
162641867|NCT04166513|587403284|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
162641868|NCT04166513|587403281|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
162641869|NCT04166513|587403282|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
162641870|NCT04166513|587403283|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
162641871|NCT04166513|587403284|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
162641872|NCT04166513|587403281|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
162641873|NCT04166513|587403282|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
162641874|NCT04166513|587403283|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
162641875|NCT04166513|587403284|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
162641876|NCT05286307|587403285|FG000|Overall Study|Incomplete outcome assessments|2|||
162641877|NCT05286307|587403286|FG001|Overall Study|Incomplete outcome assessments|1|||
162641878|NCT05286307|587403285|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
162641879|NCT05286307|587403286|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
162641880|NCT05286307|587403285|FG000|Overall Study|Lost to follow up at 6 months|25|||
162641881|NCT05286307|587403286|FG001|Overall Study|Lost to follow up at 6 months|35|||
162641882|NCT05286307|587403285|FG000|Overall Study|Study medication not available|1|||
162641883|NCT05286307|587403286|FG001|Overall Study|Study medication not available|1|||
162641884|NCT04568590|587404544|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
162641885|NCT02489344|587404545|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
162641886|NCT02489344|587404545|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
162641887|NCT02489344|587404545|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
162641888|NCT02489344|587404545|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
162641889|NCT01132482|587404546|FG000|Overall Study|Adverse Event|1|||
162641890|NCT01132482|587404547|FG001|Overall Study|Adverse Event|0|||
163020169|NCT03817229|588776396|FG000|Follow-up 2|Transferred care|0|||
163020170|NCT03817229|588776397|FG001|Follow-up 2|Transferred care|0|||
163020171|NCT03817229|588776398|FG002|Follow-up 2|Transferred care|1|||
163020172|NCT03817229|588776399|FG003|Follow-up 2|Transferred care|0|||
163020173|NCT02887183|588776401|FG000|Overall Study|Adverse Event|44|||
163020174|NCT02887183|588776401|FG000|Overall Study|Death|30|||
163020175|NCT02887183|588776401|FG000|Overall Study|Pregnancy|1|||
163020176|NCT02887183|588776401|FG000|Overall Study|Protocol Violation|6|||
163020177|NCT02887183|588776401|FG000|Overall Study|Technical Problems|2|||
163020178|NCT02887183|588776401|FG000|Overall Study|Lost to Follow-up|13|||
163020179|NCT02887183|588776401|FG000|Overall Study|Physician Decision|10|||
163020180|NCT02887183|588776401|FG000|Overall Study|Withdrawal by Subject|35|||
163020181|NCT03634033|588777870|FG000|Overall Study|Did not have a post-assessment|384|||
163020182|NCT03634033|588777871|FG001|Overall Study|Did not have a post-assessment|291|||
163020183|NCT03634033|588777872|FG002|Overall Study|Did not have a post-assessment|114|||
163020184|NCT03634033|588777873|FG003|Overall Study|Did not have a post-assessment|161|||
163020185|NCT03634033|588777874|FG004|Overall Study|Did not have a post-assessment|5|||
163020186|NCT03634033|588777875|FG005|Overall Study|Did not have a post-assessment|0|||
163020187|NCT03634033|588777876|FG006|Overall Study|Did not have a post-assessment|0|||
163020188|NCT03634033|588777870|FG000|Overall Study|Death|0|||
163020189|NCT03634033|588777871|FG001|Overall Study|Death|0|||
163020190|NCT03634033|588777872|FG002|Overall Study|Death|0|||
163020191|NCT03634033|588777873|FG003|Overall Study|Death|0|||
163020192|NCT03634033|588777874|FG004|Overall Study|Death|0|||
163020193|NCT03634033|588777875|FG005|Overall Study|Death|7|||
163020194|NCT03634033|588777876|FG006|Overall Study|Death|7|||
163020195|NCT03634033|588777870|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020196|NCT03634033|588777871|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020197|NCT03634033|588777872|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020198|NCT03634033|588777873|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020199|NCT03634033|588777874|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
163020200|NCT03634033|588777875|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
163020201|NCT03634033|588777876|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
163020202|NCT03634033|588777870|FG000|Overall Study|Lost to Follow-up|0|||
163020203|NCT03634033|588777871|FG001|Overall Study|Lost to Follow-up|0|||
163020204|NCT03634033|588777872|FG002|Overall Study|Lost to Follow-up|0|||
163020205|NCT03634033|588777873|FG003|Overall Study|Lost to Follow-up|0|||
163020206|NCT03634033|588777874|FG004|Overall Study|Lost to Follow-up|0|||
163020207|NCT03634033|588777875|FG005|Overall Study|Lost to Follow-up|1|||
163020208|NCT03634033|588777876|FG006|Overall Study|Lost to Follow-up|2|||
163020209|NCT03634033|588777870|FG000|Overall Study|Withdrawal by Subject|0|||
163020210|NCT03634033|588777871|FG001|Overall Study|Withdrawal by Subject|0|||
163020211|NCT03634033|588777872|FG002|Overall Study|Withdrawal by Subject|0|||
163020212|NCT03634033|588777873|FG003|Overall Study|Withdrawal by Subject|0|||
163020213|NCT03634033|588777874|FG004|Overall Study|Withdrawal by Subject|0|||
163020214|NCT03634033|588777875|FG005|Overall Study|Withdrawal by Subject|0|||
163020215|NCT03634033|588777876|FG006|Overall Study|Withdrawal by Subject|1|||
163020216|NCT06366087|588777877|FG000|Overall Study|Withdrawal by Subject|0|||
163020217|NCT06366087|588777878|FG001|Overall Study|Withdrawal by Subject|1|||
163020218|NCT00199797|588777879|FG000|Overall Study|Progressive Disease|1|||
163020219|NCT00199797|588777879|FG000|Overall Study|Adverse Event|1|||
163020220|NCT00199797|588777879|FG000|Overall Study|Physician Decision|1|||
163020221|NCT00504725|588777887|FG000|Overall Study|Protocol Violation|1|||
163020222|NCT00504725|588777888|FG001|Overall Study|Protocol Violation|0|||
163020223|NCT01435018|588777889|FG000|Overall Study|Death|37|||
163020224|NCT01435018|588777890|FG001|Overall Study|Death|18|||
163020225|NCT01435018|588777891|FG002|Overall Study|Death|25|||
163020226|NCT01435018|588777889|FG000|Overall Study|Site is closing|4|||
163020227|NCT01435018|588777890|FG001|Overall Study|Site is closing|9|||
163020228|NCT01435018|588777891|FG002|Overall Study|Site is closing|7|||
163020229|NCT01435018|588777889|FG000|Overall Study|Withdrew consent|0|||
163020230|NCT01435018|588777890|FG001|Overall Study|Withdrew consent|3|||
163020231|NCT01435018|588777891|FG002|Overall Study|Withdrew consent|1|||
163020232|NCT01435018|588777889|FG000|Overall Study|Not willing to adhere to requirements|0|||
163020233|NCT01435018|588777890|FG001|Overall Study|Not willing to adhere to requirements|2|||
163020234|NCT01435018|588777891|FG002|Overall Study|Not willing to adhere to requirements|3|||
163020235|NCT01435018|588777889|FG000|Overall Study|Not able to get to clinic|2|||
163020236|NCT01435018|588777890|FG001|Overall Study|Not able to get to clinic|0|||
163020237|NCT01435018|588777891|FG002|Overall Study|Not able to get to clinic|2|||
163020238|NCT01435018|588777889|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163020239|NCT01435018|588777890|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163020240|NCT01435018|588777891|FG002|Overall Study|Severe debilitation, unable to continue|1|||
163020241|NCT01435018|588777889|FG000|Overall Study|Unable to contact participant/parent|1|||
163020242|NCT01435018|588777890|FG001|Overall Study|Unable to contact participant/parent|1|||
163020243|NCT01435018|588777891|FG002|Overall Study|Unable to contact participant/parent|1|||
163020244|NCT01435018|588777889|FG000|Overall Study|Enrollment Violation|0|||
163020245|NCT01435018|588777890|FG001|Overall Study|Enrollment Violation|1|||
163020246|NCT01435018|588777891|FG002|Overall Study|Enrollment Violation|0|||
163020247|NCT01435018|588777889|FG000|Overall Study|Never started chemotherapy|3|||
163020248|NCT01435018|588777890|FG001|Overall Study|Never started chemotherapy|0|||
163020249|NCT01435018|588777891|FG002|Overall Study|Never started chemotherapy|1|||
163020250|NCT03937908|588777892|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
163063550|NCT01995201|588939906|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063551|NCT01995201|588939907|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063552|NCT01995201|588939908|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063553|NCT01995201|588939909|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063554|NCT01995201|588939910|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
163063555|NCT01995201|588939904|FG000|From Baseline Until Week 24|Death|0|||
163020251|NCT03937908|588777893|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
163020252|NCT03875092|588777894|FG000|Overall Study|Adverse Event|2|||
163020253|NCT03875092|588777895|FG001|Overall Study|Adverse Event|5|||
163020254|NCT03875092|588777894|FG000|Overall Study|Death|44|||
163020255|NCT03875092|588777895|FG001|Overall Study|Death|51|||
163020256|NCT03875092|588777894|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
163020257|NCT03875092|588777895|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
163020258|NCT03205761|588777896|FG000|Overall Study|Withdrawal by Subject|1|||
163020259|NCT03205761|588777896|FG000|Overall Study|Progressive Disease|10|||
163020260|NCT00636194|588777897|FG000|Overall Study|Study related symptoms and complaints|1|||
163020261|NCT00636194|588777898|FG001|Overall Study|Study related symptoms and complaints|0|||
163020262|NCT00636194|588777897|FG000|Overall Study|Protocol Violation|2|||
163020263|NCT00636194|588777898|FG001|Overall Study|Protocol Violation|0|||
163020264|NCT04114357|588777900|FG000|Baseline-Randomization|Adverse Event|2|||
163020265|NCT04114357|588777901|FG001|Baseline-Randomization|Adverse Event|1|||
163020266|NCT04114357|588777900|FG000|Baseline-Randomization|Lost to Follow-up|1|||
163020267|NCT04114357|588777901|FG001|Baseline-Randomization|Lost to Follow-up|1|||
163020268|NCT04114357|588777900|FG000|Cross-over|Adverse Event|0|||
163020269|NCT04114357|588777901|FG001|Cross-over|Adverse Event|1|||
163020270|NCT02163226|588777902|FG000|Overall Study|Death|2|||
163020271|NCT02163226|588777903|FG001|Overall Study|Death|1|||
163020272|NCT02163226|588777902|FG000|Overall Study|Withdrawal by Subject|5|||
163020273|NCT02163226|588777903|FG001|Overall Study|Withdrawal by Subject|2|||
163020274|NCT02163226|588777902|FG000|Overall Study|Returned home, local radiotherapy|3|||
163020275|NCT02163226|588777903|FG001|Overall Study|Returned home, local radiotherapy|0|||
163020276|NCT02163226|588777902|FG000|Overall Study|Repeat imaging showed no disease|2|||
163020277|NCT02163226|588777903|FG001|Overall Study|Repeat imaging showed no disease|0|||
163020278|NCT02163226|588777902|FG000|Overall Study|Incomplete radiotherapy|3|||
163020279|NCT02163226|588777903|FG001|Overall Study|Incomplete radiotherapy|0|||
163020280|NCT02163226|588777902|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
163020281|NCT02163226|588777903|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
163020282|NCT02163226|588777902|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
163020283|NCT02163226|588777903|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
163020284|NCT02163226|588777902|FG000|Overall Study|ineligible|0|||
163020285|NCT02163226|588777903|FG001|Overall Study|ineligible|3|||
163020286|NCT03625466|588777907|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
163020287|NCT03625466|588777908|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
163020288|NCT03625466|588777909|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
163020289|NCT03625466|588777907|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020290|NCT03625466|588777908|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163020291|NCT03625466|588777909|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
162716627|NCT04845620|587668523|FG001|Overall Study|Physician Decision|1|||
163020292|NCT03625466|588777907|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020293|NCT03625466|588777908|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
163020294|NCT03625466|588777909|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163020295|NCT00809471|588777912|FG000|Overall Study|Protocol non-compliance|15|||
163020296|NCT00809471|588777913|FG001|Overall Study|Protocol non-compliance|15|||
163020297|NCT00809471|588777914|FG002|Overall Study|Protocol non-compliance|6|||
163020298|NCT00809471|588777912|FG000|Overall Study|Lost to Follow-up|4|||
163020299|NCT00809471|588777913|FG001|Overall Study|Lost to Follow-up|2|||
163020300|NCT00809471|588777914|FG002|Overall Study|Lost to Follow-up|9|||
163020301|NCT00809471|588777912|FG000|Overall Study|Adverse Event|0|||
163020302|NCT00809471|588777913|FG001|Overall Study|Adverse Event|2|||
163020303|NCT00809471|588777914|FG002|Overall Study|Adverse Event|2|||
163020304|NCT00809471|588777912|FG000|Overall Study|Requirement for restricted medication|1|||
163020305|NCT00809471|588777913|FG001|Overall Study|Requirement for restricted medication|1|||
163020306|NCT00809471|588777914|FG002|Overall Study|Requirement for restricted medication|0|||
163020307|NCT00831311|588777915|FG000|Overall Study|Definitive Contraindication|3|||
163020308|NCT00831311|588777916|FG001|Overall Study|Definitive Contraindication|3|||
163020309|NCT00831311|588777915|FG000|Overall Study|Lost to Follow-up|3|||
163020310|NCT00831311|588777916|FG001|Overall Study|Lost to Follow-up|0|||
163020311|NCT00831311|588777915|FG000|Overall Study|Physician Decision|0|||
163020312|NCT00831311|588777916|FG001|Overall Study|Physician Decision|1|||
163020313|NCT00831311|588777915|FG000|Overall Study|Withdrawal by Subject|6|||
163020314|NCT00831311|588777916|FG001|Overall Study|Withdrawal by Subject|4|||
163020315|NCT05318092|588777920|FG000|Overall Study|Lost to Follow-up|3|||
163020316|NCT05318092|588777920|FG000|Overall Study|Withdrawal by Subject|1|||
163020317|NCT00160706|588777922|FG000|Overall Study|Adverse Event|53|||
163020318|NCT00160706|588777922|FG000|Overall Study|Adverse Event and Other Reason|105|||
163020319|NCT00160706|588777922|FG000|Overall Study|Protocol Violation|3|||
163020320|NCT00160706|588777922|FG000|Overall Study|Withdrawal by Subject|41|||
163020321|NCT00160706|588777922|FG000|Overall Study|Withdrawal by Subject and Other|12|||
163020322|NCT00160706|588777922|FG000|Overall Study|Physician Decision|10|||
163020323|NCT00160706|588777922|FG000|Overall Study|Physician Decision and Other|3|||
163020324|NCT00160706|588777922|FG000|Overall Study|Lost to Follow-up|4|||
163020325|NCT00160706|588777922|FG000|Overall Study|Lost to Follow-up and Other|1|||
163020326|NCT00160706|588777922|FG000|Overall Study|Lack of Efficacy|42|||
163020327|NCT00160706|588777922|FG000|Overall Study|Lack of Efficacy and Other|1|||
163020328|NCT00160706|588777922|FG000|Overall Study|Other Reason|11|||
163020329|NCT03214380|588777923|FG000|Lead-in|Adverse Event|3|||
163020330|NCT03214380|588777924|FG001|Lead-in|Adverse Event|0|||
163020331|NCT03214380|588777925|FG002|Lead-in|Adverse Event|0|||
163020332|NCT03214380|588777926|FG003|Lead-in|Adverse Event|1|||
163020333|NCT03214380|588777927|FG004|Lead-in|Adverse Event|0|||
163020334|NCT03214380|588777928|FG005|Lead-in|Adverse Event|0|||
163020335|NCT03214380|588777923|FG000|Lead-in|Lost to Follow-up|4|||
163020336|NCT03214380|588777924|FG001|Lead-in|Lost to Follow-up|0|||
163020337|NCT03214380|588777925|FG002|Lead-in|Lost to Follow-up|0|||
163020338|NCT03214380|588777926|FG003|Lead-in|Lost to Follow-up|1|||
163020339|NCT03214380|588777927|FG004|Lead-in|Lost to Follow-up|0|||
163020340|NCT03214380|588777928|FG005|Lead-in|Lost to Follow-up|0|||
163020341|NCT03214380|588777923|FG000|Lead-in|Eligibility Criteria|3|||
163020342|NCT03214380|588777924|FG001|Lead-in|Eligibility Criteria|0|||
163020343|NCT03214380|588777925|FG002|Lead-in|Eligibility Criteria|0|||
163020344|NCT03214380|588777926|FG003|Lead-in|Eligibility Criteria|0|||
163020345|NCT03214380|588777927|FG004|Lead-in|Eligibility Criteria|0|||
163020346|NCT03214380|588777928|FG005|Lead-in|Eligibility Criteria|0|||
163020347|NCT03214380|588777923|FG000|Lead-in|Physician Decision|6|||
163020348|NCT03214380|588777924|FG001|Lead-in|Physician Decision|0|||
163020349|NCT03214380|588777925|FG002|Lead-in|Physician Decision|0|||
163020350|NCT03214380|588777926|FG003|Lead-in|Physician Decision|0|||
163020351|NCT03214380|588777927|FG004|Lead-in|Physician Decision|0|||
163020352|NCT03214380|588777928|FG005|Lead-in|Physician Decision|0|||
163020353|NCT03214380|588777923|FG000|Lead-in|Protocol Deviation|7|||
163020354|NCT03214380|588777924|FG001|Lead-in|Protocol Deviation|0|||
163020355|NCT03214380|588777925|FG002|Lead-in|Protocol Deviation|0|||
163020356|NCT03214380|588777926|FG003|Lead-in|Protocol Deviation|3|||
163020357|NCT03214380|588777927|FG004|Lead-in|Protocol Deviation|0|||
163020358|NCT03214380|588777928|FG005|Lead-in|Protocol Deviation|0|||
163020359|NCT03214380|588777923|FG000|Lead-in|Withdrawal by Subject|41|||
163020360|NCT03214380|588777924|FG001|Lead-in|Withdrawal by Subject|0|||
163020361|NCT03214380|588777925|FG002|Lead-in|Withdrawal by Subject|0|||
163020362|NCT03214380|588777926|FG003|Lead-in|Withdrawal by Subject|14|||
163020363|NCT03214380|588777927|FG004|Lead-in|Withdrawal by Subject|0|||
163020364|NCT03214380|588777928|FG005|Lead-in|Withdrawal by Subject|0|||
163020365|NCT03214380|588777923|FG000|Lead-in|Family Emergency|1|||
163020366|NCT03214380|588777924|FG001|Lead-in|Family Emergency|0|||
163020367|NCT03214380|588777925|FG002|Lead-in|Family Emergency|0|||
163020368|NCT03214380|588777926|FG003|Lead-in|Family Emergency|0|||
163020369|NCT03214380|588777927|FG004|Lead-in|Family Emergency|0|||
163020370|NCT03214380|588777928|FG005|Lead-in|Family Emergency|0|||
163020371|NCT03214380|588777923|FG000|Lead-in|Natural Disaster|9|||
163020372|NCT03214380|588777924|FG001|Lead-in|Natural Disaster|0|||
163063556|NCT01995201|588939905|FG001|From Baseline Until Week 24|Death|1|||
163063557|NCT01995201|588939906|FG002|From Baseline Until Week 24|Death|0|||
163063558|NCT01995201|588939907|FG003|From Baseline Until Week 24|Death|0|||
163063559|NCT01995201|588939908|FG004|From Baseline Until Week 24|Death|0|||
163063560|NCT01995201|588939909|FG005|From Baseline Until Week 24|Death|0|||
163063561|NCT01995201|588939910|FG006|From Baseline Until Week 24|Death|0|||
163063562|NCT01995201|588939904|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
163063563|NCT01995201|588939905|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
163063564|NCT01995201|588939906|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
163063565|NCT01995201|588939907|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
163063566|NCT01995201|588939908|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
163063567|NCT01995201|588939909|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
163063568|NCT01995201|588939910|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
163063569|NCT01995201|588939904|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
163063570|NCT01995201|588939905|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
163063571|NCT01995201|588939906|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
163020373|NCT03214380|588777925|FG002|Lead-in|Natural Disaster|0|||
163020374|NCT03214380|588777926|FG003|Lead-in|Natural Disaster|0|||
163063572|NCT01995201|588939907|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
163063573|NCT01995201|588939908|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
163020375|NCT03214380|588777927|FG004|Lead-in|Natural Disaster|0|||
163020376|NCT03214380|588777928|FG005|Lead-in|Natural Disaster|0|||
163020377|NCT03214380|588777923|FG000|Lead-in|Non Compliance|1|||
163020378|NCT03214380|588777924|FG001|Lead-in|Non Compliance|0|||
163020379|NCT03214380|588777925|FG002|Lead-in|Non Compliance|0|||
163020380|NCT03214380|588777926|FG003|Lead-in|Non Compliance|0|||
163020381|NCT03214380|588777927|FG004|Lead-in|Non Compliance|0|||
163020382|NCT03214380|588777928|FG005|Lead-in|Non Compliance|0|||
163020383|NCT03214380|588777923|FG000|Lead-in|Participant Schedule|2|||
163063574|NCT01995201|588939909|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
162641891|NCT04499781|587404548|FG000|Overall Study|Lost to Follow-up|2|||
162641892|NCT04499781|587404549|FG001|Overall Study|Lost to Follow-up|3|||
162641893|NCT04499781|587404548|FG000|Overall Study|Withdrawal by Subject|2|||
162641894|NCT04499781|587404549|FG001|Overall Study|Withdrawal by Subject|0|||
162641895|NCT04105998|587404557|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
162641896|NCT04105998|587404558|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
162641897|NCT00613015|587404562|FG000|Overall Study|Lost to Follow-up|0|||
162641898|NCT00613015|587404563|FG001|Overall Study|Lost to Follow-up|1|||
162641899|NCT00613015|587404564|FG002|Overall Study|Lost to Follow-up|3|||
162641900|NCT00613015|587404565|FG003|Overall Study|Lost to Follow-up|3|||
162641901|NCT00613015|587404566|FG004|Overall Study|Lost to Follow-up|2|||
162641902|NCT00613015|587404567|FG005|Overall Study|Lost to Follow-up|3|||
162641903|NCT00071760|587404570|FG000|Overall Study|Adverse Event|2|||
162641904|NCT00071760|587404571|FG001|Overall Study|Adverse Event|1|||
162641905|NCT00071760|587404570|FG000|Overall Study|Lost to Follow-up|0|||
162641906|NCT00071760|587404571|FG001|Overall Study|Lost to Follow-up|3|||
162641907|NCT00071760|587404570|FG000|Overall Study|Protocol Violation|1|||
162641908|NCT00071760|587404571|FG001|Overall Study|Protocol Violation|0|||
162641909|NCT00071760|587404570|FG000|Overall Study|Withdrawal by Subject|0|||
162641910|NCT00071760|587404571|FG001|Overall Study|Withdrawal by Subject|1|||
162641911|NCT00071760|587404570|FG000|Overall Study|Insufficient Viral Load Response|1|||
162641912|NCT00071760|587404571|FG001|Overall Study|Insufficient Viral Load Response|1|||
162641913|NCT00071760|587404570|FG000|Overall Study|Lack of availability of RTV|1|||
162641914|NCT00071760|587404571|FG001|Overall Study|Lack of availability of RTV|0|||
162641915|NCT00071760|587404570|FG000|Overall Study|Physician Decision|2|||
162641916|NCT00071760|587404571|FG001|Overall Study|Physician Decision|1|||
162641917|NCT00071760|587404570|FG000|Overall Study|Relocation|0|||
162641918|NCT00071760|587404571|FG001|Overall Study|Relocation|1|||
162641919|NCT02073279|587404572|FG000|Double-blind Period|Adverse Event|1|||
162641920|NCT02073279|587404573|FG001|Double-blind Period|Adverse Event|1|||
162641921|NCT02073279|587404572|FG000|Double-blind Period|Switched to another treatment|1|||
163020384|NCT03214380|588777924|FG001|Lead-in|Participant Schedule|0|||
163020385|NCT03214380|588777925|FG002|Lead-in|Participant Schedule|0|||
163020386|NCT03214380|588777926|FG003|Lead-in|Participant Schedule|0|||
163020387|NCT03214380|588777927|FG004|Lead-in|Participant Schedule|0|||
163020388|NCT03214380|588777928|FG005|Lead-in|Participant Schedule|0|||
163020389|NCT03214380|588777923|FG000|Treatment Period|Adverse Event|0|||
163020390|NCT03214380|588777924|FG001|Treatment Period|Adverse Event|1|||
163063575|NCT01995201|588939910|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
162641922|NCT02073279|587404573|FG001|Double-blind Period|Switched to another treatment|2|||
162641923|NCT02073279|587404572|FG000|Double-blind Period|Protocol Violation|0|||
162641924|NCT02073279|587404573|FG001|Double-blind Period|Protocol Violation|1|||
162641925|NCT02073279|587404572|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
162641926|NCT02073279|587404573|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
162641927|NCT02073279|587404572|FG000|Double-blind Period|Withdrawal by Subject|2|||
162641928|NCT02073279|587404573|FG001|Double-blind Period|Withdrawal by Subject|2|||
162641929|NCT02073279|587404572|FG000|Open-label Extension Period|Adverse Event|1|||
162641930|NCT02073279|587404573|FG001|Open-label Extension Period|Adverse Event|0|||
162641931|NCT02073279|587404572|FG000|Open-label Extension Period|Lack of Efficacy|1|||
162641932|NCT02073279|587404573|FG001|Open-label Extension Period|Lack of Efficacy|0|||
162641933|NCT02073279|587404572|FG000|Open-label Extension Period|Lost to Follow-up|0|||
162641934|NCT02073279|587404573|FG001|Open-label Extension Period|Lost to Follow-up|4|||
162641935|NCT02073279|587404572|FG000|Open-label Extension Period|Switched to another treatment|1|||
162641936|NCT02073279|587404573|FG001|Open-label Extension Period|Switched to another treatment|4|||
162641937|NCT02073279|587404572|FG000|Open-label Extension Period|Protocol Violation|0|||
162641938|NCT02073279|587404573|FG001|Open-label Extension Period|Protocol Violation|1|||
162641939|NCT02073279|587404572|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163063576|NCT01995201|588939904|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
163063577|NCT01995201|588939905|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
163063578|NCT01995201|588939906|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063579|NCT01995201|588939907|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063580|NCT01995201|588939908|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
162641940|NCT02073279|587404573|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
162641941|NCT02073279|587404572|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
163020391|NCT03214380|588777925|FG002|Treatment Period|Adverse Event|1|||
162641942|NCT02073279|587404573|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
162641943|NCT01994629|587404574|FG000|Overall Study|Withdrawal by Subject|1|||
162641944|NCT01994629|587404575|FG001|Overall Study|Withdrawal by Subject|0|||
163020392|NCT03214380|588777926|FG003|Treatment Period|Adverse Event|0|||
163063581|NCT01995201|588939909|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
162641945|NCT01994629|587404574|FG000|Overall Study|Lost to Follow-up|0|||
162641946|NCT01994629|587404575|FG001|Overall Study|Lost to Follow-up|3|||
162641947|NCT03338062|587404578|FG000|Overall Study|Alternative Therapy|1|||
162641948|NCT03338062|587404579|FG001|Overall Study|Alternative Therapy|0|||
162641949|NCT04340362|587404580|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
162641950|NCT02375113|587404584|FG000|Overall Study|Undisclosed Reason(s).|1|||
162641951|NCT02375113|587404585|FG001|Overall Study|Undisclosed Reason(s).|1|||
162641952|NCT02375113|587404584|FG000|Overall Study|Poor adherence (<70%).|1|||
162641953|NCT02375113|587404585|FG001|Overall Study|Poor adherence (<70%).|0|||
162641954|NCT02375113|587404584|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
162641955|NCT02375113|587404585|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
162641956|NCT01214629|587404586|FG000|Overall Study|Progressive Disease|1|||
162641957|NCT01214629|587404587|FG001|Overall Study|Progressive Disease|1|||
162641958|NCT01214629|587404588|FG002|Overall Study|Progressive Disease|0|||
162641959|NCT01214629|587404589|FG003|Overall Study|Progressive Disease|1|||
162641960|NCT01214629|587404590|FG004|Overall Study|Progressive Disease|2|||
162641961|NCT01214629|587404591|FG005|Overall Study|Progressive Disease|3|||
162641962|NCT01214629|587404592|FG006|Overall Study|Progressive Disease|1|||
162641963|NCT01214629|587404593|FG007|Overall Study|Progressive Disease|1|||
162641964|NCT01214629|587404594|FG008|Overall Study|Progressive Disease|1|||
162641965|NCT01214629|587404595|FG009|Overall Study|Progressive Disease|5|||
162641966|NCT01214629|587404596|FG010|Overall Study|Progressive Disease|1|||
162641967|NCT01214629|587404586|FG000|Overall Study|Adverse Event|0|||
162641968|NCT01214629|587404587|FG001|Overall Study|Adverse Event|0|||
162641969|NCT01214629|587404588|FG002|Overall Study|Adverse Event|0|||
162641970|NCT01214629|587404589|FG003|Overall Study|Adverse Event|1|||
162641971|NCT01214629|587404590|FG004|Overall Study|Adverse Event|0|||
162641972|NCT01214629|587404591|FG005|Overall Study|Adverse Event|1|||
163020393|NCT03214380|588777927|FG004|Treatment Period|Adverse Event|1|||
163020394|NCT03214380|588777928|FG005|Treatment Period|Adverse Event|0|||
163020395|NCT03214380|588777923|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
163020396|NCT03214380|588777924|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
163020397|NCT03214380|588777925|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
163020398|NCT03214380|588777926|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
163020399|NCT03214380|588777927|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
163020400|NCT03214380|588777928|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
163020401|NCT03214380|588777923|FG000|Treatment Period|Withdrawal by Subject|0|||
163020402|NCT03214380|588777924|FG001|Treatment Period|Withdrawal by Subject|10|||
163020403|NCT03214380|588777925|FG002|Treatment Period|Withdrawal by Subject|8|||
163020404|NCT03214380|588777926|FG003|Treatment Period|Withdrawal by Subject|0|||
162641973|NCT01214629|587404592|FG006|Overall Study|Adverse Event|0|||
162641974|NCT01214629|587404593|FG007|Overall Study|Adverse Event|0|||
162641975|NCT01214629|587404594|FG008|Overall Study|Adverse Event|0|||
162641976|NCT01214629|587404595|FG009|Overall Study|Adverse Event|1|||
162641977|NCT01214629|587404596|FG010|Overall Study|Adverse Event|0|||
162641978|NCT01214629|587404586|FG000|Overall Study|Physician Decision|0|||
162716628|NCT00708097|587668524|FG000|Period 1|Protocol Violation|0|||
162716629|NCT00708097|587668525|FG001|Period 1|Protocol Violation|1|||
163020405|NCT03214380|588777927|FG004|Treatment Period|Withdrawal by Subject|7|||
163020406|NCT03214380|588777928|FG005|Treatment Period|Withdrawal by Subject|11|||
163020407|NCT03214380|588777923|FG000|Treatment Period|Death|0|||
163020408|NCT03214380|588777924|FG001|Treatment Period|Death|1|||
163020409|NCT03214380|588777925|FG002|Treatment Period|Death|2|||
163063582|NCT01995201|588939910|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
163063583|NCT01995201|588939904|FG000|From Baseline Until Week 24|Physician Decision|0|||
163063584|NCT01995201|588939905|FG001|From Baseline Until Week 24|Physician Decision|2|||
163063585|NCT01995201|588939906|FG002|From Baseline Until Week 24|Physician Decision|0|||
163063586|NCT01995201|588939907|FG003|From Baseline Until Week 24|Physician Decision|0|||
163063587|NCT01995201|588939908|FG004|From Baseline Until Week 24|Physician Decision|0|||
163063588|NCT01995201|588939909|FG005|From Baseline Until Week 24|Physician Decision|0|||
163063589|NCT01995201|588939910|FG006|From Baseline Until Week 24|Physician Decision|0|||
163063590|NCT01995201|588939904|FG000|From Baseline Until Week 24|Protocol Violation|0|||
163063591|NCT01995201|588939905|FG001|From Baseline Until Week 24|Protocol Violation|9|||
163063592|NCT01995201|588939906|FG002|From Baseline Until Week 24|Protocol Violation|0|||
163063593|NCT01995201|588939907|FG003|From Baseline Until Week 24|Protocol Violation|0|||
163063594|NCT01995201|588939908|FG004|From Baseline Until Week 24|Protocol Violation|0|||
163063595|NCT01995201|588939909|FG005|From Baseline Until Week 24|Protocol Violation|0|||
162641979|NCT01214629|587404587|FG001|Overall Study|Physician Decision|0|||
162641980|NCT01214629|587404588|FG002|Overall Study|Physician Decision|0|||
162641981|NCT01214629|587404589|FG003|Overall Study|Physician Decision|0|||
162641982|NCT01214629|587404590|FG004|Overall Study|Physician Decision|0|||
162641983|NCT01214629|587404591|FG005|Overall Study|Physician Decision|0|||
162641984|NCT01214629|587404592|FG006|Overall Study|Physician Decision|0|||
163063596|NCT01995201|588939910|FG006|From Baseline Until Week 24|Protocol Violation|0|||
163063597|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Adverse Event|0|||
162641985|NCT01214629|587404593|FG007|Overall Study|Physician Decision|0|||
162641986|NCT01214629|587404594|FG008|Overall Study|Physician Decision|0|||
162641987|NCT01214629|587404595|FG009|Overall Study|Physician Decision|0|||
162641988|NCT01214629|587404596|FG010|Overall Study|Physician Decision|1|||
162641989|NCT01214629|587404586|FG000|Overall Study|Withdrawal by Subject|0|||
163020410|NCT03214380|588777926|FG003|Treatment Period|Death|0|||
163020411|NCT03214380|588777927|FG004|Treatment Period|Death|0|||
163020412|NCT03214380|588777928|FG005|Treatment Period|Death|0|||
162641990|NCT01214629|587404587|FG001|Overall Study|Withdrawal by Subject|0|||
162641991|NCT01214629|587404588|FG002|Overall Study|Withdrawal by Subject|0|||
162641992|NCT01214629|587404589|FG003|Overall Study|Withdrawal by Subject|0|||
162641993|NCT01214629|587404590|FG004|Overall Study|Withdrawal by Subject|0|||
162641994|NCT01214629|587404591|FG005|Overall Study|Withdrawal by Subject|0|||
162641995|NCT01214629|587404592|FG006|Overall Study|Withdrawal by Subject|0|||
162641996|NCT01214629|587404593|FG007|Overall Study|Withdrawal by Subject|0|||
162641997|NCT01214629|587404594|FG008|Overall Study|Withdrawal by Subject|0|||
162641998|NCT01214629|587404595|FG009|Overall Study|Withdrawal by Subject|1|||
162641999|NCT01214629|587404596|FG010|Overall Study|Withdrawal by Subject|0|||
162642000|NCT00877383|587404599|FG000|Overall Study|Adverse Event|13|||
162642001|NCT00877383|587404600|FG001|Overall Study|Adverse Event|14|||
162642002|NCT00877383|587404599|FG000|Overall Study|Lost to Follow-up|5|||
162642003|NCT00877383|587404600|FG001|Overall Study|Lost to Follow-up|3|||
162642004|NCT00877383|587404599|FG000|Overall Study|Subject withdrew consent|3|||
162642005|NCT00877383|587404600|FG001|Overall Study|Subject withdrew consent|12|||
162642006|NCT00877383|587404599|FG000|Overall Study|Subject no longer requires study drug|2|||
162642007|NCT00877383|587404600|FG001|Overall Study|Subject no longer requires study drug|0|||
162642008|NCT00877383|587404599|FG000|Overall Study|Administrative problems|2|||
162642009|NCT00877383|587404600|FG001|Overall Study|Administrative problems|0|||
162642010|NCT00877383|587404599|FG000|Overall Study|Protocol deviation|2|||
162642011|NCT00877383|587404600|FG001|Overall Study|Protocol deviation|6|||
162642012|NCT00877383|587404599|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162642013|NCT00877383|587404600|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162642014|NCT00877383|587404599|FG000|Overall Study|Death|1|||
162642015|NCT00877383|587404600|FG001|Overall Study|Death|2|||
162642016|NCT00459108|587404602|FG000|Overall Study|Withdrawal by Subject|5|||
162642017|NCT00459108|587404602|FG000|Overall Study|Adverse Event|3|||
162642018|NCT00459108|587404602|FG000|Overall Study|Death|2|||
162642019|NCT00459108|587404602|FG000|Overall Study|Progression|1|||
162642020|NCT04387435|587404609|FG000|Overall Study|Physician Decision|1|||
162642021|NCT04501666|587404612|FG000|Overall Study|Physician Decision|0|||
162642022|NCT04501666|587404613|FG001|Overall Study|Physician Decision|1|||
162642023|NCT04501666|587404612|FG000|Overall Study|Adverse Event|12|||
162642024|NCT04501666|587404613|FG001|Overall Study|Adverse Event|4|||
162642025|NCT04501666|587404612|FG000|Overall Study|Subject's request|10|||
162642026|NCT04501666|587404613|FG001|Overall Study|Subject's request|6|||
162642027|NCT04501666|587404612|FG000|Overall Study|Protocol Deviation|2|||
162642028|NCT04501666|587404613|FG001|Overall Study|Protocol Deviation|1|||
162642029|NCT04501666|587404612|FG000|Overall Study|Other-- site permanently closing|0|||
162642030|NCT04501666|587404613|FG001|Overall Study|Other-- site permanently closing|1|||
162642031|NCT00642941|587404614|FG000|Overall Study|Physician Decision|3|||
162642032|NCT00642941|587404615|FG001|Overall Study|Physician Decision|1|||
162642033|NCT00642941|587404616|FG002|Overall Study|Physician Decision|0|||
162642034|NCT00642941|587404617|FG003|Overall Study|Physician Decision|0|||
162642035|NCT00642941|587404618|FG004|Overall Study|Physician Decision|0|||
162642036|NCT00642941|587404619|FG005|Overall Study|Physician Decision|0|||
162642037|NCT00642941|587404620|FG006|Overall Study|Physician Decision|1|||
162642038|NCT00642941|587404621|FG007|Overall Study|Physician Decision|0|||
162642039|NCT00642941|587404622|FG008|Overall Study|Physician Decision|0|||
162642040|NCT00642941|587404623|FG009|Overall Study|Physician Decision|1|||
162642041|NCT00642941|587404624|FG010|Overall Study|Physician Decision|0|||
162642042|NCT00642941|587404625|FG011|Overall Study|Physician Decision|1|||
163020413|NCT03214380|588777923|FG000|Treatment Period|Lost to Follow-up|0|||
163020414|NCT03214380|588777924|FG001|Treatment Period|Lost to Follow-up|6|||
162642043|NCT00642941|587404614|FG000|Overall Study|Death|4|||
162642044|NCT00642941|587404615|FG001|Overall Study|Death|0|||
163020415|NCT03214380|588777925|FG002|Treatment Period|Lost to Follow-up|3|||
163020416|NCT03214380|588777926|FG003|Treatment Period|Lost to Follow-up|0|||
163020417|NCT03214380|588777927|FG004|Treatment Period|Lost to Follow-up|0|||
163020418|NCT03214380|588777928|FG005|Treatment Period|Lost to Follow-up|0|||
162642045|NCT00642941|587404616|FG002|Overall Study|Death|1|||
163020419|NCT03214380|588777923|FG000|Treatment Period|Participant schedule|0|||
162642046|NCT00642941|587404617|FG003|Overall Study|Death|1|||
162642047|NCT00642941|587404618|FG004|Overall Study|Death|2|||
162642048|NCT00642941|587404619|FG005|Overall Study|Death|1|||
162642049|NCT00642941|587404620|FG006|Overall Study|Death|0|||
162642050|NCT00642941|587404621|FG007|Overall Study|Death|0|||
162642051|NCT00642941|587404622|FG008|Overall Study|Death|0|||
162642052|NCT00642941|587404623|FG009|Overall Study|Death|0|||
162642053|NCT00642941|587404624|FG010|Overall Study|Death|0|||
162642054|NCT00642941|587404625|FG011|Overall Study|Death|1|||
162642055|NCT00642941|587404614|FG000|Overall Study|Study closed by Sponsor|0|||
163020420|NCT03214380|588777924|FG001|Treatment Period|Participant schedule|0|||
162642056|NCT00642941|587404615|FG001|Overall Study|Study closed by Sponsor|1|||
162642057|NCT00642941|587404616|FG002|Overall Study|Study closed by Sponsor|0|||
163020421|NCT03214380|588777925|FG002|Treatment Period|Participant schedule|1|||
163020422|NCT03214380|588777926|FG003|Treatment Period|Participant schedule|0|||
163020423|NCT03214380|588777927|FG004|Treatment Period|Participant schedule|0|||
163020424|NCT03214380|588777928|FG005|Treatment Period|Participant schedule|0|||
163020425|NCT03214380|588777923|FG000|Treatment Period|Treatment Interruption|0|||
163020426|NCT03214380|588777924|FG001|Treatment Period|Treatment Interruption|0|||
163020427|NCT03214380|588777925|FG002|Treatment Period|Treatment Interruption|1|||
163020428|NCT03214380|588777926|FG003|Treatment Period|Treatment Interruption|0|||
163020429|NCT03214380|588777927|FG004|Treatment Period|Treatment Interruption|0|||
163020430|NCT03214380|588777928|FG005|Treatment Period|Treatment Interruption|0|||
163020431|NCT00614523|588777932|FG000|Overall Study|Adverse Event|4|||
163020432|NCT00614523|588777933|FG001|Overall Study|Adverse Event|20|||
163020433|NCT00614523|588777932|FG000|Overall Study|Death|5|||
163020434|NCT00614523|588777933|FG001|Overall Study|Death|8|||
163020435|NCT00614523|588777932|FG000|Overall Study|Lack of Efficacy|9|||
163020436|NCT00614523|588777933|FG001|Overall Study|Lack of Efficacy|11|||
163020437|NCT00614523|588777932|FG000|Overall Study|Lost to Follow-up|0|||
163020438|NCT00614523|588777933|FG001|Overall Study|Lost to Follow-up|1|||
163020439|NCT00614523|588777932|FG000|Overall Study|Protocol Violation|3|||
163020440|NCT00614523|588777933|FG001|Overall Study|Protocol Violation|2|||
163020441|NCT00614523|588777932|FG000|Overall Study|Withdrawal by Subject|12|||
163020442|NCT00614523|588777933|FG001|Overall Study|Withdrawal by Subject|22|||
163020443|NCT00614523|588777932|FG000|Overall Study|Other|6|||
163020444|NCT00614523|588777933|FG001|Overall Study|Other|11|||
163020445|NCT00614523|588777932|FG000|Overall Study|Ineligibility Determined|1|||
163020446|NCT00614523|588777933|FG001|Overall Study|Ineligibility Determined|2|||
163020447|NCT00614523|588777932|FG000|Overall Study|Disease Progression|0|||
163020448|NCT00614523|588777933|FG001|Overall Study|Disease Progression|8|||
163020449|NCT00614523|588777932|FG000|Overall Study|Administrative Decision|23|||
163020450|NCT00614523|588777933|FG001|Overall Study|Administrative Decision|46|||
163020451|NCT00723255|588777934|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
163020452|NCT00723255|588777934|FG000|Overall Study|Ineligible: Second primary|1|||
163020453|NCT00723255|588777934|FG000|Overall Study|Ineligible: Wrong Primary|2|||
163020454|NCT00452673|588777943|FG000|Dose Escalation Period|Disease Progression|6|||
163020455|NCT00452673|588777944|FG001|Dose Escalation Period|Disease Progression|6|||
163020456|NCT00452673|588777945|FG002|Dose Escalation Period|Disease Progression|2|||
163020457|NCT00452673|588777946|FG003|Dose Escalation Period|Disease Progression|6|||
163020458|NCT00452673|588777947|FG004|Dose Escalation Period|Disease Progression|0|||
163020459|NCT00452673|588777943|FG000|Dose Escalation Period|study drug toxicity|1|||
163020460|NCT00452673|588777944|FG001|Dose Escalation Period|study drug toxicity|3|||
163020461|NCT00452673|588777945|FG002|Dose Escalation Period|study drug toxicity|3|||
163020462|NCT00452673|588777946|FG003|Dose Escalation Period|study drug toxicity|1|||
163020463|NCT00452673|588777947|FG004|Dose Escalation Period|study drug toxicity|0|||
163020464|NCT00452673|588777943|FG000|Dose Escalation Period|Other|0|||
163020465|NCT00452673|588777944|FG001|Dose Escalation Period|Other|0|||
163020466|NCT00452673|588777945|FG002|Dose Escalation Period|Other|1|||
163020467|NCT00452673|588777946|FG003|Dose Escalation Period|Other|0|||
163020468|NCT00452673|588777947|FG004|Dose Escalation Period|Other|0|||
163020469|NCT00452673|588777943|FG000|Dose Escalation Period|Adverse Event|0|||
163020470|NCT00452673|588777944|FG001|Dose Escalation Period|Adverse Event|0|||
163020471|NCT00452673|588777945|FG002|Dose Escalation Period|Adverse Event|0|||
163020472|NCT00452673|588777946|FG003|Dose Escalation Period|Adverse Event|1|||
163020473|NCT00452673|588777947|FG004|Dose Escalation Period|Adverse Event|0|||
163020474|NCT00452673|588777943|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
163020475|NCT00452673|588777944|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
163020476|NCT00452673|588777945|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
163020477|NCT00452673|588777946|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
163020478|NCT00452673|588777947|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
163020479|NCT00452673|588777943|FG000|Dose Expansion Period|Disease Progression|0|||
163020480|NCT00452673|588777944|FG001|Dose Expansion Period|Disease Progression|0|||
163020481|NCT00452673|588777945|FG002|Dose Expansion Period|Disease Progression|0|||
163020482|NCT00452673|588777946|FG003|Dose Expansion Period|Disease Progression|0|||
163020483|NCT00452673|588777947|FG004|Dose Expansion Period|Disease Progression|19|||
163020484|NCT00452673|588777943|FG000|Dose Expansion Period|Other|0|||
163020485|NCT00452673|588777944|FG001|Dose Expansion Period|Other|0|||
163020486|NCT00452673|588777945|FG002|Dose Expansion Period|Other|0|||
163020487|NCT00452673|588777946|FG003|Dose Expansion Period|Other|0|||
163020488|NCT00452673|588777947|FG004|Dose Expansion Period|Other|2|||
163020489|NCT00748189|588777950|FG000|Overall Study|Death|99|||
163020490|NCT00748189|588777951|FG001|Overall Study|Death|84|||
163020491|NCT00748189|588777950|FG000|Overall Study|Withdrawal by Subject|23|||
163020492|NCT00748189|588777951|FG001|Overall Study|Withdrawal by Subject|29|||
163020493|NCT00748189|588777950|FG000|Overall Study|Physician Decision|16|||
163020494|NCT00748189|588777951|FG001|Overall Study|Physician Decision|5|||
163020495|NCT00748189|588777950|FG000|Overall Study|Lost to Follow-up|8|||
163020496|NCT00748189|588777951|FG001|Overall Study|Lost to Follow-up|15|||
163020497|NCT00748189|588777950|FG000|Overall Study|Study terminated by Sponsor|70|||
163020498|NCT00748189|588777951|FG001|Overall Study|Study terminated by Sponsor|79|||
163020499|NCT04481191|588777958|FG000|Overall Study|Withdrawn by parent/guardian|15|||
163020500|NCT04481191|588777959|FG001|Overall Study|Withdrawn by parent/guardian|10|||
163020501|NCT00546117|588777964|FG000|Overall Study|Withdrawal by Subject|3|||
163063598|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Adverse Event|0|||
163063599|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Adverse Event|2|||
163063600|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Adverse Event|1|||
163063601|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Adverse Event|1|||
163063602|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Adverse Event|3|||
163063603|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Adverse Event|1|||
163063604|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Death|0|||
163063605|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Death|0|||
163063606|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Death|0|||
163063607|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Death|0|||
163063608|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Death|0|||
163063609|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Death|2|||
163063610|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Death|0|||
163063611|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063612|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063613|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
163063614|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063615|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
163063616|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
163063617|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
163063618|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063619|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063620|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063621|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063622|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
163063623|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
163063624|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
163063625|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063626|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063627|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
163063628|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063629|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
163020502|NCT00546117|588777965|FG001|Overall Study|Withdrawal by Subject|0|||
163063630|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163063631|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
163020503|NCT00546117|588777964|FG000|Overall Study|Inability to schedule follow-up visit|1|||
163063632|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Physician Decision|0|||
163063633|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Physician Decision|0|||
163063634|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Physician Decision|0|||
163063635|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Physician Decision|0|||
163063636|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Physician Decision|1|||
163063637|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Physician Decision|0|||
163063638|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Physician Decision|0|||
163020504|NCT00546117|588777965|FG001|Overall Study|Inability to schedule follow-up visit|0|||
163020505|NCT01598090|588777966|FG000|Treatment Period|Poor/non-compliance|0|||
163020506|NCT01598090|588777967|FG001|Treatment Period|Poor/non-compliance|2|||
163020507|NCT01598090|588777968|FG002|Treatment Period|Poor/non-compliance|0|||
163020508|NCT01598090|588777966|FG000|Treatment Period|No longer meet study criteria|0|||
163020509|NCT01598090|588777967|FG001|Treatment Period|No longer meet study criteria|1|||
163020510|NCT01598090|588777968|FG002|Treatment Period|No longer meet study criteria|0|||
163020511|NCT01598090|588777966|FG000|Treatment Period|Lack of Efficacy|5|||
163020512|NCT01598090|588777967|FG001|Treatment Period|Lack of Efficacy|14|||
163020513|NCT01598090|588777968|FG002|Treatment Period|Lack of Efficacy|6|||
163020514|NCT01598090|588777966|FG000|Treatment Period|Adverse Event|2|||
163020515|NCT01598090|588777967|FG001|Treatment Period|Adverse Event|33|||
163020516|NCT01598090|588777968|FG002|Treatment Period|Adverse Event|17|||
163020517|NCT01598090|588777966|FG000|Treatment Period|Other reasons|0|||
163020518|NCT01598090|588777967|FG001|Treatment Period|Other reasons|4|||
163020519|NCT01598090|588777968|FG002|Treatment Period|Other reasons|1|||
163020520|NCT01598090|588777966|FG000|Treatment Period|Withdrawal by Subject|3|||
163020521|NCT01598090|588777967|FG001|Treatment Period|Withdrawal by Subject|13|||
163020522|NCT01598090|588777968|FG002|Treatment Period|Withdrawal by Subject|10|||
163020523|NCT01598090|588777966|FG000|Treatment Period|Lost to Follow-up|1|||
163020524|NCT01598090|588777967|FG001|Treatment Period|Lost to Follow-up|5|||
163020525|NCT01598090|588777968|FG002|Treatment Period|Lost to Follow-up|1|||
163020526|NCT01598090|588777966|FG000|Follow-up Period|Death|0|||
163020527|NCT01598090|588777967|FG001|Follow-up Period|Death|1|||
163020528|NCT01598090|588777968|FG002|Follow-up Period|Death|0|||
163020529|NCT01598090|588777966|FG000|Follow-up Period|No longer required per protocol|1|||
163020530|NCT01598090|588777967|FG001|Follow-up Period|No longer required per protocol|3|||
163020531|NCT01598090|588777968|FG002|Follow-up Period|No longer required per protocol|2|||
163063639|NCT01995201|588939904|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
163063640|NCT01995201|588939905|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
162642058|NCT00642941|587404617|FG003|Overall Study|Study closed by Sponsor|0|||
162642059|NCT00642941|587404618|FG004|Overall Study|Study closed by Sponsor|0|||
163063641|NCT01995201|588939906|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
163063642|NCT01995201|588939907|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
163063643|NCT01995201|588939908|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
163063644|NCT01995201|588939909|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
163063645|NCT01995201|588939910|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
163063646|NCT06001866|588939913|FG000|Overall Study|Withdrawal by Subject|0|||
163063647|NCT06001866|588939914|FG001|Overall Study|Withdrawal by Subject|2|||
163063648|NCT06001866|588939913|FG000|Overall Study|Protocol Violation|0|||
163063649|NCT06001866|588939914|FG001|Overall Study|Protocol Violation|2|||
163063650|NCT04703192|588939915|FG000|Overall Study|Withdrawal by Subject|2|||
163063651|NCT04703192|588939916|FG001|Overall Study|Withdrawal by Subject|0|||
163063652|NCT04703192|588939915|FG000|Overall Study|Death|3|||
163063653|NCT04703192|588939916|FG001|Overall Study|Death|1|||
163063654|NCT04703192|588939915|FG000|Overall Study|Adverse Event|13|||
163063655|NCT04703192|588939916|FG001|Overall Study|Adverse Event|2|||
163063656|NCT04703192|588939915|FG000|Overall Study|Progressive or Relapsed Disease|46|||
163063657|NCT04703192|588939916|FG001|Overall Study|Progressive or Relapsed Disease|7|||
163063658|NCT04703192|588939915|FG000|Overall Study|Clinical Progression|19|||
163063659|NCT04703192|588939916|FG001|Overall Study|Clinical Progression|8|||
163063660|NCT04703192|588939915|FG000|Overall Study|Lost to Follow-up|1|||
162642060|NCT00642941|587404619|FG005|Overall Study|Study closed by Sponsor|0|||
162642061|NCT00642941|587404620|FG006|Overall Study|Study closed by Sponsor|0|||
162642062|NCT00642941|587404621|FG007|Overall Study|Study closed by Sponsor|0|||
163063661|NCT04703192|588939916|FG001|Overall Study|Lost to Follow-up|0|||
163063662|NCT04703192|588939915|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
163063663|NCT04703192|588939916|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
163063664|NCT04703192|588939915|FG000|Overall Study|Other|5|||
163063665|NCT04703192|588939916|FG001|Overall Study|Other|1|||
163063666|NCT04797169|588939917|FG000|Overall Study|Lost to Follow-up|84|||
163063667|NCT04797169|588939918|FG001|Overall Study|Lost to Follow-up|67|||
163063668|NCT04797169|588939917|FG000|Overall Study|Pregnancy|1|||
163063669|NCT04797169|588939918|FG001|Overall Study|Pregnancy|3|||
163063670|NCT04797169|588939917|FG000|Overall Study|Withdrawal by Subject|27|||
162642063|NCT00642941|587404622|FG008|Overall Study|Study closed by Sponsor|0|||
162642064|NCT00642941|587404623|FG009|Overall Study|Study closed by Sponsor|0|||
162642065|NCT00642941|587404624|FG010|Overall Study|Study closed by Sponsor|0|||
162642066|NCT00642941|587404625|FG011|Overall Study|Study closed by Sponsor|0|||
163020532|NCT01598090|588777966|FG000|Follow-up Period|Not reported|0|||
163020533|NCT01598090|588777967|FG001|Follow-up Period|Not reported|10|||
163020534|NCT01598090|588777968|FG002|Follow-up Period|Not reported|4|||
163020535|NCT01598090|588777966|FG000|Follow-up Period|Withdrawal by Subject|0|||
163063671|NCT04797169|588939918|FG001|Overall Study|Withdrawal by Subject|35|||
163063672|NCT04725188|588939919|FG000|Overall Study|Death|72|||
163063673|NCT04725188|588939920|FG001|Overall Study|Death|69|||
163063674|NCT04725188|588939921|FG002|Overall Study|Death|76|||
163063675|NCT04725188|588939919|FG000|Overall Study|Lost to Follow-up|1|||
163063676|NCT04725188|588939920|FG001|Overall Study|Lost to Follow-up|0|||
163063677|NCT04725188|588939921|FG002|Overall Study|Lost to Follow-up|1|||
163020536|NCT01598090|588777967|FG001|Follow-up Period|Withdrawal by Subject|3|||
163020537|NCT01598090|588777968|FG002|Follow-up Period|Withdrawal by Subject|2|||
163020538|NCT01598090|588777966|FG000|Follow-up Period|Other reasons|2|||
163020539|NCT01598090|588777967|FG001|Follow-up Period|Other reasons|8|||
163020540|NCT01598090|588777968|FG002|Follow-up Period|Other reasons|8|||
163020541|NCT01598090|588777966|FG000|Follow-up Period|Lost to Follow-up|2|||
163020542|NCT01598090|588777967|FG001|Follow-up Period|Lost to Follow-up|10|||
163020543|NCT01598090|588777968|FG002|Follow-up Period|Lost to Follow-up|12|||
163020544|NCT00355147|588777971|FG000|Overall Study|Lost to Follow-up|10|||
163020545|NCT00355147|588777972|FG001|Overall Study|Lost to Follow-up|8|||
163020546|NCT00355147|588777971|FG000|Overall Study|Withdrawal by Subject|8|||
163020547|NCT00355147|588777972|FG001|Overall Study|Withdrawal by Subject|12|||
163020548|NCT03557931|588777977|FG000|Overall Study|Adverse Event|4|||
163020549|NCT03557931|588777978|FG001|Overall Study|Adverse Event|6|||
163020550|NCT03557931|588777979|FG002|Overall Study|Adverse Event|1|||
163020551|NCT03557931|588777977|FG000|Overall Study|Lost to Follow-up|4|||
163020552|NCT03557931|588777978|FG001|Overall Study|Lost to Follow-up|4|||
163020553|NCT03557931|588777979|FG002|Overall Study|Lost to Follow-up|1|||
163020554|NCT03557931|588777977|FG000|Overall Study|Protocol Violation|1|||
163020555|NCT03557931|588777978|FG001|Overall Study|Protocol Violation|4|||
163020556|NCT03557931|588777979|FG002|Overall Study|Protocol Violation|1|||
163020557|NCT03557931|588777977|FG000|Overall Study|Withdrawal by Subject|14|||
163020558|NCT03557931|588777978|FG001|Overall Study|Withdrawal by Subject|0|||
163020559|NCT03557931|588777979|FG002|Overall Study|Withdrawal by Subject|7|||
163020560|NCT03557931|588777977|FG000|Overall Study|Miscellaneous|8|||
163020561|NCT03557931|588777978|FG001|Overall Study|Miscellaneous|5|||
163020562|NCT03557931|588777979|FG002|Overall Study|Miscellaneous|3|||
163020563|NCT02394340|588777980|FG000|Overall Study|Failed drug screen test|1|||
163020564|NCT02394340|588777980|FG000|Overall Study|Adverse Event|1|||
163020565|NCT00886743|588777984|FG000|Overall Study|Adverse Event|3|||
163020566|NCT00886743|588777984|FG000|Overall Study|Other|1|||
163020567|NCT00478777|588777985|FG000|Overall Study|Adverse Event|29|||
163020568|NCT00478777|588777985|FG000|Overall Study|Lack of Efficacy|23|||
163020569|NCT00478777|588777985|FG000|Overall Study|Withdrawal by Subject|4|||
163020570|NCT00478777|588777985|FG000|Overall Study|Death|3|||
163020571|NCT00478777|588777985|FG000|Overall Study|Protocol Violation|3|||
163020572|NCT00478777|588777985|FG000|Overall Study|Lost to Follow-up|3|||
163020573|NCT00478777|588777985|FG000|Overall Study|Physician Decision|1|||
163020574|NCT00478777|588777985|FG000|Overall Study|Intolerance of therapy|1|||
163020575|NCT00478777|588777985|FG000|Overall Study|Lack of compliance|1|||
163020576|NCT00478777|588777985|FG000|Overall Study|Lymphocytes infusion|1|||
163020577|NCT00478777|588777985|FG000|Overall Study|End of therapy|2|||
163020578|NCT00478777|588777985|FG000|Overall Study|Not treated with lenalidomide|6|||
163020579|NCT01726270|588777988|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
163020580|NCT01726270|588777988|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
163020581|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
163020582|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
163020583|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
163020584|NCT01726270|588777988|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
163020585|NCT01323387|588777989|FG000|Overall Study|Withdrawal by Subject|41|||
163020586|NCT01323387|588777989|FG000|Overall Study|Radiographic Data Unavailable|1|||
163020587|NCT01323387|588777989|FG000|Overall Study|Revision|14|||
163020588|NCT01323387|588777989|FG000|Overall Study|Protocol Violation|12|||
163020589|NCT01323387|588777989|FG000|Overall Study|Randomized but Never Treated|16|||
163020590|NCT02157376|588777992|FG000|Overall Study|Death|10|||
163020591|NCT02157376|588777993|FG001|Overall Study|Death|4|||
163020592|NCT02157376|588777992|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163020593|NCT02157376|588777993|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162642067|NCT00642941|587404614|FG000|Overall Study|Withdrawal by Subject|1|||
162642068|NCT00642941|587404615|FG001|Overall Study|Withdrawal by Subject|0|||
162642069|NCT00642941|587404616|FG002|Overall Study|Withdrawal by Subject|0|||
162642070|NCT00642941|587404617|FG003|Overall Study|Withdrawal by Subject|2|||
162642071|NCT00642941|587404618|FG004|Overall Study|Withdrawal by Subject|0|||
162642072|NCT00642941|587404619|FG005|Overall Study|Withdrawal by Subject|0|||
163020594|NCT02157376|588777992|FG000|Overall Study|Withdrawal by Subject|3|||
163020595|NCT02157376|588777993|FG001|Overall Study|Withdrawal by Subject|8|||
163020596|NCT02157376|588777992|FG000|Overall Study|Not treated|8|||
163020597|NCT02157376|588777993|FG001|Overall Study|Not treated|3|||
163020598|NCT02157376|588777992|FG000|Overall Study|Investigator's misjudgement|1|||
163020599|NCT02157376|588777993|FG001|Overall Study|Investigator's misjudgement|2|||
163020600|NCT04200651|588777994|FG000|Overall Study|Moved to another country during follow-up|2|||
163020601|NCT04200651|588777995|FG001|Overall Study|Moved to another country during follow-up|2|||
163020602|NCT04200651|588777994|FG000|Overall Study|Lost to Follow-up|1|||
162642073|NCT00642941|587404620|FG006|Overall Study|Withdrawal by Subject|2|||
163020603|NCT04200651|588777995|FG001|Overall Study|Lost to Follow-up|3|||
163020604|NCT03319732|588778005|FG000|Overall Study|Adverse Event|40|||
163020605|NCT03319732|588778005|FG000|Overall Study|Withdrawal by Subject|50|||
163020606|NCT03319732|588778005|FG000|Overall Study|MS relapse|10|||
163020607|NCT03319732|588778005|FG000|Overall Study|reason not specified|5|||
163020608|NCT00757042|588778006|FG000|Overall Study|Lost to Follow-up|0|||
163020609|NCT00757042|588778007|FG001|Overall Study|Lost to Follow-up|0|||
163020610|NCT00757042|588778008|FG002|Overall Study|Lost to Follow-up|0|||
163020611|NCT00757042|588778009|FG003|Overall Study|Lost to Follow-up|0|||
163020612|NCT00757042|588778010|FG004|Overall Study|Lost to Follow-up|0|||
163020613|NCT00757042|588778011|FG005|Overall Study|Lost to Follow-up|0|||
163020614|NCT00757042|588778012|FG006|Overall Study|Lost to Follow-up|0|||
163020615|NCT00757042|588778013|FG007|Overall Study|Lost to Follow-up|0|||
163020616|NCT00757042|588778014|FG008|Overall Study|Lost to Follow-up|1|||
163020617|NCT00757042|588778015|FG009|Overall Study|Lost to Follow-up|0|||
163020618|NCT00757042|588778016|FG010|Overall Study|Lost to Follow-up|0|||
163020619|NCT00757042|588778006|FG000|Overall Study|Ineligibility Determined|0|||
163020620|NCT00757042|588778007|FG001|Overall Study|Ineligibility Determined|0|||
163020621|NCT00757042|588778008|FG002|Overall Study|Ineligibility Determined|0|||
163020622|NCT00757042|588778009|FG003|Overall Study|Ineligibility Determined|0|||
163020623|NCT00757042|588778010|FG004|Overall Study|Ineligibility Determined|0|||
163020624|NCT00757042|588778011|FG005|Overall Study|Ineligibility Determined|0|||
163020625|NCT00757042|588778012|FG006|Overall Study|Ineligibility Determined|0|||
163020626|NCT00757042|588778013|FG007|Overall Study|Ineligibility Determined|0|||
163020627|NCT00757042|588778014|FG008|Overall Study|Ineligibility Determined|0|||
163020628|NCT00757042|588778015|FG009|Overall Study|Ineligibility Determined|0|||
163020629|NCT00757042|588778016|FG010|Overall Study|Ineligibility Determined|1|||
163020630|NCT00757042|588778006|FG000|Overall Study|Withdrawal by Subject|0|||
163020631|NCT00757042|588778007|FG001|Overall Study|Withdrawal by Subject|0|||
163020632|NCT00757042|588778008|FG002|Overall Study|Withdrawal by Subject|0|||
163020633|NCT00757042|588778009|FG003|Overall Study|Withdrawal by Subject|0|||
163020634|NCT00757042|588778010|FG004|Overall Study|Withdrawal by Subject|0|||
163020635|NCT00757042|588778011|FG005|Overall Study|Withdrawal by Subject|0|||
163020636|NCT00757042|588778012|FG006|Overall Study|Withdrawal by Subject|0|||
163020637|NCT00757042|588778013|FG007|Overall Study|Withdrawal by Subject|0|||
163020638|NCT00757042|588778014|FG008|Overall Study|Withdrawal by Subject|0|||
163020639|NCT00757042|588778015|FG009|Overall Study|Withdrawal by Subject|1|||
163020640|NCT00757042|588778016|FG010|Overall Study|Withdrawal by Subject|0|||
163020641|NCT02654977|588778018|FG000|Overall Study|Death|1|||
163020642|NCT02654977|588778018|FG000|Overall Study|Lost to Follow-up|1|||
163020643|NCT02654977|588778018|FG000|Overall Study|Adverse Event|1|||
163020644|NCT02654977|588778018|FG000|Overall Study|Withdrawal by Subject|1|||
163020645|NCT02654977|588778018|FG000|Overall Study|Lack of Efficacy|3|||
163020646|NCT01266291|588778019|FG000|Overall Study|Adverse Event|1|||
163020647|NCT02729051|588778022|FG000|Overall Study|Adverse Event|21|||
163020648|NCT02729051|588778023|FG001|Overall Study|Adverse Event|11|||
163020649|NCT02729051|588778022|FG000|Overall Study|Lack of Efficacy|1|||
163063678|NCT04725188|588939919|FG000|Overall Study|Withdrawal by Subject|2|||
163063679|NCT04725188|588939920|FG001|Overall Study|Withdrawal by Subject|2|||
163063680|NCT04725188|588939921|FG002|Overall Study|Withdrawal by Subject|1|||
163063681|NCT04725188|588939919|FG000|Overall Study|Sponsor Decision|12|||
163063682|NCT04725188|588939920|FG001|Overall Study|Sponsor Decision|12|||
163063683|NCT04725188|588939921|FG002|Overall Study|Sponsor Decision|7|||
163063684|NCT00390013|588939923|FG000|Phase 1|tired|0|||
163063685|NCT00390013|588939924|FG001|Phase 1|tired|0|||
163063686|NCT00390013|588939925|FG002|Phase 1|tired|0|||
163063687|NCT00390013|588939926|FG003|Phase 1|tired|1|||
163063688|NCT00390013|588939923|FG000|Phase 2 First Treatment|tired|1|||
163063689|NCT00390013|588939924|FG001|Phase 2 First Treatment|tired|0|||
163063690|NCT00390013|588939925|FG002|Phase 2 First Treatment|tired|0|||
163063691|NCT00390013|588939926|FG003|Phase 2 First Treatment|tired|0|||
163020650|NCT02729051|588778023|FG001|Overall Study|Lack of Efficacy|1|||
163020651|NCT02729051|588778022|FG000|Overall Study|Lost to Follow-up|1|||
163020652|NCT02729051|588778023|FG001|Overall Study|Lost to Follow-up|2|||
163020653|NCT02729051|588778022|FG000|Overall Study|Physician Decision|1|||
163020654|NCT02729051|588778023|FG001|Overall Study|Physician Decision|1|||
163020655|NCT02729051|588778022|FG000|Overall Study|Withdrawal by Subject|6|||
163020656|NCT02729051|588778023|FG001|Overall Study|Withdrawal by Subject|17|||
163020657|NCT02702388|588778024|FG000|Overall Study|Disease Progression|18|||
163020658|NCT02702388|588778025|FG001|Overall Study|Disease Progression|25|||
163020659|NCT02702388|588778024|FG000|Overall Study|Withdrawal by Subject|9|||
163020660|NCT02702388|588778025|FG001|Overall Study|Withdrawal by Subject|7|||
163063692|NCT00390013|588939923|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
163063693|NCT00390013|588939924|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
163063694|NCT00390013|588939925|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
163063695|NCT00390013|588939926|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
163020661|NCT02702388|588778024|FG000|Overall Study|Adverse Event|11|||
163020662|NCT02702388|588778025|FG001|Overall Study|Adverse Event|15|||
163020663|NCT02702388|588778024|FG000|Overall Study|Other|2|||
163020664|NCT02702388|588778025|FG001|Overall Study|Other|4|||
163020665|NCT00596817|588778026|FG000|Open-label Period|Adverse Event|0|||
163063696|NCT03839641|588939927|FG000|Overall Study|Withdrawal by Subject|1|||
162642074|NCT00642941|587404621|FG007|Overall Study|Withdrawal by Subject|0|||
162642075|NCT00642941|587404622|FG008|Overall Study|Withdrawal by Subject|1|||
162642076|NCT00642941|587404623|FG009|Overall Study|Withdrawal by Subject|0|||
162642077|NCT00642941|587404624|FG010|Overall Study|Withdrawal by Subject|0|||
162642078|NCT00642941|587404625|FG011|Overall Study|Withdrawal by Subject|1|||
162642079|NCT00642941|587404614|FG000|Overall Study|Protocol Violation|0|||
162642080|NCT00642941|587404615|FG001|Overall Study|Protocol Violation|0|||
162642081|NCT00642941|587404616|FG002|Overall Study|Protocol Violation|0|||
162642082|NCT00642941|587404617|FG003|Overall Study|Protocol Violation|0|||
162642083|NCT00642941|587404618|FG004|Overall Study|Protocol Violation|0|||
162642084|NCT00642941|587404619|FG005|Overall Study|Protocol Violation|0|||
162642085|NCT00642941|587404620|FG006|Overall Study|Protocol Violation|1|||
162642086|NCT00642941|587404621|FG007|Overall Study|Protocol Violation|0|||
162642087|NCT00642941|587404622|FG008|Overall Study|Protocol Violation|0|||
162642088|NCT00642941|587404623|FG009|Overall Study|Protocol Violation|0|||
162642089|NCT00642941|587404624|FG010|Overall Study|Protocol Violation|0|||
163020666|NCT00596817|588778027|FG001|Open-label Period|Adverse Event|49|||
163020667|NCT00596817|588778026|FG000|Open-label Period|Lack of Efficacy|0|||
163020668|NCT00596817|588778027|FG001|Open-label Period|Lack of Efficacy|33|||
163020669|NCT00596817|588778026|FG000|Open-label Period|Other Reasons|0|||
163020670|NCT00596817|588778027|FG001|Open-label Period|Other Reasons|65|||
163020671|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
163020672|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
163020673|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
163020674|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
163020675|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
163020676|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
163020677|NCT00596817|588778026|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
163020678|NCT00596817|588778027|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
163020679|NCT00596817|588778026|FG000|Double-blind Period|Adverse Event|5|||
163020680|NCT00596817|588778027|FG001|Double-blind Period|Adverse Event|16|||
163020681|NCT00596817|588778026|FG000|Double-blind Period|Lack of Efficacy|52|||
163020682|NCT00596817|588778027|FG001|Double-blind Period|Lack of Efficacy|28|||
163020683|NCT00596817|588778026|FG000|Double-blind Period|Non-compliance With Study Product|3|||
163020684|NCT00596817|588778027|FG001|Double-blind Period|Non-compliance With Study Product|4|||
163020685|NCT00596817|588778026|FG000|Double-blind Period|Protocol Violation|11|||
163020686|NCT00596817|588778027|FG001|Double-blind Period|Protocol Violation|8|||
163020687|NCT00596817|588778026|FG000|Double-blind Period|Withdrawal of Consent|7|||
163020688|NCT00596817|588778027|FG001|Double-blind Period|Withdrawal of Consent|3|||
163020689|NCT00596817|588778026|FG000|Double-blind Period|Lost to Follow-up|0|||
163020690|NCT00596817|588778027|FG001|Double-blind Period|Lost to Follow-up|2|||
163020691|NCT00596817|588778026|FG000|Double-blind Period|Other Reasons|10|||
163020692|NCT00596817|588778027|FG001|Double-blind Period|Other Reasons|18|||
163020693|NCT01314872|588778036|FG000|Treatment Period 1|Protocol Violation|2|||
163020694|NCT01314872|588778037|FG001|Treatment Period 1|Protocol Violation|1|||
163020695|NCT01314872|588778038|FG002|Treatment Period 1|Protocol Violation|1|||
163020696|NCT01314872|588778039|FG003|Treatment Period 1|Protocol Violation|0|||
163020697|NCT01314872|588778040|FG004|Treatment Period 1|Protocol Violation|1|||
163020698|NCT01314872|588778041|FG005|Treatment Period 1|Protocol Violation|0|||
163020699|NCT01314872|588778042|FG006|Treatment Period 1|Protocol Violation|0|||
163020700|NCT01314872|588778043|FG007|Treatment Period 1|Protocol Violation|0|||
163020701|NCT01314872|588778044|FG008|Treatment Period 1|Protocol Violation|0|||
163020702|NCT01314872|588778045|FG009|Treatment Period 1|Protocol Violation|1|||
163020703|NCT01314872|588778046|FG010|Treatment Period 1|Protocol Violation|1|||
163063697|NCT03839641|588939928|FG001|Overall Study|Withdrawal by Subject|1|||
163063698|NCT03188822|588939936|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
163063699|NCT03188822|588939936|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
163020704|NCT01314872|588778047|FG011|Treatment Period 1|Protocol Violation|0|||
163020705|NCT01314872|588778048|FG012|Treatment Period 1|Protocol Violation|0|||
163020706|NCT01314872|588778049|FG013|Treatment Period 1|Protocol Violation|0|||
163063700|NCT04537299|588939937|FG000|Overall Study|Withdrawal by Subject|2|||
163063701|NCT04537299|588939938|FG001|Overall Study|Withdrawal by Subject|0|||
163063702|NCT04537299|588939937|FG000|Overall Study|Protocol Violation|1|||
163020707|NCT01314872|588778050|FG014|Treatment Period 1|Protocol Violation|0|||
162642090|NCT00642941|587404625|FG011|Overall Study|Protocol Violation|0|||
162642091|NCT00642941|587404614|FG000|Overall Study|Adverse Event|1|||
162642092|NCT00642941|587404615|FG001|Overall Study|Adverse Event|1|||
163020708|NCT01314872|588778036|FG000|Treatment Period 1|Physician Decision|0|||
163020709|NCT01314872|588778037|FG001|Treatment Period 1|Physician Decision|1|||
163020710|NCT01314872|588778038|FG002|Treatment Period 1|Physician Decision|0|||
163020711|NCT01314872|588778039|FG003|Treatment Period 1|Physician Decision|1|||
163020712|NCT01314872|588778040|FG004|Treatment Period 1|Physician Decision|0|||
163020713|NCT01314872|588778041|FG005|Treatment Period 1|Physician Decision|0|||
162642093|NCT00642941|587404616|FG002|Overall Study|Adverse Event|0|||
163020714|NCT01314872|588778042|FG006|Treatment Period 1|Physician Decision|0|||
163020715|NCT01314872|588778043|FG007|Treatment Period 1|Physician Decision|0|||
163020716|NCT01314872|588778044|FG008|Treatment Period 1|Physician Decision|0|||
163020717|NCT01314872|588778045|FG009|Treatment Period 1|Physician Decision|1|||
163020718|NCT01314872|588778046|FG010|Treatment Period 1|Physician Decision|0|||
163020719|NCT01314872|588778047|FG011|Treatment Period 1|Physician Decision|0|||
163020720|NCT01314872|588778048|FG012|Treatment Period 1|Physician Decision|0|||
163020721|NCT01314872|588778049|FG013|Treatment Period 1|Physician Decision|0|||
163020722|NCT01314872|588778050|FG014|Treatment Period 1|Physician Decision|0|||
163020723|NCT01314872|588778036|FG000|Treatment Period 1|Lack of Efficacy|1|||
163020724|NCT01314872|588778037|FG001|Treatment Period 1|Lack of Efficacy|0|||
163020725|NCT01314872|588778038|FG002|Treatment Period 1|Lack of Efficacy|0|||
163020726|NCT01314872|588778039|FG003|Treatment Period 1|Lack of Efficacy|0|||
163020727|NCT01314872|588778040|FG004|Treatment Period 1|Lack of Efficacy|0|||
163020728|NCT01314872|588778041|FG005|Treatment Period 1|Lack of Efficacy|1|||
163020729|NCT01314872|588778042|FG006|Treatment Period 1|Lack of Efficacy|0|||
163020730|NCT01314872|588778043|FG007|Treatment Period 1|Lack of Efficacy|2|||
163020731|NCT01314872|588778044|FG008|Treatment Period 1|Lack of Efficacy|0|||
163020732|NCT01314872|588778045|FG009|Treatment Period 1|Lack of Efficacy|0|||
163020733|NCT01314872|588778046|FG010|Treatment Period 1|Lack of Efficacy|0|||
163020734|NCT01314872|588778047|FG011|Treatment Period 1|Lack of Efficacy|0|||
163020735|NCT01314872|588778048|FG012|Treatment Period 1|Lack of Efficacy|0|||
163020736|NCT01314872|588778049|FG013|Treatment Period 1|Lack of Efficacy|0|||
163020737|NCT01314872|588778050|FG014|Treatment Period 1|Lack of Efficacy|0|||
163020738|NCT01314872|588778036|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
163020739|NCT01314872|588778037|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
163020740|NCT01314872|588778038|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
163020741|NCT01314872|588778039|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
163020742|NCT01314872|588778040|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
163020743|NCT01314872|588778041|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
163020744|NCT01314872|588778042|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
163020745|NCT01314872|588778043|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
163020746|NCT01314872|588778044|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
163020747|NCT01314872|588778045|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
163020748|NCT01314872|588778046|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
163020749|NCT01314872|588778047|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
163020750|NCT01314872|588778048|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
163020751|NCT01314872|588778049|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
163020752|NCT01314872|588778050|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
163020753|NCT01314872|588778036|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163020754|NCT01314872|588778037|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163020755|NCT01314872|588778038|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163020756|NCT01314872|588778039|FG003|Treatment Period 1|Withdrawal by Subject|2|||
163020757|NCT01314872|588778040|FG004|Treatment Period 1|Withdrawal by Subject|3|||
163020758|NCT01314872|588778041|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163020759|NCT01314872|588778042|FG006|Treatment Period 1|Withdrawal by Subject|3|||
163020760|NCT01314872|588778043|FG007|Treatment Period 1|Withdrawal by Subject|2|||
163020761|NCT01314872|588778044|FG008|Treatment Period 1|Withdrawal by Subject|2|||
163020762|NCT01314872|588778045|FG009|Treatment Period 1|Withdrawal by Subject|2|||
163020763|NCT01314872|588778046|FG010|Treatment Period 1|Withdrawal by Subject|1|||
163020764|NCT01314872|588778047|FG011|Treatment Period 1|Withdrawal by Subject|0|||
162642094|NCT00642941|587404617|FG003|Overall Study|Adverse Event|0|||
162642095|NCT00642941|587404618|FG004|Overall Study|Adverse Event|0|||
162642096|NCT00642941|587404619|FG005|Overall Study|Adverse Event|0|||
162642097|NCT00642941|587404620|FG006|Overall Study|Adverse Event|1|||
162642098|NCT00642941|587404621|FG007|Overall Study|Adverse Event|1|||
162642099|NCT00642941|587404622|FG008|Overall Study|Adverse Event|0|||
163020765|NCT01314872|588778048|FG012|Treatment Period 1|Withdrawal by Subject|0|||
163020766|NCT01314872|588778049|FG013|Treatment Period 1|Withdrawal by Subject|0|||
163020767|NCT01314872|588778050|FG014|Treatment Period 1|Withdrawal by Subject|0|||
163020768|NCT01314872|588778036|FG000|Treatment Period 1|Lost to Follow-up|0|||
163020769|NCT01314872|588778037|FG001|Treatment Period 1|Lost to Follow-up|1|||
163020770|NCT01314872|588778038|FG002|Treatment Period 1|Lost to Follow-up|2|||
163020771|NCT01314872|588778039|FG003|Treatment Period 1|Lost to Follow-up|2|||
163020772|NCT01314872|588778040|FG004|Treatment Period 1|Lost to Follow-up|1|||
163020773|NCT01314872|588778041|FG005|Treatment Period 1|Lost to Follow-up|1|||
163020774|NCT01314872|588778042|FG006|Treatment Period 1|Lost to Follow-up|1|||
162642100|NCT00642941|587404623|FG009|Overall Study|Adverse Event|1|||
162642101|NCT00642941|587404624|FG010|Overall Study|Adverse Event|0|||
162642102|NCT00642941|587404625|FG011|Overall Study|Adverse Event|0|||
162642103|NCT00642941|587404614|FG000|Overall Study|Other|1|||
163020775|NCT01314872|588778043|FG007|Treatment Period 1|Lost to Follow-up|1|||
163020776|NCT01314872|588778044|FG008|Treatment Period 1|Lost to Follow-up|1|||
163020777|NCT01314872|588778045|FG009|Treatment Period 1|Lost to Follow-up|0|||
163063703|NCT04537299|588939938|FG001|Overall Study|Protocol Violation|1|||
163063704|NCT00876343|588939951|FG000|Overall Study|Adverse Event|7|||
163063705|NCT00876343|588939952|FG001|Overall Study|Adverse Event|8|||
163063706|NCT00876343|588939953|FG002|Overall Study|Adverse Event|2|||
163063707|NCT00876343|588939951|FG000|Overall Study|Withdrawal by Subject|4|||
163063708|NCT00876343|588939952|FG001|Overall Study|Withdrawal by Subject|4|||
163063709|NCT00876343|588939953|FG002|Overall Study|Withdrawal by Subject|3|||
162642104|NCT00642941|587404615|FG001|Overall Study|Other|1|||
162642105|NCT00642941|587404616|FG002|Overall Study|Other|1|||
162642106|NCT00642941|587404617|FG003|Overall Study|Other|1|||
162642107|NCT00642941|587404618|FG004|Overall Study|Other|0|||
162642108|NCT00642941|587404619|FG005|Overall Study|Other|1|||
162642109|NCT00642941|587404620|FG006|Overall Study|Other|0|||
162642110|NCT00642941|587404621|FG007|Overall Study|Other|1|||
162642111|NCT00642941|587404622|FG008|Overall Study|Other|0|||
162642112|NCT00642941|587404623|FG009|Overall Study|Other|0|||
162642113|NCT00642941|587404624|FG010|Overall Study|Other|0|||
162642114|NCT00642941|587404625|FG011|Overall Study|Other|1|||
162642115|NCT00642941|587404614|FG000|Overall Study|Disease progression|60|||
162642116|NCT00642941|587404615|FG001|Overall Study|Disease progression|50|||
162642117|NCT00642941|587404616|FG002|Overall Study|Disease progression|5|||
162642118|NCT00642941|587404617|FG003|Overall Study|Disease progression|36|||
162642119|NCT00642941|587404618|FG004|Overall Study|Disease progression|23|||
162642120|NCT00642941|587404619|FG005|Overall Study|Disease progression|39|||
162642121|NCT00642941|587404620|FG006|Overall Study|Disease progression|18|||
162642122|NCT00642941|587404621|FG007|Overall Study|Disease progression|12|||
162642123|NCT00642941|587404622|FG008|Overall Study|Disease progression|10|||
162642124|NCT00642941|587404623|FG009|Overall Study|Disease progression|7|||
162642125|NCT00642941|587404624|FG010|Overall Study|Disease progression|12|||
162642126|NCT00642941|587404625|FG011|Overall Study|Disease progression|7|||
162642127|NCT03051607|587404627|FG000|Overall Study|Adverse Event|66|||
162642128|NCT00894322|587404628|FG000|Overall Study|Withdrawal by Subject|1|||
162642129|NCT00894322|587404629|FG001|Overall Study|Withdrawal by Subject|0|||
162642130|NCT00894322|587404630|FG002|Overall Study|Withdrawal by Subject|0|||
162642131|NCT03338855|587404631|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
162642132|NCT03338855|587404632|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
162642133|NCT03605303|587404640|FG000|Period 1|Study Terminated|2|||
162642134|NCT03605303|587404641|FG001|Period 1|Study Terminated|1|||
162642135|NCT00399360|587404642|FG000|Overall Study|Lost to Follow-up|2|||
162642136|NCT00399360|587404643|FG001|Overall Study|Lost to Follow-up|1|||
162642137|NCT00399360|587404644|FG002|Overall Study|Lost to Follow-up|2|||
162642138|NCT00399360|587404645|FG003|Overall Study|Lost to Follow-up|4|||
162642139|NCT00399360|587404642|FG000|Overall Study|Adverse Event|0|||
162642140|NCT00399360|587404643|FG001|Overall Study|Adverse Event|0|||
162642141|NCT00399360|587404644|FG002|Overall Study|Adverse Event|1|||
162642142|NCT00399360|587404645|FG003|Overall Study|Adverse Event|0|||
162642143|NCT00399360|587404642|FG000|Overall Study|Withdrawal by Subject|0|||
162642144|NCT00399360|587404643|FG001|Overall Study|Withdrawal by Subject|2|||
162642145|NCT00399360|587404644|FG002|Overall Study|Withdrawal by Subject|0|||
162642146|NCT00399360|587404645|FG003|Overall Study|Withdrawal by Subject|2|||
162642147|NCT02626520|587404647|FG000|Overall Study|Physician Decision|1|||
162642148|NCT02626520|587404648|FG001|Overall Study|Physician Decision|1|||
162642149|NCT02626520|587404647|FG000|Overall Study|Adverse Event|0|||
162642150|NCT02626520|587404648|FG001|Overall Study|Adverse Event|4|||
162642151|NCT02626520|587404647|FG000|Overall Study|Lack of Efficacy|0|||
162642152|NCT02626520|587404648|FG001|Overall Study|Lack of Efficacy|2|||
162642153|NCT02626520|587404647|FG000|Overall Study|Did not start protocol therapy|0|||
162642154|NCT02626520|587404648|FG001|Overall Study|Did not start protocol therapy|2|||
162642155|NCT02626520|587404647|FG000|Overall Study|Study terminated|0|||
162642156|NCT02626520|587404648|FG001|Overall Study|Study terminated|1|||
162642157|NCT02472795|587404651|FG000|Overall Study|Adverse Event|0|||
162642158|NCT02472795|587404652|FG001|Overall Study|Adverse Event|1|||
162642159|NCT02472795|587404653|FG002|Overall Study|Adverse Event|0|||
163063710|NCT00876343|588939951|FG000|Overall Study|Lack of Efficacy|0|||
162642160|NCT02472795|587404654|FG003|Overall Study|Adverse Event|0|||
162642161|NCT02472795|587404655|FG004|Overall Study|Adverse Event|2|||
162642162|NCT02472795|587404651|FG000|Overall Study|Withdrawal by Subject|0|||
162642163|NCT02472795|587404652|FG001|Overall Study|Withdrawal by Subject|0|||
162642164|NCT02472795|587404653|FG002|Overall Study|Withdrawal by Subject|0|||
162642165|NCT02472795|587404654|FG003|Overall Study|Withdrawal by Subject|0|||
162642166|NCT02472795|587404655|FG004|Overall Study|Withdrawal by Subject|1|||
162642167|NCT04318080|587406548|FG000|Overall Study|Study closed by sponsor|10|||
162642168|NCT04318080|587406549|FG001|Overall Study|Study closed by sponsor|22|||
162642169|NCT04318080|587406548|FG000|Overall Study|Death|3|||
162642170|NCT04318080|587406549|FG001|Overall Study|Death|9|||
162642171|NCT04318080|587406548|FG000|Overall Study|Withdrawal by Subject|1|||
162642172|NCT04318080|587406549|FG001|Overall Study|Withdrawal by Subject|0|||
162642173|NCT04318080|587406548|FG000|Overall Study|Protocol Deviation|1|||
162642174|NCT04318080|587406549|FG001|Overall Study|Protocol Deviation|0|||
162642175|NCT06308822|587406550|FG000|Overall Study|Mutation Status Not Confirmed|17|||
162642176|NCT06308822|587406550|FG000|Overall Study|Adverse Event|1|||
162642177|NCT06308822|587406550|FG000|Overall Study|Death|5|||
162642178|NCT06308822|587406550|FG000|Overall Study|Disease progression|8|||
162642179|NCT06308822|587406550|FG000|Overall Study|Withdrawal by Subject|1|||
162642180|NCT06308822|587406550|FG000|Overall Study|Physician Decision|3|||
162642181|NCT01536379|587406551|FG000|Overall Study|Adverse Event|1|||
162642182|NCT01536379|587406552|FG001|Overall Study|Adverse Event|2|||
162642183|NCT01536379|587406551|FG000|Overall Study|Withdrawal by Subject|1|||
162642184|NCT01536379|587406552|FG001|Overall Study|Withdrawal by Subject|1|||
162642185|NCT04734652|587406561|FG000|Overall Study|Withdrawal by Subject|2|||
162642186|NCT04734652|587406562|FG001|Overall Study|Withdrawal by Subject|0|||
162642187|NCT04734652|587406561|FG000|Overall Study|Death|0|||
162642188|NCT04734652|587406562|FG001|Overall Study|Death|1|||
162642189|NCT04729127|587406564|FG000|Overall Study|Suspended/Terminated EI Services|4|||
162642190|NCT04729127|587406565|FG001|Overall Study|Suspended/Terminated EI Services|0|||
162642191|NCT04729127|587406566|FG002|Overall Study|Suspended/Terminated EI Services|4|||
162642192|NCT04729127|587406567|FG003|Overall Study|Suspended/Terminated EI Services|6|||
162642193|NCT04729127|587406568|FG004|Overall Study|Suspended/Terminated EI Services|0|||
162642194|NCT04729127|587406569|FG005|Overall Study|Suspended/Terminated EI Services|6|||
162642195|NCT04729127|587406570|FG006|Overall Study|Suspended/Terminated EI Services|2|||
162642196|NCT04729127|587406571|FG007|Overall Study|Suspended/Terminated EI Services|0|||
162642197|NCT04729127|587406572|FG008|Overall Study|Suspended/Terminated EI Services|2|||
162642198|NCT04729127|587406564|FG000|Overall Study|Withdrawal by Subject|1|||
162642199|NCT04729127|587406565|FG001|Overall Study|Withdrawal by Subject|0|||
162642200|NCT04729127|587406566|FG002|Overall Study|Withdrawal by Subject|1|||
162642201|NCT04729127|587406567|FG003|Overall Study|Withdrawal by Subject|0|||
162642202|NCT04729127|587406568|FG004|Overall Study|Withdrawal by Subject|0|||
162642203|NCT04729127|587406569|FG005|Overall Study|Withdrawal by Subject|0|||
162642204|NCT04729127|587406570|FG006|Overall Study|Withdrawal by Subject|0|||
162642205|NCT04729127|587406571|FG007|Overall Study|Withdrawal by Subject|0|||
162642206|NCT04729127|587406572|FG008|Overall Study|Withdrawal by Subject|0|||
162642207|NCT04729127|587406564|FG000|Overall Study|Switched Agency/Setting|1|||
162642208|NCT04729127|587406565|FG001|Overall Study|Switched Agency/Setting|0|||
162642209|NCT04729127|587406566|FG002|Overall Study|Switched Agency/Setting|1|||
162642210|NCT04729127|587406567|FG003|Overall Study|Switched Agency/Setting|1|||
162642211|NCT04729127|587406568|FG004|Overall Study|Switched Agency/Setting|0|||
162642212|NCT04729127|587406569|FG005|Overall Study|Switched Agency/Setting|1|||
162642213|NCT04729127|587406570|FG006|Overall Study|Switched Agency/Setting|1|||
162642214|NCT04729127|587406571|FG007|Overall Study|Switched Agency/Setting|0|||
162642215|NCT04729127|587406572|FG008|Overall Study|Switched Agency/Setting|1|||
162642216|NCT03662542|587406575|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
162642217|NCT03662542|587406576|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642218|NCT03662542|587406577|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642219|NCT03662542|587406578|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642220|NCT03662542|587406579|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642221|NCT03662542|587406580|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642222|NCT03662542|587406581|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642223|NCT03662542|587406582|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642224|NCT03662542|587406583|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162642225|NCT03662542|587406575|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642226|NCT03662542|587406576|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
162642227|NCT03662542|587406577|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642228|NCT03662542|587406578|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642229|NCT03662542|587406579|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642230|NCT03662542|587406580|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642231|NCT03662542|587406581|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
163063711|NCT00876343|588939952|FG001|Overall Study|Lack of Efficacy|0|||
163063712|NCT00876343|588939953|FG002|Overall Study|Lack of Efficacy|1|||
163063713|NCT00876343|588939951|FG000|Overall Study|Protocol Violation|4|||
163063714|NCT00876343|588939952|FG001|Overall Study|Protocol Violation|1|||
163063715|NCT00876343|588939953|FG002|Overall Study|Protocol Violation|1|||
163063716|NCT00876343|588939951|FG000|Overall Study|Physician Decision|0|||
162642232|NCT03662542|587406582|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642233|NCT03662542|587406583|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162642234|NCT03662542|587406575|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
162642235|NCT03662542|587406576|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
162642236|NCT03662542|587406577|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
162642237|NCT03662542|587406578|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
162642238|NCT03662542|587406579|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
162642239|NCT03662542|587406580|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
162642240|NCT03662542|587406581|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
163063717|NCT00876343|588939952|FG001|Overall Study|Physician Decision|1|||
163063718|NCT00876343|588939953|FG002|Overall Study|Physician Decision|1|||
163063719|NCT00876343|588939951|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
162642241|NCT03662542|587406582|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
162642242|NCT03662542|587406583|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
162642243|NCT03662542|587406575|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
162642244|NCT03662542|587406576|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642245|NCT03662542|587406577|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642246|NCT03662542|587406578|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642247|NCT03662542|587406579|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642248|NCT03662542|587406580|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642249|NCT03662542|587406581|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642250|NCT03662542|587406582|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642251|NCT03662542|587406583|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162642252|NCT03662542|587406575|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642253|NCT03662542|587406576|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642254|NCT03662542|587406577|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642255|NCT03662542|587406578|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642256|NCT03662542|587406579|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642257|NCT03662542|587406580|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
162642258|NCT03662542|587406581|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642259|NCT03662542|587406582|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642260|NCT03662542|587406583|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162642261|NCT03662542|587406575|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162642262|NCT03662542|587406576|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162642263|NCT03662542|587406577|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162642264|NCT03662542|587406578|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
162642265|NCT03662542|587406579|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
162642266|NCT03662542|587406580|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162642267|NCT03662542|587406581|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163020778|NCT01314872|588778046|FG010|Treatment Period 1|Lost to Follow-up|0|||
163020779|NCT01314872|588778047|FG011|Treatment Period 1|Lost to Follow-up|0|||
163020780|NCT01314872|588778048|FG012|Treatment Period 1|Lost to Follow-up|0|||
163020781|NCT01314872|588778049|FG013|Treatment Period 1|Lost to Follow-up|0|||
163020782|NCT01314872|588778050|FG014|Treatment Period 1|Lost to Follow-up|0|||
163020783|NCT01314872|588778036|FG000|Period 2|Protocol Violation|0|||
163020784|NCT01314872|588778037|FG001|Period 2|Protocol Violation|0|||
163020785|NCT01314872|588778038|FG002|Period 2|Protocol Violation|0|||
163020786|NCT01314872|588778039|FG003|Period 2|Protocol Violation|0|||
163020787|NCT01314872|588778040|FG004|Period 2|Protocol Violation|0|||
163020788|NCT01314872|588778041|FG005|Period 2|Protocol Violation|0|||
163020789|NCT01314872|588778042|FG006|Period 2|Protocol Violation|0|||
163020790|NCT01314872|588778043|FG007|Period 2|Protocol Violation|0|||
163020791|NCT01314872|588778044|FG008|Period 2|Protocol Violation|0|||
163020792|NCT01314872|588778045|FG009|Period 2|Protocol Violation|0|||
163020793|NCT01314872|588778046|FG010|Period 2|Protocol Violation|0|||
163020794|NCT01314872|588778047|FG011|Period 2|Protocol Violation|3|||
163020795|NCT01314872|588778048|FG012|Period 2|Protocol Violation|3|||
163020796|NCT01314872|588778049|FG013|Period 2|Protocol Violation|2|||
163020797|NCT01314872|588778050|FG014|Period 2|Protocol Violation|0|||
163020798|NCT01314872|588778036|FG000|Period 2|Non-compliance with study drug|0|||
162642268|NCT03662542|587406582|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162642269|NCT03662542|587406583|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
163020799|NCT01314872|588778037|FG001|Period 2|Non-compliance with study drug|0|||
163020800|NCT01314872|588778038|FG002|Period 2|Non-compliance with study drug|0|||
163020801|NCT01314872|588778039|FG003|Period 2|Non-compliance with study drug|0|||
163020802|NCT01314872|588778040|FG004|Period 2|Non-compliance with study drug|0|||
163020803|NCT01314872|588778041|FG005|Period 2|Non-compliance with study drug|0|||
163020804|NCT01314872|588778042|FG006|Period 2|Non-compliance with study drug|0|||
163020805|NCT01314872|588778043|FG007|Period 2|Non-compliance with study drug|0|||
163020806|NCT01314872|588778044|FG008|Period 2|Non-compliance with study drug|0|||
163020807|NCT01314872|588778045|FG009|Period 2|Non-compliance with study drug|0|||
163020808|NCT01314872|588778046|FG010|Period 2|Non-compliance with study drug|0|||
163020809|NCT01314872|588778047|FG011|Period 2|Non-compliance with study drug|3|||
163020810|NCT01314872|588778048|FG012|Period 2|Non-compliance with study drug|3|||
163020811|NCT01314872|588778049|FG013|Period 2|Non-compliance with study drug|1|||
163020812|NCT01314872|588778050|FG014|Period 2|Non-compliance with study drug|2|||
163020813|NCT01314872|588778036|FG000|Period 2|Lack of Efficacy|0|||
162642270|NCT03662542|587406575|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162642271|NCT03662542|587406576|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162642272|NCT03662542|587406577|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
163020814|NCT01314872|588778037|FG001|Period 2|Lack of Efficacy|0|||
163020815|NCT01314872|588778038|FG002|Period 2|Lack of Efficacy|0|||
163020816|NCT01314872|588778039|FG003|Period 2|Lack of Efficacy|0|||
163020817|NCT01314872|588778040|FG004|Period 2|Lack of Efficacy|0|||
162642273|NCT03662542|587406578|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
162716630|NCT00708097|587668526|FG002|Period 1|Protocol Violation|0|||
162642274|NCT03662542|587406579|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
162642275|NCT03662542|587406580|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
162642276|NCT03662542|587406581|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162642277|NCT03662542|587406582|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162642278|NCT03662542|587406583|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162642279|NCT03662542|587406575|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642280|NCT03662542|587406576|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642281|NCT03662542|587406577|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642282|NCT03662542|587406578|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642283|NCT03662542|587406579|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
162642284|NCT03662542|587406580|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
162642285|NCT03662542|587406581|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642286|NCT03662542|587406582|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642287|NCT03662542|587406583|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162642288|NCT03662542|587406575|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642289|NCT03662542|587406576|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642290|NCT03662542|587406577|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642291|NCT03662542|587406578|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642292|NCT03662542|587406579|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642293|NCT03662542|587406580|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
162642294|NCT03662542|587406581|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642295|NCT03662542|587406582|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642296|NCT03662542|587406583|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162642297|NCT03662542|587406575|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642298|NCT03662542|587406576|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642299|NCT03662542|587406577|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642300|NCT03662542|587406578|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642301|NCT03662542|587406579|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642302|NCT03662542|587406580|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642303|NCT03662542|587406581|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642304|NCT03662542|587406582|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
162642305|NCT03662542|587406583|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
162642306|NCT03662542|587406575|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642307|NCT03662542|587406576|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642308|NCT03662542|587406577|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642309|NCT03662542|587406578|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642310|NCT03662542|587406579|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642311|NCT03662542|587406580|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642312|NCT03662542|587406581|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
162642313|NCT03662542|587406582|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162642314|NCT03662542|587406583|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
162642315|NCT03662542|587406575|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642316|NCT03662542|587406576|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642317|NCT03662542|587406577|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642318|NCT03662542|587406578|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642319|NCT03662542|587406579|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642320|NCT03662542|587406580|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642321|NCT03662542|587406581|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
162642322|NCT03662542|587406582|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162642323|NCT03662542|587406583|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
162642324|NCT03662542|587406575|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642325|NCT03662542|587406576|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642326|NCT03662542|587406577|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642327|NCT03662542|587406578|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642328|NCT03662542|587406579|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642329|NCT03662542|587406580|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
162642330|NCT03662542|587406581|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
162642331|NCT03662542|587406582|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
162642332|NCT03662542|587406583|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
163020818|NCT01314872|588778041|FG005|Period 2|Lack of Efficacy|0|||
163020819|NCT01314872|588778042|FG006|Period 2|Lack of Efficacy|0|||
162642333|NCT01217060|587406585|FG000|Overall Study|Withdrawal by Subject|1|||
162642334|NCT03388138|587406586|FG000|Overall Study|Protocol Violation|1|||
162642335|NCT03388138|587406587|FG001|Overall Study|Protocol Violation|0|||
162642336|NCT01528072|587406588|FG000|Overall Study|Withdrawal by Subject|5|||
163020820|NCT01314872|588778043|FG007|Period 2|Lack of Efficacy|0|||
162642337|NCT01528072|587406588|FG000|Overall Study|Physician Decision|1|||
162642338|NCT01528072|587406588|FG000|Overall Study|Determined not eligible by AEAC|1|||
162642339|NCT01528072|587406588|FG000|Overall Study|Missed Visit|2|||
162642340|NCT01528072|587406588|FG000|Overall Study|Lost to Follow-up|5|||
162642341|NCT01528072|587406588|FG000|Overall Study|Explanted|2|||
163020821|NCT01314872|588778044|FG008|Period 2|Lack of Efficacy|0|||
163020822|NCT01314872|588778045|FG009|Period 2|Lack of Efficacy|0|||
163020823|NCT01314872|588778046|FG010|Period 2|Lack of Efficacy|0|||
163020824|NCT01314872|588778047|FG011|Period 2|Lack of Efficacy|7|||
163020825|NCT01314872|588778048|FG012|Period 2|Lack of Efficacy|12|||
163020826|NCT01314872|588778049|FG013|Period 2|Lack of Efficacy|9|||
163020827|NCT01314872|588778050|FG014|Period 2|Lack of Efficacy|2|||
163020828|NCT01314872|588778036|FG000|Period 2|Pregnancy|0|||
163020829|NCT01314872|588778037|FG001|Period 2|Pregnancy|0|||
163020830|NCT01314872|588778038|FG002|Period 2|Pregnancy|0|||
163020831|NCT01314872|588778039|FG003|Period 2|Pregnancy|0|||
163020832|NCT01314872|588778040|FG004|Period 2|Pregnancy|0|||
163020833|NCT01314872|588778041|FG005|Period 2|Pregnancy|0|||
163020834|NCT01314872|588778042|FG006|Period 2|Pregnancy|0|||
163020835|NCT01314872|588778043|FG007|Period 2|Pregnancy|0|||
163020836|NCT01314872|588778044|FG008|Period 2|Pregnancy|0|||
163020837|NCT01314872|588778045|FG009|Period 2|Pregnancy|0|||
163020838|NCT01314872|588778046|FG010|Period 2|Pregnancy|0|||
163020839|NCT01314872|588778047|FG011|Period 2|Pregnancy|0|||
163020840|NCT01314872|588778048|FG012|Period 2|Pregnancy|0|||
163020841|NCT01314872|588778049|FG013|Period 2|Pregnancy|0|||
163020842|NCT01314872|588778050|FG014|Period 2|Pregnancy|1|||
163020843|NCT01314872|588778036|FG000|Period 2|Study terminated by Sponsor|0|||
163020844|NCT01314872|588778037|FG001|Period 2|Study terminated by Sponsor|0|||
163020845|NCT01314872|588778038|FG002|Period 2|Study terminated by Sponsor|0|||
163020846|NCT01314872|588778039|FG003|Period 2|Study terminated by Sponsor|0|||
163020847|NCT01314872|588778040|FG004|Period 2|Study terminated by Sponsor|0|||
163020848|NCT01314872|588778041|FG005|Period 2|Study terminated by Sponsor|0|||
163020849|NCT01314872|588778042|FG006|Period 2|Study terminated by Sponsor|0|||
163020850|NCT01314872|588778043|FG007|Period 2|Study terminated by Sponsor|0|||
163020851|NCT01314872|588778044|FG008|Period 2|Study terminated by Sponsor|0|||
163020852|NCT01314872|588778045|FG009|Period 2|Study terminated by Sponsor|0|||
163020853|NCT01314872|588778046|FG010|Period 2|Study terminated by Sponsor|0|||
163020854|NCT01314872|588778047|FG011|Period 2|Study terminated by Sponsor|2|||
163020855|NCT01314872|588778048|FG012|Period 2|Study terminated by Sponsor|2|||
163020856|NCT01314872|588778049|FG013|Period 2|Study terminated by Sponsor|3|||
163020857|NCT01314872|588778050|FG014|Period 2|Study terminated by Sponsor|0|||
163020858|NCT01314872|588778036|FG000|Period 2|Adverse event, non-fatal|0|||
163020859|NCT01314872|588778037|FG001|Period 2|Adverse event, non-fatal|0|||
163020860|NCT01314872|588778038|FG002|Period 2|Adverse event, non-fatal|0|||
162642342|NCT01528072|587406588|FG000|Overall Study|Site Closure|4|||
162642343|NCT01528072|587406588|FG000|Overall Study|Death|2|||
162642344|NCT01528072|587406588|FG000|Overall Study|Early Termination of Study|52|||
162642345|NCT02436759|587406595|FG000|Overall Study|Adverse Event|3|||
162642346|NCT02436759|587406596|FG001|Overall Study|Adverse Event|0|||
162642347|NCT02436759|587406595|FG000|Overall Study|Protocol Violation|1|||
162642348|NCT02436759|587406596|FG001|Overall Study|Protocol Violation|0|||
162642349|NCT02436759|587406595|FG000|Overall Study|Withdrawal by Subject|0|||
162642350|NCT02436759|587406596|FG001|Overall Study|Withdrawal by Subject|1|||
162642351|NCT04014075|587406597|FG000|Overall Study|Progressive Disease|53|||
162642352|NCT04014075|587406597|FG000|Overall Study|Adverse Event|15|||
162642353|NCT04014075|587406597|FG000|Overall Study|Clinical Progression|4|||
162642354|NCT04014075|587406597|FG000|Overall Study|Death|2|||
162642355|NCT04014075|587406597|FG000|Overall Study|Withdrawal by Subject|2|||
163020861|NCT01314872|588778039|FG003|Period 2|Adverse event, non-fatal|0|||
163020862|NCT01314872|588778040|FG004|Period 2|Adverse event, non-fatal|0|||
163020863|NCT01314872|588778041|FG005|Period 2|Adverse event, non-fatal|0|||
163063720|NCT00876343|588939952|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
163063721|NCT00876343|588939953|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
163063722|NCT00876343|588939951|FG000|Overall Study|Change of residence or other commitments|2|||
163063723|NCT00876343|588939952|FG001|Overall Study|Change of residence or other commitments|2|||
163063724|NCT00876343|588939953|FG002|Overall Study|Change of residence or other commitments|3|||
162642356|NCT04014075|587406597|FG000|Overall Study|Miscellaneous|2|||
162642357|NCT04014075|587406597|FG000|Overall Study|Physician Decision|1|||
162642358|NCT01912287|587406598|FG000|Overall Study|Ineligible|1|||
162642359|NCT01912287|587406599|FG001|Overall Study|Ineligible|0|||
162716631|NCT00708097|587668527|FG003|Period 1|Protocol Violation|2|||
163020864|NCT01314872|588778042|FG006|Period 2|Adverse event, non-fatal|0|||
162642360|NCT01912287|587406600|FG002|Overall Study|Ineligible|1|||
163020865|NCT01314872|588778043|FG007|Period 2|Adverse event, non-fatal|0|||
163020866|NCT01314872|588778044|FG008|Period 2|Adverse event, non-fatal|0|||
163020867|NCT01314872|588778045|FG009|Period 2|Adverse event, non-fatal|0|||
163020868|NCT01314872|588778046|FG010|Period 2|Adverse event, non-fatal|0|||
163020869|NCT01314872|588778047|FG011|Period 2|Adverse event, non-fatal|13|||
163020870|NCT01314872|588778048|FG012|Period 2|Adverse event, non-fatal|16|||
163063725|NCT00924898|588939957|FG000|Overall Study|Withdrawal by Subject|2|||
162642361|NCT01912287|587406598|FG000|Overall Study|No-show|0|||
162642362|NCT01912287|587406599|FG001|Overall Study|No-show|0|||
162642363|NCT01912287|587406600|FG002|Overall Study|No-show|1|||
162716632|NCT00708097|587668528|FG004|Period 1|Protocol Violation|0|||
163020871|NCT01314872|588778049|FG013|Period 2|Adverse event, non-fatal|24|||
163020872|NCT01314872|588778050|FG014|Period 2|Adverse event, non-fatal|9|||
163020873|NCT01314872|588778036|FG000|Period 2|Withdrawal by Subject|0|||
163020874|NCT01314872|588778037|FG001|Period 2|Withdrawal by Subject|0|||
163020875|NCT01314872|588778038|FG002|Period 2|Withdrawal by Subject|0|||
163020876|NCT01314872|588778039|FG003|Period 2|Withdrawal by Subject|0|||
163020877|NCT01314872|588778040|FG004|Period 2|Withdrawal by Subject|0|||
163020878|NCT01314872|588778041|FG005|Period 2|Withdrawal by Subject|0|||
163020879|NCT01314872|588778042|FG006|Period 2|Withdrawal by Subject|0|||
163020880|NCT01314872|588778043|FG007|Period 2|Withdrawal by Subject|0|||
163020881|NCT01314872|588778044|FG008|Period 2|Withdrawal by Subject|0|||
163020882|NCT01314872|588778045|FG009|Period 2|Withdrawal by Subject|0|||
163020883|NCT01314872|588778046|FG010|Period 2|Withdrawal by Subject|0|||
163020884|NCT01314872|588778047|FG011|Period 2|Withdrawal by Subject|14|||
163020885|NCT01314872|588778048|FG012|Period 2|Withdrawal by Subject|17|||
163020886|NCT01314872|588778049|FG013|Period 2|Withdrawal by Subject|12|||
163020887|NCT01314872|588778050|FG014|Period 2|Withdrawal by Subject|4|||
163020888|NCT01314872|588778036|FG000|Period 2|Lost to Follow-up|0|||
163020889|NCT01314872|588778037|FG001|Period 2|Lost to Follow-up|0|||
163020890|NCT01314872|588778038|FG002|Period 2|Lost to Follow-up|0|||
163020891|NCT01314872|588778039|FG003|Period 2|Lost to Follow-up|0|||
163020892|NCT01314872|588778040|FG004|Period 2|Lost to Follow-up|0|||
163020893|NCT01314872|588778041|FG005|Period 2|Lost to Follow-up|0|||
163020894|NCT01314872|588778042|FG006|Period 2|Lost to Follow-up|0|||
163020895|NCT01314872|588778043|FG007|Period 2|Lost to Follow-up|0|||
163020896|NCT01314872|588778044|FG008|Period 2|Lost to Follow-up|0|||
163020897|NCT01314872|588778045|FG009|Period 2|Lost to Follow-up|0|||
163020898|NCT01314872|588778046|FG010|Period 2|Lost to Follow-up|0|||
163020899|NCT01314872|588778047|FG011|Period 2|Lost to Follow-up|6|||
163020900|NCT01314872|588778048|FG012|Period 2|Lost to Follow-up|7|||
163020901|NCT01314872|588778049|FG013|Period 2|Lost to Follow-up|2|||
163020902|NCT01314872|588778050|FG014|Period 2|Lost to Follow-up|6|||
163020903|NCT01397786|588779529|FG000|Phase A|Lost to Follow-up|0|||
163020904|NCT01397786|588779530|FG001|Phase A|Lost to Follow-up|0|||
163020905|NCT01397786|588779531|FG002|Phase A|Lost to Follow-up|6|||
163020906|NCT01397786|588779529|FG000|Phase A|Adverse Event|0|||
163020907|NCT01397786|588779530|FG001|Phase A|Adverse Event|0|||
163020908|NCT01397786|588779531|FG002|Phase A|Adverse Event|8|||
163020909|NCT01397786|588779529|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
163020910|NCT01397786|588779530|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
163020911|NCT01397786|588779531|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
163020912|NCT01397786|588779529|FG000|Phase A|Physician Decision|0|||
163020913|NCT01397786|588779530|FG001|Phase A|Physician Decision|0|||
163020914|NCT01397786|588779531|FG002|Phase A|Physician Decision|1|||
163020915|NCT01397786|588779529|FG000|Phase A|Withdrawal by Subject|0|||
163020916|NCT01397786|588779530|FG001|Phase A|Withdrawal by Subject|0|||
163020917|NCT01397786|588779531|FG002|Phase A|Withdrawal by Subject|5|||
163020918|NCT01397786|588779529|FG000|Phase A|Lack of Efficacy|0|||
163020919|NCT01397786|588779530|FG001|Phase A|Lack of Efficacy|0|||
163020920|NCT01397786|588779531|FG002|Phase A|Lack of Efficacy|1|||
163020921|NCT01397786|588779529|FG000|Phase B|Lost to Follow-up|22|||
163020922|NCT01397786|588779530|FG001|Phase B|Lost to Follow-up|12|||
163020923|NCT01397786|588779531|FG002|Phase B|Lost to Follow-up|22|||
163020924|NCT01397786|588779529|FG000|Phase B|Adverse Event|109|||
162642364|NCT01912287|587406598|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
162642365|NCT01912287|587406599|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
162642366|NCT01912287|587406600|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
162642367|NCT01912287|587406598|FG000|Overall Study|Felt treatment no longer needed|0|||
162642368|NCT01912287|587406599|FG001|Overall Study|Felt treatment no longer needed|1|||
162642369|NCT01912287|587406600|FG002|Overall Study|Felt treatment no longer needed|0|||
162642370|NCT01912287|587406598|FG000|Overall Study|Life circumstances|4|||
162642371|NCT01912287|587406599|FG001|Overall Study|Life circumstances|2|||
162642372|NCT01912287|587406600|FG002|Overall Study|Life circumstances|0|||
162642373|NCT01912287|587406598|FG000|Overall Study|Lost Interest|1|||
162642374|NCT01912287|587406599|FG001|Overall Study|Lost Interest|0|||
162642375|NCT01912287|587406600|FG002|Overall Study|Lost Interest|0|||
162642376|NCT01912287|587406598|FG000|Overall Study|Uknown reason - subject drop out|5|||
162642377|NCT01912287|587406599|FG001|Overall Study|Uknown reason - subject drop out|7|||
162642378|NCT01912287|587406600|FG002|Overall Study|Uknown reason - subject drop out|3|||
162642379|NCT01912287|587406598|FG000|Overall Study|Missed Assesment|1|||
162642380|NCT01912287|587406599|FG001|Overall Study|Missed Assesment|1|||
162642381|NCT01912287|587406600|FG002|Overall Study|Missed Assesment|1|||
162642382|NCT01912287|587406598|FG000|Overall Study|Scheduling/change in availability|17|||
162642383|NCT01912287|587406599|FG001|Overall Study|Scheduling/change in availability|10|||
162642384|NCT01912287|587406600|FG002|Overall Study|Scheduling/change in availability|8|||
162642385|NCT02631850|587406601|FG000|Treatment Period|Lost to Follow-up|0|||
162642386|NCT02631850|587406602|FG001|Treatment Period|Lost to Follow-up|1|||
162642387|NCT02631850|587406603|FG002|Treatment Period|Lost to Follow-up|0|||
162642388|NCT02631850|587406604|FG003|Treatment Period|Lost to Follow-up|0|||
162642389|NCT02631850|587406601|FG000|Treatment Period|Protocol Violation|1|||
162642390|NCT02631850|587406602|FG001|Treatment Period|Protocol Violation|0|||
162642391|NCT02631850|587406603|FG002|Treatment Period|Protocol Violation|0|||
162642392|NCT02631850|587406604|FG003|Treatment Period|Protocol Violation|0|||
162642393|NCT02631850|587406601|FG000|Treatment Period|Withdrawal by Subject|0|||
162642394|NCT02631850|587406602|FG001|Treatment Period|Withdrawal by Subject|5|||
162642395|NCT02631850|587406603|FG002|Treatment Period|Withdrawal by Subject|2|||
162716633|NCT00708097|587668524|FG000|Period 1|Other Reason|0|||
162716634|NCT00708097|587668525|FG001|Period 1|Other Reason|0|||
162716635|NCT00708097|587668526|FG002|Period 1|Other Reason|0|||
163020925|NCT01397786|588779530|FG001|Phase B|Adverse Event|23|||
163020926|NCT01397786|588779531|FG002|Phase B|Adverse Event|27|||
163020927|NCT01397786|588779529|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
163020928|NCT01397786|588779530|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
163020929|NCT01397786|588779531|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
163020930|NCT01397786|588779529|FG000|Phase B|Physician Decision|9|||
163020931|NCT01397786|588779530|FG001|Phase B|Physician Decision|1|||
163020932|NCT01397786|588779531|FG002|Phase B|Physician Decision|3|||
163020933|NCT01397786|588779529|FG000|Phase B|Withdrawal by Subject|102|||
163020934|NCT01397786|588779530|FG001|Phase B|Withdrawal by Subject|45|||
163020935|NCT01397786|588779531|FG002|Phase B|Withdrawal by Subject|30|||
163020936|NCT01397786|588779529|FG000|Phase B|Protocol Deviation|1|||
163020937|NCT01397786|588779530|FG001|Phase B|Protocol Deviation|2|||
163020938|NCT01397786|588779531|FG002|Phase B|Protocol Deviation|4|||
163020939|NCT01397786|588779529|FG000|Phase B|Lack of Efficacy|22|||
163020940|NCT01397786|588779530|FG001|Phase B|Lack of Efficacy|7|||
163020941|NCT01397786|588779531|FG002|Phase B|Lack of Efficacy|14|||
163020942|NCT04250350|588779535|FG000|Overall Study|Withdrawal by Subject|13|||
163020943|NCT04250350|588779535|FG000|Overall Study|Lost to Follow-up|8|||
163020944|NCT04250350|588779535|FG000|Overall Study|Adverse Event|5|||
163020945|NCT04250350|588779535|FG000|Overall Study|Lack of Efficacy|4|||
163020946|NCT04250350|588779535|FG000|Overall Study|Physician Decision|1|||
163020947|NCT04250350|588779535|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
163020948|NCT00860249|588779536|FG000|Overall Study|trial was terminated prior to completion|21|||
163020949|NCT00860249|588779537|FG001|Overall Study|trial was terminated prior to completion|18|||
163020950|NCT00860249|588779538|FG002|Overall Study|trial was terminated prior to completion|21|||
163020951|NCT00743288|588779539|FG000|Overall Study|Adverse Event|1|||
163020952|NCT00743288|588779540|FG001|Overall Study|Adverse Event|1|||
163020953|NCT00743288|588779541|FG002|Overall Study|Adverse Event|2|||
163020954|NCT00743288|588779542|FG003|Overall Study|Adverse Event|2|||
163020955|NCT00743288|588779543|FG004|Overall Study|Adverse Event|1|||
162642396|NCT02631850|587406604|FG003|Treatment Period|Withdrawal by Subject|2|||
162642397|NCT02631850|587406601|FG000|Treatment Period|Adverse Event|1|||
162642398|NCT02631850|587406602|FG001|Treatment Period|Adverse Event|0|||
162642399|NCT02631850|587406603|FG002|Treatment Period|Adverse Event|2|||
162642400|NCT02631850|587406604|FG003|Treatment Period|Adverse Event|3|||
162642401|NCT02631850|587406601|FG000|Treatment Period|Family medical issue|1|||
162642402|NCT02631850|587406602|FG001|Treatment Period|Family medical issue|0|||
162716636|NCT00708097|587668527|FG003|Period 1|Other Reason|0|||
163020956|NCT00743288|588779544|FG005|Overall Study|Adverse Event|1|||
162642403|NCT02631850|587406603|FG002|Treatment Period|Family medical issue|0|||
162642404|NCT02631850|587406604|FG003|Treatment Period|Family medical issue|0|||
162642405|NCT02631850|587406601|FG000|6 Month Follow up|Lost to Follow-up|5|||
162642406|NCT02631850|587406602|FG001|6 Month Follow up|Lost to Follow-up|8|||
162642407|NCT02631850|587406603|FG002|6 Month Follow up|Lost to Follow-up|3|||
162642408|NCT02631850|587406604|FG003|6 Month Follow up|Lost to Follow-up|5|||
162642409|NCT02631850|587406601|FG000|6 Month Follow up|Withdrawal by Subject|1|||
162642410|NCT02631850|587406602|FG001|6 Month Follow up|Withdrawal by Subject|0|||
162642411|NCT02631850|587406603|FG002|6 Month Follow up|Withdrawal by Subject|0|||
162642412|NCT02631850|587406604|FG003|6 Month Follow up|Withdrawal by Subject|2|||
162642413|NCT02631850|587406601|FG000|6 Month Follow up|Adverse Event|1|||
162642414|NCT02631850|587406602|FG001|6 Month Follow up|Adverse Event|4|||
162642415|NCT02631850|587406603|FG002|6 Month Follow up|Adverse Event|1|||
162642416|NCT02631850|587406604|FG003|6 Month Follow up|Adverse Event|3|||
162642417|NCT02631850|587406601|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
162642418|NCT02631850|587406602|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
162642419|NCT02631850|587406603|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
162642420|NCT02631850|587406604|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
162642421|NCT00391274|587406630|FG000|Overall Study|Death Due to Study Disease|55|||
162642422|NCT00391274|587406631|FG001|Overall Study|Death Due to Study Disease|45|||
162642423|NCT00391274|587406630|FG000|Overall Study|Lost to Follow-up|0|||
162642424|NCT00391274|587406631|FG001|Overall Study|Lost to Follow-up|3|||
162642425|NCT00391274|587406630|FG000|Overall Study|Physician Decision|4|||
162642426|NCT00391274|587406631|FG001|Overall Study|Physician Decision|2|||
162642427|NCT00391274|587406630|FG000|Overall Study|Withdrawal by Subject|0|||
162642428|NCT00391274|587406631|FG001|Overall Study|Withdrawal by Subject|3|||
162642429|NCT00391274|587406630|FG000|Overall Study|Death Due to Adverse Event|1|||
162642430|NCT00391274|587406631|FG001|Overall Study|Death Due to Adverse Event|3|||
162642431|NCT00391274|587406630|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
162642432|NCT00391274|587406631|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
162642433|NCT00391274|587406630|FG000|Overall Study|Death Not Study Related|0|||
162642434|NCT00391274|587406631|FG001|Overall Study|Death Not Study Related|1|||
162642435|NCT01505868|587406633|FG000|Overall Study|Withdrawal by Subject|1|||
162642436|NCT01505868|587406634|FG001|Overall Study|Withdrawal by Subject|0|||
162642437|NCT01505868|587406635|FG002|Overall Study|Withdrawal by Subject|0|||
162642438|NCT01505868|587406636|FG003|Overall Study|Withdrawal by Subject|0|||
162642439|NCT01505868|587406637|FG004|Overall Study|Withdrawal by Subject|0|||
162642440|NCT00553150|587406638|FG000|Overall Study|Withdrawal by Subject|0|||
162642441|NCT00553150|587406639|FG001|Overall Study|Withdrawal by Subject|0|||
162642442|NCT00553150|587406640|FG002|Overall Study|Withdrawal by Subject|0|||
162642443|NCT00553150|587406641|FG003|Overall Study|Withdrawal by Subject|2|||
162642444|NCT00553150|587406638|FG000|Overall Study|Protocol Violation|0|||
162642445|NCT00553150|587406639|FG001|Overall Study|Protocol Violation|0|||
162642446|NCT00553150|587406640|FG002|Overall Study|Protocol Violation|0|||
163020957|NCT00743288|588779545|FG006|Overall Study|Adverse Event|2|||
163020958|NCT00743288|588779539|FG000|Overall Study|Withdrawal by Subject|0|||
163020959|NCT00743288|588779540|FG001|Overall Study|Withdrawal by Subject|0|||
163020960|NCT00743288|588779541|FG002|Overall Study|Withdrawal by Subject|1|||
163020961|NCT00743288|588779542|FG003|Overall Study|Withdrawal by Subject|0|||
163020962|NCT00743288|588779543|FG004|Overall Study|Withdrawal by Subject|0|||
163020963|NCT00743288|588779544|FG005|Overall Study|Withdrawal by Subject|1|||
163020964|NCT00743288|588779545|FG006|Overall Study|Withdrawal by Subject|1|||
163020965|NCT00743288|588779539|FG000|Overall Study|Progressive disease (PD)|2|||
163020966|NCT00743288|588779540|FG001|Overall Study|Progressive disease (PD)|0|||
163020967|NCT00743288|588779541|FG002|Overall Study|Progressive disease (PD)|1|||
163020968|NCT00743288|588779542|FG003|Overall Study|Progressive disease (PD)|4|||
163020969|NCT00743288|588779543|FG004|Overall Study|Progressive disease (PD)|5|||
163020970|NCT00743288|588779544|FG005|Overall Study|Progressive disease (PD)|3|||
163020971|NCT00743288|588779545|FG006|Overall Study|Progressive disease (PD)|6|||
163020972|NCT00743288|588779539|FG000|Overall Study|Worsening of condition (Not PD)|0|||
162642447|NCT00553150|587406641|FG003|Overall Study|Protocol Violation|1|||
162642448|NCT00553150|587406638|FG000|Overall Study|Ineligible|0|||
162642449|NCT00553150|587406639|FG001|Overall Study|Ineligible|0|||
162642450|NCT00553150|587406640|FG002|Overall Study|Ineligible|0|||
162642451|NCT00553150|587406641|FG003|Overall Study|Ineligible|1|||
162642452|NCT00975481|587406643|FG000|Second Intervention Period|Adverse Event|2|||
162642453|NCT00975481|587406644|FG001|Second Intervention Period|Adverse Event|1|||
162642454|NCT00975481|587406645|FG002|Second Intervention Period|Adverse Event|0|||
162642455|NCT00975481|587406646|FG003|Second Intervention Period|Adverse Event|0|||
162642456|NCT00975481|587406647|FG004|Second Intervention Period|Adverse Event|0|||
162642457|NCT00975481|587406648|FG005|Second Intervention Period|Adverse Event|0|||
162642458|NCT00975481|587406643|FG000|Second Intervention Period|Withdrawal by Subject|0|||
162642459|NCT00975481|587406644|FG001|Second Intervention Period|Withdrawal by Subject|0|||
162642460|NCT00975481|587406645|FG002|Second Intervention Period|Withdrawal by Subject|1|||
162642461|NCT00975481|587406646|FG003|Second Intervention Period|Withdrawal by Subject|0|||
162642462|NCT00975481|587406647|FG004|Second Intervention Period|Withdrawal by Subject|0|||
162642463|NCT00975481|587406648|FG005|Second Intervention Period|Withdrawal by Subject|0|||
162642464|NCT00975481|587406643|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
162642465|NCT00975481|587406644|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
162642466|NCT00975481|587406645|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
162642467|NCT00975481|587406646|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
162642468|NCT00975481|587406647|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
162642469|NCT00975481|587406648|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
163063726|NCT04153864|588939958|FG000|Overall Study|Withdrawal by Subject|21|||
163063727|NCT04153864|588939959|FG001|Overall Study|Withdrawal by Subject|7|||
163063728|NCT04153864|588939960|FG002|Overall Study|Withdrawal by Subject|23|||
163063729|NCT04153864|588939961|FG003|Overall Study|Withdrawal by Subject|2|||
163063730|NCT04153864|588939958|FG000|Overall Study|Lost to Follow-up|4|||
163063731|NCT04153864|588939959|FG001|Overall Study|Lost to Follow-up|0|||
163063732|NCT04153864|588939960|FG002|Overall Study|Lost to Follow-up|3|||
163063733|NCT04153864|588939961|FG003|Overall Study|Lost to Follow-up|0|||
163063734|NCT04153864|588939958|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
163063735|NCT04153864|588939959|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
163063736|NCT04153864|588939960|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
163063737|NCT04153864|588939961|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
163063738|NCT04717557|588939965|FG000|Overall Study|Withdrawal by Subject|2|||
163063739|NCT04717557|588939966|FG001|Overall Study|Withdrawal by Subject|0|||
163063740|NCT04717557|588939965|FG000|Overall Study|Death|1|||
163063741|NCT04717557|588939966|FG001|Overall Study|Death|0|||
163063742|NCT06354257|588939967|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163063743|NCT06354257|588939967|FG000|Treatment Period 2|Adverse Event|1|||
163063744|NCT01654276|588939968|FG000|Overall Study|Lack of Efficacy|1|||
163063745|NCT01654276|588939968|FG000|Overall Study|Lost to Follow-up|4|||
163063746|NCT01654276|588939968|FG000|Overall Study|Withdrawal by Subject|1|||
163063747|NCT02401230|588939969|FG000|Overall Study|Adverse Event|3|||
163063748|NCT02401230|588939970|FG001|Overall Study|Adverse Event|2|||
163063749|NCT02401230|588939971|FG002|Overall Study|Adverse Event|0|||
163063750|NCT02401230|588939969|FG000|Overall Study|Withdrawal by Subject|2|||
163063751|NCT02401230|588939970|FG001|Overall Study|Withdrawal by Subject|1|||
163063752|NCT02401230|588939971|FG002|Overall Study|Withdrawal by Subject|1|||
163063753|NCT02401230|588939969|FG000|Overall Study|Lost to Follow-up|1|||
163063754|NCT02401230|588939970|FG001|Overall Study|Lost to Follow-up|3|||
163063755|NCT02401230|588939971|FG002|Overall Study|Lost to Follow-up|3|||
163063756|NCT00964782|588939974|FG000|Overall Study|Lost to Follow-up|1|||
163063757|NCT00964782|588939975|FG001|Overall Study|Lost to Follow-up|0|||
163063758|NCT00720759|588939977|FG000|Overall Study|Lost to Follow-up|0|||
163063759|NCT00720759|588939978|FG001|Overall Study|Lost to Follow-up|1|||
163063760|NCT00720759|588939979|FG002|Overall Study|Lost to Follow-up|1|||
163063761|NCT00720759|588939980|FG003|Overall Study|Lost to Follow-up|0|||
163063762|NCT02318940|588939981|FG000|Overall Study|lost the record|1|||
163063763|NCT02318940|588939982|FG001|Overall Study|lost the record|0|||
163063764|NCT01047319|588939983|FG000|Overall Study|Teva requested participant withdrawal|3|||
163063765|NCT01047319|588939984|FG001|Overall Study|Teva requested participant withdrawal|0|||
163063766|NCT01047319|588939985|FG002|Overall Study|Teva requested participant withdrawal|1|||
163063767|NCT01047319|588939983|FG000|Overall Study|Protocol Violation|3|||
162642470|NCT00975481|587406643|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
163063768|NCT01047319|588939984|FG001|Overall Study|Protocol Violation|2|||
163063769|NCT01047319|588939985|FG002|Overall Study|Protocol Violation|4|||
163063770|NCT01047319|588939983|FG000|Overall Study|Lack of Efficacy|4|||
163063771|NCT01047319|588939984|FG001|Overall Study|Lack of Efficacy|3|||
163063772|NCT01047319|588939985|FG002|Overall Study|Lack of Efficacy|3|||
163063773|NCT01047319|588939983|FG000|Overall Study|Death|5|||
162642471|NCT00975481|587406644|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
162642472|NCT00975481|587406645|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
162642473|NCT00975481|587406646|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
162642474|NCT00975481|587406647|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
163063774|NCT01047319|588939984|FG001|Overall Study|Death|1|||
163063775|NCT01047319|588939985|FG002|Overall Study|Death|5|||
163063776|NCT01047319|588939983|FG000|Overall Study|Pregnancy|13|||
163063777|NCT01047319|588939984|FG001|Overall Study|Pregnancy|8|||
163063778|NCT01047319|588939985|FG002|Overall Study|Pregnancy|8|||
162642475|NCT00975481|587406648|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
162642476|NCT03559257|587406651|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
162642477|NCT03559257|587406652|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
162642478|NCT03559257|587406651|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162642479|NCT03559257|587406652|FG001|Double Blind Treatment Period|Protocol Violation|4|||
162642480|NCT03559257|587406651|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
162642481|NCT03559257|587406652|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
162642482|NCT03559257|587406651|FG000|Double Blind Treatment Period|Adverse Event|0|||
162642483|NCT03559257|587406652|FG001|Double Blind Treatment Period|Adverse Event|1|||
162642484|NCT03559257|587406651|FG000|Double Blind Treatment Period|Screen Failure|0|||
162642485|NCT03559257|587406652|FG001|Double Blind Treatment Period|Screen Failure|1|||
162642486|NCT03559257|587406651|FG000|Open-label Treatment Period|Adverse Event|1|||
162642487|NCT03559257|587406652|FG001|Open-label Treatment Period|Adverse Event|4|||
162642488|NCT03559257|587406651|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
162642489|NCT03559257|587406652|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
162642490|NCT03559257|587406651|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
162642491|NCT03559257|587406652|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162642492|NCT03559257|587406651|FG000|Open-label Treatment Period|Protocol Violation|2|||
162642493|NCT03559257|587406652|FG001|Open-label Treatment Period|Protocol Violation|0|||
162642494|NCT03559257|587406651|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
162642495|NCT03559257|587406652|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
162642496|NCT03559257|587406651|FG000|Open-label Treatment Period|Physician Decision|0|||
162642497|NCT03559257|587406652|FG001|Open-label Treatment Period|Physician Decision|1|||
162642498|NCT03630120|587406654|FG000|Overall Study|Disease progression|0|||
162642499|NCT03630120|587406655|FG001|Overall Study|Disease progression|1|||
162642500|NCT03630120|587406656|FG002|Overall Study|Disease progression|1|||
162642501|NCT03630120|587406657|FG003|Overall Study|Disease progression|1|||
162642502|NCT03251079|587406658|FG000|Overall Study|Withdrawal by Subject|1|||
162642503|NCT01387347|587406659|FG000|Overall Study|Lost to Follow-up|2|||
162642504|NCT01387347|587406660|FG001|Overall Study|Lost to Follow-up|1|||
162642505|NCT01519960|587406661|FG000|Overall Study|Withdrawal from the study|26|||
162642506|NCT01519960|587406662|FG001|Overall Study|Withdrawal from the study|22|||
162642507|NCT01519960|587406663|FG002|Overall Study|Withdrawal from the study|5|||
162642508|NCT02953314|587406677|FG000|Overall Study|Adverse Event|0|||
162642509|NCT02953314|587406678|FG001|Overall Study|Adverse Event|1|||
162642510|NCT02953314|587406677|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162642511|NCT02953314|587406678|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
162642512|NCT00535223|587406679|FG000|Overall Study|Withdrawal by Subject|4|||
162642513|NCT00535223|587406680|FG001|Overall Study|Withdrawal by Subject|1|||
162642514|NCT00492115|587406681|FG000|Overall Study|Withdrawal by Subject|3|||
162642515|NCT00492115|587406682|FG001|Overall Study|Withdrawal by Subject|4|||
162642516|NCT01288287|587406683|FG000|Overall Study|Lost to Follow-up|8|||
162642517|NCT01288287|587406683|FG000|Overall Study|Withdrawal by Subject|4|||
162642518|NCT01288287|587406683|FG000|Overall Study|Lack of Efficacy|13|||
162642519|NCT01288287|587406683|FG000|Overall Study|Other Reason|13|||
162642520|NCT01288287|587406683|FG000|Overall Study|Unknown Reason|1|||
162642521|NCT01288287|587406683|FG000|Overall Study|Unknown Status|7|||
162642522|NCT02515045|587406694|FG000|Overall Study|Adverse Event|0|||
162642523|NCT02515045|587406695|FG001|Overall Study|Adverse Event|3|||
162642524|NCT02515045|587406696|FG002|Overall Study|Adverse Event|3|||
162642525|NCT02515045|587406694|FG000|Overall Study|Lost to Follow-up|0|||
163020973|NCT00743288|588779540|FG001|Overall Study|Worsening of condition (Not PD)|2|||
163020974|NCT00743288|588779541|FG002|Overall Study|Worsening of condition (Not PD)|1|||
163020975|NCT00743288|588779542|FG003|Overall Study|Worsening of condition (Not PD)|1|||
163020976|NCT00743288|588779543|FG004|Overall Study|Worsening of condition (Not PD)|0|||
163020977|NCT00743288|588779544|FG005|Overall Study|Worsening of condition (Not PD)|0|||
163020978|NCT00743288|588779545|FG006|Overall Study|Worsening of condition (Not PD)|0|||
163020979|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
163020980|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
163020981|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
163020982|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
163020983|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
163020984|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
163020985|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
163063779|NCT01047319|588939983|FG000|Overall Study|Physician Decision|12|||
163063780|NCT01047319|588939984|FG001|Overall Study|Physician Decision|9|||
162642526|NCT02515045|587406695|FG001|Overall Study|Lost to Follow-up|1|||
162642527|NCT02515045|587406696|FG002|Overall Study|Lost to Follow-up|1|||
162642528|NCT03255382|587406697|FG000|Overall Study|Adverse Event|3|||
162642529|NCT03255382|587406698|FG001|Overall Study|Adverse Event|0|||
162642530|NCT03255382|587406697|FG000|Overall Study|Lost to Follow-up|2|||
162642531|NCT03255382|587406698|FG001|Overall Study|Lost to Follow-up|0|||
162642532|NCT03255382|587406697|FG000|Overall Study|Withdrawal by Subject|2|||
162642533|NCT03255382|587406698|FG001|Overall Study|Withdrawal by Subject|0|||
162642534|NCT03255382|587406697|FG000|Overall Study|Other|6|||
162642535|NCT03255382|587406698|FG001|Overall Study|Other|0|||
162642536|NCT00238121|587406699|FG000|Overall Study|Withdrawal by Subject|1|||
162642537|NCT00238121|587406700|FG001|Overall Study|Withdrawal by Subject|1|||
162642538|NCT00238121|587406699|FG000|Overall Study|Adverse Event|2|||
162642539|NCT00238121|587406700|FG001|Overall Study|Adverse Event|1|||
162642540|NCT02221284|587406701|FG000|Overall Study|Case Report Forms Uncollected|56|||
162642541|NCT02221284|587406701|FG000|Overall Study|Protocol Deviation|5|||
162642542|NCT00101907|587406705|FG000|Overall Study|Adverse Event|1|||
162642543|NCT00101907|587406706|FG001|Overall Study|Adverse Event|0|||
162642544|NCT00101907|587406707|FG002|Overall Study|Adverse Event|0|||
162642545|NCT00101907|587406708|FG003|Overall Study|Adverse Event|0|||
162642546|NCT00101907|587406709|FG004|Overall Study|Adverse Event|0|||
162642547|NCT00101907|587406710|FG005|Overall Study|Adverse Event|0|||
162642548|NCT00101907|587406705|FG000|Overall Study|Death|0|||
162642549|NCT00101907|587406706|FG001|Overall Study|Death|1|||
162642550|NCT00101907|587406707|FG002|Overall Study|Death|0|||
162642551|NCT00101907|587406708|FG003|Overall Study|Death|0|||
162642552|NCT00101907|587406709|FG004|Overall Study|Death|3|||
162642553|NCT00101907|587406710|FG005|Overall Study|Death|0|||
162642554|NCT00101907|587406705|FG000|Overall Study|Physician Decision|0|||
162642555|NCT00101907|587406706|FG001|Overall Study|Physician Decision|0|||
162642556|NCT00101907|587406707|FG002|Overall Study|Physician Decision|0|||
162642557|NCT00101907|587406708|FG003|Overall Study|Physician Decision|1|||
162642558|NCT00101907|587406709|FG004|Overall Study|Physician Decision|1|||
162642559|NCT00101907|587406710|FG005|Overall Study|Physician Decision|0|||
162642560|NCT00101907|587406705|FG000|Overall Study|Withdrawal by Subject|1|||
162642561|NCT00101907|587406706|FG001|Overall Study|Withdrawal by Subject|0|||
162642562|NCT00101907|587406707|FG002|Overall Study|Withdrawal by Subject|1|||
162642563|NCT00101907|587406708|FG003|Overall Study|Withdrawal by Subject|0|||
162642564|NCT00101907|587406709|FG004|Overall Study|Withdrawal by Subject|1|||
162642565|NCT00101907|587406710|FG005|Overall Study|Withdrawal by Subject|0|||
162642566|NCT00624052|587406711|FG000|Overall Study|Adverse Event|7|||
162642567|NCT00624052|587406712|FG001|Overall Study|Adverse Event|6|||
162642568|NCT00624052|587406713|FG002|Overall Study|Adverse Event|0|||
162642569|NCT00624052|587406714|FG003|Overall Study|Adverse Event|3|||
162642570|NCT00624052|587406711|FG000|Overall Study|Lack of Efficacy|1|||
162642571|NCT00624052|587406712|FG001|Overall Study|Lack of Efficacy|1|||
162642572|NCT00624052|587406713|FG002|Overall Study|Lack of Efficacy|0|||
162642573|NCT00624052|587406714|FG003|Overall Study|Lack of Efficacy|0|||
162642574|NCT00624052|587406711|FG000|Overall Study|Lost to Follow-up|2|||
162642575|NCT00624052|587406712|FG001|Overall Study|Lost to Follow-up|3|||
162642576|NCT00624052|587406713|FG002|Overall Study|Lost to Follow-up|1|||
162642577|NCT00624052|587406714|FG003|Overall Study|Lost to Follow-up|0|||
162642578|NCT00624052|587406711|FG000|Overall Study|Non compliant with the protocol|2|||
162642579|NCT00624052|587406712|FG001|Overall Study|Non compliant with the protocol|1|||
162642580|NCT00624052|587406713|FG002|Overall Study|Non compliant with the protocol|1|||
162642581|NCT00624052|587406714|FG003|Overall Study|Non compliant with the protocol|1|||
162642582|NCT00624052|587406711|FG000|Overall Study|Consent withdrawn|3|||
162642583|NCT00624052|587406712|FG001|Overall Study|Consent withdrawn|1|||
162642584|NCT00624052|587406713|FG002|Overall Study|Consent withdrawn|1|||
162642585|NCT00624052|587406714|FG003|Overall Study|Consent withdrawn|0|||
162642586|NCT00624052|587406711|FG000|Overall Study|Changed job/ran out if meds|0|||
162642587|NCT00624052|587406712|FG001|Overall Study|Changed job/ran out if meds|2|||
162642588|NCT00624052|587406713|FG002|Overall Study|Changed job/ran out if meds|0|||
162642589|NCT00624052|587406714|FG003|Overall Study|Changed job/ran out if meds|0|||
162642590|NCT01474876|587406719|FG000|Overall Study|Adverse Event|11|||
162642591|NCT01474876|587406720|FG001|Overall Study|Adverse Event|5|||
162642592|NCT01474876|587406721|FG002|Overall Study|Adverse Event|0|||
162642593|NCT01474876|587406719|FG000|Overall Study|Serious Adverse Event|2|||
162642594|NCT01474876|587406720|FG001|Overall Study|Serious Adverse Event|3|||
162716637|NCT00708097|587668528|FG004|Period 1|Other Reason|1|||
163020986|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
163020987|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
162642595|NCT01474876|587406721|FG002|Overall Study|Serious Adverse Event|0|||
162642596|NCT01474876|587406719|FG000|Overall Study|Lost to Follow-up|5|||
162642597|NCT01474876|587406720|FG001|Overall Study|Lost to Follow-up|4|||
162642598|NCT01474876|587406721|FG002|Overall Study|Lost to Follow-up|0|||
162642599|NCT01474876|587406719|FG000|Overall Study|Investigator's decision|28|||
163063781|NCT01047319|588939985|FG002|Overall Study|Physician Decision|10|||
162642600|NCT01474876|587406720|FG001|Overall Study|Investigator's decision|6|||
162642601|NCT01474876|587406721|FG002|Overall Study|Investigator's decision|0|||
162642602|NCT01474876|587406719|FG000|Overall Study|Patient's request|19|||
162642603|NCT01474876|587406720|FG001|Overall Study|Patient's request|5|||
162642604|NCT01474876|587406721|FG002|Overall Study|Patient's request|0|||
162642605|NCT01474876|587406719|FG000|Overall Study|Investigator's decision and pt request|1|||
162642606|NCT01474876|587406720|FG001|Overall Study|Investigator's decision and pt request|0|||
162642607|NCT01474876|587406721|FG002|Overall Study|Investigator's decision and pt request|0|||
162642608|NCT02291055|587406722|FG000|Overall Study|Death|2|||
162642609|NCT02291055|587406723|FG001|Overall Study|Death|2|||
162642610|NCT02291055|587406724|FG002|Overall Study|Death|5|||
162642611|NCT02291055|587406725|FG003|Overall Study|Death|8|||
162642612|NCT02291055|587406726|FG004|Overall Study|Death|12|||
162642613|NCT02291055|587406722|FG000|Overall Study|Lost to Follow-up|0|||
162642614|NCT02291055|587406723|FG001|Overall Study|Lost to Follow-up|0|||
162642615|NCT02291055|587406724|FG002|Overall Study|Lost to Follow-up|0|||
162642616|NCT02291055|587406725|FG003|Overall Study|Lost to Follow-up|1|||
162642617|NCT02291055|587406726|FG004|Overall Study|Lost to Follow-up|2|||
162642618|NCT02291055|587406722|FG000|Overall Study|Withdrawal by Subject|3|||
162642619|NCT02291055|587406723|FG001|Overall Study|Withdrawal by Subject|1|||
162642620|NCT02291055|587406724|FG002|Overall Study|Withdrawal by Subject|1|||
162642621|NCT02291055|587406725|FG003|Overall Study|Withdrawal by Subject|5|||
162642622|NCT02291055|587406726|FG004|Overall Study|Withdrawal by Subject|10|||
162642623|NCT02291055|587406722|FG000|Overall Study|Progressive Disease|0|||
162642624|NCT02291055|587406723|FG001|Overall Study|Progressive Disease|0|||
162642625|NCT02291055|587406724|FG002|Overall Study|Progressive Disease|1|||
162642626|NCT02291055|587406725|FG003|Overall Study|Progressive Disease|4|||
162642627|NCT02291055|587406726|FG004|Overall Study|Progressive Disease|2|||
162642628|NCT02291055|587406722|FG000|Overall Study|Study Terminated by Sponsor|0|||
162642629|NCT02291055|587406723|FG001|Overall Study|Study Terminated by Sponsor|0|||
162642630|NCT02291055|587406724|FG002|Overall Study|Study Terminated by Sponsor|0|||
162642631|NCT02291055|587406725|FG003|Overall Study|Study Terminated by Sponsor|5|||
162642632|NCT02291055|587406726|FG004|Overall Study|Study Terminated by Sponsor|1|||
163020988|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
163020989|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163020990|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163020991|NCT02836236|588779549|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
163020992|NCT02836236|588779550|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163020993|NCT02836236|588779551|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163020994|NCT02836236|588779552|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163063782|NCT01047319|588939983|FG000|Overall Study|Lost to Follow-up|14|||
162642633|NCT02291055|587406722|FG000|Overall Study|Other|0|||
162642634|NCT02291055|587406723|FG001|Overall Study|Other|2|||
162642635|NCT02291055|587406724|FG002|Overall Study|Other|1|||
162642636|NCT02291055|587406725|FG003|Overall Study|Other|4|||
162642637|NCT02291055|587406726|FG004|Overall Study|Other|0|||
162642638|NCT01523886|587406728|FG000|Overall Study|surgery cancelled|0|||
162642639|NCT01523886|587406729|FG001|Overall Study|surgery cancelled|1|||
162642640|NCT03839212|587406733|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
162642641|NCT00679263|587406734|FG000|Visit 2/Dose 1|Adverse Event|1|||
162642642|NCT00679263|587406735|FG001|Visit 2/Dose 1|Adverse Event|0|||
162642643|NCT00679263|587406736|FG002|Visit 2/Dose 1|Adverse Event|0|||
162642644|NCT00679263|587406734|FG000|Visit 2/Dose 1|subject not compliance|1|||
162642645|NCT00679263|587406735|FG001|Visit 2/Dose 1|subject not compliance|1|||
162642646|NCT00679263|587406736|FG002|Visit 2/Dose 1|subject not compliance|0|||
162642647|NCT00733746|587406742|FG000|Overall Study|Ineligible|5|||
162642648|NCT02113956|587406743|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
162642649|NCT02113956|587406744|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
162642650|NCT02113956|587406743|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
162642651|NCT02113956|587406744|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
162716638|NCT00708097|587668524|FG000|Period 2|Protocol Violation|0|||
163020995|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163020996|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163020997|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
163020998|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
163020999|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163021000|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163021001|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
163063783|NCT01047319|588939984|FG001|Overall Study|Lost to Follow-up|10|||
162642652|NCT02113956|587406743|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
162642653|NCT02113956|587406744|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
162642654|NCT01499563|587406747|FG000|Overall Study|Withdrawal by Subject|10|||
162642655|NCT01499563|587406748|FG001|Overall Study|Withdrawal by Subject|11|||
162642656|NCT01499563|587406749|FG002|Overall Study|Withdrawal by Subject|7|||
162642657|NCT01499563|587406750|FG003|Overall Study|Withdrawal by Subject|8|||
162642658|NCT01499563|587406747|FG000|Overall Study|Physician Decision|2|||
162642659|NCT01499563|587406748|FG001|Overall Study|Physician Decision|1|||
162642660|NCT01499563|587406749|FG002|Overall Study|Physician Decision|3|||
162642661|NCT01499563|587406750|FG003|Overall Study|Physician Decision|0|||
162642662|NCT01499563|587406747|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
162642663|NCT01499563|587406748|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
162642664|NCT01499563|587406749|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
162642665|NCT01499563|587406750|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
162642666|NCT01499563|587406747|FG000|Overall Study|Adverse Event|2|||
162642667|NCT01499563|587406748|FG001|Overall Study|Adverse Event|0|||
162642668|NCT01499563|587406749|FG002|Overall Study|Adverse Event|1|||
162642669|NCT01499563|587406750|FG003|Overall Study|Adverse Event|3|||
162642670|NCT01499563|587406747|FG000|Overall Study|Lack of Efficacy|0|||
162642671|NCT01499563|587406748|FG001|Overall Study|Lack of Efficacy|1|||
162642672|NCT01499563|587406749|FG002|Overall Study|Lack of Efficacy|6|||
162642673|NCT01499563|587406750|FG003|Overall Study|Lack of Efficacy|3|||
162642674|NCT01499563|587406747|FG000|Overall Study|Other|8|||
162642675|NCT01499563|587406748|FG001|Overall Study|Other|6|||
162642676|NCT01499563|587406749|FG002|Overall Study|Other|6|||
162642677|NCT01499563|587406750|FG003|Overall Study|Other|4|||
162642678|NCT03658538|587406751|FG000|Overall Study|Death|2|||
162642679|NCT03658538|587406752|FG001|Overall Study|Death|1|||
162642680|NCT03658538|587406751|FG000|Overall Study|Cancer diagnosis|1|||
162642681|NCT03658538|587406752|FG001|Overall Study|Cancer diagnosis|0|||
162642682|NCT03658538|587406751|FG000|Overall Study|Change residence|1|||
163063784|NCT01047319|588939985|FG002|Overall Study|Lost to Follow-up|10|||
163063785|NCT01047319|588939983|FG000|Overall Study|Adverse Event|16|||
163063786|NCT01047319|588939984|FG001|Overall Study|Adverse Event|27|||
163063787|NCT01047319|588939985|FG002|Overall Study|Adverse Event|21|||
163063788|NCT01047319|588939983|FG000|Overall Study|Withdrawal by Subject|77|||
163063789|NCT01047319|588939984|FG001|Overall Study|Withdrawal by Subject|75|||
163063790|NCT01047319|588939985|FG002|Overall Study|Withdrawal by Subject|87|||
163063791|NCT01047319|588939983|FG000|Overall Study|Study terminated by Sponsor|198|||
163063792|NCT01047319|588939984|FG001|Overall Study|Study terminated by Sponsor|215|||
163063793|NCT01047319|588939985|FG002|Overall Study|Study terminated by Sponsor|203|||
163063794|NCT05759338|588939991|FG000|Overall Study|Withdrawal by Subject|3|||
162642683|NCT03658538|587406752|FG001|Overall Study|Change residence|2|||
162642684|NCT03658538|587406751|FG000|Overall Study|Lost to Follow-up|3|||
162642685|NCT03658538|587406752|FG001|Overall Study|Lost to Follow-up|3|||
162642686|NCT03658538|587406751|FG000|Overall Study|Unblinded|2|||
162642687|NCT03658538|587406752|FG001|Overall Study|Unblinded|3|||
162642688|NCT03658538|587406751|FG000|Overall Study|Physician Decision|0|||
162642689|NCT03658538|587406752|FG001|Overall Study|Physician Decision|1|||
162642690|NCT03658538|587406751|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
162642691|NCT03658538|587406752|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
162642692|NCT03658538|587406751|FG000|Overall Study|Evicted from home|1|||
162642693|NCT03658538|587406752|FG001|Overall Study|Evicted from home|0|||
162642694|NCT00597012|587406755|FG000|Overall Study|Death|1|||
162642695|NCT00597012|587406756|FG001|Overall Study|Death|1|||
162642696|NCT00597012|587406755|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
162642697|NCT00597012|587406756|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
162642698|NCT00597012|587406755|FG000|Overall Study|Withdrawal by Subject|7|||
162642699|NCT00597012|587406756|FG001|Overall Study|Withdrawal by Subject|4|||
162642700|NCT00597012|587406755|FG000|Overall Study|Ineligible|2|||
162642701|NCT00597012|587406756|FG001|Overall Study|Ineligible|0|||
162642702|NCT00597012|587406755|FG000|Overall Study|Lost to Follow-up|0|||
162642703|NCT00597012|587406756|FG001|Overall Study|Lost to Follow-up|2|||
163063795|NCT04611126|588939992|FG000|Overall Study|TIL expansion unsuccessful|1|||
163063796|NCT04611126|588939993|FG001|Overall Study|TIL expansion unsuccessful|0|||
163063797|NCT05260008|588939994|FG000|Overall Study|Physician Decision|0|||
162642704|NCT02926924|587409263|FG000|Overall Study|withdrawal - reason unknown|0|||
162642705|NCT02926924|587409264|FG001|Overall Study|withdrawal - reason unknown|1|||
162642706|NCT04146545|587409270|FG000|Overall Study|deemed ineligible after randomization|1|||
162642707|NCT04146545|587409271|FG001|Overall Study|deemed ineligible after randomization|0|||
162642708|NCT04762680|587409281|FG000|Phase 2|Adverse Event|0|||
162642709|NCT04762680|587409282|FG001|Phase 2|Adverse Event|1|||
162642710|NCT04762680|587409283|FG002|Phase 2|Adverse Event|0|||
162642711|NCT04762680|587409284|FG003|Phase 2|Adverse Event|0|||
162642712|NCT04762680|587409285|FG004|Phase 2|Adverse Event|0|||
162642713|NCT04762680|587409286|FG005|Phase 2|Adverse Event|0|||
162716639|NCT00708097|587668525|FG001|Period 2|Protocol Violation|1|||
162716640|NCT00708097|587668526|FG002|Period 2|Protocol Violation|1|||
162642714|NCT04762680|587409287|FG006|Phase 2|Adverse Event|0|||
162642715|NCT04762680|587409288|FG007|Phase 2|Adverse Event|0|||
163063798|NCT05260008|588939995|FG001|Overall Study|Physician Decision|1|||
162642716|NCT04762680|587409289|FG008|Phase 2|Adverse Event|0|||
162642717|NCT04762680|587409290|FG009|Phase 2|Adverse Event|0|||
162642718|NCT04762680|587409291|FG010|Phase 2|Adverse Event|0|||
162642719|NCT04762680|587409292|FG011|Phase 2|Adverse Event|0|||
162642720|NCT04762680|587409293|FG012|Phase 2|Adverse Event|0|||
162642721|NCT04762680|587409294|FG013|Phase 2|Adverse Event|0|||
162642722|NCT04762680|587409295|FG014|Phase 2|Adverse Event|0|||
162642723|NCT04762680|587409296|FG015|Phase 2|Adverse Event|0|||
163063799|NCT05260008|588939996|FG002|Overall Study|Physician Decision|0|||
163063800|NCT05260008|588939997|FG003|Overall Study|Physician Decision|0|||
163063801|NCT01157845|588940000|FG000|Overall Study|Lost to Follow-up|5|||
163063802|NCT01157845|588940000|FG000|Overall Study|Withdrawal by Subject|12|||
162642724|NCT04762680|587409297|FG016|Phase 2|Adverse Event|0|||
162642725|NCT04762680|587409298|FG017|Phase 2|Adverse Event|0|||
162642726|NCT04762680|587409299|FG018|Phase 2|Adverse Event|0|||
162642727|NCT04762680|587409300|FG019|Phase 2|Adverse Event|0|||
162642728|NCT04762680|587409301|FG020|Phase 2|Adverse Event|0|||
162642729|NCT04762680|587409302|FG021|Phase 2|Adverse Event|0|||
162642730|NCT04762680|587409281|FG000|Phase 2|Protocol Violation|5|||
162642731|NCT04762680|587409282|FG001|Phase 2|Protocol Violation|5|||
162642732|NCT04762680|587409283|FG002|Phase 2|Protocol Violation|1|||
163021002|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
163021003|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Death|0|||
163021004|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Death|0|||
163021005|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Death|1|||
163021006|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Death|1|||
163021007|NCT02836236|588779549|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021008|NCT02836236|588779550|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021009|NCT02836236|588779551|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
163021010|NCT02836236|588779552|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
163021011|NCT00378508|588779553|FG000|Overall Study|Withdrawal by Subject|1|||
163021012|NCT00378508|588779554|FG001|Overall Study|Withdrawal by Subject|3|||
163021013|NCT00378508|588779553|FG000|Overall Study|Lost to Follow-up|1|||
163021014|NCT00378508|588779554|FG001|Overall Study|Lost to Follow-up|0|||
163021015|NCT00593684|588779555|FG000|Overall Study|Death|2|||
163021016|NCT00593684|588779556|FG001|Overall Study|Death|1|||
163021017|NCT04984278|588779561|FG000|Period 1|Withdrawal by Subject|1|||
163021018|NCT04984278|588779562|FG001|Period 1|Withdrawal by Subject|0|||
163021019|NCT04984278|588779561|FG000|Period 1|Other|0|||
163021020|NCT04984278|588779562|FG001|Period 1|Other|1|||
163021021|NCT04984278|588779561|FG000|Period 2|Adverse Event|1|||
163021022|NCT04984278|588779562|FG001|Period 2|Adverse Event|0|||
163021023|NCT04984278|588779561|FG000|Period 2|Other|0|||
163021024|NCT04984278|588779562|FG001|Period 2|Other|1|||
163021025|NCT04696055|588779563|FG000|Overall Study|Adverse Event|10|||
163021026|NCT04696055|588779564|FG001|Overall Study|Adverse Event|2|||
163021027|NCT04696055|588779563|FG000|Overall Study|Death|4|||
163021028|NCT04696055|588779564|FG001|Overall Study|Death|0|||
163021029|NCT04696055|588779563|FG000|Overall Study|Other|7|||
163021030|NCT04696055|588779564|FG001|Overall Study|Other|2|||
163021031|NCT04696055|588779563|FG000|Overall Study|Physician Decision|3|||
163021032|NCT04696055|588779564|FG001|Overall Study|Physician Decision|0|||
163021033|NCT04696055|588779563|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
163021034|NCT04696055|588779564|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
163021035|NCT04696055|588779563|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
163021036|NCT04696055|588779564|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
163021037|NCT04696055|588779563|FG000|Overall Study|Subject Decision|1|||
163021038|NCT04696055|588779564|FG001|Overall Study|Subject Decision|2|||
163021039|NCT03969901|588779565|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163021040|NCT03969901|588779566|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162642733|NCT04762680|587409284|FG003|Phase 2|Protocol Violation|0|||
163021041|NCT03969901|588779567|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163021042|NCT03969901|588779568|FG003|Overall Study|Withdrawal by parent/guardian|0|||
163021043|NCT03969901|588779569|FG004|Overall Study|Withdrawal by parent/guardian|1|||
163021044|NCT03969901|588779570|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163021045|NCT03969901|588779571|FG006|Overall Study|Withdrawal by parent/guardian|0|||
163021046|NCT03969901|588779572|FG007|Overall Study|Withdrawal by parent/guardian|1|||
163021047|NCT03969901|588779573|FG008|Overall Study|Withdrawal by parent/guardian|1|||
163021048|NCT03969901|588779574|FG009|Overall Study|Withdrawal by parent/guardian|0|||
163021049|NCT00348595|588779575|FG000|Overall Study|Adverse Event|5|||
163021050|NCT00348595|588779576|FG001|Overall Study|Adverse Event|8|||
163021051|NCT01920958|588779577|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
163021052|NCT03192306|588779582|FG000|Overall Study|Did not treat cold sore during study|149|||
163021053|NCT03192306|588779583|FG001|Overall Study|Did not treat cold sore during study|143|||
163021054|NCT03192306|588779582|FG000|Overall Study|Withdrawal by Subject|1|||
163021055|NCT03192306|588779583|FG001|Overall Study|Withdrawal by Subject|1|||
163021056|NCT03192306|588779582|FG000|Overall Study|Lost to Follow-up|1|||
163021057|NCT03192306|588779583|FG001|Overall Study|Lost to Follow-up|0|||
163021058|NCT03192306|588779582|FG000|Overall Study|Protocol Violation|1|||
163021059|NCT03192306|588779583|FG001|Overall Study|Protocol Violation|1|||
163021060|NCT02589626|588779588|FG000|Overall Study|Other than the reason specified|1|||
163021061|NCT02589626|588779589|FG001|Overall Study|Other than the reason specified|0|||
162642734|NCT04762680|587409285|FG004|Phase 2|Protocol Violation|0|||
162642735|NCT04762680|587409286|FG005|Phase 2|Protocol Violation|0|||
162642736|NCT04762680|587409287|FG006|Phase 2|Protocol Violation|0|||
162642737|NCT04762680|587409288|FG007|Phase 2|Protocol Violation|0|||
162642738|NCT04762680|587409289|FG008|Phase 2|Protocol Violation|0|||
163021062|NCT02589626|588779588|FG000|Overall Study|Withdrawal by Subject|1|||
163021063|NCT02589626|588779589|FG001|Overall Study|Withdrawal by Subject|1|||
163021064|NCT02589626|588779588|FG000|Overall Study|Adverse Event|1|||
163021065|NCT02589626|588779589|FG001|Overall Study|Adverse Event|1|||
163021066|NCT00379080|588779590|FG000|Overall Study|Withdrawal by Subject|0|||
163021067|NCT00379080|588779591|FG001|Overall Study|Withdrawal by Subject|4|||
163021068|NCT00379080|588779592|FG002|Overall Study|Withdrawal by Subject|0|||
163021069|NCT01089608|588779593|FG000|Overall Study|Adverse Event|0|||
163021070|NCT01089608|588779594|FG001|Overall Study|Adverse Event|4|||
163021071|NCT01089608|588779593|FG000|Overall Study|Lost to Follow-up|0|||
163021072|NCT01089608|588779594|FG001|Overall Study|Lost to Follow-up|2|||
163021073|NCT00280397|588779595|FG000|Overall Study|Adverse Event|1|||
163021074|NCT01028014|588779601|FG000|Overall Study|Lost to Follow-up|1|||
163021075|NCT01028014|588779602|FG001|Overall Study|Lost to Follow-up|2|||
163021076|NCT01028014|588779603|FG002|Overall Study|Lost to Follow-up|0|||
163021077|NCT01028014|588779604|FG003|Overall Study|Lost to Follow-up|1|||
163021078|NCT01028014|588779605|FG004|Overall Study|Lost to Follow-up|1|||
163021079|NCT01028014|588779606|FG005|Overall Study|Lost to Follow-up|2|||
163021080|NCT01127451|588779607|FG000|Overall Study|Other|2|||
163021081|NCT01127451|588779608|FG001|Overall Study|Other|1|||
163021082|NCT01127451|588779607|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
163021083|NCT01127451|588779608|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
163021084|NCT01127451|588779607|FG000|Overall Study|Death|22|||
163021085|NCT01127451|588779608|FG001|Overall Study|Death|17|||
163021086|NCT01127451|588779607|FG000|Overall Study|Lost to Follow-up|3|||
163021087|NCT01127451|588779608|FG001|Overall Study|Lost to Follow-up|0|||
163021088|NCT01127451|588779607|FG000|Overall Study|Administrative Reason by Sponsor|2|||
163021089|NCT01127451|588779608|FG001|Overall Study|Administrative Reason by Sponsor|2|||
163021090|NCT00425061|588779609|FG000|Overall Study|Adverse Event|1|||
163021091|NCT00425061|588779610|FG001|Overall Study|Adverse Event|0|||
163021092|NCT00425061|588779611|FG002|Overall Study|Adverse Event|0|||
163021093|NCT00425061|588779612|FG003|Overall Study|Adverse Event|2|||
163021094|NCT00425061|588779613|FG004|Overall Study|Adverse Event|2|||
163021095|NCT00425061|588779614|FG005|Overall Study|Adverse Event|0|||
163021096|NCT00425061|588779615|FG006|Overall Study|Adverse Event|0|||
163021097|NCT00425061|588779609|FG000|Overall Study|Lost to Follow-up|0|||
163021098|NCT00425061|588779610|FG001|Overall Study|Lost to Follow-up|1|||
163021099|NCT00425061|588779611|FG002|Overall Study|Lost to Follow-up|0|||
163021100|NCT00425061|588779612|FG003|Overall Study|Lost to Follow-up|0|||
163021101|NCT00425061|588779613|FG004|Overall Study|Lost to Follow-up|0|||
163021102|NCT00425061|588779614|FG005|Overall Study|Lost to Follow-up|0|||
163021103|NCT00425061|588779615|FG006|Overall Study|Lost to Follow-up|0|||
163021104|NCT00425061|588779609|FG000|Overall Study|Protocol Violation|1|||
163021105|NCT00425061|588779610|FG001|Overall Study|Protocol Violation|0|||
163021106|NCT00425061|588779611|FG002|Overall Study|Protocol Violation|0|||
163021107|NCT00425061|588779612|FG003|Overall Study|Protocol Violation|0|||
163021108|NCT00425061|588779613|FG004|Overall Study|Protocol Violation|0|||
163021109|NCT00425061|588779614|FG005|Overall Study|Protocol Violation|0|||
163021110|NCT00425061|588779615|FG006|Overall Study|Protocol Violation|0|||
163021111|NCT00425061|588779609|FG000|Overall Study|Withdrawal by Subject|0|||
163021112|NCT00425061|588779610|FG001|Overall Study|Withdrawal by Subject|1|||
163021113|NCT00425061|588779611|FG002|Overall Study|Withdrawal by Subject|0|||
163021114|NCT00425061|588779612|FG003|Overall Study|Withdrawal by Subject|0|||
163021115|NCT00425061|588779613|FG004|Overall Study|Withdrawal by Subject|1|||
163021116|NCT00425061|588779614|FG005|Overall Study|Withdrawal by Subject|0|||
163021117|NCT00425061|588779615|FG006|Overall Study|Withdrawal by Subject|3|||
163021118|NCT00425061|588779609|FG000|Overall Study|Sponsor's request|0|||
163021119|NCT00425061|588779610|FG001|Overall Study|Sponsor's request|0|||
163021120|NCT00425061|588779611|FG002|Overall Study|Sponsor's request|0|||
163021121|NCT00425061|588779612|FG003|Overall Study|Sponsor's request|0|||
163021122|NCT00425061|588779613|FG004|Overall Study|Sponsor's request|19|||
163021123|NCT00425061|588779614|FG005|Overall Study|Sponsor's request|4|||
163021124|NCT00425061|588779615|FG006|Overall Study|Sponsor's request|15|||
163021125|NCT00425061|588779609|FG000|Overall Study|Physician Decision|0|||
163021126|NCT00425061|588779610|FG001|Overall Study|Physician Decision|0|||
163021127|NCT00425061|588779611|FG002|Overall Study|Physician Decision|0|||
163021128|NCT00425061|588779612|FG003|Overall Study|Physician Decision|0|||
163021129|NCT00425061|588779613|FG004|Overall Study|Physician Decision|1|||
163021130|NCT00425061|588779614|FG005|Overall Study|Physician Decision|0|||
163021131|NCT00425061|588779615|FG006|Overall Study|Physician Decision|0|||
163021132|NCT00425061|588779609|FG000|Overall Study|Other|0|||
163021133|NCT00425061|588779610|FG001|Overall Study|Other|0|||
163021134|NCT00425061|588779611|FG002|Overall Study|Other|0|||
163021135|NCT00425061|588779612|FG003|Overall Study|Other|0|||
163021136|NCT00425061|588779613|FG004|Overall Study|Other|3|||
163021137|NCT00425061|588779614|FG005|Overall Study|Other|0|||
163021138|NCT00425061|588779615|FG006|Overall Study|Other|1|||
163021139|NCT02111577|588779616|FG000|Overall Study|Protocol Violation|2|||
163021140|NCT02111577|588779617|FG001|Overall Study|Protocol Violation|0|||
163021141|NCT02111577|588779616|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
163021142|NCT02111577|588779617|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
163021143|NCT02111577|588779616|FG000|Overall Study|Failure to produce study treatment|6|||
163021144|NCT02111577|588779617|FG001|Overall Study|Failure to produce study treatment|0|||
162642739|NCT04762680|587409290|FG009|Phase 2|Protocol Violation|0|||
162642740|NCT04762680|587409291|FG010|Phase 2|Protocol Violation|0|||
162642741|NCT04762680|587409292|FG011|Phase 2|Protocol Violation|0|||
162642742|NCT04762680|587409293|FG012|Phase 2|Protocol Violation|0|||
163021145|NCT02111577|588779616|FG000|Overall Study|Death|518|||
163021146|NCT02111577|588779617|FG001|Overall Study|Death|254|||
162642743|NCT04762680|587409294|FG013|Phase 2|Protocol Violation|0|||
163021147|NCT02111577|588779616|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
163021148|NCT02111577|588779617|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
163021149|NCT02111577|588779616|FG000|Overall Study|Adverse Event|1|||
163021150|NCT02111577|588779617|FG001|Overall Study|Adverse Event|1|||
163021151|NCT02111577|588779616|FG000|Overall Study|Withdrawal by Subject|51|||
163021152|NCT02111577|588779617|FG001|Overall Study|Withdrawal by Subject|23|||
163021153|NCT02111577|588779616|FG000|Overall Study|Disease progression|0|||
163021154|NCT02111577|588779617|FG001|Overall Study|Disease progression|1|||
163021155|NCT02111577|588779616|FG000|Overall Study|Lost to Follow-up|19|||
163021156|NCT02111577|588779617|FG001|Overall Study|Lost to Follow-up|10|||
163021157|NCT02429778|588779619|FG000|Overall Study|Lost to Follow-up|2|||
163021158|NCT02429778|588779620|FG001|Overall Study|Lost to Follow-up|0|||
163021159|NCT02429778|588779619|FG000|Overall Study|Withdrawal by Subject|5|||
163021160|NCT02429778|588779620|FG001|Overall Study|Withdrawal by Subject|0|||
163021161|NCT04590586|588779627|FG000|Overall Study|Death|7|||
163021162|NCT04590586|588779628|FG001|Overall Study|Death|1|||
163021163|NCT04590586|588779629|FG002|Overall Study|Death|37|||
163021164|NCT04590586|588779630|FG003|Overall Study|Death|34|||
163021165|NCT04590586|588779631|FG004|Overall Study|Death|19|||
163021166|NCT04590586|588779632|FG005|Overall Study|Death|3|||
163021167|NCT04590586|588779627|FG000|Overall Study|Lost to Follow-up|3|||
163021168|NCT04590586|588779628|FG001|Overall Study|Lost to Follow-up|0|||
163021169|NCT04590586|588779629|FG002|Overall Study|Lost to Follow-up|11|||
163021170|NCT04590586|588779630|FG003|Overall Study|Lost to Follow-up|11|||
163021171|NCT04590586|588779631|FG004|Overall Study|Lost to Follow-up|6|||
163021172|NCT04590586|588779632|FG005|Overall Study|Lost to Follow-up|0|||
163021173|NCT04590586|588779627|FG000|Overall Study|Withdrawal by Subject|0|||
163021174|NCT04590586|588779628|FG001|Overall Study|Withdrawal by Subject|0|||
163021175|NCT04590586|588779629|FG002|Overall Study|Withdrawal by Subject|6|||
163021176|NCT04590586|588779630|FG003|Overall Study|Withdrawal by Subject|0|||
163021177|NCT04590586|588779631|FG004|Overall Study|Withdrawal by Subject|3|||
163021178|NCT04590586|588779632|FG005|Overall Study|Withdrawal by Subject|0|||
163021179|NCT04590586|588779627|FG000|Overall Study|Other|3|||
163021180|NCT04590586|588779628|FG001|Overall Study|Other|0|||
163021181|NCT04590586|588779629|FG002|Overall Study|Other|1|||
163021182|NCT04590586|588779630|FG003|Overall Study|Other|1|||
163021183|NCT04590586|588779631|FG004|Overall Study|Other|2|||
163021184|NCT04590586|588779632|FG005|Overall Study|Other|1|||
163021185|NCT01609543|588779633|FG000|Overall Study|Disease Progression|28|||
163021186|NCT01609543|588779633|FG000|Overall Study|Adverse Event|5|||
163021187|NCT01609543|588779633|FG000|Overall Study|Withdrawal by Subject|1|||
163021188|NCT01609543|588779633|FG000|Overall Study|Protocol Violation|1|||
163021189|NCT01609543|588779633|FG000|Overall Study|Death|7|||
163021190|NCT01893281|588779634|FG000|Overall Study|Adverse Event|1|||
163021191|NCT01893281|588779634|FG000|Overall Study|Protocol Violation|1|||
163021192|NCT01893281|588779634|FG000|Overall Study|Withdrawal by Subject|1|||
163021193|NCT03990571|588779640|FG000|Overall Study|Withdrawal by Subject|1|||
163021194|NCT03990571|588779640|FG000|Overall Study|Insurance Issues|3|||
163021195|NCT03990571|588779640|FG000|Overall Study|Covid Restrictions|2|||
163021196|NCT03605862|588779641|FG000|Overall Study|Withdrawal by Subject|12|||
163021197|NCT03605862|588779642|FG001|Overall Study|Withdrawal by Subject|9|||
163021198|NCT03605862|588779641|FG000|Overall Study|Adverse Event|2|||
163021199|NCT03605862|588779642|FG001|Overall Study|Adverse Event|1|||
163021200|NCT03605862|588779641|FG000|Overall Study|Physician Decision|3|||
163021201|NCT03605862|588779642|FG001|Overall Study|Physician Decision|1|||
163021202|NCT03605862|588779641|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
162642744|NCT04762680|587409295|FG014|Phase 2|Protocol Violation|0|||
162642745|NCT04762680|587409296|FG015|Phase 2|Protocol Violation|0|||
162642746|NCT04762680|587409297|FG016|Phase 2|Protocol Violation|0|||
162642747|NCT04762680|587409298|FG017|Phase 2|Protocol Violation|0|||
162642748|NCT04762680|587409299|FG018|Phase 2|Protocol Violation|0|||
162642749|NCT04762680|587409300|FG019|Phase 2|Protocol Violation|0|||
163021203|NCT03605862|588779642|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
163021204|NCT00675428|588779644|FG000|Overall Study|Disease Progression|2|||
163021205|NCT00675428|588779645|FG001|Overall Study|Disease Progression|2|||
163021206|NCT00675428|588779644|FG000|Overall Study|No Disease Response After Cycle 6|0|||
163021207|NCT00675428|588779645|FG001|Overall Study|No Disease Response After Cycle 6|1|||
163021208|NCT00675428|588779644|FG000|Overall Study|Physician Decision|1|||
163021209|NCT00675428|588779645|FG001|Overall Study|Physician Decision|0|||
163021210|NCT04105218|588779646|FG000|Overall Study|Withdrawal by Subject|3|||
163021211|NCT04105218|588779647|FG001|Overall Study|Withdrawal by Subject|2|||
162642750|NCT04762680|587409301|FG020|Phase 2|Protocol Violation|0|||
163021212|NCT04105218|588779646|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
163021213|NCT04105218|588779647|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
163021214|NCT04105218|588779646|FG000|Overall Study|Failed screening tests|2|||
163021215|NCT04105218|588779647|FG001|Overall Study|Failed screening tests|1|||
162642751|NCT04762680|587409302|FG021|Phase 2|Protocol Violation|0|||
162642752|NCT04762680|587409281|FG000|Phase 2|Withdrawal by Subject|23|||
162642753|NCT04762680|587409282|FG001|Phase 2|Withdrawal by Subject|21|||
162642754|NCT04762680|587409283|FG002|Phase 2|Withdrawal by Subject|28|||
162642755|NCT04762680|587409284|FG003|Phase 2|Withdrawal by Subject|0|||
162642756|NCT04762680|587409285|FG004|Phase 2|Withdrawal by Subject|0|||
162642757|NCT04762680|587409286|FG005|Phase 2|Withdrawal by Subject|0|||
162642758|NCT04762680|587409287|FG006|Phase 2|Withdrawal by Subject|0|||
162642759|NCT04762680|587409288|FG007|Phase 2|Withdrawal by Subject|0|||
162642760|NCT04762680|587409289|FG008|Phase 2|Withdrawal by Subject|0|||
162642761|NCT04762680|587409290|FG009|Phase 2|Withdrawal by Subject|0|||
162642762|NCT04762680|587409291|FG010|Phase 2|Withdrawal by Subject|0|||
162642763|NCT04762680|587409292|FG011|Phase 2|Withdrawal by Subject|0|||
162642764|NCT04762680|587409293|FG012|Phase 2|Withdrawal by Subject|0|||
162642765|NCT04762680|587409294|FG013|Phase 2|Withdrawal by Subject|0|||
162642766|NCT04762680|587409295|FG014|Phase 2|Withdrawal by Subject|0|||
162642767|NCT04762680|587409296|FG015|Phase 2|Withdrawal by Subject|0|||
162642768|NCT04762680|587409297|FG016|Phase 2|Withdrawal by Subject|0|||
162642769|NCT04762680|587409298|FG017|Phase 2|Withdrawal by Subject|0|||
162642770|NCT04762680|587409299|FG018|Phase 2|Withdrawal by Subject|0|||
162642771|NCT04762680|587409300|FG019|Phase 2|Withdrawal by Subject|0|||
162642772|NCT04762680|587409301|FG020|Phase 2|Withdrawal by Subject|0|||
162642773|NCT04762680|587409302|FG021|Phase 2|Withdrawal by Subject|0|||
162642774|NCT04762680|587409281|FG000|Phase 2|Lost to Follow-up|14|||
162642775|NCT04762680|587409282|FG001|Phase 2|Lost to Follow-up|8|||
162642776|NCT04762680|587409283|FG002|Phase 2|Lost to Follow-up|9|||
162642777|NCT04762680|587409284|FG003|Phase 2|Lost to Follow-up|0|||
162642778|NCT04762680|587409285|FG004|Phase 2|Lost to Follow-up|0|||
162642779|NCT04762680|587409286|FG005|Phase 2|Lost to Follow-up|0|||
162642780|NCT04762680|587409287|FG006|Phase 2|Lost to Follow-up|0|||
162642781|NCT04762680|587409288|FG007|Phase 2|Lost to Follow-up|0|||
162642782|NCT04762680|587409289|FG008|Phase 2|Lost to Follow-up|0|||
162642783|NCT04762680|587409290|FG009|Phase 2|Lost to Follow-up|0|||
162642784|NCT04762680|587409291|FG010|Phase 2|Lost to Follow-up|0|||
162642785|NCT04762680|587409292|FG011|Phase 2|Lost to Follow-up|0|||
162642786|NCT04762680|587409293|FG012|Phase 2|Lost to Follow-up|0|||
162642787|NCT04762680|587409294|FG013|Phase 2|Lost to Follow-up|0|||
162642788|NCT04762680|587409295|FG014|Phase 2|Lost to Follow-up|0|||
162642789|NCT04762680|587409296|FG015|Phase 2|Lost to Follow-up|0|||
162642790|NCT04762680|587409297|FG016|Phase 2|Lost to Follow-up|0|||
162642791|NCT04762680|587409298|FG017|Phase 2|Lost to Follow-up|0|||
162642792|NCT04762680|587409299|FG018|Phase 2|Lost to Follow-up|0|||
162642793|NCT04762680|587409300|FG019|Phase 2|Lost to Follow-up|0|||
162642794|NCT04762680|587409301|FG020|Phase 2|Lost to Follow-up|0|||
162642795|NCT04762680|587409302|FG021|Phase 2|Lost to Follow-up|0|||
162642796|NCT04762680|587409281|FG000|Phase 3|Adverse Event|0|||
162642797|NCT04762680|587409282|FG001|Phase 3|Adverse Event|0|||
162642798|NCT04762680|587409283|FG002|Phase 3|Adverse Event|0|||
162642799|NCT04762680|587409284|FG003|Phase 3|Adverse Event|1|||
162642800|NCT04762680|587409285|FG004|Phase 3|Adverse Event|0|||
162642801|NCT04762680|587409286|FG005|Phase 3|Adverse Event|0|||
162642802|NCT04762680|587409287|FG006|Phase 3|Adverse Event|0|||
162642803|NCT04762680|587409288|FG007|Phase 3|Adverse Event|0|||
162642804|NCT04762680|587409289|FG008|Phase 3|Adverse Event|0|||
162642805|NCT04762680|587409290|FG009|Phase 3|Adverse Event|0|||
162642806|NCT04762680|587409291|FG010|Phase 3|Adverse Event|0|||
162642807|NCT04762680|587409292|FG011|Phase 3|Adverse Event|0|||
162642808|NCT04762680|587409293|FG012|Phase 3|Adverse Event|0|||
162642809|NCT04762680|587409294|FG013|Phase 3|Adverse Event|0|||
162642810|NCT04762680|587409295|FG014|Phase 3|Adverse Event|0|||
162642811|NCT04762680|587409296|FG015|Phase 3|Adverse Event|0|||
162642812|NCT04762680|587409297|FG016|Phase 3|Adverse Event|0|||
162642813|NCT04762680|587409298|FG017|Phase 3|Adverse Event|3|||
162642814|NCT04762680|587409299|FG018|Phase 3|Adverse Event|0|||
163021216|NCT02553499|588779652|FG000|Overall Study|Adverse Event|0|||
162642815|NCT04762680|587409300|FG019|Phase 3|Adverse Event|0|||
162642816|NCT04762680|587409301|FG020|Phase 3|Adverse Event|0|||
162642817|NCT04762680|587409302|FG021|Phase 3|Adverse Event|0|||
162642818|NCT04762680|587409281|FG000|Phase 3|Protocol Violation|0|||
162642819|NCT04762680|587409282|FG001|Phase 3|Protocol Violation|0|||
162642820|NCT04762680|587409283|FG002|Phase 3|Protocol Violation|0|||
162642821|NCT04762680|587409284|FG003|Phase 3|Protocol Violation|4|||
162716641|NCT00708097|587668527|FG003|Period 2|Protocol Violation|1|||
162642822|NCT04762680|587409285|FG004|Phase 3|Protocol Violation|1|||
162642823|NCT04762680|587409286|FG005|Phase 3|Protocol Violation|5|||
162642824|NCT04762680|587409287|FG006|Phase 3|Protocol Violation|1|||
162642825|NCT04762680|587409288|FG007|Phase 3|Protocol Violation|0|||
162642826|NCT04762680|587409289|FG008|Phase 3|Protocol Violation|0|||
162642827|NCT04762680|587409290|FG009|Phase 3|Protocol Violation|0|||
162642828|NCT04762680|587409291|FG010|Phase 3|Protocol Violation|0|||
162642829|NCT04762680|587409292|FG011|Phase 3|Protocol Violation|2|||
162642830|NCT04762680|587409293|FG012|Phase 3|Protocol Violation|3|||
162642831|NCT04762680|587409294|FG013|Phase 3|Protocol Violation|0|||
162642832|NCT04762680|587409295|FG014|Phase 3|Protocol Violation|0|||
162642833|NCT04762680|587409296|FG015|Phase 3|Protocol Violation|1|||
162642834|NCT04762680|587409297|FG016|Phase 3|Protocol Violation|0|||
162642835|NCT04762680|587409298|FG017|Phase 3|Protocol Violation|10|||
162642836|NCT04762680|587409299|FG018|Phase 3|Protocol Violation|0|||
162642837|NCT04762680|587409300|FG019|Phase 3|Protocol Violation|0|||
162642838|NCT04762680|587409301|FG020|Phase 3|Protocol Violation|0|||
162642839|NCT04762680|587409302|FG021|Phase 3|Protocol Violation|0|||
162642840|NCT04762680|587409281|FG000|Phase 3|Withdrawal by Subject|0|||
162642841|NCT04762680|587409282|FG001|Phase 3|Withdrawal by Subject|0|||
162642842|NCT04762680|587409283|FG002|Phase 3|Withdrawal by Subject|0|||
162642843|NCT04762680|587409284|FG003|Phase 3|Withdrawal by Subject|13|||
162642844|NCT04762680|587409285|FG004|Phase 3|Withdrawal by Subject|17|||
162642845|NCT04762680|587409286|FG005|Phase 3|Withdrawal by Subject|12|||
162642846|NCT04762680|587409287|FG006|Phase 3|Withdrawal by Subject|8|||
162642847|NCT04762680|587409288|FG007|Phase 3|Withdrawal by Subject|3|||
162642848|NCT04762680|587409289|FG008|Phase 3|Withdrawal by Subject|2|||
162642849|NCT04762680|587409290|FG009|Phase 3|Withdrawal by Subject|4|||
162642850|NCT04762680|587409291|FG010|Phase 3|Withdrawal by Subject|3|||
162642851|NCT04762680|587409292|FG011|Phase 3|Withdrawal by Subject|1|||
162642852|NCT04762680|587409293|FG012|Phase 3|Withdrawal by Subject|3|||
162642853|NCT04762680|587409294|FG013|Phase 3|Withdrawal by Subject|2|||
162642854|NCT04762680|587409295|FG014|Phase 3|Withdrawal by Subject|1|||
162642855|NCT04762680|587409296|FG015|Phase 3|Withdrawal by Subject|4|||
162642856|NCT04762680|587409297|FG016|Phase 3|Withdrawal by Subject|6|||
162642857|NCT04762680|587409298|FG017|Phase 3|Withdrawal by Subject|32|||
162642858|NCT04762680|587409299|FG018|Phase 3|Withdrawal by Subject|0|||
162642859|NCT04762680|587409300|FG019|Phase 3|Withdrawal by Subject|0|||
162642860|NCT04762680|587409301|FG020|Phase 3|Withdrawal by Subject|0|||
162642861|NCT04762680|587409302|FG021|Phase 3|Withdrawal by Subject|0|||
162642862|NCT04762680|587409281|FG000|Phase 3|Lost to Follow-up|0|||
162642863|NCT04762680|587409282|FG001|Phase 3|Lost to Follow-up|0|||
162642864|NCT04762680|587409283|FG002|Phase 3|Lost to Follow-up|0|||
162642865|NCT04762680|587409284|FG003|Phase 3|Lost to Follow-up|9|||
162642866|NCT04762680|587409285|FG004|Phase 3|Lost to Follow-up|22|||
162642867|NCT04762680|587409286|FG005|Phase 3|Lost to Follow-up|24|||
162642868|NCT04762680|587409287|FG006|Phase 3|Lost to Follow-up|2|||
162642869|NCT04762680|587409288|FG007|Phase 3|Lost to Follow-up|4|||
162642870|NCT04762680|587409289|FG008|Phase 3|Lost to Follow-up|6|||
162642871|NCT04762680|587409290|FG009|Phase 3|Lost to Follow-up|4|||
162642872|NCT04762680|587409291|FG010|Phase 3|Lost to Follow-up|3|||
162642873|NCT04762680|587409292|FG011|Phase 3|Lost to Follow-up|0|||
162642874|NCT04762680|587409293|FG012|Phase 3|Lost to Follow-up|5|||
162642875|NCT04762680|587409294|FG013|Phase 3|Lost to Follow-up|4|||
162642876|NCT04762680|587409295|FG014|Phase 3|Lost to Follow-up|6|||
162642877|NCT04762680|587409296|FG015|Phase 3|Lost to Follow-up|1|||
162642878|NCT04762680|587409297|FG016|Phase 3|Lost to Follow-up|1|||
162642879|NCT04762680|587409298|FG017|Phase 3|Lost to Follow-up|66|||
162642880|NCT04762680|587409299|FG018|Phase 3|Lost to Follow-up|0|||
162642881|NCT04762680|587409300|FG019|Phase 3|Lost to Follow-up|0|||
162642882|NCT04762680|587409301|FG020|Phase 3|Lost to Follow-up|0|||
162642883|NCT04762680|587409302|FG021|Phase 3|Lost to Follow-up|0|||
162642884|NCT04762680|587409281|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642885|NCT04762680|587409282|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
163021217|NCT02553499|588779653|FG001|Overall Study|Adverse Event|0|||
163021218|NCT02553499|588779654|FG002|Overall Study|Adverse Event|0|||
163021219|NCT02553499|588779655|FG003|Overall Study|Adverse Event|0|||
163021220|NCT02553499|588779656|FG004|Overall Study|Adverse Event|0|||
162642886|NCT04762680|587409283|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642887|NCT04762680|587409284|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642888|NCT04762680|587409285|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642889|NCT04762680|587409286|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642890|NCT04762680|587409287|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642891|NCT04762680|587409288|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642892|NCT04762680|587409289|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642893|NCT04762680|587409290|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642894|NCT04762680|587409291|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642895|NCT04762680|587409292|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642896|NCT04762680|587409293|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642897|NCT04762680|587409294|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642898|NCT04762680|587409295|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642899|NCT04762680|587409296|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642900|NCT04762680|587409297|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642901|NCT04762680|587409298|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642902|NCT04762680|587409299|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642903|NCT04762680|587409300|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642904|NCT04762680|587409301|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162642905|NCT04762680|587409302|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
162642906|NCT04762680|587409281|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642907|NCT04762680|587409282|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642908|NCT04762680|587409283|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642909|NCT04762680|587409284|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642910|NCT04762680|587409285|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642911|NCT04762680|587409286|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642912|NCT04762680|587409287|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642913|NCT04762680|587409288|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642914|NCT04762680|587409289|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642915|NCT04762680|587409290|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642916|NCT04762680|587409291|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642917|NCT04762680|587409292|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642918|NCT04762680|587409293|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642919|NCT04762680|587409294|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642920|NCT04762680|587409295|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642921|NCT04762680|587409296|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642922|NCT04762680|587409297|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642923|NCT04762680|587409298|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
163021221|NCT02553499|588779657|FG005|Overall Study|Adverse Event|0|||
163021222|NCT02553499|588779658|FG006|Overall Study|Adverse Event|1|||
163021223|NCT02553499|588779659|FG007|Overall Study|Adverse Event|1|||
163021224|NCT02553499|588779660|FG008|Overall Study|Adverse Event|0|||
163021225|NCT02553499|588779661|FG009|Overall Study|Adverse Event|0|||
163021226|NCT02553499|588779662|FG010|Overall Study|Adverse Event|0|||
163021227|NCT02553499|588779663|FG011|Overall Study|Adverse Event|0|||
163021228|NCT02553499|588779664|FG012|Overall Study|Adverse Event|0|||
163021229|NCT02553499|588779665|FG013|Overall Study|Adverse Event|1|||
163021230|NCT02553499|588779652|FG000|Overall Study|Death|0|||
163021231|NCT02553499|588779653|FG001|Overall Study|Death|1|||
163021232|NCT02553499|588779654|FG002|Overall Study|Death|1|||
163021233|NCT02553499|588779655|FG003|Overall Study|Death|0|||
163021234|NCT02553499|588779656|FG004|Overall Study|Death|1|||
163021235|NCT02553499|588779657|FG005|Overall Study|Death|2|||
163021236|NCT02553499|588779658|FG006|Overall Study|Death|0|||
163021237|NCT02553499|588779659|FG007|Overall Study|Death|0|||
163021238|NCT02553499|588779660|FG008|Overall Study|Death|0|||
163021239|NCT02553499|588779661|FG009|Overall Study|Death|0|||
163021240|NCT02553499|588779662|FG010|Overall Study|Death|1|||
163021241|NCT02553499|588779663|FG011|Overall Study|Death|0|||
163021242|NCT02553499|588779664|FG012|Overall Study|Death|0|||
163021243|NCT02553499|588779665|FG013|Overall Study|Death|0|||
163021244|NCT02553499|588779652|FG000|Overall Study|Lost to Follow-up|0|||
163021245|NCT02553499|588779653|FG001|Overall Study|Lost to Follow-up|0|||
163021246|NCT02553499|588779654|FG002|Overall Study|Lost to Follow-up|0|||
163021247|NCT02553499|588779655|FG003|Overall Study|Lost to Follow-up|0|||
163021248|NCT02553499|588779656|FG004|Overall Study|Lost to Follow-up|0|||
163021249|NCT02553499|588779657|FG005|Overall Study|Lost to Follow-up|0|||
163021250|NCT02553499|588779658|FG006|Overall Study|Lost to Follow-up|1|||
163021251|NCT02553499|588779659|FG007|Overall Study|Lost to Follow-up|0|||
163021252|NCT02553499|588779660|FG008|Overall Study|Lost to Follow-up|0|||
163021253|NCT02553499|588779661|FG009|Overall Study|Lost to Follow-up|0|||
163021254|NCT02553499|588779662|FG010|Overall Study|Lost to Follow-up|0|||
163021255|NCT02553499|588779663|FG011|Overall Study|Lost to Follow-up|0|||
163021256|NCT02553499|588779664|FG012|Overall Study|Lost to Follow-up|0|||
163021257|NCT02553499|588779665|FG013|Overall Study|Lost to Follow-up|0|||
163021258|NCT02553499|588779652|FG000|Overall Study|Physician Decision|0|||
163021259|NCT02553499|588779653|FG001|Overall Study|Physician Decision|1|||
163021260|NCT02553499|588779654|FG002|Overall Study|Physician Decision|1|||
163021261|NCT02553499|588779655|FG003|Overall Study|Physician Decision|0|||
163021262|NCT02553499|588779656|FG004|Overall Study|Physician Decision|1|||
163021263|NCT02553499|588779657|FG005|Overall Study|Physician Decision|0|||
163021264|NCT02553499|588779658|FG006|Overall Study|Physician Decision|0|||
163021265|NCT02553499|588779659|FG007|Overall Study|Physician Decision|1|||
162642924|NCT04762680|587409299|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
163021266|NCT02553499|588779660|FG008|Overall Study|Physician Decision|1|||
163021267|NCT02553499|588779661|FG009|Overall Study|Physician Decision|2|||
163021268|NCT02553499|588779662|FG010|Overall Study|Physician Decision|1|||
163021269|NCT02553499|588779663|FG011|Overall Study|Physician Decision|3|||
162642925|NCT04762680|587409300|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
162642926|NCT04762680|587409301|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
162642927|NCT04762680|587409302|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
163021270|NCT02553499|588779664|FG012|Overall Study|Physician Decision|1|||
163021271|NCT02553499|588779665|FG013|Overall Study|Physician Decision|0|||
162642928|NCT02584504|587409305|FG000|Double-blind Treatment|Participant withdrew consent|0|||
163021272|NCT02553499|588779652|FG000|Overall Study|Progressive Disease|0|||
163021273|NCT02553499|588779653|FG001|Overall Study|Progressive Disease|0|||
163021274|NCT02553499|588779654|FG002|Overall Study|Progressive Disease|0|||
163021275|NCT02553499|588779655|FG003|Overall Study|Progressive Disease|2|||
163021276|NCT02553499|588779656|FG004|Overall Study|Progressive Disease|1|||
163021277|NCT02553499|588779657|FG005|Overall Study|Progressive Disease|1|||
163021278|NCT02553499|588779658|FG006|Overall Study|Progressive Disease|1|||
163021279|NCT02553499|588779659|FG007|Overall Study|Progressive Disease|0|||
163021280|NCT02553499|588779660|FG008|Overall Study|Progressive Disease|0|||
163021281|NCT02553499|588779661|FG009|Overall Study|Progressive Disease|1|||
163021282|NCT02553499|588779662|FG010|Overall Study|Progressive Disease|0|||
163021283|NCT02553499|588779663|FG011|Overall Study|Progressive Disease|0|||
163021284|NCT02553499|588779664|FG012|Overall Study|Progressive Disease|2|||
163021285|NCT02553499|588779665|FG013|Overall Study|Progressive Disease|1|||
163021286|NCT02553499|588779652|FG000|Overall Study|Study Terminated by Sponsor|0|||
163021287|NCT02553499|588779653|FG001|Overall Study|Study Terminated by Sponsor|0|||
163021288|NCT02553499|588779654|FG002|Overall Study|Study Terminated by Sponsor|0|||
163021289|NCT02553499|588779655|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021290|NCT02553499|588779656|FG004|Overall Study|Study Terminated by Sponsor|0|||
163021291|NCT02553499|588779657|FG005|Overall Study|Study Terminated by Sponsor|0|||
163021292|NCT02553499|588779658|FG006|Overall Study|Study Terminated by Sponsor|0|||
163021293|NCT02553499|588779659|FG007|Overall Study|Study Terminated by Sponsor|0|||
163021294|NCT02553499|588779660|FG008|Overall Study|Study Terminated by Sponsor|1|||
163021295|NCT02553499|588779661|FG009|Overall Study|Study Terminated by Sponsor|0|||
163021296|NCT02553499|588779662|FG010|Overall Study|Study Terminated by Sponsor|0|||
163021297|NCT02553499|588779663|FG011|Overall Study|Study Terminated by Sponsor|0|||
163021298|NCT02553499|588779664|FG012|Overall Study|Study Terminated by Sponsor|0|||
163021299|NCT02553499|588779665|FG013|Overall Study|Study Terminated by Sponsor|0|||
163021300|NCT02553499|588779652|FG000|Overall Study|Withdrawal by Subject|2|||
163021301|NCT02553499|588779653|FG001|Overall Study|Withdrawal by Subject|0|||
163021302|NCT02553499|588779654|FG002|Overall Study|Withdrawal by Subject|0|||
163021303|NCT02553499|588779655|FG003|Overall Study|Withdrawal by Subject|0|||
163021304|NCT02553499|588779656|FG004|Overall Study|Withdrawal by Subject|0|||
163021305|NCT02553499|588779657|FG005|Overall Study|Withdrawal by Subject|0|||
163021306|NCT02553499|588779658|FG006|Overall Study|Withdrawal by Subject|0|||
163021307|NCT02553499|588779659|FG007|Overall Study|Withdrawal by Subject|1|||
163021308|NCT02553499|588779660|FG008|Overall Study|Withdrawal by Subject|1|||
163021309|NCT02553499|588779661|FG009|Overall Study|Withdrawal by Subject|0|||
163021310|NCT02553499|588779662|FG010|Overall Study|Withdrawal by Subject|1|||
163021311|NCT02553499|588779663|FG011|Overall Study|Withdrawal by Subject|0|||
163021312|NCT02553499|588779664|FG012|Overall Study|Withdrawal by Subject|0|||
163021313|NCT02553499|588779665|FG013|Overall Study|Withdrawal by Subject|0|||
163021314|NCT01582178|588779666|FG000|Overall Study|Physician Decision|6|||
163021315|NCT01582178|588779667|FG001|Overall Study|Physician Decision|5|||
163021316|NCT00570063|588779668|FG000|Overall Study|Adverse Event|4|||
163021317|NCT00570063|588779669|FG001|Overall Study|Adverse Event|1|||
163021318|NCT00570063|588779668|FG000|Overall Study|Lack of Efficacy|0|||
163021319|NCT00570063|588779669|FG001|Overall Study|Lack of Efficacy|1|||
163021320|NCT00570063|588779668|FG000|Overall Study|Withdrawal by Subject|4|||
163021321|NCT00570063|588779669|FG001|Overall Study|Withdrawal by Subject|3|||
163021322|NCT00570063|588779668|FG000|Overall Study|Sponsor's Decision|7|||
163021323|NCT00570063|588779669|FG001|Overall Study|Sponsor's Decision|3|||
163021324|NCT00550043|588779673|FG000|Overall Study|Adverse Event|0|||
163021325|NCT00550043|588779674|FG001|Overall Study|Adverse Event|0|||
163021326|NCT00550043|588779675|FG002|Overall Study|Adverse Event|0|||
163021327|NCT00550043|588779676|FG003|Overall Study|Adverse Event|1|||
163021328|NCT00550043|588779677|FG004|Overall Study|Adverse Event|1|||
163021329|NCT00550043|588779673|FG000|Overall Study|Subject Withdrew Consent|0|||
163021330|NCT00550043|588779674|FG001|Overall Study|Subject Withdrew Consent|2|||
163021331|NCT00550043|588779675|FG002|Overall Study|Subject Withdrew Consent|1|||
163021332|NCT00550043|588779676|FG003|Overall Study|Subject Withdrew Consent|0|||
163021333|NCT00550043|588779677|FG004|Overall Study|Subject Withdrew Consent|0|||
163021334|NCT00550043|588779673|FG000|Overall Study|Other Reasons- Unspecified|0|||
163021335|NCT00550043|588779674|FG001|Overall Study|Other Reasons- Unspecified|1|||
163021336|NCT00550043|588779675|FG002|Overall Study|Other Reasons- Unspecified|0|||
163021337|NCT00550043|588779676|FG003|Overall Study|Other Reasons- Unspecified|1|||
163021338|NCT00550043|588779677|FG004|Overall Study|Other Reasons- Unspecified|0|||
163021339|NCT01031680|588779681|FG000|Overall Study|Adverse Event|8|||
163021340|NCT01031680|588779682|FG001|Overall Study|Adverse Event|3|||
163021341|NCT01031680|588779681|FG000|Overall Study|Lost to Follow-up|2|||
163021342|NCT01031680|588779682|FG001|Overall Study|Lost to Follow-up|10|||
163021343|NCT01031680|588779681|FG000|Overall Study|Withdrawal by Subject|12|||
163021344|NCT01031680|588779682|FG001|Overall Study|Withdrawal by Subject|16|||
163021345|NCT01031680|588779681|FG000|Overall Study|Death|2|||
163021346|NCT01031680|588779682|FG001|Overall Study|Death|1|||
163021347|NCT01031680|588779681|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
163021348|NCT01031680|588779682|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
163021349|NCT01031680|588779681|FG000|Overall Study|Poor/Non-compliance|5|||
163021350|NCT01031680|588779682|FG001|Overall Study|Poor/Non-compliance|6|||
163021351|NCT01031680|588779681|FG000|Overall Study|Safety|1|||
163021352|NCT01031680|588779682|FG001|Overall Study|Safety|0|||
163021353|NCT01031680|588779681|FG000|Overall Study|Incorrect Enrolment|1|||
163021354|NCT01031680|588779682|FG001|Overall Study|Incorrect Enrolment|2|||
163021355|NCT01031680|588779681|FG000|Overall Study|Administrative Reason by Sponsor|0|||
163021356|NCT01031680|588779682|FG001|Overall Study|Administrative Reason by Sponsor|1|||
163021357|NCT01031680|588779681|FG000|Overall Study|Various|0|||
163021358|NCT01031680|588779682|FG001|Overall Study|Various|2|||
163021359|NCT01186692|588779683|FG000|Overall Study|Not Catheterized|11|||
163021360|NCT01186692|588779683|FG000|Overall Study|Futher testing contraindicated implant|19|||
163021361|NCT01186692|588779683|FG000|Overall Study|Adverse Event|2|||
163021362|NCT00789698|588779684|FG000|Overall Study|Lack of Efficacy|10|||
163021363|NCT00789698|588779685|FG001|Overall Study|Lack of Efficacy|4|||
163021364|NCT00789698|588779686|FG002|Overall Study|Lack of Efficacy|5|||
163021365|NCT00789698|588779687|FG003|Overall Study|Lack of Efficacy|18|||
163021366|NCT00789698|588779684|FG000|Overall Study|Adverse Event|5|||
163021367|NCT00789698|588779685|FG001|Overall Study|Adverse Event|5|||
163021368|NCT00789698|588779686|FG002|Overall Study|Adverse Event|3|||
163021369|NCT00789698|588779687|FG003|Overall Study|Adverse Event|4|||
163021370|NCT00789698|588779684|FG000|Overall Study|Lost to Follow-up|5|||
163021371|NCT00789698|588779685|FG001|Overall Study|Lost to Follow-up|5|||
163021372|NCT00789698|588779686|FG002|Overall Study|Lost to Follow-up|2|||
163021373|NCT00789698|588779687|FG003|Overall Study|Lost to Follow-up|9|||
163021374|NCT00789698|588779684|FG000|Overall Study|Protocol Violation|6|||
163021375|NCT00789698|588779685|FG001|Overall Study|Protocol Violation|1|||
163021376|NCT00789698|588779686|FG002|Overall Study|Protocol Violation|2|||
163021377|NCT00789698|588779687|FG003|Overall Study|Protocol Violation|1|||
163021378|NCT00789698|588779684|FG000|Overall Study|Withdrawal by Subject|14|||
163021379|NCT00789698|588779685|FG001|Overall Study|Withdrawal by Subject|15|||
163021380|NCT00789698|588779686|FG002|Overall Study|Withdrawal by Subject|12|||
163021381|NCT00789698|588779687|FG003|Overall Study|Withdrawal by Subject|19|||
163021382|NCT00789698|588779684|FG000|Overall Study|Administrative|0|||
163021383|NCT00789698|588779685|FG001|Overall Study|Administrative|3|||
163021384|NCT00789698|588779686|FG002|Overall Study|Administrative|3|||
163021385|NCT00789698|588779687|FG003|Overall Study|Administrative|1|||
163021386|NCT01921101|588779688|FG000|Overall Study|Death|16|||
163021387|NCT01921101|588779689|FG001|Overall Study|Death|6|||
163021388|NCT00519428|588782119|FG000|Overall Study|Adverse Event|5|||
163021389|NCT00519428|588782120|FG001|Overall Study|Adverse Event|2|||
163021390|NCT00519428|588782121|FG002|Overall Study|Adverse Event|10|||
163021391|NCT00519428|588782119|FG000|Overall Study|Lost to Follow-up|7|||
163021392|NCT00519428|588782120|FG001|Overall Study|Lost to Follow-up|7|||
163021393|NCT00519428|588782121|FG002|Overall Study|Lost to Follow-up|6|||
163021394|NCT00519428|588782119|FG000|Overall Study|Withdrawal by Subject|8|||
163021395|NCT00519428|588782120|FG001|Overall Study|Withdrawal by Subject|3|||
163021396|NCT00519428|588782121|FG002|Overall Study|Withdrawal by Subject|7|||
163021397|NCT00519428|588782119|FG000|Overall Study|unstated|1|||
163021398|NCT00519428|588782120|FG001|Overall Study|unstated|3|||
163021399|NCT00519428|588782121|FG002|Overall Study|unstated|2|||
163021400|NCT00688701|588782123|FG000|Overall Study|Adverse Event|1|||
163021401|NCT00688701|588782124|FG001|Overall Study|Adverse Event|0|||
163021402|NCT00688701|588782125|FG002|Overall Study|Adverse Event|5|||
163021403|NCT00688701|588782126|FG003|Overall Study|Adverse Event|3|||
163021404|NCT00688701|588782123|FG000|Overall Study|Lack of Efficacy|0|||
163021405|NCT00688701|588782124|FG001|Overall Study|Lack of Efficacy|1|||
163021406|NCT00688701|588782125|FG002|Overall Study|Lack of Efficacy|0|||
163021407|NCT00688701|588782126|FG003|Overall Study|Lack of Efficacy|0|||
163021408|NCT00688701|588782123|FG000|Overall Study|Withdrawal by Subject|3|||
163021409|NCT00688701|588782124|FG001|Overall Study|Withdrawal by Subject|3|||
163021410|NCT00688701|588782125|FG002|Overall Study|Withdrawal by Subject|4|||
163021411|NCT00688701|588782126|FG003|Overall Study|Withdrawal by Subject|8|||
163021412|NCT00688701|588782123|FG000|Overall Study|Poor compliance to protocol|0|||
163021413|NCT00688701|588782124|FG001|Overall Study|Poor compliance to protocol|1|||
163021414|NCT00688701|588782125|FG002|Overall Study|Poor compliance to protocol|1|||
163021415|NCT00688701|588782126|FG003|Overall Study|Poor compliance to protocol|0|||
163021416|NCT01275755|588782134|FG000|Double-blind Treatment Period|Adverse Event|0|||
163021417|NCT01275755|588782135|FG001|Double-blind Treatment Period|Adverse Event|2|||
163021418|NCT01275755|588782134|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163021419|NCT01275755|588782135|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
163021420|NCT01275755|588782134|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163021421|NCT01275755|588782135|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163021422|NCT01275755|588782134|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
163021423|NCT01275755|588782135|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
163021424|NCT04420585|588782140|FG000|Overall Study|Adverse Event|1|||
163021425|NCT04420585|588782140|FG000|Overall Study|Never initiated medication|2|||
163021426|NCT03693612|588782143|FG000|Overall Study|Lost to Follow-up|0|||
163021427|NCT03693612|588782144|FG001|Overall Study|Lost to Follow-up|0|||
163021428|NCT03693612|588782145|FG002|Overall Study|Lost to Follow-up|0|||
163021429|NCT03693612|588782146|FG003|Overall Study|Lost to Follow-up|0|||
163021430|NCT03693612|588782147|FG004|Overall Study|Lost to Follow-up|1|||
163021431|NCT03693612|588782148|FG005|Overall Study|Lost to Follow-up|0|||
163021432|NCT03693612|588782149|FG006|Overall Study|Lost to Follow-up|0|||
163021433|NCT03693612|588782143|FG000|Overall Study|Withdrawal by Subject|0|||
163021434|NCT03693612|588782144|FG001|Overall Study|Withdrawal by Subject|0|||
163021435|NCT03693612|588782145|FG002|Overall Study|Withdrawal by Subject|1|||
163021436|NCT03693612|588782146|FG003|Overall Study|Withdrawal by Subject|0|||
163021437|NCT03693612|588782147|FG004|Overall Study|Withdrawal by Subject|2|||
163021438|NCT03693612|588782148|FG005|Overall Study|Withdrawal by Subject|0|||
163021439|NCT03693612|588782149|FG006|Overall Study|Withdrawal by Subject|0|||
163021440|NCT03693612|588782143|FG000|Overall Study|Study Terminated by Sponsor|0|||
163021441|NCT03693612|588782144|FG001|Overall Study|Study Terminated by Sponsor|1|||
163021442|NCT03693612|588782145|FG002|Overall Study|Study Terminated by Sponsor|0|||
163021443|NCT03693612|588782146|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021444|NCT03693612|588782147|FG004|Overall Study|Study Terminated by Sponsor|3|||
163021445|NCT03693612|588782148|FG005|Overall Study|Study Terminated by Sponsor|0|||
163021446|NCT03693612|588782149|FG006|Overall Study|Study Terminated by Sponsor|0|||
163021447|NCT01669174|588782156|FG000|Overall Study|Subject withdrew consent|2|||
163021448|NCT01669174|588782157|FG001|Overall Study|Subject withdrew consent|2|||
163021449|NCT01669174|588782156|FG000|Overall Study|Lost to Follow-up|1|||
163021450|NCT01669174|588782157|FG001|Overall Study|Lost to Follow-up|0|||
163021451|NCT01669174|588782156|FG000|Overall Study|Adverse Event|2|||
163021452|NCT01669174|588782157|FG001|Overall Study|Adverse Event|2|||
163021453|NCT01669174|588782156|FG000|Overall Study|Administrative problems|1|||
163021454|NCT01669174|588782157|FG001|Overall Study|Administrative problems|2|||
163021455|NCT01953601|588782161|FG000|Part 1 (Base Study)|Adverse Event|24|||
163021456|NCT01953601|588782162|FG001|Part 1 (Base Study)|Adverse Event|37|||
163021457|NCT01953601|588782163|FG002|Part 1 (Base Study)|Adverse Event|15|||
163021458|NCT01953601|588782161|FG000|Part 1 (Base Study)|Death|2|||
163021459|NCT01953601|588782162|FG001|Part 1 (Base Study)|Death|0|||
163021460|NCT01953601|588782163|FG002|Part 1 (Base Study)|Death|3|||
163021461|NCT01953601|588782161|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
163021462|NCT01953601|588782162|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
163021463|NCT01953601|588782163|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
163021464|NCT01953601|588782161|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
163021465|NCT01953601|588782162|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
162716642|NCT00708097|587668528|FG004|Period 2|Protocol Violation|0|||
162716643|NCT03425643|587668529|FG000|Overall Study|Withdrawal by Subject|10|||
163021466|NCT01953601|588782163|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
163021467|NCT01953601|588782161|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
163021468|NCT01953601|588782162|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
163021469|NCT01953601|588782163|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
163021470|NCT01953601|588782161|FG000|Part 1 (Base Study)|Physician Decision|3|||
163021471|NCT01953601|588782162|FG001|Part 1 (Base Study)|Physician Decision|7|||
163021472|NCT01953601|588782163|FG002|Part 1 (Base Study)|Physician Decision|4|||
163021473|NCT01953601|588782161|FG000|Part 1 (Base Study)|Screen failure|1|||
163021474|NCT01953601|588782162|FG001|Part 1 (Base Study)|Screen failure|0|||
163021475|NCT01953601|588782163|FG002|Part 1 (Base Study)|Screen failure|1|||
163021476|NCT01953601|588782161|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
163021477|NCT01953601|588782162|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
163021478|NCT01953601|588782163|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
163021479|NCT01953601|588782161|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
163021480|NCT01953601|588782162|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
163021481|NCT01953601|588782163|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
163021482|NCT01953601|588782161|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
163021483|NCT01953601|588782162|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
163021484|NCT01953601|588782163|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
163021485|NCT01953601|588782161|FG000|Part 1 (Base Study)|Subject moved|2|||
163021486|NCT01953601|588782162|FG001|Part 1 (Base Study)|Subject moved|2|||
163021487|NCT01953601|588782163|FG002|Part 1 (Base Study)|Subject moved|1|||
163021488|NCT01953601|588782161|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
163021489|NCT01953601|588782162|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
163021490|NCT01953601|588782163|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
162716644|NCT03425643|587668530|FG001|Overall Study|Withdrawal by Subject|12|||
163021491|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Adverse Event|1|||
163021492|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Adverse Event|1|||
163021493|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Adverse Event|10|||
163021494|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Death|0|||
163021495|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Death|3|||
163021496|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Death|0|||
163021497|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
163021498|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
163021499|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
163021500|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
162716645|NCT03425643|587668529|FG000|Overall Study|Lost to Follow-up|2|||
163021501|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
163021502|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
163021503|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Physician Decision|2|||
163021504|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Physician Decision|0|||
163021505|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Physician Decision|2|||
163021506|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
163021507|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
163021508|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
163021509|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
163021510|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
163021511|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
163021512|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
163021513|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
163021514|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
163021515|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Subject moved|0|||
163021516|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Subject moved|0|||
163021517|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Subject moved|1|||
163021518|NCT01953601|588782161|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
163021519|NCT01953601|588782162|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
163021520|NCT01953601|588782163|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
163021521|NCT01905553|588782170|FG000|Period 2|Adverse Event|1|||
163021522|NCT01905553|588782171|FG001|Period 2|Adverse Event|0|||
163021523|NCT04310397|588782172|FG000|Overall Study|Lack of Efficacy|3|||
163021524|NCT04310397|588782172|FG000|Overall Study|Withdrawal by Subject|1|||
163021525|NCT03962790|588782175|FG000|Period 1|Adverse Event|0|||
163021526|NCT03962790|588782176|FG001|Period 1|Adverse Event|1|||
163021527|NCT03962790|588782175|FG000|Period 1|Failed to meet all eligibility criteria|1|||
163021528|NCT03962790|588782176|FG001|Period 1|Failed to meet all eligibility criteria|1|||
163021529|NCT03962790|588782175|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
163021530|NCT03962790|588782176|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
163021531|NCT03962790|588782175|FG000|Period 1|Withdrawal by Subject|1|||
163021532|NCT03962790|588782176|FG001|Period 1|Withdrawal by Subject|0|||
163021533|NCT01608087|588782184|FG000|Overall Study|Lost to Follow-up|0|||
163021534|NCT01608087|588782185|FG001|Overall Study|Lost to Follow-up|1|||
163021535|NCT01608087|588782186|FG002|Overall Study|Lost to Follow-up|0|||
163021536|NCT01608087|588782184|FG000|Overall Study|Other Reason|0|||
163021537|NCT01608087|588782185|FG001|Overall Study|Other Reason|1|||
163021538|NCT01608087|588782186|FG002|Overall Study|Other Reason|0|||
163021539|NCT00664859|588782196|FG000|Overall Study|Adverse Event|2|||
163021540|NCT00664859|588782197|FG001|Overall Study|Adverse Event|1|||
163021541|NCT00664859|588782198|FG002|Overall Study|Adverse Event|3|||
163021542|NCT00664859|588782196|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
163021543|NCT00664859|588782197|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
163021544|NCT00664859|588782198|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
163021545|NCT00664859|588782196|FG000|Overall Study|Noncompliance with protocol|1|||
163021546|NCT00664859|588782197|FG001|Overall Study|Noncompliance with protocol|0|||
163021547|NCT00664859|588782198|FG002|Overall Study|Noncompliance with protocol|4|||
163021548|NCT00664859|588782196|FG000|Overall Study|Laboratory abnormality|2|||
163021549|NCT00664859|588782197|FG001|Overall Study|Laboratory abnormality|1|||
163021550|NCT00664859|588782198|FG002|Overall Study|Laboratory abnormality|4|||
163021551|NCT00664859|588782196|FG000|Overall Study|Withdrawal by Subject|4|||
163021552|NCT00664859|588782197|FG001|Overall Study|Withdrawal by Subject|1|||
163021553|NCT00664859|588782198|FG002|Overall Study|Withdrawal by Subject|3|||
163021554|NCT00664859|588782196|FG000|Overall Study|Lost to Follow-up|2|||
163021555|NCT00664859|588782197|FG001|Overall Study|Lost to Follow-up|2|||
163021556|NCT00664859|588782198|FG002|Overall Study|Lost to Follow-up|1|||
163021557|NCT00664859|588782196|FG000|Overall Study|Other|0|||
163021558|NCT00664859|588782197|FG001|Overall Study|Other|1|||
163021559|NCT00664859|588782198|FG002|Overall Study|Other|2|||
163021560|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021561|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021562|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163063803|NCT01157845|588940000|FG000|Overall Study|Physician Decision|3|||
163021563|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021564|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021565|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021566|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021567|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021568|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
163021569|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021570|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021571|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163063804|NCT01157845|588940000|FG000|Overall Study|Protocol Violation|13|||
163063805|NCT01157845|588940000|FG000|Overall Study|Study was ended|1|||
163021572|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
162642929|NCT02584504|587409306|FG001|Double-blind Treatment|Participant withdrew consent|0|||
162642930|NCT02584504|587409307|FG002|Double-blind Treatment|Participant withdrew consent|1|||
162642931|NCT02584504|587409305|FG000|Double-blind Treatment|Adverse Event|0|||
162642932|NCT02584504|587409306|FG001|Double-blind Treatment|Adverse Event|1|||
162642933|NCT02584504|587409307|FG002|Double-blind Treatment|Adverse Event|0|||
162642934|NCT02584504|587409305|FG000|Double-blind Treatment|Family Matter|0|||
163021573|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021574|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021575|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021576|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021577|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
163021578|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021579|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021580|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021581|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021582|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
163021583|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021584|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021585|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
163021586|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021587|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021588|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021589|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021590|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021591|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021592|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021593|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021594|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021595|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
163021596|NCT01943851|588782201|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021597|NCT01943851|588782202|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021598|NCT01943851|588782203|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021599|NCT01943851|588782204|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021600|NCT01943851|588782205|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021601|NCT01943851|588782206|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021602|NCT01943851|588782207|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021603|NCT01943851|588782208|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021604|NCT01943851|588782209|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021605|NCT01943851|588782210|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021606|NCT01943851|588782211|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021607|NCT01943851|588782212|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021608|NCT01943851|588782213|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021609|NCT01943851|588782214|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
163021610|NCT01943851|588782215|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021611|NCT01943851|588782216|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021612|NCT01943851|588782217|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021613|NCT01943851|588782218|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
163021614|NCT01943851|588782201|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
162642935|NCT02584504|587409306|FG001|Double-blind Treatment|Family Matter|1|||
162642936|NCT02584504|587409307|FG002|Double-blind Treatment|Family Matter|0|||
162642937|NCT02584504|587409305|FG000|Open-label Treatment|Participant withdrew consent|0|||
162642938|NCT02584504|587409306|FG001|Open-label Treatment|Participant withdrew consent|0|||
162642939|NCT02584504|587409307|FG002|Open-label Treatment|Participant withdrew consent|4|||
163021615|NCT01943851|588782202|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021616|NCT01943851|588782203|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021617|NCT01943851|588782204|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021618|NCT01943851|588782205|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021619|NCT01943851|588782206|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021620|NCT01943851|588782207|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021621|NCT01943851|588782208|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021622|NCT01943851|588782209|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021623|NCT01943851|588782210|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021624|NCT01943851|588782211|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021625|NCT01943851|588782212|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021626|NCT01943851|588782213|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021627|NCT01943851|588782214|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021628|NCT01943851|588782215|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
162642940|NCT02584504|587409305|FG000|Open-label Treatment|Adverse Event|2|||
162642941|NCT02584504|587409306|FG001|Open-label Treatment|Adverse Event|2|||
163021629|NCT01943851|588782216|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
163021630|NCT01943851|588782217|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021631|NCT01943851|588782218|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
163021632|NCT01943851|588782201|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021633|NCT01943851|588782202|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021634|NCT01943851|588782203|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021635|NCT01943851|588782204|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021636|NCT01943851|588782205|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021637|NCT01943851|588782206|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021638|NCT01943851|588782207|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021639|NCT01943851|588782208|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021640|NCT01943851|588782209|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021641|NCT01943851|588782210|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021642|NCT01943851|588782211|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021643|NCT01943851|588782212|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021644|NCT01943851|588782213|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021645|NCT01943851|588782214|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021646|NCT01943851|588782215|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
163021647|NCT01943851|588782216|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
163021648|NCT01943851|588782217|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
163021649|NCT01943851|588782218|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
163021650|NCT00401544|588782222|FG000|Overall Study|Adverse Event|5|||
163021651|NCT00401544|588782223|FG001|Overall Study|Adverse Event|1|||
163021652|NCT00401544|588782224|FG002|Overall Study|Adverse Event|1|||
163021653|NCT00401544|588782225|FG003|Overall Study|Adverse Event|1|||
163021654|NCT00401544|588782222|FG000|Overall Study|Death|3|||
163021655|NCT00401544|588782223|FG001|Overall Study|Death|6|||
163021656|NCT00401544|588782224|FG002|Overall Study|Death|2|||
163021657|NCT00401544|588782225|FG003|Overall Study|Death|5|||
163021658|NCT00401544|588782222|FG000|Overall Study|Lost to Follow-up|2|||
163021659|NCT00401544|588782223|FG001|Overall Study|Lost to Follow-up|0|||
163021660|NCT00401544|588782224|FG002|Overall Study|Lost to Follow-up|1|||
163021661|NCT00401544|588782225|FG003|Overall Study|Lost to Follow-up|1|||
163021662|NCT00401544|588782222|FG000|Overall Study|Withdrawal by Subject|7|||
163021663|NCT00401544|588782223|FG001|Overall Study|Withdrawal by Subject|6|||
163021664|NCT00401544|588782224|FG002|Overall Study|Withdrawal by Subject|6|||
163021665|NCT00401544|588782225|FG003|Overall Study|Withdrawal by Subject|5|||
163021666|NCT00401544|588782222|FG000|Overall Study|Physician Decision|1|||
163021667|NCT00401544|588782223|FG001|Overall Study|Physician Decision|3|||
163021668|NCT00401544|588782224|FG002|Overall Study|Physician Decision|0|||
163021669|NCT00401544|588782225|FG003|Overall Study|Physician Decision|0|||
163021670|NCT00401544|588782222|FG000|Overall Study|Ineligibility determined|0|||
163021671|NCT00401544|588782223|FG001|Overall Study|Ineligibility determined|1|||
163021672|NCT00401544|588782224|FG002|Overall Study|Ineligibility determined|0|||
163021673|NCT00401544|588782225|FG003|Overall Study|Ineligibility determined|2|||
163021674|NCT00401544|588782222|FG000|Overall Study|Disease progression|0|||
163021675|NCT00401544|588782223|FG001|Overall Study|Disease progression|1|||
163021676|NCT00401544|588782224|FG002|Overall Study|Disease progression|0|||
163021677|NCT00401544|588782225|FG003|Overall Study|Disease progression|0|||
163021678|NCT00401544|588782222|FG000|Overall Study|Other|0|||
163021679|NCT00401544|588782223|FG001|Overall Study|Other|0|||
163021680|NCT00401544|588782224|FG002|Overall Study|Other|2|||
163021681|NCT00401544|588782225|FG003|Overall Study|Other|2|||
163021682|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
163021683|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021684|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021685|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
163021686|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
163063806|NCT01157845|588940000|FG000|Overall Study|Device malfunction|1|||
163063807|NCT04817410|588941483|FG000|Overall Study|Withdrawal by Subject|5|||
163063808|NCT04817410|588941483|FG000|Overall Study|Physician Decision|3|||
163063809|NCT03595748|588941484|FG000|Overall Study|Death|11|||
163063810|NCT03595748|588941485|FG001|Overall Study|Death|12|||
163063811|NCT03595748|588941484|FG000|Overall Study|Withdrawal by Subject|28|||
163021687|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
163021688|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
163021689|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
163021690|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021691|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021692|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
163021693|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
163021694|NCT03645395|588782227|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
163021695|NCT03645395|588782228|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
163021696|NCT03645395|588782229|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
163063812|NCT03595748|588941485|FG001|Overall Study|Withdrawal by Subject|29|||
163021697|NCT03645395|588782230|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
163021698|NCT01289639|588782232|FG000|Overall Study|Lost to Follow-up|1|||
163021699|NCT01289639|588782233|FG001|Overall Study|Lost to Follow-up|0|||
163021700|NCT01289639|588782234|FG002|Overall Study|Lost to Follow-up|0|||
163021701|NCT02780713|588782235|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021702|NCT02780713|588782236|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021703|NCT02780713|588782237|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
163021704|NCT02780713|588782238|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021705|NCT02780713|588782239|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
163021706|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
163021707|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
163021708|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
163021709|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
163021710|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
163021711|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
163021712|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
163021713|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
163021714|NCT01931475|588782242|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
163021715|NCT01931475|588782243|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
163021716|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
163021717|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
163021718|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
163021719|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
163021720|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
163021721|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
163021722|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
163021723|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
163021724|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
163021725|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
163021726|NCT01931475|588782242|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
163021727|NCT01931475|588782243|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
163021728|NCT01250873|588782248|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
163021729|NCT01250873|588782248|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
163021730|NCT01254318|588782255|FG000|Overall Study|Lost to Follow-up|5|||
163021731|NCT01254318|588782255|FG000|Overall Study|Death|47|||
163021732|NCT01137110|588782262|FG000|Overall Study|Protocol Violation|1|||
163021733|NCT01137110|588782263|FG001|Overall Study|Protocol Violation|0|||
163021734|NCT02828124|588782266|FG000|Overall Study|Disease Progression|1|||
163021735|NCT02828124|588782267|FG001|Overall Study|Disease Progression|2|||
163021736|NCT02828124|588782268|FG002|Overall Study|Disease Progression|1|||
163021737|NCT02828124|588782269|FG003|Overall Study|Disease Progression|4|||
163021738|NCT02828124|588782266|FG000|Overall Study|AE Unrelated to Study Drug|0|||
163021739|NCT02828124|588782267|FG001|Overall Study|AE Unrelated to Study Drug|0|||
163021740|NCT02828124|588782268|FG002|Overall Study|AE Unrelated to Study Drug|0|||
163021741|NCT02828124|588782269|FG003|Overall Study|AE Unrelated to Study Drug|1|||
163021742|NCT02828124|588782266|FG000|Overall Study|Subject Withdrew Consent|0|||
163021743|NCT02828124|588782267|FG001|Overall Study|Subject Withdrew Consent|0|||
163021744|NCT02828124|588782268|FG002|Overall Study|Subject Withdrew Consent|0|||
163021745|NCT02828124|588782269|FG003|Overall Study|Subject Withdrew Consent|1|||
163021746|NCT06586788|588782270|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
163021747|NCT03514485|588782272|FG000|Overall Study|Lost to Follow-up|5|||
163021748|NCT03514485|588782273|FG001|Overall Study|Lost to Follow-up|3|||
163021749|NCT03514485|588782274|FG002|Overall Study|Lost to Follow-up|2|||
163021750|NCT03514485|588782275|FG003|Overall Study|Lost to Follow-up|0|||
162642942|NCT02584504|587409307|FG002|Open-label Treatment|Adverse Event|3|||
162642943|NCT02584504|587409305|FG000|Open-label Treatment|Physician Decision|0|||
162716646|NCT03425643|587668530|FG001|Overall Study|Lost to Follow-up|0|||
163021751|NCT03514485|588782276|FG004|Overall Study|Lost to Follow-up|1|||
163021752|NCT03514485|588782277|FG005|Overall Study|Lost to Follow-up|4|||
163021753|NCT03514485|588782272|FG000|Overall Study|Withdrawal by Subject|0|||
163021754|NCT03514485|588782273|FG001|Overall Study|Withdrawal by Subject|1|||
163021755|NCT03514485|588782274|FG002|Overall Study|Withdrawal by Subject|3|||
163021756|NCT03514485|588782275|FG003|Overall Study|Withdrawal by Subject|1|||
163021757|NCT03514485|588782276|FG004|Overall Study|Withdrawal by Subject|2|||
163021758|NCT03514485|588782277|FG005|Overall Study|Withdrawal by Subject|1|||
163021759|NCT03075891|588782278|FG000|Overall Study|Withdrawal by Subject|3|||
163021760|NCT03075891|588782279|FG001|Overall Study|Withdrawal by Subject|6|||
163021761|NCT03075891|588782278|FG000|Overall Study|Lost to Follow-up|1|||
163021762|NCT03075891|588782279|FG001|Overall Study|Lost to Follow-up|0|||
163021763|NCT03075891|588782278|FG000|Overall Study|Pregnancy|3|||
163063813|NCT03595748|588941484|FG000|Overall Study|Protocol Violation|0|||
163063814|NCT03595748|588941485|FG001|Overall Study|Protocol Violation|1|||
163021764|NCT03075891|588782279|FG001|Overall Study|Pregnancy|1|||
163021765|NCT03075891|588782278|FG000|Overall Study|visits not performed (no time)|1|||
163021766|NCT03075891|588782279|FG001|Overall Study|visits not performed (no time)|0|||
163021767|NCT03075891|588782278|FG000|Overall Study|Drug abuse relapse issue|0|||
163021768|NCT03075891|588782279|FG001|Overall Study|Drug abuse relapse issue|1|||
163021769|NCT03075891|588782278|FG000|Overall Study|Participant requiring study withdrawal|0|||
163021770|NCT03075891|588782279|FG001|Overall Study|Participant requiring study withdrawal|1|||
163021771|NCT03075891|588782278|FG000|Overall Study|Adverse event, non-fatal|1|||
163021772|NCT03075891|588782279|FG001|Overall Study|Adverse event, non-fatal|4|||
163021773|NCT00634803|588782281|FG000|Overall Study|Lost to Follow-up|6|||
163021774|NCT00634803|588782282|FG001|Overall Study|Lost to Follow-up|7|||
163021775|NCT00634803|588782283|FG002|Overall Study|Lost to Follow-up|7|||
163021776|NCT01300338|588783589|FG000|Overall Study|Lost to Follow-up|5|||
163021777|NCT01300338|588783590|FG001|Overall Study|Lost to Follow-up|0|||
163021778|NCT02461524|588783591|FG000|Overall Study|Death|16|||
163021779|NCT02461524|588783591|FG000|Overall Study|Withdrawal by Subject|4|||
163021780|NCT02461524|588783591|FG000|Overall Study|Device Explanted|5|||
163021781|NCT02461524|588783591|FG000|Overall Study|Missed Visit|6|||
163021782|NCT00381238|588783595|FG000|Overall Study|Adverse Event|3|||
163021783|NCT00381238|588783595|FG000|Overall Study|Protocol Violation|1|||
163021784|NCT00381238|588783595|FG000|Overall Study|Withdrawal by Subject|4|||
163021785|NCT00381238|588783595|FG000|Overall Study|Lack of Efficacy|2|||
163021786|NCT00381238|588783595|FG000|Overall Study|Withdrew by physician|1|||
163021787|NCT00381238|588783595|FG000|Overall Study|Disease progression|1|||
163021788|NCT00843037|588783598|FG000|Overall Study|Lost to Follow-up|1|||
163021789|NCT02564900|588783599|FG000|Dose Escalation|Progressive disease per RECIST|2|||
163021790|NCT02564900|588783600|FG001|Dose Escalation|Progressive disease per RECIST|3|||
163021791|NCT02564900|588783601|FG002|Dose Escalation|Progressive disease per RECIST|3|||
163021792|NCT02564900|588783602|FG003|Dose Escalation|Progressive disease per RECIST|3|||
163021793|NCT02564900|588783603|FG004|Dose Escalation|Progressive disease per RECIST|3|||
163021794|NCT02564900|588783604|FG005|Dose Escalation|Progressive disease per RECIST|1|||
163021795|NCT02564900|588783605|FG006|Dose Escalation|Progressive disease per RECIST|0|||
163021796|NCT02564900|588783606|FG007|Dose Escalation|Progressive disease per RECIST|0|||
163021797|NCT02564900|588783607|FG008|Dose Escalation|Progressive disease per RECIST|0|||
163021798|NCT02564900|588783608|FG009|Dose Escalation|Progressive disease per RECIST|0|||
163021799|NCT02564900|588783609|FG010|Dose Escalation|Progressive disease per RECIST|0|||
163021800|NCT02564900|588783610|FG011|Dose Escalation|Progressive disease per RECIST|0|||
163021801|NCT02564900|588783611|FG012|Dose Escalation|Progressive disease per RECIST|0|||
163021802|NCT02564900|588783612|FG013|Dose Escalation|Progressive disease per RECIST|0|||
163021803|NCT02564900|588783613|FG014|Dose Escalation|Progressive disease per RECIST|0|||
163021804|NCT02564900|588783599|FG000|Dose Escalation|Ongoing|1|||
163021805|NCT02564900|588783600|FG001|Dose Escalation|Ongoing|0|||
163021806|NCT02564900|588783601|FG002|Dose Escalation|Ongoing|0|||
163021807|NCT02564900|588783602|FG003|Dose Escalation|Ongoing|2|||
163021808|NCT02564900|588783603|FG004|Dose Escalation|Ongoing|2|||
163021809|NCT02564900|588783604|FG005|Dose Escalation|Ongoing|2|||
163021810|NCT02564900|588783605|FG006|Dose Escalation|Ongoing|0|||
163021811|NCT02564900|588783606|FG007|Dose Escalation|Ongoing|0|||
163021812|NCT02564900|588783607|FG008|Dose Escalation|Ongoing|0|||
163021813|NCT02564900|588783608|FG009|Dose Escalation|Ongoing|0|||
163021814|NCT02564900|588783609|FG010|Dose Escalation|Ongoing|0|||
163021815|NCT02564900|588783610|FG011|Dose Escalation|Ongoing|0|||
163021816|NCT02564900|588783611|FG012|Dose Escalation|Ongoing|0|||
163021817|NCT02564900|588783612|FG013|Dose Escalation|Ongoing|0|||
163021818|NCT02564900|588783613|FG014|Dose Escalation|Ongoing|0|||
163021819|NCT02564900|588783599|FG000|Dose Escalation|Adverse Event|0|||
163021820|NCT02564900|588783600|FG001|Dose Escalation|Adverse Event|0|||
163021821|NCT02564900|588783601|FG002|Dose Escalation|Adverse Event|0|||
163021822|NCT02564900|588783602|FG003|Dose Escalation|Adverse Event|1|||
163021823|NCT02564900|588783603|FG004|Dose Escalation|Adverse Event|1|||
163021824|NCT02564900|588783604|FG005|Dose Escalation|Adverse Event|3|||
163021825|NCT02564900|588783605|FG006|Dose Escalation|Adverse Event|0|||
163063815|NCT02328014|588941486|FG000|Overall Study|Adverse Event|1|||
163063816|NCT02328014|588941487|FG001|Overall Study|Adverse Event|0|||
163021826|NCT02564900|588783606|FG007|Dose Escalation|Adverse Event|0|||
163021827|NCT02564900|588783607|FG008|Dose Escalation|Adverse Event|0|||
163021828|NCT02564900|588783608|FG009|Dose Escalation|Adverse Event|0|||
163021829|NCT02564900|588783609|FG010|Dose Escalation|Adverse Event|0|||
163021830|NCT02564900|588783610|FG011|Dose Escalation|Adverse Event|0|||
163021831|NCT02564900|588783611|FG012|Dose Escalation|Adverse Event|0|||
163021832|NCT02564900|588783612|FG013|Dose Escalation|Adverse Event|0|||
163021833|NCT02564900|588783613|FG014|Dose Escalation|Adverse Event|0|||
163021834|NCT02564900|588783599|FG000|Dose Expansion|Progressive disease per RECIST|0|||
163021835|NCT02564900|588783600|FG001|Dose Expansion|Progressive disease per RECIST|0|||
163021836|NCT02564900|588783601|FG002|Dose Expansion|Progressive disease per RECIST|0|||
163021837|NCT02564900|588783602|FG003|Dose Expansion|Progressive disease per RECIST|0|||
163021838|NCT02564900|588783603|FG004|Dose Expansion|Progressive disease per RECIST|0|||
163021839|NCT02564900|588783604|FG005|Dose Expansion|Progressive disease per RECIST|0|||
163021840|NCT02564900|588783605|FG006|Dose Expansion|Progressive disease per RECIST|19|||
163021841|NCT02564900|588783606|FG007|Dose Expansion|Progressive disease per RECIST|17|||
163021842|NCT02564900|588783607|FG008|Dose Expansion|Progressive disease per RECIST|8|||
163021843|NCT02564900|588783608|FG009|Dose Expansion|Progressive disease per RECIST|16|||
163021844|NCT02564900|588783609|FG010|Dose Expansion|Progressive disease per RECIST|13|||
163021845|NCT02564900|588783610|FG011|Dose Expansion|Progressive disease per RECIST|19|||
163021846|NCT02564900|588783611|FG012|Dose Expansion|Progressive disease per RECIST|10|||
163021847|NCT02564900|588783612|FG013|Dose Expansion|Progressive disease per RECIST|13|||
163021848|NCT02564900|588783613|FG014|Dose Expansion|Progressive disease per RECIST|11|||
163021849|NCT02564900|588783599|FG000|Dose Expansion|Clinical progression|0|||
163021850|NCT02564900|588783600|FG001|Dose Expansion|Clinical progression|0|||
163021851|NCT02564900|588783601|FG002|Dose Expansion|Clinical progression|0|||
163021852|NCT02564900|588783602|FG003|Dose Expansion|Clinical progression|0|||
163021853|NCT02564900|588783603|FG004|Dose Expansion|Clinical progression|0|||
163021854|NCT02564900|588783604|FG005|Dose Expansion|Clinical progression|0|||
163021855|NCT02564900|588783605|FG006|Dose Expansion|Clinical progression|5|||
163021856|NCT02564900|588783606|FG007|Dose Expansion|Clinical progression|12|||
163021857|NCT02564900|588783607|FG008|Dose Expansion|Clinical progression|0|||
163021858|NCT02564900|588783608|FG009|Dose Expansion|Clinical progression|3|||
163021859|NCT02564900|588783609|FG010|Dose Expansion|Clinical progression|2|||
163021860|NCT02564900|588783610|FG011|Dose Expansion|Clinical progression|0|||
163021861|NCT02564900|588783611|FG012|Dose Expansion|Clinical progression|1|||
163021862|NCT02564900|588783612|FG013|Dose Expansion|Clinical progression|3|||
163021863|NCT02564900|588783613|FG014|Dose Expansion|Clinical progression|1|||
163021864|NCT02564900|588783599|FG000|Dose Expansion|Adverse Event|0|||
163021865|NCT02564900|588783600|FG001|Dose Expansion|Adverse Event|0|||
163021866|NCT02564900|588783601|FG002|Dose Expansion|Adverse Event|0|||
163021867|NCT02564900|588783602|FG003|Dose Expansion|Adverse Event|0|||
163021868|NCT02564900|588783603|FG004|Dose Expansion|Adverse Event|0|||
163021869|NCT02564900|588783604|FG005|Dose Expansion|Adverse Event|0|||
163021870|NCT02564900|588783605|FG006|Dose Expansion|Adverse Event|9|||
163021871|NCT02564900|588783606|FG007|Dose Expansion|Adverse Event|22|||
163021872|NCT02564900|588783607|FG008|Dose Expansion|Adverse Event|0|||
163021873|NCT02564900|588783608|FG009|Dose Expansion|Adverse Event|11|||
163021874|NCT02564900|588783609|FG010|Dose Expansion|Adverse Event|0|||
163021875|NCT02564900|588783610|FG011|Dose Expansion|Adverse Event|5|||
163021876|NCT02564900|588783611|FG012|Dose Expansion|Adverse Event|2|||
163021877|NCT02564900|588783612|FG013|Dose Expansion|Adverse Event|2|||
163021878|NCT02564900|588783613|FG014|Dose Expansion|Adverse Event|1|||
163021879|NCT02564900|588783599|FG000|Dose Expansion|Ongoing|0|||
163021880|NCT02564900|588783600|FG001|Dose Expansion|Ongoing|0|||
163021881|NCT02564900|588783601|FG002|Dose Expansion|Ongoing|0|||
163021882|NCT02564900|588783602|FG003|Dose Expansion|Ongoing|0|||
163021883|NCT02564900|588783603|FG004|Dose Expansion|Ongoing|0|||
163063817|NCT02328014|588941488|FG002|Overall Study|Adverse Event|0|||
163063818|NCT02328014|588941489|FG003|Overall Study|Adverse Event|1|||
163063819|NCT02328014|588941486|FG000|Overall Study|Death|0|||
163063820|NCT02328014|588941487|FG001|Overall Study|Death|0|||
163063821|NCT02328014|588941488|FG002|Overall Study|Death|0|||
163063822|NCT02328014|588941489|FG003|Overall Study|Death|4|||
163063823|NCT02328014|588941486|FG000|Overall Study|Physician Decision|0|||
163063824|NCT02328014|588941487|FG001|Overall Study|Physician Decision|0|||
163063825|NCT02328014|588941488|FG002|Overall Study|Physician Decision|0|||
163063826|NCT02328014|588941489|FG003|Overall Study|Physician Decision|1|||
163063827|NCT02328014|588941486|FG000|Overall Study|Disease Progression|1|||
163063828|NCT02328014|588941487|FG001|Overall Study|Disease Progression|0|||
162642944|NCT02584504|587409306|FG001|Open-label Treatment|Physician Decision|1|||
162642945|NCT02584504|587409307|FG002|Open-label Treatment|Physician Decision|0|||
162642946|NCT02584504|587409305|FG000|Open-label Treatment|Entered but not treated|0|||
162642947|NCT02584504|587409306|FG001|Open-label Treatment|Entered but not treated|1|||
162642948|NCT02584504|587409307|FG002|Open-label Treatment|Entered but not treated|1|||
163021884|NCT02564900|588783604|FG005|Dose Expansion|Ongoing|0|||
163021885|NCT02564900|588783605|FG006|Dose Expansion|Ongoing|9|||
163021886|NCT02564900|588783606|FG007|Dose Expansion|Ongoing|10|||
163063829|NCT02328014|588941488|FG002|Overall Study|Disease Progression|1|||
163063830|NCT02328014|588941489|FG003|Overall Study|Disease Progression|3|||
163063831|NCT02328014|588941486|FG000|Overall Study|Study Terminated by Sponsor|4|||
163063832|NCT02328014|588941487|FG001|Overall Study|Study Terminated by Sponsor|1|||
162716647|NCT03425643|587668529|FG000|Overall Study|Death|109|||
163021887|NCT02564900|588783607|FG008|Dose Expansion|Ongoing|11|||
163021888|NCT02564900|588783608|FG009|Dose Expansion|Ongoing|3|||
163021889|NCT02564900|588783609|FG010|Dose Expansion|Ongoing|0|||
163021890|NCT02564900|588783610|FG011|Dose Expansion|Ongoing|0|||
163021891|NCT02564900|588783611|FG012|Dose Expansion|Ongoing|4|||
163063833|NCT02328014|588941488|FG002|Overall Study|Study Terminated by Sponsor|1|||
163063834|NCT02328014|588941489|FG003|Overall Study|Study Terminated by Sponsor|0|||
163021892|NCT02564900|588783612|FG013|Dose Expansion|Ongoing|0|||
163063835|NCT02328014|588941486|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
163021893|NCT02564900|588783613|FG014|Dose Expansion|Ongoing|6|||
163021894|NCT02564900|588783599|FG000|Dose Expansion|Death|0|||
163021895|NCT02564900|588783600|FG001|Dose Expansion|Death|0|||
163021896|NCT02564900|588783601|FG002|Dose Expansion|Death|0|||
163021897|NCT02564900|588783602|FG003|Dose Expansion|Death|0|||
163021898|NCT02564900|588783603|FG004|Dose Expansion|Death|0|||
163021899|NCT02564900|588783604|FG005|Dose Expansion|Death|0|||
163021900|NCT02564900|588783605|FG006|Dose Expansion|Death|1|||
163021901|NCT02564900|588783606|FG007|Dose Expansion|Death|0|||
163021902|NCT02564900|588783607|FG008|Dose Expansion|Death|0|||
163021903|NCT02564900|588783608|FG009|Dose Expansion|Death|0|||
163021904|NCT02564900|588783609|FG010|Dose Expansion|Death|1|||
163021905|NCT02564900|588783610|FG011|Dose Expansion|Death|0|||
163021906|NCT02564900|588783611|FG012|Dose Expansion|Death|1|||
163021907|NCT02564900|588783612|FG013|Dose Expansion|Death|1|||
163021908|NCT02564900|588783613|FG014|Dose Expansion|Death|0|||
163021909|NCT02564900|588783599|FG000|Dose Expansion|Withdrawal by Subject|0|||
163021910|NCT02564900|588783600|FG001|Dose Expansion|Withdrawal by Subject|0|||
163021911|NCT02564900|588783601|FG002|Dose Expansion|Withdrawal by Subject|0|||
163021912|NCT02564900|588783602|FG003|Dose Expansion|Withdrawal by Subject|0|||
163021913|NCT02564900|588783603|FG004|Dose Expansion|Withdrawal by Subject|0|||
163021914|NCT02564900|588783604|FG005|Dose Expansion|Withdrawal by Subject|0|||
163021915|NCT02564900|588783605|FG006|Dose Expansion|Withdrawal by Subject|4|||
163021916|NCT02564900|588783606|FG007|Dose Expansion|Withdrawal by Subject|0|||
163021917|NCT02564900|588783607|FG008|Dose Expansion|Withdrawal by Subject|0|||
163021918|NCT02564900|588783608|FG009|Dose Expansion|Withdrawal by Subject|0|||
163021919|NCT02564900|588783609|FG010|Dose Expansion|Withdrawal by Subject|1|||
163021920|NCT02564900|588783610|FG011|Dose Expansion|Withdrawal by Subject|0|||
163021921|NCT02564900|588783611|FG012|Dose Expansion|Withdrawal by Subject|0|||
163021922|NCT02564900|588783612|FG013|Dose Expansion|Withdrawal by Subject|1|||
163021923|NCT02564900|588783613|FG014|Dose Expansion|Withdrawal by Subject|1|||
163021924|NCT02564900|588783599|FG000|Dose Expansion|Other|0|||
163021925|NCT02564900|588783600|FG001|Dose Expansion|Other|0|||
163021926|NCT02564900|588783601|FG002|Dose Expansion|Other|0|||
163021927|NCT02564900|588783602|FG003|Dose Expansion|Other|0|||
163021928|NCT02564900|588783603|FG004|Dose Expansion|Other|0|||
163021929|NCT02564900|588783604|FG005|Dose Expansion|Other|0|||
163021930|NCT02564900|588783605|FG006|Dose Expansion|Other|1|||
163021931|NCT02564900|588783606|FG007|Dose Expansion|Other|0|||
163021932|NCT02564900|588783607|FG008|Dose Expansion|Other|1|||
163021933|NCT02564900|588783608|FG009|Dose Expansion|Other|0|||
163021934|NCT02564900|588783609|FG010|Dose Expansion|Other|0|||
163021935|NCT02564900|588783610|FG011|Dose Expansion|Other|0|||
163021936|NCT02564900|588783611|FG012|Dose Expansion|Other|0|||
162642949|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Death|3|||
162642950|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Death|2|||
162642951|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Death|4|||
162642952|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Death|3|||
162642953|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Death|0|||
162642954|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Death|0|||
162642955|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162642956|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
162642957|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
162642958|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162642959|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
163021937|NCT02564900|588783612|FG013|Dose Expansion|Other|0|||
163021938|NCT02564900|588783613|FG014|Dose Expansion|Other|1|||
163021939|NCT02564900|588783599|FG000|Dose Expansion|Did not receive treatment|0|||
163021940|NCT02564900|588783600|FG001|Dose Expansion|Did not receive treatment|0|||
162642960|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162642961|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
162642962|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
163021941|NCT02564900|588783601|FG002|Dose Expansion|Did not receive treatment|0|||
163021942|NCT02564900|588783602|FG003|Dose Expansion|Did not receive treatment|0|||
162642963|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162642964|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162716648|NCT03425643|587668530|FG001|Overall Study|Death|141|||
163021943|NCT02564900|588783603|FG004|Dose Expansion|Did not receive treatment|0|||
163021944|NCT02564900|588783604|FG005|Dose Expansion|Did not receive treatment|0|||
163021945|NCT02564900|588783605|FG006|Dose Expansion|Did not receive treatment|1|||
163021946|NCT02564900|588783606|FG007|Dose Expansion|Did not receive treatment|1|||
163021947|NCT02564900|588783607|FG008|Dose Expansion|Did not receive treatment|0|||
163021948|NCT02564900|588783608|FG009|Dose Expansion|Did not receive treatment|0|||
163021949|NCT02564900|588783609|FG010|Dose Expansion|Did not receive treatment|0|||
163021950|NCT02564900|588783610|FG011|Dose Expansion|Did not receive treatment|0|||
163021951|NCT02564900|588783611|FG012|Dose Expansion|Did not receive treatment|0|||
163021952|NCT02564900|588783612|FG013|Dose Expansion|Did not receive treatment|0|||
163021953|NCT02564900|588783613|FG014|Dose Expansion|Did not receive treatment|1|||
163021954|NCT03991299|588783614|FG000|Overall Study|Study closed, sponsor decision|3|||
163021955|NCT03991299|588783614|FG000|Overall Study|Withdrawal by Subject|1|||
163021956|NCT02278939|588783619|FG000|Overall Study|lack of time|1|||
163021957|NCT02278939|588783620|FG001|Overall Study|lack of time|0|||
163021958|NCT02278939|588783619|FG000|Overall Study|Lost to Follow-up|1|||
163021959|NCT02278939|588783620|FG001|Overall Study|Lost to Follow-up|1|||
163021960|NCT02278939|588783619|FG000|Overall Study|death in family|1|||
163021961|NCT02278939|588783620|FG001|Overall Study|death in family|0|||
163021962|NCT02278939|588783619|FG000|Overall Study|family emergency unable to commit|2|||
163021963|NCT02278939|588783620|FG001|Overall Study|family emergency unable to commit|0|||
163021964|NCT02423343|588783626|FG000|Overall Study|Withdrawal by Subject|0|||
163021965|NCT02423343|588783627|FG001|Overall Study|Withdrawal by Subject|1|||
163021966|NCT02423343|588783628|FG002|Overall Study|Withdrawal by Subject|0|||
163021967|NCT02423343|588783629|FG003|Overall Study|Withdrawal by Subject|0|||
163021968|NCT02423343|588783630|FG004|Overall Study|Withdrawal by Subject|0|||
163021969|NCT02423343|588783631|FG005|Overall Study|Withdrawal by Subject|0|||
163021970|NCT02423343|588783626|FG000|Overall Study|Progressive Disease|0|||
163021971|NCT02423343|588783627|FG001|Overall Study|Progressive Disease|0|||
163021972|NCT02423343|588783628|FG002|Overall Study|Progressive Disease|0|||
163021973|NCT02423343|588783629|FG003|Overall Study|Progressive Disease|0|||
163021974|NCT02423343|588783630|FG004|Overall Study|Progressive Disease|2|||
163021975|NCT02423343|588783631|FG005|Overall Study|Progressive Disease|0|||
163021976|NCT02423343|588783626|FG000|Overall Study|Adverse Event|0|||
163021977|NCT02423343|588783627|FG001|Overall Study|Adverse Event|0|||
163021978|NCT02423343|588783628|FG002|Overall Study|Adverse Event|0|||
163021979|NCT02423343|588783629|FG003|Overall Study|Adverse Event|0|||
163021980|NCT02423343|588783630|FG004|Overall Study|Adverse Event|2|||
163021981|NCT02423343|588783631|FG005|Overall Study|Adverse Event|0|||
163021982|NCT02423343|588783626|FG000|Overall Study|Death|0|||
163021983|NCT02423343|588783627|FG001|Overall Study|Death|0|||
163021984|NCT02423343|588783628|FG002|Overall Study|Death|0|||
163021985|NCT02423343|588783629|FG003|Overall Study|Death|0|||
163021986|NCT02423343|588783630|FG004|Overall Study|Death|1|||
163021987|NCT02423343|588783631|FG005|Overall Study|Death|0|||
163021988|NCT04429555|588783635|FG000|Overall Study|Death|0|||
163021989|NCT04429555|588783636|FG001|Overall Study|Death|2|||
162642965|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162642966|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162642967|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
162642968|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162642969|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
162642970|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
162642971|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162642972|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162642973|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162642974|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162642975|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
162642976|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
162642977|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162642978|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
163021990|NCT04429555|588783635|FG000|Overall Study|Other|2|||
163021991|NCT04429555|588783636|FG001|Overall Study|Other|0|||
163021992|NCT00930774|588783638|FG000|Overall Study|Withdrawal by Subject|1|||
163021993|NCT00930774|588783639|FG001|Overall Study|Withdrawal by Subject|9|||
163021994|NCT00930774|588783640|FG002|Overall Study|Withdrawal by Subject|2|||
163021995|NCT00930774|588783641|FG003|Overall Study|Withdrawal by Subject|0|||
163021996|NCT02703272|588783642|FG000|Overall Study|Death|4|||
163021997|NCT02703272|588783643|FG001|Overall Study|Death|9|||
163021998|NCT02703272|588783644|FG002|Overall Study|Death|19|||
163021999|NCT02703272|588783645|FG003|Overall Study|Death|10|||
163022000|NCT02703272|588783642|FG000|Overall Study|Withdrawal by Subject|0|||
163022001|NCT02703272|588783643|FG001|Overall Study|Withdrawal by Subject|0|||
162642979|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
163022002|NCT02703272|588783644|FG002|Overall Study|Withdrawal by Subject|4|||
163022003|NCT02703272|588783645|FG003|Overall Study|Withdrawal by Subject|2|||
163022004|NCT02703272|588783642|FG000|Overall Study|Study Terminated by Sponsor|6|||
163022005|NCT02703272|588783643|FG001|Overall Study|Study Terminated by Sponsor|1|||
163022006|NCT02703272|588783644|FG002|Overall Study|Study Terminated by Sponsor|12|||
163022007|NCT02703272|588783645|FG003|Overall Study|Study Terminated by Sponsor|4|||
163022008|NCT02703272|588783642|FG000|Overall Study|Other|1|||
163022009|NCT02703272|588783643|FG001|Overall Study|Other|0|||
163022010|NCT02703272|588783644|FG002|Overall Study|Other|0|||
163022011|NCT02703272|588783645|FG003|Overall Study|Other|0|||
163022012|NCT00712881|588783646|FG000|Overall Study|Adverse Event|3|||
163022013|NCT00712881|588783647|FG001|Overall Study|Adverse Event|3|||
163022014|NCT00712881|588783646|FG000|Overall Study|Withdrawal by Subject|1|||
163022015|NCT00712881|588783647|FG001|Overall Study|Withdrawal by Subject|1|||
163022016|NCT00712881|588783646|FG000|Overall Study|Disease Progression|2|||
163022017|NCT00712881|588783647|FG001|Overall Study|Disease Progression|1|||
163022018|NCT00712881|588783646|FG000|Overall Study|Lost to Follow-up|1|||
163022019|NCT00712881|588783647|FG001|Overall Study|Lost to Follow-up|1|||
163022020|NCT00712881|588783646|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
163022021|NCT00712881|588783647|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
163022022|NCT00712881|588783646|FG000|Overall Study|Protocol Violation|1|||
163022023|NCT00712881|588783647|FG001|Overall Study|Protocol Violation|1|||
163022024|NCT00712881|588783646|FG000|Overall Study|Randomized but not treated|1|||
163022025|NCT00712881|588783647|FG001|Overall Study|Randomized but not treated|0|||
163022026|NCT03200704|588783648|FG000|Overall Study|Withdrawal by Subject|1|||
163022027|NCT01680861|588783649|FG000|Early Post-transplant Period|Protocol Violation|1|||
163022028|NCT01680861|588783650|FG001|Early Post-transplant Period|Protocol Violation|1|||
163022029|NCT04967885|588783651|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
163022030|NCT04967885|588783652|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
163022031|NCT04967885|588783651|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
163022032|NCT04967885|588783652|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
163022033|NCT04967885|588783651|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
163022034|NCT04967885|588783652|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
163022035|NCT04967885|588783651|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
163022036|NCT04967885|588783652|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
163022037|NCT04967885|588783651|FG000|EMI-II Intervention|Lost to Follow-up|14|||
163022038|NCT04967885|588783652|FG001|EMI-II Intervention|Lost to Follow-up|10|||
163022039|NCT01011465|588783653|FG000|Overall Study|Withdrawal by Subject|2|||
163022040|NCT01011465|588783654|FG001|Overall Study|Withdrawal by Subject|1|||
163022041|NCT01011465|588783655|FG002|Overall Study|Withdrawal by Subject|0|||
163022042|NCT01011465|588783656|FG003|Overall Study|Withdrawal by Subject|0|||
163022043|NCT01011465|588783657|FG004|Overall Study|Withdrawal by Subject|1|||
163022044|NCT01011465|588783658|FG005|Overall Study|Withdrawal by Subject|0|||
163022045|NCT01011465|588783659|FG006|Overall Study|Withdrawal by Subject|1|||
163022046|NCT01011465|588783660|FG007|Overall Study|Withdrawal by Subject|0|||
163022047|NCT02042950|588783663|FG000|Overall Study|Progressive Disease|4|||
163022048|NCT01940887|588783667|FG000|Year 1|Protocol Violation|0|||
163022049|NCT01940887|588783668|FG001|Year 1|Protocol Violation|1|||
163022050|NCT01940887|588783667|FG000|Year 1|Physician Decision|7|||
163022051|NCT01940887|588783668|FG001|Year 1|Physician Decision|3|||
163022052|NCT01940887|588783667|FG000|Year 1|Death|5|||
163022053|NCT01940887|588783668|FG001|Year 1|Death|3|||
163022054|NCT01940887|588783667|FG000|Year 1|Adverse Event|7|||
163022055|NCT01940887|588783668|FG001|Year 1|Adverse Event|6|||
163022056|NCT01940887|588783667|FG000|Year 1|Withdrawal by Subject|18|||
163022057|NCT01940887|588783668|FG001|Year 1|Withdrawal by Subject|9|||
163022058|NCT01940887|588783667|FG000|Year 1|Lost to Follow-up|2|||
163022059|NCT01940887|588783668|FG001|Year 1|Lost to Follow-up|1|||
163022060|NCT01940887|588783667|FG000|Year 2|Physician Decision|8|||
163022061|NCT01940887|588783668|FG001|Year 2|Physician Decision|1|||
163022062|NCT01940887|588783667|FG000|Year 2|Death|0|||
163022063|NCT01940887|588783668|FG001|Year 2|Death|2|||
163022064|NCT01940887|588783667|FG000|Year 2|Sponsor Decision, early termination|192|||
163022065|NCT01940887|588783668|FG001|Year 2|Sponsor Decision, early termination|203|||
163022066|NCT01940887|588783667|FG000|Year 2|Adverse Event|8|||
163022067|NCT01940887|588783668|FG001|Year 2|Adverse Event|2|||
163022068|NCT01940887|588783667|FG000|Year 2|Withdrawal by Subject|8|||
163022069|NCT01940887|588783668|FG001|Year 2|Withdrawal by Subject|8|||
163022070|NCT01940887|588783667|FG000|Year 2|Lost to Follow-up|1|||
163022071|NCT01940887|588783668|FG001|Year 2|Lost to Follow-up|6|||
163022072|NCT00747474|588783669|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022073|NCT00747474|588783670|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022074|NCT00747474|588783671|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022075|NCT00747474|588783672|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022076|NCT00747474|588783673|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022077|NCT00747474|588783674|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022078|NCT00747474|588783675|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022079|NCT00747474|588783676|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
163022080|NCT00747474|588783677|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022081|NCT00747474|588783678|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022082|NCT00747474|588783679|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022083|NCT00747474|588783680|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
163022084|NCT00330343|588783682|FG000|Overall Study|Lost to Follow-up|5|||
163022085|NCT00256854|588783683|FG000|Overall Study|Withdrawal by Subject|2|||
163022086|NCT00256854|588783684|FG001|Overall Study|Withdrawal by Subject|3|||
163022087|NCT00256854|588783685|FG002|Overall Study|Withdrawal by Subject|0|||
163022088|NCT00256854|588783686|FG003|Overall Study|Withdrawal by Subject|0|||
163022089|NCT00256854|588783687|FG004|Overall Study|Withdrawal by Subject|0|||
163022090|NCT00256854|588783688|FG005|Overall Study|Withdrawal by Subject|0|||
163022091|NCT00256854|588783683|FG000|Overall Study|Lack of Efficacy|1|||
163022092|NCT00256854|588783684|FG001|Overall Study|Lack of Efficacy|0|||
163022093|NCT00256854|588783685|FG002|Overall Study|Lack of Efficacy|0|||
163022094|NCT00256854|588783686|FG003|Overall Study|Lack of Efficacy|0|||
163022095|NCT00256854|588783687|FG004|Overall Study|Lack of Efficacy|0|||
163022096|NCT00256854|588783688|FG005|Overall Study|Lack of Efficacy|0|||
163022097|NCT00256854|588783683|FG000|Overall Study|Protocol Violation|0|||
163022098|NCT00256854|588783684|FG001|Overall Study|Protocol Violation|1|||
163022099|NCT00256854|588783685|FG002|Overall Study|Protocol Violation|1|||
163022100|NCT00256854|588783686|FG003|Overall Study|Protocol Violation|1|||
163022101|NCT00256854|588783687|FG004|Overall Study|Protocol Violation|0|||
163022102|NCT00256854|588783688|FG005|Overall Study|Protocol Violation|0|||
163022103|NCT00256854|588783683|FG000|Overall Study|Adverse Event|0|||
163022104|NCT00256854|588783684|FG001|Overall Study|Adverse Event|0|||
163022105|NCT00256854|588783685|FG002|Overall Study|Adverse Event|2|||
163022106|NCT00256854|588783686|FG003|Overall Study|Adverse Event|2|||
163022107|NCT00256854|588783687|FG004|Overall Study|Adverse Event|0|||
163022108|NCT00256854|588783688|FG005|Overall Study|Adverse Event|1|||
163022109|NCT00256854|588783683|FG000|Overall Study|Not compliant with the study drug|0|||
163022110|NCT00256854|588783684|FG001|Overall Study|Not compliant with the study drug|0|||
163022111|NCT00256854|588783685|FG002|Overall Study|Not compliant with the study drug|0|||
163022112|NCT00256854|588783686|FG003|Overall Study|Not compliant with the study drug|0|||
163022113|NCT00256854|588783687|FG004|Overall Study|Not compliant with the study drug|1|||
163022114|NCT00256854|588783688|FG005|Overall Study|Not compliant with the study drug|0|||
163022115|NCT03047720|588783692|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
163022116|NCT03047720|588783693|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
163022117|NCT04603482|588783704|FG000|Overall Study|Lost to Follow-up|15|||
163022118|NCT04603482|588783705|FG001|Overall Study|Lost to Follow-up|15|||
163022119|NCT04603482|588783706|FG002|Overall Study|Lost to Follow-up|15|||
163022120|NCT00179673|588783707|FG000|Overall Study|Adverse Event|7|||
163022121|NCT00179673|588783707|FG000|Overall Study|Lack of Efficacy|15|||
163022122|NCT00179673|588783707|FG000|Overall Study|Withdrawal by Subject|3|||
163022123|NCT00179673|588783707|FG000|Overall Study|Death|4|||
163022124|NCT00179673|588783707|FG000|Overall Study|Other Observations and options|14|||
163022125|NCT00582608|588783724|FG000|Overall Study|Not Treated|7|||
163022126|NCT00582608|588783724|FG000|Overall Study|Patient Ineligible|1|||
163022127|NCT00582608|588783724|FG000|Overall Study|Lack of accrual|4|||
163022128|NCT03482453|588783725|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022129|NCT03482453|588783726|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022130|NCT03482453|588783727|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022131|NCT03482453|588783728|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022132|NCT03482453|588783729|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163063836|NCT02328014|588941487|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
163063837|NCT02328014|588941488|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
163022133|NCT03482453|588783730|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022134|NCT03482453|588783731|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022135|NCT03482453|588783732|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022136|NCT03482453|588783733|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022137|NCT03482453|588783734|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022138|NCT03482453|588783735|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
163022139|NCT03482453|588783736|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
163022140|NCT03478644|588783737|FG000|Phase 2|Withdrawal by Subject|2|||
163022141|NCT03478644|588783738|FG001|Phase 2|Withdrawal by Subject|1|||
163022142|NCT03478644|588783737|FG000|Phase 2|Lost to Follow-up|1|||
163022143|NCT03478644|588783738|FG001|Phase 2|Lost to Follow-up|0|||
163022144|NCT01870973|588783739|FG000|Overall Study|Lost to Follow-up|10|||
163022145|NCT01870973|588783740|FG001|Overall Study|Lost to Follow-up|3|||
163022146|NCT02504827|588783743|FG000|Overall Study|Could not produce sputum|1|||
163022147|NCT00686829|588783744|FG000|Overall Study|Adverse Event|5|||
163022148|NCT00686829|588783744|FG000|Overall Study|Lack of Efficacy|6|||
163022149|NCT00686829|588783744|FG000|Overall Study|Lost to Follow-up|4|||
163022150|NCT00686829|588783744|FG000|Overall Study|Withdrawal by Subject|14|||
163022151|NCT00686829|588783744|FG000|Overall Study|Protocol Violation|3|||
163022152|NCT00686829|588783744|FG000|Overall Study|Sponsor discontinued VCV|47|||
163022153|NCT00712543|588783745|FG000|Day 8-14|Lost to Follow-up|0|||
163022154|NCT00712543|588783746|FG001|Day 8-14|Lost to Follow-up|2|||
163022155|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
163022156|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
163022157|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
163022158|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
163022159|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
163022160|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
163022161|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
163022162|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
163022163|NCT04740827|588783747|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
163022164|NCT04740827|588783748|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
163022165|NCT04740827|588783747|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
163022166|NCT04740827|588783748|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
163022167|NCT00940823|588783749|FG000|Overall Study|Death|8|||
163022168|NCT00940823|588783750|FG001|Overall Study|Death|12|||
163022169|NCT00940823|588783749|FG000|Overall Study|Lost to Follow-up|27|||
163022170|NCT00940823|588783750|FG001|Overall Study|Lost to Follow-up|20|||
163022171|NCT00784550|588786256|FG000|Overall Study|Adverse Event|12|||
163022172|NCT00784550|588786257|FG001|Overall Study|Adverse Event|10|||
163022173|NCT00784550|588786256|FG000|Overall Study|Lack of Efficacy|0|||
163022174|NCT00784550|588786257|FG001|Overall Study|Lack of Efficacy|1|||
163022175|NCT00784550|588786256|FG000|Overall Study|Protocol Violation|10|||
163022176|NCT00784550|588786257|FG001|Overall Study|Protocol Violation|10|||
163022177|NCT00784550|588786256|FG000|Overall Study|Lost to Follow-up|8|||
163022178|NCT00784550|588786257|FG001|Overall Study|Lost to Follow-up|5|||
163022179|NCT00784550|588786256|FG000|Overall Study|Physician Decision|2|||
163022180|NCT00784550|588786257|FG001|Overall Study|Physician Decision|3|||
163022181|NCT00784550|588786256|FG000|Overall Study|Withdrawal by Subject|4|||
163022182|NCT00784550|588786257|FG001|Overall Study|Withdrawal by Subject|13|||
163022183|NCT00477750|588786259|FG000|Overall Study|Currently Receiving Treatment|11|||
163022184|NCT03558152|588786260|FG000|Overall Study|Adverse Event|0|||
163022185|NCT03558152|588786261|FG001|Overall Study|Adverse Event|0|||
163022186|NCT03558152|588786262|FG002|Overall Study|Adverse Event|1|||
163022187|NCT03558152|588786263|FG003|Overall Study|Adverse Event|1|||
163022188|NCT03558152|588786264|FG004|Overall Study|Adverse Event|2|||
163022189|NCT03558152|588786265|FG005|Overall Study|Adverse Event|1|||
163022190|NCT03558152|588786266|FG006|Overall Study|Adverse Event|1|||
163022191|NCT03558152|588786267|FG007|Overall Study|Adverse Event|0|||
163022192|NCT03558152|588786260|FG000|Overall Study|Death|0|||
163022193|NCT03558152|588786261|FG001|Overall Study|Death|0|||
163022194|NCT03558152|588786262|FG002|Overall Study|Death|0|||
163022195|NCT03558152|588786263|FG003|Overall Study|Death|0|||
163022196|NCT03558152|588786264|FG004|Overall Study|Death|1|||
163022197|NCT03558152|588786265|FG005|Overall Study|Death|0|||
163022198|NCT03558152|588786266|FG006|Overall Study|Death|0|||
163022199|NCT03558152|588786267|FG007|Overall Study|Death|0|||
163022200|NCT03558152|588786260|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
163022201|NCT03558152|588786261|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022202|NCT03558152|588786262|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022203|NCT03558152|588786263|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022204|NCT03558152|588786264|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022205|NCT03558152|588786265|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022206|NCT03558152|588786266|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022207|NCT03558152|588786267|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
163022208|NCT03558152|588786260|FG000|Overall Study|Miscalculation in mmcs|0|||
163022209|NCT03558152|588786261|FG001|Overall Study|Miscalculation in mmcs|0|||
163022210|NCT03558152|588786262|FG002|Overall Study|Miscalculation in mmcs|0|||
163022211|NCT03558152|588786263|FG003|Overall Study|Miscalculation in mmcs|0|||
163022212|NCT03558152|588786264|FG004|Overall Study|Miscalculation in mmcs|0|||
163022213|NCT03558152|588786265|FG005|Overall Study|Miscalculation in mmcs|0|||
163022214|NCT03558152|588786266|FG006|Overall Study|Miscalculation in mmcs|1|||
163022215|NCT03558152|588786267|FG007|Overall Study|Miscalculation in mmcs|0|||
163022216|NCT03558152|588786260|FG000|Overall Study|Mistake in calculation|0|||
163022217|NCT03558152|588786261|FG001|Overall Study|Mistake in calculation|0|||
163022218|NCT03558152|588786262|FG002|Overall Study|Mistake in calculation|0|||
163022219|NCT03558152|588786263|FG003|Overall Study|Mistake in calculation|1|||
163022220|NCT03558152|588786264|FG004|Overall Study|Mistake in calculation|0|||
163022221|NCT03558152|588786265|FG005|Overall Study|Mistake in calculation|0|||
163022222|NCT03558152|588786266|FG006|Overall Study|Mistake in calculation|0|||
163022223|NCT03558152|588786267|FG007|Overall Study|Mistake in calculation|0|||
163022224|NCT03558152|588786260|FG000|Overall Study|Mistake in evaluation of disease status|0|||
163022225|NCT03558152|588786261|FG001|Overall Study|Mistake in evaluation of disease status|0|||
163022226|NCT03558152|588786262|FG002|Overall Study|Mistake in evaluation of disease status|0|||
163022227|NCT03558152|588786263|FG003|Overall Study|Mistake in evaluation of disease status|0|||
163022228|NCT03558152|588786264|FG004|Overall Study|Mistake in evaluation of disease status|0|||
163022229|NCT03558152|588786265|FG005|Overall Study|Mistake in evaluation of disease status|0|||
163022230|NCT03558152|588786266|FG006|Overall Study|Mistake in evaluation of disease status|0|||
163022231|NCT03558152|588786267|FG007|Overall Study|Mistake in evaluation of disease status|1|||
163022232|NCT03558152|588786260|FG000|Overall Study|Physician Decision|0|||
163022233|NCT03558152|588786261|FG001|Overall Study|Physician Decision|0|||
163022234|NCT03558152|588786262|FG002|Overall Study|Physician Decision|0|||
163022235|NCT03558152|588786263|FG003|Overall Study|Physician Decision|0|||
163022236|NCT03558152|588786264|FG004|Overall Study|Physician Decision|0|||
163022237|NCT03558152|588786265|FG005|Overall Study|Physician Decision|0|||
163022238|NCT03558152|588786266|FG006|Overall Study|Physician Decision|1|||
163022239|NCT03558152|588786267|FG007|Overall Study|Physician Decision|0|||
163022240|NCT03558152|588786260|FG000|Overall Study|Withdrawal by Subject|2|||
163022241|NCT03558152|588786261|FG001|Overall Study|Withdrawal by Subject|3|||
163022242|NCT03558152|588786262|FG002|Overall Study|Withdrawal by Subject|2|||
163022243|NCT03558152|588786263|FG003|Overall Study|Withdrawal by Subject|1|||
163022244|NCT03558152|588786264|FG004|Overall Study|Withdrawal by Subject|1|||
163022245|NCT03558152|588786265|FG005|Overall Study|Withdrawal by Subject|1|||
163022246|NCT03558152|588786266|FG006|Overall Study|Withdrawal by Subject|3|||
163022247|NCT03558152|588786267|FG007|Overall Study|Withdrawal by Subject|2|||
163022248|NCT03558152|588786260|FG000|Overall Study|Lack of Efficacy|11|||
163022249|NCT03558152|588786261|FG001|Overall Study|Lack of Efficacy|11|||
163022250|NCT03558152|588786262|FG002|Overall Study|Lack of Efficacy|10|||
163022251|NCT03558152|588786263|FG003|Overall Study|Lack of Efficacy|11|||
163022252|NCT03558152|588786264|FG004|Overall Study|Lack of Efficacy|14|||
163022253|NCT03558152|588786265|FG005|Overall Study|Lack of Efficacy|12|||
163022254|NCT03558152|588786266|FG006|Overall Study|Lack of Efficacy|14|||
163022255|NCT03558152|588786267|FG007|Overall Study|Lack of Efficacy|13|||
163022256|NCT03558152|588786260|FG000|Overall Study|Protocol Violation|1|||
163022257|NCT03558152|588786261|FG001|Overall Study|Protocol Violation|1|||
163022258|NCT03558152|588786262|FG002|Overall Study|Protocol Violation|0|||
163022259|NCT03558152|588786263|FG003|Overall Study|Protocol Violation|1|||
163022260|NCT03558152|588786264|FG004|Overall Study|Protocol Violation|1|||
163022261|NCT03558152|588786265|FG005|Overall Study|Protocol Violation|0|||
163022262|NCT03558152|588786266|FG006|Overall Study|Protocol Violation|2|||
163022263|NCT03558152|588786267|FG007|Overall Study|Protocol Violation|0|||
163022264|NCT04166591|588786268|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163022265|NCT04166591|588786269|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163022266|NCT04166591|588786270|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022267|NCT04166591|588786271|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022268|NCT04166591|588786268|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163022269|NCT04166591|588786269|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163022270|NCT04166591|588786270|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022271|NCT04166591|588786271|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163022272|NCT03960021|588786272|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
163022273|NCT03535194|588786273|FG000|Induction Period|Adverse Event|2|||
163022274|NCT03535194|588786274|FG001|Induction Period|Adverse Event|2|||
163022275|NCT03535194|588786275|FG002|Induction Period|Adverse Event|1|||
163022276|NCT03535194|588786276|FG003|Induction Period|Adverse Event|3|||
163022277|NCT03535194|588786277|FG004|Induction Period|Adverse Event|0|||
163022278|NCT03535194|588786273|FG000|Induction Period|Death|0|||
163022279|NCT03535194|588786274|FG001|Induction Period|Death|1|||
163022280|NCT03535194|588786275|FG002|Induction Period|Death|0|||
163022281|NCT03535194|588786276|FG003|Induction Period|Death|0|||
163022282|NCT03535194|588786277|FG004|Induction Period|Death|0|||
163022283|NCT03535194|588786273|FG000|Induction Period|Lack of Efficacy|1|||
163022284|NCT03535194|588786274|FG001|Induction Period|Lack of Efficacy|3|||
163022285|NCT03535194|588786275|FG002|Induction Period|Lack of Efficacy|2|||
163022286|NCT03535194|588786276|FG003|Induction Period|Lack of Efficacy|2|||
163022287|NCT03535194|588786277|FG004|Induction Period|Lack of Efficacy|0|||
163022288|NCT03535194|588786273|FG000|Induction Period|Lost to Follow-up|3|||
163022289|NCT03535194|588786274|FG001|Induction Period|Lost to Follow-up|5|||
163022290|NCT03535194|588786275|FG002|Induction Period|Lost to Follow-up|2|||
163022291|NCT03535194|588786276|FG003|Induction Period|Lost to Follow-up|3|||
163022292|NCT03535194|588786277|FG004|Induction Period|Lost to Follow-up|0|||
163022293|NCT03535194|588786273|FG000|Induction Period|Physician Decision|1|||
163022294|NCT03535194|588786274|FG001|Induction Period|Physician Decision|1|||
163022295|NCT03535194|588786275|FG002|Induction Period|Physician Decision|0|||
163022296|NCT03535194|588786276|FG003|Induction Period|Physician Decision|0|||
163022297|NCT03535194|588786277|FG004|Induction Period|Physician Decision|0|||
163022298|NCT03535194|588786273|FG000|Induction Period|Protocol Violation|1|||
163022299|NCT03535194|588786274|FG001|Induction Period|Protocol Violation|0|||
163022300|NCT03535194|588786275|FG002|Induction Period|Protocol Violation|0|||
163022301|NCT03535194|588786276|FG003|Induction Period|Protocol Violation|1|||
163022302|NCT03535194|588786277|FG004|Induction Period|Protocol Violation|0|||
163022303|NCT03535194|588786273|FG000|Induction Period|Screen Failure|0|||
163022304|NCT03535194|588786274|FG001|Induction Period|Screen Failure|1|||
163022305|NCT03535194|588786275|FG002|Induction Period|Screen Failure|0|||
163022306|NCT03535194|588786276|FG003|Induction Period|Screen Failure|0|||
163022307|NCT03535194|588786277|FG004|Induction Period|Screen Failure|0|||
163022308|NCT03535194|588786273|FG000|Induction Period|Withdrawal by Subject|3|||
163022309|NCT03535194|588786274|FG001|Induction Period|Withdrawal by Subject|4|||
163022310|NCT03535194|588786275|FG002|Induction Period|Withdrawal by Subject|3|||
163022311|NCT03535194|588786276|FG003|Induction Period|Withdrawal by Subject|2|||
163022312|NCT03535194|588786277|FG004|Induction Period|Withdrawal by Subject|0|||
163022313|NCT03535194|588786273|FG000|Maintenance Period|Adverse Event|6|||
163022314|NCT03535194|588786274|FG001|Maintenance Period|Adverse Event|5|||
163022315|NCT03535194|588786275|FG002|Maintenance Period|Adverse Event|1|||
163022316|NCT03535194|588786276|FG003|Maintenance Period|Adverse Event|11|||
163022317|NCT03535194|588786277|FG004|Maintenance Period|Adverse Event|4|||
163022318|NCT03535194|588786273|FG000|Maintenance Period|Lack of Efficacy|3|||
163022319|NCT03535194|588786274|FG001|Maintenance Period|Lack of Efficacy|2|||
163022320|NCT03535194|588786275|FG002|Maintenance Period|Lack of Efficacy|5|||
163022321|NCT03535194|588786276|FG003|Maintenance Period|Lack of Efficacy|9|||
163022322|NCT03535194|588786277|FG004|Maintenance Period|Lack of Efficacy|0|||
163022323|NCT03535194|588786273|FG000|Maintenance Period|Lost to Follow-up|4|||
163022324|NCT03535194|588786274|FG001|Maintenance Period|Lost to Follow-up|2|||
163022325|NCT03535194|588786275|FG002|Maintenance Period|Lost to Follow-up|1|||
162716649|NCT03425643|587668529|FG000|Overall Study|Ongoing in study|276|||
162716650|NCT03425643|587668530|FG001|Overall Study|Ongoing in study|247|||
162716651|NCT04133363|587668531|FG000|Overall Study|Lost to Follow-up|2|||
162716652|NCT04133363|587668532|FG001|Overall Study|Lost to Follow-up|1|||
162716653|NCT04133363|587668533|FG002|Overall Study|Lost to Follow-up|4|||
162716654|NCT00726596|587670227|FG000|Overall Study|Adverse Event|2|||
162716655|NCT00726596|587670228|FG001|Overall Study|Adverse Event|1|||
162716656|NCT00726596|587670227|FG000|Overall Study|Withdrawal by Subject|3|||
162716657|NCT00726596|587670228|FG001|Overall Study|Withdrawal by Subject|3|||
162716658|NCT00482729|587670229|FG000|Overall Study|Adverse Event|29|||
162716659|NCT00482729|587670230|FG001|Overall Study|Adverse Event|33|||
162716660|NCT00482729|587670229|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
162716661|NCT00482729|587670230|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
162716662|NCT00482729|587670229|FG000|Overall Study|Hyperglycemia Criteria|7|||
162716663|NCT00482729|587670230|FG001|Overall Study|Hyperglycemia Criteria|5|||
162716664|NCT00482729|587670229|FG000|Overall Study|Lack of Efficacy|4|||
162716665|NCT00482729|587670230|FG001|Overall Study|Lack of Efficacy|16|||
162716666|NCT00482729|587670229|FG000|Overall Study|Lost to Follow-up|86|||
162716667|NCT00482729|587670230|FG001|Overall Study|Lost to Follow-up|66|||
162716668|NCT00482729|587670229|FG000|Overall Study|Physician Decision|10|||
162716669|NCT00482729|587670230|FG001|Overall Study|Physician Decision|7|||
162716670|NCT00482729|587670229|FG000|Overall Study|Pregnancy|4|||
162716671|NCT00482729|587670230|FG001|Overall Study|Pregnancy|2|||
162716672|NCT00482729|587670229|FG000|Overall Study|Protocol Violation|10|||
162716673|NCT00482729|587670230|FG001|Overall Study|Protocol Violation|18|||
162716674|NCT00482729|587670229|FG000|Overall Study|Withdrawal by Subject|67|||
162716675|NCT00482729|587670230|FG001|Overall Study|Withdrawal by Subject|69|||
162716676|NCT00954707|587670243|FG000|Overall Study|Death|34|||
162716677|NCT00954707|587670243|FG000|Overall Study|Withdrawal by Subject|100|||
162716678|NCT00954707|587670243|FG000|Overall Study|Lost to Follow-up|33|||
162716679|NCT00486759|587670244|FG000|Treatment|Adverse event/intercurrent illness|86|||
163022326|NCT03535194|588786276|FG003|Maintenance Period|Lost to Follow-up|5|||
163022327|NCT03535194|588786277|FG004|Maintenance Period|Lost to Follow-up|2|||
163022328|NCT03535194|588786273|FG000|Maintenance Period|Other|1|||
163022329|NCT03535194|588786274|FG001|Maintenance Period|Other|2|||
163022330|NCT03535194|588786275|FG002|Maintenance Period|Other|0|||
163022331|NCT03535194|588786276|FG003|Maintenance Period|Other|0|||
163022332|NCT03535194|588786277|FG004|Maintenance Period|Other|0|||
163022333|NCT03535194|588786273|FG000|Maintenance Period|Physician Decision|1|||
163022334|NCT03535194|588786274|FG001|Maintenance Period|Physician Decision|2|||
163022335|NCT03535194|588786275|FG002|Maintenance Period|Physician Decision|0|||
163022336|NCT03535194|588786276|FG003|Maintenance Period|Physician Decision|2|||
163022337|NCT03535194|588786277|FG004|Maintenance Period|Physician Decision|0|||
163022338|NCT03535194|588786273|FG000|Maintenance Period|Pregnancy|0|||
163022339|NCT03535194|588786274|FG001|Maintenance Period|Pregnancy|0|||
163022340|NCT03535194|588786275|FG002|Maintenance Period|Pregnancy|0|||
162716680|NCT00486759|587670245|FG001|Treatment|Adverse event/intercurrent illness|39|||
162716681|NCT00486759|587670244|FG000|Treatment|Insufficient therapeutic response|37|||
162716682|NCT00486759|587670245|FG001|Treatment|Insufficient therapeutic response|39|||
162716683|NCT00486759|587670244|FG000|Treatment|Death|17|||
162716684|NCT00486759|587670245|FG001|Treatment|Death|10|||
162716685|NCT00486759|587670244|FG000|Treatment|Withdrew consent|15|||
162716686|NCT00486759|587670245|FG001|Treatment|Withdrew consent|12|||
162716687|NCT00486759|587670244|FG000|Treatment|Administrative/reason not specified|17|||
162716688|NCT00486759|587670245|FG001|Treatment|Administrative/reason not specified|21|||
162716689|NCT00486759|587670244|FG000|Treatment|Refused treatment|10|||
162716690|NCT00486759|587670245|FG001|Treatment|Refused treatment|7|||
162716691|NCT00486759|587670244|FG000|Treatment|Violation of selection criteria at entry|3|||
162716692|NCT00486759|587670245|FG001|Treatment|Violation of selection criteria at entry|3|||
162716693|NCT00486759|587670244|FG000|Treatment|Other protocol violation|1|||
162716694|NCT00486759|587670245|FG001|Treatment|Other protocol violation|5|||
162716695|NCT00486759|587670244|FG000|Treatment|Failure to return|1|||
162716696|NCT00486759|587670245|FG001|Treatment|Failure to return|1|||
162716697|NCT00486759|587670244|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
162716698|NCT00486759|587670245|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
162716699|NCT00486759|587670244|FG000|Safety Follow-up|Death|40|||
162716700|NCT00486759|587670245|FG001|Safety Follow-up|Death|29|||
162716701|NCT00486759|587670244|FG000|Safety Follow-up|Withdrew consent|32|||
162716702|NCT00486759|587670245|FG001|Safety Follow-up|Withdrew consent|23|||
163063838|NCT02328014|588941489|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
163063839|NCT02328014|588941486|FG000|Overall Study|Withdrawal by Subject|0|||
163063840|NCT02328014|588941487|FG001|Overall Study|Withdrawal by Subject|0|||
163063841|NCT02328014|588941488|FG002|Overall Study|Withdrawal by Subject|0|||
163063842|NCT02328014|588941489|FG003|Overall Study|Withdrawal by Subject|1|||
163063843|NCT05028569|588941506|FG000|Double-Blind Phase|Death|0|||
163063844|NCT05028569|588941507|FG001|Double-Blind Phase|Death|0|||
163063845|NCT05028569|588941508|FG002|Double-Blind Phase|Death|0|||
163063846|NCT05028569|588941509|FG003|Double-Blind Phase|Death|1|||
163063847|NCT05028569|588941510|FG004|Double-Blind Phase|Death|0|||
163063848|NCT05028569|588941511|FG005|Double-Blind Phase|Death|0|||
163063849|NCT05028569|588941512|FG006|Double-Blind Phase|Death|0|||
163063850|NCT05028569|588941506|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163063851|NCT05028569|588941507|FG001|Double-Blind Phase|Lost to Follow-up|6|||
163063852|NCT05028569|588941508|FG002|Double-Blind Phase|Lost to Follow-up|3|||
163063853|NCT05028569|588941509|FG003|Double-Blind Phase|Lost to Follow-up|9|||
163063854|NCT05028569|588941510|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163063855|NCT05028569|588941511|FG005|Double-Blind Phase|Lost to Follow-up|0|||
163063856|NCT05028569|588941512|FG006|Double-Blind Phase|Lost to Follow-up|0|||
163063857|NCT05028569|588941506|FG000|Double-Blind Phase|Protocol Deviation|0|||
163063858|NCT05028569|588941507|FG001|Double-Blind Phase|Protocol Deviation|2|||
163063859|NCT05028569|588941508|FG002|Double-Blind Phase|Protocol Deviation|0|||
163063860|NCT05028569|588941509|FG003|Double-Blind Phase|Protocol Deviation|0|||
163063861|NCT05028569|588941510|FG004|Double-Blind Phase|Protocol Deviation|0|||
163063862|NCT05028569|588941511|FG005|Double-Blind Phase|Protocol Deviation|0|||
163063863|NCT05028569|588941512|FG006|Double-Blind Phase|Protocol Deviation|0|||
163063864|NCT05028569|588941506|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163063865|NCT05028569|588941507|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
163063866|NCT05028569|588941508|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
163063867|NCT05028569|588941509|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
163063868|NCT05028569|588941510|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163063869|NCT05028569|588941511|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
163063870|NCT05028569|588941512|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
163063871|NCT05028569|588941506|FG000|Double-Blind Phase|Other, not specified|0|||
163063872|NCT05028569|588941507|FG001|Double-Blind Phase|Other, not specified|5|||
162716703|NCT00486759|587670244|FG000|Safety Follow-up|Failure to return|9|||
162716704|NCT00486759|587670245|FG001|Safety Follow-up|Failure to return|6|||
162716705|NCT00486759|587670244|FG000|Safety Follow-up|Administrative/not specified|8|||
162716706|NCT00486759|587670245|FG001|Safety Follow-up|Administrative/not specified|6|||
163063873|NCT05028569|588941508|FG002|Double-Blind Phase|Other, not specified|4|||
163063874|NCT05028569|588941509|FG003|Double-Blind Phase|Other, not specified|6|||
163063875|NCT05028569|588941510|FG004|Double-Blind Phase|Other, not specified|0|||
163063876|NCT05028569|588941511|FG005|Double-Blind Phase|Other, not specified|0|||
163063877|NCT05028569|588941512|FG006|Double-Blind Phase|Other, not specified|0|||
162716707|NCT00486759|587670244|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
162716708|NCT00486759|587670245|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
162716709|NCT00486759|587670244|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
163063878|NCT05028569|588941506|FG000|Open-Label Phase|Death|0|||
163063879|NCT05028569|588941507|FG001|Open-Label Phase|Death|0|||
163063880|NCT05028569|588941508|FG002|Open-Label Phase|Death|0|||
163063881|NCT05028569|588941509|FG003|Open-Label Phase|Death|0|||
163063882|NCT05028569|588941510|FG004|Open-Label Phase|Death|0|||
163063883|NCT05028569|588941511|FG005|Open-Label Phase|Death|0|||
163063884|NCT05028569|588941512|FG006|Open-Label Phase|Death|1|||
162642980|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
162642981|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
162642982|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
162642983|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
162642984|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
162642985|NCT02432846|587409308|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162642986|NCT02432846|587409309|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162642987|NCT02432846|587409310|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
162642988|NCT02432846|587409311|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162642989|NCT02432846|587409312|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162642990|NCT02432846|587409313|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162642991|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
162642992|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
162642993|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
162642994|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
162642995|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
162642996|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
162642997|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162642998|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162642999|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162643000|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
163022341|NCT03535194|588786276|FG003|Maintenance Period|Pregnancy|2|||
163022342|NCT03535194|588786277|FG004|Maintenance Period|Pregnancy|0|||
163022343|NCT03535194|588786273|FG000|Maintenance Period|Protocol Violation|0|||
163022344|NCT03535194|588786274|FG001|Maintenance Period|Protocol Violation|1|||
163022345|NCT03535194|588786275|FG002|Maintenance Period|Protocol Violation|0|||
163022346|NCT03535194|588786276|FG003|Maintenance Period|Protocol Violation|0|||
163022347|NCT03535194|588786277|FG004|Maintenance Period|Protocol Violation|0|||
163022348|NCT03535194|588786273|FG000|Maintenance Period|Withdrawal by Subject|7|||
163022349|NCT03535194|588786274|FG001|Maintenance Period|Withdrawal by Subject|2|||
163022350|NCT03535194|588786275|FG002|Maintenance Period|Withdrawal by Subject|1|||
163022351|NCT03535194|588786276|FG003|Maintenance Period|Withdrawal by Subject|8|||
163022352|NCT03535194|588786277|FG004|Maintenance Period|Withdrawal by Subject|0|||
163022353|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Adverse Event|4|||
163022354|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Adverse Event|5|||
163022355|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Adverse Event|1|||
163022356|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Adverse Event|8|||
163022357|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Adverse Event|0|||
163022358|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
163022359|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
163022360|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
163022361|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
163022362|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
163022363|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022364|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022365|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
163022366|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
163022367|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
163022368|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Other|1|||
163022369|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Other|0|||
163022370|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Other|0|||
163022371|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Other|5|||
163022372|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Other|0|||
163022373|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Physician Decision|0|||
163022374|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Physician Decision|2|||
163022375|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Physician Decision|1|||
163063885|NCT05028569|588941506|FG000|Open-Label Phase|Lost to Follow-up|0|||
163063886|NCT05028569|588941507|FG001|Open-Label Phase|Lost to Follow-up|0|||
163063887|NCT05028569|588941508|FG002|Open-Label Phase|Lost to Follow-up|0|||
163063888|NCT05028569|588941509|FG003|Open-Label Phase|Lost to Follow-up|0|||
162643001|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
162643002|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
162643003|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162643004|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162643005|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162643006|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162643007|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
162643008|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162643009|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162643010|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162643011|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162643012|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162643013|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
162643014|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
162643015|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162643016|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162643017|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162643018|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162643019|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
162643020|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
162643021|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162643022|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162643023|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162643024|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162643025|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
162643026|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
162643027|NCT02432846|587409308|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162643028|NCT02432846|587409309|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162643029|NCT02432846|587409310|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162643030|NCT02432846|587409311|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162643031|NCT02432846|587409312|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
162643032|NCT02432846|587409313|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162643033|NCT00413192|587409314|FG000|Overall Study|Disease progression|26|||
162643034|NCT00413192|587409315|FG001|Overall Study|Disease progression|31|||
162643035|NCT00413192|587409316|FG002|Overall Study|Disease progression|16|||
162643036|NCT00413192|587409317|FG003|Overall Study|Disease progression|25|||
162643037|NCT00413192|587409314|FG000|Overall Study|Toxicity|3|||
162643038|NCT00413192|587409315|FG001|Overall Study|Toxicity|2|||
162643039|NCT00413192|587409316|FG002|Overall Study|Toxicity|2|||
162643040|NCT00413192|587409317|FG003|Overall Study|Toxicity|2|||
162643041|NCT00413192|587409314|FG000|Overall Study|Withdrawal by Subject|3|||
162643042|NCT00413192|587409315|FG001|Overall Study|Withdrawal by Subject|5|||
162643043|NCT00413192|587409316|FG002|Overall Study|Withdrawal by Subject|0|||
162643044|NCT00413192|587409317|FG003|Overall Study|Withdrawal by Subject|1|||
162643045|NCT00413192|587409314|FG000|Overall Study|Intercurrent illness|0|||
162643046|NCT00413192|587409315|FG001|Overall Study|Intercurrent illness|0|||
162643047|NCT00413192|587409316|FG002|Overall Study|Intercurrent illness|0|||
162643048|NCT00413192|587409317|FG003|Overall Study|Intercurrent illness|1|||
162643049|NCT00413192|587409314|FG000|Overall Study|Intercurrent death|0|||
162643050|NCT00413192|587409315|FG001|Overall Study|Intercurrent death|1|||
162643051|NCT00413192|587409316|FG002|Overall Study|Intercurrent death|0|||
162643052|NCT00413192|587409317|FG003|Overall Study|Intercurrent death|0|||
162643053|NCT00413192|587409314|FG000|Overall Study|Other|5|||
162643054|NCT00413192|587409315|FG001|Overall Study|Other|1|||
162643055|NCT00413192|587409316|FG002|Overall Study|Other|1|||
162643056|NCT00413192|587409317|FG003|Overall Study|Other|2|||
162643057|NCT00413192|587409314|FG000|Overall Study|Not treated|0|||
162643058|NCT00413192|587409315|FG001|Overall Study|Not treated|0|||
162643059|NCT00413192|587409316|FG002|Overall Study|Not treated|0|||
162643060|NCT00413192|587409317|FG003|Overall Study|Not treated|1|||
162643061|NCT01998633|587409318|FG000|Overall Study|Death|1|||
162643062|NCT03992781|587409319|FG000|Overall Study|Lost to Follow-up|5|||
162643063|NCT03992781|587409319|FG000|Overall Study|Adverse Event|1|||
162643064|NCT03992781|587409319|FG000|Overall Study|Lack of Efficacy|5|||
162643065|NCT01996826|587409320|FG000|Overall Study|Lost to Follow-up|6|||
162716710|NCT00486759|587670245|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
162716711|NCT00377455|587670246|FG000|Overall Study|Withdrawal by Subject|1|||
162716712|NCT03265210|587670249|FG000|Overall Study|Withdrawal by Subject|7|||
162716713|NCT03265210|587670250|FG001|Overall Study|Withdrawal by Subject|9|||
162716714|NCT03265210|587670249|FG000|Overall Study|Lost to Follow-up|2|||
162716715|NCT03265210|587670250|FG001|Overall Study|Lost to Follow-up|0|||
162716716|NCT03265210|587670249|FG000|Overall Study|Physician Decision|2|||
162716717|NCT03265210|587670250|FG001|Overall Study|Physician Decision|0|||
162716718|NCT03265210|587670249|FG000|Overall Study|Adverse Event|1|||
162716719|NCT03265210|587670250|FG001|Overall Study|Adverse Event|0|||
162716720|NCT01883492|587670251|FG000|Overall Study|Lost to Follow-up|3|||
162716721|NCT01883492|587670252|FG001|Overall Study|Lost to Follow-up|4|||
162716722|NCT01883492|587670251|FG000|Overall Study|Surgery on contra-lateral hip|0|||
162716723|NCT01883492|587670252|FG001|Overall Study|Surgery on contra-lateral hip|1|||
162716724|NCT01883492|587670251|FG000|Overall Study|Poor X-ray quality|7|||
162716725|NCT01883492|587670252|FG001|Overall Study|Poor X-ray quality|4|||
162716726|NCT01883492|587670251|FG000|Overall Study|Withdrawal by Subject|1|||
162716727|NCT01883492|587670252|FG001|Overall Study|Withdrawal by Subject|0|||
162716728|NCT01883492|587670251|FG000|Overall Study|inappropriate implant used|1|||
162716729|NCT01883492|587670252|FG001|Overall Study|inappropriate implant used|1|||
162716730|NCT01883492|587670251|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
162716731|NCT01883492|587670252|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
162716732|NCT02488980|587670258|FG000|Overall Study|Protocol Violation|2|||
162716733|NCT02488980|587670259|FG001|Overall Study|Protocol Violation|2|||
162716734|NCT02488980|587670260|FG002|Overall Study|Protocol Violation|2|||
162716735|NCT02614560|587670264|FG000|Overall Study|Death|6|||
163063889|NCT05028569|588941510|FG004|Open-Label Phase|Lost to Follow-up|5|||
163063890|NCT05028569|588941511|FG005|Open-Label Phase|Lost to Follow-up|5|||
163063891|NCT05028569|588941512|FG006|Open-Label Phase|Lost to Follow-up|4|||
163063892|NCT05028569|588941506|FG000|Open-Label Phase|Protocol Deviation|0|||
163063893|NCT05028569|588941507|FG001|Open-Label Phase|Protocol Deviation|0|||
163063894|NCT05028569|588941508|FG002|Open-Label Phase|Protocol Deviation|0|||
163063895|NCT05028569|588941509|FG003|Open-Label Phase|Protocol Deviation|0|||
163063896|NCT05028569|588941510|FG004|Open-Label Phase|Protocol Deviation|1|||
163063897|NCT05028569|588941511|FG005|Open-Label Phase|Protocol Deviation|0|||
163063898|NCT05028569|588941512|FG006|Open-Label Phase|Protocol Deviation|0|||
163063899|NCT05028569|588941506|FG000|Open-Label Phase|Pregnancy|0|||
163063900|NCT05028569|588941507|FG001|Open-Label Phase|Pregnancy|0|||
163063901|NCT05028569|588941508|FG002|Open-Label Phase|Pregnancy|0|||
162716736|NCT02614560|587670265|FG001|Overall Study|Death|2|||
162716737|NCT02192606|587670266|FG000|Overall Study|surgery type was changed|1|||
162716738|NCT02192606|587670267|FG001|Overall Study|surgery type was changed|1|||
162716739|NCT02192606|587670266|FG000|Overall Study|Physician Decision|1|||
162716740|NCT02192606|587670267|FG001|Overall Study|Physician Decision|2|||
162716741|NCT02192606|587670266|FG000|Overall Study|3D equipment rep unable to join|0|||
162716742|NCT02192606|587670267|FG001|Overall Study|3D equipment rep unable to join|1|||
162716743|NCT00738699|587670268|FG000|Overall Study|Withdrawal by Subject|5|||
162716744|NCT00738699|587670269|FG001|Overall Study|Withdrawal by Subject|0|||
162716745|NCT00738699|587670268|FG000|Overall Study|Lost to Follow-up|1|||
163063902|NCT05028569|588941509|FG003|Open-Label Phase|Pregnancy|0|||
163063903|NCT05028569|588941510|FG004|Open-Label Phase|Pregnancy|0|||
163063904|NCT05028569|588941511|FG005|Open-Label Phase|Pregnancy|1|||
163063905|NCT05028569|588941512|FG006|Open-Label Phase|Pregnancy|0|||
163063906|NCT05028569|588941506|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163063907|NCT05028569|588941507|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163063908|NCT05028569|588941508|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163063909|NCT05028569|588941509|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163063910|NCT05028569|588941510|FG004|Open-Label Phase|Withdrawal by Subject|15|||
162716746|NCT00738699|587670269|FG001|Overall Study|Lost to Follow-up|0|||
162716747|NCT00738699|587670268|FG000|Overall Study|Death|144|||
163063911|NCT05028569|588941511|FG005|Open-Label Phase|Withdrawal by Subject|8|||
163063912|NCT05028569|588941512|FG006|Open-Label Phase|Withdrawal by Subject|13|||
163063913|NCT05028569|588941506|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
163063914|NCT05028569|588941507|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
163063915|NCT05028569|588941508|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
163063916|NCT05028569|588941509|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
162716748|NCT00738699|587670269|FG001|Overall Study|Death|68|||
162716749|NCT00738699|587670268|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
162716750|NCT00738699|587670269|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
162716751|NCT00738699|587670268|FG000|Overall Study|Other|2|||
162716752|NCT00738699|587670269|FG001|Overall Study|Other|0|||
162716753|NCT00549848|587670270|FG000|Overall Study|Death|1|||
162716754|NCT00549848|587670271|FG001|Overall Study|Death|4|||
162716755|NCT00549848|587670272|FG002|Overall Study|Death|13|||
162716756|NCT00549848|587670270|FG000|Overall Study|Physician Decision|0|||
162716757|NCT00549848|587670271|FG001|Overall Study|Physician Decision|0|||
162716758|NCT00549848|587670272|FG002|Overall Study|Physician Decision|4|||
162716759|NCT00549848|587670270|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
162716760|NCT00549848|587670271|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
162716761|NCT00549848|587670272|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
162716762|NCT00549848|587670270|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
162716763|NCT00549848|587670271|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
162716764|NCT00549848|587670272|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
162716765|NCT00549848|587670270|FG000|Overall Study|Participant/Family Withdraw|2|||
162716766|NCT00549848|587670271|FG001|Overall Study|Participant/Family Withdraw|3|||
162716767|NCT00549848|587670272|FG002|Overall Study|Participant/Family Withdraw|5|||
162716768|NCT00549848|587670270|FG000|Overall Study|Second Malignancy|1|||
162716769|NCT00549848|587670271|FG001|Overall Study|Second Malignancy|0|||
162716770|NCT00549848|587670272|FG002|Overall Study|Second Malignancy|0|||
162716771|NCT00549848|587670270|FG000|Overall Study|Transplant|3|||
162716772|NCT00549848|587670271|FG001|Overall Study|Transplant|3|||
162716773|NCT00549848|587670272|FG002|Overall Study|Transplant|18|||
162716774|NCT00549848|587670270|FG000|Overall Study|Unacceptable Toxicity|1|||
162716775|NCT00549848|587670271|FG001|Overall Study|Unacceptable Toxicity|6|||
162716776|NCT00549848|587670272|FG002|Overall Study|Unacceptable Toxicity|6|||
162716777|NCT05193318|587670273|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
162716778|NCT05193318|587670273|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
162716779|NCT03670602|587670274|FG000|Overall Study|Lost to Follow-up|1|||
162716780|NCT03670602|587670275|FG001|Overall Study|Lost to Follow-up|0|||
162716781|NCT03670602|587670274|FG000|Overall Study|Withdrawal by Subject|0|||
162716782|NCT03670602|587670275|FG001|Overall Study|Withdrawal by Subject|3|||
162716783|NCT03201809|587670276|FG000|Overall Study|Lost to Follow-up|2|||
162716784|NCT03201809|587670277|FG001|Overall Study|Lost to Follow-up|0|||
162716785|NCT00957658|587670278|FG000|Overall Study|Death|1|||
162716786|NCT00957658|587670278|FG000|Overall Study|Lost to Follow-up|4|||
162716787|NCT00957658|587670278|FG000|Overall Study|Withdrawal by Subject|12|||
162716788|NCT00957658|587670278|FG000|Overall Study|Revision|1|||
162716789|NCT00957658|587670278|FG000|Overall Study|Incomplete 2 yr data|28|||
162716790|NCT00957658|587670278|FG000|Overall Study|Site termination|10|||
162716791|NCT00957658|587670278|FG000|Overall Study|unwilling/unable to return|2|||
162716792|NCT00957658|587670278|FG000|Overall Study|surgery cancelled|2|||
162716793|NCT00957658|587670278|FG000|Overall Study|Protocol Violation|5|||
162716794|NCT03383887|587670279|FG000|Overall Study|Lost to Follow-up|0|||
162716795|NCT03383887|587670280|FG001|Overall Study|Lost to Follow-up|1|||
162716796|NCT00975806|587670287|FG000|Overall Study|Adverse Event|2|||
162716797|NCT00975806|587670288|FG001|Overall Study|Adverse Event|1|||
162716798|NCT00975806|587670289|FG002|Overall Study|Adverse Event|2|||
162716799|NCT00975806|587670287|FG000|Overall Study|Disease Progression|1|||
162716800|NCT00975806|587670288|FG001|Overall Study|Disease Progression|5|||
162716801|NCT00975806|587670289|FG002|Overall Study|Disease Progression|1|||
162716802|NCT00975806|587670287|FG000|Overall Study|Withdrawal by Subject|1|||
162716803|NCT00975806|587670288|FG001|Overall Study|Withdrawal by Subject|0|||
162716804|NCT00975806|587670289|FG002|Overall Study|Withdrawal by Subject|0|||
162716805|NCT00975806|587670287|FG000|Overall Study|Death|0|||
162716806|NCT00975806|587670288|FG001|Overall Study|Death|1|||
162716807|NCT00975806|587670289|FG002|Overall Study|Death|0|||
162716808|NCT00975806|587670287|FG000|Overall Study|Physician decision and disease related|1|||
162716809|NCT00975806|587670288|FG001|Overall Study|Physician decision and disease related|0|||
162716810|NCT00975806|587670289|FG002|Overall Study|Physician decision and disease related|1|||
162716811|NCT00246012|587670290|FG000|Overall Study|Adverse Event|0|||
162716812|NCT00246012|587670291|FG001|Overall Study|Adverse Event|0|||
162716813|NCT00246012|587670292|FG002|Overall Study|Adverse Event|0|||
162716814|NCT00246012|587670293|FG003|Overall Study|Adverse Event|0|||
162716815|NCT00246012|587670294|FG004|Overall Study|Adverse Event|0|||
162716816|NCT00246012|587670295|FG005|Overall Study|Adverse Event|1|||
162716817|NCT00246012|587670296|FG006|Overall Study|Adverse Event|0|||
163063917|NCT05028569|588941510|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
163063918|NCT05028569|588941511|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
162716818|NCT00246012|587670297|FG007|Overall Study|Adverse Event|0|||
162716819|NCT00246012|587670298|FG008|Overall Study|Adverse Event|2|||
162716820|NCT00246012|587670290|FG000|Overall Study|Withdrawal by Subject|0|||
162716821|NCT00246012|587670291|FG001|Overall Study|Withdrawal by Subject|0|||
162716822|NCT00246012|587670292|FG002|Overall Study|Withdrawal by Subject|0|||
162716823|NCT00246012|587670293|FG003|Overall Study|Withdrawal by Subject|0|||
162716824|NCT00246012|587670294|FG004|Overall Study|Withdrawal by Subject|0|||
162716825|NCT00246012|587670295|FG005|Overall Study|Withdrawal by Subject|1|||
162716826|NCT00246012|587670296|FG006|Overall Study|Withdrawal by Subject|0|||
162716827|NCT00246012|587670297|FG007|Overall Study|Withdrawal by Subject|0|||
162716828|NCT00246012|587670298|FG008|Overall Study|Withdrawal by Subject|0|||
162716829|NCT00246012|587670290|FG000|Overall Study|Disease progression|3|||
162716830|NCT00246012|587670291|FG001|Overall Study|Disease progression|1|||
162716831|NCT00246012|587670292|FG002|Overall Study|Disease progression|2|||
163063919|NCT05028569|588941512|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
163063920|NCT05028569|588941506|FG000|Open-Label Phase|Other, not specified|0|||
163063921|NCT05028569|588941507|FG001|Open-Label Phase|Other, not specified|0|||
163063922|NCT05028569|588941508|FG002|Open-Label Phase|Other, not specified|0|||
163063923|NCT05028569|588941509|FG003|Open-Label Phase|Other, not specified|0|||
163063924|NCT05028569|588941510|FG004|Open-Label Phase|Other, not specified|6|||
163063925|NCT05028569|588941511|FG005|Open-Label Phase|Other, not specified|5|||
163063926|NCT05028569|588941512|FG006|Open-Label Phase|Other, not specified|7|||
162643066|NCT01996826|587409321|FG001|Overall Study|Lost to Follow-up|2|||
162643067|NCT01996826|587409320|FG000|Overall Study|Physician Decision|1|||
162643068|NCT01996826|587409321|FG001|Overall Study|Physician Decision|1|||
162643069|NCT00695396|587409322|FG000|Overall Study|Study Closed Prematurely|5|||
162643070|NCT00695396|587409323|FG001|Overall Study|Study Closed Prematurely|6|||
162643071|NCT00695396|587409324|FG002|Overall Study|Study Closed Prematurely|8|||
162643072|NCT00695396|587409322|FG000|Overall Study|Withdrawal by Subject|2|||
162643073|NCT00695396|587409323|FG001|Overall Study|Withdrawal by Subject|2|||
162643074|NCT00695396|587409324|FG002|Overall Study|Withdrawal by Subject|0|||
162643075|NCT00518323|587409326|FG000|Overall Study|Lack of Efficacy|14|||
162643076|NCT00518323|587409327|FG001|Overall Study|Lack of Efficacy|2|||
162643077|NCT00518323|587409328|FG002|Overall Study|Lack of Efficacy|4|||
162643078|NCT00518323|587409329|FG003|Overall Study|Lack of Efficacy|20|||
162643079|NCT00518323|587409326|FG000|Overall Study|Withdrawal by Subject|1|||
162643080|NCT00518323|587409327|FG001|Overall Study|Withdrawal by Subject|2|||
162643081|NCT00518323|587409328|FG002|Overall Study|Withdrawal by Subject|4|||
162643082|NCT00518323|587409329|FG003|Overall Study|Withdrawal by Subject|2|||
162643083|NCT00518323|587409326|FG000|Overall Study|Lost to Follow-up|0|||
162643084|NCT00518323|587409327|FG001|Overall Study|Lost to Follow-up|2|||
162643085|NCT00518323|587409328|FG002|Overall Study|Lost to Follow-up|1|||
162643086|NCT00518323|587409329|FG003|Overall Study|Lost to Follow-up|3|||
162643087|NCT00518323|587409326|FG000|Overall Study|Adverse Event|1|||
162643088|NCT00518323|587409327|FG001|Overall Study|Adverse Event|1|||
162643089|NCT00518323|587409328|FG002|Overall Study|Adverse Event|1|||
162643090|NCT00518323|587409329|FG003|Overall Study|Adverse Event|0|||
162643091|NCT00518323|587409326|FG000|Overall Study|Prohibited medication and others|3|||
162643092|NCT00518323|587409327|FG001|Overall Study|Prohibited medication and others|1|||
162643093|NCT00518323|587409328|FG002|Overall Study|Prohibited medication and others|1|||
162643094|NCT00518323|587409329|FG003|Overall Study|Prohibited medication and others|0|||
162643095|NCT03164928|587409330|FG000|Overall Study|Lost to Follow-up|1|||
162643096|NCT03164928|587409331|FG001|Overall Study|Lost to Follow-up|0|||
162643097|NCT00326950|587409336|FG000|Overall Study|Progressive Disease|1|||
162643098|NCT01514760|587409337|FG000|Overall Study|Lost to Follow-up|2|||
162643099|NCT01275833|587409338|FG000|Overall Study|Study terminated|1|||
162643100|NCT01275833|587409339|FG001|Overall Study|Study terminated|1|||
162643101|NCT02118012|587409341|FG000|Overall Study|Adverse Event|0|||
162643102|NCT02118012|587409342|FG001|Overall Study|Adverse Event|1|||
162643103|NCT02118012|587409341|FG000|Overall Study|Physician Decision|0|||
162643104|NCT02118012|587409342|FG001|Overall Study|Physician Decision|1|||
162643105|NCT00536107|587409343|FG000|Overall Study|Death|5|||
162643106|NCT00536107|587409344|FG001|Overall Study|Death|1|||
162643107|NCT00536107|587409343|FG000|Overall Study|Incorrect enrolment|1|||
162643108|NCT00536107|587409344|FG001|Overall Study|Incorrect enrolment|0|||
162643109|NCT00536107|587409343|FG000|Overall Study|Withdrawal by Subject|0|||
162643110|NCT00536107|587409344|FG001|Overall Study|Withdrawal by Subject|1|||
162643111|NCT00536107|587409343|FG000|Overall Study|Study Termination|2|||
162643112|NCT00536107|587409344|FG001|Overall Study|Study Termination|4|||
162643113|NCT03329690|587409345|FG000|Overall Study|Progressive disease per RECIST|85|||
162643114|NCT03329690|587409346|FG001|Overall Study|Progressive disease per RECIST|44|||
162643115|NCT03329690|587409347|FG002|Overall Study|Progressive disease per RECIST|6|||
162643116|NCT03329690|587409348|FG003|Overall Study|Progressive disease per RECIST|16|||
162643117|NCT03329690|587409349|FG004|Overall Study|Progressive disease per RECIST|20|||
162643118|NCT03329690|587409345|FG000|Overall Study|Clinical progression|7|||
162643119|NCT03329690|587409346|FG001|Overall Study|Clinical progression|4|||
162643120|NCT03329690|587409347|FG002|Overall Study|Clinical progression|1|||
162643121|NCT03329690|587409348|FG003|Overall Study|Clinical progression|1|||
162643122|NCT03329690|587409349|FG004|Overall Study|Clinical progression|1|||
162643123|NCT03329690|587409345|FG000|Overall Study|Adverse Event|22|||
162643124|NCT03329690|587409346|FG001|Overall Study|Adverse Event|4|||
162643125|NCT03329690|587409347|FG002|Overall Study|Adverse Event|0|||
162643126|NCT03329690|587409348|FG003|Overall Study|Adverse Event|1|||
162643127|NCT03329690|587409349|FG004|Overall Study|Adverse Event|2|||
162643128|NCT03329690|587409345|FG000|Overall Study|Death|2|||
162643129|NCT03329690|587409346|FG001|Overall Study|Death|0|||
162643130|NCT03329690|587409347|FG002|Overall Study|Death|0|||
162643131|NCT03329690|587409348|FG003|Overall Study|Death|1|||
162643132|NCT03329690|587409349|FG004|Overall Study|Death|0|||
162643133|NCT03329690|587409345|FG000|Overall Study|Withdrawal by Subject|2|||
162643134|NCT03329690|587409346|FG001|Overall Study|Withdrawal by Subject|3|||
162716832|NCT00246012|587670293|FG003|Overall Study|Disease progression|3|||
162716833|NCT00246012|587670294|FG004|Overall Study|Disease progression|3|||
162716834|NCT00246012|587670295|FG005|Overall Study|Disease progression|25|||
162716835|NCT00246012|587670296|FG006|Overall Study|Disease progression|30|||
162716836|NCT00246012|587670297|FG007|Overall Study|Disease progression|27|||
162716837|NCT00246012|587670298|FG008|Overall Study|Disease progression|26|||
162716838|NCT00246012|587670290|FG000|Overall Study|Other|0|||
162716839|NCT00246012|587670291|FG001|Overall Study|Other|0|||
162716840|NCT00246012|587670292|FG002|Overall Study|Other|0|||
162716841|NCT00246012|587670293|FG003|Overall Study|Other|0|||
162716842|NCT00246012|587670294|FG004|Overall Study|Other|0|||
162716843|NCT00246012|587670295|FG005|Overall Study|Other|0|||
162716844|NCT00246012|587670296|FG006|Overall Study|Other|0|||
162716845|NCT00246012|587670297|FG007|Overall Study|Other|1|||
162716846|NCT00246012|587670298|FG008|Overall Study|Other|0|||
162716847|NCT00246012|587670290|FG000|Overall Study|Randomly assigned but not treated|0|||
162716848|NCT00246012|587670291|FG001|Overall Study|Randomly assigned but not treated|0|||
162716849|NCT00246012|587670292|FG002|Overall Study|Randomly assigned but not treated|0|||
162716850|NCT00246012|587670293|FG003|Overall Study|Randomly assigned but not treated|0|||
162716851|NCT00246012|587670294|FG004|Overall Study|Randomly assigned but not treated|0|||
162716852|NCT00246012|587670295|FG005|Overall Study|Randomly assigned but not treated|1|||
162716853|NCT00246012|587670296|FG006|Overall Study|Randomly assigned but not treated|1|||
162716854|NCT00246012|587670297|FG007|Overall Study|Randomly assigned but not treated|0|||
162716855|NCT00246012|587670298|FG008|Overall Study|Randomly assigned but not treated|0|||
162716856|NCT02377362|587670299|FG000|Part A Second Treatment|Protocol Violation|0|||
162716857|NCT02377362|587670300|FG001|Part A Second Treatment|Protocol Violation|0|||
162716858|NCT02377362|587670301|FG002|Part A Second Treatment|Protocol Violation|0|||
162716859|NCT02377362|587670302|FG003|Part A Second Treatment|Protocol Violation|0|||
162716860|NCT02377362|587670303|FG004|Part A Second Treatment|Protocol Violation|1|||
162716861|NCT02377362|587670304|FG005|Part A Second Treatment|Protocol Violation|0|||
162716862|NCT02377362|587670305|FG006|Part A Second Treatment|Protocol Violation|0|||
162716863|NCT02377362|587670306|FG007|Part A Second Treatment|Protocol Violation|0|||
162716864|NCT02377362|587670307|FG008|Part A Second Treatment|Protocol Violation|0|||
162716865|NCT02377362|587670308|FG009|Part A Second Treatment|Protocol Violation|0|||
162716866|NCT02377362|587670309|FG010|Part A Second Treatment|Protocol Violation|0|||
162716867|NCT02377362|587670310|FG011|Part A Second Treatment|Protocol Violation|0|||
162716868|NCT02377362|587670311|FG012|Part A Second Treatment|Protocol Violation|0|||
162716869|NCT02377362|587670299|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716870|NCT02377362|587670300|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716871|NCT02377362|587670301|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716872|NCT02377362|587670302|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
162716873|NCT02377362|587670303|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
162716874|NCT02377362|587670304|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
162716875|NCT02377362|587670305|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716876|NCT02377362|587670306|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716877|NCT02377362|587670307|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716878|NCT02377362|587670308|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716879|NCT02377362|587670309|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716880|NCT02377362|587670310|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716881|NCT02377362|587670311|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
162716882|NCT02377362|587670299|FG000|Part B Overall|Protocol Violation|0|||
162643135|NCT03329690|587409347|FG002|Overall Study|Withdrawal by Subject|0|||
162643136|NCT03329690|587409348|FG003|Overall Study|Withdrawal by Subject|1|||
162643137|NCT03329690|587409349|FG004|Overall Study|Withdrawal by Subject|0|||
162643138|NCT03329690|587409345|FG000|Overall Study|Physician Decision|1|||
162643139|NCT03329690|587409346|FG001|Overall Study|Physician Decision|0|||
162643140|NCT03329690|587409347|FG002|Overall Study|Physician Decision|0|||
162643141|NCT03329690|587409348|FG003|Overall Study|Physician Decision|0|||
162643142|NCT03329690|587409349|FG004|Overall Study|Physician Decision|1|||
162643143|NCT03329690|587409345|FG000|Overall Study|Miscellaneous|6|||
162643144|NCT03329690|587409346|FG001|Overall Study|Miscellaneous|0|||
162643145|NCT03329690|587409347|FG002|Overall Study|Miscellaneous|0|||
162643146|NCT03329690|587409348|FG003|Overall Study|Miscellaneous|0|||
162643147|NCT03329690|587409349|FG004|Overall Study|Miscellaneous|0|||
162716883|NCT02377362|587670300|FG001|Part B Overall|Protocol Violation|0|||
162716884|NCT02377362|587670301|FG002|Part B Overall|Protocol Violation|0|||
162716885|NCT02377362|587670302|FG003|Part B Overall|Protocol Violation|0|||
162716886|NCT02377362|587670303|FG004|Part B Overall|Protocol Violation|0|||
162716887|NCT02377362|587670304|FG005|Part B Overall|Protocol Violation|0|||
162716888|NCT02377362|587670305|FG006|Part B Overall|Protocol Violation|0|||
162716889|NCT02377362|587670306|FG007|Part B Overall|Protocol Violation|0|||
162643148|NCT03329690|587409345|FG000|Overall Study|Did not receive treatment|1|||
162643149|NCT03329690|587409346|FG001|Overall Study|Did not receive treatment|0|||
162643150|NCT03329690|587409347|FG002|Overall Study|Did not receive treatment|0|||
162716890|NCT02377362|587670307|FG008|Part B Overall|Protocol Violation|0|||
163063927|NCT05028569|588941506|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063928|NCT05028569|588941507|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063929|NCT05028569|588941508|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063930|NCT05028569|588941509|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063931|NCT05028569|588941510|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063932|NCT05028569|588941511|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
163063933|NCT05028569|588941512|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
163063934|NCT05028569|588941506|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063935|NCT05028569|588941507|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
162643151|NCT03329690|587409348|FG003|Overall Study|Did not receive treatment|1|||
162643152|NCT03329690|587409349|FG004|Overall Study|Did not receive treatment|0|||
162643153|NCT00619801|587409357|FG000|Overall Study|Lack of Efficacy|0|||
162643154|NCT00619801|587409358|FG001|Overall Study|Lack of Efficacy|1|||
162643155|NCT00619801|587409357|FG000|Overall Study|Withdrawal by Subject|1|||
162643156|NCT00619801|587409358|FG001|Overall Study|Withdrawal by Subject|1|||
162643157|NCT00619801|587409357|FG000|Overall Study|Loss of efficacy|0|||
162643158|NCT00619801|587409358|FG001|Overall Study|Loss of efficacy|1|||
162643159|NCT00450333|587409361|FG000|Overall Study|Study terminated|47|||
162643160|NCT00450333|587409362|FG001|Overall Study|Study terminated|54|||
162643161|NCT00450333|587409363|FG002|Overall Study|Study terminated|16|||
162643162|NCT00450333|587409364|FG003|Overall Study|Study terminated|21|||
162643163|NCT00450333|587409361|FG000|Overall Study|Adverse Event|1|||
162643164|NCT00450333|587409362|FG001|Overall Study|Adverse Event|7|||
162643165|NCT00450333|587409363|FG002|Overall Study|Adverse Event|2|||
162643166|NCT00450333|587409364|FG003|Overall Study|Adverse Event|2|||
162643167|NCT00450333|587409361|FG000|Overall Study|Protocol Violation|1|||
162643168|NCT00450333|587409362|FG001|Overall Study|Protocol Violation|0|||
162643169|NCT00450333|587409363|FG002|Overall Study|Protocol Violation|1|||
162643170|NCT00450333|587409364|FG003|Overall Study|Protocol Violation|0|||
162643171|NCT00450333|587409361|FG000|Overall Study|Withdrawal by Subject|1|||
162643172|NCT00450333|587409362|FG001|Overall Study|Withdrawal by Subject|0|||
162643173|NCT00450333|587409363|FG002|Overall Study|Withdrawal by Subject|3|||
162643174|NCT00450333|587409364|FG003|Overall Study|Withdrawal by Subject|0|||
162643175|NCT00450333|587409361|FG000|Overall Study|Kidney transplant|1|||
162643176|NCT00450333|587409362|FG001|Overall Study|Kidney transplant|0|||
162643177|NCT00450333|587409363|FG002|Overall Study|Kidney transplant|1|||
162643178|NCT00450333|587409364|FG003|Overall Study|Kidney transplant|3|||
162643179|NCT00450333|587409361|FG000|Overall Study|Death|3|||
162643180|NCT00450333|587409362|FG001|Overall Study|Death|2|||
162643181|NCT00450333|587409363|FG002|Overall Study|Death|2|||
162643182|NCT00450333|587409364|FG003|Overall Study|Death|2|||
162643183|NCT03855280|587409372|FG000|Treatment Phase|Adverse Event|1|||
162643184|NCT03855280|587409372|FG000|Treatment Phase|Withdrawal by Subject|1|||
162643185|NCT03855280|587409372|FG000|Continuation Phase|Protocol Violation|1|||
162643186|NCT03855280|587409372|FG000|Continuation Phase|Adverse Event|1|||
162643187|NCT03855280|587409372|FG000|Continuation Phase|Sponsor Concluded Study|1|||
162643188|NCT02738450|587409375|FG000|Overall Study|Withdrawal by Subject|0|||
162643189|NCT02738450|587409376|FG001|Overall Study|Withdrawal by Subject|2|||
162643190|NCT02738450|587409377|FG002|Overall Study|Withdrawal by Subject|0|||
162643191|NCT03204305|587409378|FG000|Overall Study|Lost to Follow-up|6|||
162643192|NCT03204305|587409379|FG001|Overall Study|Lost to Follow-up|4|||
162643193|NCT03204305|587409380|FG002|Overall Study|Lost to Follow-up|0|||
162643194|NCT03204305|587409381|FG003|Overall Study|Lost to Follow-up|0|||
162643195|NCT03204305|587409378|FG000|Overall Study|Physician Decision|1|||
162643196|NCT03204305|587409379|FG001|Overall Study|Physician Decision|0|||
162643197|NCT03204305|587409380|FG002|Overall Study|Physician Decision|0|||
162643198|NCT03204305|587409381|FG003|Overall Study|Physician Decision|0|||
162643199|NCT03204305|587409378|FG000|Overall Study|failure to place arterial line|2|||
162643200|NCT03204305|587409379|FG001|Overall Study|failure to place arterial line|1|||
162643201|NCT03204305|587409380|FG002|Overall Study|failure to place arterial line|0|||
162643202|NCT03204305|587409381|FG003|Overall Study|failure to place arterial line|0|||
162643203|NCT03204305|587409378|FG000|Overall Study|Withdrawal by Subject|2|||
162643204|NCT03204305|587409379|FG001|Overall Study|Withdrawal by Subject|0|||
162643205|NCT03204305|587409380|FG002|Overall Study|Withdrawal by Subject|0|||
162643206|NCT03204305|587409381|FG003|Overall Study|Withdrawal by Subject|0|||
162643207|NCT01165554|587409388|FG000|Overall Study|Withdrawal by Subject|23|||
162643208|NCT02951156|587409389|FG000|Overall Study|Death|3|||
162643209|NCT02951156|587409390|FG001|Overall Study|Death|8|||
162643210|NCT02951156|587409391|FG002|Overall Study|Death|5|||
162643211|NCT02951156|587409389|FG000|Overall Study|Progressive disease|1|||
162643212|NCT02951156|587409390|FG001|Overall Study|Progressive disease|0|||
162643213|NCT02951156|587409391|FG002|Overall Study|Progressive disease|1|||
162643214|NCT02951156|587409389|FG000|Overall Study|Withdrawal by Subject|0|||
162643215|NCT02951156|587409390|FG001|Overall Study|Withdrawal by Subject|0|||
162716891|NCT02377362|587670308|FG009|Part B Overall|Protocol Violation|1|||
162716892|NCT02377362|587670309|FG010|Part B Overall|Protocol Violation|0|||
162716893|NCT02377362|587670310|FG011|Part B Overall|Protocol Violation|0|||
162716894|NCT02377362|587670311|FG012|Part B Overall|Protocol Violation|0|||
162716895|NCT02377362|587670299|FG000|Part B Overall|Adverse Event|0|||
162716896|NCT02377362|587670300|FG001|Part B Overall|Adverse Event|0|||
162716897|NCT02377362|587670301|FG002|Part B Overall|Adverse Event|0|||
162716898|NCT02377362|587670302|FG003|Part B Overall|Adverse Event|0|||
162716899|NCT02377362|587670303|FG004|Part B Overall|Adverse Event|0|||
162716900|NCT02377362|587670304|FG005|Part B Overall|Adverse Event|0|||
162716901|NCT02377362|587670305|FG006|Part B Overall|Adverse Event|1|||
162716902|NCT02377362|587670306|FG007|Part B Overall|Adverse Event|1|||
162716903|NCT02377362|587670307|FG008|Part B Overall|Adverse Event|0|||
162716904|NCT02377362|587670308|FG009|Part B Overall|Adverse Event|0|||
162716905|NCT02377362|587670309|FG010|Part B Overall|Adverse Event|0|||
162716906|NCT02377362|587670310|FG011|Part B Overall|Adverse Event|0|||
162716907|NCT02377362|587670311|FG012|Part B Overall|Adverse Event|0|||
162716908|NCT02377362|587670299|FG000|Part B Overall|Withdrawal by Subject|0|||
162716909|NCT02377362|587670300|FG001|Part B Overall|Withdrawal by Subject|0|||
162716910|NCT02377362|587670301|FG002|Part B Overall|Withdrawal by Subject|0|||
162716911|NCT02377362|587670302|FG003|Part B Overall|Withdrawal by Subject|0|||
162716912|NCT02377362|587670303|FG004|Part B Overall|Withdrawal by Subject|0|||
162716913|NCT02377362|587670304|FG005|Part B Overall|Withdrawal by Subject|0|||
162716914|NCT02377362|587670305|FG006|Part B Overall|Withdrawal by Subject|1|||
162716915|NCT02377362|587670306|FG007|Part B Overall|Withdrawal by Subject|0|||
162716916|NCT02377362|587670307|FG008|Part B Overall|Withdrawal by Subject|0|||
162716917|NCT02377362|587670308|FG009|Part B Overall|Withdrawal by Subject|0|||
162716918|NCT02377362|587670309|FG010|Part B Overall|Withdrawal by Subject|0|||
162716919|NCT02377362|587670310|FG011|Part B Overall|Withdrawal by Subject|1|||
162716920|NCT02377362|587670311|FG012|Part B Overall|Withdrawal by Subject|0|||
162716921|NCT01806714|587670314|FG000|Overall Study|No functioning phone number|200|||
162716922|NCT01806714|587670315|FG001|Overall Study|No functioning phone number|170|||
162716923|NCT04107805|587670316|FG000|Overall Study|Adverse Event|0|||
162716924|NCT04107805|587670317|FG001|Overall Study|Adverse Event|0|||
162716925|NCT04107805|587670318|FG002|Overall Study|Adverse Event|0|||
162716926|NCT04107805|587670319|FG003|Overall Study|Adverse Event|1|||
162716927|NCT04107805|587670320|FG004|Overall Study|Adverse Event|0|||
162716928|NCT04107805|587670321|FG005|Overall Study|Adverse Event|1|||
162716929|NCT04107805|587670322|FG006|Overall Study|Adverse Event|0|||
162716930|NCT04107805|587670323|FG007|Overall Study|Adverse Event|0|||
162716931|NCT04107805|587670324|FG008|Overall Study|Adverse Event|1|||
162716932|NCT01120275|587670328|FG000|Overall Study|Adverse Event|3|||
162716933|NCT01120275|587670328|FG000|Overall Study|Progression|27|||
162716934|NCT01120275|587670328|FG000|Overall Study|Ineligible|3|||
163063936|NCT05028569|588941508|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063937|NCT05028569|588941509|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063938|NCT05028569|588941510|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063939|NCT05028569|588941511|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
163063940|NCT05028569|588941512|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
163063941|NCT04609553|588941513|FG000|Overall Study|Lost to Follow-up|27|||
163063942|NCT04609553|588941514|FG001|Overall Study|Lost to Follow-up|31|||
163063943|NCT04609553|588941515|FG002|Overall Study|Lost to Follow-up|24|||
163063944|NCT04609553|588941513|FG000|Overall Study|Discontinued|12|||
163063945|NCT04609553|588941514|FG001|Overall Study|Discontinued|10|||
163063946|NCT04609553|588941515|FG002|Overall Study|Discontinued|9|||
163063947|NCT02362451|588941526|FG000|Overall Study|Withdrawal by Subject|0|||
163063948|NCT02362451|588941527|FG001|Overall Study|Withdrawal by Subject|1|||
163063949|NCT02362451|588941526|FG000|Overall Study|Lack of Efficacy|2|||
163063950|NCT02362451|588941527|FG001|Overall Study|Lack of Efficacy|0|||
163063951|NCT02362451|588941526|FG000|Overall Study|Progression|1|||
163063952|NCT02362451|588941527|FG001|Overall Study|Progression|0|||
163063953|NCT02362451|588941526|FG000|Overall Study|Participant chose other therapy.|1|||
163063954|NCT02362451|588941527|FG001|Overall Study|Participant chose other therapy.|0|||
163063955|NCT02101294|588941529|FG000|Overall Study|Withdrawal by Subject|5|||
163063956|NCT02101294|588941529|FG000|Overall Study|Lost to Follow-up|6|||
163063957|NCT00689936|588941530|FG000|Active Treatment Phase|Adverse Event|68|||
163063958|NCT00689936|588941531|FG001|Active Treatment Phase|Adverse Event|71|||
163063959|NCT00689936|588941532|FG002|Active Treatment Phase|Adverse Event|76|||
162716935|NCT01120275|587670328|FG000|Overall Study|Withdrawal by Subject|1|||
162716936|NCT01120275|587670328|FG000|Overall Study|Refusal|1|||
162716937|NCT01120275|587670328|FG000|Overall Study|Not specific|1|||
162716938|NCT01191086|587670330|FG000|Overall Study|Adverse Event|20|||
162716939|NCT01191086|587670330|FG000|Overall Study|Lack of Efficacy|10|||
162716940|NCT01191086|587670330|FG000|Overall Study|Lost to Follow-up|4|||
162716941|NCT01191086|587670330|FG000|Overall Study|Physician Decision|2|||
162716942|NCT01191086|587670330|FG000|Overall Study|Withdrawal by Subject|24|||
162716943|NCT01191086|587670330|FG000|Overall Study|Discontinuation criterion met|1|||
162716944|NCT01191086|587670330|FG000|Overall Study|Other|1|||
162716945|NCT01833832|587670331|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
162716946|NCT01156116|587670332|FG000|Overall Study|Withdrawal by Subject|3|||
162716947|NCT01156116|587670333|FG001|Overall Study|Withdrawal by Subject|1|||
162716948|NCT01156116|587670332|FG000|Overall Study|CPAP intolerance|2|||
162716949|NCT01156116|587670333|FG001|Overall Study|CPAP intolerance|0|||
162716950|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
162716951|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
162716952|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
162716953|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
162716954|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
162716955|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
162716956|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
162716957|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
162716958|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
162716959|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
162716960|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
162716961|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
162716962|NCT02057718|587670334|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
162716963|NCT02057718|587670335|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
162716964|NCT02057718|587670334|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
162716965|NCT02057718|587670335|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
162716966|NCT02057718|587670334|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
162716967|NCT02057718|587670335|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
162716968|NCT02057718|587670334|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
162716969|NCT02057718|587670335|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
162716970|NCT02057718|587670334|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
162716971|NCT02057718|587670335|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
162716972|NCT00130637|587670342|FG000|Overall Study|Adverse Event|2|||
162716973|NCT00130637|587670342|FG000|Overall Study|Withdrawal by Subject|1|||
162716974|NCT00139737|587670343|FG000|Overall Study|Withdrawal by Subject|190|||
162716975|NCT00139737|587670343|FG000|Overall Study|Adverse Event|58|||
162716976|NCT00139737|587670343|FG000|Overall Study|Lack of Efficacy|40|||
162716977|NCT00139737|587670343|FG000|Overall Study|Lost to Follow-up|8|||
162716978|NCT00139737|587670343|FG000|Overall Study|Death|3|||
162716979|NCT00139737|587670343|FG000|Overall Study|Laboratory Abnormality|2|||
162716980|NCT00139737|587670343|FG000|Overall Study|Protocol Violation|18|||
162716981|NCT00139737|587670343|FG000|Overall Study|Withdrew During Screening Phase|8|||
162716982|NCT00139737|587670343|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162716983|NCT00139737|587670343|FG000|Overall Study|Screened, Not Treated|13|||
162716984|NCT00217672|587670344|FG000|Allocation|Ineligible|2|||
163063960|NCT00689936|588941530|FG000|Active Treatment Phase|Disease Progression|273|||
163063961|NCT00689936|588941531|FG001|Active Treatment Phase|Disease Progression|362|||
163063962|NCT00689936|588941532|FG002|Active Treatment Phase|Disease Progression|339|||
163063963|NCT00689936|588941530|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
163063964|NCT00689936|588941531|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
163063965|NCT00689936|588941532|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
163063966|NCT00689936|588941530|FG000|Active Treatment Phase|Death|60|||
163063967|NCT00689936|588941531|FG001|Active Treatment Phase|Death|28|||
163063968|NCT00689936|588941532|FG002|Active Treatment Phase|Death|37|||
163063969|NCT00689936|588941530|FG000|Active Treatment Phase|Lost to Follow-up|0|||
163063970|NCT00689936|588941531|FG001|Active Treatment Phase|Lost to Follow-up|2|||
163063971|NCT00689936|588941532|FG002|Active Treatment Phase|Lost to Follow-up|2|||
163063972|NCT00689936|588941530|FG000|Active Treatment Phase|Protocol Violation|2|||
163063973|NCT00689936|588941531|FG001|Active Treatment Phase|Protocol Violation|2|||
162716985|NCT00217672|587670345|FG001|Allocation|Ineligible|0|||
162716986|NCT00217672|587670344|FG000|Treatment|disease progression|33|||
163063974|NCT00689936|588941532|FG002|Active Treatment Phase|Protocol Violation|4|||
163063975|NCT00689936|588941530|FG000|Active Treatment Phase|Study Close Out|64|||
162716987|NCT00217672|587670345|FG001|Treatment|disease progression|4|||
162716988|NCT00217672|587670344|FG000|Treatment|Adverse Event|18|||
162716989|NCT00217672|587670345|FG001|Treatment|Adverse Event|2|||
162716990|NCT00217672|587670344|FG000|Treatment|reqd treatment not permitted by protocol|6|||
163063976|NCT00689936|588941531|FG001|Active Treatment Phase|Study Close Out|26|||
162716991|NCT00217672|587670345|FG001|Treatment|reqd treatment not permitted by protocol|0|||
162716992|NCT00217672|587670344|FG000|Treatment|Physician Decision|6|||
162716993|NCT00217672|587670345|FG001|Treatment|Physician Decision|0|||
162716994|NCT00217672|587670344|FG000|Treatment|insurance issues|1|||
162716995|NCT00217672|587670345|FG001|Treatment|insurance issues|1|||
162716996|NCT00217672|587670344|FG000|Treatment|Death|2|||
162716997|NCT00217672|587670345|FG001|Treatment|Death|0|||
162716998|NCT00217672|587670344|FG000|Treatment|secondary malignancy|1|||
162716999|NCT00217672|587670345|FG001|Treatment|secondary malignancy|0|||
162717000|NCT00217672|587670344|FG000|Follow-up|Withdrawal by Subject|4|||
162717001|NCT00217672|587670345|FG001|Follow-up|Withdrawal by Subject|0|||
162717002|NCT00217672|587670344|FG000|Follow-up|Lost to Follow-up|1|||
162717003|NCT00217672|587670345|FG001|Follow-up|Lost to Follow-up|0|||
162717004|NCT04379713|587670351|FG000|Overall Study|Adverse Event|2|||
162717005|NCT04379713|587670352|FG001|Overall Study|Adverse Event|0|||
162717006|NCT04379713|587670351|FG000|Overall Study|Physician Decision|2|||
162717007|NCT04379713|587670352|FG001|Overall Study|Physician Decision|1|||
162717008|NCT04379713|587670351|FG000|Overall Study|Protocol Violation|11|||
162717009|NCT04379713|587670352|FG001|Overall Study|Protocol Violation|6|||
162717010|NCT04379713|587670351|FG000|Overall Study|No longer met eligibility criteria|14|||
162717011|NCT04379713|587670352|FG001|Overall Study|No longer met eligibility criteria|11|||
162717012|NCT04379713|587670351|FG000|Overall Study|Withdrawal by parent/guardian|36|||
162717013|NCT04379713|587670352|FG001|Overall Study|Withdrawal by parent/guardian|15|||
162717014|NCT04379713|587670351|FG000|Overall Study|Lost to Follow-up|31|||
162717015|NCT04379713|587670352|FG001|Overall Study|Lost to Follow-up|21|||
162717016|NCT04567888|587670353|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
162717017|NCT04567888|587670354|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
162717018|NCT04567888|587670353|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
162717019|NCT04567888|587670354|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
162717020|NCT04567888|587670353|FG000|Overall Study|Reported Unusual Birth Year|2|||
162717021|NCT04567888|587670354|FG001|Overall Study|Reported Unusual Birth Year|3|||
162717022|NCT04567888|587670353|FG000|Overall Study|Duplicate Responses|0|||
162717023|NCT04567888|587670354|FG001|Overall Study|Duplicate Responses|1|||
162717024|NCT01157182|587670355|FG000|Washout of 28 Days|Adverse Event|2|||
162717025|NCT01157182|587670356|FG001|Washout of 28 Days|Adverse Event|0|||
162717026|NCT00878722|587670357|FG000|Overall Study|Progressive disease|3|||
162717027|NCT00878722|587670358|FG001|Overall Study|Progressive disease|3|||
162717028|NCT00878722|587670359|FG002|Overall Study|Progressive disease|3|||
162717029|NCT00878722|587670360|FG003|Overall Study|Progressive disease|7|||
162717030|NCT00878722|587670361|FG004|Overall Study|Progressive disease|7|||
162717031|NCT00878722|587670362|FG005|Overall Study|Progressive disease|1|||
162717032|NCT00878722|587670363|FG006|Overall Study|Progressive disease|4|||
162717033|NCT00878722|587670364|FG007|Overall Study|Progressive disease|3|||
162717034|NCT00878722|587670357|FG000|Overall Study|Death|0|||
162717035|NCT00878722|587670358|FG001|Overall Study|Death|0|||
162717036|NCT00878722|587670359|FG002|Overall Study|Death|0|||
162717037|NCT00878722|587670360|FG003|Overall Study|Death|1|||
162717038|NCT00878722|587670361|FG004|Overall Study|Death|0|||
162717039|NCT00878722|587670362|FG005|Overall Study|Death|1|||
162717040|NCT00878722|587670363|FG006|Overall Study|Death|0|||
162717041|NCT00878722|587670364|FG007|Overall Study|Death|2|||
162717042|NCT00878722|587670357|FG000|Overall Study|Adverse Event|0|||
162717043|NCT00878722|587670358|FG001|Overall Study|Adverse Event|0|||
162717044|NCT00878722|587670359|FG002|Overall Study|Adverse Event|0|||
162717045|NCT00878722|587670360|FG003|Overall Study|Adverse Event|0|||
162717046|NCT00878722|587670361|FG004|Overall Study|Adverse Event|0|||
162717047|NCT00878722|587670362|FG005|Overall Study|Adverse Event|0|||
162717048|NCT00878722|587670363|FG006|Overall Study|Adverse Event|2|||
162717049|NCT00878722|587670364|FG007|Overall Study|Adverse Event|0|||
162717050|NCT00878722|587670357|FG000|Overall Study|Withdrawal by Subject|0|||
162717051|NCT00878722|587670358|FG001|Overall Study|Withdrawal by Subject|0|||
162717052|NCT00878722|587670359|FG002|Overall Study|Withdrawal by Subject|0|||
162717053|NCT00878722|587670360|FG003|Overall Study|Withdrawal by Subject|0|||
162717054|NCT00878722|587670361|FG004|Overall Study|Withdrawal by Subject|0|||
162717055|NCT00878722|587670362|FG005|Overall Study|Withdrawal by Subject|0|||
162717056|NCT00878722|587670363|FG006|Overall Study|Withdrawal by Subject|0|||
162717057|NCT00878722|587670364|FG007|Overall Study|Withdrawal by Subject|2|||
162717058|NCT00878722|587670357|FG000|Overall Study|Relapse|0|||
162717059|NCT00878722|587670358|FG001|Overall Study|Relapse|0|||
162717060|NCT00878722|587670359|FG002|Overall Study|Relapse|0|||
162717061|NCT00878722|587670360|FG003|Overall Study|Relapse|1|||
162717062|NCT00878722|587670361|FG004|Overall Study|Relapse|0|||
162717063|NCT00878722|587670362|FG005|Overall Study|Relapse|0|||
162717064|NCT00878722|587670363|FG006|Overall Study|Relapse|0|||
162717065|NCT00878722|587670364|FG007|Overall Study|Relapse|0|||
162717066|NCT00383188|587670365|FG000|Overall Study|Adverse Event|4|||
162717067|NCT00383188|587670366|FG001|Overall Study|Adverse Event|7|||
162717068|NCT00383188|587670367|FG002|Overall Study|Adverse Event|9|||
162717069|NCT00383188|587670368|FG003|Overall Study|Adverse Event|8|||
162717070|NCT00383188|587670369|FG004|Overall Study|Adverse Event|8|||
162717071|NCT00383188|587670365|FG000|Overall Study|Lack of Efficacy|9|||
162717072|NCT00383188|587670366|FG001|Overall Study|Lack of Efficacy|3|||
162717073|NCT00383188|587670367|FG002|Overall Study|Lack of Efficacy|3|||
162717074|NCT00383188|587670368|FG003|Overall Study|Lack of Efficacy|2|||
162717075|NCT00383188|587670369|FG004|Overall Study|Lack of Efficacy|6|||
162717076|NCT00383188|587670365|FG000|Overall Study|Other|3|||
162717077|NCT00383188|587670366|FG001|Overall Study|Other|1|||
162717078|NCT00383188|587670367|FG002|Overall Study|Other|0|||
162717079|NCT00383188|587670368|FG003|Overall Study|Other|2|||
162717080|NCT00383188|587670369|FG004|Overall Study|Other|6|||
162717081|NCT00383188|587670365|FG000|Overall Study|No longer willing to participate|1|||
162717082|NCT00383188|587670366|FG001|Overall Study|No longer willing to participate|0|||
162717083|NCT00383188|587670367|FG002|Overall Study|No longer willing to participate|1|||
162717084|NCT00383188|587670368|FG003|Overall Study|No longer willing to participate|0|||
162717085|NCT00383188|587670369|FG004|Overall Study|No longer willing to participate|2|||
162717086|NCT00383188|587670365|FG000|Overall Study|Lost to Follow-up|0|||
162717087|NCT00383188|587670366|FG001|Overall Study|Lost to Follow-up|0|||
162717088|NCT00383188|587670367|FG002|Overall Study|Lost to Follow-up|0|||
162717089|NCT00383188|587670368|FG003|Overall Study|Lost to Follow-up|0|||
162717090|NCT00383188|587670369|FG004|Overall Study|Lost to Follow-up|1|||
162717091|NCT01144182|587670377|FG000|Overall Study|Death|5|||
162717092|NCT01144182|587670378|FG001|Overall Study|Death|6|||
162717093|NCT01144182|587670377|FG000|Overall Study|Withdrawal by Subject|3|||
162717094|NCT01144182|587670378|FG001|Overall Study|Withdrawal by Subject|6|||
162717095|NCT01144182|587670377|FG000|Overall Study|Lost to Follow-up|9|||
162717096|NCT01144182|587670378|FG001|Overall Study|Lost to Follow-up|9|||
162717097|NCT01751724|587670386|FG000|Overall Study|extubated bef.start assigned treatment|1|||
162717098|NCT01751724|587670387|FG001|Overall Study|extubated bef.start assigned treatment|0|||
162717099|NCT01751724|587670386|FG000|Overall Study|withdrawn by parent|0|||
162717100|NCT01751724|587670387|FG001|Overall Study|withdrawn by parent|2|||
162717101|NCT02685033|587670390|FG000|Overall Study|Withdrawal of Consent|0|||
162717102|NCT02685033|587670391|FG001|Overall Study|Withdrawal of Consent|1|||
162717103|NCT02685033|587670390|FG000|Overall Study|Lost to Follow-up|2|||
162717104|NCT02685033|587670391|FG001|Overall Study|Lost to Follow-up|1|||
162717105|NCT02685033|587670390|FG000|Overall Study|Adverse Event|1|||
162717106|NCT02685033|587670391|FG001|Overall Study|Adverse Event|0|||
162717107|NCT00603447|587670392|FG000|Overall Study|Adverse Event|0|||
162717108|NCT00603447|587670393|FG001|Overall Study|Adverse Event|1|||
162717109|NCT00603447|587670394|FG002|Overall Study|Adverse Event|1|||
162717110|NCT00603447|587670395|FG003|Overall Study|Adverse Event|2|||
162717111|NCT00603447|587670396|FG004|Overall Study|Adverse Event|1|||
162717112|NCT00603447|587670397|FG005|Overall Study|Adverse Event|2|||
162717113|NCT00603447|587670398|FG006|Overall Study|Adverse Event|10|||
162717114|NCT00603447|587670392|FG000|Overall Study|Other|0|||
163063977|NCT00689936|588941532|FG002|Active Treatment Phase|Study Close Out|21|||
163063978|NCT00689936|588941530|FG000|Active Treatment Phase|Miscellaneous|52|||
163063979|NCT00689936|588941531|FG001|Active Treatment Phase|Miscellaneous|34|||
163063980|NCT00689936|588941532|FG002|Active Treatment Phase|Miscellaneous|47|||
163063981|NCT00689936|588941530|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
163063982|NCT00689936|588941531|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
163063983|NCT00689936|588941532|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
163063984|NCT01925794|588941543|FG000|180 Days|Death|2|||
162717115|NCT00603447|587670393|FG001|Overall Study|Other|0|||
162717116|NCT00603447|587670394|FG002|Overall Study|Other|1|||
162717117|NCT00603447|587670395|FG003|Overall Study|Other|0|||
162717118|NCT00603447|587670396|FG004|Overall Study|Other|3|||
163063985|NCT01925794|588941543|FG000|180 Days|Withdrawal by Subject|2|||
163063986|NCT01925794|588941543|FG000|270 Days|Death|2|||
163063987|NCT01925794|588941543|FG000|270 Days|Protocol Violation|3|||
163063988|NCT01901562|588941544|FG000|Overall Study|Protocol Violation|5|||
163063989|NCT01901562|588941544|FG000|Overall Study|Excluded intraoperatively|4|||
163063990|NCT03126110|588941545|FG000|Phase 1|Death|2|||
163063991|NCT03126110|588941546|FG001|Phase 1|Death|2|||
163063992|NCT03126110|588941547|FG002|Phase 1|Death|4|||
162717119|NCT00603447|587670397|FG005|Overall Study|Other|0|||
162717120|NCT00603447|587670398|FG006|Overall Study|Other|13|||
162717121|NCT00603447|587670392|FG000|Overall Study|Withdrew Consent|0|||
162717122|NCT00603447|587670393|FG001|Overall Study|Withdrew Consent|2|||
162717123|NCT00603447|587670394|FG002|Overall Study|Withdrew Consent|0|||
162717124|NCT00603447|587670395|FG003|Overall Study|Withdrew Consent|0|||
163063993|NCT03126110|588941548|FG003|Phase 1|Death|3|||
163063994|NCT03126110|588941549|FG004|Phase 1|Death|4|||
162717125|NCT00603447|587670396|FG004|Overall Study|Withdrew Consent|1|||
162717126|NCT00603447|587670397|FG005|Overall Study|Withdrew Consent|0|||
162717127|NCT00603447|587670398|FG006|Overall Study|Withdrew Consent|1|||
163063995|NCT03126110|588941550|FG005|Phase 1|Death|4|||
162717128|NCT00798265|587670399|FG000|Overall Study|Lost to Follow-up|1|||
162717129|NCT00798265|587670400|FG001|Overall Study|Lost to Follow-up|10|||
162717130|NCT00798265|587670399|FG000|Overall Study|Study closing|7|||
162717131|NCT00798265|587670400|FG001|Overall Study|Study closing|6|||
162717132|NCT00798265|587670399|FG000|Overall Study|Withdrawal by Subject|0|||
162717133|NCT00798265|587670400|FG001|Overall Study|Withdrawal by Subject|1|||
162717134|NCT00798265|587670399|FG000|Overall Study|Screen failure|0|||
163063996|NCT03126110|588941551|FG006|Phase 1|Death|3|||
163063997|NCT03126110|588941552|FG007|Phase 1|Death|4|||
163063998|NCT03126110|588941553|FG008|Phase 1|Death|5|||
163063999|NCT03126110|588941554|FG009|Phase 1|Death|2|||
163064000|NCT03126110|588941555|FG010|Phase 1|Death|6|||
163064001|NCT03126110|588941556|FG011|Phase 1|Death|0|||
163064002|NCT03126110|588941557|FG012|Phase 1|Death|0|||
163064003|NCT03126110|588941558|FG013|Phase 1|Death|0|||
163064004|NCT03126110|588941559|FG014|Phase 1|Death|0|||
163064005|NCT03126110|588941560|FG015|Phase 1|Death|0|||
163064006|NCT03126110|588941561|FG016|Phase 1|Death|0|||
162717135|NCT00798265|587670400|FG001|Overall Study|Screen failure|1|||
162717136|NCT07214922|587670401|FG000|Overall Study|Adverse Event|0|||
162717137|NCT07214922|587670402|FG001|Overall Study|Adverse Event|0|||
163064007|NCT03126110|588941545|FG000|Phase 1|Lost to Follow-up|0|||
163064008|NCT03126110|588941546|FG001|Phase 1|Lost to Follow-up|1|||
163064009|NCT03126110|588941547|FG002|Phase 1|Lost to Follow-up|0|||
163064010|NCT03126110|588941548|FG003|Phase 1|Lost to Follow-up|0|||
163064011|NCT03126110|588941549|FG004|Phase 1|Lost to Follow-up|0|||
163064012|NCT03126110|588941550|FG005|Phase 1|Lost to Follow-up|0|||
163064013|NCT03126110|588941551|FG006|Phase 1|Lost to Follow-up|0|||
163064014|NCT03126110|588941552|FG007|Phase 1|Lost to Follow-up|0|||
163064015|NCT03126110|588941553|FG008|Phase 1|Lost to Follow-up|1|||
163064016|NCT03126110|588941554|FG009|Phase 1|Lost to Follow-up|0|||
163064017|NCT03126110|588941555|FG010|Phase 1|Lost to Follow-up|0|||
163064018|NCT03126110|588941556|FG011|Phase 1|Lost to Follow-up|0|||
163064019|NCT03126110|588941557|FG012|Phase 1|Lost to Follow-up|0|||
163064020|NCT03126110|588941558|FG013|Phase 1|Lost to Follow-up|0|||
163064021|NCT03126110|588941559|FG014|Phase 1|Lost to Follow-up|0|||
163064022|NCT03126110|588941560|FG015|Phase 1|Lost to Follow-up|0|||
163064023|NCT03126110|588941561|FG016|Phase 1|Lost to Follow-up|0|||
163064024|NCT03126110|588941545|FG000|Phase 1|Withdrawal by Subject|1|||
163064025|NCT03126110|588941546|FG001|Phase 1|Withdrawal by Subject|0|||
163064026|NCT03126110|588941547|FG002|Phase 1|Withdrawal by Subject|0|||
163064027|NCT03126110|588941548|FG003|Phase 1|Withdrawal by Subject|1|||
163064028|NCT03126110|588941549|FG004|Phase 1|Withdrawal by Subject|1|||
163064029|NCT03126110|588941550|FG005|Phase 1|Withdrawal by Subject|0|||
163064030|NCT03126110|588941551|FG006|Phase 1|Withdrawal by Subject|0|||
163064031|NCT03126110|588941552|FG007|Phase 1|Withdrawal by Subject|0|||
163064032|NCT03126110|588941553|FG008|Phase 1|Withdrawal by Subject|2|||
163064033|NCT03126110|588941554|FG009|Phase 1|Withdrawal by Subject|1|||
163064034|NCT03126110|588941555|FG010|Phase 1|Withdrawal by Subject|0|||
163064035|NCT03126110|588941556|FG011|Phase 1|Withdrawal by Subject|0|||
163064036|NCT03126110|588941557|FG012|Phase 1|Withdrawal by Subject|0|||
163064037|NCT03126110|588941558|FG013|Phase 1|Withdrawal by Subject|0|||
163064038|NCT03126110|588941559|FG014|Phase 1|Withdrawal by Subject|0|||
163064039|NCT03126110|588941560|FG015|Phase 1|Withdrawal by Subject|0|||
163064040|NCT03126110|588941561|FG016|Phase 1|Withdrawal by Subject|0|||
163064041|NCT03126110|588941545|FG000|Phase 1|Safety follow-up no longer necessary|1|||
163064042|NCT03126110|588941546|FG001|Phase 1|Safety follow-up no longer necessary|0|||
163064043|NCT03126110|588941547|FG002|Phase 1|Safety follow-up no longer necessary|0|||
163064044|NCT03126110|588941548|FG003|Phase 1|Safety follow-up no longer necessary|0|||
163064045|NCT03126110|588941549|FG004|Phase 1|Safety follow-up no longer necessary|0|||
163064046|NCT03126110|588941550|FG005|Phase 1|Safety follow-up no longer necessary|0|||
162717138|NCT07214922|587670403|FG002|Overall Study|Adverse Event|1|||
163064047|NCT03126110|588941551|FG006|Phase 1|Safety follow-up no longer necessary|0|||
162717139|NCT07214922|587670404|FG003|Overall Study|Adverse Event|0|||
163064048|NCT03126110|588941552|FG007|Phase 1|Safety follow-up no longer necessary|0|||
163064049|NCT03126110|588941553|FG008|Phase 1|Safety follow-up no longer necessary|0|||
163064050|NCT03126110|588941554|FG009|Phase 1|Safety follow-up no longer necessary|0|||
163064051|NCT03126110|588941555|FG010|Phase 1|Safety follow-up no longer necessary|0|||
162717140|NCT07214922|587670401|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163064052|NCT03126110|588941556|FG011|Phase 1|Safety follow-up no longer necessary|0|||
163064053|NCT03126110|588941557|FG012|Phase 1|Safety follow-up no longer necessary|0|||
163064054|NCT03126110|588941558|FG013|Phase 1|Safety follow-up no longer necessary|0|||
163064055|NCT03126110|588941559|FG014|Phase 1|Safety follow-up no longer necessary|0|||
162717141|NCT07214922|587670402|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
163064056|NCT03126110|588941560|FG015|Phase 1|Safety follow-up no longer necessary|0|||
163064057|NCT03126110|588941561|FG016|Phase 1|Safety follow-up no longer necessary|0|||
163064058|NCT03126110|588941545|FG000|Phase 1|Survival follow-up no longer necessary|0|||
163064059|NCT03126110|588941546|FG001|Phase 1|Survival follow-up no longer necessary|0|||
162717142|NCT07214922|587670403|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
162717143|NCT07214922|587670404|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
162717144|NCT00589667|587671716|FG000|Overall Study|Adverse Event|2|||
162717145|NCT00589667|587671716|FG000|Overall Study|Withdrawal by Subject|1|||
162717146|NCT03538041|587671719|FG000|12-Week Treatment Period|Adverse Event|1|||
162717147|NCT03538041|587671720|FG001|12-Week Treatment Period|Adverse Event|1|||
162717148|NCT03538041|587671719|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
162717149|NCT03538041|587671720|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
162717150|NCT03538041|587671719|FG000|Treatment Extension Period|Adverse Event|4|||
162717151|NCT03538041|587671720|FG001|Treatment Extension Period|Adverse Event|1|||
162717152|NCT03538041|587671719|FG000|Treatment Extension Period|Physician Decision|1|||
162717153|NCT03538041|587671720|FG001|Treatment Extension Period|Physician Decision|1|||
162717154|NCT03538041|587671719|FG000|Treatment Extension Period|Lack of Efficacy|1|||
162717155|NCT03538041|587671720|FG001|Treatment Extension Period|Lack of Efficacy|4|||
162717156|NCT03538041|587671719|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
162717157|NCT03538041|587671720|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
162717158|NCT03538041|587671719|FG000|Treatment Extension Period|Death|0|||
162717159|NCT03538041|587671720|FG001|Treatment Extension Period|Death|1|||
162717160|NCT00094809|587671721|FG000|Overall Study|Protocol deviation|2|||
162717161|NCT00094809|587671722|FG001|Overall Study|Protocol deviation|2|||
162717162|NCT00094809|587671721|FG000|Overall Study|Noncompliance|1|||
162717163|NCT00094809|587671722|FG001|Overall Study|Noncompliance|0|||
162717164|NCT00094809|587671721|FG000|Overall Study|Adverse Event|3|||
162717165|NCT00094809|587671722|FG001|Overall Study|Adverse Event|1|||
162717166|NCT00094809|587671721|FG000|Overall Study|Withdrawal by Subject|8|||
162717167|NCT00094809|587671722|FG001|Overall Study|Withdrawal by Subject|9|||
162717168|NCT00094809|587671721|FG000|Overall Study|Disease progression|3|||
162717169|NCT00094809|587671722|FG001|Overall Study|Disease progression|3|||
162717170|NCT00094809|587671721|FG000|Overall Study|Physician Decision|3|||
162717171|NCT00094809|587671722|FG001|Overall Study|Physician Decision|5|||
162717172|NCT00094809|587671721|FG000|Overall Study|Lost to Follow-up|6|||
162717173|NCT00094809|587671722|FG001|Overall Study|Lost to Follow-up|6|||
162717174|NCT00094809|587671721|FG000|Overall Study|Death|19|||
162717175|NCT00094809|587671722|FG001|Overall Study|Death|25|||
162717176|NCT00094809|587671721|FG000|Overall Study|Protocol-specified criteria|1|||
162717177|NCT00094809|587671722|FG001|Overall Study|Protocol-specified criteria|1|||
162717178|NCT00094809|587671721|FG000|Overall Study|Other|2|||
162717179|NCT00094809|587671722|FG001|Overall Study|Other|4|||
162717180|NCT00094809|587671721|FG000|Overall Study|Informed consent signed after treatment|1|||
162717181|NCT00094809|587671722|FG001|Overall Study|Informed consent signed after treatment|0|||
162717182|NCT00094809|587671721|FG000|Overall Study|Study drug not received|2|||
162717183|NCT00094809|587671722|FG001|Overall Study|Study drug not received|8|||
162717184|NCT00094809|587671721|FG000|Overall Study|Other|1|||
162717185|NCT00094809|587671722|FG001|Overall Study|Other|1|||
162717186|NCT04889664|587671723|FG000|Screen|Lost to Follow-up|1|||
162717187|NCT04889664|587671723|FG000|Screen|Failed to meet screening criteria|1|||
162717188|NCT04889664|587671723|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
162717189|NCT02469064|587671729|FG000|Overall Study|Request not to receive intervention.|1|||
162717190|NCT02469064|587671730|FG001|Overall Study|Request not to receive intervention.|3|||
162717191|NCT00964366|587671743|FG000|Overall Study|Did not qualify at Day 1|1|||
162717192|NCT00964366|587671744|FG001|Overall Study|Did not qualify at Day 1|0|||
162717193|NCT00964366|587671743|FG000|Overall Study|Withdrawal by Subject|0|||
162717194|NCT00964366|587671744|FG001|Overall Study|Withdrawal by Subject|1|||
162717195|NCT02046616|587671746|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
162717196|NCT02046616|587671746|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
162717197|NCT02046616|587671746|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
162717198|NCT02046616|587671746|FG000|24-Week Treatment Period|Physician Decision|3|||
162717199|NCT02046616|587671746|FG000|24-Week Treatment Period|Other|1|||
162717200|NCT02046616|587671746|FG000|8-Week FU Period|Lost to Follow-up|1|||
162717201|NCT02957539|587671749|FG000|Baseline to Week 16|Lost to Follow-up|8|||
162717202|NCT02957539|587671750|FG001|Baseline to Week 16|Lost to Follow-up|10|||
162717203|NCT02957539|587671751|FG002|Baseline to Week 16|Lost to Follow-up|16|||
162717204|NCT02957539|587671749|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
162717205|NCT02957539|587671750|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
162717206|NCT02957539|587671751|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
162717207|NCT02957539|587671749|FG000|Week 16 to 32|Withdrawal by Subject|3|||
162717208|NCT02957539|587671750|FG001|Week 16 to 32|Withdrawal by Subject|3|||
162717209|NCT02957539|587671751|FG002|Week 16 to 32|Withdrawal by Subject|1|||
162717210|NCT02957539|587671749|FG000|Week 16 to 32|Lost to Follow-up|8|||
162717211|NCT02957539|587671750|FG001|Week 16 to 32|Lost to Follow-up|7|||
162643216|NCT02951156|587409391|FG002|Overall Study|Withdrawal by Subject|1|||
162643217|NCT02951156|587409389|FG000|Overall Study|Study terminated by sponsor|0|||
162643218|NCT02951156|587409390|FG001|Overall Study|Study terminated by sponsor|0|||
162643219|NCT02951156|587409391|FG002|Overall Study|Study terminated by sponsor|1|||
162643220|NCT02951156|587409389|FG000|Overall Study|Other|5|||
162643221|NCT02951156|587409390|FG001|Overall Study|Other|1|||
162643222|NCT02951156|587409391|FG002|Overall Study|Other|2|||
162643223|NCT01603459|587409394|FG000|Overall Study|Adverse Event|5|||
162643224|NCT01603459|587409394|FG000|Overall Study|Withdrawal by Subject|5|||
162643225|NCT01603459|587409394|FG000|Overall Study|Lost to Follow-up|3|||
162643226|NCT01603459|587409394|FG000|Overall Study|Predefined discontinuation criteria|3|||
162643227|NCT01603459|587409394|FG000|Overall Study|Non-compliance|1|||
162643228|NCT01603459|587409394|FG000|Overall Study|Administrative reason|1|||
162643229|NCT01092182|587409395|FG000|Overall Study|Death|0|||
162643230|NCT01092182|587409396|FG001|Overall Study|Death|5|||
162643231|NCT01092182|587409397|FG002|Overall Study|Death|3|||
162643232|NCT01092182|587409395|FG000|Overall Study|participant safety|1|||
162643233|NCT01092182|587409396|FG001|Overall Study|participant safety|2|||
162643234|NCT01092182|587409397|FG002|Overall Study|participant safety|0|||
162643235|NCT01092182|587409395|FG000|Overall Study|Physician Decision|0|||
162643236|NCT01092182|587409396|FG001|Overall Study|Physician Decision|6|||
162643237|NCT01092182|587409397|FG002|Overall Study|Physician Decision|0|||
162643238|NCT01092182|587409395|FG000|Overall Study|Did not meet criteria|0|||
162643239|NCT01092182|587409396|FG001|Overall Study|Did not meet criteria|0|||
162643240|NCT01092182|587409397|FG002|Overall Study|Did not meet criteria|25|||
162643241|NCT01092182|587409395|FG000|Overall Study|Non-compliance|0|||
162643242|NCT01092182|587409396|FG001|Overall Study|Non-compliance|3|||
162643243|NCT01092182|587409397|FG002|Overall Study|Non-compliance|0|||
162643244|NCT01092182|587409395|FG000|Overall Study|Participant refused follow-up|0|||
162643245|NCT01092182|587409396|FG001|Overall Study|Participant refused follow-up|2|||
162643246|NCT01092182|587409397|FG002|Overall Study|Participant refused follow-up|0|||
162643247|NCT01641692|587409398|FG000|Treatment Period 1|Adverse Event|1|||
162643248|NCT01641692|587409399|FG001|Treatment Period 1|Adverse Event|0|||
162643249|NCT01641692|587409400|FG002|Treatment Period 1|Adverse Event|0|||
162643250|NCT01641692|587409401|FG003|Treatment Period 1|Adverse Event|0|||
162643251|NCT01641692|587409402|FG004|Treatment Period 1|Adverse Event|0|||
162643252|NCT01641692|587409403|FG005|Treatment Period 1|Adverse Event|0|||
162643253|NCT01641692|587409404|FG006|Treatment Period 1|Adverse Event|0|||
162643254|NCT01641692|587409405|FG007|Treatment Period 1|Adverse Event|0|||
162643255|NCT01641692|587409398|FG000|Treatment Period 1|Lack of Efficacy|0|||
162643256|NCT01641692|587409399|FG001|Treatment Period 1|Lack of Efficacy|0|||
162643257|NCT01641692|587409400|FG002|Treatment Period 1|Lack of Efficacy|0|||
162643258|NCT01641692|587409401|FG003|Treatment Period 1|Lack of Efficacy|0|||
162643259|NCT01641692|587409402|FG004|Treatment Period 1|Lack of Efficacy|0|||
162643260|NCT01641692|587409403|FG005|Treatment Period 1|Lack of Efficacy|0|||
162643261|NCT01641692|587409404|FG006|Treatment Period 1|Lack of Efficacy|0|||
162643262|NCT01641692|587409405|FG007|Treatment Period 1|Lack of Efficacy|1|||
162643263|NCT01641692|587409398|FG000|Treatment Period 1|Protocol Violation|1|||
162643264|NCT01641692|587409399|FG001|Treatment Period 1|Protocol Violation|0|||
162643265|NCT01641692|587409400|FG002|Treatment Period 1|Protocol Violation|0|||
162643266|NCT01641692|587409401|FG003|Treatment Period 1|Protocol Violation|0|||
162643267|NCT01641692|587409402|FG004|Treatment Period 1|Protocol Violation|2|||
162643268|NCT01641692|587409403|FG005|Treatment Period 1|Protocol Violation|0|||
162643269|NCT01641692|587409404|FG006|Treatment Period 1|Protocol Violation|0|||
162643270|NCT01641692|587409405|FG007|Treatment Period 1|Protocol Violation|0|||
162643271|NCT01641692|587409398|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643272|NCT01641692|587409399|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643273|NCT01641692|587409400|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643274|NCT01641692|587409401|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643275|NCT01641692|587409402|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
162643276|NCT01641692|587409403|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643277|NCT01641692|587409404|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162643278|NCT01641692|587409405|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
162643279|NCT01641692|587409398|FG000|Treatment Period 1|Lost to Follow-up|0|||
162643280|NCT01641692|587409399|FG001|Treatment Period 1|Lost to Follow-up|0|||
162643281|NCT01641692|587409400|FG002|Treatment Period 1|Lost to Follow-up|1|||
162643282|NCT01641692|587409401|FG003|Treatment Period 1|Lost to Follow-up|0|||
162643283|NCT01641692|587409402|FG004|Treatment Period 1|Lost to Follow-up|0|||
162643284|NCT01641692|587409403|FG005|Treatment Period 1|Lost to Follow-up|0|||
162643285|NCT01641692|587409404|FG006|Treatment Period 1|Lost to Follow-up|0|||
162643286|NCT01641692|587409405|FG007|Treatment Period 1|Lost to Follow-up|0|||
162643287|NCT01641692|587409398|FG000|Treatment Period 1|Physician Decision|0|||
162643288|NCT01641692|587409399|FG001|Treatment Period 1|Physician Decision|0|||
162643289|NCT01641692|587409400|FG002|Treatment Period 1|Physician Decision|0|||
162643290|NCT01641692|587409401|FG003|Treatment Period 1|Physician Decision|0|||
162643291|NCT01641692|587409402|FG004|Treatment Period 1|Physician Decision|1|||
162717212|NCT02957539|587671751|FG002|Week 16 to 32|Lost to Follow-up|5|||
162717213|NCT02957539|587671749|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
162717214|NCT02957539|587671750|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
162717215|NCT02957539|587671751|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
162717216|NCT02957539|587671749|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
162717217|NCT02957539|587671750|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
162717218|NCT02957539|587671751|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
162717219|NCT00906035|587671754|FG000|Overall Study|Withdrawal by Subject|2|||
162717220|NCT00906035|587671755|FG001|Overall Study|Withdrawal by Subject|3|||
162717221|NCT00906035|587671756|FG002|Overall Study|Withdrawal by Subject|0|||
162717222|NCT01689519|587671761|FG000|Intent to Treat|Death|157|||
162717223|NCT01689519|587671762|FG001|Intent to Treat|Death|167|||
162717224|NCT01689519|587671761|FG000|Intent to Treat|Lost to Follow-up|4|||
162717225|NCT01689519|587671762|FG001|Intent to Treat|Lost to Follow-up|8|||
162717226|NCT01689519|587671761|FG000|Intent to Treat|Other|2|||
162717227|NCT01689519|587671762|FG001|Intent to Treat|Other|4|||
162717228|NCT01689519|587671761|FG000|Intent to Treat|Physician Decision|4|||
162717229|NCT01689519|587671762|FG001|Intent to Treat|Physician Decision|1|||
162717230|NCT01689519|587671761|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
162717231|NCT01689519|587671762|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
162717232|NCT01689519|587671761|FG000|Intent to Treat|Withdrawal by Subject|21|||
162717233|NCT01689519|587671762|FG001|Intent to Treat|Withdrawal by Subject|20|||
162717234|NCT01689519|587671761|FG000|Safety Population|Death|158|||
162717235|NCT01689519|587671762|FG001|Safety Population|Death|165|||
162717236|NCT01689519|587671761|FG000|Safety Population|Lost to Follow-up|4|||
162717237|NCT01689519|587671762|FG001|Safety Population|Lost to Follow-up|8|||
162717238|NCT01689519|587671761|FG000|Safety Population|Other|2|||
162717239|NCT01689519|587671762|FG001|Safety Population|Other|4|||
162717240|NCT01689519|587671761|FG000|Safety Population|Physician Decision|4|||
162717241|NCT01689519|587671762|FG001|Safety Population|Physician Decision|1|||
162717242|NCT01689519|587671761|FG000|Safety Population|Study Terminated By Sponsor|60|||
162717243|NCT01689519|587671762|FG001|Safety Population|Study Terminated By Sponsor|47|||
162717244|NCT01689519|587671761|FG000|Safety Population|Withdrawal by Subject|20|||
162717245|NCT01689519|587671762|FG001|Safety Population|Withdrawal by Subject|20|||
162717246|NCT03781336|587671764|FG000|Overall Study|Withdrawal by Subject|2|||
162717247|NCT03781336|587671765|FG001|Overall Study|Withdrawal by Subject|2|||
162717248|NCT01972152|587671766|FG000|First Treatment Visit|Lost to Follow-up|0|||
162717249|NCT01972152|587671767|FG001|First Treatment Visit|Lost to Follow-up|1|||
162717250|NCT01972152|587671768|FG002|First Treatment Visit|Lost to Follow-up|0|||
162717251|NCT01972152|587671769|FG003|First Treatment Visit|Lost to Follow-up|0|||
162717252|NCT01972152|587671770|FG004|First Treatment Visit|Lost to Follow-up|0|||
162717253|NCT01972152|587671771|FG005|First Treatment Visit|Lost to Follow-up|0|||
162717254|NCT01972152|587671766|FG000|Second Treatment Visit|Protocol Violation|0|||
162717255|NCT01972152|587671767|FG001|Second Treatment Visit|Protocol Violation|1|||
162717256|NCT01972152|587671768|FG002|Second Treatment Visit|Protocol Violation|0|||
162717257|NCT01972152|587671769|FG003|Second Treatment Visit|Protocol Violation|0|||
162717258|NCT01972152|587671770|FG004|Second Treatment Visit|Protocol Violation|0|||
162717259|NCT01972152|587671771|FG005|Second Treatment Visit|Protocol Violation|0|||
162717260|NCT00972504|587671772|FG000|Overall Study|Adverse Event|2|||
162717261|NCT00972504|587671772|FG000|Overall Study|Investigator discretion|1|||
162717262|NCT01839877|587671775|FG000|Overall Study|Protocol Violation|1|||
162717263|NCT02781584|587671779|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
162717264|NCT02781584|587671780|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
162717265|NCT02781584|587671781|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
162717266|NCT02781584|587671782|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
162717267|NCT02781584|587671783|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
162717268|NCT02781584|587671784|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
162717269|NCT02781584|587671785|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
162717270|NCT02781584|587671786|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
162717271|NCT02781584|587671787|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
162717272|NCT02781584|587671788|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
162717273|NCT02781584|587671789|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
162717274|NCT02781584|587671790|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
162717275|NCT02781584|587671791|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
162717276|NCT02781584|587671779|FG000|Pre-treatment Phase|Adverse Event|0|||
162717277|NCT02781584|587671780|FG001|Pre-treatment Phase|Adverse Event|0|||
162717278|NCT02781584|587671781|FG002|Pre-treatment Phase|Adverse Event|0|||
162717279|NCT02781584|587671782|FG003|Pre-treatment Phase|Adverse Event|0|||
162717280|NCT02781584|587671783|FG004|Pre-treatment Phase|Adverse Event|0|||
162717281|NCT02781584|587671784|FG005|Pre-treatment Phase|Adverse Event|0|||
162717282|NCT02781584|587671785|FG006|Pre-treatment Phase|Adverse Event|0|||
162717283|NCT02781584|587671786|FG007|Pre-treatment Phase|Adverse Event|0|||
162717284|NCT02781584|587671787|FG008|Pre-treatment Phase|Adverse Event|0|||
162717285|NCT02781584|587671788|FG009|Pre-treatment Phase|Adverse Event|0|||
162717286|NCT02781584|587671789|FG010|Pre-treatment Phase|Adverse Event|0|||
162717287|NCT02781584|587671790|FG011|Pre-treatment Phase|Adverse Event|1|||
162643292|NCT01641692|587409403|FG005|Treatment Period 1|Physician Decision|0|||
162643293|NCT01641692|587409404|FG006|Treatment Period 1|Physician Decision|0|||
162643294|NCT01641692|587409405|FG007|Treatment Period 1|Physician Decision|0|||
162643295|NCT01641692|587409398|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162643296|NCT01641692|587409399|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162643297|NCT01641692|587409400|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162643298|NCT01641692|587409401|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162643299|NCT01641692|587409402|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162643300|NCT01641692|587409403|FG005|Treatment Period 1|Withdrawal by Subject|2|||
162643301|NCT01641692|587409404|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162643302|NCT01641692|587409405|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162643303|NCT01641692|587409398|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
162643304|NCT01641692|587409399|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643305|NCT01641692|587409400|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643306|NCT01641692|587409401|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643307|NCT01641692|587409402|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643308|NCT01641692|587409403|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643309|NCT01641692|587409404|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643310|NCT01641692|587409405|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162643311|NCT01641692|587409398|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643312|NCT01641692|587409399|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643313|NCT01641692|587409400|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643314|NCT01641692|587409401|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643315|NCT01641692|587409402|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643316|NCT01641692|587409403|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643317|NCT01641692|587409404|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162643318|NCT01641692|587409405|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162643319|NCT01641692|587409398|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162643320|NCT01641692|587409399|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643321|NCT01641692|587409400|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162643322|NCT01641692|587409401|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162643323|NCT01641692|587409402|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162643324|NCT01641692|587409403|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643325|NCT01641692|587409404|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643326|NCT01641692|587409405|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162643327|NCT01641692|587409398|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162643328|NCT01641692|587409399|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162643329|NCT01641692|587409400|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162643330|NCT01641692|587409401|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162643331|NCT01641692|587409402|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162643332|NCT01641692|587409403|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162643333|NCT01641692|587409404|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162643334|NCT01641692|587409405|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162643335|NCT01641692|587409398|FG000|Treatment Period 2|Lack of Efficacy|1|||
162643336|NCT01641692|587409399|FG001|Treatment Period 2|Lack of Efficacy|0|||
162643337|NCT01641692|587409400|FG002|Treatment Period 2|Lack of Efficacy|0|||
162643338|NCT01641692|587409401|FG003|Treatment Period 2|Lack of Efficacy|0|||
162643339|NCT01641692|587409402|FG004|Treatment Period 2|Lack of Efficacy|0|||
162643340|NCT01641692|587409403|FG005|Treatment Period 2|Lack of Efficacy|0|||
162643341|NCT01641692|587409404|FG006|Treatment Period 2|Lack of Efficacy|0|||
162643342|NCT01641692|587409405|FG007|Treatment Period 2|Lack of Efficacy|0|||
162643343|NCT01641692|587409398|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
162643344|NCT01641692|587409399|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643345|NCT01641692|587409400|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643346|NCT01641692|587409401|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643347|NCT01641692|587409402|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643348|NCT01641692|587409403|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643349|NCT01641692|587409404|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643350|NCT01641692|587409405|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162643351|NCT01641692|587409398|FG000|Treatment Period 2|Lost to Follow-up|0|||
162643352|NCT01641692|587409399|FG001|Treatment Period 2|Lost to Follow-up|0|||
162643353|NCT01641692|587409400|FG002|Treatment Period 2|Lost to Follow-up|0|||
162643354|NCT01641692|587409401|FG003|Treatment Period 2|Lost to Follow-up|0|||
162643355|NCT01641692|587409402|FG004|Treatment Period 2|Lost to Follow-up|0|||
162643356|NCT01641692|587409403|FG005|Treatment Period 2|Lost to Follow-up|1|||
162643357|NCT01641692|587409404|FG006|Treatment Period 2|Lost to Follow-up|0|||
162643358|NCT01641692|587409405|FG007|Treatment Period 2|Lost to Follow-up|0|||
162643359|NCT01641692|587409398|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162643360|NCT01641692|587409399|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163064060|NCT03126110|588941547|FG002|Phase 1|Survival follow-up no longer necessary|1|||
162643361|NCT01641692|587409400|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162643362|NCT01641692|587409401|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162643363|NCT01641692|587409402|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162643364|NCT01641692|587409403|FG005|Treatment Period 2|Withdrawal by Subject|1|||
162643365|NCT01641692|587409404|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162643366|NCT01641692|587409405|FG007|Treatment Period 2|Withdrawal by Subject|1|||
162643367|NCT01641692|587409398|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643368|NCT01641692|587409399|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643369|NCT01641692|587409400|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643370|NCT01641692|587409401|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643371|NCT01641692|587409402|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162643372|NCT01641692|587409403|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643373|NCT01641692|587409404|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162643374|NCT01641692|587409405|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162643375|NCT01641692|587409398|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162643376|NCT01641692|587409399|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162643377|NCT01641692|587409400|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162643378|NCT01641692|587409401|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162643379|NCT01641692|587409402|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162643380|NCT01641692|587409403|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162643381|NCT01641692|587409404|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162643382|NCT01641692|587409405|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162643383|NCT01641692|587409398|FG000|Treatment Period 3|Adverse Event|0|||
162643384|NCT01641692|587409399|FG001|Treatment Period 3|Adverse Event|0|||
162643385|NCT01641692|587409400|FG002|Treatment Period 3|Adverse Event|0|||
162643386|NCT01641692|587409401|FG003|Treatment Period 3|Adverse Event|0|||
162643387|NCT01641692|587409402|FG004|Treatment Period 3|Adverse Event|0|||
162643388|NCT01641692|587409403|FG005|Treatment Period 3|Adverse Event|0|||
162643389|NCT01641692|587409404|FG006|Treatment Period 3|Adverse Event|1|||
162643390|NCT01641692|587409405|FG007|Treatment Period 3|Adverse Event|0|||
162643391|NCT01641692|587409398|FG000|Treatment Period 3|Protocol Violation|0|||
162643392|NCT01641692|587409399|FG001|Treatment Period 3|Protocol Violation|0|||
162643393|NCT01641692|587409400|FG002|Treatment Period 3|Protocol Violation|1|||
162643394|NCT01641692|587409401|FG003|Treatment Period 3|Protocol Violation|0|||
162643395|NCT01641692|587409402|FG004|Treatment Period 3|Protocol Violation|0|||
162643396|NCT01641692|587409403|FG005|Treatment Period 3|Protocol Violation|0|||
162643397|NCT01641692|587409404|FG006|Treatment Period 3|Protocol Violation|0|||
162643398|NCT01641692|587409405|FG007|Treatment Period 3|Protocol Violation|0|||
162643399|NCT01641692|587409398|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643400|NCT01641692|587409399|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643401|NCT01641692|587409400|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643402|NCT01641692|587409401|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643403|NCT01641692|587409402|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643404|NCT01641692|587409403|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643405|NCT01641692|587409404|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162643406|NCT01641692|587409405|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162643407|NCT01641692|587409398|FG000|Treatment Period 3|Lost to Follow-up|0|||
162643408|NCT01641692|587409399|FG001|Treatment Period 3|Lost to Follow-up|1|||
162643409|NCT01641692|587409400|FG002|Treatment Period 3|Lost to Follow-up|0|||
162643410|NCT01641692|587409401|FG003|Treatment Period 3|Lost to Follow-up|0|||
162643411|NCT01641692|587409402|FG004|Treatment Period 3|Lost to Follow-up|0|||
162643412|NCT01641692|587409403|FG005|Treatment Period 3|Lost to Follow-up|0|||
162643413|NCT01641692|587409404|FG006|Treatment Period 3|Lost to Follow-up|0|||
162643414|NCT01641692|587409405|FG007|Treatment Period 3|Lost to Follow-up|0|||
162643415|NCT01641692|587409398|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643416|NCT01641692|587409399|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643417|NCT01641692|587409400|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643418|NCT01641692|587409401|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643419|NCT01641692|587409402|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643420|NCT01641692|587409403|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
162643421|NCT01641692|587409404|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643422|NCT01641692|587409405|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
162643423|NCT01641692|587409398|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162643424|NCT01641692|587409399|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162643425|NCT01641692|587409400|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162643426|NCT01641692|587409401|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162643427|NCT01641692|587409402|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162643428|NCT01641692|587409403|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162717288|NCT02781584|587671791|FG012|Pre-treatment Phase|Adverse Event|0|||
162717289|NCT02781584|587671779|FG000|Treatment Phase|Withdrew Consent|0|||
162717290|NCT02781584|587671780|FG001|Treatment Phase|Withdrew Consent|0|||
162717291|NCT02781584|587671781|FG002|Treatment Phase|Withdrew Consent|0|||
162717292|NCT02781584|587671782|FG003|Treatment Phase|Withdrew Consent|0|||
162717293|NCT02781584|587671783|FG004|Treatment Phase|Withdrew Consent|0|||
162717294|NCT02781584|587671784|FG005|Treatment Phase|Withdrew Consent|1|||
162717295|NCT02781584|587671785|FG006|Treatment Phase|Withdrew Consent|0|||
162717296|NCT02781584|587671786|FG007|Treatment Phase|Withdrew Consent|0|||
162717297|NCT02781584|587671787|FG008|Treatment Phase|Withdrew Consent|0|||
162717298|NCT02781584|587671788|FG009|Treatment Phase|Withdrew Consent|0|||
162717299|NCT02781584|587671789|FG010|Treatment Phase|Withdrew Consent|1|||
162717300|NCT02781584|587671790|FG011|Treatment Phase|Withdrew Consent|2|||
162717301|NCT02781584|587671791|FG012|Treatment Phase|Withdrew Consent|0|||
162717302|NCT02781584|587671779|FG000|Treatment Phase|Adverse Event|0|||
162717303|NCT02781584|587671780|FG001|Treatment Phase|Adverse Event|0|||
162717304|NCT02781584|587671781|FG002|Treatment Phase|Adverse Event|0|||
162717305|NCT02781584|587671782|FG003|Treatment Phase|Adverse Event|0|||
162717306|NCT02781584|587671783|FG004|Treatment Phase|Adverse Event|0|||
162717307|NCT02781584|587671784|FG005|Treatment Phase|Adverse Event|0|||
162717308|NCT02781584|587671785|FG006|Treatment Phase|Adverse Event|0|||
162717309|NCT02781584|587671786|FG007|Treatment Phase|Adverse Event|1|||
162717310|NCT02781584|587671787|FG008|Treatment Phase|Adverse Event|0|||
162717311|NCT02781584|587671788|FG009|Treatment Phase|Adverse Event|0|||
162717312|NCT02781584|587671789|FG010|Treatment Phase|Adverse Event|0|||
162717313|NCT02781584|587671790|FG011|Treatment Phase|Adverse Event|0|||
162717314|NCT02781584|587671791|FG012|Treatment Phase|Adverse Event|0|||
162717315|NCT00554801|587671794|FG000|Overall Study|left area before completion|5|||
162717316|NCT00554801|587671795|FG001|Overall Study|left area before completion|0|||
162717317|NCT00554801|587671794|FG000|Overall Study|Withdrawal by Subject|14|||
162717318|NCT00554801|587671795|FG001|Overall Study|Withdrawal by Subject|0|||
162717319|NCT00768651|587671800|FG000|Overall Study|Withdrawal by Subject|1|||
162717320|NCT02104765|587671801|FG000|Overall Study|Lost to Follow-up|0|||
162717321|NCT02104765|587671802|FG001|Overall Study|Lost to Follow-up|0|||
162717322|NCT02104765|587671803|FG002|Overall Study|Lost to Follow-up|1|||
162717323|NCT02104765|587671804|FG003|Overall Study|Lost to Follow-up|0|||
162717324|NCT02104765|587671805|FG004|Overall Study|Lost to Follow-up|0|||
162717325|NCT02104765|587671806|FG005|Overall Study|Lost to Follow-up|0|||
162717326|NCT02104765|587671807|FG006|Overall Study|Lost to Follow-up|0|||
162717327|NCT02104765|587671801|FG000|Overall Study|Withdrawal by Subject|0|||
162717328|NCT02104765|587671802|FG001|Overall Study|Withdrawal by Subject|0|||
162717329|NCT02104765|587671803|FG002|Overall Study|Withdrawal by Subject|0|||
162717330|NCT02104765|587671804|FG003|Overall Study|Withdrawal by Subject|1|||
162717331|NCT02104765|587671805|FG004|Overall Study|Withdrawal by Subject|1|||
162717332|NCT02104765|587671806|FG005|Overall Study|Withdrawal by Subject|0|||
162717333|NCT02104765|587671807|FG006|Overall Study|Withdrawal by Subject|1|||
162717334|NCT04771273|587671808|FG000|Dose Escalation Period|Not treated with trial medication|0|||
162717335|NCT04771273|587671809|FG001|Dose Escalation Period|Not treated with trial medication|1|||
162717336|NCT04771273|587671810|FG002|Dose Escalation Period|Not treated with trial medication|1|||
162717337|NCT04771273|587671811|FG003|Dose Escalation Period|Not treated with trial medication|0|||
162717338|NCT04771273|587671808|FG000|Dose Escalation Period|Other reasons than listed|2|||
162717339|NCT04771273|587671809|FG001|Dose Escalation Period|Other reasons than listed|0|||
162717340|NCT04771273|587671810|FG002|Dose Escalation Period|Other reasons than listed|2|||
162717341|NCT04771273|587671811|FG003|Dose Escalation Period|Other reasons than listed|1|||
162717342|NCT04771273|587671808|FG000|Dose Escalation Period|Protocol Violation|0|||
162717343|NCT04771273|587671809|FG001|Dose Escalation Period|Protocol Violation|0|||
162717344|NCT04771273|587671810|FG002|Dose Escalation Period|Protocol Violation|3|||
162717345|NCT04771273|587671811|FG003|Dose Escalation Period|Protocol Violation|1|||
162717346|NCT04771273|587671808|FG000|Dose Escalation Period|Burden of study procedures|1|||
162717347|NCT04771273|587671809|FG001|Dose Escalation Period|Burden of study procedures|0|||
162717348|NCT04771273|587671810|FG002|Dose Escalation Period|Burden of study procedures|0|||
162717349|NCT04771273|587671811|FG003|Dose Escalation Period|Burden of study procedures|0|||
162717350|NCT04771273|587671808|FG000|Dose Escalation Period|Change of residence|0|||
162717351|NCT04771273|587671809|FG001|Dose Escalation Period|Change of residence|0|||
162717352|NCT04771273|587671810|FG002|Dose Escalation Period|Change of residence|0|||
162717353|NCT04771273|587671811|FG003|Dose Escalation Period|Change of residence|1|||
162717354|NCT04771273|587671808|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
162717355|NCT04771273|587671809|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
162717356|NCT04771273|587671810|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
162717357|NCT04771273|587671811|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
162717358|NCT04771273|587671808|FG000|Dose Escalation Period|Adverse Event|8|||
162717359|NCT04771273|587671809|FG001|Dose Escalation Period|Adverse Event|9|||
162717360|NCT04771273|587671810|FG002|Dose Escalation Period|Adverse Event|12|||
162717361|NCT04771273|587671811|FG003|Dose Escalation Period|Adverse Event|2|||
162717362|NCT04771273|587671808|FG000|Maintenance Period|Other than listed|4|||
162717363|NCT04771273|587671809|FG001|Maintenance Period|Other than listed|2|||
162717364|NCT04771273|587671810|FG002|Maintenance Period|Other than listed|0|||
162717365|NCT04771273|587671811|FG003|Maintenance Period|Other than listed|3|||
162717366|NCT04771273|587671808|FG000|Maintenance Period|Burden of study procedures|1|||
162717367|NCT04771273|587671809|FG001|Maintenance Period|Burden of study procedures|0|||
162717368|NCT04771273|587671810|FG002|Maintenance Period|Burden of study procedures|0|||
162717369|NCT04771273|587671811|FG003|Maintenance Period|Burden of study procedures|0|||
162717370|NCT04771273|587671808|FG000|Maintenance Period|Change of residence|0|||
162717371|NCT04771273|587671809|FG001|Maintenance Period|Change of residence|1|||
162717372|NCT04771273|587671810|FG002|Maintenance Period|Change of residence|3|||
162717373|NCT04771273|587671811|FG003|Maintenance Period|Change of residence|0|||
162717374|NCT04771273|587671808|FG000|Maintenance Period|Perceived lack of efficacy|0|||
162717375|NCT04771273|587671809|FG001|Maintenance Period|Perceived lack of efficacy|0|||
162717376|NCT04771273|587671810|FG002|Maintenance Period|Perceived lack of efficacy|0|||
162717377|NCT04771273|587671811|FG003|Maintenance Period|Perceived lack of efficacy|1|||
162717378|NCT04771273|587671808|FG000|Maintenance Period|Adverse Event|4|||
162717379|NCT04771273|587671809|FG001|Maintenance Period|Adverse Event|5|||
162717380|NCT04771273|587671810|FG002|Maintenance Period|Adverse Event|5|||
162717381|NCT04771273|587671811|FG003|Maintenance Period|Adverse Event|0|||
162717382|NCT05196737|587671812|FG000|Non-intervention Week|Lost to Follow-up|2|||
162717383|NCT05196737|587671812|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
162717384|NCT02357784|587671813|FG000|Overall Study|Withdrawal by Subject|1|||
162717385|NCT00462943|587671814|FG000|Overall Study|Failure to achieve a response|5|||
162717386|NCT00462943|587671815|FG001|Overall Study|Failure to achieve a response|5|||
162717387|NCT00462943|587671816|FG002|Overall Study|Failure to achieve a response|1|||
162717388|NCT00462943|587671814|FG000|Overall Study|Adverse Event|6|||
162717389|NCT00462943|587671815|FG001|Overall Study|Adverse Event|4|||
162717390|NCT00462943|587671816|FG002|Overall Study|Adverse Event|1|||
162717391|NCT00462943|587671814|FG000|Overall Study|Protocol Violation|1|||
162717392|NCT00462943|587671815|FG001|Overall Study|Protocol Violation|0|||
162717393|NCT00462943|587671816|FG002|Overall Study|Protocol Violation|0|||
162717394|NCT00462943|587671814|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
162717395|NCT00462943|587671815|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
162717396|NCT00462943|587671816|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
162717397|NCT00462943|587671814|FG000|Overall Study|Disease Progression|15|||
162717398|NCT00462943|587671815|FG001|Overall Study|Disease Progression|15|||
162717399|NCT00462943|587671816|FG002|Overall Study|Disease Progression|9|||
162717400|NCT00462943|587671814|FG000|Overall Study|Death|5|||
162717401|NCT00462943|587671815|FG001|Overall Study|Death|2|||
162717402|NCT00462943|587671816|FG002|Overall Study|Death|7|||
162717403|NCT00462943|587671814|FG000|Overall Study|Stem Cell Transplant|1|||
162717404|NCT00462943|587671815|FG001|Overall Study|Stem Cell Transplant|1|||
162717405|NCT00462943|587671816|FG002|Overall Study|Stem Cell Transplant|0|||
162717406|NCT00462943|587671814|FG000|Overall Study|Bone Marrow Transplant|1|||
162717407|NCT00462943|587671815|FG001|Overall Study|Bone Marrow Transplant|0|||
162717408|NCT00462943|587671816|FG002|Overall Study|Bone Marrow Transplant|0|||
162717409|NCT00462943|587671814|FG000|Overall Study|Required Lymphocyte Infusion|1|||
162717410|NCT00462943|587671815|FG001|Overall Study|Required Lymphocyte Infusion|0|||
162717411|NCT00462943|587671816|FG002|Overall Study|Required Lymphocyte Infusion|0|||
162717412|NCT00462943|587671814|FG000|Overall Study|Transplant - not specified|1|||
162717413|NCT00462943|587671815|FG001|Overall Study|Transplant - not specified|0|||
162717414|NCT00462943|587671816|FG002|Overall Study|Transplant - not specified|1|||
162717415|NCT00462943|587671814|FG000|Overall Study|Physician Decision|1|||
162717416|NCT00462943|587671815|FG001|Overall Study|Physician Decision|0|||
162717417|NCT00462943|587671816|FG002|Overall Study|Physician Decision|0|||
162717418|NCT00462943|587671814|FG000|Overall Study|Withdrawal by Subject|0|||
162717419|NCT00462943|587671815|FG001|Overall Study|Withdrawal by Subject|1|||
162717420|NCT00462943|587671816|FG002|Overall Study|Withdrawal by Subject|0|||
162717421|NCT00995709|587671817|FG000|Overall Study|Adverse Event|4|||
162717422|NCT00995709|587671818|FG001|Overall Study|Adverse Event|2|||
162717423|NCT00995709|587671819|FG002|Overall Study|Adverse Event|0|||
162717424|NCT00995709|587671817|FG000|Overall Study|Lack of Efficacy|0|||
162717425|NCT00995709|587671818|FG001|Overall Study|Lack of Efficacy|1|||
162717426|NCT00995709|587671819|FG002|Overall Study|Lack of Efficacy|4|||
162717427|NCT00995709|587671817|FG000|Overall Study|Withdrawal by Subject|0|||
162717428|NCT00995709|587671818|FG001|Overall Study|Withdrawal by Subject|4|||
162717429|NCT00995709|587671819|FG002|Overall Study|Withdrawal by Subject|1|||
162717430|NCT00995709|587671817|FG000|Overall Study|Lost to Follow-up|1|||
162717431|NCT00995709|587671818|FG001|Overall Study|Lost to Follow-up|0|||
162717432|NCT00995709|587671819|FG002|Overall Study|Lost to Follow-up|0|||
162717433|NCT00995709|587671817|FG000|Overall Study|Death|0|||
162717434|NCT00995709|587671818|FG001|Overall Study|Death|1|||
162717435|NCT00995709|587671819|FG002|Overall Study|Death|0|||
162717436|NCT00995709|587671817|FG000|Overall Study|Protocol Violation|2|||
162717437|NCT00995709|587671818|FG001|Overall Study|Protocol Violation|1|||
162717438|NCT00995709|587671819|FG002|Overall Study|Protocol Violation|0|||
162717439|NCT02698241|587671821|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
162717440|NCT02698241|587671821|FG000|Overall Study|Screening not met|7|||
162717441|NCT02698241|587671821|FG000|Overall Study|Withdrawal by Subject|7|||
162717442|NCT02698241|587671821|FG000|Overall Study|Physician Decision|2|||
162717443|NCT02698241|587671821|FG000|Overall Study|Subject underwent system modification|2|||
162717444|NCT02698241|587671821|FG000|Overall Study|Lost to Follow-up|3|||
162717445|NCT02698241|587671821|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
162717446|NCT02698241|587671821|FG000|Overall Study|geographic and licensing issue|1|||
162717447|NCT02698241|587671821|FG000|Overall Study|Death|2|||
162717448|NCT01543685|587671824|FG000|Overall Study|Lack of Efficacy|1|||
162717449|NCT01543685|587671825|FG001|Overall Study|Lack of Efficacy|2|||
162717450|NCT01543685|587671826|FG002|Overall Study|Lack of Efficacy|2|||
162717451|NCT01543685|587671827|FG003|Overall Study|Lack of Efficacy|0|||
162717452|NCT01543685|587671828|FG004|Overall Study|Lack of Efficacy|2|||
162717453|NCT01543685|587671824|FG000|Overall Study|Adverse Event|2|||
162717454|NCT01543685|587671825|FG001|Overall Study|Adverse Event|1|||
162717455|NCT01543685|587671826|FG002|Overall Study|Adverse Event|0|||
162717456|NCT01543685|587671827|FG003|Overall Study|Adverse Event|0|||
162717457|NCT01543685|587671828|FG004|Overall Study|Adverse Event|2|||
162717458|NCT00604721|587671829|FG000|Overall Study|Physician Decision|1|||
162717459|NCT00604721|587671829|FG000|Overall Study|Withdrawal by Subject|1|||
162717460|NCT04776213|587671832|FG000|Overall Study|Other|1|||
162717461|NCT04776213|587671832|FG000|Overall Study|Withdrawal by Subject|7|||
162717462|NCT04776213|587671832|FG000|Overall Study|Protocol Violation|1|||
162717463|NCT04776213|587671832|FG000|Overall Study|Lost to Follow-up|2|||
162717464|NCT01838551|587671834|FG000|Overall Study|Adverse Event|16|||
162717465|NCT01838551|587671834|FG000|Overall Study|Death|1|||
162717466|NCT01838551|587671834|FG000|Overall Study|Lack of Efficacy|10|||
162717467|NCT01838551|587671834|FG000|Overall Study|Physician Decision|4|||
162717468|NCT01838551|587671834|FG000|Overall Study|Withdrawal by Subject|10|||
162717469|NCT01838551|587671834|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
162717470|NCT00906282|587671835|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162717471|NCT00906282|587671835|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
162717472|NCT00906282|587671835|FG000|Preoperative Chemotherapy|Progressive disease|6|||
162717473|NCT00906282|587671835|FG000|Preoperative Chemotherapy|Toxicity|1|||
162717474|NCT00038103|587671836|FG000|Overall Study|Adverse Event|5|||
162717475|NCT00038103|587671837|FG001|Overall Study|Adverse Event|6|||
162717476|NCT00038103|587671836|FG000|Overall Study|Lack of Efficacy|48|||
162717477|NCT00038103|587671837|FG001|Overall Study|Lack of Efficacy|41|||
162717478|NCT00038103|587671836|FG000|Overall Study|Withdrawal by Subject|0|||
162717479|NCT00038103|587671837|FG001|Overall Study|Withdrawal by Subject|3|||
162717480|NCT00038103|587671836|FG000|Overall Study|Lost to Follow-up|0|||
162717481|NCT00038103|587671837|FG001|Overall Study|Lost to Follow-up|3|||
162717482|NCT00038103|587671836|FG000|Overall Study|Protocol Violation|0|||
162717483|NCT00038103|587671837|FG001|Overall Study|Protocol Violation|2|||
162717484|NCT00038103|587671836|FG000|Overall Study|Sponsor Decision|0|||
162717485|NCT00038103|587671837|FG001|Overall Study|Sponsor Decision|1|||
162717486|NCT00038103|587671836|FG000|Overall Study|Randomized/never treated|2|||
162717487|NCT00038103|587671837|FG001|Overall Study|Randomized/never treated|0|||
162717488|NCT02163915|587671842|FG000|Overall Study|Withdrawal by Subject|2|||
162717489|NCT02163915|587671843|FG001|Overall Study|Withdrawal by Subject|0|||
162717490|NCT02163915|587671844|FG002|Overall Study|Withdrawal by Subject|2|||
162717491|NCT02163915|587671845|FG003|Overall Study|Withdrawal by Subject|2|||
162717492|NCT02163915|587671846|FG004|Overall Study|Withdrawal by Subject|2|||
162717493|NCT02163915|587671842|FG000|Overall Study|Study termination|1|||
162717494|NCT02163915|587671843|FG001|Overall Study|Study termination|0|||
162717495|NCT02163915|587671844|FG002|Overall Study|Study termination|0|||
162717496|NCT02163915|587671845|FG003|Overall Study|Study termination|0|||
162717497|NCT02163915|587671846|FG004|Overall Study|Study termination|2|||
162717498|NCT02163915|587671842|FG000|Overall Study|Physician Decision|0|||
162717499|NCT02163915|587671843|FG001|Overall Study|Physician Decision|0|||
162717500|NCT02163915|587671844|FG002|Overall Study|Physician Decision|0|||
162717501|NCT02163915|587671845|FG003|Overall Study|Physician Decision|1|||
162717502|NCT02163915|587671846|FG004|Overall Study|Physician Decision|0|||
162717503|NCT02299336|587671851|FG000|Overall Study|Withdrawal by Subject|11|||
162717504|NCT02299336|587671851|FG000|Overall Study|Adverse Event|1|||
162717505|NCT02299336|587671851|FG000|Overall Study|Death|1|||
162717506|NCT02299336|587671851|FG000|Overall Study|Lost to Follow-up|1|||
162717507|NCT02013037|587671853|FG000|Overall Study|Death|6|||
162717508|NCT02013037|587671853|FG000|Overall Study|Withdrawal by Subject|1|||
162717509|NCT02013037|587671853|FG000|Overall Study|Awaiting Transplantation|7|||
162717510|NCT02013037|587671853|FG000|Overall Study|Transplanted without DSA|2|||
162717511|NCT02465359|587671854|FG000|Overall Study|Lack of Efficacy|1|||
162717512|NCT02465359|587671854|FG000|Overall Study|Withdrawal by Subject|1|||
162717513|NCT02465359|587671854|FG000|Overall Study|Adverse Event|1|||
162717514|NCT01304147|587671855|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
162717515|NCT01304147|587671856|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
162717516|NCT02812966|587671859|FG000|Overall Study|Death|1|||
162717517|NCT02812966|587671860|FG001|Overall Study|Death|0|||
162717518|NCT01066923|587671861|FG000|Overall Study|Withdrawal by Subject|3|||
162717519|NCT01066923|587671862|FG001|Overall Study|Withdrawal by Subject|3|||
162717520|NCT01066923|587671863|FG002|Overall Study|Withdrawal by Subject|8|||
162717521|NCT01066923|587671864|FG003|Overall Study|Withdrawal by Subject|8|||
162717522|NCT02577523|587673375|FG000|Overall Study|Adverse Event|1|||
162717523|NCT02577523|587673376|FG001|Overall Study|Adverse Event|1|||
162717524|NCT02577523|587673375|FG000|Overall Study|Lack of Efficacy|1|||
162717525|NCT02577523|587673376|FG001|Overall Study|Lack of Efficacy|1|||
162717526|NCT02577523|587673375|FG000|Overall Study|Withdrawal by Subject|1|||
162717527|NCT02577523|587673376|FG001|Overall Study|Withdrawal by Subject|0|||
162717528|NCT00864682|587673386|FG000|Overall Study|Protocol Violation|2|||
162717529|NCT00864682|587673387|FG001|Overall Study|Protocol Violation|1|||
162717530|NCT00864682|587673388|FG002|Overall Study|Protocol Violation|2|||
162717531|NCT02506257|587673391|FG000|Overall Study|Adverse Event|0|||
162717532|NCT02506257|587673392|FG001|Overall Study|Adverse Event|2|||
162717533|NCT02506257|587673393|FG002|Overall Study|Adverse Event|3|||
162717534|NCT02506257|587673394|FG003|Overall Study|Adverse Event|0|||
162717535|NCT02506257|587673391|FG000|Overall Study|Protocol Violation|0|||
162717536|NCT02506257|587673392|FG001|Overall Study|Protocol Violation|0|||
162717537|NCT02506257|587673393|FG002|Overall Study|Protocol Violation|1|||
162717538|NCT02506257|587673394|FG003|Overall Study|Protocol Violation|0|||
162717539|NCT01563354|587673396|FG000|Core Phase|Adverse Event|5|||
162717540|NCT01563354|587673397|FG001|Core Phase|Adverse Event|15|||
162717541|NCT01563354|587673398|FG002|Core Phase|Adverse Event|13|||
162717542|NCT01563354|587673396|FG000|Core Phase|Withdrawal by Subject|1|||
162717543|NCT01563354|587673397|FG001|Core Phase|Withdrawal by Subject|0|||
162717544|NCT01563354|587673398|FG002|Core Phase|Withdrawal by Subject|3|||
162717545|NCT01563354|587673396|FG000|Core Phase|Lost to Follow-up|1|||
162717546|NCT01563354|587673397|FG001|Core Phase|Lost to Follow-up|0|||
162717547|NCT01563354|587673398|FG002|Core Phase|Lost to Follow-up|0|||
162717548|NCT01563354|587673396|FG000|Core Phase|Death|1|||
162717549|NCT01563354|587673397|FG001|Core Phase|Death|5|||
162717550|NCT01563354|587673398|FG002|Core Phase|Death|2|||
162717551|NCT01563354|587673396|FG000|Core Phase|Diseasse progression|18|||
162717552|NCT01563354|587673397|FG001|Core Phase|Diseasse progression|7|||
162717553|NCT01563354|587673398|FG002|Core Phase|Diseasse progression|8|||
162717554|NCT01563354|587673396|FG000|Core Phase|Protocol deviation|2|||
162717555|NCT01563354|587673397|FG001|Core Phase|Protocol deviation|0|||
162717556|NCT01563354|587673398|FG002|Core Phase|Protocol deviation|0|||
162717557|NCT01563354|587673396|FG000|Core Phase|PI decision - did not enter extension|0|||
162717558|NCT01563354|587673397|FG001|Core Phase|PI decision - did not enter extension|1|||
162717559|NCT01563354|587673398|FG002|Core Phase|PI decision - did not enter extension|0|||
162717560|NCT01563354|587673396|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
162717561|NCT01563354|587673397|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
162717562|NCT01563354|587673398|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
162717563|NCT01563354|587673396|FG000|Extension Phase|Adverse Event|0|||
162717564|NCT01563354|587673397|FG001|Extension Phase|Adverse Event|3|||
162717565|NCT01563354|587673398|FG002|Extension Phase|Adverse Event|2|||
162717566|NCT01563354|587673396|FG000|Extension Phase|Withdrawal by Subject|0|||
162717567|NCT01563354|587673397|FG001|Extension Phase|Withdrawal by Subject|1|||
162717568|NCT01563354|587673398|FG002|Extension Phase|Withdrawal by Subject|0|||
162717569|NCT01563354|587673396|FG000|Extension Phase|Administration problems|3|||
162717570|NCT01563354|587673397|FG001|Extension Phase|Administration problems|2|||
162717571|NCT01563354|587673398|FG002|Extension Phase|Administration problems|3|||
162717572|NCT01563354|587673396|FG000|Extension Phase|Disease progression|9|||
162717573|NCT01563354|587673397|FG001|Extension Phase|Disease progression|8|||
162717574|NCT01563354|587673398|FG002|Extension Phase|Disease progression|10|||
162717575|NCT03058991|587673408|FG000|Overall Study|Lost to Follow-up|17|||
162717576|NCT03058991|587673409|FG001|Overall Study|Lost to Follow-up|12|||
162717577|NCT03058991|587673410|FG002|Overall Study|Lost to Follow-up|12|||
162717578|NCT03058991|587673408|FG000|Overall Study|Withdrawal by Subject|1|||
162717579|NCT03058991|587673409|FG001|Overall Study|Withdrawal by Subject|0|||
162717580|NCT03058991|587673410|FG002|Overall Study|Withdrawal by Subject|0|||
162717581|NCT01050569|587673414|FG000|Overall Study|Lost to Follow-up|20|||
162717582|NCT01050569|587673415|FG001|Overall Study|Lost to Follow-up|14|||
162717583|NCT01050569|587673416|FG002|Overall Study|Lost to Follow-up|16|||
162717584|NCT01050569|587673414|FG000|Overall Study|Withdrawal by Subject|9|||
162717585|NCT01050569|587673415|FG001|Overall Study|Withdrawal by Subject|3|||
162643429|NCT01641692|587409404|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162643430|NCT01641692|587409405|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162643431|NCT01166178|587409406|FG000|Overall Study|Withdrawal by Subject|1|||
162643432|NCT01166178|587409407|FG001|Overall Study|Withdrawal by Subject|0|||
162643433|NCT01166178|587409406|FG000|Overall Study|Study was terminated|20|||
162643434|NCT01166178|587409407|FG001|Overall Study|Study was terminated|8|||
162643435|NCT04948450|587409408|FG000|Overall Study|Return home|1|||
162643436|NCT04948450|587409409|FG001|Overall Study|Return home|3|||
162643437|NCT01173718|587409420|FG000|Overall Study|Death|17|||
162643438|NCT01173718|587409420|FG000|Overall Study|Abandonment of study graft|27|||
162643439|NCT02738151|587409421|FG000|Overall Study|Randomized but not treated|4|||
162643440|NCT02738151|587409422|FG001|Overall Study|Randomized but not treated|1|||
162643441|NCT02738151|587409421|FG000|Overall Study|Adverse Event|4|||
162643442|NCT02738151|587409422|FG001|Overall Study|Adverse Event|5|||
162643443|NCT02738151|587409421|FG000|Overall Study|Hypoglycemia|0|||
162643444|NCT02738151|587409422|FG001|Overall Study|Hypoglycemia|1|||
162643445|NCT02738151|587409421|FG000|Overall Study|Poor Compliance to Protocol|4|||
162643446|NCT02738151|587409422|FG001|Overall Study|Poor Compliance to Protocol|3|||
162643447|NCT02738151|587409421|FG000|Overall Study|Other than specified above|11|||
162643448|NCT02738151|587409422|FG001|Overall Study|Other than specified above|21|||
162643449|NCT03333044|587409423|FG000|Overall Study|Pregnancy|1|||
162643450|NCT03333044|587409424|FG001|Overall Study|Pregnancy|0|||
162643451|NCT03333044|587409425|FG002|Overall Study|Pregnancy|0|||
162643452|NCT03333044|587409423|FG000|Overall Study|Lost to Follow-up|0|||
162643453|NCT03333044|587409424|FG001|Overall Study|Lost to Follow-up|14|||
162643454|NCT03333044|587409425|FG002|Overall Study|Lost to Follow-up|6|||
162643455|NCT04007094|587409433|FG000|Overall Study|Lost to Follow-up|1|||
162643456|NCT04007094|587409434|FG001|Overall Study|Lost to Follow-up|1|||
162643457|NCT02921776|587409435|FG000|Overall Study|patient deterioration, fatigue|2|||
162643458|NCT02921776|587409436|FG001|Overall Study|patient deterioration, fatigue|6|||
162643459|NCT02921776|587409437|FG002|Overall Study|patient deterioration, fatigue|0|||
162643460|NCT02921776|587409438|FG003|Overall Study|patient deterioration, fatigue|0|||
162643461|NCT02921776|587409439|FG004|Overall Study|patient deterioration, fatigue|0|||
162643462|NCT02921776|587409440|FG005|Overall Study|patient deterioration, fatigue|0|||
162643463|NCT02921776|587409441|FG006|Overall Study|patient deterioration, fatigue|0|||
162643464|NCT02921776|587409442|FG007|Overall Study|patient deterioration, fatigue|0|||
162643465|NCT02921776|587409435|FG000|Overall Study|Withdrawal by Subject|0|||
162643466|NCT02921776|587409436|FG001|Overall Study|Withdrawal by Subject|2|||
162643467|NCT02921776|587409437|FG002|Overall Study|Withdrawal by Subject|0|||
162643468|NCT02921776|587409438|FG003|Overall Study|Withdrawal by Subject|1|||
162643469|NCT02921776|587409439|FG004|Overall Study|Withdrawal by Subject|1|||
162643470|NCT02921776|587409440|FG005|Overall Study|Withdrawal by Subject|0|||
162643471|NCT02921776|587409441|FG006|Overall Study|Withdrawal by Subject|8|||
162643472|NCT02921776|587409442|FG007|Overall Study|Withdrawal by Subject|1|||
162643473|NCT02921776|587409435|FG000|Overall Study|Death|0|||
162643474|NCT02921776|587409436|FG001|Overall Study|Death|0|||
162643475|NCT02921776|587409437|FG002|Overall Study|Death|0|||
162643476|NCT02921776|587409438|FG003|Overall Study|Death|2|||
162643477|NCT02921776|587409439|FG004|Overall Study|Death|0|||
162643478|NCT02921776|587409440|FG005|Overall Study|Death|0|||
162643479|NCT02921776|587409441|FG006|Overall Study|Death|0|||
162643480|NCT02921776|587409442|FG007|Overall Study|Death|0|||
162643481|NCT02921776|587409435|FG000|Overall Study|extubation or early discharge|0|||
162643482|NCT02921776|587409436|FG001|Overall Study|extubation or early discharge|0|||
162643483|NCT02921776|587409437|FG002|Overall Study|extubation or early discharge|0|||
162643484|NCT02921776|587409438|FG003|Overall Study|extubation or early discharge|5|||
162643485|NCT02921776|587409439|FG004|Overall Study|extubation or early discharge|5|||
162643486|NCT02921776|587409440|FG005|Overall Study|extubation or early discharge|0|||
162643487|NCT02921776|587409441|FG006|Overall Study|extubation or early discharge|0|||
162643488|NCT02921776|587409442|FG007|Overall Study|extubation or early discharge|0|||
162643489|NCT02921776|587409435|FG000|Overall Study|Lost to Follow-up|0|||
162643490|NCT02921776|587409436|FG001|Overall Study|Lost to Follow-up|0|||
162643491|NCT02921776|587409437|FG002|Overall Study|Lost to Follow-up|0|||
162643492|NCT02921776|587409438|FG003|Overall Study|Lost to Follow-up|0|||
162643493|NCT02921776|587409439|FG004|Overall Study|Lost to Follow-up|0|||
162643494|NCT02921776|587409440|FG005|Overall Study|Lost to Follow-up|2|||
162643495|NCT02921776|587409441|FG006|Overall Study|Lost to Follow-up|3|||
162643496|NCT02921776|587409442|FG007|Overall Study|Lost to Follow-up|6|||
162643497|NCT01239368|587411646|FG000|Overall Study|Principal investigator discretion|1|||
162643498|NCT01239368|587411647|FG001|Overall Study|Principal investigator discretion|0|||
162643499|NCT01239368|587411648|FG002|Overall Study|Principal investigator discretion|0|||
162643500|NCT01239368|587411649|FG003|Overall Study|Principal investigator discretion|0|||
162643501|NCT01239368|587411650|FG004|Overall Study|Principal investigator discretion|1|||
162643502|NCT01239368|587411651|FG005|Overall Study|Principal investigator discretion|2|||
162643503|NCT01239368|587411652|FG006|Overall Study|Principal investigator discretion|0|||
162643504|NCT01239368|587411653|FG007|Overall Study|Principal investigator discretion|0|||
162643505|NCT01239368|587411654|FG008|Overall Study|Principal investigator discretion|0|||
162643506|NCT01239368|587411655|FG009|Overall Study|Principal investigator discretion|1|||
162643507|NCT01239368|587411646|FG000|Overall Study|Disease progression on study|1|||
162643508|NCT01239368|587411647|FG001|Overall Study|Disease progression on study|1|||
162643509|NCT01239368|587411648|FG002|Overall Study|Disease progression on study|1|||
162643510|NCT01239368|587411649|FG003|Overall Study|Disease progression on study|1|||
162643511|NCT01239368|587411650|FG004|Overall Study|Disease progression on study|4|||
162643512|NCT01239368|587411651|FG005|Overall Study|Disease progression on study|2|||
162643513|NCT01239368|587411652|FG006|Overall Study|Disease progression on study|5|||
162643514|NCT01239368|587411653|FG007|Overall Study|Disease progression on study|0|||
162643515|NCT01239368|587411654|FG008|Overall Study|Disease progression on study|0|||
162643516|NCT01239368|587411655|FG009|Overall Study|Disease progression on study|2|||
162643517|NCT01239368|587411646|FG000|Overall Study|Refused further treatment|0|||
162643518|NCT01239368|587411647|FG001|Overall Study|Refused further treatment|0|||
162643519|NCT01239368|587411648|FG002|Overall Study|Refused further treatment|0|||
162643520|NCT01239368|587411649|FG003|Overall Study|Refused further treatment|0|||
162643521|NCT01239368|587411650|FG004|Overall Study|Refused further treatment|0|||
162643522|NCT01239368|587411651|FG005|Overall Study|Refused further treatment|0|||
162643523|NCT01239368|587411652|FG006|Overall Study|Refused further treatment|0|||
162643524|NCT01239368|587411653|FG007|Overall Study|Refused further treatment|0|||
162643525|NCT01239368|587411654|FG008|Overall Study|Refused further treatment|0|||
162643526|NCT01239368|587411655|FG009|Overall Study|Refused further treatment|1|||
162643527|NCT01239368|587411646|FG000|Overall Study|Death|0|||
162643528|NCT01239368|587411647|FG001|Overall Study|Death|0|||
162643529|NCT01239368|587411648|FG002|Overall Study|Death|0|||
162643530|NCT01239368|587411649|FG003|Overall Study|Death|0|||
162643531|NCT01239368|587411650|FG004|Overall Study|Death|0|||
162643532|NCT01239368|587411651|FG005|Overall Study|Death|0|||
162643533|NCT01239368|587411652|FG006|Overall Study|Death|1|||
162643534|NCT01239368|587411653|FG007|Overall Study|Death|0|||
162643535|NCT01239368|587411654|FG008|Overall Study|Death|0|||
162643536|NCT01239368|587411655|FG009|Overall Study|Death|0|||
162643537|NCT03181399|587411657|FG000|6 Months on Treatment|Protocol non-compliance|7|||
162643538|NCT03181399|587411657|FG000|6 Months on Treatment|Adverse Event|4|||
162643539|NCT03181399|587411657|FG000|6 Months on Treatment|Tried alternative treatment|2|||
162643540|NCT03181399|587411657|FG000|6 Months on Treatment|Lost to Follow-up|2|||
162643541|NCT03181399|587411657|FG000|6 Months on Treatment|Personal reasons|1|||
162643542|NCT03181399|587411657|FG000|3 Months Off-treatment|Parent unable to travel|1|||
162643543|NCT00939809|587411659|FG000|Overall Study|Adverse Event|2|||
162643544|NCT00939809|587411659|FG000|Overall Study|Death|1|||
162643545|NCT01921179|587411660|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
162643546|NCT01921179|587411661|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
162643547|NCT01921179|587411660|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
162643548|NCT01921179|587411661|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
162643549|NCT00858442|587411663|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
162643550|NCT00858442|587411664|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
162643551|NCT02016625|587411665|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
162643552|NCT02016625|587411666|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
162643553|NCT02016625|587411665|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
162643554|NCT02016625|587411666|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
162643555|NCT02016625|587411665|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
162643556|NCT02016625|587411666|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
162643557|NCT02603809|587411669|FG000|Overall Study|Withdrawal by Subject|4|||
162643558|NCT02603809|587411670|FG001|Overall Study|Withdrawal by Subject|1|||
162643559|NCT02603809|587411671|FG002|Overall Study|Withdrawal by Subject|2|||
162643560|NCT02603809|587411672|FG003|Overall Study|Withdrawal by Subject|3|||
162643561|NCT02603809|587411673|FG004|Overall Study|Withdrawal by Subject|3|||
162643562|NCT02603809|587411674|FG005|Overall Study|Withdrawal by Subject|4|||
162643563|NCT02603809|587411669|FG000|Overall Study|Lost to Follow-up|2|||
162643564|NCT02603809|587411670|FG001|Overall Study|Lost to Follow-up|3|||
162643565|NCT02603809|587411671|FG002|Overall Study|Lost to Follow-up|1|||
162643566|NCT02603809|587411672|FG003|Overall Study|Lost to Follow-up|4|||
162643567|NCT02603809|587411673|FG004|Overall Study|Lost to Follow-up|2|||
162643568|NCT02603809|587411674|FG005|Overall Study|Lost to Follow-up|2|||
162643569|NCT02603809|587411669|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
162643570|NCT02603809|587411670|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
162643571|NCT02603809|587411671|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
162643572|NCT02603809|587411672|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
162643573|NCT02603809|587411673|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
162717586|NCT01050569|587673416|FG002|Overall Study|Withdrawal by Subject|11|||
162717587|NCT01050569|587673414|FG000|Overall Study|Lack of Efficacy|5|||
162717588|NCT01050569|587673415|FG001|Overall Study|Lack of Efficacy|4|||
162717589|NCT01050569|587673416|FG002|Overall Study|Lack of Efficacy|3|||
162717590|NCT01050569|587673414|FG000|Overall Study|Adverse Event|1|||
162717591|NCT01050569|587673415|FG001|Overall Study|Adverse Event|0|||
162717592|NCT01050569|587673416|FG002|Overall Study|Adverse Event|0|||
162717593|NCT01050569|587673414|FG000|Overall Study|Physician Decision|3|||
162717594|NCT01050569|587673415|FG001|Overall Study|Physician Decision|3|||
162717595|NCT01050569|587673416|FG002|Overall Study|Physician Decision|3|||
162717596|NCT03525119|587673417|FG000|Overall Study|Adverse Event|0|||
162717597|NCT03525119|587673418|FG001|Overall Study|Adverse Event|1|||
162717598|NCT03525119|587673419|FG002|Overall Study|Adverse Event|0|||
162717599|NCT03525119|587673417|FG000|Overall Study|Lost to Follow-up|32|||
162717600|NCT03525119|587673418|FG001|Overall Study|Lost to Follow-up|33|||
162717601|NCT03525119|587673419|FG002|Overall Study|Lost to Follow-up|37|||
162717602|NCT03525119|587673417|FG000|Overall Study|Withdrawal by Subject|5|||
162717603|NCT03525119|587673418|FG001|Overall Study|Withdrawal by Subject|4|||
162717604|NCT03525119|587673419|FG002|Overall Study|Withdrawal by Subject|2|||
162717605|NCT03525119|587673417|FG000|Overall Study|Reason not Specified|2|||
162717606|NCT03525119|587673418|FG001|Overall Study|Reason not Specified|1|||
162717607|NCT03525119|587673419|FG002|Overall Study|Reason not Specified|2|||
162717608|NCT03525119|587673417|FG000|Overall Study|Randomized but not Vaccinated|1|||
162717609|NCT03525119|587673418|FG001|Overall Study|Randomized but not Vaccinated|0|||
162717610|NCT03525119|587673419|FG002|Overall Study|Randomized but not Vaccinated|2|||
162717611|NCT05046132|587673420|FG000|Overall Study|Adverse Event|4|||
162717612|NCT05046132|587673421|FG001|Overall Study|Adverse Event|0|||
162717613|NCT05046132|587673422|FG002|Overall Study|Adverse Event|0|||
162717614|NCT05046132|587673420|FG000|Overall Study|Withdrawal by Subject|3|||
162717615|NCT05046132|587673421|FG001|Overall Study|Withdrawal by Subject|0|||
162717616|NCT05046132|587673422|FG002|Overall Study|Withdrawal by Subject|0|||
162717617|NCT05046132|587673420|FG000|Overall Study|Positive Covid19 Result.|0|||
162717618|NCT05046132|587673421|FG001|Overall Study|Positive Covid19 Result.|1|||
162717619|NCT05046132|587673422|FG002|Overall Study|Positive Covid19 Result.|0|||
162717620|NCT01959412|587673423|FG000|Overall Study|Protocol deviation|1|||
162717621|NCT01959412|587673424|FG001|Overall Study|Protocol deviation|1|||
162717622|NCT01959412|587673425|FG002|Overall Study|Protocol deviation|0|||
162717623|NCT01959412|587673426|FG003|Overall Study|Protocol deviation|1|||
162717624|NCT01959412|587673427|FG004|Overall Study|Protocol deviation|3|||
162717625|NCT01959412|587673428|FG005|Overall Study|Protocol deviation|0|||
162717626|NCT01959412|587673423|FG000|Overall Study|Adverse Event|0|||
162717627|NCT01959412|587673424|FG001|Overall Study|Adverse Event|0|||
162717628|NCT01959412|587673425|FG002|Overall Study|Adverse Event|0|||
162717629|NCT01959412|587673426|FG003|Overall Study|Adverse Event|1|||
162717630|NCT01959412|587673427|FG004|Overall Study|Adverse Event|0|||
162717631|NCT01959412|587673428|FG005|Overall Study|Adverse Event|0|||
162717632|NCT01186848|587673429|FG000|Overall Study|Lost to Follow-up|4|||
162717633|NCT01186848|587673429|FG000|Overall Study|Withdrawal by Subject|2|||
162717634|NCT01186848|587673429|FG000|Overall Study|Adverse Event|2|||
162717635|NCT00158054|587673436|FG000|Overall Study|Refused to continue|3|||
162717636|NCT00158054|587673437|FG001|Overall Study|Refused to continue|0|||
162717637|NCT00158054|587673436|FG000|Overall Study|Unavailable for follow up|7|||
162717638|NCT00158054|587673437|FG001|Overall Study|Unavailable for follow up|3|||
162717639|NCT00770965|587673442|FG000|Safety Set|Withdrawal by Subject|0|||
162717640|NCT00770965|587673443|FG001|Safety Set|Withdrawal by Subject|0|||
162717641|NCT00770965|587673444|FG002|Safety Set|Withdrawal by Subject|0|||
162717642|NCT00770965|587673445|FG003|Safety Set|Withdrawal by Subject|1|||
162717643|NCT00770965|587673442|FG000|Safety Set|Protocol deviation|0|||
162717644|NCT00770965|587673443|FG001|Safety Set|Protocol deviation|0|||
162717645|NCT00770965|587673444|FG002|Safety Set|Protocol deviation|1|||
163064061|NCT03126110|588941548|FG003|Phase 1|Survival follow-up no longer necessary|0|||
163064062|NCT03126110|588941549|FG004|Phase 1|Survival follow-up no longer necessary|0|||
163064063|NCT03126110|588941550|FG005|Phase 1|Survival follow-up no longer necessary|0|||
163064064|NCT03126110|588941551|FG006|Phase 1|Survival follow-up no longer necessary|0|||
163064065|NCT03126110|588941552|FG007|Phase 1|Survival follow-up no longer necessary|0|||
162717646|NCT00770965|587673445|FG003|Safety Set|Protocol deviation|0|||
162717647|NCT00770965|587673442|FG000|Excluded Set|Administrative problems|14|||
162717648|NCT00770965|587673443|FG001|Excluded Set|Administrative problems|12|||
162717649|NCT00770965|587673444|FG002|Excluded Set|Administrative problems|12|||
162717650|NCT00770965|587673445|FG003|Excluded Set|Administrative problems|10|||
162717651|NCT00770965|587673442|FG000|Excluded Set|Withdrawal by Subject|1|||
162717652|NCT00770965|587673443|FG001|Excluded Set|Withdrawal by Subject|1|||
162717653|NCT00770965|587673444|FG002|Excluded Set|Withdrawal by Subject|2|||
162717654|NCT00770965|587673445|FG003|Excluded Set|Withdrawal by Subject|3|||
162717655|NCT00509769|587673446|FG000|Overall Study|Progressive disease|77|||
162717656|NCT00509769|587673446|FG000|Overall Study|Adverse Event|4|||
162717657|NCT00509769|587673446|FG000|Overall Study|Patient's decision|1|||
162717658|NCT00509769|587673446|FG000|Overall Study|Physician Decision|8|||
162717659|NCT00509769|587673446|FG000|Overall Study|Use of prohibited therapies during study|1|||
162717660|NCT00414648|587673447|FG000|Overall Study|Adverse Event|5|||
162717661|NCT00414648|587673448|FG001|Overall Study|Adverse Event|5|||
162717662|NCT00414648|587673447|FG000|Overall Study|Death|0|||
162717663|NCT00414648|587673448|FG001|Overall Study|Death|1|||
162717664|NCT00414648|587673447|FG000|Overall Study|Lack of Efficacy|0|||
162717665|NCT00414648|587673448|FG001|Overall Study|Lack of Efficacy|2|||
162717666|NCT00414648|587673447|FG000|Overall Study|Withdrawal by Subject|0|||
162717667|NCT00414648|587673448|FG001|Overall Study|Withdrawal by Subject|1|||
162717668|NCT02371746|587673449|FG000|Overall Study|Consent withdrawn|0|||
162717669|NCT02371746|587673450|FG001|Overall Study|Consent withdrawn|0|||
162717670|NCT02371746|587673451|FG002|Overall Study|Consent withdrawn|0|||
162717671|NCT02371746|587673452|FG003|Overall Study|Consent withdrawn|0|||
162717672|NCT02371746|587673453|FG004|Overall Study|Consent withdrawn|0|||
162717673|NCT02371746|587673454|FG005|Overall Study|Consent withdrawn|0|||
162717674|NCT02371746|587673455|FG006|Overall Study|Consent withdrawn|1|||
162717675|NCT00754936|587673456|FG000|Overall Study|Lost to Follow-up|3|||
162717676|NCT00754936|587673456|FG000|Overall Study|Physician Decision|1|||
162717677|NCT00754936|587673456|FG000|Overall Study|Withdrawal by Subject|2|||
162717678|NCT00754936|587673456|FG000|Overall Study|Side Effects|3|||
162717679|NCT00754936|587673456|FG000|Overall Study|Inter-current medical events|3|||
162717680|NCT00619645|587673457|FG000|Overall Study|Adverse Event|1|||
162717681|NCT04364269|587673462|FG000|Overall Study|Adverse Event|1|||
162717682|NCT04364269|587673463|FG001|Overall Study|Adverse Event|0|||
162717683|NCT04364269|587673464|FG002|Overall Study|Adverse Event|0|||
162717684|NCT04364269|587673462|FG000|Overall Study|Withdrawal by Subject|0|||
162717685|NCT04364269|587673463|FG001|Overall Study|Withdrawal by Subject|1|||
162717686|NCT04364269|587673464|FG002|Overall Study|Withdrawal by Subject|0|||
162717687|NCT01490580|587673465|FG000|Overall Study|Parents withdrew consent|0|||
162717688|NCT01490580|587673466|FG001|Overall Study|Parents withdrew consent|2|||
162717689|NCT02026258|587673467|FG000|Randomized|Did not start treatment|2|||
162717690|NCT02026258|587673468|FG001|Randomized|Did not start treatment|1|||
162717691|NCT02026258|587673467|FG000|Randomized|Change in treatment plan|1|||
162717692|NCT02026258|587673468|FG001|Randomized|Change in treatment plan|0|||
162717693|NCT02026258|587673467|FG000|Randomized|Presence of periodontal disease|1|||
162717694|NCT02026258|587673468|FG001|Randomized|Presence of periodontal disease|1|||
162717695|NCT02026258|587673467|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
162717696|NCT02026258|587673468|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
162717697|NCT02026258|587673467|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
162717698|NCT02026258|587673468|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
162717699|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
162717700|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
162717701|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
162717702|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
162717703|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
162717704|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
162717705|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
162717706|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
162717707|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
162717708|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
162717709|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
162717710|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
162717711|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Death|7|||
162717712|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Death|4|||
162717713|NCT00410124|587673471|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
162717714|NCT00410124|587673472|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
162717715|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
162717716|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
162717717|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
162717718|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
162717719|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
162717720|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
162717721|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
162717722|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
163064066|NCT03126110|588941553|FG008|Phase 1|Survival follow-up no longer necessary|0|||
163064067|NCT03126110|588941554|FG009|Phase 1|Survival follow-up no longer necessary|0|||
162717723|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
162717724|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
162717725|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
162717726|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
162717727|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
162717728|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
162717729|NCT00410124|587673471|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
162717730|NCT00410124|587673472|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
162717731|NCT00880048|587673473|FG000|Overall Study|Adverse Event|2|||
162717732|NCT00880048|587673474|FG001|Overall Study|Adverse Event|3|||
162717733|NCT00880048|587673475|FG002|Overall Study|Adverse Event|5|||
162717734|NCT00880048|587673473|FG000|Overall Study|Lack of Efficacy|1|||
162717735|NCT00880048|587673474|FG001|Overall Study|Lack of Efficacy|2|||
162717736|NCT00880048|587673475|FG002|Overall Study|Lack of Efficacy|2|||
162717737|NCT00880048|587673473|FG000|Overall Study|Protocol Violation|4|||
162717738|NCT00880048|587673474|FG001|Overall Study|Protocol Violation|6|||
162717739|NCT00880048|587673475|FG002|Overall Study|Protocol Violation|5|||
162717740|NCT00880048|587673473|FG000|Overall Study|Lost to Follow-up|6|||
162717741|NCT00880048|587673474|FG001|Overall Study|Lost to Follow-up|6|||
162717742|NCT00880048|587673475|FG002|Overall Study|Lost to Follow-up|5|||
162717743|NCT00880048|587673473|FG000|Overall Study|Physician Decision|1|||
162717744|NCT00880048|587673474|FG001|Overall Study|Physician Decision|1|||
162717745|NCT00880048|587673475|FG002|Overall Study|Physician Decision|7|||
162717746|NCT00880048|587673473|FG000|Overall Study|Withdrawal by Subject|5|||
162717747|NCT00880048|587673474|FG001|Overall Study|Withdrawal by Subject|8|||
162717748|NCT00880048|587673475|FG002|Overall Study|Withdrawal by Subject|5|||
162717749|NCT00880048|587673473|FG000|Overall Study|Study closed/terminated|9|||
162717750|NCT00880048|587673474|FG001|Overall Study|Study closed/terminated|7|||
162717751|NCT00880048|587673475|FG002|Overall Study|Study closed/terminated|6|||
162717752|NCT00319436|587673476|FG000|Overall Study|Withdrawal by Subject|6|||
162717753|NCT00319436|587673477|FG001|Overall Study|Withdrawal by Subject|7|||
162717754|NCT01104415|587673483|FG000|Core Phase|Consent withdrawn by subjects|1|||
162717755|NCT01104415|587673484|FG001|Core Phase|Consent withdrawn by subjects|0|||
162717756|NCT01104415|587673483|FG000|Extension Period|Progressive disease|0|||
162717757|NCT01104415|587673484|FG001|Extension Period|Progressive disease|4|||
162717758|NCT01104415|587673483|FG000|Extension Period|Death|0|||
162717759|NCT01104415|587673484|FG001|Extension Period|Death|1|||
162717760|NCT01104415|587673483|FG000|Extension Period|Physician Decision|0|||
162717761|NCT01104415|587673484|FG001|Extension Period|Physician Decision|1|||
162717762|NCT01104415|587673483|FG000|Extension Period|Transition to Study LX1606.302|0|||
162717763|NCT01104415|587673484|FG001|Extension Period|Transition to Study LX1606.302|4|||
162717764|NCT01104415|587673483|FG000|Extension Period|Heart surgery/feeling miserable|0|||
162717765|NCT01104415|587673484|FG001|Extension Period|Heart surgery/feeling miserable|1|||
162717766|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
162717767|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
162717768|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
162717769|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
162717770|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
162717771|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
162717772|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
162717773|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
162717774|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
162717775|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
162717776|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
162717777|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
162717778|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
162717779|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
162717780|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
162717781|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
162717782|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
162717783|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
162717784|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
162717785|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
162717786|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
162717787|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
162717788|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
162717789|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
162717790|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
162717791|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
162717792|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
162717793|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
162717794|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
162717795|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
162717796|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
162717797|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
162717798|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
162717799|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162643574|NCT02603809|587411674|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
162643575|NCT02603809|587411669|FG000|Overall Study|Physician Decision|0|||
162643576|NCT02603809|587411670|FG001|Overall Study|Physician Decision|0|||
162643577|NCT02603809|587411671|FG002|Overall Study|Physician Decision|0|||
162643578|NCT02603809|587411672|FG003|Overall Study|Physician Decision|1|||
162643579|NCT02603809|587411673|FG004|Overall Study|Physician Decision|2|||
162643580|NCT02603809|587411674|FG005|Overall Study|Physician Decision|1|||
162643581|NCT02603809|587411669|FG000|Overall Study|Adverse Event|3|||
162643582|NCT02603809|587411670|FG001|Overall Study|Adverse Event|0|||
162643583|NCT02603809|587411671|FG002|Overall Study|Adverse Event|2|||
162643584|NCT02603809|587411672|FG003|Overall Study|Adverse Event|2|||
162643585|NCT02603809|587411673|FG004|Overall Study|Adverse Event|1|||
162643586|NCT02603809|587411674|FG005|Overall Study|Adverse Event|1|||
162643587|NCT02603809|587411669|FG000|Overall Study|Lack of Efficacy|0|||
162643588|NCT02603809|587411670|FG001|Overall Study|Lack of Efficacy|1|||
162643589|NCT02603809|587411671|FG002|Overall Study|Lack of Efficacy|0|||
162643590|NCT02603809|587411672|FG003|Overall Study|Lack of Efficacy|0|||
162643591|NCT02603809|587411673|FG004|Overall Study|Lack of Efficacy|0|||
162643592|NCT02603809|587411674|FG005|Overall Study|Lack of Efficacy|1|||
162643593|NCT00380978|587411676|FG000|Overall Study|Refused allocated intervention|0|||
162643594|NCT00380978|587411677|FG001|Overall Study|Refused allocated intervention|6|||
162643595|NCT00380978|587411676|FG000|Overall Study|Wrong study envelope|0|||
162643596|NCT00380978|587411677|FG001|Overall Study|Wrong study envelope|2|||
162643597|NCT00380978|587411676|FG000|Overall Study|Allocation prior to analgesia request|1|||
162643598|NCT00380978|587411677|FG001|Overall Study|Allocation prior to analgesia request|2|||
162643599|NCT00380978|587411676|FG000|Overall Study|Parous patient|1|||
162643600|NCT00380978|587411677|FG001|Overall Study|Parous patient|0|||
162643601|NCT01254227|587411678|FG000|Overall Study|Withdrawal by Subject|6|||
162643602|NCT01254227|587411678|FG000|Overall Study|Lost to Follow-up|6|||
162643603|NCT01254227|587411678|FG000|Overall Study|Adverse Event|5|||
162643604|NCT01254227|587411678|FG000|Overall Study|Abnormal test procedure result|5|||
162643605|NCT01254227|587411678|FG000|Overall Study|Administrative problems|2|||
162643606|NCT01254227|587411678|FG000|Overall Study|Death|1|||
162643607|NCT01254227|587411678|FG000|Overall Study|Protocol deviation|1|||
162643608|NCT02750592|587411679|FG000|Overall Study|Adverse Event|3|||
162643609|NCT02750592|587411679|FG000|Overall Study|Lack of Efficacy|2|||
162643610|NCT02981342|587411680|FG000|Overall Study|Adverse Event|0|||
162643611|NCT02981342|587411681|FG001|Overall Study|Adverse Event|0|||
162643612|NCT02981342|587411682|FG002|Overall Study|Adverse Event|0|||
162643613|NCT02981342|587411683|FG003|Overall Study|Adverse Event|1|||
162643614|NCT02981342|587411680|FG000|Overall Study|Death|0|||
162643615|NCT02981342|587411681|FG001|Overall Study|Death|9|||
162643616|NCT02981342|587411682|FG002|Overall Study|Death|9|||
162643617|NCT02981342|587411683|FG003|Overall Study|Death|4|||
162643618|NCT02981342|587411680|FG000|Overall Study|Withdrawal by Subject|0|||
162643619|NCT02981342|587411681|FG001|Overall Study|Withdrawal by Subject|0|||
162643620|NCT02981342|587411682|FG002|Overall Study|Withdrawal by Subject|3|||
162643621|NCT02981342|587411683|FG003|Overall Study|Withdrawal by Subject|1|||
162643622|NCT02981342|587411680|FG000|Overall Study|Study closed by sponsor|0|||
162643623|NCT02981342|587411681|FG001|Overall Study|Study closed by sponsor|0|||
162643624|NCT02981342|587411682|FG002|Overall Study|Study closed by sponsor|1|||
162643625|NCT02981342|587411683|FG003|Overall Study|Study closed by sponsor|1|||
162643626|NCT02981342|587411680|FG000|Overall Study|Randomized, Never Treated|0|||
162643627|NCT02981342|587411681|FG001|Overall Study|Randomized, Never Treated|1|||
162643628|NCT02981342|587411682|FG002|Overall Study|Randomized, Never Treated|0|||
162643629|NCT02981342|587411683|FG003|Overall Study|Randomized, Never Treated|7|||
162643630|NCT02981342|587411680|FG000|Overall Study|Lost to Follow-up|0|||
162643631|NCT02981342|587411681|FG001|Overall Study|Lost to Follow-up|1|||
162643632|NCT02981342|587411682|FG002|Overall Study|Lost to Follow-up|0|||
162643633|NCT02981342|587411683|FG003|Overall Study|Lost to Follow-up|0|||
162643634|NCT03970733|587411684|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162643635|NCT03970733|587411685|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
162643636|NCT03970733|587411686|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
162643637|NCT03970733|587411687|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162643638|NCT03970733|587411688|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162643639|NCT03970733|587411684|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
162643640|NCT03970733|587411685|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
162643641|NCT03970733|587411686|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
162643642|NCT03970733|587411687|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
162643643|NCT03970733|587411688|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
162643644|NCT03970733|587411684|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
162643645|NCT03970733|587411685|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
162643646|NCT03970733|587411686|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
162643647|NCT03970733|587411687|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
162643648|NCT03970733|587411688|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
162643649|NCT03970733|587411684|FG000|Main Study Phase (18 Months)|Other|1|||
162717800|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
162717801|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
162717802|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
162717803|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717804|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717805|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717806|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717807|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717808|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717809|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162717810|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717811|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717812|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717813|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717814|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
162717815|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717816|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717817|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717818|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717819|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717820|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162717821|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
162717822|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162717823|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162717824|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162717825|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162717826|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163064068|NCT03126110|588941555|FG010|Phase 1|Survival follow-up no longer necessary|0|||
163064069|NCT03126110|588941556|FG011|Phase 1|Survival follow-up no longer necessary|0|||
163064070|NCT03126110|588941557|FG012|Phase 1|Survival follow-up no longer necessary|0|||
163064071|NCT03126110|588941558|FG013|Phase 1|Survival follow-up no longer necessary|0|||
163064072|NCT03126110|588941559|FG014|Phase 1|Survival follow-up no longer necessary|0|||
163064073|NCT03126110|588941560|FG015|Phase 1|Survival follow-up no longer necessary|0|||
163064074|NCT03126110|588941561|FG016|Phase 1|Survival follow-up no longer necessary|0|||
163064075|NCT03126110|588941545|FG000|Phase 2|Study terminated by the sponsor|0|||
163064076|NCT03126110|588941546|FG001|Phase 2|Study terminated by the sponsor|0|||
163064077|NCT03126110|588941547|FG002|Phase 2|Study terminated by the sponsor|0|||
163064078|NCT03126110|588941548|FG003|Phase 2|Study terminated by the sponsor|0|||
163064079|NCT03126110|588941549|FG004|Phase 2|Study terminated by the sponsor|0|||
163064080|NCT03126110|588941550|FG005|Phase 2|Study terminated by the sponsor|0|||
162643650|NCT03970733|587411685|FG001|Main Study Phase (18 Months)|Other|1|||
162643651|NCT03970733|587411686|FG002|Main Study Phase (18 Months)|Other|0|||
162643652|NCT03970733|587411687|FG003|Main Study Phase (18 Months)|Other|0|||
162643653|NCT03970733|587411688|FG004|Main Study Phase (18 Months)|Other|0|||
162643654|NCT03970733|587411684|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162643655|NCT03970733|587411685|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162643656|NCT03970733|587411686|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162643657|NCT03970733|587411687|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162643658|NCT03970733|587411688|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
162643659|NCT02784821|587411692|FG000|Overall Study|Death|0|||
162643660|NCT02784821|587411693|FG001|Overall Study|Death|5|||
162643661|NCT02784821|587411694|FG002|Overall Study|Death|4|||
162643662|NCT02784821|587411695|FG003|Overall Study|Death|5|||
162643663|NCT02794103|587411696|FG000|Overall Study|Loss to follow up due to high sedation|3|||
162643664|NCT01139450|587411697|FG000|Overall Study|Withdrawal by Subject|7|||
162643665|NCT01139450|587411698|FG001|Overall Study|Withdrawal by Subject|10|||
162643666|NCT01139450|587411699|FG002|Overall Study|Withdrawal by Subject|13|||
162643667|NCT01139450|587411697|FG000|Overall Study|Lack of Efficacy|3|||
162643668|NCT01139450|587411698|FG001|Overall Study|Lack of Efficacy|1|||
162643669|NCT01139450|587411699|FG002|Overall Study|Lack of Efficacy|8|||
162643670|NCT01139450|587411697|FG000|Overall Study|Protocol Violation|6|||
162643671|NCT01139450|587411698|FG001|Overall Study|Protocol Violation|5|||
162643672|NCT01139450|587411699|FG002|Overall Study|Protocol Violation|2|||
162643673|NCT01139450|587411697|FG000|Overall Study|Lost to Follow-up|9|||
162643674|NCT01139450|587411698|FG001|Overall Study|Lost to Follow-up|7|||
163022376|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Physician Decision|1|||
163022377|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Physician Decision|0|||
163022378|NCT03535194|588786273|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
163022379|NCT03535194|588786274|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
163022380|NCT03535194|588786275|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
163022381|NCT03535194|588786276|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
163022382|NCT03535194|588786277|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163022383|NCT04411810|588786278|FG000|Overall Study|Screen failure|1|||
163022384|NCT04411810|588786278|FG000|Overall Study|Withdrawal by Subject|1|||
163022385|NCT04304235|588786282|FG000|Overall Study|incomplete triage data|0|||
163022386|NCT04304235|588786283|FG001|Overall Study|incomplete triage data|69|||
163022387|NCT04304235|588786284|FG002|Overall Study|incomplete triage data|0|||
163022388|NCT04304235|588786285|FG003|Overall Study|incomplete triage data|0|||
163022389|NCT04304235|588786286|FG004|Overall Study|incomplete triage data|289|||
163022390|NCT04304235|588786287|FG005|Overall Study|incomplete triage data|123|||
163022391|NCT04304235|588786288|FG006|Overall Study|incomplete triage data|65|||
163022392|NCT04470544|588786289|FG000|Overall Study|Withdrawal by Subject|4|||
163022393|NCT04470544|588786290|FG001|Overall Study|Withdrawal by Subject|6|||
163022394|NCT02217410|588786293|FG000|Overall Study|Graft Loss|0|||
163022395|NCT02217410|588786294|FG001|Overall Study|Graft Loss|0|||
163022396|NCT02217410|588786295|FG002|Overall Study|Graft Loss|2|||
163022397|NCT02217410|588786293|FG000|Overall Study|Withdrawal by Subject|0|||
163022398|NCT02217410|588786294|FG001|Overall Study|Withdrawal by Subject|0|||
163022399|NCT02217410|588786295|FG002|Overall Study|Withdrawal by Subject|2|||
163022400|NCT02217410|588786293|FG000|Overall Study|Lost to Follow-up|0|||
163022401|NCT02217410|588786294|FG001|Overall Study|Lost to Follow-up|0|||
163022402|NCT02217410|588786295|FG002|Overall Study|Lost to Follow-up|1|||
163022403|NCT02217410|588786293|FG000|Overall Study|Lack of Efficacy|0|||
163022404|NCT02217410|588786294|FG001|Overall Study|Lack of Efficacy|1|||
163022405|NCT02217410|588786295|FG002|Overall Study|Lack of Efficacy|0|||
163022406|NCT02217410|588786293|FG000|Overall Study|Physician Decision|1|||
163022407|NCT02217410|588786294|FG001|Overall Study|Physician Decision|3|||
163022408|NCT02217410|588786295|FG002|Overall Study|Physician Decision|0|||
163022409|NCT00626821|588786296|FG000|Overall Study|Adverse Event|44|||
163022410|NCT00626821|588786296|FG000|Overall Study|Protocol Violation|33|||
163022411|NCT00626821|588786296|FG000|Overall Study|Withdrawal by Subject|10|||
163022412|NCT00626821|588786296|FG000|Overall Study|Physician Decision|9|||
163022413|NCT00626821|588786296|FG000|Overall Study|Product dysfunction|21|||
163022414|NCT00626821|588786296|FG000|Overall Study|other/unknown reason|104|||
163022415|NCT01471340|588786300|FG000|Overall Study|Death|5|||
163022416|NCT01471340|588786301|FG001|Overall Study|Death|4|||
163022417|NCT01471340|588786300|FG000|Overall Study|Lost to Follow-up|0|||
163022418|NCT01471340|588786301|FG001|Overall Study|Lost to Follow-up|1|||
163022419|NCT01471340|588786300|FG000|Overall Study|Investigational site closure|0|||
163022420|NCT01471340|588786301|FG001|Overall Study|Investigational site closure|1|||
163022421|NCT01471340|588786300|FG000|Overall Study|Invalid informed consent|1|||
163022422|NCT01471340|588786301|FG001|Overall Study|Invalid informed consent|0|||
163022423|NCT02475265|588786302|FG000|Overall Study|Physician Decision|1|||
163022424|NCT02475265|588786302|FG000|Overall Study|Withdrawal by Subject|2|||
163022425|NCT02218736|588786306|FG000|Overall Study|Withdrawal by Subject|10|||
163022426|NCT02218736|588786307|FG001|Overall Study|Withdrawal by Subject|9|||
163022427|NCT02218736|588786306|FG000|Overall Study|Protocol Violation|2|||
163022428|NCT02218736|588786307|FG001|Overall Study|Protocol Violation|0|||
163022429|NCT03452488|588786308|FG000|Overall Study|Adverse Event|4|||
163022430|NCT03452488|588786309|FG001|Overall Study|Adverse Event|6|||
163022431|NCT03452488|588786310|FG002|Overall Study|Adverse Event|1|||
163022432|NCT03452488|588786308|FG000|Overall Study|Death|0|||
163022433|NCT03452488|588786309|FG001|Overall Study|Death|0|||
163022434|NCT03452488|588786310|FG002|Overall Study|Death|1|||
163022435|NCT03452488|588786308|FG000|Overall Study|Lost to Follow-up|1|||
163022436|NCT03452488|588786309|FG001|Overall Study|Lost to Follow-up|2|||
163022437|NCT03452488|588786310|FG002|Overall Study|Lost to Follow-up|0|||
162643675|NCT01139450|587411699|FG002|Overall Study|Lost to Follow-up|11|||
163022438|NCT03452488|588786308|FG000|Overall Study|PI Decision|1|||
163022439|NCT03452488|588786309|FG001|Overall Study|PI Decision|0|||
163022440|NCT03452488|588786310|FG002|Overall Study|PI Decision|0|||
163022441|NCT03452488|588786308|FG000|Overall Study|Withdrew consent|4|||
163022442|NCT03452488|588786309|FG001|Overall Study|Withdrew consent|2|||
163022443|NCT03452488|588786310|FG002|Overall Study|Withdrew consent|2|||
163022444|NCT03452488|588786308|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
163022445|NCT03452488|588786309|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
163022446|NCT03452488|588786310|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
163022447|NCT03452488|588786308|FG000|Overall Study|Other|0|||
163022448|NCT03452488|588786309|FG001|Overall Study|Other|2|||
163022449|NCT03452488|588786310|FG002|Overall Study|Other|2|||
163022450|NCT00623935|588786313|FG000|Overall Study|Death|1|||
163022451|NCT00623935|588786313|FG000|Overall Study|Patient Declined Transplant|1|||
163022452|NCT03315286|588786314|FG000|Overall Study|Lost to Follow-up|0|||
163022453|NCT03315286|588786315|FG001|Overall Study|Lost to Follow-up|3|||
163022454|NCT03315286|588786314|FG000|Overall Study|Withdrawal by Subject|1|||
163022455|NCT03315286|588786315|FG001|Overall Study|Withdrawal by Subject|0|||
163022456|NCT03315286|588786314|FG000|Overall Study|Protocol Violation|0|||
163022457|NCT03315286|588786315|FG001|Overall Study|Protocol Violation|1|||
163022458|NCT02829723|588786316|FG000|Overall Study|Adverse Event|0|||
163022459|NCT02829723|588786317|FG001|Overall Study|Adverse Event|0|||
163022460|NCT02829723|588786318|FG002|Overall Study|Adverse Event|1|||
163022461|NCT02829723|588786319|FG003|Overall Study|Adverse Event|1|||
163022462|NCT02829723|588786320|FG004|Overall Study|Adverse Event|0|||
163022463|NCT02829723|588786321|FG005|Overall Study|Adverse Event|0|||
163022464|NCT02829723|588786322|FG006|Overall Study|Adverse Event|0|||
163022465|NCT02829723|588786323|FG007|Overall Study|Adverse Event|1|||
163022466|NCT02829723|588786324|FG008|Overall Study|Adverse Event|0|||
163022467|NCT02829723|588786325|FG009|Overall Study|Adverse Event|0|||
163022468|NCT02829723|588786326|FG010|Overall Study|Adverse Event|0|||
163022469|NCT02829723|588786327|FG011|Overall Study|Adverse Event|0|||
163022470|NCT02829723|588786328|FG012|Overall Study|Adverse Event|0|||
163022471|NCT02829723|588786329|FG013|Overall Study|Adverse Event|0|||
163022472|NCT02829723|588786330|FG014|Overall Study|Adverse Event|1|||
163022473|NCT02829723|588786331|FG015|Overall Study|Adverse Event|1|||
163022474|NCT02829723|588786332|FG016|Overall Study|Adverse Event|1|||
163022475|NCT02829723|588786333|FG017|Overall Study|Adverse Event|2|||
163022476|NCT02829723|588786334|FG018|Overall Study|Adverse Event|1|||
163022477|NCT02829723|588786335|FG019|Overall Study|Adverse Event|1|||
163022478|NCT02829723|588786336|FG020|Overall Study|Adverse Event|3|||
163022479|NCT02829723|588786337|FG021|Overall Study|Adverse Event|0|||
163022480|NCT02829723|588786338|FG022|Overall Study|Adverse Event|0|||
163022481|NCT02829723|588786339|FG023|Overall Study|Adverse Event|1|||
163022482|NCT02829723|588786340|FG024|Overall Study|Adverse Event|1|||
163022483|NCT02829723|588786341|FG025|Overall Study|Adverse Event|3|||
163022484|NCT02829723|588786342|FG026|Overall Study|Adverse Event|5|||
163022485|NCT02829723|588786316|FG000|Overall Study|Death|1|||
163022486|NCT02829723|588786317|FG001|Overall Study|Death|0|||
163022487|NCT02829723|588786318|FG002|Overall Study|Death|1|||
163022488|NCT02829723|588786319|FG003|Overall Study|Death|1|||
163022489|NCT02829723|588786320|FG004|Overall Study|Death|0|||
163022490|NCT02829723|588786321|FG005|Overall Study|Death|0|||
163022491|NCT02829723|588786322|FG006|Overall Study|Death|2|||
163022492|NCT02829723|588786323|FG007|Overall Study|Death|0|||
163022493|NCT02829723|588786324|FG008|Overall Study|Death|1|||
163022494|NCT02829723|588786325|FG009|Overall Study|Death|0|||
163022495|NCT02829723|588786326|FG010|Overall Study|Death|0|||
163022496|NCT02829723|588786327|FG011|Overall Study|Death|0|||
163022497|NCT02829723|588786328|FG012|Overall Study|Death|2|||
163022498|NCT02829723|588786329|FG013|Overall Study|Death|1|||
163022499|NCT02829723|588786330|FG014|Overall Study|Death|0|||
163022500|NCT02829723|588786331|FG015|Overall Study|Death|0|||
163022501|NCT02829723|588786332|FG016|Overall Study|Death|0|||
163022502|NCT02829723|588786333|FG017|Overall Study|Death|0|||
163022503|NCT02829723|588786334|FG018|Overall Study|Death|0|||
163022504|NCT02829723|588786335|FG019|Overall Study|Death|0|||
163022505|NCT02829723|588786336|FG020|Overall Study|Death|0|||
163022506|NCT02829723|588786337|FG021|Overall Study|Death|2|||
163022507|NCT02829723|588786338|FG022|Overall Study|Death|0|||
163022508|NCT02829723|588786339|FG023|Overall Study|Death|0|||
163022509|NCT02829723|588786340|FG024|Overall Study|Death|0|||
163022510|NCT02829723|588786341|FG025|Overall Study|Death|1|||
163022511|NCT02829723|588786342|FG026|Overall Study|Death|2|||
163022512|NCT02829723|588786316|FG000|Overall Study|Physician Decision|0|||
163022513|NCT02829723|588786317|FG001|Overall Study|Physician Decision|0|||
163022514|NCT02829723|588786318|FG002|Overall Study|Physician Decision|0|||
163022515|NCT02829723|588786319|FG003|Overall Study|Physician Decision|0|||
163022516|NCT02829723|588786320|FG004|Overall Study|Physician Decision|0|||
163022517|NCT02829723|588786321|FG005|Overall Study|Physician Decision|0|||
163022518|NCT02829723|588786322|FG006|Overall Study|Physician Decision|0|||
163022519|NCT02829723|588786323|FG007|Overall Study|Physician Decision|0|||
163022520|NCT02829723|588786324|FG008|Overall Study|Physician Decision|0|||
163022521|NCT02829723|588786325|FG009|Overall Study|Physician Decision|1|||
163022522|NCT02829723|588786326|FG010|Overall Study|Physician Decision|1|||
163022523|NCT02829723|588786327|FG011|Overall Study|Physician Decision|0|||
163022524|NCT02829723|588786328|FG012|Overall Study|Physician Decision|0|||
163022525|NCT02829723|588786329|FG013|Overall Study|Physician Decision|1|||
163022526|NCT02829723|588786330|FG014|Overall Study|Physician Decision|0|||
163022527|NCT02829723|588786331|FG015|Overall Study|Physician Decision|0|||
163022528|NCT02829723|588786332|FG016|Overall Study|Physician Decision|2|||
163022529|NCT02829723|588786333|FG017|Overall Study|Physician Decision|0|||
163022530|NCT02829723|588786334|FG018|Overall Study|Physician Decision|0|||
163022531|NCT02829723|588786335|FG019|Overall Study|Physician Decision|0|||
163022532|NCT02829723|588786336|FG020|Overall Study|Physician Decision|0|||
163022533|NCT02829723|588786337|FG021|Overall Study|Physician Decision|0|||
163022534|NCT02829723|588786338|FG022|Overall Study|Physician Decision|1|||
163022535|NCT02829723|588786339|FG023|Overall Study|Physician Decision|1|||
163022536|NCT02829723|588786340|FG024|Overall Study|Physician Decision|1|||
163022537|NCT02829723|588786341|FG025|Overall Study|Physician Decision|1|||
163022538|NCT02829723|588786342|FG026|Overall Study|Physician Decision|3|||
163022539|NCT02829723|588786316|FG000|Overall Study|Progressive disease|4|||
163022540|NCT02829723|588786317|FG001|Overall Study|Progressive disease|6|||
163022541|NCT02829723|588786318|FG002|Overall Study|Progressive disease|3|||
163022542|NCT02829723|588786319|FG003|Overall Study|Progressive disease|3|||
163022543|NCT02829723|588786320|FG004|Overall Study|Progressive disease|3|||
163022544|NCT02829723|588786321|FG005|Overall Study|Progressive disease|5|||
163022545|NCT02829723|588786322|FG006|Overall Study|Progressive disease|4|||
163022546|NCT02829723|588786323|FG007|Overall Study|Progressive disease|6|||
163022547|NCT02829723|588786324|FG008|Overall Study|Progressive disease|8|||
163022548|NCT02829723|588786325|FG009|Overall Study|Progressive disease|4|||
163022549|NCT02829723|588786326|FG010|Overall Study|Progressive disease|9|||
163022550|NCT02829723|588786327|FG011|Overall Study|Progressive disease|0|||
163022551|NCT02829723|588786328|FG012|Overall Study|Progressive disease|3|||
163022552|NCT02829723|588786329|FG013|Overall Study|Progressive disease|4|||
163022553|NCT02829723|588786330|FG014|Overall Study|Progressive disease|2|||
163022554|NCT02829723|588786331|FG015|Overall Study|Progressive disease|4|||
163022555|NCT02829723|588786332|FG016|Overall Study|Progressive disease|5|||
163022556|NCT02829723|588786333|FG017|Overall Study|Progressive disease|3|||
163022557|NCT02829723|588786334|FG018|Overall Study|Progressive disease|4|||
163022558|NCT02829723|588786335|FG019|Overall Study|Progressive disease|4|||
163022559|NCT02829723|588786336|FG020|Overall Study|Progressive disease|7|||
163022560|NCT02829723|588786337|FG021|Overall Study|Progressive disease|6|||
163022561|NCT02829723|588786338|FG022|Overall Study|Progressive disease|3|||
163022562|NCT02829723|588786339|FG023|Overall Study|Progressive disease|3|||
163022563|NCT02829723|588786340|FG024|Overall Study|Progressive disease|3|||
163022564|NCT02829723|588786341|FG025|Overall Study|Progressive disease|16|||
163022565|NCT02829723|588786342|FG026|Overall Study|Progressive disease|10|||
163022566|NCT02829723|588786316|FG000|Overall Study|Subject/guardian decision|0|||
163022567|NCT02829723|588786317|FG001|Overall Study|Subject/guardian decision|1|||
163022568|NCT02829723|588786318|FG002|Overall Study|Subject/guardian decision|0|||
163022569|NCT02829723|588786319|FG003|Overall Study|Subject/guardian decision|1|||
163022570|NCT02829723|588786320|FG004|Overall Study|Subject/guardian decision|0|||
163022571|NCT02829723|588786321|FG005|Overall Study|Subject/guardian decision|0|||
163022572|NCT02829723|588786322|FG006|Overall Study|Subject/guardian decision|0|||
163022573|NCT02829723|588786323|FG007|Overall Study|Subject/guardian decision|1|||
163022574|NCT02829723|588786324|FG008|Overall Study|Subject/guardian decision|0|||
163022575|NCT02829723|588786325|FG009|Overall Study|Subject/guardian decision|0|||
163022576|NCT02829723|588786326|FG010|Overall Study|Subject/guardian decision|0|||
163022577|NCT02829723|588786327|FG011|Overall Study|Subject/guardian decision|0|||
163022578|NCT02829723|588786328|FG012|Overall Study|Subject/guardian decision|0|||
163022579|NCT02829723|588786329|FG013|Overall Study|Subject/guardian decision|0|||
163022580|NCT02829723|588786330|FG014|Overall Study|Subject/guardian decision|1|||
163022581|NCT02829723|588786331|FG015|Overall Study|Subject/guardian decision|0|||
163022582|NCT02829723|588786332|FG016|Overall Study|Subject/guardian decision|1|||
163022583|NCT02829723|588786333|FG017|Overall Study|Subject/guardian decision|0|||
163022584|NCT02829723|588786334|FG018|Overall Study|Subject/guardian decision|1|||
163022585|NCT02829723|588786335|FG019|Overall Study|Subject/guardian decision|0|||
163022586|NCT02829723|588786336|FG020|Overall Study|Subject/guardian decision|1|||
163022587|NCT02829723|588786337|FG021|Overall Study|Subject/guardian decision|0|||
163022588|NCT02829723|588786338|FG022|Overall Study|Subject/guardian decision|0|||
163022589|NCT02829723|588786339|FG023|Overall Study|Subject/guardian decision|1|||
163064081|NCT03126110|588941551|FG006|Phase 2|Study terminated by the sponsor|0|||
162643676|NCT01139450|587411697|FG000|Overall Study|Administrative|0|||
162643677|NCT01139450|587411698|FG001|Overall Study|Administrative|0|||
162643678|NCT01139450|587411699|FG002|Overall Study|Administrative|1|||
162643679|NCT01139450|587411697|FG000|Overall Study|Adverse Event|2|||
163022590|NCT02829723|588786340|FG024|Overall Study|Subject/guardian decision|0|||
163022591|NCT02829723|588786341|FG025|Overall Study|Subject/guardian decision|1|||
163022592|NCT02829723|588786342|FG026|Overall Study|Subject/guardian decision|1|||
163022593|NCT02829723|588786316|FG000|Overall Study|Study terminated by sponsor|0|||
163022594|NCT02829723|588786317|FG001|Overall Study|Study terminated by sponsor|0|||
163022595|NCT02829723|588786318|FG002|Overall Study|Study terminated by sponsor|0|||
163022596|NCT02829723|588786319|FG003|Overall Study|Study terminated by sponsor|0|||
163022597|NCT02829723|588786320|FG004|Overall Study|Study terminated by sponsor|0|||
162643680|NCT01139450|587411698|FG001|Overall Study|Adverse Event|2|||
162643681|NCT01139450|587411699|FG002|Overall Study|Adverse Event|3|||
162643682|NCT01277523|587411700|FG000|Overall Study|Adverse Event|1|||
162643683|NCT01277523|587411701|FG001|Overall Study|Adverse Event|0|||
162643684|NCT01277523|587411702|FG002|Overall Study|Adverse Event|0|||
162643685|NCT01277523|587411700|FG000|Overall Study|Protocol Violation|2|||
163022598|NCT02829723|588786321|FG005|Overall Study|Study terminated by sponsor|0|||
163022599|NCT02829723|588786322|FG006|Overall Study|Study terminated by sponsor|0|||
163022600|NCT02829723|588786323|FG007|Overall Study|Study terminated by sponsor|0|||
163022601|NCT02829723|588786324|FG008|Overall Study|Study terminated by sponsor|0|||
163022602|NCT02829723|588786325|FG009|Overall Study|Study terminated by sponsor|0|||
163022603|NCT02829723|588786326|FG010|Overall Study|Study terminated by sponsor|0|||
163022604|NCT02829723|588786327|FG011|Overall Study|Study terminated by sponsor|0|||
163022605|NCT02829723|588786328|FG012|Overall Study|Study terminated by sponsor|0|||
163022606|NCT02829723|588786329|FG013|Overall Study|Study terminated by sponsor|0|||
163022607|NCT02829723|588786330|FG014|Overall Study|Study terminated by sponsor|0|||
163022608|NCT02829723|588786331|FG015|Overall Study|Study terminated by sponsor|0|||
163022609|NCT02829723|588786332|FG016|Overall Study|Study terminated by sponsor|0|||
163022610|NCT02829723|588786333|FG017|Overall Study|Study terminated by sponsor|0|||
163022611|NCT02829723|588786334|FG018|Overall Study|Study terminated by sponsor|0|||
163022612|NCT02829723|588786335|FG019|Overall Study|Study terminated by sponsor|0|||
163022613|NCT02829723|588786336|FG020|Overall Study|Study terminated by sponsor|0|||
163022614|NCT02829723|588786337|FG021|Overall Study|Study terminated by sponsor|1|||
163022615|NCT02829723|588786338|FG022|Overall Study|Study terminated by sponsor|0|||
163022616|NCT02829723|588786339|FG023|Overall Study|Study terminated by sponsor|0|||
163022617|NCT02829723|588786340|FG024|Overall Study|Study terminated by sponsor|0|||
163022618|NCT02829723|588786341|FG025|Overall Study|Study terminated by sponsor|0|||
163022619|NCT02829723|588786342|FG026|Overall Study|Study terminated by sponsor|0|||
163022620|NCT02989649|588786343|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
163022621|NCT02989649|588786343|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
163022622|NCT02989649|588786343|FG000|Overall Study|Lost For Observation During Study|3|||
163022623|NCT02989649|588786343|FG000|Overall Study|Reason Not Specified|13|||
163022624|NCT00281632|588786344|FG000|Overall Study|Adverse Event|7|||
163022625|NCT00281632|588786344|FG000|Overall Study|Withdrawal by Subject|2|||
163022626|NCT00281632|588786344|FG000|Overall Study|Disease Progression|22|||
163022627|NCT00281632|588786344|FG000|Overall Study|Death|1|||
163022628|NCT00281632|588786344|FG000|Overall Study|Physician Decision|1|||
163022629|NCT00281632|588786344|FG000|Overall Study|Ongoing|3|||
163022630|NCT01878084|588786347|FG000|Overall Study|Physician Decision|2|||
163022631|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
163022632|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
163022633|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
163022634|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
163022635|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
163022636|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
163022637|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
163022638|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
163022639|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
163022640|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
163022641|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Death|1|||
163022642|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Death|0|||
162643686|NCT01277523|587411701|FG001|Overall Study|Protocol Violation|0|||
162643687|NCT01277523|587411702|FG002|Overall Study|Protocol Violation|0|||
162643688|NCT01277523|587411700|FG000|Overall Study|Other Reason not Defined|0|||
162643689|NCT01277523|587411701|FG001|Overall Study|Other Reason not Defined|1|||
163022643|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
163022644|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
163022645|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
163022646|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
163022647|NCT01876784|588786348|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
163022648|NCT01876784|588786349|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
163022649|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
163022650|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
163022651|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Adverse Event|2|||
162643690|NCT01277523|587411702|FG002|Overall Study|Other Reason not Defined|0|||
162717827|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163022652|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Adverse Event|6|||
163022653|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
163022654|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
163022655|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Progressive disease|4|||
162643691|NCT00112502|587411705|FG000|Overall Study|Withdrawal by Subject|0|||
163022656|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Progressive disease|35|||
163022657|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
163022658|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
163022659|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
163022660|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
163022661|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Death|0|||
163022662|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Death|1|||
163022663|NCT01876784|588786348|FG000|Open-label Period (31 Months)|Other than specified above|9|||
163022664|NCT01876784|588786349|FG001|Open-label Period (31 Months)|Other than specified above|18|||
163022665|NCT01475851|588786350|FG000|Overall Study|Protocol defined stopping criteria|1|||
163022666|NCT01475851|588786351|FG001|Overall Study|Protocol defined stopping criteria|0|||
163022667|NCT00732758|588786352|FG000|Overall Study|Lost to Follow-up|8|||
163022668|NCT00732758|588786353|FG001|Overall Study|Lost to Follow-up|16|||
163022669|NCT00373958|588786354|FG000|Infant Series|Withdrawal by Subject|13|||
163022670|NCT00373958|588786355|FG001|Infant Series|Withdrawal by Subject|15|||
163022671|NCT00373958|588786354|FG000|Infant Series|Failed to return|8|||
163022672|NCT00373958|588786355|FG001|Infant Series|Failed to return|13|||
163022673|NCT00373958|588786354|FG000|Infant Series|Lost to Follow-up|6|||
163022674|NCT00373958|588786355|FG001|Infant Series|Lost to Follow-up|5|||
163022675|NCT00373958|588786354|FG000|Infant Series|Protocol Violation|3|||
163022676|NCT00373958|588786355|FG001|Infant Series|Protocol Violation|7|||
163022677|NCT00373958|588786354|FG000|Infant Series|Lost Kaiser coverage|4|||
163022678|NCT00373958|588786355|FG001|Infant Series|Lost Kaiser coverage|0|||
163022679|NCT00373958|588786354|FG000|Infant Series|Child relocated|1|||
163022680|NCT00373958|588786355|FG001|Infant Series|Child relocated|0|||
163022681|NCT00373958|588786354|FG000|Infant Series|Consent was not received|1|||
163022682|NCT00373958|588786355|FG001|Infant Series|Consent was not received|0|||
163022683|NCT00373958|588786354|FG000|Infant Series|Adverse Event|3|||
163022684|NCT00373958|588786355|FG001|Infant Series|Adverse Event|1|||
163022685|NCT00373958|588786354|FG000|Infant Series|Physician Decision|1|||
163022686|NCT00373958|588786355|FG001|Infant Series|Physician Decision|1|||
163022687|NCT00373958|588786354|FG000|Toddler Dose|Lost to Follow-up|5|||
163022688|NCT00373958|588786355|FG001|Toddler Dose|Lost to Follow-up|8|||
163022689|NCT00373958|588786354|FG000|Toddler Dose|Withdrawal by Subject|2|||
163022690|NCT00373958|588786355|FG001|Toddler Dose|Withdrawal by Subject|2|||
163022691|NCT00373958|588786354|FG000|Toddler Dose|Failed to return|1|||
163022692|NCT00373958|588786355|FG001|Toddler Dose|Failed to return|2|||
163022693|NCT00373958|588786354|FG000|Toddler Dose|Protocol Violation|0|||
163022694|NCT00373958|588786355|FG001|Toddler Dose|Protocol Violation|1|||
163022695|NCT00373958|588786354|FG000|Toddler Dose|Withdrawn after infant series|22|||
163022696|NCT00373958|588786355|FG001|Toddler Dose|Withdrawn after infant series|25|||
163022697|NCT01552915|588786356|FG000|Overall Study|Adverse Event|3|||
163022698|NCT01552915|588786357|FG001|Overall Study|Adverse Event|14|||
163022699|NCT01552915|588786358|FG002|Overall Study|Adverse Event|3|||
163022700|NCT01552915|588786356|FG000|Overall Study|Lost to Follow-up|4|||
163022701|NCT01552915|588786357|FG001|Overall Study|Lost to Follow-up|6|||
163022702|NCT01552915|588786358|FG002|Overall Study|Lost to Follow-up|5|||
163022703|NCT01552915|588786356|FG000|Overall Study|Withdrawal by Subject|6|||
163022704|NCT01552915|588786357|FG001|Overall Study|Withdrawal by Subject|4|||
163022705|NCT01552915|588786358|FG002|Overall Study|Withdrawal by Subject|5|||
163022706|NCT01552915|588786356|FG000|Overall Study|Protocol Violation|0|||
163022707|NCT01552915|588786357|FG001|Overall Study|Protocol Violation|4|||
163022708|NCT01552915|588786358|FG002|Overall Study|Protocol Violation|4|||
163022709|NCT01552915|588786356|FG000|Overall Study|Lack of Efficacy|8|||
163022710|NCT01552915|588786357|FG001|Overall Study|Lack of Efficacy|1|||
163022711|NCT01552915|588786358|FG002|Overall Study|Lack of Efficacy|4|||
163022712|NCT01552915|588786356|FG000|Overall Study|Other|2|||
163022713|NCT01552915|588786357|FG001|Overall Study|Other|0|||
163022714|NCT01552915|588786358|FG002|Overall Study|Other|6|||
163022715|NCT00492648|588786361|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
163022716|NCT00492648|588786362|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
163064082|NCT03126110|588941552|FG007|Phase 2|Study terminated by the sponsor|0|||
163022717|NCT00282113|588786363|FG000|Overall Study|Removed at parents request|1|||
163022718|NCT00282113|588786364|FG001|Overall Study|Removed at parents request|0|||
163022719|NCT00282113|588786365|FG002|Overall Study|Removed at parents request|0|||
163022720|NCT03382834|588786366|FG000|Step 1|Lost to Follow-up|0|||
163022721|NCT03382834|588786367|FG001|Step 1|Lost to Follow-up|1|||
163022722|NCT03382834|588786366|FG000|Step 2|Death|1|||
163022723|NCT03382834|588786367|FG001|Step 2|Death|0|||
163022724|NCT03382834|588786366|FG000|Step 2|Lost to Follow-up|2|||
163022725|NCT03382834|588786367|FG001|Step 2|Lost to Follow-up|2|||
163022726|NCT03382834|588786366|FG000|Step 2|Site Terminated by Sponsor|1|||
163022727|NCT03382834|588786367|FG001|Step 2|Site Terminated by Sponsor|0|||
163022728|NCT02387957|588786368|FG000|Overall Study|The study was discontinued|21|||
163022729|NCT02387957|588786369|FG001|Overall Study|The study was discontinued|21|||
163022730|NCT02387957|588786370|FG002|Overall Study|The study was discontinued|20|||
163022731|NCT02887248|588786371|FG000|Overall Study|Withdrawal by Subject|1|||
163022732|NCT02887248|588786371|FG000|Overall Study|Adverse Event|1|||
163022733|NCT02887248|588786371|FG000|Overall Study|Progressive Disease|1|||
163022734|NCT02294396|588786372|FG000|Overall Study|Adverse Event|26|||
163022735|NCT02294396|588786373|FG001|Overall Study|Adverse Event|25|||
163022736|NCT02294396|588786374|FG002|Overall Study|Adverse Event|21|||
163022737|NCT02294396|588786375|FG003|Overall Study|Adverse Event|24|||
163022738|NCT02294396|588786372|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
163022739|NCT02294396|588786373|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
163022740|NCT02294396|588786374|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
163022741|NCT02294396|588786375|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
163022742|NCT02294396|588786372|FG000|Overall Study|Withdrawal by Subject|8|||
163022743|NCT02294396|588786373|FG001|Overall Study|Withdrawal by Subject|6|||
163022744|NCT02294396|588786374|FG002|Overall Study|Withdrawal by Subject|6|||
163022745|NCT02294396|588786375|FG003|Overall Study|Withdrawal by Subject|8|||
163022746|NCT02294396|588786372|FG000|Overall Study|Lost to Follow-up|0|||
163022747|NCT02294396|588786373|FG001|Overall Study|Lost to Follow-up|0|||
163022748|NCT02294396|588786374|FG002|Overall Study|Lost to Follow-up|1|||
163022749|NCT02294396|588786375|FG003|Overall Study|Lost to Follow-up|1|||
163022750|NCT02294396|588786372|FG000|Overall Study|Protocol Deviation|3|||
163022751|NCT02294396|588786373|FG001|Overall Study|Protocol Deviation|2|||
163022752|NCT02294396|588786374|FG002|Overall Study|Protocol Deviation|2|||
163022753|NCT02294396|588786375|FG003|Overall Study|Protocol Deviation|1|||
163022754|NCT02294396|588786372|FG000|Overall Study|Miscellaneous|2|||
163022755|NCT02294396|588786373|FG001|Overall Study|Miscellaneous|0|||
163022756|NCT02294396|588786374|FG002|Overall Study|Miscellaneous|5|||
163022757|NCT02294396|588786375|FG003|Overall Study|Miscellaneous|2|||
163022758|NCT02120833|588786376|FG000|Overall Study|Adverse Event|1|||
163022759|NCT02120833|588786377|FG001|Overall Study|Adverse Event|0|||
163022760|NCT02120833|588786376|FG000|Overall Study|Withdrawal by Subject|2|||
163022761|NCT02120833|588786377|FG001|Overall Study|Withdrawal by Subject|0|||
163022762|NCT02120833|588786376|FG000|Overall Study|Lost to Follow-up|1|||
163022763|NCT02120833|588786377|FG001|Overall Study|Lost to Follow-up|1|||
163022764|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
163022765|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
163022766|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163022767|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
163022768|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
163022769|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022770|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022771|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163022772|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163022773|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163022774|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163022775|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163022776|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
163022777|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
163064083|NCT03126110|588941553|FG008|Phase 2|Study terminated by the sponsor|0|||
163064084|NCT03126110|588941554|FG009|Phase 2|Study terminated by the sponsor|0|||
163064085|NCT03126110|588941555|FG010|Phase 2|Study terminated by the sponsor|0|||
163064086|NCT03126110|588941556|FG011|Phase 2|Study terminated by the sponsor|0|||
163064087|NCT03126110|588941557|FG012|Phase 2|Study terminated by the sponsor|0|||
163022778|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
163022779|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
163022780|NCT02438826|588786380|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
163022781|NCT02438826|588786381|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
163022782|NCT02438826|588786382|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
163022783|NCT02438826|588786383|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
163022784|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Adverse Event|11|||
163022785|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Adverse Event|6|||
163022786|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Adverse Event|0|||
163022787|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Adverse Event|0|||
163022788|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
163022789|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
163022790|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
163064088|NCT03126110|588941558|FG013|Phase 2|Study terminated by the sponsor|4|||
163022791|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
163022792|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022793|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
163022794|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022795|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
163022796|NCT02438826|588786380|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
163022797|NCT02438826|588786381|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
163022798|NCT02438826|588786382|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
163022799|NCT02438826|588786383|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
163022800|NCT02438826|588786380|FG000|Post-Treatment Phase|Adverse Event|3|||
163022801|NCT02438826|588786381|FG001|Post-Treatment Phase|Adverse Event|0|||
163022802|NCT02438826|588786382|FG002|Post-Treatment Phase|Adverse Event|0|||
163022803|NCT02438826|588786383|FG003|Post-Treatment Phase|Adverse Event|0|||
163022804|NCT02438826|588786380|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
163022805|NCT02438826|588786381|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
163022806|NCT02438826|588786382|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
163022807|NCT02438826|588786383|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
163022808|NCT02438826|588786380|FG000|Post-Treatment Phase|Physician Decision|1|||
163022809|NCT02438826|588786381|FG001|Post-Treatment Phase|Physician Decision|0|||
163022810|NCT02438826|588786382|FG002|Post-Treatment Phase|Physician Decision|0|||
163022811|NCT02438826|588786383|FG003|Post-Treatment Phase|Physician Decision|0|||
163022812|NCT02438826|588786380|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
163022813|NCT02438826|588786381|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
163022814|NCT02438826|588786382|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
163022815|NCT02438826|588786383|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
163022816|NCT03429244|588786385|FG000|Overall Study|Withdrawal by Subject|2|||
163022817|NCT03429244|588786386|FG001|Overall Study|Withdrawal by Subject|1|||
163022818|NCT03429244|588786387|FG002|Overall Study|Withdrawal by Subject|1|||
163022819|NCT01500187|588786388|FG000|Overall Study|Lost to Follow-up|6|||
163022820|NCT01500187|588786389|FG001|Overall Study|Lost to Follow-up|0|||
163022821|NCT00586820|588786395|FG000|Overall Study|Unsuccessful PCI|1|||
163022822|NCT00586820|588786396|FG001|Overall Study|Unsuccessful PCI|0|||
163022823|NCT02073929|588786397|FG000|Overall Study|Lost to Follow-up|2|||
163022824|NCT02073929|588786398|FG001|Overall Study|Lost to Follow-up|1|||
163022825|NCT02073929|588786397|FG000|Overall Study|Adverse Event|2|||
163022826|NCT02073929|588786398|FG001|Overall Study|Adverse Event|1|||
163022827|NCT02073929|588786397|FG000|Overall Study|Withdrawal by Subject|0|||
163022828|NCT02073929|588786398|FG001|Overall Study|Withdrawal by Subject|1|||
163022829|NCT00430573|588786399|FG000|Overall Study|Withdrawal by Subject|5|||
163022830|NCT01483027|588786402|FG000|Overall Study|Administrative Reasons|2|||
163022831|NCT01483027|588786403|FG001|Overall Study|Administrative Reasons|1|||
163022832|NCT01483027|588786402|FG000|Overall Study|Withdrawal by Subject|21|||
163022833|NCT01483027|588786403|FG001|Overall Study|Withdrawal by Subject|32|||
163022834|NCT01483027|588786402|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
163022835|NCT01483027|588786403|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
163022836|NCT01483027|588786402|FG000|Overall Study|Lost to Follow-up|1|||
163022837|NCT01483027|588786403|FG001|Overall Study|Lost to Follow-up|1|||
163022838|NCT01483027|588786402|FG000|Overall Study|Adverse Event|0|||
163022839|NCT01483027|588786403|FG001|Overall Study|Adverse Event|1|||
163022840|NCT01483027|588786402|FG000|Overall Study|Withdrawal by Subject|0|||
163022841|NCT01483027|588786403|FG001|Overall Study|Withdrawal by Subject|1|||
163022842|NCT04463251|588786408|FG000|Overall Study|Death|1|||
163022843|NCT04463251|588786409|FG001|Overall Study|Death|0|||
163022844|NCT04463251|588786410|FG002|Overall Study|Death|1|||
163022845|NCT04463251|588786408|FG000|Overall Study|Adverse Event|0|||
163022846|NCT04463251|588786409|FG001|Overall Study|Adverse Event|1|||
163022847|NCT04463251|588786410|FG002|Overall Study|Adverse Event|0|||
163022848|NCT04463251|588786408|FG000|Overall Study|Lost to Follow-up|0|||
163022849|NCT04463251|588786409|FG001|Overall Study|Lost to Follow-up|1|||
163022850|NCT04463251|588786410|FG002|Overall Study|Lost to Follow-up|0|||
163022851|NCT04463251|588786408|FG000|Overall Study|Withdrawal by Subject|0|||
163022852|NCT04463251|588786409|FG001|Overall Study|Withdrawal by Subject|2|||
163022853|NCT04463251|588786410|FG002|Overall Study|Withdrawal by Subject|2|||
162717828|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163022854|NCT05020665|588786411|FG000|Overall Study|Study terminated by Sponsor|5|||
163022855|NCT05020665|588786412|FG001|Overall Study|Study terminated by Sponsor|4|||
163022856|NCT05020665|588786411|FG000|Overall Study|Death|2|||
163022857|NCT05020665|588786412|FG001|Overall Study|Death|1|||
163022858|NCT05020665|588786411|FG000|Overall Study|Physician Decision|0|||
163022859|NCT05020665|588786412|FG001|Overall Study|Physician Decision|1|||
163022860|NCT05020665|588786411|FG000|Overall Study|Withdrawal by Subject|0|||
163022861|NCT05020665|588786412|FG001|Overall Study|Withdrawal by Subject|1|||
163022862|NCT05020665|588786411|FG000|Overall Study|Reason not specified|1|||
163022863|NCT05020665|588786412|FG001|Overall Study|Reason not specified|0|||
163022864|NCT01743560|588786417|FG000|Overall Study|Disease progression|26|||
163022865|NCT01743560|588786417|FG000|Overall Study|Adverse Event|8|||
163022866|NCT01743560|588786417|FG000|Overall Study|Death|3|||
163022867|NCT01743560|588786417|FG000|Overall Study|Withdrawal by Subject|2|||
163022868|NCT01743560|588786417|FG000|Overall Study|Protocol Violation|1|||
163022869|NCT01743560|588786417|FG000|Overall Study|>1 dose of study drug|3|||
163022870|NCT01732640|588786423|FG000|Overall Study|Adverse Event|0|||
163022871|NCT01732640|588786424|FG001|Overall Study|Adverse Event|1|||
163022872|NCT01732640|588786423|FG000|Overall Study|Death|0|||
163022873|NCT01732640|588786424|FG001|Overall Study|Death|1|||
163022874|NCT00877487|588786427|FG000|Open-label Treatment Phase|Adverse Event|1|||
163022875|NCT00877487|588786428|FG001|Open-label Treatment Phase|Adverse Event|0|||
163022876|NCT00877487|588786427|FG000|Open-label Treatment Phase|Protocol Violation|3|||
163022877|NCT00877487|588786428|FG001|Open-label Treatment Phase|Protocol Violation|0|||
163022878|NCT00877487|588786427|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
163022879|NCT00877487|588786428|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
163022880|NCT00877487|588786427|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
163022881|NCT00877487|588786428|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
163022882|NCT00877487|588786427|FG000|Open-label Treatment Phase|Out of country for business|1|||
163022883|NCT00877487|588786428|FG001|Open-label Treatment Phase|Out of country for business|0|||
163022884|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
163022885|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
163022886|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
163022887|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
163022888|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
163022889|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
163022890|NCT00877487|588786427|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
163022891|NCT00877487|588786428|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
163022892|NCT03070002|588786429|FG000|Follow up for 2 Years|Death|1|||
163022893|NCT03425396|588786441|FG000|Overall Study|Lost to Follow-up|2|||
163022894|NCT03425396|588786442|FG001|Overall Study|Lost to Follow-up|5|||
163022895|NCT03425396|588786443|FG002|Overall Study|Lost to Follow-up|2|||
163022896|NCT03425396|588786444|FG003|Overall Study|Lost to Follow-up|0|||
163022897|NCT03425396|588786445|FG004|Overall Study|Lost to Follow-up|0|||
163022898|NCT03425396|588786441|FG000|Overall Study|Withdrawal by Subject|0|||
163022899|NCT03425396|588786442|FG001|Overall Study|Withdrawal by Subject|1|||
163022900|NCT03425396|588786443|FG002|Overall Study|Withdrawal by Subject|0|||
163022901|NCT03425396|588786444|FG003|Overall Study|Withdrawal by Subject|1|||
163022902|NCT03425396|588786445|FG004|Overall Study|Withdrawal by Subject|0|||
163022903|NCT03425396|588786441|FG000|Overall Study|Other|0|||
163022904|NCT03425396|588786442|FG001|Overall Study|Other|1|||
163022905|NCT03425396|588786443|FG002|Overall Study|Other|1|||
163022906|NCT03425396|588786444|FG003|Overall Study|Other|0|||
163022907|NCT03425396|588786445|FG004|Overall Study|Other|1|||
163022908|NCT00601172|588788615|FG000|Overall Study|Adverse Event|43|||
163022909|NCT00601172|588788616|FG001|Overall Study|Adverse Event|32|||
163022910|NCT00601172|588788615|FG000|Overall Study|Lack of Efficacy|11|||
163022911|NCT00601172|588788616|FG001|Overall Study|Lack of Efficacy|12|||
163022912|NCT00601172|588788615|FG000|Overall Study|Protocol Violation|2|||
163022913|NCT00601172|588788616|FG001|Overall Study|Protocol Violation|5|||
163022914|NCT00601172|588788615|FG000|Overall Study|Lost to Follow-up|4|||
163022915|NCT00601172|588788616|FG001|Overall Study|Lost to Follow-up|3|||
163022916|NCT00601172|588788615|FG000|Overall Study|Physician Decision|27|||
163022917|NCT00601172|588788616|FG001|Overall Study|Physician Decision|28|||
163022918|NCT00601172|588788615|FG000|Overall Study|Withdrawal by Subject|35|||
163022919|NCT00601172|588788616|FG001|Overall Study|Withdrawal by Subject|27|||
163022920|NCT00601172|588788615|FG000|Overall Study|Did not meet continuation criteria|19|||
163022921|NCT00601172|588788616|FG001|Overall Study|Did not meet continuation criteria|20|||
163022922|NCT04434469|588788620|FG000|Overall Study|Death|2|||
163022923|NCT04434469|588788621|FG001|Overall Study|Death|3|||
163022924|NCT04434469|588788622|FG002|Overall Study|Death|2|||
163022925|NCT04434469|588788623|FG003|Overall Study|Death|2|||
163022926|NCT04434469|588788624|FG004|Overall Study|Death|2|||
163022927|NCT04434469|588788625|FG005|Overall Study|Death|0|||
163022928|NCT04434469|588788620|FG000|Overall Study|Lost to Follow-up|0|||
163022929|NCT04434469|588788621|FG001|Overall Study|Lost to Follow-up|0|||
163022930|NCT04434469|588788622|FG002|Overall Study|Lost to Follow-up|0|||
163022931|NCT04434469|588788623|FG003|Overall Study|Lost to Follow-up|1|||
163022932|NCT04434469|588788624|FG004|Overall Study|Lost to Follow-up|1|||
163022933|NCT04434469|588788625|FG005|Overall Study|Lost to Follow-up|0|||
163022934|NCT04434469|588788620|FG000|Overall Study|Study terminated by sponsor|1|||
163022935|NCT04434469|588788621|FG001|Overall Study|Study terminated by sponsor|1|||
163022936|NCT04434469|588788622|FG002|Overall Study|Study terminated by sponsor|1|||
163022937|NCT04434469|588788623|FG003|Overall Study|Study terminated by sponsor|2|||
163022938|NCT04434469|588788624|FG004|Overall Study|Study terminated by sponsor|3|||
163022939|NCT04434469|588788625|FG005|Overall Study|Study terminated by sponsor|3|||
163022940|NCT04434469|588788620|FG000|Overall Study|Withdrawal by Subject|0|||
163022941|NCT04434469|588788621|FG001|Overall Study|Withdrawal by Subject|0|||
163022942|NCT04434469|588788622|FG002|Overall Study|Withdrawal by Subject|1|||
163022943|NCT04434469|588788623|FG003|Overall Study|Withdrawal by Subject|0|||
163022944|NCT04434469|588788624|FG004|Overall Study|Withdrawal by Subject|0|||
163022945|NCT04434469|588788625|FG005|Overall Study|Withdrawal by Subject|0|||
163022946|NCT01936181|588788629|FG000|Randomised, Double-blind|Adverse Event|27|||
163022947|NCT01936181|588788630|FG001|Randomised, Double-blind|Adverse Event|21|||
163022948|NCT01936181|588788631|FG002|Randomised, Double-blind|Adverse Event|0|||
163022949|NCT01936181|588788632|FG003|Randomised, Double-blind|Adverse Event|0|||
163022950|NCT01936181|588788629|FG000|Randomised, Double-blind|Protocol Violation|1|||
163022951|NCT01936181|588788630|FG001|Randomised, Double-blind|Protocol Violation|5|||
163022952|NCT01936181|588788631|FG002|Randomised, Double-blind|Protocol Violation|0|||
163022953|NCT01936181|588788632|FG003|Randomised, Double-blind|Protocol Violation|0|||
163022954|NCT01936181|588788629|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
163022955|NCT01936181|588788630|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
163022956|NCT01936181|588788631|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
163022957|NCT01936181|588788632|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
163022958|NCT01936181|588788629|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
163022959|NCT01936181|588788630|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
163022960|NCT01936181|588788631|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
163022961|NCT01936181|588788632|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
163022962|NCT01936181|588788629|FG000|Randomised, Double-blind|Pregnancy|0|||
163022963|NCT01936181|588788630|FG001|Randomised, Double-blind|Pregnancy|1|||
163022964|NCT01936181|588788631|FG002|Randomised, Double-blind|Pregnancy|0|||
163022965|NCT01936181|588788632|FG003|Randomised, Double-blind|Pregnancy|0|||
163022966|NCT01936181|588788629|FG000|Randomised, Double-blind|Physician Decision|4|||
163022967|NCT01936181|588788630|FG001|Randomised, Double-blind|Physician Decision|4|||
163022968|NCT01936181|588788631|FG002|Randomised, Double-blind|Physician Decision|0|||
163022969|NCT01936181|588788632|FG003|Randomised, Double-blind|Physician Decision|0|||
163022970|NCT01936181|588788629|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
163022971|NCT01936181|588788630|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
163022972|NCT01936181|588788631|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
163022973|NCT01936181|588788632|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
163022974|NCT01936181|588788629|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
163022975|NCT01936181|588788630|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
163022976|NCT01936181|588788631|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
163022977|NCT01936181|588788632|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
163022978|NCT01936181|588788629|FG000|Transition-extension|Adverse Event|3|||
163022979|NCT01936181|588788630|FG001|Transition-extension|Adverse Event|0|||
163022980|NCT01936181|588788631|FG002|Transition-extension|Adverse Event|3|||
163022981|NCT01936181|588788632|FG003|Transition-extension|Adverse Event|1|||
163022982|NCT01936181|588788629|FG000|Transition-extension|Lost to Follow-up|3|||
163022983|NCT01936181|588788630|FG001|Transition-extension|Lost to Follow-up|0|||
163022984|NCT01936181|588788631|FG002|Transition-extension|Lost to Follow-up|1|||
163022985|NCT01936181|588788632|FG003|Transition-extension|Lost to Follow-up|2|||
163022986|NCT01936181|588788629|FG000|Transition-extension|Physician Decision|2|||
163022987|NCT01936181|588788630|FG001|Transition-extension|Physician Decision|0|||
163022988|NCT01936181|588788631|FG002|Transition-extension|Physician Decision|0|||
163022989|NCT01936181|588788632|FG003|Transition-extension|Physician Decision|1|||
163022990|NCT01936181|588788629|FG000|Transition-extension|Withdrawal by Subject|7|||
163022991|NCT01936181|588788630|FG001|Transition-extension|Withdrawal by Subject|0|||
163022992|NCT01936181|588788631|FG002|Transition-extension|Withdrawal by Subject|2|||
163022993|NCT01936181|588788632|FG003|Transition-extension|Withdrawal by Subject|1|||
163022994|NCT01346189|588788633|FG000|Overall Study|Withdrawal by Subject|7|||
163022995|NCT01346189|588788634|FG001|Overall Study|Withdrawal by Subject|5|||
163022996|NCT01346189|588788635|FG002|Overall Study|Withdrawal by Subject|3|||
163064089|NCT03126110|588941559|FG014|Phase 2|Study terminated by the sponsor|0|||
163064090|NCT03126110|588941560|FG015|Phase 2|Study terminated by the sponsor|0|||
163064091|NCT03126110|588941561|FG016|Phase 2|Study terminated by the sponsor|0|||
163064092|NCT03126110|588941545|FG000|Phase 2|Withdrawal by Subject|0|||
163022997|NCT01346189|588788636|FG003|Overall Study|Withdrawal by Subject|5|||
162643692|NCT00112502|587411706|FG001|Overall Study|Withdrawal by Subject|1|||
162643693|NCT00112502|587411707|FG002|Overall Study|Withdrawal by Subject|1|||
163022998|NCT01346189|588788633|FG000|Overall Study|Physician Decision|4|||
163022999|NCT01346189|588788634|FG001|Overall Study|Physician Decision|0|||
163023000|NCT01346189|588788635|FG002|Overall Study|Physician Decision|0|||
163023001|NCT01346189|588788636|FG003|Overall Study|Physician Decision|0|||
163064093|NCT03126110|588941546|FG001|Phase 2|Withdrawal by Subject|0|||
163064094|NCT03126110|588941547|FG002|Phase 2|Withdrawal by Subject|0|||
163064095|NCT03126110|588941548|FG003|Phase 2|Withdrawal by Subject|0|||
163064096|NCT03126110|588941549|FG004|Phase 2|Withdrawal by Subject|0|||
163064097|NCT03126110|588941550|FG005|Phase 2|Withdrawal by Subject|0|||
163023002|NCT01346189|588788633|FG000|Overall Study|Moved|3|||
163023003|NCT01346189|588788634|FG001|Overall Study|Moved|0|||
163023004|NCT01346189|588788635|FG002|Overall Study|Moved|4|||
163023005|NCT01346189|588788636|FG003|Overall Study|Moved|0|||
163023006|NCT01346189|588788633|FG000|Overall Study|Other|2|||
163023007|NCT01346189|588788634|FG001|Overall Study|Other|4|||
163023008|NCT01346189|588788635|FG002|Overall Study|Other|7|||
163023009|NCT01346189|588788636|FG003|Overall Study|Other|3|||
163023010|NCT01346189|588788633|FG000|Overall Study|Death|0|||
163023011|NCT01346189|588788634|FG001|Overall Study|Death|3|||
163023012|NCT01346189|588788635|FG002|Overall Study|Death|0|||
163023013|NCT01346189|588788636|FG003|Overall Study|Death|0|||
163023014|NCT01346189|588788633|FG000|Overall Study|Non-health system primary care physician|0|||
163023015|NCT01346189|588788634|FG001|Overall Study|Non-health system primary care physician|5|||
163023016|NCT01346189|588788635|FG002|Overall Study|Non-health system primary care physician|0|||
163023017|NCT01346189|588788636|FG003|Overall Study|Non-health system primary care physician|0|||
163023018|NCT01346189|588788633|FG000|Overall Study|Travel|0|||
163023019|NCT01346189|588788634|FG001|Overall Study|Travel|0|||
163023020|NCT01346189|588788635|FG002|Overall Study|Travel|0|||
163023021|NCT01346189|588788636|FG003|Overall Study|Travel|3|||
163023022|NCT00900757|588788637|FG000|Overall Study|screen failure|19|||
163023023|NCT02005692|588788642|FG000|Overall Study|Protocol Violation|1|||
163023024|NCT02005692|588788642|FG000|Overall Study|Withdrawal by Subject|1|||
163023025|NCT02005692|588788642|FG000|Overall Study|Discharged earlier than anticipated|5|||
163023026|NCT00654875|588788643|FG000|Overall Study|Adverse Event|5|||
163023027|NCT00654875|588788644|FG001|Overall Study|Adverse Event|5|||
163023028|NCT00654875|588788643|FG000|Overall Study|Withdrawal by Subject|4|||
163023029|NCT00654875|588788644|FG001|Overall Study|Withdrawal by Subject|4|||
163023030|NCT00654875|588788643|FG000|Overall Study|Protocol Violation|3|||
163023031|NCT00654875|588788644|FG001|Overall Study|Protocol Violation|3|||
163023032|NCT00654875|588788643|FG000|Overall Study|Lack of Efficacy|2|||
163023033|NCT00654875|588788644|FG001|Overall Study|Lack of Efficacy|2|||
163023034|NCT00654875|588788643|FG000|Overall Study|Lost to Follow-up|1|||
163023035|NCT00654875|588788644|FG001|Overall Study|Lost to Follow-up|3|||
163064098|NCT03126110|588941551|FG006|Phase 2|Withdrawal by Subject|0|||
163064099|NCT03126110|588941552|FG007|Phase 2|Withdrawal by Subject|0|||
163064100|NCT03126110|588941553|FG008|Phase 2|Withdrawal by Subject|0|||
163064101|NCT03126110|588941554|FG009|Phase 2|Withdrawal by Subject|0|||
163064102|NCT03126110|588941555|FG010|Phase 2|Withdrawal by Subject|0|||
163064103|NCT03126110|588941556|FG011|Phase 2|Withdrawal by Subject|1|||
163064104|NCT03126110|588941557|FG012|Phase 2|Withdrawal by Subject|3|||
163064105|NCT03126110|588941558|FG013|Phase 2|Withdrawal by Subject|3|||
163064106|NCT03126110|588941559|FG014|Phase 2|Withdrawal by Subject|2|||
163064107|NCT03126110|588941560|FG015|Phase 2|Withdrawal by Subject|1|||
163064108|NCT03126110|588941561|FG016|Phase 2|Withdrawal by Subject|0|||
163064109|NCT03126110|588941545|FG000|Phase 2|Lost to Follow-up|0|||
163064110|NCT03126110|588941546|FG001|Phase 2|Lost to Follow-up|0|||
163064111|NCT03126110|588941547|FG002|Phase 2|Lost to Follow-up|0|||
163064112|NCT03126110|588941548|FG003|Phase 2|Lost to Follow-up|0|||
163064113|NCT03126110|588941549|FG004|Phase 2|Lost to Follow-up|0|||
163064114|NCT03126110|588941550|FG005|Phase 2|Lost to Follow-up|0|||
162643694|NCT00112502|587411708|FG003|Overall Study|Withdrawal by Subject|4|||
162643695|NCT00112502|587411709|FG004|Overall Study|Withdrawal by Subject|2|||
162643696|NCT00112502|587411710|FG005|Overall Study|Withdrawal by Subject|5|||
162643697|NCT00112502|587411711|FG006|Overall Study|Withdrawal by Subject|3|||
162643698|NCT00112502|587411712|FG007|Overall Study|Withdrawal by Subject|7|||
162643699|NCT00265343|587411715|FG000|Overall Study|Adverse Event|10|||
163023036|NCT00654875|588788643|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163023037|NCT00654875|588788644|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163023038|NCT00654875|588788643|FG000|Overall Study|Administrative Problems|1|||
163023039|NCT00654875|588788644|FG001|Overall Study|Administrative Problems|0|||
163064115|NCT03126110|588941551|FG006|Phase 2|Lost to Follow-up|0|||
163064116|NCT03126110|588941552|FG007|Phase 2|Lost to Follow-up|0|||
162643700|NCT00265343|587411716|FG001|Overall Study|Adverse Event|7|||
163023040|NCT00723008|588788645|FG000|Enrollment|Lost to Follow-up|1|||
163023041|NCT00723008|588788646|FG001|Enrollment|Lost to Follow-up|0|||
163064117|NCT03126110|588941553|FG008|Phase 2|Lost to Follow-up|0|||
163064118|NCT03126110|588941554|FG009|Phase 2|Lost to Follow-up|0|||
163064119|NCT03126110|588941555|FG010|Phase 2|Lost to Follow-up|0|||
163064120|NCT03126110|588941556|FG011|Phase 2|Lost to Follow-up|1|||
162643701|NCT00265343|587411715|FG000|Overall Study|Withdrawal by Subject|3|||
163023042|NCT00723008|588788645|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
163023043|NCT00723008|588788646|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
163064121|NCT03126110|588941557|FG012|Phase 2|Lost to Follow-up|1|||
163064122|NCT03126110|588941558|FG013|Phase 2|Lost to Follow-up|1|||
162643702|NCT00265343|587411716|FG001|Overall Study|Withdrawal by Subject|9|||
162643703|NCT00265343|587411715|FG000|Overall Study|Other|8|||
162643704|NCT00265343|587411716|FG001|Overall Study|Other|3|||
162643705|NCT02608268|587411717|FG000|Overall Study|Adverse Event|0|||
163023044|NCT00723008|588788645|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
163023045|NCT00723008|588788646|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
163023046|NCT00723008|588788645|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
163023047|NCT00723008|588788646|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
163023048|NCT00723008|588788645|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
163023049|NCT00723008|588788646|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
163023050|NCT00723008|588788645|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
163023051|NCT00723008|588788646|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
163023052|NCT05896527|588788648|FG000|Overall Study|Withdrawal by Subject|11|||
163023053|NCT05896527|588788649|FG001|Overall Study|Withdrawal by Subject|10|||
163023054|NCT05896527|588788650|FG002|Overall Study|Withdrawal by Subject|4|||
163023055|NCT05896527|588788651|FG003|Overall Study|Withdrawal by Subject|3|||
163023056|NCT05896527|588788652|FG004|Overall Study|Withdrawal by Subject|2|||
163023057|NCT05896527|588788648|FG000|Overall Study|Lost to Follow-up|0|||
163023058|NCT05896527|588788649|FG001|Overall Study|Lost to Follow-up|2|||
163023059|NCT05896527|588788650|FG002|Overall Study|Lost to Follow-up|2|||
163023060|NCT05896527|588788651|FG003|Overall Study|Lost to Follow-up|2|||
163023061|NCT05896527|588788652|FG004|Overall Study|Lost to Follow-up|1|||
163023062|NCT05896527|588788648|FG000|Overall Study|Significant protocol noncompliance|0|||
163023063|NCT05896527|588788649|FG001|Overall Study|Significant protocol noncompliance|1|||
163023064|NCT05896527|588788650|FG002|Overall Study|Significant protocol noncompliance|0|||
163023065|NCT05896527|588788651|FG003|Overall Study|Significant protocol noncompliance|0|||
163023066|NCT05896527|588788652|FG004|Overall Study|Significant protocol noncompliance|0|||
163023067|NCT05896527|588788648|FG000|Overall Study|Eligibility criteria not met|1|||
163023068|NCT05896527|588788649|FG001|Overall Study|Eligibility criteria not met|0|||
163023069|NCT05896527|588788650|FG002|Overall Study|Eligibility criteria not met|0|||
163023070|NCT05896527|588788651|FG003|Overall Study|Eligibility criteria not met|0|||
163023071|NCT05896527|588788652|FG004|Overall Study|Eligibility criteria not met|0|||
163023072|NCT05896527|588788648|FG000|Overall Study|Sponsor's decision|0|||
163023073|NCT05896527|588788649|FG001|Overall Study|Sponsor's decision|0|||
163023074|NCT05896527|588788650|FG002|Overall Study|Sponsor's decision|0|||
163023075|NCT05896527|588788651|FG003|Overall Study|Sponsor's decision|1|||
163023076|NCT05896527|588788652|FG004|Overall Study|Sponsor's decision|0|||
163023077|NCT05896527|588788648|FG000|Overall Study|Investigator's decision|0|||
163023078|NCT05896527|588788649|FG001|Overall Study|Investigator's decision|1|||
163023079|NCT05896527|588788650|FG002|Overall Study|Investigator's decision|0|||
163023080|NCT05896527|588788651|FG003|Overall Study|Investigator's decision|0|||
163023081|NCT05896527|588788652|FG004|Overall Study|Investigator's decision|0|||
163023082|NCT05896527|588788648|FG000|Overall Study|Pregnancy of his partner|0|||
163023083|NCT05896527|588788649|FG001|Overall Study|Pregnancy of his partner|0|||
163023084|NCT05896527|588788650|FG002|Overall Study|Pregnancy of his partner|0|||
163023085|NCT05896527|588788651|FG003|Overall Study|Pregnancy of his partner|1|||
163023086|NCT05896527|588788652|FG004|Overall Study|Pregnancy of his partner|0|||
163023087|NCT01279070|588788653|FG000|Overall Study|Withdrawal by Subject|2|||
163023088|NCT01279070|588788654|FG001|Overall Study|Withdrawal by Subject|3|||
163023089|NCT01279070|588788653|FG000|Overall Study|Acute exacerbation|3|||
163023090|NCT01279070|588788654|FG001|Overall Study|Acute exacerbation|1|||
163023091|NCT01014988|588788656|FG000|Overall Study|Adverse Event|20|||
163023092|NCT01014988|588788657|FG001|Overall Study|Adverse Event|0|||
163023093|NCT01014988|588788658|FG002|Overall Study|Adverse Event|1|||
163023094|NCT01014988|588788659|FG003|Overall Study|Adverse Event|0|||
163023095|NCT01014988|588788660|FG004|Overall Study|Adverse Event|1|||
163023096|NCT01014988|588788661|FG005|Overall Study|Adverse Event|3|||
163023097|NCT01014988|588788656|FG000|Overall Study|Lost to Follow-up|1|||
163023098|NCT01014988|588788657|FG001|Overall Study|Lost to Follow-up|0|||
163023099|NCT01014988|588788658|FG002|Overall Study|Lost to Follow-up|1|||
162643706|NCT02608268|587411718|FG001|Overall Study|Adverse Event|0|||
162643707|NCT02608268|587411719|FG002|Overall Study|Adverse Event|1|||
162643708|NCT02608268|587411720|FG003|Overall Study|Adverse Event|0|||
163023100|NCT01014988|588788659|FG003|Overall Study|Lost to Follow-up|0|||
163023101|NCT01014988|588788660|FG004|Overall Study|Lost to Follow-up|0|||
162643709|NCT02608268|587411721|FG004|Overall Study|Adverse Event|0|||
162643710|NCT02608268|587411722|FG005|Overall Study|Adverse Event|0|||
163023102|NCT01014988|588788661|FG005|Overall Study|Lost to Follow-up|0|||
163023103|NCT01014988|588788656|FG000|Overall Study|Physician Decision|1|||
163023104|NCT01014988|588788657|FG001|Overall Study|Physician Decision|0|||
163023105|NCT01014988|588788658|FG002|Overall Study|Physician Decision|0|||
163023106|NCT01014988|588788659|FG003|Overall Study|Physician Decision|0|||
163023107|NCT01014988|588788660|FG004|Overall Study|Physician Decision|0|||
163023108|NCT01014988|588788661|FG005|Overall Study|Physician Decision|0|||
163023109|NCT01014988|588788656|FG000|Overall Study|Withdrawal by Subject|1|||
163023110|NCT01014988|588788657|FG001|Overall Study|Withdrawal by Subject|0|||
163023111|NCT01014988|588788658|FG002|Overall Study|Withdrawal by Subject|0|||
163023112|NCT01014988|588788659|FG003|Overall Study|Withdrawal by Subject|0|||
163023113|NCT01014988|588788660|FG004|Overall Study|Withdrawal by Subject|0|||
163023114|NCT01014988|588788661|FG005|Overall Study|Withdrawal by Subject|0|||
163023115|NCT05835011|588788662|FG000|Overall Study|Study Terminated by the Sponsor|1|||
163023116|NCT05835011|588788662|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
163023117|NCT01683266|588788665|FG000|Overall Study|Adverse Event|5|||
163023118|NCT01683266|588788666|FG001|Overall Study|Adverse Event|4|||
163023119|NCT01683266|588788665|FG000|Overall Study|Lack of Efficacy|5|||
163023120|NCT01683266|588788666|FG001|Overall Study|Lack of Efficacy|2|||
163023121|NCT01683266|588788665|FG000|Overall Study|Protocol Violation|13|||
163023122|NCT01683266|588788666|FG001|Overall Study|Protocol Violation|6|||
163023123|NCT01683266|588788665|FG000|Overall Study|Personal Reason|17|||
163023124|NCT01683266|588788666|FG001|Overall Study|Personal Reason|25|||
163023125|NCT01683266|588788665|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
163023126|NCT01683266|588788666|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
163023127|NCT01683266|588788665|FG000|Overall Study|Lost to Follow-up|5|||
163023128|NCT01683266|588788666|FG001|Overall Study|Lost to Follow-up|0|||
163023129|NCT01683266|588788665|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
163023130|NCT01683266|588788666|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
163023131|NCT01683266|588788665|FG000|Overall Study|Nonserious Hypoglycemia|0|||
163023132|NCT01683266|588788666|FG001|Overall Study|Nonserious Hypoglycemia|3|||
163023133|NCT01683266|588788665|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163023134|NCT01683266|588788666|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163023135|NCT01683266|588788665|FG000|Overall Study|Possibly Hypoglycemia|1|||
163023136|NCT01683266|588788666|FG001|Overall Study|Possibly Hypoglycemia|0|||
163023137|NCT01683266|588788665|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
163023138|NCT01683266|588788666|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
163023139|NCT02222545|588788667|FG000|Overall Study|Adverse Event|1|||
163023140|NCT02222545|588788668|FG001|Overall Study|Adverse Event|0|||
163023141|NCT02222545|588788669|FG002|Overall Study|Adverse Event|2|||
163023142|NCT02222545|588788667|FG000|Overall Study|Death|0|||
163023143|NCT02222545|588788668|FG001|Overall Study|Death|0|||
163023144|NCT02222545|588788669|FG002|Overall Study|Death|9|||
163023145|NCT02222545|588788667|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
163023146|NCT02222545|588788668|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
163023147|NCT02222545|588788669|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
163023148|NCT02222545|588788667|FG000|Overall Study|Withdrawal by Subject|0|||
163023149|NCT02222545|588788668|FG001|Overall Study|Withdrawal by Subject|0|||
163023150|NCT02222545|588788669|FG002|Overall Study|Withdrawal by Subject|3|||
162643711|NCT02608268|587411723|FG006|Overall Study|Adverse Event|0|||
162643712|NCT02608268|587411724|FG007|Overall Study|Adverse Event|0|||
162643713|NCT02608268|587411725|FG008|Overall Study|Adverse Event|0|||
162643714|NCT02608268|587411726|FG009|Overall Study|Adverse Event|0|||
163023151|NCT02222545|588788667|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
163023152|NCT02222545|588788668|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
163023153|NCT02222545|588788669|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
163023154|NCT00090220|588788670|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
163023155|NCT00090220|588788671|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
163023156|NCT00090220|588788672|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023157|NCT00090220|588788673|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023158|NCT00090220|588788674|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023159|NCT00090220|588788675|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163023160|NCT00090220|588788670|FG000|Base Study Vaccination Period|Adverse Event|6|||
163023161|NCT00090220|588788671|FG001|Base Study Vaccination Period|Adverse Event|1|||
163023162|NCT00090220|588788672|FG002|Base Study Vaccination Period|Adverse Event|0|||
163023163|NCT00090220|588788673|FG003|Base Study Vaccination Period|Adverse Event|0|||
163023164|NCT00090220|588788674|FG004|Base Study Vaccination Period|Adverse Event|0|||
163023165|NCT00090220|588788675|FG005|Base Study Vaccination Period|Adverse Event|0|||
163023166|NCT00090220|588788670|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
163023167|NCT00090220|588788671|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
163023168|NCT00090220|588788672|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
163023169|NCT00090220|588788673|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163023170|NCT00090220|588788674|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163023171|NCT00090220|588788675|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
163023172|NCT00090220|588788670|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
163023173|NCT00090220|588788671|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
163023174|NCT00090220|588788672|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023175|NCT00090220|588788673|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023176|NCT00090220|588788674|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023177|NCT00090220|588788675|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
163023178|NCT00090220|588788670|FG000|Base Study Vaccination Period|Patient Moved|6|||
163023179|NCT00090220|588788671|FG001|Base Study Vaccination Period|Patient Moved|2|||
163023180|NCT00090220|588788672|FG002|Base Study Vaccination Period|Patient Moved|0|||
163023181|NCT00090220|588788673|FG003|Base Study Vaccination Period|Patient Moved|0|||
163023182|NCT00090220|588788674|FG004|Base Study Vaccination Period|Patient Moved|0|||
163023183|NCT00090220|588788675|FG005|Base Study Vaccination Period|Patient Moved|0|||
163023184|NCT00090220|588788670|FG000|Base Study Vaccination Period|Other|4|||
163023185|NCT00090220|588788671|FG001|Base Study Vaccination Period|Other|4|||
163023186|NCT00090220|588788672|FG002|Base Study Vaccination Period|Other|0|||
163023187|NCT00090220|588788673|FG003|Base Study Vaccination Period|Other|0|||
163023188|NCT00090220|588788674|FG004|Base Study Vaccination Period|Other|0|||
163023189|NCT00090220|588788675|FG005|Base Study Vaccination Period|Other|0|||
163023190|NCT00090220|588788670|FG000|Base Study Follow-up Period|Adverse Event|6|||
163023191|NCT00090220|588788671|FG001|Base Study Follow-up Period|Adverse Event|1|||
163023192|NCT00090220|588788672|FG002|Base Study Follow-up Period|Adverse Event|0|||
163023193|NCT00090220|588788673|FG003|Base Study Follow-up Period|Adverse Event|0|||
163023194|NCT00090220|588788674|FG004|Base Study Follow-up Period|Adverse Event|0|||
163023195|NCT00090220|588788675|FG005|Base Study Follow-up Period|Adverse Event|0|||
163023196|NCT00090220|588788670|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
163023197|NCT00090220|588788671|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
163023198|NCT00090220|588788672|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
163023199|NCT00090220|588788673|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
163023200|NCT00090220|588788674|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
163023201|NCT00090220|588788675|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
163023202|NCT00090220|588788670|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
163023203|NCT00090220|588788671|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
163023204|NCT00090220|588788672|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023205|NCT00090220|588788673|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023206|NCT00090220|588788674|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023207|NCT00090220|588788675|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
163023208|NCT00090220|588788670|FG000|Base Study Follow-up Period|Patient Moved|20|||
163023209|NCT00090220|588788671|FG001|Base Study Follow-up Period|Patient Moved|28|||
163023210|NCT00090220|588788672|FG002|Base Study Follow-up Period|Patient Moved|0|||
163023211|NCT00090220|588788673|FG003|Base Study Follow-up Period|Patient Moved|0|||
163023212|NCT00090220|588788674|FG004|Base Study Follow-up Period|Patient Moved|0|||
163023213|NCT00090220|588788675|FG005|Base Study Follow-up Period|Patient Moved|0|||
163023214|NCT00090220|588788670|FG000|Base Study Follow-up Period|Other|19|||
163023215|NCT00090220|588788671|FG001|Base Study Follow-up Period|Other|21|||
162643715|NCT02608268|587411727|FG010|Overall Study|Adverse Event|0|||
162643716|NCT02608268|587411728|FG011|Overall Study|Adverse Event|0|||
163023216|NCT00090220|588788672|FG002|Base Study Follow-up Period|Other|0|||
163023217|NCT00090220|588788673|FG003|Base Study Follow-up Period|Other|0|||
163023218|NCT00090220|588788674|FG004|Base Study Follow-up Period|Other|0|||
163023219|NCT00090220|588788675|FG005|Base Study Follow-up Period|Other|0|||
163023220|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Adverse Event|0|||
163023221|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Adverse Event|0|||
163023222|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Adverse Event|4|||
163023223|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Adverse Event|0|||
163023224|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Adverse Event|0|||
163023225|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Adverse Event|0|||
163023226|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023227|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023228|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
163023229|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023230|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023231|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
163023232|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Moved|0|||
163023233|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Moved|0|||
163023234|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Moved|2|||
163023235|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Moved|1|||
163023236|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Moved|0|||
163023237|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Moved|0|||
163023238|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023239|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023240|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
163023241|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023242|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023243|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
163023244|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
163023245|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
163023246|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
163023247|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
163023248|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
163023249|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
163023250|NCT00090220|588788670|FG000|Extension 1 (EXT1)|Other reason|0|||
163023251|NCT00090220|588788671|FG001|Extension 1 (EXT1)|Other reason|0|||
163023252|NCT00090220|588788672|FG002|Extension 1 (EXT1)|Other reason|2|||
163023253|NCT00090220|588788673|FG003|Extension 1 (EXT1)|Other reason|0|||
163023254|NCT00090220|588788674|FG004|Extension 1 (EXT1)|Other reason|0|||
163023255|NCT00090220|588788675|FG005|Extension 1 (EXT1)|Other reason|0|||
163023256|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023257|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023258|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023259|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
163023260|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
163023261|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
163023262|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Death|0|||
163023263|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Death|0|||
163023264|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Death|0|||
163023265|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Death|0|||
163023266|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Death|1|||
163023267|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Death|1|||
163023268|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023269|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023270|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023271|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
163023272|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
163023273|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
163023274|NCT00090220|588788670|FG000|Long-term Follow-up (EXT2)|Other|0|||
163023275|NCT00090220|588788671|FG001|Long-term Follow-up (EXT2)|Other|0|||
163023276|NCT00090220|588788672|FG002|Long-term Follow-up (EXT2)|Other|0|||
163023277|NCT00090220|588788673|FG003|Long-term Follow-up (EXT2)|Other|0|||
163023278|NCT00090220|588788674|FG004|Long-term Follow-up (EXT2)|Other|1|||
162643717|NCT02608268|587411729|FG012|Overall Study|Adverse Event|2|||
163023279|NCT00090220|588788675|FG005|Long-term Follow-up (EXT2)|Other|0|||
163023280|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
163023281|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
163023282|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
163023283|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
163023284|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
163023285|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023286|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023287|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023288|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
163023289|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
163023290|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
162643718|NCT02608268|587411730|FG013|Overall Study|Adverse Event|0|||
162643719|NCT02608268|587411731|FG014|Overall Study|Adverse Event|0|||
162643720|NCT02608268|587411732|FG015|Overall Study|Adverse Event|0|||
162643721|NCT02608268|587411733|FG016|Overall Study|Adverse Event|0|||
163023291|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
163023292|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
163023293|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
163023294|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
163023295|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Death|0|||
163023296|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Death|0|||
163023297|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Death|1|||
163023298|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Death|2|||
163023299|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Death|7|||
163023300|NCT00941863|588788676|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
163023301|NCT00941863|588788677|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
163023302|NCT00941863|588788678|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
163023303|NCT00941863|588788679|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
163023304|NCT00941863|588788680|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
163023305|NCT00941863|588788676|FG000|Continued After PCD|Withdrawal by Subject|0|||
163023306|NCT00941863|588788677|FG001|Continued After PCD|Withdrawal by Subject|0|||
163023307|NCT00941863|588788678|FG002|Continued After PCD|Withdrawal by Subject|0|||
163023308|NCT00941863|588788679|FG003|Continued After PCD|Withdrawal by Subject|0|||
163023309|NCT00941863|588788680|FG004|Continued After PCD|Withdrawal by Subject|1|||
163023310|NCT00941863|588788676|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023311|NCT00941863|588788677|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023312|NCT00941863|588788678|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023313|NCT00941863|588788679|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
163023314|NCT00941863|588788680|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
163023315|NCT02651155|588788683|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163023316|NCT02651155|588788684|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
163023317|NCT02651155|588788683|FG000|Overall Study|Voluntary Withdrawal|5|||
163023318|NCT02651155|588788684|FG001|Overall Study|Voluntary Withdrawal|0|||
163023319|NCT01867710|588788685|FG000|Overall Study|Death|25|||
163023320|NCT01867710|588788686|FG001|Overall Study|Death|15|||
163023321|NCT01867710|588788687|FG002|Overall Study|Death|27|||
163023322|NCT01867710|588788688|FG003|Overall Study|Death|20|||
163023323|NCT01867710|588788685|FG000|Overall Study|Lost to Follow-up|3|||
163023324|NCT01867710|588788686|FG001|Overall Study|Lost to Follow-up|4|||
163023325|NCT01867710|588788687|FG002|Overall Study|Lost to Follow-up|3|||
163023326|NCT01867710|588788688|FG003|Overall Study|Lost to Follow-up|2|||
163023327|NCT01867710|588788685|FG000|Overall Study|Withdrawal of consent|2|||
163023328|NCT01867710|588788686|FG001|Overall Study|Withdrawal of consent|5|||
163023329|NCT01867710|588788687|FG002|Overall Study|Withdrawal of consent|1|||
163023330|NCT01867710|588788688|FG003|Overall Study|Withdrawal of consent|2|||
163023331|NCT01867710|588788685|FG000|Overall Study|Study Terminated by Sponsor|9|||
163023332|NCT01867710|588788686|FG001|Overall Study|Study Terminated by Sponsor|13|||
163023333|NCT01867710|588788687|FG002|Overall Study|Study Terminated by Sponsor|8|||
163023334|NCT01867710|588788688|FG003|Overall Study|Study Terminated by Sponsor|16|||
163023335|NCT01867710|588788685|FG000|Overall Study|Biochemical progression|0|||
163023336|NCT01867710|588788686|FG001|Overall Study|Biochemical progression|1|||
163023337|NCT01867710|588788687|FG002|Overall Study|Biochemical progression|0|||
163023338|NCT01867710|588788688|FG003|Overall Study|Biochemical progression|0|||
163023339|NCT01867710|588788685|FG000|Overall Study|Clinical progression|0|||
163023340|NCT01867710|588788686|FG001|Overall Study|Clinical progression|0|||
163023341|NCT01867710|588788687|FG002|Overall Study|Clinical progression|1|||
163023342|NCT01867710|588788688|FG003|Overall Study|Clinical progression|0|||
163023343|NCT01867710|588788685|FG000|Overall Study|Disease progression|1|||
163023344|NCT01867710|588788686|FG001|Overall Study|Disease progression|0|||
163023345|NCT01867710|588788687|FG002|Overall Study|Disease progression|0|||
163023346|NCT01867710|588788688|FG003|Overall Study|Disease progression|0|||
163023347|NCT01867710|588788685|FG000|Overall Study|Patient decision|0|||
163023348|NCT01867710|588788686|FG001|Overall Study|Patient decision|0|||
162643722|NCT02608268|587411734|FG017|Overall Study|Adverse Event|0|||
162643723|NCT02608268|587411735|FG018|Overall Study|Adverse Event|0|||
163023349|NCT01867710|588788687|FG002|Overall Study|Patient decision|0|||
163023350|NCT01867710|588788688|FG003|Overall Study|Patient decision|1|||
163023351|NCT01867710|588788685|FG000|Overall Study|Patient to follow subsequent treatment|0|||
163023352|NCT01867710|588788686|FG001|Overall Study|Patient to follow subsequent treatment|1|||
163023353|NCT01867710|588788687|FG002|Overall Study|Patient to follow subsequent treatment|0|||
163023354|NCT01867710|588788688|FG003|Overall Study|Patient to follow subsequent treatment|0|||
163023355|NCT01867710|588788685|FG000|Overall Study|Progressive disease|1|||
163023356|NCT01867710|588788686|FG001|Overall Study|Progressive disease|0|||
163023357|NCT01867710|588788687|FG002|Overall Study|Progressive disease|0|||
163023358|NCT01867710|588788688|FG003|Overall Study|Progressive disease|0|||
163023359|NCT01867710|588788685|FG000|Overall Study|Protocol Violation|0|||
163023360|NCT01867710|588788686|FG001|Overall Study|Protocol Violation|0|||
163023361|NCT01867710|588788687|FG002|Overall Study|Protocol Violation|0|||
163023362|NCT01867710|588788688|FG003|Overall Study|Protocol Violation|1|||
163023363|NCT01867710|588788685|FG000|Overall Study|PSA-progression|0|||
163023364|NCT01867710|588788686|FG001|Overall Study|PSA-progression|1|||
163023365|NCT01867710|588788687|FG002|Overall Study|PSA-progression|0|||
163023366|NCT01867710|588788688|FG003|Overall Study|PSA-progression|0|||
163023367|NCT01867710|588788685|FG000|Overall Study|Study medication no longer effective|0|||
163023368|NCT01867710|588788686|FG001|Overall Study|Study medication no longer effective|1|||
163023369|NCT01867710|588788687|FG002|Overall Study|Study medication no longer effective|0|||
163023370|NCT01867710|588788688|FG003|Overall Study|Study medication no longer effective|0|||
163023371|NCT05113979|588788689|FG000|Overall Study|Death|2|||
163023372|NCT05113979|588788689|FG000|Overall Study|Lost to Follow-up|1|||
163023373|NCT00976820|588788690|FG000|Overall Study|Lost to Follow-up|5|||
162643724|NCT02608268|587411736|FG019|Overall Study|Adverse Event|0|||
162643725|NCT02608268|587411737|FG020|Overall Study|Adverse Event|1|||
162643726|NCT02608268|587411738|FG021|Overall Study|Adverse Event|1|||
163023374|NCT00976820|588788691|FG001|Overall Study|Lost to Follow-up|16|||
163023375|NCT00976820|588788692|FG002|Overall Study|Lost to Follow-up|2|||
163023376|NCT00976820|588788693|FG003|Overall Study|Lost to Follow-up|3|||
163023377|NCT00976820|588788690|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
163023378|NCT00976820|588788691|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
163023379|NCT00976820|588788692|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
163023380|NCT00976820|588788693|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
163023381|NCT00976820|588788690|FG000|Overall Study|Withdrawal by Subject|2|||
163023382|NCT00976820|588788691|FG001|Overall Study|Withdrawal by Subject|4|||
163023383|NCT00976820|588788692|FG002|Overall Study|Withdrawal by Subject|1|||
163023384|NCT00976820|588788693|FG003|Overall Study|Withdrawal by Subject|4|||
163023385|NCT02048826|588788694|FG000|Overall Study|Withdrawal by Subject|1|||
163023386|NCT02048826|588788695|FG001|Overall Study|Withdrawal by Subject|0|||
163023387|NCT00526669|588788696|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
163023388|NCT00526669|588788697|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
163023389|NCT00526669|588788696|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
163023390|NCT00526669|588788697|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
163023391|NCT00526669|588788696|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
163023392|NCT00526669|588788697|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
163023393|NCT00526669|588788696|FG000|Combined Treatment Phase|Death|0|||
163023394|NCT00526669|588788697|FG001|Combined Treatment Phase|Death|2|||
163023395|NCT00968981|588788698|FG000|Overall Study|Adverse Event|2|||
163023396|NCT00968981|588788699|FG001|Overall Study|Adverse Event|0|||
163023397|NCT00968981|588788700|FG002|Overall Study|Adverse Event|0|||
163023398|NCT00968981|588788698|FG000|Overall Study|Disease Progression|14|||
163023399|NCT00968981|588788699|FG001|Overall Study|Disease Progression|16|||
163023400|NCT00968981|588788700|FG002|Overall Study|Disease Progression|13|||
163023401|NCT00968981|588788698|FG000|Overall Study|Lost to Follow-up|0|||
163023402|NCT00968981|588788699|FG001|Overall Study|Lost to Follow-up|0|||
163023403|NCT00968981|588788700|FG002|Overall Study|Lost to Follow-up|1|||
163064123|NCT03126110|588941559|FG014|Phase 2|Lost to Follow-up|2|||
163064124|NCT03126110|588941560|FG015|Phase 2|Lost to Follow-up|0|||
163064125|NCT03126110|588941561|FG016|Phase 2|Lost to Follow-up|0|||
163064126|NCT03126110|588941545|FG000|Phase 2|Death|0|||
163064127|NCT03126110|588941546|FG001|Phase 2|Death|0|||
163064128|NCT03126110|588941547|FG002|Phase 2|Death|0|||
163064129|NCT03126110|588941548|FG003|Phase 2|Death|0|||
162643727|NCT02608268|587411739|FG022|Overall Study|Adverse Event|0|||
162643728|NCT02608268|587411740|FG023|Overall Study|Adverse Event|0|||
163023404|NCT00968981|588788698|FG000|Overall Study|Physician Decision|5|||
163023405|NCT00968981|588788699|FG001|Overall Study|Physician Decision|3|||
163023406|NCT00968981|588788700|FG002|Overall Study|Physician Decision|5|||
163023407|NCT00968981|588788698|FG000|Overall Study|Withdrawal by Subject|1|||
163064130|NCT03126110|588941549|FG004|Phase 2|Death|0|||
163064131|NCT03126110|588941550|FG005|Phase 2|Death|0|||
163023408|NCT00968981|588788699|FG001|Overall Study|Withdrawal by Subject|3|||
163064132|NCT03126110|588941551|FG006|Phase 2|Death|0|||
163064133|NCT03126110|588941552|FG007|Phase 2|Death|0|||
163064134|NCT03126110|588941553|FG008|Phase 2|Death|0|||
162643729|NCT02608268|587411741|FG024|Overall Study|Adverse Event|1|||
163023409|NCT00968981|588788700|FG002|Overall Study|Withdrawal by Subject|3|||
163064135|NCT03126110|588941554|FG009|Phase 2|Death|0|||
162643730|NCT02608268|587411742|FG025|Overall Study|Adverse Event|0|||
162643731|NCT02608268|587411743|FG026|Overall Study|Adverse Event|0|||
163023410|NCT01489254|588788711|FG000|Double-blind Part|Adverse Event|7|||
163023411|NCT01489254|588788712|FG001|Double-blind Part|Adverse Event|2|||
163023412|NCT01489254|588788713|FG002|Double-blind Part|Adverse Event|2|||
163023413|NCT01489254|588788714|FG003|Double-blind Part|Adverse Event|0|||
163064136|NCT03126110|588941555|FG010|Phase 2|Death|0|||
163064137|NCT03126110|588941556|FG011|Phase 2|Death|6|||
163064138|NCT03126110|588941557|FG012|Phase 2|Death|12|||
163023414|NCT01489254|588788711|FG000|Double-blind Part|Pregnancy|1|||
163023415|NCT01489254|588788712|FG001|Double-blind Part|Pregnancy|3|||
163023416|NCT01489254|588788713|FG002|Double-blind Part|Pregnancy|0|||
163023417|NCT01489254|588788714|FG003|Double-blind Part|Pregnancy|0|||
163023418|NCT01489254|588788711|FG000|Double-blind Part|Withdrawal by Subject|12|||
163023419|NCT01489254|588788712|FG001|Double-blind Part|Withdrawal by Subject|20|||
163023420|NCT01489254|588788713|FG002|Double-blind Part|Withdrawal by Subject|1|||
163023421|NCT01489254|588788714|FG003|Double-blind Part|Withdrawal by Subject|0|||
163023422|NCT01489254|588788711|FG000|Double-blind Part|Lost to Follow-up|1|||
163023423|NCT01489254|588788712|FG001|Double-blind Part|Lost to Follow-up|2|||
163023424|NCT01489254|588788713|FG002|Double-blind Part|Lost to Follow-up|0|||
163023425|NCT01489254|588788714|FG003|Double-blind Part|Lost to Follow-up|0|||
163023426|NCT01489254|588788711|FG000|Double-blind Part|Other reasons for not completing study|4|||
163023427|NCT01489254|588788712|FG001|Double-blind Part|Other reasons for not completing study|6|||
163023428|NCT01489254|588788713|FG002|Double-blind Part|Other reasons for not completing study|0|||
163023429|NCT01489254|588788714|FG003|Double-blind Part|Other reasons for not completing study|0|||
163023430|NCT01489254|588788711|FG000|Open-label Extension Part|Adverse Event|0|||
163023431|NCT01489254|588788712|FG001|Open-label Extension Part|Adverse Event|0|||
163023432|NCT01489254|588788713|FG002|Open-label Extension Part|Adverse Event|0|||
163023433|NCT01489254|588788714|FG003|Open-label Extension Part|Adverse Event|10|||
163023434|NCT01489254|588788711|FG000|Open-label Extension Part|Pregnancy|0|||
163023435|NCT01489254|588788712|FG001|Open-label Extension Part|Pregnancy|0|||
163023436|NCT01489254|588788713|FG002|Open-label Extension Part|Pregnancy|0|||
163023437|NCT01489254|588788714|FG003|Open-label Extension Part|Pregnancy|3|||
163023438|NCT01489254|588788711|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
163023439|NCT01489254|588788712|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
163023440|NCT01489254|588788713|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
163023441|NCT01489254|588788714|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
163023442|NCT01489254|588788711|FG000|Open-label Extension Part|Protocol Violation|0|||
163023443|NCT01489254|588788712|FG001|Open-label Extension Part|Protocol Violation|0|||
163023444|NCT01489254|588788713|FG002|Open-label Extension Part|Protocol Violation|0|||
163023445|NCT01489254|588788714|FG003|Open-label Extension Part|Protocol Violation|1|||
163023446|NCT01489254|588788711|FG000|Open-label Extension Part|Lost to Follow-up|0|||
163023447|NCT01489254|588788712|FG001|Open-label Extension Part|Lost to Follow-up|0|||
163023448|NCT01489254|588788713|FG002|Open-label Extension Part|Lost to Follow-up|0|||
163023449|NCT01489254|588788714|FG003|Open-label Extension Part|Lost to Follow-up|9|||
163023450|NCT01489254|588788711|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
163023451|NCT01489254|588788712|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
163023452|NCT01489254|588788713|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
163023453|NCT01489254|588788714|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
163023454|NCT01981954|588788715|FG000|Titration Period|Protocol Deviation|1|||
163023455|NCT01981954|588788715|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
163023456|NCT04016779|588788717|FG000|Overall Study|Adverse Event|9|||
163023457|NCT04016779|588788718|FG001|Overall Study|Adverse Event|17|||
163023458|NCT04016779|588788717|FG000|Overall Study|Lack of Efficacy|4|||
163023459|NCT04016779|588788718|FG001|Overall Study|Lack of Efficacy|1|||
163023460|NCT04016779|588788717|FG000|Overall Study|Lost to Follow-up|5|||
163023461|NCT04016779|588788718|FG001|Overall Study|Lost to Follow-up|14|||
163023462|NCT04016779|588788717|FG000|Overall Study|Physician Decision|1|||
163023463|NCT04016779|588788718|FG001|Overall Study|Physician Decision|3|||
163023464|NCT04016779|588788717|FG000|Overall Study|Withdrawal by Subject|6|||
163023465|NCT04016779|588788718|FG001|Overall Study|Withdrawal by Subject|8|||
163023466|NCT04016779|588788717|FG000|Overall Study|Non-compliance with Study Drug|2|||
163023467|NCT04016779|588788718|FG001|Overall Study|Non-compliance with Study Drug|3|||
163023468|NCT04016779|588788717|FG000|Overall Study|Other, Multiple categories|17|||
163023469|NCT04016779|588788718|FG001|Overall Study|Other, Multiple categories|17|||
163023470|NCT02738879|588788731|FG000|Overall Study|Adverse Event|1|||
163023471|NCT02738879|588788732|FG001|Overall Study|Adverse Event|1|||
163023472|NCT02738879|588788731|FG000|Overall Study|Death|0|||
163023473|NCT02738879|588788732|FG001|Overall Study|Death|2|||
162643732|NCT02608268|587411744|FG027|Overall Study|Adverse Event|0|||
163023474|NCT02738879|588788731|FG000|Overall Study|Lost to Follow-up|1|||
163023475|NCT02738879|588788732|FG001|Overall Study|Lost to Follow-up|5|||
163023476|NCT02738879|588788731|FG000|Overall Study|Protocol Violation|1|||
162643733|NCT02608268|587411745|FG028|Overall Study|Adverse Event|1|||
163023477|NCT02738879|588788732|FG001|Overall Study|Protocol Violation|3|||
163023478|NCT02738879|588788731|FG000|Overall Study|Physician Decision|3|||
163023479|NCT02738879|588788732|FG001|Overall Study|Physician Decision|4|||
163023480|NCT02738879|588788731|FG000|Overall Study|Pregnancy|0|||
163023481|NCT02738879|588788732|FG001|Overall Study|Pregnancy|1|||
163023482|NCT02738879|588788731|FG000|Overall Study|Screen Failure|1|||
163023483|NCT02738879|588788732|FG001|Overall Study|Screen Failure|2|||
163023484|NCT02738879|588788731|FG000|Overall Study|Site Discontinued Study Participation|1|||
163023485|NCT02738879|588788732|FG001|Overall Study|Site Discontinued Study Participation|0|||
163023486|NCT02738879|588788731|FG000|Overall Study|Withdrawal by Subject|5|||
162643734|NCT02608268|587411746|FG029|Overall Study|Adverse Event|0|||
162643735|NCT02608268|587411717|FG000|Overall Study|Death|1|||
162643736|NCT02608268|587411718|FG001|Overall Study|Death|0|||
162643737|NCT02608268|587411719|FG002|Overall Study|Death|0|||
163023487|NCT02738879|588788732|FG001|Overall Study|Withdrawal by Subject|7|||
163023488|NCT00890084|588788733|FG000|Overall Study|Adverse Event|16|||
163023489|NCT00890084|588788733|FG000|Overall Study|Lost to Follow-up|126|||
163023490|NCT03089697|588788738|FG000|Overall Study|Adverse Event|1|||
163023491|NCT03089697|588788739|FG001|Overall Study|Adverse Event|2|||
163023492|NCT03089697|588788738|FG000|Overall Study|Withdrawal by Subject|1|||
163023493|NCT03089697|588788739|FG001|Overall Study|Withdrawal by Subject|0|||
163023494|NCT00638443|588788740|FG000|First Intervention|Adverse Event|2|||
163023495|NCT00638443|588788741|FG001|First Intervention|Adverse Event|1|||
163023496|NCT01044290|588788742|FG000|Follow-up 1|Death|3|||
163023497|NCT01044290|588788743|FG001|Follow-up 1|Death|3|||
163023498|NCT01044290|588788744|FG002|Follow-up 1|Death|1|||
163023499|NCT01044290|588788742|FG000|Follow-up 1|Withdrawal by Subject|2|||
163023500|NCT01044290|588788743|FG001|Follow-up 1|Withdrawal by Subject|2|||
163023501|NCT01044290|588788744|FG002|Follow-up 1|Withdrawal by Subject|0|||
163023502|NCT01044290|588788742|FG000|Follow-Up 2|Death|0|||
163023503|NCT01044290|588788743|FG001|Follow-Up 2|Death|1|||
163023504|NCT01044290|588788744|FG002|Follow-Up 2|Death|1|||
163023505|NCT01044290|588788742|FG000|Follow-Up 2|Withdrawal by Subject|0|||
163023506|NCT01044290|588788743|FG001|Follow-Up 2|Withdrawal by Subject|1|||
163023507|NCT01044290|588788744|FG002|Follow-Up 2|Withdrawal by Subject|1|||
163023508|NCT03613649|588788750|FG000|Second Treatment|Lost to Follow-up|0|||
163023509|NCT03613649|588788751|FG001|Second Treatment|Lost to Follow-up|0|||
163023510|NCT03613649|588788752|FG002|Second Treatment|Lost to Follow-up|1|||
163023511|NCT03613649|588788753|FG003|Second Treatment|Lost to Follow-up|0|||
163023512|NCT03613649|588788754|FG004|Second Treatment|Lost to Follow-up|0|||
163023513|NCT03613649|588788755|FG005|Second Treatment|Lost to Follow-up|0|||
163023514|NCT03613649|588788756|FG006|Second Treatment|Lost to Follow-up|0|||
163023515|NCT03613649|588788757|FG007|Second Treatment|Lost to Follow-up|0|||
163023516|NCT03613649|588788758|FG008|Second Treatment|Lost to Follow-up|0|||
163023517|NCT03613649|588788759|FG009|Second Treatment|Lost to Follow-up|0|||
163023518|NCT03613649|588788760|FG010|Second Treatment|Lost to Follow-up|0|||
163023519|NCT03613649|588788761|FG011|Second Treatment|Lost to Follow-up|0|||
163023520|NCT03613649|588788750|FG000|Second Treatment|Withdrawal by Subject|0|||
163023521|NCT03613649|588788751|FG001|Second Treatment|Withdrawal by Subject|0|||
163023522|NCT03613649|588788752|FG002|Second Treatment|Withdrawal by Subject|0|||
163023523|NCT03613649|588788753|FG003|Second Treatment|Withdrawal by Subject|0|||
163023524|NCT03613649|588788754|FG004|Second Treatment|Withdrawal by Subject|1|||
163023525|NCT03613649|588788755|FG005|Second Treatment|Withdrawal by Subject|0|||
163023526|NCT03613649|588788756|FG006|Second Treatment|Withdrawal by Subject|0|||
163023527|NCT03613649|588788757|FG007|Second Treatment|Withdrawal by Subject|0|||
163023528|NCT03613649|588788758|FG008|Second Treatment|Withdrawal by Subject|0|||
163023529|NCT03613649|588788759|FG009|Second Treatment|Withdrawal by Subject|0|||
163023530|NCT03613649|588788760|FG010|Second Treatment|Withdrawal by Subject|0|||
163023531|NCT03613649|588788761|FG011|Second Treatment|Withdrawal by Subject|0|||
163023532|NCT03613649|588788750|FG000|Third Treatment|Lost to Follow-up|0|||
163023533|NCT03613649|588788751|FG001|Third Treatment|Lost to Follow-up|0|||
162643738|NCT02608268|587411720|FG003|Overall Study|Death|0|||
163023534|NCT03613649|588788752|FG002|Third Treatment|Lost to Follow-up|0|||
163023535|NCT03613649|588788753|FG003|Third Treatment|Lost to Follow-up|0|||
163023536|NCT03613649|588788754|FG004|Third Treatment|Lost to Follow-up|1|||
163023537|NCT03613649|588788755|FG005|Third Treatment|Lost to Follow-up|0|||
163023538|NCT03613649|588788756|FG006|Third Treatment|Lost to Follow-up|0|||
163023539|NCT03613649|588788757|FG007|Third Treatment|Lost to Follow-up|0|||
163023540|NCT03613649|588788758|FG008|Third Treatment|Lost to Follow-up|0|||
163023541|NCT03613649|588788759|FG009|Third Treatment|Lost to Follow-up|0|||
162643739|NCT02608268|587411721|FG004|Overall Study|Death|0|||
162643740|NCT02608268|587411722|FG005|Overall Study|Death|0|||
162643741|NCT02608268|587411723|FG006|Overall Study|Death|0|||
162643742|NCT02608268|587411724|FG007|Overall Study|Death|0|||
163023542|NCT03613649|588788760|FG010|Third Treatment|Lost to Follow-up|0|||
163023543|NCT03613649|588788761|FG011|Third Treatment|Lost to Follow-up|1|||
163023544|NCT03613649|588788750|FG000|Third Treatment|Protocol Violation|0|||
163023545|NCT03613649|588788751|FG001|Third Treatment|Protocol Violation|0|||
163023546|NCT03613649|588788752|FG002|Third Treatment|Protocol Violation|0|||
163023547|NCT03613649|588788753|FG003|Third Treatment|Protocol Violation|0|||
163023548|NCT03613649|588788754|FG004|Third Treatment|Protocol Violation|0|||
163023549|NCT03613649|588788755|FG005|Third Treatment|Protocol Violation|0|||
163023550|NCT03613649|588788756|FG006|Third Treatment|Protocol Violation|1|||
163023551|NCT03613649|588788757|FG007|Third Treatment|Protocol Violation|0|||
163023552|NCT03613649|588788758|FG008|Third Treatment|Protocol Violation|0|||
163023553|NCT03613649|588788759|FG009|Third Treatment|Protocol Violation|0|||
163023554|NCT03613649|588788760|FG010|Third Treatment|Protocol Violation|0|||
163023555|NCT03613649|588788761|FG011|Third Treatment|Protocol Violation|1|||
163023556|NCT03613649|588788750|FG000|Fourth Treatment|Protocol Violation|1|||
162643743|NCT02608268|587411725|FG008|Overall Study|Death|1|||
163023557|NCT03613649|588788751|FG001|Fourth Treatment|Protocol Violation|0|||
163023558|NCT03613649|588788752|FG002|Fourth Treatment|Protocol Violation|0|||
163023559|NCT03613649|588788753|FG003|Fourth Treatment|Protocol Violation|0|||
163023560|NCT03613649|588788754|FG004|Fourth Treatment|Protocol Violation|1|||
163023561|NCT03613649|588788755|FG005|Fourth Treatment|Protocol Violation|0|||
163023562|NCT03613649|588788756|FG006|Fourth Treatment|Protocol Violation|0|||
163023563|NCT03613649|588788757|FG007|Fourth Treatment|Protocol Violation|0|||
163023564|NCT03613649|588788758|FG008|Fourth Treatment|Protocol Violation|0|||
163023565|NCT03613649|588788759|FG009|Fourth Treatment|Protocol Violation|0|||
163023566|NCT03613649|588788760|FG010|Fourth Treatment|Protocol Violation|0|||
163023567|NCT03613649|588788761|FG011|Fourth Treatment|Protocol Violation|0|||
163023568|NCT03613649|588788750|FG000|Fourth Treatment|Physician Decision|0|||
163023569|NCT03613649|588788751|FG001|Fourth Treatment|Physician Decision|0|||
163023570|NCT03613649|588788752|FG002|Fourth Treatment|Physician Decision|0|||
163023571|NCT03613649|588788753|FG003|Fourth Treatment|Physician Decision|0|||
163023572|NCT03613649|588788754|FG004|Fourth Treatment|Physician Decision|0|||
163023573|NCT03613649|588788755|FG005|Fourth Treatment|Physician Decision|0|||
163023574|NCT03613649|588788756|FG006|Fourth Treatment|Physician Decision|1|||
163023575|NCT03613649|588788757|FG007|Fourth Treatment|Physician Decision|0|||
163023576|NCT03613649|588788758|FG008|Fourth Treatment|Physician Decision|0|||
163023577|NCT03613649|588788759|FG009|Fourth Treatment|Physician Decision|0|||
163023578|NCT03613649|588788760|FG010|Fourth Treatment|Physician Decision|0|||
163023579|NCT03613649|588788761|FG011|Fourth Treatment|Physician Decision|0|||
163023580|NCT02783729|588788762|FG000|Overall Study|Lack of Efficacy|1|||
163023581|NCT02783729|588788763|FG001|Overall Study|Lack of Efficacy|0|||
163023582|NCT02783729|588788764|FG002|Overall Study|Lack of Efficacy|0|||
163023583|NCT02783729|588788765|FG003|Overall Study|Lack of Efficacy|0|||
163023584|NCT02783729|588788762|FG000|Overall Study|Adverse Event|2|||
163023585|NCT02783729|588788763|FG001|Overall Study|Adverse Event|6|||
163023586|NCT02783729|588788764|FG002|Overall Study|Adverse Event|2|||
163023587|NCT02783729|588788765|FG003|Overall Study|Adverse Event|3|||
163023588|NCT02783729|588788762|FG000|Overall Study|Other|1|||
163023589|NCT02783729|588788763|FG001|Overall Study|Other|6|||
163023590|NCT02783729|588788764|FG002|Overall Study|Other|2|||
163023591|NCT02783729|588788765|FG003|Overall Study|Other|3|||
163023592|NCT02783729|588788762|FG000|Overall Study|Withdrawal by Subject|2|||
163023593|NCT02783729|588788763|FG001|Overall Study|Withdrawal by Subject|3|||
163023594|NCT02783729|588788764|FG002|Overall Study|Withdrawal by Subject|1|||
163023595|NCT02783729|588788765|FG003|Overall Study|Withdrawal by Subject|2|||
163023596|NCT02783729|588788762|FG000|Overall Study|Participant's choice|2|||
163023597|NCT02783729|588788763|FG001|Overall Study|Participant's choice|1|||
163023598|NCT02783729|588788764|FG002|Overall Study|Participant's choice|2|||
163023599|NCT02783729|588788765|FG003|Overall Study|Participant's choice|1|||
163023600|NCT02783729|588788762|FG000|Overall Study|Lost to Follow-up|2|||
163023601|NCT02783729|588788763|FG001|Overall Study|Lost to Follow-up|1|||
163023602|NCT02783729|588788764|FG002|Overall Study|Lost to Follow-up|1|||
163023603|NCT02783729|588788765|FG003|Overall Study|Lost to Follow-up|0|||
163023604|NCT00319592|588788766|FG000|Overall Study|Protocol Violation|1|||
163023605|NCT00319592|588788767|FG001|Overall Study|Protocol Violation|0|||
163023606|NCT00319592|588788766|FG000|Overall Study|Physician Decision|0|||
163023607|NCT00319592|588788767|FG001|Overall Study|Physician Decision|1|||
163023608|NCT00750139|588788774|FG000|Overall Study|Adverse Event|1|||
163023609|NCT00750139|588788775|FG001|Overall Study|Adverse Event|2|||
163064139|NCT03126110|588941558|FG013|Phase 2|Death|25|||
163064140|NCT03126110|588941559|FG014|Phase 2|Death|11|||
163023610|NCT00750139|588788776|FG002|Overall Study|Adverse Event|0|||
163023611|NCT00750139|588788777|FG003|Overall Study|Adverse Event|1|||
163023612|NCT00750139|588788774|FG000|Overall Study|Lost to Follow-up|17|||
163023613|NCT00750139|588788775|FG001|Overall Study|Lost to Follow-up|12|||
163023614|NCT00750139|588788776|FG002|Overall Study|Lost to Follow-up|15|||
163064141|NCT03126110|588941560|FG015|Phase 2|Death|3|||
163023615|NCT00750139|588788777|FG003|Overall Study|Lost to Follow-up|6|||
163023616|NCT00750139|588788774|FG000|Overall Study|Withdrawal by Subject|3|||
163023617|NCT00750139|588788775|FG001|Overall Study|Withdrawal by Subject|2|||
163023618|NCT00750139|588788776|FG002|Overall Study|Withdrawal by Subject|6|||
163023619|NCT00750139|588788777|FG003|Overall Study|Withdrawal by Subject|2|||
163023620|NCT00750139|588788774|FG000|Overall Study|Physician Decision|1|||
163023621|NCT00750139|588788775|FG001|Overall Study|Physician Decision|1|||
163023622|NCT00750139|588788776|FG002|Overall Study|Physician Decision|0|||
163023623|NCT00750139|588788777|FG003|Overall Study|Physician Decision|0|||
163023624|NCT00750139|588788774|FG000|Overall Study|Non-compliance|1|||
163023625|NCT00750139|588788775|FG001|Overall Study|Non-compliance|0|||
163023626|NCT00750139|588788776|FG002|Overall Study|Non-compliance|1|||
163064142|NCT03126110|588941561|FG016|Phase 2|Death|2|||
162643744|NCT02608268|587411726|FG009|Overall Study|Death|1|||
162643745|NCT02608268|587411727|FG010|Overall Study|Death|0|||
162643746|NCT02608268|587411728|FG011|Overall Study|Death|0|||
162643747|NCT02608268|587411729|FG012|Overall Study|Death|0|||
162643748|NCT02608268|587411730|FG013|Overall Study|Death|0|||
162643749|NCT02608268|587411731|FG014|Overall Study|Death|0|||
163023627|NCT00750139|588788777|FG003|Overall Study|Non-compliance|3|||
163023628|NCT00750139|588788774|FG000|Overall Study|Termination by sponsor|4|||
163023629|NCT00750139|588788775|FG001|Overall Study|Termination by sponsor|0|||
163023630|NCT00750139|588788776|FG002|Overall Study|Termination by sponsor|0|||
163023631|NCT00750139|588788777|FG003|Overall Study|Termination by sponsor|1|||
163023632|NCT00750139|588788774|FG000|Overall Study|Non-specific|62|||
163023633|NCT00750139|588788775|FG001|Overall Study|Non-specific|42|||
163023634|NCT00750139|588788776|FG002|Overall Study|Non-specific|79|||
163023635|NCT00750139|588788777|FG003|Overall Study|Non-specific|33|||
163023636|NCT00658775|588788778|FG000|Overall Study|Adverse Event|4|||
163023637|NCT00658775|588788779|FG001|Overall Study|Adverse Event|6|||
163023638|NCT00658775|588788778|FG000|Overall Study|Lost to Follow-up|17|||
163023639|NCT00658775|588788779|FG001|Overall Study|Lost to Follow-up|18|||
163023640|NCT00658775|588788778|FG000|Overall Study|Withdrawal by Subject|6|||
163023641|NCT00658775|588788779|FG001|Overall Study|Withdrawal by Subject|4|||
163023642|NCT00658775|588788778|FG000|Overall Study|Withdrawal of consent|8|||
163023643|NCT00658775|588788779|FG001|Overall Study|Withdrawal of consent|7|||
163023644|NCT00658775|588788778|FG000|Overall Study|Other|7|||
163023645|NCT00658775|588788779|FG001|Overall Study|Other|8|||
163023646|NCT04152837|588788792|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
163023647|NCT04152837|588788792|FG000|Maintenance Period|Adverse Event|1|||
163023648|NCT04152837|588788792|FG000|Maintenance Period|Withdrawal by Subject|1|||
163023649|NCT04152837|588788792|FG000|Maintenance Period|Sponsor Termination of Study|2|||
163023650|NCT01082211|588788793|FG000|Overall Study|Protocol Violation|4|||
163023651|NCT01082211|588788793|FG000|Overall Study|No protocol treatment received|3|||
163023652|NCT04999163|588788794|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
163023653|NCT04999163|588788795|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
163023654|NCT04999163|588788794|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
163023655|NCT04999163|588788795|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
163023656|NCT04999163|588788794|FG000|Overall Study|Withdrawal by Subject|1|||
163023657|NCT04999163|588788795|FG001|Overall Study|Withdrawal by Subject|0|||
163023658|NCT05903924|588791021|FG000|Overall Study|Lost to Follow-up|1|||
163023659|NCT05903924|588791022|FG001|Overall Study|Lost to Follow-up|0|||
163023660|NCT05903924|588791023|FG002|Overall Study|Lost to Follow-up|0|||
163023661|NCT04338269|588791024|FG000|Overall Study|Death|86|||
163023662|NCT04338269|588791025|FG001|Overall Study|Death|89|||
163023663|NCT04338269|588791024|FG000|Overall Study|Lost to Follow-up|1|||
163023664|NCT04338269|588791025|FG001|Overall Study|Lost to Follow-up|2|||
163023665|NCT04338269|588791024|FG000|Overall Study|Physician Decision|1|||
163023666|NCT04338269|588791025|FG001|Overall Study|Physician Decision|0|||
163023667|NCT04338269|588791024|FG000|Overall Study|Withdrawal by Subject|14|||
163023668|NCT04338269|588791025|FG001|Overall Study|Withdrawal by Subject|11|||
163023669|NCT00174967|588791026|FG000|Overall Study|Adverse Event|1|||
163023670|NCT00174967|588791027|FG001|Overall Study|Adverse Event|2|||
163023671|NCT00174967|588791028|FG002|Overall Study|Adverse Event|2|||
163023672|NCT00174967|588791029|FG003|Overall Study|Adverse Event|1|||
163023673|NCT00174967|588791026|FG000|Overall Study|Gout Flare|0|||
163023674|NCT00174967|588791027|FG001|Overall Study|Gout Flare|0|||
163023675|NCT00174967|588791028|FG002|Overall Study|Gout Flare|0|||
162643750|NCT02608268|587411732|FG015|Overall Study|Death|1|||
162643751|NCT02608268|587411733|FG016|Overall Study|Death|0|||
162643752|NCT02608268|587411734|FG017|Overall Study|Death|1|||
162643753|NCT02608268|587411735|FG018|Overall Study|Death|0|||
162643754|NCT02608268|587411736|FG019|Overall Study|Death|1|||
162643755|NCT02608268|587411737|FG020|Overall Study|Death|1|||
162643756|NCT02608268|587411738|FG021|Overall Study|Death|0|||
162643757|NCT02608268|587411739|FG022|Overall Study|Death|0|||
162643758|NCT02608268|587411740|FG023|Overall Study|Death|0|||
163023676|NCT00174967|588791029|FG003|Overall Study|Gout Flare|1|||
163023677|NCT00174967|588791026|FG000|Overall Study|Other|0|||
163023678|NCT00174967|588791027|FG001|Overall Study|Other|1|||
163023679|NCT00174967|588791028|FG002|Overall Study|Other|0|||
163023680|NCT00174967|588791029|FG003|Overall Study|Other|0|||
163023681|NCT03030989|588791030|FG000|Overall Study|Fever|2|||
163023682|NCT03030989|588791031|FG001|Overall Study|Fever|2|||
163023683|NCT03030989|588791030|FG000|Overall Study|Rash|2|||
163023684|NCT03030989|588791031|FG001|Overall Study|Rash|1|||
163023685|NCT03030989|588791030|FG000|Overall Study|Fatigue/Overwhelmed|1|||
163023686|NCT03030989|588791031|FG001|Overall Study|Fatigue/Overwhelmed|5|||
162643759|NCT02608268|587411741|FG024|Overall Study|Death|1|||
162643760|NCT02608268|587411742|FG025|Overall Study|Death|2|||
163023687|NCT03030989|588791030|FG000|Overall Study|Positive Blood Cultures|2|||
163023688|NCT03030989|588791031|FG001|Overall Study|Positive Blood Cultures|1|||
163023689|NCT03030989|588791030|FG000|Overall Study|Line Removed|0|||
163023690|NCT03030989|588791031|FG001|Overall Study|Line Removed|2|||
163023691|NCT03030989|588791030|FG000|Overall Study|No longer interested|5|||
163023692|NCT03030989|588791031|FG001|Overall Study|No longer interested|3|||
163023693|NCT02730377|588791032|FG000|Overall Study|Other|5|||
163023694|NCT02730377|588791033|FG001|Overall Study|Other|4|||
163023695|NCT02730377|588791032|FG000|Overall Study|Death|1|||
163023696|NCT02730377|588791033|FG001|Overall Study|Death|8|||
163023697|NCT02730377|588791032|FG000|Overall Study|Inadequate glycaemic control|368|||
163023698|NCT02730377|588791033|FG001|Overall Study|Inadequate glycaemic control|473|||
163023699|NCT02730377|588791032|FG000|Overall Study|Adverse Event|79|||
163023700|NCT02730377|588791033|FG001|Overall Study|Adverse Event|41|||
163023701|NCT02730377|588791032|FG000|Overall Study|Protocol Violation|23|||
163023702|NCT02730377|588791033|FG001|Overall Study|Protocol Violation|30|||
163023703|NCT02730377|588791032|FG000|Overall Study|Lack of Efficacy|4|||
163023704|NCT02730377|588791033|FG001|Overall Study|Lack of Efficacy|13|||
163023705|NCT02730377|588791032|FG000|Overall Study|Pregnancy|0|||
163023706|NCT02730377|588791033|FG001|Overall Study|Pregnancy|1|||
163023707|NCT02730377|588791032|FG000|Overall Study|Withdrawal by Subject|45|||
163023708|NCT02730377|588791033|FG001|Overall Study|Withdrawal by Subject|42|||
163023709|NCT02730377|588791032|FG000|Overall Study|Lost to Follow-up|25|||
163023710|NCT02730377|588791033|FG001|Overall Study|Lost to Follow-up|21|||
163023711|NCT02706886|588791034|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
163023712|NCT02706886|588791035|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
163023713|NCT02706886|588791036|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
163023714|NCT02706886|588791037|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
163023715|NCT02706886|588791038|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
163023716|NCT02706886|588791039|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
163023717|NCT02706886|588791040|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
163023718|NCT02706886|588791041|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
163023719|NCT02706886|588791042|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
163023720|NCT03917472|588791043|FG000|Overall Study|Physician Decision|4|||
163023721|NCT03917472|588791044|FG001|Overall Study|Physician Decision|0|||
163023722|NCT03917472|588791043|FG000|Overall Study|Adverse Event|3|||
163023723|NCT03917472|588791044|FG001|Overall Study|Adverse Event|1|||
163023724|NCT03917472|588791043|FG000|Overall Study|Death|7|||
163023725|NCT03917472|588791044|FG001|Overall Study|Death|5|||
163023726|NCT03917472|588791043|FG000|Overall Study|Withdrawal by Subject|11|||
163023727|NCT03917472|588791044|FG001|Overall Study|Withdrawal by Subject|4|||
163023728|NCT03917472|588791043|FG000|Overall Study|Lost to Follow-up|10|||
163023729|NCT03917472|588791044|FG001|Overall Study|Lost to Follow-up|5|||
163023730|NCT01154296|588791045|FG000|Randomization and Intervention|Decided to decline|1|||
163023731|NCT01154296|588791046|FG001|Randomization and Intervention|Decided to decline|1|||
163023732|NCT01154296|588791045|FG000|Randomization and Intervention|Declined by staff|1|||
163023733|NCT01154296|588791046|FG001|Randomization and Intervention|Declined by staff|0|||
163023734|NCT01154296|588791045|FG000|Randomization and Intervention|Did not return|1|||
163023735|NCT01154296|588791046|FG001|Randomization and Intervention|Did not return|0|||
163023736|NCT01154296|588791045|FG000|Randomization and Intervention|Left before test|0|||
163023737|NCT01154296|588791046|FG001|Randomization and Intervention|Left before test|1|||
163023738|NCT01154296|588791045|FG000|Randomization and Intervention|Left clinic early|2|||
163023739|NCT01154296|588791046|FG001|Randomization and Intervention|Left clinic early|0|||
163023740|NCT01154296|588791045|FG000|6-month Follow-up|Lost contact|269|||
163023741|NCT01154296|588791046|FG001|6-month Follow-up|Lost contact|275|||
163023742|NCT01154296|588791045|FG000|6-month Follow-up|Incarcerated|37|||
163023743|NCT01154296|588791046|FG001|6-month Follow-up|Incarcerated|32|||
163023744|NCT01154296|588791045|FG000|6-month Follow-up|Withdrew consent|14|||
163023745|NCT01154296|588791046|FG001|6-month Follow-up|Withdrew consent|15|||
163023746|NCT01154296|588791045|FG000|6-month Follow-up|Death|3|||
163023747|NCT01154296|588791046|FG001|6-month Follow-up|Death|2|||
163023748|NCT01154296|588791045|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
163023749|NCT01154296|588791046|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
163023750|NCT02203851|588791047|FG000|Overall Study|Lost to Follow-up|4|||
163023751|NCT02203851|588791047|FG000|Overall Study|Withdrawal by Subject|6|||
163023752|NCT02203851|588791047|FG000|Overall Study|Other|1|||
163023753|NCT04934189|588791048|FG000|Overall Study|Lost to Follow-up|4|||
163023754|NCT04934189|588791048|FG000|Overall Study|Withdrawal by Subject|17|||
163023755|NCT01194999|588791049|FG000|Overall Study|Lost to Follow-up|17|||
163023756|NCT03781583|588791052|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
163023757|NCT03781583|588791053|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
163023758|NCT03781583|588791054|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
163023759|NCT03781583|588791055|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
163023760|NCT03781583|588791052|FG000|Overall Study|Technology did not work for that person in that environment|1|||
163023761|NCT03781583|588791053|FG001|Overall Study|Technology did not work for that person in that environment|0|||
163023762|NCT03781583|588791054|FG002|Overall Study|Technology did not work for that person in that environment|0|||
163023763|NCT03781583|588791055|FG003|Overall Study|Technology did not work for that person in that environment|0|||
163023764|NCT03781583|588791052|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
163023765|NCT03781583|588791053|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
163023766|NCT03781583|588791054|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
163023767|NCT03781583|588791055|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
163023768|NCT03781583|588791052|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023769|NCT03781583|588791053|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
163023770|NCT03781583|588791054|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023771|NCT03781583|588791055|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
163023772|NCT01938430|588791056|FG000|Overall Study|Randomized but Not Treated|0|||
163023773|NCT01938430|588791057|FG001|Overall Study|Randomized but Not Treated|0|||
163023774|NCT01938430|588791058|FG002|Overall Study|Randomized but Not Treated|0|||
163023775|NCT01938430|588791059|FG003|Overall Study|Randomized but Not Treated|0|||
163023776|NCT01938430|588791060|FG004|Overall Study|Randomized but Not Treated|0|||
163023777|NCT01938430|588791061|FG005|Overall Study|Randomized but Not Treated|0|||
163023778|NCT01938430|588791062|FG006|Overall Study|Randomized but Not Treated|0|||
163023779|NCT01938430|588791063|FG007|Overall Study|Randomized but Not Treated|0|||
163023780|NCT01938430|588791064|FG008|Overall Study|Randomized but Not Treated|0|||
163023781|NCT01938430|588791065|FG009|Overall Study|Randomized but Not Treated|0|||
163023782|NCT01938430|588791066|FG010|Overall Study|Randomized but Not Treated|1|||
163023783|NCT01938430|588791067|FG011|Overall Study|Randomized but Not Treated|0|||
163023784|NCT01938430|588791068|FG012|Overall Study|Randomized but Not Treated|0|||
163023785|NCT01938430|588791069|FG013|Overall Study|Randomized but Not Treated|1|||
163023786|NCT01938430|588791056|FG000|Overall Study|Adverse Event|0|||
163023787|NCT01938430|588791057|FG001|Overall Study|Adverse Event|0|||
163023788|NCT01938430|588791058|FG002|Overall Study|Adverse Event|0|||
163023789|NCT01938430|588791059|FG003|Overall Study|Adverse Event|0|||
163023790|NCT01938430|588791060|FG004|Overall Study|Adverse Event|0|||
163023791|NCT01938430|588791061|FG005|Overall Study|Adverse Event|0|||
163023792|NCT01938430|588791062|FG006|Overall Study|Adverse Event|1|||
163023793|NCT01938430|588791063|FG007|Overall Study|Adverse Event|0|||
163023794|NCT01938430|588791064|FG008|Overall Study|Adverse Event|0|||
163023795|NCT01938430|588791065|FG009|Overall Study|Adverse Event|0|||
163023796|NCT01938430|588791066|FG010|Overall Study|Adverse Event|0|||
163023797|NCT01938430|588791067|FG011|Overall Study|Adverse Event|0|||
163023798|NCT01938430|588791068|FG012|Overall Study|Adverse Event|0|||
163023799|NCT01938430|588791069|FG013|Overall Study|Adverse Event|0|||
163023800|NCT01938430|588791056|FG000|Overall Study|Death|1|||
163023801|NCT01938430|588791057|FG001|Overall Study|Death|2|||
163023802|NCT01938430|588791058|FG002|Overall Study|Death|2|||
163023803|NCT01938430|588791059|FG003|Overall Study|Death|1|||
163023804|NCT01938430|588791060|FG004|Overall Study|Death|0|||
163023805|NCT01938430|588791061|FG005|Overall Study|Death|0|||
163023806|NCT01938430|588791062|FG006|Overall Study|Death|1|||
163023807|NCT01938430|588791063|FG007|Overall Study|Death|1|||
163023808|NCT01938430|588791064|FG008|Overall Study|Death|2|||
163023809|NCT01938430|588791065|FG009|Overall Study|Death|3|||
163023810|NCT01938430|588791066|FG010|Overall Study|Death|0|||
163023811|NCT01938430|588791067|FG011|Overall Study|Death|0|||
163023812|NCT01938430|588791068|FG012|Overall Study|Death|0|||
163023813|NCT01938430|588791069|FG013|Overall Study|Death|0|||
163023814|NCT01938430|588791056|FG000|Overall Study|Investigator's Discretion|0|||
163023815|NCT01938430|588791057|FG001|Overall Study|Investigator's Discretion|0|||
163023816|NCT01938430|588791058|FG002|Overall Study|Investigator's Discretion|1|||
163023817|NCT01938430|588791059|FG003|Overall Study|Investigator's Discretion|0|||
163023818|NCT01938430|588791060|FG004|Overall Study|Investigator's Discretion|0|||
163023819|NCT01938430|588791061|FG005|Overall Study|Investigator's Discretion|0|||
163023820|NCT01938430|588791062|FG006|Overall Study|Investigator's Discretion|0|||
163023821|NCT01938430|588791063|FG007|Overall Study|Investigator's Discretion|0|||
163064143|NCT03126110|588941545|FG000|Phase 2|Progressive Disease|0|||
163023822|NCT01938430|588791064|FG008|Overall Study|Investigator's Discretion|0|||
163023823|NCT01938430|588791065|FG009|Overall Study|Investigator's Discretion|0|||
163023824|NCT01938430|588791066|FG010|Overall Study|Investigator's Discretion|0|||
163023825|NCT01938430|588791067|FG011|Overall Study|Investigator's Discretion|0|||
163023826|NCT01938430|588791068|FG012|Overall Study|Investigator's Discretion|0|||
163023827|NCT01938430|588791069|FG013|Overall Study|Investigator's Discretion|0|||
163023828|NCT01938430|588791056|FG000|Overall Study|Lack of Efficacy|3|||
163023829|NCT01938430|588791057|FG001|Overall Study|Lack of Efficacy|1|||
163023830|NCT01938430|588791058|FG002|Overall Study|Lack of Efficacy|1|||
163023831|NCT01938430|588791059|FG003|Overall Study|Lack of Efficacy|1|||
163023832|NCT01938430|588791060|FG004|Overall Study|Lack of Efficacy|0|||
163023833|NCT01938430|588791061|FG005|Overall Study|Lack of Efficacy|0|||
163023834|NCT01938430|588791062|FG006|Overall Study|Lack of Efficacy|0|||
163023835|NCT01938430|588791063|FG007|Overall Study|Lack of Efficacy|0|||
163023836|NCT01938430|588791064|FG008|Overall Study|Lack of Efficacy|1|||
163023837|NCT01938430|588791065|FG009|Overall Study|Lack of Efficacy|0|||
163023838|NCT01938430|588791066|FG010|Overall Study|Lack of Efficacy|2|||
163023839|NCT01938430|588791067|FG011|Overall Study|Lack of Efficacy|1|||
163023840|NCT01938430|588791068|FG012|Overall Study|Lack of Efficacy|0|||
163023841|NCT01938430|588791069|FG013|Overall Study|Lack of Efficacy|0|||
163023842|NCT01938430|588791056|FG000|Overall Study|Lost to Follow-up|0|||
163023843|NCT01938430|588791057|FG001|Overall Study|Lost to Follow-up|0|||
163023844|NCT01938430|588791058|FG002|Overall Study|Lost to Follow-up|1|||
163023845|NCT01938430|588791059|FG003|Overall Study|Lost to Follow-up|0|||
163023846|NCT01938430|588791060|FG004|Overall Study|Lost to Follow-up|0|||
163023847|NCT01938430|588791061|FG005|Overall Study|Lost to Follow-up|1|||
163023848|NCT01938430|588791062|FG006|Overall Study|Lost to Follow-up|0|||
163023849|NCT01938430|588791063|FG007|Overall Study|Lost to Follow-up|0|||
163023850|NCT01938430|588791064|FG008|Overall Study|Lost to Follow-up|0|||
163023851|NCT01938430|588791065|FG009|Overall Study|Lost to Follow-up|0|||
163023852|NCT01938430|588791066|FG010|Overall Study|Lost to Follow-up|0|||
163023853|NCT01938430|588791067|FG011|Overall Study|Lost to Follow-up|0|||
163023854|NCT01938430|588791068|FG012|Overall Study|Lost to Follow-up|0|||
163023855|NCT01938430|588791069|FG013|Overall Study|Lost to Follow-up|0|||
163023856|NCT01938430|588791056|FG000|Overall Study|Withdrew Consent|0|||
163023857|NCT01938430|588791057|FG001|Overall Study|Withdrew Consent|0|||
163023858|NCT01938430|588791058|FG002|Overall Study|Withdrew Consent|0|||
163023859|NCT01938430|588791059|FG003|Overall Study|Withdrew Consent|0|||
163023860|NCT01938430|588791060|FG004|Overall Study|Withdrew Consent|0|||
163023861|NCT01938430|588791061|FG005|Overall Study|Withdrew Consent|0|||
163023862|NCT01938430|588791062|FG006|Overall Study|Withdrew Consent|0|||
163023863|NCT01938430|588791063|FG007|Overall Study|Withdrew Consent|0|||
163023864|NCT01938430|588791064|FG008|Overall Study|Withdrew Consent|1|||
163023865|NCT01938430|588791065|FG009|Overall Study|Withdrew Consent|0|||
163023866|NCT01938430|588791066|FG010|Overall Study|Withdrew Consent|0|||
163023867|NCT01938430|588791067|FG011|Overall Study|Withdrew Consent|0|||
163023868|NCT01938430|588791068|FG012|Overall Study|Withdrew Consent|0|||
163023869|NCT01938430|588791069|FG013|Overall Study|Withdrew Consent|0|||
163023870|NCT02980341|588791074|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023871|NCT02980341|588791075|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023872|NCT02980341|588791076|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
163023873|NCT02980341|588791077|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
163023874|NCT02980341|588791078|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
163023875|NCT02980341|588791079|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023876|NCT02980341|588791080|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023877|NCT02980341|588791081|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023878|NCT02980341|588791082|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163064144|NCT03126110|588941546|FG001|Phase 2|Progressive Disease|0|||
163064145|NCT03126110|588941547|FG002|Phase 2|Progressive Disease|0|||
163064146|NCT03126110|588941548|FG003|Phase 2|Progressive Disease|0|||
163064147|NCT03126110|588941549|FG004|Phase 2|Progressive Disease|0|||
163064148|NCT03126110|588941550|FG005|Phase 2|Progressive Disease|0|||
163064149|NCT03126110|588941551|FG006|Phase 2|Progressive Disease|0|||
163064150|NCT03126110|588941552|FG007|Phase 2|Progressive Disease|0|||
163064151|NCT03126110|588941553|FG008|Phase 2|Progressive Disease|0|||
163064152|NCT03126110|588941554|FG009|Phase 2|Progressive Disease|0|||
163064153|NCT03126110|588941555|FG010|Phase 2|Progressive Disease|0|||
163064154|NCT03126110|588941556|FG011|Phase 2|Progressive Disease|0|||
163064155|NCT03126110|588941557|FG012|Phase 2|Progressive Disease|0|||
163023879|NCT02980341|588791083|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023880|NCT02980341|588791084|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
163023881|NCT02980341|588791074|FG000|Dose Escalation|Clinical progression|0|||
163064156|NCT03126110|588941558|FG013|Phase 2|Progressive Disease|1|||
163023882|NCT02980341|588791075|FG001|Dose Escalation|Clinical progression|0|||
163023883|NCT02980341|588791076|FG002|Dose Escalation|Clinical progression|2|||
163023884|NCT02980341|588791077|FG003|Dose Escalation|Clinical progression|1|||
163023885|NCT02980341|588791078|FG004|Dose Escalation|Clinical progression|0|||
163023886|NCT02980341|588791079|FG005|Dose Escalation|Clinical progression|0|||
163023887|NCT02980341|588791080|FG006|Dose Escalation|Clinical progression|0|||
163064157|NCT03126110|588941559|FG014|Phase 2|Progressive Disease|0|||
163064158|NCT03126110|588941560|FG015|Phase 2|Progressive Disease|0|||
163023888|NCT02980341|588791081|FG007|Dose Escalation|Clinical progression|0|||
163023889|NCT02980341|588791082|FG008|Dose Escalation|Clinical progression|0|||
163023890|NCT02980341|588791083|FG009|Dose Escalation|Clinical progression|0|||
163023891|NCT02980341|588791084|FG010|Dose Escalation|Clinical progression|0|||
163023892|NCT02980341|588791074|FG000|Dose Escalation|Adverse Event|0|||
163023893|NCT02980341|588791075|FG001|Dose Escalation|Adverse Event|0|||
163023894|NCT02980341|588791076|FG002|Dose Escalation|Adverse Event|1|||
163023895|NCT02980341|588791077|FG003|Dose Escalation|Adverse Event|2|||
163023896|NCT02980341|588791078|FG004|Dose Escalation|Adverse Event|2|||
163023897|NCT02980341|588791079|FG005|Dose Escalation|Adverse Event|0|||
163023898|NCT02980341|588791080|FG006|Dose Escalation|Adverse Event|0|||
163023899|NCT02980341|588791081|FG007|Dose Escalation|Adverse Event|0|||
163023900|NCT02980341|588791082|FG008|Dose Escalation|Adverse Event|0|||
163023901|NCT02980341|588791083|FG009|Dose Escalation|Adverse Event|0|||
163023902|NCT02980341|588791084|FG010|Dose Escalation|Adverse Event|0|||
163023903|NCT02980341|588791074|FG000|Dose Escalation|Withdrawal by Subject|0|||
163023904|NCT02980341|588791075|FG001|Dose Escalation|Withdrawal by Subject|0|||
163023905|NCT02980341|588791076|FG002|Dose Escalation|Withdrawal by Subject|1|||
163023906|NCT02980341|588791077|FG003|Dose Escalation|Withdrawal by Subject|0|||
163023907|NCT02980341|588791078|FG004|Dose Escalation|Withdrawal by Subject|0|||
163023908|NCT02980341|588791079|FG005|Dose Escalation|Withdrawal by Subject|0|||
163023909|NCT02980341|588791080|FG006|Dose Escalation|Withdrawal by Subject|0|||
163023910|NCT02980341|588791081|FG007|Dose Escalation|Withdrawal by Subject|0|||
163023911|NCT02980341|588791082|FG008|Dose Escalation|Withdrawal by Subject|0|||
163023912|NCT02980341|588791083|FG009|Dose Escalation|Withdrawal by Subject|0|||
163023913|NCT02980341|588791084|FG010|Dose Escalation|Withdrawal by Subject|0|||
163023914|NCT02980341|588791074|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023915|NCT02980341|588791075|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023916|NCT02980341|588791076|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023917|NCT02980341|588791077|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
163023918|NCT02980341|588791078|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023919|NCT02980341|588791079|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023920|NCT02980341|588791080|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023921|NCT02980341|588791081|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023922|NCT02980341|588791082|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023923|NCT02980341|588791083|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023924|NCT02980341|588791084|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
163023925|NCT02980341|588791074|FG000|Dose Escalation|Due to investigator's decision|0|||
163023926|NCT02980341|588791075|FG001|Dose Escalation|Due to investigator's decision|0|||
163023927|NCT02980341|588791076|FG002|Dose Escalation|Due to investigator's decision|0|||
163023928|NCT02980341|588791077|FG003|Dose Escalation|Due to investigator's decision|0|||
163023929|NCT02980341|588791078|FG004|Dose Escalation|Due to investigator's decision|1|||
163023930|NCT02980341|588791079|FG005|Dose Escalation|Due to investigator's decision|0|||
163023931|NCT02980341|588791080|FG006|Dose Escalation|Due to investigator's decision|0|||
163023932|NCT02980341|588791081|FG007|Dose Escalation|Due to investigator's decision|0|||
163023933|NCT02980341|588791082|FG008|Dose Escalation|Due to investigator's decision|0|||
163023934|NCT02980341|588791083|FG009|Dose Escalation|Due to investigator's decision|0|||
163023935|NCT02980341|588791084|FG010|Dose Escalation|Due to investigator's decision|0|||
163023936|NCT02980341|588791074|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023937|NCT02980341|588791075|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023938|NCT02980341|588791076|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023939|NCT02980341|588791077|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023940|NCT02980341|588791078|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023941|NCT02980341|588791079|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
163023942|NCT02980341|588791080|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
163023943|NCT02980341|588791081|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023944|NCT02980341|588791082|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023945|NCT02980341|588791083|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023946|NCT02980341|588791084|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
163023947|NCT02980341|588791074|FG000|Dose Finding|Adverse Event|0|||
163023948|NCT02980341|588791075|FG001|Dose Finding|Adverse Event|0|||
163023949|NCT02980341|588791076|FG002|Dose Finding|Adverse Event|0|||
163023950|NCT02980341|588791077|FG003|Dose Finding|Adverse Event|0|||
163064159|NCT03126110|588941561|FG016|Phase 2|Progressive Disease|0|||
163064160|NCT03126110|588941545|FG000|Phase 2|Started new treatment|0|||
163023951|NCT02980341|588791078|FG004|Dose Finding|Adverse Event|0|||
163023952|NCT02980341|588791079|FG005|Dose Finding|Adverse Event|3|||
163023953|NCT02980341|588791080|FG006|Dose Finding|Adverse Event|0|||
163023954|NCT02980341|588791081|FG007|Dose Finding|Adverse Event|0|||
163023955|NCT02980341|588791082|FG008|Dose Finding|Adverse Event|0|||
163023956|NCT02980341|588791083|FG009|Dose Finding|Adverse Event|0|||
163023957|NCT02980341|588791084|FG010|Dose Finding|Adverse Event|0|||
163023958|NCT02980341|588791074|FG000|Dose Finding|Withdrawal by Subject|0|||
163023959|NCT02980341|588791075|FG001|Dose Finding|Withdrawal by Subject|0|||
163023960|NCT02980341|588791076|FG002|Dose Finding|Withdrawal by Subject|0|||
163023961|NCT02980341|588791077|FG003|Dose Finding|Withdrawal by Subject|0|||
163023962|NCT02980341|588791078|FG004|Dose Finding|Withdrawal by Subject|0|||
163023963|NCT02980341|588791079|FG005|Dose Finding|Withdrawal by Subject|1|||
163023964|NCT02980341|588791080|FG006|Dose Finding|Withdrawal by Subject|1|||
163023965|NCT02980341|588791081|FG007|Dose Finding|Withdrawal by Subject|0|||
163023966|NCT02980341|588791082|FG008|Dose Finding|Withdrawal by Subject|0|||
163023967|NCT02980341|588791083|FG009|Dose Finding|Withdrawal by Subject|0|||
163023968|NCT02980341|588791084|FG010|Dose Finding|Withdrawal by Subject|0|||
163023969|NCT02980341|588791074|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023970|NCT02980341|588791075|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023971|NCT02980341|588791076|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023972|NCT02980341|588791077|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023973|NCT02980341|588791078|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023974|NCT02980341|588791079|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023975|NCT02980341|588791080|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
163023976|NCT02980341|588791081|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
163023977|NCT02980341|588791082|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
163023978|NCT02980341|588791083|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
163023979|NCT02980341|588791084|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
163023980|NCT02980341|588791074|FG000|Dose Expansion|Clinical progression|0|||
163023981|NCT02980341|588791075|FG001|Dose Expansion|Clinical progression|0|||
163023982|NCT02980341|588791076|FG002|Dose Expansion|Clinical progression|0|||
163023983|NCT02980341|588791077|FG003|Dose Expansion|Clinical progression|0|||
163023984|NCT02980341|588791078|FG004|Dose Expansion|Clinical progression|0|||
163023985|NCT02980341|588791079|FG005|Dose Expansion|Clinical progression|0|||
163023986|NCT02980341|588791080|FG006|Dose Expansion|Clinical progression|0|||
163023987|NCT02980341|588791081|FG007|Dose Expansion|Clinical progression|4|||
163023988|NCT02980341|588791082|FG008|Dose Expansion|Clinical progression|3|||
163023989|NCT02980341|588791083|FG009|Dose Expansion|Clinical progression|1|||
163023990|NCT02980341|588791084|FG010|Dose Expansion|Clinical progression|4|||
163023991|NCT02980341|588791074|FG000|Dose Expansion|Adverse Event|0|||
163023992|NCT02980341|588791075|FG001|Dose Expansion|Adverse Event|0|||
163023993|NCT02980341|588791076|FG002|Dose Expansion|Adverse Event|0|||
163023994|NCT02980341|588791077|FG003|Dose Expansion|Adverse Event|0|||
163023995|NCT02980341|588791078|FG004|Dose Expansion|Adverse Event|0|||
163023996|NCT02980341|588791079|FG005|Dose Expansion|Adverse Event|0|||
163023997|NCT02980341|588791080|FG006|Dose Expansion|Adverse Event|0|||
163023998|NCT02980341|588791081|FG007|Dose Expansion|Adverse Event|3|||
163023999|NCT02980341|588791082|FG008|Dose Expansion|Adverse Event|0|||
163024000|NCT02980341|588791083|FG009|Dose Expansion|Adverse Event|1|||
163024001|NCT02980341|588791084|FG010|Dose Expansion|Adverse Event|3|||
163024002|NCT02980341|588791074|FG000|Dose Expansion|Death|0|||
163024003|NCT02980341|588791075|FG001|Dose Expansion|Death|0|||
163024004|NCT02980341|588791076|FG002|Dose Expansion|Death|0|||
163024005|NCT02980341|588791077|FG003|Dose Expansion|Death|0|||
163024006|NCT02980341|588791078|FG004|Dose Expansion|Death|0|||
163024007|NCT02980341|588791079|FG005|Dose Expansion|Death|0|||
163024008|NCT02980341|588791080|FG006|Dose Expansion|Death|0|||
163024009|NCT02980341|588791081|FG007|Dose Expansion|Death|0|||
163024010|NCT02980341|588791082|FG008|Dose Expansion|Death|2|||
163024011|NCT02980341|588791083|FG009|Dose Expansion|Death|1|||
163024012|NCT02980341|588791084|FG010|Dose Expansion|Death|0|||
163024013|NCT02980341|588791074|FG000|Dose Expansion|Withdrawal by Subject|0|||
163024014|NCT02980341|588791075|FG001|Dose Expansion|Withdrawal by Subject|0|||
163024015|NCT02980341|588791076|FG002|Dose Expansion|Withdrawal by Subject|0|||
163024016|NCT02980341|588791077|FG003|Dose Expansion|Withdrawal by Subject|0|||
163024017|NCT02980341|588791078|FG004|Dose Expansion|Withdrawal by Subject|0|||
163024018|NCT02980341|588791079|FG005|Dose Expansion|Withdrawal by Subject|0|||
163024019|NCT02980341|588791080|FG006|Dose Expansion|Withdrawal by Subject|0|||
163024020|NCT02980341|588791081|FG007|Dose Expansion|Withdrawal by Subject|2|||
163024021|NCT02980341|588791082|FG008|Dose Expansion|Withdrawal by Subject|0|||
163024022|NCT02980341|588791083|FG009|Dose Expansion|Withdrawal by Subject|1|||
163024023|NCT02980341|588791084|FG010|Dose Expansion|Withdrawal by Subject|0|||
162643761|NCT02608268|587411743|FG026|Overall Study|Death|0|||
162643762|NCT02608268|587411744|FG027|Overall Study|Death|1|||
163024024|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024025|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024026|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024027|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024028|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024029|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163064161|NCT03126110|588941546|FG001|Phase 2|Started new treatment|0|||
163064162|NCT03126110|588941547|FG002|Phase 2|Started new treatment|0|||
163064163|NCT03126110|588941548|FG003|Phase 2|Started new treatment|0|||
163064164|NCT03126110|588941549|FG004|Phase 2|Started new treatment|0|||
163064165|NCT03126110|588941550|FG005|Phase 2|Started new treatment|0|||
163064166|NCT03126110|588941551|FG006|Phase 2|Started new treatment|0|||
163064167|NCT03126110|588941552|FG007|Phase 2|Started new treatment|0|||
163064168|NCT03126110|588941553|FG008|Phase 2|Started new treatment|0|||
163064169|NCT03126110|588941554|FG009|Phase 2|Started new treatment|0|||
163064170|NCT03126110|588941555|FG010|Phase 2|Started new treatment|0|||
163064171|NCT03126110|588941556|FG011|Phase 2|Started new treatment|0|||
163064172|NCT03126110|588941557|FG012|Phase 2|Started new treatment|0|||
163064173|NCT03126110|588941558|FG013|Phase 2|Started new treatment|0|||
163064174|NCT03126110|588941559|FG014|Phase 2|Started new treatment|1|||
163064175|NCT03126110|588941560|FG015|Phase 2|Started new treatment|0|||
163064176|NCT03126110|588941561|FG016|Phase 2|Started new treatment|0|||
163064177|NCT00314145|588941562|FG000|Overall Study|Withdrawal by Subject|8|||
163064178|NCT00314145|588941563|FG001|Overall Study|Withdrawal by Subject|10|||
163064179|NCT00314145|588941562|FG000|Overall Study|Lost to Follow-up|5|||
163064180|NCT00314145|588941563|FG001|Overall Study|Lost to Follow-up|12|||
163064181|NCT00314145|588941562|FG000|Overall Study|Physician Decision|3|||
163064182|NCT00314145|588941563|FG001|Overall Study|Physician Decision|4|||
163064183|NCT00314145|588941562|FG000|Overall Study|Adverse Event|0|||
163064184|NCT00314145|588941563|FG001|Overall Study|Adverse Event|3|||
163064185|NCT00314145|588941562|FG000|Overall Study|Protocol Violation|3|||
163064186|NCT00314145|588941563|FG001|Overall Study|Protocol Violation|0|||
163064187|NCT00314145|588941562|FG000|Overall Study|Sponsor Decision|2|||
163064188|NCT00314145|588941563|FG001|Overall Study|Sponsor Decision|0|||
163024030|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024031|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
163024032|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024033|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024034|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
163024035|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024036|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024037|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024038|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024039|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024040|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024041|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024042|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024043|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
163024044|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024045|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
163024046|NCT02980341|588791074|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024047|NCT02980341|588791075|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024048|NCT02980341|588791076|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024049|NCT02980341|588791077|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024050|NCT02980341|588791078|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024051|NCT02980341|588791079|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024052|NCT02980341|588791080|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024053|NCT02980341|588791081|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024054|NCT02980341|588791082|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
163024055|NCT02980341|588791083|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163064189|NCT00294658|588941564|FG000|Overall Study|Death|0|||
163064190|NCT00294658|588941565|FG001|Overall Study|Death|1|||
163064191|NCT00294658|588941564|FG000|Overall Study|Lost to Follow-up|4|||
163064192|NCT00294658|588941565|FG001|Overall Study|Lost to Follow-up|0|||
163064193|NCT00294658|588941564|FG000|Overall Study|Physician Decision|1|||
163064194|NCT00294658|588941565|FG001|Overall Study|Physician Decision|2|||
163064195|NCT00294658|588941564|FG000|Overall Study|Pregnancy|0|||
163064196|NCT00294658|588941565|FG001|Overall Study|Pregnancy|1|||
163064197|NCT00294658|588941564|FG000|Overall Study|Withdrawal by Subject|0|||
163064198|NCT00294658|588941565|FG001|Overall Study|Withdrawal by Subject|4|||
163064199|NCT00294658|588941564|FG000|Overall Study|Found to have invasive thymoma|1|||
163064200|NCT00294658|588941565|FG001|Overall Study|Found to have invasive thymoma|0|||
163064201|NCT00294658|588941564|FG000|Overall Study|Patient and family were not satisfied|0|||
163024056|NCT02980341|588791084|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
163024057|NCT02980341|588791074|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024058|NCT02980341|588791075|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024059|NCT02980341|588791076|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024060|NCT02980341|588791077|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024061|NCT02980341|588791078|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024062|NCT02980341|588791079|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024063|NCT02980341|588791080|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024064|NCT02980341|588791081|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024065|NCT02980341|588791082|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024066|NCT02980341|588791083|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
163024067|NCT02980341|588791084|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
163024068|NCT01647516|588791085|FG000|Induction Period (IP)|Physician Decision|2|||
163024069|NCT01647516|588791086|FG001|Induction Period (IP)|Physician Decision|0|||
163024070|NCT01647516|588791087|FG002|Induction Period (IP)|Physician Decision|0|||
163024071|NCT01647516|588791088|FG003|Induction Period (IP)|Physician Decision|0|||
163024072|NCT01647516|588791089|FG004|Induction Period (IP)|Physician Decision|0|||
163024073|NCT01647516|588791090|FG005|Induction Period (IP)|Physician Decision|0|||
163024074|NCT01647516|588791085|FG000|Induction Period (IP)|Adverse Event|1|||
163024075|NCT01647516|588791086|FG001|Induction Period (IP)|Adverse Event|2|||
163024076|NCT01647516|588791087|FG002|Induction Period (IP)|Adverse Event|0|||
163024077|NCT01647516|588791088|FG003|Induction Period (IP)|Adverse Event|0|||
163024078|NCT01647516|588791089|FG004|Induction Period (IP)|Adverse Event|0|||
163024079|NCT01647516|588791090|FG005|Induction Period (IP)|Adverse Event|0|||
163024080|NCT01647516|588791085|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
163024081|NCT01647516|588791086|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
163024082|NCT01647516|588791087|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
163024083|NCT01647516|588791088|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
163024084|NCT01647516|588791089|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
163024085|NCT01647516|588791090|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
163024086|NCT01647516|588791085|FG000|Induction Period (IP)|Participant Choice|0|||
163024087|NCT01647516|588791086|FG001|Induction Period (IP)|Participant Choice|0|||
163024088|NCT01647516|588791087|FG002|Induction Period (IP)|Participant Choice|1|||
163024089|NCT01647516|588791088|FG003|Induction Period (IP)|Participant Choice|0|||
163024090|NCT01647516|588791089|FG004|Induction Period (IP)|Participant Choice|0|||
163024091|NCT01647516|588791090|FG005|Induction Period (IP)|Participant Choice|0|||
163024092|NCT01647516|588791085|FG000|Induction Period (IP)|Lack of Efficacy|1|||
163024093|NCT01647516|588791086|FG001|Induction Period (IP)|Lack of Efficacy|0|||
163024094|NCT01647516|588791087|FG002|Induction Period (IP)|Lack of Efficacy|0|||
163024095|NCT01647516|588791088|FG003|Induction Period (IP)|Lack of Efficacy|0|||
163024096|NCT01647516|588791089|FG004|Induction Period (IP)|Lack of Efficacy|0|||
163024097|NCT01647516|588791090|FG005|Induction Period (IP)|Lack of Efficacy|0|||
163024098|NCT01647516|588791085|FG000|Induction Period (IP)|No study drug received|1|||
163024099|NCT01647516|588791086|FG001|Induction Period (IP)|No study drug received|1|||
163024100|NCT01647516|588791087|FG002|Induction Period (IP)|No study drug received|0|||
163024101|NCT01647516|588791088|FG003|Induction Period (IP)|No study drug received|0|||
163024102|NCT01647516|588791089|FG004|Induction Period (IP)|No study drug received|0|||
163024103|NCT01647516|588791090|FG005|Induction Period (IP)|No study drug received|0|||
163024104|NCT01647516|588791085|FG000|Maintenance Period (MP)|Adverse Event|2|||
163024105|NCT01647516|588791086|FG001|Maintenance Period (MP)|Adverse Event|1|||
163024106|NCT01647516|588791087|FG002|Maintenance Period (MP)|Adverse Event|0|||
163024107|NCT01647516|588791088|FG003|Maintenance Period (MP)|Adverse Event|0|||
163024108|NCT01647516|588791089|FG004|Maintenance Period (MP)|Adverse Event|0|||
163024109|NCT01647516|588791090|FG005|Maintenance Period (MP)|Adverse Event|0|||
163024110|NCT01647516|588791085|FG000|Maintenance Period (MP)|Non-compliance|1|||
163024111|NCT01647516|588791086|FG001|Maintenance Period (MP)|Non-compliance|0|||
162643763|NCT02608268|587411745|FG028|Overall Study|Death|4|||
162643764|NCT02608268|587411746|FG029|Overall Study|Death|0|||
162643765|NCT02608268|587411717|FG000|Overall Study|Physician Decision|0|||
163024112|NCT01647516|588791087|FG002|Maintenance Period (MP)|Non-compliance|0|||
163024113|NCT01647516|588791088|FG003|Maintenance Period (MP)|Non-compliance|0|||
163024114|NCT01647516|588791089|FG004|Maintenance Period (MP)|Non-compliance|0|||
163024115|NCT01647516|588791090|FG005|Maintenance Period (MP)|Non-compliance|0|||
163024116|NCT01647516|588791085|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024117|NCT01647516|588791086|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
163024118|NCT01647516|588791087|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
163024119|NCT01647516|588791088|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024120|NCT01647516|588791089|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024121|NCT01647516|588791090|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
163024122|NCT01647516|588791085|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
163024123|NCT01647516|588791086|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
163024124|NCT01647516|588791087|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
163024125|NCT01647516|588791088|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
163024126|NCT01647516|588791089|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
163024127|NCT01647516|588791090|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
163024128|NCT01647516|588791085|FG000|Open-Label Period|Adverse Event|0|||
163024129|NCT01647516|588791086|FG001|Open-Label Period|Adverse Event|0|||
163024130|NCT01647516|588791087|FG002|Open-Label Period|Adverse Event|0|||
163024131|NCT01647516|588791088|FG003|Open-Label Period|Adverse Event|5|||
163024132|NCT01647516|588791089|FG004|Open-Label Period|Adverse Event|6|||
163024133|NCT01647516|588791090|FG005|Open-Label Period|Adverse Event|3|||
163024134|NCT01647516|588791085|FG000|Open-Label Period|Pregnancy|0|||
163024135|NCT01647516|588791086|FG001|Open-Label Period|Pregnancy|0|||
163024136|NCT01647516|588791087|FG002|Open-Label Period|Pregnancy|0|||
163024137|NCT01647516|588791088|FG003|Open-Label Period|Pregnancy|0|||
163024138|NCT01647516|588791089|FG004|Open-Label Period|Pregnancy|0|||
163024139|NCT01647516|588791090|FG005|Open-Label Period|Pregnancy|1|||
163024140|NCT01647516|588791085|FG000|Open-Label Period|Non-compliance|0|||
163024141|NCT01647516|588791086|FG001|Open-Label Period|Non-compliance|0|||
163024142|NCT01647516|588791087|FG002|Open-Label Period|Non-compliance|0|||
163024143|NCT01647516|588791088|FG003|Open-Label Period|Non-compliance|1|||
163024144|NCT01647516|588791089|FG004|Open-Label Period|Non-compliance|0|||
163024145|NCT01647516|588791090|FG005|Open-Label Period|Non-compliance|1|||
163024146|NCT01647516|588791085|FG000|Open-Label Period|Physician Decision|0|||
163024147|NCT01647516|588791086|FG001|Open-Label Period|Physician Decision|0|||
163024148|NCT01647516|588791087|FG002|Open-Label Period|Physician Decision|0|||
163024149|NCT01647516|588791088|FG003|Open-Label Period|Physician Decision|1|||
163024150|NCT01647516|588791089|FG004|Open-Label Period|Physician Decision|1|||
163024151|NCT01647516|588791090|FG005|Open-Label Period|Physician Decision|0|||
163024152|NCT01647516|588791085|FG000|Open-Label Period|Withdrawal by Subject|0|||
163024153|NCT01647516|588791086|FG001|Open-Label Period|Withdrawal by Subject|0|||
163024154|NCT01647516|588791087|FG002|Open-Label Period|Withdrawal by Subject|0|||
163024155|NCT01647516|588791088|FG003|Open-Label Period|Withdrawal by Subject|9|||
163024156|NCT01647516|588791089|FG004|Open-Label Period|Withdrawal by Subject|11|||
163024157|NCT01647516|588791090|FG005|Open-Label Period|Withdrawal by Subject|6|||
163024158|NCT01647516|588791085|FG000|Open-Label Period|Lost to Follow-up|0|||
163024159|NCT01647516|588791086|FG001|Open-Label Period|Lost to Follow-up|0|||
163024160|NCT01647516|588791087|FG002|Open-Label Period|Lost to Follow-up|0|||
163024161|NCT01647516|588791088|FG003|Open-Label Period|Lost to Follow-up|1|||
163024162|NCT01647516|588791089|FG004|Open-Label Period|Lost to Follow-up|0|||
163024163|NCT01647516|588791090|FG005|Open-Label Period|Lost to Follow-up|1|||
163024164|NCT01647516|588791085|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024165|NCT01647516|588791086|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024166|NCT01647516|588791087|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
163024167|NCT01647516|588791088|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
163024168|NCT01647516|588791089|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
163024169|NCT01647516|588791090|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
163024170|NCT01647516|588791085|FG000|Open-Label Period|Lack of Efficacy|0|||
163024171|NCT01647516|588791086|FG001|Open-Label Period|Lack of Efficacy|0|||
163024172|NCT01647516|588791087|FG002|Open-Label Period|Lack of Efficacy|0|||
163024173|NCT01647516|588791088|FG003|Open-Label Period|Lack of Efficacy|7|||
163024174|NCT01647516|588791089|FG004|Open-Label Period|Lack of Efficacy|9|||
163024175|NCT01647516|588791090|FG005|Open-Label Period|Lack of Efficacy|10|||
163024176|NCT01647516|588791085|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024177|NCT01647516|588791086|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024178|NCT01647516|588791087|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
163024179|NCT01647516|588791088|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
163024180|NCT01647516|588791089|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
163024181|NCT01647516|588791090|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
163024182|NCT01647516|588791085|FG000|Open-Label Period|No completion / discontinuation visit|0|||
163024183|NCT01647516|588791086|FG001|Open-Label Period|No completion / discontinuation visit|0|||
163024184|NCT01647516|588791087|FG002|Open-Label Period|No completion / discontinuation visit|0|||
163024185|NCT01647516|588791088|FG003|Open-Label Period|No completion / discontinuation visit|0|||
163024186|NCT01647516|588791089|FG004|Open-Label Period|No completion / discontinuation visit|2|||
163024187|NCT01647516|588791090|FG005|Open-Label Period|No completion / discontinuation visit|1|||
163024188|NCT04964544|588791093|FG000|Overall Study|Screen failure or other uncategorised|10|||
163024189|NCT04964544|588791093|FG000|Overall Study|Physician Decision|4|||
163024190|NCT04964544|588791093|FG000|Overall Study|Lost to Follow-up|9|||
163024191|NCT04964544|588791093|FG000|Overall Study|Withdrawal by Subject|18|||
163024192|NCT04964544|588791093|FG000|Overall Study|Death|1|||
163024193|NCT01613222|588791096|FG000|Overall Study|Physician Decision|1|||
163024194|NCT01613222|588791096|FG000|Overall Study|Unable to place arterial line|1|||
163024195|NCT01613222|588791096|FG000|Overall Study|Reused disposable sensors|10|||
163024196|NCT02691936|588791098|FG000|Overall Study|Withdrawal by Subject|2|||
163024197|NCT02691936|588791099|FG001|Overall Study|Withdrawal by Subject|5|||
163024198|NCT00749684|588791103|FG000|Overall Study|Death|1|||
163024199|NCT00749684|588791103|FG000|Overall Study|Adverse Event|27|||
163024200|NCT00749684|588791103|FG000|Overall Study|Participant's Wish|10|||
163024201|NCT00749684|588791103|FG000|Overall Study|Not Documented|1|||
163024202|NCT00749684|588791103|FG000|Overall Study|Progressive Desease|31|||
163024203|NCT00749684|588791103|FG000|Overall Study|Therapy according to protocol + AE|2|||
163024204|NCT00749684|588791103|FG000|Overall Study|AE+discontinuation on participants wish|1|||
163024205|NCT00749684|588791103|FG000|Overall Study|Missing|9|||
163024206|NCT01194531|588791104|FG000|Overall Study|Withdrawal by Subject|1|||
163024207|NCT01194531|588791105|FG001|Overall Study|Withdrawal by Subject|0|||
163024208|NCT01194531|588791104|FG000|Overall Study|Protocol Violation|4|||
163024209|NCT01194531|588791105|FG001|Overall Study|Protocol Violation|1|||
163024210|NCT01194531|588791104|FG000|Overall Study|Physician Decision|0|||
163024211|NCT01194531|588791105|FG001|Overall Study|Physician Decision|2|||
163024212|NCT04143594|588791108|FG000|Overall Study|Withdrew consent|3|||
163024213|NCT04143594|588791109|FG001|Overall Study|Withdrew consent|10|||
163024214|NCT04143594|588791110|FG002|Overall Study|Withdrew consent|3|||
163024215|NCT04143594|588791111|FG003|Overall Study|Withdrew consent|1|||
163024216|NCT04143594|588791108|FG000|Overall Study|Lost to Follow-up|3|||
163024217|NCT04143594|588791109|FG001|Overall Study|Lost to Follow-up|5|||
163024218|NCT04143594|588791110|FG002|Overall Study|Lost to Follow-up|11|||
163024219|NCT04143594|588791111|FG003|Overall Study|Lost to Follow-up|0|||
163024220|NCT04143594|588791108|FG000|Overall Study|Investigator's discretion|2|||
163024221|NCT04143594|588791109|FG001|Overall Study|Investigator's discretion|2|||
163024222|NCT04143594|588791110|FG002|Overall Study|Investigator's discretion|0|||
163024223|NCT04143594|588791111|FG003|Overall Study|Investigator's discretion|0|||
163024224|NCT04143594|588791108|FG000|Overall Study|Randomized but never treated|0|||
163024225|NCT04143594|588791109|FG001|Overall Study|Randomized but never treated|0|||
163024226|NCT04143594|588791110|FG002|Overall Study|Randomized but never treated|0|||
163024227|NCT04143594|588791111|FG003|Overall Study|Randomized but never treated|1|||
163024228|NCT04143594|588791108|FG000|Overall Study|Death|1|||
163024229|NCT04143594|588791109|FG001|Overall Study|Death|0|||
163024230|NCT04143594|588791110|FG002|Overall Study|Death|1|||
163024231|NCT04143594|588791111|FG003|Overall Study|Death|0|||
163024232|NCT04143594|588791108|FG000|Overall Study|Adverse Event|1|||
163024233|NCT04143594|588791109|FG001|Overall Study|Adverse Event|0|||
163024234|NCT04143594|588791110|FG002|Overall Study|Adverse Event|0|||
163024235|NCT04143594|588791111|FG003|Overall Study|Adverse Event|0|||
163024236|NCT04143594|588791108|FG000|Overall Study|Pregnancy|0|||
163024237|NCT04143594|588791109|FG001|Overall Study|Pregnancy|0|||
163024238|NCT04143594|588791110|FG002|Overall Study|Pregnancy|1|||
163024239|NCT04143594|588791111|FG003|Overall Study|Pregnancy|0|||
163024240|NCT04143594|588791108|FG000|Overall Study|Lack of Efficacy|1|||
163024241|NCT04143594|588791109|FG001|Overall Study|Lack of Efficacy|1|||
163024242|NCT04143594|588791110|FG002|Overall Study|Lack of Efficacy|0|||
163024243|NCT04143594|588791111|FG003|Overall Study|Lack of Efficacy|0|||
163024244|NCT01023256|588791114|FG000|Overall Study|Protocol Violation|2|||
163024245|NCT01023256|588791115|FG001|Overall Study|Protocol Violation|3|||
163024246|NCT01023256|588791116|FG002|Overall Study|Protocol Violation|0|||
163024247|NCT01023256|588791117|FG003|Overall Study|Protocol Violation|0|||
163024248|NCT01023256|588791114|FG000|Overall Study|Randomized but not treated|1|||
163024249|NCT01023256|588791115|FG001|Overall Study|Randomized but not treated|0|||
163024250|NCT01023256|588791116|FG002|Overall Study|Randomized but not treated|1|||
163024251|NCT01023256|588791117|FG003|Overall Study|Randomized but not treated|0|||
163024252|NCT01023256|588791114|FG000|Overall Study|Other|1|||
163024253|NCT01023256|588791115|FG001|Overall Study|Other|0|||
163024254|NCT01023256|588791116|FG002|Overall Study|Other|0|||
163024255|NCT01023256|588791117|FG003|Overall Study|Other|2|||
163024256|NCT01023256|588791114|FG000|Overall Study|Adverse Event|0|||
163024257|NCT01023256|588791115|FG001|Overall Study|Adverse Event|0|||
163024258|NCT01023256|588791116|FG002|Overall Study|Adverse Event|0|||
163024259|NCT01023256|588791117|FG003|Overall Study|Adverse Event|1|||
163024260|NCT01023256|588791114|FG000|Overall Study|Withdrawal by Subject|0|||
163024261|NCT01023256|588791115|FG001|Overall Study|Withdrawal by Subject|0|||
163024262|NCT01023256|588791116|FG002|Overall Study|Withdrawal by Subject|0|||
163064202|NCT00294658|588941565|FG001|Overall Study|Patient and family were not satisfied|1|||
163064203|NCT00976027|588941567|FG000|Overall Study|Serious Adverse Event|36|||
163064204|NCT00976027|588941568|FG001|Overall Study|Serious Adverse Event|17|||
163064205|NCT00976027|588941567|FG000|Overall Study|Adverse Event|0|||
163064206|NCT00976027|588941568|FG001|Overall Study|Adverse Event|2|||
163064207|NCT00976027|588941567|FG000|Overall Study|Protocol Violation|60|||
163064208|NCT00976027|588941568|FG001|Overall Study|Protocol Violation|27|||
163064209|NCT00976027|588941567|FG000|Overall Study|Lost to Follow-up|208|||
163064210|NCT00976027|588941568|FG001|Overall Study|Lost to Follow-up|103|||
163064211|NCT00976027|588941567|FG000|Overall Study|Withdrawal by Subject|107|||
163064212|NCT00976027|588941568|FG001|Overall Study|Withdrawal by Subject|66|||
163064213|NCT01771107|588941574|FG000|Overall Study|Adverse Event|1|||
163064214|NCT01771107|588941575|FG001|Overall Study|Adverse Event|3|||
163064215|NCT01771107|588941574|FG000|Overall Study|Withdrawal by Subject|0|||
163064216|NCT01771107|588941575|FG001|Overall Study|Withdrawal by Subject|2|||
163064217|NCT01771107|588941574|FG000|Overall Study|Lost to Follow-up|0|||
163064218|NCT01771107|588941575|FG001|Overall Study|Lost to Follow-up|1|||
163024263|NCT01023256|588791117|FG003|Overall Study|Withdrawal by Subject|2|||
163024264|NCT00308087|588791118|FG000|Overall Study|Progressive Disease|19|||
163024265|NCT00308087|588791119|FG001|Overall Study|Progressive Disease|21|||
163024266|NCT00308087|588791118|FG000|Overall Study|Study Closure|11|||
163024267|NCT00308087|588791119|FG001|Overall Study|Study Closure|12|||
163024268|NCT00308087|588791118|FG000|Overall Study|Withdrawal by Subject|2|||
163024269|NCT00308087|588791119|FG001|Overall Study|Withdrawal by Subject|1|||
163024270|NCT00308087|588791118|FG000|Overall Study|Other|4|||
163024271|NCT00308087|588791119|FG001|Overall Study|Other|3|||
163024272|NCT01967706|588791120|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163024273|NCT01967706|588791121|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024274|NCT01967706|588791122|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024275|NCT01967706|588791123|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
163024276|NCT01154088|588791124|FG000|Overall Study|Lost to Follow-up|4|||
163024277|NCT01154088|588791125|FG001|Overall Study|Lost to Follow-up|6|||
163024278|NCT01154088|588791126|FG002|Overall Study|Lost to Follow-up|7|||
163024279|NCT05129137|588791127|FG000|Second Period|Adverse Event|1|||
163024280|NCT05129137|588791128|FG001|Second Period|Adverse Event|0|||
163024281|NCT05129137|588791129|FG002|Second Period|Adverse Event|0|||
163024282|NCT05129137|588791130|FG003|Second Period|Adverse Event|0|||
163024283|NCT05129137|588791127|FG000|Second Period|Protocol Violation|0|||
163024284|NCT05129137|588791128|FG001|Second Period|Protocol Violation|0|||
163024285|NCT05129137|588791129|FG002|Second Period|Protocol Violation|0|||
163024286|NCT05129137|588791130|FG003|Second Period|Protocol Violation|1|||
163024287|NCT05129137|588791127|FG000|Third Period|Protocol Violation|0|||
163024288|NCT05129137|588791128|FG001|Third Period|Protocol Violation|0|||
163024289|NCT05129137|588791129|FG002|Third Period|Protocol Violation|0|||
163024290|NCT05129137|588791130|FG003|Third Period|Protocol Violation|1|||
163024291|NCT05129137|588791127|FG000|Forth Period|Protocol Violation|0|||
163024292|NCT05129137|588791128|FG001|Forth Period|Protocol Violation|1|||
163024293|NCT05129137|588791129|FG002|Forth Period|Protocol Violation|0|||
163024294|NCT05129137|588791130|FG003|Forth Period|Protocol Violation|0|||
163024295|NCT05129137|588791127|FG000|Forth Period|Withdrawal by Subject|0|||
163024296|NCT05129137|588791128|FG001|Forth Period|Withdrawal by Subject|0|||
163024297|NCT05129137|588791129|FG002|Forth Period|Withdrawal by Subject|1|||
163024298|NCT05129137|588791130|FG003|Forth Period|Withdrawal by Subject|0|||
163024299|NCT02949843|588791132|FG000|Overall Study|Withdrawal by Subject|0|||
163024300|NCT02949843|588791133|FG001|Overall Study|Withdrawal by Subject|1|||
163024301|NCT02949843|588791134|FG002|Overall Study|Withdrawal by Subject|1|||
163024302|NCT02693171|588791137|FG000|Overall Study|Adverse Event|1|||
163024303|NCT02693171|588791137|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
163024304|NCT03085238|588791141|FG000|Overall Study|Adverse Event|2|||
163064219|NCT01771107|588941574|FG000|Overall Study|participant moved|0|||
163064220|NCT01771107|588941575|FG001|Overall Study|participant moved|1|||
162643766|NCT02608268|587411718|FG001|Overall Study|Physician Decision|0|||
163024305|NCT03085238|588791141|FG000|Overall Study|Death|2|||
163024306|NCT01992653|588791142|FG000|Overall Study|Death|0|||
163024307|NCT01992653|588791143|FG001|Overall Study|Death|0|||
162643767|NCT02608268|587411719|FG002|Overall Study|Physician Decision|0|||
163024308|NCT01992653|588791144|FG002|Overall Study|Death|1|||
163024309|NCT01992653|588791145|FG003|Overall Study|Death|0|||
163024310|NCT01992653|588791146|FG004|Overall Study|Death|1|||
163024311|NCT01992653|588791147|FG005|Overall Study|Death|0|||
163024312|NCT01992653|588791148|FG006|Overall Study|Death|4|||
163024313|NCT01992653|588791149|FG007|Overall Study|Death|2|||
163024314|NCT01992653|588791142|FG000|Overall Study|Lost to Follow-up|0|||
163024315|NCT01992653|588791143|FG001|Overall Study|Lost to Follow-up|0|||
163024316|NCT01992653|588791144|FG002|Overall Study|Lost to Follow-up|0|||
163064221|NCT01771107|588941574|FG000|Overall Study|Other|0|||
163064222|NCT01771107|588941575|FG001|Overall Study|Other|1|||
163064223|NCT03805841|588941576|FG000|Overall Study|Clinical Progression|2|||
163024317|NCT01992653|588791145|FG003|Overall Study|Lost to Follow-up|0|||
163024318|NCT01992653|588791146|FG004|Overall Study|Lost to Follow-up|0|||
163064224|NCT03805841|588941577|FG001|Overall Study|Clinical Progression|0|||
163064225|NCT03805841|588941578|FG002|Overall Study|Clinical Progression|0|||
163064226|NCT03805841|588941576|FG000|Overall Study|Death|0|||
163064227|NCT03805841|588941577|FG001|Overall Study|Death|3|||
163064228|NCT03805841|588941578|FG002|Overall Study|Death|1|||
163064229|NCT03805841|588941576|FG000|Overall Study|Lost to Follow-up|0|||
163064230|NCT03805841|588941577|FG001|Overall Study|Lost to Follow-up|0|||
163064231|NCT03805841|588941578|FG002|Overall Study|Lost to Follow-up|1|||
163064232|NCT03805841|588941576|FG000|Overall Study|Withdrawal by Subject|2|||
163064233|NCT03805841|588941577|FG001|Overall Study|Withdrawal by Subject|3|||
163064234|NCT03805841|588941578|FG002|Overall Study|Withdrawal by Subject|0|||
163064235|NCT03805841|588941576|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
163064236|NCT03805841|588941577|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
163064237|NCT03805841|588941578|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
163064238|NCT03621592|588941581|FG000|Overall Study|Lost to Follow-up|1|||
163064239|NCT03621592|588941582|FG001|Overall Study|Lost to Follow-up|0|||
163064240|NCT03621592|588941581|FG000|Overall Study|Lack of Improvement|1|||
163064241|NCT03621592|588941582|FG001|Overall Study|Lack of Improvement|0|||
163064242|NCT03621592|588941581|FG000|Overall Study|Preference to receive wound care closer to home|1|||
163064243|NCT03621592|588941582|FG001|Overall Study|Preference to receive wound care closer to home|0|||
163064244|NCT03621592|588941581|FG000|Overall Study|Lack of healing|0|||
163064245|NCT03621592|588941582|FG001|Overall Study|Lack of healing|2|||
163064246|NCT00831844|588941588|FG000|Overall Study|Adverse Event|2|||
163064247|NCT00831844|588941589|FG001|Overall Study|Adverse Event|0|||
163064248|NCT00831844|588941590|FG002|Overall Study|Adverse Event|0|||
163064249|NCT00831844|588941591|FG003|Overall Study|Adverse Event|0|||
163064250|NCT00831844|588941592|FG004|Overall Study|Adverse Event|1|||
163064251|NCT00831844|588941593|FG005|Overall Study|Adverse Event|1|||
163064252|NCT00831844|588941594|FG006|Overall Study|Adverse Event|2|||
163064253|NCT00831844|588941595|FG007|Overall Study|Adverse Event|0|||
163064254|NCT00831844|588941596|FG008|Overall Study|Adverse Event|0|||
163064255|NCT00831844|588941597|FG009|Overall Study|Adverse Event|0|||
163064256|NCT00831844|588941588|FG000|Overall Study|Death|0|||
163064257|NCT00831844|588941589|FG001|Overall Study|Death|0|||
163064258|NCT00831844|588941590|FG002|Overall Study|Death|0|||
163064259|NCT00831844|588941591|FG003|Overall Study|Death|1|||
163064260|NCT00831844|588941592|FG004|Overall Study|Death|0|||
163064261|NCT00831844|588941593|FG005|Overall Study|Death|0|||
163064262|NCT00831844|588941594|FG006|Overall Study|Death|0|||
163064263|NCT00831844|588941595|FG007|Overall Study|Death|0|||
163064264|NCT00831844|588941596|FG008|Overall Study|Death|0|||
163064265|NCT00831844|588941597|FG009|Overall Study|Death|0|||
163064266|NCT00831844|588941588|FG000|Overall Study|Lack of Efficacy|8|||
163064267|NCT00831844|588941589|FG001|Overall Study|Lack of Efficacy|10|||
163024319|NCT01992653|588791147|FG005|Overall Study|Lost to Follow-up|0|||
163024320|NCT01992653|588791148|FG006|Overall Study|Lost to Follow-up|0|||
163024321|NCT01992653|588791149|FG007|Overall Study|Lost to Follow-up|1|||
163024322|NCT01992653|588791142|FG000|Overall Study|Study Completed|0|||
163024323|NCT01992653|588791143|FG001|Overall Study|Study Completed|0|||
163024324|NCT01992653|588791144|FG002|Overall Study|Study Completed|0|||
163024325|NCT01992653|588791145|FG003|Overall Study|Study Completed|0|||
163024326|NCT01992653|588791146|FG004|Overall Study|Study Completed|0|||
163024327|NCT01992653|588791147|FG005|Overall Study|Study Completed|0|||
163024328|NCT01992653|588791148|FG006|Overall Study|Study Completed|0|||
163024329|NCT01992653|588791149|FG007|Overall Study|Study Completed|1|||
163024330|NCT01992653|588791142|FG000|Overall Study|Disease Progression|0|||
163024331|NCT01992653|588791143|FG001|Overall Study|Disease Progression|0|||
163024332|NCT01992653|588791144|FG002|Overall Study|Disease Progression|0|||
163024333|NCT01992653|588791145|FG003|Overall Study|Disease Progression|0|||
163024334|NCT01992653|588791146|FG004|Overall Study|Disease Progression|0|||
163024335|NCT01992653|588791147|FG005|Overall Study|Disease Progression|0|||
163024336|NCT01992653|588791148|FG006|Overall Study|Disease Progression|4|||
163024337|NCT01992653|588791149|FG007|Overall Study|Disease Progression|0|||
163024338|NCT01435460|588791150|FG000|Overall Study|Adverse Event|2|||
163024339|NCT01435460|588791151|FG001|Overall Study|Adverse Event|1|||
163024340|NCT01435460|588791150|FG000|Overall Study|Lost to Follow-up|6|||
163024341|NCT01435460|588791151|FG001|Overall Study|Lost to Follow-up|1|||
163024342|NCT01435460|588791150|FG000|Overall Study|Withdrawal by Subject|1|||
163064268|NCT00831844|588941590|FG002|Overall Study|Lack of Efficacy|15|||
163064269|NCT00831844|588941591|FG003|Overall Study|Lack of Efficacy|8|||
163064270|NCT00831844|588941592|FG004|Overall Study|Lack of Efficacy|11|||
163064271|NCT00831844|588941593|FG005|Overall Study|Lack of Efficacy|17|||
163064272|NCT00831844|588941594|FG006|Overall Study|Lack of Efficacy|8|||
163064273|NCT00831844|588941595|FG007|Overall Study|Lack of Efficacy|9|||
163064274|NCT00831844|588941596|FG008|Overall Study|Lack of Efficacy|7|||
163064275|NCT00831844|588941597|FG009|Overall Study|Lack of Efficacy|0|||
163064276|NCT00831844|588941588|FG000|Overall Study|Physician Decision|0|||
163024343|NCT01435460|588791151|FG001|Overall Study|Withdrawal by Subject|3|||
163024344|NCT01435460|588791150|FG000|Overall Study|Protocol Violation|0|||
163024345|NCT01435460|588791151|FG001|Overall Study|Protocol Violation|1|||
163024346|NCT01435460|588791150|FG000|Overall Study|Did not meet eligibility criteria|2|||
163024347|NCT01435460|588791151|FG001|Overall Study|Did not meet eligibility criteria|0|||
163024348|NCT01706939|588791152|FG000|Pre Randomization|Screen Failure|1|||
163024349|NCT01706939|588791153|FG001|Pre Randomization|Screen Failure|0|||
163024350|NCT01706939|588791154|FG002|Pre Randomization|Screen Failure|0|||
163024351|NCT01706939|588791152|FG000|Pre Randomization|Ineligible for Randomization|1|||
163024352|NCT01706939|588791153|FG001|Pre Randomization|Ineligible for Randomization|0|||
163024353|NCT01706939|588791154|FG002|Pre Randomization|Ineligible for Randomization|0|||
163024354|NCT01706939|588791152|FG000|Pre Randomization|Withdrawal by Subject|1|||
163024355|NCT01706939|588791153|FG001|Pre Randomization|Withdrawal by Subject|0|||
163024356|NCT01706939|588791154|FG002|Pre Randomization|Withdrawal by Subject|0|||
163024357|NCT01706939|588791152|FG000|Randomization|Insufficient QoL survey compliance|0|||
163024358|NCT01706939|588791153|FG001|Randomization|Insufficient QoL survey compliance|1|||
163024359|NCT01706939|588791154|FG002|Randomization|Insufficient QoL survey compliance|1|||
163024360|NCT01706939|588791152|FG000|Randomization|Progression of disease|0|||
163024361|NCT01706939|588791153|FG001|Randomization|Progression of disease|2|||
163024362|NCT01706939|588791154|FG002|Randomization|Progression of disease|1|||
163024363|NCT01046903|588791155|FG000|Overall Study|Lost to Follow-up|16|||
163024364|NCT01046903|588791155|FG000|Overall Study|Adverse Event|4|||
163024365|NCT01046903|588791155|FG000|Overall Study|Withdrawal by Subject|3|||
163024366|NCT01046903|588791155|FG000|Overall Study|Other|5|||
163024367|NCT00977314|588791156|FG000|Overall Study|Withdrawal by Subject|1|||
163024368|NCT00977314|588791157|FG001|Overall Study|Withdrawal by Subject|0|||
163024369|NCT00977314|588791156|FG000|Overall Study|Physician Decision|1|||
163024370|NCT00977314|588791157|FG001|Overall Study|Physician Decision|0|||
163024371|NCT01343277|588791158|FG000|Overall Study|Other|3|||
163024372|NCT01343277|588791159|FG001|Overall Study|Other|3|||
163024373|NCT01343277|588791158|FG000|Overall Study|Withdrawal by Subject|18|||
163024374|NCT01343277|588791159|FG001|Overall Study|Withdrawal by Subject|13|||
163024375|NCT01343277|588791158|FG000|Overall Study|Physician Decision|1|||
163024376|NCT01343277|588791159|FG001|Overall Study|Physician Decision|2|||
163024377|NCT01343277|588791158|FG000|Overall Study|Death|10|||
163024378|NCT01343277|588791159|FG001|Overall Study|Death|1|||
163024379|NCT01343277|588791158|FG000|Overall Study|Adverse Event|67|||
163024380|NCT01343277|588791159|FG001|Overall Study|Adverse Event|13|||
163024381|NCT01343277|588791158|FG000|Overall Study|Disease progression|270|||
163024382|NCT01343277|588791159|FG001|Overall Study|Disease progression|138|||
163024383|NCT01343277|588791158|FG000|Overall Study|Randomized not treated|6|||
163024384|NCT01343277|588791159|FG001|Overall Study|Randomized not treated|21|||
163024385|NCT01343277|588791158|FG000|Overall Study|Treatment ongoing|8|||
163024386|NCT01343277|588791159|FG001|Overall Study|Treatment ongoing|2|||
163024387|NCT01343277|588791158|FG000|Overall Study|Subsequent anticancer therapy|1|||
163024388|NCT01343277|588791159|FG001|Overall Study|Subsequent anticancer therapy|0|||
163024389|NCT01894100|588791162|FG000|Overall Study|Lost to Follow-up|0|||
163024390|NCT01894100|588791163|FG001|Overall Study|Lost to Follow-up|1|||
163024391|NCT01894100|588791162|FG000|Overall Study|Withdrawal by Subject|3|||
163024392|NCT01894100|588791163|FG001|Overall Study|Withdrawal by Subject|0|||
163024393|NCT00135512|588791166|FG000|Overall Study|Adverse Event|56|||
163024394|NCT00135512|588791166|FG000|Overall Study|Lack of Efficacy|25|||
163024395|NCT00135512|588791166|FG000|Overall Study|Other|42|||
163024396|NCT01094301|588791167|FG000|Trial Stage|Withdrawal by Subject|1|||
163024397|NCT01094301|588791167|FG000|Implant Stage|Adverse Event|1|||
163024398|NCT01094301|588791167|FG000|Implant Stage|Protocol Violation|1|||
163024399|NCT01094301|588791167|FG000|Implant Stage|Withdrawal by Subject|2|||
163024400|NCT01094301|588791167|FG000|Implant Stage|No return of pain|4|||
163024401|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
163024402|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
163024403|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
163024404|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
163024405|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024406|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024407|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
163024408|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
163024409|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
162643768|NCT02608268|587411720|FG003|Overall Study|Physician Decision|0|||
162643769|NCT02608268|587411721|FG004|Overall Study|Physician Decision|0|||
163024410|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024411|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024412|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
163024413|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
163024414|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
163024415|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
163024416|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
163064277|NCT00831844|588941589|FG001|Overall Study|Physician Decision|1|||
163064278|NCT00831844|588941590|FG002|Overall Study|Physician Decision|3|||
163064279|NCT00831844|588941591|FG003|Overall Study|Physician Decision|1|||
163064280|NCT00831844|588941592|FG004|Overall Study|Physician Decision|1|||
162643770|NCT02608268|587411722|FG005|Overall Study|Physician Decision|0|||
162643771|NCT02608268|587411723|FG006|Overall Study|Physician Decision|0|||
162643772|NCT02608268|587411724|FG007|Overall Study|Physician Decision|0|||
162643773|NCT02608268|587411725|FG008|Overall Study|Physician Decision|0|||
162643774|NCT02608268|587411726|FG009|Overall Study|Physician Decision|0|||
162643775|NCT02608268|587411727|FG010|Overall Study|Physician Decision|1|||
162643776|NCT02608268|587411728|FG011|Overall Study|Physician Decision|0|||
163024417|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024418|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
163024419|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024420|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
163024421|NCT00556933|588791171|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024422|NCT00556933|588791172|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
163024423|NCT00556933|588791173|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024424|NCT00556933|588791174|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
163024425|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
163024426|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
163024427|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
163024428|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
163024429|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
163024430|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
163024431|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
163024432|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
163024433|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
163024434|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
163024435|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
163024436|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
163024437|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
163024438|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
163024439|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
163024440|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
163024441|NCT00556933|588791171|FG000|CNI Withdrawal vs. Minimization|Death|0|||
163024442|NCT00556933|588791172|FG001|CNI Withdrawal vs. Minimization|Death|0|||
163024443|NCT00556933|588791173|FG002|CNI Withdrawal vs. Minimization|Death|0|||
163024444|NCT00556933|588791174|FG003|CNI Withdrawal vs. Minimization|Death|1|||
163064281|NCT00831844|588941593|FG005|Overall Study|Physician Decision|1|||
162643777|NCT02608268|587411729|FG012|Overall Study|Physician Decision|0|||
162643778|NCT02608268|587411730|FG013|Overall Study|Physician Decision|1|||
162643779|NCT02608268|587411731|FG014|Overall Study|Physician Decision|0|||
162643780|NCT02608268|587411732|FG015|Overall Study|Physician Decision|0|||
162643781|NCT02608268|587411733|FG016|Overall Study|Physician Decision|0|||
162643782|NCT02608268|587411734|FG017|Overall Study|Physician Decision|0|||
162643783|NCT02608268|587411735|FG018|Overall Study|Physician Decision|0|||
162643784|NCT02608268|587411736|FG019|Overall Study|Physician Decision|0|||
163024445|NCT00767455|588791175|FG000|Overall Study|Investigator error|19|||
163024446|NCT00746564|588791176|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
163024447|NCT01827267|588791177|FG000|Overall Study|Did not receive study drug|1|||
163024448|NCT01827267|588791178|FG001|Overall Study|Did not receive study drug|1|||
163024449|NCT01827267|588791177|FG000|Overall Study|Physician Decision|1|||
163024450|NCT01827267|588791178|FG001|Overall Study|Physician Decision|0|||
163024451|NCT01827267|588791177|FG000|Overall Study|Disease Progression|1|||
163024452|NCT01827267|588791178|FG001|Overall Study|Disease Progression|1|||
163024453|NCT01827267|588791177|FG000|Overall Study|Sponsor Discontinued Study|2|||
163024454|NCT01827267|588791178|FG001|Overall Study|Sponsor Discontinued Study|8|||
163024455|NCT01827267|588791177|FG000|Overall Study|Still on study|0|||
163024456|NCT01827267|588791178|FG001|Overall Study|Still on study|2|||
163024457|NCT02147158|588791185|FG000|Treatment Course 1|Adverse Event|1|||
163024458|NCT02147158|588791186|FG001|Treatment Course 1|Adverse Event|4|||
163024459|NCT02147158|588791187|FG002|Treatment Course 1|Adverse Event|3|||
163024460|NCT02147158|588791188|FG003|Treatment Course 1|Adverse Event|4|||
163024461|NCT02147158|588791189|FG004|Treatment Course 1|Adverse Event|1|||
163024462|NCT02147158|588791190|FG005|Treatment Course 1|Adverse Event|2|||
163024463|NCT02147158|588791185|FG000|Treatment Course 1|Lost to Follow-up|2|||
163024464|NCT02147158|588791186|FG001|Treatment Course 1|Lost to Follow-up|4|||
163024465|NCT02147158|588791187|FG002|Treatment Course 1|Lost to Follow-up|3|||
163024466|NCT02147158|588791188|FG003|Treatment Course 1|Lost to Follow-up|3|||
163024467|NCT02147158|588791189|FG004|Treatment Course 1|Lost to Follow-up|2|||
163024468|NCT02147158|588791190|FG005|Treatment Course 1|Lost to Follow-up|4|||
163024469|NCT02147158|588791185|FG000|Treatment Course 1|Protocol Violation|0|||
163024470|NCT02147158|588791186|FG001|Treatment Course 1|Protocol Violation|0|||
163024471|NCT02147158|588791187|FG002|Treatment Course 1|Protocol Violation|1|||
163024472|NCT02147158|588791188|FG003|Treatment Course 1|Protocol Violation|1|||
163024473|NCT02147158|588791189|FG004|Treatment Course 1|Protocol Violation|0|||
163024474|NCT02147158|588791190|FG005|Treatment Course 1|Protocol Violation|0|||
163024475|NCT02147158|588791185|FG000|Treatment Course 1|Withdrawal of Consent|1|||
163024476|NCT02147158|588791186|FG001|Treatment Course 1|Withdrawal of Consent|1|||
163024477|NCT02147158|588791187|FG002|Treatment Course 1|Withdrawal of Consent|1|||
163024478|NCT02147158|588791188|FG003|Treatment Course 1|Withdrawal of Consent|5|||
163024479|NCT02147158|588791189|FG004|Treatment Course 1|Withdrawal of Consent|3|||
163024480|NCT02147158|588791190|FG005|Treatment Course 1|Withdrawal of Consent|2|||
163024481|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Adverse Event|1|||
163024482|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Adverse Event|0|||
163024483|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Adverse Event|0|||
163024484|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Adverse Event|1|||
163024485|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Adverse Event|0|||
163024486|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Adverse Event|0|||
163024487|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024488|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
163024489|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
163024490|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024491|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
163024492|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
163024493|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
163024494|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
163024495|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
163024496|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
163024497|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
163024498|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
163024499|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
163024500|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
163024501|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
163024502|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
163024503|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
163024504|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
163024505|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024506|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
163064282|NCT00831844|588941594|FG006|Overall Study|Physician Decision|0|||
163024507|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
163064283|NCT00831844|588941595|FG007|Overall Study|Physician Decision|0|||
162643785|NCT02608268|587411737|FG020|Overall Study|Physician Decision|0|||
162643786|NCT02608268|587411738|FG021|Overall Study|Physician Decision|0|||
163024508|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024509|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
162643787|NCT02608268|587411739|FG022|Overall Study|Physician Decision|1|||
163024510|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
163024511|NCT02147158|588791185|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
163024512|NCT02147158|588791186|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024513|NCT02147158|588791187|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
163024514|NCT02147158|588791188|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
163024515|NCT02147158|588791189|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024516|NCT02147158|588791190|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
163024517|NCT02147158|588791185|FG000|Treatment Course 2|Adverse Event|0|||
163024518|NCT02147158|588791186|FG001|Treatment Course 2|Adverse Event|4|||
163024519|NCT02147158|588791187|FG002|Treatment Course 2|Adverse Event|2|||
163024520|NCT02147158|588791188|FG003|Treatment Course 2|Adverse Event|1|||
163024521|NCT02147158|588791189|FG004|Treatment Course 2|Adverse Event|0|||
163024522|NCT02147158|588791190|FG005|Treatment Course 2|Adverse Event|1|||
163024523|NCT02147158|588791185|FG000|Treatment Course 2|Withdrawal of Consent|0|||
163024524|NCT02147158|588791186|FG001|Treatment Course 2|Withdrawal of Consent|1|||
163024525|NCT02147158|588791187|FG002|Treatment Course 2|Withdrawal of Consent|2|||
163024526|NCT02147158|588791188|FG003|Treatment Course 2|Withdrawal of Consent|3|||
163024527|NCT02147158|588791189|FG004|Treatment Course 2|Withdrawal of Consent|0|||
163024528|NCT02147158|588791190|FG005|Treatment Course 2|Withdrawal of Consent|0|||
163024529|NCT02147158|588791185|FG000|Treatment Course 2|Lost to Follow-up|1|||
163024530|NCT02147158|588791186|FG001|Treatment Course 2|Lost to Follow-up|0|||
163024531|NCT02147158|588791187|FG002|Treatment Course 2|Lost to Follow-up|1|||
163024532|NCT02147158|588791188|FG003|Treatment Course 2|Lost to Follow-up|1|||
163024533|NCT02147158|588791189|FG004|Treatment Course 2|Lost to Follow-up|0|||
163024534|NCT02147158|588791190|FG005|Treatment Course 2|Lost to Follow-up|1|||
163024535|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024536|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
163024537|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
163024538|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024539|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024540|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
163024541|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
163024542|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
163024543|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
163024544|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
163024545|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
163024546|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
163024547|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
163024548|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
163024549|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
163024550|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024551|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024552|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
163024553|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
163024554|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
163024555|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
163024556|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
163024557|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
163024558|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
163024559|NCT02147158|588791185|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
163024560|NCT02147158|588791186|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
163024561|NCT02147158|588791187|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
163024562|NCT02147158|588791188|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
163024563|NCT02147158|588791189|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
163024564|NCT02147158|588791190|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
163024565|NCT04520997|588791191|FG000|Overall Study|Lost to Follow-up|1|||
163024566|NCT04520997|588791192|FG001|Overall Study|Lost to Follow-up|1|||
163024567|NCT04520997|588791191|FG000|Overall Study|Withdrawal by Subject|1|||
163024568|NCT04520997|588791192|FG001|Overall Study|Withdrawal by Subject|0|||
163024569|NCT04520997|588791191|FG000|Overall Study|Not Treated|0|||
163024570|NCT04520997|588791192|FG001|Overall Study|Not Treated|1|||
163024571|NCT03689374|588791193|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
163024572|NCT03689374|588791194|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
163024573|NCT03689374|588791195|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
162643788|NCT02608268|587411740|FG023|Overall Study|Physician Decision|1|||
163024574|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
163024575|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
163024576|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
163024577|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
163024578|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
163024579|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
163024580|NCT03689374|588791193|FG000|Treatment Period (Week 0 to 52)|Death|0|||
163024581|NCT03689374|588791194|FG001|Treatment Period (Week 0 to 52)|Death|11|||
163024582|NCT03689374|588791195|FG002|Treatment Period (Week 0 to 52)|Death|1|||
163024583|NCT05367973|588791196|FG000|Overall Study|Adverse Event|0|||
163024584|NCT05367973|588791197|FG001|Overall Study|Adverse Event|2|||
163024585|NCT00986921|588791198|FG000|Overall Study|Physician Decision|1|||
163024586|NCT00986921|588791199|FG001|Overall Study|Physician Decision|0|||
163024587|NCT01758731|588791200|FG000|Overall Study|Physician Decision|1|||
163024588|NCT04445714|588791201|FG000|Overall Study|Discontinuation of the study|14|||
163024589|NCT04445714|588791201|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
163024590|NCT04445714|588791201|FG000|Overall Study|Withdrawal of Informed Consent|8|||
163024591|NCT02396420|588791206|FG000|Overall Study|Death|1|||
163024592|NCT01273623|588791208|FG000|Overall Study|did not meet IVUS criteria|29|||
163024593|NCT02122887|588791216|FG000|Overall Study|Withdrawal by Subject|20|||
163024594|NCT02122887|588791217|FG001|Overall Study|Withdrawal by Subject|2|||
163024595|NCT03320850|588792671|FG000|Overall Study|Lost to Follow-up|0|||
163024596|NCT03320850|588792672|FG001|Overall Study|Lost to Follow-up|0|||
163024597|NCT03320850|588792673|FG002|Overall Study|Lost to Follow-up|0|||
163024598|NCT03320850|588792674|FG003|Overall Study|Lost to Follow-up|0|||
163024599|NCT03320850|588792675|FG004|Overall Study|Lost to Follow-up|1|||
163024600|NCT03320850|588792676|FG005|Overall Study|Lost to Follow-up|2|||
163024601|NCT03320850|588792677|FG006|Overall Study|Lost to Follow-up|2|||
163024602|NCT03320850|588792678|FG007|Overall Study|Lost to Follow-up|0|||
163024603|NCT03320850|588792679|FG008|Overall Study|Lost to Follow-up|6|||
163024604|NCT03320850|588792680|FG009|Overall Study|Lost to Follow-up|4|||
163024605|NCT03320850|588792671|FG000|Overall Study|Withdrawal by Subject|0|||
163024606|NCT03320850|588792672|FG001|Overall Study|Withdrawal by Subject|0|||
163024607|NCT03320850|588792673|FG002|Overall Study|Withdrawal by Subject|0|||
163024608|NCT03320850|588792674|FG003|Overall Study|Withdrawal by Subject|0|||
163024609|NCT03320850|588792675|FG004|Overall Study|Withdrawal by Subject|1|||
163024610|NCT03320850|588792676|FG005|Overall Study|Withdrawal by Subject|2|||
163024611|NCT03320850|588792677|FG006|Overall Study|Withdrawal by Subject|4|||
163024612|NCT03320850|588792678|FG007|Overall Study|Withdrawal by Subject|5|||
162643789|NCT02608268|587411741|FG024|Overall Study|Physician Decision|1|||
163024613|NCT03320850|588792679|FG008|Overall Study|Withdrawal by Subject|2|||
163024614|NCT03320850|588792680|FG009|Overall Study|Withdrawal by Subject|1|||
163024615|NCT03320850|588792671|FG000|Overall Study|Lack of Efficacy|0|||
163024616|NCT03320850|588792672|FG001|Overall Study|Lack of Efficacy|0|||
163024617|NCT03320850|588792673|FG002|Overall Study|Lack of Efficacy|0|||
163024618|NCT03320850|588792674|FG003|Overall Study|Lack of Efficacy|1|||
163024619|NCT03320850|588792675|FG004|Overall Study|Lack of Efficacy|0|||
163024620|NCT03320850|588792676|FG005|Overall Study|Lack of Efficacy|1|||
163024621|NCT03320850|588792677|FG006|Overall Study|Lack of Efficacy|0|||
163024622|NCT03320850|588792678|FG007|Overall Study|Lack of Efficacy|2|||
163024623|NCT03320850|588792679|FG008|Overall Study|Lack of Efficacy|0|||
163024624|NCT03320850|588792680|FG009|Overall Study|Lack of Efficacy|3|||
163024625|NCT03320850|588792671|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163024626|NCT03320850|588792672|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163024627|NCT03320850|588792673|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163024628|NCT03320850|588792674|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
163024629|NCT03320850|588792675|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
163024630|NCT03320850|588792676|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
163024631|NCT03320850|588792677|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
163024632|NCT03320850|588792678|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
163024633|NCT03320850|588792679|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
163024634|NCT03320850|588792680|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
163024635|NCT03320850|588792671|FG000|Overall Study|Adverse Event|0|||
163024636|NCT03320850|588792672|FG001|Overall Study|Adverse Event|0|||
163024637|NCT03320850|588792673|FG002|Overall Study|Adverse Event|0|||
163024638|NCT03320850|588792674|FG003|Overall Study|Adverse Event|0|||
163024639|NCT03320850|588792675|FG004|Overall Study|Adverse Event|0|||
163024640|NCT03320850|588792676|FG005|Overall Study|Adverse Event|2|||
163024641|NCT03320850|588792677|FG006|Overall Study|Adverse Event|1|||
163024642|NCT03320850|588792678|FG007|Overall Study|Adverse Event|0|||
163024643|NCT03320850|588792679|FG008|Overall Study|Adverse Event|2|||
163024644|NCT03320850|588792680|FG009|Overall Study|Adverse Event|0|||
163024645|NCT03320850|588792671|FG000|Overall Study|Reason Not Specified|0|||
163024646|NCT03320850|588792672|FG001|Overall Study|Reason Not Specified|0|||
163024647|NCT03320850|588792673|FG002|Overall Study|Reason Not Specified|0|||
163024648|NCT03320850|588792674|FG003|Overall Study|Reason Not Specified|0|||
163024649|NCT03320850|588792675|FG004|Overall Study|Reason Not Specified|0|||
163024650|NCT03320850|588792676|FG005|Overall Study|Reason Not Specified|1|||
163024651|NCT03320850|588792677|FG006|Overall Study|Reason Not Specified|0|||
163024652|NCT03320850|588792678|FG007|Overall Study|Reason Not Specified|0|||
163024653|NCT03320850|588792679|FG008|Overall Study|Reason Not Specified|0|||
163024654|NCT03320850|588792680|FG009|Overall Study|Reason Not Specified|1|||
163024655|NCT02002533|588792683|FG000|Overall Study|Withdrawal by Subject|6|||
163024656|NCT02002533|588792684|FG001|Overall Study|Withdrawal by Subject|13|||
163024657|NCT02002533|588792683|FG000|Overall Study|Protocol Violation|0|||
163024658|NCT02002533|588792684|FG001|Overall Study|Protocol Violation|1|||
163024659|NCT02002533|588792683|FG000|Overall Study|Adverse Event|0|||
163024660|NCT02002533|588792684|FG001|Overall Study|Adverse Event|3|||
163024661|NCT02002533|588792683|FG000|Overall Study|Lost to Follow-up|0|||
163024662|NCT02002533|588792684|FG001|Overall Study|Lost to Follow-up|1|||
163024663|NCT02086448|588792690|FG000|Overall Study|Withdrawal by Subject|1|||
163024664|NCT02086448|588792691|FG001|Overall Study|Withdrawal by Subject|0|||
163024665|NCT02086448|588792692|FG002|Overall Study|Withdrawal by Subject|0|||
163024666|NCT02086448|588792693|FG003|Overall Study|Withdrawal by Subject|2|||
163024667|NCT02031640|588792702|FG000|Screening Period|Adverse Event|1|||
163024668|NCT02031640|588792703|FG001|Screening Period|Adverse Event|0|||
163024669|NCT02031640|588792704|FG002|Screening Period|Adverse Event|0|||
163024670|NCT02031640|588792705|FG003|Screening Period|Adverse Event|0|||
163024671|NCT02031640|588792706|FG004|Screening Period|Adverse Event|0|||
163024672|NCT02031640|588792707|FG005|Screening Period|Adverse Event|0|||
163024673|NCT02031640|588792702|FG000|Screening Period|Withdrawal by Subject|29|||
163024674|NCT02031640|588792703|FG001|Screening Period|Withdrawal by Subject|0|||
162643790|NCT02608268|587411742|FG025|Overall Study|Physician Decision|0|||
162643791|NCT02608268|587411743|FG026|Overall Study|Physician Decision|0|||
163024675|NCT02031640|588792704|FG002|Screening Period|Withdrawal by Subject|0|||
163024676|NCT02031640|588792705|FG003|Screening Period|Withdrawal by Subject|0|||
163024677|NCT02031640|588792706|FG004|Screening Period|Withdrawal by Subject|0|||
163024678|NCT02031640|588792707|FG005|Screening Period|Withdrawal by Subject|0|||
163024679|NCT02031640|588792702|FG000|Screening Period|Inclusion criteria not met|312|||
163024680|NCT02031640|588792703|FG001|Screening Period|Inclusion criteria not met|0|||
163024681|NCT02031640|588792704|FG002|Screening Period|Inclusion criteria not met|0|||
162643792|NCT02608268|587411744|FG027|Overall Study|Physician Decision|2|||
162643793|NCT02608268|587411745|FG028|Overall Study|Physician Decision|1|||
163024682|NCT02031640|588792705|FG003|Screening Period|Inclusion criteria not met|0|||
163024683|NCT02031640|588792706|FG004|Screening Period|Inclusion criteria not met|0|||
163024684|NCT02031640|588792707|FG005|Screening Period|Inclusion criteria not met|0|||
163064284|NCT00831844|588941596|FG008|Overall Study|Physician Decision|1|||
163064285|NCT00831844|588941597|FG009|Overall Study|Physician Decision|0|||
163064286|NCT00831844|588941588|FG000|Overall Study|Withdrawal by Subject|0|||
163064287|NCT00831844|588941589|FG001|Overall Study|Withdrawal by Subject|0|||
163064288|NCT00831844|588941590|FG002|Overall Study|Withdrawal by Subject|1|||
163064289|NCT00831844|588941591|FG003|Overall Study|Withdrawal by Subject|0|||
163064290|NCT00831844|588941592|FG004|Overall Study|Withdrawal by Subject|0|||
163064291|NCT00831844|588941593|FG005|Overall Study|Withdrawal by Subject|0|||
163064292|NCT00831844|588941594|FG006|Overall Study|Withdrawal by Subject|0|||
163064293|NCT00831844|588941595|FG007|Overall Study|Withdrawal by Subject|1|||
163064294|NCT00831844|588941596|FG008|Overall Study|Withdrawal by Subject|1|||
163064295|NCT00831844|588941597|FG009|Overall Study|Withdrawal by Subject|0|||
163064296|NCT00831844|588941588|FG000|Overall Study|Ineligible|0|||
163064297|NCT00831844|588941589|FG001|Overall Study|Ineligible|1|||
163064298|NCT00831844|588941590|FG002|Overall Study|Ineligible|1|||
163064299|NCT00831844|588941591|FG003|Overall Study|Ineligible|0|||
163064300|NCT00831844|588941592|FG004|Overall Study|Ineligible|1|||
163064301|NCT00831844|588941593|FG005|Overall Study|Ineligible|0|||
163064302|NCT00831844|588941594|FG006|Overall Study|Ineligible|0|||
163064303|NCT00831844|588941595|FG007|Overall Study|Ineligible|0|||
163064304|NCT00831844|588941596|FG008|Overall Study|Ineligible|0|||
163064305|NCT00831844|588941597|FG009|Overall Study|Ineligible|0|||
163064306|NCT03980223|588941600|FG000|Overall Study|Lost to Follow-up|3|||
163064307|NCT03980223|588941601|FG001|Overall Study|Lost to Follow-up|7|||
163064308|NCT03980223|588941602|FG002|Overall Study|Lost to Follow-up|10|||
163064309|NCT03980223|588941603|FG003|Overall Study|Lost to Follow-up|8|||
163064310|NCT03980223|588941600|FG000|Overall Study|Withdrawal by Subject|0|||
163064311|NCT03980223|588941601|FG001|Overall Study|Withdrawal by Subject|0|||
163064312|NCT03980223|588941602|FG002|Overall Study|Withdrawal by Subject|1|||
163064313|NCT03980223|588941603|FG003|Overall Study|Withdrawal by Subject|2|||
163064314|NCT03980223|588941600|FG000|Overall Study|Physician Decision|0|||
163064315|NCT03980223|588941601|FG001|Overall Study|Physician Decision|0|||
163064316|NCT03980223|588941602|FG002|Overall Study|Physician Decision|1|||
163064317|NCT03980223|588941603|FG003|Overall Study|Physician Decision|0|||
163064318|NCT03980223|588941600|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
163064319|NCT03980223|588941601|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
163064320|NCT03980223|588941602|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
163064321|NCT03980223|588941603|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
163064322|NCT02460289|588941607|FG000|Overall Study|Adverse Event|1|||
163064323|NCT02460289|588941607|FG000|Overall Study|Withdrawal by Subject|8|||
163064324|NCT02460289|588941607|FG000|Overall Study|Lost to Follow-up|1|||
163064325|NCT02916927|588941608|FG000|Overall Study|Discharged prior to study drug receipt|0|||
163064326|NCT02916927|588941609|FG001|Overall Study|Discharged prior to study drug receipt|2|||
163064327|NCT02916927|588941608|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
163064328|NCT02916927|588941609|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
163064329|NCT02916927|588941608|FG000|Overall Study|Withdrawal before first time point|1|||
163064330|NCT02916927|588941609|FG001|Overall Study|Withdrawal before first time point|0|||
163064331|NCT01020123|588941610|FG000|Main Period|Withdrawal by Subject|6|||
163064332|NCT01020123|588941611|FG001|Main Period|Withdrawal by Subject|5|||
163064333|NCT01020123|588941612|FG002|Main Period|Withdrawal by Subject|3|||
163064334|NCT01020123|588941613|FG003|Main Period|Withdrawal by Subject|1|||
163064335|NCT01020123|588941614|FG004|Main Period|Withdrawal by Subject|6|||
163064336|NCT01020123|588941615|FG005|Main Period|Withdrawal by Subject|3|||
163064337|NCT01020123|588941616|FG006|Main Period|Withdrawal by Subject|2|||
163064338|NCT01020123|588941610|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
163064339|NCT01020123|588941611|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
163064340|NCT01020123|588941612|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
163064341|NCT01020123|588941613|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
163064342|NCT01020123|588941614|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
163064343|NCT01020123|588941615|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
163064344|NCT01020123|588941616|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
163064345|NCT01020123|588941610|FG000|Main Period|Adverse Event|5|||
163064346|NCT01020123|588941611|FG001|Main Period|Adverse Event|2|||
163064347|NCT01020123|588941612|FG002|Main Period|Adverse Event|2|||
163064348|NCT01020123|588941613|FG003|Main Period|Adverse Event|1|||
163064349|NCT01020123|588941614|FG004|Main Period|Adverse Event|1|||
163064350|NCT01020123|588941615|FG005|Main Period|Adverse Event|2|||
163064351|NCT01020123|588941616|FG006|Main Period|Adverse Event|1|||
163064352|NCT01020123|588941610|FG000|Main Period|Protocol Violation|4|||
163064353|NCT01020123|588941611|FG001|Main Period|Protocol Violation|4|||
163064354|NCT01020123|588941612|FG002|Main Period|Protocol Violation|2|||
163064355|NCT01020123|588941613|FG003|Main Period|Protocol Violation|5|||
163064356|NCT01020123|588941614|FG004|Main Period|Protocol Violation|2|||
163064357|NCT01020123|588941615|FG005|Main Period|Protocol Violation|3|||
163064358|NCT01020123|588941616|FG006|Main Period|Protocol Violation|2|||
163064359|NCT01020123|588941610|FG000|Main Period|Lost to Follow-up|0|||
163024685|NCT02031640|588792702|FG000|Screening Period|Exclusion criteria met|30|||
163024686|NCT02031640|588792703|FG001|Screening Period|Exclusion criteria met|0|||
163024687|NCT02031640|588792704|FG002|Screening Period|Exclusion criteria met|0|||
163024688|NCT02031640|588792705|FG003|Screening Period|Exclusion criteria met|0|||
163024689|NCT02031640|588792706|FG004|Screening Period|Exclusion criteria met|0|||
163024690|NCT02031640|588792707|FG005|Screening Period|Exclusion criteria met|0|||
163024691|NCT02031640|588792702|FG000|Screening Period|Lost to Follow-up|14|||
163024692|NCT02031640|588792703|FG001|Screening Period|Lost to Follow-up|0|||
163024693|NCT02031640|588792704|FG002|Screening Period|Lost to Follow-up|0|||
163024694|NCT02031640|588792705|FG003|Screening Period|Lost to Follow-up|0|||
163024695|NCT02031640|588792706|FG004|Screening Period|Lost to Follow-up|0|||
163024696|NCT02031640|588792707|FG005|Screening Period|Lost to Follow-up|0|||
163024697|NCT02031640|588792702|FG000|Screening Period|Enrollment closed|26|||
163024698|NCT02031640|588792703|FG001|Screening Period|Enrollment closed|0|||
163024699|NCT02031640|588792704|FG002|Screening Period|Enrollment closed|0|||
163024700|NCT02031640|588792705|FG003|Screening Period|Enrollment closed|0|||
163024701|NCT02031640|588792706|FG004|Screening Period|Enrollment closed|0|||
163024702|NCT02031640|588792707|FG005|Screening Period|Enrollment closed|0|||
163024703|NCT02031640|588792702|FG000|Run-In Period|Adverse Event|4|||
163024704|NCT02031640|588792703|FG001|Run-In Period|Adverse Event|0|||
163024705|NCT02031640|588792704|FG002|Run-In Period|Adverse Event|0|||
163024706|NCT02031640|588792705|FG003|Run-In Period|Adverse Event|0|||
163024707|NCT02031640|588792706|FG004|Run-In Period|Adverse Event|0|||
163024708|NCT02031640|588792707|FG005|Run-In Period|Adverse Event|0|||
163024709|NCT02031640|588792702|FG000|Run-In Period|Withdrawal by Subject|17|||
163024710|NCT02031640|588792703|FG001|Run-In Period|Withdrawal by Subject|0|||
163024711|NCT02031640|588792704|FG002|Run-In Period|Withdrawal by Subject|0|||
163024712|NCT02031640|588792705|FG003|Run-In Period|Withdrawal by Subject|0|||
163024713|NCT02031640|588792706|FG004|Run-In Period|Withdrawal by Subject|0|||
163024714|NCT02031640|588792707|FG005|Run-In Period|Withdrawal by Subject|0|||
163024715|NCT02031640|588792702|FG000|Run-In Period|Inclusion criteria not met|38|||
163024716|NCT02031640|588792703|FG001|Run-In Period|Inclusion criteria not met|0|||
163024717|NCT02031640|588792704|FG002|Run-In Period|Inclusion criteria not met|0|||
163024718|NCT02031640|588792705|FG003|Run-In Period|Inclusion criteria not met|0|||
163024719|NCT02031640|588792706|FG004|Run-In Period|Inclusion criteria not met|0|||
163024720|NCT02031640|588792707|FG005|Run-In Period|Inclusion criteria not met|0|||
163024721|NCT02031640|588792702|FG000|Run-In Period|Exclusion criteria met|8|||
163024722|NCT02031640|588792703|FG001|Run-In Period|Exclusion criteria met|0|||
163024723|NCT02031640|588792704|FG002|Run-In Period|Exclusion criteria met|0|||
163024724|NCT02031640|588792705|FG003|Run-In Period|Exclusion criteria met|0|||
163024725|NCT02031640|588792706|FG004|Run-In Period|Exclusion criteria met|0|||
163024726|NCT02031640|588792707|FG005|Run-In Period|Exclusion criteria met|0|||
163024727|NCT02031640|588792702|FG000|Run-In Period|Randomization criteria not met|85|||
163024728|NCT02031640|588792703|FG001|Run-In Period|Randomization criteria not met|0|||
163024729|NCT02031640|588792704|FG002|Run-In Period|Randomization criteria not met|0|||
163024730|NCT02031640|588792705|FG003|Run-In Period|Randomization criteria not met|0|||
163024731|NCT02031640|588792706|FG004|Run-In Period|Randomization criteria not met|0|||
163024732|NCT02031640|588792707|FG005|Run-In Period|Randomization criteria not met|0|||
163024733|NCT02031640|588792702|FG000|Run-In Period|Various administrative reasons|17|||
163024734|NCT02031640|588792703|FG001|Run-In Period|Various administrative reasons|0|||
163024735|NCT02031640|588792704|FG002|Run-In Period|Various administrative reasons|0|||
163024736|NCT02031640|588792705|FG003|Run-In Period|Various administrative reasons|0|||
163024737|NCT02031640|588792706|FG004|Run-In Period|Various administrative reasons|0|||
163024738|NCT02031640|588792707|FG005|Run-In Period|Various administrative reasons|0|||
163024739|NCT02031640|588792702|FG000|Double-blind Treatment Period|Protocol deviation|0|||
163024740|NCT02031640|588792703|FG001|Double-blind Treatment Period|Protocol deviation|2|||
163024741|NCT02031640|588792704|FG002|Double-blind Treatment Period|Protocol deviation|0|||
163024742|NCT02031640|588792705|FG003|Double-blind Treatment Period|Protocol deviation|1|||
163024743|NCT02031640|588792706|FG004|Double-blind Treatment Period|Protocol deviation|3|||
163024744|NCT02031640|588792707|FG005|Double-blind Treatment Period|Protocol deviation|1|||
162643794|NCT02608268|587411746|FG029|Overall Study|Physician Decision|1|||
162643795|NCT02608268|587411717|FG000|Overall Study|Progressive disease|12|||
162643796|NCT02608268|587411718|FG001|Overall Study|Progressive disease|8|||
163024745|NCT02031640|588792702|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163024746|NCT02031640|588792703|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
163024747|NCT02031640|588792704|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
163024748|NCT02031640|588792705|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
163024749|NCT02031640|588792706|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
162643797|NCT02608268|587411719|FG002|Overall Study|Progressive disease|13|||
162643798|NCT02608268|587411720|FG003|Overall Study|Progressive disease|5|||
163024750|NCT02031640|588792707|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
163024751|NCT02031640|588792702|FG000|Double-blind Treatment Period|Non-compliance|0|||
163024752|NCT02031640|588792703|FG001|Double-blind Treatment Period|Non-compliance|1|||
163064360|NCT01020123|588941611|FG001|Main Period|Lost to Follow-up|2|||
163064361|NCT01020123|588941612|FG002|Main Period|Lost to Follow-up|0|||
163064362|NCT01020123|588941613|FG003|Main Period|Lost to Follow-up|0|||
163064363|NCT01020123|588941614|FG004|Main Period|Lost to Follow-up|0|||
163064364|NCT01020123|588941615|FG005|Main Period|Lost to Follow-up|0|||
163064365|NCT01020123|588941616|FG006|Main Period|Lost to Follow-up|0|||
163064366|NCT01020123|588941610|FG000|Main Period|Unclasified|2|||
163064367|NCT01020123|588941611|FG001|Main Period|Unclasified|0|||
163064368|NCT01020123|588941612|FG002|Main Period|Unclasified|1|||
163064369|NCT01020123|588941613|FG003|Main Period|Unclasified|0|||
163064370|NCT01020123|588941614|FG004|Main Period|Unclasified|1|||
163064371|NCT01020123|588941615|FG005|Main Period|Unclasified|3|||
163064372|NCT01020123|588941616|FG006|Main Period|Unclasified|6|||
163064373|NCT01020123|588941610|FG000|Extention Period|Withdrawal by Subject|2|||
163064374|NCT01020123|588941611|FG001|Extention Period|Withdrawal by Subject|1|||
163064375|NCT01020123|588941612|FG002|Extention Period|Withdrawal by Subject|1|||
163064376|NCT01020123|588941613|FG003|Extention Period|Withdrawal by Subject|0|||
163064377|NCT01020123|588941614|FG004|Extention Period|Withdrawal by Subject|0|||
163064378|NCT01020123|588941615|FG005|Extention Period|Withdrawal by Subject|0|||
163064379|NCT01020123|588941616|FG006|Extention Period|Withdrawal by Subject|0|||
163064380|NCT01020123|588941610|FG000|Extention Period|Adverse Event|0|||
163064381|NCT01020123|588941611|FG001|Extention Period|Adverse Event|0|||
163064382|NCT01020123|588941612|FG002|Extention Period|Adverse Event|0|||
163064383|NCT01020123|588941613|FG003|Extention Period|Adverse Event|1|||
163064384|NCT01020123|588941614|FG004|Extention Period|Adverse Event|0|||
163064385|NCT01020123|588941615|FG005|Extention Period|Adverse Event|0|||
163064386|NCT01020123|588941616|FG006|Extention Period|Adverse Event|0|||
163064387|NCT01020123|588941610|FG000|Extention Period|Protocol Violation|1|||
163064388|NCT01020123|588941611|FG001|Extention Period|Protocol Violation|1|||
163064389|NCT01020123|588941612|FG002|Extention Period|Protocol Violation|1|||
163064390|NCT01020123|588941613|FG003|Extention Period|Protocol Violation|0|||
163064391|NCT01020123|588941614|FG004|Extention Period|Protocol Violation|0|||
163064392|NCT01020123|588941615|FG005|Extention Period|Protocol Violation|0|||
163064393|NCT01020123|588941616|FG006|Extention Period|Protocol Violation|1|||
163064394|NCT01020123|588941610|FG000|Extention Period|Lost to Follow-up|0|||
163064395|NCT01020123|588941611|FG001|Extention Period|Lost to Follow-up|0|||
163064396|NCT01020123|588941612|FG002|Extention Period|Lost to Follow-up|0|||
163064397|NCT01020123|588941613|FG003|Extention Period|Lost to Follow-up|0|||
163064398|NCT01020123|588941614|FG004|Extention Period|Lost to Follow-up|0|||
163064399|NCT01020123|588941615|FG005|Extention Period|Lost to Follow-up|2|||
163064400|NCT01020123|588941616|FG006|Extention Period|Lost to Follow-up|0|||
163064401|NCT01349595|588941617|FG000|Overall Study|Lack of funding|2|||
163064402|NCT01349595|588941618|FG001|Overall Study|Lack of funding|2|||
163064403|NCT03479905|588941621|FG000|Overall Study|Other airway method used|4|||
163064404|NCT03479905|588941622|FG001|Overall Study|Other airway method used|5|||
163064405|NCT03479905|588941623|FG002|Overall Study|Other airway method used|5|||
163064406|NCT01706328|588941628|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
163064407|NCT01706328|588941629|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163064408|NCT01706328|588941630|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163064409|NCT01706328|588941628|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
163064410|NCT01706328|588941629|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163064411|NCT01706328|588941630|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163064412|NCT01706328|588941628|FG000|2-week Run-in Period|Physician Decision|4|||
163064413|NCT01706328|588941629|FG001|2-week Run-in Period|Physician Decision|0|||
163064414|NCT01706328|588941630|FG002|2-week Run-in Period|Physician Decision|0|||
163064415|NCT01706328|588941628|FG000|2-week Run-in Period|Adverse Event|4|||
163064416|NCT01706328|588941629|FG001|2-week Run-in Period|Adverse Event|0|||
163064417|NCT01706328|588941630|FG002|2-week Run-in Period|Adverse Event|0|||
163064418|NCT01706328|588941628|FG000|2-week Run-in Period|Lost to Follow-up|2|||
163064419|NCT01706328|588941629|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163064420|NCT01706328|588941630|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163064421|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
163064422|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
163064423|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
163064424|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
163064425|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
163064426|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
163064427|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
163064428|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
163064429|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
163064430|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
163064431|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
163064432|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
163064433|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
163064434|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
162643799|NCT02608268|587411721|FG004|Overall Study|Progressive disease|2|||
162643800|NCT02608268|587411722|FG005|Overall Study|Progressive disease|4|||
162643801|NCT02608268|587411723|FG006|Overall Study|Progressive disease|6|||
162643802|NCT02608268|587411724|FG007|Overall Study|Progressive disease|2|||
162643803|NCT02608268|587411725|FG008|Overall Study|Progressive disease|5|||
162643804|NCT02608268|587411726|FG009|Overall Study|Progressive disease|6|||
162643805|NCT02608268|587411727|FG010|Overall Study|Progressive disease|5|||
162643806|NCT02608268|587411728|FG011|Overall Study|Progressive disease|5|||
162643807|NCT02608268|587411729|FG012|Overall Study|Progressive disease|4|||
162643808|NCT02608268|587411730|FG013|Overall Study|Progressive disease|11|||
162643809|NCT02608268|587411731|FG014|Overall Study|Progressive disease|6|||
162643810|NCT02608268|587411732|FG015|Overall Study|Progressive disease|3|||
162643811|NCT02608268|587411733|FG016|Overall Study|Progressive disease|5|||
163024753|NCT02031640|588792704|FG002|Double-blind Treatment Period|Non-compliance|0|||
163024754|NCT02031640|588792705|FG003|Double-blind Treatment Period|Non-compliance|1|||
163024755|NCT02031640|588792706|FG004|Double-blind Treatment Period|Non-compliance|1|||
163024756|NCT02031640|588792707|FG005|Double-blind Treatment Period|Non-compliance|0|||
163024757|NCT02031640|588792702|FG000|Double-blind Treatment Period|Adverse Event|0|||
163024758|NCT02031640|588792703|FG001|Double-blind Treatment Period|Adverse Event|0|||
163024759|NCT02031640|588792704|FG002|Double-blind Treatment Period|Adverse Event|0|||
163024760|NCT02031640|588792705|FG003|Double-blind Treatment Period|Adverse Event|2|||
163024761|NCT02031640|588792706|FG004|Double-blind Treatment Period|Adverse Event|0|||
163024762|NCT02031640|588792707|FG005|Double-blind Treatment Period|Adverse Event|0|||
163024763|NCT02031640|588792702|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163024764|NCT02031640|588792703|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163024765|NCT02031640|588792704|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
163024766|NCT02031640|588792705|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024767|NCT02031640|588792706|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024768|NCT02031640|588792707|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
163024769|NCT02031640|588792702|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163024770|NCT02031640|588792703|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
163024771|NCT02031640|588792704|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163024772|NCT02031640|588792705|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163024773|NCT02031640|588792706|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
163024774|NCT02031640|588792707|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
163024775|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
163024776|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
163024777|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
163024778|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
163024779|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
163024780|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
163024781|NCT01895270|588792712|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
163024782|NCT01895270|588792713|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
163024783|NCT01895270|588792712|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
163024784|NCT01895270|588792713|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
163024785|NCT01895270|588792712|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
163024786|NCT01895270|588792713|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
163024787|NCT01895270|588792712|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
163024788|NCT01895270|588792713|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
163024789|NCT02091375|588792716|FG000|Overall Study|Adverse Event|8|||
163024790|NCT02091375|588792717|FG001|Overall Study|Adverse Event|1|||
163024791|NCT02091375|588792716|FG000|Overall Study|Lost to Follow-up|0|||
163024792|NCT02091375|588792717|FG001|Overall Study|Lost to Follow-up|1|||
163024793|NCT02091375|588792716|FG000|Overall Study|Withdrawal by Subject|0|||
163024794|NCT02091375|588792717|FG001|Overall Study|Withdrawal by Subject|1|||
163024795|NCT02091375|588792716|FG000|Overall Study|Withdrawn by the investigator|1|||
163024796|NCT02091375|588792717|FG001|Overall Study|Withdrawn by the investigator|0|||
163024797|NCT04720911|588792719|FG000|Overall Study|Withdrawal by Subject|0|||
163024798|NCT04720911|588792720|FG001|Overall Study|Withdrawal by Subject|1|||
163024799|NCT04720911|588792721|FG002|Overall Study|Withdrawal by Subject|0|||
163024800|NCT00537316|588792723|FG000|Part 1|Adverse Event|7|||
163024801|NCT00537316|588792724|FG001|Part 1|Adverse Event|11|||
163024802|NCT00537316|588792725|FG002|Part 1|Adverse Event|8|||
163024803|NCT00537316|588792726|FG003|Part 1|Adverse Event|0|||
163024804|NCT00537316|588792727|FG004|Part 1|Adverse Event|0|||
163024805|NCT00537316|588792728|FG005|Part 1|Adverse Event|0|||
163024806|NCT00537316|588792729|FG006|Part 1|Adverse Event|0|||
163024807|NCT00537316|588792723|FG000|Part 1|Protocol defined clinical event|1|||
163024808|NCT00537316|588792724|FG001|Part 1|Protocol defined clinical event|0|||
163024809|NCT00537316|588792725|FG002|Part 1|Protocol defined clinical event|0|||
163024810|NCT00537316|588792726|FG003|Part 1|Protocol defined clinical event|0|||
162643812|NCT02608268|587411734|FG017|Overall Study|Progressive disease|5|||
163024811|NCT00537316|588792727|FG004|Part 1|Protocol defined clinical event|0|||
163064435|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
163064436|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
163064437|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
162643813|NCT02608268|587411735|FG018|Overall Study|Progressive disease|5|||
162643814|NCT02608268|587411736|FG019|Overall Study|Progressive disease|2|||
162643815|NCT02608268|587411737|FG020|Overall Study|Progressive disease|10|||
162643816|NCT02608268|587411738|FG021|Overall Study|Progressive disease|4|||
163064438|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
163064439|NCT01706328|588941628|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163064440|NCT01706328|588941629|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
163064441|NCT01706328|588941630|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
163064442|NCT06481579|588941632|FG000|Overall Study|Death|1|||
163064443|NCT06481579|588941633|FG001|Overall Study|Death|0|||
163064444|NCT06481579|588941632|FG000|Overall Study|Withdrawal by Subject|3|||
163064445|NCT06481579|588941633|FG001|Overall Study|Withdrawal by Subject|0|||
163064446|NCT06481579|588941632|FG000|Overall Study|Other|1|||
163064447|NCT06481579|588941633|FG001|Overall Study|Other|1|||
163064448|NCT04584788|588941634|FG000|Overall Study|Physician Decision|8|||
163064449|NCT04584788|588941634|FG000|Overall Study|Withdrawal by Subject|1|||
163064450|NCT04584788|588941634|FG000|Overall Study|Adverse Event|3|||
163064451|NCT03311555|588941635|FG000|Overall Study|Adverse Event|1|||
163064452|NCT04284774|588941637|FG000|Overall Study|Progressive disease|5|||
163064453|NCT01240746|588943494|FG000|Overall Study|Adverse Event|2|||
163064454|NCT01240746|588943495|FG001|Overall Study|Adverse Event|0|||
163064455|NCT01240746|588943496|FG002|Overall Study|Adverse Event|10|||
163064456|NCT01240746|588943494|FG000|Overall Study|Lost to Follow-up|23|||
163064457|NCT01240746|588943495|FG001|Overall Study|Lost to Follow-up|20|||
163064458|NCT01240746|588943496|FG002|Overall Study|Lost to Follow-up|102|||
163064459|NCT01240746|588943494|FG000|Overall Study|Protocol Violation|24|||
163064460|NCT01240746|588943495|FG001|Overall Study|Protocol Violation|15|||
163064461|NCT01240746|588943496|FG002|Overall Study|Protocol Violation|72|||
163064462|NCT01240746|588943494|FG000|Overall Study|Withdrawal by Subject|10|||
163064463|NCT01240746|588943495|FG001|Overall Study|Withdrawal by Subject|13|||
163064464|NCT01240746|588943496|FG002|Overall Study|Withdrawal by Subject|59|||
163064465|NCT01136954|588943497|FG000|Overall Study|Adverse Event|3|||
163064466|NCT01136954|588943498|FG001|Overall Study|Adverse Event|2|||
163064467|NCT01136954|588943497|FG000|Overall Study|Withdrawal by Subject|6|||
163064468|NCT01136954|588943498|FG001|Overall Study|Withdrawal by Subject|2|||
163064469|NCT01136954|588943497|FG000|Overall Study|Lack of Efficacy|14|||
163064470|NCT01136954|588943498|FG001|Overall Study|Lack of Efficacy|13|||
163064471|NCT01136954|588943497|FG000|Overall Study|Physician Decision|0|||
163064472|NCT01136954|588943498|FG001|Overall Study|Physician Decision|1|||
163064473|NCT01136954|588943497|FG000|Overall Study|Other|1|||
163064474|NCT01136954|588943498|FG001|Overall Study|Other|3|||
163064475|NCT04190225|588943516|FG000|Overall Study|Lost to Follow-up|2|||
163064476|NCT04190225|588943517|FG001|Overall Study|Lost to Follow-up|3|||
163064477|NCT04190225|588943516|FG000|Overall Study|Withdrawal by Subject|3|||
163064478|NCT04190225|588943517|FG001|Overall Study|Withdrawal by Subject|2|||
163064479|NCT04190225|588943516|FG000|Overall Study|Unrelated health condition|2|||
163064480|NCT04190225|588943517|FG001|Overall Study|Unrelated health condition|0|||
163064481|NCT01732783|588943520|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
163064482|NCT01732783|588943521|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
163064483|NCT01732783|588943522|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
163064484|NCT01732783|588943520|FG000|Overall Study|Death|13|||
163064485|NCT01732783|588943521|FG001|Overall Study|Death|4|||
163064486|NCT01732783|588943522|FG002|Overall Study|Death|1|||
162643817|NCT02608268|587411739|FG022|Overall Study|Progressive disease|5|||
163064487|NCT01732783|588943520|FG000|Overall Study|Lost to Follow-up|7|||
163064488|NCT01732783|588943521|FG001|Overall Study|Lost to Follow-up|1|||
163064489|NCT01732783|588943522|FG002|Overall Study|Lost to Follow-up|1|||
163064490|NCT01732783|588943520|FG000|Overall Study|Administrative Decision|8|||
163064491|NCT01732783|588943521|FG001|Overall Study|Administrative Decision|2|||
163064492|NCT01732783|588943522|FG002|Overall Study|Administrative Decision|1|||
163064493|NCT01732783|588943520|FG000|Overall Study|Withdrawal by Subject|1|||
163064494|NCT01732783|588943521|FG001|Overall Study|Withdrawal by Subject|0|||
163064495|NCT01732783|588943522|FG002|Overall Study|Withdrawal by Subject|0|||
163064496|NCT02239328|588943523|FG000|Overall Study|Benign disease noted at time of surgery|6|||
163064497|NCT02239328|588943523|FG000|Overall Study|Equipment or website malfunction|2|||
163064498|NCT04429971|588943525|FG000|Overall Study|Lost to Follow-up|7|||
163064499|NCT04429971|588943526|FG001|Overall Study|Lost to Follow-up|8|||
163064500|NCT03331562|588943527|FG000|Overall Study|Adverse Event|2|||
162643818|NCT02608268|587411740|FG023|Overall Study|Progressive disease|5|||
163064501|NCT03331562|588943528|FG001|Overall Study|Adverse Event|0|||
163064502|NCT03331562|588943527|FG000|Overall Study|Death|1|||
163064503|NCT03331562|588943528|FG001|Overall Study|Death|0|||
163064504|NCT03718000|588943536|FG000|Overall Study|Relocation|2|||
162643819|NCT02608268|587411741|FG024|Overall Study|Progressive disease|3|||
163064505|NCT03718000|588943537|FG001|Overall Study|Relocation|4|||
162643820|NCT02608268|587411742|FG025|Overall Study|Progressive disease|11|||
162643821|NCT02608268|587411743|FG026|Overall Study|Progressive disease|16|||
162643822|NCT02608268|587411744|FG027|Overall Study|Progressive disease|11|||
162643823|NCT02608268|587411745|FG028|Overall Study|Progressive disease|10|||
162643824|NCT02608268|587411746|FG029|Overall Study|Progressive disease|15|||
162643825|NCT02608268|587411717|FG000|Overall Study|Subject/guardian decision|1|||
162643826|NCT02608268|587411718|FG001|Overall Study|Subject/guardian decision|1|||
162643827|NCT02608268|587411719|FG002|Overall Study|Subject/guardian decision|2|||
162643828|NCT02608268|587411720|FG003|Overall Study|Subject/guardian decision|0|||
162643829|NCT02608268|587411721|FG004|Overall Study|Subject/guardian decision|0|||
162643830|NCT02608268|587411722|FG005|Overall Study|Subject/guardian decision|0|||
162643831|NCT02608268|587411723|FG006|Overall Study|Subject/guardian decision|0|||
163024812|NCT00537316|588792728|FG005|Part 1|Protocol defined clinical event|0|||
163024813|NCT00537316|588792729|FG006|Part 1|Protocol defined clinical event|0|||
163024814|NCT00537316|588792723|FG000|Part 1|Lost to Follow-up|1|||
163024815|NCT00537316|588792724|FG001|Part 1|Lost to Follow-up|0|||
163024816|NCT00537316|588792725|FG002|Part 1|Lost to Follow-up|0|||
163024817|NCT00537316|588792726|FG003|Part 1|Lost to Follow-up|0|||
163024818|NCT00537316|588792727|FG004|Part 1|Lost to Follow-up|0|||
163024819|NCT00537316|588792728|FG005|Part 1|Lost to Follow-up|0|||
163024820|NCT00537316|588792729|FG006|Part 1|Lost to Follow-up|0|||
163024821|NCT00537316|588792723|FG000|Part 1|Withdrawal by Subject|3|||
163024822|NCT00537316|588792724|FG001|Part 1|Withdrawal by Subject|8|||
163024823|NCT00537316|588792725|FG002|Part 1|Withdrawal by Subject|4|||
163024824|NCT00537316|588792726|FG003|Part 1|Withdrawal by Subject|0|||
163024825|NCT00537316|588792727|FG004|Part 1|Withdrawal by Subject|0|||
163024826|NCT00537316|588792728|FG005|Part 1|Withdrawal by Subject|0|||
163024827|NCT00537316|588792729|FG006|Part 1|Withdrawal by Subject|0|||
163024828|NCT00537316|588792723|FG000|Part 1|Protocol Violation|1|||
163024829|NCT00537316|588792724|FG001|Part 1|Protocol Violation|5|||
163024830|NCT00537316|588792725|FG002|Part 1|Protocol Violation|1|||
163024831|NCT00537316|588792726|FG003|Part 1|Protocol Violation|0|||
163024832|NCT00537316|588792727|FG004|Part 1|Protocol Violation|0|||
163024833|NCT00537316|588792728|FG005|Part 1|Protocol Violation|0|||
163024834|NCT00537316|588792729|FG006|Part 1|Protocol Violation|0|||
163024835|NCT00537316|588792723|FG000|Part 1|Did not meet protocol eligibility|1|||
163024836|NCT00537316|588792724|FG001|Part 1|Did not meet protocol eligibility|3|||
163024837|NCT00537316|588792725|FG002|Part 1|Did not meet protocol eligibility|2|||
163024838|NCT00537316|588792726|FG003|Part 1|Did not meet protocol eligibility|0|||
163024839|NCT00537316|588792727|FG004|Part 1|Did not meet protocol eligibility|0|||
163024840|NCT00537316|588792728|FG005|Part 1|Did not meet protocol eligibility|0|||
163024841|NCT00537316|588792729|FG006|Part 1|Did not meet protocol eligibility|0|||
163024842|NCT00537316|588792723|FG000|Part 1|Administrative|0|||
163024843|NCT00537316|588792724|FG001|Part 1|Administrative|0|||
163024844|NCT00537316|588792725|FG002|Part 1|Administrative|2|||
163024845|NCT00537316|588792726|FG003|Part 1|Administrative|0|||
163024846|NCT00537316|588792727|FG004|Part 1|Administrative|0|||
163024847|NCT00537316|588792728|FG005|Part 1|Administrative|0|||
163024848|NCT00537316|588792729|FG006|Part 1|Administrative|0|||
163024849|NCT00537316|588792723|FG000|Part 2|Never entered follow-up|0|||
163024850|NCT00537316|588792724|FG001|Part 2|Never entered follow-up|0|||
163024851|NCT00537316|588792725|FG002|Part 2|Never entered follow-up|0|||
163024852|NCT00537316|588792726|FG003|Part 2|Never entered follow-up|0|||
163024853|NCT00537316|588792727|FG004|Part 2|Never entered follow-up|0|||
163024854|NCT00537316|588792728|FG005|Part 2|Never entered follow-up|0|||
163024855|NCT00537316|588792729|FG006|Part 2|Never entered follow-up|1|||
163024856|NCT00537316|588792723|FG000|Part 2|Adverse Event|4|||
163024857|NCT00537316|588792724|FG001|Part 2|Adverse Event|0|||
163024858|NCT00537316|588792725|FG002|Part 2|Adverse Event|2|||
163024859|NCT00537316|588792726|FG003|Part 2|Adverse Event|0|||
163024860|NCT00537316|588792727|FG004|Part 2|Adverse Event|0|||
163024861|NCT00537316|588792728|FG005|Part 2|Adverse Event|0|||
163024862|NCT00537316|588792729|FG006|Part 2|Adverse Event|0|||
163024863|NCT00537316|588792723|FG000|Part 2|Lost to Follow-up|1|||
163064506|NCT03718000|588943536|FG000|Overall Study|Pregnancy|0|||
162643832|NCT02608268|587411724|FG007|Overall Study|Subject/guardian decision|0|||
162643833|NCT02608268|587411725|FG008|Overall Study|Subject/guardian decision|2|||
162643834|NCT02608268|587411726|FG009|Overall Study|Subject/guardian decision|2|||
162643835|NCT02608268|587411727|FG010|Overall Study|Subject/guardian decision|0|||
163024864|NCT00537316|588792724|FG001|Part 2|Lost to Follow-up|0|||
163024865|NCT00537316|588792725|FG002|Part 2|Lost to Follow-up|2|||
163024866|NCT00537316|588792726|FG003|Part 2|Lost to Follow-up|0|||
163024867|NCT00537316|588792727|FG004|Part 2|Lost to Follow-up|0|||
163024868|NCT00537316|588792728|FG005|Part 2|Lost to Follow-up|0|||
163024869|NCT00537316|588792729|FG006|Part 2|Lost to Follow-up|0|||
163024870|NCT00537316|588792723|FG000|Part 2|Withdrawal by Subject|5|||
163024871|NCT00537316|588792724|FG001|Part 2|Withdrawal by Subject|1|||
163024872|NCT00537316|588792725|FG002|Part 2|Withdrawal by Subject|4|||
163024873|NCT00537316|588792726|FG003|Part 2|Withdrawal by Subject|0|||
163024874|NCT00537316|588792727|FG004|Part 2|Withdrawal by Subject|0|||
163024875|NCT00537316|588792728|FG005|Part 2|Withdrawal by Subject|0|||
163024876|NCT00537316|588792729|FG006|Part 2|Withdrawal by Subject|0|||
163024877|NCT00537316|588792723|FG000|Part 2|Administrative|16|||
163024878|NCT00537316|588792724|FG001|Part 2|Administrative|8|||
163024879|NCT00537316|588792725|FG002|Part 2|Administrative|24|||
163024880|NCT00537316|588792726|FG003|Part 2|Administrative|3|||
163024881|NCT00537316|588792727|FG004|Part 2|Administrative|1|||
163024882|NCT00537316|588792728|FG005|Part 2|Administrative|4|||
163024883|NCT00537316|588792729|FG006|Part 2|Administrative|1|||
163024884|NCT04533412|588792731|FG000|Overall Study|Withdrawal by Subject|1|||
163024885|NCT04533412|588792732|FG001|Overall Study|Withdrawal by Subject|1|||
163024886|NCT04533412|588792731|FG000|Overall Study|Lost to Follow-up|1|||
163024887|NCT04533412|588792732|FG001|Overall Study|Lost to Follow-up|4|||
163024888|NCT03261674|588792733|FG000|Overall Study|Lost to Follow-up|6|||
163024889|NCT03261674|588792734|FG001|Overall Study|Lost to Follow-up|7|||
163024890|NCT03261674|588792733|FG000|Overall Study|Protocol Violation|1|||
163024891|NCT03261674|588792734|FG001|Overall Study|Protocol Violation|4|||
163024892|NCT03261674|588792733|FG000|Overall Study|Withdrawal by Subject|1|||
163024893|NCT03261674|588792734|FG001|Overall Study|Withdrawal by Subject|4|||
163024894|NCT03261674|588792733|FG000|Overall Study|Physician Decision|1|||
163024895|NCT03261674|588792734|FG001|Overall Study|Physician Decision|0|||
163024896|NCT00782184|588792735|FG000|Overall Study|Adverse Event|1|||
163024897|NCT00782184|588792736|FG001|Overall Study|Adverse Event|2|||
163024898|NCT00782184|588792735|FG000|Overall Study|Protocol Violation|0|||
163024899|NCT00782184|588792736|FG001|Overall Study|Protocol Violation|1|||
163024900|NCT00782184|588792735|FG000|Overall Study|Withdrawal by Subject|3|||
163024901|NCT00782184|588792736|FG001|Overall Study|Withdrawal by Subject|2|||
163024902|NCT01438294|588792737|FG000|Overall Study|Lost to Follow-up|3|||
163024903|NCT01438294|588792738|FG001|Overall Study|Lost to Follow-up|7|||
163024904|NCT01730534|588792743|FG000|Overall Study|Withdrawal by Subject|97|||
163024905|NCT01730534|588792744|FG001|Overall Study|Withdrawal by Subject|127|||
163024906|NCT01730534|588792743|FG000|Overall Study|Lost to Follow-up|12|||
163024907|NCT01730534|588792744|FG001|Overall Study|Lost to Follow-up|18|||
163024908|NCT01676896|588792745|FG000|Overall Study|Withdrawal by Subject|12|||
163024909|NCT01676896|588792746|FG001|Overall Study|Withdrawal by Subject|7|||
163024910|NCT01676896|588792747|FG002|Overall Study|Withdrawal by Subject|19|||
163024911|NCT03614078|588792748|FG000|Overall Study|Withdrawal by Subject|2|||
163024912|NCT03614078|588792749|FG001|Overall Study|Withdrawal by Subject|2|||
163024913|NCT03614078|588792750|FG002|Overall Study|Withdrawal by Subject|3|||
163024914|NCT03614078|588792748|FG000|Overall Study|Participant Did Not Return for Visit|0|||
163024915|NCT03614078|588792749|FG001|Overall Study|Participant Did Not Return for Visit|1|||
163024916|NCT03614078|588792750|FG002|Overall Study|Participant Did Not Return for Visit|0|||
163024917|NCT03614078|588792748|FG000|Overall Study|High Neutrophils|0|||
163024918|NCT03614078|588792749|FG001|Overall Study|High Neutrophils|0|||
163024919|NCT03614078|588792750|FG002|Overall Study|High Neutrophils|2|||
163024920|NCT03614078|588792748|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
163024921|NCT03614078|588792749|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
163024922|NCT03614078|588792750|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
163024923|NCT03614078|588792748|FG000|Overall Study|Exacerbation of Psoriasis|0|||
163024924|NCT03614078|588792749|FG001|Overall Study|Exacerbation of Psoriasis|1|||
163024925|NCT03614078|588792750|FG002|Overall Study|Exacerbation of Psoriasis|0|||
163024926|NCT03614078|588792748|FG000|Overall Study|Adverse Event|0|||
163024927|NCT03614078|588792749|FG001|Overall Study|Adverse Event|2|||
163024928|NCT03614078|588792750|FG002|Overall Study|Adverse Event|0|||
163024929|NCT03614078|588792748|FG000|Overall Study|Dizziness and Rash|0|||
163024930|NCT03614078|588792749|FG001|Overall Study|Dizziness and Rash|1|||
163024931|NCT03614078|588792750|FG002|Overall Study|Dizziness and Rash|0|||
163024932|NCT01895608|588792752|FG000|Overall Study|change in health status|0|||
163024933|NCT01895608|588792753|FG001|Overall Study|change in health status|1|||
163024934|NCT01895608|588792754|FG002|Overall Study|change in health status|1|||
163024935|NCT01895608|588792755|FG003|Overall Study|change in health status|0|||
163024936|NCT01895608|588792752|FG000|Overall Study|Withdrawal by Subject|0|||
163024937|NCT01895608|588792753|FG001|Overall Study|Withdrawal by Subject|0|||
163024938|NCT01895608|588792754|FG002|Overall Study|Withdrawal by Subject|2|||
163024939|NCT01895608|588792755|FG003|Overall Study|Withdrawal by Subject|0|||
163024940|NCT03696108|588792757|FG000|Overall Study|Physician Decision|1|||
163024941|NCT03696108|588792758|FG001|Overall Study|Physician Decision|0|||
163024942|NCT03696108|588792757|FG000|Overall Study|Withdrawal by Subject|3|||
163024943|NCT03696108|588792758|FG001|Overall Study|Withdrawal by Subject|6|||
163024944|NCT03505593|588792760|FG000|Overall Study|Withdrawal by Subject|1|||
163064507|NCT03718000|588943537|FG001|Overall Study|Pregnancy|1|||
163064508|NCT05522751|588943543|FG000|Overall Study|Adverse Event|1|||
163064509|NCT04044690|588943545|FG000|Period 1|Lack of Efficacy|1|||
163064510|NCT04044690|588943546|FG001|Period 1|Lack of Efficacy|1|||
163064511|NCT04044690|588943545|FG000|Period 1|Adverse Event|4|||
163064512|NCT04044690|588943546|FG001|Period 1|Adverse Event|2|||
163064513|NCT04044690|588943545|FG000|Period 1|Physician Decision|0|||
163064514|NCT04044690|588943546|FG001|Period 1|Physician Decision|1|||
163064515|NCT04044690|588943545|FG000|Period 1|Withdrawal by Subject|2|||
163064516|NCT04044690|588943546|FG001|Period 1|Withdrawal by Subject|5|||
163064517|NCT04044690|588943545|FG000|Period 1|Protocol Deviation|2|||
163064518|NCT04044690|588943546|FG001|Period 1|Protocol Deviation|0|||
163064519|NCT04044690|588943545|FG000|Period 1|Site Terminated by Sponsor|0|||
163064520|NCT04044690|588943546|FG001|Period 1|Site Terminated by Sponsor|1|||
163064521|NCT04044690|588943545|FG000|Period 1|Study Terminated by Sponsor|0|||
163064522|NCT04044690|588943546|FG001|Period 1|Study Terminated by Sponsor|1|||
163064523|NCT04044690|588943545|FG000|Period 1|Death|1|||
163064524|NCT04044690|588943546|FG001|Period 1|Death|1|||
163064525|NCT04044690|588943545|FG000|Period 1|Other: Unspecified|1|||
163064526|NCT04044690|588943546|FG001|Period 1|Other: Unspecified|0|||
163064527|NCT04044690|588943545|FG000|Period 2|Lack of Efficacy|0|||
163064528|NCT04044690|588943546|FG001|Period 2|Lack of Efficacy|1|||
163064529|NCT04044690|588943545|FG000|Period 2|Adverse Event|0|||
163064530|NCT04044690|588943546|FG001|Period 2|Adverse Event|1|||
163064531|NCT04044690|588943545|FG000|Period 2|Physician Decision|0|||
163064532|NCT04044690|588943546|FG001|Period 2|Physician Decision|2|||
163064533|NCT04044690|588943545|FG000|Period 2|Withdrawal by Subject|5|||
163064534|NCT04044690|588943546|FG001|Period 2|Withdrawal by Subject|5|||
163064535|NCT04044690|588943545|FG000|Period 2|Lost to Follow-up|0|||
163064536|NCT04044690|588943546|FG001|Period 2|Lost to Follow-up|1|||
163064537|NCT04044690|588943545|FG000|Period 2|Site Terminated by Sponsor|1|||
163064538|NCT04044690|588943546|FG001|Period 2|Site Terminated by Sponsor|3|||
163064539|NCT04044690|588943545|FG000|Period 2|Study Terminated by Sponsor|8|||
163064540|NCT04044690|588943546|FG001|Period 2|Study Terminated by Sponsor|3|||
163064541|NCT04044690|588943545|FG000|Period 2|Death|1|||
163064542|NCT04044690|588943546|FG001|Period 2|Death|0|||
163064543|NCT04044690|588943545|FG000|Period 2|Other: Unspecified|1|||
163024945|NCT03505593|588792760|FG000|Overall Study|Died before procedure|1|||
163024946|NCT03505593|588792760|FG000|Overall Study|Anatomical abnormality|1|||
163024947|NCT03505593|588792760|FG000|Overall Study|Unable to pass through esophagus|1|||
163024948|NCT03505593|588792760|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
163024949|NCT03891862|588792761|FG000|Open-label Period|Adverse Event|2|||
163024950|NCT03891862|588792762|FG001|Open-label Period|Adverse Event|0|||
163024951|NCT03891862|588792763|FG002|Open-label Period|Adverse Event|0|||
163024952|NCT03891862|588792761|FG000|Open-label Period|Protocol Violation|5|||
163024953|NCT03891862|588792762|FG001|Open-label Period|Protocol Violation|0|||
163024954|NCT03891862|588792763|FG002|Open-label Period|Protocol Violation|0|||
163024955|NCT03891862|588792761|FG000|Open-label Period|Withdrawal by Subject|6|||
163024956|NCT03891862|588792762|FG001|Open-label Period|Withdrawal by Subject|0|||
163024957|NCT03891862|588792763|FG002|Open-label Period|Withdrawal by Subject|0|||
163024958|NCT03891862|588792761|FG000|Open-label Period|Death|1|||
163024959|NCT03891862|588792762|FG001|Open-label Period|Death|0|||
163024960|NCT03891862|588792763|FG002|Open-label Period|Death|0|||
163064544|NCT04044690|588943546|FG001|Period 2|Other: Unspecified|1|||
163064545|NCT04044690|588943545|FG000|Period 3|Site Terminated by Sponsor|1|||
163064546|NCT04044690|588943546|FG001|Period 3|Site Terminated by Sponsor|2|||
163064547|NCT04044690|588943545|FG000|Period 3|Study Terminated by Sponsor|24|||
163064548|NCT04044690|588943546|FG001|Period 3|Study Terminated by Sponsor|18|||
163064549|NCT04044690|588943545|FG000|Period 3|Missing|0|||
163064550|NCT04044690|588943546|FG001|Period 3|Missing|2|||
163064551|NCT01582451|588943552|FG000|Overall Study|Adverse Event|1|||
163064552|NCT01582451|588943553|FG001|Overall Study|Adverse Event|3|||
163064553|NCT01582451|588943552|FG000|Overall Study|Death|3|||
163064554|NCT01582451|588943553|FG001|Overall Study|Death|3|||
162643836|NCT02608268|587411728|FG011|Overall Study|Subject/guardian decision|1|||
162643837|NCT02608268|587411729|FG012|Overall Study|Subject/guardian decision|0|||
162643838|NCT02608268|587411730|FG013|Overall Study|Subject/guardian decision|1|||
162643839|NCT02608268|587411731|FG014|Overall Study|Subject/guardian decision|0|||
163064555|NCT01582451|588943552|FG000|Overall Study|Lost to Follow-up|0|||
163064556|NCT01582451|588943553|FG001|Overall Study|Lost to Follow-up|2|||
163064557|NCT01582451|588943552|FG000|Overall Study|Protocol Violation|11|||
163064558|NCT01582451|588943553|FG001|Overall Study|Protocol Violation|3|||
163064559|NCT01582451|588943552|FG000|Overall Study|Withdrawal by Subject|13|||
163064560|NCT01582451|588943553|FG001|Overall Study|Withdrawal by Subject|9|||
162643840|NCT02608268|587411732|FG015|Overall Study|Subject/guardian decision|1|||
163024961|NCT03891862|588792761|FG000|Open-label Period|Lost to Follow-up|2|||
163064561|NCT01582451|588943552|FG000|Overall Study|Physician Decision|3|||
163064562|NCT01582451|588943553|FG001|Overall Study|Physician Decision|0|||
163064563|NCT01582451|588943552|FG000|Overall Study|Sponsor Decision|1|||
163064564|NCT01582451|588943553|FG001|Overall Study|Sponsor Decision|0|||
163064565|NCT00716417|588943556|FG000|Overall Study|Adverse Event|0|||
163064566|NCT00716417|588943557|FG001|Overall Study|Adverse Event|0|||
163064567|NCT00716417|588943558|FG002|Overall Study|Adverse Event|2|||
163064568|NCT00716417|588943559|FG003|Overall Study|Adverse Event|1|||
163064569|NCT00716417|588943560|FG004|Overall Study|Adverse Event|0|||
163064570|NCT00716417|588943561|FG005|Overall Study|Adverse Event|0|||
163064571|NCT00716417|588943562|FG006|Overall Study|Adverse Event|3|||
163064572|NCT00716417|588943563|FG007|Overall Study|Adverse Event|1|||
163064573|NCT00716417|588943564|FG008|Overall Study|Adverse Event|0|||
163064574|NCT00716417|588943565|FG009|Overall Study|Adverse Event|3|||
163064575|NCT00716417|588943556|FG000|Overall Study|Withdrawal by Subject|0|||
163064576|NCT00716417|588943557|FG001|Overall Study|Withdrawal by Subject|1|||
163064577|NCT00716417|588943558|FG002|Overall Study|Withdrawal by Subject|0|||
163064578|NCT00716417|588943559|FG003|Overall Study|Withdrawal by Subject|2|||
163064579|NCT00716417|588943560|FG004|Overall Study|Withdrawal by Subject|0|||
163064580|NCT00716417|588943561|FG005|Overall Study|Withdrawal by Subject|0|||
163064581|NCT00716417|588943562|FG006|Overall Study|Withdrawal by Subject|1|||
163064582|NCT00716417|588943563|FG007|Overall Study|Withdrawal by Subject|0|||
163064583|NCT00716417|588943564|FG008|Overall Study|Withdrawal by Subject|0|||
163064584|NCT00716417|588943565|FG009|Overall Study|Withdrawal by Subject|0|||
163064585|NCT00716417|588943556|FG000|Overall Study|Progressive disease|3|||
163064586|NCT00716417|588943557|FG001|Overall Study|Progressive disease|5|||
163064587|NCT00716417|588943558|FG002|Overall Study|Progressive disease|3|||
163064588|NCT00716417|588943559|FG003|Overall Study|Progressive disease|8|||
163064589|NCT00716417|588943560|FG004|Overall Study|Progressive disease|0|||
163064590|NCT00716417|588943561|FG005|Overall Study|Progressive disease|3|||
163064591|NCT00716417|588943562|FG006|Overall Study|Progressive disease|3|||
163064592|NCT00716417|588943563|FG007|Overall Study|Progressive disease|1|||
163064593|NCT00716417|588943564|FG008|Overall Study|Progressive disease|5|||
163064594|NCT00716417|588943565|FG009|Overall Study|Progressive disease|0|||
163064595|NCT00716417|588943556|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
163064596|NCT00716417|588943557|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
163064597|NCT00716417|588943558|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
163064598|NCT00716417|588943559|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
163064599|NCT00716417|588943560|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
163064600|NCT00716417|588943561|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
163064601|NCT00716417|588943562|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
163064602|NCT00716417|588943563|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
163064603|NCT00716417|588943564|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
163064604|NCT00716417|588943565|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
163064605|NCT00716417|588943556|FG000|Overall Study|On patient request due to toxicities|0|||
163064606|NCT00716417|588943557|FG001|Overall Study|On patient request due to toxicities|0|||
163064607|NCT00716417|588943558|FG002|Overall Study|On patient request due to toxicities|0|||
163064608|NCT00716417|588943559|FG003|Overall Study|On patient request due to toxicities|0|||
163064609|NCT00716417|588943560|FG004|Overall Study|On patient request due to toxicities|0|||
163064610|NCT00716417|588943561|FG005|Overall Study|On patient request due to toxicities|0|||
163064611|NCT00716417|588943562|FG006|Overall Study|On patient request due to toxicities|0|||
163064612|NCT00716417|588943563|FG007|Overall Study|On patient request due to toxicities|1|||
163064613|NCT00716417|588943564|FG008|Overall Study|On patient request due to toxicities|0|||
163064614|NCT00716417|588943565|FG009|Overall Study|On patient request due to toxicities|0|||
163064615|NCT00487188|588943566|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
163064616|NCT00487188|588943567|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
163064617|NCT00487188|588943568|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
163064618|NCT00487188|588943566|FG000|Induction Phase|Adverse Event|5|||
163064619|NCT00487188|588943567|FG001|Induction Phase|Adverse Event|0|||
163064620|NCT00487188|588943568|FG002|Induction Phase|Adverse Event|0|||
162643841|NCT02608268|587411733|FG016|Overall Study|Subject/guardian decision|0|||
162643842|NCT02608268|587411734|FG017|Overall Study|Subject/guardian decision|0|||
162643843|NCT02608268|587411735|FG018|Overall Study|Subject/guardian decision|1|||
162643844|NCT02608268|587411736|FG019|Overall Study|Subject/guardian decision|0|||
163064621|NCT00487188|588943566|FG000|Induction Phase|Lack of Efficacy|0|||
163064622|NCT00487188|588943567|FG001|Induction Phase|Lack of Efficacy|1|||
163064623|NCT00487188|588943568|FG002|Induction Phase|Lack of Efficacy|0|||
163064624|NCT00487188|588943566|FG000|Induction Phase|Protocol Violation|1|||
163064625|NCT00487188|588943567|FG001|Induction Phase|Protocol Violation|0|||
163064626|NCT00487188|588943568|FG002|Induction Phase|Protocol Violation|0|||
163064627|NCT00487188|588943566|FG000|Induction Phase|Refused Treatment|1|||
163064628|NCT00487188|588943567|FG001|Induction Phase|Refused Treatment|2|||
163064629|NCT00487188|588943568|FG002|Induction Phase|Refused Treatment|0|||
163064630|NCT00487188|588943566|FG000|Induction Phase|Lost to Follow-up|2|||
163064631|NCT00487188|588943567|FG001|Induction Phase|Lost to Follow-up|2|||
163064632|NCT00487188|588943568|FG002|Induction Phase|Lost to Follow-up|0|||
163064633|NCT00487188|588943566|FG000|Induction Phase|Administrative|0|||
162643845|NCT02608268|587411737|FG020|Overall Study|Subject/guardian decision|0|||
162643846|NCT02608268|587411738|FG021|Overall Study|Subject/guardian decision|0|||
162643847|NCT02608268|587411739|FG022|Overall Study|Subject/guardian decision|1|||
162643848|NCT02608268|587411740|FG023|Overall Study|Subject/guardian decision|0|||
162643849|NCT02608268|587411741|FG024|Overall Study|Subject/guardian decision|0|||
162643850|NCT02608268|587411742|FG025|Overall Study|Subject/guardian decision|1|||
162643851|NCT02608268|587411743|FG026|Overall Study|Subject/guardian decision|1|||
162643852|NCT02608268|587411744|FG027|Overall Study|Subject/guardian decision|1|||
163064634|NCT00487188|588943567|FG001|Induction Phase|Administrative|1|||
163064635|NCT00487188|588943568|FG002|Induction Phase|Administrative|0|||
163064636|NCT00487188|588943566|FG000|Maintenance Phase|Adverse Event|1|||
163064637|NCT00487188|588943567|FG001|Maintenance Phase|Adverse Event|0|||
163064638|NCT00487188|588943568|FG002|Maintenance Phase|Adverse Event|0|||
163064639|NCT00487188|588943566|FG000|Maintenance Phase|Death|1|||
163064640|NCT00487188|588943567|FG001|Maintenance Phase|Death|0|||
163064641|NCT00487188|588943568|FG002|Maintenance Phase|Death|0|||
163064642|NCT00487188|588943566|FG000|Maintenance Phase|Lost to Follow-up|1|||
163064643|NCT00487188|588943567|FG001|Maintenance Phase|Lost to Follow-up|0|||
163064644|NCT00487188|588943568|FG002|Maintenance Phase|Lost to Follow-up|0|||
163064645|NCT00487188|588943566|FG000|Maintenance Phase|Administrative|0|||
163064646|NCT00487188|588943567|FG001|Maintenance Phase|Administrative|0|||
163064647|NCT00487188|588943568|FG002|Maintenance Phase|Administrative|1|||
163064648|NCT01838876|588943569|FG000|Overall Study|Adverse Event|49|||
163064649|NCT01838876|588943569|FG000|Overall Study|Insufficient Therapeutic Response|10|||
163064650|NCT01838876|588943569|FG000|Overall Study|Protocol Violation|34|||
163064651|NCT01838876|588943569|FG000|Overall Study|Withdrawal of Consent|33|||
163064652|NCT01838876|588943569|FG000|Overall Study|Lost to Follow-up|21|||
163064653|NCT01838876|588943569|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
163064654|NCT01838876|588943569|FG000|Overall Study|Reason not Specified|7|||
163064655|NCT01838876|588943569|FG000|Overall Study|Did not meet eligibility criteria|78|||
163064656|NCT01682031|588943570|FG000|Overall Study|Withdrawal by Subject|0|||
163064657|NCT01682031|588943571|FG001|Overall Study|Withdrawal by Subject|1|||
163064658|NCT01682031|588943570|FG000|Overall Study|Adverse Event|0|||
163064659|NCT01682031|588943571|FG001|Overall Study|Adverse Event|2|||
163064660|NCT01682031|588943570|FG000|Overall Study|MRI results indicate increased nodul|0|||
163064661|NCT01682031|588943571|FG001|Overall Study|MRI results indicate increased nodul|1|||
163064662|NCT01682031|588943570|FG000|Overall Study|Patient could not swallow tablets|1|||
163064663|NCT01682031|588943571|FG001|Overall Study|Patient could not swallow tablets|0|||
163064664|NCT01682031|588943570|FG000|Overall Study|Patient stopped selenium on his own|0|||
163064665|NCT01682031|588943571|FG001|Overall Study|Patient stopped selenium on his own|1|||
163064666|NCT03881371|588943576|FG000|Overall Study|Adverse Event|8|||
163064667|NCT03881371|588943577|FG001|Overall Study|Adverse Event|9|||
163064668|NCT03881371|588943576|FG000|Overall Study|Death|1|||
163064669|NCT03881371|588943577|FG001|Overall Study|Death|0|||
163064670|NCT03881371|588943576|FG000|Overall Study|Lost to Follow-up|1|||
163064671|NCT03881371|588943577|FG001|Overall Study|Lost to Follow-up|0|||
163064672|NCT03881371|588943576|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163064673|NCT03881371|588943577|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163064674|NCT03881371|588943576|FG000|Overall Study|Physician Decision|3|||
163064675|NCT03881371|588943577|FG001|Overall Study|Physician Decision|3|||
163064676|NCT03881371|588943576|FG000|Overall Study|Withdrawal by Subject|2|||
163064677|NCT03881371|588943577|FG001|Overall Study|Withdrawal by Subject|10|||
162643853|NCT02608268|587411745|FG028|Overall Study|Subject/guardian decision|1|||
162643854|NCT02608268|587411746|FG029|Overall Study|Subject/guardian decision|0|||
162643855|NCT01859494|587411756|FG000|Overall Study|Adverse Event|1|||
162643856|NCT01290666|587411762|FG000|Overall Study|Lost to Follow-up|11|||
162643857|NCT01290666|587411762|FG000|Overall Study|Withdrawal by Subject|23|||
162643858|NCT01290666|587411762|FG000|Overall Study|Early Termination of Study|4|||
163064678|NCT03881371|588943576|FG000|Overall Study|Discontinuation from Study|1|||
163064679|NCT03881371|588943577|FG001|Overall Study|Discontinuation from Study|0|||
163064680|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
163064681|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
163064682|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
163064683|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
163064684|NCT05376358|588943583|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
163064685|NCT05376358|588943584|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
163064686|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
163064687|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
162643859|NCT00297037|587411765|FG000|Overall Study|Withdrawal by Subject|2|||
162643860|NCT00297037|587411766|FG001|Overall Study|Withdrawal by Subject|0|||
162643861|NCT03814746|587411769|FG000|Overall Study|Participant decision|9|||
162643862|NCT03814746|587411770|FG001|Overall Study|Participant decision|6|||
162643863|NCT03814746|587411771|FG002|Overall Study|Participant decision|15|||
163024962|NCT03891862|588792762|FG001|Open-label Period|Lost to Follow-up|0|||
163024963|NCT03891862|588792763|FG002|Open-label Period|Lost to Follow-up|0|||
163024964|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
163024965|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
163024966|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
163024967|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
163024968|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
163024969|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
163024970|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
163024971|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
163024972|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
163024973|NCT03891862|588792761|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
163024974|NCT03891862|588792762|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
163024975|NCT03891862|588792763|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
163024976|NCT01053962|588792764|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024977|NCT01053962|588792765|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024978|NCT01053962|588792766|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
163024979|NCT01053962|588792767|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
163024980|NCT01053962|588792768|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
163024981|NCT01053962|588792764|FG000|Pretreatment Period|Venipuncture Failure|0|||
163024982|NCT01053962|588792765|FG001|Pretreatment Period|Venipuncture Failure|0|||
163024983|NCT01053962|588792766|FG002|Pretreatment Period|Venipuncture Failure|1|||
163024984|NCT01053962|588792767|FG003|Pretreatment Period|Venipuncture Failure|0|||
163024985|NCT01053962|588792768|FG004|Pretreatment Period|Venipuncture Failure|0|||
163024986|NCT01053962|588792764|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024987|NCT01053962|588792765|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
163024988|NCT01053962|588792766|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024989|NCT01053962|588792767|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024990|NCT01053962|588792768|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
163024991|NCT01053962|588792764|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024992|NCT01053962|588792765|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024993|NCT01053962|588792766|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024994|NCT01053962|588792767|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
163024995|NCT01053962|588792768|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
163024996|NCT01053962|588792764|FG000|Treatment Period|Lack of Efficacy|0|||
163024997|NCT01053962|588792765|FG001|Treatment Period|Lack of Efficacy|0|||
163024998|NCT01053962|588792766|FG002|Treatment Period|Lack of Efficacy|0|||
163024999|NCT01053962|588792767|FG003|Treatment Period|Lack of Efficacy|0|||
163025000|NCT01053962|588792768|FG004|Treatment Period|Lack of Efficacy|1|||
163025001|NCT01053962|588792764|FG000|Treatment Period|Adverse Event|0|||
163025002|NCT01053962|588792765|FG001|Treatment Period|Adverse Event|0|||
163025003|NCT01053962|588792766|FG002|Treatment Period|Adverse Event|0|||
163025004|NCT01053962|588792767|FG003|Treatment Period|Adverse Event|0|||
163025005|NCT01053962|588792768|FG004|Treatment Period|Adverse Event|1|||
163025006|NCT01053962|588792764|FG000|Treatment Period|Withdrawal by Subject|0|||
163025007|NCT01053962|588792765|FG001|Treatment Period|Withdrawal by Subject|0|||
163025008|NCT01053962|588792766|FG002|Treatment Period|Withdrawal by Subject|0|||
163025009|NCT01053962|588792767|FG003|Treatment Period|Withdrawal by Subject|0|||
163025010|NCT01053962|588792768|FG004|Treatment Period|Withdrawal by Subject|1|||
163025011|NCT01053962|588792764|FG000|Treatment Period|Noncompliance with protocol|1|||
163025012|NCT01053962|588792765|FG001|Treatment Period|Noncompliance with protocol|0|||
163025013|NCT01053962|588792766|FG002|Treatment Period|Noncompliance with protocol|0|||
163025014|NCT01053962|588792767|FG003|Treatment Period|Noncompliance with protocol|0|||
163025015|NCT01053962|588792768|FG004|Treatment Period|Noncompliance with protocol|0|||
163025016|NCT02833844|588792769|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163025017|NCT02833844|588792770|FG001|Double-Blind Period|Withdrawal by Subject|3|||
163025018|NCT02833844|588792769|FG000|Double-Blind Period|Protocol Violation|0|||
163025019|NCT02833844|588792770|FG001|Double-Blind Period|Protocol Violation|4|||
163025020|NCT02833844|588792769|FG000|Open-Label Period|Death|0|||
163025021|NCT02833844|588792770|FG001|Open-Label Period|Death|2|||
163025022|NCT02833844|588792769|FG000|Open-Label Period|Lost to Follow-up|1|||
163025023|NCT02833844|588792770|FG001|Open-Label Period|Lost to Follow-up|0|||
163025024|NCT02833844|588792769|FG000|Open-Label Period|Withdrawal by Subject|1|||
163025025|NCT02833844|588792770|FG001|Open-Label Period|Withdrawal by Subject|0|||
162643864|NCT03814746|587411769|FG000|Overall Study|Physician Decision|2|||
163025026|NCT01646021|588792772|FG000|Overall Study|Death|77|||
163025027|NCT01646021|588792773|FG001|Overall Study|Death|83|||
163025028|NCT01646021|588792772|FG000|Overall Study|Study Terminated by Sponsor|50|||
163025029|NCT01646021|588792773|FG001|Overall Study|Study Terminated by Sponsor|41|||
163025030|NCT01646021|588792772|FG000|Overall Study|Lost to Follow-up|2|||
163025031|NCT01646021|588792773|FG001|Overall Study|Lost to Follow-up|2|||
162643865|NCT03814746|587411770|FG001|Overall Study|Physician Decision|2|||
162643866|NCT03814746|587411771|FG002|Overall Study|Physician Decision|4|||
163064688|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
163064689|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
163064690|NCT05376358|588943583|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
163064691|NCT05376358|588943584|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
163064692|NCT04225832|588943585|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
163064693|NCT04225832|588943586|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
163064694|NCT04225832|588943585|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
163064695|NCT04225832|588943586|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
163064696|NCT00311168|588943587|FG000|First Intervention|Withdrawal by Subject|2|||
163064697|NCT00311168|588943588|FG001|First Intervention|Withdrawal by Subject|2|||
163064698|NCT00311168|588943587|FG000|First Intervention|Lost to Follow-up|1|||
163064699|NCT00311168|588943588|FG001|First Intervention|Lost to Follow-up|1|||
163064700|NCT00311168|588943587|FG000|First Intervention|Protocol Violation|1|||
163064701|NCT00311168|588943588|FG001|First Intervention|Protocol Violation|1|||
163064702|NCT00311168|588943587|FG000|First Intervention|Adverse Event|1|||
163064703|NCT00311168|588943588|FG001|First Intervention|Adverse Event|0|||
163064704|NCT00311168|588943587|FG000|First Intervention|Other|2|||
163064705|NCT00311168|588943588|FG001|First Intervention|Other|2|||
163064706|NCT00311168|588943587|FG000|Second Intervention|Lost to Follow-up|9|||
163064707|NCT00311168|588943588|FG001|Second Intervention|Lost to Follow-up|2|||
163064708|NCT00311168|588943587|FG000|Second Intervention|Withdrawal by Subject|0|||
163064709|NCT00311168|588943588|FG001|Second Intervention|Withdrawal by Subject|1|||
163064710|NCT00311168|588943587|FG000|Second Intervention|Other|1|||
163064711|NCT00311168|588943588|FG001|Second Intervention|Other|1|||
163064712|NCT05472142|588943589|FG000|Total Participants|Lost to Follow-up|312|||
163064713|NCT05472142|588943590|FG001|Total Participants|Lost to Follow-up|0|||
163064714|NCT05472142|588943589|FG000|Clinic Patients|Lost to Follow-up|312|||
163064715|NCT05472142|588943590|FG001|Clinic Patients|Lost to Follow-up|0|||
163064716|NCT02452190|588943591|FG000|Overall Study|Withdrawal by Sponsor|1|||
163064717|NCT02452190|588943592|FG001|Overall Study|Withdrawal by Sponsor|3|||
163064718|NCT02452190|588943591|FG000|Overall Study|Pregnancy|1|||
163064719|NCT02452190|588943592|FG001|Overall Study|Pregnancy|0|||
163064720|NCT02452190|588943591|FG000|Overall Study|Investigator's Decision|2|||
163064721|NCT02452190|588943592|FG001|Overall Study|Investigator's Decision|0|||
163064722|NCT02452190|588943591|FG000|Overall Study|Lack of Efficacy|3|||
163064723|NCT02452190|588943592|FG001|Overall Study|Lack of Efficacy|1|||
163064724|NCT02452190|588943591|FG000|Overall Study|Lost to Follow-up|4|||
163064725|NCT02452190|588943592|FG001|Overall Study|Lost to Follow-up|3|||
163064726|NCT02452190|588943591|FG000|Overall Study|Adverse Event|2|||
163064727|NCT02452190|588943592|FG001|Overall Study|Adverse Event|5|||
163064728|NCT02452190|588943591|FG000|Overall Study|Withdrawal by Subject|20|||
163064729|NCT02452190|588943592|FG001|Overall Study|Withdrawal by Subject|11|||
163064730|NCT02452190|588943591|FG000|Overall Study|Noncompliance with study drug|1|||
163064731|NCT02452190|588943592|FG001|Overall Study|Noncompliance with study drug|0|||
163064732|NCT02452190|588943591|FG000|Overall Study|Participant traveled abroad|1|||
163064733|NCT02452190|588943592|FG001|Overall Study|Participant traveled abroad|0|||
163064734|NCT02452190|588943591|FG000|Overall Study|Death|0|||
163064735|NCT02452190|588943592|FG001|Overall Study|Death|1|||
163064736|NCT06001021|588943593|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
162643867|NCT03814746|587411769|FG000|Overall Study|Death|2|||
162643868|NCT03814746|587411770|FG001|Overall Study|Death|2|||
163064737|NCT06001021|588943594|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064738|NCT06001021|588943595|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064739|NCT06001021|588943596|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
163064740|NCT06001021|588943597|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
162643869|NCT03814746|587411771|FG002|Overall Study|Death|2|||
162643870|NCT03814746|587411769|FG000|Overall Study|Adverse Event|2|||
163064741|NCT06001021|588943598|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
163064742|NCT06001021|588943599|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
163064743|NCT06001021|588943593|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
163064744|NCT06001021|588943594|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163064745|NCT06001021|588943595|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163064746|NCT06001021|588943596|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
163064747|NCT06001021|588943597|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
163064748|NCT06001021|588943598|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
162643871|NCT03814746|587411770|FG001|Overall Study|Adverse Event|2|||
162643872|NCT03814746|587411771|FG002|Overall Study|Adverse Event|1|||
163064749|NCT06001021|588943599|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
163064750|NCT03112603|588943602|FG000|End of Randomization Period|Lost to Follow-up|3|||
163064751|NCT03112603|588943603|FG001|End of Randomization Period|Lost to Follow-up|0|||
163064752|NCT03112603|588943604|FG002|End of Randomization Period|Lost to Follow-up|0|||
163064753|NCT03112603|588943602|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
163064754|NCT03112603|588943603|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
163064755|NCT03112603|588943604|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
163064756|NCT03112603|588943602|FG000|End of Randomization Period|Physician Decision|43|||
163064757|NCT03112603|588943603|FG001|End of Randomization Period|Physician Decision|18|||
163064758|NCT03112603|588943604|FG002|End of Randomization Period|Physician Decision|0|||
163064759|NCT03112603|588943602|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
163064760|NCT03112603|588943603|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
163064761|NCT03112603|588943604|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
163064762|NCT03112603|588943602|FG000|End of Randomization Period|Death|10|||
163064763|NCT03112603|588943603|FG001|End of Randomization Period|Death|7|||
163064764|NCT03112603|588943604|FG002|End of Randomization Period|Death|0|||
163064765|NCT03112603|588943602|FG000|End of Randomization Period|Disease Relapse|12|||
163064766|NCT03112603|588943603|FG001|End of Randomization Period|Disease Relapse|7|||
163064767|NCT03112603|588943604|FG002|End of Randomization Period|Disease Relapse|0|||
163064768|NCT03112603|588943602|FG000|End of Randomization Period|Lack of Efficacy|25|||
163064769|NCT03112603|588943603|FG001|End of Randomization Period|Lack of Efficacy|77|||
163064770|NCT03112603|588943604|FG002|End of Randomization Period|Lack of Efficacy|0|||
163064771|NCT03112603|588943602|FG000|End of Randomization Period|Adverse Event|32|||
163064772|NCT03112603|588943603|FG001|End of Randomization Period|Adverse Event|12|||
163064773|NCT03112603|588943604|FG002|End of Randomization Period|Adverse Event|0|||
163064774|NCT03112603|588943602|FG000|End of Cross Over Period|Death|0|||
163064775|NCT03112603|588943603|FG001|End of Cross Over Period|Death|0|||
163064776|NCT03112603|588943604|FG002|End of Cross Over Period|Death|2|||
163064777|NCT03112603|588943602|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
163064778|NCT03112603|588943603|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
163064779|NCT03112603|588943604|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
163064780|NCT03112603|588943602|FG000|End of Cross Over Period|Physician Decision|0|||
163064781|NCT03112603|588943603|FG001|End of Cross Over Period|Physician Decision|0|||
163064782|NCT03112603|588943604|FG002|End of Cross Over Period|Physician Decision|29|||
163064783|NCT03112603|588943602|FG000|End of Cross Over Period|Lack of Efficacy|0|||
163064784|NCT03112603|588943603|FG001|End of Cross Over Period|Lack of Efficacy|0|||
163064785|NCT03112603|588943604|FG002|End of Cross Over Period|Lack of Efficacy|8|||
163064786|NCT03112603|588943602|FG000|End of Cross Over Period|Adverse Event|0|||
163064787|NCT03112603|588943603|FG001|End of Cross Over Period|Adverse Event|0|||
163064788|NCT03112603|588943604|FG002|End of Cross Over Period|Adverse Event|6|||
163064789|NCT03112603|588943602|FG000|End of Cross Over Period|Disease Relapse|0|||
163064790|NCT03112603|588943603|FG001|End of Cross Over Period|Disease Relapse|0|||
163064791|NCT03112603|588943604|FG002|End of Cross Over Period|Disease Relapse|2|||
163064792|NCT02278354|588943605|FG000|Overall Study|Lost to Follow-up|2|||
163064793|NCT02278354|588943606|FG001|Overall Study|Lost to Follow-up|2|||
163064794|NCT02278354|588943605|FG000|Overall Study|Withdrawal by Subject|0|||
163064795|NCT02278354|588943606|FG001|Overall Study|Withdrawal by Subject|1|||
163064796|NCT02278354|588943605|FG000|Overall Study|<10 professional fights|2|||
163064797|NCT02278354|588943606|FG001|Overall Study|<10 professional fights|0|||
163064798|NCT01564407|588943614|FG000|Overall Study|Lost to Follow-up|0|||
163064799|NCT01564407|588943615|FG001|Overall Study|Lost to Follow-up|1|||
163064800|NCT01564407|588943616|FG002|Overall Study|Lost to Follow-up|0|||
163064801|NCT01564407|588943617|FG003|Overall Study|Lost to Follow-up|0|||
163064802|NCT01564407|588943618|FG004|Overall Study|Lost to Follow-up|0|||
163064803|NCT01564407|588943614|FG000|Overall Study|Withdrawal by Subject|0|||
163064804|NCT01564407|588943615|FG001|Overall Study|Withdrawal by Subject|1|||
163064805|NCT01564407|588943616|FG002|Overall Study|Withdrawal by Subject|0|||
162643873|NCT03814746|587411769|FG000|Overall Study|Lost to Follow-up|2|||
163064806|NCT01564407|588943617|FG003|Overall Study|Withdrawal by Subject|0|||
163064807|NCT01564407|588943618|FG004|Overall Study|Withdrawal by Subject|0|||
163064808|NCT01564407|588943614|FG000|Overall Study|funding lost, study ended|0|||
162643874|NCT03814746|587411770|FG001|Overall Study|Lost to Follow-up|1|||
163064809|NCT01564407|588943615|FG001|Overall Study|funding lost, study ended|0|||
162643875|NCT03814746|587411771|FG002|Overall Study|Lost to Follow-up|2|||
162643876|NCT03814746|587411769|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163064810|NCT01564407|588943616|FG002|Overall Study|funding lost, study ended|0|||
163064811|NCT01564407|588943617|FG003|Overall Study|funding lost, study ended|1|||
163064812|NCT01564407|588943618|FG004|Overall Study|funding lost, study ended|0|||
163025032|NCT01646021|588792772|FG000|Overall Study|Withdrawal by Subject|10|||
163025033|NCT01646021|588792773|FG001|Overall Study|Withdrawal by Subject|15|||
163025034|NCT02347891|588792774|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
163025035|NCT02347891|588792775|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
163025036|NCT02347891|588792774|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
163025037|NCT02347891|588792775|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
163025038|NCT00614120|588792779|FG000|Overall Study|Adverse Event|9|||
163025039|NCT00614120|588792780|FG001|Overall Study|Adverse Event|22|||
163025040|NCT00614120|588792781|FG002|Overall Study|Adverse Event|30|||
163025041|NCT00614120|588792782|FG003|Overall Study|Adverse Event|3|||
163025042|NCT00614120|588792779|FG000|Overall Study|Lack of Efficacy|3|||
163025043|NCT00614120|588792780|FG001|Overall Study|Lack of Efficacy|3|||
163025044|NCT00614120|588792781|FG002|Overall Study|Lack of Efficacy|2|||
163025045|NCT00614120|588792782|FG003|Overall Study|Lack of Efficacy|2|||
163025046|NCT00614120|588792779|FG000|Overall Study|Protocol Violation|2|||
163025047|NCT00614120|588792780|FG001|Overall Study|Protocol Violation|5|||
163025048|NCT00614120|588792781|FG002|Overall Study|Protocol Violation|3|||
163025049|NCT00614120|588792782|FG003|Overall Study|Protocol Violation|1|||
163025050|NCT00614120|588792779|FG000|Overall Study|Withdrawal criteria|1|||
163025051|NCT00614120|588792780|FG001|Overall Study|Withdrawal criteria|0|||
163025052|NCT00614120|588792781|FG002|Overall Study|Withdrawal criteria|0|||
163025053|NCT00614120|588792782|FG003|Overall Study|Withdrawal criteria|0|||
163025054|NCT00614120|588792779|FG000|Overall Study|Withdrawal by Subject|9|||
163025055|NCT00614120|588792780|FG001|Overall Study|Withdrawal by Subject|10|||
163025056|NCT00614120|588792781|FG002|Overall Study|Withdrawal by Subject|16|||
163025057|NCT00614120|588792782|FG003|Overall Study|Withdrawal by Subject|3|||
163025058|NCT00614120|588792779|FG000|Overall Study|Did not meet trial criteria|0|||
163025059|NCT00614120|588792780|FG001|Overall Study|Did not meet trial criteria|1|||
163025060|NCT00614120|588792781|FG002|Overall Study|Did not meet trial criteria|1|||
163025061|NCT00614120|588792782|FG003|Overall Study|Did not meet trial criteria|1|||
163025062|NCT00614120|588792779|FG000|Overall Study|hCG positive (not pregnant)|0|||
163025063|NCT00614120|588792780|FG001|Overall Study|hCG positive (not pregnant)|0|||
163025064|NCT00614120|588792781|FG002|Overall Study|hCG positive (not pregnant)|1|||
163025065|NCT00614120|588792782|FG003|Overall Study|hCG positive (not pregnant)|0|||
163025066|NCT00614120|588792779|FG000|Overall Study|Hypoglycaemia|0|||
163025067|NCT00614120|588792780|FG001|Overall Study|Hypoglycaemia|0|||
163025068|NCT00614120|588792781|FG002|Overall Study|Hypoglycaemia|0|||
163025069|NCT00614120|588792782|FG003|Overall Study|Hypoglycaemia|1|||
163025070|NCT00614120|588792779|FG000|Overall Study|Lack of trial product|3|||
163025071|NCT00614120|588792780|FG001|Overall Study|Lack of trial product|3|||
163025072|NCT00614120|588792781|FG002|Overall Study|Lack of trial product|2|||
163025073|NCT00614120|588792782|FG003|Overall Study|Lack of trial product|0|||
163025074|NCT00614120|588792779|FG000|Overall Study|Late syphilis, latent|1|||
163025075|NCT00614120|588792780|FG001|Overall Study|Late syphilis, latent|0|||
163025076|NCT00614120|588792781|FG002|Overall Study|Late syphilis, latent|0|||
163025077|NCT00614120|588792782|FG003|Overall Study|Late syphilis, latent|0|||
163025078|NCT00614120|588792779|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
163025079|NCT00614120|588792780|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
163025080|NCT00614120|588792781|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
163025081|NCT00614120|588792782|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
163025082|NCT00614120|588792779|FG000|Overall Study|Lost to Follow-up|1|||
163025083|NCT00614120|588792780|FG001|Overall Study|Lost to Follow-up|2|||
163025084|NCT00614120|588792781|FG002|Overall Study|Lost to Follow-up|3|||
163025085|NCT00614120|588792782|FG003|Overall Study|Lost to Follow-up|4|||
163025086|NCT00727844|588792783|FG000|Initial Randomization|Physician Decision|2|||
163025087|NCT00727844|588792784|FG001|Initial Randomization|Physician Decision|0|||
163025088|NCT00727844|588792785|FG002|Initial Randomization|Physician Decision|0|||
163025089|NCT00727844|588792786|FG003|Initial Randomization|Physician Decision|0|||
163025090|NCT04439214|588792787|FG000|Overall Study|Adverse Event|13|||
163025091|NCT04439214|588792787|FG000|Overall Study|Disease progression|16|||
163025092|NCT04439214|588792787|FG000|Overall Study|Death|1|||
163025093|NCT04439214|588792787|FG000|Overall Study|Withdrawal by Subject|2|||
163025094|NCT04439214|588792787|FG000|Overall Study|Declining health|1|||
163025095|NCT04439214|588792787|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
163025096|NCT04439214|588792787|FG000|Overall Study|Ineligible|5|||
163025097|NCT02964208|588792788|FG000|Overall Study|Death|103|||
163025098|NCT02964208|588792788|FG000|Overall Study|Withdrawal by Subject|6|||
163025099|NCT02964208|588792788|FG000|Overall Study|Lost to Follow-up|6|||
163025100|NCT02964208|588792788|FG000|Overall Study|Unsuccessful Procedure|5|||
163025101|NCT02964208|588792788|FG000|Overall Study|Device Explant|1|||
163025102|NCT02964208|588792788|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
163025103|NCT04013672|588792793|FG000|Overall Study|Withdrawal by Subject|3|||
163025104|NCT04013672|588792794|FG001|Overall Study|Withdrawal by Subject|0|||
163064813|NCT05845619|588943619|FG000|Overall Study|duplicate enrollment|2|||
163064814|NCT05845619|588943620|FG001|Overall Study|duplicate enrollment|2|||
163064815|NCT05845619|588943621|FG002|Overall Study|duplicate enrollment|1|||
163064816|NCT04967222|588943624|FG000|Randomized|Lost to Follow-up|0|||
163064817|NCT04967222|588943625|FG001|Randomized|Lost to Follow-up|1|||
163064818|NCT04967222|588943626|FG002|Randomized|Lost to Follow-up|1|||
163064819|NCT04967222|588943624|FG000|Randomized|Physician Decision|0|||
163064820|NCT04967222|588943625|FG001|Randomized|Physician Decision|0|||
163064821|NCT04967222|588943626|FG002|Randomized|Physician Decision|1|||
163064822|NCT04967222|588943624|FG000|Randomized|Withdrawal by Subject|0|||
163064823|NCT04967222|588943625|FG001|Randomized|Withdrawal by Subject|0|||
163064824|NCT04967222|588943626|FG002|Randomized|Withdrawal by Subject|2|||
163064825|NCT04967222|588943624|FG000|Randomized|abnormal finding in MRI|0|||
163064826|NCT04967222|588943625|FG001|Randomized|abnormal finding in MRI|2|||
163064827|NCT04967222|588943626|FG002|Randomized|abnormal finding in MRI|0|||
163064828|NCT02629159|588943627|FG000|Overall Study|Adverse Event|17|||
163064829|NCT02629159|588943628|FG001|Overall Study|Adverse Event|20|||
163064830|NCT02629159|588943629|FG002|Overall Study|Adverse Event|22|||
163064831|NCT02629159|588943627|FG000|Overall Study|Withdrawal by Subject|22|||
163064832|NCT02629159|588943628|FG001|Overall Study|Withdrawal by Subject|11|||
163064833|NCT02629159|588943629|FG002|Overall Study|Withdrawal by Subject|15|||
163064834|NCT02629159|588943627|FG000|Overall Study|Lost to Follow-up|7|||
163064835|NCT02629159|588943628|FG001|Overall Study|Lost to Follow-up|4|||
163064836|NCT02629159|588943629|FG002|Overall Study|Lost to Follow-up|5|||
163064837|NCT02629159|588943627|FG000|Overall Study|Lack of Efficacy|4|||
163064838|NCT02629159|588943628|FG001|Overall Study|Lack of Efficacy|0|||
163064839|NCT02629159|588943629|FG002|Overall Study|Lack of Efficacy|1|||
163064840|NCT02629159|588943627|FG000|Overall Study|Other|6|||
163064841|NCT02629159|588943628|FG001|Overall Study|Other|4|||
163064842|NCT02629159|588943629|FG002|Overall Study|Other|8|||
163064843|NCT05722015|588943630|FG000|Overall Study|Death|57|||
163064844|NCT05722015|588943631|FG001|Overall Study|Death|37|||
163064845|NCT05722015|588943630|FG000|Overall Study|Lost to Follow-up|1|||
163064846|NCT05722015|588943631|FG001|Overall Study|Lost to Follow-up|0|||
163064847|NCT05722015|588943630|FG000|Overall Study|Withdrawal by Subject|5|||
163064848|NCT05722015|588943631|FG001|Overall Study|Withdrawal by Subject|1|||
163064849|NCT05722015|588943630|FG000|Overall Study|Participants Ongoing|188|||
163064850|NCT05722015|588943631|FG001|Overall Study|Participants Ongoing|88|||
163064851|NCT02685735|588943632|FG000|Overall Study|Surgery Cancelled|4|||
163064852|NCT02685735|588943633|FG001|Overall Study|Surgery Cancelled|9|||
163064853|NCT02685735|588943632|FG000|Overall Study|Adverse Event|10|||
163064854|NCT02685735|588943633|FG001|Overall Study|Adverse Event|3|||
163064855|NCT02685735|588943632|FG000|Overall Study|Preop testing found to be incomplete|2|||
163064856|NCT02685735|588943633|FG001|Overall Study|Preop testing found to be incomplete|2|||
163064857|NCT02685735|588943632|FG000|Overall Study|Withdrawal by Subject|1|||
163064858|NCT02685735|588943633|FG001|Overall Study|Withdrawal by Subject|2|||
163064859|NCT02685735|588943632|FG000|Overall Study|Death|1|||
163064860|NCT02685735|588943633|FG001|Overall Study|Death|0|||
163064861|NCT04133909|588943634|FG000|Overall Study|Death|11|||
163064862|NCT04133909|588943635|FG001|Overall Study|Death|11|||
163064863|NCT04133909|588943634|FG000|Overall Study|Adverse Event|4|||
163064864|NCT04133909|588943635|FG001|Overall Study|Adverse Event|5|||
163064865|NCT04133909|588943634|FG000|Overall Study|Lost to Follow-up|3|||
163064866|NCT04133909|588943635|FG001|Overall Study|Lost to Follow-up|5|||
163064867|NCT04133909|588943634|FG000|Overall Study|Physician Decision|4|||
163064868|NCT04133909|588943635|FG001|Overall Study|Physician Decision|7|||
163064869|NCT04133909|588943634|FG000|Overall Study|Withdrawal by Subject|40|||
163064870|NCT04133909|588943635|FG001|Overall Study|Withdrawal by Subject|35|||
163064871|NCT04133909|588943634|FG000|Overall Study|Lack of Efficacy|2|||
163064872|NCT04133909|588943635|FG001|Overall Study|Lack of Efficacy|7|||
163064873|NCT04133909|588943634|FG000|Overall Study|Randomized in error|1|||
163064874|NCT04133909|588943635|FG001|Overall Study|Randomized in error|1|||
163064875|NCT05020743|588943636|FG000|Overall Study|Enrollment in Interventional Study|2|||
162643877|NCT03814746|587411770|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162643878|NCT03814746|587411771|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163064876|NCT05020743|588943637|FG001|Overall Study|Enrollment in Interventional Study|9|||
163064877|NCT05020743|588943638|FG002|Overall Study|Enrollment in Interventional Study|0|||
163064878|NCT05020743|588943636|FG000|Overall Study|Withdrawal by Subject|0|||
163064879|NCT05020743|588943637|FG001|Overall Study|Withdrawal by Subject|3|||
163064880|NCT05020743|588943638|FG002|Overall Study|Withdrawal by Subject|1|||
163064881|NCT05020743|588943636|FG000|Overall Study|Lost to Follow-up|1|||
163064882|NCT05020743|588943637|FG001|Overall Study|Lost to Follow-up|0|||
163064883|NCT05020743|588943638|FG002|Overall Study|Lost to Follow-up|0|||
163064884|NCT05020743|588943636|FG000|Overall Study|Study Termination by Sponsor|10|||
163064885|NCT05020743|588943637|FG001|Overall Study|Study Termination by Sponsor|11|||
163064886|NCT05020743|588943638|FG002|Overall Study|Study Termination by Sponsor|10|||
163064887|NCT02003924|588943639|FG000|Double-blind Phase|Lost to Follow-up|2|||
162643879|NCT03814746|587411769|FG000|Overall Study|Pregnancy|0|||
163064888|NCT02003924|588943640|FG001|Double-blind Phase|Lost to Follow-up|1|||
163064889|NCT02003924|588943641|FG002|Double-blind Phase|Lost to Follow-up|0|||
163064890|NCT02003924|588943639|FG000|Double-blind Phase|Protocol Violation|1|||
163064891|NCT02003924|588943640|FG001|Double-blind Phase|Protocol Violation|2|||
163064892|NCT02003924|588943641|FG002|Double-blind Phase|Protocol Violation|0|||
163064893|NCT02003924|588943639|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
163064894|NCT02003924|588943640|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
163064895|NCT02003924|588943641|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
163064896|NCT02003924|588943639|FG000|Double-blind Phase|Disease Progression|229|||
163064897|NCT02003924|588943640|FG001|Double-blind Phase|Disease Progression|247|||
163064898|NCT02003924|588943641|FG002|Double-blind Phase|Disease Progression|0|||
163064899|NCT02003924|588943639|FG000|Double-blind Phase|Adverse Event|120|||
163064900|NCT02003924|588943640|FG001|Double-blind Phase|Adverse Event|31|||
163064901|NCT02003924|588943641|FG002|Double-blind Phase|Adverse Event|0|||
163064902|NCT02003924|588943639|FG000|Double-blind Phase|Randomized But not Treated|3|||
163064903|NCT02003924|588943640|FG001|Double-blind Phase|Randomized But not Treated|3|||
163064904|NCT02003924|588943641|FG002|Double-blind Phase|Randomized But not Treated|0|||
163064905|NCT02003924|588943639|FG000|Double-blind Phase|Other|29|||
163064906|NCT02003924|588943640|FG001|Double-blind Phase|Other|50|||
163064907|NCT02003924|588943641|FG002|Double-blind Phase|Other|0|||
163064908|NCT02003924|588943639|FG000|Open-label Phase|Lost to Follow-up|0|||
163064909|NCT02003924|588943640|FG001|Open-label Phase|Lost to Follow-up|0|||
163064910|NCT02003924|588943641|FG002|Open-label Phase|Lost to Follow-up|1|||
163064911|NCT02003924|588943639|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
163064912|NCT02003924|588943640|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
163064913|NCT02003924|588943641|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
163064914|NCT02003924|588943639|FG000|Open-label Phase|Disease Progression|59|||
163064915|NCT02003924|588943640|FG001|Open-label Phase|Disease Progression|0|||
163064916|NCT02003924|588943641|FG002|Open-label Phase|Disease Progression|5|||
163064917|NCT02003924|588943639|FG000|Open-label Phase|Adverse Event|25|||
163064918|NCT02003924|588943640|FG001|Open-label Phase|Adverse Event|0|||
163064919|NCT02003924|588943641|FG002|Open-label Phase|Adverse Event|10|||
163064920|NCT02003924|588943639|FG000|Open-label Phase|Other|7|||
163064921|NCT02003924|588943640|FG001|Open-label Phase|Other|0|||
163064922|NCT02003924|588943641|FG002|Open-label Phase|Other|0|||
163064923|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Death|288|||
163064924|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Death|174|||
163064925|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Death|4|||
163064926|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
163064927|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
163064928|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
163064929|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
163064930|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
163064931|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
163064932|NCT02003924|588943639|FG000|Long-term Follow-up Phase|Other|5|||
163064933|NCT02003924|588943640|FG001|Long-term Follow-up Phase|Other|2|||
163064934|NCT02003924|588943641|FG002|Long-term Follow-up Phase|Other|1|||
163064935|NCT02340949|588943642|FG000|Overall Study|Adverse Event|4|||
163064936|NCT02340949|588943643|FG001|Overall Study|Adverse Event|2|||
163064937|NCT02340949|588943642|FG000|Overall Study|Withdrawal by Subject|2|||
163064938|NCT02340949|588943643|FG001|Overall Study|Withdrawal by Subject|0|||
163064939|NCT02340949|588943642|FG000|Overall Study|Progression disease|6|||
163064940|NCT02340949|588943643|FG001|Overall Study|Progression disease|2|||
163064941|NCT02340949|588943642|FG000|Overall Study|Death|3|||
163064942|NCT02340949|588943643|FG001|Overall Study|Death|0|||
163064943|NCT02340949|588943642|FG000|Overall Study|Physician Decision|1|||
163064944|NCT02340949|588943643|FG001|Overall Study|Physician Decision|0|||
163064945|NCT01155570|588943644|FG000|Overall Study|Adverse Event|39|||
163064946|NCT01155570|588943644|FG000|Overall Study|Lack of Efficacy|46|||
163064947|NCT01155570|588943644|FG000|Overall Study|Participant's Economic Reasons|17|||
163064948|NCT01155570|588943644|FG000|Overall Study|No Hospital Visits|7|||
163064949|NCT01155570|588943644|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
163064950|NCT01155570|588943644|FG000|Overall Study|Adverse Event + Other Reasons|7|||
163064951|NCT01155570|588943644|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
163064952|NCT01155570|588943644|FG000|Overall Study|Other Reasons|23|||
163064953|NCT01922934|588943645|FG000|Eligible Patients|Death|0|||
163064954|NCT01922934|588943646|FG001|Eligible Patients|Death|7|||
163064955|NCT01922934|588943645|FG000|Eligible Patients|Physician Decision|17|||
163064956|NCT01922934|588943646|FG001|Eligible Patients|Physician Decision|0|||
163064957|NCT01922934|588943645|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
163064958|NCT01922934|588943646|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
163064959|NCT01922934|588943645|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
163064960|NCT01922934|588943646|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
163064961|NCT01922934|588943645|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
163064962|NCT01922934|588943646|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
163025105|NCT04013672|588792793|FG000|Overall Study|Death|1|||
163025106|NCT04013672|588792794|FG001|Overall Study|Death|0|||
163025107|NCT04013672|588792793|FG000|Overall Study|Physician Decision|5|||
163025108|NCT04013672|588792794|FG001|Overall Study|Physician Decision|0|||
163025109|NCT02847494|588792799|FG000|Overall Study|Lost to Follow-up|8|||
163025110|NCT02847494|588792800|FG001|Overall Study|Lost to Follow-up|5|||
163025111|NCT03887442|588792804|FG000|Overall Study|Adverse Event|1|||
163025112|NCT03887442|588792805|FG001|Overall Study|Adverse Event|0|||
163025113|NCT01628198|588792808|FG000|Overall Study|Lost to Follow-up|7|||
163025114|NCT01628198|588792808|FG000|Overall Study|Withdrawal by Subject|10|||
163025115|NCT01628198|588792808|FG000|Overall Study|Screen failure|1|||
163025116|NCT00022698|588792809|FG000|Overall Study|Adverse Event|5|||
163025117|NCT00022698|588792810|FG001|Overall Study|Adverse Event|9|||
163025118|NCT00022698|588792809|FG000|Overall Study|Death|0|||
163025119|NCT00022698|588792810|FG001|Overall Study|Death|2|||
163025120|NCT00022698|588792809|FG000|Overall Study|Failure to return|0|||
163025121|NCT00022698|588792810|FG001|Overall Study|Failure to return|1|||
163025122|NCT00022698|588792809|FG000|Overall Study|Refused treatment|0|||
163025123|NCT00022698|588792810|FG001|Overall Study|Refused treatment|2|||
163025124|NCT00022698|588792809|FG000|Overall Study|Insufficient therapeutic response|2|||
163025125|NCT00022698|588792810|FG001|Overall Study|Insufficient therapeutic response|14|||
163025126|NCT00022698|588792809|FG000|Overall Study|Administrative /other|1|||
163025127|NCT00022698|588792810|FG001|Overall Study|Administrative /other|7|||
163025128|NCT03386994|588792811|FG000|Overall Study|Lung transplant|1|||
163025129|NCT03386994|588792811|FG000|Overall Study|Adverse Event|14|||
163025130|NCT03386994|588792811|FG000|Overall Study|Lost to Follow-up|4|||
163025131|NCT03386994|588792811|FG000|Overall Study|Withdrawal by Subject|3|||
163025132|NCT03386994|588792811|FG000|Overall Study|Death|16|||
163025133|NCT04553471|588792813|FG000|Overall Study|Did not start treatment on protocol|3|||
163025134|NCT04553471|588792813|FG000|Overall Study|Death|1|||
163025135|NCT01441765|588792814|FG000|Overall Study|Death|1|||
163025136|NCT01441765|588792815|FG001|Overall Study|Death|0|||
163025137|NCT00813813|588792818|FG000|Overall Study|Withdrawal by Subject|1|||
163025138|NCT00813813|588792819|FG001|Overall Study|Withdrawal by Subject|1|||
163025139|NCT00813813|588792818|FG000|Overall Study|Lost to Follow-up|2|||
163025140|NCT00813813|588792819|FG001|Overall Study|Lost to Follow-up|7|||
163025141|NCT00813813|588792818|FG000|Overall Study|Other|0|||
163025142|NCT00813813|588792819|FG001|Overall Study|Other|1|||
163025143|NCT01684943|588792822|FG000|Overall Study|Inadequate Venous Access|3|||
163025144|NCT01684943|588792823|FG001|Overall Study|Inadequate Venous Access|0|||
163025145|NCT01684943|588792824|FG002|Overall Study|Inadequate Venous Access|0|||
163025146|NCT01684943|588792822|FG000|Overall Study|Principal Investigator Determination|1|||
163025147|NCT01684943|588792823|FG001|Overall Study|Principal Investigator Determination|0|||
163025148|NCT01684943|588792824|FG002|Overall Study|Principal Investigator Determination|0|||
163025149|NCT01684943|588792822|FG000|Overall Study|Excluded from Analysis|1|||
163025150|NCT01684943|588792823|FG001|Overall Study|Excluded from Analysis|1|||
163025151|NCT01684943|588792824|FG002|Overall Study|Excluded from Analysis|1|||
163025152|NCT01684943|588792822|FG000|Overall Study|Lost to Follow-up|3|||
163025153|NCT01684943|588792823|FG001|Overall Study|Lost to Follow-up|0|||
163025154|NCT01684943|588792824|FG002|Overall Study|Lost to Follow-up|0|||
163025155|NCT01684943|588792822|FG000|Overall Study|Planning Pregnancy|1|||
163025156|NCT01684943|588792823|FG001|Overall Study|Planning Pregnancy|0|||
163025157|NCT01684943|588792824|FG002|Overall Study|Planning Pregnancy|0|||
163025158|NCT01493284|588792825|FG000|Overall Study|Death|29|||
163025159|NCT01493284|588792825|FG000|Overall Study|Withdrawal by Subject|32|||
163025160|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
163025161|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
163025162|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
163025163|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025164|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025165|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025166|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
163025167|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025168|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
163025169|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
163025170|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025171|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163064963|NCT01922934|588943645|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
163064964|NCT01922934|588943646|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
163064965|NCT02774889|588943649|FG000|Overall Study|Lost to Follow-up|2|||
163064966|NCT02774889|588943650|FG001|Overall Study|Lost to Follow-up|1|||
163064967|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
163064968|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
163064969|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
163064970|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
163064971|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
163064972|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
163064973|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
163064974|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
163064975|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
163064976|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
163064977|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
163064978|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
163064979|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
163064980|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
163064981|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
163064982|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
163064983|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
163064984|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
163064985|NCT01069939|588943651|FG000|Randomised and Included in the Analyses|Removal|1|||
163064986|NCT01069939|588943652|FG001|Randomised and Included in the Analyses|Removal|0|||
163064987|NCT00724945|588943653|FG000|Period 1|non-compliance|1|||
163064988|NCT00724945|588943654|FG001|Period 1|non-compliance|0|||
163064989|NCT00724945|588943653|FG000|Period 1|Adverse Event|1|||
163064990|NCT00724945|588943654|FG001|Period 1|Adverse Event|1|||
163064991|NCT00724945|588943653|FG000|Period 1|Lost to Follow-up|1|||
163064992|NCT00724945|588943654|FG001|Period 1|Lost to Follow-up|0|||
163064993|NCT00724945|588943653|FG000|Period 2|lens comfort issue|3|||
163064994|NCT00724945|588943654|FG001|Period 2|lens comfort issue|0|||
163064995|NCT00724945|588943653|FG000|Period 2|lens physiology issue|1|||
163064996|NCT00724945|588943654|FG001|Period 2|lens physiology issue|0|||
163064997|NCT05166876|588943655|FG000|Overall Study|Withdrawal by Subject|1|||
163064998|NCT05166876|588943656|FG001|Overall Study|Withdrawal by Subject|0|||
163064999|NCT05166876|588943657|FG002|Overall Study|Withdrawal by Subject|0|||
163065000|NCT00658528|588943658|FG000|Overall Study|Adverse Event|5|||
163065001|NCT00658528|588943659|FG001|Overall Study|Adverse Event|7|||
163065002|NCT00658528|588943658|FG000|Overall Study|Lost to Follow-up|14|||
163065003|NCT00658528|588943659|FG001|Overall Study|Lost to Follow-up|22|||
163065004|NCT00658528|588943658|FG000|Overall Study|Withdrawal by Subject|8|||
163065005|NCT00658528|588943659|FG001|Overall Study|Withdrawal by Subject|6|||
163065006|NCT00658528|588943658|FG000|Overall Study|Withdrawal of consent|5|||
163065007|NCT00658528|588943659|FG001|Overall Study|Withdrawal of consent|6|||
163065008|NCT00658528|588943658|FG000|Overall Study|Other|8|||
163065009|NCT00658528|588943659|FG001|Overall Study|Other|4|||
163065010|NCT01147458|588943666|FG000|First Intervention|Study terminated by sponsor|8|||
163065011|NCT01147458|588943667|FG001|First Intervention|Study terminated by sponsor|8|||
163065012|NCT01147458|588943668|FG002|First Intervention|Study terminated by sponsor|7|||
163065013|NCT01147458|588943669|FG003|First Intervention|Study terminated by sponsor|8|||
163065014|NCT01147458|588943666|FG000|First Intervention|Protocol Violation|2|||
163065015|NCT01147458|588943667|FG001|First Intervention|Protocol Violation|3|||
163065016|NCT01147458|588943668|FG002|First Intervention|Protocol Violation|2|||
163065017|NCT01147458|588943669|FG003|First Intervention|Protocol Violation|3|||
163065018|NCT01147458|588943666|FG000|First Intervention|Withdrawal by Subject|3|||
163065019|NCT01147458|588943667|FG001|First Intervention|Withdrawal by Subject|0|||
163065020|NCT01147458|588943668|FG002|First Intervention|Withdrawal by Subject|1|||
163065021|NCT01147458|588943669|FG003|First Intervention|Withdrawal by Subject|0|||
163065022|NCT01147458|588943666|FG000|First Intervention|Adverse Event|0|||
163065023|NCT01147458|588943667|FG001|First Intervention|Adverse Event|3|||
163065024|NCT01147458|588943668|FG002|First Intervention|Adverse Event|2|||
163065025|NCT01147458|588943669|FG003|First Intervention|Adverse Event|3|||
163065026|NCT01147458|588943666|FG000|First Intervention|Other|1|||
163065027|NCT01147458|588943667|FG001|First Intervention|Other|2|||
163065028|NCT01147458|588943668|FG002|First Intervention|Other|0|||
163065029|NCT01147458|588943669|FG003|First Intervention|Other|0|||
163065030|NCT01147458|588943666|FG000|Second Intervention|Study terminated by sponsor|7|||
162643880|NCT03814746|587411770|FG001|Overall Study|Pregnancy|1|||
162643881|NCT03814746|587411771|FG002|Overall Study|Pregnancy|1|||
162643882|NCT03814746|587411769|FG000|Overall Study|Protocol Violation|1|||
162643883|NCT03814746|587411770|FG001|Overall Study|Protocol Violation|0|||
162643884|NCT03814746|587411771|FG002|Overall Study|Protocol Violation|0|||
163065031|NCT01147458|588943667|FG001|Second Intervention|Study terminated by sponsor|5|||
163065032|NCT01147458|588943668|FG002|Second Intervention|Study terminated by sponsor|5|||
163065033|NCT01147458|588943669|FG003|Second Intervention|Study terminated by sponsor|3|||
163065034|NCT01147458|588943666|FG000|Second Intervention|Protocol Violation|0|||
163065035|NCT01147458|588943667|FG001|Second Intervention|Protocol Violation|1|||
163065036|NCT01147458|588943668|FG002|Second Intervention|Protocol Violation|1|||
163065037|NCT01147458|588943669|FG003|Second Intervention|Protocol Violation|0|||
163065038|NCT01147458|588943666|FG000|Second Intervention|Withdrawal by Subject|0|||
163065039|NCT01147458|588943667|FG001|Second Intervention|Withdrawal by Subject|1|||
163065040|NCT01147458|588943668|FG002|Second Intervention|Withdrawal by Subject|0|||
163065041|NCT01147458|588943669|FG003|Second Intervention|Withdrawal by Subject|0|||
163065042|NCT01147458|588943666|FG000|Second Intervention|Adverse Event|2|||
163065043|NCT01147458|588943667|FG001|Second Intervention|Adverse Event|0|||
163065044|NCT01147458|588943668|FG002|Second Intervention|Adverse Event|1|||
163065045|NCT01147458|588943669|FG003|Second Intervention|Adverse Event|1|||
163065046|NCT01147458|588943666|FG000|Second Intervention|Other|0|||
163065047|NCT01147458|588943667|FG001|Second Intervention|Other|0|||
163065048|NCT01147458|588943668|FG002|Second Intervention|Other|1|||
163065049|NCT01147458|588943669|FG003|Second Intervention|Other|0|||
163065050|NCT02811159|588943681|FG000|Treatment Course 1|Lost to Follow-up|1|||
163065051|NCT04603066|588943682|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
163065052|NCT04603066|588943683|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
163065053|NCT04409002|588943684|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
163065054|NCT00963235|588945669|FG000|Overall Study|Withdrawal by Subject|22|||
163065055|NCT00963235|588945669|FG000|Overall Study|Lost to Follow-up|14|||
163065056|NCT00963235|588945669|FG000|Overall Study|Failed to return|9|||
163065057|NCT00963235|588945669|FG000|Overall Study|Protocol Violation|7|||
163065058|NCT00963235|588945669|FG000|Overall Study|Adverse Event|5|||
163065059|NCT00963235|588945669|FG000|Overall Study|Physician Decision|2|||
163065060|NCT00963235|588945669|FG000|Overall Study|Other|1|||
163065061|NCT01756235|588945670|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
163065062|NCT02327078|588945677|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065063|NCT02327078|588945678|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065064|NCT02327078|588945679|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
163065065|NCT02327078|588945680|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065066|NCT02327078|588945681|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
163065067|NCT02327078|588945682|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065068|NCT02327078|588945683|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
163065069|NCT02327078|588945684|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
163065070|NCT02327078|588945685|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
163065071|NCT02327078|588945677|FG000|Overall Study|Death|2|||
163065072|NCT02327078|588945678|FG001|Overall Study|Death|4|||
163065073|NCT02327078|588945679|FG002|Overall Study|Death|10|||
163065074|NCT02327078|588945680|FG003|Overall Study|Death|6|||
163065075|NCT02327078|588945681|FG004|Overall Study|Death|4|||
163065076|NCT02327078|588945682|FG005|Overall Study|Death|3|||
163065077|NCT02327078|588945683|FG006|Overall Study|Death|2|||
163065078|NCT02327078|588945684|FG007|Overall Study|Death|51|||
163065079|NCT02327078|588945685|FG008|Overall Study|Death|97|||
163065080|NCT02327078|588945677|FG000|Overall Study|Lost to Follow-up|0|||
163065081|NCT02327078|588945678|FG001|Overall Study|Lost to Follow-up|1|||
163065082|NCT02327078|588945679|FG002|Overall Study|Lost to Follow-up|1|||
163065083|NCT02327078|588945680|FG003|Overall Study|Lost to Follow-up|0|||
163065084|NCT02327078|588945681|FG004|Overall Study|Lost to Follow-up|0|||
163065085|NCT02327078|588945682|FG005|Overall Study|Lost to Follow-up|0|||
163065086|NCT02327078|588945683|FG006|Overall Study|Lost to Follow-up|0|||
163065087|NCT02327078|588945684|FG007|Overall Study|Lost to Follow-up|2|||
163065088|NCT02327078|588945685|FG008|Overall Study|Lost to Follow-up|5|||
163065089|NCT02327078|588945677|FG000|Overall Study|Site Terminated by Sponsor|1|||
163065090|NCT02327078|588945678|FG001|Overall Study|Site Terminated by Sponsor|0|||
163065091|NCT02327078|588945679|FG002|Overall Study|Site Terminated by Sponsor|1|||
163065092|NCT02327078|588945680|FG003|Overall Study|Site Terminated by Sponsor|4|||
163065093|NCT02327078|588945681|FG004|Overall Study|Site Terminated by Sponsor|0|||
162643885|NCT05089682|587411772|FG000|Overall Study|Withdrawal by Subject|2|||
163065094|NCT02327078|588945682|FG005|Overall Study|Site Terminated by Sponsor|0|||
163065095|NCT02327078|588945683|FG006|Overall Study|Site Terminated by Sponsor|0|||
163065096|NCT02327078|588945684|FG007|Overall Study|Site Terminated by Sponsor|11|||
163065097|NCT02327078|588945685|FG008|Overall Study|Site Terminated by Sponsor|25|||
163065098|NCT02327078|588945677|FG000|Overall Study|Physician Decision|0|||
162643886|NCT00371254|587411778|FG000|Overall Study|Disease progression|13|||
163065099|NCT02327078|588945678|FG001|Overall Study|Physician Decision|0|||
163065100|NCT02327078|588945679|FG002|Overall Study|Physician Decision|0|||
163065101|NCT02327078|588945680|FG003|Overall Study|Physician Decision|1|||
163065102|NCT02327078|588945681|FG004|Overall Study|Physician Decision|0|||
163065103|NCT02327078|588945682|FG005|Overall Study|Physician Decision|0|||
162643887|NCT00371254|587411779|FG001|Overall Study|Disease progression|13|||
162643888|NCT00371254|587411778|FG000|Overall Study|Study drug toxicity|3|||
162643889|NCT00371254|587411779|FG001|Overall Study|Study drug toxicity|5|||
162643890|NCT00371254|587411778|FG000|Overall Study|Subject request|5|||
162643891|NCT00371254|587411779|FG001|Overall Study|Subject request|0|||
162643892|NCT00371254|587411778|FG000|Overall Study|Investigator Decision|2|||
162643893|NCT00371254|587411779|FG001|Overall Study|Investigator Decision|0|||
162643894|NCT00371254|587411778|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162643895|NCT00371254|587411779|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162643896|NCT00371254|587411778|FG000|Overall Study|Lost to Follow-up|0|||
162643897|NCT00371254|587411779|FG001|Overall Study|Lost to Follow-up|1|||
162643898|NCT00371254|587411778|FG000|Overall Study|Withdrawal by Subject|0|||
162643899|NCT00371254|587411779|FG001|Overall Study|Withdrawal by Subject|1|||
162643900|NCT01817725|587411780|FG000|Overall Study|Withdrawal by Subject|1|||
162643901|NCT00909779|587411781|FG000|Overall Study|Adverse Event|53|||
162643902|NCT00909779|587411782|FG001|Overall Study|Adverse Event|55|||
162643903|NCT00909779|587411781|FG000|Overall Study|Lack of Efficacy|7|||
162643904|NCT00909779|587411782|FG001|Overall Study|Lack of Efficacy|4|||
163025172|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025173|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
163025174|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
163025175|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
163025176|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025177|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025178|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025179|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025180|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
163025181|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025182|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
163025183|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025184|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025185|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025186|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025187|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
163025188|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
163025189|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025190|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
163025191|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025192|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025193|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025194|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
163025195|NCT03395184|588792826|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
163025196|NCT03395184|588792827|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
163025197|NCT03395184|588792828|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
163025198|NCT03395184|588792829|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
163025199|NCT03395184|588792830|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
163025200|NCT03395184|588792831|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
163025201|NCT03395184|588792832|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
163025202|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
163025203|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
163025204|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
163025205|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
163025206|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
163025207|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
163025208|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
163025209|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025210|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025211|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
163025212|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
163025213|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
163025214|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
163025215|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
163025216|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025217|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163065104|NCT02327078|588945683|FG006|Overall Study|Physician Decision|0|||
163025218|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163065105|NCT02327078|588945684|FG007|Overall Study|Physician Decision|0|||
163065106|NCT02327078|588945685|FG008|Overall Study|Physician Decision|1|||
162643905|NCT00909779|587411781|FG000|Overall Study|Lost to Follow-up|19|||
162643906|NCT00909779|587411782|FG001|Overall Study|Lost to Follow-up|15|||
162643907|NCT00909779|587411781|FG000|Overall Study|Physician Decision|8|||
162643908|NCT00909779|587411782|FG001|Overall Study|Physician Decision|2|||
162717829|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162717830|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163025219|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025220|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
163025221|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025222|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
163025223|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025224|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025225|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
163025226|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
163025227|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
163025228|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
163025229|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
163025230|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025231|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025232|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025233|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
163025234|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025235|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
163025236|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
163025237|NCT03395184|588792826|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025238|NCT03395184|588792827|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025239|NCT03395184|588792828|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
163025240|NCT03395184|588792829|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
163025241|NCT03395184|588792830|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
163025242|NCT03395184|588792831|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
163025243|NCT03395184|588792832|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
163025244|NCT05033262|588792838|FG000|Overall Study|Lost to Follow-up|1|||
163025245|NCT05033262|588792839|FG001|Overall Study|Lost to Follow-up|0|||
163025246|NCT05033262|588792840|FG002|Overall Study|Lost to Follow-up|0|||
163025247|NCT05033262|588792841|FG003|Overall Study|Lost to Follow-up|1|||
163025248|NCT03197467|588794527|FG000|Overall Study|Withdrawal by Subject|1|||
163025249|NCT03666533|588794528|FG000|Overall Study|Lost to Follow-up|2|||
163025250|NCT03666533|588794529|FG001|Overall Study|Lost to Follow-up|2|||
163025251|NCT02017717|588794530|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025252|NCT02017717|588794531|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025253|NCT02017717|588794532|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025254|NCT02017717|588794533|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025255|NCT02017717|588794534|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025256|NCT02017717|588794535|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025257|NCT02017717|588794536|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025258|NCT02017717|588794537|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
163025259|NCT02017717|588794538|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
163025260|NCT02017717|588794530|FG000|Before Treatment Period|Participant request to stop therapy|0|||
163025261|NCT02017717|588794531|FG001|Before Treatment Period|Participant request to stop therapy|0|||
163025262|NCT02017717|588794532|FG002|Before Treatment Period|Participant request to stop therapy|0|||
163025263|NCT02017717|588794533|FG003|Before Treatment Period|Participant request to stop therapy|0|||
163025264|NCT02017717|588794534|FG004|Before Treatment Period|Participant request to stop therapy|0|||
163025265|NCT02017717|588794535|FG005|Before Treatment Period|Participant request to stop therapy|0|||
163025266|NCT02017717|588794536|FG006|Before Treatment Period|Participant request to stop therapy|0|||
163025267|NCT02017717|588794537|FG007|Before Treatment Period|Participant request to stop therapy|0|||
163025268|NCT02017717|588794538|FG008|Before Treatment Period|Participant request to stop therapy|5|||
163025269|NCT02017717|588794530|FG000|Before Treatment Period|Participant withdrew consent|0|||
163025270|NCT02017717|588794531|FG001|Before Treatment Period|Participant withdrew consent|0|||
163025271|NCT02017717|588794532|FG002|Before Treatment Period|Participant withdrew consent|0|||
163025272|NCT02017717|588794533|FG003|Before Treatment Period|Participant withdrew consent|0|||
163025273|NCT02017717|588794534|FG004|Before Treatment Period|Participant withdrew consent|0|||
163025274|NCT02017717|588794535|FG005|Before Treatment Period|Participant withdrew consent|0|||
163025275|NCT02017717|588794536|FG006|Before Treatment Period|Participant withdrew consent|2|||
163025276|NCT02017717|588794537|FG007|Before Treatment Period|Participant withdrew consent|0|||
163025277|NCT02017717|588794538|FG008|Before Treatment Period|Participant withdrew consent|11|||
163025278|NCT02017717|588794530|FG000|Before Treatment Period|Lost to Follow-up|0|||
163025279|NCT02017717|588794531|FG001|Before Treatment Period|Lost to Follow-up|0|||
163025280|NCT02017717|588794532|FG002|Before Treatment Period|Lost to Follow-up|0|||
163025281|NCT02017717|588794533|FG003|Before Treatment Period|Lost to Follow-up|0|||
163025282|NCT02017717|588794534|FG004|Before Treatment Period|Lost to Follow-up|0|||
162717831|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162643909|NCT00909779|587411781|FG000|Overall Study|Protocol Violation|2|||
162643910|NCT00909779|587411782|FG001|Overall Study|Protocol Violation|5|||
162643911|NCT00909779|587411781|FG000|Overall Study|Withdrawal by Subject|116|||
162643912|NCT00909779|587411782|FG001|Overall Study|Withdrawal by Subject|80|||
162643913|NCT00909779|587411781|FG000|Overall Study|Site Ceasing Operation|2|||
163025283|NCT02017717|588794535|FG005|Before Treatment Period|Lost to Follow-up|0|||
163025284|NCT02017717|588794536|FG006|Before Treatment Period|Lost to Follow-up|0|||
163025285|NCT02017717|588794537|FG007|Before Treatment Period|Lost to Follow-up|0|||
163025286|NCT02017717|588794538|FG008|Before Treatment Period|Lost to Follow-up|1|||
163025287|NCT02017717|588794530|FG000|Before Treatment Period|Participant no longer met criteria|0|||
163025288|NCT02017717|588794531|FG001|Before Treatment Period|Participant no longer met criteria|0|||
163025289|NCT02017717|588794532|FG002|Before Treatment Period|Participant no longer met criteria|0|||
163025290|NCT02017717|588794533|FG003|Before Treatment Period|Participant no longer met criteria|0|||
163025291|NCT02017717|588794534|FG004|Before Treatment Period|Participant no longer met criteria|0|||
163025292|NCT02017717|588794535|FG005|Before Treatment Period|Participant no longer met criteria|1|||
163025293|NCT02017717|588794536|FG006|Before Treatment Period|Participant no longer met criteria|0|||
163025294|NCT02017717|588794537|FG007|Before Treatment Period|Participant no longer met criteria|1|||
163025295|NCT02017717|588794538|FG008|Before Treatment Period|Participant no longer met criteria|2|||
163025296|NCT02017717|588794530|FG000|Before Treatment Period|other reason|0|||
163025297|NCT02017717|588794531|FG001|Before Treatment Period|other reason|0|||
163025298|NCT02017717|588794532|FG002|Before Treatment Period|other reason|0|||
163025299|NCT02017717|588794533|FG003|Before Treatment Period|other reason|0|||
163025300|NCT02017717|588794534|FG004|Before Treatment Period|other reason|0|||
163025301|NCT02017717|588794535|FG005|Before Treatment Period|other reason|0|||
163025302|NCT02017717|588794536|FG006|Before Treatment Period|other reason|0|||
163025303|NCT02017717|588794537|FG007|Before Treatment Period|other reason|0|||
163025304|NCT02017717|588794538|FG008|Before Treatment Period|other reason|1|||
163025305|NCT02017717|588794530|FG000|Treatment Period|Disease progression|7|||
163025306|NCT02017717|588794531|FG001|Treatment Period|Disease progression|9|||
163025307|NCT02017717|588794532|FG002|Treatment Period|Disease progression|12|||
163025308|NCT02017717|588794533|FG003|Treatment Period|Disease progression|20|||
163025309|NCT02017717|588794534|FG004|Treatment Period|Disease progression|26|||
163025310|NCT02017717|588794535|FG005|Treatment Period|Disease progression|16|||
163025311|NCT02017717|588794536|FG006|Treatment Period|Disease progression|22|||
163025312|NCT02017717|588794537|FG007|Treatment Period|Disease progression|165|||
163025313|NCT02017717|588794538|FG008|Treatment Period|Disease progression|135|||
163025314|NCT02017717|588794530|FG000|Treatment Period|Study drug toxicity|3|||
163025315|NCT02017717|588794531|FG001|Treatment Period|Study drug toxicity|0|||
163025316|NCT02017717|588794532|FG002|Treatment Period|Study drug toxicity|1|||
163025317|NCT02017717|588794533|FG003|Treatment Period|Study drug toxicity|4|||
163025318|NCT02017717|588794534|FG004|Treatment Period|Study drug toxicity|4|||
163025319|NCT02017717|588794535|FG005|Treatment Period|Study drug toxicity|5|||
163025320|NCT02017717|588794536|FG006|Treatment Period|Study drug toxicity|3|||
163025321|NCT02017717|588794537|FG007|Treatment Period|Study drug toxicity|7|||
163025322|NCT02017717|588794538|FG008|Treatment Period|Study drug toxicity|11|||
163025323|NCT02017717|588794530|FG000|Treatment Period|Death|0|||
163025324|NCT02017717|588794531|FG001|Treatment Period|Death|0|||
163025325|NCT02017717|588794532|FG002|Treatment Period|Death|1|||
163025326|NCT02017717|588794533|FG003|Treatment Period|Death|0|||
163025327|NCT02017717|588794534|FG004|Treatment Period|Death|0|||
163025328|NCT02017717|588794535|FG005|Treatment Period|Death|2|||
163025329|NCT02017717|588794536|FG006|Treatment Period|Death|0|||
163025330|NCT02017717|588794537|FG007|Treatment Period|Death|0|||
163025331|NCT02017717|588794538|FG008|Treatment Period|Death|0|||
163025332|NCT02017717|588794530|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
163025333|NCT02017717|588794531|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
163025334|NCT02017717|588794532|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
163025335|NCT02017717|588794533|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
163025336|NCT02017717|588794534|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
163025337|NCT02017717|588794535|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
163025338|NCT02017717|588794536|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
163025339|NCT02017717|588794537|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
163025340|NCT02017717|588794538|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
163025341|NCT02017717|588794530|FG000|Treatment Period|Participant request to stop therapy|0|||
163025342|NCT02017717|588794531|FG001|Treatment Period|Participant request to stop therapy|0|||
163025343|NCT02017717|588794532|FG002|Treatment Period|Participant request to stop therapy|3|||
163025344|NCT02017717|588794533|FG003|Treatment Period|Participant request to stop therapy|6|||
163025345|NCT02017717|588794534|FG004|Treatment Period|Participant request to stop therapy|0|||
163025346|NCT02017717|588794535|FG005|Treatment Period|Participant request to stop therapy|2|||
163065107|NCT02327078|588945677|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
162643914|NCT00909779|587411782|FG001|Overall Study|Site Ceasing Operation|2|||
162643915|NCT00909779|587411781|FG000|Overall Study|Medical Monitor Decision|1|||
162643916|NCT00909779|587411782|FG001|Overall Study|Medical Monitor Decision|0|||
162643917|NCT00909779|587411781|FG000|Overall Study|Noncompliance|1|||
162643918|NCT00909779|587411782|FG001|Overall Study|Noncompliance|1|||
162643919|NCT00909779|587411781|FG000|Overall Study|Randomized in error|1|||
162643920|NCT00909779|587411782|FG001|Overall Study|Randomized in error|1|||
162643921|NCT02809677|587411783|FG000|Overall Study|Withdrawal by Subject|8|||
162643922|NCT05172544|587411786|FG000|Overall Study|Withdrawal by Subject|1|||
162643923|NCT05172544|587411787|FG001|Overall Study|Withdrawal by Subject|0|||
162643924|NCT05172544|587411788|FG002|Overall Study|Withdrawal by Subject|0|||
162643925|NCT05172544|587411786|FG000|Overall Study|Physician Decision|0|||
162643926|NCT05172544|587411787|FG001|Overall Study|Physician Decision|0|||
162643927|NCT05172544|587411788|FG002|Overall Study|Physician Decision|1|||
162643928|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
162643929|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
162643930|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
162643931|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
162643932|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
163025347|NCT02017717|588794536|FG006|Treatment Period|Participant request to stop therapy|1|||
163025348|NCT02017717|588794537|FG007|Treatment Period|Participant request to stop therapy|4|||
163025349|NCT02017717|588794538|FG008|Treatment Period|Participant request to stop therapy|7|||
163025350|NCT02017717|588794530|FG000|Treatment Period|Participant withdrew consent|0|||
163025351|NCT02017717|588794531|FG001|Treatment Period|Participant withdrew consent|0|||
163025352|NCT02017717|588794532|FG002|Treatment Period|Participant withdrew consent|1|||
163025353|NCT02017717|588794533|FG003|Treatment Period|Participant withdrew consent|0|||
163025354|NCT02017717|588794534|FG004|Treatment Period|Participant withdrew consent|0|||
163025355|NCT02017717|588794535|FG005|Treatment Period|Participant withdrew consent|2|||
163025356|NCT02017717|588794536|FG006|Treatment Period|Participant withdrew consent|0|||
163025357|NCT02017717|588794537|FG007|Treatment Period|Participant withdrew consent|1|||
163025358|NCT02017717|588794538|FG008|Treatment Period|Participant withdrew consent|4|||
163025359|NCT02017717|588794530|FG000|Treatment Period|Participant no longer met criteria|0|||
163025360|NCT02017717|588794531|FG001|Treatment Period|Participant no longer met criteria|0|||
163025361|NCT02017717|588794532|FG002|Treatment Period|Participant no longer met criteria|0|||
163025362|NCT02017717|588794533|FG003|Treatment Period|Participant no longer met criteria|0|||
163025363|NCT02017717|588794534|FG004|Treatment Period|Participant no longer met criteria|0|||
163025364|NCT02017717|588794535|FG005|Treatment Period|Participant no longer met criteria|0|||
163025365|NCT02017717|588794536|FG006|Treatment Period|Participant no longer met criteria|0|||
163025366|NCT02017717|588794537|FG007|Treatment Period|Participant no longer met criteria|0|||
163025367|NCT02017717|588794538|FG008|Treatment Period|Participant no longer met criteria|1|||
163025368|NCT02017717|588794530|FG000|Treatment Period|Other reasons|0|||
163025369|NCT02017717|588794531|FG001|Treatment Period|Other reasons|0|||
163025370|NCT02017717|588794532|FG002|Treatment Period|Other reasons|0|||
163025371|NCT02017717|588794533|FG003|Treatment Period|Other reasons|1|||
163025372|NCT02017717|588794534|FG004|Treatment Period|Other reasons|0|||
163025373|NCT02017717|588794535|FG005|Treatment Period|Other reasons|1|||
163025374|NCT02017717|588794536|FG006|Treatment Period|Other reasons|1|||
163025375|NCT02017717|588794537|FG007|Treatment Period|Other reasons|1|||
163025376|NCT02017717|588794538|FG008|Treatment Period|Other reasons|1|||
163025377|NCT02017717|588794530|FG000|Treatment Period|Maximum clinical benefit|0|||
163025378|NCT02017717|588794531|FG001|Treatment Period|Maximum clinical benefit|0|||
163025379|NCT02017717|588794532|FG002|Treatment Period|Maximum clinical benefit|0|||
163025380|NCT02017717|588794533|FG003|Treatment Period|Maximum clinical benefit|0|||
163025381|NCT02017717|588794534|FG004|Treatment Period|Maximum clinical benefit|0|||
163025382|NCT02017717|588794535|FG005|Treatment Period|Maximum clinical benefit|0|||
163025383|NCT02017717|588794536|FG006|Treatment Period|Maximum clinical benefit|0|||
163025384|NCT02017717|588794537|FG007|Treatment Period|Maximum clinical benefit|0|||
163025385|NCT02017717|588794538|FG008|Treatment Period|Maximum clinical benefit|1|||
163025386|NCT02017717|588794530|FG000|Treatment Period|Not reported|0|||
163025387|NCT02017717|588794531|FG001|Treatment Period|Not reported|1|||
163025388|NCT02017717|588794532|FG002|Treatment Period|Not reported|0|||
163025389|NCT02017717|588794533|FG003|Treatment Period|Not reported|0|||
163025390|NCT02017717|588794534|FG004|Treatment Period|Not reported|0|||
163025391|NCT02017717|588794535|FG005|Treatment Period|Not reported|0|||
163025392|NCT02017717|588794536|FG006|Treatment Period|Not reported|0|||
162643933|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
163025393|NCT02017717|588794537|FG007|Treatment Period|Not reported|0|||
163025394|NCT02017717|588794538|FG008|Treatment Period|Not reported|0|||
163025395|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
163025396|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
163025397|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
162643934|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
162643935|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
162643936|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
163065108|NCT02327078|588945678|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163065109|NCT02327078|588945679|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
163065110|NCT02327078|588945680|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065111|NCT02327078|588945681|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065112|NCT02327078|588945682|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
162643937|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
162643938|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
162643939|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
162643940|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
162643941|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
162643942|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
163065113|NCT02327078|588945683|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
163065114|NCT02327078|588945684|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
163065115|NCT02327078|588945685|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
163065116|NCT02327078|588945677|FG000|Overall Study|Reason not Specified|0|||
163065117|NCT02327078|588945678|FG001|Overall Study|Reason not Specified|0|||
163065118|NCT02327078|588945679|FG002|Overall Study|Reason not Specified|0|||
163065119|NCT02327078|588945680|FG003|Overall Study|Reason not Specified|0|||
163065120|NCT02327078|588945681|FG004|Overall Study|Reason not Specified|0|||
163065121|NCT02327078|588945682|FG005|Overall Study|Reason not Specified|0|||
163065122|NCT02327078|588945683|FG006|Overall Study|Reason not Specified|0|||
163065123|NCT02327078|588945684|FG007|Overall Study|Reason not Specified|5|||
162643943|NCT00561080|587411793|FG000|Vaccination Period (up to Month 4)|Other|0|||
162643944|NCT00561080|587411794|FG001|Vaccination Period (up to Month 4)|Other|2|||
163025398|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
163025399|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
163025400|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
163025401|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
163025402|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
163025403|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
163025404|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
163025405|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
163025406|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
163025407|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
163065124|NCT02327078|588945685|FG008|Overall Study|Reason not Specified|12|||
163065125|NCT04092777|588945687|FG000|Overall Study|Lost to Follow-up|28|||
162643945|NCT00561080|587411795|FG002|Vaccination Period (up to Month 4)|Other|1|||
163025408|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
163025409|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
163025410|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
163025411|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
163025412|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
163025413|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
163025414|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
163025415|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
163025416|NCT04488419|588794540|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
163025417|NCT04488419|588794541|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
163025418|NCT04488419|588794542|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
163025419|NCT04488419|588794540|FG000|Primary Analysis Population|Adverse Event|6|||
163025420|NCT04488419|588794541|FG001|Primary Analysis Population|Adverse Event|9|||
163025421|NCT04488419|588794542|FG002|Primary Analysis Population|Adverse Event|0|||
163025422|NCT04488419|588794540|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
163025423|NCT04488419|588794541|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
163025424|NCT04488419|588794542|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
163025425|NCT04488419|588794540|FG000|Primary Analysis Population|Protocol Violation|1|||
163025426|NCT04488419|588794541|FG001|Primary Analysis Population|Protocol Violation|1|||
163025427|NCT04488419|588794542|FG002|Primary Analysis Population|Protocol Violation|0|||
163025428|NCT04488419|588794540|FG000|Primary Analysis Population|Undetermined|7|||
163025429|NCT04488419|588794541|FG001|Primary Analysis Population|Undetermined|3|||
163025430|NCT04488419|588794542|FG002|Primary Analysis Population|Undetermined|0|||
163025431|NCT04488419|588794540|FG000|Primary Analysis Population|>1 Reason|2|||
163025432|NCT04488419|588794541|FG001|Primary Analysis Population|>1 Reason|4|||
163025433|NCT04488419|588794542|FG002|Primary Analysis Population|>1 Reason|0|||
163025434|NCT00970632|588794548|FG000|Overall Study|Adverse Event|2|||
163025435|NCT00970632|588794549|FG001|Overall Study|Adverse Event|2|||
163025436|NCT00970632|588794550|FG002|Overall Study|Adverse Event|1|||
163025437|NCT00970632|588794548|FG000|Overall Study|Lack of Efficacy|3|||
163025438|NCT00970632|588794549|FG001|Overall Study|Lack of Efficacy|0|||
163025439|NCT00970632|588794550|FG002|Overall Study|Lack of Efficacy|0|||
163025440|NCT00970632|588794548|FG000|Overall Study|Lost to Follow-up|3|||
163025441|NCT00970632|588794549|FG001|Overall Study|Lost to Follow-up|0|||
163025442|NCT00970632|588794550|FG002|Overall Study|Lost to Follow-up|2|||
163025443|NCT00970632|588794548|FG000|Overall Study|Protocol Violation|8|||
163025444|NCT00970632|588794549|FG001|Overall Study|Protocol Violation|5|||
163025445|NCT00970632|588794550|FG002|Overall Study|Protocol Violation|8|||
163025446|NCT00970632|588794548|FG000|Overall Study|Withdrawal by Subject|7|||
163025447|NCT00970632|588794549|FG001|Overall Study|Withdrawal by Subject|6|||
163025448|NCT00970632|588794550|FG002|Overall Study|Withdrawal by Subject|4|||
163025449|NCT00970632|588794548|FG000|Overall Study|Entry criteria not met|0|||
163025450|NCT00970632|588794549|FG001|Overall Study|Entry criteria not met|2|||
163025451|NCT00970632|588794550|FG002|Overall Study|Entry criteria not met|2|||
163025452|NCT00970632|588794548|FG000|Overall Study|Sponsor decision|1|||
163025453|NCT00970632|588794549|FG001|Overall Study|Sponsor decision|0|||
163025454|NCT00970632|588794550|FG002|Overall Study|Sponsor decision|1|||
163025455|NCT01286168|588794557|FG000|Overall Study|Withdrawal by Subject|1|||
163025456|NCT01286168|588794557|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
163025457|NCT02487771|588794558|FG000|Overall Study|Lost to Follow-up|2|||
163025458|NCT02487771|588794559|FG001|Overall Study|Lost to Follow-up|3|||
163025459|NCT02487771|588794558|FG000|Overall Study|Moved out of area|5|||
163025460|NCT02487771|588794559|FG001|Overall Study|Moved out of area|6|||
163025461|NCT02487771|588794558|FG000|Overall Study|Withdrawal by Subject|3|||
163025462|NCT02487771|588794559|FG001|Overall Study|Withdrawal by Subject|5|||
163025463|NCT01871402|588794566|FG000|Overall Study|Lost to Follow-up|1|||
163025464|NCT01871402|588794567|FG001|Overall Study|Lost to Follow-up|0|||
163025465|NCT01871402|588794566|FG000|Overall Study|Withdrawal by Subject|0|||
163025466|NCT01871402|588794567|FG001|Overall Study|Withdrawal by Subject|2|||
163025467|NCT01871402|588794566|FG000|Overall Study|Non-compliance|0|||
163065126|NCT04092777|588945688|FG001|Overall Study|Lost to Follow-up|46|||
163065127|NCT04092777|588945687|FG000|Overall Study|Withdrawal by Subject|8|||
163025468|NCT01871402|588794567|FG001|Overall Study|Non-compliance|1|||
163025469|NCT04594941|588794568|FG000|Overall Study|Other|0|||
163025470|NCT04594941|588794569|FG001|Overall Study|Other|3|||
163065128|NCT04092777|588945688|FG001|Overall Study|Withdrawal by Subject|5|||
163065129|NCT03330197|588945691|FG000|Overall Study|Adverse Event|0|||
163065130|NCT03330197|588945692|FG001|Overall Study|Adverse Event|1|||
163065131|NCT03330197|588945691|FG000|Overall Study|Withdrawal by Subject|0|||
163065132|NCT03330197|588945692|FG001|Overall Study|Withdrawal by Subject|1|||
163065133|NCT03765073|588945693|FG000|Stage 1|Lost to Follow-up|1|||
163065134|NCT03765073|588945694|FG001|Stage 1|Lost to Follow-up|0|||
163065135|NCT03765073|588945695|FG002|Stage 1|Lost to Follow-up|0|||
163065136|NCT03765073|588945696|FG003|Stage 1|Lost to Follow-up|0|||
163065137|NCT03765073|588945697|FG004|Stage 1|Lost to Follow-up|0|||
163065138|NCT03765073|588945698|FG005|Stage 1|Lost to Follow-up|0|||
163065139|NCT03765073|588945699|FG006|Stage 1|Lost to Follow-up|0|||
163065140|NCT03765073|588945700|FG007|Stage 1|Lost to Follow-up|0|||
163065141|NCT03765073|588945701|FG008|Stage 1|Lost to Follow-up|0|||
163065142|NCT03765073|588945702|FG009|Stage 1|Lost to Follow-up|0|||
163065143|NCT03765073|588945703|FG010|Stage 1|Lost to Follow-up|0|||
163065144|NCT03765073|588945704|FG011|Stage 1|Lost to Follow-up|0|||
163065145|NCT03765073|588945705|FG012|Stage 1|Lost to Follow-up|0|||
163065146|NCT03765073|588945706|FG013|Stage 1|Lost to Follow-up|0|||
163065147|NCT03765073|588945707|FG014|Stage 1|Lost to Follow-up|0|||
163065148|NCT03765073|588945708|FG015|Stage 1|Lost to Follow-up|0|||
163065149|NCT03765073|588945709|FG016|Stage 1|Lost to Follow-up|0|||
163065150|NCT03765073|588945710|FG017|Stage 1|Lost to Follow-up|0|||
163065151|NCT03765073|588945711|FG018|Stage 1|Lost to Follow-up|0|||
163065152|NCT03765073|588945712|FG019|Stage 1|Lost to Follow-up|0|||
163065153|NCT03765073|588945713|FG020|Stage 1|Lost to Follow-up|0|||
163065154|NCT03765073|588945693|FG000|Stage 1|Withdrawal by participant|0|||
163065155|NCT03765073|588945694|FG001|Stage 1|Withdrawal by participant|1|||
163065156|NCT03765073|588945695|FG002|Stage 1|Withdrawal by participant|0|||
163065157|NCT03765073|588945696|FG003|Stage 1|Withdrawal by participant|0|||
163065158|NCT03765073|588945697|FG004|Stage 1|Withdrawal by participant|0|||
163065159|NCT03765073|588945698|FG005|Stage 1|Withdrawal by participant|0|||
163065160|NCT03765073|588945699|FG006|Stage 1|Withdrawal by participant|0|||
163065161|NCT03765073|588945700|FG007|Stage 1|Withdrawal by participant|0|||
163065162|NCT03765073|588945701|FG008|Stage 1|Withdrawal by participant|0|||
163065163|NCT03765073|588945702|FG009|Stage 1|Withdrawal by participant|0|||
163065164|NCT03765073|588945703|FG010|Stage 1|Withdrawal by participant|0|||
163065165|NCT03765073|588945704|FG011|Stage 1|Withdrawal by participant|0|||
163065166|NCT03765073|588945705|FG012|Stage 1|Withdrawal by participant|0|||
163065167|NCT03765073|588945706|FG013|Stage 1|Withdrawal by participant|0|||
163065168|NCT03765073|588945707|FG014|Stage 1|Withdrawal by participant|0|||
163065169|NCT03765073|588945708|FG015|Stage 1|Withdrawal by participant|0|||
163065170|NCT03765073|588945709|FG016|Stage 1|Withdrawal by participant|0|||
163065171|NCT03765073|588945710|FG017|Stage 1|Withdrawal by participant|0|||
163065172|NCT03765073|588945711|FG018|Stage 1|Withdrawal by participant|0|||
163065173|NCT03765073|588945712|FG019|Stage 1|Withdrawal by participant|0|||
163065174|NCT03765073|588945713|FG020|Stage 1|Withdrawal by participant|0|||
163065175|NCT03765073|588945693|FG000|Stage 2|Death|0|||
163065176|NCT03765073|588945694|FG001|Stage 2|Death|0|||
163065177|NCT03765073|588945695|FG002|Stage 2|Death|0|||
163065178|NCT03765073|588945696|FG003|Stage 2|Death|0|||
163065179|NCT03765073|588945697|FG004|Stage 2|Death|0|||
163065180|NCT03765073|588945698|FG005|Stage 2|Death|0|||
163065181|NCT03765073|588945699|FG006|Stage 2|Death|0|||
163065182|NCT03765073|588945700|FG007|Stage 2|Death|0|||
163065183|NCT03765073|588945701|FG008|Stage 2|Death|0|||
163065184|NCT03765073|588945702|FG009|Stage 2|Death|1|||
163065185|NCT03765073|588945703|FG010|Stage 2|Death|0|||
163065186|NCT03765073|588945704|FG011|Stage 2|Death|1|||
163065187|NCT03765073|588945705|FG012|Stage 2|Death|0|||
163065188|NCT03765073|588945706|FG013|Stage 2|Death|0|||
163065189|NCT03765073|588945707|FG014|Stage 2|Death|0|||
163065190|NCT03765073|588945708|FG015|Stage 2|Death|0|||
163065191|NCT03765073|588945709|FG016|Stage 2|Death|2|||
163065192|NCT03765073|588945710|FG017|Stage 2|Death|0|||
163065193|NCT03765073|588945711|FG018|Stage 2|Death|0|||
162717832|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
163065194|NCT03765073|588945712|FG019|Stage 2|Death|0|||
162717833|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
163065195|NCT03765073|588945713|FG020|Stage 2|Death|0|||
163065196|NCT03765073|588945693|FG000|Stage 2|Lost to Follow-up|0|||
163065197|NCT03765073|588945694|FG001|Stage 2|Lost to Follow-up|0|||
163065198|NCT03765073|588945695|FG002|Stage 2|Lost to Follow-up|0|||
163065199|NCT03765073|588945696|FG003|Stage 2|Lost to Follow-up|5|||
163065200|NCT03765073|588945697|FG004|Stage 2|Lost to Follow-up|1|||
163065201|NCT03765073|588945698|FG005|Stage 2|Lost to Follow-up|0|||
163065202|NCT03765073|588945699|FG006|Stage 2|Lost to Follow-up|3|||
163065203|NCT03765073|588945700|FG007|Stage 2|Lost to Follow-up|3|||
163065204|NCT03765073|588945701|FG008|Stage 2|Lost to Follow-up|1|||
163065205|NCT03765073|588945702|FG009|Stage 2|Lost to Follow-up|6|||
163065206|NCT03765073|588945703|FG010|Stage 2|Lost to Follow-up|5|||
163065207|NCT03765073|588945704|FG011|Stage 2|Lost to Follow-up|1|||
162717834|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
162717835|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
163025471|NCT04594941|588794570|FG002|Overall Study|Other|1|||
163025472|NCT04594941|588794571|FG003|Overall Study|Other|0|||
163025473|NCT03408444|588794572|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
163025474|NCT03408444|588794573|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025475|NCT03408444|588794574|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025476|NCT03408444|588794575|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
163025477|NCT03408444|588794572|FG000|Overall Study|Lens Discomfort|0|||
163025478|NCT03408444|588794573|FG001|Overall Study|Lens Discomfort|1|||
163025479|NCT03408444|588794574|FG002|Overall Study|Lens Discomfort|0|||
163025480|NCT03408444|588794575|FG003|Overall Study|Lens Discomfort|0|||
163025481|NCT03408444|588794572|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025482|NCT03408444|588794573|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025483|NCT03408444|588794574|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
163025484|NCT03408444|588794575|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
163025485|NCT03408444|588794572|FG000|Overall Study|Withdrawal by Subject|0|||
163025486|NCT03408444|588794573|FG001|Overall Study|Withdrawal by Subject|2|||
163025487|NCT03408444|588794574|FG002|Overall Study|Withdrawal by Subject|3|||
163025488|NCT03408444|588794575|FG003|Overall Study|Withdrawal by Subject|0|||
163025489|NCT03408444|588794572|FG000|Overall Study|Lost to Follow-up|0|||
163025490|NCT03408444|588794573|FG001|Overall Study|Lost to Follow-up|0|||
163025491|NCT03408444|588794574|FG002|Overall Study|Lost to Follow-up|1|||
163025492|NCT03408444|588794575|FG003|Overall Study|Lost to Follow-up|0|||
163025493|NCT03408444|588794572|FG000|Overall Study|Adverse Event|0|||
163025494|NCT03408444|588794573|FG001|Overall Study|Adverse Event|0|||
163025495|NCT03408444|588794574|FG002|Overall Study|Adverse Event|0|||
163025496|NCT03408444|588794575|FG003|Overall Study|Adverse Event|1|||
163025497|NCT03408444|588794572|FG000|Overall Study|Lens Handling Difficulties|0|||
163025498|NCT03408444|588794573|FG001|Overall Study|Lens Handling Difficulties|0|||
163025499|NCT03408444|588794574|FG002|Overall Study|Lens Handling Difficulties|1|||
163025500|NCT03408444|588794575|FG003|Overall Study|Lens Handling Difficulties|0|||
163025501|NCT03408444|588794572|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025502|NCT03408444|588794573|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025503|NCT03408444|588794574|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
163025504|NCT03408444|588794575|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
163025505|NCT01482065|588794576|FG000|Overall Study|Withdrawal by Subject|0|||
163025506|NCT01482065|588794577|FG001|Overall Study|Withdrawal by Subject|1|||
163025507|NCT03728426|588794578|FG000|Overall Study|Death|3|||
163025508|NCT00231114|588794579|FG000|Randomized|Withdrawal by Subject|6|||
163025509|NCT00231114|588794580|FG001|Randomized|Withdrawal by Subject|3|||
163025510|NCT00231114|588794579|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
163025511|NCT00231114|588794580|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
163025512|NCT00231114|588794579|FG000|Post-Treatment Period|Lost to Follow-up|6|||
163025513|NCT00231114|588794580|FG001|Post-Treatment Period|Lost to Follow-up|1|||
163025514|NCT00231114|588794579|FG000|Post-Treatment Period|Physician Decision|1|||
163025515|NCT00231114|588794580|FG001|Post-Treatment Period|Physician Decision|0|||
163025516|NCT00231114|588794579|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
163025517|NCT00231114|588794580|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
163025518|NCT02682823|588794582|FG000|Overall Study|Withdrawal by Subject|0|||
163025519|NCT02682823|588794583|FG001|Overall Study|Withdrawal by Subject|0|||
163025520|NCT02682823|588794584|FG002|Overall Study|Withdrawal by Subject|1|||
163025521|NCT02682823|588794585|FG003|Overall Study|Withdrawal by Subject|0|||
163025522|NCT02682823|588794586|FG004|Overall Study|Withdrawal by Subject|1|||
163025523|NCT02682823|588794582|FG000|Overall Study|Protocol Deviation|0|||
163025524|NCT02682823|588794583|FG001|Overall Study|Protocol Deviation|1|||
163025525|NCT02682823|588794584|FG002|Overall Study|Protocol Deviation|0|||
163025526|NCT02682823|588794585|FG003|Overall Study|Protocol Deviation|0|||
163025527|NCT02682823|588794586|FG004|Overall Study|Protocol Deviation|0|||
163025528|NCT02682823|588794582|FG000|Overall Study|Adverse Event|0|||
163025529|NCT02682823|588794583|FG001|Overall Study|Adverse Event|0|||
163025530|NCT02682823|588794584|FG002|Overall Study|Adverse Event|0|||
163025531|NCT02682823|588794585|FG003|Overall Study|Adverse Event|1|||
163025532|NCT02682823|588794586|FG004|Overall Study|Adverse Event|0|||
163025533|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
163025534|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
163025535|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
163025536|NCT01995175|588794587|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
163025537|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
163025538|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
163025539|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
163025540|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
163025541|NCT01995175|588794587|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
163025542|NCT01741792|588794588|FG000|Overall Study|Death|6|||
163025543|NCT01741792|588794589|FG001|Overall Study|Death|1|||
163025544|NCT01741792|588794590|FG002|Overall Study|Death|12|||
163025545|NCT02045862|588794591|FG000|Overall Study|Death|0|||
163025546|NCT02045862|588794592|FG001|Overall Study|Death|0|||
163025547|NCT02045862|588794593|FG002|Overall Study|Death|1|||
163025548|NCT02045862|588794591|FG000|Overall Study|Miscellaneous|5|||
163025549|NCT02045862|588794592|FG001|Overall Study|Miscellaneous|0|||
163025550|NCT02045862|588794593|FG002|Overall Study|Miscellaneous|8|||
163025551|NCT02045862|588794591|FG000|Overall Study|Withdrawal by Patient|18|||
163025552|NCT02045862|588794592|FG001|Overall Study|Withdrawal by Patient|27|||
163025553|NCT02045862|588794593|FG002|Overall Study|Withdrawal by Patient|57|||
163025554|NCT02045862|588794591|FG000|Overall Study|Protocol Violation|0|||
163025555|NCT02045862|588794592|FG001|Overall Study|Protocol Violation|0|||
163025556|NCT02045862|588794593|FG002|Overall Study|Protocol Violation|6|||
163025557|NCT02045862|588794591|FG000|Overall Study|Lack of Efficacy|8|||
163025558|NCT02045862|588794592|FG001|Overall Study|Lack of Efficacy|4|||
163025559|NCT02045862|588794593|FG002|Overall Study|Lack of Efficacy|13|||
163025560|NCT02045862|588794591|FG000|Overall Study|Randomized but not Received Study Drug|0|||
163025561|NCT02045862|588794592|FG001|Overall Study|Randomized but not Received Study Drug|2|||
163025562|NCT02045862|588794593|FG002|Overall Study|Randomized but not Received Study Drug|8|||
163025563|NCT02045862|588794591|FG000|Overall Study|Adverse Event|7|||
163025564|NCT02045862|588794592|FG001|Overall Study|Adverse Event|5|||
163025565|NCT02045862|588794593|FG002|Overall Study|Adverse Event|27|||
163025566|NCT02045862|588794591|FG000|Overall Study|Lost to Follow-up|1|||
163025567|NCT02045862|588794592|FG001|Overall Study|Lost to Follow-up|2|||
163025568|NCT02045862|588794593|FG002|Overall Study|Lost to Follow-up|6|||
163025569|NCT02353442|588794598|FG000|Overall Study|Withdrawal by Subject|3|||
163025570|NCT02353442|588794599|FG001|Overall Study|Withdrawal by Subject|4|||
163025571|NCT01075646|588794602|FG000|Overall Study|Lost to Follow-up|4|||
163025572|NCT01075646|588794603|FG001|Overall Study|Lost to Follow-up|3|||
163025573|NCT01075646|588794604|FG002|Overall Study|Lost to Follow-up|1|||
163025574|NCT01075646|588794605|FG003|Overall Study|Lost to Follow-up|2|||
163025575|NCT02004886|588794609|FG000|Overall Study|Adverse Event|0|||
163025576|NCT02004886|588794610|FG001|Overall Study|Adverse Event|1|||
163025577|NCT02004886|588794611|FG002|Overall Study|Adverse Event|0|||
163025578|NCT02004886|588794612|FG003|Overall Study|Adverse Event|0|||
163025579|NCT02004886|588794609|FG000|Overall Study|Unable to attend future visits|1|||
163025580|NCT02004886|588794610|FG001|Overall Study|Unable to attend future visits|0|||
163025581|NCT02004886|588794611|FG002|Overall Study|Unable to attend future visits|0|||
163025582|NCT02004886|588794612|FG003|Overall Study|Unable to attend future visits|0|||
163025583|NCT02822573|588794613|FG000|Overall Study|Lost to Follow-up|5|||
163025584|NCT02822573|588794614|FG001|Overall Study|Lost to Follow-up|3|||
163025585|NCT02822573|588794613|FG000|Overall Study|Physician Decision|1|||
163025586|NCT02822573|588794614|FG001|Overall Study|Physician Decision|1|||
163025587|NCT02822573|588794613|FG000|Overall Study|Withdrawal by Subject|9|||
163025588|NCT02822573|588794614|FG001|Overall Study|Withdrawal by Subject|5|||
163025589|NCT02822573|588794613|FG000|Overall Study|Protocol Violation|6|||
163025590|NCT02822573|588794614|FG001|Overall Study|Protocol Violation|4|||
163025591|NCT02822573|588794613|FG000|Overall Study|Too sick or ill|2|||
163025592|NCT02822573|588794614|FG001|Overall Study|Too sick or ill|1|||
163025593|NCT02822573|588794613|FG000|Overall Study|Disease Progression|1|||
163025594|NCT02822573|588794614|FG001|Overall Study|Disease Progression|1|||
163025595|NCT02822573|588794613|FG000|Overall Study|No reason given|6|||
163025596|NCT02822573|588794614|FG001|Overall Study|No reason given|4|||
163025597|NCT02892422|588794616|FG000|Overall Study|Enrolled not treated|4|||
163025598|NCT02892422|588794616|FG000|Overall Study|Adverse Event|38|||
163025599|NCT02892422|588794616|FG000|Overall Study|Lack of Efficacy|32|||
163025600|NCT02892422|588794616|FG000|Overall Study|Non-compliance with study drug|11|||
163025601|NCT02892422|588794616|FG000|Overall Study|Protocol Violation|4|||
163025602|NCT02892422|588794616|FG000|Overall Study|Withdrawal by Subject|56|||
163025603|NCT02892422|588794616|FG000|Overall Study|Lost to Follow-up|5|||
163025604|NCT02892422|588794616|FG000|Overall Study|sponsor information 16159A results|21|||
163025605|NCT02892422|588794616|FG000|Overall Study|withdrawal of consent|13|||
163025606|NCT02892422|588794616|FG000|Overall Study|exclusion criteria met|3|||
163025607|NCT02892422|588794616|FG000|Overall Study|moving elsewhere|4|||
163025608|NCT02892422|588794616|FG000|Overall Study|non-compliance|10|||
163025609|NCT02892422|588794616|FG000|Overall Study|patient legally incapable|1|||
163025610|NCT02892422|588794616|FG000|Overall Study|patient decision|7|||
163025611|NCT02892422|588794616|FG000|Overall Study|Investigator decision|1|||
163025612|NCT04323306|588794617|FG000|Overall Study|Physician Decision|1|||
163025613|NCT04323306|588794618|FG001|Overall Study|Physician Decision|0|||
163025614|NCT04323306|588794619|FG002|Overall Study|Physician Decision|0|||
163025615|NCT04323306|588794620|FG003|Overall Study|Physician Decision|0|||
163065208|NCT03765073|588945705|FG012|Stage 2|Lost to Follow-up|1|||
163025616|NCT04323306|588794621|FG004|Overall Study|Physician Decision|0|||
163025617|NCT04323306|588794622|FG005|Overall Study|Physician Decision|0|||
163025618|NCT04323306|588794623|FG006|Overall Study|Physician Decision|0|||
163025619|NCT04323306|588794624|FG007|Overall Study|Physician Decision|0|||
162643946|NCT00561080|587411793|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
162643947|NCT00561080|587411794|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
162643948|NCT00561080|587411795|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
162643949|NCT00561080|587411793|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
162643950|NCT00561080|587411794|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
162643951|NCT00561080|587411795|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
162643952|NCT00561080|587411793|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
162717836|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
163025620|NCT04323306|588794625|FG008|Overall Study|Physician Decision|0|||
163025621|NCT04323306|588794617|FG000|Overall Study|Withdrawal by Subject|0|||
163025622|NCT04323306|588794618|FG001|Overall Study|Withdrawal by Subject|0|||
163025623|NCT04323306|588794619|FG002|Overall Study|Withdrawal by Subject|0|||
163025624|NCT04323306|588794620|FG003|Overall Study|Withdrawal by Subject|0|||
163025625|NCT04323306|588794621|FG004|Overall Study|Withdrawal by Subject|0|||
163025626|NCT04323306|588794622|FG005|Overall Study|Withdrawal by Subject|1|||
163025627|NCT04323306|588794623|FG006|Overall Study|Withdrawal by Subject|3|||
163025628|NCT04323306|588794624|FG007|Overall Study|Withdrawal by Subject|0|||
163025629|NCT04323306|588794625|FG008|Overall Study|Withdrawal by Subject|1|||
163025630|NCT00759785|588794626|FG000|Overall Study|Participant sample not evaluable|11|||
163025631|NCT00759785|588794627|FG001|Overall Study|Participant sample not evaluable|2|||
163025632|NCT00759785|588794626|FG000|Overall Study|Participant sample lost|0|||
163025633|NCT00759785|588794627|FG001|Overall Study|Participant sample lost|1|||
163025634|NCT00759785|588794626|FG000|Overall Study|Protocol Violation|1|||
163025635|NCT00759785|588794627|FG001|Overall Study|Protocol Violation|0|||
163025636|NCT00759785|588794626|FG000|Overall Study|Physician Decision|0|||
163025637|NCT00759785|588794627|FG001|Overall Study|Physician Decision|1|||
163025638|NCT00759785|588794626|FG000|Overall Study|Withdrawal by Subject|0|||
163025639|NCT00759785|588794627|FG001|Overall Study|Withdrawal by Subject|1|||
163025640|NCT00089778|588794628|FG000|Overall Study|Protocol Violation|0|||
163025641|NCT00089778|588794629|FG001|Overall Study|Protocol Violation|0|||
163025642|NCT00089778|588794630|FG002|Overall Study|Protocol Violation|1|||
163025643|NCT04712019|588794631|FG000|Overall Study|Withdrawal by Subject|2|||
163025644|NCT04712019|588794632|FG001|Overall Study|Withdrawal by Subject|2|||
163025645|NCT04712019|588794631|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
163025646|NCT04712019|588794632|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
163025647|NCT00725608|588794640|FG000|Overall Study|Lost to Follow-up|60|||
163025648|NCT00725608|588794640|FG000|Overall Study|Adverse Event|14|||
163025649|NCT00725608|588794640|FG000|Overall Study|Individual reasons|86|||
163025650|NCT00725608|588794640|FG000|Overall Study|Other|7|||
163025651|NCT01084668|588794641|FG000|Overall Study|Lack of Efficacy|5|||
163025652|NCT01084668|588794641|FG000|Overall Study|Withdrawal by Subject|2|||
163025653|NCT01084668|588794641|FG000|Overall Study|Pregnancy|1|||
163025654|NCT01084668|588794641|FG000|Overall Study|Non-compliance|1|||
163025655|NCT03729570|588794644|FG000|Overall Study|Lost to Follow-up|16|||
163025656|NCT03729570|588794645|FG001|Overall Study|Lost to Follow-up|20|||
163025657|NCT03729570|588794644|FG000|Overall Study|Seroconversion|5|||
163025658|NCT03729570|588794645|FG001|Overall Study|Seroconversion|0|||
163025659|NCT03729570|588794644|FG000|Overall Study|Moved out of the city|1|||
163025660|NCT03729570|588794645|FG001|Overall Study|Moved out of the city|0|||
163025661|NCT03729570|588794644|FG000|Overall Study|Time Conflict|1|||
163025662|NCT03729570|588794645|FG001|Overall Study|Time Conflict|0|||
163025663|NCT03729570|588794644|FG000|Overall Study|Time Commitment|2|||
163025664|NCT03729570|588794645|FG001|Overall Study|Time Commitment|0|||
163025665|NCT03729570|588794644|FG000|Overall Study|Bad Experience|0|||
163025666|NCT03729570|588794645|FG001|Overall Study|Bad Experience|1|||
163025667|NCT03729570|588794644|FG000|Overall Study|No reason provided|2|||
163025668|NCT03729570|588794645|FG001|Overall Study|No reason provided|1|||
163025669|NCT03729570|588794644|FG000|Overall Study|Family Conflict|0|||
163025670|NCT03729570|588794645|FG001|Overall Study|Family Conflict|1|||
163025671|NCT03729570|588794644|FG000|Overall Study|Did not want to continue taking medications|0|||
163025672|NCT03729570|588794645|FG001|Overall Study|Did not want to continue taking medications|1|||
163025673|NCT03729570|588794644|FG000|Overall Study|Found another PrEP provider|1|||
163025674|NCT03729570|588794645|FG001|Overall Study|Found another PrEP provider|0|||
163025675|NCT03729570|588794644|FG000|Overall Study|Did not enjoy being in the control group|0|||
163025676|NCT03729570|588794645|FG001|Overall Study|Did not enjoy being in the control group|1|||
163025677|NCT02447497|588794646|FG000|Overall Study|Did not meet treatment day baseline.|6|||
162717837|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
163025678|NCT02447497|588794647|FG001|Overall Study|Did not meet treatment day baseline.|5|||
163025679|NCT02447497|588794648|FG002|Overall Study|Did not meet treatment day baseline.|2|||
162717838|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
163025680|NCT02447497|588794649|FG003|Overall Study|Did not meet treatment day baseline.|2|||
163025681|NCT02447497|588794646|FG000|Overall Study|Dressing was compromised|0|||
162717839|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
163025682|NCT02447497|588794647|FG001|Overall Study|Dressing was compromised|1|||
163025683|NCT02447497|588794648|FG002|Overall Study|Dressing was compromised|0|||
163025684|NCT02447497|588794649|FG003|Overall Study|Dressing was compromised|0|||
163025685|NCT02017912|588794650|FG000|Overall Study|Withdrawal by Subject|2|||
162717840|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
163025686|NCT02017912|588794651|FG001|Overall Study|Withdrawal by Subject|1|||
163025687|NCT02017912|588794650|FG000|Overall Study|miscellaneous|1|||
163025688|NCT02017912|588794651|FG001|Overall Study|miscellaneous|1|||
163025689|NCT04569968|588794652|FG000|Overall Study|Lost to Follow-up|2|||
163025690|NCT04569968|588794653|FG001|Overall Study|Lost to Follow-up|5|||
163025691|NCT04569968|588794652|FG000|Overall Study|Story of head and/or neck surgery|2|||
163025692|NCT04569968|588794653|FG001|Overall Study|Story of head and/or neck surgery|2|||
163025693|NCT04569968|588794652|FG000|Overall Study|Time of stroke onset|8|||
163025694|NCT04569968|588794653|FG001|Overall Study|Time of stroke onset|7|||
163025695|NCT04569968|588794652|FG000|Overall Study|Type of strokr|12|||
163025696|NCT04569968|588794653|FG001|Overall Study|Type of strokr|8|||
163025697|NCT04569968|588794652|FG000|Overall Study|Cooperation|8|||
163025698|NCT04569968|588794653|FG001|Overall Study|Cooperation|8|||
163025699|NCT04569968|588794652|FG000|Overall Study|Age interval|17|||
163025700|NCT04569968|588794653|FG001|Overall Study|Age interval|6|||
163025701|NCT04569968|588794652|FG000|Overall Study|Denial of participation to the study|0|||
163025702|NCT04569968|588794653|FG001|Overall Study|Denial of participation to the study|3|||
163025703|NCT04569968|588794652|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
163025704|NCT04569968|588794653|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
163025705|NCT04569968|588794652|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
163025706|NCT04569968|588794653|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
163025707|NCT04569968|588794652|FG000|Overall Study|Quarantine|1|||
163025708|NCT04569968|588794653|FG001|Overall Study|Quarantine|0|||
163025709|NCT04569968|588794652|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
163025710|NCT04569968|588794653|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
163025711|NCT04569968|588794652|FG000|Overall Study|Repetitive stroke|8|||
163025712|NCT04569968|588794653|FG001|Overall Study|Repetitive stroke|0|||
163025713|NCT04569968|588794652|FG000|Overall Study|Insufficient mastication|1|||
163025714|NCT04569968|588794653|FG001|Overall Study|Insufficient mastication|0|||
163025715|NCT04569968|588794652|FG000|Overall Study|Infection|1|||
163025716|NCT04569968|588794653|FG001|Overall Study|Infection|0|||
163025717|NCT00985959|588794658|FG000|Overall Study|Adverse Event|0|||
163025718|NCT00985959|588794659|FG001|Overall Study|Adverse Event|0|||
163025719|NCT00985959|588794660|FG002|Overall Study|Adverse Event|19|||
163025720|NCT00985959|588794658|FG000|Overall Study|Withdrawal by Subject|0|||
163025721|NCT00985959|588794659|FG001|Overall Study|Withdrawal by Subject|0|||
163025722|NCT00985959|588794660|FG002|Overall Study|Withdrawal by Subject|8|||
163025723|NCT00985959|588794658|FG000|Overall Study|Progressive disease|1|||
163025724|NCT00985959|588794659|FG001|Overall Study|Progressive disease|2|||
163025725|NCT00985959|588794660|FG002|Overall Study|Progressive disease|8|||
163025726|NCT00985959|588794658|FG000|Overall Study|Unrecovered toxicity|0|||
163025727|NCT00985959|588794659|FG001|Overall Study|Unrecovered toxicity|0|||
163025728|NCT00985959|588794660|FG002|Overall Study|Unrecovered toxicity|7|||
163025729|NCT00985959|588794658|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
163025730|NCT00985959|588794659|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
163025731|NCT00985959|588794660|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
163025732|NCT00985959|588794658|FG000|Overall Study|Complete response observed over 2 cycles|0|||
163025733|NCT00985959|588794659|FG001|Overall Study|Complete response observed over 2 cycles|1|||
163025734|NCT00985959|588794660|FG002|Overall Study|Complete response observed over 2 cycles|4|||
163025735|NCT00985959|588794658|FG000|Overall Study|Other|0|||
163025736|NCT00985959|588794659|FG001|Overall Study|Other|0|||
163025737|NCT00985959|588794660|FG002|Overall Study|Other|11|||
163025738|NCT00979420|588794661|FG000|Overall Study|Adverse Event|1|||
163025739|NCT00979420|588794662|FG001|Overall Study|Adverse Event|0|||
163025740|NCT00979420|588794663|FG002|Overall Study|Adverse Event|0|||
163025741|NCT00979420|588794664|FG003|Overall Study|Adverse Event|0|||
163025742|NCT00979420|588794661|FG000|Overall Study|Lack of Efficacy|3|||
163025743|NCT00979420|588794662|FG001|Overall Study|Lack of Efficacy|0|||
163025744|NCT00979420|588794663|FG002|Overall Study|Lack of Efficacy|1|||
163025745|NCT00979420|588794664|FG003|Overall Study|Lack of Efficacy|1|||
163025746|NCT00979420|588794661|FG000|Overall Study|Other reasons not related to Viramune|3|||
163025747|NCT00979420|588794662|FG001|Overall Study|Other reasons not related to Viramune|0|||
163025748|NCT00979420|588794663|FG002|Overall Study|Other reasons not related to Viramune|0|||
163025749|NCT00979420|588794664|FG003|Overall Study|Other reasons not related to Viramune|1|||
163025750|NCT02107859|588794666|FG000|Overall Study|Withdrawal by Subject|14|||
163025751|NCT02107859|588794666|FG000|Overall Study|Adverse Event|3|||
163025752|NCT02107859|588794666|FG000|Overall Study|Study closure|41|||
163025753|NCT02107859|588794666|FG000|Overall Study|Other than specified|3|||
163025754|NCT02235077|588794667|FG000|Overall Study|Death|5|||
163025755|NCT02235077|588794668|FG001|Overall Study|Death|7|||
163025756|NCT02235077|588794667|FG000|Overall Study|Lost to Follow-up|5|||
163025757|NCT02235077|588794668|FG001|Overall Study|Lost to Follow-up|6|||
162717841|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
163065209|NCT03765073|588945706|FG013|Stage 2|Lost to Follow-up|3|||
163065210|NCT03765073|588945707|FG014|Stage 2|Lost to Follow-up|3|||
163065211|NCT03765073|588945708|FG015|Stage 2|Lost to Follow-up|1|||
163065212|NCT03765073|588945709|FG016|Stage 2|Lost to Follow-up|6|||
163065213|NCT03765073|588945710|FG017|Stage 2|Lost to Follow-up|0|||
163065214|NCT03765073|588945711|FG018|Stage 2|Lost to Follow-up|0|||
163065215|NCT03765073|588945712|FG019|Stage 2|Lost to Follow-up|0|||
163065216|NCT03765073|588945713|FG020|Stage 2|Lost to Follow-up|0|||
163065217|NCT03765073|588945693|FG000|Stage 2|Other|0|||
163065218|NCT03765073|588945694|FG001|Stage 2|Other|0|||
163065219|NCT03765073|588945695|FG002|Stage 2|Other|0|||
163065220|NCT03765073|588945696|FG003|Stage 2|Other|0|||
163065221|NCT03765073|588945697|FG004|Stage 2|Other|0|||
163065222|NCT03765073|588945698|FG005|Stage 2|Other|0|||
163065223|NCT03765073|588945699|FG006|Stage 2|Other|0|||
163065224|NCT03765073|588945700|FG007|Stage 2|Other|1|||
163065225|NCT03765073|588945701|FG008|Stage 2|Other|1|||
163065226|NCT03765073|588945702|FG009|Stage 2|Other|3|||
163065227|NCT03765073|588945703|FG010|Stage 2|Other|0|||
163065228|NCT03765073|588945704|FG011|Stage 2|Other|0|||
163065229|NCT03765073|588945705|FG012|Stage 2|Other|0|||
163065230|NCT03765073|588945706|FG013|Stage 2|Other|0|||
163065231|NCT03765073|588945707|FG014|Stage 2|Other|0|||
163065232|NCT03765073|588945708|FG015|Stage 2|Other|1|||
163065233|NCT03765073|588945709|FG016|Stage 2|Other|2|||
163065234|NCT03765073|588945710|FG017|Stage 2|Other|0|||
163065235|NCT03765073|588945711|FG018|Stage 2|Other|0|||
163065236|NCT03765073|588945712|FG019|Stage 2|Other|0|||
163065237|NCT03765073|588945713|FG020|Stage 2|Other|0|||
163065238|NCT03765073|588945693|FG000|Stage 2|Withdrawal by parent/guardian|0|||
163065239|NCT03765073|588945694|FG001|Stage 2|Withdrawal by parent/guardian|0|||
163065240|NCT03765073|588945695|FG002|Stage 2|Withdrawal by parent/guardian|0|||
163065241|NCT03765073|588945696|FG003|Stage 2|Withdrawal by parent/guardian|0|||
163065242|NCT03765073|588945697|FG004|Stage 2|Withdrawal by parent/guardian|0|||
163065243|NCT03765073|588945698|FG005|Stage 2|Withdrawal by parent/guardian|0|||
163065244|NCT03765073|588945699|FG006|Stage 2|Withdrawal by parent/guardian|0|||
163065245|NCT03765073|588945700|FG007|Stage 2|Withdrawal by parent/guardian|0|||
163065246|NCT03765073|588945701|FG008|Stage 2|Withdrawal by parent/guardian|0|||
163065247|NCT03765073|588945702|FG009|Stage 2|Withdrawal by parent/guardian|0|||
163065248|NCT03765073|588945703|FG010|Stage 2|Withdrawal by parent/guardian|3|||
163065249|NCT03765073|588945704|FG011|Stage 2|Withdrawal by parent/guardian|3|||
163065250|NCT03765073|588945705|FG012|Stage 2|Withdrawal by parent/guardian|3|||
163065251|NCT03765073|588945706|FG013|Stage 2|Withdrawal by parent/guardian|1|||
163065252|NCT03765073|588945707|FG014|Stage 2|Withdrawal by parent/guardian|1|||
163065253|NCT03765073|588945708|FG015|Stage 2|Withdrawal by parent/guardian|0|||
163065254|NCT03765073|588945709|FG016|Stage 2|Withdrawal by parent/guardian|3|||
163065255|NCT03765073|588945710|FG017|Stage 2|Withdrawal by parent/guardian|0|||
163065256|NCT03765073|588945711|FG018|Stage 2|Withdrawal by parent/guardian|0|||
163065257|NCT03765073|588945712|FG019|Stage 2|Withdrawal by parent/guardian|0|||
163065258|NCT03765073|588945713|FG020|Stage 2|Withdrawal by parent/guardian|0|||
163065259|NCT03765073|588945693|FG000|Stage 2|Withdrawal by Subject|0|||
163065260|NCT03765073|588945694|FG001|Stage 2|Withdrawal by Subject|0|||
163065261|NCT03765073|588945695|FG002|Stage 2|Withdrawal by Subject|0|||
163065262|NCT03765073|588945696|FG003|Stage 2|Withdrawal by Subject|3|||
163065263|NCT03765073|588945697|FG004|Stage 2|Withdrawal by Subject|3|||
163065264|NCT03765073|588945698|FG005|Stage 2|Withdrawal by Subject|3|||
163065265|NCT03765073|588945699|FG006|Stage 2|Withdrawal by Subject|0|||
163065266|NCT03765073|588945700|FG007|Stage 2|Withdrawal by Subject|1|||
163065267|NCT03765073|588945701|FG008|Stage 2|Withdrawal by Subject|0|||
163065268|NCT03765073|588945702|FG009|Stage 2|Withdrawal by Subject|5|||
163065269|NCT03765073|588945703|FG010|Stage 2|Withdrawal by Subject|0|||
163065270|NCT03765073|588945704|FG011|Stage 2|Withdrawal by Subject|0|||
163065271|NCT03765073|588945705|FG012|Stage 2|Withdrawal by Subject|0|||
163065272|NCT03765073|588945706|FG013|Stage 2|Withdrawal by Subject|0|||
163065273|NCT03765073|588945707|FG014|Stage 2|Withdrawal by Subject|0|||
163065274|NCT03765073|588945708|FG015|Stage 2|Withdrawal by Subject|0|||
163065275|NCT03765073|588945709|FG016|Stage 2|Withdrawal by Subject|0|||
163065276|NCT03765073|588945710|FG017|Stage 2|Withdrawal by Subject|0|||
163065277|NCT03765073|588945711|FG018|Stage 2|Withdrawal by Subject|0|||
163065278|NCT03765073|588945712|FG019|Stage 2|Withdrawal by Subject|0|||
163065279|NCT03765073|588945713|FG020|Stage 2|Withdrawal by Subject|0|||
163065280|NCT03765073|588945693|FG000|Stage 3|Adverse Event|0|||
163065281|NCT03765073|588945694|FG001|Stage 3|Adverse Event|0|||
163065282|NCT03765073|588945695|FG002|Stage 3|Adverse Event|0|||
163065283|NCT03765073|588945696|FG003|Stage 3|Adverse Event|0|||
163065284|NCT03765073|588945697|FG004|Stage 3|Adverse Event|0|||
163065285|NCT03765073|588945698|FG005|Stage 3|Adverse Event|0|||
163065286|NCT03765073|588945699|FG006|Stage 3|Adverse Event|0|||
163065287|NCT03765073|588945700|FG007|Stage 3|Adverse Event|0|||
163065288|NCT03765073|588945701|FG008|Stage 3|Adverse Event|0|||
163065289|NCT03765073|588945702|FG009|Stage 3|Adverse Event|0|||
163065290|NCT03765073|588945703|FG010|Stage 3|Adverse Event|0|||
163065291|NCT03765073|588945704|FG011|Stage 3|Adverse Event|0|||
163065292|NCT03765073|588945705|FG012|Stage 3|Adverse Event|0|||
163065293|NCT03765073|588945706|FG013|Stage 3|Adverse Event|0|||
163065294|NCT03765073|588945707|FG014|Stage 3|Adverse Event|0|||
163065295|NCT03765073|588945708|FG015|Stage 3|Adverse Event|0|||
163065296|NCT03765073|588945709|FG016|Stage 3|Adverse Event|0|||
163065297|NCT03765073|588945710|FG017|Stage 3|Adverse Event|0|||
163065298|NCT03765073|588945711|FG018|Stage 3|Adverse Event|1|||
163065299|NCT03765073|588945712|FG019|Stage 3|Adverse Event|0|||
163065300|NCT03765073|588945713|FG020|Stage 3|Adverse Event|0|||
163065301|NCT03765073|588945693|FG000|Stage 3|Death|0|||
163065302|NCT03765073|588945694|FG001|Stage 3|Death|0|||
163065303|NCT03765073|588945695|FG002|Stage 3|Death|0|||
163065304|NCT03765073|588945696|FG003|Stage 3|Death|0|||
163065305|NCT03765073|588945697|FG004|Stage 3|Death|0|||
163065306|NCT03765073|588945698|FG005|Stage 3|Death|0|||
163065307|NCT03765073|588945699|FG006|Stage 3|Death|0|||
163065308|NCT03765073|588945700|FG007|Stage 3|Death|0|||
163065309|NCT03765073|588945701|FG008|Stage 3|Death|0|||
163065310|NCT03765073|588945702|FG009|Stage 3|Death|0|||
163065311|NCT03765073|588945703|FG010|Stage 3|Death|0|||
163065312|NCT03765073|588945704|FG011|Stage 3|Death|0|||
163065313|NCT03765073|588945705|FG012|Stage 3|Death|0|||
163065314|NCT03765073|588945706|FG013|Stage 3|Death|0|||
163065315|NCT03765073|588945707|FG014|Stage 3|Death|0|||
163065316|NCT03765073|588945708|FG015|Stage 3|Death|0|||
163065317|NCT03765073|588945709|FG016|Stage 3|Death|0|||
163065318|NCT03765073|588945710|FG017|Stage 3|Death|0|||
163065319|NCT03765073|588945711|FG018|Stage 3|Death|0|||
163065320|NCT03765073|588945712|FG019|Stage 3|Death|3|||
163065321|NCT03765073|588945713|FG020|Stage 3|Death|2|||
163065322|NCT03765073|588945693|FG000|Stage 3|Lost to Follow-up|0|||
163065323|NCT03765073|588945694|FG001|Stage 3|Lost to Follow-up|0|||
163065324|NCT03765073|588945695|FG002|Stage 3|Lost to Follow-up|0|||
163065325|NCT03765073|588945696|FG003|Stage 3|Lost to Follow-up|0|||
163065326|NCT03765073|588945697|FG004|Stage 3|Lost to Follow-up|0|||
163065327|NCT03765073|588945698|FG005|Stage 3|Lost to Follow-up|0|||
163065328|NCT03765073|588945699|FG006|Stage 3|Lost to Follow-up|0|||
163065329|NCT03765073|588945700|FG007|Stage 3|Lost to Follow-up|0|||
163065330|NCT03765073|588945701|FG008|Stage 3|Lost to Follow-up|0|||
163065331|NCT03765073|588945702|FG009|Stage 3|Lost to Follow-up|0|||
163065332|NCT03765073|588945703|FG010|Stage 3|Lost to Follow-up|0|||
163065333|NCT03765073|588945704|FG011|Stage 3|Lost to Follow-up|0|||
163065334|NCT03765073|588945705|FG012|Stage 3|Lost to Follow-up|0|||
163065335|NCT03765073|588945706|FG013|Stage 3|Lost to Follow-up|0|||
163065336|NCT03765073|588945707|FG014|Stage 3|Lost to Follow-up|0|||
163065337|NCT03765073|588945708|FG015|Stage 3|Lost to Follow-up|0|||
163065338|NCT03765073|588945709|FG016|Stage 3|Lost to Follow-up|0|||
163065339|NCT03765073|588945710|FG017|Stage 3|Lost to Follow-up|8|||
163065340|NCT03765073|588945711|FG018|Stage 3|Lost to Follow-up|5|||
163065341|NCT03765073|588945712|FG019|Stage 3|Lost to Follow-up|7|||
163065342|NCT03765073|588945713|FG020|Stage 3|Lost to Follow-up|4|||
163065343|NCT03765073|588945693|FG000|Stage 3|No longer meets eligibility criteria|0|||
163065344|NCT03765073|588945694|FG001|Stage 3|No longer meets eligibility criteria|0|||
163065345|NCT03765073|588945695|FG002|Stage 3|No longer meets eligibility criteria|0|||
163065346|NCT03765073|588945696|FG003|Stage 3|No longer meets eligibility criteria|0|||
163065347|NCT03765073|588945697|FG004|Stage 3|No longer meets eligibility criteria|0|||
163065348|NCT03765073|588945698|FG005|Stage 3|No longer meets eligibility criteria|0|||
163065349|NCT03765073|588945699|FG006|Stage 3|No longer meets eligibility criteria|0|||
163065350|NCT03765073|588945700|FG007|Stage 3|No longer meets eligibility criteria|0|||
163065351|NCT03765073|588945701|FG008|Stage 3|No longer meets eligibility criteria|0|||
163065352|NCT03765073|588945702|FG009|Stage 3|No longer meets eligibility criteria|0|||
163065353|NCT03765073|588945703|FG010|Stage 3|No longer meets eligibility criteria|0|||
163065354|NCT03765073|588945704|FG011|Stage 3|No longer meets eligibility criteria|0|||
163065355|NCT03765073|588945705|FG012|Stage 3|No longer meets eligibility criteria|0|||
163065356|NCT03765073|588945706|FG013|Stage 3|No longer meets eligibility criteria|0|||
163065357|NCT03765073|588945707|FG014|Stage 3|No longer meets eligibility criteria|0|||
163065358|NCT03765073|588945708|FG015|Stage 3|No longer meets eligibility criteria|0|||
163065359|NCT03765073|588945709|FG016|Stage 3|No longer meets eligibility criteria|0|||
163065360|NCT03765073|588945710|FG017|Stage 3|No longer meets eligibility criteria|0|||
163065361|NCT03765073|588945711|FG018|Stage 3|No longer meets eligibility criteria|1|||
163065362|NCT03765073|588945712|FG019|Stage 3|No longer meets eligibility criteria|0|||
163065363|NCT03765073|588945713|FG020|Stage 3|No longer meets eligibility criteria|1|||
163065364|NCT03765073|588945693|FG000|Stage 3|Other|0|||
163065365|NCT03765073|588945694|FG001|Stage 3|Other|0|||
163065366|NCT03765073|588945695|FG002|Stage 3|Other|0|||
163065367|NCT03765073|588945696|FG003|Stage 3|Other|0|||
163065368|NCT03765073|588945697|FG004|Stage 3|Other|0|||
163065369|NCT03765073|588945698|FG005|Stage 3|Other|0|||
163065370|NCT03765073|588945699|FG006|Stage 3|Other|0|||
163065371|NCT03765073|588945700|FG007|Stage 3|Other|0|||
163065372|NCT03765073|588945701|FG008|Stage 3|Other|0|||
163065373|NCT03765073|588945702|FG009|Stage 3|Other|0|||
163065374|NCT03765073|588945703|FG010|Stage 3|Other|0|||
163065375|NCT03765073|588945704|FG011|Stage 3|Other|0|||
163065376|NCT03765073|588945705|FG012|Stage 3|Other|0|||
163065377|NCT03765073|588945706|FG013|Stage 3|Other|0|||
163065378|NCT03765073|588945707|FG014|Stage 3|Other|0|||
163065379|NCT03765073|588945708|FG015|Stage 3|Other|0|||
163065380|NCT03765073|588945709|FG016|Stage 3|Other|0|||
163065381|NCT03765073|588945710|FG017|Stage 3|Other|1|||
163065382|NCT03765073|588945711|FG018|Stage 3|Other|2|||
163065383|NCT03765073|588945712|FG019|Stage 3|Other|2|||
163065384|NCT03765073|588945713|FG020|Stage 3|Other|2|||
163065385|NCT03765073|588945693|FG000|Stage 3|Withdrawal by parent/guardian|0|||
163065386|NCT03765073|588945694|FG001|Stage 3|Withdrawal by parent/guardian|0|||
163065387|NCT03765073|588945695|FG002|Stage 3|Withdrawal by parent/guardian|0|||
163065388|NCT03765073|588945696|FG003|Stage 3|Withdrawal by parent/guardian|0|||
163065389|NCT03765073|588945697|FG004|Stage 3|Withdrawal by parent/guardian|0|||
163065390|NCT03765073|588945698|FG005|Stage 3|Withdrawal by parent/guardian|0|||
163065391|NCT03765073|588945699|FG006|Stage 3|Withdrawal by parent/guardian|0|||
163065392|NCT03765073|588945700|FG007|Stage 3|Withdrawal by parent/guardian|0|||
163065393|NCT03765073|588945701|FG008|Stage 3|Withdrawal by parent/guardian|0|||
163065394|NCT03765073|588945702|FG009|Stage 3|Withdrawal by parent/guardian|0|||
163065395|NCT03765073|588945703|FG010|Stage 3|Withdrawal by parent/guardian|0|||
163065396|NCT03765073|588945704|FG011|Stage 3|Withdrawal by parent/guardian|0|||
163065397|NCT03765073|588945705|FG012|Stage 3|Withdrawal by parent/guardian|0|||
163065398|NCT03765073|588945706|FG013|Stage 3|Withdrawal by parent/guardian|0|||
163065399|NCT03765073|588945707|FG014|Stage 3|Withdrawal by parent/guardian|0|||
163065400|NCT03765073|588945708|FG015|Stage 3|Withdrawal by parent/guardian|0|||
163065401|NCT03765073|588945709|FG016|Stage 3|Withdrawal by parent/guardian|0|||
163065402|NCT03765073|588945710|FG017|Stage 3|Withdrawal by parent/guardian|0|||
163065403|NCT03765073|588945711|FG018|Stage 3|Withdrawal by parent/guardian|0|||
163065404|NCT03765073|588945712|FG019|Stage 3|Withdrawal by parent/guardian|6|||
163065405|NCT03765073|588945713|FG020|Stage 3|Withdrawal by parent/guardian|9|||
163065406|NCT03765073|588945693|FG000|Stage 3|Withdrawal by Subject|0|||
163065407|NCT03765073|588945694|FG001|Stage 3|Withdrawal by Subject|0|||
163065408|NCT03765073|588945695|FG002|Stage 3|Withdrawal by Subject|0|||
163065409|NCT03765073|588945696|FG003|Stage 3|Withdrawal by Subject|0|||
163065410|NCT03765073|588945697|FG004|Stage 3|Withdrawal by Subject|0|||
163065411|NCT03765073|588945698|FG005|Stage 3|Withdrawal by Subject|0|||
163065412|NCT03765073|588945699|FG006|Stage 3|Withdrawal by Subject|0|||
163065413|NCT03765073|588945700|FG007|Stage 3|Withdrawal by Subject|0|||
163065414|NCT03765073|588945701|FG008|Stage 3|Withdrawal by Subject|0|||
163065415|NCT03765073|588945702|FG009|Stage 3|Withdrawal by Subject|0|||
163065416|NCT03765073|588945703|FG010|Stage 3|Withdrawal by Subject|0|||
163065417|NCT03765073|588945704|FG011|Stage 3|Withdrawal by Subject|0|||
163065418|NCT03765073|588945705|FG012|Stage 3|Withdrawal by Subject|0|||
163065419|NCT03765073|588945706|FG013|Stage 3|Withdrawal by Subject|0|||
163065420|NCT03765073|588945707|FG014|Stage 3|Withdrawal by Subject|0|||
163065421|NCT03765073|588945708|FG015|Stage 3|Withdrawal by Subject|0|||
163065422|NCT03765073|588945709|FG016|Stage 3|Withdrawal by Subject|0|||
163065423|NCT03765073|588945710|FG017|Stage 3|Withdrawal by Subject|8|||
163065424|NCT03765073|588945711|FG018|Stage 3|Withdrawal by Subject|11|||
162643953|NCT00561080|587411794|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
162643954|NCT00561080|587411795|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
162643955|NCT00561080|587411793|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
163065425|NCT03765073|588945712|FG019|Stage 3|Withdrawal by Subject|0|||
163065426|NCT03765073|588945713|FG020|Stage 3|Withdrawal by Subject|0|||
163065427|NCT02802228|588945717|FG000|Overall Study|Withdrawal by Subject|2|||
163065428|NCT02802228|588945718|FG001|Overall Study|Withdrawal by Subject|0|||
163065429|NCT02802228|588945717|FG000|Overall Study|Lost to Follow-up|1|||
163065430|NCT02802228|588945718|FG001|Overall Study|Lost to Follow-up|0|||
163065431|NCT02802228|588945717|FG000|Overall Study|Adverse Event|1|||
163065432|NCT02802228|588945718|FG001|Overall Study|Adverse Event|0|||
163065433|NCT02802228|588945717|FG000|Overall Study|Physician Decision|1|||
163065434|NCT02802228|588945718|FG001|Overall Study|Physician Decision|0|||
163065435|NCT00695019|588945721|FG000|Overall Study|Withdrawal by Subject|8|||
163065436|NCT00695019|588945722|FG001|Overall Study|Withdrawal by Subject|6|||
163065437|NCT00695019|588945723|FG002|Overall Study|Withdrawal by Subject|4|||
163065438|NCT00695019|588945721|FG000|Overall Study|Protocol Violation|1|||
163065439|NCT00695019|588945722|FG001|Overall Study|Protocol Violation|3|||
163065440|NCT00695019|588945723|FG002|Overall Study|Protocol Violation|1|||
163065441|NCT00695019|588945721|FG000|Overall Study|Lack of Efficacy|0|||
163065442|NCT00695019|588945722|FG001|Overall Study|Lack of Efficacy|0|||
163065443|NCT00695019|588945723|FG002|Overall Study|Lack of Efficacy|1|||
163065444|NCT00695019|588945721|FG000|Overall Study|Various|4|||
163065445|NCT00695019|588945722|FG001|Overall Study|Various|5|||
163065446|NCT00695019|588945723|FG002|Overall Study|Various|4|||
163065447|NCT00580840|588945730|FG000|Run-in|Adverse Event|17|||
163065448|NCT00580840|588945731|FG001|Run-in|Adverse Event|0|||
163065449|NCT00580840|588945732|FG002|Run-in|Adverse Event|0|||
163065450|NCT00580840|588945733|FG003|Run-in|Adverse Event|0|||
163065451|NCT00580840|588945730|FG000|Run-in|Lack of Efficacy|93|||
163065452|NCT00580840|588945731|FG001|Run-in|Lack of Efficacy|0|||
163065453|NCT00580840|588945732|FG002|Run-in|Lack of Efficacy|0|||
163065454|NCT00580840|588945733|FG003|Run-in|Lack of Efficacy|0|||
163065455|NCT00580840|588945730|FG000|Run-in|Loss of Efficacy|1|||
163065456|NCT00580840|588945731|FG001|Run-in|Loss of Efficacy|0|||
163065457|NCT00580840|588945732|FG002|Run-in|Loss of Efficacy|0|||
163065458|NCT00580840|588945733|FG003|Run-in|Loss of Efficacy|0|||
163065459|NCT00580840|588945730|FG000|Run-in|Lost to Follow-up|4|||
163065460|NCT00580840|588945731|FG001|Run-in|Lost to Follow-up|0|||
163065461|NCT00580840|588945732|FG002|Run-in|Lost to Follow-up|0|||
163065462|NCT00580840|588945733|FG003|Run-in|Lost to Follow-up|0|||
163065463|NCT00580840|588945730|FG000|Run-in|Withdrawal by Subject|5|||
163065464|NCT00580840|588945731|FG001|Run-in|Withdrawal by Subject|0|||
163065465|NCT00580840|588945732|FG002|Run-in|Withdrawal by Subject|0|||
163065466|NCT00580840|588945733|FG003|Run-in|Withdrawal by Subject|0|||
163065467|NCT00580840|588945730|FG000|Run-in|Other: Per Sponsor Request|2|||
163065468|NCT00580840|588945731|FG001|Run-in|Other: Per Sponsor Request|0|||
163065469|NCT00580840|588945732|FG002|Run-in|Other: Per Sponsor Request|0|||
163065470|NCT00580840|588945733|FG003|Run-in|Other: Per Sponsor Request|0|||
163065471|NCT00580840|588945730|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
163065472|NCT00580840|588945731|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065473|NCT00580840|588945732|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065474|NCT00580840|588945733|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
163065475|NCT00580840|588945730|FG000|Run-in|Other: Exclusionary Lab Value|1|||
163065476|NCT00580840|588945731|FG001|Run-in|Other: Exclusionary Lab Value|0|||
163065477|NCT00580840|588945732|FG002|Run-in|Other: Exclusionary Lab Value|0|||
163065478|NCT00580840|588945733|FG003|Run-in|Other: Exclusionary Lab Value|0|||
163065479|NCT00580840|588945730|FG000|Double-Blind|Adverse Event|0|||
163065480|NCT00580840|588945731|FG001|Double-Blind|Adverse Event|3|||
163065481|NCT00580840|588945732|FG002|Double-Blind|Adverse Event|4|||
163065482|NCT00580840|588945733|FG003|Double-Blind|Adverse Event|1|||
163065483|NCT00580840|588945730|FG000|Double-Blind|Loss of Efficacy|0|||
163065484|NCT00580840|588945731|FG001|Double-Blind|Loss of Efficacy|1|||
163065485|NCT00580840|588945732|FG002|Double-Blind|Loss of Efficacy|2|||
163065486|NCT00580840|588945733|FG003|Double-Blind|Loss of Efficacy|10|||
163065487|NCT00580840|588945730|FG000|Double-Blind|Lost to Follow-up|0|||
163065488|NCT00580840|588945731|FG001|Double-Blind|Lost to Follow-up|1|||
163065489|NCT00580840|588945732|FG002|Double-Blind|Lost to Follow-up|0|||
163065490|NCT00580840|588945733|FG003|Double-Blind|Lost to Follow-up|2|||
163065491|NCT00580840|588945730|FG000|Double-Blind|Withdrawal by Subject|0|||
163065492|NCT00580840|588945731|FG001|Double-Blind|Withdrawal by Subject|1|||
163065493|NCT00580840|588945732|FG002|Double-Blind|Withdrawal by Subject|2|||
163065494|NCT00580840|588945733|FG003|Double-Blind|Withdrawal by Subject|2|||
163065495|NCT00580840|588945730|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
163065496|NCT00580840|588945731|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
163065497|NCT00580840|588945732|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
163065498|NCT00580840|588945733|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
163065499|NCT00580840|588945730|FG000|Double-Blind|Other: Forbidden Medication|0|||
163065500|NCT00580840|588945731|FG001|Double-Blind|Other: Forbidden Medication|0|||
163065501|NCT00580840|588945732|FG002|Double-Blind|Other: Forbidden Medication|1|||
163065502|NCT00580840|588945733|FG003|Double-Blind|Other: Forbidden Medication|0|||
163065503|NCT01160614|588945736|FG000|Overall Study|Withdrawal by Subject|0|||
163065504|NCT01160614|588945737|FG001|Overall Study|Withdrawal by Subject|2|||
163065505|NCT00984399|588945738|FG000|Overall Study|Adverse Event|0|||
163065506|NCT00984399|588945739|FG001|Overall Study|Adverse Event|1|||
163065507|NCT00984399|588945738|FG000|Overall Study|Physician Decision|1|||
163065508|NCT00984399|588945739|FG001|Overall Study|Physician Decision|0|||
163065509|NCT00984399|588945738|FG000|Overall Study|Withdrawal by Subject|1|||
163065510|NCT00984399|588945739|FG001|Overall Study|Withdrawal by Subject|1|||
163065511|NCT00984399|588945738|FG000|Overall Study|Protocol Violation|0|||
163065512|NCT00984399|588945739|FG001|Overall Study|Protocol Violation|1|||
163065513|NCT00984399|588945738|FG000|Overall Study|Pts did not start treatment|2|||
163065514|NCT00984399|588945739|FG001|Overall Study|Pts did not start treatment|2|||
163065515|NCT05049122|588945740|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
163065516|NCT05049122|588945740|FG000|Overall Study|Participant moved|1|||
163065517|NCT05049122|588945740|FG000|Overall Study|At the direction of the doctor|1|||
163065518|NCT01723774|588945742|FG000|Neoadjuvant|Ki67 > 10%|4|||
163065519|NCT01723774|588945743|FG001|Neoadjuvant|Ki67 > 10%|0|||
163065520|NCT01723774|588945744|FG002|Neoadjuvant|Ki67 > 10%|10|||
163065521|NCT01723774|588945745|FG003|Neoadjuvant|Ki67 > 10%|0|||
163065522|NCT01723774|588945742|FG000|Neoadjuvant|Withdrawal by Subject|3|||
163065523|NCT01723774|588945743|FG001|Neoadjuvant|Withdrawal by Subject|1|||
163065524|NCT01723774|588945744|FG002|Neoadjuvant|Withdrawal by Subject|0|||
163065525|NCT01723774|588945745|FG003|Neoadjuvant|Withdrawal by Subject|0|||
163065526|NCT01723774|588945742|FG000|Neoadjuvant|Disease progression|0|||
163065527|NCT01723774|588945743|FG001|Neoadjuvant|Disease progression|1|||
163065528|NCT01723774|588945744|FG002|Neoadjuvant|Disease progression|1|||
163065529|NCT01723774|588945745|FG003|Neoadjuvant|Disease progression|0|||
163065530|NCT01723774|588945742|FG000|Neoadjuvant|Adverse Event|0|||
163065531|NCT01723774|588945743|FG001|Neoadjuvant|Adverse Event|1|||
163065532|NCT01723774|588945744|FG002|Neoadjuvant|Adverse Event|2|||
163065533|NCT01723774|588945745|FG003|Neoadjuvant|Adverse Event|0|||
163065534|NCT01723774|588945742|FG000|Neoadjuvant|High estradiol|0|||
163065535|NCT01723774|588945743|FG001|Neoadjuvant|High estradiol|1|||
163065536|NCT01723774|588945744|FG002|Neoadjuvant|High estradiol|0|||
163065537|NCT01723774|588945745|FG003|Neoadjuvant|High estradiol|0|||
163065538|NCT01910441|588945746|FG000|Overall Study|Sponsor decision|0|||
163065539|NCT01910441|588945747|FG001|Overall Study|Sponsor decision|2|||
163065540|NCT01910441|588945746|FG000|Overall Study|Lost to Follow-up|6|||
163065541|NCT01910441|588945747|FG001|Overall Study|Lost to Follow-up|5|||
163065542|NCT01910441|588945746|FG000|Overall Study|Withdrawal by Subject|0|||
163065543|NCT01910441|588945747|FG001|Overall Study|Withdrawal by Subject|1|||
163065544|NCT01910441|588945746|FG000|Overall Study|Non-compliance|0|||
163065545|NCT01910441|588945747|FG001|Overall Study|Non-compliance|1|||
163065546|NCT01910441|588945746|FG000|Overall Study|Adverse Event|1|||
163065547|NCT01910441|588945747|FG001|Overall Study|Adverse Event|0|||
163065548|NCT01910441|588945746|FG000|Overall Study|Physician Decision|0|||
163065549|NCT01910441|588945747|FG001|Overall Study|Physician Decision|1|||
163065550|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065551|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
163065552|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065553|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065554|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065555|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
163065556|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065557|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
163065558|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065559|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065560|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065561|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065562|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065563|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
163065564|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065565|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
163065566|NCT02964182|588945748|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065567|NCT02964182|588945749|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
163065568|NCT02964182|588945750|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065569|NCT02964182|588945751|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065570|NCT02964182|588945752|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065571|NCT02964182|588945753|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
163065572|NCT02964182|588945754|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065573|NCT02964182|588945755|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
163065574|NCT02964182|588945748|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065575|NCT02964182|588945749|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065576|NCT02964182|588945750|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
163065577|NCT02964182|588945751|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
163065578|NCT02964182|588945752|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065579|NCT02964182|588945753|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065580|NCT02964182|588945754|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
163065581|NCT02964182|588945755|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
163065582|NCT02964182|588945748|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065583|NCT02964182|588945749|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065584|NCT02964182|588945750|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
163065585|NCT02964182|588945751|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
163065586|NCT02964182|588945752|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065587|NCT02964182|588945753|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065588|NCT02964182|588945754|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
163065589|NCT02964182|588945755|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
162643956|NCT00561080|587411794|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
163065590|NCT02964182|588945748|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065591|NCT02964182|588945749|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065592|NCT02964182|588945750|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
163065593|NCT02964182|588945751|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
163065594|NCT02964182|588945752|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065595|NCT02964182|588945753|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065596|NCT02964182|588945754|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065597|NCT02964182|588945755|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
163065598|NCT02964182|588945748|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065599|NCT02964182|588945749|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065600|NCT02964182|588945750|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
163065601|NCT02964182|588945751|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
163065602|NCT02964182|588945752|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065603|NCT02964182|588945753|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065604|NCT02964182|588945754|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
163065605|NCT02964182|588945755|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
163065606|NCT03636477|588945756|FG000|Overall Study|Adverse Event|0|||
163065607|NCT03636477|588945757|FG001|Overall Study|Adverse Event|0|||
163065608|NCT03636477|588945758|FG002|Overall Study|Adverse Event|1|||
163065609|NCT02382380|588945760|FG000|Overall Study|Withdrawal by Subject|2|||
163065610|NCT02382380|588945761|FG001|Overall Study|Withdrawal by Subject|2|||
163065611|NCT02382380|588945760|FG000|Overall Study|Lost to Follow-up|0|||
163065612|NCT02382380|588945761|FG001|Overall Study|Lost to Follow-up|1|||
163065613|NCT01295944|588945762|FG000|Overall Study|Switched to alternative treatment|1|||
163065614|NCT01295944|588945762|FG000|Overall Study|Ineligible|9|||
163065615|NCT01295944|588945762|FG000|Overall Study|Withdrawal by Subject|1|||
163065616|NCT01295944|588945762|FG000|Overall Study|Participant chose to be treated in Peru|1|||
163065617|NCT01295944|588945762|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
163065618|NCT01295944|588945762|FG000|Overall Study|Physician Decision|1|||
163065619|NCT01295944|588945762|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
163065620|NCT01295944|588945762|FG000|Overall Study|Disease progression|4|||
163065621|NCT01295944|588945762|FG000|Overall Study|Transferred care before starting new treatment|1|||
163065622|NCT03785366|588945763|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
163065623|NCT03785366|588945764|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
163065624|NCT03785366|588945763|FG000|Overall Study|Lost to Follow-up|1|||
163065625|NCT03785366|588945764|FG001|Overall Study|Lost to Follow-up|0|||
163065626|NCT03785366|588945763|FG000|Overall Study|Partial IUD Expulsion|0|||
163065627|NCT03785366|588945764|FG001|Overall Study|Partial IUD Expulsion|2|||
163065628|NCT03785366|588945763|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
163065629|NCT03785366|588945764|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
163065630|NCT05168800|588945765|FG000|Time 1 Survey|Did not start T1 survey|182|||
163065631|NCT05168800|588945766|FG001|Time 1 Survey|Did not start T1 survey|150|||
163065632|NCT05168800|588945767|FG002|Time 1 Survey|Did not start T1 survey|140|||
163065633|NCT05168800|588945765|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
163065634|NCT05168800|588945766|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
163065635|NCT05168800|588945767|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
163065636|NCT05168800|588945765|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
163065637|NCT05168800|588945766|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
163065638|NCT05168800|588945767|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
163065639|NCT05168800|588945765|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
163065640|NCT05168800|588945766|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
163065641|NCT05168800|588945767|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
163065642|NCT05168800|588945765|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
163065643|NCT05168800|588945766|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
163065644|NCT05168800|588945767|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
163065645|NCT05168800|588945765|FG000|Time 1 Survey|Withdrawal by Subject|6|||
163065646|NCT05168800|588945766|FG001|Time 1 Survey|Withdrawal by Subject|3|||
163065647|NCT05168800|588945767|FG002|Time 1 Survey|Withdrawal by Subject|2|||
163065648|NCT05168800|588945765|FG000|Time 2 Survey|Already excluded at Time 1|228|||
163065649|NCT05168800|588945766|FG001|Time 2 Survey|Already excluded at Time 1|202|||
163065650|NCT05168800|588945767|FG002|Time 2 Survey|Already excluded at Time 1|173|||
163065651|NCT05168800|588945765|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
163065652|NCT05168800|588945766|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
163065653|NCT05168800|588945767|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
163065654|NCT05168800|588945765|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
163065655|NCT05168800|588945766|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
163065656|NCT05168800|588945767|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
163065657|NCT05168800|588945765|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
163065658|NCT05168800|588945766|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
163065659|NCT05168800|588945767|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
162643957|NCT00561080|587411795|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
162643958|NCT02295995|587411796|FG000|Overall Study|Lost to Follow-up|5|||
162643959|NCT02295995|587411797|FG001|Overall Study|Lost to Follow-up|1|||
162643960|NCT04350788|587411806|FG000|Overall Study|Lost to Follow-up|6|||
163065660|NCT05168800|588945765|FG000|Time 2 Survey|Withdrawal by Subject|1|||
162643961|NCT04350788|587411807|FG001|Overall Study|Lost to Follow-up|2|||
163065661|NCT05168800|588945766|FG001|Time 2 Survey|Withdrawal by Subject|0|||
162643962|NCT04350788|587411806|FG000|Overall Study|Withdrawal by Subject|2|||
163065662|NCT05168800|588945767|FG002|Time 2 Survey|Withdrawal by Subject|1|||
163065663|NCT05168800|588945765|FG000|Time 3 Survey|Already excluded at Time 1|228|||
162643963|NCT04350788|587411807|FG001|Overall Study|Withdrawal by Subject|4|||
162643964|NCT04350788|587411806|FG000|Overall Study|Protocol Violation|4|||
163065664|NCT05168800|588945766|FG001|Time 3 Survey|Already excluded at Time 1|200|||
163065665|NCT05168800|588945767|FG002|Time 3 Survey|Already excluded at Time 1|173|||
162643965|NCT04350788|587411807|FG001|Overall Study|Protocol Violation|0|||
162643966|NCT04537234|587411808|FG000|Overall Study|Withdrawal by Subject|2|||
163065666|NCT05168800|588945765|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
163065667|NCT05168800|588945766|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
163065668|NCT05168800|588945767|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
163065669|NCT05168800|588945765|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
163065670|NCT05168800|588945766|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
163065671|NCT05168800|588945767|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
163065672|NCT05168800|588945765|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
163065673|NCT05168800|588945766|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
163065674|NCT05168800|588945767|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
163065675|NCT03240874|588945768|FG000|Overall Study|Lost to Follow-up|0|||
163065676|NCT03240874|588945769|FG001|Overall Study|Lost to Follow-up|2|||
163065677|NCT03240874|588945770|FG002|Overall Study|Lost to Follow-up|4|||
163065678|NCT03240874|588945771|FG003|Overall Study|Lost to Follow-up|1|||
163065679|NCT04958707|588945772|FG000|Post Intervention|Withdrawal by Subject|1|||
163065680|NCT04958707|588945773|FG001|Post Intervention|Withdrawal by Subject|0|||
163065681|NCT04958707|588945774|FG002|Post Intervention|Withdrawal by Subject|0|||
163065682|NCT04958707|588945772|FG000|3 Months Follow- up|Lost to Follow-up|0|||
163065683|NCT04958707|588945773|FG001|3 Months Follow- up|Lost to Follow-up|3|||
163065684|NCT04958707|588945774|FG002|3 Months Follow- up|Lost to Follow-up|0|||
163065685|NCT04958707|588945772|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
163065686|NCT04958707|588945773|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
163065687|NCT04958707|588945774|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
163065688|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
163065689|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
163065690|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
163065691|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
163065692|NCT04279522|588945777|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
163065693|NCT04279522|588945778|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
163065694|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
163065695|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
163065696|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
163065697|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
163065698|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Physician Decision|0|||
163065699|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Physician Decision|3|||
163065700|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Adverse Event|0|||
163065701|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Adverse Event|1|||
163065702|NCT04279522|588945777|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
163065703|NCT04279522|588945778|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
163065704|NCT02783274|588945784|FG000|Overall Study|Withdrawal by Subject|16|||
163065705|NCT02783274|588945784|FG000|Overall Study|Physician Decision|6|||
163065706|NCT02783274|588945784|FG000|Overall Study|Death|9|||
163065707|NCT02783274|588945784|FG000|Overall Study|Lost to Follow-up|22|||
163065708|NCT02783274|588945784|FG000|Overall Study|Other|22|||
163065709|NCT05567172|588945787|FG000|Overall Study|Death|3|||
163065710|NCT02246777|588945790|FG000|Overall Study|Adverse Event|2|||
163065711|NCT02246777|588945790|FG000|Overall Study|Change of residence|1|||
163065712|NCT00927472|588945791|FG000|Overall Study|Withdrawal by Subject|10|||
163065713|NCT00927472|588945792|FG001|Overall Study|Withdrawal by Subject|11|||
163065714|NCT00927472|588945791|FG000|Overall Study|Lost to Follow-up|1|||
163065715|NCT00927472|588945792|FG001|Overall Study|Lost to Follow-up|6|||
163065716|NCT00927472|588945791|FG000|Overall Study|Protocol Violation|0|||
163065717|NCT00927472|588945792|FG001|Overall Study|Protocol Violation|1|||
163065718|NCT00927472|588945791|FG000|Overall Study|Post treatment Assessment out of window|0|||
163065719|NCT00927472|588945792|FG001|Overall Study|Post treatment Assessment out of window|4|||
162643967|NCT04537234|587411809|FG001|Overall Study|Withdrawal by Subject|0|||
162643968|NCT00378209|587411810|FG000|Overall Study|Progressive disease|11|||
162643969|NCT00378209|587411810|FG000|Overall Study|Adverse Event|3|||
162643970|NCT00378209|587411810|FG000|Overall Study|Initiation of non-protocol therapy|3|||
162643971|NCT00378209|587411810|FG000|Overall Study|Physician Decision|3|||
163065720|NCT04707469|588945793|FG000|Overall Study|Site closure|0|||
163065721|NCT04707469|588945794|FG001|Overall Study|Site closure|2|||
163065722|NCT04707469|588945795|FG002|Overall Study|Site closure|0|||
163065723|NCT04707469|588945793|FG000|Overall Study|Physician Decision|2|||
163065724|NCT04707469|588945794|FG001|Overall Study|Physician Decision|2|||
163065725|NCT04707469|588945795|FG002|Overall Study|Physician Decision|2|||
163065726|NCT04707469|588945793|FG000|Overall Study|Death|1|||
162643972|NCT00378209|587411810|FG000|Overall Study|Death|1|||
163065727|NCT04707469|588945794|FG001|Overall Study|Death|6|||
163065728|NCT04707469|588945795|FG002|Overall Study|Death|2|||
162643973|NCT00378209|587411810|FG000|Overall Study|Treatment delay|1|||
162643974|NCT02070744|587411811|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163065729|NCT04707469|588945793|FG000|Overall Study|Lost to Follow-up|9|||
163065730|NCT04707469|588945794|FG001|Overall Study|Lost to Follow-up|19|||
163065731|NCT04707469|588945795|FG002|Overall Study|Lost to Follow-up|14|||
163065732|NCT04707469|588945793|FG000|Overall Study|Withdrawal by Subject|17|||
163065733|NCT04707469|588945794|FG001|Overall Study|Withdrawal by Subject|16|||
163065734|NCT04707469|588945795|FG002|Overall Study|Withdrawal by Subject|12|||
163065735|NCT04635423|588945808|FG000|Overall Study|Ongoing|493|||
163065736|NCT04635423|588945809|FG001|Overall Study|Ongoing|501|||
163065737|NCT04635423|588945808|FG000|Overall Study|Withdrawal by Subject|36|||
163065738|NCT04635423|588945809|FG001|Overall Study|Withdrawal by Subject|29|||
163065739|NCT05556057|588945810|FG000|Overall Study|Lost to Follow-up|5|||
163065740|NCT05556057|588945811|FG001|Overall Study|Lost to Follow-up|4|||
163065741|NCT05556057|588945810|FG000|Overall Study|Withdrawal by Subject|0|||
163065742|NCT05556057|588945811|FG001|Overall Study|Withdrawal by Subject|2|||
163065743|NCT03488524|588945822|FG000|Overall Study|Withdrawal by Subject|51|||
162717842|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
162717843|NCT02914522|587673489|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163065744|NCT03488524|588945822|FG000|Overall Study|Death|19|||
163065745|NCT03488524|588945822|FG000|Overall Study|Study Sponsor|11|||
163065746|NCT03488524|588945822|FG000|Overall Study|Physician Decision|4|||
163065747|NCT03488524|588945822|FG000|Overall Study|Lost to Follow-up|3|||
163065748|NCT00830765|588945823|FG000|Overall Study|Protocol Violation|3|||
163065749|NCT00830765|588945824|FG001|Overall Study|Protocol Violation|2|||
163065750|NCT00315445|588945825|FG000|Overall Study|Adverse Event|7|||
163065751|NCT00315445|588945826|FG001|Overall Study|Adverse Event|12|||
163065752|NCT00315445|588945827|FG002|Overall Study|Adverse Event|15|||
163065753|NCT00315445|588945825|FG000|Overall Study|Lack of Efficacy|16|||
163065754|NCT00315445|588945826|FG001|Overall Study|Lack of Efficacy|1|||
163065755|NCT00315445|588945827|FG002|Overall Study|Lack of Efficacy|7|||
163065756|NCT00315445|588945825|FG000|Overall Study|Lost to Follow-up|1|||
163065757|NCT00315445|588945826|FG001|Overall Study|Lost to Follow-up|0|||
163065758|NCT00315445|588945827|FG002|Overall Study|Lost to Follow-up|1|||
163065759|NCT00315445|588945825|FG000|Overall Study|Protocol Violation|2|||
163065760|NCT00315445|588945826|FG001|Overall Study|Protocol Violation|0|||
163065761|NCT00315445|588945827|FG002|Overall Study|Protocol Violation|1|||
163065762|NCT00315445|588945825|FG000|Overall Study|Other|1|||
163065763|NCT00315445|588945826|FG001|Overall Study|Other|3|||
163065764|NCT00315445|588945827|FG002|Overall Study|Other|0|||
163065765|NCT02390284|588945828|FG000|Overall Study|Physician Decision|0|||
163065766|NCT02390284|588945829|FG001|Overall Study|Physician Decision|0|||
163065767|NCT02390284|588945830|FG002|Overall Study|Physician Decision|9|||
163065768|NCT01299909|588945831|FG000|Overall Study|Lost to Follow-up|22|||
163065769|NCT01299909|588945832|FG001|Overall Study|Lost to Follow-up|18|||
163065770|NCT01299909|588945833|FG002|Overall Study|Lost to Follow-up|17|||
163065771|NCT01811238|588945834|FG000|Overall Study|Withdrawal by Subject|42|||
163065772|NCT01811238|588945834|FG000|Overall Study|Adverse Event|25|||
163065773|NCT01811238|588945834|FG000|Overall Study|Protocol Violation|4|||
163065774|NCT01811238|588945834|FG000|Overall Study|Lack of Efficacy|4|||
163065775|NCT01811238|588945834|FG000|Overall Study|subject refused study medication|6|||
163065776|NCT01977846|588945835|FG000|Total Study - Prospective|Death|0|||
163065777|NCT01977846|588945836|FG001|Total Study - Prospective|Death|1|||
163065778|NCT01977846|588945835|FG000|Total Study - Prospective|Lost to Follow-up|0|||
163065779|NCT01977846|588945836|FG001|Total Study - Prospective|Lost to Follow-up|8|||
163065780|NCT01977846|588945835|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
163065781|NCT01977846|588945836|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
163065782|NCT01977846|588945835|FG000|Total Study - Prospective|Not available at time of visit|0|||
163065783|NCT01977846|588945836|FG001|Total Study - Prospective|Not available at time of visit|5|||
163065784|NCT01977846|588945835|FG000|Total Study - Prospective|No show|0|||
163065785|NCT01977846|588945836|FG001|Total Study - Prospective|No show|1|||
163065786|NCT01977846|588945835|FG000|Total Study - Prospective|Protocol Violation|0|||
163065787|NCT01977846|588945836|FG001|Total Study - Prospective|Protocol Violation|1|||
163065788|NCT00143507|588947348|FG000|Overall Study|Death|572|||
163065789|NCT00143507|588947349|FG001|Overall Study|Death|547|||
163065790|NCT00143507|588947348|FG000|Overall Study|Withdrawal by Subject|114|||
163065791|NCT00143507|588947349|FG001|Overall Study|Withdrawal by Subject|102|||
163065792|NCT00143507|588947348|FG000|Overall Study|Lost to Follow-up|1|||
163065793|NCT00143507|588947349|FG001|Overall Study|Lost to Follow-up|0|||
163065794|NCT00143507|588947348|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
163065795|NCT00143507|588947349|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
163065796|NCT00177671|588947350|FG000|Overall Study|Withdrawal by Subject|5|||
163065797|NCT00177671|588947351|FG001|Overall Study|Withdrawal by Subject|6|||
163065798|NCT00177671|588947350|FG000|Overall Study|medical complications|2|||
163065799|NCT00177671|588947351|FG001|Overall Study|medical complications|0|||
163065800|NCT00177671|588947350|FG000|Overall Study|Adverse Event|6|||
163065801|NCT00177671|588947351|FG001|Overall Study|Adverse Event|0|||
163065802|NCT00177671|588947350|FG000|Overall Study|Physician Decision|12|||
163065803|NCT00177671|588947351|FG001|Overall Study|Physician Decision|8|||
163065804|NCT00690898|588947352|FG000|SCREENING|Screen failure|18|||
163065805|NCT00690898|588947352|FG000|TREATMENT|Adverse Event|3|||
163065806|NCT00690898|588947352|FG000|TREATMENT|Lack of Efficacy|18|||
163065807|NCT00690898|588947352|FG000|TREATMENT|Withdrawal by Subject|4|||
163065808|NCT00690898|588947352|FG000|TREATMENT|Other (not otherwise specified)|1|||
163065809|NCT01121926|588947353|FG000|First Intervention Period|Adverse Event|1|||
163065810|NCT01121926|588947354|FG001|First Intervention Period|Adverse Event|0|||
163065811|NCT01121926|588947353|FG000|Washout Period|Adverse Event|0|||
163065812|NCT01121926|588947354|FG001|Washout Period|Adverse Event|1|||
162643975|NCT02070744|587411812|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
163065813|NCT01121926|588947353|FG000|Washout Period|Positive pregnancy test|0|||
163065814|NCT01121926|588947354|FG001|Washout Period|Positive pregnancy test|1|||
163065815|NCT00356590|588947355|FG000|Overall Study|Adverse Event|54|||
163065816|NCT00356590|588947355|FG000|Overall Study|Death|10|||
163065817|NCT00356590|588947355|FG000|Overall Study|Lost to Follow-up|35|||
163065818|NCT00356590|588947355|FG000|Overall Study|Physician Decision|46|||
163065819|NCT00356590|588947355|FG000|Overall Study|Withdrawal by Subject|41|||
162643976|NCT02070744|587411813|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162643977|NCT02070744|587411814|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
163065820|NCT00356590|588947355|FG000|Overall Study|Completed month 12 only|2|||
163065821|NCT00356590|588947355|FG000|Overall Study|Protocol issues|6|||
163065822|NCT00356590|588947355|FG000|Overall Study|Response status|28|||
163065823|NCT00356590|588947355|FG000|Overall Study|Other|52|||
163065824|NCT01496456|588947357|FG000|Overall Study|Protocol Violation|1|||
163065825|NCT01496456|588947357|FG000|Overall Study|Lost to Follow-up|7|||
163065826|NCT04919161|588947358|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
163065827|NCT04919161|588947359|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
163065828|NCT04919161|588947358|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
163065829|NCT04919161|588947359|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
163065830|NCT04919161|588947358|FG000|Overall Study|Acute ankle sprain after session 1|0|||
163065831|NCT04919161|588947359|FG001|Overall Study|Acute ankle sprain after session 1|1|||
163065832|NCT02175758|588947360|FG000|Treatment Phase|Lost to Follow-up|0|||
163065833|NCT02175758|588947361|FG001|Treatment Phase|Lost to Follow-up|1|||
163065834|NCT02175758|588947362|FG002|Treatment Phase|Lost to Follow-up|0|||
163065835|NCT02175758|588947363|FG003|Treatment Phase|Lost to Follow-up|0|||
163065836|NCT02175758|588947364|FG004|Treatment Phase|Lost to Follow-up|0|||
163065837|NCT02175758|588947365|FG005|Treatment Phase|Lost to Follow-up|0|||
163065838|NCT02175758|588947360|FG000|Treatment Phase|Adverse Event|0|||
163065839|NCT02175758|588947361|FG001|Treatment Phase|Adverse Event|0|||
163065840|NCT02175758|588947362|FG002|Treatment Phase|Adverse Event|0|||
163065841|NCT02175758|588947363|FG003|Treatment Phase|Adverse Event|0|||
163065842|NCT02175758|588947364|FG004|Treatment Phase|Adverse Event|1|||
163065843|NCT02175758|588947365|FG005|Treatment Phase|Adverse Event|0|||
163065844|NCT02489773|588947366|FG000|Overall Study|Lost to Follow-up|4|||
163065845|NCT02489773|588947367|FG001|Overall Study|Lost to Follow-up|1|||
163065846|NCT02489773|588947366|FG000|Overall Study|Physician Decision|1|||
163065847|NCT02489773|588947367|FG001|Overall Study|Physician Decision|0|||
163065848|NCT02489773|588947366|FG000|Overall Study|Withdrawal by Subject|1|||
163065849|NCT02489773|588947367|FG001|Overall Study|Withdrawal by Subject|0|||
163065850|NCT02489773|588947366|FG000|Overall Study|Leave the country or the state|1|||
163065851|NCT02489773|588947367|FG001|Overall Study|Leave the country or the state|1|||
163065852|NCT00712920|588947368|FG000|Overall Study|Adverse Event|3|||
163065853|NCT00712920|588947369|FG001|Overall Study|Adverse Event|4|||
163065854|NCT00712920|588947370|FG002|Overall Study|Adverse Event|7|||
163065855|NCT00712920|588947368|FG000|Overall Study|Withdrawal by Subject|4|||
163065856|NCT00712920|588947369|FG001|Overall Study|Withdrawal by Subject|2|||
163065857|NCT00712920|588947370|FG002|Overall Study|Withdrawal by Subject|1|||
163065858|NCT00712920|588947368|FG000|Overall Study|Lost to Follow-up|1|||
163065859|NCT00712920|588947369|FG001|Overall Study|Lost to Follow-up|4|||
163065860|NCT00712920|588947370|FG002|Overall Study|Lost to Follow-up|0|||
163065861|NCT00712920|588947368|FG000|Overall Study|Lack of Efficacy|1|||
163065862|NCT00712920|588947369|FG001|Overall Study|Lack of Efficacy|0|||
163065863|NCT00712920|588947370|FG002|Overall Study|Lack of Efficacy|1|||
163065864|NCT00712920|588947368|FG000|Overall Study|Other|5|||
163065865|NCT00712920|588947369|FG001|Overall Study|Other|7|||
163065866|NCT00712920|588947370|FG002|Overall Study|Other|3|||
163065867|NCT00712920|588947368|FG000|Overall Study|Non-compliance|3|||
163065868|NCT00712920|588947369|FG001|Overall Study|Non-compliance|0|||
163065869|NCT00712920|588947370|FG002|Overall Study|Non-compliance|0|||
163065870|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
163065871|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
163065872|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
163065873|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
163065874|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
163065875|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
163065876|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065877|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065878|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
163065879|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
163065880|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
163065881|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
163065882|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
163065883|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
163065884|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
163065885|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
163065886|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065887|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
163065888|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065889|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
163065890|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065891|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
163065892|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065893|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163065894|NCT00620542|588947372|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
163065895|NCT00620542|588947373|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
163065896|NCT00620542|588947374|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
163065897|NCT00620542|588947375|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
163065898|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
163065899|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
163065900|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
162643978|NCT02070744|587411815|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162643979|NCT02070744|587411811|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162643980|NCT02070744|587411812|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162643981|NCT02070744|587411813|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162643982|NCT02070744|587411814|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162643983|NCT02070744|587411815|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
162643984|NCT02070744|587411811|FG000|OLE Phase (48 Weeks)|Other|0|||
162643985|NCT02070744|587411812|FG001|OLE Phase (48 Weeks)|Other|0|||
162643986|NCT02070744|587411813|FG002|OLE Phase (48 Weeks)|Other|0|||
163065901|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
163065902|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
163065903|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
163065904|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
163065905|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
163065906|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
163065907|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
163065908|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
163065909|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
163065910|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
163065911|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
163065912|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
163065913|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
163065914|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
163065915|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
163065916|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
163065917|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
163065918|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
163065919|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
163065920|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
163065921|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
163065922|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
163065923|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
163065924|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
163065925|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
163065926|NCT00620542|588947372|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
163065927|NCT00620542|588947373|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
163065928|NCT00620542|588947374|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
163065929|NCT00620542|588947375|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
163065930|NCT02550795|588947382|FG000|Overall Study|Physician Decision|0|||
163065931|NCT02550795|588947383|FG001|Overall Study|Physician Decision|1|||
163065932|NCT02550795|588947384|FG002|Overall Study|Physician Decision|0|||
163065933|NCT02225587|588947385|FG000|Overall Study|Adverse Event|5|||
163065934|NCT02225587|588947386|FG001|Overall Study|Adverse Event|5|||
163065935|NCT02225587|588947385|FG000|Overall Study|Lost to Follow-up|5|||
163065936|NCT02225587|588947386|FG001|Overall Study|Lost to Follow-up|5|||
163065937|NCT02225587|588947385|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163065938|NCT02225587|588947386|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163065939|NCT02225587|588947385|FG000|Overall Study|Physician Decision|2|||
163065940|NCT02225587|588947386|FG001|Overall Study|Physician Decision|0|||
163065941|NCT02225587|588947385|FG000|Overall Study|Protocol Violation|1|||
163065942|NCT02225587|588947386|FG001|Overall Study|Protocol Violation|0|||
163065943|NCT02225587|588947385|FG000|Overall Study|Participant Moved|1|||
163065944|NCT02225587|588947386|FG001|Overall Study|Participant Moved|0|||
163065945|NCT02225587|588947385|FG000|Overall Study|Withdrawal by Subject|13|||
163065946|NCT02225587|588947386|FG001|Overall Study|Withdrawal by Subject|28|||
163065947|NCT03483584|588947389|FG000|Overall Study|Lost to Follow-up|40|||
163065948|NCT03483584|588947390|FG001|Overall Study|Lost to Follow-up|7|||
163065949|NCT03483584|588947389|FG000|Overall Study|Withdrawal by Subject|4|||
163065950|NCT03483584|588947390|FG001|Overall Study|Withdrawal by Subject|1|||
163065951|NCT02879695|588947391|FG000|Overall Study|Did not start study treatment|2|||
163065952|NCT02879695|588947392|FG001|Overall Study|Did not start study treatment|0|||
163065953|NCT02879695|588947393|FG002|Overall Study|Did not start study treatment|3|||
163065954|NCT02879695|588947394|FG003|Overall Study|Did not start study treatment|0|||
163065955|NCT04063163|588947395|FG000|Overall Study|Death|281|||
163065956|NCT04063163|588947396|FG001|Overall Study|Death|166|||
163065957|NCT04063163|588947395|FG000|Overall Study|Lost to Follow-up|12|||
163065958|NCT04063163|588947396|FG001|Overall Study|Lost to Follow-up|8|||
163065959|NCT04063163|588947395|FG000|Overall Study|Withdrawal by Subject|19|||
163065960|NCT04063163|588947396|FG001|Overall Study|Withdrawal by Subject|10|||
163065961|NCT02572167|588947397|FG000|Overall Study|Withdrawal by Subject|0|||
163065962|NCT02572167|588947398|FG001|Overall Study|Withdrawal by Subject|3|||
163065963|NCT02572167|588947399|FG002|Overall Study|Withdrawal by Subject|0|||
162643987|NCT02070744|587411814|FG003|OLE Phase (48 Weeks)|Other|0|||
162643988|NCT02070744|587411815|FG004|OLE Phase (48 Weeks)|Other|1|||
163065964|NCT02572167|588947397|FG000|Overall Study|Lost to Follow-up|2|||
163065965|NCT02572167|588947398|FG001|Overall Study|Lost to Follow-up|5|||
163065966|NCT02572167|588947399|FG002|Overall Study|Lost to Follow-up|3|||
163065967|NCT02572167|588947397|FG000|Overall Study|Death|0|||
163065968|NCT02572167|588947398|FG001|Overall Study|Death|8|||
163065969|NCT02572167|588947399|FG002|Overall Study|Death|3|||
163065970|NCT02572167|588947397|FG000|Overall Study|Did not meet inclusion criteria|0|||
163065971|NCT02572167|588947398|FG001|Overall Study|Did not meet inclusion criteria|0|||
163065972|NCT02572167|588947399|FG002|Overall Study|Did not meet inclusion criteria|1|||
163065973|NCT02572167|588947397|FG000|Overall Study|Study closure by Sponsor|4|||
163065974|NCT02572167|588947398|FG001|Overall Study|Study closure by Sponsor|40|||
163065975|NCT02572167|588947399|FG002|Overall Study|Study closure by Sponsor|24|||
163065976|NCT00005047|588947400|FG000|Overall Study|Withdrawal by Subject|12|||
163065977|NCT00005047|588947401|FG001|Overall Study|Withdrawal by Subject|0|||
163065978|NCT00005047|588947402|FG002|Overall Study|Withdrawal by Subject|0|||
163065979|NCT00005047|588947403|FG003|Overall Study|Withdrawal by Subject|0|||
163065980|NCT00005047|588947400|FG000|Overall Study|Adverse Event|5|||
163065981|NCT00005047|588947401|FG001|Overall Study|Adverse Event|0|||
163065982|NCT00005047|588947402|FG002|Overall Study|Adverse Event|0|||
163065983|NCT00005047|588947403|FG003|Overall Study|Adverse Event|0|||
163065984|NCT00005047|588947400|FG000|Overall Study|Lost to Follow-up|1|||
163065985|NCT00005047|588947401|FG001|Overall Study|Lost to Follow-up|0|||
163065986|NCT00005047|588947402|FG002|Overall Study|Lost to Follow-up|0|||
163065987|NCT00005047|588947403|FG003|Overall Study|Lost to Follow-up|0|||
162643989|NCT07114198|587411819|FG000|Overall Study|Protocol Violation|1|||
162643990|NCT07114198|587411820|FG001|Overall Study|Protocol Violation|1|||
162643991|NCT04709575|587413477|FG000|Overall Study|Withdrawal by Subject|6|||
163065988|NCT00005047|588947400|FG000|Overall Study|Lack of Efficacy|1|||
163065989|NCT00005047|588947401|FG001|Overall Study|Lack of Efficacy|0|||
163065990|NCT00005047|588947402|FG002|Overall Study|Lack of Efficacy|0|||
163065991|NCT00005047|588947403|FG003|Overall Study|Lack of Efficacy|0|||
163065992|NCT04435626|588947404|FG000|Overall Study|Lost to Follow-up|1|||
163065993|NCT04435626|588947405|FG001|Overall Study|Lost to Follow-up|5|||
163065994|NCT04435626|588947404|FG000|Overall Study|Withdrawal by Subject|6|||
163065995|NCT04435626|588947405|FG001|Overall Study|Withdrawal by Subject|7|||
163065996|NCT04435626|588947404|FG000|Overall Study|major GCP violations|8|||
163065997|NCT04435626|588947405|FG001|Overall Study|major GCP violations|7|||
163065998|NCT05248386|588947413|FG000|Overall Study|Technical problems|0|||
163065999|NCT05248386|588947414|FG001|Overall Study|Technical problems|1|||
163066000|NCT05248386|588947413|FG000|Overall Study|Withdrawal by Subject|15|||
163066001|NCT05248386|588947414|FG001|Overall Study|Withdrawal by Subject|10|||
163066002|NCT05248386|588947413|FG000|Overall Study|Physician Decision|0|||
163066003|NCT05248386|588947414|FG001|Overall Study|Physician Decision|1|||
163066004|NCT05248386|588947413|FG000|Overall Study|Adverse Event|2|||
163066005|NCT05248386|588947414|FG001|Overall Study|Adverse Event|4|||
163066006|NCT05248386|588947413|FG000|Overall Study|Other|1|||
163066007|NCT05248386|588947414|FG001|Overall Study|Other|0|||
163066008|NCT05248386|588947413|FG000|Overall Study|Lack of Efficacy|14|||
163066009|NCT05248386|588947414|FG001|Overall Study|Lack of Efficacy|12|||
163066010|NCT03036254|588947425|FG000|Overall Study|Adverse Event|6|||
163066011|NCT03036254|588947426|FG001|Overall Study|Adverse Event|4|||
163066012|NCT03036254|588947425|FG000|Overall Study|Death|3|||
163066013|NCT03036254|588947426|FG001|Overall Study|Death|1|||
163066014|NCT03036254|588947425|FG000|Overall Study|Lack of Efficacy|5|||
163066015|NCT03036254|588947426|FG001|Overall Study|Lack of Efficacy|1|||
163066016|NCT03036254|588947425|FG000|Overall Study|Withdrawal by Subject|3|||
163066017|NCT03036254|588947426|FG001|Overall Study|Withdrawal by Subject|5|||
163066018|NCT01802281|588947438|FG000|Overall Study|Death|1|||
162643992|NCT04709575|587413478|FG001|Overall Study|Withdrawal by Subject|2|||
163066019|NCT01802281|588947439|FG001|Overall Study|Death|2|||
163066020|NCT01802281|588947438|FG000|Overall Study|Withdrawal by Subject|2|||
163066021|NCT01802281|588947439|FG001|Overall Study|Withdrawal by Subject|1|||
162643993|NCT04709575|587413477|FG000|Overall Study|Lost to Follow-up|2|||
162643994|NCT04709575|587413478|FG001|Overall Study|Lost to Follow-up|2|||
162643995|NCT04709575|587413477|FG000|Overall Study|Adverse Event|1|||
162643996|NCT04709575|587413478|FG001|Overall Study|Adverse Event|0|||
163066022|NCT01802281|588947438|FG000|Overall Study|Ineligible|5|||
163066023|NCT01802281|588947439|FG001|Overall Study|Ineligible|3|||
163066024|NCT05523297|588947440|FG000|Overall Study|Death|7|||
163066025|NCT05523297|588947441|FG001|Overall Study|Death|8|||
163066026|NCT05523297|588947440|FG000|Overall Study|Lost to Follow-up|2|||
163066027|NCT05523297|588947441|FG001|Overall Study|Lost to Follow-up|1|||
163066028|NCT03168672|588947444|FG000|Overall Study|Withdrawal by Subject|13|||
163066029|NCT03168672|588947444|FG000|Overall Study|Death|3|||
162643997|NCT04709575|587413477|FG000|Overall Study|Protocol Violation|1|||
163066030|NCT03168672|588947444|FG000|Overall Study|Investigator's Decision|137|||
163066031|NCT03168672|588947444|FG000|Overall Study|Adverse Event|1|||
163066032|NCT03168672|588947444|FG000|Overall Study|Other|2|||
163066033|NCT03168672|588947444|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
163066034|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
163066035|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
163066036|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
163066037|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
163066038|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
163066039|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
163066040|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
163066041|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
163066042|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
163066043|NCT00433537|588947445|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
163066044|NCT00433537|588947446|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
163066045|NCT00433537|588947447|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
163066046|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
163066047|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
163066048|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
163066049|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
163066050|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
163066051|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
163066052|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
163066053|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
163066054|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
163066055|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
163066056|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
163066057|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
163066058|NCT00433537|588947445|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
163066059|NCT00433537|588947446|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
163066060|NCT00433537|588947447|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
163066061|NCT04556097|588947448|FG000|Overall Study|Death|0|||
163066062|NCT04556097|588947449|FG001|Overall Study|Death|5|||
163066063|NCT04556097|588947450|FG002|Overall Study|Death|0|||
163066064|NCT04556097|588947451|FG003|Overall Study|Death|0|||
163066065|NCT04556097|588947448|FG000|Overall Study|No caregiver|43|||
163066066|NCT04556097|588947449|FG001|Overall Study|No caregiver|53|||
163066067|NCT04556097|588947450|FG002|Overall Study|No caregiver|0|||
163066068|NCT04556097|588947451|FG003|Overall Study|No caregiver|0|||
163066069|NCT04556097|588947448|FG000|Overall Study|Ineligible, SNF|2|||
163066070|NCT04556097|588947449|FG001|Overall Study|Ineligible, SNF|2|||
163066071|NCT04556097|588947450|FG002|Overall Study|Ineligible, SNF|0|||
163066072|NCT04556097|588947451|FG003|Overall Study|Ineligible, SNF|0|||
163066073|NCT04556097|588947448|FG000|Overall Study|Ineligible, health|3|||
162643998|NCT04709575|587413478|FG001|Overall Study|Protocol Violation|1|||
162643999|NCT02967692|587413479|FG000|Overall Study|Progressive disease|3|||
162644000|NCT02967692|587413480|FG001|Overall Study|Progressive disease|15|||
162644001|NCT02967692|587413481|FG002|Overall Study|Progressive disease|114|||
162644002|NCT02967692|587413482|FG003|Overall Study|Progressive disease|151|||
162644003|NCT02967692|587413479|FG000|Overall Study|Subject/guardian decision|1|||
162644004|NCT02967692|587413480|FG001|Overall Study|Subject/guardian decision|1|||
162644005|NCT02967692|587413481|FG002|Overall Study|Subject/guardian decision|14|||
162717844|NCT02914522|587673490|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163066074|NCT04556097|588947449|FG001|Overall Study|Ineligible, health|4|||
163066075|NCT04556097|588947450|FG002|Overall Study|Ineligible, health|0|||
163066076|NCT04556097|588947451|FG003|Overall Study|Ineligible, health|0|||
163066077|NCT04556097|588947448|FG000|Overall Study|Ineligible, language|0|||
163066078|NCT04556097|588947449|FG001|Overall Study|Ineligible, language|1|||
163066079|NCT04556097|588947450|FG002|Overall Study|Ineligible, language|0|||
163066080|NCT04556097|588947451|FG003|Overall Study|Ineligible, language|0|||
162717845|NCT02914522|587673491|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163066081|NCT04556097|588947448|FG000|Overall Study|Ineligible, no longer in care management|0|||
163066082|NCT04556097|588947449|FG001|Overall Study|Ineligible, no longer in care management|2|||
163066083|NCT04556097|588947450|FG002|Overall Study|Ineligible, no longer in care management|1|||
163066084|NCT04556097|588947451|FG003|Overall Study|Ineligible, no longer in care management|0|||
163066085|NCT04556097|588947448|FG000|Overall Study|No dementia|13|||
163066086|NCT04556097|588947449|FG001|Overall Study|No dementia|3|||
163066087|NCT04556097|588947450|FG002|Overall Study|No dementia|0|||
162644006|NCT02967692|587413482|FG003|Overall Study|Subject/guardian decision|22|||
162644007|NCT02967692|587413479|FG000|Overall Study|Death|0|||
163066088|NCT04556097|588947451|FG003|Overall Study|No dementia|0|||
163066089|NCT04556097|588947448|FG000|Overall Study|Missing identifier|2|||
163066090|NCT04556097|588947449|FG001|Overall Study|Missing identifier|4|||
163066091|NCT04556097|588947450|FG002|Overall Study|Missing identifier|0|||
163066092|NCT04556097|588947451|FG003|Overall Study|Missing identifier|0|||
163066093|NCT04556097|588947448|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
163066094|NCT04556097|588947449|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
163066095|NCT04556097|588947450|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
163066096|NCT04556097|588947451|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
163066097|NCT05436613|588947452|FG000|Overall Study|Lost to Follow-up|9|||
163066098|NCT05436613|588947452|FG000|Overall Study|Withdrawal by Subject|3|||
163066099|NCT05317546|588947455|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
163066100|NCT05317546|588947456|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
163066101|NCT02555878|588947470|FG000|Overall Study|Lost to Follow-up|2|||
163066102|NCT02555878|588947471|FG001|Overall Study|Lost to Follow-up|3|||
163066103|NCT02555878|588947470|FG000|Overall Study|Withdrawal by Subject|48|||
163066104|NCT02555878|588947471|FG001|Overall Study|Withdrawal by Subject|48|||
163066105|NCT02555878|588947470|FG000|Overall Study|Adverse Event|12|||
163066106|NCT02555878|588947471|FG001|Overall Study|Adverse Event|8|||
163066107|NCT02555878|588947470|FG000|Overall Study|Death|74|||
163066108|NCT02555878|588947471|FG001|Overall Study|Death|59|||
163066109|NCT02555878|588947470|FG000|Overall Study|Protocol Violation|1|||
163066110|NCT02555878|588947471|FG001|Overall Study|Protocol Violation|2|||
163066111|NCT02555878|588947470|FG000|Overall Study|Physician Decision|12|||
163066112|NCT02555878|588947471|FG001|Overall Study|Physician Decision|13|||
163066113|NCT02555878|588947470|FG000|Overall Study|Other|17|||
163066114|NCT02555878|588947471|FG001|Overall Study|Other|17|||
163066115|NCT00765076|588947472|FG000|Overall Study|Adverse Event|1|||
163066116|NCT00765076|588947473|FG001|Overall Study|Adverse Event|0|||
163066117|NCT00765076|588947474|FG002|Overall Study|Adverse Event|0|||
163066118|NCT00765076|588947472|FG000|Overall Study|Withdrawal by Subject|0|||
163066119|NCT00765076|588947473|FG001|Overall Study|Withdrawal by Subject|0|||
163066120|NCT00765076|588947474|FG002|Overall Study|Withdrawal by Subject|1|||
163066121|NCT01164475|588947475|FG000|Overall Study|Lack of Efficacy|1|||
163066122|NCT01164475|588947476|FG001|Overall Study|Lack of Efficacy|0|||
163066123|NCT01164475|588947475|FG000|Overall Study|Other|0|||
163066124|NCT01164475|588947476|FG001|Overall Study|Other|1|||
163066125|NCT01164475|588947475|FG000|Overall Study|Progressive disease|0|||
163066126|NCT01164475|588947476|FG001|Overall Study|Progressive disease|1|||
163066127|NCT01164475|588947475|FG000|Overall Study|Protocol Violation|1|||
163066128|NCT01164475|588947476|FG001|Overall Study|Protocol Violation|0|||
163066129|NCT02335944|588947477|FG000|Treatment Phase|Progressive Disease|2|||
163066130|NCT02335944|588947478|FG001|Treatment Phase|Progressive Disease|5|||
163066131|NCT02335944|588947479|FG002|Treatment Phase|Progressive Disease|2|||
163066132|NCT02335944|588947480|FG003|Treatment Phase|Progressive Disease|11|||
163066133|NCT02335944|588947481|FG004|Treatment Phase|Progressive Disease|4|||
163066134|NCT02335944|588947482|FG005|Treatment Phase|Progressive Disease|25|||
163066135|NCT02335944|588947483|FG006|Treatment Phase|Progressive Disease|2|||
163066136|NCT02335944|588947484|FG007|Treatment Phase|Progressive Disease|30|||
163066137|NCT02335944|588947485|FG008|Treatment Phase|Progressive Disease|27|||
163066138|NCT02335944|588947486|FG009|Treatment Phase|Progressive Disease|0|||
163066139|NCT02335944|588947477|FG000|Treatment Phase|Adverse Event|2|||
163066140|NCT02335944|588947478|FG001|Treatment Phase|Adverse Event|0|||
163066141|NCT02335944|588947479|FG002|Treatment Phase|Adverse Event|0|||
163066142|NCT02335944|588947480|FG003|Treatment Phase|Adverse Event|2|||
163066143|NCT02335944|588947481|FG004|Treatment Phase|Adverse Event|1|||
163066144|NCT02335944|588947482|FG005|Treatment Phase|Adverse Event|15|||
163066145|NCT02335944|588947483|FG006|Treatment Phase|Adverse Event|0|||
163066146|NCT02335944|588947484|FG007|Treatment Phase|Adverse Event|5|||
163066147|NCT02335944|588947485|FG008|Treatment Phase|Adverse Event|7|||
163066148|NCT02335944|588947486|FG009|Treatment Phase|Adverse Event|0|||
163066149|NCT02335944|588947477|FG000|Treatment Phase|Physician Decision|0|||
163066150|NCT02335944|588947478|FG001|Treatment Phase|Physician Decision|0|||
163066151|NCT02335944|588947479|FG002|Treatment Phase|Physician Decision|0|||
163066152|NCT02335944|588947480|FG003|Treatment Phase|Physician Decision|1|||
163066153|NCT02335944|588947481|FG004|Treatment Phase|Physician Decision|0|||
163066154|NCT02335944|588947482|FG005|Treatment Phase|Physician Decision|6|||
163066155|NCT02335944|588947483|FG006|Treatment Phase|Physician Decision|1|||
163066156|NCT02335944|588947484|FG007|Treatment Phase|Physician Decision|2|||
163066157|NCT02335944|588947485|FG008|Treatment Phase|Physician Decision|1|||
163066158|NCT02335944|588947486|FG009|Treatment Phase|Physician Decision|0|||
163066159|NCT02335944|588947477|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
162644008|NCT02967692|587413480|FG001|Overall Study|Death|1|||
162644009|NCT02967692|587413481|FG002|Overall Study|Death|13|||
163066160|NCT02335944|588947478|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
162644010|NCT02967692|587413482|FG003|Overall Study|Death|13|||
163066161|NCT02335944|588947479|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
163066162|NCT02335944|588947480|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
162644011|NCT02967692|587413479|FG000|Overall Study|Protocol deviation|1|||
162644012|NCT02967692|587413480|FG001|Overall Study|Protocol deviation|0|||
163066163|NCT02335944|588947481|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
163066164|NCT02335944|588947482|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
163066165|NCT02335944|588947483|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
163066166|NCT02335944|588947484|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
163066167|NCT02335944|588947485|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
163066168|NCT02335944|588947486|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
163066169|NCT02335944|588947477|FG000|Treatment Phase|Subject/Guardian Decision|0|||
163066170|NCT02335944|588947478|FG001|Treatment Phase|Subject/Guardian Decision|0|||
163066171|NCT02335944|588947479|FG002|Treatment Phase|Subject/Guardian Decision|1|||
163066172|NCT02335944|588947480|FG003|Treatment Phase|Subject/Guardian Decision|0|||
163066173|NCT02335944|588947481|FG004|Treatment Phase|Subject/Guardian Decision|0|||
163066174|NCT02335944|588947482|FG005|Treatment Phase|Subject/Guardian Decision|1|||
163066175|NCT02335944|588947483|FG006|Treatment Phase|Subject/Guardian Decision|0|||
163066176|NCT02335944|588947484|FG007|Treatment Phase|Subject/Guardian Decision|4|||
163066177|NCT02335944|588947485|FG008|Treatment Phase|Subject/Guardian Decision|0|||
163066178|NCT02335944|588947486|FG009|Treatment Phase|Subject/Guardian Decision|0|||
163066179|NCT02335944|588947477|FG000|Post-treatment Follow-up|Progressive Disease|0|||
163066180|NCT02335944|588947478|FG001|Post-treatment Follow-up|Progressive Disease|0|||
163066181|NCT02335944|588947479|FG002|Post-treatment Follow-up|Progressive Disease|0|||
163066182|NCT02335944|588947480|FG003|Post-treatment Follow-up|Progressive Disease|1|||
163066183|NCT02335944|588947481|FG004|Post-treatment Follow-up|Progressive Disease|0|||
163066184|NCT02335944|588947482|FG005|Post-treatment Follow-up|Progressive Disease|9|||
163066185|NCT02335944|588947483|FG006|Post-treatment Follow-up|Progressive Disease|0|||
163066186|NCT02335944|588947484|FG007|Post-treatment Follow-up|Progressive Disease|2|||
163066187|NCT02335944|588947485|FG008|Post-treatment Follow-up|Progressive Disease|3|||
163066188|NCT02335944|588947486|FG009|Post-treatment Follow-up|Progressive Disease|0|||
163066189|NCT02335944|588947477|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066190|NCT02335944|588947478|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066191|NCT02335944|588947479|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066192|NCT02335944|588947480|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066193|NCT02335944|588947481|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066194|NCT02335944|588947482|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
163066195|NCT02335944|588947483|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066196|NCT02335944|588947484|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066197|NCT02335944|588947485|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066198|NCT02335944|588947486|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163066199|NCT02335944|588947477|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066200|NCT02335944|588947478|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066201|NCT02335944|588947479|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066202|NCT02335944|588947480|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066203|NCT02335944|588947481|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066204|NCT02335944|588947482|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066205|NCT02335944|588947483|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066206|NCT02335944|588947484|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
163066207|NCT02335944|588947485|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066208|NCT02335944|588947486|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
163066209|NCT02335944|588947477|FG000|Post-treatment Follow-up|Adverse Event|0|||
163066210|NCT02335944|588947478|FG001|Post-treatment Follow-up|Adverse Event|0|||
163066211|NCT02335944|588947479|FG002|Post-treatment Follow-up|Adverse Event|0|||
163066212|NCT02335944|588947480|FG003|Post-treatment Follow-up|Adverse Event|0|||
163066213|NCT02335944|588947481|FG004|Post-treatment Follow-up|Adverse Event|0|||
163066214|NCT02335944|588947482|FG005|Post-treatment Follow-up|Adverse Event|1|||
163066215|NCT02335944|588947483|FG006|Post-treatment Follow-up|Adverse Event|0|||
163066216|NCT02335944|588947484|FG007|Post-treatment Follow-up|Adverse Event|0|||
163066217|NCT02335944|588947485|FG008|Post-treatment Follow-up|Adverse Event|0|||
163066218|NCT02335944|588947486|FG009|Post-treatment Follow-up|Adverse Event|0|||
163066219|NCT02335944|588947477|FG000|Post-treatment Follow-up|Death|0|||
163066220|NCT02335944|588947478|FG001|Post-treatment Follow-up|Death|0|||
163066221|NCT02335944|588947479|FG002|Post-treatment Follow-up|Death|0|||
163066222|NCT02335944|588947480|FG003|Post-treatment Follow-up|Death|1|||
163066223|NCT02335944|588947481|FG004|Post-treatment Follow-up|Death|0|||
163066224|NCT02335944|588947482|FG005|Post-treatment Follow-up|Death|1|||
163066225|NCT02335944|588947483|FG006|Post-treatment Follow-up|Death|0|||
163066226|NCT02335944|588947484|FG007|Post-treatment Follow-up|Death|0|||
163066227|NCT02335944|588947485|FG008|Post-treatment Follow-up|Death|0|||
163066228|NCT02335944|588947486|FG009|Post-treatment Follow-up|Death|0|||
163066229|NCT02335944|588947477|FG000|Post-treatment Follow-up|Physician Decision|1|||
163066230|NCT02335944|588947478|FG001|Post-treatment Follow-up|Physician Decision|0|||
163066231|NCT02335944|588947479|FG002|Post-treatment Follow-up|Physician Decision|0|||
163066232|NCT02335944|588947480|FG003|Post-treatment Follow-up|Physician Decision|0|||
162644013|NCT02967692|587413481|FG002|Overall Study|Protocol deviation|1|||
163066233|NCT02335944|588947481|FG004|Post-treatment Follow-up|Physician Decision|0|||
163066234|NCT02335944|588947482|FG005|Post-treatment Follow-up|Physician Decision|0|||
163066235|NCT02335944|588947483|FG006|Post-treatment Follow-up|Physician Decision|0|||
163066236|NCT02335944|588947484|FG007|Post-treatment Follow-up|Physician Decision|1|||
162644014|NCT02967692|587413482|FG003|Overall Study|Protocol deviation|1|||
162644015|NCT02967692|587413479|FG000|Overall Study|Lost to Follow-up|0|||
163066237|NCT02335944|588947485|FG008|Post-treatment Follow-up|Physician Decision|0|||
163066238|NCT02335944|588947486|FG009|Post-treatment Follow-up|Physician Decision|0|||
163066239|NCT00832975|588947487|FG000|Overall Study|Lost to Follow-up|7|||
163066240|NCT00832975|588947487|FG000|Overall Study|Protocol Violation|6|||
163066241|NCT00832975|588947487|FG000|Overall Study|Death|5|||
163066242|NCT00832975|588947487|FG000|Overall Study|Physician Decision|4|||
163066243|NCT00832975|588947487|FG000|Overall Study|Withdrawal by Subject|3|||
163066244|NCT00832975|588947487|FG000|Overall Study|Other reasons|14|||
163066245|NCT06081829|588947490|FG000|Overall Study|Participants still on-study|8|||
163066246|NCT06081829|588947490|FG000|Overall Study|Death|4|||
163066247|NCT04835441|588947491|FG000|Overall Study|Physician Decision|4|||
163066248|NCT04835441|588947492|FG001|Overall Study|Physician Decision|4|||
163066249|NCT04835441|588947491|FG000|Overall Study|Other|1|||
163066250|NCT04835441|588947492|FG001|Overall Study|Other|1|||
163066251|NCT04835441|588947491|FG000|Overall Study|Lost to Follow-up|0|||
163066252|NCT04835441|588947492|FG001|Overall Study|Lost to Follow-up|1|||
163066253|NCT02293499|588948412|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
163066254|NCT02293499|588948413|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
163066255|NCT02293499|588948414|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
163066256|NCT02293499|588948412|FG000|Intervention - Camp|Withdrawal by Subject|3|||
163066257|NCT02293499|588948413|FG001|Intervention - Camp|Withdrawal by Subject|6|||
163066258|NCT02293499|588948414|FG002|Intervention - Camp|Withdrawal by Subject|2|||
163066259|NCT02293499|588948412|FG000|Intervention - Camp|these are those not showing up at camp|24|||
163066260|NCT02293499|588948413|FG001|Intervention - Camp|these are those not showing up at camp|28|||
163066261|NCT02293499|588948414|FG002|Intervention - Camp|these are those not showing up at camp|4|||
163066262|NCT02293499|588948412|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
163066263|NCT02293499|588948413|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
163066264|NCT02293499|588948414|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
163066265|NCT02293499|588948412|FG000|3 Month Follow Up|Lost to Follow-up|14|||
163066266|NCT02293499|588948413|FG001|3 Month Follow Up|Lost to Follow-up|15|||
163066267|NCT02293499|588948414|FG002|3 Month Follow Up|Lost to Follow-up|6|||
163066268|NCT02293499|588948412|FG000|6 Month Follow Up|Lost to Follow-up|17|||
163066269|NCT02293499|588948413|FG001|6 Month Follow Up|Lost to Follow-up|27|||
163066270|NCT02293499|588948414|FG002|6 Month Follow Up|Lost to Follow-up|6|||
163066271|NCT02293499|588948412|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
163066272|NCT02293499|588948413|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
163066273|NCT02293499|588948414|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
163066274|NCT02293499|588948412|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
163066275|NCT02293499|588948413|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
163066276|NCT02293499|588948414|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
163066277|NCT02293499|588948412|FG000|9 Month Follow Up|Lost to Follow-up|24|||
163066278|NCT02293499|588948413|FG001|9 Month Follow Up|Lost to Follow-up|28|||
163066279|NCT02293499|588948414|FG002|9 Month Follow Up|Lost to Follow-up|4|||
163066280|NCT02293499|588948412|FG000|12 Month Follow Up|Lost to Follow-up|26|||
163066281|NCT02293499|588948413|FG001|12 Month Follow Up|Lost to Follow-up|25|||
163066282|NCT02293499|588948414|FG002|12 Month Follow Up|Lost to Follow-up|6|||
163066283|NCT02293499|588948412|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
163066284|NCT02293499|588948413|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
163066285|NCT02293499|588948414|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
163066286|NCT02293499|588948412|FG000|15 Month Follow Up|Lost to Follow-up|22|||
163066287|NCT02293499|588948413|FG001|15 Month Follow Up|Lost to Follow-up|22|||
163066288|NCT02293499|588948414|FG002|15 Month Follow Up|Lost to Follow-up|7|||
163066289|NCT03915067|588948415|FG000|Overall Study|Adverse Event|0|||
163066290|NCT03915067|588948416|FG001|Overall Study|Adverse Event|0|||
163066291|NCT03915067|588948417|FG002|Overall Study|Adverse Event|1|||
163066292|NCT03915067|588948415|FG000|Overall Study|Withdrawal by Subject|4|||
163066293|NCT03915067|588948416|FG001|Overall Study|Withdrawal by Subject|3|||
163066294|NCT03915067|588948417|FG002|Overall Study|Withdrawal by Subject|0|||
163066295|NCT03915067|588948415|FG000|Overall Study|Lost to Follow-up|3|||
163066296|NCT03915067|588948416|FG001|Overall Study|Lost to Follow-up|2|||
163066297|NCT03915067|588948417|FG002|Overall Study|Lost to Follow-up|0|||
163066298|NCT03915067|588948415|FG000|Overall Study|Protocol Deviation|0|||
163066299|NCT03915067|588948416|FG001|Overall Study|Protocol Deviation|0|||
162644016|NCT02967692|587413480|FG001|Overall Study|Lost to Follow-up|0|||
163066300|NCT03915067|588948417|FG002|Overall Study|Protocol Deviation|1|||
163066301|NCT03915067|588948415|FG000|Overall Study|Covid-19 Related Issues|2|||
162644017|NCT02967692|587413481|FG002|Overall Study|Lost to Follow-up|1|||
162644018|NCT02967692|587413482|FG003|Overall Study|Lost to Follow-up|0|||
162644019|NCT02967692|587413479|FG000|Overall Study|Physician Decision|0|||
163066302|NCT03915067|588948416|FG001|Overall Study|Covid-19 Related Issues|4|||
163066303|NCT03915067|588948417|FG002|Overall Study|Covid-19 Related Issues|4|||
163066304|NCT03915067|588948415|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
163066305|NCT03915067|588948416|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
163066306|NCT03915067|588948417|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
163066307|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
162644020|NCT02967692|587413480|FG001|Overall Study|Physician Decision|0|||
163066308|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
163066309|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
163066310|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
163066311|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
163066312|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066313|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
163066314|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066315|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066316|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
163066317|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Death|0|||
163066318|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Death|0|||
163066319|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Death|1|||
163066320|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Death|0|||
163066321|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Death|0|||
163066322|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
163066323|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
163066324|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
163066325|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
163066326|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
163066327|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Other|2|||
163066328|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Other|1|||
163066329|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Other|0|||
163066330|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Other|0|||
163066331|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Other|0|||
163066332|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066333|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066334|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
163066335|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066336|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
163066337|NCT03317496|588948418|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066338|NCT03317496|588948419|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
163066339|NCT03317496|588948420|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066340|NCT03317496|588948421|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
163066341|NCT03317496|588948422|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
163066342|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
163066343|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
163066344|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
163066345|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
163066346|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
163066347|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
163066348|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066349|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066350|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066351|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
163066352|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066353|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066354|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
163066355|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066356|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
163066357|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
163066358|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
163066359|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
163066360|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
163066361|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
163066362|NCT03317496|588948418|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
163066363|NCT03317496|588948419|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
163066364|NCT03317496|588948420|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
163066365|NCT03317496|588948421|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
163066366|NCT03317496|588948422|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
163066367|NCT03317496|588948418|FG000|Phase 2: Treatment|Adverse Event|0|||
162644021|NCT02967692|587413481|FG002|Overall Study|Physician Decision|22|||
162644022|NCT02967692|587413482|FG003|Overall Study|Physician Decision|13|||
163066368|NCT03317496|588948419|FG001|Phase 2: Treatment|Adverse Event|0|||
163066369|NCT03317496|588948420|FG002|Phase 2: Treatment|Adverse Event|0|||
163066370|NCT03317496|588948421|FG003|Phase 2: Treatment|Adverse Event|0|||
163066371|NCT03317496|588948422|FG004|Phase 2: Treatment|Adverse Event|6|||
163066372|NCT03317496|588948418|FG000|Phase 2: Treatment|Progressive disease|0|||
163066373|NCT03317496|588948419|FG001|Phase 2: Treatment|Progressive disease|0|||
163066374|NCT03317496|588948420|FG002|Phase 2: Treatment|Progressive disease|0|||
162644023|NCT02967692|587413479|FG000|Overall Study|Adverse Event|2|||
162644024|NCT02967692|587413480|FG001|Overall Study|Adverse Event|9|||
162644025|NCT02967692|587413481|FG002|Overall Study|Adverse Event|60|||
163066375|NCT03317496|588948421|FG003|Phase 2: Treatment|Progressive disease|0|||
163066376|NCT03317496|588948422|FG004|Phase 2: Treatment|Progressive disease|22|||
163066377|NCT03317496|588948418|FG000|Phase 2: Treatment|Other|0|||
163066378|NCT03317496|588948419|FG001|Phase 2: Treatment|Other|0|||
163066379|NCT03317496|588948420|FG002|Phase 2: Treatment|Other|0|||
163066380|NCT03317496|588948421|FG003|Phase 2: Treatment|Other|0|||
163066381|NCT03317496|588948422|FG004|Phase 2: Treatment|Other|4|||
163066382|NCT03317496|588948418|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
163066383|NCT03317496|588948419|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
163066384|NCT03317496|588948420|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
163066385|NCT03317496|588948421|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
163066386|NCT03317496|588948422|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
163066387|NCT03317496|588948418|FG000|Phase 2: Treatment|Physician Decision|0|||
163066388|NCT03317496|588948419|FG001|Phase 2: Treatment|Physician Decision|0|||
163066389|NCT03317496|588948420|FG002|Phase 2: Treatment|Physician Decision|0|||
163066390|NCT03317496|588948421|FG003|Phase 2: Treatment|Physician Decision|0|||
163066391|NCT03317496|588948422|FG004|Phase 2: Treatment|Physician Decision|1|||
163066392|NCT03317496|588948418|FG000|Phase 2: Treatment|Death|0|||
163066393|NCT03317496|588948419|FG001|Phase 2: Treatment|Death|0|||
163066394|NCT03317496|588948420|FG002|Phase 2: Treatment|Death|0|||
163066395|NCT03317496|588948421|FG003|Phase 2: Treatment|Death|0|||
163066396|NCT03317496|588948422|FG004|Phase 2: Treatment|Death|1|||
163066397|NCT03317496|588948418|FG000|Phase 2: Follow-up|Death|0|||
163066398|NCT03317496|588948419|FG001|Phase 2: Follow-up|Death|0|||
163066399|NCT03317496|588948420|FG002|Phase 2: Follow-up|Death|0|||
163066400|NCT03317496|588948421|FG003|Phase 2: Follow-up|Death|0|||
163066401|NCT03317496|588948422|FG004|Phase 2: Follow-up|Death|24|||
163066402|NCT03317496|588948418|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
163066403|NCT03317496|588948419|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
163066404|NCT03317496|588948420|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
163066405|NCT03317496|588948421|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
163066406|NCT03317496|588948422|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
163066407|NCT03317496|588948418|FG000|Phase 2: Follow-up|Other|0|||
163066408|NCT03317496|588948419|FG001|Phase 2: Follow-up|Other|0|||
163066409|NCT03317496|588948420|FG002|Phase 2: Follow-up|Other|0|||
163066410|NCT03317496|588948421|FG003|Phase 2: Follow-up|Other|0|||
163066411|NCT03317496|588948422|FG004|Phase 2: Follow-up|Other|1|||
163066412|NCT03317496|588948418|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066413|NCT03317496|588948419|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066414|NCT03317496|588948420|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066415|NCT03317496|588948421|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
163066416|NCT03317496|588948422|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
163066417|NCT02693418|588948423|FG000|Overall Study|Lost to Follow-up|1|||
163066418|NCT02693418|588948424|FG001|Overall Study|Lost to Follow-up|2|||
163066419|NCT02693418|588948425|FG002|Overall Study|Lost to Follow-up|0|||
163066420|NCT02693418|588948426|FG003|Overall Study|Lost to Follow-up|0|||
163066421|NCT02693418|588948427|FG004|Overall Study|Lost to Follow-up|0|||
163066422|NCT02693418|588948423|FG000|Overall Study|Menses during study period|0|||
163066423|NCT02693418|588948424|FG001|Overall Study|Menses during study period|0|||
163066424|NCT02693418|588948425|FG002|Overall Study|Menses during study period|2|||
163066425|NCT02693418|588948426|FG003|Overall Study|Menses during study period|0|||
163066426|NCT02693418|588948427|FG004|Overall Study|Menses during study period|0|||
163066427|NCT01750346|588948428|FG000|Overall Study|Adverse Event|1|||
163066428|NCT01750346|588948429|FG001|Overall Study|Adverse Event|0|||
163066429|NCT01750346|588948430|FG002|Overall Study|Adverse Event|0|||
163066430|NCT01001104|588948433|FG000|Overall Study|Adverse Event|2|||
163066431|NCT01001104|588948434|FG001|Overall Study|Adverse Event|1|||
163066432|NCT01001104|588948435|FG002|Overall Study|Adverse Event|0|||
163066433|NCT01001104|588948436|FG003|Overall Study|Adverse Event|0|||
163066434|NCT01001104|588948433|FG000|Overall Study|Lost to Follow-up|0|||
163066435|NCT01001104|588948434|FG001|Overall Study|Lost to Follow-up|0|||
163066436|NCT01001104|588948435|FG002|Overall Study|Lost to Follow-up|1|||
163066437|NCT01001104|588948436|FG003|Overall Study|Lost to Follow-up|0|||
163066438|NCT01001104|588948433|FG000|Overall Study|Entry Criteria Not Met|0|||
163066439|NCT01001104|588948434|FG001|Overall Study|Entry Criteria Not Met|0|||
163066440|NCT01001104|588948435|FG002|Overall Study|Entry Criteria Not Met|0|||
163066441|NCT01001104|588948436|FG003|Overall Study|Entry Criteria Not Met|1|||
163066442|NCT01001104|588948433|FG000|Overall Study|Withdrawal by Subject|0|||
163066443|NCT01001104|588948434|FG001|Overall Study|Withdrawal by Subject|0|||
163066444|NCT01001104|588948435|FG002|Overall Study|Withdrawal by Subject|0|||
162644026|NCT02967692|587413482|FG003|Overall Study|Adverse Event|28|||
162644027|NCT02967692|587413479|FG000|Overall Study|Study terminated by sponsor|2|||
162644028|NCT02967692|587413480|FG001|Overall Study|Study terminated by sponsor|1|||
163066445|NCT01001104|588948436|FG003|Overall Study|Withdrawal by Subject|2|||
163066446|NCT02034591|588948437|FG000|Overall Study|Withdrawal by Subject|0|||
163066447|NCT02034591|588948438|FG001|Overall Study|Withdrawal by Subject|0|||
162644029|NCT02967692|587413481|FG002|Overall Study|Study terminated by sponsor|42|||
162644030|NCT02967692|587413482|FG003|Overall Study|Study terminated by sponsor|37|||
163025758|NCT02235077|588794667|FG000|Overall Study|Withdrawal by Subject|8|||
163025759|NCT02235077|588794668|FG001|Overall Study|Withdrawal by Subject|5|||
163025760|NCT02235077|588794667|FG000|Overall Study|Physician Decision|0|||
163025761|NCT02235077|588794668|FG001|Overall Study|Physician Decision|1|||
163025762|NCT03852628|588794669|FG000|Overall Study|Lost to Follow-up|7|||
163025763|NCT03852628|588794670|FG001|Overall Study|Lost to Follow-up|6|||
163025764|NCT03852628|588794669|FG000|Overall Study|Lack of Efficacy|6|||
163025765|NCT03852628|588794670|FG001|Overall Study|Lack of Efficacy|6|||
163025766|NCT00325156|588794676|FG000|Overall Study|Protocol Violation|8|||
163025767|NCT00325156|588794676|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
163025768|NCT00325156|588794676|FG000|Overall Study|Migrated/moved from study area|12|||
163025769|NCT00325156|588794676|FG000|Overall Study|Adverse event, non-fatal|3|||
163025770|NCT00325156|588794676|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
163025771|NCT00325156|588794676|FG000|Overall Study|Other|1|||
163025772|NCT00325156|588794676|FG000|Overall Study|Withdrawal by Subject|31|||
163025773|NCT04064411|588794677|FG000|Overall Study|Adverse Event|29|||
163025774|NCT04064411|588794678|FG001|Overall Study|Adverse Event|19|||
163025775|NCT04064411|588794677|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
163025776|NCT04064411|588794678|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
163025777|NCT04064411|588794677|FG000|Overall Study|Protocol Deviation|0|||
163025778|NCT04064411|588794678|FG001|Overall Study|Protocol Deviation|2|||
163025779|NCT04064411|588794677|FG000|Overall Study|Withdrawal by Subject|25|||
163025780|NCT04064411|588794678|FG001|Overall Study|Withdrawal by Subject|29|||
163025781|NCT04064411|588794677|FG000|Overall Study|Lost to Follow-up|5|||
163025782|NCT04064411|588794678|FG001|Overall Study|Lost to Follow-up|2|||
163025783|NCT04064411|588794677|FG000|Overall Study|Other than Specified|4|||
163025784|NCT04064411|588794678|FG001|Overall Study|Other than Specified|1|||
163025785|NCT04064411|588794677|FG000|Overall Study|Death|1|||
163025786|NCT04064411|588794678|FG001|Overall Study|Death|0|||
163025787|NCT03512210|588794680|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
163025788|NCT03512210|588794680|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
163025789|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Death|2|||
163025790|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
163025791|NCT03512210|588794680|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
163025792|NCT01672710|588794681|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
163025793|NCT01672710|588794682|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
163025794|NCT01672710|588794681|FG000|3 Month Follow up|Lost to Follow-up|2|||
163025795|NCT01672710|588794682|FG001|3 Month Follow up|Lost to Follow-up|3|||
163025796|NCT01672710|588794681|FG000|3 Month Follow up|follow up due after termination date|4|||
163025797|NCT01672710|588794682|FG001|3 Month Follow up|follow up due after termination date|1|||
163025798|NCT03725761|588794683|FG000|Overall Study|still on study|1|||
163025799|NCT05239494|588797113|FG000|Overall Study|Lost to Follow-up|1|||
163025800|NCT02855359|588797114|FG000|Overall Study|Death|2|||
163025801|NCT02855359|588797115|FG001|Overall Study|Death|2|||
163025802|NCT02855359|588797116|FG002|Overall Study|Death|0|||
163025803|NCT02855359|588797117|FG003|Overall Study|Death|0|||
163025804|NCT02855359|588797114|FG000|Overall Study|Study Termination by Sponsor|9|||
163025805|NCT02855359|588797115|FG001|Overall Study|Study Termination by Sponsor|11|||
163025806|NCT02855359|588797116|FG002|Overall Study|Study Termination by Sponsor|0|||
163025807|NCT02855359|588797117|FG003|Overall Study|Study Termination by Sponsor|0|||
163025808|NCT03155178|588797118|FG000|Overall Study|Did not meet treatment day baseline|7|||
163025809|NCT03155178|588797119|FG001|Overall Study|Did not meet treatment day baseline|7|||
163025810|NCT03155178|588797120|FG002|Overall Study|Did not meet treatment day baseline|7|||
163025811|NCT03155178|588797121|FG003|Overall Study|Did not meet treatment day baseline|7|||
163025812|NCT02677038|588797126|FG000|Overall Study|Physician Decision|1|||
163025813|NCT02677038|588797126|FG000|Overall Study|Withdrawal by Subject|1|||
163025814|NCT02777970|588797131|FG000|Overall Study|Lost to Follow-up|0|||
163025815|NCT02777970|588797132|FG001|Overall Study|Lost to Follow-up|1|||
163025816|NCT02777970|588797133|FG002|Overall Study|Lost to Follow-up|0|||
162644031|NCT04447417|587413486|FG000|Overall Study|Withdrawal by Subject|1|||
162644032|NCT04447417|587413487|FG001|Overall Study|Withdrawal by Subject|0|||
162644033|NCT04447417|587413486|FG000|Overall Study|Failure to meet inclusion criteria|1|||
162644034|NCT04447417|587413487|FG001|Overall Study|Failure to meet inclusion criteria|0|||
163025817|NCT02777970|588797131|FG000|Overall Study|Protocol Violation|1|||
163025818|NCT02777970|588797132|FG001|Overall Study|Protocol Violation|0|||
163025819|NCT02777970|588797133|FG002|Overall Study|Protocol Violation|0|||
163066448|NCT02034591|588948439|FG002|Overall Study|Withdrawal by Subject|0|||
162644035|NCT04447417|587413486|FG000|Overall Study|Lost to Follow-up|1|||
163025820|NCT02541669|588797141|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025821|NCT02541669|588797142|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025822|NCT02541669|588797143|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
162644036|NCT04447417|587413487|FG001|Overall Study|Lost to Follow-up|0|||
163066449|NCT02034591|588948440|FG003|Overall Study|Withdrawal by Subject|0|||
163066450|NCT02034591|588948441|FG004|Overall Study|Withdrawal by Subject|1|||
163066451|NCT02034591|588948442|FG005|Overall Study|Withdrawal by Subject|0|||
163066452|NCT00599313|588948443|FG000|Overall Study|Adverse Event|19|||
163066453|NCT00599313|588948443|FG000|Overall Study|Disease Progression|12|||
163066454|NCT00599313|588948443|FG000|Overall Study|Patient Request|4|||
163066455|NCT00599313|588948443|FG000|Overall Study|Ineligible|1|||
163066456|NCT02782468|588948446|FG000|Overall Study|Progressive Disease|2|||
163066457|NCT02782468|588948447|FG001|Overall Study|Progressive Disease|5|||
163066458|NCT02782468|588948448|FG002|Overall Study|Progressive Disease|0|||
163066459|NCT02782468|588948449|FG003|Overall Study|Progressive Disease|4|||
163066460|NCT02782468|588948446|FG000|Overall Study|Adverse Event|0|||
163066461|NCT02782468|588948447|FG001|Overall Study|Adverse Event|2|||
163066462|NCT02782468|588948448|FG002|Overall Study|Adverse Event|2|||
163066463|NCT02782468|588948449|FG003|Overall Study|Adverse Event|3|||
163066464|NCT02782468|588948446|FG000|Overall Study|Other|0|||
163066465|NCT02782468|588948447|FG001|Overall Study|Other|0|||
163066466|NCT02782468|588948448|FG002|Overall Study|Other|1|||
163066467|NCT02782468|588948449|FG003|Overall Study|Other|1|||
163066468|NCT02782468|588948446|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066469|NCT02782468|588948447|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066470|NCT02782468|588948448|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
163066471|NCT02782468|588948449|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
163066472|NCT02782468|588948446|FG000|Overall Study|Symptomatic Deterioration|0|||
163066473|NCT02782468|588948447|FG001|Overall Study|Symptomatic Deterioration|0|||
163066474|NCT02782468|588948448|FG002|Overall Study|Symptomatic Deterioration|0|||
163066475|NCT02782468|588948449|FG003|Overall Study|Symptomatic Deterioration|1|||
163066476|NCT02782468|588948446|FG000|Overall Study|Withdrawal by Subject|1|||
163066477|NCT02782468|588948447|FG001|Overall Study|Withdrawal by Subject|0|||
163066478|NCT02782468|588948448|FG002|Overall Study|Withdrawal by Subject|0|||
163066479|NCT02782468|588948449|FG003|Overall Study|Withdrawal by Subject|0|||
163066480|NCT05350202|588948452|FG000|Visit 1 - Baseline|Not-treated|18|||
163066481|NCT05350202|588948453|FG001|Visit 1 - Baseline|Not-treated|0|||
163066482|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
163066483|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
163066484|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
163066485|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
163066486|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
163066487|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
163066488|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
163066489|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
163066490|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
163066491|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
163066492|NCT05350202|588948452|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
163066493|NCT05350202|588948453|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
163066494|NCT04364646|588948454|FG000|Overall Study|Lost to Follow-up|1|||
163066495|NCT04364646|588948455|FG001|Overall Study|Lost to Follow-up|0|||
163066496|NCT04364646|588948454|FG000|Overall Study|Withdrawal by Subject|7|||
163066497|NCT04364646|588948455|FG001|Overall Study|Withdrawal by Subject|14|||
163066498|NCT04364646|588948454|FG000|Overall Study|Protocol Violation|4|||
163066499|NCT04364646|588948455|FG001|Overall Study|Protocol Violation|5|||
163066500|NCT01525589|588948460|FG000|Overall Study|Non-treatment-related AE|1|||
163066501|NCT01525589|588948461|FG001|Overall Study|Non-treatment-related AE|0|||
163066502|NCT01525589|588948462|FG002|Overall Study|Non-treatment-related AE|0|||
163066503|NCT01525589|588948460|FG000|Overall Study|Progressive disease|48|||
163066504|NCT01525589|588948461|FG001|Overall Study|Progressive disease|15|||
163066505|NCT01525589|588948462|FG002|Overall Study|Progressive disease|29|||
163066506|NCT01525589|588948460|FG000|Overall Study|Never treated|2|||
163066507|NCT01525589|588948461|FG001|Overall Study|Never treated|0|||
163066508|NCT01525589|588948462|FG002|Overall Study|Never treated|0|||
163066509|NCT01525589|588948460|FG000|Overall Study|Physician Decision|4|||
163066510|NCT01525589|588948461|FG001|Overall Study|Physician Decision|2|||
163066511|NCT01525589|588948462|FG002|Overall Study|Physician Decision|2|||
163066512|NCT01525589|588948460|FG000|Overall Study|Death|0|||
163066513|NCT01525589|588948461|FG001|Overall Study|Death|0|||
163066514|NCT01525589|588948462|FG002|Overall Study|Death|2|||
163066515|NCT01525589|588948460|FG000|Overall Study|Treatment-related AE|1|||
163066516|NCT01525589|588948461|FG001|Overall Study|Treatment-related AE|1|||
163066517|NCT01525589|588948462|FG002|Overall Study|Treatment-related AE|2|||
163066518|NCT01525589|588948460|FG000|Overall Study|Other reasons|0|||
163066519|NCT01525589|588948461|FG001|Overall Study|Other reasons|1|||
163066520|NCT01525589|588948462|FG002|Overall Study|Other reasons|0|||
163066521|NCT01525589|588948460|FG000|Overall Study|Withdrawal by Subject|0|||
163066522|NCT01525589|588948461|FG001|Overall Study|Withdrawal by Subject|1|||
163066523|NCT01525589|588948462|FG002|Overall Study|Withdrawal by Subject|0|||
162644037|NCT00066066|587413488|FG000|Overall Study|Lost to Follow-up|6|||
163066524|NCT02924376|588948463|FG000|Overall Study|Progressive Disease|4|||
163066525|NCT02924376|588948464|FG001|Overall Study|Progressive Disease|0|||
163066526|NCT02924376|588948465|FG002|Overall Study|Progressive Disease|1|||
163066527|NCT02924376|588948466|FG003|Overall Study|Progressive Disease|0|||
163066528|NCT02924376|588948463|FG000|Overall Study|Death|73|||
163066529|NCT02924376|588948464|FG001|Overall Study|Death|18|||
163066530|NCT02924376|588948465|FG002|Overall Study|Death|15|||
163066531|NCT02924376|588948466|FG003|Overall Study|Death|2|||
163066532|NCT02924376|588948463|FG000|Overall Study|Lost to Follow-up|3|||
163066533|NCT02924376|588948464|FG001|Overall Study|Lost to Follow-up|0|||
163066534|NCT02924376|588948465|FG002|Overall Study|Lost to Follow-up|0|||
163066535|NCT02924376|588948466|FG003|Overall Study|Lost to Follow-up|0|||
163066536|NCT02924376|588948463|FG000|Overall Study|Study Terminated by Sponsor|19|||
163066537|NCT02924376|588948464|FG001|Overall Study|Study Terminated by Sponsor|0|||
163066538|NCT02924376|588948465|FG002|Overall Study|Study Terminated by Sponsor|0|||
163066539|NCT02924376|588948466|FG003|Overall Study|Study Terminated by Sponsor|0|||
163066540|NCT02924376|588948463|FG000|Overall Study|Physician Decision|1|||
163066541|NCT02924376|588948464|FG001|Overall Study|Physician Decision|0|||
163066542|NCT02924376|588948465|FG002|Overall Study|Physician Decision|0|||
163066543|NCT02924376|588948466|FG003|Overall Study|Physician Decision|0|||
163066544|NCT02924376|588948463|FG000|Overall Study|Withdrawal by Subject|7|||
163066545|NCT02924376|588948464|FG001|Overall Study|Withdrawal by Subject|2|||
163066546|NCT02924376|588948465|FG002|Overall Study|Withdrawal by Subject|1|||
163066547|NCT02924376|588948466|FG003|Overall Study|Withdrawal by Subject|0|||
163066548|NCT02924376|588948463|FG000|Overall Study|Rolled Over to Another Study|1|||
163066549|NCT02924376|588948464|FG001|Overall Study|Rolled Over to Another Study|0|||
163066550|NCT02924376|588948465|FG002|Overall Study|Rolled Over to Another Study|0|||
163066551|NCT02924376|588948466|FG003|Overall Study|Rolled Over to Another Study|0|||
163066552|NCT03608033|588948467|FG000|Treatment Period|Death|0|||
163066553|NCT03608033|588948468|FG001|Treatment Period|Death|1|||
163066554|NCT03608033|588948467|FG000|Treatment Period|Adverse Event|1|||
163066555|NCT03608033|588948468|FG001|Treatment Period|Adverse Event|5|||
163066556|NCT03608033|588948467|FG000|Treatment Period|Lack of Efficacy|4|||
163066557|NCT03608033|588948468|FG001|Treatment Period|Lack of Efficacy|3|||
163066558|NCT03608033|588948467|FG000|Treatment Period|Lost to Follow-up|2|||
163066559|NCT03608033|588948468|FG001|Treatment Period|Lost to Follow-up|6|||
163066560|NCT03608033|588948467|FG000|Treatment Period|Physician Decision|6|||
163066561|NCT03608033|588948468|FG001|Treatment Period|Physician Decision|10|||
163066562|NCT03608033|588948467|FG000|Treatment Period|Pregnancy|1|||
163066563|NCT03608033|588948468|FG001|Treatment Period|Pregnancy|0|||
163066564|NCT03608033|588948467|FG000|Treatment Period|Protocol Violation|1|||
163066565|NCT03608033|588948468|FG001|Treatment Period|Protocol Violation|2|||
163066566|NCT03608033|588948467|FG000|Treatment Period|Withdrawal by Subject|46|||
163066567|NCT03608033|588948468|FG001|Treatment Period|Withdrawal by Subject|45|||
163066568|NCT03608033|588948467|FG000|Treatment Period|Study terminated by sponsor|82|||
163066569|NCT03608033|588948468|FG001|Treatment Period|Study terminated by sponsor|68|||
163066570|NCT03608033|588948467|FG000|Treatment Period|Site Terminated by Sponsor|1|||
163066571|NCT03608033|588948468|FG001|Treatment Period|Site Terminated by Sponsor|0|||
163066572|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Adverse Event|1|||
163066573|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Adverse Event|0|||
163066574|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
163066575|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
163066576|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
163066577|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
163066578|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
163066579|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
163066580|NCT03608033|588948467|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
163066581|NCT03608033|588948468|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
163066582|NCT05253807|588948470|FG000|Overall Study|Death|1|||
163066583|NCT05253807|588948471|FG001|Overall Study|Death|4|||
163066584|NCT05253807|588948470|FG000|Overall Study|Withdrawal by Subject|1|||
163066585|NCT05253807|588948471|FG001|Overall Study|Withdrawal by Subject|0|||
162644038|NCT00066066|587413489|FG001|Overall Study|Lost to Follow-up|4|||
162644039|NCT00066066|587413490|FG002|Overall Study|Lost to Follow-up|7|||
163066586|NCT05253807|588948470|FG000|Overall Study|Study Terminated by Sponsor|1|||
163066587|NCT05253807|588948471|FG001|Overall Study|Study Terminated by Sponsor|1|||
163066588|NCT02360579|588948473|FG000|Initial|Death|16|||
163066589|NCT02360579|588948474|FG001|Initial|Death|49|||
163066590|NCT02360579|588948475|FG002|Initial|Death|0|||
163066591|NCT02360579|588948476|FG003|Initial|Death|71|||
163066592|NCT02360579|588948473|FG000|Initial|Lost to Follow-up|0|||
163066593|NCT02360579|588948474|FG001|Initial|Lost to Follow-up|4|||
163066594|NCT02360579|588948475|FG002|Initial|Lost to Follow-up|0|||
163066595|NCT02360579|588948476|FG003|Initial|Lost to Follow-up|1|||
163066596|NCT02360579|588948473|FG000|Initial|Withdrawal by Subject|0|||
163066597|NCT02360579|588948474|FG001|Initial|Withdrawal by Subject|0|||
163066598|NCT02360579|588948475|FG002|Initial|Withdrawal by Subject|0|||
163066599|NCT02360579|588948476|FG003|Initial|Withdrawal by Subject|3|||
163066600|NCT02360579|588948473|FG000|Initial|Other|7|||
163066601|NCT02360579|588948474|FG001|Initial|Other|0|||
163066602|NCT02360579|588948475|FG002|Initial|Other|0|||
163066603|NCT02360579|588948476|FG003|Initial|Other|0|||
163066604|NCT02360579|588948473|FG000|Initial|Did not receive TIL|8|||
163066605|NCT02360579|588948474|FG001|Initial|Did not receive TIL|11|||
163066606|NCT02360579|588948475|FG002|Initial|Did not receive TIL|0|||
163066607|NCT02360579|588948476|FG003|Initial|Did not receive TIL|22|||
163066608|NCT02360579|588948473|FG000|Retreatment|Death|0|||
163066609|NCT02360579|588948474|FG001|Retreatment|Death|0|||
163066610|NCT02360579|588948475|FG002|Retreatment|Death|11|||
163066611|NCT02360579|588948476|FG003|Retreatment|Death|0|||
163066612|NCT06455111|588948479|FG000|Overall Study|Withdrawal by Subject|11|||
163066613|NCT06455111|588948480|FG001|Overall Study|Withdrawal by Subject|4|||
163066614|NCT03682848|588948481|FG000|Overall Study|Withdrawal by Subject|3|||
163066615|NCT03682848|588948481|FG000|Overall Study|Site closed|5|||
163066616|NCT03682848|588948481|FG000|Overall Study|Protocol Deviation|1|||
163066617|NCT03682848|588948481|FG000|Overall Study|Adverse Event|2|||
163066618|NCT03682848|588948481|FG000|Overall Study|Lack of Efficacy|1|||
163066619|NCT02145390|588948485|FG000|Overall Study|Withdrawal by Subject|1|||
163066620|NCT01991314|588949520|FG000|Overall Study|Adverse Event|5|||
163066621|NCT01991314|588949521|FG001|Overall Study|Adverse Event|1|||
163066622|NCT01991314|588949520|FG000|Overall Study|Lost to Follow-up|6|||
163066623|NCT01991314|588949521|FG001|Overall Study|Lost to Follow-up|10|||
163066624|NCT00970944|588949523|FG000|Overall Study|Death|1|||
163066625|NCT00970944|588949524|FG001|Overall Study|Death|0|||
163066626|NCT00970944|588949523|FG000|Overall Study|Physician Decision|0|||
163066627|NCT00970944|588949524|FG001|Overall Study|Physician Decision|2|||
163066628|NCT02008370|588949525|FG000|Overall Study|Lost to Follow-up|7|||
163066629|NCT00662259|588949526|FG000|Overall Study|Adverse Event|2|||
163066630|NCT00662259|588949527|FG001|Overall Study|Adverse Event|0|||
163066631|NCT00972738|588949528|FG000|Overall Study|Adverse Event|7|||
163066632|NCT00972738|588949529|FG001|Overall Study|Adverse Event|1|||
163066633|NCT00972738|588949530|FG002|Overall Study|Adverse Event|8|||
163066634|NCT00972738|588949528|FG000|Overall Study|Protocol Violation|2|||
163066635|NCT00972738|588949529|FG001|Overall Study|Protocol Violation|1|||
163066636|NCT00972738|588949530|FG002|Overall Study|Protocol Violation|3|||
163066637|NCT00972738|588949528|FG000|Overall Study|Lost to Follow-up|1|||
163066638|NCT00972738|588949529|FG001|Overall Study|Lost to Follow-up|0|||
163066639|NCT00972738|588949530|FG002|Overall Study|Lost to Follow-up|1|||
163066640|NCT00972738|588949528|FG000|Overall Study|Lack of Efficacy|5|||
163066641|NCT00972738|588949529|FG001|Overall Study|Lack of Efficacy|1|||
163066642|NCT00972738|588949530|FG002|Overall Study|Lack of Efficacy|11|||
163066643|NCT00972738|588949528|FG000|Overall Study|Withdrawal by Subject|5|||
163066644|NCT00972738|588949529|FG001|Overall Study|Withdrawal by Subject|1|||
163066645|NCT00972738|588949530|FG002|Overall Study|Withdrawal by Subject|4|||
163066646|NCT00972738|588949528|FG000|Overall Study|Moved|0|||
163066647|NCT00972738|588949529|FG001|Overall Study|Moved|0|||
163066648|NCT00972738|588949530|FG002|Overall Study|Moved|1|||
163066649|NCT00972738|588949528|FG000|Overall Study|Other|1|||
163066650|NCT00972738|588949529|FG001|Overall Study|Other|2|||
163066651|NCT00972738|588949530|FG002|Overall Study|Other|1|||
163066652|NCT02636283|588949535|FG000|Overall Study|Adverse Event|2|||
163066653|NCT02636283|588949536|FG001|Overall Study|Adverse Event|0|||
163066654|NCT02636283|588949535|FG000|Overall Study|Trial Terminated Prematurely|0|||
163066655|NCT02636283|588949536|FG001|Overall Study|Trial Terminated Prematurely|3|||
163066656|NCT01879852|588949537|FG000|Overall Study|Withdrawal by Subject|2|||
163066657|NCT01879852|588949538|FG001|Overall Study|Withdrawal by Subject|0|||
163066658|NCT02696616|588949540|FG000|Overall Study|Adverse Event|0|||
163066659|NCT02696616|588949541|FG001|Overall Study|Adverse Event|1|||
163066660|NCT02696616|588949542|FG002|Overall Study|Adverse Event|0|||
163066661|NCT02696616|588949543|FG003|Overall Study|Adverse Event|0|||
163066662|NCT02696616|588949544|FG004|Overall Study|Adverse Event|0|||
163066663|NCT02696616|588949545|FG005|Overall Study|Adverse Event|0|||
163066664|NCT02696616|588949546|FG006|Overall Study|Adverse Event|0|||
163066665|NCT03086343|588949547|FG000|Period 1|Adverse Event|7|||
163066666|NCT03086343|588949548|FG001|Period 1|Adverse Event|7|||
163066667|NCT03086343|588949549|FG002|Period 1|Adverse Event|0|||
163066668|NCT03086343|588949550|FG003|Period 1|Adverse Event|1|||
163066669|NCT03086343|588949547|FG000|Period 1|Withdrawal by Subject|6|||
163066670|NCT03086343|588949548|FG001|Period 1|Withdrawal by Subject|10|||
163066671|NCT03086343|588949549|FG002|Period 1|Withdrawal by Subject|0|||
163066672|NCT03086343|588949550|FG003|Period 1|Withdrawal by Subject|0|||
163066673|NCT03086343|588949547|FG000|Period 1|Lost to Follow-up|1|||
163066674|NCT03086343|588949548|FG001|Period 1|Lost to Follow-up|3|||
163066675|NCT03086343|588949549|FG002|Period 1|Lost to Follow-up|1|||
163066676|NCT03086343|588949550|FG003|Period 1|Lost to Follow-up|0|||
163066677|NCT03086343|588949547|FG000|Period 1|Other, Not Specified|10|||
163066678|NCT03086343|588949548|FG001|Period 1|Other, Not Specified|12|||
163066679|NCT03086343|588949549|FG002|Period 1|Other, Not Specified|2|||
163066680|NCT03086343|588949550|FG003|Period 1|Other, Not Specified|1|||
163066681|NCT03086343|588949547|FG000|Period 1|Missing|1|||
163066682|NCT03086343|588949548|FG001|Period 1|Missing|0|||
162644040|NCT00066066|587413491|FG003|Overall Study|Lost to Follow-up|4|||
162644041|NCT00066066|587413492|FG004|Overall Study|Lost to Follow-up|3|||
162644042|NCT00066066|587413493|FG005|Overall Study|Lost to Follow-up|5|||
163066683|NCT03086343|588949549|FG002|Period 1|Missing|0|||
163066684|NCT03086343|588949550|FG003|Period 1|Missing|0|||
163066685|NCT03086343|588949547|FG000|Period 2|Adverse Event|20|||
163066686|NCT03086343|588949548|FG001|Period 2|Adverse Event|11|||
163066687|NCT03086343|588949549|FG002|Period 2|Adverse Event|1|||
163066688|NCT03086343|588949550|FG003|Period 2|Adverse Event|2|||
163066689|NCT03086343|588949547|FG000|Period 2|Withdrawal by Subject|15|||
163066690|NCT03086343|588949548|FG001|Period 2|Withdrawal by Subject|25|||
163066691|NCT03086343|588949549|FG002|Period 2|Withdrawal by Subject|2|||
163066692|NCT03086343|588949550|FG003|Period 2|Withdrawal by Subject|2|||
163066693|NCT03086343|588949547|FG000|Period 2|Lost to Follow-up|6|||
163066694|NCT03086343|588949548|FG001|Period 2|Lost to Follow-up|11|||
163066695|NCT03086343|588949549|FG002|Period 2|Lost to Follow-up|1|||
163066696|NCT03086343|588949550|FG003|Period 2|Lost to Follow-up|0|||
163066697|NCT03086343|588949547|FG000|Period 2|COVID-19 Infection|5|||
163066698|NCT03086343|588949548|FG001|Period 2|COVID-19 Infection|0|||
163066699|NCT03086343|588949549|FG002|Period 2|COVID-19 Infection|0|||
163066700|NCT03086343|588949550|FG003|Period 2|COVID-19 Infection|0|||
163066701|NCT03086343|588949547|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
163066702|NCT03086343|588949548|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
163066703|NCT03086343|588949549|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
163066704|NCT03086343|588949550|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
163066705|NCT03086343|588949547|FG000|Period 2|Other, Not Specified|23|||
163066706|NCT03086343|588949548|FG001|Period 2|Other, Not Specified|22|||
163066707|NCT03086343|588949549|FG002|Period 2|Other, Not Specified|2|||
163066708|NCT03086343|588949550|FG003|Period 2|Other, Not Specified|4|||
163066709|NCT04900272|588949551|FG000|Overall Study|Lost to Follow-up|2|||
163066710|NCT04900272|588949551|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
163066711|NCT04900272|588949551|FG000|Overall Study|Withdrawal by Subject|1|||
163066712|NCT01625182|588949553|FG000|Overall Study|Administrative problems|1|||
163066713|NCT01625182|588949554|FG001|Overall Study|Administrative problems|0|||
163066714|NCT01625182|588949553|FG000|Overall Study|Protocol deviation|0|||
163066715|NCT01625182|588949554|FG001|Overall Study|Protocol deviation|2|||
163066716|NCT01625182|588949553|FG000|Overall Study|Adverse Event|2|||
163066717|NCT01625182|588949554|FG001|Overall Study|Adverse Event|0|||
163066718|NCT01625182|588949553|FG000|Overall Study|Withdrawal by Subject|5|||
163066719|NCT01625182|588949554|FG001|Overall Study|Withdrawal by Subject|1|||
163066720|NCT01625182|588949553|FG000|Overall Study|Lack of Efficacy|12|||
163066721|NCT01625182|588949554|FG001|Overall Study|Lack of Efficacy|8|||
163066722|NCT01500083|588949555|FG000|Overall Study|Adverse Event|4|||
163066723|NCT01500083|588949556|FG001|Overall Study|Adverse Event|17|||
163066724|NCT01500083|588949555|FG000|Overall Study|Death|0|||
163066725|NCT01500083|588949556|FG001|Overall Study|Death|2|||
163066726|NCT01500083|588949555|FG000|Overall Study|Lost to Follow-up|1|||
163066727|NCT01500083|588949556|FG001|Overall Study|Lost to Follow-up|0|||
163066728|NCT01500083|588949555|FG000|Overall Study|Withdrawal of Consent|0|||
163066729|NCT01500083|588949556|FG001|Overall Study|Withdrawal of Consent|1|||
163066730|NCT01500083|588949555|FG000|Overall Study|Disease Progression|2|||
163066731|NCT01500083|588949556|FG001|Overall Study|Disease Progression|10|||
163066732|NCT01500083|588949555|FG000|Overall Study|Investigator Discretion|3|||
163066733|NCT01500083|588949556|FG001|Overall Study|Investigator Discretion|8|||
163066734|NCT01500083|588949555|FG000|Overall Study|Other Reasons|2|||
163066735|NCT01500083|588949556|FG001|Overall Study|Other Reasons|5|||
163066736|NCT00741611|588949557|FG000|Overall Study|Death|0|||
163066737|NCT00741611|588949558|FG001|Overall Study|Death|0|||
163066738|NCT00741611|588949559|FG002|Overall Study|Death|1|||
163066739|NCT00741611|588949557|FG000|Overall Study|Withdrawal by Subject|0|||
163066740|NCT00741611|588949558|FG001|Overall Study|Withdrawal by Subject|2|||
163066741|NCT00741611|588949559|FG002|Overall Study|Withdrawal by Subject|2|||
163066742|NCT01970371|588949560|FG000|Overall Study|Death|8|||
163066743|NCT01970371|588949561|FG001|Overall Study|Death|13|||
163066744|NCT01970371|588949562|FG002|Overall Study|Death|12|||
163066745|NCT01970371|588949560|FG000|Overall Study|Lost to Follow-up|0|||
163066746|NCT01970371|588949561|FG001|Overall Study|Lost to Follow-up|0|||
163066747|NCT01970371|588949562|FG002|Overall Study|Lost to Follow-up|1|||
163066748|NCT01481779|588949563|FG000|Overall Study|Adverse Event|23|||
163066749|NCT01481779|588949564|FG001|Overall Study|Adverse Event|5|||
162644043|NCT02155738|587413494|FG000|Overall Study|Missing critical information|1|||
162644044|NCT02155738|587413495|FG001|Overall Study|Missing critical information|0|||
163066750|NCT01481779|588949563|FG000|Overall Study|Lost to Follow-up|3|||
163066751|NCT01481779|588949564|FG001|Overall Study|Lost to Follow-up|2|||
163066752|NCT01481779|588949563|FG000|Overall Study|Protocol Violation|2|||
163066753|NCT01481779|588949564|FG001|Overall Study|Protocol Violation|3|||
163066754|NCT01481779|588949563|FG000|Overall Study|Withdrawal by Subject|26|||
163066755|NCT01481779|588949564|FG001|Overall Study|Withdrawal by Subject|13|||
163066756|NCT01481779|588949563|FG000|Overall Study|Physician Decision|13|||
163066757|NCT01481779|588949564|FG001|Overall Study|Physician Decision|4|||
163066758|NCT01481779|588949563|FG000|Overall Study|Sponsor Decision|3|||
163066759|NCT01481779|588949564|FG001|Overall Study|Sponsor Decision|1|||
163066760|NCT01555931|588949567|FG000|Overall Study|Lost to Follow-up|2|||
163066761|NCT01555931|588949568|FG001|Overall Study|Lost to Follow-up|5|||
163066762|NCT01922011|588949569|FG000|Overall Study|Protocol Violation|0|||
163066763|NCT01922011|588949570|FG001|Overall Study|Protocol Violation|1|||
163066764|NCT01922011|588949569|FG000|Overall Study|Physician Decision|0|||
163066765|NCT01922011|588949570|FG001|Overall Study|Physician Decision|1|||
163066766|NCT01922011|588949569|FG000|Overall Study|Parent/Guardian Decision|3|||
163066767|NCT01922011|588949570|FG001|Overall Study|Parent/Guardian Decision|0|||
163066768|NCT01922011|588949569|FG000|Overall Study|Lost to Follow-up|0|||
163066769|NCT01922011|588949570|FG001|Overall Study|Lost to Follow-up|1|||
163066770|NCT01922011|588949569|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
163066771|NCT01922011|588949570|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
163066772|NCT01922011|588949569|FG000|Overall Study|Not Treated|1|||
163066773|NCT01922011|588949570|FG001|Overall Study|Not Treated|0|||
163066774|NCT01922011|588949569|FG000|Overall Study|Lack of willing home health agency|1|||
163066775|NCT01922011|588949570|FG001|Overall Study|Lack of willing home health agency|0|||
163066776|NCT01922011|588949569|FG000|Overall Study|Randomized in error|1|||
163066777|NCT01922011|588949570|FG001|Overall Study|Randomized in error|0|||
163066778|NCT01510756|588949571|FG000|Overall Study|Death|1|||
162644045|NCT02155738|587413496|FG002|Overall Study|Missing critical information|0|||
163025823|NCT02541669|588797144|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
163025824|NCT02541669|588797145|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
163025825|NCT00834639|588797146|FG000|Second Intervention|Physician Decision|0|||
163025826|NCT00834639|588797147|FG001|Second Intervention|Physician Decision|2|||
163025827|NCT04739722|588797151|FG000|Overall Study|Lost to Follow-up|5301|||
163025828|NCT04739722|588797151|FG000|Overall Study|Withdrawal by Subject|42|||
163025829|NCT04739722|588797151|FG000|Overall Study|Non Average-risk|1157|||
163025830|NCT01968707|588797154|FG000|Overall Study|Did not meet treatment day baseline|49|||
163025831|NCT01968707|588797155|FG001|Overall Study|Did not meet treatment day baseline|12|||
163025832|NCT01968707|588797156|FG002|Overall Study|Did not meet treatment day baseline|41|||
163025833|NCT01968707|588797157|FG003|Overall Study|Did not meet treatment day baseline|44|||
163025834|NCT01968707|588797158|FG004|Overall Study|Did not meet treatment day baseline|36|||
163025835|NCT01968707|588797159|FG005|Overall Study|Did not meet treatment day baseline|11|||
163025836|NCT01968707|588797160|FG006|Overall Study|Did not meet treatment day baseline|34|||
163025837|NCT01968707|588797161|FG007|Overall Study|Did not meet treatment day baseline|35|||
163025838|NCT00631410|588797167|FG000|Overall Study|Adverse Event|1|||
163025839|NCT00631410|588797168|FG001|Overall Study|Adverse Event|3|||
163025840|NCT00631410|588797167|FG000|Overall Study|Objective Progression or Relapse|4|||
163025841|NCT00631410|588797168|FG001|Overall Study|Objective Progression or Relapse|3|||
163025842|NCT00631410|588797167|FG000|Overall Study|Surgery|1|||
163025843|NCT00631410|588797168|FG001|Overall Study|Surgery|0|||
163025844|NCT02083185|588797170|FG000|Overall Study|Lost to Follow-up|0|||
163025845|NCT02083185|588797171|FG001|Overall Study|Lost to Follow-up|3|||
163025846|NCT02083185|588797172|FG002|Overall Study|Lost to Follow-up|0|||
163025847|NCT02083185|588797170|FG000|Overall Study|Withdrawal by Subject|9|||
163025848|NCT02083185|588797171|FG001|Overall Study|Withdrawal by Subject|15|||
163025849|NCT02083185|588797172|FG002|Overall Study|Withdrawal by Subject|1|||
163025850|NCT02083185|588797170|FG000|Overall Study|Death|2|||
163025851|NCT02083185|588797171|FG001|Overall Study|Death|2|||
163025852|NCT02083185|588797172|FG002|Overall Study|Death|1|||
163025853|NCT02083185|588797170|FG000|Overall Study|Reason not Specified|9|||
163025854|NCT02083185|588797171|FG001|Overall Study|Reason not Specified|6|||
163025855|NCT02083185|588797172|FG002|Overall Study|Reason not Specified|5|||
163025856|NCT02083185|588797170|FG000|Overall Study|Study Terminated by Sponsor|0|||
163025857|NCT02083185|588797171|FG001|Overall Study|Study Terminated by Sponsor|1|||
163025858|NCT02083185|588797172|FG002|Overall Study|Study Terminated by Sponsor|0|||
163025859|NCT02083185|588797170|FG000|Overall Study|Did not Receive Study Drug|0|||
163025860|NCT02083185|588797171|FG001|Overall Study|Did not Receive Study Drug|2|||
163066779|NCT01510756|588949571|FG000|Overall Study|Lack of Efficacy|2|||
163066780|NCT01510756|588949571|FG000|Overall Study|Physician Decision|1|||
163066781|NCT04398134|588949578|FG000|Overall Study|Adverse Event|0|||
163066782|NCT04398134|588949579|FG001|Overall Study|Adverse Event|0|||
163066783|NCT04398134|588949580|FG002|Overall Study|Adverse Event|1|||
163066784|NCT04398134|588949581|FG003|Overall Study|Adverse Event|0|||
163066785|NCT04398134|588949578|FG000|Overall Study|Withdrawal by Subject|2|||
162644046|NCT02155738|587413497|FG003|Overall Study|Missing critical information|1|||
162644047|NCT01466348|587413498|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
163025861|NCT02083185|588797172|FG002|Overall Study|Did not Receive Study Drug|0|||
163025862|NCT03419598|588797173|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
163025863|NCT02474589|588797174|FG000|Overall Study|Adverse Event|6|||
163025864|NCT02474589|588797175|FG001|Overall Study|Adverse Event|2|||
163025865|NCT02474589|588797174|FG000|Overall Study|Lost to Follow-up|6|||
163066786|NCT04398134|588949579|FG001|Overall Study|Withdrawal by Subject|0|||
163066787|NCT04398134|588949580|FG002|Overall Study|Withdrawal by Subject|0|||
163066788|NCT04398134|588949581|FG003|Overall Study|Withdrawal by Subject|1|||
163066789|NCT04398134|588949578|FG000|Overall Study|Study Terminated by Sponsor|30|||
163066790|NCT04398134|588949579|FG001|Overall Study|Study Terminated by Sponsor|11|||
163066791|NCT04398134|588949580|FG002|Overall Study|Study Terminated by Sponsor|32|||
163066792|NCT04398134|588949581|FG003|Overall Study|Study Terminated by Sponsor|11|||
163066793|NCT04225039|588949586|FG000|Overall Study|Withdrawal by Subject|1|||
163066794|NCT04225039|588949587|FG001|Overall Study|Withdrawal by Subject|0|||
163066795|NCT04225039|588949588|FG002|Overall Study|Withdrawal by Subject|0|||
163066796|NCT04225039|588949589|FG003|Overall Study|Withdrawal by Subject|1|||
163066797|NCT04225039|588949586|FG000|Overall Study|Currently active on study treatment|0|||
163066798|NCT04225039|588949587|FG001|Overall Study|Currently active on study treatment|1|||
163066799|NCT04225039|588949588|FG002|Overall Study|Currently active on study treatment|0|||
163066800|NCT04225039|588949589|FG003|Overall Study|Currently active on study treatment|0|||
163066801|NCT04225039|588949586|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
163066802|NCT04225039|588949587|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066803|NCT04225039|588949588|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066804|NCT04225039|588949589|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
163066805|NCT04225039|588949586|FG000|Overall Study|Ineligible for treatment|0|||
163066806|NCT04225039|588949587|FG001|Overall Study|Ineligible for treatment|0|||
163066807|NCT04225039|588949588|FG002|Overall Study|Ineligible for treatment|0|||
163066808|NCT04225039|588949589|FG003|Overall Study|Ineligible for treatment|4|||
163066809|NCT00975923|588949590|FG000|Overall Study|Withdrawal by Subject|0|||
163066810|NCT00975923|588949591|FG001|Overall Study|Withdrawal by Subject|1|||
163066811|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
163066812|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
163066813|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
163066814|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
163066815|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
163066816|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
163066817|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
163066818|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
163066819|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
163066820|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
163066821|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
163066822|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
163066823|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066824|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066825|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066826|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066827|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066828|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066829|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066830|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066831|NCT01964404|588949592|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
163066832|NCT01964404|588949593|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
163066833|NCT01964404|588949594|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066834|NCT01964404|588949595|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
163066835|NCT01964404|588949596|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066836|NCT01964404|588949597|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066837|NCT01964404|588949598|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066838|NCT01964404|588949599|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066839|NCT01964404|588949600|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066840|NCT01964404|588949601|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
163066841|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
163066842|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
163066843|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
163066844|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
163066845|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
163066846|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
163066847|NCT00325416|588949604|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
163066848|NCT00325416|588949605|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
163066849|NCT00325416|588949604|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
163066850|NCT00325416|588949605|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
163066851|NCT00325416|588949604|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
162644048|NCT01466348|587413499|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
163066852|NCT00325416|588949605|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
163066853|NCT06239610|588949606|FG000|Overall Study|no usable migration data for minimum of one day|11|||
163066854|NCT02830087|588949609|FG000|Overall Study|No study staff to follow-up patients|4|||
163066855|NCT02830087|588949610|FG001|Overall Study|No study staff to follow-up patients|4|||
163066856|NCT02830087|588949611|FG002|Overall Study|No study staff to follow-up patients|4|||
163066857|NCT02830087|588949612|FG003|Overall Study|No study staff to follow-up patients|3|||
163066858|NCT02830087|588949613|FG004|Overall Study|No study staff to follow-up patients|3|||
163066859|NCT02830087|588949614|FG005|Overall Study|No study staff to follow-up patients|3|||
163066860|NCT02916771|588949615|FG000|Overall Study|Withdrawal by Subject|9|||
163066861|NCT02916771|588949615|FG000|Overall Study|Physician Decision|1|||
163066862|NCT02916771|588949615|FG000|Overall Study|Began treatment for another active malignancy|1|||
163066863|NCT02337686|588949616|FG000|Overall Study|Adverse Event|1|||
163066864|NCT00479232|588950803|FG000|Overall Study|Adverse Event|0|||
163066865|NCT00479232|588950804|FG001|Overall Study|Adverse Event|0|||
163066866|NCT00479232|588950805|FG002|Overall Study|Adverse Event|5|||
163066867|NCT00479232|588950806|FG003|Overall Study|Adverse Event|0|||
163066868|NCT00479232|588950807|FG004|Overall Study|Adverse Event|0|||
163066869|NCT00479232|588950808|FG005|Overall Study|Adverse Event|10|||
163066870|NCT00479232|588950803|FG000|Overall Study|Deviation from Protocol|0|||
163066871|NCT00479232|588950804|FG001|Overall Study|Deviation from Protocol|0|||
163066872|NCT00479232|588950805|FG002|Overall Study|Deviation from Protocol|1|||
163066873|NCT00479232|588950806|FG003|Overall Study|Deviation from Protocol|0|||
163066874|NCT00479232|588950807|FG004|Overall Study|Deviation from Protocol|0|||
163066875|NCT00479232|588950808|FG005|Overall Study|Deviation from Protocol|0|||
163066876|NCT00479232|588950803|FG000|Overall Study|Lack of Efficacy|0|||
163066877|NCT00479232|588950804|FG001|Overall Study|Lack of Efficacy|0|||
163066878|NCT00479232|588950805|FG002|Overall Study|Lack of Efficacy|2|||
163066879|NCT00479232|588950806|FG003|Overall Study|Lack of Efficacy|0|||
163066880|NCT00479232|588950807|FG004|Overall Study|Lack of Efficacy|0|||
163066881|NCT00479232|588950808|FG005|Overall Study|Lack of Efficacy|4|||
163066882|NCT00479232|588950803|FG000|Overall Study|Physician Decision|0|||
163066883|NCT00479232|588950804|FG001|Overall Study|Physician Decision|0|||
163066884|NCT00479232|588950805|FG002|Overall Study|Physician Decision|2|||
163066885|NCT00479232|588950806|FG003|Overall Study|Physician Decision|0|||
163066886|NCT00479232|588950807|FG004|Overall Study|Physician Decision|0|||
163066887|NCT00479232|588950808|FG005|Overall Study|Physician Decision|1|||
163066888|NCT00479232|588950803|FG000|Overall Study|Progressive Disease|3|||
163066889|NCT00479232|588950804|FG001|Overall Study|Progressive Disease|1|||
163066890|NCT00479232|588950805|FG002|Overall Study|Progressive Disease|12|||
163066891|NCT00479232|588950806|FG003|Overall Study|Progressive Disease|3|||
163066892|NCT00479232|588950807|FG004|Overall Study|Progressive Disease|3|||
163066893|NCT00479232|588950808|FG005|Overall Study|Progressive Disease|12|||
163066894|NCT00479232|588950803|FG000|Overall Study|Withdrew Consent|0|||
163066895|NCT00479232|588950804|FG001|Overall Study|Withdrew Consent|2|||
163066896|NCT00479232|588950805|FG002|Overall Study|Withdrew Consent|6|||
163066897|NCT00479232|588950806|FG003|Overall Study|Withdrew Consent|0|||
163066898|NCT00479232|588950807|FG004|Overall Study|Withdrew Consent|1|||
163066899|NCT00479232|588950808|FG005|Overall Study|Withdrew Consent|3|||
163066900|NCT05977868|588950809|FG000|Overall Study|Withdrawal by Subject|1|||
163066901|NCT05977868|588950810|FG001|Overall Study|Withdrawal by Subject|2|||
163066902|NCT05977868|588950809|FG000|Overall Study|Transitioned to comfort care|1|||
163066903|NCT05977868|588950810|FG001|Overall Study|Transitioned to comfort care|0|||
163025866|NCT02474589|588797175|FG001|Overall Study|Lost to Follow-up|1|||
163025867|NCT02474589|588797174|FG000|Overall Study|Protocol Violation|4|||
163025868|NCT02474589|588797175|FG001|Overall Study|Protocol Violation|1|||
163025869|NCT02474589|588797174|FG000|Overall Study|Withdrawal by Subject|4|||
163025870|NCT02474589|588797175|FG001|Overall Study|Withdrawal by Subject|0|||
163025871|NCT02474589|588797174|FG000|Overall Study|Inability to complete study procedures|5|||
163025872|NCT02474589|588797175|FG001|Overall Study|Inability to complete study procedures|1|||
163025873|NCT00380081|588797178|FG000|Overall Study|Withdrawal by Subject|0|||
163025874|NCT00380081|588797179|FG001|Overall Study|Withdrawal by Subject|0|||
163025875|NCT00380081|588797180|FG002|Overall Study|Withdrawal by Subject|0|||
163025876|NCT00380081|588797181|FG003|Overall Study|Withdrawal by Subject|0|||
163025877|NCT00380081|588797182|FG004|Overall Study|Withdrawal by Subject|1|||
163025878|NCT00380081|588797183|FG005|Overall Study|Withdrawal by Subject|0|||
163025879|NCT00380081|588797178|FG000|Overall Study|Family Emergency|0|||
163025880|NCT00380081|588797179|FG001|Overall Study|Family Emergency|0|||
163025881|NCT00380081|588797180|FG002|Overall Study|Family Emergency|0|||
163025882|NCT00380081|588797181|FG003|Overall Study|Family Emergency|0|||
163025883|NCT00380081|588797182|FG004|Overall Study|Family Emergency|0|||
163025884|NCT00380081|588797183|FG005|Overall Study|Family Emergency|1|||
163025885|NCT02231879|588797184|FG000|Overall Study|Adverse Event|2|||
163025886|NCT02231879|588797185|FG001|Overall Study|Adverse Event|1|||
163066904|NCT00876395|588950811|FG000|Overall Study|Untreated|8|||
163066905|NCT00876395|588950812|FG001|Overall Study|Untreated|1|||
163066906|NCT00876395|588950811|FG000|Overall Study|Adverse Event|63|||
163066907|NCT00876395|588950812|FG001|Overall Study|Adverse Event|11|||
163066908|NCT00876395|588950811|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163066909|NCT00876395|588950812|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163066910|NCT00876395|588950811|FG000|Overall Study|Disease progression|259|||
163066911|NCT00876395|588950812|FG001|Overall Study|Disease progression|162|||
163066912|NCT00876395|588950811|FG000|Overall Study|New cancer therapy|25|||
163066913|NCT00876395|588950812|FG001|Overall Study|New cancer therapy|7|||
163066914|NCT00876395|588950811|FG000|Overall Study|Protocol Violation|5|||
163066915|NCT00876395|588950812|FG001|Overall Study|Protocol Violation|2|||
163066916|NCT00876395|588950811|FG000|Overall Study|Withdrawal by Subject|66|||
163066917|NCT00876395|588950812|FG001|Overall Study|Withdrawal by Subject|33|||
163066918|NCT00876395|588950811|FG000|Overall Study|Lost to Follow-up|2|||
163066919|NCT00876395|588950812|FG001|Overall Study|Lost to Follow-up|0|||
163066920|NCT00876395|588950811|FG000|Overall Study|Administrative problems|39|||
163066921|NCT00876395|588950812|FG001|Overall Study|Administrative problems|23|||
163066922|NCT00876395|588950811|FG000|Overall Study|Death|12|||
163066923|NCT00876395|588950812|FG001|Overall Study|Death|0|||
163066924|NCT01787838|588950817|FG000|Overall Study|refused|1413|||
163066925|NCT02260986|588950822|FG000|Overall Study|Adverse Event|24|||
163066926|NCT02260986|588950823|FG001|Overall Study|Adverse Event|0|||
163066927|NCT02260986|588950824|FG002|Overall Study|Adverse Event|11|||
163066928|NCT02260986|588950822|FG000|Overall Study|Lack of Efficacy|27|||
163066929|NCT02260986|588950823|FG001|Overall Study|Lack of Efficacy|3|||
163066930|NCT02260986|588950824|FG002|Overall Study|Lack of Efficacy|0|||
163066931|NCT02260986|588950822|FG000|Overall Study|Protocol Violation|14|||
163066932|NCT02260986|588950823|FG001|Overall Study|Protocol Violation|5|||
163066933|NCT02260986|588950824|FG002|Overall Study|Protocol Violation|16|||
163066934|NCT02260986|588950822|FG000|Overall Study|Car accident|0|||
163066935|NCT02260986|588950823|FG001|Overall Study|Car accident|0|||
163066936|NCT02260986|588950824|FG002|Overall Study|Car accident|1|||
163066937|NCT02260986|588950822|FG000|Overall Study|Withdrawal by Subject|17|||
163066938|NCT02260986|588950823|FG001|Overall Study|Withdrawal by Subject|4|||
163066939|NCT02260986|588950824|FG002|Overall Study|Withdrawal by Subject|9|||
163066940|NCT02260986|588950822|FG000|Overall Study|Incorrect randomization|0|||
163066941|NCT02260986|588950823|FG001|Overall Study|Incorrect randomization|1|||
163066942|NCT02260986|588950824|FG002|Overall Study|Incorrect randomization|0|||
163066943|NCT02260986|588950822|FG000|Overall Study|Lack of investigation product supply|2|||
163066944|NCT02260986|588950823|FG001|Overall Study|Lack of investigation product supply|0|||
163066945|NCT02260986|588950824|FG002|Overall Study|Lack of investigation product supply|1|||
163066946|NCT02260986|588950822|FG000|Overall Study|Lost to Follow-up|4|||
163066947|NCT02260986|588950823|FG001|Overall Study|Lost to Follow-up|0|||
163066948|NCT02260986|588950824|FG002|Overall Study|Lost to Follow-up|3|||
163066949|NCT02260986|588950822|FG000|Overall Study|Pregnancy|2|||
163066950|NCT02260986|588950823|FG001|Overall Study|Pregnancy|0|||
163066951|NCT02260986|588950824|FG002|Overall Study|Pregnancy|0|||
163066952|NCT01793935|588950825|FG000|Overall Study|Pregnancy|1|||
163066953|NCT01793935|588950826|FG001|Overall Study|Pregnancy|0|||
163066954|NCT01793935|588950825|FG000|Overall Study|Protocol Violation|2|||
163066955|NCT01793935|588950826|FG001|Overall Study|Protocol Violation|1|||
163066956|NCT01793935|588950825|FG000|Overall Study|Adverse Event|2|||
163066957|NCT01793935|588950826|FG001|Overall Study|Adverse Event|0|||
163066958|NCT01793935|588950825|FG000|Overall Study|Patient did not take study medication|1|||
163066959|NCT01793935|588950826|FG001|Overall Study|Patient did not take study medication|1|||
163066960|NCT01793935|588950825|FG000|Overall Study|Lost to Follow-up|0|||
163066961|NCT01793935|588950826|FG001|Overall Study|Lost to Follow-up|1|||
163066962|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Adverse Event|2|||
163066963|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
163066964|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
163066965|NCT02536794|588950828|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
163066966|NCT02536794|588950828|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
163066967|NCT02536794|588950828|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
163066968|NCT00313170|588950829|FG000|Overall Study|Death|2|||
163066969|NCT00313170|588950830|FG001|Overall Study|Death|4|||
163066970|NCT00313170|588950831|FG002|Overall Study|Death|2|||
163066971|NCT00313170|588950829|FG000|Overall Study|Adverse Event|1|||
163066972|NCT00313170|588950830|FG001|Overall Study|Adverse Event|2|||
163066973|NCT00313170|588950831|FG002|Overall Study|Adverse Event|0|||
163066974|NCT00313170|588950829|FG000|Overall Study|Disease progression|31|||
163066975|NCT00313170|588950830|FG001|Overall Study|Disease progression|26|||
163066976|NCT00313170|588950831|FG002|Overall Study|Disease progression|27|||
163066977|NCT00313170|588950829|FG000|Overall Study|Withdrawal by Subject|1|||
163066978|NCT00313170|588950830|FG001|Overall Study|Withdrawal by Subject|0|||
163066979|NCT00313170|588950831|FG002|Overall Study|Withdrawal by Subject|1|||
162644049|NCT02189473|587413502|FG000|Overall Study|Death|22|||
163066980|NCT00313170|588950829|FG000|Overall Study|Incorrect enrollment|0|||
163066981|NCT00313170|588950830|FG001|Overall Study|Incorrect enrollment|2|||
163066982|NCT00313170|588950831|FG002|Overall Study|Incorrect enrollment|1|||
163066983|NCT00313170|588950829|FG000|Overall Study|Lost to Follow-up|0|||
163066984|NCT00313170|588950830|FG001|Overall Study|Lost to Follow-up|0|||
163066985|NCT00313170|588950831|FG002|Overall Study|Lost to Follow-up|1|||
162644050|NCT02189473|587413503|FG001|Overall Study|Death|23|||
163066986|NCT00313170|588950829|FG000|Overall Study|Progression (investigators opinion)|1|||
163066987|NCT00313170|588950830|FG001|Overall Study|Progression (investigators opinion)|0|||
163066988|NCT00313170|588950831|FG002|Overall Study|Progression (investigators opinion)|0|||
163066989|NCT00817063|588950837|FG000|Overall Study|Adverse Event|32|||
163066990|NCT00817063|588950838|FG001|Overall Study|Adverse Event|13|||
163066991|NCT00817063|588950837|FG000|Overall Study|Death|1|||
163066992|NCT00817063|588950838|FG001|Overall Study|Death|1|||
163066993|NCT00817063|588950837|FG000|Overall Study|Lack of Efficacy|33|||
163066994|NCT00817063|588950838|FG001|Overall Study|Lack of Efficacy|86|||
163066995|NCT00817063|588950837|FG000|Overall Study|Failure to Return|13|||
163066996|NCT00817063|588950838|FG001|Overall Study|Failure to Return|12|||
163066997|NCT00817063|588950837|FG000|Overall Study|Violation of Selection at Entry|7|||
163066998|NCT00817063|588950838|FG001|Overall Study|Violation of Selection at Entry|4|||
163066999|NCT00817063|588950837|FG000|Overall Study|Protocol Violation|3|||
163067000|NCT00817063|588950838|FG001|Overall Study|Protocol Violation|8|||
163067001|NCT00817063|588950837|FG000|Overall Study|Withdrawal by Subject|17|||
163067002|NCT00817063|588950838|FG001|Overall Study|Withdrawal by Subject|37|||
163067003|NCT00817063|588950837|FG000|Overall Study|Early Improvement|19|||
163067004|NCT00817063|588950838|FG001|Overall Study|Early Improvement|4|||
163067005|NCT00817063|588950837|FG000|Overall Study|Administrative|10|||
163067006|NCT00817063|588950838|FG001|Overall Study|Administrative|4|||
163067007|NCT00817063|588950837|FG000|Overall Study|Abnormality of Laboratory Test|2|||
163067008|NCT00817063|588950838|FG001|Overall Study|Abnormality of Laboratory Test|1|||
163067009|NCT00529035|588950839|FG000|Overall Study|Withdrawal by Subject|1|||
163067010|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Other|4|||
163067011|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Other|1|||
163067012|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
163067013|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163067014|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
163067015|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
163067016|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
163067017|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
163067018|NCT03439514|588950840|FG000|Double-Blind Treatment Period|Death|1|||
163067019|NCT03439514|588950841|FG001|Double-Blind Treatment Period|Death|2|||
163067020|NCT01521364|588950842|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
163067021|NCT01521364|588950842|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
163067022|NCT03418675|588950843|FG000|Overall Study|Lost to Follow-up|13|||
163067023|NCT03418675|588950844|FG001|Overall Study|Lost to Follow-up|10|||
163067024|NCT03418675|588950843|FG000|Overall Study|Adverse Event|2|||
163067025|NCT03418675|588950844|FG001|Overall Study|Adverse Event|0|||
163067026|NCT02447029|588950848|FG000|Overall Study|Withdrawal by Subject|3|||
163067027|NCT02447029|588950849|FG001|Overall Study|Withdrawal by Subject|2|||
163067028|NCT06420232|588950851|FG000|Overall Study|Withdrawal by Subject|3|||
163067029|NCT01697579|588950852|FG000|Base Study-Cycle 1|Adverse Event|1|||
163067030|NCT01697579|588950853|FG001|Base Study-Cycle 1|Adverse Event|0|||
163067031|NCT01697579|588950854|FG002|Base Study-Cycle 1|Adverse Event|0|||
163067032|NCT01697579|588950855|FG003|Base Study-Cycle 1|Adverse Event|0|||
163067033|NCT01697579|588950856|FG004|Base Study-Cycle 1|Adverse Event|0|||
163067034|NCT01697579|588950857|FG005|Base Study-Cycle 1|Adverse Event|0|||
163067035|NCT01697579|588950858|FG006|Base Study-Cycle 1|Adverse Event|0|||
163067036|NCT01697579|588950852|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
163067037|NCT01697579|588950853|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067038|NCT01697579|588950854|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067039|NCT01697579|588950855|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067040|NCT01697579|588950856|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067041|NCT01697579|588950857|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067042|NCT01697579|588950858|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
163067043|NCT01697579|588950852|FG000|Base Study-Cycle 1|Protocol Violation|0|||
163067044|NCT01697579|588950853|FG001|Base Study-Cycle 1|Protocol Violation|0|||
163067045|NCT01697579|588950854|FG002|Base Study-Cycle 1|Protocol Violation|0|||
163067046|NCT01697579|588950855|FG003|Base Study-Cycle 1|Protocol Violation|0|||
163067047|NCT01697579|588950856|FG004|Base Study-Cycle 1|Protocol Violation|3|||
163067048|NCT01697579|588950857|FG005|Base Study-Cycle 1|Protocol Violation|0|||
163067049|NCT01697579|588950858|FG006|Base Study-Cycle 1|Protocol Violation|0|||
163067050|NCT01697579|588950852|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067051|NCT01697579|588950853|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
163067052|NCT01697579|588950854|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067053|NCT01697579|588950855|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067054|NCT01697579|588950856|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067055|NCT01697579|588950857|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067056|NCT01697579|588950858|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
163067057|NCT01697579|588950852|FG000|Base Study-Cycle 1|Technical Problems|0|||
163067058|NCT01697579|588950853|FG001|Base Study-Cycle 1|Technical Problems|0|||
163067059|NCT01697579|588950854|FG002|Base Study-Cycle 1|Technical Problems|1|||
163067060|NCT01697579|588950855|FG003|Base Study-Cycle 1|Technical Problems|1|||
163067061|NCT01697579|588950856|FG004|Base Study-Cycle 1|Technical Problems|0|||
163067062|NCT01697579|588950857|FG005|Base Study-Cycle 1|Technical Problems|0|||
163067063|NCT01697579|588950858|FG006|Base Study-Cycle 1|Technical Problems|0|||
163067064|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Death|0|||
163067065|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Death|0|||
163067066|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Death|0|||
163067067|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Death|0|||
163067068|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Death|0|||
163067069|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Death|0|||
163067070|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Death|2|||
163067071|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067072|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067073|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067074|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067075|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163067076|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
163067077|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
163067078|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067079|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067080|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067081|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067082|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
163067083|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
163067084|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
163067085|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067086|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067087|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067088|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067089|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067090|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
163067091|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
163067092|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067093|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067094|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067095|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067096|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
163067097|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
163067098|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
163067099|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067100|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067101|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067102|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067103|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067104|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
163067105|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
163067106|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067107|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067108|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067109|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067110|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
163067111|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
163067112|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
163067113|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067114|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067115|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067116|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067117|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163067118|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
163067119|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
163067120|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067121|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067122|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067123|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067124|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067125|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
163067126|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
162644051|NCT02189473|587413502|FG000|Overall Study|Lost to Follow-up|1|||
162644052|NCT02189473|587413503|FG001|Overall Study|Lost to Follow-up|2|||
162644053|NCT02385266|587413509|FG000|Overall Study|Withdrawal by Subject|1|||
162644054|NCT02385266|587413510|FG001|Overall Study|Withdrawal by Subject|3|||
163025887|NCT02231879|588797184|FG000|Overall Study|Lack of Efficacy|0|||
163025888|NCT02231879|588797185|FG001|Overall Study|Lack of Efficacy|1|||
163025889|NCT00189306|588797186|FG000|Treatment Period|Withdrawal by Subject|2|||
163025890|NCT00189306|588797186|FG000|Treatment Period|Adverse Event|2|||
163025891|NCT00189306|588797186|FG000|Treatment Period|Protocol Violation|1|||
163025892|NCT00189306|588797186|FG000|Posttreatment Period|Death|1|||
163025893|NCT00189306|588797186|FG000|Posttreatment Period|Withdrawal by Subject|2|||
163025894|NCT00189306|588797186|FG000|Posttreatment Period|Noncompliance|1|||
163025895|NCT00189306|588797186|FG000|Posttreatment Period|Target lesion excised|1|||
163025896|NCT00189306|588797186|FG000|Posttreatment Period|Protocol Violation|1|||
163025897|NCT00189306|588797186|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
163025898|NCT00189306|588797186|FG000|Posttreatment Period|Local skin reaction/sign|1|||
163025899|NCT00189306|588797186|FG000|Long-Term Follow-up|Adverse Event|2|||
163025900|NCT00189306|588797186|FG000|Long-Term Follow-up|Death|4|||
163025901|NCT00189306|588797186|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
163025902|NCT00189306|588797186|FG000|Long-Term Follow-up|Intercurrent disease|2|||
163025903|NCT00189306|588797186|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
163025904|NCT00189306|588797186|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
163025905|NCT00459706|588797187|FG000|Overall Study|Adverse Event|19|||
163025906|NCT00459706|588797188|FG001|Overall Study|Adverse Event|13|||
163025907|NCT00459706|588797187|FG000|Overall Study|Withdrawal by Subject|1|||
163025908|NCT00459706|588797188|FG001|Overall Study|Withdrawal by Subject|6|||
163025909|NCT00459706|588797187|FG000|Overall Study|Physician Decision|2|||
163025910|NCT00459706|588797188|FG001|Overall Study|Physician Decision|0|||
163025911|NCT00459706|588797187|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163025912|NCT00459706|588797188|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163025913|NCT00459706|588797187|FG000|Overall Study|Protocol Violation|2|||
163025914|NCT00459706|588797188|FG001|Overall Study|Protocol Violation|1|||
163025915|NCT00459706|588797187|FG000|Overall Study|Failed to Return|1|||
163025916|NCT00459706|588797188|FG001|Overall Study|Failed to Return|0|||
163025917|NCT00459706|588797187|FG000|Overall Study|Other|0|||
163025918|NCT00459706|588797188|FG001|Overall Study|Other|1|||
163025919|NCT03640481|588797189|FG000|Overall Study|Death|14|||
163025920|NCT03640481|588797190|FG001|Overall Study|Death|14|||
163025921|NCT03640481|588797191|FG002|Overall Study|Death|0|||
163025922|NCT03640481|588797192|FG003|Overall Study|Death|0|||
163025923|NCT03640481|588797189|FG000|Overall Study|Lost to Follow-up|2|||
163025924|NCT03640481|588797190|FG001|Overall Study|Lost to Follow-up|0|||
163025925|NCT03640481|588797191|FG002|Overall Study|Lost to Follow-up|0|||
163025926|NCT03640481|588797192|FG003|Overall Study|Lost to Follow-up|0|||
163025927|NCT03640481|588797189|FG000|Overall Study|Site terminated by sponsor|1|||
163025928|NCT03640481|588797190|FG001|Overall Study|Site terminated by sponsor|3|||
163025929|NCT03640481|588797191|FG002|Overall Study|Site terminated by sponsor|0|||
163025930|NCT03640481|588797192|FG003|Overall Study|Site terminated by sponsor|0|||
163025931|NCT03640481|588797189|FG000|Overall Study|Study terminated by sponsor|29|||
163025932|NCT03640481|588797190|FG001|Overall Study|Study terminated by sponsor|42|||
163025933|NCT03640481|588797191|FG002|Overall Study|Study terminated by sponsor|1|||
163025934|NCT03640481|588797192|FG003|Overall Study|Study terminated by sponsor|0|||
163025935|NCT03640481|588797189|FG000|Overall Study|Withdrawal by Subject|5|||
163025936|NCT03640481|588797190|FG001|Overall Study|Withdrawal by Subject|4|||
163025937|NCT03640481|588797191|FG002|Overall Study|Withdrawal by Subject|0|||
163025938|NCT03640481|588797192|FG003|Overall Study|Withdrawal by Subject|1|||
163025939|NCT03640481|588797189|FG000|Overall Study|Other|26|||
163025940|NCT03640481|588797190|FG001|Overall Study|Other|12|||
163025941|NCT03640481|588797191|FG002|Overall Study|Other|1|||
163025942|NCT03640481|588797192|FG003|Overall Study|Other|0|||
163025943|NCT03640481|588797189|FG000|Overall Study|Randomized, but not treated|1|||
163025944|NCT03640481|588797190|FG001|Overall Study|Randomized, but not treated|3|||
163025945|NCT03640481|588797191|FG002|Overall Study|Randomized, but not treated|0|||
163025946|NCT03640481|588797192|FG003|Overall Study|Randomized, but not treated|0|||
163025947|NCT01322035|588797193|FG000|Overall Study|Lost to Follow-up|8|||
163025948|NCT01322035|588797194|FG001|Overall Study|Lost to Follow-up|3|||
163025949|NCT00535847|588797195|FG000|Overall Study|Adverse Event|5|||
163025950|NCT00535847|588797196|FG001|Overall Study|Adverse Event|3|||
163025951|NCT00535847|588797197|FG002|Overall Study|Adverse Event|2|||
163025952|NCT00535847|588797195|FG000|Overall Study|Non compliance|1|||
163025953|NCT00535847|588797196|FG001|Overall Study|Non compliance|1|||
163025954|NCT00535847|588797197|FG002|Overall Study|Non compliance|0|||
163025955|NCT00535847|588797195|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
163025956|NCT00535847|588797196|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
163025957|NCT00535847|588797197|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
162644055|NCT00914810|587413511|FG000|Overall Study|Withdrawal by Subject|1|||
162644056|NCT00914810|587413512|FG001|Overall Study|Withdrawal by Subject|0|||
162644057|NCT00914810|587413511|FG000|Overall Study|Relocated out of state|1|||
162644058|NCT00914810|587413512|FG001|Overall Study|Relocated out of state|0|||
162644059|NCT00914810|587413511|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
163025958|NCT01546168|588797200|FG000|Overall Study|Lost to Follow-up|1|||
163025959|NCT01546168|588797201|FG001|Overall Study|Lost to Follow-up|0|||
163025960|NCT01546168|588797200|FG000|Overall Study|Withdrawal by Subject|1|||
163025961|NCT01546168|588797201|FG001|Overall Study|Withdrawal by Subject|0|||
163025962|NCT01546168|588797200|FG000|Overall Study|ineligible after signing consent|2|||
163025963|NCT01546168|588797201|FG001|Overall Study|ineligible after signing consent|0|||
163025964|NCT02850016|588797204|FG000|Overall Study|Withdrawal by Subject|1|||
163025965|NCT02850016|588797205|FG001|Overall Study|Withdrawal by Subject|2|||
163025966|NCT00070018|588797208|FG000|Overall Study|Adverse Event|2|||
163025967|NCT00070018|588797208|FG000|Overall Study|Lack of Efficacy|1|||
163025968|NCT00070018|588797208|FG000|Overall Study|Withdrawal by Subject|1|||
163025969|NCT02939716|588797209|FG000|Overall Study|scanner failure|0|||
163025970|NCT02939716|588797210|FG001|Overall Study|scanner failure|0|||
163025971|NCT02939716|588797211|FG002|Overall Study|scanner failure|0|||
163025972|NCT02939716|588797212|FG003|Overall Study|scanner failure|1|||
163025973|NCT02939716|588797213|FG004|Overall Study|scanner failure|1|||
163025974|NCT02939716|588797214|FG005|Overall Study|scanner failure|1|||
163025975|NCT01054196|588797220|FG000|Overall Study|Physician Decision|0|||
163025976|NCT01054196|588797221|FG001|Overall Study|Physician Decision|0|||
163025977|NCT01054196|588797222|FG002|Overall Study|Physician Decision|0|||
163025978|NCT01054196|588797223|FG003|Overall Study|Physician Decision|1|||
163025979|NCT01054196|588797224|FG004|Overall Study|Physician Decision|0|||
163025980|NCT01054196|588797225|FG005|Overall Study|Physician Decision|0|||
163025981|NCT01054196|588797226|FG006|Overall Study|Physician Decision|1|||
163025982|NCT01820572|588797231|FG000|Randomization|Not Treated|2|||
163025983|NCT01820572|588797232|FG001|Randomization|Not Treated|1|||
163025984|NCT01820572|588797231|FG000|Treatment Period|Adverse Event|12|||
163025985|NCT01820572|588797232|FG001|Treatment Period|Adverse Event|7|||
163025986|NCT01820572|588797231|FG000|Treatment Period|Death|3|||
163025987|NCT01820572|588797232|FG001|Treatment Period|Death|3|||
163025988|NCT01820572|588797231|FG000|Treatment Period|Lack of Efficacy|1|||
163025989|NCT01820572|588797232|FG001|Treatment Period|Lack of Efficacy|0|||
163025990|NCT01820572|588797231|FG000|Treatment Period|poor/non compliance|0|||
163025991|NCT01820572|588797232|FG001|Treatment Period|poor/non compliance|3|||
163025992|NCT01820572|588797231|FG000|Treatment Period|request to discontinue|6|||
163025993|NCT01820572|588797232|FG001|Treatment Period|request to discontinue|11|||
163025994|NCT01820572|588797231|FG000|Treatment Period|No longer meets study criteria|3|||
163025995|NCT01820572|588797232|FG001|Treatment Period|No longer meets study criteria|10|||
163025996|NCT01820572|588797231|FG000|Treatment Period|withdrew consent|1|||
163025997|NCT01820572|588797232|FG001|Treatment Period|withdrew consent|2|||
163025998|NCT00595517|588797233|FG000|Overall Study|Adverse Event|6|||
163025999|NCT00595517|588797233|FG000|Overall Study|Withdrawal by Subject|4|||
163026000|NCT00595517|588797233|FG000|Overall Study|Protocol Violation|2|||
163026001|NCT00595517|588797233|FG000|Overall Study|Recurrence of ulcer|5|||
163026002|NCT00595517|588797233|FG000|Overall Study|usage of prohibited treatment|1|||
163026003|NCT00595517|588797233|FG000|Overall Study|No intention to attend regularly|1|||
163026004|NCT00387010|588797236|FG000|Dose Titration Period|Adverse Event|12|||
163026005|NCT00387010|588797236|FG000|Dose Titration Period|Lack of Efficacy|5|||
163026006|NCT00387010|588797236|FG000|Dose Titration Period|Withdrawal by Subject|3|||
163026007|NCT00387010|588797236|FG000|Dose Titration Period|Protocol Violation|1|||
163026008|NCT00387010|588797236|FG000|Dose Titration Period|Lost to Follow-up|2|||
163026009|NCT00387010|588797236|FG000|Dose Titration Period|Noncompliance with study medication|8|||
163026010|NCT00387010|588797236|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
163026011|NCT00387010|588797236|FG000|Treatment Period|Adverse Event|4|||
163026012|NCT00387010|588797236|FG000|Treatment Period|Withdrawal by Subject|1|||
163026013|NCT00387010|588797236|FG000|Treatment Period|Noncompliance with study medication|2|||
163026014|NCT00387010|588797236|FG000|Treatment Period|Noncompliance with study procedures|3|||
163026015|NCT00387010|588797236|FG000|Treatment Period|Participant reported study drug stolen|1|||
163067127|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
162644060|NCT00914810|587413512|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
162644061|NCT02082210|587413513|FG000|Overall Study|Death|0|||
162644062|NCT02082210|587413514|FG001|Overall Study|Death|0|||
163026016|NCT01167881|588797241|FG000|Overall Study|Adverse Event|47|||
163026017|NCT01167881|588797242|FG001|Overall Study|Adverse Event|51|||
163026018|NCT01167881|588797241|FG000|Overall Study|Lack of Efficacy|4|||
163026019|NCT01167881|588797242|FG001|Overall Study|Lack of Efficacy|7|||
163026020|NCT01167881|588797241|FG000|Overall Study|Non compliant with protocol|9|||
163026021|NCT01167881|588797242|FG001|Overall Study|Non compliant with protocol|18|||
162644063|NCT02082210|587413515|FG002|Overall Study|Death|1|||
162644064|NCT02082210|587413516|FG003|Overall Study|Death|1|||
162644065|NCT02082210|587413517|FG004|Overall Study|Death|1|||
163026022|NCT01167881|588797241|FG000|Overall Study|Lost to Follow-up|19|||
163026023|NCT01167881|588797242|FG001|Overall Study|Lost to Follow-up|20|||
163026024|NCT01167881|588797241|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
163026025|NCT01167881|588797242|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
163026026|NCT01167881|588797241|FG000|Overall Study|Not treated|4|||
163026027|NCT01167881|588797242|FG001|Overall Study|Not treated|0|||
163026028|NCT01167881|588797241|FG000|Overall Study|Other not defined above|31|||
163026029|NCT01167881|588797242|FG001|Overall Study|Other not defined above|55|||
163026030|NCT01931956|588797243|FG000|Overall Study|Death|42|||
163026031|NCT01931956|588797244|FG001|Overall Study|Death|7|||
163026032|NCT01931956|588797245|FG002|Overall Study|Death|379|||
163026033|NCT01931956|588797246|FG003|Overall Study|Death|96|||
163026034|NCT01931956|588797243|FG000|Overall Study|Withdrawal by Subject|5|||
163026035|NCT01931956|588797244|FG001|Overall Study|Withdrawal by Subject|0|||
163026036|NCT01931956|588797245|FG002|Overall Study|Withdrawal by Subject|70|||
163026037|NCT01931956|588797246|FG003|Overall Study|Withdrawal by Subject|30|||
163026038|NCT01931956|588797243|FG000|Overall Study|Lost to Follow-up|2|||
163026039|NCT01931956|588797244|FG001|Overall Study|Lost to Follow-up|0|||
163026040|NCT01931956|588797245|FG002|Overall Study|Lost to Follow-up|11|||
163026041|NCT01931956|588797246|FG003|Overall Study|Lost to Follow-up|7|||
163026042|NCT01931956|588797243|FG000|Overall Study|Expected|2|||
163026043|NCT01931956|588797244|FG001|Overall Study|Expected|0|||
163026044|NCT01931956|588797245|FG002|Overall Study|Expected|6|||
163026045|NCT01931956|588797246|FG003|Overall Study|Expected|0|||
163026046|NCT01931956|588797243|FG000|Overall Study|Not due|0|||
163026047|NCT01931956|588797244|FG001|Overall Study|Not due|0|||
163026048|NCT01931956|588797245|FG002|Overall Study|Not due|21|||
163026049|NCT01931956|588797246|FG003|Overall Study|Not due|0|||
163026050|NCT02294175|588797247|FG000|Overall Study|Withdrawal by Subject|1|||
163026051|NCT02294175|588797248|FG001|Overall Study|Withdrawal by Subject|2|||
163026052|NCT02294175|588797247|FG000|Overall Study|pt taking excluded medication|3|||
163026053|NCT02294175|588797248|FG001|Overall Study|pt taking excluded medication|1|||
163026054|NCT02294175|588797247|FG000|Overall Study|Protocol Violation|1|||
163026055|NCT02294175|588797248|FG001|Overall Study|Protocol Violation|0|||
163026056|NCT02294175|588797247|FG000|Overall Study|Lost to Follow-up|0|||
163026057|NCT02294175|588797248|FG001|Overall Study|Lost to Follow-up|1|||
163026058|NCT02294175|588797247|FG000|Overall Study|wound healed|0|||
163026059|NCT02294175|588797248|FG001|Overall Study|wound healed|2|||
163026060|NCT02548351|588797249|FG000|Overall Study|Withdrawal by Subject|149|||
163026061|NCT02548351|588797250|FG001|Overall Study|Withdrawal by Subject|154|||
163026062|NCT02548351|588797251|FG002|Overall Study|Withdrawal by Subject|152|||
163026063|NCT02548351|588797249|FG000|Overall Study|Death|11|||
163026064|NCT02548351|588797250|FG001|Overall Study|Death|15|||
163026065|NCT02548351|588797251|FG002|Overall Study|Death|12|||
163026066|NCT02548351|588797249|FG000|Overall Study|Adverse Event|22|||
163026067|NCT02548351|588797250|FG001|Overall Study|Adverse Event|56|||
163026068|NCT02548351|588797251|FG002|Overall Study|Adverse Event|36|||
163026069|NCT02548351|588797249|FG000|Overall Study|Study Terminated by Sponsor|549|||
163026070|NCT02548351|588797250|FG001|Overall Study|Study Terminated by Sponsor|509|||
163026071|NCT02548351|588797251|FG002|Overall Study|Study Terminated by Sponsor|528|||
163026072|NCT02548351|588797249|FG000|Overall Study|Site Closure|14|||
163026073|NCT02548351|588797250|FG001|Overall Study|Site Closure|5|||
163026074|NCT02548351|588797251|FG002|Overall Study|Site Closure|7|||
163026075|NCT02548351|588797249|FG000|Overall Study|Non-compliance with Study Drug|4|||
163026076|NCT02548351|588797250|FG001|Overall Study|Non-compliance with Study Drug|2|||
163026077|NCT02548351|588797251|FG002|Overall Study|Non-compliance with Study Drug|0|||
163026078|NCT02548351|588797249|FG000|Overall Study|Protocol Violation|2|||
163026079|NCT02548351|588797250|FG001|Overall Study|Protocol Violation|1|||
163026080|NCT02548351|588797251|FG002|Overall Study|Protocol Violation|2|||
163026081|NCT02548351|588797249|FG000|Overall Study|Physician Decision|11|||
163026082|NCT02548351|588797250|FG001|Overall Study|Physician Decision|18|||
163026083|NCT02548351|588797251|FG002|Overall Study|Physician Decision|11|||
163026084|NCT02548351|588797249|FG000|Overall Study|Lost to Follow-up|43|||
163026085|NCT02548351|588797250|FG001|Overall Study|Lost to Follow-up|50|||
163026086|NCT02548351|588797251|FG002|Overall Study|Lost to Follow-up|57|||
163026087|NCT02548351|588797249|FG000|Overall Study|Other|19|||
163026088|NCT02548351|588797250|FG001|Overall Study|Other|16|||
163026089|NCT02548351|588797251|FG002|Overall Study|Other|20|||
163026090|NCT02548351|588797249|FG000|Overall Study|Missing|1|||
163026091|NCT02548351|588797250|FG001|Overall Study|Missing|1|||
163026092|NCT02548351|588797251|FG002|Overall Study|Missing|0|||
163026093|NCT01901653|588797252|FG000|Overall Study|Death|2|||
163026094|NCT01901653|588797253|FG001|Overall Study|Death|1|||
163026095|NCT01901653|588797254|FG002|Overall Study|Death|8|||
163026096|NCT01901653|588797255|FG003|Overall Study|Death|3|||
163026097|NCT01901653|588797256|FG004|Overall Study|Death|2|||
163026098|NCT01901653|588797257|FG005|Overall Study|Death|2|||
163026099|NCT01901653|588797258|FG006|Overall Study|Death|6|||
163026100|NCT01901653|588797259|FG007|Overall Study|Death|9|||
163026101|NCT01901653|588797260|FG008|Overall Study|Death|1|||
163026102|NCT01901653|588797261|FG009|Overall Study|Death|16|||
163026103|NCT01901653|588797262|FG010|Overall Study|Death|2|||
163026104|NCT01901653|588797263|FG011|Overall Study|Death|15|||
163067128|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067129|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067130|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067131|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067132|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
163067133|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
163067134|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067135|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067136|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067137|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067138|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067139|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
163067140|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
163067141|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067142|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067143|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067144|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067145|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
163067146|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
163067147|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
163067148|NCT01697579|588950852|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067149|NCT01697579|588950853|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067150|NCT01697579|588950854|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067151|NCT01697579|588950855|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067152|NCT01697579|588950856|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067153|NCT01697579|588950857|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
163067154|NCT01697579|588950858|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
163067155|NCT01044498|588950859|FG000|Overall Study|Withdrew consent|1|||
163067156|NCT01044498|588950860|FG001|Overall Study|Withdrew consent|1|||
163067157|NCT01044498|588950859|FG000|Overall Study|Adverse Event|1|||
163067158|NCT01044498|588950860|FG001|Overall Study|Adverse Event|1|||
163067159|NCT01044498|588950859|FG000|Overall Study|Other|1|||
163067160|NCT01044498|588950860|FG001|Overall Study|Other|0|||
163067161|NCT02903914|588950865|FG000|Overall Study|Adverse Event|0|||
163067162|NCT02903914|588950866|FG001|Overall Study|Adverse Event|0|||
163067163|NCT02903914|588950867|FG002|Overall Study|Adverse Event|1|||
163067164|NCT02903914|588950868|FG003|Overall Study|Adverse Event|0|||
163067165|NCT02903914|588950869|FG004|Overall Study|Adverse Event|0|||
163067166|NCT02903914|588950870|FG005|Overall Study|Adverse Event|0|||
163067167|NCT02903914|588950871|FG006|Overall Study|Adverse Event|2|||
163067168|NCT02903914|588950872|FG007|Overall Study|Adverse Event|0|||
163067169|NCT02903914|588950865|FG000|Overall Study|Withdrawal by Subject|3|||
163067170|NCT02903914|588950866|FG001|Overall Study|Withdrawal by Subject|1|||
163067171|NCT02903914|588950867|FG002|Overall Study|Withdrawal by Subject|28|||
163067172|NCT02903914|588950868|FG003|Overall Study|Withdrawal by Subject|0|||
163067173|NCT02903914|588950869|FG004|Overall Study|Withdrawal by Subject|1|||
163067174|NCT02903914|588950870|FG005|Overall Study|Withdrawal by Subject|2|||
163067175|NCT02903914|588950871|FG006|Overall Study|Withdrawal by Subject|12|||
163067176|NCT02903914|588950872|FG007|Overall Study|Withdrawal by Subject|0|||
163067177|NCT02903914|588950865|FG000|Overall Study|Progressive Disease|1|||
163067178|NCT02903914|588950866|FG001|Overall Study|Progressive Disease|0|||
163067179|NCT02903914|588950867|FG002|Overall Study|Progressive Disease|4|||
163067180|NCT02903914|588950868|FG003|Overall Study|Progressive Disease|0|||
163067181|NCT02903914|588950869|FG004|Overall Study|Progressive Disease|0|||
163067182|NCT02903914|588950870|FG005|Overall Study|Progressive Disease|0|||
163067183|NCT02903914|588950871|FG006|Overall Study|Progressive Disease|2|||
163067184|NCT02903914|588950872|FG007|Overall Study|Progressive Disease|0|||
163067185|NCT02903914|588950865|FG000|Overall Study|Death|0|||
163067186|NCT02903914|588950866|FG001|Overall Study|Death|0|||
162644066|NCT02082210|587413518|FG005|Overall Study|Death|0|||
163067187|NCT02903914|588950867|FG002|Overall Study|Death|9|||
163067188|NCT02903914|588950868|FG003|Overall Study|Death|0|||
163067189|NCT02903914|588950869|FG004|Overall Study|Death|1|||
163067190|NCT02903914|588950870|FG005|Overall Study|Death|3|||
163067191|NCT02903914|588950871|FG006|Overall Study|Death|24|||
163067192|NCT02903914|588950872|FG007|Overall Study|Death|2|||
163067193|NCT02903914|588950865|FG000|Overall Study|Lost to Follow-up|0|||
163067194|NCT02903914|588950866|FG001|Overall Study|Lost to Follow-up|1|||
163067195|NCT02903914|588950867|FG002|Overall Study|Lost to Follow-up|0|||
163067196|NCT02903914|588950868|FG003|Overall Study|Lost to Follow-up|0|||
163067197|NCT02903914|588950869|FG004|Overall Study|Lost to Follow-up|2|||
163067198|NCT02903914|588950870|FG005|Overall Study|Lost to Follow-up|0|||
163067199|NCT02903914|588950871|FG006|Overall Study|Lost to Follow-up|1|||
163067200|NCT02903914|588950872|FG007|Overall Study|Lost to Follow-up|0|||
163067201|NCT02903914|588950865|FG000|Overall Study|Physician Decision|0|||
163067202|NCT02903914|588950866|FG001|Overall Study|Physician Decision|0|||
163067203|NCT02903914|588950867|FG002|Overall Study|Physician Decision|1|||
163067204|NCT02903914|588950868|FG003|Overall Study|Physician Decision|0|||
163067205|NCT02903914|588950869|FG004|Overall Study|Physician Decision|0|||
163067206|NCT02903914|588950870|FG005|Overall Study|Physician Decision|0|||
163067207|NCT02903914|588950871|FG006|Overall Study|Physician Decision|1|||
163067208|NCT02903914|588950872|FG007|Overall Study|Physician Decision|0|||
163067209|NCT02903914|588950865|FG000|Overall Study|Symptomatic Deterioration|0|||
163067210|NCT02903914|588950866|FG001|Overall Study|Symptomatic Deterioration|0|||
163067211|NCT02903914|588950867|FG002|Overall Study|Symptomatic Deterioration|1|||
163067212|NCT02903914|588950868|FG003|Overall Study|Symptomatic Deterioration|0|||
163067213|NCT02903914|588950869|FG004|Overall Study|Symptomatic Deterioration|0|||
163067214|NCT02903914|588950870|FG005|Overall Study|Symptomatic Deterioration|0|||
163067215|NCT02903914|588950871|FG006|Overall Study|Symptomatic Deterioration|0|||
163067216|NCT02903914|588950872|FG007|Overall Study|Symptomatic Deterioration|0|||
163067217|NCT02903914|588950865|FG000|Overall Study|New Cancer Therapy|2|||
163067218|NCT02903914|588950866|FG001|Overall Study|New Cancer Therapy|2|||
163067219|NCT02903914|588950867|FG002|Overall Study|New Cancer Therapy|21|||
163067220|NCT02903914|588950868|FG003|Overall Study|New Cancer Therapy|4|||
163067221|NCT02903914|588950869|FG004|Overall Study|New Cancer Therapy|3|||
163067222|NCT02903914|588950870|FG005|Overall Study|New Cancer Therapy|6|||
163067223|NCT02903914|588950871|FG006|Overall Study|New Cancer Therapy|56|||
163067224|NCT02903914|588950872|FG007|Overall Study|New Cancer Therapy|3|||
163067225|NCT02903914|588950865|FG000|Overall Study|Didn't Return to Site|1|||
163067226|NCT02903914|588950866|FG001|Overall Study|Didn't Return to Site|0|||
163067227|NCT02903914|588950867|FG002|Overall Study|Didn't Return to Site|1|||
163067228|NCT02903914|588950868|FG003|Overall Study|Didn't Return to Site|1|||
163067229|NCT02903914|588950869|FG004|Overall Study|Didn't Return to Site|0|||
163067230|NCT02903914|588950870|FG005|Overall Study|Didn't Return to Site|0|||
163067231|NCT02903914|588950871|FG006|Overall Study|Didn't Return to Site|2|||
163067232|NCT02903914|588950872|FG007|Overall Study|Didn't Return to Site|0|||
163067233|NCT02903914|588950865|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
163067234|NCT02903914|588950866|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
163067235|NCT02903914|588950867|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
163067236|NCT02903914|588950868|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
163067237|NCT02903914|588950869|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
163067238|NCT02903914|588950870|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
163067239|NCT02903914|588950871|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
163067240|NCT02903914|588950872|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
163067241|NCT02903914|588950865|FG000|Overall Study|Follow-up Did Not Occur|0|||
163067242|NCT02903914|588950866|FG001|Overall Study|Follow-up Did Not Occur|1|||
163067243|NCT02903914|588950867|FG002|Overall Study|Follow-up Did Not Occur|1|||
163067244|NCT02903914|588950868|FG003|Overall Study|Follow-up Did Not Occur|0|||
163067245|NCT02903914|588950869|FG004|Overall Study|Follow-up Did Not Occur|2|||
163067246|NCT02903914|588950870|FG005|Overall Study|Follow-up Did Not Occur|0|||
163067247|NCT02903914|588950871|FG006|Overall Study|Follow-up Did Not Occur|8|||
163067248|NCT02903914|588950872|FG007|Overall Study|Follow-up Did Not Occur|0|||
163067249|NCT02903914|588950865|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
163067250|NCT02903914|588950866|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
163067251|NCT02903914|588950867|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
163067252|NCT02903914|588950868|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
163067253|NCT02903914|588950869|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
163067254|NCT02903914|588950870|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
163067255|NCT02903914|588950871|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
163067256|NCT02903914|588950872|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
163067257|NCT02903914|588950865|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067258|NCT02903914|588950866|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067259|NCT02903914|588950867|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
163067260|NCT02903914|588950868|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067261|NCT02903914|588950869|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067262|NCT02903914|588950870|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
163067263|NCT02903914|588950871|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067264|NCT02903914|588950872|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
163067265|NCT02903914|588950865|FG000|Overall Study|Clinical Disease Progression|0|||
163067266|NCT02903914|588950866|FG001|Overall Study|Clinical Disease Progression|0|||
163067267|NCT02903914|588950867|FG002|Overall Study|Clinical Disease Progression|2|||
163067268|NCT02903914|588950868|FG003|Overall Study|Clinical Disease Progression|0|||
163067269|NCT02903914|588950869|FG004|Overall Study|Clinical Disease Progression|0|||
163067270|NCT02903914|588950870|FG005|Overall Study|Clinical Disease Progression|0|||
163067271|NCT02903914|588950871|FG006|Overall Study|Clinical Disease Progression|0|||
163067272|NCT02903914|588950872|FG007|Overall Study|Clinical Disease Progression|0|||
163067273|NCT02903914|588950865|FG000|Overall Study|Completed Follow-up Period|0|||
163067274|NCT02903914|588950866|FG001|Overall Study|Completed Follow-up Period|0|||
163067275|NCT02903914|588950867|FG002|Overall Study|Completed Follow-up Period|6|||
163067276|NCT02903914|588950868|FG003|Overall Study|Completed Follow-up Period|2|||
163067277|NCT02903914|588950869|FG004|Overall Study|Completed Follow-up Period|1|||
163067278|NCT02903914|588950870|FG005|Overall Study|Completed Follow-up Period|0|||
163067279|NCT02903914|588950871|FG006|Overall Study|Completed Follow-up Period|9|||
163067280|NCT02903914|588950872|FG007|Overall Study|Completed Follow-up Period|1|||
163067281|NCT02903914|588950865|FG000|Overall Study|Taken off Treatment per Protocol|0|||
163067282|NCT02903914|588950866|FG001|Overall Study|Taken off Treatment per Protocol|0|||
163067283|NCT02903914|588950867|FG002|Overall Study|Taken off Treatment per Protocol|0|||
163067284|NCT02903914|588950868|FG003|Overall Study|Taken off Treatment per Protocol|0|||
163067285|NCT02903914|588950869|FG004|Overall Study|Taken off Treatment per Protocol|0|||
163067286|NCT02903914|588950870|FG005|Overall Study|Taken off Treatment per Protocol|1|||
163067287|NCT02903914|588950871|FG006|Overall Study|Taken off Treatment per Protocol|0|||
163067288|NCT02903914|588950872|FG007|Overall Study|Taken off Treatment per Protocol|0|||
163067289|NCT02903914|588950865|FG000|Overall Study|Refused Further Treatment/Contact|0|||
163067290|NCT02903914|588950866|FG001|Overall Study|Refused Further Treatment/Contact|0|||
163067291|NCT02903914|588950867|FG002|Overall Study|Refused Further Treatment/Contact|0|||
163067292|NCT02903914|588950868|FG003|Overall Study|Refused Further Treatment/Contact|0|||
163067293|NCT02903914|588950869|FG004|Overall Study|Refused Further Treatment/Contact|0|||
163067294|NCT02903914|588950870|FG005|Overall Study|Refused Further Treatment/Contact|0|||
163067295|NCT02903914|588950871|FG006|Overall Study|Refused Further Treatment/Contact|1|||
163067296|NCT02903914|588950872|FG007|Overall Study|Refused Further Treatment/Contact|0|||
163067297|NCT02903914|588950865|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067298|NCT02903914|588950866|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067299|NCT02903914|588950867|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067300|NCT02903914|588950868|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067301|NCT02903914|588950869|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067302|NCT02903914|588950870|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067303|NCT02903914|588950871|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
163067304|NCT02903914|588950872|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
163067305|NCT03487445|588950875|FG000|Randomization|Not treated for administrative reasons|1|||
163067306|NCT03487445|588950876|FG001|Randomization|Not treated for administrative reasons|0|||
163067307|NCT04132050|588950881|FG000|Period I (Double-blind Period)|Adverse Event|3|||
163067308|NCT04132050|588950882|FG001|Period I (Double-blind Period)|Adverse Event|0|||
163067309|NCT04132050|588950881|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
163067310|NCT04132050|588950882|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
163067311|NCT04132050|588950881|FG000|R788 Treatment Period|Adverse Event|5|||
163067312|NCT04132050|588950882|FG001|R788 Treatment Period|Adverse Event|0|||
163067313|NCT04132050|588950881|FG000|R788 Treatment Period|Lack of Efficacy|5|||
163067314|NCT04132050|588950882|FG001|R788 Treatment Period|Lack of Efficacy|0|||
163067315|NCT04132050|588950881|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
163067316|NCT04132050|588950882|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
163067317|NCT02406612|588950892|FG000|Overall Study|Screening Failure|3|||
163067318|NCT02406612|588950893|FG001|Overall Study|Screening Failure|0|||
163067319|NCT02406612|588950892|FG000|Overall Study|Intra-procedural Exclusion|1|||
163067320|NCT02406612|588950893|FG001|Overall Study|Intra-procedural Exclusion|3|||
163067321|NCT02406612|588950892|FG000|Overall Study|Guidewire Failure|0|||
163067322|NCT02406612|588950893|FG001|Overall Study|Guidewire Failure|1|||
163067323|NCT03483012|588950897|FG000|Overall Study|Lack of Efficacy|6|||
163067324|NCT02900976|588950898|FG000|Overall Study|Adverse Event|0|||
163067325|NCT02900976|588950899|FG001|Overall Study|Adverse Event|1|||
163067326|NCT02900976|588950898|FG000|Overall Study|Physician Decision|0|||
163067327|NCT02900976|588950899|FG001|Overall Study|Physician Decision|2|||
163067328|NCT02900976|588950898|FG000|Overall Study|Progressive disease|0|||
163067329|NCT02900976|588950899|FG001|Overall Study|Progressive disease|6|||
163067330|NCT03611946|588950906|FG000|Overall Study|Withdrawal by Subject|0|||
163067331|NCT03611946|588950907|FG001|Overall Study|Withdrawal by Subject|0|||
163067332|NCT03611946|588950908|FG002|Overall Study|Withdrawal by Subject|1|||
163067333|NCT03611946|588950909|FG003|Overall Study|Withdrawal by Subject|0|||
163067334|NCT02872714|588950913|FG000|Overall Study|Progressive Disease|1|||
162644067|NCT02082210|587413513|FG000|Overall Study|Withdrawal by Subject|0|||
162644068|NCT02082210|587413514|FG001|Overall Study|Withdrawal by Subject|0|||
163067335|NCT02872714|588950914|FG001|Overall Study|Progressive Disease|2|||
163067336|NCT02872714|588950915|FG002|Overall Study|Progressive Disease|0|||
163067337|NCT02872714|588950916|FG003|Overall Study|Progressive Disease|0|||
163067338|NCT02872714|588950917|FG004|Overall Study|Progressive Disease|0|||
162644069|NCT02082210|587413515|FG002|Overall Study|Withdrawal by Subject|0|||
162644070|NCT02082210|587413516|FG003|Overall Study|Withdrawal by Subject|1|||
163067339|NCT02872714|588950913|FG000|Overall Study|Death|87|||
163067340|NCT02872714|588950914|FG001|Overall Study|Death|36|||
163067341|NCT02872714|588950915|FG002|Overall Study|Death|8|||
163067342|NCT02872714|588950916|FG003|Overall Study|Death|81|||
163067343|NCT02872714|588950917|FG004|Overall Study|Death|2|||
163067344|NCT02872714|588950913|FG000|Overall Study|Lost to Follow-up|2|||
163067345|NCT02872714|588950914|FG001|Overall Study|Lost to Follow-up|1|||
163067346|NCT02872714|588950915|FG002|Overall Study|Lost to Follow-up|0|||
162644071|NCT02082210|587413517|FG004|Overall Study|Withdrawal by Subject|2|||
162644072|NCT02082210|587413518|FG005|Overall Study|Withdrawal by Subject|2|||
163067347|NCT02872714|588950916|FG003|Overall Study|Lost to Follow-up|3|||
163067348|NCT02872714|588950917|FG004|Overall Study|Lost to Follow-up|0|||
163067349|NCT02872714|588950913|FG000|Overall Study|Physician Decision|0|||
163067350|NCT02872714|588950914|FG001|Overall Study|Physician Decision|0|||
163067351|NCT02872714|588950915|FG002|Overall Study|Physician Decision|0|||
163067352|NCT02872714|588950916|FG003|Overall Study|Physician Decision|1|||
163067353|NCT02872714|588950917|FG004|Overall Study|Physician Decision|0|||
163067354|NCT02872714|588950913|FG000|Overall Study|Withdrawal by Subject|1|||
163067355|NCT02872714|588950914|FG001|Overall Study|Withdrawal by Subject|3|||
163067356|NCT02872714|588950915|FG002|Overall Study|Withdrawal by Subject|0|||
163067357|NCT02872714|588950916|FG003|Overall Study|Withdrawal by Subject|2|||
163067358|NCT02872714|588950917|FG004|Overall Study|Withdrawal by Subject|0|||
163067359|NCT02872714|588950913|FG000|Overall Study|Captured as Other|2|||
163067360|NCT02872714|588950914|FG001|Overall Study|Captured as Other|0|||
163067361|NCT02872714|588950915|FG002|Overall Study|Captured as Other|0|||
163067362|NCT02872714|588950916|FG003|Overall Study|Captured as Other|1|||
163067363|NCT02872714|588950917|FG004|Overall Study|Captured as Other|0|||
163067364|NCT06717399|588950918|FG000|Overall Study|Death|1|||
163067365|NCT03043573|588950919|FG000|Overall Study|Lost to Follow-up|3|||
163067366|NCT03043573|588950920|FG001|Overall Study|Lost to Follow-up|3|||
163067367|NCT03043573|588950919|FG000|Overall Study|Physician Decision|0|||
163067368|NCT03043573|588950920|FG001|Overall Study|Physician Decision|5|||
163067369|NCT03043573|588950919|FG000|Overall Study|Withdrawal by Subject|0|||
163067370|NCT03043573|588950920|FG001|Overall Study|Withdrawal by Subject|4|||
163067371|NCT03580928|588950921|FG000|Overall Study|Death|0|||
163067372|NCT03580928|588950922|FG001|Overall Study|Death|3|||
163067373|NCT03580928|588950921|FG000|Overall Study|Withdrawal by Subject|2|||
163067374|NCT03580928|588950922|FG001|Overall Study|Withdrawal by Subject|1|||
163067375|NCT03580928|588950921|FG000|Overall Study|Lost to Follow-up|2|||
163067376|NCT03580928|588950922|FG001|Overall Study|Lost to Follow-up|0|||
163067377|NCT03580928|588950921|FG000|Overall Study|Progressive Disease|0|||
163067378|NCT03580928|588950922|FG001|Overall Study|Progressive Disease|1|||
163067379|NCT00484159|588952512|FG000|Overall Study|Lost to Follow-up|1|||
163067380|NCT00484159|588952513|FG001|Overall Study|Lost to Follow-up|1|||
163067381|NCT00484159|588952514|FG002|Overall Study|Lost to Follow-up|0|||
163067382|NCT01239680|588952517|FG000|Overall Study|Withdrawal by Subject|2|||
163067383|NCT01239680|588952518|FG001|Overall Study|Withdrawal by Subject|0|||
163067384|NCT00639379|588952519|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
163067385|NCT00639379|588952520|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
163067386|NCT00639379|588952519|FG000|Period 1 - 2 Weeks|lens issue|3|||
163067387|NCT00639379|588952520|FG001|Period 1 - 2 Weeks|lens issue|0|||
163067388|NCT01797185|588952521|FG000|Overall Study|Adverse Event|5|||
163067389|NCT01797185|588952522|FG001|Overall Study|Adverse Event|15|||
163067390|NCT01797185|588952523|FG002|Overall Study|Adverse Event|6|||
163067391|NCT01797185|588952521|FG000|Overall Study|Withdrawal by Subject|6|||
163067392|NCT01797185|588952522|FG001|Overall Study|Withdrawal by Subject|9|||
163067393|NCT01797185|588952523|FG002|Overall Study|Withdrawal by Subject|5|||
163067394|NCT01797185|588952521|FG000|Overall Study|Site terminated|8|||
163067395|NCT01797185|588952522|FG001|Overall Study|Site terminated|4|||
163067396|NCT01797185|588952523|FG002|Overall Study|Site terminated|0|||
162644073|NCT02082210|587413513|FG000|Overall Study|Clinical Progression|0|||
162644074|NCT02082210|587413514|FG001|Overall Study|Clinical Progression|0|||
162644075|NCT02082210|587413515|FG002|Overall Study|Clinical Progression|0|||
162644076|NCT02082210|587413516|FG003|Overall Study|Clinical Progression|1|||
162644077|NCT02082210|587413517|FG004|Overall Study|Clinical Progression|0|||
163067397|NCT01797185|588952521|FG000|Overall Study|Lost to Follow-up|2|||
163067398|NCT01797185|588952522|FG001|Overall Study|Lost to Follow-up|6|||
162644078|NCT02082210|587413518|FG005|Overall Study|Clinical Progression|0|||
162644079|NCT02082210|587413513|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
163067399|NCT01797185|588952523|FG002|Overall Study|Lost to Follow-up|1|||
163067400|NCT01797185|588952521|FG000|Overall Study|Withdrawn per sponsor|5|||
163067401|NCT01797185|588952522|FG001|Overall Study|Withdrawn per sponsor|0|||
163067402|NCT01797185|588952523|FG002|Overall Study|Withdrawn per sponsor|0|||
163067403|NCT01797185|588952521|FG000|Overall Study|Physician Decision|1|||
163067404|NCT01797185|588952522|FG001|Overall Study|Physician Decision|3|||
163067405|NCT01797185|588952523|FG002|Overall Study|Physician Decision|0|||
163067406|NCT01797185|588952521|FG000|Overall Study|Protocol Violation|1|||
163067407|NCT01797185|588952522|FG001|Overall Study|Protocol Violation|1|||
163067408|NCT01797185|588952523|FG002|Overall Study|Protocol Violation|0|||
163067409|NCT01033942|588952524|FG000|Overall Study|Withdrawal by Subject|1|||
163067410|NCT01033942|588952525|FG001|Overall Study|Withdrawal by Subject|1|||
163067411|NCT01033942|588952526|FG002|Overall Study|Withdrawal by Subject|1|||
163067412|NCT01033942|588952524|FG000|Overall Study|Lost to Follow-up|1|||
163067413|NCT01033942|588952525|FG001|Overall Study|Lost to Follow-up|0|||
163067414|NCT01033942|588952526|FG002|Overall Study|Lost to Follow-up|0|||
163067415|NCT01033942|588952524|FG000|Overall Study|Enrolled in Extension Study|0|||
163067416|NCT01033942|588952525|FG001|Overall Study|Enrolled in Extension Study|3|||
163067417|NCT01033942|588952526|FG002|Overall Study|Enrolled in Extension Study|0|||
163067418|NCT02115386|588952533|FG000|Overall Study|Protocol Violation|1|||
163067419|NCT02115386|588952533|FG000|Overall Study|Administrative - trial was terminated|6|||
163067420|NCT02493855|588952534|FG000|Overall Study|Non-compliance|1|||
163067421|NCT02493855|588952535|FG001|Overall Study|Non-compliance|0|||
163067422|NCT02493855|588952536|FG002|Overall Study|Non-compliance|0|||
163067423|NCT02493855|588952534|FG000|Overall Study|Adverse Event|0|||
163067424|NCT02493855|588952535|FG001|Overall Study|Adverse Event|1|||
163067425|NCT02493855|588952536|FG002|Overall Study|Adverse Event|0|||
163067426|NCT02493855|588952534|FG000|Overall Study|Withdrawal by Subject|1|||
163067427|NCT02493855|588952535|FG001|Overall Study|Withdrawal by Subject|0|||
163067428|NCT02493855|588952536|FG002|Overall Study|Withdrawal by Subject|0|||
163067429|NCT02299167|588952537|FG000|Overall Study|patients were excluded from the study|11|||
163067430|NCT03600428|588952538|FG000|Overall Study|Not eligible|0|||
163067431|NCT03600428|588952539|FG001|Overall Study|Not eligible|1|||
163067432|NCT03600428|588952538|FG000|Overall Study|Lost to Follow-up|5|||
163067433|NCT03600428|588952539|FG001|Overall Study|Lost to Follow-up|4|||
163067434|NCT00549328|588952540|FG000|Overall Study|Adverse Event|2|||
163067435|NCT00549328|588952540|FG000|Overall Study|Disease Progression|10|||
163067436|NCT00549328|588952540|FG000|Overall Study|Death|1|||
163067437|NCT00549328|588952540|FG000|Overall Study|Use of Prohibited Medication|1|||
163067438|NCT04868682|588952546|FG000|Post-treatment|Lost to Follow-up|1|||
163067439|NCT04868682|588952547|FG001|Post-treatment|Lost to Follow-up|1|||
163067440|NCT04868682|588952546|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
163067441|NCT04868682|588952547|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
163067442|NCT04868682|588952546|FG000|Six-month Assessment|Lost to Follow-up|1|||
163067443|NCT04868682|588952547|FG001|Six-month Assessment|Lost to Follow-up|0|||
162644080|NCT02082210|587413514|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
162644081|NCT02082210|587413515|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
162644082|NCT02082210|587413516|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
163067444|NCT04868682|588952546|FG000|Six-month Assessment|Death|1|||
163067445|NCT04868682|588952547|FG001|Six-month Assessment|Death|0|||
163067446|NCT04868682|588952546|FG000|Six-month Assessment|Refused|0|||
163067447|NCT04868682|588952547|FG001|Six-month Assessment|Refused|1|||
163067448|NCT04868682|588952546|FG000|12-month Assessment|Lost to Follow-up|2|||
163067449|NCT04868682|588952547|FG001|12-month Assessment|Lost to Follow-up|1|||
163067450|NCT04868682|588952546|FG000|12-month Assessment|Death|0|||
163067451|NCT04868682|588952547|FG001|12-month Assessment|Death|1|||
163067452|NCT03880565|588952551|FG000|Overall Study|Withdrawal by Subject|1|||
162644083|NCT02082210|587413517|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
162644084|NCT02082210|587413518|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
162644085|NCT02082210|587413513|FG000|Overall Study|Physician Decision|0|||
162644086|NCT02082210|587413514|FG001|Overall Study|Physician Decision|0|||
162644087|NCT02082210|587413515|FG002|Overall Study|Physician Decision|1|||
162644088|NCT02082210|587413516|FG003|Overall Study|Physician Decision|1|||
162644089|NCT02082210|587413517|FG004|Overall Study|Physician Decision|0|||
162644090|NCT02082210|587413518|FG005|Overall Study|Physician Decision|0|||
162644091|NCT00952341|587413525|FG000|Cycle 1|Adverse Event|4|||
162644092|NCT00952341|587413526|FG001|Cycle 1|Adverse Event|1|||
162644093|NCT00952341|587413525|FG000|Cycle 1|Withdrawal by Subject|3|||
162644094|NCT00952341|587413526|FG001|Cycle 1|Withdrawal by Subject|8|||
162644095|NCT00952341|587413525|FG000|Cycle 1|Protocol Violation|2|||
162644096|NCT00952341|587413526|FG001|Cycle 1|Protocol Violation|1|||
162644097|NCT00952341|587413525|FG000|Cycle 1|Lost to Follow-up|11|||
162644098|NCT00952341|587413526|FG001|Cycle 1|Lost to Follow-up|2|||
162644099|NCT00952341|587413525|FG000|Cycle 1|Physician Decision|0|||
163067453|NCT03880565|588952552|FG001|Overall Study|Withdrawal by Subject|0|||
163067454|NCT02202616|588952553|FG000|Overall Study|Screen failed|24|||
163067455|NCT02202616|588952553|FG000|Overall Study|Adverse Event|32|||
163067456|NCT02202616|588952553|FG000|Overall Study|Protocol deviation|18|||
163067457|NCT02202616|588952553|FG000|Overall Study|Patient withdrew consent|12|||
163067458|NCT02202616|588952553|FG000|Overall Study|Lost to Follow-up|6|||
163067459|NCT02202616|588952553|FG000|Overall Study|Administrative problems|6|||
162644100|NCT00952341|587413526|FG001|Cycle 1|Physician Decision|1|||
162644101|NCT00952341|587413525|FG000|Cycle 2|Withdrawal by Subject|1|||
162644102|NCT00952341|587413526|FG001|Cycle 2|Withdrawal by Subject|1|||
162644103|NCT00952341|587413525|FG000|Cycle 2|Protocol Violation|1|||
162644104|NCT00952341|587413526|FG001|Cycle 2|Protocol Violation|0|||
162644105|NCT00952341|587413525|FG000|Cycle 2|Lost to Follow-up|6|||
162644106|NCT00952341|587413526|FG001|Cycle 2|Lost to Follow-up|9|||
163026105|NCT01901653|588797264|FG012|Overall Study|Death|4|||
163026106|NCT01901653|588797252|FG000|Overall Study|Lost to Follow-up|1|||
163026107|NCT01901653|588797253|FG001|Overall Study|Lost to Follow-up|0|||
163026108|NCT01901653|588797254|FG002|Overall Study|Lost to Follow-up|2|||
163026109|NCT01901653|588797255|FG003|Overall Study|Lost to Follow-up|0|||
163026110|NCT01901653|588797256|FG004|Overall Study|Lost to Follow-up|0|||
163026111|NCT01901653|588797257|FG005|Overall Study|Lost to Follow-up|1|||
163026112|NCT01901653|588797258|FG006|Overall Study|Lost to Follow-up|0|||
163026113|NCT01901653|588797259|FG007|Overall Study|Lost to Follow-up|1|||
163026114|NCT01901653|588797260|FG008|Overall Study|Lost to Follow-up|0|||
163026115|NCT01901653|588797261|FG009|Overall Study|Lost to Follow-up|0|||
163026116|NCT01901653|588797262|FG010|Overall Study|Lost to Follow-up|0|||
163026117|NCT01901653|588797263|FG011|Overall Study|Lost to Follow-up|0|||
163026118|NCT01901653|588797264|FG012|Overall Study|Lost to Follow-up|0|||
163026119|NCT01901653|588797252|FG000|Overall Study|Withdrawal by Subject|0|||
163026120|NCT01901653|588797253|FG001|Overall Study|Withdrawal by Subject|0|||
163026121|NCT01901653|588797254|FG002|Overall Study|Withdrawal by Subject|0|||
163026122|NCT01901653|588797255|FG003|Overall Study|Withdrawal by Subject|0|||
163026123|NCT01901653|588797256|FG004|Overall Study|Withdrawal by Subject|0|||
163026124|NCT01901653|588797257|FG005|Overall Study|Withdrawal by Subject|0|||
163026125|NCT01901653|588797258|FG006|Overall Study|Withdrawal by Subject|1|||
163026126|NCT01901653|588797259|FG007|Overall Study|Withdrawal by Subject|0|||
163026127|NCT01901653|588797260|FG008|Overall Study|Withdrawal by Subject|0|||
163026128|NCT01901653|588797261|FG009|Overall Study|Withdrawal by Subject|0|||
163026129|NCT01901653|588797262|FG010|Overall Study|Withdrawal by Subject|0|||
163026130|NCT01901653|588797263|FG011|Overall Study|Withdrawal by Subject|0|||
163026131|NCT01901653|588797264|FG012|Overall Study|Withdrawal by Subject|0|||
163026132|NCT01901653|588797252|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
163026133|NCT01901653|588797253|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
163026134|NCT01901653|588797254|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
163026135|NCT01901653|588797255|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
163026136|NCT01901653|588797256|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
163026137|NCT01901653|588797257|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
163026138|NCT01901653|588797258|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
163026139|NCT01901653|588797259|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
163026140|NCT01901653|588797260|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
163026141|NCT01901653|588797261|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
163026142|NCT01901653|588797262|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
163026143|NCT01901653|588797263|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
163026144|NCT01901653|588797264|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
163026145|NCT01295827|588797269|FG000|Overall Study|Adverse Event|1|||
163026146|NCT01295827|588797270|FG001|Overall Study|Adverse Event|2|||
163026147|NCT01295827|588797271|FG002|Overall Study|Adverse Event|2|||
163026148|NCT01295827|588797272|FG003|Overall Study|Adverse Event|1|||
163026149|NCT01295827|588797273|FG004|Overall Study|Adverse Event|1|||
163026150|NCT01295827|588797274|FG005|Overall Study|Adverse Event|4|||
163026151|NCT01295827|588797275|FG006|Overall Study|Adverse Event|15|||
163026152|NCT01295827|588797276|FG007|Overall Study|Adverse Event|49|||
163026153|NCT01295827|588797277|FG008|Overall Study|Adverse Event|22|||
163026154|NCT01295827|588797278|FG009|Overall Study|Adverse Event|7|||
163026155|NCT01295827|588797279|FG010|Overall Study|Adverse Event|50|||
163026156|NCT01295827|588797280|FG011|Overall Study|Adverse Event|21|||
163067460|NCT02202616|588952553|FG000|Overall Study|Abnormal test procedure result|1|||
163026157|NCT01295827|588797281|FG012|Overall Study|Adverse Event|0|||
163026158|NCT01295827|588797282|FG013|Overall Study|Adverse Event|0|||
163026159|NCT01295827|588797283|FG014|Overall Study|Adverse Event|0|||
163026160|NCT01295827|588797269|FG000|Overall Study|Lost to Follow-up|0|||
163026161|NCT01295827|588797270|FG001|Overall Study|Lost to Follow-up|0|||
163067461|NCT02202616|588952553|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163026162|NCT01295827|588797271|FG002|Overall Study|Lost to Follow-up|3|||
163026163|NCT01295827|588797272|FG003|Overall Study|Lost to Follow-up|0|||
163026164|NCT01295827|588797273|FG004|Overall Study|Lost to Follow-up|1|||
163026165|NCT01295827|588797274|FG005|Overall Study|Lost to Follow-up|0|||
163026166|NCT01295827|588797275|FG006|Overall Study|Lost to Follow-up|4|||
163026167|NCT01295827|588797276|FG007|Overall Study|Lost to Follow-up|8|||
163026168|NCT01295827|588797277|FG008|Overall Study|Lost to Follow-up|7|||
163026169|NCT01295827|588797278|FG009|Overall Study|Lost to Follow-up|4|||
162644107|NCT00952341|587413525|FG000|Cycle 2|Physician Decision|1|||
162644108|NCT00952341|587413526|FG001|Cycle 2|Physician Decision|1|||
162644109|NCT00952341|587413525|FG000|Cycle 2|Progressive Disease|0|||
163067462|NCT04327271|588952557|FG000|Overall Study|Death|1|||
163067463|NCT04327271|588952558|FG001|Overall Study|Death|0|||
163067464|NCT04327271|588952557|FG000|Overall Study|Withdrawal by Subject|1|||
163067465|NCT04327271|588952558|FG001|Overall Study|Withdrawal by Subject|0|||
163067466|NCT04327271|588952557|FG000|Overall Study|randomization error (data capture)|4|||
163067467|NCT04327271|588952558|FG001|Overall Study|randomization error (data capture)|3|||
163067468|NCT01695746|588952562|FG000|Overall Study|Adverse Event|1|||
163067469|NCT01695746|588952562|FG000|Overall Study|Non-compliance by the participant|3|||
163067470|NCT01695746|588952562|FG000|Overall Study|Protocol Violation|5|||
163067471|NCT01695746|588952562|FG000|Overall Study|Participant not willing to participate|3|||
163067472|NCT03506477|588952568|FG000|Overall Study|Withdrawal by Subject|1|||
163067473|NCT03506477|588952569|FG001|Overall Study|Withdrawal by Subject|0|||
163067474|NCT03462680|588952570|FG000|Overall Study|Withdrawal by Subject|3|||
163067475|NCT03462680|588952571|FG001|Overall Study|Withdrawal by Subject|5|||
163067476|NCT02516241|588952572|FG000|Overall Study|Death|255|||
163067477|NCT02516241|588952573|FG001|Overall Study|Death|262|||
163067478|NCT02516241|588952574|FG002|Overall Study|Death|270|||
163067479|NCT02516241|588952572|FG000|Overall Study|Lost to Follow-up|1|||
163067480|NCT02516241|588952573|FG001|Overall Study|Lost to Follow-up|1|||
163067481|NCT02516241|588952574|FG002|Overall Study|Lost to Follow-up|3|||
163067482|NCT02516241|588952572|FG000|Overall Study|Withdrawal by Subject|2|||
163067483|NCT02516241|588952573|FG001|Overall Study|Withdrawal by Subject|7|||
163067484|NCT02516241|588952574|FG002|Overall Study|Withdrawal by Subject|12|||
163067485|NCT02516241|588952572|FG000|Overall Study|participants ongoing at data cut-off|84|||
163067486|NCT02516241|588952573|FG001|Overall Study|participants ongoing at data cut-off|76|||
163067487|NCT02516241|588952574|FG002|Overall Study|participants ongoing at data cut-off|59|||
163067488|NCT00462462|588952576|FG000|Overall Study|Physician Decision|0|||
163067489|NCT00462462|588952577|FG001|Overall Study|Physician Decision|1|||
162644110|NCT00952341|587413526|FG001|Cycle 2|Progressive Disease|1|||
162644111|NCT02066467|587413531|FG000|Overall Study|Did not undergo implant procedure|24|||
163067490|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067491|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
163067492|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067493|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067494|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067495|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163026170|NCT01295827|588797279|FG010|Overall Study|Lost to Follow-up|7|||
163026171|NCT01295827|588797280|FG011|Overall Study|Lost to Follow-up|3|||
163026172|NCT01295827|588797281|FG012|Overall Study|Lost to Follow-up|0|||
163026173|NCT01295827|588797282|FG013|Overall Study|Lost to Follow-up|0|||
163026174|NCT01295827|588797283|FG014|Overall Study|Lost to Follow-up|0|||
163026175|NCT01295827|588797269|FG000|Overall Study|Not Reported|0|||
163067496|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067497|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
163067498|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067499|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
163067500|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067501|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067502|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067503|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067504|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067505|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
163067506|NCT01163617|588952578|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067507|NCT01163617|588952579|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067508|NCT01163617|588952580|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
163067509|NCT01163617|588952581|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067510|NCT01163617|588952582|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067511|NCT01163617|588952583|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067512|NCT01163617|588952584|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067513|NCT01163617|588952585|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
163067514|NCT02394756|588952586|FG000|Period 1|Lens Discomfort|0|||
163067515|NCT02394756|588952587|FG001|Period 1|Lens Discomfort|0|||
163067516|NCT02394756|588952588|FG002|Period 1|Lens Discomfort|0|||
163067517|NCT02394756|588952589|FG003|Period 1|Lens Discomfort|0|||
163067518|NCT02394756|588952590|FG004|Period 1|Lens Discomfort|0|||
163067519|NCT02394756|588952591|FG005|Period 1|Lens Discomfort|1|||
163067520|NCT02394756|588952586|FG000|Period 1|Withdrawal by Subject|0|||
163067521|NCT02394756|588952587|FG001|Period 1|Withdrawal by Subject|1|||
163067522|NCT02394756|588952588|FG002|Period 1|Withdrawal by Subject|1|||
163067523|NCT02394756|588952589|FG003|Period 1|Withdrawal by Subject|1|||
163067524|NCT02394756|588952590|FG004|Period 1|Withdrawal by Subject|0|||
163067525|NCT02394756|588952591|FG005|Period 1|Withdrawal by Subject|0|||
163067526|NCT02394756|588952586|FG000|Period 2|Unsatisfactory Visual Response|0|||
163067527|NCT02394756|588952587|FG001|Period 2|Unsatisfactory Visual Response|0|||
163067528|NCT02394756|588952588|FG002|Period 2|Unsatisfactory Visual Response|0|||
163067529|NCT02394756|588952589|FG003|Period 2|Unsatisfactory Visual Response|0|||
163067530|NCT02394756|588952590|FG004|Period 2|Unsatisfactory Visual Response|1|||
163067531|NCT02394756|588952591|FG005|Period 2|Unsatisfactory Visual Response|0|||
163067532|NCT00191100|588952594|FG000|Overall Study|Adverse Event|18|||
163067533|NCT00191100|588952595|FG001|Overall Study|Adverse Event|1|||
163067534|NCT00191100|588952594|FG000|Overall Study|Lost to Follow-up|2|||
163067535|NCT00191100|588952595|FG001|Overall Study|Lost to Follow-up|0|||
163067536|NCT00191100|588952594|FG000|Overall Study|Patient Moved|0|||
163067537|NCT00191100|588952595|FG001|Overall Study|Patient Moved|1|||
163067538|NCT00191100|588952594|FG000|Overall Study|Withdrawal by Subject|9|||
163067539|NCT00191100|588952595|FG001|Overall Study|Withdrawal by Subject|3|||
163067540|NCT00191100|588952594|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
163067541|NCT00191100|588952595|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
163026176|NCT01295827|588797270|FG001|Overall Study|Not Reported|0|||
163026177|NCT01295827|588797271|FG002|Overall Study|Not Reported|0|||
163026178|NCT01295827|588797272|FG003|Overall Study|Not Reported|1|||
163026179|NCT01295827|588797273|FG004|Overall Study|Not Reported|0|||
163026180|NCT01295827|588797274|FG005|Overall Study|Not Reported|0|||
163026181|NCT01295827|588797275|FG006|Overall Study|Not Reported|24|||
163067542|NCT00191100|588952594|FG000|Overall Study|Clinical Relapse|2|||
163067543|NCT00191100|588952595|FG001|Overall Study|Clinical Relapse|1|||
163067544|NCT00191100|588952594|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
163067545|NCT00191100|588952595|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
163067546|NCT00191100|588952594|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
163067547|NCT00191100|588952595|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
163067548|NCT00191100|588952594|FG000|Overall Study|Physician Decision|3|||
163067549|NCT00191100|588952595|FG001|Overall Study|Physician Decision|1|||
163026182|NCT01295827|588797276|FG007|Overall Study|Not Reported|58|||
163026183|NCT01295827|588797277|FG008|Overall Study|Not Reported|41|||
163026184|NCT01295827|588797278|FG009|Overall Study|Not Reported|2|||
163026185|NCT01295827|588797279|FG010|Overall Study|Not Reported|23|||
163067550|NCT00191100|588952594|FG000|Overall Study|Death from Study Drug Toxicity|2|||
163026186|NCT01295827|588797280|FG011|Overall Study|Not Reported|13|||
162644112|NCT02066467|587413531|FG000|Overall Study|Attempted to implant withoput success|43|||
162644113|NCT02066467|587413531|FG000|Overall Study|Consent ineligible|1|||
162644114|NCT02066467|587413531|FG000|Overall Study|Death|54|||
162644115|NCT02066467|587413531|FG000|Overall Study|Lost to Follow-up|51|||
162644116|NCT02066467|587413531|FG000|Overall Study|Adverse Event|20|||
162644117|NCT02066467|587413531|FG000|Overall Study|Withdrawal by Subject|16|||
162644118|NCT02066467|587413531|FG000|Overall Study|Physician Decision|2|||
162644119|NCT02066467|587413531|FG000|Overall Study|Not defined|4|||
162644120|NCT00483379|587413539|FG000|Treatment Period|Adverse Event|1|||
162644121|NCT00483379|587413540|FG001|Treatment Period|Adverse Event|0|||
163026187|NCT01295827|588797281|FG012|Overall Study|Not Reported|0|||
163026188|NCT01295827|588797282|FG013|Overall Study|Not Reported|0|||
163026189|NCT01295827|588797283|FG014|Overall Study|Not Reported|0|||
163026190|NCT01295827|588797269|FG000|Overall Study|Progressive Disease|2|||
163026191|NCT01295827|588797270|FG001|Overall Study|Progressive Disease|1|||
163026192|NCT01295827|588797271|FG002|Overall Study|Progressive Disease|5|||
163026193|NCT01295827|588797272|FG003|Overall Study|Progressive Disease|2|||
163026194|NCT01295827|588797273|FG004|Overall Study|Progressive Disease|0|||
163026195|NCT01295827|588797274|FG005|Overall Study|Progressive Disease|1|||
163026196|NCT01295827|588797275|FG006|Overall Study|Progressive Disease|87|||
163026197|NCT01295827|588797276|FG007|Overall Study|Progressive Disease|144|||
163026198|NCT01295827|588797277|FG008|Overall Study|Progressive Disease|85|||
163026199|NCT01295827|588797278|FG009|Overall Study|Progressive Disease|40|||
163026200|NCT01295827|588797279|FG010|Overall Study|Progressive Disease|175|||
163026201|NCT01295827|588797280|FG011|Overall Study|Progressive Disease|136|||
163026202|NCT01295827|588797281|FG012|Overall Study|Progressive Disease|0|||
163026203|NCT01295827|588797282|FG013|Overall Study|Progressive Disease|0|||
163026204|NCT01295827|588797283|FG014|Overall Study|Progressive Disease|0|||
163026205|NCT01295827|588797269|FG000|Overall Study|Screen Failure|0|||
163026206|NCT01295827|588797270|FG001|Overall Study|Screen Failure|0|||
163026207|NCT01295827|588797271|FG002|Overall Study|Screen Failure|0|||
163026208|NCT01295827|588797272|FG003|Overall Study|Screen Failure|0|||
163026209|NCT01295827|588797273|FG004|Overall Study|Screen Failure|0|||
163026210|NCT01295827|588797274|FG005|Overall Study|Screen Failure|0|||
163026211|NCT01295827|588797275|FG006|Overall Study|Screen Failure|2|||
163026212|NCT01295827|588797276|FG007|Overall Study|Screen Failure|2|||
163026213|NCT01295827|588797277|FG008|Overall Study|Screen Failure|2|||
163026214|NCT01295827|588797278|FG009|Overall Study|Screen Failure|0|||
163026215|NCT01295827|588797279|FG010|Overall Study|Screen Failure|1|||
163026216|NCT01295827|588797280|FG011|Overall Study|Screen Failure|0|||
163026217|NCT01295827|588797281|FG012|Overall Study|Screen Failure|0|||
163026218|NCT01295827|588797282|FG013|Overall Study|Screen Failure|0|||
163026219|NCT01295827|588797283|FG014|Overall Study|Screen Failure|0|||
163026220|NCT01295827|588797269|FG000|Overall Study|Withdrawal by Subject|1|||
163026221|NCT01295827|588797270|FG001|Overall Study|Withdrawal by Subject|0|||
163026222|NCT01295827|588797271|FG002|Overall Study|Withdrawal by Subject|2|||
163026223|NCT01295827|588797272|FG003|Overall Study|Withdrawal by Subject|0|||
163026224|NCT01295827|588797273|FG004|Overall Study|Withdrawal by Subject|0|||
163026225|NCT01295827|588797274|FG005|Overall Study|Withdrawal by Subject|1|||
163026226|NCT01295827|588797275|FG006|Overall Study|Withdrawal by Subject|13|||
163026227|NCT01295827|588797276|FG007|Overall Study|Withdrawal by Subject|35|||
163026228|NCT01295827|588797277|FG008|Overall Study|Withdrawal by Subject|11|||
163026229|NCT01295827|588797278|FG009|Overall Study|Withdrawal by Subject|2|||
163026230|NCT01295827|588797279|FG010|Overall Study|Withdrawal by Subject|18|||
163026231|NCT01295827|588797280|FG011|Overall Study|Withdrawal by Subject|13|||
163026232|NCT01295827|588797281|FG012|Overall Study|Withdrawal by Subject|0|||
163026233|NCT01295827|588797282|FG013|Overall Study|Withdrawal by Subject|0|||
163026234|NCT01295827|588797283|FG014|Overall Study|Withdrawal by Subject|0|||
163026235|NCT01295827|588797269|FG000|Overall Study|Other|0|||
163026236|NCT01295827|588797270|FG001|Overall Study|Other|0|||
163026237|NCT01295827|588797271|FG002|Overall Study|Other|0|||
163026238|NCT01295827|588797272|FG003|Overall Study|Other|0|||
163026239|NCT01295827|588797273|FG004|Overall Study|Other|0|||
163026240|NCT01295827|588797274|FG005|Overall Study|Other|0|||
163026241|NCT01295827|588797275|FG006|Overall Study|Other|1|||
163026242|NCT01295827|588797276|FG007|Overall Study|Other|1|||
163026243|NCT01295827|588797277|FG008|Overall Study|Other|1|||
163026244|NCT01295827|588797278|FG009|Overall Study|Other|0|||
163026245|NCT01295827|588797279|FG010|Overall Study|Other|2|||
163026246|NCT01295827|588797280|FG011|Overall Study|Other|0|||
163026247|NCT01295827|588797281|FG012|Overall Study|Other|0|||
163026248|NCT01295827|588797282|FG013|Overall Study|Other|0|||
163026249|NCT01295827|588797283|FG014|Overall Study|Other|0|||
163026250|NCT01668173|588797284|FG000|Overall Study|Adverse Event|3|||
163026251|NCT01668173|588797284|FG000|Overall Study|Trial suspension|4|||
163026252|NCT00101166|588797285|FG000|Overall Study|progressive disease|10|||
163026253|NCT01868022|588797286|FG000|Overall Study|Withdrawal by Subject|0|||
162644122|NCT00483379|587413539|FG000|Treatment Period|Withdrawal by Subject|1|||
163026254|NCT01868022|588797287|FG001|Overall Study|Withdrawal by Subject|0|||
163026255|NCT01868022|588797288|FG002|Overall Study|Withdrawal by Subject|1|||
163026256|NCT01868022|588797289|FG003|Overall Study|Withdrawal by Subject|1|||
162644123|NCT00483379|587413540|FG001|Treatment Period|Withdrawal by Subject|0|||
162644124|NCT02418468|587413542|FG000|Overall Study|Adverse Event|1|||
162644125|NCT02418468|587413543|FG001|Overall Study|Adverse Event|0|||
162644126|NCT02418468|587413542|FG000|Overall Study|Withdrawal of informed consent|1|||
162644127|NCT02418468|587413543|FG001|Overall Study|Withdrawal of informed consent|1|||
162644128|NCT02914769|587413544|FG000|Overall Study|Protocol Violation|3|||
162644129|NCT02914769|587413545|FG001|Overall Study|Protocol Violation|2|||
162644130|NCT02914769|587413544|FG000|Overall Study|Withdrawal by Subject|0|||
162644131|NCT02914769|587413545|FG001|Overall Study|Withdrawal by Subject|1|||
162644132|NCT02337907|587413546|FG000|Overall Study|Other than listed|1|||
162644133|NCT02337907|587413547|FG001|Overall Study|Other than listed|0|||
163067551|NCT00191100|588952595|FG001|Overall Study|Death from Study Drug Toxicity|0|||
163067552|NCT00191100|588952594|FG000|Overall Study|Protocol Violation|1|||
163067553|NCT00191100|588952595|FG001|Overall Study|Protocol Violation|1|||
163067554|NCT00191100|588952594|FG000|Overall Study|Death from Other Cause|1|||
163067555|NCT00191100|588952595|FG001|Overall Study|Death from Other Cause|0|||
163067556|NCT00191100|588952594|FG000|Overall Study|Reason Not Specified|0|||
163067557|NCT00191100|588952595|FG001|Overall Study|Reason Not Specified|1|||
163067558|NCT04766333|588953764|FG000|Overall Study|Lost to Follow-up|40|||
163067559|NCT04766333|588953765|FG001|Overall Study|Lost to Follow-up|826|||
163067560|NCT03234881|588953766|FG000|Overall Study|Lost to Follow-up|9|||
163067561|NCT03234881|588953767|FG001|Overall Study|Lost to Follow-up|3|||
163067562|NCT03807843|588953768|FG000|Overall Study|Lost to Follow-up|1|||
163067563|NCT03807843|588953769|FG001|Overall Study|Lost to Follow-up|0|||
163067564|NCT05177094|588953774|FG000|Overall Study|Adverse Event|5|||
163067565|NCT05177094|588953775|FG001|Overall Study|Adverse Event|5|||
163067566|NCT05177094|588953774|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
163067567|NCT05177094|588953775|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
163067568|NCT05177094|588953774|FG000|Overall Study|Protocol Deviation|3|||
163067569|NCT05177094|588953775|FG001|Overall Study|Protocol Deviation|0|||
163067570|NCT05177094|588953774|FG000|Overall Study|Withdrawal by Subject|6|||
163067571|NCT05177094|588953775|FG001|Overall Study|Withdrawal by Subject|3|||
163067572|NCT05177094|588953774|FG000|Overall Study|Participant could not tolerate long study visits|1|||
163067573|NCT05177094|588953775|FG001|Overall Study|Participant could not tolerate long study visits|0|||
163067574|NCT02737618|588953776|FG000|Overall Study|Withdrawal by Subject|9|||
163067575|NCT05276804|588953780|FG000|Overall Study|screen failure|23|||
163067576|NCT05276804|588953781|FG001|Overall Study|screen failure|0|||
163067577|NCT02827708|588953782|FG000|Overall Study|Lost to Follow-up|3|||
163067578|NCT02827708|588953783|FG001|Overall Study|Lost to Follow-up|1|||
163067579|NCT02827708|588953782|FG000|Overall Study|Withdrawal by Subject|1|||
163067580|NCT02827708|588953783|FG001|Overall Study|Withdrawal by Subject|2|||
163067581|NCT02827708|588953782|FG000|Overall Study|Death|1|||
163067582|NCT02827708|588953783|FG001|Overall Study|Death|2|||
163067583|NCT00407511|588953785|FG000|Overall Study|Adverse Event|9|||
163067584|NCT00407511|588953785|FG000|Overall Study|Lost to Follow-up|4|||
163067585|NCT00407511|588953785|FG000|Overall Study|Other|5|||
163067586|NCT00407511|588953785|FG000|Overall Study|Withdrawal by Subject|4|||
163067587|NCT05059080|588953786|FG000|Overall Study|Withdrawal by Subject|3|||
163067588|NCT05059080|588953786|FG000|Overall Study|Study Terminated by Sponsor|64|||
163067589|NCT01047501|588953787|FG000|Overall Study|Adverse Event|7|||
163067590|NCT01047501|588953788|FG001|Overall Study|Adverse Event|8|||
163067591|NCT01047501|588953789|FG002|Overall Study|Adverse Event|5|||
163067592|NCT01047501|588953787|FG000|Overall Study|Withdrew Consent|6|||
163067593|NCT01047501|588953788|FG001|Overall Study|Withdrew Consent|2|||
163067594|NCT01047501|588953789|FG002|Overall Study|Withdrew Consent|4|||
163067595|NCT01047501|588953787|FG000|Overall Study|Lost to Follow-up|0|||
163067596|NCT01047501|588953788|FG001|Overall Study|Lost to Follow-up|1|||
163067597|NCT01047501|588953789|FG002|Overall Study|Lost to Follow-up|1|||
163067598|NCT01047501|588953787|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
163067599|NCT01047501|588953788|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
163067600|NCT01047501|588953789|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
163067601|NCT01047501|588953787|FG000|Overall Study|Death|1|||
163067602|NCT01047501|588953788|FG001|Overall Study|Death|0|||
163067603|NCT01047501|588953789|FG002|Overall Study|Death|0|||
163067604|NCT01047501|588953787|FG000|Overall Study|Other discontinuation|1|||
163067605|NCT01047501|588953788|FG001|Overall Study|Other discontinuation|0|||
163067606|NCT01047501|588953789|FG002|Overall Study|Other discontinuation|1|||
163067607|NCT01047501|588953787|FG000|Overall Study|Investigator judgement|0|||
163067608|NCT01047501|588953788|FG001|Overall Study|Investigator judgement|0|||
163067609|NCT01047501|588953789|FG002|Overall Study|Investigator judgement|1|||
163067610|NCT00770484|588953792|FG000|Overall Study|Withdrawal by Subject|1|||
162644134|NCT02337907|587413548|FG002|Overall Study|Other than listed|0|||
162644135|NCT02337907|587413549|FG003|Overall Study|Other than listed|1|||
163067611|NCT00770484|588953793|FG001|Overall Study|Withdrawal by Subject|0|||
163067612|NCT05696847|588953795|FG000|Overall Study|Withdrawal by Subject|1|||
163067613|NCT05696847|588953796|FG001|Overall Study|Withdrawal by Subject|0|||
163067614|NCT05696847|588953797|FG002|Overall Study|Withdrawal by Subject|0|||
163067615|NCT05696847|588953798|FG003|Overall Study|Withdrawal by Subject|0|||
163067616|NCT05696847|588953799|FG004|Overall Study|Withdrawal by Subject|0|||
163067617|NCT05696847|588953800|FG005|Overall Study|Withdrawal by Subject|0|||
163067618|NCT05696847|588953795|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163067619|NCT05696847|588953796|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163067620|NCT05696847|588953797|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163067621|NCT05696847|588953798|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163067622|NCT05696847|588953799|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163067623|NCT05696847|588953800|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163067624|NCT05696847|588953795|FG000|Overall Study|Adverse Event|0|||
163067625|NCT05696847|588953796|FG001|Overall Study|Adverse Event|0|||
163067626|NCT05696847|588953797|FG002|Overall Study|Adverse Event|0|||
163067627|NCT05696847|588953798|FG003|Overall Study|Adverse Event|0|||
163067628|NCT05696847|588953799|FG004|Overall Study|Adverse Event|0|||
163067629|NCT05696847|588953800|FG005|Overall Study|Adverse Event|1|||
163067630|NCT05696847|588953795|FG000|Overall Study|Sponsor Decision|0|||
163067631|NCT05696847|588953796|FG001|Overall Study|Sponsor Decision|0|||
163067632|NCT05696847|588953797|FG002|Overall Study|Sponsor Decision|0|||
163067633|NCT05696847|588953798|FG003|Overall Study|Sponsor Decision|1|||
163067634|NCT05696847|588953799|FG004|Overall Study|Sponsor Decision|0|||
163067635|NCT05696847|588953800|FG005|Overall Study|Sponsor Decision|0|||
163067636|NCT05513950|588953801|FG000|Overall Study|Not treated due to technical reasons|0|||
163067637|NCT05513950|588953802|FG001|Overall Study|Not treated due to technical reasons|0|||
163067638|NCT05513950|588953803|FG002|Overall Study|Not treated due to technical reasons|1|||
163067639|NCT05513950|588953804|FG003|Overall Study|Not treated due to technical reasons|0|||
163067640|NCT05561140|588953805|FG000|Randomized Treatment Period|Adverse Event|1|||
163067641|NCT05561140|588953806|FG001|Randomized Treatment Period|Adverse Event|0|||
163067642|NCT05561140|588953805|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163067643|NCT05561140|588953806|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163067644|NCT05561140|588953805|FG000|Open Label Treatment Period|Adverse Event|6|||
163067645|NCT05561140|588953806|FG001|Open Label Treatment Period|Adverse Event|4|||
163067646|NCT05561140|588953805|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
163067647|NCT05561140|588953806|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
163067648|NCT05561140|588953805|FG000|Open Label Treatment Period|Physician Decision|0|||
163067649|NCT05561140|588953806|FG001|Open Label Treatment Period|Physician Decision|1|||
163067650|NCT05561140|588953805|FG000|Open Label Treatment Period|Pregnancy|1|||
163067651|NCT05561140|588953806|FG001|Open Label Treatment Period|Pregnancy|0|||
163067652|NCT05561140|588953805|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
163067653|NCT05561140|588953806|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
163067654|NCT05561140|588953805|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
163067655|NCT05561140|588953806|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
163067656|NCT05561140|588953805|FG000|Open Label Treatment Period|Other|1|||
163067657|NCT05561140|588953806|FG001|Open Label Treatment Period|Other|0|||
163067658|NCT00221104|588953807|FG000|Overall Study|Adverse Event|1|||
163067659|NCT00221104|588953808|FG001|Overall Study|Adverse Event|0|||
163067660|NCT00221104|588953807|FG000|Overall Study|Physician Decision|1|||
163067661|NCT00221104|588953808|FG001|Overall Study|Physician Decision|0|||
163067662|NCT00221104|588953807|FG000|Overall Study|Protocol Violation|2|||
163067663|NCT00221104|588953808|FG001|Overall Study|Protocol Violation|0|||
163067664|NCT00221104|588953807|FG000|Overall Study|Withdrawal by Subject|42|||
163067665|NCT00221104|588953808|FG001|Overall Study|Withdrawal by Subject|29|||
163067666|NCT00221104|588953807|FG000|Overall Study|Others|37|||
163067667|NCT00221104|588953808|FG001|Overall Study|Others|47|||
163067668|NCT02989389|588953809|FG000|Period 1|Lost to Follow-up|0|||
163067669|NCT02989389|588953810|FG001|Period 1|Lost to Follow-up|1|||
163067670|NCT02989389|588953811|FG002|Period 1|Lost to Follow-up|0|||
163067671|NCT02989389|588953812|FG003|Period 1|Lost to Follow-up|0|||
163067672|NCT02989389|588953813|FG004|Period 1|Lost to Follow-up|0|||
163067673|NCT02989389|588953814|FG005|Period 1|Lost to Follow-up|0|||
163067674|NCT02989389|588953815|FG006|Period 1|Lost to Follow-up|0|||
163067675|NCT02989389|588953816|FG007|Period 1|Lost to Follow-up|0|||
163067676|NCT02989389|588953817|FG008|Period 1|Lost to Follow-up|0|||
163067677|NCT02989389|588953818|FG009|Period 1|Lost to Follow-up|0|||
163067678|NCT02989389|588953809|FG000|Period 1|Physician Decision|0|||
163067679|NCT02989389|588953810|FG001|Period 1|Physician Decision|0|||
163067680|NCT02989389|588953811|FG002|Period 1|Physician Decision|0|||
163067681|NCT02989389|588953812|FG003|Period 1|Physician Decision|0|||
163067682|NCT02989389|588953813|FG004|Period 1|Physician Decision|0|||
163067683|NCT02989389|588953814|FG005|Period 1|Physician Decision|0|||
163067684|NCT02989389|588953815|FG006|Period 1|Physician Decision|0|||
163067685|NCT02989389|588953816|FG007|Period 1|Physician Decision|0|||
163067686|NCT02989389|588953817|FG008|Period 1|Physician Decision|1|||
162644136|NCT02337907|587413550|FG004|Overall Study|Other than listed|1|||
162644137|NCT02337907|587413551|FG005|Overall Study|Other than listed|0|||
162644138|NCT02337907|587413546|FG000|Overall Study|Withdrawal by Subject|2|||
162644139|NCT02337907|587413547|FG001|Overall Study|Withdrawal by Subject|3|||
162644140|NCT02337907|587413548|FG002|Overall Study|Withdrawal by Subject|0|||
163026257|NCT01868022|588797290|FG004|Overall Study|Withdrawal by Subject|0|||
163026258|NCT01868022|588797291|FG005|Overall Study|Withdrawal by Subject|0|||
163026259|NCT01868022|588797292|FG006|Overall Study|Withdrawal by Subject|0|||
163026260|NCT01868022|588797293|FG007|Overall Study|Withdrawal by Subject|1|||
163026261|NCT01868022|588797294|FG008|Overall Study|Withdrawal by Subject|0|||
163026262|NCT01868022|588797286|FG000|Overall Study|Adverse Event|0|||
163026263|NCT01868022|588797287|FG001|Overall Study|Adverse Event|0|||
163026264|NCT01868022|588797288|FG002|Overall Study|Adverse Event|0|||
163026265|NCT01868022|588797289|FG003|Overall Study|Adverse Event|0|||
163026266|NCT01868022|588797290|FG004|Overall Study|Adverse Event|2|||
163026267|NCT01868022|588797291|FG005|Overall Study|Adverse Event|0|||
163026268|NCT01868022|588797292|FG006|Overall Study|Adverse Event|0|||
163026269|NCT01868022|588797293|FG007|Overall Study|Adverse Event|2|||
163026270|NCT01868022|588797294|FG008|Overall Study|Adverse Event|2|||
163026271|NCT01868022|588797286|FG000|Overall Study|Physician Decision|0|||
163026272|NCT01868022|588797287|FG001|Overall Study|Physician Decision|0|||
163026273|NCT01868022|588797288|FG002|Overall Study|Physician Decision|0|||
163026274|NCT01868022|588797289|FG003|Overall Study|Physician Decision|0|||
163026275|NCT01868022|588797290|FG004|Overall Study|Physician Decision|0|||
163026276|NCT01868022|588797291|FG005|Overall Study|Physician Decision|1|||
163026277|NCT01868022|588797292|FG006|Overall Study|Physician Decision|0|||
163026278|NCT01868022|588797293|FG007|Overall Study|Physician Decision|2|||
163026279|NCT01868022|588797294|FG008|Overall Study|Physician Decision|0|||
163026280|NCT01868022|588797286|FG000|Overall Study|Study closed/terminated|0|||
163026281|NCT01868022|588797287|FG001|Overall Study|Study closed/terminated|0|||
163026282|NCT01868022|588797288|FG002|Overall Study|Study closed/terminated|0|||
163026283|NCT01868022|588797289|FG003|Overall Study|Study closed/terminated|0|||
163026284|NCT01868022|588797290|FG004|Overall Study|Study closed/terminated|0|||
163026285|NCT01868022|588797291|FG005|Overall Study|Study closed/terminated|0|||
163026286|NCT01868022|588797292|FG006|Overall Study|Study closed/terminated|0|||
163026287|NCT01868022|588797293|FG007|Overall Study|Study closed/terminated|1|||
163026288|NCT01868022|588797294|FG008|Overall Study|Study closed/terminated|0|||
163026289|NCT01868022|588797286|FG000|Overall Study|Ongoing|0|||
163026290|NCT01868022|588797287|FG001|Overall Study|Ongoing|0|||
163026291|NCT01868022|588797288|FG002|Overall Study|Ongoing|0|||
163026292|NCT01868022|588797289|FG003|Overall Study|Ongoing|0|||
163026293|NCT01868022|588797290|FG004|Overall Study|Ongoing|0|||
163026294|NCT01868022|588797291|FG005|Overall Study|Ongoing|0|||
163026295|NCT01868022|588797292|FG006|Overall Study|Ongoing|0|||
163026296|NCT01868022|588797293|FG007|Overall Study|Ongoing|3|||
163026297|NCT01868022|588797294|FG008|Overall Study|Ongoing|0|||
163026298|NCT03226769|588797297|FG000|Overall Study|Withdrawal by Subject|0|||
163026299|NCT03226769|588797298|FG001|Overall Study|Withdrawal by Subject|1|||
163026300|NCT01516008|588797299|FG000|Overall Study|Adverse Event|0|||
163026301|NCT01516008|588797300|FG001|Overall Study|Adverse Event|2|||
163026302|NCT01516008|588797301|FG002|Overall Study|Adverse Event|7|||
163026303|NCT01516008|588797299|FG000|Overall Study|Lack of Efficacy|44|||
163026304|NCT01516008|588797300|FG001|Overall Study|Lack of Efficacy|14|||
163026305|NCT01516008|588797301|FG002|Overall Study|Lack of Efficacy|10|||
163026306|NCT01516008|588797299|FG000|Overall Study|Protocol Violation|1|||
163026307|NCT01516008|588797300|FG001|Overall Study|Protocol Violation|0|||
163026308|NCT01516008|588797301|FG002|Overall Study|Protocol Violation|0|||
163026309|NCT01516008|588797299|FG000|Overall Study|Reason not specified|0|||
163026310|NCT01516008|588797300|FG001|Overall Study|Reason not specified|0|||
163026311|NCT01516008|588797301|FG002|Overall Study|Reason not specified|1|||
163026312|NCT01217476|588797302|FG000|Overall Study|Adverse Event|6|||
163026313|NCT01217476|588797303|FG001|Overall Study|Adverse Event|1|||
163026314|NCT01217476|588797302|FG000|Overall Study|Physician Decision|0|||
163026315|NCT01217476|588797303|FG001|Overall Study|Physician Decision|1|||
163026316|NCT01217476|588797302|FG000|Overall Study|Withdrawal by Subject|3|||
163026317|NCT01217476|588797303|FG001|Overall Study|Withdrawal by Subject|3|||
163026318|NCT01217476|588797302|FG000|Overall Study|Surgery on the Target Limb|0|||
163026319|NCT01217476|588797303|FG001|Overall Study|Surgery on the Target Limb|2|||
163026320|NCT01217476|588797302|FG000|Overall Study|Protocol Deviation|1|||
163026321|NCT01217476|588797303|FG001|Overall Study|Protocol Deviation|0|||
163026322|NCT01217476|588797302|FG000|Overall Study|Other|2|||
163026323|NCT01217476|588797303|FG001|Overall Study|Other|0|||
163026324|NCT03033602|588797304|FG000|Overall Study|Withdrawal by Subject|11|||
162644141|NCT02337907|587413549|FG003|Overall Study|Withdrawal by Subject|2|||
163026325|NCT03033602|588797305|FG001|Overall Study|Withdrawal by Subject|21|||
162644142|NCT02337907|587413550|FG004|Overall Study|Withdrawal by Subject|5|||
162644143|NCT02337907|587413551|FG005|Overall Study|Withdrawal by Subject|0|||
163026326|NCT03033602|588797304|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
162644144|NCT02337907|587413546|FG000|Overall Study|Lost to Follow-up|0|||
163067687|NCT02989389|588953818|FG009|Period 1|Physician Decision|0|||
163067688|NCT01666652|588953819|FG000|Overall Study|Serious Adverse Event|0|||
163067689|NCT01666652|588953820|FG001|Overall Study|Serious Adverse Event|0|||
163067690|NCT01666652|588953821|FG002|Overall Study|Serious Adverse Event|0|||
163067691|NCT01666652|588953822|FG003|Overall Study|Serious Adverse Event|1|||
163067692|NCT01666652|588953823|FG004|Overall Study|Serious Adverse Event|0|||
163067693|NCT01666652|588953819|FG000|Overall Study|Withdrawal by Subject|0|||
163067694|NCT01666652|588953820|FG001|Overall Study|Withdrawal by Subject|0|||
163067695|NCT01666652|588953821|FG002|Overall Study|Withdrawal by Subject|0|||
163067696|NCT01666652|588953822|FG003|Overall Study|Withdrawal by Subject|0|||
163067697|NCT01666652|588953823|FG004|Overall Study|Withdrawal by Subject|1|||
163067698|NCT01666652|588953819|FG000|Overall Study|Moved from study area|1|||
163067699|NCT01666652|588953820|FG001|Overall Study|Moved from study area|0|||
163067700|NCT01666652|588953821|FG002|Overall Study|Moved from study area|0|||
163067701|NCT01666652|588953822|FG003|Overall Study|Moved from study area|2|||
163067702|NCT01666652|588953823|FG004|Overall Study|Moved from study area|0|||
163067703|NCT01666652|588953819|FG000|Overall Study|Lost to Follow-up|1|||
163067704|NCT01666652|588953820|FG001|Overall Study|Lost to Follow-up|1|||
163067705|NCT01666652|588953821|FG002|Overall Study|Lost to Follow-up|1|||
163067706|NCT01666652|588953822|FG003|Overall Study|Lost to Follow-up|1|||
163067707|NCT01666652|588953823|FG004|Overall Study|Lost to Follow-up|0|||
163067708|NCT00088153|588953824|FG000|Overall Study|Physician Decision|3|||
163067709|NCT00088153|588953825|FG001|Overall Study|Physician Decision|3|||
163067710|NCT00088153|588953824|FG000|Overall Study|Withdrawal by Subject|10|||
163067711|NCT00088153|588953825|FG001|Overall Study|Withdrawal by Subject|10|||
163067712|NCT00088153|588953824|FG000|Overall Study|Lost to Follow-up|11|||
163067713|NCT00088153|588953825|FG001|Overall Study|Lost to Follow-up|12|||
163067714|NCT01132755|588953826|FG000|Overall Study|Procedure not done due to medical reason|23|||
163067715|NCT01132755|588953826|FG000|Overall Study|Protocol Violation|15|||
163067716|NCT01132755|588953826|FG000|Overall Study|Withdrawal by Subject|4|||
163067717|NCT01757847|588953827|FG000|Overall Study|Withdrawal by Subject|3|||
163067718|NCT01757847|588953828|FG001|Overall Study|Withdrawal by Subject|4|||
163067719|NCT04057365|588953829|FG000|Overall Study|Withdrawal by Subject|2|||
163067720|NCT04057365|588953830|FG001|Overall Study|Withdrawal by Subject|0|||
163067721|NCT01063114|588953831|FG000|Overall Study|Lost to Follow-up|1|||
163067722|NCT04598828|588953834|FG000|Overall Study|Physician Decision|1|||
163067723|NCT04598828|588953835|FG001|Overall Study|Physician Decision|0|||
163067724|NCT04598828|588953834|FG000|Overall Study|Withdrawal by Subject|0|||
163067725|NCT04598828|588953835|FG001|Overall Study|Withdrawal by Subject|1|||
163067726|NCT04598828|588953834|FG000|Overall Study|Withdrawal by Subject|0|||
163067727|NCT04598828|588953835|FG001|Overall Study|Withdrawal by Subject|1|||
163067728|NCT02676973|588953836|FG000|Overall Study|Withdrawal by Subject|9|||
163067729|NCT02676973|588953837|FG001|Overall Study|Withdrawal by Subject|8|||
163067730|NCT02676973|588953838|FG002|Overall Study|Withdrawal by Subject|11|||
163067731|NCT02676973|588953836|FG000|Overall Study|Lost to Follow-up|8|||
163067732|NCT02676973|588953837|FG001|Overall Study|Lost to Follow-up|12|||
163067733|NCT02676973|588953838|FG002|Overall Study|Lost to Follow-up|8|||
163067734|NCT02676973|588953836|FG000|Overall Study|Death|2|||
163067735|NCT02676973|588953837|FG001|Overall Study|Death|1|||
163067736|NCT02676973|588953838|FG002|Overall Study|Death|5|||
163067737|NCT01078662|588953840|FG000|Overall Study|Death|41|||
163067738|NCT01078662|588953841|FG001|Overall Study|Death|103|||
163067739|NCT01078662|588953842|FG002|Overall Study|Death|18|||
163067740|NCT01078662|588953843|FG003|Overall Study|Death|5|||
163067741|NCT01078662|588953844|FG004|Overall Study|Death|8|||
163067742|NCT01078662|588953840|FG000|Overall Study|Patients reached data cut-off|12|||
163067743|NCT01078662|588953841|FG001|Overall Study|Patients reached data cut-off|53|||
163067744|NCT01078662|588953842|FG002|Overall Study|Patients reached data cut-off|2|||
163067745|NCT01078662|588953843|FG003|Overall Study|Patients reached data cut-off|2|||
163067746|NCT01078662|588953844|FG004|Overall Study|Patients reached data cut-off|3|||
163067747|NCT01078662|588953840|FG000|Overall Study|Withdrawal by Subject|4|||
163067748|NCT01078662|588953841|FG001|Overall Study|Withdrawal by Subject|11|||
163067749|NCT01078662|588953842|FG002|Overall Study|Withdrawal by Subject|1|||
163067750|NCT01078662|588953843|FG003|Overall Study|Withdrawal by Subject|0|||
163067751|NCT01078662|588953844|FG004|Overall Study|Withdrawal by Subject|0|||
163067752|NCT01078662|588953840|FG000|Overall Study|Protocol Violation|0|||
163067753|NCT01078662|588953841|FG001|Overall Study|Protocol Violation|1|||
163067754|NCT01078662|588953842|FG002|Overall Study|Protocol Violation|0|||
163067755|NCT01078662|588953843|FG003|Overall Study|Protocol Violation|0|||
163067756|NCT01078662|588953844|FG004|Overall Study|Protocol Violation|0|||
163067757|NCT01078662|588953840|FG000|Overall Study|Lost to Follow-up|1|||
163067758|NCT01078662|588953841|FG001|Overall Study|Lost to Follow-up|0|||
163067759|NCT01078662|588953842|FG002|Overall Study|Lost to Follow-up|0|||
163067760|NCT01078662|588953843|FG003|Overall Study|Lost to Follow-up|0|||
163067761|NCT01078662|588953844|FG004|Overall Study|Lost to Follow-up|0|||
163067762|NCT02875080|588953849|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
163067763|NCT02875080|588953850|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
163067764|NCT02875080|588953851|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
163067765|NCT03018938|588953852|FG000|Overall Study|Death|0|||
163067766|NCT03018938|588953853|FG001|Overall Study|Death|1|||
163067767|NCT03018938|588953852|FG000|Overall Study|Lost to Follow-up|21|||
163067768|NCT03018938|588953853|FG001|Overall Study|Lost to Follow-up|32|||
163067769|NCT03018938|588953852|FG000|Overall Study|Withdrawal by Subject|38|||
163067770|NCT03018938|588953853|FG001|Overall Study|Withdrawal by Subject|45|||
163067771|NCT03018938|588953852|FG000|Overall Study|Physician Decision|3|||
163067772|NCT03018938|588953853|FG001|Overall Study|Physician Decision|2|||
163067773|NCT03018938|588953852|FG000|Overall Study|Sponsor Decision|0|||
163067774|NCT03018938|588953853|FG001|Overall Study|Sponsor Decision|1|||
163067775|NCT03018938|588953852|FG000|Overall Study|Screen failure-After randomization|4|||
163067776|NCT03018938|588953853|FG001|Overall Study|Screen failure-After randomization|2|||
163067777|NCT03018938|588953852|FG000|Overall Study|Not recorded|0|||
163067778|NCT03018938|588953853|FG001|Overall Study|Not recorded|2|||
163067779|NCT03069989|588953866|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
163067780|NCT03069989|588953867|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
163067781|NCT01127061|588955069|FG000|Overall Study|Lost to Follow-up|7|||
163067782|NCT01127061|588955070|FG001|Overall Study|Lost to Follow-up|10|||
163067783|NCT01127061|588955069|FG000|Overall Study|Physician Decision|3|||
163067784|NCT01127061|588955070|FG001|Overall Study|Physician Decision|3|||
163067785|NCT03921541|588955073|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
163067786|NCT03921541|588955074|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
163067787|NCT00003456|588955075|FG000|Overall Study|Not evaluable|8|||
163067788|NCT00420407|588955077|FG000|Overall Study|Lost to Follow-up|0|||
163067789|NCT00420407|588955078|FG001|Overall Study|Lost to Follow-up|3|||
163067790|NCT00420407|588955077|FG000|Overall Study|Physician Decision|2|||
163067791|NCT00420407|588955078|FG001|Overall Study|Physician Decision|1|||
163067792|NCT00420407|588955077|FG000|Overall Study|subject identified as detainee|1|||
163067793|NCT00420407|588955078|FG001|Overall Study|subject identified as detainee|0|||
163067794|NCT00420407|588955077|FG000|Overall Study|subject identified as Jehovah's witness|1|||
163067795|NCT00420407|588955078|FG001|Overall Study|subject identified as Jehovah's witness|0|||
163067796|NCT00420407|588955077|FG000|Overall Study|Withdrawal by Subject|0|||
163067797|NCT00420407|588955078|FG001|Overall Study|Withdrawal by Subject|2|||
163067798|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
163067799|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
163067800|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
163067801|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
163067802|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
163067803|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
163067804|NCT04633447|588955081|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
163067805|NCT04633447|588955082|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
163067806|NCT04633447|588955081|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
163067807|NCT04633447|588955082|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
163067808|NCT04633447|588955081|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
163067809|NCT04633447|588955082|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
163067810|NCT04333498|588955083|FG000|Overall Study|Lost to Follow-up|1|||
163067811|NCT04333498|588955084|FG001|Overall Study|Lost to Follow-up|0|||
163067812|NCT04333498|588955083|FG000|Overall Study|Lost to Follow-up|0|||
163067813|NCT04333498|588955084|FG001|Overall Study|Lost to Follow-up|1|||
163067814|NCT01565694|588955085|FG000|Dose-Titration Period|Adverse Event|4|||
163067815|NCT01565694|588955085|FG000|Dose-Titration Period|Protocol Violation|10|||
163067816|NCT01565694|588955085|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
163067817|NCT05399771|588955087|FG000|Overall Study|Physician Decision|3|||
163067818|NCT05399771|588955087|FG000|Overall Study|Adverse Event|1|||
163067819|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
163067820|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
163067821|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
163067822|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
163067823|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
163067824|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
163067825|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067826|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067827|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067828|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067829|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
163067830|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
163067831|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067832|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067833|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
162644145|NCT02337907|587413547|FG001|Overall Study|Lost to Follow-up|0|||
162644146|NCT02337907|587413548|FG002|Overall Study|Lost to Follow-up|0|||
162644147|NCT02337907|587413549|FG003|Overall Study|Lost to Follow-up|0|||
162644148|NCT02337907|587413550|FG004|Overall Study|Lost to Follow-up|0|||
162644149|NCT02337907|587413551|FG005|Overall Study|Lost to Follow-up|1|||
162644150|NCT02337907|587413546|FG000|Overall Study|Adverse Event|1|||
162644151|NCT02337907|587413547|FG001|Overall Study|Adverse Event|1|||
162644152|NCT02337907|587413548|FG002|Overall Study|Adverse Event|1|||
162644153|NCT02337907|587413549|FG003|Overall Study|Adverse Event|1|||
162644154|NCT02337907|587413550|FG004|Overall Study|Adverse Event|4|||
163067834|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067835|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
163067836|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
163067837|NCT00541229|588955090|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067838|NCT00541229|588955091|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
163067839|NCT00541229|588955092|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
163067840|NCT00541229|588955093|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
163067841|NCT00541229|588955094|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067842|NCT00541229|588955095|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
163067843|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
163067844|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
163067845|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
163067846|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
163067847|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
163067848|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
163067849|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
163067850|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
163067851|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
163067852|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
163067853|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
163067854|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
163067855|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067856|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067857|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067858|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067859|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
163067860|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
163067861|NCT00541229|588955090|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067862|NCT00541229|588955091|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
163067863|NCT00541229|588955092|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067864|NCT00541229|588955093|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
163067865|NCT00541229|588955094|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
163067866|NCT00541229|588955095|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
163067867|NCT00541229|588955090|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
163067868|NCT00541229|588955091|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
163067869|NCT00541229|588955092|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
163067870|NCT00541229|588955093|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
163067871|NCT00541229|588955094|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
163067872|NCT00541229|588955095|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
163067873|NCT00541229|588955090|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
163067874|NCT00541229|588955091|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067875|NCT00541229|588955092|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067876|NCT00541229|588955093|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067877|NCT00541229|588955094|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
163067878|NCT00541229|588955095|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
163067879|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
163067880|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067881|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067882|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
163067883|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
162644155|NCT02337907|587413551|FG005|Overall Study|Adverse Event|0|||
162644156|NCT01592344|587413552|FG000|Overall Study|Adverse Event|1|||
162644157|NCT01592344|587413553|FG001|Overall Study|Adverse Event|1|||
162644158|NCT01592344|587413552|FG000|Overall Study|Lack of Efficacy|1|||
162644159|NCT01592344|587413553|FG001|Overall Study|Lack of Efficacy|0|||
162644160|NCT01592344|587413552|FG000|Overall Study|not available at primary outcome visit|2|||
163067884|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
162644161|NCT01592344|587413553|FG001|Overall Study|not available at primary outcome visit|4|||
163067885|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067886|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
162644162|NCT00099437|587413554|FG000|Overall Study|Lost to Follow-up|30|||
162644163|NCT00099437|587413555|FG001|Overall Study|Lost to Follow-up|33|||
162644164|NCT00099437|587413554|FG000|Overall Study|Death|293|||
163067887|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067888|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067889|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
163067890|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
163067891|NCT00541229|588955090|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067892|NCT00541229|588955091|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
163067893|NCT00541229|588955092|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
163067894|NCT00541229|588955093|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
163067895|NCT00541229|588955094|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067896|NCT00541229|588955095|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
163067897|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
163067898|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
163067899|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
163067900|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
163067901|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
163067902|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
163067903|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067904|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067905|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067906|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067907|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
163067908|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
163067909|NCT00541229|588955090|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067910|NCT00541229|588955091|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067911|NCT00541229|588955092|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
163067912|NCT00541229|588955093|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067913|NCT00541229|588955094|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067914|NCT00541229|588955095|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
163067915|NCT01312129|588955096|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
163067916|NCT01312129|588955097|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
163067917|NCT02397837|588955101|FG000|Overall Study|Withdrawal by Subject|6|||
163067918|NCT02397837|588955102|FG001|Overall Study|Withdrawal by Subject|5|||
163067919|NCT02397837|588955101|FG000|Overall Study|Physician Decision|1|||
163067920|NCT02397837|588955102|FG001|Overall Study|Physician Decision|1|||
163067921|NCT00263562|588955109|FG000|Overall Study|Protocol Violation|3|||
163067922|NCT00263562|588955110|FG001|Overall Study|Protocol Violation|0|||
163067923|NCT04602000|588955111|FG000|Overall Study|Withdrawal by Subject|3|||
163067924|NCT04602000|588955112|FG001|Overall Study|Withdrawal by Subject|6|||
163067925|NCT04602000|588955113|FG002|Overall Study|Withdrawal by Subject|3|||
163067926|NCT04602000|588955114|FG003|Overall Study|Withdrawal by Subject|27|||
163067927|NCT04602000|588955115|FG004|Overall Study|Withdrawal by Subject|39|||
163067928|NCT04602000|588955111|FG000|Overall Study|Physician Decision|1|||
163067929|NCT04602000|588955112|FG001|Overall Study|Physician Decision|0|||
163067930|NCT04602000|588955113|FG002|Overall Study|Physician Decision|0|||
163067931|NCT04602000|588955114|FG003|Overall Study|Physician Decision|2|||
163067932|NCT04602000|588955115|FG004|Overall Study|Physician Decision|2|||
163067933|NCT04602000|588955111|FG000|Overall Study|Death|0|||
163067934|NCT04602000|588955112|FG001|Overall Study|Death|1|||
163067935|NCT04602000|588955113|FG002|Overall Study|Death|0|||
163067936|NCT04602000|588955114|FG003|Overall Study|Death|1|||
163067937|NCT04602000|588955115|FG004|Overall Study|Death|2|||
163067938|NCT04602000|588955111|FG000|Overall Study|Lost to Follow-up|0|||
163067939|NCT04602000|588955112|FG001|Overall Study|Lost to Follow-up|0|||
163067940|NCT04602000|588955113|FG002|Overall Study|Lost to Follow-up|0|||
163067941|NCT04602000|588955114|FG003|Overall Study|Lost to Follow-up|3|||
163067942|NCT04602000|588955115|FG004|Overall Study|Lost to Follow-up|4|||
163067943|NCT04602000|588955111|FG000|Overall Study|Other|4|||
163067944|NCT04602000|588955112|FG001|Overall Study|Other|1|||
162644165|NCT00099437|587413555|FG001|Overall Study|Death|261|||
162644166|NCT00099437|587413554|FG000|Overall Study|Withdrawal by Subject|6|||
162644167|NCT00099437|587413555|FG001|Overall Study|Withdrawal by Subject|10|||
162644168|NCT00099437|587413554|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
162644169|NCT00099437|587413555|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
162644170|NCT02738333|587413556|FG000|Overall Study|Death|1|||
162644171|NCT02738333|587413557|FG001|Overall Study|Death|0|||
162644172|NCT02738333|587413558|FG002|Overall Study|Death|0|||
162644173|NCT02738333|587413556|FG000|Overall Study|Lost to Follow-up|1|||
163067945|NCT04602000|588955113|FG002|Overall Study|Other|2|||
163067946|NCT04602000|588955114|FG003|Overall Study|Other|5|||
163067947|NCT04602000|588955115|FG004|Overall Study|Other|4|||
163067948|NCT04602000|588955111|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067949|NCT04602000|588955112|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
162644174|NCT02738333|587413557|FG001|Overall Study|Lost to Follow-up|0|||
162644175|NCT02738333|587413558|FG002|Overall Study|Lost to Follow-up|0|||
162644176|NCT00949325|587413559|FG000|Overall Study|Adverse Event|0|||
162644177|NCT00949325|587413560|FG001|Overall Study|Adverse Event|2|||
162644178|NCT00949325|587413561|FG002|Overall Study|Adverse Event|0|||
162644179|NCT03311659|587413566|FG000|Overall Study|Protocol Violation|1|||
162644180|NCT04327388|587413567|FG000|Overall Study|Adverse Event|17|||
162644181|NCT04327388|587413568|FG001|Overall Study|Adverse Event|18|||
162644182|NCT04327388|587413569|FG002|Overall Study|Adverse Event|9|||
162644183|NCT04327388|587413567|FG000|Overall Study|Other|1|||
162644184|NCT04327388|587413568|FG001|Overall Study|Other|2|||
162644185|NCT04327388|587413569|FG002|Overall Study|Other|0|||
162644186|NCT04327388|587413567|FG000|Overall Study|Randomized and not treated|2|||
162644187|NCT04327388|587413568|FG001|Overall Study|Randomized and not treated|0|||
162644188|NCT04327388|587413569|FG002|Overall Study|Randomized and not treated|2|||
162644189|NCT04829318|587413570|FG000|Overall Study|Adverse Event|6|||
162644190|NCT04829318|587413570|FG000|Overall Study|Death|1|||
162644191|NCT04829318|587413570|FG000|Overall Study|Lost to Follow-up|1|||
163026327|NCT03033602|588797305|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
163026328|NCT02805660|588797307|FG000|Overall Study|Death|5|||
163026329|NCT02805660|588797308|FG001|Overall Study|Death|2|||
163026330|NCT02805660|588797309|FG002|Overall Study|Death|9|||
163026331|NCT02805660|588797310|FG003|Overall Study|Death|5|||
163026332|NCT02805660|588797311|FG004|Overall Study|Death|0|||
163026333|NCT02805660|588797312|FG005|Overall Study|Death|14|||
163026334|NCT02805660|588797313|FG006|Overall Study|Death|12|||
163026335|NCT02805660|588797307|FG000|Overall Study|Lost to Follow-up|0|||
163026336|NCT02805660|588797308|FG001|Overall Study|Lost to Follow-up|1|||
163026337|NCT02805660|588797309|FG002|Overall Study|Lost to Follow-up|1|||
163026338|NCT02805660|588797310|FG003|Overall Study|Lost to Follow-up|2|||
163026339|NCT02805660|588797311|FG004|Overall Study|Lost to Follow-up|0|||
163026340|NCT02805660|588797312|FG005|Overall Study|Lost to Follow-up|0|||
163026341|NCT02805660|588797313|FG006|Overall Study|Lost to Follow-up|0|||
163026342|NCT02805660|588797307|FG000|Overall Study|Withdrawal by Subject|0|||
163026343|NCT02805660|588797308|FG001|Overall Study|Withdrawal by Subject|0|||
163026344|NCT02805660|588797309|FG002|Overall Study|Withdrawal by Subject|0|||
163026345|NCT02805660|588797310|FG003|Overall Study|Withdrawal by Subject|3|||
163026346|NCT02805660|588797311|FG004|Overall Study|Withdrawal by Subject|1|||
163026347|NCT02805660|588797312|FG005|Overall Study|Withdrawal by Subject|0|||
163026348|NCT02805660|588797313|FG006|Overall Study|Withdrawal by Subject|2|||
163026349|NCT02805660|588797307|FG000|Overall Study|Study terminated by Sponsor|0|||
163026350|NCT02805660|588797308|FG001|Overall Study|Study terminated by Sponsor|0|||
163026351|NCT02805660|588797309|FG002|Overall Study|Study terminated by Sponsor|1|||
163026352|NCT02805660|588797310|FG003|Overall Study|Study terminated by Sponsor|4|||
163026353|NCT02805660|588797311|FG004|Overall Study|Study terminated by Sponsor|2|||
163026354|NCT02805660|588797312|FG005|Overall Study|Study terminated by Sponsor|3|||
163026355|NCT02805660|588797313|FG006|Overall Study|Study terminated by Sponsor|1|||
163026356|NCT02805660|588797307|FG000|Overall Study|Miscellaneous|0|||
163026357|NCT02805660|588797308|FG001|Overall Study|Miscellaneous|1|||
163026358|NCT02805660|588797309|FG002|Overall Study|Miscellaneous|0|||
163026359|NCT02805660|588797310|FG003|Overall Study|Miscellaneous|4|||
163026360|NCT02805660|588797311|FG004|Overall Study|Miscellaneous|0|||
163026361|NCT02805660|588797312|FG005|Overall Study|Miscellaneous|6|||
163026362|NCT02805660|588797313|FG006|Overall Study|Miscellaneous|4|||
163026363|NCT02572076|588797314|FG000|Overall Study|Protocol Violation|1|||
163026364|NCT02778074|588797315|FG000|Overall Study|Lost to Follow-up|7|||
163026365|NCT02778074|588797316|FG001|Overall Study|Lost to Follow-up|10|||
163026366|NCT03489707|588797317|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
163026367|NCT03489707|588797318|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
163026368|NCT03489707|588797317|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
163026369|NCT03489707|588797318|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
163026370|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163026371|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
163026372|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
163026373|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
163026374|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
163026375|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
162644192|NCT04829318|587413570|FG000|Overall Study|Physician Decision|1|||
162644193|NCT04829318|587413570|FG000|Overall Study|Withdrawal by Subject|19|||
162644194|NCT04829318|587413570|FG000|Overall Study|Site terminated by sponsor|1|||
162644195|NCT04829318|587413570|FG000|Overall Study|Sponsor decision|5|||
162644196|NCT04829318|587413570|FG000|Overall Study|Other|1|||
162644197|NCT00728130|587413571|FG000|Overall Study|Withdrawal by Subject|1|||
163026376|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
163026377|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163026378|NCT03963232|588797319|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
163026379|NCT03963232|588797320|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
163026380|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Adverse Event|1|||
163026381|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Adverse Event|2|||
163026382|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
163026383|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
163026384|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
163026385|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
163026386|NCT03963232|588797319|FG000|Open-Label Treatment Phase|Pregnancy|1|||
163026387|NCT03963232|588797320|FG001|Open-Label Treatment Phase|Pregnancy|0|||
163026388|NCT03963232|588797319|FG000|Follow-up Phase|Withdrawal by Subject|7|||
163026389|NCT03963232|588797320|FG001|Follow-up Phase|Withdrawal by Subject|5|||
163026390|NCT03963232|588797319|FG000|Follow-up Phase|Protocol Violation|0|||
163026391|NCT03963232|588797320|FG001|Follow-up Phase|Protocol Violation|2|||
163026392|NCT03963232|588797319|FG000|Follow-up Phase|Adverse Event|0|||
163026393|NCT03963232|588797320|FG001|Follow-up Phase|Adverse Event|1|||
163026394|NCT03963232|588797319|FG000|Follow-up Phase|Lost to Follow-up|0|||
163026395|NCT03963232|588797320|FG001|Follow-up Phase|Lost to Follow-up|1|||
163026396|NCT00356135|588797321|FG000|Overall Study|Protocol Violation|1|||
163026397|NCT00356135|588797322|FG001|Overall Study|Protocol Violation|0|||
163026398|NCT00356135|588797323|FG002|Overall Study|Protocol Violation|0|||
163026399|NCT00356135|588797321|FG000|Overall Study|Adverse Event|1|||
163026400|NCT00356135|588797322|FG001|Overall Study|Adverse Event|0|||
163026401|NCT00356135|588797323|FG002|Overall Study|Adverse Event|0|||
163026402|NCT00356135|588797321|FG000|Overall Study|Lost to Follow-up|0|||
163026403|NCT00356135|588797322|FG001|Overall Study|Lost to Follow-up|0|||
163026404|NCT00356135|588797323|FG002|Overall Study|Lost to Follow-up|1|||
163026405|NCT00356135|588797321|FG000|Overall Study|Physician Decision|1|||
163026406|NCT00356135|588797322|FG001|Overall Study|Physician Decision|1|||
163026407|NCT00356135|588797323|FG002|Overall Study|Physician Decision|1|||
163026408|NCT00356135|588797321|FG000|Overall Study|Subject non-compliance|1|||
163026409|NCT00356135|588797322|FG001|Overall Study|Subject non-compliance|1|||
163026410|NCT00356135|588797323|FG002|Overall Study|Subject non-compliance|3|||
163026411|NCT03617770|588797324|FG000|Overall Study|Lost to Follow-up|1|||
163026412|NCT03617770|588797325|FG001|Overall Study|Lost to Follow-up|0|||
163026413|NCT05270395|588797331|FG000|Overall Study|Lost to Follow-up|2|||
163026414|NCT05270395|588797332|FG001|Overall Study|Lost to Follow-up|2|||
163026415|NCT05270395|588797331|FG000|Overall Study|Death|1|||
163026416|NCT05270395|588797332|FG001|Overall Study|Death|2|||
163026417|NCT05270395|588797331|FG000|Overall Study|Study Team Withdrew|1|||
163026418|NCT05270395|588797332|FG001|Overall Study|Study Team Withdrew|0|||
163026419|NCT03055494|588799154|FG000|Overall Study|Lost to Follow-up|6|||
163026420|NCT03055494|588799155|FG001|Overall Study|Lost to Follow-up|0|||
163026421|NCT03055494|588799154|FG000|Overall Study|Physician Decision|2|||
163026422|NCT03055494|588799155|FG001|Overall Study|Physician Decision|0|||
163026423|NCT03055494|588799154|FG000|Overall Study|Withdrawal by Subject|1|||
163026424|NCT03055494|588799155|FG001|Overall Study|Withdrawal by Subject|0|||
163026425|NCT03055494|588799154|FG000|Overall Study|Adverse Event|0|||
163026426|NCT03055494|588799155|FG001|Overall Study|Adverse Event|1|||
163026427|NCT03055494|588799154|FG000|Overall Study|Non-compliance with study treatment|1|||
163026428|NCT03055494|588799155|FG001|Overall Study|Non-compliance with study treatment|0|||
163026429|NCT04743804|588799158|FG000|Overall Study|Other|1|||
163026430|NCT04743804|588799159|FG001|Overall Study|Other|0|||
163026431|NCT04743804|588799158|FG000|Overall Study|Withdrawal by Subject|0|||
163026432|NCT04743804|588799159|FG001|Overall Study|Withdrawal by Subject|1|||
163026433|NCT04743804|588799158|FG000|Overall Study|Study Terminated by Sponsor|1|||
163026434|NCT04743804|588799159|FG001|Overall Study|Study Terminated by Sponsor|4|||
163026435|NCT04743804|588799158|FG000|Overall Study|Physician Decision|0|||
163026436|NCT04743804|588799159|FG001|Overall Study|Physician Decision|1|||
163026437|NCT04743804|588799158|FG000|Overall Study|Death|3|||
163026438|NCT04743804|588799159|FG001|Overall Study|Death|0|||
163026439|NCT04598451|588799160|FG000|Overall Study|Adverse Event|3|||
163026440|NCT04598451|588799161|FG001|Overall Study|Adverse Event|2|||
163026441|NCT04598451|588799160|FG000|Overall Study|Withdrawal by Subject|3|||
163026442|NCT04598451|588799161|FG001|Overall Study|Withdrawal by Subject|7|||
163026443|NCT04598451|588799160|FG000|Overall Study|Lost to Follow-up|2|||
163026444|NCT04598451|588799161|FG001|Overall Study|Lost to Follow-up|0|||
163026445|NCT04598451|588799160|FG000|Overall Study|Physician Decision|4|||
163026446|NCT04598451|588799161|FG001|Overall Study|Physician Decision|1|||
163026447|NCT04598451|588799160|FG000|Overall Study|Requires Prohibited Medication|1|||
163026448|NCT04598451|588799161|FG001|Overall Study|Requires Prohibited Medication|0|||
163026449|NCT04598451|588799160|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
163026450|NCT04598451|588799161|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
163026451|NCT01632150|588799162|FG000|Overall Study|Disease progression|27|||
163026452|NCT01632150|588799162|FG000|Overall Study|Study drug toxicity|1|||
163026453|NCT01632150|588799162|FG000|Overall Study|Unrelated adverse event|7|||
163026454|NCT01632150|588799162|FG000|Overall Study|Withdrawal by Subject|2|||
163026455|NCT01632150|588799162|FG000|Overall Study|Patient underwent autologous transplant|1|||
163026456|NCT01632150|588799162|FG000|Overall Study|Moved to compassionate program|2|||
163026457|NCT02879994|588799165|FG000|Overall Study|off treatment early|7|||
163026458|NCT02879994|588799165|FG000|Overall Study|Adverse Event|2|||
163026459|NCT02879994|588799165|FG000|Overall Study|Death|2|||
163026460|NCT02143791|588799166|FG000|Enrolled|Withdrawal by Subject|4|||
163026461|NCT02143791|588799166|FG000|Trial Stimulation|Lack of Efficacy|21|||
163026462|NCT02143791|588799166|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
163026463|NCT02143791|588799166|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
163026464|NCT02143791|588799166|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
163026465|NCT02143791|588799166|FG000|Any Programming (3-6 Months)|Missing Data|1|||
163026466|NCT02143791|588799166|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
163026467|NCT04984681|588799171|FG000|Overall Study|Lost to Follow-up|3|||
163026468|NCT04984681|588799172|FG001|Overall Study|Lost to Follow-up|1|||
163026469|NCT04327661|588799173|FG000|Overall Study|Withdrawal by Subject|1|||
163026470|NCT04327661|588799174|FG001|Overall Study|Withdrawal by Subject|0|||
163026471|NCT04327661|588799175|FG002|Overall Study|Withdrawal by Subject|0|||
163026472|NCT02091960|588799176|FG000|Overall Study|Death|7|||
163026473|NCT02091960|588799176|FG000|Overall Study|Withdrawal by Subject|1|||
163026474|NCT02091960|588799176|FG000|Overall Study|Miscellaneous Reasons|37|||
163026475|NCT01942486|588799187|FG000|Overall Study|Lost to Follow-up|27|||
163026476|NCT02424630|588799190|FG000|Overall Study|No rotator cuff tear|1|||
163026477|NCT02424630|588799191|FG001|Overall Study|No rotator cuff tear|2|||
163026478|NCT02424630|588799190|FG000|Overall Study|Open procedure|0|||
163026479|NCT02424630|588799191|FG001|Overall Study|Open procedure|1|||
163026480|NCT02637895|588799192|FG000|Overall Study|Lost to Follow-up|4|||
163026481|NCT02637895|588799193|FG001|Overall Study|Lost to Follow-up|0|||
163026482|NCT02637895|588799192|FG000|Overall Study|Protocol Violation|0|||
163026483|NCT02637895|588799193|FG001|Overall Study|Protocol Violation|1|||
163026484|NCT02637895|588799192|FG000|Overall Study|Lack of Efficacy|1|||
163026485|NCT02637895|588799193|FG001|Overall Study|Lack of Efficacy|0|||
163026486|NCT02637895|588799192|FG000|Overall Study|Withdrawal by Subject|1|||
163026487|NCT02637895|588799193|FG001|Overall Study|Withdrawal by Subject|1|||
163026488|NCT02637895|588799192|FG000|Overall Study|Abnormal baseline lab|0|||
163026489|NCT02637895|588799193|FG001|Overall Study|Abnormal baseline lab|1|||
163026490|NCT00984061|588799196|FG000|Clarithromycin Alone|Protocol Violation|1|||
163026491|NCT05139303|588799197|FG000|Overall Study|Lost to Follow-up|3|||
163026492|NCT05139303|588799198|FG001|Overall Study|Lost to Follow-up|0|||
163026493|NCT05139303|588799197|FG000|Overall Study|Adverse Event|1|||
163026494|NCT05139303|588799198|FG001|Overall Study|Adverse Event|0|||
163026495|NCT04507256|588799202|FG000|Overall Study|Withdrawal by Subject|1|||
163026496|NCT04507256|588799203|FG001|Overall Study|Withdrawal by Subject|0|||
163026497|NCT04507256|588799204|FG002|Overall Study|Withdrawal by Subject|0|||
163026498|NCT04507256|588799205|FG003|Overall Study|Withdrawal by Subject|1|||
163026499|NCT04507256|588799206|FG004|Overall Study|Withdrawal by Subject|0|||
163026500|NCT04507256|588799207|FG005|Overall Study|Withdrawal by Subject|0|||
163026501|NCT04240457|588799208|FG000|Overall Study|Lost to Follow-up|5|||
163026502|NCT04240457|588799209|FG001|Overall Study|Lost to Follow-up|1|||
163026503|NCT02858180|588799214|FG000|Overall Study|Lost to Follow-up|0|||
163026504|NCT02858180|588799215|FG001|Overall Study|Lost to Follow-up|2|||
163026505|NCT00844480|588799216|FG000|Overall Study|Withdrawal by Subject|2|||
163026506|NCT00844480|588799217|FG001|Overall Study|Withdrawal by Subject|3|||
163026507|NCT00574249|588799222|FG000|Overall Study|Adverse Event|6|||
163026508|NCT00574249|588799223|FG001|Overall Study|Adverse Event|18|||
163026509|NCT00574249|588799222|FG000|Overall Study|Lack of Efficacy|5|||
163026510|NCT00574249|588799223|FG001|Overall Study|Lack of Efficacy|3|||
163026511|NCT00574249|588799222|FG000|Overall Study|Lost to Follow-up|4|||
163026512|NCT00574249|588799223|FG001|Overall Study|Lost to Follow-up|3|||
163026513|NCT00574249|588799222|FG000|Overall Study|Protocol Violation|5|||
163026514|NCT00574249|588799223|FG001|Overall Study|Protocol Violation|2|||
163026515|NCT00574249|588799222|FG000|Overall Study|History of carcinoma|1|||
163026516|NCT00574249|588799223|FG001|Overall Study|History of carcinoma|0|||
163026517|NCT00574249|588799222|FG000|Overall Study|Withdrawal by Subject|3|||
163026518|NCT00574249|588799223|FG001|Overall Study|Withdrawal by Subject|0|||
162717846|NCT02914522|587673492|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163026519|NCT00574249|588799222|FG000|Overall Study|Physician Decision|1|||
163026520|NCT00574249|588799223|FG001|Overall Study|Physician Decision|0|||
163026521|NCT00574249|588799222|FG000|Overall Study|Pregnancy|1|||
163026522|NCT00574249|588799223|FG001|Overall Study|Pregnancy|0|||
163026523|NCT00574249|588799222|FG000|Overall Study|Excluded by company|0|||
163026524|NCT00574249|588799223|FG001|Overall Study|Excluded by company|1|||
163026525|NCT00574249|588799222|FG000|Overall Study|PPD test taken twice|0|||
163026526|NCT00574249|588799223|FG001|Overall Study|PPD test taken twice|1|||
163026527|NCT03197870|588799224|FG000|Overall Study|Adverse Event|9|||
163026528|NCT03197870|588799225|FG001|Overall Study|Adverse Event|4|||
163026529|NCT03197870|588799226|FG002|Overall Study|Adverse Event|6|||
163067950|NCT04602000|588955113|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
163067951|NCT04602000|588955114|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067952|NCT04602000|588955115|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
163067953|NCT01257542|588955119|FG000|Overall Study|Protocol Violation|3|||
163067954|NCT01257542|588955120|FG001|Overall Study|Protocol Violation|5|||
163067955|NCT01257542|588955119|FG000|Overall Study|Withdrawal by Subject|0|||
163067956|NCT01257542|588955120|FG001|Overall Study|Withdrawal by Subject|2|||
163067957|NCT03097315|588955125|FG000|Overall Study|Withdrawal by Subject|1|||
163067958|NCT00195429|588955126|FG000|Overall Study|Adverse Event|2|||
163067959|NCT00195429|588955127|FG001|Overall Study|Adverse Event|4|||
163067960|NCT00195429|588955126|FG000|Overall Study|Lack of Efficacy|2|||
163067961|NCT00195429|588955127|FG001|Overall Study|Lack of Efficacy|1|||
163067962|NCT00195429|588955126|FG000|Overall Study|Lost to Follow-up|1|||
163067963|NCT00195429|588955127|FG001|Overall Study|Lost to Follow-up|0|||
163026530|NCT03197870|588799224|FG000|Overall Study|Withdrawal by Subject|2|||
163026531|NCT03197870|588799225|FG001|Overall Study|Withdrawal by Subject|3|||
163026532|NCT03197870|588799226|FG002|Overall Study|Withdrawal by Subject|0|||
163026533|NCT03197870|588799224|FG000|Overall Study|Lost to Follow-up|2|||
163026534|NCT03197870|588799225|FG001|Overall Study|Lost to Follow-up|2|||
163026535|NCT03197870|588799226|FG002|Overall Study|Lost to Follow-up|0|||
163026536|NCT03197870|588799224|FG000|Overall Study|data not available|1|||
163026537|NCT03197870|588799225|FG001|Overall Study|data not available|1|||
163026538|NCT03197870|588799226|FG002|Overall Study|data not available|0|||
163026539|NCT01618019|588799228|FG000|Overall Study|Withdrawal by Subject|14|||
163026540|NCT01618019|588799229|FG001|Overall Study|Withdrawal by Subject|14|||
163026541|NCT01542034|588799230|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
163026542|NCT01542034|588799231|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
163026543|NCT01542034|588799230|FG000|Overall Study|Administrative decision|0|||
163026544|NCT01542034|588799231|FG001|Overall Study|Administrative decision|3|||
163026545|NCT01542034|588799230|FG000|Overall Study|Subject Noncompliance|1|||
163026546|NCT01542034|588799231|FG001|Overall Study|Subject Noncompliance|0|||
163026547|NCT01542034|588799230|FG000|Overall Study|Adverse Event|2|||
163026548|NCT01542034|588799231|FG001|Overall Study|Adverse Event|2|||
163026549|NCT01542034|588799230|FG000|Overall Study|Lost to Follow-up|7|||
163026550|NCT01542034|588799231|FG001|Overall Study|Lost to Follow-up|6|||
163026551|NCT02612610|588799232|FG000|Overall Study|Withdrawal by Subject|1|||
163026552|NCT02612610|588799233|FG001|Overall Study|Withdrawal by Subject|1|||
163026553|NCT02612610|588799234|FG002|Overall Study|Withdrawal by Subject|0|||
163026554|NCT02612610|588799235|FG003|Overall Study|Withdrawal by Subject|2|||
163026555|NCT02612610|588799232|FG000|Overall Study|Adverse Event|2|||
163026556|NCT02612610|588799233|FG001|Overall Study|Adverse Event|2|||
163026557|NCT02612610|588799234|FG002|Overall Study|Adverse Event|3|||
163026558|NCT02612610|588799235|FG003|Overall Study|Adverse Event|10|||
163026559|NCT02612610|588799232|FG000|Overall Study|Lost to Follow-up|0|||
163026560|NCT02612610|588799233|FG001|Overall Study|Lost to Follow-up|1|||
163026561|NCT02612610|588799234|FG002|Overall Study|Lost to Follow-up|0|||
163026562|NCT02612610|588799235|FG003|Overall Study|Lost to Follow-up|0|||
163026563|NCT02612610|588799232|FG000|Overall Study|Protocol Violation|0|||
163026564|NCT02612610|588799233|FG001|Overall Study|Protocol Violation|1|||
163026565|NCT02612610|588799234|FG002|Overall Study|Protocol Violation|1|||
163026566|NCT02612610|588799235|FG003|Overall Study|Protocol Violation|0|||
163026567|NCT02612610|588799232|FG000|Overall Study|Lack of Efficacy|1|||
163026568|NCT02612610|588799233|FG001|Overall Study|Lack of Efficacy|2|||
163026569|NCT02612610|588799234|FG002|Overall Study|Lack of Efficacy|0|||
163026570|NCT02612610|588799235|FG003|Overall Study|Lack of Efficacy|1|||
163026571|NCT02612610|588799232|FG000|Overall Study|Physician Decision|0|||
163026572|NCT02612610|588799233|FG001|Overall Study|Physician Decision|1|||
163026573|NCT02612610|588799234|FG002|Overall Study|Physician Decision|0|||
163026574|NCT02612610|588799235|FG003|Overall Study|Physician Decision|0|||
163026575|NCT02612610|588799232|FG000|Overall Study|Noncompliance|1|||
163026576|NCT02612610|588799233|FG001|Overall Study|Noncompliance|0|||
163026577|NCT02612610|588799234|FG002|Overall Study|Noncompliance|0|||
163026578|NCT02612610|588799235|FG003|Overall Study|Noncompliance|0|||
163026579|NCT02612610|588799232|FG000|Overall Study|Cough Improvement|0|||
163026580|NCT02612610|588799233|FG001|Overall Study|Cough Improvement|0|||
163026581|NCT02612610|588799234|FG002|Overall Study|Cough Improvement|1|||
163067964|NCT00367458|588955128|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
163067965|NCT00367458|588955129|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
163026582|NCT02612610|588799235|FG003|Overall Study|Cough Improvement|0|||
163026583|NCT01546571|588799238|FG000|Overall Study|Adverse Event|1|||
163026584|NCT01546571|588799239|FG001|Overall Study|Adverse Event|0|||
163026585|NCT01546571|588799240|FG002|Overall Study|Adverse Event|0|||
163026586|NCT01546571|588799241|FG003|Overall Study|Adverse Event|1|||
163026587|NCT01546571|588799242|FG004|Overall Study|Adverse Event|0|||
163026588|NCT01546571|588799238|FG000|Overall Study|assigned placebo in Part A|0|||
163026589|NCT01546571|588799239|FG001|Overall Study|assigned placebo in Part A|0|||
163026590|NCT01546571|588799240|FG002|Overall Study|assigned placebo in Part A|22|||
163067966|NCT02948400|588955132|FG000|Overall Study|Withdrawal by Subject|17|||
163067967|NCT02948400|588955133|FG001|Overall Study|Withdrawal by Subject|10|||
163067968|NCT02948400|588955132|FG000|Overall Study|failed to attend appointments|47|||
163067969|NCT02948400|588955133|FG001|Overall Study|failed to attend appointments|34|||
163067970|NCT02948400|588955132|FG000|Overall Study|COVID-related closure|6|||
163067971|NCT02948400|588955133|FG001|Overall Study|COVID-related closure|2|||
163067972|NCT02948400|588955132|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
163067973|NCT02948400|588955133|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
163067974|NCT02948400|588955132|FG000|Overall Study|motion sickness in virtual reality|2|||
163067975|NCT02948400|588955133|FG001|Overall Study|motion sickness in virtual reality|0|||
163067976|NCT01716156|588955134|FG000|Overall Study|Protocol Violation|1|||
163067977|NCT01716156|588955135|FG001|Overall Study|Protocol Violation|0|||
163067978|NCT01716156|588955136|FG002|Overall Study|Protocol Violation|0|||
163067979|NCT01716156|588955134|FG000|Overall Study|Withdrawal by Subject|0|||
163067980|NCT01716156|588955135|FG001|Overall Study|Withdrawal by Subject|1|||
163067981|NCT01716156|588955136|FG002|Overall Study|Withdrawal by Subject|2|||
163067982|NCT01716156|588955134|FG000|Overall Study|Lost to Follow-up|1|||
163067983|NCT01716156|588955135|FG001|Overall Study|Lost to Follow-up|0|||
163067984|NCT01716156|588955136|FG002|Overall Study|Lost to Follow-up|0|||
163067985|NCT05221866|588955139|FG000|Overall Study|Withdrawal by Subject|5|||
163067986|NCT05221866|588955140|FG001|Overall Study|Withdrawal by Subject|7|||
162644198|NCT00728130|587413571|FG000|Overall Study|Paperwork not completed in time|1|||
162644199|NCT00728130|587413571|FG000|Overall Study|Physician Decision|1|||
162644200|NCT04053023|587413572|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
162644201|NCT04053023|587413573|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
162644202|NCT03447990|587413574|FG000|Overall Study|Withdrawal by Subject|0|||
163026591|NCT01546571|588799241|FG003|Overall Study|assigned placebo in Part A|0|||
163026592|NCT01546571|588799242|FG004|Overall Study|assigned placebo in Part A|0|||
163026593|NCT01546571|588799238|FG000|Overall Study|Death|0|||
163026594|NCT01546571|588799239|FG001|Overall Study|Death|1|||
163026595|NCT01546571|588799240|FG002|Overall Study|Death|0|||
163026596|NCT01546571|588799241|FG003|Overall Study|Death|0|||
163026597|NCT01546571|588799242|FG004|Overall Study|Death|0|||
163026598|NCT01546571|588799238|FG000|Overall Study|Lost to Follow-up|0|||
163026599|NCT01546571|588799239|FG001|Overall Study|Lost to Follow-up|0|||
163026600|NCT01546571|588799240|FG002|Overall Study|Lost to Follow-up|2|||
163026601|NCT01546571|588799241|FG003|Overall Study|Lost to Follow-up|2|||
163026602|NCT01546571|588799242|FG004|Overall Study|Lost to Follow-up|3|||
163026603|NCT01546571|588799238|FG000|Overall Study|Pregnancy|0|||
163026604|NCT01546571|588799239|FG001|Overall Study|Pregnancy|0|||
163026605|NCT01546571|588799240|FG002|Overall Study|Pregnancy|0|||
163026606|NCT01546571|588799241|FG003|Overall Study|Pregnancy|1|||
163026607|NCT01546571|588799242|FG004|Overall Study|Pregnancy|0|||
163026608|NCT01546571|588799238|FG000|Overall Study|Disease Progression|20|||
163026609|NCT01546571|588799239|FG001|Overall Study|Disease Progression|18|||
163026610|NCT01546571|588799240|FG002|Overall Study|Disease Progression|15|||
163026611|NCT01546571|588799241|FG003|Overall Study|Disease Progression|73|||
163026612|NCT01546571|588799242|FG004|Overall Study|Disease Progression|37|||
163026613|NCT01546571|588799238|FG000|Overall Study|Withdrawal by Subject|1|||
163026614|NCT01546571|588799239|FG001|Overall Study|Withdrawal by Subject|2|||
163026615|NCT01546571|588799240|FG002|Overall Study|Withdrawal by Subject|4|||
163026616|NCT01546571|588799241|FG003|Overall Study|Withdrawal by Subject|9|||
163026617|NCT01546571|588799242|FG004|Overall Study|Withdrawal by Subject|2|||
163026618|NCT01546571|588799238|FG000|Overall Study|Intercurrent Illness|1|||
163026619|NCT01546571|588799239|FG001|Overall Study|Intercurrent Illness|2|||
163026620|NCT01546571|588799240|FG002|Overall Study|Intercurrent Illness|0|||
163026621|NCT01546571|588799241|FG003|Overall Study|Intercurrent Illness|0|||
163026622|NCT01546571|588799242|FG004|Overall Study|Intercurrent Illness|0|||
163026623|NCT01546571|588799238|FG000|Overall Study|Other Cancers|0|||
163026624|NCT01546571|588799239|FG001|Overall Study|Other Cancers|0|||
163026625|NCT01546571|588799240|FG002|Overall Study|Other Cancers|0|||
163026626|NCT01546571|588799241|FG003|Overall Study|Other Cancers|3|||
163026627|NCT01546571|588799242|FG004|Overall Study|Other Cancers|1|||
163026628|NCT01546571|588799238|FG000|Overall Study|Other|0|||
163026629|NCT01546571|588799239|FG001|Overall Study|Other|0|||
163026630|NCT01546571|588799240|FG002|Overall Study|Other|3|||
163026631|NCT01546571|588799241|FG003|Overall Study|Other|0|||
163067987|NCT05221866|588955141|FG002|Overall Study|Withdrawal by Subject|6|||
163067988|NCT05221866|588955142|FG003|Overall Study|Withdrawal by Subject|4|||
163067989|NCT05221866|588955139|FG000|Overall Study|Physician Decision|3|||
163067990|NCT05221866|588955140|FG001|Overall Study|Physician Decision|2|||
162644203|NCT03447990|587413575|FG001|Overall Study|Withdrawal by Subject|0|||
163026632|NCT01546571|588799242|FG004|Overall Study|Other|0|||
163026633|NCT00478699|588799248|FG000|Overall Study|Inclusion Error|1|||
163026634|NCT00478699|588799249|FG001|Overall Study|Inclusion Error|7|||
163026635|NCT00478699|588799248|FG000|Overall Study|Not receive study treatment|6|||
163026636|NCT00478699|588799249|FG001|Overall Study|Not receive study treatment|30|||
163026637|NCT01508130|588799250|FG000|Overall Study|Adverse Event|81|||
163067991|NCT05221866|588955141|FG002|Overall Study|Physician Decision|1|||
163067992|NCT05221866|588955142|FG003|Overall Study|Physician Decision|4|||
163067993|NCT05221866|588955139|FG000|Overall Study|Lost to Follow-up|12|||
163067994|NCT05221866|588955140|FG001|Overall Study|Lost to Follow-up|17|||
163067995|NCT05221866|588955141|FG002|Overall Study|Lost to Follow-up|14|||
163067996|NCT05221866|588955142|FG003|Overall Study|Lost to Follow-up|14|||
163067997|NCT05221866|588955139|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
163067998|NCT05221866|588955140|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
163067999|NCT05221866|588955141|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
163068000|NCT05221866|588955142|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
163068001|NCT05774977|588955145|FG000|Overall Study|Withdrawal by Subject|2|||
163068002|NCT04470427|588955147|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
163068003|NCT04470427|588955148|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
163068004|NCT04470427|588955149|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
163068005|NCT04470427|588955150|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
163068006|NCT04470427|588955151|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
163068007|NCT04470427|588955152|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
163068008|NCT04470427|588955147|FG000|Part B :Open-label|Other than specified|0|||
163068009|NCT04470427|588955148|FG001|Part B :Open-label|Other than specified|0|||
163068010|NCT04470427|588955149|FG002|Part B :Open-label|Other than specified|788|||
163068011|NCT04470427|588955150|FG003|Part B :Open-label|Other than specified|0|||
163068012|NCT04470427|588955151|FG004|Part B :Open-label|Other than specified|523|||
163068013|NCT04470427|588955152|FG005|Part B :Open-label|Other than specified|0|||
163068014|NCT04470427|588955147|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
163068015|NCT04470427|588955148|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
163068016|NCT04470427|588955149|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
163068017|NCT04470427|588955150|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
163068018|NCT04470427|588955151|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
163068019|NCT04470427|588955152|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
163068020|NCT04470427|588955147|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
163068021|NCT04470427|588955148|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
163068022|NCT04470427|588955149|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
163068023|NCT04470427|588955150|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
163068024|NCT04470427|588955151|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
163068025|NCT04470427|588955152|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
163068026|NCT01018979|588955153|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
163068027|NCT01018979|588955154|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
163068028|NCT01018979|588955153|FG000|Overall Study|Not received at least one dose|0|||
163068029|NCT01018979|588955154|FG001|Overall Study|Not received at least one dose|1|||
163068030|NCT02324153|588955157|FG000|Overall Study|Withdrawal by Subject|4|||
163068031|NCT02324153|588955158|FG001|Overall Study|Withdrawal by Subject|1|||
163068032|NCT02324153|588955157|FG000|Overall Study|Surgery postponed after randomization|3|||
163068033|NCT02324153|588955158|FG001|Overall Study|Surgery postponed after randomization|0|||
163068034|NCT02324153|588955157|FG000|Overall Study|Developed delirium preoperatively|1|||
163068035|NCT02324153|588955158|FG001|Overall Study|Developed delirium preoperatively|0|||
163068036|NCT01937299|588955159|FG000|Overall Study|Adverse Event|13|||
163068037|NCT01937299|588955160|FG001|Overall Study|Adverse Event|0|||
163068038|NCT01937299|588955159|FG000|Overall Study|Lack of Efficacy|0|||
163068039|NCT01937299|588955160|FG001|Overall Study|Lack of Efficacy|4|||
163068040|NCT01937299|588955159|FG000|Overall Study|Withdrawal by Subject|1|||
163068041|NCT01937299|588955160|FG001|Overall Study|Withdrawal by Subject|0|||
163068042|NCT01913353|588955161|FG000|Overall Study|Adverse Event|2|||
163068043|NCT01913353|588955162|FG001|Overall Study|Adverse Event|0|||
163068044|NCT01913353|588955161|FG000|Overall Study|Physician Decision|0|||
163068045|NCT01913353|588955162|FG001|Overall Study|Physician Decision|2|||
163068046|NCT01913353|588955161|FG000|Overall Study|Withdrawal by Subject|20|||
163068047|NCT01913353|588955162|FG001|Overall Study|Withdrawal by Subject|6|||
163068048|NCT01913353|588955161|FG000|Overall Study|multiple reasons|10|||
163068049|NCT01913353|588955162|FG001|Overall Study|multiple reasons|7|||
163068050|NCT00385840|588955163|FG000|Overall Study|Adverse Event|1|||
163068051|NCT00385840|588955164|FG001|Overall Study|Adverse Event|1|||
163068052|NCT00385840|588955163|FG000|Overall Study|Lost to Follow-up|3|||
163068053|NCT00385840|588955164|FG001|Overall Study|Lost to Follow-up|13|||
163068054|NCT04017962|588955165|FG000|Overall Study|Death|2|||
163068055|NCT04017962|588955166|FG001|Overall Study|Death|0|||
163068056|NCT04017962|588955165|FG000|Overall Study|Lost to Follow-up|2|||
163068057|NCT04017962|588955166|FG001|Overall Study|Lost to Follow-up|0|||
163068058|NCT04017962|588955165|FG000|Overall Study|Physician Decision|1|||
163068059|NCT04017962|588955166|FG001|Overall Study|Physician Decision|0|||
163068060|NCT04017962|588955165|FG000|Overall Study|Discontinued LTV|5|||
163068061|NCT04017962|588955166|FG001|Overall Study|Discontinued LTV|0|||
163068062|NCT00700635|588955167|FG000|Overall Study|Adverse Event|1|||
163068063|NCT00700635|588955168|FG001|Overall Study|Adverse Event|0|||
163068064|NCT00700635|588955169|FG002|Overall Study|Adverse Event|0|||
163068065|NCT00700635|588955167|FG000|Overall Study|Lost to Follow-up|1|||
163068066|NCT00700635|588955168|FG001|Overall Study|Lost to Follow-up|3|||
163068067|NCT00700635|588955169|FG002|Overall Study|Lost to Follow-up|0|||
163068068|NCT00700635|588955167|FG000|Overall Study|Protocol Violation|2|||
163068069|NCT00700635|588955168|FG001|Overall Study|Protocol Violation|2|||
163068070|NCT00700635|588955169|FG002|Overall Study|Protocol Violation|0|||
163068071|NCT00700635|588955167|FG000|Overall Study|Withdrawal by Subject|7|||
163068072|NCT00700635|588955168|FG001|Overall Study|Withdrawal by Subject|3|||
163068073|NCT00700635|588955169|FG002|Overall Study|Withdrawal by Subject|1|||
163068074|NCT05172570|588955170|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
163068075|NCT05172570|588955171|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
163068076|NCT05172570|588955172|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
163068077|NCT05172570|588955170|FG000|Overall Study|PI Decision due to equipment shortages|0|||
163068078|NCT05172570|588955171|FG001|Overall Study|PI Decision due to equipment shortages|0|||
163068079|NCT05172570|588955172|FG002|Overall Study|PI Decision due to equipment shortages|1|||
163068080|NCT01260948|588955173|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
163068081|NCT01260948|588955174|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
163068082|NCT01260948|588955173|FG000|Second Intervention|Emesis|0|||
163068083|NCT01260948|588955174|FG001|Second Intervention|Emesis|1|||
163068084|NCT00768053|588955175|FG000|Overall Study|Adverse Event|10|||
163068085|NCT00768053|588955175|FG000|Overall Study|Lost to Follow-up|1|||
163068086|NCT01202591|588955176|FG000|Overall Study|Adverse Event|2|||
163068087|NCT01202591|588955177|FG001|Overall Study|Adverse Event|1|||
163068088|NCT01202591|588955178|FG002|Overall Study|Adverse Event|4|||
163068089|NCT01202591|588955179|FG003|Overall Study|Adverse Event|4|||
163068090|NCT01202591|588955180|FG004|Overall Study|Adverse Event|0|||
163068091|NCT01202591|588955181|FG005|Overall Study|Adverse Event|0|||
163068092|NCT01202591|588955176|FG000|Overall Study|Other reason as per investigator|3|||
163068093|NCT01202591|588955177|FG001|Overall Study|Other reason as per investigator|4|||
163068094|NCT01202591|588955178|FG002|Overall Study|Other reason as per investigator|7|||
163068095|NCT01202591|588955179|FG003|Overall Study|Other reason as per investigator|3|||
163068096|NCT01202591|588955180|FG004|Overall Study|Other reason as per investigator|1|||
163068097|NCT01202591|588955181|FG005|Overall Study|Other reason as per investigator|3|||
163068098|NCT01202591|588955176|FG000|Overall Study|Withdrawal by Subject|0|||
163068099|NCT01202591|588955177|FG001|Overall Study|Withdrawal by Subject|0|||
163068100|NCT01202591|588955178|FG002|Overall Study|Withdrawal by Subject|0|||
163068101|NCT01202591|588955179|FG003|Overall Study|Withdrawal by Subject|0|||
163068102|NCT01202591|588955180|FG004|Overall Study|Withdrawal by Subject|2|||
163068103|NCT01202591|588955181|FG005|Overall Study|Withdrawal by Subject|1|||
163068104|NCT01202591|588955176|FG000|Overall Study|Objective Disease Progression|0|||
163068105|NCT01202591|588955177|FG001|Overall Study|Objective Disease Progression|0|||
163068106|NCT01202591|588955178|FG002|Overall Study|Objective Disease Progression|0|||
163068107|NCT01202591|588955179|FG003|Overall Study|Objective Disease Progression|0|||
163068108|NCT01202591|588955180|FG004|Overall Study|Objective Disease Progression|2|||
163068109|NCT01202591|588955181|FG005|Overall Study|Objective Disease Progression|0|||
163068110|NCT00182637|588955804|FG000|Overall Study|Adverse Event|2|||
163068111|NCT00182637|588955804|FG000|Overall Study|Disease Progression|1|||
162644204|NCT03447990|587413576|FG002|Overall Study|Withdrawal by Subject|0|||
162644205|NCT03447990|587413577|FG003|Overall Study|Withdrawal by Subject|0|||
162644206|NCT03447990|587413578|FG004|Overall Study|Withdrawal by Subject|0|||
162644207|NCT03447990|587413579|FG005|Overall Study|Withdrawal by Subject|0|||
162644208|NCT03447990|587413580|FG006|Overall Study|Withdrawal by Subject|1|||
163026638|NCT01508130|588799251|FG001|Overall Study|Adverse Event|28|||
163026639|NCT01508130|588799250|FG000|Overall Study|Death|3|||
163026640|NCT01508130|588799251|FG001|Overall Study|Death|1|||
163026641|NCT01508130|588799250|FG000|Overall Study|Protocol Violation|2|||
163026642|NCT01508130|588799251|FG001|Overall Study|Protocol Violation|0|||
163026643|NCT01508130|588799250|FG000|Overall Study|Lost to Follow-up|25|||
163026644|NCT01508130|588799251|FG001|Overall Study|Lost to Follow-up|2|||
163026645|NCT01508130|588799250|FG000|Overall Study|Withdrawal by Subject|3|||
163026646|NCT01508130|588799251|FG001|Overall Study|Withdrawal by Subject|3|||
163026647|NCT01508130|588799250|FG000|Overall Study|Subject's substantial non-compliance|25|||
163026648|NCT01508130|588799251|FG001|Overall Study|Subject's substantial non-compliance|9|||
163068112|NCT02068794|588955805|FG000|Overall Study|Withdrawal by Subject|0|||
163068113|NCT02068794|588955806|FG001|Overall Study|Withdrawal by Subject|1|||
163068114|NCT02068794|588955807|FG002|Overall Study|Withdrawal by Subject|2|||
163068115|NCT02068794|588955805|FG000|Overall Study|Early Progression|1|||
163068116|NCT02068794|588955806|FG001|Overall Study|Early Progression|0|||
163068117|NCT02068794|588955807|FG002|Overall Study|Early Progression|1|||
163068118|NCT02068794|588955805|FG000|Overall Study|Ineligible|0|||
162644209|NCT00423150|587413582|FG000|Overall Study|Adverse Event|11|||
162644210|NCT00423150|587413582|FG000|Overall Study|Progression of disease being studied|69|||
163068119|NCT02068794|588955806|FG001|Overall Study|Ineligible|0|||
163068120|NCT02068794|588955807|FG002|Overall Study|Ineligible|1|||
163068121|NCT00898807|588955808|FG000|Overall Study|Withdrawal by Subject|5|||
163068122|NCT00898807|588955809|FG001|Overall Study|Withdrawal by Subject|3|||
163068123|NCT00898807|588955808|FG000|Overall Study|Family pressure to discontinue|2|||
163068124|NCT00898807|588955809|FG001|Overall Study|Family pressure to discontinue|2|||
163068125|NCT00898807|588955808|FG000|Overall Study|Lost to Follow-up|1|||
163068126|NCT00898807|588955809|FG001|Overall Study|Lost to Follow-up|3|||
163068127|NCT00898807|588955808|FG000|Overall Study|Death|0|||
163068128|NCT00898807|588955809|FG001|Overall Study|Death|1|||
163068129|NCT01482221|588955812|FG000|Overall Study|Lack of Efficacy|1|||
163068130|NCT01482221|588955813|FG001|Overall Study|Lack of Efficacy|0|||
163068131|NCT01482221|588955814|FG002|Overall Study|Lack of Efficacy|1|||
163068132|NCT01482221|588955812|FG000|Overall Study|Lost to Follow-up|3|||
163068133|NCT01482221|588955813|FG001|Overall Study|Lost to Follow-up|2|||
163068134|NCT01482221|588955814|FG002|Overall Study|Lost to Follow-up|1|||
163068135|NCT01482221|588955812|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
163068136|NCT01482221|588955813|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
163068137|NCT01482221|588955814|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
163068138|NCT01482221|588955812|FG000|Overall Study|Condition under Investigation Worsened|3|||
163068139|NCT01482221|588955813|FG001|Overall Study|Condition under Investigation Worsened|2|||
163068140|NCT01482221|588955814|FG002|Overall Study|Condition under Investigation Worsened|4|||
163068141|NCT01482221|588955812|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
163068142|NCT01482221|588955813|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
163068143|NCT01482221|588955814|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
163068144|NCT01482221|588955812|FG000|Overall Study|Adverse Event|1|||
163068145|NCT01482221|588955813|FG001|Overall Study|Adverse Event|7|||
163068146|NCT01482221|588955814|FG002|Overall Study|Adverse Event|3|||
163068147|NCT01482221|588955812|FG000|Overall Study|Withdrawal by Subject|10|||
163068148|NCT01482221|588955813|FG001|Overall Study|Withdrawal by Subject|7|||
163068149|NCT01482221|588955814|FG002|Overall Study|Withdrawal by Subject|12|||
163068150|NCT01482221|588955812|FG000|Overall Study|Incorrect randomization|0|||
163068151|NCT01482221|588955813|FG001|Overall Study|Incorrect randomization|1|||
163068152|NCT01482221|588955814|FG002|Overall Study|Incorrect randomization|0|||
163068153|NCT01482221|588955812|FG000|Overall Study|Physician Decision|0|||
163068154|NCT01482221|588955813|FG001|Overall Study|Physician Decision|1|||
163068155|NCT01482221|588955814|FG002|Overall Study|Physician Decision|0|||
163068156|NCT05607043|588955815|FG000|Overall Study|Lost to Follow-up|2|||
163068157|NCT05427916|588955819|FG000|Overall Study|Adverse Event|3|||
163068158|NCT05427916|588955820|FG001|Overall Study|Adverse Event|0|||
163068159|NCT05427916|588955819|FG000|Overall Study|Lack of Efficacy|6|||
163068160|NCT05427916|588955820|FG001|Overall Study|Lack of Efficacy|0|||
163068161|NCT05427916|588955819|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
163068162|NCT05427916|588955820|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
163068163|NCT00081458|588955823|FG000|Overall Study|Adverse Event|1|||
163068164|NCT00081458|588955824|FG001|Overall Study|Adverse Event|5|||
163068165|NCT00081458|588955825|FG002|Overall Study|Adverse Event|2|||
163068166|NCT00081458|588955823|FG000|Overall Study|Withdrawal by Subject|0|||
163068167|NCT00081458|588955824|FG001|Overall Study|Withdrawal by Subject|3|||
163068168|NCT00081458|588955825|FG002|Overall Study|Withdrawal by Subject|1|||
163068169|NCT00081458|588955823|FG000|Overall Study|Randomized but not dosed|0|||
163068170|NCT00081458|588955824|FG001|Overall Study|Randomized but not dosed|0|||
163068171|NCT00081458|588955825|FG002|Overall Study|Randomized but not dosed|1|||
163068172|NCT03384966|588955826|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
163068173|NCT03384966|588955827|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
163068174|NCT03384966|588955828|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
163068175|NCT03384966|588955826|FG000|Follow-up Period|Adverse Event|1|||
163068176|NCT03384966|588955827|FG001|Follow-up Period|Adverse Event|0|||
163068177|NCT03384966|588955828|FG002|Follow-up Period|Adverse Event|0|||
163068178|NCT04790201|588955829|FG000|Overall Study|Lost to Follow-up|0|||
163068179|NCT04790201|588955830|FG001|Overall Study|Lost to Follow-up|0|||
162644211|NCT00423150|587413582|FG000|Overall Study|Withdrawal by Subject|1|||
162644212|NCT00423150|587413582|FG000|Overall Study|Non-compliance with protocol|1|||
162644213|NCT00423150|587413582|FG000|Overall Study|Administrative|4|||
162644214|NCT05104567|587413584|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162644215|NCT05104567|587413585|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
163068180|NCT04790201|588955831|FG002|Overall Study|Lost to Follow-up|2|||
163068181|NCT04790201|588955829|FG000|Overall Study|Death|0|||
163068182|NCT04790201|588955830|FG001|Overall Study|Death|1|||
163068183|NCT04790201|588955831|FG002|Overall Study|Death|0|||
163068184|NCT04790201|588955829|FG000|Overall Study|Protocol Violation|1|||
163068185|NCT04790201|588955830|FG001|Overall Study|Protocol Violation|0|||
163068186|NCT04790201|588955831|FG002|Overall Study|Protocol Violation|1|||
163068187|NCT01334515|588955832|FG000|Overall Study|Adverse Event|1|||
163068188|NCT01334515|588955833|FG001|Overall Study|Adverse Event|6|||
163068189|NCT01334515|588955832|FG000|Overall Study|Death|1|||
163068190|NCT01334515|588955833|FG001|Overall Study|Death|0|||
163068191|NCT01334515|588955832|FG000|Overall Study|Lack of Efficacy|8|||
163068192|NCT01334515|588955833|FG001|Overall Study|Lack of Efficacy|21|||
163068193|NCT01334515|588955832|FG000|Overall Study|Physician Decision|1|||
163068194|NCT01334515|588955833|FG001|Overall Study|Physician Decision|1|||
163068195|NCT01334515|588955832|FG000|Overall Study|Withdrawal by Subject|1|||
163068196|NCT01334515|588955833|FG001|Overall Study|Withdrawal by Subject|1|||
163068197|NCT03637374|588955834|FG000|Overall Study|Death|2|||
163068198|NCT03637374|588955835|FG001|Overall Study|Death|0|||
163068199|NCT00776997|588955837|FG000|Overall Study|Adverse Event|2|||
163068200|NCT00933166|588955838|FG000|Overall Study|Lost to Follow-up|4|||
163068201|NCT00933166|588955838|FG000|Overall Study|Lack of Efficacy|9|||
163026649|NCT01508130|588799250|FG000|Overall Study|Insufficient therapeutic response|74|||
163026650|NCT01508130|588799251|FG001|Overall Study|Insufficient therapeutic response|23|||
163026651|NCT01508130|588799250|FG000|Overall Study|Administrative|14|||
163026652|NCT01508130|588799251|FG001|Overall Study|Administrative|3|||
163026653|NCT01880086|588799253|FG000|Overall Study|Lost to Follow-up|1|||
163068202|NCT00933166|588955838|FG000|Overall Study|Unavailable|4|||
163068203|NCT00933166|588955838|FG000|Overall Study|Withdrawal by Subject|1|||
163068204|NCT03925220|588955840|FG000|Overall Study|Withdrawal by Subject|4|||
163068205|NCT03925220|588955841|FG001|Overall Study|Withdrawal by Subject|4|||
163068206|NCT03925220|588955842|FG002|Overall Study|Withdrawal by Subject|4|||
163026654|NCT01880086|588799254|FG001|Overall Study|Lost to Follow-up|1|||
163026655|NCT02288091|588799257|FG000|Overall Study|Lost to Follow-up|1|||
163026656|NCT02288091|588799257|FG000|Overall Study|Screen fail|7|||
163026657|NCT03843632|588799264|FG000|Overall Study|Withdrawal by Subject|1|||
163026658|NCT03843632|588799265|FG001|Overall Study|Withdrawal by Subject|0|||
163026659|NCT03843632|588799266|FG002|Overall Study|Withdrawal by Subject|0|||
163026660|NCT03843632|588799267|FG003|Overall Study|Withdrawal by Subject|0|||
163026661|NCT03403751|588799269|FG000|Overall Study|Death|5|||
163026662|NCT03403751|588799270|FG001|Overall Study|Death|6|||
163026663|NCT03403751|588799269|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
163026664|NCT03403751|588799270|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
163026665|NCT00520481|588799277|FG000|Overall Study|Adverse Event|4|||
163026666|NCT00520481|588799278|FG001|Overall Study|Adverse Event|1|||
163026667|NCT00520481|588799277|FG000|Overall Study|Withdrawal by Subject|3|||
163026668|NCT00520481|588799278|FG001|Overall Study|Withdrawal by Subject|0|||
163026669|NCT04442269|588799281|FG000|Overall Study|Adverse Event|1|||
163026670|NCT04442269|588799282|FG001|Overall Study|Adverse Event|0|||
163026671|NCT04442269|588799281|FG000|Overall Study|Death|0|||
163026672|NCT04442269|588799282|FG001|Overall Study|Death|1|||
163026673|NCT04442269|588799281|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
163026674|NCT04442269|588799282|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
163026675|NCT04442269|588799281|FG000|Overall Study|Lost to Follow-up|1|||
163026676|NCT04442269|588799282|FG001|Overall Study|Lost to Follow-up|0|||
163026677|NCT04442269|588799281|FG000|Overall Study|Withdrawal by Subject|3|||
163026678|NCT04442269|588799282|FG001|Overall Study|Withdrawal by Subject|2|||
163026679|NCT04442269|588799281|FG000|Overall Study|Protocol Deviation|0|||
163026680|NCT04442269|588799282|FG001|Overall Study|Protocol Deviation|1|||
163026681|NCT04442269|588799281|FG000|Overall Study|Travel Limitations|1|||
163026682|NCT04442269|588799282|FG001|Overall Study|Travel Limitations|1|||
163026683|NCT03802565|588799286|FG000|Overall Study|Adverse Event|0|||
163026684|NCT03802565|588799287|FG001|Overall Study|Adverse Event|1|||
163026685|NCT03802565|588799288|FG002|Overall Study|Adverse Event|2|||
163026686|NCT03802565|588799289|FG003|Overall Study|Adverse Event|1|||
163026687|NCT03802565|588799290|FG004|Overall Study|Adverse Event|1|||
163026688|NCT03802565|588799286|FG000|Overall Study|Withdrawal by Subject|2|||
163026689|NCT03802565|588799287|FG001|Overall Study|Withdrawal by Subject|2|||
163026690|NCT03802565|588799288|FG002|Overall Study|Withdrawal by Subject|2|||
163026691|NCT03802565|588799289|FG003|Overall Study|Withdrawal by Subject|0|||
163026692|NCT03802565|588799290|FG004|Overall Study|Withdrawal by Subject|1|||
163026693|NCT03802565|588799286|FG000|Overall Study|Protocol Violation|2|||
163068207|NCT03925220|588955843|FG003|Overall Study|Withdrawal by Subject|4|||
162644216|NCT05104567|587413586|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163026694|NCT03802565|588799287|FG001|Overall Study|Protocol Violation|1|||
163068208|NCT03925220|588955840|FG000|Overall Study|Lost to Follow-up|40|||
163068209|NCT03925220|588955841|FG001|Overall Study|Lost to Follow-up|46|||
163068210|NCT03925220|588955842|FG002|Overall Study|Lost to Follow-up|37|||
163068211|NCT03925220|588955843|FG003|Overall Study|Lost to Follow-up|38|||
162644217|NCT05104567|587413587|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
163026695|NCT03802565|588799288|FG002|Overall Study|Protocol Violation|4|||
163026696|NCT03802565|588799289|FG003|Overall Study|Protocol Violation|5|||
163026697|NCT03802565|588799290|FG004|Overall Study|Protocol Violation|1|||
163026698|NCT03802565|588799286|FG000|Overall Study|Lost to Follow-up|0|||
163026699|NCT03802565|588799287|FG001|Overall Study|Lost to Follow-up|0|||
163026700|NCT03802565|588799288|FG002|Overall Study|Lost to Follow-up|1|||
163068212|NCT00374868|588955844|FG000|Overall Study|Adverse Event|12|||
163068213|NCT00374868|588955844|FG000|Overall Study|Progressive Disease|7|||
163068214|NCT00374868|588955844|FG000|Overall Study|Physician Decision|13|||
163068215|NCT00374868|588955844|FG000|Overall Study|Lost to Follow-up|1|||
163068216|NCT00374868|588955844|FG000|Overall Study|Death|2|||
163068217|NCT00374868|588955844|FG000|Overall Study|Other - Not Specified|1|||
163068218|NCT03188185|588955845|FG000|Stage 1|Adverse Event|4|||
163068219|NCT03188185|588955846|FG001|Stage 1|Adverse Event|12|||
163068220|NCT03188185|588955847|FG002|Stage 1|Adverse Event|0|||
163068221|NCT03188185|588955848|FG003|Stage 1|Adverse Event|0|||
163068222|NCT03188185|588955845|FG000|Stage 1|Lack of Efficacy|0|||
163068223|NCT03188185|588955846|FG001|Stage 1|Lack of Efficacy|2|||
163068224|NCT03188185|588955847|FG002|Stage 1|Lack of Efficacy|0|||
163068225|NCT03188185|588955848|FG003|Stage 1|Lack of Efficacy|0|||
163068226|NCT03188185|588955845|FG000|Stage 1|Lost to Follow-up|6|||
163068227|NCT03188185|588955846|FG001|Stage 1|Lost to Follow-up|1|||
163068228|NCT03188185|588955847|FG002|Stage 1|Lost to Follow-up|0|||
163068229|NCT03188185|588955848|FG003|Stage 1|Lost to Follow-up|0|||
163068230|NCT03188185|588955845|FG000|Stage 1|Withdrawal by Subject|9|||
163068231|NCT03188185|588955846|FG001|Stage 1|Withdrawal by Subject|0|||
163068232|NCT03188185|588955847|FG002|Stage 1|Withdrawal by Subject|0|||
163068233|NCT03188185|588955848|FG003|Stage 1|Withdrawal by Subject|0|||
163068234|NCT03188185|588955845|FG000|Stage 1|Identified as a professional patient|0|||
163068235|NCT03188185|588955846|FG001|Stage 1|Identified as a professional patient|1|||
163068236|NCT03188185|588955847|FG002|Stage 1|Identified as a professional patient|0|||
163068237|NCT03188185|588955848|FG003|Stage 1|Identified as a professional patient|0|||
163068238|NCT03188185|588955845|FG000|Stage 2|Adverse Event|0|||
163068239|NCT03188185|588955846|FG001|Stage 2|Adverse Event|0|||
163068240|NCT03188185|588955847|FG002|Stage 2|Adverse Event|2|||
163068241|NCT03188185|588955848|FG003|Stage 2|Adverse Event|4|||
163068242|NCT03188185|588955845|FG000|Stage 2|Lack of Efficacy|0|||
163068243|NCT03188185|588955846|FG001|Stage 2|Lack of Efficacy|0|||
163068244|NCT03188185|588955847|FG002|Stage 2|Lack of Efficacy|3|||
163068245|NCT03188185|588955848|FG003|Stage 2|Lack of Efficacy|0|||
163068246|NCT03188185|588955845|FG000|Stage 2|Lost to Follow-up|0|||
163068247|NCT03188185|588955846|FG001|Stage 2|Lost to Follow-up|0|||
163068248|NCT03188185|588955847|FG002|Stage 2|Lost to Follow-up|1|||
163068249|NCT03188185|588955848|FG003|Stage 2|Lost to Follow-up|0|||
163068250|NCT03188185|588955845|FG000|Stage 2|Physician Decision|0|||
163068251|NCT03188185|588955846|FG001|Stage 2|Physician Decision|0|||
163068252|NCT03188185|588955847|FG002|Stage 2|Physician Decision|0|||
163068253|NCT03188185|588955848|FG003|Stage 2|Physician Decision|1|||
163068254|NCT03188185|588955845|FG000|Stage 2|Withdrawal by Subject|0|||
163068255|NCT03188185|588955846|FG001|Stage 2|Withdrawal by Subject|0|||
163068256|NCT03188185|588955847|FG002|Stage 2|Withdrawal by Subject|3|||
163068257|NCT03188185|588955848|FG003|Stage 2|Withdrawal by Subject|1|||
163068258|NCT03301714|588955849|FG000|Overall Study|Lost to Follow-up|10|||
163068259|NCT03301714|588955850|FG001|Overall Study|Lost to Follow-up|4|||
163068260|NCT03301714|588955851|FG002|Overall Study|Lost to Follow-up|4|||
163068261|NCT03301714|588955849|FG000|Overall Study|Did not receive allocated intervention|0|||
163068262|NCT03301714|588955850|FG001|Overall Study|Did not receive allocated intervention|2|||
163068263|NCT03301714|588955851|FG002|Overall Study|Did not receive allocated intervention|3|||
163068264|NCT04465955|588955852|FG000|Overall Study|Withdrew consent|6|||
163068265|NCT04465955|588955853|FG001|Overall Study|Withdrew consent|10|||
163068266|NCT04465955|588955854|FG002|Overall Study|Withdrew consent|7|||
163068267|NCT04465955|588955852|FG000|Overall Study|Adverse Event|6|||
163068268|NCT04465955|588955853|FG001|Overall Study|Adverse Event|5|||
163068269|NCT04465955|588955854|FG002|Overall Study|Adverse Event|1|||
163068270|NCT04465955|588955852|FG000|Overall Study|Lost to Follow-up|2|||
163068271|NCT04465955|588955853|FG001|Overall Study|Lost to Follow-up|0|||
163068272|NCT04465955|588955854|FG002|Overall Study|Lost to Follow-up|3|||
163068273|NCT04465955|588955852|FG000|Overall Study|Other|1|||
163068274|NCT04465955|588955853|FG001|Overall Study|Other|1|||
163068275|NCT04465955|588955854|FG002|Overall Study|Other|3|||
163068276|NCT04738487|588955855|FG000|Overall Study|Participant Ongoing in Study|298|||
163068277|NCT04738487|588955856|FG001|Overall Study|Participant Ongoing in Study|297|||
163068278|NCT04738487|588955855|FG000|Overall Study|Withdrawal by Subject|7|||
163068279|NCT04738487|588955856|FG001|Overall Study|Withdrawal by Subject|9|||
163068280|NCT04738487|588955855|FG000|Overall Study|Lost to Follow-up|2|||
163068281|NCT04738487|588955856|FG001|Overall Study|Lost to Follow-up|0|||
163068282|NCT04738487|588955855|FG000|Overall Study|Death|287|||
163068283|NCT04738487|588955856|FG001|Overall Study|Death|306|||
163068284|NCT00632359|588955857|FG000|Overall Study|Withdrawal by Subject|2|||
163068285|NCT03599713|588955860|FG000|Overall Study|Death|38|||
163068286|NCT03599713|588955861|FG001|Overall Study|Death|3|||
163068287|NCT03599713|588955860|FG000|Overall Study|Withdrawal by Subject|17|||
163068288|NCT03599713|588955861|FG001|Overall Study|Withdrawal by Subject|0|||
163068289|NCT03599713|588955860|FG000|Overall Study|Lost to Follow-up|4|||
163068290|NCT03599713|588955861|FG001|Overall Study|Lost to Follow-up|0|||
163068291|NCT03599713|588955860|FG000|Overall Study|Discontinued Due to End of Study|42|||
163068292|NCT03599713|588955861|FG001|Overall Study|Discontinued Due to End of Study|3|||
163068293|NCT05578872|588955862|FG000|Overall Study|Withdrawal by Subject|2|||
163068294|NCT05578872|588955863|FG001|Overall Study|Withdrawal by Subject|1|||
163068295|NCT05578872|588955862|FG000|Overall Study|Adverse Event|1|||
163068296|NCT05578872|588955863|FG001|Overall Study|Adverse Event|1|||
163068297|NCT05578872|588955862|FG000|Overall Study|Physician Decision|1|||
163068298|NCT05578872|588955863|FG001|Overall Study|Physician Decision|2|||
163068299|NCT05578872|588955862|FG000|Overall Study|Progressive disease|10|||
163068300|NCT05578872|588955863|FG001|Overall Study|Progressive disease|9|||
163068301|NCT05578872|588955862|FG000|Overall Study|Sponsor decision|0|||
163068302|NCT05578872|588955863|FG001|Overall Study|Sponsor decision|1|||
163068303|NCT05578872|588955862|FG000|Overall Study|Toxicity and Patient's decision|0|||
163068304|NCT05578872|588955863|FG001|Overall Study|Toxicity and Patient's decision|1|||
163068305|NCT04941898|588957225|FG000|Overall Study|Protocol Violation|1|||
163068306|NCT03641924|588957226|FG000|Overall Study|Withdrawal by Subject|26|||
163068307|NCT03641924|588957226|FG000|Overall Study|Lost to Follow-up|16|||
163068308|NCT03641924|588957226|FG000|Overall Study|Protocol Violation|10|||
163068309|NCT01022580|588957227|FG000|Overall Study|Death|18|||
163068310|NCT01022580|588957228|FG001|Overall Study|Death|22|||
163068311|NCT03439839|588957229|FG000|Overall Study|Death|3|||
163068312|NCT03439839|588957230|FG001|Overall Study|Death|0|||
163068313|NCT03720847|588957231|FG000|Washout|Physician Decision|1|||
163068314|NCT03720847|588957232|FG001|Washout|Physician Decision|2|||
163068315|NCT01500096|588957233|FG000|Overall Study|Lost to Follow-up|1|||
163068316|NCT01500096|588957234|FG001|Overall Study|Lost to Follow-up|0|||
163068317|NCT01500096|588957235|FG002|Overall Study|Lost to Follow-up|0|||
163068318|NCT01500096|588957236|FG003|Overall Study|Lost to Follow-up|2|||
163068319|NCT03033901|588957240|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
163068320|NCT03033901|588957240|FG000|Overall Study|Refused PSG|23|||
163068321|NCT03033901|588957240|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
163068322|NCT03033901|588957240|FG000|Overall Study|Missing Oximetry Data|3|||
163068323|NCT00924651|588957243|FG000|Overall Study|Chemo started too soon|2|||
163068324|NCT00924651|588957244|FG001|Overall Study|Chemo started too soon|3|||
163068325|NCT00924651|588957243|FG000|Overall Study|No Reason|3|||
163068326|NCT00924651|588957244|FG001|Overall Study|No Reason|7|||
163068327|NCT00924651|588957243|FG000|Overall Study|Overwhelmed|6|||
163068328|NCT00924651|588957244|FG001|Overall Study|Overwhelmed|6|||
163068329|NCT00924651|588957243|FG000|Overall Study|Noncompliant|1|||
163068330|NCT00924651|588957244|FG001|Overall Study|Noncompliant|4|||
163068331|NCT00924651|588957243|FG000|Overall Study|Medical|1|||
163068332|NCT00924651|588957244|FG001|Overall Study|Medical|3|||
163068333|NCT00924651|588957243|FG000|Overall Study|Changed Mind|10|||
163068334|NCT00924651|588957244|FG001|Overall Study|Changed Mind|1|||
163068335|NCT00924651|588957243|FG000|Overall Study|Incomplete Form|2|||
163068336|NCT00924651|588957244|FG001|Overall Study|Incomplete Form|1|||
163068337|NCT00723944|588957245|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
163068338|NCT00723944|588957246|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
163068339|NCT00723944|588957245|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
163068340|NCT00723944|588957246|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
163068341|NCT00723944|588957245|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
163068342|NCT00723944|588957246|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
163068343|NCT00835978|588957247|FG000|Overall Study|Death|33|||
163068344|NCT00835978|588957248|FG001|Overall Study|Death|40|||
163068345|NCT00835978|588957249|FG002|Overall Study|Death|49|||
163068346|NCT00835978|588957250|FG003|Overall Study|Death|4|||
163068347|NCT00835978|588957247|FG000|Overall Study|Lost to Follow-up|3|||
163068348|NCT00835978|588957248|FG001|Overall Study|Lost to Follow-up|4|||
163068349|NCT00835978|588957249|FG002|Overall Study|Lost to Follow-up|2|||
163068350|NCT00835978|588957250|FG003|Overall Study|Lost to Follow-up|1|||
163068351|NCT00835978|588957247|FG000|Overall Study|Other|5|||
163068352|NCT00835978|588957248|FG001|Overall Study|Other|1|||
163068353|NCT00835978|588957249|FG002|Overall Study|Other|8|||
163068354|NCT00835978|588957250|FG003|Overall Study|Other|0|||
163068355|NCT00835978|588957247|FG000|Overall Study|Objective progression or relapse|2|||
163068356|NCT00835978|588957248|FG001|Overall Study|Objective progression or relapse|0|||
163068357|NCT00835978|588957249|FG002|Overall Study|Objective progression or relapse|1|||
163068358|NCT00835978|588957250|FG003|Overall Study|Objective progression or relapse|0|||
163068359|NCT00835978|588957247|FG000|Overall Study|Adverse Event|1|||
163068360|NCT00835978|588957248|FG001|Overall Study|Adverse Event|0|||
163068361|NCT00835978|588957249|FG002|Overall Study|Adverse Event|1|||
163068362|NCT00835978|588957250|FG003|Overall Study|Adverse Event|0|||
163068363|NCT00835978|588957247|FG000|Overall Study|Withdrawal by Subject|0|||
163068364|NCT00835978|588957248|FG001|Overall Study|Withdrawal by Subject|3|||
163068365|NCT00835978|588957249|FG002|Overall Study|Withdrawal by Subject|0|||
163068366|NCT00835978|588957250|FG003|Overall Study|Withdrawal by Subject|5|||
163068367|NCT00835978|588957247|FG000|Overall Study|Study terminated by sponsor|12|||
163068368|NCT00835978|588957248|FG001|Overall Study|Study terminated by sponsor|8|||
163068369|NCT00835978|588957249|FG002|Overall Study|Study terminated by sponsor|30|||
163068370|NCT00835978|588957250|FG003|Overall Study|Study terminated by sponsor|0|||
163068371|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Death|1|||
163068372|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Death|0|||
163068373|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
163068374|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
163068375|NCT02506036|588957251|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
163068376|NCT02506036|588957252|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
163068377|NCT01410604|588957254|FG000|Overall Study|Adverse Event|2|||
163068378|NCT01410604|588957255|FG001|Overall Study|Adverse Event|1|||
163068379|NCT01410604|588957254|FG000|Overall Study|Lost to Follow-up|1|||
163068380|NCT01410604|588957255|FG001|Overall Study|Lost to Follow-up|0|||
163068381|NCT01410604|588957254|FG000|Overall Study|Physician Decision|0|||
163068382|NCT01410604|588957255|FG001|Overall Study|Physician Decision|1|||
163068383|NCT02383173|588957260|FG000|Overall Study|Palliative Care Team withdrew|0|||
163068384|NCT02383173|588957261|FG001|Overall Study|Palliative Care Team withdrew|2|||
163068385|NCT00800540|588957262|FG000|Period One: 6 Weeks|Noncompliance|1|||
163068386|NCT00800540|588957263|FG001|Period One: 6 Weeks|Noncompliance|0|||
163068387|NCT00800540|588957262|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
163068388|NCT00800540|588957263|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
163068389|NCT00800540|588957262|FG000|Period 2: 6 Weeks|Adverse Event|0|||
163068390|NCT00800540|588957263|FG001|Period 2: 6 Weeks|Adverse Event|1|||
163068391|NCT00429299|588957264|FG000|Overall Study|Disease Progression|1|||
163068392|NCT00429299|588957265|FG001|Overall Study|Disease Progression|1|||
163068393|NCT00429299|588957266|FG002|Overall Study|Disease Progression|0|||
163068394|NCT00429299|588957264|FG000|Overall Study|Adverse Event|2|||
163068395|NCT00429299|588957265|FG001|Overall Study|Adverse Event|5|||
163068396|NCT00429299|588957266|FG002|Overall Study|Adverse Event|1|||
163068397|NCT00429299|588957264|FG000|Overall Study|Protocol Violation|1|||
163068398|NCT00429299|588957265|FG001|Overall Study|Protocol Violation|0|||
163068399|NCT00429299|588957266|FG002|Overall Study|Protocol Violation|0|||
163068400|NCT00429299|588957264|FG000|Overall Study|Withdrawal by Subject|0|||
163026701|NCT03802565|588799289|FG003|Overall Study|Lost to Follow-up|0|||
163026702|NCT03802565|588799290|FG004|Overall Study|Lost to Follow-up|0|||
163026703|NCT03802565|588799286|FG000|Overall Study|Subjects Related to Each Other|1|||
163026704|NCT03802565|588799287|FG001|Overall Study|Subjects Related to Each Other|0|||
163026705|NCT03802565|588799288|FG002|Overall Study|Subjects Related to Each Other|0|||
163026706|NCT03802565|588799289|FG003|Overall Study|Subjects Related to Each Other|2|||
163026707|NCT03802565|588799290|FG004|Overall Study|Subjects Related to Each Other|1|||
163026708|NCT03802565|588799286|FG000|Overall Study|Elevated Enzymes|0|||
163026709|NCT03802565|588799287|FG001|Overall Study|Elevated Enzymes|0|||
163026710|NCT03802565|588799288|FG002|Overall Study|Elevated Enzymes|0|||
163026711|NCT03802565|588799289|FG003|Overall Study|Elevated Enzymes|0|||
163026712|NCT03802565|588799290|FG004|Overall Study|Elevated Enzymes|2|||
163026713|NCT00430352|588799291|FG000|Overall Study|Disease progression|58|||
163026714|NCT00430352|588799291|FG000|Overall Study|Withdrawal by Subject|11|||
163026715|NCT00430352|588799291|FG000|Overall Study|Adverse Event|16|||
163026716|NCT00430352|588799291|FG000|Overall Study|Death|5|||
163026717|NCT00430352|588799291|FG000|Overall Study|Other|48|||
163026718|NCT03099694|588799292|FG000|Overall Study|Withdrawal by Subject|11|||
163026719|NCT03099694|588799293|FG001|Overall Study|Withdrawal by Subject|13|||
163026720|NCT03099694|588799292|FG000|Overall Study|Lost to Follow-up|9|||
163026721|NCT03099694|588799293|FG001|Overall Study|Lost to Follow-up|5|||
163026722|NCT04326439|588799294|FG000|Overall Study|Withdrawal by Subject|1|||
163026723|NCT04326439|588799295|FG001|Overall Study|Withdrawal by Subject|0|||
163026724|NCT04326439|588799294|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
163026725|NCT04326439|588799295|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
163026726|NCT04326439|588799294|FG000|Overall Study|Relapse after Induction 2|0|||
163026727|NCT04326439|588799295|FG001|Overall Study|Relapse after Induction 2|1|||
163026728|NCT04326439|588799294|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
163026729|NCT04326439|588799295|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
163068401|NCT00429299|588957265|FG001|Overall Study|Withdrawal by Subject|1|||
163026730|NCT00471718|588799297|FG000|Overall Study|Adverse Event|3|||
163026731|NCT00471718|588799297|FG000|Overall Study|other complicating disease|1|||
163026732|NCT00471718|588799297|FG000|Overall Study|disease progression|22|||
163068402|NCT00429299|588957266|FG002|Overall Study|Withdrawal by Subject|3|||
163068403|NCT04871113|588957267|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068404|NCT04871113|588957268|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068405|NCT04871113|588957269|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068406|NCT04871113|588957270|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068407|NCT04871113|588957271|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068408|NCT04871113|588957272|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
163068409|NCT04871113|588957273|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068410|NCT04871113|588957274|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068411|NCT04871113|588957275|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068412|NCT04871113|588957276|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
163068413|NCT04871113|588957267|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068414|NCT04871113|588957268|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068415|NCT04871113|588957269|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068416|NCT04871113|588957270|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068417|NCT04871113|588957271|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068418|NCT04871113|588957272|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068419|NCT04871113|588957273|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
163068420|NCT04871113|588957274|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
163068421|NCT04871113|588957275|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068422|NCT04871113|588957276|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
163068423|NCT02143778|588957277|FG000|Overall Study|Withdrawal by Subject|2|||
163068424|NCT02143778|588957277|FG000|Overall Study|Device malfunction|1|||
163068425|NCT05630755|588957278|FG000|Overall Study|Lost to Follow-up|7|||
163068426|NCT05630755|588957279|FG001|Overall Study|Lost to Follow-up|0|||
163068427|NCT05630755|588957278|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
163068428|NCT05630755|588957279|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
163068429|NCT05630755|588957278|FG000|Overall Study|Withdrawal by Subject|9|||
163068430|NCT05630755|588957279|FG001|Overall Study|Withdrawal by Subject|3|||
163068431|NCT05630755|588957278|FG000|Overall Study|Participant moved away from trial site|0|||
163068432|NCT05630755|588957279|FG001|Overall Study|Participant moved away from trial site|1|||
163068433|NCT05630755|588957278|FG000|Overall Study|Status not Recorded|316|||
163068434|NCT05630755|588957279|FG001|Overall Study|Status not Recorded|161|||
163068435|NCT02836769|588957285|FG000|Overall Study|Lost to Follow-up|10|||
163068436|NCT02836769|588957285|FG000|Overall Study|Medical withdrawal|2|||
163068437|NCT02836769|588957285|FG000|Overall Study|Withdrawal by Subject|3|||
163068438|NCT04339972|588957286|FG000|Overall Study|Scheduling Issues|3|||
163068439|NCT04339972|588957287|FG001|Overall Study|Scheduling Issues|3|||
163068440|NCT04339972|588957286|FG000|Overall Study|dropout|1|||
163068441|NCT04339972|588957287|FG001|Overall Study|dropout|1|||
163068442|NCT04339972|588957286|FG000|Overall Study|Technical issues|1|||
163068443|NCT04339972|588957287|FG001|Overall Study|Technical issues|0|||
163068444|NCT04339972|588957286|FG000|Overall Study|Claustraphobia|0|||
163068445|NCT04339972|588957287|FG001|Overall Study|Claustraphobia|1|||
163068446|NCT02403271|588957291|FG000|Period 1|Other varied reasons|1|||
163068447|NCT02403271|588957292|FG001|Period 1|Other varied reasons|0|||
163068448|NCT02403271|588957291|FG000|Period 2|Withdrawal by Subject|0|||
163068449|NCT02403271|588957292|FG001|Period 2|Withdrawal by Subject|14|||
163068450|NCT02403271|588957291|FG000|Period 2|Death|0|||
163068451|NCT02403271|588957292|FG001|Period 2|Death|84|||
163068452|NCT02403271|588957291|FG000|Period 2|Lost to Follow-up|0|||
163068453|NCT02403271|588957292|FG001|Period 2|Lost to Follow-up|2|||
163068454|NCT02403271|588957291|FG000|Period 2|Study Terminated by Sponsor|0|||
163068455|NCT02403271|588957292|FG001|Period 2|Study Terminated by Sponsor|14|||
163068456|NCT02403271|588957291|FG000|Period 2|Other varied reasons|0|||
163068457|NCT02403271|588957292|FG001|Period 2|Other varied reasons|10|||
163068458|NCT02112552|588957295|FG000|Overall Study|Withdrawal by Subject|1|||
163068459|NCT02112552|588957295|FG000|Overall Study|Adverse Event|1|||
163068460|NCT00774748|588957296|FG000|Overall Study|Lost to Follow-up|3|||
163068461|NCT03349515|588957298|FG000|Overall Study|Lack of Efficacy|2|||
163068462|NCT03349515|588957299|FG001|Overall Study|Lack of Efficacy|0|||
163068463|NCT03349515|588957298|FG000|Overall Study|Physician Decision|3|||
163068464|NCT03349515|588957299|FG001|Overall Study|Physician Decision|1|||
163068465|NCT02965456|588957306|FG000|Overall Study|Lost to Follow-up|40|||
163068466|NCT02965456|588957307|FG001|Overall Study|Lost to Follow-up|18|||
163068467|NCT02965456|588957306|FG000|Overall Study|Subject Request|22|||
163068468|NCT02965456|588957307|FG001|Overall Study|Subject Request|13|||
163068469|NCT02965456|588957306|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
163068470|NCT02965456|588957307|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
163068471|NCT02965456|588957306|FG000|Overall Study|Adverse Event|3|||
163068472|NCT02965456|588957307|FG001|Overall Study|Adverse Event|0|||
163068473|NCT02965456|588957306|FG000|Overall Study|Noncompliance with Study Drug|1|||
163068474|NCT02965456|588957307|FG001|Overall Study|Noncompliance with Study Drug|1|||
163068475|NCT02965456|588957306|FG000|Overall Study|Worsening Condition|0|||
163068476|NCT02965456|588957307|FG001|Overall Study|Worsening Condition|2|||
163068477|NCT02965456|588957306|FG000|Overall Study|Lack of Efficacy|1|||
163068478|NCT02965456|588957307|FG001|Overall Study|Lack of Efficacy|0|||
163068479|NCT02965456|588957306|FG000|Overall Study|Physician Decision|0|||
163068480|NCT02965456|588957307|FG001|Overall Study|Physician Decision|1|||
163068481|NCT02965456|588957306|FG000|Overall Study|Pregnancy|1|||
163068482|NCT02965456|588957307|FG001|Overall Study|Pregnancy|0|||
163068483|NCT02965456|588957306|FG000|Overall Study|Protocol Violation|0|||
163068484|NCT02965456|588957307|FG001|Overall Study|Protocol Violation|1|||
163068485|NCT02965456|588957306|FG000|Overall Study|Participant ran out of study drug|0|||
163068486|NCT02965456|588957307|FG001|Overall Study|Participant ran out of study drug|1|||
163068487|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
163068488|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
163068489|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
163068490|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Death|1|||
163068491|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Death|0|||
163068492|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Death|0|||
163068493|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
163068494|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
163068495|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
163068496|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
163068497|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
163068498|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
163068499|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
163068500|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
163068501|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
163068502|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
163068503|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
163068504|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
163068505|NCT05073315|588957308|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
163068506|NCT05073315|588957309|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
163068507|NCT05073315|588957310|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
163068508|NCT05073315|588957308|FG000|Period 2|Adverse Event|0|||
163068509|NCT05073315|588957309|FG001|Period 2|Adverse Event|3|||
163068510|NCT05073315|588957310|FG002|Period 2|Adverse Event|6|||
163068511|NCT05073315|588957308|FG000|Period 2|Lost to Follow-up|0|||
163068512|NCT05073315|588957309|FG001|Period 2|Lost to Follow-up|5|||
163068513|NCT05073315|588957310|FG002|Period 2|Lost to Follow-up|5|||
163068514|NCT05073315|588957308|FG000|Period 2|Withdrawal by Subject|0|||
163068515|NCT05073315|588957309|FG001|Period 2|Withdrawal by Subject|4|||
163068516|NCT05073315|588957310|FG002|Period 2|Withdrawal by Subject|9|||
163068517|NCT05073315|588957308|FG000|Period 2|Protocol Violation|0|||
163068518|NCT05073315|588957309|FG001|Period 2|Protocol Violation|0|||
163068519|NCT05073315|588957310|FG002|Period 2|Protocol Violation|1|||
163068520|NCT01529268|588957311|FG000|Overall Study|Lost to Follow-up|9|||
163068521|NCT01529268|588957312|FG001|Overall Study|Lost to Follow-up|3|||
163068522|NCT01529268|588957311|FG000|Overall Study|Moved|3|||
163068523|NCT01529268|588957312|FG001|Overall Study|Moved|0|||
163068524|NCT00303953|588957313|FG000|Overall Study|Ineligible|1|||
163068525|NCT00303953|588957313|FG000|Overall Study|Death|1|||
163068526|NCT00303953|588957313|FG000|Overall Study|Adverse Event|4|||
163068527|NCT00303953|588957313|FG000|Overall Study|Lack of Efficacy|12|||
163068528|NCT00303953|588957313|FG000|Overall Study|Physician Decision|1|||
163068529|NCT00021255|588957314|FG000|Overall Study|Death|1|||
163068530|NCT00021255|588957315|FG001|Overall Study|Death|0|||
163068531|NCT00021255|588957316|FG002|Overall Study|Death|2|||
163068532|NCT00021255|588957314|FG000|Overall Study|Breast cancer relapse|5|||
163068533|NCT00021255|588957315|FG001|Overall Study|Breast cancer relapse|18|||
163068534|NCT00021255|588957316|FG002|Overall Study|Breast cancer relapse|11|||
163068535|NCT00021255|588957314|FG000|Overall Study|Second primary malignancy|0|||
163068536|NCT00021255|588957315|FG001|Overall Study|Second primary malignancy|4|||
163068537|NCT00021255|588957316|FG002|Overall Study|Second primary malignancy|1|||
163068538|NCT00021255|588957314|FG000|Overall Study|Withdrawal by Subject|41|||
163068539|NCT00021255|588957315|FG001|Overall Study|Withdrawal by Subject|64|||
163068540|NCT00021255|588957316|FG002|Overall Study|Withdrawal by Subject|26|||
163068541|NCT00021255|588957314|FG000|Overall Study|Lost to Follow-up|0|||
163068542|NCT00021255|588957315|FG001|Overall Study|Lost to Follow-up|2|||
163068543|NCT00021255|588957316|FG002|Overall Study|Lost to Follow-up|3|||
163068544|NCT00021255|588957314|FG000|Overall Study|Cardiac toxicity|0|||
163068545|NCT00021255|588957315|FG001|Overall Study|Cardiac toxicity|61|||
163068546|NCT00021255|588957316|FG002|Overall Study|Cardiac toxicity|32|||
163068547|NCT00021255|588957314|FG000|Overall Study|Herceptin toxicity|0|||
163068548|NCT00021255|588957315|FG001|Overall Study|Herceptin toxicity|22|||
163068549|NCT00021255|588957316|FG002|Overall Study|Herceptin toxicity|6|||
163068550|NCT00021255|588957314|FG000|Overall Study|Adverse Event|46|||
163068551|NCT00021255|588957315|FG001|Overall Study|Adverse Event|30|||
163068552|NCT00021255|588957316|FG002|Overall Study|Adverse Event|18|||
163068553|NCT00021255|588957314|FG000|Overall Study|Protocol Violation|0|||
163068554|NCT00021255|588957315|FG001|Overall Study|Protocol Violation|2|||
163068555|NCT00021255|588957316|FG002|Overall Study|Protocol Violation|0|||
163068556|NCT00021255|588957314|FG000|Overall Study|Other than specified above|0|||
163068557|NCT00021255|588957315|FG001|Overall Study|Other than specified above|38|||
163068558|NCT00021255|588957316|FG002|Overall Study|Other than specified above|19|||
163068559|NCT00021255|588957314|FG000|Overall Study|Missing|0|||
163068560|NCT00021255|588957315|FG001|Overall Study|Missing|27|||
163068561|NCT00021255|588957316|FG002|Overall Study|Missing|13|||
163068562|NCT00021255|588957314|FG000|Overall Study|Randomized but not treated|28|||
163068563|NCT00021255|588957315|FG001|Overall Study|Randomized but not treated|2|||
163068564|NCT00021255|588957316|FG002|Overall Study|Randomized but not treated|18|||
163068565|NCT02232698|588957317|FG000|Overall Study|Pregnancy|1|||
163068566|NCT02232698|588957318|FG001|Overall Study|Pregnancy|1|||
163068567|NCT02232698|588957317|FG000|Overall Study|Met exclusion criteria|1|||
163068568|NCT02232698|588957318|FG001|Overall Study|Met exclusion criteria|1|||
163068569|NCT02232698|588957317|FG000|Overall Study|Had device-associated symptoms|7|||
163068570|NCT02232698|588957318|FG001|Overall Study|Had device-associated symptoms|0|||
163068571|NCT02232698|588957317|FG000|Overall Study|Non-compliance with study device|1|||
163068572|NCT02232698|588957318|FG001|Overall Study|Non-compliance with study device|4|||
163068573|NCT02232698|588957317|FG000|Overall Study|Allocated to control group|0|||
163068574|NCT02232698|588957318|FG001|Overall Study|Allocated to control group|3|||
163068575|NCT02232698|588957317|FG000|Overall Study|Withdrawal by Subject|0|||
163068576|NCT02232698|588957318|FG001|Overall Study|Withdrawal by Subject|11|||
163068577|NCT02393755|588957319|FG000|Overall Study|Withdrawal by Subject|0|||
163068578|NCT02393755|588957320|FG001|Overall Study|Withdrawal by Subject|3|||
163068579|NCT02393755|588957319|FG000|Overall Study|Adverse Event|0|||
163068580|NCT02393755|588957320|FG001|Overall Study|Adverse Event|2|||
163068581|NCT02393755|588957319|FG000|Overall Study|Physician Decision|0|||
163068582|NCT02393755|588957320|FG001|Overall Study|Physician Decision|2|||
163068583|NCT05324371|588957321|FG000|Overall Study|Withdrawal by Subject|1|||
163068584|NCT05324371|588957321|FG000|Overall Study|Death|1|||
163068585|NCT04069520|588957324|FG000|Overall Study|Lost to Follow-up|0|||
163068586|NCT04069520|588957325|FG001|Overall Study|Lost to Follow-up|2|||
163068587|NCT04069520|588957324|FG000|Overall Study|Withdrawal by Subject|0|||
163068588|NCT04069520|588957325|FG001|Overall Study|Withdrawal by Subject|1|||
163068589|NCT04069520|588957324|FG000|Overall Study|Prior Injury|1|||
163068590|NCT04069520|588957325|FG001|Overall Study|Prior Injury|0|||
163068591|NCT04069520|588957324|FG000|Overall Study|Orthodontia|1|||
163068592|NCT04069520|588957325|FG001|Overall Study|Orthodontia|0|||
163068593|NCT04069520|588957324|FG000|Overall Study|Cut from team|0|||
163068594|NCT04069520|588957325|FG001|Overall Study|Cut from team|2|||
163068595|NCT01068912|588957326|FG000|Overall Study|Adverse Event|2|||
163068596|NCT01068912|588957327|FG001|Overall Study|Adverse Event|3|||
163068597|NCT01068912|588957328|FG002|Overall Study|Adverse Event|2|||
163068598|NCT01068912|588957326|FG000|Overall Study|Withdrawal by Subject|5|||
163068599|NCT01068912|588957327|FG001|Overall Study|Withdrawal by Subject|6|||
163068600|NCT01068912|588957328|FG002|Overall Study|Withdrawal by Subject|6|||
163068601|NCT01068912|588957326|FG000|Overall Study|Lost to Follow-up|3|||
163068602|NCT01068912|588957327|FG001|Overall Study|Lost to Follow-up|7|||
163068603|NCT01068912|588957328|FG002|Overall Study|Lost to Follow-up|3|||
163068604|NCT01068912|588957326|FG000|Overall Study|Protocol Violation|0|||
163068605|NCT01068912|588957327|FG001|Overall Study|Protocol Violation|2|||
163068606|NCT01068912|588957328|FG002|Overall Study|Protocol Violation|0|||
163068607|NCT01068912|588957326|FG000|Overall Study|aggravation influenza|1|||
163068608|NCT01068912|588957327|FG001|Overall Study|aggravation influenza|1|||
163068609|NCT01068912|588957328|FG002|Overall Study|aggravation influenza|1|||
163068610|NCT01068912|588957326|FG000|Overall Study|other underlying illness|0|||
163068611|NCT01068912|588957327|FG001|Overall Study|other underlying illness|3|||
162644218|NCT05104567|587413588|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162644219|NCT05104567|587413589|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162644220|NCT05104567|587413590|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162644221|NCT05104567|587413584|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
163068612|NCT01068912|588957328|FG002|Overall Study|other underlying illness|3|||
163068613|NCT04822194|588957329|FG000|Overall Study|Withdrawal by Subject|5|||
163068614|NCT04822194|588957330|FG001|Overall Study|Withdrawal by Subject|4|||
163068615|NCT04822194|588957329|FG000|Overall Study|Technical issues with MR scanner|1|||
163068616|NCT04822194|588957330|FG001|Overall Study|Technical issues with MR scanner|0|||
163068617|NCT04822194|588957329|FG000|Overall Study|Lost to Follow-up|5|||
163068618|NCT04822194|588957330|FG001|Overall Study|Lost to Follow-up|7|||
163068619|NCT05182125|588957331|FG000|Overall Study|Withdrawal by Subject|0|||
163068620|NCT05182125|588957332|FG001|Overall Study|Withdrawal by Subject|0|||
163068621|NCT05182125|588957333|FG002|Overall Study|Withdrawal by Subject|0|||
163068622|NCT05182125|588957334|FG003|Overall Study|Withdrawal by Subject|0|||
163068623|NCT05182125|588957335|FG004|Overall Study|Withdrawal by Subject|2|||
163068624|NCT05182125|588957336|FG005|Overall Study|Withdrawal by Subject|0|||
163068625|NCT05182125|588957331|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068626|NCT05182125|588957332|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068627|NCT05182125|588957333|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068628|NCT05182125|588957334|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
163068629|NCT05182125|588957335|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068630|NCT05182125|588957336|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
163068631|NCT05182125|588957331|FG000|Overall Study|Death|0|||
163068632|NCT05182125|588957332|FG001|Overall Study|Death|0|||
163068633|NCT05182125|588957333|FG002|Overall Study|Death|0|||
163068634|NCT05182125|588957334|FG003|Overall Study|Death|0|||
163068635|NCT05182125|588957335|FG004|Overall Study|Death|1|||
163068636|NCT05182125|588957336|FG005|Overall Study|Death|0|||
163068637|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
163068638|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
163068639|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163068640|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
163068641|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
163068642|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
163068643|NCT02965833|588957341|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
163068644|NCT02965833|588957342|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
163068645|NCT02965833|588957341|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
163068646|NCT02965833|588957342|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
163068647|NCT03370302|588957343|FG000|Dose Escalation Phase|Other|0|||
163068648|NCT03370302|588957344|FG001|Dose Escalation Phase|Other|1|||
163068649|NCT03370302|588957345|FG002|Dose Escalation Phase|Other|1|||
163068650|NCT03370302|588957346|FG003|Dose Escalation Phase|Other|0|||
163068651|NCT03370302|588957347|FG004|Dose Escalation Phase|Other|0|||
163068652|NCT03370302|588957348|FG005|Dose Escalation Phase|Other|0|||
163068653|NCT03370302|588957343|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163068654|NCT03370302|588957344|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
163068655|NCT03370302|588957345|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
163068656|NCT03370302|588957346|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163068657|NCT03370302|588957347|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
163068658|NCT03370302|588957348|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
163068659|NCT03370302|588957343|FG000|Dose Escalation Phase|Adverse Event|1|||
163068660|NCT03370302|588957344|FG001|Dose Escalation Phase|Adverse Event|0|||
163068661|NCT03370302|588957345|FG002|Dose Escalation Phase|Adverse Event|2|||
163068662|NCT03370302|588957346|FG003|Dose Escalation Phase|Adverse Event|0|||
163068663|NCT03370302|588957347|FG004|Dose Escalation Phase|Adverse Event|0|||
163068664|NCT03370302|588957348|FG005|Dose Escalation Phase|Adverse Event|0|||
163068665|NCT03370302|588957343|FG000|Dose Escalation Phase|Progressive Disease|2|||
163068666|NCT03370302|588957344|FG001|Dose Escalation Phase|Progressive Disease|4|||
163068667|NCT03370302|588957345|FG002|Dose Escalation Phase|Progressive Disease|2|||
163068668|NCT03370302|588957346|FG003|Dose Escalation Phase|Progressive Disease|0|||
163068669|NCT03370302|588957347|FG004|Dose Escalation Phase|Progressive Disease|3|||
163068670|NCT03370302|588957348|FG005|Dose Escalation Phase|Progressive Disease|1|||
163068671|NCT03370302|588957343|FG000|Dose Expansion Phase|Progressive Disease|0|||
163068672|NCT03370302|588957344|FG001|Dose Expansion Phase|Progressive Disease|0|||
163068673|NCT03370302|588957345|FG002|Dose Expansion Phase|Progressive Disease|0|||
163068674|NCT03370302|588957346|FG003|Dose Expansion Phase|Progressive Disease|6|||
163068675|NCT03370302|588957347|FG004|Dose Expansion Phase|Progressive Disease|0|||
163068676|NCT03370302|588957348|FG005|Dose Expansion Phase|Progressive Disease|0|||
163068677|NCT00118287|588957349|FG000|Overall Study|Intracranial haemorrhage|1|||
163068678|NCT00118287|588957349|FG000|Overall Study|Muscle pain|1|||
163068679|NCT03976375|588957350|FG000|Overall Study|Death|158|||
163068680|NCT03976375|588957351|FG001|Overall Study|Death|160|||
163068681|NCT03976375|588957352|FG002|Overall Study|Death|42|||
163068682|NCT03976375|588957350|FG000|Overall Study|Lost to Follow-up|2|||
163068683|NCT03976375|588957351|FG001|Overall Study|Lost to Follow-up|1|||
163068684|NCT03976375|588957352|FG002|Overall Study|Lost to Follow-up|1|||
163068685|NCT03976375|588957350|FG000|Overall Study|Withdrawal by Subject|5|||
163068686|NCT03976375|588957351|FG001|Overall Study|Withdrawal by Subject|9|||
163068687|NCT03976375|588957352|FG002|Overall Study|Withdrawal by Subject|4|||
163068688|NCT03976375|588957350|FG000|Overall Study|Sponsor decision|20|||
163068689|NCT03976375|588957351|FG001|Overall Study|Sponsor decision|19|||
163068690|NCT03976375|588957352|FG002|Overall Study|Sponsor decision|1|||
163068691|NCT04818112|588957353|FG000|Overall Study|Withdrawal by Subject|54|||
162717847|NCT02914522|587673493|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163068692|NCT04818112|588957354|FG001|Overall Study|Withdrawal by Subject|12|||
163068693|NCT04818112|588957353|FG000|Overall Study|Lost to Follow-up|38|||
163068694|NCT04818112|588957354|FG001|Overall Study|Lost to Follow-up|10|||
163068695|NCT03091439|588957355|FG000|Overall Study|Study Terminated by the Sponsor|1|||
163068696|NCT03091439|588957356|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163068697|NCT03122106|588957357|FG000|Overall Study|Not enough tissue|1|||
163068698|NCT03122106|588957357|FG000|Overall Study|Disease progression during screening|2|||
163068699|NCT03122106|588957357|FG000|Overall Study|Poor RNA quality for vaccine|1|||
163068700|NCT00640289|588957358|FG000|Overall Study|Death|3|||
163068701|NCT00640289|588957358|FG000|Overall Study|Withdrawal by Subject|1|||
163068702|NCT00640289|588957358|FG000|Overall Study|Lost to Follow-up|1|||
163068703|NCT00640289|588957358|FG000|Overall Study|Data collected under different amendment|2|||
163068704|NCT00640289|588957358|FG000|Overall Study|Transferred to another center|1|||
163068705|NCT00640289|588957358|FG000|Overall Study|Missing status|5|||
163068706|NCT03550209|588957360|FG000|Overall Study|Lost to Follow-up|1|||
163068707|NCT03550209|588957361|FG001|Overall Study|Lost to Follow-up|0|||
163068708|NCT03550209|588957362|FG002|Overall Study|Lost to Follow-up|1|||
163068709|NCT03550209|588957363|FG003|Overall Study|Lost to Follow-up|0|||
163068710|NCT03550209|588957360|FG000|Overall Study|Withdrawal by Subject|0|||
163068711|NCT03550209|588957361|FG001|Overall Study|Withdrawal by Subject|3|||
163068712|NCT03550209|588957362|FG002|Overall Study|Withdrawal by Subject|1|||
163068713|NCT03550209|588957363|FG003|Overall Study|Withdrawal by Subject|2|||
163068714|NCT03550209|588957360|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
163068715|NCT03550209|588957361|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
163068716|NCT03550209|588957362|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
163068717|NCT03550209|588957363|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
163068718|NCT06170827|588957366|FG000|Overall Study|Withdrawal by Subject|1|||
163068719|NCT06170827|588957367|FG001|Overall Study|Withdrawal by Subject|1|||
163068720|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
163068721|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
163068722|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163068723|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163068724|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163068725|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163068726|NCT05643794|588958923|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068727|NCT05643794|588958924|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
163068728|NCT05643794|588958925|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068729|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163068730|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162644222|NCT05104567|587413585|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
162644223|NCT05104567|587413586|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
162644224|NCT05104567|587413587|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
162644225|NCT05104567|587413588|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
162644226|NCT05104567|587413589|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
162644227|NCT05104567|587413590|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
162644228|NCT05104567|587413584|FG000|Overall Study|Progressive disease|3|||
162644229|NCT05104567|587413585|FG001|Overall Study|Progressive disease|13|||
162644230|NCT05104567|587413586|FG002|Overall Study|Progressive disease|13|||
162644231|NCT05104567|587413587|FG003|Overall Study|Progressive disease|17|||
162644232|NCT05104567|587413588|FG004|Overall Study|Progressive disease|17|||
162644233|NCT05104567|587413589|FG005|Overall Study|Progressive disease|28|||
162644234|NCT05104567|587413590|FG006|Overall Study|Progressive disease|24|||
162644235|NCT05104567|587413584|FG000|Overall Study|Withdrawal by Subject|1|||
162644236|NCT05104567|587413585|FG001|Overall Study|Withdrawal by Subject|1|||
162644237|NCT05104567|587413586|FG002|Overall Study|Withdrawal by Subject|2|||
162644238|NCT05104567|587413587|FG003|Overall Study|Withdrawal by Subject|0|||
162644239|NCT05104567|587413588|FG004|Overall Study|Withdrawal by Subject|0|||
162644240|NCT05104567|587413589|FG005|Overall Study|Withdrawal by Subject|0|||
163026733|NCT00471718|588799297|FG000|Overall Study|Withdrawal by Subject|1|||
163026734|NCT01446237|588799298|FG000|Overall Study|Adverse Event|1|||
163026735|NCT01446237|588799298|FG000|Overall Study|Lost to Follow-up|2|||
163026736|NCT01446237|588799298|FG000|Overall Study|Withdrawal by Subject|7|||
163026737|NCT02640677|588799310|FG000|Overall Study|Lost to Follow-up|1|||
163026738|NCT02640677|588799310|FG000|Overall Study|Withdrawal by Subject|1|||
163026739|NCT01817582|588799329|FG000|Overall Study|Withdrawal by Subject|0|||
163026740|NCT01817582|588799330|FG001|Overall Study|Withdrawal by Subject|1|||
163026741|NCT01817582|588799331|FG002|Overall Study|Withdrawal by Subject|0|||
163026742|NCT01817582|588799329|FG000|Overall Study|Participant revealed masked treatment|1|||
163026743|NCT01817582|588799330|FG001|Overall Study|Participant revealed masked treatment|0|||
163026744|NCT01817582|588799331|FG002|Overall Study|Participant revealed masked treatment|0|||
163026745|NCT01817582|588799329|FG000|Overall Study|Randomized but exclusion criteria met|1|||
163026746|NCT01817582|588799330|FG001|Overall Study|Randomized but exclusion criteria met|0|||
163026747|NCT01817582|588799331|FG002|Overall Study|Randomized but exclusion criteria met|0|||
163068731|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
162644241|NCT05104567|587413590|FG006|Overall Study|Withdrawal by Subject|0|||
162644242|NCT05104567|587413584|FG000|Overall Study|Other|1|||
163068732|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
163026748|NCT03053063|588799332|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
163026749|NCT03053063|588799333|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
163026750|NCT03053063|588799334|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
163026751|NCT03053063|588799335|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
163026752|NCT03053063|588799332|FG000|Randomized Phase|Withdrew consent|8|||
163026753|NCT03053063|588799333|FG001|Randomized Phase|Withdrew consent|11|||
163026754|NCT03053063|588799334|FG002|Randomized Phase|Withdrew consent|5|||
163026755|NCT03053063|588799335|FG003|Randomized Phase|Withdrew consent|0|||
163026756|NCT03053063|588799332|FG000|Randomized Phase|Investigator's Discretion|8|||
163026757|NCT03053063|588799333|FG001|Randomized Phase|Investigator's Discretion|6|||
163026758|NCT03053063|588799334|FG002|Randomized Phase|Investigator's Discretion|2|||
163026759|NCT03053063|588799335|FG003|Randomized Phase|Investigator's Discretion|0|||
163026760|NCT03053063|588799332|FG000|Randomized Phase|Lost to Follow-up|3|||
163026761|NCT03053063|588799333|FG001|Randomized Phase|Lost to Follow-up|5|||
163026762|NCT03053063|588799334|FG002|Randomized Phase|Lost to Follow-up|1|||
163026763|NCT03053063|588799335|FG003|Randomized Phase|Lost to Follow-up|0|||
163026764|NCT03053063|588799332|FG000|Randomized Phase|Adverse Event|0|||
163026765|NCT03053063|588799333|FG001|Randomized Phase|Adverse Event|1|||
163026766|NCT03053063|588799334|FG002|Randomized Phase|Adverse Event|0|||
163026767|NCT03053063|588799335|FG003|Randomized Phase|Adverse Event|0|||
163026768|NCT03053063|588799332|FG000|Randomized Phase|Randomized but Never Treated|1|||
163026769|NCT03053063|588799333|FG001|Randomized Phase|Randomized but Never Treated|3|||
163026770|NCT03053063|588799334|FG002|Randomized Phase|Randomized but Never Treated|2|||
163026771|NCT03053063|588799335|FG003|Randomized Phase|Randomized but Never Treated|0|||
163026772|NCT03053063|588799332|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
163026773|NCT03053063|588799333|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
163026774|NCT03053063|588799334|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
163026775|NCT03053063|588799335|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
163026776|NCT03053063|588799332|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
163026777|NCT03053063|588799333|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
163026778|NCT03053063|588799334|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
163026779|NCT03053063|588799335|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
163026780|NCT03053063|588799332|FG000|Open-Label Phase|Death|0|||
163026781|NCT03053063|588799333|FG001|Open-Label Phase|Death|0|||
163026782|NCT03053063|588799334|FG002|Open-Label Phase|Death|0|||
163026783|NCT03053063|588799335|FG003|Open-Label Phase|Death|2|||
163026784|NCT03053063|588799332|FG000|Open-Label Phase|Investigator's discretion|0|||
163026785|NCT03053063|588799333|FG001|Open-Label Phase|Investigator's discretion|0|||
163026786|NCT03053063|588799334|FG002|Open-Label Phase|Investigator's discretion|0|||
163026787|NCT03053063|588799335|FG003|Open-Label Phase|Investigator's discretion|2|||
163026788|NCT02600845|588799336|FG000|Overall Study|Reason Not Specified|3|||
163026789|NCT02600845|588799336|FG000|Overall Study|Non-compliance with Study Procedures|10|||
163026790|NCT02600845|588799336|FG000|Overall Study|Consent Withdrawal|5|||
163026791|NCT00197002|588801288|FG000|Overall Study|Adverse Event|0|||
163026792|NCT00197002|588801289|FG001|Overall Study|Adverse Event|1|||
163026793|NCT00197002|588801290|FG002|Overall Study|Adverse Event|0|||
163026794|NCT00197002|588801288|FG000|Overall Study|Protocol Violation|1|||
163026795|NCT00197002|588801289|FG001|Overall Study|Protocol Violation|0|||
163026796|NCT00197002|588801290|FG002|Overall Study|Protocol Violation|2|||
163026797|NCT00197002|588801288|FG000|Overall Study|Withdrawal by Subject|9|||
163026798|NCT00197002|588801289|FG001|Overall Study|Withdrawal by Subject|5|||
163026799|NCT00197002|588801290|FG002|Overall Study|Withdrawal by Subject|7|||
163026800|NCT00197002|588801288|FG000|Overall Study|Migrated/moved from study area|3|||
163026801|NCT00197002|588801289|FG001|Overall Study|Migrated/moved from study area|5|||
163026802|NCT00197002|588801290|FG002|Overall Study|Migrated/moved from study area|1|||
163026803|NCT00197002|588801288|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
163026804|NCT00197002|588801289|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
163026805|NCT00197002|588801290|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
163026806|NCT00197002|588801288|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
163026807|NCT00197002|588801289|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
163026808|NCT00197002|588801290|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
163026809|NCT00197002|588801288|FG000|Overall Study|Others|3|||
163026810|NCT00197002|588801289|FG001|Overall Study|Others|1|||
163026811|NCT00197002|588801290|FG002|Overall Study|Others|1|||
163026812|NCT03569293|588801293|FG000|Overall Study|Adverse Event|4|||
163026813|NCT03569293|588801294|FG001|Overall Study|Adverse Event|1|||
163026814|NCT03569293|588801295|FG002|Overall Study|Adverse Event|5|||
163026815|NCT03569293|588801296|FG003|Overall Study|Adverse Event|1|||
163026816|NCT03569293|588801297|FG004|Overall Study|Adverse Event|0|||
163026817|NCT03569293|588801298|FG005|Overall Study|Adverse Event|0|||
163026818|NCT03569293|588801293|FG000|Overall Study|Withdrawal by Subject|16|||
163026819|NCT03569293|588801294|FG001|Overall Study|Withdrawal by Subject|2|||
163026820|NCT03569293|588801295|FG002|Overall Study|Withdrawal by Subject|4|||
163026821|NCT03569293|588801296|FG003|Overall Study|Withdrawal by Subject|1|||
163026822|NCT03569293|588801297|FG004|Overall Study|Withdrawal by Subject|0|||
163068733|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068734|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
163068735|NCT05643794|588958923|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
163068736|NCT05643794|588958924|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
163068737|NCT05643794|588958925|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
163068738|NCT00587457|588958926|FG000|Overall Study|Adverse Event|1|||
163068739|NCT00587457|588958927|FG001|Overall Study|Adverse Event|2|||
163068740|NCT00587457|588958928|FG002|Overall Study|Adverse Event|1|||
163068741|NCT00587457|588958926|FG000|Overall Study|Disease progression|2|||
163068742|NCT00587457|588958927|FG001|Overall Study|Disease progression|0|||
163068743|NCT00587457|588958928|FG002|Overall Study|Disease progression|2|||
163068744|NCT00587457|588958926|FG000|Overall Study|Initiation of alternative therapy|0|||
163068745|NCT00587457|588958927|FG001|Overall Study|Initiation of alternative therapy|1|||
163068746|NCT00587457|588958928|FG002|Overall Study|Initiation of alternative therapy|0|||
163068747|NCT00587457|588958926|FG000|Overall Study|Undefined|0|||
163068748|NCT00587457|588958927|FG001|Overall Study|Undefined|0|||
163068749|NCT00587457|588958928|FG002|Overall Study|Undefined|1|||
163068750|NCT00587457|588958926|FG000|Overall Study|Development of neutralizing Abs|0|||
163068751|NCT00587457|588958927|FG001|Overall Study|Development of neutralizing Abs|0|||
163068752|NCT00587457|588958928|FG002|Overall Study|Development of neutralizing Abs|1|||
163068753|NCT02927145|588958929|FG000|Initial Recruitment|Withdrawal by Subject|0|||
163068754|NCT02927145|588958930|FG001|Initial Recruitment|Withdrawal by Subject|1|||
163068755|NCT02927145|588958931|FG002|Initial Recruitment|Withdrawal by Subject|1|||
163068756|NCT02927145|588958932|FG003|Initial Recruitment|Withdrawal by Subject|4|||
163068757|NCT02927145|588958933|FG004|Initial Recruitment|Withdrawal by Subject|1|||
163068758|NCT02927145|588958934|FG005|Initial Recruitment|Withdrawal by Subject|1|||
163068759|NCT02927145|588958935|FG006|Initial Recruitment|Withdrawal by Subject|0|||
163068760|NCT02927145|588958936|FG007|Initial Recruitment|Withdrawal by Subject|0|||
163068761|NCT02927145|588958937|FG008|Initial Recruitment|Withdrawal by Subject|2|||
163068762|NCT02927145|588958929|FG000|Initial Recruitment|Adverse Event|0|||
163068763|NCT02927145|588958930|FG001|Initial Recruitment|Adverse Event|0|||
163068764|NCT02927145|588958931|FG002|Initial Recruitment|Adverse Event|0|||
163068765|NCT02927145|588958932|FG003|Initial Recruitment|Adverse Event|0|||
163068766|NCT02927145|588958933|FG004|Initial Recruitment|Adverse Event|2|||
163068767|NCT02927145|588958934|FG005|Initial Recruitment|Adverse Event|0|||
163068768|NCT02927145|588958935|FG006|Initial Recruitment|Adverse Event|0|||
163068769|NCT02927145|588958936|FG007|Initial Recruitment|Adverse Event|0|||
163068770|NCT02927145|588958937|FG008|Initial Recruitment|Adverse Event|0|||
163068771|NCT02927145|588958929|FG000|Invitation for Additional Challenge|Pregnancy|0|||
163068772|NCT02927145|588958930|FG001|Invitation for Additional Challenge|Pregnancy|0|||
163068773|NCT02927145|588958931|FG002|Invitation for Additional Challenge|Pregnancy|0|||
163068774|NCT02927145|588958932|FG003|Invitation for Additional Challenge|Pregnancy|0|||
163068775|NCT02927145|588958933|FG004|Invitation for Additional Challenge|Pregnancy|0|||
163068776|NCT02927145|588958934|FG005|Invitation for Additional Challenge|Pregnancy|0|||
163068777|NCT02927145|588958935|FG006|Invitation for Additional Challenge|Pregnancy|1|||
163068778|NCT02927145|588958936|FG007|Invitation for Additional Challenge|Pregnancy|0|||
163068779|NCT02927145|588958937|FG008|Invitation for Additional Challenge|Pregnancy|0|||
163068780|NCT03298061|588958938|FG000|Overall Study|Adverse Event|3|||
163068781|NCT03298061|588958938|FG000|Overall Study|Lack of Efficacy|6|||
163068782|NCT03298061|588958938|FG000|Overall Study|Protocol Violation|1|||
163068783|NCT03298061|588958938|FG000|Overall Study|Physician Decision|7|||
163068784|NCT03298061|588958938|FG000|Overall Study|Withdrawal by Subject|10|||
163068785|NCT01239745|588958945|FG000|Overall Study|Study terminated by sponsor|45|||
163068786|NCT01239745|588958945|FG000|Overall Study|Adverse Event|1|||
163068787|NCT01946802|588958950|FG000|Overall Study|Death|1|||
163068788|NCT01946802|588958950|FG000|Overall Study|Withdrawal by Subject|2|||
163068789|NCT01946802|588958950|FG000|Overall Study|Combined septic shock|1|||
163068790|NCT01946802|588958950|FG000|Overall Study|Protocol Violation|1|||
163068791|NCT00153920|588958951|FG000|Overall Study|Adverse Event|9|||
162644243|NCT05104567|587413585|FG001|Overall Study|Other|1|||
162644244|NCT05104567|587413586|FG002|Overall Study|Other|1|||
162644245|NCT05104567|587413587|FG003|Overall Study|Other|0|||
162644246|NCT05104567|587413588|FG004|Overall Study|Other|0|||
162644247|NCT05104567|587413589|FG005|Overall Study|Other|0|||
162644248|NCT05104567|587413590|FG006|Overall Study|Other|0|||
162644249|NCT01464346|587413591|FG000|Overall Study|Withdrawal by Subject|0|||
163068792|NCT00153920|588958951|FG000|Overall Study|Progressive Disease|9|||
163068793|NCT00153920|588958951|FG000|Overall Study|Physician Decision|3|||
163068794|NCT00153920|588958951|FG000|Overall Study|Lack of Response|3|||
162644250|NCT01464346|587413592|FG001|Overall Study|Withdrawal by Subject|0|||
163068795|NCT00153920|588958951|FG000|Overall Study|Death|2|||
162644251|NCT01464346|587413593|FG002|Overall Study|Withdrawal by Subject|1|||
162644252|NCT03999892|587413594|FG000|Overall Study|Lost to Follow-up|1|||
163068796|NCT00153920|588958951|FG000|Overall Study|Withdrawal by Subject|1|||
163068797|NCT00153920|588958951|FG000|Overall Study|Non-Protocol Therapy|1|||
163068798|NCT00153920|588958951|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
163068799|NCT00153920|588958951|FG000|Overall Study|Progressive Disease before Trt|1|||
163068800|NCT02541903|588958952|FG000|Overall Study|Death|1|||
163068801|NCT02969018|588958953|FG000|Overall Study|Adverse Event|2|||
163068802|NCT02969018|588958954|FG001|Overall Study|Adverse Event|4|||
163068803|NCT02969018|588958955|FG002|Overall Study|Adverse Event|1|||
163068804|NCT02969018|588958956|FG003|Overall Study|Adverse Event|2|||
163068805|NCT02969018|588958957|FG004|Overall Study|Adverse Event|0|||
163068806|NCT02969018|588958958|FG005|Overall Study|Adverse Event|1|||
163068807|NCT02969018|588958959|FG006|Overall Study|Adverse Event|2|||
163068808|NCT02969018|588958960|FG007|Overall Study|Adverse Event|0|||
163068809|NCT02969018|588958953|FG000|Overall Study|Lack of Efficacy|0|||
163068810|NCT02969018|588958954|FG001|Overall Study|Lack of Efficacy|1|||
163068811|NCT02969018|588958955|FG002|Overall Study|Lack of Efficacy|0|||
163068812|NCT02969018|588958956|FG003|Overall Study|Lack of Efficacy|0|||
163068813|NCT02969018|588958957|FG004|Overall Study|Lack of Efficacy|1|||
163068814|NCT02969018|588958958|FG005|Overall Study|Lack of Efficacy|1|||
163068815|NCT02969018|588958959|FG006|Overall Study|Lack of Efficacy|1|||
163068816|NCT02969018|588958960|FG007|Overall Study|Lack of Efficacy|1|||
163068817|NCT02969018|588958953|FG000|Overall Study|Lost to Follow-up|1|||
163068818|NCT02969018|588958954|FG001|Overall Study|Lost to Follow-up|2|||
163068819|NCT02969018|588958955|FG002|Overall Study|Lost to Follow-up|2|||
163068820|NCT02969018|588958956|FG003|Overall Study|Lost to Follow-up|0|||
163068821|NCT02969018|588958957|FG004|Overall Study|Lost to Follow-up|1|||
163068822|NCT02969018|588958958|FG005|Overall Study|Lost to Follow-up|1|||
163068823|NCT02969018|588958959|FG006|Overall Study|Lost to Follow-up|0|||
163068824|NCT02969018|588958960|FG007|Overall Study|Lost to Follow-up|1|||
163068825|NCT02969018|588958953|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068826|NCT02969018|588958954|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068827|NCT02969018|588958955|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068828|NCT02969018|588958956|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068829|NCT02969018|588958957|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068830|NCT02969018|588958958|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068831|NCT02969018|588958959|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
163068832|NCT02969018|588958960|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163068833|NCT02969018|588958953|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163068834|NCT02969018|588958954|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163068835|NCT02969018|588958955|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163068836|NCT02969018|588958956|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163068837|NCT02969018|588958957|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163068838|NCT02969018|588958958|FG005|Overall Study|Non-Compliance With Study Drug|0|||
163068839|NCT02969018|588958959|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163068840|NCT02969018|588958960|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163068841|NCT02969018|588958953|FG000|Overall Study|Other|0|||
163068842|NCT02969018|588958954|FG001|Overall Study|Other|0|||
163068843|NCT02969018|588958955|FG002|Overall Study|Other|0|||
163068844|NCT02969018|588958956|FG003|Overall Study|Other|1|||
163068845|NCT02969018|588958957|FG004|Overall Study|Other|0|||
163068846|NCT02969018|588958958|FG005|Overall Study|Other|0|||
163068847|NCT02969018|588958959|FG006|Overall Study|Other|0|||
163068848|NCT02969018|588958960|FG007|Overall Study|Other|2|||
163068849|NCT02969018|588958953|FG000|Overall Study|Pregnancy|0|||
163068850|NCT02969018|588958954|FG001|Overall Study|Pregnancy|0|||
163068851|NCT02969018|588958955|FG002|Overall Study|Pregnancy|0|||
163068852|NCT02969018|588958956|FG003|Overall Study|Pregnancy|0|||
163068853|NCT02969018|588958957|FG004|Overall Study|Pregnancy|0|||
163068854|NCT02969018|588958958|FG005|Overall Study|Pregnancy|1|||
163068855|NCT02969018|588958959|FG006|Overall Study|Pregnancy|0|||
163068856|NCT02969018|588958960|FG007|Overall Study|Pregnancy|0|||
163068857|NCT02969018|588958953|FG000|Overall Study|Protocol Violation|0|||
163068858|NCT02969018|588958954|FG001|Overall Study|Protocol Violation|0|||
163068859|NCT02969018|588958955|FG002|Overall Study|Protocol Violation|1|||
163068860|NCT02969018|588958956|FG003|Overall Study|Protocol Violation|1|||
163068861|NCT02969018|588958957|FG004|Overall Study|Protocol Violation|0|||
163068862|NCT02969018|588958958|FG005|Overall Study|Protocol Violation|0|||
163068863|NCT02969018|588958959|FG006|Overall Study|Protocol Violation|0|||
163068864|NCT02969018|588958960|FG007|Overall Study|Protocol Violation|0|||
163068865|NCT02969018|588958953|FG000|Overall Study|Withdrawal by Subject|0|||
163068866|NCT02969018|588958954|FG001|Overall Study|Withdrawal by Subject|1|||
163068867|NCT02969018|588958955|FG002|Overall Study|Withdrawal by Subject|2|||
163068868|NCT02969018|588958956|FG003|Overall Study|Withdrawal by Subject|1|||
163068869|NCT02969018|588958957|FG004|Overall Study|Withdrawal by Subject|0|||
163068870|NCT02969018|588958958|FG005|Overall Study|Withdrawal by Subject|4|||
163068871|NCT02969018|588958959|FG006|Overall Study|Withdrawal by Subject|4|||
163068872|NCT02969018|588958960|FG007|Overall Study|Withdrawal by Subject|3|||
163068873|NCT00827242|588958961|FG000|Overall Study|Withdrawal by Subject|2|||
163068874|NCT00827242|588958962|FG001|Overall Study|Withdrawal by Subject|4|||
163068875|NCT00827242|588958961|FG000|Overall Study|Protocol Violation|1|||
163068876|NCT00827242|588958962|FG001|Overall Study|Protocol Violation|3|||
163068877|NCT00827242|588958961|FG000|Overall Study|Lost to Follow-up|0|||
163068878|NCT00827242|588958962|FG001|Overall Study|Lost to Follow-up|3|||
163068879|NCT00827242|588958961|FG000|Overall Study|Adverse Event Excluding Death|2|||
163068880|NCT00827242|588958962|FG001|Overall Study|Adverse Event Excluding Death|1|||
163068881|NCT00827242|588958961|FG000|Overall Study|Entry Criteria Not Met|4|||
163068882|NCT00827242|588958962|FG001|Overall Study|Entry Criteria Not Met|1|||
163068883|NCT00827242|588958961|FG000|Overall Study|Physician Decision|2|||
163068884|NCT00827242|588958962|FG001|Overall Study|Physician Decision|0|||
163068885|NCT00827242|588958961|FG000|Overall Study|Death|1|||
163068886|NCT00827242|588958962|FG001|Overall Study|Death|0|||
163068887|NCT00827242|588958961|FG000|Overall Study|Lack of Efficacy|1|||
163068888|NCT00827242|588958962|FG001|Overall Study|Lack of Efficacy|0|||
163068889|NCT05762679|588958963|FG000|Overall Study|Withdrawal by Subject|1|||
163068890|NCT05762679|588958963|FG000|Overall Study|No analyzable imaging data|1|||
163068891|NCT04795323|588958968|FG000|Overall Study|Did not interact with TARA|1|||
163068892|NCT04795323|588958969|FG001|Overall Study|Did not interact with TARA|0|||
162644253|NCT01848756|587413595|FG000|Overall Study|Adverse Event|1|||
163068893|NCT01479530|588958970|FG000|Overall Study|Adverse Event|5|||
163068894|NCT01479530|588958971|FG001|Overall Study|Adverse Event|6|||
163068895|NCT01479530|588958970|FG000|Overall Study|Lack of Efficacy|0|||
163068896|NCT01479530|588958971|FG001|Overall Study|Lack of Efficacy|1|||
163068897|NCT01479530|588958970|FG000|Overall Study|Protocol Violation|2|||
163068898|NCT01479530|588958971|FG001|Overall Study|Protocol Violation|3|||
163068899|NCT01479530|588958970|FG000|Overall Study|Withdrawal of Consent|3|||
163068900|NCT01479530|588958971|FG001|Overall Study|Withdrawal of Consent|2|||
163068901|NCT00376506|588958979|FG000|Overall Study|Death|0|||
163068902|NCT00376506|588958980|FG001|Overall Study|Death|2|||
163068903|NCT01944774|588958981|FG000|Overall Study|Withdrawal by Subject|2|||
163068904|NCT01944774|588958982|FG001|Overall Study|Withdrawal by Subject|3|||
163068905|NCT01944774|588958983|FG002|Overall Study|Withdrawal by Subject|3|||
163068906|NCT01944774|588958981|FG000|Overall Study|Adverse Event|3|||
163068907|NCT01944774|588958982|FG001|Overall Study|Adverse Event|2|||
163068908|NCT01944774|588958983|FG002|Overall Study|Adverse Event|3|||
163068909|NCT01944774|588958981|FG000|Overall Study|Lack of Efficacy|1|||
163068910|NCT01944774|588958982|FG001|Overall Study|Lack of Efficacy|2|||
163068911|NCT01944774|588958983|FG002|Overall Study|Lack of Efficacy|2|||
163068912|NCT01944774|588958981|FG000|Overall Study|Lost to Follow-up|0|||
163068913|NCT01944774|588958982|FG001|Overall Study|Lost to Follow-up|1|||
163068914|NCT01944774|588958983|FG002|Overall Study|Lost to Follow-up|0|||
163068915|NCT00812097|588958984|FG000|Overall Study|Death|3|||
163068916|NCT00812097|588958985|FG001|Overall Study|Death|10|||
163068917|NCT00812097|588958986|FG002|Overall Study|Death|3|||
163068918|NCT00812097|588958987|FG003|Overall Study|Death|3|||
163068919|NCT00812097|588958984|FG000|Overall Study|Withdrawal by Subject|14|||
163068920|NCT00812097|588958985|FG001|Overall Study|Withdrawal by Subject|12|||
163068921|NCT00812097|588958986|FG002|Overall Study|Withdrawal by Subject|8|||
163068922|NCT00812097|588958987|FG003|Overall Study|Withdrawal by Subject|2|||
163068923|NCT00812097|588958984|FG000|Overall Study|Lost to Follow-up|90|||
163068924|NCT00812097|588958985|FG001|Overall Study|Lost to Follow-up|14|||
163068925|NCT00812097|588958986|FG002|Overall Study|Lost to Follow-up|17|||
163068926|NCT00812097|588958987|FG003|Overall Study|Lost to Follow-up|5|||
163068927|NCT00812097|588958984|FG000|Overall Study|Explantation of study device(s)|27|||
163068928|NCT00812097|588958985|FG001|Overall Study|Explantation of study device(s)|29|||
163068929|NCT00812097|588958986|FG002|Overall Study|Explantation of study device(s)|14|||
163068930|NCT00812097|588958987|FG003|Overall Study|Explantation of study device(s)|20|||
163068931|NCT00812097|588958984|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
163068932|NCT00812097|588958985|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
163068933|NCT00812097|588958986|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
163068934|NCT00812097|588958987|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
163068935|NCT00927082|588958988|FG000|Overall Study|Lost to Follow-up|9|||
163068936|NCT00927082|588958989|FG001|Overall Study|Lost to Follow-up|8|||
163068937|NCT00927082|588958990|FG002|Overall Study|Lost to Follow-up|12|||
163068938|NCT00927082|588958991|FG003|Overall Study|Lost to Follow-up|16|||
163068939|NCT00927082|588958988|FG000|Overall Study|Withdrawal by Subject|3|||
163068940|NCT00927082|588958989|FG001|Overall Study|Withdrawal by Subject|2|||
163068941|NCT00927082|588958990|FG002|Overall Study|Withdrawal by Subject|7|||
163068942|NCT00927082|588958991|FG003|Overall Study|Withdrawal by Subject|2|||
163068943|NCT00927082|588958988|FG000|Overall Study|Death|0|||
163068944|NCT00927082|588958989|FG001|Overall Study|Death|0|||
163068945|NCT00927082|588958990|FG002|Overall Study|Death|1|||
163068946|NCT00927082|588958991|FG003|Overall Study|Death|0|||
163068947|NCT00927082|588958988|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
163068948|NCT00927082|588958989|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
163068949|NCT00927082|588958990|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
163068950|NCT00927082|588958991|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
163068951|NCT01786109|588958993|FG000|Overall Study|fail manometry barostat tube placement|1|||
163068952|NCT01786109|588958994|FG001|Overall Study|fail manometry barostat tube placement|0|||
163068953|NCT01786109|588958995|FG002|Overall Study|fail manometry barostat tube placement|0|||
163068954|NCT01786109|588958993|FG000|Overall Study|unrelated illness|0|||
163068955|NCT01786109|588958994|FG001|Overall Study|unrelated illness|0|||
163068956|NCT01786109|588958995|FG002|Overall Study|unrelated illness|1|||
163068957|NCT01786109|588958993|FG000|Overall Study|adverse effects colon preparation|0|||
163068958|NCT01786109|588958994|FG001|Overall Study|adverse effects colon preparation|0|||
163068959|NCT01786109|588958995|FG002|Overall Study|adverse effects colon preparation|1|||
163068960|NCT02513563|588958996|FG000|Overall Study|Death|4|||
163068961|NCT02513563|588958996|FG000|Overall Study|Withdrawal by Subject|4|||
163068962|NCT02513563|588958996|FG000|Overall Study|Physician Decision|1|||
163068963|NCT00317369|588958997|FG000|Overall Study|Adverse Event|2|||
163068964|NCT00317369|588958998|FG001|Overall Study|Adverse Event|1|||
163068965|NCT00317369|588958999|FG002|Overall Study|Adverse Event|0|||
163068966|NCT00317369|588958997|FG000|Overall Study|Lack of Efficacy|0|||
163068967|NCT00317369|588958998|FG001|Overall Study|Lack of Efficacy|1|||
163068968|NCT00317369|588958999|FG002|Overall Study|Lack of Efficacy|1|||
163068969|NCT00317369|588958997|FG000|Overall Study|Withdrawal by Subject|0|||
163068970|NCT00317369|588958998|FG001|Overall Study|Withdrawal by Subject|0|||
163068971|NCT00317369|588958999|FG002|Overall Study|Withdrawal by Subject|1|||
163068972|NCT00825175|588959004|FG000|Overall Study|Withdrawal by Subject|0|||
163068973|NCT00825175|588959005|FG001|Overall Study|Withdrawal by Subject|5|||
163068974|NCT03998462|588959009|FG000|Overall Study|Withdrawal by Subject|10|||
163068975|NCT03998462|588959010|FG001|Overall Study|Withdrawal by Subject|4|||
163068976|NCT03998462|588959009|FG000|Overall Study|Lost to Follow-up|1|||
163068977|NCT03998462|588959010|FG001|Overall Study|Lost to Follow-up|0|||
163068978|NCT03998462|588959009|FG000|Overall Study|Technical Difficulties|1|||
163068979|NCT03998462|588959010|FG001|Overall Study|Technical Difficulties|2|||
163068980|NCT05710224|588959011|FG000|Overall Study|Death|1|||
163068981|NCT05710224|588959012|FG001|Overall Study|Death|0|||
163068982|NCT05710224|588959011|FG000|Overall Study|Lost to Follow-up|16|||
163068983|NCT05710224|588959012|FG001|Overall Study|Lost to Follow-up|7|||
163026823|NCT03569293|588801298|FG005|Overall Study|Withdrawal by Subject|0|||
163026824|NCT03569293|588801293|FG000|Overall Study|Lost to Follow-up|1|||
163026825|NCT03569293|588801294|FG001|Overall Study|Lost to Follow-up|3|||
163026826|NCT03569293|588801295|FG002|Overall Study|Lost to Follow-up|1|||
163026827|NCT03569293|588801296|FG003|Overall Study|Lost to Follow-up|1|||
163026828|NCT03569293|588801297|FG004|Overall Study|Lost to Follow-up|0|||
163026829|NCT03569293|588801298|FG005|Overall Study|Lost to Follow-up|0|||
163026830|NCT03569293|588801293|FG000|Overall Study|Other|8|||
163026831|NCT03569293|588801294|FG001|Overall Study|Other|2|||
163026832|NCT03569293|588801295|FG002|Overall Study|Other|1|||
163026833|NCT03569293|588801296|FG003|Overall Study|Other|1|||
163026834|NCT03569293|588801297|FG004|Overall Study|Other|0|||
163026835|NCT03569293|588801298|FG005|Overall Study|Other|0|||
163026836|NCT03569293|588801293|FG000|Overall Study|Ongoing at Time of Analysis|8|||
163026837|NCT03569293|588801294|FG001|Overall Study|Ongoing at Time of Analysis|1|||
163026838|NCT03569293|588801295|FG002|Overall Study|Ongoing at Time of Analysis|3|||
163026839|NCT03569293|588801296|FG003|Overall Study|Ongoing at Time of Analysis|0|||
163026840|NCT03569293|588801297|FG004|Overall Study|Ongoing at Time of Analysis|0|||
163026841|NCT03569293|588801298|FG005|Overall Study|Ongoing at Time of Analysis|0|||
163026842|NCT05072106|588801309|FG000|Overall Study|Progressive disease|3|||
163026843|NCT05072106|588801310|FG001|Overall Study|Progressive disease|3|||
163026844|NCT05072106|588801309|FG000|Overall Study|Compassionate use|3|||
163026845|NCT05072106|588801310|FG001|Overall Study|Compassionate use|1|||
163026846|NCT05072106|588801309|FG000|Overall Study|Withdrawal by Subject|1|||
163026847|NCT05072106|588801310|FG001|Overall Study|Withdrawal by Subject|0|||
163026848|NCT03839459|588801311|FG000|Overall Study|Withdrawal by Subject|2|||
163026849|NCT03839459|588801311|FG000|Overall Study|progression of disease|3|||
163026850|NCT05376241|588801312|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
163026851|NCT05376241|588801312|FG000|Overall Study|103 did not complete the survey|103|||
163026852|NCT05376241|588801312|FG000|Overall Study|17 failed 2 attention check questions|17|||
163026853|NCT04240886|588801313|FG000|Treatment Phase|Death|4|||
163026854|NCT04240886|588801313|FG000|Treatment Phase|Discontinuation by Subject|1|||
163026855|NCT04240886|588801313|FG000|Treatment Phase|Adverse Event|5|||
163026856|NCT04240886|588801313|FG000|Follow-up Phase|Withdrawal by Subject|1|||
163026857|NCT04240886|588801313|FG000|Follow-up Phase|Discontinuation by Subject|1|||
163026858|NCT04240886|588801313|FG000|Follow-up Phase|Death|2|||
163026859|NCT02276053|588801314|FG000|Overall Study|Death|2|||
163026860|NCT02276053|588801314|FG000|Overall Study|Adverse Event|5|||
163026861|NCT02276053|588801314|FG000|Overall Study|Lack of Efficacy|2|||
163026862|NCT02276053|588801314|FG000|Overall Study|Withdrawal by Subject|1|||
163026863|NCT02276053|588801314|FG000|Overall Study|Patient does not meet selection criteria|3|||
163026864|NCT02276053|588801314|FG000|Overall Study|Patient needs to increase baseline AED|1|||
163026865|NCT02059434|588801315|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
163026866|NCT02059434|588801316|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
163026867|NCT02059434|588801317|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
163026868|NCT02059434|588801318|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
163026869|NCT02059434|588801319|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
163026870|NCT02059434|588801320|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
163026871|NCT02059434|588801321|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
163026872|NCT02059434|588801322|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
163026873|NCT02059434|588801323|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
163026874|NCT02059434|588801315|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
163026875|NCT02059434|588801316|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
163026876|NCT02059434|588801317|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
163026877|NCT02059434|588801318|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
163026878|NCT02059434|588801319|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
163026879|NCT02059434|588801320|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
163026880|NCT02059434|588801321|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
163026881|NCT02059434|588801322|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
163026882|NCT02059434|588801323|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
163026883|NCT02059434|588801315|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
163026884|NCT02059434|588801316|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
163026885|NCT02059434|588801317|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
163026886|NCT02059434|588801318|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
163026887|NCT02059434|588801319|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
163026888|NCT02059434|588801320|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
163026889|NCT02059434|588801321|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
163026890|NCT02059434|588801322|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
163026891|NCT02059434|588801323|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
163026892|NCT02059434|588801315|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
163026893|NCT02059434|588801316|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
163068984|NCT05710224|588959011|FG000|Overall Study|Withdrawal by Subject|4|||
163068985|NCT05710224|588959012|FG001|Overall Study|Withdrawal by Subject|6|||
162644254|NCT01848756|587413595|FG000|Overall Study|Withdrawal by Subject|1|||
163068986|NCT05710224|588959011|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163068987|NCT05710224|588959012|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163068988|NCT05710224|588959011|FG000|Overall Study|Participants Left The City|0|||
163068989|NCT05710224|588959012|FG001|Overall Study|Participants Left The City|2|||
163068990|NCT03369223|588959015|FG000|Overall Study|Lost to Follow-up|0|||
163068991|NCT03369223|588959016|FG001|Overall Study|Lost to Follow-up|0|||
163068992|NCT03369223|588959017|FG002|Overall Study|Lost to Follow-up|0|||
163068993|NCT03369223|588959018|FG003|Overall Study|Lost to Follow-up|0|||
163068994|NCT03369223|588959019|FG004|Overall Study|Lost to Follow-up|0|||
163068995|NCT03369223|588959020|FG005|Overall Study|Lost to Follow-up|0|||
163068996|NCT03369223|588959021|FG006|Overall Study|Lost to Follow-up|0|||
163068997|NCT03369223|588959022|FG007|Overall Study|Lost to Follow-up|0|||
163068998|NCT03369223|588959023|FG008|Overall Study|Lost to Follow-up|0|||
163068999|NCT03369223|588959024|FG009|Overall Study|Lost to Follow-up|0|||
163069000|NCT03369223|588959025|FG010|Overall Study|Lost to Follow-up|0|||
163069001|NCT03369223|588959026|FG011|Overall Study|Lost to Follow-up|0|||
162644255|NCT01848756|587413595|FG000|Overall Study|Enrolled in Error|1|||
162644256|NCT01286012|587413596|FG000|Overall Study|Adverse Event|3|||
162644257|NCT01286012|587413597|FG001|Overall Study|Adverse Event|3|||
162644258|NCT01286012|587413596|FG000|Overall Study|Death|2|||
162644259|NCT01286012|587413597|FG001|Overall Study|Death|3|||
162644260|NCT01286012|587413596|FG000|Overall Study|Protocol Violation|1|||
162644261|NCT01286012|587413597|FG001|Overall Study|Protocol Violation|1|||
162644262|NCT01286012|587413596|FG000|Overall Study|Withdrawal by Subject|4|||
162644263|NCT01286012|587413597|FG001|Overall Study|Withdrawal by Subject|4|||
162644264|NCT01286012|587413596|FG000|Overall Study|Physician Decision|2|||
162644265|NCT01286012|587413597|FG001|Overall Study|Physician Decision|0|||
162644266|NCT01286012|587413596|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
162644267|NCT01286012|587413597|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
162644268|NCT04056195|587413600|FG000|Overall Study|Adverse Event|1|||
162644269|NCT04056195|587413601|FG001|Overall Study|Adverse Event|0|||
162644270|NCT04056195|587413602|FG002|Overall Study|Adverse Event|0|||
162644271|NCT04056195|587413600|FG000|Overall Study|Withdrawal by Subject|0|||
162644272|NCT04056195|587413601|FG001|Overall Study|Withdrawal by Subject|1|||
162644273|NCT04056195|587413602|FG002|Overall Study|Withdrawal by Subject|1|||
163026894|NCT02059434|588801317|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
163026895|NCT02059434|588801318|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
163026896|NCT02059434|588801319|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
163026897|NCT02059434|588801320|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
163026898|NCT02059434|588801321|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
163026899|NCT02059434|588801322|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
163026900|NCT02059434|588801323|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
163026901|NCT02059434|588801315|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026902|NCT02059434|588801316|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026903|NCT02059434|588801317|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026904|NCT02059434|588801318|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026905|NCT02059434|588801319|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026906|NCT02059434|588801320|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026907|NCT02059434|588801321|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026908|NCT02059434|588801322|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
163026909|NCT02059434|588801323|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
163026910|NCT02928770|588801328|FG000|Overall Study|Withdrawal by Subject|2|||
163026911|NCT03201874|588801329|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
163026912|NCT03201874|588801330|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
163026913|NCT03201874|588801329|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
163026914|NCT03201874|588801330|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
163026915|NCT02759055|588801336|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
163026916|NCT02759055|588801337|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
163026917|NCT02515994|588801338|FG000|Overall Study|Protocol Violation|3|||
163026918|NCT02515994|588801339|FG001|Overall Study|Protocol Violation|5|||
163026919|NCT02515994|588801338|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
163026920|NCT02515994|588801339|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
163026921|NCT02515994|588801338|FG000|Overall Study|Adverse Event|3|||
163026922|NCT02515994|588801339|FG001|Overall Study|Adverse Event|1|||
163026923|NCT02515994|588801338|FG000|Overall Study|Withdrawal by Subject|2|||
163026924|NCT02515994|588801339|FG001|Overall Study|Withdrawal by Subject|0|||
163069002|NCT03369223|588959027|FG012|Overall Study|Lost to Follow-up|0|||
163069003|NCT03369223|588959028|FG013|Overall Study|Lost to Follow-up|0|||
162644274|NCT04056195|587413600|FG000|Overall Study|Physician Decision|1|||
162644275|NCT04056195|587413601|FG001|Overall Study|Physician Decision|1|||
162644276|NCT04056195|587413602|FG002|Overall Study|Physician Decision|1|||
163069004|NCT03369223|588959029|FG014|Overall Study|Lost to Follow-up|0|||
163069005|NCT03369223|588959030|FG015|Overall Study|Lost to Follow-up|0|||
163069006|NCT03369223|588959031|FG016|Overall Study|Lost to Follow-up|0|||
163069007|NCT03369223|588959032|FG017|Overall Study|Lost to Follow-up|0|||
163069008|NCT03369223|588959033|FG018|Overall Study|Lost to Follow-up|2|||
163069009|NCT03369223|588959034|FG019|Overall Study|Lost to Follow-up|1|||
163069010|NCT03369223|588959015|FG000|Overall Study|Participant no longer meets study criteria|0|||
163069011|NCT03369223|588959016|FG001|Overall Study|Participant no longer meets study criteria|0|||
163069012|NCT03369223|588959017|FG002|Overall Study|Participant no longer meets study criteria|0|||
163069013|NCT03369223|588959018|FG003|Overall Study|Participant no longer meets study criteria|0|||
163069014|NCT03369223|588959019|FG004|Overall Study|Participant no longer meets study criteria|0|||
163069015|NCT03369223|588959020|FG005|Overall Study|Participant no longer meets study criteria|0|||
163069016|NCT03369223|588959021|FG006|Overall Study|Participant no longer meets study criteria|0|||
163069017|NCT03369223|588959022|FG007|Overall Study|Participant no longer meets study criteria|0|||
163069018|NCT03369223|588959023|FG008|Overall Study|Participant no longer meets study criteria|0|||
163069019|NCT03369223|588959024|FG009|Overall Study|Participant no longer meets study criteria|0|||
163069020|NCT03369223|588959025|FG010|Overall Study|Participant no longer meets study criteria|0|||
163069021|NCT03369223|588959026|FG011|Overall Study|Participant no longer meets study criteria|0|||
163069022|NCT03369223|588959027|FG012|Overall Study|Participant no longer meets study criteria|0|||
163069023|NCT03369223|588959028|FG013|Overall Study|Participant no longer meets study criteria|0|||
163069024|NCT03369223|588959029|FG014|Overall Study|Participant no longer meets study criteria|2|||
163069025|NCT03369223|588959030|FG015|Overall Study|Participant no longer meets study criteria|0|||
163069026|NCT03369223|588959031|FG016|Overall Study|Participant no longer meets study criteria|2|||
163069027|NCT03369223|588959032|FG017|Overall Study|Participant no longer meets study criteria|0|||
163069028|NCT03369223|588959033|FG018|Overall Study|Participant no longer meets study criteria|0|||
163069029|NCT03369223|588959034|FG019|Overall Study|Participant no longer meets study criteria|0|||
163069030|NCT03369223|588959015|FG000|Overall Study|Other reasons|0|||
163069031|NCT03369223|588959016|FG001|Overall Study|Other reasons|0|||
163069032|NCT03369223|588959017|FG002|Overall Study|Other reasons|0|||
163069033|NCT03369223|588959018|FG003|Overall Study|Other reasons|0|||
163069034|NCT03369223|588959019|FG004|Overall Study|Other reasons|0|||
163069035|NCT03369223|588959020|FG005|Overall Study|Other reasons|0|||
163069036|NCT03369223|588959021|FG006|Overall Study|Other reasons|0|||
163069037|NCT03369223|588959022|FG007|Overall Study|Other reasons|0|||
163069038|NCT03369223|588959023|FG008|Overall Study|Other reasons|0|||
163069039|NCT03369223|588959024|FG009|Overall Study|Other reasons|0|||
163069040|NCT03369223|588959025|FG010|Overall Study|Other reasons|0|||
163069041|NCT03369223|588959026|FG011|Overall Study|Other reasons|0|||
163069042|NCT03369223|588959027|FG012|Overall Study|Other reasons|0|||
163069043|NCT03369223|588959028|FG013|Overall Study|Other reasons|1|||
163069044|NCT03369223|588959029|FG014|Overall Study|Other reasons|2|||
163069045|NCT03369223|588959030|FG015|Overall Study|Other reasons|0|||
163069046|NCT03369223|588959031|FG016|Overall Study|Other reasons|1|||
163069047|NCT03369223|588959032|FG017|Overall Study|Other reasons|0|||
163069048|NCT03369223|588959033|FG018|Overall Study|Other reasons|0|||
163069049|NCT03369223|588959034|FG019|Overall Study|Other reasons|2|||
163069050|NCT03369223|588959015|FG000|Overall Study|Death|0|||
163069051|NCT03369223|588959016|FG001|Overall Study|Death|0|||
163069052|NCT03369223|588959017|FG002|Overall Study|Death|0|||
163069053|NCT03369223|588959018|FG003|Overall Study|Death|0|||
163069054|NCT03369223|588959019|FG004|Overall Study|Death|0|||
163069055|NCT03369223|588959020|FG005|Overall Study|Death|0|||
163069056|NCT03369223|588959021|FG006|Overall Study|Death|0|||
163069057|NCT03369223|588959022|FG007|Overall Study|Death|0|||
163069058|NCT03369223|588959023|FG008|Overall Study|Death|0|||
163069059|NCT03369223|588959024|FG009|Overall Study|Death|0|||
163069060|NCT03369223|588959025|FG010|Overall Study|Death|0|||
163069061|NCT03369223|588959026|FG011|Overall Study|Death|0|||
163069062|NCT03369223|588959027|FG012|Overall Study|Death|0|||
163069063|NCT03369223|588959028|FG013|Overall Study|Death|1|||
163069064|NCT03369223|588959029|FG014|Overall Study|Death|0|||
163069065|NCT03369223|588959030|FG015|Overall Study|Death|0|||
163069066|NCT03369223|588959031|FG016|Overall Study|Death|0|||
163069067|NCT03369223|588959032|FG017|Overall Study|Death|0|||
163069068|NCT03369223|588959033|FG018|Overall Study|Death|1|||
163069069|NCT03369223|588959034|FG019|Overall Study|Death|0|||
163069070|NCT03369223|588959015|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163069071|NCT03369223|588959016|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163069072|NCT03369223|588959017|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163069073|NCT03369223|588959018|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163069074|NCT03369223|588959019|FG004|Overall Study|Adverse event unrelated to study drug|0|||
163069075|NCT03369223|588959020|FG005|Overall Study|Adverse event unrelated to study drug|0|||
163069076|NCT03369223|588959021|FG006|Overall Study|Adverse event unrelated to study drug|1|||
163069077|NCT03369223|588959022|FG007|Overall Study|Adverse event unrelated to study drug|0|||
163069078|NCT03369223|588959023|FG008|Overall Study|Adverse event unrelated to study drug|0|||
163069079|NCT03369223|588959024|FG009|Overall Study|Adverse event unrelated to study drug|1|||
163069080|NCT03369223|588959025|FG010|Overall Study|Adverse event unrelated to study drug|0|||
163069081|NCT03369223|588959026|FG011|Overall Study|Adverse event unrelated to study drug|0|||
163069082|NCT03369223|588959027|FG012|Overall Study|Adverse event unrelated to study drug|0|||
163069083|NCT03369223|588959028|FG013|Overall Study|Adverse event unrelated to study drug|4|||
163069084|NCT03369223|588959029|FG014|Overall Study|Adverse event unrelated to study drug|2|||
163069085|NCT03369223|588959030|FG015|Overall Study|Adverse event unrelated to study drug|0|||
163069086|NCT03369223|588959031|FG016|Overall Study|Adverse event unrelated to study drug|2|||
163069087|NCT03369223|588959032|FG017|Overall Study|Adverse event unrelated to study drug|1|||
163069088|NCT03369223|588959033|FG018|Overall Study|Adverse event unrelated to study drug|3|||
163069089|NCT03369223|588959034|FG019|Overall Study|Adverse event unrelated to study drug|2|||
163069090|NCT03369223|588959015|FG000|Overall Study|Disease progression|6|||
163069091|NCT03369223|588959016|FG001|Overall Study|Disease progression|8|||
163069092|NCT03369223|588959017|FG002|Overall Study|Disease progression|5|||
163069093|NCT03369223|588959018|FG003|Overall Study|Disease progression|1|||
163069094|NCT03369223|588959019|FG004|Overall Study|Disease progression|9|||
163069095|NCT03369223|588959020|FG005|Overall Study|Disease progression|9|||
163069096|NCT03369223|588959021|FG006|Overall Study|Disease progression|4|||
163069097|NCT03369223|588959022|FG007|Overall Study|Disease progression|6|||
163069098|NCT03369223|588959023|FG008|Overall Study|Disease progression|10|||
163069099|NCT03369223|588959024|FG009|Overall Study|Disease progression|7|||
163069100|NCT03369223|588959025|FG010|Overall Study|Disease progression|4|||
162644277|NCT01498458|587413603|FG000|Overall Study|Adverse Event|4|||
163026925|NCT01424514|588801341|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
163026926|NCT01424514|588801342|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
163026927|NCT01424514|588801341|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
163026928|NCT01424514|588801342|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
163026929|NCT02653170|588801343|FG000|Overall Study|Withdrawal by Subject|3|||
163026930|NCT02653170|588801344|FG001|Overall Study|Withdrawal by Subject|8|||
163026931|NCT02653170|588801345|FG002|Overall Study|Withdrawal by Subject|3|||
163026932|NCT02653170|588801343|FG000|Overall Study|withdrawn by study team|2|||
163026933|NCT02653170|588801344|FG001|Overall Study|withdrawn by study team|4|||
163026934|NCT02653170|588801345|FG002|Overall Study|withdrawn by study team|5|||
163026935|NCT02653170|588801343|FG000|Overall Study|Lost to Follow-up|12|||
163069101|NCT03369223|588959026|FG011|Overall Study|Disease progression|1|||
163069102|NCT03369223|588959027|FG012|Overall Study|Disease progression|1|||
163069103|NCT03369223|588959028|FG013|Overall Study|Disease progression|25|||
163069104|NCT03369223|588959029|FG014|Overall Study|Disease progression|22|||
163069105|NCT03369223|588959030|FG015|Overall Study|Disease progression|2|||
163069106|NCT03369223|588959031|FG016|Overall Study|Disease progression|10|||
163069107|NCT03369223|588959032|FG017|Overall Study|Disease progression|1|||
163069108|NCT03369223|588959033|FG018|Overall Study|Disease progression|18|||
163069109|NCT03369223|588959034|FG019|Overall Study|Disease progression|28|||
163069110|NCT03369223|588959015|FG000|Overall Study|Study drug toxicity|0|||
163069111|NCT03369223|588959016|FG001|Overall Study|Study drug toxicity|1|||
163069112|NCT03369223|588959017|FG002|Overall Study|Study drug toxicity|4|||
163069113|NCT03369223|588959018|FG003|Overall Study|Study drug toxicity|0|||
163069114|NCT03369223|588959019|FG004|Overall Study|Study drug toxicity|1|||
163069115|NCT03369223|588959020|FG005|Overall Study|Study drug toxicity|2|||
163069116|NCT03369223|588959021|FG006|Overall Study|Study drug toxicity|4|||
163069117|NCT03369223|588959022|FG007|Overall Study|Study drug toxicity|2|||
163069118|NCT03369223|588959023|FG008|Overall Study|Study drug toxicity|2|||
163069119|NCT03369223|588959024|FG009|Overall Study|Study drug toxicity|0|||
163069120|NCT03369223|588959025|FG010|Overall Study|Study drug toxicity|6|||
163069121|NCT03369223|588959026|FG011|Overall Study|Study drug toxicity|1|||
163069122|NCT03369223|588959027|FG012|Overall Study|Study drug toxicity|2|||
163069123|NCT03369223|588959028|FG013|Overall Study|Study drug toxicity|19|||
163069124|NCT03369223|588959029|FG014|Overall Study|Study drug toxicity|19|||
163069125|NCT03369223|588959030|FG015|Overall Study|Study drug toxicity|0|||
163069126|NCT03369223|588959031|FG016|Overall Study|Study drug toxicity|18|||
163069127|NCT03369223|588959032|FG017|Overall Study|Study drug toxicity|3|||
163069128|NCT03369223|588959033|FG018|Overall Study|Study drug toxicity|11|||
163069129|NCT03369223|588959034|FG019|Overall Study|Study drug toxicity|7|||
163069130|NCT03369223|588959015|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163069131|NCT03369223|588959016|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163069132|NCT03369223|588959017|FG002|Overall Study|Participant request to discontinue study treatment|0|||
163069133|NCT03369223|588959018|FG003|Overall Study|Participant request to discontinue study treatment|0|||
163069134|NCT03369223|588959019|FG004|Overall Study|Participant request to discontinue study treatment|1|||
163069135|NCT03369223|588959020|FG005|Overall Study|Participant request to discontinue study treatment|1|||
163069136|NCT03369223|588959021|FG006|Overall Study|Participant request to discontinue study treatment|1|||
163069137|NCT03369223|588959022|FG007|Overall Study|Participant request to discontinue study treatment|0|||
163069138|NCT03369223|588959023|FG008|Overall Study|Participant request to discontinue study treatment|0|||
163069139|NCT03369223|588959024|FG009|Overall Study|Participant request to discontinue study treatment|0|||
163069140|NCT03369223|588959025|FG010|Overall Study|Participant request to discontinue study treatment|0|||
163069141|NCT03369223|588959026|FG011|Overall Study|Participant request to discontinue study treatment|0|||
163069142|NCT03369223|588959027|FG012|Overall Study|Participant request to discontinue study treatment|0|||
163069143|NCT03369223|588959028|FG013|Overall Study|Participant request to discontinue study treatment|1|||
163069144|NCT03369223|588959029|FG014|Overall Study|Participant request to discontinue study treatment|1|||
163069145|NCT03369223|588959030|FG015|Overall Study|Participant request to discontinue study treatment|0|||
163069146|NCT03369223|588959031|FG016|Overall Study|Participant request to discontinue study treatment|0|||
163069147|NCT03369223|588959032|FG017|Overall Study|Participant request to discontinue study treatment|0|||
163069148|NCT03369223|588959033|FG018|Overall Study|Participant request to discontinue study treatment|1|||
163069149|NCT03369223|588959034|FG019|Overall Study|Participant request to discontinue study treatment|0|||
163069150|NCT03369223|588959015|FG000|Overall Study|Participant withdrew consent|0|||
163069151|NCT03369223|588959016|FG001|Overall Study|Participant withdrew consent|1|||
163069152|NCT03369223|588959017|FG002|Overall Study|Participant withdrew consent|1|||
163069153|NCT03369223|588959018|FG003|Overall Study|Participant withdrew consent|0|||
163069154|NCT03369223|588959019|FG004|Overall Study|Participant withdrew consent|0|||
163069155|NCT03369223|588959020|FG005|Overall Study|Participant withdrew consent|0|||
163069156|NCT03369223|588959021|FG006|Overall Study|Participant withdrew consent|1|||
163069157|NCT03369223|588959022|FG007|Overall Study|Participant withdrew consent|1|||
163069158|NCT03369223|588959023|FG008|Overall Study|Participant withdrew consent|1|||
163069159|NCT03369223|588959024|FG009|Overall Study|Participant withdrew consent|0|||
163069160|NCT03369223|588959025|FG010|Overall Study|Participant withdrew consent|0|||
163069161|NCT03369223|588959026|FG011|Overall Study|Participant withdrew consent|1|||
163069162|NCT03369223|588959027|FG012|Overall Study|Participant withdrew consent|0|||
163069163|NCT03369223|588959028|FG013|Overall Study|Participant withdrew consent|0|||
163069164|NCT03369223|588959029|FG014|Overall Study|Participant withdrew consent|3|||
163069165|NCT03369223|588959030|FG015|Overall Study|Participant withdrew consent|0|||
163069166|NCT03369223|588959031|FG016|Overall Study|Participant withdrew consent|1|||
163069167|NCT03369223|588959032|FG017|Overall Study|Participant withdrew consent|0|||
162644278|NCT01498458|587413603|FG000|Overall Study|Physician Decision|3|||
162644279|NCT02226003|587413604|FG000|Overall Study|Lost to Follow-up|2|||
162644280|NCT02226003|587413605|FG001|Overall Study|Lost to Follow-up|1|||
162644281|NCT02226003|587413606|FG002|Overall Study|Lost to Follow-up|3|||
163069168|NCT03369223|588959033|FG018|Overall Study|Participant withdrew consent|4|||
162644282|NCT02226003|587413604|FG000|Overall Study|Withdrawal by Subject|0|||
162644283|NCT02226003|587413605|FG001|Overall Study|Withdrawal by Subject|0|||
163069169|NCT03369223|588959034|FG019|Overall Study|Participant withdrew consent|2|||
163069170|NCT03369223|588959015|FG000|Overall Study|Randomized but not treated|0|||
163069171|NCT03369223|588959016|FG001|Overall Study|Randomized but not treated|0|||
163069172|NCT03369223|588959017|FG002|Overall Study|Randomized but not treated|0|||
163069173|NCT03369223|588959018|FG003|Overall Study|Randomized but not treated|0|||
163069174|NCT03369223|588959019|FG004|Overall Study|Randomized but not treated|0|||
163069175|NCT03369223|588959020|FG005|Overall Study|Randomized but not treated|0|||
163069176|NCT03369223|588959021|FG006|Overall Study|Randomized but not treated|0|||
163069177|NCT03369223|588959022|FG007|Overall Study|Randomized but not treated|0|||
163069178|NCT03369223|588959023|FG008|Overall Study|Randomized but not treated|0|||
163069179|NCT03369223|588959024|FG009|Overall Study|Randomized but not treated|0|||
163069180|NCT03369223|588959025|FG010|Overall Study|Randomized but not treated|0|||
163069181|NCT03369223|588959026|FG011|Overall Study|Randomized but not treated|0|||
163069182|NCT03369223|588959027|FG012|Overall Study|Randomized but not treated|0|||
163069183|NCT03369223|588959028|FG013|Overall Study|Randomized but not treated|1|||
163069184|NCT03369223|588959029|FG014|Overall Study|Randomized but not treated|1|||
163069185|NCT03369223|588959030|FG015|Overall Study|Randomized but not treated|0|||
163069186|NCT03369223|588959031|FG016|Overall Study|Randomized but not treated|0|||
163069187|NCT03369223|588959032|FG017|Overall Study|Randomized but not treated|0|||
163069188|NCT03369223|588959033|FG018|Overall Study|Randomized but not treated|0|||
163069189|NCT03369223|588959034|FG019|Overall Study|Randomized but not treated|0|||
163069190|NCT04615507|588959035|FG000|Period 1|Covid-19 exposure|2|||
163069191|NCT04615507|588959036|FG001|Period 1|Covid-19 exposure|1|||
163069192|NCT04615507|588959035|FG000|Period 2|Covid-19 exposure|0|||
163069193|NCT04615507|588959036|FG001|Period 2|Covid-19 exposure|1|||
163069194|NCT04615507|588959035|FG000|Period 2|Protocol Violation|1|||
163069195|NCT04615507|588959036|FG001|Period 2|Protocol Violation|0|||
163069196|NCT04615507|588959035|FG000|Period 2|Withdrawal by Subject|1|||
163069197|NCT04615507|588959036|FG001|Period 2|Withdrawal by Subject|0|||
163069198|NCT04615507|588959035|FG000|Period 2|Adverse Event|0|||
163069199|NCT04615507|588959036|FG001|Period 2|Adverse Event|1|||
163069200|NCT04615507|588959035|FG000|Period 3|Covid-19 exposure|0|||
163069201|NCT04615507|588959036|FG001|Period 3|Covid-19 exposure|1|||
163069202|NCT03407482|588959037|FG000|Overall Study|Adverse Event|12|||
163069203|NCT03407482|588959037|FG000|Overall Study|Disease Relapse|1|||
163069204|NCT03407482|588959037|FG000|Overall Study|Lost to Follow-up|1|||
163069205|NCT03407482|588959037|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163069206|NCT03407482|588959037|FG000|Overall Study|Pregnancy|2|||
163069207|NCT03407482|588959037|FG000|Overall Study|Protocol Violation|1|||
163069208|NCT03407482|588959037|FG000|Overall Study|Study Terminated By Sponsor|106|||
163069209|NCT03407482|588959037|FG000|Overall Study|Withdrawal by Subject|6|||
163069210|NCT03407482|588959037|FG000|Overall Study|Data Entry Error|1|||
163069211|NCT05887401|588959041|FG000|Overall Study|Withdrawal by Subject|0|||
163069212|NCT05887401|588959042|FG001|Overall Study|Withdrawal by Subject|0|||
163069213|NCT05887401|588959043|FG002|Overall Study|Withdrawal by Subject|0|||
163069214|NCT05887401|588959044|FG003|Overall Study|Withdrawal by Subject|0|||
163069215|NCT05887401|588959045|FG004|Overall Study|Withdrawal by Subject|0|||
163069216|NCT05887401|588959046|FG005|Overall Study|Withdrawal by Subject|0|||
163069217|NCT05887401|588959047|FG006|Overall Study|Withdrawal by Subject|0|||
163069218|NCT05887401|588959048|FG007|Overall Study|Withdrawal by Subject|0|||
163069219|NCT05887401|588959049|FG008|Overall Study|Withdrawal by Subject|0|||
163069220|NCT05887401|588959050|FG009|Overall Study|Withdrawal by Subject|1|||
163069221|NCT05887401|588959051|FG010|Overall Study|Withdrawal by Subject|0|||
163069222|NCT05887401|588959052|FG011|Overall Study|Withdrawal by Subject|0|||
162644284|NCT02226003|587413606|FG002|Overall Study|Withdrawal by Subject|3|||
162644285|NCT03279692|587413612|FG000|Overall Study|Withdrawal by Subject|1|||
162644286|NCT02446990|587413615|FG000|Overall Study|Death|485|||
163069223|NCT05887401|588959053|FG012|Overall Study|Withdrawal by Subject|0|||
163069224|NCT05887401|588959054|FG013|Overall Study|Withdrawal by Subject|0|||
163069225|NCT05887401|588959055|FG014|Overall Study|Withdrawal by Subject|0|||
163069226|NCT05887401|588959056|FG015|Overall Study|Withdrawal by Subject|1|||
163069227|NCT05887401|588959041|FG000|Overall Study|Lost to Follow-up|0|||
163069228|NCT05887401|588959042|FG001|Overall Study|Lost to Follow-up|1|||
162644287|NCT02446990|587413616|FG001|Overall Study|Death|458|||
163069229|NCT05887401|588959043|FG002|Overall Study|Lost to Follow-up|1|||
162644288|NCT02446990|587413615|FG000|Overall Study|Lost to Follow-up|3|||
163069230|NCT05887401|588959044|FG003|Overall Study|Lost to Follow-up|2|||
163069231|NCT05887401|588959045|FG004|Overall Study|Lost to Follow-up|0|||
163069232|NCT05887401|588959046|FG005|Overall Study|Lost to Follow-up|0|||
163069233|NCT05887401|588959047|FG006|Overall Study|Lost to Follow-up|0|||
163069234|NCT05887401|588959048|FG007|Overall Study|Lost to Follow-up|0|||
163069235|NCT05887401|588959049|FG008|Overall Study|Lost to Follow-up|1|||
162644289|NCT02446990|587413616|FG001|Overall Study|Lost to Follow-up|1|||
163069236|NCT05887401|588959050|FG009|Overall Study|Lost to Follow-up|1|||
163069237|NCT05887401|588959051|FG010|Overall Study|Lost to Follow-up|2|||
163069238|NCT05887401|588959052|FG011|Overall Study|Lost to Follow-up|1|||
163069239|NCT05887401|588959053|FG012|Overall Study|Lost to Follow-up|0|||
163069240|NCT05887401|588959054|FG013|Overall Study|Lost to Follow-up|0|||
163069241|NCT05887401|588959055|FG014|Overall Study|Lost to Follow-up|0|||
163069242|NCT05887401|588959056|FG015|Overall Study|Lost to Follow-up|0|||
163069243|NCT02369458|588959060|FG000|Overall Study|Determined to be not eligible|1|||
163069244|NCT02369458|588959061|FG001|Overall Study|Determined to be not eligible|0|||
163069245|NCT03853798|588959062|FG000|Overall Study|Death|0|||
163069246|NCT03853798|588959063|FG001|Overall Study|Death|0|||
163069247|NCT03853798|588959064|FG002|Overall Study|Death|0|||
163069248|NCT03853798|588959065|FG003|Overall Study|Death|0|||
163069249|NCT03853798|588959066|FG004|Overall Study|Death|0|||
163069250|NCT03853798|588959067|FG005|Overall Study|Death|1|||
163069251|NCT03853798|588959068|FG006|Overall Study|Death|0|||
163069252|NCT03853798|588959069|FG007|Overall Study|Death|0|||
163069253|NCT03853798|588959070|FG008|Overall Study|Death|0|||
163069254|NCT03853798|588959062|FG000|Overall Study|Adverse Event|0|||
162644290|NCT02446990|587413615|FG000|Overall Study|Physician Decision|1|||
162644291|NCT02446990|587413616|FG001|Overall Study|Physician Decision|0|||
162644292|NCT02446990|587413615|FG000|Overall Study|Withdrawal by Subject|231|||
162644293|NCT02446990|587413616|FG001|Overall Study|Withdrawal by Subject|199|||
162644294|NCT01064401|587413617|FG000|Overall Study|Adverse Event|47|||
162644295|NCT01064401|587413618|FG001|Overall Study|Adverse Event|56|||
162644296|NCT01064401|587413617|FG000|Overall Study|Lack of Efficacy|46|||
162644297|NCT01064401|587413618|FG001|Overall Study|Lack of Efficacy|23|||
162644298|NCT01064401|587413617|FG000|Overall Study|Lost to Follow-up|12|||
162644299|NCT01064401|587413618|FG001|Overall Study|Lost to Follow-up|9|||
162644300|NCT01064401|587413617|FG000|Overall Study|Consent Withdrawn|98|||
162644301|NCT01064401|587413618|FG001|Overall Study|Consent Withdrawn|80|||
162644302|NCT01064401|587413617|FG000|Overall Study|Investigator Decision|4|||
162644303|NCT01064401|587413618|FG001|Overall Study|Investigator Decision|6|||
162644304|NCT01064401|587413617|FG000|Overall Study|Death|4|||
162644305|NCT01064401|587413618|FG001|Overall Study|Death|0|||
163069255|NCT03853798|588959063|FG001|Overall Study|Adverse Event|0|||
163069256|NCT03853798|588959064|FG002|Overall Study|Adverse Event|2|||
163069257|NCT03853798|588959065|FG003|Overall Study|Adverse Event|0|||
163069258|NCT03853798|588959066|FG004|Overall Study|Adverse Event|0|||
163069259|NCT03853798|588959067|FG005|Overall Study|Adverse Event|0|||
163069260|NCT03853798|588959068|FG006|Overall Study|Adverse Event|0|||
163069261|NCT03853798|588959069|FG007|Overall Study|Adverse Event|0|||
163069262|NCT03853798|588959070|FG008|Overall Study|Adverse Event|0|||
163069263|NCT03853798|588959062|FG000|Overall Study|Withdrawal by Subject|0|||
163069264|NCT03853798|588959063|FG001|Overall Study|Withdrawal by Subject|1|||
163069265|NCT03853798|588959064|FG002|Overall Study|Withdrawal by Subject|4|||
163069266|NCT03853798|588959065|FG003|Overall Study|Withdrawal by Subject|0|||
163069267|NCT03853798|588959066|FG004|Overall Study|Withdrawal by Subject|0|||
163069268|NCT03853798|588959067|FG005|Overall Study|Withdrawal by Subject|5|||
163069269|NCT03853798|588959068|FG006|Overall Study|Withdrawal by Subject|0|||
163069270|NCT03853798|588959069|FG007|Overall Study|Withdrawal by Subject|0|||
163069271|NCT03853798|588959070|FG008|Overall Study|Withdrawal by Subject|4|||
163069272|NCT03853798|588959062|FG000|Overall Study|Physician Decision|1|||
163069273|NCT03853798|588959063|FG001|Overall Study|Physician Decision|0|||
163069274|NCT03853798|588959064|FG002|Overall Study|Physician Decision|0|||
163069275|NCT03853798|588959065|FG003|Overall Study|Physician Decision|0|||
163069276|NCT03853798|588959066|FG004|Overall Study|Physician Decision|0|||
163069277|NCT03853798|588959067|FG005|Overall Study|Physician Decision|0|||
163069278|NCT03853798|588959068|FG006|Overall Study|Physician Decision|0|||
162644306|NCT01064401|587413617|FG000|Overall Study|Pregnancy|4|||
162644307|NCT01064401|587413618|FG001|Overall Study|Pregnancy|7|||
162644308|NCT01064401|587413617|FG000|Overall Study|Noncompliance|7|||
162644309|NCT01064401|587413618|FG001|Overall Study|Noncompliance|8|||
162644310|NCT01064401|587413617|FG000|Overall Study|Site Closure|4|||
162644311|NCT01064401|587413618|FG001|Overall Study|Site Closure|5|||
162644312|NCT01064401|587413617|FG000|Overall Study|Other|2|||
163069279|NCT03853798|588959069|FG007|Overall Study|Physician Decision|0|||
163069280|NCT03853798|588959070|FG008|Overall Study|Physician Decision|1|||
163069281|NCT03853798|588959062|FG000|Overall Study|Lack of Efficacy|0|||
163069282|NCT03853798|588959063|FG001|Overall Study|Lack of Efficacy|0|||
162644313|NCT01064401|587413618|FG001|Overall Study|Other|1|||
162644314|NCT03158051|587413619|FG000|Overall Study|Lost to Follow-up|41|||
162644315|NCT03158051|587413620|FG001|Overall Study|Lost to Follow-up|47|||
163069283|NCT03853798|588959064|FG002|Overall Study|Lack of Efficacy|2|||
163069284|NCT03853798|588959065|FG003|Overall Study|Lack of Efficacy|0|||
163069285|NCT03853798|588959066|FG004|Overall Study|Lack of Efficacy|0|||
163069286|NCT03853798|588959067|FG005|Overall Study|Lack of Efficacy|0|||
163069287|NCT03853798|588959068|FG006|Overall Study|Lack of Efficacy|0|||
163069288|NCT03853798|588959069|FG007|Overall Study|Lack of Efficacy|0|||
163069289|NCT03853798|588959070|FG008|Overall Study|Lack of Efficacy|1|||
163069290|NCT03853798|588959062|FG000|Overall Study|Approved Drug Available for Indication|0|||
163069291|NCT03853798|588959063|FG001|Overall Study|Approved Drug Available for Indication|0|||
162644316|NCT03158051|587413619|FG000|Overall Study|Physician Decision|6|||
162644317|NCT03158051|587413620|FG001|Overall Study|Physician Decision|7|||
162644318|NCT03158051|587413619|FG000|Overall Study|Withdrawal by Subject|24|||
163069292|NCT03853798|588959064|FG002|Overall Study|Approved Drug Available for Indication|1|||
163069293|NCT03853798|588959065|FG003|Overall Study|Approved Drug Available for Indication|0|||
163069294|NCT03853798|588959066|FG004|Overall Study|Approved Drug Available for Indication|0|||
163069295|NCT03853798|588959067|FG005|Overall Study|Approved Drug Available for Indication|1|||
163069296|NCT03853798|588959068|FG006|Overall Study|Approved Drug Available for Indication|0|||
163069297|NCT03853798|588959069|FG007|Overall Study|Approved Drug Available for Indication|0|||
163069298|NCT03853798|588959070|FG008|Overall Study|Approved Drug Available for Indication|0|||
163069299|NCT03853798|588959062|FG000|Overall Study|Other un-specified|0|||
163069300|NCT03853798|588959063|FG001|Overall Study|Other un-specified|0|||
163069301|NCT03853798|588959064|FG002|Overall Study|Other un-specified|2|||
163069302|NCT03853798|588959065|FG003|Overall Study|Other un-specified|0|||
163069303|NCT03853798|588959066|FG004|Overall Study|Other un-specified|0|||
163069304|NCT03853798|588959067|FG005|Overall Study|Other un-specified|1|||
163069305|NCT03853798|588959068|FG006|Overall Study|Other un-specified|0|||
163069306|NCT03853798|588959069|FG007|Overall Study|Other un-specified|0|||
163069307|NCT03853798|588959070|FG008|Overall Study|Other un-specified|0|||
163069308|NCT02743494|588959071|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
163069309|NCT02743494|588959072|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
163069310|NCT02743494|588959071|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
163069311|NCT02743494|588959072|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
163069312|NCT02743494|588959071|FG000|Treatment Period|Disease recurrence|152|||
163069313|NCT02743494|588959072|FG001|Treatment Period|Disease recurrence|115|||
163069314|NCT02743494|588959071|FG000|Treatment Period|Study drug toxicity|56|||
163069315|NCT02743494|588959072|FG001|Treatment Period|Study drug toxicity|8|||
163069316|NCT02743494|588959071|FG000|Treatment Period|Death|1|||
163069317|NCT02743494|588959072|FG001|Treatment Period|Death|1|||
163069318|NCT02743494|588959071|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
163069319|NCT02743494|588959072|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
163069320|NCT02743494|588959071|FG000|Treatment Period|Participant request to discontinue treatment|31|||
163069321|NCT02743494|588959072|FG001|Treatment Period|Participant request to discontinue treatment|5|||
163069322|NCT02743494|588959071|FG000|Treatment Period|Participant withdrew consent|11|||
163069323|NCT02743494|588959072|FG001|Treatment Period|Participant withdrew consent|4|||
163069324|NCT02743494|588959071|FG000|Treatment Period|Lost to Follow-up|0|||
163069325|NCT02743494|588959072|FG001|Treatment Period|Lost to Follow-up|1|||
163069326|NCT02743494|588959071|FG000|Treatment Period|Poor/Non-compliance|2|||
163069327|NCT02743494|588959072|FG001|Treatment Period|Poor/Non-compliance|0|||
163069328|NCT02743494|588959071|FG000|Treatment Period|Other reasons|4|||
163069329|NCT02743494|588959072|FG001|Treatment Period|Other reasons|1|||
163069330|NCT02207608|588959073|FG000|Overall Study|Adverse Event|1|||
163069331|NCT02207608|588959074|FG001|Overall Study|Adverse Event|0|||
163069332|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069333|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069334|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069335|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
163069336|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069337|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069338|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069339|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
163069340|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069341|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069342|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
163069343|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
163069344|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069345|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069346|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069347|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
163069348|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069349|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069350|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
163069351|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069352|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069353|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069354|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069355|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
163069356|NCT02850406|588959081|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
163069357|NCT02850406|588959082|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
163069358|NCT02850406|588959083|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
163069359|NCT02850406|588959084|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
163069360|NCT02850406|588959085|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
163069361|NCT02850406|588959086|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
163069362|NCT02850406|588959087|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
163069363|NCT02850406|588959088|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
163069364|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069365|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069366|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069367|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069368|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
163069369|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
162644319|NCT03158051|587413620|FG001|Overall Study|Withdrawal by Subject|15|||
162644320|NCT03158051|587413619|FG000|Overall Study|Death|0|||
162644321|NCT03158051|587413620|FG001|Overall Study|Death|1|||
162644322|NCT02005250|587413621|FG000|Overall Study|Lost to Follow-up|15|||
162644323|NCT02005250|587413622|FG001|Overall Study|Lost to Follow-up|5|||
162644324|NCT02588833|587413623|FG000|Part 1|Withdrawal by Subject|1|||
162644325|NCT02588833|587413624|FG001|Part 1|Withdrawal by Subject|0|||
163069370|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069371|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
163069372|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
162644326|NCT02588833|587413623|FG000|Part 2A|Physician Decision|0|||
163069373|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069374|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069375|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069376|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
163069377|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
163069378|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069379|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069380|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069381|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069382|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069383|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069384|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
163069385|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069386|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069387|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
163069388|NCT02850406|588959081|FG000|Part C (Up to 52 Weeks)|Other|0|||
162644327|NCT02588833|587413624|FG001|Part 2A|Physician Decision|1|||
162644328|NCT02588833|587413623|FG000|Part 2A|Withdrawal by Subject|0|||
162644329|NCT02588833|587413624|FG001|Part 2A|Withdrawal by Subject|1|||
162644330|NCT02588833|587413623|FG000|Part 2B|Adverse Event|0|||
162644331|NCT02588833|587413624|FG001|Part 2B|Adverse Event|1|||
162644332|NCT02588833|587413623|FG000|Part 2C|Adverse Event|0|||
162644333|NCT02588833|587413624|FG001|Part 2C|Adverse Event|1|||
162717848|NCT02914522|587673494|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
162717849|NCT02914522|587673495|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162717850|NCT02914522|587673496|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162717851|NCT02914522|587673497|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162717852|NCT02914522|587673498|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163026936|NCT02653170|588801344|FG001|Overall Study|Lost to Follow-up|4|||
163026937|NCT02653170|588801345|FG002|Overall Study|Lost to Follow-up|10|||
163026938|NCT01473394|588801346|FG000|Overall Study|Adverse Event|13|||
163026939|NCT01473394|588801347|FG001|Overall Study|Adverse Event|16|||
163026940|NCT01473394|588801346|FG000|Overall Study|Insufficient Therapeutic Response|4|||
163026941|NCT01473394|588801347|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163026942|NCT01473394|588801346|FG000|Overall Study|Protocol Violation|7|||
163026943|NCT01473394|588801347|FG001|Overall Study|Protocol Violation|5|||
163026944|NCT01473394|588801346|FG000|Overall Study|Withdrew Consent|12|||
163026945|NCT01473394|588801347|FG001|Overall Study|Withdrew Consent|10|||
163026946|NCT01473394|588801346|FG000|Overall Study|Lost to Follow-up|9|||
163026947|NCT01473394|588801347|FG001|Overall Study|Lost to Follow-up|11|||
163026948|NCT03391232|588801348|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
163026949|NCT03391232|588801349|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
163026950|NCT03391232|588801348|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
163026951|NCT03391232|588801349|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
163026952|NCT00761280|588801350|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
163026953|NCT00761280|588801351|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
163069389|NCT02850406|588959082|FG001|Part C (Up to 52 Weeks)|Other|0|||
163069390|NCT02850406|588959083|FG002|Part C (Up to 52 Weeks)|Other|0|||
162644334|NCT02588833|587413623|FG000|Part 2C|Withdrawal by Subject|0|||
162644335|NCT02588833|587413624|FG001|Part 2C|Withdrawal by Subject|1|||
163026954|NCT00761280|588801350|FG000|Randomization to First Dose|Sponsor decision|1|||
163026955|NCT00761280|588801351|FG001|Randomization to First Dose|Sponsor decision|0|||
163026956|NCT00761280|588801350|FG000|Randomization to First Dose|Other|1|||
163026957|NCT00761280|588801351|FG001|Randomization to First Dose|Other|0|||
163026958|NCT00761280|588801350|FG000|First Dose to End of Study|End of trial|5|||
163026959|NCT00761280|588801351|FG001|First Dose to End of Study|End of trial|5|||
163026960|NCT00761280|588801350|FG000|First Dose to End of Study|Progressive disease|5|||
163069391|NCT02850406|588959084|FG003|Part C (Up to 52 Weeks)|Other|0|||
163069392|NCT02850406|588959085|FG004|Part C (Up to 52 Weeks)|Other|1|||
163069393|NCT02850406|588959086|FG005|Part C (Up to 52 Weeks)|Other|3|||
163069394|NCT02850406|588959087|FG006|Part C (Up to 52 Weeks)|Other|0|||
163069395|NCT02850406|588959088|FG007|Part C (Up to 52 Weeks)|Other|0|||
163069396|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069397|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069398|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069399|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069400|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069401|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069402|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
163069403|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
163069404|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069405|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069406|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069407|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069408|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069409|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069410|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
163069411|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
163069412|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069413|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069414|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069415|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069416|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069417|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
163069418|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
163069419|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
163069420|NCT02850406|588959081|FG000|Part D (Up to 52 Weeks)|Other|0|||
163069421|NCT02850406|588959082|FG001|Part D (Up to 52 Weeks)|Other|0|||
163069422|NCT02850406|588959083|FG002|Part D (Up to 52 Weeks)|Other|0|||
163069423|NCT02850406|588959084|FG003|Part D (Up to 52 Weeks)|Other|0|||
163069424|NCT02850406|588959085|FG004|Part D (Up to 52 Weeks)|Other|0|||
163069425|NCT02850406|588959086|FG005|Part D (Up to 52 Weeks)|Other|0|||
163069426|NCT02850406|588959087|FG006|Part D (Up to 52 Weeks)|Other|0|||
163069427|NCT02850406|588959088|FG007|Part D (Up to 52 Weeks)|Other|1|||
163154763|NCT03113487|589281413|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
163154764|NCT03777982|589281414|FG000|Overall Study|Physician Decision|0|||
163154765|NCT03777982|589281415|FG001|Overall Study|Physician Decision|1|||
163154766|NCT01502293|589281416|FG000|Overall Study|Progressive Disease|20|||
163154767|NCT01502293|589281417|FG001|Overall Study|Progressive Disease|12|||
163154768|NCT01502293|589281418|FG002|Overall Study|Progressive Disease|2|||
163154769|NCT01502293|589281416|FG000|Overall Study|Withdrawal by Subject|3|||
163154770|NCT01502293|589281417|FG001|Overall Study|Withdrawal by Subject|3|||
163154771|NCT01502293|589281418|FG002|Overall Study|Withdrawal by Subject|1|||
163154772|NCT01502293|589281416|FG000|Overall Study|Adverse Event|0|||
163154773|NCT01502293|589281417|FG001|Overall Study|Adverse Event|2|||
163154774|NCT01502293|589281418|FG002|Overall Study|Adverse Event|0|||
163154775|NCT01502293|589281416|FG000|Overall Study|Reason Not Specified|2|||
163154776|NCT01502293|589281417|FG001|Overall Study|Reason Not Specified|0|||
163154777|NCT01502293|589281418|FG002|Overall Study|Reason Not Specified|0|||
163154778|NCT01502293|589281416|FG000|Overall Study|Physician Decision|0|||
163154779|NCT01502293|589281417|FG001|Overall Study|Physician Decision|0|||
163154780|NCT01502293|589281418|FG002|Overall Study|Physician Decision|1|||
163154781|NCT03944577|589281423|FG000|Overall Study|Adverse Event|3|||
163154782|NCT00391586|589281425|FG000|Overall Study|Progressive disease|13|||
163154783|NCT00391586|589281425|FG000|Overall Study|Adverse Event|5|||
163154784|NCT00391586|589281425|FG000|Overall Study|Physician Decision|2|||
163154785|NCT00391586|589281425|FG000|Overall Study|Death|4|||
162644336|NCT02588833|587413623|FG000|Part 3 (Safety Follow-up)|Other|0|||
162644337|NCT02588833|587413624|FG001|Part 3 (Safety Follow-up)|Other|2|||
162644338|NCT03649711|587413627|FG000|Overall Study|Adverse Event|0|||
162644339|NCT03649711|587413628|FG001|Overall Study|Adverse Event|1|||
162644340|NCT03649711|587413629|FG002|Overall Study|Adverse Event|0|||
162644341|NCT03649711|587413627|FG000|Overall Study|Kidney Transplant|1|||
162644342|NCT03649711|587413628|FG001|Overall Study|Kidney Transplant|0|||
162644343|NCT03649711|587413629|FG002|Overall Study|Kidney Transplant|0|||
162644344|NCT01581307|587413631|FG000|Overall Study|Withdrawal by Subject|1|||
163154786|NCT00198822|589281426|FG000|Overall Study|Lost to Follow-up|14|||
163154787|NCT00198822|589281427|FG001|Overall Study|Lost to Follow-up|20|||
163154788|NCT00198822|589281428|FG002|Overall Study|Lost to Follow-up|21|||
163154789|NCT03011099|589281429|FG000|Overall Study|Withdrawal by Subject|0|||
163154790|NCT03011099|589281430|FG001|Overall Study|Withdrawal by Subject|2|||
163154791|NCT03058146|589281434|FG000|Overall Study|Withdrawal by Subject|4|||
163154792|NCT03058146|589281435|FG001|Overall Study|Withdrawal by Subject|1|||
163154793|NCT03058146|589281434|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
163154794|NCT03058146|589281435|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
163069428|NCT01653262|588960383|FG000|Overall Study|Lack of Efficacy|1|||
163069429|NCT01653262|588960383|FG000|Overall Study|SAE, non-fatal|1|||
163069430|NCT01653262|588960383|FG000|Overall Study|AE, non-serious non-fatal|1|||
163069431|NCT01112267|588960385|FG000|Overall Study|Adverse Event|24|||
163069432|NCT01112267|588960386|FG001|Overall Study|Adverse Event|6|||
163069433|NCT01112267|588960385|FG000|Overall Study|Withdrawal by Subject|3|||
163069434|NCT01112267|588960386|FG001|Overall Study|Withdrawal by Subject|5|||
163069435|NCT01112267|588960385|FG000|Overall Study|Protocol Violation|5|||
163069436|NCT01112267|588960386|FG001|Overall Study|Protocol Violation|3|||
163069437|NCT01112267|588960385|FG000|Overall Study|Participants not compliant|1|||
163069438|NCT01112267|588960386|FG001|Overall Study|Participants not compliant|2|||
163069439|NCT01112267|588960385|FG000|Overall Study|Participants not receive any study drug|1|||
163069440|NCT01112267|588960386|FG001|Overall Study|Participants not receive any study drug|2|||
163069441|NCT02014103|588960387|FG000|Overall Study|Protocol Violation|7|||
163069442|NCT02014103|588960388|FG001|Overall Study|Protocol Violation|7|||
163069443|NCT02014103|588960387|FG000|Overall Study|Adverse Event|1|||
163069444|NCT02014103|588960388|FG001|Overall Study|Adverse Event|0|||
163069445|NCT02014103|588960387|FG000|Overall Study|Lost venous access|1|||
163069446|NCT02014103|588960388|FG001|Overall Study|Lost venous access|0|||
163069447|NCT02014103|588960387|FG000|Overall Study|Withdrawal by Subject|0|||
163069448|NCT02014103|588960388|FG001|Overall Study|Withdrawal by Subject|2|||
163069449|NCT05638737|588960389|FG000|Overall Study|Withdrawal by Subject|4|||
163069450|NCT05638737|588960390|FG001|Overall Study|Withdrawal by Subject|7|||
163069451|NCT01373229|588960393|FG000|Overall Study|Death|3|||
163069452|NCT01373229|588960393|FG000|Overall Study|Physician Decision|3|||
163069453|NCT04439175|588960394|FG000|Overall Study|Never started treatment|4|||
163069454|NCT04439175|588960394|FG000|Overall Study|Ineligible|5|||
163069455|NCT04439175|588960394|FG000|Overall Study|Adverse Event|6|||
163069456|NCT04439175|588960394|FG000|Overall Study|Death|4|||
163069457|NCT04439175|588960394|FG000|Overall Study|Disease progression|44|||
163069458|NCT04439175|588960394|FG000|Overall Study|Withdrawal by Subject|4|||
163069459|NCT04439175|588960394|FG000|Overall Study|Alternative Therapy|1|||
163069460|NCT04439175|588960394|FG000|Overall Study|Other|2|||
163069461|NCT05417113|588960397|FG000|Overall Study|Lost to Follow-up|2|||
163069462|NCT05417113|588960398|FG001|Overall Study|Lost to Follow-up|2|||
163069463|NCT01847209|588960399|FG000|Overall Study|Withdrawal by Subject|1|||
163069464|NCT01847209|588960399|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
163069465|NCT00729586|588960400|FG000|Overall Study|Ineligible|0|||
163069466|NCT00729586|588960401|FG001|Overall Study|Ineligible|1|||
163069467|NCT00729586|588960400|FG000|Overall Study|never treated|1|||
163069468|NCT00729586|588960401|FG001|Overall Study|never treated|0|||
163069469|NCT02513199|588960404|FG000|Treatment|Death|1|||
163069470|NCT02513199|588960404|FG000|Treatment|Lost to Follow-up|1|||
163069471|NCT02513199|588960404|FG000|Follow-Up|Death|11|||
163069472|NCT04307394|588960410|FG000|Overall Study|Lost to Follow-up|3|||
163069473|NCT04307394|588960410|FG000|Overall Study|Withdrawal by Subject|2|||
163069474|NCT00530075|588960411|FG000|Overall Study|Adverse Event|1|||
163069475|NCT00530075|588960411|FG000|Overall Study|Death|1|||
163069476|NCT00530075|588960411|FG000|Overall Study|Lack of Efficacy|3|||
163069477|NCT00530075|588960411|FG000|Overall Study|Protocol Violation|1|||
163069478|NCT00530075|588960411|FG000|Overall Study|Withdrawal by Subject|1|||
163069479|NCT01166945|588960412|FG000|Randomized|diagnosed with Group A strep|4|||
163069480|NCT01166945|588960413|FG001|Randomized|diagnosed with Group A strep|4|||
162644345|NCT04439253|587415745|FG000|Overall Study|Adverse Event|1|||
163069481|NCT01166945|588960412|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
163069482|NCT01166945|588960413|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
163069483|NCT01166945|588960412|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
163069484|NCT01166945|588960413|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
163069485|NCT01166945|588960412|FG000|Day 30|Lost to Follow-up|4|||
163069486|NCT01166945|588960413|FG001|Day 30|Lost to Follow-up|3|||
163069487|NCT02453048|588960416|FG000|Overall Study|Only part of initial 6 mo. study|0|||
163069488|NCT02453048|588960417|FG001|Overall Study|Only part of initial 6 mo. study|0|||
163069489|NCT02453048|588960418|FG002|Overall Study|Only part of initial 6 mo. study|0|||
163069490|NCT02453048|588960419|FG003|Overall Study|Only part of initial 6 mo. study|0|||
163069491|NCT02453048|588960420|FG004|Overall Study|Only part of initial 6 mo. study|6|||
163069492|NCT02453048|588960416|FG000|Overall Study|Lost to Follow-up|0|||
163069493|NCT02453048|588960417|FG001|Overall Study|Lost to Follow-up|1|||
163069494|NCT02453048|588960418|FG002|Overall Study|Lost to Follow-up|2|||
163069495|NCT02453048|588960419|FG003|Overall Study|Lost to Follow-up|0|||
163069496|NCT02453048|588960420|FG004|Overall Study|Lost to Follow-up|0|||
163069497|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
163069498|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
163069499|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
163069500|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
163069501|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
163069502|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
163069503|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
163069504|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
163069505|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
163069506|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
163069507|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
163069508|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
163069509|NCT00447278|588960424|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
163069510|NCT00447278|588960425|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
163069511|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
162644346|NCT04439253|587415745|FG000|Overall Study|Disease progression|2|||
162644347|NCT04439253|587415745|FG000|Overall Study|Complicating disease|1|||
162644348|NCT00702403|587415746|FG000|From Consent to Engraftment|Progressive leukemia|6|||
162644349|NCT00702403|587415746|FG000|From Consent to Engraftment|Critically ill|2|||
163026961|NCT00761280|588801351|FG001|First Dose to End of Study|Progressive disease|3|||
163026962|NCT00761280|588801350|FG000|First Dose to End of Study|Sponsor decision|1|||
163026963|NCT00761280|588801351|FG001|First Dose to End of Study|Sponsor decision|2|||
163026964|NCT00761280|588801350|FG000|First Dose to End of Study|Death|1|||
163026965|NCT00761280|588801351|FG001|First Dose to End of Study|Death|0|||
163026966|NCT00761280|588801350|FG000|First Dose to End of Study|Lost to Follow-up|0|||
163026967|NCT00761280|588801351|FG001|First Dose to End of Study|Lost to Follow-up|1|||
163026968|NCT03875482|588801352|FG000|Overall Study|Adverse Event|0|||
163026969|NCT03875482|588801353|FG001|Overall Study|Adverse Event|1|||
163026970|NCT03875482|588801352|FG000|Overall Study|Withdrew consent|5|||
163026971|NCT03875482|588801353|FG001|Overall Study|Withdrew consent|6|||
163026972|NCT03875482|588801352|FG000|Overall Study|Lost to Follow-up|8|||
163026973|NCT03875482|588801353|FG001|Overall Study|Lost to Follow-up|2|||
163026974|NCT03875482|588801352|FG000|Overall Study|Lack of Efficacy|0|||
163026975|NCT03875482|588801353|FG001|Overall Study|Lack of Efficacy|11|||
163026976|NCT04777201|588801354|FG000|Main Study|Withdrawal by Subject|19|||
163026977|NCT04777201|588801355|FG001|Main Study|Withdrawal by Subject|27|||
163026978|NCT04777201|588801356|FG002|Main Study|Withdrawal by Subject|0|||
163026979|NCT04777201|588801354|FG000|Main Study|Death|13|||
163026980|NCT04777201|588801355|FG001|Main Study|Death|27|||
163026981|NCT04777201|588801356|FG002|Main Study|Death|0|||
163026982|NCT04777201|588801354|FG000|Main Study|Subject missed the safety follow-up visit|9|||
163026983|NCT04777201|588801355|FG001|Main Study|Subject missed the safety follow-up visit|10|||
163026984|NCT04777201|588801356|FG002|Main Study|Subject missed the safety follow-up visit|0|||
163026985|NCT04777201|588801354|FG000|Main Study|Physician Decision|8|||
163026986|NCT04777201|588801355|FG001|Main Study|Physician Decision|10|||
163026987|NCT04777201|588801356|FG002|Main Study|Physician Decision|0|||
163026988|NCT04777201|588801354|FG000|Main Study|Adverse Event|8|||
163026989|NCT04777201|588801355|FG001|Main Study|Adverse Event|8|||
163026990|NCT04777201|588801356|FG002|Main Study|Adverse Event|0|||
163026991|NCT04777201|588801354|FG000|Main Study|Lost to Follow-up|9|||
163026992|NCT04777201|588801355|FG001|Main Study|Lost to Follow-up|4|||
163026993|NCT04777201|588801356|FG002|Main Study|Lost to Follow-up|0|||
163026994|NCT04777201|588801354|FG000|Main Study|Reason not specified|3|||
163026995|NCT04777201|588801355|FG001|Main Study|Reason not specified|3|||
163026996|NCT04777201|588801356|FG002|Main Study|Reason not specified|0|||
163026997|NCT04777201|588801354|FG000|Main Study|Lack of Efficacy|1|||
163026998|NCT04777201|588801355|FG001|Main Study|Lack of Efficacy|1|||
163026999|NCT04777201|588801356|FG002|Main Study|Lack of Efficacy|0|||
163027000|NCT04777201|588801354|FG000|Main Study|Protocol Violation|1|||
163027001|NCT04777201|588801355|FG001|Main Study|Protocol Violation|0|||
163027002|NCT04777201|588801356|FG002|Main Study|Protocol Violation|0|||
163027003|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
163027004|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
163027005|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
163027006|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
163027007|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
163027008|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
163027009|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
163027010|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
163027011|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
163154795|NCT03041181|589281436|FG000|Overall Study|Disease Progression|1|||
163069512|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
163069513|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
163069514|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
163069515|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
163069516|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
163069517|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
163069518|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
163069519|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
163069520|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
163069521|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
163069522|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
163069523|NCT00447278|588960424|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
163069524|NCT00447278|588960425|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
163069525|NCT03677401|588960426|FG000|Overall Study|Adverse Event|4|||
163069526|NCT03677401|588960427|FG001|Overall Study|Adverse Event|14|||
163069527|NCT03677401|588960426|FG000|Overall Study|Lack of Efficacy|3|||
163069528|NCT03677401|588960427|FG001|Overall Study|Lack of Efficacy|1|||
163069529|NCT03677401|588960426|FG000|Overall Study|Withdrawal by Subject|2|||
163069530|NCT03677401|588960427|FG001|Overall Study|Withdrawal by Subject|2|||
163069531|NCT03677401|588960426|FG000|Overall Study|Sponsor decision|0|||
163069532|NCT03677401|588960427|FG001|Overall Study|Sponsor decision|1|||
163069533|NCT03677401|588960426|FG000|Overall Study|Reason Unspecified|1|||
163069534|NCT03677401|588960427|FG001|Overall Study|Reason Unspecified|0|||
163069535|NCT00726557|588960428|FG000|Overall Study|Screening failure|4|||
163069536|NCT00726557|588960428|FG000|Overall Study|No end of treatment documentation|37|||
163069537|NCT00726557|588960428|FG000|Overall Study|No follow-up documentation available|55|||
163027012|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
163027013|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
163027014|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
163027015|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
163027016|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
163027017|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
163027018|NCT04777201|588801354|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
163027019|NCT04777201|588801355|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
163027020|NCT04777201|588801356|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
163027021|NCT00507819|588801359|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
163027022|NCT00507819|588801360|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
163027023|NCT02691013|588801363|FG000|Overall Study|Withdrawal by Subject|3|||
163027024|NCT02691013|588801364|FG001|Overall Study|Withdrawal by Subject|0|||
163027025|NCT02111785|588801367|FG000|Overall Study|Death|0|||
163027026|NCT02111785|588801368|FG001|Overall Study|Death|1|||
163027027|NCT02111785|588801369|FG002|Overall Study|Death|0|||
163027028|NCT02111785|588801370|FG003|Overall Study|Death|0|||
163027029|NCT02256982|588801372|FG000|Overall Study|Disease Progression|0|||
163027030|NCT02256982|588801373|FG001|Overall Study|Disease Progression|1|||
163027031|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Adverse Event|6|||
163027032|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Adverse Event|14|||
163027033|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Death|3|||
163027034|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Death|1|||
163027035|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
163027036|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
163027037|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
163027038|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
163027039|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
163027040|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
163027041|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
163027042|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
163027043|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
163027044|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
163027045|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Physician Decision|2|||
163027046|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Physician Decision|4|||
163069538|NCT00726557|588960428|FG000|Overall Study|Treatment less than 3 months|17|||
163069539|NCT00726557|588960428|FG000|Overall Study|Inclusion criteria not met|15|||
163027047|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Pregnancy|2|||
163027048|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Pregnancy|1|||
163027049|NCT02275780|588801374|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
163027050|NCT02275780|588801375|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
163027051|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
163027052|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
163027053|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
163069540|NCT06262607|588960431|FG000|Overall Study|Physician Decision|0|||
163069541|NCT06262607|588960432|FG001|Overall Study|Physician Decision|1|||
163069542|NCT06262607|588960431|FG000|Overall Study|Withdrawal by Subject|2|||
163069543|NCT06262607|588960432|FG001|Overall Study|Withdrawal by Subject|0|||
163069544|NCT00574951|588960433|FG000|Overall Study|Ineligible - improper prior treatment|1|||
163069545|NCT05161936|588960434|FG000|Overall Study|Study terminated by Sponsor|1|||
163069546|NCT05161936|588960435|FG001|Overall Study|Study terminated by Sponsor|0|||
163069547|NCT05161936|588960436|FG002|Overall Study|Study terminated by Sponsor|0|||
163069548|NCT05161936|588960434|FG000|Overall Study|Withdrawal by Subject|0|||
163069549|NCT05161936|588960435|FG001|Overall Study|Withdrawal by Subject|0|||
163069550|NCT05161936|588960436|FG002|Overall Study|Withdrawal by Subject|1|||
163069551|NCT04925934|588960442|FG000|Overall Study|Adverse Event|1|||
163069552|NCT04925934|588960443|FG001|Overall Study|Adverse Event|0|||
163069553|NCT04925934|588960444|FG002|Overall Study|Adverse Event|0|||
163069554|NCT04925934|588960442|FG000|Overall Study|Lost to Follow-up|2|||
163069555|NCT04925934|588960443|FG001|Overall Study|Lost to Follow-up|0|||
163069556|NCT04925934|588960444|FG002|Overall Study|Lost to Follow-up|1|||
163069557|NCT04925934|588960442|FG000|Overall Study|Death|0|||
163069558|NCT04925934|588960443|FG001|Overall Study|Death|1|||
163069559|NCT04925934|588960444|FG002|Overall Study|Death|0|||
163069560|NCT04925934|588960442|FG000|Overall Study|Withdrawal by Subject|8|||
163069561|NCT04925934|588960443|FG001|Overall Study|Withdrawal by Subject|5|||
163069562|NCT04925934|588960444|FG002|Overall Study|Withdrawal by Subject|9|||
163069563|NCT04925934|588960442|FG000|Overall Study|Other|2|||
163069564|NCT04925934|588960443|FG001|Overall Study|Other|2|||
163069565|NCT04925934|588960444|FG002|Overall Study|Other|2|||
163069566|NCT04925934|588960442|FG000|Overall Study|Eastern European Conflict|7|||
163069567|NCT04925934|588960443|FG001|Overall Study|Eastern European Conflict|3|||
163069568|NCT04925934|588960444|FG002|Overall Study|Eastern European Conflict|2|||
163069569|NCT04425018|588960446|FG000|Overall Study|Withdrawal by Subject|1|||
163069570|NCT04425018|588960447|FG001|Overall Study|Withdrawal by Subject|2|||
163069571|NCT02503865|588960448|FG000|Overall Study|Moved out of area|1|||
163069572|NCT02503865|588960449|FG001|Overall Study|Moved out of area|8|||
163069573|NCT02503865|588960450|FG002|Overall Study|Moved out of area|0|||
163069574|NCT02503865|588960448|FG000|Overall Study|Refused treatment|4|||
163069575|NCT02503865|588960449|FG001|Overall Study|Refused treatment|39|||
163069576|NCT02503865|588960450|FG002|Overall Study|Refused treatment|2|||
163069577|NCT01327703|588960451|FG000|Second Treatment Period|Adverse Event|1|||
163069578|NCT01327703|588960452|FG001|Second Treatment Period|Adverse Event|1|||
163069579|NCT01327703|588960451|FG000|Second Treatment Period|Protocol Violation|0|||
163069580|NCT01327703|588960452|FG001|Second Treatment Period|Protocol Violation|1|||
163069581|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
163069582|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
163069583|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
163069584|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
163069585|NCT00849472|588960459|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
163069586|NCT00849472|588960459|FG000|Weekly Paclitaxel|Disease Progression|1|||
163069587|NCT00849472|588960459|FG000|Weekly Paclitaxel|Adverse Event|11|||
163069588|NCT00849472|588960459|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
163069589|NCT00849472|588960459|FG000|Weekly Paclitaxel|Physician Decision|3|||
163069590|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
163069591|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
163069592|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
163069593|NCT00849472|588960459|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
163069594|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
163069595|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
163069596|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
163069597|NCT00849472|588960459|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
163069598|NCT05128942|588960460|FG000|Overall Study|Withdrawal by Subject|1|||
163069599|NCT05128942|588960461|FG001|Overall Study|Withdrawal by Subject|0|||
163069600|NCT05128942|588960462|FG002|Overall Study|Withdrawal by Subject|1|||
163069601|NCT05128942|588960463|FG003|Overall Study|Withdrawal by Subject|0|||
163069602|NCT05128942|588960464|FG004|Overall Study|Withdrawal by Subject|0|||
163069603|NCT05128942|588960465|FG005|Overall Study|Withdrawal by Subject|0|||
163069604|NCT05128942|588960466|FG006|Overall Study|Withdrawal by Subject|0|||
163069605|NCT05128942|588960467|FG007|Overall Study|Withdrawal by Subject|0|||
163069606|NCT05128942|588960468|FG008|Overall Study|Withdrawal by Subject|0|||
163069607|NCT05128942|588960460|FG000|Overall Study|Other|2|||
163069608|NCT05128942|588960461|FG001|Overall Study|Other|0|||
163069609|NCT05128942|588960462|FG002|Overall Study|Other|2|||
163069610|NCT05128942|588960463|FG003|Overall Study|Other|0|||
163069611|NCT05128942|588960464|FG004|Overall Study|Other|0|||
163069612|NCT05128942|588960465|FG005|Overall Study|Other|0|||
163069613|NCT05128942|588960466|FG006|Overall Study|Other|0|||
163069614|NCT05128942|588960467|FG007|Overall Study|Other|0|||
163069615|NCT05128942|588960468|FG008|Overall Study|Other|0|||
163069616|NCT05128942|588960460|FG000|Overall Study|Termination by Sponsor|2|||
163069617|NCT05128942|588960461|FG001|Overall Study|Termination by Sponsor|6|||
163069618|NCT05128942|588960462|FG002|Overall Study|Termination by Sponsor|14|||
163069619|NCT05128942|588960463|FG003|Overall Study|Termination by Sponsor|2|||
163069620|NCT05128942|588960464|FG004|Overall Study|Termination by Sponsor|4|||
163069621|NCT05128942|588960465|FG005|Overall Study|Termination by Sponsor|8|||
163069622|NCT05128942|588960466|FG006|Overall Study|Termination by Sponsor|11|||
163069623|NCT05128942|588960467|FG007|Overall Study|Termination by Sponsor|6|||
163069624|NCT05128942|588960468|FG008|Overall Study|Termination by Sponsor|0|||
163069625|NCT05128942|588960460|FG000|Overall Study|Adverse Event|0|||
163069626|NCT05128942|588960461|FG001|Overall Study|Adverse Event|0|||
163069627|NCT05128942|588960462|FG002|Overall Study|Adverse Event|0|||
163069628|NCT05128942|588960463|FG003|Overall Study|Adverse Event|0|||
163069629|NCT05128942|588960464|FG004|Overall Study|Adverse Event|0|||
163069630|NCT05128942|588960465|FG005|Overall Study|Adverse Event|0|||
163069631|NCT05128942|588960466|FG006|Overall Study|Adverse Event|1|||
163069632|NCT05128942|588960467|FG007|Overall Study|Adverse Event|1|||
163069633|NCT05128942|588960468|FG008|Overall Study|Adverse Event|0|||
163069634|NCT05128942|588960460|FG000|Overall Study|Lost to Follow-up|0|||
163069635|NCT05128942|588960461|FG001|Overall Study|Lost to Follow-up|0|||
163069636|NCT05128942|588960462|FG002|Overall Study|Lost to Follow-up|0|||
163069637|NCT05128942|588960463|FG003|Overall Study|Lost to Follow-up|0|||
163069638|NCT05128942|588960464|FG004|Overall Study|Lost to Follow-up|1|||
163069639|NCT05128942|588960465|FG005|Overall Study|Lost to Follow-up|0|||
163069640|NCT05128942|588960466|FG006|Overall Study|Lost to Follow-up|0|||
163069641|NCT05128942|588960467|FG007|Overall Study|Lost to Follow-up|0|||
163069642|NCT05128942|588960468|FG008|Overall Study|Lost to Follow-up|0|||
163069643|NCT05942040|588960469|FG000|Overall Study|No longer employed at study site.|0|||
163069644|NCT05942040|588960470|FG001|Overall Study|No longer employed at study site.|0|||
163069645|NCT05942040|588960471|FG002|Overall Study|No longer employed at study site.|3|||
163069646|NCT03442569|588960472|FG000|Overall Study|Subject was ineligible after enrollment|1|||
163069647|NCT06461455|588960473|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
163069648|NCT06461455|588960474|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
163069649|NCT06461455|588960473|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
163069650|NCT06461455|588960474|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
163069651|NCT06461455|588960473|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
163069652|NCT06461455|588960474|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
163069653|NCT06142383|588960475|FG000|Overall Study|Mis-randomized|0|||
163069654|NCT06142383|588960476|FG001|Overall Study|Mis-randomized|0|||
163069655|NCT06142383|588960477|FG002|Overall Study|Mis-randomized|1|||
163069656|NCT06142383|588960478|FG003|Overall Study|Mis-randomized|0|||
163069657|NCT06142383|588960479|FG004|Overall Study|Mis-randomized|0|||
163069658|NCT06142383|588960475|FG000|Overall Study|Adverse Event|0|||
163069659|NCT06142383|588960476|FG001|Overall Study|Adverse Event|1|||
163069660|NCT06142383|588960477|FG002|Overall Study|Adverse Event|1|||
163069661|NCT06142383|588960478|FG003|Overall Study|Adverse Event|0|||
162644350|NCT00702403|587415746|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
162644351|NCT00702403|587415746|FG000|From Consent to Engraftment|Myocardial infarction|1|||
163069662|NCT06142383|588960479|FG004|Overall Study|Adverse Event|0|||
163069663|NCT06142383|588960475|FG000|Overall Study|Death|0|||
163069664|NCT06142383|588960476|FG001|Overall Study|Death|1|||
163069665|NCT06142383|588960477|FG002|Overall Study|Death|3|||
163069666|NCT06142383|588960478|FG003|Overall Study|Death|0|||
163069667|NCT06142383|588960479|FG004|Overall Study|Death|1|||
163069668|NCT06142383|588960475|FG000|Overall Study|Study Terminated by Sponsor|20|||
162644352|NCT00702403|587415746|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
163069669|NCT06142383|588960476|FG001|Overall Study|Study Terminated by Sponsor|17|||
163069670|NCT06142383|588960477|FG002|Overall Study|Study Terminated by Sponsor|33|||
163069671|NCT06142383|588960478|FG003|Overall Study|Study Terminated by Sponsor|0|||
163069672|NCT06142383|588960479|FG004|Overall Study|Study Terminated by Sponsor|21|||
163069673|NCT06142383|588960475|FG000|Overall Study|Subject Decision|0|||
163069674|NCT06142383|588960476|FG001|Overall Study|Subject Decision|1|||
163069675|NCT06142383|588960477|FG002|Overall Study|Subject Decision|2|||
163069676|NCT06142383|588960478|FG003|Overall Study|Subject Decision|0|||
163069677|NCT06142383|588960479|FG004|Overall Study|Subject Decision|0|||
163069678|NCT03010501|588960482|FG000|Study Week 1|Withdrawal by Subject|2|||
163069679|NCT03010501|588960483|FG001|Study Week 1|Withdrawal by Subject|1|||
163069680|NCT03010501|588960484|FG002|Study Week 1|Withdrawal by Subject|0|||
163069681|NCT03010501|588960485|FG003|Study Week 1|Withdrawal by Subject|2|||
163069682|NCT03010501|588960486|FG004|Study Week 1|Withdrawal by Subject|0|||
163069683|NCT03010501|588960487|FG005|Study Week 1|Withdrawal by Subject|0|||
163069684|NCT03010501|588960482|FG000|Study Week 3|Withdrawal by Subject|0|||
163069685|NCT03010501|588960483|FG001|Study Week 3|Withdrawal by Subject|0|||
163069686|NCT03010501|588960484|FG002|Study Week 3|Withdrawal by Subject|0|||
163069687|NCT03010501|588960485|FG003|Study Week 3|Withdrawal by Subject|1|||
163069688|NCT03010501|588960486|FG004|Study Week 3|Withdrawal by Subject|0|||
163069689|NCT03010501|588960487|FG005|Study Week 3|Withdrawal by Subject|0|||
163069690|NCT02347787|588960490|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
163069691|NCT02347787|588960491|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
163069692|NCT02347787|588960490|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
163069693|NCT02347787|588960491|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
163069694|NCT02347787|588960490|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
163069695|NCT02347787|588960491|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
163069696|NCT02347787|588960490|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
163069697|NCT02347787|588960491|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
163069698|NCT00544882|588960495|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
163069699|NCT00544882|588960496|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
163069700|NCT00544882|588960497|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
163069701|NCT00544882|588960495|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
163069702|NCT00544882|588960496|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
163069703|NCT00544882|588960497|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
163069704|NCT00544882|588960495|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
163069705|NCT00544882|588960496|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
163069706|NCT00544882|588960497|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
163069707|NCT00544882|588960495|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
163069708|NCT00544882|588960496|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
163069709|NCT00544882|588960497|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
163069710|NCT00544882|588960495|FG000|Cycle 3: Follow-up|Noncompliance|0|||
163069711|NCT00544882|588960496|FG001|Cycle 3: Follow-up|Noncompliance|1|||
163069712|NCT00544882|588960497|FG002|Cycle 3: Follow-up|Noncompliance|0|||
163069713|NCT00544882|588960495|FG000|Cycle 3: Follow-up|Pregnancy|0|||
163069714|NCT00544882|588960496|FG001|Cycle 3: Follow-up|Pregnancy|1|||
163069715|NCT00544882|588960497|FG002|Cycle 3: Follow-up|Pregnancy|0|||
163069716|NCT00308685|588960498|FG000|Overall Study|Lost to Follow-up|1|||
163069717|NCT00308685|588960499|FG001|Overall Study|Lost to Follow-up|0|||
163069718|NCT00308685|588960498|FG000|Overall Study|Need to administer prohibited medication|1|||
163069719|NCT00308685|588960499|FG001|Overall Study|Need to administer prohibited medication|2|||
163069720|NCT00308685|588960498|FG000|Overall Study|Other than specified|1|||
163069721|NCT00308685|588960499|FG001|Overall Study|Other than specified|3|||
163069722|NCT01121575|588960500|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
163069723|NCT01121575|588960501|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
163069724|NCT01121575|588960502|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
163069725|NCT01121575|588960503|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
163069726|NCT01121575|588960504|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
163069727|NCT01121575|588960505|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
163069728|NCT01121575|588960500|FG000|Overall Study|Unspecified Reasons|8|||
163069729|NCT01121575|588960501|FG001|Overall Study|Unspecified Reasons|6|||
163069730|NCT01121575|588960502|FG002|Overall Study|Unspecified Reasons|7|||
163069731|NCT01121575|588960503|FG003|Overall Study|Unspecified Reasons|5|||
163069732|NCT01121575|588960504|FG004|Overall Study|Unspecified Reasons|13|||
163069733|NCT01121575|588960505|FG005|Overall Study|Unspecified Reasons|10|||
163069734|NCT01121575|588960500|FG000|Overall Study|Death|6|||
163069735|NCT01121575|588960501|FG001|Overall Study|Death|0|||
163069736|NCT01121575|588960502|FG002|Overall Study|Death|0|||
163069737|NCT01121575|588960503|FG003|Overall Study|Death|1|||
163069738|NCT01121575|588960504|FG004|Overall Study|Death|7|||
163069739|NCT01121575|588960505|FG005|Overall Study|Death|1|||
163069740|NCT02583269|588960506|FG000|Overall Study|Patient hospitalized prior to start|1|||
163069741|NCT02583269|588960507|FG001|Overall Study|Patient hospitalized prior to start|0|||
163069742|NCT02583269|588960508|FG002|Overall Study|Patient hospitalized prior to start|0|||
163069743|NCT02583269|588960509|FG003|Overall Study|Patient hospitalized prior to start|0|||
163069744|NCT02583269|588960510|FG004|Overall Study|Patient hospitalized prior to start|0|||
163069745|NCT03244189|588960512|FG000|Overall Study|Death|0|||
163069746|NCT03244189|588960513|FG001|Overall Study|Death|2|||
163069747|NCT03244189|588960512|FG000|Overall Study|Lost to Follow-up|92|||
163069748|NCT03244189|588960513|FG001|Overall Study|Lost to Follow-up|107|||
163069749|NCT03244189|588960512|FG000|Overall Study|Physician Decision|4|||
163069750|NCT03244189|588960513|FG001|Overall Study|Physician Decision|2|||
163069751|NCT03244189|588960512|FG000|Overall Study|Pregnancy|7|||
163069752|NCT03244189|588960513|FG001|Overall Study|Pregnancy|5|||
163069753|NCT03244189|588960512|FG000|Overall Study|Protocol Violation|0|||
163069754|NCT03244189|588960513|FG001|Overall Study|Protocol Violation|2|||
163069755|NCT03244189|588960512|FG000|Overall Study|Withdrawal by Subject|45|||
163069756|NCT03244189|588960513|FG001|Overall Study|Withdrawal by Subject|23|||
163069757|NCT03244189|588960512|FG000|Overall Study|Technical Problems|2|||
163069758|NCT03244189|588960513|FG001|Overall Study|Technical Problems|0|||
163069759|NCT03860584|588960521|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
163069760|NCT03860584|588960522|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
163069761|NCT03860584|588960521|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
163069762|NCT03860584|588960522|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
163069763|NCT03860584|588960521|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
163069764|NCT03860584|588960522|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
163069765|NCT03860584|588960521|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
163069766|NCT03860584|588960522|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
163069767|NCT05800145|588960523|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
163069768|NCT05800145|588960524|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069769|NCT05800145|588960525|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069770|NCT05800145|588960526|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
163069771|NCT05800145|588960527|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069772|NCT05800145|588960528|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163069773|NCT05800145|588960523|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
163069774|NCT05800145|588960524|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069775|NCT05800145|588960525|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069776|NCT05800145|588960526|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
163069777|NCT05800145|588960527|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069778|NCT05800145|588960528|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
163069779|NCT05800145|588960523|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163069780|NCT05800145|588960524|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
163069781|NCT05800145|588960525|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
163069782|NCT05800145|588960526|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
163069783|NCT05800145|588960527|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
163069784|NCT05800145|588960528|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163069785|NCT04167670|588962268|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
163069786|NCT04167670|588962269|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
163069787|NCT04167670|588962270|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
163069788|NCT04167670|588962268|FG000|Overall Study|Significant protocol deviation|3|||
163069789|NCT04167670|588962269|FG001|Overall Study|Significant protocol deviation|1|||
163069790|NCT04167670|588962270|FG002|Overall Study|Significant protocol deviation|0|||
163069791|NCT04167670|588962268|FG000|Overall Study|Lost to Follow-up|0|||
163069792|NCT04167670|588962269|FG001|Overall Study|Lost to Follow-up|3|||
163069793|NCT04167670|588962270|FG002|Overall Study|Lost to Follow-up|3|||
163069794|NCT04167670|588962268|FG000|Overall Study|Voluntary Withdrawal|0|||
163069795|NCT04167670|588962269|FG001|Overall Study|Voluntary Withdrawal|1|||
163069796|NCT04167670|588962270|FG002|Overall Study|Voluntary Withdrawal|1|||
163069797|NCT04167670|588962268|FG000|Overall Study|Withdrawal of Consent|4|||
163069798|NCT04167670|588962269|FG001|Overall Study|Withdrawal of Consent|1|||
163069799|NCT04167670|588962270|FG002|Overall Study|Withdrawal of Consent|3|||
163069800|NCT04167670|588962268|FG000|Overall Study|Miscellaneous|7|||
163069801|NCT04167670|588962269|FG001|Overall Study|Miscellaneous|5|||
163069802|NCT04167670|588962270|FG002|Overall Study|Miscellaneous|3|||
163069803|NCT04827446|588962271|FG000|Overall Study|Lost to Follow-up|1|||
163069804|NCT04827446|588962272|FG001|Overall Study|Lost to Follow-up|1|||
163069805|NCT04827446|588962271|FG000|Overall Study|Death|2|||
163069806|NCT04827446|588962272|FG001|Overall Study|Death|0|||
163069807|NCT04827446|588962271|FG000|Overall Study|Withdrawal by Subject|2|||
163069808|NCT04827446|588962272|FG001|Overall Study|Withdrawal by Subject|2|||
163069809|NCT05399485|588962273|FG000|DBT Phase|Other|6|||
163069810|NCT05399485|588962274|FG001|DBT Phase|Other|5|||
163069811|NCT05399485|588962273|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
163069812|NCT05399485|588962274|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
163069813|NCT05399485|588962273|FG000|DBT Phase|Withdrawal by Subject|3|||
163069814|NCT05399485|588962274|FG001|DBT Phase|Withdrawal by Subject|2|||
163069815|NCT05399485|588962273|FG000|DBT Phase|Protocol Violation|2|||
163069816|NCT05399485|588962274|FG001|DBT Phase|Protocol Violation|1|||
163069817|NCT05399485|588962273|FG000|DBT Phase|Physician Decision|0|||
163069818|NCT05399485|588962274|FG001|DBT Phase|Physician Decision|1|||
163069819|NCT05399485|588962273|FG000|DBT Phase|Adverse Event|2|||
163069820|NCT05399485|588962274|FG001|DBT Phase|Adverse Event|1|||
163069821|NCT05399485|588962273|FG000|OLE Phase|Protocol deviation|1|||
163069822|NCT05399485|588962274|FG001|OLE Phase|Protocol deviation|0|||
163069823|NCT05399485|588962273|FG000|OLE Phase|Other|5|||
163069824|NCT05399485|588962274|FG001|OLE Phase|Other|5|||
163069825|NCT05399485|588962273|FG000|OLE Phase|Withdrawal by Subject|12|||
163069826|NCT05399485|588962274|FG001|OLE Phase|Withdrawal by Subject|7|||
163069827|NCT05399485|588962273|FG000|OLE Phase|Pregnancy|0|||
163069828|NCT05399485|588962274|FG001|OLE Phase|Pregnancy|2|||
163069829|NCT05399485|588962273|FG000|OLE Phase|Physician Decision|3|||
163069830|NCT05399485|588962274|FG001|OLE Phase|Physician Decision|0|||
163069831|NCT05399485|588962273|FG000|OLE Phase|Adverse Event|2|||
163069832|NCT05399485|588962274|FG001|OLE Phase|Adverse Event|2|||
163069833|NCT03554473|588962277|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
163069834|NCT03554473|588962278|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
163069835|NCT03554473|588962279|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
163069836|NCT03554473|588962277|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
163069837|NCT03554473|588962278|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
163069838|NCT03554473|588962279|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
163069839|NCT03554473|588962277|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
163069840|NCT03554473|588962278|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
163069841|NCT03554473|588962279|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
163069842|NCT01363076|588962280|FG000|Overall Study|Withdrawal by Subject|0|||
163069843|NCT01363076|588962281|FG001|Overall Study|Withdrawal by Subject|1|||
163069844|NCT04706403|588962282|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
163069845|NCT04706403|588962283|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
163069846|NCT04706403|588962284|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
163069847|NCT04706403|588962285|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
163069848|NCT04706403|588962286|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
163069849|NCT02642679|588962287|FG000|Overall Study|Withdrawal by Subject|1|||
163069850|NCT02642679|588962287|FG000|Overall Study|Physician Decision|1|||
163069851|NCT02642679|588962287|FG000|Overall Study|Physician Decision|1|||
163069852|NCT05206604|588962288|FG000|Overall Study|Non-compliance with study drug|0|||
163069853|NCT05206604|588962289|FG001|Overall Study|Non-compliance with study drug|0|||
163069854|NCT05206604|588962290|FG002|Overall Study|Non-compliance with study drug|0|||
163069855|NCT05206604|588962291|FG003|Overall Study|Non-compliance with study drug|0|||
163069856|NCT05206604|588962292|FG004|Overall Study|Non-compliance with study drug|0|||
163069857|NCT05206604|588962293|FG005|Overall Study|Non-compliance with study drug|1|||
163069858|NCT05206604|588962294|FG006|Overall Study|Non-compliance with study drug|0|||
163069859|NCT05206604|588962295|FG007|Overall Study|Non-compliance with study drug|0|||
163069860|NCT03735498|588962296|FG000|Overall Study|Withdrawal by Subject|3|||
163069861|NCT03735498|588962296|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
163069862|NCT00160615|588962297|FG000|Overall Study|Adverse Event|5|||
163069863|NCT00160615|588962298|FG001|Overall Study|Adverse Event|12|||
163069864|NCT00160615|588962297|FG000|Overall Study|Withdrawal by Subject|0|||
163069865|NCT00160615|588962298|FG001|Overall Study|Withdrawal by Subject|2|||
163069866|NCT00160615|588962297|FG000|Overall Study|Lack of Efficacy|11|||
163069867|NCT00160615|588962298|FG001|Overall Study|Lack of Efficacy|23|||
163069868|NCT00160615|588962297|FG000|Overall Study|Patient decision|1|||
163069869|NCT00160615|588962298|FG001|Overall Study|Patient decision|2|||
163069870|NCT00160615|588962297|FG000|Overall Study|Investigator decision|1|||
163069871|NCT00160615|588962298|FG001|Overall Study|Investigator decision|1|||
163069872|NCT00160615|588962297|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
163069873|NCT00160615|588962298|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
163069874|NCT00160615|588962297|FG000|Overall Study|Switch to surgical treatment|0|||
163069875|NCT00160615|588962298|FG001|Overall Study|Switch to surgical treatment|2|||
163069876|NCT00160615|588962297|FG000|Overall Study|Non-compliance was suspected|0|||
163069877|NCT00160615|588962298|FG001|Overall Study|Non-compliance was suspected|1|||
163069878|NCT00160615|588962297|FG000|Overall Study|Poor compliance|0|||
163069879|NCT00160615|588962298|FG001|Overall Study|Poor compliance|1|||
163069880|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069881|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
163069882|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069883|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069884|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069885|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
163069886|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
163069887|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
162644353|NCT00702403|587415746|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
162644354|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
163069888|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069889|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069890|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069891|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
163069892|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
163069893|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069894|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069895|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069896|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069897|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
163069898|NCT03928704|588962303|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
163069899|NCT03928704|588962304|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
163069900|NCT03928704|588962305|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069901|NCT03928704|588962306|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069902|NCT03928704|588962307|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069903|NCT03928704|588962308|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
163069904|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069905|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069906|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
163069907|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069908|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069909|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
163069910|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069911|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069912|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
163069913|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069914|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069915|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
163069916|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
163069917|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
163069918|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
163069919|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
163069920|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
163069921|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
163069922|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069923|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069924|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
163069925|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069926|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069927|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
163069928|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069929|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069930|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069931|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069932|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
163069933|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
163069934|NCT03928704|588962303|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069935|NCT03928704|588962304|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069936|NCT03928704|588962305|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069937|NCT03928704|588962306|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069938|NCT03928704|588962307|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
163069939|NCT03928704|588962308|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
163069940|NCT01631188|588962309|FG000|Overall Study|Physician Decision|75|||
163069941|NCT04575324|588962313|FG000|Overall Study|Lost to Follow-up|29|||
163069942|NCT04575324|588962314|FG001|Overall Study|Lost to Follow-up|25|||
163069943|NCT04575324|588962313|FG000|Overall Study|Death|1|||
163069944|NCT04575324|588962314|FG001|Overall Study|Death|2|||
163069945|NCT04575324|588962313|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
163069946|NCT04575324|588962314|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
163069947|NCT01105130|588962315|FG000|Overall Study|Withdrawal by Subject|4|||
163069948|NCT01105130|588962316|FG001|Overall Study|Withdrawal by Subject|6|||
163069949|NCT01105130|588962317|FG002|Overall Study|Withdrawal by Subject|2|||
163069950|NCT01105130|588962315|FG000|Overall Study|Never Started|2|||
163069951|NCT01105130|588962316|FG001|Overall Study|Never Started|2|||
163069952|NCT01105130|588962317|FG002|Overall Study|Never Started|4|||
163069953|NCT01105130|588962315|FG000|Overall Study|Toxicity|1|||
163069954|NCT01105130|588962316|FG001|Overall Study|Toxicity|3|||
163069955|NCT01105130|588962317|FG002|Overall Study|Toxicity|2|||
163069956|NCT01105130|588962315|FG000|Overall Study|Multiple Reasons|3|||
163069957|NCT01105130|588962316|FG001|Overall Study|Multiple Reasons|0|||
163069958|NCT01105130|588962317|FG002|Overall Study|Multiple Reasons|2|||
163069959|NCT02582632|588962319|FG000|Overall Study|Other|1|||
163069960|NCT00266812|588962322|FG000|Overall Study|Disease Progression|9|||
163069961|NCT00266812|588962323|FG001|Overall Study|Disease Progression|3|||
163069962|NCT00266812|588962322|FG000|Overall Study|Death|5|||
163069963|NCT00266812|588962323|FG001|Overall Study|Death|4|||
163069964|NCT00266812|588962322|FG000|Overall Study|Adverse Event|3|||
163069965|NCT00266812|588962323|FG001|Overall Study|Adverse Event|1|||
163069966|NCT00266812|588962322|FG000|Overall Study|Protocol Violation|0|||
163069967|NCT00266812|588962323|FG001|Overall Study|Protocol Violation|1|||
163069968|NCT00266812|588962322|FG000|Overall Study|Withdrawal by Subject|0|||
163069969|NCT00266812|588962323|FG001|Overall Study|Withdrawal by Subject|2|||
163069970|NCT00266812|588962322|FG000|Overall Study|Discontinued before starting study drug|4|||
163069971|NCT00266812|588962323|FG001|Overall Study|Discontinued before starting study drug|0|||
163069972|NCT02323334|588962324|FG000|Period 3|Lost to Follow-up|0|||
163069973|NCT02323334|588962325|FG001|Period 3|Lost to Follow-up|0|||
163069974|NCT02323334|588962326|FG002|Period 3|Lost to Follow-up|1|||
163069975|NCT02323334|588962327|FG003|Period 3|Lost to Follow-up|0|||
163069976|NCT02323334|588962328|FG004|Period 3|Lost to Follow-up|0|||
163069977|NCT02323334|588962329|FG005|Period 3|Lost to Follow-up|0|||
163069978|NCT02323334|588962330|FG006|Period 3|Lost to Follow-up|0|||
163069979|NCT02323334|588962331|FG007|Period 3|Lost to Follow-up|0|||
163069980|NCT02323334|588962332|FG008|Period 3|Lost to Follow-up|0|||
163069981|NCT02323334|588962333|FG009|Period 3|Lost to Follow-up|0|||
163069982|NCT02323334|588962334|FG010|Period 3|Lost to Follow-up|0|||
163069983|NCT02323334|588962335|FG011|Period 3|Lost to Follow-up|0|||
163069984|NCT02323334|588962336|FG012|Period 3|Lost to Follow-up|0|||
163069985|NCT02323334|588962337|FG013|Period 3|Lost to Follow-up|0|||
163069986|NCT02323334|588962338|FG014|Period 3|Lost to Follow-up|0|||
163069987|NCT02323334|588962339|FG015|Period 3|Lost to Follow-up|0|||
163069988|NCT02323334|588962340|FG016|Period 3|Lost to Follow-up|0|||
163069989|NCT02323334|588962324|FG000|Period 3|Withdrawal by Subject|1|||
163069990|NCT02323334|588962325|FG001|Period 3|Withdrawal by Subject|0|||
163069991|NCT02323334|588962326|FG002|Period 3|Withdrawal by Subject|0|||
163069992|NCT02323334|588962327|FG003|Period 3|Withdrawal by Subject|0|||
163069993|NCT02323334|588962328|FG004|Period 3|Withdrawal by Subject|0|||
163069994|NCT02323334|588962329|FG005|Period 3|Withdrawal by Subject|0|||
163069995|NCT02323334|588962330|FG006|Period 3|Withdrawal by Subject|0|||
163069996|NCT02323334|588962331|FG007|Period 3|Withdrawal by Subject|0|||
163069997|NCT02323334|588962332|FG008|Period 3|Withdrawal by Subject|0|||
163069998|NCT02323334|588962333|FG009|Period 3|Withdrawal by Subject|0|||
163069999|NCT02323334|588962334|FG010|Period 3|Withdrawal by Subject|0|||
163070000|NCT02323334|588962335|FG011|Period 3|Withdrawal by Subject|0|||
163070001|NCT02323334|588962336|FG012|Period 3|Withdrawal by Subject|0|||
163070002|NCT02323334|588962337|FG013|Period 3|Withdrawal by Subject|0|||
163070003|NCT02323334|588962338|FG014|Period 3|Withdrawal by Subject|0|||
163070004|NCT02323334|588962339|FG015|Period 3|Withdrawal by Subject|0|||
163070005|NCT02323334|588962340|FG016|Period 3|Withdrawal by Subject|0|||
163070006|NCT01617967|588962342|FG000|Overall Study|Protocol Violation|0|||
163070007|NCT01617967|588962343|FG001|Overall Study|Protocol Violation|0|||
163070008|NCT01617967|588962344|FG002|Overall Study|Protocol Violation|0|||
163070009|NCT01617967|588962345|FG003|Overall Study|Protocol Violation|1|||
163070010|NCT01617967|588962346|FG004|Overall Study|Protocol Violation|0|||
163070011|NCT01617967|588962347|FG005|Overall Study|Protocol Violation|0|||
163070012|NCT01617967|588962342|FG000|Overall Study|Withdrawal by Subject|0|||
163070013|NCT01617967|588962343|FG001|Overall Study|Withdrawal by Subject|0|||
163070014|NCT01617967|588962344|FG002|Overall Study|Withdrawal by Subject|0|||
163070015|NCT01617967|588962345|FG003|Overall Study|Withdrawal by Subject|0|||
163070016|NCT01617967|588962346|FG004|Overall Study|Withdrawal by Subject|0|||
163070017|NCT01617967|588962347|FG005|Overall Study|Withdrawal by Subject|1|||
163070018|NCT01617967|588962342|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
163070019|NCT01617967|588962343|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
163070020|NCT01617967|588962344|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
163070021|NCT01617967|588962345|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
163070022|NCT01617967|588962346|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
163070023|NCT01617967|588962347|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
163070024|NCT00416949|588962350|FG000|Overall Study|Patients refused to participate|5|||
163070025|NCT03520569|588962353|FG000|Overall Study|Withdrawal by Subject|1|||
163070026|NCT01178411|588962354|FG000|Overall Study|Adverse Event|5|||
163070027|NCT01178411|588962354|FG000|Overall Study|Withdrawal by Subject|4|||
163070028|NCT01178411|588962354|FG000|Overall Study|Protocol Violation|1|||
163070029|NCT01178411|588962354|FG000|Overall Study|Progressive disease per RECIST|32|||
163070030|NCT01178411|588962354|FG000|Overall Study|Progressive disease per clinician|9|||
163070031|NCT01178411|588962354|FG000|Overall Study|Physician Decision|6|||
163070032|NCT01178411|588962354|FG000|Overall Study|Death|1|||
163070033|NCT01178411|588962354|FG000|Overall Study|No reason provided|1|||
163070034|NCT01178411|588962354|FG000|Overall Study|Drug manufacturing ended|1|||
163070035|NCT00784927|588962355|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
163070036|NCT00784927|588962355|FG000|Overall Study|Protocol Violation|1|||
163070037|NCT00784927|588962355|FG000|Overall Study|Ineligible|1|||
163070038|NCT01137812|588962358|FG000|Overall Study|Adverse Event|21|||
163070039|NCT01137812|588962359|FG001|Overall Study|Adverse Event|14|||
163070040|NCT01137812|588962358|FG000|Overall Study|Lost to Follow-up|6|||
163070041|NCT01137812|588962359|FG001|Overall Study|Lost to Follow-up|8|||
163070042|NCT01137812|588962358|FG000|Overall Study|Physician Decision|25|||
163070043|NCT01137812|588962359|FG001|Overall Study|Physician Decision|17|||
163070044|NCT01137812|588962358|FG000|Overall Study|Protocol Violation|5|||
163070045|NCT01137812|588962359|FG001|Overall Study|Protocol Violation|4|||
163070046|NCT01137812|588962358|FG000|Overall Study|Withdrawal by Subject|5|||
163070047|NCT01137812|588962359|FG001|Overall Study|Withdrawal by Subject|13|||
163070048|NCT01137812|588962358|FG000|Overall Study|Death|2|||
163070049|NCT01137812|588962359|FG001|Overall Study|Death|0|||
163070050|NCT01137812|588962358|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
163070051|NCT01137812|588962359|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
163070052|NCT01137812|588962358|FG000|Overall Study|Other|19|||
163070053|NCT01137812|588962359|FG001|Overall Study|Other|27|||
163070054|NCT02265744|588962362|FG000|Overall Study|Poor/Non-compliance|1|||
163070055|NCT02265744|588962363|FG001|Overall Study|Poor/Non-compliance|1|||
163070056|NCT02265744|588962364|FG002|Overall Study|Poor/Non-compliance|0|||
163070057|NCT02265744|588962365|FG003|Overall Study|Poor/Non-compliance|0|||
163070058|NCT02265744|588962366|FG004|Overall Study|Poor/Non-compliance|2|||
163070059|NCT02265744|588962362|FG000|Overall Study|Lost to Follow-up|0|||
163070060|NCT02265744|588962363|FG001|Overall Study|Lost to Follow-up|0|||
163070061|NCT02265744|588962364|FG002|Overall Study|Lost to Follow-up|0|||
163070062|NCT02265744|588962365|FG003|Overall Study|Lost to Follow-up|1|||
163070063|NCT02265744|588962366|FG004|Overall Study|Lost to Follow-up|0|||
163070064|NCT02265744|588962362|FG000|Overall Study|Death|0|||
163070065|NCT02265744|588962363|FG001|Overall Study|Death|0|||
163070066|NCT02265744|588962364|FG002|Overall Study|Death|0|||
163070067|NCT02265744|588962365|FG003|Overall Study|Death|2|||
163070068|NCT02265744|588962366|FG004|Overall Study|Death|0|||
163070069|NCT02265744|588962362|FG000|Overall Study|Withdrawal by Subject|2|||
163070070|NCT02265744|588962363|FG001|Overall Study|Withdrawal by Subject|0|||
163070071|NCT02265744|588962364|FG002|Overall Study|Withdrawal by Subject|0|||
163070072|NCT02265744|588962365|FG003|Overall Study|Withdrawal by Subject|2|||
163070073|NCT02265744|588962366|FG004|Overall Study|Withdrawal by Subject|0|||
163070074|NCT02265744|588962362|FG000|Overall Study|Participant request to discontinue|2|||
163070075|NCT02265744|588962363|FG001|Overall Study|Participant request to discontinue|2|||
163070076|NCT02265744|588962364|FG002|Overall Study|Participant request to discontinue|2|||
163070077|NCT02265744|588962365|FG003|Overall Study|Participant request to discontinue|0|||
163070078|NCT02265744|588962366|FG004|Overall Study|Participant request to discontinue|0|||
163070079|NCT02265744|588962362|FG000|Overall Study|Adverse Event|8|||
163070080|NCT02265744|588962363|FG001|Overall Study|Adverse Event|4|||
163070081|NCT02265744|588962364|FG002|Overall Study|Adverse Event|9|||
163070082|NCT02265744|588962365|FG003|Overall Study|Adverse Event|8|||
163070083|NCT02265744|588962366|FG004|Overall Study|Adverse Event|2|||
163070084|NCT02265744|588962362|FG000|Overall Study|Lack of Efficacy|2|||
163070085|NCT02265744|588962363|FG001|Overall Study|Lack of Efficacy|4|||
163070086|NCT02265744|588962364|FG002|Overall Study|Lack of Efficacy|3|||
163070087|NCT02265744|588962365|FG003|Overall Study|Lack of Efficacy|4|||
163070088|NCT02265744|588962366|FG004|Overall Study|Lack of Efficacy|5|||
163070089|NCT02265744|588962362|FG000|Overall Study|Reason not provided by Investigator|1|||
163070090|NCT02265744|588962363|FG001|Overall Study|Reason not provided by Investigator|0|||
163070091|NCT02265744|588962364|FG002|Overall Study|Reason not provided by Investigator|0|||
163070092|NCT02265744|588962365|FG003|Overall Study|Reason not provided by Investigator|2|||
163070093|NCT02265744|588962366|FG004|Overall Study|Reason not provided by Investigator|0|||
162644355|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
163070094|NCT02265744|588962362|FG000|Overall Study|Administrative reason by sponsor|3|||
163070095|NCT02265744|588962363|FG001|Overall Study|Administrative reason by sponsor|2|||
163070096|NCT02265744|588962364|FG002|Overall Study|Administrative reason by sponsor|2|||
163070097|NCT02265744|588962365|FG003|Overall Study|Administrative reason by sponsor|3|||
163070098|NCT02265744|588962366|FG004|Overall Study|Administrative reason by sponsor|3|||
163070099|NCT02265744|588962362|FG000|Overall Study|Subject no longer meets study criteria|0|||
163070100|NCT02265744|588962363|FG001|Overall Study|Subject no longer meets study criteria|0|||
163070101|NCT02265744|588962364|FG002|Overall Study|Subject no longer meets study criteria|0|||
163070102|NCT02265744|588962365|FG003|Overall Study|Subject no longer meets study criteria|0|||
163070103|NCT02265744|588962366|FG004|Overall Study|Subject no longer meets study criteria|1|||
163070104|NCT02265744|588962362|FG000|Overall Study|Pregnancy|1|||
163070105|NCT02265744|588962363|FG001|Overall Study|Pregnancy|2|||
163070106|NCT02265744|588962364|FG002|Overall Study|Pregnancy|1|||
163070107|NCT02265744|588962365|FG003|Overall Study|Pregnancy|1|||
163070108|NCT02265744|588962366|FG004|Overall Study|Pregnancy|0|||
163070109|NCT00923702|588962367|FG000|Overall Study|Ongoing enrollment|0|||
163070110|NCT00923702|588962368|FG001|Overall Study|Ongoing enrollment|0|||
163070111|NCT00923702|588962369|FG002|Overall Study|Ongoing enrollment|0|||
163070112|NCT00923702|588962370|FG003|Overall Study|Ongoing enrollment|0|||
163070113|NCT00923702|588962371|FG004|Overall Study|Ongoing enrollment|354|||
163070114|NCT05950906|588962375|FG000|Overall Study|Adverse Event|0|||
163070115|NCT05950906|588962376|FG001|Overall Study|Adverse Event|0|||
163070116|NCT05950906|588962377|FG002|Overall Study|Adverse Event|0|||
163070117|NCT05950906|588962378|FG003|Overall Study|Adverse Event|0|||
163070118|NCT05950906|588962379|FG004|Overall Study|Adverse Event|0|||
163070119|NCT05950906|588962380|FG005|Overall Study|Adverse Event|0|||
163070120|NCT05950906|588962381|FG006|Overall Study|Adverse Event|0|||
163070121|NCT05950906|588962382|FG007|Overall Study|Adverse Event|0|||
163070122|NCT05950906|588962383|FG008|Overall Study|Adverse Event|0|||
163070123|NCT05950906|588962384|FG009|Overall Study|Adverse Event|0|||
163070124|NCT05950906|588962385|FG010|Overall Study|Adverse Event|0|||
163070125|NCT05950906|588962386|FG011|Overall Study|Adverse Event|0|||
163070126|NCT05950906|588962387|FG012|Overall Study|Adverse Event|1|||
163070127|NCT05950906|588962388|FG013|Overall Study|Adverse Event|0|||
163070128|NCT05950906|588962375|FG000|Overall Study|Physician Decision|0|||
163070129|NCT05950906|588962376|FG001|Overall Study|Physician Decision|0|||
163070130|NCT05950906|588962377|FG002|Overall Study|Physician Decision|0|||
163070131|NCT05950906|588962378|FG003|Overall Study|Physician Decision|0|||
163070132|NCT05950906|588962379|FG004|Overall Study|Physician Decision|0|||
163070133|NCT05950906|588962380|FG005|Overall Study|Physician Decision|0|||
163070134|NCT05950906|588962381|FG006|Overall Study|Physician Decision|0|||
163070135|NCT05950906|588962382|FG007|Overall Study|Physician Decision|0|||
163070136|NCT05950906|588962383|FG008|Overall Study|Physician Decision|0|||
163070137|NCT05950906|588962384|FG009|Overall Study|Physician Decision|0|||
163070138|NCT05950906|588962385|FG010|Overall Study|Physician Decision|0|||
163070139|NCT05950906|588962386|FG011|Overall Study|Physician Decision|0|||
163070140|NCT05950906|588962387|FG012|Overall Study|Physician Decision|1|||
163070141|NCT05950906|588962388|FG013|Overall Study|Physician Decision|0|||
163070142|NCT02448043|588962389|FG000|Overall Study|Withdrawal by Subject|2|||
163070143|NCT02448043|588962390|FG001|Overall Study|Withdrawal by Subject|2|||
163070144|NCT02448043|588962389|FG000|Overall Study|Protocol Violation|1|||
163070145|NCT02448043|588962390|FG001|Overall Study|Protocol Violation|2|||
163070146|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
163070147|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
163070148|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
163070149|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
163070150|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
163070151|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
163070152|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
163070153|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
163070154|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
163070155|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
163070156|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
163070157|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
163070158|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
163070159|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
163070160|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
163070161|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
163070162|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
163070163|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
163070164|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
163070165|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
163070166|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
163070167|NCT02337946|588962399|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
163070168|NCT02337946|588962400|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
163070169|NCT02337946|588962401|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
163070170|NCT02337946|588962399|FG000|In-between Period|Without Informed Consent|1|||
163070171|NCT02337946|588962400|FG001|In-between Period|Without Informed Consent|0|||
163070172|NCT02337946|588962401|FG002|In-between Period|Without Informed Consent|0|||
163070173|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
163070174|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
163070175|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
163070176|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
163070177|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
163070178|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
163070179|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
163070180|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
163070181|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
163070182|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
163070183|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
163070184|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
163070185|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
163070186|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
163070187|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
163070188|NCT02337946|588962399|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
163070189|NCT02337946|588962400|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
163070190|NCT02337946|588962401|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
163070191|NCT01131585|588962402|FG000|Overall Study|Adverse Event|0|||
163070192|NCT01131585|588962403|FG001|Overall Study|Adverse Event|2|||
163070193|NCT01131585|588962402|FG000|Overall Study|Abnormal laboratory value|1|||
163070194|NCT01131585|588962403|FG001|Overall Study|Abnormal laboratory value|0|||
163070195|NCT01131585|588962402|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163070196|NCT01131585|588962403|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163070197|NCT01131585|588962402|FG000|Overall Study|Protocol Violation|2|||
163070198|NCT01131585|588962403|FG001|Overall Study|Protocol Violation|1|||
163070199|NCT01131585|588962402|FG000|Overall Study|Withdrawal by Subject|3|||
163070200|NCT01131585|588962403|FG001|Overall Study|Withdrawal by Subject|3|||
163070201|NCT01131585|588962402|FG000|Overall Study|Lost to Follow-up|0|||
163070202|NCT01131585|588962403|FG001|Overall Study|Lost to Follow-up|1|||
163070203|NCT01131585|588962402|FG000|Overall Study|Administrative problems|1|||
163070204|NCT01131585|588962403|FG001|Overall Study|Administrative problems|1|||
163070205|NCT01131585|588962402|FG000|Overall Study|Study termination|78|||
163070206|NCT01131585|588962403|FG001|Overall Study|Study termination|32|||
163070207|NCT02949934|588962404|FG000|Natural Drinking Period|Adverse Event|1|||
163070208|NCT02949934|588962405|FG001|Natural Drinking Period|Adverse Event|0|||
163070209|NCT02949934|588962406|FG002|Natural Drinking Period|Adverse Event|0|||
163070210|NCT02949934|588962407|FG003|Natural Drinking Period|Adverse Event|1|||
163070211|NCT02949934|588962408|FG004|Natural Drinking Period|Adverse Event|0|||
163070212|NCT02949934|588962409|FG005|Natural Drinking Period|Adverse Event|0|||
163070213|NCT02949934|588962404|FG000|Natural Drinking Period|Lost to Follow-up|0|||
163070214|NCT02949934|588962405|FG001|Natural Drinking Period|Lost to Follow-up|0|||
163070215|NCT02949934|588962406|FG002|Natural Drinking Period|Lost to Follow-up|0|||
163070216|NCT02949934|588962407|FG003|Natural Drinking Period|Lost to Follow-up|0|||
163070217|NCT02949934|588962408|FG004|Natural Drinking Period|Lost to Follow-up|1|||
163070218|NCT02949934|588962409|FG005|Natural Drinking Period|Lost to Follow-up|0|||
163070219|NCT02949934|588962404|FG000|Neuroimaging|Protocol Violation|2|||
163070220|NCT02949934|588962405|FG001|Neuroimaging|Protocol Violation|0|||
163070221|NCT02949934|588962406|FG002|Neuroimaging|Protocol Violation|0|||
163070222|NCT02949934|588962407|FG003|Neuroimaging|Protocol Violation|0|||
163070223|NCT02949934|588962408|FG004|Neuroimaging|Protocol Violation|1|||
163070224|NCT02949934|588962409|FG005|Neuroimaging|Protocol Violation|0|||
163070225|NCT02949934|588962404|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
163070226|NCT02949934|588962405|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
163070227|NCT02949934|588962406|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
163070228|NCT02949934|588962407|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
163070229|NCT02949934|588962408|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
163070230|NCT02949934|588962409|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
163070231|NCT02949934|588962404|FG000|Neuroimaging|Not scanned|0|||
163070232|NCT02949934|588962405|FG001|Neuroimaging|Not scanned|0|||
163070233|NCT02949934|588962406|FG002|Neuroimaging|Not scanned|1|||
163070234|NCT02949934|588962407|FG003|Neuroimaging|Not scanned|0|||
163070235|NCT02949934|588962408|FG004|Neuroimaging|Not scanned|0|||
162717853|NCT02914522|587673499|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162717854|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162717855|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162717856|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162717857|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163070236|NCT02949934|588962409|FG005|Neuroimaging|Not scanned|2|||
163070237|NCT02949934|588962404|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
163070238|NCT02949934|588962405|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070239|NCT02949934|588962406|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070240|NCT02949934|588962407|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
162644356|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Non-compliance|2|||
162644357|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
162644358|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
162644359|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Suicide|1|||
162644360|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
163070241|NCT02949934|588962408|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
163070242|NCT02949934|588962409|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
163070243|NCT02949934|588962404|FG000|Bar Laboratory|Adverse Event|1|||
163070244|NCT02949934|588962405|FG001|Bar Laboratory|Adverse Event|0|||
163070245|NCT02949934|588962406|FG002|Bar Laboratory|Adverse Event|2|||
163070246|NCT02949934|588962407|FG003|Bar Laboratory|Adverse Event|0|||
163070247|NCT02949934|588962408|FG004|Bar Laboratory|Adverse Event|1|||
163070248|NCT02949934|588962409|FG005|Bar Laboratory|Adverse Event|0|||
163070249|NCT02949934|588962404|FG000|Bar Laboratory|Protocol Violation|0|||
163070250|NCT02949934|588962405|FG001|Bar Laboratory|Protocol Violation|0|||
163070251|NCT02949934|588962406|FG002|Bar Laboratory|Protocol Violation|0|||
163070252|NCT02949934|588962407|FG003|Bar Laboratory|Protocol Violation|1|||
163070253|NCT02949934|588962408|FG004|Bar Laboratory|Protocol Violation|0|||
163070254|NCT02949934|588962409|FG005|Bar Laboratory|Protocol Violation|0|||
163070255|NCT04530526|588962413|FG000|Overall Study|Withdrawal by Subject|6|||
163070256|NCT03770455|588962414|FG000|Overall Study|Screen failures|3|||
163070257|NCT03971422|588963686|FG000|Overall Study|Lost to Follow-up|0|||
163070258|NCT03971422|588963687|FG001|Overall Study|Lost to Follow-up|1|||
163070259|NCT03971422|588963688|FG002|Overall Study|Lost to Follow-up|0|||
163070260|NCT03971422|588963686|FG000|Overall Study|Lack of Efficacy|5|||
163070261|NCT03971422|588963687|FG001|Overall Study|Lack of Efficacy|1|||
163070262|NCT03971422|588963688|FG002|Overall Study|Lack of Efficacy|1|||
163070263|NCT03971422|588963686|FG000|Overall Study|Adverse event, not fatal|2|||
163070264|NCT03971422|588963687|FG001|Overall Study|Adverse event, not fatal|2|||
163070265|NCT03971422|588963688|FG002|Overall Study|Adverse event, not fatal|5|||
163070266|NCT03971422|588963686|FG000|Overall Study|Worsening of MG Symptoms|1|||
163070267|NCT03971422|588963687|FG001|Overall Study|Worsening of MG Symptoms|4|||
163070268|NCT03971422|588963688|FG002|Overall Study|Worsening of MG Symptoms|2|||
163070269|NCT03971422|588963686|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
163070270|NCT03971422|588963687|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
163070271|NCT03971422|588963688|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
163070272|NCT03971422|588963686|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
163070273|NCT03971422|588963687|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
163070274|NCT03971422|588963688|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
163070275|NCT03971422|588963686|FG000|Overall Study|Due to COVID-19 pandemic|0|||
163070276|NCT03971422|588963687|FG001|Overall Study|Due to COVID-19 pandemic|1|||
163070277|NCT03971422|588963688|FG002|Overall Study|Due to COVID-19 pandemic|1|||
163070278|NCT01658878|588963689|FG000|Treatment Period|Disease Progression|1|||
163070279|NCT01658878|588963690|FG001|Treatment Period|Disease Progression|3|||
163070280|NCT01658878|588963691|FG002|Treatment Period|Disease Progression|2|||
163070281|NCT01658878|588963692|FG003|Treatment Period|Disease Progression|1|||
162644361|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
162644362|NCT00702403|587415746|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
162644363|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
162644364|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
162644365|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
162644366|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
162644367|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
162644368|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
162717858|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162736239|NCT03699709|587744922|FG000|Overall Study|scheduled, but no show|0|||
163070282|NCT01658878|588963693|FG004|Treatment Period|Disease Progression|13|||
163070283|NCT01658878|588963694|FG005|Treatment Period|Disease Progression|3|||
163070284|NCT01658878|588963695|FG006|Treatment Period|Disease Progression|4|||
163070285|NCT01658878|588963696|FG007|Treatment Period|Disease Progression|3|||
163070286|NCT01658878|588963697|FG008|Treatment Period|Disease Progression|5|||
163070287|NCT01658878|588963698|FG009|Treatment Period|Disease Progression|3|||
163070288|NCT01658878|588963699|FG010|Treatment Period|Disease Progression|3|||
163070289|NCT01658878|588963700|FG011|Treatment Period|Disease Progression|4|||
163070290|NCT01658878|588963701|FG012|Treatment Period|Disease Progression|43|||
163070291|NCT01658878|588963702|FG013|Treatment Period|Disease Progression|48|||
163070292|NCT01658878|588963703|FG014|Treatment Period|Disease Progression|33|||
163070293|NCT01658878|588963704|FG015|Treatment Period|Disease Progression|46|||
163070294|NCT01658878|588963705|FG016|Treatment Period|Disease Progression|41|||
163070295|NCT01658878|588963706|FG017|Treatment Period|Disease Progression|42|||
163070296|NCT01658878|588963707|FG018|Treatment Period|Disease Progression|28|||
163070297|NCT01658878|588963708|FG019|Treatment Period|Disease Progression|37|||
163070298|NCT01658878|588963709|FG020|Treatment Period|Disease Progression|37|||
163070299|NCT01658878|588963710|FG021|Treatment Period|Disease Progression|39|||
163070300|NCT01658878|588963711|FG022|Treatment Period|Disease Progression|27|||
163070301|NCT01658878|588963712|FG023|Treatment Period|Disease Progression|19|||
163070302|NCT01658878|588963689|FG000|Treatment Period|Study Drug Toxicity|0|||
163070303|NCT01658878|588963690|FG001|Treatment Period|Study Drug Toxicity|0|||
163070304|NCT01658878|588963691|FG002|Treatment Period|Study Drug Toxicity|0|||
163070305|NCT01658878|588963692|FG003|Treatment Period|Study Drug Toxicity|1|||
163070306|NCT01658878|588963693|FG004|Treatment Period|Study Drug Toxicity|0|||
163070307|NCT01658878|588963694|FG005|Treatment Period|Study Drug Toxicity|0|||
163070308|NCT01658878|588963695|FG006|Treatment Period|Study Drug Toxicity|0|||
163070309|NCT01658878|588963696|FG007|Treatment Period|Study Drug Toxicity|0|||
163070310|NCT01658878|588963697|FG008|Treatment Period|Study Drug Toxicity|0|||
163070311|NCT01658878|588963698|FG009|Treatment Period|Study Drug Toxicity|0|||
163070312|NCT01658878|588963699|FG010|Treatment Period|Study Drug Toxicity|0|||
163070313|NCT01658878|588963700|FG011|Treatment Period|Study Drug Toxicity|0|||
163070314|NCT01658878|588963701|FG012|Treatment Period|Study Drug Toxicity|7|||
163070315|NCT01658878|588963702|FG013|Treatment Period|Study Drug Toxicity|1|||
163070316|NCT01658878|588963703|FG014|Treatment Period|Study Drug Toxicity|5|||
163070317|NCT01658878|588963704|FG015|Treatment Period|Study Drug Toxicity|0|||
163070318|NCT01658878|588963705|FG016|Treatment Period|Study Drug Toxicity|5|||
163070319|NCT01658878|588963706|FG017|Treatment Period|Study Drug Toxicity|10|||
163070320|NCT01658878|588963707|FG018|Treatment Period|Study Drug Toxicity|12|||
163070321|NCT01658878|588963708|FG019|Treatment Period|Study Drug Toxicity|4|||
163070322|NCT01658878|588963709|FG020|Treatment Period|Study Drug Toxicity|2|||
163070323|NCT01658878|588963710|FG021|Treatment Period|Study Drug Toxicity|3|||
163070324|NCT01658878|588963711|FG022|Treatment Period|Study Drug Toxicity|2|||
163070325|NCT01658878|588963712|FG023|Treatment Period|Study Drug Toxicity|6|||
163070326|NCT01658878|588963689|FG000|Treatment Period|Maximum Clinical Benefit|0|||
163070327|NCT01658878|588963690|FG001|Treatment Period|Maximum Clinical Benefit|0|||
163070328|NCT01658878|588963691|FG002|Treatment Period|Maximum Clinical Benefit|1|||
163070329|NCT01658878|588963692|FG003|Treatment Period|Maximum Clinical Benefit|0|||
163070330|NCT01658878|588963693|FG004|Treatment Period|Maximum Clinical Benefit|0|||
163070331|NCT01658878|588963694|FG005|Treatment Period|Maximum Clinical Benefit|0|||
163070332|NCT01658878|588963695|FG006|Treatment Period|Maximum Clinical Benefit|0|||
163070333|NCT01658878|588963696|FG007|Treatment Period|Maximum Clinical Benefit|0|||
163070334|NCT01658878|588963697|FG008|Treatment Period|Maximum Clinical Benefit|0|||
163070335|NCT01658878|588963698|FG009|Treatment Period|Maximum Clinical Benefit|0|||
163070336|NCT01658878|588963699|FG010|Treatment Period|Maximum Clinical Benefit|0|||
163070337|NCT01658878|588963700|FG011|Treatment Period|Maximum Clinical Benefit|0|||
163070338|NCT01658878|588963701|FG012|Treatment Period|Maximum Clinical Benefit|0|||
163070339|NCT01658878|588963702|FG013|Treatment Period|Maximum Clinical Benefit|0|||
163070340|NCT01658878|588963703|FG014|Treatment Period|Maximum Clinical Benefit|0|||
163070341|NCT01658878|588963704|FG015|Treatment Period|Maximum Clinical Benefit|0|||
163070342|NCT01658878|588963705|FG016|Treatment Period|Maximum Clinical Benefit|0|||
163070343|NCT01658878|588963706|FG017|Treatment Period|Maximum Clinical Benefit|0|||
163070344|NCT01658878|588963707|FG018|Treatment Period|Maximum Clinical Benefit|1|||
163070345|NCT01658878|588963708|FG019|Treatment Period|Maximum Clinical Benefit|1|||
163070346|NCT01658878|588963709|FG020|Treatment Period|Maximum Clinical Benefit|0|||
163070347|NCT01658878|588963710|FG021|Treatment Period|Maximum Clinical Benefit|0|||
163070348|NCT01658878|588963711|FG022|Treatment Period|Maximum Clinical Benefit|0|||
163070349|NCT01658878|588963712|FG023|Treatment Period|Maximum Clinical Benefit|0|||
163070350|NCT01658878|588963689|FG000|Treatment Period|Other Reasons|0|||
163070351|NCT01658878|588963690|FG001|Treatment Period|Other Reasons|0|||
163070352|NCT01658878|588963691|FG002|Treatment Period|Other Reasons|0|||
163070353|NCT01658878|588963692|FG003|Treatment Period|Other Reasons|1|||
163070354|NCT01658878|588963693|FG004|Treatment Period|Other Reasons|0|||
163070355|NCT01658878|588963694|FG005|Treatment Period|Other Reasons|0|||
163070356|NCT01658878|588963695|FG006|Treatment Period|Other Reasons|0|||
163070357|NCT01658878|588963696|FG007|Treatment Period|Other Reasons|0|||
163070358|NCT01658878|588963697|FG008|Treatment Period|Other Reasons|0|||
163070359|NCT01658878|588963698|FG009|Treatment Period|Other Reasons|0|||
163070360|NCT01658878|588963699|FG010|Treatment Period|Other Reasons|0|||
163070361|NCT01658878|588963700|FG011|Treatment Period|Other Reasons|0|||
163070362|NCT01658878|588963701|FG012|Treatment Period|Other Reasons|2|||
163070363|NCT01658878|588963702|FG013|Treatment Period|Other Reasons|0|||
163070364|NCT01658878|588963703|FG014|Treatment Period|Other Reasons|0|||
163070365|NCT01658878|588963704|FG015|Treatment Period|Other Reasons|2|||
163070366|NCT01658878|588963705|FG016|Treatment Period|Other Reasons|1|||
163070367|NCT01658878|588963706|FG017|Treatment Period|Other Reasons|1|||
163070368|NCT01658878|588963707|FG018|Treatment Period|Other Reasons|3|||
163070369|NCT01658878|588963708|FG019|Treatment Period|Other Reasons|1|||
163070370|NCT01658878|588963709|FG020|Treatment Period|Other Reasons|4|||
163070371|NCT01658878|588963710|FG021|Treatment Period|Other Reasons|0|||
163070372|NCT01658878|588963711|FG022|Treatment Period|Other Reasons|0|||
163070373|NCT01658878|588963712|FG023|Treatment Period|Other Reasons|4|||
163070374|NCT01658878|588963689|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070375|NCT01658878|588963690|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070376|NCT01658878|588963691|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070377|NCT01658878|588963692|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070378|NCT01658878|588963693|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070379|NCT01658878|588963694|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070380|NCT01658878|588963695|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070381|NCT01658878|588963696|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070382|NCT01658878|588963697|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070383|NCT01658878|588963698|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070384|NCT01658878|588963699|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070385|NCT01658878|588963700|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070386|NCT01658878|588963701|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070387|NCT01658878|588963702|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070388|NCT01658878|588963703|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
163070389|NCT01658878|588963704|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070390|NCT01658878|588963705|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070391|NCT01658878|588963706|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
163070392|NCT01658878|588963707|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070393|NCT01658878|588963708|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070394|NCT01658878|588963709|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070395|NCT01658878|588963710|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070396|NCT01658878|588963711|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070397|NCT01658878|588963712|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
163070398|NCT01658878|588963689|FG000|Treatment Period|Poor/Non-compliance|0|||
163070399|NCT01658878|588963690|FG001|Treatment Period|Poor/Non-compliance|0|||
163070400|NCT01658878|588963691|FG002|Treatment Period|Poor/Non-compliance|0|||
163070401|NCT01658878|588963692|FG003|Treatment Period|Poor/Non-compliance|0|||
163070402|NCT01658878|588963693|FG004|Treatment Period|Poor/Non-compliance|0|||
163070403|NCT01658878|588963694|FG005|Treatment Period|Poor/Non-compliance|0|||
163070404|NCT01658878|588963695|FG006|Treatment Period|Poor/Non-compliance|0|||
163070405|NCT01658878|588963696|FG007|Treatment Period|Poor/Non-compliance|0|||
163070406|NCT01658878|588963697|FG008|Treatment Period|Poor/Non-compliance|0|||
163070407|NCT01658878|588963698|FG009|Treatment Period|Poor/Non-compliance|0|||
163070408|NCT01658878|588963699|FG010|Treatment Period|Poor/Non-compliance|0|||
163070409|NCT01658878|588963700|FG011|Treatment Period|Poor/Non-compliance|0|||
163070410|NCT01658878|588963701|FG012|Treatment Period|Poor/Non-compliance|0|||
163070411|NCT01658878|588963702|FG013|Treatment Period|Poor/Non-compliance|0|||
163070412|NCT01658878|588963703|FG014|Treatment Period|Poor/Non-compliance|0|||
163070413|NCT01658878|588963704|FG015|Treatment Period|Poor/Non-compliance|1|||
163070414|NCT01658878|588963705|FG016|Treatment Period|Poor/Non-compliance|0|||
163070415|NCT01658878|588963706|FG017|Treatment Period|Poor/Non-compliance|0|||
163070416|NCT01658878|588963707|FG018|Treatment Period|Poor/Non-compliance|0|||
163070417|NCT01658878|588963708|FG019|Treatment Period|Poor/Non-compliance|0|||
163070418|NCT01658878|588963709|FG020|Treatment Period|Poor/Non-compliance|0|||
163070419|NCT01658878|588963710|FG021|Treatment Period|Poor/Non-compliance|0|||
163070420|NCT01658878|588963711|FG022|Treatment Period|Poor/Non-compliance|0|||
163070421|NCT01658878|588963712|FG023|Treatment Period|Poor/Non-compliance|0|||
163070422|NCT01658878|588963689|FG000|Treatment Period|Participant Withdrew Consent|0|||
163070423|NCT01658878|588963690|FG001|Treatment Period|Participant Withdrew Consent|0|||
163070424|NCT01658878|588963691|FG002|Treatment Period|Participant Withdrew Consent|0|||
163070425|NCT01658878|588963692|FG003|Treatment Period|Participant Withdrew Consent|0|||
163070426|NCT01658878|588963693|FG004|Treatment Period|Participant Withdrew Consent|0|||
163070427|NCT01658878|588963694|FG005|Treatment Period|Participant Withdrew Consent|0|||
163070428|NCT01658878|588963695|FG006|Treatment Period|Participant Withdrew Consent|0|||
163070429|NCT01658878|588963696|FG007|Treatment Period|Participant Withdrew Consent|0|||
163070430|NCT01658878|588963697|FG008|Treatment Period|Participant Withdrew Consent|0|||
163070431|NCT01658878|588963698|FG009|Treatment Period|Participant Withdrew Consent|0|||
163070432|NCT01658878|588963699|FG010|Treatment Period|Participant Withdrew Consent|0|||
163070433|NCT01658878|588963700|FG011|Treatment Period|Participant Withdrew Consent|0|||
163070434|NCT01658878|588963701|FG012|Treatment Period|Participant Withdrew Consent|1|||
163070435|NCT01658878|588963702|FG013|Treatment Period|Participant Withdrew Consent|0|||
163070436|NCT01658878|588963703|FG014|Treatment Period|Participant Withdrew Consent|2|||
163070437|NCT01658878|588963704|FG015|Treatment Period|Participant Withdrew Consent|0|||
163070438|NCT01658878|588963705|FG016|Treatment Period|Participant Withdrew Consent|0|||
163070439|NCT01658878|588963706|FG017|Treatment Period|Participant Withdrew Consent|2|||
163070440|NCT01658878|588963707|FG018|Treatment Period|Participant Withdrew Consent|1|||
162717859|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162717860|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
163070441|NCT01658878|588963708|FG019|Treatment Period|Participant Withdrew Consent|2|||
163070442|NCT01658878|588963709|FG020|Treatment Period|Participant Withdrew Consent|1|||
163070443|NCT01658878|588963710|FG021|Treatment Period|Participant Withdrew Consent|0|||
163070444|NCT01658878|588963711|FG022|Treatment Period|Participant Withdrew Consent|2|||
163070445|NCT01658878|588963712|FG023|Treatment Period|Participant Withdrew Consent|2|||
163070446|NCT01658878|588963689|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070447|NCT01658878|588963690|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070448|NCT01658878|588963691|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070449|NCT01658878|588963692|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070450|NCT01658878|588963693|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070451|NCT01658878|588963694|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070452|NCT01658878|588963695|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070453|NCT01658878|588963696|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070454|NCT01658878|588963697|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070455|NCT01658878|588963698|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070456|NCT01658878|588963699|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070457|NCT01658878|588963700|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070458|NCT01658878|588963701|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070459|NCT01658878|588963702|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
163070460|NCT01658878|588963703|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
163070461|NCT01658878|588963704|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070462|NCT01658878|588963705|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070463|NCT01658878|588963706|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070464|NCT01658878|588963707|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070465|NCT01658878|588963708|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070466|NCT01658878|588963709|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070467|NCT01658878|588963710|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163070468|NCT01658878|588963711|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
163070469|NCT01658878|588963712|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
163070470|NCT01658878|588963689|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
163070471|NCT01658878|588963690|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
163070472|NCT01658878|588963691|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
163070473|NCT01658878|588963692|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
163070474|NCT01658878|588963693|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
163070475|NCT01658878|588963694|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
163070476|NCT01658878|588963695|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
163070477|NCT01658878|588963696|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
163070478|NCT01658878|588963697|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
163070479|NCT01658878|588963698|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
163070480|NCT01658878|588963699|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
163070481|NCT01658878|588963700|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
163070482|NCT01658878|588963701|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
163070483|NCT01658878|588963702|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
163070484|NCT01658878|588963703|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
163070485|NCT01658878|588963704|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
163070486|NCT01658878|588963705|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
163070487|NCT01658878|588963706|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
163070488|NCT01658878|588963707|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
163070489|NCT01658878|588963708|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
163070490|NCT01658878|588963709|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
163070491|NCT01658878|588963710|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
163070492|NCT01658878|588963711|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
163070493|NCT01658878|588963712|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
163070494|NCT01658878|588963689|FG000|Treatment Period|Death|0|||
163070495|NCT01658878|588963690|FG001|Treatment Period|Death|0|||
163070496|NCT01658878|588963691|FG002|Treatment Period|Death|0|||
163070497|NCT01658878|588963692|FG003|Treatment Period|Death|0|||
163070498|NCT01658878|588963693|FG004|Treatment Period|Death|0|||
163070499|NCT01658878|588963694|FG005|Treatment Period|Death|0|||
163070500|NCT01658878|588963695|FG006|Treatment Period|Death|0|||
163070501|NCT01658878|588963696|FG007|Treatment Period|Death|0|||
163070502|NCT01658878|588963697|FG008|Treatment Period|Death|0|||
163070503|NCT01658878|588963698|FG009|Treatment Period|Death|0|||
163070504|NCT01658878|588963699|FG010|Treatment Period|Death|0|||
163070505|NCT01658878|588963700|FG011|Treatment Period|Death|0|||
162644369|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
163070506|NCT01658878|588963701|FG012|Treatment Period|Death|1|||
163070507|NCT01658878|588963702|FG013|Treatment Period|Death|0|||
163070508|NCT01658878|588963703|FG014|Treatment Period|Death|0|||
163070509|NCT01658878|588963704|FG015|Treatment Period|Death|0|||
163070510|NCT01658878|588963705|FG016|Treatment Period|Death|1|||
163070511|NCT01658878|588963706|FG017|Treatment Period|Death|1|||
163070512|NCT01658878|588963707|FG018|Treatment Period|Death|0|||
163070513|NCT01658878|588963708|FG019|Treatment Period|Death|0|||
163070514|NCT01658878|588963709|FG020|Treatment Period|Death|0|||
163070515|NCT01658878|588963710|FG021|Treatment Period|Death|2|||
163070516|NCT01658878|588963711|FG022|Treatment Period|Death|0|||
163070517|NCT01658878|588963712|FG023|Treatment Period|Death|0|||
163070518|NCT01658878|588963689|FG000|Treatment Period|Adverse Event|0|||
163070519|NCT01658878|588963690|FG001|Treatment Period|Adverse Event|0|||
163070520|NCT01658878|588963691|FG002|Treatment Period|Adverse Event|0|||
163070521|NCT01658878|588963692|FG003|Treatment Period|Adverse Event|0|||
163070522|NCT01658878|588963693|FG004|Treatment Period|Adverse Event|0|||
163070523|NCT01658878|588963694|FG005|Treatment Period|Adverse Event|0|||
163070524|NCT01658878|588963695|FG006|Treatment Period|Adverse Event|0|||
163070525|NCT01658878|588963696|FG007|Treatment Period|Adverse Event|0|||
163070526|NCT01658878|588963697|FG008|Treatment Period|Adverse Event|0|||
163070527|NCT01658878|588963698|FG009|Treatment Period|Adverse Event|0|||
163070528|NCT01658878|588963699|FG010|Treatment Period|Adverse Event|0|||
163070529|NCT01658878|588963700|FG011|Treatment Period|Adverse Event|0|||
163070530|NCT01658878|588963701|FG012|Treatment Period|Adverse Event|0|||
163070531|NCT01658878|588963702|FG013|Treatment Period|Adverse Event|0|||
163070532|NCT01658878|588963703|FG014|Treatment Period|Adverse Event|0|||
163070533|NCT01658878|588963704|FG015|Treatment Period|Adverse Event|0|||
163070534|NCT01658878|588963705|FG016|Treatment Period|Adverse Event|10|||
163070535|NCT01658878|588963706|FG017|Treatment Period|Adverse Event|3|||
163070536|NCT01658878|588963707|FG018|Treatment Period|Adverse Event|3|||
163070537|NCT01658878|588963708|FG019|Treatment Period|Adverse Event|2|||
163070538|NCT01658878|588963709|FG020|Treatment Period|Adverse Event|3|||
163070539|NCT01658878|588963710|FG021|Treatment Period|Adverse Event|3|||
163070540|NCT01658878|588963711|FG022|Treatment Period|Adverse Event|4|||
163070541|NCT01658878|588963712|FG023|Treatment Period|Adverse Event|3|||
163070542|NCT01658878|588963689|FG000|Treatment Period|Lost to Follow-up|0|||
163070543|NCT01658878|588963690|FG001|Treatment Period|Lost to Follow-up|0|||
163070544|NCT01658878|588963691|FG002|Treatment Period|Lost to Follow-up|0|||
163070545|NCT01658878|588963692|FG003|Treatment Period|Lost to Follow-up|0|||
163070546|NCT01658878|588963693|FG004|Treatment Period|Lost to Follow-up|0|||
163070547|NCT01658878|588963694|FG005|Treatment Period|Lost to Follow-up|0|||
163070548|NCT01658878|588963695|FG006|Treatment Period|Lost to Follow-up|0|||
163070549|NCT01658878|588963696|FG007|Treatment Period|Lost to Follow-up|0|||
163070550|NCT01658878|588963697|FG008|Treatment Period|Lost to Follow-up|0|||
163070551|NCT01658878|588963698|FG009|Treatment Period|Lost to Follow-up|0|||
163070552|NCT01658878|588963699|FG010|Treatment Period|Lost to Follow-up|0|||
163070553|NCT01658878|588963700|FG011|Treatment Period|Lost to Follow-up|0|||
163070554|NCT01658878|588963701|FG012|Treatment Period|Lost to Follow-up|0|||
163070555|NCT01658878|588963702|FG013|Treatment Period|Lost to Follow-up|0|||
163070556|NCT01658878|588963703|FG014|Treatment Period|Lost to Follow-up|0|||
163070557|NCT01658878|588963704|FG015|Treatment Period|Lost to Follow-up|0|||
163070558|NCT01658878|588963705|FG016|Treatment Period|Lost to Follow-up|1|||
163070559|NCT01658878|588963706|FG017|Treatment Period|Lost to Follow-up|0|||
163070560|NCT01658878|588963707|FG018|Treatment Period|Lost to Follow-up|1|||
163070561|NCT01658878|588963708|FG019|Treatment Period|Lost to Follow-up|1|||
163070562|NCT01658878|588963709|FG020|Treatment Period|Lost to Follow-up|0|||
163070563|NCT01658878|588963710|FG021|Treatment Period|Lost to Follow-up|0|||
163070564|NCT01658878|588963711|FG022|Treatment Period|Lost to Follow-up|1|||
163070565|NCT01658878|588963712|FG023|Treatment Period|Lost to Follow-up|0|||
163070566|NCT00327171|588963715|FG000|Overall Study|Did not receive study medication|3|||
163070567|NCT00327171|588963716|FG001|Overall Study|Did not receive study medication|0|||
163070568|NCT00327171|588963715|FG000|Overall Study|Adverse Event|23|||
163070569|NCT00327171|588963716|FG001|Overall Study|Adverse Event|23|||
163070570|NCT00327171|588963715|FG000|Overall Study|Disease progression/lack of efficacy|68|||
163070571|NCT00327171|588963716|FG001|Overall Study|Disease progression/lack of efficacy|69|||
163070572|NCT00327171|588963715|FG000|Overall Study|Investigator/participant request|1|||
163070573|NCT00327171|588963716|FG001|Overall Study|Investigator/participant request|8|||
163070574|NCT00327171|588963715|FG000|Overall Study|Clinical progression|12|||
163070575|NCT00327171|588963716|FG001|Overall Study|Clinical progression|8|||
163070576|NCT00327171|588963715|FG000|Overall Study|Undisclosed history of ischemia|0|||
163070577|NCT00327171|588963716|FG001|Overall Study|Undisclosed history of ischemia|1|||
163070578|NCT00327171|588963715|FG000|Overall Study|Other|1|||
163070579|NCT00327171|588963716|FG001|Overall Study|Other|0|||
163070580|NCT01363440|588963717|FG000|Overall Study|Adverse Event|5|||
163070581|NCT01363440|588963718|FG001|Overall Study|Adverse Event|4|||
163070582|NCT01363440|588963719|FG002|Overall Study|Adverse Event|4|||
163070583|NCT01363440|588963717|FG000|Overall Study|Death|3|||
163070584|NCT01363440|588963718|FG001|Overall Study|Death|7|||
163070585|NCT01363440|588963719|FG002|Overall Study|Death|5|||
163070586|NCT01363440|588963717|FG000|Overall Study|Withdrawal by Subject|9|||
163070587|NCT01363440|588963718|FG001|Overall Study|Withdrawal by Subject|11|||
163070588|NCT01363440|588963719|FG002|Overall Study|Withdrawal by Subject|11|||
163070589|NCT01363440|588963717|FG000|Overall Study|Lost to Follow-up|2|||
163070590|NCT01363440|588963718|FG001|Overall Study|Lost to Follow-up|4|||
163070591|NCT01363440|588963719|FG002|Overall Study|Lost to Follow-up|5|||
163070592|NCT01363440|588963717|FG000|Overall Study|Other|4|||
163070593|NCT01363440|588963718|FG001|Overall Study|Other|5|||
163070594|NCT01363440|588963719|FG002|Overall Study|Other|2|||
163070595|NCT00992836|588963720|FG000|Overall Study|Lost to Follow-up|1|||
163070596|NCT00992836|588963720|FG000|Overall Study|Withdrawal by Subject|2|||
163070597|NCT00992836|588963720|FG000|Overall Study|Protocol Violation|2|||
163070598|NCT03695094|588963721|FG000|Overall Study|Adverse Event|1|||
163070599|NCT03695094|588963722|FG001|Overall Study|Adverse Event|1|||
163070600|NCT03695094|588963721|FG000|Overall Study|Withdrawal by Subject|1|||
163070601|NCT03695094|588963722|FG001|Overall Study|Withdrawal by Subject|0|||
163070602|NCT01471574|588963723|FG000|Treatment Period|Lack of Efficacy|12|||
163070603|NCT01471574|588963724|FG001|Treatment Period|Lack of Efficacy|4|||
163070604|NCT01471574|588963725|FG002|Treatment Period|Lack of Efficacy|14|||
163070605|NCT01471574|588963726|FG003|Treatment Period|Lack of Efficacy|1|||
163070606|NCT01471574|588963723|FG000|Treatment Period|Adverse Event|7|||
163070607|NCT01471574|588963724|FG001|Treatment Period|Adverse Event|3|||
163070608|NCT01471574|588963725|FG002|Treatment Period|Adverse Event|6|||
163070609|NCT01471574|588963726|FG003|Treatment Period|Adverse Event|1|||
163070610|NCT01471574|588963723|FG000|Treatment Period|Withdrawal by Subject|5|||
163070611|NCT01471574|588963724|FG001|Treatment Period|Withdrawal by Subject|1|||
163070612|NCT01471574|588963725|FG002|Treatment Period|Withdrawal by Subject|1|||
163070613|NCT01471574|588963726|FG003|Treatment Period|Withdrawal by Subject|0|||
163070614|NCT01471574|588963723|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
163070615|NCT01471574|588963724|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
163070616|NCT01471574|588963725|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
163070617|NCT01471574|588963726|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
163070618|NCT01471574|588963723|FG000|Treatment Period|Lost to Follow-up|1|||
163070619|NCT01471574|588963724|FG001|Treatment Period|Lost to Follow-up|2|||
163070620|NCT01471574|588963725|FG002|Treatment Period|Lost to Follow-up|2|||
163070621|NCT01471574|588963726|FG003|Treatment Period|Lost to Follow-up|0|||
163070622|NCT01471574|588963723|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
163070623|NCT01471574|588963724|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070624|NCT01471574|588963725|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070625|NCT01471574|588963726|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
163070626|NCT01471574|588963723|FG000|Treatment Period|Other|1|||
163070627|NCT01471574|588963724|FG001|Treatment Period|Other|0|||
163070628|NCT01471574|588963725|FG002|Treatment Period|Other|0|||
163070629|NCT01471574|588963726|FG003|Treatment Period|Other|0|||
163070630|NCT01471574|588963723|FG000|Follow-up Period|Withdrawal by Subject|3|||
163070631|NCT01471574|588963724|FG001|Follow-up Period|Withdrawal by Subject|0|||
163070632|NCT01471574|588963725|FG002|Follow-up Period|Withdrawal by Subject|3|||
163070633|NCT01471574|588963726|FG003|Follow-up Period|Withdrawal by Subject|1|||
163070634|NCT01471574|588963723|FG000|Follow-up Period|Lost to Follow-up|4|||
163070635|NCT01471574|588963724|FG001|Follow-up Period|Lost to Follow-up|1|||
163070636|NCT01471574|588963725|FG002|Follow-up Period|Lost to Follow-up|3|||
163070637|NCT01471574|588963726|FG003|Follow-up Period|Lost to Follow-up|2|||
163070638|NCT01471574|588963723|FG000|Follow-up Period|Death|0|||
163070639|NCT01471574|588963724|FG001|Follow-up Period|Death|0|||
163070640|NCT01471574|588963725|FG002|Follow-up Period|Death|1|||
163070641|NCT01471574|588963726|FG003|Follow-up Period|Death|0|||
163070642|NCT01471574|588963723|FG000|Follow-up Period|Follow-up no longer required|0|||
163070643|NCT01471574|588963724|FG001|Follow-up Period|Follow-up no longer required|1|||
163070644|NCT01471574|588963725|FG002|Follow-up Period|Follow-up no longer required|0|||
163070645|NCT01471574|588963726|FG003|Follow-up Period|Follow-up no longer required|0|||
163070646|NCT01795937|588963727|FG000|Overall Study|Withdrawal by Subject|1|||
163070647|NCT01795937|588963728|FG001|Overall Study|Withdrawal by Subject|0|||
163070648|NCT01795937|588963729|FG002|Overall Study|Withdrawal by Subject|0|||
163070649|NCT01795937|588963727|FG000|Overall Study|Physician Decision|0|||
163070650|NCT01795937|588963728|FG001|Overall Study|Physician Decision|1|||
163070651|NCT01795937|588963729|FG002|Overall Study|Physician Decision|0|||
163070652|NCT03927157|588963731|FG000|Overall Study|Adverse Event|1|||
163070653|NCT03927157|588963732|FG001|Overall Study|Adverse Event|3|||
163070654|NCT03927157|588963731|FG000|Overall Study|Protocol Violation|1|||
163070655|NCT03927157|588963732|FG001|Overall Study|Protocol Violation|2|||
163070656|NCT03927157|588963731|FG000|Overall Study|Withdrawal by Subject|8|||
163070657|NCT03927157|588963732|FG001|Overall Study|Withdrawal by Subject|21|||
163070658|NCT03927157|588963731|FG000|Overall Study|Due to COVID-19 pandemic|5|||
163070659|NCT03927157|588963732|FG001|Overall Study|Due to COVID-19 pandemic|2|||
163070660|NCT03927157|588963731|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
163070661|NCT03927157|588963732|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
163070662|NCT03927157|588963731|FG000|Overall Study|Other than above|0|||
163070663|NCT03927157|588963732|FG001|Overall Study|Other than above|1|||
163070664|NCT02965716|588963733|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163070665|NCT02965716|588963734|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
163070666|NCT02965716|588963733|FG000|Overall Study|Progression/Relapse|8|||
163070667|NCT02965716|588963734|FG001|Overall Study|Progression/Relapse|16|||
163070668|NCT02965716|588963733|FG000|Overall Study|Death|1|||
163070669|NCT02965716|588963734|FG001|Overall Study|Death|0|||
163070670|NCT02965716|588963733|FG000|Overall Study|Not Protocol Specified|1|||
163070671|NCT02965716|588963734|FG001|Overall Study|Not Protocol Specified|3|||
163070672|NCT02691663|588963739|FG000|Overall Study|Screen failure after baseline|2|||
163070673|NCT02691663|588963740|FG001|Overall Study|Screen failure after baseline|2|||
163070674|NCT02691663|588963739|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
163070675|NCT02691663|588963740|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
163070676|NCT02691663|588963739|FG000|Overall Study|Withdrawn after Follow up 2|1|||
163070677|NCT02691663|588963740|FG001|Overall Study|Withdrawn after Follow up 2|1|||
163070678|NCT02691663|588963739|FG000|Overall Study|Lost to Follow-up|3|||
163070679|NCT02691663|588963740|FG001|Overall Study|Lost to Follow-up|2|||
163070680|NCT00303628|588963741|FG000|Overall Study|Disease progression|0|||
163070681|NCT00303628|588963742|FG001|Overall Study|Disease progression|1|||
163070682|NCT00303628|588963741|FG000|Overall Study|Adverse Event|26|||
163070683|NCT00303628|588963742|FG001|Overall Study|Adverse Event|36|||
163070684|NCT00303628|588963741|FG000|Overall Study|Death|0|||
163070685|NCT00303628|588963742|FG001|Overall Study|Death|1|||
163070686|NCT00303628|588963741|FG000|Overall Study|Withdrawal by Subject|11|||
163070687|NCT00303628|588963742|FG001|Overall Study|Withdrawal by Subject|20|||
163070688|NCT00303628|588963741|FG000|Overall Study|Alternative therapy|2|||
163070689|NCT00303628|588963742|FG001|Overall Study|Alternative therapy|0|||
163070690|NCT00303628|588963741|FG000|Overall Study|Other complicating disease|0|||
163070691|NCT00303628|588963742|FG001|Overall Study|Other complicating disease|1|||
163070692|NCT00303628|588963741|FG000|Overall Study|Not start protocol therapy|3|||
163070693|NCT00303628|588963742|FG001|Overall Study|Not start protocol therapy|5|||
163070694|NCT00303628|588963741|FG000|Overall Study|Other|8|||
163070695|NCT00303628|588963742|FG001|Overall Study|Other|9|||
163070696|NCT03158688|588963743|FG000|Overall Study|Withdrawal by Subject|14|||
163070697|NCT03158688|588963744|FG001|Overall Study|Withdrawal by Subject|28|||
163070698|NCT03158688|588963743|FG000|Overall Study|Decision by sponsor|13|||
163070699|NCT03158688|588963744|FG001|Overall Study|Decision by sponsor|37|||
163070700|NCT03158688|588963743|FG000|Overall Study|Lost to Follow-up|4|||
163070701|NCT03158688|588963744|FG001|Overall Study|Lost to Follow-up|3|||
163070702|NCT03158688|588963743|FG000|Overall Study|Death|74|||
163070703|NCT03158688|588963744|FG001|Overall Study|Death|142|||
163070704|NCT02942407|588963745|FG000|Overall Study|Lost to Follow-up|3|||
163070705|NCT02942407|588963746|FG001|Overall Study|Lost to Follow-up|2|||
163070706|NCT02942407|588963745|FG000|Overall Study|Withdrawal by Subject|7|||
163070707|NCT02942407|588963746|FG001|Overall Study|Withdrawal by Subject|9|||
163070708|NCT02942407|588963745|FG000|Overall Study|Death|16|||
163070709|NCT02942407|588963746|FG001|Overall Study|Death|13|||
163070710|NCT05887908|588963747|FG000|Overall Study|Adverse Event|6|||
163070711|NCT05887908|588963748|FG001|Overall Study|Adverse Event|1|||
163070712|NCT05887908|588963749|FG002|Overall Study|Adverse Event|1|||
163070713|NCT05887908|588963747|FG000|Overall Study|Physician Decision|4|||
163070714|NCT05887908|588963748|FG001|Overall Study|Physician Decision|1|||
163070715|NCT05887908|588963749|FG002|Overall Study|Physician Decision|0|||
163070716|NCT05887908|588963747|FG000|Overall Study|Withdrawal by Subject|3|||
163070717|NCT05887908|588963748|FG001|Overall Study|Withdrawal by Subject|2|||
163070718|NCT05887908|588963749|FG002|Overall Study|Withdrawal by Subject|3|||
163070719|NCT05887908|588963747|FG000|Overall Study|Ineligibility after the start of the study|4|||
163070720|NCT05887908|588963748|FG001|Overall Study|Ineligibility after the start of the study|1|||
163070721|NCT05887908|588963749|FG002|Overall Study|Ineligibility after the start of the study|0|||
163070722|NCT05887908|588963747|FG000|Overall Study|Subject non-compliance|4|||
163070723|NCT05887908|588963748|FG001|Overall Study|Subject non-compliance|0|||
163070724|NCT05887908|588963749|FG002|Overall Study|Subject non-compliance|4|||
163070725|NCT05887908|588963747|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
163070726|NCT05887908|588963748|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
163070727|NCT05887908|588963749|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
163070728|NCT05887908|588963747|FG000|Overall Study|Pregnancy|0|||
163070729|NCT05887908|588963748|FG001|Overall Study|Pregnancy|1|||
163070730|NCT05887908|588963749|FG002|Overall Study|Pregnancy|0|||
163070731|NCT05887908|588963747|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
163070732|NCT05887908|588963748|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
163070733|NCT05887908|588963749|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
163070734|NCT05887908|588963747|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
163070735|NCT05887908|588963748|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
163070736|NCT05887908|588963749|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
163070737|NCT05887908|588963747|FG000|Overall Study|Other Reason|3|||
163070738|NCT05887908|588963748|FG001|Overall Study|Other Reason|3|||
163070739|NCT05887908|588963749|FG002|Overall Study|Other Reason|3|||
163070740|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
163070741|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
163070742|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
163070743|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
163070744|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
163070745|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
163070746|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
163070747|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
163070748|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
163070749|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
163070750|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
163070751|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
163070752|NCT03928743|588963750|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
163070753|NCT03928743|588963751|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
163070754|NCT03928743|588963752|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
163070755|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
163070756|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
163070757|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
163070758|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
163070759|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
163070760|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
163070761|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
163070762|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
163070763|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
163070764|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
163070765|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
163070766|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
163070767|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
163070768|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
163070769|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
163070770|NCT03928743|588963750|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
163070771|NCT03928743|588963751|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
163070772|NCT03928743|588963752|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
163070773|NCT03325439|588963755|FG000|Overall Study|Ineligibility|3|||
163070774|NCT02315625|588963756|FG000|First Intervention|Disease Progression|1|||
163070775|NCT02315625|588963757|FG001|First Intervention|Disease Progression|0|||
163070776|NCT02315625|588963756|FG000|Second Intervention|Physician Decision|2|||
163070777|NCT02315625|588963757|FG001|Second Intervention|Physician Decision|1|||
163070778|NCT02315625|588963756|FG000|Second Intervention|Study closure|1|||
163070779|NCT02315625|588963757|FG001|Second Intervention|Study closure|0|||
162644370|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
163070780|NCT02315625|588963756|FG000|Second Intervention|Disease Progression|1|||
163070781|NCT02315625|588963757|FG001|Second Intervention|Disease Progression|0|||
163070782|NCT06132386|588963758|FG000|Overall Study|ineligble laboratory|1|||
163070783|NCT06132386|588963759|FG001|Overall Study|ineligble laboratory|0|||
163070784|NCT06132386|588963760|FG002|Overall Study|ineligble laboratory|0|||
163070785|NCT06132386|588963761|FG003|Overall Study|ineligble laboratory|0|||
163070786|NCT06132386|588963762|FG004|Overall Study|ineligble laboratory|1|||
163070787|NCT06132386|588963763|FG005|Overall Study|ineligble laboratory|0|||
163070788|NCT06132386|588963758|FG000|Overall Study|ineligible vital signs|0|||
163070789|NCT06132386|588963759|FG001|Overall Study|ineligible vital signs|1|||
163070790|NCT06132386|588963760|FG002|Overall Study|ineligible vital signs|0|||
163070791|NCT06132386|588963761|FG003|Overall Study|ineligible vital signs|0|||
163070792|NCT06132386|588963762|FG004|Overall Study|ineligible vital signs|0|||
163070793|NCT06132386|588963763|FG005|Overall Study|ineligible vital signs|0|||
163070794|NCT02762604|588963764|FG000|Overall Study|Lost to Follow-up|2|||
163070795|NCT02762604|588963765|FG001|Overall Study|Lost to Follow-up|7|||
163070796|NCT02762604|588963764|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
163070797|NCT02762604|588963765|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
163070798|NCT06061952|588963766|FG000|Overall Study|Withdrawal by Subject|1|||
163070799|NCT06061952|588963767|FG001|Overall Study|Withdrawal by Subject|2|||
162644371|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
162644372|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
162644373|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
162644374|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
162644375|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
162644376|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
162644377|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
162644378|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
162644379|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
162644380|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
162644381|NCT00887354|587415754|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
162644382|NCT00887354|587415755|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
162644383|NCT00887354|587415754|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
163027054|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
163027055|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
163027056|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
163027057|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
163027058|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
163027059|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
163027060|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
163027061|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
163027062|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
163027063|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
163027064|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
163027065|NCT02275780|588801374|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
163027066|NCT02275780|588801375|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
163027067|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
163027068|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
163027069|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
163027070|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
163027071|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
163027072|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
163027073|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
163027074|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
163027075|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
163027076|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
163027077|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
163027078|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
163027079|NCT02275780|588801374|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
163027080|NCT02275780|588801375|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
163027081|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
163027082|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
163027083|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
163027084|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
163027085|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
163027086|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
163027087|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
163027088|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
163027089|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
163027090|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
163027091|NCT02275780|588801374|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
163027092|NCT02275780|588801375|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
163027093|NCT01054300|588801380|FG000|Period 1|Adverse Event|1|||
163027094|NCT01054300|588801381|FG001|Period 1|Adverse Event|0|||
163027095|NCT01054300|588801382|FG002|Period 1|Adverse Event|0|||
163027096|NCT01054300|588801383|FG003|Period 1|Adverse Event|0|||
163027097|NCT01054300|588801380|FG000|Period 2|Withdrawal by Subject|0|||
163027098|NCT01054300|588801381|FG001|Period 2|Withdrawal by Subject|0|||
163027099|NCT01054300|588801382|FG002|Period 2|Withdrawal by Subject|1|||
163027100|NCT01054300|588801383|FG003|Period 2|Withdrawal by Subject|0|||
163027101|NCT01899742|588801388|FG000|Overall Study|Adverse Event|5|||
163027102|NCT01899742|588801389|FG001|Overall Study|Adverse Event|4|||
163027103|NCT01899742|588801388|FG000|Overall Study|Lack of Efficacy|1|||
163027104|NCT01899742|588801389|FG001|Overall Study|Lack of Efficacy|5|||
163027105|NCT01899742|588801388|FG000|Overall Study|Protocol Violation|2|||
163027106|NCT01899742|588801389|FG001|Overall Study|Protocol Violation|2|||
163027107|NCT01899742|588801388|FG000|Overall Study|Withdrawal by Subject|9|||
163070800|NCT06061952|588963766|FG000|Overall Study|Lost to Follow-up|2|||
163070801|NCT06061952|588963767|FG001|Overall Study|Lost to Follow-up|2|||
163070802|NCT01405911|588963768|FG000|Overall Study|Pre-treatment lab AE|0|||
163070803|NCT01405911|588963769|FG001|Overall Study|Pre-treatment lab AE|1|||
163070804|NCT01405911|588963770|FG002|Overall Study|Pre-treatment lab AE|0|||
163070805|NCT01405911|588963768|FG000|Overall Study|Lost to Follow-up|0|||
163070806|NCT01405911|588963769|FG001|Overall Study|Lost to Follow-up|1|||
163070807|NCT01405911|588963770|FG002|Overall Study|Lost to Follow-up|0|||
163070808|NCT01405911|588963768|FG000|Overall Study|Protocol Violation|1|||
163070809|NCT01405911|588963769|FG001|Overall Study|Protocol Violation|0|||
163070810|NCT01405911|588963770|FG002|Overall Study|Protocol Violation|0|||
163070811|NCT01405911|588963768|FG000|Overall Study|Withdrawal by Subject|3|||
163070812|NCT01405911|588963769|FG001|Overall Study|Withdrawal by Subject|1|||
163070813|NCT01405911|588963770|FG002|Overall Study|Withdrawal by Subject|1|||
163070814|NCT04937387|588963779|FG000|Overall Study|Adverse Event|1|||
163070815|NCT04937387|588963780|FG001|Overall Study|Adverse Event|0|||
163070816|NCT04937387|588963781|FG002|Overall Study|Adverse Event|2|||
163070817|NCT04937387|588963782|FG003|Overall Study|Adverse Event|0|||
163070818|NCT04937387|588963779|FG000|Overall Study|Lack of Efficacy|1|||
163070819|NCT04937387|588963780|FG001|Overall Study|Lack of Efficacy|0|||
163070820|NCT04937387|588963781|FG002|Overall Study|Lack of Efficacy|0|||
163070821|NCT04937387|588963782|FG003|Overall Study|Lack of Efficacy|1|||
163070822|NCT04937387|588963779|FG000|Overall Study|Withdrawal by Subject|1|||
163070823|NCT04937387|588963780|FG001|Overall Study|Withdrawal by Subject|0|||
163070824|NCT04937387|588963781|FG002|Overall Study|Withdrawal by Subject|1|||
163070825|NCT04937387|588963782|FG003|Overall Study|Withdrawal by Subject|1|||
163070826|NCT04937387|588963779|FG000|Overall Study|Randomized in error|0|||
163070827|NCT04937387|588963780|FG001|Overall Study|Randomized in error|0|||
163070828|NCT04937387|588963781|FG002|Overall Study|Randomized in error|0|||
163070829|NCT04937387|588963782|FG003|Overall Study|Randomized in error|1|||
163070830|NCT01039675|588963783|FG000|Overall Study|Adverse Event|0|||
163070831|NCT01039675|588963784|FG001|Overall Study|Adverse Event|2|||
163070832|NCT01039675|588963783|FG000|Overall Study|Lack of Efficacy|0|||
163070833|NCT01039675|588963784|FG001|Overall Study|Lack of Efficacy|2|||
163070834|NCT01039675|588963783|FG000|Overall Study|Withdrawal by Subject|0|||
163070835|NCT01039675|588963784|FG001|Overall Study|Withdrawal by Subject|1|||
163070836|NCT01039675|588963783|FG000|Overall Study|Lost to Follow-up|0|||
163070837|NCT01039675|588963784|FG001|Overall Study|Lost to Follow-up|1|||
163070838|NCT01039675|588963783|FG000|Overall Study|Physician Decision|0|||
163070839|NCT01039675|588963784|FG001|Overall Study|Physician Decision|1|||
163070840|NCT03514017|588963789|FG000|Overall Study|Death|1|||
163070841|NCT03514017|588963789|FG000|Overall Study|Adverse Event|1|||
163070842|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070843|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
163070844|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
163070845|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070846|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070847|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070848|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
163070849|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
163070850|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070851|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
163070852|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070853|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070854|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070855|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
163070856|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070857|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070858|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
163070859|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070860|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070861|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070862|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
163070863|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
163070864|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070865|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070866|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070867|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070868|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070869|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
163070870|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070871|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070872|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
163070873|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070874|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070875|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070876|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
163070877|NCT01807520|588964702|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
163070878|NCT01807520|588964703|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070879|NCT01807520|588964704|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070880|NCT01807520|588964705|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070881|NCT01807520|588964706|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070882|NCT01807520|588964707|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070883|NCT01807520|588964708|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
163070884|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
163070885|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
163070886|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070887|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070888|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
163070889|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070890|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
163070891|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070892|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070893|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070894|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
163070895|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070896|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070897|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
163070898|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
163070899|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070900|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070901|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070902|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070903|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070904|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
163070905|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070906|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
163070907|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070908|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070909|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070910|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070911|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
163070912|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
163070913|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070914|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070915|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
163070916|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070917|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070918|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
163070919|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
163070920|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
163070921|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070922|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070923|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
163070924|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070925|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
163070926|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070927|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070928|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070929|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
163070930|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070931|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070932|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
163070933|NCT01807520|588964702|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
163070934|NCT01807520|588964703|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
163070935|NCT01807520|588964704|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070936|NCT01807520|588964705|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
163070937|NCT01807520|588964706|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
163070938|NCT01807520|588964707|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070939|NCT01807520|588964708|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
163070940|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070941|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070942|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070943|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070944|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070945|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
163070946|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
163070947|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070948|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070949|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070950|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070951|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070952|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
163070953|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163070954|NCT01807520|588964702|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070955|NCT01807520|588964703|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070956|NCT01807520|588964704|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070957|NCT01807520|588964705|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070958|NCT01807520|588964706|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
163070959|NCT01807520|588964707|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
163070960|NCT01807520|588964708|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
163070961|NCT03600350|588964712|FG000|Overall Study|Death|1|||
163070962|NCT03600350|588964712|FG000|Overall Study|On Follow Up|18|||
163070963|NCT02400736|588964713|FG000|Overall Study|Lost to Follow-up|6|||
163070964|NCT02400736|588964714|FG001|Overall Study|Lost to Follow-up|6|||
163070965|NCT02400736|588964713|FG000|Overall Study|Withdrawal by Subject|2|||
163070966|NCT02400736|588964714|FG001|Overall Study|Withdrawal by Subject|1|||
163070967|NCT02400736|588964713|FG000|Overall Study|Moved from the area|3|||
163070968|NCT02400736|588964714|FG001|Overall Study|Moved from the area|1|||
163070969|NCT01771913|588964715|FG000|Overall Study|Withdrawal by Subject|1|||
163070970|NCT01771913|588964716|FG001|Overall Study|Withdrawal by Subject|0|||
163070971|NCT00552058|588964717|FG000|Overall Study|Adverse Event|8|||
163070972|NCT00552058|588964718|FG001|Overall Study|Adverse Event|7|||
163070973|NCT00552058|588964717|FG000|Overall Study|Lack of Efficacy|1|||
163070974|NCT00552058|588964718|FG001|Overall Study|Lack of Efficacy|5|||
163070975|NCT00552058|588964717|FG000|Overall Study|Lost to Follow-up|1|||
163070976|NCT00552058|588964718|FG001|Overall Study|Lost to Follow-up|0|||
163070977|NCT00552058|588964717|FG000|Overall Study|Withdrawal by Subject|4|||
163070978|NCT00552058|588964718|FG001|Overall Study|Withdrawal by Subject|4|||
163070979|NCT00552058|588964717|FG000|Overall Study|Other: Protocol Violation|0|||
163070980|NCT00552058|588964718|FG001|Overall Study|Other: Protocol Violation|1|||
163070981|NCT00552058|588964717|FG000|Overall Study|Other: Non Compliance|1|||
163070982|NCT00552058|588964718|FG001|Overall Study|Other: Non Compliance|2|||
163070983|NCT00552058|588964717|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
163070984|NCT00552058|588964718|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
163070985|NCT00552058|588964717|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
163070986|NCT00552058|588964718|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
163070987|NCT00552058|588964717|FG000|Overall Study|Other: Positive Stool Result|0|||
163070988|NCT00552058|588964718|FG001|Overall Study|Other: Positive Stool Result|1|||
163070989|NCT00552058|588964717|FG000|Overall Study|Other: Randomized in error|0|||
163070990|NCT00552058|588964718|FG001|Overall Study|Other: Randomized in error|1|||
163070991|NCT00552058|588964717|FG000|Overall Study|Other: Sponsors Decision|0|||
163070992|NCT00552058|588964718|FG001|Overall Study|Other: Sponsors Decision|1|||
163070993|NCT00552058|588964717|FG000|Overall Study|Other: Early Roll Over|1|||
163070994|NCT00552058|588964718|FG001|Overall Study|Other: Early Roll Over|0|||
163070995|NCT01028053|588964725|FG000|Overall Study|Screen Failure|113|||
163070996|NCT01028053|588964725|FG000|Overall Study|Patient Request|11|||
163070997|NCT01028053|588964725|FG000|Overall Study|Protocol Violation|1|||
163070998|NCT01028053|588964725|FG000|Overall Study|Physician Decision|2|||
163070999|NCT01028053|588964725|FG000|Overall Study|Technical Problem|1|||
163071000|NCT01028053|588964725|FG000|Overall Study|Terminated by Sponsor|1|||
163071001|NCT01028053|588964725|FG000|Overall Study|Various reasons|4|||
163071002|NCT01177410|588964726|FG000|Overall Study|Adverse Event|0|||
163071003|NCT01177410|588964727|FG001|Overall Study|Adverse Event|2|||
163071004|NCT01177410|588964728|FG002|Overall Study|Adverse Event|2|||
163071005|NCT01177410|588964726|FG000|Overall Study|Withdrawal by Subject|1|||
163071006|NCT01177410|588964727|FG001|Overall Study|Withdrawal by Subject|4|||
163071007|NCT01177410|588964728|FG002|Overall Study|Withdrawal by Subject|3|||
163071008|NCT01177410|588964726|FG000|Overall Study|Lost to Follow-up|0|||
163071009|NCT01177410|588964727|FG001|Overall Study|Lost to Follow-up|1|||
163071010|NCT01177410|588964728|FG002|Overall Study|Lost to Follow-up|0|||
163071011|NCT00471354|588964729|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
163071012|NCT00471354|588964729|FG000|Overall Study|Adverse Event|13|||
163071013|NCT00471354|588964729|FG000|Overall Study|Protocol Violation|12|||
163071014|NCT00471354|588964729|FG000|Overall Study|Withdrawal by Subject|1|||
163071015|NCT00471354|588964729|FG000|Overall Study|Physician Decision|4|||
163071016|NCT00471354|588964729|FG000|Overall Study|Sponsor Decision|1|||
163071017|NCT00471354|588964729|FG000|Overall Study|Lost to Follow-up|3|||
163071018|NCT00471354|588964729|FG000|Overall Study|Lack of Efficacy|5|||
163071019|NCT00471354|588964729|FG000|Overall Study|Patient/Caregiver Decision|12|||
163071020|NCT05558410|588964730|FG000|Overall Study|Adverse Event|1|||
163071021|NCT05558410|588964731|FG001|Overall Study|Adverse Event|2|||
163071022|NCT05558410|588964732|FG002|Overall Study|Adverse Event|0|||
163071023|NCT05558410|588964730|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
163071024|NCT05558410|588964731|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163071025|NCT05558410|588964732|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
163071026|NCT05558410|588964730|FG000|Overall Study|Lost to Follow-up|10|||
163071027|NCT05558410|588964731|FG001|Overall Study|Lost to Follow-up|17|||
163071028|NCT05558410|588964732|FG002|Overall Study|Lost to Follow-up|19|||
163071029|NCT05558410|588964730|FG000|Overall Study|Death|1|||
163071030|NCT05558410|588964731|FG001|Overall Study|Death|0|||
163071031|NCT05558410|588964732|FG002|Overall Study|Death|0|||
163071032|NCT05558410|588964730|FG000|Overall Study|Other non-compliance|0|||
163071033|NCT05558410|588964731|FG001|Overall Study|Other non-compliance|1|||
163071034|NCT05558410|588964732|FG002|Overall Study|Other non-compliance|2|||
163071035|NCT05558410|588964730|FG000|Overall Study|Sponsor Decision|1|||
163071036|NCT05558410|588964731|FG001|Overall Study|Sponsor Decision|0|||
163071037|NCT05558410|588964732|FG002|Overall Study|Sponsor Decision|0|||
163071038|NCT05558410|588964730|FG000|Overall Study|Other|1|||
163071039|NCT05558410|588964731|FG001|Overall Study|Other|0|||
163071040|NCT05558410|588964732|FG002|Overall Study|Other|1|||
163071041|NCT01336972|588964736|FG000|Overall Study|Adverse Event|1|||
163071042|NCT01336972|588964737|FG001|Overall Study|Adverse Event|1|||
163071043|NCT01336972|588964738|FG002|Overall Study|Adverse Event|0|||
163071044|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
163071045|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
163071046|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
163071047|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
163071048|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
163071049|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
163071050|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
163071051|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
163071052|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
163071053|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
163071054|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
163071055|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
163071056|NCT03446573|588964739|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
163071057|NCT03446573|588964740|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
163071058|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
163071059|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
163071060|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
163071061|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
163071062|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
163071063|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
163071064|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
163071065|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
163071066|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
163071067|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
163071068|NCT03446573|588964739|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
163071069|NCT03446573|588964740|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
163071070|NCT02639559|588964741|FG000|Overall Study|Mobilization failure|0|||
163071071|NCT02639559|588964742|FG001|Overall Study|Mobilization failure|3|||
163071072|NCT02639559|588964741|FG000|Overall Study|Issues with vascular acess|1|||
163071073|NCT02639559|588964742|FG001|Overall Study|Issues with vascular acess|0|||
162644384|NCT00887354|587415755|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
162644385|NCT00887354|587415754|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
162644386|NCT00887354|587415755|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
162644387|NCT00887354|587415754|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
163071074|NCT03142750|588964745|FG000|Overall Study|Lost to Follow-up|4|||
163071075|NCT03142750|588964746|FG001|Overall Study|Lost to Follow-up|1|||
163071076|NCT00471107|588964751|FG000|Overall Study|Technical problems/data loss|3|||
163071077|NCT00471107|588964752|FG001|Overall Study|Technical problems/data loss|1|||
163071078|NCT00471107|588964753|FG002|Overall Study|Technical problems/data loss|3|||
163071079|NCT04828486|588964759|FG000|Overall Study|Adverse Event|2|||
163071080|NCT04828486|588964759|FG000|Overall Study|Death|1|||
163071081|NCT04828486|588964759|FG000|Overall Study|Disease Progression|8|||
163071082|NCT04828486|588964759|FG000|Overall Study|Other Complicating Disease|1|||
163071083|NCT04828486|588964759|FG000|Overall Study|Withdrawal by Subject|1|||
163071084|NCT06204887|588964760|FG000|Overall Study|Lost to Follow-up|3|||
163071085|NCT06204887|588964761|FG001|Overall Study|Lost to Follow-up|4|||
163071086|NCT06204887|588964762|FG002|Overall Study|Lost to Follow-up|1|||
163071087|NCT06204887|588964763|FG003|Overall Study|Lost to Follow-up|6|||
163071088|NCT03833167|588964767|FG000|Overall Study|Withdrawal by Subject|4|||
163071089|NCT03833167|588964768|FG001|Overall Study|Withdrawal by Subject|6|||
163071090|NCT03833167|588964767|FG000|Overall Study|Ongoing|186|||
163071091|NCT03833167|588964768|FG001|Overall Study|Ongoing|194|||
163071092|NCT03833167|588964767|FG000|Overall Study|Lost to Follow-up|1|||
163071093|NCT03833167|588964768|FG001|Overall Study|Lost to Follow-up|1|||
163071094|NCT03833167|588964767|FG000|Overall Study|Physician Decision|0|||
163071095|NCT03833167|588964768|FG001|Overall Study|Physician Decision|2|||
163071096|NCT03833167|588964767|FG000|Overall Study|Death|34|||
163071097|NCT03833167|588964768|FG001|Overall Study|Death|22|||
163071098|NCT02227199|588964770|FG000|Overall Study|Physician Decision|0|||
163071099|NCT02227199|588964771|FG001|Overall Study|Physician Decision|0|||
163071100|NCT02227199|588964772|FG002|Overall Study|Physician Decision|1|||
163071101|NCT02227199|588964770|FG000|Overall Study|Adverse Event|0|||
163071102|NCT02227199|588964771|FG001|Overall Study|Adverse Event|0|||
163071103|NCT02227199|588964772|FG002|Overall Study|Adverse Event|3|||
163071104|NCT01428128|588964773|FG000|Overall Study|Withdrawal by Subject|4|||
163071105|NCT01428128|588964773|FG000|Overall Study|Screen failure by p53|10|||
163071106|NCT01428128|588964773|FG000|Overall Study|Received Neulasta in one cycle|2|||
163071107|NCT01428128|588964773|FG000|Overall Study|Adverse Event|1|||
163071108|NCT03003962|588964774|FG000|Overall Study|Withdrawal by Subject|5|||
163071109|NCT03003962|588964775|FG001|Overall Study|Withdrawal by Subject|17|||
163071110|NCT03003962|588964774|FG000|Overall Study|Death|274|||
163071111|NCT03003962|588964775|FG001|Overall Study|Death|277|||
163071112|NCT03003962|588964774|FG000|Overall Study|Participants ongoing at DCO|55|||
163071113|NCT03003962|588964775|FG001|Overall Study|Participants ongoing at DCO|40|||
163071114|NCT05179603|588964776|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
163071115|NCT05179603|588964776|FG000|Overall Study|Withdrawal by Subject|1|||
163071116|NCT05179603|588964776|FG000|Overall Study|Progressive disease|4|||
163071117|NCT05179603|588964776|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
163071118|NCT05937373|588964777|FG000|Overall Study|Out of Window|2|||
163071119|NCT05937373|588964778|FG001|Overall Study|Out of Window|0|||
163071120|NCT05937373|588964777|FG000|Overall Study|Device fell off prior to date of surgery|0|||
163071121|NCT05937373|588964778|FG001|Overall Study|Device fell off prior to date of surgery|2|||
163071122|NCT04337021|588964780|FG000|Overall Study|Lost to Follow-up|54|||
163071123|NCT04337021|588964781|FG001|Overall Study|Lost to Follow-up|66|||
163071124|NCT06375655|588964782|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
163071125|NCT06375655|588964783|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
163071126|NCT01685437|588964784|FG000|Overall Study|Withdrawal by Subject|22|||
163071127|NCT01685437|588964784|FG000|Overall Study|Lost to Follow-up|3|||
163071128|NCT01685437|588964784|FG000|Overall Study|Adverse Event|1|||
163071129|NCT01685437|588964784|FG000|Overall Study|Protocol Violation|4|||
163071130|NCT01685437|588964784|FG000|Overall Study|Unable to make visits due to work|1|||
163071131|NCT00567580|588966035|FG000|Overall Study|Protocol Violation|28|||
163071132|NCT00567580|588966036|FG001|Overall Study|Protocol Violation|24|||
163071133|NCT00567580|588966037|FG002|Overall Study|Protocol Violation|24|||
163071134|NCT00134719|588966038|FG000|Primary Vaccination Phase|Adverse Event|4|||
163071135|NCT00134719|588966039|FG001|Primary Vaccination Phase|Adverse Event|0|||
163071136|NCT00134719|588966040|FG002|Primary Vaccination Phase|Adverse Event|0|||
163071137|NCT00134719|588966038|FG000|Primary Vaccination Phase|Protocol Violation|1|||
163071138|NCT00134719|588966039|FG001|Primary Vaccination Phase|Protocol Violation|0|||
163071139|NCT00134719|588966040|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163071140|NCT00134719|588966038|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
163071141|NCT00134719|588966039|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
163071142|NCT00134719|588966040|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
163071143|NCT00134719|588966038|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
163071144|NCT00134719|588966039|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
163071145|NCT00134719|588966040|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
163071146|NCT00134719|588966038|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
163071147|NCT00134719|588966039|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
163071148|NCT00134719|588966040|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
163071149|NCT00134719|588966038|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
163071150|NCT00134719|588966039|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
163071151|NCT00134719|588966040|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
163071152|NCT00620035|588966041|FG000|Overall Study|Adverse Event|106|||
163071153|NCT00620035|588966041|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163071154|NCT00620035|588966041|FG000|Overall Study|Other Reason|38|||
163071155|NCT01002105|588966042|FG000|Overall Study|Lost to Follow-up|10|||
163071156|NCT01002105|588966043|FG001|Overall Study|Lost to Follow-up|16|||
163071157|NCT01002105|588966042|FG000|Overall Study|non compliance|5|||
163071158|NCT01002105|588966043|FG001|Overall Study|non compliance|3|||
163071159|NCT01002105|588966042|FG000|Overall Study|condition worsened|4|||
163071160|NCT01002105|588966043|FG001|Overall Study|condition worsened|2|||
163071161|NCT00845182|588966044|FG000|Overall Study|Lost to Follow-up|3|||
163071162|NCT00845182|588966045|FG001|Overall Study|Lost to Follow-up|3|||
163071163|NCT00845182|588966046|FG002|Overall Study|Lost to Follow-up|4|||
163071164|NCT00845182|588966044|FG000|Overall Study|Adverse Event|0|||
163071165|NCT00845182|588966045|FG001|Overall Study|Adverse Event|1|||
163071166|NCT00845182|588966046|FG002|Overall Study|Adverse Event|1|||
163071167|NCT00845182|588966044|FG000|Overall Study|Physician Decision|0|||
163071168|NCT00845182|588966045|FG001|Overall Study|Physician Decision|0|||
163071169|NCT00845182|588966046|FG002|Overall Study|Physician Decision|1|||
163071170|NCT04621760|588966047|FG000|Overall Study|Lost to Follow-up|2|||
162644388|NCT00887354|587415755|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
162644389|NCT00887354|587415754|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
163027108|NCT01899742|588801389|FG001|Overall Study|Withdrawal by Subject|5|||
163027109|NCT00738881|588801393|FG000|Overall Study|Withdrawal by Subject|0|||
163027110|NCT00738881|588801394|FG001|Overall Study|Withdrawal by Subject|2|||
163027111|NCT02662764|588801395|FG000|Overall Study|Adverse Event|6|||
163027112|NCT02662764|588801395|FG000|Overall Study|Lack of Efficacy|8|||
163027113|NCT02662764|588801395|FG000|Overall Study|Protocol Violation|1|||
163027114|NCT02662764|588801395|FG000|Overall Study|Withdrawal by Subject|5|||
163027115|NCT02662764|588801395|FG000|Overall Study|Device failure|4|||
163027116|NCT02662764|588801395|FG000|Overall Study|Patient changed treatment|1|||
163027117|NCT02662764|588801395|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
163027118|NCT00177307|588801397|FG000|Overall Study|Withdrawal by Subject|1|||
163027119|NCT01282164|588801400|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
163027120|NCT01282164|588801401|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
163027121|NCT04521621|588801402|FG000|Overall Study|Death|17|||
163027122|NCT04521621|588801403|FG001|Overall Study|Death|8|||
163027123|NCT04521621|588801404|FG002|Overall Study|Death|8|||
163027124|NCT04521621|588801405|FG003|Overall Study|Death|5|||
163027125|NCT04521621|588801406|FG004|Overall Study|Death|2|||
163027126|NCT04521621|588801407|FG005|Overall Study|Death|7|||
163027127|NCT04521621|588801408|FG006|Overall Study|Death|0|||
163027128|NCT04521621|588801409|FG007|Overall Study|Death|0|||
163071171|NCT04621760|588966048|FG001|Overall Study|Lost to Follow-up|4|||
163071172|NCT04621760|588966047|FG000|Overall Study|Withdrawal by Subject|1|||
163071173|NCT04621760|588966048|FG001|Overall Study|Withdrawal by Subject|0|||
163071174|NCT05141357|588966049|FG000|Overall Study|Adverse Event|3|||
163071175|NCT05141357|588966049|FG000|Overall Study|Lack of Efficacy|2|||
163071176|NCT01028560|588966050|FG000|Overall Study|Lack of Efficacy|3|||
163071177|NCT01028560|588966051|FG001|Overall Study|Lack of Efficacy|6|||
163071178|NCT01028560|588966050|FG000|Overall Study|Withdrawal by Subject|7|||
163071179|NCT01028560|588966051|FG001|Overall Study|Withdrawal by Subject|12|||
163071180|NCT01960842|588966054|FG000|Overall Study|Adverse Event|1|||
163071181|NCT01960842|588966054|FG000|Overall Study|Withdrawal by Subject|2|||
163071182|NCT02029443|588966056|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
163071183|NCT02029443|588966057|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
163071184|NCT02029443|588966058|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
163071185|NCT02029443|588966059|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
163071186|NCT02029443|588966060|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
163071187|NCT02029443|588966056|FG000|Overall Study|Death|13|||
163027129|NCT04521621|588801402|FG000|Overall Study|Study Terminated by Sponsor|4|||
163027130|NCT04521621|588801403|FG001|Overall Study|Study Terminated by Sponsor|6|||
163027131|NCT04521621|588801404|FG002|Overall Study|Study Terminated by Sponsor|8|||
163027132|NCT04521621|588801405|FG003|Overall Study|Study Terminated by Sponsor|0|||
163071188|NCT02029443|588966057|FG001|Overall Study|Death|2|||
163071189|NCT02029443|588966058|FG002|Overall Study|Death|2|||
163071190|NCT02029443|588966059|FG003|Overall Study|Death|11|||
163071191|NCT02029443|588966060|FG004|Overall Study|Death|2|||
163071192|NCT02029443|588966056|FG000|Overall Study|Lost to Follow-up|1|||
163071193|NCT02029443|588966057|FG001|Overall Study|Lost to Follow-up|0|||
163071194|NCT02029443|588966058|FG002|Overall Study|Lost to Follow-up|1|||
163071195|NCT02029443|588966059|FG003|Overall Study|Lost to Follow-up|1|||
163071196|NCT02029443|588966060|FG004|Overall Study|Lost to Follow-up|0|||
163071197|NCT02029443|588966056|FG000|Overall Study|Started other anti-cancer therapy|17|||
163071198|NCT02029443|588966057|FG001|Overall Study|Started other anti-cancer therapy|4|||
163071199|NCT02029443|588966058|FG002|Overall Study|Started other anti-cancer therapy|7|||
163071200|NCT02029443|588966059|FG003|Overall Study|Started other anti-cancer therapy|9|||
163071201|NCT02029443|588966060|FG004|Overall Study|Started other anti-cancer therapy|3|||
163071202|NCT02029443|588966056|FG000|Overall Study|Withdrawal by Subject|3|||
163071203|NCT02029443|588966057|FG001|Overall Study|Withdrawal by Subject|1|||
163071204|NCT02029443|588966058|FG002|Overall Study|Withdrawal by Subject|1|||
163071205|NCT02029443|588966059|FG003|Overall Study|Withdrawal by Subject|1|||
163071206|NCT02029443|588966060|FG004|Overall Study|Withdrawal by Subject|0|||
163071207|NCT02029443|588966056|FG000|Overall Study|Other|6|||
163071208|NCT02029443|588966057|FG001|Overall Study|Other|6|||
163071209|NCT02029443|588966058|FG002|Overall Study|Other|4|||
163071210|NCT02029443|588966059|FG003|Overall Study|Other|2|||
163071211|NCT02029443|588966060|FG004|Overall Study|Other|0|||
163071212|NCT03123588|588966061|FG000|Overall Study|Study Terminated by Sponsor|2|||
163071213|NCT03123588|588966062|FG001|Overall Study|Study Terminated by Sponsor|5|||
163071214|NCT03123588|588966061|FG000|Overall Study|Withdrawal by Subject|1|||
163071215|NCT03123588|588966062|FG001|Overall Study|Withdrawal by Subject|0|||
163071216|NCT03123588|588966061|FG000|Overall Study|Adverse Event|1|||
163071217|NCT03123588|588966062|FG001|Overall Study|Adverse Event|0|||
163071218|NCT03123588|588966061|FG000|Overall Study|Physician Decision|2|||
163071219|NCT03123588|588966062|FG001|Overall Study|Physician Decision|1|||
163071220|NCT04740567|588966063|FG000|Overall Study|Death|31|||
163071221|NCT04740567|588966064|FG001|Overall Study|Death|43|||
163071222|NCT04740567|588966063|FG000|Overall Study|Lost to Follow-up|2|||
163071223|NCT04740567|588966064|FG001|Overall Study|Lost to Follow-up|11|||
163071224|NCT04740567|588966063|FG000|Overall Study|Patient declined to participate|13|||
163071225|NCT04740567|588966064|FG001|Overall Study|Patient declined to participate|26|||
163071226|NCT04740567|588966063|FG000|Overall Study|Patient was physically incapable|1|||
163071227|NCT04740567|588966064|FG001|Overall Study|Patient was physically incapable|3|||
163071228|NCT04740567|588966063|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
163071229|NCT04740567|588966064|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
163071230|NCT02063724|588966065|FG000|Overall Study|Disease progression|1|||
163071231|NCT00896233|588966066|FG000|Overall Study|Claustrophobia during MRI|1|||
163071232|NCT02697422|588966067|FG000|Overall Study|Declined exit survey|9|||
163071233|NCT02697422|588966068|FG001|Overall Study|Declined exit survey|2|||
163071234|NCT02697422|588966067|FG000|Overall Study|Lost to Follow-up|13|||
163071235|NCT02697422|588966068|FG001|Overall Study|Lost to Follow-up|8|||
163071236|NCT02697422|588966067|FG000|Overall Study|Death|2|||
163071237|NCT02697422|588966068|FG001|Overall Study|Death|1|||
163071238|NCT02697422|588966067|FG000|Overall Study|Withdrawal by Subject|0|||
163071239|NCT02697422|588966068|FG001|Overall Study|Withdrawal by Subject|1|||
163071240|NCT02697422|588966067|FG000|Overall Study|Physician Decision|1|||
163071241|NCT02697422|588966068|FG001|Overall Study|Physician Decision|1|||
163071242|NCT02697422|588966067|FG000|Overall Study|Exit survey data lost|1|||
163071243|NCT02697422|588966068|FG001|Overall Study|Exit survey data lost|0|||
163071244|NCT02068599|588966070|FG000|Overall Study|Adverse Event|4|||
163071245|NCT02068599|588966071|FG001|Overall Study|Adverse Event|1|||
163071246|NCT02068599|588966072|FG002|Overall Study|Adverse Event|1|||
163071247|NCT02068599|588966070|FG000|Overall Study|Withdrawal by Subject|2|||
163071248|NCT02068599|588966071|FG001|Overall Study|Withdrawal by Subject|7|||
163071249|NCT02068599|588966072|FG002|Overall Study|Withdrawal by Subject|5|||
163071250|NCT02068599|588966070|FG000|Overall Study|Protocol Violation|4|||
163071251|NCT02068599|588966071|FG001|Overall Study|Protocol Violation|2|||
163071252|NCT02068599|588966072|FG002|Overall Study|Protocol Violation|3|||
163071253|NCT02068599|588966070|FG000|Overall Study|Lost to Follow-up|1|||
163071254|NCT02068599|588966071|FG001|Overall Study|Lost to Follow-up|0|||
163071255|NCT02068599|588966072|FG002|Overall Study|Lost to Follow-up|0|||
163071256|NCT02068599|588966070|FG000|Overall Study|Lack of Efficacy|0|||
163071257|NCT02068599|588966071|FG001|Overall Study|Lack of Efficacy|0|||
163071258|NCT02068599|588966072|FG002|Overall Study|Lack of Efficacy|3|||
163071259|NCT02068599|588966070|FG000|Overall Study|Noncompliance|0|||
163071260|NCT02068599|588966071|FG001|Overall Study|Noncompliance|0|||
163071261|NCT02068599|588966072|FG002|Overall Study|Noncompliance|1|||
163071262|NCT01263028|588966073|FG000|Overall Study|Withdrawal by Subject|1|||
163071263|NCT01263028|588966073|FG000|Overall Study|Adverse Event|1|||
163071264|NCT01263028|588966073|FG000|Overall Study|Study terminated due to low enrollment.|4|||
163071265|NCT03019588|588966074|FG000|Overall Study|Death|44|||
163071266|NCT03019588|588966075|FG001|Overall Study|Death|46|||
163071267|NCT03019588|588966074|FG000|Overall Study|Study terminated by Sponsor|3|||
163071268|NCT03019588|588966075|FG001|Overall Study|Study terminated by Sponsor|1|||
163071269|NCT00366535|588966076|FG000|First Phase: 12 Weeks|Adverse Event|1|||
163071270|NCT00366535|588966077|FG001|First Phase: 12 Weeks|Adverse Event|3|||
163071271|NCT00366535|588966076|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
163071272|NCT00366535|588966077|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
163071273|NCT00366535|588966076|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
163071274|NCT00366535|588966077|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
163071275|NCT00366535|588966076|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
163071276|NCT00366535|588966077|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
163071277|NCT02958527|588966082|FG000|Overall Study|Not collected CRFs|12|||
163071278|NCT06042855|588966085|FG000|Overall Study|No Receipt of Study Drug|48|||
163071279|NCT06042855|588966086|FG001|Overall Study|No Receipt of Study Drug|57|||
163071280|NCT06042855|588966085|FG000|Overall Study|Administratively Withdrawn|59|||
163071281|NCT06042855|588966086|FG001|Overall Study|Administratively Withdrawn|59|||
163071282|NCT02939781|588966092|FG000|Overall Study|Protocol Violation|8|||
163071283|NCT02939781|588966092|FG000|Overall Study|Withdrawal by Subject|1|||
163071284|NCT06100250|588966093|FG000|Overall Study|Lost to Follow-up|5|||
163071285|NCT05259033|588966096|FG000|Overall Study|Withdrawal by Subject|10|||
163071286|NCT05259033|588966097|FG001|Overall Study|Withdrawal by Subject|5|||
163071287|NCT05259033|588966096|FG000|Overall Study|Lost to Follow-up|1|||
163071288|NCT05259033|588966097|FG001|Overall Study|Lost to Follow-up|0|||
163071289|NCT05259033|588966096|FG000|Overall Study|Death|2|||
163071290|NCT05259033|588966097|FG001|Overall Study|Death|0|||
163071291|NCT05537571|588966098|FG000|Overall Study|Withdrawal by Subject|1|||
163071292|NCT05537571|588966099|FG001|Overall Study|Withdrawal by Subject|1|||
163071293|NCT05537571|588966100|FG002|Overall Study|Withdrawal by Subject|0|||
163071294|NCT05537571|588966101|FG003|Overall Study|Withdrawal by Subject|0|||
163071295|NCT05537571|588966102|FG004|Overall Study|Withdrawal by Subject|0|||
163071296|NCT05537571|588966098|FG000|Overall Study|Adverse Event|2|||
163071297|NCT05537571|588966099|FG001|Overall Study|Adverse Event|0|||
163071298|NCT05537571|588966100|FG002|Overall Study|Adverse Event|0|||
163071299|NCT05537571|588966101|FG003|Overall Study|Adverse Event|0|||
163071300|NCT05537571|588966102|FG004|Overall Study|Adverse Event|0|||
163071301|NCT05537571|588966098|FG000|Overall Study|Hepatitis A screening result|2|||
163071302|NCT05537571|588966099|FG001|Overall Study|Hepatitis A screening result|0|||
163071303|NCT05537571|588966100|FG002|Overall Study|Hepatitis A screening result|0|||
163071304|NCT05537571|588966101|FG003|Overall Study|Hepatitis A screening result|0|||
163071305|NCT05537571|588966102|FG004|Overall Study|Hepatitis A screening result|0|||
163071306|NCT05537571|588966098|FG000|Overall Study|Lost to Follow-up|0|||
163071307|NCT05537571|588966099|FG001|Overall Study|Lost to Follow-up|0|||
163071308|NCT05537571|588966100|FG002|Overall Study|Lost to Follow-up|1|||
163071309|NCT05537571|588966101|FG003|Overall Study|Lost to Follow-up|0|||
163071310|NCT05537571|588966102|FG004|Overall Study|Lost to Follow-up|1|||
163071311|NCT00424008|588966103|FG000|Overall Study|Adverse Event|8|||
163071312|NCT00424008|588966104|FG001|Overall Study|Adverse Event|6|||
163071313|NCT00424008|588966103|FG000|Overall Study|Lack of Efficacy|40|||
163071314|NCT00424008|588966104|FG001|Overall Study|Lack of Efficacy|34|||
163071315|NCT00424008|588966103|FG000|Overall Study|Lost to Follow-up|1|||
163071316|NCT00424008|588966104|FG001|Overall Study|Lost to Follow-up|2|||
163071317|NCT00424008|588966103|FG000|Overall Study|Withdrawal by Subject|5|||
163071318|NCT00424008|588966104|FG001|Overall Study|Withdrawal by Subject|8|||
163071319|NCT00424008|588966103|FG000|Overall Study|Noncompliance with protocol|13|||
163071320|NCT00424008|588966104|FG001|Overall Study|Noncompliance with protocol|7|||
163071321|NCT00424008|588966103|FG000|Overall Study|Did not meet protocol eligibility|16|||
163071322|NCT00424008|588966104|FG001|Overall Study|Did not meet protocol eligibility|21|||
163071323|NCT00424008|588966103|FG000|Overall Study|Administrative|266|||
163071324|NCT00424008|588966104|FG001|Overall Study|Administrative|257|||
163071325|NCT02530242|588966108|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
163071326|NCT02530242|588966109|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
163071327|NCT00283959|588966110|FG000|Extension Period|Low Compliance|1|||
163071328|NCT02665455|588966113|FG000|Overall Study|Withdrawal by Subject|6|||
163071329|NCT02665455|588966113|FG000|Overall Study|Lost to Follow-up|1|||
163071330|NCT02665455|588966113|FG000|Overall Study|Adverse Event|1|||
163071331|NCT02665455|588966113|FG000|Overall Study|Protocol Violation|1|||
163071332|NCT05865886|588966114|FG000|Overall Study|Serious adverse event|0|||
163071333|NCT05865886|588966115|FG001|Overall Study|Serious adverse event|1|||
163071334|NCT06394323|588966116|FG000|Overall Study|Death|0|||
163071335|NCT06394323|588966117|FG001|Overall Study|Death|1|||
163071336|NCT06394323|588966118|FG002|Overall Study|Death|0|||
163071337|NCT06394323|588966119|FG003|Overall Study|Death|0|||
163071338|NCT06394323|588966116|FG000|Overall Study|Physician Decision|0|||
163071339|NCT06394323|588966117|FG001|Overall Study|Physician Decision|2|||
163071340|NCT06394323|588966118|FG002|Overall Study|Physician Decision|0|||
163071341|NCT06394323|588966119|FG003|Overall Study|Physician Decision|0|||
163071342|NCT06394323|588966116|FG000|Overall Study|Withdrawal by Subject|4|||
163071343|NCT06394323|588966117|FG001|Overall Study|Withdrawal by Subject|4|||
163071344|NCT06394323|588966118|FG002|Overall Study|Withdrawal by Subject|0|||
163071345|NCT06394323|588966119|FG003|Overall Study|Withdrawal by Subject|0|||
163071346|NCT03787212|588967110|FG000|Period 1|Study Termination|2|||
163071347|NCT03787212|588967111|FG001|Period 1|Study Termination|2|||
163071348|NCT01778985|588967116|FG000|Overall Study|Lost to Follow-up|1|||
163071349|NCT01778985|588967117|FG001|Overall Study|Lost to Follow-up|0|||
163071350|NCT01778985|588967116|FG000|Overall Study|Physician Decision|2|||
163071351|NCT01778985|588967117|FG001|Overall Study|Physician Decision|2|||
163071352|NCT01778985|588967116|FG000|Overall Study|Protocol Violation|4|||
163071353|NCT01778985|588967117|FG001|Overall Study|Protocol Violation|1|||
163071354|NCT05788328|588967119|FG000|Treatment Period 4 (5 Days)|Other|1|||
163071355|NCT05788328|588967119|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
163071356|NCT00145327|588967120|FG000|Overall Study|Withdrawal by Subject|77|||
163071357|NCT00145327|588967121|FG001|Overall Study|Withdrawal by Subject|72|||
163071358|NCT00145327|588967122|FG002|Overall Study|Withdrawal by Subject|164|||
163071359|NCT00145327|588967120|FG000|Overall Study|Death|26|||
163071360|NCT00145327|588967121|FG001|Overall Study|Death|18|||
163071361|NCT00145327|588967122|FG002|Overall Study|Death|30|||
163071362|NCT00145327|588967120|FG000|Overall Study|Adverse Event|14|||
163071363|NCT00145327|588967121|FG001|Overall Study|Adverse Event|11|||
163071364|NCT00145327|588967122|FG002|Overall Study|Adverse Event|22|||
163071365|NCT00145327|588967120|FG000|Overall Study|Lost to Follow-up|9|||
163071366|NCT00145327|588967121|FG001|Overall Study|Lost to Follow-up|14|||
163071367|NCT00145327|588967122|FG002|Overall Study|Lost to Follow-up|14|||
163071368|NCT00145327|588967120|FG000|Overall Study|Administrative problems|12|||
163071369|NCT00145327|588967121|FG001|Overall Study|Administrative problems|9|||
163071370|NCT00145327|588967122|FG002|Overall Study|Administrative problems|13|||
163071371|NCT00145327|588967120|FG000|Overall Study|Protocol Violation|2|||
163071372|NCT00145327|588967121|FG001|Overall Study|Protocol Violation|0|||
163071373|NCT00145327|588967122|FG002|Overall Study|Protocol Violation|2|||
163071374|NCT00145327|588967120|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163071375|NCT00145327|588967121|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163071376|NCT00145327|588967122|FG002|Overall Study|Abnormal laboratory value(s)|2|||
163071377|NCT00145327|588967120|FG000|Overall Study|Missing - not stated|1|||
163071378|NCT00145327|588967121|FG001|Overall Study|Missing - not stated|0|||
163071379|NCT00145327|588967122|FG002|Overall Study|Missing - not stated|1|||
163071380|NCT01875237|588967127|FG000|Overall Study|GVDH before DLI|1|||
163071381|NCT01875237|588967128|FG001|Overall Study|GVDH before DLI|0|||
163071382|NCT01875237|588967127|FG000|Overall Study|DLI cells could not be produced|1|||
163071383|NCT01875237|588967128|FG001|Overall Study|DLI cells could not be produced|0|||
163071384|NCT02441114|588967129|FG000|Washout2|Withdrawal by Subject|4|||
163071385|NCT05278065|588967130|FG000|Overall Study|Withdrawal by Subject|1|||
163071386|NCT05278065|588967131|FG001|Overall Study|Withdrawal by Subject|0|||
163071387|NCT02070991|588967137|FG000|Overall Study|Death|2|||
163071388|NCT02070991|588967138|FG001|Overall Study|Death|0|||
163071389|NCT02070991|588967137|FG000|Overall Study|Withdrawal by Subject|1|||
162644390|NCT00887354|587415755|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
162644391|NCT00887354|587415754|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
163027133|NCT04521621|588801406|FG004|Overall Study|Study Terminated by Sponsor|1|||
163027134|NCT04521621|588801407|FG005|Overall Study|Study Terminated by Sponsor|7|||
163027135|NCT04521621|588801408|FG006|Overall Study|Study Terminated by Sponsor|0|||
163027136|NCT04521621|588801409|FG007|Overall Study|Study Terminated by Sponsor|0|||
163027137|NCT04521621|588801402|FG000|Overall Study|Withdrawal by Subject|0|||
163027138|NCT04521621|588801403|FG001|Overall Study|Withdrawal by Subject|0|||
163027139|NCT04521621|588801404|FG002|Overall Study|Withdrawal by Subject|1|||
163027140|NCT04521621|588801405|FG003|Overall Study|Withdrawal by Subject|1|||
163027141|NCT04521621|588801406|FG004|Overall Study|Withdrawal by Subject|0|||
163027142|NCT04521621|588801407|FG005|Overall Study|Withdrawal by Subject|0|||
163071390|NCT02070991|588967138|FG001|Overall Study|Withdrawal by Subject|0|||
163071391|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
163071392|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
163071393|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
163071394|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
163027143|NCT04521621|588801408|FG006|Overall Study|Withdrawal by Subject|0|||
163027144|NCT04521621|588801409|FG007|Overall Study|Withdrawal by Subject|0|||
163071395|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
163071396|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
163071397|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
163071398|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
163071399|NCT04999020|588967139|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
163154796|NCT03041181|589281437|FG001|Overall Study|Disease Progression|2|||
163154797|NCT02667119|589281438|FG000|Overall Study|Lost to Follow-up|3|||
162644392|NCT00887354|587415755|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
162644393|NCT00192504|587415758|FG000|Overall Study|Lost to Follow-up|1|||
162644394|NCT00192504|587415759|FG001|Overall Study|Lost to Follow-up|0|||
162644395|NCT00192504|587415760|FG002|Overall Study|Lost to Follow-up|0|||
162644396|NCT00192504|587415761|FG003|Overall Study|Lost to Follow-up|0|||
162644397|NCT00192504|587415758|FG000|Overall Study|Dosing window missed|0|||
162644398|NCT00192504|587415759|FG001|Overall Study|Dosing window missed|0|||
162644399|NCT00192504|587415760|FG002|Overall Study|Dosing window missed|1|||
162644400|NCT00192504|587415761|FG003|Overall Study|Dosing window missed|0|||
162644401|NCT00542919|587415764|FG000|Overall Study|Adverse Event|1|||
162644402|NCT00542919|587415765|FG001|Overall Study|Adverse Event|5|||
162644403|NCT00542919|587415766|FG002|Overall Study|Adverse Event|1|||
162644404|NCT00542919|587415764|FG000|Overall Study|Withdrawal by Subject|1|||
162644405|NCT00542919|587415765|FG001|Overall Study|Withdrawal by Subject|0|||
162644406|NCT00542919|587415766|FG002|Overall Study|Withdrawal by Subject|3|||
162644407|NCT00542919|587415764|FG000|Overall Study|Physician Decision|2|||
163071400|NCT04999020|588967140|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071401|NCT04999020|588967141|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071402|NCT04999020|588967142|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
163071403|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163071404|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163071405|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163071406|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163071407|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163071408|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163071409|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
163071410|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
163071411|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071412|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071413|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
163071414|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
163071415|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071416|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071417|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163071418|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163071419|NCT04999020|588967139|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071420|NCT04999020|588967140|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071421|NCT04999020|588967141|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
163071422|NCT04999020|588967142|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
163071423|NCT00866320|588967148|FG000|Overall Study|Withdrawal by Subject|4|||
163071424|NCT00866320|588967148|FG000|Overall Study|Death|2|||
163071425|NCT06038643|588967156|FG000|Overall Study|Withdrawal by Subject|9|||
163071426|NCT06038643|588967157|FG001|Overall Study|Withdrawal by Subject|4|||
163071427|NCT06038643|588967156|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
163071428|NCT06038643|588967157|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
163071429|NCT03573882|588967158|FG000|Overall Study|Study Terminated by Sponsor|22|||
163071430|NCT03573882|588967159|FG001|Overall Study|Study Terminated by Sponsor|17|||
163071431|NCT03573882|588967160|FG002|Overall Study|Study Terminated by Sponsor|18|||
163071432|NCT03573882|588967158|FG000|Overall Study|Withdrawal by Subject|6|||
163071433|NCT03573882|588967159|FG001|Overall Study|Withdrawal by Subject|11|||
163071434|NCT03573882|588967160|FG002|Overall Study|Withdrawal by Subject|7|||
163071435|NCT03573882|588967158|FG000|Overall Study|Adverse Event|7|||
163071436|NCT03573882|588967159|FG001|Overall Study|Adverse Event|5|||
163071437|NCT03573882|588967160|FG002|Overall Study|Adverse Event|6|||
163071438|NCT03573882|588967158|FG000|Overall Study|Lost to Follow-up|2|||
163071439|NCT03573882|588967159|FG001|Overall Study|Lost to Follow-up|5|||
163071440|NCT03573882|588967160|FG002|Overall Study|Lost to Follow-up|3|||
163071441|NCT03573882|588967158|FG000|Overall Study|Physician Decision|4|||
163071442|NCT03573882|588967159|FG001|Overall Study|Physician Decision|3|||
163071443|NCT03573882|588967160|FG002|Overall Study|Physician Decision|2|||
162644408|NCT00542919|587415765|FG001|Overall Study|Physician Decision|2|||
162644409|NCT00542919|587415766|FG002|Overall Study|Physician Decision|1|||
162644410|NCT00542919|587415764|FG000|Overall Study|Sponsor Decision|1|||
162644411|NCT00542919|587415765|FG001|Overall Study|Sponsor Decision|0|||
162644412|NCT00542919|587415766|FG002|Overall Study|Sponsor Decision|0|||
162644413|NCT00542919|587415764|FG000|Overall Study|Lost to Follow-up|2|||
163071444|NCT03573882|588967158|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
163071445|NCT03573882|588967159|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
163071446|NCT03573882|588967160|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
163071447|NCT03573882|588967158|FG000|Overall Study|Pregnancy|1|||
163071448|NCT03573882|588967159|FG001|Overall Study|Pregnancy|2|||
163071449|NCT03573882|588967160|FG002|Overall Study|Pregnancy|0|||
162644414|NCT00542919|587415765|FG001|Overall Study|Lost to Follow-up|0|||
163071450|NCT03573882|588967158|FG000|Overall Study|Other|4|||
163071451|NCT03573882|588967159|FG001|Overall Study|Other|2|||
163071452|NCT03573882|588967160|FG002|Overall Study|Other|2|||
163071453|NCT02691572|588967161|FG000|Overall Study|Withdrawal by Subject|1|||
163071454|NCT02691572|588967162|FG001|Overall Study|Withdrawal by Subject|0|||
163071455|NCT02691572|588967161|FG000|Overall Study|Protocol Violation|0|||
163071456|NCT02691572|588967162|FG001|Overall Study|Protocol Violation|1|||
163071457|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
163071458|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
163071459|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Death|28|||
163071460|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Death|29|||
163071461|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
163071462|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
163071463|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Other|30|||
163071464|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Other|20|||
163071465|NCT00699751|588967163|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
163071466|NCT00699751|588967164|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
163071467|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
163071468|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
163071469|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
163071470|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
163071471|NCT00699751|588967163|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
163071472|NCT00699751|588967164|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
163071473|NCT01947933|588967165|FG000|Overall Study|Withdrawal by Subject|0|||
163071474|NCT01947933|588967166|FG001|Overall Study|Withdrawal by Subject|0|||
163071475|NCT01947933|588967167|FG002|Overall Study|Withdrawal by Subject|1|||
163071476|NCT01947933|588967168|FG003|Overall Study|Withdrawal by Subject|0|||
163071477|NCT01947933|588967169|FG004|Overall Study|Withdrawal by Subject|0|||
163071478|NCT01947933|588967170|FG005|Overall Study|Withdrawal by Subject|0|||
163071479|NCT01947933|588967171|FG006|Overall Study|Withdrawal by Subject|0|||
163071480|NCT01947933|588967172|FG007|Overall Study|Withdrawal by Subject|0|||
163071481|NCT01947933|588967173|FG008|Overall Study|Withdrawal by Subject|0|||
163071482|NCT01947933|588967165|FG000|Overall Study|Lost to Follow-up|0|||
163071483|NCT01947933|588967166|FG001|Overall Study|Lost to Follow-up|0|||
163071484|NCT01947933|588967167|FG002|Overall Study|Lost to Follow-up|0|||
163071485|NCT01947933|588967168|FG003|Overall Study|Lost to Follow-up|0|||
163071486|NCT01947933|588967169|FG004|Overall Study|Lost to Follow-up|0|||
163071487|NCT01947933|588967170|FG005|Overall Study|Lost to Follow-up|0|||
163071488|NCT01947933|588967171|FG006|Overall Study|Lost to Follow-up|0|||
163071489|NCT01947933|588967172|FG007|Overall Study|Lost to Follow-up|0|||
163071490|NCT01947933|588967173|FG008|Overall Study|Lost to Follow-up|1|||
163071491|NCT00294398|588967174|FG000|Overall Study|Lost to Follow-up|21|||
163071492|NCT00294398|588967175|FG001|Overall Study|Lost to Follow-up|26|||
163071493|NCT00250718|588967178|FG000|Overall Study|Death|1|||
163071494|NCT00250718|588967178|FG000|Overall Study|Adverse Event|1|||
163071495|NCT00250718|588967178|FG000|Overall Study|Withdrawal by Subject|1|||
163071496|NCT04439123|588967181|FG000|Overall Study|Adverse Event|11|||
163071497|NCT04439123|588967181|FG000|Overall Study|Death|1|||
163071498|NCT04439123|588967181|FG000|Overall Study|Disease progression|19|||
163071499|NCT04439123|588967181|FG000|Overall Study|Withdrawal by Subject|2|||
163071500|NCT04439123|588967181|FG000|Overall Study|Still on treatment|2|||
163071501|NCT02593864|588967183|FG000|Overall Study|Withdrawal by Subject|3|||
163071502|NCT02593864|588967183|FG000|Overall Study|Lost to Follow-up|3|||
163071503|NCT02114684|588967189|FG000|Overall Study|Death|6|||
163071504|NCT02114684|588967190|FG001|Overall Study|Death|4|||
163071505|NCT02114684|588967189|FG000|Overall Study|Lost to Follow-up|1|||
163071506|NCT02114684|588967190|FG001|Overall Study|Lost to Follow-up|2|||
163071507|NCT02114684|588967189|FG000|Overall Study|Withdrawal by Subject|1|||
163071508|NCT02114684|588967190|FG001|Overall Study|Withdrawal by Subject|2|||
163071509|NCT02114684|588967189|FG000|Overall Study|Relocation|3|||
163071510|NCT02114684|588967190|FG001|Overall Study|Relocation|1|||
163071511|NCT02114684|588967189|FG000|Overall Study|Rifampicin resistant on culture|0|||
163071512|NCT02114684|588967190|FG001|Overall Study|Rifampicin resistant on culture|1|||
163071513|NCT02114684|588967189|FG000|Overall Study|Patient Incarcerated|1|||
163071514|NCT02114684|588967190|FG001|Overall Study|Patient Incarcerated|0|||
163071515|NCT03828383|588967193|FG000|Overall Study|Lost to Follow-up|3|||
163071516|NCT03828383|588967194|FG001|Overall Study|Lost to Follow-up|2|||
163071517|NCT03828383|588967193|FG000|Overall Study|Withdrawal by Subject|4|||
163071518|NCT03828383|588967194|FG001|Overall Study|Withdrawal by Subject|5|||
163071519|NCT03345095|588967195|FG000|Overall Study|Lack of Efficacy|184|||
163071520|NCT03345095|588967196|FG001|Overall Study|Lack of Efficacy|156|||
163071521|NCT03345095|588967195|FG000|Overall Study|Adverse Event|36|||
163071522|NCT03345095|588967196|FG001|Overall Study|Adverse Event|118|||
163071523|NCT03345095|588967195|FG000|Overall Study|Withdrawal by Subject|22|||
162644415|NCT00542919|587415766|FG002|Overall Study|Lost to Follow-up|1|||
163071524|NCT03345095|588967196|FG001|Overall Study|Withdrawal by Subject|59|||
163071525|NCT03345095|588967195|FG000|Overall Study|Physician Decision|3|||
163071526|NCT03345095|588967196|FG001|Overall Study|Physician Decision|18|||
163071527|NCT03345095|588967195|FG000|Overall Study|Death|2|||
163071528|NCT03345095|588967196|FG001|Overall Study|Death|4|||
163071529|NCT03345095|588967195|FG000|Overall Study|Other reasons|2|||
163071530|NCT03345095|588967196|FG001|Overall Study|Other reasons|11|||
163071531|NCT03345095|588967195|FG000|Overall Study|Protocol Violation|0|||
163071532|NCT03345095|588967196|FG001|Overall Study|Protocol Violation|1|||
163071533|NCT06991803|588967199|FG000|Overall Study|Lost to Follow-up|0|||
163071534|NCT06991803|588967200|FG001|Overall Study|Lost to Follow-up|4|||
163071535|NCT06991803|588967201|FG002|Overall Study|Lost to Follow-up|0|||
163071536|NCT06991803|588967202|FG003|Overall Study|Lost to Follow-up|3|||
163071537|NCT06991803|588967203|FG004|Overall Study|Lost to Follow-up|2|||
163071538|NCT06991803|588967204|FG005|Overall Study|Lost to Follow-up|5|||
163071539|NCT01671059|588967205|FG000|Overall Study|Adverse Event|4|||
163071540|NCT01671059|588967205|FG000|Overall Study|Lack of Efficacy|1|||
163071541|NCT02564978|588967211|FG000|Overall Study|Adverse Event|8|||
163071542|NCT02564978|588967211|FG000|Overall Study|Death|1|||
163071543|NCT02564978|588967211|FG000|Overall Study|Lost to Follow-up|1|||
163071544|NCT02564978|588967211|FG000|Overall Study|Withdrawal by Subject|15|||
163071545|NCT02564978|588967211|FG000|Overall Study|Early Study Closure|2|||
163071546|NCT02564978|588967211|FG000|Overall Study|Other Reason|5|||
163071547|NCT03166631|588969579|FG000|Overall Study|Progressive disease|2|||
163071548|NCT03166631|588969580|FG001|Overall Study|Progressive disease|1|||
163071549|NCT03166631|588969581|FG002|Overall Study|Progressive disease|3|||
163071550|NCT03166631|588969582|FG003|Overall Study|Progressive disease|4|||
163071551|NCT03166631|588969583|FG004|Overall Study|Progressive disease|2|||
163071552|NCT03166631|588969584|FG005|Overall Study|Progressive disease|2|||
163071553|NCT03166631|588969585|FG006|Overall Study|Progressive disease|5|||
163071554|NCT03166631|588969586|FG007|Overall Study|Progressive disease|6|||
163071555|NCT03166631|588969587|FG008|Overall Study|Progressive disease|11|||
163071556|NCT03166631|588969588|FG009|Overall Study|Progressive disease|5|||
163071557|NCT03166631|588969589|FG010|Overall Study|Progressive disease|7|||
163071558|NCT03166631|588969579|FG000|Overall Study|Physician Decision|0|||
163071559|NCT03166631|588969580|FG001|Overall Study|Physician Decision|0|||
163071560|NCT03166631|588969581|FG002|Overall Study|Physician Decision|0|||
163071561|NCT03166631|588969582|FG003|Overall Study|Physician Decision|0|||
163071562|NCT03166631|588969583|FG004|Overall Study|Physician Decision|0|||
163071563|NCT03166631|588969584|FG005|Overall Study|Physician Decision|0|||
163071564|NCT03166631|588969585|FG006|Overall Study|Physician Decision|1|||
163071565|NCT03166631|588969586|FG007|Overall Study|Physician Decision|0|||
163071566|NCT03166631|588969587|FG008|Overall Study|Physician Decision|1|||
163071567|NCT03166631|588969588|FG009|Overall Study|Physician Decision|0|||
163071568|NCT03166631|588969589|FG010|Overall Study|Physician Decision|1|||
163071569|NCT03166631|588969579|FG000|Overall Study|Death|0|||
163071570|NCT03166631|588969580|FG001|Overall Study|Death|0|||
163071571|NCT03166631|588969581|FG002|Overall Study|Death|0|||
163071572|NCT03166631|588969582|FG003|Overall Study|Death|0|||
163071573|NCT03166631|588969583|FG004|Overall Study|Death|1|||
163071574|NCT03166631|588969584|FG005|Overall Study|Death|0|||
163071575|NCT03166631|588969585|FG006|Overall Study|Death|1|||
163071576|NCT03166631|588969586|FG007|Overall Study|Death|0|||
163071577|NCT03166631|588969587|FG008|Overall Study|Death|0|||
163071578|NCT03166631|588969588|FG009|Overall Study|Death|0|||
163071579|NCT03166631|588969589|FG010|Overall Study|Death|0|||
163071580|NCT03166631|588969579|FG000|Overall Study|Adverse Event|1|||
163071581|NCT03166631|588969580|FG001|Overall Study|Adverse Event|0|||
163071582|NCT03166631|588969581|FG002|Overall Study|Adverse Event|0|||
163071583|NCT03166631|588969582|FG003|Overall Study|Adverse Event|0|||
163071584|NCT03166631|588969583|FG004|Overall Study|Adverse Event|0|||
163071585|NCT03166631|588969584|FG005|Overall Study|Adverse Event|1|||
163071586|NCT03166631|588969585|FG006|Overall Study|Adverse Event|1|||
163071587|NCT03166631|588969586|FG007|Overall Study|Adverse Event|0|||
163071588|NCT03166631|588969587|FG008|Overall Study|Adverse Event|1|||
163071589|NCT03166631|588969588|FG009|Overall Study|Adverse Event|2|||
163071590|NCT03166631|588969589|FG010|Overall Study|Adverse Event|1|||
163071591|NCT03166631|588969579|FG000|Overall Study|Withdrawal by Subject|0|||
163071592|NCT03166631|588969580|FG001|Overall Study|Withdrawal by Subject|0|||
163071593|NCT03166631|588969581|FG002|Overall Study|Withdrawal by Subject|0|||
163071594|NCT03166631|588969582|FG003|Overall Study|Withdrawal by Subject|0|||
163071595|NCT03166631|588969583|FG004|Overall Study|Withdrawal by Subject|0|||
163071596|NCT03166631|588969584|FG005|Overall Study|Withdrawal by Subject|0|||
163071597|NCT03166631|588969585|FG006|Overall Study|Withdrawal by Subject|0|||
163071598|NCT03166631|588969586|FG007|Overall Study|Withdrawal by Subject|0|||
163071599|NCT03166631|588969587|FG008|Overall Study|Withdrawal by Subject|1|||
162644416|NCT05123222|587415773|FG000|Overall Study|Lost to Follow-up|2|||
163071600|NCT03166631|588969588|FG009|Overall Study|Withdrawal by Subject|1|||
163071601|NCT03166631|588969589|FG010|Overall Study|Withdrawal by Subject|0|||
163071602|NCT03022630|588969590|FG000|Overall Study|Death|9|||
163071603|NCT03022630|588969591|FG001|Overall Study|Death|7|||
163071604|NCT03022630|588969590|FG000|Overall Study|Withdrawal by Subject|0|||
163071605|NCT03022630|588969591|FG001|Overall Study|Withdrawal by Subject|5|||
163071606|NCT00382070|588969592|FG000|Overall Study|No follow up data mapped to Other|17|||
163071607|NCT00382070|588969593|FG001|Overall Study|No follow up data mapped to Other|19|||
163071608|NCT00382070|588969592|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
163071609|NCT00382070|588969593|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
163071610|NCT00382070|588969592|FG000|Overall Study|No clinical assessment|9|||
163071611|NCT00382070|588969593|FG001|Overall Study|No clinical assessment|11|||
163071612|NCT00504231|588969594|FG000|Overall Study|Discrepant chart documentation re route|0|||
163071613|NCT00504231|588969595|FG001|Overall Study|Discrepant chart documentation re route|0|||
163071614|NCT00504231|588969596|FG002|Overall Study|Discrepant chart documentation re route|1|||
163071615|NCT00504231|588969597|FG003|Overall Study|Discrepant chart documentation re route|0|||
163071616|NCT01629563|588969598|FG000|Overall Study|Adverse Event|16|||
163071617|NCT01629563|588969599|FG001|Overall Study|Adverse Event|16|||
163071618|NCT01629563|588969598|FG000|Overall Study|Death|2|||
163071619|NCT01629563|588969599|FG001|Overall Study|Death|0|||
163071620|NCT01629563|588969598|FG000|Overall Study|Lack of Efficacy|2|||
163071621|NCT01629563|588969599|FG001|Overall Study|Lack of Efficacy|3|||
163071622|NCT01629563|588969598|FG000|Overall Study|Lost to Follow-up|1|||
163071623|NCT01629563|588969599|FG001|Overall Study|Lost to Follow-up|0|||
163071624|NCT01629563|588969598|FG000|Overall Study|Pregnancy|1|||
163071625|NCT01629563|588969599|FG001|Overall Study|Pregnancy|2|||
163071626|NCT01629563|588969598|FG000|Overall Study|Protocol Violation|0|||
163071627|NCT01629563|588969599|FG001|Overall Study|Protocol Violation|1|||
163071628|NCT01629563|588969598|FG000|Overall Study|Withdrawal by Subject|27|||
163071629|NCT01629563|588969599|FG001|Overall Study|Withdrawal by Subject|20|||
163071630|NCT01629563|588969598|FG000|Overall Study|surgery|0|||
163071631|NCT01629563|588969599|FG001|Overall Study|surgery|3|||
163071632|NCT01629563|588969598|FG000|Overall Study|Lack of return of menses|12|||
163071633|NCT01629563|588969599|FG001|Overall Study|Lack of return of menses|7|||
163071634|NCT01629563|588969598|FG000|Overall Study|Protocol Violation|0|||
163071635|NCT01629563|588969599|FG001|Overall Study|Protocol Violation|1|||
163071636|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
163071637|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Adverse Event|1|||
163071638|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
163071639|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Physician Decision|1|||
163071640|NCT00088881|588969601|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
163071641|NCT00088881|588969601|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
163071642|NCT00088881|588969601|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
163071643|NCT02370394|588969609|FG000|Overall Study|Lost to Follow-up|2|||
163071644|NCT02370394|588969610|FG001|Overall Study|Lost to Follow-up|1|||
163071645|NCT02370394|588969609|FG000|Overall Study|Withdrawal by Subject|0|||
163071646|NCT02370394|588969610|FG001|Overall Study|Withdrawal by Subject|1|||
163071647|NCT00456612|588969612|FG000|Overall Study|Withdrawal by Subject|3|||
163071648|NCT02316613|588969613|FG000|Overall Study|Death|63|||
163071649|NCT02316613|588969613|FG000|Overall Study|Lost to Follow-up|9|||
163071650|NCT02316613|588969613|FG000|Overall Study|Lymphoma transformation|2|||
163071651|NCT02316613|588969613|FG000|Overall Study|Participant moved/changed medical team|11|||
163071652|NCT02316613|588969613|FG000|Overall Study|No data and duplicate cases|5|||
163071653|NCT02316613|588969613|FG000|Overall Study|Did not met selection criteria|14|||
163071654|NCT02545127|588969620|FG000|Overall Study|Lost to Follow-up|1|||
163071655|NCT02545127|588969621|FG001|Overall Study|Lost to Follow-up|0|||
163071656|NCT03309605|588969626|FG000|Overall Study|Adverse Event|0|||
163071657|NCT03309605|588969627|FG001|Overall Study|Adverse Event|0|||
163071658|NCT03309605|588969628|FG002|Overall Study|Adverse Event|0|||
163071659|NCT03309605|588969629|FG003|Overall Study|Adverse Event|1|||
163071660|NCT03309605|588969630|FG004|Overall Study|Adverse Event|0|||
163071661|NCT03309605|588969631|FG005|Overall Study|Adverse Event|0|||
163071662|NCT03309605|588969632|FG006|Overall Study|Adverse Event|2|||
163071663|NCT03309605|588969633|FG007|Overall Study|Adverse Event|1|||
163071664|NCT03309605|588969626|FG000|Overall Study|Withdrawal by Subject|0|||
162644417|NCT05123222|587415774|FG001|Overall Study|Lost to Follow-up|0|||
163071665|NCT03309605|588969627|FG001|Overall Study|Withdrawal by Subject|0|||
163071666|NCT03309605|588969628|FG002|Overall Study|Withdrawal by Subject|0|||
163071667|NCT03309605|588969629|FG003|Overall Study|Withdrawal by Subject|0|||
163071668|NCT03309605|588969630|FG004|Overall Study|Withdrawal by Subject|1|||
163071669|NCT03309605|588969631|FG005|Overall Study|Withdrawal by Subject|0|||
163071670|NCT03309605|588969632|FG006|Overall Study|Withdrawal by Subject|1|||
163071671|NCT03309605|588969633|FG007|Overall Study|Withdrawal by Subject|1|||
163071672|NCT01129284|588969634|FG000|Overall Study|Adverse Event|2|||
163071673|NCT01129284|588969635|FG001|Overall Study|Adverse Event|0|||
163071674|NCT01129284|588969636|FG002|Overall Study|Adverse Event|1|||
163071675|NCT02082483|588969637|FG000|Overall Study|Lost to Follow-up|1|||
163071676|NCT02082483|588969638|FG001|Overall Study|Lost to Follow-up|1|||
163071677|NCT02082483|588969637|FG000|Overall Study|Withdrawal by Subject|2|||
163071678|NCT02082483|588969638|FG001|Overall Study|Withdrawal by Subject|1|||
163071679|NCT02082483|588969637|FG000|Overall Study|Physician Decision|1|||
163071680|NCT02082483|588969638|FG001|Overall Study|Physician Decision|1|||
163071681|NCT02082483|588969637|FG000|Overall Study|Death|2|||
163071682|NCT02082483|588969638|FG001|Overall Study|Death|3|||
163071683|NCT00422461|588969639|FG000|Overall Study|Adverse Event|1|||
163071684|NCT00422461|588969640|FG001|Overall Study|Adverse Event|2|||
163071685|NCT00422461|588969641|FG002|Overall Study|Adverse Event|1|||
163071686|NCT00422461|588969642|FG003|Overall Study|Adverse Event|1|||
163071687|NCT00422461|588969639|FG000|Overall Study|Other|0|||
163071688|NCT00422461|588969640|FG001|Overall Study|Other|0|||
163071689|NCT00422461|588969641|FG002|Overall Study|Other|0|||
163071690|NCT00422461|588969642|FG003|Overall Study|Other|2|||
163071691|NCT00422461|588969639|FG000|Overall Study|Participants no longer willing to participate in study|1|||
163071692|NCT00422461|588969640|FG001|Overall Study|Participants no longer willing to participate in study|0|||
163071693|NCT00422461|588969641|FG002|Overall Study|Participants no longer willing to participate in study|0|||
163071694|NCT00422461|588969642|FG003|Overall Study|Participants no longer willing to participate in study|0|||
163071695|NCT00422461|588969639|FG000|Overall Study|Randomized but not treated|1|||
163071696|NCT00422461|588969640|FG001|Overall Study|Randomized but not treated|1|||
163071697|NCT00422461|588969641|FG002|Overall Study|Randomized but not treated|0|||
163071698|NCT00422461|588969642|FG003|Overall Study|Randomized but not treated|0|||
163071699|NCT02181621|588969643|FG000|Overall Study|Adverse Event|1|||
163071700|NCT02181621|588969644|FG001|Overall Study|Adverse Event|0|||
163071701|NCT02181621|588969643|FG000|Overall Study|Previously Enrolled|0|||
163071702|NCT02181621|588969644|FG001|Overall Study|Previously Enrolled|1|||
163071703|NCT02181621|588969643|FG000|Overall Study|Enrollment Hold|1|||
163071704|NCT02181621|588969644|FG001|Overall Study|Enrollment Hold|1|||
163071705|NCT00960856|588969645|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071706|NCT00960856|588969646|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
163071707|NCT00960856|588969647|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071708|NCT00960856|588969648|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
163071709|NCT00960856|588969645|FG000|Washout Period of 7 Days|Adverse Event|0|||
163071710|NCT00960856|588969646|FG001|Washout Period of 7 Days|Adverse Event|0|||
163071711|NCT00960856|588969647|FG002|Washout Period of 7 Days|Adverse Event|1|||
163071712|NCT00960856|588969648|FG003|Washout Period of 7 Days|Adverse Event|0|||
163071713|NCT04027946|588969650|FG000|Overall Study|Screen failures|3|||
163071714|NCT05938010|588969651|FG000|Overall Study|Lost to Follow-up|2|||
163071715|NCT00985192|588969652|FG000|Overall Study|Withdrawal by Subject|1|||
163071716|NCT00985192|588969652|FG000|Overall Study|Disease Progression|1|||
163071717|NCT00985192|588969652|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
163071718|NCT01454063|588969653|FG000|Randomized|Adverse Event|1|||
163071719|NCT01454063|588969654|FG001|Randomized|Adverse Event|1|||
163071720|NCT01454063|588969653|FG000|Randomized|Protocol Violation|0|||
163071721|NCT01454063|588969654|FG001|Randomized|Protocol Violation|1|||
163071722|NCT01562444|588969657|FG000|Overall Study|Did not meet entry criteria|2|||
163071723|NCT01562444|588969658|FG001|Overall Study|Did not meet entry criteria|0|||
163071724|NCT01562444|588969659|FG002|Overall Study|Did not meet entry criteria|3|||
163071725|NCT01562444|588969657|FG000|Overall Study|Did not comply with blood draw schedule|1|||
163071726|NCT01562444|588969658|FG001|Overall Study|Did not comply with blood draw schedule|0|||
163071727|NCT01562444|588969659|FG002|Overall Study|Did not comply with blood draw schedule|1|||
162644418|NCT05123222|587415775|FG002|Overall Study|Lost to Follow-up|0|||
162644419|NCT05123222|587415776|FG003|Overall Study|Lost to Follow-up|0|||
162644420|NCT05123222|587415773|FG000|Overall Study|Protocol Violation|0|||
162644421|NCT05123222|587415774|FG001|Overall Study|Protocol Violation|0|||
162644422|NCT05123222|587415775|FG002|Overall Study|Protocol Violation|1|||
162644423|NCT05123222|587415776|FG003|Overall Study|Protocol Violation|0|||
162644424|NCT02535741|587415777|FG000|Overall Study|Adverse Event|3|||
162644425|NCT02535741|587415777|FG000|Overall Study|Withdrawal by Subject|9|||
163071728|NCT01562444|588969657|FG000|Overall Study|Unavailable serological results|0|||
163071729|NCT01562444|588969658|FG001|Overall Study|Unavailable serological results|2|||
163071730|NCT01562444|588969659|FG002|Overall Study|Unavailable serological results|2|||
163071731|NCT01562444|588969657|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
163071732|NCT01562444|588969658|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
163071733|NCT01562444|588969659|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
163071734|NCT01562444|588969657|FG000|Overall Study|Protocol forbidden medication|1|||
163071735|NCT01562444|588969658|FG001|Overall Study|Protocol forbidden medication|0|||
163071736|NCT01562444|588969659|FG002|Overall Study|Protocol forbidden medication|0|||
163071737|NCT03055195|588969662|FG000|Overall Study|Lack of Efficacy|1|||
162644426|NCT02535741|587415777|FG000|Overall Study|Lost to Follow-up|10|||
163071738|NCT03055195|588969663|FG001|Overall Study|Lack of Efficacy|0|||
163071739|NCT03055195|588969662|FG000|Overall Study|Withdrawal by Subject|6|||
163071740|NCT03055195|588969663|FG001|Overall Study|Withdrawal by Subject|7|||
163071741|NCT03055195|588969662|FG000|Overall Study|Study Terminated by Sponsor|2|||
163071742|NCT03055195|588969663|FG001|Overall Study|Study Terminated by Sponsor|6|||
162644427|NCT02535741|587415777|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
163071743|NCT03055195|588969662|FG000|Overall Study|Protocol Violation|2|||
163071744|NCT03055195|588969663|FG001|Overall Study|Protocol Violation|1|||
163071745|NCT03055195|588969662|FG000|Overall Study|Physician Decision|1|||
163071746|NCT03055195|588969663|FG001|Overall Study|Physician Decision|0|||
163071747|NCT00421733|588969667|FG000|Overall Study|Adverse Event|4|||
163071748|NCT00421733|588969668|FG001|Overall Study|Adverse Event|9|||
163071749|NCT00421733|588969669|FG002|Overall Study|Adverse Event|2|||
163071750|NCT00421733|588969667|FG000|Overall Study|Lost to Follow-up|1|||
163071751|NCT00421733|588969668|FG001|Overall Study|Lost to Follow-up|2|||
163071752|NCT00421733|588969669|FG002|Overall Study|Lost to Follow-up|4|||
163071753|NCT00421733|588969667|FG000|Overall Study|Withdrawal by Subject|1|||
163071754|NCT00421733|588969668|FG001|Overall Study|Withdrawal by Subject|2|||
163071755|NCT00421733|588969669|FG002|Overall Study|Withdrawal by Subject|7|||
163071756|NCT00421733|588969667|FG000|Overall Study|Death|0|||
163071757|NCT00421733|588969668|FG001|Overall Study|Death|3|||
163071758|NCT00421733|588969669|FG002|Overall Study|Death|0|||
163071759|NCT00421733|588969667|FG000|Overall Study|Required dialysis|1|||
163071760|NCT00421733|588969668|FG001|Overall Study|Required dialysis|0|||
163071761|NCT00421733|588969669|FG002|Overall Study|Required dialysis|0|||
163071762|NCT00421733|588969667|FG000|Overall Study|Administrative|2|||
163071763|NCT00421733|588969668|FG001|Overall Study|Administrative|0|||
163071764|NCT00421733|588969669|FG002|Overall Study|Administrative|0|||
163071765|NCT00421733|588969667|FG000|Overall Study|Did not satisfy entry criteria|1|||
163071766|NCT00421733|588969668|FG001|Overall Study|Did not satisfy entry criteria|3|||
163071767|NCT00421733|588969669|FG002|Overall Study|Did not satisfy entry criteria|2|||
163071768|NCT00421733|588969667|FG000|Overall Study|Sponsor request|1|||
163071769|NCT00421733|588969668|FG001|Overall Study|Sponsor request|0|||
163071770|NCT00421733|588969669|FG002|Overall Study|Sponsor request|3|||
163071771|NCT00421733|588969667|FG000|Overall Study|Protocol deviation|4|||
163071772|NCT00421733|588969668|FG001|Overall Study|Protocol deviation|7|||
163071773|NCT00421733|588969669|FG002|Overall Study|Protocol deviation|2|||
163071774|NCT00790933|588969670|FG000|Overall Study|Adverse Event|94|||
163071775|NCT00790933|588969671|FG001|Overall Study|Adverse Event|119|||
163071776|NCT00790933|588969672|FG002|Overall Study|Adverse Event|65|||
163071777|NCT00790933|588969673|FG003|Overall Study|Adverse Event|5|||
163071778|NCT00790933|588969674|FG004|Overall Study|Adverse Event|69|||
163071779|NCT00790933|588969670|FG000|Overall Study|Protocol Violation(s)|8|||
163071780|NCT00790933|588969671|FG001|Overall Study|Protocol Violation(s)|18|||
163071781|NCT00790933|588969672|FG002|Overall Study|Protocol Violation(s)|7|||
163071782|NCT00790933|588969673|FG003|Overall Study|Protocol Violation(s)|0|||
163071783|NCT00790933|588969674|FG004|Overall Study|Protocol Violation(s)|12|||
163071784|NCT00790933|588969670|FG000|Overall Study|Lack of Efficacy|192|||
163071785|NCT00790933|588969671|FG001|Overall Study|Lack of Efficacy|176|||
163071786|NCT00790933|588969672|FG002|Overall Study|Lack of Efficacy|130|||
163071787|NCT00790933|588969673|FG003|Overall Study|Lack of Efficacy|1|||
163071788|NCT00790933|588969674|FG004|Overall Study|Lack of Efficacy|121|||
163071789|NCT00790933|588969670|FG000|Overall Study|Study Terminated by Sponsor|0|||
163071790|NCT00790933|588969671|FG001|Overall Study|Study Terminated by Sponsor|0|||
163071791|NCT00790933|588969672|FG002|Overall Study|Study Terminated by Sponsor|1|||
163071792|NCT00790933|588969673|FG003|Overall Study|Study Terminated by Sponsor|0|||
163071793|NCT00790933|588969674|FG004|Overall Study|Study Terminated by Sponsor|0|||
163071794|NCT00790933|588969670|FG000|Overall Study|Withdrawal by Subject|123|||
162644428|NCT02535741|587415777|FG000|Overall Study|Missing data|6|||
162644429|NCT03020823|587415780|FG000|Overall Study|Physician Decision|4|||
162644430|NCT03020823|587415780|FG000|Overall Study|Lack of Efficacy|4|||
162644431|NCT03020823|587415780|FG000|Overall Study|Adverse Event|2|||
162644432|NCT03739112|587415781|FG000|Overall Study|Adverse Event|2|||
162644433|NCT03739112|587415782|FG001|Overall Study|Adverse Event|2|||
162644434|NCT03739112|587415781|FG000|Overall Study|Withdrawal by Subject|38|||
162644435|NCT03739112|587415782|FG001|Overall Study|Withdrawal by Subject|19|||
162644436|NCT03739112|587415781|FG000|Overall Study|Lost to Follow-up|31|||
162644437|NCT03739112|587415782|FG001|Overall Study|Lost to Follow-up|33|||
162644438|NCT03739112|587415781|FG000|Overall Study|Protocol Deviation|12|||
163071795|NCT00790933|588969671|FG001|Overall Study|Withdrawal by Subject|120|||
162644439|NCT03739112|587415782|FG001|Overall Study|Protocol Deviation|9|||
162644440|NCT03739112|587415781|FG000|Overall Study|Physician Decision|1|||
162644441|NCT03739112|587415782|FG001|Overall Study|Physician Decision|0|||
162644442|NCT03739112|587415781|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
163071796|NCT00790933|588969672|FG002|Overall Study|Withdrawal by Subject|52|||
163071797|NCT00790933|588969673|FG003|Overall Study|Withdrawal by Subject|6|||
163071798|NCT00790933|588969674|FG004|Overall Study|Withdrawal by Subject|50|||
163071799|NCT00790933|588969670|FG000|Overall Study|Lost to Follow-up|13|||
163071800|NCT00790933|588969671|FG001|Overall Study|Lost to Follow-up|31|||
163071801|NCT00790933|588969672|FG002|Overall Study|Lost to Follow-up|10|||
163071802|NCT00790933|588969673|FG003|Overall Study|Lost to Follow-up|1|||
163071803|NCT00790933|588969674|FG004|Overall Study|Lost to Follow-up|15|||
163071804|NCT00790933|588969670|FG000|Overall Study|Reason Not Specified|8|||
163071805|NCT00790933|588969671|FG001|Overall Study|Reason Not Specified|16|||
163071806|NCT00790933|588969672|FG002|Overall Study|Reason Not Specified|4|||
163071807|NCT00790933|588969673|FG003|Overall Study|Reason Not Specified|1|||
163071808|NCT00790933|588969674|FG004|Overall Study|Reason Not Specified|9|||
163071809|NCT00720083|588969677|FG000|Overall Study|Ineligible|1|||
163071810|NCT00720083|588969678|FG001|Overall Study|Ineligible|2|||
163071811|NCT00894647|588969679|FG000|Overall Study|Adverse Event|5|||
163071812|NCT00894647|588969680|FG001|Overall Study|Adverse Event|4|||
163071813|NCT00894647|588969679|FG000|Overall Study|Withdrawal by Subject|4|||
163071814|NCT00894647|588969680|FG001|Overall Study|Withdrawal by Subject|4|||
163071815|NCT00894647|588969679|FG000|Overall Study|Lost to Follow-up|0|||
163071816|NCT00894647|588969680|FG001|Overall Study|Lost to Follow-up|2|||
163071817|NCT00894647|588969679|FG000|Overall Study|Non-compliance with study procedures|0|||
163071818|NCT00894647|588969680|FG001|Overall Study|Non-compliance with study procedures|2|||
163071819|NCT00894647|588969679|FG000|Overall Study|Other, not due to AE|1|||
163071820|NCT00894647|588969680|FG001|Overall Study|Other, not due to AE|2|||
163071821|NCT01913470|588969687|FG000|Overall Study|Lost to Follow-up|0|||
163071822|NCT01913470|588969688|FG001|Overall Study|Lost to Follow-up|1|||
163071823|NCT01913470|588969687|FG000|Overall Study|Physician Decision|0|||
163071824|NCT01913470|588969688|FG001|Overall Study|Physician Decision|1|||
163071825|NCT01913470|588969687|FG000|Overall Study|Withdrawal by Subject|0|||
163071826|NCT01913470|588969688|FG001|Overall Study|Withdrawal by Subject|1|||
163071827|NCT00245570|588969689|FG000|Washout Between Periods III and IV|Adverse Event|0|||
163071828|NCT00245570|588969690|FG001|Washout Between Periods III and IV|Adverse Event|1|||
163071829|NCT00245570|588969691|FG002|Washout Between Periods III and IV|Adverse Event|0|||
163071830|NCT00245570|588969692|FG003|Washout Between Periods III and IV|Adverse Event|0|||
163071831|NCT00245570|588969693|FG004|Washout Between Periods III and IV|Adverse Event|0|||
163071832|NCT00245570|588969694|FG005|Washout Between Periods III and IV|Adverse Event|0|||
163071833|NCT01524705|588969695|FG000|Overall Study|Adverse Event|2|||
163071834|NCT01524705|588969696|FG001|Overall Study|Adverse Event|0|||
163071835|NCT01524705|588969695|FG000|Overall Study|Death|1|||
163071836|NCT01524705|588969696|FG001|Overall Study|Death|0|||
163071837|NCT01524705|588969695|FG000|Overall Study|Lost to Follow-up|0|||
163071838|NCT01524705|588969696|FG001|Overall Study|Lost to Follow-up|1|||
163071839|NCT01524705|588969695|FG000|Overall Study|Withdrawal by Subject|0|||
163071840|NCT01524705|588969696|FG001|Overall Study|Withdrawal by Subject|1|||
163071841|NCT01524705|588969695|FG000|Overall Study|Pancreatic Cancer|0|||
163071842|NCT01524705|588969696|FG001|Overall Study|Pancreatic Cancer|1|||
163071843|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071844|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071845|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
163071846|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
163071847|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
163071848|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
163071849|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
163071850|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
163071851|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
163071852|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
163071853|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
163071854|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
163071855|NCT02573467|588969706|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
163071856|NCT02573467|588969707|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
163071857|NCT02573467|588969708|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
163071858|NCT02573467|588969709|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
163071859|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Death|1|||
163071860|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Death|1|||
163071861|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Death|0|||
163071862|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Death|1|||
163071863|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
163071864|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
163071865|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
163071866|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
163071867|NCT02573467|588969706|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
163071868|NCT02573467|588969707|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
163071869|NCT02573467|588969708|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
163071870|NCT02573467|588969709|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
163071871|NCT01829165|588969710|FG000|Overall Study|Did not complete intervention|2|||
163071872|NCT01829165|588969711|FG001|Overall Study|Did not complete intervention|0|||
163071873|NCT00103506|588969712|FG000|Overall Study|Study closed by sponsor|34|||
163071874|NCT00103506|588969713|FG001|Overall Study|Study closed by sponsor|37|||
163071875|NCT00103506|588969712|FG000|Overall Study|Death|257|||
163071876|NCT00103506|588969713|FG001|Overall Study|Death|253|||
163071877|NCT00103506|588969712|FG000|Overall Study|Lost to Follow-up|13|||
163071878|NCT00103506|588969713|FG001|Overall Study|Lost to Follow-up|13|||
163071879|NCT00103506|588969712|FG000|Overall Study|Withdrawal by Subject|18|||
163071880|NCT00103506|588969713|FG001|Overall Study|Withdrawal by Subject|21|||
163071881|NCT00710970|588969716|FG000|Overall Study|Never took drug|3|||
163071882|NCT02153827|588969717|FG000|Overall Study|Lost to Follow-up|3|||
163071883|NCT02153827|588969718|FG001|Overall Study|Lost to Follow-up|9|||
163071884|NCT00625378|588969725|FG000|Overall Study|Adverse Event|22|||
163071885|NCT00625378|588969726|FG001|Overall Study|Adverse Event|0|||
163071886|NCT00625378|588969725|FG000|Overall Study|Withdrawal by Subject|16|||
163071887|NCT00625378|588969726|FG001|Overall Study|Withdrawal by Subject|0|||
163071888|NCT00625378|588969725|FG000|Overall Study|Death|38|||
163071889|NCT00625378|588969726|FG001|Overall Study|Death|0|||
163071890|NCT00625378|588969725|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
163071891|NCT00625378|588969726|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
163071892|NCT00625378|588969725|FG000|Overall Study|Lost to Follow-up|17|||
163071893|NCT00625378|588969726|FG001|Overall Study|Lost to Follow-up|0|||
163071894|NCT00625378|588969725|FG000|Overall Study|Non-compliant with study medication|3|||
163071895|NCT00625378|588969726|FG001|Overall Study|Non-compliant with study medication|0|||
163071896|NCT00625378|588969725|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
163071897|NCT00625378|588969726|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
163071898|NCT00625378|588969725|FG000|Overall Study|Medical decision|1|||
163071899|NCT00625378|588969726|FG001|Overall Study|Medical decision|0|||
163071900|NCT00625378|588969725|FG000|Overall Study|Multiple toxicities|1|||
163071901|NCT00625378|588969726|FG001|Overall Study|Multiple toxicities|0|||
163071902|NCT00625378|588969725|FG000|Overall Study|New cancer|1|||
163071903|NCT00625378|588969726|FG001|Overall Study|New cancer|0|||
163071904|NCT00625378|588969725|FG000|Overall Study|PTA program|2|||
163071905|NCT00625378|588969726|FG001|Overall Study|PTA program|0|||
163071906|NCT00625378|588969725|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
163071907|NCT00625378|588969726|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
163071908|NCT00625378|588969725|FG000|Overall Study|Sponsor decision|1|||
163071909|NCT00625378|588969726|FG001|Overall Study|Sponsor decision|0|||
163071910|NCT00625378|588969725|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
163071911|NCT00625378|588969726|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
163071912|NCT00625378|588969725|FG000|Overall Study|Switch to commercial drug|6|||
163071913|NCT00625378|588969726|FG001|Overall Study|Switch to commercial drug|1|||
163071914|NCT00625378|588969725|FG000|Overall Study|Missing|2|||
163071915|NCT00625378|588969726|FG001|Overall Study|Missing|0|||
163071916|NCT00625378|588969725|FG000|Overall Study|End of treatment not available|2|||
163071917|NCT00625378|588969726|FG001|Overall Study|End of treatment not available|0|||
163071918|NCT00625378|588969725|FG000|Overall Study|Never treated|2|||
163071919|NCT00625378|588969726|FG001|Overall Study|Never treated|0|||
163071920|NCT02609633|588969729|FG000|Overall Study|Consent Withdrawn|0|||
163071921|NCT02609633|588969730|FG001|Overall Study|Consent Withdrawn|1|||
163071922|NCT02609633|588969729|FG000|Overall Study|Protocol Deviation|1|||
163071923|NCT02609633|588969730|FG001|Overall Study|Protocol Deviation|0|||
163071924|NCT02609633|588969729|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
163071925|NCT02609633|588969730|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
163071926|NCT02609633|588969729|FG000|Overall Study|Reason not Specified|2|||
163071927|NCT02609633|588969730|FG001|Overall Study|Reason not Specified|1|||
163071928|NCT01769443|588969733|FG000|Overall Study|Study closure|1|||
163071929|NCT01769443|588969734|FG001|Overall Study|Study closure|0|||
163071930|NCT02583477|588969735|FG000|Overall Study|Adverse Event|0|||
163071931|NCT02583477|588969736|FG001|Overall Study|Adverse Event|2|||
163071932|NCT02583477|588969735|FG000|Overall Study|Death|1|||
163071933|NCT02583477|588969736|FG001|Overall Study|Death|16|||
163071934|NCT02583477|588969735|FG000|Overall Study|Study terminated|2|||
163071935|NCT02583477|588969736|FG001|Overall Study|Study terminated|2|||
163071936|NCT05507450|588969737|FG000|Overall Study|Death|0|||
163071937|NCT05507450|588969738|FG001|Overall Study|Death|0|||
163071938|NCT05507450|588969739|FG002|Overall Study|Death|1|||
163071939|NCT05507450|588969740|FG003|Overall Study|Death|0|||
163071940|NCT05507450|588969737|FG000|Overall Study|Lost to Follow-up|22|||
163071941|NCT05507450|588969738|FG001|Overall Study|Lost to Follow-up|20|||
163071942|NCT05507450|588969739|FG002|Overall Study|Lost to Follow-up|20|||
163071943|NCT05507450|588969740|FG003|Overall Study|Lost to Follow-up|7|||
162644443|NCT03739112|587415782|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
163071944|NCT05507450|588969737|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163071945|NCT05507450|588969738|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163071946|NCT05507450|588969739|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163071947|NCT05507450|588969740|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163071948|NCT05507450|588969737|FG000|Overall Study|Withdrawal by Subject|4|||
163071949|NCT05507450|588969738|FG001|Overall Study|Withdrawal by Subject|11|||
163071950|NCT05507450|588969739|FG002|Overall Study|Withdrawal by Subject|7|||
163071951|NCT05507450|588969740|FG003|Overall Study|Withdrawal by Subject|3|||
163071952|NCT05507450|588969737|FG000|Overall Study|Participant left the country|0|||
163071953|NCT05507450|588969738|FG001|Overall Study|Participant left the country|0|||
163071954|NCT05507450|588969739|FG002|Overall Study|Participant left the country|1|||
163071955|NCT05507450|588969740|FG003|Overall Study|Participant left the country|0|||
163071956|NCT05436288|588969741|FG000|Overall Study|Lost to Follow-up|1|||
163071957|NCT05436288|588969741|FG000|Overall Study|Adverse Event|1|||
163071958|NCT03767894|588969744|FG000|Overall Study|Withdrawal by Subject|1|||
163071959|NCT00387127|588969745|FG000|Overall Study|Lost to Follow-up|0|||
163071960|NCT00387127|588969746|FG001|Overall Study|Lost to Follow-up|4|||
163071961|NCT00387127|588969745|FG000|Overall Study|Death|16|||
163071962|NCT00387127|588969746|FG001|Overall Study|Death|16|||
163071963|NCT00387127|588969745|FG000|Overall Study|Physician Decision|0|||
163027145|NCT04521621|588801402|FG000|Overall Study|Allocated in error without study intervention|1|||
163027146|NCT04521621|588801403|FG001|Overall Study|Allocated in error without study intervention|0|||
163027147|NCT04521621|588801404|FG002|Overall Study|Allocated in error without study intervention|0|||
163027148|NCT04521621|588801405|FG003|Overall Study|Allocated in error without study intervention|0|||
163027149|NCT04521621|588801406|FG004|Overall Study|Allocated in error without study intervention|0|||
163027150|NCT04521621|588801407|FG005|Overall Study|Allocated in error without study intervention|0|||
163027151|NCT04521621|588801408|FG006|Overall Study|Allocated in error without study intervention|0|||
163027152|NCT04521621|588801409|FG007|Overall Study|Allocated in error without study intervention|0|||
163027153|NCT03671564|588801410|FG000|Overall Study|Progressive Disease|3|||
163027154|NCT03671564|588801411|FG001|Overall Study|Progressive Disease|5|||
163027155|NCT03671564|588801412|FG002|Overall Study|Progressive Disease|3|||
163027156|NCT03671564|588801410|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
163027157|NCT03671564|588801411|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
163027158|NCT03671564|588801412|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
163027159|NCT03671564|588801410|FG000|Overall Study|Withdrawal by Subject|1|||
163027160|NCT03671564|588801411|FG001|Overall Study|Withdrawal by Subject|1|||
163027161|NCT03671564|588801412|FG002|Overall Study|Withdrawal by Subject|0|||
163027162|NCT05845567|588801417|FG000|Overall Study|Withdrawal by Subject|1|||
163027163|NCT01104246|588801422|FG000|Overall Study|Withdrawal by Subject|1|||
163027164|NCT01104246|588801422|FG000|Overall Study|did not meet inclusion criteria|4|||
163027165|NCT05178641|588801423|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
163027166|NCT05178641|588801424|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
163027167|NCT05178641|588801423|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
163027168|NCT05178641|588801424|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
163027169|NCT01869699|588801427|FG000|Overall Study|Withdrawal by Subject|1|||
163027170|NCT01869699|588801428|FG001|Overall Study|Withdrawal by Subject|0|||
163027171|NCT01083186|588801430|FG000|Overall Study|Lost to Follow-up|48|||
163027172|NCT01083186|588801430|FG000|Overall Study|Consent Withdrawal|7|||
163027173|NCT01083186|588801430|FG000|Overall Study|Death|3|||
163027174|NCT01083186|588801430|FG000|Overall Study|Adverse Event|3|||
163027175|NCT01083186|588801430|FG000|Overall Study|Lack of Efficacy|2|||
163027176|NCT01083186|588801430|FG000|Overall Study|Hemodialysis Initiation|28|||
163027177|NCT01083186|588801430|FG000|Overall Study|Administrative Reasons|2|||
163027178|NCT01083186|588801430|FG000|Overall Study|Non-compliance to Study Treatment|1|||
163027179|NCT01867294|588801438|FG000|Overall Study|Withdrawal by Subject|1|||
163027180|NCT01867294|588801439|FG001|Overall Study|Withdrawal by Subject|1|||
163027181|NCT01867294|588801440|FG002|Overall Study|Withdrawal by Subject|0|||
163027182|NCT01867294|588801441|FG003|Overall Study|Withdrawal by Subject|0|||
163027183|NCT02035748|588801442|FG000|Overall Study|Adverse Event|5|||
163027184|NCT02035748|588801442|FG000|Overall Study|Death|3|||
163027185|NCT02035748|588801442|FG000|Overall Study|Lost to Follow-up|2|||
163027186|NCT02035748|588801442|FG000|Overall Study|Physician Decision|3|||
163027187|NCT02035748|588801442|FG000|Overall Study|Withdrawal by Subject|6|||
163027188|NCT02035748|588801442|FG000|Overall Study|Progressive Disease|1|||
163027189|NCT01740128|588801443|FG000|Overall Study|Pregnancy|0|||
163027190|NCT01740128|588801444|FG001|Overall Study|Pregnancy|1|||
163027191|NCT01740128|588801443|FG000|Overall Study|Protocol Violation|1|||
163027192|NCT01740128|588801444|FG001|Overall Study|Protocol Violation|2|||
163027193|NCT01740128|588801443|FG000|Overall Study|Lost to Follow-up|2|||
163027194|NCT01740128|588801444|FG001|Overall Study|Lost to Follow-up|2|||
163027195|NCT01740128|588801443|FG000|Overall Study|Withdrawal by Subject|1|||
163027196|NCT01740128|588801444|FG001|Overall Study|Withdrawal by Subject|0|||
163027197|NCT01740128|588801443|FG000|Overall Study|Insufficient protocol compliance|2|||
163027198|NCT01740128|588801444|FG001|Overall Study|Insufficient protocol compliance|2|||
163027199|NCT01041976|588801445|FG000|Overall Study|Withdrawal by Subject|3|||
163027200|NCT01041976|588801446|FG001|Overall Study|Withdrawal by Subject|0|||
163027201|NCT01041976|588801445|FG000|Overall Study|Incarceration|2|||
163071964|NCT00387127|588969746|FG001|Overall Study|Physician Decision|1|||
163027202|NCT01041976|588801446|FG001|Overall Study|Incarceration|0|||
163027203|NCT01041976|588801445|FG000|Overall Study|Death|0|||
163027204|NCT01041976|588801446|FG001|Overall Study|Death|4|||
163027205|NCT02658734|588801447|FG000|Overall Study|Adverse Event|2|||
163027206|NCT02658734|588801447|FG000|Overall Study|Death|4|||
163027207|NCT02658734|588801447|FG000|Overall Study|Lost to Follow-up|7|||
163027208|NCT02658734|588801447|FG000|Overall Study|Withdrawal of Consent|16|||
163071965|NCT00387127|588969745|FG000|Overall Study|Withdrawal by Subject|3|||
163071966|NCT00387127|588969746|FG001|Overall Study|Withdrawal by Subject|2|||
163071967|NCT00387127|588969745|FG000|Overall Study|Required by Protocol Amendment #4|12|||
163071968|NCT00387127|588969746|FG001|Overall Study|Required by Protocol Amendment #4|10|||
163071969|NCT00387127|588969745|FG000|Overall Study|Serious Adverse Event|1|||
163071970|NCT00387127|588969746|FG001|Overall Study|Serious Adverse Event|1|||
163071971|NCT00387127|588969745|FG000|Overall Study|Sponsor Unblinded|1|||
163071972|NCT00387127|588969746|FG001|Overall Study|Sponsor Unblinded|0|||
163071973|NCT04149353|588969747|FG000|Overall Study|Study terminated|1|||
163071974|NCT01871727|588969748|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
163071975|NCT01871727|588969749|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
163071976|NCT01871727|588969750|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
163071977|NCT01871727|588969751|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
163071978|NCT01871727|588969752|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
163071979|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
163071980|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
163071981|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
163071982|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
163071983|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
163071984|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071985|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071986|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071987|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
163071988|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
163071989|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071990|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071991|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071992|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
163071993|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
163071994|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071995|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071996|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071997|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
163071998|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
163071999|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072000|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072001|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072002|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
163072003|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
163072004|NCT01871727|588969748|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072005|NCT01871727|588969749|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072006|NCT01871727|588969750|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072007|NCT01871727|588969751|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
163072008|NCT01871727|588969752|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
163072009|NCT00002874|588969753|FG000|Overall Study|Withdrawal by Subject|1|||
163072010|NCT00002874|588969754|FG001|Overall Study|Withdrawal by Subject|1|||
163072011|NCT00002874|588969753|FG000|Overall Study|Protocol Violation|44|||
163072012|NCT00002874|588969754|FG001|Overall Study|Protocol Violation|34|||
163072013|NCT04971837|588971350|FG000|Overall Study|Long Term Illness|1|||
163072014|NCT04971837|588971350|FG000|Overall Study|BMI too low|9|||
163072015|NCT04971837|588971350|FG000|Overall Study|geographic location|1|||
163072016|NCT04971837|588971350|FG000|Overall Study|Discontinued scheduling conflict|1|||
163072017|NCT04289298|588971351|FG000|Overall Study|Lost to Follow-up|5|||
163072018|NCT04289298|588971352|FG001|Overall Study|Lost to Follow-up|0|||
163072019|NCT04289298|588971351|FG000|Overall Study|Withdrawal by Subject|2|||
163072020|NCT04289298|588971352|FG001|Overall Study|Withdrawal by Subject|0|||
163072021|NCT01734928|588971353|FG000|Randomization|Physician Decision|0|||
163072022|NCT01734928|588971354|FG001|Randomization|Physician Decision|1|||
163072023|NCT01734928|588971353|FG000|Randomization|clinical progression|0|||
163072024|NCT01734928|588971354|FG001|Randomization|clinical progression|1|||
163072025|NCT01734928|588971353|FG000|Randomization|progressive disease|0|||
163072026|NCT01734928|588971354|FG001|Randomization|progressive disease|2|||
163072027|NCT01734928|588971353|FG000|Randomization|Withdrew informed consent|0|||
163072028|NCT01734928|588971354|FG001|Randomization|Withdrew informed consent|4|||
163072029|NCT01734928|588971353|FG000|Randomization|Death|1|||
163072030|NCT01734928|588971354|FG001|Randomization|Death|0|||
163072031|NCT01734928|588971353|FG000|Randomization|Randomization error|1|||
163072032|NCT01734928|588971354|FG001|Randomization|Randomization error|0|||
163072033|NCT01734928|588971353|FG000|Randomization|Lost to Follow-up|1|||
163072034|NCT01734928|588971354|FG001|Randomization|Lost to Follow-up|0|||
163072035|NCT01734928|588971353|FG000|Treatment Period|Lost to Follow-up|0|||
163072036|NCT01734928|588971354|FG001|Treatment Period|Lost to Follow-up|2|||
163072037|NCT01734928|588971353|FG000|Treatment Period|Progressive Disease|167|||
163072038|NCT01734928|588971354|FG001|Treatment Period|Progressive Disease|165|||
163072039|NCT01734928|588971353|FG000|Treatment Period|Adverse Event|39|||
163072040|NCT01734928|588971354|FG001|Treatment Period|Adverse Event|52|||
163072041|NCT01734928|588971353|FG000|Treatment Period|Withdrawal of Consent|25|||
163072042|NCT01734928|588971354|FG001|Treatment Period|Withdrawal of Consent|22|||
163072043|NCT01734928|588971353|FG000|Treatment Period|Death|20|||
163072044|NCT01734928|588971354|FG001|Treatment Period|Death|9|||
163072045|NCT01734928|588971353|FG000|Treatment Period|Other Reasons|27|||
163072046|NCT01734928|588971354|FG001|Treatment Period|Other Reasons|19|||
163072047|NCT01734928|588971353|FG000|Treatment Period|Pregnancy|0|||
163072048|NCT01734928|588971354|FG001|Treatment Period|Pregnancy|1|||
163072049|NCT01108796|588971357|FG000|Overall Study|Adverse Event|0|||
163072050|NCT01108796|588971358|FG001|Overall Study|Adverse Event|1|||
163072051|NCT01108796|588971357|FG000|Overall Study|Lost to Follow-up|7|||
163072052|NCT01108796|588971358|FG001|Overall Study|Lost to Follow-up|6|||
163072053|NCT00397930|588971365|FG000|Overall Study|Personal reasons|14|||
163072054|NCT00397930|588971366|FG001|Overall Study|Personal reasons|8|||
163072055|NCT00397930|588971365|FG000|Overall Study|Other medical|9|||
163072056|NCT00397930|588971366|FG001|Overall Study|Other medical|4|||
163072057|NCT00397930|588971365|FG000|Overall Study|Unknown reasons|9|||
163072058|NCT00397930|588971366|FG001|Overall Study|Unknown reasons|14|||
163072059|NCT00397930|588971365|FG000|Overall Study|Noncompliant|3|||
163072060|NCT00397930|588971366|FG001|Overall Study|Noncompliant|2|||
163072061|NCT00397930|588971365|FG000|Overall Study|Too time-consuming|2|||
163072062|NCT00397930|588971366|FG001|Overall Study|Too time-consuming|9|||
163072063|NCT00397930|588971365|FG000|Overall Study|Started own yoga program|1|||
163072064|NCT00397930|588971366|FG001|Overall Study|Started own yoga program|1|||
163072065|NCT00397930|588971365|FG000|Overall Study|Did not want to be in control group|0|||
163072066|NCT00397930|588971366|FG001|Overall Study|Did not want to be in control group|1|||
163072067|NCT00397930|588971365|FG000|Overall Study|Withdrawal by Subject|0|||
163072068|NCT00397930|588971366|FG001|Overall Study|Withdrawal by Subject|8|||
163072069|NCT00397930|588971365|FG000|Overall Study|Missing data|0|||
163072070|NCT00397930|588971366|FG001|Overall Study|Missing data|4|||
163072071|NCT01158404|588971367|FG000|Overall Study|Withdrawal by Subject|0|||
163072072|NCT01158404|588971368|FG001|Overall Study|Withdrawal by Subject|1|||
163072073|NCT01158404|588971369|FG002|Overall Study|Withdrawal by Subject|0|||
163072074|NCT01158404|588971370|FG003|Overall Study|Withdrawal by Subject|0|||
163072075|NCT01158404|588971371|FG004|Overall Study|Withdrawal by Subject|3|||
163072076|NCT01158404|588971372|FG005|Overall Study|Withdrawal by Subject|1|||
163072077|NCT01158404|588971373|FG006|Overall Study|Withdrawal by Subject|0|||
163072078|NCT01158404|588971374|FG007|Overall Study|Withdrawal by Subject|1|||
163072079|NCT01158404|588971367|FG000|Overall Study|Physician Decision|0|||
163072080|NCT01158404|588971368|FG001|Overall Study|Physician Decision|0|||
163072081|NCT01158404|588971369|FG002|Overall Study|Physician Decision|0|||
163072082|NCT01158404|588971370|FG003|Overall Study|Physician Decision|0|||
163072083|NCT01158404|588971371|FG004|Overall Study|Physician Decision|0|||
163072084|NCT01158404|588971372|FG005|Overall Study|Physician Decision|0|||
163072085|NCT01158404|588971373|FG006|Overall Study|Physician Decision|0|||
163072086|NCT01158404|588971374|FG007|Overall Study|Physician Decision|1|||
163072087|NCT01158404|588971367|FG000|Overall Study|Progressive Disease|0|||
162644444|NCT03739112|587415781|FG000|Overall Study|Site went on hold|65|||
162644445|NCT03739112|587415782|FG001|Overall Study|Site went on hold|67|||
163072088|NCT01158404|588971368|FG001|Overall Study|Progressive Disease|0|||
163072089|NCT01158404|588971369|FG002|Overall Study|Progressive Disease|0|||
163072090|NCT01158404|588971370|FG003|Overall Study|Progressive Disease|0|||
163072091|NCT01158404|588971371|FG004|Overall Study|Progressive Disease|0|||
163072092|NCT01158404|588971372|FG005|Overall Study|Progressive Disease|0|||
163072093|NCT01158404|588971373|FG006|Overall Study|Progressive Disease|1|||
163072094|NCT01158404|588971374|FG007|Overall Study|Progressive Disease|0|||
163072095|NCT02056288|588971375|FG000|In-Hospital Data|Surgery cancelled|1|||
163072096|NCT02056288|588971376|FG001|In-Hospital Data|Surgery cancelled|0|||
163072097|NCT02056288|588971375|FG000|In-Hospital Data|Protocol Violation|3|||
163072098|NCT02056288|588971376|FG001|In-Hospital Data|Protocol Violation|0|||
163072099|NCT02056288|588971375|FG000|In-Hospital Data|Physician Decision|1|||
163072100|NCT02056288|588971376|FG001|In-Hospital Data|Physician Decision|0|||
163072101|NCT02056288|588971375|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
163072102|NCT02056288|588971376|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
163072103|NCT02400580|588971379|FG000|Overall Study|Withdrawal by Subject|1|||
163072104|NCT02400580|588971380|FG001|Overall Study|Withdrawal by Subject|1|||
163072105|NCT02400580|588971379|FG000|Overall Study|Adverse Event|1|||
163072106|NCT02400580|588971380|FG001|Overall Study|Adverse Event|0|||
163072107|NCT00965094|588971381|FG000|Overall Study|Adverse Event|5|||
163072108|NCT00965094|588971382|FG001|Overall Study|Adverse Event|0|||
163072109|NCT00965094|588971381|FG000|Overall Study|Lost to Follow-up|0|||
163072110|NCT00965094|588971382|FG001|Overall Study|Lost to Follow-up|1|||
163072111|NCT01060111|588971383|FG000|Overall Study|Adverse Event|9|||
163072112|NCT01060111|588971384|FG001|Overall Study|Adverse Event|5|||
163072113|NCT01060111|588971385|FG002|Overall Study|Adverse Event|18|||
163072114|NCT01060111|588971383|FG000|Overall Study|Lack of Efficacy|2|||
163072115|NCT01060111|588971384|FG001|Overall Study|Lack of Efficacy|1|||
163072116|NCT01060111|588971385|FG002|Overall Study|Lack of Efficacy|0|||
163072117|NCT01060111|588971383|FG000|Overall Study|Inappropriate participant|5|||
163072118|NCT01060111|588971384|FG001|Overall Study|Inappropriate participant|4|||
163072119|NCT01060111|588971385|FG002|Overall Study|Inappropriate participant|5|||
163072120|NCT01060111|588971383|FG000|Overall Study|Participants' evasion for hospital visit|0|||
163072121|NCT01060111|588971384|FG001|Overall Study|Participants' evasion for hospital visit|3|||
163072122|NCT01060111|588971385|FG002|Overall Study|Participants' evasion for hospital visit|2|||
163072123|NCT01060111|588971383|FG000|Overall Study|Participants' non-cooperation|8|||
163072124|NCT01060111|588971384|FG001|Overall Study|Participants' non-cooperation|6|||
163072125|NCT01060111|588971385|FG002|Overall Study|Participants' non-cooperation|6|||
163072126|NCT01060111|588971383|FG000|Overall Study|Adverse event and insufficient effect|0|||
163072127|NCT01060111|588971384|FG001|Overall Study|Adverse event and insufficient effect|1|||
163072128|NCT01060111|588971385|FG002|Overall Study|Adverse event and insufficient effect|0|||
163072129|NCT01060111|588971383|FG000|Overall Study|Participants' non-cooperation|1|||
163072130|NCT01060111|588971384|FG001|Overall Study|Participants' non-cooperation|0|||
163072131|NCT01060111|588971385|FG002|Overall Study|Participants' non-cooperation|0|||
163072132|NCT01060111|588971383|FG000|Overall Study|Other|2|||
163072133|NCT01060111|588971384|FG001|Overall Study|Other|3|||
163072134|NCT01060111|588971385|FG002|Overall Study|Other|4|||
163072135|NCT01433978|588971386|FG000|Core Study|Adverse Event, Non-Fatal|0|||
163072136|NCT01433978|588971387|FG001|Core Study|Adverse Event, Non-Fatal|1|||
163072137|NCT01433978|588971388|FG002|Core Study|Adverse Event, Non-Fatal|0|||
163072138|NCT01433978|588971386|FG000|Core Study|Lack of Efficacy|5|||
163072139|NCT01433978|588971387|FG001|Core Study|Lack of Efficacy|1|||
163072140|NCT01433978|588971388|FG002|Core Study|Lack of Efficacy|0|||
163072141|NCT01433978|588971386|FG000|Core Study|Study Terminated by Sponsor|6|||
163072142|NCT01433978|588971387|FG001|Core Study|Study Terminated by Sponsor|9|||
163072143|NCT01433978|588971388|FG002|Core Study|Study Terminated by Sponsor|0|||
163072144|NCT01433978|588971386|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
163072145|NCT01433978|588971387|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
163072146|NCT01433978|588971388|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
163072147|NCT01433978|588971386|FG000|Extension Phase|Lack of Efficacy|0|||
163072148|NCT01433978|588971387|FG001|Extension Phase|Lack of Efficacy|0|||
163072149|NCT01433978|588971388|FG002|Extension Phase|Lack of Efficacy|1|||
163072150|NCT01433978|588971386|FG000|Extension Phase|Study Terminated by Sponsor|0|||
163072151|NCT01433978|588971387|FG001|Extension Phase|Study Terminated by Sponsor|0|||
163072152|NCT01433978|588971388|FG002|Extension Phase|Study Terminated by Sponsor|4|||
163072153|NCT01773889|588971390|FG000|Overall Study|lack of funding|2|||
163072154|NCT04233580|588971391|FG000|Overall Study|Adverse Event|3|||
163072155|NCT04233580|588971392|FG001|Overall Study|Adverse Event|3|||
163072156|NCT04233580|588971391|FG000|Overall Study|Withdrawal by Subject|2|||
163072157|NCT04233580|588971392|FG001|Overall Study|Withdrawal by Subject|1|||
163072158|NCT03954938|588971393|FG000|Overall Study|Withdrawal by Subject|2|||
163072159|NCT03954938|588971393|FG000|Overall Study|Adverse Event|1|||
163072160|NCT01371565|588971394|FG000|Overall Study|Withdrawal by Subject|1|||
163072161|NCT01371565|588971394|FG000|Overall Study|Death|1|||
163072162|NCT01371565|588971394|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
163072163|NCT02565186|588971395|FG000|Overall Study|Adverse Event|113|||
163072164|NCT02565186|588971396|FG001|Overall Study|Adverse Event|148|||
163072165|NCT02565186|588971395|FG000|Overall Study|Lost to Follow-up|102|||
163072166|NCT02565186|588971396|FG001|Overall Study|Lost to Follow-up|93|||
163072167|NCT02565186|588971395|FG000|Overall Study|Non-Compliance|57|||
163072168|NCT02565186|588971396|FG001|Overall Study|Non-Compliance|55|||
163072169|NCT02565186|588971395|FG000|Overall Study|Withdrawal by Subject|229|||
163072170|NCT02565186|588971396|FG001|Overall Study|Withdrawal by Subject|214|||
163072171|NCT02565186|588971395|FG000|Overall Study|Physician Decision|18|||
163072172|NCT02565186|588971396|FG001|Overall Study|Physician Decision|16|||
163072173|NCT02565186|588971395|FG000|Overall Study|Sponsor Request|5|||
163072174|NCT02565186|588971396|FG001|Overall Study|Sponsor Request|9|||
163027209|NCT02658734|588801447|FG000|Overall Study|Disease Progression|28|||
163027210|NCT00976209|588801450|FG000|Treatment Period 1|Protocol Violation|1|||
163027211|NCT00976209|588801451|FG001|Treatment Period 1|Protocol Violation|0|||
163027212|NCT00976209|588801450|FG000|Treatment Period 1|Lost to Follow-up|2|||
163027213|NCT00976209|588801451|FG001|Treatment Period 1|Lost to Follow-up|0|||
163027214|NCT00976209|588801450|FG000|Treatment Period 1|Other|0|||
163027215|NCT00976209|588801451|FG001|Treatment Period 1|Other|1|||
163027216|NCT00976209|588801450|FG000|Wash-out Period|Adverse Event|1|||
163027217|NCT00976209|588801451|FG001|Wash-out Period|Adverse Event|2|||
163027218|NCT00976209|588801450|FG000|Wash-out Period|Lost to Follow-up|1|||
163027219|NCT00976209|588801451|FG001|Wash-out Period|Lost to Follow-up|0|||
163027220|NCT00976209|588801450|FG000|Wash-out Period|Protocol Violation|1|||
163027221|NCT00976209|588801451|FG001|Wash-out Period|Protocol Violation|0|||
163027222|NCT00976209|588801450|FG000|Wash-out Period|Other|1|||
163027223|NCT00976209|588801451|FG001|Wash-out Period|Other|0|||
163027224|NCT00976209|588801450|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163027225|NCT00976209|588801451|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163027226|NCT00976209|588801450|FG000|Treatment Period 2|Lost to Follow-up|0|||
163027227|NCT00976209|588801451|FG001|Treatment Period 2|Lost to Follow-up|1|||
163027228|NCT01252563|588801452|FG000|Overall Study|Contract Deviation|41|||
163027229|NCT01252563|588801452|FG000|Overall Study|Centralized Registration Deviation|30|||
163027230|NCT01252563|588801452|FG000|Overall Study|Lost to Follow-up|161|||
163027231|NCT01252563|588801452|FG000|Overall Study|No visit after first day of treatment|194|||
163027232|NCT01252563|588801452|FG000|Overall Study|No drug administration|6|||
163027233|NCT01866657|588801453|FG000|Overall Study|Surgery canceled|2|||
163027234|NCT01866657|588801454|FG001|Overall Study|Surgery canceled|0|||
163027235|NCT00978250|588801460|FG000|Overall Study|Late determination of ineligibility|0|||
163027236|NCT00978250|588801461|FG001|Overall Study|Late determination of ineligibility|1|||
163027237|NCT00978250|588801462|FG002|Overall Study|Late determination of ineligibility|0|||
163027238|NCT00978250|588801463|FG003|Overall Study|Late determination of ineligibility|1|||
163027239|NCT03036098|588803989|FG000|Pre-Treatment|Other Reasons|1|||
163027240|NCT03036098|588803990|FG001|Pre-Treatment|Other Reasons|2|||
163027241|NCT03036098|588803991|FG002|Pre-Treatment|Other Reasons|0|||
163027242|NCT03036098|588803992|FG003|Pre-Treatment|Other Reasons|5|||
163027243|NCT03036098|588803989|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
163027244|NCT03036098|588803990|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
163027245|NCT03036098|588803991|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
163027246|NCT03036098|588803992|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
163027247|NCT03036098|588803989|FG000|Pre-Treatment|Withdrawal by Subject|1|||
163027248|NCT03036098|588803990|FG001|Pre-Treatment|Withdrawal by Subject|14|||
163027249|NCT03036098|588803991|FG002|Pre-Treatment|Withdrawal by Subject|0|||
163027250|NCT03036098|588803992|FG003|Pre-Treatment|Withdrawal by Subject|5|||
163027251|NCT03036098|588803989|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
163027252|NCT03036098|588803990|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
163027253|NCT03036098|588803991|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
163027254|NCT03036098|588803992|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
163027255|NCT03036098|588803989|FG000|Treatment|Disease Progression|130|||
163027256|NCT03036098|588803990|FG001|Treatment|Disease Progression|77|||
163027257|NCT03036098|588803991|FG002|Treatment|Disease Progression|168|||
163027258|NCT03036098|588803992|FG003|Treatment|Disease Progression|50|||
163027259|NCT03036098|588803989|FG000|Treatment|Study Drug Toxicity|95|||
163027260|NCT03036098|588803990|FG001|Treatment|Study Drug Toxicity|45|||
163027261|NCT03036098|588803991|FG002|Treatment|Study Drug Toxicity|26|||
163027262|NCT03036098|588803992|FG003|Treatment|Study Drug Toxicity|22|||
163027263|NCT03036098|588803989|FG000|Treatment|Death|9|||
163027264|NCT03036098|588803990|FG001|Treatment|Death|3|||
163027265|NCT03036098|588803991|FG002|Treatment|Death|1|||
163027266|NCT03036098|588803992|FG003|Treatment|Death|2|||
163027267|NCT03036098|588803989|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
163027268|NCT03036098|588803990|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
163027269|NCT03036098|588803991|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
162644446|NCT03739112|587415781|FG000|Overall Study|Other than specified|8|||
162644447|NCT03739112|587415782|FG001|Overall Study|Other than specified|5|||
162644448|NCT03739112|587415781|FG000|Overall Study|Randomized but not vaccinated|31|||
163027270|NCT03036098|588803992|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
163027271|NCT03036098|588803989|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
163027272|NCT03036098|588803990|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
163027273|NCT03036098|588803991|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
163027274|NCT03036098|588803992|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
163027275|NCT03036098|588803989|FG000|Treatment|Withdrawal by Subject|2|||
163027276|NCT03036098|588803990|FG001|Treatment|Withdrawal by Subject|9|||
163027277|NCT03036098|588803991|FG002|Treatment|Withdrawal by Subject|2|||
163027278|NCT03036098|588803992|FG003|Treatment|Withdrawal by Subject|4|||
163027279|NCT03036098|588803989|FG000|Treatment|Maximum Clinical Benefit|6|||
163027280|NCT03036098|588803990|FG001|Treatment|Maximum Clinical Benefit|1|||
163072175|NCT02565186|588971395|FG000|Overall Study|Missing|1|||
163072176|NCT02565186|588971396|FG001|Overall Study|Missing|0|||
163072177|NCT02565186|588971395|FG000|Overall Study|Did Not Receive Study Drug|55|||
163072178|NCT02565186|588971396|FG001|Overall Study|Did Not Receive Study Drug|86|||
163072179|NCT00617903|588971397|FG000|Overall Study|Withdrawal by Subject|2|||
163072180|NCT00617903|588971398|FG001|Overall Study|Withdrawal by Subject|3|||
163072181|NCT00617903|588971397|FG000|Overall Study|Lost to Follow-up|1|||
163072182|NCT00617903|588971398|FG001|Overall Study|Lost to Follow-up|1|||
163072183|NCT00617903|588971397|FG000|Overall Study|Lack of Efficacy|0|||
163072184|NCT00617903|588971398|FG001|Overall Study|Lack of Efficacy|1|||
163072185|NCT00617903|588971397|FG000|Overall Study|Adverse Event|0|||
163072186|NCT00617903|588971398|FG001|Overall Study|Adverse Event|1|||
163072187|NCT00617903|588971397|FG000|Overall Study|noncompliance|0|||
163072188|NCT00617903|588971398|FG001|Overall Study|noncompliance|1|||
163072189|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
163072190|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
163072191|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
163072192|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
163072193|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
163072194|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
163072195|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
163072196|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
163072197|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
163072198|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
163072199|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
163072200|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
163072201|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
163072202|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
163072203|NCT00976391|588971399|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
163072204|NCT00976391|588971400|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
163072205|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
163072206|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
163072207|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163072208|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
163072209|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
163072210|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
163072211|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
163072212|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
163072213|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
163072214|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
163072215|NCT00976391|588971399|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
163072216|NCT00976391|588971400|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
163072217|NCT04676646|588971401|FG000|Open-label Run-in Phase|Adverse Event|3|||
163072218|NCT04676646|588971402|FG001|Open-label Run-in Phase|Adverse Event|0|||
163072219|NCT04676646|588971403|FG002|Open-label Run-in Phase|Adverse Event|0|||
163072220|NCT04676646|588971401|FG000|Open-label Run-in Phase|Death|3|||
163072221|NCT04676646|588971402|FG001|Open-label Run-in Phase|Death|0|||
163072222|NCT04676646|588971403|FG002|Open-label Run-in Phase|Death|0|||
163072223|NCT04676646|588971401|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
163072224|NCT04676646|588971402|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
163072225|NCT04676646|588971403|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
163072226|NCT04676646|588971401|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
163072227|NCT04676646|588971402|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
163072228|NCT04676646|588971403|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
163072229|NCT04676646|588971401|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
163072230|NCT04676646|588971402|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
163072231|NCT04676646|588971403|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
163072232|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
163072233|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
163072234|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
163072235|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
163072236|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
163072237|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
163072238|NCT04676646|588971401|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
163072239|NCT04676646|588971402|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
163072240|NCT04676646|588971403|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
163072241|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
163072242|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
163072243|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
163072244|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Death|0|||
163072245|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Death|1|||
163072246|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Death|2|||
163072247|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
163072248|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
163072249|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
163072250|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
163072251|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
163072252|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
163072253|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
163072254|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
163072255|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
163072256|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
163072257|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
163072258|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
163072259|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
163072260|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
163072261|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
163072262|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
163072263|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
163072264|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
163072265|NCT04676646|588971401|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
163072266|NCT04676646|588971402|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
163072267|NCT04676646|588971403|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
163072268|NCT04270760|588971404|FG000|Overall Study|Withdrawal by Subject|0|||
163072269|NCT04270760|588971405|FG001|Overall Study|Withdrawal by Subject|1|||
163072270|NCT04270760|588971406|FG002|Overall Study|Withdrawal by Subject|3|||
163072271|NCT04270760|588971407|FG003|Overall Study|Withdrawal by Subject|0|||
163072272|NCT04270760|588971408|FG004|Overall Study|Withdrawal by Subject|0|||
163072273|NCT04270760|588971404|FG000|Overall Study|Lost to Follow-up|1|||
163072274|NCT04270760|588971405|FG001|Overall Study|Lost to Follow-up|2|||
163072275|NCT04270760|588971406|FG002|Overall Study|Lost to Follow-up|1|||
163072276|NCT04270760|588971407|FG003|Overall Study|Lost to Follow-up|0|||
163072277|NCT04270760|588971408|FG004|Overall Study|Lost to Follow-up|0|||
163072278|NCT04270760|588971404|FG000|Overall Study|Death|0|||
163072279|NCT04270760|588971405|FG001|Overall Study|Death|0|||
163072280|NCT04270760|588971406|FG002|Overall Study|Death|0|||
163072281|NCT04270760|588971407|FG003|Overall Study|Death|0|||
163072282|NCT04270760|588971408|FG004|Overall Study|Death|1|||
163072283|NCT05156125|588971409|FG000|Overall Study|Lack of Efficacy|1|||
163072284|NCT05156125|588971410|FG001|Overall Study|Lack of Efficacy|1|||
163072285|NCT05156125|588971411|FG002|Overall Study|Lack of Efficacy|1|||
163072286|NCT05156125|588971409|FG000|Overall Study|Physician Decision|0|||
163072287|NCT05156125|588971410|FG001|Overall Study|Physician Decision|0|||
163072288|NCT05156125|588971411|FG002|Overall Study|Physician Decision|1|||
163072289|NCT05156125|588971409|FG000|Overall Study|Non-compliance|0|||
163072290|NCT05156125|588971410|FG001|Overall Study|Non-compliance|1|||
163072291|NCT05156125|588971411|FG002|Overall Study|Non-compliance|1|||
163072292|NCT05156125|588971409|FG000|Overall Study|Withdrawal by Subject|0|||
163072293|NCT05156125|588971410|FG001|Overall Study|Withdrawal by Subject|0|||
163072294|NCT05156125|588971411|FG002|Overall Study|Withdrawal by Subject|1|||
163072295|NCT05156125|588971409|FG000|Overall Study|Adverse Event|2|||
163072296|NCT05156125|588971410|FG001|Overall Study|Adverse Event|1|||
162644449|NCT03739112|587415782|FG001|Overall Study|Randomized but not vaccinated|25|||
162644450|NCT00588822|587415784|FG000|Overall Study|progression of disease|8|||
162644451|NCT01727141|587415788|FG000|Overall Study|Physician Decision|0|||
162644452|NCT01727141|587415789|FG001|Overall Study|Physician Decision|1|||
162644453|NCT01727141|587415790|FG002|Overall Study|Physician Decision|0|||
162644454|NCT01727141|587415791|FG003|Overall Study|Physician Decision|2|||
162644455|NCT01727141|587415788|FG000|Overall Study|Lost to Follow-up|0|||
162644456|NCT01727141|587415789|FG001|Overall Study|Lost to Follow-up|2|||
162644457|NCT01727141|587415790|FG002|Overall Study|Lost to Follow-up|0|||
162644458|NCT01727141|587415791|FG003|Overall Study|Lost to Follow-up|0|||
162644459|NCT01727141|587415788|FG000|Overall Study|Death|0|||
162644460|NCT01727141|587415789|FG001|Overall Study|Death|1|||
162644461|NCT01727141|587415790|FG002|Overall Study|Death|1|||
163072297|NCT05156125|588971411|FG002|Overall Study|Adverse Event|0|||
163072298|NCT03670628|588971412|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
163072299|NCT03670628|588971413|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
163072300|NCT03670628|588971412|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
163072301|NCT03670628|588971413|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
163072302|NCT00997126|588971417|FG000|Overall Study|Physician Decision|7|||
163072303|NCT00997126|588971418|FG001|Overall Study|Physician Decision|11|||
163072304|NCT01755637|588971419|FG000|Period 1|Adverse Event|0|||
163072305|NCT01755637|588971420|FG001|Period 1|Adverse Event|1|||
163072306|NCT00899847|588971421|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
163072307|NCT02287025|588971422|FG000|Overall Study|Not treated|2|||
163072308|NCT02287025|588971423|FG001|Overall Study|Not treated|0|||
163072309|NCT02287025|588971422|FG000|Overall Study|Progression of disease|3|||
163072310|NCT02287025|588971423|FG001|Overall Study|Progression of disease|2|||
163072311|NCT02287025|588971422|FG000|Overall Study|Adverse Event|2|||
163072312|NCT02287025|588971423|FG001|Overall Study|Adverse Event|4|||
163072313|NCT02287025|588971422|FG000|Overall Study|Withdrawal by Subject|2|||
163072314|NCT02287025|588971423|FG001|Overall Study|Withdrawal by Subject|2|||
163072315|NCT02287025|588971422|FG000|Overall Study|Screening failed|1|||
163072316|NCT02287025|588971423|FG001|Overall Study|Screening failed|1|||
163072317|NCT03338023|588971424|FG000|Overall Study|Withdrawal by Subject|3|||
163072318|NCT03338023|588971425|FG001|Overall Study|Withdrawal by Subject|4|||
163072319|NCT03338023|588971424|FG000|Overall Study|Protocol Violation|3|||
163072320|NCT03338023|588971425|FG001|Overall Study|Protocol Violation|3|||
163072321|NCT03338023|588971424|FG000|Overall Study|Lost to Follow-up|2|||
163072322|NCT03338023|588971425|FG001|Overall Study|Lost to Follow-up|1|||
163072323|NCT03338023|588971424|FG000|Overall Study|Physician Decision|1|||
163072324|NCT03338023|588971425|FG001|Overall Study|Physician Decision|2|||
163072325|NCT04996264|588971426|FG000|Overall Study|Lost to Follow-up|0|||
163072326|NCT04996264|588971427|FG001|Overall Study|Lost to Follow-up|1|||
163072327|NCT04996264|588971426|FG000|Overall Study|Withdrawal by Subject|4|||
163072328|NCT04996264|588971427|FG001|Overall Study|Withdrawal by Subject|3|||
163072329|NCT04996264|588971426|FG000|Overall Study|1 left AMA|0|||
163072330|NCT04996264|588971427|FG001|Overall Study|1 left AMA|1|||
163072331|NCT04996264|588971426|FG000|Overall Study|Subject changed hospitals|0|||
163072332|NCT04996264|588971427|FG001|Overall Study|Subject changed hospitals|1|||
163072333|NCT04996264|588971426|FG000|Overall Study|unable to complete due to work|0|||
163072334|NCT04996264|588971427|FG001|Overall Study|unable to complete due to work|1|||
163072335|NCT00685698|588971428|FG000|Overall Study|Withdrawal by Subject|1|||
163072336|NCT00685698|588971428|FG000|Overall Study|Protocol Violation|6|||
163072337|NCT00685698|588971428|FG000|Overall Study|Adverse Event|3|||
163072338|NCT00685698|588971428|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
163072339|NCT00685698|588971428|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
163072340|NCT00685698|588971428|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
163072341|NCT02030418|588971429|FG000|Overall Study|Death|78|||
162644462|NCT01727141|587415791|FG003|Overall Study|Death|1|||
163072342|NCT02030418|588971429|FG000|Overall Study|Missed 12-Month Visit|9|||
163072343|NCT02030418|588971429|FG000|Overall Study|Withdrawn|57|||
163072344|NCT03412890|588971430|FG000|Overall Study|Adverse Event|5|||
163072345|NCT03412890|588971431|FG001|Overall Study|Adverse Event|5|||
163072346|NCT03412890|588971432|FG002|Overall Study|Adverse Event|9|||
163072347|NCT03412890|588971430|FG000|Overall Study|Protocol deviation|2|||
163072348|NCT03412890|588971431|FG001|Overall Study|Protocol deviation|1|||
163072349|NCT03412890|588971432|FG002|Overall Study|Protocol deviation|2|||
163072350|NCT03412890|588971430|FG000|Overall Study|Lost to Follow-up|7|||
163072351|NCT03412890|588971431|FG001|Overall Study|Lost to Follow-up|10|||
162644463|NCT01727141|587415788|FG000|Overall Study|Protocol deviation|1|||
163072352|NCT03412890|588971432|FG002|Overall Study|Lost to Follow-up|10|||
163072353|NCT03412890|588971430|FG000|Overall Study|Withdrawal by Subject|9|||
163072354|NCT03412890|588971431|FG001|Overall Study|Withdrawal by Subject|12|||
163072355|NCT03412890|588971432|FG002|Overall Study|Withdrawal by Subject|11|||
163072356|NCT03412890|588971430|FG000|Overall Study|Lack of Efficacy|2|||
163072357|NCT03412890|588971431|FG001|Overall Study|Lack of Efficacy|7|||
162644464|NCT01727141|587415789|FG001|Overall Study|Protocol deviation|1|||
162644465|NCT01727141|587415790|FG002|Overall Study|Protocol deviation|0|||
162644466|NCT01727141|587415791|FG003|Overall Study|Protocol deviation|1|||
163072358|NCT03412890|588971432|FG002|Overall Study|Lack of Efficacy|5|||
163072359|NCT03412890|588971430|FG000|Overall Study|Other|5|||
163072360|NCT03412890|588971431|FG001|Overall Study|Other|6|||
163072361|NCT03412890|588971432|FG002|Overall Study|Other|5|||
163072362|NCT03412890|588971430|FG000|Overall Study|Participants who did not receive any study drug|0|||
163072363|NCT03412890|588971431|FG001|Overall Study|Participants who did not receive any study drug|1|||
163072364|NCT03412890|588971432|FG002|Overall Study|Participants who did not receive any study drug|0|||
163072365|NCT00887588|588971436|FG000|Core Period|Death|1|||
163072366|NCT00887588|588971437|FG001|Core Period|Death|1|||
163072367|NCT00887588|588971436|FG000|Core Period|Lost to Follow-up|3|||
163072368|NCT00887588|588971437|FG001|Core Period|Lost to Follow-up|1|||
163072369|NCT00887588|588971436|FG000|Core Period|Withdrawal by Subject|6|||
163072370|NCT00887588|588971437|FG001|Core Period|Withdrawal by Subject|8|||
163072371|NCT00887588|588971436|FG000|Core Period|Adverse Event|9|||
163072372|NCT00887588|588971437|FG001|Core Period|Adverse Event|11|||
163072373|NCT00887588|588971436|FG000|Extension Period|Adverse Event|4|||
163072374|NCT00887588|588971437|FG001|Extension Period|Adverse Event|4|||
163072375|NCT00887588|588971436|FG000|Extension Period|Death|0|||
163072376|NCT00887588|588971437|FG001|Extension Period|Death|1|||
163072377|NCT00887588|588971436|FG000|Extension Period|Protocol deviation|1|||
163072378|NCT00887588|588971437|FG001|Extension Period|Protocol deviation|0|||
163072379|NCT00887588|588971436|FG000|Extension Period|Lost to Follow-up|1|||
163072380|NCT00887588|588971437|FG001|Extension Period|Lost to Follow-up|0|||
163072381|NCT00567112|588971438|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163072382|NCT00567112|588971439|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
163072383|NCT00567112|588971440|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163072384|NCT00567112|588971438|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
163072385|NCT00567112|588971439|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
163072386|NCT00567112|588971440|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
163072387|NCT00567112|588971438|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
163072388|NCT00567112|588971439|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
163072389|NCT00567112|588971440|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
163072390|NCT03753542|588971444|FG000|Overall Study|Lost to Follow-up|9|||
163072391|NCT03753542|588971445|FG001|Overall Study|Lost to Follow-up|14|||
163072392|NCT04180696|588971448|FG000|Overall Study|Death|5|||
163072393|NCT04180696|588971449|FG001|Overall Study|Death|6|||
163072394|NCT04180696|588971448|FG000|Overall Study|Lost to Follow-up|1|||
163072395|NCT04180696|588971449|FG001|Overall Study|Lost to Follow-up|0|||
163072396|NCT04180696|588971448|FG000|Overall Study|Withdrawal by Subject|0|||
163072397|NCT04180696|588971449|FG001|Overall Study|Withdrawal by Subject|1|||
163072398|NCT04210375|588971452|FG000|Overall Study|Death|0|||
163072399|NCT04210375|588971453|FG001|Overall Study|Death|1|||
163072400|NCT04210375|588971454|FG002|Overall Study|Death|0|||
163072401|NCT04210375|588971455|FG003|Overall Study|Death|0|||
163072402|NCT05752487|588971458|FG000|Overall Study|Enrolled, not treated|9|||
163072403|NCT05752487|588971458|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
163072404|NCT05752487|588971458|FG000|Overall Study|Withdrawal by Subject|2|||
163072405|NCT04124965|588971460|FG000|Overall Study|Adverse event, non-fatal|3|||
163072406|NCT04124965|588971461|FG001|Overall Study|Adverse event, non-fatal|1|||
163072407|NCT04124965|588971460|FG000|Overall Study|Withdrawal by Subject|1|||
163072408|NCT04124965|588971461|FG001|Overall Study|Withdrawal by Subject|1|||
163072409|NCT04124965|588971460|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
163072410|NCT04124965|588971461|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
163072411|NCT04124965|588971460|FG000|Overall Study|Pregnancy|1|||
163072412|NCT04124965|588971461|FG001|Overall Study|Pregnancy|0|||
163072413|NCT04124965|588971460|FG000|Overall Study|Sponsor and participant decision|0|||
163072414|NCT04124965|588971461|FG001|Overall Study|Sponsor and participant decision|1|||
163072415|NCT04124965|588971460|FG000|Overall Study|Personal surgery|0|||
163072416|NCT04124965|588971461|FG001|Overall Study|Personal surgery|1|||
163072417|NCT04124965|588971460|FG000|Overall Study|Physician Decision|0|||
163072418|NCT04124965|588971461|FG001|Overall Study|Physician Decision|1|||
163072419|NCT01214720|588971464|FG000|Overall Study|Alive and still on treatment|34|||
163072420|NCT01214720|588971465|FG001|Overall Study|Alive and still on treatment|18|||
163072421|NCT01214720|588971464|FG000|Overall Study|Alive and in follow-up|45|||
163072422|NCT01214720|588971465|FG001|Overall Study|Alive and in follow-up|48|||
163072423|NCT01214720|588971464|FG000|Overall Study|Lost to Follow-up|6|||
163072424|NCT01214720|588971465|FG001|Overall Study|Lost to Follow-up|2|||
163072425|NCT04625972|588971466|FG000|Overall Study|Death|3|||
163072426|NCT04625972|588971467|FG001|Overall Study|Death|2|||
163072427|NCT04625972|588971466|FG000|Overall Study|Lost to Follow-up|82|||
163072428|NCT04625972|588971467|FG001|Overall Study|Lost to Follow-up|38|||
162644467|NCT01727141|587415788|FG000|Overall Study|Withdrawal by Subject|4|||
162644468|NCT01727141|587415789|FG001|Overall Study|Withdrawal by Subject|4|||
162644469|NCT01727141|587415790|FG002|Overall Study|Withdrawal by Subject|2|||
162644470|NCT01727141|587415791|FG003|Overall Study|Withdrawal by Subject|11|||
162644471|NCT02529137|587415792|FG000|Overall Study|Discontinuation for different reasons|8|||
162644472|NCT02731729|587415795|FG000|Overall Study|Death|2|||
162644473|NCT02731729|587415796|FG001|Overall Study|Death|2|||
162644474|NCT02731729|587415795|FG000|Overall Study|Study terminated by Sponsor|6|||
163027281|NCT03036098|588803991|FG002|Treatment|Maximum Clinical Benefit|6|||
163027282|NCT03036098|588803992|FG003|Treatment|Maximum Clinical Benefit|10|||
163027283|NCT03036098|588803989|FG000|Treatment|Poor/Non Compliance|1|||
163027284|NCT03036098|588803990|FG001|Treatment|Poor/Non Compliance|2|||
163027285|NCT03036098|588803991|FG002|Treatment|Poor/Non Compliance|0|||
163027286|NCT03036098|588803992|FG003|Treatment|Poor/Non Compliance|1|||
163027287|NCT03036098|588803989|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
163027288|NCT03036098|588803990|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
163027289|NCT03036098|588803991|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
163027290|NCT03036098|588803992|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
163027291|NCT03036098|588803989|FG000|Treatment|Administrative Reason by Sponsor|1|||
163027292|NCT03036098|588803990|FG001|Treatment|Administrative Reason by Sponsor|0|||
163027293|NCT03036098|588803991|FG002|Treatment|Administrative Reason by Sponsor|2|||
163027294|NCT03036098|588803992|FG003|Treatment|Administrative Reason by Sponsor|1|||
163027295|NCT03036098|588803989|FG000|Treatment|Other Reasons|31|||
163027296|NCT03036098|588803990|FG001|Treatment|Other Reasons|5|||
163027297|NCT03036098|588803991|FG002|Treatment|Other Reasons|21|||
163027298|NCT03036098|588803992|FG003|Treatment|Other Reasons|8|||
163027299|NCT03036098|588803989|FG000|Treatment|Ongoing Treatment|0|||
163027300|NCT03036098|588803990|FG001|Treatment|Ongoing Treatment|0|||
163027301|NCT03036098|588803991|FG002|Treatment|Ongoing Treatment|23|||
163027302|NCT03036098|588803992|FG003|Treatment|Ongoing Treatment|0|||
163027303|NCT01632904|588803997|FG000|Overall Study|Adverse Event|4|||
163027304|NCT01632904|588803998|FG001|Overall Study|Adverse Event|1|||
163027305|NCT01632904|588803997|FG000|Overall Study|Physician Decision|0|||
163027306|NCT01632904|588803998|FG001|Overall Study|Physician Decision|1|||
163027307|NCT01632904|588803997|FG000|Overall Study|Subject decision|3|||
163027308|NCT01632904|588803998|FG001|Overall Study|Subject decision|2|||
163027309|NCT01632904|588803997|FG000|Overall Study|Disease Progression|0|||
163027310|NCT01632904|588803998|FG001|Overall Study|Disease Progression|1|||
163027311|NCT01632904|588803997|FG000|Overall Study|Reason for discontinuation not available|0|||
163027312|NCT01632904|588803998|FG001|Overall Study|Reason for discontinuation not available|1|||
163027313|NCT01004406|588803999|FG000|Overall Study|Withdrawal by Subject|2|||
163027314|NCT01004406|588804000|FG001|Overall Study|Withdrawal by Subject|0|||
163027315|NCT01004406|588803999|FG000|Overall Study|Lost to Follow-up|1|||
163027316|NCT01004406|588804000|FG001|Overall Study|Lost to Follow-up|0|||
163027317|NCT04542499|588804005|FG000|Overall Study|Adverse Event|23|||
163027318|NCT04542499|588804006|FG001|Overall Study|Adverse Event|43|||
163027319|NCT04542499|588804005|FG000|Overall Study|Lack of Efficacy|5|||
163027320|NCT04542499|588804006|FG001|Overall Study|Lack of Efficacy|2|||
163027321|NCT04542499|588804005|FG000|Overall Study|Lost to Follow-up|3|||
163027322|NCT04542499|588804006|FG001|Overall Study|Lost to Follow-up|4|||
163027323|NCT04542499|588804005|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163027324|NCT04542499|588804006|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
163027325|NCT04542499|588804005|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
163027326|NCT04542499|588804006|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163027327|NCT04542499|588804005|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163027328|NCT04542499|588804006|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163027329|NCT04542499|588804005|FG000|Overall Study|Physician Decision|0|||
163027330|NCT04542499|588804006|FG001|Overall Study|Physician Decision|1|||
163027331|NCT04542499|588804005|FG000|Overall Study|Site Terminated by Sponsor|3|||
163027332|NCT04542499|588804006|FG001|Overall Study|Site Terminated by Sponsor|5|||
163027333|NCT04542499|588804005|FG000|Overall Study|Withdrawal by Subject|12|||
163027334|NCT04542499|588804006|FG001|Overall Study|Withdrawal by Subject|33|||
162644475|NCT02731729|587415796|FG001|Overall Study|Study terminated by Sponsor|6|||
162644476|NCT02731729|587415795|FG000|Overall Study|Withdrawal by Subject|1|||
163027335|NCT04542499|588804005|FG000|Overall Study|Other|2|||
163027336|NCT04542499|588804006|FG001|Overall Study|Other|2|||
163027337|NCT05906836|588804010|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
163027338|NCT05906836|588804010|FG000|Overall Study|Lost to Follow-up|1|||
163027339|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027340|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027341|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027342|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
162644477|NCT02731729|587415796|FG001|Overall Study|Withdrawal by Subject|0|||
162644478|NCT01344447|587415797|FG000|Overall Study|Adverse Event|1|||
163027343|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027344|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027345|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027346|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027347|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027348|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027349|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027350|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027351|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027352|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027353|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027354|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
163027355|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027356|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
163027357|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027358|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
163027359|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027360|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027361|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
163027362|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
163027363|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
163027364|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
163027365|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027366|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027367|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027368|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027369|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027370|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027371|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027372|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027373|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027374|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
163027375|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027376|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
163027377|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
163027378|NCT04035434|588804013|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027379|NCT04035434|588804014|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027380|NCT04035434|588804015|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027381|NCT04035434|588804016|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
163027382|NCT04035434|588804017|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027383|NCT04035434|588804018|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027384|NCT04035434|588804019|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027385|NCT04035434|588804020|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027386|NCT04035434|588804021|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027387|NCT04035434|588804022|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027388|NCT04035434|588804023|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027389|NCT04035434|588804024|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027390|NCT04035434|588804025|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
163027391|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027392|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027393|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027394|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027395|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027396|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
163027397|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
163027398|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027399|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027400|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027401|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027402|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163027403|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
163072429|NCT04625972|588971466|FG000|Overall Study|Physician Decision|2|||
163072430|NCT04625972|588971467|FG001|Overall Study|Physician Decision|0|||
163072431|NCT04625972|588971466|FG000|Overall Study|Protocol Violation|0|||
163072432|NCT04625972|588971467|FG001|Overall Study|Protocol Violation|1|||
163072433|NCT04625972|588971466|FG000|Overall Study|Withdrawal by Subject|37|||
163072434|NCT04625972|588971467|FG001|Overall Study|Withdrawal by Subject|24|||
163072435|NCT04625972|588971466|FG000|Overall Study|Not specified elsewhere|8|||
163072436|NCT04625972|588971467|FG001|Overall Study|Not specified elsewhere|6|||
163072437|NCT05591755|588971468|FG000|Overall Study|Screen Failure|1|||
163072438|NCT05591755|588971469|FG001|Overall Study|Screen Failure|0|||
163072439|NCT05591755|588971470|FG002|Overall Study|Screen Failure|0|||
163072440|NCT05591755|588971471|FG003|Overall Study|Screen Failure|0|||
163072441|NCT05591755|588971468|FG000|Overall Study|Protocol Violation|0|||
163072442|NCT05591755|588971469|FG001|Overall Study|Protocol Violation|0|||
163072443|NCT05591755|588971470|FG002|Overall Study|Protocol Violation|2|||
163072444|NCT05591755|588971471|FG003|Overall Study|Protocol Violation|0|||
163072445|NCT05591755|588971468|FG000|Overall Study|Withdrawal by Subject|0|||
163072446|NCT05591755|588971469|FG001|Overall Study|Withdrawal by Subject|1|||
163072447|NCT05591755|588971470|FG002|Overall Study|Withdrawal by Subject|0|||
163072448|NCT05591755|588971471|FG003|Overall Study|Withdrawal by Subject|0|||
163072449|NCT00433290|588971472|FG000|Overall Study|Adverse Event|24|||
163072450|NCT00433290|588971473|FG001|Overall Study|Adverse Event|7|||
163072451|NCT00433290|588971472|FG000|Overall Study|Lack of Efficacy|1|||
163072452|NCT00433290|588971473|FG001|Overall Study|Lack of Efficacy|5|||
163072453|NCT00433290|588971472|FG000|Overall Study|Withdrawal by Subject|4|||
163072454|NCT00433290|588971473|FG001|Overall Study|Withdrawal by Subject|2|||
163072455|NCT00433290|588971472|FG000|Overall Study|Protocol Violation|3|||
163072456|NCT00433290|588971473|FG001|Overall Study|Protocol Violation|2|||
163072457|NCT00433290|588971472|FG000|Overall Study|Physician Decision|2|||
163072458|NCT00433290|588971473|FG001|Overall Study|Physician Decision|0|||
163072459|NCT00433290|588971472|FG000|Overall Study|Entry Criteria Not Met|0|||
163072460|NCT00433290|588971473|FG001|Overall Study|Entry Criteria Not Met|1|||
163072461|NCT00433290|588971472|FG000|Overall Study|Lost to Follow-up|1|||
163072462|NCT00433290|588971473|FG001|Overall Study|Lost to Follow-up|0|||
163072463|NCT01397747|588971475|FG000|Overall Study|Multitarget DNA test excluded|689|||
163072464|NCT01397747|588971475|FG000|Overall Study|Colonoscopy excluded|304|||
163072465|NCT01397747|588971475|FG000|Overall Study|FIT excluded|34|||
163072466|NCT00504309|588971476|FG000|Overall Study|Death|0|||
163072467|NCT00504309|588971477|FG001|Overall Study|Death|0|||
163072468|NCT00504309|588971478|FG002|Overall Study|Death|0|||
163072469|NCT00504309|588971479|FG003|Overall Study|Death|0|||
163072470|NCT00504309|588971480|FG004|Overall Study|Death|1|||
163072471|NCT00504309|588971481|FG005|Overall Study|Death|0|||
163072472|NCT00504309|588971476|FG000|Overall Study|Withdrawal by Subject|0|||
163072473|NCT00504309|588971477|FG001|Overall Study|Withdrawal by Subject|0|||
163072474|NCT00504309|588971478|FG002|Overall Study|Withdrawal by Subject|1|||
163072475|NCT00504309|588971479|FG003|Overall Study|Withdrawal by Subject|0|||
163072476|NCT00504309|588971480|FG004|Overall Study|Withdrawal by Subject|0|||
163072477|NCT00504309|588971481|FG005|Overall Study|Withdrawal by Subject|0|||
163072478|NCT00983957|588971491|FG000|Overall Study|Adverse Event|1|||
163072479|NCT00983957|588971491|FG000|Overall Study|Personal Reasons|1|||
163072480|NCT01560416|588971492|FG000|Randomized Phase|Crossover Participants|7|||
163072481|NCT01560416|588971493|FG001|Randomized Phase|Crossover Participants|0|||
163072482|NCT00884949|588972944|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
163072483|NCT00884949|588972944|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
163072484|NCT03684057|588972949|FG000|Overall Study|Withdrawal by Subject|4|||
163072485|NCT03684057|588972950|FG001|Overall Study|Withdrawal by Subject|5|||
163072486|NCT00758043|588972951|FG000|Overall Study|Adverse Event|1|||
163072487|NCT00758043|588972952|FG001|Overall Study|Adverse Event|20|||
163072488|NCT00758043|588972953|FG002|Overall Study|Adverse Event|12|||
163072489|NCT00758043|588972954|FG003|Overall Study|Adverse Event|62|||
163072490|NCT00758043|588972951|FG000|Overall Study|Lack of Efficacy|0|||
163072491|NCT00758043|588972952|FG001|Overall Study|Lack of Efficacy|6|||
163072492|NCT00758043|588972953|FG002|Overall Study|Lack of Efficacy|18|||
163072493|NCT00758043|588972954|FG003|Overall Study|Lack of Efficacy|12|||
163072494|NCT00758043|588972951|FG000|Overall Study|Refused Further Treatment|0|||
163072495|NCT00758043|588972952|FG001|Overall Study|Refused Further Treatment|11|||
163072496|NCT00758043|588972953|FG002|Overall Study|Refused Further Treatment|5|||
163072497|NCT00758043|588972954|FG003|Overall Study|Refused Further Treatment|8|||
163072498|NCT00758043|588972951|FG000|Overall Study|Lost to Follow-up|0|||
163072499|NCT00758043|588972952|FG001|Overall Study|Lost to Follow-up|2|||
163072500|NCT00758043|588972953|FG002|Overall Study|Lost to Follow-up|2|||
163072501|NCT00758043|588972954|FG003|Overall Study|Lost to Follow-up|5|||
163072502|NCT00758043|588972951|FG000|Overall Study|Withdrawal by Subject|0|||
163072503|NCT00758043|588972952|FG001|Overall Study|Withdrawal by Subject|1|||
163072504|NCT00758043|588972953|FG002|Overall Study|Withdrawal by Subject|1|||
163072505|NCT00758043|588972954|FG003|Overall Study|Withdrawal by Subject|4|||
163072506|NCT00758043|588972951|FG000|Overall Study|Required Prohibited Medication|0|||
163154798|NCT02667119|589281439|FG001|Overall Study|Lost to Follow-up|0|||
163072507|NCT00758043|588972952|FG001|Overall Study|Required Prohibited Medication|0|||
163072508|NCT00758043|588972953|FG002|Overall Study|Required Prohibited Medication|1|||
163072509|NCT00758043|588972954|FG003|Overall Study|Required Prohibited Medication|3|||
163072510|NCT00758043|588972951|FG000|Overall Study|Non-Compliant With study Drug|0|||
163072511|NCT00758043|588972952|FG001|Overall Study|Non-Compliant With study Drug|0|||
163072512|NCT00758043|588972953|FG002|Overall Study|Non-Compliant With study Drug|0|||
163072513|NCT00758043|588972954|FG003|Overall Study|Non-Compliant With study Drug|1|||
163072514|NCT00758043|588972951|FG000|Overall Study|Other Reasons|0|||
163072515|NCT00758043|588972952|FG001|Overall Study|Other Reasons|1|||
163072516|NCT00758043|588972953|FG002|Overall Study|Other Reasons|0|||
163072517|NCT00758043|588972954|FG003|Overall Study|Other Reasons|5|||
163072518|NCT03422718|588972955|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
163072519|NCT03422718|588972956|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
163072520|NCT03422718|588972957|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
163072521|NCT03422718|588972958|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
163072522|NCT03422718|588972959|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
163072523|NCT03422718|588972960|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
163072524|NCT03422718|588972961|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
163072525|NCT03422718|588972962|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
163072526|NCT03422718|588972955|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
163072527|NCT03422718|588972956|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
163072528|NCT03422718|588972957|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
163072529|NCT03422718|588972958|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
163072530|NCT03422718|588972959|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
163072531|NCT03422718|588972960|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
163072532|NCT03422718|588972961|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
163072533|NCT03422718|588972962|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
163072534|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
163072535|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
163072536|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
163072537|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072538|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
163072539|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072540|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
163072541|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
163072542|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072543|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
163072544|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072545|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072546|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
163072547|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
163072548|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072549|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163072550|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
163072551|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
163072552|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
163072553|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
163072554|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
163072555|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
163072556|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
163072557|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
163072558|NCT03422718|588972955|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
163072559|NCT03422718|588972956|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
163072560|NCT03422718|588972957|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
163072561|NCT03422718|588972958|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
163072562|NCT03422718|588972959|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
163072563|NCT03422718|588972960|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
163072564|NCT03422718|588972961|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
163072565|NCT03422718|588972962|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
163072566|NCT03197935|588972968|FG000|Overall Study|Death due to any cause|26|||
163072567|NCT03197935|588972969|FG001|Overall Study|Death due to any cause|15|||
163072568|NCT03197935|588972968|FG000|Overall Study|Lost to Follow-up|3|||
163072569|NCT03197935|588972969|FG001|Overall Study|Lost to Follow-up|5|||
163072570|NCT03197935|588972968|FG000|Overall Study|Physician Decision|2|||
163072571|NCT03197935|588972969|FG001|Overall Study|Physician Decision|1|||
163072572|NCT03197935|588972968|FG000|Overall Study|Withdrawal by Subject|16|||
163072573|NCT03197935|588972969|FG001|Overall Study|Withdrawal by Subject|8|||
162644479|NCT01344447|587415797|FG000|Overall Study|Protocol Violation|1|||
163027404|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027405|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027406|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027407|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027408|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027409|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027410|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
163027411|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027412|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027413|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027414|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027415|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027416|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
163027417|NCT04035434|588804013|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027418|NCT04035434|588804014|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027419|NCT04035434|588804015|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027420|NCT04035434|588804016|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027421|NCT04035434|588804017|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027422|NCT04035434|588804018|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
163027423|NCT04035434|588804019|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
163027424|NCT04035434|588804020|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027425|NCT04035434|588804021|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027426|NCT04035434|588804022|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027427|NCT04035434|588804023|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027428|NCT04035434|588804024|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027429|NCT04035434|588804025|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
163027430|NCT04488497|588804026|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
163027431|NCT04488497|588804027|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
163027432|NCT04488497|588804026|FG000|Intervention|Physician Decision|2|||
163027433|NCT04488497|588804027|FG001|Intervention|Physician Decision|1|||
163027434|NCT04488497|588804026|FG000|Intervention|Withdrawal by Subject|5|||
163027435|NCT04488497|588804027|FG001|Intervention|Withdrawal by Subject|6|||
163027436|NCT04488497|588804026|FG000|Intervention|Lost to Follow-up|2|||
163027437|NCT04488497|588804027|FG001|Intervention|Lost to Follow-up|0|||
163027438|NCT04488497|588804026|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
163027439|NCT04488497|588804027|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
163027440|NCT04488497|588804026|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
163027441|NCT04488497|588804027|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
163027442|NCT04322539|588804028|FG000|Overall Study|Adverse Event|2|||
163027443|NCT04322539|588804029|FG001|Overall Study|Adverse Event|0|||
163027444|NCT04322539|588804028|FG000|Overall Study|Death|411|||
163027445|NCT04322539|588804029|FG001|Overall Study|Death|203|||
163027446|NCT04322539|588804028|FG000|Overall Study|Lost to Follow-up|3|||
163027447|NCT04322539|588804029|FG001|Overall Study|Lost to Follow-up|1|||
163027448|NCT04322539|588804028|FG000|Overall Study|Withdrawal of consent|14|||
163027449|NCT04322539|588804029|FG001|Overall Study|Withdrawal of consent|8|||
163027450|NCT04322539|588804028|FG000|Overall Study|Radiological Disease Progression|6|||
163027451|NCT04322539|588804029|FG001|Overall Study|Radiological Disease Progression|0|||
163027452|NCT04322539|588804028|FG000|Overall Study|Sponsor Decision|19|||
163027453|NCT04322539|588804029|FG001|Overall Study|Sponsor Decision|14|||
163027454|NCT04322539|588804028|FG000|Overall Study|Other|6|||
163027455|NCT04322539|588804029|FG001|Overall Study|Other|4|||
163027456|NCT04161079|588804032|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
163027457|NCT01702532|588804033|FG000|Overall Study|Adverse Event|0|||
163027458|NCT01702532|588804034|FG001|Overall Study|Adverse Event|1|||
163027459|NCT03617861|588804035|FG000|Second Intervention (1 Day)|Adverse Event|0|||
163027460|NCT03617861|588804036|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163027461|NCT03617861|588804037|FG002|Second Intervention (1 Day)|Adverse Event|1|||
163027462|NCT03617861|588804038|FG003|Second Intervention (1 Day)|Adverse Event|0|||
163027463|NCT00623597|588804039|FG000|Overall Study|Failed to return|1|||
163072574|NCT03315689|588972974|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
162644480|NCT01344447|587415797|FG000|Overall Study|Withdrawal by Subject|1|||
162644481|NCT01344447|587415797|FG000|Overall Study|The contrast was not seen|1|||
162644482|NCT01344447|587415797|FG000|Overall Study|Physician Decision|1|||
163027464|NCT00623597|588804040|FG001|Overall Study|Failed to return|0|||
163027465|NCT01451164|588804041|FG000|Overall Study|Adverse Event|19|||
163027466|NCT01451164|588804042|FG001|Overall Study|Adverse Event|12|||
162644483|NCT01344447|587415797|FG000|Overall Study|MRA unsuccessful|1|||
162644484|NCT01344447|587415797|FG000|Overall Study|Bolus tracking failed|1|||
162644485|NCT01344447|587415797|FG000|Overall Study|Error of power injector|1|||
162644486|NCT01660711|587415798|FG000|Overall Study|Adverse Event|7|||
162644487|NCT01660711|587415798|FG000|Overall Study|Withdrawal by Subject|1|||
162644488|NCT01652664|587415799|FG000|Overall Study|Treatment Failure|5|||
162644489|NCT01652664|587415800|FG001|Overall Study|Treatment Failure|1|||
162644490|NCT01652664|587415799|FG000|Overall Study|Inadequate IOP control|1|||
162644491|NCT01652664|587415800|FG001|Overall Study|Inadequate IOP control|0|||
162644492|NCT00581776|587415804|FG000|Overall Study|Disease progression or no response|3|||
162644493|NCT02357901|587415805|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
163027467|NCT01451164|588804043|FG002|Overall Study|Adverse Event|18|||
163027468|NCT01451164|588804044|FG003|Overall Study|Adverse Event|21|||
163027469|NCT01451164|588804041|FG000|Overall Study|Withdrawal Criteria|1|||
163027470|NCT01451164|588804042|FG001|Overall Study|Withdrawal Criteria|1|||
163027471|NCT01451164|588804043|FG002|Overall Study|Withdrawal Criteria|1|||
163027472|NCT01451164|588804044|FG003|Overall Study|Withdrawal Criteria|1|||
163027473|NCT01451164|588804041|FG000|Overall Study|Physician Decision|2|||
163027474|NCT01451164|588804042|FG001|Overall Study|Physician Decision|0|||
163027475|NCT01451164|588804043|FG002|Overall Study|Physician Decision|1|||
163027476|NCT01451164|588804044|FG003|Overall Study|Physician Decision|0|||
163027477|NCT01451164|588804041|FG000|Overall Study|Withdrawal by Subject|14|||
163027478|NCT01451164|588804042|FG001|Overall Study|Withdrawal by Subject|11|||
163027479|NCT01451164|588804043|FG002|Overall Study|Withdrawal by Subject|16|||
163027480|NCT01451164|588804044|FG003|Overall Study|Withdrawal by Subject|17|||
163027481|NCT01451164|588804041|FG000|Overall Study|Protocol Violation|0|||
163027482|NCT01451164|588804042|FG001|Overall Study|Protocol Violation|1|||
163027483|NCT01451164|588804043|FG002|Overall Study|Protocol Violation|0|||
163027484|NCT01451164|588804044|FG003|Overall Study|Protocol Violation|0|||
163027485|NCT01451164|588804041|FG000|Overall Study|Lack of Efficacy|7|||
163027486|NCT01451164|588804042|FG001|Overall Study|Lack of Efficacy|9|||
163027487|NCT01451164|588804043|FG002|Overall Study|Lack of Efficacy|9|||
163027488|NCT01451164|588804044|FG003|Overall Study|Lack of Efficacy|7|||
163027489|NCT04045132|588804049|FG000|Overall Study|Lost to Follow-up|3|||
163027490|NCT04045132|588804050|FG001|Overall Study|Lost to Follow-up|6|||
163027491|NCT02963558|588804051|FG000|Overall Study|Withdrawn by investigator|1|||
163027492|NCT02963558|588804052|FG001|Overall Study|Withdrawn by investigator|0|||
163027493|NCT02963558|588804051|FG000|Overall Study|Withdrawal by Subject|0|||
163027494|NCT02963558|588804052|FG001|Overall Study|Withdrawal by Subject|1|||
163027495|NCT04063657|588804056|FG000|Overall Study|Lost to Follow-up|1|||
163027496|NCT04063657|588804057|FG001|Overall Study|Lost to Follow-up|0|||
163027497|NCT01214252|588804058|FG000|Overall Study|Not eligible per protocol|82|||
163027498|NCT01371877|588804060|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
163027499|NCT01371877|588804061|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
163027500|NCT05932225|588804062|FG000|Overall Study|Lost to Follow-up|0|||
163027501|NCT05932225|588804063|FG001|Overall Study|Lost to Follow-up|1|||
163027502|NCT05932225|588804064|FG002|Overall Study|Lost to Follow-up|0|||
163027503|NCT05932225|588804062|FG000|Overall Study|Withdrawal by Subject|1|||
163027504|NCT05932225|588804063|FG001|Overall Study|Withdrawal by Subject|0|||
163027505|NCT05932225|588804064|FG002|Overall Study|Withdrawal by Subject|0|||
163027506|NCT05932225|588804062|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
163027507|NCT05932225|588804063|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
163027508|NCT05932225|588804064|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
163027509|NCT00552032|588804065|FG000|Overall Study|Withdrawal by Subject|2|||
163027510|NCT00552032|588804066|FG001|Overall Study|Withdrawal by Subject|2|||
163027511|NCT00552032|588804065|FG000|Overall Study|Protocol Violation|7|||
163027512|NCT00552032|588804066|FG001|Overall Study|Protocol Violation|12|||
163027513|NCT00552032|588804065|FG000|Overall Study|Lost to Follow-up|8|||
163027514|NCT00552032|588804066|FG001|Overall Study|Lost to Follow-up|5|||
163027515|NCT00345878|588804067|FG000|Overall Study|Adverse Event|1|||
163027516|NCT00345878|588804068|FG001|Overall Study|Adverse Event|0|||
163027517|NCT00345878|588804067|FG000|Overall Study|Lost to Follow-up|2|||
162644494|NCT02357901|587415806|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
163027518|NCT00345878|588804068|FG001|Overall Study|Lost to Follow-up|1|||
163027519|NCT00345878|588804067|FG000|Overall Study|Other|1|||
163027520|NCT00345878|588804068|FG001|Overall Study|Other|0|||
163027521|NCT02045732|588804069|FG000|Overall Study|At the discretion of the investigator|1|||
163027522|NCT02045732|588804070|FG001|Overall Study|At the discretion of the investigator|1|||
163027523|NCT01877551|588804074|FG000|Overall Study|Physician Decision|0|||
163027524|NCT01877551|588804075|FG001|Overall Study|Physician Decision|1|||
163027525|NCT02659514|588804078|FG000|Overall Study|Adverse Event|3|||
163027526|NCT02659514|588804079|FG001|Overall Study|Adverse Event|12|||
163027527|NCT02659514|588804078|FG000|Overall Study|Disease Progression|23|||
163027528|NCT02659514|588804079|FG001|Overall Study|Disease Progression|13|||
163027529|NCT02659514|588804078|FG000|Overall Study|Withdrawal by Subject|0|||
163072575|NCT03315689|588972975|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
162644495|NCT02357901|587415807|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
163027530|NCT02659514|588804079|FG001|Overall Study|Withdrawal by Subject|4|||
162644496|NCT02357901|587415808|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
162644497|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
162644498|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
162644499|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
162644500|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
162644501|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
162644502|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
162644503|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
162644504|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
162644505|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162644506|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
162644507|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
162644508|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
162644509|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
162644510|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
162644511|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
162644512|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
163072576|NCT03315689|588972974|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
163072577|NCT03315689|588972975|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
163072578|NCT03315689|588972974|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
163072579|NCT03315689|588972975|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
163072580|NCT00864513|588972976|FG000|Overall Study|Withdrawal by Subject|3|||
162644513|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
162644514|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
163027531|NCT02659514|588804078|FG000|Overall Study|Lost to Follow-up|0|||
163027532|NCT02659514|588804079|FG001|Overall Study|Lost to Follow-up|1|||
163027533|NCT02659514|588804078|FG000|Overall Study|Death|6|||
163027534|NCT02659514|588804079|FG001|Overall Study|Death|1|||
163027535|NCT02659514|588804078|FG000|Overall Study|Reason Unspecified|0|||
163027536|NCT02659514|588804079|FG001|Overall Study|Reason Unspecified|3|||
163027537|NCT03409107|588804080|FG000|Overall Study|Withdrawal by Subject|4|||
163027538|NCT03409107|588804081|FG001|Overall Study|Withdrawal by Subject|2|||
163027539|NCT03409107|588804080|FG000|Overall Study|Physician Decision|1|||
163027540|NCT03409107|588804081|FG001|Overall Study|Physician Decision|0|||
163027541|NCT03409107|588804080|FG000|Overall Study|Lost to Follow-up|7|||
163027542|NCT03409107|588804081|FG001|Overall Study|Lost to Follow-up|2|||
163027543|NCT03409107|588804080|FG000|Overall Study|Adverse Event|5|||
163027544|NCT03409107|588804081|FG001|Overall Study|Adverse Event|3|||
163027545|NCT02062944|588804088|FG000|Overall Study|Lost to Follow-up|1|||
163027546|NCT02062944|588804088|FG000|Overall Study|New hemotological disorder identified|1|||
163027547|NCT02062944|588804088|FG000|Overall Study|Uncontrolled Hypertension|1|||
163027548|NCT02062944|588804088|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
163027549|NCT00278148|588804089|FG000|Phase II - Expansion Phase|Disease progression|0|||
163027550|NCT00278148|588804090|FG001|Phase II - Expansion Phase|Disease progression|0|||
163027551|NCT00278148|588804091|FG002|Phase II - Expansion Phase|Disease progression|4|||
163027552|NCT00278148|588804089|FG000|Phase II - Expansion Phase|Adverse Event|0|||
163027553|NCT00278148|588804090|FG001|Phase II - Expansion Phase|Adverse Event|0|||
163027554|NCT00278148|588804091|FG002|Phase II - Expansion Phase|Adverse Event|2|||
163027555|NCT01459718|588804094|FG000|Overall Study|Physician Decision|1|||
163027556|NCT01459718|588804094|FG000|Overall Study|Lost to Follow-up|1|||
163027557|NCT01459718|588804094|FG000|Overall Study|Adverse Event|1|||
163027558|NCT05174949|588804100|FG000|Overall Study|Physician Decision|1|||
163027559|NCT05174949|588804101|FG001|Overall Study|Physician Decision|2|||
163027560|NCT05174949|588804102|FG002|Overall Study|Physician Decision|0|||
163027561|NCT05174949|588804103|FG003|Overall Study|Physician Decision|1|||
163027562|NCT05174949|588804104|FG004|Overall Study|Physician Decision|0|||
163027563|NCT05174949|588804105|FG005|Overall Study|Physician Decision|0|||
163027564|NCT05174949|588804100|FG000|Overall Study|Withdrawal by Subject|0|||
163027565|NCT05174949|588804101|FG001|Overall Study|Withdrawal by Subject|1|||
163027566|NCT05174949|588804102|FG002|Overall Study|Withdrawal by Subject|0|||
163027567|NCT05174949|588804103|FG003|Overall Study|Withdrawal by Subject|0|||
163027568|NCT05174949|588804104|FG004|Overall Study|Withdrawal by Subject|0|||
163027569|NCT05174949|588804105|FG005|Overall Study|Withdrawal by Subject|0|||
163027570|NCT05174949|588804100|FG000|Overall Study|Lost to Follow-up|0|||
163027571|NCT05174949|588804101|FG001|Overall Study|Lost to Follow-up|0|||
163027572|NCT05174949|588804102|FG002|Overall Study|Lost to Follow-up|0|||
163027573|NCT05174949|588804103|FG003|Overall Study|Lost to Follow-up|1|||
163027574|NCT05174949|588804104|FG004|Overall Study|Lost to Follow-up|0|||
163027575|NCT05174949|588804105|FG005|Overall Study|Lost to Follow-up|0|||
163027576|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
163027577|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
163027578|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
163072581|NCT00762788|588972977|FG000|Overall Study|Lost to Follow-up|26|||
163072582|NCT00762788|588972978|FG001|Overall Study|Lost to Follow-up|37|||
163072583|NCT00762788|588972979|FG002|Overall Study|Lost to Follow-up|21|||
163072584|NCT00762788|588972980|FG003|Overall Study|Lost to Follow-up|26|||
163072585|NCT00762788|588972981|FG004|Overall Study|Lost to Follow-up|13|||
163072586|NCT00762788|588972982|FG005|Overall Study|Lost to Follow-up|21|||
163072587|NCT03073109|588972983|FG000|Overall Study|Adverse Event|0|||
163072588|NCT03073109|588972984|FG001|Overall Study|Adverse Event|1|||
163072589|NCT03073109|588972983|FG000|Overall Study|Other|2|||
163072590|NCT03073109|588972984|FG001|Overall Study|Other|0|||
163072591|NCT03073109|588972983|FG000|Overall Study|Lost to Follow-up|8|||
163072592|NCT03073109|588972984|FG001|Overall Study|Lost to Follow-up|1|||
163072593|NCT00669331|588972987|FG000|Randomisation to First Dose|Adverse Event|1|||
163072594|NCT00669331|588972988|FG001|Randomisation to First Dose|Adverse Event|0|||
163072595|NCT00669331|588972987|FG000|Randomisation to First Dose|Protocol Violation|1|||
163072596|NCT00669331|588972988|FG001|Randomisation to First Dose|Protocol Violation|0|||
163072597|NCT00669331|588972987|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
163072598|NCT00669331|588972988|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
163072599|NCT00669331|588972987|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
163072600|NCT00669331|588972988|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
163072601|NCT00669331|588972987|FG000|Randomisation to First Dose|Death|1|||
163072602|NCT00669331|588972988|FG001|Randomisation to First Dose|Death|0|||
163072603|NCT00669331|588972987|FG000|Randomisation to First Dose|Sponsor decision|0|||
163072604|NCT00669331|588972988|FG001|Randomisation to First Dose|Sponsor decision|1|||
163072605|NCT00669331|588972987|FG000|Randomisation to First Dose|Randomised in error|3|||
162717861|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
162717862|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
163027579|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
163027580|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
163027581|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
163027582|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
163027583|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
163027584|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
163027585|NCT02951533|588804106|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
163027586|NCT02951533|588804107|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
163027587|NCT02951533|588804108|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
163027588|NCT02951533|588804106|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
163027589|NCT02951533|588804107|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
163027590|NCT02951533|588804108|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
163027591|NCT02951533|588804106|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
163027592|NCT02951533|588804107|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
163027593|NCT02951533|588804108|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
163027594|NCT02951533|588804106|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
163027595|NCT02951533|588804107|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
163027596|NCT02951533|588804108|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
163027597|NCT02951533|588804106|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
163027598|NCT02951533|588804107|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
163027599|NCT02951533|588804108|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
163027600|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
163027601|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
163027602|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
163027603|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
163027604|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
163027605|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
163027606|NCT02951533|588804106|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
163027607|NCT02951533|588804107|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
163027608|NCT02951533|588804108|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
163027609|NCT02029989|588804109|FG000|Overall Study|Withdrawal by Subject|1|||
163027610|NCT02029989|588804110|FG001|Overall Study|Withdrawal by Subject|0|||
163027611|NCT02029989|588804109|FG000|Overall Study|Withdrawal: Fear of needles|1|||
163027612|NCT02029989|588804110|FG001|Overall Study|Withdrawal: Fear of needles|0|||
163072606|NCT00669331|588972988|FG001|Randomisation to First Dose|Randomised in error|10|||
163072607|NCT00669331|588972987|FG000|Blinded Treatment Period|Adverse Event|16|||
163072608|NCT00669331|588972988|FG001|Blinded Treatment Period|Adverse Event|10|||
163072609|NCT00669331|588972987|FG000|Blinded Treatment Period|Protocol Violation|1|||
163072610|NCT00669331|588972988|FG001|Blinded Treatment Period|Protocol Violation|1|||
163072611|NCT00669331|588972987|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
163072612|NCT00669331|588972988|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
163072613|NCT00669331|588972987|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
163072614|NCT00669331|588972988|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
163072615|NCT00669331|588972987|FG000|Blinded Treatment Period|Death|0|||
163072616|NCT00669331|588972988|FG001|Blinded Treatment Period|Death|2|||
162644515|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
162644516|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
162644517|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
162644518|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
163072617|NCT00669331|588972987|FG000|Blinded Treatment Period|Physician Decision|3|||
163072618|NCT00669331|588972988|FG001|Blinded Treatment Period|Physician Decision|3|||
163072619|NCT00669331|588972987|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
163072620|NCT00669331|588972988|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
163072621|NCT03387046|588972989|FG000|Overall Study|Adverse Event|1|||
163072622|NCT03387046|588972990|FG001|Overall Study|Adverse Event|1|||
163072623|NCT00509600|588972991|FG000|Overall Study|Adverse Event|1|||
163072624|NCT00986232|588972992|FG000|Overall Study|Adverse Event|1|||
163072625|NCT00986232|588972993|FG001|Overall Study|Adverse Event|2|||
163072626|NCT00986232|588972994|FG002|Overall Study|Adverse Event|3|||
163072627|NCT00986232|588972995|FG003|Overall Study|Adverse Event|0|||
163072628|NCT00986232|588972992|FG000|Overall Study|Lost to Follow-up|19|||
163072629|NCT00986232|588972993|FG001|Overall Study|Lost to Follow-up|12|||
163072630|NCT00986232|588972994|FG002|Overall Study|Lost to Follow-up|12|||
163072631|NCT00986232|588972995|FG003|Overall Study|Lost to Follow-up|7|||
163072632|NCT00986232|588972992|FG000|Overall Study|Protocol Violation|2|||
163072633|NCT00986232|588972993|FG001|Overall Study|Protocol Violation|3|||
163072634|NCT00986232|588972994|FG002|Overall Study|Protocol Violation|0|||
163072635|NCT00986232|588972995|FG003|Overall Study|Protocol Violation|1|||
163072636|NCT00986232|588972992|FG000|Overall Study|Withdrawal by Subject|13|||
163072637|NCT00986232|588972993|FG001|Overall Study|Withdrawal by Subject|16|||
163072638|NCT00986232|588972994|FG002|Overall Study|Withdrawal by Subject|12|||
163072639|NCT00986232|588972995|FG003|Overall Study|Withdrawal by Subject|3|||
163072640|NCT00986232|588972992|FG000|Overall Study|Missed one or more bleeds|13|||
163072641|NCT00986232|588972993|FG001|Overall Study|Missed one or more bleeds|10|||
163072642|NCT00986232|588972994|FG002|Overall Study|Missed one or more bleeds|6|||
163072643|NCT00986232|588972995|FG003|Overall Study|Missed one or more bleeds|7|||
163072644|NCT00986232|588972992|FG000|Overall Study|Incomplete safety follow-up|3|||
163072645|NCT00986232|588972993|FG001|Overall Study|Incomplete safety follow-up|7|||
163072646|NCT00986232|588972994|FG002|Overall Study|Incomplete safety follow-up|2|||
163072647|NCT00986232|588972995|FG003|Overall Study|Incomplete safety follow-up|2|||
163072648|NCT02568423|588972996|FG000|Overall Study|Lost to Follow-up|0|||
163072649|NCT02568423|588972997|FG001|Overall Study|Lost to Follow-up|2|||
163072650|NCT02568423|588972998|FG002|Overall Study|Lost to Follow-up|0|||
163072651|NCT02568423|588972999|FG003|Overall Study|Lost to Follow-up|0|||
163072652|NCT02568423|588973000|FG004|Overall Study|Lost to Follow-up|0|||
163072653|NCT02568423|588973001|FG005|Overall Study|Lost to Follow-up|0|||
163072654|NCT02568423|588973002|FG006|Overall Study|Lost to Follow-up|0|||
163072655|NCT02568423|588973003|FG007|Overall Study|Lost to Follow-up|0|||
163072656|NCT02568423|588972996|FG000|Overall Study|Physician Decision|0|||
163072657|NCT02568423|588972997|FG001|Overall Study|Physician Decision|0|||
163072658|NCT02568423|588972998|FG002|Overall Study|Physician Decision|0|||
163072659|NCT02568423|588972999|FG003|Overall Study|Physician Decision|0|||
163072660|NCT02568423|588973000|FG004|Overall Study|Physician Decision|0|||
162644519|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
162644520|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
163072661|NCT02568423|588973001|FG005|Overall Study|Physician Decision|1|||
163072662|NCT02568423|588973002|FG006|Overall Study|Physician Decision|0|||
163072663|NCT02568423|588973003|FG007|Overall Study|Physician Decision|0|||
162644521|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
162644522|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
162644523|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
163072664|NCT03794544|588973004|FG000|Overall Study|Withdrawal by Subject|1|||
163072665|NCT03794544|588973005|FG001|Overall Study|Withdrawal by Subject|1|||
163072666|NCT03794544|588973006|FG002|Overall Study|Withdrawal by Subject|0|||
163072667|NCT03794544|588973007|FG003|Overall Study|Withdrawal by Subject|0|||
163072668|NCT03794544|588973004|FG000|Overall Study|Death|0|||
163072669|NCT03794544|588973005|FG001|Overall Study|Death|0|||
163072670|NCT03794544|588973006|FG002|Overall Study|Death|0|||
163072671|NCT03794544|588973007|FG003|Overall Study|Death|1|||
163072672|NCT03794544|588973004|FG000|Overall Study|Lost to Follow-up|0|||
163072673|NCT03794544|588973005|FG001|Overall Study|Lost to Follow-up|1|||
163072674|NCT03794544|588973006|FG002|Overall Study|Lost to Follow-up|1|||
163072675|NCT03794544|588973007|FG003|Overall Study|Lost to Follow-up|0|||
163072676|NCT03794544|588973004|FG000|Overall Study|Other|0|||
163072677|NCT03794544|588973005|FG001|Overall Study|Other|1|||
162644524|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
162644525|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
162644526|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
162644527|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
162644528|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
162644529|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
162644530|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
162644531|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
162644532|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
162644533|NCT02357901|587415805|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
162644534|NCT02357901|587415806|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
162644535|NCT02357901|587415807|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
162644536|NCT02357901|587415808|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
162644537|NCT02759120|587415811|FG000|Overall Study|Death|34|||
162644538|NCT02759120|587415812|FG001|Overall Study|Death|36|||
162644539|NCT02759120|587415811|FG000|Overall Study|Lost to Follow-up|4|||
162644540|NCT02759120|587415812|FG001|Overall Study|Lost to Follow-up|7|||
162644541|NCT02759120|587415811|FG000|Overall Study|Physician Decision|3|||
162644542|NCT02759120|587415812|FG001|Overall Study|Physician Decision|0|||
162644543|NCT02759120|587415811|FG000|Overall Study|Withdrawal by Subject|28|||
162644544|NCT02759120|587415812|FG001|Overall Study|Withdrawal by Subject|15|||
162644545|NCT02759120|587415811|FG000|Overall Study|Moved out of area|3|||
162644546|NCT02759120|587415812|FG001|Overall Study|Moved out of area|4|||
162644547|NCT02759120|587415811|FG000|Overall Study|Lung transplant|3|||
162644548|NCT02759120|587415812|FG001|Overall Study|Lung transplant|5|||
162644549|NCT02759120|587415811|FG000|Overall Study|Other reason not completed|10|||
162644550|NCT02759120|587415812|FG001|Overall Study|Other reason not completed|12|||
162644551|NCT04461015|587415816|FG000|Overall Study|IV access lost during the study|0|||
162644552|NCT04461015|587415817|FG001|Overall Study|IV access lost during the study|1|||
162644553|NCT04461015|587415816|FG000|Overall Study|Withdrawal by Subject|0|||
162644554|NCT04461015|587415817|FG001|Overall Study|Withdrawal by Subject|1|||
162644555|NCT00491387|587415819|FG000|Overall Study|study terminated|20|||
162644556|NCT02063854|587415826|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
163027613|NCT02029989|588804109|FG000|Overall Study|Change of location|2|||
163027614|NCT02029989|588804110|FG001|Overall Study|Change of location|3|||
163027615|NCT02029989|588804109|FG000|Overall Study|Physician Decision|2|||
163027616|NCT02029989|588804110|FG001|Overall Study|Physician Decision|0|||
163027617|NCT02029989|588804109|FG000|Overall Study|Lost to Follow-up|9|||
163027618|NCT02029989|588804110|FG001|Overall Study|Lost to Follow-up|7|||
163027619|NCT02029989|588804109|FG000|Overall Study|Death|0|||
163027620|NCT02029989|588804110|FG001|Overall Study|Death|1|||
163027621|NCT02029989|588804109|FG000|Overall Study|Protocol Violation|1|||
163027622|NCT02029989|588804110|FG001|Overall Study|Protocol Violation|0|||
163027623|NCT04351373|588804111|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
163027624|NCT01123941|588804117|FG000|Overall Study|Lost to Follow-up|2|||
163027625|NCT01123941|588804118|FG001|Overall Study|Lost to Follow-up|1|||
163027626|NCT05036668|588804119|FG000|Overall Study|lost to follow Up|0|||
163027627|NCT05036668|588804120|FG001|Overall Study|lost to follow Up|0|||
163027628|NCT05036668|588804121|FG002|Overall Study|lost to follow Up|1|||
163027629|NCT01537068|588804122|FG000|Overall Study|Lost to Follow-up|2|||
163027630|NCT01537068|588804123|FG001|Overall Study|Lost to Follow-up|1|||
163027631|NCT01537068|588804122|FG000|Overall Study|Adverse Event|0|||
163027632|NCT01537068|588804123|FG001|Overall Study|Adverse Event|1|||
163027633|NCT01537068|588804122|FG000|Overall Study|Withdrawal by Subject|1|||
163027634|NCT01537068|588804123|FG001|Overall Study|Withdrawal by Subject|1|||
163027635|NCT01537068|588804122|FG000|Overall Study|Lack of Efficacy|1|||
163027636|NCT01537068|588804123|FG001|Overall Study|Lack of Efficacy|0|||
163027637|NCT06011161|588804124|FG000|Overall Study|Withdrawal by Subject|2|||
163027638|NCT06011161|588804124|FG000|Overall Study|Lost to Follow-up|5|||
163027639|NCT02291601|588804125|FG000|Abdomen|Did not qualify|333|||
163027640|NCT02291601|588804126|FG001|Abdomen|Did not qualify|54|||
163027641|NCT02291601|588804127|FG002|Abdomen|Did not qualify|339|||
163027642|NCT02291601|588804125|FG000|Groin|Did not qualify|183|||
163027643|NCT02291601|588804126|FG001|Groin|Did not qualify|30|||
163027644|NCT02291601|588804127|FG002|Groin|Did not qualify|177|||
163027645|NCT04017832|588804130|FG000|Overall Study|Withdrawal by Subject|13|||
163027646|NCT04017832|588804131|FG001|Overall Study|Withdrawal by Subject|12|||
163027647|NCT04017832|588804132|FG002|Overall Study|Withdrawal by Subject|21|||
162644557|NCT02063854|587415827|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
162644558|NCT02063854|587415828|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
162644559|NCT02063854|587415829|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
163027648|NCT04017832|588804133|FG003|Overall Study|Withdrawal by Subject|7|||
163027649|NCT04017832|588804130|FG000|Overall Study|Lost to Follow-up|0|||
163027650|NCT04017832|588804131|FG001|Overall Study|Lost to Follow-up|3|||
163027651|NCT04017832|588804132|FG002|Overall Study|Lost to Follow-up|3|||
163072678|NCT03794544|588973006|FG002|Overall Study|Other|0|||
162644560|NCT02063854|587415830|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
162644561|NCT02063854|587415831|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
162644562|NCT02063854|587415832|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
162644563|NCT02063854|587415826|FG000|Overall Study|Major Protocol Deviation|0|||
162644564|NCT02063854|587415827|FG001|Overall Study|Major Protocol Deviation|0|||
163072679|NCT03794544|588973007|FG003|Overall Study|Other|0|||
163072680|NCT02502383|588973009|FG000|Overall Study|Lost to Follow-up|130|||
163072681|NCT02502383|588973010|FG001|Overall Study|Lost to Follow-up|131|||
163072682|NCT02502383|588973009|FG000|Overall Study|Withdrawal by Subject|31|||
163072683|NCT02502383|588973010|FG001|Overall Study|Withdrawal by Subject|24|||
163072684|NCT01428713|588973011|FG000|Overall Study|Non-compliance|2|||
163072685|NCT01428713|588973012|FG001|Overall Study|Non-compliance|2|||
163072686|NCT01428713|588973011|FG000|Overall Study|Withdrawal by Subject|1|||
163072687|NCT01428713|588973012|FG001|Overall Study|Withdrawal by Subject|1|||
163072688|NCT01428713|588973011|FG000|Overall Study|Adverse Event|0|||
163072689|NCT01428713|588973012|FG001|Overall Study|Adverse Event|2|||
163072690|NCT00875667|588973015|FG000|Overall Study|Adverse Event|29|||
163072691|NCT00875667|588973016|FG001|Overall Study|Adverse Event|10|||
163072692|NCT00875667|588973015|FG000|Overall Study|Withdrawal by Subject|17|||
163072693|NCT00875667|588973016|FG001|Overall Study|Withdrawal by Subject|5|||
163072694|NCT00875667|588973015|FG000|Overall Study|Death|7|||
163072695|NCT00875667|588973016|FG001|Overall Study|Death|2|||
163072696|NCT00875667|588973015|FG000|Overall Study|Protocol Violation|2|||
163072697|NCT00875667|588973016|FG001|Overall Study|Protocol Violation|0|||
163072698|NCT00875667|588973015|FG000|Overall Study|Disease Progression|100|||
163072699|NCT00875667|588973016|FG001|Overall Study|Disease Progression|49|||
163072700|NCT00875667|588973015|FG000|Overall Study|Miscellaneous|12|||
163072701|NCT00875667|588973016|FG001|Overall Study|Miscellaneous|6|||
163072702|NCT00875667|588973015|FG000|Overall Study|Randomized but no Study Drug Given|3|||
163072703|NCT00875667|588973016|FG001|Overall Study|Randomized but no Study Drug Given|1|||
163072704|NCT00120250|588973017|FG000|Overall Study|Lost to Follow-up|1|||
163072705|NCT00120250|588973018|FG001|Overall Study|Lost to Follow-up|1|||
163072706|NCT00120250|588973017|FG000|Overall Study|Protocol Violation|0|||
163072707|NCT00120250|588973018|FG001|Overall Study|Protocol Violation|1|||
163072708|NCT01967277|588973019|FG000|Overall Study|Lost to Follow-up|1|||
163072709|NCT01967277|588973020|FG001|Overall Study|Lost to Follow-up|2|||
163072710|NCT01967277|588973019|FG000|Overall Study|Unrelated illness|0|||
163072711|NCT01967277|588973020|FG001|Overall Study|Unrelated illness|1|||
163072712|NCT02384460|588973029|FG000|Overall Study|Protocol Violation|0|||
163072713|NCT02384460|588973030|FG001|Overall Study|Protocol Violation|1|||
163072714|NCT02384460|588973029|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
163072715|NCT02384460|588973030|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
163072716|NCT02384460|588973029|FG000|Overall Study|Adverse Event|5|||
163072717|NCT02384460|588973030|FG001|Overall Study|Adverse Event|2|||
163072718|NCT02384460|588973029|FG000|Overall Study|Withdrawal by Subject|0|||
163072719|NCT02384460|588973030|FG001|Overall Study|Withdrawal by Subject|3|||
163072720|NCT02384460|588973029|FG000|Overall Study|Elective medical treatment|1|||
163072721|NCT02384460|588973030|FG001|Overall Study|Elective medical treatment|0|||
163072722|NCT02384460|588973029|FG000|Overall Study|Non-compliance|1|||
163072723|NCT02384460|588973030|FG001|Overall Study|Non-compliance|0|||
163072724|NCT02301429|588973034|FG000|Overall Study|not acceptable vascular anatomy|3|||
163072725|NCT01279200|588973040|FG000|Overall Study|Withdrawal by Subject|1|||
163072726|NCT01279200|588973041|FG001|Overall Study|Withdrawal by Subject|3|||
163072727|NCT01279200|588973040|FG000|Overall Study|Patient withdrawal due to high cost|0|||
163072728|NCT01279200|588973041|FG001|Overall Study|Patient withdrawal due to high cost|1|||
163072729|NCT01279200|588973040|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
163072730|NCT01279200|588973041|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
163072731|NCT01279200|588973040|FG000|Overall Study|ultrasound screening failure|0|||
163072732|NCT01279200|588973041|FG001|Overall Study|ultrasound screening failure|1|||
163072733|NCT01279200|588973040|FG000|Overall Study|Lost to Follow-up|0|||
162644565|NCT02063854|587415828|FG002|Overall Study|Major Protocol Deviation|3|||
162644566|NCT02063854|587415829|FG003|Overall Study|Major Protocol Deviation|0|||
162644567|NCT02063854|587415830|FG004|Overall Study|Major Protocol Deviation|0|||
162644568|NCT02063854|587415831|FG005|Overall Study|Major Protocol Deviation|0|||
162644569|NCT02063854|587415832|FG006|Overall Study|Major Protocol Deviation|0|||
163072734|NCT01279200|588973041|FG001|Overall Study|Lost to Follow-up|1|||
163072735|NCT01279200|588973040|FG000|Overall Study|Adverse Event|1|||
163072736|NCT01279200|588973041|FG001|Overall Study|Adverse Event|0|||
163072737|NCT01399099|588973042|FG000|Overall Study|Lost to Follow-up|14|||
163072738|NCT01399099|588973042|FG000|Overall Study|Physician Decision|1|||
163072739|NCT01399099|588973042|FG000|Overall Study|Protocol Violation|1|||
163072740|NCT01399099|588973042|FG000|Overall Study|Skin Irritation|13|||
163072741|NCT01399099|588973042|FG000|Overall Study|Infection|1|||
163072742|NCT01399099|588973042|FG000|Overall Study|Miscellaneous|4|||
163072743|NCT01179516|588973043|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163072744|NCT01179516|588973044|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
163072745|NCT01179516|588973045|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
163072746|NCT01179516|588973043|FG000|Overall Study|Lack of Efficacy|4|||
163072747|NCT01179516|588973044|FG001|Overall Study|Lack of Efficacy|2|||
163072748|NCT01179516|588973045|FG002|Overall Study|Lack of Efficacy|0|||
163072749|NCT01179516|588973043|FG000|Overall Study|Noncompliance with Study Drug|2|||
163072750|NCT01179516|588973044|FG001|Overall Study|Noncompliance with Study Drug|0|||
163072751|NCT01179516|588973045|FG002|Overall Study|Noncompliance with Study Drug|1|||
163072752|NCT01179516|588973043|FG000|Overall Study|Protocol Deviations|4|||
163072753|NCT01179516|588973044|FG001|Overall Study|Protocol Deviations|3|||
163072754|NCT01179516|588973045|FG002|Overall Study|Protocol Deviations|3|||
163072755|NCT01179516|588973043|FG000|Overall Study|Withdrawal of Consent|2|||
163072756|NCT01179516|588973044|FG001|Overall Study|Withdrawal of Consent|6|||
163072757|NCT01179516|588973045|FG002|Overall Study|Withdrawal of Consent|10|||
163072758|NCT01179516|588973043|FG000|Overall Study|Lost to Follow-up|7|||
163072759|NCT01179516|588973044|FG001|Overall Study|Lost to Follow-up|7|||
163072760|NCT01179516|588973045|FG002|Overall Study|Lost to Follow-up|3|||
163072761|NCT01179516|588973043|FG000|Overall Study|Other|2|||
163072762|NCT01179516|588973044|FG001|Overall Study|Other|0|||
163072763|NCT01179516|588973045|FG002|Overall Study|Other|2|||
163072764|NCT01668537|588973046|FG000|Overall Study|Request to Discontinue Prematurely|1|||
163072765|NCT01668537|588973047|FG001|Overall Study|Request to Discontinue Prematurely|1|||
163072766|NCT01668537|588973046|FG000|Overall Study|Subject unwilling/unable to comply|5|||
163072767|NCT01668537|588973047|FG001|Overall Study|Subject unwilling/unable to comply|0|||
163072768|NCT01668537|588973046|FG000|Overall Study|Reason Precludes Participation|1|||
163072769|NCT01668537|588973047|FG001|Overall Study|Reason Precludes Participation|0|||
163072770|NCT01668537|588973046|FG000|Overall Study|Lost to Follow-up|13|||
163072771|NCT01668537|588973047|FG001|Overall Study|Lost to Follow-up|6|||
163072772|NCT01668537|588973046|FG000|Overall Study|Other|2|||
163072773|NCT01668537|588973047|FG001|Overall Study|Other|3|||
163072774|NCT01149538|588973048|FG000|Overall Study|Lost to Follow-up|0|||
163072775|NCT01149538|588973049|FG001|Overall Study|Lost to Follow-up|1|||
163072776|NCT01149538|588973048|FG000|Overall Study|Withdrawal by Subject|5|||
163072777|NCT01149538|588973049|FG001|Overall Study|Withdrawal by Subject|3|||
163072778|NCT02336503|588973054|FG000|Overall Study|Lost to Follow-up|0|||
163072779|NCT02336503|588973055|FG001|Overall Study|Lost to Follow-up|3|||
163072780|NCT02336503|588973056|FG002|Overall Study|Lost to Follow-up|0|||
163072781|NCT02336503|588973057|FG003|Overall Study|Lost to Follow-up|2|||
163072782|NCT02336503|588973054|FG000|Overall Study|Withdrawal by Subject|2|||
163072783|NCT02336503|588973055|FG001|Overall Study|Withdrawal by Subject|0|||
163072784|NCT02336503|588973056|FG002|Overall Study|Withdrawal by Subject|0|||
163072785|NCT02336503|588973057|FG003|Overall Study|Withdrawal by Subject|4|||
163072786|NCT02336503|588973054|FG000|Overall Study|Adverse Event|0|||
163072787|NCT02336503|588973055|FG001|Overall Study|Adverse Event|0|||
163072788|NCT02336503|588973056|FG002|Overall Study|Adverse Event|1|||
163072789|NCT02336503|588973057|FG003|Overall Study|Adverse Event|0|||
163072790|NCT01436500|588973059|FG000|Overall Study|Death|1|||
163072791|NCT01436500|588973060|FG001|Overall Study|Death|0|||
163072792|NCT01436500|588973061|FG002|Overall Study|Death|0|||
163072793|NCT01436500|588973062|FG003|Overall Study|Death|0|||
163072794|NCT01436500|588973063|FG004|Overall Study|Death|0|||
163072795|NCT01436500|588973059|FG000|Overall Study|Adverse Event|0|||
163072796|NCT01436500|588973060|FG001|Overall Study|Adverse Event|2|||
163072797|NCT01436500|588973061|FG002|Overall Study|Adverse Event|2|||
163072798|NCT01436500|588973062|FG003|Overall Study|Adverse Event|0|||
163072799|NCT01436500|588973063|FG004|Overall Study|Adverse Event|1|||
163072800|NCT01436500|588973059|FG000|Overall Study|Withdrawal by Subject|0|||
163072801|NCT01436500|588973060|FG001|Overall Study|Withdrawal by Subject|0|||
163072802|NCT01436500|588973061|FG002|Overall Study|Withdrawal by Subject|2|||
163072803|NCT01436500|588973062|FG003|Overall Study|Withdrawal by Subject|0|||
163072804|NCT01436500|588973063|FG004|Overall Study|Withdrawal by Subject|2|||
163072805|NCT01436500|588973059|FG000|Overall Study|Physician Decision|0|||
163072806|NCT01436500|588973060|FG001|Overall Study|Physician Decision|0|||
163072807|NCT01436500|588973061|FG002|Overall Study|Physician Decision|1|||
163072808|NCT01436500|588973062|FG003|Overall Study|Physician Decision|0|||
163072809|NCT01436500|588973063|FG004|Overall Study|Physician Decision|0|||
163072810|NCT01436500|588973059|FG000|Overall Study|liver transplant|1|||
163072811|NCT01436500|588973060|FG001|Overall Study|liver transplant|0|||
163072812|NCT01436500|588973061|FG002|Overall Study|liver transplant|0|||
163072813|NCT01436500|588973062|FG003|Overall Study|liver transplant|0|||
163072814|NCT01436500|588973063|FG004|Overall Study|liver transplant|0|||
163072815|NCT01436500|588973059|FG000|Overall Study|initiation of dialysis|0|||
163072816|NCT01436500|588973060|FG001|Overall Study|initiation of dialysis|0|||
163072817|NCT01436500|588973061|FG002|Overall Study|initiation of dialysis|0|||
163072818|NCT01436500|588973062|FG003|Overall Study|initiation of dialysis|0|||
162644570|NCT02063854|587415826|FG000|Overall Study|Voluntary Withdrawal|2|||
162644571|NCT02063854|587415827|FG001|Overall Study|Voluntary Withdrawal|0|||
163072819|NCT01436500|588973063|FG004|Overall Study|initiation of dialysis|1|||
163072820|NCT01436500|588973059|FG000|Overall Study|discontinued study drug|1|||
163072821|NCT01436500|588973060|FG001|Overall Study|discontinued study drug|0|||
163072822|NCT01436500|588973061|FG002|Overall Study|discontinued study drug|0|||
163072823|NCT01436500|588973062|FG003|Overall Study|discontinued study drug|0|||
163072824|NCT01436500|588973063|FG004|Overall Study|discontinued study drug|0|||
163072825|NCT01436500|588973059|FG000|Overall Study|Other|0|||
163072826|NCT01436500|588973060|FG001|Overall Study|Other|1|||
163072827|NCT01436500|588973061|FG002|Overall Study|Other|0|||
163072828|NCT01436500|588973062|FG003|Overall Study|Other|1|||
163072829|NCT01436500|588973063|FG004|Overall Study|Other|0|||
163072830|NCT02184156|588973069|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
163072831|NCT02184156|588973070|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
163072832|NCT02184156|588973069|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
163072833|NCT02184156|588973070|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
163072834|NCT02405962|588973072|FG000|Overall Study|Lost to Follow-up|1|||
163072835|NCT02405962|588973073|FG001|Overall Study|Lost to Follow-up|4|||
163072836|NCT02405962|588973072|FG000|Overall Study|A participant has moved to another place|0|||
163072837|NCT02405962|588973073|FG001|Overall Study|A participant has moved to another place|1|||
163072838|NCT01980888|588973074|FG000|Overall Study|Study Terminated by Sponsor|116|||
163072839|NCT01980888|588973075|FG001|Overall Study|Study Terminated by Sponsor|122|||
163072840|NCT01980888|588973074|FG000|Overall Study|Withdrew Consent|17|||
163072841|NCT01980888|588973075|FG001|Overall Study|Withdrew Consent|6|||
163072842|NCT01980888|588973074|FG000|Overall Study|Investigator's Discretion|8|||
163072843|NCT01980888|588973075|FG001|Overall Study|Investigator's Discretion|3|||
163072844|NCT01980888|588973074|FG000|Overall Study|Non-Compliance with Study Drug|3|||
163072845|NCT01980888|588973075|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163072846|NCT00086307|588973080|FG000|Overall Study|Lack of Efficacy|1|||
163072847|NCT00086307|588973081|FG001|Overall Study|Lack of Efficacy|1|||
163072848|NCT00086307|588973082|FG002|Overall Study|Lack of Efficacy|2|||
163072849|NCT00086307|588973080|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
163072850|NCT00086307|588973081|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
163072851|NCT00086307|588973082|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
163072852|NCT00086307|588973080|FG000|Overall Study|Nausea and headaches|0|||
163072853|NCT00086307|588973081|FG001|Overall Study|Nausea and headaches|0|||
163072854|NCT00086307|588973082|FG002|Overall Study|Nausea and headaches|1|||
163072855|NCT00086307|588973080|FG000|Overall Study|Constipation and sleepiness|0|||
163072856|NCT00086307|588973081|FG001|Overall Study|Constipation and sleepiness|0|||
163072857|NCT00086307|588973082|FG002|Overall Study|Constipation and sleepiness|1|||
163072858|NCT00086307|588973080|FG000|Overall Study|Suicidal ideation|0|||
163072859|NCT00086307|588973081|FG001|Overall Study|Suicidal ideation|0|||
163072860|NCT00086307|588973082|FG002|Overall Study|Suicidal ideation|1|||
163072861|NCT00086307|588973080|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
163072862|NCT00086307|588973081|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
163072863|NCT00086307|588973082|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
163072864|NCT00086307|588973080|FG000|Overall Study|Withdrawal by Subject|0|||
163072865|NCT00086307|588973081|FG001|Overall Study|Withdrawal by Subject|0|||
163072866|NCT00086307|588973082|FG002|Overall Study|Withdrawal by Subject|2|||
163072867|NCT03158311|588973085|FG000|Overall Study|Subject/Guardian Decision|10|||
163072868|NCT03158311|588973086|FG001|Overall Study|Subject/Guardian Decision|6|||
163072869|NCT03158311|588973087|FG002|Overall Study|Subject/Guardian Decision|11|||
163072870|NCT03158311|588973085|FG000|Overall Study|Adverse Event|5|||
163072871|NCT03158311|588973086|FG001|Overall Study|Adverse Event|3|||
163072872|NCT03158311|588973087|FG002|Overall Study|Adverse Event|3|||
163072873|NCT03158311|588973085|FG000|Overall Study|Techinical Problems|3|||
163072874|NCT03158311|588973086|FG001|Overall Study|Techinical Problems|1|||
163072875|NCT03158311|588973087|FG002|Overall Study|Techinical Problems|5|||
163072876|NCT03158311|588973085|FG000|Overall Study|Physician Decision|2|||
163072877|NCT03158311|588973086|FG001|Overall Study|Physician Decision|3|||
163072878|NCT03158311|588973087|FG002|Overall Study|Physician Decision|7|||
163072879|NCT03158311|588973085|FG000|Overall Study|Lost to Follow-up|1|||
163072880|NCT03158311|588973086|FG001|Overall Study|Lost to Follow-up|1|||
163072881|NCT03158311|588973087|FG002|Overall Study|Lost to Follow-up|1|||
163072882|NCT03158311|588973085|FG000|Overall Study|Sponsor decision|1|||
163072883|NCT03158311|588973086|FG001|Overall Study|Sponsor decision|0|||
163072884|NCT03158311|588973087|FG002|Overall Study|Sponsor decision|0|||
163072885|NCT03158311|588973085|FG000|Overall Study|Pregnancy|0|||
163072886|NCT03158311|588973086|FG001|Overall Study|Pregnancy|2|||
162644572|NCT02063854|587415828|FG002|Overall Study|Voluntary Withdrawal|8|||
163072887|NCT03158311|588973087|FG002|Overall Study|Pregnancy|0|||
163072888|NCT03158311|588973085|FG000|Overall Study|Randomized in error|0|||
163072889|NCT03158311|588973086|FG001|Overall Study|Randomized in error|0|||
163072890|NCT03158311|588973087|FG002|Overall Study|Randomized in error|1|||
163072891|NCT01018953|588973088|FG000|Overall Study|Adverse Event|2|||
163072892|NCT01018953|588973088|FG000|Overall Study|Withdrawal by Subject|1|||
163072893|NCT01018953|588973088|FG000|Overall Study|Study termination by sponsor|5|||
163072894|NCT00724503|588973089|FG000|Overall Study|Lost to Follow-up|4|||
163072895|NCT00724503|588973090|FG001|Overall Study|Lost to Follow-up|8|||
163072896|NCT00724503|588973089|FG000|Overall Study|Withdrawal by Subject|11|||
163072897|NCT00724503|588973090|FG001|Overall Study|Withdrawal by Subject|23|||
163072898|NCT00724503|588973089|FG000|Overall Study|Death|190|||
163072899|NCT00724503|588973090|FG001|Overall Study|Death|182|||
163072900|NCT00724503|588973089|FG000|Overall Study|Adverse Event|1|||
163072901|NCT00724503|588973090|FG001|Overall Study|Adverse Event|0|||
163072902|NCT00724503|588973089|FG000|Overall Study|Not otherwise specified|4|||
163072903|NCT00724503|588973090|FG001|Overall Study|Not otherwise specified|7|||
163072904|NCT01184118|588973091|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
163072905|NCT01184118|588973091|FG000|Overall Study|No physiologic confirmation of asthma|8|||
163072906|NCT01184118|588973091|FG000|Overall Study|FEV1 <60% predicted|2|||
163072907|NCT01184118|588973091|FG000|Overall Study|Exclusionary medical condition|2|||
163072908|NCT01184118|588973091|FG000|Overall Study|Withdrawal by Subject|5|||
163072909|NCT01186419|588973092|FG000|Overall Study|Withdrawal by Subject|5|||
163072910|NCT01186419|588973093|FG001|Overall Study|Withdrawal by Subject|3|||
163072911|NCT01186419|588973092|FG000|Overall Study|Adverse Event|1|||
163072912|NCT01186419|588973093|FG001|Overall Study|Adverse Event|2|||
163072913|NCT01186419|588973092|FG000|Overall Study|Physician Decision|0|||
163072914|NCT01186419|588973093|FG001|Overall Study|Physician Decision|3|||
163072915|NCT01186419|588973092|FG000|Overall Study|Other|1|||
163072916|NCT01186419|588973093|FG001|Overall Study|Other|1|||
163072917|NCT01033071|588973099|FG000|Overall Study|Adverse Event|28|||
163072918|NCT01033071|588973100|FG001|Overall Study|Adverse Event|51|||
163072919|NCT01033071|588973101|FG002|Overall Study|Adverse Event|26|||
163072920|NCT01033071|588973099|FG000|Overall Study|Protocol Violation|0|||
163072921|NCT01033071|588973100|FG001|Overall Study|Protocol Violation|2|||
162644573|NCT02063854|587415829|FG003|Overall Study|Voluntary Withdrawal|1|||
162644574|NCT02063854|587415830|FG004|Overall Study|Voluntary Withdrawal|3|||
162644575|NCT02063854|587415831|FG005|Overall Study|Voluntary Withdrawal|6|||
162644576|NCT02063854|587415832|FG006|Overall Study|Voluntary Withdrawal|1|||
162644577|NCT02063854|587415826|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
162644578|NCT02063854|587415827|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
162644579|NCT02063854|587415828|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
162644580|NCT02063854|587415829|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
162644581|NCT02063854|587415830|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
162644582|NCT02063854|587415831|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
162644583|NCT02063854|587415832|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
163072922|NCT01033071|588973101|FG002|Overall Study|Protocol Violation|1|||
163072923|NCT01033071|588973099|FG000|Overall Study|Lost to Follow-up|4|||
163072924|NCT01033071|588973100|FG001|Overall Study|Lost to Follow-up|5|||
163072925|NCT01033071|588973101|FG002|Overall Study|Lost to Follow-up|5|||
163072926|NCT01033071|588973099|FG000|Overall Study|Withdrawal by Subject|17|||
163072927|NCT01033071|588973100|FG001|Overall Study|Withdrawal by Subject|14|||
163072928|NCT01033071|588973101|FG002|Overall Study|Withdrawal by Subject|11|||
163072929|NCT01033071|588973099|FG000|Overall Study|Lack of Efficacy|0|||
163072930|NCT01033071|588973100|FG001|Overall Study|Lack of Efficacy|1|||
163072931|NCT01033071|588973101|FG002|Overall Study|Lack of Efficacy|1|||
163072932|NCT01033071|588973099|FG000|Overall Study|Other|6|||
163072933|NCT01033071|588973100|FG001|Overall Study|Other|4|||
163072934|NCT01033071|588973101|FG002|Overall Study|Other|3|||
163072935|NCT04073407|588973104|FG000|Part 1|Withdrawal by Subject|1|||
163072936|NCT04073407|588973105|FG001|Part 1|Withdrawal by Subject|0|||
163072937|NCT04073407|588973104|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
163072938|NCT04073407|588973105|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
163072939|NCT04073407|588973104|FG000|Part 2|Withdrawal by Subject|0|||
163072940|NCT04073407|588973105|FG001|Part 2|Withdrawal by Subject|1|||
163072941|NCT00585585|588974496|FG000|Overall Study|Adverse Event|1|||
163072942|NCT01964560|588974499|FG000|Overall Study|Adverse Event|23|||
163072943|NCT01964560|588974499|FG000|Overall Study|Lack of Efficacy|46|||
163072944|NCT01964560|588974499|FG000|Overall Study|Protocol deviation|2|||
163072945|NCT01964560|588974499|FG000|Overall Study|Lost to Follow-up|4|||
163072946|NCT01964560|588974499|FG000|Overall Study|Withdrawal by Subject|64|||
163072947|NCT01964560|588974499|FG000|Overall Study|Surgery-hemispherotomy|1|||
163072948|NCT01964560|588974499|FG000|Overall Study|Surgery|1|||
162644584|NCT02063854|587415826|FG000|Overall Study|Reason Not Specified|1|||
163072949|NCT01964560|588974499|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
163072950|NCT01964560|588974499|FG000|Overall Study|Patient and Investigator choice|1|||
163072951|NCT01964560|588974499|FG000|Overall Study|Patient was prescribed CBD|1|||
163072952|NCT01964560|588974499|FG000|Overall Study|Participant moved to another country|1|||
163072953|NCT02217982|588974511|FG000|Overall Study|Trial discontinued|1|||
163072954|NCT02217982|588974512|FG001|Overall Study|Trial discontinued|0|||
163072955|NCT02217982|588974511|FG000|Overall Study|Adverse Event|0|||
163072956|NCT02217982|588974512|FG001|Overall Study|Adverse Event|1|||
163072957|NCT03791060|588974513|FG000|Overall Study|Withdrawal by Subject|1|||
163072958|NCT01011283|588974514|FG000|Overall Study|Adverse Event|4|||
163072959|NCT01011283|588974515|FG001|Overall Study|Adverse Event|2|||
163072960|NCT01011283|588974514|FG000|Overall Study|Progressive Disease|0|||
163072961|NCT01011283|588974515|FG001|Overall Study|Progressive Disease|2|||
163072962|NCT01011283|588974514|FG000|Overall Study|Terminated by Sponsor|5|||
163072963|NCT01011283|588974515|FG001|Overall Study|Terminated by Sponsor|5|||
163072964|NCT01011283|588974514|FG000|Overall Study|Other|2|||
163072965|NCT01011283|588974515|FG001|Overall Study|Other|2|||
163072966|NCT01717859|588974516|FG000|Overall Study|Adverse Event|5|||
163072967|NCT01717859|588974516|FG000|Overall Study|Moved out of state|1|||
163072968|NCT01717859|588974516|FG000|Overall Study|Patient concerned about mental health|1|||
163072969|NCT01717859|588974516|FG000|Overall Study|Lost to Follow-up|1|||
163072970|NCT01717859|588974516|FG000|Overall Study|Withdrawal by Subject|2|||
163072971|NCT04389671|588974517|FG000|Overall Study|Death|7|||
163072972|NCT00724893|588974526|FG000|Overall Study|Adverse Event|76|||
163072973|NCT00724893|588974527|FG001|Overall Study|Adverse Event|142|||
163072974|NCT00724893|588974526|FG000|Overall Study|Withdrawal by Subject|0|||
163072975|NCT00724893|588974527|FG001|Overall Study|Withdrawal by Subject|1|||
163072976|NCT00724893|588974526|FG000|Overall Study|Lack of virologic response|94|||
163072977|NCT00724893|588974527|FG001|Overall Study|Lack of virologic response|202|||
163072978|NCT00724893|588974526|FG000|Overall Study|Reason not specified|193|||
163072979|NCT00724893|588974527|FG001|Overall Study|Reason not specified|7|||
163072980|NCT00724893|588974526|FG000|Overall Study|Patient choice|0|||
163072981|NCT00724893|588974527|FG001|Overall Study|Patient choice|26|||
163072982|NCT00724893|588974526|FG000|Overall Study|Geographic reasons|0|||
163072983|NCT00724893|588974527|FG001|Overall Study|Geographic reasons|11|||
163072984|NCT00724893|588974526|FG000|Overall Study|Incarceration|0|||
163072985|NCT00724893|588974527|FG001|Overall Study|Incarceration|9|||
163072986|NCT00724893|588974526|FG000|Overall Study|Substance abuse|0|||
163072987|NCT00724893|588974527|FG001|Overall Study|Substance abuse|3|||
163072988|NCT00724893|588974526|FG000|Overall Study|Financial reasons|0|||
163072989|NCT00724893|588974527|FG001|Overall Study|Financial reasons|2|||
163072990|NCT00724893|588974526|FG000|Overall Study|Assigned shorter treatment|0|||
163072991|NCT00724893|588974527|FG001|Overall Study|Assigned shorter treatment|2|||
163072992|NCT00724893|588974526|FG000|Overall Study|Lost to Follow-up|0|||
163072993|NCT00724893|588974527|FG001|Overall Study|Lost to Follow-up|52|||
163072994|NCT00724893|588974526|FG000|Overall Study|Unknown, missing data|1|||
163072995|NCT00724893|588974527|FG001|Overall Study|Unknown, missing data|1|||
163072996|NCT01290731|588974528|FG000|Overall Study|Withdrawal by Subject|1|||
163072997|NCT02181738|588974536|FG000|Overall Study|Participant Withdrew Consent|2|||
163072998|NCT02181738|588974537|FG001|Overall Study|Participant Withdrew Consent|1|||
163072999|NCT02181738|588974538|FG002|Overall Study|Participant Withdrew Consent|1|||
163073000|NCT02181738|588974539|FG003|Overall Study|Participant Withdrew Consent|1|||
163073001|NCT02181738|588974536|FG000|Overall Study|Lost to Follow-up|1|||
163073002|NCT02181738|588974537|FG001|Overall Study|Lost to Follow-up|2|||
163073003|NCT02181738|588974538|FG002|Overall Study|Lost to Follow-up|1|||
163073004|NCT02181738|588974539|FG003|Overall Study|Lost to Follow-up|1|||
163073005|NCT02181738|588974536|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073006|NCT02181738|588974537|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073007|NCT02181738|588974538|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
163073008|NCT02181738|588974539|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
163073009|NCT02181738|588974536|FG000|Overall Study|Poor/Non-Compliance|1|||
163073010|NCT02181738|588974537|FG001|Overall Study|Poor/Non-Compliance|0|||
163073011|NCT02181738|588974538|FG002|Overall Study|Poor/Non-Compliance|2|||
163073012|NCT02181738|588974539|FG003|Overall Study|Poor/Non-Compliance|1|||
163073013|NCT02181738|588974536|FG000|Overall Study|Disease Progression|28|||
163073014|NCT02181738|588974537|FG001|Overall Study|Disease Progression|35|||
163073015|NCT02181738|588974538|FG002|Overall Study|Disease Progression|40|||
163073016|NCT02181738|588974539|FG003|Overall Study|Disease Progression|0|||
163073017|NCT02181738|588974536|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
163073018|NCT02181738|588974537|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
163073019|NCT02181738|588974538|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
163073020|NCT02181738|588974539|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
163073021|NCT02181738|588974536|FG000|Overall Study|Study Drug Toxicity|6|||
163073022|NCT02181738|588974537|FG001|Overall Study|Study Drug Toxicity|11|||
163073023|NCT02181738|588974538|FG002|Overall Study|Study Drug Toxicity|8|||
163073024|NCT02181738|588974539|FG003|Overall Study|Study Drug Toxicity|1|||
163073025|NCT02181738|588974536|FG000|Overall Study|Other Reasons|14|||
163073026|NCT02181738|588974537|FG001|Overall Study|Other Reasons|16|||
163073027|NCT02181738|588974538|FG002|Overall Study|Other Reasons|28|||
163073028|NCT02181738|588974539|FG003|Overall Study|Other Reasons|0|||
163073029|NCT02181738|588974536|FG000|Overall Study|Maximum Clinical Benefit|3|||
163073030|NCT02181738|588974537|FG001|Overall Study|Maximum Clinical Benefit|0|||
163073031|NCT02181738|588974538|FG002|Overall Study|Maximum Clinical Benefit|1|||
163073032|NCT02181738|588974539|FG003|Overall Study|Maximum Clinical Benefit|0|||
163073033|NCT02181738|588974536|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163073034|NCT02181738|588974537|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163073035|NCT02181738|588974538|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163073036|NCT02181738|588974539|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163073037|NCT00888849|588974542|FG000|Overall Study|Death|4|||
163073038|NCT00888849|588974543|FG001|Overall Study|Death|7|||
163073039|NCT00888849|588974542|FG000|Overall Study|Lost to Follow-up|1|||
163073040|NCT00888849|588974543|FG001|Overall Study|Lost to Follow-up|2|||
163073041|NCT05064800|588974544|FG000|Period 3|Withdrawal by Subject|0|||
163073042|NCT05064800|588974545|FG001|Period 3|Withdrawal by Subject|0|||
163073043|NCT05064800|588974546|FG002|Period 3|Withdrawal by Subject|0|||
163073044|NCT05064800|588974547|FG003|Period 3|Withdrawal by Subject|0|||
163073045|NCT05064800|588974548|FG004|Period 3|Withdrawal by Subject|1|||
163073046|NCT05064800|588974549|FG005|Period 3|Withdrawal by Subject|0|||
163073047|NCT00629239|588974552|FG000|Overall Study|Adverse Event|7|||
163073048|NCT00629239|588974553|FG001|Overall Study|Adverse Event|4|||
162644585|NCT02063854|587415827|FG001|Overall Study|Reason Not Specified|0|||
163073049|NCT00629239|588974552|FG000|Overall Study|Physician Decision|1|||
163073050|NCT00629239|588974553|FG001|Overall Study|Physician Decision|0|||
163073051|NCT00183391|588974554|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
163073052|NCT00183391|588974555|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
162644586|NCT02063854|587415828|FG002|Overall Study|Reason Not Specified|0|||
162644587|NCT02063854|587415829|FG003|Overall Study|Reason Not Specified|0|||
162644588|NCT02063854|587415830|FG004|Overall Study|Reason Not Specified|0|||
162644589|NCT02063854|587415831|FG005|Overall Study|Reason Not Specified|0|||
162644590|NCT02063854|587415832|FG006|Overall Study|Reason Not Specified|0|||
162644591|NCT02063854|587415826|FG000|Overall Study|Did Not Receive Study Drug|0|||
162644592|NCT02063854|587415827|FG001|Overall Study|Did Not Receive Study Drug|0|||
162717863|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
162644593|NCT02063854|587415828|FG002|Overall Study|Did Not Receive Study Drug|0|||
163027652|NCT04017832|588804133|FG003|Overall Study|Lost to Follow-up|1|||
163027653|NCT04017832|588804130|FG000|Overall Study|Physician Decision|1|||
163027654|NCT04017832|588804131|FG001|Overall Study|Physician Decision|1|||
163027655|NCT04017832|588804132|FG002|Overall Study|Physician Decision|1|||
163027656|NCT04017832|588804133|FG003|Overall Study|Physician Decision|1|||
163027657|NCT04017832|588804130|FG000|Overall Study|Death|2|||
163027658|NCT04017832|588804131|FG001|Overall Study|Death|2|||
163027659|NCT04017832|588804132|FG002|Overall Study|Death|1|||
163027660|NCT04017832|588804133|FG003|Overall Study|Death|0|||
163027661|NCT01744184|588804137|FG000|Overall Study|Adverse Event|1|||
163027662|NCT01744184|588804138|FG001|Overall Study|Adverse Event|0|||
163027663|NCT01744184|588804137|FG000|Overall Study|Withdrawal by Subject|0|||
163027664|NCT01744184|588804138|FG001|Overall Study|Withdrawal by Subject|1|||
163027665|NCT00072280|588804139|FG000|Treatment|Found ineligible|1|||
163027666|NCT00072280|588804140|FG001|Treatment|Found ineligible|2|||
163027667|NCT00072280|588804139|FG000|Follow-up|Early termination of study|2|||
163027668|NCT00072280|588804140|FG001|Follow-up|Early termination of study|2|||
163027669|NCT02841280|588804141|FG000|Overall Study|Adverse Event|2|||
163027670|NCT02841280|588804142|FG001|Overall Study|Adverse Event|1|||
163027671|NCT02841280|588804141|FG000|Overall Study|Death|1|||
163027672|NCT02841280|588804142|FG001|Overall Study|Death|0|||
163027673|NCT02841280|588804141|FG000|Overall Study|Lost to Follow-up|2|||
163027674|NCT02841280|588804142|FG001|Overall Study|Lost to Follow-up|2|||
163027675|NCT02841280|588804141|FG000|Overall Study|Withdrawal by Subject|7|||
163027676|NCT02841280|588804142|FG001|Overall Study|Withdrawal by Subject|3|||
163027677|NCT02841280|588804141|FG000|Overall Study|Stop Point: BP above threshold|2|||
163027678|NCT02841280|588804142|FG001|Overall Study|Stop Point: BP above threshold|0|||
163027679|NCT00125242|588804143|FG000|Overall Study|did not qualify|7|||
163027680|NCT00125242|588804144|FG001|Overall Study|did not qualify|2|||
163027681|NCT01664949|588804145|FG000|Overall Study|Adverse Event|11|||
163027682|NCT01664949|588804146|FG001|Overall Study|Adverse Event|12|||
163027683|NCT01664949|588804145|FG000|Overall Study|Lack of Efficacy|1|||
163027684|NCT01664949|588804146|FG001|Overall Study|Lack of Efficacy|1|||
163027685|NCT01664949|588804145|FG000|Overall Study|Lost to Follow-up|1|||
163027686|NCT01664949|588804146|FG001|Overall Study|Lost to Follow-up|2|||
163073053|NCT00183391|588974554|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
163073054|NCT00183391|588974555|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
163073055|NCT00395512|588974556|FG000|Overall Study|Adverse Event|3|||
163073056|NCT00395512|588974557|FG001|Overall Study|Adverse Event|8|||
163073057|NCT00395512|588974558|FG002|Overall Study|Adverse Event|6|||
163073058|NCT00395512|588974559|FG003|Overall Study|Adverse Event|6|||
163073059|NCT00395512|588974556|FG000|Overall Study|Protocol Violation|2|||
163073060|NCT00395512|588974557|FG001|Overall Study|Protocol Violation|3|||
163073061|NCT00395512|588974558|FG002|Overall Study|Protocol Violation|6|||
163073062|NCT00395512|588974559|FG003|Overall Study|Protocol Violation|7|||
163073063|NCT00395512|588974556|FG000|Overall Study|Lost to Follow-up|2|||
163073064|NCT00395512|588974557|FG001|Overall Study|Lost to Follow-up|6|||
163073065|NCT00395512|588974558|FG002|Overall Study|Lost to Follow-up|5|||
163073066|NCT00395512|588974559|FG003|Overall Study|Lost to Follow-up|5|||
163073067|NCT00395512|588974556|FG000|Overall Study|Withdrawal by Subject|6|||
163073068|NCT00395512|588974557|FG001|Overall Study|Withdrawal by Subject|5|||
163073069|NCT00395512|588974558|FG002|Overall Study|Withdrawal by Subject|5|||
163073070|NCT00395512|588974559|FG003|Overall Study|Withdrawal by Subject|12|||
163073071|NCT00395512|588974556|FG000|Overall Study|Physician Decision|6|||
163073072|NCT00395512|588974557|FG001|Overall Study|Physician Decision|4|||
163073073|NCT00395512|588974558|FG002|Overall Study|Physician Decision|2|||
163073074|NCT00395512|588974559|FG003|Overall Study|Physician Decision|2|||
163073075|NCT00395512|588974556|FG000|Overall Study|Other|1|||
163073076|NCT00395512|588974557|FG001|Overall Study|Other|1|||
163073077|NCT00395512|588974558|FG002|Overall Study|Other|0|||
163073078|NCT00395512|588974559|FG003|Overall Study|Other|0|||
163073079|NCT00395512|588974556|FG000|Overall Study|Hyperglycemic Rescue|18|||
163073080|NCT00395512|588974557|FG001|Overall Study|Hyperglycemic Rescue|10|||
163073081|NCT00395512|588974558|FG002|Overall Study|Hyperglycemic Rescue|4|||
163073082|NCT00395512|588974559|FG003|Overall Study|Hyperglycemic Rescue|6|||
163073083|NCT04584554|588974560|FG000|Overall Study|Withdrawal by Subject|2|||
163073084|NCT04584554|588974561|FG001|Overall Study|Withdrawal by Subject|2|||
163073085|NCT03983109|588974564|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
163073086|NCT03983109|588974565|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
163073087|NCT02021318|588974566|FG000|Overall Study|Adverse Event|2|||
163073088|NCT02021318|588974567|FG001|Overall Study|Adverse Event|1|||
163073089|NCT02021318|588974566|FG000|Overall Study|Death|33|||
163073090|NCT02021318|588974567|FG001|Overall Study|Death|34|||
163073091|NCT02021318|588974566|FG000|Overall Study|Lost to Follow-up|3|||
163073092|NCT02021318|588974567|FG001|Overall Study|Lost to Follow-up|3|||
163073093|NCT02021318|588974566|FG000|Overall Study|Progressive Disease|0|||
163073094|NCT02021318|588974567|FG001|Overall Study|Progressive Disease|1|||
163073095|NCT02021318|588974566|FG000|Overall Study|Withdrawal by Subject|30|||
163073096|NCT02021318|588974567|FG001|Overall Study|Withdrawal by Subject|18|||
163073097|NCT02021318|588974566|FG000|Overall Study|Physician Decision|3|||
163073098|NCT02021318|588974567|FG001|Overall Study|Physician Decision|3|||
163073099|NCT02021318|588974566|FG000|Overall Study|Miscellaneous|2|||
163073100|NCT02021318|588974567|FG001|Overall Study|Miscellaneous|3|||
163073101|NCT01068249|588974568|FG000|Overall Study|Death|1|||
163073102|NCT01068249|588974568|FG000|Overall Study|Withdrawal by Subject|3|||
163073103|NCT01740427|588974569|FG000|Overall Study|Objective Progression or Relapse|286|||
163073104|NCT01740427|588974570|FG001|Overall Study|Objective Progression or Relapse|172|||
163073105|NCT01740427|588974569|FG000|Overall Study|Adverse Event|32|||
163073106|NCT01740427|588974570|FG001|Overall Study|Adverse Event|9|||
163073107|NCT01740427|588974569|FG000|Overall Study|Global Deterioration of Health Status|28|||
163073108|NCT01740427|588974570|FG001|Overall Study|Global Deterioration of Health Status|12|||
163073109|NCT01740427|588974569|FG000|Overall Study|Participant Refused Continued Treatment|27|||
163073110|NCT01740427|588974570|FG001|Overall Study|Participant Refused Continued Treatment|15|||
163073111|NCT01740427|588974569|FG000|Overall Study|Unspecified reasons|52|||
163073112|NCT01740427|588974570|FG001|Overall Study|Unspecified reasons|8|||
163073113|NCT01740427|588974569|FG000|Overall Study|Death|10|||
163073114|NCT01740427|588974570|FG001|Overall Study|Death|3|||
163073115|NCT01740427|588974569|FG000|Overall Study|Protocol Violation|5|||
163073116|NCT01740427|588974570|FG001|Overall Study|Protocol Violation|3|||
163073117|NCT01740427|588974569|FG000|Overall Study|Lost to Follow-up|3|||
163073118|NCT01740427|588974570|FG001|Overall Study|Lost to Follow-up|0|||
163073119|NCT01740427|588974569|FG000|Overall Study|Site Terminated by Sponsor|1|||
163073120|NCT01740427|588974570|FG001|Overall Study|Site Terminated by Sponsor|0|||
163073121|NCT00165698|588974573|FG000|Overall Study|Adverse Event|2|||
163073122|NCT00165698|588974574|FG001|Overall Study|Adverse Event|10|||
163073123|NCT00165698|588974573|FG000|Overall Study|Lost to Follow-up|2|||
163073124|NCT00165698|588974574|FG001|Overall Study|Lost to Follow-up|2|||
163073125|NCT00165698|588974573|FG000|Overall Study|Withdrawal by Subject|2|||
163073126|NCT00165698|588974574|FG001|Overall Study|Withdrawal by Subject|1|||
163073127|NCT00165698|588974573|FG000|Overall Study|Protocol Violation|1|||
163073128|NCT00165698|588974574|FG001|Overall Study|Protocol Violation|0|||
163073129|NCT00165698|588974573|FG000|Overall Study|Not Taken/Lost the medicine|1|||
163073130|NCT00165698|588974574|FG001|Overall Study|Not Taken/Lost the medicine|2|||
163073131|NCT01483651|588974575|FG000|Overall Study|Withdrawal by Subject|0|||
163073132|NCT01483651|588974576|FG001|Overall Study|Withdrawal by Subject|1|||
163073133|NCT01483651|588974577|FG002|Overall Study|Withdrawal by Subject|1|||
163073134|NCT01483651|588974578|FG003|Overall Study|Withdrawal by Subject|0|||
163073135|NCT01483651|588974579|FG004|Overall Study|Withdrawal by Subject|0|||
163073136|NCT01483651|588974580|FG005|Overall Study|Withdrawal by Subject|1|||
163073137|NCT02547935|588974587|FG000|Overall Study|Other|0|||
163073138|NCT02547935|588974588|FG001|Overall Study|Other|1|||
163073139|NCT02547935|588974589|FG002|Overall Study|Other|0|||
163073140|NCT02547935|588974587|FG000|Overall Study|Withdrawal by Subject|2|||
163073141|NCT02547935|588974588|FG001|Overall Study|Withdrawal by Subject|3|||
163073142|NCT02547935|588974589|FG002|Overall Study|Withdrawal by Subject|4|||
163073143|NCT02547935|588974587|FG000|Overall Study|Screen Failure|2|||
163073144|NCT02547935|588974588|FG001|Overall Study|Screen Failure|0|||
163073145|NCT02547935|588974589|FG002|Overall Study|Screen Failure|0|||
163073146|NCT02547935|588974587|FG000|Overall Study|Physician Decision|0|||
163073147|NCT02547935|588974588|FG001|Overall Study|Physician Decision|1|||
163073148|NCT02547935|588974589|FG002|Overall Study|Physician Decision|0|||
163073149|NCT02547935|588974587|FG000|Overall Study|Lost to Follow-up|0|||
163073150|NCT02547935|588974588|FG001|Overall Study|Lost to Follow-up|2|||
163073151|NCT02547935|588974589|FG002|Overall Study|Lost to Follow-up|1|||
163073152|NCT02547935|588974587|FG000|Overall Study|Death|1|||
163073153|NCT02547935|588974588|FG001|Overall Study|Death|1|||
163073154|NCT02547935|588974589|FG002|Overall Study|Death|0|||
163073155|NCT03020888|588974594|FG000|Overall Study|Physician Decision|4|||
163073156|NCT03020888|588974594|FG000|Overall Study|Withdrawal by Subject|6|||
163073157|NCT03020888|588974594|FG000|Overall Study|Insurance coverage|2|||
163073158|NCT03020888|588974594|FG000|Overall Study|Lost to Follow-up|1|||
163073159|NCT01928771|588974598|FG000|Overall Study|Adverse Event|6|||
163073160|NCT01928771|588974599|FG001|Overall Study|Adverse Event|5|||
163073161|NCT01928771|588974600|FG002|Overall Study|Adverse Event|1|||
163073162|NCT01928771|588974598|FG000|Overall Study|Death|2|||
163073163|NCT01928771|588974599|FG001|Overall Study|Death|2|||
163073164|NCT01928771|588974600|FG002|Overall Study|Death|2|||
162644594|NCT02063854|587415829|FG003|Overall Study|Did Not Receive Study Drug|0|||
163073165|NCT01928771|588974598|FG000|Overall Study|Lost to Follow-up|5|||
163073166|NCT01928771|588974599|FG001|Overall Study|Lost to Follow-up|6|||
163073167|NCT01928771|588974600|FG002|Overall Study|Lost to Follow-up|3|||
163073168|NCT01928771|588974598|FG000|Overall Study|Withdrawal by Subject|20|||
163073169|NCT01928771|588974599|FG001|Overall Study|Withdrawal by Subject|15|||
163073170|NCT01928771|588974600|FG002|Overall Study|Withdrawal by Subject|17|||
163073171|NCT01928771|588974598|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163073172|NCT01928771|588974599|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163073173|NCT01928771|588974600|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
163073174|NCT01928771|588974598|FG000|Overall Study|Other Reasons|9|||
163073175|NCT01928771|588974599|FG001|Overall Study|Other Reasons|9|||
163073176|NCT01928771|588974600|FG002|Overall Study|Other Reasons|14|||
163073177|NCT01928771|588974598|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
163073178|NCT01928771|588974599|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
163073179|NCT01928771|588974600|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
163073180|NCT01937117|588974601|FG000|Overall Study|Disease Progression|7|||
163073181|NCT01937117|588974601|FG000|Overall Study|Physician Decision|4|||
163073182|NCT01937117|588974601|FG000|Overall Study|Adverse Event|2|||
163073183|NCT01407367|588974604|FG000|Overall Study|Death|24|||
163073184|NCT01407367|588974605|FG001|Overall Study|Death|32|||
163073185|NCT01407367|588974604|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
163073186|NCT01407367|588974605|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
163073187|NCT01407367|588974604|FG000|Overall Study|Withdrawal by Subject|4|||
163073188|NCT01407367|588974605|FG001|Overall Study|Withdrawal by Subject|15|||
163073189|NCT01407367|588974604|FG000|Overall Study|Lost to Follow-up|0|||
162644595|NCT02063854|587415830|FG004|Overall Study|Did Not Receive Study Drug|0|||
163073190|NCT01407367|588974605|FG001|Overall Study|Lost to Follow-up|2|||
163073191|NCT01695772|588974611|FG000|Overall Study|Withdrawal by Subject|18|||
163073192|NCT01695772|588974611|FG000|Overall Study|Progressive Disease|8|||
163073193|NCT01695772|588974611|FG000|Overall Study|Investigator Decision|5|||
163073194|NCT01695772|588974611|FG000|Overall Study|Lost to Follow-up|4|||
163073195|NCT01695772|588974611|FG000|Overall Study|Protocol Violation|2|||
163073196|NCT01695772|588974611|FG000|Overall Study|Unspecified Reason|1|||
163073197|NCT00004859|588974612|FG000|Overall Study|Lack of Efficacy|43|||
163073198|NCT00004859|588974613|FG001|Overall Study|Lack of Efficacy|113|||
163073199|NCT00004859|588974612|FG000|Overall Study|Adverse Event|31|||
163073200|NCT00004859|588974613|FG001|Overall Study|Adverse Event|93|||
163073201|NCT00004859|588974612|FG000|Overall Study|Death|5|||
163073202|NCT00004859|588974613|FG001|Overall Study|Death|5|||
163073203|NCT00004859|588974612|FG000|Overall Study|Withdrawal by Subject|7|||
163073204|NCT00004859|588974613|FG001|Overall Study|Withdrawal by Subject|33|||
163073205|NCT00004859|588974612|FG000|Overall Study|Protocol Violation|2|||
163073206|NCT00004859|588974613|FG001|Overall Study|Protocol Violation|2|||
163073207|NCT00004859|588974612|FG000|Overall Study|other disease|0|||
163073208|NCT00004859|588974613|FG001|Overall Study|other disease|3|||
163073209|NCT00004859|588974612|FG000|Overall Study|error|3|||
163073210|NCT00004859|588974613|FG001|Overall Study|error|1|||
163073211|NCT00004859|588974612|FG000|Overall Study|missing data|14|||
163073212|NCT00004859|588974613|FG001|Overall Study|missing data|11|||
163073213|NCT00004859|588974612|FG000|Overall Study|Other|13|||
162644596|NCT02063854|587415831|FG005|Overall Study|Did Not Receive Study Drug|1|||
162644597|NCT02063854|587415832|FG006|Overall Study|Did Not Receive Study Drug|0|||
162644598|NCT01413360|587415837|FG000|Overall Study|Lost to Follow-up|2|||
162644599|NCT01413360|587415837|FG000|Overall Study|Adverse Event|1|||
162644600|NCT02246673|587415839|FG000|Overall Study|Sponsor Decision|1|||
162644601|NCT02246673|587415840|FG001|Overall Study|Sponsor Decision|0|||
163073214|NCT00004859|588974613|FG001|Overall Study|Other|21|||
163073215|NCT03882801|588976373|FG000|Period 1|Adverse Event|0|||
163073216|NCT03882801|588976374|FG001|Period 1|Adverse Event|1|||
163073217|NCT03882801|588976373|FG000|Period 1|Non-compliance with study drug|1|||
163073218|NCT03882801|588976374|FG001|Period 1|Non-compliance with study drug|1|||
163073219|NCT03882801|588976373|FG000|Period 1|Never treated with study drug|1|||
163073220|NCT03882801|588976374|FG001|Period 1|Never treated with study drug|0|||
163073221|NCT03882801|588976373|FG000|Washout Period|Physician Decision|0|||
163073222|NCT03882801|588976374|FG001|Washout Period|Physician Decision|1|||
163073223|NCT03882801|588976373|FG000|Period 2|Non-compliance with study drug|0|||
163073224|NCT03882801|588976374|FG001|Period 2|Non-compliance with study drug|1|||
163073225|NCT01567085|588976375|FG000|Overall Study|Death|6|||
163073226|NCT01567085|588976375|FG000|Overall Study|Adverse Event|6|||
163073227|NCT01567085|588976375|FG000|Overall Study|Lost to Follow-up|3|||
163073228|NCT01567085|588976375|FG000|Overall Study|Graft loss|2|||
163073229|NCT01567085|588976375|FG000|Overall Study|Renal transplantectomy|1|||
163073230|NCT01567085|588976375|FG000|Overall Study|Returned to chronic dialysis|1|||
163073231|NCT01567085|588976375|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
163073232|NCT04193176|588976376|FG000|Overall Study|Withdrawal by Subject|6|||
162644602|NCT02246673|587415841|FG002|Overall Study|Sponsor Decision|0|||
162644603|NCT02246673|587415842|FG003|Overall Study|Sponsor Decision|0|||
162644604|NCT02246673|587415843|FG004|Overall Study|Sponsor Decision|0|||
163027687|NCT01664949|588804145|FG000|Overall Study|Personal Reasons|3|||
163027688|NCT01664949|588804146|FG001|Overall Study|Personal Reasons|4|||
163027689|NCT01664949|588804145|FG000|Overall Study|Protocol Violation|5|||
163027690|NCT01664949|588804146|FG001|Overall Study|Protocol Violation|5|||
163027691|NCT01664949|588804145|FG000|Overall Study|Other Miscellaneous Reasons|3|||
163027692|NCT01664949|588804146|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163027693|NCT02727777|588804153|FG000|Overall Study|Screen Failure|2|||
163027694|NCT02727777|588804154|FG001|Overall Study|Screen Failure|0|||
163027695|NCT02727777|588804155|FG002|Overall Study|Screen Failure|0|||
163027696|NCT02727777|588804153|FG000|Overall Study|Progressive disease|2|||
163027697|NCT02727777|588804154|FG001|Overall Study|Progressive disease|0|||
163027698|NCT02727777|588804155|FG002|Overall Study|Progressive disease|0|||
163027699|NCT03003494|588804156|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
163027700|NCT00957268|588804157|FG000|Overall Study|Voluntary Withdrawal|0|||
163027701|NCT00957268|588804158|FG001|Overall Study|Voluntary Withdrawal|0|||
163073233|NCT04193176|588976377|FG001|Overall Study|Withdrawal by Subject|10|||
163027702|NCT00957268|588804159|FG002|Overall Study|Voluntary Withdrawal|1|||
163073234|NCT00944645|588976382|FG000|Period 2|Adverse Event|1|||
163073235|NCT00944645|588976383|FG001|Period 2|Adverse Event|0|||
163073236|NCT00944645|588976382|FG000|Period 2|Lost to Follow-up|0|||
163073237|NCT00944645|588976383|FG001|Period 2|Lost to Follow-up|3|||
163073238|NCT00944645|588976382|FG000|Period 2|Withdrawal by Subject|7|||
163073239|NCT00944645|588976383|FG001|Period 2|Withdrawal by Subject|6|||
163073240|NCT03537729|588976387|FG000|Overall Study|Death|2|||
163073241|NCT03537729|588976388|FG001|Overall Study|Death|2|||
163073242|NCT03537729|588976389|FG002|Overall Study|Death|7|||
163073243|NCT03537729|588976387|FG000|Overall Study|Withdrawal by Subject|3|||
163073244|NCT03537729|588976388|FG001|Overall Study|Withdrawal by Subject|3|||
163073245|NCT03537729|588976389|FG002|Overall Study|Withdrawal by Subject|0|||
163073246|NCT03537729|588976387|FG000|Overall Study|Subject Moved|8|||
163073247|NCT03537729|588976388|FG001|Overall Study|Subject Moved|5|||
163073248|NCT03537729|588976389|FG002|Overall Study|Subject Moved|4|||
163073249|NCT03537729|588976387|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
163073250|NCT03537729|588976388|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
163073251|NCT03537729|588976389|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
163073252|NCT03537729|588976387|FG000|Overall Study|COVID-19 Site Restrictions|11|||
163073253|NCT03537729|588976388|FG001|Overall Study|COVID-19 Site Restrictions|15|||
163073254|NCT03537729|588976389|FG002|Overall Study|COVID-19 Site Restrictions|18|||
163073255|NCT03537729|588976387|FG000|Overall Study|Decline in Health|5|||
163073256|NCT03537729|588976388|FG001|Overall Study|Decline in Health|9|||
163073257|NCT03537729|588976389|FG002|Overall Study|Decline in Health|4|||
163073258|NCT03537729|588976387|FG000|Overall Study|Determined Ineligible|0|||
163073259|NCT03537729|588976388|FG001|Overall Study|Determined Ineligible|0|||
163073260|NCT03537729|588976389|FG002|Overall Study|Determined Ineligible|1|||
163073261|NCT00284934|588976392|FG000|Overall Study|Adverse Event|1|||
163073262|NCT00284934|588976393|FG001|Overall Study|Adverse Event|2|||
163073263|NCT00284934|588976392|FG000|Overall Study|Other reasons|3|||
163073264|NCT00284934|588976393|FG001|Overall Study|Other reasons|1|||
163073265|NCT01783015|588976399|FG000|Blinded Treatment|Adverse Event|0|||
163073266|NCT01783015|588976400|FG001|Blinded Treatment|Adverse Event|1|||
163073267|NCT01783015|588976401|FG002|Blinded Treatment|Adverse Event|0|||
163073268|NCT01783015|588976399|FG000|Blinded Treatment|Protocol Violation|0|||
163073269|NCT01783015|588976400|FG001|Blinded Treatment|Protocol Violation|1|||
163073270|NCT01783015|588976401|FG002|Blinded Treatment|Protocol Violation|0|||
163073271|NCT01783015|588976399|FG000|Blinded Treatment|Withdrawal by Subject|0|||
163073272|NCT01783015|588976400|FG001|Blinded Treatment|Withdrawal by Subject|1|||
163073273|NCT01783015|588976401|FG002|Blinded Treatment|Withdrawal by Subject|0|||
163073274|NCT01783015|588976399|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
163073275|NCT01783015|588976400|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
163073276|NCT01783015|588976401|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
163073277|NCT01783015|588976399|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
163073278|NCT01783015|588976400|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
163073279|NCT01783015|588976401|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
163073280|NCT01297244|588976402|FG000|Overall Study|Progressive disease|22|||
163073281|NCT01297244|588976403|FG001|Overall Study|Progressive disease|3|||
163073282|NCT01297244|588976402|FG000|Overall Study|Adverse Event|9|||
163073283|NCT01297244|588976403|FG001|Overall Study|Adverse Event|1|||
163073284|NCT01297244|588976402|FG000|Overall Study|Death|1|||
163073285|NCT01297244|588976403|FG001|Overall Study|Death|1|||
163073286|NCT01297244|588976402|FG000|Overall Study|Clinical progression|1|||
163073287|NCT01297244|588976403|FG001|Overall Study|Clinical progression|1|||
163073288|NCT01297244|588976402|FG000|Overall Study|Withdrawal by Subject|2|||
163073289|NCT01297244|588976403|FG001|Overall Study|Withdrawal by Subject|0|||
163073290|NCT01348698|588976404|FG000|Overall Study|Does not meet lesion size criteria|1|||
163073291|NCT01348698|588976404|FG000|Overall Study|Death|3|||
163073292|NCT01348698|588976404|FG000|Overall Study|PI decision to close study|68|||
163073293|NCT02595749|588976405|FG000|Overall Study|Withdrawal by Subject|12|||
163073294|NCT02595749|588976406|FG001|Overall Study|Withdrawal by Subject|7|||
163073295|NCT00504556|588976412|FG000|Overall Study|Adverse Event|11|||
163073296|NCT00504556|588976413|FG001|Overall Study|Adverse Event|11|||
163073297|NCT00504556|588976414|FG002|Overall Study|Adverse Event|14|||
163073298|NCT00504556|588976415|FG003|Overall Study|Adverse Event|13|||
163073299|NCT00504556|588976416|FG004|Overall Study|Adverse Event|5|||
163073300|NCT00504556|588976412|FG000|Overall Study|Death|3|||
163073301|NCT00504556|588976413|FG001|Overall Study|Death|3|||
163073302|NCT00504556|588976414|FG002|Overall Study|Death|1|||
163073303|NCT00504556|588976415|FG003|Overall Study|Death|0|||
163073304|NCT00504556|588976416|FG004|Overall Study|Death|2|||
163073305|NCT00504556|588976412|FG000|Overall Study|Protocol Violation|1|||
163073306|NCT00504556|588976413|FG001|Overall Study|Protocol Violation|3|||
163073307|NCT00504556|588976414|FG002|Overall Study|Protocol Violation|2|||
163073308|NCT00504556|588976415|FG003|Overall Study|Protocol Violation|1|||
163073309|NCT00504556|588976416|FG004|Overall Study|Protocol Violation|2|||
163073310|NCT00504556|588976412|FG000|Overall Study|Lost to Follow-up|0|||
163073311|NCT00504556|588976413|FG001|Overall Study|Lost to Follow-up|0|||
163073312|NCT00504556|588976414|FG002|Overall Study|Lost to Follow-up|1|||
163073313|NCT00504556|588976415|FG003|Overall Study|Lost to Follow-up|1|||
163073314|NCT00504556|588976416|FG004|Overall Study|Lost to Follow-up|1|||
163073315|NCT00504556|588976412|FG000|Overall Study|Withdrawal by Subject|16|||
163073316|NCT00504556|588976413|FG001|Overall Study|Withdrawal by Subject|16|||
163073317|NCT00504556|588976414|FG002|Overall Study|Withdrawal by Subject|7|||
163073318|NCT00504556|588976415|FG003|Overall Study|Withdrawal by Subject|8|||
163073319|NCT00504556|588976416|FG004|Overall Study|Withdrawal by Subject|12|||
163027703|NCT00957268|588804160|FG003|Overall Study|Voluntary Withdrawal|0|||
163027704|NCT00957268|588804161|FG004|Overall Study|Voluntary Withdrawal|0|||
163027705|NCT01738503|588804162|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
163027706|NCT01738503|588804163|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027707|NCT01738503|588804164|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027708|NCT01738503|588804165|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027709|NCT01738503|588804166|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027710|NCT01738503|588804167|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027711|NCT01738503|588804168|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
163027712|NCT01738503|588804162|FG000|Treatment Period|Adverse Event|0|||
163027713|NCT01738503|588804163|FG001|Treatment Period|Adverse Event|1|||
163027714|NCT01738503|588804164|FG002|Treatment Period|Adverse Event|0|||
163027715|NCT01738503|588804165|FG003|Treatment Period|Adverse Event|1|||
163027716|NCT01738503|588804166|FG004|Treatment Period|Adverse Event|2|||
163027717|NCT01738503|588804167|FG005|Treatment Period|Adverse Event|2|||
163027718|NCT01738503|588804168|FG006|Treatment Period|Adverse Event|2|||
163027719|NCT01738503|588804162|FG000|Treatment Period|Lost to Follow-up|0|||
163027720|NCT01738503|588804163|FG001|Treatment Period|Lost to Follow-up|0|||
163027721|NCT01738503|588804164|FG002|Treatment Period|Lost to Follow-up|3|||
163027722|NCT01738503|588804165|FG003|Treatment Period|Lost to Follow-up|4|||
163027723|NCT01738503|588804166|FG004|Treatment Period|Lost to Follow-up|1|||
163027724|NCT01738503|588804167|FG005|Treatment Period|Lost to Follow-up|1|||
163027725|NCT01738503|588804168|FG006|Treatment Period|Lost to Follow-up|5|||
163027726|NCT01738503|588804162|FG000|Treatment Period|Withdrawal by Subject|0|||
163027727|NCT01738503|588804163|FG001|Treatment Period|Withdrawal by Subject|1|||
163027728|NCT01738503|588804164|FG002|Treatment Period|Withdrawal by Subject|0|||
163027729|NCT01738503|588804165|FG003|Treatment Period|Withdrawal by Subject|1|||
163027730|NCT01738503|588804166|FG004|Treatment Period|Withdrawal by Subject|1|||
163027731|NCT01738503|588804167|FG005|Treatment Period|Withdrawal by Subject|1|||
163027732|NCT01738503|588804168|FG006|Treatment Period|Withdrawal by Subject|1|||
163027733|NCT01738503|588804162|FG000|Treatment Period|Protocol Violation|0|||
163027734|NCT01738503|588804163|FG001|Treatment Period|Protocol Violation|3|||
163027735|NCT01738503|588804164|FG002|Treatment Period|Protocol Violation|1|||
163027736|NCT01738503|588804165|FG003|Treatment Period|Protocol Violation|0|||
163027737|NCT01738503|588804166|FG004|Treatment Period|Protocol Violation|4|||
163027738|NCT01738503|588804167|FG005|Treatment Period|Protocol Violation|2|||
163073320|NCT00504556|588976412|FG000|Overall Study|administrative reasons|0|||
163073321|NCT00504556|588976413|FG001|Overall Study|administrative reasons|2|||
163073322|NCT00504556|588976414|FG002|Overall Study|administrative reasons|2|||
163073323|NCT00504556|588976415|FG003|Overall Study|administrative reasons|1|||
163073324|NCT00504556|588976416|FG004|Overall Study|administrative reasons|2|||
163073325|NCT00504556|588976412|FG000|Overall Study|did not meet entry criteria|2|||
163073326|NCT00504556|588976413|FG001|Overall Study|did not meet entry criteria|0|||
163073327|NCT00504556|588976414|FG002|Overall Study|did not meet entry criteria|1|||
163073328|NCT00504556|588976415|FG003|Overall Study|did not meet entry criteria|1|||
163073329|NCT00504556|588976416|FG004|Overall Study|did not meet entry criteria|0|||
163073330|NCT00504556|588976412|FG000|Overall Study|data monitor committee decision|0|||
163073331|NCT00504556|588976413|FG001|Overall Study|data monitor committee decision|0|||
163073332|NCT00504556|588976414|FG002|Overall Study|data monitor committee decision|0|||
163073333|NCT00504556|588976415|FG003|Overall Study|data monitor committee decision|100|||
163073334|NCT00504556|588976416|FG004|Overall Study|data monitor committee decision|0|||
163073335|NCT00504556|588976412|FG000|Overall Study|Other|2|||
163073336|NCT00504556|588976413|FG001|Overall Study|Other|2|||
163073337|NCT00504556|588976414|FG002|Overall Study|Other|2|||
163073338|NCT00504556|588976415|FG003|Overall Study|Other|3|||
163073339|NCT00504556|588976416|FG004|Overall Study|Other|0|||
163073340|NCT00504556|588976412|FG000|Overall Study|not in safety analysis set|0|||
163073341|NCT00504556|588976413|FG001|Overall Study|not in safety analysis set|1|||
163073342|NCT00504556|588976414|FG002|Overall Study|not in safety analysis set|1|||
163073343|NCT00504556|588976415|FG003|Overall Study|not in safety analysis set|0|||
163073344|NCT00504556|588976416|FG004|Overall Study|not in safety analysis set|1|||
163073345|NCT03558672|588976417|FG000|Overall Study|Study Early Termination|10|||
163073346|NCT03607695|588976418|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
163073347|NCT03607695|588976418|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
163073348|NCT01027416|588976419|FG000|Overall Study|Withdrawal by Subject|0|||
163073349|NCT01027416|588976420|FG001|Overall Study|Withdrawal by Subject|1|||
163073350|NCT01027416|588976419|FG000|Overall Study|Physician Decision|1|||
163073351|NCT01027416|588976420|FG001|Overall Study|Physician Decision|4|||
163073352|NCT01560988|588976440|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
163073353|NCT01560988|588976441|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
163073354|NCT01560988|588976440|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
163073355|NCT01560988|588976441|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
163073356|NCT01560988|588976440|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
163073357|NCT01560988|588976441|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
163073358|NCT01441414|588976444|FG000|Overall Study|Participant died|9|||
163073359|NCT01441414|588976444|FG000|Overall Study|Other reasons|3|||
163073360|NCT01441414|588976444|FG000|Overall Study|Study terminated by sponsor|2|||
163073361|NCT01441414|588976444|FG000|Overall Study|Subject refused further follow-up|1|||
163073362|NCT00500110|588976445|FG000|Overall Study|Withdrawal by Subject|3|||
163073363|NCT00605657|588976446|FG000|Overall Study|Adverse Event|1|||
163073364|NCT00605657|588976446|FG000|Overall Study|Protocol Violation|1|||
163073365|NCT02018887|588976451|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
163073366|NCT02018887|588976452|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073367|NCT02018887|588976453|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073368|NCT02018887|588976454|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073369|NCT02018887|588976455|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073370|NCT02018887|588976456|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073371|NCT02018887|588976457|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073372|NCT02018887|588976458|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073373|NCT02018887|588976459|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073374|NCT02018887|588976460|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073375|NCT02018887|588976461|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
163073376|NCT02018887|588976451|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073377|NCT02018887|588976452|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073378|NCT02018887|588976453|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073379|NCT02018887|588976454|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073380|NCT02018887|588976455|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
163073381|NCT02018887|588976456|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073382|NCT02018887|588976457|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
163073383|NCT02018887|588976458|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
162717864|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
163073384|NCT02018887|588976459|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073385|NCT02018887|588976460|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073386|NCT02018887|588976461|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
163073387|NCT02018887|588976451|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
163073388|NCT02018887|588976452|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
163073389|NCT02018887|588976453|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
163073390|NCT02018887|588976454|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
163073391|NCT02018887|588976455|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
163073392|NCT02018887|588976456|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
162644605|NCT02246673|587415839|FG000|Overall Study|Withdrawal by Subject|0|||
162644606|NCT02246673|587415840|FG001|Overall Study|Withdrawal by Subject|0|||
162644607|NCT02246673|587415841|FG002|Overall Study|Withdrawal by Subject|0|||
162644608|NCT02246673|587415842|FG003|Overall Study|Withdrawal by Subject|0|||
162644609|NCT02246673|587415843|FG004|Overall Study|Withdrawal by Subject|1|||
163073393|NCT02018887|588976457|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
163073394|NCT02018887|588976458|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
163073395|NCT02018887|588976459|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
163073396|NCT02018887|588976460|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
163073397|NCT02018887|588976461|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
163073398|NCT02018887|588976451|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
163073399|NCT02018887|588976452|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
163073400|NCT02018887|588976453|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
163073401|NCT02018887|588976454|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
163073402|NCT02018887|588976455|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
163073403|NCT02018887|588976456|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
163073404|NCT02018887|588976457|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
163073405|NCT02018887|588976458|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
163073406|NCT02018887|588976459|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
163073407|NCT02018887|588976460|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
163073408|NCT02018887|588976461|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
163073409|NCT01058005|588976462|FG000|Overall Study|Adverse Event|0|||
163073410|NCT01058005|588976463|FG001|Overall Study|Adverse Event|2|||
163073411|NCT01058005|588976464|FG002|Overall Study|Adverse Event|1|||
163073412|NCT01058005|588976462|FG000|Overall Study|Physician Decision|2|||
163073413|NCT01058005|588976463|FG001|Overall Study|Physician Decision|2|||
163073414|NCT01058005|588976464|FG002|Overall Study|Physician Decision|0|||
163073415|NCT01058005|588976462|FG000|Overall Study|Withdrawal by Subject|4|||
163073416|NCT01058005|588976463|FG001|Overall Study|Withdrawal by Subject|5|||
163073417|NCT01058005|588976464|FG002|Overall Study|Withdrawal by Subject|11|||
163073418|NCT01058005|588976462|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
163073419|NCT01058005|588976463|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
163073420|NCT01058005|588976464|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
163073421|NCT01058005|588976462|FG000|Overall Study|Reason Missing|5|||
163073422|NCT01058005|588976463|FG001|Overall Study|Reason Missing|3|||
163073423|NCT01058005|588976464|FG002|Overall Study|Reason Missing|1|||
163073424|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|No Data|249|||
163073425|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|No Data|66|||
163073426|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|No Data|2|||
163073427|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Other|33|||
163073428|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Other|20|||
163073429|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Other|0|||
163073430|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
163073431|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
163073432|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
163073433|NCT01623752|588976465|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
163073434|NCT01623752|588976466|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
163073435|NCT01623752|588976467|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
163073436|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
163073437|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
163073438|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
163073439|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Other|5|||
163073440|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Other|1|||
163073441|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Other|0|||
163073442|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|No Data|43|||
163073443|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|No Data|11|||
163073444|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|No Data|0|||
163073445|NCT01623752|588976465|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
163073446|NCT01623752|588976466|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
163073447|NCT01623752|588976467|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
163073448|NCT01814332|588976468|FG000|Overall Study|Adverse Event|8|||
163073449|NCT01814332|588976469|FG001|Overall Study|Adverse Event|3|||
163073450|NCT01814332|588976468|FG000|Overall Study|Withdrawal by Subject|3|||
163073451|NCT01814332|588976469|FG001|Overall Study|Withdrawal by Subject|8|||
163073452|NCT01814332|588976468|FG000|Overall Study|Protocol Violation|0|||
162644610|NCT02246673|587415839|FG000|Overall Study|Lost to Follow-up|0|||
162644611|NCT02246673|587415840|FG001|Overall Study|Lost to Follow-up|0|||
162644612|NCT02246673|587415841|FG002|Overall Study|Lost to Follow-up|0|||
163073453|NCT01814332|588976469|FG001|Overall Study|Protocol Violation|4|||
163073454|NCT01814332|588976468|FG000|Overall Study|Lost to Follow-up|5|||
163073455|NCT01814332|588976469|FG001|Overall Study|Lost to Follow-up|1|||
163073456|NCT05987540|588976470|FG000|Overall Study|Withdrawal by Subject|2|||
163073457|NCT05987540|588976470|FG000|Overall Study|Death|1|||
163073458|NCT05987540|588976470|FG000|Overall Study|Study Termination|1|||
163073459|NCT05987540|588976470|FG000|Overall Study|Adverse Event|2|||
163073460|NCT04053452|588976471|FG000|Overall Study|Withdrawal by Subject|1|||
163073461|NCT04053452|588976472|FG001|Overall Study|Withdrawal by Subject|0|||
163154799|NCT00521079|589281440|FG000|Overall Study|Adverse Event|7|||
163073462|NCT04053452|588976471|FG000|Overall Study|Time restraint due to inpatient needs|1|||
163073463|NCT04053452|588976472|FG001|Overall Study|Time restraint due to inpatient needs|2|||
163073464|NCT01421134|588976473|FG000|Overall Study|Adverse Event|3|||
163073465|NCT01421134|588976474|FG001|Overall Study|Adverse Event|5|||
163073466|NCT01421134|588976473|FG000|Overall Study|Lack of Efficacy|2|||
163073467|NCT01421134|588976474|FG001|Overall Study|Lack of Efficacy|4|||
163073468|NCT01421134|588976473|FG000|Overall Study|Protocol Violation|0|||
163073469|NCT01421134|588976474|FG001|Overall Study|Protocol Violation|3|||
163073470|NCT01421134|588976473|FG000|Overall Study|Withdrawal by Subject|1|||
163073471|NCT01421134|588976474|FG001|Overall Study|Withdrawal by Subject|1|||
163073472|NCT01421134|588976473|FG000|Overall Study|Administrative|0|||
163073473|NCT01421134|588976474|FG001|Overall Study|Administrative|1|||
163073474|NCT01421134|588976473|FG000|Overall Study|Lost to Follow-up|1|||
163073475|NCT01421134|588976474|FG001|Overall Study|Lost to Follow-up|1|||
163073476|NCT02959892|588976475|FG000|Overall Study|PET tracer synthesis failure|1|||
163073477|NCT02959892|588976476|FG001|Overall Study|PET tracer synthesis failure|0|||
163073478|NCT02959892|588976475|FG000|Overall Study|Study termination|0|||
163073479|NCT02959892|588976476|FG001|Overall Study|Study termination|1|||
163073480|NCT00122187|588976477|FG000|Overall Study|Withdrew because of resource limitations|2|||
163073481|NCT00122187|588976478|FG001|Overall Study|Withdrew because of resource limitations|2|||
163073482|NCT02061592|588976482|FG000|Period 1|Withdrawal by Subject|1|||
163073483|NCT02061592|588976483|FG001|Period 1|Withdrawal by Subject|0|||
163073484|NCT02061592|588976482|FG000|Period 1|Protocol Violation|1|||
163073485|NCT02061592|588976483|FG001|Period 1|Protocol Violation|0|||
163073486|NCT02061592|588976482|FG000|Period 2|Lost to Follow-up|0|||
163073487|NCT02061592|588976483|FG001|Period 2|Lost to Follow-up|1|||
163073488|NCT04433975|588976484|FG000|1-month Follow Up|Withdrawal by Subject|1|||
163073489|NCT04433975|588976485|FG001|1-month Follow Up|Withdrawal by Subject|1|||
163073490|NCT04433975|588976484|FG000|1-month Follow Up|Lost to Follow-up|21|||
163073491|NCT04433975|588976485|FG001|1-month Follow Up|Lost to Follow-up|25|||
163073492|NCT04433975|588976484|FG000|3-month Follow Up|Lost to Follow-up|20|||
163073493|NCT04433975|588976485|FG001|3-month Follow Up|Lost to Follow-up|24|||
163073494|NCT04433975|588976484|FG000|3-month Follow Up|Death|1|||
163073495|NCT04433975|588976485|FG001|3-month Follow Up|Death|0|||
163073496|NCT04433975|588976484|FG000|3-month Follow Up|Withdrawal by Subject|2|||
163073497|NCT04433975|588976485|FG001|3-month Follow Up|Withdrawal by Subject|0|||
163073498|NCT04433975|588976484|FG000|6-month Follow Up|Lost to Follow-up|23|||
163073499|NCT04433975|588976485|FG001|6-month Follow Up|Lost to Follow-up|28|||
163073500|NCT04433975|588976484|FG000|6-month Follow Up|Withdrawal by Subject|1|||
163073501|NCT04433975|588976485|FG001|6-month Follow Up|Withdrawal by Subject|1|||
163073502|NCT04433975|588976484|FG000|9-month Follow Up|Lost to Follow-up|27|||
163073503|NCT04433975|588976485|FG001|9-month Follow Up|Lost to Follow-up|36|||
163073504|NCT04433975|588976484|FG000|9-month Follow Up|Death|0|||
163073505|NCT04433975|588976485|FG001|9-month Follow Up|Death|1|||
163073506|NCT04433975|588976484|FG000|12-month Follow Up|Lost to Follow-up|27|||
163073507|NCT04433975|588976485|FG001|12-month Follow Up|Lost to Follow-up|31|||
163073508|NCT04882215|588976486|FG000|Overall Study|Withdrawal by Subject|5|||
163073509|NCT04882215|588976487|FG001|Overall Study|Withdrawal by Subject|0|||
163073510|NCT06083493|588976488|FG000|Overall Study|Technical issues with the interventional device|2|||
163073511|NCT06083493|588976489|FG001|Overall Study|Technical issues with the interventional device|2|||
163073512|NCT06083493|588976488|FG000|Overall Study|Performed incorrect visual task|1|||
163073513|NCT06083493|588976489|FG001|Overall Study|Performed incorrect visual task|0|||
163073514|NCT06083493|588976488|FG000|Overall Study|Insufficient baseline performance|0|||
163073515|NCT06083493|588976489|FG001|Overall Study|Insufficient baseline performance|1|||
163073516|NCT04392635|588976492|FG000|Overall Study|Lost to Follow-up|0|||
163073517|NCT04392635|588976493|FG001|Overall Study|Lost to Follow-up|1|||
163073518|NCT01851369|588976498|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073519|NCT01851369|588976499|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073520|NCT01851369|588976500|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073521|NCT01851369|588976501|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073522|NCT01851369|588976502|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073523|NCT01851369|588976503|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
163073524|NCT01851369|588976504|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073525|NCT01851369|588976505|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073526|NCT01851369|588976506|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073527|NCT01851369|588976507|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073528|NCT01851369|588976508|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073529|NCT01851369|588976509|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073530|NCT01851369|588976510|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
163073531|NCT02460380|588976512|FG000|Overall Study|Withdrawal by Subject|10|||
163073532|NCT02460380|588976513|FG001|Overall Study|Withdrawal by Subject|5|||
163073533|NCT01936974|588976518|FG000|Overall Study|Physician Decision|2|||
163073534|NCT01936974|588976519|FG001|Overall Study|Physician Decision|5|||
163073535|NCT00063999|588976520|FG000|Overall Study|Withdrawal by Subject|1|||
163073536|NCT00063999|588976521|FG001|Overall Study|Withdrawal by Subject|0|||
163073537|NCT00063999|588976520|FG000|Overall Study|Ineligible|44|||
163073538|NCT00063999|588976521|FG001|Overall Study|Ineligible|24|||
163073539|NCT02497755|588976523|FG000|Overall Study|Protocol Violation|1|||
163073540|NCT02497755|588976524|FG001|Overall Study|Protocol Violation|0|||
163073541|NCT04560309|588976539|FG000|Overall Study|Meet drop out criteria|1|||
163073542|NCT04560309|588976540|FG001|Overall Study|Meet drop out criteria|1|||
163073543|NCT05085405|588976541|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073544|NCT05085405|588976542|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073545|NCT05085405|588976543|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
163073546|NCT05085405|588976544|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
163073547|NCT05085405|588976545|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073548|NCT05085405|588976546|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
163073549|NCT05085405|588976541|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073550|NCT05085405|588976542|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073551|NCT05085405|588976543|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073552|NCT05085405|588976544|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
163073553|NCT05085405|588976545|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073554|NCT05085405|588976546|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
163073555|NCT01860404|588976547|FG000|Overall Study|Lost to Follow-up|3|||
163073556|NCT01860404|588976548|FG001|Overall Study|Lost to Follow-up|4|||
163073557|NCT01860404|588976549|FG002|Overall Study|Lost to Follow-up|1|||
163073558|NCT01860404|588976550|FG003|Overall Study|Lost to Follow-up|6|||
163073559|NCT01860404|588976551|FG004|Overall Study|Lost to Follow-up|4|||
163073560|NCT01860404|588976547|FG000|Overall Study|Withdrawal by Subject|0|||
163073561|NCT01860404|588976548|FG001|Overall Study|Withdrawal by Subject|0|||
163073562|NCT01860404|588976549|FG002|Overall Study|Withdrawal by Subject|4|||
163073563|NCT01860404|588976550|FG003|Overall Study|Withdrawal by Subject|0|||
163073564|NCT01860404|588976551|FG004|Overall Study|Withdrawal by Subject|0|||
163073565|NCT00356421|588976553|FG000|Overall Study|Lack of Efficacy|3|||
163073566|NCT00356421|588976554|FG001|Overall Study|Lack of Efficacy|0|||
163073567|NCT00356421|588976553|FG000|Overall Study|Withdrawal by Subject|9|||
163073568|NCT00356421|588976554|FG001|Overall Study|Withdrawal by Subject|2|||
163073569|NCT00356421|588976553|FG000|Overall Study|Related to study drug|15|||
163073570|NCT00356421|588976554|FG001|Overall Study|Related to study drug|12|||
163073571|NCT00356421|588976553|FG000|Overall Study|Not related to study drug|5|||
163073572|NCT00356421|588976554|FG001|Overall Study|Not related to study drug|3|||
162644613|NCT02246673|587415842|FG003|Overall Study|Lost to Follow-up|1|||
162644614|NCT02246673|587415843|FG004|Overall Study|Lost to Follow-up|0|||
162644615|NCT02246673|587415839|FG000|Overall Study|Protocol Violation|0|||
162644616|NCT02246673|587415840|FG001|Overall Study|Protocol Violation|0|||
162644617|NCT02246673|587415841|FG002|Overall Study|Protocol Violation|0|||
162644618|NCT02246673|587415842|FG003|Overall Study|Protocol Violation|1|||
162644619|NCT02246673|587415843|FG004|Overall Study|Protocol Violation|0|||
163073573|NCT04689009|588976555|FG000|Overall Study|Adverse Event|1|||
163073574|NCT04689009|588976556|FG001|Overall Study|Adverse Event|0|||
163073575|NCT04689009|588976555|FG000|Overall Study|Lost to Follow-up|1|||
163073576|NCT04689009|588976556|FG001|Overall Study|Lost to Follow-up|2|||
163073577|NCT04689009|588976555|FG000|Overall Study|Withdrawal by Subject|4|||
163073578|NCT04689009|588976556|FG001|Overall Study|Withdrawal by Subject|3|||
163073579|NCT04689009|588976555|FG000|Overall Study|Protocol Violation|1|||
163073580|NCT04689009|588976556|FG001|Overall Study|Protocol Violation|0|||
163073581|NCT02187055|588976557|FG000|Overall Study|Lack of Efficacy|10|||
163073582|NCT02187055|588976558|FG001|Overall Study|Lack of Efficacy|3|||
163073583|NCT02187055|588976559|FG002|Overall Study|Lack of Efficacy|7|||
163073584|NCT02187055|588976557|FG000|Overall Study|Lost to Follow-up|2|||
163073585|NCT02187055|588976558|FG001|Overall Study|Lost to Follow-up|7|||
163073586|NCT02187055|588976559|FG002|Overall Study|Lost to Follow-up|3|||
163073587|NCT02187055|588976557|FG000|Overall Study|No longer meets eligibility criteria|0|||
163073588|NCT02187055|588976558|FG001|Overall Study|No longer meets eligibility criteria|2|||
163073589|NCT02187055|588976559|FG002|Overall Study|No longer meets eligibility criteria|0|||
163073590|NCT02187055|588976557|FG000|Overall Study|No longer willing to participate|6|||
163073591|NCT02187055|588976558|FG001|Overall Study|No longer willing to participate|8|||
163073592|NCT02187055|588976559|FG002|Overall Study|No longer willing to participate|10|||
163073593|NCT02187055|588976557|FG000|Overall Study|Other|5|||
163073594|NCT02187055|588976558|FG001|Overall Study|Other|6|||
162644620|NCT05413369|587415844|FG000|Overall Study|Adverse Event|1|||
162644621|NCT05413369|587415845|FG001|Overall Study|Adverse Event|1|||
162644622|NCT05413369|587415844|FG000|Overall Study|Withdrawal by Subject|13|||
163073595|NCT02187055|588976559|FG002|Overall Study|Other|3|||
163073596|NCT02187055|588976557|FG000|Overall Study|Protocol Violation|9|||
163073597|NCT02187055|588976558|FG001|Overall Study|Protocol Violation|9|||
163073598|NCT02187055|588976559|FG002|Overall Study|Protocol Violation|4|||
163073599|NCT02187055|588976557|FG000|Overall Study|Pregnancy|3|||
163073600|NCT02187055|588976558|FG001|Overall Study|Pregnancy|1|||
163073601|NCT02187055|588976559|FG002|Overall Study|Pregnancy|0|||
163073602|NCT02187055|588976557|FG000|Overall Study|Withdrawal by Subject|11|||
163073603|NCT02187055|588976558|FG001|Overall Study|Withdrawal by Subject|11|||
163073604|NCT02187055|588976559|FG002|Overall Study|Withdrawal by Subject|11|||
163073605|NCT02187055|588976557|FG000|Overall Study|Adverse Event|21|||
163073606|NCT02187055|588976558|FG001|Overall Study|Adverse Event|26|||
163073607|NCT02187055|588976559|FG002|Overall Study|Adverse Event|36|||
163073608|NCT02187055|588976557|FG000|Overall Study|Death|2|||
163073609|NCT02187055|588976558|FG001|Overall Study|Death|0|||
163073610|NCT02187055|588976559|FG002|Overall Study|Death|0|||
163073611|NCT00985790|588976562|FG000|Overall Study|Withdrawal by Subject|1|||
163073612|NCT00985790|588976563|FG001|Overall Study|Withdrawal by Subject|1|||
163073613|NCT00985790|588976562|FG000|Overall Study|Lost to Follow-up|6|||
163073614|NCT00985790|588976563|FG001|Overall Study|Lost to Follow-up|7|||
163073615|NCT01030900|588976564|FG000|Overall Study|Not treated due to congestive heart failure|1|||
163073616|NCT01030900|588976564|FG000|Overall Study|Not treated due to rapid disease|1|||
163073617|NCT00441896|588976565|FG000|Overall Study|Withdrawal by Subject|0|||
163073618|NCT00441896|588976566|FG001|Overall Study|Withdrawal by Subject|0|||
163073619|NCT00441896|588976567|FG002|Overall Study|Withdrawal by Subject|0|||
163073620|NCT00441896|588976568|FG003|Overall Study|Withdrawal by Subject|1|||
163073621|NCT00441896|588976569|FG004|Overall Study|Withdrawal by Subject|0|||
163073622|NCT00441896|588976570|FG005|Overall Study|Withdrawal by Subject|0|||
163073623|NCT00441896|588976571|FG006|Overall Study|Withdrawal by Subject|0|||
163073624|NCT00441896|588976572|FG007|Overall Study|Withdrawal by Subject|0|||
163073625|NCT00441896|588976573|FG008|Overall Study|Withdrawal by Subject|0|||
163073626|NCT00441896|588976574|FG009|Overall Study|Withdrawal by Subject|0|||
163073627|NCT00441896|588976565|FG000|Overall Study|Other|0|||
163073628|NCT00441896|588976566|FG001|Overall Study|Other|0|||
162644623|NCT05413369|587415845|FG001|Overall Study|Withdrawal by Subject|4|||
162644624|NCT05413369|587415844|FG000|Overall Study|Non-compliance with study schedule|2|||
162644625|NCT05413369|587415845|FG001|Overall Study|Non-compliance with study schedule|1|||
162644626|NCT05413369|587415844|FG000|Overall Study|Other|1|||
162644627|NCT05413369|587415845|FG001|Overall Study|Other|1|||
162644628|NCT01679002|587415850|FG000|Overall Study|Adverse Event|1|||
162644629|NCT01679002|587415851|FG001|Overall Study|Adverse Event|1|||
162644630|NCT01679002|587415852|FG002|Overall Study|Adverse Event|0|||
162644631|NCT00730912|587415855|FG000|Overall Study|Discontinued|0|||
162644632|NCT00730912|587415856|FG001|Overall Study|Discontinued|0|||
162644633|NCT00730912|587415857|FG002|Overall Study|Discontinued|1|||
162644634|NCT02205333|587415865|FG000|Overall Study|Death|5|||
162644635|NCT02205333|587415866|FG001|Overall Study|Death|6|||
162644636|NCT02205333|587415867|FG002|Overall Study|Death|2|||
162644637|NCT02205333|587415868|FG003|Overall Study|Death|6|||
162644638|NCT02205333|587415869|FG004|Overall Study|Death|5|||
162644639|NCT02205333|587415870|FG005|Overall Study|Death|3|||
162644640|NCT02205333|587415871|FG006|Overall Study|Death|3|||
162644641|NCT02205333|587415872|FG007|Overall Study|Death|2|||
162644642|NCT02205333|587415873|FG008|Overall Study|Death|0|||
162644643|NCT02205333|587415865|FG000|Overall Study|Withdrawal by Subject|1|||
162644644|NCT02205333|587415866|FG001|Overall Study|Withdrawal by Subject|0|||
162644645|NCT02205333|587415867|FG002|Overall Study|Withdrawal by Subject|0|||
162644646|NCT02205333|587415868|FG003|Overall Study|Withdrawal by Subject|1|||
162644647|NCT02205333|587415869|FG004|Overall Study|Withdrawal by Subject|0|||
163073629|NCT00441896|588976567|FG002|Overall Study|Other|0|||
163073630|NCT00441896|588976568|FG003|Overall Study|Other|0|||
163073631|NCT00441896|588976569|FG004|Overall Study|Other|1|||
163073632|NCT00441896|588976570|FG005|Overall Study|Other|0|||
162644648|NCT02205333|587415870|FG005|Overall Study|Withdrawal by Subject|0|||
162644649|NCT02205333|587415871|FG006|Overall Study|Withdrawal by Subject|2|||
162644650|NCT02205333|587415872|FG007|Overall Study|Withdrawal by Subject|0|||
162644651|NCT02205333|587415873|FG008|Overall Study|Withdrawal by Subject|0|||
162644652|NCT01176266|587415874|FG000|Overall Study|Death|6|||
162644653|NCT01176266|587415874|FG000|Overall Study|Withdrawal by Subject|3|||
162644654|NCT01179477|587415875|FG000|Overall Study|Death|542|||
162644655|NCT01179477|587415875|FG000|Overall Study|Unsuccessful implant|80|||
162644656|NCT01179477|587415875|FG000|Overall Study|Non-death withdrawal|438|||
163073633|NCT00441896|588976571|FG006|Overall Study|Other|0|||
163073634|NCT00441896|588976572|FG007|Overall Study|Other|0|||
163073635|NCT00441896|588976573|FG008|Overall Study|Other|0|||
163073636|NCT00441896|588976574|FG009|Overall Study|Other|0|||
163073637|NCT01301092|588976575|FG000|Overall Study|Lost to Follow-up|0|||
163073638|NCT01301092|588976576|FG001|Overall Study|Lost to Follow-up|0|||
163073639|NCT01301092|588976577|FG002|Overall Study|Lost to Follow-up|1|||
163073640|NCT03334175|588976578|FG000|Overall Study|Lost to Follow-up|0|||
163073641|NCT03334175|588976579|FG001|Overall Study|Lost to Follow-up|1|||
163073642|NCT01793129|588978172|FG000|Overall Study|Lost to Follow-up|3|||
163073643|NCT01793129|588978173|FG001|Overall Study|Lost to Follow-up|7|||
163073644|NCT01793129|588978172|FG000|Overall Study|Withdrawal by Subject|0|||
163073645|NCT01793129|588978173|FG001|Overall Study|Withdrawal by Subject|2|||
163073646|NCT00454142|588978176|FG000|Overall Study|Withdrawal by Subject|1|||
163073647|NCT00520572|588978177|FG000|Overall Study|Adverse Event|9|||
163073648|NCT00520572|588978178|FG001|Overall Study|Adverse Event|3|||
163073649|NCT00520572|588978179|FG002|Overall Study|Adverse Event|6|||
163073650|NCT00520572|588978180|FG003|Overall Study|Adverse Event|9|||
163073651|NCT00520572|588978181|FG004|Overall Study|Adverse Event|7|||
163073652|NCT00520572|588978182|FG005|Overall Study|Adverse Event|2|||
163073653|NCT00520572|588978177|FG000|Overall Study|Withdrawal by Subject|0|||
163073654|NCT00520572|588978178|FG001|Overall Study|Withdrawal by Subject|9|||
163073655|NCT00520572|588978179|FG002|Overall Study|Withdrawal by Subject|5|||
163073656|NCT00520572|588978180|FG003|Overall Study|Withdrawal by Subject|2|||
163073657|NCT00520572|588978181|FG004|Overall Study|Withdrawal by Subject|2|||
163073658|NCT00520572|588978182|FG005|Overall Study|Withdrawal by Subject|0|||
163073659|NCT00520572|588978177|FG000|Overall Study|Protocol Violation|0|||
163073660|NCT00520572|588978178|FG001|Overall Study|Protocol Violation|0|||
162644657|NCT01179477|587415875|FG000|Overall Study|Did not complete final visit|27|||
162644658|NCT03755414|587415879|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
162644659|NCT03755414|587415880|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
162644660|NCT03755414|587415881|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
162644661|NCT03755414|587415879|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
162644662|NCT03755414|587415880|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
163073661|NCT00520572|588978179|FG002|Overall Study|Protocol Violation|1|||
163073662|NCT00520572|588978180|FG003|Overall Study|Protocol Violation|0|||
163073663|NCT00520572|588978181|FG004|Overall Study|Protocol Violation|0|||
163073664|NCT00520572|588978182|FG005|Overall Study|Protocol Violation|0|||
163073665|NCT00520572|588978177|FG000|Overall Study|Lack of Efficacy|1|||
163073666|NCT00520572|588978178|FG001|Overall Study|Lack of Efficacy|1|||
163073667|NCT00520572|588978179|FG002|Overall Study|Lack of Efficacy|1|||
163073668|NCT00520572|588978180|FG003|Overall Study|Lack of Efficacy|2|||
163073669|NCT00520572|588978181|FG004|Overall Study|Lack of Efficacy|1|||
163073670|NCT00520572|588978182|FG005|Overall Study|Lack of Efficacy|0|||
163073671|NCT00520572|588978177|FG000|Overall Study|Lost to Follow-up|0|||
163073672|NCT00520572|588978178|FG001|Overall Study|Lost to Follow-up|0|||
163073673|NCT00520572|588978179|FG002|Overall Study|Lost to Follow-up|0|||
163073674|NCT00520572|588978180|FG003|Overall Study|Lost to Follow-up|0|||
163073675|NCT00520572|588978181|FG004|Overall Study|Lost to Follow-up|1|||
163073676|NCT00520572|588978182|FG005|Overall Study|Lost to Follow-up|0|||
163073677|NCT00520572|588978177|FG000|Overall Study|Incorrect enrollment|1|||
163073678|NCT00520572|588978178|FG001|Overall Study|Incorrect enrollment|0|||
163073679|NCT00520572|588978179|FG002|Overall Study|Incorrect enrollment|1|||
163073680|NCT00520572|588978180|FG003|Overall Study|Incorrect enrollment|0|||
163073681|NCT00520572|588978181|FG004|Overall Study|Incorrect enrollment|1|||
163073682|NCT00520572|588978182|FG005|Overall Study|Incorrect enrollment|0|||
163073683|NCT00520572|588978177|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073684|NCT00520572|588978178|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
163073685|NCT00520572|588978179|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073686|NCT00520572|588978180|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073687|NCT00520572|588978181|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073688|NCT00520572|588978182|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
163073689|NCT00520572|588978177|FG000|Overall Study|Long break in taking Medication|0|||
163073690|NCT00520572|588978178|FG001|Overall Study|Long break in taking Medication|0|||
162717865|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163073691|NCT00520572|588978179|FG002|Overall Study|Long break in taking Medication|0|||
163073692|NCT00520572|588978180|FG003|Overall Study|Long break in taking Medication|1|||
163073693|NCT00520572|588978181|FG004|Overall Study|Long break in taking Medication|0|||
163073694|NCT00520572|588978182|FG005|Overall Study|Long break in taking Medication|0|||
163073695|NCT00520572|588978177|FG000|Overall Study|Did not receive Treatment|1|||
163073696|NCT00520572|588978178|FG001|Overall Study|Did not receive Treatment|0|||
163073697|NCT00520572|588978179|FG002|Overall Study|Did not receive Treatment|1|||
163073698|NCT00520572|588978180|FG003|Overall Study|Did not receive Treatment|0|||
163073699|NCT00520572|588978181|FG004|Overall Study|Did not receive Treatment|0|||
163073700|NCT00520572|588978182|FG005|Overall Study|Did not receive Treatment|0|||
163073701|NCT03548415|588978185|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073702|NCT03548415|588978186|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
163073703|NCT03548415|588978187|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073704|NCT03548415|588978188|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
163073705|NCT03548415|588978189|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
163073706|NCT04605588|588978190|FG000|Overall Study|Withdrawal by Subject|1|||
163073707|NCT04605588|588978191|FG001|Overall Study|Withdrawal by Subject|0|||
163073708|NCT01230814|588978192|FG000|Overall Study|Lost to Follow-up|11|||
162644663|NCT03755414|587415881|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
163073709|NCT01230814|588978193|FG001|Overall Study|Lost to Follow-up|3|||
163073710|NCT01230814|588978192|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
163073711|NCT01230814|588978193|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
163073712|NCT01803737|588978194|FG000|Overall Study|Lack of Time|1|||
163073713|NCT01803737|588978195|FG001|Overall Study|Lack of Time|0|||
163073714|NCT01803737|588978194|FG000|Overall Study|Medical Reason|0|||
163073715|NCT01803737|588978195|FG001|Overall Study|Medical Reason|1|||
163073716|NCT01803737|588978194|FG000|Overall Study|Lost to Follow-up|0|||
163073717|NCT01803737|588978195|FG001|Overall Study|Lost to Follow-up|2|||
163073718|NCT02741193|588978196|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
163073719|NCT02741193|588978196|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
163073720|NCT00676052|588978200|FG000|Overall Study|Adverse Event|0|||
163073721|NCT00676052|588978201|FG001|Overall Study|Adverse Event|1|||
163073722|NCT00676052|588978202|FG002|Overall Study|Adverse Event|1|||
163073723|NCT00676052|588978203|FG003|Overall Study|Adverse Event|2|||
163073724|NCT00676052|588978204|FG004|Overall Study|Adverse Event|2|||
163073725|NCT00676052|588978205|FG005|Overall Study|Adverse Event|2|||
163073726|NCT00676052|588978200|FG000|Overall Study|Lack of Efficacy|2|||
163073727|NCT00676052|588978201|FG001|Overall Study|Lack of Efficacy|2|||
163073728|NCT00676052|588978202|FG002|Overall Study|Lack of Efficacy|1|||
163073729|NCT00676052|588978203|FG003|Overall Study|Lack of Efficacy|1|||
163073730|NCT00676052|588978204|FG004|Overall Study|Lack of Efficacy|2|||
163073731|NCT00676052|588978205|FG005|Overall Study|Lack of Efficacy|1|||
163073732|NCT00676052|588978200|FG000|Overall Study|Protocol Violation|5|||
163073733|NCT00676052|588978201|FG001|Overall Study|Protocol Violation|3|||
163073734|NCT00676052|588978202|FG002|Overall Study|Protocol Violation|2|||
163073735|NCT00676052|588978203|FG003|Overall Study|Protocol Violation|2|||
163073736|NCT00676052|588978204|FG004|Overall Study|Protocol Violation|1|||
163073737|NCT00676052|588978205|FG005|Overall Study|Protocol Violation|2|||
163073738|NCT00676052|588978200|FG000|Overall Study|Lost to Follow-up|0|||
163073739|NCT00676052|588978201|FG001|Overall Study|Lost to Follow-up|0|||
163073740|NCT00676052|588978202|FG002|Overall Study|Lost to Follow-up|0|||
163073741|NCT00676052|588978203|FG003|Overall Study|Lost to Follow-up|0|||
163073742|NCT00676052|588978204|FG004|Overall Study|Lost to Follow-up|1|||
163073743|NCT00676052|588978205|FG005|Overall Study|Lost to Follow-up|0|||
163073744|NCT00676052|588978200|FG000|Overall Study|Physician Decision|1|||
163073745|NCT00676052|588978201|FG001|Overall Study|Physician Decision|1|||
163073746|NCT00676052|588978202|FG002|Overall Study|Physician Decision|1|||
163073747|NCT00676052|588978203|FG003|Overall Study|Physician Decision|0|||
163073748|NCT00676052|588978204|FG004|Overall Study|Physician Decision|0|||
163073749|NCT00676052|588978205|FG005|Overall Study|Physician Decision|1|||
162644664|NCT03755414|587415879|FG000|Overall Study|Non-compliance|0|||
162644665|NCT03755414|587415880|FG001|Overall Study|Non-compliance|1|||
162644666|NCT03755414|587415881|FG002|Overall Study|Non-compliance|0|||
162644667|NCT02153112|587415882|FG000|Overall Study|Adverse Event|0|||
162644668|NCT02153112|587415883|FG001|Overall Study|Adverse Event|0|||
162644669|NCT02153112|587415884|FG002|Overall Study|Adverse Event|1|||
162644670|NCT02153112|587415885|FG003|Overall Study|Adverse Event|0|||
162644671|NCT02153112|587415886|FG004|Overall Study|Adverse Event|0|||
163073750|NCT00676052|588978200|FG000|Overall Study|Withdrawal by Subject|1|||
163073751|NCT00676052|588978201|FG001|Overall Study|Withdrawal by Subject|0|||
163073752|NCT00676052|588978202|FG002|Overall Study|Withdrawal by Subject|1|||
163073753|NCT00676052|588978203|FG003|Overall Study|Withdrawal by Subject|0|||
163073754|NCT00676052|588978204|FG004|Overall Study|Withdrawal by Subject|0|||
163073755|NCT00676052|588978205|FG005|Overall Study|Withdrawal by Subject|0|||
163073756|NCT00903344|588978206|FG000|Overall Study|Pregnancy|2|||
162644672|NCT02153112|587415887|FG005|Overall Study|Adverse Event|0|||
163073757|NCT00903344|588978207|FG001|Overall Study|Pregnancy|3|||
163073758|NCT00903344|588978206|FG000|Overall Study|Lost to Follow-up|3|||
163073759|NCT00903344|588978207|FG001|Overall Study|Lost to Follow-up|0|||
163073760|NCT00585169|588978208|FG000|Overall Study|Withdrawal by Subject|1|||
163073761|NCT03055221|588978209|FG000|Overall Study|Adverse Event|2|||
163073762|NCT03055221|588978209|FG000|Overall Study|Withdrawal by Subject|4|||
163073763|NCT03055221|588978209|FG000|Overall Study|Death|6|||
163073764|NCT03055221|588978209|FG000|Overall Study|Physician Decision|1|||
162644673|NCT02153112|587415888|FG006|Overall Study|Adverse Event|0|||
162644674|NCT02153112|587415889|FG007|Overall Study|Adverse Event|0|||
162644675|NCT02153112|587415890|FG008|Overall Study|Adverse Event|0|||
162644676|NCT02153112|587415891|FG009|Overall Study|Adverse Event|0|||
162644677|NCT02153112|587415882|FG000|Overall Study|Lost to Follow-up|1|||
162644678|NCT02153112|587415883|FG001|Overall Study|Lost to Follow-up|1|||
162644679|NCT02153112|587415884|FG002|Overall Study|Lost to Follow-up|0|||
162644680|NCT02153112|587415885|FG003|Overall Study|Lost to Follow-up|0|||
162644681|NCT02153112|587415886|FG004|Overall Study|Lost to Follow-up|2|||
162644682|NCT02153112|587415887|FG005|Overall Study|Lost to Follow-up|1|||
162644683|NCT02153112|587415888|FG006|Overall Study|Lost to Follow-up|1|||
162644684|NCT02153112|587415889|FG007|Overall Study|Lost to Follow-up|0|||
162644685|NCT02153112|587415890|FG008|Overall Study|Lost to Follow-up|1|||
162644686|NCT02153112|587415891|FG009|Overall Study|Lost to Follow-up|1|||
162644687|NCT02153112|587415882|FG000|Overall Study|Withdrawal by Subject|3|||
162644688|NCT02153112|587415883|FG001|Overall Study|Withdrawal by Subject|1|||
162644689|NCT02153112|587415884|FG002|Overall Study|Withdrawal by Subject|2|||
162644690|NCT02153112|587415885|FG003|Overall Study|Withdrawal by Subject|2|||
162644691|NCT02153112|587415886|FG004|Overall Study|Withdrawal by Subject|1|||
163073765|NCT03055221|588978209|FG000|Overall Study|Study terminated by Sponsor|3|||
163073766|NCT03055221|588978209|FG000|Overall Study|Lost to Follow-up|4|||
163073767|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
163073768|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
163073769|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
163073770|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
163073771|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
163073772|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
163073773|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
163073774|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
163073775|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
163073776|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
163073777|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
163073778|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
163073779|NCT01243424|588978210|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
163073780|NCT01243424|588978211|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
163073781|NCT01243424|588978210|FG000|Discontinuation From Treatment|Not treated|5|||
163073782|NCT01243424|588978211|FG001|Discontinuation From Treatment|Not treated|4|||
163073783|NCT01243424|588978210|FG000|Discontinuation From Treatment|Adverse Event|457|||
163073784|NCT01243424|588978211|FG001|Discontinuation From Treatment|Adverse Event|523|||
163073785|NCT01243424|588978210|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
163073786|NCT01243424|588978211|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
163073787|NCT01243424|588978210|FG000|Discontinuation From Treatment|Protocol Violation|46|||
163073788|NCT01243424|588978211|FG001|Discontinuation From Treatment|Protocol Violation|47|||
163073789|NCT01243424|588978210|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
163073790|NCT01243424|588978211|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
163073791|NCT01243424|588978210|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
163073792|NCT01243424|588978211|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
163073793|NCT01243424|588978210|FG000|Discontinuation From Treatment|Other than listed above|230|||
163073794|NCT01243424|588978211|FG001|Discontinuation From Treatment|Other than listed above|211|||
162644692|NCT02153112|587415887|FG005|Overall Study|Withdrawal by Subject|1|||
162644693|NCT02153112|587415888|FG006|Overall Study|Withdrawal by Subject|7|||
162644694|NCT02153112|587415889|FG007|Overall Study|Withdrawal by Subject|2|||
162644695|NCT02153112|587415890|FG008|Overall Study|Withdrawal by Subject|13|||
162644696|NCT02153112|587415891|FG009|Overall Study|Withdrawal by Subject|12|||
162644697|NCT02153112|587415882|FG000|Overall Study|Reason not Specified|0|||
162644698|NCT02153112|587415883|FG001|Overall Study|Reason not Specified|0|||
162644699|NCT02153112|587415884|FG002|Overall Study|Reason not Specified|0|||
163073795|NCT00710554|588978212|FG000|Overall Study|Adverse Event|24|||
163073796|NCT00710554|588978213|FG001|Overall Study|Adverse Event|7|||
163073797|NCT00710554|588978212|FG000|Overall Study|Withdrawal by Subject|7|||
163073798|NCT00710554|588978213|FG001|Overall Study|Withdrawal by Subject|3|||
163073799|NCT00710554|588978212|FG000|Overall Study|Lost to Follow-up|7|||
163073800|NCT00710554|588978213|FG001|Overall Study|Lost to Follow-up|1|||
163073801|NCT00710554|588978212|FG000|Overall Study|Lack of Efficacy|11|||
163073802|NCT00710554|588978213|FG001|Overall Study|Lack of Efficacy|12|||
162644700|NCT02153112|587415885|FG003|Overall Study|Reason not Specified|0|||
162644701|NCT02153112|587415886|FG004|Overall Study|Reason not Specified|0|||
162644702|NCT02153112|587415887|FG005|Overall Study|Reason not Specified|0|||
162644703|NCT02153112|587415888|FG006|Overall Study|Reason not Specified|0|||
162644704|NCT02153112|587415889|FG007|Overall Study|Reason not Specified|0|||
162644705|NCT02153112|587415890|FG008|Overall Study|Reason not Specified|1|||
162644706|NCT02153112|587415891|FG009|Overall Study|Reason not Specified|1|||
162644707|NCT00455429|587415892|FG000|Overall Study|Study Terminated by Sponsor|0|||
162644708|NCT00455429|587415893|FG001|Overall Study|Study Terminated by Sponsor|0|||
162644709|NCT00455429|587415894|FG002|Overall Study|Study Terminated by Sponsor|0|||
162644710|NCT00455429|587415895|FG003|Overall Study|Study Terminated by Sponsor|3|||
162644711|NCT00455429|587415892|FG000|Overall Study|Lost to Follow-up|1|||
162644712|NCT00455429|587415893|FG001|Overall Study|Lost to Follow-up|0|||
162644713|NCT00455429|587415894|FG002|Overall Study|Lost to Follow-up|0|||
162644714|NCT00455429|587415895|FG003|Overall Study|Lost to Follow-up|3|||
162644715|NCT00455429|587415892|FG000|Overall Study|Withdrawal by Subject|0|||
162644716|NCT00455429|587415893|FG001|Overall Study|Withdrawal by Subject|1|||
162644717|NCT00455429|587415894|FG002|Overall Study|Withdrawal by Subject|1|||
162644718|NCT00455429|587415895|FG003|Overall Study|Withdrawal by Subject|0|||
162644719|NCT00455429|587415892|FG000|Overall Study|Lack of Efficacy|0|||
162644720|NCT00455429|587415893|FG001|Overall Study|Lack of Efficacy|1|||
162644721|NCT00455429|587415894|FG002|Overall Study|Lack of Efficacy|0|||
163073803|NCT00710554|588978212|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
163073804|NCT00710554|588978213|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
163073805|NCT01093885|588978214|FG000|Overall Study|Adverse Event|4|||
163073806|NCT01093885|588978214|FG000|Overall Study|Lost to Follow-up|1|||
163073807|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
163073808|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
163073809|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
163073810|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
163073811|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
163073812|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
163073813|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
163073814|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
163073815|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
163073816|NCT00292370|588978219|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
163073817|NCT00292370|588978220|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
163073818|NCT00292370|588978221|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
163073819|NCT00292370|588978219|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
163073820|NCT00292370|588978220|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
163073821|NCT00292370|588978221|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
163073822|NCT00292370|588978219|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
163073823|NCT00292370|588978220|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
163073824|NCT00292370|588978221|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
163073825|NCT01346709|588978222|FG000|Overall Study|Protocol Violation|35|||
163073826|NCT01346709|588978222|FG000|Overall Study|Lost to Follow-up|31|||
163073827|NCT01346709|588978222|FG000|Overall Study|Missing data in candidate risk factor|285|||
163073828|NCT02365064|588978223|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
163073829|NCT02365064|588978224|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
163073830|NCT02365064|588978223|FG000|Overall Study|Withdrawal by Subject|6|||
163073831|NCT02365064|588978224|FG001|Overall Study|Withdrawal by Subject|9|||
163073832|NCT02365064|588978223|FG000|Overall Study|Treatment intolerance|2|||
163073833|NCT02365064|588978224|FG001|Overall Study|Treatment intolerance|4|||
163073834|NCT00662038|588978233|FG000|Overall Study|Reason not specified|3|||
163073835|NCT00662038|588978233|FG000|Overall Study|Withdrawn consent|22|||
163073836|NCT00662038|588978233|FG000|Overall Study|Withdrawal by Subject|83|||
163073837|NCT00662038|588978233|FG000|Overall Study|Sponsor decision|1|||
163073838|NCT00662038|588978233|FG000|Overall Study|Physician Decision|19|||
163073839|NCT00662038|588978233|FG000|Overall Study|Lung transplantation|44|||
163073840|NCT00662038|588978233|FG000|Overall Study|Lost to Follow-up|1|||
163073841|NCT00662038|588978233|FG000|Overall Study|Death|95|||
163073842|NCT00662038|588978233|FG000|Overall Study|Adverse Event|358|||
163073843|NCT00662038|588978233|FG000|Overall Study|Continued treatment|5|||
163073844|NCT00397046|588978234|FG000|Overall Study|Disease Progression|3|||
163073845|NCT00397046|588978235|FG001|Overall Study|Disease Progression|3|||
163073846|NCT00397046|588978236|FG002|Overall Study|Disease Progression|10|||
162644722|NCT00455429|587415895|FG003|Overall Study|Lack of Efficacy|1|||
162644723|NCT00455429|587415892|FG000|Overall Study|Adverse Event|0|||
163073847|NCT00397046|588978237|FG003|Overall Study|Disease Progression|5|||
163073848|NCT01975285|588978239|FG000|Overall Study|Failed Block and follow up|2|||
162644724|NCT00455429|587415893|FG001|Overall Study|Adverse Event|1|||
162644725|NCT00455429|587415894|FG002|Overall Study|Adverse Event|0|||
162644726|NCT00455429|587415895|FG003|Overall Study|Adverse Event|3|||
162644727|NCT00455429|587415892|FG000|Overall Study|Randomly assigned but not treated|0|||
162644728|NCT00455429|587415893|FG001|Overall Study|Randomly assigned but not treated|0|||
162644729|NCT00455429|587415894|FG002|Overall Study|Randomly assigned but not treated|0|||
163073849|NCT01975285|588978240|FG001|Overall Study|Failed Block and follow up|2|||
163073850|NCT04535362|588978241|FG000|Overall Study|Lost to Follow-up|3|||
163073851|NCT04535362|588978242|FG001|Overall Study|Lost to Follow-up|1|||
163073852|NCT02421510|588978246|FG000|Overall Study|Other|4|||
163073853|NCT02421510|588978247|FG001|Overall Study|Other|2|||
163073854|NCT02421510|588978248|FG002|Overall Study|Other|3|||
163073855|NCT02421510|588978246|FG000|Overall Study|Protocol Violation|1|||
163073856|NCT02421510|588978247|FG001|Overall Study|Protocol Violation|2|||
163073857|NCT02421510|588978248|FG002|Overall Study|Protocol Violation|0|||
163073858|NCT02421510|588978246|FG000|Overall Study|Death|1|||
163073859|NCT02421510|588978247|FG001|Overall Study|Death|0|||
163073860|NCT02421510|588978248|FG002|Overall Study|Death|0|||
163073861|NCT02421510|588978246|FG000|Overall Study|Noncompliance with study drug|1|||
163073862|NCT02421510|588978247|FG001|Overall Study|Noncompliance with study drug|0|||
163073863|NCT02421510|588978248|FG002|Overall Study|Noncompliance with study drug|0|||
163073864|NCT02421510|588978246|FG000|Overall Study|Physician Decision|1|||
163073865|NCT02421510|588978247|FG001|Overall Study|Physician Decision|1|||
163073866|NCT02421510|588978248|FG002|Overall Study|Physician Decision|3|||
163073867|NCT02421510|588978246|FG000|Overall Study|Adverse Event|9|||
163073868|NCT02421510|588978247|FG001|Overall Study|Adverse Event|10|||
163073869|NCT02421510|588978248|FG002|Overall Study|Adverse Event|18|||
163073870|NCT02421510|588978246|FG000|Overall Study|Pregnancy|1|||
163073871|NCT02421510|588978247|FG001|Overall Study|Pregnancy|1|||
163073872|NCT02421510|588978248|FG002|Overall Study|Pregnancy|0|||
163073873|NCT02421510|588978246|FG000|Overall Study|Withdrawal by Subject|14|||
163073874|NCT02421510|588978247|FG001|Overall Study|Withdrawal by Subject|18|||
163073875|NCT02421510|588978248|FG002|Overall Study|Withdrawal by Subject|12|||
163073876|NCT02421510|588978246|FG000|Overall Study|Lost to Follow-up|1|||
163073877|NCT02421510|588978247|FG001|Overall Study|Lost to Follow-up|1|||
163073878|NCT02421510|588978248|FG002|Overall Study|Lost to Follow-up|0|||
163073879|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
163073880|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
163073881|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
163073882|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
163073883|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
163073884|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073885|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073886|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163073887|NCT04098302|588978258|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
163073888|NCT04098302|588978259|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
163073889|NCT04098302|588978260|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
163073890|NCT04098302|588978261|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
163073891|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
163073892|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
163073893|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
163073894|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
163073895|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
163073896|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
163073897|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
163073898|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
163073899|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073900|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073901|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
163073902|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
163073903|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
163073904|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
162644730|NCT00455429|587415895|FG003|Overall Study|Randomly assigned but not treated|2|||
163073905|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
162644731|NCT00455429|587415892|FG000|Overall Study|Personal Reason|1|||
162644732|NCT00455429|587415893|FG001|Overall Study|Personal Reason|0|||
163073906|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
163073907|NCT04098302|588978258|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073908|NCT04098302|588978259|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073909|NCT04098302|588978260|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
163073910|NCT04098302|588978261|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
163073911|NCT05061706|588978262|FG000|Overall Study|Adverse Event|29|||
163073912|NCT05061706|588978263|FG001|Overall Study|Adverse Event|1|||
163073913|NCT05061706|588978262|FG000|Overall Study|Lack of Efficacy|0|||
162644733|NCT00455429|587415894|FG002|Overall Study|Personal Reason|0|||
162644734|NCT00455429|587415895|FG003|Overall Study|Personal Reason|0|||
162644735|NCT00455429|587415892|FG000|Overall Study|Non-compliance|0|||
162644736|NCT00455429|587415893|FG001|Overall Study|Non-compliance|0|||
162644737|NCT00455429|587415894|FG002|Overall Study|Non-compliance|0|||
162644738|NCT00455429|587415895|FG003|Overall Study|Non-compliance|1|||
162644739|NCT00455429|587415892|FG000|Overall Study|Other|0|||
162644740|NCT00455429|587415893|FG001|Overall Study|Other|2|||
162644741|NCT00455429|587415894|FG002|Overall Study|Other|0|||
162644742|NCT00455429|587415895|FG003|Overall Study|Other|1|||
162644743|NCT04351087|587415896|FG000|Overall Study|Lost to Follow-up|7|||
162644744|NCT04351087|587415897|FG001|Overall Study|Lost to Follow-up|3|||
162644745|NCT04351087|587415896|FG000|Overall Study|Withdrawal by Subject|3|||
162644746|NCT04351087|587415897|FG001|Overall Study|Withdrawal by Subject|4|||
162644747|NCT04351087|587415896|FG000|Overall Study|Lack of Efficacy|3|||
162644748|NCT04351087|587415897|FG001|Overall Study|Lack of Efficacy|2|||
162644749|NCT03519347|587415898|FG000|Interventional Crossover Period 1|Death|0|||
162644750|NCT03519347|587415899|FG001|Interventional Crossover Period 1|Death|0|||
162644751|NCT03519347|587415900|FG002|Interventional Crossover Period 1|Death|0|||
162644752|NCT03519347|587415901|FG003|Interventional Crossover Period 1|Death|1|||
162644753|NCT01412021|587415902|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
163073914|NCT05061706|588978263|FG001|Overall Study|Lack of Efficacy|1|||
163073915|NCT05061706|588978262|FG000|Overall Study|Lost to Follow-up|2|||
163073916|NCT05061706|588978263|FG001|Overall Study|Lost to Follow-up|2|||
163073917|NCT05061706|588978262|FG000|Overall Study|Protocol Violation|3|||
163073918|NCT05061706|588978263|FG001|Overall Study|Protocol Violation|1|||
163073919|NCT05061706|588978262|FG000|Overall Study|Withdrawal by Subject|3|||
163073920|NCT05061706|588978263|FG001|Overall Study|Withdrawal by Subject|9|||
163073921|NCT00191152|588978264|FG000|Initial Treatment|Adverse Event|43|||
163073922|NCT00191152|588978265|FG001|Initial Treatment|Adverse Event|67|||
163073923|NCT00191152|588978264|FG000|Initial Treatment|Physician Decision|40|||
163073924|NCT00191152|588978265|FG001|Initial Treatment|Physician Decision|31|||
163073925|NCT00191152|588978264|FG000|Initial Treatment|Withdrawal by Subject|40|||
163073926|NCT00191152|588978265|FG001|Initial Treatment|Withdrawal by Subject|28|||
163073927|NCT00191152|588978264|FG000|Initial Treatment|Lost to Follow-up|0|||
163073928|NCT00191152|588978265|FG001|Initial Treatment|Lost to Follow-up|6|||
163073929|NCT00191152|588978264|FG000|Initial Treatment|Other|18|||
163073930|NCT00191152|588978265|FG001|Initial Treatment|Other|21|||
163073931|NCT00191152|588978264|FG000|Crossover Treatment|Adverse Event|8|||
163073932|NCT00191152|588978265|FG001|Crossover Treatment|Adverse Event|8|||
163073933|NCT00191152|588978264|FG000|Crossover Treatment|Physician Decision|7|||
163073934|NCT00191152|588978265|FG001|Crossover Treatment|Physician Decision|7|||
163073935|NCT00191152|588978264|FG000|Crossover Treatment|Withdrawal by Subject|6|||
163073936|NCT00191152|588978265|FG001|Crossover Treatment|Withdrawal by Subject|9|||
163073937|NCT00191152|588978264|FG000|Crossover Treatment|Lost to Follow-up|2|||
163073938|NCT00191152|588978265|FG001|Crossover Treatment|Lost to Follow-up|1|||
163073939|NCT00191152|588978264|FG000|Crossover Treatment|Other|4|||
163073940|NCT00191152|588978265|FG001|Crossover Treatment|Other|3|||
163073941|NCT00114777|588978266|FG000|Randomization to Month 36|Death|10|||
163073942|NCT00114777|588978267|FG001|Randomization to Month 36|Death|4|||
163073943|NCT00114777|588978268|FG002|Randomization to Month 36|Death|3|||
163073944|NCT00114777|588978266|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
163073945|NCT00114777|588978267|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
163073946|NCT00114777|588978268|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
163073947|NCT00114777|588978266|FG000|Randomization to Month 36|Lack of Efficacy|19|||
163073948|NCT00114777|588978267|FG001|Randomization to Month 36|Lack of Efficacy|15|||
163073949|NCT00114777|588978268|FG002|Randomization to Month 36|Lack of Efficacy|17|||
163073950|NCT00114777|588978266|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
162644754|NCT01412021|587415902|FG000|Overall Study|Treatment Prior to Approval|3|||
162644755|NCT01412021|587415902|FG000|Overall Study|Transferred to Other Hospital|9|||
162644756|NCT00484939|587415905|FG000|Overall Study|Death|9|||
162644757|NCT00484939|587415906|FG001|Overall Study|Death|13|||
162644758|NCT00484939|587415905|FG000|Overall Study|Adverse Event|22|||
162644759|NCT00484939|587415906|FG001|Overall Study|Adverse Event|12|||
162644760|NCT00484939|587415905|FG000|Overall Study|Patient Withdrew Consent|19|||
162644761|NCT00484939|587415906|FG001|Overall Study|Patient Withdrew Consent|10|||
163073951|NCT00114777|588978267|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
163073952|NCT00114777|588978268|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
163073953|NCT00114777|588978266|FG000|Randomization to Month 36|Adverse Event|34|||
163073954|NCT00114777|588978267|FG001|Randomization to Month 36|Adverse Event|35|||
163073955|NCT00114777|588978268|FG002|Randomization to Month 36|Adverse Event|44|||
163073956|NCT00114777|588978266|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
163073957|NCT00114777|588978267|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
163073958|NCT00114777|588978268|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
162644762|NCT00484939|587415905|FG000|Overall Study|Protocol Violation|3|||
162644763|NCT00484939|587415906|FG001|Overall Study|Protocol Violation|3|||
162644764|NCT00484939|587415905|FG000|Overall Study|Lost to Follow-up|0|||
162644765|NCT00484939|587415906|FG001|Overall Study|Lost to Follow-up|3|||
162644766|NCT00484939|587415905|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
162644767|NCT00484939|587415906|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
162644768|NCT00484939|587415905|FG000|Overall Study|Disease progression|67|||
162644769|NCT00484939|587415906|FG001|Overall Study|Disease progression|88|||
162644770|NCT00484939|587415905|FG000|Overall Study|Screen Failure|2|||
162644771|NCT00484939|587415906|FG001|Overall Study|Screen Failure|2|||
162644772|NCT00484939|587415905|FG000|Overall Study|Reason Not Specified|11|||
162644773|NCT00484939|587415906|FG001|Overall Study|Reason Not Specified|6|||
162644774|NCT01522365|587415907|FG000|Overall Study|Withdrawal by Subject|1|||
162644775|NCT01522365|587415908|FG001|Overall Study|Withdrawal by Subject|1|||
162644776|NCT01522365|587415907|FG000|Overall Study|Lost to Follow-up|1|||
162644777|NCT01522365|587415908|FG001|Overall Study|Lost to Follow-up|1|||
162644778|NCT02466555|587415911|FG000|Overall Study|Lost to Follow-up|2|||
162644779|NCT02865915|587415912|FG000|Overall Study|Pregnancy|1|||
162644780|NCT02865915|587415913|FG001|Overall Study|Pregnancy|0|||
162644781|NCT02865915|587415912|FG000|Overall Study|Withdrawal by Subject|1|||
162644782|NCT02865915|587415913|FG001|Overall Study|Withdrawal by Subject|1|||
162644783|NCT02865915|587415912|FG000|Overall Study|Adverse Event|0|||
162644784|NCT02865915|587415913|FG001|Overall Study|Adverse Event|4|||
162644785|NCT02865915|587415912|FG000|Overall Study|Lost to Follow-up|0|||
162644786|NCT02865915|587415913|FG001|Overall Study|Lost to Follow-up|1|||
162644787|NCT02865915|587415912|FG000|Overall Study|Protocol Violation|0|||
162644788|NCT02865915|587415913|FG001|Overall Study|Protocol Violation|1|||
162644789|NCT02865915|587415912|FG000|Overall Study|Study terminated by sponsor|23|||
162644790|NCT02865915|587415913|FG001|Overall Study|Study terminated by sponsor|18|||
163027739|NCT01738503|588804168|FG006|Treatment Period|Protocol Violation|0|||
163027740|NCT01738503|588804162|FG000|Treatment Period|Other|0|||
163027741|NCT01738503|588804163|FG001|Treatment Period|Other|0|||
163027742|NCT01738503|588804164|FG002|Treatment Period|Other|1|||
163027743|NCT01738503|588804165|FG003|Treatment Period|Other|0|||
163027744|NCT01738503|588804166|FG004|Treatment Period|Other|0|||
163027745|NCT01738503|588804167|FG005|Treatment Period|Other|0|||
163027746|NCT01738503|588804168|FG006|Treatment Period|Other|0|||
163027747|NCT01738503|588804162|FG000|PET Imaging Sub-study|Adverse Event|0|||
163027748|NCT01738503|588804163|FG001|PET Imaging Sub-study|Adverse Event|0|||
163027749|NCT01738503|588804164|FG002|PET Imaging Sub-study|Adverse Event|0|||
163027750|NCT01738503|588804165|FG003|PET Imaging Sub-study|Adverse Event|0|||
163027751|NCT01738503|588804166|FG004|PET Imaging Sub-study|Adverse Event|0|||
163027752|NCT01738503|588804167|FG005|PET Imaging Sub-study|Adverse Event|1|||
163027753|NCT01738503|588804168|FG006|PET Imaging Sub-study|Adverse Event|0|||
163027754|NCT01738503|588804162|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027755|NCT01738503|588804163|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027756|NCT01738503|588804164|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027757|NCT01738503|588804165|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027758|NCT01738503|588804166|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
163027759|NCT01738503|588804167|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
163027760|NCT01738503|588804168|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
163027761|NCT01340027|588804170|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
163027762|NCT01340027|588804171|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
163027763|NCT01340027|588804172|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
163027764|NCT01340027|588804173|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
163027765|NCT01340027|588804174|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
163027766|NCT01340027|588804175|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
163027767|NCT01340027|588804176|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
163027768|NCT01340027|588804177|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
163027769|NCT01340027|588804178|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
163027770|NCT01340027|588804179|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
163027771|NCT01340027|588804180|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
163027772|NCT01340027|588804181|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
163027773|NCT01340027|588804170|FG000|Overall Study|Adverse Event|0|||
163027774|NCT01340027|588804171|FG001|Overall Study|Adverse Event|1|||
163027775|NCT01340027|588804172|FG002|Overall Study|Adverse Event|2|||
163027776|NCT01340027|588804173|FG003|Overall Study|Adverse Event|0|||
163027777|NCT01340027|588804174|FG004|Overall Study|Adverse Event|1|||
163027778|NCT01340027|588804175|FG005|Overall Study|Adverse Event|2|||
162644791|NCT02865915|587415912|FG000|Overall Study|Dosing group discontinued|0|||
162644792|NCT02865915|587415913|FG001|Overall Study|Dosing group discontinued|5|||
162644793|NCT05760300|587415918|FG000|Overall Study|Adverse Event|0|||
162644794|NCT05760300|587415919|FG001|Overall Study|Adverse Event|0|||
162644795|NCT05760300|587415920|FG002|Overall Study|Adverse Event|1|||
162644796|NCT05760300|587415921|FG003|Overall Study|Adverse Event|0|||
162644797|NCT05760300|587415918|FG000|Overall Study|Participant Decision|1|||
162644798|NCT05760300|587415919|FG001|Overall Study|Participant Decision|0|||
162644799|NCT05760300|587415920|FG002|Overall Study|Participant Decision|0|||
162644800|NCT05760300|587415921|FG003|Overall Study|Participant Decision|0|||
162644801|NCT03989440|587417629|FG000|Overall Study|COVID-19 travel restrictions|0|||
162644802|NCT03989440|587417630|FG001|Overall Study|COVID-19 travel restrictions|0|||
162644803|NCT03989440|587417631|FG002|Overall Study|COVID-19 travel restrictions|1|||
162644804|NCT03989440|587417632|FG003|Overall Study|COVID-19 travel restrictions|0|||
162644805|NCT03989440|587417633|FG004|Overall Study|COVID-19 travel restrictions|0|||
162644806|NCT03989440|587417634|FG005|Overall Study|COVID-19 travel restrictions|0|||
162644807|NCT03989440|587417629|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
162644808|NCT03989440|587417630|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
162644809|NCT03989440|587417631|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
162644810|NCT03989440|587417632|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
162644811|NCT03989440|587417633|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
163027779|NCT01340027|588804176|FG006|Overall Study|Adverse Event|2|||
163027780|NCT01340027|588804177|FG007|Overall Study|Adverse Event|1|||
163027781|NCT01340027|588804178|FG008|Overall Study|Adverse Event|4|||
163027782|NCT01340027|588804179|FG009|Overall Study|Adverse Event|1|||
163027783|NCT01340027|588804180|FG010|Overall Study|Adverse Event|1|||
163027784|NCT01340027|588804181|FG011|Overall Study|Adverse Event|3|||
163027785|NCT01340027|588804170|FG000|Overall Study|Lack of Efficacy|0|||
163027786|NCT01340027|588804171|FG001|Overall Study|Lack of Efficacy|0|||
163027787|NCT01340027|588804172|FG002|Overall Study|Lack of Efficacy|0|||
163027788|NCT01340027|588804173|FG003|Overall Study|Lack of Efficacy|0|||
163027789|NCT01340027|588804174|FG004|Overall Study|Lack of Efficacy|0|||
163027790|NCT01340027|588804175|FG005|Overall Study|Lack of Efficacy|0|||
163027791|NCT01340027|588804176|FG006|Overall Study|Lack of Efficacy|1|||
163027792|NCT01340027|588804177|FG007|Overall Study|Lack of Efficacy|1|||
163027793|NCT01340027|588804178|FG008|Overall Study|Lack of Efficacy|1|||
163027794|NCT01340027|588804179|FG009|Overall Study|Lack of Efficacy|0|||
163027795|NCT01340027|588804180|FG010|Overall Study|Lack of Efficacy|0|||
163027796|NCT01340027|588804181|FG011|Overall Study|Lack of Efficacy|0|||
163027797|NCT01340027|588804170|FG000|Overall Study|Lost to Follow-up|0|||
163027798|NCT01340027|588804171|FG001|Overall Study|Lost to Follow-up|1|||
163027799|NCT01340027|588804172|FG002|Overall Study|Lost to Follow-up|0|||
163027800|NCT01340027|588804173|FG003|Overall Study|Lost to Follow-up|0|||
163027801|NCT01340027|588804174|FG004|Overall Study|Lost to Follow-up|0|||
163027802|NCT01340027|588804175|FG005|Overall Study|Lost to Follow-up|0|||
163027803|NCT01340027|588804176|FG006|Overall Study|Lost to Follow-up|1|||
163027804|NCT01340027|588804177|FG007|Overall Study|Lost to Follow-up|0|||
163027805|NCT01340027|588804178|FG008|Overall Study|Lost to Follow-up|0|||
163027806|NCT01340027|588804179|FG009|Overall Study|Lost to Follow-up|1|||
163027807|NCT01340027|588804180|FG010|Overall Study|Lost to Follow-up|0|||
163027808|NCT01340027|588804181|FG011|Overall Study|Lost to Follow-up|0|||
163027809|NCT01340027|588804170|FG000|Overall Study|Protocol Violation|1|||
163027810|NCT01340027|588804171|FG001|Overall Study|Protocol Violation|2|||
163027811|NCT01340027|588804172|FG002|Overall Study|Protocol Violation|0|||
163027812|NCT01340027|588804173|FG003|Overall Study|Protocol Violation|0|||
163027813|NCT01340027|588804174|FG004|Overall Study|Protocol Violation|6|||
163027814|NCT01340027|588804175|FG005|Overall Study|Protocol Violation|0|||
163027815|NCT01340027|588804176|FG006|Overall Study|Protocol Violation|0|||
163027816|NCT01340027|588804177|FG007|Overall Study|Protocol Violation|1|||
163027817|NCT01340027|588804178|FG008|Overall Study|Protocol Violation|2|||
163027818|NCT01340027|588804179|FG009|Overall Study|Protocol Violation|2|||
163027819|NCT01340027|588804180|FG010|Overall Study|Protocol Violation|0|||
163027820|NCT01340027|588804181|FG011|Overall Study|Protocol Violation|0|||
163027821|NCT01340027|588804170|FG000|Overall Study|Withdrawal by Subject|4|||
163027822|NCT01340027|588804171|FG001|Overall Study|Withdrawal by Subject|3|||
163027823|NCT01340027|588804172|FG002|Overall Study|Withdrawal by Subject|1|||
163027824|NCT01340027|588804173|FG003|Overall Study|Withdrawal by Subject|3|||
163027825|NCT01340027|588804174|FG004|Overall Study|Withdrawal by Subject|3|||
163027826|NCT01340027|588804175|FG005|Overall Study|Withdrawal by Subject|2|||
163027827|NCT01340027|588804176|FG006|Overall Study|Withdrawal by Subject|3|||
163027828|NCT01340027|588804177|FG007|Overall Study|Withdrawal by Subject|4|||
163027829|NCT01340027|588804178|FG008|Overall Study|Withdrawal by Subject|1|||
163027830|NCT01340027|588804179|FG009|Overall Study|Withdrawal by Subject|2|||
163027831|NCT01340027|588804180|FG010|Overall Study|Withdrawal by Subject|0|||
163027832|NCT01340027|588804181|FG011|Overall Study|Withdrawal by Subject|1|||
162644812|NCT03989440|587417634|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
163027833|NCT01340027|588804170|FG000|Overall Study|Miscellaneous|0|||
163027834|NCT01340027|588804171|FG001|Overall Study|Miscellaneous|0|||
163027835|NCT01340027|588804172|FG002|Overall Study|Miscellaneous|0|||
163027836|NCT01340027|588804173|FG003|Overall Study|Miscellaneous|1|||
163027837|NCT01340027|588804174|FG004|Overall Study|Miscellaneous|0|||
163027838|NCT01340027|588804175|FG005|Overall Study|Miscellaneous|0|||
163027839|NCT01340027|588804176|FG006|Overall Study|Miscellaneous|0|||
163073959|NCT00114777|588978266|FG000|Randomization to Month 36|Other|9|||
163073960|NCT00114777|588978267|FG001|Randomization to Month 36|Other|3|||
163073961|NCT00114777|588978268|FG002|Randomization to Month 36|Other|12|||
163073962|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Death|8|||
163073963|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Death|13|||
163073964|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Death|7|||
163073965|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
163073966|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
163073967|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
163073968|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
163073969|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
163073970|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
163073971|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
163073972|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
163073973|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
163073974|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
163073975|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
163073976|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
163073977|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
163073978|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
163073979|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
163073980|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
163073981|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
163073982|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
163073983|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
163073984|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
163073985|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
163073986|NCT00114777|588978266|FG000|Long-Term Extension to Month 84|Other|2|||
163073987|NCT00114777|588978267|FG001|Long-Term Extension to Month 84|Other|0|||
163073988|NCT00114777|588978268|FG002|Long-Term Extension to Month 84|Other|2|||
163073989|NCT01181128|588978272|FG000|Overall Study|Withdrawal by Subject|2|||
163027840|NCT01340027|588804177|FG007|Overall Study|Miscellaneous|0|||
163027841|NCT01340027|588804178|FG008|Overall Study|Miscellaneous|0|||
163027842|NCT01340027|588804179|FG009|Overall Study|Miscellaneous|0|||
163027843|NCT01340027|588804180|FG010|Overall Study|Miscellaneous|1|||
163027844|NCT01340027|588804181|FG011|Overall Study|Miscellaneous|0|||
163027845|NCT03005327|588804182|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027846|NCT03005327|588804183|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027847|NCT03005327|588804184|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
163027848|NCT03005327|588804185|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
163027849|NCT03005327|588804182|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027850|NCT03005327|588804183|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163027851|NCT03005327|588804184|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027852|NCT03005327|588804185|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163027853|NCT00833482|588804186|FG000|Days 11-20|Adverse Event|0|||
163027854|NCT00833482|588804187|FG001|Days 11-20|Adverse Event|2|||
163027855|NCT00833482|588804188|FG002|Days 11-20|Adverse Event|0|||
163027856|NCT00833482|588804189|FG003|Days 11-20|Adverse Event|0|||
163027857|NCT00833482|588804190|FG004|Days 11-20|Adverse Event|0|||
163027858|NCT00833482|588804191|FG005|Days 11-20|Adverse Event|0|||
163027859|NCT00833482|588804186|FG000|Days 11-20|Withdrawal by Subject|0|||
163027860|NCT00833482|588804187|FG001|Days 11-20|Withdrawal by Subject|1|||
163027861|NCT00833482|588804188|FG002|Days 11-20|Withdrawal by Subject|0|||
163027862|NCT00833482|588804189|FG003|Days 11-20|Withdrawal by Subject|0|||
163027863|NCT00833482|588804190|FG004|Days 11-20|Withdrawal by Subject|0|||
163027864|NCT00833482|588804191|FG005|Days 11-20|Withdrawal by Subject|0|||
163027865|NCT00833482|588804186|FG000|Days 21-30|Adverse Event|0|||
163027866|NCT00833482|588804187|FG001|Days 21-30|Adverse Event|0|||
163027867|NCT00833482|588804188|FG002|Days 21-30|Adverse Event|1|||
163027868|NCT00833482|588804189|FG003|Days 21-30|Adverse Event|0|||
163027869|NCT00833482|588804190|FG004|Days 21-30|Adverse Event|0|||
163027870|NCT00833482|588804191|FG005|Days 21-30|Adverse Event|0|||
163027871|NCT00833482|588804186|FG000|Days 21-30|Withdrawal by Subject|0|||
163027872|NCT00833482|588804187|FG001|Days 21-30|Withdrawal by Subject|0|||
163027873|NCT00833482|588804188|FG002|Days 21-30|Withdrawal by Subject|0|||
163027874|NCT00833482|588804189|FG003|Days 21-30|Withdrawal by Subject|0|||
163027875|NCT00833482|588804190|FG004|Days 21-30|Withdrawal by Subject|1|||
163027876|NCT00833482|588804191|FG005|Days 21-30|Withdrawal by Subject|0|||
163027877|NCT01794793|588804193|FG000|Treatment Period|Withdrawal by Subject|24|||
163027878|NCT01794793|588804193|FG000|Treatment Period|Lack of Efficacy|22|||
163027879|NCT01794793|588804193|FG000|Treatment Period|Adverse Event|17|||
163027880|NCT01794793|588804193|FG000|Treatment Period|Physician Decision|14|||
163073990|NCT01181128|588978273|FG001|Overall Study|Withdrawal by Subject|2|||
163073991|NCT01181128|588978274|FG002|Overall Study|Withdrawal by Subject|0|||
163073992|NCT01181128|588978272|FG000|Overall Study|Death|1|||
163073993|NCT01181128|588978273|FG001|Overall Study|Death|0|||
163073994|NCT01181128|588978274|FG002|Overall Study|Death|0|||
163073995|NCT01181128|588978272|FG000|Overall Study|Physician Decision|2|||
163073996|NCT01181128|588978273|FG001|Overall Study|Physician Decision|0|||
163073997|NCT01181128|588978274|FG002|Overall Study|Physician Decision|0|||
163073998|NCT01181128|588978272|FG000|Overall Study|Adverse Event|0|||
163073999|NCT01181128|588978273|FG001|Overall Study|Adverse Event|2|||
163074000|NCT01181128|588978274|FG002|Overall Study|Adverse Event|0|||
163074001|NCT01181128|588978272|FG000|Overall Study|Other|1|||
163074002|NCT01181128|588978273|FG001|Overall Study|Other|1|||
163074003|NCT01181128|588978274|FG002|Overall Study|Other|1|||
163074004|NCT04477486|588978277|FG000|Overall Study|Death|2|||
163074005|NCT04477486|588978277|FG000|Overall Study|Ongoing at Time of Analysis|11|||
163074006|NCT01543503|588978279|FG000|Overall Study|Lost to Follow-up|32|||
163074007|NCT01543503|588978280|FG001|Overall Study|Lost to Follow-up|36|||
163074008|NCT01543503|588978279|FG000|Overall Study|Adverse Event|9|||
163074009|NCT01543503|588978280|FG001|Overall Study|Adverse Event|13|||
163074010|NCT01543503|588978279|FG000|Overall Study|Lack of Efficacy|4|||
163074011|NCT01543503|588978280|FG001|Overall Study|Lack of Efficacy|16|||
163074012|NCT01543503|588978279|FG000|Overall Study|Participant withdrew informed consent|8|||
163074013|NCT01543503|588978280|FG001|Overall Study|Participant withdrew informed consent|10|||
163074014|NCT01543503|588978279|FG000|Overall Study|Change of jobs|0|||
163074015|NCT01543503|588978280|FG001|Overall Study|Change of jobs|1|||
163074016|NCT01543503|588978279|FG000|Overall Study|Intolerance to the biologic treatment|0|||
163074017|NCT01543503|588978280|FG001|Overall Study|Intolerance to the biologic treatment|1|||
163074018|NCT01543503|588978279|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
162644813|NCT01955161|587417635|FG000|Overall Study|Withdrawal before treatment|2|||
162644814|NCT01955161|587417636|FG001|Overall Study|Withdrawal before treatment|0|||
162644815|NCT01955161|587417637|FG002|Overall Study|Withdrawal before treatment|1|||
163074019|NCT01543503|588978280|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
163074020|NCT01543503|588978279|FG000|Overall Study|Participant did not complete last visit|0|||
163074021|NCT01543503|588978280|FG001|Overall Study|Participant did not complete last visit|2|||
163074022|NCT01543503|588978279|FG000|Overall Study|Refused to continue treatment|7|||
163074023|NCT01543503|588978280|FG001|Overall Study|Refused to continue treatment|0|||
163074024|NCT01543503|588978279|FG000|Overall Study|Incorrect medication received|1|||
163074025|NCT01543503|588978280|FG001|Overall Study|Incorrect medication received|0|||
163074026|NCT01543503|588978279|FG000|Overall Study|Participant moved to another city|2|||
163074027|NCT01543503|588978280|FG001|Overall Study|Participant moved to another city|0|||
163074028|NCT01543503|588978279|FG000|Overall Study|Participant will not return for visits|0|||
163074029|NCT01543503|588978280|FG001|Overall Study|Participant will not return for visits|2|||
163074030|NCT01543503|588978279|FG000|Overall Study|Participant transferred to another city|1|||
163074031|NCT01543503|588978280|FG001|Overall Study|Participant transferred to another city|0|||
163074032|NCT01543503|588978279|FG000|Overall Study|Participant moved to Scotland|1|||
163074033|NCT01543503|588978280|FG001|Overall Study|Participant moved to Scotland|0|||
163074034|NCT01543503|588978279|FG000|Overall Study|Participant decision to stop treatment|1|||
163074035|NCT01543503|588978280|FG001|Overall Study|Participant decision to stop treatment|0|||
163074036|NCT01543503|588978279|FG000|Overall Study|Investigator did not wish to participate|1|||
163074037|NCT01543503|588978280|FG001|Overall Study|Investigator did not wish to participate|1|||
163074038|NCT01543503|588978279|FG000|Overall Study|Participant recruited after closing date|0|||
163074039|NCT01543503|588978280|FG001|Overall Study|Participant recruited after closing date|1|||
163074040|NCT01543503|588978279|FG000|Overall Study|Site stopped participation|5|||
163074041|NCT01543503|588978280|FG001|Overall Study|Site stopped participation|1|||
163074042|NCT01543503|588978279|FG000|Overall Study|Participant did not attend a visit|1|||
163074043|NCT01543503|588978280|FG001|Overall Study|Participant did not attend a visit|0|||
163074044|NCT01543503|588978279|FG000|Overall Study|Moved to other rheumatologic site|0|||
162644816|NCT01955161|587417635|FG000|Overall Study|Adverse Event|10|||
162644817|NCT01955161|587417636|FG001|Overall Study|Adverse Event|14|||
162644818|NCT01955161|587417637|FG002|Overall Study|Adverse Event|15|||
162644819|NCT01955161|587417635|FG000|Overall Study|Death|1|||
163074045|NCT01543503|588978280|FG001|Overall Study|Moved to other rheumatologic site|1|||
163074046|NCT01543503|588978279|FG000|Overall Study|Participant consented to another study|0|||
163074047|NCT01543503|588978280|FG001|Overall Study|Participant consented to another study|2|||
163074048|NCT01543503|588978279|FG000|Overall Study|Participant went to United States|1|||
163074049|NCT01543503|588978280|FG001|Overall Study|Participant went to United States|0|||
163074050|NCT01543503|588978279|FG000|Overall Study|Screen failure|1|||
163074051|NCT01543503|588978280|FG001|Overall Study|Screen failure|0|||
163074052|NCT01986751|588978281|FG000|Overall Study|improperly consented|10|||
163074053|NCT01986751|588978282|FG001|Overall Study|improperly consented|2|||
162644820|NCT01955161|587417636|FG001|Overall Study|Death|1|||
163074054|NCT00052715|588978288|FG000|Overall Study|wrong histology|1|||
163074055|NCT01774370|588978295|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
163074056|NCT01774370|588978295|FG000|Overall Study|Administered prior to the contract date|4|||
163074057|NCT01774370|588978295|FG000|Overall Study|Subjects of contraindications|34|||
163074058|NCT01774370|588978295|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
163074059|NCT01774370|588978295|FG000|Overall Study|Follow-up failure|34|||
163074060|NCT00514917|588978296|FG000|Overall Study|Death|4|||
163074061|NCT00514917|588978297|FG001|Overall Study|Death|10|||
163074062|NCT00514917|588978296|FG000|Overall Study|Protocol Violation|1|||
163074063|NCT00514917|588978297|FG001|Overall Study|Protocol Violation|0|||
163074064|NCT00514917|588978296|FG000|Overall Study|Lost to Follow-up|4|||
163074065|NCT00514917|588978297|FG001|Overall Study|Lost to Follow-up|3|||
163074066|NCT00514917|588978296|FG000|Overall Study|Withdrawal by Subject|18|||
163074067|NCT00514917|588978297|FG001|Overall Study|Withdrawal by Subject|16|||
163074068|NCT00514917|588978296|FG000|Overall Study|Discontinued due to study closure|88|||
163074069|NCT00514917|588978297|FG001|Overall Study|Discontinued due to study closure|81|||
163074070|NCT00514917|588978296|FG000|Overall Study|Undefined|11|||
163074071|NCT00514917|588978297|FG001|Overall Study|Undefined|5|||
163074072|NCT04243837|588978298|FG000|Overall Study|Adverse Event|2|||
163074073|NCT04243837|588978299|FG001|Overall Study|Adverse Event|1|||
163074074|NCT04243837|588978298|FG000|Overall Study|Withdrawal by Subject|4|||
163074075|NCT04243837|588978299|FG001|Overall Study|Withdrawal by Subject|2|||
163074076|NCT04243837|588978298|FG000|Overall Study|Covid-19 lock down|1|||
163074077|NCT04243837|588978299|FG001|Overall Study|Covid-19 lock down|0|||
163074078|NCT04243837|588978298|FG000|Overall Study|Study Terminated by Sponsor|11|||
163074079|NCT04243837|588978299|FG001|Overall Study|Study Terminated by Sponsor|12|||
163074080|NCT02280499|588978300|FG000|Overall Study|Death|14|||
163074081|NCT02280499|588978300|FG000|Overall Study|Lost to Follow-up|42|||
163074082|NCT02280499|588978300|FG000|Overall Study|Adverse Event|5|||
163074083|NCT01666314|588978306|FG000|Overall Study|Adverse Event|3|||
163074084|NCT01666314|588978307|FG001|Overall Study|Adverse Event|13|||
163074085|NCT01666314|588978308|FG002|Overall Study|Adverse Event|7|||
163074086|NCT01666314|588978309|FG003|Overall Study|Adverse Event|7|||
163074087|NCT01666314|588978306|FG000|Overall Study|Progressive Disease|11|||
163074088|NCT01666314|588978307|FG001|Overall Study|Progressive Disease|9|||
163074089|NCT01666314|588978308|FG002|Overall Study|Progressive Disease|19|||
163074090|NCT01666314|588978309|FG003|Overall Study|Progressive Disease|20|||
163074091|NCT01666314|588978306|FG000|Overall Study|Symptomatic Deterioration|1|||
163074092|NCT01666314|588978307|FG001|Overall Study|Symptomatic Deterioration|0|||
163074093|NCT01666314|588978308|FG002|Overall Study|Symptomatic Deterioration|2|||
163074094|NCT01666314|588978309|FG003|Overall Study|Symptomatic Deterioration|0|||
163074095|NCT01666314|588978306|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
163074096|NCT01666314|588978307|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
163074097|NCT01666314|588978308|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
163074098|NCT01666314|588978309|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
163074099|NCT01666314|588978306|FG000|Overall Study|Withdrawal by Subject|1|||
163074100|NCT01666314|588978307|FG001|Overall Study|Withdrawal by Subject|1|||
163074101|NCT01666314|588978308|FG002|Overall Study|Withdrawal by Subject|2|||
163074102|NCT01666314|588978309|FG003|Overall Study|Withdrawal by Subject|3|||
163074103|NCT01666314|588978306|FG000|Overall Study|Reason not Specified|10|||
163074104|NCT01666314|588978307|FG001|Overall Study|Reason not Specified|7|||
163074105|NCT01666314|588978308|FG002|Overall Study|Reason not Specified|5|||
163074106|NCT01666314|588978309|FG003|Overall Study|Reason not Specified|5|||
163074107|NCT03462563|588978313|FG000|Overall Study|Death|1|||
163074108|NCT03462563|588978314|FG001|Overall Study|Death|1|||
163074109|NCT03462563|588978313|FG000|Overall Study|Termination of study|2|||
163074110|NCT03462563|588978314|FG001|Overall Study|Termination of study|1|||
163074111|NCT03462563|588978313|FG000|Overall Study|Adverse Event|1|||
163074112|NCT03462563|588978314|FG001|Overall Study|Adverse Event|3|||
163074113|NCT03462563|588978313|FG000|Overall Study|Unspecified reason|10|||
163074114|NCT03462563|588978314|FG001|Overall Study|Unspecified reason|12|||
163074115|NCT03462563|588978313|FG000|Overall Study|Physician Decision|1|||
163074116|NCT03462563|588978314|FG001|Overall Study|Physician Decision|0|||
163074117|NCT05089357|588978315|FG000|Overall Study|Withdrawal by Subject|23|||
163074118|NCT05089357|588978315|FG000|Overall Study|Lost to Follow-up|6|||
163074119|NCT05089357|588978315|FG000|Overall Study|Medical reason|1|||
163074120|NCT05089357|588978315|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
163074121|NCT05089357|588978315|FG000|Overall Study|Pregnancy|2|||
163074122|NCT00689052|588978316|FG000|Overall Study|Adverse Event|4|||
163074123|NCT00689052|588978317|FG001|Overall Study|Adverse Event|6|||
163074124|NCT00689052|588978316|FG000|Overall Study|Protocol Violation|1|||
163074125|NCT00689052|588978317|FG001|Overall Study|Protocol Violation|0|||
163074126|NCT00689052|588978316|FG000|Overall Study|Lost to Follow-up|2|||
163074127|NCT00689052|588978317|FG001|Overall Study|Lost to Follow-up|0|||
163154800|NCT00521079|589281441|FG001|Overall Study|Adverse Event|1|||
163154801|NCT00521079|589281440|FG000|Overall Study|Lost to Follow-up|2|||
163154802|NCT00521079|589281441|FG001|Overall Study|Lost to Follow-up|1|||
163074128|NCT00689052|588978316|FG000|Overall Study|Withdrawal by Subject|2|||
163074129|NCT00689052|588978317|FG001|Overall Study|Withdrawal by Subject|0|||
163074130|NCT00689052|588978316|FG000|Overall Study|Early termination of the trial|22|||
163074131|NCT00689052|588978317|FG001|Overall Study|Early termination of the trial|24|||
163074132|NCT04796207|588978318|FG000|Overall Study|Lost to Follow-up|7|||
163074133|NCT04796207|588978319|FG001|Overall Study|Lost to Follow-up|2|||
163074134|NCT01860989|588978322|FG000|Overall Study|Unsatisfactory therapeutic|5|||
163074135|NCT04739709|588978323|FG000|Overall Study|Physician Decision|1|||
163074136|NCT04739709|588978324|FG001|Overall Study|Physician Decision|0|||
163074143|NCT00421993|588978330|FG000|Overall Study|Withdrawal by Subject|22|||
163074144|NCT00421993|588978331|FG001|Overall Study|Withdrawal by Subject|23|||
163027881|NCT01794793|588804193|FG000|Treatment Period|Lost to Follow-up|7|||
163027882|NCT01794793|588804193|FG000|Treatment Period|Death|6|||
163027883|NCT01794793|588804193|FG000|Treatment Period|Protocol Violation|5|||
163027884|NCT01794793|588804193|FG000|Treatment Period|administrative problem|3|||
163027885|NCT01794793|588804193|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
163027886|NCT01794793|588804193|FG000|Post-treatment Follow-up|Adverse Event|8|||
163027887|NCT01794793|588804193|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
163027888|NCT01794793|588804193|FG000|Post-treatment Follow-up|administrative problem|5|||
163027889|NCT01794793|588804193|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
163027890|NCT01794793|588804193|FG000|Post-treatment Follow-up|Protocol Violation|3|||
163027891|NCT02234596|588804194|FG000|Overall Study|Participant not treated|2|||
163027892|NCT04852679|588804195|FG000|Main Intervention Period|Withdrawal by Subject|3|||
163027893|NCT04852679|588804195|FG000|Main Intervention Period|Adverse Event|1|||
163027894|NCT04852679|588804195|FG000|Main Intervention Period|Progressive Disease|16|||
163027895|NCT04852679|588804195|FG000|Main Intervention Period|Refused study visit|1|||
163027896|NCT04852679|588804195|FG000|Independent Injection Period|Missed study visit|1|||
163027897|NCT02907593|588805310|FG000|Overall Study|Withdrawal by Subject|0|||
163027898|NCT02907593|588805311|FG001|Overall Study|Withdrawal by Subject|0|||
163027899|NCT02907593|588805312|FG002|Overall Study|Withdrawal by Subject|1|||
163027900|NCT02907593|588805313|FG003|Overall Study|Withdrawal by Subject|0|||
163027901|NCT01944670|588805314|FG000|Overall Study|Lost to Follow-up|2|||
163027902|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027903|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027904|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
163027905|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
163027906|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
163027907|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
163027908|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027909|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
163027910|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027911|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027912|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027913|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
163027914|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
163027915|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
163027916|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027917|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027918|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
163027919|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
163027920|NCT01752634|588805318|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
163027921|NCT01752634|588805319|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027922|NCT01752634|588805320|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
163027923|NCT01752634|588805321|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027924|NCT01752634|588805322|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
163027925|NCT01752634|588805323|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
163027926|NCT01752634|588805318|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
163027927|NCT01752634|588805319|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
163027928|NCT01752634|588805320|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
163027929|NCT01752634|588805321|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
163027930|NCT01752634|588805322|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
163027931|NCT01752634|588805323|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
163027932|NCT01752634|588805318|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
163027933|NCT01752634|588805319|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
163074145|NCT00421993|588978332|FG002|Overall Study|Withdrawal by Subject|23|||
163074146|NCT00421993|588978333|FG003|Overall Study|Withdrawal by Subject|24|||
163074147|NCT00421993|588978330|FG000|Overall Study|Lost to Follow-up|18|||
163074148|NCT00421993|588978331|FG001|Overall Study|Lost to Follow-up|19|||
163074149|NCT00421993|588978332|FG002|Overall Study|Lost to Follow-up|22|||
163074150|NCT00421993|588978333|FG003|Overall Study|Lost to Follow-up|20|||
163074151|NCT00421993|588978330|FG000|Overall Study|Adverse Event|11|||
163074152|NCT00421993|588978331|FG001|Overall Study|Adverse Event|1|||
163074153|NCT00421993|588978332|FG002|Overall Study|Adverse Event|6|||
162717866|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163074154|NCT00421993|588978333|FG003|Overall Study|Adverse Event|4|||
163074155|NCT00421993|588978330|FG000|Overall Study|Protocol Violation|2|||
163074156|NCT00421993|588978331|FG001|Overall Study|Protocol Violation|2|||
163074157|NCT00421993|588978332|FG002|Overall Study|Protocol Violation|0|||
163074158|NCT00421993|588978333|FG003|Overall Study|Protocol Violation|1|||
163074159|NCT00421993|588978330|FG000|Overall Study|Lack of Efficacy|0|||
163074160|NCT00421993|588978331|FG001|Overall Study|Lack of Efficacy|3|||
163074161|NCT00421993|588978332|FG002|Overall Study|Lack of Efficacy|0|||
163074162|NCT00421993|588978333|FG003|Overall Study|Lack of Efficacy|5|||
163074163|NCT00421993|588978330|FG000|Overall Study|Pregnancy|0|||
163074164|NCT00421993|588978331|FG001|Overall Study|Pregnancy|1|||
163074165|NCT00421993|588978332|FG002|Overall Study|Pregnancy|1|||
163074166|NCT00421993|588978333|FG003|Overall Study|Pregnancy|2|||
163074167|NCT00421993|588978330|FG000|Overall Study|Subject transportation issues|0|||
163074168|NCT00421993|588978331|FG001|Overall Study|Subject transportation issues|0|||
163074169|NCT00421993|588978332|FG002|Overall Study|Subject transportation issues|0|||
163074170|NCT00421993|588978333|FG003|Overall Study|Subject transportation issues|1|||
163074171|NCT01751685|588978334|FG000|6-mo Followup|Missed study visit|1|||
163074172|NCT01751685|588978335|FG001|6-mo Followup|Missed study visit|0|||
163074173|NCT01751685|588978334|FG000|6-mo Followup|Withdrawal by Subject|2|||
163074174|NCT01751685|588978335|FG001|6-mo Followup|Withdrawal by Subject|2|||
163074175|NCT01751685|588978334|FG000|6-mo Followup|Lost to Follow-up|0|||
163074176|NCT01751685|588978335|FG001|6-mo Followup|Lost to Follow-up|1|||
163074177|NCT01751685|588978334|FG000|12-mo Followup|Lost to Follow-up|5|||
163074178|NCT01751685|588978335|FG001|12-mo Followup|Lost to Follow-up|0|||
163074179|NCT02724644|588980488|FG000|Overall Study|Adverse Event|7|||
163074180|NCT02724644|588980489|FG001|Overall Study|Adverse Event|1|||
163074181|NCT02724644|588980488|FG000|Overall Study|Lost to Follow-up|6|||
163074182|NCT02724644|588980489|FG001|Overall Study|Lost to Follow-up|2|||
163074183|NCT02724644|588980488|FG000|Overall Study|Withdrawal by Subject|7|||
163074184|NCT02724644|588980489|FG001|Overall Study|Withdrawal by Subject|1|||
163074185|NCT02724644|588980488|FG000|Overall Study|Administrative|1|||
163074186|NCT02724644|588980489|FG001|Overall Study|Administrative|0|||
163074187|NCT01882829|588980490|FG000|Overall Study|Adverse Event|4|||
163074188|NCT01882829|588980490|FG000|Overall Study|Protocol Violation|1|||
163074189|NCT01882829|588980490|FG000|Overall Study|Withdrawal by Subject|1|||
163074190|NCT03312114|588980491|FG000|Overall Study|All the five enrolled dropped out of the|5|||
163074191|NCT02469961|588980498|FG000|Overall Study|Physician Decision|4|||
163074192|NCT02469961|588980499|FG001|Overall Study|Physician Decision|1|||
163074193|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
163074194|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
163074195|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
163074196|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
163074197|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074198|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074199|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
163074200|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
163074201|NCT01245751|588980507|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074202|NCT01245751|588980508|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
163074203|NCT01245751|588980509|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074204|NCT01245751|588980510|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
163074205|NCT01748552|588980515|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
163074206|NCT01748552|588980516|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
163074207|NCT01748552|588980517|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
163074208|NCT01748552|588980518|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
163074209|NCT01748552|588980519|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
163074210|NCT01748552|588980520|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
163074211|NCT01748552|588980521|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
163074212|NCT01748552|588980522|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
163074213|NCT01748552|588980523|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
163074214|NCT01748552|588980524|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
163074215|NCT01748552|588980525|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
163074216|NCT01748552|588980526|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
163074217|NCT01748552|588980515|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074218|NCT01748552|588980516|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074219|NCT01748552|588980517|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074220|NCT01748552|588980518|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074221|NCT01748552|588980519|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074222|NCT01748552|588980520|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074223|NCT01748552|588980521|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074224|NCT01748552|588980522|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074225|NCT01748552|588980523|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
163074226|NCT01748552|588980524|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074227|NCT01748552|588980525|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074228|NCT01748552|588980526|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
163074229|NCT01386645|588980527|FG000|Overall Study|Physician Decision|0|||
163074230|NCT01386645|588980528|FG001|Overall Study|Physician Decision|0|||
163074231|NCT01386645|588980529|FG002|Overall Study|Physician Decision|1|||
163074232|NCT01386645|588980527|FG000|Overall Study|Withdrawal by Subject|0|||
163074233|NCT01386645|588980528|FG001|Overall Study|Withdrawal by Subject|1|||
163074234|NCT01386645|588980529|FG002|Overall Study|Withdrawal by Subject|1|||
163074235|NCT02930941|588980530|FG000|Overall Study|Lost to Follow-up|1|||
163074236|NCT02930941|588980531|FG001|Overall Study|Lost to Follow-up|2|||
163074237|NCT00289978|588980532|FG000|Overall Study|Withdrawal by Subject|31|||
163074238|NCT00289978|588980533|FG001|Overall Study|Withdrawal by Subject|17|||
163074239|NCT00289978|588980534|FG002|Overall Study|Withdrawal by Subject|28|||
163074240|NCT00289978|588980532|FG000|Overall Study|Adverse Event|22|||
163074241|NCT00289978|588980533|FG001|Overall Study|Adverse Event|13|||
163074242|NCT00289978|588980534|FG002|Overall Study|Adverse Event|18|||
163074243|NCT00289978|588980532|FG000|Overall Study|Lack of Efficacy|13|||
163074244|NCT00289978|588980533|FG001|Overall Study|Lack of Efficacy|6|||
163074245|NCT00289978|588980534|FG002|Overall Study|Lack of Efficacy|25|||
163074246|NCT00289978|588980532|FG000|Overall Study|Abnormal laboratory value(s)|20|||
163074247|NCT00289978|588980533|FG001|Overall Study|Abnormal laboratory value(s)|9|||
163074248|NCT00289978|588980534|FG002|Overall Study|Abnormal laboratory value(s)|1|||
163074249|NCT00289978|588980532|FG000|Overall Study|Lost to Follow-up|3|||
163074250|NCT00289978|588980533|FG001|Overall Study|Lost to Follow-up|5|||
163074251|NCT00289978|588980534|FG002|Overall Study|Lost to Follow-up|7|||
163074252|NCT00289978|588980532|FG000|Overall Study|Protocol Violation|5|||
163074253|NCT00289978|588980533|FG001|Overall Study|Protocol Violation|5|||
163074254|NCT00289978|588980534|FG002|Overall Study|Protocol Violation|4|||
163074255|NCT00289978|588980532|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163074256|NCT00289978|588980533|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163074257|NCT00289978|588980534|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163074258|NCT00289978|588980532|FG000|Overall Study|Death|1|||
163074259|NCT00289978|588980533|FG001|Overall Study|Death|0|||
163074260|NCT00289978|588980534|FG002|Overall Study|Death|2|||
163074261|NCT00527748|588980547|FG000|Overall Study|Other|3|||
163074262|NCT02391584|588980553|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
163074263|NCT02391584|588980554|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
163074264|NCT02391584|588980553|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
163074265|NCT02391584|588980554|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
163074266|NCT02391584|588980553|FG000|3 Month|Lost to Follow-up|1|||
163074267|NCT02391584|588980554|FG001|3 Month|Lost to Follow-up|0|||
163074268|NCT02391584|588980553|FG000|6 Month|Withdrawal by Subject|1|||
163074269|NCT02391584|588980554|FG001|6 Month|Withdrawal by Subject|0|||
163074270|NCT02391584|588980553|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
163074271|NCT02391584|588980554|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
163074272|NCT04621786|588980555|FG000|Overall Study|Lost to Follow-up|9|||
163074273|NCT04621786|588980555|FG000|Overall Study|Protocol Violation|3|||
163074274|NCT01301001|588980556|FG000|First Intervention|Lost to Follow-up|4|||
163074275|NCT01301001|588980557|FG001|First Intervention|Lost to Follow-up|4|||
163074276|NCT01301001|588980556|FG000|First Intervention|Withdrawal by Subject|1|||
163074277|NCT01301001|588980557|FG001|First Intervention|Withdrawal by Subject|4|||
163074278|NCT01301001|588980556|FG000|First Intervention|Adverse Event|5|||
163074279|NCT01301001|588980557|FG001|First Intervention|Adverse Event|0|||
163074280|NCT01301001|588980556|FG000|First Intervention|Protocol Violation|0|||
163074281|NCT01301001|588980557|FG001|First Intervention|Protocol Violation|1|||
163074282|NCT01301001|588980556|FG000|Second Intervention|Adverse Event|2|||
163074283|NCT01301001|588980557|FG001|Second Intervention|Adverse Event|0|||
163074284|NCT01301001|588980556|FG000|Second Intervention|Withdrawal by Subject|2|||
163074285|NCT01301001|588980557|FG001|Second Intervention|Withdrawal by Subject|0|||
163074286|NCT04821245|588980558|FG000|Overall Study|Withdrawal by Subject|3|||
163074287|NCT04821245|588980558|FG000|Overall Study|Physician Decision|1|||
163074288|NCT04821245|588980558|FG000|Overall Study|Protocol Violation|5|||
163074289|NCT01840163|588980559|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
163074290|NCT01840163|588980560|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
163074291|NCT01840163|588980559|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
163074292|NCT01840163|588980560|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
163074293|NCT01840163|588980559|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
163074294|NCT01840163|588980560|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
163074295|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
163074296|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
163074297|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
163074298|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
162644821|NCT01955161|587417637|FG002|Overall Study|Death|3|||
162644822|NCT01955161|587417635|FG000|Overall Study|Withdrawal by Subject|9|||
162644823|NCT01955161|587417636|FG001|Overall Study|Withdrawal by Subject|8|||
163074299|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163074300|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163074301|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
163074302|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074303|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074304|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
163074305|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
163074306|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
163074307|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Other|6|||
163074308|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Other|3|||
163074309|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Other|0|||
163074310|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
163074311|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163074312|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163074313|NCT03636269|588980564|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
163074314|NCT03636269|588980565|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
163074315|NCT03636269|588980566|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
163074316|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Adverse Event|0|||
163074317|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Adverse Event|0|||
163074318|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Adverse Event|21|||
163074319|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
163074320|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
163074321|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
163074322|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074323|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
163074324|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
163074325|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
163074326|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
163074327|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
163074328|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Administrative|0|||
163074329|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Administrative|0|||
163074330|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Administrative|36|||
163074331|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Other|0|||
163074332|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Other|0|||
163074333|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Other|9|||
163074334|NCT03636269|588980564|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
163074335|NCT03636269|588980565|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
163074336|NCT03636269|588980566|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
163074337|NCT02852434|588980582|FG000|Overall Study|Withdrawal by Subject|0|||
163074338|NCT02852434|588980583|FG001|Overall Study|Withdrawal by Subject|1|||
163074339|NCT02852434|588980582|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
163074340|NCT02852434|588980583|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
163074341|NCT03774810|588980586|FG000|Phase 1|Lack of Efficacy|21|||
163074342|NCT03774810|588980587|FG001|Phase 1|Lack of Efficacy|0|||
163074343|NCT03774810|588980588|FG002|Phase 1|Lack of Efficacy|0|||
163074344|NCT03774810|588980589|FG003|Phase 1|Lack of Efficacy|0|||
163074345|NCT03774810|588980590|FG004|Phase 1|Lack of Efficacy|0|||
163074346|NCT03774810|588980586|FG000|Phase 1|Withdrawal by Subject|9|||
163074347|NCT03774810|588980587|FG001|Phase 1|Withdrawal by Subject|0|||
163074348|NCT03774810|588980588|FG002|Phase 1|Withdrawal by Subject|0|||
163074349|NCT03774810|588980589|FG003|Phase 1|Withdrawal by Subject|0|||
162644824|NCT01955161|587417637|FG002|Overall Study|Withdrawal by Subject|12|||
162644825|NCT01955161|587417635|FG000|Overall Study|Protocol Violation|2|||
163074350|NCT03774810|588980590|FG004|Phase 1|Withdrawal by Subject|0|||
163074351|NCT03774810|588980586|FG000|Phase 1|Lost to Follow-up|2|||
163074352|NCT03774810|588980587|FG001|Phase 1|Lost to Follow-up|0|||
163074353|NCT03774810|588980588|FG002|Phase 1|Lost to Follow-up|0|||
163074354|NCT03774810|588980589|FG003|Phase 1|Lost to Follow-up|0|||
162644826|NCT01955161|587417636|FG001|Overall Study|Protocol Violation|0|||
163074355|NCT03774810|588980590|FG004|Phase 1|Lost to Follow-up|0|||
163074356|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
163074357|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
163074358|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
163074359|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
163074360|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
163074361|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
163074362|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
163074363|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
163074364|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
163074365|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
163074366|NCT03774810|588980586|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074367|NCT03774810|588980587|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
163074368|NCT03774810|588980588|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074369|NCT03774810|588980589|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074370|NCT03774810|588980590|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
163074371|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
163074372|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
163074373|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
163074374|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
163074375|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
163074376|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
163074377|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
163074378|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
163074379|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
163074380|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
163074381|NCT03774810|588980586|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074382|NCT03774810|588980587|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074383|NCT03774810|588980588|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
163074384|NCT03774810|588980589|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
163074385|NCT03774810|588980590|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
163074386|NCT00927186|588980591|FG000|12 Months Primary Study|Adverse Event|5|||
163074387|NCT00927186|588980592|FG001|12 Months Primary Study|Adverse Event|2|||
163074388|NCT00927186|588980591|FG000|12 Months Primary Study|Lost to Follow-up|1|||
163074389|NCT00927186|588980592|FG001|12 Months Primary Study|Lost to Follow-up|0|||
163074390|NCT00927186|588980591|FG000|12 Months Primary Study|Protocol Violation|0|||
163074391|NCT00927186|588980592|FG001|12 Months Primary Study|Protocol Violation|1|||
163074392|NCT00927186|588980591|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
163074393|NCT00927186|588980592|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
163074394|NCT01145222|588980593|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074395|NCT01145222|588980594|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074396|NCT01145222|588980595|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
163074397|NCT01145222|588980596|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
163074398|NCT01145222|588980593|FG000|Overall Study|Poor bowel preparation|0|||
163074399|NCT01145222|588980594|FG001|Overall Study|Poor bowel preparation|0|||
163074400|NCT01145222|588980595|FG002|Overall Study|Poor bowel preparation|0|||
163074401|NCT01145222|588980596|FG003|Overall Study|Poor bowel preparation|1|||
163074402|NCT00604383|588980597|FG000|Overall Study|Withdrawal by Subject|33|||
163074403|NCT00604383|588980598|FG001|Overall Study|Withdrawal by Subject|31|||
163074404|NCT00604383|588980597|FG000|Overall Study|Lost to Follow-up|24|||
163074405|NCT00604383|588980598|FG001|Overall Study|Lost to Follow-up|19|||
163074406|NCT00604383|588980597|FG000|Overall Study|Death|14|||
163074407|NCT00604383|588980598|FG001|Overall Study|Death|22|||
163074408|NCT00604383|588980597|FG000|Overall Study|Adverse Event|16|||
163074409|NCT00604383|588980598|FG001|Overall Study|Adverse Event|9|||
163074410|NCT00604383|588980597|FG000|Overall Study|Physician Decision|0|||
163074411|NCT00604383|588980598|FG001|Overall Study|Physician Decision|3|||
163074412|NCT01698008|588980599|FG000|Overall Study|Withdrawal by Subject|1|||
163074413|NCT01698008|588980600|FG001|Overall Study|Withdrawal by Subject|2|||
163074414|NCT03994120|588980605|FG000|Overall Study|Lost to Follow-up|3|||
163074415|NCT03994120|588980606|FG001|Overall Study|Lost to Follow-up|1|||
163074416|NCT01429623|588980607|FG000|Overall Study|Death|1|||
163074417|NCT01429623|588980608|FG001|Overall Study|Death|0|||
163074418|NCT01429623|588980607|FG000|Overall Study|Adverse Event|7|||
163074419|NCT01429623|588980608|FG001|Overall Study|Adverse Event|14|||
163074420|NCT01429623|588980607|FG000|Overall Study|Withdrawal by Subject|19|||
163074421|NCT01429623|588980608|FG001|Overall Study|Withdrawal by Subject|13|||
163074422|NCT01429623|588980607|FG000|Overall Study|Physician Decision|2|||
163074423|NCT01429623|588980608|FG001|Overall Study|Physician Decision|3|||
163074424|NCT01429623|588980607|FG000|Overall Study|Protocol Violation|3|||
163074425|NCT01429623|588980608|FG001|Overall Study|Protocol Violation|2|||
163074426|NCT01429623|588980607|FG000|Overall Study|Assorted|1|||
163074427|NCT01429623|588980608|FG001|Overall Study|Assorted|2|||
163074428|NCT01429623|588980607|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
163074429|NCT01429623|588980608|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
163074430|NCT01429623|588980607|FG000|Overall Study|No post baseline data|4|||
163074431|NCT01429623|588980608|FG001|Overall Study|No post baseline data|4|||
163074432|NCT00981175|588980609|FG000|Primary Dose Vaccination|Adverse Event|1|||
163074433|NCT00981175|588980610|FG001|Primary Dose Vaccination|Adverse Event|0|||
163074434|NCT00981175|588980609|FG000|Primary Dose Vaccination|Protocol Violation|0|||
163074435|NCT00981175|588980610|FG001|Primary Dose Vaccination|Protocol Violation|1|||
163074436|NCT00981175|588980609|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
163074437|NCT00981175|588980610|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
163074438|NCT00981175|588980609|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
163074439|NCT00981175|588980610|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
163074440|NCT02619812|588980611|FG000|Overall Study|Withdrawal by Subject|0|||
163074441|NCT02619812|588980612|FG001|Overall Study|Withdrawal by Subject|0|||
163074442|NCT02619812|588980613|FG002|Overall Study|Withdrawal by Subject|1|||
163074443|NCT02619812|588980614|FG003|Overall Study|Withdrawal by Subject|2|||
163074444|NCT00621322|588980626|FG000|Overall Study|Lost to Follow-up|0|||
163074445|NCT00621322|588980627|FG001|Overall Study|Lost to Follow-up|0|||
163074446|NCT00621322|588980628|FG002|Overall Study|Lost to Follow-up|0|||
163074447|NCT00621322|588980629|FG003|Overall Study|Lost to Follow-up|0|||
163074448|NCT00621322|588980630|FG004|Overall Study|Lost to Follow-up|1|||
163074449|NCT00621322|588980631|FG005|Overall Study|Lost to Follow-up|0|||
163074450|NCT00621322|588980626|FG000|Overall Study|Physician Decision|0|||
163074451|NCT00621322|588980627|FG001|Overall Study|Physician Decision|0|||
163074452|NCT00621322|588980628|FG002|Overall Study|Physician Decision|1|||
163074453|NCT00621322|588980629|FG003|Overall Study|Physician Decision|1|||
163074454|NCT00621322|588980630|FG004|Overall Study|Physician Decision|0|||
163074455|NCT00621322|588980631|FG005|Overall Study|Physician Decision|0|||
163074456|NCT00621322|588980626|FG000|Overall Study|Withdrawal by Subject|0|||
163074457|NCT00621322|588980627|FG001|Overall Study|Withdrawal by Subject|0|||
163074458|NCT00621322|588980628|FG002|Overall Study|Withdrawal by Subject|0|||
163074459|NCT00621322|588980629|FG003|Overall Study|Withdrawal by Subject|1|||
163074460|NCT00621322|588980630|FG004|Overall Study|Withdrawal by Subject|0|||
163074461|NCT00621322|588980631|FG005|Overall Study|Withdrawal by Subject|2|||
163074462|NCT00621322|588980626|FG000|Overall Study|Migrated/moved from study area|1|||
163074463|NCT00621322|588980627|FG001|Overall Study|Migrated/moved from study area|0|||
163074464|NCT00621322|588980628|FG002|Overall Study|Migrated/moved from study area|1|||
163074465|NCT00621322|588980629|FG003|Overall Study|Migrated/moved from study area|1|||
163074466|NCT00621322|588980630|FG004|Overall Study|Migrated/moved from study area|0|||
163074467|NCT00621322|588980631|FG005|Overall Study|Migrated/moved from study area|2|||
163074468|NCT04865978|588980635|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
163074469|NCT04865978|588980636|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
163074470|NCT05587998|588980637|FG000|Overall Study|Withdrawal by Subject|1|||
163074471|NCT05587998|588980638|FG001|Overall Study|Withdrawal by Subject|1|||
163027934|NCT01752634|588805320|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
163027935|NCT01752634|588805321|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
163027936|NCT01752634|588805322|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
163027937|NCT01752634|588805323|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
163027938|NCT01752634|588805318|FG000|Week 24 to Week 260|Physician Decision|1|||
163027939|NCT01752634|588805319|FG001|Week 24 to Week 260|Physician Decision|2|||
163027940|NCT01752634|588805320|FG002|Week 24 to Week 260|Physician Decision|4|||
163027941|NCT01752634|588805321|FG003|Week 24 to Week 260|Physician Decision|2|||
163027942|NCT01752634|588805322|FG004|Week 24 to Week 260|Physician Decision|1|||
163027943|NCT01752634|588805323|FG005|Week 24 to Week 260|Physician Decision|0|||
163027944|NCT01752634|588805318|FG000|Week 24 to Week 260|Death|0|||
163027945|NCT01752634|588805319|FG001|Week 24 to Week 260|Death|1|||
163027946|NCT01752634|588805320|FG002|Week 24 to Week 260|Death|0|||
163027947|NCT01752634|588805321|FG003|Week 24 to Week 260|Death|0|||
163027948|NCT01752634|588805322|FG004|Week 24 to Week 260|Death|0|||
163027949|NCT01752634|588805323|FG005|Week 24 to Week 260|Death|0|||
163027950|NCT01752634|588805318|FG000|Week 24 to Week 260|Pregnancy|0|||
163027951|NCT01752634|588805319|FG001|Week 24 to Week 260|Pregnancy|0|||
163027952|NCT01752634|588805320|FG002|Week 24 to Week 260|Pregnancy|1|||
163027953|NCT01752634|588805321|FG003|Week 24 to Week 260|Pregnancy|0|||
163027954|NCT01752634|588805322|FG004|Week 24 to Week 260|Pregnancy|0|||
162644827|NCT01955161|587417637|FG002|Overall Study|Protocol Violation|0|||
162644828|NCT01955161|587417635|FG000|Overall Study|Other reason: physician decision|0|||
162644829|NCT01955161|587417636|FG001|Overall Study|Other reason: physician decision|1|||
162644830|NCT01955161|587417637|FG002|Overall Study|Other reason: physician decision|1|||
162644831|NCT01955161|587417635|FG000|Overall Study|Other reason: disallowed medication|1|||
162644832|NCT01955161|587417636|FG001|Overall Study|Other reason: disallowed medication|0|||
162644833|NCT01955161|587417637|FG002|Overall Study|Other reason: disallowed medication|1|||
162644834|NCT01955161|587417635|FG000|Overall Study|Other reason: caregiver unavailable|1|||
162644835|NCT01955161|587417636|FG001|Overall Study|Other reason: caregiver unavailable|0|||
162644836|NCT01955161|587417637|FG002|Overall Study|Other reason: caregiver unavailable|0|||
162644837|NCT01955161|587417635|FG000|Overall Study|Other reason: moved to nursing home|0|||
162644838|NCT01955161|587417636|FG001|Overall Study|Other reason: moved to nursing home|1|||
162644839|NCT01955161|587417637|FG002|Overall Study|Other reason: moved to nursing home|0|||
162644840|NCT01955161|587417635|FG000|Overall Study|Other reason: insufficient compliance|0|||
162644841|NCT01955161|587417636|FG001|Overall Study|Other reason: insufficient compliance|0|||
162644842|NCT01955161|587417637|FG002|Overall Study|Other reason: insufficient compliance|1|||
162644843|NCT01955161|587417635|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
162644844|NCT01955161|587417636|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
162644845|NCT01955161|587417637|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
162644846|NCT01955161|587417635|FG000|Overall Study|Other reason: patient's will|0|||
162644847|NCT01955161|587417636|FG001|Overall Study|Other reason: patient's will|0|||
162644848|NCT01955161|587417637|FG002|Overall Study|Other reason: patient's will|1|||
162644849|NCT04608500|587417638|FG000|Overall Study|Adverse Event|2|||
162644850|NCT04608500|587417639|FG001|Overall Study|Adverse Event|0|||
162644851|NCT04608500|587417638|FG000|Overall Study|Lost to Follow-up|15|||
162644852|NCT04608500|587417639|FG001|Overall Study|Lost to Follow-up|9|||
162644853|NCT04608500|587417638|FG000|Overall Study|Participant request|11|||
162644854|NCT04608500|587417639|FG001|Overall Study|Participant request|7|||
162644855|NCT04608500|587417638|FG000|Overall Study|Protocol Violation|1|||
162644856|NCT04608500|587417639|FG001|Overall Study|Protocol Violation|0|||
162644857|NCT04608500|587417638|FG000|Overall Study|Other|6|||
162644858|NCT04608500|587417639|FG001|Overall Study|Other|2|||
162644859|NCT01030523|587417640|FG000|Initial Study (5 Years)|Death|1|||
162644860|NCT01030523|587417641|FG001|Initial Study (5 Years)|Death|0|||
162644861|NCT01030523|587417640|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
163074472|NCT05587998|588980637|FG000|Overall Study|Not treated|3|||
163074473|NCT05587998|588980638|FG001|Overall Study|Not treated|1|||
163074474|NCT05587998|588980637|FG000|Overall Study|Non-compliance with study procedures|0|||
163074475|NCT05587998|588980638|FG001|Overall Study|Non-compliance with study procedures|1|||
163074476|NCT04263532|588980639|FG000|Overall Study|Withdrawal by Subject|2|||
163074477|NCT04263532|588980640|FG001|Overall Study|Withdrawal by Subject|0|||
163074478|NCT00601107|588980641|FG000|Overall Study|Adverse Event|0|||
163074479|NCT00601107|588980642|FG001|Overall Study|Adverse Event|1|||
163074480|NCT00601107|588980643|FG002|Overall Study|Adverse Event|3|||
163074481|NCT00601107|588980644|FG003|Overall Study|Adverse Event|0|||
163074482|NCT00601107|588980641|FG000|Overall Study|Withdrawal by Subject|5|||
163074483|NCT00601107|588980642|FG001|Overall Study|Withdrawal by Subject|4|||
163074484|NCT00601107|588980643|FG002|Overall Study|Withdrawal by Subject|7|||
163074485|NCT00601107|588980644|FG003|Overall Study|Withdrawal by Subject|4|||
163074486|NCT00601107|588980641|FG000|Overall Study|Lost to Follow-up|3|||
163074487|NCT00601107|588980642|FG001|Overall Study|Lost to Follow-up|3|||
163074488|NCT00601107|588980643|FG002|Overall Study|Lost to Follow-up|0|||
163074489|NCT00601107|588980644|FG003|Overall Study|Lost to Follow-up|3|||
163074490|NCT00601107|588980641|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074491|NCT00601107|588980642|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074492|NCT00601107|588980643|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
163074493|NCT00601107|588980644|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
163074494|NCT00601107|588980641|FG000|Overall Study|Worsening of Psoriasis|4|||
163074495|NCT00601107|588980642|FG001|Overall Study|Worsening of Psoriasis|1|||
162644862|NCT01030523|587417641|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
162644863|NCT01030523|587417640|FG000|Initial Study (5 Years)|Implant failure|1|||
162644864|NCT01030523|587417641|FG001|Initial Study (5 Years)|Implant failure|0|||
162644865|NCT01030523|587417640|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
162644866|NCT01030523|587417641|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
162644867|NCT01030523|587417640|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
163027955|NCT01752634|588805323|FG005|Week 24 to Week 260|Pregnancy|0|||
163027956|NCT01752634|588805318|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027957|NCT01752634|588805319|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027958|NCT01752634|588805320|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
163027959|NCT01752634|588805321|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027960|NCT01752634|588805322|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027961|NCT01752634|588805323|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
163027962|NCT01752634|588805318|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
163027963|NCT01752634|588805319|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
163027964|NCT01752634|588805320|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
163027965|NCT01752634|588805321|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
163027966|NCT01752634|588805322|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
163027967|NCT01752634|588805323|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
163027968|NCT01752634|588805318|FG000|Week 24 to Week 260|Adverse Event|4|||
163027969|NCT01752634|588805319|FG001|Week 24 to Week 260|Adverse Event|8|||
163027970|NCT01752634|588805320|FG002|Week 24 to Week 260|Adverse Event|8|||
163027971|NCT01752634|588805321|FG003|Week 24 to Week 260|Adverse Event|4|||
163027972|NCT01752634|588805322|FG004|Week 24 to Week 260|Adverse Event|2|||
163027973|NCT01752634|588805323|FG005|Week 24 to Week 260|Adverse Event|0|||
163027974|NCT05128773|588805332|FG000|Overall Study|Sponsor decision to terminate study|3|||
163027975|NCT04250714|588805333|FG000|Overall Study|Treatment - withdrawal by subject|14|||
163027976|NCT04250714|588805333|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
163027977|NCT04250714|588805333|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
163027978|NCT04250714|588805333|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
163027979|NCT04250714|588805333|FG000|Overall Study|Treatment - Death|1|||
163027980|NCT04250714|588805333|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
163027981|NCT04250714|588805333|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
163027982|NCT04250714|588805333|FG000|Overall Study|Attempt|2|||
163027983|NCT04250714|588805333|FG000|Overall Study|Intent|7|||
163027984|NCT04697056|588805334|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
163027985|NCT04697056|588805335|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
163027986|NCT03339726|588805336|FG000|Overall Study|Withdrawal by Subject|1|||
163027987|NCT03339726|588805337|FG001|Overall Study|Withdrawal by Subject|0|||
163027988|NCT03339726|588805338|FG002|Overall Study|Withdrawal by Subject|0|||
163027989|NCT03339726|588805336|FG000|Overall Study|Lost to Follow-up|0|||
163027990|NCT03339726|588805337|FG001|Overall Study|Lost to Follow-up|1|||
163027991|NCT03339726|588805338|FG002|Overall Study|Lost to Follow-up|0|||
163027992|NCT00308750|588805344|FG000|Overall Study|Adverse Event|9|||
163027993|NCT00308750|588805345|FG001|Overall Study|Adverse Event|9|||
163027994|NCT00308750|588805346|FG002|Overall Study|Adverse Event|13|||
163027995|NCT00308750|588805344|FG000|Overall Study|Withdrawal by Subject|6|||
163027996|NCT00308750|588805345|FG001|Overall Study|Withdrawal by Subject|2|||
163027997|NCT00308750|588805346|FG002|Overall Study|Withdrawal by Subject|3|||
163027998|NCT00308750|588805344|FG000|Overall Study|Physician Decision|3|||
163027999|NCT00308750|588805345|FG001|Overall Study|Physician Decision|4|||
163028000|NCT00308750|588805346|FG002|Overall Study|Physician Decision|3|||
163028001|NCT00308750|588805344|FG000|Overall Study|Sponsor Decision|1|||
163028002|NCT00308750|588805345|FG001|Overall Study|Sponsor Decision|0|||
163028003|NCT00308750|588805346|FG002|Overall Study|Sponsor Decision|0|||
163028004|NCT00308750|588805344|FG000|Overall Study|Disease Progression|47|||
163028005|NCT00308750|588805345|FG001|Overall Study|Disease Progression|24|||
163028006|NCT00308750|588805346|FG002|Overall Study|Disease Progression|28|||
163028007|NCT00308750|588805344|FG000|Overall Study|Unrelated Complication|3|||
163028008|NCT00308750|588805345|FG001|Overall Study|Unrelated Complication|0|||
163028009|NCT00308750|588805346|FG002|Overall Study|Unrelated Complication|1|||
163028010|NCT00308750|588805344|FG000|Overall Study|Death|1|||
163028011|NCT00308750|588805345|FG001|Overall Study|Death|0|||
163028012|NCT00308750|588805346|FG002|Overall Study|Death|1|||
163028013|NCT00308750|588805344|FG000|Overall Study|Protocol Violation|1|||
163028014|NCT00308750|588805345|FG001|Overall Study|Protocol Violation|0|||
163028015|NCT00308750|588805346|FG002|Overall Study|Protocol Violation|0|||
163028016|NCT00308750|588805344|FG000|Overall Study|New Primary Disease Identified|1|||
163028017|NCT00308750|588805345|FG001|Overall Study|New Primary Disease Identified|1|||
163028018|NCT00308750|588805346|FG002|Overall Study|New Primary Disease Identified|0|||
163028019|NCT01088243|588805353|FG000|Overall Study|Adverse Event|1|||
163028020|NCT01088243|588805354|FG001|Overall Study|Adverse Event|0|||
163028021|NCT05007041|588805368|FG000|Overall Study|Missing Diary Entries|0|||
163028022|NCT05007041|588805369|FG001|Overall Study|Missing Diary Entries|1|||
163028023|NCT04495816|588805370|FG000|Overall Study|Lost to Follow-up|10|||
163028024|NCT04495816|588805371|FG001|Overall Study|Lost to Follow-up|4|||
163028025|NCT04495816|588805370|FG000|Overall Study|Withdrawal by Subject|3|||
163028026|NCT04495816|588805371|FG001|Overall Study|Withdrawal by Subject|5|||
163028027|NCT02370667|588805372|FG000|Overall Study|Lost to Follow-up|0|||
163028028|NCT02370667|588805373|FG001|Overall Study|Lost to Follow-up|1|||
163028029|NCT02370667|588805374|FG002|Overall Study|Lost to Follow-up|0|||
163028030|NCT03536949|588805375|FG000|Overall Study|Adverse Event|4|||
163028031|NCT03536949|588805376|FG001|Overall Study|Adverse Event|0|||
163028032|NCT03536949|588805375|FG000|Overall Study|Lost to Follow-up|2|||
163028033|NCT03536949|588805376|FG001|Overall Study|Lost to Follow-up|1|||
163028034|NCT03536949|588805375|FG000|Overall Study|Withdrawal by Subject|6|||
163028035|NCT03536949|588805376|FG001|Overall Study|Withdrawal by Subject|0|||
163028036|NCT03536949|588805375|FG000|Overall Study|Non-compliance|2|||
163074496|NCT00601107|588980643|FG002|Overall Study|Worsening of Psoriasis|1|||
163074497|NCT00601107|588980644|FG003|Overall Study|Worsening of Psoriasis|4|||
163074498|NCT00601107|588980641|FG000|Overall Study|Undefined|1|||
163074499|NCT00601107|588980642|FG001|Overall Study|Undefined|0|||
163074500|NCT00601107|588980643|FG002|Overall Study|Undefined|1|||
163074501|NCT00601107|588980644|FG003|Overall Study|Undefined|0|||
163074502|NCT01078545|588980651|FG000|Overall Study|Lost to Follow-up|13|||
163074503|NCT01078545|588980651|FG000|Overall Study|Physician Decision|6|||
163074504|NCT01078545|588980651|FG000|Overall Study|Withdrawal by Subject|3|||
163074505|NCT01078545|588980651|FG000|Overall Study|Death|3|||
163074506|NCT01078545|588980651|FG000|Overall Study|Participant moved to another physician|1|||
163074507|NCT03501277|588980659|FG000|Intervention Period 1 (4 Days)|Other|0|||
163074508|NCT03501277|588980660|FG001|Intervention Period 1 (4 Days)|Other|0|||
163074509|NCT03501277|588980661|FG002|Intervention Period 1 (4 Days)|Other|1|||
163074510|NCT03501277|588980662|FG003|Intervention Period 1 (4 Days)|Other|0|||
163074511|NCT03501277|588980659|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074512|NCT03501277|588980660|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074513|NCT03501277|588980661|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
163074514|NCT03501277|588980662|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
163074515|NCT03501277|588980659|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074516|NCT03501277|588980660|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074517|NCT03501277|588980661|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
163074518|NCT03501277|588980662|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
163074519|NCT03501277|588980659|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074520|NCT03501277|588980660|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074521|NCT03501277|588980661|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
163074522|NCT03501277|588980662|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
163074523|NCT01489358|588980664|FG000|Overall Study|Lost to Follow-up|0|||
163074524|NCT01489358|588980665|FG001|Overall Study|Lost to Follow-up|0|||
163074525|NCT01489358|588980666|FG002|Overall Study|Lost to Follow-up|2|||
163074526|NCT01873833|588980667|FG000|Overall Study|Withdrawal by Subject|1|||
163074527|NCT01968785|588980668|FG000|Overall Study|Withdrawal by Subject|1|||
163074528|NCT01968785|588980669|FG001|Overall Study|Withdrawal by Subject|0|||
163074529|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Adverse Event|14|||
163074530|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Adverse Event|27|||
163074531|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Adverse Event|60|||
163074532|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Adverse Event|0|||
163074533|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Adverse Event|0|||
163074534|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Pregnancy|0|||
163074535|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Pregnancy|7|||
163074536|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Pregnancy|9|||
163074537|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Pregnancy|0|||
163074538|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Pregnancy|0|||
163074539|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
163074540|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
163074541|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
163074542|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
163074543|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
163074544|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
163074545|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
163074546|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
163074547|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
163074548|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
163074549|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Death|1|||
163074550|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Death|2|||
163074551|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Death|2|||
163074552|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Death|0|||
163074553|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Death|0|||
163074554|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
163074555|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
163074556|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
163074557|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
163074558|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
163074559|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
163074560|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
163074561|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
163074562|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
163074563|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
163074564|NCT00098293|588980670|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
163074565|NCT00098293|588980671|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074566|NCT00098293|588980672|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074567|NCT00098293|588980673|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074568|NCT00098293|588980674|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
163074569|NCT00098293|588980670|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
162644868|NCT01030523|587417641|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
162644869|NCT01030523|587417640|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
162644870|NCT01030523|587417641|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
162644871|NCT01063764|587417644|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
162644872|NCT01063764|587417644|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
162644873|NCT01063764|587417644|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
162644874|NCT01063764|587417644|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
162644875|NCT01063764|587417644|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
162644876|NCT01063764|587417644|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
162644877|NCT01063764|587417644|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
162644878|NCT00697515|587417645|FG000|Dose Optimization Period|Adverse Event|4|||
162644879|NCT00697515|587417646|FG001|Dose Optimization Period|Adverse Event|0|||
162644880|NCT00697515|587417645|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
162644881|NCT00697515|587417646|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
163074570|NCT00098293|588980671|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074571|NCT00098293|588980672|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
163074572|NCT00098293|588980673|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074573|NCT00098293|588980674|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
163074574|NCT00098293|588980670|FG000|Open-label (OL) Phase|Adverse Event|0|||
163074575|NCT00098293|588980671|FG001|Open-label (OL) Phase|Adverse Event|3|||
163074576|NCT00098293|588980672|FG002|Open-label (OL) Phase|Adverse Event|7|||
163074577|NCT00098293|588980673|FG003|Open-label (OL) Phase|Adverse Event|6|||
163074578|NCT00098293|588980674|FG004|Open-label (OL) Phase|Adverse Event|0|||
163074579|NCT00098293|588980670|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
163074580|NCT00098293|588980671|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
163074581|NCT00098293|588980672|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
163074582|NCT00098293|588980673|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
163074583|NCT00098293|588980674|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
163074584|NCT00098293|588980670|FG000|Open-label (OL) Phase|Pregnancy|0|||
163074585|NCT00098293|588980671|FG001|Open-label (OL) Phase|Pregnancy|1|||
163074586|NCT00098293|588980672|FG002|Open-label (OL) Phase|Pregnancy|0|||
163074587|NCT00098293|588980673|FG003|Open-label (OL) Phase|Pregnancy|3|||
163074588|NCT00098293|588980674|FG004|Open-label (OL) Phase|Pregnancy|0|||
163074589|NCT00098293|588980670|FG000|Open-label (OL) Phase|Protocol Violation|0|||
163074590|NCT00098293|588980671|FG001|Open-label (OL) Phase|Protocol Violation|6|||
163074591|NCT00098293|588980672|FG002|Open-label (OL) Phase|Protocol Violation|13|||
163074592|NCT00098293|588980673|FG003|Open-label (OL) Phase|Protocol Violation|16|||
163074593|NCT00098293|588980674|FG004|Open-label (OL) Phase|Protocol Violation|0|||
163074594|NCT00098293|588980670|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
163074595|NCT00098293|588980671|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
163074596|NCT00098293|588980672|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
163074597|NCT00098293|588980673|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
163074598|NCT00098293|588980674|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
163074599|NCT00098293|588980670|FG000|Open-label (OL) Phase|Death|0|||
163074600|NCT00098293|588980671|FG001|Open-label (OL) Phase|Death|2|||
163074601|NCT00098293|588980672|FG002|Open-label (OL) Phase|Death|3|||
163074602|NCT00098293|588980673|FG003|Open-label (OL) Phase|Death|0|||
163074603|NCT00098293|588980674|FG004|Open-label (OL) Phase|Death|0|||
163074604|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Death|0|||
163074605|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Death|0|||
163074606|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Death|0|||
163074607|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Death|0|||
163074608|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Death|1|||
163074609|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074610|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074611|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074612|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
163074613|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
163074614|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074615|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074616|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074617|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
163074618|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
163074619|NCT00098293|588980670|FG000|Supplemental Phase (SP)|Other|0|||
163074620|NCT00098293|588980671|FG001|Supplemental Phase (SP)|Other|0|||
163074621|NCT00098293|588980672|FG002|Supplemental Phase (SP)|Other|0|||
163074622|NCT00098293|588980673|FG003|Supplemental Phase (SP)|Other|0|||
163074623|NCT00098293|588980674|FG004|Supplemental Phase (SP)|Other|22|||
162717867|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163074624|NCT01727154|588980678|FG000|Overall Study|Death|17|||
163074625|NCT01727154|588980678|FG000|Overall Study|Withdrawal by Subject|14|||
163074626|NCT01727154|588980678|FG000|Overall Study|Subject Withdrew Consent|18|||
163074627|NCT01727154|588980678|FG000|Overall Study|Study Terminated|6|||
163074628|NCT01727154|588980678|FG000|Overall Study|No Discontinuation Documentation|4|||
162644882|NCT00697515|587417645|FG000|Dose Optimization Period|Lost to Follow-up|2|||
162644883|NCT00697515|587417646|FG001|Dose Optimization Period|Lost to Follow-up|0|||
162644884|NCT00697515|587417645|FG000|Dose Optimization Period|sponsor request|2|||
162644885|NCT00697515|587417646|FG001|Dose Optimization Period|sponsor request|0|||
163074629|NCT00003474|588980679|FG000|Overall Study|Not Evaluable|14|||
163074630|NCT01198548|588980683|FG000|Overall Study|Disease Progression|9|||
163074631|NCT01198548|588980683|FG000|Overall Study|Administrative Decision|1|||
163074632|NCT02186171|588980685|FG000|Overall Study|Withdrawal by Subject|1|||
163074633|NCT02186171|588980686|FG001|Overall Study|Withdrawal by Subject|9|||
163074634|NCT02186171|588980685|FG000|Overall Study|Lost to Follow-up|2|||
163074635|NCT02186171|588980686|FG001|Overall Study|Lost to Follow-up|2|||
163074636|NCT02186171|588980685|FG000|Overall Study|Death|1|||
163074637|NCT02186171|588980686|FG001|Overall Study|Death|2|||
163074638|NCT02186171|588980685|FG000|Overall Study|Protocol-specified Criteria|0|||
163074639|NCT02186171|588980686|FG001|Overall Study|Protocol-specified Criteria|2|||
163074640|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
163074641|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
163074642|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
163074643|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Physician Decision|2|||
163074644|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Physician Decision|4|||
163074645|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Physician Decision|0|||
163074646|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
163074647|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
163074648|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
163074649|NCT01245062|588980687|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
163074650|NCT01245062|588980688|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
163074651|NCT01245062|588980689|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
163074652|NCT01245062|588980687|FG000|Cross-over Phase|Lost to Follow-up|0|||
163074653|NCT01245062|588980688|FG001|Cross-over Phase|Lost to Follow-up|0|||
163074654|NCT01245062|588980689|FG002|Cross-over Phase|Lost to Follow-up|1|||
163074655|NCT01245062|588980687|FG000|Cross-over Phase|Physician Decision|0|||
163074656|NCT01245062|588980688|FG001|Cross-over Phase|Physician Decision|0|||
163074657|NCT01245062|588980689|FG002|Cross-over Phase|Physician Decision|1|||
163074658|NCT01245062|588980687|FG000|Cross-over Phase|Withdrew Consent|0|||
163074659|NCT01245062|588980688|FG001|Cross-over Phase|Withdrew Consent|0|||
163074660|NCT01245062|588980689|FG002|Cross-over Phase|Withdrew Consent|4|||
163074661|NCT01245062|588980687|FG000|Cross-over Phase|Study closed/ terminated|0|||
163074662|NCT01245062|588980688|FG001|Cross-over Phase|Study closed/ terminated|0|||
163074663|NCT01245062|588980689|FG002|Cross-over Phase|Study closed/ terminated|11|||
163074664|NCT06025695|588980691|FG000|Overall Study|Adverse Event|5|||
163074665|NCT06025695|588980692|FG001|Overall Study|Adverse Event|6|||
163074666|NCT06025695|588980691|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
163074667|NCT06025695|588980692|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
163074668|NCT06025695|588980691|FG000|Overall Study|Other|23|||
163074669|NCT06025695|588980692|FG001|Overall Study|Other|19|||
163074670|NCT06025695|588980691|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
162644886|NCT00697515|587417645|FG000|Dose Optimization Period|called to active duty|1|||
162644887|NCT00697515|587417646|FG001|Dose Optimization Period|called to active duty|0|||
162644888|NCT00697515|587417645|FG000|Dose Optimization Period|elevated QTc|1|||
162644889|NCT00697515|587417646|FG001|Dose Optimization Period|elevated QTc|0|||
162644890|NCT00697515|587417645|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
162644891|NCT00697515|587417646|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
163028037|NCT03536949|588805376|FG001|Overall Study|Non-compliance|1|||
163028038|NCT00705718|588805377|FG000|Overall Study|Death|6|||
163028039|NCT00705718|588805378|FG001|Overall Study|Death|6|||
163028040|NCT00705718|588805377|FG000|Overall Study|Not due for Visit|0|||
163028041|NCT00705718|588805378|FG001|Overall Study|Not due for Visit|12|||
163028042|NCT00705718|588805377|FG000|Overall Study|Follow up not done|1|||
163028043|NCT00705718|588805378|FG001|Overall Study|Follow up not done|4|||
163028044|NCT01258075|588805383|FG000|Overall Study|Adverse Event|8|||
163028045|NCT01258075|588805384|FG001|Overall Study|Adverse Event|3|||
163028046|NCT01258075|588805383|FG000|Overall Study|Lost to Follow-up|11|||
163028047|NCT01258075|588805384|FG001|Overall Study|Lost to Follow-up|6|||
163028048|NCT01258075|588805383|FG000|Overall Study|Withdrawal by Subject|10|||
163028049|NCT01258075|588805384|FG001|Overall Study|Withdrawal by Subject|7|||
163028050|NCT01258075|588805383|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
163028051|NCT01258075|588805384|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
163028052|NCT01258075|588805383|FG000|Overall Study|Other|12|||
163028053|NCT01258075|588805384|FG001|Overall Study|Other|5|||
163074671|NCT06025695|588980692|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
163074672|NCT01452347|588980693|FG000|Overall Study|Adverse Event|2|||
163074673|NCT01452347|588980694|FG001|Overall Study|Adverse Event|1|||
163074674|NCT01452347|588980693|FG000|Overall Study|Non compliance protocol|2|||
163074675|NCT01452347|588980694|FG001|Overall Study|Non compliance protocol|0|||
163074676|NCT01452347|588980693|FG000|Overall Study|Lost to Follow-up|2|||
163074677|NCT01452347|588980694|FG001|Overall Study|Lost to Follow-up|0|||
163074678|NCT01452347|588980693|FG000|Overall Study|Withdrawal by Subject|3|||
163074679|NCT01452347|588980694|FG001|Overall Study|Withdrawal by Subject|3|||
163074680|NCT01452347|588980693|FG000|Overall Study|Not treated|6|||
163074681|NCT01452347|588980694|FG001|Overall Study|Not treated|3|||
163074682|NCT01452347|588980693|FG000|Overall Study|Other reason not defined above|2|||
163074683|NCT01452347|588980694|FG001|Overall Study|Other reason not defined above|0|||
163074684|NCT05762744|588980695|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
163074685|NCT05762744|588980696|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
163074686|NCT05762744|588980695|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
163074687|NCT05762744|588980696|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
163074688|NCT01350973|588980697|FG000|Overall Study|Adverse Event|4|||
163074689|NCT01350973|588980698|FG001|Overall Study|Adverse Event|7|||
163074690|NCT01350973|588980699|FG002|Overall Study|Adverse Event|7|||
163074691|NCT01350973|588980697|FG000|Overall Study|Voluntary Withdrawal|2|||
163074692|NCT01350973|588980698|FG001|Overall Study|Voluntary Withdrawal|1|||
163074693|NCT01350973|588980699|FG002|Overall Study|Voluntary Withdrawal|1|||
163074694|NCT01160744|588982283|FG000|Overall Study|Withdrawal by Subject|11|||
163074695|NCT01160744|588982284|FG001|Overall Study|Withdrawal by Subject|5|||
163074696|NCT01160744|588982285|FG002|Overall Study|Withdrawal by Subject|6|||
163074697|NCT01160744|588982286|FG003|Overall Study|Withdrawal by Subject|4|||
163074698|NCT01160744|588982283|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074699|NCT01160744|588982284|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074700|NCT01160744|588982285|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
163074701|NCT01160744|588982286|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
163074702|NCT01502072|588982288|FG000|Overall Study|Withdrawal by Subject|1|||
163074703|NCT01502072|588982289|FG001|Overall Study|Withdrawal by Subject|0|||
163074704|NCT01502072|588982290|FG002|Overall Study|Withdrawal by Subject|0|||
163074705|NCT01502072|588982288|FG000|Overall Study|Death|0|||
163074706|NCT01502072|588982289|FG001|Overall Study|Death|1|||
163074707|NCT01502072|588982290|FG002|Overall Study|Death|0|||
163074708|NCT02773537|588982298|FG000|Overall Study|Lost to Follow-up|0|||
163074709|NCT02773537|588982299|FG001|Overall Study|Lost to Follow-up|1|||
163074710|NCT02773537|588982300|FG002|Overall Study|Lost to Follow-up|4|||
163074711|NCT03188705|588982301|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
163074712|NCT03188705|588982301|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
163074713|NCT03156621|588982303|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
163074714|NCT03156621|588982304|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
163074715|NCT03156621|588982303|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163074716|NCT03156621|588982304|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163074717|NCT04985682|588982305|FG000|Overall Study|Withdrawal by Subject|1|||
163074718|NCT03016403|588982308|FG000|Baseline|Death|5|||
163074719|NCT03016403|588982309|FG001|Baseline|Death|8|||
163074720|NCT03016403|588982310|FG002|Baseline|Death|1|||
163074721|NCT03016403|588982311|FG003|Baseline|Death|0|||
163074722|NCT03016403|588982308|FG000|Baseline|Withdrawal by Subject|2|||
163074723|NCT03016403|588982309|FG001|Baseline|Withdrawal by Subject|8|||
163074724|NCT03016403|588982310|FG002|Baseline|Withdrawal by Subject|4|||
163074725|NCT03016403|588982311|FG003|Baseline|Withdrawal by Subject|10|||
163074726|NCT03016403|588982308|FG000|Baseline|Lost to Follow-up|9|||
163074727|NCT03016403|588982309|FG001|Baseline|Lost to Follow-up|11|||
163074728|NCT03016403|588982310|FG002|Baseline|Lost to Follow-up|6|||
163074729|NCT03016403|588982311|FG003|Baseline|Lost to Follow-up|24|||
163074730|NCT03016403|588982308|FG000|6-week Follow-up|Death|1|||
163074731|NCT03016403|588982309|FG001|6-week Follow-up|Death|4|||
163074732|NCT03016403|588982310|FG002|6-week Follow-up|Death|0|||
163074733|NCT03016403|588982311|FG003|6-week Follow-up|Death|0|||
163074734|NCT03016403|588982308|FG000|6-week Follow-up|Lost to Follow-up|2|||
163074735|NCT03016403|588982309|FG001|6-week Follow-up|Lost to Follow-up|7|||
163074736|NCT03016403|588982310|FG002|6-week Follow-up|Lost to Follow-up|4|||
163074737|NCT03016403|588982311|FG003|6-week Follow-up|Lost to Follow-up|8|||
163074738|NCT03016403|588982308|FG000|6-week Follow-up|Withdrawal by Subject|0|||
163074739|NCT03016403|588982309|FG001|6-week Follow-up|Withdrawal by Subject|2|||
163074740|NCT03016403|588982310|FG002|6-week Follow-up|Withdrawal by Subject|0|||
163074741|NCT03016403|588982311|FG003|6-week Follow-up|Withdrawal by Subject|1|||
163074742|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
163074743|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
163074744|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
163074745|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
163074746|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
163074747|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
163074748|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
163074749|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
163074750|NCT03016403|588982308|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074751|NCT03016403|588982309|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074752|NCT03016403|588982310|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
163074753|NCT03016403|588982311|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
163074754|NCT00799864|588982312|FG000|Overall Study|Participant reached a virologic endpoint|9|||
163074755|NCT00799864|588982313|FG001|Overall Study|Participant reached a virologic endpoint|2|||
163074756|NCT00799864|588982314|FG002|Overall Study|Participant reached a virologic endpoint|2|||
163074757|NCT00799864|588982315|FG003|Overall Study|Participant reached a virologic endpoint|0|||
163074758|NCT00799864|588982316|FG004|Overall Study|Participant reached a virologic endpoint|0|||
163074759|NCT00799864|588982312|FG000|Overall Study|Other|2|||
163074760|NCT00799864|588982313|FG001|Overall Study|Other|1|||
163074761|NCT00799864|588982314|FG002|Overall Study|Other|0|||
163074762|NCT00799864|588982315|FG003|Overall Study|Other|0|||
163074763|NCT00799864|588982316|FG004|Overall Study|Other|0|||
163074764|NCT00225758|588982317|FG000|Overall Study|Adverse Event|4|||
163074765|NCT00576407|588982318|FG000|Overall Study|Death|7|||
163074766|NCT00576407|588982318|FG000|Overall Study|Physician Decision|1|||
163074767|NCT04641975|588982319|FG000|Overall Study|Protocol Violation|1|||
163074768|NCT04641975|588982320|FG001|Overall Study|Protocol Violation|2|||
163074769|NCT04641975|588982321|FG002|Overall Study|Protocol Violation|0|||
163074770|NCT04641975|588982322|FG003|Overall Study|Protocol Violation|0|||
163074771|NCT04641975|588982319|FG000|Overall Study|Adverse Event|0|||
163074772|NCT04641975|588982320|FG001|Overall Study|Adverse Event|0|||
163074773|NCT04641975|588982321|FG002|Overall Study|Adverse Event|1|||
163074774|NCT04641975|588982322|FG003|Overall Study|Adverse Event|1|||
163074775|NCT04641975|588982319|FG000|Overall Study|Withdrawal by Subject|1|||
163074776|NCT04641975|588982320|FG001|Overall Study|Withdrawal by Subject|0|||
163074777|NCT04641975|588982321|FG002|Overall Study|Withdrawal by Subject|0|||
163074778|NCT04641975|588982322|FG003|Overall Study|Withdrawal by Subject|0|||
163074779|NCT01259024|588982324|FG000|Overall Study|Physician Decision|1|||
163074780|NCT01657500|588982325|FG000|Overall Study|set impropperly matched|3|||
163074781|NCT01657500|588982326|FG001|Overall Study|set impropperly matched|3|||
163074782|NCT01657500|588982325|FG000|Overall Study|Lost to Follow-up|2|||
163074783|NCT01657500|588982326|FG001|Overall Study|Lost to Follow-up|2|||
163074784|NCT00756444|588982329|FG000|Overall Study|Adverse Event|1|||
163074785|NCT00756444|588982330|FG001|Overall Study|Adverse Event|1|||
163074786|NCT00756444|588982329|FG000|Overall Study|Withdrawal by Subject|6|||
163074787|NCT00756444|588982330|FG001|Overall Study|Withdrawal by Subject|8|||
163074788|NCT00756444|588982329|FG000|Overall Study|Lost to Follow-up|0|||
163074789|NCT00756444|588982330|FG001|Overall Study|Lost to Follow-up|1|||
163074790|NCT00756444|588982329|FG000|Overall Study|Death|5|||
163074791|NCT00756444|588982330|FG001|Overall Study|Death|4|||
163074792|NCT00756444|588982329|FG000|Overall Study|Disease Progression|2|||
163074793|NCT00756444|588982330|FG001|Overall Study|Disease Progression|7|||
163074794|NCT00756444|588982329|FG000|Overall Study|Ineligibility Determined|1|||
163074795|NCT00756444|588982330|FG001|Overall Study|Ineligibility Determined|0|||
163074796|NCT03528577|588982333|FG000|Sequence 1|Failed Spirometry|1|||
163074797|NCT03528577|588982333|FG000|Sequence 1|Restricted medication|1|||
163074798|NCT03528577|588982333|FG000|Sequence 2|Adverse Event|1|||
163074799|NCT03528577|588982333|FG000|Sequence 2|Withdrawal by Subject|1|||
163074800|NCT03528577|588982333|FG000|Sequence 2|Failed Spirometry|1|||
163074801|NCT03528577|588982333|FG000|Sequence 3|Failed Spirometry|1|||
163074802|NCT03528577|588982333|FG000|Sequence 4|Failed Spirometry|2|||
163074803|NCT03528577|588982333|FG000|Sequence 4|Adverse Event|1|||
163074804|NCT03892915|588982334|FG000|Overall Study|Lost to Follow-up|6|||
163074805|NCT03892915|588982335|FG001|Overall Study|Lost to Follow-up|12|||
163074806|NCT03892915|588982334|FG000|Overall Study|Death|0|||
163074807|NCT03892915|588982335|FG001|Overall Study|Death|2|||
163074808|NCT03892915|588982334|FG000|Overall Study|Withdrawal by Subject|1|||
163074809|NCT03892915|588982335|FG001|Overall Study|Withdrawal by Subject|1|||
163074810|NCT03892915|588982334|FG000|Overall Study|unsuccessful delivery|13|||
163074811|NCT03892915|588982335|FG001|Overall Study|unsuccessful delivery|18|||
163074812|NCT03364686|588982336|FG000|Overall Study|Physician Decision|2|||
163074813|NCT01520714|588982337|FG000|Overall Study|Protocol Violation|0|||
163074814|NCT01520714|588982338|FG001|Overall Study|Protocol Violation|3|||
163074815|NCT01520714|588982337|FG000|Overall Study|Adverse Event|0|||
163074816|NCT01520714|588982338|FG001|Overall Study|Adverse Event|2|||
163074817|NCT01520714|588982337|FG000|Overall Study|Lack of Efficacy|0|||
163074818|NCT01520714|588982338|FG001|Overall Study|Lack of Efficacy|1|||
163074819|NCT01478087|588982343|FG000|Overall Study|due to sponsor closing study|1|||
163074820|NCT03566550|588982344|FG000|Overall Study|Withdrawal by Subject|0|||
163074821|NCT03566550|588982345|FG001|Overall Study|Withdrawal by Subject|1|||
163074822|NCT03518203|588982349|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
163074823|NCT03518203|588982349|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
163074824|NCT02829957|588982350|FG000|Overall Study|Lost to Follow-up|2|||
163074825|NCT02829957|588982351|FG001|Overall Study|Lost to Follow-up|1|||
163074826|NCT03511066|588982353|FG000|Overall Study|Withdrawal by Subject|1|||
163074827|NCT03511066|588982354|FG001|Overall Study|Withdrawal by Subject|2|||
163074828|NCT03511066|588982355|FG002|Overall Study|Withdrawal by Subject|3|||
163074829|NCT03511066|588982353|FG000|Overall Study|Lost to Follow-up|2|||
163074830|NCT03511066|588982354|FG001|Overall Study|Lost to Follow-up|3|||
163074831|NCT03511066|588982355|FG002|Overall Study|Lost to Follow-up|0|||
163074832|NCT04146909|588982356|FG000|Overall Study|Withdrawal by Subject|3|||
163074833|NCT04146909|588982356|FG000|Overall Study|Did not qualify after consented|1|||
163074834|NCT00345592|588982357|FG000|Overall Study|Death|14|||
163074835|NCT00345592|588982358|FG001|Overall Study|Death|16|||
163074836|NCT00345592|588982357|FG000|Overall Study|Withdrawal by Subject|11|||
163074837|NCT00345592|588982358|FG001|Overall Study|Withdrawal by Subject|8|||
163074838|NCT03467945|588982363|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163074839|NCT03467945|588982364|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163074840|NCT03467945|588982365|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163074841|NCT03467945|588982366|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163074842|NCT03467945|588982363|FG000|Treatment Period 3|Withdrawal by Subject|1|||
163074843|NCT03467945|588982364|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163074844|NCT03467945|588982365|FG002|Treatment Period 3|Withdrawal by Subject|2|||
163074845|NCT03467945|588982366|FG003|Treatment Period 3|Withdrawal by Subject|1|||
163074846|NCT03336866|588982381|FG000|Overall Study|Lost to Follow-up|2|||
163074847|NCT03336866|588982382|FG001|Overall Study|Lost to Follow-up|0|||
163074848|NCT03336866|588982383|FG002|Overall Study|Lost to Follow-up|3|||
163074849|NCT03336866|588982381|FG000|Overall Study|Withdrawal by Subject|1|||
163074850|NCT03336866|588982382|FG001|Overall Study|Withdrawal by Subject|1|||
163074851|NCT03336866|588982383|FG002|Overall Study|Withdrawal by Subject|0|||
163074852|NCT03336866|588982381|FG000|Overall Study|Noncompliance with clinic house rules|0|||
163074853|NCT03336866|588982382|FG001|Overall Study|Noncompliance with clinic house rules|0|||
163074854|NCT03336866|588982383|FG002|Overall Study|Noncompliance with clinic house rules|1|||
163074855|NCT00032487|588982384|FG000|Overall Study|Withdrawal by Subject|67|||
163074856|NCT00032487|588982385|FG001|Overall Study|Withdrawal by Subject|43|||
163074857|NCT00032487|588982384|FG000|Overall Study|Adverse Event|3|||
163074858|NCT00032487|588982385|FG001|Overall Study|Adverse Event|7|||
163074859|NCT00032487|588982384|FG000|Overall Study|Lost to Follow-up|57|||
163074860|NCT00032487|588982385|FG001|Overall Study|Lost to Follow-up|58|||
163074861|NCT00032487|588982384|FG000|Overall Study|Had other reason|12|||
163074862|NCT00032487|588982385|FG001|Overall Study|Had other reason|12|||
163074863|NCT02218268|588982386|FG000|24 Hour Washout|Physician Decision|11|||
163074864|NCT02218268|588982387|FG001|24 Hour Washout|Physician Decision|9|||
163074865|NCT03651336|588982388|FG000|Overall Study|Withdrawal by Subject|4|||
163074866|NCT01341990|588982389|FG000|Overall Study|Adverse Event|0|||
163074867|NCT01341990|588982390|FG001|Overall Study|Adverse Event|1|||
163074868|NCT01341990|588982389|FG000|Overall Study|Torn Study Lens|1|||
163074869|NCT01341990|588982390|FG001|Overall Study|Torn Study Lens|0|||
163074870|NCT01341990|588982389|FG000|Overall Study|Withdrawal by Subject|2|||
163074871|NCT01341990|588982390|FG001|Overall Study|Withdrawal by Subject|0|||
163074872|NCT01125748|588982392|FG000|Overall Study|Adverse Event|0|||
163074873|NCT01125748|588982393|FG001|Overall Study|Adverse Event|2|||
162717868|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163074874|NCT01125748|588982392|FG000|Overall Study|Lost to Follow-up|0|||
162717869|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163074875|NCT01125748|588982393|FG001|Overall Study|Lost to Follow-up|1|||
163074876|NCT01125748|588982392|FG000|Overall Study|Physician Decision|8|||
163074877|NCT01125748|588982393|FG001|Overall Study|Physician Decision|7|||
163074878|NCT01125748|588982392|FG000|Overall Study|Patient Decision to Withdraw|2|||
163074879|NCT01125748|588982393|FG001|Overall Study|Patient Decision to Withdraw|4|||
163074880|NCT01028391|588982394|FG000|Overall Study|Adverse Event|4|||
163074881|NCT01028391|588982395|FG001|Overall Study|Adverse Event|0|||
163074882|NCT01028391|588982394|FG000|Overall Study|Lack of Efficacy|0|||
163074883|NCT01028391|588982395|FG001|Overall Study|Lack of Efficacy|2|||
163074884|NCT01028391|588982394|FG000|Overall Study|Lost to Follow-up|3|||
163074885|NCT01028391|588982395|FG001|Overall Study|Lost to Follow-up|4|||
163074886|NCT01028391|588982394|FG000|Overall Study|Physician Decision|0|||
163074887|NCT01028391|588982395|FG001|Overall Study|Physician Decision|1|||
163074888|NCT01028391|588982394|FG000|Overall Study|Withdrawal by Subject|6|||
163074889|NCT01028391|588982395|FG001|Overall Study|Withdrawal by Subject|3|||
163074890|NCT01028391|588982394|FG000|Overall Study|Needed excluded medication|1|||
163074891|NCT01028391|588982395|FG001|Overall Study|Needed excluded medication|1|||
163074892|NCT01107457|588982396|FG000|Part A|Adverse Event|1|||
163074893|NCT01107457|588982397|FG001|Part A|Adverse Event|2|||
163074894|NCT01107457|588982398|FG002|Part A|Adverse Event|1|||
163074895|NCT01107457|588982399|FG003|Part A|Adverse Event|0|||
163074896|NCT01107457|588982400|FG004|Part A|Adverse Event|0|||
163074897|NCT01107457|588982401|FG005|Part A|Adverse Event|0|||
163074898|NCT01107457|588982396|FG000|Part A|Withdrawal by Subject|3|||
163074899|NCT01107457|588982397|FG001|Part A|Withdrawal by Subject|3|||
163074900|NCT01107457|588982398|FG002|Part A|Withdrawal by Subject|0|||
163074901|NCT01107457|588982399|FG003|Part A|Withdrawal by Subject|3|||
163074902|NCT01107457|588982400|FG004|Part A|Withdrawal by Subject|1|||
163074903|NCT01107457|588982401|FG005|Part A|Withdrawal by Subject|0|||
163074904|NCT01107457|588982396|FG000|Part A|Lost to Follow-up|0|||
163074905|NCT01107457|588982397|FG001|Part A|Lost to Follow-up|1|||
163074906|NCT01107457|588982398|FG002|Part A|Lost to Follow-up|0|||
163074907|NCT01107457|588982399|FG003|Part A|Lost to Follow-up|0|||
163074908|NCT01107457|588982400|FG004|Part A|Lost to Follow-up|0|||
163074909|NCT01107457|588982401|FG005|Part A|Lost to Follow-up|0|||
163074910|NCT01107457|588982396|FG000|Part A|Lack of Efficacy|1|||
163074911|NCT01107457|588982397|FG001|Part A|Lack of Efficacy|0|||
163074912|NCT01107457|588982398|FG002|Part A|Lack of Efficacy|0|||
163074913|NCT01107457|588982399|FG003|Part A|Lack of Efficacy|0|||
163074914|NCT01107457|588982400|FG004|Part A|Lack of Efficacy|0|||
163074915|NCT01107457|588982401|FG005|Part A|Lack of Efficacy|0|||
163074916|NCT01107457|588982396|FG000|Part A|Protocol Violation|0|||
163074917|NCT01107457|588982397|FG001|Part A|Protocol Violation|1|||
163074918|NCT01107457|588982398|FG002|Part A|Protocol Violation|0|||
163074919|NCT01107457|588982399|FG003|Part A|Protocol Violation|0|||
163074920|NCT01107457|588982400|FG004|Part A|Protocol Violation|0|||
163074921|NCT01107457|588982401|FG005|Part A|Protocol Violation|0|||
163074922|NCT01107457|588982396|FG000|Part B and C|Adverse Event|0|||
163074923|NCT01107457|588982397|FG001|Part B and C|Adverse Event|0|||
163074924|NCT01107457|588982398|FG002|Part B and C|Adverse Event|0|||
163074925|NCT01107457|588982399|FG003|Part B and C|Adverse Event|0|||
163074926|NCT01107457|588982400|FG004|Part B and C|Adverse Event|0|||
163074927|NCT01107457|588982401|FG005|Part B and C|Adverse Event|12|||
163074928|NCT01107457|588982396|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074929|NCT01107457|588982397|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074930|NCT01107457|588982398|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074931|NCT01107457|588982399|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163074932|NCT01107457|588982400|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
162717870|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162717871|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
163074933|NCT01107457|588982401|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
163074934|NCT01107457|588982396|FG000|Part B and C|Physician Decision|0|||
163074935|NCT01107457|588982397|FG001|Part B and C|Physician Decision|0|||
163074936|NCT01107457|588982398|FG002|Part B and C|Physician Decision|0|||
163074937|NCT01107457|588982399|FG003|Part B and C|Physician Decision|0|||
163074938|NCT01107457|588982400|FG004|Part B and C|Physician Decision|0|||
163074939|NCT01107457|588982401|FG005|Part B and C|Physician Decision|3|||
163074940|NCT01107457|588982396|FG000|Part B and C|Lack of Efficacy|0|||
163074941|NCT01107457|588982397|FG001|Part B and C|Lack of Efficacy|0|||
163074942|NCT01107457|588982398|FG002|Part B and C|Lack of Efficacy|0|||
163074943|NCT01107457|588982399|FG003|Part B and C|Lack of Efficacy|0|||
163074944|NCT01107457|588982400|FG004|Part B and C|Lack of Efficacy|0|||
163074945|NCT01107457|588982401|FG005|Part B and C|Lack of Efficacy|7|||
163074946|NCT01107457|588982396|FG000|Part B and C|Lost to Follow-up|0|||
163074947|NCT01107457|588982397|FG001|Part B and C|Lost to Follow-up|0|||
163074948|NCT01107457|588982398|FG002|Part B and C|Lost to Follow-up|0|||
163074949|NCT01107457|588982399|FG003|Part B and C|Lost to Follow-up|0|||
163074950|NCT01107457|588982400|FG004|Part B and C|Lost to Follow-up|0|||
163074951|NCT01107457|588982401|FG005|Part B and C|Lost to Follow-up|10|||
163074952|NCT01107457|588982396|FG000|Part B and C|Protocol Violation|0|||
163074953|NCT01107457|588982397|FG001|Part B and C|Protocol Violation|0|||
163074954|NCT01107457|588982398|FG002|Part B and C|Protocol Violation|0|||
163074955|NCT01107457|588982399|FG003|Part B and C|Protocol Violation|0|||
163074956|NCT01107457|588982400|FG004|Part B and C|Protocol Violation|0|||
163074957|NCT01107457|588982401|FG005|Part B and C|Protocol Violation|1|||
163074958|NCT01107457|588982396|FG000|Part B and C|Sponsor Decision|0|||
163074959|NCT01107457|588982397|FG001|Part B and C|Sponsor Decision|0|||
163074960|NCT01107457|588982398|FG002|Part B and C|Sponsor Decision|0|||
163074961|NCT01107457|588982399|FG003|Part B and C|Sponsor Decision|0|||
163074962|NCT01107457|588982400|FG004|Part B and C|Sponsor Decision|0|||
163074963|NCT01107457|588982401|FG005|Part B and C|Sponsor Decision|66|||
163074964|NCT01107457|588982396|FG000|Part B and C|Withdrawal by Subject|0|||
163074965|NCT01107457|588982397|FG001|Part B and C|Withdrawal by Subject|0|||
163074966|NCT01107457|588982398|FG002|Part B and C|Withdrawal by Subject|0|||
163074967|NCT01107457|588982399|FG003|Part B and C|Withdrawal by Subject|0|||
163074968|NCT01107457|588982400|FG004|Part B and C|Withdrawal by Subject|0|||
163074969|NCT01107457|588982401|FG005|Part B and C|Withdrawal by Subject|16|||
163074970|NCT01107457|588982396|FG000|Part B and C|Clinical Relapse|0|||
163074971|NCT01107457|588982397|FG001|Part B and C|Clinical Relapse|0|||
163074972|NCT01107457|588982398|FG002|Part B and C|Clinical Relapse|0|||
163074973|NCT01107457|588982399|FG003|Part B and C|Clinical Relapse|0|||
163074974|NCT01107457|588982400|FG004|Part B and C|Clinical Relapse|0|||
163074975|NCT01107457|588982401|FG005|Part B and C|Clinical Relapse|4|||
163074976|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
163074977|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
163074978|NCT00694161|588982402|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
163074979|NCT03601052|588982403|FG000|Overall Study|Lost to Follow-up|2|||
163074980|NCT01227395|588982404|FG000|Overall Study|Protocol Violation|0|||
163074981|NCT01227395|588982405|FG001|Overall Study|Protocol Violation|1|||
163074982|NCT00105508|588982406|FG000|Overall Study|Prephase Dropout|1|||
163074983|NCT00105508|588982407|FG001|Overall Study|Prephase Dropout|0|||
163074984|NCT00105508|588982406|FG000|Overall Study|Adverse Event|16|||
163074985|NCT00105508|588982407|FG001|Overall Study|Adverse Event|19|||
163074986|NCT00105508|588982406|FG000|Overall Study|Insufficient Efficacy|1|||
163074987|NCT00105508|588982407|FG001|Overall Study|Insufficient Efficacy|0|||
163074988|NCT00105508|588982406|FG000|Overall Study|Withdrawal by Subject|10|||
163074989|NCT00105508|588982407|FG001|Overall Study|Withdrawal by Subject|6|||
163074990|NCT00105508|588982406|FG000|Overall Study|Lost to Follow-up|3|||
163074991|NCT00105508|588982407|FG001|Overall Study|Lost to Follow-up|0|||
163074992|NCT00105508|588982406|FG000|Overall Study|Protocol Violation|1|||
163074993|NCT00105508|588982407|FG001|Overall Study|Protocol Violation|2|||
163074994|NCT00105508|588982406|FG000|Overall Study|Other|8|||
163074995|NCT00105508|588982407|FG001|Overall Study|Other|9|||
163074996|NCT00683384|588982408|FG000|Overall Study|Death|1|||
163074997|NCT00683384|588982408|FG000|Overall Study|Adverse Event|1|||
163074998|NCT00120874|588982409|FG000|Overall Study|Death|0|||
163074999|NCT00120874|588982410|FG001|Overall Study|Death|1|||
163075000|NCT01108055|588982411|FG000|Overall Study|Ineligible|11|||
163075001|NCT01108055|588982411|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
163075002|NCT01049828|588982414|FG000|Overall Study|Claustrophibia and Frustration|2|||
163075003|NCT02015104|588982415|FG000|Overall Study|Withdrew consent after first dose drug|1|||
163075004|NCT02015104|588982416|FG001|Overall Study|Withdrew consent after first dose drug|0|||
163075005|NCT02015104|588982415|FG000|Overall Study|Withdrew consent prior to treatment|0|||
163075006|NCT02015104|588982416|FG001|Overall Study|Withdrew consent prior to treatment|1|||
163075007|NCT03011372|588982417|FG000|Overall Study|Death|16|||
163075008|NCT03011372|588982417|FG000|Overall Study|Lost to Follow-up|2|||
163075009|NCT03011372|588982417|FG000|Overall Study|Sponsor Decision|17|||
163075010|NCT03011372|588982417|FG000|Overall Study|Withdrawal by Subject|7|||
163075011|NCT03011372|588982417|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
163075012|NCT03011372|588982417|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
163075013|NCT03011372|588982417|FG000|Overall Study|Sponsor's Decision|2|||
163075014|NCT03572218|588982418|FG000|Overall Study|Lost to Follow-up|3|||
163075015|NCT03572218|588982419|FG001|Overall Study|Lost to Follow-up|2|||
163075016|NCT03572218|588982418|FG000|Overall Study|No longer available for study visits|2|||
163075017|NCT03572218|588982419|FG001|Overall Study|No longer available for study visits|1|||
163075018|NCT03572218|588982418|FG000|Overall Study|No longer interested|1|||
163075019|NCT03572218|588982419|FG001|Overall Study|No longer interested|2|||
163075020|NCT00853047|588982420|FG000|Core Phase|Participant Request|0|||
163075021|NCT00853047|588982421|FG001|Core Phase|Participant Request|0|||
163075022|NCT00853047|588982422|FG002|Core Phase|Participant Request|0|||
163075023|NCT00853047|588982423|FG003|Core Phase|Participant Request|1|||
163075024|NCT00853047|588982424|FG004|Core Phase|Participant Request|0|||
163075025|NCT00853047|588982425|FG005|Core Phase|Participant Request|0|||
163075026|NCT00853047|588982420|FG000|Open-Label Extension Phase|Participant Request|0|||
163075027|NCT00853047|588982421|FG001|Open-Label Extension Phase|Participant Request|0|||
163075028|NCT00853047|588982422|FG002|Open-Label Extension Phase|Participant Request|0|||
163075029|NCT00853047|588982423|FG003|Open-Label Extension Phase|Participant Request|0|||
163075030|NCT00853047|588982424|FG004|Open-Label Extension Phase|Participant Request|0|||
163075031|NCT00853047|588982425|FG005|Open-Label Extension Phase|Participant Request|7|||
163075032|NCT00853047|588982420|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163075033|NCT00853047|588982421|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163075034|NCT00853047|588982422|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163075035|NCT00853047|588982423|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
163075036|NCT00853047|588982424|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
163075037|NCT00853047|588982425|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
162644892|NCT00697515|587417645|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
162644893|NCT00697515|587417646|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
162644894|NCT00697515|587417645|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
162644895|NCT00697515|587417646|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
162644896|NCT00697515|587417645|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
162644897|NCT00697515|587417646|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
162644898|NCT01957462|587417647|FG000|Test Period 1|Withdrawal by Subject|1|||
162644899|NCT01957462|587417648|FG001|Test Period 1|Withdrawal by Subject|0|||
162644900|NCT01957462|587417647|FG000|Test Period 1|Adverse Event|1|||
162644901|NCT01957462|587417648|FG001|Test Period 1|Adverse Event|0|||
162644902|NCT05954052|587417649|FG000|Overall Study|Adverse Event|1|||
162644903|NCT03102918|587417650|FG000|Overall Study|Protocol Violation|1|||
162644904|NCT03102918|587417651|FG001|Overall Study|Protocol Violation|0|||
162644905|NCT04519645|587417654|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
162644906|NCT04519645|587417655|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
162644907|NCT04519645|587417656|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
162644908|NCT04519645|587417654|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
162644909|NCT04519645|587417655|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
162644910|NCT04519645|587417656|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
162644911|NCT04519645|587417654|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
162644912|NCT04519645|587417655|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
162644913|NCT04519645|587417656|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
162644914|NCT04519645|587417654|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
162644915|NCT04519645|587417655|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
162644916|NCT04519645|587417656|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
162644917|NCT05517382|587417665|FG000|Overall Study|Lost to Follow-up|0|||
162644918|NCT05517382|587417666|FG001|Overall Study|Lost to Follow-up|1|||
162644919|NCT03886220|587417669|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
162644920|NCT03886220|587417670|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
163075038|NCT00853047|588982420|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075039|NCT00853047|588982421|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075040|NCT00853047|588982422|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075041|NCT00853047|588982423|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075042|NCT00853047|588982424|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
163075043|NCT00853047|588982425|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
163075044|NCT00853047|588982420|FG000|Open-Label Extension Phase|Investigator Decision|0|||
163075045|NCT00853047|588982421|FG001|Open-Label Extension Phase|Investigator Decision|0|||
163075046|NCT00853047|588982422|FG002|Open-Label Extension Phase|Investigator Decision|0|||
163075047|NCT00853047|588982423|FG003|Open-Label Extension Phase|Investigator Decision|0|||
163075048|NCT00853047|588982424|FG004|Open-Label Extension Phase|Investigator Decision|0|||
163075049|NCT00853047|588982425|FG005|Open-Label Extension Phase|Investigator Decision|1|||
163075050|NCT00853047|588982420|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
163075051|NCT00853047|588982421|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
163075052|NCT00853047|588982422|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
163075053|NCT00853047|588982423|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
163075054|NCT00853047|588982424|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
163075055|NCT00853047|588982425|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
163075056|NCT02638493|588982426|FG000|Overall Study|Inability to provide semen samples|2|||
163075057|NCT02638493|588982427|FG001|Overall Study|Inability to provide semen samples|0|||
163075058|NCT02638493|588982428|FG002|Overall Study|Inability to provide semen samples|0|||
163075059|NCT01569763|588984596|FG000|Overall Study|Lack of Efficacy|2|||
163075060|NCT01569763|588984597|FG001|Overall Study|Lack of Efficacy|7|||
163075061|NCT01569763|588984596|FG000|Overall Study|Adverse Event|1|||
163075062|NCT01569763|588984597|FG001|Overall Study|Adverse Event|0|||
163075063|NCT01926509|588984598|FG000|Overall Study|vital sign met discontinuation criteria|1|||
163075064|NCT01926509|588984599|FG001|Overall Study|vital sign met discontinuation criteria|0|||
163075065|NCT01926509|588984600|FG002|Overall Study|vital sign met discontinuation criteria|0|||
163075066|NCT01926509|588984601|FG003|Overall Study|vital sign met discontinuation criteria|0|||
163075067|NCT02730169|588984602|FG000|Overall Study|Protocol Violation|1|||
163075068|NCT02730169|588984603|FG001|Overall Study|Protocol Violation|0|||
163075069|NCT02730169|588984604|FG002|Overall Study|Protocol Violation|0|||
163075070|NCT02730169|588984605|FG003|Overall Study|Protocol Violation|1|||
163075071|NCT02730169|588984602|FG000|Overall Study|Adverse Event|2|||
163075072|NCT02730169|588984603|FG001|Overall Study|Adverse Event|3|||
163075073|NCT02730169|588984604|FG002|Overall Study|Adverse Event|3|||
163075074|NCT02730169|588984605|FG003|Overall Study|Adverse Event|0|||
163075075|NCT02730169|588984602|FG000|Overall Study|Adverse Event of Special Interest|0|||
163075076|NCT02730169|588984603|FG001|Overall Study|Adverse Event of Special Interest|1|||
163075077|NCT02730169|588984604|FG002|Overall Study|Adverse Event of Special Interest|2|||
163075078|NCT02730169|588984605|FG003|Overall Study|Adverse Event of Special Interest|0|||
163075079|NCT02730169|588984602|FG000|Overall Study|Withdrawal by Subject|6|||
163075080|NCT02730169|588984603|FG001|Overall Study|Withdrawal by Subject|11|||
163075081|NCT02730169|588984604|FG002|Overall Study|Withdrawal by Subject|6|||
163075082|NCT02730169|588984605|FG003|Overall Study|Withdrawal by Subject|8|||
163075083|NCT02730169|588984602|FG000|Overall Study|Lost to Follow-up|5|||
163075084|NCT02730169|588984603|FG001|Overall Study|Lost to Follow-up|6|||
163075085|NCT02730169|588984604|FG002|Overall Study|Lost to Follow-up|5|||
163075086|NCT02730169|588984605|FG003|Overall Study|Lost to Follow-up|6|||
163075087|NCT02730169|588984602|FG000|Overall Study|Other|0|||
163075088|NCT02730169|588984603|FG001|Overall Study|Other|0|||
163075089|NCT02730169|588984604|FG002|Overall Study|Other|1|||
163075090|NCT02730169|588984605|FG003|Overall Study|Other|1|||
163075091|NCT03004183|588984606|FG000|Overall Study|Adverse Event|7|||
163075092|NCT03004183|588984606|FG000|Overall Study|Lost to Follow-up|1|||
163075093|NCT03004183|588984606|FG000|Overall Study|Physician Decision|40|||
163075094|NCT03004183|588984606|FG000|Overall Study|Withdrawal by Subject|1|||
163075095|NCT03004183|588984606|FG000|Overall Study|COVID-19|1|||
163075096|NCT02698787|588984610|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
163075097|NCT02698787|588984611|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
163075098|NCT02168439|588984615|FG000|Overall Study|Protocol Violation|0|||
163075099|NCT02168439|588984616|FG001|Overall Study|Protocol Violation|2|||
163075100|NCT02004275|588984617|FG000|Phase 1|Ineligible|0|||
162717872|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
163075101|NCT02004275|588984618|FG001|Phase 1|Ineligible|0|||
163075102|NCT02004275|588984619|FG002|Phase 1|Ineligible|0|||
163075103|NCT02004275|588984620|FG003|Phase 1|Ineligible|1|||
163075104|NCT02004275|588984621|FG004|Phase 1|Ineligible|1|||
163075105|NCT02004275|588984622|FG005|Phase 1|Ineligible|0|||
163075106|NCT02004275|588984617|FG000|Phase 1|Protocol Violation|0|||
163075107|NCT02004275|588984618|FG001|Phase 1|Protocol Violation|0|||
163075108|NCT02004275|588984619|FG002|Phase 1|Protocol Violation|0|||
163075109|NCT02004275|588984620|FG003|Phase 1|Protocol Violation|1|||
162644921|NCT03886220|587417669|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
162644922|NCT03886220|587417670|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
163075110|NCT02004275|588984621|FG004|Phase 1|Protocol Violation|0|||
163075111|NCT02004275|588984622|FG005|Phase 1|Protocol Violation|5|||
163075112|NCT02004275|588984617|FG000|Phase 2 Part 1|Ineligible|6|||
163075113|NCT02004275|588984618|FG001|Phase 2 Part 1|Ineligible|9|||
163075114|NCT02004275|588984619|FG002|Phase 2 Part 1|Ineligible|0|||
163075115|NCT02004275|588984620|FG003|Phase 2 Part 1|Ineligible|0|||
163075116|NCT02004275|588984621|FG004|Phase 2 Part 1|Ineligible|0|||
163075117|NCT02004275|588984622|FG005|Phase 2 Part 1|Ineligible|0|||
163075118|NCT02004275|588984617|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
163075119|NCT02004275|588984618|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
163075120|NCT02004275|588984619|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
163075121|NCT02004275|588984620|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
163075122|NCT02004275|588984621|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
163075123|NCT02004275|588984622|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
163075124|NCT02533674|588984623|FG000|Dose Level I|Progressive disease|1|||
163075125|NCT02533674|588984624|FG001|Dose Level I|Progressive disease|0|||
163075126|NCT02533674|588984625|FG002|Dose Level I|Progressive disease|0|||
163075127|NCT02533674|588984626|FG003|Dose Level I|Progressive disease|0|||
163075128|NCT02533674|588984627|FG004|Dose Level I|Progressive disease|0|||
163075129|NCT02533674|588984628|FG005|Dose Level I|Progressive disease|0|||
163075130|NCT02533674|588984629|FG006|Dose Level I|Progressive disease|0|||
163075131|NCT02533674|588984630|FG007|Dose Level I|Progressive disease|0|||
163075132|NCT02533674|588984623|FG000|Dose Level I|Withdrawal by Subject|1|||
163075133|NCT02533674|588984624|FG001|Dose Level I|Withdrawal by Subject|0|||
163075134|NCT02533674|588984625|FG002|Dose Level I|Withdrawal by Subject|0|||
163075135|NCT02533674|588984626|FG003|Dose Level I|Withdrawal by Subject|0|||
163075136|NCT02533674|588984627|FG004|Dose Level I|Withdrawal by Subject|0|||
163075137|NCT02533674|588984628|FG005|Dose Level I|Withdrawal by Subject|0|||
163075138|NCT02533674|588984629|FG006|Dose Level I|Withdrawal by Subject|0|||
163075139|NCT02533674|588984630|FG007|Dose Level I|Withdrawal by Subject|0|||
163075140|NCT02533674|588984623|FG000|Dose Level I|Physician Decision|1|||
163075141|NCT02533674|588984624|FG001|Dose Level I|Physician Decision|0|||
163075142|NCT02533674|588984625|FG002|Dose Level I|Physician Decision|0|||
163075143|NCT02533674|588984626|FG003|Dose Level I|Physician Decision|0|||
163075144|NCT02533674|588984627|FG004|Dose Level I|Physician Decision|0|||
163075145|NCT02533674|588984628|FG005|Dose Level I|Physician Decision|0|||
163075146|NCT02533674|588984629|FG006|Dose Level I|Physician Decision|0|||
163075147|NCT02533674|588984630|FG007|Dose Level I|Physician Decision|0|||
163075148|NCT02533674|588984623|FG000|Dose Level I|Death|1|||
163075149|NCT02533674|588984624|FG001|Dose Level I|Death|0|||
163075150|NCT02533674|588984625|FG002|Dose Level I|Death|0|||
163075151|NCT02533674|588984626|FG003|Dose Level I|Death|0|||
163075152|NCT02533674|588984627|FG004|Dose Level I|Death|0|||
163075153|NCT02533674|588984628|FG005|Dose Level I|Death|0|||
163075154|NCT02533674|588984629|FG006|Dose Level I|Death|0|||
163075155|NCT02533674|588984630|FG007|Dose Level I|Death|0|||
163075156|NCT02533674|588984623|FG000|Dose Level I|Never Treated|1|||
163075157|NCT02533674|588984624|FG001|Dose Level I|Never Treated|0|||
163075158|NCT02533674|588984625|FG002|Dose Level I|Never Treated|0|||
163075159|NCT02533674|588984626|FG003|Dose Level I|Never Treated|0|||
163075160|NCT02533674|588984627|FG004|Dose Level I|Never Treated|0|||
163075161|NCT02533674|588984628|FG005|Dose Level I|Never Treated|0|||
163075162|NCT02533674|588984629|FG006|Dose Level I|Never Treated|0|||
163075163|NCT02533674|588984630|FG007|Dose Level I|Never Treated|0|||
163075164|NCT02533674|588984623|FG000|Dose Level II|Progressive disease|0|||
163075165|NCT02533674|588984624|FG001|Dose Level II|Progressive disease|3|||
163075166|NCT02533674|588984625|FG002|Dose Level II|Progressive disease|0|||
163075167|NCT02533674|588984626|FG003|Dose Level II|Progressive disease|0|||
163075168|NCT02533674|588984627|FG004|Dose Level II|Progressive disease|0|||
163075169|NCT02533674|588984628|FG005|Dose Level II|Progressive disease|0|||
163075170|NCT02533674|588984629|FG006|Dose Level II|Progressive disease|0|||
162644923|NCT03886220|587417669|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
163075171|NCT02533674|588984630|FG007|Dose Level II|Progressive disease|0|||
163075172|NCT02533674|588984623|FG000|Dose Level II|Withdrawal by Subject|0|||
163075173|NCT02533674|588984624|FG001|Dose Level II|Withdrawal by Subject|1|||
163075174|NCT02533674|588984625|FG002|Dose Level II|Withdrawal by Subject|0|||
163075175|NCT02533674|588984626|FG003|Dose Level II|Withdrawal by Subject|0|||
163075176|NCT02533674|588984627|FG004|Dose Level II|Withdrawal by Subject|0|||
163075177|NCT02533674|588984628|FG005|Dose Level II|Withdrawal by Subject|0|||
163075178|NCT02533674|588984629|FG006|Dose Level II|Withdrawal by Subject|0|||
163075179|NCT02533674|588984630|FG007|Dose Level II|Withdrawal by Subject|0|||
163075180|NCT02533674|588984623|FG000|Dose Level II|Treatment-related AE|0|||
163075181|NCT02533674|588984624|FG001|Dose Level II|Treatment-related AE|1|||
163075182|NCT02533674|588984625|FG002|Dose Level II|Treatment-related AE|0|||
163075183|NCT02533674|588984626|FG003|Dose Level II|Treatment-related AE|0|||
163075184|NCT02533674|588984627|FG004|Dose Level II|Treatment-related AE|0|||
163075185|NCT02533674|588984628|FG005|Dose Level II|Treatment-related AE|0|||
162644924|NCT03886220|587417670|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163075186|NCT02533674|588984629|FG006|Dose Level II|Treatment-related AE|0|||
163075187|NCT02533674|588984630|FG007|Dose Level II|Treatment-related AE|0|||
163075188|NCT02533674|588984623|FG000|Dose Level II|Physician Decision|0|||
163075189|NCT02533674|588984624|FG001|Dose Level II|Physician Decision|1|||
163075190|NCT02533674|588984625|FG002|Dose Level II|Physician Decision|0|||
163075191|NCT02533674|588984626|FG003|Dose Level II|Physician Decision|0|||
163075192|NCT02533674|588984627|FG004|Dose Level II|Physician Decision|0|||
163075193|NCT02533674|588984628|FG005|Dose Level II|Physician Decision|0|||
163075194|NCT02533674|588984629|FG006|Dose Level II|Physician Decision|0|||
163075195|NCT02533674|588984630|FG007|Dose Level II|Physician Decision|0|||
163075196|NCT02533674|588984623|FG000|Dose Level II|Non-treatment-related AE|0|||
163075197|NCT02533674|588984624|FG001|Dose Level II|Non-treatment-related AE|1|||
163075198|NCT02533674|588984625|FG002|Dose Level II|Non-treatment-related AE|0|||
163075199|NCT02533674|588984626|FG003|Dose Level II|Non-treatment-related AE|0|||
163075200|NCT02533674|588984627|FG004|Dose Level II|Non-treatment-related AE|0|||
163075201|NCT02533674|588984628|FG005|Dose Level II|Non-treatment-related AE|0|||
163075202|NCT02533674|588984629|FG006|Dose Level II|Non-treatment-related AE|0|||
163075203|NCT02533674|588984630|FG007|Dose Level II|Non-treatment-related AE|0|||
163075204|NCT02533674|588984623|FG000|Dose Level III|Progressive disease|0|||
163075205|NCT02533674|588984624|FG001|Dose Level III|Progressive disease|0|||
163075206|NCT02533674|588984625|FG002|Dose Level III|Progressive disease|2|||
163075207|NCT02533674|588984626|FG003|Dose Level III|Progressive disease|0|||
163075208|NCT02533674|588984627|FG004|Dose Level III|Progressive disease|0|||
163075209|NCT02533674|588984628|FG005|Dose Level III|Progressive disease|0|||
163075210|NCT02533674|588984629|FG006|Dose Level III|Progressive disease|0|||
163075211|NCT02533674|588984630|FG007|Dose Level III|Progressive disease|0|||
163075212|NCT02533674|588984623|FG000|Dose Level III|Withdrawal by Subject|0|||
163075213|NCT02533674|588984624|FG001|Dose Level III|Withdrawal by Subject|0|||
163075214|NCT02533674|588984625|FG002|Dose Level III|Withdrawal by Subject|1|||
163075215|NCT02533674|588984626|FG003|Dose Level III|Withdrawal by Subject|0|||
163075216|NCT02533674|588984627|FG004|Dose Level III|Withdrawal by Subject|0|||
163075217|NCT02533674|588984628|FG005|Dose Level III|Withdrawal by Subject|0|||
163075218|NCT02533674|588984629|FG006|Dose Level III|Withdrawal by Subject|0|||
163075219|NCT02533674|588984630|FG007|Dose Level III|Withdrawal by Subject|0|||
163075220|NCT02533674|588984623|FG000|Dose Level III|Treatment-related AE|0|||
163075221|NCT02533674|588984624|FG001|Dose Level III|Treatment-related AE|0|||
163075222|NCT02533674|588984625|FG002|Dose Level III|Treatment-related AE|1|||
163075223|NCT02533674|588984626|FG003|Dose Level III|Treatment-related AE|0|||
163075224|NCT02533674|588984627|FG004|Dose Level III|Treatment-related AE|0|||
163075225|NCT02533674|588984628|FG005|Dose Level III|Treatment-related AE|0|||
163075226|NCT02533674|588984629|FG006|Dose Level III|Treatment-related AE|0|||
163075227|NCT02533674|588984630|FG007|Dose Level III|Treatment-related AE|0|||
163075228|NCT02533674|588984623|FG000|Dose Level IV|Progressive disease|0|||
163075229|NCT02533674|588984624|FG001|Dose Level IV|Progressive disease|0|||
163075230|NCT02533674|588984625|FG002|Dose Level IV|Progressive disease|0|||
163075231|NCT02533674|588984626|FG003|Dose Level IV|Progressive disease|3|||
163075232|NCT02533674|588984627|FG004|Dose Level IV|Progressive disease|0|||
163075233|NCT02533674|588984628|FG005|Dose Level IV|Progressive disease|0|||
163075234|NCT02533674|588984629|FG006|Dose Level IV|Progressive disease|0|||
163075235|NCT02533674|588984630|FG007|Dose Level IV|Progressive disease|0|||
163075236|NCT02533674|588984623|FG000|Dose Level IV|Withdrawal by Subject|0|||
163075237|NCT02533674|588984624|FG001|Dose Level IV|Withdrawal by Subject|0|||
163075238|NCT02533674|588984625|FG002|Dose Level IV|Withdrawal by Subject|0|||
163075239|NCT02533674|588984626|FG003|Dose Level IV|Withdrawal by Subject|1|||
163075240|NCT02533674|588984627|FG004|Dose Level IV|Withdrawal by Subject|0|||
163075241|NCT02533674|588984628|FG005|Dose Level IV|Withdrawal by Subject|0|||
163075242|NCT02533674|588984629|FG006|Dose Level IV|Withdrawal by Subject|0|||
162644925|NCT01675128|587417675|FG000|Overall Study|Disease progression on study|1|||
162644926|NCT01675128|587417676|FG001|Overall Study|Disease progression on study|1|||
162644927|NCT01675128|587417677|FG002|Overall Study|Disease progression on study|1|||
163075243|NCT02533674|588984630|FG007|Dose Level IV|Withdrawal by Subject|0|||
163075244|NCT02533674|588984623|FG000|Dose Level IV|Physician Decision|0|||
163075245|NCT02533674|588984624|FG001|Dose Level IV|Physician Decision|0|||
163075246|NCT02533674|588984625|FG002|Dose Level IV|Physician Decision|0|||
163075247|NCT02533674|588984626|FG003|Dose Level IV|Physician Decision|1|||
163075248|NCT02533674|588984627|FG004|Dose Level IV|Physician Decision|0|||
162644928|NCT01675128|587417675|FG000|Overall Study|Refused further treatment|1|||
163075249|NCT02533674|588984628|FG005|Dose Level IV|Physician Decision|0|||
163075250|NCT02533674|588984629|FG006|Dose Level IV|Physician Decision|0|||
163075251|NCT02533674|588984630|FG007|Dose Level IV|Physician Decision|0|||
163075252|NCT02533674|588984623|FG000|Dose Level V|Progressive disease|0|||
163075253|NCT02533674|588984624|FG001|Dose Level V|Progressive disease|0|||
163075254|NCT02533674|588984625|FG002|Dose Level V|Progressive disease|0|||
163075255|NCT02533674|588984626|FG003|Dose Level V|Progressive disease|0|||
163075256|NCT02533674|588984627|FG004|Dose Level V|Progressive disease|3|||
163075257|NCT02533674|588984628|FG005|Dose Level V|Progressive disease|0|||
163075258|NCT02533674|588984629|FG006|Dose Level V|Progressive disease|0|||
163075259|NCT02533674|588984630|FG007|Dose Level V|Progressive disease|0|||
163075260|NCT02533674|588984623|FG000|Dose Level V|Withdrawal by Subject|0|||
163075261|NCT02533674|588984624|FG001|Dose Level V|Withdrawal by Subject|0|||
163075262|NCT02533674|588984625|FG002|Dose Level V|Withdrawal by Subject|0|||
163075263|NCT02533674|588984626|FG003|Dose Level V|Withdrawal by Subject|0|||
163075264|NCT02533674|588984627|FG004|Dose Level V|Withdrawal by Subject|1|||
163075265|NCT02533674|588984628|FG005|Dose Level V|Withdrawal by Subject|0|||
163075266|NCT02533674|588984629|FG006|Dose Level V|Withdrawal by Subject|0|||
163075267|NCT02533674|588984630|FG007|Dose Level V|Withdrawal by Subject|0|||
163075268|NCT02533674|588984623|FG000|Dose Level V|Physician Decision|0|||
163075269|NCT02533674|588984624|FG001|Dose Level V|Physician Decision|0|||
163075270|NCT02533674|588984625|FG002|Dose Level V|Physician Decision|0|||
163075271|NCT02533674|588984626|FG003|Dose Level V|Physician Decision|0|||
163075272|NCT02533674|588984627|FG004|Dose Level V|Physician Decision|1|||
163075273|NCT02533674|588984628|FG005|Dose Level V|Physician Decision|0|||
163075274|NCT02533674|588984629|FG006|Dose Level V|Physician Decision|0|||
163075275|NCT02533674|588984630|FG007|Dose Level V|Physician Decision|0|||
163075276|NCT02533674|588984623|FG000|Dose Level VI|Progressive disease|0|||
163075277|NCT02533674|588984624|FG001|Dose Level VI|Progressive disease|0|||
163075278|NCT02533674|588984625|FG002|Dose Level VI|Progressive disease|0|||
163075279|NCT02533674|588984626|FG003|Dose Level VI|Progressive disease|0|||
163075280|NCT02533674|588984627|FG004|Dose Level VI|Progressive disease|0|||
163075281|NCT02533674|588984628|FG005|Dose Level VI|Progressive disease|7|||
163075282|NCT02533674|588984629|FG006|Dose Level VI|Progressive disease|0|||
163075283|NCT02533674|588984630|FG007|Dose Level VI|Progressive disease|0|||
163075284|NCT02533674|588984623|FG000|Dose Level VI|Withdrawal by Subject|0|||
163075285|NCT02533674|588984624|FG001|Dose Level VI|Withdrawal by Subject|0|||
163075286|NCT02533674|588984625|FG002|Dose Level VI|Withdrawal by Subject|0|||
163075287|NCT02533674|588984626|FG003|Dose Level VI|Withdrawal by Subject|0|||
163075288|NCT02533674|588984627|FG004|Dose Level VI|Withdrawal by Subject|0|||
163075289|NCT02533674|588984628|FG005|Dose Level VI|Withdrawal by Subject|1|||
163075290|NCT02533674|588984629|FG006|Dose Level VI|Withdrawal by Subject|0|||
163075291|NCT02533674|588984630|FG007|Dose Level VI|Withdrawal by Subject|0|||
163075292|NCT02533674|588984623|FG000|Dose Level VI|Treatment-related AE|0|||
163075293|NCT02533674|588984624|FG001|Dose Level VI|Treatment-related AE|0|||
163075294|NCT02533674|588984625|FG002|Dose Level VI|Treatment-related AE|0|||
163075295|NCT02533674|588984626|FG003|Dose Level VI|Treatment-related AE|0|||
163075296|NCT02533674|588984627|FG004|Dose Level VI|Treatment-related AE|0|||
163075297|NCT02533674|588984628|FG005|Dose Level VI|Treatment-related AE|1|||
163075298|NCT02533674|588984629|FG006|Dose Level VI|Treatment-related AE|0|||
163075299|NCT02533674|588984630|FG007|Dose Level VI|Treatment-related AE|0|||
163075300|NCT02533674|588984623|FG000|Dose Level VII|Progressive disease|0|||
163075301|NCT02533674|588984624|FG001|Dose Level VII|Progressive disease|0|||
163075302|NCT02533674|588984625|FG002|Dose Level VII|Progressive disease|0|||
163075303|NCT02533674|588984626|FG003|Dose Level VII|Progressive disease|0|||
163075304|NCT02533674|588984627|FG004|Dose Level VII|Progressive disease|0|||
163075305|NCT02533674|588984628|FG005|Dose Level VII|Progressive disease|0|||
163075306|NCT02533674|588984629|FG006|Dose Level VII|Progressive disease|10|||
163075307|NCT02533674|588984630|FG007|Dose Level VII|Progressive disease|0|||
163075308|NCT02533674|588984623|FG000|Dose Level VII|Withdrawal by Subject|0|||
163075309|NCT02533674|588984624|FG001|Dose Level VII|Withdrawal by Subject|0|||
163075310|NCT02533674|588984625|FG002|Dose Level VII|Withdrawal by Subject|0|||
163075311|NCT02533674|588984626|FG003|Dose Level VII|Withdrawal by Subject|0|||
163075312|NCT02533674|588984627|FG004|Dose Level VII|Withdrawal by Subject|0|||
163075313|NCT02533674|588984628|FG005|Dose Level VII|Withdrawal by Subject|0|||
163075314|NCT02533674|588984629|FG006|Dose Level VII|Withdrawal by Subject|3|||
163075315|NCT02533674|588984630|FG007|Dose Level VII|Withdrawal by Subject|0|||
163075316|NCT02533674|588984623|FG000|Dose Level VII|Treatment-related AE|0|||
163075317|NCT02533674|588984624|FG001|Dose Level VII|Treatment-related AE|0|||
163075318|NCT02533674|588984625|FG002|Dose Level VII|Treatment-related AE|0|||
163075319|NCT02533674|588984626|FG003|Dose Level VII|Treatment-related AE|0|||
163075320|NCT02533674|588984627|FG004|Dose Level VII|Treatment-related AE|0|||
163075321|NCT02533674|588984628|FG005|Dose Level VII|Treatment-related AE|0|||
163075322|NCT02533674|588984629|FG006|Dose Level VII|Treatment-related AE|1|||
163075323|NCT02533674|588984630|FG007|Dose Level VII|Treatment-related AE|0|||
163075324|NCT02533674|588984623|FG000|Dose Level VII|Death|0|||
163075325|NCT02533674|588984624|FG001|Dose Level VII|Death|0|||
163075326|NCT02533674|588984625|FG002|Dose Level VII|Death|0|||
163075327|NCT02533674|588984626|FG003|Dose Level VII|Death|0|||
163075328|NCT02533674|588984627|FG004|Dose Level VII|Death|0|||
163075329|NCT02533674|588984628|FG005|Dose Level VII|Death|0|||
163075330|NCT02533674|588984629|FG006|Dose Level VII|Death|2|||
163075331|NCT02533674|588984630|FG007|Dose Level VII|Death|0|||
163028054|NCT04021121|588805390|FG000|Overall Study|Death|3|||
163028055|NCT04021121|588805391|FG001|Overall Study|Death|3|||
163028056|NCT04021121|588805392|FG002|Overall Study|Death|5|||
163028057|NCT04021121|588805393|FG003|Overall Study|Death|4|||
163028058|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
163028059|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
163028060|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
163028061|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
163028062|NCT01597375|588805401|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163028063|NCT01597375|588805402|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163028064|NCT01597375|588805401|FG000|Washout (2 Weeks)|Adverse Event|1|||
163028065|NCT01597375|588805402|FG001|Washout (2 Weeks)|Adverse Event|0|||
163028066|NCT01597375|588805401|FG000|Second Intervention|Failed to react at both Aspirin|1|||
163028067|NCT01597375|588805402|FG001|Second Intervention|Failed to react at both Aspirin|1|||
163028068|NCT02375555|588805403|FG000|Induction Period|Adverse Event|7|||
163028069|NCT02375555|588805403|FG000|Induction Period|Withdrawal by Subject|2|||
163028070|NCT02375555|588805403|FG000|Induction Period|Other|1|||
163028071|NCT02375555|588805403|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
163028072|NCT02375555|588805403|FG000|Maintenance Period|Adverse Event|2|||
163028073|NCT02375555|588805403|FG000|Maintenance Period|Withdrawal by Subject|4|||
163028074|NCT02375555|588805403|FG000|Maintenance Period|Death|1|||
163028075|NCT02375555|588805403|FG000|Maintenance Period|Disease Progression|5|||
163028076|NCT02375555|588805403|FG000|Maintenance Period|Patient Non-compliance|1|||
163028077|NCT02375555|588805403|FG000|Maintenance Period|Still on maintenance|16|||
163028078|NCT02091986|588805405|FG000|Overall Study|7 rand in error 1 patient decision|2|||
163028079|NCT02091986|588805406|FG001|Overall Study|7 rand in error 1 patient decision|3|||
163028080|NCT02091986|588805407|FG002|Overall Study|7 rand in error 1 patient decision|3|||
163028081|NCT02091986|588805405|FG000|Overall Study|Lost to Follow-up|1|||
163028082|NCT02091986|588805406|FG001|Overall Study|Lost to Follow-up|0|||
163028083|NCT02091986|588805407|FG002|Overall Study|Lost to Follow-up|0|||
163028084|NCT02091986|588805405|FG000|Overall Study|Withdrawal by Subject|4|||
163028085|NCT02091986|588805406|FG001|Overall Study|Withdrawal by Subject|8|||
163028086|NCT02091986|588805407|FG002|Overall Study|Withdrawal by Subject|3|||
163028087|NCT02091986|588805405|FG000|Overall Study|Adverse Event|0|||
163028088|NCT02091986|588805406|FG001|Overall Study|Adverse Event|0|||
163028089|NCT02091986|588805407|FG002|Overall Study|Adverse Event|2|||
163028090|NCT00915876|588805410|FG000|Overall Study|Adverse Event|0|||
163028091|NCT00915876|588805411|FG001|Overall Study|Adverse Event|1|||
163028092|NCT02496091|588805417|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163028093|NCT02272842|588805418|FG000|Overall Study|Lost to Follow-up|8|||
163028094|NCT02272842|588805419|FG001|Overall Study|Lost to Follow-up|8|||
163028095|NCT02272842|588805418|FG000|Overall Study|Withdrawal by Subject|8|||
163028096|NCT02272842|588805419|FG001|Overall Study|Withdrawal by Subject|2|||
163028097|NCT01984892|588805422|FG000|Overall Study|Progressive disease|7|||
163028098|NCT04464720|588805423|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
163028099|NCT05723328|588805425|FG000|Overall Study|Investigator's Decision|5|||
163028100|NCT05723328|588805426|FG001|Overall Study|Investigator's Decision|2|||
163028101|NCT02000882|588807191|FG000|Overall Study|Adverse Event|3|||
163028102|NCT02000882|588807191|FG000|Overall Study|Physician Decision|2|||
163028103|NCT02000882|588807191|FG000|Overall Study|Withdrawal by Subject|1|||
163028104|NCT02417961|588807192|FG000|Overall Study|Adverse Event|1|||
163028105|NCT02417961|588807192|FG000|Overall Study|Lost to Follow-up|1|||
163028106|NCT02417961|588807192|FG000|Overall Study|Withdrawal by Subject|2|||
163028107|NCT01390428|588807193|FG000|Overall Study|Elective Surgery|0|||
163028108|NCT01390428|588807194|FG001|Overall Study|Elective Surgery|0|||
163028109|NCT01390428|588807195|FG002|Overall Study|Elective Surgery|0|||
163028110|NCT01390428|588807196|FG003|Overall Study|Elective Surgery|0|||
163028111|NCT01390428|588807197|FG004|Overall Study|Elective Surgery|1|||
163028112|NCT01390428|588807198|FG005|Overall Study|Elective Surgery|0|||
163028113|NCT01390428|588807193|FG000|Overall Study|Withdrawal by Subject|0|||
163028114|NCT01390428|588807194|FG001|Overall Study|Withdrawal by Subject|0|||
163028115|NCT01390428|588807195|FG002|Overall Study|Withdrawal by Subject|1|||
163028116|NCT01390428|588807196|FG003|Overall Study|Withdrawal by Subject|0|||
163028117|NCT01390428|588807197|FG004|Overall Study|Withdrawal by Subject|0|||
163028118|NCT01390428|588807198|FG005|Overall Study|Withdrawal by Subject|0|||
163028119|NCT05897827|588807199|FG000|Overall Study|Lost to Follow-up|33|||
163028120|NCT05897827|588807200|FG001|Overall Study|Lost to Follow-up|14|||
163028121|NCT05897827|588807199|FG000|Overall Study|Withdrawal by Subject|1|||
163028122|NCT05897827|588807200|FG001|Overall Study|Withdrawal by Subject|1|||
163028123|NCT04599933|588807201|FG000|Overall Study|Adverse Event|4|||
162644929|NCT01675128|587417676|FG001|Overall Study|Refused further treatment|0|||
162644930|NCT01675128|587417677|FG002|Overall Study|Refused further treatment|0|||
162644931|NCT01675128|587417675|FG000|Overall Study|Pulmonary complication; off study|0|||
162644932|NCT01675128|587417676|FG001|Overall Study|Pulmonary complication; off study|1|||
162644933|NCT01675128|587417677|FG002|Overall Study|Pulmonary complication; off study|0|||
162644934|NCT03526458|587417683|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
162644935|NCT03526458|587417684|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
162644936|NCT03526458|587417683|FG000|Overall Study|Stone passed, surgery cancelled|2|||
162644937|NCT03526458|587417684|FG001|Overall Study|Stone passed, surgery cancelled|1|||
162644938|NCT03526458|587417683|FG000|Overall Study|Withdrawal by Subject|1|||
162644939|NCT03526458|587417684|FG001|Overall Study|Withdrawal by Subject|0|||
162644940|NCT03526458|587417683|FG000|Overall Study|Physician Decision|2|||
162644941|NCT03526458|587417684|FG001|Overall Study|Physician Decision|1|||
162644942|NCT03526458|587417683|FG000|Overall Study|Lack of equipment|1|||
162644943|NCT03526458|587417684|FG001|Overall Study|Lack of equipment|1|||
162644944|NCT00271947|587417685|FG000|Overall Study|Lost to Follow-up|1|||
162644945|NCT04404855|587417686|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
162644946|NCT04404855|587417687|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
162644947|NCT00735878|587417688|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
162644948|NCT00735878|587417689|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
162644949|NCT00735878|587417690|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
162644950|NCT00651755|587417693|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
162644951|NCT00651755|587417694|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
162644952|NCT00651755|587417693|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
162644953|NCT00651755|587417694|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
162644954|NCT01120756|587417695|FG000|Overall Study|Withdrawal by Subject|1|||
162644955|NCT01120756|587417696|FG001|Overall Study|Withdrawal by Subject|1|||
162644956|NCT00698581|587417701|FG000|Overall Study|Lack of Efficacy|23|||
162644957|NCT00698581|587417702|FG001|Overall Study|Lack of Efficacy|11|||
162644958|NCT00698581|587417701|FG000|Overall Study|Withdrawal by Subject|6|||
162644959|NCT00698581|587417702|FG001|Overall Study|Withdrawal by Subject|0|||
162644960|NCT00698581|587417701|FG000|Overall Study|Other reason|9|||
162644961|NCT00698581|587417702|FG001|Overall Study|Other reason|1|||
162644962|NCT00698581|587417701|FG000|Overall Study|SAE, non-fatal|1|||
163028124|NCT04599933|588807202|FG001|Overall Study|Adverse Event|1|||
163028125|NCT04599933|588807201|FG000|Overall Study|Withdrawal by Subject|4|||
163028126|NCT04599933|588807202|FG001|Overall Study|Withdrawal by Subject|2|||
163028127|NCT04599933|588807201|FG000|Overall Study|Lost to Follow-up|0|||
163028128|NCT04599933|588807202|FG001|Overall Study|Lost to Follow-up|1|||
163028129|NCT04599933|588807201|FG000|Overall Study|Physician Decision|0|||
163028130|NCT04599933|588807202|FG001|Overall Study|Physician Decision|1|||
163028131|NCT04599933|588807201|FG000|Overall Study|Screen Failure|1|||
163028132|NCT04599933|588807202|FG001|Overall Study|Screen Failure|2|||
163028133|NCT01358578|588807210|FG000|Induction Period|Adverse Event|2|||
163028134|NCT01358578|588807211|FG001|Induction Period|Adverse Event|4|||
163028135|NCT01358578|588807212|FG002|Induction Period|Adverse Event|2|||
163028136|NCT01358578|588807213|FG003|Induction Period|Adverse Event|6|||
163028137|NCT01358578|588807214|FG004|Induction Period|Adverse Event|0|||
163028138|NCT01358578|588807215|FG005|Induction Period|Adverse Event|0|||
163028139|NCT01358578|588807210|FG000|Induction Period|Lack of Efficacy|0|||
163028140|NCT01358578|588807211|FG001|Induction Period|Lack of Efficacy|0|||
163028141|NCT01358578|588807212|FG002|Induction Period|Lack of Efficacy|9|||
163028142|NCT01358578|588807213|FG003|Induction Period|Lack of Efficacy|1|||
163028143|NCT01358578|588807214|FG004|Induction Period|Lack of Efficacy|0|||
163028144|NCT01358578|588807215|FG005|Induction Period|Lack of Efficacy|0|||
163028145|NCT01358578|588807210|FG000|Induction Period|Lost to Follow-up|0|||
163028146|NCT01358578|588807211|FG001|Induction Period|Lost to Follow-up|0|||
163028147|NCT01358578|588807212|FG002|Induction Period|Lost to Follow-up|1|||
163028148|NCT01358578|588807213|FG003|Induction Period|Lost to Follow-up|4|||
163028149|NCT01358578|588807214|FG004|Induction Period|Lost to Follow-up|0|||
163028150|NCT01358578|588807215|FG005|Induction Period|Lost to Follow-up|0|||
163028151|NCT01358578|588807210|FG000|Induction Period|Physician Decision|2|||
163028152|NCT01358578|588807211|FG001|Induction Period|Physician Decision|1|||
163028153|NCT01358578|588807212|FG002|Induction Period|Physician Decision|2|||
163028154|NCT01358578|588807213|FG003|Induction Period|Physician Decision|0|||
163028155|NCT01358578|588807214|FG004|Induction Period|Physician Decision|0|||
163028156|NCT01358578|588807215|FG005|Induction Period|Physician Decision|0|||
163028157|NCT01358578|588807210|FG000|Induction Period|Protocol Deviation|3|||
163028158|NCT01358578|588807211|FG001|Induction Period|Protocol Deviation|5|||
162644963|NCT00698581|587417702|FG001|Overall Study|SAE, non-fatal|0|||
163028159|NCT01358578|588807212|FG002|Induction Period|Protocol Deviation|0|||
163028160|NCT01358578|588807213|FG003|Induction Period|Protocol Deviation|3|||
163028161|NCT01358578|588807214|FG004|Induction Period|Protocol Deviation|0|||
163028162|NCT01358578|588807215|FG005|Induction Period|Protocol Deviation|0|||
163028163|NCT01358578|588807210|FG000|Induction Period|technical problems|0|||
163075332|NCT02533674|588984623|FG000|Dose Level VIII|Progressive disease|0|||
163075333|NCT02533674|588984624|FG001|Dose Level VIII|Progressive disease|0|||
163075334|NCT02533674|588984625|FG002|Dose Level VIII|Progressive disease|0|||
163075335|NCT02533674|588984626|FG003|Dose Level VIII|Progressive disease|0|||
163075336|NCT02533674|588984627|FG004|Dose Level VIII|Progressive disease|0|||
163075337|NCT02533674|588984628|FG005|Dose Level VIII|Progressive disease|0|||
163075338|NCT02533674|588984629|FG006|Dose Level VIII|Progressive disease|0|||
163075339|NCT02533674|588984630|FG007|Dose Level VIII|Progressive disease|3|||
163075340|NCT02533674|588984623|FG000|Dose Level VIII|Withdrawal by Subject|0|||
163075341|NCT02533674|588984624|FG001|Dose Level VIII|Withdrawal by Subject|0|||
163075342|NCT02533674|588984625|FG002|Dose Level VIII|Withdrawal by Subject|0|||
163075343|NCT02533674|588984626|FG003|Dose Level VIII|Withdrawal by Subject|0|||
163075344|NCT02533674|588984627|FG004|Dose Level VIII|Withdrawal by Subject|0|||
163075345|NCT02533674|588984628|FG005|Dose Level VIII|Withdrawal by Subject|0|||
163075346|NCT02533674|588984629|FG006|Dose Level VIII|Withdrawal by Subject|0|||
163075347|NCT02533674|588984630|FG007|Dose Level VIII|Withdrawal by Subject|1|||
163075348|NCT02533674|588984623|FG000|Dose Level VIII|Treatment-related AE|0|||
163075349|NCT02533674|588984624|FG001|Dose Level VIII|Treatment-related AE|0|||
163075350|NCT02533674|588984625|FG002|Dose Level VIII|Treatment-related AE|0|||
163075351|NCT02533674|588984626|FG003|Dose Level VIII|Treatment-related AE|0|||
163075352|NCT02533674|588984627|FG004|Dose Level VIII|Treatment-related AE|0|||
163075353|NCT02533674|588984628|FG005|Dose Level VIII|Treatment-related AE|0|||
163075354|NCT02533674|588984629|FG006|Dose Level VIII|Treatment-related AE|0|||
163075355|NCT02533674|588984630|FG007|Dose Level VIII|Treatment-related AE|1|||
163075356|NCT02533674|588984623|FG000|Dose Level VIII|Never treated|0|||
163075357|NCT02533674|588984624|FG001|Dose Level VIII|Never treated|0|||
163075358|NCT02533674|588984625|FG002|Dose Level VIII|Never treated|0|||
163075359|NCT02533674|588984626|FG003|Dose Level VIII|Never treated|0|||
163075360|NCT02533674|588984627|FG004|Dose Level VIII|Never treated|0|||
163075361|NCT02533674|588984628|FG005|Dose Level VIII|Never treated|0|||
163075362|NCT02533674|588984629|FG006|Dose Level VIII|Never treated|0|||
163075363|NCT02533674|588984630|FG007|Dose Level VIII|Never treated|1|||
163075364|NCT01908699|588984638|FG000|Overall Study|Adverse Event|8|||
163075365|NCT01908699|588984639|FG001|Overall Study|Adverse Event|12|||
163075366|NCT01908699|588984638|FG000|Overall Study|Lack of Efficacy|2|||
163075367|NCT01908699|588984639|FG001|Overall Study|Lack of Efficacy|2|||
163075368|NCT01908699|588984638|FG000|Overall Study|Lost to Follow-up|2|||
163075369|NCT01908699|588984639|FG001|Overall Study|Lost to Follow-up|4|||
163075370|NCT01908699|588984638|FG000|Overall Study|Physician Decision|8|||
163075371|NCT01908699|588984639|FG001|Overall Study|Physician Decision|8|||
163075372|NCT01908699|588984638|FG000|Overall Study|Withdrawal by Subject|15|||
163075373|NCT01908699|588984639|FG001|Overall Study|Withdrawal by Subject|10|||
163075374|NCT01908699|588984638|FG000|Overall Study|Pregnancy|0|||
163075375|NCT01908699|588984639|FG001|Overall Study|Pregnancy|1|||
163075376|NCT01908699|588984638|FG000|Overall Study|Randomized in Error|1|||
163075377|NCT01908699|588984639|FG001|Overall Study|Randomized in Error|0|||
163075378|NCT01908699|588984638|FG000|Overall Study|Death|9|||
163075379|NCT01908699|588984639|FG001|Overall Study|Death|12|||
163075380|NCT01908699|588984638|FG000|Overall Study|Progressive Disease|30|||
163075381|NCT01908699|588984639|FG001|Overall Study|Progressive Disease|29|||
163075382|NCT01697501|588984640|FG000|Overall Study|Protocol Violation|2|||
163075383|NCT02242903|588984641|FG000|Overall Study|Withdrawal by Subject|1|||
163075384|NCT02242903|588984642|FG001|Overall Study|Withdrawal by Subject|0|||
163075385|NCT02242903|588984643|FG002|Overall Study|Withdrawal by Subject|0|||
162717873|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
163075386|NCT02242903|588984644|FG003|Overall Study|Withdrawal by Subject|0|||
163075387|NCT02242903|588984645|FG004|Overall Study|Withdrawal by Subject|0|||
163075388|NCT02242903|588984646|FG005|Overall Study|Withdrawal by Subject|0|||
163075389|NCT02242903|588984647|FG006|Overall Study|Withdrawal by Subject|0|||
163075390|NCT02105012|588984648|FG000|Overall Study|Withdrawal by Subject|11|||
163075391|NCT02105012|588984648|FG000|Overall Study|Protocol Specified Criteria|9|||
163075392|NCT02105012|588984648|FG000|Overall Study|Lost to Follow-up|4|||
163075393|NCT02105012|588984648|FG000|Overall Study|Protocol Violation|4|||
163075394|NCT02105012|588984648|FG000|Overall Study|Physician Decision|3|||
163075395|NCT02105012|588984648|FG000|Overall Study|Adverse Event|1|||
162717874|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
163075396|NCT02105012|588984648|FG000|Overall Study|Lack of Efficacy|1|||
162717875|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
163075397|NCT00493285|588984649|FG000|Overall Study|Lost to Follow-up|0|||
163075398|NCT00493285|588984650|FG001|Overall Study|Lost to Follow-up|0|||
163075399|NCT00493285|588984651|FG002|Overall Study|Lost to Follow-up|0|||
163075400|NCT00493285|588984652|FG003|Overall Study|Lost to Follow-up|0|||
163075401|NCT00493285|588984653|FG004|Overall Study|Lost to Follow-up|1|||
163075402|NCT00493285|588984654|FG005|Overall Study|Lost to Follow-up|0|||
163075403|NCT03021005|588984655|FG000|Overall Study|Lost to Follow-up|39|||
163075404|NCT03021005|588984656|FG001|Overall Study|Lost to Follow-up|26|||
163075405|NCT00779909|588984659|FG000|Overall Study|Lost to Follow-up|1|||
163075406|NCT00779909|588984660|FG001|Overall Study|Lost to Follow-up|0|||
163075407|NCT00779909|588984661|FG002|Overall Study|Lost to Follow-up|0|||
163075408|NCT00779909|588984662|FG003|Overall Study|Lost to Follow-up|1|||
163075409|NCT00779909|588984659|FG000|Overall Study|Withdrawal by Subject|0|||
163075410|NCT00779909|588984660|FG001|Overall Study|Withdrawal by Subject|1|||
163075411|NCT00779909|588984661|FG002|Overall Study|Withdrawal by Subject|0|||
163075412|NCT00779909|588984662|FG003|Overall Study|Withdrawal by Subject|0|||
163075413|NCT01174459|588984666|FG000|Overall Study|case report form (CRF) not collected|5|||
163075414|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
163075415|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
163075416|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
163075417|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
163075418|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
163075419|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
163075420|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
163075421|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
163075422|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
163075423|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
163075424|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
163028164|NCT01358578|588807211|FG001|Induction Period|technical problems|0|||
163028165|NCT01358578|588807212|FG002|Induction Period|technical problems|1|||
163028166|NCT01358578|588807213|FG003|Induction Period|technical problems|1|||
163028167|NCT01358578|588807214|FG004|Induction Period|technical problems|0|||
163028168|NCT01358578|588807215|FG005|Induction Period|technical problems|0|||
163028169|NCT01358578|588807210|FG000|Induction Period|Withdrawal by Subject|5|||
163028170|NCT01358578|588807211|FG001|Induction Period|Withdrawal by Subject|5|||
163028171|NCT01358578|588807212|FG002|Induction Period|Withdrawal by Subject|10|||
163028172|NCT01358578|588807213|FG003|Induction Period|Withdrawal by Subject|6|||
163028173|NCT01358578|588807214|FG004|Induction Period|Withdrawal by Subject|0|||
163028174|NCT01358578|588807215|FG005|Induction Period|Withdrawal by Subject|0|||
163028175|NCT01358578|588807210|FG000|Maintenance Period|Adverse Event|2|||
163028176|NCT01358578|588807211|FG001|Maintenance Period|Adverse Event|7|||
163028177|NCT01358578|588807212|FG002|Maintenance Period|Adverse Event|0|||
163028178|NCT01358578|588807213|FG003|Maintenance Period|Adverse Event|6|||
163028179|NCT01358578|588807214|FG004|Maintenance Period|Adverse Event|4|||
163028180|NCT01358578|588807215|FG005|Maintenance Period|Adverse Event|3|||
163028181|NCT01358578|588807210|FG000|Maintenance Period|Lack of Efficacy|10|||
163028182|NCT01358578|588807211|FG001|Maintenance Period|Lack of Efficacy|2|||
163028183|NCT01358578|588807212|FG002|Maintenance Period|Lack of Efficacy|0|||
163028184|NCT01358578|588807213|FG003|Maintenance Period|Lack of Efficacy|11|||
163028185|NCT01358578|588807214|FG004|Maintenance Period|Lack of Efficacy|3|||
163028186|NCT01358578|588807215|FG005|Maintenance Period|Lack of Efficacy|0|||
163028187|NCT01358578|588807210|FG000|Maintenance Period|Lost to Follow-up|4|||
163028188|NCT01358578|588807211|FG001|Maintenance Period|Lost to Follow-up|0|||
163028189|NCT01358578|588807212|FG002|Maintenance Period|Lost to Follow-up|0|||
163028190|NCT01358578|588807213|FG003|Maintenance Period|Lost to Follow-up|5|||
163028191|NCT01358578|588807214|FG004|Maintenance Period|Lost to Follow-up|1|||
163028192|NCT01358578|588807215|FG005|Maintenance Period|Lost to Follow-up|1|||
163028193|NCT01358578|588807210|FG000|Maintenance Period|Non-compliance with study treatment|3|||
163028194|NCT01358578|588807211|FG001|Maintenance Period|Non-compliance with study treatment|1|||
163028195|NCT01358578|588807212|FG002|Maintenance Period|Non-compliance with study treatment|0|||
163028196|NCT01358578|588807213|FG003|Maintenance Period|Non-compliance with study treatment|2|||
163028197|NCT01358578|588807214|FG004|Maintenance Period|Non-compliance with study treatment|1|||
163028198|NCT01358578|588807215|FG005|Maintenance Period|Non-compliance with study treatment|2|||
163028199|NCT01358578|588807210|FG000|Maintenance Period|Physician Decision|0|||
163028200|NCT01358578|588807211|FG001|Maintenance Period|Physician Decision|1|||
163028201|NCT01358578|588807212|FG002|Maintenance Period|Physician Decision|0|||
163028202|NCT01358578|588807213|FG003|Maintenance Period|Physician Decision|1|||
163028203|NCT01358578|588807214|FG004|Maintenance Period|Physician Decision|0|||
163028204|NCT01358578|588807215|FG005|Maintenance Period|Physician Decision|0|||
163028205|NCT01358578|588807210|FG000|Maintenance Period|Pregnancy|1|||
163028206|NCT01358578|588807211|FG001|Maintenance Period|Pregnancy|0|||
163028207|NCT01358578|588807212|FG002|Maintenance Period|Pregnancy|0|||
163028208|NCT01358578|588807213|FG003|Maintenance Period|Pregnancy|0|||
163028209|NCT01358578|588807214|FG004|Maintenance Period|Pregnancy|0|||
163075425|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
162644964|NCT00698581|587417701|FG000|Overall Study|AE, non-serious non-fatal|4|||
162644965|NCT00698581|587417702|FG001|Overall Study|AE, non-serious non-fatal|0|||
163028210|NCT01358578|588807215|FG005|Maintenance Period|Pregnancy|0|||
163028211|NCT01358578|588807210|FG000|Maintenance Period|Protocol deviation|7|||
163028212|NCT01358578|588807211|FG001|Maintenance Period|Protocol deviation|4|||
163028213|NCT01358578|588807212|FG002|Maintenance Period|Protocol deviation|0|||
163028214|NCT01358578|588807213|FG003|Maintenance Period|Protocol deviation|2|||
163028215|NCT01358578|588807214|FG004|Maintenance Period|Protocol deviation|2|||
163028216|NCT01358578|588807215|FG005|Maintenance Period|Protocol deviation|2|||
163028217|NCT01358578|588807210|FG000|Maintenance Period|Withdrawal by Subject|12|||
163028218|NCT01358578|588807211|FG001|Maintenance Period|Withdrawal by Subject|7|||
163028219|NCT01358578|588807212|FG002|Maintenance Period|Withdrawal by Subject|2|||
163028220|NCT01358578|588807213|FG003|Maintenance Period|Withdrawal by Subject|15|||
163028221|NCT01358578|588807214|FG004|Maintenance Period|Withdrawal by Subject|6|||
163028222|NCT01358578|588807215|FG005|Maintenance Period|Withdrawal by Subject|3|||
163028223|NCT01358578|588807210|FG000|Follow-up Period|Adverse Event|1|||
163028224|NCT01358578|588807211|FG001|Follow-up Period|Adverse Event|1|||
163028225|NCT01358578|588807212|FG002|Follow-up Period|Adverse Event|0|||
163028226|NCT01358578|588807213|FG003|Follow-up Period|Adverse Event|0|||
163028227|NCT01358578|588807214|FG004|Follow-up Period|Adverse Event|0|||
163028228|NCT01358578|588807215|FG005|Follow-up Period|Adverse Event|0|||
163028229|NCT01358578|588807210|FG000|Follow-up Period|Lack of Efficacy|3|||
163028230|NCT01358578|588807211|FG001|Follow-up Period|Lack of Efficacy|0|||
163028231|NCT01358578|588807212|FG002|Follow-up Period|Lack of Efficacy|4|||
163028232|NCT01358578|588807213|FG003|Follow-up Period|Lack of Efficacy|1|||
163028233|NCT01358578|588807214|FG004|Follow-up Period|Lack of Efficacy|0|||
163028234|NCT01358578|588807215|FG005|Follow-up Period|Lack of Efficacy|0|||
163028235|NCT01358578|588807210|FG000|Follow-up Period|Lost to Follow-up|0|||
163028236|NCT01358578|588807211|FG001|Follow-up Period|Lost to Follow-up|1|||
163028237|NCT01358578|588807212|FG002|Follow-up Period|Lost to Follow-up|0|||
163028238|NCT01358578|588807213|FG003|Follow-up Period|Lost to Follow-up|4|||
163028239|NCT01358578|588807214|FG004|Follow-up Period|Lost to Follow-up|0|||
163028240|NCT01358578|588807215|FG005|Follow-up Period|Lost to Follow-up|0|||
163028241|NCT01358578|588807210|FG000|Follow-up Period|non- compliance with study treatment|1|||
163028242|NCT01358578|588807211|FG001|Follow-up Period|non- compliance with study treatment|0|||
163028243|NCT01358578|588807212|FG002|Follow-up Period|non- compliance with study treatment|0|||
163028244|NCT01358578|588807213|FG003|Follow-up Period|non- compliance with study treatment|0|||
163028245|NCT01358578|588807214|FG004|Follow-up Period|non- compliance with study treatment|0|||
163028246|NCT01358578|588807215|FG005|Follow-up Period|non- compliance with study treatment|0|||
163028247|NCT01358578|588807210|FG000|Follow-up Period|Pregnancy|1|||
163028248|NCT01358578|588807211|FG001|Follow-up Period|Pregnancy|0|||
163028249|NCT01358578|588807212|FG002|Follow-up Period|Pregnancy|0|||
163028250|NCT01358578|588807213|FG003|Follow-up Period|Pregnancy|0|||
163028251|NCT01358578|588807214|FG004|Follow-up Period|Pregnancy|0|||
163028252|NCT01358578|588807215|FG005|Follow-up Period|Pregnancy|0|||
163028253|NCT01358578|588807210|FG000|Follow-up Period|Withdrawal by Subject|3|||
163028254|NCT01358578|588807211|FG001|Follow-up Period|Withdrawal by Subject|3|||
163028255|NCT01358578|588807212|FG002|Follow-up Period|Withdrawal by Subject|1|||
163028256|NCT01358578|588807213|FG003|Follow-up Period|Withdrawal by Subject|12|||
163028257|NCT01358578|588807214|FG004|Follow-up Period|Withdrawal by Subject|0|||
163028258|NCT01358578|588807215|FG005|Follow-up Period|Withdrawal by Subject|0|||
163028259|NCT01358578|588807210|FG000|Follow-up Period|Physician Decision|1|||
163028260|NCT01358578|588807211|FG001|Follow-up Period|Physician Decision|1|||
163028261|NCT01358578|588807212|FG002|Follow-up Period|Physician Decision|0|||
163028262|NCT01358578|588807213|FG003|Follow-up Period|Physician Decision|2|||
163028263|NCT01358578|588807214|FG004|Follow-up Period|Physician Decision|0|||
163028264|NCT01358578|588807215|FG005|Follow-up Period|Physician Decision|0|||
163028265|NCT01643798|588807216|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
163028266|NCT01643798|588807217|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
163028267|NCT03605849|588807218|FG000|Overall Study|Adverse Event|20|||
163028268|NCT03605849|588807219|FG001|Overall Study|Adverse Event|21|||
163028269|NCT03605849|588807220|FG002|Overall Study|Adverse Event|29|||
163028270|NCT03605849|588807221|FG003|Overall Study|Adverse Event|11|||
163028271|NCT03605849|588807218|FG000|Overall Study|Lack of Efficacy|4|||
163028272|NCT03605849|588807219|FG001|Overall Study|Lack of Efficacy|7|||
163028273|NCT03605849|588807220|FG002|Overall Study|Lack of Efficacy|9|||
163028274|NCT03605849|588807221|FG003|Overall Study|Lack of Efficacy|2|||
163028275|NCT03605849|588807218|FG000|Overall Study|Lost to Follow-up|8|||
163028276|NCT03605849|588807219|FG001|Overall Study|Lost to Follow-up|8|||
163028277|NCT03605849|588807220|FG002|Overall Study|Lost to Follow-up|14|||
163028278|NCT03605849|588807221|FG003|Overall Study|Lost to Follow-up|11|||
163028279|NCT03605849|588807218|FG000|Overall Study|Non-compliance With IMP|6|||
163028280|NCT03605849|588807219|FG001|Overall Study|Non-compliance With IMP|5|||
163028281|NCT03605849|588807220|FG002|Overall Study|Non-compliance With IMP|2|||
163028282|NCT03605849|588807221|FG003|Overall Study|Non-compliance With IMP|1|||
163028283|NCT03605849|588807218|FG000|Overall Study|Protocol Deviation|1|||
163075426|NCT00290758|588984667|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
163075427|NCT00290758|588984668|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
163075428|NCT00290758|588984667|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
163075429|NCT00290758|588984668|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
163075430|NCT01111292|588984670|FG000|Treatment|Physician Decision|1|||
163075431|NCT01111292|588984671|FG001|Treatment|Physician Decision|1|||
163075432|NCT00215553|588984672|FG000|Overall Study|Adverse Event|0|||
163075433|NCT00215553|588984673|FG001|Overall Study|Adverse Event|1|||
163075434|NCT00215553|588984674|FG002|Overall Study|Adverse Event|2|||
163075435|NCT00215553|588984675|FG003|Overall Study|Adverse Event|1|||
163075436|NCT00215553|588984676|FG004|Overall Study|Adverse Event|2|||
163075437|NCT00215553|588984677|FG005|Overall Study|Adverse Event|6|||
163075438|NCT00215553|588984678|FG006|Overall Study|Adverse Event|0|||
163075439|NCT03142334|588984679|FG000|Overall Study|Death|18|||
163075440|NCT03142334|588984680|FG001|Overall Study|Death|33|||
162644966|NCT00698581|587417701|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162644967|NCT00698581|587417702|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162644968|NCT00698581|587417701|FG000|Overall Study|AE of unknown type|1|||
162644969|NCT00698581|587417702|FG001|Overall Study|AE of unknown type|0|||
162644970|NCT03760146|587417703|FG000|Overall Study|Adverse Event|11|||
162644971|NCT03760146|587417704|FG001|Overall Study|Adverse Event|8|||
162644972|NCT03760146|587417705|FG002|Overall Study|Adverse Event|0|||
162644973|NCT03760146|587417706|FG003|Overall Study|Adverse Event|0|||
162644974|NCT03760146|587417707|FG004|Overall Study|Adverse Event|0|||
162644975|NCT03760146|587417708|FG005|Overall Study|Adverse Event|0|||
162644976|NCT03760146|587417703|FG000|Overall Study|Death|1|||
162644977|NCT03760146|587417704|FG001|Overall Study|Death|0|||
162644978|NCT03760146|587417705|FG002|Overall Study|Death|0|||
162644979|NCT03760146|587417706|FG003|Overall Study|Death|0|||
162644980|NCT03760146|587417707|FG004|Overall Study|Death|0|||
162644981|NCT03760146|587417708|FG005|Overall Study|Death|0|||
162644982|NCT03760146|587417703|FG000|Overall Study|Lost to Follow-up|41|||
162644983|NCT03760146|587417704|FG001|Overall Study|Lost to Follow-up|28|||
162644984|NCT03760146|587417705|FG002|Overall Study|Lost to Follow-up|9|||
162644985|NCT03760146|587417706|FG003|Overall Study|Lost to Follow-up|2|||
162644986|NCT03760146|587417707|FG004|Overall Study|Lost to Follow-up|14|||
162644987|NCT03760146|587417708|FG005|Overall Study|Lost to Follow-up|8|||
162644988|NCT03760146|587417703|FG000|Overall Study|No longer met eligibility criteria|3|||
162644989|NCT03760146|587417704|FG001|Overall Study|No longer met eligibility criteria|9|||
162644990|NCT03760146|587417705|FG002|Overall Study|No longer met eligibility criteria|0|||
162644991|NCT03760146|587417706|FG003|Overall Study|No longer met eligibility criteria|0|||
162644992|NCT03760146|587417707|FG004|Overall Study|No longer met eligibility criteria|1|||
162644993|NCT03760146|587417708|FG005|Overall Study|No longer met eligibility criteria|0|||
162644994|NCT03760146|587417703|FG000|Overall Study|Protocol Violation|21|||
162644995|NCT03760146|587417704|FG001|Overall Study|Protocol Violation|13|||
162644996|NCT03760146|587417705|FG002|Overall Study|Protocol Violation|1|||
162644997|NCT03760146|587417706|FG003|Overall Study|Protocol Violation|0|||
162644998|NCT03760146|587417707|FG004|Overall Study|Protocol Violation|1|||
162644999|NCT03760146|587417708|FG005|Overall Study|Protocol Violation|0|||
162645000|NCT03760146|587417703|FG000|Overall Study|Withdrawal by Subject|19|||
162645001|NCT03760146|587417704|FG001|Overall Study|Withdrawal by Subject|20|||
162645002|NCT03760146|587417705|FG002|Overall Study|Withdrawal by Subject|1|||
162645003|NCT03760146|587417706|FG003|Overall Study|Withdrawal by Subject|0|||
162645004|NCT03760146|587417707|FG004|Overall Study|Withdrawal by Subject|1|||
162645005|NCT03760146|587417708|FG005|Overall Study|Withdrawal by Subject|0|||
162645006|NCT00449644|587417709|FG000|Overall Study|Adverse Event|0|||
162645007|NCT00449644|587417710|FG001|Overall Study|Adverse Event|0|||
162645008|NCT00449644|587417711|FG002|Overall Study|Adverse Event|3|||
162645009|NCT00449644|587417712|FG003|Overall Study|Adverse Event|5|||
162645010|NCT00449644|587417709|FG000|Overall Study|Death|1|||
162645011|NCT00449644|587417710|FG001|Overall Study|Death|0|||
162645012|NCT00449644|587417711|FG002|Overall Study|Death|6|||
162645013|NCT00449644|587417712|FG003|Overall Study|Death|1|||
162645014|NCT00449644|587417709|FG000|Overall Study|Lost to Follow-up|1|||
162645015|NCT00449644|587417710|FG001|Overall Study|Lost to Follow-up|1|||
162645016|NCT00449644|587417711|FG002|Overall Study|Lost to Follow-up|5|||
162645017|NCT00449644|587417712|FG003|Overall Study|Lost to Follow-up|3|||
162645018|NCT00449644|587417709|FG000|Overall Study|Pregnancy|0|||
162645019|NCT00449644|587417710|FG001|Overall Study|Pregnancy|0|||
162645020|NCT00449644|587417711|FG002|Overall Study|Pregnancy|3|||
162645021|NCT00449644|587417712|FG003|Overall Study|Pregnancy|2|||
162645022|NCT00449644|587417709|FG000|Overall Study|Protocol Violation|4|||
162645023|NCT00449644|587417710|FG001|Overall Study|Protocol Violation|4|||
162645024|NCT00449644|587417711|FG002|Overall Study|Protocol Violation|3|||
162645025|NCT00449644|587417712|FG003|Overall Study|Protocol Violation|7|||
162645026|NCT00449644|587417709|FG000|Overall Study|Withdrawal by Subject|3|||
163075441|NCT03142334|588984679|FG000|Overall Study|Withdrawal by Subject|15|||
163075442|NCT03142334|588984680|FG001|Overall Study|Withdrawal by Subject|11|||
162645027|NCT00449644|587417710|FG001|Overall Study|Withdrawal by Subject|4|||
163075443|NCT03142334|588984679|FG000|Overall Study|Ongoing on trial follow up|463|||
163075444|NCT03142334|588984680|FG001|Overall Study|Ongoing on trial follow up|454|||
163075445|NCT01217047|588984681|FG000|Overall Study|Lost to Follow-up|0|||
163075446|NCT01217047|588984682|FG001|Overall Study|Lost to Follow-up|1|||
163075447|NCT01217047|588984683|FG002|Overall Study|Lost to Follow-up|0|||
163075448|NCT03835117|588984684|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
163075449|NCT03835117|588984685|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
163075450|NCT03225989|588984689|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
163075451|NCT03225989|588984690|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
163075452|NCT03225989|588984691|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
163075453|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
163075454|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
163075455|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
163075456|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
163075457|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
163075458|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
163075459|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
163075460|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
163075461|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
163075462|NCT03225989|588984689|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
163075463|NCT03225989|588984690|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
163075464|NCT03225989|588984691|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
163075465|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
163075466|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
163075467|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
163075468|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
163075469|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
163075470|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
163075471|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
163075472|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
163075473|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
163075474|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
163075475|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
163075476|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
163075477|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
163075478|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
163075479|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
163075480|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
163075481|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
163075482|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
163075483|NCT03225989|588984689|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
163075484|NCT03225989|588984690|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
163075485|NCT03225989|588984691|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
163075486|NCT03093870|588984695|FG000|Overall Study|Withdrawal by Subject|2|||
163075487|NCT03093870|588984696|FG001|Overall Study|Withdrawal by Subject|6|||
163075488|NCT03093870|588984697|FG002|Overall Study|Withdrawal by Subject|5|||
163075489|NCT03093870|588984695|FG000|Overall Study|Death|1|||
163075490|NCT03093870|588984696|FG001|Overall Study|Death|35|||
163075491|NCT03093870|588984697|FG002|Overall Study|Death|35|||
163075492|NCT03093870|588984695|FG000|Overall Study|Radiographic disease progression|10|||
163075493|NCT03093870|588984696|FG001|Overall Study|Radiographic disease progression|0|||
163075494|NCT03093870|588984697|FG002|Overall Study|Radiographic disease progression|0|||
163075495|NCT03093870|588984695|FG000|Overall Study|Clinical disease progression|1|||
163075496|NCT03093870|588984696|FG001|Overall Study|Clinical disease progression|0|||
163075497|NCT03093870|588984697|FG002|Overall Study|Clinical disease progression|0|||
163075498|NCT03093870|588984695|FG000|Overall Study|Physician Decision|2|||
163075499|NCT03093870|588984696|FG001|Overall Study|Physician Decision|0|||
163075500|NCT03093870|588984697|FG002|Overall Study|Physician Decision|0|||
163075501|NCT03093870|588984695|FG000|Overall Study|Adverse Event|7|||
163075502|NCT03093870|588984696|FG001|Overall Study|Adverse Event|0|||
163075503|NCT03093870|588984697|FG002|Overall Study|Adverse Event|0|||
163075504|NCT03093870|588984695|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
163075505|NCT03093870|588984696|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
163075506|NCT03093870|588984697|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
162645028|NCT00449644|587417711|FG002|Overall Study|Withdrawal by Subject|6|||
162645029|NCT00449644|587417712|FG003|Overall Study|Withdrawal by Subject|7|||
163075507|NCT03093870|588984695|FG000|Overall Study|Lost to Follow-up|0|||
163075508|NCT03093870|588984696|FG001|Overall Study|Lost to Follow-up|0|||
163075509|NCT03093870|588984697|FG002|Overall Study|Lost to Follow-up|1|||
163075510|NCT01530997|588984698|FG000|Overall Study|Physician Decision|1|||
163075511|NCT01530997|588984698|FG000|Overall Study|Withdrawal by Subject|1|||
163075512|NCT02318277|588984700|FG000|Overall Study|Physician Decision|0|||
163075513|NCT02318277|588984701|FG001|Overall Study|Physician Decision|0|||
163075514|NCT02318277|588984702|FG002|Overall Study|Physician Decision|0|||
163075515|NCT02318277|588984703|FG003|Overall Study|Physician Decision|0|||
163075516|NCT02318277|588984704|FG004|Overall Study|Physician Decision|0|||
163075517|NCT02318277|588984705|FG005|Overall Study|Physician Decision|0|||
163075518|NCT02318277|588984706|FG006|Overall Study|Physician Decision|0|||
163075519|NCT02318277|588984707|FG007|Overall Study|Physician Decision|1|||
163075520|NCT02318277|588984700|FG000|Overall Study|Other|0|||
163075521|NCT02318277|588984701|FG001|Overall Study|Other|0|||
163075522|NCT02318277|588984702|FG002|Overall Study|Other|0|||
163075523|NCT02318277|588984703|FG003|Overall Study|Other|0|||
163075524|NCT02318277|588984704|FG004|Overall Study|Other|0|||
163075525|NCT02318277|588984705|FG005|Overall Study|Other|0|||
163075526|NCT02318277|588984706|FG006|Overall Study|Other|1|||
163075527|NCT02318277|588984707|FG007|Overall Study|Other|0|||
163075528|NCT02318277|588984700|FG000|Overall Study|Withdrawal by Subject|0|||
163075529|NCT02318277|588984701|FG001|Overall Study|Withdrawal by Subject|0|||
163075530|NCT02318277|588984702|FG002|Overall Study|Withdrawal by Subject|1|||
163075531|NCT02318277|588984703|FG003|Overall Study|Withdrawal by Subject|0|||
163075532|NCT02318277|588984704|FG004|Overall Study|Withdrawal by Subject|1|||
163075533|NCT02318277|588984705|FG005|Overall Study|Withdrawal by Subject|1|||
163075534|NCT02318277|588984706|FG006|Overall Study|Withdrawal by Subject|6|||
163075535|NCT02318277|588984707|FG007|Overall Study|Withdrawal by Subject|14|||
163075536|NCT02318277|588984700|FG000|Overall Study|Participant trial terminated by sponsor|0|||
163075537|NCT02318277|588984701|FG001|Overall Study|Participant trial terminated by sponsor|0|||
163075538|NCT02318277|588984702|FG002|Overall Study|Participant trial terminated by sponsor|1|||
163075539|NCT02318277|588984703|FG003|Overall Study|Participant trial terminated by sponsor|0|||
163075540|NCT02318277|588984704|FG004|Overall Study|Participant trial terminated by sponsor|1|||
163075541|NCT02318277|588984705|FG005|Overall Study|Participant trial terminated by sponsor|2|||
163075542|NCT02318277|588984706|FG006|Overall Study|Participant trial terminated by sponsor|5|||
163075543|NCT02318277|588984707|FG007|Overall Study|Participant trial terminated by sponsor|16|||
163075544|NCT02318277|588984700|FG000|Overall Study|Lost to Follow-up|1|||
163075545|NCT02318277|588984701|FG001|Overall Study|Lost to Follow-up|0|||
163075546|NCT02318277|588984702|FG002|Overall Study|Lost to Follow-up|1|||
163075547|NCT02318277|588984703|FG003|Overall Study|Lost to Follow-up|0|||
163075548|NCT02318277|588984704|FG004|Overall Study|Lost to Follow-up|0|||
163075549|NCT02318277|588984705|FG005|Overall Study|Lost to Follow-up|0|||
162645030|NCT00449644|587417709|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
162645031|NCT00449644|587417710|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
162645032|NCT00449644|587417711|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
162645033|NCT00449644|587417712|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
162645034|NCT00449644|587417709|FG000|Overall Study|Other|1|||
162645035|NCT00449644|587417710|FG001|Overall Study|Other|4|||
162645036|NCT00449644|587417711|FG002|Overall Study|Other|1|||
162645037|NCT00449644|587417712|FG003|Overall Study|Other|0|||
162645038|NCT00449644|587417709|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
162645039|NCT00449644|587417710|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
162645040|NCT00449644|587417711|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
162645041|NCT00449644|587417712|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
162645042|NCT00529542|587417713|FG000|Overall Study|Withdrawal by Subject|1|||
162645043|NCT00529542|587417714|FG001|Overall Study|Withdrawal by Subject|0|||
162645044|NCT00529542|587417713|FG000|Overall Study|Lost to Follow-up|0|||
162645045|NCT00529542|587417714|FG001|Overall Study|Lost to Follow-up|1|||
162645046|NCT00445965|587417725|FG000|Overall Study|Adverse Event|2|||
163075550|NCT02318277|588984706|FG006|Overall Study|Lost to Follow-up|3|||
163075551|NCT02318277|588984707|FG007|Overall Study|Lost to Follow-up|4|||
162645047|NCT00445965|587417725|FG000|Overall Study|Physician Decision|1|||
162645048|NCT00445965|587417725|FG000|Overall Study|Enrolled but not treated|1|||
163075552|NCT02318277|588984700|FG000|Overall Study|Death|5|||
163075553|NCT02318277|588984701|FG001|Overall Study|Death|3|||
163075554|NCT02318277|588984702|FG002|Overall Study|Death|1|||
163075555|NCT02318277|588984703|FG003|Overall Study|Death|4|||
163075556|NCT02318277|588984704|FG004|Overall Study|Death|6|||
163075557|NCT02318277|588984705|FG005|Overall Study|Death|5|||
163075558|NCT02318277|588984706|FG006|Overall Study|Death|34|||
163075559|NCT02318277|588984707|FG007|Overall Study|Death|58|||
163075560|NCT02318277|588984700|FG000|Overall Study|Transitioned to Hospice|0|||
163075561|NCT02318277|588984701|FG001|Overall Study|Transitioned to Hospice|0|||
163075562|NCT02318277|588984702|FG002|Overall Study|Transitioned to Hospice|0|||
163075563|NCT02318277|588984703|FG003|Overall Study|Transitioned to Hospice|0|||
163075564|NCT02318277|588984704|FG004|Overall Study|Transitioned to Hospice|0|||
163075565|NCT02318277|588984705|FG005|Overall Study|Transitioned to Hospice|1|||
163075566|NCT02318277|588984706|FG006|Overall Study|Transitioned to Hospice|0|||
163075567|NCT02318277|588984707|FG007|Overall Study|Transitioned to Hospice|0|||
163075568|NCT02006654|588984708|FG000|Overall Study|Withdrawal before treatment|4|||
163075569|NCT02006654|588984709|FG001|Overall Study|Withdrawal before treatment|2|||
163075570|NCT02006654|588984708|FG000|Overall Study|Adverse Event|16|||
163075571|NCT02006654|588984709|FG001|Overall Study|Adverse Event|17|||
163075572|NCT02006654|588984708|FG000|Overall Study|Death|1|||
163075573|NCT02006654|588984709|FG001|Overall Study|Death|0|||
163075574|NCT02006654|588984708|FG000|Overall Study|Withdrawal by Subject|14|||
163075575|NCT02006654|588984709|FG001|Overall Study|Withdrawal by Subject|12|||
163075576|NCT02006654|588984708|FG000|Overall Study|Protocol Violation|5|||
163075577|NCT02006654|588984709|FG001|Overall Study|Protocol Violation|8|||
163075578|NCT02006654|588984708|FG000|Overall Study|Lost to Follow-up|1|||
163075579|NCT02006654|588984709|FG001|Overall Study|Lost to Follow-up|0|||
163075580|NCT02006654|588984708|FG000|Overall Study|patient's will|2|||
163075581|NCT02006654|588984709|FG001|Overall Study|patient's will|1|||
163075582|NCT02006654|588984708|FG000|Overall Study|insufficient compliance|1|||
163075583|NCT02006654|588984709|FG001|Overall Study|insufficient compliance|0|||
163075584|NCT02006654|588984708|FG000|Overall Study|worsening cognitive condition|0|||
163075585|NCT02006654|588984709|FG001|Overall Study|worsening cognitive condition|1|||
163075586|NCT02006654|588984708|FG000|Overall Study|faecal incontinence|0|||
163075587|NCT02006654|588984709|FG001|Overall Study|faecal incontinence|1|||
163075588|NCT02006654|588984708|FG000|Overall Study|mood disorder|0|||
163075589|NCT02006654|588984709|FG001|Overall Study|mood disorder|1|||
163075590|NCT02006654|588984708|FG000|Overall Study|disallowed medication|1|||
163075591|NCT02006654|588984709|FG001|Overall Study|disallowed medication|0|||
163075592|NCT02006654|588984708|FG000|Overall Study|moving out of state|0|||
163075593|NCT02006654|588984709|FG001|Overall Study|moving out of state|1|||
163075594|NCT04193527|588984710|FG000|Overall Study|Other|1|||
163075595|NCT04193527|588984711|FG001|Overall Study|Other|1|||
163075596|NCT04193527|588984712|FG002|Overall Study|Other|0|||
163075597|NCT03808909|588984713|FG000|Overall Study|Lost to Follow-up|3|||
163075598|NCT03808909|588984714|FG001|Overall Study|Lost to Follow-up|0|||
163075599|NCT00676689|588984717|FG000|Overall Study|Screen Failure|2|||
163075600|NCT00676689|588984717|FG000|Overall Study|Death|2|||
163075601|NCT00676689|588984717|FG000|Overall Study|Lost to Follow-up|4|||
163075602|NCT00676689|588984717|FG000|Overall Study|Physician Decision|1|||
163075603|NCT00676689|588984717|FG000|Overall Study|Withdrawal by Subject|3|||
163075604|NCT00676689|588984717|FG000|Overall Study|Continuing FU|49|||
163075605|NCT01827943|588984718|FG000|Overall Study|Protocol Violation|8|||
163075606|NCT01827943|588984718|FG000|Overall Study|Never treated because of an rapid progression|1|||
163075607|NCT00501085|588984719|FG000|Overall Study|Lost to Follow-up|195|||
163075608|NCT00501085|588984719|FG000|Overall Study|Withdrawal by Subject|34|||
163075609|NCT00501085|588984719|FG000|Overall Study|Subject Decision|1|||
163075610|NCT00501085|588984719|FG000|Overall Study|Revision Surgery|7|||
163075611|NCT00501085|588984719|FG000|Overall Study|Explantation Surgery|26|||
163075612|NCT00501085|588984719|FG000|Overall Study|Adverse Event|4|||
163075613|NCT00501085|588984719|FG000|Overall Study|Non-Compliance|24|||
163075614|NCT00501085|588984719|FG000|Overall Study|Study closed by sponsor|109|||
163075615|NCT00501085|588984719|FG000|Overall Study|Other loss to follow-up|32|||
163075616|NCT01487161|588984720|FG000|Overall Study|Adverse Event|1|||
163075617|NCT01487161|588984721|FG001|Overall Study|Adverse Event|0|||
163075618|NCT01487161|588984722|FG002|Overall Study|Adverse Event|0|||
163075619|NCT01487161|588984723|FG003|Overall Study|Adverse Event|0|||
163075620|NCT01487161|588984720|FG000|Overall Study|Withdrawal by Subject|1|||
163075621|NCT01487161|588984721|FG001|Overall Study|Withdrawal by Subject|1|||
163075622|NCT01487161|588984722|FG002|Overall Study|Withdrawal by Subject|1|||
163075623|NCT01487161|588984723|FG003|Overall Study|Withdrawal by Subject|2|||
163075624|NCT01487161|588984720|FG000|Overall Study|missing data|0|||
163075625|NCT01487161|588984721|FG001|Overall Study|missing data|1|||
163075626|NCT01487161|588984722|FG002|Overall Study|missing data|0|||
163075627|NCT01487161|588984723|FG003|Overall Study|missing data|0|||
163075628|NCT01084135|588984724|FG000|20 Week|Physician Decision|0|||
163075629|NCT01084135|588984725|FG001|20 Week|Physician Decision|1|||
163075630|NCT00663351|588984726|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
163075631|NCT00663351|588984727|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
163075632|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
163075633|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
163075634|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
163075635|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
163075636|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
163075637|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
163075638|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
163075639|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
163075640|NCT00663351|588984726|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
163075641|NCT00663351|588984727|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
163075642|NCT02366130|588984728|FG000|Overall Study|Withdrawal by Subject|3|||
163075643|NCT02366130|588984728|FG000|Overall Study|Ineligible|6|||
163075644|NCT01608308|588984729|FG000|Overall Study|pretreatment medical and billing reasons|0|||
163075645|NCT01608308|588984730|FG001|Overall Study|pretreatment medical and billing reasons|2|||
163075646|NCT03113136|588984731|FG000|Overall Study|Lost to Follow-up|22|||
163075647|NCT03113136|588984732|FG001|Overall Study|Lost to Follow-up|47|||
163075648|NCT03113136|588984733|FG002|Overall Study|Lost to Follow-up|54|||
163075649|NCT03113136|588984731|FG000|Overall Study|Withdrawal by Subject|4|||
163075650|NCT03113136|588984732|FG001|Overall Study|Withdrawal by Subject|13|||
163075651|NCT03113136|588984733|FG002|Overall Study|Withdrawal by Subject|14|||
163075652|NCT03113136|588984731|FG000|Overall Study|Ineligible|0|||
163075653|NCT03113136|588984732|FG001|Overall Study|Ineligible|2|||
163075654|NCT03113136|588984733|FG002|Overall Study|Ineligible|1|||
163075655|NCT03113136|588984731|FG000|Overall Study|Study Team Decision|1|||
163075656|NCT03113136|588984732|FG001|Overall Study|Study Team Decision|4|||
163075657|NCT03113136|588984733|FG002|Overall Study|Study Team Decision|0|||
163075658|NCT02675452|588984740|FG000|Overall Study|Sponsor decision|0|||
163075659|NCT02675452|588984741|FG001|Overall Study|Sponsor decision|0|||
163075660|NCT02675452|588984742|FG002|Overall Study|Sponsor decision|0|||
163075661|NCT02675452|588984743|FG003|Overall Study|Sponsor decision|0|||
163075662|NCT02675452|588984744|FG004|Overall Study|Sponsor decision|0|||
163075663|NCT02675452|588984745|FG005|Overall Study|Sponsor decision|0|||
162645049|NCT00445965|587417725|FG000|Overall Study|Removed due to progressive disease|29|||
162645050|NCT05778786|587417726|FG000|Period 1|COVID-19 Related|3|||
162645051|NCT05778786|587417727|FG001|Period 1|COVID-19 Related|3|||
163028284|NCT03605849|588807219|FG001|Overall Study|Protocol Deviation|2|||
163028285|NCT03605849|588807220|FG002|Overall Study|Protocol Deviation|1|||
163028286|NCT03605849|588807221|FG003|Overall Study|Protocol Deviation|3|||
163028287|NCT03605849|588807218|FG000|Overall Study|Withdrawal by Subject|33|||
163028288|NCT03605849|588807219|FG001|Overall Study|Withdrawal by Subject|28|||
163028289|NCT03605849|588807220|FG002|Overall Study|Withdrawal by Subject|30|||
163028290|NCT03605849|588807221|FG003|Overall Study|Withdrawal by Subject|28|||
163028291|NCT03605849|588807218|FG000|Overall Study|Site Terminated by Sponsor|0|||
163028292|NCT03605849|588807219|FG001|Overall Study|Site Terminated by Sponsor|0|||
163028293|NCT03605849|588807220|FG002|Overall Study|Site Terminated by Sponsor|0|||
163028294|NCT03605849|588807221|FG003|Overall Study|Site Terminated by Sponsor|1|||
163028295|NCT03605849|588807218|FG000|Overall Study|Physician Decision|2|||
163028296|NCT03605849|588807219|FG001|Overall Study|Physician Decision|1|||
163028297|NCT03605849|588807220|FG002|Overall Study|Physician Decision|2|||
163028298|NCT03605849|588807221|FG003|Overall Study|Physician Decision|1|||
163028299|NCT03605849|588807218|FG000|Overall Study|Enrolled, but not Treated|2|||
163028300|NCT03605849|588807219|FG001|Overall Study|Enrolled, but not Treated|2|||
163028301|NCT03605849|588807220|FG002|Overall Study|Enrolled, but not Treated|3|||
163028302|NCT03605849|588807221|FG003|Overall Study|Enrolled, but not Treated|2|||
163028303|NCT03605849|588807218|FG000|Overall Study|Other (COVID-19 Related)|0|||
163028304|NCT03605849|588807219|FG001|Overall Study|Other (COVID-19 Related)|1|||
163028305|NCT03605849|588807220|FG002|Overall Study|Other (COVID-19 Related)|1|||
163028306|NCT03605849|588807221|FG003|Overall Study|Other (COVID-19 Related)|0|||
163028307|NCT03605849|588807218|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
163028308|NCT03605849|588807219|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
163028309|NCT03605849|588807220|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
163028310|NCT03605849|588807221|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
163028311|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
163028312|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
163028313|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
163028314|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
163028315|NCT01911780|588807222|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
163028316|NCT01911780|588807223|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
163028317|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
163028318|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
163028319|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
163028320|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
163028321|NCT01911780|588807222|FG000|Extension Period (52 Weeks)|Personal reason|1|||
163028322|NCT01911780|588807223|FG001|Extension Period (52 Weeks)|Personal reason|1|||
163028323|NCT06303167|588807230|FG000|Overall Study|Ineligible|1|||
163028324|NCT06303167|588807230|FG000|Overall Study|Never start protocol therapy|2|||
163028325|NCT06303167|588807230|FG000|Overall Study|Disease progression|16|||
163028326|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Death|117|||
163028327|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Death|197|||
163028328|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
163075664|NCT02675452|588984746|FG006|Overall Study|Sponsor decision|0|||
163075665|NCT02675452|588984747|FG007|Overall Study|Sponsor decision|0|||
163075666|NCT02675452|588984748|FG008|Overall Study|Sponsor decision|0|||
163075667|NCT02675452|588984749|FG009|Overall Study|Sponsor decision|1|||
163075668|NCT02675452|588984750|FG010|Overall Study|Sponsor decision|0|||
163075669|NCT02675452|588984751|FG011|Overall Study|Sponsor decision|0|||
163075670|NCT02675452|588984752|FG012|Overall Study|Sponsor decision|0|||
163075671|NCT02675452|588984753|FG013|Overall Study|Sponsor decision|2|||
163075672|NCT02675452|588984754|FG014|Overall Study|Sponsor decision|1|||
163075673|NCT02675452|588984755|FG015|Overall Study|Sponsor decision|0|||
163075674|NCT02675452|588984756|FG016|Overall Study|Sponsor decision|1|||
163075675|NCT02675452|588984757|FG017|Overall Study|Sponsor decision|0|||
163075676|NCT02675452|588984758|FG018|Overall Study|Sponsor decision|0|||
163075677|NCT02675452|588984759|FG019|Overall Study|Sponsor decision|0|||
163075678|NCT02675452|588984760|FG020|Overall Study|Sponsor decision|0|||
163075679|NCT02675452|588984761|FG021|Overall Study|Sponsor decision|0|||
163075680|NCT02675452|588984762|FG022|Overall Study|Sponsor decision|0|||
163075681|NCT02675452|588984763|FG023|Overall Study|Sponsor decision|0|||
163075682|NCT02675452|588984764|FG024|Overall Study|Sponsor decision|0|||
163075683|NCT02675452|588984765|FG025|Overall Study|Sponsor decision|0|||
163075684|NCT02675452|588984766|FG026|Overall Study|Sponsor decision|2|||
163075685|NCT02675452|588984767|FG027|Overall Study|Sponsor decision|0|||
163075686|NCT02675452|588984768|FG028|Overall Study|Sponsor decision|0|||
163075687|NCT02675452|588984740|FG000|Overall Study|Withdrawal by Subject|0|||
163075688|NCT02675452|588984741|FG001|Overall Study|Withdrawal by Subject|0|||
163075689|NCT02675452|588984742|FG002|Overall Study|Withdrawal by Subject|0|||
163075690|NCT02675452|588984743|FG003|Overall Study|Withdrawal by Subject|0|||
163075691|NCT02675452|588984744|FG004|Overall Study|Withdrawal by Subject|0|||
163075692|NCT02675452|588984745|FG005|Overall Study|Withdrawal by Subject|0|||
163075693|NCT02675452|588984746|FG006|Overall Study|Withdrawal by Subject|0|||
163075694|NCT02675452|588984747|FG007|Overall Study|Withdrawal by Subject|0|||
163075695|NCT02675452|588984748|FG008|Overall Study|Withdrawal by Subject|0|||
163075696|NCT02675452|588984749|FG009|Overall Study|Withdrawal by Subject|1|||
163075697|NCT02675452|588984750|FG010|Overall Study|Withdrawal by Subject|0|||
163075698|NCT02675452|588984751|FG011|Overall Study|Withdrawal by Subject|1|||
163075699|NCT02675452|588984752|FG012|Overall Study|Withdrawal by Subject|0|||
163075700|NCT02675452|588984753|FG013|Overall Study|Withdrawal by Subject|1|||
163075701|NCT02675452|588984754|FG014|Overall Study|Withdrawal by Subject|1|||
163075702|NCT02675452|588984755|FG015|Overall Study|Withdrawal by Subject|0|||
163075703|NCT02675452|588984756|FG016|Overall Study|Withdrawal by Subject|2|||
163075704|NCT02675452|588984757|FG017|Overall Study|Withdrawal by Subject|0|||
163075705|NCT02675452|588984758|FG018|Overall Study|Withdrawal by Subject|0|||
163075706|NCT02675452|588984759|FG019|Overall Study|Withdrawal by Subject|0|||
163075707|NCT02675452|588984760|FG020|Overall Study|Withdrawal by Subject|0|||
163075708|NCT02675452|588984761|FG021|Overall Study|Withdrawal by Subject|0|||
163075709|NCT02675452|588984762|FG022|Overall Study|Withdrawal by Subject|3|||
163075710|NCT02675452|588984763|FG023|Overall Study|Withdrawal by Subject|0|||
163075711|NCT02675452|588984764|FG024|Overall Study|Withdrawal by Subject|1|||
163075712|NCT02675452|588984765|FG025|Overall Study|Withdrawal by Subject|0|||
163075713|NCT02675452|588984766|FG026|Overall Study|Withdrawal by Subject|1|||
163075714|NCT02675452|588984767|FG027|Overall Study|Withdrawal by Subject|3|||
163075715|NCT02675452|588984768|FG028|Overall Study|Withdrawal by Subject|4|||
163075716|NCT02675452|588984740|FG000|Overall Study|Death|0|||
163075717|NCT02675452|588984741|FG001|Overall Study|Death|0|||
163075718|NCT02675452|588984742|FG002|Overall Study|Death|1|||
163075719|NCT02675452|588984743|FG003|Overall Study|Death|0|||
163075720|NCT02675452|588984744|FG004|Overall Study|Death|0|||
163075721|NCT02675452|588984745|FG005|Overall Study|Death|1|||
163075722|NCT02675452|588984746|FG006|Overall Study|Death|0|||
163075723|NCT02675452|588984747|FG007|Overall Study|Death|0|||
163075724|NCT02675452|588984748|FG008|Overall Study|Death|1|||
163075725|NCT02675452|588984749|FG009|Overall Study|Death|0|||
163075726|NCT02675452|588984750|FG010|Overall Study|Death|0|||
163075727|NCT02675452|588984751|FG011|Overall Study|Death|0|||
163075728|NCT02675452|588984752|FG012|Overall Study|Death|1|||
163075729|NCT02675452|588984753|FG013|Overall Study|Death|0|||
163075730|NCT02675452|588984754|FG014|Overall Study|Death|0|||
163075731|NCT02675452|588984755|FG015|Overall Study|Death|2|||
163075732|NCT02675452|588984756|FG016|Overall Study|Death|0|||
163075733|NCT02675452|588984757|FG017|Overall Study|Death|0|||
163075734|NCT02675452|588984758|FG018|Overall Study|Death|4|||
163075735|NCT02675452|588984759|FG019|Overall Study|Death|3|||
163075736|NCT02675452|588984760|FG020|Overall Study|Death|3|||
163075737|NCT02675452|588984761|FG021|Overall Study|Death|3|||
163075738|NCT02675452|588984762|FG022|Overall Study|Death|7|||
163075739|NCT02675452|588984763|FG023|Overall Study|Death|5|||
163075740|NCT02675452|588984764|FG024|Overall Study|Death|3|||
163075741|NCT02675452|588984765|FG025|Overall Study|Death|4|||
163075742|NCT02675452|588984766|FG026|Overall Study|Death|7|||
163075743|NCT02675452|588984767|FG027|Overall Study|Death|6|||
163075744|NCT02675452|588984768|FG028|Overall Study|Death|9|||
163075745|NCT02675452|588984740|FG000|Overall Study|Lost to Follow-up|0|||
163075746|NCT02675452|588984741|FG001|Overall Study|Lost to Follow-up|1|||
163075747|NCT02675452|588984742|FG002|Overall Study|Lost to Follow-up|0|||
163075748|NCT02675452|588984743|FG003|Overall Study|Lost to Follow-up|0|||
163075749|NCT02675452|588984744|FG004|Overall Study|Lost to Follow-up|0|||
163075750|NCT02675452|588984745|FG005|Overall Study|Lost to Follow-up|0|||
163075751|NCT02675452|588984746|FG006|Overall Study|Lost to Follow-up|0|||
163075752|NCT02675452|588984747|FG007|Overall Study|Lost to Follow-up|0|||
163075753|NCT02675452|588984748|FG008|Overall Study|Lost to Follow-up|0|||
163075754|NCT02675452|588984749|FG009|Overall Study|Lost to Follow-up|0|||
163075755|NCT02675452|588984750|FG010|Overall Study|Lost to Follow-up|0|||
163075756|NCT02675452|588984751|FG011|Overall Study|Lost to Follow-up|0|||
163075757|NCT02675452|588984752|FG012|Overall Study|Lost to Follow-up|1|||
163075758|NCT02675452|588984753|FG013|Overall Study|Lost to Follow-up|0|||
163075759|NCT02675452|588984754|FG014|Overall Study|Lost to Follow-up|0|||
163075760|NCT02675452|588984755|FG015|Overall Study|Lost to Follow-up|0|||
163075761|NCT02675452|588984756|FG016|Overall Study|Lost to Follow-up|0|||
163075762|NCT02675452|588984757|FG017|Overall Study|Lost to Follow-up|0|||
163075763|NCT02675452|588984758|FG018|Overall Study|Lost to Follow-up|0|||
163075764|NCT02675452|588984759|FG019|Overall Study|Lost to Follow-up|0|||
163075765|NCT02675452|588984760|FG020|Overall Study|Lost to Follow-up|0|||
163075766|NCT02675452|588984761|FG021|Overall Study|Lost to Follow-up|0|||
163075767|NCT02675452|588984762|FG022|Overall Study|Lost to Follow-up|0|||
162645052|NCT05778786|587417726|FG000|Period 1|Withdrew Consent during Study|1|||
162645053|NCT05778786|587417727|FG001|Period 1|Withdrew Consent during Study|0|||
162645054|NCT05778786|587417726|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
162645055|NCT05778786|587417727|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
162645056|NCT05778786|587417726|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
162645057|NCT05778786|587417727|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
162645058|NCT02075658|587417728|FG000|Overall Study|Physician Decision|2|||
162645059|NCT02075658|587417729|FG001|Overall Study|Physician Decision|2|||
162645060|NCT02406651|587417731|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
162645061|NCT00718328|587417736|FG000|Overall Study|Lost to Follow-up|1|||
162645062|NCT00718328|587417737|FG001|Overall Study|Lost to Follow-up|0|||
162645063|NCT00663052|587417738|FG000|Overall Study|Adverse Event|6|||
162645064|NCT00663052|587417739|FG001|Overall Study|Adverse Event|3|||
162645065|NCT00663052|587417738|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
162645066|NCT00663052|587417739|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162645067|NCT00663052|587417738|FG000|Overall Study|Protocol Violation|1|||
162645068|NCT00663052|587417739|FG001|Overall Study|Protocol Violation|0|||
162645069|NCT00663052|587417738|FG000|Overall Study|Withdrawal by Subject|2|||
162645070|NCT00663052|587417739|FG001|Overall Study|Withdrawal by Subject|5|||
162645071|NCT00663052|587417738|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
162645072|NCT00663052|587417739|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
162645073|NCT00663052|587417738|FG000|Overall Study|Other|0|||
162645074|NCT00663052|587417739|FG001|Overall Study|Other|1|||
162645075|NCT02946047|587417741|FG000|Overall Study|Adverse Event|1|||
162645076|NCT02946047|587417742|FG001|Overall Study|Adverse Event|0|||
162645077|NCT02946047|587417743|FG002|Overall Study|Adverse Event|0|||
162645078|NCT02946047|587417744|FG003|Overall Study|Adverse Event|0|||
162645079|NCT03615105|587417745|FG000|Overall Study|Protocol Violation|1|||
162645080|NCT03615105|587417746|FG001|Overall Study|Protocol Violation|0|||
162645081|NCT03615105|587417747|FG002|Overall Study|Protocol Violation|0|||
162645082|NCT03615105|587417745|FG000|Overall Study|Death|0|||
162645083|NCT03615105|587417746|FG001|Overall Study|Death|2|||
162645084|NCT03615105|587417747|FG002|Overall Study|Death|0|||
162645085|NCT05041322|587417748|FG000|Baseline|Withdrawal by Subject|1|||
162645086|NCT05041322|587417749|FG001|Baseline|Withdrawal by Subject|0|||
162645087|NCT05041322|587417748|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
162645088|NCT05041322|587417749|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
162645089|NCT05041322|587417748|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
162645090|NCT05041322|587417749|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
162645091|NCT01252940|587417750|FG000|Main Study Phase|Randomized but not treated|4|||
162645092|NCT01252940|587417751|FG001|Main Study Phase|Randomized but not treated|2|||
162645093|NCT01252940|587417750|FG000|Main Study Phase|Adverse Event|3|||
163075768|NCT02675452|588984763|FG023|Overall Study|Lost to Follow-up|0|||
163075769|NCT02675452|588984764|FG024|Overall Study|Lost to Follow-up|0|||
163075770|NCT02675452|588984765|FG025|Overall Study|Lost to Follow-up|0|||
163075771|NCT02675452|588984766|FG026|Overall Study|Lost to Follow-up|1|||
162645094|NCT01252940|587417751|FG001|Main Study Phase|Adverse Event|1|||
162645095|NCT01252940|587417750|FG000|Main Study Phase|Lack of Efficacy|1|||
162645096|NCT01252940|587417751|FG001|Main Study Phase|Lack of Efficacy|0|||
163075772|NCT02675452|588984767|FG027|Overall Study|Lost to Follow-up|0|||
163075773|NCT02675452|588984768|FG028|Overall Study|Lost to Follow-up|0|||
163075774|NCT02675452|588984740|FG000|Overall Study|Other|0|||
163075775|NCT02675452|588984741|FG001|Overall Study|Other|0|||
163075776|NCT02675452|588984742|FG002|Overall Study|Other|0|||
163075777|NCT02675452|588984743|FG003|Overall Study|Other|0|||
163075778|NCT02675452|588984744|FG004|Overall Study|Other|0|||
163075779|NCT02675452|588984745|FG005|Overall Study|Other|0|||
163075780|NCT02675452|588984746|FG006|Overall Study|Other|0|||
163075781|NCT02675452|588984747|FG007|Overall Study|Other|0|||
163075782|NCT02675452|588984748|FG008|Overall Study|Other|0|||
163075783|NCT02675452|588984749|FG009|Overall Study|Other|0|||
163075784|NCT02675452|588984750|FG010|Overall Study|Other|0|||
163075785|NCT02675452|588984751|FG011|Overall Study|Other|0|||
163075786|NCT02675452|588984752|FG012|Overall Study|Other|0|||
163075787|NCT02675452|588984753|FG013|Overall Study|Other|0|||
163075788|NCT02675452|588984754|FG014|Overall Study|Other|0|||
163075789|NCT02675452|588984755|FG015|Overall Study|Other|0|||
163075790|NCT02675452|588984756|FG016|Overall Study|Other|0|||
163075791|NCT02675452|588984757|FG017|Overall Study|Other|0|||
163075792|NCT02675452|588984758|FG018|Overall Study|Other|0|||
163075793|NCT02675452|588984759|FG019|Overall Study|Other|0|||
163075794|NCT02675452|588984760|FG020|Overall Study|Other|0|||
163075795|NCT02675452|588984761|FG021|Overall Study|Other|0|||
163075796|NCT02675452|588984762|FG022|Overall Study|Other|0|||
163075797|NCT02675452|588984763|FG023|Overall Study|Other|0|||
163075798|NCT02675452|588984764|FG024|Overall Study|Other|0|||
163075799|NCT02675452|588984765|FG025|Overall Study|Other|0|||
163075800|NCT02675452|588984766|FG026|Overall Study|Other|1|||
163075801|NCT02675452|588984767|FG027|Overall Study|Other|0|||
163075802|NCT02675452|588984768|FG028|Overall Study|Other|0|||
163075803|NCT00977561|588984769|FG000|Overall Study|Death|3|||
163075804|NCT00977561|588984770|FG001|Overall Study|Death|2|||
163075805|NCT00977561|588984769|FG000|Overall Study|Study terminated|0|||
163075806|NCT00977561|588984770|FG001|Overall Study|Study terminated|2|||
163075807|NCT00977561|588984769|FG000|Overall Study|Other|2|||
163075808|NCT00977561|588984770|FG001|Overall Study|Other|0|||
162645097|NCT01252940|587417750|FG000|Main Study Phase|Lost to Follow-up|6|||
162645098|NCT01252940|587417751|FG001|Main Study Phase|Lost to Follow-up|1|||
162645099|NCT01252940|587417750|FG000|Main Study Phase|Physician Decision|1|||
162645100|NCT01252940|587417751|FG001|Main Study Phase|Physician Decision|0|||
162645101|NCT01252940|587417750|FG000|Main Study Phase|Protocol Violation|4|||
162645102|NCT01252940|587417751|FG001|Main Study Phase|Protocol Violation|2|||
162645103|NCT01252940|587417750|FG000|Main Study Phase|Withdrawal by Subject|6|||
162645104|NCT01252940|587417751|FG001|Main Study Phase|Withdrawal by Subject|5|||
162645105|NCT01252940|587417750|FG000|Main Study Phase|Subject Non-compliance|1|||
162645106|NCT01252940|587417751|FG001|Main Study Phase|Subject Non-compliance|1|||
162645107|NCT01252940|587417750|FG000|Extension Phase|Adverse Event|2|||
162645108|NCT01252940|587417751|FG001|Extension Phase|Adverse Event|1|||
162645109|NCT01252940|587417750|FG000|Extension Phase|Lack of Efficacy|1|||
162645110|NCT01252940|587417751|FG001|Extension Phase|Lack of Efficacy|0|||
162645111|NCT01252940|587417750|FG000|Extension Phase|Lost to Follow-up|5|||
162645112|NCT01252940|587417751|FG001|Extension Phase|Lost to Follow-up|0|||
162645113|NCT01252940|587417750|FG000|Extension Phase|Physician Decision|0|||
162645114|NCT01252940|587417751|FG001|Extension Phase|Physician Decision|1|||
162645115|NCT01252940|587417750|FG000|Extension Phase|Subject Non-compliance|1|||
162645116|NCT01252940|587417751|FG001|Extension Phase|Subject Non-compliance|0|||
162645117|NCT01252940|587417750|FG000|Extension Phase|Withdrawal by Subject|1|||
162645118|NCT01252940|587417751|FG001|Extension Phase|Withdrawal by Subject|1|||
162645119|NCT01502423|587417752|FG000|Overall Study|Withdrawal by Subject|0|||
163075809|NCT04595370|588984771|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
163075810|NCT04595370|588984772|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075811|NCT04595370|588984773|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075812|NCT04595370|588984774|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075813|NCT04595370|588984775|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075814|NCT04595370|588984776|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
163075815|NCT04595370|588984771|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075816|NCT04595370|588984772|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075817|NCT04595370|588984773|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
163075818|NCT04595370|588984774|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075819|NCT04595370|588984775|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075820|NCT04595370|588984776|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
163075821|NCT04595370|588984771|FG000|Overall Study|Adverse Event|0|||
163075822|NCT04595370|588984772|FG001|Overall Study|Adverse Event|4|||
163075823|NCT04595370|588984773|FG002|Overall Study|Adverse Event|3|||
163075824|NCT04595370|588984774|FG003|Overall Study|Adverse Event|1|||
163075825|NCT04595370|588984775|FG004|Overall Study|Adverse Event|1|||
163075826|NCT04595370|588984776|FG005|Overall Study|Adverse Event|1|||
163075827|NCT04595370|588984771|FG000|Overall Study|Withdrawal of Consent|1|||
163075828|NCT04595370|588984772|FG001|Overall Study|Withdrawal of Consent|1|||
163075829|NCT04595370|588984773|FG002|Overall Study|Withdrawal of Consent|1|||
163075830|NCT04595370|588984774|FG003|Overall Study|Withdrawal of Consent|0|||
163075831|NCT04595370|588984775|FG004|Overall Study|Withdrawal of Consent|0|||
163075832|NCT04595370|588984776|FG005|Overall Study|Withdrawal of Consent|0|||
163075833|NCT04595370|588984771|FG000|Overall Study|Death|0|||
163075834|NCT04595370|588984772|FG001|Overall Study|Death|1|||
163075835|NCT04595370|588984773|FG002|Overall Study|Death|0|||
163075836|NCT04595370|588984774|FG003|Overall Study|Death|0|||
163075837|NCT04595370|588984775|FG004|Overall Study|Death|1|||
163075838|NCT04595370|588984776|FG005|Overall Study|Death|0|||
163075839|NCT04595370|588984771|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075840|NCT04595370|588984772|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075841|NCT04595370|588984773|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163075842|NCT04595370|588984774|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075843|NCT04595370|588984775|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075844|NCT04595370|588984776|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163075845|NCT04595370|588984771|FG000|Overall Study|Withdrawal by Subject|0|||
163075846|NCT04595370|588984772|FG001|Overall Study|Withdrawal by Subject|0|||
163075847|NCT04595370|588984773|FG002|Overall Study|Withdrawal by Subject|1|||
163075848|NCT04595370|588984774|FG003|Overall Study|Withdrawal by Subject|0|||
163075849|NCT04595370|588984775|FG004|Overall Study|Withdrawal by Subject|2|||
163075850|NCT04595370|588984776|FG005|Overall Study|Withdrawal by Subject|0|||
163075851|NCT04595370|588984771|FG000|Overall Study|Lost to Follow-up|0|||
163075852|NCT04595370|588984772|FG001|Overall Study|Lost to Follow-up|0|||
163075853|NCT04595370|588984773|FG002|Overall Study|Lost to Follow-up|0|||
163075854|NCT04595370|588984774|FG003|Overall Study|Lost to Follow-up|0|||
163075855|NCT04595370|588984775|FG004|Overall Study|Lost to Follow-up|1|||
163075856|NCT04595370|588984776|FG005|Overall Study|Lost to Follow-up|0|||
163075857|NCT04595370|588984771|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075858|NCT04595370|588984772|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
163075859|NCT04595370|588984773|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
163075860|NCT04595370|588984774|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075861|NCT04595370|588984775|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
163075862|NCT04595370|588984776|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
163075863|NCT03520387|588984777|FG000|Pre-Randomization|Withdrawal by Subject|1|||
163075864|NCT03520387|588984778|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163075865|NCT03520387|588984779|FG002|Pre-Randomization|Withdrawal by Subject|0|||
163075866|NCT03520387|588984780|FG003|Pre-Randomization|Withdrawal by Subject|0|||
163075867|NCT03520387|588984781|FG004|Pre-Randomization|Withdrawal by Subject|0|||
163075868|NCT03520387|588984777|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
163075869|NCT03520387|588984778|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075870|NCT03520387|588984779|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075871|NCT03520387|588984780|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075872|NCT03520387|588984781|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
163075873|NCT00541775|588984782|FG000|Overall Study|Adverse Event|3|||
163075874|NCT00541775|588984783|FG001|Overall Study|Adverse Event|2|||
163075875|NCT00541775|588984784|FG002|Overall Study|Adverse Event|1|||
163075876|NCT00541775|588984782|FG000|Overall Study|Lack of Efficacy|0|||
163075877|NCT00541775|588984783|FG001|Overall Study|Lack of Efficacy|0|||
163075878|NCT00541775|588984784|FG002|Overall Study|Lack of Efficacy|3|||
163075879|NCT00541775|588984782|FG000|Overall Study|Lost to Follow-up|0|||
163075880|NCT00541775|588984783|FG001|Overall Study|Lost to Follow-up|0|||
163075881|NCT00541775|588984784|FG002|Overall Study|Lost to Follow-up|2|||
163075882|NCT00541775|588984782|FG000|Overall Study|Protocol Violation|1|||
163075883|NCT00541775|588984783|FG001|Overall Study|Protocol Violation|0|||
163075884|NCT00541775|588984784|FG002|Overall Study|Protocol Violation|0|||
163075885|NCT00541775|588984782|FG000|Overall Study|Withdrawal by Subject and Other|5|||
163075886|NCT00541775|588984783|FG001|Overall Study|Withdrawal by Subject and Other|0|||
163075887|NCT00541775|588984784|FG002|Overall Study|Withdrawal by Subject and Other|2|||
163075888|NCT01945242|588984785|FG000|Overall Study|Physician Decision|3|||
163075889|NCT01945242|588984786|FG001|Overall Study|Physician Decision|3|||
163075890|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Death|0|||
163075891|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Death|2|||
163075892|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Death|2|||
163075893|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Death|0|||
163075894|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
163075895|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
163075896|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
163075897|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
163075898|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
163075899|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
163075900|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
163075901|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
163075902|NCT04913675|588984788|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
163075903|NCT04913675|588984789|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
163075904|NCT04913675|588984790|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
163075905|NCT04913675|588984791|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
163075906|NCT04913675|588984788|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075907|NCT04913675|588984789|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075908|NCT04913675|588984790|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
163075909|NCT04913675|588984791|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
163075910|NCT05660538|588984792|FG000|Overall Study|Adverse Event|0|||
163075911|NCT05660538|588984793|FG001|Overall Study|Adverse Event|0|||
163075912|NCT05660538|588984794|FG002|Overall Study|Adverse Event|1|||
163075913|NCT05660538|588984795|FG003|Overall Study|Adverse Event|0|||
163075914|NCT05660538|588984792|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163075915|NCT05660538|588984793|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163075916|NCT05660538|588984794|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
163075917|NCT05660538|588984795|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
163075918|NCT05660538|588984792|FG000|Overall Study|Lost to Follow-up|0|||
163075919|NCT05660538|588984793|FG001|Overall Study|Lost to Follow-up|0|||
163075920|NCT05660538|588984794|FG002|Overall Study|Lost to Follow-up|1|||
163075921|NCT05660538|588984795|FG003|Overall Study|Lost to Follow-up|1|||
163075922|NCT05660538|588984792|FG000|Overall Study|Death|0|||
163075923|NCT05660538|588984793|FG001|Overall Study|Death|0|||
163075924|NCT05660538|588984794|FG002|Overall Study|Death|1|||
163075925|NCT05660538|588984795|FG003|Overall Study|Death|0|||
163075926|NCT05660538|588984792|FG000|Overall Study|Physician Decision|0|||
163075927|NCT05660538|588984793|FG001|Overall Study|Physician Decision|0|||
163075928|NCT05660538|588984794|FG002|Overall Study|Physician Decision|0|||
163075929|NCT05660538|588984795|FG003|Overall Study|Physician Decision|1|||
163075930|NCT05660538|588984792|FG000|Overall Study|Sponsor Decision|1|||
163075931|NCT05660538|588984793|FG001|Overall Study|Sponsor Decision|0|||
163075932|NCT05660538|588984794|FG002|Overall Study|Sponsor Decision|0|||
163075933|NCT05660538|588984795|FG003|Overall Study|Sponsor Decision|0|||
163075934|NCT05660538|588984792|FG000|Overall Study|Other|1|||
163075935|NCT05660538|588984793|FG001|Overall Study|Other|0|||
163075936|NCT05660538|588984794|FG002|Overall Study|Other|0|||
163075937|NCT05660538|588984795|FG003|Overall Study|Other|1|||
163075938|NCT05660538|588984792|FG000|Overall Study|Randomized but did not receive study drug|1|||
163075939|NCT05660538|588984793|FG001|Overall Study|Randomized but did not receive study drug|0|||
163075940|NCT05660538|588984794|FG002|Overall Study|Randomized but did not receive study drug|0|||
163075941|NCT05660538|588984795|FG003|Overall Study|Randomized but did not receive study drug|1|||
163075942|NCT05660538|588984792|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075943|NCT05660538|588984793|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
163075944|NCT05660538|588984794|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075945|NCT05660538|588984795|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
163075946|NCT04648241|588984796|FG000|Overall Study|Lost to Follow-up|1|||
163075947|NCT04648241|588984797|FG001|Overall Study|Lost to Follow-up|0|||
163075948|NCT02489045|588984798|FG000|Overall Study|unable to collect usable data|53|||
163075949|NCT02489045|588984798|FG000|Follow-up|Lost to Follow-up|10|||
163075950|NCT00837330|588984801|FG000|Overall Study|Lost to Follow-up|1|||
162645120|NCT01502423|587417753|FG001|Overall Study|Withdrawal by Subject|1|||
162645121|NCT04199117|587417754|FG000|Overall Study|Withdrawal by Subject|3|||
162645122|NCT04199117|587417755|FG001|Overall Study|Withdrawal by Subject|0|||
162645123|NCT04199117|587417756|FG002|Overall Study|Withdrawal by Subject|0|||
163028329|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
163028330|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
163028331|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
163028332|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
163028333|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
163028334|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
163028335|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
163028336|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
163028337|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
163028338|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
163028339|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
163028340|NCT02677896|588807231|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
163028341|NCT02677896|588807232|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
163028342|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
163028343|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
163028344|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
163028345|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
163028346|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
163028347|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
163028348|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
163028349|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
163028350|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
163028351|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
163028352|NCT02677896|588807231|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
163028353|NCT02677896|588807232|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
163028354|NCT00348790|588807238|FG000|Completed Treatment|Withdrawal by Subject|4|||
163028355|NCT00348790|588807238|FG000|Completed Treatment|Disease progression|14|||
163028356|NCT00348790|588807238|FG000|Completed Treatment|Adverse Event|4|||
163028357|NCT00348790|588807238|FG000|Completed Treatment|Required surgery|2|||
163028358|NCT00348790|588807238|FG000|Completed Treatment|Unable to travel to study site|1|||
163028359|NCT01185509|588807239|FG000|Overall Study|Progression/Relapse|9|||
163028360|NCT01185509|588807240|FG001|Overall Study|Progression/Relapse|15|||
163028361|NCT01185509|588807239|FG000|Overall Study|Physician Decision|2|||
163028362|NCT01185509|588807240|FG001|Overall Study|Physician Decision|2|||
163028363|NCT01185509|588807239|FG000|Overall Study|Withdrawal by Subject|0|||
163028364|NCT01185509|588807240|FG001|Overall Study|Withdrawal by Subject|1|||
163028365|NCT01185509|588807239|FG000|Overall Study|Death|0|||
163028366|NCT01185509|588807240|FG001|Overall Study|Death|1|||
163028367|NCT01185509|588807239|FG000|Overall Study|Intercurrent Illness|0|||
163028368|NCT01185509|588807240|FG001|Overall Study|Intercurrent Illness|1|||
163028369|NCT03687372|588807241|FG000|Overall Study|Lost to Follow-up|12|||
163028370|NCT03687372|588807242|FG001|Overall Study|Lost to Follow-up|21|||
163028371|NCT03687372|588807241|FG000|Overall Study|Withdrawal by Subject|4|||
163028372|NCT03687372|588807242|FG001|Overall Study|Withdrawal by Subject|17|||
163028373|NCT03687372|588807241|FG000|Overall Study|Investigator Decision|1|||
163028374|NCT03687372|588807242|FG001|Overall Study|Investigator Decision|1|||
163028375|NCT00655733|588807243|FG000|Overall Study|Lost to Follow-up|2|||
163028376|NCT00655733|588807244|FG001|Overall Study|Lost to Follow-up|2|||
163028377|NCT00655733|588807243|FG000|Overall Study|Adverse Event|2|||
163028378|NCT00655733|588807244|FG001|Overall Study|Adverse Event|2|||
163028379|NCT00655733|588807243|FG000|Overall Study|Withdrawal by Subject|3|||
163028380|NCT00655733|588807244|FG001|Overall Study|Withdrawal by Subject|3|||
163028381|NCT00655733|588807243|FG000|Overall Study|Physician Decision|0|||
163028382|NCT00655733|588807244|FG001|Overall Study|Physician Decision|1|||
163028383|NCT01482962|588807248|FG000|Overall Study|Progressive Disease|65|||
163028384|NCT01482962|588807249|FG001|Overall Study|Progressive Disease|53|||
163028385|NCT01482962|588807248|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
162645124|NCT04199117|587417757|FG003|Overall Study|Withdrawal by Subject|1|||
163028386|NCT01482962|588807249|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
163028387|NCT01482962|588807248|FG000|Overall Study|Adverse Event|18|||
163028388|NCT01482962|588807249|FG001|Overall Study|Adverse Event|22|||
163028389|NCT01482962|588807248|FG000|Overall Study|Withdrawal by Participant|8|||
163028390|NCT01482962|588807249|FG001|Overall Study|Withdrawal by Participant|13|||
163028391|NCT01482962|588807248|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
163028392|NCT01482962|588807249|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
163028393|NCT01482962|588807248|FG000|Overall Study|Other Reason|1|||
163028394|NCT01482962|588807249|FG001|Overall Study|Other Reason|5|||
162645125|NCT04199117|587417758|FG004|Overall Study|Withdrawal by Subject|1|||
163075951|NCT00837330|588984802|FG001|Overall Study|Lost to Follow-up|3|||
163028395|NCT01482962|588807248|FG000|Overall Study|Study Terminated by Sponsor|5|||
163028396|NCT01482962|588807249|FG001|Overall Study|Study Terminated by Sponsor|2|||
163028397|NCT01482962|588807248|FG000|Overall Study|Did not Receive Study Drug|1|||
163028398|NCT01482962|588807249|FG001|Overall Study|Did not Receive Study Drug|6|||
163028399|NCT02407457|588807250|FG000|1 Month|Death|3|||
163028400|NCT02407457|588807251|FG001|1 Month|Death|0|||
163028401|NCT02407457|588807250|FG000|1 Month|Lost to Follow-up|1|||
163028402|NCT02407457|588807251|FG001|1 Month|Lost to Follow-up|1|||
163028403|NCT02407457|588807250|FG000|1 Month|missed visit|2|||
163028404|NCT02407457|588807251|FG001|1 Month|missed visit|5|||
163028405|NCT02407457|588807250|FG000|6-Month|Death|2|||
163028406|NCT02407457|588807251|FG001|6-Month|Death|8|||
163028407|NCT02407457|588807250|FG000|6-Month|Lost to Follow-up|2|||
163028408|NCT02407457|588807251|FG001|6-Month|Lost to Follow-up|2|||
163028409|NCT02407457|588807250|FG000|6-Month|missed visit|16|||
163028410|NCT02407457|588807251|FG001|6-Month|missed visit|14|||
163028411|NCT02407457|588807250|FG000|6-Month|Open Repair|0|||
163028412|NCT02407457|588807251|FG001|6-Month|Open Repair|1|||
163028413|NCT02407457|588807250|FG000|1 Year|Death|6|||
163028414|NCT02407457|588807251|FG001|1 Year|Death|11|||
163028415|NCT02407457|588807250|FG000|1 Year|Lost to Follow-up|3|||
163028416|NCT02407457|588807251|FG001|1 Year|Lost to Follow-up|2|||
163028417|NCT02407457|588807250|FG000|1 Year|Missed Visit|24|||
163028418|NCT02407457|588807251|FG001|1 Year|Missed Visit|14|||
163028419|NCT02407457|588807250|FG000|1 Year|Open Repair|0|||
163028420|NCT02407457|588807251|FG001|1 Year|Open Repair|1|||
163028421|NCT02407457|588807250|FG000|2-year|Death|14|||
163028422|NCT02407457|588807251|FG001|2-year|Death|8|||
163028423|NCT02407457|588807250|FG000|2-year|Lost to Follow-up|7|||
163028424|NCT02407457|588807251|FG001|2-year|Lost to Follow-up|10|||
163028425|NCT02407457|588807250|FG000|2-year|Missed Visit|13|||
163028426|NCT02407457|588807251|FG001|2-year|Missed Visit|15|||
163028427|NCT02407457|588807250|FG000|2-year|Open Repair|0|||
163028428|NCT02407457|588807251|FG001|2-year|Open Repair|2|||
163028429|NCT02407457|588807250|FG000|3-year|Death|11|||
163028430|NCT02407457|588807251|FG001|3-year|Death|10|||
163028431|NCT02407457|588807250|FG000|3-year|Lost to Follow-up|9|||
163028432|NCT02407457|588807251|FG001|3-year|Lost to Follow-up|10|||
163028433|NCT02407457|588807250|FG000|3-year|Missed Visit|19|||
163028434|NCT02407457|588807251|FG001|3-year|Missed Visit|16|||
163028435|NCT02407457|588807250|FG000|4-year|Death|18|||
163028436|NCT02407457|588807251|FG001|4-year|Death|10|||
163028437|NCT02407457|588807250|FG000|4-year|Lost to Follow-up|10|||
163028438|NCT02407457|588807251|FG001|4-year|Lost to Follow-up|12|||
163028439|NCT02407457|588807250|FG000|4-year|Missed Visit|18|||
163028440|NCT02407457|588807251|FG001|4-year|Missed Visit|16|||
163028441|NCT02407457|588807250|FG000|5-year|Death|10|||
163028442|NCT02407457|588807251|FG001|5-year|Death|3|||
163028443|NCT02407457|588807250|FG000|5-year|Lost to Follow-up|22|||
163028444|NCT02407457|588807251|FG001|5-year|Lost to Follow-up|13|||
163028445|NCT02407457|588807250|FG000|5-year|Missed Visit|9|||
163028446|NCT02407457|588807251|FG001|5-year|Missed Visit|1|||
163028447|NCT02954653|588807256|FG000|Overall Study|Death|3|||
163028448|NCT02954653|588807257|FG001|Overall Study|Death|1|||
163028449|NCT02954653|588807258|FG002|Overall Study|Death|0|||
163028450|NCT02954653|588807259|FG003|Overall Study|Death|0|||
163028451|NCT02954653|588807260|FG004|Overall Study|Death|0|||
163028452|NCT02954653|588807261|FG005|Overall Study|Death|0|||
163028453|NCT02954653|588807262|FG006|Overall Study|Death|0|||
163028454|NCT02954653|588807263|FG007|Overall Study|Death|0|||
163028455|NCT02954653|588807264|FG008|Overall Study|Death|0|||
163028456|NCT02954653|588807256|FG000|Overall Study|Randomized but did not receive treatment|1|||
163028457|NCT02954653|588807257|FG001|Overall Study|Randomized but did not receive treatment|0|||
163028458|NCT02954653|588807258|FG002|Overall Study|Randomized but did not receive treatment|0|||
163028459|NCT02954653|588807259|FG003|Overall Study|Randomized but did not receive treatment|0|||
163028460|NCT02954653|588807260|FG004|Overall Study|Randomized but did not receive treatment|0|||
163028461|NCT02954653|588807261|FG005|Overall Study|Randomized but did not receive treatment|0|||
163028462|NCT02954653|588807262|FG006|Overall Study|Randomized but did not receive treatment|0|||
163075952|NCT02774278|588984803|FG000|Overall Study|Lack of Efficacy|199|||
163028463|NCT02954653|588807263|FG007|Overall Study|Randomized but did not receive treatment|0|||
163028464|NCT02954653|588807264|FG008|Overall Study|Randomized but did not receive treatment|0|||
163028465|NCT02954653|588807256|FG000|Overall Study|Started another anti-cancer therapy|0|||
163028466|NCT02954653|588807257|FG001|Overall Study|Started another anti-cancer therapy|1|||
163028467|NCT02954653|588807258|FG002|Overall Study|Started another anti-cancer therapy|0|||
163028468|NCT02954653|588807259|FG003|Overall Study|Started another anti-cancer therapy|0|||
163028469|NCT02954653|588807260|FG004|Overall Study|Started another anti-cancer therapy|0|||
163028470|NCT02954653|588807261|FG005|Overall Study|Started another anti-cancer therapy|0|||
163028471|NCT02954653|588807262|FG006|Overall Study|Started another anti-cancer therapy|0|||
163028472|NCT02954653|588807263|FG007|Overall Study|Started another anti-cancer therapy|0|||
163028473|NCT02954653|588807264|FG008|Overall Study|Started another anti-cancer therapy|0|||
163028474|NCT02954653|588807256|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
163075953|NCT02774278|588984803|FG000|Overall Study|Death|29|||
163075954|NCT02774278|588984803|FG000|Overall Study|Adverse event/intercurrent illness|16|||
163075955|NCT02774278|588984803|FG000|Overall Study|Refused treatment/did not cooperate|9|||
162645126|NCT04199117|587417759|FG005|Overall Study|Withdrawal by Subject|0|||
162645127|NCT04199117|587417760|FG006|Overall Study|Withdrawal by Subject|0|||
162645128|NCT04199117|587417761|FG007|Overall Study|Withdrawal by Subject|2|||
162645129|NCT04199117|587417762|FG008|Overall Study|Withdrawal by Subject|0|||
162645130|NCT04199117|587417763|FG009|Overall Study|Withdrawal by Subject|0|||
162645131|NCT04199117|587417764|FG010|Overall Study|Withdrawal by Subject|1|||
162645132|NCT04199117|587417765|FG011|Overall Study|Withdrawal by Subject|1|||
162645133|NCT04199117|587417766|FG012|Overall Study|Withdrawal by Subject|2|||
162645134|NCT04199117|587417767|FG013|Overall Study|Withdrawal by Subject|1|||
162645135|NCT04199117|587417768|FG014|Overall Study|Withdrawal by Subject|1|||
162645136|NCT04199117|587417769|FG015|Overall Study|Withdrawal by Subject|1|||
162645137|NCT04199117|587417754|FG000|Overall Study|Death|1|||
162645138|NCT04199117|587417755|FG001|Overall Study|Death|1|||
162645139|NCT04199117|587417756|FG002|Overall Study|Death|0|||
162645140|NCT04199117|587417757|FG003|Overall Study|Death|0|||
162645141|NCT04199117|587417758|FG004|Overall Study|Death|0|||
162645142|NCT04199117|587417759|FG005|Overall Study|Death|0|||
162645143|NCT04199117|587417760|FG006|Overall Study|Death|0|||
162645144|NCT04199117|587417761|FG007|Overall Study|Death|0|||
162645145|NCT04199117|587417762|FG008|Overall Study|Death|0|||
162645146|NCT04199117|587417763|FG009|Overall Study|Death|0|||
162645147|NCT04199117|587417764|FG010|Overall Study|Death|0|||
162645148|NCT04199117|587417765|FG011|Overall Study|Death|1|||
162645149|NCT04199117|587417766|FG012|Overall Study|Death|0|||
162645150|NCT04199117|587417767|FG013|Overall Study|Death|1|||
162645151|NCT04199117|587417768|FG014|Overall Study|Death|0|||
162645152|NCT04199117|587417769|FG015|Overall Study|Death|0|||
162645153|NCT04199117|587417754|FG000|Overall Study|Withdrawal by PI|0|||
162645154|NCT04199117|587417755|FG001|Overall Study|Withdrawal by PI|0|||
162645155|NCT04199117|587417756|FG002|Overall Study|Withdrawal by PI|0|||
162645156|NCT04199117|587417757|FG003|Overall Study|Withdrawal by PI|0|||
162645157|NCT04199117|587417758|FG004|Overall Study|Withdrawal by PI|0|||
162645158|NCT04199117|587417759|FG005|Overall Study|Withdrawal by PI|0|||
162645159|NCT04199117|587417760|FG006|Overall Study|Withdrawal by PI|0|||
162645160|NCT04199117|587417761|FG007|Overall Study|Withdrawal by PI|0|||
162645161|NCT04199117|587417762|FG008|Overall Study|Withdrawal by PI|0|||
162645162|NCT04199117|587417763|FG009|Overall Study|Withdrawal by PI|0|||
162645163|NCT04199117|587417764|FG010|Overall Study|Withdrawal by PI|0|||
162645164|NCT04199117|587417765|FG011|Overall Study|Withdrawal by PI|0|||
162645165|NCT04199117|587417766|FG012|Overall Study|Withdrawal by PI|1|||
162645166|NCT04199117|587417767|FG013|Overall Study|Withdrawal by PI|0|||
162645167|NCT04199117|587417768|FG014|Overall Study|Withdrawal by PI|0|||
162645168|NCT04199117|587417769|FG015|Overall Study|Withdrawal by PI|0|||
162645169|NCT04383743|587417770|FG000|Overall Study|Withdrawal by Subject|1|||
162645170|NCT04383743|587417770|FG000|Overall Study|Adverse Event|1|||
162645171|NCT04814433|587417773|FG000|Overall Study|Survey not returned|4|||
162645172|NCT04814433|587417774|FG001|Overall Study|Survey not returned|8|||
162645173|NCT04814433|587417775|FG002|Overall Study|Survey not returned|4|||
162645174|NCT04814433|587417776|FG003|Overall Study|Survey not returned|5|||
162645175|NCT03482791|587417781|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
162645176|NCT03482791|587417782|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
162645177|NCT00296374|587417784|FG000|Overall Study|Adverse Event|14|||
162645178|NCT00296374|587417785|FG001|Overall Study|Adverse Event|10|||
162645179|NCT00296374|587417786|FG002|Overall Study|Adverse Event|7|||
162645180|NCT00296374|587417784|FG000|Overall Study|Withdrawal by Subject|3|||
162645181|NCT00296374|587417785|FG001|Overall Study|Withdrawal by Subject|5|||
162645182|NCT00296374|587417786|FG002|Overall Study|Withdrawal by Subject|11|||
162645183|NCT00296374|587417784|FG000|Overall Study|Incorrect enrollment|3|||
163075956|NCT02774278|588984803|FG000|Overall Study|Administrative reasons|6|||
163075957|NCT02774278|588984803|FG000|Overall Study|Withdrawal by Subject|3|||
163075958|NCT02774278|588984803|FG000|Overall Study|Protocol Violation|2|||
163075959|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
162645184|NCT00296374|587417785|FG001|Overall Study|Incorrect enrollment|3|||
162645185|NCT00296374|587417786|FG002|Overall Study|Incorrect enrollment|4|||
162645186|NCT00296374|587417784|FG000|Overall Study|Protocol Violation|1|||
162645187|NCT00296374|587417785|FG001|Overall Study|Protocol Violation|2|||
162645188|NCT00296374|587417786|FG002|Overall Study|Protocol Violation|3|||
162645189|NCT00296374|587417784|FG000|Overall Study|Lost to Follow-up|3|||
162645190|NCT00296374|587417785|FG001|Overall Study|Lost to Follow-up|1|||
162645191|NCT00296374|587417786|FG002|Overall Study|Lost to Follow-up|1|||
162645192|NCT00296374|587417784|FG000|Overall Study|Relocated to another state|1|||
162645193|NCT00296374|587417785|FG001|Overall Study|Relocated to another state|0|||
162645194|NCT00296374|587417786|FG002|Overall Study|Relocated to another state|0|||
162645195|NCT00296374|587417784|FG000|Overall Study|Stopped drug before end of study visit|0|||
162645196|NCT00296374|587417785|FG001|Overall Study|Stopped drug before end of study visit|1|||
162645197|NCT00296374|587417786|FG002|Overall Study|Stopped drug before end of study visit|0|||
163075960|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
163075961|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
163075962|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
163075963|NCT00694122|588984806|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
163075964|NCT00694122|588984807|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
163075965|NCT03339453|588984815|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
163075966|NCT03339453|588984816|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
163075967|NCT03632720|588984825|FG000|Overall Study|Adverse Event|2|||
163075968|NCT03632720|588984826|FG001|Overall Study|Adverse Event|0|||
163075969|NCT03632720|588984827|FG002|Overall Study|Adverse Event|0|||
163075970|NCT03632720|588984825|FG000|Overall Study|Lost to Follow-up|0|||
163075971|NCT03632720|588984826|FG001|Overall Study|Lost to Follow-up|1|||
163075972|NCT03632720|588984827|FG002|Overall Study|Lost to Follow-up|0|||
163075973|NCT03632720|588984825|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
163075974|NCT03632720|588984826|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
163075975|NCT03632720|588984827|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
163075976|NCT03632720|588984825|FG000|Overall Study|Screen failure|0|||
163075977|NCT03632720|588984826|FG001|Overall Study|Screen failure|1|||
163075978|NCT03632720|588984827|FG002|Overall Study|Screen failure|0|||
163075979|NCT00290238|588984830|FG000|Overall Study|Study terminated|27|||
163075980|NCT00290238|588984831|FG001|Overall Study|Study terminated|27|||
163075981|NCT00290238|588984830|FG000|Overall Study|Lost to Follow-up|0|||
163075982|NCT00290238|588984831|FG001|Overall Study|Lost to Follow-up|1|||
163075983|NCT00290238|588984830|FG000|Overall Study|Withdrawal by Subject|15|||
163075984|NCT00290238|588984831|FG001|Overall Study|Withdrawal by Subject|13|||
163075985|NCT03834883|588984832|FG000|Second Treatment|Withdrawal by Subject|1|||
163075986|NCT03834883|588984833|FG001|Second Treatment|Withdrawal by Subject|0|||
163075987|NCT03834883|588984834|FG002|Second Treatment|Withdrawal by Subject|0|||
163075988|NCT03834883|588984835|FG003|Second Treatment|Withdrawal by Subject|0|||
163075989|NCT03834883|588984832|FG000|Second Treatment|COVID-19 pandemic|1|||
163075990|NCT03834883|588984833|FG001|Second Treatment|COVID-19 pandemic|0|||
163075991|NCT03834883|588984834|FG002|Second Treatment|COVID-19 pandemic|1|||
163075992|NCT03834883|588984835|FG003|Second Treatment|COVID-19 pandemic|1|||
163075993|NCT01179399|588984836|FG000|Overall Study|Adverse Event|1|||
163075994|NCT01179399|588984836|FG000|Overall Study|Lack of Efficacy|30|||
163075995|NCT01179399|588984836|FG000|Overall Study|Withdrawal by Subject|1|||
163075996|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163075997|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
163075998|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
163075999|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
163076000|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
163076001|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163076002|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
163076003|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
163076004|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
163076005|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
163076006|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
163076007|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
163076008|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
163076009|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163076010|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
163076011|NCT03738215|588984837|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163076012|NCT03738215|588984838|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163076013|NCT03738215|588984839|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
163076014|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
163076015|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
163076016|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
163076017|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
163076018|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
163076019|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
163076020|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
163076021|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
163076022|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
163076023|NCT03738215|588984837|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
163076024|NCT03738215|588984838|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
163076025|NCT03738215|588984839|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
163076026|NCT00394472|588986838|FG000|Overall Study|Protocol Violation|1|||
163076027|NCT00394472|588986839|FG001|Overall Study|Protocol Violation|3|||
163076028|NCT00394472|588986838|FG000|Overall Study|incorrect enrolment|4|||
163076029|NCT00394472|588986839|FG001|Overall Study|incorrect enrolment|2|||
163076030|NCT00394472|588986838|FG000|Overall Study|Adverse Event|4|||
163076031|NCT00394472|588986839|FG001|Overall Study|Adverse Event|2|||
163076032|NCT00394472|588986838|FG000|Overall Study|Withdrawal by Subject|0|||
163076033|NCT00394472|588986839|FG001|Overall Study|Withdrawal by Subject|2|||
163076034|NCT00394472|588986838|FG000|Overall Study|Physician Decision|0|||
163076035|NCT00394472|588986839|FG001|Overall Study|Physician Decision|1|||
163076036|NCT00394472|588986838|FG000|Overall Study|Lost to Follow-up|0|||
163076037|NCT00394472|588986839|FG001|Overall Study|Lost to Follow-up|1|||
163076038|NCT03211858|588986840|FG000|Overall Study|Adverse Event|8|||
163076039|NCT03211858|588986841|FG001|Overall Study|Adverse Event|6|||
163076040|NCT03211858|588986840|FG000|Overall Study|Lack of Efficacy|0|||
163076041|NCT03211858|588986841|FG001|Overall Study|Lack of Efficacy|4|||
163076042|NCT03211858|588986840|FG000|Overall Study|Poor compliance to protocol|6|||
163076043|NCT03211858|588986841|FG001|Overall Study|Poor compliance to protocol|2|||
163076044|NCT03211858|588986840|FG000|Overall Study|Non-serious Hypoglycemia|1|||
163076045|NCT03211858|588986841|FG001|Overall Study|Non-serious Hypoglycemia|0|||
163076046|NCT03211858|588986840|FG000|Overall Study|Other than specified above|22|||
163076047|NCT03211858|588986841|FG001|Overall Study|Other than specified above|21|||
163076048|NCT00004228|588986842|FG000|Overall Study|Adverse Event|0|||
163076049|NCT00004228|588986843|FG001|Overall Study|Adverse Event|1|||
163076050|NCT00004228|588986844|FG002|Overall Study|Adverse Event|0|||
163076051|NCT00004228|588986845|FG003|Overall Study|Adverse Event|0|||
163076052|NCT00004228|588986846|FG004|Overall Study|Adverse Event|1|||
163076053|NCT00004228|588986847|FG005|Overall Study|Adverse Event|0|||
163076054|NCT00004228|588986848|FG006|Overall Study|Adverse Event|0|||
163076055|NCT00004228|588986842|FG000|Overall Study|Death|0|||
163076056|NCT00004228|588986843|FG001|Overall Study|Death|1|||
163076057|NCT00004228|588986844|FG002|Overall Study|Death|2|||
163076058|NCT00004228|588986845|FG003|Overall Study|Death|0|||
163076059|NCT00004228|588986846|FG004|Overall Study|Death|1|||
163076060|NCT00004228|588986847|FG005|Overall Study|Death|0|||
163076061|NCT00004228|588986848|FG006|Overall Study|Death|0|||
163076062|NCT00004228|588986842|FG000|Overall Study|Lack of Efficacy|1|||
163076063|NCT00004228|588986843|FG001|Overall Study|Lack of Efficacy|6|||
163076064|NCT00004228|588986844|FG002|Overall Study|Lack of Efficacy|5|||
163076065|NCT00004228|588986845|FG003|Overall Study|Lack of Efficacy|3|||
163076066|NCT00004228|588986846|FG004|Overall Study|Lack of Efficacy|9|||
163076067|NCT00004228|588986847|FG005|Overall Study|Lack of Efficacy|8|||
163076068|NCT00004228|588986848|FG006|Overall Study|Lack of Efficacy|4|||
163076069|NCT00004228|588986842|FG000|Overall Study|Lost to Follow-up|0|||
163076070|NCT00004228|588986843|FG001|Overall Study|Lost to Follow-up|0|||
163076071|NCT00004228|588986844|FG002|Overall Study|Lost to Follow-up|1|||
163076072|NCT00004228|588986845|FG003|Overall Study|Lost to Follow-up|0|||
163076073|NCT00004228|588986846|FG004|Overall Study|Lost to Follow-up|0|||
163076074|NCT00004228|588986847|FG005|Overall Study|Lost to Follow-up|0|||
163076075|NCT00004228|588986848|FG006|Overall Study|Lost to Follow-up|0|||
163076076|NCT00004228|588986842|FG000|Overall Study|Physician Decision|1|||
163076077|NCT00004228|588986843|FG001|Overall Study|Physician Decision|0|||
163076078|NCT00004228|588986844|FG002|Overall Study|Physician Decision|3|||
163076079|NCT00004228|588986845|FG003|Overall Study|Physician Decision|2|||
163076080|NCT00004228|588986846|FG004|Overall Study|Physician Decision|1|||
163076081|NCT00004228|588986847|FG005|Overall Study|Physician Decision|1|||
163076082|NCT00004228|588986848|FG006|Overall Study|Physician Decision|1|||
163076083|NCT00004228|588986842|FG000|Overall Study|Protocol Violation|0|||
163076084|NCT00004228|588986843|FG001|Overall Study|Protocol Violation|5|||
162645198|NCT00296374|587417784|FG000|Overall Study|Nephrologist introduced ACE|0|||
162645199|NCT00296374|587417785|FG001|Overall Study|Nephrologist introduced ACE|1|||
163076085|NCT00004228|588986844|FG002|Overall Study|Protocol Violation|2|||
163076086|NCT00004228|588986845|FG003|Overall Study|Protocol Violation|1|||
163076087|NCT00004228|588986846|FG004|Overall Study|Protocol Violation|1|||
163076088|NCT00004228|588986847|FG005|Overall Study|Protocol Violation|2|||
163076089|NCT00004228|588986848|FG006|Overall Study|Protocol Violation|0|||
163076090|NCT00004228|588986842|FG000|Overall Study|Withdrawal by Subject|3|||
163076091|NCT00004228|588986843|FG001|Overall Study|Withdrawal by Subject|0|||
163076092|NCT00004228|588986844|FG002|Overall Study|Withdrawal by Subject|1|||
163076093|NCT00004228|588986845|FG003|Overall Study|Withdrawal by Subject|0|||
163076094|NCT00004228|588986846|FG004|Overall Study|Withdrawal by Subject|2|||
163076095|NCT00004228|588986847|FG005|Overall Study|Withdrawal by Subject|1|||
163076096|NCT00004228|588986848|FG006|Overall Study|Withdrawal by Subject|2|||
163076097|NCT00004228|588986842|FG000|Overall Study|Other|0|||
163076098|NCT00004228|588986843|FG001|Overall Study|Other|0|||
163076099|NCT00004228|588986844|FG002|Overall Study|Other|1|||
163076100|NCT00004228|588986845|FG003|Overall Study|Other|0|||
163076101|NCT00004228|588986846|FG004|Overall Study|Other|0|||
163076102|NCT00004228|588986847|FG005|Overall Study|Other|0|||
163076103|NCT00004228|588986848|FG006|Overall Study|Other|0|||
163076104|NCT00004228|588986842|FG000|Overall Study|ineligible|4|||
163076105|NCT00004228|588986843|FG001|Overall Study|ineligible|2|||
163076106|NCT00004228|588986844|FG002|Overall Study|ineligible|4|||
163076107|NCT00004228|588986845|FG003|Overall Study|ineligible|1|||
163076108|NCT00004228|588986846|FG004|Overall Study|ineligible|1|||
163076109|NCT00004228|588986847|FG005|Overall Study|ineligible|2|||
163076110|NCT00004228|588986848|FG006|Overall Study|ineligible|5|||
163076111|NCT01529112|588986849|FG000|Overall Study|Adverse Event|2|||
162717876|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162717877|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163028475|NCT02954653|588807257|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
163028476|NCT02954653|588807258|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
163028477|NCT02954653|588807259|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
163028478|NCT02954653|588807260|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
163028479|NCT02954653|588807261|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
163028480|NCT02954653|588807262|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
163028481|NCT02954653|588807263|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
163028482|NCT02954653|588807264|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
163028483|NCT04329091|588807267|FG000|Overall Study|Physician Decision|5|||
163028484|NCT00423189|588807270|FG000|Overall Study|Death|0|||
163028485|NCT00423189|588807271|FG001|Overall Study|Death|1|||
163028486|NCT00423189|588807272|FG002|Overall Study|Death|0|||
163028487|NCT03787303|588807273|FG000|Overall Study|Death|1|||
163028488|NCT03787303|588807273|FG000|Overall Study|Premature Termination of Study|1|||
163028489|NCT01210495|588807278|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
163028490|NCT01210495|588807279|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
163028491|NCT01210495|588807280|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
163028492|NCT01210495|588807281|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
163028493|NCT01210495|588807278|FG000|Overall Study|Death|14|||
163028494|NCT01210495|588807279|FG001|Overall Study|Death|7|||
163028495|NCT01210495|588807280|FG002|Overall Study|Death|112|||
163028496|NCT01210495|588807281|FG003|Overall Study|Death|54|||
163028497|NCT01210495|588807278|FG000|Overall Study|Study Terminated by Sponsor|0|||
163028498|NCT01210495|588807279|FG001|Overall Study|Study Terminated by Sponsor|0|||
163028499|NCT01210495|588807280|FG002|Overall Study|Study Terminated by Sponsor|4|||
163028500|NCT01210495|588807281|FG003|Overall Study|Study Terminated by Sponsor|11|||
163028501|NCT01210495|588807278|FG000|Overall Study|Lost to Follow-up|0|||
163028502|NCT01210495|588807279|FG001|Overall Study|Lost to Follow-up|0|||
163028503|NCT01210495|588807280|FG002|Overall Study|Lost to Follow-up|1|||
163028504|NCT01210495|588807281|FG003|Overall Study|Lost to Follow-up|1|||
163028505|NCT01210495|588807278|FG000|Overall Study|Other unspecified|0|||
163028506|NCT01210495|588807279|FG001|Overall Study|Other unspecified|0|||
163028507|NCT01210495|588807280|FG002|Overall Study|Other unspecified|6|||
163028508|NCT01210495|588807281|FG003|Overall Study|Other unspecified|0|||
163028509|NCT01826370|588807286|FG000|Overall Study|Protocol Violation|6|||
163028510|NCT01826370|588807286|FG000|Overall Study|Lost to Follow-up|12|||
163028511|NCT01826370|588807286|FG000|Overall Study|Other reason not defined above|2|||
163028512|NCT04416737|588807287|FG000|Week 1 (First Injection)|Physician Decision|0|||
163028513|NCT04416737|588807288|FG001|Week 1 (First Injection)|Physician Decision|1|||
163028514|NCT03332628|588807289|FG000|Overall Study|Physician Decision|2|||
163028515|NCT02543892|588807297|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
163028516|NCT02543892|588807298|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163028517|NCT02543892|588807299|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
163028518|NCT02543892|588807300|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163028519|NCT02543892|588807301|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163028520|NCT02543892|588807302|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
163028521|NCT02543892|588807303|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
163028522|NCT02543892|588807304|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
163076112|NCT01529112|588986850|FG001|Overall Study|Adverse Event|0|||
163076113|NCT01529112|588986849|FG000|Overall Study|Death|59|||
163076114|NCT01529112|588986850|FG001|Overall Study|Death|38|||
163076115|NCT01529112|588986849|FG000|Overall Study|Protocol Violation|1|||
163076116|NCT01529112|588986850|FG001|Overall Study|Protocol Violation|0|||
163076117|NCT01529112|588986849|FG000|Overall Study|Withdrawal by Subject|7|||
163076118|NCT01529112|588986850|FG001|Overall Study|Withdrawal by Subject|3|||
163076119|NCT00107614|588986851|FG000|Overall Study|Physician Decision|10|||
163076120|NCT00107614|588986851|FG000|Overall Study|Death|2|||
163076121|NCT01013870|588986852|FG000|Overall Study|Lost to Follow-up|1|||
163076122|NCT01013870|588986853|FG001|Overall Study|Lost to Follow-up|3|||
163076123|NCT02457546|588986855|FG000|Overall Study|Other reasons|4|||
163076124|NCT02457546|588986856|FG001|Overall Study|Other reasons|1|||
163076125|NCT02457546|588986855|FG000|Overall Study|Refused to complete study/procedures|1|||
163076126|NCT02457546|588986856|FG001|Overall Study|Refused to complete study/procedures|1|||
163076127|NCT02457546|588986855|FG000|Overall Study|Lost to Follow-up|4|||
163076128|NCT02457546|588986856|FG001|Overall Study|Lost to Follow-up|1|||
163076129|NCT02457546|588986855|FG000|Overall Study|Adverse Event|0|||
163076130|NCT02457546|588986856|FG001|Overall Study|Adverse Event|1|||
163076131|NCT00474968|588986861|FG000|Overall Study|Withdrawal by Subject|8|||
163076132|NCT00474968|588986862|FG001|Overall Study|Withdrawal by Subject|7|||
163076133|NCT00474968|588986861|FG000|Overall Study|Protocol Violation|9|||
163076134|NCT00474968|588986862|FG001|Overall Study|Protocol Violation|8|||
163076135|NCT00474968|588986861|FG000|Overall Study|Sample not collected|1|||
163076136|NCT00474968|588986862|FG001|Overall Study|Sample not collected|1|||
163076137|NCT04914000|588986863|FG000|Overall Study|Lost to Follow-up|8|||
163076138|NCT04914000|588986863|FG000|Overall Study|Withdrawal by Subject|1|||
163076139|NCT01096186|588986865|FG000|Overall Study|Adverse Event|16|||
163076140|NCT01096186|588986865|FG000|Overall Study|Death|4|||
163076141|NCT01096186|588986865|FG000|Overall Study|Lack of Efficacy|4|||
163076142|NCT01096186|588986865|FG000|Overall Study|Lost to Follow-up|2|||
163076143|NCT01096186|588986865|FG000|Overall Study|Withdrawal by Subject|22|||
163076144|NCT01096186|588986865|FG000|Overall Study|Physician Decision|1|||
163076145|NCT01096186|588986865|FG000|Overall Study|Noncompliance with study drug|1|||
163076146|NCT01896986|588986866|FG000|Overall Study|samples lost|14|||
162645200|NCT00296374|587417786|FG002|Overall Study|Nephrologist introduced ACE|0|||
162645201|NCT00296374|587417784|FG000|Overall Study|Pregnancy|0|||
162645202|NCT00296374|587417785|FG001|Overall Study|Pregnancy|0|||
162645203|NCT00296374|587417786|FG002|Overall Study|Pregnancy|2|||
162645204|NCT00296374|587417784|FG000|Overall Study|Other|0|||
162645205|NCT00296374|587417785|FG001|Overall Study|Other|0|||
162645206|NCT00296374|587417786|FG002|Overall Study|Other|1|||
162645207|NCT01721330|587417787|FG000|Overall Study|Withdrawal by Subject|0|||
162645208|NCT01721330|587417788|FG001|Overall Study|Withdrawal by Subject|1|||
162645209|NCT01816893|587417789|FG000|Washout Period|Withdrawal by Subject|2|||
162645210|NCT01816893|587417790|FG001|Washout Period|Withdrawal by Subject|0|||
162645211|NCT00699972|587419269|FG000|Overall Study|Adverse Event|7|||
162645212|NCT00699972|587419270|FG001|Overall Study|Adverse Event|9|||
162645213|NCT00699972|587419271|FG002|Overall Study|Adverse Event|24|||
162645214|NCT00699972|587419269|FG000|Overall Study|Lost to Follow-up|0|||
162645215|NCT00699972|587419270|FG001|Overall Study|Lost to Follow-up|2|||
162645216|NCT00699972|587419271|FG002|Overall Study|Lost to Follow-up|0|||
162645217|NCT00699972|587419269|FG000|Overall Study|Withdrawal by Subject|3|||
162645218|NCT00699972|587419270|FG001|Overall Study|Withdrawal by Subject|7|||
162645219|NCT00699972|587419271|FG002|Overall Study|Withdrawal by Subject|4|||
162645220|NCT00699972|587419269|FG000|Overall Study|Lack of Efficacy|2|||
162645221|NCT00699972|587419270|FG001|Overall Study|Lack of Efficacy|0|||
162645222|NCT00699972|587419271|FG002|Overall Study|Lack of Efficacy|2|||
162645223|NCT00699972|587419269|FG000|Overall Study|Administrative/Other|3|||
162645224|NCT00699972|587419270|FG001|Overall Study|Administrative/Other|1|||
162645225|NCT00699972|587419271|FG002|Overall Study|Administrative/Other|4|||
162645226|NCT00699972|587419269|FG000|Overall Study|Randomized, Not Treated|1|||
162645227|NCT00699972|587419270|FG001|Overall Study|Randomized, Not Treated|0|||
162645228|NCT00699972|587419271|FG002|Overall Study|Randomized, Not Treated|1|||
162645229|NCT01545817|587419272|FG000|Pazopanib|Disease progression|51|||
162645230|NCT01545817|587419273|FG001|Pazopanib|Disease progression|0|||
162645231|NCT01545817|587419272|FG000|Pazopanib|Adverse Event|19|||
162645232|NCT01545817|587419273|FG001|Pazopanib|Adverse Event|0|||
162645233|NCT01545817|587419272|FG000|Pazopanib|Other reason|4|||
162645234|NCT01545817|587419273|FG001|Pazopanib|Other reason|0|||
162645235|NCT01545817|587419272|FG000|Everolimus|Other reason|0|||
162645236|NCT01545817|587419273|FG001|Everolimus|Other reason|7|||
162645237|NCT01545817|587419272|FG000|Everolimus|Disease progression|0|||
162645238|NCT01545817|587419273|FG001|Everolimus|Disease progression|25|||
162645239|NCT01545817|587419272|FG000|Everolimus|Adverse Event|0|||
162645240|NCT01545817|587419273|FG001|Everolimus|Adverse Event|6|||
162645241|NCT00706641|587419278|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
162645242|NCT00706641|587419278|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
163076147|NCT01896986|588986867|FG001|Overall Study|samples lost|23|||
163076148|NCT01750281|588986868|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
163076149|NCT01750281|588986869|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
163076150|NCT01750281|588986870|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
163076151|NCT01750281|588986868|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
163076152|NCT01750281|588986869|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
163076153|NCT01750281|588986870|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
163076154|NCT01750281|588986868|FG000|Overall Study|Did not receive treatment|0|||
163076155|NCT01750281|588986869|FG001|Overall Study|Did not receive treatment|1|||
163076156|NCT01750281|588986870|FG002|Overall Study|Did not receive treatment|0|||
163076157|NCT01658735|588986874|FG000|Overall Study|Lack of Efficacy|1|||
163076158|NCT01658735|588986875|FG001|Overall Study|Lack of Efficacy|0|||
163076159|NCT01658735|588986876|FG002|Overall Study|Lack of Efficacy|1|||
163076160|NCT01658735|588986874|FG000|Overall Study|Lost to Follow-up|1|||
163076161|NCT01658735|588986875|FG001|Overall Study|Lost to Follow-up|1|||
163076162|NCT01658735|588986876|FG002|Overall Study|Lost to Follow-up|0|||
163076163|NCT01658735|588986874|FG000|Overall Study|Protocol Violation|0|||
163076164|NCT01658735|588986875|FG001|Overall Study|Protocol Violation|1|||
163076165|NCT01658735|588986876|FG002|Overall Study|Protocol Violation|0|||
163076166|NCT01658735|588986874|FG000|Overall Study|Withdrawal by Subject|3|||
163076167|NCT01658735|588986875|FG001|Overall Study|Withdrawal by Subject|5|||
163076168|NCT01658735|588986876|FG002|Overall Study|Withdrawal by Subject|3|||
163076169|NCT03302936|588986878|FG000|Overall Study|Protocol Violation|3|||
163076170|NCT03302936|588986879|FG001|Overall Study|Protocol Violation|4|||
163076171|NCT01379937|588986880|FG000|Overall Study|Protocol Violation|0|||
163076172|NCT01379937|588986881|FG001|Overall Study|Protocol Violation|0|||
163076173|NCT01379937|588986882|FG002|Overall Study|Protocol Violation|0|||
163076174|NCT01379937|588986883|FG003|Overall Study|Protocol Violation|1|||
163076175|NCT01379937|588986880|FG000|Overall Study|Consent withdrawal|0|||
163076176|NCT01379937|588986881|FG001|Overall Study|Consent withdrawal|1|||
163076177|NCT01379937|588986882|FG002|Overall Study|Consent withdrawal|0|||
163076178|NCT01379937|588986883|FG003|Overall Study|Consent withdrawal|0|||
163076179|NCT01379937|588986880|FG000|Overall Study|Lost to Follow-up|1|||
163076180|NCT01379937|588986881|FG001|Overall Study|Lost to Follow-up|2|||
163076181|NCT01379937|588986882|FG002|Overall Study|Lost to Follow-up|2|||
163076182|NCT01379937|588986883|FG003|Overall Study|Lost to Follow-up|0|||
163076183|NCT00079781|588986884|FG000|Pre-implant Period|Withdrawal by Subject|2|||
163076184|NCT00079781|588986885|FG001|Pre-implant Period|Withdrawal by Subject|0|||
163076185|NCT00079781|588986886|FG002|Pre-implant Period|Withdrawal by Subject|0|||
163076186|NCT00079781|588986884|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
163076187|NCT00079781|588986885|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
163076188|NCT00079781|588986886|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
163076189|NCT00079781|588986884|FG000|Follow-up Period|Withdrawal by Subject|3|||
163076190|NCT00079781|588986885|FG001|Follow-up Period|Withdrawal by Subject|0|||
163076191|NCT00079781|588986886|FG002|Follow-up Period|Withdrawal by Subject|1|||
163076192|NCT00079781|588986884|FG000|Follow-up Period|Lost to Follow-up|1|||
163076193|NCT00079781|588986885|FG001|Follow-up Period|Lost to Follow-up|0|||
163076194|NCT00079781|588986886|FG002|Follow-up Period|Lost to Follow-up|0|||
163076195|NCT00079781|588986884|FG000|Follow-up Period|Death|0|||
163076196|NCT00079781|588986885|FG001|Follow-up Period|Death|0|||
163076197|NCT00079781|588986886|FG002|Follow-up Period|Death|1|||
163076198|NCT00564070|588986887|FG000|Overall Study|Lost to Follow-up|9|||
163076199|NCT00564070|588986888|FG001|Overall Study|Lost to Follow-up|7|||
163076200|NCT00564070|588986887|FG000|Overall Study|Worsening depression, referred to care|3|||
163076201|NCT00564070|588986888|FG001|Overall Study|Worsening depression, referred to care|0|||
163076202|NCT02264821|588986891|FG000|Overall Study|Protocol Violation|1|||
163076203|NCT02264821|588986892|FG001|Overall Study|Protocol Violation|3|||
163076204|NCT02264821|588986893|FG002|Overall Study|Protocol Violation|6|||
163076205|NCT02067156|588986895|FG000|Overall Study|Lost to Follow-up|4|||
163076206|NCT01853280|588986896|FG000|Overall Study|Lack of Efficacy|2|||
163076207|NCT01853280|588986897|FG001|Overall Study|Lack of Efficacy|2|||
163076208|NCT01853280|588986896|FG000|Overall Study|Lost to Follow-up|0|||
163076209|NCT01853280|588986897|FG001|Overall Study|Lost to Follow-up|1|||
163076210|NCT01853280|588986896|FG000|Overall Study|Physician Decision|0|||
163076211|NCT01853280|588986897|FG001|Overall Study|Physician Decision|1|||
163076212|NCT01853280|588986896|FG000|Overall Study|Withdrawal by Subject|0|||
163076213|NCT01853280|588986897|FG001|Overall Study|Withdrawal by Subject|1|||
163076214|NCT01853280|588986896|FG000|Overall Study|Ineligible|0|||
162645243|NCT00706641|587419278|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
162645244|NCT04782856|587419279|FG000|Overall Study|Withdrawal by Subject|0|||
162645245|NCT04782856|587419280|FG001|Overall Study|Withdrawal by Subject|1|||
163076215|NCT01853280|588986897|FG001|Overall Study|Ineligible|1|||
163076216|NCT01655069|588986898|FG000|Overall Study|Physician Decision|0|||
163076217|NCT01655069|588986899|FG001|Overall Study|Physician Decision|0|||
163076218|NCT01655069|588986900|FG002|Overall Study|Physician Decision|0|||
162645246|NCT00798369|587419281|FG000|Overall Study|Subject withdrew consent|0|||
163076219|NCT01655069|588986901|FG003|Overall Study|Physician Decision|1|||
163076220|NCT01655069|588986898|FG000|Overall Study|Adverse Event|6|||
162645247|NCT00798369|587419282|FG001|Overall Study|Subject withdrew consent|0|||
163076221|NCT01655069|588986899|FG001|Overall Study|Adverse Event|7|||
163076222|NCT01655069|588986900|FG002|Overall Study|Adverse Event|2|||
163076223|NCT01655069|588986901|FG003|Overall Study|Adverse Event|3|||
163076224|NCT01655069|588986898|FG000|Overall Study|Lack of Efficacy|0|||
163076225|NCT01655069|588986899|FG001|Overall Study|Lack of Efficacy|1|||
163076226|NCT01655069|588986900|FG002|Overall Study|Lack of Efficacy|0|||
163076227|NCT01655069|588986901|FG003|Overall Study|Lack of Efficacy|0|||
163076228|NCT01655069|588986898|FG000|Overall Study|No Treatment Needed|0|||
163076229|NCT01655069|588986899|FG001|Overall Study|No Treatment Needed|1|||
163076230|NCT01655069|588986900|FG002|Overall Study|No Treatment Needed|0|||
163076231|NCT01655069|588986901|FG003|Overall Study|No Treatment Needed|0|||
163076232|NCT01655069|588986898|FG000|Overall Study|Withdrawal by Subject|2|||
163076233|NCT01655069|588986899|FG001|Overall Study|Withdrawal by Subject|3|||
163076234|NCT01655069|588986900|FG002|Overall Study|Withdrawal by Subject|0|||
163076235|NCT01655069|588986901|FG003|Overall Study|Withdrawal by Subject|0|||
163076236|NCT00835042|588986902|FG000|First Intervention|Withdrawal by Subject|3|||
162645248|NCT00798369|587419283|FG002|Overall Study|Subject withdrew consent|1|||
162645249|NCT00798369|587419284|FG003|Overall Study|Subject withdrew consent|1|||
162645250|NCT00798369|587419285|FG004|Overall Study|Subject withdrew consent|0|||
162645251|NCT00798369|587419286|FG005|Overall Study|Subject withdrew consent|2|||
162645252|NCT00798369|587419281|FG000|Overall Study|Lost to Follow-up|1|||
162645253|NCT00798369|587419282|FG001|Overall Study|Lost to Follow-up|1|||
162645254|NCT00798369|587419283|FG002|Overall Study|Lost to Follow-up|1|||
162645255|NCT00798369|587419284|FG003|Overall Study|Lost to Follow-up|0|||
162645256|NCT00798369|587419285|FG004|Overall Study|Lost to Follow-up|1|||
162645257|NCT00798369|587419286|FG005|Overall Study|Lost to Follow-up|0|||
162645258|NCT00798369|587419281|FG000|Overall Study|Adminstrative problems|0|||
162645259|NCT00798369|587419282|FG001|Overall Study|Adminstrative problems|0|||
162645260|NCT00798369|587419283|FG002|Overall Study|Adminstrative problems|0|||
163028523|NCT02543892|588807297|FG000|Received Vaccination 2|Physician Decision|0|||
163028524|NCT02543892|588807298|FG001|Received Vaccination 2|Physician Decision|0|||
163028525|NCT02543892|588807299|FG002|Received Vaccination 2|Physician Decision|0|||
163028526|NCT02543892|588807300|FG003|Received Vaccination 2|Physician Decision|0|||
163028527|NCT02543892|588807301|FG004|Received Vaccination 2|Physician Decision|0|||
163028528|NCT02543892|588807302|FG005|Received Vaccination 2|Physician Decision|1|||
163028529|NCT02543892|588807303|FG006|Received Vaccination 2|Physician Decision|0|||
163028530|NCT02543892|588807304|FG007|Received Vaccination 2|Physician Decision|0|||
163028531|NCT02543892|588807297|FG000|Received Vaccination 2|Adverse Event|0|||
163028532|NCT02543892|588807298|FG001|Received Vaccination 2|Adverse Event|1|||
163028533|NCT02543892|588807299|FG002|Received Vaccination 2|Adverse Event|0|||
163028534|NCT02543892|588807300|FG003|Received Vaccination 2|Adverse Event|0|||
163028535|NCT02543892|588807301|FG004|Received Vaccination 2|Adverse Event|0|||
163028536|NCT02543892|588807302|FG005|Received Vaccination 2|Adverse Event|0|||
163028537|NCT02543892|588807303|FG006|Received Vaccination 2|Adverse Event|0|||
163028538|NCT02543892|588807304|FG007|Received Vaccination 2|Adverse Event|0|||
163028539|NCT02543892|588807297|FG000|Had Immunology Data|Withdrawal by Subject|0|||
163028540|NCT02543892|588807298|FG001|Had Immunology Data|Withdrawal by Subject|0|||
163028541|NCT02543892|588807299|FG002|Had Immunology Data|Withdrawal by Subject|0|||
163028542|NCT02543892|588807300|FG003|Had Immunology Data|Withdrawal by Subject|0|||
163028543|NCT02543892|588807301|FG004|Had Immunology Data|Withdrawal by Subject|0|||
163028544|NCT02543892|588807302|FG005|Had Immunology Data|Withdrawal by Subject|0|||
163028545|NCT02543892|588807303|FG006|Had Immunology Data|Withdrawal by Subject|1|||
163028546|NCT02543892|588807304|FG007|Had Immunology Data|Withdrawal by Subject|0|||
163028547|NCT01199822|588807305|FG000|Overall Study|Investigator discontinued therapy|0|||
163028548|NCT01199822|588807306|FG001|Overall Study|Investigator discontinued therapy|1|||
163028549|NCT01199822|588807307|FG002|Overall Study|Investigator discontinued therapy|0|||
163028550|NCT01500213|588807308|FG000|Overall Study|Adverse Event|35|||
163028551|NCT01500213|588807309|FG001|Overall Study|Adverse Event|35|||
163028552|NCT01500213|588807308|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
163028553|NCT01500213|588807309|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
163028554|NCT01500213|588807308|FG000|Overall Study|Withdrawal by Subject|28|||
163028555|NCT01500213|588807309|FG001|Overall Study|Withdrawal by Subject|37|||
163028556|NCT01500213|588807308|FG000|Overall Study|Death|7|||
163028557|NCT01500213|588807309|FG001|Overall Study|Death|3|||
163028558|NCT01500213|588807308|FG000|Overall Study|Disease Progression|13|||
163028559|NCT01500213|588807309|FG001|Overall Study|Disease Progression|21|||
163028560|NCT01500213|588807308|FG000|Overall Study|Protocol Violation|19|||
163028561|NCT01500213|588807309|FG001|Overall Study|Protocol Violation|19|||
163028562|NCT01500213|588807308|FG000|Overall Study|Physician Decision|12|||
163028563|NCT01500213|588807309|FG001|Overall Study|Physician Decision|10|||
163028564|NCT01500213|588807308|FG000|Overall Study|Lack of Efficacy|9|||
163028565|NCT01500213|588807309|FG001|Overall Study|Lack of Efficacy|7|||
163028566|NCT01500213|588807308|FG000|Overall Study|Lost to Follow-up|3|||
163028567|NCT01500213|588807309|FG001|Overall Study|Lost to Follow-up|6|||
163028568|NCT01500213|588807308|FG000|Overall Study|Other Reasons|7|||
163028569|NCT01500213|588807309|FG001|Overall Study|Other Reasons|5|||
163028570|NCT04027075|588807310|FG000|Overall Study|Lost to Follow-up|41|||
163028571|NCT04027075|588807311|FG001|Overall Study|Lost to Follow-up|22|||
163028572|NCT01195844|588807312|FG000|Overall Study|Fecal sample not collected|40|||
163028573|NCT00581542|588807313|FG000|Overall Study|they met an exclusion criteria|2|||
163028574|NCT00581542|588807314|FG001|Overall Study|they met an exclusion criteria|2|||
163028575|NCT00581542|588807313|FG000|Overall Study|Lost to Follow-up|9|||
162645261|NCT00798369|587419284|FG003|Overall Study|Adminstrative problems|0|||
163076237|NCT00835042|588986903|FG001|First Intervention|Withdrawal by Subject|0|||
163076238|NCT00835042|588986902|FG000|First Intervention|Adverse Event|1|||
163076239|NCT00835042|588986903|FG001|First Intervention|Adverse Event|2|||
163076240|NCT00835042|588986902|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
163076241|NCT00835042|588986903|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
163076242|NCT02453191|588986905|FG000|Overall Study|Withdrawal by Subject|1|||
163076243|NCT02571244|588986906|FG000|Overall Study|Lost to Follow-up|0|||
163076244|NCT02571244|588986907|FG001|Overall Study|Lost to Follow-up|1|||
163076245|NCT02571244|588986906|FG000|Overall Study|Unable to reach out post discharge|3|||
163076246|NCT02571244|588986907|FG001|Overall Study|Unable to reach out post discharge|0|||
163076247|NCT01696214|588986910|FG000|Overall Study|Lost to Follow-up|1|||
163076248|NCT01696214|588986911|FG001|Overall Study|Lost to Follow-up|0|||
163028576|NCT00581542|588807314|FG001|Overall Study|Lost to Follow-up|21|||
163028577|NCT01801280|588807315|FG000|Period 1|Withdrawal by Subject|0|||
163028578|NCT01801280|588807316|FG001|Period 1|Withdrawal by Subject|1|||
163028579|NCT01801280|588807317|FG002|Period 1|Withdrawal by Subject|0|||
163028580|NCT01801280|588807318|FG003|Period 1|Withdrawal by Subject|0|||
163028581|NCT01801280|588807315|FG000|Period 2|Withdrawal by Subject|1|||
163028582|NCT01801280|588807316|FG001|Period 2|Withdrawal by Subject|0|||
163028583|NCT01801280|588807317|FG002|Period 2|Withdrawal by Subject|0|||
163028584|NCT01801280|588807318|FG003|Period 2|Withdrawal by Subject|0|||
163028585|NCT01801280|588807315|FG000|Period 4|Protocol Violation|0|||
163028586|NCT01801280|588807316|FG001|Period 4|Protocol Violation|0|||
163028587|NCT01801280|588807317|FG002|Period 4|Protocol Violation|1|||
163028588|NCT01801280|588807318|FG003|Period 4|Protocol Violation|0|||
163028589|NCT00176644|588807319|FG000|Overall Study|Withdrawal by Subject|1|||
163028590|NCT05020366|588807320|FG000|Overall Study|Lost to Follow-up|2|||
163028591|NCT05020366|588807321|FG001|Overall Study|Lost to Follow-up|0|||
163028592|NCT05020366|588807320|FG000|Overall Study|Withdrawal by Subject|2|||
163028593|NCT05020366|588807321|FG001|Overall Study|Withdrawal by Subject|0|||
163028594|NCT00195494|588807323|FG000|Year 1|Adverse Event|0|||
163028595|NCT00195494|588807324|FG001|Year 1|Adverse Event|0|||
163028596|NCT00195494|588807325|FG002|Year 1|Adverse Event|0|||
163028597|NCT00195494|588807326|FG003|Year 1|Adverse Event|0|||
163028598|NCT00195494|588807327|FG004|Year 1|Adverse Event|34|||
163028599|NCT00195494|588807328|FG005|Year 1|Adverse Event|27|||
163028600|NCT00195494|588807323|FG000|Year 1|System Toxicity|0|||
163028601|NCT00195494|588807324|FG001|Year 1|System Toxicity|0|||
163028602|NCT00195494|588807325|FG002|Year 1|System Toxicity|0|||
163028603|NCT00195494|588807326|FG003|Year 1|System Toxicity|0|||
163028604|NCT00195494|588807327|FG004|Year 1|System Toxicity|0|||
163028605|NCT00195494|588807328|FG005|Year 1|System Toxicity|1|||
163028606|NCT00195494|588807323|FG000|Year 1|Lack of Efficacy|0|||
163028607|NCT00195494|588807324|FG001|Year 1|Lack of Efficacy|0|||
163028608|NCT00195494|588807325|FG002|Year 1|Lack of Efficacy|0|||
163028609|NCT00195494|588807326|FG003|Year 1|Lack of Efficacy|0|||
163028610|NCT00195494|588807327|FG004|Year 1|Lack of Efficacy|24|||
163028611|NCT00195494|588807328|FG005|Year 1|Lack of Efficacy|9|||
163028612|NCT00195494|588807323|FG000|Year 1|Compliance|0|||
163028613|NCT00195494|588807324|FG001|Year 1|Compliance|0|||
163028614|NCT00195494|588807325|FG002|Year 1|Compliance|0|||
163028615|NCT00195494|588807326|FG003|Year 1|Compliance|0|||
163028616|NCT00195494|588807327|FG004|Year 1|Compliance|5|||
163028617|NCT00195494|588807328|FG005|Year 1|Compliance|1|||
163028618|NCT00195494|588807323|FG000|Year 1|Lost to Follow-up|0|||
163028619|NCT00195494|588807324|FG001|Year 1|Lost to Follow-up|0|||
163028620|NCT00195494|588807325|FG002|Year 1|Lost to Follow-up|0|||
163028621|NCT00195494|588807326|FG003|Year 1|Lost to Follow-up|0|||
163028622|NCT00195494|588807327|FG004|Year 1|Lost to Follow-up|1|||
163028623|NCT00195494|588807328|FG005|Year 1|Lost to Follow-up|0|||
163028624|NCT00195494|588807323|FG000|Year 1|Missed >4 consecutive doses|0|||
163028625|NCT00195494|588807324|FG001|Year 1|Missed >4 consecutive doses|0|||
163028626|NCT00195494|588807325|FG002|Year 1|Missed >4 consecutive doses|0|||
163028627|NCT00195494|588807326|FG003|Year 1|Missed >4 consecutive doses|0|||
163028628|NCT00195494|588807327|FG004|Year 1|Missed >4 consecutive doses|3|||
163028629|NCT00195494|588807328|FG005|Year 1|Missed >4 consecutive doses|2|||
163028630|NCT00195494|588807323|FG000|Year 1|Protocol deviation|0|||
163028631|NCT00195494|588807324|FG001|Year 1|Protocol deviation|0|||
163028632|NCT00195494|588807325|FG002|Year 1|Protocol deviation|0|||
163028633|NCT00195494|588807326|FG003|Year 1|Protocol deviation|0|||
163028634|NCT00195494|588807327|FG004|Year 1|Protocol deviation|2|||
163028635|NCT00195494|588807328|FG005|Year 1|Protocol deviation|3|||
163028636|NCT00195494|588807323|FG000|Year 1|Physician Decision|0|||
163028637|NCT00195494|588807324|FG001|Year 1|Physician Decision|0|||
163028638|NCT00195494|588807325|FG002|Year 1|Physician Decision|0|||
163028639|NCT00195494|588807326|FG003|Year 1|Physician Decision|0|||
163028640|NCT00195494|588807327|FG004|Year 1|Physician Decision|1|||
163028641|NCT00195494|588807328|FG005|Year 1|Physician Decision|0|||
163028642|NCT00195494|588807323|FG000|Year 1|Withdrawal by Subject|0|||
163028643|NCT00195494|588807324|FG001|Year 1|Withdrawal by Subject|0|||
163028644|NCT00195494|588807325|FG002|Year 1|Withdrawal by Subject|0|||
163028645|NCT00195494|588807326|FG003|Year 1|Withdrawal by Subject|0|||
163028646|NCT00195494|588807327|FG004|Year 1|Withdrawal by Subject|8|||
163028647|NCT00195494|588807328|FG005|Year 1|Withdrawal by Subject|9|||
163076249|NCT01696214|588986912|FG002|Overall Study|Lost to Follow-up|0|||
162645262|NCT00798369|587419285|FG004|Overall Study|Adminstrative problems|0|||
162645263|NCT00798369|587419286|FG005|Overall Study|Adminstrative problems|1|||
162645264|NCT04475588|587419287|FG000|Overall Study|Adverse Event|2|||
162645265|NCT04475588|587419288|FG001|Overall Study|Adverse Event|0|||
162645266|NCT01327300|587419289|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
162645267|NCT01327300|587419290|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
162645268|NCT02603432|587419291|FG000|Overall Study|Adverse Event|1|||
162645269|NCT02603432|587419292|FG001|Overall Study|Adverse Event|0|||
162645270|NCT02603432|587419291|FG000|Overall Study|Death|221|||
162645271|NCT02603432|587419292|FG001|Overall Study|Death|242|||
162645272|NCT02603432|587419291|FG000|Overall Study|Lost to Follow-up|3|||
162645273|NCT02603432|587419292|FG001|Overall Study|Lost to Follow-up|9|||
163028648|NCT00195494|588807323|FG000|Year 1|Protocol Violation|0|||
163028649|NCT00195494|588807324|FG001|Year 1|Protocol Violation|0|||
163028650|NCT00195494|588807325|FG002|Year 1|Protocol Violation|0|||
163028651|NCT00195494|588807326|FG003|Year 1|Protocol Violation|0|||
163028652|NCT00195494|588807327|FG004|Year 1|Protocol Violation|1|||
163028653|NCT00195494|588807328|FG005|Year 1|Protocol Violation|1|||
163028654|NCT00195494|588807323|FG000|Year 2|Adverse Event|3|||
163028655|NCT00195494|588807324|FG001|Year 2|Adverse Event|7|||
163028656|NCT00195494|588807325|FG002|Year 2|Adverse Event|5|||
163028657|NCT00195494|588807326|FG003|Year 2|Adverse Event|9|||
163028658|NCT00195494|588807327|FG004|Year 2|Adverse Event|0|||
163028659|NCT00195494|588807328|FG005|Year 2|Adverse Event|0|||
163028660|NCT00195494|588807323|FG000|Year 2|Lack of Efficacy|0|||
163028661|NCT00195494|588807324|FG001|Year 2|Lack of Efficacy|1|||
163028662|NCT00195494|588807325|FG002|Year 2|Lack of Efficacy|7|||
163028663|NCT00195494|588807326|FG003|Year 2|Lack of Efficacy|7|||
163028664|NCT00195494|588807327|FG004|Year 2|Lack of Efficacy|0|||
163028665|NCT00195494|588807328|FG005|Year 2|Lack of Efficacy|0|||
163028666|NCT00195494|588807323|FG000|Year 2|Compliance|1|||
163028667|NCT00195494|588807324|FG001|Year 2|Compliance|0|||
163028668|NCT00195494|588807325|FG002|Year 2|Compliance|0|||
163028669|NCT00195494|588807326|FG003|Year 2|Compliance|2|||
163028670|NCT00195494|588807327|FG004|Year 2|Compliance|0|||
163028671|NCT00195494|588807328|FG005|Year 2|Compliance|0|||
163028672|NCT00195494|588807323|FG000|Year 2|Lost to Follow-up|0|||
163028673|NCT00195494|588807324|FG001|Year 2|Lost to Follow-up|0|||
163028674|NCT00195494|588807325|FG002|Year 2|Lost to Follow-up|1|||
163028675|NCT00195494|588807326|FG003|Year 2|Lost to Follow-up|1|||
163028676|NCT00195494|588807327|FG004|Year 2|Lost to Follow-up|0|||
163028677|NCT00195494|588807328|FG005|Year 2|Lost to Follow-up|0|||
163028678|NCT00195494|588807323|FG000|Year 2|Missed >4 consecutive doses|1|||
163028679|NCT00195494|588807324|FG001|Year 2|Missed >4 consecutive doses|1|||
163028680|NCT00195494|588807325|FG002|Year 2|Missed >4 consecutive doses|1|||
163028681|NCT00195494|588807326|FG003|Year 2|Missed >4 consecutive doses|0|||
163028682|NCT00195494|588807327|FG004|Year 2|Missed >4 consecutive doses|0|||
163028683|NCT00195494|588807328|FG005|Year 2|Missed >4 consecutive doses|0|||
163028684|NCT00195494|588807323|FG000|Year 2|Protocol deviation|0|||
163028685|NCT00195494|588807324|FG001|Year 2|Protocol deviation|1|||
163028686|NCT00195494|588807325|FG002|Year 2|Protocol deviation|0|||
163028687|NCT00195494|588807326|FG003|Year 2|Protocol deviation|0|||
163028688|NCT00195494|588807327|FG004|Year 2|Protocol deviation|0|||
163028689|NCT00195494|588807328|FG005|Year 2|Protocol deviation|0|||
163028690|NCT00195494|588807323|FG000|Year 2|Physician Decision|1|||
163028691|NCT00195494|588807324|FG001|Year 2|Physician Decision|1|||
163028692|NCT00195494|588807325|FG002|Year 2|Physician Decision|0|||
163028693|NCT00195494|588807326|FG003|Year 2|Physician Decision|0|||
163028694|NCT00195494|588807327|FG004|Year 2|Physician Decision|0|||
163028695|NCT00195494|588807328|FG005|Year 2|Physician Decision|0|||
163028696|NCT00195494|588807323|FG000|Year 2|Withdrawal by Subject|1|||
163028697|NCT00195494|588807324|FG001|Year 2|Withdrawal by Subject|5|||
163028698|NCT00195494|588807325|FG002|Year 2|Withdrawal by Subject|4|||
163028699|NCT00195494|588807326|FG003|Year 2|Withdrawal by Subject|3|||
163028700|NCT00195494|588807327|FG004|Year 2|Withdrawal by Subject|0|||
163028701|NCT00195494|588807328|FG005|Year 2|Withdrawal by Subject|0|||
163028702|NCT00195494|588807323|FG000|Year 2|System toxicity|0|||
163076250|NCT01696214|588986913|FG003|Overall Study|Lost to Follow-up|0|||
163028703|NCT00195494|588807324|FG001|Year 2|System toxicity|0|||
163028704|NCT00195494|588807325|FG002|Year 2|System toxicity|0|||
163028705|NCT00195494|588807326|FG003|Year 2|System toxicity|1|||
163028706|NCT00195494|588807327|FG004|Year 2|System toxicity|0|||
163028707|NCT00195494|588807328|FG005|Year 2|System toxicity|0|||
163028708|NCT00381043|588807333|FG000|Overall Study|Lost to Follow-up|8|||
163028709|NCT00381043|588807334|FG001|Overall Study|Lost to Follow-up|6|||
162645274|NCT02603432|587419291|FG000|Overall Study|Progressive Disease|7|||
162645275|NCT02603432|587419292|FG001|Overall Study|Progressive Disease|5|||
162645276|NCT02603432|587419291|FG000|Overall Study|Withdrawal by Subject|12|||
163028710|NCT00381043|588807333|FG000|Overall Study|Withdrawal by Subject|3|||
163028711|NCT00381043|588807334|FG001|Overall Study|Withdrawal by Subject|1|||
163028712|NCT00381043|588807333|FG000|Overall Study|wanted more care|0|||
163028713|NCT00381043|588807334|FG001|Overall Study|wanted more care|1|||
163028714|NCT00381043|588807333|FG000|Overall Study|incarcerated|1|||
163028715|NCT00381043|588807334|FG001|Overall Study|incarcerated|0|||
163076251|NCT02134028|588986914|FG000|Overall Study|Lack of Efficacy|1|||
163076252|NCT02134028|588986915|FG001|Overall Study|Lack of Efficacy|0|||
163076253|NCT02134028|588986916|FG002|Overall Study|Lack of Efficacy|3|||
163076254|NCT02134028|588986917|FG003|Overall Study|Lack of Efficacy|2|||
163076255|NCT02134028|588986918|FG004|Overall Study|Lack of Efficacy|1|||
163076256|NCT02134028|588986919|FG005|Overall Study|Lack of Efficacy|2|||
163076257|NCT02134028|588986920|FG006|Overall Study|Lack of Efficacy|1|||
163076258|NCT02134028|588986921|FG007|Overall Study|Lack of Efficacy|0|||
163076259|NCT02134028|588986914|FG000|Overall Study|Poor compliance to protocol|1|||
163076260|NCT02134028|588986915|FG001|Overall Study|Poor compliance to protocol|1|||
163076261|NCT02134028|588986916|FG002|Overall Study|Poor compliance to protocol|3|||
163076262|NCT02134028|588986917|FG003|Overall Study|Poor compliance to protocol|7|||
162645277|NCT02603432|587419292|FG001|Overall Study|Withdrawal by Subject|18|||
162645278|NCT02603432|587419291|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
162645279|NCT02603432|587419292|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163028716|NCT03045276|588807337|FG000|Intervention Phase|Withdrawal by Subject|7|||
163028717|NCT03045276|588807338|FG001|Intervention Phase|Withdrawal by Subject|2|||
163028718|NCT03045276|588807339|FG002|Intervention Phase|Withdrawal by Subject|3|||
163028719|NCT03045276|588807340|FG003|Intervention Phase|Withdrawal by Subject|7|||
163028720|NCT03045276|588807337|FG000|Intervention Phase|Developed exclusionary criteria|3|||
163028721|NCT03045276|588807338|FG001|Intervention Phase|Developed exclusionary criteria|3|||
163028722|NCT03045276|588807339|FG002|Intervention Phase|Developed exclusionary criteria|0|||
163028723|NCT03045276|588807340|FG003|Intervention Phase|Developed exclusionary criteria|0|||
163028724|NCT03045276|588807337|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
163028725|NCT03045276|588807338|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
163028726|NCT03045276|588807339|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
163028727|NCT03045276|588807340|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
163028728|NCT03045276|588807337|FG000|Follow-Up Phase|Lost to Follow-up|0|||
163028729|NCT03045276|588807338|FG001|Follow-Up Phase|Lost to Follow-up|1|||
163028730|NCT03045276|588807339|FG002|Follow-Up Phase|Lost to Follow-up|0|||
163028731|NCT03045276|588807340|FG003|Follow-Up Phase|Lost to Follow-up|1|||
163028732|NCT03045276|588807337|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
163028733|NCT03045276|588807338|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
163028734|NCT03045276|588807339|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
163028735|NCT03045276|588807340|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
163028736|NCT00347919|588807343|FG000|Overall Study|Lost to Follow-up|11|||
163028737|NCT00347919|588807344|FG001|Overall Study|Lost to Follow-up|13|||
163028738|NCT00347919|588807345|FG002|Overall Study|Lost to Follow-up|0|||
163028739|NCT00347919|588807343|FG000|Overall Study|Withdrawal by Subject|6|||
163028740|NCT00347919|588807344|FG001|Overall Study|Withdrawal by Subject|8|||
163028741|NCT00347919|588807345|FG002|Overall Study|Withdrawal by Subject|0|||
163028742|NCT00347919|588807343|FG000|Overall Study|Physician Decision|1|||
163028743|NCT00347919|588807344|FG001|Overall Study|Physician Decision|1|||
163028744|NCT00347919|588807345|FG002|Overall Study|Physician Decision|0|||
163028745|NCT00347919|588807343|FG000|Overall Study|Sponsor terminated study|15|||
163028746|NCT00347919|588807344|FG001|Overall Study|Sponsor terminated study|10|||
163028747|NCT00347919|588807345|FG002|Overall Study|Sponsor terminated study|16|||
163028748|NCT00347919|588807343|FG000|Overall Study|Death|35|||
163028749|NCT00347919|588807344|FG001|Overall Study|Death|42|||
163028750|NCT00347919|588807345|FG002|Overall Study|Death|19|||
163028751|NCT00347919|588807343|FG000|Overall Study|Par. Started Other Treatment|1|||
163028752|NCT00347919|588807344|FG001|Overall Study|Par. Started Other Treatment|1|||
163028753|NCT00347919|588807345|FG002|Overall Study|Par. Started Other Treatment|1|||
163028754|NCT00347919|588807343|FG000|Overall Study|Missing|2|||
163028755|NCT00347919|588807344|FG001|Overall Study|Missing|1|||
163028756|NCT00347919|588807345|FG002|Overall Study|Missing|2|||
163028757|NCT00533702|588807351|FG000|Overall Study|Withdrawal by Subject|3|||
163028758|NCT00533702|588807352|FG001|Overall Study|Withdrawal by Subject|1|||
163028759|NCT00533702|588807351|FG000|Overall Study|Found ineligible after randomization|2|||
163028760|NCT00533702|588807352|FG001|Overall Study|Found ineligible after randomization|1|||
163028761|NCT01970475|588807355|FG000|Overall Study|Withdrawal by Subject|11|||
163028762|NCT01970475|588807356|FG001|Overall Study|Withdrawal by Subject|6|||
163028763|NCT01970475|588807355|FG000|Overall Study|Adverse Event|7|||
163028764|NCT01970475|588807356|FG001|Overall Study|Adverse Event|3|||
163028765|NCT01970475|588807355|FG000|Overall Study|Lost to Follow-up|2|||
163028766|NCT01970475|588807356|FG001|Overall Study|Lost to Follow-up|2|||
163076263|NCT02134028|588986918|FG004|Overall Study|Poor compliance to protocol|1|||
163076264|NCT02134028|588986919|FG005|Overall Study|Poor compliance to protocol|1|||
163076265|NCT02134028|588986920|FG006|Overall Study|Poor compliance to protocol|0|||
163076266|NCT02134028|588986921|FG007|Overall Study|Poor compliance to protocol|0|||
163076267|NCT02134028|588986914|FG000|Overall Study|Other unspecified|4|||
163076268|NCT02134028|588986915|FG001|Overall Study|Other unspecified|22|||
163076269|NCT02134028|588986916|FG002|Overall Study|Other unspecified|33|||
163076270|NCT02134028|588986917|FG003|Overall Study|Other unspecified|64|||
163076271|NCT02134028|588986918|FG004|Overall Study|Other unspecified|8|||
163076272|NCT02134028|588986919|FG005|Overall Study|Other unspecified|6|||
163076273|NCT02134028|588986920|FG006|Overall Study|Other unspecified|2|||
163076274|NCT02134028|588986921|FG007|Overall Study|Other unspecified|1|||
163076275|NCT02134028|588986914|FG000|Overall Study|Adverse Event|3|||
163076276|NCT02134028|588986915|FG001|Overall Study|Adverse Event|19|||
163076277|NCT02134028|588986916|FG002|Overall Study|Adverse Event|13|||
163076278|NCT02134028|588986917|FG003|Overall Study|Adverse Event|32|||
163076279|NCT02134028|588986918|FG004|Overall Study|Adverse Event|4|||
163076280|NCT02134028|588986919|FG005|Overall Study|Adverse Event|5|||
163076281|NCT02134028|588986920|FG006|Overall Study|Adverse Event|1|||
163076282|NCT02134028|588986921|FG007|Overall Study|Adverse Event|2|||
163076283|NCT01309100|588986924|FG000|Overall Study|Protocol Violation|1|||
163076284|NCT01309100|588986924|FG000|Overall Study|Positive Slit lamp finding|1|||
163076285|NCT03722030|588986925|FG000|Overall Study|Withdrawal by Subject|1|||
163076286|NCT03722030|588986926|FG001|Overall Study|Withdrawal by Subject|0|||
163076287|NCT01663987|588986928|FG000|Overall Study|Adverse Event|7|||
163076288|NCT01663987|588986929|FG001|Overall Study|Adverse Event|2|||
163076289|NCT01663987|588986928|FG000|Overall Study|Lost to Follow-up|1|||
163076290|NCT01663987|588986929|FG001|Overall Study|Lost to Follow-up|1|||
163076291|NCT01663987|588986928|FG000|Overall Study|Withdrawal by Subject|2|||
163076292|NCT01663987|588986929|FG001|Overall Study|Withdrawal by Subject|3|||
163076293|NCT01663987|588986928|FG000|Overall Study|Other reason not defined above|3|||
163076294|NCT01663987|588986929|FG001|Overall Study|Other reason not defined above|0|||
163076295|NCT01065766|588986930|FG000|Overall Study|Assessed before the contracted date|1|||
163076296|NCT01065766|588986930|FG000|Overall Study|Contraindication to administration|6|||
163076297|NCT01065766|588986930|FG000|Overall Study|Violated dosage/administration|25|||
163076298|NCT02362412|588986934|FG000|Treatment Period III|Lost to Follow-up|0|||
163076299|NCT02362412|588986935|FG001|Treatment Period III|Lost to Follow-up|1|||
163076300|NCT00545948|588986936|FG000|Overall Study|Not Treated|1|||
163076301|NCT00545948|588986937|FG001|Overall Study|Not Treated|1|||
163076302|NCT00545948|588986938|FG002|Overall Study|Not Treated|7|||
163076303|NCT01541254|588986942|FG000|Overall Study|Withdrawal by Subject|1|||
163076304|NCT01541254|588986942|FG000|Overall Study|excluded - metal allergy|1|||
163076305|NCT01541254|588986942|FG000|Overall Study|enrolled after study closed|1|||
163076306|NCT01541254|588986942|FG000|Overall Study|GI bleed prior to procedure|1|||
163076307|NCT01541254|588986942|FG000|Overall Study|stent not required|1|||
163076308|NCT01541254|588986942|FG000|Overall Study|alternate stent used|1|||
163076309|NCT04518410|588986943|FG000|Overall Study|Lost to Follow-up|1|||
163076310|NCT04518410|588986944|FG001|Overall Study|Lost to Follow-up|1|||
163076311|NCT04518410|588986945|FG002|Overall Study|Lost to Follow-up|8|||
163076312|NCT04518410|588986946|FG003|Overall Study|Lost to Follow-up|5|||
163076313|NCT04518410|588986947|FG004|Overall Study|Lost to Follow-up|92|||
163076314|NCT04518410|588986948|FG005|Overall Study|Lost to Follow-up|25|||
163076315|NCT04518410|588986949|FG006|Overall Study|Lost to Follow-up|25|||
163076316|NCT04518410|588986950|FG007|Overall Study|Lost to Follow-up|3|||
163076317|NCT04518410|588986951|FG008|Overall Study|Lost to Follow-up|2|||
163076318|NCT04518410|588986952|FG009|Overall Study|Lost to Follow-up|13|||
163076319|NCT04518410|588986953|FG010|Overall Study|Lost to Follow-up|9|||
163076320|NCT04518410|588986954|FG011|Overall Study|Lost to Follow-up|13|||
163076321|NCT04518410|588986955|FG012|Overall Study|Lost to Follow-up|9|||
163076322|NCT04518410|588986956|FG013|Overall Study|Lost to Follow-up|13|||
163076323|NCT04518410|588986957|FG014|Overall Study|Lost to Follow-up|8|||
163076324|NCT04518410|588986958|FG015|Overall Study|Lost to Follow-up|10|||
163076325|NCT04518410|588986959|FG016|Overall Study|Lost to Follow-up|6|||
163076326|NCT04518410|588986960|FG017|Overall Study|Lost to Follow-up|13|||
163076327|NCT04518410|588986961|FG018|Overall Study|Lost to Follow-up|21|||
163076328|NCT04518410|588986962|FG019|Overall Study|Lost to Follow-up|6|||
163076329|NCT04518410|588986963|FG020|Overall Study|Lost to Follow-up|7|||
163076330|NCT04518410|588986964|FG021|Overall Study|Lost to Follow-up|21|||
163076331|NCT04518410|588986965|FG022|Overall Study|Lost to Follow-up|1|||
163076332|NCT04518410|588986966|FG023|Overall Study|Lost to Follow-up|7|||
163076333|NCT04518410|588986967|FG024|Overall Study|Lost to Follow-up|6|||
163076334|NCT04518410|588986943|FG000|Overall Study|Withdrawal by Subject|1|||
163076335|NCT04518410|588986944|FG001|Overall Study|Withdrawal by Subject|2|||
163076336|NCT04518410|588986945|FG002|Overall Study|Withdrawal by Subject|2|||
163076337|NCT04518410|588986946|FG003|Overall Study|Withdrawal by Subject|3|||
163076338|NCT04518410|588986947|FG004|Overall Study|Withdrawal by Subject|20|||
163076339|NCT04518410|588986948|FG005|Overall Study|Withdrawal by Subject|20|||
163076340|NCT04518410|588986949|FG006|Overall Study|Withdrawal by Subject|25|||
163076341|NCT04518410|588986950|FG007|Overall Study|Withdrawal by Subject|6|||
163076342|NCT04518410|588986951|FG008|Overall Study|Withdrawal by Subject|1|||
162645280|NCT02603432|587419291|FG000|Overall Study|Study terminated by sponsor|74|||
162645281|NCT02603432|587419292|FG001|Overall Study|Study terminated by sponsor|75|||
162645282|NCT02603432|587419291|FG000|Overall Study|Other|13|||
162645283|NCT02603432|587419292|FG001|Overall Study|Other|0|||
162645284|NCT00666757|587419296|FG000|Overall Study|Lost to Follow-up|39|||
162645285|NCT00666757|587419297|FG001|Overall Study|Lost to Follow-up|35|||
162645286|NCT00666757|587419296|FG000|Overall Study|Protocol Violation|23|||
162645287|NCT00666757|587419297|FG001|Overall Study|Protocol Violation|24|||
162645288|NCT00666757|587419296|FG000|Overall Study|Adverse Event|22|||
162645289|NCT00666757|587419297|FG001|Overall Study|Adverse Event|12|||
162645290|NCT00666757|587419296|FG000|Overall Study|Withdrawal by Subject|13|||
162645291|NCT00666757|587419297|FG001|Overall Study|Withdrawal by Subject|17|||
162645292|NCT00666757|587419296|FG000|Overall Study|Lack of Efficacy|3|||
162645293|NCT00666757|587419297|FG001|Overall Study|Lack of Efficacy|6|||
162645294|NCT00666757|587419296|FG000|Overall Study|Physician Decision|0|||
162645295|NCT00666757|587419297|FG001|Overall Study|Physician Decision|2|||
162645296|NCT00666757|587419296|FG000|Overall Study|Sponsor decision|0|||
162645297|NCT00666757|587419297|FG001|Overall Study|Sponsor decision|1|||
162645298|NCT01231581|587419298|FG000|Overall Study|Lost to Follow-up|2|||
162645299|NCT01231581|587419299|FG001|Overall Study|Lost to Follow-up|2|||
162645300|NCT01231581|587419298|FG000|Overall Study|Withdrawal by Subject|6|||
162645301|NCT01231581|587419299|FG001|Overall Study|Withdrawal by Subject|9|||
162645302|NCT01231581|587419298|FG000|Overall Study|Study Closed/Terminated|6|||
162645303|NCT01231581|587419299|FG001|Overall Study|Study Closed/Terminated|5|||
162645304|NCT01231581|587419298|FG000|Overall Study|Death|65|||
162645305|NCT01231581|587419299|FG001|Overall Study|Death|64|||
163028767|NCT01970475|588807355|FG000|Overall Study|Protocol Violation|1|||
163028768|NCT01970475|588807356|FG001|Overall Study|Protocol Violation|0|||
163028769|NCT04413552|588807361|FG000|Overall Study|Adverse Event|0|||
163028770|NCT04413552|588807362|FG001|Overall Study|Adverse Event|0|||
163028771|NCT04413552|588807363|FG002|Overall Study|Adverse Event|0|||
163028772|NCT04413552|588807364|FG003|Overall Study|Adverse Event|0|||
163028773|NCT04413552|588807365|FG004|Overall Study|Adverse Event|0|||
163028774|NCT04413552|588807366|FG005|Overall Study|Adverse Event|0|||
163028775|NCT04413552|588807367|FG006|Overall Study|Adverse Event|1|||
163028776|NCT04413552|588807368|FG007|Overall Study|Adverse Event|0|||
163028777|NCT04413552|588807369|FG008|Overall Study|Adverse Event|0|||
163028778|NCT04413552|588807370|FG009|Overall Study|Adverse Event|0|||
163028779|NCT01317797|588807371|FG000|Overall Study|Other|0|||
163028780|NCT01317797|588807372|FG001|Overall Study|Other|1|||
163028781|NCT01317797|588807373|FG002|Overall Study|Other|0|||
163028782|NCT01317797|588807371|FG000|Overall Study|Withdrawal of Patient|0|||
163028783|NCT01317797|588807372|FG001|Overall Study|Withdrawal of Patient|0|||
163028784|NCT01317797|588807373|FG002|Overall Study|Withdrawal of Patient|1|||
163028785|NCT03026530|588807374|FG000|Overall Study|Lost to Follow-up|19|||
163028786|NCT03026530|588807375|FG001|Overall Study|Lost to Follow-up|24|||
163028787|NCT03026530|588807374|FG000|Overall Study|Protocol Violation|2|||
163028788|NCT03026530|588807375|FG001|Overall Study|Protocol Violation|5|||
163028789|NCT03721835|588807377|FG000|Overall Study|Participant not able to return|1|||
163028790|NCT03721835|588807377|FG000|Overall Study|Lost to Follow-up|1|||
163028791|NCT03721835|588807377|FG000|Overall Study|Revision of the components of the study device|2|||
163028792|NCT03721835|588807377|FG000|Overall Study|Sponsor terminated study|6|||
163028793|NCT03721835|588807377|FG000|Overall Study|Death|1|||
163028794|NCT03721835|588807377|FG000|Overall Study|Sponsor decision|1|||
163028795|NCT03495154|588807378|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
163028796|NCT03495154|588807378|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
163028797|NCT03495154|588807378|FG000|Overall Study|Screen Failures During Surgery|6|||
163028798|NCT03495154|588807378|FG000|Overall Study|Death|2|||
163028799|NCT03495154|588807378|FG000|Overall Study|Lost to Follow-up|16|||
163028800|NCT03495154|588807378|FG000|Overall Study|Withdrawal by Subject|2|||
163028801|NCT03495154|588807378|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
163028802|NCT01294696|588807382|FG000|Overall Study|Screening failures|7|||
163028803|NCT01294696|588807382|FG000|Overall Study|Protocol Violation|8|||
163028804|NCT01294696|588807382|FG000|Overall Study|Missing BPI Response|7|||
163028805|NCT01294696|588807382|FG000|Overall Study|Site closure|52|||
163028806|NCT05079750|588808764|FG000|Overall Study|Lost to Follow-up|0|||
163028807|NCT05079750|588808765|FG001|Overall Study|Lost to Follow-up|0|||
163028808|NCT05079750|588808766|FG002|Overall Study|Lost to Follow-up|1|||
162645306|NCT01231581|587419298|FG000|Overall Study|Ongoing|1|||
162645307|NCT01231581|587419299|FG001|Overall Study|Ongoing|0|||
162645308|NCT01649375|587419302|FG000|Up to Week 16|Adverse Event|2|||
162645309|NCT01649375|587419303|FG001|Up to Week 16|Adverse Event|5|||
162645310|NCT01649375|587419304|FG002|Up to Week 16|Adverse Event|4|||
162645311|NCT01649375|587419305|FG003|Up to Week 16|Adverse Event|0|||
163028809|NCT05091346|588808769|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
163028810|NCT05091346|588808770|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
163028811|NCT05091346|588808771|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
163028812|NCT05091346|588808772|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
163076343|NCT04518410|588986952|FG009|Overall Study|Withdrawal by Subject|12|||
163076344|NCT04518410|588986953|FG010|Overall Study|Withdrawal by Subject|5|||
163076345|NCT04518410|588986954|FG011|Overall Study|Withdrawal by Subject|7|||
163076346|NCT04518410|588986955|FG012|Overall Study|Withdrawal by Subject|2|||
163076347|NCT04518410|588986956|FG013|Overall Study|Withdrawal by Subject|13|||
163076348|NCT04518410|588986957|FG014|Overall Study|Withdrawal by Subject|4|||
163076349|NCT04518410|588986958|FG015|Overall Study|Withdrawal by Subject|9|||
163076350|NCT04518410|588986959|FG016|Overall Study|Withdrawal by Subject|0|||
163076351|NCT04518410|588986960|FG017|Overall Study|Withdrawal by Subject|15|||
163076352|NCT04518410|588986961|FG018|Overall Study|Withdrawal by Subject|12|||
163076353|NCT04518410|588986962|FG019|Overall Study|Withdrawal by Subject|9|||
163076354|NCT04518410|588986963|FG020|Overall Study|Withdrawal by Subject|14|||
163076355|NCT04518410|588986964|FG021|Overall Study|Withdrawal by Subject|3|||
163076356|NCT04518410|588986965|FG022|Overall Study|Withdrawal by Subject|2|||
163076357|NCT04518410|588986966|FG023|Overall Study|Withdrawal by Subject|9|||
163076358|NCT04518410|588986967|FG024|Overall Study|Withdrawal by Subject|8|||
163076359|NCT04518410|588986943|FG000|Overall Study|Other|1|||
163076360|NCT04518410|588986944|FG001|Overall Study|Other|0|||
163076361|NCT04518410|588986945|FG002|Overall Study|Other|0|||
163076362|NCT04518410|588986946|FG003|Overall Study|Other|1|||
163076363|NCT04518410|588986947|FG004|Overall Study|Other|6|||
163076364|NCT04518410|588986948|FG005|Overall Study|Other|6|||
163076365|NCT04518410|588986949|FG006|Overall Study|Other|5|||
163076366|NCT04518410|588986950|FG007|Overall Study|Other|2|||
163076367|NCT04518410|588986951|FG008|Overall Study|Other|0|||
163076368|NCT04518410|588986952|FG009|Overall Study|Other|1|||
163076369|NCT04518410|588986953|FG010|Overall Study|Other|0|||
163076370|NCT04518410|588986954|FG011|Overall Study|Other|2|||
163076371|NCT04518410|588986955|FG012|Overall Study|Other|0|||
163028813|NCT05091346|588808773|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
163028814|NCT05091346|588808769|FG000|Overall Study|Death|6|||
163028815|NCT05091346|588808770|FG001|Overall Study|Death|5|||
163028816|NCT05091346|588808771|FG002|Overall Study|Death|8|||
163028817|NCT05091346|588808772|FG003|Overall Study|Death|16|||
163028818|NCT05091346|588808773|FG004|Overall Study|Death|26|||
163028819|NCT05091346|588808769|FG000|Overall Study|Lost to Follow-up|0|||
163028820|NCT05091346|588808770|FG001|Overall Study|Lost to Follow-up|0|||
163028821|NCT05091346|588808771|FG002|Overall Study|Lost to Follow-up|0|||
163028822|NCT05091346|588808772|FG003|Overall Study|Lost to Follow-up|1|||
163028823|NCT05091346|588808773|FG004|Overall Study|Lost to Follow-up|0|||
163028824|NCT05091346|588808769|FG000|Overall Study|Withdrawal by Subject|0|||
163028825|NCT05091346|588808770|FG001|Overall Study|Withdrawal by Subject|1|||
163028826|NCT05091346|588808771|FG002|Overall Study|Withdrawal by Subject|2|||
163028827|NCT05091346|588808772|FG003|Overall Study|Withdrawal by Subject|2|||
163028828|NCT05091346|588808773|FG004|Overall Study|Withdrawal by Subject|1|||
163028829|NCT02339155|588808776|FG000|Overall Study|Adverse Event|0|||
163028830|NCT02339155|588808777|FG001|Overall Study|Adverse Event|6|||
163028831|NCT02339155|588808776|FG000|Overall Study|Death|1|||
163028832|NCT02339155|588808777|FG001|Overall Study|Death|1|||
163028833|NCT02339155|588808776|FG000|Overall Study|Lost to Follow-up|8|||
163028834|NCT02339155|588808777|FG001|Overall Study|Lost to Follow-up|9|||
163028835|NCT02339155|588808776|FG000|Overall Study|Physician Decision|2|||
163028836|NCT02339155|588808777|FG001|Overall Study|Physician Decision|1|||
163028837|NCT02339155|588808776|FG000|Overall Study|Withdrawal by Subject|4|||
163028838|NCT02339155|588808777|FG001|Overall Study|Withdrawal by Subject|4|||
163028839|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Adverse Event|0|||
163028840|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Adverse Event|1|||
163028841|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Adverse Event|0|||
163028842|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Adverse Event|0|||
163028843|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Adverse Event|0|||
163028844|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Adverse Event|0|||
163028845|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Death|0|||
163028846|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Death|0|||
163028847|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Death|1|||
163028848|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Death|0|||
163028849|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Death|0|||
163028850|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Death|0|||
163028851|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028852|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
163028853|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028854|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
163028855|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
163076372|NCT04518410|588986956|FG013|Overall Study|Other|0|||
163076373|NCT04518410|588986957|FG014|Overall Study|Other|0|||
163076374|NCT04518410|588986958|FG015|Overall Study|Other|3|||
163076375|NCT04518410|588986959|FG016|Overall Study|Other|1|||
163076376|NCT04518410|588986960|FG017|Overall Study|Other|1|||
162645312|NCT01649375|587419306|FG004|Up to Week 16|Adverse Event|0|||
162645313|NCT01649375|587419302|FG000|Up to Week 16|Lack of Efficacy|0|||
162645314|NCT01649375|587419303|FG001|Up to Week 16|Lack of Efficacy|0|||
162645315|NCT01649375|587419304|FG002|Up to Week 16|Lack of Efficacy|1|||
162645316|NCT01649375|587419305|FG003|Up to Week 16|Lack of Efficacy|0|||
162645317|NCT01649375|587419306|FG004|Up to Week 16|Lack of Efficacy|0|||
162645318|NCT01649375|587419302|FG000|Up to Week 16|Physician Decision|0|||
162645319|NCT01649375|587419303|FG001|Up to Week 16|Physician Decision|0|||
162645320|NCT01649375|587419304|FG002|Up to Week 16|Physician Decision|1|||
162645321|NCT01649375|587419305|FG003|Up to Week 16|Physician Decision|0|||
162645322|NCT01649375|587419306|FG004|Up to Week 16|Physician Decision|0|||
162645323|NCT01649375|587419302|FG000|Up to Week 16|Withdrawal by Subject|2|||
162645324|NCT01649375|587419303|FG001|Up to Week 16|Withdrawal by Subject|1|||
162645325|NCT01649375|587419304|FG002|Up to Week 16|Withdrawal by Subject|2|||
162645326|NCT01649375|587419305|FG003|Up to Week 16|Withdrawal by Subject|0|||
162645327|NCT01649375|587419306|FG004|Up to Week 16|Withdrawal by Subject|0|||
162645328|NCT01649375|587419302|FG000|Up to Week 16|Death|1|||
162645329|NCT01649375|587419303|FG001|Up to Week 16|Death|0|||
162645330|NCT01649375|587419304|FG002|Up to Week 16|Death|0|||
162645331|NCT01649375|587419305|FG003|Up to Week 16|Death|0|||
162645332|NCT01649375|587419306|FG004|Up to Week 16|Death|0|||
162645333|NCT01649375|587419302|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
162645334|NCT01649375|587419303|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
162645335|NCT01649375|587419304|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
163076377|NCT04518410|588986961|FG018|Overall Study|Other|1|||
163076378|NCT04518410|588986962|FG019|Overall Study|Other|0|||
163076379|NCT04518410|588986963|FG020|Overall Study|Other|1|||
163076380|NCT04518410|588986964|FG021|Overall Study|Other|0|||
163076381|NCT04518410|588986965|FG022|Overall Study|Other|1|||
163076382|NCT04518410|588986966|FG023|Overall Study|Other|2|||
163076383|NCT04518410|588986967|FG024|Overall Study|Other|2|||
163076384|NCT04518410|588986943|FG000|Overall Study|Protocol Violation|0|||
163076385|NCT04518410|588986944|FG001|Overall Study|Protocol Violation|0|||
163076386|NCT04518410|588986945|FG002|Overall Study|Protocol Violation|0|||
163076387|NCT04518410|588986946|FG003|Overall Study|Protocol Violation|2|||
163076388|NCT04518410|588986947|FG004|Overall Study|Protocol Violation|17|||
163076389|NCT04518410|588986948|FG005|Overall Study|Protocol Violation|1|||
163076390|NCT04518410|588986949|FG006|Overall Study|Protocol Violation|2|||
163076391|NCT04518410|588986950|FG007|Overall Study|Protocol Violation|1|||
163076392|NCT04518410|588986951|FG008|Overall Study|Protocol Violation|0|||
163076393|NCT04518410|588986952|FG009|Overall Study|Protocol Violation|0|||
163076394|NCT04518410|588986953|FG010|Overall Study|Protocol Violation|0|||
163076395|NCT04518410|588986954|FG011|Overall Study|Protocol Violation|0|||
163076396|NCT04518410|588986955|FG012|Overall Study|Protocol Violation|0|||
163076397|NCT04518410|588986956|FG013|Overall Study|Protocol Violation|0|||
163076398|NCT04518410|588986957|FG014|Overall Study|Protocol Violation|0|||
162645336|NCT01649375|587419305|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
162645337|NCT01649375|587419306|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
162645338|NCT01649375|587419302|FG000|Week 16 up to Week 260|Non-compliance|0|||
162645339|NCT01649375|587419303|FG001|Week 16 up to Week 260|Non-compliance|1|||
162645340|NCT01649375|587419304|FG002|Week 16 up to Week 260|Non-compliance|0|||
163076399|NCT04518410|588986958|FG015|Overall Study|Protocol Violation|0|||
163076400|NCT04518410|588986959|FG016|Overall Study|Protocol Violation|1|||
163076401|NCT04518410|588986960|FG017|Overall Study|Protocol Violation|1|||
162645341|NCT01649375|587419305|FG003|Week 16 up to Week 260|Non-compliance|1|||
163076402|NCT04518410|588986961|FG018|Overall Study|Protocol Violation|0|||
163076403|NCT04518410|588986962|FG019|Overall Study|Protocol Violation|0|||
163076404|NCT04518410|588986963|FG020|Overall Study|Protocol Violation|1|||
163076405|NCT04518410|588986964|FG021|Overall Study|Protocol Violation|2|||
163076406|NCT04518410|588986965|FG022|Overall Study|Protocol Violation|0|||
163076407|NCT04518410|588986966|FG023|Overall Study|Protocol Violation|3|||
163076408|NCT04518410|588986967|FG024|Overall Study|Protocol Violation|0|||
163076409|NCT04518410|588986943|FG000|Overall Study|Death|0|||
163076410|NCT04518410|588986944|FG001|Overall Study|Death|0|||
163076411|NCT04518410|588986945|FG002|Overall Study|Death|0|||
163076412|NCT04518410|588986946|FG003|Overall Study|Death|0|||
163076413|NCT04518410|588986947|FG004|Overall Study|Death|12|||
162645342|NCT01649375|587419306|FG004|Week 16 up to Week 260|Non-compliance|0|||
162645343|NCT01649375|587419302|FG000|Week 16 up to Week 260|Physician Decision|0|||
162645344|NCT01649375|587419303|FG001|Week 16 up to Week 260|Physician Decision|2|||
162645345|NCT01649375|587419304|FG002|Week 16 up to Week 260|Physician Decision|0|||
162645346|NCT01649375|587419305|FG003|Week 16 up to Week 260|Physician Decision|0|||
162645347|NCT01649375|587419306|FG004|Week 16 up to Week 260|Physician Decision|0|||
162645348|NCT01649375|587419302|FG000|Week 16 up to Week 260|Technical issues|0|||
162645349|NCT01649375|587419303|FG001|Week 16 up to Week 260|Technical issues|1|||
162645350|NCT01649375|587419304|FG002|Week 16 up to Week 260|Technical issues|0|||
162645351|NCT01649375|587419305|FG003|Week 16 up to Week 260|Technical issues|1|||
162645352|NCT01649375|587419306|FG004|Week 16 up to Week 260|Technical issues|0|||
163076414|NCT04518410|588986948|FG005|Overall Study|Death|2|||
163076415|NCT04518410|588986949|FG006|Overall Study|Death|11|||
163076416|NCT04518410|588986950|FG007|Overall Study|Death|0|||
162645353|NCT01649375|587419302|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
162645354|NCT01649375|587419303|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
163076417|NCT04518410|588986951|FG008|Overall Study|Death|1|||
163076418|NCT04518410|588986952|FG009|Overall Study|Death|0|||
163076419|NCT04518410|588986953|FG010|Overall Study|Death|0|||
163076420|NCT04518410|588986954|FG011|Overall Study|Death|0|||
163076421|NCT04518410|588986955|FG012|Overall Study|Death|0|||
163076422|NCT04518410|588986956|FG013|Overall Study|Death|1|||
163076423|NCT04518410|588986957|FG014|Overall Study|Death|1|||
163076424|NCT04518410|588986958|FG015|Overall Study|Death|0|||
163076425|NCT04518410|588986959|FG016|Overall Study|Death|0|||
163076426|NCT04518410|588986960|FG017|Overall Study|Death|1|||
163076427|NCT04518410|588986961|FG018|Overall Study|Death|4|||
163076428|NCT04518410|588986962|FG019|Overall Study|Death|4|||
163076429|NCT04518410|588986963|FG020|Overall Study|Death|1|||
163076430|NCT04518410|588986964|FG021|Overall Study|Death|0|||
163076431|NCT04518410|588986965|FG022|Overall Study|Death|0|||
163076432|NCT04518410|588986966|FG023|Overall Study|Death|0|||
163076433|NCT04518410|588986967|FG024|Overall Study|Death|0|||
163076434|NCT04518410|588986943|FG000|Overall Study|Requirement to start alternative therapy|0|||
163076435|NCT04518410|588986944|FG001|Overall Study|Requirement to start alternative therapy|0|||
163076436|NCT04518410|588986945|FG002|Overall Study|Requirement to start alternative therapy|1|||
163076437|NCT04518410|588986946|FG003|Overall Study|Requirement to start alternative therapy|0|||
163076438|NCT04518410|588986947|FG004|Overall Study|Requirement to start alternative therapy|0|||
163076439|NCT04518410|588986948|FG005|Overall Study|Requirement to start alternative therapy|0|||
163076440|NCT04518410|588986949|FG006|Overall Study|Requirement to start alternative therapy|0|||
163076441|NCT04518410|588986950|FG007|Overall Study|Requirement to start alternative therapy|0|||
163076442|NCT04518410|588986951|FG008|Overall Study|Requirement to start alternative therapy|0|||
163076443|NCT04518410|588986952|FG009|Overall Study|Requirement to start alternative therapy|0|||
163076444|NCT04518410|588986953|FG010|Overall Study|Requirement to start alternative therapy|0|||
163076445|NCT04518410|588986954|FG011|Overall Study|Requirement to start alternative therapy|0|||
163076446|NCT04518410|588986955|FG012|Overall Study|Requirement to start alternative therapy|0|||
163076447|NCT04518410|588986956|FG013|Overall Study|Requirement to start alternative therapy|0|||
163076448|NCT04518410|588986957|FG014|Overall Study|Requirement to start alternative therapy|0|||
163076449|NCT04518410|588986958|FG015|Overall Study|Requirement to start alternative therapy|0|||
163076450|NCT04518410|588986959|FG016|Overall Study|Requirement to start alternative therapy|0|||
163076451|NCT04518410|588986960|FG017|Overall Study|Requirement to start alternative therapy|0|||
163076452|NCT04518410|588986961|FG018|Overall Study|Requirement to start alternative therapy|0|||
163076453|NCT04518410|588986962|FG019|Overall Study|Requirement to start alternative therapy|0|||
163076454|NCT04518410|588986963|FG020|Overall Study|Requirement to start alternative therapy|0|||
163076455|NCT04518410|588986964|FG021|Overall Study|Requirement to start alternative therapy|0|||
163076456|NCT04518410|588986965|FG022|Overall Study|Requirement to start alternative therapy|0|||
163076457|NCT04518410|588986966|FG023|Overall Study|Requirement to start alternative therapy|0|||
163076458|NCT04518410|588986967|FG024|Overall Study|Requirement to start alternative therapy|0|||
162645355|NCT01649375|587419304|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
162645356|NCT01649375|587419305|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
162645357|NCT01649375|587419306|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
162645358|NCT01649375|587419302|FG000|Week 16 up to Week 260|Death|1|||
162645359|NCT01649375|587419303|FG001|Week 16 up to Week 260|Death|1|||
163076459|NCT04518410|588986943|FG000|Overall Study|Randomized but not treated|0|||
163076460|NCT04518410|588986944|FG001|Overall Study|Randomized but not treated|0|||
163076461|NCT04518410|588986945|FG002|Overall Study|Randomized but not treated|0|||
163076462|NCT04518410|588986946|FG003|Overall Study|Randomized but not treated|2|||
163076463|NCT04518410|588986947|FG004|Overall Study|Randomized but not treated|6|||
163076464|NCT04518410|588986948|FG005|Overall Study|Randomized but not treated|4|||
163076465|NCT04518410|588986949|FG006|Overall Study|Randomized but not treated|3|||
163076466|NCT04518410|588986950|FG007|Overall Study|Randomized but not treated|3|||
163076467|NCT04518410|588986951|FG008|Overall Study|Randomized but not treated|0|||
163076468|NCT04518410|588986952|FG009|Overall Study|Randomized but not treated|4|||
163076469|NCT04518410|588986953|FG010|Overall Study|Randomized but not treated|0|||
163076470|NCT04518410|588986954|FG011|Overall Study|Randomized but not treated|0|||
163076471|NCT04518410|588986955|FG012|Overall Study|Randomized but not treated|1|||
163076472|NCT04518410|588986956|FG013|Overall Study|Randomized but not treated|3|||
163076473|NCT04518410|588986957|FG014|Overall Study|Randomized but not treated|3|||
163076474|NCT04518410|588986958|FG015|Overall Study|Randomized but not treated|3|||
163076475|NCT04518410|588986959|FG016|Overall Study|Randomized but not treated|4|||
163076476|NCT04518410|588986960|FG017|Overall Study|Randomized but not treated|5|||
162645360|NCT01649375|587419304|FG002|Week 16 up to Week 260|Death|0|||
162717878|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163076477|NCT04518410|588986961|FG018|Overall Study|Randomized but not treated|4|||
163076478|NCT04518410|588986962|FG019|Overall Study|Randomized but not treated|0|||
163076479|NCT04518410|588986963|FG020|Overall Study|Randomized but not treated|0|||
162645361|NCT01649375|587419305|FG003|Week 16 up to Week 260|Death|0|||
162645362|NCT01649375|587419306|FG004|Week 16 up to Week 260|Death|0|||
162645363|NCT01649375|587419302|FG000|Week 16 up to Week 260|Adverse Event|5|||
162645364|NCT01649375|587419303|FG001|Week 16 up to Week 260|Adverse Event|2|||
162645365|NCT01649375|587419304|FG002|Week 16 up to Week 260|Adverse Event|0|||
162645366|NCT01649375|587419305|FG003|Week 16 up to Week 260|Adverse Event|3|||
162645367|NCT01649375|587419306|FG004|Week 16 up to Week 260|Adverse Event|2|||
162645368|NCT01856790|587419307|FG000|Closed Loop Control|Withdrawal by Subject|2|||
162645369|NCT01856790|587419307|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
162645370|NCT04091646|587419310|FG000|Overall Study|Adverse Event|2|||
162645371|NCT04091646|587419311|FG001|Overall Study|Adverse Event|1|||
162645372|NCT04091646|587419310|FG000|Overall Study|Lost to Follow-up|6|||
162645373|NCT04091646|587419311|FG001|Overall Study|Lost to Follow-up|2|||
162645374|NCT04091646|587419310|FG000|Overall Study|Protocol Violation|0|||
162645375|NCT04091646|587419311|FG001|Overall Study|Protocol Violation|1|||
162645376|NCT04091646|587419310|FG000|Overall Study|Withdrawal by Subject|4|||
162645377|NCT04091646|587419311|FG001|Overall Study|Withdrawal by Subject|1|||
162645378|NCT04091646|587419310|FG000|Overall Study|Participant Incarcerated|1|||
162645379|NCT04091646|587419311|FG001|Overall Study|Participant Incarcerated|0|||
162645380|NCT01921829|587419312|FG000|Overall Study|Withdrawal by Subject|0|||
162645381|NCT01921829|587419313|FG001|Overall Study|Withdrawal by Subject|1|||
162645382|NCT04765358|587419318|FG000|Overall Study|Withdrawal by Subject|1|||
162645383|NCT01316276|587419319|FG000|Overall Study|Death|1|||
162645384|NCT01316276|587419319|FG000|Overall Study|Adverse Event|19|||
162717879|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162717880|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163076480|NCT04518410|588986964|FG021|Overall Study|Randomized but not treated|5|||
163076481|NCT04518410|588986965|FG022|Overall Study|Randomized but not treated|0|||
163076482|NCT04518410|588986966|FG023|Overall Study|Randomized but not treated|3|||
163076483|NCT04518410|588986967|FG024|Overall Study|Randomized but not treated|1|||
163076484|NCT04518410|588986943|FG000|Overall Study|Screen Fail but Randomized|0|||
163076485|NCT04518410|588986944|FG001|Overall Study|Screen Fail but Randomized|0|||
163076486|NCT04518410|588986945|FG002|Overall Study|Screen Fail but Randomized|0|||
163076487|NCT04518410|588986946|FG003|Overall Study|Screen Fail but Randomized|0|||
163076488|NCT04518410|588986947|FG004|Overall Study|Screen Fail but Randomized|2|||
163076489|NCT04518410|588986948|FG005|Overall Study|Screen Fail but Randomized|0|||
163076490|NCT04518410|588986949|FG006|Overall Study|Screen Fail but Randomized|0|||
163076491|NCT04518410|588986950|FG007|Overall Study|Screen Fail but Randomized|0|||
163076492|NCT04518410|588986951|FG008|Overall Study|Screen Fail but Randomized|0|||
163076493|NCT04518410|588986952|FG009|Overall Study|Screen Fail but Randomized|0|||
163076494|NCT04518410|588986953|FG010|Overall Study|Screen Fail but Randomized|0|||
163076495|NCT04518410|588986954|FG011|Overall Study|Screen Fail but Randomized|0|||
163076496|NCT04518410|588986955|FG012|Overall Study|Screen Fail but Randomized|0|||
163076497|NCT04518410|588986956|FG013|Overall Study|Screen Fail but Randomized|0|||
163076498|NCT04518410|588986957|FG014|Overall Study|Screen Fail but Randomized|0|||
163076499|NCT04518410|588986958|FG015|Overall Study|Screen Fail but Randomized|0|||
163076500|NCT04518410|588986959|FG016|Overall Study|Screen Fail but Randomized|0|||
163076501|NCT04518410|588986960|FG017|Overall Study|Screen Fail but Randomized|0|||
163076502|NCT04518410|588986961|FG018|Overall Study|Screen Fail but Randomized|0|||
163076503|NCT04518410|588986962|FG019|Overall Study|Screen Fail but Randomized|0|||
163076504|NCT04518410|588986963|FG020|Overall Study|Screen Fail but Randomized|0|||
163076505|NCT04518410|588986964|FG021|Overall Study|Screen Fail but Randomized|0|||
163076506|NCT04518410|588986965|FG022|Overall Study|Screen Fail but Randomized|0|||
163076507|NCT04518410|588986966|FG023|Overall Study|Screen Fail but Randomized|0|||
163076508|NCT04518410|588986967|FG024|Overall Study|Screen Fail but Randomized|0|||
163076509|NCT04518410|588986943|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076510|NCT04518410|588986944|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076511|NCT04518410|588986945|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076512|NCT04518410|588986946|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076513|NCT04518410|588986947|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
162645385|NCT01316276|587419319|FG000|Overall Study|Withdrawal of consent|24|||
162645386|NCT01316276|587419319|FG000|Overall Study|Lost to Follow-up|1|||
162717881|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163076514|NCT04518410|588986948|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
163076515|NCT04518410|588986949|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
163076516|NCT04518410|588986950|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163154803|NCT00521079|589281440|FG000|Overall Study|Withdrawal by Subject|5|||
162645387|NCT01316276|587419319|FG000|Overall Study|Other|22|||
162645388|NCT00605475|587419320|FG000|Overall Study|Abnormal Laboratory Values|0|||
162645389|NCT00605475|587419321|FG001|Overall Study|Abnormal Laboratory Values|0|||
162717882|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
162717883|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
163076517|NCT04518410|588986951|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
163076518|NCT04518410|588986952|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
163076519|NCT04518410|588986953|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076520|NCT04518410|588986954|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076521|NCT04518410|588986955|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076522|NCT04518410|588986956|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076523|NCT04518410|588986957|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
163076524|NCT04518410|588986958|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
163076525|NCT04518410|588986959|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
163076526|NCT04518410|588986960|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
163076527|NCT04518410|588986961|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
163076528|NCT04518410|588986962|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
163076529|NCT04518410|588986963|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
163076530|NCT04518410|588986964|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
163076531|NCT04518410|588986965|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
163076532|NCT04518410|588986966|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
163076533|NCT04518410|588986967|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
163076534|NCT04518410|588986943|FG000|Overall Study|Dual Enrolled Subject|0|||
163076535|NCT04518410|588986944|FG001|Overall Study|Dual Enrolled Subject|0|||
163076536|NCT04518410|588986945|FG002|Overall Study|Dual Enrolled Subject|0|||
163076537|NCT04518410|588986946|FG003|Overall Study|Dual Enrolled Subject|0|||
163076538|NCT04518410|588986947|FG004|Overall Study|Dual Enrolled Subject|0|||
163076539|NCT04518410|588986948|FG005|Overall Study|Dual Enrolled Subject|0|||
163076540|NCT04518410|588986949|FG006|Overall Study|Dual Enrolled Subject|0|||
163076541|NCT04518410|588986950|FG007|Overall Study|Dual Enrolled Subject|0|||
163076542|NCT04518410|588986951|FG008|Overall Study|Dual Enrolled Subject|0|||
163076543|NCT04518410|588986952|FG009|Overall Study|Dual Enrolled Subject|0|||
163076544|NCT04518410|588986953|FG010|Overall Study|Dual Enrolled Subject|0|||
163076545|NCT04518410|588986954|FG011|Overall Study|Dual Enrolled Subject|0|||
163076546|NCT04518410|588986955|FG012|Overall Study|Dual Enrolled Subject|0|||
163076547|NCT04518410|588986956|FG013|Overall Study|Dual Enrolled Subject|0|||
163076548|NCT04518410|588986957|FG014|Overall Study|Dual Enrolled Subject|0|||
163076549|NCT04518410|588986958|FG015|Overall Study|Dual Enrolled Subject|0|||
163076550|NCT04518410|588986959|FG016|Overall Study|Dual Enrolled Subject|0|||
163076551|NCT04518410|588986960|FG017|Overall Study|Dual Enrolled Subject|1|||
163076552|NCT04518410|588986961|FG018|Overall Study|Dual Enrolled Subject|0|||
163076553|NCT04518410|588986962|FG019|Overall Study|Dual Enrolled Subject|0|||
163076554|NCT04518410|588986963|FG020|Overall Study|Dual Enrolled Subject|0|||
163076555|NCT04518410|588986964|FG021|Overall Study|Dual Enrolled Subject|0|||
163076556|NCT04518410|588986965|FG022|Overall Study|Dual Enrolled Subject|0|||
162717884|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
162717885|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163076557|NCT04518410|588986966|FG023|Overall Study|Dual Enrolled Subject|0|||
163076558|NCT04518410|588986967|FG024|Overall Study|Dual Enrolled Subject|0|||
163076559|NCT05737745|588986968|FG000|Overall Study|Withdrawal by Subject|0|||
163076560|NCT05737745|588986969|FG001|Overall Study|Withdrawal by Subject|6|||
163076561|NCT05737745|588986970|FG002|Overall Study|Withdrawal by Subject|1|||
163076562|NCT02569242|588986971|FG000|Overall Study|Death|1|||
163076563|NCT02569242|588986972|FG001|Overall Study|Death|0|||
163076564|NCT02569242|588986971|FG000|Overall Study|Withdrawal by Subject|0|||
163076565|NCT02569242|588986972|FG001|Overall Study|Withdrawal by Subject|1|||
163076566|NCT02057666|588986973|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
163076567|NCT02057666|588986974|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
163076568|NCT02057666|588986973|FG000|Double Blind Treatment Period|Poor tolerability|7|||
163076569|NCT02057666|588986974|FG001|Double Blind Treatment Period|Poor tolerability|2|||
163076570|NCT02057666|588986973|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
163076571|NCT02057666|588986974|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
163076572|NCT02057666|588986973|FG000|Double Blind Treatment Period|Physician Decision|1|||
163076573|NCT02057666|588986974|FG001|Double Blind Treatment Period|Physician Decision|0|||
163076574|NCT02057666|588986973|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
163076575|NCT02057666|588986974|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
163076576|NCT02057666|588986973|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
163076577|NCT02057666|588986974|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
163076578|NCT02057666|588986973|FG000|Double Blind Treatment Period|Sponsor's request|70|||
163076579|NCT02057666|588986974|FG001|Double Blind Treatment Period|Sponsor's request|34|||
163076580|NCT02057666|588986973|FG000|Open-Label Treatment Period|Poor tolerability|0|||
163076581|NCT02057666|588986974|FG001|Open-Label Treatment Period|Poor tolerability|1|||
163076582|NCT02057666|588986973|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
163076583|NCT02057666|588986974|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
163076584|NCT02057666|588986973|FG000|Open-Label Treatment Period|Sponsor's request|0|||
163076585|NCT02057666|588986974|FG001|Open-Label Treatment Period|Sponsor's request|4|||
163076586|NCT05661734|588986975|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
163076587|NCT05661734|588986975|FG000|Overall Study|Lost to Follow-up|13|||
163076588|NCT05661734|588986975|FG000|Overall Study|Enrolled but not dosed|2|||
163076589|NCT01348490|588986980|FG000|Overall Study|Death|1|||
163076590|NCT01348490|588986980|FG000|Overall Study|Adverse Event|3|||
163076591|NCT01348490|588986980|FG000|Overall Study|Consent withdrawn|7|||
163076592|NCT01348490|588986980|FG000|Overall Study|Disease progression|3|||
163076593|NCT01348490|588986980|FG000|Overall Study|Lost to Follow-up|1|||
163076594|NCT01348490|588986980|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
163076595|NCT01348490|588986980|FG000|Overall Study|Other Unspecified|8|||
163076596|NCT00300495|588986981|FG000|Overall Study|Protocol Violation|4|||
163076597|NCT00300495|588986982|FG001|Overall Study|Protocol Violation|1|||
163076598|NCT02487199|588986985|FG000|Overall Study|Withdrew Consent|0|||
163076599|NCT02487199|588986986|FG001|Overall Study|Withdrew Consent|1|||
163076600|NCT00286455|588986987|FG000|Overall Study|Hyperglycemia rescue|19|||
163076601|NCT00286455|588986988|FG001|Overall Study|Hyperglycemia rescue|13|||
163076602|NCT00286455|588986989|FG002|Overall Study|Hyperglycemia rescue|10|||
163076603|NCT00286455|588986987|FG000|Overall Study|Adverse Event|1|||
163076604|NCT00286455|588986988|FG001|Overall Study|Adverse Event|3|||
163076605|NCT00286455|588986989|FG002|Overall Study|Adverse Event|2|||
163076606|NCT00286455|588986987|FG000|Overall Study|Lost to Follow-up|0|||
163076607|NCT00286455|588986988|FG001|Overall Study|Lost to Follow-up|3|||
163076608|NCT00286455|588986989|FG002|Overall Study|Lost to Follow-up|3|||
163076609|NCT00286455|588986987|FG000|Overall Study|Physician Decision|3|||
163076610|NCT00286455|588986988|FG001|Overall Study|Physician Decision|0|||
163076611|NCT00286455|588986989|FG002|Overall Study|Physician Decision|2|||
163076612|NCT00286455|588986987|FG000|Overall Study|Protocol Violation|1|||
163076613|NCT00286455|588986988|FG001|Overall Study|Protocol Violation|1|||
163076614|NCT00286455|588986989|FG002|Overall Study|Protocol Violation|0|||
163076615|NCT00286455|588986987|FG000|Overall Study|Participant Non-compliance|1|||
163076616|NCT00286455|588986988|FG001|Overall Study|Participant Non-compliance|0|||
163076617|NCT00286455|588986989|FG002|Overall Study|Participant Non-compliance|0|||
163076618|NCT00286455|588986987|FG000|Overall Study|Withdrawal by Subject|0|||
163076619|NCT00286455|588986988|FG001|Overall Study|Withdrawal by Subject|8|||
163076620|NCT00286455|588986989|FG002|Overall Study|Withdrawal by Subject|7|||
163076621|NCT01213251|588988965|FG000|Overall Study|Death|2|||
163076622|NCT01213251|588988966|FG001|Overall Study|Death|1|||
163076623|NCT01213251|588988967|FG002|Overall Study|Death|2|||
163076624|NCT01213251|588988965|FG000|Overall Study|Exit|3|||
163076625|NCT01213251|588988966|FG001|Overall Study|Exit|2|||
163076626|NCT01213251|588988967|FG002|Overall Study|Exit|8|||
163076627|NCT01213251|588988965|FG000|Overall Study|Protocol Violation|1|||
163076628|NCT01213251|588988966|FG001|Overall Study|Protocol Violation|1|||
163076629|NCT01213251|588988967|FG002|Overall Study|Protocol Violation|0|||
163076630|NCT01213251|588988965|FG000|Overall Study|Missed 18-Month Follow-up|0|||
163076631|NCT01213251|588988966|FG001|Overall Study|Missed 18-Month Follow-up|0|||
163076632|NCT01213251|588988967|FG002|Overall Study|Missed 18-Month Follow-up|1|||
163076633|NCT02933151|588988968|FG000|Overall Study|Lost to Follow-up|19|||
163076634|NCT02933151|588988969|FG001|Overall Study|Lost to Follow-up|18|||
163076635|NCT02933151|588988968|FG000|Overall Study|Death|1732|||
163076636|NCT02933151|588988969|FG001|Overall Study|Death|1827|||
163076637|NCT02933151|588988968|FG000|Overall Study|Transplant|210|||
163076638|NCT02933151|588988969|FG001|Overall Study|Transplant|278|||
163028856|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
163076639|NCT02933151|588988968|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
163076640|NCT02933151|588988969|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
163076641|NCT02933151|588988968|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
163076642|NCT02933151|588988969|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
163076643|NCT02933151|588988968|FG000|Overall Study|Recovered Kidney Function|47|||
163076644|NCT02933151|588988969|FG001|Overall Study|Recovered Kidney Function|29|||
163076645|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
163076646|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
163028857|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028858|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028859|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
163028860|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028861|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028862|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
163028863|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028864|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028865|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028866|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
163028867|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028868|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
163028869|NCT03226678|588808784|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
163028870|NCT03226678|588808785|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
163028871|NCT03226678|588808786|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028872|NCT03226678|588808787|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028873|NCT03226678|588808788|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028874|NCT03226678|588808789|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
163028875|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028876|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028877|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028878|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
163028879|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
163028880|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
163028881|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Death|0|||
163028882|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Death|0|||
163028883|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Death|0|||
163028884|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Death|0|||
163028885|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Death|0|||
163028886|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Death|1|||
163028887|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028888|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028889|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028890|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028891|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
163028892|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
163028893|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028894|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028895|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028896|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
163028897|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
163028898|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
163028899|NCT03226678|588808784|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028900|NCT03226678|588808785|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028901|NCT03226678|588808786|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028902|NCT03226678|588808787|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028903|NCT03226678|588808788|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
163028904|NCT03226678|588808789|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
163028905|NCT05014815|588808794|FG000|Overall Study|Death|63|||
163028906|NCT05014815|588808795|FG001|Overall Study|Death|70|||
163028907|NCT05014815|588808794|FG000|Overall Study|Withdrawal by Subject|10|||
163028908|NCT05014815|588808795|FG001|Overall Study|Withdrawal by Subject|10|||
163028909|NCT05014815|588808794|FG000|Overall Study|Lost to Follow-up|4|||
163028910|NCT05014815|588808795|FG001|Overall Study|Lost to Follow-up|2|||
163028911|NCT05014815|588808794|FG000|Overall Study|Physician Decision|2|||
163028912|NCT05014815|588808795|FG001|Overall Study|Physician Decision|4|||
163028913|NCT00916344|588808804|FG000|Overall Study|Death|2|||
163028914|NCT00916344|588808804|FG000|Overall Study|ICD upgrade|1|||
163076647|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
162645390|NCT00605475|587419322|FG002|Overall Study|Abnormal Laboratory Values|0|||
162645391|NCT00605475|587419323|FG003|Overall Study|Abnormal Laboratory Values|0|||
162645392|NCT00605475|587419324|FG004|Overall Study|Abnormal Laboratory Values|0|||
162645393|NCT00605475|587419325|FG005|Overall Study|Abnormal Laboratory Values|0|||
162645394|NCT00605475|587419326|FG006|Overall Study|Abnormal Laboratory Values|0|||
162645395|NCT00605475|587419327|FG007|Overall Study|Abnormal Laboratory Values|0|||
162645396|NCT00605475|587419328|FG008|Overall Study|Abnormal Laboratory Values|1|||
163028915|NCT00916344|588808804|FG000|Overall Study|Drop-out|5|||
163028916|NCT03602391|588808805|FG000|Overall Study|COVID-19|7|||
163028917|NCT03602391|588808806|FG001|Overall Study|COVID-19|6|||
163028918|NCT00108485|588808811|FG000|Overall Study|Withdrawal by Subject|3|||
163028919|NCT00108485|588808812|FG001|Overall Study|Withdrawal by Subject|0|||
163028920|NCT00108485|588808811|FG000|Overall Study|Lost to Follow-up|0|||
163028921|NCT00108485|588808812|FG001|Overall Study|Lost to Follow-up|2|||
163028922|NCT00878969|588808817|FG000|Overall Study|Physician Decision|5|||
163028923|NCT00878969|588808818|FG001|Overall Study|Physician Decision|3|||
163028924|NCT00878969|588808819|FG002|Overall Study|Physician Decision|2|||
163028925|NCT00878969|588808817|FG000|Overall Study|Withdrawal by Subject|1|||
163028926|NCT00878969|588808818|FG001|Overall Study|Withdrawal by Subject|6|||
163028927|NCT00878969|588808819|FG002|Overall Study|Withdrawal by Subject|3|||
163028928|NCT00878969|588808817|FG000|Overall Study|kidney transplant|2|||
163028929|NCT00878969|588808818|FG001|Overall Study|kidney transplant|3|||
163028930|NCT00878969|588808819|FG002|Overall Study|kidney transplant|2|||
163028931|NCT00878969|588808817|FG000|Overall Study|Adverse Event|3|||
163028932|NCT00878969|588808818|FG001|Overall Study|Adverse Event|1|||
163028933|NCT00878969|588808819|FG002|Overall Study|Adverse Event|2|||
163028934|NCT00878969|588808817|FG000|Overall Study|Lost to Follow-up|2|||
163028935|NCT00878969|588808818|FG001|Overall Study|Lost to Follow-up|1|||
163028936|NCT00878969|588808819|FG002|Overall Study|Lost to Follow-up|0|||
163028937|NCT00878969|588808817|FG000|Overall Study|Protocol Violation|2|||
163028938|NCT00878969|588808818|FG001|Overall Study|Protocol Violation|0|||
163028939|NCT00878969|588808819|FG002|Overall Study|Protocol Violation|0|||
163028940|NCT00878969|588808817|FG000|Overall Study|Death|0|||
163028941|NCT00878969|588808818|FG001|Overall Study|Death|0|||
163028942|NCT00878969|588808819|FG002|Overall Study|Death|2|||
163028943|NCT00878969|588808817|FG000|Overall Study|Pregnancy|0|||
163028944|NCT00878969|588808818|FG001|Overall Study|Pregnancy|1|||
163028945|NCT00878969|588808819|FG002|Overall Study|Pregnancy|0|||
163028946|NCT01527487|588808822|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
163028947|NCT01527487|588808823|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
163028948|NCT01527487|588808822|FG000|Overall Study|Disease Progression|4|||
163028949|NCT01527487|588808823|FG001|Overall Study|Disease Progression|1|||
163028950|NCT01527487|588808822|FG000|Overall Study|Adverse Event|1|||
163028951|NCT01527487|588808823|FG001|Overall Study|Adverse Event|1|||
163028952|NCT01527487|588808822|FG000|Overall Study|Death|0|||
163028953|NCT01527487|588808823|FG001|Overall Study|Death|1|||
163028954|NCT01384019|588808824|FG000|Overall Study|Withdrawal by Subject|3|||
163028955|NCT01384019|588808825|FG001|Overall Study|Withdrawal by Subject|0|||
163028956|NCT01384019|588808824|FG000|Overall Study|Death|1|||
163028957|NCT01384019|588808825|FG001|Overall Study|Death|0|||
163028958|NCT01384019|588808824|FG000|Overall Study|MRI refusal|6|||
163028959|NCT01384019|588808825|FG001|Overall Study|MRI refusal|6|||
163028960|NCT04489381|588808831|FG000|Overall Study|Lost to Follow-up|2|||
163028961|NCT04489381|588808832|FG001|Overall Study|Lost to Follow-up|3|||
163028962|NCT04489381|588808831|FG000|Overall Study|Withdrawal by Subject|1|||
163028963|NCT04489381|588808832|FG001|Overall Study|Withdrawal by Subject|0|||
163028964|NCT03199612|588808835|FG000|Overall Study|Adverse Event|1|||
163028965|NCT03199612|588808836|FG001|Overall Study|Adverse Event|0|||
163028966|NCT00785213|588808839|FG000|Quinine Sulfate Alone|Adverse Event|4|||
163028967|NCT00785213|588808839|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
163028968|NCT02386345|588808840|FG000|Overall Study|Not treated|14|||
163028969|NCT02386345|588808840|FG000|Overall Study|Lost to Follow-up|1|||
163028970|NCT02386345|588808840|FG000|Overall Study|Adverse Event|5|||
163028971|NCT02386345|588808840|FG000|Overall Study|Repeat Procedure|10|||
163028972|NCT02386345|588808840|FG000|Overall Study|Did not complete 12-month follow-up|72|||
163028973|NCT03448939|588808842|FG000|Overall Study|Adverse Event|5|||
163028974|NCT03448939|588808843|FG001|Overall Study|Adverse Event|1|||
163028975|NCT03448939|588808842|FG000|Overall Study|Lost to Follow-up|6|||
163028976|NCT03448939|588808843|FG001|Overall Study|Lost to Follow-up|6|||
163028977|NCT03448939|588808842|FG000|Overall Study|Pregnancy|1|||
163028978|NCT03448939|588808843|FG001|Overall Study|Pregnancy|1|||
163028979|NCT03448939|588808842|FG000|Overall Study|Withdrawal by Subject|9|||
163028980|NCT03448939|588808843|FG001|Overall Study|Withdrawal by Subject|3|||
163028981|NCT01259375|588808844|FG000|Overall Study|Adverse Event|1|||
163028982|NCT00986986|588808845|FG000|Overall Study|Lost to Follow-up|0|||
163028983|NCT00986986|588808846|FG001|Overall Study|Lost to Follow-up|1|||
162645397|NCT00605475|587419329|FG009|Overall Study|Abnormal Laboratory Values|0|||
162645398|NCT00605475|587419320|FG000|Overall Study|Administrative problems|0|||
162645399|NCT00605475|587419321|FG001|Overall Study|Administrative problems|0|||
162645400|NCT00605475|587419322|FG002|Overall Study|Administrative problems|0|||
162645401|NCT00605475|587419323|FG003|Overall Study|Administrative problems|0|||
162645402|NCT00605475|587419324|FG004|Overall Study|Administrative problems|0|||
162645403|NCT00605475|587419325|FG005|Overall Study|Administrative problems|0|||
162645404|NCT00605475|587419326|FG006|Overall Study|Administrative problems|1|||
163028984|NCT00628095|588808847|FG000|Overall Study|Adverse Event|5|||
163028985|NCT00628095|588808848|FG001|Overall Study|Adverse Event|3|||
163028986|NCT00628095|588808847|FG000|Overall Study|Lack of Efficacy|0|||
163028987|NCT00628095|588808848|FG001|Overall Study|Lack of Efficacy|3|||
163028988|NCT00628095|588808847|FG000|Overall Study|Withdrawal by Subject|2|||
163028989|NCT00628095|588808848|FG001|Overall Study|Withdrawal by Subject|0|||
163028990|NCT00628095|588808847|FG000|Overall Study|Other|0|||
163028991|NCT00628095|588808848|FG001|Overall Study|Other|1|||
163028992|NCT01043705|588808853|FG000|Overall Study|Death|28|||
163028993|NCT01043705|588808854|FG001|Overall Study|Death|60|||
163028994|NCT01043705|588808855|FG002|Overall Study|Death|26|||
163028995|NCT01043705|588808853|FG000|Overall Study|Lost to Follow-up|27|||
163028996|NCT01043705|588808854|FG001|Overall Study|Lost to Follow-up|12|||
163028997|NCT01043705|588808855|FG002|Overall Study|Lost to Follow-up|0|||
163028998|NCT01043705|588808853|FG000|Overall Study|Multiple Reasons|4|||
163028999|NCT01043705|588808854|FG001|Overall Study|Multiple Reasons|7|||
163029000|NCT01043705|588808855|FG002|Overall Study|Multiple Reasons|0|||
163029001|NCT01043705|588808853|FG000|Overall Study|Protocol Violation|2|||
163029002|NCT01043705|588808854|FG001|Overall Study|Protocol Violation|1|||
163029003|NCT01043705|588808855|FG002|Overall Study|Protocol Violation|0|||
163029004|NCT01043705|588808853|FG000|Overall Study|Withdrawal by Subject|8|||
163029005|NCT01043705|588808854|FG001|Overall Study|Withdrawal by Subject|6|||
163029006|NCT01043705|588808855|FG002|Overall Study|Withdrawal by Subject|0|||
163029007|NCT01043705|588808853|FG000|Overall Study|Site Closure|8|||
163029008|NCT01043705|588808854|FG001|Overall Study|Site Closure|0|||
163029009|NCT01043705|588808855|FG002|Overall Study|Site Closure|0|||
163029010|NCT01043705|588808853|FG000|Overall Study|Subsequent Procedure|9|||
163029011|NCT01043705|588808854|FG001|Overall Study|Subsequent Procedure|24|||
163029012|NCT01043705|588808855|FG002|Overall Study|Subsequent Procedure|29|||
163029013|NCT01043705|588808853|FG000|Overall Study|Adverse Event|0|||
163029014|NCT01043705|588808854|FG001|Overall Study|Adverse Event|2|||
163029015|NCT01043705|588808855|FG002|Overall Study|Adverse Event|0|||
163029016|NCT01043705|588808853|FG000|Overall Study|Screen Fail|21|||
163029017|NCT01043705|588808854|FG001|Overall Study|Screen Fail|0|||
163029018|NCT01043705|588808855|FG002|Overall Study|Screen Fail|0|||
163029019|NCT01043705|588808853|FG000|Overall Study|Other|0|||
163029020|NCT01043705|588808854|FG001|Overall Study|Other|19|||
163029021|NCT01043705|588808855|FG002|Overall Study|Other|25|||
163029022|NCT02003963|588808859|FG000|Overall Study|Lost to Follow-up|2|||
163029023|NCT02003963|588808860|FG001|Overall Study|Lost to Follow-up|1|||
163029024|NCT04050124|588808869|FG000|Overall Study|Death|1|||
163029025|NCT04050124|588808870|FG001|Overall Study|Death|0|||
163029026|NCT05083923|588808875|FG000|Overall Study|Adverse Event|2|||
163029027|NCT05083923|588808876|FG001|Overall Study|Adverse Event|0|||
163029028|NCT05083923|588808875|FG000|Overall Study|Lack of Efficacy|1|||
163029029|NCT05083923|588808876|FG001|Overall Study|Lack of Efficacy|3|||
163029030|NCT05083923|588808875|FG000|Overall Study|Withdrawal by Subject|2|||
163029031|NCT05083923|588808876|FG001|Overall Study|Withdrawal by Subject|6|||
163029032|NCT05083923|588808875|FG000|Overall Study|Reason Not Specified|0|||
163029033|NCT05083923|588808876|FG001|Overall Study|Reason Not Specified|1|||
163029034|NCT01785849|588808883|FG000|Overall Study|Death|7|||
163029035|NCT01785849|588808884|FG001|Overall Study|Death|9|||
163029036|NCT01785849|588808883|FG000|Overall Study|Protocol Specified Criteria|29|||
163029037|NCT01785849|588808884|FG001|Overall Study|Protocol Specified Criteria|1|||
163029038|NCT01785849|588808883|FG000|Overall Study|Withdrawal by Subject|15|||
163029039|NCT01785849|588808884|FG001|Overall Study|Withdrawal by Subject|12|||
163029040|NCT01785849|588808883|FG000|Overall Study|Sponsor Decision|0|||
163029041|NCT01785849|588808884|FG001|Overall Study|Sponsor Decision|1|||
163029042|NCT01785849|588808883|FG000|Overall Study|Lost to Follow-up|10|||
163029043|NCT01785849|588808884|FG001|Overall Study|Lost to Follow-up|11|||
163029044|NCT02880865|588808885|FG000|Overall Study|Adverse Event|1|||
163029045|NCT02880865|588808886|FG001|Overall Study|Adverse Event|0|||
163029046|NCT02880865|588808885|FG000|Overall Study|Withdrawal by Subject|0|||
163029047|NCT02880865|588808886|FG001|Overall Study|Withdrawal by Subject|2|||
163029048|NCT02880865|588808885|FG000|Overall Study|Physician Decision|0|||
163029049|NCT02880865|588808886|FG001|Overall Study|Physician Decision|1|||
162645405|NCT00605475|587419327|FG007|Overall Study|Administrative problems|0|||
163029050|NCT03379753|588808887|FG000|Overall Study|Withdrawal by Subject|2|||
163029051|NCT03379753|588808888|FG001|Overall Study|Withdrawal by Subject|1|||
163029052|NCT03379753|588808887|FG000|Overall Study|not having correct procedure|1|||
163029053|NCT03379753|588808888|FG001|Overall Study|not having correct procedure|2|||
163029054|NCT03379753|588808887|FG000|Overall Study|No primary outcome|12|||
163076648|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
163076649|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
163076650|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
163076651|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
163076652|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
163076653|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076654|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076655|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
163076656|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
163076657|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
163076658|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
163076659|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
163076660|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
163076661|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
163076662|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
163076663|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
163076664|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
163076665|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
163076666|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
163076667|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
163076668|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
163076669|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
163076670|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076671|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076672|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
163076673|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
163076674|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
163076675|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
163076676|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
163076677|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076678|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076679|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
163076680|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
163076681|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076682|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076683|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
163076684|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
163076685|NCT02596893|588988970|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
163076686|NCT02596893|588988971|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
163076687|NCT02596893|588988972|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
163076688|NCT02596893|588988973|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
163076689|NCT03280615|588988974|FG000|Overall Study|Lost to Follow-up|1|||
163076690|NCT03280615|588988975|FG001|Overall Study|Lost to Follow-up|2|||
163076691|NCT03280615|588988974|FG000|Overall Study|Adverse Event|1|||
163076692|NCT03280615|588988975|FG001|Overall Study|Adverse Event|1|||
163076693|NCT03280615|588988974|FG000|Overall Study|Withdrawal by Subject|2|||
163076694|NCT03280615|588988975|FG001|Overall Study|Withdrawal by Subject|2|||
163076695|NCT00090402|588988980|FG000|Overall Study|Death|1|||
163076696|NCT00090402|588988981|FG001|Overall Study|Death|1|||
163076697|NCT00090402|588988982|FG002|Overall Study|Death|0|||
163076698|NCT00090402|588988980|FG000|Overall Study|subject moved|0|||
163076699|NCT00090402|588988981|FG001|Overall Study|subject moved|1|||
163076700|NCT00090402|588988982|FG002|Overall Study|subject moved|0|||
163076701|NCT00090402|588988980|FG000|Overall Study|stopped taking study medication|1|||
163076702|NCT00090402|588988981|FG001|Overall Study|stopped taking study medication|0|||
163076703|NCT00090402|588988982|FG002|Overall Study|stopped taking study medication|1|||
163076704|NCT01530256|588988983|FG000|Overall Study|Death|2|||
163076705|NCT00862277|588988984|FG000|Overall Study|Protocol Violation|1|||
163076706|NCT00862277|588988985|FG001|Overall Study|Protocol Violation|2|||
162645406|NCT00605475|587419328|FG008|Overall Study|Administrative problems|0|||
163076707|NCT00862277|588988986|FG002|Overall Study|Protocol Violation|5|||
163076708|NCT04432298|588988989|FG000|Overall Study|Other than specified|1|||
163076709|NCT04432298|588988990|FG001|Overall Study|Other than specified|0|||
163076710|NCT04432298|588988989|FG000|Overall Study|Lost to Follow-up|0|||
163076711|NCT04432298|588988990|FG001|Overall Study|Lost to Follow-up|1|||
163076712|NCT04432298|588988989|FG000|Overall Study|Death|3|||
163076713|NCT04432298|588988990|FG001|Overall Study|Death|2|||
163076714|NCT04432298|588988989|FG000|Overall Study|Withdrawal by Subject|2|||
162645407|NCT00605475|587419329|FG009|Overall Study|Administrative problems|0|||
163076715|NCT04432298|588988990|FG001|Overall Study|Withdrawal by Subject|0|||
162645408|NCT00605475|587419320|FG000|Overall Study|Lost to Follow-up|0|||
162645409|NCT00605475|587419321|FG001|Overall Study|Lost to Follow-up|0|||
162645410|NCT00605475|587419322|FG002|Overall Study|Lost to Follow-up|0|||
162645411|NCT00605475|587419323|FG003|Overall Study|Lost to Follow-up|0|||
162645412|NCT00605475|587419324|FG004|Overall Study|Lost to Follow-up|0|||
162645413|NCT00605475|587419325|FG005|Overall Study|Lost to Follow-up|0|||
162645414|NCT00605475|587419326|FG006|Overall Study|Lost to Follow-up|0|||
162645415|NCT00605475|587419327|FG007|Overall Study|Lost to Follow-up|0|||
162645416|NCT00605475|587419328|FG008|Overall Study|Lost to Follow-up|1|||
162645417|NCT00605475|587419329|FG009|Overall Study|Lost to Follow-up|1|||
162645418|NCT00605475|587419320|FG000|Overall Study|Protocol Violation|0|||
162645419|NCT00605475|587419321|FG001|Overall Study|Protocol Violation|0|||
162645420|NCT00605475|587419322|FG002|Overall Study|Protocol Violation|0|||
162645421|NCT00605475|587419323|FG003|Overall Study|Protocol Violation|0|||
162645422|NCT00605475|587419324|FG004|Overall Study|Protocol Violation|1|||
163076716|NCT02451007|588988993|FG000|Overall Study|Withdrawal by Subject|4|||
163076717|NCT02451007|588988993|FG000|Overall Study|Adverse Event|1|||
163076718|NCT02451007|588988993|FG000|Overall Study|Disease Progression|2|||
163076719|NCT00348374|588988994|FG000|Overall Study|Adverse Event|1|||
163076720|NCT00348374|588988995|FG001|Overall Study|Adverse Event|4|||
163076721|NCT00348374|588988994|FG000|Overall Study|Lost to Follow-up|1|||
163076722|NCT00348374|588988995|FG001|Overall Study|Lost to Follow-up|3|||
163076723|NCT00348374|588988994|FG000|Overall Study|Withdrawal by Subject|5|||
163076724|NCT00348374|588988995|FG001|Overall Study|Withdrawal by Subject|5|||
163076725|NCT00348374|588988994|FG000|Overall Study|Other|11|||
163076726|NCT00348374|588988995|FG001|Overall Study|Other|12|||
163076727|NCT00348374|588988994|FG000|Overall Study|ongoing at date of cutoff|1|||
163076728|NCT00348374|588988995|FG001|Overall Study|ongoing at date of cutoff|1|||
163076729|NCT00348374|588988994|FG000|Overall Study|randomized but did not receive treatment|0|||
163076730|NCT00348374|588988995|FG001|Overall Study|randomized but did not receive treatment|7|||
163076731|NCT02123511|588989001|FG000|Overall Study|Cancelled treatment|1|||
163076732|NCT02123511|588989002|FG001|Overall Study|Cancelled treatment|0|||
163076733|NCT02123511|588989001|FG000|Overall Study|Incomplete data|1|||
163076734|NCT02123511|588989002|FG001|Overall Study|Incomplete data|3|||
163076735|NCT02123511|588989001|FG000|Overall Study|Ineligible|0|||
163076736|NCT02123511|588989002|FG001|Overall Study|Ineligible|1|||
163076737|NCT01423084|588989003|FG000|Overall Study|Adverse Event|0|||
163076738|NCT01423084|588989004|FG001|Overall Study|Adverse Event|1|||
163076739|NCT01423084|588989003|FG000|Overall Study|Withdrawal by Subject|2|||
163076740|NCT01423084|588989004|FG001|Overall Study|Withdrawal by Subject|3|||
163076741|NCT01133977|588989008|FG000|Overall Study|Adverse Event|0|||
163076742|NCT01133977|588989009|FG001|Overall Study|Adverse Event|0|||
163076743|NCT01133977|588989010|FG002|Overall Study|Adverse Event|1|||
163076744|NCT01133977|588989011|FG003|Overall Study|Adverse Event|0|||
163076745|NCT01133977|588989012|FG004|Overall Study|Adverse Event|0|||
163076746|NCT01133977|588989008|FG000|Overall Study|Death|1|||
163076747|NCT01133977|588989009|FG001|Overall Study|Death|1|||
163076748|NCT01133977|588989010|FG002|Overall Study|Death|1|||
163076749|NCT01133977|588989011|FG003|Overall Study|Death|7|||
163076750|NCT01133977|588989012|FG004|Overall Study|Death|3|||
163076751|NCT01133977|588989008|FG000|Overall Study|Started a New Line of Therapy|2|||
163076752|NCT01133977|588989009|FG001|Overall Study|Started a New Line of Therapy|6|||
163076753|NCT01133977|588989010|FG002|Overall Study|Started a New Line of Therapy|4|||
163076754|NCT01133977|588989011|FG003|Overall Study|Started a New Line of Therapy|25|||
163076755|NCT01133977|588989012|FG004|Overall Study|Started a New Line of Therapy|33|||
163076756|NCT01133977|588989008|FG000|Overall Study|Lost to Follow-up|0|||
163076757|NCT01133977|588989009|FG001|Overall Study|Lost to Follow-up|0|||
163076758|NCT01133977|588989010|FG002|Overall Study|Lost to Follow-up|0|||
163076759|NCT01133977|588989011|FG003|Overall Study|Lost to Follow-up|2|||
163076760|NCT01133977|588989012|FG004|Overall Study|Lost to Follow-up|1|||
163076761|NCT01133977|588989008|FG000|Overall Study|Withdrawal by Subject|0|||
163076762|NCT01133977|588989009|FG001|Overall Study|Withdrawal by Subject|0|||
163076763|NCT01133977|588989010|FG002|Overall Study|Withdrawal by Subject|0|||
163076764|NCT01133977|588989011|FG003|Overall Study|Withdrawal by Subject|5|||
163076765|NCT01133977|588989012|FG004|Overall Study|Withdrawal by Subject|1|||
163076766|NCT02462057|588989013|FG000|Overall Study|Left Vitality|32|||
163076767|NCT02462057|588989014|FG001|Overall Study|Left Vitality|27|||
163076768|NCT02462057|588989015|FG002|Overall Study|Left Vitality|23|||
163076769|NCT02462057|588989016|FG003|Overall Study|Left Vitality|35|||
163076770|NCT02462057|588989017|FG004|Overall Study|Left Vitality|33|||
162645423|NCT00605475|587419325|FG005|Overall Study|Protocol Violation|0|||
162645424|NCT00605475|587419326|FG006|Overall Study|Protocol Violation|0|||
162645425|NCT00605475|587419327|FG007|Overall Study|Protocol Violation|0|||
162645426|NCT00605475|587419328|FG008|Overall Study|Protocol Violation|0|||
162645427|NCT00605475|587419329|FG009|Overall Study|Protocol Violation|0|||
163076771|NCT02462057|588989013|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
163076772|NCT02462057|588989014|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
163076773|NCT02462057|588989015|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
163076774|NCT02462057|588989016|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
162645428|NCT00605475|587419320|FG000|Overall Study|Withdrawal by Subject|0|||
162645429|NCT00605475|587419321|FG001|Overall Study|Withdrawal by Subject|0|||
163029055|NCT03379753|588808888|FG001|Overall Study|No primary outcome|22|||
163029056|NCT01190267|588808893|FG000|Overall Study|Adverse Event|10|||
163029057|NCT01190267|588808894|FG001|Overall Study|Adverse Event|0|||
163029058|NCT01190267|588808893|FG000|Overall Study|Treatment Failure|8|||
163029059|NCT01190267|588808894|FG001|Overall Study|Treatment Failure|2|||
163029060|NCT01190267|588808893|FG000|Overall Study|Lost to Follow-up|2|||
163029061|NCT01190267|588808894|FG001|Overall Study|Lost to Follow-up|0|||
163029062|NCT01190267|588808893|FG000|Overall Study|Withdrawal by Subject|13|||
163029063|NCT01190267|588808894|FG001|Overall Study|Withdrawal by Subject|1|||
163029064|NCT01190267|588808893|FG000|Overall Study|Protocol Violation|8|||
163029065|NCT01190267|588808894|FG001|Overall Study|Protocol Violation|1|||
163029066|NCT05513703|588808898|FG000|Overall Study|Death|4|||
163029067|NCT05513703|588808898|FG000|Overall Study|Study terminated by sponsor|5|||
163029068|NCT04450407|588808906|FG000|Overall Study|Withdrawal by Subject|10|||
163029069|NCT04450407|588808907|FG001|Overall Study|Withdrawal by Subject|1|||
163029070|NCT04450407|588808908|FG002|Overall Study|Withdrawal by Subject|4|||
163029071|NCT04450407|588808906|FG000|Overall Study|Adverse Event|0|||
163029072|NCT04450407|588808907|FG001|Overall Study|Adverse Event|0|||
163029073|NCT04450407|588808908|FG002|Overall Study|Adverse Event|1|||
163029074|NCT04450407|588808906|FG000|Overall Study|Lost to Follow-up|1|||
163029075|NCT04450407|588808907|FG001|Overall Study|Lost to Follow-up|0|||
163029076|NCT04450407|588808908|FG002|Overall Study|Lost to Follow-up|0|||
163029077|NCT04450407|588808906|FG000|Overall Study|Physician Decision|0|||
163029078|NCT04450407|588808907|FG001|Overall Study|Physician Decision|0|||
163029079|NCT04450407|588808908|FG002|Overall Study|Physician Decision|1|||
163029080|NCT04450407|588808906|FG000|Overall Study|Pregnancy|1|||
163029081|NCT04450407|588808907|FG001|Overall Study|Pregnancy|0|||
163029082|NCT04450407|588808908|FG002|Overall Study|Pregnancy|0|||
163029083|NCT04450407|588808906|FG000|Overall Study|Protocol Violation|2|||
163029084|NCT04450407|588808907|FG001|Overall Study|Protocol Violation|0|||
163029085|NCT04450407|588808908|FG002|Overall Study|Protocol Violation|0|||
163029086|NCT04450407|588808906|FG000|Overall Study|Investigational site terminated by sponsor|3|||
163029087|NCT04450407|588808907|FG001|Overall Study|Investigational site terminated by sponsor|0|||
163029088|NCT04450407|588808908|FG002|Overall Study|Investigational site terminated by sponsor|2|||
163029089|NCT04696354|588808911|FG000|Overall Study|Study termination|6|||
163029090|NCT04696354|588808912|FG001|Overall Study|Study termination|6|||
163029091|NCT05741346|588810325|FG000|Overall Study|Withdrawn due to termination of study|28|||
163029092|NCT04439357|588810326|FG000|Overall Study|Disease Progression|4|||
163029093|NCT01668966|588810335|FG000|Overall Study|Withdrawal by Subject|1|||
163029094|NCT01668966|588810335|FG000|Overall Study|Death|1|||
163029095|NCT01668966|588810335|FG000|Overall Study|Not treated|2|||
163029096|NCT01573767|588810336|FG000|Overall Study|Adverse Event|0|||
163029097|NCT01573767|588810337|FG001|Overall Study|Adverse Event|1|||
163029098|NCT01573767|588810338|FG002|Overall Study|Adverse Event|0|||
163029099|NCT01573767|588810339|FG003|Overall Study|Adverse Event|1|||
163029100|NCT01573767|588810336|FG000|Overall Study|Lack of Efficacy|18|||
163029101|NCT01573767|588810337|FG001|Overall Study|Lack of Efficacy|15|||
163029102|NCT01573767|588810338|FG002|Overall Study|Lack of Efficacy|12|||
163029103|NCT01573767|588810339|FG003|Overall Study|Lack of Efficacy|17|||
163029104|NCT01573767|588810336|FG000|Overall Study|Protocol Violation|3|||
163029105|NCT01573767|588810337|FG001|Overall Study|Protocol Violation|1|||
163029106|NCT01573767|588810338|FG002|Overall Study|Protocol Violation|1|||
163029107|NCT01573767|588810339|FG003|Overall Study|Protocol Violation|3|||
163029108|NCT01573767|588810336|FG000|Overall Study|Lost to Follow-up|0|||
163029109|NCT01573767|588810337|FG001|Overall Study|Lost to Follow-up|1|||
163029110|NCT01573767|588810338|FG002|Overall Study|Lost to Follow-up|1|||
163029111|NCT01573767|588810339|FG003|Overall Study|Lost to Follow-up|1|||
163029112|NCT01573767|588810336|FG000|Overall Study|Physician Decision|1|||
163029113|NCT01573767|588810337|FG001|Overall Study|Physician Decision|2|||
163029114|NCT01573767|588810338|FG002|Overall Study|Physician Decision|0|||
163029115|NCT01573767|588810339|FG003|Overall Study|Physician Decision|2|||
163029116|NCT01573767|588810336|FG000|Overall Study|Withdrawal by Subject|0|||
163029117|NCT01573767|588810337|FG001|Overall Study|Withdrawal by Subject|1|||
163029118|NCT01573767|588810338|FG002|Overall Study|Withdrawal by Subject|0|||
163029119|NCT01573767|588810339|FG003|Overall Study|Withdrawal by Subject|0|||
163029120|NCT04247880|588810340|FG000|Overall Study|Lost to Follow-up|24|||
163029121|NCT04247880|588810341|FG001|Overall Study|Lost to Follow-up|17|||
163029122|NCT04247880|588810340|FG000|Overall Study|Withdrawal by Subject|3|||
163029123|NCT04247880|588810341|FG001|Overall Study|Withdrawal by Subject|0|||
163029124|NCT01701193|588810342|FG000|Overall Study|Withdrawal by Subject|2|||
163029125|NCT01701193|588810343|FG001|Overall Study|Withdrawal by Subject|2|||
163029126|NCT01701193|588810344|FG002|Overall Study|Withdrawal by Subject|1|||
163029127|NCT01701193|588810345|FG003|Overall Study|Withdrawal by Subject|2|||
163029128|NCT01701193|588810342|FG000|Overall Study|Adverse Event|1|||
163029129|NCT01701193|588810343|FG001|Overall Study|Adverse Event|0|||
163029130|NCT01701193|588810344|FG002|Overall Study|Adverse Event|0|||
163029131|NCT01701193|588810345|FG003|Overall Study|Adverse Event|0|||
163029132|NCT03054064|588810346|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
163029133|NCT03054064|588810346|FG000|Overall Study|Investigator Decision|2|||
163029134|NCT03054064|588810346|FG000|Overall Study|Bladder Issue|1|||
163029135|NCT03054064|588810346|FG000|Overall Study|High Blood Pressure|1|||
163029136|NCT03054064|588810346|FG000|Overall Study|Change in Status|1|||
163029137|NCT00081731|588810349|FG000|Overall Study|scientific integrity issue|8|||
163029138|NCT00081731|588810350|FG001|Overall Study|scientific integrity issue|8|||
163029139|NCT01629823|588810354|FG000|Trial Period|Missed visit|11|||
163029140|NCT01629823|588810355|FG001|Trial Period|Missed visit|9|||
163029141|NCT01629823|588810356|FG002|Trial Period|Missed visit|8|||
163029142|NCT01629823|588810354|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029143|NCT01629823|588810355|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029144|NCT01629823|588810356|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
163029145|NCT01629823|588810354|FG000|Trial Period|Pregnancy|1|||
163029146|NCT01629823|588810355|FG001|Trial Period|Pregnancy|0|||
163029147|NCT01629823|588810356|FG002|Trial Period|Pregnancy|0|||
163029148|NCT01629823|588810354|FG000|Trial Period|Adverse Event|0|||
163029149|NCT01629823|588810355|FG001|Trial Period|Adverse Event|1|||
163029150|NCT01629823|588810356|FG002|Trial Period|Adverse Event|0|||
163029151|NCT01629823|588810354|FG000|Trial Period|Out-of-window visit|0|||
163029152|NCT01629823|588810355|FG001|Trial Period|Out-of-window visit|2|||
163029153|NCT01629823|588810356|FG002|Trial Period|Out-of-window visit|0|||
163029154|NCT01629823|588810354|FG000|Trial Period|Failed to hold medication|0|||
163029155|NCT01629823|588810355|FG001|Trial Period|Failed to hold medication|0|||
163029156|NCT01629823|588810356|FG002|Trial Period|Failed to hold medication|1|||
163029157|NCT01629823|588810354|FG000|Washout Period|Safety|2|||
163029158|NCT01629823|588810355|FG001|Washout Period|Safety|5|||
163029159|NCT01629823|588810356|FG002|Washout Period|Safety|0|||
163029160|NCT01629823|588810354|FG000|Washout Period|Pregnancy|1|||
163029161|NCT01629823|588810355|FG001|Washout Period|Pregnancy|0|||
163029162|NCT01629823|588810356|FG002|Washout Period|Pregnancy|0|||
163029163|NCT01629823|588810354|FG000|Washout Period|Protocol Violation|0|||
163029164|NCT01629823|588810355|FG001|Washout Period|Protocol Violation|1|||
163029165|NCT01629823|588810356|FG002|Washout Period|Protocol Violation|0|||
163029166|NCT00526331|588810358|FG000|Overall Study|Sponsor Termination|55|||
163029167|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
163029168|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
163029169|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
163029170|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
163029171|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
163029172|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
163029173|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
163029174|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
163029175|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
163029176|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
163029177|NCT00455520|588810359|FG000|Open Label Tapentadol Extended Release|All other|33|||
163029178|NCT00455520|588810360|FG001|Open Label Tapentadol Extended Release|All other|0|||
163029179|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
163029180|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
163029181|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
163029182|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
163029183|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
163029184|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
163029185|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
163029186|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
163029187|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
163029188|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
163029189|NCT00455520|588810359|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
163029190|NCT00455520|588810360|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
163029191|NCT03973918|588810361|FG000|Overall Study|Adverse Event|0|||
163029192|NCT03973918|588810362|FG001|Overall Study|Adverse Event|0|||
163029193|NCT03973918|588810363|FG002|Overall Study|Adverse Event|0|||
163076775|NCT02462057|588989017|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
163076776|NCT01682603|588989018|FG000|Overall Study|Lost to Follow-up|3|||
163076777|NCT01791205|588989019|FG000|Phase II|Lack of Efficacy|6|||
163076778|NCT01791205|588989020|FG001|Phase II|Lack of Efficacy|0|||
163076779|NCT01791205|588989019|FG000|Phase II|Adverse Event|2|||
163076780|NCT01791205|588989020|FG001|Phase II|Adverse Event|0|||
163076781|NCT01791205|588989019|FG000|Phase II|Safety|1|||
163076782|NCT01791205|588989020|FG001|Phase II|Safety|0|||
163076783|NCT01791205|588989019|FG000|Phase II|Lost to Follow-up|1|||
163076784|NCT01791205|588989020|FG001|Phase II|Lost to Follow-up|0|||
163076785|NCT01791205|588989019|FG000|Phase II|Remission of disease|1|||
163076786|NCT01791205|588989020|FG001|Phase II|Remission of disease|0|||
163076787|NCT01791205|588989019|FG000|Phase II|Physician's decision|1|||
163076788|NCT01791205|588989020|FG001|Phase II|Physician's decision|0|||
163076789|NCT05345405|588989031|FG000|Overall Study|Withdrawal by Subject|2|||
163076790|NCT05345405|588989032|FG001|Overall Study|Withdrawal by Subject|0|||
163076791|NCT05345405|588989033|FG002|Overall Study|Withdrawal by Subject|0|||
163076792|NCT05345405|588989031|FG000|Overall Study|Did not meet eligibility criteria|0|||
163076793|NCT05345405|588989032|FG001|Overall Study|Did not meet eligibility criteria|2|||
163076794|NCT05345405|588989033|FG002|Overall Study|Did not meet eligibility criteria|0|||
163076795|NCT05345405|588989031|FG000|Overall Study|Lost to Follow-up|0|||
163076796|NCT05345405|588989032|FG001|Overall Study|Lost to Follow-up|0|||
163076797|NCT05345405|588989033|FG002|Overall Study|Lost to Follow-up|1|||
163076798|NCT04189588|588989034|FG000|Overall Study|Death|0|||
163076799|NCT04189588|588989035|FG001|Overall Study|Death|1|||
163076800|NCT04189588|588989034|FG000|Overall Study|Lost to Follow-up|0|||
163076801|NCT04189588|588989035|FG001|Overall Study|Lost to Follow-up|1|||
163076802|NCT03757715|588989038|FG000|Overall Study|Lost to Follow-up|4|||
163076803|NCT03757715|588989039|FG001|Overall Study|Lost to Follow-up|9|||
163076804|NCT03757715|588989038|FG000|Overall Study|Withdrawal by Subject|1|||
163076805|NCT03757715|588989039|FG001|Overall Study|Withdrawal by Subject|1|||
163076806|NCT00281580|588989040|FG000|Overall Study|Adverse Event|2|||
163076807|NCT00281580|588989041|FG001|Overall Study|Adverse Event|0|||
163076808|NCT00281580|588989042|FG002|Overall Study|Adverse Event|2|||
163076809|NCT00281580|588989043|FG003|Overall Study|Adverse Event|4|||
163076810|NCT00281580|588989044|FG004|Overall Study|Adverse Event|1|||
163076811|NCT00281580|588989045|FG005|Overall Study|Adverse Event|0|||
163076812|NCT00281580|588989046|FG006|Overall Study|Adverse Event|1|||
163076813|NCT00281580|588989047|FG007|Overall Study|Adverse Event|0|||
163076814|NCT00281580|588989048|FG008|Overall Study|Adverse Event|1|||
163076815|NCT00281580|588989049|FG009|Overall Study|Adverse Event|6|||
163076816|NCT00281580|588989050|FG010|Overall Study|Adverse Event|0|||
163076817|NCT00281580|588989051|FG011|Overall Study|Adverse Event|5|||
163076818|NCT00281580|588989052|FG012|Overall Study|Adverse Event|8|||
163076819|NCT00281580|588989053|FG013|Overall Study|Adverse Event|2|||
163076820|NCT00281580|588989054|FG014|Overall Study|Adverse Event|3|||
163076821|NCT00281580|588989055|FG015|Overall Study|Adverse Event|3|||
163076822|NCT00281580|588989040|FG000|Overall Study|Protocol Violation|0|||
163076823|NCT00281580|588989041|FG001|Overall Study|Protocol Violation|0|||
163076824|NCT00281580|588989042|FG002|Overall Study|Protocol Violation|1|||
163076825|NCT00281580|588989043|FG003|Overall Study|Protocol Violation|1|||
163076826|NCT00281580|588989044|FG004|Overall Study|Protocol Violation|0|||
163076827|NCT00281580|588989045|FG005|Overall Study|Protocol Violation|0|||
163029194|NCT03973918|588810364|FG003|Overall Study|Adverse Event|1|||
163029195|NCT03973918|588810361|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029196|NCT03973918|588810362|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
163029197|NCT03973918|588810363|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029198|NCT03973918|588810364|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
163029199|NCT04601103|588810367|FG000|Overall Study|Needed crown & cleaning|0|||
163029200|NCT04601103|588810368|FG001|Overall Study|Needed crown & cleaning|0|||
163029201|NCT04601103|588810369|FG002|Overall Study|Needed crown & cleaning|1|||
163029202|NCT04601103|588810367|FG000|Overall Study|study was terminated|18|||
163029203|NCT04601103|588810368|FG001|Overall Study|study was terminated|18|||
163029204|NCT04601103|588810369|FG002|Overall Study|study was terminated|16|||
163029205|NCT01068626|588810377|FG000|Overall Study|Adverse Event|3|||
163029206|NCT01068626|588810378|FG001|Overall Study|Adverse Event|0|||
163029207|NCT01068626|588810377|FG000|Overall Study|Withdrawal by Subject|0|||
163029208|NCT01068626|588810378|FG001|Overall Study|Withdrawal by Subject|2|||
163076828|NCT00281580|588989046|FG006|Overall Study|Protocol Violation|1|||
163076829|NCT00281580|588989047|FG007|Overall Study|Protocol Violation|0|||
163076830|NCT00281580|588989048|FG008|Overall Study|Protocol Violation|2|||
163076831|NCT00281580|588989049|FG009|Overall Study|Protocol Violation|0|||
163076832|NCT00281580|588989050|FG010|Overall Study|Protocol Violation|1|||
163076833|NCT00281580|588989051|FG011|Overall Study|Protocol Violation|2|||
163076834|NCT00281580|588989052|FG012|Overall Study|Protocol Violation|0|||
163076835|NCT00281580|588989053|FG013|Overall Study|Protocol Violation|1|||
163076836|NCT00281580|588989054|FG014|Overall Study|Protocol Violation|1|||
163076837|NCT00281580|588989055|FG015|Overall Study|Protocol Violation|3|||
163076838|NCT00281580|588989040|FG000|Overall Study|Withdrawal by Subject|3|||
163076839|NCT00281580|588989041|FG001|Overall Study|Withdrawal by Subject|0|||
163076840|NCT00281580|588989042|FG002|Overall Study|Withdrawal by Subject|1|||
163076841|NCT00281580|588989043|FG003|Overall Study|Withdrawal by Subject|1|||
163076842|NCT00281580|588989044|FG004|Overall Study|Withdrawal by Subject|1|||
163076843|NCT00281580|588989045|FG005|Overall Study|Withdrawal by Subject|2|||
163076844|NCT00281580|588989046|FG006|Overall Study|Withdrawal by Subject|2|||
163076845|NCT00281580|588989047|FG007|Overall Study|Withdrawal by Subject|0|||
163076846|NCT00281580|588989048|FG008|Overall Study|Withdrawal by Subject|1|||
163076847|NCT00281580|588989049|FG009|Overall Study|Withdrawal by Subject|4|||
163076848|NCT00281580|588989050|FG010|Overall Study|Withdrawal by Subject|1|||
163076849|NCT00281580|588989051|FG011|Overall Study|Withdrawal by Subject|1|||
163076850|NCT00281580|588989052|FG012|Overall Study|Withdrawal by Subject|2|||
163076851|NCT00281580|588989053|FG013|Overall Study|Withdrawal by Subject|2|||
163076852|NCT00281580|588989054|FG014|Overall Study|Withdrawal by Subject|1|||
163076853|NCT00281580|588989055|FG015|Overall Study|Withdrawal by Subject|5|||
163076854|NCT00281580|588989040|FG000|Overall Study|Lack of Efficacy|2|||
163076855|NCT00281580|588989041|FG001|Overall Study|Lack of Efficacy|1|||
163076856|NCT00281580|588989042|FG002|Overall Study|Lack of Efficacy|1|||
163076857|NCT00281580|588989043|FG003|Overall Study|Lack of Efficacy|6|||
163076858|NCT00281580|588989044|FG004|Overall Study|Lack of Efficacy|2|||
163076859|NCT00281580|588989045|FG005|Overall Study|Lack of Efficacy|0|||
163076860|NCT00281580|588989046|FG006|Overall Study|Lack of Efficacy|0|||
163076861|NCT00281580|588989047|FG007|Overall Study|Lack of Efficacy|0|||
163076862|NCT00281580|588989048|FG008|Overall Study|Lack of Efficacy|0|||
163076863|NCT00281580|588989049|FG009|Overall Study|Lack of Efficacy|0|||
163076864|NCT00281580|588989050|FG010|Overall Study|Lack of Efficacy|0|||
163076865|NCT00281580|588989051|FG011|Overall Study|Lack of Efficacy|1|||
163076866|NCT00281580|588989052|FG012|Overall Study|Lack of Efficacy|0|||
163076867|NCT00281580|588989053|FG013|Overall Study|Lack of Efficacy|2|||
163076868|NCT00281580|588989054|FG014|Overall Study|Lack of Efficacy|1|||
163076869|NCT00281580|588989055|FG015|Overall Study|Lack of Efficacy|0|||
163076870|NCT00281580|588989040|FG000|Overall Study|Lost to Follow-up|0|||
163076871|NCT00281580|588989041|FG001|Overall Study|Lost to Follow-up|0|||
163076872|NCT00281580|588989042|FG002|Overall Study|Lost to Follow-up|0|||
163076873|NCT00281580|588989043|FG003|Overall Study|Lost to Follow-up|3|||
163076874|NCT00281580|588989044|FG004|Overall Study|Lost to Follow-up|0|||
163076875|NCT00281580|588989045|FG005|Overall Study|Lost to Follow-up|1|||
163076876|NCT00281580|588989046|FG006|Overall Study|Lost to Follow-up|0|||
163076877|NCT00281580|588989047|FG007|Overall Study|Lost to Follow-up|1|||
163076878|NCT00281580|588989048|FG008|Overall Study|Lost to Follow-up|2|||
163076879|NCT00281580|588989049|FG009|Overall Study|Lost to Follow-up|1|||
163076880|NCT00281580|588989050|FG010|Overall Study|Lost to Follow-up|1|||
163076881|NCT00281580|588989051|FG011|Overall Study|Lost to Follow-up|0|||
163076882|NCT00281580|588989052|FG012|Overall Study|Lost to Follow-up|1|||
163076883|NCT00281580|588989053|FG013|Overall Study|Lost to Follow-up|0|||
163076884|NCT00281580|588989054|FG014|Overall Study|Lost to Follow-up|0|||
163076885|NCT00281580|588989055|FG015|Overall Study|Lost to Follow-up|0|||
163076886|NCT00281580|588989040|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
163076887|NCT00281580|588989041|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
163076888|NCT00281580|588989042|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
163076889|NCT00281580|588989043|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
163076890|NCT00281580|588989044|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
163076891|NCT00281580|588989045|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
163076892|NCT00281580|588989046|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
163076893|NCT00281580|588989047|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
163076894|NCT00281580|588989048|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
163076895|NCT00281580|588989049|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
163076896|NCT00281580|588989050|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
162645430|NCT00605475|587419322|FG002|Overall Study|Withdrawal by Subject|0|||
163076897|NCT00281580|588989051|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
163076898|NCT00281580|588989052|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
163076899|NCT00281580|588989053|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
162645431|NCT00605475|587419323|FG003|Overall Study|Withdrawal by Subject|0|||
163076900|NCT00281580|588989054|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
163076901|NCT00281580|588989055|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
163076902|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
163076903|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
163076904|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
163076905|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
163076906|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
163076907|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
163076908|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
163076909|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
163076910|NCT01122680|588989056|FG000|Period 1 (4 Weeks)|Other|1|||
163076911|NCT01122680|588989057|FG001|Period 1 (4 Weeks)|Other|1|||
163076912|NCT01122680|588989058|FG002|Period 1 (4 Weeks)|Other|0|||
163076913|NCT01122680|588989059|FG003|Period 1 (4 Weeks)|Other|0|||
163076914|NCT01122680|588989056|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
163076915|NCT01122680|588989057|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
163076916|NCT01122680|588989058|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
163076917|NCT01122680|588989059|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
163076918|NCT01122680|588989056|FG000|Period 2 (4 Weeks)|Other|1|||
163076919|NCT01122680|588989057|FG001|Period 2 (4 Weeks)|Other|0|||
163076920|NCT01122680|588989058|FG002|Period 2 (4 Weeks)|Other|0|||
162645432|NCT00605475|587419324|FG004|Overall Study|Withdrawal by Subject|0|||
162645433|NCT00605475|587419325|FG005|Overall Study|Withdrawal by Subject|2|||
162645434|NCT00605475|587419326|FG006|Overall Study|Withdrawal by Subject|0|||
162645435|NCT00605475|587419327|FG007|Overall Study|Withdrawal by Subject|0|||
162645436|NCT00605475|587419328|FG008|Overall Study|Withdrawal by Subject|0|||
162645437|NCT00605475|587419329|FG009|Overall Study|Withdrawal by Subject|1|||
162645438|NCT03538158|587419335|FG000|Overall Study|Lost to Follow-up|13|||
162645439|NCT03538158|587419336|FG001|Overall Study|Lost to Follow-up|7|||
162645440|NCT03538158|587419335|FG000|Overall Study|Withdrawal by Subject|2|||
162645441|NCT03538158|587419336|FG001|Overall Study|Withdrawal by Subject|1|||
162645442|NCT02419742|587419339|FG000|Overall Study|Adverse Event|2|||
163076921|NCT01122680|588989059|FG003|Period 2 (4 Weeks)|Other|0|||
163076922|NCT01122680|588989056|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
163076923|NCT01122680|588989057|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
163076924|NCT01122680|588989058|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
163076925|NCT01122680|588989059|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
163076926|NCT01122680|588989056|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076927|NCT01122680|588989057|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
163076928|NCT01122680|588989058|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076929|NCT01122680|588989059|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
163076930|NCT00104884|588989061|FG000|Overall Study|Disease progression|4|||
163076931|NCT03473301|588989062|FG000|Overall Study|Protocol Violation|4|||
163076932|NCT03473301|588989063|FG001|Overall Study|Protocol Violation|0|||
163076933|NCT03473301|588989064|FG002|Overall Study|Protocol Violation|0|||
163076934|NCT03473301|588989062|FG000|Overall Study|Withdrawal by Subject|0|||
162645443|NCT02419742|587419340|FG001|Overall Study|Adverse Event|0|||
163076935|NCT03473301|588989063|FG001|Overall Study|Withdrawal by Subject|1|||
163076936|NCT03473301|588989064|FG002|Overall Study|Withdrawal by Subject|0|||
163076937|NCT03473301|588989062|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
162645444|NCT02419742|587419339|FG000|Overall Study|Disease Progression|0|||
163076938|NCT03473301|588989063|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
163076939|NCT03473301|588989064|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
163076940|NCT05529173|588989065|FG000|Overall Study|Physician Decision|3|||
162645445|NCT02419742|587419340|FG001|Overall Study|Disease Progression|1|||
162645446|NCT02419742|587419339|FG000|Overall Study|Withdrew Consent|2|||
163076941|NCT05529173|588989066|FG001|Overall Study|Physician Decision|6|||
163076942|NCT05529173|588989065|FG000|Overall Study|Sample shipment delay more than one day|4|||
163076943|NCT05529173|588989066|FG001|Overall Study|Sample shipment delay more than one day|0|||
163076944|NCT03760081|588989069|FG000|Overall Study|Miscellaneous|0|||
163076945|NCT03760081|588989070|FG001|Overall Study|Miscellaneous|1|||
163076946|NCT03760081|588989069|FG000|Overall Study|Progressive Disease|5|||
163076947|NCT03760081|588989070|FG001|Overall Study|Progressive Disease|10|||
163076948|NCT03760081|588989069|FG000|Overall Study|Death|1|||
163076949|NCT03760081|588989070|FG001|Overall Study|Death|1|||
163076950|NCT04034056|588989071|FG000|Overall Study|Withdrawal by Subject|2|||
163076951|NCT04034056|588989071|FG000|Overall Study|Reason Not Specified|13|||
163076952|NCT04034056|588989071|FG000|Overall Study|Adverse Event|56|||
163076953|NCT04135352|588989072|FG000|Overall Study|Not treated-randomization error|0|||
163076954|NCT04135352|588989073|FG001|Overall Study|Not treated-randomization error|0|||
163076955|NCT04135352|588989074|FG002|Overall Study|Not treated-randomization error|1|||
163076956|NCT04135352|588989075|FG003|Overall Study|Not treated-randomization error|0|||
163076957|NCT04135352|588989076|FG004|Overall Study|Not treated-randomization error|0|||
163076958|NCT04135352|588989077|FG005|Overall Study|Not treated-randomization error|0|||
163076959|NCT04135352|588989078|FG006|Overall Study|Not treated-randomization error|0|||
163076960|NCT04135352|588989079|FG007|Overall Study|Not treated-randomization error|0|||
163076961|NCT04135352|588989072|FG000|Overall Study|Withdrawal by Subject|0|||
163076962|NCT04135352|588989073|FG001|Overall Study|Withdrawal by Subject|0|||
163076963|NCT04135352|588989074|FG002|Overall Study|Withdrawal by Subject|2|||
163076964|NCT04135352|588989075|FG003|Overall Study|Withdrawal by Subject|0|||
163076965|NCT04135352|588989076|FG004|Overall Study|Withdrawal by Subject|0|||
163076966|NCT04135352|588989077|FG005|Overall Study|Withdrawal by Subject|0|||
163076967|NCT04135352|588989078|FG006|Overall Study|Withdrawal by Subject|0|||
163076968|NCT04135352|588989079|FG007|Overall Study|Withdrawal by Subject|0|||
163076969|NCT04135352|588989072|FG000|Overall Study|Sponsor Decision|0|||
163076970|NCT04135352|588989073|FG001|Overall Study|Sponsor Decision|0|||
163076971|NCT04135352|588989074|FG002|Overall Study|Sponsor Decision|2|||
163076972|NCT04135352|588989075|FG003|Overall Study|Sponsor Decision|5|||
163076973|NCT04135352|588989076|FG004|Overall Study|Sponsor Decision|1|||
163076974|NCT04135352|588989077|FG005|Overall Study|Sponsor Decision|4|||
163076975|NCT04135352|588989078|FG006|Overall Study|Sponsor Decision|0|||
163076976|NCT04135352|588989079|FG007|Overall Study|Sponsor Decision|0|||
163076977|NCT04135352|588989072|FG000|Overall Study|Physician Decision|0|||
163076978|NCT04135352|588989073|FG001|Overall Study|Physician Decision|0|||
163076979|NCT04135352|588989074|FG002|Overall Study|Physician Decision|1|||
163076980|NCT04135352|588989075|FG003|Overall Study|Physician Decision|0|||
163076981|NCT04135352|588989076|FG004|Overall Study|Physician Decision|1|||
163076982|NCT04135352|588989077|FG005|Overall Study|Physician Decision|0|||
163076983|NCT04135352|588989078|FG006|Overall Study|Physician Decision|0|||
163076984|NCT04135352|588989079|FG007|Overall Study|Physician Decision|0|||
163076985|NCT04135352|588989072|FG000|Overall Study|Death|3|||
163076986|NCT04135352|588989073|FG001|Overall Study|Death|4|||
163076987|NCT04135352|588989074|FG002|Overall Study|Death|7|||
163076988|NCT04135352|588989075|FG003|Overall Study|Death|0|||
163076989|NCT04135352|588989076|FG004|Overall Study|Death|3|||
163076990|NCT04135352|588989077|FG005|Overall Study|Death|1|||
163076991|NCT04135352|588989078|FG006|Overall Study|Death|0|||
163076992|NCT04135352|588989079|FG007|Overall Study|Death|0|||
163076993|NCT01210443|588989080|FG000|Overall Study|Study terminated by sponsor|2|||
163076994|NCT02807181|588989081|FG000|Overall Study|Death|28|||
163076995|NCT02807181|588989082|FG001|Overall Study|Death|24|||
163076996|NCT02807181|588989081|FG000|Overall Study|Withdrawal by Subject|1|||
163076997|NCT02807181|588989082|FG001|Overall Study|Withdrawal by Subject|1|||
163076998|NCT02807181|588989081|FG000|Overall Study|Lost to Follow-up|0|||
163076999|NCT02807181|588989082|FG001|Overall Study|Lost to Follow-up|2|||
163077000|NCT02807181|588989081|FG000|Overall Study|Subject decision|1|||
163077001|NCT02807181|588989082|FG001|Overall Study|Subject decision|0|||
163077002|NCT02807181|588989081|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
163077003|NCT02807181|588989082|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
163077004|NCT02807181|588989081|FG000|Overall Study|In Study|3|||
163077005|NCT02807181|588989082|FG001|Overall Study|In Study|3|||
163077006|NCT02807181|588989081|FG000|Overall Study|Post Progression|3|||
163077007|NCT02807181|588989082|FG001|Overall Study|Post Progression|2|||
163077008|NCT01452789|588989085|FG000|Overall Study|Withdrawal by Subject|3|||
163077009|NCT01452789|588989086|FG001|Overall Study|Withdrawal by Subject|2|||
162717886|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
163077010|NCT00066170|588989087|FG000|Overall Study|Adverse Event|2|||
163077011|NCT00066170|588989088|FG001|Overall Study|Adverse Event|4|||
163077012|NCT00066170|588989089|FG002|Overall Study|Adverse Event|1|||
163077013|NCT00066170|588989090|FG003|Overall Study|Adverse Event|7|||
163077014|NCT00066170|588989087|FG000|Overall Study|Serious Adverse Event|0|||
163077015|NCT00066170|588989088|FG001|Overall Study|Serious Adverse Event|0|||
163077016|NCT00066170|588989089|FG002|Overall Study|Serious Adverse Event|1|||
163077017|NCT00066170|588989090|FG003|Overall Study|Serious Adverse Event|1|||
163077018|NCT00066170|588989087|FG000|Overall Study|Lost to Follow-up|0|||
163077019|NCT00066170|588989088|FG001|Overall Study|Lost to Follow-up|1|||
163077020|NCT00066170|588989089|FG002|Overall Study|Lost to Follow-up|0|||
163077021|NCT00066170|588989090|FG003|Overall Study|Lost to Follow-up|0|||
163077022|NCT00066170|588989087|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
163077023|NCT00066170|588989088|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
163077024|NCT00066170|588989089|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
163077025|NCT00066170|588989090|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
163077026|NCT00066170|588989087|FG000|Overall Study|Protocol Violation|3|||
163077027|NCT00066170|588989088|FG001|Overall Study|Protocol Violation|0|||
163077028|NCT00066170|588989089|FG002|Overall Study|Protocol Violation|0|||
163077029|NCT00066170|588989090|FG003|Overall Study|Protocol Violation|0|||
163077030|NCT00066170|588989087|FG000|Overall Study|Other|1|||
163077031|NCT00066170|588989088|FG001|Overall Study|Other|5|||
163077032|NCT00066170|588989089|FG002|Overall Study|Other|2|||
163077033|NCT00066170|588989090|FG003|Overall Study|Other|0|||
163077034|NCT01089543|588989093|FG000|Overall Study|Withdrawal by Subject|2|||
163077035|NCT01089543|588989094|FG001|Overall Study|Withdrawal by Subject|3|||
163077036|NCT01089543|588989095|FG002|Overall Study|Withdrawal by Subject|3|||
163077037|NCT01089543|588989096|FG003|Overall Study|Withdrawal by Subject|1|||
163077038|NCT01089543|588989093|FG000|Overall Study|Physician Decision|1|||
163077039|NCT01089543|588989094|FG001|Overall Study|Physician Decision|0|||
163077040|NCT01089543|588989095|FG002|Overall Study|Physician Decision|0|||
163077041|NCT01089543|588989096|FG003|Overall Study|Physician Decision|1|||
163077042|NCT01089543|588989093|FG000|Overall Study|Adverse Event|0|||
163077043|NCT01089543|588989094|FG001|Overall Study|Adverse Event|1|||
163077044|NCT01089543|588989095|FG002|Overall Study|Adverse Event|0|||
163077045|NCT01089543|588989096|FG003|Overall Study|Adverse Event|0|||
163077046|NCT00754559|588989097|FG000|Overall Study|Adverse Event|15|||
163077047|NCT00754559|588989097|FG000|Overall Study|Protocol Violation|11|||
163077048|NCT00754559|588989097|FG000|Overall Study|Lack of Efficacy|10|||
163077049|NCT00754559|588989097|FG000|Overall Study|Lost to Follow-up|2|||
163077050|NCT00754559|588989097|FG000|Overall Study|Administrative reason|1|||
163077051|NCT00754559|588989097|FG000|Overall Study|Other|5|||
163077052|NCT00754559|588989097|FG000|Overall Study|Withdrawal by Subject|3|||
163077053|NCT01248468|588989098|FG000|Overall Study|Administrative problem|1|||
163077054|NCT01248468|588989099|FG001|Overall Study|Administrative problem|0|||
163077055|NCT01248468|588989100|FG002|Overall Study|Administrative problem|0|||
163077056|NCT01248468|588989098|FG000|Overall Study|Lost to Follow-up|9|||
163077057|NCT01248468|588989099|FG001|Overall Study|Lost to Follow-up|12|||
163077058|NCT01248468|588989100|FG002|Overall Study|Lost to Follow-up|4|||
163077059|NCT01248468|588989098|FG000|Overall Study|Pregnancy|1|||
163077060|NCT01248468|588989099|FG001|Overall Study|Pregnancy|0|||
163077061|NCT01248468|588989100|FG002|Overall Study|Pregnancy|0|||
163077062|NCT01248468|588989098|FG000|Overall Study|Withdrawal by Subject|4|||
163077063|NCT01248468|588989099|FG001|Overall Study|Withdrawal by Subject|2|||
163077064|NCT01248468|588989100|FG002|Overall Study|Withdrawal by Subject|0|||
163077065|NCT00468546|588989102|FG000|Week 24 Analysis|Lack of Efficacy|83|||
163077066|NCT00468546|588989103|FG001|Week 24 Analysis|Lack of Efficacy|37|||
163077067|NCT00468546|588989102|FG000|Week 24 Analysis|Refused treatment|5|||
163077068|NCT00468546|588989103|FG001|Week 24 Analysis|Refused treatment|5|||
163077069|NCT00468546|588989102|FG000|Week 24 Analysis|Adverse Event|1|||
163077070|NCT00468546|588989103|FG001|Week 24 Analysis|Adverse Event|8|||
163077071|NCT00468546|588989102|FG000|Week 24 Analysis|Failure to return|3|||
163077072|NCT00468546|588989103|FG001|Week 24 Analysis|Failure to return|4|||
163077073|NCT00468546|588989102|FG000|Week 24 Analysis|Rescue therapy|2|||
163077074|NCT00468546|588989103|FG001|Week 24 Analysis|Rescue therapy|0|||
163077075|NCT00468546|588989102|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
163077076|NCT00468546|588989103|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
163077077|NCT00468546|588989102|FG000|Week 24 Analysis|Due to clinical hold|1|||
163077078|NCT00468546|588989103|FG001|Week 24 Analysis|Due to clinical hold|0|||
163077079|NCT00468546|588989102|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
163077080|NCT00468546|588989103|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
163077081|NCT00468546|588989102|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
163077082|NCT00468546|588989103|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
163077083|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
163077084|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
163077085|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Death|1|||
163077086|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Death|0|||
162645447|NCT02419742|587419340|FG001|Overall Study|Withdrew Consent|1|||
162717887|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163077087|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
163077088|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
163077089|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
163077090|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
163077091|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
163077092|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
163077093|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
163077094|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
163077095|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
163077096|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
163077097|NCT00468546|588989102|FG000|Week 24 to Week 104 Analysis|Other|17|||
163077098|NCT00468546|588989103|FG001|Week 24 to Week 104 Analysis|Other|14|||
163077099|NCT04000724|588989106|FG000|Overall Study|Withdrawal by Subject|5|||
163077100|NCT04000724|588989107|FG001|Overall Study|Withdrawal by Subject|3|||
163077101|NCT04000724|588989108|FG002|Overall Study|Withdrawal by Subject|4|||
163077102|NCT04000724|588989106|FG000|Overall Study|Lost to Follow-up|11|||
163077103|NCT04000724|588989107|FG001|Overall Study|Lost to Follow-up|7|||
163077104|NCT04000724|588989108|FG002|Overall Study|Lost to Follow-up|13|||
163077105|NCT00455455|588989109|FG000|Washout|Withdrawal by Subject|0|||
163077106|NCT00455455|588989110|FG001|Washout|Withdrawal by Subject|1|||
163077107|NCT00455455|588989109|FG000|Washout|Withdrawal by Subject|1|||
163077108|NCT00455455|588989110|FG001|Washout|Withdrawal by Subject|0|||
163077109|NCT00472641|588989111|FG000|Overall Study|Lack of Efficacy|3|||
163077110|NCT00472641|588989111|FG000|Overall Study|Adverse Event|3|||
163077111|NCT00472641|588989111|FG000|Overall Study|Lost to Follow-up|1|||
163077112|NCT01370538|588989112|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
163077113|NCT01370538|588989113|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
163077114|NCT01370538|588989112|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163077115|NCT01370538|588989113|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163077116|NCT01370538|588989112|FG000|Overall Study|Adverse Event|1|||
163077117|NCT01370538|588989113|FG001|Overall Study|Adverse Event|0|||
163077118|NCT01370538|588989112|FG000|Overall Study|Protocol Violation|8|||
163077119|NCT01370538|588989113|FG001|Overall Study|Protocol Violation|5|||
163077120|NCT01370538|588989112|FG000|Overall Study|Development of study specific withdrawal|1|||
163077121|NCT01370538|588989113|FG001|Overall Study|Development of study specific withdrawal|1|||
163077122|NCT01370538|588989112|FG000|Overall Study|Lost to follow up|6|||
163077123|NCT01370538|588989113|FG001|Overall Study|Lost to follow up|10|||
163077124|NCT00309244|588989114|FG000|Overall Study|Adverse Event|29|||
163077125|NCT00309244|588989115|FG001|Overall Study|Adverse Event|12|||
163077126|NCT00309244|588989114|FG000|Overall Study|Lost to Follow-up|6|||
163077127|NCT00309244|588989115|FG001|Overall Study|Lost to Follow-up|22|||
163077128|NCT00309244|588989114|FG000|Overall Study|Physician Decision|5|||
163077129|NCT00309244|588989115|FG001|Overall Study|Physician Decision|8|||
163077130|NCT00309244|588989114|FG000|Overall Study|Protocol Violation|6|||
163077131|NCT00309244|588989115|FG001|Overall Study|Protocol Violation|3|||
163077132|NCT00309244|588989114|FG000|Overall Study|Withdrawal by Subject|50|||
163077133|NCT00309244|588989115|FG001|Overall Study|Withdrawal by Subject|32|||
163077134|NCT00309244|588989114|FG000|Overall Study|Various|7|||
163077135|NCT00309244|588989115|FG001|Overall Study|Various|7|||
163077136|NCT00309244|588989114|FG000|Overall Study|Randomized but not dosed|11|||
163077137|NCT00309244|588989115|FG001|Overall Study|Randomized but not dosed|12|||
163077138|NCT00309244|588989114|FG000|Overall Study|Death|4|||
163077139|NCT00309244|588989115|FG001|Overall Study|Death|1|||
163077140|NCT01905267|588989116|FG000|Overall Study|Physician Decision|2|||
163077141|NCT01905267|588989117|FG001|Overall Study|Physician Decision|2|||
163077142|NCT03438656|588989118|FG000|Overall Study|Lost to Follow-up|2|||
163077143|NCT03335566|588989119|FG000|Overall Study|Adverse Event|0|||
163077144|NCT03335566|588989120|FG001|Overall Study|Adverse Event|1|||
163077145|NCT03335566|588989119|FG000|Overall Study|Lost to Follow-up|1|||
163077146|NCT03335566|588989120|FG001|Overall Study|Lost to Follow-up|0|||
163077147|NCT03335566|588989119|FG000|Overall Study|Technical Problems|1|||
163077148|NCT03335566|588989120|FG001|Overall Study|Technical Problems|0|||
163077149|NCT03335566|588989119|FG000|Overall Study|Protocol Violation|1|||
163077150|NCT03335566|588989120|FG001|Overall Study|Protocol Violation|0|||
163077151|NCT03335566|588989119|FG000|Overall Study|Other than specified above|1|||
163077152|NCT03335566|588989120|FG001|Overall Study|Other than specified above|2|||
163077153|NCT04223687|588989121|FG000|Overall Study|Missing primary outcome|1|||
163077154|NCT04223687|588989122|FG001|Overall Study|Missing primary outcome|0|||
163077155|NCT02945046|588989124|FG000|Overall Study|Adverse Event|1|||
163077156|NCT02945046|588989125|FG001|Overall Study|Adverse Event|0|||
163077157|NCT02945046|588989126|FG002|Overall Study|Adverse Event|2|||
163077158|NCT02945046|588989124|FG000|Overall Study|Withdrawal by Subject|3|||
163077159|NCT02945046|588989125|FG001|Overall Study|Withdrawal by Subject|3|||
163077160|NCT02945046|588989126|FG002|Overall Study|Withdrawal by Subject|3|||
163077161|NCT02945046|588989124|FG000|Overall Study|Protocol Violation|2|||
163077162|NCT02945046|588989125|FG001|Overall Study|Protocol Violation|3|||
163077163|NCT02945046|588989126|FG002|Overall Study|Protocol Violation|2|||
163077164|NCT02945046|588989124|FG000|Overall Study|Lost to Follow-up|1|||
163077165|NCT02945046|588989125|FG001|Overall Study|Lost to Follow-up|1|||
163077166|NCT02945046|588989126|FG002|Overall Study|Lost to Follow-up|0|||
163077167|NCT02945046|588989124|FG000|Overall Study|Lack of Efficacy|1|||
163077168|NCT02945046|588989125|FG001|Overall Study|Lack of Efficacy|2|||
163077169|NCT02945046|588989126|FG002|Overall Study|Lack of Efficacy|1|||
163077170|NCT02945046|588989124|FG000|Overall Study|Other than specified|5|||
163077171|NCT02945046|588989125|FG001|Overall Study|Other than specified|4|||
163077172|NCT02945046|588989126|FG002|Overall Study|Other than specified|7|||
163077173|NCT03259308|588989132|FG000|Overall Study|Adverse Event|5|||
163077174|NCT03259308|588989133|FG001|Overall Study|Adverse Event|4|||
163077175|NCT03259308|588989134|FG002|Overall Study|Adverse Event|1|||
163077176|NCT03259308|588989132|FG000|Overall Study|Withdrawal by Subject|2|||
163077177|NCT03259308|588989133|FG001|Overall Study|Withdrawal by Subject|1|||
163077178|NCT03259308|588989134|FG002|Overall Study|Withdrawal by Subject|3|||
163077179|NCT03259308|588989132|FG000|Overall Study|Lost to Follow-up|0|||
163077180|NCT03259308|588989133|FG001|Overall Study|Lost to Follow-up|0|||
163077181|NCT03259308|588989134|FG002|Overall Study|Lost to Follow-up|1|||
163077182|NCT03259308|588989132|FG000|Overall Study|Pregnancy|0|||
163077183|NCT03259308|588989133|FG001|Overall Study|Pregnancy|0|||
163077184|NCT03259308|588989134|FG002|Overall Study|Pregnancy|1|||
163077185|NCT03259308|588989132|FG000|Overall Study|Protocol Deviation|0|||
163077186|NCT03259308|588989133|FG001|Overall Study|Protocol Deviation|3|||
163077187|NCT03259308|588989134|FG002|Overall Study|Protocol Deviation|0|||
163077188|NCT03259308|588989132|FG000|Overall Study|Lack of Efficacy|0|||
163077189|NCT03259308|588989133|FG001|Overall Study|Lack of Efficacy|0|||
163077190|NCT03259308|588989134|FG002|Overall Study|Lack of Efficacy|1|||
163077191|NCT06868667|588989146|FG000|Overall Study|Death|0|||
163077192|NCT06868667|588989147|FG001|Overall Study|Death|4|||
163077193|NCT06868667|588989146|FG000|Overall Study|Lost to Follow-up|0|||
163077194|NCT06868667|588989147|FG001|Overall Study|Lost to Follow-up|1|||
163077195|NCT06868667|588989146|FG000|Overall Study|Withdrawal by Subject|1|||
163077196|NCT06868667|588989147|FG001|Overall Study|Withdrawal by Subject|0|||
163077197|NCT06868667|588989146|FG000|Overall Study|Ongoing|9|||
163077198|NCT06868667|588989147|FG001|Overall Study|Ongoing|9|||
163077199|NCT01251965|588991192|FG000|Overall Study|Participant/physician decision|1|||
163077200|NCT01251965|588991193|FG001|Overall Study|Participant/physician decision|2|||
163077201|NCT01251965|588991194|FG002|Overall Study|Participant/physician decision|0|||
163077202|NCT01251965|588991192|FG000|Overall Study|Death|0|||
163077203|NCT01251965|588991193|FG001|Overall Study|Death|0|||
163077204|NCT01251965|588991194|FG002|Overall Study|Death|11|||
163077205|NCT01027754|588991195|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
163077206|NCT01027754|588991196|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
163077207|NCT01027754|588991195|FG000|Overall Study|Withdrawal by Subject|0|||
163077208|NCT01027754|588991196|FG001|Overall Study|Withdrawal by Subject|5|||
163077209|NCT02529488|588991197|FG000|Overall Study|Adverse Event|1|||
163077210|NCT02529488|588991197|FG000|Overall Study|Death|3|||
163077211|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
163077212|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077213|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077214|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077215|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077216|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
163077217|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
163077218|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
163077219|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077220|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
163077221|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077222|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077223|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077224|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
163077225|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
163077226|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077227|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077228|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077229|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077230|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077231|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
163077232|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
163077233|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077234|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077235|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077236|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077237|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
163077238|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
163077239|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163154804|NCT00521079|589281441|FG001|Overall Study|Withdrawal by Subject|3|||
163154805|NCT04123470|589281442|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
163077240|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
163077241|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077242|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077243|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077244|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077245|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163077246|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077247|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077248|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077249|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077250|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
163077251|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
163077252|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
163077253|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077254|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077255|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077256|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077257|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077258|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
163077259|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
163077260|NCT01557244|588991204|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
163077261|NCT01557244|588991205|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077262|NCT01557244|588991206|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
163077263|NCT01557244|588991207|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077264|NCT01557244|588991208|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077265|NCT01557244|588991209|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077266|NCT01557244|588991210|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
163077267|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077268|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077269|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077270|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077271|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077272|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
163077273|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
163077274|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
163077275|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
163077276|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077277|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077278|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077279|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077280|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163077281|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077282|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077283|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077284|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
163077285|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077286|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077287|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
163077288|NCT01557244|588991204|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
163077289|NCT01557244|588991205|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
163077290|NCT01557244|588991206|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077291|NCT01557244|588991207|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077292|NCT01557244|588991208|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077293|NCT01557244|588991209|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077294|NCT01557244|588991210|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
163077295|NCT01313676|588991211|FG000|Overall Study|Adverse Event|395|||
163077296|NCT01313676|588991212|FG001|Overall Study|Adverse Event|365|||
163077297|NCT01313676|588991213|FG002|Overall Study|Adverse Event|372|||
163077298|NCT01313676|588991214|FG003|Overall Study|Adverse Event|333|||
163077299|NCT01313676|588991211|FG000|Overall Study|Lack of Efficacy|98|||
163077300|NCT01313676|588991212|FG001|Overall Study|Lack of Efficacy|90|||
163077301|NCT01313676|588991213|FG002|Overall Study|Lack of Efficacy|65|||
163077302|NCT01313676|588991214|FG003|Overall Study|Lack of Efficacy|46|||
163077303|NCT01313676|588991211|FG000|Overall Study|Protocol Violation|37|||
163077304|NCT01313676|588991212|FG001|Overall Study|Protocol Violation|44|||
163077305|NCT01313676|588991213|FG002|Overall Study|Protocol Violation|46|||
163077306|NCT01313676|588991214|FG003|Overall Study|Protocol Violation|44|||
163077307|NCT01313676|588991211|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
163077308|NCT01313676|588991212|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
163077309|NCT01313676|588991213|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
163077310|NCT01313676|588991214|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
163077311|NCT01313676|588991211|FG000|Overall Study|Study Closed/terminated|7|||
163077312|NCT01313676|588991212|FG001|Overall Study|Study Closed/terminated|6|||
163077313|NCT01313676|588991213|FG002|Overall Study|Study Closed/terminated|9|||
163077314|NCT01313676|588991214|FG003|Overall Study|Study Closed/terminated|9|||
163077315|NCT01313676|588991211|FG000|Overall Study|Lost to Follow-up|0|||
163077316|NCT01313676|588991212|FG001|Overall Study|Lost to Follow-up|0|||
163077317|NCT01313676|588991213|FG002|Overall Study|Lost to Follow-up|1|||
163077318|NCT01313676|588991214|FG003|Overall Study|Lost to Follow-up|0|||
163077319|NCT01313676|588991211|FG000|Overall Study|Physician Decision|53|||
163077320|NCT01313676|588991212|FG001|Overall Study|Physician Decision|64|||
163077321|NCT01313676|588991213|FG002|Overall Study|Physician Decision|62|||
163077322|NCT01313676|588991214|FG003|Overall Study|Physician Decision|48|||
163077323|NCT01313676|588991211|FG000|Overall Study|Decision by Participant or Proxy|643|||
163077324|NCT01313676|588991212|FG001|Overall Study|Decision by Participant or Proxy|527|||
163077325|NCT01313676|588991213|FG002|Overall Study|Decision by Participant or Proxy|515|||
163077326|NCT01313676|588991214|FG003|Overall Study|Decision by Participant or Proxy|492|||
163077327|NCT01313676|588991211|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
163077328|NCT01313676|588991212|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
163077329|NCT01313676|588991213|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
163077330|NCT01313676|588991214|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
163077331|NCT01313676|588991211|FG000|Overall Study|Investigator Site Closed|12|||
163077332|NCT01313676|588991212|FG001|Overall Study|Investigator Site Closed|11|||
163077333|NCT01313676|588991213|FG002|Overall Study|Investigator Site Closed|15|||
163077334|NCT01313676|588991214|FG003|Overall Study|Investigator Site Closed|10|||
163077335|NCT01313676|588991211|FG000|Overall Study|Missing|1|||
163077336|NCT01313676|588991212|FG001|Overall Study|Missing|1|||
163077337|NCT01313676|588991213|FG002|Overall Study|Missing|1|||
163077338|NCT01313676|588991214|FG003|Overall Study|Missing|0|||
163077339|NCT00326495|588991215|FG000|Overall Study|Switched to alternative treatment|1|||
163077340|NCT00326495|588991215|FG000|Overall Study|Disease progression before treatment|1|||
163077341|NCT00326495|588991215|FG000|Overall Study|Refused further treatment|2|||
163077342|NCT00326495|588991215|FG000|Overall Study|Subject off study before assessment|1|||
163077343|NCT01654250|588991216|FG000|Overall Study|Lost to Follow-up|1|||
163077344|NCT01654250|588991217|FG001|Overall Study|Lost to Follow-up|0|||
163077345|NCT01897896|588991220|FG000|Overall Study|Death|1|||
163077346|NCT01897896|588991221|FG001|Overall Study|Death|0|||
163077347|NCT01897896|588991220|FG000|Overall Study|Adverse Event|11|||
163077348|NCT01897896|588991221|FG001|Overall Study|Adverse Event|1|||
163077349|NCT01897896|588991220|FG000|Overall Study|Lost to Follow-up|1|||
163077350|NCT01897896|588991221|FG001|Overall Study|Lost to Follow-up|0|||
163077351|NCT01897896|588991220|FG000|Overall Study|Non-compliance with study drug dosing|1|||
163077352|NCT01897896|588991221|FG001|Overall Study|Non-compliance with study drug dosing|1|||
163077353|NCT01897896|588991220|FG000|Overall Study|Withdrawal by Subject|7|||
163077354|NCT01897896|588991221|FG001|Overall Study|Withdrawal by Subject|1|||
163077355|NCT01897896|588991220|FG000|Overall Study|Require drug that interfere with study|1|||
163077356|NCT01897896|588991221|FG001|Overall Study|Require drug that interfere with study|4|||
163077357|NCT01897896|588991220|FG000|Overall Study|Protocol Violation|1|||
163077358|NCT01897896|588991221|FG001|Overall Study|Protocol Violation|1|||
163077359|NCT01897896|588991220|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
163077360|NCT01897896|588991221|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
163077361|NCT01897896|588991220|FG000|Overall Study|Caregiver can no longer participate|0|||
163077362|NCT01897896|588991221|FG001|Overall Study|Caregiver can no longer participate|2|||
163077363|NCT01897896|588991220|FG000|Overall Study|Other than specified|2|||
163077364|NCT01897896|588991221|FG001|Overall Study|Other than specified|1|||
162717888|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163077365|NCT01716559|588991231|FG000|Overall Study|Adverse Event|11|||
163077366|NCT01716559|588991231|FG000|Overall Study|Death|21|||
163077367|NCT01716559|588991231|FG000|Overall Study|Withdrawal by Subject|4|||
163077368|NCT01716559|588991231|FG000|Overall Study|Other withdrawal reason|75|||
163077369|NCT00458705|588991237|FG000|Overall Study|Adverse Event|4|||
163077370|NCT00458705|588991237|FG000|Overall Study|Not Treated|1|||
163077371|NCT02180672|588991238|FG000|Overall Study|Lost to Follow-up|5|||
163077372|NCT02180672|588991239|FG001|Overall Study|Lost to Follow-up|7|||
163077373|NCT00378560|588991243|FG000|Overall Study|Adverse Event|1|||
163077374|NCT00378560|588991244|FG001|Overall Study|Adverse Event|0|||
163077375|NCT00378560|588991243|FG000|Overall Study|Lost to Follow-up|24|||
163077376|NCT00378560|588991244|FG001|Overall Study|Lost to Follow-up|29|||
163077377|NCT00378560|588991243|FG000|Overall Study|Protocol Violation|2|||
163077378|NCT00378560|588991244|FG001|Overall Study|Protocol Violation|0|||
163077379|NCT00378560|588991243|FG000|Overall Study|Withdrawal by Subject|17|||
163077380|NCT00378560|588991244|FG001|Overall Study|Withdrawal by Subject|21|||
163077381|NCT00378560|588991243|FG000|Overall Study|Moved|4|||
163077382|NCT00378560|588991244|FG001|Overall Study|Moved|3|||
162717889|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163077383|NCT00378560|588991243|FG000|Overall Study|Pregnancy|7|||
163077384|NCT00378560|588991244|FG001|Overall Study|Pregnancy|5|||
163077385|NCT00378560|588991243|FG000|Overall Study|Laboratory test values abnormal|1|||
163077386|NCT00378560|588991244|FG001|Overall Study|Laboratory test values abnormal|0|||
163077387|NCT02070380|588991245|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
163077388|NCT02070380|588991246|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
163077389|NCT02070380|588991247|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
163077390|NCT02070380|588991248|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
163077391|NCT02070380|588991245|FG000|Second Injection|Image sets missing or technically inadeq|0|||
163077392|NCT02070380|588991246|FG001|Second Injection|Image sets missing or technically inadeq|1|||
163077393|NCT02070380|588991247|FG002|Second Injection|Image sets missing or technically inadeq|0|||
163077394|NCT02070380|588991248|FG003|Second Injection|Image sets missing or technically inadeq|0|||
163077395|NCT02070380|588991245|FG000|Second Injection|Protocol Violation|0|||
163077396|NCT02070380|588991246|FG001|Second Injection|Protocol Violation|1|||
163077397|NCT02070380|588991247|FG002|Second Injection|Protocol Violation|1|||
163077398|NCT02070380|588991248|FG003|Second Injection|Protocol Violation|5|||
163077399|NCT05463705|588991265|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
163077400|NCT05463705|588991266|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
163077401|NCT05463705|588991267|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
163077402|NCT05463705|588991268|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
163077403|NCT05463705|588991269|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
163077404|NCT05463705|588991270|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
163077405|NCT00552279|588991275|FG000|Overall Study|Adverse Event|0|||
163077406|NCT00552279|588991276|FG001|Overall Study|Adverse Event|1|||
163077407|NCT00552279|588991275|FG000|Overall Study|Withdrawal by Subject|12|||
163077408|NCT00552279|588991276|FG001|Overall Study|Withdrawal by Subject|1|||
163077409|NCT00552279|588991275|FG000|Overall Study|Lost to Follow-up|1|||
163077410|NCT00552279|588991276|FG001|Overall Study|Lost to Follow-up|0|||
163077411|NCT00552279|588991275|FG000|Overall Study|Other|1|||
163077412|NCT00552279|588991276|FG001|Overall Study|Other|1|||
163077413|NCT03596983|588991277|FG000|Overall Study|Withdrawal by Subject|3|||
163077414|NCT03071965|588991278|FG000|Overall Study|Adverse Event|0|||
163077415|NCT03071965|588991279|FG001|Overall Study|Adverse Event|0|||
163077416|NCT03071965|588991280|FG002|Overall Study|Adverse Event|1|||
163077417|NCT03071965|588991281|FG003|Overall Study|Adverse Event|0|||
163077418|NCT03071965|588991278|FG000|Overall Study|Death|0|||
163077419|NCT03071965|588991279|FG001|Overall Study|Death|0|||
163077420|NCT03071965|588991280|FG002|Overall Study|Death|1|||
163077421|NCT03071965|588991281|FG003|Overall Study|Death|1|||
163077422|NCT03071965|588991278|FG000|Overall Study|COVID-19|0|||
163077423|NCT03071965|588991279|FG001|Overall Study|COVID-19|1|||
163077424|NCT03071965|588991280|FG002|Overall Study|COVID-19|0|||
163077425|NCT03071965|588991281|FG003|Overall Study|COVID-19|1|||
163077426|NCT03071965|588991278|FG000|Overall Study|Other Health Reason|0|||
163077427|NCT03071965|588991279|FG001|Overall Study|Other Health Reason|0|||
163077428|NCT03071965|588991280|FG002|Overall Study|Other Health Reason|0|||
163077429|NCT03071965|588991281|FG003|Overall Study|Other Health Reason|1|||
163077430|NCT02346370|588991282|FG000|Overall Study|Not treated|1|||
163077431|NCT02346370|588991283|FG001|Overall Study|Not treated|0|||
163077432|NCT02346370|588991284|FG002|Overall Study|Not treated|0|||
163077433|NCT02346370|588991282|FG000|Overall Study|Withdrawal of consent|1|||
163077434|NCT02346370|588991283|FG001|Overall Study|Withdrawal of consent|0|||
163077435|NCT02346370|588991284|FG002|Overall Study|Withdrawal of consent|0|||
163077436|NCT02346370|588991282|FG000|Overall Study|Death|1|||
163077437|NCT02346370|588991283|FG001|Overall Study|Death|3|||
163077438|NCT02346370|588991284|FG002|Overall Study|Death|1|||
163077439|NCT02346370|588991282|FG000|Overall Study|Sponsor discontinued study|5|||
163077440|NCT02346370|588991283|FG001|Overall Study|Sponsor discontinued study|0|||
163077441|NCT02346370|588991284|FG002|Overall Study|Sponsor discontinued study|2|||
163077442|NCT02346370|588991282|FG000|Overall Study|Radiologic progression|0|||
163077443|NCT02346370|588991283|FG001|Overall Study|Radiologic progression|0|||
163077444|NCT02346370|588991284|FG002|Overall Study|Radiologic progression|1|||
163077445|NCT02346370|588991282|FG000|Overall Study|Physician Decision|0|||
163077446|NCT02346370|588991283|FG001|Overall Study|Physician Decision|1|||
163077447|NCT02346370|588991284|FG002|Overall Study|Physician Decision|0|||
163077448|NCT06399471|588991285|FG000|Overall Study|Withdrawal by Subject|1|||
163077449|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
163077450|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
163077451|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
163077452|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
163077453|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
163077454|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
163077455|NCT02662582|588991286|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163077456|NCT02662582|588991287|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163077457|NCT00609973|588991289|FG000|Overall Study|Adverse Event|2|||
163077458|NCT00609973|588991290|FG001|Overall Study|Adverse Event|1|||
163077459|NCT00609973|588991289|FG000|Overall Study|Protocol Violation|4|||
163077460|NCT00609973|588991290|FG001|Overall Study|Protocol Violation|3|||
163077461|NCT00609973|588991289|FG000|Overall Study|Lost to Follow-up|2|||
163077462|NCT00609973|588991290|FG001|Overall Study|Lost to Follow-up|1|||
163077463|NCT00609973|588991289|FG000|Overall Study|Withdrawal by Subject|0|||
163077464|NCT00609973|588991290|FG001|Overall Study|Withdrawal by Subject|1|||
163077465|NCT01362270|588991293|FG000|Overall Study|Withdrawal by Subject|1|||
163077466|NCT01362270|588991294|FG001|Overall Study|Withdrawal by Subject|0|||
163077467|NCT01362270|588991293|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
163077468|NCT01362270|588991294|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
163077469|NCT01362270|588991293|FG000|Overall Study|Met excl. criteria before 1st session|1|||
163077470|NCT01362270|588991294|FG001|Overall Study|Met excl. criteria before 1st session|1|||
163077471|NCT01691482|588991295|FG000|Treatment Period 2|Adverse Event|0|||
163077472|NCT01691482|588991296|FG001|Treatment Period 2|Adverse Event|1|||
163077473|NCT01691482|588991295|FG000|Treatment Period 2|Protocol Violation|1|||
163077474|NCT01691482|588991296|FG001|Treatment Period 2|Protocol Violation|1|||
163077475|NCT01953354|588991297|FG000|Overall Study|Withdrawal by Subject|0|||
163077476|NCT01953354|588991298|FG001|Overall Study|Withdrawal by Subject|1|||
163077477|NCT01953354|588991297|FG000|Overall Study|Decision of Sponsor|0|||
163077478|NCT01953354|588991298|FG001|Overall Study|Decision of Sponsor|1|||
163077479|NCT01953354|588991297|FG000|Overall Study|Disease Exacerbation|1|||
163077480|NCT01953354|588991298|FG001|Overall Study|Disease Exacerbation|0|||
163077481|NCT01392495|588991299|FG000|Overall Study|Death|3|||
163077482|NCT01392495|588991299|FG000|Overall Study|Administrative problems|8|||
163077483|NCT01392495|588991299|FG000|Overall Study|Withdrawal by Subject|2|||
163077484|NCT01392495|588991299|FG000|Overall Study|Adverse Event|3|||
163077485|NCT00806026|588991300|FG000|Overall Study|Death|0|||
163077486|NCT00806026|588991301|FG001|Overall Study|Death|0|||
163077487|NCT00806026|588991302|FG002|Overall Study|Death|0|||
163077488|NCT00806026|588991303|FG003|Overall Study|Death|1|||
163077489|NCT00806026|588991304|FG004|Overall Study|Death|0|||
163077490|NCT00806026|588991305|FG005|Overall Study|Death|0|||
163077491|NCT00806026|588991300|FG000|Overall Study|Did not meet entrance criteria|4|||
163077492|NCT00806026|588991301|FG001|Overall Study|Did not meet entrance criteria|1|||
163077493|NCT00806026|588991302|FG002|Overall Study|Did not meet entrance criteria|2|||
163077494|NCT00806026|588991303|FG003|Overall Study|Did not meet entrance criteria|1|||
163077495|NCT00806026|588991304|FG004|Overall Study|Did not meet entrance criteria|0|||
163077496|NCT00806026|588991305|FG005|Overall Study|Did not meet entrance criteria|0|||
163077497|NCT00806026|588991300|FG000|Overall Study|Lack of Efficacy|5|||
163077498|NCT00806026|588991301|FG001|Overall Study|Lack of Efficacy|18|||
163077499|NCT00806026|588991302|FG002|Overall Study|Lack of Efficacy|13|||
163077500|NCT00806026|588991303|FG003|Overall Study|Lack of Efficacy|4|||
163077501|NCT00806026|588991304|FG004|Overall Study|Lack of Efficacy|8|||
163077502|NCT00806026|588991305|FG005|Overall Study|Lack of Efficacy|7|||
163077503|NCT00806026|588991300|FG000|Overall Study|Lost to Follow-up|8|||
163077504|NCT00806026|588991301|FG001|Overall Study|Lost to Follow-up|15|||
163077505|NCT00806026|588991302|FG002|Overall Study|Lost to Follow-up|8|||
163077506|NCT00806026|588991303|FG003|Overall Study|Lost to Follow-up|2|||
163077507|NCT00806026|588991304|FG004|Overall Study|Lost to Follow-up|6|||
163077508|NCT00806026|588991305|FG005|Overall Study|Lost to Follow-up|6|||
162645448|NCT02419742|587419339|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
162645449|NCT02419742|587419340|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
162645450|NCT04356963|587419346|FG000|First Session|Withdrawal by Subject|1|||
162645451|NCT04356963|587419346|FG000|Second Session|Withdrawal by Subject|3|||
162645452|NCT04356963|587419346|FG000|Second Session|Lost to Follow-up|1|||
162645453|NCT04356963|587419346|FG000|Third Session|Lost to Follow-up|6|||
163077509|NCT00806026|588991300|FG000|Overall Study|Withdrawal by Subject|14|||
163077510|NCT00806026|588991301|FG001|Overall Study|Withdrawal by Subject|17|||
163077511|NCT00806026|588991302|FG002|Overall Study|Withdrawal by Subject|9|||
163077512|NCT00806026|588991303|FG003|Overall Study|Withdrawal by Subject|2|||
163077513|NCT00806026|588991304|FG004|Overall Study|Withdrawal by Subject|5|||
163077514|NCT00806026|588991305|FG005|Overall Study|Withdrawal by Subject|3|||
163077515|NCT00806026|588991300|FG000|Overall Study|Other|3|||
163077516|NCT00806026|588991301|FG001|Overall Study|Other|6|||
163077517|NCT00806026|588991302|FG002|Overall Study|Other|8|||
163077518|NCT00806026|588991303|FG003|Overall Study|Other|2|||
163077519|NCT00806026|588991304|FG004|Overall Study|Other|0|||
163077520|NCT00806026|588991305|FG005|Overall Study|Other|4|||
163077521|NCT00806026|588991300|FG000|Overall Study|Protocol Violation|6|||
163077522|NCT00806026|588991301|FG001|Overall Study|Protocol Violation|9|||
163077523|NCT00806026|588991302|FG002|Overall Study|Protocol Violation|9|||
163077524|NCT00806026|588991303|FG003|Overall Study|Protocol Violation|0|||
163077525|NCT00806026|588991304|FG004|Overall Study|Protocol Violation|2|||
163077526|NCT00806026|588991305|FG005|Overall Study|Protocol Violation|3|||
163077527|NCT00806026|588991300|FG000|Overall Study|Adverse Event|52|||
163077528|NCT00806026|588991301|FG001|Overall Study|Adverse Event|35|||
163077529|NCT00806026|588991302|FG002|Overall Study|Adverse Event|44|||
163077530|NCT00806026|588991303|FG003|Overall Study|Adverse Event|17|||
163077531|NCT00806026|588991304|FG004|Overall Study|Adverse Event|9|||
163077532|NCT00806026|588991305|FG005|Overall Study|Adverse Event|9|||
163077533|NCT00147537|588991317|FG000|Phase 1b|Death|0|||
163077534|NCT00147537|588991318|FG001|Phase 1b|Death|1|||
163077535|NCT00147537|588991319|FG002|Phase 1b|Death|2|||
163077536|NCT00147537|588991320|FG003|Phase 1b|Death|1|||
163077537|NCT00147537|588991321|FG004|Phase 1b|Death|2|||
163077538|NCT00147537|588991322|FG005|Phase 1b|Death|2|||
163077539|NCT00147537|588991323|FG006|Phase 1b|Death|1|||
163077540|NCT00147537|588991324|FG007|Phase 1b|Death|3|||
163077541|NCT00147537|588991325|FG008|Phase 1b|Death|9|||
163077542|NCT00147537|588991326|FG009|Phase 1b|Death|0|||
163077543|NCT00147537|588991327|FG010|Phase 1b|Death|0|||
163077544|NCT00147537|588991317|FG000|Phase 1b|Lost to Follow-up|2|||
163077545|NCT00147537|588991318|FG001|Phase 1b|Lost to Follow-up|1|||
163077546|NCT00147537|588991319|FG002|Phase 1b|Lost to Follow-up|0|||
163077547|NCT00147537|588991320|FG003|Phase 1b|Lost to Follow-up|0|||
163077548|NCT00147537|588991321|FG004|Phase 1b|Lost to Follow-up|0|||
163077549|NCT00147537|588991322|FG005|Phase 1b|Lost to Follow-up|0|||
163077550|NCT00147537|588991323|FG006|Phase 1b|Lost to Follow-up|2|||
163077551|NCT00147537|588991324|FG007|Phase 1b|Lost to Follow-up|0|||
163077552|NCT00147537|588991325|FG008|Phase 1b|Lost to Follow-up|1|||
163077553|NCT00147537|588991326|FG009|Phase 1b|Lost to Follow-up|0|||
163077554|NCT00147537|588991327|FG010|Phase 1b|Lost to Follow-up|0|||
163077555|NCT00147537|588991317|FG000|Phase 1b|Other|0|||
163077556|NCT00147537|588991318|FG001|Phase 1b|Other|0|||
163077557|NCT00147537|588991319|FG002|Phase 1b|Other|2|||
163077558|NCT00147537|588991320|FG003|Phase 1b|Other|1|||
163077559|NCT00147537|588991321|FG004|Phase 1b|Other|1|||
163077560|NCT00147537|588991322|FG005|Phase 1b|Other|1|||
163077561|NCT00147537|588991323|FG006|Phase 1b|Other|14|||
163077562|NCT00147537|588991324|FG007|Phase 1b|Other|4|||
163077563|NCT00147537|588991325|FG008|Phase 1b|Other|4|||
163077564|NCT00147537|588991326|FG009|Phase 1b|Other|0|||
163077565|NCT00147537|588991327|FG010|Phase 1b|Other|0|||
163077566|NCT00147537|588991317|FG000|Phase 1b|Withdrawal by Subject|0|||
163077567|NCT00147537|588991318|FG001|Phase 1b|Withdrawal by Subject|0|||
163077568|NCT00147537|588991319|FG002|Phase 1b|Withdrawal by Subject|0|||
163077569|NCT00147537|588991320|FG003|Phase 1b|Withdrawal by Subject|0|||
163077570|NCT00147537|588991321|FG004|Phase 1b|Withdrawal by Subject|0|||
163077571|NCT00147537|588991322|FG005|Phase 1b|Withdrawal by Subject|0|||
163077572|NCT00147537|588991323|FG006|Phase 1b|Withdrawal by Subject|0|||
163077573|NCT00147537|588991324|FG007|Phase 1b|Withdrawal by Subject|0|||
163077574|NCT00147537|588991325|FG008|Phase 1b|Withdrawal by Subject|2|||
163077575|NCT00147537|588991326|FG009|Phase 1b|Withdrawal by Subject|0|||
163077576|NCT00147537|588991327|FG010|Phase 1b|Withdrawal by Subject|0|||
163077577|NCT00147537|588991317|FG000|Phase 1b|Randomized but not treated|0|||
163077578|NCT00147537|588991318|FG001|Phase 1b|Randomized but not treated|0|||
163077579|NCT00147537|588991319|FG002|Phase 1b|Randomized but not treated|0|||
163077580|NCT00147537|588991320|FG003|Phase 1b|Randomized but not treated|0|||
163077581|NCT00147537|588991321|FG004|Phase 1b|Randomized but not treated|0|||
163077582|NCT00147537|588991322|FG005|Phase 1b|Randomized but not treated|0|||
163077583|NCT00147537|588991323|FG006|Phase 1b|Randomized but not treated|1|||
163077584|NCT00147537|588991324|FG007|Phase 1b|Randomized but not treated|0|||
163077585|NCT00147537|588991325|FG008|Phase 1b|Randomized but not treated|1|||
163077586|NCT00147537|588991326|FG009|Phase 1b|Randomized but not treated|0|||
163029209|NCT03932331|588810380|FG000|Overall Study|Death|0|||
163077587|NCT00147537|588991327|FG010|Phase 1b|Randomized but not treated|0|||
163077588|NCT00147537|588991317|FG000|Phase 2|Death|0|||
163029210|NCT03932331|588810381|FG001|Overall Study|Death|7|||
163029211|NCT03932331|588810382|FG002|Overall Study|Death|2|||
163029212|NCT03932331|588810380|FG000|Overall Study|Withdrawal by Subject|0|||
163029213|NCT03932331|588810381|FG001|Overall Study|Withdrawal by Subject|3|||
163029214|NCT03932331|588810382|FG002|Overall Study|Withdrawal by Subject|0|||
163029215|NCT03932331|588810380|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
163029216|NCT03932331|588810381|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
163029217|NCT03932331|588810382|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
163029218|NCT03932331|588810380|FG000|Overall Study|Progressive disease|3|||
163029219|NCT03932331|588810381|FG001|Overall Study|Progressive disease|0|||
163029220|NCT03932331|588810382|FG002|Overall Study|Progressive disease|0|||
163029221|NCT03932331|588810380|FG000|Overall Study|Lung infection|1|||
163029222|NCT03932331|588810381|FG001|Overall Study|Lung infection|0|||
163077589|NCT00147537|588991318|FG001|Phase 2|Death|0|||
163077590|NCT00147537|588991319|FG002|Phase 2|Death|0|||
163077591|NCT00147537|588991320|FG003|Phase 2|Death|0|||
163077592|NCT00147537|588991321|FG004|Phase 2|Death|0|||
163077593|NCT00147537|588991322|FG005|Phase 2|Death|0|||
163077594|NCT00147537|588991323|FG006|Phase 2|Death|0|||
163077595|NCT00147537|588991324|FG007|Phase 2|Death|0|||
163077596|NCT00147537|588991325|FG008|Phase 2|Death|0|||
163077597|NCT00147537|588991326|FG009|Phase 2|Death|85|||
163077598|NCT00147537|588991327|FG010|Phase 2|Death|31|||
163077599|NCT00147537|588991317|FG000|Phase 2|Lost to Follow-up|0|||
163077600|NCT00147537|588991318|FG001|Phase 2|Lost to Follow-up|0|||
163077601|NCT00147537|588991319|FG002|Phase 2|Lost to Follow-up|0|||
163077602|NCT00147537|588991320|FG003|Phase 2|Lost to Follow-up|0|||
163077603|NCT00147537|588991321|FG004|Phase 2|Lost to Follow-up|0|||
163077604|NCT00147537|588991322|FG005|Phase 2|Lost to Follow-up|0|||
163077605|NCT00147537|588991323|FG006|Phase 2|Lost to Follow-up|0|||
163077606|NCT00147537|588991324|FG007|Phase 2|Lost to Follow-up|0|||
163077607|NCT00147537|588991325|FG008|Phase 2|Lost to Follow-up|0|||
163077608|NCT00147537|588991326|FG009|Phase 2|Lost to Follow-up|12|||
163077609|NCT00147537|588991327|FG010|Phase 2|Lost to Follow-up|4|||
163077610|NCT00147537|588991317|FG000|Phase 2|Other|0|||
163077611|NCT00147537|588991318|FG001|Phase 2|Other|0|||
163077612|NCT00147537|588991319|FG002|Phase 2|Other|0|||
163077613|NCT00147537|588991320|FG003|Phase 2|Other|0|||
163077614|NCT00147537|588991321|FG004|Phase 2|Other|0|||
163077615|NCT00147537|588991322|FG005|Phase 2|Other|0|||
163077616|NCT00147537|588991323|FG006|Phase 2|Other|0|||
163077617|NCT00147537|588991324|FG007|Phase 2|Other|0|||
163077618|NCT00147537|588991325|FG008|Phase 2|Other|0|||
163077619|NCT00147537|588991326|FG009|Phase 2|Other|47|||
163077620|NCT00147537|588991327|FG010|Phase 2|Other|12|||
163077621|NCT00147537|588991317|FG000|Phase 2|Withdrawal by Subject|0|||
163077622|NCT00147537|588991318|FG001|Phase 2|Withdrawal by Subject|0|||
163077623|NCT00147537|588991319|FG002|Phase 2|Withdrawal by Subject|0|||
163077624|NCT00147537|588991320|FG003|Phase 2|Withdrawal by Subject|0|||
163077625|NCT00147537|588991321|FG004|Phase 2|Withdrawal by Subject|0|||
163077626|NCT00147537|588991322|FG005|Phase 2|Withdrawal by Subject|0|||
163077627|NCT00147537|588991323|FG006|Phase 2|Withdrawal by Subject|0|||
163077628|NCT00147537|588991324|FG007|Phase 2|Withdrawal by Subject|0|||
163077629|NCT00147537|588991325|FG008|Phase 2|Withdrawal by Subject|0|||
163077630|NCT00147537|588991326|FG009|Phase 2|Withdrawal by Subject|16|||
163077631|NCT00147537|588991327|FG010|Phase 2|Withdrawal by Subject|4|||
163077632|NCT00147537|588991317|FG000|Phase 2|Randomized but not treated|0|||
163077633|NCT00147537|588991318|FG001|Phase 2|Randomized but not treated|0|||
163077634|NCT00147537|588991319|FG002|Phase 2|Randomized but not treated|0|||
163077635|NCT00147537|588991320|FG003|Phase 2|Randomized but not treated|0|||
163077636|NCT00147537|588991321|FG004|Phase 2|Randomized but not treated|0|||
163077637|NCT00147537|588991322|FG005|Phase 2|Randomized but not treated|0|||
163077638|NCT00147537|588991323|FG006|Phase 2|Randomized but not treated|0|||
163077639|NCT00147537|588991324|FG007|Phase 2|Randomized but not treated|0|||
163077640|NCT00147537|588991325|FG008|Phase 2|Randomized but not treated|0|||
163077641|NCT00147537|588991326|FG009|Phase 2|Randomized but not treated|1|||
163077642|NCT00147537|588991327|FG010|Phase 2|Randomized but not treated|1|||
163077643|NCT01927861|588991328|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
163077644|NCT01927861|588991329|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
163077645|NCT01927861|588991328|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
163077646|NCT01927861|588991329|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
163077647|NCT00987935|588991330|FG000|Overall Study|Progressive disease|3|||
163077648|NCT00987935|588991331|FG001|Overall Study|Progressive disease|2|||
163077649|NCT00987935|588991332|FG002|Overall Study|Progressive disease|3|||
163077650|NCT00987935|588991333|FG003|Overall Study|Progressive disease|2|||
163077651|NCT00987935|588991334|FG004|Overall Study|Progressive disease|5|||
163077652|NCT00987935|588991335|FG005|Overall Study|Progressive disease|3|||
163077653|NCT00987935|588991336|FG006|Overall Study|Progressive disease|9|||
163077654|NCT00987935|588991337|FG007|Overall Study|Progressive disease|48|||
163077655|NCT00987935|588991338|FG008|Overall Study|Progressive disease|23|||
163077656|NCT00987935|588991330|FG000|Overall Study|Adverse Event|0|||
163077657|NCT00987935|588991331|FG001|Overall Study|Adverse Event|1|||
163077658|NCT00987935|588991332|FG002|Overall Study|Adverse Event|0|||
163077659|NCT00987935|588991333|FG003|Overall Study|Adverse Event|1|||
163077660|NCT00987935|588991334|FG004|Overall Study|Adverse Event|1|||
163077661|NCT00987935|588991335|FG005|Overall Study|Adverse Event|0|||
163077662|NCT00987935|588991336|FG006|Overall Study|Adverse Event|2|||
163077663|NCT00987935|588991337|FG007|Overall Study|Adverse Event|10|||
163077664|NCT00987935|588991338|FG008|Overall Study|Adverse Event|6|||
163077665|NCT00987935|588991330|FG000|Overall Study|Refused to continue taking trial med.|1|||
163077666|NCT00987935|588991331|FG001|Overall Study|Refused to continue taking trial med.|0|||
163077667|NCT00987935|588991332|FG002|Overall Study|Refused to continue taking trial med.|0|||
163077668|NCT00987935|588991333|FG003|Overall Study|Refused to continue taking trial med.|0|||
163077669|NCT00987935|588991334|FG004|Overall Study|Refused to continue taking trial med.|1|||
163077670|NCT00987935|588991335|FG005|Overall Study|Refused to continue taking trial med.|0|||
163077671|NCT00987935|588991336|FG006|Overall Study|Refused to continue taking trial med.|4|||
163077672|NCT00987935|588991337|FG007|Overall Study|Refused to continue taking trial med.|4|||
163077673|NCT00987935|588991338|FG008|Overall Study|Refused to continue taking trial med.|2|||
163077674|NCT00987935|588991330|FG000|Overall Study|Reason other than those specified above|0|||
163077675|NCT00987935|588991331|FG001|Overall Study|Reason other than those specified above|0|||
163077676|NCT00987935|588991332|FG002|Overall Study|Reason other than those specified above|0|||
163077677|NCT00987935|588991333|FG003|Overall Study|Reason other than those specified above|0|||
163077678|NCT00987935|588991334|FG004|Overall Study|Reason other than those specified above|0|||
163077679|NCT00987935|588991335|FG005|Overall Study|Reason other than those specified above|0|||
163077680|NCT00987935|588991336|FG006|Overall Study|Reason other than those specified above|0|||
163077681|NCT00987935|588991337|FG007|Overall Study|Reason other than those specified above|0|||
163077682|NCT00987935|588991338|FG008|Overall Study|Reason other than those specified above|1|||
163077683|NCT00452530|588991339|FG000|Overall Study|Death|1|||
163077684|NCT00452530|588991340|FG001|Overall Study|Death|0|||
163077685|NCT00452530|588991339|FG000|Overall Study|Adverse Event|40|||
163077686|NCT00452530|588991340|FG001|Overall Study|Adverse Event|44|||
163077687|NCT00452530|588991339|FG000|Overall Study|Withdrawal by Subject|68|||
163077688|NCT00452530|588991340|FG001|Overall Study|Withdrawal by Subject|57|||
163077689|NCT00452530|588991339|FG000|Overall Study|Lost to Follow-up|1|||
163077690|NCT00452530|588991340|FG001|Overall Study|Lost to Follow-up|0|||
163077691|NCT00452530|588991339|FG000|Overall Study|Poor compliance/noncompliance|1|||
163077692|NCT00452530|588991340|FG001|Overall Study|Poor compliance/noncompliance|2|||
163077693|NCT00452530|588991339|FG000|Overall Study|No longer met study criteria|18|||
163077694|NCT00452530|588991340|FG001|Overall Study|No longer met study criteria|22|||
162717890|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163077695|NCT00452530|588991339|FG000|Overall Study|Other|7|||
163077696|NCT00452530|588991340|FG001|Overall Study|Other|11|||
163077697|NCT02191397|588991342|FG000|Overall Study|Adverse Event|28|||
163077698|NCT02191397|588991343|FG001|Overall Study|Adverse Event|17|||
163077699|NCT02191397|588991342|FG000|Overall Study|Lack of Efficacy|10|||
163077700|NCT02191397|588991343|FG001|Overall Study|Lack of Efficacy|5|||
163077701|NCT02191397|588991342|FG000|Overall Study|Protocol Violation|0|||
163077702|NCT02191397|588991343|FG001|Overall Study|Protocol Violation|3|||
163077703|NCT02191397|588991342|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
163077704|NCT02191397|588991343|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
163077705|NCT02191397|588991342|FG000|Overall Study|Lost to Follow-up|10|||
163077706|NCT02191397|588991343|FG001|Overall Study|Lost to Follow-up|11|||
163077707|NCT02191397|588991342|FG000|Overall Study|Physician Decision|8|||
163077708|NCT02191397|588991343|FG001|Overall Study|Physician Decision|3|||
163077709|NCT02191397|588991342|FG000|Overall Study|Withdrawal by Subject|22|||
163077710|NCT02191397|588991343|FG001|Overall Study|Withdrawal by Subject|27|||
163077711|NCT00728182|588991345|FG000|Overall Study|Adverse Event|1|||
163077712|NCT00728182|588991346|FG001|Overall Study|Adverse Event|0|||
163077713|NCT00728182|588991345|FG000|Overall Study|Lost to Follow-up|2|||
163077714|NCT00728182|588991346|FG001|Overall Study|Lost to Follow-up|0|||
163077715|NCT00728182|588991345|FG000|Overall Study|Death|0|||
163077716|NCT00728182|588991346|FG001|Overall Study|Death|2|||
163077717|NCT00728182|588991345|FG000|Overall Study|Protocol Noncompliance|0|||
163077718|NCT00728182|588991346|FG001|Overall Study|Protocol Noncompliance|1|||
163077719|NCT01898091|588991349|FG000|Overall Study|Lost to Follow-up|1|||
163077720|NCT01898091|588991350|FG001|Overall Study|Lost to Follow-up|1|||
163077721|NCT01898091|588991349|FG000|Overall Study|Withdrawal by Subject|1|||
163077722|NCT01898091|588991350|FG001|Overall Study|Withdrawal by Subject|5|||
163077723|NCT03888482|588991353|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
163077724|NCT03888482|588991354|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
163077725|NCT03888482|588991353|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
163077726|NCT03888482|588991354|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
163077727|NCT02294019|588991355|FG000|Overall Study|Adverse Event|2|||
163077728|NCT02294019|588991355|FG000|Overall Study|Protocol Violation|68|||
163077729|NCT02294019|588991355|FG000|Overall Study|Lost to Follow-up|31|||
163077730|NCT02294019|588991355|FG000|Overall Study|Other|1|||
163077731|NCT02294019|588991355|FG000|Overall Study|Withdrawal by Subject|1|||
163077732|NCT01189227|588991357|FG000|Overall Study|Study terminated due to low accrual|6|||
163077733|NCT01189227|588991358|FG001|Overall Study|Study terminated due to low accrual|3|||
163077734|NCT01016015|588991359|FG000|Overall Study|Not Treated|3|||
163077735|NCT01016015|588991359|FG000|Overall Study|Withdrawal by Subject|1|||
163077736|NCT01016015|588991359|FG000|Overall Study|Adverse Event|15|||
163077737|NCT00362609|588991365|FG000|Overall Study|Withdrawal by Subject|0|||
163077738|NCT00362609|588991366|FG001|Overall Study|Withdrawal by Subject|1|||
163077739|NCT00362609|588991365|FG000|Overall Study|Protocol Violation|0|||
163077740|NCT00362609|588991366|FG001|Overall Study|Protocol Violation|1|||
163077741|NCT02205359|588991367|FG000|Overall Study|Death|293|||
163077742|NCT02205359|588991368|FG001|Overall Study|Death|327|||
163077743|NCT02205359|588991367|FG000|Overall Study|Lost to Follow-up|182|||
163077744|NCT02205359|588991368|FG001|Overall Study|Lost to Follow-up|162|||
163077745|NCT02205359|588991367|FG000|Overall Study|Physician Decision|51|||
163077746|NCT02205359|588991368|FG001|Overall Study|Physician Decision|53|||
163077747|NCT02205359|588991367|FG000|Overall Study|Withdrawal by Subject|167|||
163077748|NCT02205359|588991368|FG001|Overall Study|Withdrawal by Subject|169|||
163077749|NCT00236197|588991369|FG000|Overall Study|Withdrawal by Subject|3|||
163077750|NCT00236197|588991370|FG001|Overall Study|Withdrawal by Subject|2|||
163077751|NCT00236197|588991369|FG000|Overall Study|Lost to Follow-up|1|||
163077752|NCT00236197|588991370|FG001|Overall Study|Lost to Follow-up|5|||
163077753|NCT00236197|588991369|FG000|Overall Study|Protocol Violation|0|||
163077754|NCT00236197|588991370|FG001|Overall Study|Protocol Violation|3|||
163077755|NCT00236197|588991369|FG000|Overall Study|Medication non-compliance|1|||
163077756|NCT00236197|588991370|FG001|Overall Study|Medication non-compliance|2|||
163077757|NCT00236197|588991369|FG000|Overall Study|Other|0|||
163077758|NCT00236197|588991370|FG001|Overall Study|Other|2|||
163077759|NCT00480025|588991371|FG000|Overall Study|Protocol Violation|12|||
163077760|NCT00480025|588991372|FG001|Overall Study|Protocol Violation|7|||
163077761|NCT00480025|588991371|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
163077762|NCT00480025|588991372|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
163077763|NCT00480025|588991371|FG000|Overall Study|Disease Progression / Recurrence|449|||
163077764|NCT00480025|588991372|FG001|Overall Study|Disease Progression / Recurrence|224|||
163077765|NCT00480025|588991371|FG000|Overall Study|Adverse Event|44|||
163077766|NCT00480025|588991372|FG001|Overall Study|Adverse Event|12|||
163077767|NCT00480025|588991371|FG000|Overall Study|Other|70|||
163077768|NCT00480025|588991372|FG001|Overall Study|Other|29|||
163077769|NCT00480025|588991371|FG000|Overall Study|SAE including intercurrent illness|76|||
163077770|NCT00480025|588991372|FG001|Overall Study|SAE including intercurrent illness|42|||
163077771|NCT03681093|588992987|FG000|Overall Study|Subject decision|0|||
163077772|NCT03681093|588992988|FG001|Overall Study|Subject decision|2|||
163077773|NCT03681093|588992989|FG002|Overall Study|Subject decision|1|||
163077774|NCT00368849|588992992|FG000|Overall Study|Withdrawal by Subject|0|||
163077775|NCT00368849|588992993|FG001|Overall Study|Withdrawal by Subject|1|||
163077776|NCT00368849|588992992|FG000|Overall Study|Physician Decision|0|||
163077777|NCT00368849|588992993|FG001|Overall Study|Physician Decision|1|||
163077778|NCT01902303|588992994|FG000|Overall Study|Adverse Event|0|||
163077779|NCT01902303|588992995|FG001|Overall Study|Adverse Event|1|||
163077780|NCT01902303|588992994|FG000|Overall Study|Lost to Follow-up|0|||
163077781|NCT01902303|588992995|FG001|Overall Study|Lost to Follow-up|1|||
163077782|NCT01902303|588992994|FG000|Overall Study|Protocol Violation|2|||
163077783|NCT01902303|588992995|FG001|Overall Study|Protocol Violation|2|||
163077784|NCT01902303|588992994|FG000|Overall Study|subject lost investigational product|0|||
163077785|NCT01902303|588992995|FG001|Overall Study|subject lost investigational product|1|||
163077786|NCT01902303|588992994|FG000|Overall Study|Did not develop a cold sore|21|||
163077787|NCT01902303|588992995|FG001|Overall Study|Did not develop a cold sore|19|||
163077788|NCT01699685|588992996|FG000|Period 1|Adverse Event|1|||
163077789|NCT01699685|588992997|FG001|Period 1|Adverse Event|1|||
163077790|NCT01699685|588992996|FG000|Period 1|Medical or ethical, noncompliance|2|||
163077791|NCT01699685|588992997|FG001|Period 1|Medical or ethical, noncompliance|0|||
163077792|NCT01699685|588992996|FG000|Period 1|Other|0|||
163077793|NCT01699685|588992997|FG001|Period 1|Other|1|||
163077794|NCT01699685|588992996|FG000|Period 1|Patient request|0|||
163077795|NCT01699685|588992997|FG001|Period 1|Patient request|1|||
163077796|NCT01699685|588992996|FG000|Period 2|Lost to Follow-up|1|||
163077797|NCT01699685|588992997|FG001|Period 2|Lost to Follow-up|0|||
163077798|NCT03635996|588992998|FG000|Overall Study|Study terminated by Sponsor|94|||
163077799|NCT03635996|588992998|FG000|Overall Study|Withdrawal by Subject|20|||
163077800|NCT03635996|588992998|FG000|Overall Study|Ablation|26|||
163077801|NCT03635996|588992998|FG000|Overall Study|Adverse Event|7|||
163077802|NCT03635996|588992998|FG000|Overall Study|Physician Decision|3|||
163077803|NCT03635996|588992998|FG000|Overall Study|Prohibited medication|5|||
163077804|NCT03635996|588992998|FG000|Overall Study|Did not meet eligibility criteria|5|||
163077805|NCT03635996|588992998|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
163077806|NCT03635996|588992998|FG000|Overall Study|Protocol Violation|1|||
163077807|NCT03635996|588992998|FG000|Overall Study|Lost to Follow-up|1|||
163077808|NCT02821000|588992999|FG000|Overall Study|Death|89|||
163077809|NCT02821000|588992999|FG000|Overall Study|Sponsor Decision|12|||
163077810|NCT02821000|588992999|FG000|Overall Study|Withdrawal by Subject|2|||
163077811|NCT05058456|588993000|FG000|Overall Study|Death|1|||
163077812|NCT05058456|588993000|FG000|Overall Study|End of Study data not yet due for release|34|||
163077813|NCT02802865|588993001|FG000|Overall Study|Pregnancy|1|||
163077814|NCT02802865|588993002|FG001|Overall Study|Pregnancy|1|||
163077815|NCT02802865|588993001|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
163077816|NCT02802865|588993002|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
163077817|NCT01862029|588993003|FG000|Overall Study|Physician Decision|1|||
163077818|NCT03931785|588993004|FG000|Overall Study|Lost to Follow-up|4|||
163077819|NCT03931785|588993005|FG001|Overall Study|Lost to Follow-up|1|||
163077820|NCT03931785|588993006|FG002|Overall Study|Lost to Follow-up|4|||
163077821|NCT03931785|588993007|FG003|Overall Study|Lost to Follow-up|3|||
163077822|NCT03931785|588993004|FG000|Overall Study|Adverse Event|1|||
163077823|NCT03931785|588993005|FG001|Overall Study|Adverse Event|0|||
163077824|NCT03931785|588993006|FG002|Overall Study|Adverse Event|3|||
163077825|NCT03931785|588993007|FG003|Overall Study|Adverse Event|4|||
163077826|NCT03931785|588993004|FG000|Overall Study|Protocol Violation|0|||
163077827|NCT03931785|588993005|FG001|Overall Study|Protocol Violation|1|||
163077828|NCT03931785|588993006|FG002|Overall Study|Protocol Violation|0|||
163077829|NCT03931785|588993007|FG003|Overall Study|Protocol Violation|0|||
163077830|NCT03931785|588993004|FG000|Overall Study|Noncompliance With Study drug|0|||
163077831|NCT03931785|588993005|FG001|Overall Study|Noncompliance With Study drug|1|||
163077832|NCT03931785|588993006|FG002|Overall Study|Noncompliance With Study drug|0|||
163077833|NCT03931785|588993007|FG003|Overall Study|Noncompliance With Study drug|0|||
163077834|NCT03931785|588993004|FG000|Overall Study|Other Not specified|0|||
163077835|NCT03931785|588993005|FG001|Overall Study|Other Not specified|2|||
163077836|NCT03931785|588993006|FG002|Overall Study|Other Not specified|2|||
163077837|NCT03931785|588993007|FG003|Overall Study|Other Not specified|2|||
163077838|NCT03931785|588993004|FG000|Overall Study|Withdrawal by Subject|0|||
163077839|NCT03931785|588993005|FG001|Overall Study|Withdrawal by Subject|2|||
163077840|NCT03931785|588993006|FG002|Overall Study|Withdrawal by Subject|4|||
163077841|NCT03931785|588993007|FG003|Overall Study|Withdrawal by Subject|1|||
163077842|NCT03931785|588993004|FG000|Overall Study|Pregnancy|0|||
163077843|NCT03931785|588993005|FG001|Overall Study|Pregnancy|0|||
163077844|NCT03931785|588993006|FG002|Overall Study|Pregnancy|0|||
163077845|NCT03931785|588993007|FG003|Overall Study|Pregnancy|1|||
163077846|NCT01832038|588993008|FG000|Overall Study|Death|5|||
163077847|NCT01832038|588993008|FG000|Overall Study|Adverse Event|50|||
163077848|NCT01832038|588993008|FG000|Overall Study|Lack of Efficacy|81|||
163077849|NCT01832038|588993008|FG000|Overall Study|Protocol Violation|7|||
163077850|NCT01832038|588993008|FG000|Overall Study|Lost to Follow-up|10|||
163077851|NCT01832038|588993008|FG000|Overall Study|Withdrawal by Subject|49|||
163077852|NCT01832038|588993008|FG000|Overall Study|Visit non-compliance|2|||
163077853|NCT01832038|588993008|FG000|Overall Study|Subject refused to return visit|2|||
163077854|NCT01832038|588993008|FG000|Overall Study|Not convenient to come back to site|2|||
163077855|NCT01832038|588993008|FG000|Overall Study|Participant was asked to quit|5|||
163077856|NCT01832038|588993008|FG000|Overall Study|Back home|1|||
163077857|NCT01832038|588993008|FG000|Overall Study|Pregnancy|1|||
163077858|NCT01832038|588993008|FG000|Overall Study|Low compliance|3|||
163077859|NCT01832038|588993008|FG000|Overall Study|Prohibit procedure|2|||
163077860|NCT01832038|588993008|FG000|Overall Study|Not possible to visit the hospital|1|||
163077861|NCT01832038|588993008|FG000|Overall Study|Changes of implementation system|3|||
163077862|NCT01832038|588993008|FG000|Overall Study|Plan to pregnancy|7|||
163077863|NCT01832038|588993008|FG000|Overall Study|Bad mood and has suicidal thought|1|||
163077864|NCT01832038|588993008|FG000|Overall Study|Prohibited concomitant medication|1|||
163077865|NCT01832038|588993008|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
163077866|NCT01832038|588993008|FG000|Overall Study|Subject considered the efficacy was poor|1|||
163077867|NCT03810365|588993009|FG000|Overall Study|Lost to Follow-up|2|||
163077868|NCT03810365|588993010|FG001|Overall Study|Lost to Follow-up|2|||
163077869|NCT03810365|588993009|FG000|Overall Study|Withdrawal by Subject|4|||
163077870|NCT03810365|588993010|FG001|Overall Study|Withdrawal by Subject|5|||
163077871|NCT01292473|588993011|FG000|Overall Study|Adverse Event|1|||
163077872|NCT01292473|588993012|FG001|Overall Study|Adverse Event|0|||
163077873|NCT01292473|588993013|FG002|Overall Study|Adverse Event|1|||
163077874|NCT01292473|588993014|FG003|Overall Study|Adverse Event|1|||
163077875|NCT01292473|588993011|FG000|Overall Study|Lost to Follow-up|1|||
163077876|NCT01292473|588993012|FG001|Overall Study|Lost to Follow-up|1|||
163077877|NCT01292473|588993013|FG002|Overall Study|Lost to Follow-up|2|||
163077878|NCT01292473|588993014|FG003|Overall Study|Lost to Follow-up|2|||
163077879|NCT01292473|588993011|FG000|Overall Study|Withdrawal by Subject|3|||
163077880|NCT01292473|588993012|FG001|Overall Study|Withdrawal by Subject|4|||
163077881|NCT01292473|588993013|FG002|Overall Study|Withdrawal by Subject|3|||
163077882|NCT01292473|588993014|FG003|Overall Study|Withdrawal by Subject|3|||
163077883|NCT01292473|588993011|FG000|Overall Study|Physician Decision|0|||
163077884|NCT01292473|588993012|FG001|Overall Study|Physician Decision|1|||
163077885|NCT01292473|588993013|FG002|Overall Study|Physician Decision|0|||
163077886|NCT01292473|588993014|FG003|Overall Study|Physician Decision|0|||
163077887|NCT01292473|588993011|FG000|Overall Study|Disease Progression|0|||
163077888|NCT01292473|588993012|FG001|Overall Study|Disease Progression|1|||
163077889|NCT01292473|588993013|FG002|Overall Study|Disease Progression|3|||
163077890|NCT01292473|588993014|FG003|Overall Study|Disease Progression|6|||
163077891|NCT00449787|588993015|FG000|Overall Study|Lost to Follow-up|10|||
163077892|NCT00449787|588993016|FG001|Overall Study|Lost to Follow-up|8|||
163077893|NCT00449787|588993015|FG000|Overall Study|Did not require medication|95|||
163077894|NCT00449787|588993016|FG001|Overall Study|Did not require medication|92|||
163077895|NCT03574389|588993021|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
163077896|NCT03574389|588993022|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
163077897|NCT03574389|588993023|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
163077898|NCT03574389|588993024|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
163077899|NCT03574389|588993025|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
163077900|NCT03574389|588993026|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
163077901|NCT03574389|588993027|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
163077902|NCT03574389|588993021|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
163077903|NCT03574389|588993022|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
163077904|NCT03574389|588993023|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
163077905|NCT03574389|588993024|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
163077906|NCT03574389|588993025|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077907|NCT03574389|588993026|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077908|NCT03574389|588993027|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
163077909|NCT03574389|588993021|FG000|Vaccination Period|Other|6|||
163077910|NCT03574389|588993022|FG001|Vaccination Period|Other|0|||
163077911|NCT03574389|588993023|FG002|Vaccination Period|Other|0|||
162645454|NCT04356963|587419346|FG000|Third Session|Withdrawal by Subject|1|||
163077912|NCT03574389|588993024|FG003|Vaccination Period|Other|0|||
163077913|NCT03574389|588993025|FG004|Vaccination Period|Other|0|||
163077914|NCT03574389|588993026|FG005|Vaccination Period|Other|0|||
162645455|NCT02410954|587419349|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
163077915|NCT03574389|588993027|FG006|Vaccination Period|Other|0|||
163077916|NCT03574389|588993021|FG000|Vaccination Period|Adverse Event|0|||
163077917|NCT03574389|588993022|FG001|Vaccination Period|Adverse Event|1|||
163077918|NCT03574389|588993023|FG002|Vaccination Period|Adverse Event|0|||
163077919|NCT03574389|588993024|FG003|Vaccination Period|Adverse Event|0|||
163077920|NCT03574389|588993025|FG004|Vaccination Period|Adverse Event|0|||
163077921|NCT03574389|588993026|FG005|Vaccination Period|Adverse Event|0|||
163077922|NCT03574389|588993027|FG006|Vaccination Period|Adverse Event|0|||
163077923|NCT03574389|588993021|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
163077924|NCT03574389|588993022|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
163077925|NCT03574389|588993023|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
163077926|NCT03574389|588993024|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
163077927|NCT03574389|588993025|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
163077928|NCT03574389|588993026|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
163077929|NCT03574389|588993027|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
163077930|NCT02094885|588993032|FG000|Overall Study|Death|1|||
163077931|NCT02094885|588993033|FG001|Overall Study|Death|5|||
163077932|NCT02094885|588993032|FG000|Overall Study|Withdrawn due to age|1|||
163077933|NCT02094885|588993033|FG001|Overall Study|Withdrawn due to age|0|||
163077934|NCT00337194|588993034|FG000|Overall Study|Adverse Event|5|||
163077935|NCT00337194|588993035|FG001|Overall Study|Adverse Event|1|||
163077936|NCT00337194|588993034|FG000|Overall Study|Death|2|||
163077937|NCT00337194|588993035|FG001|Overall Study|Death|0|||
163077938|NCT00337194|588993034|FG000|Overall Study|Withdrawal by Subject|1|||
163077939|NCT00337194|588993035|FG001|Overall Study|Withdrawal by Subject|0|||
163077940|NCT00337194|588993034|FG000|Overall Study|Disease progression|1|||
163077941|NCT00337194|588993035|FG001|Overall Study|Disease progression|2|||
163077942|NCT00337194|588993034|FG000|Overall Study|Subsequent non-protocol therapy|3|||
163077943|NCT00337194|588993035|FG001|Overall Study|Subsequent non-protocol therapy|1|||
163077944|NCT01061710|588993038|FG000|Overall Study|Protocol Violation|14|||
163077945|NCT01903720|588993039|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
163077946|NCT01903720|588993039|FG000|Overall Study|Adverse Event|1|||
163077947|NCT01903720|588993039|FG000|Overall Study|Rescinding of informed consent|2|||
163077948|NCT01903720|588993039|FG000|Overall Study|Lost to Follow-up|2|||
163077949|NCT01903720|588993039|FG000|Overall Study|Treatment with alternative drug|1|||
163077950|NCT00159874|588993040|FG000|Overall Study|Adverse Event|2|||
163077951|NCT00159874|588993041|FG001|Overall Study|Adverse Event|2|||
163077952|NCT00159874|588993042|FG002|Overall Study|Adverse Event|5|||
163077953|NCT00159874|588993043|FG003|Overall Study|Adverse Event|1|||
163077954|NCT00159874|588993044|FG004|Overall Study|Adverse Event|1|||
163077955|NCT00159874|588993045|FG005|Overall Study|Adverse Event|2|||
163077956|NCT00159874|588993046|FG006|Overall Study|Adverse Event|0|||
163077957|NCT00159874|588993040|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
163077958|NCT00159874|588993041|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
163077959|NCT00159874|588993042|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
163077960|NCT00159874|588993043|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
163077961|NCT00159874|588993044|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
163077962|NCT00159874|588993045|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
163077963|NCT00159874|588993046|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
163077964|NCT00159874|588993040|FG000|Overall Study|Lack of Efficacy|2|||
163077965|NCT00159874|588993041|FG001|Overall Study|Lack of Efficacy|0|||
163077966|NCT00159874|588993042|FG002|Overall Study|Lack of Efficacy|1|||
163077967|NCT00159874|588993043|FG003|Overall Study|Lack of Efficacy|1|||
163077968|NCT00159874|588993044|FG004|Overall Study|Lack of Efficacy|0|||
163077969|NCT00159874|588993045|FG005|Overall Study|Lack of Efficacy|3|||
163077970|NCT00159874|588993046|FG006|Overall Study|Lack of Efficacy|0|||
163077971|NCT00159874|588993040|FG000|Overall Study|Lost to Follow-up|1|||
163077972|NCT00159874|588993041|FG001|Overall Study|Lost to Follow-up|0|||
163077973|NCT00159874|588993042|FG002|Overall Study|Lost to Follow-up|3|||
163077974|NCT00159874|588993043|FG003|Overall Study|Lost to Follow-up|0|||
163077975|NCT00159874|588993044|FG004|Overall Study|Lost to Follow-up|1|||
163077976|NCT00159874|588993045|FG005|Overall Study|Lost to Follow-up|2|||
163077977|NCT00159874|588993046|FG006|Overall Study|Lost to Follow-up|1|||
163077978|NCT00159874|588993040|FG000|Overall Study|Other|8|||
163077979|NCT00159874|588993041|FG001|Overall Study|Other|8|||
163077980|NCT00159874|588993042|FG002|Overall Study|Other|8|||
163077981|NCT00159874|588993043|FG003|Overall Study|Other|0|||
163077982|NCT00159874|588993044|FG004|Overall Study|Other|2|||
163077983|NCT00159874|588993045|FG005|Overall Study|Other|1|||
163077984|NCT00159874|588993046|FG006|Overall Study|Other|3|||
163077985|NCT00159874|588993040|FG000|Overall Study|Protocol Violation|0|||
163077986|NCT00159874|588993041|FG001|Overall Study|Protocol Violation|5|||
163077987|NCT00159874|588993042|FG002|Overall Study|Protocol Violation|2|||
163077988|NCT00159874|588993043|FG003|Overall Study|Protocol Violation|0|||
163077989|NCT00159874|588993044|FG004|Overall Study|Protocol Violation|0|||
163077990|NCT00159874|588993045|FG005|Overall Study|Protocol Violation|0|||
163077991|NCT00159874|588993046|FG006|Overall Study|Protocol Violation|0|||
163077992|NCT00159874|588993040|FG000|Overall Study|Death|3|||
163077993|NCT00159874|588993041|FG001|Overall Study|Death|8|||
163077994|NCT00159874|588993042|FG002|Overall Study|Death|15|||
162717891|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163077995|NCT00159874|588993043|FG003|Overall Study|Death|0|||
163077996|NCT00159874|588993044|FG004|Overall Study|Death|1|||
163077997|NCT00159874|588993045|FG005|Overall Study|Death|2|||
163077998|NCT00159874|588993046|FG006|Overall Study|Death|0|||
163077999|NCT00159874|588993040|FG000|Overall Study|Withdrawal by Subject|2|||
163078000|NCT00159874|588993041|FG001|Overall Study|Withdrawal by Subject|6|||
162645456|NCT02410954|587419350|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
162645457|NCT02410954|587419349|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
162645458|NCT02410954|587419350|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
162645459|NCT00791518|587419352|FG000|Overall Study|Protocol Violation|93|||
162645460|NCT02488681|587419353|FG000|Overall Study|Implant unsuccessful|7|||
162645461|NCT00720057|587419354|FG000|Overall Study|Lost to Follow-up|0|||
162645462|NCT00720057|587419355|FG001|Overall Study|Lost to Follow-up|2|||
162645463|NCT00720057|587419354|FG000|Overall Study|Protocol Violation|1|||
162645464|NCT00720057|587419355|FG001|Overall Study|Protocol Violation|0|||
162645465|NCT00720057|587419354|FG000|Overall Study|Withdrawal by Subject|0|||
162645466|NCT00720057|587419355|FG001|Overall Study|Withdrawal by Subject|1|||
162645467|NCT00271609|587419367|FG000|Overall Study|Adverse Event|11|||
162645468|NCT00271609|587419368|FG001|Overall Study|Adverse Event|3|||
162645469|NCT00271609|587419367|FG000|Overall Study|Withdrawal by Subject|2|||
162645470|NCT00271609|587419368|FG001|Overall Study|Withdrawal by Subject|0|||
162645471|NCT03341533|587419369|FG000|Overall Study|Withdrawal by Subject|1|||
162645472|NCT03341533|587419370|FG001|Overall Study|Withdrawal by Subject|1|||
162645473|NCT03341533|587419369|FG000|Overall Study|Not eligible after randomization|2|||
162645474|NCT03341533|587419370|FG001|Overall Study|Not eligible after randomization|1|||
162645475|NCT00643682|587419371|FG000|Overall Study|did not keep appointment|522|||
162645476|NCT00643682|587419372|FG001|Overall Study|did not keep appointment|509|||
162645477|NCT01782664|587419374|FG000|Overall Study|Adverse Event|2|||
162645478|NCT01782664|587419375|FG001|Overall Study|Adverse Event|2|||
162645479|NCT01782664|587419376|FG002|Overall Study|Adverse Event|2|||
162645480|NCT01782664|587419377|FG003|Overall Study|Adverse Event|2|||
163029223|NCT03932331|588810382|FG002|Overall Study|Lung infection|0|||
163029224|NCT03932331|588810380|FG000|Overall Study|Other|0|||
163029225|NCT03932331|588810381|FG001|Overall Study|Other|0|||
163029226|NCT03932331|588810382|FG002|Overall Study|Other|58|||
163029227|NCT01032239|588810383|FG000|Overall Study|Lost to Follow-up|3|||
163029228|NCT01032239|588810384|FG001|Overall Study|Lost to Follow-up|2|||
163029229|NCT01032239|588810383|FG000|Overall Study|Withdrawal by Subject|2|||
163029230|NCT01032239|588810384|FG001|Overall Study|Withdrawal by Subject|3|||
163029231|NCT01032239|588810383|FG000|Overall Study|Death|1|||
163029232|NCT01032239|588810384|FG001|Overall Study|Death|0|||
163029233|NCT01032239|588810383|FG000|Overall Study|Protocol Violation|1|||
163029234|NCT01032239|588810384|FG001|Overall Study|Protocol Violation|0|||
163029235|NCT00204477|588810385|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
163029236|NCT00204477|588810386|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
163029237|NCT00204477|588810385|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
163029238|NCT00204477|588810386|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
163029239|NCT01940900|588810389|FG000|Overall Study|Physician Decision|4|||
163029240|NCT01940900|588810390|FG001|Overall Study|Physician Decision|0|||
163029241|NCT01940900|588810389|FG000|Overall Study|Adverse Event|10|||
163029242|NCT01940900|588810390|FG001|Overall Study|Adverse Event|15|||
163029243|NCT01940900|588810389|FG000|Overall Study|Withdrawal by Subject|11|||
163029244|NCT01940900|588810390|FG001|Overall Study|Withdrawal by Subject|15|||
163029245|NCT01940900|588810389|FG000|Overall Study|Lost to Follow-up|1|||
163029246|NCT01940900|588810390|FG001|Overall Study|Lost to Follow-up|0|||
163029247|NCT01940900|588810389|FG000|Overall Study|Sponsor Decision|1|||
163029248|NCT01940900|588810390|FG001|Overall Study|Sponsor Decision|0|||
163029249|NCT01940900|588810389|FG000|Overall Study|subject non-compliance|1|||
163029250|NCT01940900|588810390|FG001|Overall Study|subject non-compliance|1|||
163029251|NCT01940900|588810389|FG000|Overall Study|other|1|||
163029252|NCT01940900|588810390|FG001|Overall Study|other|0|||
163029253|NCT04713592|588810391|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029254|NCT04713592|588810392|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
163029255|NCT04713592|588810393|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029256|NCT04713592|588810394|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
163029257|NCT04713592|588810391|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
163029258|NCT04713592|588810392|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
163029259|NCT04713592|588810393|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
163029260|NCT04713592|588810394|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
163029261|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
163029262|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
163029263|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
163029264|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
163029265|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163029266|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
162645481|NCT01782664|587419378|FG004|Overall Study|Adverse Event|0|||
162645482|NCT01782664|587419379|FG005|Overall Study|Adverse Event|0|||
162645483|NCT01782664|587419374|FG000|Overall Study|Lack of Efficacy|2|||
162645484|NCT01782664|587419375|FG001|Overall Study|Lack of Efficacy|0|||
163029267|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
163078001|NCT00159874|588993042|FG002|Overall Study|Withdrawal by Subject|8|||
163078002|NCT00159874|588993043|FG003|Overall Study|Withdrawal by Subject|4|||
163078003|NCT00159874|588993044|FG004|Overall Study|Withdrawal by Subject|3|||
163078004|NCT00159874|588993045|FG005|Overall Study|Withdrawal by Subject|2|||
163078005|NCT00159874|588993046|FG006|Overall Study|Withdrawal by Subject|1|||
163078006|NCT00159874|588993040|FG000|Overall Study|Pregnancy|1|||
163078007|NCT00159874|588993041|FG001|Overall Study|Pregnancy|1|||
163078008|NCT00159874|588993042|FG002|Overall Study|Pregnancy|0|||
163078009|NCT00159874|588993043|FG003|Overall Study|Pregnancy|0|||
163078010|NCT00159874|588993044|FG004|Overall Study|Pregnancy|0|||
163078011|NCT00159874|588993045|FG005|Overall Study|Pregnancy|0|||
163078012|NCT00159874|588993046|FG006|Overall Study|Pregnancy|0|||
163078013|NCT01104870|588993047|FG000|Overall Study|Adverse Event|1|||
163078014|NCT01104870|588993048|FG001|Overall Study|Adverse Event|1|||
163078015|NCT01104870|588993049|FG002|Overall Study|Adverse Event|0|||
163078016|NCT01104870|588993047|FG000|Overall Study|Death|0|||
163078017|NCT01104870|588993048|FG001|Overall Study|Death|0|||
163078018|NCT01104870|588993049|FG002|Overall Study|Death|1|||
163078019|NCT01104870|588993047|FG000|Overall Study|Withdrawal by Subject|0|||
163078020|NCT01104870|588993048|FG001|Overall Study|Withdrawal by Subject|0|||
163078021|NCT01104870|588993049|FG002|Overall Study|Withdrawal by Subject|1|||
163078022|NCT02771145|588993051|FG000|Overall Study|Adverse Event|3|||
163078023|NCT02771145|588993051|FG000|Overall Study|Lost to Follow-up|1|||
163078024|NCT00276380|588993052|FG000|Overall Study|Adverse Event|5|||
163078025|NCT00276380|588993053|FG001|Overall Study|Adverse Event|3|||
163078026|NCT00276380|588993052|FG000|Overall Study|Lost to Follow-up|1|||
163078027|NCT00276380|588993053|FG001|Overall Study|Lost to Follow-up|1|||
163078028|NCT00276380|588993052|FG000|Overall Study|Withdrawal by Subject|3|||
163078029|NCT00276380|588993053|FG001|Overall Study|Withdrawal by Subject|6|||
163078030|NCT00276380|588993052|FG000|Overall Study|Death|5|||
163078031|NCT00276380|588993053|FG001|Overall Study|Death|3|||
163078032|NCT00276380|588993052|FG000|Overall Study|Abnormal aPPT Levels|0|||
163078033|NCT00276380|588993053|FG001|Overall Study|Abnormal aPPT Levels|1|||
163078034|NCT03654326|588993054|FG000|Overall Study|Withdrawal by Subject|5|||
163078035|NCT03654326|588993055|FG001|Overall Study|Withdrawal by Subject|3|||
163078036|NCT03654326|588993054|FG000|Overall Study|Physician Decision|0|||
163078037|NCT03654326|588993055|FG001|Overall Study|Physician Decision|1|||
163078038|NCT03654326|588993054|FG000|Overall Study|Unable to adhere to study schedule|0|||
163078039|NCT03654326|588993055|FG001|Overall Study|Unable to adhere to study schedule|1|||
163078040|NCT03654326|588993054|FG000|Overall Study|Lost to Follow-up|1|||
163078041|NCT03654326|588993055|FG001|Overall Study|Lost to Follow-up|1|||
163078042|NCT05287685|588993056|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
163078043|NCT05287685|588993057|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
163078044|NCT05287685|588993056|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
163078045|NCT05287685|588993057|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
163078046|NCT04829214|588993058|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
163078047|NCT04829214|588993059|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
163078048|NCT04829214|588993058|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
163078049|NCT04829214|588993059|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
163078050|NCT04008069|588993060|FG000|Open-Label Period|Adverse Event|1|||
163078051|NCT04008069|588993061|FG001|Open-Label Period|Adverse Event|0|||
163078052|NCT04008069|588993062|FG002|Open-Label Period|Adverse Event|0|||
163078053|NCT04008069|588993060|FG000|Open-Label Period|Lack of Efficacy|4|||
163078054|NCT04008069|588993061|FG001|Open-Label Period|Lack of Efficacy|0|||
163078055|NCT04008069|588993062|FG002|Open-Label Period|Lack of Efficacy|0|||
163078056|NCT04008069|588993060|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
163078057|NCT04008069|588993061|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
163078058|NCT04008069|588993062|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
162645485|NCT01782664|587419376|FG002|Overall Study|Lack of Efficacy|2|||
162645486|NCT01782664|587419377|FG003|Overall Study|Lack of Efficacy|2|||
162645487|NCT01782664|587419378|FG004|Overall Study|Lack of Efficacy|0|||
162645488|NCT01782664|587419379|FG005|Overall Study|Lack of Efficacy|0|||
162645489|NCT01782664|587419374|FG000|Overall Study|Protocol Violation|0|||
163078059|NCT04008069|588993060|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
163078060|NCT04008069|588993061|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
163078061|NCT04008069|588993062|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
163078062|NCT00511199|588993063|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
163078063|NCT00511199|588993064|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
163078064|NCT00511199|588993063|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
163078065|NCT00511199|588993064|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
163078066|NCT00511199|588993063|FG000|Overall Study|Withdrawal of Informed Consent|19|||
163078067|NCT00511199|588993064|FG001|Overall Study|Withdrawal of Informed Consent|4|||
162645490|NCT01782664|587419375|FG001|Overall Study|Protocol Violation|1|||
162645491|NCT01782664|587419376|FG002|Overall Study|Protocol Violation|0|||
163078068|NCT00511199|588993063|FG000|Overall Study|Pregnancy|6|||
162645492|NCT01782664|587419377|FG003|Overall Study|Protocol Violation|1|||
162645493|NCT01782664|587419378|FG004|Overall Study|Protocol Violation|0|||
162645494|NCT01782664|587419379|FG005|Overall Study|Protocol Violation|0|||
162645495|NCT01782664|587419374|FG000|Overall Study|Withdrawal by Subject|2|||
163078069|NCT00511199|588993064|FG001|Overall Study|Pregnancy|3|||
163078070|NCT00511199|588993063|FG000|Overall Study|Pregnancy Wish|16|||
163078071|NCT00511199|588993064|FG001|Overall Study|Pregnancy Wish|8|||
163078072|NCT00511199|588993063|FG000|Overall Study|Lost to Follow-up|40|||
163078073|NCT00511199|588993064|FG001|Overall Study|Lost to Follow-up|17|||
163078074|NCT00511199|588993063|FG000|Overall Study|Other Reason|78|||
163078075|NCT00511199|588993064|FG001|Overall Study|Other Reason|37|||
163078076|NCT01570192|588993072|FG000|Overall Study|no qualifying organism|6|||
163078077|NCT01570192|588993073|FG001|Overall Study|no qualifying organism|12|||
163078078|NCT01570192|588993072|FG000|Overall Study|changed to palliative care|1|||
163078079|NCT01570192|588993073|FG001|Overall Study|changed to palliative care|0|||
163078080|NCT01570192|588993072|FG000|Overall Study|Physician Decision|0|||
163078081|NCT01570192|588993073|FG001|Overall Study|Physician Decision|1|||
163078082|NCT02965976|588993074|FG000|Overall Study|Withdrawal by Subject|2|||
163078083|NCT02965976|588993075|FG001|Overall Study|Withdrawal by Subject|0|||
163078084|NCT00819832|588993076|FG000|Overall Study|Sponsor Termination of Study|3|||
163078085|NCT00819832|588993077|FG001|Overall Study|Sponsor Termination of Study|0|||
163078086|NCT00819832|588993078|FG002|Overall Study|Sponsor Termination of Study|0|||
163078087|NCT00819832|588993079|FG003|Overall Study|Sponsor Termination of Study|0|||
163078088|NCT00819832|588993080|FG004|Overall Study|Sponsor Termination of Study|0|||
163078089|NCT00819832|588993081|FG005|Overall Study|Sponsor Termination of Study|0|||
163078090|NCT01063881|588993082|FG000|Overall Study|Adverse Event|12|||
163078091|NCT01063881|588993083|FG001|Overall Study|Adverse Event|2|||
163078092|NCT01063881|588993084|FG002|Overall Study|Adverse Event|0|||
163078093|NCT01063881|588993082|FG000|Overall Study|Lost to Follow-up|13|||
163078094|NCT01063881|588993083|FG001|Overall Study|Lost to Follow-up|7|||
163078095|NCT01063881|588993084|FG002|Overall Study|Lost to Follow-up|1|||
163078096|NCT01063881|588993082|FG000|Overall Study|Withdrawal by Subject|25|||
163078097|NCT01063881|588993083|FG001|Overall Study|Withdrawal by Subject|1|||
163078098|NCT01063881|588993084|FG002|Overall Study|Withdrawal by Subject|0|||
163078099|NCT01063881|588993082|FG000|Overall Study|Reason for not completed not specified|5|||
163078100|NCT01063881|588993083|FG001|Overall Study|Reason for not completed not specified|1|||
163078101|NCT01063881|588993084|FG002|Overall Study|Reason for not completed not specified|0|||
163078102|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
163078103|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
163078104|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
163078105|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
163078106|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
163078107|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
163078108|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078109|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078110|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
163078111|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078112|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078113|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
163078114|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163078115|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
163078116|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
163078117|NCT00407030|588993085|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
163078118|NCT00407030|588993086|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
163078119|NCT00407030|588993087|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
163078120|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
163078121|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
163078122|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
163078123|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
163078124|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
163078125|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
163078126|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
163078127|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
163078128|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
163078129|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
163078130|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
163078131|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
163078132|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
163078133|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
163078134|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
163078135|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
162645496|NCT01782664|587419375|FG001|Overall Study|Withdrawal by Subject|2|||
163078136|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
163078137|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
163078138|NCT00407030|588993085|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
163078139|NCT00407030|588993086|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
163078140|NCT00407030|588993087|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
163078141|NCT00736476|588993088|FG000|Overall Study|Adverse Event|1|||
163078142|NCT00736476|588993089|FG001|Overall Study|Adverse Event|0|||
163078143|NCT01370642|588993090|FG000|Overall Study|Adverse Event|2|||
163078144|NCT01370642|588993091|FG001|Overall Study|Adverse Event|1|||
163078145|NCT01370642|588993092|FG002|Overall Study|Adverse Event|1|||
163078146|NCT01370642|588993090|FG000|Overall Study|Detectable HCV RNA|0|||
163078147|NCT01370642|588993091|FG001|Overall Study|Detectable HCV RNA|0|||
163078148|NCT01370642|588993092|FG002|Overall Study|Detectable HCV RNA|22|||
163078149|NCT01370642|588993090|FG000|Overall Study|Lost to Follow-up|0|||
163078150|NCT01370642|588993091|FG001|Overall Study|Lost to Follow-up|0|||
162717892|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162717893|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
162717894|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
162717895|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
162717896|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
162717897|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
162717898|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
162717899|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
162717900|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
162717901|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
162717902|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
163078151|NCT01370642|588993092|FG002|Overall Study|Lost to Follow-up|1|||
163078152|NCT01370642|588993090|FG000|Overall Study|Physician Decision|4|||
163078153|NCT01370642|588993091|FG001|Overall Study|Physician Decision|1|||
163078154|NCT01370642|588993092|FG002|Overall Study|Physician Decision|2|||
163078155|NCT01370642|588993090|FG000|Overall Study|Withdrawal by Subject|2|||
163078156|NCT01370642|588993091|FG001|Overall Study|Withdrawal by Subject|4|||
163078157|NCT01370642|588993092|FG002|Overall Study|Withdrawal by Subject|3|||
163078158|NCT01796470|588993093|FG000|Overall Study|Adverse Event|4|||
163078159|NCT01796470|588993094|FG001|Overall Study|Adverse Event|2|||
163078160|NCT01796470|588993095|FG002|Overall Study|Adverse Event|2|||
163078161|NCT01796470|588993096|FG003|Overall Study|Adverse Event|1|||
163078162|NCT01796470|588993097|FG004|Overall Study|Adverse Event|3|||
163078163|NCT01796470|588993093|FG000|Overall Study|Death|2|||
163078164|NCT01796470|588993094|FG001|Overall Study|Death|0|||
163078165|NCT01796470|588993095|FG002|Overall Study|Death|0|||
163078166|NCT01796470|588993096|FG003|Overall Study|Death|0|||
163078167|NCT01796470|588993097|FG004|Overall Study|Death|1|||
163078168|NCT01796470|588993093|FG000|Overall Study|Initiated New Therapy|9|||
163078169|NCT01796470|588993094|FG001|Overall Study|Initiated New Therapy|0|||
163078170|NCT01796470|588993095|FG002|Overall Study|Initiated New Therapy|0|||
163078171|NCT01796470|588993096|FG003|Overall Study|Initiated New Therapy|0|||
163078172|NCT01796470|588993097|FG004|Overall Study|Initiated New Therapy|2|||
163078173|NCT01796470|588993093|FG000|Overall Study|Lost to Follow-up|0|||
163078174|NCT01796470|588993094|FG001|Overall Study|Lost to Follow-up|1|||
163078175|NCT01796470|588993095|FG002|Overall Study|Lost to Follow-up|0|||
163078176|NCT01796470|588993096|FG003|Overall Study|Lost to Follow-up|0|||
163078177|NCT01796470|588993097|FG004|Overall Study|Lost to Follow-up|0|||
163078178|NCT01796470|588993093|FG000|Overall Study|Physician Decision|5|||
163078179|NCT01796470|588993094|FG001|Overall Study|Physician Decision|4|||
163078180|NCT01796470|588993095|FG002|Overall Study|Physician Decision|1|||
163078181|NCT01796470|588993096|FG003|Overall Study|Physician Decision|0|||
163078182|NCT01796470|588993097|FG004|Overall Study|Physician Decision|1|||
163078183|NCT01796470|588993093|FG000|Overall Study|Progressive Disease|7|||
163078184|NCT01796470|588993094|FG001|Overall Study|Progressive Disease|7|||
163078185|NCT01796470|588993095|FG002|Overall Study|Progressive Disease|3|||
163078186|NCT01796470|588993096|FG003|Overall Study|Progressive Disease|2|||
163078187|NCT01796470|588993097|FG004|Overall Study|Progressive Disease|0|||
163078188|NCT01796470|588993093|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
163078189|NCT01796470|588993094|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
163078190|NCT01796470|588993095|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
163078191|NCT01796470|588993096|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
163078192|NCT01796470|588993097|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
163078193|NCT01796470|588993093|FG000|Overall Study|Withdrawal by Subject|7|||
163078194|NCT01796470|588993094|FG001|Overall Study|Withdrawal by Subject|0|||
163078195|NCT01796470|588993095|FG002|Overall Study|Withdrawal by Subject|0|||
163078196|NCT01796470|588993096|FG003|Overall Study|Withdrawal by Subject|0|||
163078197|NCT01796470|588993097|FG004|Overall Study|Withdrawal by Subject|1|||
163078198|NCT04818086|588993104|FG000|Overall Study|Physician Decision|1|||
163078199|NCT04818086|588993105|FG001|Overall Study|Physician Decision|0|||
163078200|NCT04818086|588993104|FG000|Overall Study|Withdrawal by Subject|0|||
163078201|NCT04818086|588993105|FG001|Overall Study|Withdrawal by Subject|1|||
163078202|NCT04128228|588993107|FG000|Overall Study|Withdrawal by Subject|3|||
163078203|NCT04128228|588993108|FG001|Overall Study|Withdrawal by Subject|3|||
163078204|NCT04128228|588993109|FG002|Overall Study|Withdrawal by Subject|0|||
163078205|NCT04128228|588993110|FG003|Overall Study|Withdrawal by Subject|0|||
163078206|NCT04128228|588993107|FG000|Overall Study|noncompliance|2|||
163078207|NCT04128228|588993108|FG001|Overall Study|noncompliance|2|||
163078208|NCT04128228|588993109|FG002|Overall Study|noncompliance|0|||
163078209|NCT04128228|588993110|FG003|Overall Study|noncompliance|0|||
163078210|NCT01117350|588993111|FG000|Comparative Period|Not Treated|5|||
163078211|NCT01117350|588993112|FG001|Comparative Period|Not Treated|8|||
163078212|NCT01117350|588993111|FG000|Comparative Period|Adverse Event|6|||
163078213|NCT01117350|588993112|FG001|Comparative Period|Adverse Event|33|||
163078214|NCT01117350|588993111|FG000|Comparative Period|Lost to Follow-up|11|||
163078215|NCT01117350|588993112|FG001|Comparative Period|Lost to Follow-up|7|||
163078216|NCT01117350|588993111|FG000|Comparative Period|Withdrawal by Subject|9|||
163078217|NCT01117350|588993112|FG001|Comparative Period|Withdrawal by Subject|13|||
163078218|NCT01117350|588993111|FG000|Comparative Period|Protocol Violation|8|||
163078219|NCT01117350|588993112|FG001|Comparative Period|Protocol Violation|12|||
163078220|NCT01117350|588993111|FG000|Comparative Period|Lack of Efficacy|1|||
163078221|NCT01117350|588993112|FG001|Comparative Period|Lack of Efficacy|0|||
163078222|NCT01117350|588993111|FG000|Comparative Period|Physician Decision|0|||
163078223|NCT01117350|588993112|FG001|Comparative Period|Physician Decision|1|||
163078224|NCT01117350|588993111|FG000|Comparative Period|Move to another city/country|2|||
163078225|NCT01117350|588993112|FG001|Comparative Period|Move to another city/country|1|||
163078226|NCT01117350|588993111|FG000|Extension Period|Not included in extension, not treated|0|||
163078227|NCT01117350|588993112|FG001|Extension Period|Not included in extension, not treated|50|||
163078228|NCT01117350|588993111|FG000|Extension Period|Adverse Event|0|||
163078229|NCT01117350|588993112|FG001|Extension Period|Adverse Event|2|||
163078230|NCT01117350|588993111|FG000|Extension Period|Protocol Violation|0|||
163078231|NCT01117350|588993112|FG001|Extension Period|Protocol Violation|2|||
163078232|NCT01117350|588993111|FG000|Extension Period|Lost to Follow-up|0|||
163078233|NCT01117350|588993112|FG001|Extension Period|Lost to Follow-up|2|||
163078234|NCT01117350|588993111|FG000|Extension Period|Withdrawal by Subject|0|||
163078235|NCT01117350|588993112|FG001|Extension Period|Withdrawal by Subject|3|||
163078236|NCT01117350|588993111|FG000|Extension Period|Lack of Efficacy|0|||
163078237|NCT01117350|588993112|FG001|Extension Period|Lack of Efficacy|2|||
163078238|NCT01117350|588993111|FG000|Extension Period|Inclusion criteria not respected|0|||
163078239|NCT01117350|588993112|FG001|Extension Period|Inclusion criteria not respected|1|||
163078240|NCT01117350|588993111|FG000|Extension Period|Prohibited medication|0|||
163078241|NCT01117350|588993112|FG001|Extension Period|Prohibited medication|1|||
163078242|NCT03760666|588993113|FG000|Overall Study|Adverse Event|2|||
163078243|NCT03760666|588993114|FG001|Overall Study|Adverse Event|4|||
163078244|NCT03760666|588993115|FG002|Overall Study|Adverse Event|1|||
163078245|NCT03760666|588993113|FG000|Overall Study|AML Disease Progression|3|||
163078246|NCT03760666|588993114|FG001|Overall Study|AML Disease Progression|3|||
163078247|NCT03760666|588993115|FG002|Overall Study|AML Disease Progression|0|||
163078248|NCT03760666|588993113|FG000|Overall Study|Physician Decision|0|||
163078249|NCT03760666|588993114|FG001|Overall Study|Physician Decision|3|||
163078250|NCT03760666|588993115|FG002|Overall Study|Physician Decision|0|||
163078251|NCT03760666|588993113|FG000|Overall Study|Withdrawal by Subject|0|||
163078252|NCT03760666|588993114|FG001|Overall Study|Withdrawal by Subject|1|||
163078253|NCT03760666|588993115|FG002|Overall Study|Withdrawal by Subject|0|||
163078254|NCT01800058|588993121|FG000|Overall Study|Lost to Follow-up|1|||
163078255|NCT01064622|588993122|FG000|Randomized Phase II|Withdrawal by Subject|2|||
163078256|NCT01064622|588993123|FG001|Randomized Phase II|Withdrawal by Subject|2|||
163078257|NCT01064622|588993122|FG000|Randomized Phase II|Protocol Violation|0|||
163078258|NCT01064622|588993123|FG001|Randomized Phase II|Protocol Violation|1|||
163078259|NCT05330429|588993126|FG000|Overall Study|Study Terminated by Sponsor|4|||
163078260|NCT05330429|588993127|FG001|Overall Study|Study Terminated by Sponsor|33|||
163078261|NCT05330429|588993128|FG002|Overall Study|Study Terminated by Sponsor|12|||
163078262|NCT05330429|588993126|FG000|Overall Study|Death|5|||
163078263|NCT05330429|588993127|FG001|Overall Study|Death|2|||
163078264|NCT05330429|588993128|FG002|Overall Study|Death|4|||
163078265|NCT05330429|588993126|FG000|Overall Study|Withdrew Consent|0|||
163078266|NCT05330429|588993127|FG001|Overall Study|Withdrew Consent|5|||
163078267|NCT05330429|588993128|FG002|Overall Study|Withdrew Consent|4|||
163078268|NCT05330429|588993126|FG000|Overall Study|Investigator's Discretion|0|||
163078269|NCT05330429|588993127|FG001|Overall Study|Investigator's Discretion|1|||
163078270|NCT05330429|588993128|FG002|Overall Study|Investigator's Discretion|3|||
163078271|NCT05330429|588993126|FG000|Overall Study|Subject Decision|1|||
163078272|NCT05330429|588993127|FG001|Overall Study|Subject Decision|2|||
163078273|NCT05330429|588993128|FG002|Overall Study|Subject Decision|0|||
163078274|NCT05330429|588993126|FG000|Overall Study|Lost to Follow-up|0|||
163078275|NCT05330429|588993127|FG001|Overall Study|Lost to Follow-up|1|||
163078276|NCT05330429|588993128|FG002|Overall Study|Lost to Follow-up|0|||
163078277|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
163078278|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
163078279|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
163078280|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Adverse Event|5|||
163078281|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Adverse Event|1|||
163078282|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Adverse Event|0|||
163078283|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
163078284|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
163078285|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
163078286|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Death|8|||
163078287|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Death|24|||
163078288|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Death|0|||
163078289|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
163078290|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
163078291|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
163078292|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
163078293|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
163078294|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
163078295|NCT02931539|588993132|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
163078296|NCT02931539|588993133|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
163078297|NCT02931539|588993134|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
163078298|NCT02931539|588993132|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
163078299|NCT02931539|588993133|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
163078300|NCT02931539|588993134|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
163078301|NCT06097273|588993137|FG000|Overall Study|Death|2|||
163078302|NCT06097273|588993138|FG001|Overall Study|Death|1|||
163078303|NCT06097273|588993139|FG002|Overall Study|Death|2|||
163078304|NCT06097273|588993140|FG003|Overall Study|Death|2|||
163078305|NCT06097273|588993137|FG000|Overall Study|Lost to Follow-up|27|||
163078306|NCT06097273|588993138|FG001|Overall Study|Lost to Follow-up|18|||
163078307|NCT06097273|588993139|FG002|Overall Study|Lost to Follow-up|36|||
163078308|NCT06097273|588993140|FG003|Overall Study|Lost to Follow-up|31|||
163078309|NCT06097273|588993137|FG000|Overall Study|Physician Decision|0|||
163078310|NCT06097273|588993138|FG001|Overall Study|Physician Decision|1|||
163078311|NCT06097273|588993139|FG002|Overall Study|Physician Decision|0|||
163078312|NCT06097273|588993140|FG003|Overall Study|Physician Decision|3|||
163078313|NCT06097273|588993137|FG000|Overall Study|Protocol Violation|1|||
163078314|NCT06097273|588993138|FG001|Overall Study|Protocol Violation|1|||
163078315|NCT06097273|588993139|FG002|Overall Study|Protocol Violation|2|||
163078316|NCT06097273|588993140|FG003|Overall Study|Protocol Violation|1|||
163078317|NCT06097273|588993137|FG000|Overall Study|Withdrawal by Subject|14|||
163078318|NCT06097273|588993138|FG001|Overall Study|Withdrawal by Subject|11|||
163078319|NCT06097273|588993139|FG002|Overall Study|Withdrawal by Subject|14|||
163078320|NCT06097273|588993140|FG003|Overall Study|Withdrawal by Subject|15|||
163078321|NCT06097273|588993137|FG000|Overall Study|Other Than Specified|7|||
163078322|NCT06097273|588993138|FG001|Overall Study|Other Than Specified|3|||
163078323|NCT06097273|588993139|FG002|Overall Study|Other Than Specified|11|||
163078324|NCT06097273|588993140|FG003|Overall Study|Other Than Specified|6|||
163078325|NCT02562040|588994959|FG000|Overall Study|Lost to Follow-up|20|||
163078326|NCT02562040|588994960|FG001|Overall Study|Lost to Follow-up|28|||
163078327|NCT02562040|588994959|FG000|Overall Study|Withdrawal by Subject|8|||
163078328|NCT02562040|588994960|FG001|Overall Study|Withdrawal by Subject|7|||
163078329|NCT02562040|588994959|FG000|Overall Study|Adverse Event|1|||
163078330|NCT02562040|588994960|FG001|Overall Study|Adverse Event|0|||
163078331|NCT04359680|588994963|FG000|Overall Study|Withdrawal by Subject|29|||
163078332|NCT04359680|588994964|FG001|Overall Study|Withdrawal by Subject|24|||
163078333|NCT04359680|588994963|FG000|Overall Study|Adverse Event|6|||
163078334|NCT04359680|588994964|FG001|Overall Study|Adverse Event|2|||
163078335|NCT04359680|588994963|FG000|Overall Study|Lost to Follow-up|56|||
163078336|NCT04359680|588994964|FG001|Overall Study|Lost to Follow-up|59|||
163078337|NCT04359680|588994963|FG000|Overall Study|Protocol Violation|3|||
163078338|NCT04359680|588994964|FG001|Overall Study|Protocol Violation|5|||
163078339|NCT04359680|588994963|FG000|Overall Study|Physician Decision|1|||
163078340|NCT04359680|588994964|FG001|Overall Study|Physician Decision|1|||
163078341|NCT04359680|588994963|FG000|Overall Study|Sponsor Decision|0|||
163078342|NCT04359680|588994964|FG001|Overall Study|Sponsor Decision|1|||
163078343|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
163078344|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
163078345|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
162645497|NCT01782664|587419376|FG002|Overall Study|Withdrawal by Subject|0|||
162645498|NCT01782664|587419377|FG003|Overall Study|Withdrawal by Subject|0|||
162645499|NCT01782664|587419378|FG004|Overall Study|Withdrawal by Subject|0|||
162645500|NCT01782664|587419379|FG005|Overall Study|Withdrawal by Subject|0|||
163078346|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
163078347|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
163078348|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
163078349|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
163078350|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
163078351|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
163078352|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
163078353|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
163078354|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
163078355|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
163078356|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
163078357|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
163078358|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
163078359|NCT01755156|588994966|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
163078360|NCT01755156|588994967|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
163078361|NCT01755156|588994966|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
163078362|NCT01755156|588994967|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
163078363|NCT01755156|588994966|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
163078364|NCT01755156|588994967|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
163078365|NCT03142451|588994968|FG000|Overall Study|Adverse Event|5|||
163078366|NCT03142451|588994969|FG001|Overall Study|Adverse Event|2|||
163078367|NCT03142451|588994968|FG000|Overall Study|Lost to Follow-up|25|||
163078368|NCT03142451|588994969|FG001|Overall Study|Lost to Follow-up|8|||
163078369|NCT03142451|588994968|FG000|Overall Study|Participant request|24|||
163078370|NCT03142451|588994969|FG001|Overall Study|Participant request|12|||
163078371|NCT03142451|588994968|FG000|Overall Study|Protocol Violation|3|||
163078372|NCT03142451|588994969|FG001|Overall Study|Protocol Violation|1|||
163078373|NCT03142451|588994968|FG000|Overall Study|Other|1|||
163078374|NCT03142451|588994969|FG001|Overall Study|Other|1|||
163078375|NCT05333965|588994970|FG000|First Intervention|Adverse Event|0|||
163078376|NCT05333965|588994971|FG001|First Intervention|Adverse Event|1|||
163078377|NCT05333965|588994970|FG000|First Intervention|Withdrawal by Subject|0|||
163078378|NCT05333965|588994971|FG001|First Intervention|Withdrawal by Subject|1|||
163078379|NCT03048019|588994972|FG000|Overall Study|Adverse Event|1|||
163078380|NCT03048019|588994973|FG001|Overall Study|Adverse Event|0|||
163078381|NCT01730729|588994974|FG000|Overall Study|Adverse Event|1|||
163078382|NCT01730729|588994974|FG000|Overall Study|Death|1|||
163078383|NCT01730729|588994974|FG000|Overall Study|Progressive Disease|12|||
163078384|NCT00382863|588994975|FG000|Overall Study|Death|9|||
163078385|NCT00382863|588994976|FG001|Overall Study|Death|9|||
163078386|NCT00382863|588994975|FG000|Overall Study|Lost to Follow-up|1|||
163078387|NCT00382863|588994976|FG001|Overall Study|Lost to Follow-up|2|||
163078388|NCT00382863|588994975|FG000|Overall Study|Withdrawal by Subject|5|||
163078389|NCT00382863|588994976|FG001|Overall Study|Withdrawal by Subject|25|||
163078390|NCT00203242|588994979|FG000|Overall Study|Lost to Follow-up|1|||
163078391|NCT02595437|588994980|FG000|Triferic Via IV|Withdrawal by Subject|1|||
163078392|NCT02150863|588994988|FG000|Overall Study|Lost to Follow-up|0|||
163078393|NCT02150863|588994989|FG001|Overall Study|Lost to Follow-up|1|||
163078394|NCT02150863|588994990|FG002|Overall Study|Lost to Follow-up|0|||
163078395|NCT01651208|588994991|FG000|Overall Study|Lost to Follow-up|14|||
163078396|NCT01651208|588994992|FG001|Overall Study|Lost to Follow-up|16|||
163078397|NCT00986102|588995009|FG000|Overall Study|Lost to Follow-up|0|||
163078398|NCT00986102|588995010|FG001|Overall Study|Lost to Follow-up|1|||
163078399|NCT00986102|588995011|FG002|Overall Study|Lost to Follow-up|0|||
163078400|NCT00986102|588995012|FG003|Overall Study|Lost to Follow-up|1|||
163078401|NCT00986102|588995009|FG000|Overall Study|Withdrawal by Subject|1|||
163078402|NCT00986102|588995010|FG001|Overall Study|Withdrawal by Subject|1|||
163078403|NCT00986102|588995011|FG002|Overall Study|Withdrawal by Subject|0|||
163078404|NCT00986102|588995012|FG003|Overall Study|Withdrawal by Subject|0|||
163078405|NCT02314247|588995013|FG000|Overall Study|Adverse Event|2|||
163078406|NCT02314247|588995014|FG001|Overall Study|Adverse Event|1|||
163078407|NCT02314247|588995015|FG002|Overall Study|Adverse Event|0|||
163078408|NCT02314247|588995013|FG000|Overall Study|Withdrawal by Subject|1|||
163078409|NCT02314247|588995014|FG001|Overall Study|Withdrawal by Subject|3|||
163078410|NCT02314247|588995015|FG002|Overall Study|Withdrawal by Subject|1|||
163078411|NCT02314247|588995013|FG000|Overall Study|Progression of Disease|6|||
163078412|NCT02314247|588995014|FG001|Overall Study|Progression of Disease|2|||
163078413|NCT02314247|588995015|FG002|Overall Study|Progression of Disease|0|||
163078414|NCT01260311|588995023|FG000|Overall Study|Adverse Event|11|||
162645501|NCT04170348|587419380|FG000|Overall Study|Lost to Follow-up|2|||
163078415|NCT01260311|588995023|FG000|Overall Study|Lack of Efficacy|4|||
163078416|NCT01260311|588995023|FG000|Overall Study|Lost to Follow-up|25|||
163078417|NCT01260311|588995023|FG000|Overall Study|Withdrawal by Subject|6|||
163078418|NCT01260311|588995023|FG000|Overall Study|Financial Constraints|77|||
163078419|NCT01260311|588995023|FG000|Overall Study|Gone to Province|2|||
163078420|NCT01260311|588995023|FG000|Overall Study|Medication Stopped|1|||
163078421|NCT01260311|588995023|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
163078422|NCT01340170|588995024|FG000|Overall Study|Lost to Follow-up|2|||
163078423|NCT01340170|588995025|FG001|Overall Study|Lost to Follow-up|4|||
163078424|NCT01340170|588995026|FG002|Overall Study|Lost to Follow-up|0|||
163078425|NCT01340170|588995024|FG000|Overall Study|Implant failure|1|||
163078426|NCT01340170|588995025|FG001|Overall Study|Implant failure|3|||
163078427|NCT01340170|588995026|FG002|Overall Study|Implant failure|0|||
163078428|NCT03878602|588995027|FG000|Overall Study|cord blood donation|7|||
163078429|NCT03878602|588995028|FG001|Overall Study|cord blood donation|1|||
163078430|NCT03878602|588995027|FG000|Overall Study|incomplete data collection|2|||
162645502|NCT04170348|587419381|FG001|Overall Study|Lost to Follow-up|2|||
162645503|NCT04170348|587419380|FG000|Overall Study|Withdrawal by Subject|1|||
162645504|NCT04170348|587419381|FG001|Overall Study|Withdrawal by Subject|5|||
162645505|NCT04170348|587419380|FG000|Overall Study|Non-adherence|1|||
163078431|NCT03878602|588995028|FG001|Overall Study|incomplete data collection|0|||
163078432|NCT02633527|588995029|FG000|Overall Study|Failed to meet eligibility|0|||
163078433|NCT02633527|588995030|FG001|Overall Study|Failed to meet eligibility|1|||
163078434|NCT02633527|588995031|FG002|Overall Study|Failed to meet eligibility|1|||
163078435|NCT02633527|588995032|FG003|Overall Study|Failed to meet eligibility|0|||
163078436|NCT02633527|588995033|FG004|Overall Study|Failed to meet eligibility|1|||
163078437|NCT02633527|588995029|FG000|Overall Study|Adverse Event|0|||
163078438|NCT02633527|588995030|FG001|Overall Study|Adverse Event|4|||
163078439|NCT02633527|588995031|FG002|Overall Study|Adverse Event|3|||
163078440|NCT02633527|588995032|FG003|Overall Study|Adverse Event|1|||
163078441|NCT02633527|588995033|FG004|Overall Study|Adverse Event|5|||
163078442|NCT02633527|588995029|FG000|Overall Study|Lost to Follow-up|1|||
163078443|NCT02633527|588995030|FG001|Overall Study|Lost to Follow-up|2|||
163078444|NCT02633527|588995031|FG002|Overall Study|Lost to Follow-up|5|||
163078445|NCT02633527|588995032|FG003|Overall Study|Lost to Follow-up|5|||
163078446|NCT02633527|588995033|FG004|Overall Study|Lost to Follow-up|4|||
163078447|NCT02633527|588995029|FG000|Overall Study|Withdrawal by Subject|0|||
163078448|NCT02633527|588995030|FG001|Overall Study|Withdrawal by Subject|3|||
163078449|NCT02633527|588995031|FG002|Overall Study|Withdrawal by Subject|5|||
163078450|NCT02633527|588995032|FG003|Overall Study|Withdrawal by Subject|4|||
163078451|NCT02633527|588995033|FG004|Overall Study|Withdrawal by Subject|4|||
163078452|NCT02633527|588995029|FG000|Overall Study|Protocol Violation|0|||
163078453|NCT02633527|588995030|FG001|Overall Study|Protocol Violation|1|||
163078454|NCT02633527|588995031|FG002|Overall Study|Protocol Violation|1|||
163078455|NCT02633527|588995032|FG003|Overall Study|Protocol Violation|1|||
163078456|NCT02633527|588995033|FG004|Overall Study|Protocol Violation|1|||
163078457|NCT02633527|588995029|FG000|Overall Study|Physician Decision|0|||
163078458|NCT02633527|588995030|FG001|Overall Study|Physician Decision|0|||
163078459|NCT02633527|588995031|FG002|Overall Study|Physician Decision|0|||
163078460|NCT02633527|588995032|FG003|Overall Study|Physician Decision|0|||
163078461|NCT02633527|588995033|FG004|Overall Study|Physician Decision|1|||
163078462|NCT02633527|588995029|FG000|Overall Study|Administrative reason|1|||
163078463|NCT02633527|588995030|FG001|Overall Study|Administrative reason|0|||
163078464|NCT02633527|588995031|FG002|Overall Study|Administrative reason|0|||
163078465|NCT02633527|588995032|FG003|Overall Study|Administrative reason|1|||
163078466|NCT02633527|588995033|FG004|Overall Study|Administrative reason|0|||
163078467|NCT02633527|588995029|FG000|Overall Study|Multiple reasons|1|||
163078468|NCT02633527|588995030|FG001|Overall Study|Multiple reasons|0|||
163078469|NCT02633527|588995031|FG002|Overall Study|Multiple reasons|2|||
163078470|NCT02633527|588995032|FG003|Overall Study|Multiple reasons|2|||
163078471|NCT02633527|588995033|FG004|Overall Study|Multiple reasons|1|||
163078472|NCT06091956|588995034|FG000|Overall Study|Withdrawal by Subject|1|||
163078473|NCT06091956|588995034|FG000|Overall Study|Complicating Disease|1|||
163078474|NCT02176525|588995037|FG000|Overall Study|Adverse Event|0|||
163078475|NCT02176525|588995038|FG001|Overall Study|Adverse Event|0|||
163078476|NCT02176525|588995039|FG002|Overall Study|Adverse Event|0|||
163078477|NCT02176525|588995040|FG003|Overall Study|Adverse Event|1|||
163078478|NCT02176525|588995041|FG004|Overall Study|Adverse Event|1|||
163078479|NCT02176525|588995042|FG005|Overall Study|Adverse Event|0|||
163078480|NCT02176525|588995043|FG006|Overall Study|Adverse Event|1|||
163078481|NCT02176525|588995044|FG007|Overall Study|Adverse Event|0|||
163078482|NCT02176525|588995037|FG000|Overall Study|not treated|1|||
163078483|NCT02176525|588995038|FG001|Overall Study|not treated|0|||
163078484|NCT02176525|588995039|FG002|Overall Study|not treated|0|||
163078485|NCT02176525|588995040|FG003|Overall Study|not treated|0|||
163078486|NCT02176525|588995041|FG004|Overall Study|not treated|0|||
163078487|NCT02176525|588995042|FG005|Overall Study|not treated|1|||
163078488|NCT02176525|588995043|FG006|Overall Study|not treated|0|||
163078489|NCT02176525|588995044|FG007|Overall Study|not treated|0|||
163078490|NCT02100644|588995047|FG000|LTG Escalation Phase|Adverse Event|9|||
162645506|NCT04170348|587419381|FG001|Overall Study|Non-adherence|1|||
162645507|NCT04170348|587419380|FG000|Overall Study|Adverse Event|1|||
163078491|NCT02100644|588995048|FG001|LTG Escalation Phase|Adverse Event|0|||
163078492|NCT02100644|588995049|FG002|LTG Escalation Phase|Adverse Event|0|||
163078493|NCT02100644|588995047|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
163078494|NCT02100644|588995048|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
163078495|NCT02100644|588995049|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
163078496|NCT02100644|588995047|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
163078497|NCT02100644|588995048|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
163078498|NCT02100644|588995049|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
163078499|NCT00478140|588995050|FG000|Overall Study|Clinical Disease Progression|1|||
163078500|NCT03163264|588995054|FG000|Overall Study|Withdrawal by Subject|13|||
163078501|NCT03163264|588995055|FG001|Overall Study|Withdrawal by Subject|3|||
163078502|NCT03163264|588995056|FG002|Overall Study|Withdrawal by Subject|4|||
163078503|NCT03163264|588995057|FG003|Overall Study|Withdrawal by Subject|2|||
163078504|NCT03163264|588995054|FG000|Overall Study|Lost to Follow-up|17|||
163078505|NCT03163264|588995055|FG001|Overall Study|Lost to Follow-up|20|||
163078506|NCT03163264|588995056|FG002|Overall Study|Lost to Follow-up|0|||
163078507|NCT03163264|588995057|FG003|Overall Study|Lost to Follow-up|0|||
163078508|NCT03163264|588995054|FG000|Overall Study|Death|0|||
163078509|NCT03163264|588995055|FG001|Overall Study|Death|2|||
163078510|NCT03163264|588995056|FG002|Overall Study|Death|0|||
163078511|NCT03163264|588995057|FG003|Overall Study|Death|0|||
163078512|NCT02614066|588995058|FG000|Overall Study|Death|6|||
163078513|NCT02614066|588995059|FG001|Overall Study|Death|14|||
163078514|NCT02614066|588995060|FG002|Overall Study|Death|11|||
163078515|NCT02614066|588995061|FG003|Overall Study|Death|29|||
163078516|NCT02614066|588995058|FG000|Overall Study|Full consent withdrawn|0|||
163078517|NCT02614066|588995059|FG001|Overall Study|Full consent withdrawn|1|||
163078518|NCT02614066|588995060|FG002|Overall Study|Full consent withdrawn|0|||
163078519|NCT02614066|588995061|FG003|Overall Study|Full consent withdrawn|8|||
163078520|NCT02614066|588995058|FG000|Overall Study|Lost to Follow-up|0|||
163078521|NCT02614066|588995059|FG001|Overall Study|Lost to Follow-up|2|||
163078522|NCT02614066|588995060|FG002|Overall Study|Lost to Follow-up|2|||
163078523|NCT02614066|588995061|FG003|Overall Study|Lost to Follow-up|2|||
163078524|NCT02614066|588995058|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
163078525|NCT02614066|588995059|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
163078526|NCT02614066|588995060|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
163078527|NCT02614066|588995061|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
163078528|NCT02614066|588995058|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
163078529|NCT02614066|588995059|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
163078530|NCT02614066|588995060|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
163078531|NCT02614066|588995061|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
163078532|NCT02614066|588995058|FG000|Overall Study|Reason not specified|0|||
163078533|NCT02614066|588995059|FG001|Overall Study|Reason not specified|2|||
163078534|NCT02614066|588995060|FG002|Overall Study|Reason not specified|1|||
163078535|NCT02614066|588995061|FG003|Overall Study|Reason not specified|1|||
163078536|NCT04565756|588995062|FG000|Overall Study|Withdrawal by Subject|0|||
163078537|NCT04565756|588995063|FG001|Overall Study|Withdrawal by Subject|0|||
163078538|NCT04565756|588995064|FG002|Overall Study|Withdrawal by Subject|0|||
163078539|NCT04565756|588995065|FG003|Overall Study|Withdrawal by Subject|0|||
163078540|NCT04565756|588995066|FG004|Overall Study|Withdrawal by Subject|1|||
163078541|NCT04565756|588995067|FG005|Overall Study|Withdrawal by Subject|0|||
163078542|NCT04565756|588995062|FG000|Overall Study|Protocol Violation|0|||
163078543|NCT04565756|588995063|FG001|Overall Study|Protocol Violation|0|||
163078544|NCT04565756|588995064|FG002|Overall Study|Protocol Violation|0|||
163078545|NCT04565756|588995065|FG003|Overall Study|Protocol Violation|0|||
163078546|NCT04565756|588995066|FG004|Overall Study|Protocol Violation|0|||
163078547|NCT04565756|588995067|FG005|Overall Study|Protocol Violation|1|||
163078548|NCT00968968|588995072|FG000|Overall Study|Study closed/terminated|10|||
163078549|NCT00968968|588995073|FG001|Overall Study|Study closed/terminated|10|||
163078550|NCT00968968|588995072|FG000|Overall Study|Protocol defined stopping criteria|3|||
163078551|NCT00968968|588995073|FG001|Overall Study|Protocol defined stopping criteria|1|||
163078552|NCT00968968|588995072|FG000|Overall Study|Withdrawal by Subject|2|||
163078553|NCT00968968|588995073|FG001|Overall Study|Withdrawal by Subject|0|||
163078554|NCT00968968|588995072|FG000|Overall Study|Physician Decision|1|||
163078555|NCT00968968|588995073|FG001|Overall Study|Physician Decision|2|||
163078556|NCT00968968|588995072|FG000|Overall Study|Lost to Follow-up|0|||
163078557|NCT00968968|588995073|FG001|Overall Study|Lost to Follow-up|1|||
163078558|NCT04401293|588995074|FG000|Overall Study|Withdrawal by Subject|1|||
163078559|NCT04401293|588995075|FG001|Overall Study|Withdrawal by Subject|3|||
163078560|NCT01026038|588995076|FG000|Overall Study|Lost to Follow-up|1|||
163078561|NCT01026038|588995077|FG001|Overall Study|Lost to Follow-up|1|||
163078562|NCT01026038|588995078|FG002|Overall Study|Lost to Follow-up|0|||
163078563|NCT03679884|588995079|FG000|Overall Study|Other|12|||
163078564|NCT03679884|588995080|FG001|Overall Study|Other|12|||
163078565|NCT03679884|588995081|FG002|Overall Study|Other|12|||
163078566|NCT03679884|588995082|FG003|Overall Study|Other|7|||
163078567|NCT03679884|588995083|FG004|Overall Study|Other|8|||
163078568|NCT03679884|588995079|FG000|Overall Study|Lack of Efficacy|15|||
163078569|NCT03679884|588995080|FG001|Overall Study|Lack of Efficacy|29|||
163078570|NCT03679884|588995081|FG002|Overall Study|Lack of Efficacy|13|||
163078571|NCT03679884|588995082|FG003|Overall Study|Lack of Efficacy|29|||
163078572|NCT03679884|588995083|FG004|Overall Study|Lack of Efficacy|10|||
163078573|NCT03679884|588995079|FG000|Overall Study|Death|1|||
163078574|NCT03679884|588995080|FG001|Overall Study|Death|0|||
163078575|NCT03679884|588995081|FG002|Overall Study|Death|0|||
163078576|NCT03679884|588995082|FG003|Overall Study|Death|0|||
163078577|NCT03679884|588995083|FG004|Overall Study|Death|0|||
163078578|NCT03679884|588995079|FG000|Overall Study|Adverse Event|2|||
163078579|NCT03679884|588995080|FG001|Overall Study|Adverse Event|10|||
163078580|NCT03679884|588995081|FG002|Overall Study|Adverse Event|9|||
163078581|NCT03679884|588995082|FG003|Overall Study|Adverse Event|6|||
163078582|NCT03679884|588995083|FG004|Overall Study|Adverse Event|6|||
163078583|NCT03679884|588995079|FG000|Overall Study|Withdrawal by Subject|12|||
163078584|NCT03679884|588995080|FG001|Overall Study|Withdrawal by Subject|23|||
163078585|NCT03679884|588995081|FG002|Overall Study|Withdrawal by Subject|8|||
163078586|NCT03679884|588995082|FG003|Overall Study|Withdrawal by Subject|8|||
163078587|NCT03679884|588995083|FG004|Overall Study|Withdrawal by Subject|9|||
163078588|NCT03679884|588995079|FG000|Overall Study|Lost to Follow-up|1|||
163078589|NCT03679884|588995080|FG001|Overall Study|Lost to Follow-up|4|||
163078590|NCT03679884|588995081|FG002|Overall Study|Lost to Follow-up|2|||
163078591|NCT03679884|588995082|FG003|Overall Study|Lost to Follow-up|0|||
163078592|NCT03679884|588995083|FG004|Overall Study|Lost to Follow-up|3|||
163078593|NCT01783938|588995092|FG000|Overall Study|Disease Progression|18|||
163078594|NCT01783938|588995093|FG001|Overall Study|Disease Progression|41|||
163078595|NCT01783938|588995092|FG000|Overall Study|Study Drug Toxicity|27|||
163078596|NCT01783938|588995093|FG001|Overall Study|Study Drug Toxicity|14|||
163078597|NCT01783938|588995092|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
163078598|NCT01783938|588995093|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163078599|NCT01783938|588995092|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
163078600|NCT01783938|588995093|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
163078601|NCT01783938|588995092|FG000|Overall Study|Participant Withdrew Consent|2|||
163078602|NCT01783938|588995093|FG001|Overall Study|Participant Withdrew Consent|0|||
163078603|NCT01783938|588995092|FG000|Overall Study|Maximum Clinical Benefit|1|||
163078604|NCT01783938|588995093|FG001|Overall Study|Maximum Clinical Benefit|0|||
163078605|NCT01783938|588995092|FG000|Overall Study|Other Reasons|3|||
163078606|NCT01783938|588995093|FG001|Overall Study|Other Reasons|1|||
163078607|NCT00930176|588995095|FG000|Overall Study|Death|1|||
163078608|NCT01712074|588995100|FG000|Placebo Run-in Period|Adverse Event|2|||
163078609|NCT01712074|588995101|FG001|Placebo Run-in Period|Adverse Event|0|||
163078610|NCT01712074|588995102|FG002|Placebo Run-in Period|Adverse Event|0|||
163078611|NCT01712074|588995100|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
163078612|NCT01712074|588995101|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
163078613|NCT01712074|588995102|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
163078614|NCT01712074|588995100|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
163078615|NCT01712074|588995101|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
163078616|NCT01712074|588995102|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
163078617|NCT01712074|588995100|FG000|Placebo Run-in Period|Other|1|||
163078618|NCT01712074|588995101|FG001|Placebo Run-in Period|Other|0|||
163078619|NCT01712074|588995102|FG002|Placebo Run-in Period|Other|0|||
163078620|NCT01712074|588995100|FG000|Placebo Run-in Period|No longer willing to participate|1|||
163078621|NCT01712074|588995101|FG001|Placebo Run-in Period|No longer willing to participate|0|||
163078622|NCT01712074|588995102|FG002|Placebo Run-in Period|No longer willing to participate|0|||
163078623|NCT01712074|588995100|FG000|Double Blind Period|Adverse Event|0|||
163078624|NCT01712074|588995101|FG001|Double Blind Period|Adverse Event|2|||
163078625|NCT01712074|588995102|FG002|Double Blind Period|Adverse Event|1|||
163078626|NCT01712074|588995100|FG000|Double Blind Period|No longer willing to participate|0|||
162645508|NCT04170348|587419381|FG001|Overall Study|Adverse Event|0|||
162645509|NCT03642717|587419383|FG000|Overall Study|Lost to Follow-up|2|||
162645510|NCT03642717|587419383|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
162645511|NCT03642717|587419383|FG000|Overall Study|Taken study drug prior to contract date|3|||
162645512|NCT02587065|587419384|FG000|Overall Study|Adverse Event|14|||
163078627|NCT01712074|588995101|FG001|Double Blind Period|No longer willing to participate|2|||
163078628|NCT01712074|588995102|FG002|Double Blind Period|No longer willing to participate|4|||
162645513|NCT02587065|587419384|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
162645514|NCT02587065|587419384|FG000|Overall Study|Non-adherence to the Protocol|3|||
162717903|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
162717904|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
163078629|NCT01712074|588995100|FG000|Double Blind Period|Death|0|||
162645515|NCT02587065|587419384|FG000|Overall Study|Discontinuation of Study Medication|2|||
162645516|NCT02587065|587419384|FG000|Overall Study|Reason not Specified|3|||
163078630|NCT01712074|588995101|FG001|Double Blind Period|Death|1|||
163078631|NCT01712074|588995102|FG002|Double Blind Period|Death|0|||
163078632|NCT01712074|588995100|FG000|Double Blind Period|Lost to Follow-up|0|||
163078633|NCT01712074|588995101|FG001|Double Blind Period|Lost to Follow-up|2|||
163078634|NCT01712074|588995102|FG002|Double Blind Period|Lost to Follow-up|1|||
163078635|NCT01712074|588995100|FG000|Double Blind Period|Other|0|||
163078636|NCT01712074|588995101|FG001|Double Blind Period|Other|4|||
163078637|NCT01712074|588995102|FG002|Double Blind Period|Other|1|||
163078638|NCT01712074|588995100|FG000|Double Blind Period|Protocol Violation|0|||
163078639|NCT01712074|588995101|FG001|Double Blind Period|Protocol Violation|0|||
163078640|NCT01712074|588995102|FG002|Double Blind Period|Protocol Violation|1|||
163078641|NCT01712074|588995100|FG000|Double Blind Period|No longer met eligibility criteria|0|||
163078642|NCT01712074|588995101|FG001|Double Blind Period|No longer met eligibility criteria|3|||
163078643|NCT01712074|588995102|FG002|Double Blind Period|No longer met eligibility criteria|0|||
163078644|NCT03478787|588995103|FG000|Overall Study|Adverse Event|5|||
163078645|NCT03478787|588995104|FG001|Overall Study|Adverse Event|1|||
163078646|NCT03478787|588995103|FG000|Overall Study|Protocol Violation|3|||
163078647|NCT03478787|588995104|FG001|Overall Study|Protocol Violation|0|||
163078648|NCT03478787|588995103|FG000|Overall Study|Lack of Efficacy|7|||
163078649|NCT03478787|588995104|FG001|Overall Study|Lack of Efficacy|1|||
163029268|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
163029269|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
163029270|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
163029271|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
163029272|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
163029273|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163029274|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163029275|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163029276|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163029277|NCT04713592|588810391|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
163029278|NCT04713592|588810392|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
163029279|NCT04713592|588810393|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
163029280|NCT04713592|588810394|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
163029281|NCT02225366|588810399|FG000|Overall Study|Lack of Efficacy|1|||
163029282|NCT02225366|588810400|FG001|Overall Study|Lack of Efficacy|0|||
163029283|NCT03782298|588810403|FG000|Overall Study|Protocol Deviation|4|||
163029284|NCT02431806|588810404|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029285|NCT02431806|588810405|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
163029286|NCT02431806|588810406|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029287|NCT02431806|588810407|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
163029288|NCT02431806|588810404|FG000|Double-blind Treatment Period|Adverse Event|4|||
163029289|NCT02431806|588810405|FG001|Double-blind Treatment Period|Adverse Event|7|||
163078650|NCT03478787|588995103|FG000|Overall Study|Lost to Follow-up|9|||
162645517|NCT01559012|587419385|FG000|Overall Study|Withdrawal by Subject|0|||
162645518|NCT01559012|587419386|FG001|Overall Study|Withdrawal by Subject|1|||
162645519|NCT00302458|587419387|FG000|Overall Study|Lost to Follow-up|1|||
162645520|NCT00302458|587419387|FG000|Overall Study|Ineligible after screening|1|||
162645521|NCT00302458|587419387|FG000|Overall Study|Withdrawal by Subject|1|||
162645522|NCT00946712|587419388|FG000|Overall Study|Adverse Event|118|||
162645523|NCT00946712|587419389|FG001|Overall Study|Adverse Event|124|||
162645524|NCT00946712|587419388|FG000|Overall Study|Disease progression|308|||
162645525|NCT00946712|587419389|FG001|Overall Study|Disease progression|404|||
162645526|NCT00946712|587419388|FG000|Overall Study|Death|21|||
162645527|NCT00946712|587419389|FG001|Overall Study|Death|22|||
162645528|NCT00946712|587419388|FG000|Overall Study|No treatment given|25|||
162645529|NCT00946712|587419389|FG001|Overall Study|No treatment given|29|||
162645530|NCT00946712|587419388|FG000|Overall Study|Other reasons|61|||
162645531|NCT00946712|587419389|FG001|Overall Study|Other reasons|73|||
162645532|NCT00946712|587419388|FG000|Overall Study|On Treatment|0|||
162645533|NCT00946712|587419389|FG001|Overall Study|On Treatment|4|||
162645534|NCT00946712|587419388|FG000|Overall Study|Ineligible|14|||
162645535|NCT00946712|587419389|FG001|Overall Study|Ineligible|6|||
162645536|NCT00853723|587419392|FG000|Overall Study|Adverse Event|3|||
162645537|NCT00853723|587419393|FG001|Overall Study|Adverse Event|4|||
162645538|NCT00853723|587419394|FG002|Overall Study|Adverse Event|1|||
162645539|NCT00853723|587419392|FG000|Overall Study|Withdrawal by Subject|2|||
163029290|NCT02431806|588810406|FG002|Double-blind Treatment Period|Adverse Event|11|||
163029291|NCT02431806|588810407|FG003|Double-blind Treatment Period|Adverse Event|7|||
163029292|NCT02431806|588810404|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
163029293|NCT02431806|588810405|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163029294|NCT02431806|588810406|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
163029295|NCT02431806|588810407|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
163029296|NCT02431806|588810404|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
163029297|NCT02431806|588810405|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
163029298|NCT02431806|588810406|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
163029299|NCT02431806|588810407|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
163029300|NCT02431806|588810404|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
163029301|NCT02431806|588810405|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
163029302|NCT02431806|588810406|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163029303|NCT02431806|588810407|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
163029304|NCT02431806|588810404|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
163029305|NCT02431806|588810405|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
163029306|NCT02431806|588810406|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
163029307|NCT02431806|588810407|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
163029308|NCT02431806|588810404|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
163029309|NCT02431806|588810405|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
163029310|NCT02431806|588810406|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
163029311|NCT02431806|588810407|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
163029312|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
163029313|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
163029314|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
163029315|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
163029316|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
163029317|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
163029318|NCT00742508|588810408|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
163029319|NCT00742508|588810409|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
163029320|NCT00742508|588810408|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
163029321|NCT00742508|588810409|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
163029322|NCT01382225|588810410|FG000|Overall Study|Adverse Event|3|||
163029323|NCT01382225|588810411|FG001|Overall Study|Adverse Event|2|||
163029324|NCT01382225|588810410|FG000|Overall Study|Protocol Violation|2|||
163029325|NCT01382225|588810411|FG001|Overall Study|Protocol Violation|1|||
163029326|NCT01382225|588810410|FG000|Overall Study|Subject Withdrew Consent|5|||
163029327|NCT01382225|588810411|FG001|Overall Study|Subject Withdrew Consent|2|||
163029328|NCT01382225|588810410|FG000|Overall Study|Other|4|||
163029329|NCT01382225|588810411|FG001|Overall Study|Other|2|||
163029330|NCT01797081|588810412|FG000|Overall Study|Adverse Event|1|||
163029331|NCT01797081|588810413|FG001|Overall Study|Adverse Event|0|||
162645540|NCT00853723|587419393|FG001|Overall Study|Withdrawal by Subject|1|||
162645541|NCT00853723|587419394|FG002|Overall Study|Withdrawal by Subject|0|||
162645542|NCT00853723|587419392|FG000|Overall Study|Protocol Violation|1|||
162645543|NCT00853723|587419393|FG001|Overall Study|Protocol Violation|2|||
162645544|NCT00853723|587419394|FG002|Overall Study|Protocol Violation|1|||
162645545|NCT04248933|587419395|FG000|Overall Study|Lost to Follow-up|9|||
162645546|NCT04248933|587419395|FG000|Overall Study|Withdrawal by Subject|2|||
162645547|NCT02642432|587419398|FG000|Overall Study|Adverse Event|2|||
162645548|NCT02642432|587419398|FG000|Overall Study|Withdrew Consent|1|||
162645549|NCT02642432|587419398|FG000|Overall Study|Lost to Follow-up|2|||
162645550|NCT02642432|587419398|FG000|Overall Study|Other|3|||
162645551|NCT02447081|587419399|FG000|Overall Study|Death|161|||
162645552|NCT02447081|587419399|FG000|Overall Study|Lost to Follow-up|36|||
162645553|NCT02447081|587419399|FG000|Overall Study|Visit not completed|17|||
162645554|NCT02447081|587419399|FG000|Overall Study|unsuccessful implant procedure|10|||
162645555|NCT02867709|587419402|FG000|Treatment Period|Adverse Event|1|||
162645556|NCT02867709|587419403|FG001|Treatment Period|Adverse Event|1|||
162645557|NCT02867709|587419404|FG002|Treatment Period|Adverse Event|2|||
162645558|NCT02867709|587419402|FG000|Treatment Period|Withdrawal of Consent|7|||
162645559|NCT02867709|587419403|FG001|Treatment Period|Withdrawal of Consent|9|||
162645560|NCT02867709|587419404|FG002|Treatment Period|Withdrawal of Consent|8|||
162645561|NCT02867709|587419402|FG000|Treatment Period|Lost to Follow-up|17|||
162645562|NCT02867709|587419403|FG001|Treatment Period|Lost to Follow-up|20|||
162645563|NCT02867709|587419404|FG002|Treatment Period|Lost to Follow-up|20|||
162645564|NCT02867709|587419402|FG000|Treatment Period|Lack of Qualifying Event|42|||
162645565|NCT02867709|587419403|FG001|Treatment Period|Lack of Qualifying Event|55|||
162645566|NCT02867709|587419404|FG002|Treatment Period|Lack of Qualifying Event|42|||
162645567|NCT02867709|587419402|FG000|Treatment Period|Protocol Violation|3|||
162645568|NCT02867709|587419403|FG001|Treatment Period|Protocol Violation|2|||
162645569|NCT02867709|587419404|FG002|Treatment Period|Protocol Violation|3|||
162645570|NCT02867709|587419402|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
162645571|NCT02867709|587419403|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
162645572|NCT02867709|587419404|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
162645573|NCT02867709|587419402|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
162645574|NCT02867709|587419403|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
162645575|NCT02867709|587419404|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
162645576|NCT02867709|587419402|FG000|Safety Follow-up Period|Pregnancy|0|||
162645577|NCT02867709|587419403|FG001|Safety Follow-up Period|Pregnancy|1|||
162645578|NCT02867709|587419404|FG002|Safety Follow-up Period|Pregnancy|0|||
162645579|NCT02867709|587419402|FG000|Safety Follow-up Period|Protocol Violation|0|||
162645580|NCT02867709|587419403|FG001|Safety Follow-up Period|Protocol Violation|1|||
162645581|NCT02867709|587419404|FG002|Safety Follow-up Period|Protocol Violation|1|||
162645582|NCT03188094|587419407|FG000|Overall Study|Screen failure|1|||
162645583|NCT03188094|587419408|FG001|Overall Study|Screen failure|0|||
162645584|NCT03188094|587419409|FG002|Overall Study|Screen failure|0|||
162645585|NCT03188094|587419407|FG000|Overall Study|Pregnancy|3|||
162645586|NCT03188094|587419408|FG001|Overall Study|Pregnancy|0|||
162645587|NCT03188094|587419409|FG002|Overall Study|Pregnancy|0|||
162645588|NCT03188094|587419407|FG000|Overall Study|Ineligible|1|||
162645589|NCT03188094|587419408|FG001|Overall Study|Ineligible|0|||
162645590|NCT03188094|587419409|FG002|Overall Study|Ineligible|0|||
162645591|NCT03188094|587419407|FG000|Overall Study|Lost to Follow-up|0|||
162645592|NCT03188094|587419408|FG001|Overall Study|Lost to Follow-up|0|||
162645593|NCT03188094|587419409|FG002|Overall Study|Lost to Follow-up|17|||
162645594|NCT01894581|587419410|FG000|Overall Study|Withdrawal by Subject|2|||
162645595|NCT01894581|587419411|FG001|Overall Study|Withdrawal by Subject|3|||
162645596|NCT01894581|587419410|FG000|Overall Study|Screen Failure|3|||
163029332|NCT01797081|588810414|FG002|Overall Study|Adverse Event|1|||
163029333|NCT01797081|588810415|FG003|Overall Study|Adverse Event|0|||
163029334|NCT01797081|588810412|FG000|Overall Study|Pregnancy|1|||
163029335|NCT01797081|588810413|FG001|Overall Study|Pregnancy|0|||
163029336|NCT01797081|588810414|FG002|Overall Study|Pregnancy|0|||
163029337|NCT01797081|588810415|FG003|Overall Study|Pregnancy|0|||
163029338|NCT01797081|588810412|FG000|Overall Study|Personal Reasons|12|||
163029339|NCT01797081|588810413|FG001|Overall Study|Personal Reasons|4|||
163029340|NCT01797081|588810414|FG002|Overall Study|Personal Reasons|4|||
163029341|NCT01797081|588810415|FG003|Overall Study|Personal Reasons|8|||
163029342|NCT01797081|588810412|FG000|Overall Study|Protocol Violation|0|||
163029343|NCT01797081|588810413|FG001|Overall Study|Protocol Violation|0|||
163029344|NCT01797081|588810414|FG002|Overall Study|Protocol Violation|0|||
163029345|NCT01797081|588810415|FG003|Overall Study|Protocol Violation|1|||
163029346|NCT02484651|588810423|FG000|Overall Study|Patients' data files were corrupted.|1|||
163029347|NCT02484651|588810424|FG001|Overall Study|Patients' data files were corrupted.|1|||
163029348|NCT02484651|588810423|FG000|Overall Study|BIS monitoring failed.|1|||
163029349|NCT02484651|588810424|FG001|Overall Study|BIS monitoring failed.|1|||
163029350|NCT02484651|588810423|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
162645597|NCT01894581|587419411|FG001|Overall Study|Screen Failure|4|||
162645598|NCT03313804|587419412|FG000|Treatment|Death|5|||
162645599|NCT03313804|587419412|FG000|Treatment|still on treatment|2|||
162645600|NCT03313804|587419412|FG000|Follow Up|still on follow up|3|||
162645601|NCT03795298|587419413|FG000|Overall Study|Death|34|||
162645602|NCT03795298|587419414|FG001|Overall Study|Death|29|||
162645603|NCT03795298|587419413|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
162645604|NCT03795298|587419414|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
162645605|NCT03795298|587419413|FG000|Overall Study|Lost to Follow-up|28|||
162645606|NCT03795298|587419414|FG001|Overall Study|Lost to Follow-up|17|||
162645607|NCT03795298|587419413|FG000|Overall Study|Physician Decision|5|||
163078651|NCT03478787|588995104|FG001|Overall Study|Lost to Follow-up|5|||
163078652|NCT03478787|588995103|FG000|Overall Study|Withdrawal by Subject|2|||
163078653|NCT03478787|588995104|FG001|Overall Study|Withdrawal by Subject|6|||
163078654|NCT03478787|588995103|FG000|Overall Study|Other, Not Specified|3|||
163078655|NCT03478787|588995104|FG001|Overall Study|Other, Not Specified|0|||
163078656|NCT02792257|588995109|FG000|Overall Study|Lost to Follow-up|3|||
163078657|NCT02792257|588995110|FG001|Overall Study|Lost to Follow-up|4|||
163078658|NCT02792257|588995109|FG000|Overall Study|Allergy|0|||
163078659|NCT02792257|588995110|FG001|Overall Study|Allergy|1|||
163078660|NCT02792257|588995109|FG000|Overall Study|Protocol Violation|2|||
163078661|NCT02792257|588995110|FG001|Overall Study|Protocol Violation|0|||
163078662|NCT02792257|588995109|FG000|Overall Study|Excessive Agitation|0|||
163078663|NCT02792257|588995110|FG001|Overall Study|Excessive Agitation|1|||
163078664|NCT02792257|588995109|FG000|Overall Study|Not Feeling Well|0|||
163078665|NCT02792257|588995110|FG001|Overall Study|Not Feeling Well|1|||
163078666|NCT02766478|588995112|FG000|Overall Study|Withdrawal by Subject|1|||
163078667|NCT02766478|588995113|FG001|Overall Study|Withdrawal by Subject|1|||
163078668|NCT01093573|588995114|FG000|Overall Study|Physician Decision|0|||
163078669|NCT01093573|588995115|FG001|Overall Study|Physician Decision|0|||
163078670|NCT01093573|588995116|FG002|Overall Study|Physician Decision|1|||
163078671|NCT01093573|588995114|FG000|Overall Study|Insurance Denied|0|||
163078672|NCT01093573|588995115|FG001|Overall Study|Insurance Denied|0|||
163078673|NCT01093573|588995116|FG002|Overall Study|Insurance Denied|1|||
163078674|NCT05626686|588995117|FG000|Overall Study|Protocol Violation|3|||
163078675|NCT05626686|588995117|FG000|Overall Study|Withdrawal by Subject|3|||
163078676|NCT00682435|588995118|FG000|Overall Study|Insufficient data|5|||
163078677|NCT00682435|588995118|FG000|Overall Study|Erroneously enrolled twice|2|||
163078678|NCT00089583|588995119|FG000|Overall Study|Adverse Event|0|||
163078679|NCT00089583|588995120|FG001|Overall Study|Adverse Event|3|||
163078680|NCT00089583|588995119|FG000|Overall Study|Insufficient Viral Load Response|5|||
163078681|NCT00089583|588995120|FG001|Overall Study|Insufficient Viral Load Response|5|||
163078682|NCT00089583|588995119|FG000|Overall Study|Withdrawal by Subject|0|||
163078683|NCT00089583|588995120|FG001|Overall Study|Withdrawal by Subject|4|||
163078684|NCT00089583|588995119|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
163078685|NCT00089583|588995120|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
163078686|NCT00089583|588995119|FG000|Overall Study|Participant Refused Study Medication|0|||
163078687|NCT00089583|588995120|FG001|Overall Study|Participant Refused Study Medication|2|||
163078688|NCT00089583|588995119|FG000|Overall Study|Non-Compliance|0|||
163078689|NCT00089583|588995120|FG001|Overall Study|Non-Compliance|4|||
163078690|NCT00089583|588995119|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
163078691|NCT00089583|588995120|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
163078692|NCT00089583|588995119|FG000|Overall Study|Participant Management Criteria Met|0|||
163078693|NCT00089583|588995120|FG001|Overall Study|Participant Management Criteria Met|1|||
163078694|NCT00089583|588995119|FG000|Overall Study|Reason Not Provided|0|||
163078695|NCT00089583|588995120|FG001|Overall Study|Reason Not Provided|1|||
163078696|NCT00089583|588995119|FG000|Overall Study|Protocol Violation|0|||
163078697|NCT00089583|588995120|FG001|Overall Study|Protocol Violation|3|||
163078698|NCT00089583|588995119|FG000|Overall Study|Principal Investigator Decision|0|||
163078699|NCT00089583|588995120|FG001|Overall Study|Principal Investigator Decision|10|||
163078700|NCT00089583|588995119|FG000|Overall Study|Start of Disallowed Medication|0|||
163078701|NCT00089583|588995120|FG001|Overall Study|Start of Disallowed Medication|1|||
162645608|NCT03795298|587419414|FG001|Overall Study|Physician Decision|4|||
162645609|NCT03795298|587419413|FG000|Overall Study|Withdrawal by Subject|43|||
162645610|NCT03795298|587419414|FG001|Overall Study|Withdrawal by Subject|28|||
162645611|NCT03795298|587419413|FG000|Overall Study|Reason not reported|7|||
162645612|NCT03795298|587419414|FG001|Overall Study|Reason not reported|9|||
162645613|NCT03971695|587421241|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645614|NCT03971695|587421242|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
163078702|NCT00089583|588995119|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
163078703|NCT00089583|588995120|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
163078704|NCT00089583|588995119|FG000|Overall Study|Participant Incarcerated|0|||
163078705|NCT00089583|588995120|FG001|Overall Study|Participant Incarcerated|1|||
163078706|NCT01412983|588995121|FG000|1st Period|Ineligible|0|||
163078707|NCT01412983|588995122|FG001|1st Period|Ineligible|1|||
163078708|NCT01412983|588995121|FG000|1st Period|Positive slit lamp finding|0|||
163078709|NCT01412983|588995122|FG001|1st Period|Positive slit lamp finding|1|||
163078710|NCT01412983|588995121|FG000|1st Period|Unacceptable lens movement|0|||
163078711|NCT01412983|588995122|FG001|1st Period|Unacceptable lens movement|1|||
163078712|NCT01412983|588995121|FG000|1st Period|Inability to maintain wear|0|||
163078713|NCT01412983|588995122|FG001|1st Period|Inability to maintain wear|1|||
163078714|NCT02946996|588995123|FG000|Overall Study|non-evaluable|3|||
163078715|NCT02946996|588995124|FG001|Overall Study|non-evaluable|6|||
163078716|NCT02946996|588995125|FG002|Overall Study|non-evaluable|5|||
163078717|NCT00176254|588995126|FG000|Overall Study|Lost to Follow-up|1|||
163078718|NCT03289741|588995127|FG000|Overall Study|Adverse Event|1|||
163078719|NCT03289741|588995128|FG001|Overall Study|Adverse Event|1|||
163078720|NCT03289741|588995127|FG000|Overall Study|Physician Decision|2|||
163078721|NCT03289741|588995128|FG001|Overall Study|Physician Decision|2|||
163078722|NCT03289741|588995127|FG000|Overall Study|Withdrawal by Subject|1|||
163078723|NCT03289741|588995128|FG001|Overall Study|Withdrawal by Subject|0|||
163078724|NCT00992394|588995133|FG000|Overall Study|Lack of Efficacy|6|||
163078725|NCT00992394|588995134|FG001|Overall Study|Lack of Efficacy|3|||
163078726|NCT00992394|588995133|FG000|Overall Study|Adverse Event|4|||
163078727|NCT00992394|588995134|FG001|Overall Study|Adverse Event|5|||
163078728|NCT00992394|588995133|FG000|Overall Study|Withdrawal by Subject|8|||
163078729|NCT00992394|588995134|FG001|Overall Study|Withdrawal by Subject|2|||
163078730|NCT00992394|588995133|FG000|Overall Study|Physician Decision|1|||
163078731|NCT00992394|588995134|FG001|Overall Study|Physician Decision|0|||
163078732|NCT00992394|588995133|FG000|Overall Study|Protocol Violation|2|||
163078733|NCT00992394|588995134|FG001|Overall Study|Protocol Violation|4|||
163078734|NCT00992394|588995133|FG000|Overall Study|Lost to Follow-up|2|||
163078735|NCT00992394|588995134|FG001|Overall Study|Lost to Follow-up|0|||
163078736|NCT00992394|588995133|FG000|Overall Study|Other event|1|||
163078737|NCT00992394|588995134|FG001|Overall Study|Other event|0|||
163078738|NCT01245049|588995135|FG000|Overall Study|Migrated/moved from study area|0|||
163078739|NCT01245049|588995136|FG001|Overall Study|Migrated/moved from study area|1|||
163078740|NCT01245049|588995135|FG000|Overall Study|Withdrawal by Subject|0|||
163078741|NCT01245049|588995136|FG001|Overall Study|Withdrawal by Subject|1|||
163078742|NCT01245049|588995135|FG000|Overall Study|Lost to Follow-up|1|||
163078743|NCT01245049|588995136|FG001|Overall Study|Lost to Follow-up|2|||
163078744|NCT00450749|588995137|FG000|Overall Study|Withdrawal by Subject|0|||
163078745|NCT00450749|588995138|FG001|Overall Study|Withdrawal by Subject|0|||
163078746|NCT00450749|588995139|FG002|Overall Study|Withdrawal by Subject|2|||
163078747|NCT00450749|588995137|FG000|Overall Study|Noncompliant|0|||
163078748|NCT00450749|588995138|FG001|Overall Study|Noncompliant|1|||
163078749|NCT00450749|588995139|FG002|Overall Study|Noncompliant|0|||
163078750|NCT02568254|588995140|FG000|Period 2|Adverse Event|0|||
163078751|NCT02568254|588995141|FG001|Period 2|Adverse Event|0|||
163078752|NCT02568254|588995142|FG002|Period 2|Adverse Event|1|||
163078753|NCT02568254|588995143|FG003|Period 2|Adverse Event|0|||
163078754|NCT02568254|588995144|FG004|Period 2|Adverse Event|0|||
163078755|NCT02568254|588995145|FG005|Period 2|Adverse Event|0|||
163078756|NCT02568254|588995140|FG000|Period 3|Unstatisfactory Lens fitting|0|||
163078757|NCT02568254|588995141|FG001|Period 3|Unstatisfactory Lens fitting|0|||
163078758|NCT02568254|588995142|FG002|Period 3|Unstatisfactory Lens fitting|0|||
163078759|NCT02568254|588995143|FG003|Period 3|Unstatisfactory Lens fitting|0|||
163078760|NCT02568254|588995144|FG004|Period 3|Unstatisfactory Lens fitting|1|||
163078761|NCT02568254|588995145|FG005|Period 3|Unstatisfactory Lens fitting|0|||
163078762|NCT01197300|588996824|FG000|Overall Study|Lost to Follow-up|0|||
163078763|NCT01197300|588996825|FG001|Overall Study|Lost to Follow-up|1|||
163078764|NCT01197300|588996824|FG000|Overall Study|Protocol Violation|0|||
163078765|NCT01197300|588996825|FG001|Overall Study|Protocol Violation|1|||
163078766|NCT02113878|588996828|FG000|Overall Study|Adverse Event|1|||
163078767|NCT02113878|588996829|FG001|Overall Study|Adverse Event|0|||
163078768|NCT02113878|588996828|FG000|Overall Study|Withdrawal by Subject|1|||
163078769|NCT02113878|588996829|FG001|Overall Study|Withdrawal by Subject|0|||
163078770|NCT02113878|588996828|FG000|Overall Study|patient non-compliance|1|||
163078771|NCT02113878|588996829|FG001|Overall Study|patient non-compliance|0|||
163078772|NCT02255279|588996830|FG000|Overall Study|Lost to Follow-up|2|||
163078773|NCT02255279|588996831|FG001|Overall Study|Lost to Follow-up|2|||
163078774|NCT02255279|588996830|FG000|Overall Study|Protocol Violation|0|||
163078775|NCT02255279|588996831|FG001|Overall Study|Protocol Violation|1|||
163078776|NCT02255279|588996830|FG000|Overall Study|Withdrawal by Subject|3|||
163078777|NCT02255279|588996831|FG001|Overall Study|Withdrawal by Subject|6|||
163078778|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
163078779|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
163078780|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
163078781|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
163078782|NCT02144337|588996853|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
163078783|NCT02144337|588996854|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
163078784|NCT02144337|588996853|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
163078785|NCT02144337|588996854|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
163078786|NCT02144337|588996853|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
163078787|NCT02144337|588996854|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
163078788|NCT01052428|588996857|FG000|Overall Study|Death|1|||
163078789|NCT01052428|588996858|FG001|Overall Study|Death|0|||
163078790|NCT01052428|588996857|FG000|Overall Study|Withdrawal by Subject|0|||
163078791|NCT01052428|588996858|FG001|Overall Study|Withdrawal by Subject|1|||
163078792|NCT00871000|588996859|FG000|Overall Study|Withdrawal by Subject|1|||
163078793|NCT00871000|588996860|FG001|Overall Study|Withdrawal by Subject|0|||
163078794|NCT03400787|588996861|FG000|Overall Study|Lost to Follow-up|1|||
163078795|NCT03400787|588996862|FG001|Overall Study|Lost to Follow-up|0|||
163078796|NCT03400787|588996861|FG000|Overall Study|Death|1|||
163078797|NCT03400787|588996862|FG001|Overall Study|Death|0|||
163078798|NCT03400787|588996861|FG000|Overall Study|Protocol Violation|0|||
163078799|NCT03400787|588996862|FG001|Overall Study|Protocol Violation|2|||
163078800|NCT03400787|588996861|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
163078801|NCT03400787|588996862|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
163078802|NCT02402907|588996865|FG000|Overall Study|Delivered vaginally|9|||
163078803|NCT02402907|588996866|FG001|Overall Study|Delivered vaginally|3|||
163078804|NCT02402907|588996865|FG000|Overall Study|Delivered outside of Sinai|1|||
163078805|NCT02402907|588996866|FG001|Overall Study|Delivered outside of Sinai|1|||
163078806|NCT02402907|588996865|FG000|Overall Study|Lost to follow up after C-Section|10|||
163078807|NCT02402907|588996866|FG001|Overall Study|Lost to follow up after C-Section|23|||
163078808|NCT02837952|588996868|FG000|Overall Study|Adverse Event|0|||
163078809|NCT02837952|588996869|FG001|Overall Study|Adverse Event|1|||
163078810|NCT02837952|588996868|FG000|Overall Study|Withdrawal by Subject|4|||
163078811|NCT02837952|588996869|FG001|Overall Study|Withdrawal by Subject|5|||
163078812|NCT02837952|588996868|FG000|Overall Study|Medication Error|1|||
163078813|NCT02837952|588996869|FG001|Overall Study|Medication Error|0|||
163078814|NCT01959919|588996870|FG000|Overall Study|Did not meet the eligibility criteria|2|||
163078815|NCT03439072|588996871|FG000|Overall Study|Withdrawal by Subject|2|||
163078816|NCT03439072|588996872|FG001|Overall Study|Withdrawal by Subject|3|||
163078817|NCT03439072|588996871|FG000|Overall Study|Physician Decision|0|||
163078818|NCT03439072|588996872|FG001|Overall Study|Physician Decision|1|||
163078819|NCT02003898|588996874|FG000|Overall Study|Death|3|||
163078820|NCT02003898|588996874|FG000|Overall Study|Lost to Follow-up|12|||
163078821|NCT02003898|588996874|FG000|Overall Study|Withdrawal by Subject|52|||
163078822|NCT00128492|588996875|FG000|Overall Study|AE unrelated to study|2|||
163078823|NCT00128492|588996876|FG001|Overall Study|AE unrelated to study|9|||
163078824|NCT00128492|588996875|FG000|Overall Study|Study drug intolerance (AE)|2|||
163078825|NCT00128492|588996876|FG001|Overall Study|Study drug intolerance (AE)|8|||
163078826|NCT00128492|588996875|FG000|Overall Study|AE related to study|1|||
163078827|NCT00128492|588996876|FG001|Overall Study|AE related to study|4|||
163078828|NCT00128492|588996875|FG000|Overall Study|Death|1|||
163078829|NCT00128492|588996876|FG001|Overall Study|Death|0|||
163078830|NCT00128492|588996875|FG000|Overall Study|Lost to Follow-up|1|||
163078831|NCT00128492|588996876|FG001|Overall Study|Lost to Follow-up|5|||
163078832|NCT00128492|588996875|FG000|Overall Study|Noncompliance|0|||
163078833|NCT00128492|588996876|FG001|Overall Study|Noncompliance|5|||
163078834|NCT00128492|588996875|FG000|Overall Study|Personal or administrative|10|||
163078835|NCT00128492|588996876|FG001|Overall Study|Personal or administrative|22|||
163078836|NCT00128492|588996875|FG000|Overall Study|Withdrawal by Subject|3|||
163078837|NCT00128492|588996876|FG001|Overall Study|Withdrawal by Subject|5|||
163078838|NCT00128492|588996875|FG000|Overall Study|Pregnancy|0|||
163078839|NCT00128492|588996876|FG001|Overall Study|Pregnancy|1|||
163078840|NCT03436420|588996877|FG000|Overall Study|Lack of Efficacy|3|||
163078841|NCT00756314|588996878|FG000|Overall Study|Lost to Follow-up|2|||
163078842|NCT00756314|588996879|FG001|Overall Study|Lost to Follow-up|59|||
163078843|NCT02605967|588996880|FG000|Overall Study|subject / guardian decision|1|||
163078844|NCT02605967|588996881|FG001|Overall Study|subject / guardian decision|2|||
163078845|NCT02605967|588996880|FG000|Overall Study|Physician Decision|10|||
163078846|NCT02605967|588996881|FG001|Overall Study|Physician Decision|1|||
163078847|NCT02605967|588996880|FG000|Overall Study|Death|4|||
163078848|NCT02605967|588996881|FG001|Overall Study|Death|2|||
163078849|NCT02605967|588996880|FG000|Overall Study|Adverse Event|1|||
163078850|NCT02605967|588996881|FG001|Overall Study|Adverse Event|0|||
163078851|NCT02605967|588996880|FG000|Overall Study|progressive disease|66|||
163078852|NCT02605967|588996881|FG001|Overall Study|progressive disease|35|||
163078853|NCT03627468|588996882|FG000|Overall Study|Adverse Event|5|||
163078854|NCT03627468|588996883|FG001|Overall Study|Adverse Event|33|||
163078855|NCT03627468|588996882|FG000|Overall Study|Withdrawal by Subject|13|||
163078856|NCT03627468|588996883|FG001|Overall Study|Withdrawal by Subject|23|||
163078857|NCT03627468|588996882|FG000|Overall Study|Physician Decision|1|||
163078858|NCT03627468|588996883|FG001|Overall Study|Physician Decision|0|||
163078859|NCT03627468|588996882|FG000|Overall Study|Protocol Violation|0|||
163078860|NCT03627468|588996883|FG001|Overall Study|Protocol Violation|2|||
163078861|NCT03627468|588996882|FG000|Overall Study|Lost to Follow-up|10|||
163078862|NCT03627468|588996883|FG001|Overall Study|Lost to Follow-up|16|||
163078863|NCT03627468|588996882|FG000|Overall Study|Death|1|||
163078864|NCT03627468|588996883|FG001|Overall Study|Death|0|||
163078865|NCT03627468|588996882|FG000|Overall Study|Pregnancy|1|||
163078866|NCT03627468|588996883|FG001|Overall Study|Pregnancy|1|||
163078867|NCT03627468|588996882|FG000|Overall Study|Lack of Efficacy|0|||
163078868|NCT03627468|588996883|FG001|Overall Study|Lack of Efficacy|2|||
163078869|NCT03627468|588996882|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
163078870|NCT03627468|588996883|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
163078871|NCT01475825|588996887|FG000|Overall Study|Adverse Event|41|||
163078872|NCT01475825|588996888|FG001|Overall Study|Adverse Event|15|||
163078873|NCT01475825|588996889|FG002|Overall Study|Adverse Event|27|||
163078874|NCT01475825|588996890|FG003|Overall Study|Adverse Event|11|||
162645615|NCT03971695|587421243|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645616|NCT03971695|587421244|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
162645617|NCT03971695|587421245|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
162645618|NCT03971695|587421246|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645619|NCT03971695|587421247|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645620|NCT03971695|587421248|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645621|NCT03971695|587421249|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
162645622|NCT03971695|587421250|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162645623|NCT03971695|587421251|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162645624|NCT03971695|587421252|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162645625|NCT03971695|587421253|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162645626|NCT00156533|587421254|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
162645627|NCT00156533|587421255|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
162645628|NCT00156533|587421256|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
162645629|NCT00156533|587421257|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
162645630|NCT00156533|587421254|FG000|Overall Study|Withdrawal by Subject|1|||
162645631|NCT00156533|587421255|FG001|Overall Study|Withdrawal by Subject|0|||
162645632|NCT00156533|587421256|FG002|Overall Study|Withdrawal by Subject|0|||
162645633|NCT00156533|587421257|FG003|Overall Study|Withdrawal by Subject|1|||
162645634|NCT00156533|587421254|FG000|Overall Study|Failed Screening|1|||
162645635|NCT00156533|587421255|FG001|Overall Study|Failed Screening|0|||
162645636|NCT00156533|587421256|FG002|Overall Study|Failed Screening|1|||
162645637|NCT00156533|587421257|FG003|Overall Study|Failed Screening|1|||
162645638|NCT01881230|587421258|FG000|Overall Study|Death|2|||
162645639|NCT01881230|587421259|FG001|Overall Study|Death|0|||
162645640|NCT01881230|587421260|FG002|Overall Study|Death|1|||
162645641|NCT01881230|587421258|FG000|Overall Study|Adverse Event|9|||
163029351|NCT02484651|588810424|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
163029352|NCT01698879|588810425|FG000|Overall Study|Withdrawal by Subject|1|||
163029353|NCT01698879|588810426|FG001|Overall Study|Withdrawal by Subject|0|||
163029354|NCT01698879|588810427|FG002|Overall Study|Withdrawal by Subject|0|||
163029355|NCT04972968|588810428|FG000|Overall Study|Adverse Event|3|||
163029356|NCT04972968|588810429|FG001|Overall Study|Adverse Event|1|||
163029357|NCT04972968|588810430|FG002|Overall Study|Adverse Event|1|||
163029358|NCT04972968|588810431|FG003|Overall Study|Adverse Event|7|||
163029359|NCT04972968|588810428|FG000|Overall Study|Lack of Efficacy|2|||
163029360|NCT04972968|588810429|FG001|Overall Study|Lack of Efficacy|1|||
163029361|NCT04972968|588810430|FG002|Overall Study|Lack of Efficacy|0|||
163029362|NCT04972968|588810431|FG003|Overall Study|Lack of Efficacy|0|||
163029363|NCT04972968|588810428|FG000|Overall Study|Withdrawal by Subject|7|||
163029364|NCT04972968|588810429|FG001|Overall Study|Withdrawal by Subject|4|||
163029365|NCT04972968|588810430|FG002|Overall Study|Withdrawal by Subject|3|||
163029366|NCT04972968|588810431|FG003|Overall Study|Withdrawal by Subject|2|||
163029367|NCT04972968|588810428|FG000|Overall Study|Study Terminated by Sponsor|25|||
163029368|NCT04972968|588810429|FG001|Overall Study|Study Terminated by Sponsor|28|||
163029369|NCT04972968|588810430|FG002|Overall Study|Study Terminated by Sponsor|32|||
163029370|NCT04972968|588810431|FG003|Overall Study|Study Terminated by Sponsor|27|||
163029371|NCT04972968|588810428|FG000|Overall Study|Other|1|||
163029372|NCT04972968|588810429|FG001|Overall Study|Other|0|||
163029373|NCT04972968|588810430|FG002|Overall Study|Other|1|||
163029374|NCT04972968|588810431|FG003|Overall Study|Other|1|||
163029375|NCT00150800|588810432|FG000|Overall Study|Adverse Event|89|||
163029376|NCT00150800|588810432|FG000|Overall Study|Death|18|||
163029377|NCT00150800|588810432|FG000|Overall Study|Lack of Efficacy|166|||
163029378|NCT00150800|588810432|FG000|Overall Study|Lost to Follow-up|58|||
163029379|NCT00150800|588810432|FG000|Overall Study|Subject's choice|90|||
163029380|NCT00150800|588810432|FG000|Overall Study|No compliance|18|||
163029381|NCT00150800|588810432|FG000|Overall Study|IP misshandling|1|||
163029382|NCT00150800|588810432|FG000|Overall Study|Site closure|24|||
163029383|NCT00150800|588810432|FG000|Overall Study|Protocol non-adherence|2|||
163029384|NCT00150800|588810432|FG000|Overall Study|Nobody to accompany patient|1|||
163029385|NCT00150800|588810432|FG000|Overall Study|Distance too long for patient|1|||
163029386|NCT00150800|588810432|FG000|Overall Study|Neurosurgery|2|||
163029387|NCT00150800|588810432|FG000|Overall Study|BRV monotherapy|1|||
163029388|NCT00150800|588810432|FG000|Overall Study|Visit refusal|3|||
162645642|NCT01881230|587421259|FG001|Overall Study|Adverse Event|13|||
162645643|NCT01881230|587421260|FG002|Overall Study|Adverse Event|12|||
163029389|NCT00150800|588810432|FG000|Overall Study|Sponsor's request|2|||
163029390|NCT00150800|588810432|FG000|Overall Study|Generalized Epilepsy|1|||
163029391|NCT00150800|588810432|FG000|Overall Study|Moved from area/country|8|||
163029392|NCT00150800|588810432|FG000|Overall Study|PI retiring|2|||
163029393|NCT00150800|588810432|FG000|Overall Study|PI leaving site|2|||
163029394|NCT00150800|588810432|FG000|Overall Study|Patient insurance|1|||
163029395|NCT00150800|588810432|FG000|Overall Study|Surgical intervention|4|||
162645644|NCT01881230|587421258|FG000|Overall Study|Progressive Disease|31|||
162645645|NCT01881230|587421259|FG001|Overall Study|Progressive Disease|35|||
162645646|NCT01881230|587421260|FG002|Overall Study|Progressive Disease|36|||
163078875|NCT01475825|588996887|FG000|Overall Study|Death|1|||
163078876|NCT01475825|588996888|FG001|Overall Study|Death|0|||
163078877|NCT01475825|588996889|FG002|Overall Study|Death|1|||
163078878|NCT01475825|588996890|FG003|Overall Study|Death|0|||
163078879|NCT01475825|588996887|FG000|Overall Study|Lack of Efficacy|0|||
163078880|NCT01475825|588996888|FG001|Overall Study|Lack of Efficacy|0|||
163078881|NCT01475825|588996889|FG002|Overall Study|Lack of Efficacy|1|||
163078882|NCT01475825|588996890|FG003|Overall Study|Lack of Efficacy|0|||
163078883|NCT01475825|588996887|FG000|Overall Study|Lost to Follow-up|0|||
163078884|NCT01475825|588996888|FG001|Overall Study|Lost to Follow-up|0|||
163078885|NCT01475825|588996889|FG002|Overall Study|Lost to Follow-up|3|||
163078886|NCT01475825|588996890|FG003|Overall Study|Lost to Follow-up|1|||
163078887|NCT01475825|588996887|FG000|Overall Study|Non-compliance with Study Drug|1|||
163078888|NCT01475825|588996888|FG001|Overall Study|Non-compliance with Study Drug|2|||
163078889|NCT01475825|588996889|FG002|Overall Study|Non-compliance with Study Drug|4|||
163078890|NCT01475825|588996890|FG003|Overall Study|Non-compliance with Study Drug|0|||
163078891|NCT01475825|588996887|FG000|Overall Study|Other: Not available|0|||
163078892|NCT01475825|588996888|FG001|Overall Study|Other: Not available|0|||
163078893|NCT01475825|588996889|FG002|Overall Study|Other: Not available|2|||
163078894|NCT01475825|588996890|FG003|Overall Study|Other: Not available|0|||
163078895|NCT01475825|588996887|FG000|Overall Study|Protocol Violation|1|||
163078896|NCT01475825|588996888|FG001|Overall Study|Protocol Violation|0|||
163078897|NCT01475825|588996889|FG002|Overall Study|Protocol Violation|0|||
163078898|NCT01475825|588996890|FG003|Overall Study|Protocol Violation|0|||
163078899|NCT01475825|588996887|FG000|Overall Study|Physician Decision|0|||
163078900|NCT01475825|588996888|FG001|Overall Study|Physician Decision|1|||
163078901|NCT01475825|588996889|FG002|Overall Study|Physician Decision|0|||
163078902|NCT01475825|588996890|FG003|Overall Study|Physician Decision|0|||
163078903|NCT01475825|588996887|FG000|Overall Study|Withdrawal by Subject|8|||
163078904|NCT01475825|588996888|FG001|Overall Study|Withdrawal by Subject|3|||
163078905|NCT01475825|588996889|FG002|Overall Study|Withdrawal by Subject|11|||
163078906|NCT01475825|588996890|FG003|Overall Study|Withdrawal by Subject|7|||
163078907|NCT01475825|588996887|FG000|Overall Study|Did not enter OLC|15|||
163078908|NCT01475825|588996888|FG001|Overall Study|Did not enter OLC|11|||
163078909|NCT01475825|588996889|FG002|Overall Study|Did not enter OLC|15|||
163078910|NCT01475825|588996890|FG003|Overall Study|Did not enter OLC|11|||
163078911|NCT01903733|588996893|FG000|Overall Study|Death|23|||
163078912|NCT01903733|588996894|FG001|Overall Study|Death|54|||
163078913|NCT01903733|588996895|FG002|Overall Study|Death|30|||
163078914|NCT01903733|588996896|FG003|Overall Study|Death|98|||
163078915|NCT01903733|588996893|FG000|Overall Study|Participant refused further follow-up|35|||
163078916|NCT01903733|588996894|FG001|Overall Study|Participant refused further follow-up|38|||
163078917|NCT01903733|588996895|FG002|Overall Study|Participant refused further follow-up|13|||
163078918|NCT01903733|588996896|FG003|Overall Study|Participant refused further follow-up|9|||
163078919|NCT01903733|588996893|FG000|Overall Study|Lost to Follow-up|18|||
163078920|NCT01903733|588996894|FG001|Overall Study|Lost to Follow-up|19|||
163078921|NCT01903733|588996895|FG002|Overall Study|Lost to Follow-up|6|||
163078922|NCT01903733|588996896|FG003|Overall Study|Lost to Follow-up|9|||
163078923|NCT01903733|588996893|FG000|Overall Study|Other|10|||
163078924|NCT01903733|588996894|FG001|Overall Study|Other|15|||
163078925|NCT01903733|588996895|FG002|Overall Study|Other|12|||
163078926|NCT01903733|588996896|FG003|Overall Study|Other|3|||
163078927|NCT01903733|588996893|FG000|Overall Study|Missing|2|||
163078928|NCT01903733|588996894|FG001|Overall Study|Missing|0|||
162645647|NCT01881230|587421258|FG000|Overall Study|Symptomatic Deterioration|3|||
162645648|NCT01881230|587421259|FG001|Overall Study|Symptomatic Deterioration|3|||
162645649|NCT01881230|587421260|FG002|Overall Study|Symptomatic Deterioration|1|||
163078929|NCT01903733|588996895|FG002|Overall Study|Missing|0|||
163078930|NCT01903733|588996896|FG003|Overall Study|Missing|0|||
163078931|NCT01903733|588996893|FG000|Overall Study|Investigator request|18|||
163078932|NCT01903733|588996894|FG001|Overall Study|Investigator request|0|||
163078933|NCT01903733|588996895|FG002|Overall Study|Investigator request|0|||
163078934|NCT01903733|588996896|FG003|Overall Study|Investigator request|0|||
163078935|NCT03721107|588996899|FG000|Overall Study|Adverse Event|1|||
163078936|NCT03721107|588996900|FG001|Overall Study|Adverse Event|1|||
163078937|NCT03721107|588996901|FG002|Overall Study|Adverse Event|6|||
163078938|NCT03721107|588996902|FG003|Overall Study|Adverse Event|5|||
162645650|NCT01881230|587421258|FG000|Overall Study|Withdrawal by Subject|6|||
163078939|NCT03721107|588996899|FG000|Overall Study|Lost to Follow-up|2|||
162645651|NCT01881230|587421259|FG001|Overall Study|Withdrawal by Subject|4|||
162645652|NCT01881230|587421260|FG002|Overall Study|Withdrawal by Subject|6|||
163078940|NCT03721107|588996900|FG001|Overall Study|Lost to Follow-up|0|||
163078941|NCT03721107|588996901|FG002|Overall Study|Lost to Follow-up|3|||
163078942|NCT03721107|588996902|FG003|Overall Study|Lost to Follow-up|0|||
163078943|NCT03721107|588996899|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
163078944|NCT03721107|588996900|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
162645653|NCT01881230|587421258|FG000|Overall Study|Physician Decision|4|||
162645654|NCT01881230|587421259|FG001|Overall Study|Physician Decision|3|||
162645655|NCT01881230|587421260|FG002|Overall Study|Physician Decision|6|||
162645656|NCT01881230|587421258|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162645657|NCT01881230|587421259|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162645658|NCT01881230|587421260|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162645659|NCT01881230|587421258|FG000|Overall Study|Given Commercially Available Drug|0|||
163029396|NCT00150800|588810432|FG000|Overall Study|Pregnancy planned|1|||
163029397|NCT00150800|588810432|FG000|Overall Study|PI discontinuation request|1|||
163029398|NCT03649178|588810433|FG000|Overall Study|Adverse Event|1|||
163029399|NCT03649178|588810434|FG001|Overall Study|Adverse Event|2|||
163029400|NCT03649178|588810433|FG000|Overall Study|Withdrawal by Subject|0|||
163029401|NCT03649178|588810434|FG001|Overall Study|Withdrawal by Subject|2|||
163029402|NCT03649178|588810433|FG000|Overall Study|COVID regulation required halt in protocol|1|||
163029403|NCT03649178|588810434|FG001|Overall Study|COVID regulation required halt in protocol|0|||
163029404|NCT03619902|588810436|FG000|Overall Study|Termination of Study by Investigator|1|||
163029405|NCT03619902|588810436|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
163029406|NCT00794040|588810440|FG000|Overall Study|Withdrawal by Subject|3|||
163029407|NCT00794040|588810441|FG001|Overall Study|Withdrawal by Subject|4|||
163029408|NCT00794040|588810440|FG000|Overall Study|Physician Decision|0|||
163029409|NCT00794040|588810441|FG001|Overall Study|Physician Decision|1|||
163029410|NCT04687072|588810442|FG000|Overall Study|Adverse Event|2|||
163029411|NCT04687072|588810443|FG001|Overall Study|Adverse Event|0|||
163029412|NCT04687072|588810442|FG000|Overall Study|Death|1|||
163029413|NCT04687072|588810443|FG001|Overall Study|Death|0|||
163029414|NCT04687072|588810442|FG000|Overall Study|Lack of Efficacy|2|||
163029415|NCT04687072|588810443|FG001|Overall Study|Lack of Efficacy|1|||
163029416|NCT04687072|588810442|FG000|Overall Study|Physician Decision|1|||
163029417|NCT04687072|588810443|FG001|Overall Study|Physician Decision|0|||
163029418|NCT04687072|588810442|FG000|Overall Study|Pregnancy|1|||
163029419|NCT04687072|588810443|FG001|Overall Study|Pregnancy|0|||
163029420|NCT04687072|588810442|FG000|Overall Study|Requires Prohibited Medication|2|||
163029421|NCT04687072|588810443|FG001|Overall Study|Requires Prohibited Medication|0|||
163029422|NCT04687072|588810442|FG000|Overall Study|Withdrawal of Consent|11|||
163029423|NCT04687072|588810443|FG001|Overall Study|Withdrawal of Consent|6|||
163029424|NCT04687072|588810442|FG000|Overall Study|Miscellaneous|4|||
163029425|NCT04687072|588810443|FG001|Overall Study|Miscellaneous|1|||
163029426|NCT01263782|588810444|FG000|Overall Study|Death|0|||
163029427|NCT01263782|588810445|FG001|Overall Study|Death|0|||
163029428|NCT01263782|588810446|FG002|Overall Study|Death|1|||
163029429|NCT01263782|588810447|FG003|Overall Study|Death|0|||
163029430|NCT01263782|588810444|FG000|Overall Study|Progressive disease|0|||
163029431|NCT01263782|588810445|FG001|Overall Study|Progressive disease|0|||
163029432|NCT01263782|588810446|FG002|Overall Study|Progressive disease|0|||
163029433|NCT01263782|588810447|FG003|Overall Study|Progressive disease|1|||
163029434|NCT01263782|588810444|FG000|Overall Study|Too early|0|||
163029435|NCT01263782|588810445|FG001|Overall Study|Too early|0|||
163029436|NCT01263782|588810446|FG002|Overall Study|Too early|1|||
163029437|NCT01263782|588810447|FG003|Overall Study|Too early|0|||
163029438|NCT01263782|588810444|FG000|Overall Study|Inevaluable|0|||
163029439|NCT01263782|588810445|FG001|Overall Study|Inevaluable|0|||
163029440|NCT01263782|588810446|FG002|Overall Study|Inevaluable|1|||
163029441|NCT01263782|588810447|FG003|Overall Study|Inevaluable|0|||
163029442|NCT04545567|588810449|FG000|Overall Study|tested positive for SARS-co-V2|1|||
163029443|NCT04545567|588810450|FG001|Overall Study|tested positive for SARS-co-V2|1|||
163029444|NCT04545567|588810449|FG000|Overall Study|Withdrawal by Subject|0|||
163029445|NCT04545567|588810450|FG001|Overall Study|Withdrawal by Subject|1|||
163029446|NCT03626363|588810456|FG000|Overall Study|Protocol Violation|4|||
163029447|NCT03626363|588810457|FG001|Overall Study|Protocol Violation|0|||
163029448|NCT03626363|588810456|FG000|Overall Study|Lost to Follow-up|5|||
163029449|NCT03626363|588810457|FG001|Overall Study|Lost to Follow-up|7|||
163029450|NCT00965341|588810461|FG000|Overall Study|Withdrew consent|1|||
163029451|NCT00965341|588810462|FG001|Overall Study|Withdrew consent|5|||
163029452|NCT00965341|588810461|FG000|Overall Study|Lost to Follow-up|1|||
163029453|NCT00965341|588810462|FG001|Overall Study|Lost to Follow-up|0|||
163029454|NCT00965341|588810461|FG000|Overall Study|Transportation issues|4|||
163029455|NCT00965341|588810462|FG001|Overall Study|Transportation issues|3|||
163029456|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
163029457|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
163029458|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
163029459|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
163029460|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
163029461|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
163029462|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
163029463|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
163078945|NCT03721107|588996901|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
163078946|NCT03721107|588996902|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
163078947|NCT03721107|588996899|FG000|Overall Study|Physician Decision|0|||
163078948|NCT03721107|588996900|FG001|Overall Study|Physician Decision|1|||
163078949|NCT03721107|588996901|FG002|Overall Study|Physician Decision|0|||
163078950|NCT03721107|588996902|FG003|Overall Study|Physician Decision|0|||
163078951|NCT03721107|588996899|FG000|Overall Study|Pregnancy|0|||
163078952|NCT03721107|588996900|FG001|Overall Study|Pregnancy|0|||
163078953|NCT03721107|588996901|FG002|Overall Study|Pregnancy|1|||
163078954|NCT03721107|588996902|FG003|Overall Study|Pregnancy|0|||
163078955|NCT03721107|588996899|FG000|Overall Study|Withdrawal by Subject|1|||
163078956|NCT03721107|588996900|FG001|Overall Study|Withdrawal by Subject|1|||
163078957|NCT03721107|588996901|FG002|Overall Study|Withdrawal by Subject|5|||
163078958|NCT03721107|588996902|FG003|Overall Study|Withdrawal by Subject|5|||
163078959|NCT03721107|588996899|FG000|Overall Study|Other|1|||
163078960|NCT03721107|588996900|FG001|Overall Study|Other|0|||
163078961|NCT03721107|588996901|FG002|Overall Study|Other|0|||
163078962|NCT03721107|588996902|FG003|Overall Study|Other|1|||
163078963|NCT02991859|588996908|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078964|NCT02991859|588996909|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
163078965|NCT02991859|588996910|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078966|NCT02991859|588996911|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078967|NCT02991859|588996912|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
163078968|NCT02991859|588996913|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078969|NCT02991859|588996914|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078970|NCT02991859|588996915|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078971|NCT02991859|588996916|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078972|NCT02991859|588996917|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078973|NCT02991859|588996918|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078974|NCT02991859|588996919|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078975|NCT02991859|588996920|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078976|NCT02991859|588996921|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078977|NCT02991859|588996922|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078978|NCT02991859|588996923|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078979|NCT02991859|588996924|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
163078980|NCT02991859|588996908|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078981|NCT02991859|588996909|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078982|NCT02991859|588996910|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078983|NCT02991859|588996911|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078984|NCT02991859|588996912|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078985|NCT02991859|588996913|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078986|NCT02991859|588996914|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078987|NCT02991859|588996915|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078988|NCT02991859|588996916|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078989|NCT02991859|588996917|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078990|NCT02991859|588996918|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078991|NCT02991859|588996919|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078992|NCT02991859|588996920|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
163078993|NCT02991859|588996921|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
163078994|NCT02991859|588996922|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078995|NCT02991859|588996923|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
163078996|NCT02991859|588996924|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
162645660|NCT01881230|587421259|FG001|Overall Study|Given Commercially Available Drug|0|||
162645661|NCT01881230|587421260|FG002|Overall Study|Given Commercially Available Drug|2|||
162645662|NCT01881230|587421258|FG000|Overall Study|Protocol Violation|1|||
162645663|NCT01881230|587421259|FG001|Overall Study|Protocol Violation|1|||
162645664|NCT01881230|587421260|FG002|Overall Study|Protocol Violation|0|||
162645665|NCT01881230|587421258|FG000|Overall Study|Miscellaneous|3|||
162645666|NCT01881230|587421259|FG001|Overall Study|Miscellaneous|3|||
162645667|NCT01881230|587421260|FG002|Overall Study|Miscellaneous|0|||
162645668|NCT01881230|587421258|FG000|Overall Study|Untreated: Other|0|||
162717905|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
162717906|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
163078997|NCT02991859|588996908|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163078998|NCT02991859|588996909|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163078999|NCT02991859|588996910|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079000|NCT02991859|588996911|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
162645669|NCT01881230|587421259|FG001|Overall Study|Untreated: Other|0|||
162645670|NCT01881230|587421260|FG002|Overall Study|Untreated: Other|1|||
162645671|NCT01881230|587421258|FG000|Overall Study|Untreated: Death|0|||
162645672|NCT01881230|587421259|FG001|Overall Study|Untreated: Death|0|||
162645673|NCT01881230|587421260|FG002|Overall Study|Untreated: Death|1|||
162645674|NCT01881230|587421258|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
162645675|NCT01881230|587421259|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
163079001|NCT02991859|588996912|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079002|NCT02991859|588996913|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
163079003|NCT02991859|588996914|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079004|NCT02991859|588996915|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079005|NCT02991859|588996916|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079006|NCT02991859|588996917|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079007|NCT02991859|588996918|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079008|NCT02991859|588996919|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079009|NCT02991859|588996920|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079010|NCT02991859|588996921|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079011|NCT02991859|588996922|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079012|NCT02991859|588996923|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079013|NCT02991859|588996924|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
163079014|NCT02991859|588996908|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079015|NCT02991859|588996909|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079016|NCT02991859|588996910|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079017|NCT02991859|588996911|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079018|NCT02991859|588996912|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079019|NCT02991859|588996913|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079020|NCT02991859|588996914|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079021|NCT02991859|588996915|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079022|NCT02991859|588996916|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079023|NCT02991859|588996917|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
163079024|NCT02991859|588996918|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079025|NCT02991859|588996919|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079026|NCT02991859|588996920|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079027|NCT02991859|588996921|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079028|NCT02991859|588996922|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079029|NCT02991859|588996923|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079030|NCT02991859|588996924|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163079031|NCT02991859|588996908|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
162645676|NCT01881230|587421260|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
162645677|NCT02747420|587421261|FG000|Overall Study|Lost to Follow-up|4|||
162645678|NCT02747420|587421262|FG001|Overall Study|Lost to Follow-up|2|||
162645679|NCT02747420|587421261|FG000|Overall Study|Withdrawal by Subject|3|||
162645680|NCT02747420|587421262|FG001|Overall Study|Withdrawal by Subject|2|||
163029464|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
163029465|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029466|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029467|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
163029468|NCT00960986|588810463|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163029469|NCT00960986|588810464|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
163029470|NCT00960986|588810465|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163029471|NCT00960986|588810466|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
163079032|NCT02991859|588996909|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079033|NCT02991859|588996910|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079034|NCT02991859|588996911|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079035|NCT02991859|588996912|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079036|NCT02991859|588996913|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079037|NCT02991859|588996914|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079038|NCT02991859|588996915|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079039|NCT02991859|588996916|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
163079040|NCT02991859|588996917|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079041|NCT02991859|588996918|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079042|NCT02991859|588996919|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079043|NCT02991859|588996920|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079044|NCT02991859|588996921|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079045|NCT02991859|588996922|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079046|NCT02991859|588996923|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
162645681|NCT05129488|587421263|FG000|Overall Study|Protocol Violation|3|||
163079047|NCT02991859|588996924|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
163079048|NCT00425854|588996932|FG000|Overall Study|Progressive Disease|19|||
163079049|NCT00425854|588996933|FG001|Overall Study|Progressive Disease|12|||
163079050|NCT00425854|588996932|FG000|Overall Study|Dose reduction toxicity AE|8|||
163079051|NCT00425854|588996933|FG001|Overall Study|Dose reduction toxicity AE|7|||
163079052|NCT00425854|588996932|FG000|Overall Study|Other Adverse Event|2|||
163079053|NCT00425854|588996933|FG001|Overall Study|Other Adverse Event|2|||
163079054|NCT01630811|588996934|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163079055|NCT01630811|588996935|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163079056|NCT01725308|588996938|FG000|Treatment Period I|Did Not Receive Drug|1|||
163079057|NCT01725308|588996939|FG001|Treatment Period I|Did Not Receive Drug|0|||
163079058|NCT01725308|588996940|FG002|Treatment Period I|Did Not Receive Drug|0|||
163079059|NCT01725308|588996938|FG000|Treatment Period I|Adverse Event|5|||
163079060|NCT01725308|588996939|FG001|Treatment Period I|Adverse Event|4|||
163079061|NCT01725308|588996940|FG002|Treatment Period I|Adverse Event|21|||
163079062|NCT01725308|588996938|FG000|Treatment Period I|Insufficient Response|7|||
163079063|NCT01725308|588996939|FG001|Treatment Period I|Insufficient Response|0|||
163079064|NCT01725308|588996940|FG002|Treatment Period I|Insufficient Response|5|||
163079065|NCT01725308|588996938|FG000|Treatment Period I|Worsening of the Target Disease|8|||
163079066|NCT01725308|588996939|FG001|Treatment Period I|Worsening of the Target Disease|0|||
163079067|NCT01725308|588996940|FG002|Treatment Period I|Worsening of the Target Disease|2|||
163079068|NCT01725308|588996938|FG000|Treatment Period I|Changes in the Episodes|3|||
163079069|NCT01725308|588996939|FG001|Treatment Period I|Changes in the Episodes|0|||
163079070|NCT01725308|588996940|FG002|Treatment Period I|Changes in the Episodes|2|||
163079071|NCT01725308|588996938|FG000|Treatment Period I|Withdrawal of Consent|12|||
163079072|NCT01725308|588996939|FG001|Treatment Period I|Withdrawal of Consent|7|||
163079073|NCT01725308|588996940|FG002|Treatment Period I|Withdrawal of Consent|5|||
163079074|NCT01725308|588996938|FG000|Treatment Period I|Lost to Follow-up|3|||
163079075|NCT01725308|588996939|FG001|Treatment Period I|Lost to Follow-up|2|||
163079076|NCT01725308|588996940|FG002|Treatment Period I|Lost to Follow-up|2|||
163079077|NCT01725308|588996938|FG000|Treatment Period I|Protocol Deviations|3|||
163079078|NCT01725308|588996939|FG001|Treatment Period I|Protocol Deviations|1|||
163079079|NCT01725308|588996940|FG002|Treatment Period I|Protocol Deviations|1|||
163079080|NCT01725308|588996938|FG000|Treatment Period I|Miscellaneous|2|||
163079081|NCT01725308|588996939|FG001|Treatment Period I|Miscellaneous|0|||
163079082|NCT01725308|588996940|FG002|Treatment Period I|Miscellaneous|3|||
163079083|NCT01725308|588996938|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
163079084|NCT01725308|588996939|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
163079085|NCT01725308|588996940|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
163079086|NCT01725308|588996938|FG000|Treatment Period II|Did Not Receive Drug|4|||
163079087|NCT01725308|588996939|FG001|Treatment Period II|Did Not Receive Drug|0|||
163079088|NCT01725308|588996940|FG002|Treatment Period II|Did Not Receive Drug|0|||
162645682|NCT04307446|587421264|FG000|Overall Study|Lost to Follow-up|2|||
162645683|NCT04307446|587421265|FG001|Overall Study|Lost to Follow-up|0|||
163079089|NCT01725308|588996938|FG000|Treatment Period II|Adverse Event|13|||
163079090|NCT01725308|588996939|FG001|Treatment Period II|Adverse Event|8|||
163079091|NCT01725308|588996940|FG002|Treatment Period II|Adverse Event|20|||
162645684|NCT02515942|587421266|FG000|Overall Study|Adverse Event|5|||
162645685|NCT02515942|587421267|FG001|Overall Study|Adverse Event|0|||
162645686|NCT02515942|587421268|FG002|Overall Study|Adverse Event|0|||
162645687|NCT02515942|587421266|FG000|Overall Study|Death|0|||
162645688|NCT02515942|587421267|FG001|Overall Study|Death|0|||
162645689|NCT02515942|587421268|FG002|Overall Study|Death|1|||
162645690|NCT02515942|587421266|FG000|Overall Study|Lack of Efficacy|0|||
163079092|NCT01725308|588996938|FG000|Treatment Period II|Insufficient Response|2|||
163079093|NCT01725308|588996939|FG001|Treatment Period II|Insufficient Response|4|||
163079094|NCT01725308|588996940|FG002|Treatment Period II|Insufficient Response|6|||
163079095|NCT01725308|588996938|FG000|Treatment Period II|Worsening of the Target Disease|1|||
163079096|NCT01725308|588996939|FG001|Treatment Period II|Worsening of the Target Disease|4|||
162645691|NCT02515942|587421267|FG001|Overall Study|Lack of Efficacy|0|||
162645692|NCT02515942|587421268|FG002|Overall Study|Lack of Efficacy|1|||
162645693|NCT02515942|587421266|FG000|Overall Study|Lost to Follow-up|2|||
162645694|NCT02515942|587421267|FG001|Overall Study|Lost to Follow-up|0|||
162645695|NCT02515942|587421268|FG002|Overall Study|Lost to Follow-up|0|||
162645696|NCT02515942|587421266|FG000|Overall Study|Withdrawal by Subject|0|||
162645697|NCT02515942|587421267|FG001|Overall Study|Withdrawal by Subject|3|||
162645698|NCT02515942|587421268|FG002|Overall Study|Withdrawal by Subject|2|||
162645699|NCT05620576|587421269|FG000|Overall Study|Adverse Event|1|||
162645700|NCT05620576|587421270|FG001|Overall Study|Adverse Event|1|||
162645701|NCT05620576|587421269|FG000|Overall Study|Lost to Follow-up|3|||
162645702|NCT05620576|587421270|FG001|Overall Study|Lost to Follow-up|1|||
162645703|NCT05620576|587421269|FG000|Overall Study|Physician Decision|0|||
162645704|NCT05620576|587421270|FG001|Overall Study|Physician Decision|1|||
162645705|NCT05620576|587421269|FG000|Overall Study|Protocol Deviation|1|||
162645706|NCT05620576|587421270|FG001|Overall Study|Protocol Deviation|1|||
162645707|NCT05620576|587421269|FG000|Overall Study|Withdrawal by Subject|2|||
162645708|NCT05620576|587421270|FG001|Overall Study|Withdrawal by Subject|3|||
162645709|NCT02622828|587421271|FG000|Overall Study|participant withdrew|3|||
162645710|NCT03616912|587421272|FG000|Overall Study|Adverse Event|17|||
162645711|NCT03616912|587421273|FG001|Overall Study|Adverse Event|21|||
162645712|NCT03616912|587421274|FG002|Overall Study|Adverse Event|9|||
162645713|NCT03616912|587421275|FG003|Overall Study|Adverse Event|0|||
162645714|NCT03616912|587421276|FG004|Overall Study|Adverse Event|0|||
162645715|NCT03616912|587421277|FG005|Overall Study|Adverse Event|0|||
162645716|NCT03616912|587421272|FG000|Overall Study|Death|1|||
162645717|NCT03616912|587421273|FG001|Overall Study|Death|1|||
162645718|NCT03616912|587421274|FG002|Overall Study|Death|0|||
162645719|NCT03616912|587421275|FG003|Overall Study|Death|0|||
163079097|NCT01725308|588996940|FG002|Treatment Period II|Worsening of the Target Disease|2|||
163079098|NCT01725308|588996938|FG000|Treatment Period II|Changes in the Episodes|1|||
163079099|NCT01725308|588996939|FG001|Treatment Period II|Changes in the Episodes|0|||
163079100|NCT01725308|588996940|FG002|Treatment Period II|Changes in the Episodes|5|||
163079101|NCT01725308|588996938|FG000|Treatment Period II|Withdrawal of Consent|28|||
163079102|NCT01725308|588996939|FG001|Treatment Period II|Withdrawal of Consent|2|||
163079103|NCT01725308|588996940|FG002|Treatment Period II|Withdrawal of Consent|16|||
163079104|NCT01725308|588996938|FG000|Treatment Period II|Lost to Follow-up|1|||
163079105|NCT01725308|588996939|FG001|Treatment Period II|Lost to Follow-up|5|||
163079106|NCT01725308|588996940|FG002|Treatment Period II|Lost to Follow-up|3|||
163079107|NCT01725308|588996938|FG000|Treatment Period II|Protocol Deviations|0|||
163079108|NCT01725308|588996939|FG001|Treatment Period II|Protocol Deviations|0|||
163079109|NCT01725308|588996940|FG002|Treatment Period II|Protocol Deviations|1|||
163079110|NCT01725308|588996938|FG000|Treatment Period II|Miscellaneous|5|||
163079111|NCT01725308|588996939|FG001|Treatment Period II|Miscellaneous|3|||
163079112|NCT01725308|588996940|FG002|Treatment Period II|Miscellaneous|7|||
163079113|NCT05652140|588996942|FG000|Overall Study|Lost to Follow-up|7|||
163079114|NCT05652140|588996943|FG001|Overall Study|Lost to Follow-up|16|||
163079115|NCT05652140|588996944|FG002|Overall Study|Lost to Follow-up|22|||
163079116|NCT05652140|588996945|FG003|Overall Study|Lost to Follow-up|31|||
163079117|NCT06048705|588996949|FG000|Overall Study|Physician Decision|1|||
163079118|NCT06048705|588996950|FG001|Overall Study|Physician Decision|0|||
163079119|NCT06048705|588996951|FG002|Overall Study|Physician Decision|0|||
163079120|NCT06048705|588996949|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
163079121|NCT06048705|588996950|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
163079122|NCT06048705|588996951|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
163079123|NCT06048705|588996949|FG000|Overall Study|Death prior to lymphodepletion|0|||
163079124|NCT06048705|588996950|FG001|Overall Study|Death prior to lymphodepletion|0|||
163079125|NCT06048705|588996951|FG002|Overall Study|Death prior to lymphodepletion|1|||
163079126|NCT02413346|588996952|FG000|Overall Study|Adverse Event|6|||
163079127|NCT02413346|588996953|FG001|Overall Study|Adverse Event|6|||
162645720|NCT03616912|587421276|FG004|Overall Study|Death|0|||
162645721|NCT03616912|587421277|FG005|Overall Study|Death|0|||
163079128|NCT02413346|588996952|FG000|Overall Study|Withdrawal by Subject|30|||
162645722|NCT03616912|587421272|FG000|Overall Study|Lack of Efficacy|13|||
162645723|NCT03616912|587421273|FG001|Overall Study|Lack of Efficacy|6|||
162645724|NCT03616912|587421274|FG002|Overall Study|Lack of Efficacy|8|||
163079129|NCT02413346|588996953|FG001|Overall Study|Withdrawal by Subject|40|||
163079130|NCT02413346|588996952|FG000|Overall Study|Lost to Follow-up|17|||
163079131|NCT02413346|588996953|FG001|Overall Study|Lost to Follow-up|21|||
163079132|NCT02413346|588996952|FG000|Overall Study|Protocol Violation|2|||
162645725|NCT03616912|587421275|FG003|Overall Study|Lack of Efficacy|4|||
162645726|NCT03616912|587421276|FG004|Overall Study|Lack of Efficacy|5|||
162645727|NCT03616912|587421277|FG005|Overall Study|Lack of Efficacy|1|||
162645728|NCT03616912|587421272|FG000|Overall Study|Lost to Follow-up|1|||
162645729|NCT03616912|587421273|FG001|Overall Study|Lost to Follow-up|2|||
162645730|NCT03616912|587421274|FG002|Overall Study|Lost to Follow-up|3|||
162645731|NCT03616912|587421275|FG003|Overall Study|Lost to Follow-up|0|||
162645732|NCT03616912|587421276|FG004|Overall Study|Lost to Follow-up|0|||
163079133|NCT02413346|588996953|FG001|Overall Study|Protocol Violation|0|||
163079134|NCT02413346|588996952|FG000|Overall Study|Other Miscellaneous Reasons|4|||
162645733|NCT03616912|587421277|FG005|Overall Study|Lost to Follow-up|0|||
162645734|NCT03616912|587421272|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
162645735|NCT03616912|587421273|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
162645736|NCT03616912|587421274|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
162645737|NCT03616912|587421275|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
162645738|NCT03616912|587421276|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
162645739|NCT03616912|587421277|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
162645740|NCT03616912|587421272|FG000|Overall Study|Withdrawal by Subject|12|||
162645741|NCT03616912|587421273|FG001|Overall Study|Withdrawal by Subject|12|||
162717907|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
162717908|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
163029472|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
163029473|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
163029474|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
163029475|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
163029476|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Death|0|||
163029477|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Death|0|||
163029478|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Death|1|||
163029479|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Death|0|||
163029480|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029481|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029482|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
163029483|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
163029484|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
163029485|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
163029486|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
163029487|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
163029488|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029489|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029490|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
163029491|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
163029492|NCT00960986|588810463|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
163029493|NCT00960986|588810464|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
163029494|NCT00960986|588810465|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
163029495|NCT00960986|588810466|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
163029496|NCT01077739|588810467|FG000|Overall Study|Premature withdrawal|1|||
163029497|NCT01077739|588810468|FG001|Overall Study|Premature withdrawal|3|||
163029498|NCT01077739|588810467|FG000|Overall Study|Withdrawal by Subject|1|||
163029499|NCT01077739|588810468|FG001|Overall Study|Withdrawal by Subject|0|||
163029500|NCT01077739|588810467|FG000|Overall Study|Death|0|||
163029501|NCT01077739|588810468|FG001|Overall Study|Death|3|||
163029502|NCT01077739|588810467|FG000|Overall Study|Unacceptable toxicity|1|||
163029503|NCT01077739|588810468|FG001|Overall Study|Unacceptable toxicity|2|||
163029504|NCT01077739|588810467|FG000|Overall Study|Other|2|||
163029505|NCT01077739|588810468|FG001|Overall Study|Other|2|||
163029506|NCT00877071|588810469|FG000|Overall Study|disease progression|2|||
163029507|NCT02100670|588810475|FG000|Overall Study|Adverse Event|10|||
163029508|NCT02100670|588810476|FG001|Overall Study|Adverse Event|3|||
163029509|NCT02100670|588810477|FG002|Overall Study|Adverse Event|3|||
163029510|NCT02100670|588810478|FG003|Overall Study|Adverse Event|0|||
163029511|NCT02100670|588810475|FG000|Overall Study|Lost to Follow-up|1|||
163029512|NCT02100670|588810476|FG001|Overall Study|Lost to Follow-up|0|||
163029513|NCT02100670|588810477|FG002|Overall Study|Lost to Follow-up|0|||
163029514|NCT02100670|588810478|FG003|Overall Study|Lost to Follow-up|0|||
163029515|NCT02100670|588810475|FG000|Overall Study|Protocol Violation|0|||
163029516|NCT02100670|588810476|FG001|Overall Study|Protocol Violation|1|||
163029517|NCT02100670|588810477|FG002|Overall Study|Protocol Violation|0|||
163029518|NCT02100670|588810478|FG003|Overall Study|Protocol Violation|1|||
163029519|NCT02100670|588810475|FG000|Overall Study|Withdrawal of Consent|0|||
163029520|NCT02100670|588810476|FG001|Overall Study|Withdrawal of Consent|1|||
163029521|NCT02100670|588810477|FG002|Overall Study|Withdrawal of Consent|1|||
163029522|NCT02100670|588810478|FG003|Overall Study|Withdrawal of Consent|0|||
163029523|NCT02100670|588810475|FG000|Overall Study|No swelling no pain|1|||
163029524|NCT02100670|588810476|FG001|Overall Study|No swelling no pain|0|||
163029525|NCT02100670|588810477|FG002|Overall Study|No swelling no pain|0|||
163029526|NCT02100670|588810478|FG003|Overall Study|No swelling no pain|0|||
163029527|NCT02100670|588810475|FG000|Overall Study|Poor Efficacy|0|||
163029528|NCT02100670|588810476|FG001|Overall Study|Poor Efficacy|1|||
163029529|NCT02100670|588810477|FG002|Overall Study|Poor Efficacy|0|||
163029530|NCT02100670|588810478|FG003|Overall Study|Poor Efficacy|0|||
163029531|NCT02100670|588810475|FG000|Overall Study|Physician Decision|0|||
163029532|NCT02100670|588810476|FG001|Overall Study|Physician Decision|1|||
163029533|NCT02100670|588810477|FG002|Overall Study|Physician Decision|0|||
163029534|NCT02100670|588810478|FG003|Overall Study|Physician Decision|0|||
162645742|NCT03616912|587421274|FG002|Overall Study|Withdrawal by Subject|15|||
163079135|NCT02413346|588996953|FG001|Overall Study|Other Miscellaneous Reasons|3|||
163079136|NCT00562861|588996958|FG000|Overall Study|Adverse Event|1|||
163079137|NCT00562861|588996959|FG001|Overall Study|Adverse Event|1|||
163079138|NCT00562861|588996958|FG000|Overall Study|Lack of Efficacy|5|||
163079139|NCT00562861|588996959|FG001|Overall Study|Lack of Efficacy|5|||
163079140|NCT00562861|588996958|FG000|Overall Study|noncompliance, moved|7|||
163079141|NCT00562861|588996959|FG001|Overall Study|noncompliance, moved|2|||
163079142|NCT00562861|588996958|FG000|Overall Study|Lost to Follow-up|7|||
163079143|NCT00562861|588996959|FG001|Overall Study|Lost to Follow-up|3|||
163079144|NCT00655356|588996962|FG000|Overall Study|Withdrawal by Subject|3|||
163079145|NCT00655356|588996963|FG001|Overall Study|Withdrawal by Subject|4|||
163079146|NCT00655356|588996962|FG000|Overall Study|Sponsor Request|10|||
163079147|NCT00655356|588996963|FG001|Overall Study|Sponsor Request|4|||
163079148|NCT00655356|588996962|FG000|Overall Study|Adverse Event|1|||
163079149|NCT00655356|588996963|FG001|Overall Study|Adverse Event|1|||
163079150|NCT00655356|588996962|FG000|Overall Study|Protocol Violation|2|||
163079151|NCT00655356|588996963|FG001|Overall Study|Protocol Violation|1|||
163079152|NCT00655356|588996962|FG000|Overall Study|Other Reason|1|||
163079153|NCT00655356|588996963|FG001|Overall Study|Other Reason|0|||
163079154|NCT01623154|588996966|FG000|Overall Study|Did not drink Pranactin Citric|4|||
163079155|NCT04349098|588996967|FG000|Overall Study|Death|16|||
163079156|NCT04349098|588996968|FG001|Overall Study|Death|8|||
163079157|NCT04349098|588996967|FG000|Overall Study|Lost to Follow-up|11|||
163079158|NCT04349098|588996968|FG001|Overall Study|Lost to Follow-up|8|||
163079159|NCT04349098|588996967|FG000|Overall Study|Withdrawal by Subject|8|||
163079160|NCT04349098|588996968|FG001|Overall Study|Withdrawal by Subject|5|||
163079161|NCT04349098|588996967|FG000|Overall Study|Other|3|||
163079162|NCT04349098|588996968|FG001|Overall Study|Other|5|||
163079163|NCT00800384|588996969|FG000|Overall Study|Withdrawal by Subject|24|||
163079164|NCT00800384|588996970|FG001|Overall Study|Withdrawal by Subject|17|||
163079165|NCT00800384|588996969|FG000|Overall Study|Lost to Follow-up|17|||
163079166|NCT00800384|588996970|FG001|Overall Study|Lost to Follow-up|26|||
163079167|NCT02151604|588996972|FG000|Overall Study|Lost to Follow-up|3|||
163079168|NCT02151604|588996972|FG000|Overall Study|Withdrawal by Subject|2|||
163079169|NCT02151604|588996972|FG000|Overall Study|Physician Decision|3|||
163079170|NCT02151604|588996972|FG000|Overall Study|Death|1|||
163079171|NCT00537082|588996973|FG000|Overall Study|Adverse Event|6|||
163079172|NCT00537082|588996974|FG001|Overall Study|Adverse Event|6|||
163079173|NCT00537082|588996975|FG002|Overall Study|Adverse Event|3|||
163079174|NCT00537082|588996973|FG000|Overall Study|Protocol Violation|0|||
163079175|NCT00537082|588996974|FG001|Overall Study|Protocol Violation|2|||
163079176|NCT00537082|588996975|FG002|Overall Study|Protocol Violation|1|||
163079177|NCT00537082|588996973|FG000|Overall Study|Lack of Efficacy|0|||
163079178|NCT00537082|588996974|FG001|Overall Study|Lack of Efficacy|0|||
163079179|NCT00537082|588996975|FG002|Overall Study|Lack of Efficacy|2|||
163079180|NCT00537082|588996973|FG000|Overall Study|Withdrawal by Subject|0|||
163079181|NCT00537082|588996974|FG001|Overall Study|Withdrawal by Subject|1|||
163079182|NCT00537082|588996975|FG002|Overall Study|Withdrawal by Subject|0|||
163079183|NCT00537082|588996973|FG000|Overall Study|Discontinued before initiating treatment|3|||
163079184|NCT00537082|588996974|FG001|Overall Study|Discontinued before initiating treatment|0|||
163079185|NCT00537082|588996975|FG002|Overall Study|Discontinued before initiating treatment|0|||
163079186|NCT04495478|588996977|FG000|Overall Study|Withdrawal by Subject|0|||
163079187|NCT04495478|588996978|FG001|Overall Study|Withdrawal by Subject|0|||
163079188|NCT04495478|588996979|FG002|Overall Study|Withdrawal by Subject|0|||
163079189|NCT04495478|588996980|FG003|Overall Study|Withdrawal by Subject|1|||
163079190|NCT04495478|588996981|FG004|Overall Study|Withdrawal by Subject|0|||
163079191|NCT04495478|588996982|FG005|Overall Study|Withdrawal by Subject|0|||
163079192|NCT04495478|588996983|FG006|Overall Study|Withdrawal by Subject|0|||
163079193|NCT04495478|588996977|FG000|Overall Study|Physician Decision|0|||
163079194|NCT04495478|588996978|FG001|Overall Study|Physician Decision|1|||
162645743|NCT03616912|587421275|FG003|Overall Study|Withdrawal by Subject|2|||
162645744|NCT03616912|587421276|FG004|Overall Study|Withdrawal by Subject|0|||
163079195|NCT04495478|588996979|FG002|Overall Study|Physician Decision|0|||
163079196|NCT04495478|588996980|FG003|Overall Study|Physician Decision|0|||
163079197|NCT04495478|588996981|FG004|Overall Study|Physician Decision|1|||
162645745|NCT03616912|587421277|FG005|Overall Study|Withdrawal by Subject|2|||
163079198|NCT04495478|588996982|FG005|Overall Study|Physician Decision|0|||
163079199|NCT04495478|588996983|FG006|Overall Study|Physician Decision|0|||
163079200|NCT00655746|588996984|FG000|Overall Study|Withdrawal by Subject|1|||
163079201|NCT00561821|588996985|FG000|Overall Study|Not treated|0|||
163079202|NCT00561821|588996986|FG001|Overall Study|Not treated|0|||
163079203|NCT00561821|588996987|FG002|Overall Study|Not treated|1|||
163079204|NCT00561821|588996988|FG003|Overall Study|Not treated|0|||
163079205|NCT00561821|588996985|FG000|Overall Study|Withdrawal by Subject|0|||
163079206|NCT00561821|588996986|FG001|Overall Study|Withdrawal by Subject|1|||
163079207|NCT00561821|588996987|FG002|Overall Study|Withdrawal by Subject|0|||
163079208|NCT00561821|588996988|FG003|Overall Study|Withdrawal by Subject|2|||
163079209|NCT00561821|588996985|FG000|Overall Study|Reasons not related to trial|2|||
163079210|NCT00561821|588996986|FG001|Overall Study|Reasons not related to trial|1|||
163079211|NCT00561821|588996987|FG002|Overall Study|Reasons not related to trial|0|||
163079212|NCT00561821|588996988|FG003|Overall Study|Reasons not related to trial|0|||
163079213|NCT00561821|588996985|FG000|Overall Study|Other (reason not specified)|1|||
163079214|NCT00561821|588996986|FG001|Overall Study|Other (reason not specified)|1|||
163079215|NCT00561821|588996987|FG002|Overall Study|Other (reason not specified)|0|||
163079216|NCT00561821|588996988|FG003|Overall Study|Other (reason not specified)|0|||
163079217|NCT00561821|588996985|FG000|Overall Study|Adverse Event|2|||
163079218|NCT00561821|588996986|FG001|Overall Study|Adverse Event|3|||
163079219|NCT00561821|588996987|FG002|Overall Study|Adverse Event|1|||
163079220|NCT00561821|588996988|FG003|Overall Study|Adverse Event|1|||
163079221|NCT03178942|588996989|FG000|Overall Study|Withdrawal by Subject|2|||
163079222|NCT03178942|588996990|FG001|Overall Study|Withdrawal by Subject|0|||
163079223|NCT03178942|588996989|FG000|Overall Study|Lost to Follow-up|1|||
163079224|NCT03178942|588996990|FG001|Overall Study|Lost to Follow-up|2|||
163079225|NCT04280783|588999178|FG000|Overall Study|Family issues unrelated to the study.|1|||
163079226|NCT04280783|588999179|FG001|Overall Study|Family issues unrelated to the study.|0|||
163079227|NCT04280783|588999178|FG000|Overall Study|Withdrawal by Subject|0|||
163079228|NCT04280783|588999179|FG001|Overall Study|Withdrawal by Subject|1|||
163079229|NCT03443401|588999186|FG000|Overall Study|Lost to Follow-up|13|||
163079230|NCT03443401|588999186|FG000|Overall Study|Influential outlier|1|||
163079231|NCT02363283|588999187|FG000|Overall Study|Withdrawal by Subject|1|||
163079232|NCT02363283|588999187|FG000|Overall Study|Not eligible due to transaminitis|1|||
163079233|NCT00530257|588999193|FG000|Overall Study|Lost to Follow-up|1|||
163079234|NCT04110145|588999197|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079235|NCT04110145|588999198|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079236|NCT04110145|588999199|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079237|NCT04110145|588999200|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
163079238|NCT04110145|588999201|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
163079239|NCT05401409|588999202|FG000|Overall Study|Lost to Follow-up|1|||
163079240|NCT05401409|588999203|FG001|Overall Study|Lost to Follow-up|0|||
163079241|NCT00432991|588999206|FG000|Overall Study|Protocol Violation|7|||
163079242|NCT00432991|588999207|FG001|Overall Study|Protocol Violation|12|||
163079243|NCT00363467|588999208|FG000|Overall Study|Physician Decision|1|||
163079244|NCT03160573|588999211|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
163079245|NCT03160573|588999212|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
163079246|NCT03160573|588999213|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
163079247|NCT03160573|588999214|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
163079248|NCT02715856|588999219|FG000|Overall Study|Software Issues|12|||
163079249|NCT02715856|588999220|FG001|Overall Study|Software Issues|7|||
163079250|NCT02715856|588999219|FG000|Overall Study|Death|6|||
163079251|NCT02715856|588999220|FG001|Overall Study|Death|5|||
163079252|NCT02715856|588999219|FG000|Overall Study|Non- Compliant|0|||
163079253|NCT02715856|588999220|FG001|Overall Study|Non- Compliant|40|||
163079254|NCT02336555|588999221|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163079255|NCT02336555|588999222|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163079256|NCT02336555|588999221|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
163079257|NCT02336555|588999222|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
163079258|NCT02336555|588999221|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
163079259|NCT02336555|588999222|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
163079260|NCT01537432|588999223|FG000|Overall Study|Lost to Follow-up|3|||
163079261|NCT01537432|588999224|FG001|Overall Study|Lost to Follow-up|1|||
162645746|NCT03616912|587421272|FG000|Overall Study|Study Terminated by Sponsor|0|||
162645747|NCT03616912|587421273|FG001|Overall Study|Study Terminated by Sponsor|0|||
162645748|NCT03616912|587421274|FG002|Overall Study|Study Terminated by Sponsor|0|||
162645749|NCT03616912|587421275|FG003|Overall Study|Study Terminated by Sponsor|10|||
162645750|NCT03616912|587421276|FG004|Overall Study|Study Terminated by Sponsor|9|||
162645751|NCT03616912|587421277|FG005|Overall Study|Study Terminated by Sponsor|11|||
163079262|NCT01537432|588999223|FG000|Overall Study|Withdrawal by Subject|0|||
162645752|NCT03616912|587421272|FG000|Overall Study|Protocol Deviation|1|||
162645753|NCT03616912|587421273|FG001|Overall Study|Protocol Deviation|1|||
163079263|NCT01537432|588999224|FG001|Overall Study|Withdrawal by Subject|1|||
163079264|NCT01537432|588999223|FG000|Overall Study|Administrative problems|1|||
163079265|NCT01537432|588999224|FG001|Overall Study|Administrative problems|0|||
163079266|NCT01537432|588999223|FG000|Overall Study|Adverse Event|1|||
163079267|NCT01537432|588999224|FG001|Overall Study|Adverse Event|0|||
163079268|NCT01537432|588999223|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163079269|NCT01537432|588999224|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163079270|NCT03682367|588999227|FG000|Overall Study|Protocol Violation|2|||
163079271|NCT03682367|588999228|FG001|Overall Study|Protocol Violation|1|||
163079272|NCT03682367|588999227|FG000|Overall Study|Closed Study Early|0|||
163079273|NCT03682367|588999228|FG001|Overall Study|Closed Study Early|3|||
163079274|NCT05166902|588999229|FG000|First Intervention|Lost to Follow-up|0|||
163079275|NCT05166902|588999230|FG001|First Intervention|Lost to Follow-up|1|||
163079276|NCT04157738|588999239|FG000|Overall Study|Moved out of state|0|||
163079277|NCT04157738|588999240|FG001|Overall Study|Moved out of state|2|||
163079278|NCT04157738|588999239|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
163079279|NCT04157738|588999240|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
163079280|NCT00309946|588999241|FG000|Overall Study|Withdrawal by Subject|1|||
163079281|NCT02244957|588999242|FG000|Overall Study|Lack of Efficacy|1|||
163079282|NCT02244957|588999243|FG001|Overall Study|Lack of Efficacy|0|||
163079283|NCT01347086|588999244|FG000|Overall Study|failed screening visit|0|||
163079284|NCT01347086|588999245|FG001|Overall Study|failed screening visit|0|||
163079285|NCT01347086|588999246|FG002|Overall Study|failed screening visit|1|||
163079286|NCT01347086|588999247|FG003|Overall Study|failed screening visit|0|||
163079287|NCT01347086|588999248|FG004|Overall Study|failed screening visit|0|||
163079288|NCT01347086|588999249|FG005|Overall Study|failed screening visit|0|||
163079289|NCT01347086|588999250|FG006|Overall Study|failed screening visit|1|||
163079290|NCT01347086|588999251|FG007|Overall Study|failed screening visit|1|||
163079291|NCT01347086|588999252|FG008|Overall Study|failed screening visit|0|||
163079292|NCT01347086|588999253|FG009|Overall Study|failed screening visit|1|||
163079293|NCT03111108|588999256|FG000|Overall Study|Death|0|||
163079294|NCT03111108|588999257|FG001|Overall Study|Death|1|||
163079295|NCT03111108|588999256|FG000|Overall Study|Withdrawal by Subject|1|||
163079296|NCT03111108|588999257|FG001|Overall Study|Withdrawal by Subject|0|||
163079297|NCT01514357|588999258|FG000|Overall Study|Screen failure|2|||
163079298|NCT01514357|588999259|FG001|Overall Study|Screen failure|0|||
163079299|NCT01514357|588999258|FG000|Overall Study|Withdrawal by Subject|2|||
163079300|NCT01514357|588999259|FG001|Overall Study|Withdrawal by Subject|0|||
163079301|NCT04691115|588999260|FG000|Overall Study|Withdrawal by Subject|0|||
163079302|NCT04691115|588999261|FG001|Overall Study|Withdrawal by Subject|0|||
163079303|NCT04691115|588999262|FG002|Overall Study|Withdrawal by Subject|0|||
163079304|NCT04691115|588999263|FG003|Overall Study|Withdrawal by Subject|0|||
163079305|NCT04691115|588999264|FG004|Overall Study|Withdrawal by Subject|0|||
163079306|NCT04691115|588999265|FG005|Overall Study|Withdrawal by Subject|1|||
163079307|NCT04691115|588999266|FG006|Overall Study|Withdrawal by Subject|0|||
163079308|NCT04691115|588999267|FG007|Overall Study|Withdrawal by Subject|0|||
163079309|NCT04691115|588999268|FG008|Overall Study|Withdrawal by Subject|0|||
163079310|NCT04691115|588999269|FG009|Overall Study|Withdrawal by Subject|0|||
163079311|NCT04691115|588999270|FG010|Overall Study|Withdrawal by Subject|0|||
163079312|NCT04691115|588999271|FG011|Overall Study|Withdrawal by Subject|0|||
163079313|NCT04691115|588999272|FG012|Overall Study|Withdrawal by Subject|0|||
163079314|NCT04691115|588999273|FG013|Overall Study|Withdrawal by Subject|0|||
163079315|NCT00830336|588999277|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
163079316|NCT00830336|588999278|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
163079317|NCT00347269|588999283|FG000|Overall Study|Lost to Follow-up|74|||
163079318|NCT00347269|588999284|FG001|Overall Study|Lost to Follow-up|65|||
163079319|NCT00347269|588999283|FG000|Overall Study|Withdrawal by Subject|18|||
163079320|NCT00347269|588999284|FG001|Overall Study|Withdrawal by Subject|38|||
163079321|NCT00347269|588999283|FG000|Overall Study|Death|2|||
163079322|NCT00347269|588999284|FG001|Overall Study|Death|3|||
163079323|NCT00835549|588999285|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
163079324|NCT00835549|588999286|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163079325|NCT01725282|588999291|FG000|Overall Study|Adverse Event|1|||
163079326|NCT01725282|588999292|FG001|Overall Study|Adverse Event|3|||
163079327|NCT01725282|588999293|FG002|Overall Study|Adverse Event|6|||
163079328|NCT01725282|588999294|FG003|Overall Study|Adverse Event|4|||
163079329|NCT01725282|588999291|FG000|Overall Study|Exacerbation of Target Disease|1|||
163079330|NCT01725282|588999292|FG001|Overall Study|Exacerbation of Target Disease|0|||
163079331|NCT01725282|588999293|FG002|Overall Study|Exacerbation of Target Disease|0|||
163079332|NCT01725282|588999294|FG003|Overall Study|Exacerbation of Target Disease|1|||
163079333|NCT01725282|588999291|FG000|Overall Study|Met Exclusion Criteria|0|||
163079334|NCT01725282|588999292|FG001|Overall Study|Met Exclusion Criteria|0|||
163079335|NCT01725282|588999293|FG002|Overall Study|Met Exclusion Criteria|1|||
163079336|NCT01725282|588999294|FG003|Overall Study|Met Exclusion Criteria|0|||
163079337|NCT01725282|588999291|FG000|Overall Study|Study Site Withdrawal|0|||
163079338|NCT01725282|588999292|FG001|Overall Study|Study Site Withdrawal|1|||
163079339|NCT01725282|588999293|FG002|Overall Study|Study Site Withdrawal|0|||
163079340|NCT01725282|588999294|FG003|Overall Study|Study Site Withdrawal|0|||
163079341|NCT01725282|588999291|FG000|Overall Study|Withdrawal by Subject|0|||
163079342|NCT01725282|588999292|FG001|Overall Study|Withdrawal by Subject|0|||
163079343|NCT01725282|588999293|FG002|Overall Study|Withdrawal by Subject|1|||
163079344|NCT01725282|588999294|FG003|Overall Study|Withdrawal by Subject|1|||
163079345|NCT01725282|588999291|FG000|Overall Study|Lack of Efficacy|0|||
163079346|NCT01725282|588999292|FG001|Overall Study|Lack of Efficacy|1|||
163079347|NCT01725282|588999293|FG002|Overall Study|Lack of Efficacy|0|||
163079348|NCT01725282|588999294|FG003|Overall Study|Lack of Efficacy|1|||
163079349|NCT05071027|588999295|FG000|Overall Study|Lost to Follow-up|1|||
163079350|NCT05071027|588999296|FG001|Overall Study|Lost to Follow-up|4|||
163079351|NCT04576481|588999297|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
163079352|NCT04576481|588999298|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
163079353|NCT04576481|588999299|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
163079354|NCT04576481|588999300|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
163079355|NCT05463952|588999304|FG000|Treatment|Progressive disease|4|||
163079356|NCT05463952|588999304|FG000|Treatment|Ongoing|2|||
163079357|NCT02739828|588999306|FG000|Overall Study|Adverse Event|1|||
163079358|NCT02739828|588999306|FG000|Overall Study|Lost to Follow-up|4|||
163079359|NCT00489359|588999307|FG000|Overall Study|Death|0|||
163079360|NCT00489359|588999308|FG001|Overall Study|Death|2|||
163079361|NCT00489359|588999307|FG000|Overall Study|Progressive Disease|5|||
163079362|NCT00489359|588999308|FG001|Overall Study|Progressive Disease|6|||
163079363|NCT00489359|588999307|FG000|Overall Study|Lost to Follow-up|1|||
163079364|NCT00489359|588999308|FG001|Overall Study|Lost to Follow-up|0|||
163079365|NCT00489359|588999307|FG000|Overall Study|Withdrawal by Subject|1|||
163079366|NCT00489359|588999308|FG001|Overall Study|Withdrawal by Subject|5|||
163079367|NCT00489359|588999307|FG000|Overall Study|Adverse Event|0|||
163079368|NCT00489359|588999308|FG001|Overall Study|Adverse Event|16|||
163079369|NCT03180138|588999309|FG000|Overall Study|Mobile-phone could not be verified|2|||
163079370|NCT03180138|588999310|FG001|Overall Study|Mobile-phone could not be verified|13|||
163079371|NCT03180138|588999311|FG002|Overall Study|Mobile-phone could not be verified|15|||
163079372|NCT03180138|588999309|FG000|Overall Study|No prior immunization records|17|||
163079373|NCT03180138|588999310|FG001|Overall Study|No prior immunization records|0|||
163079374|NCT03180138|588999311|FG002|Overall Study|No prior immunization records|6|||
163079375|NCT03180138|588999309|FG000|Overall Study|Found to be >24 mon after randomization|3|||
163079376|NCT03180138|588999310|FG001|Overall Study|Found to be >24 mon after randomization|0|||
163079377|NCT03180138|588999311|FG002|Overall Study|Found to be >24 mon after randomization|3|||
163079378|NCT04191733|588999313|FG000|Overall Study|Withdrawn due to study closure|13|||
163079379|NCT04191733|588999314|FG001|Overall Study|Withdrawn due to study closure|14|||
163079380|NCT04191733|588999313|FG000|Overall Study|Withdrawal by Subject|2|||
163079381|NCT04191733|588999314|FG001|Overall Study|Withdrawal by Subject|4|||
163079382|NCT04191733|588999313|FG000|Overall Study|Physician Decision|1|||
163079383|NCT04191733|588999314|FG001|Overall Study|Physician Decision|1|||
163079384|NCT04191733|588999313|FG000|Overall Study|Lost to Follow-up|5|||
163079385|NCT04191733|588999314|FG001|Overall Study|Lost to Follow-up|6|||
163079386|NCT04191733|588999313|FG000|Overall Study|Death|0|||
163079387|NCT04191733|588999314|FG001|Overall Study|Death|1|||
163079388|NCT02202577|588999317|FG000|Overall Study|Lost to Follow-up|6|||
163079389|NCT02202577|588999318|FG001|Overall Study|Lost to Follow-up|16|||
163079390|NCT02202577|588999317|FG000|Overall Study|Protocol Violation|7|||
163079391|NCT02202577|588999318|FG001|Overall Study|Protocol Violation|3|||
163079392|NCT01714063|588999319|FG000|Overall Study|Equipment malfunction|2|||
163079393|NCT01646216|588999320|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
163079394|NCT01646216|588999321|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
163079395|NCT01646216|588999320|FG000|Overall Study|Did not complete training|0|||
163079396|NCT01646216|588999321|FG001|Overall Study|Did not complete training|2|||
163079397|NCT01646216|588999320|FG000|Overall Study|Investigator decision|1|||
163079398|NCT01646216|588999321|FG001|Overall Study|Investigator decision|1|||
163079399|NCT02369159|588999322|FG000|Overall Study|Adverse Event|0|||
163079400|NCT02369159|588999323|FG001|Overall Study|Adverse Event|1|||
163079401|NCT02369159|588999322|FG000|Overall Study|Lost to Follow-up|1|||
163079402|NCT02369159|588999323|FG001|Overall Study|Lost to Follow-up|1|||
163079403|NCT02369159|588999322|FG000|Overall Study|Withdrawal by Subject|7|||
163079404|NCT02369159|588999323|FG001|Overall Study|Withdrawal by Subject|0|||
163079405|NCT00563316|588999324|FG000|Overall Study|Adverse Event|2|||
163079406|NCT00563316|588999324|FG000|Overall Study|Physician Decision|1|||
162645754|NCT03616912|587421274|FG002|Overall Study|Protocol Deviation|0|||
162645755|NCT03616912|587421275|FG003|Overall Study|Protocol Deviation|0|||
162645756|NCT03616912|587421276|FG004|Overall Study|Protocol Deviation|0|||
162645757|NCT03616912|587421277|FG005|Overall Study|Protocol Deviation|0|||
162645758|NCT03616912|587421272|FG000|Overall Study|Pregnancy|1|||
163079407|NCT00563316|588999324|FG000|Overall Study|Lost to Follow-up|2|||
163079408|NCT00563316|588999324|FG000|Overall Study|Death|1|||
163079409|NCT00563316|588999324|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
163079410|NCT00563316|588999324|FG000|Overall Study|Other|1|||
163079411|NCT01514422|588999325|FG000|Overall Study|Lost to Follow-up|1|||
163079412|NCT03511209|588999326|FG000|Overall Study|Withdrawal by Subject|2|||
163079413|NCT03511209|588999327|FG001|Overall Study|Withdrawal by Subject|4|||
163079414|NCT03511209|588999326|FG000|Overall Study|Death|1|||
163079415|NCT03511209|588999327|FG001|Overall Study|Death|0|||
163079416|NCT03511209|588999326|FG000|Overall Study|Lost to Follow-up|0|||
163079417|NCT03511209|588999327|FG001|Overall Study|Lost to Follow-up|2|||
163079418|NCT02757963|588999330|FG000|Overall Study|Adverse Event|3|||
163079419|NCT02757963|588999330|FG000|Overall Study|Reached Stopping Criteria|1054|||
163079420|NCT02757963|588999330|FG000|Overall Study|Lost to Follow-up|5|||
162645759|NCT03616912|587421273|FG001|Overall Study|Pregnancy|0|||
163079421|NCT02757963|588999330|FG000|Overall Study|Physician Decision|1|||
163079422|NCT02757963|588999330|FG000|Overall Study|Withdrawal by Subject|34|||
163079423|NCT03769467|588999331|FG000|Overall Study|Adverse Event|1|||
163079424|NCT03769467|588999332|FG001|Overall Study|Adverse Event|1|||
163079425|NCT03769467|588999333|FG002|Overall Study|Adverse Event|0|||
163079426|NCT03769467|588999331|FG000|Overall Study|Death|3|||
163079427|NCT03769467|588999332|FG001|Overall Study|Death|3|||
163079428|NCT03769467|588999333|FG002|Overall Study|Death|0|||
163079429|NCT03769467|588999331|FG000|Overall Study|Study Terminated By Sponsor|2|||
163079430|NCT03769467|588999332|FG001|Overall Study|Study Terminated By Sponsor|1|||
163079431|NCT03769467|588999333|FG002|Overall Study|Study Terminated By Sponsor|0|||
163079432|NCT03769467|588999331|FG000|Overall Study|Withdrawal by Subject|0|||
163079433|NCT03769467|588999332|FG001|Overall Study|Withdrawal by Subject|1|||
163079434|NCT03769467|588999333|FG002|Overall Study|Withdrawal by Subject|0|||
163079435|NCT01887600|588999334|FG000|Overall Study|Death|39|||
163079436|NCT01887600|588999335|FG001|Overall Study|Death|16|||
163079437|NCT01887600|588999334|FG000|Overall Study|Lack of Efficacy|3|||
163079438|NCT01887600|588999335|FG001|Overall Study|Lack of Efficacy|26|||
163079439|NCT01887600|588999334|FG000|Overall Study|Lost to Follow-up|5|||
163079440|NCT01887600|588999335|FG001|Overall Study|Lost to Follow-up|1|||
163079441|NCT01887600|588999334|FG000|Overall Study|Physician Decision|7|||
163079442|NCT01887600|588999335|FG001|Overall Study|Physician Decision|8|||
163079443|NCT01887600|588999334|FG000|Overall Study|Protocol Deviation|3|||
163079444|NCT01887600|588999335|FG001|Overall Study|Protocol Deviation|0|||
163079445|NCT01887600|588999334|FG000|Overall Study|Withdrawal by Subject|58|||
163079446|NCT01887600|588999335|FG001|Overall Study|Withdrawal by Subject|52|||
163079447|NCT01887600|588999334|FG000|Overall Study|Adverse Event|21|||
163079448|NCT01887600|588999335|FG001|Overall Study|Adverse Event|9|||
163079449|NCT01887600|588999334|FG000|Overall Study|Non-compliance with study drug|3|||
163079450|NCT01887600|588999335|FG001|Overall Study|Non-compliance with study drug|0|||
163079451|NCT01887600|588999334|FG000|Overall Study|Miscellaneous|6|||
163079452|NCT01887600|588999335|FG001|Overall Study|Miscellaneous|2|||
163079453|NCT01887600|588999334|FG000|Overall Study|Progressive Disease|1|||
163079454|NCT01887600|588999335|FG001|Overall Study|Progressive Disease|0|||
163079455|NCT03688139|588999336|FG000|Overall Study|Lost to Follow-up|2|||
163079456|NCT03688139|588999337|FG001|Overall Study|Lost to Follow-up|0|||
163079457|NCT03688139|588999336|FG000|Overall Study|Physician Decision|0|||
163079458|NCT03688139|588999337|FG001|Overall Study|Physician Decision|1|||
163079459|NCT03688139|588999336|FG000|Overall Study|Withdrawal by Subject|2|||
163079460|NCT03688139|588999337|FG001|Overall Study|Withdrawal by Subject|3|||
163079461|NCT00127933|588999338|FG000|Overall Study|Randomized but not dosed|1|||
163079462|NCT00127933|588999339|FG001|Overall Study|Randomized but not dosed|0|||
163079463|NCT00498485|588999340|FG000|Overall Study|Adverse Event|1|||
163079464|NCT00498485|588999341|FG001|Overall Study|Adverse Event|5|||
163079465|NCT01943825|588999342|FG000|Overall Study|Lost to Follow-up|9|||
163079466|NCT01943825|588999343|FG001|Overall Study|Lost to Follow-up|3|||
163079467|NCT01943825|588999344|FG002|Overall Study|Lost to Follow-up|12|||
163079468|NCT01943825|588999345|FG003|Overall Study|Lost to Follow-up|8|||
163079469|NCT01943825|588999342|FG000|Overall Study|Withdrawal by Subject|1|||
163079470|NCT01943825|588999343|FG001|Overall Study|Withdrawal by Subject|0|||
163079471|NCT01943825|588999344|FG002|Overall Study|Withdrawal by Subject|3|||
163079472|NCT01943825|588999345|FG003|Overall Study|Withdrawal by Subject|2|||
163079473|NCT01943825|588999342|FG000|Overall Study|Other than specified above|0|||
163079474|NCT01943825|588999343|FG001|Overall Study|Other than specified above|1|||
163079475|NCT01943825|588999344|FG002|Overall Study|Other than specified above|0|||
163079476|NCT01943825|588999345|FG003|Overall Study|Other than specified above|1|||
163079477|NCT00452400|588999346|FG000|Overall Study|Adverse Event|1|||
163079478|NCT00452400|588999347|FG001|Overall Study|Adverse Event|1|||
163079479|NCT00452400|588999348|FG002|Overall Study|Adverse Event|5|||
163079480|NCT00452400|588999349|FG003|Overall Study|Adverse Event|0|||
163079481|NCT00452400|588999350|FG004|Overall Study|Adverse Event|2|||
163079482|NCT00452400|588999346|FG000|Overall Study|Protocol Violation|0|||
163079483|NCT00452400|588999347|FG001|Overall Study|Protocol Violation|0|||
163079484|NCT00452400|588999348|FG002|Overall Study|Protocol Violation|1|||
163079485|NCT00452400|588999349|FG003|Overall Study|Protocol Violation|0|||
163079486|NCT00452400|588999350|FG004|Overall Study|Protocol Violation|0|||
163079487|NCT00452400|588999346|FG000|Overall Study|Lost to Follow-up|1|||
163079488|NCT00452400|588999347|FG001|Overall Study|Lost to Follow-up|0|||
163079489|NCT00452400|588999348|FG002|Overall Study|Lost to Follow-up|0|||
163079490|NCT00452400|588999349|FG003|Overall Study|Lost to Follow-up|0|||
163079491|NCT00452400|588999350|FG004|Overall Study|Lost to Follow-up|0|||
163079492|NCT00452400|588999346|FG000|Overall Study|Withdrawal by Subject|1|||
163079493|NCT00452400|588999347|FG001|Overall Study|Withdrawal by Subject|0|||
163079494|NCT00452400|588999348|FG002|Overall Study|Withdrawal by Subject|1|||
163079495|NCT00452400|588999349|FG003|Overall Study|Withdrawal by Subject|0|||
163079496|NCT00452400|588999350|FG004|Overall Study|Withdrawal by Subject|0|||
163079497|NCT00452400|588999346|FG000|Overall Study|Lack of Efficacy|2|||
163079498|NCT00452400|588999347|FG001|Overall Study|Lack of Efficacy|0|||
163079499|NCT00452400|588999348|FG002|Overall Study|Lack of Efficacy|0|||
162645760|NCT03616912|587421274|FG002|Overall Study|Pregnancy|4|||
162645761|NCT03616912|587421275|FG003|Overall Study|Pregnancy|0|||
162645762|NCT03616912|587421276|FG004|Overall Study|Pregnancy|0|||
162645763|NCT03616912|587421277|FG005|Overall Study|Pregnancy|0|||
163079500|NCT00452400|588999349|FG003|Overall Study|Lack of Efficacy|0|||
163079501|NCT00452400|588999350|FG004|Overall Study|Lack of Efficacy|0|||
163079502|NCT00452400|588999346|FG000|Overall Study|Other reasons not listed above|0|||
162645764|NCT03616912|587421272|FG000|Overall Study|Protocol Violation|1|||
162645765|NCT03616912|587421273|FG001|Overall Study|Protocol Violation|0|||
162645766|NCT03616912|587421274|FG002|Overall Study|Protocol Violation|2|||
162645767|NCT03616912|587421275|FG003|Overall Study|Protocol Violation|0|||
162645768|NCT03616912|587421276|FG004|Overall Study|Protocol Violation|0|||
162645769|NCT03616912|587421277|FG005|Overall Study|Protocol Violation|0|||
162645770|NCT03616912|587421272|FG000|Overall Study|Physician Decision|2|||
162645771|NCT03616912|587421273|FG001|Overall Study|Physician Decision|0|||
162645772|NCT03616912|587421274|FG002|Overall Study|Physician Decision|0|||
162645773|NCT03616912|587421275|FG003|Overall Study|Physician Decision|0|||
162645774|NCT03616912|587421276|FG004|Overall Study|Physician Decision|1|||
162645775|NCT03616912|587421277|FG005|Overall Study|Physician Decision|0|||
162645776|NCT03616912|587421272|FG000|Overall Study|Randomized But Never Treated|0|||
162645777|NCT03616912|587421273|FG001|Overall Study|Randomized But Never Treated|2|||
162645778|NCT03616912|587421274|FG002|Overall Study|Randomized But Never Treated|0|||
162645779|NCT03616912|587421275|FG003|Overall Study|Randomized But Never Treated|0|||
162645780|NCT03616912|587421276|FG004|Overall Study|Randomized But Never Treated|0|||
162645781|NCT03616912|587421277|FG005|Overall Study|Randomized But Never Treated|0|||
162645782|NCT01723163|587421278|FG000|Treatment Phase|Withdrawal by Subject|14|||
162645783|NCT01723163|587421279|FG001|Treatment Phase|Withdrawal by Subject|6|||
162645784|NCT01723163|587421278|FG000|Treatment Phase|Withdrawal by PI|5|||
162645785|NCT01723163|587421279|FG001|Treatment Phase|Withdrawal by PI|1|||
162645786|NCT01723163|587421278|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
162645787|NCT01723163|587421279|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
162645788|NCT01723163|587421278|FG000|3-Month Follow-up|Unable to Contact|12|||
162645789|NCT01723163|587421279|FG001|3-Month Follow-up|Unable to Contact|19|||
162645790|NCT01723163|587421278|FG000|6-Month Follow-up|Death|1|||
162645791|NCT01723163|587421279|FG001|6-Month Follow-up|Death|0|||
162645792|NCT01723163|587421278|FG000|6-Month Follow-up|Unable to Contact|17|||
162645793|NCT01723163|587421279|FG001|6-Month Follow-up|Unable to Contact|15|||
162645794|NCT01723163|587421278|FG000|12-Month Follow-up|Death|1|||
162645795|NCT01723163|587421279|FG001|12-Month Follow-up|Death|0|||
162645796|NCT01723163|587421278|FG000|12-Month Follow-up|Unable to Contact|23|||
162645797|NCT01723163|587421279|FG001|12-Month Follow-up|Unable to Contact|28|||
162645798|NCT02510794|587421280|FG000|Overall Study|Adverse Event|0|||
162645799|NCT02510794|587421281|FG001|Overall Study|Adverse Event|1|||
162645800|NCT02510794|587421282|FG002|Overall Study|Adverse Event|0|||
163029535|NCT02100670|588810475|FG000|Overall Study|Withdrawal by Subject|1|||
163029536|NCT02100670|588810476|FG001|Overall Study|Withdrawal by Subject|0|||
163029537|NCT02100670|588810477|FG002|Overall Study|Withdrawal by Subject|0|||
163029538|NCT02100670|588810478|FG003|Overall Study|Withdrawal by Subject|0|||
163029539|NCT01556997|588811804|FG000|Overall Study|Adverse Event|10|||
163029540|NCT01556997|588811805|FG001|Overall Study|Adverse Event|12|||
163029541|NCT01556997|588811806|FG002|Overall Study|Adverse Event|12|||
163029542|NCT01556997|588811804|FG000|Overall Study|Lost to Follow-up|6|||
163029543|NCT01556997|588811805|FG001|Overall Study|Lost to Follow-up|6|||
163029544|NCT01556997|588811806|FG002|Overall Study|Lost to Follow-up|4|||
163029545|NCT01556997|588811804|FG000|Overall Study|Physician Decision|1|||
163029546|NCT01556997|588811805|FG001|Overall Study|Physician Decision|1|||
163029547|NCT01556997|588811806|FG002|Overall Study|Physician Decision|1|||
163029548|NCT01556997|588811804|FG000|Overall Study|Withdrawal by Subject|7|||
163029549|NCT01556997|588811805|FG001|Overall Study|Withdrawal by Subject|6|||
163029550|NCT01556997|588811806|FG002|Overall Study|Withdrawal by Subject|8|||
163029551|NCT01556997|588811804|FG000|Overall Study|Other|2|||
163029552|NCT01556997|588811805|FG001|Overall Study|Other|3|||
163029553|NCT01556997|588811806|FG002|Overall Study|Other|7|||
163029554|NCT05459558|588811807|FG000|Overall Study|Adverse Event|1|||
163029555|NCT05459558|588811808|FG001|Overall Study|Adverse Event|0|||
163029556|NCT05459558|588811809|FG002|Overall Study|Adverse Event|0|||
163029557|NCT05459558|588811807|FG000|Overall Study|Scheduling issue|0|||
163029558|NCT05459558|588811808|FG001|Overall Study|Scheduling issue|1|||
163029559|NCT05459558|588811809|FG002|Overall Study|Scheduling issue|3|||
163079503|NCT00452400|588999347|FG001|Overall Study|Other reasons not listed above|0|||
163079504|NCT00452400|588999348|FG002|Overall Study|Other reasons not listed above|0|||
162645801|NCT02510794|587421283|FG003|Overall Study|Adverse Event|0|||
162645802|NCT02510794|587421280|FG000|Overall Study|Death|1|||
162645803|NCT02510794|587421281|FG001|Overall Study|Death|2|||
162645804|NCT02510794|587421282|FG002|Overall Study|Death|1|||
162645805|NCT02510794|587421283|FG003|Overall Study|Death|1|||
162645806|NCT02510794|587421280|FG000|Overall Study|Lack of Efficacy|3|||
162645807|NCT02510794|587421281|FG001|Overall Study|Lack of Efficacy|1|||
162645808|NCT02510794|587421282|FG002|Overall Study|Lack of Efficacy|1|||
162645809|NCT02510794|587421283|FG003|Overall Study|Lack of Efficacy|0|||
162645810|NCT02510794|587421280|FG000|Overall Study|Participant moved out of the area|0|||
162645811|NCT02510794|587421281|FG001|Overall Study|Participant moved out of the area|0|||
162645812|NCT02510794|587421282|FG002|Overall Study|Participant moved out of the area|0|||
163079505|NCT00452400|588999349|FG003|Overall Study|Other reasons not listed above|1|||
163079506|NCT00452400|588999350|FG004|Overall Study|Other reasons not listed above|1|||
163079507|NCT03378635|588999351|FG000|Overall Study|Adverse Event|1|||
163079508|NCT03378635|588999352|FG001|Overall Study|Adverse Event|0|||
163079509|NCT03378635|588999353|FG002|Overall Study|Adverse Event|0|||
163079510|NCT03378635|588999351|FG000|Overall Study|Withdrawal by Subject|1|||
163079511|NCT03378635|588999352|FG001|Overall Study|Withdrawal by Subject|0|||
163079512|NCT03378635|588999353|FG002|Overall Study|Withdrawal by Subject|0|||
163079513|NCT01472835|588999358|FG000|Overall Study|Lost to Follow-up|2|||
163079514|NCT01472835|588999359|FG001|Overall Study|Lost to Follow-up|0|||
163079515|NCT01835431|588999376|FG000|Overall Study|Adverse Event|1|||
163079516|NCT01835431|588999377|FG001|Overall Study|Adverse Event|0|||
163079517|NCT01835431|588999376|FG000|Overall Study|other|0|||
163079518|NCT01835431|588999377|FG001|Overall Study|other|2|||
163079519|NCT01835431|588999376|FG000|Overall Study|Withdrawal by Subject|6|||
163079520|NCT01835431|588999377|FG001|Overall Study|Withdrawal by Subject|10|||
163079521|NCT01835431|588999376|FG000|Overall Study|Protocol Violation|1|||
163079522|NCT01835431|588999377|FG001|Overall Study|Protocol Violation|0|||
163079523|NCT01316900|588999378|FG000|Overall Study|Adverse Event|10|||
163079524|NCT01316900|588999379|FG001|Overall Study|Adverse Event|10|||
163079525|NCT01316900|588999380|FG002|Overall Study|Adverse Event|15|||
163079526|NCT01316900|588999381|FG003|Overall Study|Adverse Event|9|||
163079527|NCT01316900|588999378|FG000|Overall Study|Lack of Efficacy|17|||
163079528|NCT01316900|588999379|FG001|Overall Study|Lack of Efficacy|9|||
163079529|NCT01316900|588999380|FG002|Overall Study|Lack of Efficacy|5|||
163079530|NCT01316900|588999381|FG003|Overall Study|Lack of Efficacy|7|||
163079531|NCT01316900|588999378|FG000|Overall Study|Protocol Violation|7|||
163079532|NCT01316900|588999379|FG001|Overall Study|Protocol Violation|1|||
163079533|NCT01316900|588999380|FG002|Overall Study|Protocol Violation|4|||
163079534|NCT01316900|588999381|FG003|Overall Study|Protocol Violation|0|||
163079535|NCT01316900|588999378|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
163079536|NCT01316900|588999379|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
163079537|NCT01316900|588999380|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
163079538|NCT01316900|588999381|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
163079539|NCT01316900|588999378|FG000|Overall Study|Lost to Follow-up|1|||
163079540|NCT01316900|588999379|FG001|Overall Study|Lost to Follow-up|0|||
163079541|NCT01316900|588999380|FG002|Overall Study|Lost to Follow-up|1|||
163079542|NCT01316900|588999381|FG003|Overall Study|Lost to Follow-up|1|||
163079543|NCT01316900|588999378|FG000|Overall Study|Withdrawal by Subject|7|||
163079544|NCT01316900|588999379|FG001|Overall Study|Withdrawal by Subject|8|||
163079545|NCT01316900|588999380|FG002|Overall Study|Withdrawal by Subject|6|||
163079546|NCT01316900|588999381|FG003|Overall Study|Withdrawal by Subject|9|||
163079547|NCT05346640|588999382|FG000|Overall Study|Lack of Efficacy|2|||
163079548|NCT05346640|588999382|FG000|Overall Study|Lost to Follow-up|14|||
163079549|NCT05346640|588999382|FG000|Overall Study|Protocol Violation|4|||
163079550|NCT05346640|588999382|FG000|Overall Study|Withdrawal by Subject|2|||
163079551|NCT05346640|588999382|FG000|Overall Study|Physiological Complications|3|||
163079552|NCT05346640|588999382|FG000|Overall Study|Other Reason|3|||
163079553|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163079554|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
162645813|NCT02510794|587421283|FG003|Overall Study|Participant moved out of the area|1|||
162645814|NCT02510794|587421280|FG000|Overall Study|Physician Decision|3|||
163079555|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163079556|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
163079557|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
162645815|NCT02510794|587421281|FG001|Overall Study|Physician Decision|0|||
162645816|NCT02510794|587421282|FG002|Overall Study|Physician Decision|0|||
162645817|NCT02510794|587421283|FG003|Overall Study|Physician Decision|0|||
163079558|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
163079559|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
163079560|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163079561|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163079562|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
163079563|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163079564|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163079565|NCT01703221|588999383|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163079566|NCT01703221|588999384|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163079567|NCT01703221|588999385|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
163079568|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
163079569|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
162645818|NCT02510794|587421280|FG000|Overall Study|Protocol Violation|0|||
163079570|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
162645819|NCT02510794|587421281|FG001|Overall Study|Protocol Violation|0|||
163079571|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
163079572|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
163079573|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
163079574|NCT01703221|588999383|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
163079575|NCT01703221|588999384|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
163079576|NCT01703221|588999385|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
163079577|NCT01152385|588999386|FG000|Overall Study|Withdrawal by Subject|3|||
163079578|NCT01152385|588999387|FG001|Overall Study|Withdrawal by Subject|1|||
163079579|NCT01152385|588999388|FG002|Overall Study|Withdrawal by Subject|1|||
163079580|NCT01152385|588999389|FG003|Overall Study|Withdrawal by Subject|1|||
163079581|NCT01152385|588999386|FG000|Overall Study|Protocol Violation|0|||
163079582|NCT01152385|588999387|FG001|Overall Study|Protocol Violation|0|||
163079583|NCT01152385|588999388|FG002|Overall Study|Protocol Violation|0|||
163079584|NCT01152385|588999389|FG003|Overall Study|Protocol Violation|1|||
163079585|NCT01152385|588999386|FG000|Overall Study|Adverse Event|1|||
163079586|NCT01152385|588999387|FG001|Overall Study|Adverse Event|1|||
163079587|NCT01152385|588999388|FG002|Overall Study|Adverse Event|0|||
163079588|NCT01152385|588999389|FG003|Overall Study|Adverse Event|0|||
163079589|NCT01152385|588999386|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163079590|NCT01152385|588999387|FG001|Overall Study|Study-specific withdrawal criteria|1|||
163079591|NCT01152385|588999388|FG002|Overall Study|Study-specific withdrawal criteria|2|||
163079592|NCT01152385|588999389|FG003|Overall Study|Study-specific withdrawal criteria|0|||
163079593|NCT01152385|588999386|FG000|Overall Study|Other|4|||
163079594|NCT01152385|588999387|FG001|Overall Study|Other|3|||
163079595|NCT01152385|588999388|FG002|Overall Study|Other|2|||
163079596|NCT01152385|588999389|FG003|Overall Study|Other|3|||
163079597|NCT03927846|588999392|FG000|Overall Study|Lost to Follow-up|10|||
162645820|NCT02510794|587421282|FG002|Overall Study|Protocol Violation|1|||
162645821|NCT02510794|587421283|FG003|Overall Study|Protocol Violation|0|||
162645822|NCT02510794|587421280|FG000|Overall Study|Withdrawal by Subject|1|||
162645823|NCT02510794|587421281|FG001|Overall Study|Withdrawal by Subject|2|||
163079598|NCT03927846|588999393|FG001|Overall Study|Lost to Follow-up|11|||
163079599|NCT03061214|588999396|FG000|Overall Study|Withdrawal by Subject|21|||
163079600|NCT03061214|588999397|FG001|Overall Study|Withdrawal by Subject|26|||
163079601|NCT03061214|588999398|FG002|Overall Study|Withdrawal by Subject|9|||
163079602|NCT03061214|588999396|FG000|Overall Study|Lost to Follow-up|3|||
163079603|NCT03061214|588999397|FG001|Overall Study|Lost to Follow-up|1|||
163079604|NCT03061214|588999398|FG002|Overall Study|Lost to Follow-up|1|||
163079605|NCT03061214|588999396|FG000|Overall Study|Death|1|||
163079606|NCT03061214|588999397|FG001|Overall Study|Death|1|||
163079607|NCT03061214|588999398|FG002|Overall Study|Death|0|||
163079608|NCT01394185|589001115|FG000|Overall Study|Withdrawal by Subject|2|||
163079609|NCT01394185|589001116|FG001|Overall Study|Withdrawal by Subject|0|||
163079610|NCT01394185|589001117|FG002|Overall Study|Withdrawal by Subject|0|||
163079611|NCT01394185|589001118|FG003|Overall Study|Withdrawal by Subject|0|||
163079612|NCT01394185|589001119|FG004|Overall Study|Withdrawal by Subject|1|||
163079613|NCT01394185|589001120|FG005|Overall Study|Withdrawal by Subject|0|||
163079614|NCT01394185|589001115|FG000|Overall Study|Change in protocol|3|||
163079615|NCT01394185|589001116|FG001|Overall Study|Change in protocol|0|||
163079616|NCT01394185|589001117|FG002|Overall Study|Change in protocol|0|||
163079617|NCT01394185|589001118|FG003|Overall Study|Change in protocol|0|||
163079618|NCT01394185|589001119|FG004|Overall Study|Change in protocol|3|||
163079619|NCT01394185|589001120|FG005|Overall Study|Change in protocol|0|||
163079620|NCT01394185|589001115|FG000|Overall Study|Protocol Violation|1|||
163079621|NCT01394185|589001116|FG001|Overall Study|Protocol Violation|0|||
163079622|NCT01394185|589001117|FG002|Overall Study|Protocol Violation|0|||
163079623|NCT01394185|589001118|FG003|Overall Study|Protocol Violation|1|||
163079624|NCT01394185|589001119|FG004|Overall Study|Protocol Violation|0|||
163079625|NCT01394185|589001120|FG005|Overall Study|Protocol Violation|1|||
163079626|NCT02371889|589001121|FG000|Overall Study|Adverse medication effect|11|||
163079627|NCT02371889|589001122|FG001|Overall Study|Adverse medication effect|2|||
163079628|NCT02371889|589001121|FG000|Overall Study|Lost to Follow-up|6|||
163079629|NCT02371889|589001122|FG001|Overall Study|Lost to Follow-up|5|||
163079630|NCT02371889|589001121|FG000|Overall Study|Personal time constraints|2|||
163079631|NCT02371889|589001122|FG001|Overall Study|Personal time constraints|4|||
163079632|NCT02371889|589001121|FG000|Overall Study|Lack of Efficacy|0|||
163079633|NCT02371889|589001122|FG001|Overall Study|Lack of Efficacy|2|||
163079634|NCT02371889|589001121|FG000|Overall Study|Relapse|0|||
163079635|NCT02371889|589001122|FG001|Overall Study|Relapse|1|||
163079636|NCT05130281|589001123|FG000|Overall Study|Withdrawal by Subject|0|||
163079637|NCT05130281|589001124|FG001|Overall Study|Withdrawal by Subject|0|||
163079638|NCT05130281|589001125|FG002|Overall Study|Withdrawal by Subject|1|||
163079639|NCT06844812|589001126|FG000|Overall Study|Lost to Follow-up|5|||
163079640|NCT06844812|589001126|FG000|Overall Study|stigmatization concerns|2|||
163079641|NCT06844812|589001126|FG000|Overall Study|medication refusal|2|||
163079642|NCT06844812|589001126|FG000|Overall Study|concerns about possible side effects|2|||
162645824|NCT02510794|587421282|FG002|Overall Study|Withdrawal by Subject|4|||
162645825|NCT02510794|587421283|FG003|Overall Study|Withdrawal by Subject|3|||
162645826|NCT01124604|587421284|FG000|Overall Study|Adverse Event|10|||
162645827|NCT01124604|587421285|FG001|Overall Study|Adverse Event|1|||
162645828|NCT01124604|587421284|FG000|Overall Study|Lack of Efficacy|1|||
162645829|NCT01124604|587421285|FG001|Overall Study|Lack of Efficacy|0|||
162645830|NCT01124604|587421284|FG000|Overall Study|Withdrawal by Subject|4|||
162645831|NCT01124604|587421285|FG001|Overall Study|Withdrawal by Subject|0|||
162645832|NCT01124604|587421284|FG000|Overall Study|Disease Progression|0|||
162645833|NCT01124604|587421285|FG001|Overall Study|Disease Progression|1|||
162645834|NCT01859507|587421286|FG000|Overall Study|left the country|4|||
162645835|NCT01762943|587421287|FG000|Overall Study|Physician Decision|1|||
162645836|NCT01762943|587421288|FG001|Overall Study|Physician Decision|1|||
162645837|NCT01762943|587421287|FG000|Overall Study|Protocol Violation|1|||
162645838|NCT01762943|587421288|FG001|Overall Study|Protocol Violation|0|||
162645839|NCT01762943|587421287|FG000|Overall Study|Withdrawal by Subject|2|||
163029560|NCT05459558|588811807|FG000|Overall Study|Withdrawal by Subject|0|||
163029561|NCT05459558|588811808|FG001|Overall Study|Withdrawal by Subject|0|||
163029562|NCT05459558|588811809|FG002|Overall Study|Withdrawal by Subject|2|||
163029563|NCT01250171|588811815|FG000|Overall Study|Administrative reasons|1|||
163029564|NCT01250171|588811816|FG001|Overall Study|Administrative reasons|0|||
163029565|NCT01250171|588811817|FG002|Overall Study|Administrative reasons|0|||
163029566|NCT00250458|588811834|FG000|Overall Study|Lost to Follow-up|4|||
163029567|NCT00250458|588811835|FG001|Overall Study|Lost to Follow-up|2|||
163029568|NCT00250458|588811834|FG000|Overall Study|Protocol Violation|0|||
163029569|NCT00250458|588811835|FG001|Overall Study|Protocol Violation|1|||
163029570|NCT00250458|588811834|FG000|Overall Study|Withdrawal by Subject|4|||
163029571|NCT00250458|588811835|FG001|Overall Study|Withdrawal by Subject|2|||
163029572|NCT00250458|588811834|FG000|Overall Study|Lack of Migraine Attack|20|||
163029573|NCT00250458|588811835|FG001|Overall Study|Lack of Migraine Attack|9|||
163029574|NCT00250458|588811834|FG000|Overall Study|Qualifying migraine but did not treat|3|||
163029575|NCT00250458|588811835|FG001|Overall Study|Qualifying migraine but did not treat|3|||
163029576|NCT00250458|588811834|FG000|Overall Study|Other|1|||
163029577|NCT00250458|588811835|FG001|Overall Study|Other|0|||
163029578|NCT00741091|588811836|FG000|Overall Study|Death|13|||
163029579|NCT00741091|588811836|FG000|Overall Study|Lost to Follow-up|16|||
163029580|NCT00741091|588811836|FG000|Overall Study|Withdrawal by Subject|6|||
163029581|NCT00741091|588811836|FG000|Overall Study|Missed Visit|22|||
163029582|NCT01892085|588811839|FG000|Overall Study|Death|4|||
163029583|NCT01892085|588811840|FG001|Overall Study|Death|1|||
163029584|NCT01892085|588811841|FG002|Overall Study|Death|3|||
163029585|NCT01892085|588811839|FG000|Overall Study|Withdrawal by Subject|2|||
163029586|NCT01892085|588811840|FG001|Overall Study|Withdrawal by Subject|0|||
163029587|NCT01892085|588811841|FG002|Overall Study|Withdrawal by Subject|2|||
163029588|NCT01472757|588811842|FG000|Overall Study|Withdrawal by Subject|1|||
163029589|NCT01472757|588811843|FG001|Overall Study|Withdrawal by Subject|2|||
163029590|NCT01472757|588811844|FG002|Overall Study|Withdrawal by Subject|2|||
163029591|NCT01472757|588811845|FG003|Overall Study|Withdrawal by Subject|0|||
163029592|NCT01472757|588811842|FG000|Overall Study|Asthma exacerbation|4|||
163029593|NCT01472757|588811843|FG001|Overall Study|Asthma exacerbation|1|||
163029594|NCT01472757|588811844|FG002|Overall Study|Asthma exacerbation|2|||
163029595|NCT01472757|588811845|FG003|Overall Study|Asthma exacerbation|1|||
163029596|NCT01472757|588811842|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
163029597|NCT01472757|588811843|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
163029598|NCT01472757|588811844|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
163029599|NCT01472757|588811845|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
163029600|NCT01472757|588811842|FG000|Overall Study|Protocol Violation|3|||
163029601|NCT01472757|588811843|FG001|Overall Study|Protocol Violation|2|||
163029602|NCT01472757|588811844|FG002|Overall Study|Protocol Violation|4|||
163029603|NCT01472757|588811845|FG003|Overall Study|Protocol Violation|4|||
163029604|NCT01472757|588811842|FG000|Overall Study|Other reasons|1|||
163029605|NCT01472757|588811843|FG001|Overall Study|Other reasons|0|||
163029606|NCT01472757|588811844|FG002|Overall Study|Other reasons|2|||
163029607|NCT01472757|588811845|FG003|Overall Study|Other reasons|2|||
163029608|NCT00597506|588811846|FG000|Overall Study|Subject is being followed for survival|1|||
163029609|NCT00525902|588811848|FG000|Overall Study|Lack of Efficacy|1|||
163029610|NCT00480493|588811849|FG000|Overall Study|moved|2|||
162645840|NCT01762943|587421288|FG001|Overall Study|Withdrawal by Subject|1|||
162645841|NCT00539838|587421289|FG000|Overall Study|Fail to return|2|||
162645842|NCT00539838|587421290|FG001|Overall Study|Fail to return|0|||
163029611|NCT00480493|588811850|FG001|Overall Study|moved|7|||
163029612|NCT03747302|588811851|FG000|Overall Study|Withdrawal by Subject|1|||
163029613|NCT03747302|588811852|FG001|Overall Study|Withdrawal by Subject|2|||
163029614|NCT03769675|588811855|FG000|Overall Study|Lost to Follow-up|1|||
163029615|NCT02844907|588811856|FG000|With Dexamethasone|No IV access|1|||
163029616|NCT00738062|588811857|FG000|Open Label Treatment|Lack of Efficacy|5|||
162645843|NCT00539838|587421291|FG002|Overall Study|Fail to return|0|||
162645844|NCT00539838|587421289|FG000|Overall Study|Withdrawal by Subject|0|||
162645845|NCT00539838|587421290|FG001|Overall Study|Withdrawal by Subject|4|||
162645846|NCT00539838|587421291|FG002|Overall Study|Withdrawal by Subject|0|||
162645847|NCT00539838|587421289|FG000|Overall Study|Death|0|||
162645848|NCT00539838|587421290|FG001|Overall Study|Death|2|||
162645849|NCT00539838|587421291|FG002|Overall Study|Death|0|||
162645850|NCT00539838|587421289|FG000|Overall Study|Did not cooperate|1|||
162645851|NCT00539838|587421290|FG001|Overall Study|Did not cooperate|0|||
162645852|NCT00539838|587421291|FG002|Overall Study|Did not cooperate|1|||
162645853|NCT00539838|587421289|FG000|Overall Study|Administrative|4|||
162645854|NCT00539838|587421290|FG001|Overall Study|Administrative|0|||
162645855|NCT00539838|587421291|FG002|Overall Study|Administrative|8|||
162645856|NCT03090100|587421295|FG000|Overall Study|Adverse Event|9|||
162645857|NCT03090100|587421296|FG001|Overall Study|Adverse Event|11|||
163029617|NCT00738062|588811858|FG001|Open Label Treatment|Lack of Efficacy|0|||
163029618|NCT00738062|588811859|FG002|Open Label Treatment|Lack of Efficacy|0|||
163029619|NCT00738062|588811857|FG000|Open Label Treatment|Adverse Event|11|||
163029620|NCT00738062|588811858|FG001|Open Label Treatment|Adverse Event|0|||
163029621|NCT00738062|588811859|FG002|Open Label Treatment|Adverse Event|0|||
163029622|NCT00738062|588811857|FG000|Open Label Treatment|Protocol Violation|2|||
163029623|NCT00738062|588811858|FG001|Open Label Treatment|Protocol Violation|0|||
163029624|NCT00738062|588811859|FG002|Open Label Treatment|Protocol Violation|0|||
163029625|NCT00738062|588811857|FG000|Open Label Treatment|Withdrawal by Subject|9|||
163029626|NCT00738062|588811858|FG001|Open Label Treatment|Withdrawal by Subject|0|||
163029627|NCT00738062|588811859|FG002|Open Label Treatment|Withdrawal by Subject|0|||
163029628|NCT00738062|588811857|FG000|Open Label Treatment|Investigator Decision|1|||
163029629|NCT00738062|588811858|FG001|Open Label Treatment|Investigator Decision|0|||
163029630|NCT00738062|588811859|FG002|Open Label Treatment|Investigator Decision|0|||
163029631|NCT00738062|588811857|FG000|Open-Label Extension|Adverse Event|5|||
163029632|NCT00738062|588811858|FG001|Open-Label Extension|Adverse Event|0|||
163029633|NCT00738062|588811859|FG002|Open-Label Extension|Adverse Event|0|||
163029634|NCT00738062|588811857|FG000|Open-Label Extension|Physician Decision|1|||
163029635|NCT00738062|588811858|FG001|Open-Label Extension|Physician Decision|0|||
163029636|NCT00738062|588811859|FG002|Open-Label Extension|Physician Decision|0|||
163029637|NCT00738062|588811857|FG000|Open-Label Extension|Lack of Efficacy|2|||
163029638|NCT00738062|588811858|FG001|Open-Label Extension|Lack of Efficacy|0|||
163029639|NCT00738062|588811859|FG002|Open-Label Extension|Lack of Efficacy|0|||
163029640|NCT00738062|588811857|FG000|Open-Label Extension|Withdrawal by Subject|6|||
163029641|NCT00738062|588811858|FG001|Open-Label Extension|Withdrawal by Subject|0|||
163029642|NCT00738062|588811859|FG002|Open-Label Extension|Withdrawal by Subject|0|||
163029643|NCT00738062|588811857|FG000|Open-Label Extension|Protocol Violation|1|||
163029644|NCT00738062|588811858|FG001|Open-Label Extension|Protocol Violation|0|||
163029645|NCT00738062|588811859|FG002|Open-Label Extension|Protocol Violation|0|||
163029646|NCT00738062|588811857|FG000|Open-Label Extension|Study Terminated|2|||
163029647|NCT00738062|588811858|FG001|Open-Label Extension|Study Terminated|0|||
163029648|NCT00738062|588811859|FG002|Open-Label Extension|Study Terminated|0|||
163029649|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
163029650|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
163029651|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
163029652|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
163029653|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Death|1|||
163029654|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Death|1|||
163029655|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
163029656|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
163029657|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
163029658|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
163029659|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
163029660|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
163029661|NCT00033657|588811864|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
163029662|NCT00033657|588811865|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
163029663|NCT00033657|588811864|FG000|Surgical Resection|not complete resection|0|||
163029664|NCT00033657|588811865|FG001|Surgical Resection|not complete resection|3|||
163029665|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
163029666|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
163029667|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
163029668|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
163029669|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Death|2|||
163029670|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Death|1|||
163029671|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
163029672|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
163029673|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
162645858|NCT03090100|587421295|FG000|Overall Study|Pregnancy|1|||
162645859|NCT03090100|587421296|FG001|Overall Study|Pregnancy|1|||
162645860|NCT03090100|587421295|FG000|Overall Study|Lack of Efficacy|2|||
162645861|NCT03090100|587421296|FG001|Overall Study|Lack of Efficacy|7|||
163029674|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
163079643|NCT06844812|589001126|FG000|Overall Study|wanting to seek another specialist opinion|2|||
163079644|NCT06844812|589001126|FG000|Overall Study|side effects (dizziness)|1|||
163079645|NCT02410200|589001132|FG000|Overall Study|Adverse Event|2|||
163079646|NCT05069415|589001133|FG000|Overall Study|Withdrawal by Subject|2|||
163079647|NCT05069415|589001134|FG001|Overall Study|Withdrawal by Subject|0|||
163079648|NCT05069415|589001133|FG000|Overall Study|Adverse Event|2|||
163079649|NCT05069415|589001134|FG001|Overall Study|Adverse Event|0|||
163079650|NCT00101400|589001135|FG000|Survival Follow-Up|Alive|7|||
163079651|NCT03701074|589001136|FG000|Overall Study|Physician Decision|1|||
163079652|NCT03701074|589001137|FG001|Overall Study|Physician Decision|0|||
163079653|NCT01500135|589001138|FG000|Overall Study|Withdrawal of Consent|4|||
163079654|NCT01500135|589001139|FG001|Overall Study|Withdrawal of Consent|0|||
163079655|NCT01500135|589001138|FG000|Overall Study|Lost to Follow-up|6|||
163079656|NCT01500135|589001139|FG001|Overall Study|Lost to Follow-up|4|||
163079657|NCT01500135|589001138|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
163079658|NCT01500135|589001139|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
163079659|NCT01500135|589001138|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
163079660|NCT01500135|589001139|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
163079661|NCT01500135|589001138|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
163079662|NCT01500135|589001139|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
163079663|NCT01500135|589001138|FG000|Overall Study|Participant was a Safety Concern|1|||
163079664|NCT01500135|589001139|FG001|Overall Study|Participant was a Safety Concern|0|||
163079665|NCT01500135|589001138|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
163079666|NCT01500135|589001139|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
162645862|NCT03090100|587421295|FG000|Overall Study|Lost to Follow-up|2|||
163079667|NCT01661595|589001140|FG000|Phase 1: Week 0-4|Adverse Event|1|||
162645863|NCT03090100|587421296|FG001|Overall Study|Lost to Follow-up|2|||
163079668|NCT01661595|589001141|FG001|Phase 1: Week 0-4|Adverse Event|0|||
163079669|NCT01661595|589001142|FG002|Phase 1: Week 0-4|Adverse Event|0|||
163079670|NCT01661595|589001143|FG003|Phase 1: Week 0-4|Adverse Event|0|||
163079671|NCT01661595|589001140|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
163079672|NCT01661595|589001141|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
163079673|NCT01661595|589001142|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
163079674|NCT01661595|589001143|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
163079675|NCT00661687|589001144|FG000|Overall Study|Study related symptoms and complaints|5|||
163079676|NCT00661687|589001144|FG000|Overall Study|Positive slit lamp findings|4|||
163079677|NCT00661687|589001144|FG000|Overall Study|Inability to maintain wearing schedule|3|||
163079678|NCT00661687|589001144|FG000|Overall Study|Physician Decision|1|||
163079679|NCT00661687|589001144|FG000|Overall Study|Adverse Event|2|||
163079680|NCT00912509|589001145|FG000|Overall Study|Lost to Follow-up|1|||
163079681|NCT00912509|589001146|FG001|Overall Study|Lost to Follow-up|0|||
163079682|NCT00912509|589001145|FG000|Overall Study|Lack of Efficacy|4|||
163079683|NCT00912509|589001146|FG001|Overall Study|Lack of Efficacy|3|||
163079684|NCT05538728|589001147|FG000|Overall Study|Withdrawal by Subject|1|||
163079685|NCT05538728|589001148|FG001|Overall Study|Withdrawal by Subject|1|||
163079686|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Adverse Event|2|||
163079687|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Adverse Event|0|||
163079688|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Physician Decision|0|||
163079689|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Physician Decision|1|||
163079690|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
163079691|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
163079692|NCT01362530|589001150|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
163079693|NCT01362530|589001151|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
163079694|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
163079695|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
163079696|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
163079697|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
163079698|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
163079699|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
163079700|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
163079701|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
163079702|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
163079703|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
163079704|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
163079705|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
163079706|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
163079707|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
163079708|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
163079709|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
163079710|NCT01362530|589001150|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
163079711|NCT01362530|589001151|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
163079712|NCT01557569|589001152|FG000|Overall Study|Adverse Event|2|||
163079713|NCT01557569|589001153|FG001|Overall Study|Adverse Event|0|||
163079714|NCT01557569|589001152|FG000|Overall Study|high blood pressure|0|||
163079715|NCT01557569|589001153|FG001|Overall Study|high blood pressure|1|||
163079716|NCT01557569|589001152|FG000|Overall Study|Withdrawal by Subject|3|||
163079717|NCT01557569|589001153|FG001|Overall Study|Withdrawal by Subject|5|||
163079718|NCT01557569|589001152|FG000|Overall Study|noncompliance with rules of residential|0|||
162645864|NCT03090100|587421295|FG000|Overall Study|Withdrawal by Subject|7|||
163079719|NCT01557569|589001153|FG001|Overall Study|noncompliance with rules of residential|1|||
163079720|NCT02254460|589001154|FG000|Overall Study|Adverse Event|1|||
163079721|NCT02254460|589001155|FG001|Overall Study|Adverse Event|0|||
163079722|NCT01050218|589001156|FG000|Overall Study|Adverse Event|37|||
163079723|NCT01050218|589001156|FG000|Overall Study|Lack of Efficacy|8|||
163079724|NCT01050218|589001156|FG000|Overall Study|Protocol Violation|3|||
163079725|NCT01050218|589001156|FG000|Overall Study|Withdrawal by Subject|18|||
163079726|NCT01050218|589001156|FG000|Overall Study|Discontinued by sponsor|18|||
162645865|NCT03090100|587421296|FG001|Overall Study|Withdrawal by Subject|19|||
163079727|NCT01050218|589001156|FG000|Overall Study|Compliance|2|||
163079728|NCT01050218|589001156|FG000|Overall Study|Failed to return|7|||
163079729|NCT01050218|589001156|FG000|Overall Study|Serious Adverse Event|1|||
163079730|NCT01050218|589001156|FG000|Overall Study|Family emergency|1|||
163079731|NCT01772693|589001157|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
163079732|NCT01772693|589001158|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
163079733|NCT01772693|589001157|FG000|Overall Study|Withdrawal by Subject|2|||
163079734|NCT01772693|589001158|FG001|Overall Study|Withdrawal by Subject|0|||
163079735|NCT01772693|589001157|FG000|Overall Study|Alternative Treatment|2|||
163079736|NCT01772693|589001158|FG001|Overall Study|Alternative Treatment|0|||
163079737|NCT01633112|589001159|FG000|Overall Study|Lack of Efficacy|1|||
163079738|NCT01633112|589001160|FG001|Overall Study|Lack of Efficacy|6|||
163079739|NCT01633112|589001161|FG002|Overall Study|Lack of Efficacy|13|||
163079740|NCT01633112|589001159|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163079741|NCT01633112|589001160|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163079742|NCT01633112|589001161|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163079743|NCT01633112|589001159|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163079744|NCT01633112|589001160|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163079745|NCT01633112|589001161|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163079746|NCT01633112|589001159|FG000|Overall Study|Administrative problems|1|||
163079747|NCT01633112|589001160|FG001|Overall Study|Administrative problems|2|||
163079748|NCT01633112|589001161|FG002|Overall Study|Administrative problems|5|||
163079749|NCT01633112|589001159|FG000|Overall Study|Adverse Event|16|||
163079750|NCT01633112|589001160|FG001|Overall Study|Adverse Event|18|||
163079751|NCT01633112|589001161|FG002|Overall Study|Adverse Event|20|||
163079752|NCT01633112|589001159|FG000|Overall Study|Lost to Follow-up|7|||
163079753|NCT01633112|589001160|FG001|Overall Study|Lost to Follow-up|19|||
163079754|NCT01633112|589001161|FG002|Overall Study|Lost to Follow-up|6|||
163079755|NCT01633112|589001159|FG000|Overall Study|Protocol Violation|4|||
163079756|NCT01633112|589001160|FG001|Overall Study|Protocol Violation|0|||
163079757|NCT01633112|589001161|FG002|Overall Study|Protocol Violation|2|||
163079758|NCT01633112|589001159|FG000|Overall Study|Subject no longer requires study drug|0|||
163079759|NCT01633112|589001160|FG001|Overall Study|Subject no longer requires study drug|0|||
163079760|NCT01633112|589001161|FG002|Overall Study|Subject no longer requires study drug|1|||
163079761|NCT01633112|589001159|FG000|Overall Study|Withdrawal by Subject|20|||
163079762|NCT01633112|589001160|FG001|Overall Study|Withdrawal by Subject|12|||
163079763|NCT01633112|589001161|FG002|Overall Study|Withdrawal by Subject|41|||
163079764|NCT01633112|589001159|FG000|Overall Study|missing Study Completion CRF|1|||
163079765|NCT01633112|589001160|FG001|Overall Study|missing Study Completion CRF|1|||
163079766|NCT01633112|589001161|FG002|Overall Study|missing Study Completion CRF|4|||
163079767|NCT02872142|589001163|FG000|Overall Study|Adverse Event|2|||
163079768|NCT02872142|589001163|FG000|Overall Study|Death|1|||
163079769|NCT02872142|589001163|FG000|Overall Study|Participant Decision|3|||
163079770|NCT01550965|589001166|FG000|Overall Study|Adverse Event|26|||
163079771|NCT01550965|589001166|FG000|Overall Study|Withdrawal by Subject|10|||
163079772|NCT01550965|589001166|FG000|Overall Study|Lost to Follow-up|2|||
163079773|NCT01550965|589001166|FG000|Overall Study|Lack of Efficacy|59|||
163079774|NCT01550965|589001166|FG000|Overall Study|Other|13|||
163079775|NCT00160563|589001169|FG000|Overall Study|Adverse Event|1|||
163079776|NCT00160563|589001170|FG001|Overall Study|Adverse Event|1|||
163079777|NCT00160563|589001171|FG002|Overall Study|Adverse Event|1|||
163079778|NCT00160563|589001169|FG000|Overall Study|Lost to Follow-up|1|||
163079779|NCT00160563|589001170|FG001|Overall Study|Lost to Follow-up|1|||
163079780|NCT00160563|589001171|FG002|Overall Study|Lost to Follow-up|2|||
163079781|NCT00160563|589001169|FG000|Overall Study|Protocol Violation|0|||
163079782|NCT00160563|589001170|FG001|Overall Study|Protocol Violation|0|||
163079783|NCT00160563|589001171|FG002|Overall Study|Protocol Violation|3|||
163079784|NCT00160563|589001169|FG000|Overall Study|Withdrawal by Subject|1|||
163079785|NCT00160563|589001170|FG001|Overall Study|Withdrawal by Subject|2|||
163079786|NCT00160563|589001171|FG002|Overall Study|Withdrawal by Subject|3|||
163079787|NCT00160563|589001169|FG000|Overall Study|Other (listed in the study report)|48|||
163079788|NCT00160563|589001170|FG001|Overall Study|Other (listed in the study report)|40|||
163079789|NCT00160563|589001171|FG002|Overall Study|Other (listed in the study report)|81|||
163079790|NCT00160563|589001169|FG000|Overall Study|Missing reason|0|||
163079791|NCT00160563|589001170|FG001|Overall Study|Missing reason|1|||
163079792|NCT00160563|589001171|FG002|Overall Study|Missing reason|0|||
163079793|NCT02624687|589001177|FG000|Overall Study|Withdrawal by Subject|1|||
163079794|NCT02624687|589001178|FG001|Overall Study|Withdrawal by Subject|1|||
163079795|NCT02624687|589001177|FG000|Overall Study|medical leave from work|0|||
163079796|NCT02624687|589001178|FG001|Overall Study|medical leave from work|1|||
163079797|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|0|||
163079798|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|1|||
163079799|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|1|||
163079800|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|0|||
163079801|NCT00867334|589001181|FG000|Overall Study|Withdrawal by Subject|1|||
163079802|NCT00867334|589001182|FG001|Overall Study|Withdrawal by Subject|0|||
163079803|NCT01148771|589001183|FG000|Washout Period|Withdrawal by Subject|0|||
163079804|NCT01148771|589001184|FG001|Washout Period|Withdrawal by Subject|1|||
163079805|NCT01437189|589001185|FG000|Overall Study|Adverse Event|3|||
163079806|NCT01437189|589001185|FG000|Overall Study|Lack of Efficacy|4|||
163079807|NCT01437189|589001185|FG000|Overall Study|Withdrawal by Subject|8|||
163079808|NCT01689649|589001186|FG000|Overall Study|Lack of Efficacy|3|||
163079809|NCT01689649|589001186|FG000|Overall Study|Non-compliance|11|||
163079810|NCT01689649|589001186|FG000|Overall Study|Protocol Violation|3|||
163079811|NCT01689649|589001186|FG000|Overall Study|Lost to Follow-up|5|||
163079812|NCT04893811|589001187|FG000|Vaccination Phase|Death|1|||
163079813|NCT04893811|589001188|FG001|Vaccination Phase|Death|0|||
163079814|NCT04893811|589001187|FG000|Vaccination Phase|Lost to Follow-up|1|||
163079815|NCT04893811|589001188|FG001|Vaccination Phase|Lost to Follow-up|1|||
163079816|NCT04893811|589001187|FG000|Vaccination Phase|Protocol Violation|2|||
163079817|NCT04893811|589001188|FG001|Vaccination Phase|Protocol Violation|0|||
163079818|NCT04893811|589001187|FG000|Vaccination Phase|Withdrawal by Subject|2|||
163079819|NCT04893811|589001188|FG001|Vaccination Phase|Withdrawal by Subject|1|||
163079820|NCT04893811|589001187|FG000|Vaccination Phase|Other|0|||
163079821|NCT04893811|589001188|FG001|Vaccination Phase|Other|1|||
163079822|NCT04893811|589001187|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
163079823|NCT04893811|589001188|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
163079824|NCT04893811|589001187|FG000|Follow-up Phase|Lost to Follow-up|0|||
163079825|NCT04893811|589001188|FG001|Follow-up Phase|Lost to Follow-up|1|||
163079826|NCT03268499|589001189|FG000|Overall Study|Withdrawal by Subject|2|||
163079827|NCT03268499|589001190|FG001|Overall Study|Withdrawal by Subject|1|||
163079828|NCT04064567|589001191|FG000|Overall Study|Lost to Follow-up|23|||
163079829|NCT04064567|589001192|FG001|Overall Study|Lost to Follow-up|22|||
163079830|NCT04064567|589001191|FG000|Overall Study|Withdrawal by Subject|0|||
163079831|NCT04064567|589001192|FG001|Overall Study|Withdrawal by Subject|1|||
163079832|NCT04064567|589001191|FG000|Overall Study|Reincarcerated|7|||
163079833|NCT04064567|589001192|FG001|Overall Study|Reincarcerated|10|||
163079834|NCT04064567|589001191|FG000|Overall Study|Moved out of U.S.|0|||
163079835|NCT04064567|589001192|FG001|Overall Study|Moved out of U.S.|1|||
163079836|NCT03464461|589001195|FG000|Overall Study|exclusionary medication given ,|1|||
163079837|NCT03464461|589001196|FG001|Overall Study|exclusionary medication given ,|2|||
163079838|NCT03464461|589001197|FG002|Overall Study|exclusionary medication given ,|0|||
163079839|NCT03464461|589001195|FG000|Overall Study|Physician Decision|0|||
163079840|NCT03464461|589001196|FG001|Overall Study|Physician Decision|1|||
163079841|NCT03464461|589001197|FG002|Overall Study|Physician Decision|0|||
163079842|NCT05524948|589001198|FG000|Overall Study|Withdrawal by Subject|1|||
163079843|NCT05524948|589001199|FG001|Overall Study|Withdrawal by Subject|0|||
163079844|NCT05524948|589001198|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
163079845|NCT05524948|589001199|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
163079846|NCT03460704|589001202|FG000|Overall Study|Withdrawal by Subject|11|||
163079847|NCT03460704|589001203|FG001|Overall Study|Withdrawal by Subject|14|||
163079848|NCT03460704|589001202|FG000|Overall Study|Study terminated by the Sponsor|29|||
163079849|NCT03460704|589001203|FG001|Overall Study|Study terminated by the Sponsor|19|||
163079850|NCT03460704|589001202|FG000|Overall Study|Adverse Event|10|||
163079851|NCT03460704|589001203|FG001|Overall Study|Adverse Event|5|||
163079852|NCT03460704|589001202|FG000|Overall Study|Death|3|||
163079853|NCT03460704|589001203|FG001|Overall Study|Death|2|||
163079854|NCT03460704|589001202|FG000|Overall Study|Non-Compliance with Study Drug|3|||
163079855|NCT03460704|589001203|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163079856|NCT03460704|589001202|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163079857|NCT03460704|589001203|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
163079858|NCT03460704|589001202|FG000|Overall Study|Other|2|||
163079859|NCT03460704|589001203|FG001|Overall Study|Other|1|||
163079860|NCT02913326|589001204|FG000|Overall Study|Reason not listed|0|||
163079861|NCT02913326|589001205|FG001|Overall Study|Reason not listed|1|||
163079862|NCT02913326|589001204|FG000|Overall Study|Lost to Follow-up|0|||
163079863|NCT02913326|589001205|FG001|Overall Study|Lost to Follow-up|1|||
163079864|NCT02913326|589001204|FG000|Overall Study|Adverse Event|1|||
163079865|NCT02913326|589001205|FG001|Overall Study|Adverse Event|0|||
163079866|NCT01767857|589001206|FG000|Overall Study|Adverse Event|27|||
163079867|NCT01767857|589001207|FG001|Overall Study|Adverse Event|7|||
163079868|NCT01767857|589001206|FG000|Overall Study|Death|28|||
163079869|NCT01767857|589001207|FG001|Overall Study|Death|13|||
163079870|NCT01767857|589001206|FG000|Overall Study|Lack of Efficacy|299|||
163079871|NCT01767857|589001207|FG001|Overall Study|Lack of Efficacy|151|||
163079872|NCT01767857|589001206|FG000|Overall Study|Lost to Follow-up|1|||
163079873|NCT01767857|589001207|FG001|Overall Study|Lost to Follow-up|1|||
163079874|NCT01767857|589001206|FG000|Overall Study|Withdrawal by Subject|38|||
163079875|NCT01767857|589001207|FG001|Overall Study|Withdrawal by Subject|18|||
163079876|NCT01767857|589001206|FG000|Overall Study|Physician Decision|17|||
163079877|NCT01767857|589001207|FG001|Overall Study|Physician Decision|10|||
163079878|NCT01767857|589001206|FG000|Overall Study|Protocol Terminated|1|||
163079879|NCT01767857|589001207|FG001|Overall Study|Protocol Terminated|0|||
163079880|NCT01767857|589001206|FG000|Overall Study|Randomized But Never Treated|19|||
163079881|NCT01767857|589001207|FG001|Overall Study|Randomized But Never Treated|13|||
163079882|NCT01421459|589001208|FG000|Overall Study|Adverse Event|6|||
163079883|NCT01421459|589001209|FG001|Overall Study|Adverse Event|10|||
163079884|NCT01421459|589001208|FG000|Overall Study|Death|1|||
163079885|NCT01421459|589001209|FG001|Overall Study|Death|1|||
163079886|NCT01421459|589001208|FG000|Overall Study|Lack of Efficacy|1|||
163079887|NCT01421459|589001209|FG001|Overall Study|Lack of Efficacy|2|||
163079888|NCT01421459|589001208|FG000|Overall Study|Lost to Follow-up|8|||
163079889|NCT01421459|589001209|FG001|Overall Study|Lost to Follow-up|9|||
163079890|NCT01421459|589001208|FG000|Overall Study|Physician Decision|9|||
163079891|NCT01421459|589001209|FG001|Overall Study|Physician Decision|9|||
163079892|NCT01421459|589001208|FG000|Overall Study|Protocol Violation|8|||
163079893|NCT01421459|589001209|FG001|Overall Study|Protocol Violation|5|||
163079894|NCT01421459|589001208|FG000|Overall Study|Withdrawal by Subject|12|||
163079895|NCT01421459|589001209|FG001|Overall Study|Withdrawal by Subject|16|||
163079896|NCT01422382|589001210|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
163079897|NCT00967499|589001211|FG000|Overall Study|Adverse Event|0|||
163079898|NCT00967499|589001212|FG001|Overall Study|Adverse Event|1|||
163079899|NCT00967499|589001211|FG000|Overall Study|Protocol Violation|1|||
163079900|NCT00967499|589001212|FG001|Overall Study|Protocol Violation|0|||
163079901|NCT00967499|589001211|FG000|Overall Study|Sponsor Decision|1|||
163079902|NCT00967499|589001212|FG001|Overall Study|Sponsor Decision|0|||
163079903|NCT00967499|589001211|FG000|Overall Study|Randomized but not treated|63|||
163079904|NCT00967499|589001212|FG001|Overall Study|Randomized but not treated|59|||
163079905|NCT02899754|589001213|FG000|Overall Study|Lost to Follow-up|7|||
163079906|NCT02899754|589001214|FG001|Overall Study|Lost to Follow-up|9|||
163079907|NCT04818229|589001215|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
163079908|NCT04818229|589001216|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
163079909|NCT04818229|589001217|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
163079910|NCT04818229|589001215|FG000|Overall Study|Adverse Event|3|||
163079911|NCT04818229|589001216|FG001|Overall Study|Adverse Event|1|||
163079912|NCT04818229|589001217|FG002|Overall Study|Adverse Event|1|||
163079913|NCT04818229|589001215|FG000|Overall Study|Withdrawal by Subject|0|||
163079914|NCT04818229|589001216|FG001|Overall Study|Withdrawal by Subject|0|||
163079915|NCT04818229|589001217|FG002|Overall Study|Withdrawal by Subject|2|||
163079916|NCT04818229|589001215|FG000|Overall Study|Lost to Follow-up|0|||
163079917|NCT04818229|589001216|FG001|Overall Study|Lost to Follow-up|0|||
163079918|NCT04818229|589001217|FG002|Overall Study|Lost to Follow-up|1|||
163079919|NCT04082364|589001218|FG000|Overall Study|Death|23|||
163079920|NCT04082364|589001219|FG001|Overall Study|Death|1|||
163079921|NCT04082364|589001220|FG002|Overall Study|Death|1|||
163079922|NCT04082364|589001221|FG003|Overall Study|Death|2|||
163079923|NCT04082364|589001222|FG004|Overall Study|Death|1|||
163079924|NCT04082364|589001218|FG000|Overall Study|Lost to Follow-up|1|||
163079925|NCT04082364|589001219|FG001|Overall Study|Lost to Follow-up|0|||
163079926|NCT04082364|589001220|FG002|Overall Study|Lost to Follow-up|0|||
163079927|NCT04082364|589001221|FG003|Overall Study|Lost to Follow-up|0|||
163079928|NCT04082364|589001222|FG004|Overall Study|Lost to Follow-up|1|||
163079929|NCT04082364|589001218|FG000|Overall Study|Physician Decision|1|||
163079930|NCT04082364|589001219|FG001|Overall Study|Physician Decision|1|||
163079931|NCT04082364|589001220|FG002|Overall Study|Physician Decision|0|||
163079932|NCT04082364|589001221|FG003|Overall Study|Physician Decision|2|||
163079933|NCT04082364|589001222|FG004|Overall Study|Physician Decision|1|||
163079934|NCT04082364|589001218|FG000|Overall Study|Withdrawal by Subject|1|||
163079935|NCT04082364|589001219|FG001|Overall Study|Withdrawal by Subject|1|||
163079936|NCT04082364|589001220|FG002|Overall Study|Withdrawal by Subject|0|||
163079937|NCT04082364|589001221|FG003|Overall Study|Withdrawal by Subject|0|||
163079938|NCT04082364|589001222|FG004|Overall Study|Withdrawal by Subject|1|||
163079939|NCT04082364|589001218|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
163079940|NCT04082364|589001219|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
163079941|NCT04082364|589001220|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
163079942|NCT04082364|589001221|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
163079943|NCT04082364|589001222|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
163079944|NCT04082364|589001218|FG000|Overall Study|Disease progression|0|||
163079945|NCT04082364|589001219|FG001|Overall Study|Disease progression|0|||
163079946|NCT04082364|589001220|FG002|Overall Study|Disease progression|0|||
163079947|NCT04082364|589001221|FG003|Overall Study|Disease progression|1|||
162645866|NCT03090100|587421295|FG000|Overall Study|Protocol Violation|2|||
162645867|NCT03090100|587421296|FG001|Overall Study|Protocol Violation|6|||
163079948|NCT04082364|589001222|FG004|Overall Study|Disease progression|0|||
163079949|NCT03186378|589001223|FG000|Overall Study|Lost to Follow-up|1|||
163079950|NCT03186378|589001224|FG001|Overall Study|Lost to Follow-up|0|||
163079951|NCT03247673|589001226|FG000|Overall Study|Withdrawal by Subject|1|||
163079952|NCT03247673|589001227|FG001|Overall Study|Withdrawal by Subject|0|||
163079953|NCT03247673|589001228|FG002|Overall Study|Withdrawal by Subject|3|||
163079954|NCT03247673|589001226|FG000|Overall Study|Lost to Follow-up|0|||
162645868|NCT03090100|587421295|FG000|Overall Study|Non-compliance|2|||
163079955|NCT03247673|589001227|FG001|Overall Study|Lost to Follow-up|0|||
163079956|NCT03247673|589001228|FG002|Overall Study|Lost to Follow-up|1|||
163079957|NCT02971137|589001233|FG000|Overall Study|Lost to Follow-up|44|||
163079958|NCT02971137|589001234|FG001|Overall Study|Lost to Follow-up|56|||
163079959|NCT00215657|589001238|FG000|Overall Study|Adverse Event|5|||
163079960|NCT00215657|589001239|FG001|Overall Study|Adverse Event|1|||
163079961|NCT00215657|589001240|FG002|Overall Study|Adverse Event|3|||
163079962|NCT00215657|589001241|FG003|Overall Study|Adverse Event|0|||
163079963|NCT00215657|589001242|FG004|Overall Study|Adverse Event|3|||
163079964|NCT00215657|589001243|FG005|Overall Study|Adverse Event|1|||
163079965|NCT00215657|589001244|FG006|Overall Study|Adverse Event|0|||
163079966|NCT00215657|589001245|FG007|Overall Study|Adverse Event|3|||
163079967|NCT00215657|589001238|FG000|Overall Study|Withdrawal by Subject|6|||
163079968|NCT00215657|589001239|FG001|Overall Study|Withdrawal by Subject|3|||
163079969|NCT00215657|589001240|FG002|Overall Study|Withdrawal by Subject|3|||
163079970|NCT00215657|589001241|FG003|Overall Study|Withdrawal by Subject|1|||
163079971|NCT00215657|589001242|FG004|Overall Study|Withdrawal by Subject|6|||
163079972|NCT00215657|589001243|FG005|Overall Study|Withdrawal by Subject|1|||
163079973|NCT00215657|589001244|FG006|Overall Study|Withdrawal by Subject|10|||
163079974|NCT00215657|589001245|FG007|Overall Study|Withdrawal by Subject|3|||
163079975|NCT00215657|589001238|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
163079976|NCT00215657|589001239|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
163079977|NCT00215657|589001240|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
163079978|NCT00215657|589001241|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
163079979|NCT00215657|589001242|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
163079980|NCT00215657|589001243|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
163079981|NCT00215657|589001244|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
163079982|NCT00215657|589001245|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
163079983|NCT00215657|589001238|FG000|Overall Study|Insufficient testosterone response|5|||
163079984|NCT00215657|589001239|FG001|Overall Study|Insufficient testosterone response|4|||
163079985|NCT00215657|589001240|FG002|Overall Study|Insufficient testosterone response|1|||
163079986|NCT00215657|589001241|FG003|Overall Study|Insufficient testosterone response|12|||
163079987|NCT00215657|589001242|FG004|Overall Study|Insufficient testosterone response|8|||
163079988|NCT00215657|589001243|FG005|Overall Study|Insufficient testosterone response|12|||
163079989|NCT00215657|589001244|FG006|Overall Study|Insufficient testosterone response|4|||
163079990|NCT00215657|589001245|FG007|Overall Study|Insufficient testosterone response|7|||
163079991|NCT00215657|589001238|FG000|Overall Study|Other|3|||
163079992|NCT00215657|589001239|FG001|Overall Study|Other|1|||
163079993|NCT00215657|589001240|FG002|Overall Study|Other|2|||
163079994|NCT00215657|589001241|FG003|Overall Study|Other|3|||
163079995|NCT00215657|589001242|FG004|Overall Study|Other|5|||
163079996|NCT00215657|589001243|FG005|Overall Study|Other|4|||
163079997|NCT00215657|589001244|FG006|Overall Study|Other|6|||
163079998|NCT00215657|589001245|FG007|Overall Study|Other|1|||
163079999|NCT04755231|589001246|FG000|Overall Study|Lost to Follow-up|5|||
163080000|NCT04755231|589001246|FG000|Overall Study|Withdrawal by Subject|5|||
163080001|NCT04754399|589001247|FG000|Overall Study|Adverse Event|5|||
163080002|NCT04754399|589001247|FG000|Overall Study|Withdrawal by Subject|6|||
163080003|NCT05259722|589001250|FG000|Overall Study|Adverse Event|2|||
163080004|NCT05259722|589001251|FG001|Overall Study|Adverse Event|24|||
163080005|NCT05259722|589001250|FG000|Overall Study|Lost to Follow-up|5|||
163080006|NCT05259722|589001251|FG001|Overall Study|Lost to Follow-up|1|||
163080007|NCT05259722|589001250|FG000|Overall Study|Lack of Efficacy|8|||
163080008|NCT05259722|589001251|FG001|Overall Study|Lack of Efficacy|26|||
163080009|NCT05259722|589001250|FG000|Overall Study|Withdrawal by Subject|15|||
162645869|NCT03090100|587421296|FG001|Overall Study|Non-compliance|0|||
163080010|NCT05259722|589001251|FG001|Overall Study|Withdrawal by Subject|33|||
163080011|NCT05259722|589001250|FG000|Overall Study|Various reasons|3|||
163080012|NCT05259722|589001251|FG001|Overall Study|Various reasons|9|||
163080013|NCT05259722|589001250|FG000|Overall Study|Not exposed to IMP|1|||
163080014|NCT05259722|589001251|FG001|Overall Study|Not exposed to IMP|12|||
163080015|NCT05259722|589001250|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
163080016|NCT05259722|589001251|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
163080017|NCT00962650|589001252|FG000|Overall Study|Transgastric DP was not completed|2|||
163080018|NCT00231465|589001253|FG000|Overall Study|Completed only one cycle|1|||
163080019|NCT00231465|589001253|FG000|Overall Study|Did not have follow up CT scans|1|||
163080020|NCT00420056|589001254|FG000|Overall Study|Objective progression or relapse|17|||
163080021|NCT03111732|589001260|FG000|Overall Study|Enrolled in different study|1|||
163080022|NCT03111732|589001260|FG000|Overall Study|Progressive disease|3|||
163080023|NCT03111732|589001260|FG000|Overall Study|Withdrawal by Subject|1|||
163080024|NCT03072875|589001261|FG000|Overall Study|Lost to Follow-up|1|||
163080025|NCT01684033|589001264|FG000|Period 1, First 30 Days|Adverse Event|1|||
163080026|NCT01684033|589001265|FG001|Period 1, First 30 Days|Adverse Event|1|||
163080027|NCT01684033|589001264|FG000|Period 1, First 30 Days|Noncompliance|1|||
163080028|NCT01684033|589001265|FG001|Period 1, First 30 Days|Noncompliance|0|||
163080029|NCT01684033|589001264|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
163080030|NCT01684033|589001265|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
163080031|NCT01684033|589001264|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
163080032|NCT01684033|589001265|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
163080033|NCT01684033|589001264|FG000|Period 2, Second 30 Days|Adverse Event|1|||
163080034|NCT01684033|589001265|FG001|Period 2, Second 30 Days|Adverse Event|0|||
163080035|NCT03726879|589001266|FG000|Overall Study|Death|11|||
163080036|NCT03726879|589001267|FG001|Overall Study|Death|13|||
163080037|NCT03726879|589001266|FG000|Overall Study|Physician Decision|0|||
163080038|NCT03726879|589001267|FG001|Overall Study|Physician Decision|2|||
163080039|NCT03726879|589001266|FG000|Overall Study|Protocol Violation|0|||
163080040|NCT03726879|589001267|FG001|Overall Study|Protocol Violation|1|||
163080041|NCT03726879|589001266|FG000|Overall Study|Withdrawal by Subject|5|||
163080042|NCT03726879|589001267|FG001|Overall Study|Withdrawal by Subject|6|||
163080043|NCT03726879|589001266|FG000|Overall Study|TSH result is unstable|0|||
163080044|NCT03726879|589001267|FG001|Overall Study|TSH result is unstable|1|||
163080045|NCT03726879|589001266|FG000|Overall Study|Disease relapse|1|||
163080046|NCT03726879|589001267|FG001|Overall Study|Disease relapse|0|||
163080047|NCT03726879|589001266|FG000|Overall Study|Lost to Follow-up|3|||
163080048|NCT03726879|589001267|FG001|Overall Study|Lost to Follow-up|0|||
163080049|NCT02496156|589001268|FG000|Overall Study|Lost to Follow-up|5|||
163080050|NCT02496156|589001269|FG001|Overall Study|Lost to Follow-up|0|||
163080051|NCT02496156|589001268|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
163080052|NCT02496156|589001269|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
163080053|NCT00507507|589001270|FG000|Treatment Period|Lost to Follow-up|0|||
163080054|NCT00507507|589001271|FG001|Treatment Period|Lost to Follow-up|2|||
163080055|NCT00507507|589001270|FG000|Treatment Period|Physician Decision|4|||
163080056|NCT00507507|589001271|FG001|Treatment Period|Physician Decision|1|||
163080057|NCT00507507|589001270|FG000|Treatment Period|Protocol Violation|1|||
163080058|NCT00507507|589001271|FG001|Treatment Period|Protocol Violation|2|||
162645870|NCT03090100|587421295|FG000|Overall Study|Other|2|||
162645871|NCT03090100|587421296|FG001|Overall Study|Other|2|||
162645872|NCT03446040|587421297|FG000|Overall Study|Disease progression|3|||
163080059|NCT00507507|589001270|FG000|Treatment Period|Adverse Event|1|||
163080060|NCT00507507|589001271|FG001|Treatment Period|Adverse Event|1|||
163080061|NCT00507507|589001270|FG000|Treatment Period|Withdrawal by Subject|46|||
163080062|NCT00507507|589001271|FG001|Treatment Period|Withdrawal by Subject|47|||
163080063|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
163080064|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
163080065|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
163080066|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
163080067|NCT00507507|589001270|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
163080068|NCT00507507|589001271|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
163080069|NCT00289900|589001272|FG000|Overall Study|Adverse Event|28|||
163080070|NCT00289900|589001273|FG001|Overall Study|Adverse Event|40|||
163080071|NCT00289900|589001274|FG002|Overall Study|Adverse Event|13|||
163080072|NCT00289900|589001275|FG003|Overall Study|Adverse Event|19|||
163080073|NCT00289900|589001276|FG004|Overall Study|Adverse Event|20|||
162645873|NCT03446040|587421298|FG001|Overall Study|Disease progression|3|||
162645874|NCT03446040|587421299|FG002|Overall Study|Disease progression|3|||
162645875|NCT03446040|587421300|FG003|Overall Study|Disease progression|4|||
162645876|NCT03446040|587421301|FG004|Overall Study|Disease progression|4|||
162645877|NCT03446040|587421302|FG005|Overall Study|Disease progression|6|||
162645878|NCT03446040|587421303|FG006|Overall Study|Disease progression|3|||
162645879|NCT03446040|587421304|FG007|Overall Study|Disease progression|4|||
163029675|NCT00033657|588811864|FG000|Adjuvant Chemotherapy|Other|0|||
163029676|NCT00033657|588811865|FG001|Adjuvant Chemotherapy|Other|2|||
163029677|NCT03235115|588811867|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029678|NCT03235115|588811868|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029679|NCT03235115|588811869|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029680|NCT03235115|588811870|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029681|NCT03235115|588811871|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
163029682|NCT03235115|588811872|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
163029683|NCT00503997|588811874|FG000|Overall Study|disease progression|1|||
163029684|NCT00503997|588811874|FG000|Overall Study|Adverse Event|5|||
163029685|NCT00503997|588811874|FG000|Overall Study|Death|1|||
163029686|NCT00503997|588811874|FG000|Overall Study|Withdrawal by Subject|1|||
163029687|NCT01162122|588811879|FG000|Overall Study|Withdrawal by Subject|52|||
163029688|NCT01162122|588811880|FG001|Overall Study|Withdrawal by Subject|43|||
163029689|NCT01162122|588811879|FG000|Overall Study|Lost to Follow-up|73|||
163029690|NCT01162122|588811880|FG001|Overall Study|Lost to Follow-up|91|||
163029691|NCT01162122|588811879|FG000|Overall Study|Adverse Event|3|||
163029692|NCT01162122|588811880|FG001|Overall Study|Adverse Event|2|||
163029693|NCT01162122|588811879|FG000|Overall Study|Death|51|||
163029694|NCT01162122|588811880|FG001|Overall Study|Death|46|||
163029695|NCT01162122|588811879|FG000|Overall Study|Protocol Violation|2|||
163029696|NCT01162122|588811880|FG001|Overall Study|Protocol Violation|2|||
163029697|NCT01162122|588811879|FG000|Overall Study|Inappropriate enrollment|5|||
163080074|NCT00289900|589001277|FG005|Overall Study|Adverse Event|33|||
163080075|NCT00289900|589001272|FG000|Overall Study|Lost to Follow-up|7|||
163029698|NCT01162122|588811880|FG001|Overall Study|Inappropriate enrollment|4|||
163029699|NCT01162122|588811879|FG000|Overall Study|Administrative reason|1|||
163029700|NCT01162122|588811880|FG001|Overall Study|Administrative reason|1|||
163029701|NCT01162122|588811879|FG000|Overall Study|Unable to classify|3|||
163080076|NCT00289900|589001273|FG001|Overall Study|Lost to Follow-up|7|||
162645880|NCT03446040|587421305|FG008|Overall Study|Disease progression|2|||
163029702|NCT01162122|588811880|FG001|Overall Study|Unable to classify|7|||
163029703|NCT01162122|588811879|FG000|Overall Study|Missing primary reason|1|||
163080077|NCT00289900|589001274|FG002|Overall Study|Lost to Follow-up|8|||
163080078|NCT00289900|589001275|FG003|Overall Study|Lost to Follow-up|8|||
163080079|NCT00289900|589001276|FG004|Overall Study|Lost to Follow-up|4|||
163080080|NCT00289900|589001277|FG005|Overall Study|Lost to Follow-up|8|||
163080081|NCT00289900|589001272|FG000|Overall Study|Participant had flushing|18|||
163080082|NCT00289900|589001273|FG001|Overall Study|Participant had flushing|42|||
163080083|NCT00289900|589001274|FG002|Overall Study|Participant had flushing|1|||
163080084|NCT00289900|589001275|FG003|Overall Study|Participant had flushing|2|||
163080085|NCT00289900|589001276|FG004|Overall Study|Participant had flushing|0|||
163080086|NCT00289900|589001277|FG005|Overall Study|Participant had flushing|4|||
163080087|NCT00289900|589001272|FG000|Overall Study|Other|0|||
163080088|NCT00289900|589001273|FG001|Overall Study|Other|0|||
163080089|NCT00289900|589001274|FG002|Overall Study|Other|0|||
163080090|NCT00289900|589001275|FG003|Overall Study|Other|5|||
163080091|NCT00289900|589001276|FG004|Overall Study|Other|1|||
163080092|NCT00289900|589001277|FG005|Overall Study|Other|0|||
163080093|NCT00289900|589001272|FG000|Overall Study|Participant moved|1|||
163080094|NCT00289900|589001273|FG001|Overall Study|Participant moved|0|||
163080095|NCT00289900|589001274|FG002|Overall Study|Participant moved|0|||
163080096|NCT00289900|589001275|FG003|Overall Study|Participant moved|1|||
163080097|NCT00289900|589001276|FG004|Overall Study|Participant moved|1|||
163080098|NCT00289900|589001277|FG005|Overall Study|Participant moved|1|||
163080099|NCT00289900|589001272|FG000|Overall Study|Withdrawal by Subject|10|||
163080100|NCT00289900|589001273|FG001|Overall Study|Withdrawal by Subject|21|||
163080101|NCT00289900|589001274|FG002|Overall Study|Withdrawal by Subject|8|||
163080102|NCT00289900|589001275|FG003|Overall Study|Withdrawal by Subject|18|||
163080103|NCT00289900|589001276|FG004|Overall Study|Withdrawal by Subject|12|||
163080104|NCT00289900|589001277|FG005|Overall Study|Withdrawal by Subject|11|||
163080105|NCT00289900|589001272|FG000|Overall Study|Protocol Violation|3|||
163080106|NCT00289900|589001273|FG001|Overall Study|Protocol Violation|9|||
163080107|NCT00289900|589001274|FG002|Overall Study|Protocol Violation|2|||
162645881|NCT03446040|587421306|FG009|Overall Study|Disease progression|4|||
162645882|NCT03446040|587421307|FG010|Overall Study|Disease progression|9|||
162645883|NCT03446040|587421308|FG011|Overall Study|Disease progression|3|||
162645884|NCT03446040|587421309|FG012|Overall Study|Disease progression|7|||
162645885|NCT03446040|587421310|FG013|Overall Study|Disease progression|7|||
162645886|NCT03446040|587421297|FG000|Overall Study|Study drug toxicity|0|||
162645887|NCT03446040|587421298|FG001|Overall Study|Study drug toxicity|0|||
162645888|NCT03446040|587421299|FG002|Overall Study|Study drug toxicity|0|||
162645889|NCT03446040|587421300|FG003|Overall Study|Study drug toxicity|0|||
162645890|NCT03446040|587421301|FG004|Overall Study|Study drug toxicity|0|||
162645891|NCT03446040|587421302|FG005|Overall Study|Study drug toxicity|0|||
162645892|NCT03446040|587421303|FG006|Overall Study|Study drug toxicity|0|||
162645893|NCT03446040|587421304|FG007|Overall Study|Study drug toxicity|0|||
162645894|NCT03446040|587421305|FG008|Overall Study|Study drug toxicity|1|||
162645895|NCT03446040|587421306|FG009|Overall Study|Study drug toxicity|0|||
162645896|NCT03446040|587421307|FG010|Overall Study|Study drug toxicity|0|||
162645897|NCT03446040|587421308|FG011|Overall Study|Study drug toxicity|0|||
162645898|NCT03446040|587421309|FG012|Overall Study|Study drug toxicity|0|||
162645899|NCT03446040|587421310|FG013|Overall Study|Study drug toxicity|0|||
162645900|NCT03446040|587421297|FG000|Overall Study|Adverse Event|0|||
162645901|NCT03446040|587421298|FG001|Overall Study|Adverse Event|0|||
162645902|NCT03446040|587421299|FG002|Overall Study|Adverse Event|0|||
162645903|NCT03446040|587421300|FG003|Overall Study|Adverse Event|0|||
162645904|NCT03446040|587421301|FG004|Overall Study|Adverse Event|0|||
162645905|NCT03446040|587421302|FG005|Overall Study|Adverse Event|2|||
162645906|NCT03446040|587421303|FG006|Overall Study|Adverse Event|0|||
162645907|NCT03446040|587421304|FG007|Overall Study|Adverse Event|0|||
162645908|NCT03446040|587421305|FG008|Overall Study|Adverse Event|1|||
162645909|NCT03446040|587421306|FG009|Overall Study|Adverse Event|0|||
162645910|NCT03446040|587421307|FG010|Overall Study|Adverse Event|0|||
162645911|NCT03446040|587421308|FG011|Overall Study|Adverse Event|0|||
162645912|NCT03446040|587421309|FG012|Overall Study|Adverse Event|0|||
162645913|NCT03446040|587421310|FG013|Overall Study|Adverse Event|0|||
162645914|NCT03446040|587421297|FG000|Overall Study|Death|0|||
162645915|NCT03446040|587421298|FG001|Overall Study|Death|0|||
162645916|NCT03446040|587421299|FG002|Overall Study|Death|0|||
162645917|NCT03446040|587421300|FG003|Overall Study|Death|0|||
162645918|NCT03446040|587421301|FG004|Overall Study|Death|0|||
162645919|NCT03446040|587421302|FG005|Overall Study|Death|0|||
162645920|NCT03446040|587421303|FG006|Overall Study|Death|0|||
162645921|NCT03446040|587421304|FG007|Overall Study|Death|0|||
162645922|NCT03446040|587421305|FG008|Overall Study|Death|0|||
162645923|NCT03446040|587421306|FG009|Overall Study|Death|0|||
162645924|NCT03446040|587421307|FG010|Overall Study|Death|1|||
162645925|NCT03446040|587421308|FG011|Overall Study|Death|0|||
162645926|NCT03446040|587421309|FG012|Overall Study|Death|0|||
162645927|NCT03446040|587421310|FG013|Overall Study|Death|2|||
162645928|NCT03446040|587421297|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162645929|NCT03446040|587421298|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
162645930|NCT03446040|587421299|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162645931|NCT03446040|587421300|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
162645932|NCT03446040|587421301|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
162645933|NCT03446040|587421302|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
162645934|NCT03446040|587421303|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
162645935|NCT03446040|587421304|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
162645936|NCT03446040|587421305|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
162645937|NCT03446040|587421306|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
162645938|NCT03446040|587421307|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
162645939|NCT03446040|587421308|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
162645940|NCT03446040|587421309|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
162645941|NCT03446040|587421310|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
162645942|NCT03446040|587421297|FG000|Overall Study|Participant withdrew consent|0|||
162645943|NCT03446040|587421298|FG001|Overall Study|Participant withdrew consent|0|||
162645944|NCT03446040|587421299|FG002|Overall Study|Participant withdrew consent|0|||
163029704|NCT01162122|588811880|FG001|Overall Study|Missing primary reason|0|||
163029705|NCT02020512|588811881|FG000|Overall Study|Adverse Event|1|||
163029706|NCT02020512|588811881|FG000|Overall Study|Lost to Follow-up|3|||
163029707|NCT02020512|588811881|FG000|Overall Study|Protocol Violation|4|||
163029708|NCT00656851|588811884|FG000|Overall Study|Withdrawal by Subject|0|||
163029709|NCT00656851|588811885|FG001|Overall Study|Withdrawal by Subject|4|||
163029710|NCT00835679|588811887|FG000|Overall Study|Withdrawal by Subject|1|||
163029711|NCT00835679|588811888|FG001|Overall Study|Withdrawal by Subject|0|||
163029712|NCT00835679|588811889|FG002|Overall Study|Withdrawal by Subject|0|||
162645945|NCT03446040|587421300|FG003|Overall Study|Participant withdrew consent|0|||
162645946|NCT03446040|587421301|FG004|Overall Study|Participant withdrew consent|0|||
163080108|NCT00289900|589001275|FG003|Overall Study|Protocol Violation|6|||
163080109|NCT00289900|589001276|FG004|Overall Study|Protocol Violation|7|||
163080110|NCT00289900|589001277|FG005|Overall Study|Protocol Violation|4|||
163080111|NCT00289900|589001272|FG000|Overall Study|site terminated|1|||
163080112|NCT00289900|589001273|FG001|Overall Study|site terminated|0|||
163080113|NCT00289900|589001274|FG002|Overall Study|site terminated|1|||
163080114|NCT00289900|589001275|FG003|Overall Study|site terminated|0|||
163080115|NCT00289900|589001276|FG004|Overall Study|site terminated|0|||
163080116|NCT00289900|589001277|FG005|Overall Study|site terminated|0|||
163080117|NCT00289900|589001272|FG000|Overall Study|Not treated|0|||
163080118|NCT00289900|589001273|FG001|Overall Study|Not treated|1|||
163080119|NCT00289900|589001274|FG002|Overall Study|Not treated|0|||
163080120|NCT00289900|589001275|FG003|Overall Study|Not treated|0|||
163080121|NCT00289900|589001276|FG004|Overall Study|Not treated|0|||
163080122|NCT00289900|589001277|FG005|Overall Study|Not treated|0|||
163080123|NCT03249558|589001278|FG000|Overall Study|Lost to Follow-up|2|||
163080124|NCT03249558|589001279|FG001|Overall Study|Lost to Follow-up|1|||
163080125|NCT03249558|589001280|FG002|Overall Study|Lost to Follow-up|4|||
163080126|NCT03249558|589001278|FG000|Overall Study|Physician Decision|1|||
163080127|NCT03249558|589001279|FG001|Overall Study|Physician Decision|0|||
163080128|NCT03249558|589001280|FG002|Overall Study|Physician Decision|0|||
163080129|NCT03249558|589001278|FG000|Overall Study|Withdrawal by Subject|6|||
163080130|NCT03249558|589001279|FG001|Overall Study|Withdrawal by Subject|5|||
163080131|NCT03249558|589001280|FG002|Overall Study|Withdrawal by Subject|7|||
163080132|NCT03249558|589001278|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
163080133|NCT03249558|589001279|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
163080134|NCT03249558|589001280|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
163080135|NCT03249558|589001278|FG000|Overall Study|Protocol Violation|1|||
163080136|NCT03249558|589001279|FG001|Overall Study|Protocol Violation|1|||
163080137|NCT03249558|589001280|FG002|Overall Study|Protocol Violation|2|||
163080138|NCT02656173|589001281|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
163080139|NCT02656173|589001282|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
163080140|NCT02656173|589001281|FG000|Overall Study|Adverse Event|7|||
163080141|NCT02656173|589001282|FG001|Overall Study|Adverse Event|5|||
163080142|NCT02656173|589001281|FG000|Overall Study|Withdrawal by Subject|1|||
163080143|NCT02656173|589001282|FG001|Overall Study|Withdrawal by Subject|3|||
163080144|NCT02656173|589001281|FG000|Overall Study|Protocol Violation|0|||
163080145|NCT02656173|589001282|FG001|Overall Study|Protocol Violation|1|||
163080146|NCT02656173|589001281|FG000|Overall Study|Miscellaneous|2|||
163080147|NCT02656173|589001282|FG001|Overall Study|Miscellaneous|0|||
163080148|NCT03449147|589001284|FG000|52-week Treatment Period|Death|0|||
163080149|NCT03449147|589001285|FG001|52-week Treatment Period|Death|1|||
163080150|NCT03449147|589001286|FG002|52-week Treatment Period|Death|0|||
163080151|NCT03449147|589001284|FG000|52-week Treatment Period|Lost to Follow-up|6|||
163080152|NCT03449147|589001285|FG001|52-week Treatment Period|Lost to Follow-up|2|||
163080153|NCT03449147|589001286|FG002|52-week Treatment Period|Lost to Follow-up|5|||
163080154|NCT03449147|589001284|FG000|52-week Treatment Period|Other|0|||
163080155|NCT03449147|589001285|FG001|52-week Treatment Period|Other|1|||
163080156|NCT03449147|589001286|FG002|52-week Treatment Period|Other|2|||
163080157|NCT03449147|589001284|FG000|52-week Treatment Period|Physician Decision|1|||
163080158|NCT03449147|589001285|FG001|52-week Treatment Period|Physician Decision|0|||
163080159|NCT03449147|589001286|FG002|52-week Treatment Period|Physician Decision|3|||
163080160|NCT03449147|589001284|FG000|52-week Treatment Period|Screen Failure|1|||
163080161|NCT03449147|589001285|FG001|52-week Treatment Period|Screen Failure|2|||
163080162|NCT03449147|589001286|FG002|52-week Treatment Period|Screen Failure|0|||
163080163|NCT03449147|589001284|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
163080164|NCT03449147|589001285|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
163080165|NCT03449147|589001286|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
163080166|NCT03449147|589001284|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
163080167|NCT03449147|589001285|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
163080168|NCT03449147|589001286|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
163080169|NCT03449147|589001284|FG000|12-Week Off-Treatment Durability Period|Other|0|||
163080170|NCT03449147|589001285|FG001|12-Week Off-Treatment Durability Period|Other|1|||
163080171|NCT03449147|589001286|FG002|12-Week Off-Treatment Durability Period|Other|0|||
163080172|NCT00954538|589001287|FG000|Part III|Withdrawal by Subject|0|||
163080173|NCT00954538|589001288|FG001|Part III|Withdrawal by Subject|0|||
163080174|NCT00954538|589001289|FG002|Part III|Withdrawal by Subject|0|||
163080175|NCT00954538|589001290|FG003|Part III|Withdrawal by Subject|0|||
163080176|NCT00954538|589001291|FG004|Part III|Withdrawal by Subject|1|||
163080177|NCT00954538|589001292|FG005|Part III|Withdrawal by Subject|0|||
163080178|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Death|2|||
163080179|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
163080180|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
163080181|NCT00974233|589001297|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
163080182|NCT00974233|589001297|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
163029713|NCT00835679|588811890|FG003|Overall Study|Withdrawal by Subject|0|||
163029714|NCT00955968|588811891|FG000|Overall Study|Death|2|||
163029715|NCT00955968|588811892|FG001|Overall Study|Death|4|||
163029716|NCT00955968|588811891|FG000|Overall Study|Withdrawal by Subject|35|||
163029717|NCT00955968|588811892|FG001|Overall Study|Withdrawal by Subject|31|||
163029718|NCT00955968|588811891|FG000|Overall Study|Lost to Follow-up|45|||
163029719|NCT00955968|588811892|FG001|Overall Study|Lost to Follow-up|39|||
163029720|NCT00955968|588811891|FG000|Overall Study|Site closed|55|||
163029721|NCT00955968|588811892|FG001|Overall Study|Site closed|52|||
163029722|NCT05020899|588811893|FG000|8 Week Follow-up|Lost to Follow-up|3|||
163029723|NCT05020899|588811894|FG001|8 Week Follow-up|Lost to Follow-up|6|||
163029724|NCT05020899|588811893|FG000|12 Week Follow-up|Lost to Follow-up|1|||
163029725|NCT05020899|588811894|FG001|12 Week Follow-up|Lost to Follow-up|0|||
163029726|NCT05020899|588811893|FG000|12 Week Follow-up|Death|0|||
163029727|NCT05020899|588811894|FG001|12 Week Follow-up|Death|1|||
163029728|NCT01793688|588811899|FG000|Overall Study|Protocol Violation|2|||
163029729|NCT01419080|588811900|FG000|Overall Study|Withdrawal by Subject|75|||
163029730|NCT01419080|588811900|FG000|Overall Study|Death|30|||
163029731|NCT01419080|588811900|FG000|Overall Study|Lost to Follow-up|23|||
163029732|NCT01419080|588811900|FG000|Overall Study|Too Ill|3|||
163029733|NCT00474045|588811907|FG000|Overall Study|Adverse Event|18|||
163029734|NCT00474045|588811908|FG001|Overall Study|Adverse Event|8|||
163029735|NCT00474045|588811907|FG000|Overall Study|Unclassified|1|||
163029736|NCT00474045|588811908|FG001|Overall Study|Unclassified|3|||
163029737|NCT00474045|588811907|FG000|Overall Study|Lack of Efficacy|0|||
163029738|NCT00474045|588811908|FG001|Overall Study|Lack of Efficacy|9|||
163029739|NCT00474045|588811907|FG000|Overall Study|Lost to Follow-up|1|||
163029740|NCT00474045|588811908|FG001|Overall Study|Lost to Follow-up|1|||
163029741|NCT00474045|588811907|FG000|Overall Study|Protocol Violation|10|||
163029742|NCT00474045|588811908|FG001|Overall Study|Protocol Violation|12|||
163029743|NCT00474045|588811907|FG000|Overall Study|Withdrawal by Subject|16|||
163029744|NCT00474045|588811908|FG001|Overall Study|Withdrawal by Subject|18|||
163029745|NCT00474045|588811907|FG000|Overall Study|Withdrawal criteria|60|||
163029746|NCT00474045|588811908|FG001|Overall Study|Withdrawal criteria|50|||
163029747|NCT02135107|588811909|FG000|Treatment Period|Withdrawal by Subject|11|||
163029748|NCT02135107|588811910|FG001|Treatment Period|Withdrawal by Subject|0|||
163029749|NCT02135107|588811911|FG002|Treatment Period|Withdrawal by Subject|0|||
163029750|NCT02135107|588811912|FG003|Treatment Period|Withdrawal by Subject|0|||
163029751|NCT02135107|588811909|FG000|Treatment Period|Adverse Event|5|||
163029752|NCT02135107|588811910|FG001|Treatment Period|Adverse Event|2|||
163029753|NCT02135107|588811911|FG002|Treatment Period|Adverse Event|0|||
163029754|NCT02135107|588811912|FG003|Treatment Period|Adverse Event|0|||
163029755|NCT02135107|588811909|FG000|Treatment Period|Pregnancy|1|||
163029756|NCT02135107|588811910|FG001|Treatment Period|Pregnancy|0|||
163029757|NCT02135107|588811911|FG002|Treatment Period|Pregnancy|0|||
163029758|NCT02135107|588811912|FG003|Treatment Period|Pregnancy|0|||
163029759|NCT02135107|588811909|FG000|Treatment Period|Other|115|||
163029760|NCT02135107|588811910|FG001|Treatment Period|Other|24|||
163029761|NCT02135107|588811911|FG002|Treatment Period|Other|0|||
163029762|NCT02135107|588811912|FG003|Treatment Period|Other|0|||
163029763|NCT02135107|588811909|FG000|Maintenance Therapy Period|Adverse Event|0|||
163029764|NCT02135107|588811910|FG001|Maintenance Therapy Period|Adverse Event|0|||
163029765|NCT02135107|588811911|FG002|Maintenance Therapy Period|Adverse Event|3|||
163029766|NCT02135107|588811912|FG003|Maintenance Therapy Period|Adverse Event|7|||
163029767|NCT02135107|588811909|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
163029768|NCT02135107|588811910|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
163029769|NCT02135107|588811911|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
163029770|NCT02135107|588811912|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
163029771|NCT02135107|588811909|FG000|Maintenance Therapy Period|Pregnancy|0|||
163029772|NCT02135107|588811910|FG001|Maintenance Therapy Period|Pregnancy|0|||
162645947|NCT03446040|587421302|FG005|Overall Study|Participant withdrew consent|1|||
163029773|NCT02135107|588811911|FG002|Maintenance Therapy Period|Pregnancy|0|||
163029774|NCT02135107|588811912|FG003|Maintenance Therapy Period|Pregnancy|1|||
163029775|NCT02135107|588811909|FG000|Maintenance Therapy Period|Other|0|||
163029776|NCT02135107|588811910|FG001|Maintenance Therapy Period|Other|0|||
163029777|NCT02135107|588811911|FG002|Maintenance Therapy Period|Other|7|||
163029778|NCT02135107|588811912|FG003|Maintenance Therapy Period|Other|8|||
163029779|NCT02278120|588811915|FG000|Treatment Period|Progressive disease|234|||
163029780|NCT02278120|588811916|FG001|Treatment Period|Progressive disease|260|||
163029781|NCT02278120|588811915|FG000|Treatment Period|Subject/guardian decision|23|||
163029782|NCT02278120|588811916|FG001|Treatment Period|Subject/guardian decision|20|||
163029783|NCT02278120|588811915|FG000|Treatment Period|Adverse Event|16|||
163029784|NCT02278120|588811916|FG001|Treatment Period|Adverse Event|14|||
163029785|NCT02278120|588811915|FG000|Treatment Period|Physician Decision|14|||
163029786|NCT02278120|588811916|FG001|Treatment Period|Physician Decision|27|||
163029787|NCT02278120|588811915|FG000|Treatment Period|Death|3|||
163029788|NCT02278120|588811916|FG001|Treatment Period|Death|3|||
163029789|NCT02278120|588811915|FG000|Treatment Period|Lost to Follow-up|2|||
163029790|NCT02278120|588811916|FG001|Treatment Period|Lost to Follow-up|0|||
162645948|NCT03446040|587421303|FG006|Overall Study|Participant withdrew consent|0|||
163080183|NCT00974233|589001297|FG000|Maintenance Lenalidomide|Adverse Event|8|||
163080184|NCT05520333|589002744|FG000|Overall Study|Lost to Follow-up|3|||
163080185|NCT05520333|589002745|FG001|Overall Study|Lost to Follow-up|6|||
163080186|NCT02904265|589002748|FG000|Overall Study|Physician Decision|1|||
163080187|NCT02904265|589002749|FG001|Overall Study|Physician Decision|2|||
163080188|NCT00185614|589002754|FG000|Inter-treatment Period|Physician Decision|1|||
163080189|NCT00185614|589002754|FG000|Inter-treatment Period|Relapse|2|||
163080190|NCT00185614|589002754|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
163080191|NCT01034657|589002763|FG000|Core Phase|Withdrawal by Subject|1|||
163080192|NCT01034657|589002764|FG001|Core Phase|Withdrawal by Subject|0|||
163080193|NCT01034657|589002765|FG002|Core Phase|Withdrawal by Subject|0|||
163080194|NCT01034657|589002763|FG000|Core Phase|Lack of Efficacy|2|||
163080195|NCT01034657|589002764|FG001|Core Phase|Lack of Efficacy|0|||
163080196|NCT01034657|589002765|FG002|Core Phase|Lack of Efficacy|0|||
163080197|NCT01034657|589002763|FG000|Core Phase|Abnormal laboratory value|1|||
163080198|NCT01034657|589002764|FG001|Core Phase|Abnormal laboratory value|0|||
163080199|NCT01034657|589002765|FG002|Core Phase|Abnormal laboratory value|0|||
163080200|NCT01034657|589002763|FG000|Core Phase|Adverse Event|8|||
163080201|NCT01034657|589002764|FG001|Core Phase|Adverse Event|0|||
163080202|NCT01034657|589002765|FG002|Core Phase|Adverse Event|0|||
163080203|NCT01034657|589002763|FG000|Core Phase|Protocol Violation|2|||
163080204|NCT01034657|589002764|FG001|Core Phase|Protocol Violation|0|||
163080205|NCT01034657|589002765|FG002|Core Phase|Protocol Violation|0|||
163080206|NCT01034657|589002763|FG000|Randomized Phase|Withdrawal by Subject|0|||
163080207|NCT01034657|589002764|FG001|Randomized Phase|Withdrawal by Subject|2|||
163080208|NCT01034657|589002765|FG002|Randomized Phase|Withdrawal by Subject|0|||
163080209|NCT01034657|589002763|FG000|Randomized Phase|Lack of Efficacy|5|||
163080210|NCT01034657|589002764|FG001|Randomized Phase|Lack of Efficacy|1|||
163080211|NCT01034657|589002765|FG002|Randomized Phase|Lack of Efficacy|0|||
163080212|NCT01034657|589002763|FG000|Randomized Phase|Abnormal laboratory value|0|||
163080213|NCT01034657|589002764|FG001|Randomized Phase|Abnormal laboratory value|1|||
163080214|NCT01034657|589002765|FG002|Randomized Phase|Abnormal laboratory value|0|||
163080215|NCT01034657|589002763|FG000|Randomized Phase|Adverse Event|0|||
163080216|NCT01034657|589002764|FG001|Randomized Phase|Adverse Event|2|||
163080217|NCT01034657|589002765|FG002|Randomized Phase|Adverse Event|1|||
163080218|NCT01517178|589002766|FG000|Period 1|Adverse Event|1|||
163080219|NCT01517178|589002767|FG001|Period 1|Adverse Event|2|||
163080220|NCT01517178|589002766|FG000|Period 1|Lack of Efficacy|0|||
163080221|NCT01517178|589002767|FG001|Period 1|Lack of Efficacy|1|||
163080222|NCT01517178|589002766|FG000|Period 1|E.g. study termination|3|||
163080223|NCT01517178|589002767|FG001|Period 1|E.g. study termination|1|||
163080224|NCT01517178|589002766|FG000|Period 1|Withdrawal by Subject|0|||
163080225|NCT01517178|589002767|FG001|Period 1|Withdrawal by Subject|1|||
163080226|NCT01517178|589002766|FG000|Period 2|Adverse Event|1|||
163080227|NCT01517178|589002767|FG001|Period 2|Adverse Event|0|||
163080228|NCT01517178|589002766|FG000|Period 2|Withdrawal by Subject|3|||
163080229|NCT01517178|589002767|FG001|Period 2|Withdrawal by Subject|0|||
163080230|NCT01517178|589002766|FG000|Period 2|E.g. study termination|2|||
163080231|NCT01517178|589002767|FG001|Period 2|E.g. study termination|2|||
163080232|NCT01225952|589002781|FG000|Overall Study|Lost to Follow-up|1|||
163080233|NCT01225952|589002782|FG001|Overall Study|Lost to Follow-up|0|||
163080234|NCT01225952|589002783|FG002|Overall Study|Lost to Follow-up|0|||
163080235|NCT01225952|589002781|FG000|Overall Study|Study Eye Explanted|0|||
163080236|NCT01225952|589002782|FG001|Overall Study|Study Eye Explanted|0|||
163080237|NCT01225952|589002783|FG002|Overall Study|Study Eye Explanted|1|||
162645949|NCT03446040|587421304|FG007|Overall Study|Participant withdrew consent|1|||
162645950|NCT03446040|587421305|FG008|Overall Study|Participant withdrew consent|0|||
162645951|NCT03446040|587421306|FG009|Overall Study|Participant withdrew consent|0|||
162645952|NCT03446040|587421307|FG010|Overall Study|Participant withdrew consent|0|||
162645953|NCT03446040|587421308|FG011|Overall Study|Participant withdrew consent|0|||
162645954|NCT03446040|587421309|FG012|Overall Study|Participant withdrew consent|0|||
162645955|NCT03446040|587421310|FG013|Overall Study|Participant withdrew consent|0|||
162645956|NCT03446040|587421297|FG000|Overall Study|Not reported|0|||
163080238|NCT01225952|589002781|FG000|Overall Study|Withdrawal by Subject|4|||
163080239|NCT01225952|589002782|FG001|Overall Study|Withdrawal by Subject|4|||
163080240|NCT01225952|589002783|FG002|Overall Study|Withdrawal by Subject|5|||
163080241|NCT01225952|589002781|FG000|Overall Study|Surgical complications|1|||
163080242|NCT01225952|589002782|FG001|Overall Study|Surgical complications|0|||
163080243|NCT01225952|589002783|FG002|Overall Study|Surgical complications|0|||
163080244|NCT00889005|589002784|FG000|Overall Study|Lost to Follow-up|4|||
163080245|NCT00889005|589002785|FG001|Overall Study|Lost to Follow-up|2|||
163080246|NCT00889005|589002784|FG000|Overall Study|Withdrawal by Subject|4|||
163080247|NCT00889005|589002785|FG001|Overall Study|Withdrawal by Subject|0|||
163080248|NCT01998477|589002788|FG000|Overall Study|Lost to Follow-up|4|||
163080249|NCT01998477|589002789|FG001|Overall Study|Lost to Follow-up|5|||
163080250|NCT01998477|589002788|FG000|Overall Study|Withdrawal by Subject|6|||
163080251|NCT01998477|589002789|FG001|Overall Study|Withdrawal by Subject|0|||
163080252|NCT00129974|589002790|FG000|Overall Study|Other|1|||
163080253|NCT05122143|589002791|FG000|Overall Study|Adverse Event|1|||
163080254|NCT05122143|589002792|FG001|Overall Study|Adverse Event|0|||
163080255|NCT05122143|589002793|FG002|Overall Study|Adverse Event|0|||
163080256|NCT05122143|589002794|FG003|Overall Study|Adverse Event|0|||
163080257|NCT05122143|589002795|FG004|Overall Study|Adverse Event|1|||
163080258|NCT05122143|589002796|FG005|Overall Study|Adverse Event|0|||
163080259|NCT05122143|589002791|FG000|Overall Study|Protocol non-compliance|0|||
163080260|NCT05122143|589002792|FG001|Overall Study|Protocol non-compliance|0|||
163080261|NCT05122143|589002793|FG002|Overall Study|Protocol non-compliance|1|||
163080262|NCT05122143|589002794|FG003|Overall Study|Protocol non-compliance|0|||
163080263|NCT05122143|589002795|FG004|Overall Study|Protocol non-compliance|0|||
163080264|NCT05122143|589002796|FG005|Overall Study|Protocol non-compliance|0|||
163080265|NCT05122143|589002791|FG000|Overall Study|Covid contact|0|||
163080266|NCT05122143|589002792|FG001|Overall Study|Covid contact|0|||
163080267|NCT05122143|589002793|FG002|Overall Study|Covid contact|0|||
163080268|NCT05122143|589002794|FG003|Overall Study|Covid contact|0|||
163080269|NCT05122143|589002795|FG004|Overall Study|Covid contact|1|||
163080270|NCT05122143|589002796|FG005|Overall Study|Covid contact|0|||
163080271|NCT00692237|589002797|FG000|Overall Study|Withdrawal by Subject|1|||
163080272|NCT00692237|589002798|FG001|Overall Study|Withdrawal by Subject|3|||
163080273|NCT00692237|589002797|FG000|Overall Study|Adverse Event|0|||
163080274|NCT00692237|589002798|FG001|Overall Study|Adverse Event|1|||
163080275|NCT00395447|589002799|FG000|Overall Study|Death|37|||
163080276|NCT00395447|589002800|FG001|Overall Study|Death|32|||
163080277|NCT00395447|589002799|FG000|Overall Study|Lost to Follow-up|52|||
163080278|NCT00395447|589002800|FG001|Overall Study|Lost to Follow-up|43|||
163080279|NCT00395447|589002799|FG000|Overall Study|Withdrawal by Subject|24|||
163080280|NCT00395447|589002800|FG001|Overall Study|Withdrawal by Subject|19|||
163080281|NCT00395447|589002799|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
163080282|NCT00395447|589002800|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
163080283|NCT03766906|589002801|FG000|Overall Study|Withdrawal by Subject|6|||
163080284|NCT00836901|589002802|FG000|First Intervention|Withdrawal by Subject|1|||
163080285|NCT00836901|589002803|FG001|First Intervention|Withdrawal by Subject|0|||
163080286|NCT01047540|589002806|FG000|Overall Study|Protocol Violation|1|||
163080287|NCT01047540|589002807|FG001|Overall Study|Protocol Violation|0|||
163080288|NCT01047540|589002808|FG002|Overall Study|Protocol Violation|0|||
163080289|NCT01047540|589002809|FG003|Overall Study|Protocol Violation|0|||
163080290|NCT01047540|589002810|FG004|Overall Study|Protocol Violation|0|||
163080291|NCT01047540|589002806|FG000|Overall Study|Lost to Follow-up|1|||
163080292|NCT01047540|589002807|FG001|Overall Study|Lost to Follow-up|0|||
163080293|NCT01047540|589002808|FG002|Overall Study|Lost to Follow-up|0|||
163080294|NCT01047540|589002809|FG003|Overall Study|Lost to Follow-up|0|||
163080295|NCT01047540|589002810|FG004|Overall Study|Lost to Follow-up|0|||
163080296|NCT01047540|589002806|FG000|Overall Study|Withdrawal by Subject|1|||
163080297|NCT01047540|589002807|FG001|Overall Study|Withdrawal by Subject|0|||
163080298|NCT01047540|589002808|FG002|Overall Study|Withdrawal by Subject|3|||
163080299|NCT01047540|589002809|FG003|Overall Study|Withdrawal by Subject|0|||
163080300|NCT01047540|589002810|FG004|Overall Study|Withdrawal by Subject|1|||
163080301|NCT01047540|589002806|FG000|Overall Study|Pregnancy|1|||
163080302|NCT01047540|589002807|FG001|Overall Study|Pregnancy|0|||
163080303|NCT01047540|589002808|FG002|Overall Study|Pregnancy|0|||
163080304|NCT01047540|589002809|FG003|Overall Study|Pregnancy|0|||
163080305|NCT01047540|589002810|FG004|Overall Study|Pregnancy|0|||
163080306|NCT01047540|589002806|FG000|Overall Study|Adverse Event|1|||
163080307|NCT01047540|589002807|FG001|Overall Study|Adverse Event|0|||
163080308|NCT01047540|589002808|FG002|Overall Study|Adverse Event|0|||
163080309|NCT01047540|589002809|FG003|Overall Study|Adverse Event|0|||
163080310|NCT01047540|589002810|FG004|Overall Study|Adverse Event|0|||
163080311|NCT03032484|589002816|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
163080312|NCT03032484|589002817|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
163080313|NCT03032484|589002816|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
163080314|NCT03032484|589002817|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
163080315|NCT00595075|589002824|FG000|Overall Study|Withdrawal by Subject|1|||
163080316|NCT00595075|589002825|FG001|Overall Study|Withdrawal by Subject|0|||
163080317|NCT05261490|589002827|FG000|Overall Study|Other|1|||
163080318|NCT05261490|589002828|FG001|Overall Study|Other|0|||
163080319|NCT05261490|589002829|FG002|Overall Study|Other|0|||
163080320|NCT05261490|589002827|FG000|Overall Study|Study Terminated by Sponsor|1|||
163080321|NCT05261490|589002828|FG001|Overall Study|Study Terminated by Sponsor|1|||
163080322|NCT05261490|589002829|FG002|Overall Study|Study Terminated by Sponsor|4|||
163080323|NCT05261490|589002827|FG000|Overall Study|Death|1|||
163080324|NCT05261490|589002828|FG001|Overall Study|Death|2|||
163080325|NCT05261490|589002829|FG002|Overall Study|Death|0|||
163080326|NCT01335685|589002833|FG000|Overall Study|Study Terminated by Sponsor|2|||
163080327|NCT01335685|589002834|FG001|Overall Study|Study Terminated by Sponsor|1|||
163080328|NCT01335685|589002835|FG002|Overall Study|Study Terminated by Sponsor|1|||
163080329|NCT01335685|589002836|FG003|Overall Study|Study Terminated by Sponsor|10|||
163080330|NCT01335685|589002837|FG004|Overall Study|Study Terminated by Sponsor|0|||
163080331|NCT01335685|589002838|FG005|Overall Study|Study Terminated by Sponsor|4|||
163080332|NCT01335685|589002839|FG006|Overall Study|Study Terminated by Sponsor|2|||
163080333|NCT01335685|589002840|FG007|Overall Study|Study Terminated by Sponsor|3|||
163080334|NCT01335685|589002833|FG000|Overall Study|Withdrawal by Subject|1|||
163080335|NCT01335685|589002834|FG001|Overall Study|Withdrawal by Subject|0|||
163080336|NCT01335685|589002835|FG002|Overall Study|Withdrawal by Subject|0|||
163080337|NCT01335685|589002836|FG003|Overall Study|Withdrawal by Subject|1|||
163080338|NCT01335685|589002837|FG004|Overall Study|Withdrawal by Subject|0|||
163080339|NCT01335685|589002838|FG005|Overall Study|Withdrawal by Subject|0|||
163080340|NCT01335685|589002839|FG006|Overall Study|Withdrawal by Subject|0|||
163080341|NCT01335685|589002840|FG007|Overall Study|Withdrawal by Subject|0|||
163080342|NCT01335685|589002833|FG000|Overall Study|Reason not Specified|0|||
163080343|NCT01335685|589002834|FG001|Overall Study|Reason not Specified|0|||
163080344|NCT01335685|589002835|FG002|Overall Study|Reason not Specified|1|||
163080345|NCT01335685|589002836|FG003|Overall Study|Reason not Specified|0|||
163080346|NCT01335685|589002837|FG004|Overall Study|Reason not Specified|0|||
163080347|NCT01335685|589002838|FG005|Overall Study|Reason not Specified|1|||
163080348|NCT01335685|589002839|FG006|Overall Study|Reason not Specified|0|||
163080349|NCT01335685|589002840|FG007|Overall Study|Reason not Specified|0|||
163080350|NCT02554474|589002841|FG000|Overall Study|Protocol Violation|1|||
163080351|NCT02554474|589002842|FG001|Overall Study|Protocol Violation|1|||
163080352|NCT02554474|589002841|FG000|Overall Study|Health issue not related to the study|1|||
163080353|NCT02554474|589002842|FG001|Overall Study|Health issue not related to the study|0|||
163080354|NCT02554474|589002841|FG000|Overall Study|Withdrawal by Subject|1|||
163080355|NCT02554474|589002842|FG001|Overall Study|Withdrawal by Subject|1|||
163080356|NCT03211832|589002845|FG000|Overall Study|No longer with agency|32|||
163080357|NCT03211832|589002846|FG001|Overall Study|No longer with agency|49|||
163080358|NCT03211832|589002847|FG002|Overall Study|No longer with agency|30|||
163080359|NCT03211832|589002845|FG000|Overall Study|Declined survey|3|||
163080360|NCT03211832|589002846|FG001|Overall Study|Declined survey|3|||
163080361|NCT03211832|589002847|FG002|Overall Study|Declined survey|2|||
163080362|NCT03211832|589002845|FG000|Overall Study|Not available during data collection|1|||
163080363|NCT03211832|589002846|FG001|Overall Study|Not available during data collection|0|||
163080364|NCT03211832|589002847|FG002|Overall Study|Not available during data collection|2|||
163080365|NCT03777020|589002851|FG000|Overall Study|Withdrawal by Subject|4|||
163080366|NCT03777020|589002852|FG001|Overall Study|Withdrawal by Subject|4|||
163080367|NCT03777020|589002851|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
163080368|NCT03777020|589002852|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
163080369|NCT00489476|589002853|FG000|Overall Study|Lost to Follow-up|0|||
163080370|NCT00489476|589002854|FG001|Overall Study|Lost to Follow-up|1|||
163080371|NCT00489476|589002855|FG002|Overall Study|Lost to Follow-up|0|||
163080372|NCT00489476|589002856|FG003|Overall Study|Lost to Follow-up|0|||
163080373|NCT04003389|589002859|FG000|Overall Study|Adverse Event|27|||
163080374|NCT04003389|589002860|FG001|Overall Study|Adverse Event|34|||
162645957|NCT03446040|587421298|FG001|Overall Study|Not reported|0|||
162645958|NCT03446040|587421299|FG002|Overall Study|Not reported|1|||
162645959|NCT03446040|587421300|FG003|Overall Study|Not reported|0|||
162645960|NCT03446040|587421301|FG004|Overall Study|Not reported|0|||
163080375|NCT04003389|589002861|FG002|Overall Study|Adverse Event|28|||
163080376|NCT04003389|589002859|FG000|Overall Study|Lost to Follow-up|39|||
163080377|NCT04003389|589002860|FG001|Overall Study|Lost to Follow-up|30|||
163080378|NCT04003389|589002861|FG002|Overall Study|Lost to Follow-up|33|||
163080379|NCT04003389|589002859|FG000|Overall Study|Protocol Violation|1|||
163080380|NCT04003389|589002860|FG001|Overall Study|Protocol Violation|6|||
163080381|NCT04003389|589002861|FG002|Overall Study|Protocol Violation|5|||
163080382|NCT04003389|589002859|FG000|Overall Study|Withdrawal by Subject|119|||
163080383|NCT04003389|589002860|FG001|Overall Study|Withdrawal by Subject|79|||
163080384|NCT04003389|589002861|FG002|Overall Study|Withdrawal by Subject|85|||
163080385|NCT04003389|589002859|FG000|Overall Study|Miscellaneous|14|||
163080386|NCT04003389|589002860|FG001|Overall Study|Miscellaneous|11|||
163080387|NCT04003389|589002861|FG002|Overall Study|Miscellaneous|14|||
163080388|NCT04003389|589002859|FG000|Overall Study|Participant did not receive study drug|1|||
163080389|NCT04003389|589002860|FG001|Overall Study|Participant did not receive study drug|0|||
163080390|NCT04003389|589002861|FG002|Overall Study|Participant did not receive study drug|0|||
163080391|NCT02514746|589002866|FG000|Overall Study|Chronically Ill|1|||
163080392|NCT02514746|589002867|FG001|Overall Study|Chronically Ill|2|||
163080393|NCT02514746|589002866|FG000|Overall Study|Physician Decision|4|||
163080394|NCT02514746|589002867|FG001|Overall Study|Physician Decision|2|||
163080395|NCT02514746|589002866|FG000|Overall Study|Withdrawal by Subject|12|||
163080396|NCT02514746|589002867|FG001|Overall Study|Withdrawal by Subject|10|||
163080397|NCT02514746|589002866|FG000|Overall Study|Other|5|||
163080398|NCT02514746|589002867|FG001|Overall Study|Other|1|||
163080399|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
163080400|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
163080401|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
163080402|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
163080403|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
163080404|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
163080405|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
163080406|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
163080407|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
163080408|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
163080409|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
163080410|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
163080411|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080412|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080413|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
163080414|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
163080415|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
163080416|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
163080417|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
163080418|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
163080419|NCT04003142|589002871|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
163080420|NCT04003142|589002872|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
163080421|NCT04003142|589002873|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
163080422|NCT04003142|589002874|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
163080423|NCT04003142|589002875|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
163080424|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
163080425|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
163080426|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
163080427|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
163080428|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
163080429|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Death|0|||
163080430|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Death|0|||
163080431|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Death|0|||
163080432|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Death|0|||
163080433|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Death|1|||
163080434|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
163080435|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
163080436|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
163080437|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
163080438|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
163080439|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080440|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080441|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
163080442|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080443|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
163080444|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
163080445|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
163080446|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
163080447|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
163080448|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
163080449|NCT04003142|589002871|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
163080450|NCT04003142|589002872|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
163080451|NCT04003142|589002873|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
163080452|NCT04003142|589002874|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
163080453|NCT04003142|589002875|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
163080454|NCT04806373|589002876|FG000|Overall Study|Withdrawal by Subject|1|||
163080455|NCT04806373|589002877|FG001|Overall Study|Withdrawal by Subject|1|||
163080456|NCT03382873|589002878|FG000|Overall Study|Lost to Follow-up|9|||
163080457|NCT03382873|589002879|FG001|Overall Study|Lost to Follow-up|10|||
163080458|NCT03382873|589002878|FG000|Overall Study|Withdrawal by Subject|6|||
163080459|NCT03382873|589002879|FG001|Overall Study|Withdrawal by Subject|11|||
163080460|NCT03382873|589002878|FG000|Overall Study|Visit not completed due to pandemic|16|||
163080461|NCT03382873|589002879|FG001|Overall Study|Visit not completed due to pandemic|41|||
163080462|NCT03624036|589002880|FG000|Overall Study|Death|2|||
163080463|NCT03624036|589002881|FG001|Overall Study|Death|3|||
163080464|NCT03624036|589002882|FG002|Overall Study|Death|0|||
163080465|NCT03624036|589002883|FG003|Overall Study|Death|1|||
163080466|NCT03624036|589002880|FG000|Overall Study|Withdrawal by Subject|1|||
163080467|NCT03624036|589002881|FG001|Overall Study|Withdrawal by Subject|0|||
163080468|NCT03624036|589002882|FG002|Overall Study|Withdrawal by Subject|1|||
163080469|NCT03624036|589002883|FG003|Overall Study|Withdrawal by Subject|0|||
163080470|NCT03624036|589002880|FG000|Overall Study|Enrolled but Never Treated|1|||
163080471|NCT03624036|589002881|FG001|Overall Study|Enrolled but Never Treated|0|||
163080472|NCT03624036|589002882|FG002|Overall Study|Enrolled but Never Treated|0|||
163080473|NCT03624036|589002883|FG003|Overall Study|Enrolled but Never Treated|0|||
163080474|NCT03624036|589002880|FG000|Overall Study|Reason not Specified|3|||
163080475|NCT03624036|589002881|FG001|Overall Study|Reason not Specified|0|||
163080476|NCT03624036|589002882|FG002|Overall Study|Reason not Specified|2|||
163080477|NCT03624036|589002883|FG003|Overall Study|Reason not Specified|2|||
163080478|NCT01185366|589002892|FG000|First Line Therapy|Insurance Coverage Denied|1|||
163080479|NCT01185366|589002893|FG001|First Line Therapy|Insurance Coverage Denied|1|||
163080480|NCT01185366|589002892|FG000|First Line Therapy|Withdrawal by Subject|1|||
163080481|NCT01185366|589002893|FG001|First Line Therapy|Withdrawal by Subject|0|||
163080482|NCT01185366|589002892|FG000|First Line Therapy|Lack of Metastatic Site|1|||
163080483|NCT01185366|589002893|FG001|First Line Therapy|Lack of Metastatic Site|0|||
163080484|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
163080485|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
163080486|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
163080487|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
163080488|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
163080489|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
163080490|NCT01185366|589002892|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
163080491|NCT01185366|589002893|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
163080492|NCT02539394|589002898|FG000|Overall Study|Protocol Violation|1|||
163080493|NCT02539394|589002899|FG001|Overall Study|Protocol Violation|3|||
163080494|NCT02539394|589002898|FG000|Overall Study|Lost to Follow-up|1|||
163080495|NCT02539394|589002899|FG001|Overall Study|Lost to Follow-up|2|||
163080496|NCT02539394|589002898|FG000|Overall Study|Incomplete dataset|6|||
163080497|NCT02539394|589002899|FG001|Overall Study|Incomplete dataset|6|||
163080498|NCT03425188|589002901|FG000|Overall Study|Withdrawal by Subject|1|||
163080499|NCT00834587|589002907|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163080500|NCT00834587|589002908|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163080501|NCT01691092|589002909|FG000|Overall Study|Lost to Follow-up|10|||
163080502|NCT01691092|589002909|FG000|Overall Study|Physician Decision|4|||
163080503|NCT01691092|589002909|FG000|Overall Study|Withdrawal by Subject|3|||
163080504|NCT01691092|589002909|FG000|Overall Study|non-compliance|3|||
163080505|NCT01691092|589002909|FG000|Overall Study|used for different study|2|||
163080506|NCT01691092|589002909|FG000|Overall Study|screen fail|19|||
163080507|NCT01657942|589002910|FG000|Overall Study|Alternative Treatment|7|||
163080508|NCT01657942|589002910|FG000|Overall Study|Lost to Follow-up|1|||
163080509|NCT00581100|589004131|FG000|Overall Study|Death|1|||
163080510|NCT00581100|589004132|FG001|Overall Study|Death|0|||
163080511|NCT00581100|589004131|FG000|Overall Study|Adverse Event|2|||
163080512|NCT00581100|589004132|FG001|Overall Study|Adverse Event|1|||
163080513|NCT00581100|589004131|FG000|Overall Study|Withdrawal by Subject|1|||
163080514|NCT00581100|589004132|FG001|Overall Study|Withdrawal by Subject|4|||
163080515|NCT00581100|589004131|FG000|Overall Study|Other|3|||
163080516|NCT00581100|589004132|FG001|Overall Study|Other|0|||
163080517|NCT04129398|589004133|FG000|Overall Study|Physician Decision|2|||
163080518|NCT00590317|589004134|FG000|Overall Study|Lack of Efficacy|1|||
163080519|NCT00590317|589004135|FG001|Overall Study|Lack of Efficacy|5|||
163080520|NCT00993473|589004139|FG000|Overall Study|Adverse Event|0|||
163080521|NCT00993473|589004140|FG001|Overall Study|Adverse Event|2|||
163080522|NCT00993473|589004139|FG000|Overall Study|Protocol Violation|1|||
163080523|NCT00993473|589004140|FG001|Overall Study|Protocol Violation|2|||
163080524|NCT00993473|589004139|FG000|Overall Study|Lost to Follow-up|1|||
163080525|NCT00993473|589004140|FG001|Overall Study|Lost to Follow-up|0|||
163080526|NCT00993473|589004139|FG000|Overall Study|Withdrawal by Subject|1|||
163080527|NCT00993473|589004140|FG001|Overall Study|Withdrawal by Subject|5|||
163080528|NCT00993473|589004139|FG000|Overall Study|Technical problem with CGM device|0|||
163080529|NCT00993473|589004140|FG001|Overall Study|Technical problem with CGM device|1|||
163080530|NCT00993473|589004139|FG000|Overall Study|Family event|1|||
163080531|NCT00993473|589004140|FG001|Overall Study|Family event|0|||
163080532|NCT00770679|589004149|FG000|Overall Study|Lost to Follow-up|3|||
163080533|NCT00770679|589004149|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
163080534|NCT00069953|589004152|FG000|Overall Study|Protocol Violation|2|||
163080535|NCT00113373|589004155|FG000|Overall Study|Ineligible: wrong primary|1|||
163080536|NCT00113373|589004155|FG000|Overall Study|Ineligible: second primary|1|||
163080537|NCT00113373|589004155|FG000|Overall Study|Never Treated|1|||
163080538|NCT02395627|589004156|FG000|Overall Study|Withdrawal by Subject|0|||
163080539|NCT02395627|589004157|FG001|Overall Study|Withdrawal by Subject|2|||
163080540|NCT02395627|589004158|FG002|Overall Study|Withdrawal by Subject|0|||
163080541|NCT02395627|589004156|FG000|Overall Study|Did not receive pembrolizumab|3|||
163080542|NCT02395627|589004157|FG001|Overall Study|Did not receive pembrolizumab|1|||
163080543|NCT02395627|589004158|FG002|Overall Study|Did not receive pembrolizumab|0|||
163080544|NCT03253627|589004159|FG000|Overall Study|Lost to Follow-up|1|||
163080545|NCT03253627|589004160|FG001|Overall Study|Lost to Follow-up|2|||
163080546|NCT03253627|589004159|FG000|Overall Study|Withdrawal by Subject|0|||
163080547|NCT03253627|589004160|FG001|Overall Study|Withdrawal by Subject|2|||
163080548|NCT03253627|589004159|FG000|Overall Study|Inability to complete MRI|1|||
163080549|NCT03253627|589004160|FG001|Overall Study|Inability to complete MRI|0|||
163080550|NCT04629521|589004167|FG000|Overall Study|Death|1|||
163080551|NCT04629521|589004167|FG000|Overall Study|Lost to Follow-up|3|||
163080552|NCT04629521|589004167|FG000|Overall Study|Subject withdrew consent|3|||
163080553|NCT04629521|589004167|FG000|Overall Study|Enrolled in error|1|||
163080554|NCT03163667|589004168|FG000|Overall Study|Death|15|||
163080555|NCT03163667|589004169|FG001|Overall Study|Death|27|||
163080556|NCT03163667|589004168|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
163080557|NCT03163667|589004169|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
163080558|NCT00979407|589004170|FG000|Overall Study|Withdrawal by Subject|3|||
163080559|NCT00979407|589004171|FG001|Overall Study|Withdrawal by Subject|4|||
163080560|NCT00979407|589004170|FG000|Overall Study|Lost to Follow-up|3|||
163080561|NCT00979407|589004171|FG001|Overall Study|Lost to Follow-up|3|||
163080562|NCT00855166|589004172|FG000|Overall Study|Adverse Event|0|||
163080563|NCT00855166|589004173|FG001|Overall Study|Adverse Event|2|||
163080564|NCT00855166|589004172|FG000|Overall Study|Death|0|||
163080565|NCT00855166|589004173|FG001|Overall Study|Death|1|||
163080566|NCT00855166|589004172|FG000|Overall Study|Withdrawal by Subject|1|||
163080567|NCT00855166|589004173|FG001|Overall Study|Withdrawal by Subject|4|||
163080568|NCT00855166|589004172|FG000|Overall Study|Poor/non-compliance|2|||
163080569|NCT00855166|589004173|FG001|Overall Study|Poor/non-compliance|0|||
163080570|NCT00855166|589004172|FG000|Overall Study|Administrative reasons by sponsor|1|||
163080571|NCT00855166|589004173|FG001|Overall Study|Administrative reasons by sponsor|0|||
163080572|NCT00855166|589004172|FG000|Overall Study|Subject no longer meets study criteria|1|||
163080573|NCT00855166|589004173|FG001|Overall Study|Subject no longer meets study criteria|1|||
163080574|NCT02940223|589004174|FG000|Overall Study|Failed Requirement|2|||
163080575|NCT02940223|589004175|FG001|Overall Study|Failed Requirement|0|||
163080576|NCT03769116|589004179|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
163080577|NCT03769116|589004180|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
163080578|NCT03769116|589004179|FG000|Part 3 - Open Label|Physician Decision|1|||
163080579|NCT03769116|589004180|FG001|Part 3 - Open Label|Physician Decision|0|||
163080580|NCT03769116|589004179|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
163080581|NCT03769116|589004180|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
163080582|NCT05810597|589004182|FG000|Period 1|Adverse Event|2|||
163080583|NCT05810597|589004183|FG001|Period 1|Adverse Event|0|||
163080584|NCT05810597|589004182|FG000|Period 1|Physician Decision|1|||
163080585|NCT05810597|589004183|FG001|Period 1|Physician Decision|0|||
163080586|NCT01450631|589004184|FG000|Overall Study|Lost to Follow-up|2|||
163080587|NCT01450631|589004185|FG001|Overall Study|Lost to Follow-up|4|||
163080588|NCT01450631|589004184|FG000|Overall Study|Withdrawal by Subject|1|||
163080589|NCT01450631|589004185|FG001|Overall Study|Withdrawal by Subject|0|||
163080590|NCT04903093|589004191|FG000|Overall Study|Withdrawal by Subject|0|||
163080591|NCT04903093|589004192|FG001|Overall Study|Withdrawal by Subject|0|||
163080592|NCT04903093|589004193|FG002|Overall Study|Withdrawal by Subject|0|||
163080593|NCT04903093|589004194|FG003|Overall Study|Withdrawal by Subject|1|||
163080594|NCT04903093|589004195|FG004|Overall Study|Withdrawal by Subject|0|||
163080595|NCT04903093|589004196|FG005|Overall Study|Withdrawal by Subject|0|||
163080596|NCT01390584|589004209|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
163080597|NCT01390584|589004210|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
163080598|NCT01390584|589004211|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
163080599|NCT00025233|589004212|FG000|Overall Study|Ineligible: wrong cell type|1|||
163080600|NCT00025233|589004212|FG000|Overall Study|Ineligible: wrong primary|1|||
163080601|NCT00025233|589004212|FG000|Overall Study|Ineligible: improper prior treatment|1|||
163080602|NCT00025233|589004212|FG000|Overall Study|Never treated|1|||
163080603|NCT00401830|589004213|FG000|Overall Study|Adverse Event|10|||
163080604|NCT00401830|589004214|FG001|Overall Study|Adverse Event|18|||
163080605|NCT00401830|589004213|FG000|Overall Study|Lack of Efficacy|11|||
163080606|NCT00401830|589004214|FG001|Overall Study|Lack of Efficacy|5|||
163080607|NCT00401830|589004213|FG000|Overall Study|Withdrawal by Subject|4|||
163080608|NCT00401830|589004214|FG001|Overall Study|Withdrawal by Subject|3|||
163080609|NCT00401830|589004213|FG000|Overall Study|Protocol Violation|3|||
163080610|NCT00401830|589004214|FG001|Overall Study|Protocol Violation|3|||
163080611|NCT00401830|589004213|FG000|Overall Study|Non-compliance with drug study|1|||
163080612|NCT00401830|589004214|FG001|Overall Study|Non-compliance with drug study|0|||
163080613|NCT00401830|589004213|FG000|Overall Study|Lost to Follow-up|1|||
163080614|NCT00401830|589004214|FG001|Overall Study|Lost to Follow-up|3|||
163080615|NCT00401830|589004213|FG000|Overall Study|Other: Personal / Family problems|1|||
163080616|NCT00401830|589004214|FG001|Overall Study|Other: Personal / Family problems|0|||
163080617|NCT01720602|589004215|FG000|Overall Study|Adverse Event|3|||
163080618|NCT01720602|589004215|FG000|Overall Study|Progressive disease on therapy|2|||
163080619|NCT01539525|589004216|FG000|Overall Study|Lost to Follow-up|19|||
163080620|NCT01539525|589004217|FG001|Overall Study|Lost to Follow-up|12|||
163080621|NCT01539525|589004218|FG002|Overall Study|Lost to Follow-up|11|||
163080622|NCT01539525|589004216|FG000|Overall Study|Withdrawal by Subject|0|||
163080623|NCT01539525|589004217|FG001|Overall Study|Withdrawal by Subject|3|||
163080624|NCT01539525|589004218|FG002|Overall Study|Withdrawal by Subject|2|||
163080625|NCT01539525|589004216|FG000|Overall Study|Protocol Violation|1|||
163080626|NCT01539525|589004217|FG001|Overall Study|Protocol Violation|1|||
163080627|NCT01539525|589004218|FG002|Overall Study|Protocol Violation|4|||
163080628|NCT02268851|589004219|FG000|Overall Study|Death|0|||
163080629|NCT02268851|589004220|FG001|Overall Study|Death|0|||
163080630|NCT02268851|589004221|FG002|Overall Study|Death|0|||
163080631|NCT02268851|589004222|FG003|Overall Study|Death|1|||
163080632|NCT02268851|589004223|FG004|Overall Study|Death|2|||
163080633|NCT02268851|589004224|FG005|Overall Study|Death|1|||
163080634|NCT02268851|589004219|FG000|Overall Study|Adverse Event|0|||
163080635|NCT02268851|589004220|FG001|Overall Study|Adverse Event|0|||
162645961|NCT03446040|587421302|FG005|Overall Study|Not reported|0|||
163080636|NCT02268851|589004221|FG002|Overall Study|Adverse Event|0|||
163080637|NCT02268851|589004222|FG003|Overall Study|Adverse Event|0|||
163080638|NCT02268851|589004223|FG004|Overall Study|Adverse Event|2|||
163080639|NCT02268851|589004224|FG005|Overall Study|Adverse Event|2|||
163080640|NCT02268851|589004219|FG000|Overall Study|Withdrawal by Subject|0|||
163080641|NCT02268851|589004220|FG001|Overall Study|Withdrawal by Subject|0|||
163080642|NCT02268851|589004221|FG002|Overall Study|Withdrawal by Subject|0|||
163080643|NCT02268851|589004222|FG003|Overall Study|Withdrawal by Subject|2|||
162645962|NCT03446040|587421303|FG006|Overall Study|Not reported|0|||
162645963|NCT03446040|587421304|FG007|Overall Study|Not reported|0|||
162645964|NCT03446040|587421305|FG008|Overall Study|Not reported|0|||
163080644|NCT02268851|589004223|FG004|Overall Study|Withdrawal by Subject|0|||
163080645|NCT02268851|589004224|FG005|Overall Study|Withdrawal by Subject|1|||
163080646|NCT02268851|589004219|FG000|Overall Study|Progressive Disease|1|||
163080647|NCT02268851|589004220|FG001|Overall Study|Progressive Disease|3|||
163080648|NCT02268851|589004221|FG002|Overall Study|Progressive Disease|0|||
163080649|NCT02268851|589004222|FG003|Overall Study|Progressive Disease|0|||
163080650|NCT02268851|589004223|FG004|Overall Study|Progressive Disease|1|||
163080651|NCT02268851|589004224|FG005|Overall Study|Progressive Disease|4|||
163080652|NCT02268851|589004219|FG000|Overall Study|Physician Decision|0|||
163080653|NCT02268851|589004220|FG001|Overall Study|Physician Decision|0|||
163080654|NCT02268851|589004221|FG002|Overall Study|Physician Decision|1|||
163080655|NCT02268851|589004222|FG003|Overall Study|Physician Decision|0|||
163080656|NCT02268851|589004223|FG004|Overall Study|Physician Decision|0|||
163080657|NCT02268851|589004224|FG005|Overall Study|Physician Decision|1|||
163080658|NCT02268851|589004219|FG000|Overall Study|Patient Compliance|0|||
163080659|NCT02268851|589004220|FG001|Overall Study|Patient Compliance|0|||
163080660|NCT02268851|589004221|FG002|Overall Study|Patient Compliance|0|||
163080661|NCT02268851|589004222|FG003|Overall Study|Patient Compliance|0|||
163080662|NCT02268851|589004223|FG004|Overall Study|Patient Compliance|1|||
163080663|NCT02268851|589004224|FG005|Overall Study|Patient Compliance|1|||
163080664|NCT02268851|589004219|FG000|Overall Study|Co-Morbid Condition|0|||
163080665|NCT02268851|589004220|FG001|Overall Study|Co-Morbid Condition|0|||
163080666|NCT02268851|589004221|FG002|Overall Study|Co-Morbid Condition|0|||
163080667|NCT02268851|589004222|FG003|Overall Study|Co-Morbid Condition|0|||
163080668|NCT02268851|589004223|FG004|Overall Study|Co-Morbid Condition|1|||
163080669|NCT02268851|589004224|FG005|Overall Study|Co-Morbid Condition|1|||
163080670|NCT02184442|589004225|FG000|Overall Study|Death|61|||
163080671|NCT02184442|589004226|FG001|Overall Study|Death|65|||
163080672|NCT02184442|589004225|FG000|Overall Study|Withdrawal by Subject|3|||
163080673|NCT02184442|589004226|FG001|Overall Study|Withdrawal by Subject|11|||
163080674|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
163080675|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
163080676|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
163080677|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163080678|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163080679|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163080680|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Other|2|||
163080681|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Other|1|||
163080682|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Other|1|||
163080683|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
163080684|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
163080685|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
163080686|NCT02691494|589004227|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
163080687|NCT02691494|589004228|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
163080688|NCT02691494|589004229|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
163080689|NCT04634331|589004230|FG000|Overall Study|Withdrawal by Subject|2|||
163080690|NCT04634331|589004231|FG001|Overall Study|Withdrawal by Subject|2|||
163080691|NCT00461812|589004235|FG000|Overall Study|study terminated|10|||
163080692|NCT02916433|589004236|FG000|Overall Study|Withdrawal by Subject|1|||
163080693|NCT02916433|589004237|FG001|Overall Study|Withdrawal by Subject|0|||
163080694|NCT02916433|589004236|FG000|Overall Study|Physician Decision|1|||
163080695|NCT02916433|589004237|FG001|Overall Study|Physician Decision|0|||
163080696|NCT01694771|589004238|FG000|Overall Study|Adverse Event|18|||
162645965|NCT03446040|587421306|FG009|Overall Study|Not reported|0|||
163080697|NCT01694771|589004239|FG001|Overall Study|Adverse Event|16|||
163080698|NCT01694771|589004238|FG000|Overall Study|Lack of Efficacy|1|||
163080699|NCT01694771|589004239|FG001|Overall Study|Lack of Efficacy|0|||
163080700|NCT01694771|589004238|FG000|Overall Study|Non compliance protocol|7|||
162645966|NCT03446040|587421307|FG010|Overall Study|Not reported|0|||
163080701|NCT01694771|589004239|FG001|Overall Study|Non compliance protocol|6|||
163080702|NCT01694771|589004238|FG000|Overall Study|Lost to Follow-up|2|||
163080703|NCT01694771|589004239|FG001|Overall Study|Lost to Follow-up|3|||
163080704|NCT01694771|589004238|FG000|Overall Study|Consent withdrawn|7|||
163080705|NCT01694771|589004239|FG001|Overall Study|Consent withdrawn|9|||
163080706|NCT01694771|589004238|FG000|Overall Study|Other reasons|5|||
163080707|NCT01694771|589004239|FG001|Overall Study|Other reasons|6|||
163080708|NCT00890097|589004240|FG000|Overall Study|Adverse Event|21|||
163080709|NCT00890097|589004241|FG001|Overall Study|Adverse Event|32|||
163080710|NCT00890097|589004242|FG002|Overall Study|Adverse Event|28|||
163080711|NCT00890097|589004240|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
163080712|NCT00890097|589004241|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
163080713|NCT00890097|589004242|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
163080714|NCT00890097|589004240|FG000|Overall Study|Withdrew Consent|9|||
163080715|NCT00890097|589004241|FG001|Overall Study|Withdrew Consent|6|||
163080716|NCT00890097|589004242|FG002|Overall Study|Withdrew Consent|9|||
163080717|NCT00890097|589004240|FG000|Overall Study|Lost to Follow-up|5|||
163080718|NCT00890097|589004241|FG001|Overall Study|Lost to Follow-up|5|||
163080719|NCT00890097|589004242|FG002|Overall Study|Lost to Follow-up|5|||
163080720|NCT00890097|589004240|FG000|Overall Study|Noncompliance|0|||
163080721|NCT00890097|589004241|FG001|Overall Study|Noncompliance|4|||
163080722|NCT00890097|589004242|FG002|Overall Study|Noncompliance|4|||
163080723|NCT00890097|589004240|FG000|Overall Study|Sponsor Decision|7|||
163080724|NCT00890097|589004241|FG001|Overall Study|Sponsor Decision|11|||
163080725|NCT00890097|589004242|FG002|Overall Study|Sponsor Decision|7|||
163080726|NCT00890097|589004240|FG000|Overall Study|Did not attend final visit|2|||
163080727|NCT00890097|589004241|FG001|Overall Study|Did not attend final visit|3|||
162645967|NCT03446040|587421308|FG011|Overall Study|Not reported|0|||
162645968|NCT03446040|587421309|FG012|Overall Study|Not reported|0|||
162645969|NCT03446040|587421310|FG013|Overall Study|Not reported|0|||
162645970|NCT00456521|587421311|FG000|Overall Study|Adverse Event|150|||
162645971|NCT00456521|587421312|FG001|Overall Study|Adverse Event|25|||
162645972|NCT00456521|587421311|FG000|Overall Study|Withdrawal by Subject|43|||
162645973|NCT00456521|587421312|FG001|Overall Study|Withdrawal by Subject|24|||
162645974|NCT00456521|587421311|FG000|Overall Study|Lost to Follow-up|22|||
162645975|NCT00456521|587421312|FG001|Overall Study|Lost to Follow-up|17|||
162645976|NCT00456521|587421311|FG000|Overall Study|Lack of Efficacy|3|||
162645977|NCT00456521|587421312|FG001|Overall Study|Lack of Efficacy|6|||
162645978|NCT00456521|587421311|FG000|Overall Study|Protocol Violation|4|||
162645979|NCT00456521|587421312|FG001|Overall Study|Protocol Violation|0|||
162645980|NCT00456521|587421311|FG000|Overall Study|Pregnancy|1|||
162645981|NCT00456521|587421312|FG001|Overall Study|Pregnancy|1|||
162645982|NCT00456521|587421311|FG000|Overall Study|Drug non-compliance, moved, other|26|||
162645983|NCT00456521|587421312|FG001|Overall Study|Drug non-compliance, moved, other|11|||
162645984|NCT02596854|587421313|FG000|Overall Study|Withdrawn|8|||
162645985|NCT00464568|587421316|FG000|Overall Study|Adverse Event|2|||
162645986|NCT00405587|587421317|FG000|Overall Study|Death|0|||
162645987|NCT00405587|587421318|FG001|Overall Study|Death|0|||
162645988|NCT00405587|587421319|FG002|Overall Study|Death|0|||
162645989|NCT00405587|587421320|FG003|Overall Study|Death|1|||
162645990|NCT00405587|587421317|FG000|Overall Study|Disease Progression|22|||
162645991|NCT00405587|587421318|FG001|Overall Study|Disease Progression|23|||
162645992|NCT00405587|587421319|FG002|Overall Study|Disease Progression|21|||
163080728|NCT00890097|589004242|FG002|Overall Study|Did not attend final visit|0|||
163080729|NCT00890097|589004240|FG000|Overall Study|Subject Decision|3|||
163080730|NCT00890097|589004241|FG001|Overall Study|Subject Decision|2|||
163080731|NCT00890097|589004242|FG002|Overall Study|Subject Decision|6|||
163080732|NCT00890097|589004240|FG000|Overall Study|Randomization Error|2|||
163080733|NCT00890097|589004241|FG001|Overall Study|Randomization Error|0|||
163080734|NCT00890097|589004242|FG002|Overall Study|Randomization Error|0|||
163080735|NCT00890097|589004240|FG000|Overall Study|Failed inclusion criteria|3|||
162645993|NCT00405587|587421320|FG003|Overall Study|Disease Progression|17|||
162645994|NCT00405587|587421317|FG000|Overall Study|Physician Decision|3|||
162645995|NCT00405587|587421318|FG001|Overall Study|Physician Decision|2|||
162645996|NCT00405587|587421319|FG002|Overall Study|Physician Decision|0|||
163080736|NCT00890097|589004241|FG001|Overall Study|Failed inclusion criteria|4|||
162645997|NCT00405587|587421320|FG003|Overall Study|Physician Decision|0|||
162645998|NCT00405587|587421317|FG000|Overall Study|Adverse Event|1|||
163080737|NCT00890097|589004242|FG002|Overall Study|Failed inclusion criteria|0|||
163080738|NCT00890097|589004240|FG000|Overall Study|Transportation|0|||
163080739|NCT00890097|589004241|FG001|Overall Study|Transportation|2|||
163080740|NCT00890097|589004242|FG002|Overall Study|Transportation|0|||
163080741|NCT00890097|589004240|FG000|Overall Study|Subject Moved|0|||
163080742|NCT00890097|589004241|FG001|Overall Study|Subject Moved|4|||
162645999|NCT00405587|587421318|FG001|Overall Study|Adverse Event|0|||
162646000|NCT00405587|587421319|FG002|Overall Study|Adverse Event|0|||
162646001|NCT00405587|587421320|FG003|Overall Study|Adverse Event|0|||
163080743|NCT00890097|589004242|FG002|Overall Study|Subject Moved|0|||
163080744|NCT00890097|589004240|FG000|Overall Study|Protocol Deviation|1|||
163080745|NCT00890097|589004241|FG001|Overall Study|Protocol Deviation|1|||
163080746|NCT00890097|589004242|FG002|Overall Study|Protocol Deviation|1|||
163080747|NCT03878069|589004247|FG000|Overall Study|Death|0|||
163080748|NCT03878069|589004248|FG001|Overall Study|Death|1|||
163080749|NCT03878069|589004249|FG002|Overall Study|Death|0|||
163080750|NCT03810495|589004250|FG000|Overall Study|Lost to Follow-up|2|||
163080751|NCT03810495|589004250|FG000|Overall Study|Withdrawal by Subject|1|||
163080752|NCT02536339|589004252|FG000|Overall Study|Death|20|||
163080753|NCT02536339|589004252|FG000|Overall Study|Withdrawal by Subject|3|||
162646002|NCT00405587|587421317|FG000|Overall Study|Lost to Follow-up|0|||
162646003|NCT00405587|587421318|FG001|Overall Study|Lost to Follow-up|1|||
162646004|NCT00405587|587421319|FG002|Overall Study|Lost to Follow-up|1|||
162646005|NCT00405587|587421320|FG003|Overall Study|Lost to Follow-up|0|||
162646006|NCT00405587|587421317|FG000|Overall Study|Radiation induced necrosis|0|||
162646007|NCT00405587|587421318|FG001|Overall Study|Radiation induced necrosis|1|||
162646008|NCT00405587|587421319|FG002|Overall Study|Radiation induced necrosis|0|||
162646009|NCT00405587|587421320|FG003|Overall Study|Radiation induced necrosis|0|||
162646010|NCT00405587|587421317|FG000|Overall Study|Withdrawal by Subject|0|||
162646011|NCT00405587|587421318|FG001|Overall Study|Withdrawal by Subject|0|||
162646012|NCT00405587|587421319|FG002|Overall Study|Withdrawal by Subject|0|||
162646013|NCT00405587|587421320|FG003|Overall Study|Withdrawal by Subject|2|||
162646014|NCT00405587|587421317|FG000|Overall Study|Participant not dosed|0|||
162646015|NCT00405587|587421318|FG001|Overall Study|Participant not dosed|1|||
162646016|NCT00405587|587421319|FG002|Overall Study|Participant not dosed|0|||
163080754|NCT02536339|589004252|FG000|Overall Study|Lost to Follow-up|2|||
163080755|NCT02536339|589004252|FG000|Overall Study|Treatment discontinued|2|||
163080756|NCT02536339|589004252|FG000|Overall Study|Physician Decision|1|||
163080757|NCT03759379|589005954|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
163080758|NCT03759379|589005955|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
163080759|NCT03759379|589005954|FG000|Treatment Period|Death|2|||
163080760|NCT03759379|589005955|FG001|Treatment Period|Death|3|||
163080761|NCT03759379|589005954|FG000|Treatment Period|Lost to Follow-up|1|||
163080762|NCT03759379|589005955|FG001|Treatment Period|Lost to Follow-up|0|||
163080763|NCT03759379|589005954|FG000|Treatment Period|Physician Decision|0|||
163080764|NCT03759379|589005955|FG001|Treatment Period|Physician Decision|1|||
163080765|NCT04924608|589005956|FG000|Overall Study|Adverse Event|10|||
163080766|NCT04924608|589005957|FG001|Overall Study|Adverse Event|6|||
163080767|NCT04924608|589005956|FG000|Overall Study|Lost to Follow-up|1|||
163080768|NCT04924608|589005957|FG001|Overall Study|Lost to Follow-up|1|||
163080769|NCT04924608|589005956|FG000|Overall Study|Ongoing at the data cut-off date|54|||
163080770|NCT04924608|589005957|FG001|Overall Study|Ongoing at the data cut-off date|60|||
163080771|NCT04924608|589005956|FG000|Overall Study|Progressive Disease|2|||
163080772|NCT04924608|589005957|FG001|Overall Study|Progressive Disease|0|||
163080773|NCT04924608|589005956|FG000|Overall Study|Withdrawal by Subject|3|||
163080774|NCT04924608|589005957|FG001|Overall Study|Withdrawal by Subject|6|||
163080775|NCT04924608|589005956|FG000|Overall Study|Other reason|1|||
163080776|NCT04924608|589005957|FG001|Overall Study|Other reason|1|||
163080777|NCT05415215|589005958|FG000|Neoadjuvant Phase|Adverse Event|0|||
163080778|NCT05415215|589005959|FG001|Neoadjuvant Phase|Adverse Event|8|||
163080779|NCT05415215|589005960|FG002|Neoadjuvant Phase|Adverse Event|0|||
163080780|NCT05415215|589005961|FG003|Neoadjuvant Phase|Adverse Event|0|||
163080781|NCT05415215|589005962|FG004|Neoadjuvant Phase|Adverse Event|0|||
163080782|NCT05415215|589005963|FG005|Neoadjuvant Phase|Adverse Event|0|||
163080783|NCT05415215|589005964|FG006|Neoadjuvant Phase|Adverse Event|0|||
163080784|NCT05415215|589005965|FG007|Neoadjuvant Phase|Adverse Event|0|||
163080785|NCT05415215|589005958|FG000|Neoadjuvant Phase|Death|0|||
163080786|NCT05415215|589005959|FG001|Neoadjuvant Phase|Death|4|||
163080787|NCT05415215|589005960|FG002|Neoadjuvant Phase|Death|0|||
163080788|NCT05415215|589005961|FG003|Neoadjuvant Phase|Death|0|||
163080789|NCT05415215|589005962|FG004|Neoadjuvant Phase|Death|0|||
162646017|NCT00405587|587421320|FG003|Overall Study|Participant not dosed|0|||
162646018|NCT00507442|587421325|FG000|Overall Study|Adverse Event|8|||
163080790|NCT05415215|589005963|FG005|Neoadjuvant Phase|Death|0|||
162646019|NCT00507442|587421326|FG001|Overall Study|Adverse Event|11|||
162646020|NCT00507442|587421327|FG002|Overall Study|Adverse Event|4|||
163080791|NCT05415215|589005964|FG006|Neoadjuvant Phase|Death|0|||
163080792|NCT05415215|589005965|FG007|Neoadjuvant Phase|Death|0|||
163080793|NCT05415215|589005958|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
163080794|NCT05415215|589005959|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
163080795|NCT05415215|589005960|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080796|NCT05415215|589005961|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
162646021|NCT00507442|587421328|FG003|Overall Study|Adverse Event|1|||
162646022|NCT00507442|587421325|FG000|Overall Study|Protocol Violation|0|||
162646023|NCT00507442|587421326|FG001|Overall Study|Protocol Violation|1|||
162646024|NCT00507442|587421327|FG002|Overall Study|Protocol Violation|0|||
163080797|NCT05415215|589005962|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080798|NCT05415215|589005963|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080799|NCT05415215|589005964|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
163080800|NCT05415215|589005965|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
162646025|NCT00507442|587421328|FG003|Overall Study|Protocol Violation|0|||
162646026|NCT00507442|587421325|FG000|Overall Study|Lost to Follow-up|0|||
162646027|NCT00507442|587421326|FG001|Overall Study|Lost to Follow-up|0|||
162646028|NCT00507442|587421327|FG002|Overall Study|Lost to Follow-up|1|||
162646029|NCT00507442|587421328|FG003|Overall Study|Lost to Follow-up|0|||
162646030|NCT00507442|587421325|FG000|Overall Study|Physician Decision|0|||
162646031|NCT00507442|587421326|FG001|Overall Study|Physician Decision|2|||
162646032|NCT00507442|587421327|FG002|Overall Study|Physician Decision|4|||
162646033|NCT00507442|587421328|FG003|Overall Study|Physician Decision|1|||
162646034|NCT00507442|587421325|FG000|Overall Study|Progressive Disease|2|||
162646035|NCT00507442|587421326|FG001|Overall Study|Progressive Disease|4|||
162646036|NCT00507442|587421327|FG002|Overall Study|Progressive Disease|2|||
162646037|NCT00507442|587421328|FG003|Overall Study|Progressive Disease|0|||
162646038|NCT00507442|587421325|FG000|Overall Study|Withdrawal by Subject|4|||
163029791|NCT02278120|588811915|FG000|Treatment Period|Protocol deviation|0|||
163029792|NCT02278120|588811916|FG001|Treatment Period|Protocol deviation|2|||
163029793|NCT02278120|588811915|FG000|Treatment Period|Study terminated as per protocol|43|||
163029794|NCT02278120|588811916|FG001|Treatment Period|Study terminated as per protocol|11|||
162646039|NCT00507442|587421326|FG001|Overall Study|Withdrawal by Subject|4|||
162646040|NCT00507442|587421327|FG002|Overall Study|Withdrawal by Subject|2|||
162646041|NCT00507442|587421328|FG003|Overall Study|Withdrawal by Subject|1|||
162646042|NCT00507442|587421325|FG000|Overall Study|Other|2|||
162646043|NCT00507442|587421326|FG001|Overall Study|Other|5|||
162646044|NCT00507442|587421327|FG002|Overall Study|Other|2|||
162646045|NCT00507442|587421328|FG003|Overall Study|Other|2|||
162646046|NCT02255981|587421330|FG000|Overall Study|Lost to Follow-up|3|||
162646047|NCT02255981|587421330|FG000|Overall Study|Withdrawal by Subject|1|||
162646048|NCT02672423|587421331|FG000|Period 1|Adverse Event|0|||
162646049|NCT02672423|587421332|FG001|Period 1|Adverse Event|0|||
162646050|NCT02672423|587421333|FG002|Period 1|Adverse Event|0|||
162646051|NCT02672423|587421334|FG003|Period 1|Adverse Event|0|||
162646052|NCT02672423|587421335|FG004|Period 1|Adverse Event|1|||
162646053|NCT02672423|587421336|FG005|Period 1|Adverse Event|0|||
162646054|NCT02672423|587421337|FG006|Period 1|Adverse Event|0|||
162646055|NCT02672423|587421338|FG007|Period 1|Adverse Event|0|||
162646056|NCT02672423|587421339|FG008|Period 1|Adverse Event|0|||
162646057|NCT02672423|587421340|FG009|Period 1|Adverse Event|0|||
162646058|NCT02672423|587421331|FG000|Period 2|Withdrawal by Subject|0|||
162646059|NCT02672423|587421332|FG001|Period 2|Withdrawal by Subject|0|||
162646060|NCT02672423|587421333|FG002|Period 2|Withdrawal by Subject|1|||
162646061|NCT02672423|587421334|FG003|Period 2|Withdrawal by Subject|0|||
162646062|NCT02672423|587421335|FG004|Period 2|Withdrawal by Subject|0|||
162646063|NCT02672423|587421336|FG005|Period 2|Withdrawal by Subject|0|||
162646064|NCT02672423|587421337|FG006|Period 2|Withdrawal by Subject|0|||
162646065|NCT02672423|587421338|FG007|Period 2|Withdrawal by Subject|0|||
162646066|NCT02672423|587421339|FG008|Period 2|Withdrawal by Subject|0|||
162646067|NCT02672423|587421340|FG009|Period 2|Withdrawal by Subject|0|||
162646068|NCT02672423|587421331|FG000|Period 3|Withdrawal by Subject|0|||
162646069|NCT02672423|587421332|FG001|Period 3|Withdrawal by Subject|0|||
162646070|NCT02672423|587421333|FG002|Period 3|Withdrawal by Subject|0|||
162646071|NCT02672423|587421334|FG003|Period 3|Withdrawal by Subject|0|||
162646072|NCT02672423|587421335|FG004|Period 3|Withdrawal by Subject|0|||
162646073|NCT02672423|587421336|FG005|Period 3|Withdrawal by Subject|0|||
162646074|NCT02672423|587421337|FG006|Period 3|Withdrawal by Subject|0|||
163029795|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Death|0|||
163029796|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Death|1|||
163029797|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
163029798|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163029799|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
163029800|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
163029801|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
163029802|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
163029803|NCT02278120|588811915|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163029804|NCT02278120|588811916|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163029805|NCT00808639|588811918|FG000|Overall Study|Disease progression before surgery.|1|||
163029806|NCT01966068|588811921|FG000|Overall Study|Withdrawal by Subject|57|||
163029807|NCT01966068|588811921|FG000|Overall Study|Lost to Follow-up|81|||
163029808|NCT03197324|588811922|FG000|Overall Study|Adverse Event|0|||
163029809|NCT03197324|588811923|FG001|Overall Study|Adverse Event|1|||
163029810|NCT03589976|588811930|FG000|Overall Study|Death|5|||
163029811|NCT03589976|588811931|FG001|Overall Study|Death|1|||
163029812|NCT03589976|588811930|FG000|Overall Study|Adverse Event|5|||
163029813|NCT03589976|588811931|FG001|Overall Study|Adverse Event|1|||
162646075|NCT02672423|587421338|FG007|Period 3|Withdrawal by Subject|1|||
162646076|NCT02672423|587421339|FG008|Period 3|Withdrawal by Subject|0|||
162646077|NCT02672423|587421340|FG009|Period 3|Withdrawal by Subject|0|||
163029814|NCT03589976|588811930|FG000|Overall Study|Withdrawal by Subject|4|||
163080801|NCT05415215|589005958|FG000|Neoadjuvant Phase|Progressive Disease|0|||
163080802|NCT05415215|589005959|FG001|Neoadjuvant Phase|Progressive Disease|2|||
163080803|NCT05415215|589005960|FG002|Neoadjuvant Phase|Progressive Disease|0|||
163080804|NCT05415215|589005961|FG003|Neoadjuvant Phase|Progressive Disease|0|||
163080805|NCT05415215|589005962|FG004|Neoadjuvant Phase|Progressive Disease|0|||
163080806|NCT05415215|589005963|FG005|Neoadjuvant Phase|Progressive Disease|0|||
163080807|NCT05415215|589005964|FG006|Neoadjuvant Phase|Progressive Disease|0|||
163080808|NCT05415215|589005965|FG007|Neoadjuvant Phase|Progressive Disease|0|||
163080809|NCT05415215|589005958|FG000|Neoadjuvant Phase|Reason not Specified|1|||
163080810|NCT05415215|589005959|FG001|Neoadjuvant Phase|Reason not Specified|4|||
163080811|NCT05415215|589005960|FG002|Neoadjuvant Phase|Reason not Specified|0|||
163080812|NCT05415215|589005961|FG003|Neoadjuvant Phase|Reason not Specified|0|||
163080813|NCT05415215|589005962|FG004|Neoadjuvant Phase|Reason not Specified|0|||
163080814|NCT05415215|589005963|FG005|Neoadjuvant Phase|Reason not Specified|0|||
163080815|NCT05415215|589005964|FG006|Neoadjuvant Phase|Reason not Specified|0|||
163080816|NCT05415215|589005965|FG007|Neoadjuvant Phase|Reason not Specified|0|||
163080817|NCT05415215|589005958|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
163080818|NCT05415215|589005959|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
163080819|NCT05415215|589005960|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
163080820|NCT05415215|589005961|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
163080821|NCT05415215|589005962|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
163080822|NCT05415215|589005963|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
163080823|NCT05415215|589005964|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
163080824|NCT05415215|589005965|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
163080825|NCT05415215|589005958|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
163080826|NCT05415215|589005959|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
163080827|NCT05415215|589005960|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
163080828|NCT05415215|589005961|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
163080829|NCT05415215|589005962|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
163080830|NCT05415215|589005963|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
163080831|NCT05415215|589005964|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
163080832|NCT05415215|589005965|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
163080833|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080834|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080835|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080836|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
163080837|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
163080838|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080839|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080840|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
163080841|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080842|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080843|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080844|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
163080845|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
163080846|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080847|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080848|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
163080849|NCT05415215|589005958|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080850|NCT05415215|589005959|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080851|NCT05415215|589005960|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080852|NCT05415215|589005961|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080853|NCT05415215|589005962|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
163080854|NCT05415215|589005963|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080855|NCT05415215|589005964|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080856|NCT05415215|589005965|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
163080857|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080858|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080859|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080860|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080861|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080862|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080863|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
163080864|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
163080865|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080866|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080867|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080868|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080869|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080870|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
163080871|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080872|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
163080873|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080874|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080875|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080876|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080877|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080878|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
163080879|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080880|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
163080881|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080882|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080883|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080884|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080885|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080886|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
163080887|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
163080888|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
163080889|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080890|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080891|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080892|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080893|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080894|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080895|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
163080896|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
163080897|NCT05415215|589005958|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080898|NCT05415215|589005959|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080899|NCT05415215|589005960|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080900|NCT05415215|589005961|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080901|NCT05415215|589005962|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080902|NCT05415215|589005963|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
163080903|NCT05415215|589005964|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
163080904|NCT05415215|589005965|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163080905|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080906|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080907|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080908|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080909|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080910|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080911|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
163080912|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
163080913|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080914|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080915|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080916|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080917|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080918|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080919|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
163080920|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
163080921|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080922|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080923|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080924|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080925|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080926|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080927|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
163080928|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
163080929|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080930|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080931|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080932|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080933|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080934|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080935|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
163080936|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
163080937|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080938|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080939|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080940|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080941|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080942|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080943|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
163080944|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
163080945|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080946|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080947|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080948|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080949|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080950|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080951|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
163080952|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
163080953|NCT05415215|589005958|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080954|NCT05415215|589005959|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080955|NCT05415215|589005960|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080956|NCT05415215|589005961|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080957|NCT05415215|589005962|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080958|NCT05415215|589005963|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080959|NCT05415215|589005964|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163080960|NCT05415215|589005965|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
163080961|NCT05415215|589005958|FG000|Follow-up Period|Ongoing in Follow-up|0|||
163080962|NCT05415215|589005959|FG001|Follow-up Period|Ongoing in Follow-up|0|||
163080963|NCT05415215|589005960|FG002|Follow-up Period|Ongoing in Follow-up|0|||
163080964|NCT05415215|589005961|FG003|Follow-up Period|Ongoing in Follow-up|0|||
163080965|NCT05415215|589005962|FG004|Follow-up Period|Ongoing in Follow-up|0|||
163080966|NCT05415215|589005963|FG005|Follow-up Period|Ongoing in Follow-up|44|||
163080967|NCT05415215|589005964|FG006|Follow-up Period|Ongoing in Follow-up|45|||
163080968|NCT05415215|589005965|FG007|Follow-up Period|Ongoing in Follow-up|51|||
163080969|NCT05415215|589005958|FG000|Follow-up Period|Adverse Event|0|||
163080970|NCT05415215|589005959|FG001|Follow-up Period|Adverse Event|0|||
163080971|NCT05415215|589005960|FG002|Follow-up Period|Adverse Event|0|||
163080972|NCT05415215|589005961|FG003|Follow-up Period|Adverse Event|0|||
163080973|NCT05415215|589005962|FG004|Follow-up Period|Adverse Event|0|||
163080974|NCT05415215|589005963|FG005|Follow-up Period|Adverse Event|0|||
163080975|NCT05415215|589005964|FG006|Follow-up Period|Adverse Event|1|||
163080976|NCT05415215|589005965|FG007|Follow-up Period|Adverse Event|0|||
163080977|NCT05415215|589005958|FG000|Follow-up Period|Lost to Follow-up|0|||
163080978|NCT05415215|589005959|FG001|Follow-up Period|Lost to Follow-up|0|||
163080979|NCT05415215|589005960|FG002|Follow-up Period|Lost to Follow-up|0|||
163080980|NCT05415215|589005961|FG003|Follow-up Period|Lost to Follow-up|0|||
163080981|NCT05415215|589005962|FG004|Follow-up Period|Lost to Follow-up|0|||
163080982|NCT05415215|589005963|FG005|Follow-up Period|Lost to Follow-up|1|||
163080983|NCT05415215|589005964|FG006|Follow-up Period|Lost to Follow-up|1|||
163080984|NCT05415215|589005965|FG007|Follow-up Period|Lost to Follow-up|0|||
163080985|NCT05415215|589005958|FG000|Follow-up Period|Withdrawal by Subject|0|||
163080986|NCT05415215|589005959|FG001|Follow-up Period|Withdrawal by Subject|0|||
163080987|NCT05415215|589005960|FG002|Follow-up Period|Withdrawal by Subject|0|||
163080988|NCT05415215|589005961|FG003|Follow-up Period|Withdrawal by Subject|0|||
163080989|NCT05415215|589005962|FG004|Follow-up Period|Withdrawal by Subject|0|||
163080990|NCT05415215|589005963|FG005|Follow-up Period|Withdrawal by Subject|0|||
163080991|NCT05415215|589005964|FG006|Follow-up Period|Withdrawal by Subject|0|||
163080992|NCT05415215|589005965|FG007|Follow-up Period|Withdrawal by Subject|2|||
163080993|NCT03727022|589005966|FG000|Phase A|Lost to Follow-up|2|||
163080994|NCT03727022|589005967|FG001|Phase A|Lost to Follow-up|3|||
163080995|NCT03727022|589005966|FG000|Phase A|Withdrawal by Subject|10|||
163080996|NCT03727022|589005967|FG001|Phase A|Withdrawal by Subject|9|||
163080997|NCT03727022|589005966|FG000|Phase B|Lost to Follow-up|0|||
163080998|NCT03727022|589005967|FG001|Phase B|Lost to Follow-up|1|||
163080999|NCT03727022|589005966|FG000|Phase B|Subject Non-Compliance|1|||
163081000|NCT03727022|589005967|FG001|Phase B|Subject Non-Compliance|0|||
163081001|NCT03727022|589005966|FG000|Phase B|Withdrawal by Subject|3|||
163081002|NCT03727022|589005967|FG001|Phase B|Withdrawal by Subject|3|||
163081003|NCT03727022|589005966|FG000|Phase B|Site Closure|4|||
163081004|NCT03727022|589005967|FG001|Phase B|Site Closure|0|||
163081005|NCT05550818|589005968|FG000|Overall Study|Protocol Violation|1|||
163081006|NCT05550818|589005969|FG001|Overall Study|Protocol Violation|1|||
163081007|NCT05550818|589005968|FG000|Overall Study|Withdrawal by Subject|2|||
163081008|NCT05550818|589005969|FG001|Overall Study|Withdrawal by Subject|1|||
163081009|NCT02797522|589005970|FG000|Overall Study|Study Terminated by Sponsor|0|||
163081010|NCT02797522|589005971|FG001|Overall Study|Study Terminated by Sponsor|0|||
163081011|NCT02797522|589005972|FG002|Overall Study|Study Terminated by Sponsor|0|||
163081012|NCT02797522|589005973|FG003|Overall Study|Study Terminated by Sponsor|0|||
163081013|NCT02797522|589005974|FG004|Overall Study|Study Terminated by Sponsor|0|||
163081014|NCT02797522|589005975|FG005|Overall Study|Study Terminated by Sponsor|0|||
163081015|NCT02797522|589005976|FG006|Overall Study|Study Terminated by Sponsor|0|||
163081016|NCT02797522|589005977|FG007|Overall Study|Study Terminated by Sponsor|4|||
163081017|NCT02797522|589005978|FG008|Overall Study|Study Terminated by Sponsor|2|||
163081018|NCT02797522|589005979|FG009|Overall Study|Study Terminated by Sponsor|4|||
163081019|NCT02797522|589005980|FG010|Overall Study|Study Terminated by Sponsor|1|||
163081020|NCT03031912|589005981|FG000|Overall Study|Lost to Follow-up|1|||
163081021|NCT03031912|589005982|FG001|Overall Study|Lost to Follow-up|1|||
163081022|NCT03031912|589005983|FG002|Overall Study|Lost to Follow-up|0|||
163081023|NCT03031912|589005984|FG003|Overall Study|Lost to Follow-up|1|||
163081024|NCT03031912|589005985|FG004|Overall Study|Lost to Follow-up|0|||
163081025|NCT03031912|589005986|FG005|Overall Study|Lost to Follow-up|0|||
163081026|NCT03031912|589005987|FG006|Overall Study|Lost to Follow-up|0|||
163081027|NCT03031912|589005988|FG007|Overall Study|Lost to Follow-up|0|||
163081028|NCT03031912|589005989|FG008|Overall Study|Lost to Follow-up|0|||
163081029|NCT03031912|589005990|FG009|Overall Study|Lost to Follow-up|0|||
163081030|NCT04097743|589005993|FG000|Overall Study|Non-compliance of the study instruction.|1|||
163081031|NCT04097743|589005994|FG001|Overall Study|Non-compliance of the study instruction.|0|||
163081032|NCT02932410|589005997|FG000|Overall Study|Death|7|||
163081033|NCT02932410|589005998|FG001|Overall Study|Death|6|||
163081034|NCT02932410|589005999|FG002|Overall Study|Death|0|||
163081035|NCT02932410|589006000|FG003|Overall Study|Death|0|||
163081036|NCT02932410|589005997|FG000|Overall Study|Lost to Follow-up|1|||
163081037|NCT02932410|589005998|FG001|Overall Study|Lost to Follow-up|2|||
163081038|NCT02932410|589005999|FG002|Overall Study|Lost to Follow-up|0|||
163081039|NCT02932410|589006000|FG003|Overall Study|Lost to Follow-up|0|||
163081040|NCT02932410|589005997|FG000|Overall Study|Parent/Subjects decision|6|||
163081041|NCT02932410|589005998|FG001|Overall Study|Parent/Subjects decision|6|||
163081042|NCT02932410|589005999|FG002|Overall Study|Parent/Subjects decision|1|||
163081043|NCT02932410|589006000|FG003|Overall Study|Parent/Subjects decision|0|||
163081044|NCT02932410|589005997|FG000|Overall Study|Physician Decision|0|||
163081045|NCT02932410|589005998|FG001|Overall Study|Physician Decision|1|||
163081046|NCT02932410|589005999|FG002|Overall Study|Physician Decision|0|||
163081047|NCT02932410|589006000|FG003|Overall Study|Physician Decision|0|||
163081048|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
163081049|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
163081050|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Death|5|||
163081051|NCT04557735|589006003|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
163081052|NCT04557735|589006003|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
163081053|NCT04557735|589006003|FG000|Follow-Up Period (26 Weeks)|Death|4|||
163081054|NCT05562934|589006004|FG000|Overall Study|Adverse Event|0|||
163081055|NCT05562934|589006005|FG001|Overall Study|Adverse Event|2|||
163081056|NCT05562934|589006006|FG002|Overall Study|Adverse Event|0|||
163081057|NCT05562934|589006007|FG003|Overall Study|Adverse Event|0|||
163081058|NCT05562934|589006008|FG004|Overall Study|Adverse Event|2|||
163081059|NCT05562934|589006004|FG000|Overall Study|Lost to Follow-up|0|||
163081060|NCT05562934|589006005|FG001|Overall Study|Lost to Follow-up|0|||
163081061|NCT05562934|589006006|FG002|Overall Study|Lost to Follow-up|0|||
163081062|NCT05562934|589006007|FG003|Overall Study|Lost to Follow-up|0|||
163081063|NCT05562934|589006008|FG004|Overall Study|Lost to Follow-up|1|||
163081064|NCT05562934|589006004|FG000|Overall Study|Protocol Violation|0|||
163081065|NCT05562934|589006005|FG001|Overall Study|Protocol Violation|0|||
163081066|NCT05562934|589006006|FG002|Overall Study|Protocol Violation|0|||
163081067|NCT05562934|589006007|FG003|Overall Study|Protocol Violation|1|||
163081068|NCT05562934|589006008|FG004|Overall Study|Protocol Violation|1|||
163081069|NCT05562934|589006004|FG000|Overall Study|Withdrawal by Subject|0|||
163081070|NCT05562934|589006005|FG001|Overall Study|Withdrawal by Subject|0|||
163081071|NCT05562934|589006006|FG002|Overall Study|Withdrawal by Subject|1|||
163081072|NCT05562934|589006007|FG003|Overall Study|Withdrawal by Subject|1|||
163081073|NCT05562934|589006008|FG004|Overall Study|Withdrawal by Subject|0|||
163081074|NCT05365217|589006009|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163081075|NCT05365217|589006010|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163081076|NCT03997383|589006014|FG000|Double-blind Treatment Period|Adverse Event|4|||
163081077|NCT03997383|589006015|FG001|Double-blind Treatment Period|Adverse Event|3|||
163081078|NCT03997383|589006014|FG000|Double-blind Treatment Period|Death|4|||
163081079|NCT03997383|589006015|FG001|Double-blind Treatment Period|Death|4|||
163081080|NCT03997383|589006014|FG000|Double-blind Treatment Period|Physician Decision|2|||
163081081|NCT03997383|589006015|FG001|Double-blind Treatment Period|Physician Decision|0|||
163081082|NCT03997383|589006014|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
163081083|NCT03997383|589006015|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
163081084|NCT03997383|589006014|FG000|Open-label Extension Period|Ongoing|148|||
163081085|NCT03997383|589006015|FG001|Open-label Extension Period|Ongoing|151|||
163081086|NCT03997383|589006014|FG000|Open-label Extension Period|Adverse Event|4|||
163081087|NCT03997383|589006015|FG001|Open-label Extension Period|Adverse Event|1|||
163081088|NCT03997383|589006014|FG000|Open-label Extension Period|Death|8|||
163081089|NCT03997383|589006015|FG001|Open-label Extension Period|Death|9|||
163081090|NCT03997383|589006014|FG000|Open-label Extension Period|Physician Decision|1|||
163081091|NCT03997383|589006015|FG001|Open-label Extension Period|Physician Decision|1|||
163081092|NCT03997383|589006014|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
163081093|NCT03997383|589006015|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
163081094|NCT03997383|589006014|FG000|Open-label Extension Period|Reason Not Specified|2|||
163081095|NCT03997383|589006015|FG001|Open-label Extension Period|Reason Not Specified|0|||
163081096|NCT05451329|589006022|FG000|Overall Study|Adverse Event|1|||
163081097|NCT05451329|589006023|FG001|Overall Study|Adverse Event|1|||
163081098|NCT05451329|589006024|FG002|Overall Study|Adverse Event|0|||
163081099|NCT05451329|589006022|FG000|Overall Study|Withdrawal by Subject|1|||
163081100|NCT05451329|589006023|FG001|Overall Study|Withdrawal by Subject|0|||
163081101|NCT05451329|589006024|FG002|Overall Study|Withdrawal by Subject|0|||
163081102|NCT05451329|589006022|FG000|Overall Study|Investigational Product Lot exchange|1|||
163081103|NCT05451329|589006023|FG001|Overall Study|Investigational Product Lot exchange|1|||
163081104|NCT05451329|589006024|FG002|Overall Study|Investigational Product Lot exchange|0|||
163081105|NCT03019406|589006027|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
163081106|NCT03019406|589006028|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
163081107|NCT03019406|589006029|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
163081108|NCT03019406|589006030|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
163081109|NCT02556736|589006031|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
163081110|NCT02556736|589006032|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
163081111|NCT02556736|589006033|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
163081112|NCT02556736|589006034|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
163081113|NCT02556736|589006031|FG000|Open Label Treatment Period|Adverse Event|0|||
163081114|NCT02556736|589006032|FG001|Open Label Treatment Period|Adverse Event|0|||
163081115|NCT02556736|589006033|FG002|Open Label Treatment Period|Adverse Event|0|||
163081116|NCT02556736|589006034|FG003|Open Label Treatment Period|Adverse Event|1|||
163081117|NCT02556736|589006031|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
163081118|NCT02556736|589006032|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
163081119|NCT02556736|589006033|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
163081120|NCT02556736|589006034|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
163081121|NCT01302834|589006042|FG000|Overall Study|Protocol Violation|17|||
163081122|NCT01302834|589006043|FG001|Overall Study|Protocol Violation|23|||
163081123|NCT01302834|589006042|FG000|Overall Study|HIV positive|1|||
163081124|NCT01302834|589006043|FG001|Overall Study|HIV positive|3|||
163081125|NCT05528510|589006044|FG000|Overall Study|Death|1|||
163081126|NCT05528510|589006045|FG001|Overall Study|Death|0|||
163081127|NCT05528510|589006046|FG002|Overall Study|Death|0|||
163081128|NCT05528510|589006044|FG000|Overall Study|Lost to Follow-up|1|||
163081129|NCT05528510|589006045|FG001|Overall Study|Lost to Follow-up|0|||
163081130|NCT05528510|589006046|FG002|Overall Study|Lost to Follow-up|0|||
163081131|NCT05528510|589006044|FG000|Overall Study|Withdrawal by Subject|4|||
163081132|NCT05528510|589006045|FG001|Overall Study|Withdrawal by Subject|1|||
163081133|NCT05528510|589006046|FG002|Overall Study|Withdrawal by Subject|3|||
163081134|NCT05528510|589006044|FG000|Overall Study|Other|2|||
163081135|NCT05528510|589006045|FG001|Overall Study|Other|2|||
163081136|NCT05528510|589006046|FG002|Overall Study|Other|1|||
163081137|NCT01856478|589006049|FG000|Overall Study|Not treated|0|||
163081138|NCT01856478|589006050|FG001|Overall Study|Not treated|8|||
163081139|NCT01856478|589006049|FG000|Overall Study|Progressive disease per RECIST|146|||
163081140|NCT01856478|589006050|FG001|Overall Study|Progressive disease per RECIST|49|||
163081141|NCT01856478|589006049|FG000|Overall Study|Worsening of underlying cancer|6|||
163081142|NCT01856478|589006050|FG001|Overall Study|Worsening of underlying cancer|2|||
163081143|NCT01856478|589006049|FG000|Overall Study|Adverse events|57|||
162646078|NCT02672423|587421331|FG000|Period 3|Physician Decision|0|||
162646079|NCT02672423|587421332|FG001|Period 3|Physician Decision|0|||
162646080|NCT02672423|587421333|FG002|Period 3|Physician Decision|0|||
162646081|NCT02672423|587421334|FG003|Period 3|Physician Decision|0|||
162646082|NCT02672423|587421335|FG004|Period 3|Physician Decision|0|||
163081144|NCT01856478|589006050|FG001|Overall Study|Adverse events|30|||
163081145|NCT01856478|589006049|FG000|Overall Study|Non-compliant with protocol|1|||
163081146|NCT01856478|589006050|FG001|Overall Study|Non-compliant with protocol|1|||
163081147|NCT01856478|589006049|FG000|Overall Study|Lost to Follow-up|1|||
163081148|NCT01856478|589006050|FG001|Overall Study|Lost to Follow-up|1|||
163081149|NCT01856478|589006049|FG000|Overall Study|Refused to continue trial medication|13|||
163081150|NCT01856478|589006050|FG001|Overall Study|Refused to continue trial medication|11|||
162646083|NCT02672423|587421336|FG005|Period 3|Physician Decision|1|||
163081151|NCT01856478|589006049|FG000|Overall Study|Other reason than listed|4|||
163081152|NCT01856478|589006050|FG001|Overall Study|Other reason than listed|10|||
163081153|NCT05032820|589006051|FG000|Overall Study|Lost to Follow-up|1|||
163081154|NCT05032820|589006051|FG000|Overall Study|Withdrawal by Subject|1|||
163081155|NCT04108208|589006052|FG000|Overall Study|Withdrawal by Subject|2|||
163081156|NCT04108208|589006053|FG001|Overall Study|Withdrawal by Subject|6|||
163081157|NCT04108208|589006052|FG000|Overall Study|other-ongoing|20|||
163081158|NCT04108208|589006053|FG001|Overall Study|other-ongoing|40|||
163081159|NCT04108208|589006052|FG000|Overall Study|Death|1|||
163081160|NCT04108208|589006053|FG001|Overall Study|Death|4|||
163081161|NCT04108208|589006052|FG000|Overall Study|Lost to Follow-up|2|||
163081162|NCT04108208|589006053|FG001|Overall Study|Lost to Follow-up|0|||
163081163|NCT04936308|589006054|FG000|Overall Study|Death|0|||
163081164|NCT04936308|589006055|FG001|Overall Study|Death|0|||
163081165|NCT04936308|589006056|FG002|Overall Study|Death|1|||
163081166|NCT04936308|589006054|FG000|Overall Study|Withdrawal by Subject|6|||
163081167|NCT04936308|589006055|FG001|Overall Study|Withdrawal by Subject|3|||
163081168|NCT04936308|589006056|FG002|Overall Study|Withdrawal by Subject|0|||
163081169|NCT04936308|589006054|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
163081170|NCT04936308|589006055|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
163081171|NCT04936308|589006056|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
163081172|NCT04936308|589006054|FG000|Overall Study|Completed protocol-required follow-up|1|||
163081173|NCT04936308|589006055|FG001|Overall Study|Completed protocol-required follow-up|2|||
163081174|NCT04936308|589006056|FG002|Overall Study|Completed protocol-required follow-up|2|||
163081175|NCT04936308|589006054|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
163081176|NCT04936308|589006055|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
163081177|NCT04936308|589006056|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
163081178|NCT04936308|589006054|FG000|Overall Study|Other|3|||
163081179|NCT04936308|589006055|FG001|Overall Study|Other|0|||
163081180|NCT04936308|589006056|FG002|Overall Study|Other|2|||
163081181|NCT04770272|589006057|FG000|Overall Study|Death|1|||
163081182|NCT04770272|589006058|FG001|Overall Study|Death|0|||
163081183|NCT04770272|589006057|FG000|Overall Study|Withdrawal by Subject|11|||
163081184|NCT04770272|589006058|FG001|Overall Study|Withdrawal by Subject|12|||
163081185|NCT04770272|589006057|FG000|Overall Study|Protocol Violation|0|||
163081186|NCT04770272|589006058|FG001|Overall Study|Protocol Violation|2|||
163081187|NCT04770272|589006057|FG000|Overall Study|Adverse Event|23|||
163081188|NCT04770272|589006058|FG001|Overall Study|Adverse Event|21|||
163081189|NCT04770272|589006057|FG000|Overall Study|Physician Decision|7|||
163081190|NCT04770272|589006058|FG001|Overall Study|Physician Decision|3|||
163081191|NCT04770272|589006057|FG000|Overall Study|Disease progression|4|||
163081192|NCT04770272|589006058|FG001|Overall Study|Disease progression|8|||
163081193|NCT04770272|589006057|FG000|Overall Study|Switched to other therapy.|0|||
163081194|NCT04770272|589006058|FG001|Overall Study|Switched to other therapy.|2|||
163081195|NCT02363946|589006059|FG000|Overall Study|Lost to Follow-up|0|||
163081196|NCT02363946|589006060|FG001|Overall Study|Lost to Follow-up|0|||
163081197|NCT02363946|589006061|FG002|Overall Study|Lost to Follow-up|0|||
163081198|NCT02363946|589006062|FG003|Overall Study|Lost to Follow-up|0|||
163081199|NCT02363946|589006063|FG004|Overall Study|Lost to Follow-up|0|||
163081200|NCT02363946|589006064|FG005|Overall Study|Lost to Follow-up|0|||
163081201|NCT02363946|589006065|FG006|Overall Study|Lost to Follow-up|0|||
163081202|NCT02363946|589006066|FG007|Overall Study|Lost to Follow-up|1|||
163081203|NCT02363946|589006067|FG008|Overall Study|Lost to Follow-up|0|||
163081204|NCT02363946|589006068|FG009|Overall Study|Lost to Follow-up|0|||
163081205|NCT02363946|589006069|FG010|Overall Study|Lost to Follow-up|0|||
163081206|NCT02363946|589006070|FG011|Overall Study|Lost to Follow-up|0|||
163081207|NCT02363946|589006071|FG012|Overall Study|Lost to Follow-up|0|||
163081208|NCT03030261|589006072|FG000|Overall Study|Still receiving continuation therapy|5|||
163081209|NCT01615029|589006073|FG000|Overall Study|Adverse Event|1|||
163081210|NCT01615029|589006074|FG001|Overall Study|Adverse Event|0|||
163081211|NCT01615029|589006075|FG002|Overall Study|Adverse Event|3|||
163081212|NCT01615029|589006076|FG003|Overall Study|Adverse Event|0|||
163081213|NCT01615029|589006077|FG004|Overall Study|Adverse Event|4|||
163081214|NCT01615029|589006073|FG000|Overall Study|Progressive disease|1|||
163081215|NCT01615029|589006074|FG001|Overall Study|Progressive disease|1|||
163081216|NCT01615029|589006075|FG002|Overall Study|Progressive disease|1|||
163081217|NCT01615029|589006076|FG003|Overall Study|Progressive disease|1|||
163081218|NCT01615029|589006077|FG004|Overall Study|Progressive disease|10|||
163081219|NCT01615029|589006073|FG000|Overall Study|Physician Decision|0|||
163081220|NCT01615029|589006074|FG001|Overall Study|Physician Decision|0|||
163081221|NCT01615029|589006075|FG002|Overall Study|Physician Decision|0|||
163081222|NCT01615029|589006076|FG003|Overall Study|Physician Decision|0|||
163081223|NCT01615029|589006077|FG004|Overall Study|Physician Decision|2|||
163081224|NCT05213624|589006078|FG000|Overall Study|Adverse Event|0|||
163081225|NCT05213624|589006079|FG001|Overall Study|Adverse Event|3|||
163081226|NCT05213624|589006080|FG002|Overall Study|Adverse Event|0|||
163081227|NCT05213624|589006081|FG003|Overall Study|Adverse Event|0|||
163081228|NCT05213624|589006078|FG000|Overall Study|Protocol deviation|0|||
163081229|NCT05213624|589006079|FG001|Overall Study|Protocol deviation|2|||
163081230|NCT05213624|589006080|FG002|Overall Study|Protocol deviation|0|||
163081231|NCT05213624|589006081|FG003|Overall Study|Protocol deviation|0|||
163081232|NCT05213624|589006078|FG000|Overall Study|Withdrawal by Subject|0|||
163029815|NCT03589976|588811931|FG001|Overall Study|Withdrawal by Subject|1|||
163029816|NCT03589976|588811930|FG000|Overall Study|Lost to Follow-up|1|||
163029817|NCT03589976|588811931|FG001|Overall Study|Lost to Follow-up|0|||
163029818|NCT03589976|588811930|FG000|Overall Study|Other|4|||
163029819|NCT03589976|588811931|FG001|Overall Study|Other|3|||
163029820|NCT00710684|588811932|FG000|Overall Study|Adverse Event|11|||
163029821|NCT00710684|588811933|FG001|Overall Study|Adverse Event|19|||
163029822|NCT00710684|588811934|FG002|Overall Study|Adverse Event|16|||
163029823|NCT00710684|588811932|FG000|Overall Study|Lack of Efficacy|4|||
163029824|NCT00710684|588811933|FG001|Overall Study|Lack of Efficacy|3|||
163029825|NCT00710684|588811934|FG002|Overall Study|Lack of Efficacy|5|||
163029826|NCT00710684|588811932|FG000|Overall Study|Protocol Violation|5|||
163029827|NCT00710684|588811933|FG001|Overall Study|Protocol Violation|5|||
163029828|NCT00710684|588811934|FG002|Overall Study|Protocol Violation|5|||
163029829|NCT00710684|588811932|FG000|Overall Study|Lost to Follow-up|4|||
163029830|NCT00710684|588811933|FG001|Overall Study|Lost to Follow-up|6|||
163029831|NCT00710684|588811934|FG002|Overall Study|Lost to Follow-up|7|||
163029832|NCT00710684|588811932|FG000|Overall Study|Physician Decision|0|||
163029833|NCT00710684|588811933|FG001|Overall Study|Physician Decision|2|||
163029834|NCT00710684|588811934|FG002|Overall Study|Physician Decision|4|||
163029835|NCT00710684|588811932|FG000|Overall Study|Withdrawal by Subject|24|||
163029836|NCT00710684|588811933|FG001|Overall Study|Withdrawal by Subject|18|||
163029837|NCT00710684|588811934|FG002|Overall Study|Withdrawal by Subject|11|||
163029838|NCT00710684|588811932|FG000|Overall Study|Missing|1|||
163029839|NCT00710684|588811933|FG001|Overall Study|Missing|0|||
163029840|NCT00710684|588811934|FG002|Overall Study|Missing|0|||
163029841|NCT00710684|588811932|FG000|Overall Study|Did not continue after week 24|25|||
163029842|NCT00710684|588811933|FG001|Overall Study|Did not continue after week 24|21|||
163029843|NCT00710684|588811934|FG002|Overall Study|Did not continue after week 24|16|||
163029844|NCT04778059|588811935|FG000|Overall Study|Death|2|||
163029845|NCT04778059|588811936|FG001|Overall Study|Death|2|||
163029846|NCT04778059|588811937|FG002|Overall Study|Death|1|||
163029847|NCT04778059|588811938|FG003|Overall Study|Death|1|||
163029848|NCT04778059|588811939|FG004|Overall Study|Death|1|||
163029849|NCT04778059|588811935|FG000|Overall Study|Lost to Follow-up|0|||
163029850|NCT04778059|588811936|FG001|Overall Study|Lost to Follow-up|0|||
163029851|NCT04778059|588811937|FG002|Overall Study|Lost to Follow-up|0|||
163029852|NCT04778059|588811938|FG003|Overall Study|Lost to Follow-up|0|||
163029853|NCT04778059|588811939|FG004|Overall Study|Lost to Follow-up|1|||
163029854|NCT04778059|588811935|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029855|NCT04778059|588811936|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029856|NCT04778059|588811937|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029857|NCT04778059|588811938|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
163029858|NCT04778059|588811939|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
163029859|NCT02832375|588811940|FG000|Overall Study|Lost to Follow-up|1|||
163029860|NCT02832375|588811941|FG001|Overall Study|Lost to Follow-up|0|||
163029861|NCT02832375|588811940|FG000|Overall Study|Withdrawal of Consent|1|||
163029862|NCT02832375|588811941|FG001|Overall Study|Withdrawal of Consent|0|||
163029863|NCT00514904|588811942|FG000|Overall Study|Withdrawal by Subject|3|||
163029864|NCT00514904|588811943|FG001|Overall Study|Withdrawal by Subject|2|||
163029865|NCT00514904|588811942|FG000|Overall Study|Lost to Follow-up|21|||
163029866|NCT00514904|588811943|FG001|Overall Study|Lost to Follow-up|3|||
163029867|NCT00084318|588811944|FG000|Overall Study|Withdrawal by Subject|5|||
163029868|NCT00084318|588811945|FG001|Overall Study|Withdrawal by Subject|2|||
163029869|NCT00084318|588811944|FG000|Overall Study|Protocol Violation|15|||
163029870|NCT00084318|588811945|FG001|Overall Study|Protocol Violation|11|||
163029871|NCT00084318|588811944|FG000|Overall Study|No protocol treatment|2|||
163029872|NCT00084318|588811945|FG001|Overall Study|No protocol treatment|0|||
163029873|NCT00549601|588813708|FG000|Randomized|Protocol Violation|0|||
163029874|NCT00549601|588813709|FG001|Randomized|Protocol Violation|0|||
163029875|NCT00549601|588813710|FG002|Randomized|Protocol Violation|1|||
163029876|NCT00549601|588813708|FG000|Randomized|Withdrawal by Subject|0|||
163029877|NCT00549601|588813709|FG001|Randomized|Withdrawal by Subject|1|||
163029878|NCT00549601|588813710|FG002|Randomized|Withdrawal by Subject|1|||
163029879|NCT00549601|588813708|FG000|Received Study Drug|Adverse Event|2|||
163029880|NCT00549601|588813709|FG001|Received Study Drug|Adverse Event|5|||
163029881|NCT00549601|588813710|FG002|Received Study Drug|Adverse Event|1|||
163029882|NCT00549601|588813708|FG000|Received Study Drug|Death|0|||
163029883|NCT00549601|588813709|FG001|Received Study Drug|Death|1|||
163029884|NCT00549601|588813710|FG002|Received Study Drug|Death|0|||
163029885|NCT00549601|588813708|FG000|Received Study Drug|Lost to Follow-up|0|||
163029886|NCT00549601|588813709|FG001|Received Study Drug|Lost to Follow-up|1|||
163029887|NCT00549601|588813710|FG002|Received Study Drug|Lost to Follow-up|1|||
163029888|NCT00549601|588813708|FG000|Received Study Drug|Protocol Violation|3|||
163029889|NCT00549601|588813709|FG001|Received Study Drug|Protocol Violation|4|||
163029890|NCT00549601|588813710|FG002|Received Study Drug|Protocol Violation|1|||
163029891|NCT00549601|588813708|FG000|Received Study Drug|Withdrawal by Subject|2|||
163029892|NCT00549601|588813709|FG001|Received Study Drug|Withdrawal by Subject|0|||
163081233|NCT05213624|589006079|FG001|Overall Study|Withdrawal by Subject|0|||
163081234|NCT05213624|589006080|FG002|Overall Study|Withdrawal by Subject|0|||
163081235|NCT05213624|589006081|FG003|Overall Study|Withdrawal by Subject|1|||
163081236|NCT05213624|589006078|FG000|Overall Study|Not treated|0|||
163081237|NCT05213624|589006079|FG001|Overall Study|Not treated|1|||
163081238|NCT05213624|589006080|FG002|Overall Study|Not treated|2|||
163081239|NCT05213624|589006081|FG003|Overall Study|Not treated|2|||
163081240|NCT01602380|589006082|FG000|Overall Study|Death|147|||
163081241|NCT01602380|589006083|FG001|Overall Study|Death|145|||
163081242|NCT01602380|589006082|FG000|Overall Study|Withdrawal by Subject|39|||
163081243|NCT01602380|589006083|FG001|Overall Study|Withdrawal by Subject|41|||
163081244|NCT01602380|589006082|FG000|Overall Study|Lost to Follow-up|15|||
163081245|NCT01602380|589006083|FG001|Overall Study|Lost to Follow-up|12|||
163081246|NCT01602380|589006082|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163081247|NCT01602380|589006083|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
163081248|NCT01602380|589006082|FG000|Overall Study|Other|2|||
163081249|NCT01602380|589006083|FG001|Overall Study|Other|0|||
163081250|NCT01044459|589006085|FG000|Overall Study|Withdrawal by Subject|21|||
163081251|NCT01044459|589006086|FG001|Overall Study|Withdrawal by Subject|28|||
163081252|NCT01044459|589006085|FG000|Overall Study|Terminated by Sponsor|22|||
163081253|NCT01044459|589006086|FG001|Overall Study|Terminated by Sponsor|21|||
163081254|NCT01044459|589006085|FG000|Overall Study|Adverse Event|22|||
163081255|NCT01044459|589006086|FG001|Overall Study|Adverse Event|20|||
163081256|NCT01044459|589006085|FG000|Overall Study|Lack of Efficacy|23|||
163081257|NCT01044459|589006086|FG001|Overall Study|Lack of Efficacy|12|||
163081258|NCT01044459|589006085|FG000|Overall Study|Protocol Violation|11|||
163081259|NCT01044459|589006086|FG001|Overall Study|Protocol Violation|16|||
163081260|NCT01044459|589006085|FG000|Overall Study|Other Reason|7|||
163081261|NCT01044459|589006086|FG001|Overall Study|Other Reason|14|||
163081262|NCT01044459|589006085|FG000|Overall Study|COPD exacerbation|9|||
163081263|NCT01044459|589006086|FG001|Overall Study|COPD exacerbation|8|||
163081264|NCT01044459|589006085|FG000|Overall Study|Lost to Follow-up|18|||
163081265|NCT01044459|589006086|FG001|Overall Study|Lost to Follow-up|12|||
163081266|NCT00787800|589006091|FG000|Overall Study|Withdrawal by Subject|3|||
163081267|NCT00787800|589006092|FG001|Overall Study|Withdrawal by Subject|5|||
163081268|NCT00787800|589006091|FG000|Overall Study|Death|0|||
162646084|NCT02672423|587421337|FG006|Period 3|Physician Decision|0|||
162646085|NCT02672423|587421338|FG007|Period 3|Physician Decision|0|||
162646086|NCT02672423|587421339|FG008|Period 3|Physician Decision|0|||
162646087|NCT02672423|587421340|FG009|Period 3|Physician Decision|0|||
162646088|NCT01454570|587421349|FG000|Overall Study|Withdrawal by Subject|2|||
162646089|NCT01454570|587421349|FG000|Overall Study|Screen Failure|7|||
162646090|NCT00885755|587421350|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
162646091|NCT00885755|587421351|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
162646092|NCT00885755|587421352|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
162646093|NCT00885755|587421350|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
162646094|NCT00885755|587421351|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
162646095|NCT00885755|587421352|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
163081269|NCT00787800|589006092|FG001|Overall Study|Death|2|||
163081270|NCT03369704|589006096|FG000|Treatment Epoch|technical problems|1|||
163081271|NCT03369704|589006097|FG001|Treatment Epoch|technical problems|0|||
163081272|NCT03369704|589006096|FG000|Treatment Epoch|Protocol Violation|1|||
163081273|NCT03369704|589006097|FG001|Treatment Epoch|Protocol Violation|0|||
163081274|NCT03369704|589006096|FG000|Treatment Epoch|Lost to Follow-up|0|||
163081275|NCT03369704|589006097|FG001|Treatment Epoch|Lost to Follow-up|1|||
163081276|NCT03369704|589006096|FG000|Treatment Epoch|Lack of Efficacy|0|||
162646096|NCT00885755|587421350|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
162646097|NCT00885755|587421351|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
162646098|NCT00885755|587421352|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
163081277|NCT03369704|589006097|FG001|Treatment Epoch|Lack of Efficacy|2|||
163081278|NCT03369704|589006096|FG000|Treatment Epoch|Adverse Event|2|||
163081279|NCT03369704|589006097|FG001|Treatment Epoch|Adverse Event|0|||
163081280|NCT03369704|589006096|FG000|Follow-up Epoch|Lost to Follow-up|1|||
163081281|NCT03369704|589006097|FG001|Follow-up Epoch|Lost to Follow-up|0|||
163081282|NCT01905683|589006101|FG000|Overall Study|Protocol Violation|1|||
163081283|NCT01905683|589006101|FG000|Overall Study|Re-injection criteria not met; others|13|||
163081284|NCT01905683|589006101|FG000|Overall Study|Physician Decision|1|||
163081285|NCT01905683|589006101|FG000|Overall Study|Lack of Efficacy|8|||
163081286|NCT01905683|589006101|FG000|Overall Study|Withdrawal by Subject|20|||
163081287|NCT01905683|589006101|FG000|Overall Study|Adverse Event|4|||
163081288|NCT01905683|589006101|FG000|Overall Study|Lost to Follow-up|4|||
163081289|NCT02037984|589006104|FG000|Overall Study|Lack of Efficacy|0|||
163081290|NCT02037984|589006105|FG001|Overall Study|Lack of Efficacy|0|||
163081291|NCT02037984|589006106|FG002|Overall Study|Lack of Efficacy|3|||
163081292|NCT02037984|589006107|FG003|Overall Study|Lack of Efficacy|10|||
163081293|NCT02037984|589006108|FG004|Overall Study|Lack of Efficacy|2|||
163081294|NCT02037984|589006109|FG005|Overall Study|Lack of Efficacy|2|||
163081295|NCT02037984|589006110|FG006|Overall Study|Lack of Efficacy|4|||
163081296|NCT02037984|589006111|FG007|Overall Study|Lack of Efficacy|3|||
163081297|NCT02037984|589006104|FG000|Overall Study|Lost to Follow-up|1|||
163081298|NCT02037984|589006105|FG001|Overall Study|Lost to Follow-up|0|||
163081299|NCT02037984|589006106|FG002|Overall Study|Lost to Follow-up|3|||
163081300|NCT02037984|589006107|FG003|Overall Study|Lost to Follow-up|5|||
163081301|NCT02037984|589006108|FG004|Overall Study|Lost to Follow-up|2|||
163081302|NCT02037984|589006109|FG005|Overall Study|Lost to Follow-up|2|||
163081303|NCT02037984|589006110|FG006|Overall Study|Lost to Follow-up|2|||
163081304|NCT02037984|589006111|FG007|Overall Study|Lost to Follow-up|4|||
163081305|NCT02037984|589006104|FG000|Overall Study|Physician Decision|0|||
163081306|NCT02037984|589006105|FG001|Overall Study|Physician Decision|0|||
163081307|NCT02037984|589006106|FG002|Overall Study|Physician Decision|0|||
163081308|NCT02037984|589006107|FG003|Overall Study|Physician Decision|0|||
163081309|NCT02037984|589006108|FG004|Overall Study|Physician Decision|0|||
163081310|NCT02037984|589006109|FG005|Overall Study|Physician Decision|0|||
163081311|NCT02037984|589006110|FG006|Overall Study|Physician Decision|1|||
163081312|NCT02037984|589006111|FG007|Overall Study|Physician Decision|0|||
163081313|NCT02037984|589006104|FG000|Overall Study|Protocol Violation|0|||
163081314|NCT02037984|589006105|FG001|Overall Study|Protocol Violation|0|||
163081315|NCT02037984|589006106|FG002|Overall Study|Protocol Violation|0|||
163081316|NCT02037984|589006107|FG003|Overall Study|Protocol Violation|0|||
163081317|NCT02037984|589006108|FG004|Overall Study|Protocol Violation|0|||
163081318|NCT02037984|589006109|FG005|Overall Study|Protocol Violation|1|||
163081319|NCT02037984|589006110|FG006|Overall Study|Protocol Violation|2|||
163081320|NCT02037984|589006111|FG007|Overall Study|Protocol Violation|0|||
163081321|NCT02037984|589006104|FG000|Overall Study|Technical Problems|0|||
163081322|NCT02037984|589006105|FG001|Overall Study|Technical Problems|0|||
163081323|NCT02037984|589006106|FG002|Overall Study|Technical Problems|3|||
163081324|NCT02037984|589006107|FG003|Overall Study|Technical Problems|3|||
163081325|NCT02037984|589006108|FG004|Overall Study|Technical Problems|2|||
163029893|NCT00549601|588813710|FG002|Received Study Drug|Withdrawal by Subject|1|||
163029894|NCT00908596|588813714|FG000|Overall Study|Other reasons|46|||
163029895|NCT00908596|588813715|FG001|Overall Study|Other reasons|6|||
163029896|NCT00908596|588813716|FG002|Overall Study|Other reasons|2|||
163029897|NCT00908596|588813717|FG003|Overall Study|Other reasons|0|||
163029898|NCT00908596|588813714|FG000|Overall Study|Lost to Follow-up|0|||
163029899|NCT00908596|588813715|FG001|Overall Study|Lost to Follow-up|1|||
163029900|NCT00908596|588813716|FG002|Overall Study|Lost to Follow-up|12|||
163029901|NCT00908596|588813717|FG003|Overall Study|Lost to Follow-up|4|||
163029902|NCT00908596|588813714|FG000|Overall Study|Death|0|||
163029903|NCT00908596|588813715|FG001|Overall Study|Death|5|||
163029904|NCT00908596|588813716|FG002|Overall Study|Death|57|||
163029905|NCT00908596|588813717|FG003|Overall Study|Death|32|||
163029906|NCT00908596|588813714|FG000|Overall Study|Protocol Violation|1|||
163029907|NCT00908596|588813715|FG001|Overall Study|Protocol Violation|0|||
163029908|NCT00908596|588813716|FG002|Overall Study|Protocol Violation|0|||
163029909|NCT00908596|588813717|FG003|Overall Study|Protocol Violation|0|||
163029910|NCT00908596|588813714|FG000|Overall Study|Withdrawal by Subject|0|||
163029911|NCT00908596|588813715|FG001|Overall Study|Withdrawal by Subject|1|||
163029912|NCT00908596|588813716|FG002|Overall Study|Withdrawal by Subject|3|||
163029913|NCT00908596|588813717|FG003|Overall Study|Withdrawal by Subject|1|||
163029914|NCT00224406|588813718|FG000|Overall Study|Re-transplant|0|||
163029915|NCT00224406|588813719|FG001|Overall Study|Re-transplant|2|||
163029916|NCT00224406|588813718|FG000|Overall Study|Death|0|||
163029917|NCT00224406|588813719|FG001|Overall Study|Death|1|||
163029918|NCT00224406|588813718|FG000|Overall Study|Transplant cancelled|0|||
163029919|NCT00224406|588813719|FG001|Overall Study|Transplant cancelled|4|||
163029920|NCT00224406|588813718|FG000|Overall Study|Drug not delivered|2|||
163029921|NCT00224406|588813719|FG001|Overall Study|Drug not delivered|0|||
163029922|NCT00224406|588813718|FG000|Overall Study|Other|4|||
163029923|NCT00224406|588813719|FG001|Overall Study|Other|0|||
163029924|NCT00224406|588813718|FG000|Overall Study|Transplant cancelled|3|||
163029925|NCT00224406|588813719|FG001|Overall Study|Transplant cancelled|0|||
163029926|NCT04823130|588813724|FG000|Overall Study|Withdrawal by Subject|2|||
163029927|NCT04823130|588813725|FG001|Overall Study|Withdrawal by Subject|3|||
163029928|NCT04823130|588813724|FG000|Overall Study|Failure to meet inclusion criteria|6|||
163029929|NCT04823130|588813725|FG001|Overall Study|Failure to meet inclusion criteria|4|||
163081326|NCT02037984|589006109|FG005|Overall Study|Technical Problems|3|||
163081327|NCT02037984|589006110|FG006|Overall Study|Technical Problems|4|||
163081328|NCT02037984|589006111|FG007|Overall Study|Technical Problems|2|||
162646099|NCT00885755|587421350|FG000|Part I: Trastuzumab+Taxane|Death|0|||
163029930|NCT04823130|588813724|FG000|Overall Study|Other-unspecified|1|||
163029931|NCT04823130|588813725|FG001|Overall Study|Other-unspecified|0|||
163029932|NCT03315455|588813727|FG000|Overall Study|Ongoing in the Study|13|||
163029933|NCT03315455|588813728|FG001|Overall Study|Ongoing in the Study|24|||
163029934|NCT03315455|588813729|FG002|Overall Study|Ongoing in the Study|17|||
163029935|NCT03315455|588813730|FG003|Overall Study|Ongoing in the Study|15|||
163029936|NCT03315455|588813727|FG000|Overall Study|Withdrawal by Subject|0|||
163029937|NCT03315455|588813728|FG001|Overall Study|Withdrawal by Subject|1|||
163029938|NCT03315455|588813729|FG002|Overall Study|Withdrawal by Subject|0|||
163029939|NCT03315455|588813730|FG003|Overall Study|Withdrawal by Subject|0|||
163029940|NCT01846221|588813733|FG000|Overall Study|Catheter Failure|2|||
163029941|NCT01846221|588813734|FG001|Overall Study|Catheter Failure|0|||
163029942|NCT01846221|588813733|FG000|Overall Study|Age Exclusion|1|||
163029943|NCT01846221|588813734|FG001|Overall Study|Age Exclusion|0|||
163029944|NCT03427268|588813735|FG000|Overall Study|Progressive disease|25|||
163029945|NCT03427268|588813735|FG000|Overall Study|Never treated|2|||
163029946|NCT03427268|588813735|FG000|Overall Study|Compassionate use|1|||
163029947|NCT03427268|588813735|FG000|Overall Study|Withdrawal by Subject|1|||
163029948|NCT03427268|588813735|FG000|Overall Study|Adverse Event|3|||
163029949|NCT02304380|588813737|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029950|NCT02304380|588813738|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029951|NCT02304380|588813739|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029952|NCT02304380|588813740|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
163029953|NCT02304380|588813741|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029954|NCT02304380|588813742|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
163029955|NCT01027897|588813743|FG000|Overall Study|Protocol Violation|1|||
163029956|NCT01027897|588813743|FG000|Overall Study|Withdrawal by Subject|1|||
163029957|NCT00328094|588813744|FG000|Overall Study|Physician Decision|3|||
163029958|NCT00328094|588813745|FG001|Overall Study|Physician Decision|3|||
163029959|NCT00473824|588813746|FG000|Overall Study|Virologic Breakthrough|1|||
163029960|NCT00473824|588813747|FG001|Overall Study|Virologic Breakthrough|0|||
163029961|NCT00473824|588813746|FG000|Overall Study|Adverse Event|1|||
163029962|NCT00473824|588813747|FG001|Overall Study|Adverse Event|0|||
163029963|NCT00473824|588813746|FG000|Overall Study|Death|1|||
163029964|NCT00473824|588813747|FG001|Overall Study|Death|0|||
163029965|NCT00473824|588813746|FG000|Overall Study|Lost to Follow-up|1|||
163029966|NCT00473824|588813747|FG001|Overall Study|Lost to Follow-up|0|||
163029967|NCT00473824|588813746|FG000|Overall Study|Withdrawal by physician|1|||
163029968|NCT00473824|588813747|FG001|Overall Study|Withdrawal by physician|0|||
163029969|NCT01349322|588813748|FG000|Overall Study|Protocol Violation|45|||
163029970|NCT01349322|588813749|FG001|Overall Study|Protocol Violation|47|||
163029971|NCT04076059|588813755|FG000|Double Blind Phase|Progressive disease|22|||
163029972|NCT04076059|588813756|FG001|Double Blind Phase|Progressive disease|26|||
163029973|NCT04076059|588813757|FG002|Double Blind Phase|Progressive disease|0|||
163029974|NCT04076059|588813755|FG000|Double Blind Phase|Withdrawal by Subject|4|||
163029975|NCT04076059|588813756|FG001|Double Blind Phase|Withdrawal by Subject|11|||
163029976|NCT04076059|588813757|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163029977|NCT04076059|588813755|FG000|Double Blind Phase|Death|1|||
163029978|NCT04076059|588813756|FG001|Double Blind Phase|Death|1|||
163029979|NCT04076059|588813757|FG002|Double Blind Phase|Death|0|||
163029980|NCT04076059|588813755|FG000|Double Blind Phase|Lost to Follow-up|1|||
163029981|NCT04076059|588813756|FG001|Double Blind Phase|Lost to Follow-up|0|||
163029982|NCT04076059|588813757|FG002|Double Blind Phase|Lost to Follow-up|0|||
163029983|NCT04076059|588813755|FG000|Double Blind Phase|Adverse Event|5|||
163029984|NCT04076059|588813756|FG001|Double Blind Phase|Adverse Event|1|||
163029985|NCT04076059|588813757|FG002|Double Blind Phase|Adverse Event|0|||
163029986|NCT04076059|588813755|FG000|Double Blind Phase|Ongoing Participants|82|||
163029987|NCT04076059|588813756|FG001|Double Blind Phase|Ongoing Participants|18|||
163029988|NCT04076059|588813757|FG002|Double Blind Phase|Ongoing Participants|0|||
163029989|NCT04076059|588813755|FG000|Double Blind Phase|Miscellaneous|3|||
163029990|NCT04076059|588813756|FG001|Double Blind Phase|Miscellaneous|1|||
163029991|NCT04076059|588813757|FG002|Double Blind Phase|Miscellaneous|0|||
163029992|NCT04076059|588813755|FG000|Double Blind Phase|Protocol Deviation|1|||
163029993|NCT04076059|588813756|FG001|Double Blind Phase|Protocol Deviation|1|||
163029994|NCT04076059|588813757|FG002|Double Blind Phase|Protocol Deviation|0|||
162717909|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163029995|NCT04076059|588813755|FG000|Double Blind Phase|Did not take study drug|1|||
163029996|NCT04076059|588813756|FG001|Double Blind Phase|Did not take study drug|1|||
163029997|NCT04076059|588813757|FG002|Double Blind Phase|Did not take study drug|0|||
163029998|NCT04076059|588813755|FG000|Open Label Phase|Progressive disease|0|||
163029999|NCT04076059|588813756|FG001|Open Label Phase|Progressive disease|0|||
163030000|NCT04076059|588813757|FG002|Open Label Phase|Progressive disease|7|||
163030001|NCT04076059|588813755|FG000|Open Label Phase|Withdrawal by Subject|0|||
163030002|NCT04076059|588813756|FG001|Open Label Phase|Withdrawal by Subject|0|||
163030003|NCT04076059|588813757|FG002|Open Label Phase|Withdrawal by Subject|3|||
163030004|NCT04076059|588813755|FG000|Open Label Phase|Death|0|||
163030005|NCT04076059|588813756|FG001|Open Label Phase|Death|0|||
163030006|NCT04076059|588813757|FG002|Open Label Phase|Death|2|||
163030007|NCT04076059|588813755|FG000|Open Label Phase|Ongoing Participants|0|||
163030008|NCT04076059|588813756|FG001|Open Label Phase|Ongoing Participants|0|||
163030009|NCT04076059|588813757|FG002|Open Label Phase|Ongoing Participants|11|||
163030010|NCT04186806|588813758|FG000|Period 1: 7 Days|Adverse Event|1|||
163030011|NCT04186806|588813759|FG001|Period 1: 7 Days|Adverse Event|0|||
163030012|NCT02720744|588813761|FG000|Overall Study|Protocol Violation|0|||
163030013|NCT02720744|588813762|FG001|Overall Study|Protocol Violation|2|||
163030014|NCT02720744|588813761|FG000|Overall Study|Pregnancy|2|||
163030015|NCT02720744|588813762|FG001|Overall Study|Pregnancy|0|||
163030016|NCT02720744|588813761|FG000|Overall Study|Lack of Efficacy|2|||
163030017|NCT02720744|588813762|FG001|Overall Study|Lack of Efficacy|8|||
163030018|NCT02720744|588813761|FG000|Overall Study|Adverse Event|21|||
163030019|NCT02720744|588813762|FG001|Overall Study|Adverse Event|3|||
163030020|NCT02720744|588813761|FG000|Overall Study|Withdrawal by Subject|11|||
163030021|NCT02720744|588813762|FG001|Overall Study|Withdrawal by Subject|11|||
163030022|NCT02720744|588813761|FG000|Overall Study|Lost to follow up|2|||
163030023|NCT02720744|588813762|FG001|Overall Study|Lost to follow up|0|||
163030024|NCT02720744|588813761|FG000|Overall Study|Non Compliance with Investigational Product|0|||
163030025|NCT02720744|588813762|FG001|Overall Study|Non Compliance with Investigational Product|1|||
163030026|NCT02720744|588813761|FG000|Overall Study|Excluded Concomitant Medication|0|||
163030027|NCT02720744|588813762|FG001|Overall Study|Excluded Concomitant Medication|1|||
163030028|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
163030029|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030030|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
163030031|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
163030032|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030033|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
163030034|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Other|0|||
163030035|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Other|0|||
163030036|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Other|1|||
163030037|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Other|0|||
163030038|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Other|0|||
163030039|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Other|0|||
163030040|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030041|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
163030042|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030043|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030044|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030045|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
163030046|NCT02122770|588813763|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
163030047|NCT02122770|588813764|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
163030048|NCT02122770|588813765|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030049|NCT02122770|588813766|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
163030050|NCT02122770|588813767|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030051|NCT02122770|588813768|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
163030052|NCT02122770|588813763|FG000|Part B: Standard of Care|Adverse Event|0|||
163030053|NCT02122770|588813764|FG001|Part B: Standard of Care|Adverse Event|0|||
163030054|NCT02122770|588813765|FG002|Part B: Standard of Care|Adverse Event|0|||
163030055|NCT02122770|588813766|FG003|Part B: Standard of Care|Adverse Event|0|||
163030056|NCT02122770|588813767|FG004|Part B: Standard of Care|Adverse Event|4|||
163030057|NCT02122770|588813768|FG005|Part B: Standard of Care|Adverse Event|1|||
163030058|NCT02122770|588813763|FG000|Part B: Standard of Care|Other|0|||
163030059|NCT02122770|588813764|FG001|Part B: Standard of Care|Other|0|||
163030060|NCT02122770|588813765|FG002|Part B: Standard of Care|Other|0|||
163030061|NCT02122770|588813766|FG003|Part B: Standard of Care|Other|0|||
163030062|NCT02122770|588813767|FG004|Part B: Standard of Care|Other|0|||
163030063|NCT02122770|588813768|FG005|Part B: Standard of Care|Other|2|||
163030064|NCT02122770|588813763|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
163030065|NCT02122770|588813764|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
163081329|NCT02037984|589006104|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163081330|NCT02037984|589006105|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163081331|NCT02037984|589006106|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
163081332|NCT02037984|589006107|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
163081333|NCT02037984|589006108|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
163081334|NCT02037984|589006109|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
163081335|NCT02037984|589006110|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
163081336|NCT02037984|589006111|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
163081337|NCT02037984|589006104|FG000|Overall Study|Withdrawal by Subject|0|||
163081338|NCT02037984|589006105|FG001|Overall Study|Withdrawal by Subject|0|||
163081339|NCT02037984|589006106|FG002|Overall Study|Withdrawal by Subject|0|||
163081340|NCT02037984|589006107|FG003|Overall Study|Withdrawal by Subject|1|||
163081341|NCT02037984|589006108|FG004|Overall Study|Withdrawal by Subject|1|||
163081342|NCT02037984|589006109|FG005|Overall Study|Withdrawal by Subject|3|||
163081343|NCT02037984|589006110|FG006|Overall Study|Withdrawal by Subject|0|||
163081344|NCT02037984|589006111|FG007|Overall Study|Withdrawal by Subject|1|||
163081345|NCT04693715|589006977|FG000|Overall Study|Adverse Events Leading to Death|2|||
163081346|NCT04693715|589006978|FG001|Overall Study|Adverse Events Leading to Death|2|||
163081347|NCT04693715|589006979|FG002|Overall Study|Adverse Events Leading to Death|4|||
163081348|NCT04693715|589006977|FG000|Overall Study|Lost to Follow-up|0|||
163081349|NCT04693715|589006978|FG001|Overall Study|Lost to Follow-up|2|||
163081350|NCT04693715|589006979|FG002|Overall Study|Lost to Follow-up|2|||
163081351|NCT04693715|589006977|FG000|Overall Study|Physician Decision|0|||
163081352|NCT04693715|589006978|FG001|Overall Study|Physician Decision|1|||
163081353|NCT04693715|589006979|FG002|Overall Study|Physician Decision|0|||
163081354|NCT04693715|589006977|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
163081355|NCT04693715|589006978|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
163081356|NCT04693715|589006979|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
163081357|NCT04693715|589006977|FG000|Overall Study|Withdrawal by Subject|0|||
163081358|NCT04693715|589006978|FG001|Overall Study|Withdrawal by Subject|0|||
163081359|NCT04693715|589006979|FG002|Overall Study|Withdrawal by Subject|1|||
163081360|NCT06433908|589006980|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
163081361|NCT06433908|589006981|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081362|NCT06433908|589006982|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081363|NCT06433908|589006983|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
163081364|NCT06433908|589006980|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081365|NCT06433908|589006981|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
163081366|NCT06433908|589006982|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081367|NCT06433908|589006983|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
163081368|NCT06433908|589006980|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081369|NCT06433908|589006981|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081370|NCT06433908|589006982|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
163081371|NCT06433908|589006983|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
163081372|NCT04403880|589006984|FG000|Overall Study|Death|1|||
163081373|NCT04403880|589006985|FG001|Overall Study|Death|0|||
163081374|NCT04403880|589006986|FG002|Overall Study|Death|2|||
163081375|NCT04403880|589006987|FG003|Overall Study|Death|0|||
163081376|NCT04403880|589006988|FG004|Overall Study|Death|0|||
163081377|NCT04403880|589006989|FG005|Overall Study|Death|0|||
163081378|NCT04403880|589006990|FG006|Overall Study|Death|0|||
163081379|NCT04403880|589006984|FG000|Overall Study|Physician Decision|0|||
163081380|NCT04403880|589006985|FG001|Overall Study|Physician Decision|0|||
163081381|NCT04403880|589006986|FG002|Overall Study|Physician Decision|0|||
163081382|NCT04403880|589006987|FG003|Overall Study|Physician Decision|0|||
163081383|NCT04403880|589006988|FG004|Overall Study|Physician Decision|1|||
163081384|NCT04403880|589006989|FG005|Overall Study|Physician Decision|0|||
163081385|NCT04403880|589006990|FG006|Overall Study|Physician Decision|0|||
163081386|NCT04403880|589006984|FG000|Overall Study|Lost to Follow-up|4|||
163081387|NCT04403880|589006985|FG001|Overall Study|Lost to Follow-up|3|||
163081388|NCT04403880|589006986|FG002|Overall Study|Lost to Follow-up|8|||
163081389|NCT04403880|589006987|FG003|Overall Study|Lost to Follow-up|7|||
163081390|NCT04403880|589006988|FG004|Overall Study|Lost to Follow-up|8|||
163081391|NCT04403880|589006989|FG005|Overall Study|Lost to Follow-up|1|||
163081392|NCT04403880|589006990|FG006|Overall Study|Lost to Follow-up|8|||
163081393|NCT04403880|589006984|FG000|Overall Study|Withdrawal by Subject|8|||
163081394|NCT04403880|589006985|FG001|Overall Study|Withdrawal by Subject|9|||
163081395|NCT04403880|589006986|FG002|Overall Study|Withdrawal by Subject|22|||
163081396|NCT04403880|589006987|FG003|Overall Study|Withdrawal by Subject|16|||
163081397|NCT04403880|589006988|FG004|Overall Study|Withdrawal by Subject|16|||
163081398|NCT04403880|589006989|FG005|Overall Study|Withdrawal by Subject|8|||
163081399|NCT04403880|589006990|FG006|Overall Study|Withdrawal by Subject|11|||
163081400|NCT04403880|589006984|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
163081401|NCT04403880|589006985|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
163081402|NCT04403880|589006986|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
163081403|NCT04403880|589006987|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
163081404|NCT04403880|589006988|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
163081405|NCT04403880|589006989|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163081406|NCT04403880|589006990|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
163081407|NCT04403880|589006984|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
163081408|NCT04403880|589006985|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
163081409|NCT04403880|589006986|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
163081410|NCT04403880|589006987|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
163081411|NCT04403880|589006988|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
163081412|NCT04403880|589006989|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
163081413|NCT04403880|589006990|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
163081414|NCT04403880|589006984|FG000|Overall Study|Pregnancy|2|||
163081415|NCT04403880|589006985|FG001|Overall Study|Pregnancy|0|||
163081416|NCT04403880|589006986|FG002|Overall Study|Pregnancy|5|||
163081417|NCT04403880|589006987|FG003|Overall Study|Pregnancy|0|||
163081418|NCT04403880|589006988|FG004|Overall Study|Pregnancy|1|||
163081419|NCT04403880|589006989|FG005|Overall Study|Pregnancy|0|||
163081420|NCT04403880|589006990|FG006|Overall Study|Pregnancy|1|||
163081421|NCT04403880|589006984|FG000|Overall Study|Sponsor Decision|2|||
163081422|NCT04403880|589006985|FG001|Overall Study|Sponsor Decision|0|||
163081423|NCT04403880|589006986|FG002|Overall Study|Sponsor Decision|14|||
163081424|NCT04403880|589006987|FG003|Overall Study|Sponsor Decision|1|||
163081425|NCT04403880|589006988|FG004|Overall Study|Sponsor Decision|1|||
163081426|NCT04403880|589006989|FG005|Overall Study|Sponsor Decision|0|||
163081427|NCT04403880|589006990|FG006|Overall Study|Sponsor Decision|2|||
163081428|NCT04403880|589006984|FG000|Overall Study|Other|18|||
163081429|NCT04403880|589006985|FG001|Overall Study|Other|9|||
163081430|NCT04403880|589006986|FG002|Overall Study|Other|14|||
163081431|NCT04403880|589006987|FG003|Overall Study|Other|10|||
163081432|NCT04403880|589006988|FG004|Overall Study|Other|11|||
163081433|NCT04403880|589006989|FG005|Overall Study|Other|12|||
163081434|NCT04403880|589006990|FG006|Overall Study|Other|15|||
163081435|NCT04138277|589006991|FG000|Pretreatment|Withdrawal by Subject|1|||
163081436|NCT04138277|589006992|FG001|Pretreatment|Withdrawal by Subject|0|||
163081437|NCT04138277|589006991|FG000|Treatment|Adverse Event|6|||
163081438|NCT04138277|589006992|FG001|Treatment|Adverse Event|2|||
163081439|NCT04138277|589006991|FG000|Treatment|Lost to Follow-up|1|||
163081440|NCT04138277|589006992|FG001|Treatment|Lost to Follow-up|0|||
163081441|NCT04138277|589006991|FG000|Treatment|Pregnancy|3|||
163081442|NCT04138277|589006992|FG001|Treatment|Pregnancy|0|||
163081443|NCT04138277|589006991|FG000|Treatment|COVID-19 pandemic|1|||
163081444|NCT04138277|589006992|FG001|Treatment|COVID-19 pandemic|0|||
163081445|NCT04138277|589006991|FG000|Treatment|Withdrawal by Subject|9|||
163081446|NCT04138277|589006992|FG001|Treatment|Withdrawal by Subject|3|||
163081447|NCT04138277|589006991|FG000|Treatment|Sponsor decision|1|||
163081448|NCT04138277|589006992|FG001|Treatment|Sponsor decision|0|||
163081449|NCT04138277|589006991|FG000|Treatment|Physician Decision|1|||
163081450|NCT04138277|589006992|FG001|Treatment|Physician Decision|0|||
163081451|NCT04138277|589006991|FG000|Treatment|Worsening of condition|1|||
163081452|NCT04138277|589006992|FG001|Treatment|Worsening of condition|2|||
163081453|NCT03768414|589006993|FG000|Overall Study|Adverse Event or side effects|72|||
163081454|NCT03768414|589006994|FG001|Overall Study|Adverse Event or side effects|28|||
163081455|NCT03768414|589006993|FG000|Overall Study|Refusal unrelated to adverse event|33|||
163081456|NCT03768414|589006994|FG001|Overall Study|Refusal unrelated to adverse event|33|||
163081457|NCT03768414|589006993|FG000|Overall Study|Progression/relapse|132|||
163081458|NCT03768414|589006994|FG001|Overall Study|Progression/relapse|60|||
163081459|NCT03768414|589006993|FG000|Overall Study|Death|9|||
163081460|NCT03768414|589006994|FG001|Overall Study|Death|6|||
163081461|NCT03768414|589006993|FG000|Overall Study|Other - not protocol specified|45|||
163081462|NCT03768414|589006994|FG001|Overall Study|Other - not protocol specified|18|||
163081463|NCT03768414|589006993|FG000|Overall Study|Reason under review|3|||
162646100|NCT00885755|587421351|FG001|Part I: Trastuzumab+Taxane|Death|0|||
162646101|NCT00885755|587421352|FG002|Part I: Trastuzumab+Taxane|Death|1|||
162646102|NCT00885755|587421350|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
162646103|NCT00885755|587421351|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
162646104|NCT00885755|587421352|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
162646105|NCT00325754|587421353|FG000|Overall Study|Adverse Event|4|||
162646106|NCT00325754|587421354|FG001|Overall Study|Adverse Event|1|||
162646107|NCT02625090|587421361|FG000|Overall Study|Participant wants to be pregnant|2|||
162646108|NCT02625090|587421361|FG000|Overall Study|For the Promoter|1|||
162646109|NCT02625090|587421361|FG000|Overall Study|Sponsor's Decision|9|||
163030066|NCT02122770|588813765|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
163030067|NCT02122770|588813766|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
163030068|NCT02122770|588813767|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
163030069|NCT02122770|588813768|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
163030070|NCT02122770|588813763|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030071|NCT02122770|588813764|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030072|NCT02122770|588813765|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030073|NCT02122770|588813766|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030074|NCT02122770|588813767|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
163030075|NCT02122770|588813768|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
163030076|NCT02122770|588813763|FG000|Part B: Standard of Care|Progressive Disease|0|||
163030077|NCT02122770|588813764|FG001|Part B: Standard of Care|Progressive Disease|0|||
163030078|NCT02122770|588813765|FG002|Part B: Standard of Care|Progressive Disease|0|||
163030079|NCT02122770|588813766|FG003|Part B: Standard of Care|Progressive Disease|0|||
163030080|NCT02122770|588813767|FG004|Part B: Standard of Care|Progressive Disease|10|||
163030081|NCT02122770|588813768|FG005|Part B: Standard of Care|Progressive Disease|8|||
163030082|NCT06137703|588813769|FG000|Overall Study|Other|0|||
163030083|NCT06137703|588813770|FG001|Overall Study|Other|1|||
163030084|NCT06137703|588813771|FG002|Overall Study|Other|0|||
163030085|NCT06137703|588813772|FG003|Overall Study|Other|0|||
163030086|NCT06137703|588813769|FG000|Overall Study|Adverse Event|0|||
163030087|NCT06137703|588813770|FG001|Overall Study|Adverse Event|0|||
163030088|NCT06137703|588813771|FG002|Overall Study|Adverse Event|1|||
163030089|NCT06137703|588813772|FG003|Overall Study|Adverse Event|0|||
163030090|NCT01801358|588813773|FG000|Overall Study|Adverse Event|0|||
163030091|NCT01801358|588813774|FG001|Overall Study|Adverse Event|2|||
163030092|NCT01801358|588813775|FG002|Overall Study|Adverse Event|1|||
163030093|NCT01801358|588813776|FG003|Overall Study|Adverse Event|0|||
163030094|NCT01801358|588813777|FG004|Overall Study|Adverse Event|0|||
163030095|NCT01801358|588813778|FG005|Overall Study|Adverse Event|1|||
163030096|NCT01801358|588813773|FG000|Overall Study|Physician Decision|0|||
163030097|NCT01801358|588813774|FG001|Overall Study|Physician Decision|0|||
163030098|NCT01801358|588813775|FG002|Overall Study|Physician Decision|1|||
163030099|NCT01801358|588813776|FG003|Overall Study|Physician Decision|0|||
163030100|NCT01801358|588813777|FG004|Overall Study|Physician Decision|0|||
163030101|NCT01801358|588813778|FG005|Overall Study|Physician Decision|0|||
163030102|NCT01801358|588813773|FG000|Overall Study|Progressive Disease|6|||
163030103|NCT01801358|588813774|FG001|Overall Study|Progressive Disease|4|||
163030104|NCT01801358|588813775|FG002|Overall Study|Progressive Disease|4|||
163030105|NCT01801358|588813776|FG003|Overall Study|Progressive Disease|5|||
163030106|NCT01801358|588813777|FG004|Overall Study|Progressive Disease|6|||
163030107|NCT01801358|588813778|FG005|Overall Study|Progressive Disease|5|||
163030108|NCT01801358|588813773|FG000|Overall Study|Withdrawal by Subject|0|||
163030109|NCT01801358|588813774|FG001|Overall Study|Withdrawal by Subject|0|||
163030110|NCT01801358|588813775|FG002|Overall Study|Withdrawal by Subject|0|||
163030111|NCT01801358|588813776|FG003|Overall Study|Withdrawal by Subject|1|||
163030112|NCT01801358|588813777|FG004|Overall Study|Withdrawal by Subject|0|||
163030113|NCT01801358|588813778|FG005|Overall Study|Withdrawal by Subject|2|||
163030114|NCT00767039|588813779|FG000|Overall Study|Death|5|||
163030115|NCT00767039|588813780|FG001|Overall Study|Death|2|||
163030116|NCT02505334|588813781|FG000|Main Treatment Period|Adverse Event|3|||
163030117|NCT02505334|588813782|FG001|Main Treatment Period|Adverse Event|3|||
163030118|NCT02505334|588813781|FG000|Main Treatment Period|Lack of Efficacy|7|||
163030119|NCT02505334|588813782|FG001|Main Treatment Period|Lack of Efficacy|17|||
163030120|NCT02505334|588813781|FG000|Main Treatment Period|Protocol Violation|0|||
163030121|NCT02505334|588813782|FG001|Main Treatment Period|Protocol Violation|1|||
163030122|NCT02505334|588813781|FG000|Main Treatment Period|Withdrawal by Subject|1|||
163030123|NCT02505334|588813782|FG001|Main Treatment Period|Withdrawal by Subject|8|||
163030124|NCT02505334|588813781|FG000|Main Treatment Period|Unclassified|4|||
163081464|NCT03768414|589006994|FG001|Overall Study|Reason under review|2|||
163081465|NCT00124306|589006996|FG000|Overall Study|Adverse Event|7|||
163081466|NCT00124306|589006997|FG001|Overall Study|Adverse Event|2|||
163081467|NCT00124306|589006996|FG000|Overall Study|Lost to Follow-up|10|||
163081468|NCT00124306|589006997|FG001|Overall Study|Lost to Follow-up|6|||
163081469|NCT00124306|589006996|FG000|Overall Study|Lack of Efficacy|3|||
163081470|NCT00124306|589006997|FG001|Overall Study|Lack of Efficacy|6|||
163081471|NCT00124306|589006996|FG000|Overall Study|Personal constraints|0|||
163081472|NCT00124306|589006997|FG001|Overall Study|Personal constraints|2|||
163081473|NCT00124306|589006996|FG000|Overall Study|Use of unacceptable medication|1|||
163081474|NCT00124306|589006997|FG001|Overall Study|Use of unacceptable medication|0|||
163081475|NCT00124306|589006996|FG000|Overall Study|Abnormal lab result|0|||
163081476|NCT00124306|589006997|FG001|Overall Study|Abnormal lab result|1|||
163081477|NCT00124306|589006996|FG000|Overall Study|Other|2|||
163081478|NCT00124306|589006997|FG001|Overall Study|Other|0|||
163081479|NCT04153149|589006999|FG000|Double Blind Period|Death|63|||
163081480|NCT04153149|589007000|FG001|Double Blind Period|Death|49|||
163081481|NCT04153149|589007001|FG002|Double Blind Period|Death|0|||
163081482|NCT04153149|589007002|FG003|Double Blind Period|Death|0|||
163081483|NCT04153149|589006999|FG000|Double Blind Period|Withdrawal by Subject|16|||
163081484|NCT04153149|589007000|FG001|Double Blind Period|Withdrawal by Subject|11|||
163081485|NCT04153149|589007001|FG002|Double Blind Period|Withdrawal by Subject|0|||
163081486|NCT04153149|589007002|FG003|Double Blind Period|Withdrawal by Subject|0|||
163081487|NCT04153149|589006999|FG000|Double Blind Period|Adverse Event|6|||
163081488|NCT04153149|589007000|FG001|Double Blind Period|Adverse Event|2|||
163081489|NCT04153149|589007001|FG002|Double Blind Period|Adverse Event|0|||
163081490|NCT04153149|589007002|FG003|Double Blind Period|Adverse Event|0|||
163081491|NCT04153149|589006999|FG000|Double Blind Period|Lost to Follow-up|2|||
163081492|NCT04153149|589007000|FG001|Double Blind Period|Lost to Follow-up|1|||
163081493|NCT04153149|589007001|FG002|Double Blind Period|Lost to Follow-up|0|||
163081494|NCT04153149|589007002|FG003|Double Blind Period|Lost to Follow-up|0|||
163081495|NCT04153149|589006999|FG000|Double Blind Period|Withdrawal by guardian|0|||
163081496|NCT04153149|589007000|FG001|Double Blind Period|Withdrawal by guardian|2|||
163081497|NCT04153149|589007001|FG002|Double Blind Period|Withdrawal by guardian|0|||
163081498|NCT04153149|589007002|FG003|Double Blind Period|Withdrawal by guardian|0|||
163081499|NCT04153149|589006999|FG000|Double Blind Period|Reason Not Specified|5|||
163081500|NCT04153149|589007000|FG001|Double Blind Period|Reason Not Specified|4|||
163081501|NCT04153149|589007001|FG002|Double Blind Period|Reason Not Specified|0|||
163081502|NCT04153149|589007002|FG003|Double Blind Period|Reason Not Specified|0|||
163081503|NCT04153149|589006999|FG000|Double Blind Period|Physician Decision|2|||
163081504|NCT04153149|589007000|FG001|Double Blind Period|Physician Decision|0|||
163081505|NCT04153149|589007001|FG002|Double Blind Period|Physician Decision|0|||
163081506|NCT04153149|589007002|FG003|Double Blind Period|Physician Decision|0|||
163081507|NCT04153149|589006999|FG000|Open Label Extension Period|Death|0|||
163081508|NCT04153149|589007000|FG001|Open Label Extension Period|Death|0|||
163081509|NCT04153149|589007001|FG002|Open Label Extension Period|Death|7|||
163081510|NCT04153149|589007002|FG003|Open Label Extension Period|Death|3|||
163081511|NCT04153149|589006999|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
163081512|NCT04153149|589007000|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
163081513|NCT04153149|589007001|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
163081514|NCT04153149|589007002|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
163081515|NCT04153149|589006999|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081516|NCT04153149|589007000|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081517|NCT04153149|589007001|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
163081518|NCT04153149|589007002|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
163081519|NCT04153149|589006999|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
163081520|NCT04153149|589007000|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
163081521|NCT04153149|589007001|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
163081522|NCT04153149|589007002|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
163081523|NCT00866775|589008006|FG000|Overall Study|Adverse Event|5|||
163081524|NCT00866775|589008007|FG001|Overall Study|Adverse Event|19|||
163081525|NCT00866775|589008006|FG000|Overall Study|Death|1|||
163081526|NCT00866775|589008007|FG001|Overall Study|Death|0|||
163081527|NCT00866775|589008006|FG000|Overall Study|Lost to Follow-up|0|||
163081528|NCT00866775|589008007|FG001|Overall Study|Lost to Follow-up|4|||
163081529|NCT00866775|589008006|FG000|Overall Study|Physician Decision|0|||
163081530|NCT00866775|589008007|FG001|Overall Study|Physician Decision|3|||
163081531|NCT00866775|589008006|FG000|Overall Study|Protocol Violation|3|||
163081532|NCT00866775|589008007|FG001|Overall Study|Protocol Violation|4|||
163081533|NCT00866775|589008006|FG000|Overall Study|Withdrawal by Subject|4|||
163081534|NCT00866775|589008007|FG001|Overall Study|Withdrawal by Subject|4|||
163081535|NCT00866775|589008006|FG000|Overall Study|met exit criteria|23|||
163081536|NCT00866775|589008007|FG001|Overall Study|met exit criteria|17|||
163081537|NCT00866775|589008006|FG000|Overall Study|discontinued due to communication error|0|||
162646110|NCT02625090|587421361|FG000|Overall Study|Somnolence|1|||
162646111|NCT02625090|587421361|FG000|Overall Study|Study terminated by Sponsor|7|||
162646112|NCT02625090|587421361|FG000|Overall Study|Negative Benefit/Risk|1|||
162646113|NCT02625090|587421361|FG000|Overall Study|Protocol Deviation|2|||
163081538|NCT00866775|589008007|FG001|Overall Study|discontinued due to communication error|1|||
163081539|NCT00833703|589008008|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
163081540|NCT00833703|589008009|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
163081541|NCT00003907|589008010|FG000|Overall Study|Adverse Event|2|||
163081542|NCT00003907|589008011|FG001|Overall Study|Adverse Event|11|||
163081543|NCT00003907|589008010|FG000|Overall Study|Death|2|||
163081544|NCT00003907|589008011|FG001|Overall Study|Death|0|||
163081545|NCT00003907|589008010|FG000|Overall Study|Withdrawal by Subject|1|||
163081546|NCT00003907|589008011|FG001|Overall Study|Withdrawal by Subject|3|||
163081547|NCT00003907|589008010|FG000|Overall Study|Progressive disease|4|||
163081548|NCT00003907|589008011|FG001|Overall Study|Progressive disease|4|||
163081549|NCT00003907|589008010|FG000|Overall Study|Complicating disease|1|||
163081550|NCT00003907|589008011|FG001|Overall Study|Complicating disease|0|||
163081551|NCT00003907|589008010|FG000|Overall Study|Other|1|||
163081552|NCT00003907|589008011|FG001|Overall Study|Other|3|||
163081553|NCT00003907|589008010|FG000|Overall Study|ineligible or not treated|2|||
163081554|NCT00003907|589008011|FG001|Overall Study|ineligible or not treated|2|||
163081555|NCT00266032|589008014|FG000|Treatment|Adverse Event|42|||
163081556|NCT00266032|589008015|FG001|Treatment|Adverse Event|26|||
163081557|NCT00266032|589008016|FG002|Treatment|Adverse Event|10|||
163081558|NCT00266032|589008014|FG000|Treatment|Lost to Follow-up|19|||
163081559|NCT00266032|589008015|FG001|Treatment|Lost to Follow-up|4|||
163081560|NCT00266032|589008016|FG002|Treatment|Lost to Follow-up|2|||
163081561|NCT00266032|589008014|FG000|Treatment|Pregnancy|3|||
163081562|NCT00266032|589008015|FG001|Treatment|Pregnancy|2|||
163081563|NCT00266032|589008016|FG002|Treatment|Pregnancy|2|||
163081564|NCT00266032|589008014|FG000|Treatment|Protocol Violation|6|||
163081565|NCT00266032|589008015|FG001|Treatment|Protocol Violation|14|||
163081566|NCT00266032|589008016|FG002|Treatment|Protocol Violation|13|||
163081567|NCT00266032|589008014|FG000|Treatment|Withdrawal by Subject|28|||
163081568|NCT00266032|589008015|FG001|Treatment|Withdrawal by Subject|13|||
163081569|NCT00266032|589008016|FG002|Treatment|Withdrawal by Subject|12|||
163081570|NCT00266032|589008014|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
163081571|NCT00266032|589008015|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
163081572|NCT00266032|589008016|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
163081573|NCT00266032|589008014|FG000|Open-label Safety Extension|Adverse Event|5|||
163081574|NCT00266032|589008015|FG001|Open-label Safety Extension|Adverse Event|0|||
163081575|NCT00266032|589008016|FG002|Open-label Safety Extension|Adverse Event|4|||
163081576|NCT00266032|589008014|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
163081577|NCT00266032|589008015|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
163081578|NCT00266032|589008016|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
163081579|NCT00266032|589008014|FG000|Open-label Safety Extension|Pregnancy|4|||
163081580|NCT00266032|589008015|FG001|Open-label Safety Extension|Pregnancy|1|||
163081581|NCT00266032|589008016|FG002|Open-label Safety Extension|Pregnancy|2|||
163081582|NCT00266032|589008014|FG000|Open-label Safety Extension|Protocol Violation|1|||
163081583|NCT00266032|589008015|FG001|Open-label Safety Extension|Protocol Violation|3|||
163081584|NCT00266032|589008016|FG002|Open-label Safety Extension|Protocol Violation|2|||
163081585|NCT00266032|589008014|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
163081586|NCT00266032|589008015|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
163081587|NCT00266032|589008016|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
163081588|NCT00266032|589008014|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
163081589|NCT00266032|589008015|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
162646114|NCT02625090|587421361|FG000|Overall Study|Lack of Efficacy|16|||
162646115|NCT02625090|587421361|FG000|Overall Study|Adverse Event|3|||
162646116|NCT04649164|587421362|FG000|Overall Study|Withdrawal by Subject|1|||
162646117|NCT04649164|587421363|FG001|Overall Study|Withdrawal by Subject|1|||
163081590|NCT00266032|589008016|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
163081591|NCT00124657|589008018|FG000|Overall Study|Toxicity|0|||
163081592|NCT00124657|589008019|FG001|Overall Study|Toxicity|0|||
163081593|NCT00124657|589008020|FG002|Overall Study|Toxicity|1|||
162646118|NCT04649164|587421364|FG002|Overall Study|Withdrawal by Subject|2|||
162646119|NCT04649164|587421362|FG000|Overall Study|Participant's care recipient expired|0|||
163081594|NCT00124657|589008018|FG000|Overall Study|Non-compliance|1|||
163081595|NCT00124657|589008019|FG001|Overall Study|Non-compliance|0|||
163081596|NCT00124657|589008020|FG002|Overall Study|Non-compliance|4|||
163081597|NCT00124657|589008018|FG000|Overall Study|Progressive disease|14|||
163081598|NCT00124657|589008019|FG001|Overall Study|Progressive disease|5|||
163081599|NCT00124657|589008020|FG002|Overall Study|Progressive disease|27|||
163081600|NCT00124657|589008018|FG000|Overall Study|Intercurrent illness|1|||
163081601|NCT00124657|589008019|FG001|Overall Study|Intercurrent illness|0|||
163081602|NCT00124657|589008020|FG002|Overall Study|Intercurrent illness|0|||
163081603|NCT02367885|589008023|FG000|Overall Study|Lost to Follow-up|1|||
163081604|NCT02367885|589008024|FG001|Overall Study|Lost to Follow-up|0|||
163081605|NCT02367885|589008025|FG002|Overall Study|Lost to Follow-up|0|||
163081606|NCT02367885|589008023|FG000|Overall Study|Withdrawal by Subject|1|||
163081607|NCT02367885|589008024|FG001|Overall Study|Withdrawal by Subject|0|||
163081608|NCT02367885|589008025|FG002|Overall Study|Withdrawal by Subject|0|||
163081609|NCT01378195|589008026|FG000|Overall Study|Lost to Follow-up|29|||
163081610|NCT01378195|589008027|FG001|Overall Study|Lost to Follow-up|18|||
163081611|NCT00752219|589008028|FG000|Overall Study|Clinical failure|0|||
163081612|NCT00752219|589008029|FG001|Overall Study|Clinical failure|1|||
163081613|NCT00752219|589008028|FG000|Overall Study|Adverse Event|5|||
163081614|NCT00752219|589008029|FG001|Overall Study|Adverse Event|3|||
163081615|NCT00752219|589008028|FG000|Overall Study|Protocol deviation|1|||
163081616|NCT00752219|589008029|FG001|Overall Study|Protocol deviation|0|||
163081617|NCT00752219|589008028|FG000|Overall Study|Lost to Follow-up|1|||
163081618|NCT00752219|589008029|FG001|Overall Study|Lost to Follow-up|2|||
163081619|NCT00752219|589008028|FG000|Overall Study|Randomized but not treated|1|||
163081620|NCT00752219|589008029|FG001|Overall Study|Randomized but not treated|0|||
163081621|NCT00752219|589008028|FG000|Overall Study|Other|3|||
163081622|NCT00752219|589008029|FG001|Overall Study|Other|0|||
163081623|NCT03533491|589008031|FG000|Overall Study|Lost to Follow-up|2|||
163081624|NCT05418426|589008035|FG000|Overall Study|Adverse Event|0|||
163081625|NCT05418426|589008036|FG001|Overall Study|Adverse Event|1|||
163081626|NCT05418426|589008037|FG002|Overall Study|Adverse Event|0|||
163081627|NCT05418426|589008035|FG000|Overall Study|Withdrawal by Subject|0|||
163081628|NCT05418426|589008036|FG001|Overall Study|Withdrawal by Subject|1|||
163081629|NCT05418426|589008037|FG002|Overall Study|Withdrawal by Subject|0|||
163081630|NCT05418426|589008035|FG000|Overall Study|Protocol Violation|0|||
163081631|NCT05418426|589008036|FG001|Overall Study|Protocol Violation|0|||
163081632|NCT05418426|589008037|FG002|Overall Study|Protocol Violation|1|||
163081633|NCT03829683|589008042|FG000|Overall Study|Lost to Follow-up|1|||
163081634|NCT03829683|589008043|FG001|Overall Study|Lost to Follow-up|0|||
163081635|NCT03829683|589008042|FG000|Overall Study|Physician Decision|3|||
163081636|NCT03829683|589008043|FG001|Overall Study|Physician Decision|1|||
163081637|NCT03829683|589008042|FG000|Overall Study|Withdrawal by Subject|0|||
163081638|NCT03829683|589008043|FG001|Overall Study|Withdrawal by Subject|1|||
163081639|NCT03829683|589008042|FG000|Overall Study|Discharge from hospital|1|||
163081640|NCT03829683|589008043|FG001|Overall Study|Discharge from hospital|0|||
163081641|NCT00803049|589008048|FG000|Overall Study|Adverse Event|21|||
163081642|NCT00803049|589008049|FG001|Overall Study|Adverse Event|33|||
163081643|NCT00803049|589008050|FG002|Overall Study|Adverse Event|13|||
163081644|NCT00803049|589008051|FG003|Overall Study|Adverse Event|27|||
163081645|NCT00803049|589008048|FG000|Overall Study|Lack of Efficacy|10|||
163081646|NCT00803049|589008049|FG001|Overall Study|Lack of Efficacy|19|||
162646120|NCT04649164|587421363|FG001|Overall Study|Participant's care recipient expired|0|||
163081647|NCT00803049|589008050|FG002|Overall Study|Lack of Efficacy|6|||
163081648|NCT00803049|589008051|FG003|Overall Study|Lack of Efficacy|13|||
163081649|NCT00803049|589008048|FG000|Overall Study|Lost to Follow-up|0|||
163081650|NCT00803049|589008049|FG001|Overall Study|Lost to Follow-up|2|||
163081651|NCT00803049|589008050|FG002|Overall Study|Lost to Follow-up|0|||
163081652|NCT00803049|589008051|FG003|Overall Study|Lost to Follow-up|3|||
163081653|NCT00803049|589008048|FG000|Overall Study|Death|2|||
163081654|NCT00803049|589008049|FG001|Overall Study|Death|1|||
163081655|NCT00803049|589008050|FG002|Overall Study|Death|0|||
163081656|NCT00803049|589008051|FG003|Overall Study|Death|2|||
163081657|NCT00803049|589008048|FG000|Overall Study|Progressive Disease|6|||
163081658|NCT00803049|589008049|FG001|Overall Study|Progressive Disease|10|||
163081659|NCT00803049|589008050|FG002|Overall Study|Progressive Disease|6|||
163081660|NCT00803049|589008051|FG003|Overall Study|Progressive Disease|6|||
163081661|NCT00803049|589008048|FG000|Overall Study|Withdrawal by Subject|19|||
162646121|NCT04649164|587421364|FG002|Overall Study|Participant's care recipient expired|2|||
163081662|NCT00803049|589008049|FG001|Overall Study|Withdrawal by Subject|43|||
163081663|NCT00803049|589008050|FG002|Overall Study|Withdrawal by Subject|16|||
163081664|NCT00803049|589008051|FG003|Overall Study|Withdrawal by Subject|44|||
163081665|NCT00803049|589008048|FG000|Overall Study|Protocol Violation|0|||
162646122|NCT02250443|587421365|FG000|Overall Study|Administrative problems|7|||
163081666|NCT00803049|589008049|FG001|Overall Study|Protocol Violation|1|||
163081667|NCT00803049|589008050|FG002|Overall Study|Protocol Violation|1|||
163081668|NCT00803049|589008051|FG003|Overall Study|Protocol Violation|0|||
163081669|NCT00803049|589008048|FG000|Overall Study|Randomized and Not Treated|0|||
163081670|NCT00803049|589008049|FG001|Overall Study|Randomized and Not Treated|0|||
163081671|NCT00803049|589008050|FG002|Overall Study|Randomized and Not Treated|0|||
162646123|NCT02250443|587421365|FG000|Overall Study|Adverse Event|3|||
163081672|NCT00803049|589008051|FG003|Overall Study|Randomized and Not Treated|2|||
163081673|NCT00803049|589008048|FG000|Overall Study|Other than Specified Above|3|||
163081674|NCT00803049|589008049|FG001|Overall Study|Other than Specified Above|9|||
163081675|NCT00803049|589008050|FG002|Overall Study|Other than Specified Above|2|||
163081676|NCT00803049|589008051|FG003|Overall Study|Other than Specified Above|5|||
163081677|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
163081678|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
163081679|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
163081680|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
163081681|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
163081682|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
163081683|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
163081684|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
163081685|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
163081686|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
163081687|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
163081688|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
163081689|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
163081690|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
163081691|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
163081692|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
163081693|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
163081694|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
163081695|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
163081696|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
163081697|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
163081698|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
163081699|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
163081700|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
163081701|NCT01272219|589008052|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
163081702|NCT01272219|589008053|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
163081703|NCT01272219|589008054|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
163081704|NCT01272219|589008055|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
163081705|NCT01272219|589008056|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
163081706|NCT01272219|589008057|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
163081707|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081708|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
163081709|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
163081710|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
163081711|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081712|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
163081713|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081714|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081715|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081716|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
163081717|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081718|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
163081719|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081720|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
163081721|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081722|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
163081723|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081724|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
163081725|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081726|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
163081727|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
163081728|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
163081729|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081730|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
163081731|NCT01272219|589008052|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081732|NCT01272219|589008053|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
163081733|NCT01272219|589008054|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
163081734|NCT01272219|589008055|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
163081735|NCT01272219|589008056|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081736|NCT01272219|589008057|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
163081737|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081738|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081739|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081740|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
163081741|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
162646124|NCT03168464|587421366|FG000|Overall Study|Death|9|||
163081742|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
163081743|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081744|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081745|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081746|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
163081747|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
163081748|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
163081749|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081750|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081751|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081752|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
163081753|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
163081754|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
163081755|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081756|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081757|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081758|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
163081759|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
163081760|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
163081761|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
163081762|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
163081763|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
163081764|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
163081765|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
163081766|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
163081767|NCT01272219|589008052|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
163081768|NCT01272219|589008053|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
163081769|NCT01272219|589008054|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
163081770|NCT01272219|589008055|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
163081771|NCT01272219|589008056|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
163081772|NCT01272219|589008057|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
163081773|NCT03301415|589008062|FG000|Overall Study|Lost to Follow-up|2|||
163081774|NCT03301415|589008062|FG000|Overall Study|Unable to comply with visit schedule|2|||
163081775|NCT00392288|589008063|FG000|Overall Study|Adverse Event|17|||
163081776|NCT00392288|589008064|FG001|Overall Study|Adverse Event|7|||
163081777|NCT00392288|589008065|FG002|Overall Study|Adverse Event|8|||
163081778|NCT00392288|589008063|FG000|Overall Study|Lack of Efficacy|8|||
163081779|NCT00392288|589008064|FG001|Overall Study|Lack of Efficacy|5|||
163081780|NCT00392288|589008065|FG002|Overall Study|Lack of Efficacy|3|||
163081781|NCT00392288|589008063|FG000|Overall Study|Protocol Violation|1|||
163081782|NCT00392288|589008064|FG001|Overall Study|Protocol Violation|3|||
163081783|NCT00392288|589008065|FG002|Overall Study|Protocol Violation|1|||
163081784|NCT00392288|589008063|FG000|Overall Study|Lost to Follow-up|1|||
163081785|NCT00392288|589008064|FG001|Overall Study|Lost to Follow-up|1|||
163081786|NCT00392288|589008065|FG002|Overall Study|Lost to Follow-up|1|||
163081787|NCT00392288|589008063|FG000|Overall Study|Withdrawal by Subject|1|||
163081788|NCT00392288|589008064|FG001|Overall Study|Withdrawal by Subject|0|||
163081789|NCT00392288|589008065|FG002|Overall Study|Withdrawal by Subject|2|||
163081790|NCT00392288|589008063|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
163081791|NCT00392288|589008064|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
163081792|NCT00392288|589008065|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
163081793|NCT00392288|589008063|FG000|Overall Study|Other|3|||
163081794|NCT00392288|589008064|FG001|Overall Study|Other|4|||
163081795|NCT00392288|589008065|FG002|Overall Study|Other|1|||
163081796|NCT02544763|589008066|FG000|Overall Study|Adverse Event|8|||
163081797|NCT02544763|589008067|FG001|Overall Study|Adverse Event|8|||
163081798|NCT02544763|589008068|FG002|Overall Study|Adverse Event|0|||
163081799|NCT02544763|589008066|FG000|Overall Study|Withdrawn by parent/guardian|1|||
163081800|NCT02544763|589008067|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163081801|NCT02544763|589008068|FG002|Overall Study|Withdrawn by parent/guardian|1|||
163081802|NCT02544763|589008066|FG000|Overall Study|Met withdrawal criteria|0|||
163081803|NCT02544763|589008067|FG001|Overall Study|Met withdrawal criteria|2|||
163081804|NCT02544763|589008068|FG002|Overall Study|Met withdrawal criteria|0|||
162646125|NCT03168464|587421366|FG000|Overall Study|Progression of disease|6|||
162646126|NCT01549964|587421367|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
162646127|NCT01549964|587421368|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
163081805|NCT02544763|589008066|FG000|Overall Study|Physician Decision|0|||
163081806|NCT02544763|589008067|FG001|Overall Study|Physician Decision|1|||
163081807|NCT02544763|589008068|FG002|Overall Study|Physician Decision|0|||
163081808|NCT02544763|589008066|FG000|Overall Study|Difficulties taking IMP|1|||
162646128|NCT01549964|587421369|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
162646129|NCT01549964|587421370|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
163081809|NCT02544763|589008067|FG001|Overall Study|Difficulties taking IMP|0|||
163081810|NCT02544763|589008068|FG002|Overall Study|Difficulties taking IMP|0|||
163081811|NCT02097225|589008069|FG000|Dose Level 4|Adverse Event|0|||
163081812|NCT02097225|589008070|FG001|Dose Level 4|Adverse Event|0|||
163081813|NCT02097225|589008071|FG002|Dose Level 4|Adverse Event|0|||
163081814|NCT02097225|589008072|FG003|Dose Level 4|Adverse Event|0|||
163081815|NCT02097225|589008073|FG004|Dose Level 4|Adverse Event|1|||
163081816|NCT02528305|589008078|FG000|Overall Study|Withdrawal by Subject|1|||
163081817|NCT02528305|589008078|FG000|Overall Study|Adverse Event|1|||
163081818|NCT02528305|589008078|FG000|Overall Study|Physician Decision|1|||
163081819|NCT01308788|589008079|FG000|2-year Treatment|medication change by treating physician|4|||
163081820|NCT01308788|589008080|FG001|2-year Treatment|medication change by treating physician|11|||
163081821|NCT00322218|589008081|FG000|Overall Study|Death|3|||
163081822|NCT00322218|589008082|FG001|Overall Study|Death|6|||
163081823|NCT03596645|589008092|FG000|Overall Study|Adverse Event|17|||
163081824|NCT03596645|589008093|FG001|Overall Study|Adverse Event|0|||
163081825|NCT03596645|589008092|FG000|Overall Study|Lack of Efficacy|8|||
163081826|NCT03596645|589008093|FG001|Overall Study|Lack of Efficacy|0|||
163081827|NCT03596645|589008092|FG000|Overall Study|Lost to Follow-up|1|||
163081828|NCT03596645|589008093|FG001|Overall Study|Lost to Follow-up|1|||
163081829|NCT03596645|589008092|FG000|Overall Study|Physician Decision|1|||
163081830|NCT03596645|589008093|FG001|Overall Study|Physician Decision|1|||
163081831|NCT03596645|589008092|FG000|Overall Study|Protocol Violation|1|||
163081832|NCT03596645|589008093|FG001|Overall Study|Protocol Violation|0|||
163081833|NCT03596645|589008092|FG000|Overall Study|Initiated Prohibited Medication|1|||
163081834|NCT03596645|589008093|FG001|Overall Study|Initiated Prohibited Medication|0|||
163081835|NCT03596645|589008092|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163081836|NCT03596645|589008093|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163081837|NCT03596645|589008092|FG000|Overall Study|No mucosal healing achieved|1|||
163081838|NCT03596645|589008093|FG001|Overall Study|No mucosal healing achieved|0|||
163081839|NCT03596645|589008092|FG000|Overall Study|Disease progression|1|||
163081840|NCT03596645|589008093|FG001|Overall Study|Disease progression|0|||
163081841|NCT03596645|589008092|FG000|Overall Study|Ongoing|37|||
163081842|NCT03596645|589008093|FG001|Overall Study|Ongoing|12|||
163081843|NCT03596645|589008092|FG000|Overall Study|Randomized but not treated|0|||
163081844|NCT03596645|589008093|FG001|Overall Study|Randomized but not treated|1|||
163081845|NCT04101331|589009569|FG000|Overall Study|Adverse Event|9|||
163081846|NCT04101331|589009569|FG000|Overall Study|Disease progression|82|||
163081847|NCT04101331|589009569|FG000|Overall Study|Withdrawal by Subject|1|||
163081848|NCT04101331|589009569|FG000|Overall Study|Investigator decision|6|||
163081849|NCT04101331|589009569|FG000|Overall Study|Death|6|||
163081850|NCT04101331|589009569|FG000|Overall Study|Allogenic transplant|1|||
163081851|NCT04616196|589009570|FG000|Overall Study|Progressive Disease|3|||
163081852|NCT04616196|589009571|FG001|Overall Study|Progressive Disease|0|||
163081853|NCT04616196|589009572|FG002|Overall Study|Progressive Disease|4|||
163081854|NCT04616196|589009573|FG003|Overall Study|Progressive Disease|1|||
163081855|NCT04616196|589009570|FG000|Overall Study|Death|2|||
163081856|NCT04616196|589009571|FG001|Overall Study|Death|4|||
163081857|NCT04616196|589009572|FG002|Overall Study|Death|1|||
163081858|NCT04616196|589009573|FG003|Overall Study|Death|0|||
163081859|NCT04616196|589009570|FG000|Overall Study|Withdrawal by Subject|0|||
163081860|NCT04616196|589009571|FG001|Overall Study|Withdrawal by Subject|2|||
163081861|NCT04616196|589009572|FG002|Overall Study|Withdrawal by Subject|0|||
163081862|NCT04616196|589009573|FG003|Overall Study|Withdrawal by Subject|0|||
163081863|NCT04616196|589009570|FG000|Overall Study|Lost to Follow-up|1|||
163081864|NCT04616196|589009571|FG001|Overall Study|Lost to Follow-up|0|||
163081865|NCT04616196|589009572|FG002|Overall Study|Lost to Follow-up|0|||
163081866|NCT04616196|589009573|FG003|Overall Study|Lost to Follow-up|0|||
163081867|NCT04616196|589009570|FG000|Overall Study|Sponsor request|2|||
163081868|NCT04616196|589009571|FG001|Overall Study|Sponsor request|1|||
163081869|NCT04616196|589009572|FG002|Overall Study|Sponsor request|1|||
163081870|NCT04616196|589009573|FG003|Overall Study|Sponsor request|2|||
163081871|NCT06790303|589009576|FG000|Overall Study|Study Terminated by sponsor|4|||
163081872|NCT06790303|589009576|FG000|Overall Study|Death|4|||
163081873|NCT02579759|589009579|FG000|Overall Study|Protocol Violation|2|||
163081874|NCT02579759|589009580|FG001|Overall Study|Protocol Violation|0|||
163081875|NCT02579759|589009581|FG002|Overall Study|Protocol Violation|0|||
163081876|NCT02579759|589009579|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
163081877|NCT02579759|589009580|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
163081878|NCT02579759|589009581|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
163081879|NCT02579759|589009579|FG000|Overall Study|BfArM hold|13|||
163081880|NCT02579759|589009580|FG001|Overall Study|BfArM hold|12|||
163081881|NCT02579759|589009581|FG002|Overall Study|BfArM hold|12|||
163081882|NCT02579759|589009579|FG000|Overall Study|Sponsor stopped Dose 2|0|||
163081883|NCT02579759|589009580|FG001|Overall Study|Sponsor stopped Dose 2|41|||
163081884|NCT02579759|589009581|FG002|Overall Study|Sponsor stopped Dose 2|0|||
163081885|NCT02579759|589009579|FG000|Overall Study|Non compliance|0|||
163081886|NCT02579759|589009580|FG001|Overall Study|Non compliance|1|||
163081887|NCT02579759|589009581|FG002|Overall Study|Non compliance|0|||
162646130|NCT01549964|587421367|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
162646131|NCT01549964|587421368|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
162646132|NCT01549964|587421369|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
162646133|NCT01549964|587421370|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
162646134|NCT01549964|587421367|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
162646135|NCT01549964|587421368|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162646136|NCT01549964|587421369|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162646137|NCT01549964|587421370|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162646138|NCT01549964|587421367|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
162646139|NCT01549964|587421368|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
162646140|NCT01549964|587421369|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
162646141|NCT01549964|587421370|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
162646142|NCT01549964|587421367|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
162646143|NCT01549964|587421368|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
162646144|NCT01549964|587421369|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
162646145|NCT01549964|587421370|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
162646146|NCT01549964|587421367|FG000|24-Week Treatment Period|Other|1|||
162646147|NCT01549964|587421368|FG001|24-Week Treatment Period|Other|0|||
162646148|NCT01549964|587421369|FG002|24-Week Treatment Period|Other|1|||
162646149|NCT01549964|587421370|FG003|24-Week Treatment Period|Other|0|||
162646150|NCT01549964|587421367|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162646151|NCT01549964|587421368|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162646152|NCT01549964|587421369|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
162646153|NCT01549964|587421370|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162646154|NCT01549964|587421367|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
162646155|NCT01549964|587421368|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
162646156|NCT01549964|587421369|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
162646157|NCT01549964|587421370|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
162646158|NCT01549964|587421367|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
162646159|NCT01549964|587421368|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
162646160|NCT01549964|587421369|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
162646161|NCT01549964|587421370|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
162646162|NCT01549964|587421367|FG000|80-Week Extension Period|Pregnancy|0|||
162646163|NCT01549964|587421368|FG001|80-Week Extension Period|Pregnancy|0|||
162646164|NCT01549964|587421369|FG002|80-Week Extension Period|Pregnancy|1|||
162646165|NCT01549964|587421370|FG003|80-Week Extension Period|Pregnancy|0|||
162646166|NCT01549964|587421367|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
162646167|NCT01549964|587421368|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
162646168|NCT01549964|587421369|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
162646169|NCT01549964|587421370|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
162646170|NCT01549964|587421367|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
163081888|NCT02579759|589009579|FG000|Overall Study|Pregnancy|0|||
163081889|NCT02579759|589009580|FG001|Overall Study|Pregnancy|1|||
163081890|NCT02579759|589009581|FG002|Overall Study|Pregnancy|0|||
163081891|NCT02579759|589009579|FG000|Overall Study|Inclusion/exclusion criteria|0|||
163081892|NCT02579759|589009580|FG001|Overall Study|Inclusion/exclusion criteria|0|||
163081893|NCT02579759|589009581|FG002|Overall Study|Inclusion/exclusion criteria|1|||
163081894|NCT02579759|589009579|FG000|Overall Study|Adverse Event|4|||
163081895|NCT02579759|589009580|FG001|Overall Study|Adverse Event|3|||
163081896|NCT02579759|589009581|FG002|Overall Study|Adverse Event|1|||
163081897|NCT02579759|589009579|FG000|Overall Study|Withdrawal by Subject|3|||
163081898|NCT02579759|589009580|FG001|Overall Study|Withdrawal by Subject|3|||
163081899|NCT02579759|589009581|FG002|Overall Study|Withdrawal by Subject|5|||
163081900|NCT02579759|589009579|FG000|Overall Study|Lost to Follow-up|2|||
163081901|NCT02579759|589009580|FG001|Overall Study|Lost to Follow-up|2|||
163081902|NCT02579759|589009581|FG002|Overall Study|Lost to Follow-up|2|||
163081903|NCT01904279|589009586|FG000|Overall Study|Lack of Efficacy|2|||
163081904|NCT01904279|589009587|FG001|Overall Study|Lack of Efficacy|3|||
163081905|NCT01904279|589009586|FG000|Overall Study|Withdrawal by Subject|1|||
163081906|NCT01904279|589009587|FG001|Overall Study|Withdrawal by Subject|0|||
163081907|NCT03283241|589009590|FG000|Overall Study|Adverse Event|4|||
163081908|NCT03283241|589009591|FG001|Overall Study|Adverse Event|1|||
162646171|NCT01549964|587421368|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
163081909|NCT03283241|589009590|FG000|Overall Study|Withdrawal by Subject|0|||
163081910|NCT03283241|589009591|FG001|Overall Study|Withdrawal by Subject|1|||
162646172|NCT01549964|587421369|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
162646173|NCT01549964|587421370|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
162646174|NCT01549964|587421367|FG000|80-Week Extension Period|Lost to Follow-up|1|||
163081911|NCT03283241|589009590|FG000|Overall Study|Subject relocated to Finland|0|||
163081912|NCT03283241|589009591|FG001|Overall Study|Subject relocated to Finland|1|||
163081913|NCT00666263|589009592|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
162646175|NCT01549964|587421368|FG001|80-Week Extension Period|Lost to Follow-up|0|||
162646176|NCT01549964|587421369|FG002|80-Week Extension Period|Lost to Follow-up|2|||
162646177|NCT01549964|587421370|FG003|80-Week Extension Period|Lost to Follow-up|1|||
162646178|NCT01549964|587421367|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
162646179|NCT01549964|587421368|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
162646180|NCT01549964|587421369|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
162646181|NCT01549964|587421370|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
162646182|NCT00634088|587421373|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
162646183|NCT00634088|587421374|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
162646184|NCT00634088|587421375|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
162646185|NCT00634088|587421376|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
162646186|NCT00634088|587421373|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
162646187|NCT00634088|587421374|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
162646188|NCT00634088|587421375|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
162646189|NCT00634088|587421376|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
162646190|NCT00634088|587421373|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
162646191|NCT00634088|587421374|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
162646192|NCT00634088|587421375|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
162646193|NCT00634088|587421376|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
162646194|NCT00634088|587421373|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
162646195|NCT00634088|587421374|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
162646196|NCT00634088|587421375|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
162646197|NCT00634088|587421376|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
162646198|NCT00634088|587421373|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
162646199|NCT00634088|587421374|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
162646200|NCT00634088|587421375|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
162646201|NCT00634088|587421376|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
162646202|NCT00634088|587421373|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
162646203|NCT00634088|587421374|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
162646204|NCT00634088|587421375|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
162646205|NCT00634088|587421376|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
162646206|NCT02290821|587421379|FG000|Overall Study|Withdrawal by Subject|1|||
162646207|NCT02290821|587421380|FG001|Overall Study|Withdrawal by Subject|1|||
162646208|NCT02290821|587421379|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
162646209|NCT02290821|587421380|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
163081914|NCT00666263|589009593|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
163081915|NCT00666263|589009592|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
163081916|NCT00666263|589009593|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
163081917|NCT00666263|589009592|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
163081918|NCT00666263|589009593|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
163081919|NCT02439957|589009594|FG000|Overall Study|Study Terminated|3|||
163081920|NCT02439957|589009595|FG001|Overall Study|Study Terminated|3|||
163081921|NCT00586157|589009596|FG000|First Intervention|Worsening behavior|1|||
163081922|NCT00586157|589009597|FG001|First Intervention|Worsening behavior|0|||
163081923|NCT00586157|589009596|FG000|Second Intervention|Withdrawal by Subject|1|||
163081924|NCT00586157|589009597|FG001|Second Intervention|Withdrawal by Subject|0|||
163081925|NCT00586157|589009596|FG000|Second Intervention|Worsening behavior|1|||
163081926|NCT00586157|589009597|FG001|Second Intervention|Worsening behavior|0|||
163081927|NCT00586157|589009596|FG000|Second Intervention|Adverse Event|0|||
163081928|NCT00586157|589009597|FG001|Second Intervention|Adverse Event|1|||
163081929|NCT00414609|589009598|FG000|Core Study|Adverse Event|9|||
163081930|NCT00414609|589009599|FG001|Core Study|Adverse Event|11|||
163081931|NCT00414609|589009600|FG002|Core Study|Adverse Event|0|||
163081932|NCT00414609|589009598|FG000|Core Study|Abnormal laboratory values|0|||
163081933|NCT00414609|589009599|FG001|Core Study|Abnormal laboratory values|1|||
163081934|NCT00414609|589009600|FG002|Core Study|Abnormal laboratory values|0|||
163081935|NCT00414609|589009598|FG000|Core Study|Abnormal test procedure results|1|||
163081936|NCT00414609|589009599|FG001|Core Study|Abnormal test procedure results|1|||
163081937|NCT00414609|589009600|FG002|Core Study|Abnormal test procedure results|0|||
163081938|NCT00414609|589009598|FG000|Core Study|Protocol deviation|0|||
163081939|NCT00414609|589009599|FG001|Core Study|Protocol deviation|1|||
162646210|NCT02290821|587421379|FG000|Overall Study|Lost to Follow-up|3|||
163081940|NCT00414609|589009600|FG002|Core Study|Protocol deviation|0|||
163081941|NCT00414609|589009598|FG000|Core Study|Patient withdrew consent|10|||
163081942|NCT00414609|589009599|FG001|Core Study|Patient withdrew consent|11|||
163081943|NCT00414609|589009600|FG002|Core Study|Patient withdrew consent|0|||
162646211|NCT02290821|587421380|FG001|Overall Study|Lost to Follow-up|2|||
162646212|NCT02438722|587421386|FG000|Overall Study|Adverse Event|12|||
162646213|NCT02438722|587421387|FG001|Overall Study|Adverse Event|9|||
163081944|NCT00414609|589009598|FG000|Core Study|Lost to Follow-up|7|||
163081945|NCT00414609|589009599|FG001|Core Study|Lost to Follow-up|4|||
163081946|NCT00414609|589009600|FG002|Core Study|Lost to Follow-up|0|||
163081947|NCT00414609|589009598|FG000|Core Study|Administrative problems|0|||
163081948|NCT00414609|589009599|FG001|Core Study|Administrative problems|2|||
163081949|NCT00414609|589009600|FG002|Core Study|Administrative problems|0|||
163081950|NCT00414609|589009598|FG000|Core Study|Death|7|||
163081951|NCT00414609|589009599|FG001|Core Study|Death|14|||
163081952|NCT00414609|589009600|FG002|Core Study|Death|0|||
163081953|NCT00414609|589009598|FG000|Extension Study|Adverse Event|0|||
163081954|NCT00414609|589009599|FG001|Extension Study|Adverse Event|0|||
163081955|NCT00414609|589009600|FG002|Extension Study|Adverse Event|14|||
163081956|NCT00414609|589009598|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
163081957|NCT00414609|589009599|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
163081958|NCT00414609|589009600|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
163081959|NCT00414609|589009598|FG000|Extension Study|Withdrawal by Subject|0|||
163081960|NCT00414609|589009599|FG001|Extension Study|Withdrawal by Subject|0|||
163081961|NCT00414609|589009600|FG002|Extension Study|Withdrawal by Subject|13|||
163081962|NCT00414609|589009598|FG000|Extension Study|Lost to Follow-up|0|||
163081963|NCT00414609|589009599|FG001|Extension Study|Lost to Follow-up|0|||
163081964|NCT00414609|589009600|FG002|Extension Study|Lost to Follow-up|10|||
163081965|NCT00414609|589009598|FG000|Extension Study|Administrative problems|0|||
163081966|NCT00414609|589009599|FG001|Extension Study|Administrative problems|0|||
163081967|NCT00414609|589009600|FG002|Extension Study|Administrative problems|1|||
163081968|NCT00414609|589009598|FG000|Extension Study|Death|0|||
163081969|NCT00414609|589009599|FG001|Extension Study|Death|0|||
163081970|NCT00414609|589009600|FG002|Extension Study|Death|17|||
163081971|NCT02853136|589009603|FG000|Wash-out|Adverse Event|0|||
163081972|NCT02853136|589009604|FG001|Wash-out|Adverse Event|0|||
163081973|NCT02853136|589009605|FG002|Wash-out|Adverse Event|0|||
163081974|NCT02853136|589009606|FG003|Wash-out|Adverse Event|1|||
163081975|NCT00841815|589009607|FG000|Washout|Withdrawal by Subject|0|||
163081976|NCT00841815|589009608|FG001|Washout|Withdrawal by Subject|1|||
163081977|NCT02758626|589009618|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
163081978|NCT02758626|589009619|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
163081979|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
163081980|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
163081981|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
163081982|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
163081983|NCT02758626|589009618|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
163081984|NCT02758626|589009619|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
163081985|NCT01682720|589009624|FG000|Overall Study|Randomized but Not Treated|0|||
163081986|NCT01682720|589009625|FG001|Overall Study|Randomized but Not Treated|1|||
163081987|NCT01682720|589009626|FG002|Overall Study|Randomized but Not Treated|1|||
163081988|NCT01682720|589009627|FG003|Overall Study|Randomized but Not Treated|0|||
163081989|NCT01682720|589009624|FG000|Overall Study|Terminated by Sponsor|83|||
163081990|NCT01682720|589009625|FG001|Overall Study|Terminated by Sponsor|0|||
163081991|NCT01682720|589009626|FG002|Overall Study|Terminated by Sponsor|0|||
163081992|NCT01682720|589009627|FG003|Overall Study|Terminated by Sponsor|0|||
163081993|NCT01682720|589009624|FG000|Overall Study|Efficacy Failure|0|||
163081994|NCT01682720|589009625|FG001|Overall Study|Efficacy Failure|3|||
163081995|NCT01682720|589009626|FG002|Overall Study|Efficacy Failure|3|||
163081996|NCT01682720|589009627|FG003|Overall Study|Efficacy Failure|30|||
163081997|NCT01682720|589009624|FG000|Overall Study|Lost to Follow-up|1|||
163081998|NCT01682720|589009625|FG001|Overall Study|Lost to Follow-up|1|||
163081999|NCT01682720|589009626|FG002|Overall Study|Lost to Follow-up|0|||
163082000|NCT01682720|589009627|FG003|Overall Study|Lost to Follow-up|6|||
163082001|NCT01682720|589009624|FG000|Overall Study|Subject Withdrew Consent|0|||
163082002|NCT01682720|589009625|FG001|Overall Study|Subject Withdrew Consent|0|||
163082003|NCT01682720|589009626|FG002|Overall Study|Subject Withdrew Consent|2|||
163082004|NCT01682720|589009627|FG003|Overall Study|Subject Withdrew Consent|2|||
163082005|NCT01682720|589009624|FG000|Overall Study|Adverse Event|1|||
163082006|NCT01682720|589009625|FG001|Overall Study|Adverse Event|0|||
163082007|NCT01682720|589009626|FG002|Overall Study|Adverse Event|1|||
163082008|NCT01682720|589009627|FG003|Overall Study|Adverse Event|1|||
163082009|NCT01687595|589009628|FG000|Overall Study|Withdrawal by Subject|8|||
163082010|NCT01687595|589009629|FG001|Overall Study|Withdrawal by Subject|0|||
163082011|NCT01687595|589009628|FG000|Overall Study|Lost to Follow-up|3|||
163082012|NCT01687595|589009629|FG001|Overall Study|Lost to Follow-up|1|||
163082013|NCT01687595|589009628|FG000|Overall Study|Investigator's decision|1|||
163082014|NCT01687595|589009629|FG001|Overall Study|Investigator's decision|0|||
163082015|NCT01687595|589009628|FG000|Overall Study|Sponsor's decision|1|||
163082016|NCT01687595|589009629|FG001|Overall Study|Sponsor's decision|0|||
163082017|NCT01687595|589009628|FG000|Overall Study|Noncompliance|1|||
163082018|NCT01687595|589009629|FG001|Overall Study|Noncompliance|2|||
163082019|NCT01687595|589009628|FG000|Overall Study|Other than specified|56|||
162646214|NCT02438722|587421386|FG000|Overall Study|Refusal unrelated to AE|2|||
162646215|NCT02438722|587421387|FG001|Overall Study|Refusal unrelated to AE|5|||
162646216|NCT02438722|587421386|FG000|Overall Study|Disease progression/relapse|46|||
162646217|NCT02438722|587421387|FG001|Overall Study|Disease progression/relapse|51|||
162646218|NCT02438722|587421386|FG000|Overall Study|Death|0|||
162646219|NCT02438722|587421387|FG001|Overall Study|Death|3|||
162646220|NCT02438722|587421386|FG000|Overall Study|Physician Decision|2|||
162646221|NCT02438722|587421387|FG001|Overall Study|Physician Decision|2|||
162646222|NCT02438722|587421386|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
162646223|NCT02438722|587421387|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
162646224|NCT02438722|587421386|FG000|Overall Study|Withdrawal by Subject|0|||
162646225|NCT02438722|587421387|FG001|Overall Study|Withdrawal by Subject|1|||
162646226|NCT02438722|587421386|FG000|Overall Study|On protocol treatment|15|||
162646227|NCT02438722|587421387|FG001|Overall Study|On protocol treatment|14|||
162646228|NCT02438722|587421386|FG000|Overall Study|Did not receive protocol treatment|5|||
162646229|NCT02438722|587421387|FG001|Overall Study|Did not receive protocol treatment|0|||
162646230|NCT03343483|587421388|FG000|Overall Study|Death|0|||
162646231|NCT03343483|587421389|FG001|Overall Study|Death|3|||
163030125|NCT02505334|588813782|FG001|Main Treatment Period|Unclassified|10|||
163030126|NCT02505334|588813781|FG000|Extension Treatment Period|Adverse Event|5|||
163030127|NCT02505334|588813782|FG001|Extension Treatment Period|Adverse Event|0|||
163030128|NCT02505334|588813781|FG000|Extension Treatment Period|Lack of Efficacy|4|||
163030129|NCT02505334|588813782|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163030130|NCT02505334|588813781|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
163030131|NCT02505334|588813782|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163030132|NCT02505334|588813781|FG000|Extension Treatment Period|Unclassified|3|||
163030133|NCT02505334|588813782|FG001|Extension Treatment Period|Unclassified|0|||
163030134|NCT01549041|588813785|FG000|Overall Study|Lack of Efficacy|2|||
163030135|NCT01549041|588813786|FG001|Overall Study|Lack of Efficacy|4|||
163030136|NCT01549041|588813785|FG000|Overall Study|Adverse Event|0|||
163030137|NCT01549041|588813786|FG001|Overall Study|Adverse Event|4|||
163030138|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
163030139|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
163030140|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
163030141|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
163030142|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|No response|5|||
163030143|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|No response|5|||
163030144|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|No response|5|||
163030145|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|No response|2|||
163030146|NCT04093492|588813789|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030147|NCT04093492|588813790|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030148|NCT04093492|588813791|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
163030149|NCT04093492|588813792|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
163030150|NCT04093492|588813789|FG000|30 Weeks GA|Delivered before assessment|1|||
163030151|NCT04093492|588813790|FG001|30 Weeks GA|Delivered before assessment|2|||
163030152|NCT04093492|588813791|FG002|30 Weeks GA|Delivered before assessment|0|||
163030153|NCT04093492|588813792|FG003|30 Weeks GA|Delivered before assessment|0|||
163030154|NCT04093492|588813789|FG000|30 Weeks GA|No response|7|||
163030155|NCT04093492|588813790|FG001|30 Weeks GA|No response|5|||
163030156|NCT04093492|588813791|FG002|30 Weeks GA|No response|5|||
163030157|NCT04093492|588813792|FG003|30 Weeks GA|No response|2|||
163030158|NCT04093492|588813789|FG000|30 Weeks GA|Lost to Follow-up|0|||
163030159|NCT04093492|588813790|FG001|30 Weeks GA|Lost to Follow-up|1|||
163030160|NCT04093492|588813791|FG002|30 Weeks GA|Lost to Follow-up|0|||
163030161|NCT04093492|588813792|FG003|30 Weeks GA|Lost to Follow-up|0|||
163030162|NCT04093492|588813789|FG000|34 Weeks GA|Delivered before assessment|6|||
163030163|NCT04093492|588813790|FG001|34 Weeks GA|Delivered before assessment|3|||
163030164|NCT04093492|588813791|FG002|34 Weeks GA|Delivered before assessment|0|||
163030165|NCT04093492|588813792|FG003|34 Weeks GA|Delivered before assessment|0|||
163030166|NCT04093492|588813789|FG000|34 Weeks GA|No response|0|||
163030167|NCT04093492|588813790|FG001|34 Weeks GA|No response|7|||
163030168|NCT04093492|588813791|FG002|34 Weeks GA|No response|5|||
163030169|NCT04093492|588813792|FG003|34 Weeks GA|No response|3|||
163030170|NCT04093492|588813789|FG000|34 Weeks GA|Lost to Follow-up|0|||
163030171|NCT04093492|588813790|FG001|34 Weeks GA|Lost to Follow-up|1|||
163030172|NCT04093492|588813791|FG002|34 Weeks GA|Lost to Follow-up|0|||
163030173|NCT04093492|588813792|FG003|34 Weeks GA|Lost to Follow-up|0|||
163030174|NCT02945254|588813797|FG000|Overall Study|Lost to Follow-up|1|||
163030175|NCT02945254|588813798|FG001|Overall Study|Lost to Follow-up|0|||
163030176|NCT02945254|588813797|FG000|Overall Study|Withdrawal by Subject|1|||
163030177|NCT02945254|588813798|FG001|Overall Study|Withdrawal by Subject|0|||
163030178|NCT01711619|588813799|FG000|Overall Study|Early study termination|10|||
163030179|NCT01711619|588813800|FG001|Overall Study|Early study termination|14|||
163030180|NCT01711619|588813799|FG000|Overall Study|Withdrawal by Subject|3|||
163030181|NCT01711619|588813800|FG001|Overall Study|Withdrawal by Subject|7|||
163030182|NCT01711619|588813799|FG000|Overall Study|Protocol Violation|2|||
163030183|NCT01711619|588813800|FG001|Overall Study|Protocol Violation|3|||
163030184|NCT01711619|588813799|FG000|Overall Study|Adverse Event|2|||
163030185|NCT01711619|588813800|FG001|Overall Study|Adverse Event|0|||
163030186|NCT01711619|588813799|FG000|Overall Study|Lost to Follow-up|1|||
163030187|NCT01711619|588813800|FG001|Overall Study|Lost to Follow-up|0|||
163030188|NCT00783224|588813801|FG000|Overall Study|Adverse Event|0|||
163030189|NCT00783224|588813802|FG001|Overall Study|Adverse Event|0|||
163030190|NCT00783224|588813803|FG002|Overall Study|Adverse Event|1|||
163030191|NCT00783224|588813804|FG003|Overall Study|Adverse Event|0|||
163082020|NCT01687595|589009629|FG001|Overall Study|Other than specified|7|||
163082021|NCT04204902|589009630|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
163082022|NCT04204902|589009631|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
163082023|NCT02096354|589009632|FG000|Overall Study|Physician Decision|4|||
163082024|NCT02096354|589009633|FG001|Overall Study|Physician Decision|5|||
163082025|NCT02096354|589009634|FG002|Overall Study|Physician Decision|0|||
163082026|NCT02096354|589009632|FG000|Overall Study|Withdrawal by Subject|3|||
163082027|NCT02096354|589009633|FG001|Overall Study|Withdrawal by Subject|1|||
163082028|NCT02096354|589009634|FG002|Overall Study|Withdrawal by Subject|0|||
163082029|NCT02096354|589009632|FG000|Overall Study|Adverse Event|7|||
163082030|NCT02096354|589009633|FG001|Overall Study|Adverse Event|4|||
163082031|NCT02096354|589009634|FG002|Overall Study|Adverse Event|0|||
163082032|NCT02096354|589009632|FG000|Overall Study|Ineligible|0|||
163082033|NCT02096354|589009633|FG001|Overall Study|Ineligible|0|||
163082034|NCT02096354|589009634|FG002|Overall Study|Ineligible|11|||
163082035|NCT03715829|589009635|FG000|Dose Ranging Period|Adverse Event|2|||
163082036|NCT03715829|589009636|FG001|Dose Ranging Period|Adverse Event|4|||
163082037|NCT03715829|589009637|FG002|Dose Ranging Period|Adverse Event|5|||
163082038|NCT03715829|589009638|FG003|Dose Ranging Period|Adverse Event|2|||
163082039|NCT03715829|589009639|FG004|Dose Ranging Period|Adverse Event|3|||
163082040|NCT03715829|589009640|FG005|Dose Ranging Period|Adverse Event|3|||
163082041|NCT03715829|589009641|FG006|Dose Ranging Period|Adverse Event|0|||
163082042|NCT03715829|589009642|FG007|Dose Ranging Period|Adverse Event|0|||
163082043|NCT03715829|589009643|FG008|Dose Ranging Period|Adverse Event|0|||
163082044|NCT03715829|589009644|FG009|Dose Ranging Period|Adverse Event|0|||
163082045|NCT03715829|589009645|FG010|Dose Ranging Period|Adverse Event|0|||
163082046|NCT03715829|589009635|FG000|Dose Ranging Period|Lack of Efficacy|0|||
163082047|NCT03715829|589009636|FG001|Dose Ranging Period|Lack of Efficacy|1|||
163082048|NCT03715829|589009637|FG002|Dose Ranging Period|Lack of Efficacy|0|||
163082049|NCT03715829|589009638|FG003|Dose Ranging Period|Lack of Efficacy|1|||
163082050|NCT03715829|589009639|FG004|Dose Ranging Period|Lack of Efficacy|0|||
163082051|NCT03715829|589009640|FG005|Dose Ranging Period|Lack of Efficacy|0|||
163082052|NCT03715829|589009641|FG006|Dose Ranging Period|Lack of Efficacy|0|||
163082053|NCT03715829|589009642|FG007|Dose Ranging Period|Lack of Efficacy|0|||
163082054|NCT03715829|589009643|FG008|Dose Ranging Period|Lack of Efficacy|0|||
163082055|NCT03715829|589009644|FG009|Dose Ranging Period|Lack of Efficacy|0|||
163082056|NCT03715829|589009645|FG010|Dose Ranging Period|Lack of Efficacy|0|||
163082057|NCT03715829|589009635|FG000|Dose Ranging Period|Lost to Follow-up|2|||
163082058|NCT03715829|589009636|FG001|Dose Ranging Period|Lost to Follow-up|0|||
162646232|NCT03343483|587421388|FG000|Overall Study|Lost to Follow-up|9|||
162646233|NCT03343483|587421389|FG001|Overall Study|Lost to Follow-up|13|||
162646234|NCT03343483|587421388|FG000|Overall Study|Withdrawal by Subject|8|||
162646235|NCT03343483|587421389|FG001|Overall Study|Withdrawal by Subject|17|||
162646236|NCT01488097|587421392|FG000|Overall Study|Lost to Follow-up|1|||
162646237|NCT01577758|587421393|FG000|Dose Escalation Phase|Adverse Event|0|||
162646238|NCT01577758|587421394|FG001|Dose Escalation Phase|Adverse Event|0|||
163082059|NCT03715829|589009637|FG002|Dose Ranging Period|Lost to Follow-up|1|||
163082060|NCT03715829|589009638|FG003|Dose Ranging Period|Lost to Follow-up|1|||
163082061|NCT03715829|589009639|FG004|Dose Ranging Period|Lost to Follow-up|1|||
163082062|NCT03715829|589009640|FG005|Dose Ranging Period|Lost to Follow-up|2|||
163082063|NCT03715829|589009641|FG006|Dose Ranging Period|Lost to Follow-up|0|||
163082064|NCT03715829|589009642|FG007|Dose Ranging Period|Lost to Follow-up|0|||
163082065|NCT03715829|589009643|FG008|Dose Ranging Period|Lost to Follow-up|0|||
163082066|NCT03715829|589009644|FG009|Dose Ranging Period|Lost to Follow-up|0|||
163082067|NCT03715829|589009645|FG010|Dose Ranging Period|Lost to Follow-up|0|||
162646239|NCT01577758|587421395|FG002|Dose Escalation Phase|Adverse Event|0|||
163082068|NCT03715829|589009635|FG000|Dose Ranging Period|Protocol Violation|0|||
163030192|NCT00783224|588813801|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
163082069|NCT03715829|589009636|FG001|Dose Ranging Period|Protocol Violation|0|||
163082070|NCT03715829|589009637|FG002|Dose Ranging Period|Protocol Violation|0|||
163082071|NCT03715829|589009638|FG003|Dose Ranging Period|Protocol Violation|1|||
163082072|NCT03715829|589009639|FG004|Dose Ranging Period|Protocol Violation|0|||
163082073|NCT03715829|589009640|FG005|Dose Ranging Period|Protocol Violation|0|||
163082074|NCT03715829|589009641|FG006|Dose Ranging Period|Protocol Violation|0|||
163082075|NCT03715829|589009642|FG007|Dose Ranging Period|Protocol Violation|0|||
163030193|NCT00783224|588813802|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
163082076|NCT03715829|589009643|FG008|Dose Ranging Period|Protocol Violation|0|||
163082077|NCT03715829|589009644|FG009|Dose Ranging Period|Protocol Violation|0|||
163082078|NCT03715829|589009645|FG010|Dose Ranging Period|Protocol Violation|0|||
163082079|NCT03715829|589009635|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
163082080|NCT03715829|589009636|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
163082081|NCT03715829|589009637|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
163082082|NCT03715829|589009638|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
163082083|NCT03715829|589009639|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
163082084|NCT03715829|589009640|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
163082085|NCT03715829|589009641|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
163082086|NCT03715829|589009642|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
163082087|NCT03715829|589009643|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
163082088|NCT03715829|589009644|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
163082089|NCT03715829|589009645|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
163082090|NCT03715829|589009635|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082091|NCT03715829|589009636|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082092|NCT03715829|589009637|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
163082093|NCT03715829|589009638|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082094|NCT03715829|589009639|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082095|NCT03715829|589009640|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082096|NCT03715829|589009641|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082097|NCT03715829|589009642|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082098|NCT03715829|589009643|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082099|NCT03715829|589009644|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082100|NCT03715829|589009645|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
163082101|NCT03715829|589009635|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082102|NCT03715829|589009636|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082103|NCT03715829|589009637|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
163082104|NCT03715829|589009638|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082105|NCT03715829|589009639|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
163082106|NCT03715829|589009640|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082107|NCT03715829|589009641|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082108|NCT03715829|589009642|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082109|NCT03715829|589009643|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082110|NCT03715829|589009644|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082111|NCT03715829|589009645|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
163082112|NCT03715829|589009635|FG000|Dose Ranging Period|Other|0|||
163082113|NCT03715829|589009636|FG001|Dose Ranging Period|Other|0|||
163082114|NCT03715829|589009637|FG002|Dose Ranging Period|Other|2|||
163082115|NCT03715829|589009638|FG003|Dose Ranging Period|Other|0|||
163082116|NCT03715829|589009639|FG004|Dose Ranging Period|Other|0|||
163082117|NCT03715829|589009640|FG005|Dose Ranging Period|Other|3|||
163082118|NCT03715829|589009641|FG006|Dose Ranging Period|Other|0|||
163082119|NCT03715829|589009642|FG007|Dose Ranging Period|Other|0|||
163082120|NCT03715829|589009643|FG008|Dose Ranging Period|Other|0|||
163082121|NCT03715829|589009644|FG009|Dose Ranging Period|Other|0|||
163082122|NCT03715829|589009645|FG010|Dose Ranging Period|Other|0|||
163082123|NCT03715829|589009635|FG000|Extension Period|Adverse Event|0|||
163082124|NCT03715829|589009636|FG001|Extension Period|Adverse Event|0|||
163082125|NCT03715829|589009637|FG002|Extension Period|Adverse Event|0|||
163082126|NCT03715829|589009638|FG003|Extension Period|Adverse Event|0|||
163082127|NCT03715829|589009639|FG004|Extension Period|Adverse Event|0|||
163082128|NCT03715829|589009640|FG005|Extension Period|Adverse Event|0|||
163082129|NCT03715829|589009641|FG006|Extension Period|Adverse Event|3|||
163082130|NCT03715829|589009642|FG007|Extension Period|Adverse Event|1|||
163082131|NCT03715829|589009643|FG008|Extension Period|Adverse Event|6|||
163082132|NCT03715829|589009644|FG009|Extension Period|Adverse Event|0|||
163082133|NCT03715829|589009645|FG010|Extension Period|Adverse Event|0|||
163082134|NCT03715829|589009635|FG000|Extension Period|Lack of Efficacy|0|||
163082135|NCT03715829|589009636|FG001|Extension Period|Lack of Efficacy|0|||
163082136|NCT03715829|589009637|FG002|Extension Period|Lack of Efficacy|0|||
163082137|NCT03715829|589009638|FG003|Extension Period|Lack of Efficacy|0|||
163082138|NCT03715829|589009639|FG004|Extension Period|Lack of Efficacy|0|||
163082139|NCT03715829|589009640|FG005|Extension Period|Lack of Efficacy|0|||
163082140|NCT03715829|589009641|FG006|Extension Period|Lack of Efficacy|1|||
163082141|NCT03715829|589009642|FG007|Extension Period|Lack of Efficacy|9|||
163082142|NCT03715829|589009643|FG008|Extension Period|Lack of Efficacy|2|||
163082143|NCT03715829|589009644|FG009|Extension Period|Lack of Efficacy|0|||
163082144|NCT03715829|589009645|FG010|Extension Period|Lack of Efficacy|0|||
163082145|NCT03715829|589009635|FG000|Extension Period|Lost to Follow-up|0|||
163082146|NCT03715829|589009636|FG001|Extension Period|Lost to Follow-up|0|||
163082147|NCT03715829|589009637|FG002|Extension Period|Lost to Follow-up|0|||
162646240|NCT01577758|587421396|FG003|Dose Escalation Phase|Adverse Event|0|||
163082148|NCT03715829|589009638|FG003|Extension Period|Lost to Follow-up|0|||
163082149|NCT03715829|589009639|FG004|Extension Period|Lost to Follow-up|0|||
163082150|NCT03715829|589009640|FG005|Extension Period|Lost to Follow-up|0|||
163082151|NCT03715829|589009641|FG006|Extension Period|Lost to Follow-up|0|||
163082152|NCT03715829|589009642|FG007|Extension Period|Lost to Follow-up|0|||
163082153|NCT03715829|589009643|FG008|Extension Period|Lost to Follow-up|2|||
163082154|NCT03715829|589009644|FG009|Extension Period|Lost to Follow-up|0|||
163082155|NCT03715829|589009645|FG010|Extension Period|Lost to Follow-up|0|||
163082156|NCT03715829|589009635|FG000|Extension Period|Protocol Violation|0|||
163082157|NCT03715829|589009636|FG001|Extension Period|Protocol Violation|0|||
163082158|NCT03715829|589009637|FG002|Extension Period|Protocol Violation|0|||
163082159|NCT03715829|589009638|FG003|Extension Period|Protocol Violation|0|||
163082160|NCT03715829|589009639|FG004|Extension Period|Protocol Violation|0|||
163082161|NCT03715829|589009640|FG005|Extension Period|Protocol Violation|0|||
163082162|NCT03715829|589009641|FG006|Extension Period|Protocol Violation|0|||
163082163|NCT03715829|589009642|FG007|Extension Period|Protocol Violation|0|||
163082164|NCT03715829|589009643|FG008|Extension Period|Protocol Violation|1|||
163082165|NCT03715829|589009644|FG009|Extension Period|Protocol Violation|0|||
163082166|NCT03715829|589009645|FG010|Extension Period|Protocol Violation|0|||
163082167|NCT03715829|589009635|FG000|Extension Period|Withdrawal by Subject|0|||
163082168|NCT03715829|589009636|FG001|Extension Period|Withdrawal by Subject|0|||
163082169|NCT03715829|589009637|FG002|Extension Period|Withdrawal by Subject|0|||
163082170|NCT03715829|589009638|FG003|Extension Period|Withdrawal by Subject|0|||
163082171|NCT03715829|589009639|FG004|Extension Period|Withdrawal by Subject|0|||
163082172|NCT03715829|589009640|FG005|Extension Period|Withdrawal by Subject|0|||
163082173|NCT03715829|589009641|FG006|Extension Period|Withdrawal by Subject|3|||
163082174|NCT03715829|589009642|FG007|Extension Period|Withdrawal by Subject|3|||
163082175|NCT03715829|589009643|FG008|Extension Period|Withdrawal by Subject|12|||
163082176|NCT03715829|589009644|FG009|Extension Period|Withdrawal by Subject|3|||
163082177|NCT03715829|589009645|FG010|Extension Period|Withdrawal by Subject|0|||
163082178|NCT03715829|589009635|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082179|NCT03715829|589009636|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082180|NCT03715829|589009637|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082181|NCT03715829|589009638|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082182|NCT03715829|589009639|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082183|NCT03715829|589009640|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082184|NCT03715829|589009641|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082185|NCT03715829|589009642|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
163082186|NCT03715829|589009643|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
163082187|NCT03715829|589009644|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082188|NCT03715829|589009645|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
163082189|NCT03715829|589009635|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082190|NCT03715829|589009636|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082191|NCT03715829|589009637|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082192|NCT03715829|589009638|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082193|NCT03715829|589009639|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082194|NCT03715829|589009640|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082195|NCT03715829|589009641|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082196|NCT03715829|589009642|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082197|NCT03715829|589009643|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
163082198|NCT03715829|589009644|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082199|NCT03715829|589009645|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
163082200|NCT03715829|589009635|FG000|Extension Period|Other|0|||
163082201|NCT03715829|589009636|FG001|Extension Period|Other|0|||
163082202|NCT03715829|589009637|FG002|Extension Period|Other|0|||
163082203|NCT03715829|589009638|FG003|Extension Period|Other|0|||
163082204|NCT03715829|589009639|FG004|Extension Period|Other|0|||
163082205|NCT03715829|589009640|FG005|Extension Period|Other|0|||
163082206|NCT03715829|589009641|FG006|Extension Period|Other|1|||
163082207|NCT03715829|589009642|FG007|Extension Period|Other|2|||
163082208|NCT03715829|589009643|FG008|Extension Period|Other|4|||
163082209|NCT03715829|589009644|FG009|Extension Period|Other|0|||
162646241|NCT01577758|587421397|FG004|Dose Escalation Phase|Adverse Event|0|||
163082210|NCT03715829|589009645|FG010|Extension Period|Other|0|||
163082211|NCT03647137|589009647|FG000|Overall Study|Scan Limitation|2|||
163082212|NCT03647137|589009648|FG001|Overall Study|Scan Limitation|1|||
163082213|NCT03647137|589009649|FG002|Overall Study|Scan Limitation|1|||
163082214|NCT03647137|589009650|FG003|Overall Study|Scan Limitation|2|||
163082215|NCT03579719|589009651|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
163082216|NCT01443026|589009652|FG000|Overall Study|Physician Decision|1|||
163082217|NCT01443026|589009653|FG001|Overall Study|Physician Decision|0|||
163082218|NCT01443026|589009652|FG000|Overall Study|Death|0|||
163082219|NCT01443026|589009653|FG001|Overall Study|Death|1|||
163082220|NCT01443026|589009652|FG000|Overall Study|Withdrawal by Subject|0|||
163082221|NCT01443026|589009653|FG001|Overall Study|Withdrawal by Subject|3|||
163082222|NCT01443026|589009652|FG000|Overall Study|Lost to Follow-up|2|||
163082223|NCT01443026|589009653|FG001|Overall Study|Lost to Follow-up|1|||
163082224|NCT03900650|589009654|FG000|Overall Study|Withdrawal by Subject|1|||
163082225|NCT03900650|589009655|FG001|Overall Study|Withdrawal by Subject|1|||
163082226|NCT03900650|589009656|FG002|Overall Study|Withdrawal by Subject|0|||
163082227|NCT03900650|589009657|FG003|Overall Study|Withdrawal by Subject|0|||
163082228|NCT03900650|589009654|FG000|Overall Study|Withdrawn by staff|1|||
163082229|NCT03900650|589009655|FG001|Overall Study|Withdrawn by staff|0|||
163082230|NCT03900650|589009656|FG002|Overall Study|Withdrawn by staff|0|||
163082231|NCT03900650|589009657|FG003|Overall Study|Withdrawn by staff|0|||
163082232|NCT00829868|589009658|FG000|Washout|Physician Decision|1|||
163082233|NCT00829868|589009659|FG001|Washout|Physician Decision|0|||
163082234|NCT01554904|589009663|FG000|Overall Study|Withdrawal by Subject|3|||
163082235|NCT01554904|589009663|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
163082236|NCT01681849|589009666|FG000|Overall Study|Protocol Violation|2|||
163082237|NCT01681849|589009667|FG001|Overall Study|Protocol Violation|0|||
163082238|NCT01681849|589009668|FG002|Overall Study|Protocol Violation|0|||
163082239|NCT01681849|589009666|FG000|Overall Study|Withdrawal by Subject|3|||
163082240|NCT01681849|589009667|FG001|Overall Study|Withdrawal by Subject|5|||
163082241|NCT01681849|589009668|FG002|Overall Study|Withdrawal by Subject|33|||
163082242|NCT01681849|589009666|FG000|Overall Study|Lost to Follow-up|3|||
163082243|NCT01681849|589009667|FG001|Overall Study|Lost to Follow-up|2|||
163082244|NCT01681849|589009668|FG002|Overall Study|Lost to Follow-up|6|||
163082245|NCT04525183|589009669|FG000|Overall Study|Withdrawal by Subject|0|||
162646242|NCT01577758|587421398|FG005|Dose Escalation Phase|Adverse Event|2|||
162646243|NCT01577758|587421399|FG006|Dose Escalation Phase|Adverse Event|1|||
162646244|NCT01577758|587421400|FG007|Dose Escalation Phase|Adverse Event|0|||
162646245|NCT01577758|587421393|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
162646246|NCT01577758|587421394|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
162646247|NCT01577758|587421395|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
162646248|NCT01577758|587421396|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
162646249|NCT01577758|587421397|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
162646250|NCT01577758|587421398|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
162646251|NCT01577758|587421399|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
162646252|NCT01577758|587421400|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
162646253|NCT01577758|587421393|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
162646254|NCT01577758|587421394|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162646255|NCT01577758|587421395|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162646256|NCT01577758|587421396|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162646257|NCT01577758|587421397|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
162646258|NCT01577758|587421398|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
162646259|NCT01577758|587421399|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
162646260|NCT01577758|587421400|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
162646261|NCT01577758|587421393|FG000|Dose Escalation Phase|Progression Disease|2|||
162646262|NCT01577758|587421394|FG001|Dose Escalation Phase|Progression Disease|2|||
162646263|NCT01577758|587421395|FG002|Dose Escalation Phase|Progression Disease|1|||
162646264|NCT01577758|587421396|FG003|Dose Escalation Phase|Progression Disease|2|||
162646265|NCT01577758|587421397|FG004|Dose Escalation Phase|Progression Disease|5|||
162646266|NCT01577758|587421398|FG005|Dose Escalation Phase|Progression Disease|0|||
162646267|NCT01577758|587421399|FG006|Dose Escalation Phase|Progression Disease|0|||
162646268|NCT01577758|587421400|FG007|Dose Escalation Phase|Progression Disease|0|||
162646269|NCT01577758|587421393|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162717910|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163082246|NCT04525183|589009670|FG001|Overall Study|Withdrawal by Subject|0|||
163082247|NCT04525183|589009671|FG002|Overall Study|Withdrawal by Subject|3|||
162646270|NCT01577758|587421394|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162646271|NCT01577758|587421395|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162717911|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162646272|NCT01577758|587421396|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162646273|NCT01577758|587421397|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162646274|NCT01577758|587421398|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
163082248|NCT04525183|589009669|FG000|Overall Study|Study non-compliance|0|||
163082249|NCT04525183|589009670|FG001|Overall Study|Study non-compliance|0|||
163082250|NCT04525183|589009671|FG002|Overall Study|Study non-compliance|1|||
163082251|NCT04525183|589009669|FG000|Overall Study|Recurrent disease before starting on study|0|||
163082252|NCT04525183|589009670|FG001|Overall Study|Recurrent disease before starting on study|0|||
163082253|NCT04525183|589009671|FG002|Overall Study|Recurrent disease before starting on study|1|||
163082254|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
163082255|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
163082256|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
163082257|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
163082258|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
163082259|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
163082260|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
163082261|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
163082262|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
163082263|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
163082264|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082265|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082266|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
163082267|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
163082268|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
163082269|NCT05014919|589009673|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
163082270|NCT05014919|589009674|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
163082271|NCT05014919|589009675|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
163082272|NCT05014919|589009673|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
163082273|NCT05014919|589009674|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
163082274|NCT05014919|589009675|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
163082275|NCT05014919|589009673|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
163082276|NCT05014919|589009674|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
163082277|NCT05014919|589009675|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
163082278|NCT04126174|589009681|FG000|Overall Study|Lost to Follow-up|3|||
163082279|NCT04126174|589009682|FG001|Overall Study|Lost to Follow-up|3|||
163082280|NCT03773562|589009683|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
163082281|NCT03773562|589009683|FG000|Overall Study|Lost to Follow-up|10|||
163082282|NCT03773562|589009683|FG000|Overall Study|Withdrawal by Subject|1|||
163082283|NCT05305651|589009684|FG000|Overall Study|Death|1|||
163082284|NCT05305651|589009684|FG000|Overall Study|Withdrawal by Subject|4|||
163082285|NCT05305651|589009684|FG000|Overall Study|Lost to Follow-up|4|||
163082286|NCT01491919|589009687|FG000|Overall Study|Insufficient PK sampling|1|||
163082287|NCT01491919|589009688|FG001|Overall Study|Insufficient PK sampling|2|||
163082288|NCT01491919|589009689|FG002|Overall Study|Insufficient PK sampling|1|||
163082289|NCT05021224|589009693|FG000|Overall Study|Did not complete all survey items|4|||
163082290|NCT05021224|589009694|FG001|Overall Study|Did not complete all survey items|1|||
163082291|NCT05021224|589009695|FG002|Overall Study|Did not complete all survey items|0|||
163082292|NCT05021224|589009696|FG003|Overall Study|Did not complete all survey items|2|||
163082293|NCT03996395|589009697|FG000|Overall Study|Lost to Follow-up|4|||
163082294|NCT03996395|589009697|FG000|Overall Study|Withdrawal by Subject|1|||
163082295|NCT03996395|589009697|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
163082296|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
163082297|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082298|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082299|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
163082300|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163082301|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
163082302|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163082303|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
163082304|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
163082305|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
163082306|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
163082307|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
163082308|NCT05375929|589009700|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082309|NCT05375929|589009701|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
163082310|NCT05375929|589009702|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082311|NCT05375929|589009703|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
163082312|NCT05375929|589009700|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
163082313|NCT05375929|589009701|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
162646275|NCT01577758|587421399|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162646276|NCT01577758|587421400|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
162646277|NCT01577758|587421393|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646278|NCT01577758|587421394|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646279|NCT01577758|587421395|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646280|NCT01577758|587421396|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
163082314|NCT05375929|589009702|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
163082315|NCT05375929|589009703|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
163082316|NCT05375929|589009700|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082317|NCT05375929|589009701|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
163082318|NCT05375929|589009702|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082319|NCT05375929|589009703|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
163082320|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082321|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082322|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
163082323|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
163082324|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082325|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082326|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
163082327|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
163082328|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082329|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082330|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
163082331|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
163082332|NCT05375929|589009700|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082333|NCT05375929|589009701|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082334|NCT05375929|589009702|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
163082335|NCT05375929|589009703|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
163082336|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
163082337|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082338|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082339|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082340|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
163082341|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082342|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082343|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
163082344|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082345|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082346|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082347|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
163082348|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
163082349|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082350|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082351|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
163082352|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082353|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082354|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082355|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082356|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
163082357|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082358|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
163082359|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
163082360|NCT03973489|589009709|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
163082361|NCT03973489|589009710|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082362|NCT03973489|589009711|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082363|NCT03973489|589009712|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
163082364|NCT03973489|589009713|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082365|NCT03973489|589009714|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082366|NCT03973489|589009715|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
163082367|NCT03973489|589009716|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
162646281|NCT01577758|587421397|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646282|NCT01577758|587421398|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646283|NCT01577758|587421399|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
162646284|NCT01577758|587421400|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
163082368|NCT03973489|589009709|FG000|Second Intervention (1 Day)|Adverse Event|0|||
163082369|NCT03973489|589009710|FG001|Second Intervention (1 Day)|Adverse Event|0|||
163082370|NCT03973489|589009711|FG002|Second Intervention (1 Day)|Adverse Event|0|||
163082371|NCT03973489|589009712|FG003|Second Intervention (1 Day)|Adverse Event|1|||
163082372|NCT03973489|589009713|FG004|Second Intervention (1 Day)|Adverse Event|0|||
163082373|NCT03973489|589009714|FG005|Second Intervention (1 Day)|Adverse Event|0|||
162646285|NCT01577758|587421393|FG000|mCRC Expansion Phase|Progression Disease|0|||
163082374|NCT03973489|589009715|FG006|Second Intervention (1 Day)|Adverse Event|0|||
163082375|NCT03973489|589009716|FG007|Second Intervention (1 Day)|Adverse Event|0|||
163082376|NCT04573881|589009717|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
163082377|NCT03379870|589011986|FG000|Overall Study|Lost to Follow-up|1|||
163082378|NCT03379870|589011987|FG001|Overall Study|Lost to Follow-up|0|||
163082379|NCT03379870|589011986|FG000|Overall Study|Protocol Violation|1|||
163082380|NCT03379870|589011987|FG001|Overall Study|Protocol Violation|1|||
163082381|NCT00003645|589011988|FG000|Overall Study|Death|4|||
163082382|NCT00003645|589011989|FG001|Overall Study|Death|1|||
163082383|NCT00003645|589011988|FG000|Overall Study|Lost to Follow-up|7|||
163082384|NCT00003645|589011989|FG001|Overall Study|Lost to Follow-up|8|||
163082385|NCT00003645|589011988|FG000|Overall Study|Withdrawal by Subject|1|||
163082386|NCT00003645|589011989|FG001|Overall Study|Withdrawal by Subject|3|||
163082387|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
163082388|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
163082389|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
163082390|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
163082391|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
163082392|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
163082393|NCT01373281|589011990|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
163082394|NCT01373281|589011991|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
163082395|NCT01373281|589011990|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
163082396|NCT01373281|589011991|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
163082397|NCT01373281|589011990|FG000|Surveillance Expansion Period|Protocol Violation|9|||
163082398|NCT01373281|589011991|FG001|Surveillance Expansion Period|Protocol Violation|1|||
163082399|NCT01373281|589011990|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
163082400|NCT01373281|589011991|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
163082401|NCT01373281|589011990|FG000|Surveillance Expansion Period|Serious adverse event|3|||
163082402|NCT01373281|589011991|FG001|Surveillance Expansion Period|Serious adverse event|4|||
163082403|NCT03502681|589011992|FG000|Overall Study|Adverse Event|1|||
163082404|NCT03502681|589011993|FG001|Overall Study|Adverse Event|1|||
163082405|NCT03502681|589011992|FG000|Overall Study|Disease Progression|2|||
163082406|NCT03502681|589011993|FG001|Overall Study|Disease Progression|1|||
163082407|NCT02254291|589011994|FG000|Overall Study|Withdrawal by Subject|0|||
163082408|NCT02254291|589011995|FG001|Overall Study|Withdrawal by Subject|3|||
163082409|NCT02254291|589011996|FG002|Overall Study|Withdrawal by Subject|1|||
163082410|NCT02254291|589011994|FG000|Overall Study|Missing follow-up information|0|||
163082411|NCT02254291|589011995|FG001|Overall Study|Missing follow-up information|0|||
163082412|NCT02254291|589011996|FG002|Overall Study|Missing follow-up information|1|||
163082413|NCT03436732|589011999|FG000|Overall Study|Not treated-enrolled in different study|1|||
163082414|NCT03436732|589012000|FG001|Overall Study|Not treated-enrolled in different study|0|||
163082415|NCT03436732|589011999|FG000|Overall Study|Off study after cycle 1|1|||
163082416|NCT03436732|589012000|FG001|Overall Study|Off study after cycle 1|0|||
163082417|NCT03436732|589011999|FG000|Overall Study|Adverse Event|2|||
163082418|NCT03436732|589012000|FG001|Overall Study|Adverse Event|0|||
163082419|NCT03436732|589011999|FG000|Overall Study|Death|0|||
163082420|NCT03436732|589012000|FG001|Overall Study|Death|1|||
163082421|NCT03257657|589012003|FG000|Overall Study|Lost to Follow-up|0|||
163082422|NCT03257657|589012004|FG001|Overall Study|Lost to Follow-up|3|||
163082423|NCT03257657|589012003|FG000|Overall Study|Withdrawn|0|||
163082424|NCT03257657|589012004|FG001|Overall Study|Withdrawn|1|||
163082425|NCT03257657|589012003|FG000|Overall Study|Noted not eligible right after enrolled|0|||
163082426|NCT03257657|589012004|FG001|Overall Study|Noted not eligible right after enrolled|1|||
163082427|NCT02801578|589012005|FG000|Overall Study|Adverse Event|2|||
163082428|NCT00668642|589012011|FG000|First Off-cycle|Cancer progression|1|||
163082429|NCT00668642|589012012|FG001|First Off-cycle|Cancer progression|0|||
163082430|NCT00668642|589012011|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
163082431|NCT00668642|589012012|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
163082432|NCT02014467|589012013|FG000|Overall Study|Adverse Event|4|||
163082433|NCT02014467|589012014|FG001|Overall Study|Adverse Event|0|||
163082434|NCT02014467|589012013|FG000|Overall Study|Protocol Violation|3|||
162646286|NCT01577758|587421394|FG001|mCRC Expansion Phase|Progression Disease|0|||
162646287|NCT01577758|587421395|FG002|mCRC Expansion Phase|Progression Disease|0|||
162646288|NCT01577758|587421396|FG003|mCRC Expansion Phase|Progression Disease|0|||
162646289|NCT01577758|587421397|FG004|mCRC Expansion Phase|Progression Disease|0|||
163082435|NCT02014467|589012014|FG001|Overall Study|Protocol Violation|0|||
163082436|NCT02014467|589012013|FG000|Overall Study|Physician Decision|2|||
163082437|NCT02014467|589012014|FG001|Overall Study|Physician Decision|3|||
163082438|NCT02014467|589012013|FG000|Overall Study|Withdrawal by Subject|16|||
163082439|NCT02014467|589012014|FG001|Overall Study|Withdrawal by Subject|4|||
163082440|NCT01217892|589012016|FG000|Overall Study|Adverse Event|1|||
163082441|NCT01217892|589012017|FG001|Overall Study|Adverse Event|1|||
163082442|NCT01217892|589012018|FG002|Overall Study|Adverse Event|1|||
163082443|NCT01217892|589012019|FG003|Overall Study|Adverse Event|0|||
163082444|NCT01217892|589012016|FG000|Overall Study|Withdrawal by Subject|0|||
162646290|NCT01577758|587421398|FG005|mCRC Expansion Phase|Progression Disease|0|||
163082445|NCT01217892|589012017|FG001|Overall Study|Withdrawal by Subject|2|||
163082446|NCT01217892|589012018|FG002|Overall Study|Withdrawal by Subject|1|||
163082447|NCT01217892|589012019|FG003|Overall Study|Withdrawal by Subject|0|||
163082448|NCT01217892|589012016|FG000|Overall Study|Lab value|1|||
163082449|NCT01217892|589012017|FG001|Overall Study|Lab value|0|||
163082450|NCT01217892|589012018|FG002|Overall Study|Lab value|1|||
163082451|NCT01217892|589012019|FG003|Overall Study|Lab value|0|||
163082452|NCT01217892|589012016|FG000|Overall Study|Subject no longer meets study criteria|5|||
163082453|NCT01217892|589012017|FG001|Overall Study|Subject no longer meets study criteria|2|||
163082454|NCT01217892|589012018|FG002|Overall Study|Subject no longer meets study criteria|4|||
163082455|NCT01217892|589012019|FG003|Overall Study|Subject no longer meets study criteria|8|||
163082456|NCT01217892|589012016|FG000|Overall Study|Incorrect enrollment|0|||
163082457|NCT01217892|589012017|FG001|Overall Study|Incorrect enrollment|1|||
163082458|NCT01217892|589012018|FG002|Overall Study|Incorrect enrollment|1|||
163082459|NCT01217892|589012019|FG003|Overall Study|Incorrect enrollment|0|||
163082460|NCT01217892|589012016|FG000|Overall Study|Poor/Non-Compliance|0|||
163082461|NCT01217892|589012017|FG001|Overall Study|Poor/Non-Compliance|0|||
163082462|NCT01217892|589012018|FG002|Overall Study|Poor/Non-Compliance|1|||
163082463|NCT01217892|589012019|FG003|Overall Study|Poor/Non-Compliance|0|||
163082464|NCT00831389|589012021|FG000|Overall Study|Withdrawal by Subject|0|||
163082465|NCT00831389|589012022|FG001|Overall Study|Withdrawal by Subject|1|||
163082466|NCT00278161|589012024|FG000|Overall Study|Death|11|||
163082467|NCT01817777|589012025|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
163082468|NCT01817777|589012026|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
163082469|NCT01817777|589012027|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
163082470|NCT01817777|589012025|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
163082471|NCT01817777|589012026|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
163082472|NCT01817777|589012027|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
163082473|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
163082474|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
163082475|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
163082476|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
163082477|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
163082478|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
163082479|NCT01817777|589012025|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
163082480|NCT01817777|589012026|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
163082481|NCT01817777|589012027|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
163082482|NCT00443456|589012028|FG000|Overall Study|Adverse Event|16|||
163082483|NCT00443456|589012028|FG000|Overall Study|Move|1|||
163082484|NCT00443456|589012028|FG000|Overall Study|Withdrawal by Subject|1|||
163082485|NCT03242434|589012029|FG000|Overall Study|Death|0|||
163082486|NCT03242434|589012030|FG001|Overall Study|Death|2|||
163082487|NCT01592747|589012036|FG000|Overall Study|Loss of Therapeutic Response|107|||
163082488|NCT01592747|589012037|FG001|Overall Study|Loss of Therapeutic Response|108|||
163082489|NCT01592747|589012038|FG002|Overall Study|Loss of Therapeutic Response|100|||
163082490|NCT01592747|589012036|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163082491|NCT01592747|589012037|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163082492|NCT01592747|589012038|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
163082493|NCT01592747|589012036|FG000|Overall Study|Adverse Event|1|||
163082494|NCT01592747|589012037|FG001|Overall Study|Adverse Event|0|||
163082495|NCT01592747|589012038|FG002|Overall Study|Adverse Event|0|||
163082496|NCT01592747|589012036|FG000|Overall Study|Protocol Violation|4|||
163082497|NCT01592747|589012037|FG001|Overall Study|Protocol Violation|0|||
163082498|NCT01592747|589012038|FG002|Overall Study|Protocol Violation|4|||
163082499|NCT01592747|589012036|FG000|Overall Study|Lack of Efficacy|0|||
163082500|NCT01592747|589012037|FG001|Overall Study|Lack of Efficacy|1|||
163082501|NCT01592747|589012038|FG002|Overall Study|Lack of Efficacy|0|||
163082502|NCT01592747|589012036|FG000|Overall Study|Withdrawal by Subject|2|||
163082503|NCT01592747|589012037|FG001|Overall Study|Withdrawal by Subject|0|||
163082504|NCT01592747|589012038|FG002|Overall Study|Withdrawal by Subject|2|||
163082505|NCT01592747|589012036|FG000|Overall Study|Lost to Follow-up|1|||
163082506|NCT01592747|589012037|FG001|Overall Study|Lost to Follow-up|0|||
163082507|NCT01592747|589012038|FG002|Overall Study|Lost to Follow-up|1|||
163082508|NCT01592747|589012036|FG000|Overall Study|Other Reasons|1|||
163082509|NCT01592747|589012037|FG001|Overall Study|Other Reasons|1|||
163082510|NCT01592747|589012038|FG002|Overall Study|Other Reasons|0|||
163082511|NCT01935947|589012041|FG000|Overall Study|Adverse Event|0|||
163082512|NCT01935947|589012042|FG001|Overall Study|Adverse Event|2|||
163082513|NCT01935947|589012043|FG002|Overall Study|Adverse Event|0|||
163082514|NCT01935947|589012041|FG000|Overall Study|Diease Progression|2|||
163082515|NCT01935947|589012042|FG001|Overall Study|Diease Progression|2|||
163082516|NCT01935947|589012043|FG002|Overall Study|Diease Progression|2|||
163082517|NCT01935947|589012041|FG000|Overall Study|Death|1|||
163082518|NCT01935947|589012042|FG001|Overall Study|Death|0|||
163082519|NCT01935947|589012043|FG002|Overall Study|Death|0|||
163082520|NCT02327169|589012044|FG000|Overall Study|Progressive Disease|1|||
163082521|NCT02327169|589012045|FG001|Overall Study|Progressive Disease|3|||
163082522|NCT02327169|589012046|FG002|Overall Study|Progressive Disease|4|||
163082523|NCT02327169|589012047|FG003|Overall Study|Progressive Disease|3|||
163082524|NCT02327169|589012048|FG004|Overall Study|Progressive Disease|4|||
163082525|NCT02327169|589012049|FG005|Overall Study|Progressive Disease|3|||
163082526|NCT02327169|589012050|FG006|Overall Study|Progressive Disease|3|||
163082527|NCT02327169|589012051|FG007|Overall Study|Progressive Disease|3|||
163082528|NCT02327169|589012052|FG008|Overall Study|Progressive Disease|4|||
163082529|NCT02327169|589012053|FG009|Overall Study|Progressive Disease|4|||
163082530|NCT02327169|589012054|FG010|Overall Study|Progressive Disease|4|||
163082531|NCT02327169|589012055|FG011|Overall Study|Progressive Disease|3|||
163082532|NCT02327169|589012056|FG012|Overall Study|Progressive Disease|1|||
163082533|NCT02327169|589012057|FG013|Overall Study|Progressive Disease|3|||
163082534|NCT02327169|589012058|FG014|Overall Study|Progressive Disease|3|||
163082535|NCT02327169|589012044|FG000|Overall Study|Adverse Event|2|||
163082536|NCT02327169|589012045|FG001|Overall Study|Adverse Event|0|||
163082537|NCT02327169|589012046|FG002|Overall Study|Adverse Event|1|||
163082538|NCT02327169|589012047|FG003|Overall Study|Adverse Event|0|||
163082539|NCT02327169|589012048|FG004|Overall Study|Adverse Event|1|||
163082540|NCT02327169|589012049|FG005|Overall Study|Adverse Event|0|||
163082541|NCT02327169|589012050|FG006|Overall Study|Adverse Event|0|||
163082542|NCT02327169|589012051|FG007|Overall Study|Adverse Event|0|||
163082543|NCT02327169|589012052|FG008|Overall Study|Adverse Event|0|||
163082544|NCT02327169|589012053|FG009|Overall Study|Adverse Event|2|||
163082545|NCT02327169|589012054|FG010|Overall Study|Adverse Event|0|||
163082546|NCT02327169|589012055|FG011|Overall Study|Adverse Event|3|||
163082547|NCT02327169|589012056|FG012|Overall Study|Adverse Event|0|||
163082548|NCT02327169|589012057|FG013|Overall Study|Adverse Event|2|||
163082549|NCT02327169|589012058|FG014|Overall Study|Adverse Event|1|||
163082550|NCT02327169|589012044|FG000|Overall Study|Symptomatic Deterioration|0|||
163082551|NCT02327169|589012045|FG001|Overall Study|Symptomatic Deterioration|0|||
163082552|NCT02327169|589012046|FG002|Overall Study|Symptomatic Deterioration|1|||
163082553|NCT02327169|589012047|FG003|Overall Study|Symptomatic Deterioration|0|||
163082554|NCT02327169|589012048|FG004|Overall Study|Symptomatic Deterioration|1|||
163082555|NCT02327169|589012049|FG005|Overall Study|Symptomatic Deterioration|1|||
163082556|NCT02327169|589012050|FG006|Overall Study|Symptomatic Deterioration|0|||
163082557|NCT02327169|589012051|FG007|Overall Study|Symptomatic Deterioration|0|||
163082558|NCT02327169|589012052|FG008|Overall Study|Symptomatic Deterioration|2|||
163082559|NCT02327169|589012053|FG009|Overall Study|Symptomatic Deterioration|1|||
163082560|NCT02327169|589012054|FG010|Overall Study|Symptomatic Deterioration|0|||
163082561|NCT02327169|589012055|FG011|Overall Study|Symptomatic Deterioration|0|||
163082562|NCT02327169|589012056|FG012|Overall Study|Symptomatic Deterioration|0|||
163082563|NCT02327169|589012057|FG013|Overall Study|Symptomatic Deterioration|2|||
163082564|NCT02327169|589012058|FG014|Overall Study|Symptomatic Deterioration|1|||
163082565|NCT02327169|589012044|FG000|Overall Study|Reason Not Specified|0|||
163082566|NCT02327169|589012045|FG001|Overall Study|Reason Not Specified|0|||
163082567|NCT02327169|589012046|FG002|Overall Study|Reason Not Specified|1|||
163082568|NCT02327169|589012047|FG003|Overall Study|Reason Not Specified|0|||
163082569|NCT02327169|589012048|FG004|Overall Study|Reason Not Specified|0|||
163082570|NCT02327169|589012049|FG005|Overall Study|Reason Not Specified|0|||
163082571|NCT02327169|589012050|FG006|Overall Study|Reason Not Specified|0|||
163082572|NCT02327169|589012051|FG007|Overall Study|Reason Not Specified|0|||
162646291|NCT01577758|587421399|FG006|mCRC Expansion Phase|Progression Disease|0|||
162646292|NCT01577758|587421400|FG007|mCRC Expansion Phase|Progression Disease|19|||
163082573|NCT02327169|589012052|FG008|Overall Study|Reason Not Specified|0|||
163082574|NCT02327169|589012053|FG009|Overall Study|Reason Not Specified|1|||
163082575|NCT02327169|589012054|FG010|Overall Study|Reason Not Specified|2|||
163082576|NCT02327169|589012055|FG011|Overall Study|Reason Not Specified|1|||
162646293|NCT04969224|587421405|FG000|Overall Study|Adverse Event|1|||
163082577|NCT02327169|589012056|FG012|Overall Study|Reason Not Specified|0|||
163082578|NCT02327169|589012057|FG013|Overall Study|Reason Not Specified|0|||
163082579|NCT02327169|589012058|FG014|Overall Study|Reason Not Specified|2|||
163082580|NCT02327169|589012044|FG000|Overall Study|Withdrawal by Subject|1|||
163082581|NCT02327169|589012045|FG001|Overall Study|Withdrawal by Subject|0|||
163082582|NCT02327169|589012046|FG002|Overall Study|Withdrawal by Subject|0|||
163082583|NCT02327169|589012047|FG003|Overall Study|Withdrawal by Subject|0|||
163082584|NCT02327169|589012048|FG004|Overall Study|Withdrawal by Subject|1|||
163082585|NCT02327169|589012049|FG005|Overall Study|Withdrawal by Subject|0|||
163082586|NCT02327169|589012050|FG006|Overall Study|Withdrawal by Subject|0|||
163082587|NCT02327169|589012051|FG007|Overall Study|Withdrawal by Subject|1|||
163082588|NCT02327169|589012052|FG008|Overall Study|Withdrawal by Subject|0|||
163082589|NCT02327169|589012053|FG009|Overall Study|Withdrawal by Subject|0|||
163082590|NCT02327169|589012054|FG010|Overall Study|Withdrawal by Subject|0|||
163082591|NCT02327169|589012055|FG011|Overall Study|Withdrawal by Subject|0|||
163082592|NCT02327169|589012056|FG012|Overall Study|Withdrawal by Subject|0|||
163082593|NCT02327169|589012057|FG013|Overall Study|Withdrawal by Subject|0|||
163082594|NCT02327169|589012058|FG014|Overall Study|Withdrawal by Subject|3|||
163082595|NCT02327169|589012044|FG000|Overall Study|Lost to Follow-up|0|||
163082596|NCT02327169|589012045|FG001|Overall Study|Lost to Follow-up|0|||
163082597|NCT02327169|589012046|FG002|Overall Study|Lost to Follow-up|0|||
163082598|NCT02327169|589012047|FG003|Overall Study|Lost to Follow-up|0|||
163082599|NCT02327169|589012048|FG004|Overall Study|Lost to Follow-up|1|||
163082600|NCT02327169|589012049|FG005|Overall Study|Lost to Follow-up|0|||
163082601|NCT02327169|589012050|FG006|Overall Study|Lost to Follow-up|0|||
163082602|NCT02327169|589012051|FG007|Overall Study|Lost to Follow-up|0|||
163082603|NCT02327169|589012052|FG008|Overall Study|Lost to Follow-up|0|||
163082604|NCT02327169|589012053|FG009|Overall Study|Lost to Follow-up|0|||
163082605|NCT02327169|589012054|FG010|Overall Study|Lost to Follow-up|0|||
163082606|NCT02327169|589012055|FG011|Overall Study|Lost to Follow-up|0|||
163082607|NCT02327169|589012056|FG012|Overall Study|Lost to Follow-up|0|||
163082608|NCT02327169|589012057|FG013|Overall Study|Lost to Follow-up|0|||
163082609|NCT02327169|589012058|FG014|Overall Study|Lost to Follow-up|0|||
163082610|NCT03787615|589012059|FG000|Overall Study|Withdrawal by Subject|2|||
163082611|NCT03787615|589012059|FG000|Overall Study|Lost to Follow-up|2|||
163082612|NCT01229111|589012061|FG000|Overall Study|Death|1|||
163082613|NCT04102514|589012062|FG000|Overall Study|Death|3|||
163082614|NCT04102514|589012063|FG001|Overall Study|Death|0|||
163082615|NCT04102514|589012064|FG002|Overall Study|Death|0|||
163082616|NCT04102514|589012065|FG003|Overall Study|Death|0|||
163082617|NCT04102514|589012062|FG000|Overall Study|Lost to Follow-up|0|||
163082618|NCT04102514|589012063|FG001|Overall Study|Lost to Follow-up|0|||
163082619|NCT04102514|589012064|FG002|Overall Study|Lost to Follow-up|3|||
163082620|NCT04102514|589012065|FG003|Overall Study|Lost to Follow-up|0|||
163082621|NCT04102514|589012062|FG000|Overall Study|Physician Decision|0|||
163082622|NCT04102514|589012063|FG001|Overall Study|Physician Decision|0|||
163082623|NCT04102514|589012064|FG002|Overall Study|Physician Decision|1|||
163082624|NCT04102514|589012065|FG003|Overall Study|Physician Decision|0|||
163082625|NCT04102514|589012062|FG000|Overall Study|Withdrawal by Subject|7|||
163082626|NCT04102514|589012063|FG001|Overall Study|Withdrawal by Subject|13|||
163082627|NCT04102514|589012064|FG002|Overall Study|Withdrawal by Subject|7|||
163082628|NCT04102514|589012065|FG003|Overall Study|Withdrawal by Subject|14|||
163082629|NCT04102514|589012062|FG000|Overall Study|Moved to longterm care facility|6|||
163082630|NCT04102514|589012063|FG001|Overall Study|Moved to longterm care facility|0|||
163082631|NCT04102514|589012064|FG002|Overall Study|Moved to longterm care facility|4|||
163082632|NCT04102514|589012065|FG003|Overall Study|Moved to longterm care facility|0|||
163082633|NCT00619918|589012066|FG000|Overall Study|Withdrawal by Subject|4|||
163082634|NCT00619918|589012067|FG001|Overall Study|Withdrawal by Subject|3|||
163082635|NCT00619918|589012066|FG000|Overall Study|Physician Decision|2|||
163082636|NCT00619918|589012067|FG001|Overall Study|Physician Decision|4|||
163082637|NCT00619918|589012066|FG000|Overall Study|Transfer to outside facility|3|||
163082638|NCT00619918|589012067|FG001|Overall Study|Transfer to outside facility|3|||
163082639|NCT00619918|589012066|FG000|Overall Study|Left before receiving first dose|7|||
163082640|NCT00619918|589012067|FG001|Overall Study|Left before receiving first dose|6|||
163082641|NCT00619918|589012066|FG000|Overall Study|ICU admission|4|||
163082642|NCT00619918|589012067|FG001|Overall Study|ICU admission|6|||
163082643|NCT00456365|589012070|FG000|Overall Study|Lost to Follow-up|1|||
163082644|NCT00456365|589012071|FG001|Overall Study|Lost to Follow-up|3|||
163082645|NCT00456365|589012070|FG000|Overall Study|Withdrawal by Subject|4|||
163082646|NCT00456365|589012071|FG001|Overall Study|Withdrawal by Subject|7|||
163082647|NCT00456365|589012070|FG000|Overall Study|Pregnancy|1|||
163082648|NCT00456365|589012071|FG001|Overall Study|Pregnancy|1|||
163082649|NCT00456365|589012070|FG000|Overall Study|oncologic diagnosis|1|||
163082650|NCT00456365|589012071|FG001|Overall Study|oncologic diagnosis|1|||
163082651|NCT00721110|589012078|FG000|Overall Study|Ultram use|1|||
163082652|NCT00721110|589012079|FG001|Overall Study|Ultram use|0|||
163082653|NCT00721110|589012080|FG002|Overall Study|Ultram use|0|||
163082654|NCT00721110|589012081|FG003|Overall Study|Ultram use|0|||
163082655|NCT00721110|589012078|FG000|Overall Study|vertical incision|0|||
163082656|NCT00721110|589012079|FG001|Overall Study|vertical incision|0|||
163082657|NCT00721110|589012080|FG002|Overall Study|vertical incision|1|||
163082658|NCT00721110|589012081|FG003|Overall Study|vertical incision|0|||
163082659|NCT01051661|589012084|FG000|Overall Study|Adverse Event|1|||
163082660|NCT01051661|589012085|FG001|Overall Study|Adverse Event|1|||
163082661|NCT01051661|589012086|FG002|Overall Study|Adverse Event|1|||
163082662|NCT01051661|589012087|FG003|Overall Study|Adverse Event|1|||
163082663|NCT01051661|589012088|FG004|Overall Study|Adverse Event|0|||
163082664|NCT01051661|589012089|FG005|Overall Study|Adverse Event|0|||
163082665|NCT01051661|589012084|FG000|Overall Study|Lost to Follow-up|13|||
163082666|NCT01051661|589012085|FG001|Overall Study|Lost to Follow-up|22|||
163082667|NCT01051661|589012086|FG002|Overall Study|Lost to Follow-up|15|||
163082668|NCT01051661|589012087|FG003|Overall Study|Lost to Follow-up|17|||
163082669|NCT01051661|589012088|FG004|Overall Study|Lost to Follow-up|10|||
163082670|NCT01051661|589012089|FG005|Overall Study|Lost to Follow-up|24|||
163082671|NCT01051661|589012084|FG000|Overall Study|Migrated/moved from study area|1|||
163082672|NCT01051661|589012085|FG001|Overall Study|Migrated/moved from study area|6|||
163082673|NCT01051661|589012086|FG002|Overall Study|Migrated/moved from study area|6|||
163082674|NCT01051661|589012087|FG003|Overall Study|Migrated/moved from study area|8|||
163082675|NCT01051661|589012088|FG004|Overall Study|Migrated/moved from study area|7|||
163082676|NCT01051661|589012089|FG005|Overall Study|Migrated/moved from study area|3|||
163082677|NCT01051661|589012084|FG000|Overall Study|Refused blood sampling|0|||
163082678|NCT01051661|589012085|FG001|Overall Study|Refused blood sampling|0|||
163082679|NCT01051661|589012086|FG002|Overall Study|Refused blood sampling|0|||
163082680|NCT01051661|589012087|FG003|Overall Study|Refused blood sampling|0|||
163082681|NCT01051661|589012088|FG004|Overall Study|Refused blood sampling|0|||
163082682|NCT01051661|589012089|FG005|Overall Study|Refused blood sampling|1|||
163082683|NCT01051661|589012084|FG000|Overall Study|Data not reliable|1|||
163082684|NCT01051661|589012085|FG001|Overall Study|Data not reliable|0|||
163082685|NCT01051661|589012086|FG002|Overall Study|Data not reliable|0|||
163082686|NCT01051661|589012087|FG003|Overall Study|Data not reliable|0|||
163082687|NCT01051661|589012088|FG004|Overall Study|Data not reliable|0|||
163082688|NCT01051661|589012089|FG005|Overall Study|Data not reliable|1|||
163082689|NCT01051661|589012084|FG000|Overall Study|Unable to attend visit(s)|2|||
163082690|NCT01051661|589012085|FG001|Overall Study|Unable to attend visit(s)|4|||
163082691|NCT01051661|589012086|FG002|Overall Study|Unable to attend visit(s)|2|||
163082692|NCT01051661|589012087|FG003|Overall Study|Unable to attend visit(s)|1|||
163082693|NCT01051661|589012088|FG004|Overall Study|Unable to attend visit(s)|3|||
163082694|NCT01051661|589012089|FG005|Overall Study|Unable to attend visit(s)|2|||
163082695|NCT01051661|589012084|FG000|Overall Study|Consent not received from both parents|0|||
163082696|NCT01051661|589012085|FG001|Overall Study|Consent not received from both parents|0|||
163082697|NCT01051661|589012086|FG002|Overall Study|Consent not received from both parents|0|||
163082698|NCT01051661|589012087|FG003|Overall Study|Consent not received from both parents|0|||
163082699|NCT01051661|589012088|FG004|Overall Study|Consent not received from both parents|0|||
163082700|NCT01051661|589012089|FG005|Overall Study|Consent not received from both parents|1|||
163082701|NCT01051661|589012084|FG000|Overall Study|Failure to comply with protocol|0|||
163082702|NCT01051661|589012085|FG001|Overall Study|Failure to comply with protocol|0|||
163082703|NCT01051661|589012086|FG002|Overall Study|Failure to comply with protocol|2|||
163082704|NCT01051661|589012087|FG003|Overall Study|Failure to comply with protocol|0|||
163082705|NCT01051661|589012088|FG004|Overall Study|Failure to comply with protocol|0|||
163082706|NCT01051661|589012089|FG005|Overall Study|Failure to comply with protocol|0|||
163082707|NCT01051661|589012084|FG000|Overall Study|Subject lost legal representation|0|||
163082708|NCT01051661|589012085|FG001|Overall Study|Subject lost legal representation|0|||
163082709|NCT01051661|589012086|FG002|Overall Study|Subject lost legal representation|0|||
163082710|NCT01051661|589012087|FG003|Overall Study|Subject lost legal representation|0|||
163082711|NCT01051661|589012088|FG004|Overall Study|Subject lost legal representation|1|||
163082712|NCT01051661|589012089|FG005|Overall Study|Subject lost legal representation|0|||
163082713|NCT01051661|589012084|FG000|Overall Study|Protocol Violation|0|||
163082714|NCT01051661|589012085|FG001|Overall Study|Protocol Violation|0|||
163082715|NCT01051661|589012086|FG002|Overall Study|Protocol Violation|0|||
163082716|NCT01051661|589012087|FG003|Overall Study|Protocol Violation|1|||
163082717|NCT01051661|589012088|FG004|Overall Study|Protocol Violation|2|||
163082718|NCT01051661|589012089|FG005|Overall Study|Protocol Violation|1|||
163082719|NCT01051661|589012084|FG000|Overall Study|Withdrawal by Subject|16|||
163082720|NCT01051661|589012085|FG001|Overall Study|Withdrawal by Subject|30|||
163082721|NCT01051661|589012086|FG002|Overall Study|Withdrawal by Subject|13|||
163082722|NCT01051661|589012087|FG003|Overall Study|Withdrawal by Subject|28|||
163082723|NCT01051661|589012088|FG004|Overall Study|Withdrawal by Subject|12|||
163082724|NCT01051661|589012089|FG005|Overall Study|Withdrawal by Subject|34|||
163082725|NCT02852005|589012091|FG000|Overall Study|Lost to Follow-up|0|||
163082726|NCT02852005|589012092|FG001|Overall Study|Lost to Follow-up|0|||
163082727|NCT02852005|589012093|FG002|Overall Study|Lost to Follow-up|0|||
163082728|NCT02852005|589012094|FG003|Overall Study|Lost to Follow-up|0|||
163082729|NCT02852005|589012095|FG004|Overall Study|Lost to Follow-up|1|||
163082730|NCT02852005|589012091|FG000|Overall Study|Withdrawal by Subject|1|||
163082731|NCT02852005|589012092|FG001|Overall Study|Withdrawal by Subject|0|||
163082732|NCT02852005|589012093|FG002|Overall Study|Withdrawal by Subject|0|||
163082733|NCT02852005|589012094|FG003|Overall Study|Withdrawal by Subject|0|||
163082734|NCT02852005|589012095|FG004|Overall Study|Withdrawal by Subject|0|||
163082735|NCT01922895|589012096|FG000|Overall Study|Death|0|||
163082736|NCT01922895|589012097|FG001|Overall Study|Death|1|||
163082737|NCT01922895|589012096|FG000|Overall Study|Withdrawal by Subject|1|||
163082738|NCT01922895|589012097|FG001|Overall Study|Withdrawal by Subject|2|||
163082739|NCT01922895|589012096|FG000|Overall Study|Lost to Follow-up|5|||
163082740|NCT01922895|589012097|FG001|Overall Study|Lost to Follow-up|11|||
163082741|NCT01916226|589012098|FG000|Overall Study|Adverse Event|1|||
163082742|NCT01916226|589012099|FG001|Overall Study|Adverse Event|0|||
163082743|NCT01916226|589012100|FG002|Overall Study|Adverse Event|1|||
163082744|NCT01916226|589012101|FG003|Overall Study|Adverse Event|1|||
163082745|NCT01916226|589012098|FG000|Overall Study|Lack of Efficacy|0|||
163082746|NCT01916226|589012099|FG001|Overall Study|Lack of Efficacy|0|||
163082747|NCT01916226|589012100|FG002|Overall Study|Lack of Efficacy|2|||
163082748|NCT01916226|589012101|FG003|Overall Study|Lack of Efficacy|1|||
163082749|NCT01916226|589012098|FG000|Overall Study|Protocol Violation|0|||
163082750|NCT01916226|589012099|FG001|Overall Study|Protocol Violation|1|||
162717912|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163082751|NCT01916226|589012100|FG002|Overall Study|Protocol Violation|0|||
163082752|NCT01916226|589012101|FG003|Overall Study|Protocol Violation|1|||
163082753|NCT01916226|589012098|FG000|Overall Study|Physician Decision|0|||
163082754|NCT01916226|589012099|FG001|Overall Study|Physician Decision|0|||
163082755|NCT01916226|589012100|FG002|Overall Study|Physician Decision|0|||
163082756|NCT01916226|589012101|FG003|Overall Study|Physician Decision|1|||
163082757|NCT01166646|589012104|FG000|Overall Study|Protocol Violation|0|||
163082758|NCT01166646|589012105|FG001|Overall Study|Protocol Violation|1|||
163082759|NCT01166646|589012104|FG000|Overall Study|Adverse Event|1|||
163082760|NCT01166646|589012105|FG001|Overall Study|Adverse Event|0|||
163082761|NCT05142306|589012106|FG000|Overall Study|Withdrawal by Subject|0|||
163082762|NCT05142306|589012107|FG001|Overall Study|Withdrawal by Subject|0|||
163082763|NCT05142306|589012108|FG002|Overall Study|Withdrawal by Subject|1|||
163082764|NCT04079920|589012109|FG000|Overall Study|Adverse event, not related to study drug|2|||
163082765|NCT04079920|589012109|FG000|Overall Study|Adverse event related to study drug|10|||
163082766|NCT04079920|589012109|FG000|Overall Study|Death|2|||
163082767|NCT04079920|589012109|FG000|Overall Study|Lost to Follow-up|22|||
163082768|NCT04079920|589012109|FG000|Overall Study|Physician Decision|1|||
163082769|NCT04079920|589012109|FG000|Overall Study|Withdrawal by Subject|11|||
163082770|NCT03760068|589012110|FG000|Overall Study|Withdrawal by Subject|7|||
163082771|NCT03760068|589012111|FG001|Overall Study|Withdrawal by Subject|8|||
163082772|NCT03760068|589012110|FG000|Overall Study|Adverse Event|1|||
163082773|NCT03760068|589012111|FG001|Overall Study|Adverse Event|2|||
163082774|NCT03760068|589012110|FG000|Overall Study|Administrative Decision by Sponsor|0|||
163082775|NCT03760068|589012111|FG001|Overall Study|Administrative Decision by Sponsor|2|||
163082776|NCT03760068|589012110|FG000|Overall Study|Physician Decision|1|||
163082777|NCT03760068|589012111|FG001|Overall Study|Physician Decision|2|||
163082778|NCT03760068|589012110|FG000|Overall Study|Lost to Follow-up|4|||
163082779|NCT03760068|589012111|FG001|Overall Study|Lost to Follow-up|9|||
163082780|NCT03760068|589012110|FG000|Overall Study|Subject Moved Out of State|1|||
163082781|NCT03760068|589012111|FG001|Overall Study|Subject Moved Out of State|0|||
163082782|NCT05430919|589012112|FG000|Overall Study|Protocol Violation|0|||
163082783|NCT05430919|589012113|FG001|Overall Study|Protocol Violation|0|||
163082784|NCT05430919|589012114|FG002|Overall Study|Protocol Violation|1|||
163082785|NCT05430919|589012115|FG003|Overall Study|Protocol Violation|0|||
163082786|NCT05430919|589012112|FG000|Overall Study|Lost to Follow-up|0|||
163082787|NCT05430919|589012113|FG001|Overall Study|Lost to Follow-up|1|||
163082788|NCT05430919|589012114|FG002|Overall Study|Lost to Follow-up|0|||
163082789|NCT05430919|589012115|FG003|Overall Study|Lost to Follow-up|0|||
163082790|NCT05430919|589012112|FG000|Overall Study|Withdrawal by Subject|3|||
163082791|NCT05430919|589012113|FG001|Overall Study|Withdrawal by Subject|0|||
163082792|NCT05430919|589012114|FG002|Overall Study|Withdrawal by Subject|0|||
163082793|NCT05430919|589012115|FG003|Overall Study|Withdrawal by Subject|1|||
163082794|NCT03204812|589012136|FG000|Overall Study|Adverse Event|3|||
163082795|NCT01027351|589012137|FG000|Overall Study|Withdrawal by Subject|1|||
163082796|NCT01027351|589012138|FG001|Overall Study|Withdrawal by Subject|0|||
163082797|NCT01027351|589012139|FG002|Overall Study|Withdrawal by Subject|1|||
163082798|NCT01027351|589012140|FG003|Overall Study|Withdrawal by Subject|0|||
163082799|NCT01027351|589012141|FG004|Overall Study|Withdrawal by Subject|3|||
163082800|NCT01027351|589012142|FG005|Overall Study|Withdrawal by Subject|5|||
163082801|NCT01027351|589012137|FG000|Overall Study|Lost to Follow-up|1|||
163082802|NCT01027351|589012138|FG001|Overall Study|Lost to Follow-up|1|||
163082803|NCT01027351|589012139|FG002|Overall Study|Lost to Follow-up|0|||
163082804|NCT01027351|589012140|FG003|Overall Study|Lost to Follow-up|1|||
163082805|NCT01027351|589012141|FG004|Overall Study|Lost to Follow-up|6|||
163082806|NCT01027351|589012142|FG005|Overall Study|Lost to Follow-up|0|||
163082807|NCT01027351|589012137|FG000|Overall Study|Inappropriate enrollment|0|||
163082808|NCT01027351|589012138|FG001|Overall Study|Inappropriate enrollment|0|||
163082809|NCT01027351|589012139|FG002|Overall Study|Inappropriate enrollment|0|||
163082810|NCT01027351|589012140|FG003|Overall Study|Inappropriate enrollment|0|||
163082811|NCT01027351|589012141|FG004|Overall Study|Inappropriate enrollment|1|||
163082812|NCT01027351|589012142|FG005|Overall Study|Inappropriate enrollment|0|||
163082813|NCT01027351|589012137|FG000|Overall Study|Protocol Violation|1|||
163082814|NCT01027351|589012138|FG001|Overall Study|Protocol Violation|0|||
163082815|NCT01027351|589012139|FG002|Overall Study|Protocol Violation|0|||
163082816|NCT01027351|589012140|FG003|Overall Study|Protocol Violation|1|||
163082817|NCT01027351|589012141|FG004|Overall Study|Protocol Violation|1|||
163082818|NCT01027351|589012142|FG005|Overall Study|Protocol Violation|0|||
163082819|NCT00911157|589012143|FG000|Overall Study|Adverse Event|4|||
163082820|NCT00911157|589012144|FG001|Overall Study|Adverse Event|1|||
163082821|NCT00911157|589012143|FG000|Overall Study|Withdrawal by Subject|1|||
163082822|NCT00911157|589012144|FG001|Overall Study|Withdrawal by Subject|1|||
163082823|NCT00911157|589012143|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
163082824|NCT00911157|589012144|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
163082825|NCT00911157|589012143|FG000|Overall Study|Need to treat for lung cancer|1|||
163082826|NCT00911157|589012144|FG001|Overall Study|Need to treat for lung cancer|0|||
163082827|NCT04650893|589012145|FG000|Overall Study|Lost to Follow-up|11|||
163082828|NCT04650893|589012146|FG001|Overall Study|Lost to Follow-up|10|||
163082829|NCT04650893|589012147|FG002|Overall Study|Lost to Follow-up|11|||
163082830|NCT01852214|589012148|FG000|Period 1|Adverse Event|1|||
163082831|NCT01852214|589012149|FG001|Period 1|Adverse Event|2|||
163082832|NCT01852214|589012148|FG000|Period 1|Withdrawal by Subject|0|||
163082833|NCT01852214|589012149|FG001|Period 1|Withdrawal by Subject|1|||
163082834|NCT01852214|589012148|FG000|Washout Period|Withdrawal by Subject|0|||
163082835|NCT01852214|589012149|FG001|Washout Period|Withdrawal by Subject|1|||
163082836|NCT04091438|589012150|FG000|Treatment Period 1 (1 Day)|Other|1|||
163082837|NCT04091438|589012151|FG001|Treatment Period 1 (1 Day)|Other|0|||
163082838|NCT04091438|589012150|FG000|Washout Period (1 Day)|Protocol deviation|0|||
163082839|NCT04091438|589012151|FG001|Washout Period (1 Day)|Protocol deviation|1|||
163082840|NCT04091438|589012150|FG000|Washout Period (1 Day)|Other|0|||
163082841|NCT04091438|589012151|FG001|Washout Period (1 Day)|Other|1|||
163082842|NCT00421408|589012152|FG000|Overall Study|Lost to Follow-up|30|||
163082843|NCT00421408|589012153|FG001|Overall Study|Lost to Follow-up|20|||
163082844|NCT00421408|589012152|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
163082845|NCT00421408|589012153|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
163082846|NCT04105725|589012154|FG000|Primary Intervention|Lost to Follow-up|0|||
163082847|NCT04105725|589012155|FG001|Primary Intervention|Lost to Follow-up|2|||
163082848|NCT04105725|589012154|FG000|Primary Intervention|Withdrawal by Subject|0|||
163082849|NCT04105725|589012155|FG001|Primary Intervention|Withdrawal by Subject|1|||
163082850|NCT00553475|589012160|FG000|Overall Study|Adverse Event|7|||
163082851|NCT00553475|589012161|FG001|Overall Study|Adverse Event|17|||
163082852|NCT00553475|589012162|FG002|Overall Study|Adverse Event|13|||
163082853|NCT00553475|589012160|FG000|Overall Study|Lack of Efficacy|7|||
163082854|NCT00553475|589012161|FG001|Overall Study|Lack of Efficacy|1|||
163082855|NCT00553475|589012162|FG002|Overall Study|Lack of Efficacy|0|||
163082856|NCT00553475|589012160|FG000|Overall Study|Withdrawal by Subject|1|||
163082857|NCT00553475|589012161|FG001|Overall Study|Withdrawal by Subject|1|||
163082858|NCT00553475|589012162|FG002|Overall Study|Withdrawal by Subject|0|||
163082859|NCT00553475|589012160|FG000|Overall Study|Physician Decision|1|||
163082860|NCT00553475|589012161|FG001|Overall Study|Physician Decision|0|||
163082861|NCT00553475|589012162|FG002|Overall Study|Physician Decision|0|||
163082862|NCT00553475|589012160|FG000|Overall Study|Due to moving|0|||
163082863|NCT00553475|589012161|FG001|Overall Study|Due to moving|1|||
163082864|NCT00553475|589012162|FG002|Overall Study|Due to moving|0|||
163082865|NCT00773461|589012163|FG000|Overall Study|Adverse Event|1|||
163082866|NCT00773461|589012164|FG001|Overall Study|Adverse Event|3|||
163082867|NCT00773461|589012163|FG000|Overall Study|Withdrawal by Subject|4|||
163082868|NCT00773461|589012164|FG001|Overall Study|Withdrawal by Subject|1|||
163082869|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
163082870|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
163082871|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
163082872|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
163082873|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
163082874|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
162646294|NCT04969224|587421405|FG000|Overall Study|Enrolled but never dosed|1|||
162646295|NCT02726074|587421409|FG000|Overall Study|Withdrawal by Subject|4|||
163082875|NCT00913835|589012165|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
163082876|NCT00913835|589012166|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
163082877|NCT00913835|589012165|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
163082878|NCT00913835|589012166|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
163082879|NCT03058952|589013536|FG000|Overall Study|Adverse Event|1|||
163082880|NCT03058952|589013537|FG001|Overall Study|Adverse Event|0|||
163082881|NCT03058952|589013536|FG000|Overall Study|Lost to Follow-up|15|||
163082882|NCT03058952|589013537|FG001|Overall Study|Lost to Follow-up|15|||
162646296|NCT02726074|587421409|FG000|Overall Study|Adverse Event|14|||
162646297|NCT02726074|587421409|FG000|Overall Study|Protocol Violation|3|||
162646298|NCT02726074|587421409|FG000|Overall Study|Lost to Follow-up|2|||
163082883|NCT03058952|589013536|FG000|Overall Study|Withdrawal by Subject|7|||
163082884|NCT03058952|589013537|FG001|Overall Study|Withdrawal by Subject|11|||
163082885|NCT02296476|589013540|FG000|Overall Study|Disease Progression|6|||
163082886|NCT02296476|589013541|FG001|Overall Study|Disease Progression|4|||
163082887|NCT02296476|589013542|FG002|Overall Study|Disease Progression|2|||
163082888|NCT00980044|589013547|FG000|Overall Study|Withdrawal by Subject|5|||
162646299|NCT02726074|587421409|FG000|Overall Study|Others|3|||
163082889|NCT00980044|589013548|FG001|Overall Study|Withdrawal by Subject|7|||
163082890|NCT00980044|589013549|FG002|Overall Study|Withdrawal by Subject|3|||
163082891|NCT00980044|589013547|FG000|Overall Study|Protocol Violation|0|||
163082892|NCT00980044|589013548|FG001|Overall Study|Protocol Violation|0|||
163082893|NCT00980044|589013549|FG002|Overall Study|Protocol Violation|2|||
163082894|NCT00442702|589013550|FG000|Titration Period|Adverse Event|2|||
163082895|NCT00442702|589013551|FG001|Titration Period|Adverse Event|0|||
163082896|NCT00442702|589013550|FG000|Titration Period|Death|3|||
163082897|NCT00442702|589013551|FG001|Titration Period|Death|2|||
163082898|NCT00442702|589013550|FG000|Titration Period|Insufficient Therapeutic Response|1|||
163082899|NCT00442702|589013551|FG001|Titration Period|Insufficient Therapeutic Response|0|||
163082900|NCT00442702|589013550|FG000|Titration Period|Refused Treatment|4|||
163082901|NCT00442702|589013551|FG001|Titration Period|Refused Treatment|1|||
163082902|NCT00442702|589013550|FG000|Titration Period|Failure to return|1|||
163082903|NCT00442702|589013551|FG001|Titration Period|Failure to return|0|||
163082904|NCT00442702|589013550|FG000|Titration Period|Hospitalized in another hospital|1|||
163082905|NCT00442702|589013551|FG001|Titration Period|Hospitalized in another hospital|0|||
163082906|NCT00442702|589013550|FG000|Evaluation Period|Adverse Event|1|||
163082907|NCT00442702|589013551|FG001|Evaluation Period|Adverse Event|0|||
163082908|NCT00442702|589013550|FG000|Evaluation Period|Death|1|||
163082909|NCT00442702|589013551|FG001|Evaluation Period|Death|1|||
163082910|NCT00442702|589013550|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
163082911|NCT00442702|589013551|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
163082912|NCT00442702|589013550|FG000|Evaluation Period|Refused treatment|1|||
163082913|NCT00442702|589013551|FG001|Evaluation Period|Refused treatment|1|||
163082914|NCT00442702|589013550|FG000|Evaluation Period|Renal transplant|0|||
163082915|NCT00442702|589013551|FG001|Evaluation Period|Renal transplant|1|||
163082916|NCT00442702|589013550|FG000|Evaluation Period|Failure to return|1|||
163082917|NCT00442702|589013551|FG001|Evaluation Period|Failure to return|0|||
163082918|NCT00442702|589013550|FG000|Evaluation Period|Site closure|0|||
163082919|NCT00442702|589013551|FG001|Evaluation Period|Site closure|1|||
163082920|NCT03345550|589013553|FG000|Overall Study|Withdrawal by Subject|1|||
163082921|NCT03345550|589013554|FG001|Overall Study|Withdrawal by Subject|0|||
163082922|NCT03345550|589013553|FG000|Overall Study|Lost to Follow-up|4|||
163082923|NCT03345550|589013554|FG001|Overall Study|Lost to Follow-up|5|||
163082924|NCT01149460|589013560|FG000|Overall Study|Withdrawal by Subject|0|||
163082925|NCT01149460|589013561|FG001|Overall Study|Withdrawal by Subject|2|||
163082926|NCT03014089|589013562|FG000|Overall Study|Withdrawal by Subject|0|||
163082927|NCT03014089|589013563|FG001|Overall Study|Withdrawal by Subject|1|||
163082928|NCT03014089|589013564|FG002|Overall Study|Withdrawal by Subject|1|||
163082929|NCT03014089|589013565|FG003|Overall Study|Withdrawal by Subject|1|||
163082930|NCT03014089|589013562|FG000|Overall Study|Lost to Follow-up|1|||
163082931|NCT03014089|589013563|FG001|Overall Study|Lost to Follow-up|0|||
163082932|NCT03014089|589013564|FG002|Overall Study|Lost to Follow-up|0|||
163082933|NCT03014089|589013565|FG003|Overall Study|Lost to Follow-up|0|||
163082934|NCT03014089|589013562|FG000|Overall Study|Adverse Event|1|||
163082935|NCT03014089|589013563|FG001|Overall Study|Adverse Event|0|||
163082936|NCT03014089|589013564|FG002|Overall Study|Adverse Event|1|||
163082937|NCT03014089|589013565|FG003|Overall Study|Adverse Event|0|||
163082938|NCT00321932|589013566|FG000|Overall Study|Death|3|||
163082939|NCT00321932|589013567|FG001|Overall Study|Death|6|||
163082940|NCT00321932|589013566|FG000|Overall Study|Withdrawal by Subject|3|||
163082941|NCT00321932|589013567|FG001|Overall Study|Withdrawal by Subject|6|||
163082942|NCT00321932|589013566|FG000|Overall Study|Early relapse|2|||
163082943|NCT00321932|589013567|FG001|Overall Study|Early relapse|8|||
163082944|NCT00321932|589013566|FG000|Overall Study|Missing data|2|||
163082945|NCT00321932|589013567|FG001|Overall Study|Missing data|1|||
163082946|NCT00734032|589013568|FG000|Overall Study|Adverse Event|0|||
163082947|NCT00734032|589013569|FG001|Overall Study|Adverse Event|1|||
163082948|NCT00734032|589013570|FG002|Overall Study|Adverse Event|0|||
163082949|NCT00734032|589013571|FG003|Overall Study|Adverse Event|0|||
163082950|NCT03468998|589013574|FG000|Overall Study|Withdrawal by Subject|1|||
163082951|NCT03468998|589013575|FG001|Overall Study|Withdrawal by Subject|1|||
163082952|NCT03468998|589013576|FG002|Overall Study|Withdrawal by Subject|0|||
162646300|NCT00579826|587421410|FG000|Overall Study|Withdrawal by Subject|5|||
162646301|NCT00579826|587421411|FG001|Overall Study|Withdrawal by Subject|3|||
162646302|NCT04191382|587421412|FG000|Overall Study|Withdrawal by Subject|1|||
163082953|NCT03468998|589013577|FG003|Overall Study|Withdrawal by Subject|4|||
163082954|NCT03468998|589013578|FG004|Overall Study|Withdrawal by Subject|1|||
163082955|NCT03468998|589013579|FG005|Overall Study|Withdrawal by Subject|0|||
163082956|NCT00137449|589013580|FG000|Overall Study|Disease Progression|8|||
163082957|NCT00137449|589013581|FG001|Overall Study|Disease Progression|13|||
163082958|NCT00137449|589013580|FG000|Overall Study|Death|4|||
163082959|NCT00137449|589013581|FG001|Overall Study|Death|3|||
163082960|NCT00137449|589013580|FG000|Overall Study|Adverse Event|3|||
163082961|NCT00137449|589013581|FG001|Overall Study|Adverse Event|1|||
163082962|NCT00137449|589013580|FG000|Overall Study|Withdrawal by Subject|1|||
163082963|NCT00137449|589013581|FG001|Overall Study|Withdrawal by Subject|1|||
162646303|NCT04191382|587421413|FG001|Overall Study|Withdrawal by Subject|0|||
162646304|NCT04191382|587421414|FG002|Overall Study|Withdrawal by Subject|0|||
163082964|NCT01356940|589013584|FG000|First Intervention (28 Days)|Adverse Event|1|||
163082965|NCT01356940|589013585|FG001|First Intervention (28 Days)|Adverse Event|0|||
163082966|NCT01356940|589013584|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
163082967|NCT01356940|589013585|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
163082968|NCT03412591|589013586|FG000|Overall Study|Withdrawal by Subject|1|||
163082969|NCT03412591|589013587|FG001|Overall Study|Withdrawal by Subject|8|||
163082970|NCT03412591|589013586|FG000|Overall Study|Adverse Event|0|||
163082971|NCT03412591|589013587|FG001|Overall Study|Adverse Event|1|||
163082972|NCT02272985|589013588|FG000|Overall Study|Withdrawal by Subject|1|||
163082973|NCT02272985|589013588|FG000|Overall Study|hip fracture|1|||
163082974|NCT02272985|589013588|FG000|Overall Study|kidney transplantation|1|||
163082975|NCT02489279|589013591|FG000|Overall Study|Lost to Follow-up|12|||
163082976|NCT02489279|589013592|FG001|Overall Study|Lost to Follow-up|10|||
163082977|NCT03440411|589013593|FG000|Overall Study|Adverse Event|0|||
163082978|NCT03440411|589013594|FG001|Overall Study|Adverse Event|0|||
163082979|NCT03440411|589013595|FG002|Overall Study|Adverse Event|1|||
163082980|NCT03440411|589013596|FG003|Overall Study|Adverse Event|0|||
163082981|NCT03440411|589013593|FG000|Overall Study|PD|2|||
163082982|NCT03440411|589013594|FG001|Overall Study|PD|1|||
163082983|NCT03440411|589013595|FG002|Overall Study|PD|1|||
163082984|NCT03440411|589013596|FG003|Overall Study|PD|1|||
163082985|NCT03440411|589013593|FG000|Overall Study|Withdrawal by Subject|1|||
163082986|NCT03440411|589013594|FG001|Overall Study|Withdrawal by Subject|0|||
163082987|NCT03440411|589013595|FG002|Overall Study|Withdrawal by Subject|0|||
163082988|NCT03440411|589013596|FG003|Overall Study|Withdrawal by Subject|0|||
163082989|NCT03440411|589013593|FG000|Overall Study|Closed study by sponsor|0|||
163082990|NCT03440411|589013594|FG001|Overall Study|Closed study by sponsor|0|||
163082991|NCT03440411|589013595|FG002|Overall Study|Closed study by sponsor|0|||
163082992|NCT03440411|589013596|FG003|Overall Study|Closed study by sponsor|1|||
163082993|NCT00505687|589013597|FG000|Overall Study|Important protocol violation|2|||
163082994|NCT00505687|589013597|FG000|Overall Study|Lack of Efficacy|15|||
163082995|NCT00505687|589013597|FG000|Overall Study|Adverse Event|48|||
163082996|NCT00505687|589013597|FG000|Overall Study|Subject withdrew consent|15|||
163082997|NCT00505687|589013597|FG000|Overall Study|Lost to Follow-up|1|||
163082998|NCT00505687|589013597|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
163082999|NCT00505687|589013597|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
163083000|NCT00505687|589013597|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
163083001|NCT00505687|589013597|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
163083002|NCT00505687|589013597|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
163083003|NCT00505687|589013597|FG000|Overall Study|Other: Disease Progression|1|||
163083004|NCT00505687|589013597|FG000|Overall Study|Other: As Per Sponsor|8|||
163083005|NCT03707821|589013598|FG000|Overall Study|Protocol Violation|0|||
163083006|NCT03707821|589013599|FG001|Overall Study|Protocol Violation|1|||
163083007|NCT03707821|589013598|FG000|Overall Study|Unsatisfactory Visual Response|1|||
163083008|NCT03707821|589013599|FG001|Overall Study|Unsatisfactory Visual Response|0|||
163083009|NCT03707821|589013598|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
163083010|NCT03707821|589013599|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
163083011|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
163083012|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
163083013|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
163083014|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
163083015|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
163083016|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
163083017|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
163083018|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
163083019|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
163083020|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
162646305|NCT00454987|587421417|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
162646306|NCT00454987|587421418|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
162646307|NCT00454987|587421419|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
162646308|NCT00454987|587421417|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
163083021|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
163083022|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
163083023|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
163083024|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
163083025|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
163083026|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
163083027|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
163083028|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
163083029|NCT01432444|589013600|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
163083030|NCT01432444|589013601|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
163083031|NCT01432444|589013602|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
163083032|NCT01432444|589013600|FG000|Treatment Phase|Lost to Follow-up|0|||
163083033|NCT01432444|589013601|FG001|Treatment Phase|Lost to Follow-up|33|||
163083034|NCT01432444|589013602|FG002|Treatment Phase|Lost to Follow-up|0|||
163083035|NCT01432444|589013600|FG000|Treatment Phase|Adverse Event|0|||
163083036|NCT01432444|589013601|FG001|Treatment Phase|Adverse Event|37|||
163083037|NCT01432444|589013602|FG002|Treatment Phase|Adverse Event|0|||
163083038|NCT01432444|589013600|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
163083039|NCT01432444|589013601|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
163083040|NCT01432444|589013602|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
163083041|NCT01432444|589013600|FG000|Treatment Phase|Physician Decision|0|||
163083042|NCT01432444|589013601|FG001|Treatment Phase|Physician Decision|5|||
163083043|NCT01432444|589013602|FG002|Treatment Phase|Physician Decision|0|||
163083044|NCT01432444|589013600|FG000|Treatment Phase|Withdrawal by Subject|0|||
163083045|NCT01432444|589013601|FG001|Treatment Phase|Withdrawal by Subject|41|||
163083046|NCT01432444|589013602|FG002|Treatment Phase|Withdrawal by Subject|0|||
163083047|NCT01432444|589013600|FG000|Treatment Phase|Protocol Deviation|0|||
163083048|NCT01432444|589013601|FG001|Treatment Phase|Protocol Deviation|3|||
163083049|NCT01432444|589013602|FG002|Treatment Phase|Protocol Deviation|0|||
163083050|NCT01432444|589013600|FG000|Treatment Phase|Lack of Efficacy|0|||
163083051|NCT01432444|589013601|FG001|Treatment Phase|Lack of Efficacy|10|||
163083052|NCT01432444|589013602|FG002|Treatment Phase|Lack of Efficacy|0|||
163083053|NCT01432444|589013600|FG000|Extension Phase|Lost to Follow-up|0|||
163083054|NCT01432444|589013601|FG001|Extension Phase|Lost to Follow-up|0|||
163083055|NCT01432444|589013602|FG002|Extension Phase|Lost to Follow-up|17|||
163083056|NCT01432444|589013600|FG000|Extension Phase|Adverse Event|0|||
163083057|NCT01432444|589013601|FG001|Extension Phase|Adverse Event|0|||
163083058|NCT01432444|589013602|FG002|Extension Phase|Adverse Event|10|||
163083059|NCT01432444|589013600|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
163083060|NCT01432444|589013601|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
163083061|NCT01432444|589013602|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
163083062|NCT01432444|589013600|FG000|Extension Phase|Met Withdrawal Criteria|0|||
163083063|NCT01432444|589013601|FG001|Extension Phase|Met Withdrawal Criteria|0|||
163083064|NCT01432444|589013602|FG002|Extension Phase|Met Withdrawal Criteria|144|||
163083065|NCT01432444|589013600|FG000|Extension Phase|Physician Decision|0|||
163083066|NCT01432444|589013601|FG001|Extension Phase|Physician Decision|0|||
163083067|NCT01432444|589013602|FG002|Extension Phase|Physician Decision|1|||
163083068|NCT01432444|589013600|FG000|Extension Phase|Withdrawal by Subject|0|||
163083069|NCT01432444|589013601|FG001|Extension Phase|Withdrawal by Subject|0|||
163083070|NCT01432444|589013602|FG002|Extension Phase|Withdrawal by Subject|13|||
163083071|NCT03673176|589013603|FG000|Overall Study|Death prior to intervention|1|||
163083072|NCT03673176|589013603|FG000|Overall Study|Death following intervention|3|||
163083073|NCT03673176|589013603|FG000|Overall Study|Withdrawal by Subject|1|||
163083074|NCT02378480|589013604|FG000|Overall Study|Physician Decision|1|||
163083075|NCT02378480|589013605|FG001|Overall Study|Physician Decision|1|||
163083076|NCT02378480|589013604|FG000|Overall Study|Death|1|||
163083077|NCT02378480|589013605|FG001|Overall Study|Death|2|||
163083078|NCT02378480|589013604|FG000|Overall Study|Randomized, but Not Treated|6|||
163083079|NCT02378480|589013605|FG001|Overall Study|Randomized, but Not Treated|4|||
163083080|NCT02378480|589013604|FG000|Overall Study|Adverse Event|0|||
163083081|NCT02378480|589013605|FG001|Overall Study|Adverse Event|1|||
163083082|NCT02378480|589013604|FG000|Overall Study|Missed EOT/PTE Visit|1|||
163083083|NCT02378480|589013605|FG001|Overall Study|Missed EOT/PTE Visit|2|||
163083084|NCT02378480|589013604|FG000|Overall Study|Withdrawal by Subject|9|||
163083085|NCT02378480|589013605|FG001|Overall Study|Withdrawal by Subject|4|||
163083086|NCT02378480|589013604|FG000|Overall Study|Lost to Follow-up|10|||
163083087|NCT02378480|589013605|FG001|Overall Study|Lost to Follow-up|18|||
163083088|NCT01230060|589013609|FG000|Overall Study|Withdrawal by Subject|1|||
163083089|NCT03802916|589013610|FG000|Overall Study|Adverse Event|0|||
163083090|NCT03802916|589013611|FG001|Overall Study|Adverse Event|1|||
163083091|NCT03802916|589013610|FG000|Overall Study|Withdrawal by Subject|0|||
163083092|NCT03802916|589013611|FG001|Overall Study|Withdrawal by Subject|1|||
163083093|NCT00480532|589013612|FG000|Overall Study|Withdrawal by Subject|2|||
163083094|NCT00480532|589013613|FG001|Overall Study|Withdrawal by Subject|4|||
163083095|NCT00480532|589013614|FG002|Overall Study|Withdrawal by Subject|3|||
163083096|NCT00480532|589013615|FG003|Overall Study|Withdrawal by Subject|1|||
163083097|NCT00480532|589013612|FG000|Overall Study|Protocol Violation|0|||
163083098|NCT00480532|589013613|FG001|Overall Study|Protocol Violation|0|||
163083099|NCT00480532|589013614|FG002|Overall Study|Protocol Violation|1|||
163083100|NCT00480532|589013615|FG003|Overall Study|Protocol Violation|0|||
163083101|NCT01285102|589013616|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
163083102|NCT02157610|589013617|FG000|Overall Study|Death|4|||
163083103|NCT02157610|589013618|FG001|Overall Study|Death|4|||
163083104|NCT00814983|589013619|FG000|Overall Study|Screen failure|1|||
163083105|NCT00814983|589013620|FG001|Overall Study|Screen failure|0|||
163083106|NCT00814983|589013619|FG000|Overall Study|Withdrawal by Subject|1|||
163083107|NCT00814983|589013620|FG001|Overall Study|Withdrawal by Subject|0|||
163083108|NCT00814983|589013619|FG000|Overall Study|Graft failure|1|||
163083109|NCT00814983|589013620|FG001|Overall Study|Graft failure|0|||
163083110|NCT02697448|589013621|FG000|Overall Study|Protocol Violation|2|||
163083111|NCT02697448|589013622|FG001|Overall Study|Protocol Violation|4|||
163083112|NCT02697448|589013621|FG000|Overall Study|Clinical concerns during ablation|1|||
163083113|NCT02697448|589013622|FG001|Overall Study|Clinical concerns during ablation|1|||
163083114|NCT02697448|589013621|FG000|Overall Study|No data collected|2|||
163083115|NCT02697448|589013622|FG001|Overall Study|No data collected|0|||
163083116|NCT05473715|589013623|FG000|Overall Study|Trial terminate|2|||
163083117|NCT05473715|589013624|FG001|Overall Study|Trial terminate|1|||
163083118|NCT02743221|589013625|FG000|Overall Study|Progressive disease|29|||
163083119|NCT02743221|589013626|FG001|Overall Study|Progressive disease|38|||
163083120|NCT02743221|589013625|FG000|Overall Study|Adverse Event|17|||
163083121|NCT02743221|589013626|FG001|Overall Study|Adverse Event|14|||
163083122|NCT02743221|589013625|FG000|Overall Study|non medical reason|8|||
163083123|NCT02743221|589013626|FG001|Overall Study|non medical reason|2|||
163083124|NCT02743221|589013625|FG000|Overall Study|Physician Decision|2|||
163083125|NCT02743221|589013626|FG001|Overall Study|Physician Decision|5|||
163083126|NCT02743221|589013625|FG000|Overall Study|Patient not eligible, not treated|0|||
163083127|NCT02743221|589013626|FG001|Overall Study|Patient not eligible, not treated|1|||
163083128|NCT01946880|589013629|FG000|Overall Study|Lost to Follow-up|1|||
163083129|NCT01946880|589013630|FG001|Overall Study|Lost to Follow-up|0|||
163083130|NCT01946880|589013629|FG000|Overall Study|Physician Decision|1|||
163083131|NCT01946880|589013630|FG001|Overall Study|Physician Decision|1|||
163083132|NCT01946880|589013629|FG000|Overall Study|Withdrawal by Subject|3|||
163083133|NCT01946880|589013630|FG001|Overall Study|Withdrawal by Subject|2|||
163083134|NCT01946880|589013629|FG000|Overall Study|Met Primary Endpoint|1|||
163083135|NCT01946880|589013630|FG001|Overall Study|Met Primary Endpoint|0|||
163083136|NCT01946880|589013629|FG000|Overall Study|Personal and Family Issues|1|||
163083137|NCT01946880|589013630|FG001|Overall Study|Personal and Family Issues|0|||
163083138|NCT02609503|589013631|FG000|Overall Study|Adverse Event|1|||
163083139|NCT02609503|589013631|FG000|Overall Study|Death|1|||
163083140|NCT02609503|589013631|FG000|Overall Study|Withdrawal by Subject|1|||
163083141|NCT02609503|589013631|FG000|Overall Study|Disease progression|1|||
163083142|NCT01969409|589013634|FG000|Overall Study|Death|2|||
163083143|NCT01969409|589013635|FG001|Overall Study|Death|2|||
163083144|NCT01969409|589013634|FG000|Overall Study|Transplant|1|||
163083145|NCT01969409|589013635|FG001|Overall Study|Transplant|1|||
163083146|NCT01969409|589013634|FG000|Overall Study|Withdrawal by Subject|0|||
163083147|NCT01969409|589013635|FG001|Overall Study|Withdrawal by Subject|1|||
163083148|NCT02799043|589013636|FG000|Overall Study|Adverse Event|0|||
163083149|NCT02799043|589013637|FG001|Overall Study|Adverse Event|1|||
163083150|NCT02799043|589013636|FG000|Overall Study|Death|1|||
163083151|NCT02799043|589013637|FG001|Overall Study|Death|1|||
163083152|NCT02799043|589013636|FG000|Overall Study|Lost to Follow-up|3|||
163083153|NCT02799043|589013637|FG001|Overall Study|Lost to Follow-up|6|||
163083154|NCT02799043|589013636|FG000|Overall Study|Withdrawal by Subject|4|||
163083155|NCT02799043|589013637|FG001|Overall Study|Withdrawal by Subject|4|||
163083156|NCT02799043|589013636|FG000|Overall Study|Moved to different country|0|||
163083157|NCT02799043|589013637|FG001|Overall Study|Moved to different country|1|||
163083158|NCT02799043|589013636|FG000|Overall Study|Trial Screen Failure|1|||
163083159|NCT02799043|589013637|FG001|Overall Study|Trial Screen Failure|0|||
163083160|NCT02799043|589013636|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
163083161|NCT02799043|589013637|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
163083162|NCT04642079|589013638|FG000|Overall Study|Lost to Follow-up|2|||
163083163|NCT04642079|589013639|FG001|Overall Study|Lost to Follow-up|5|||
163083164|NCT04642079|589013640|FG002|Overall Study|Lost to Follow-up|2|||
163083165|NCT04642079|589013641|FG003|Overall Study|Lost to Follow-up|0|||
163083166|NCT04642079|589013638|FG000|Overall Study|Withdrawal by Subject|0|||
163083167|NCT04642079|589013639|FG001|Overall Study|Withdrawal by Subject|4|||
163083168|NCT04642079|589013640|FG002|Overall Study|Withdrawal by Subject|1|||
163083169|NCT04642079|589013641|FG003|Overall Study|Withdrawal by Subject|2|||
163083170|NCT04642079|589013638|FG000|Overall Study|Other|0|||
163083171|NCT04642079|589013639|FG001|Overall Study|Other|0|||
163083172|NCT04642079|589013640|FG002|Overall Study|Other|0|||
163083173|NCT04642079|589013641|FG003|Overall Study|Other|1|||
163083174|NCT04642079|589013638|FG000|Overall Study|No longer met eligibility criteria|1|||
163083175|NCT04642079|589013639|FG001|Overall Study|No longer met eligibility criteria|0|||
163083176|NCT04642079|589013640|FG002|Overall Study|No longer met eligibility criteria|1|||
163083177|NCT04642079|589013641|FG003|Overall Study|No longer met eligibility criteria|1|||
163083178|NCT02226653|589013644|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
163083179|NCT02226653|589013645|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
163083180|NCT02226653|589013644|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
163083181|NCT02226653|589013645|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
163083182|NCT00680914|589013646|FG000|Overall Study|Consent withdrawal|6|||
163083183|NCT00680914|589013647|FG001|Overall Study|Consent withdrawal|3|||
163083184|NCT00680914|589013646|FG000|Overall Study|Lost to Follow-up|4|||
163083185|NCT00680914|589013647|FG001|Overall Study|Lost to Follow-up|0|||
163083186|NCT00680914|589013646|FG000|Overall Study|serious adverse event (SAE)|0|||
163083187|NCT00680914|589013647|FG001|Overall Study|serious adverse event (SAE)|1|||
163083188|NCT03131479|589013648|FG000|Overall Study|Adverse Event|0|||
163083189|NCT03131479|589013649|FG001|Overall Study|Adverse Event|0|||
163083190|NCT03131479|589013650|FG002|Overall Study|Adverse Event|1|||
163083191|NCT03131479|589013651|FG003|Overall Study|Adverse Event|1|||
163083192|NCT03131479|589013652|FG004|Overall Study|Adverse Event|0|||
163083193|NCT03131479|589013648|FG000|Overall Study|Subject/Guardian Decision|0|||
163083194|NCT03131479|589013649|FG001|Overall Study|Subject/Guardian Decision|0|||
163083195|NCT03131479|589013650|FG002|Overall Study|Subject/Guardian Decision|0|||
163083196|NCT03131479|589013651|FG003|Overall Study|Subject/Guardian Decision|1|||
163083197|NCT03131479|589013652|FG004|Overall Study|Subject/Guardian Decision|0|||
163083198|NCT04439903|589013653|FG000|Overall Study|Withdrawal by Subject|2|||
163083199|NCT04439903|589013653|FG000|Overall Study|Screen Failure|1|||
163083200|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
163083201|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083202|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083203|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083204|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
163083205|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
163083206|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083207|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083208|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083209|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
163083210|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
163083211|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083212|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083213|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083214|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
163083215|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
163083216|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083217|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083218|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083219|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
163083220|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
163083221|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083222|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083223|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083224|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
163083225|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
163083226|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083227|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083228|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083229|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
163083230|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
163083231|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083232|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083233|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083234|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
163083235|NCT01111552|589013654|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
163083236|NCT01111552|589013655|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083237|NCT01111552|589013656|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083238|NCT01111552|589013657|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083239|NCT01111552|589013658|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
163083240|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083241|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083242|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083243|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
163083244|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
163083245|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
163083246|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163083247|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
163083248|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
163083249|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
163083250|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083251|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
163083252|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083253|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083254|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
163083255|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083256|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
163083257|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083258|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083259|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
163083260|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083261|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
163083262|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083263|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083264|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
163083265|NCT01111552|589013654|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083266|NCT01111552|589013655|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083267|NCT01111552|589013656|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
163083268|NCT01111552|589013657|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083269|NCT01111552|589013658|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
163083270|NCT04309500|589013661|FG000|Overall Study|Lost to Follow-up|1|||
163083271|NCT04309500|589013662|FG001|Overall Study|Lost to Follow-up|0|||
163083272|NCT04309500|589013663|FG002|Overall Study|Lost to Follow-up|0|||
163083273|NCT04309500|589013664|FG003|Overall Study|Lost to Follow-up|0|||
163083274|NCT00637156|589013665|FG000|Overall Study|Withdrawal by Subject|0|||
163083275|NCT00637156|589013666|FG001|Overall Study|Withdrawal by Subject|7|||
163083276|NCT00637156|589013665|FG000|Overall Study|Death|0|||
163083277|NCT00637156|589013666|FG001|Overall Study|Death|1|||
163083278|NCT00637156|589013665|FG000|Overall Study|Lost to Follow-up|10|||
163083279|NCT00637156|589013666|FG001|Overall Study|Lost to Follow-up|16|||
163083280|NCT02679274|589013667|FG000|Overall Study|Withdrawal by Subject|1|||
163083281|NCT02679274|589013668|FG001|Overall Study|Withdrawal by Subject|0|||
163083282|NCT03193437|589013675|FG000|Overall Study|Adverse Event|4|||
163083283|NCT03193437|589013675|FG000|Overall Study|Withdrawal by Subject|2|||
163083284|NCT03193437|589013675|FG000|Overall Study|Disease Progression|2|||
163083285|NCT04976855|589013676|FG000|Part I|Withdrawal by Subject|0|||
163083286|NCT04976855|589013677|FG001|Part I|Withdrawal by Subject|1|||
163083287|NCT04976855|589013678|FG002|Part I|Withdrawal by Subject|0|||
163083288|NCT04976855|589013679|FG003|Part I|Withdrawal by Subject|0|||
163083289|NCT04976855|589013680|FG004|Part I|Withdrawal by Subject|0|||
163083290|NCT04976855|589013681|FG005|Part I|Withdrawal by Subject|0|||
163083291|NCT04976855|589013682|FG006|Part I|Withdrawal by Subject|0|||
163083292|NCT04976855|589013676|FG000|Part II|Adverse Event|0|||
163083293|NCT04976855|589013677|FG001|Part II|Adverse Event|0|||
163083294|NCT04976855|589013678|FG002|Part II|Adverse Event|0|||
163083295|NCT04976855|589013679|FG003|Part II|Adverse Event|1|||
163083296|NCT04976855|589013680|FG004|Part II|Adverse Event|0|||
163083297|NCT04976855|589013681|FG005|Part II|Adverse Event|0|||
163083298|NCT04976855|589013682|FG006|Part II|Adverse Event|0|||
163083299|NCT04976855|589013676|FG000|Part II|Withdrawal by Subject|0|||
163083300|NCT04976855|589013677|FG001|Part II|Withdrawal by Subject|0|||
162646309|NCT00454987|587421418|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
163083301|NCT04976855|589013678|FG002|Part II|Withdrawal by Subject|0|||
163083302|NCT04976855|589013679|FG003|Part II|Withdrawal by Subject|0|||
163083303|NCT04976855|589013680|FG004|Part II|Withdrawal by Subject|1|||
163083304|NCT04976855|589013681|FG005|Part II|Withdrawal by Subject|0|||
163083305|NCT04976855|589013682|FG006|Part II|Withdrawal by Subject|0|||
163083306|NCT04976855|589013676|FG000|Part II|Lost to Follow-up|0|||
163083307|NCT04976855|589013677|FG001|Part II|Lost to Follow-up|0|||
163083308|NCT04976855|589013678|FG002|Part II|Lost to Follow-up|0|||
163083309|NCT04976855|589013679|FG003|Part II|Lost to Follow-up|0|||
163083310|NCT04976855|589013680|FG004|Part II|Lost to Follow-up|0|||
163083311|NCT04976855|589013681|FG005|Part II|Lost to Follow-up|1|||
163083312|NCT04976855|589013682|FG006|Part II|Lost to Follow-up|0|||
163083313|NCT02038036|589013683|FG000|Core Study|Adverse Event|7|||
163083314|NCT02038036|589013684|FG001|Core Study|Adverse Event|7|||
163083315|NCT02038036|589013683|FG000|Core Study|Death|1|||
163083316|NCT02038036|589013684|FG001|Core Study|Death|1|||
163083317|NCT02038036|589013683|FG000|Core Study|Disease progression|2|||
163083318|NCT02038036|589013684|FG001|Core Study|Disease progression|2|||
163083319|NCT02038036|589013683|FG000|Core Study|Lost to Follow-up|0|||
163083320|NCT02038036|589013684|FG001|Core Study|Lost to Follow-up|1|||
163083321|NCT02038036|589013683|FG000|Core Study|Physician Decision|2|||
163083322|NCT02038036|589013684|FG001|Core Study|Physician Decision|1|||
163083323|NCT02038036|589013683|FG000|Core Study|Subject/guardian decision|0|||
163083324|NCT02038036|589013684|FG001|Core Study|Subject/guardian decision|1|||
163083325|NCT02038036|589013683|FG000|Core Study|Withdrawal by Subject|3|||
163083326|NCT02038036|589013684|FG001|Core Study|Withdrawal by Subject|1|||
163083327|NCT02038036|589013683|FG000|Crossover Period|Withdrawal by Subject|0|||
163083328|NCT02038036|589013684|FG001|Crossover Period|Withdrawal by Subject|3|||
163083329|NCT02038036|589013683|FG000|Crossover Period|Adverse Event|0|||
163083330|NCT02038036|589013684|FG001|Crossover Period|Adverse Event|9|||
163083331|NCT02038036|589013683|FG000|Crossover Period|Death|0|||
163083332|NCT02038036|589013684|FG001|Crossover Period|Death|2|||
163083333|NCT02038036|589013683|FG000|Crossover Period|Disease progression|0|||
163083334|NCT02038036|589013684|FG001|Crossover Period|Disease progression|3|||
163083335|NCT02038036|589013683|FG000|Crossover Period|Lost to Follow-up|0|||
163083336|NCT02038036|589013684|FG001|Crossover Period|Lost to Follow-up|1|||
163083337|NCT02038036|589013683|FG000|Crossover Period|Physician Decision|0|||
163083338|NCT02038036|589013684|FG001|Crossover Period|Physician Decision|2|||
163083339|NCT00908141|589013693|FG000|Overall Study|Withdrawal by Subject|0|||
163083340|NCT00908141|589013694|FG001|Overall Study|Withdrawal by Subject|1|||
163083341|NCT02657356|589015215|FG000|Overall Study|Death|1|||
163083342|NCT02657356|589015216|FG001|Overall Study|Death|0|||
163083343|NCT02657356|589015215|FG000|Overall Study|Withdrawal by Subject|5|||
163083344|NCT02657356|589015216|FG001|Overall Study|Withdrawal by Subject|6|||
163083345|NCT02657356|589015215|FG000|Overall Study|Terminated by Sponsor|8|||
163083346|NCT02657356|589015216|FG001|Overall Study|Terminated by Sponsor|5|||
163083347|NCT02657356|589015215|FG000|Overall Study|Rolled over to EAP study|6|||
163083348|NCT02657356|589015216|FG001|Overall Study|Rolled over to EAP study|4|||
163083349|NCT03768336|589015219|FG000|Overall Study|Lost to Follow-up|3|||
163083350|NCT03768336|589015220|FG001|Overall Study|Lost to Follow-up|2|||
163083351|NCT03768336|589015219|FG000|Overall Study|Became Ineligible|2|||
163083352|NCT03768336|589015220|FG001|Overall Study|Became Ineligible|0|||
163083353|NCT03768336|589015219|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
163083354|NCT03768336|589015220|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
163083355|NCT03768336|589015219|FG000|Overall Study|Missed final survey (post-treatment|0|||
163083356|NCT03768336|589015220|FG001|Overall Study|Missed final survey (post-treatment|1|||
163083357|NCT02278003|589015221|FG000|Overall Study|Withdrawal by Subject|11|||
163083358|NCT02278003|589015222|FG001|Overall Study|Withdrawal by Subject|0|||
163083359|NCT02278003|589015221|FG000|Overall Study|Not Treated|1|||
163083360|NCT02278003|589015222|FG001|Overall Study|Not Treated|0|||
163083361|NCT02278003|589015221|FG000|Overall Study|Recognition task improperly completed|7|||
163083362|NCT02278003|589015222|FG001|Overall Study|Recognition task improperly completed|0|||
163083363|NCT01444781|589015223|FG000|Overall Study|Lost to Follow-up|0|||
163083364|NCT01444781|589015224|FG001|Overall Study|Lost to Follow-up|3|||
163083365|NCT01444781|589015225|FG002|Overall Study|Lost to Follow-up|1|||
163083366|NCT01444781|589015223|FG000|Overall Study|Withdrawal by Subject|3|||
163083367|NCT01444781|589015224|FG001|Overall Study|Withdrawal by Subject|1|||
163083368|NCT01444781|589015225|FG002|Overall Study|Withdrawal by Subject|2|||
162646310|NCT00454987|587421419|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
162646311|NCT00454987|587421417|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
163083369|NCT00500331|589015227|FG000|Overall Study|Adverse Event|0|||
163083370|NCT00500331|589015228|FG001|Overall Study|Adverse Event|2|||
163083371|NCT00500331|589015229|FG002|Overall Study|Adverse Event|0|||
163083372|NCT00500331|589015230|FG003|Overall Study|Adverse Event|1|||
163083373|NCT00500331|589015231|FG004|Overall Study|Adverse Event|2|||
163083374|NCT00500331|589015232|FG005|Overall Study|Adverse Event|2|||
163083375|NCT00500331|589015233|FG006|Overall Study|Adverse Event|0|||
163083376|NCT00500331|589015227|FG000|Overall Study|Lost to Follow-up|1|||
163083377|NCT00500331|589015228|FG001|Overall Study|Lost to Follow-up|1|||
163083378|NCT00500331|589015229|FG002|Overall Study|Lost to Follow-up|1|||
163083379|NCT00500331|589015230|FG003|Overall Study|Lost to Follow-up|2|||
163083380|NCT00500331|589015231|FG004|Overall Study|Lost to Follow-up|1|||
163083381|NCT00500331|589015232|FG005|Overall Study|Lost to Follow-up|0|||
163083382|NCT00500331|589015233|FG006|Overall Study|Lost to Follow-up|0|||
163083383|NCT00500331|589015227|FG000|Overall Study|Protocol Violation|3|||
163083384|NCT00500331|589015228|FG001|Overall Study|Protocol Violation|1|||
163083385|NCT00500331|589015229|FG002|Overall Study|Protocol Violation|1|||
163083386|NCT00500331|589015230|FG003|Overall Study|Protocol Violation|0|||
163083387|NCT00500331|589015231|FG004|Overall Study|Protocol Violation|1|||
163083388|NCT00500331|589015232|FG005|Overall Study|Protocol Violation|1|||
163083389|NCT00500331|589015233|FG006|Overall Study|Protocol Violation|1|||
163083390|NCT00500331|589015227|FG000|Overall Study|Withdrawal by Subject|4|||
163083391|NCT00500331|589015228|FG001|Overall Study|Withdrawal by Subject|0|||
163083392|NCT00500331|589015229|FG002|Overall Study|Withdrawal by Subject|1|||
163083393|NCT00500331|589015230|FG003|Overall Study|Withdrawal by Subject|5|||
163083394|NCT00500331|589015231|FG004|Overall Study|Withdrawal by Subject|0|||
163083395|NCT00500331|589015232|FG005|Overall Study|Withdrawal by Subject|1|||
163083396|NCT00500331|589015233|FG006|Overall Study|Withdrawal by Subject|1|||
163083397|NCT00500331|589015227|FG000|Overall Study|Lack of Efficacy|3|||
163083398|NCT00500331|589015228|FG001|Overall Study|Lack of Efficacy|1|||
163083399|NCT00500331|589015229|FG002|Overall Study|Lack of Efficacy|0|||
163083400|NCT00500331|589015230|FG003|Overall Study|Lack of Efficacy|0|||
163083401|NCT00500331|589015231|FG004|Overall Study|Lack of Efficacy|0|||
163083402|NCT00500331|589015232|FG005|Overall Study|Lack of Efficacy|0|||
163083403|NCT00500331|589015233|FG006|Overall Study|Lack of Efficacy|0|||
163083404|NCT00500331|589015227|FG000|Overall Study|Liver function test abnormality|0|||
163083405|NCT00500331|589015228|FG001|Overall Study|Liver function test abnormality|0|||
163083406|NCT00500331|589015229|FG002|Overall Study|Liver function test abnormality|1|||
163083407|NCT00500331|589015230|FG003|Overall Study|Liver function test abnormality|0|||
163083408|NCT00500331|589015231|FG004|Overall Study|Liver function test abnormality|0|||
163083409|NCT00500331|589015232|FG005|Overall Study|Liver function test abnormality|0|||
163083410|NCT00500331|589015233|FG006|Overall Study|Liver function test abnormality|0|||
163083411|NCT00500331|589015227|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
163083412|NCT00500331|589015228|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
163083413|NCT00500331|589015229|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
163083414|NCT00500331|589015230|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
163083415|NCT00500331|589015231|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
163083416|NCT00500331|589015232|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
163083417|NCT00500331|589015233|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
163083418|NCT00500331|589015227|FG000|Overall Study|Didn't return for continuation of study|1|||
163083419|NCT00500331|589015228|FG001|Overall Study|Didn't return for continuation of study|0|||
163083420|NCT00500331|589015229|FG002|Overall Study|Didn't return for continuation of study|0|||
163083421|NCT00500331|589015230|FG003|Overall Study|Didn't return for continuation of study|0|||
163083422|NCT00500331|589015231|FG004|Overall Study|Didn't return for continuation of study|0|||
163083423|NCT00500331|589015232|FG005|Overall Study|Didn't return for continuation of study|0|||
163083424|NCT00500331|589015233|FG006|Overall Study|Didn't return for continuation of study|0|||
163083425|NCT00500331|589015227|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
163083426|NCT00500331|589015228|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083427|NCT00500331|589015229|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083428|NCT00500331|589015230|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083429|NCT00500331|589015231|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083430|NCT00500331|589015232|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083431|NCT00500331|589015233|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
163083432|NCT00500331|589015227|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
163083433|NCT00500331|589015228|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
163083434|NCT00500331|589015229|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
163083435|NCT00500331|589015230|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
163083436|NCT00500331|589015231|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
163083437|NCT00500331|589015232|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
163083438|NCT00500331|589015233|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
163083439|NCT00500331|589015227|FG000|Overall Study|Participant was randomized by mistake|1|||
163083440|NCT00500331|589015228|FG001|Overall Study|Participant was randomized by mistake|0|||
163083441|NCT00500331|589015229|FG002|Overall Study|Participant was randomized by mistake|0|||
163083442|NCT00500331|589015230|FG003|Overall Study|Participant was randomized by mistake|0|||
163083443|NCT00500331|589015231|FG004|Overall Study|Participant was randomized by mistake|0|||
163083444|NCT00500331|589015232|FG005|Overall Study|Participant was randomized by mistake|0|||
163083445|NCT00500331|589015233|FG006|Overall Study|Participant was randomized by mistake|0|||
163083446|NCT00500331|589015227|FG000|Overall Study|Diabetologist nurse in the study|0|||
163083447|NCT00500331|589015228|FG001|Overall Study|Diabetologist nurse in the study|0|||
163083448|NCT00500331|589015229|FG002|Overall Study|Diabetologist nurse in the study|1|||
163083449|NCT00500331|589015230|FG003|Overall Study|Diabetologist nurse in the study|0|||
163083450|NCT00500331|589015231|FG004|Overall Study|Diabetologist nurse in the study|0|||
163083451|NCT00500331|589015232|FG005|Overall Study|Diabetologist nurse in the study|0|||
163083452|NCT00500331|589015233|FG006|Overall Study|Diabetologist nurse in the study|0|||
163083453|NCT00500331|589015227|FG000|Overall Study|State ban of biological samples export|0|||
163083454|NCT00500331|589015228|FG001|Overall Study|State ban of biological samples export|0|||
163083455|NCT00500331|589015229|FG002|Overall Study|State ban of biological samples export|0|||
163083456|NCT00500331|589015230|FG003|Overall Study|State ban of biological samples export|1|||
163083457|NCT00500331|589015231|FG004|Overall Study|State ban of biological samples export|0|||
163083458|NCT00500331|589015232|FG005|Overall Study|State ban of biological samples export|0|||
163083459|NCT00500331|589015233|FG006|Overall Study|State ban of biological samples export|0|||
163083460|NCT00500331|589015227|FG000|Overall Study|Protocol violated|0|||
163083461|NCT00500331|589015228|FG001|Overall Study|Protocol violated|0|||
163083462|NCT00500331|589015229|FG002|Overall Study|Protocol violated|0|||
163083463|NCT00500331|589015230|FG003|Overall Study|Protocol violated|1|||
163083464|NCT00500331|589015231|FG004|Overall Study|Protocol violated|0|||
163083465|NCT00500331|589015232|FG005|Overall Study|Protocol violated|0|||
163083466|NCT00500331|589015233|FG006|Overall Study|Protocol violated|0|||
163083467|NCT00856557|589015240|FG000|Overall Study|No patients with contextual flags|12|||
163083468|NCT00856557|589015241|FG001|Overall Study|No patients with contextual flags|16|||
163083469|NCT02301897|589015242|FG000|Treatment Course 1|Non-Compliance|0|||
163083470|NCT02301897|589015243|FG001|Treatment Course 1|Non-Compliance|0|||
163083471|NCT02301897|589015244|FG002|Treatment Course 1|Non-Compliance|1|||
163083472|NCT02301897|589015242|FG000|Treatment Course 1|Adverse Event|1|||
163083473|NCT02301897|589015243|FG001|Treatment Course 1|Adverse Event|1|||
163083474|NCT02301897|589015244|FG002|Treatment Course 1|Adverse Event|0|||
163083475|NCT02301897|589015242|FG000|Treatment Course 1|Lost to Follow-up|1|||
163083476|NCT02301897|589015243|FG001|Treatment Course 1|Lost to Follow-up|2|||
163083477|NCT02301897|589015244|FG002|Treatment Course 1|Lost to Follow-up|1|||
163083478|NCT02301897|589015242|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
163083479|NCT02301897|589015243|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
163083480|NCT02301897|589015244|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
163083481|NCT02301897|589015242|FG000|Treatment Course 1|Withdrawal by Subject|0|||
163083482|NCT02301897|589015243|FG001|Treatment Course 1|Withdrawal by Subject|0|||
163083483|NCT02301897|589015244|FG002|Treatment Course 1|Withdrawal by Subject|2|||
163083484|NCT02301897|589015242|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
163083485|NCT02301897|589015243|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
163083486|NCT02301897|589015244|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
163083487|NCT02301897|589015242|FG000|Treatment Course 2|Lost to Follow-up|0|||
163083488|NCT02301897|589015243|FG001|Treatment Course 2|Lost to Follow-up|2|||
163083489|NCT02301897|589015244|FG002|Treatment Course 2|Lost to Follow-up|0|||
163083490|NCT02301897|589015242|FG000|Treatment Course 2|Pregnancy|0|||
163083491|NCT02301897|589015243|FG001|Treatment Course 2|Pregnancy|1|||
163083492|NCT02301897|589015244|FG002|Treatment Course 2|Pregnancy|1|||
163083493|NCT02301897|589015242|FG000|Treatment Course 2|Withdrawal by Subject|0|||
163083494|NCT02301897|589015243|FG001|Treatment Course 2|Withdrawal by Subject|2|||
163083495|NCT02301897|589015244|FG002|Treatment Course 2|Withdrawal by Subject|0|||
163083496|NCT02301897|589015242|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
163083497|NCT02301897|589015243|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
163083498|NCT02301897|589015244|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
163083499|NCT00337168|589015245|FG000|Overall Study|Death|5|||
163083500|NCT00337168|589015245|FG000|Overall Study|Not protocol specified|2|||
163083501|NCT00337168|589015245|FG000|Overall Study|Did not start therapy|1|||
163083502|NCT02684461|589015248|FG000|Overall Study|Adverse Event|1|||
163083503|NCT02684461|589015249|FG001|Overall Study|Adverse Event|0|||
163083504|NCT02684461|589015250|FG002|Overall Study|Adverse Event|0|||
163083505|NCT02684461|589015248|FG000|Overall Study|Lack of Efficacy|1|||
163083506|NCT02684461|589015249|FG001|Overall Study|Lack of Efficacy|2|||
163083507|NCT02684461|589015250|FG002|Overall Study|Lack of Efficacy|0|||
163083508|NCT03663582|589015251|FG000|Overall Study|Physician Decision|1|||
163083509|NCT00557440|589015263|FG000|Treatment Period 1|Adverse Event|0|||
163083510|NCT00557440|589015264|FG001|Treatment Period 1|Adverse Event|0|||
163083511|NCT00557440|589015265|FG002|Treatment Period 1|Adverse Event|1|||
163083512|NCT04507763|589015266|FG000|Overall Study|Participants did not meet entrance criteria|201|||
163083513|NCT03322566|589015267|FG000|Overall Study|Death|34|||
163083514|NCT03322566|589015268|FG001|Overall Study|Death|35|||
163083515|NCT03322566|589015269|FG002|Overall Study|Death|23|||
163083516|NCT03322566|589015267|FG000|Overall Study|Physician Decision|6|||
163083517|NCT03322566|589015268|FG001|Overall Study|Physician Decision|7|||
163083518|NCT03322566|589015269|FG002|Overall Study|Physician Decision|2|||
163083519|NCT03322566|589015267|FG000|Overall Study|Withdrawal by Subject|4|||
163083520|NCT03322566|589015268|FG001|Overall Study|Withdrawal by Subject|3|||
163083521|NCT03322566|589015269|FG002|Overall Study|Withdrawal by Subject|6|||
163083522|NCT03322566|589015267|FG000|Overall Study|Lost to Follow-up|0|||
163083523|NCT03322566|589015268|FG001|Overall Study|Lost to Follow-up|0|||
163083524|NCT03322566|589015269|FG002|Overall Study|Lost to Follow-up|1|||
163083525|NCT03322566|589015267|FG000|Overall Study|Study terminated by sponsor|1|||
163083526|NCT03322566|589015268|FG001|Overall Study|Study terminated by sponsor|0|||
163083527|NCT03322566|589015269|FG002|Overall Study|Study terminated by sponsor|1|||
163083528|NCT01602484|589015270|FG000|Overall Study|Airway issues unrelated to study|0|||
163083529|NCT01602484|589015271|FG001|Overall Study|Airway issues unrelated to study|1|||
163083530|NCT00425555|589015274|FG000|Overall Study|Withdrawal by Subject|11|||
163083531|NCT00425555|589015275|FG001|Overall Study|Withdrawal by Subject|8|||
163083532|NCT00425555|589015274|FG000|Overall Study|Lost to Follow-up|0|||
163083533|NCT00425555|589015275|FG001|Overall Study|Lost to Follow-up|1|||
163083534|NCT00425555|589015274|FG000|Overall Study|Administrative problems|3|||
163083535|NCT00425555|589015275|FG001|Overall Study|Administrative problems|0|||
163083536|NCT00425555|589015274|FG000|Overall Study|Death|1|||
163083537|NCT00425555|589015275|FG001|Overall Study|Death|2|||
163083538|NCT00425555|589015274|FG000|Overall Study|New cancer therapy|2|||
163083539|NCT00425555|589015275|FG001|Overall Study|New cancer therapy|1|||
163083540|NCT00425555|589015274|FG000|Overall Study|Disease progression|36|||
163083541|NCT00425555|589015275|FG001|Overall Study|Disease progression|33|||
163083542|NCT00425555|589015274|FG000|Overall Study|Adverse Event|25|||
163083543|NCT00425555|589015275|FG001|Overall Study|Adverse Event|15|||
163083544|NCT00425555|589015274|FG000|Overall Study|Protocol Violation|1|||
163083545|NCT00425555|589015275|FG001|Overall Study|Protocol Violation|0|||
163083546|NCT05763381|589015276|FG000|Overall Study|Lost to Follow-up|2|||
163083547|NCT05763381|589015277|FG001|Overall Study|Lost to Follow-up|3|||
163083548|NCT05763381|589015276|FG000|Overall Study|Withdrawal by Subject|1|||
163083549|NCT05763381|589015277|FG001|Overall Study|Withdrawal by Subject|2|||
163083550|NCT02592863|589015282|FG000|Overall Study|Withdrawal by Subject|2|||
163083551|NCT02592863|589015283|FG001|Overall Study|Withdrawal by Subject|2|||
163083552|NCT02592863|589015282|FG000|Overall Study|Lost to Follow-up|1|||
163083553|NCT02592863|589015283|FG001|Overall Study|Lost to Follow-up|1|||
163083554|NCT01674062|589015291|FG000|Overall Study|Insufficient Therapeutic Response|56|||
163083555|NCT01674062|589015292|FG001|Overall Study|Insufficient Therapeutic Response|26|||
163083556|NCT01674062|589015291|FG000|Overall Study|Other|8|||
163083557|NCT01674062|589015292|FG001|Overall Study|Other|1|||
163083558|NCT01674062|589015291|FG000|Overall Study|Adverse Event|1|||
163083559|NCT01674062|589015292|FG001|Overall Study|Adverse Event|1|||
163083560|NCT01674062|589015291|FG000|Overall Study|Death|0|||
163083561|NCT01674062|589015292|FG001|Overall Study|Death|1|||
163083562|NCT01674062|589015291|FG000|Overall Study|Programming Error|1|||
163083563|NCT01674062|589015292|FG001|Overall Study|Programming Error|0|||
163083564|NCT04661839|589015293|FG000|Overall Study|Not Treated|0|||
163083565|NCT04661839|589015294|FG001|Overall Study|Not Treated|0|||
163083566|NCT04661839|589015295|FG002|Overall Study|Not Treated|1|||
163083567|NCT04661839|589015296|FG003|Overall Study|Not Treated|0|||
163083568|NCT04661839|589015293|FG000|Overall Study|Lost to Follow-up|1|||
163083569|NCT04661839|589015294|FG001|Overall Study|Lost to Follow-up|0|||
163083570|NCT04661839|589015295|FG002|Overall Study|Lost to Follow-up|0|||
163083571|NCT04661839|589015296|FG003|Overall Study|Lost to Follow-up|1|||
163083572|NCT03895372|589015297|FG000|Investigational Treatment Period|Adverse Event|1|||
163083573|NCT03895372|589015298|FG001|Investigational Treatment Period|Adverse Event|0|||
163083574|NCT03895372|589015299|FG002|Investigational Treatment Period|Adverse Event|0|||
163083575|NCT03895372|589015300|FG003|Investigational Treatment Period|Adverse Event|0|||
163083576|NCT03895372|589015301|FG004|Investigational Treatment Period|Adverse Event|0|||
163083577|NCT03895372|589015302|FG005|Investigational Treatment Period|Adverse Event|0|||
163083578|NCT03895372|589015303|FG006|Investigational Treatment Period|Adverse Event|4|||
163083579|NCT03895372|589015304|FG007|Investigational Treatment Period|Adverse Event|3|||
163083580|NCT03895372|589015297|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
163083581|NCT03895372|589015298|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
163083582|NCT03895372|589015299|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
163083583|NCT03895372|589015300|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
163083584|NCT03895372|589015301|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
163083585|NCT03895372|589015302|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
162646312|NCT00454987|587421418|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
162646313|NCT00454987|587421419|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
162646314|NCT03054870|587421421|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
162646315|NCT03054870|587421421|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
163083586|NCT03895372|589015303|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
162646316|NCT02009046|587421422|FG000|Overall Study|Lost to Follow-up|256|||
162646317|NCT02009046|587421423|FG001|Overall Study|Lost to Follow-up|206|||
163083587|NCT03895372|589015304|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
163083588|NCT03895372|589015297|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
163083589|NCT03895372|589015298|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
162646318|NCT01082965|587421427|FG000|Overall Study|Protocol Violation|0|||
163083590|NCT03895372|589015299|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
163083591|NCT03895372|589015300|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
163083592|NCT03895372|589015301|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
163083593|NCT03895372|589015302|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
163083594|NCT03895372|589015303|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
163083595|NCT03895372|589015304|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
163083596|NCT03895372|589015297|FG000|Investigational Treatment Period|Other|0|||
163083597|NCT03895372|589015298|FG001|Investigational Treatment Period|Other|0|||
163083598|NCT03895372|589015299|FG002|Investigational Treatment Period|Other|0|||
163083599|NCT03895372|589015300|FG003|Investigational Treatment Period|Other|0|||
163083600|NCT03895372|589015301|FG004|Investigational Treatment Period|Other|0|||
163083601|NCT03895372|589015302|FG005|Investigational Treatment Period|Other|1|||
163083602|NCT03895372|589015303|FG006|Investigational Treatment Period|Other|0|||
163083603|NCT03895372|589015304|FG007|Investigational Treatment Period|Other|2|||
163083604|NCT03895372|589015297|FG000|Investigational Treatment Period|Protocol Violation|0|||
163083605|NCT03895372|589015298|FG001|Investigational Treatment Period|Protocol Violation|0|||
163083606|NCT03895372|589015299|FG002|Investigational Treatment Period|Protocol Violation|0|||
163083607|NCT03895372|589015300|FG003|Investigational Treatment Period|Protocol Violation|1|||
163083608|NCT03895372|589015301|FG004|Investigational Treatment Period|Protocol Violation|0|||
163083609|NCT03895372|589015302|FG005|Investigational Treatment Period|Protocol Violation|0|||
163083610|NCT03895372|589015303|FG006|Investigational Treatment Period|Protocol Violation|0|||
163083611|NCT03895372|589015304|FG007|Investigational Treatment Period|Protocol Violation|0|||
163083612|NCT03895372|589015297|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
163083613|NCT03895372|589015298|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
163083614|NCT03895372|589015299|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
163083615|NCT03895372|589015300|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
163083616|NCT03895372|589015301|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
163083617|NCT03895372|589015302|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
163083618|NCT03895372|589015303|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
163083619|NCT03895372|589015304|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
163083620|NCT03895372|589015297|FG000|Extension Treatment Period|Adverse Event|0|||
163083621|NCT03895372|589015298|FG001|Extension Treatment Period|Adverse Event|1|||
163083622|NCT03895372|589015299|FG002|Extension Treatment Period|Adverse Event|0|||
163083623|NCT03895372|589015300|FG003|Extension Treatment Period|Adverse Event|1|||
163083624|NCT03895372|589015301|FG004|Extension Treatment Period|Adverse Event|0|||
163083625|NCT03895372|589015302|FG005|Extension Treatment Period|Adverse Event|0|||
163083626|NCT03895372|589015303|FG006|Extension Treatment Period|Adverse Event|3|||
163083627|NCT03895372|589015304|FG007|Extension Treatment Period|Adverse Event|3|||
163083628|NCT03895372|589015297|FG000|Extension Treatment Period|Other|1|||
163083629|NCT03895372|589015298|FG001|Extension Treatment Period|Other|3|||
163083630|NCT03895372|589015299|FG002|Extension Treatment Period|Other|0|||
163083631|NCT03895372|589015300|FG003|Extension Treatment Period|Other|0|||
163083632|NCT03895372|589015301|FG004|Extension Treatment Period|Other|1|||
163083633|NCT03895372|589015302|FG005|Extension Treatment Period|Other|0|||
163083634|NCT03895372|589015303|FG006|Extension Treatment Period|Other|0|||
163083635|NCT03895372|589015304|FG007|Extension Treatment Period|Other|2|||
163083636|NCT03895372|589015297|FG000|Extension Treatment Period|Pregnancy|0|||
163083637|NCT03895372|589015298|FG001|Extension Treatment Period|Pregnancy|0|||
163083638|NCT03895372|589015299|FG002|Extension Treatment Period|Pregnancy|0|||
163083639|NCT03895372|589015300|FG003|Extension Treatment Period|Pregnancy|0|||
163083640|NCT03895372|589015301|FG004|Extension Treatment Period|Pregnancy|1|||
163083641|NCT03895372|589015302|FG005|Extension Treatment Period|Pregnancy|0|||
163083642|NCT03895372|589015303|FG006|Extension Treatment Period|Pregnancy|0|||
163083643|NCT03895372|589015304|FG007|Extension Treatment Period|Pregnancy|0|||
163083644|NCT03895372|589015297|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
163083645|NCT03895372|589015298|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
163083646|NCT03895372|589015299|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163083647|NCT03895372|589015300|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
163083648|NCT03895372|589015301|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
163083649|NCT03895372|589015302|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
163083650|NCT03895372|589015303|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
163083651|NCT03895372|589015304|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
163083652|NCT03685149|589015305|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
163083653|NCT03685149|589015306|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
163083654|NCT03685149|589015305|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163083655|NCT03685149|589015306|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163083656|NCT03685149|589015305|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
163083657|NCT03685149|589015306|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
163083658|NCT02951819|589015308|FG000|Overall Study|Death|9|||
163083659|NCT02951819|589015309|FG001|Overall Study|Death|7|||
163083660|NCT02951819|589015308|FG000|Overall Study|Withdrawal by Subject|3|||
163083661|NCT02951819|589015309|FG001|Overall Study|Withdrawal by Subject|0|||
163083662|NCT02951819|589015308|FG000|Overall Study|Adverse Event|1|||
163083663|NCT02951819|589015309|FG001|Overall Study|Adverse Event|0|||
163083664|NCT02951819|589015308|FG000|Overall Study|Lack of Efficacy|4|||
163083665|NCT02951819|589015309|FG001|Overall Study|Lack of Efficacy|0|||
163083666|NCT02951819|589015308|FG000|Overall Study|Lost to Follow-up|1|||
163083667|NCT02951819|589015309|FG001|Overall Study|Lost to Follow-up|0|||
162717913|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163083668|NCT02951819|589015308|FG000|Overall Study|Progressive Disease|1|||
163083669|NCT02951819|589015309|FG001|Overall Study|Progressive Disease|0|||
163083670|NCT02951819|589015308|FG000|Overall Study|Other|9|||
163083671|NCT02951819|589015309|FG001|Overall Study|Other|0|||
163083672|NCT00581919|589015313|FG000|Overall Study|Adverse Event|8|||
163083673|NCT00581919|589015313|FG000|Overall Study|Death|1|||
163083674|NCT00581919|589015313|FG000|Overall Study|Disease Progression|10|||
163083675|NCT00581919|589015313|FG000|Overall Study|Physician Decision|1|||
163083676|NCT00581919|589015313|FG000|Overall Study|Other Complicating Disease|1|||
163083677|NCT00581919|589015313|FG000|Overall Study|Started Non-Protocol Therapy|2|||
163083678|NCT00581919|589015313|FG000|Overall Study|Withdrawal by Subject|1|||
163083679|NCT02034565|589015314|FG000|Overall Study|Adverse Event|1|||
163083680|NCT02034565|589015315|FG001|Overall Study|Adverse Event|0|||
163083681|NCT03232567|589015318|FG000|Overall Study|Withdrawal by Subject|0|||
163083682|NCT03232567|589015319|FG001|Overall Study|Withdrawal by Subject|1|||
163083683|NCT03232567|589015320|FG002|Overall Study|Withdrawal by Subject|0|||
163083684|NCT03232567|589015321|FG003|Overall Study|Withdrawal by Subject|0|||
163083685|NCT02655601|589015322|FG000|Overall Study|Adverse Event|0|||
163083686|NCT02655601|589015323|FG001|Overall Study|Adverse Event|0|||
163083687|NCT02655601|589015324|FG002|Overall Study|Adverse Event|0|||
163083688|NCT02655601|589015325|FG003|Overall Study|Adverse Event|1|||
163083689|NCT02655601|589015326|FG004|Overall Study|Adverse Event|1|||
163083690|NCT02655601|589015327|FG005|Overall Study|Adverse Event|0|||
163083691|NCT02655601|589015322|FG000|Overall Study|Physician Decision|0|||
163083692|NCT02655601|589015323|FG001|Overall Study|Physician Decision|0|||
163083693|NCT02655601|589015324|FG002|Overall Study|Physician Decision|0|||
163083694|NCT02655601|589015325|FG003|Overall Study|Physician Decision|0|||
163083695|NCT02655601|589015326|FG004|Overall Study|Physician Decision|1|||
163083696|NCT02655601|589015327|FG005|Overall Study|Physician Decision|1|||
162646319|NCT01082965|587421428|FG001|Overall Study|Protocol Violation|1|||
163083697|NCT02655601|589015322|FG000|Overall Study|Withdrawal by Subject|0|||
163083698|NCT02655601|589015323|FG001|Overall Study|Withdrawal by Subject|0|||
163083699|NCT02655601|589015324|FG002|Overall Study|Withdrawal by Subject|0|||
163083700|NCT02655601|589015325|FG003|Overall Study|Withdrawal by Subject|0|||
163083701|NCT02655601|589015326|FG004|Overall Study|Withdrawal by Subject|4|||
163083702|NCT02655601|589015327|FG005|Overall Study|Withdrawal by Subject|8|||
163083703|NCT02655601|589015322|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
163083704|NCT02655601|589015323|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083705|NCT02655601|589015324|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083706|NCT02655601|589015325|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083707|NCT02655601|589015326|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083708|NCT02655601|589015327|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
163083709|NCT05837481|589015328|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
163083710|NCT05837481|589015329|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
163083711|NCT02014376|589015330|FG000|Overall Study|Adverse Event|1|||
163083712|NCT02014376|589015331|FG001|Overall Study|Adverse Event|1|||
163083713|NCT02014376|589015332|FG002|Overall Study|Adverse Event|0|||
163083714|NCT02014376|589015330|FG000|Overall Study|Lost to Follow-up|2|||
163083715|NCT02014376|589015331|FG001|Overall Study|Lost to Follow-up|0|||
163083716|NCT02014376|589015332|FG002|Overall Study|Lost to Follow-up|0|||
163083717|NCT00759395|589015335|FG000|Overall Study|Adverse Event|1|||
163083718|NCT00759395|589015336|FG001|Overall Study|Adverse Event|0|||
163083719|NCT00759395|589015335|FG000|Overall Study|Withdrawal by Subject|1|||
163083720|NCT00759395|589015336|FG001|Overall Study|Withdrawal by Subject|0|||
163083721|NCT00759395|589015335|FG000|Overall Study|Lack of Efficacy|0|||
163083722|NCT00759395|589015336|FG001|Overall Study|Lack of Efficacy|2|||
163083723|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
163083724|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
163083725|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
163083726|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
162646320|NCT01082965|587421427|FG000|Overall Study|Other|1|||
162646321|NCT01082965|587421428|FG001|Overall Study|Other|1|||
162646322|NCT05198843|587421430|FG000|Overall Study|Lack of Efficacy|1|||
162646323|NCT00902564|587422705|FG000|Overall Study|Withdrawal by Subject|2|||
162646324|NCT02474199|587422706|FG000|Overall Study|Lost to Follow-up|1|||
162646325|NCT02474199|587422707|FG001|Overall Study|Lost to Follow-up|0|||
162646326|NCT02474199|587422708|FG002|Overall Study|Lost to Follow-up|0|||
162646327|NCT02474199|587422709|FG003|Overall Study|Lost to Follow-up|0|||
162646328|NCT02474199|587422706|FG000|Overall Study|Withdrawal by Subject|1|||
162646329|NCT02474199|587422707|FG001|Overall Study|Withdrawal by Subject|2|||
162646330|NCT02474199|587422708|FG002|Overall Study|Withdrawal by Subject|0|||
162646331|NCT02474199|587422709|FG003|Overall Study|Withdrawal by Subject|1|||
162646332|NCT02474199|587422706|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162646333|NCT02474199|587422707|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
162646334|NCT02474199|587422708|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162646335|NCT02474199|587422709|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162646336|NCT02474199|587422706|FG000|Overall Study|Did not meet eligibility criteria|0|||
162646337|NCT02474199|587422707|FG001|Overall Study|Did not meet eligibility criteria|0|||
162646338|NCT02474199|587422708|FG002|Overall Study|Did not meet eligibility criteria|2|||
163083727|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
163083728|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
163083729|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
163083730|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
163083731|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
163083732|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
163083733|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
163083734|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
163083735|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
162646339|NCT02474199|587422709|FG003|Overall Study|Did not meet eligibility criteria|2|||
162646340|NCT03406858|587422714|FG000|Overall Study|Failure to receive treatment drug.|1|||
163083736|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
163083737|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
163083738|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
163083739|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
163083740|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
163083741|NCT00086515|589015337|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
163083742|NCT00086515|589015338|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
163083743|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
163083744|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
163083745|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
163083746|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
163083747|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
163083748|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
163083749|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
163083750|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
163083751|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
163083752|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
163083753|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
163083754|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
163083755|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
163083756|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
163083757|NCT00086515|589015337|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
163083758|NCT00086515|589015338|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
163083759|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
163083760|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
163083761|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
163083762|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
163083763|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
163083764|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
163083765|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
163083766|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
163083767|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
163083768|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
163083769|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
163083770|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
163083771|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
163083772|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
163083773|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
163083774|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
163083775|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
163083776|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
163083777|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
163083778|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
163083779|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
163083780|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
163083781|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
163083782|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
163083783|NCT00086515|589015337|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
163083784|NCT00086515|589015338|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
163083785|NCT02420314|589015342|FG000|Overall Study|Withdrawal by Subject|1|||
163083786|NCT02420314|589015342|FG000|Overall Study|Protocol Violation|1|||
163083787|NCT02251041|589015343|FG000|Overall Study|Did not receive intervention|15|||
163083788|NCT02251041|589015344|FG001|Overall Study|Did not receive intervention|4|||
163083789|NCT01618708|589015347|FG000|Overall Study|Adverse Event|10|||
163083790|NCT01618708|589015348|FG001|Overall Study|Adverse Event|10|||
163083791|NCT01618708|589015347|FG000|Overall Study|Lost to Follow-up|3|||
163083792|NCT01618708|589015348|FG001|Overall Study|Lost to Follow-up|3|||
163083793|NCT01618708|589015347|FG000|Overall Study|Withdrawal by Subject|17|||
163083794|NCT01618708|589015348|FG001|Overall Study|Withdrawal by Subject|22|||
162646341|NCT03406858|587422714|FG000|Overall Study|ineligible|1|||
162646342|NCT06027866|587422715|FG000|Overall Study|Withdrawal by Subject|2|||
162646343|NCT00930579|587422716|FG000|Overall Study|Withdrawal by Subject|1|||
162646344|NCT00930579|587422716|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
162646345|NCT01046682|587422725|FG000|Overall Study|Adverse Event|2|||
163083795|NCT01618708|589015347|FG000|Overall Study|Lack of Efficacy|8|||
162646346|NCT01046682|587422726|FG001|Overall Study|Adverse Event|0|||
162646347|NCT05071183|587422727|FG000|Overall Study|Death|1|||
163083796|NCT01618708|589015348|FG001|Overall Study|Lack of Efficacy|8|||
163083797|NCT01618708|589015347|FG000|Overall Study|Technical problems|2|||
163083798|NCT01618708|589015348|FG001|Overall Study|Technical problems|0|||
163083799|NCT01618708|589015347|FG000|Overall Study|Other than specified above|1|||
163083800|NCT01618708|589015348|FG001|Overall Study|Other than specified above|1|||
163083801|NCT01618708|589015347|FG000|Overall Study|Randomized but not treated|3|||
163083802|NCT01618708|589015348|FG001|Overall Study|Randomized but not treated|2|||
163083803|NCT01848457|589015351|FG000|Overall Study|Death|1|||
163083804|NCT01848457|589015352|FG001|Overall Study|Death|0|||
163083805|NCT01848457|589015353|FG002|Overall Study|Death|0|||
163083806|NCT01848457|589015354|FG003|Overall Study|Death|0|||
163083807|NCT02181413|589015356|FG000|Overall Study|Withdrawal by Subject|45|||
163083808|NCT02181413|589015357|FG001|Overall Study|Withdrawal by Subject|61|||
163083809|NCT02181413|589015356|FG000|Overall Study|Reason Not Specified|2|||
163083810|NCT02181413|589015357|FG001|Overall Study|Reason Not Specified|5|||
163083811|NCT02181413|589015356|FG000|Overall Study|Lost to Follow-up|8|||
163083812|NCT02181413|589015357|FG001|Overall Study|Lost to Follow-up|7|||
163083813|NCT02298946|589015359|FG000|Overall Study|Did not receive treatment|2|||
163083814|NCT02298946|589015360|FG001|Overall Study|Did not receive treatment|0|||
163083815|NCT02298946|589015359|FG000|Overall Study|Unevaluable|2|||
163083816|NCT02298946|589015360|FG001|Overall Study|Unevaluable|1|||
163083817|NCT00050011|589015361|FG000|Overall Study|Adverse Event|41|||
163083818|NCT00050011|589015362|FG001|Overall Study|Adverse Event|46|||
163083819|NCT00050011|589015361|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163083820|NCT00050011|589015362|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163083821|NCT00050011|589015361|FG000|Overall Study|Abnormal test procedure results|0|||
163083822|NCT00050011|589015362|FG001|Overall Study|Abnormal test procedure results|1|||
163083823|NCT00050011|589015361|FG000|Overall Study|Lack of Efficacy|16|||
163083824|NCT00050011|589015362|FG001|Overall Study|Lack of Efficacy|21|||
163083825|NCT00050011|589015361|FG000|Overall Study|Participant condition no longer required|1|||
163083826|NCT00050011|589015362|FG001|Overall Study|Participant condition no longer required|0|||
163083827|NCT00050011|589015361|FG000|Overall Study|Protocol Violation|4|||
163083828|NCT00050011|589015362|FG001|Overall Study|Protocol Violation|10|||
163083829|NCT00050011|589015361|FG000|Overall Study|Withdrawal by Subject|34|||
163083830|NCT00050011|589015362|FG001|Overall Study|Withdrawal by Subject|26|||
163083831|NCT00050011|589015361|FG000|Overall Study|Lost to Follow-up|7|||
163083832|NCT00050011|589015362|FG001|Overall Study|Lost to Follow-up|9|||
163083833|NCT00050011|589015361|FG000|Overall Study|Administrative problems|10|||
163083834|NCT00050011|589015362|FG001|Overall Study|Administrative problems|6|||
163083835|NCT00050011|589015361|FG000|Overall Study|Death|7|||
163083836|NCT00050011|589015362|FG001|Overall Study|Death|4|||
163083837|NCT00050011|589015361|FG000|Overall Study|Unknown - Reason is missing|0|||
163083838|NCT00050011|589015362|FG001|Overall Study|Unknown - Reason is missing|2|||
163083839|NCT03034044|589015363|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
163083840|NCT02412436|589015364|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
163083841|NCT02412436|589015364|FG000|Overall Study|Lost to Follow-up|6|||
163083842|NCT02412436|589015364|FG000|Overall Study|Unable to get to clinic|3|||
163083843|NCT02412436|589015364|FG000|Overall Study|Death|1|||
163083844|NCT02412436|589015364|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
163083845|NCT03514134|589016773|FG000|Overall Study|Lost to Follow-up|0|||
163083846|NCT03514134|589016774|FG001|Overall Study|Lost to Follow-up|1|||
163083847|NCT00462826|589016775|FG000|Overall Study|Ineligible - second primary|1|||
163083848|NCT00462826|589016775|FG000|Overall Study|Ineligible - wrong cell type|1|||
163083849|NCT00462826|589016775|FG000|Overall Study|Ineligible - wrong primary|2|||
163083850|NCT00462826|589016775|FG000|Overall Study|Never treated|1|||
163083851|NCT04976777|589016776|FG000|Overall Study|COVID-19 Infection|1|||
163083852|NCT04976777|589016777|FG001|Overall Study|COVID-19 Infection|0|||
163083853|NCT05654181|589016778|FG000|Overall Study|Adverse Event|1|||
163083854|NCT05654181|589016779|FG001|Overall Study|Adverse Event|0|||
163083855|NCT05654181|589016780|FG002|Overall Study|Adverse Event|0|||
163083856|NCT05654181|589016781|FG003|Overall Study|Adverse Event|0|||
163083857|NCT05654181|589016782|FG004|Overall Study|Adverse Event|0|||
163083858|NCT05654181|589016783|FG005|Overall Study|Adverse Event|0|||
163083859|NCT05654181|589016784|FG006|Overall Study|Adverse Event|0|||
163083860|NCT05654181|589016785|FG007|Overall Study|Adverse Event|1|||
163083861|NCT05654181|589016786|FG008|Overall Study|Adverse Event|0|||
163083862|NCT05654181|589016787|FG009|Overall Study|Adverse Event|0|||
163083863|NCT05654181|589016778|FG000|Overall Study|Withdrawal by Subject|0|||
163083864|NCT05654181|589016779|FG001|Overall Study|Withdrawal by Subject|0|||
163083865|NCT05654181|589016780|FG002|Overall Study|Withdrawal by Subject|0|||
163083866|NCT05654181|589016781|FG003|Overall Study|Withdrawal by Subject|0|||
163083867|NCT05654181|589016782|FG004|Overall Study|Withdrawal by Subject|0|||
163083868|NCT05654181|589016783|FG005|Overall Study|Withdrawal by Subject|0|||
163083869|NCT05654181|589016784|FG006|Overall Study|Withdrawal by Subject|0|||
163083870|NCT05654181|589016785|FG007|Overall Study|Withdrawal by Subject|1|||
163083871|NCT05654181|589016786|FG008|Overall Study|Withdrawal by Subject|0|||
163083872|NCT05654181|589016787|FG009|Overall Study|Withdrawal by Subject|0|||
163083873|NCT05654181|589016778|FG000|Overall Study|Other|0|||
163083874|NCT05654181|589016779|FG001|Overall Study|Other|0|||
163083875|NCT05654181|589016780|FG002|Overall Study|Other|0|||
163083876|NCT05654181|589016781|FG003|Overall Study|Other|0|||
163083877|NCT05654181|589016782|FG004|Overall Study|Other|1|||
163083878|NCT05654181|589016783|FG005|Overall Study|Other|1|||
162646348|NCT05071183|587422728|FG001|Overall Study|Death|2|||
162646349|NCT05071183|587422729|FG002|Overall Study|Death|0|||
162646350|NCT05071183|587422727|FG000|Overall Study|Other Reasons|1|||
162646351|NCT05071183|587422728|FG001|Overall Study|Other Reasons|3|||
163083879|NCT05654181|589016784|FG006|Overall Study|Other|0|||
163083880|NCT05654181|589016785|FG007|Overall Study|Other|0|||
163083881|NCT05654181|589016786|FG008|Overall Study|Other|0|||
163083882|NCT05654181|589016787|FG009|Overall Study|Other|0|||
163083883|NCT01397253|589016788|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
163083884|NCT01397253|589016789|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
163083885|NCT03033784|589016795|FG000|Overall Study|Anxiety related to MRI scanner|0|||
163083886|NCT03033784|589016796|FG001|Overall Study|Anxiety related to MRI scanner|1|||
163083887|NCT03033784|589016797|FG002|Overall Study|Anxiety related to MRI scanner|0|||
163083888|NCT03033784|589016798|FG003|Overall Study|Anxiety related to MRI scanner|0|||
163083889|NCT03033784|589016799|FG004|Overall Study|Anxiety related to MRI scanner|0|||
163083890|NCT03033784|589016800|FG005|Overall Study|Anxiety related to MRI scanner|0|||
163083891|NCT03033784|589016801|FG006|Overall Study|Anxiety related to MRI scanner|0|||
163083892|NCT03033784|589016802|FG007|Overall Study|Anxiety related to MRI scanner|0|||
163083893|NCT03033784|589016803|FG008|Overall Study|Anxiety related to MRI scanner|0|||
163083894|NCT03033784|589016804|FG009|Overall Study|Anxiety related to MRI scanner|0|||
163083895|NCT03033784|589016805|FG010|Overall Study|Anxiety related to MRI scanner|0|||
163083896|NCT03033784|589016806|FG011|Overall Study|Anxiety related to MRI scanner|0|||
163083897|NCT03033784|589016807|FG012|Overall Study|Anxiety related to MRI scanner|0|||
163083898|NCT03033784|589016795|FG000|Overall Study|Withdrawal by Subject|0|||
163083899|NCT03033784|589016796|FG001|Overall Study|Withdrawal by Subject|0|||
163083900|NCT03033784|589016797|FG002|Overall Study|Withdrawal by Subject|0|||
163083901|NCT03033784|589016798|FG003|Overall Study|Withdrawal by Subject|0|||
163083902|NCT03033784|589016799|FG004|Overall Study|Withdrawal by Subject|0|||
163083903|NCT03033784|589016800|FG005|Overall Study|Withdrawal by Subject|0|||
163083904|NCT03033784|589016801|FG006|Overall Study|Withdrawal by Subject|0|||
163083905|NCT03033784|589016802|FG007|Overall Study|Withdrawal by Subject|0|||
163083906|NCT03033784|589016803|FG008|Overall Study|Withdrawal by Subject|0|||
163083907|NCT03033784|589016804|FG009|Overall Study|Withdrawal by Subject|0|||
163083908|NCT03033784|589016805|FG010|Overall Study|Withdrawal by Subject|0|||
163083909|NCT03033784|589016806|FG011|Overall Study|Withdrawal by Subject|0|||
163083910|NCT03033784|589016807|FG012|Overall Study|Withdrawal by Subject|2|||
163083911|NCT00267488|589016808|FG000|Overall Study|Sponsor Terminated Study|9|||
163083912|NCT00267488|589016808|FG000|Overall Study|Protocol Violation|1|||
163083913|NCT00267488|589016808|FG000|Overall Study|Other (Disease Progression)|1|||
163083914|NCT02093520|589016809|FG000|Overall Study|Not treated|6|||
163083915|NCT02093520|589016810|FG001|Overall Study|Not treated|22|||
163083916|NCT00851084|589016811|FG000|Overall Study|Randomized but not treated|1|||
163083917|NCT00851084|589016812|FG001|Overall Study|Randomized but not treated|0|||
163083918|NCT00851084|589016811|FG000|Overall Study|Adverse Event|26|||
163083919|NCT00851084|589016812|FG001|Overall Study|Adverse Event|36|||
163083920|NCT00851084|589016811|FG000|Overall Study|Disease progression|52|||
163083921|NCT00851084|589016812|FG001|Overall Study|Disease progression|47|||
163083922|NCT00851084|589016811|FG000|Overall Study|Poor compliance to protocol|1|||
163083923|NCT00851084|589016812|FG001|Overall Study|Poor compliance to protocol|1|||
163083924|NCT00851084|589016811|FG000|Overall Study|Physician Decision|13|||
163083925|NCT00851084|589016812|FG001|Overall Study|Physician Decision|14|||
163083926|NCT00851084|589016811|FG000|Overall Study|Consent withdrawn|0|||
163083927|NCT00851084|589016812|FG001|Overall Study|Consent withdrawn|2|||
163083928|NCT00851084|589016811|FG000|Overall Study|Withdrawal by Subject|11|||
163083929|NCT00851084|589016812|FG001|Overall Study|Withdrawal by Subject|12|||
163083930|NCT00851084|589016811|FG000|Overall Study|Metastatic surgery|6|||
163083931|NCT00851084|589016812|FG001|Overall Study|Metastatic surgery|6|||
163083932|NCT00851084|589016811|FG000|Overall Study|Other|7|||
163083933|NCT00851084|589016812|FG001|Overall Study|Other|1|||
162646352|NCT05071183|587422729|FG002|Overall Study|Other Reasons|2|||
163083934|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163083935|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
163083936|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163083937|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
163083938|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
163083939|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
163083940|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
163083941|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
163083942|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
163083943|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083944|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162646353|NCT02046148|587422730|FG000|Overall Study|Lost to Follow-up|1|||
163083945|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
163083946|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083947|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083948|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083949|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083950|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163083951|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163083952|NCT01892189|589016815|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083953|NCT01892189|589016816|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083954|NCT01892189|589016817|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083955|NCT01892189|589016818|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083956|NCT01892189|589016819|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083957|NCT01892189|589016820|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
163083958|NCT01892189|589016821|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083959|NCT01892189|589016822|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083960|NCT01892189|589016823|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
163083961|NCT02263547|589016826|FG000|Overall Study|Adverse Event|1|||
163083962|NCT02263547|589016826|FG000|Overall Study|Lost to Follow-up|2|||
163083963|NCT02332928|589016827|FG000|Overall Study|Withdrawal by Subject|0|||
163083964|NCT02332928|589016828|FG001|Overall Study|Withdrawal by Subject|2|||
163083965|NCT02332928|589016827|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
163083966|NCT02332928|589016828|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
163083967|NCT01497197|589016829|FG000|Overall Study|Lost to Follow-up|1|||
163083968|NCT01497197|589016830|FG001|Overall Study|Lost to Follow-up|0|||
163083969|NCT01497197|589016829|FG000|Overall Study|Protocol Violation|0|||
163083970|NCT01497197|589016830|FG001|Overall Study|Protocol Violation|2|||
163083971|NCT01497197|589016829|FG000|Overall Study|Withdrawal by Subject|2|||
163083972|NCT01497197|589016830|FG001|Overall Study|Withdrawal by Subject|1|||
163083973|NCT01497197|589016829|FG000|Overall Study|Excessive/lack of response to treatment|1|||
163083974|NCT01497197|589016830|FG001|Overall Study|Excessive/lack of response to treatment|0|||
163083975|NCT01497197|589016829|FG000|Overall Study|Risk of OHSS|1|||
163083976|NCT01497197|589016830|FG001|Overall Study|Risk of OHSS|0|||
163083977|NCT01497197|589016829|FG000|Overall Study|No oocytes retrieved|3|||
163083978|NCT01497197|589016830|FG001|Overall Study|No oocytes retrieved|2|||
163083979|NCT01497197|589016829|FG000|Overall Study|No fertilisation|6|||
163083980|NCT01497197|589016830|FG001|Overall Study|No fertilisation|5|||
163083981|NCT01497197|589016829|FG000|Overall Study|Intention to freeze all embryos|0|||
163083982|NCT01497197|589016830|FG001|Overall Study|Intention to freeze all embryos|1|||
163083983|NCT01497197|589016829|FG000|Overall Study|All embryos discarded|0|||
163083984|NCT01497197|589016830|FG001|Overall Study|All embryos discarded|3|||
163083985|NCT01497197|589016829|FG000|Overall Study|Other|3|||
163083986|NCT01497197|589016830|FG001|Overall Study|Other|1|||
163083987|NCT01052779|589016832|FG000|Overall Study|Adverse Event|1|||
163083988|NCT01052779|589016833|FG001|Overall Study|Adverse Event|4|||
163083989|NCT01052779|589016832|FG000|Overall Study|Withdrawal by Subject|1|||
163083990|NCT01052779|589016833|FG001|Overall Study|Withdrawal by Subject|2|||
163083991|NCT01052779|589016832|FG000|Overall Study|Other-Protocol Violation|1|||
163083992|NCT01052779|589016833|FG001|Overall Study|Other-Protocol Violation|1|||
163083993|NCT01052779|589016832|FG000|Overall Study|Other-Surgery|0|||
163083994|NCT01052779|589016833|FG001|Overall Study|Other-Surgery|2|||
163083995|NCT01052779|589016832|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
163083996|NCT01052779|589016833|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
163083997|NCT03580044|589016834|FG000|Overall Study|Death|2|||
163083998|NCT03580044|589016835|FG001|Overall Study|Death|1|||
163083999|NCT03580044|589016834|FG000|Overall Study|Withdrawal by Subject|1|||
163084000|NCT03580044|589016835|FG001|Overall Study|Withdrawal by Subject|1|||
162646354|NCT02046148|587422731|FG001|Overall Study|Lost to Follow-up|1|||
163084001|NCT03524157|589016836|FG000|Overall Study|cytology not readable|0|||
163084002|NCT03524157|589016837|FG001|Overall Study|cytology not readable|0|||
163084003|NCT03524157|589016838|FG002|Overall Study|cytology not readable|1|||
163084004|NCT02743962|589016839|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
163084005|NCT02743962|589016840|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
163084006|NCT06582732|589016844|FG000|Initial Study Period|Adverse Event|0|||
163084007|NCT06582732|589016845|FG001|Initial Study Period|Adverse Event|0|||
162646355|NCT02046148|587422730|FG000|Overall Study|Withdrawal by Subject|0|||
162646356|NCT02046148|587422731|FG001|Overall Study|Withdrawal by Subject|2|||
163084008|NCT06582732|589016846|FG002|Initial Study Period|Adverse Event|0|||
163084009|NCT06582732|589016847|FG003|Initial Study Period|Adverse Event|2|||
163084010|NCT06582732|589016848|FG004|Initial Study Period|Adverse Event|0|||
163084011|NCT06582732|589016849|FG005|Initial Study Period|Adverse Event|0|||
163084012|NCT06582732|589016850|FG006|Initial Study Period|Adverse Event|0|||
163084013|NCT06582732|589016844|FG000|Initial Study Period|Death|1|||
163084014|NCT06582732|589016845|FG001|Initial Study Period|Death|0|||
163084015|NCT06582732|589016846|FG002|Initial Study Period|Death|0|||
162646357|NCT02939560|587422734|FG000|Overall Study|Withdrawal by Subject|2|||
163084016|NCT06582732|589016847|FG003|Initial Study Period|Death|0|||
163084017|NCT06582732|589016848|FG004|Initial Study Period|Death|1|||
163084018|NCT06582732|589016849|FG005|Initial Study Period|Death|0|||
163084019|NCT06582732|589016850|FG006|Initial Study Period|Death|0|||
163084020|NCT06582732|589016844|FG000|Initial Study Period|Lost to Follow-up|0|||
163084021|NCT06582732|589016845|FG001|Initial Study Period|Lost to Follow-up|0|||
163084022|NCT06582732|589016846|FG002|Initial Study Period|Lost to Follow-up|2|||
163084023|NCT06582732|589016847|FG003|Initial Study Period|Lost to Follow-up|0|||
163084024|NCT06582732|589016848|FG004|Initial Study Period|Lost to Follow-up|0|||
163084025|NCT06582732|589016849|FG005|Initial Study Period|Lost to Follow-up|0|||
163084026|NCT06582732|589016850|FG006|Initial Study Period|Lost to Follow-up|0|||
163084027|NCT06582732|589016844|FG000|Initial Study Period|Withdrawal by Subject|0|||
163084028|NCT06582732|589016845|FG001|Initial Study Period|Withdrawal by Subject|1|||
163084029|NCT06582732|589016846|FG002|Initial Study Period|Withdrawal by Subject|0|||
163084030|NCT06582732|589016847|FG003|Initial Study Period|Withdrawal by Subject|1|||
163084031|NCT06582732|589016848|FG004|Initial Study Period|Withdrawal by Subject|3|||
163084032|NCT06582732|589016849|FG005|Initial Study Period|Withdrawal by Subject|1|||
163084033|NCT06582732|589016850|FG006|Initial Study Period|Withdrawal by Subject|2|||
163084034|NCT06582732|589016844|FG000|Initial Study Period|Moved Away|0|||
163084035|NCT06582732|589016845|FG001|Initial Study Period|Moved Away|0|||
163084036|NCT06582732|589016846|FG002|Initial Study Period|Moved Away|0|||
163084037|NCT06582732|589016847|FG003|Initial Study Period|Moved Away|0|||
163084038|NCT06582732|589016848|FG004|Initial Study Period|Moved Away|1|||
163084039|NCT06582732|589016849|FG005|Initial Study Period|Moved Away|0|||
163084040|NCT06582732|589016850|FG006|Initial Study Period|Moved Away|0|||
163084041|NCT03931330|589016851|FG000|Overall Study|Physician Decision|1|||
163084042|NCT03412929|589016852|FG000|Overall Study|Protocol Violation|3|||
163084043|NCT01381679|589016857|FG000|Overall Study|Adverse Event|3|||
163084044|NCT01381679|589016857|FG000|Overall Study|Lost to Follow-up|885|||
163084045|NCT02135133|589016858|FG000|Overall Study|Adverse Event|10|||
163084046|NCT02135133|589016858|FG000|Overall Study|regulatory mandate|5|||
163084047|NCT03312543|589016869|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
163084048|NCT03312543|589016870|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
163084049|NCT03312543|589016869|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
163084050|NCT03312543|589016870|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
163084051|NCT03312543|589016869|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
163084052|NCT03312543|589016870|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
163084053|NCT03312543|589016869|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
163084054|NCT03312543|589016870|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
163084055|NCT03312543|589016869|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
163084056|NCT03312543|589016870|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
163084057|NCT03312543|589016869|FG000|Regression (Week 12 to Week 24)|Death|0|||
163084058|NCT03312543|589016870|FG001|Regression (Week 12 to Week 24)|Death|1|||
163084059|NCT04507269|589016871|FG000|Overall Study|Withdrawal by Subject|1|||
163084060|NCT04507269|589016872|FG001|Overall Study|Withdrawal by Subject|1|||
163084061|NCT04507269|589016873|FG002|Overall Study|Withdrawal by Subject|0|||
163084062|NCT04507269|589016874|FG003|Overall Study|Withdrawal by Subject|0|||
163084063|NCT04507269|589016875|FG004|Overall Study|Withdrawal by Subject|0|||
163084064|NCT04507269|589016876|FG005|Overall Study|Withdrawal by Subject|0|||
163084065|NCT04507269|589016871|FG000|Overall Study|Lost to Follow-up|0|||
163084066|NCT04507269|589016872|FG001|Overall Study|Lost to Follow-up|0|||
163084067|NCT04507269|589016873|FG002|Overall Study|Lost to Follow-up|0|||
163084068|NCT04507269|589016874|FG003|Overall Study|Lost to Follow-up|0|||
163084069|NCT04507269|589016875|FG004|Overall Study|Lost to Follow-up|1|||
163084070|NCT04507269|589016876|FG005|Overall Study|Lost to Follow-up|0|||
163084071|NCT05852340|589016877|FG000|Period 5|Not completing the meal|0|||
163084072|NCT05852340|589016878|FG001|Period 5|Not completing the meal|1|||
163084073|NCT05852340|589016879|FG002|Period 5|Not completing the meal|0|||
163084074|NCT05852340|589016880|FG003|Period 5|Not completing the meal|0|||
163084075|NCT05852340|589016877|FG000|Period 5|Adverse Event|0|||
163084076|NCT05852340|589016878|FG001|Period 5|Adverse Event|0|||
163084077|NCT05852340|589016879|FG002|Period 5|Adverse Event|0|||
163084078|NCT05852340|589016880|FG003|Period 5|Adverse Event|1|||
163084079|NCT00071032|589016883|FG000|Overall Study|Lost to Follow-up|1|||
163084080|NCT00071032|589016884|FG001|Overall Study|Lost to Follow-up|1|||
163084081|NCT00071032|589016883|FG000|Overall Study|Withdrawal by Subject|8|||
163084082|NCT00071032|589016884|FG001|Overall Study|Withdrawal by Subject|6|||
163084083|NCT00071032|589016883|FG000|Overall Study|Missing Primary Outcome|0|||
163084084|NCT00071032|589016884|FG001|Overall Study|Missing Primary Outcome|1|||
163084085|NCT04197583|589016885|FG000|Overall Study|Study Stent Replacement|34|||
163084086|NCT04197583|589016886|FG001|Overall Study|Study Stent Replacement|8|||
163084087|NCT04197583|589016885|FG000|Overall Study|Lost to Follow-up|14|||
163084088|NCT04197583|589016886|FG001|Overall Study|Lost to Follow-up|3|||
163084089|NCT04197583|589016885|FG000|Overall Study|Death|3|||
163084090|NCT04197583|589016886|FG001|Overall Study|Death|0|||
163084091|NCT04197583|589016885|FG000|Overall Study|Physician Decision|1|||
163084092|NCT04197583|589016886|FG001|Overall Study|Physician Decision|0|||
163084093|NCT04197583|589016885|FG000|Overall Study|Withdrawal by Subject|1|||
163084094|NCT04197583|589016886|FG001|Overall Study|Withdrawal by Subject|1|||
163084095|NCT04197583|589016885|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
163084096|NCT04197583|589016886|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
163084097|NCT04197583|589016885|FG000|Overall Study|Screen Failure|0|||
163084098|NCT04197583|589016886|FG001|Overall Study|Screen Failure|20|||
163084099|NCT04042311|589016893|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
163084100|NCT04042311|589016893|FG000|Overall Study|Unable to tolerate|4|||
163084101|NCT04042311|589016893|FG000|Overall Study|Concurrent illness|2|||
163084102|NCT04042311|589016893|FG000|Overall Study|Adverse Event|2|||
163084103|NCT04042311|589016893|FG000|Overall Study|No longer meeting inclusion criteria|2|||
163084104|NCT04042311|589016893|FG000|Overall Study|No reason given|1|||
163084105|NCT04042311|589016893|FG000|Overall Study|Withdrawal by Subject|4|||
163084106|NCT04134936|589016894|FG000|Overall Study|Adverse Event|3|||
163084107|NCT04134936|589016895|FG001|Overall Study|Adverse Event|2|||
163084108|NCT04134936|589016894|FG000|Overall Study|Withdrawal by Subject|2|||
163084109|NCT04134936|589016895|FG001|Overall Study|Withdrawal by Subject|3|||
163084110|NCT04134936|589016894|FG000|Overall Study|Physician Decision|0|||
163084111|NCT04134936|589016895|FG001|Overall Study|Physician Decision|1|||
163084112|NCT04134936|589016894|FG000|Overall Study|Progressive disease, joined another trial|1|||
163084113|NCT04134936|589016895|FG001|Overall Study|Progressive disease, joined another trial|0|||
163084114|NCT04134936|589016894|FG000|Overall Study|Progressive disease|1|||
163084115|NCT04134936|589016895|FG001|Overall Study|Progressive disease|0|||
163084116|NCT03518060|589016896|FG000|Overall Study|Death|1|||
163084117|NCT03518060|589016896|FG000|Overall Study|Poor adherence|1|||
163084118|NCT03518060|589016896|FG000|Overall Study|Withdrawal of informed consent|2|||
163084119|NCT03518060|589016896|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
163084120|NCT03518060|589016896|FG000|Overall Study|Physician Decision|7|||
163084121|NCT03518060|589016896|FG000|Overall Study|Adverse drug reactions|23|||
163084122|NCT03518060|589016896|FG000|Overall Study|Withdrawal by Subject|25|||
163084123|NCT03518060|589016896|FG000|Overall Study|Lost to Follow-up|13|||
163084124|NCT00323622|589016897|FG000|Overall Study|Other|30|||
163084125|NCT00323622|589016898|FG001|Overall Study|Other|91|||
163084126|NCT00323622|589016899|FG002|Overall Study|Other|4|||
163084127|NCT00323622|589016900|FG003|Overall Study|Other|12|||
163084128|NCT00323622|589016901|FG004|Overall Study|Other|32|||
163084129|NCT00323622|589016902|FG005|Overall Study|Other|74|||
163084130|NCT00323622|589016903|FG006|Overall Study|Other|5|||
163084131|NCT00323622|589016904|FG007|Overall Study|Other|13|||
163084132|NCT00323622|589016897|FG000|Overall Study|Death|1|||
163084133|NCT00323622|589016898|FG001|Overall Study|Death|1|||
163084134|NCT00323622|589016899|FG002|Overall Study|Death|0|||
163084135|NCT00323622|589016900|FG003|Overall Study|Death|0|||
163084136|NCT00323622|589016901|FG004|Overall Study|Death|7|||
163084137|NCT00323622|589016902|FG005|Overall Study|Death|0|||
163084138|NCT00323622|589016903|FG006|Overall Study|Death|0|||
163084139|NCT00323622|589016904|FG007|Overall Study|Death|2|||
163084140|NCT03709472|589016911|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
163084141|NCT03709472|589016912|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
163084142|NCT03709472|589016911|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
163084143|NCT03709472|589016912|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
163084144|NCT00112385|589016915|FG000|Overall Study|Lost to Follow-up|1|||
163084145|NCT00112385|589016916|FG001|Overall Study|Lost to Follow-up|0|||
163084146|NCT00112385|589016915|FG000|Overall Study|Withdrawal by Subject|0|||
163084147|NCT00112385|589016916|FG001|Overall Study|Withdrawal by Subject|1|||
163084148|NCT02613507|589016924|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
163084149|NCT02613507|589016925|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
163084150|NCT02613507|589016924|FG000|Pre-Treamtent|Participant withdrew consent|0|||
163084151|NCT02613507|589016925|FG001|Pre-Treamtent|Participant withdrew consent|4|||
163084152|NCT02613507|589016924|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
163084153|NCT02613507|589016925|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
163084154|NCT02613507|589016924|FG000|Treatment|Not reported|3|||
163084155|NCT02613507|589016925|FG001|Treatment|Not reported|0|||
163084156|NCT02613507|589016924|FG000|Treatment|Other reasons|8|||
163084157|NCT02613507|589016925|FG001|Treatment|Other reasons|0|||
163084158|NCT02613507|589016924|FG000|Treatment|Participant no longer meets criteria|3|||
163084159|NCT02613507|589016925|FG001|Treatment|Participant no longer meets criteria|0|||
163084160|NCT02613507|589016924|FG000|Treatment|Maximum clinical benefit|5|||
163084161|NCT02613507|589016925|FG001|Treatment|Maximum clinical benefit|10|||
163084162|NCT02613507|589016924|FG000|Treatment|Lost to Follow-up|1|||
163084163|NCT02613507|589016925|FG001|Treatment|Lost to Follow-up|0|||
163084164|NCT02613507|589016924|FG000|Treatment|Participant withdrew consent|0|||
163084165|NCT02613507|589016925|FG001|Treatment|Participant withdrew consent|2|||
163084166|NCT02613507|589016924|FG000|Treatment|Participant request to discontinue study treatment|13|||
163084167|NCT02613507|589016925|FG001|Treatment|Participant request to discontinue study treatment|17|||
163084168|NCT02613507|589016924|FG000|Treatment|Adverse event unrelated to study drug|20|||
163084169|NCT02613507|589016925|FG001|Treatment|Adverse event unrelated to study drug|3|||
163084170|NCT02613507|589016924|FG000|Treatment|Death|2|||
163084171|NCT02613507|589016925|FG001|Treatment|Death|0|||
163084172|NCT02613507|589016924|FG000|Treatment|Study drug toxicity|19|||
163084173|NCT02613507|589016925|FG001|Treatment|Study drug toxicity|14|||
163084174|NCT02613507|589016924|FG000|Treatment|Disease progression|263|||
163084175|NCT02613507|589016925|FG001|Treatment|Disease progression|110|||
163084176|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
163084177|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
163084178|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
163084179|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
163084180|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
163084181|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
163084182|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
163084183|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
163084184|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
163084185|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
163084186|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
163084187|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084188|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084189|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084190|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
163084191|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084192|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084193|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084194|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084195|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084196|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084197|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
163084198|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084199|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084200|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
163084201|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084202|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084203|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084204|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084205|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084206|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084207|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084208|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
163084209|NCT02471144|589018419|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
163084210|NCT02471144|589018420|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
163084211|NCT02471144|589018421|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084212|NCT02471144|589018422|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084213|NCT02471144|589018423|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084214|NCT02471144|589018424|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084215|NCT02471144|589018425|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084216|NCT02471144|589018426|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084217|NCT02471144|589018427|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084218|NCT02471144|589018428|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084219|NCT02471144|589018429|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
163084220|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084221|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084222|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084223|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084224|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084225|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084226|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084227|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084228|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
163084229|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084230|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
163084231|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084232|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084233|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084234|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084235|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084236|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
163084237|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084238|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
162646358|NCT02939560|587422734|FG000|Overall Study|Protocol Violation|1|||
162646359|NCT03340025|587422735|FG000|Overall Study|Lost to Follow-up|2|||
162646360|NCT03340025|587422736|FG001|Overall Study|Lost to Follow-up|2|||
162646361|NCT02420691|587422737|FG000|Overall Study|Adverse Event|3|||
162646362|NCT02420691|587422737|FG000|Overall Study|Withdrawal by Subject|3|||
162646363|NCT01852812|587422738|FG000|Overall Study|Adverse Event|0|||
162646364|NCT01852812|587422739|FG001|Overall Study|Adverse Event|0|||
162646365|NCT01852812|587422740|FG002|Overall Study|Adverse Event|1|||
162646366|NCT01852812|587422738|FG000|Overall Study|Non-compliance With Study Drug|0|||
162646367|NCT01852812|587422739|FG001|Overall Study|Non-compliance With Study Drug|1|||
162646368|NCT01852812|587422740|FG002|Overall Study|Non-compliance With Study Drug|0|||
162646369|NCT01293240|587422744|FG000|Overall Study|Noncompliance|2|||
162646370|NCT01520363|587422745|FG000|Overall Study|Withdrawal by Subject|2|||
162646371|NCT01520363|587422746|FG001|Overall Study|Withdrawal by Subject|0|||
162646372|NCT03165110|587422750|FG000|Overall Study|Anroid phone software incompatibility|1|||
162646373|NCT01498952|587422751|FG000|Overall Study|Death|2|||
162646374|NCT01498952|587422752|FG001|Overall Study|Death|2|||
162646375|NCT01498952|587422753|FG002|Overall Study|Death|0|||
162646376|NCT01498952|587422754|FG003|Overall Study|Death|0|||
162646377|NCT01498952|587422755|FG004|Overall Study|Death|0|||
162646378|NCT05533632|587422756|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
162646379|NCT05533632|587422756|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
162646380|NCT05533632|587422756|FG000|Overall Study|Lost to Follow-up|1|||
162646381|NCT05533632|587422756|FG000|Overall Study|Withdrawal by Subject|4|||
162646382|NCT05533632|587422756|FG000|Overall Study|Adverse Event|4|||
162646383|NCT00304356|587422757|FG000|Nitazoxanide|Physician Decision|5|||
162646384|NCT00304356|587422757|FG000|Nitazoxanide|Physician Decision|1|||
162646385|NCT00304356|587422757|FG000|Nitazoxanide|number is 0|1|||
162646386|NCT00304356|587422757|FG000|Nitazoxanide|Physician Decision|1|||
162646387|NCT00304356|587422757|FG000|Nitazoxanide|Physician Decision|1|||
162646388|NCT00304356|587422757|FG000|Nitazoxanide|Physician Decision|1|||
162646389|NCT00973479|587422760|FG000|Overall Study|Lost to Follow-up|0|||
163084239|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
163084240|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084241|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
163084242|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084243|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084244|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084245|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084246|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084247|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084248|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084249|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084250|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
163084251|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084252|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
163084253|NCT02471144|589018419|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084254|NCT02471144|589018420|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084255|NCT02471144|589018421|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084256|NCT02471144|589018422|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084257|NCT02471144|589018423|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084258|NCT02471144|589018424|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084259|NCT02471144|589018425|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084260|NCT02471144|589018426|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
162646390|NCT00973479|587422761|FG001|Overall Study|Lost to Follow-up|3|||
162646391|NCT00973479|587422760|FG000|Overall Study|Death|2|||
163084261|NCT02471144|589018427|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
163084262|NCT02471144|589018428|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084263|NCT02471144|589018429|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
163084264|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084265|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084266|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084267|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084268|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
162646392|NCT00973479|587422761|FG001|Overall Study|Death|2|||
162646393|NCT00973479|587422760|FG000|Overall Study|Withdrawal by Subject|15|||
162646394|NCT00973479|587422761|FG001|Overall Study|Withdrawal by Subject|16|||
162646395|NCT00973479|587422760|FG000|Overall Study|Lack of Efficacy|5|||
163084269|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084270|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084271|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084272|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
163084273|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
163084274|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
163084275|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084276|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084277|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084278|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084279|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084280|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084281|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084282|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084283|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084284|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
163084285|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
163084286|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084287|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084288|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084289|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084290|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084291|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084292|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084293|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084294|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084295|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
163084296|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
163084297|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084298|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084299|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084300|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084301|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084302|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084303|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084304|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084305|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
163084306|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
163084307|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
163084308|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084309|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084310|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084311|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084312|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084313|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084314|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084315|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084316|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084317|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
163084318|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
163084319|NCT02471144|589018419|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084320|NCT02471144|589018420|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084321|NCT02471144|589018421|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084322|NCT02471144|589018422|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084323|NCT02471144|589018423|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084324|NCT02471144|589018424|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084325|NCT02471144|589018425|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084326|NCT02471144|589018426|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084327|NCT02471144|589018427|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
163084328|NCT02471144|589018428|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
163084329|NCT02471144|589018429|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
163084330|NCT03977155|589018434|FG000|Overall Study|Adverse Event|3|||
163084331|NCT03977155|589018435|FG001|Overall Study|Adverse Event|0|||
163084332|NCT03977155|589018436|FG002|Overall Study|Adverse Event|0|||
163084333|NCT03977155|589018434|FG000|Overall Study|Lost to Follow-up|0|||
163084334|NCT03977155|589018435|FG001|Overall Study|Lost to Follow-up|1|||
163084335|NCT03977155|589018436|FG002|Overall Study|Lost to Follow-up|0|||
163084336|NCT03977155|589018434|FG000|Overall Study|Withdrawal by Subject|1|||
163084337|NCT03977155|589018435|FG001|Overall Study|Withdrawal by Subject|1|||
163084338|NCT03977155|589018436|FG002|Overall Study|Withdrawal by Subject|2|||
163084339|NCT03977155|589018434|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
163084340|NCT03977155|589018435|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
163084341|NCT03977155|589018436|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
163084342|NCT00936936|589018437|FG000|Overall Study|Adverse Event|7|||
163084343|NCT00936936|589018438|FG001|Overall Study|Adverse Event|1|||
163084344|NCT00936936|589018437|FG000|Overall Study|Disease Progression|2|||
163084345|NCT00936936|589018438|FG001|Overall Study|Disease Progression|2|||
163084346|NCT00936936|589018437|FG000|Overall Study|Unrelated|3|||
163084347|NCT00936936|589018438|FG001|Overall Study|Unrelated|1|||
163084348|NCT03440385|589018448|FG000|Overall Study|Other Reason|4|||
163084349|NCT03440385|589018449|FG001|Overall Study|Other Reason|1|||
163084350|NCT03440385|589018448|FG000|Overall Study|Site Closed|1|||
163084351|NCT03440385|589018449|FG001|Overall Study|Site Closed|0|||
163084352|NCT03440385|589018448|FG000|Overall Study|Lost to Follow-up|2|||
163084353|NCT03440385|589018449|FG001|Overall Study|Lost to Follow-up|0|||
163084354|NCT03440385|589018448|FG000|Overall Study|Withdrawal by Subject|12|||
163084355|NCT03440385|589018449|FG001|Overall Study|Withdrawal by Subject|6|||
163084356|NCT03440385|589018448|FG000|Overall Study|Lack of Efficacy|9|||
163084357|NCT03440385|589018449|FG001|Overall Study|Lack of Efficacy|2|||
163084358|NCT03440385|589018448|FG000|Overall Study|Adverse Event|15|||
163084359|NCT03440385|589018449|FG001|Overall Study|Adverse Event|11|||
163084360|NCT00488293|589018450|FG000|Overall Study|Lost to Follow-up|28|||
163084361|NCT00488293|589018451|FG001|Overall Study|Lost to Follow-up|25|||
163084362|NCT00488293|589018450|FG000|Overall Study|Withdrawal by Subject|5|||
163084363|NCT00488293|589018451|FG001|Overall Study|Withdrawal by Subject|3|||
163084364|NCT00488293|589018450|FG000|Overall Study|Death|2|||
163084365|NCT00488293|589018451|FG001|Overall Study|Death|1|||
163084366|NCT00488293|589018450|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
163084367|NCT00488293|589018451|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
163084368|NCT00939185|589018452|FG000|Overall Study|Adverse Event|3|||
163084369|NCT00939185|589018452|FG000|Overall Study|Lack of Efficacy|1|||
163084370|NCT00939185|589018452|FG000|Overall Study|Lost to Follow-up|6|||
163084371|NCT00939185|589018452|FG000|Overall Study|Other|3|||
163084372|NCT00939185|589018452|FG000|Overall Study|Withdrawal by Subject|2|||
163084373|NCT00939185|589018452|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
163084374|NCT00363298|589018453|FG000|First Study Week|Lack of Efficacy|6|||
163084375|NCT00363298|589018454|FG001|First Study Week|Lack of Efficacy|5|||
163084376|NCT00363298|589018453|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
163084377|NCT00363298|589018454|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
163084378|NCT02374255|589018455|FG000|Overall Study|Withdrawal by Subject|2|||
163084379|NCT02374255|589018456|FG001|Overall Study|Withdrawal by Subject|0|||
163084380|NCT02374255|589018457|FG002|Overall Study|Withdrawal by Subject|0|||
163084381|NCT02374255|589018458|FG003|Overall Study|Withdrawal by Subject|0|||
163084382|NCT00730327|589018459|FG000|Overall Study|Lost to Follow-up|14|||
163084383|NCT00730327|589018460|FG001|Overall Study|Lost to Follow-up|16|||
163084384|NCT00730327|589018459|FG000|Overall Study|Adverse Event|8|||
163084385|NCT00730327|589018460|FG001|Overall Study|Adverse Event|1|||
163084386|NCT00730327|589018459|FG000|Overall Study|Withdrawal by Subject|3|||
163084387|NCT00730327|589018460|FG001|Overall Study|Withdrawal by Subject|13|||
163084388|NCT00730327|589018459|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
163084389|NCT00730327|589018460|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
163084390|NCT00095576|589018461|FG000|Overall Study|Adverse Event|5|||
163084391|NCT00095576|589018462|FG001|Overall Study|Adverse Event|3|||
163084392|NCT00095576|589018461|FG000|Overall Study|Lost to Follow-up|233|||
163084393|NCT00095576|589018462|FG001|Overall Study|Lost to Follow-up|229|||
163084394|NCT00095576|589018461|FG000|Overall Study|Protocol Violation|1|||
163084395|NCT00095576|589018462|FG001|Overall Study|Protocol Violation|0|||
163084396|NCT00095576|589018461|FG000|Overall Study|Withdrawal by Subject|34|||
163084397|NCT00095576|589018462|FG001|Overall Study|Withdrawal by Subject|47|||
163084398|NCT00095576|589018461|FG000|Overall Study|Option to switch to a rollover study|1097|||
163084399|NCT00095576|589018462|FG001|Overall Study|Option to switch to a rollover study|1099|||
163084400|NCT00095576|589018461|FG000|Overall Study|Site terminated|75|||
163084401|NCT00095576|589018462|FG001|Overall Study|Site terminated|67|||
163084402|NCT00095576|589018461|FG000|Overall Study|Subject moved|30|||
163084403|NCT00095576|589018462|FG001|Overall Study|Subject moved|36|||
163084404|NCT01425814|589018465|FG000|Period 1|Stability criteria not fulfilled|0|||
163084405|NCT01425814|589018466|FG001|Period 1|Stability criteria not fulfilled|1|||
163084406|NCT01425814|589018467|FG002|Period 1|Stability criteria not fulfilled|0|||
163084407|NCT01425814|589018468|FG003|Period 1|Stability criteria not fulfilled|0|||
163084408|NCT01425814|589018469|FG004|Period 1|Stability criteria not fulfilled|0|||
163084409|NCT01425814|589018470|FG005|Period 1|Stability criteria not fulfilled|0|||
163084410|NCT01425814|589018465|FG000|Period 2|Stability criteria not fulfilled|0|||
163084411|NCT01425814|589018466|FG001|Period 2|Stability criteria not fulfilled|1|||
163084412|NCT01425814|589018467|FG002|Period 2|Stability criteria not fulfilled|0|||
163084413|NCT01425814|589018468|FG003|Period 2|Stability criteria not fulfilled|0|||
163084414|NCT01425814|589018469|FG004|Period 2|Stability criteria not fulfilled|0|||
163084415|NCT01425814|589018470|FG005|Period 2|Stability criteria not fulfilled|0|||
163084416|NCT01425814|589018465|FG000|Period 3|Adverse Event|0|||
163084417|NCT01425814|589018466|FG001|Period 3|Adverse Event|0|||
162646396|NCT00973479|587422761|FG001|Overall Study|Lack of Efficacy|7|||
162646397|NCT00973479|587422760|FG000|Overall Study|Adverse Event|12|||
162646398|NCT00973479|587422761|FG001|Overall Study|Adverse Event|32|||
162646399|NCT00973479|587422760|FG000|Overall Study|Protocol Violation|2|||
162646400|NCT00973479|587422761|FG001|Overall Study|Protocol Violation|2|||
162646401|NCT00973479|587422760|FG000|Overall Study|Other|1|||
162646402|NCT00973479|587422761|FG001|Overall Study|Other|7|||
162646403|NCT05075850|587422762|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
162646404|NCT04256785|587422763|FG000|Overall Study|Adverse Event|8|||
162646405|NCT04256785|587422764|FG001|Overall Study|Adverse Event|6|||
162646406|NCT04256785|587422763|FG000|Overall Study|Lack of Efficacy|3|||
162646407|NCT04256785|587422764|FG001|Overall Study|Lack of Efficacy|4|||
162646408|NCT04256785|587422763|FG000|Overall Study|Lost to Follow-up|7|||
162646409|NCT04256785|587422764|FG001|Overall Study|Lost to Follow-up|7|||
162646410|NCT04256785|587422763|FG000|Overall Study|Protocol Violation|1|||
162646411|NCT04256785|587422764|FG001|Overall Study|Protocol Violation|0|||
162646412|NCT04256785|587422763|FG000|Overall Study|Withdrawal by Subject|4|||
162646413|NCT04256785|587422764|FG001|Overall Study|Withdrawal by Subject|1|||
162646414|NCT04256785|587422763|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
162646415|NCT04256785|587422764|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
162646416|NCT01265849|587422765|FG000|Overall Study|Randomized//Treatment not initiated|1|||
162646417|NCT01265849|587422766|FG001|Overall Study|Randomized//Treatment not initiated|4|||
162646418|NCT01265849|587422767|FG002|Overall Study|Randomized//Treatment not initiated|0|||
162646419|NCT01265849|587422765|FG000|Overall Study|Physician Decision|1|||
162646420|NCT01265849|587422766|FG001|Overall Study|Physician Decision|2|||
162646421|NCT01265849|587422767|FG002|Overall Study|Physician Decision|0|||
162646422|NCT01265849|587422765|FG000|Overall Study|Lost to Follow-up|18|||
162646423|NCT01265849|587422766|FG001|Overall Study|Lost to Follow-up|15|||
162646424|NCT01265849|587422767|FG002|Overall Study|Lost to Follow-up|5|||
162646425|NCT01265849|587422765|FG000|Overall Study|Not otherwise specified|1|||
162646426|NCT01265849|587422766|FG001|Overall Study|Not otherwise specified|6|||
162646427|NCT01265849|587422767|FG002|Overall Study|Not otherwise specified|1|||
162646428|NCT01265849|587422765|FG000|Overall Study|Withdrawal by Subject|25|||
162646429|NCT01265849|587422766|FG001|Overall Study|Withdrawal by Subject|34|||
162646430|NCT01265849|587422767|FG002|Overall Study|Withdrawal by Subject|13|||
162646431|NCT01154218|587422768|FG000|Third Intervention Period|Adverse Event|0|||
163084418|NCT01425814|589018467|FG002|Period 3|Adverse Event|0|||
163084419|NCT01425814|589018468|FG003|Period 3|Adverse Event|0|||
163084420|NCT01425814|589018469|FG004|Period 3|Adverse Event|0|||
163084421|NCT01425814|589018470|FG005|Period 3|Adverse Event|1|||
163084422|NCT01425814|589018465|FG000|Period 4|Adverse Event|1|||
163084423|NCT01425814|589018466|FG001|Period 4|Adverse Event|0|||
163084424|NCT01425814|589018467|FG002|Period 4|Adverse Event|1|||
163084425|NCT01425814|589018468|FG003|Period 4|Adverse Event|0|||
162646432|NCT01154218|587422769|FG001|Third Intervention Period|Adverse Event|1|||
162646433|NCT01154218|587422770|FG002|Third Intervention Period|Adverse Event|0|||
163084426|NCT01425814|589018469|FG004|Period 4|Adverse Event|0|||
163084427|NCT01425814|589018470|FG005|Period 4|Adverse Event|0|||
163084428|NCT01425814|589018465|FG000|Period 5|Stability criteria not fulfilled|0|||
163084429|NCT01425814|589018466|FG001|Period 5|Stability criteria not fulfilled|0|||
163084430|NCT01425814|589018467|FG002|Period 5|Stability criteria not fulfilled|1|||
162646434|NCT01154218|587422771|FG003|Third Intervention Period|Adverse Event|0|||
162646435|NCT01154218|587422768|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162646436|NCT01154218|587422769|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162646437|NCT01154218|587422770|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
163084431|NCT01425814|589018468|FG003|Period 5|Stability criteria not fulfilled|0|||
163084432|NCT01425814|589018469|FG004|Period 5|Stability criteria not fulfilled|0|||
163084433|NCT01425814|589018470|FG005|Period 5|Stability criteria not fulfilled|1|||
162646438|NCT01154218|587422771|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
162646439|NCT01154218|587422768|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
163084434|NCT01358734|589018471|FG000|Overall Study|Adverse Event|4|||
163084435|NCT01358734|589018472|FG001|Overall Study|Adverse Event|7|||
163084436|NCT01358734|589018473|FG002|Overall Study|Adverse Event|3|||
163084437|NCT01358734|589018471|FG000|Overall Study|Lack of Efficacy|0|||
163084438|NCT01358734|589018472|FG001|Overall Study|Lack of Efficacy|1|||
163084439|NCT01358734|589018473|FG002|Overall Study|Lack of Efficacy|3|||
163084440|NCT01358734|589018471|FG000|Overall Study|Withdrawal by Subject|1|||
163084441|NCT01358734|589018472|FG001|Overall Study|Withdrawal by Subject|6|||
163084442|NCT01358734|589018473|FG002|Overall Study|Withdrawal by Subject|3|||
163084443|NCT01358734|589018471|FG000|Overall Study|Death|3|||
163084444|NCT01358734|589018472|FG001|Overall Study|Death|7|||
163084445|NCT01358734|589018473|FG002|Overall Study|Death|2|||
163084446|NCT01358734|589018471|FG000|Overall Study|Progressive Disease|5|||
163084447|NCT01358734|589018472|FG001|Overall Study|Progressive Disease|13|||
163084448|NCT01358734|589018473|FG002|Overall Study|Progressive Disease|16|||
163084449|NCT01358734|589018471|FG000|Overall Study|Non-compliance with study drug|0|||
163084450|NCT01358734|589018472|FG001|Overall Study|Non-compliance with study drug|0|||
163084451|NCT01358734|589018473|FG002|Overall Study|Non-compliance with study drug|1|||
163084452|NCT01358734|589018471|FG000|Overall Study|Other|2|||
163084453|NCT01358734|589018472|FG001|Overall Study|Other|5|||
163084454|NCT01358734|589018473|FG002|Overall Study|Other|4|||
163084455|NCT01358734|589018471|FG000|Overall Study|Protocol Violation|0|||
163084456|NCT01358734|589018472|FG001|Overall Study|Protocol Violation|0|||
163084457|NCT01358734|589018473|FG002|Overall Study|Protocol Violation|2|||
163084458|NCT03427619|589018476|FG000|Overall Study|Physician Decision|3|||
163084459|NCT03427619|589018476|FG000|Overall Study|Withdrawal by Subject|4|||
163084460|NCT03427619|589018476|FG000|Overall Study|Lost to Follow-up|5|||
163084461|NCT03427619|589018476|FG000|Overall Study|Administrative|4|||
163084462|NCT03427619|589018476|FG000|Overall Study|Other|2|||
163084463|NCT03427619|589018476|FG000|Overall Study|Unknown or Missing Completion Status|48|||
163084464|NCT01055028|589018485|FG000|Screening|Screen Failure|1|||
163084465|NCT01055028|589018486|FG001|Screening|Screen Failure|1|||
163084466|NCT01055028|589018485|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
163084467|NCT01055028|589018486|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
163084468|NCT01055028|589018485|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
163084469|NCT01055028|589018486|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
163084470|NCT01055028|589018485|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
163084471|NCT01055028|589018486|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
163084472|NCT02919618|589018490|FG000|Overall Study|Death|1|||
163084473|NCT03528902|589018491|FG000|Overall Study|Adverse Event|1|||
163084474|NCT03528902|589018492|FG001|Overall Study|Adverse Event|0|||
163084475|NCT03411044|589018493|FG000|Overall Study|Death|30|||
163084476|NCT03411044|589018493|FG000|Overall Study|Withdrawal by Subject|48|||
163084477|NCT03411044|589018493|FG000|Overall Study|Lost to Follow-up|78|||
163084478|NCT03411044|589018493|FG000|Overall Study|Adverse Event|30|||
163084479|NCT03411044|589018493|FG000|Overall Study|Missing status|4|||
163084480|NCT04620668|589018494|FG000|Overall Study|Withdrawal by Subject|2|||
163084481|NCT04620668|589018495|FG001|Overall Study|Withdrawal by Subject|0|||
163084482|NCT04620668|589018494|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
163084483|NCT04620668|589018495|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
163084484|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: missing data|2|||
163084485|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: missing data|0|||
163084486|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
163084487|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
163084488|NCT04620668|589018494|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
163084489|NCT04620668|589018495|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
163084490|NCT00427700|589018502|FG000|Overall Study|Lost to Follow-up|2|||
163084491|NCT00427700|589018503|FG001|Overall Study|Lost to Follow-up|5|||
163084492|NCT00427700|589018502|FG000|Overall Study|no induction of menses|1|||
163084493|NCT00427700|589018503|FG001|Overall Study|no induction of menses|4|||
163084494|NCT00427700|589018502|FG000|Overall Study|Pregnancy|0|||
163084495|NCT00427700|589018503|FG001|Overall Study|Pregnancy|2|||
163084496|NCT04581395|589018504|FG000|Overall Study|Protocol Violation|4|||
163084497|NCT04581395|589018505|FG001|Overall Study|Protocol Violation|3|||
163084498|NCT04581395|589018506|FG002|Overall Study|Protocol Violation|2|||
163084499|NCT04581395|589018504|FG000|Overall Study|Physician Decision|0|||
163084500|NCT04581395|589018505|FG001|Overall Study|Physician Decision|1|||
163084501|NCT04581395|589018506|FG002|Overall Study|Physician Decision|0|||
163084502|NCT00815633|589018511|FG000|Overall Study|study terminated|1|||
163084503|NCT02259231|589018515|FG000|Overall Study|Adverse Event|1|||
163084504|NCT02259231|589018516|FG001|Overall Study|Adverse Event|1|||
163084505|NCT02259231|589018517|FG002|Overall Study|Adverse Event|2|||
163084506|NCT02259231|589018518|FG003|Overall Study|Adverse Event|0|||
163084507|NCT02259231|589018519|FG004|Overall Study|Adverse Event|0|||
163084508|NCT02259231|589018520|FG005|Overall Study|Adverse Event|0|||
163084509|NCT02259231|589018521|FG006|Overall Study|Adverse Event|0|||
163084510|NCT02259231|589018515|FG000|Overall Study|Progressive Disease|4|||
163084511|NCT02259231|589018516|FG001|Overall Study|Progressive Disease|5|||
163084512|NCT02259231|589018517|FG002|Overall Study|Progressive Disease|4|||
163084513|NCT02259231|589018518|FG003|Overall Study|Progressive Disease|5|||
163084514|NCT02259231|589018519|FG004|Overall Study|Progressive Disease|4|||
163084515|NCT02259231|589018520|FG005|Overall Study|Progressive Disease|5|||
163084516|NCT02259231|589018521|FG006|Overall Study|Progressive Disease|4|||
163084517|NCT02259231|589018515|FG000|Overall Study|Sponsor termination of study|1|||
163084518|NCT02259231|589018516|FG001|Overall Study|Sponsor termination of study|0|||
163084519|NCT02259231|589018517|FG002|Overall Study|Sponsor termination of study|0|||
163084520|NCT02259231|589018518|FG003|Overall Study|Sponsor termination of study|1|||
163084521|NCT02259231|589018519|FG004|Overall Study|Sponsor termination of study|2|||
163084522|NCT02259231|589018520|FG005|Overall Study|Sponsor termination of study|1|||
163084523|NCT02259231|589018521|FG006|Overall Study|Sponsor termination of study|1|||
163084524|NCT03238196|589018522|FG000|Overall Study|Adverse Event|3|||
163084525|NCT03238196|589018523|FG001|Overall Study|Adverse Event|0|||
163084526|NCT03238196|589018524|FG002|Overall Study|Adverse Event|2|||
163084527|NCT03238196|589018525|FG003|Overall Study|Adverse Event|2|||
163084528|NCT03238196|589018522|FG000|Overall Study|Withdrawal by Subject|4|||
163084529|NCT03238196|589018523|FG001|Overall Study|Withdrawal by Subject|1|||
163084530|NCT03238196|589018524|FG002|Overall Study|Withdrawal by Subject|1|||
163084531|NCT03238196|589018525|FG003|Overall Study|Withdrawal by Subject|0|||
163084532|NCT03238196|589018522|FG000|Overall Study|Disease progression|14|||
163084533|NCT03238196|589018523|FG001|Overall Study|Disease progression|2|||
163084534|NCT03238196|589018524|FG002|Overall Study|Disease progression|3|||
163084535|NCT03238196|589018525|FG003|Overall Study|Disease progression|2|||
163084536|NCT03238196|589018522|FG000|Overall Study|Still on treatment|1|||
163084537|NCT03238196|589018523|FG001|Overall Study|Still on treatment|0|||
163084538|NCT03238196|589018524|FG002|Overall Study|Still on treatment|0|||
163084539|NCT03238196|589018525|FG003|Overall Study|Still on treatment|0|||
163084540|NCT05081843|589018526|FG000|Overall Study|Lost to Follow-up|135|||
163084541|NCT05081843|589018527|FG001|Overall Study|Lost to Follow-up|145|||
163084542|NCT04629196|589018528|FG000|Overall Study|Subject discontinued study drug|1|||
163084543|NCT04629196|589018529|FG001|Overall Study|Subject discontinued study drug|0|||
163084544|NCT04629196|589018528|FG000|Overall Study|Subject study drug dosing increased|1|||
163084545|NCT04629196|589018529|FG001|Overall Study|Subject study drug dosing increased|1|||
163084546|NCT04629196|589018528|FG000|Overall Study|Withdrawal by Subject|1|||
163084547|NCT04629196|589018529|FG001|Overall Study|Withdrawal by Subject|2|||
163084548|NCT00835354|589018533|FG000|First Intervention|Adverse Event|0|||
163084549|NCT00835354|589018534|FG001|First Intervention|Adverse Event|1|||
163084550|NCT02061085|589018535|FG000|Overall Study|Adverse Event|8|||
163084551|NCT05487378|589018536|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
163084552|NCT05487378|589018537|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
163084553|NCT05487378|589018536|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
163084554|NCT05487378|589018537|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
163084555|NCT01385995|589018539|FG000|Period 1, 2 Months|Physician Decision|1|||
163084556|NCT01385995|589018540|FG001|Period 1, 2 Months|Physician Decision|0|||
163084557|NCT02414841|589018541|FG000|Overall Study|Withdrawal by Subject|7|||
163084558|NCT02414841|589018542|FG001|Overall Study|Withdrawal by Subject|5|||
163084559|NCT02414841|589018541|FG000|Overall Study|Lost to Follow-up|13|||
163084560|NCT02414841|589018542|FG001|Overall Study|Lost to Follow-up|6|||
163084561|NCT02414841|589018541|FG000|Overall Study|Death|17|||
163084562|NCT02414841|589018542|FG001|Overall Study|Death|14|||
163084563|NCT02414841|589018541|FG000|Overall Study|Received a Kidney Transplant|13|||
163084564|NCT02414841|589018542|FG001|Overall Study|Received a Kidney Transplant|4|||
163084565|NCT02414841|589018541|FG000|Overall Study|Randomized But Not Treated|6|||
163084566|NCT02414841|589018542|FG001|Overall Study|Randomized But Not Treated|4|||
163084567|NCT03164356|589018547|FG000|Overall Study|Lost to Follow-up|1|||
163084568|NCT03164356|589018548|FG001|Overall Study|Lost to Follow-up|1|||
163084569|NCT03164356|589018549|FG002|Overall Study|Lost to Follow-up|2|||
163084570|NCT03164356|589018550|FG003|Overall Study|Lost to Follow-up|1|||
162646440|NCT01154218|587422769|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
163084571|NCT03164356|589018547|FG000|Overall Study|Physician Decision|0|||
163084572|NCT03164356|589018548|FG001|Overall Study|Physician Decision|0|||
163084573|NCT03164356|589018549|FG002|Overall Study|Physician Decision|3|||
163084574|NCT03164356|589018550|FG003|Overall Study|Physician Decision|0|||
162646441|NCT01154218|587422770|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
163084575|NCT03164356|589018547|FG000|Overall Study|Protocol Violation|2|||
163084576|NCT03164356|589018548|FG001|Overall Study|Protocol Violation|1|||
163084577|NCT03164356|589018549|FG002|Overall Study|Protocol Violation|0|||
163084578|NCT03164356|589018550|FG003|Overall Study|Protocol Violation|0|||
163084579|NCT03164356|589018547|FG000|Overall Study|Withdrawal by Subject|1|||
163084580|NCT03164356|589018548|FG001|Overall Study|Withdrawal by Subject|0|||
163084581|NCT03164356|589018549|FG002|Overall Study|Withdrawal by Subject|0|||
163084582|NCT03164356|589018550|FG003|Overall Study|Withdrawal by Subject|0|||
163084583|NCT03164356|589018547|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
163084584|NCT03164356|589018548|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
163084585|NCT03164356|589018549|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
163084586|NCT03164356|589018550|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
163084587|NCT03164356|589018547|FG000|Overall Study|Subject Incarcerated|0|||
163084588|NCT03164356|589018548|FG001|Overall Study|Subject Incarcerated|1|||
163084589|NCT03164356|589018549|FG002|Overall Study|Subject Incarcerated|0|||
163084590|NCT03164356|589018550|FG003|Overall Study|Subject Incarcerated|0|||
163084591|NCT03164356|589018547|FG000|Overall Study|Prosthetist unable to participate|0|||
163084592|NCT03164356|589018548|FG001|Overall Study|Prosthetist unable to participate|2|||
163084593|NCT03164356|589018549|FG002|Overall Study|Prosthetist unable to participate|1|||
163084594|NCT03164356|589018550|FG003|Overall Study|Prosthetist unable to participate|0|||
163084595|NCT03648372|589018553|FG000|Overall Study|Withdrawal by Subject|2|||
163084596|NCT03648372|589018554|FG001|Overall Study|Withdrawal by Subject|0|||
163084597|NCT03648372|589018555|FG002|Overall Study|Withdrawal by Subject|0|||
163084598|NCT03648372|589018556|FG003|Overall Study|Withdrawal by Subject|0|||
163084599|NCT03648372|589018557|FG004|Overall Study|Withdrawal by Subject|0|||
163084600|NCT03648372|589018558|FG005|Overall Study|Withdrawal by Subject|1|||
163084601|NCT03648372|589018559|FG006|Overall Study|Withdrawal by Subject|2|||
163084602|NCT03648372|589018560|FG007|Overall Study|Withdrawal by Subject|0|||
163084603|NCT03648372|589018561|FG008|Overall Study|Withdrawal by Subject|0|||
163084604|NCT03648372|589018562|FG009|Overall Study|Withdrawal by Subject|0|||
163084605|NCT03648372|589018563|FG010|Overall Study|Withdrawal by Subject|2|||
163084606|NCT03648372|589018564|FG011|Overall Study|Withdrawal by Subject|0|||
163084607|NCT03648372|589018565|FG012|Overall Study|Withdrawal by Subject|2|||
163084608|NCT03648372|589018566|FG013|Overall Study|Withdrawal by Subject|0|||
163084609|NCT03648372|589018567|FG014|Overall Study|Withdrawal by Subject|0|||
163084610|NCT03648372|589018568|FG015|Overall Study|Withdrawal by Subject|0|||
163084611|NCT03648372|589018569|FG016|Overall Study|Withdrawal by Subject|1|||
163084612|NCT03648372|589018570|FG017|Overall Study|Withdrawal by Subject|0|||
163084613|NCT03648372|589018571|FG018|Overall Study|Withdrawal by Subject|0|||
163084614|NCT03648372|589018572|FG019|Overall Study|Withdrawal by Subject|0|||
163084615|NCT03648372|589018573|FG020|Overall Study|Withdrawal by Subject|0|||
163084616|NCT03648372|589018553|FG000|Overall Study|Progressive Disease|2|||
163084617|NCT03648372|589018554|FG001|Overall Study|Progressive Disease|3|||
163084618|NCT03648372|589018555|FG002|Overall Study|Progressive Disease|4|||
163084619|NCT03648372|589018556|FG003|Overall Study|Progressive Disease|3|||
163084620|NCT03648372|589018557|FG004|Overall Study|Progressive Disease|2|||
163084621|NCT03648372|589018558|FG005|Overall Study|Progressive Disease|2|||
163084622|NCT03648372|589018559|FG006|Overall Study|Progressive Disease|3|||
163084623|NCT03648372|589018560|FG007|Overall Study|Progressive Disease|3|||
163084624|NCT03648372|589018561|FG008|Overall Study|Progressive Disease|5|||
163084625|NCT03648372|589018562|FG009|Overall Study|Progressive Disease|5|||
163084626|NCT03648372|589018563|FG010|Overall Study|Progressive Disease|2|||
163084627|NCT03648372|589018564|FG011|Overall Study|Progressive Disease|3|||
163084628|NCT03648372|589018565|FG012|Overall Study|Progressive Disease|3|||
163084629|NCT03648372|589018566|FG013|Overall Study|Progressive Disease|3|||
163084630|NCT03648372|589018567|FG014|Overall Study|Progressive Disease|6|||
163084631|NCT03648372|589018568|FG015|Overall Study|Progressive Disease|0|||
162646442|NCT01154218|587422771|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
162646443|NCT00362115|587422772|FG000|Overall Study|Adverse Event|0|||
162646444|NCT00362115|587422773|FG001|Overall Study|Adverse Event|1|||
162646445|NCT00362115|587422774|FG002|Overall Study|Adverse Event|1|||
162646446|NCT00362115|587422775|FG003|Overall Study|Adverse Event|1|||
162646447|NCT00362115|587422776|FG004|Overall Study|Adverse Event|2|||
162646448|NCT00362115|587422777|FG005|Overall Study|Adverse Event|2|||
162646449|NCT00362115|587422778|FG006|Overall Study|Adverse Event|1|||
162646450|NCT00362115|587422772|FG000|Overall Study|Protocol Violation|0|||
162646451|NCT00362115|587422773|FG001|Overall Study|Protocol Violation|0|||
162646452|NCT00362115|587422774|FG002|Overall Study|Protocol Violation|0|||
162646453|NCT00362115|587422775|FG003|Overall Study|Protocol Violation|0|||
163084632|NCT03648372|589018569|FG016|Overall Study|Progressive Disease|0|||
163084633|NCT03648372|589018570|FG017|Overall Study|Progressive Disease|0|||
163084634|NCT03648372|589018571|FG018|Overall Study|Progressive Disease|0|||
163084635|NCT03648372|589018572|FG019|Overall Study|Progressive Disease|0|||
163084636|NCT03648372|589018573|FG020|Overall Study|Progressive Disease|0|||
163084637|NCT03648372|589018553|FG000|Overall Study|Other|0|||
163084638|NCT03648372|589018554|FG001|Overall Study|Other|0|||
163084639|NCT03648372|589018555|FG002|Overall Study|Other|0|||
163084640|NCT03648372|589018556|FG003|Overall Study|Other|0|||
163084641|NCT03648372|589018557|FG004|Overall Study|Other|1|||
163084642|NCT03648372|589018558|FG005|Overall Study|Other|0|||
163084643|NCT03648372|589018559|FG006|Overall Study|Other|0|||
163084644|NCT03648372|589018560|FG007|Overall Study|Other|0|||
163084645|NCT03648372|589018561|FG008|Overall Study|Other|0|||
163084646|NCT03648372|589018562|FG009|Overall Study|Other|0|||
163084647|NCT03648372|589018563|FG010|Overall Study|Other|1|||
163084648|NCT03648372|589018564|FG011|Overall Study|Other|2|||
163084649|NCT03648372|589018565|FG012|Overall Study|Other|1|||
163084650|NCT03648372|589018566|FG013|Overall Study|Other|3|||
163084651|NCT03648372|589018567|FG014|Overall Study|Other|0|||
163084652|NCT03648372|589018568|FG015|Overall Study|Other|5|||
163084653|NCT03648372|589018569|FG016|Overall Study|Other|1|||
163084654|NCT03648372|589018570|FG017|Overall Study|Other|5|||
163084655|NCT03648372|589018571|FG018|Overall Study|Other|0|||
163084656|NCT03648372|589018572|FG019|Overall Study|Other|1|||
163084657|NCT03648372|589018573|FG020|Overall Study|Other|0|||
163084658|NCT03648372|589018553|FG000|Overall Study|Lost to Follow-up|0|||
163084659|NCT03648372|589018554|FG001|Overall Study|Lost to Follow-up|0|||
163084660|NCT03648372|589018555|FG002|Overall Study|Lost to Follow-up|0|||
163084661|NCT03648372|589018556|FG003|Overall Study|Lost to Follow-up|0|||
163084662|NCT03648372|589018557|FG004|Overall Study|Lost to Follow-up|0|||
163084663|NCT03648372|589018558|FG005|Overall Study|Lost to Follow-up|0|||
163084664|NCT03648372|589018559|FG006|Overall Study|Lost to Follow-up|0|||
163084665|NCT03648372|589018560|FG007|Overall Study|Lost to Follow-up|0|||
163084666|NCT03648372|589018561|FG008|Overall Study|Lost to Follow-up|0|||
163084667|NCT03648372|589018562|FG009|Overall Study|Lost to Follow-up|0|||
163084668|NCT03648372|589018563|FG010|Overall Study|Lost to Follow-up|0|||
163084669|NCT03648372|589018564|FG011|Overall Study|Lost to Follow-up|0|||
163084670|NCT03648372|589018565|FG012|Overall Study|Lost to Follow-up|0|||
163084671|NCT03648372|589018566|FG013|Overall Study|Lost to Follow-up|1|||
163084672|NCT03648372|589018567|FG014|Overall Study|Lost to Follow-up|0|||
163084673|NCT03648372|589018568|FG015|Overall Study|Lost to Follow-up|1|||
163084674|NCT03648372|589018569|FG016|Overall Study|Lost to Follow-up|0|||
163084675|NCT03648372|589018570|FG017|Overall Study|Lost to Follow-up|1|||
163084676|NCT03648372|589018571|FG018|Overall Study|Lost to Follow-up|0|||
163084677|NCT03648372|589018572|FG019|Overall Study|Lost to Follow-up|0|||
163084678|NCT03648372|589018573|FG020|Overall Study|Lost to Follow-up|0|||
163084679|NCT03648372|589018553|FG000|Overall Study|Start of a New Systemic Treatment|0|||
163084680|NCT03648372|589018554|FG001|Overall Study|Start of a New Systemic Treatment|0|||
163084681|NCT03648372|589018555|FG002|Overall Study|Start of a New Systemic Treatment|0|||
163084682|NCT03648372|589018556|FG003|Overall Study|Start of a New Systemic Treatment|0|||
163084683|NCT03648372|589018557|FG004|Overall Study|Start of a New Systemic Treatment|0|||
163084684|NCT03648372|589018558|FG005|Overall Study|Start of a New Systemic Treatment|0|||
163084685|NCT03648372|589018559|FG006|Overall Study|Start of a New Systemic Treatment|0|||
163084686|NCT03648372|589018560|FG007|Overall Study|Start of a New Systemic Treatment|2|||
163084687|NCT03648372|589018561|FG008|Overall Study|Start of a New Systemic Treatment|0|||
163084688|NCT03648372|589018562|FG009|Overall Study|Start of a New Systemic Treatment|0|||
163084689|NCT03648372|589018563|FG010|Overall Study|Start of a New Systemic Treatment|1|||
163084690|NCT03648372|589018564|FG011|Overall Study|Start of a New Systemic Treatment|0|||
163084691|NCT03648372|589018565|FG012|Overall Study|Start of a New Systemic Treatment|0|||
163084692|NCT03648372|589018566|FG013|Overall Study|Start of a New Systemic Treatment|0|||
163084693|NCT03648372|589018567|FG014|Overall Study|Start of a New Systemic Treatment|0|||
163084694|NCT03648372|589018568|FG015|Overall Study|Start of a New Systemic Treatment|0|||
163084695|NCT03648372|589018569|FG016|Overall Study|Start of a New Systemic Treatment|0|||
163084696|NCT03648372|589018570|FG017|Overall Study|Start of a New Systemic Treatment|0|||
163084697|NCT03648372|589018571|FG018|Overall Study|Start of a New Systemic Treatment|0|||
163084698|NCT03648372|589018572|FG019|Overall Study|Start of a New Systemic Treatment|0|||
163084699|NCT03648372|589018573|FG020|Overall Study|Start of a New Systemic Treatment|0|||
162646454|NCT00362115|587422776|FG004|Overall Study|Protocol Violation|0|||
163084700|NCT03332056|589020230|FG000|Overall Study|Incomplete questionnaires|8|||
163084701|NCT03332056|589020231|FG001|Overall Study|Incomplete questionnaires|9|||
163084702|NCT03332056|589020230|FG000|Overall Study|Passed stone prior to surgery date|1|||
163084703|NCT03332056|589020231|FG001|Overall Study|Passed stone prior to surgery date|0|||
163084704|NCT03332056|589020230|FG000|Overall Study|Did not require a ureteral stent|0|||
163084705|NCT03332056|589020231|FG001|Overall Study|Did not require a ureteral stent|1|||
163084706|NCT03360344|589020234|FG000|Overall Study|Withdrawal by Subject|0|||
163084707|NCT03360344|589020235|FG001|Overall Study|Withdrawal by Subject|1|||
163084708|NCT03360344|589020236|FG002|Overall Study|Withdrawal by Subject|1|||
163084709|NCT00133705|589020241|FG000|Overall Study|Withdrawal by Subject|2|||
163084710|NCT00133705|589020242|FG001|Overall Study|Withdrawal by Subject|3|||
163084711|NCT00959049|589020243|FG000|Overall Study|Adverse Event|1|||
163084712|NCT00959049|589020244|FG001|Overall Study|Adverse Event|0|||
163084713|NCT00959049|589020245|FG002|Overall Study|Adverse Event|0|||
163084714|NCT00959049|589020246|FG003|Overall Study|Adverse Event|0|||
163084715|NCT00959049|589020247|FG004|Overall Study|Adverse Event|0|||
163084716|NCT00959049|589020248|FG005|Overall Study|Adverse Event|0|||
163084717|NCT00959049|589020243|FG000|Overall Study|Lost to Follow-up|17|||
163084718|NCT00959049|589020244|FG001|Overall Study|Lost to Follow-up|5|||
163084719|NCT00959049|589020245|FG002|Overall Study|Lost to Follow-up|1|||
163084720|NCT00959049|589020246|FG003|Overall Study|Lost to Follow-up|10|||
163084721|NCT00959049|589020247|FG004|Overall Study|Lost to Follow-up|9|||
163084722|NCT00959049|589020248|FG005|Overall Study|Lost to Follow-up|1|||
163084723|NCT00959049|589020243|FG000|Overall Study|Contraindicated medication|0|||
163084724|NCT00959049|589020244|FG001|Overall Study|Contraindicated medication|0|||
163084725|NCT00959049|589020245|FG002|Overall Study|Contraindicated medication|0|||
163084726|NCT00959049|589020246|FG003|Overall Study|Contraindicated medication|1|||
163084727|NCT00959049|589020247|FG004|Overall Study|Contraindicated medication|0|||
163084728|NCT00959049|589020248|FG005|Overall Study|Contraindicated medication|0|||
163084729|NCT00959049|589020243|FG000|Overall Study|Withdrawal by Subject|0|||
163084730|NCT00959049|589020244|FG001|Overall Study|Withdrawal by Subject|2|||
163084731|NCT00959049|589020245|FG002|Overall Study|Withdrawal by Subject|0|||
163084732|NCT00959049|589020246|FG003|Overall Study|Withdrawal by Subject|0|||
163084733|NCT00959049|589020247|FG004|Overall Study|Withdrawal by Subject|0|||
163084734|NCT00959049|589020248|FG005|Overall Study|Withdrawal by Subject|0|||
163084735|NCT00688740|589020256|FG000|Overall Study|Adverse Event|45|||
163084736|NCT00688740|589020257|FG001|Overall Study|Adverse Event|8|||
163084737|NCT00688740|589020256|FG000|Overall Study|Death|2|||
163084738|NCT00688740|589020257|FG001|Overall Study|Death|2|||
163084739|NCT00688740|589020256|FG000|Overall Study|Lost to Follow-up|0|||
163084740|NCT00688740|589020257|FG001|Overall Study|Lost to Follow-up|1|||
163084741|NCT00688740|589020256|FG000|Overall Study|Consent Withdrawn|17|||
163084742|NCT00688740|589020257|FG001|Overall Study|Consent Withdrawn|17|||
163084743|NCT00688740|589020256|FG000|Overall Study|Breast Cancer Relapse|1|||
163084744|NCT00688740|589020257|FG001|Overall Study|Breast Cancer Relapse|4|||
163084745|NCT00688740|589020256|FG000|Overall Study|Violation of Inclusion Criteria|1|||
163084746|NCT00688740|589020257|FG001|Overall Study|Violation of Inclusion Criteria|3|||
163084747|NCT04484857|589020258|FG000|Overall Study|Adverse Event|2|||
163084748|NCT04484857|589020258|FG000|Overall Study|Death|10|||
163084749|NCT04484857|589020258|FG000|Overall Study|Withdrawal by Subject|3|||
163084750|NCT04484857|589020258|FG000|Overall Study|Transferred/Relocation|5|||
163084751|NCT04484857|589020258|FG000|Overall Study|Kidney Transplant|7|||
163084752|NCT04484857|589020258|FG000|Overall Study|Other than specified|4|||
163084753|NCT04484857|589020258|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
163084754|NCT00565747|589020259|FG000|Overall Study|No embryo transfer|67|||
163084755|NCT00565747|589020260|FG001|Overall Study|No embryo transfer|73|||
163084756|NCT04507204|589020261|FG000|Overall Study|Adverse Event|8|||
163084757|NCT04507204|589020262|FG001|Overall Study|Adverse Event|13|||
163084758|NCT04507204|589020261|FG000|Overall Study|Death|0|||
163084759|NCT04507204|589020262|FG001|Overall Study|Death|1|||
163084760|NCT04507204|589020261|FG000|Overall Study|Lost to Follow-up|15|||
163084761|NCT04507204|589020262|FG001|Overall Study|Lost to Follow-up|14|||
163084762|NCT04507204|589020261|FG000|Overall Study|Poor Compliance with Protocol|2|||
163084763|NCT04507204|589020262|FG001|Overall Study|Poor Compliance with Protocol|4|||
163084764|NCT04507204|589020261|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
163084765|NCT04507204|589020262|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
163084766|NCT04507204|589020261|FG000|Overall Study|Withdrawal of Patient Consent|21|||
163084767|NCT04507204|589020262|FG001|Overall Study|Withdrawal of Patient Consent|13|||
163084768|NCT01206517|589020263|FG000|Overall Study|Withdrawal by Subject|0|||
163084769|NCT01206517|589020264|FG001|Overall Study|Withdrawal by Subject|0|||
163084770|NCT01206517|589020265|FG002|Overall Study|Withdrawal by Subject|2|||
163084771|NCT01206517|589020266|FG003|Overall Study|Withdrawal by Subject|0|||
163084772|NCT01206517|589020267|FG004|Overall Study|Withdrawal by Subject|1|||
163084773|NCT01206517|589020268|FG005|Overall Study|Withdrawal by Subject|0|||
163084774|NCT01905540|589020271|FG000|Period 3|Other|1|||
163084775|NCT01905540|589020272|FG001|Period 3|Other|0|||
163084776|NCT01905540|589020273|FG002|Period 3|Other|1|||
163084777|NCT01905540|589020274|FG003|Period 3|Other|1|||
163084778|NCT03729609|589020275|FG000|Overall Study|Protocol Violation|1|||
163084779|NCT04770285|589020278|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
163084780|NCT04770285|589020279|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
163084781|NCT04770285|589020278|FG000|Overall Study|Lack of Efficacy|0|||
163084782|NCT04770285|589020279|FG001|Overall Study|Lack of Efficacy|1|||
163084783|NCT04770285|589020278|FG000|Overall Study|Lost to Follow-up|11|||
163084784|NCT04770285|589020279|FG001|Overall Study|Lost to Follow-up|8|||
163084785|NCT04770285|589020278|FG000|Overall Study|Protocol Deviation|6|||
163084786|NCT04770285|589020279|FG001|Overall Study|Protocol Deviation|6|||
163084787|NCT04770285|589020278|FG000|Overall Study|Technical Problem|0|||
163084788|NCT04770285|589020279|FG001|Overall Study|Technical Problem|1|||
163084789|NCT04770285|589020278|FG000|Overall Study|Withdrawal by Subject|9|||
163084790|NCT04770285|589020279|FG001|Overall Study|Withdrawal by Subject|8|||
163084791|NCT04770285|589020278|FG000|Overall Study|Reason Not Specified|0|||
163084792|NCT04770285|589020279|FG001|Overall Study|Reason Not Specified|1|||
163084793|NCT00645658|589020280|FG000|Overall Study|Withdrawal by Subject|1|||
163084794|NCT00645658|589020281|FG001|Overall Study|Withdrawal by Subject|0|||
163084795|NCT00645658|589020280|FG000|Overall Study|Did not complete all assesments|0|||
162646455|NCT00362115|587422777|FG005|Overall Study|Protocol Violation|1|||
162646456|NCT00362115|587422778|FG006|Overall Study|Protocol Violation|0|||
162646457|NCT00362115|587422772|FG000|Overall Study|Lost to Follow-up|0|||
162646458|NCT00362115|587422773|FG001|Overall Study|Lost to Follow-up|1|||
162646459|NCT00362115|587422774|FG002|Overall Study|Lost to Follow-up|0|||
162646460|NCT00362115|587422775|FG003|Overall Study|Lost to Follow-up|0|||
162646461|NCT00362115|587422776|FG004|Overall Study|Lost to Follow-up|2|||
162646462|NCT00362115|587422777|FG005|Overall Study|Lost to Follow-up|0|||
162646463|NCT00362115|587422778|FG006|Overall Study|Lost to Follow-up|1|||
162646464|NCT00362115|587422772|FG000|Overall Study|Withdrawal by Subject|1|||
162646465|NCT00362115|587422773|FG001|Overall Study|Withdrawal by Subject|3|||
162646466|NCT00362115|587422774|FG002|Overall Study|Withdrawal by Subject|1|||
162646467|NCT00362115|587422775|FG003|Overall Study|Withdrawal by Subject|0|||
162646468|NCT00362115|587422776|FG004|Overall Study|Withdrawal by Subject|1|||
162646469|NCT00362115|587422777|FG005|Overall Study|Withdrawal by Subject|3|||
162646470|NCT00362115|587422778|FG006|Overall Study|Withdrawal by Subject|4|||
162646471|NCT00362115|587422772|FG000|Overall Study|Lack of Efficacy|1|||
162646472|NCT00362115|587422773|FG001|Overall Study|Lack of Efficacy|0|||
162646473|NCT00362115|587422774|FG002|Overall Study|Lack of Efficacy|5|||
162646474|NCT00362115|587422775|FG003|Overall Study|Lack of Efficacy|2|||
162646475|NCT00362115|587422776|FG004|Overall Study|Lack of Efficacy|2|||
162646476|NCT00362115|587422777|FG005|Overall Study|Lack of Efficacy|0|||
162646477|NCT00362115|587422778|FG006|Overall Study|Lack of Efficacy|3|||
162646478|NCT00362115|587422772|FG000|Overall Study|Physician Decision|0|||
162646479|NCT00362115|587422773|FG001|Overall Study|Physician Decision|0|||
162646480|NCT00362115|587422774|FG002|Overall Study|Physician Decision|0|||
162646481|NCT00362115|587422775|FG003|Overall Study|Physician Decision|0|||
162646482|NCT00362115|587422776|FG004|Overall Study|Physician Decision|0|||
162646483|NCT00362115|587422777|FG005|Overall Study|Physician Decision|0|||
162646484|NCT00362115|587422778|FG006|Overall Study|Physician Decision|3|||
162646485|NCT00362115|587422772|FG000|Overall Study|Other|0|||
162646486|NCT00362115|587422773|FG001|Overall Study|Other|1|||
162646487|NCT00362115|587422774|FG002|Overall Study|Other|0|||
162646488|NCT00362115|587422775|FG003|Overall Study|Other|1|||
162646489|NCT00362115|587422776|FG004|Overall Study|Other|0|||
163084796|NCT00645658|589020281|FG001|Overall Study|Did not complete all assesments|2|||
163084797|NCT02457065|589020288|FG000|Overall Study|Lost to Follow-up|9|||
163084798|NCT02457065|589020289|FG001|Overall Study|Lost to Follow-up|11|||
163084799|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
163084800|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084801|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084802|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084803|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084804|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084805|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163084806|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
163084807|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
163084808|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
163084809|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
163084810|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
163084811|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
163084812|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
163084813|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
163084814|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
163084815|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
163084816|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
163084817|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
163084818|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
163084819|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
163084820|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
162646490|NCT00362115|587422777|FG005|Overall Study|Other|1|||
162646491|NCT00362115|587422778|FG006|Overall Study|Other|0|||
163084821|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
163084822|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
162646492|NCT01170091|587422779|FG000|Overall Study|Missing efficacy evaluation|3|||
162646493|NCT01170091|587422779|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
162646494|NCT03194321|587422780|FG000|Overall Study|Withdrawal by Subject|1|||
162717914|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162646495|NCT03194321|587422780|FG000|Overall Study|Lost to Follow-up|1|||
162646496|NCT03194321|587422780|FG000|Overall Study|Travel for Follow-up|1|||
162646497|NCT02188589|587422781|FG000|Overall Study|Withdrawal by Subject|5|||
162646498|NCT00003641|587422789|FG000|Overall Study|Withdrawal by Subject|0|||
162646499|NCT00003641|587422790|FG001|Overall Study|Withdrawal by Subject|100|||
162646500|NCT00003641|587422789|FG000|Overall Study|Adverse Event|0|||
162646501|NCT00003641|587422790|FG001|Overall Study|Adverse Event|38|||
162646502|NCT00003641|587422789|FG000|Overall Study|Disease progression|0|||
162646503|NCT00003641|587422790|FG001|Overall Study|Disease progression|2|||
162646504|NCT00003641|587422789|FG000|Overall Study|Unknown/missing|0|||
162646505|NCT00003641|587422790|FG001|Overall Study|Unknown/missing|22|||
162646506|NCT00003641|587422789|FG000|Overall Study|Should not receive interferon therapy|2|||
162646507|NCT00003641|587422790|FG001|Overall Study|Should not receive interferon therapy|0|||
162646508|NCT00003641|587422789|FG000|Overall Study|Never started interferon|567|||
162646509|NCT00003641|587422790|FG001|Overall Study|Never started interferon|12|||
162646510|NCT00741039|587422794|FG000|Overall Study|Patient non-compliance|2|||
162646511|NCT00741039|587422795|FG001|Overall Study|Patient non-compliance|0|||
162646512|NCT00878709|587422796|FG000|Overall Study|Withdrawal by Subject|197|||
162646513|NCT00878709|587422797|FG001|Overall Study|Withdrawal by Subject|120|||
162646514|NCT00878709|587422796|FG000|Overall Study|Lost to Follow-up|35|||
162646515|NCT00878709|587422797|FG001|Overall Study|Lost to Follow-up|33|||
162646516|NCT00878709|587422796|FG000|Overall Study|Other Reasons|93|||
162646517|NCT00878709|587422797|FG001|Overall Study|Other Reasons|84|||
162646518|NCT00768300|587422798|FG000|Overall Study|Randomized but not treated|1|||
162646519|NCT00768300|587422799|FG001|Overall Study|Randomized but not treated|1|||
162646520|NCT00768300|587422798|FG000|Overall Study|Adverse Event|10|||
162646521|NCT00768300|587422799|FG001|Overall Study|Adverse Event|2|||
162646522|NCT00768300|587422798|FG000|Overall Study|Protocol Violation|6|||
162646523|NCT00768300|587422799|FG001|Overall Study|Protocol Violation|1|||
162646524|NCT00768300|587422798|FG000|Overall Study|Withdrawal by Subject|13|||
163084823|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
163084824|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
163084825|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
163084826|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
163084827|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
163084828|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
163084829|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
163084830|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
163084831|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
163084832|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
163084833|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
163084834|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
163084835|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
163084836|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
163084837|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
163084838|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
163084839|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
163084840|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
163084841|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
163084842|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084843|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084844|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084845|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084846|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084847|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
163084848|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084849|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
163084850|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084851|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084852|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084853|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084854|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
163084855|NCT01362790|589020290|FG000|Pilot Phase & Phase 2|Death on study|0|||
163084856|NCT01362790|589020291|FG001|Pilot Phase & Phase 2|Death on study|0|||
163084857|NCT01362790|589020292|FG002|Pilot Phase & Phase 2|Death on study|0|||
163084858|NCT01362790|589020293|FG003|Pilot Phase & Phase 2|Death on study|1|||
162646525|NCT00768300|587422799|FG001|Overall Study|Withdrawal by Subject|7|||
162646526|NCT00768300|587422798|FG000|Overall Study|Physician Decision|2|||
162646527|NCT00768300|587422799|FG001|Overall Study|Physician Decision|3|||
163084859|NCT01362790|589020294|FG004|Pilot Phase & Phase 2|Death on study|0|||
163084860|NCT01362790|589020295|FG005|Pilot Phase & Phase 2|Death on study|0|||
162646528|NCT00768300|587422798|FG000|Overall Study|Study discontinued by Sponsor|271|||
162646529|NCT00768300|587422799|FG001|Overall Study|Study discontinued by Sponsor|140|||
162646530|NCT00768300|587422798|FG000|Overall Study|Death|21|||
162646531|NCT00768300|587422799|FG001|Overall Study|Death|5|||
163084861|NCT01362790|589020296|FG006|Pilot Phase & Phase 2|Death on study|0|||
163084862|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
163084863|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
162646532|NCT00768300|587422798|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
162646533|NCT00768300|587422799|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
162646534|NCT00768300|587422798|FG000|Overall Study|Screen failure following randomization|1|||
162646535|NCT00768300|587422799|FG001|Overall Study|Screen failure following randomization|0|||
162646536|NCT00768300|587422798|FG000|Overall Study|Received lung transplant|1|||
162646537|NCT00768300|587422799|FG001|Overall Study|Received lung transplant|1|||
162646538|NCT00768300|587422798|FG000|Overall Study|Lost to Follow-up|0|||
162646539|NCT00768300|587422799|FG001|Overall Study|Lost to Follow-up|1|||
162646540|NCT00768300|587422798|FG000|Overall Study|Began prohibited concomitant medication|0|||
162646541|NCT00768300|587422799|FG001|Overall Study|Began prohibited concomitant medication|1|||
162646542|NCT00768300|587422798|FG000|Overall Study|Treated but never dosed with Study drug|1|||
162646543|NCT00768300|587422799|FG001|Overall Study|Treated but never dosed with Study drug|0|||
162717915|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162717916|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
163084864|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
163084865|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
163084866|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
163084867|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
162717917|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
163084868|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
163084869|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084870|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084871|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084872|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
162717918|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162717919|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162717920|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717921|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163084873|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
163084874|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084875|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
163084876|NCT01362790|589020290|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
163084877|NCT01362790|589020291|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
163084878|NCT01362790|589020292|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
163084879|NCT01362790|589020293|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
163084880|NCT01362790|589020294|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
163084881|NCT01362790|589020295|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
163084882|NCT01362790|589020296|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
163084883|NCT03038087|589020297|FG000|Overall Study|lost data|1|||
163084884|NCT00654355|589020298|FG000|Overall Study|Lost to Follow-up|2|||
163084885|NCT00654355|589020299|FG001|Overall Study|Lost to Follow-up|2|||
163084886|NCT01435356|589020301|FG000|Overall Study|Adverse Event|2|||
163084887|NCT01435356|589020302|FG001|Overall Study|Adverse Event|0|||
163084888|NCT01435356|589020301|FG000|Overall Study|Disease progression/recurrence|17|||
163084889|NCT01435356|589020302|FG001|Overall Study|Disease progression/recurrence|10|||
163084890|NCT01435356|589020301|FG000|Overall Study|Protocol Violation|0|||
163084891|NCT01435356|589020302|FG001|Overall Study|Protocol Violation|1|||
163084892|NCT01435356|589020301|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
163084893|NCT01435356|589020302|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
163084894|NCT01435356|589020301|FG000|Overall Study|Withdrawal by Subject|1|||
163084895|NCT01435356|589020302|FG001|Overall Study|Withdrawal by Subject|1|||
163084896|NCT01435356|589020301|FG000|Overall Study|Facial palsy|1|||
163084897|NCT01435356|589020302|FG001|Overall Study|Facial palsy|0|||
163084898|NCT01435356|589020301|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
163084899|NCT01435356|589020302|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
163084900|NCT01435356|589020301|FG000|Overall Study|Physician Decision|1|||
163084901|NCT01435356|589020302|FG001|Overall Study|Physician Decision|0|||
163084902|NCT01435356|589020301|FG000|Overall Study|Patient decision|3|||
163084903|NCT01435356|589020302|FG001|Overall Study|Patient decision|0|||
163084904|NCT01435356|589020301|FG000|Overall Study|Patient moved to another city|1|||
163084905|NCT01435356|589020302|FG001|Overall Study|Patient moved to another city|1|||
163084906|NCT02796651|589020303|FG000|Overall Study|Adverse Event|6|||
163084907|NCT02796651|589020303|FG000|Overall Study|Lost to Follow-up|1|||
163084908|NCT02796651|589020303|FG000|Overall Study|Withdrawal by Subject|4|||
163084909|NCT02796651|589020303|FG000|Overall Study|Protocol Violation|4|||
163084910|NCT02796651|589020303|FG000|Overall Study|Lack of Efficacy|1|||
163084911|NCT02796651|589020303|FG000|Overall Study|Other|10|||
163084912|NCT05360784|589020304|FG000|Overall Study|Discontinued|25|||
163084913|NCT05360784|589020305|FG001|Overall Study|Discontinued|11|||
162646544|NCT00768300|587422798|FG000|Overall Study|Missing data|1|||
162646545|NCT00768300|587422799|FG001|Overall Study|Missing data|0|||
162646546|NCT02068222|587422800|FG000|Overall Study|Lost to Follow-up|1|||
162646547|NCT01374087|587422803|FG000|Overall Study|Adverse Event|1|||
163084914|NCT00437073|589020306|FG000|Overall Study|Sponsor Terminated Study|1|||
163084915|NCT00437073|589020307|FG001|Overall Study|Sponsor Terminated Study|0|||
163084916|NCT00437073|589020306|FG000|Overall Study|Physician Decision|0|||
163084917|NCT00437073|589020307|FG001|Overall Study|Physician Decision|1|||
163084918|NCT03485157|589020308|FG000|Double Blind Phase|Lost to Follow-up|4|||
163084919|NCT03485157|589020309|FG001|Double Blind Phase|Lost to Follow-up|4|||
163084920|NCT03485157|589020308|FG000|Double Blind Phase|Adverse Event|2|||
163084921|NCT03485157|589020309|FG001|Double Blind Phase|Adverse Event|1|||
163084922|NCT03485157|589020308|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163084923|NCT03485157|589020309|FG001|Double Blind Phase|Withdrawal by Subject|9|||
163084924|NCT03485157|589020308|FG000|Double Blind Phase|Removal by PI|3|||
163084925|NCT03485157|589020309|FG001|Double Blind Phase|Removal by PI|7|||
163084926|NCT03485157|589020308|FG000|Open Label Phase|Lost to Follow-up|1|||
163084927|NCT03485157|589020309|FG001|Open Label Phase|Lost to Follow-up|2|||
163084928|NCT03485157|589020308|FG000|Open Label Phase|Adverse Event|0|||
163084929|NCT03485157|589020309|FG001|Open Label Phase|Adverse Event|1|||
163084930|NCT03485157|589020308|FG000|Open Label Phase|Withdrawal by Subject|1|||
163084931|NCT03485157|589020309|FG001|Open Label Phase|Withdrawal by Subject|2|||
163084932|NCT03485157|589020308|FG000|Open Label Phase|Removal by PI|2|||
163084933|NCT03485157|589020309|FG001|Open Label Phase|Removal by PI|0|||
163084934|NCT04918771|589020310|FG000|Overall Study|Withdrawal by Subject|4|||
163084935|NCT04918771|589020311|FG001|Overall Study|Withdrawal by Subject|5|||
163084936|NCT04918771|589020310|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
163084937|NCT04918771|589020311|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
163084938|NCT02971163|589020312|FG000|Overall Study|Lost to Follow-up|4|||
163084939|NCT02971163|589020313|FG001|Overall Study|Lost to Follow-up|2|||
163084940|NCT01849276|589020314|FG000|Followed for Survival for 5 Years|Death|1|||
163084941|NCT01849276|589020314|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
163084942|NCT02657343|589020317|FG000|Overall Study|Death|0|||
163084943|NCT02657343|589020318|FG001|Overall Study|Death|2|||
163084944|NCT02657343|589020319|FG002|Overall Study|Death|0|||
163084945|NCT02657343|589020320|FG003|Overall Study|Death|0|||
163084946|NCT02657343|589020321|FG004|Overall Study|Death|0|||
163084947|NCT02657343|589020322|FG005|Overall Study|Death|0|||
163084948|NCT02657343|589020317|FG000|Overall Study|Patient went to hospice|1|||
163084949|NCT02657343|589020318|FG001|Overall Study|Patient went to hospice|0|||
163084950|NCT02657343|589020319|FG002|Overall Study|Patient went to hospice|0|||
163084951|NCT02657343|589020320|FG003|Overall Study|Patient went to hospice|0|||
163084952|NCT02657343|589020321|FG004|Overall Study|Patient went to hospice|0|||
163084953|NCT02657343|589020322|FG005|Overall Study|Patient went to hospice|0|||
163084954|NCT02657343|589020317|FG000|Overall Study|Withdrawal by Subject|0|||
163084955|NCT02657343|589020318|FG001|Overall Study|Withdrawal by Subject|0|||
163084956|NCT02657343|589020319|FG002|Overall Study|Withdrawal by Subject|0|||
163084957|NCT02657343|589020320|FG003|Overall Study|Withdrawal by Subject|0|||
163084958|NCT02657343|589020321|FG004|Overall Study|Withdrawal by Subject|1|||
163084959|NCT02657343|589020322|FG005|Overall Study|Withdrawal by Subject|0|||
163084960|NCT01813357|589020329|FG000|Overall Study|Lost to Follow-up|5|||
163084961|NCT01813357|589020330|FG001|Overall Study|Lost to Follow-up|6|||
163084962|NCT02607722|589020342|FG000|Overall Study|No data reliability|1|||
163084963|NCT02607722|589020342|FG000|Overall Study|no patient visit|18|||
163084964|NCT02607722|589020342|FG000|Overall Study|missing info in CRF|13|||
163084965|NCT02607722|589020342|FG000|Overall Study|Withdrawal by Subject|616|||
163084966|NCT02607722|589020342|FG000|Overall Study|Lost to Follow-up|312|||
163084967|NCT02607722|589020342|FG000|Overall Study|Improved|22|||
163084968|NCT02607722|589020342|FG000|Overall Study|Lack of Efficacy|316|||
163084969|NCT02607722|589020342|FG000|Overall Study|Adverse Event|2553|||
163084970|NCT02607722|589020342|FG000|Overall Study|Not treated|1|||
163084971|NCT02607722|589020342|FG000|Overall Study|No CRF collected|138|||
163084972|NCT02607722|589020342|FG000|Overall Study|without CRF|4225|||
163084973|NCT02607722|589020342|FG000|Overall Study|Physician Decision|367|||
163084974|NCT04347538|589020343|FG000|Overall Study|Lost to Follow-up|4|||
163084975|NCT04347538|589020344|FG001|Overall Study|Lost to Follow-up|5|||
163084976|NCT04347538|589020345|FG002|Overall Study|Lost to Follow-up|7|||
163084977|NCT02871219|589020346|FG000|Overall Study|Adverse Event|15|||
163084978|NCT02871219|589020346|FG000|Overall Study|Death|3|||
163084979|NCT02871219|589020346|FG000|Overall Study|Progression|3|||
163084980|NCT02871219|589020346|FG000|Overall Study|Infections|7|||
163084981|NCT02871219|589020346|FG000|Overall Study|Infusion Related|4|||
163084982|NCT04938427|589020347|FG000|Overall Study|Adverse Event|5|||
163084983|NCT04938427|589020348|FG001|Overall Study|Adverse Event|19|||
163084984|NCT04938427|589020347|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163084985|NCT04938427|589020348|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163084986|NCT04938427|589020347|FG000|Overall Study|Withdrawal by Subject|1|||
163084987|NCT04938427|589020348|FG001|Overall Study|Withdrawal by Subject|0|||
163084988|NCT04938427|589020347|FG000|Overall Study|Reason Not Specified|2|||
163084989|NCT04938427|589020348|FG001|Overall Study|Reason Not Specified|1|||
163084990|NCT01107496|589020354|FG000|Overall Study|Adverse Event|1|||
163084991|NCT01107496|589020355|FG001|Overall Study|Adverse Event|0|||
163084992|NCT01107496|589020354|FG000|Overall Study|Lack of Efficacy|1|||
163084993|NCT01107496|589020355|FG001|Overall Study|Lack of Efficacy|0|||
163030194|NCT00783224|588813803|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
163030195|NCT00783224|588813804|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
163030196|NCT00783224|588813801|FG000|Overall Study|Inappropriate as a study subject|0|||
163030197|NCT00783224|588813802|FG001|Overall Study|Inappropriate as a study subject|0|||
163030198|NCT00783224|588813803|FG002|Overall Study|Inappropriate as a study subject|0|||
163030199|NCT00783224|588813804|FG003|Overall Study|Inappropriate as a study subject|1|||
163030200|NCT03422159|588813805|FG000|Overall Study|Exclusion due to terminal disease|2|||
163030201|NCT03422159|588813806|FG001|Overall Study|Exclusion due to terminal disease|1|||
163030202|NCT04631107|588813807|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
163030203|NCT04631107|588813807|FG000|Second Intervention (1 Night)|Adverse Event|1|||
163030204|NCT04631107|588813807|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
163030205|NCT04631107|588813807|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
163030206|NCT00087126|588813811|FG000|Overall Study|Ineligible - second primary|1|||
163030207|NCT00087126|588813811|FG000|Overall Study|Never treated|1|||
163030208|NCT01432275|588813812|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
163030209|NCT01432275|588813813|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
163030210|NCT01432275|588813812|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
163030211|NCT01432275|588813813|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
163030212|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
163030213|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
163030214|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
163030215|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
163030216|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
163030217|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
163030218|NCT01432275|588813812|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
163030219|NCT01432275|588813813|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
163030220|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
163030221|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
163030222|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
163030223|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
163030224|NCT01432275|588813812|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
163030225|NCT01432275|588813813|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
163030226|NCT01935700|588813818|FG000|Overall Study|Withdrawal by Subject|1|||
163030227|NCT01935700|588813819|FG001|Overall Study|Withdrawal by Subject|0|||
163030228|NCT01935700|588813818|FG000|Overall Study|Physician Decision|4|||
163030229|NCT01935700|588813819|FG001|Overall Study|Physician Decision|0|||
163030230|NCT01935128|588813822|FG000|Overall Study|Death|1|||
163030231|NCT01935128|588813822|FG000|Overall Study|Adverse Event|6|||
163030232|NCT00096993|588813823|FG000|Overall Study|Death|1|||
163030233|NCT00096993|588813824|FG001|Overall Study|Death|0|||
163030234|NCT00096993|588813823|FG000|Overall Study|Disease progression|56|||
163030235|NCT00096993|588813824|FG001|Overall Study|Disease progression|53|||
163030236|NCT00096993|588813823|FG000|Overall Study|Adverse Event|2|||
163030237|NCT00096993|588813824|FG001|Overall Study|Adverse Event|8|||
163030238|NCT00096993|588813823|FG000|Overall Study|Subject's decision|3|||
163030239|NCT00096993|588813824|FG001|Overall Study|Subject's decision|1|||
163030240|NCT00096993|588813823|FG000|Overall Study|Physician Decision|2|||
163030241|NCT00096993|588813824|FG001|Overall Study|Physician Decision|1|||
163030242|NCT00096993|588813823|FG000|Overall Study|Non-compliance|0|||
163030243|NCT00096993|588813824|FG001|Overall Study|Non-compliance|1|||
163030244|NCT00096993|588813823|FG000|Overall Study|Other unspecified|1|||
163030245|NCT00096993|588813824|FG001|Overall Study|Other unspecified|1|||
163030246|NCT01438814|588813826|FG000|Overall Study|Adverse Event|3|||
163030247|NCT01438814|588813827|FG001|Overall Study|Adverse Event|3|||
162646548|NCT01374087|587422804|FG001|Overall Study|Adverse Event|0|||
163030248|NCT01438814|588813826|FG000|Overall Study|Protocol Violation|1|||
163030249|NCT01438814|588813827|FG001|Overall Study|Protocol Violation|2|||
163030250|NCT01438814|588813826|FG000|Overall Study|Lost to Follow-up|4|||
163084994|NCT01107496|589020354|FG000|Overall Study|Protocol Violation|0|||
162646549|NCT01374087|587422803|FG000|Overall Study|Disease progression|2|||
163030251|NCT01438814|588813827|FG001|Overall Study|Lost to Follow-up|3|||
163030252|NCT01438814|588813826|FG000|Overall Study|Withdrawal by Subject|4|||
163030253|NCT01438814|588813827|FG001|Overall Study|Withdrawal by Subject|2|||
163030254|NCT01438814|588813826|FG000|Overall Study|Other|2|||
163030255|NCT01438814|588813827|FG001|Overall Study|Other|4|||
163084995|NCT01107496|589020355|FG001|Overall Study|Protocol Violation|1|||
163030256|NCT01739764|588813828|FG000|Overall Study|Adverse Event|0|||
163030257|NCT01739764|588813829|FG001|Overall Study|Adverse Event|3|||
163030258|NCT01739764|588813830|FG002|Overall Study|Adverse Event|4|||
163030259|NCT01739764|588813828|FG000|Overall Study|Death|4|||
163030260|NCT01739764|588813829|FG001|Overall Study|Death|6|||
163084996|NCT01107496|589020354|FG000|Overall Study|Lost to Follow-up|0|||
163084997|NCT01107496|589020355|FG001|Overall Study|Lost to Follow-up|1|||
163030261|NCT01739764|588813830|FG002|Overall Study|Death|38|||
163030262|NCT01739764|588813828|FG000|Overall Study|Lost to Follow-up|0|||
163030263|NCT01739764|588813829|FG001|Overall Study|Lost to Follow-up|0|||
163030264|NCT01739764|588813830|FG002|Overall Study|Lost to Follow-up|5|||
163030265|NCT01739764|588813828|FG000|Overall Study|Non-Compliance|0|||
163030266|NCT01739764|588813829|FG001|Overall Study|Non-Compliance|0|||
163030267|NCT01739764|588813830|FG002|Overall Study|Non-Compliance|1|||
163030268|NCT01739764|588813828|FG000|Overall Study|Multiple Reasons|3|||
163030269|NCT01739764|588813829|FG001|Overall Study|Multiple Reasons|2|||
163030270|NCT01739764|588813830|FG002|Overall Study|Multiple Reasons|3|||
163030271|NCT01739764|588813828|FG000|Overall Study|Physician Decision|2|||
163030272|NCT01739764|588813829|FG001|Overall Study|Physician Decision|2|||
163030273|NCT01739764|588813830|FG002|Overall Study|Physician Decision|4|||
163030274|NCT01739764|588813828|FG000|Overall Study|Progressive Disease|3|||
163030275|NCT01739764|588813829|FG001|Overall Study|Progressive Disease|5|||
163030276|NCT01739764|588813830|FG002|Overall Study|Progressive Disease|16|||
163030277|NCT01739764|588813828|FG000|Overall Study|Protocol Violation|0|||
163030278|NCT01739764|588813829|FG001|Overall Study|Protocol Violation|0|||
163030279|NCT01739764|588813830|FG002|Overall Study|Protocol Violation|2|||
163030280|NCT01739764|588813828|FG000|Overall Study|Study Terminated by Sponsor|8|||
163030281|NCT01739764|588813829|FG001|Overall Study|Study Terminated by Sponsor|13|||
163030282|NCT01739764|588813830|FG002|Overall Study|Study Terminated by Sponsor|26|||
163030283|NCT01739764|588813828|FG000|Overall Study|Withdrawal by Subject|6|||
163030284|NCT01739764|588813829|FG001|Overall Study|Withdrawal by Subject|5|||
163030285|NCT01739764|588813830|FG002|Overall Study|Withdrawal by Subject|27|||
163030286|NCT00404924|588813831|FG000|Overall Study|Adverse Event|75|||
163030287|NCT00404924|588813832|FG001|Overall Study|Adverse Event|16|||
163030288|NCT00404924|588813831|FG000|Overall Study|Condition under investigation worsened|475|||
163030289|NCT00404924|588813832|FG001|Overall Study|Condition under investigation worsened|264|||
163030290|NCT00404924|588813831|FG000|Overall Study|Lost to Follow-up|1|||
163030291|NCT00404924|588813832|FG001|Overall Study|Lost to Follow-up|1|||
163030292|NCT00404924|588813831|FG000|Overall Study|Withdrawal by Subject|26|||
163030293|NCT00404924|588813832|FG001|Overall Study|Withdrawal by Subject|13|||
163030294|NCT00404924|588813831|FG000|Overall Study|Other|25|||
163030295|NCT00404924|588813832|FG001|Overall Study|Other|11|||
163030296|NCT00404924|588813831|FG000|Overall Study|Randomised but not received treatment|1|||
163030297|NCT00404924|588813832|FG001|Overall Study|Randomised but not received treatment|1|||
163030298|NCT00513357|588813837|FG000|Overall Study|did not receive allocated placebo|2|||
163030299|NCT00513357|588813838|FG001|Overall Study|did not receive allocated placebo|3|||
163030300|NCT00513357|588813837|FG000|Overall Study|Adverse Event|4|||
163030301|NCT00513357|588813838|FG001|Overall Study|Adverse Event|2|||
163030302|NCT00513357|588813837|FG000|Overall Study|Death|2|||
163030303|NCT00513357|588813838|FG001|Overall Study|Death|0|||
163030304|NCT00513357|588813837|FG000|Overall Study|Withdrawal by Subject|5|||
163030305|NCT00513357|588813838|FG001|Overall Study|Withdrawal by Subject|4|||
163030306|NCT00513357|588813837|FG000|Overall Study|Disease Progression|2|||
163030307|NCT00513357|588813838|FG001|Overall Study|Disease Progression|1|||
163030308|NCT05238025|588813842|FG000|Overall Study|Adverse Event|2|||
163030309|NCT05238025|588813843|FG001|Overall Study|Adverse Event|2|||
163030310|NCT05238025|588813842|FG000|Overall Study|Lost to Follow-up|334|||
163030311|NCT05238025|588813843|FG001|Overall Study|Lost to Follow-up|339|||
163030312|NCT05238025|588813842|FG000|Overall Study|Withdrawal by Subject|203|||
163030313|NCT05238025|588813843|FG001|Overall Study|Withdrawal by Subject|222|||
163030314|NCT05238025|588813842|FG000|Overall Study|Physician Decision|20|||
163030315|NCT05238025|588813843|FG001|Overall Study|Physician Decision|8|||
163030316|NCT05238025|588813842|FG000|Overall Study|Protocol Violation|6|||
163030317|NCT05238025|588813843|FG001|Overall Study|Protocol Violation|2|||
163030318|NCT05238025|588813842|FG000|Overall Study|Death|38|||
163030319|NCT05238025|588813843|FG001|Overall Study|Death|32|||
163030320|NCT05238025|588813842|FG000|Overall Study|Study terminated by Sponsor|6358|||
163030321|NCT05238025|588813843|FG001|Overall Study|Study terminated by Sponsor|6358|||
163030322|NCT05238025|588813842|FG000|Overall Study|Other Reason|669|||
163030323|NCT05238025|588813843|FG001|Overall Study|Other Reason|690|||
163030324|NCT03814720|588813846|FG000|Overall Study|Lost to Follow-up|0|||
163030325|NCT03814720|588813847|FG001|Overall Study|Lost to Follow-up|1|||
163030326|NCT03814720|588813848|FG002|Overall Study|Lost to Follow-up|0|||
163030327|NCT03814720|588813849|FG003|Overall Study|Lost to Follow-up|0|||
163030328|NCT03814720|588813850|FG004|Overall Study|Lost to Follow-up|0|||
163030329|NCT02419612|588813851|FG000|Short-term Treatment Period|Adverse Event|1|||
163030330|NCT02419612|588813852|FG001|Short-term Treatment Period|Adverse Event|1|||
163030331|NCT02419612|588813851|FG000|Short-term Treatment Period|Death|0|||
163030332|NCT02419612|588813852|FG001|Short-term Treatment Period|Death|2|||
163030333|NCT02419612|588813851|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
163030334|NCT02419612|588813852|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
163030335|NCT02419612|588813851|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
163030336|NCT02419612|588813852|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
163030337|NCT02419612|588813851|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
163030338|NCT02419612|588813852|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
163030339|NCT02419612|588813851|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
163030340|NCT02419612|588813852|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
163030341|NCT02419612|588813851|FG000|Short-term Treatment Period|Worsening of liver function|0|||
163030342|NCT02419612|588813852|FG001|Short-term Treatment Period|Worsening of liver function|1|||
163030343|NCT02419612|588813851|FG000|Short-term Treatment Period|Subject moved out of state|0|||
163030344|NCT02419612|588813852|FG001|Short-term Treatment Period|Subject moved out of state|1|||
163030345|NCT02419612|588813851|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
163030346|NCT02419612|588813852|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
163030347|NCT02419612|588813851|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
163030348|NCT02419612|588813852|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
163030349|NCT02419612|588813851|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
163030350|NCT02419612|588813852|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
163030351|NCT02419612|588813851|FG000|Long-term Treatment Period|Death|0|||
163030352|NCT02419612|588813852|FG001|Long-term Treatment Period|Death|1|||
163030353|NCT02419612|588813851|FG000|Long-term Treatment Period|Adverse Event|0|||
163030354|NCT02419612|588813852|FG001|Long-term Treatment Period|Adverse Event|5|||
163030355|NCT02419612|588813851|FG000|Long-term Treatment Period|Other|4|||
163030356|NCT02419612|588813852|FG001|Long-term Treatment Period|Other|4|||
162646550|NCT01374087|587422804|FG001|Overall Study|Disease progression|2|||
163030357|NCT02419612|588813851|FG000|Long-term Treatment Period|Subject Decision|2|||
162646551|NCT01374087|587422803|FG000|Overall Study|Study discontinued|13|||
162646552|NCT01374087|587422804|FG001|Overall Study|Study discontinued|13|||
162646553|NCT03011307|587422805|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
162646554|NCT03011307|587422806|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
162646555|NCT03011307|587422805|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
162646556|NCT03011307|587422806|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
162646557|NCT03011307|587422805|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
162646558|NCT03011307|587422806|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
162646559|NCT00567892|587422810|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162646560|NCT00567892|587422811|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162646561|NCT00567892|587422812|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
162646562|NCT00567892|587422813|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
162646563|NCT00567892|587422810|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
163030358|NCT02419612|588813852|FG001|Long-term Treatment Period|Subject Decision|4|||
163030359|NCT02419612|588813851|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
163030360|NCT02419612|588813852|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
163030361|NCT01095978|588813853|FG000|Overall Study|Did not take Klacid SR|2|||
162646564|NCT00567892|587422811|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162646565|NCT00567892|587422812|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162646566|NCT00567892|587422813|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
163030362|NCT01095978|588813853|FG000|Overall Study|Adverse Event|1|||
163030363|NCT02009397|588813855|FG000|Overall Study|Protocol Violation|6|||
163030364|NCT02009397|588813855|FG000|Overall Study|Death|8|||
163030365|NCT02009397|588813855|FG000|Overall Study|Lost to Follow-up|6|||
163030366|NCT00191282|588813856|FG000|Overall Study|Adverse Event|5|||
163030367|NCT00191282|588813857|FG001|Overall Study|Adverse Event|6|||
163030368|NCT00191282|588813856|FG000|Overall Study|Death|51|||
163030369|NCT00191282|588813857|FG001|Overall Study|Death|51|||
163030370|NCT00191282|588813856|FG000|Overall Study|Lack of Efficacy|11|||
163030371|NCT00191282|588813857|FG001|Overall Study|Lack of Efficacy|6|||
163030372|NCT00191282|588813856|FG000|Overall Study|Noncompliance|14|||
163030373|NCT00191282|588813857|FG001|Overall Study|Noncompliance|17|||
163030374|NCT00191282|588813856|FG000|Overall Study|Patient moved|11|||
163030375|NCT00191282|588813857|FG001|Overall Study|Patient moved|14|||
162646567|NCT04690751|587422815|FG000|Overall Study|Protocol Violation|0|||
163030376|NCT00191282|588813856|FG000|Overall Study|Withdrawal by Subject|59|||
162646568|NCT04690751|587422816|FG001|Overall Study|Protocol Violation|1|||
162646569|NCT04690751|587422817|FG002|Overall Study|Protocol Violation|0|||
162646570|NCT04690751|587422818|FG003|Overall Study|Protocol Violation|1|||
163030377|NCT00191282|588813857|FG001|Overall Study|Withdrawal by Subject|44|||
163030378|NCT00191282|588813856|FG000|Overall Study|Physician Decision|18|||
162646571|NCT04690751|587422819|FG004|Overall Study|Protocol Violation|2|||
163030379|NCT00191282|588813857|FG001|Overall Study|Physician Decision|15|||
163030380|NCT00191282|588813856|FG000|Overall Study|Protocol entry criteria not met|14|||
163030381|NCT00191282|588813857|FG001|Overall Study|Protocol entry criteria not met|9|||
163030382|NCT00191282|588813856|FG000|Overall Study|Protocol Violation|9|||
162646572|NCT04690751|587422820|FG005|Overall Study|Protocol Violation|0|||
162646573|NCT04690751|587422815|FG000|Overall Study|Adverse Event|0|||
162646574|NCT04690751|587422816|FG001|Overall Study|Adverse Event|0|||
162646575|NCT04690751|587422817|FG002|Overall Study|Adverse Event|1|||
162646576|NCT04690751|587422818|FG003|Overall Study|Adverse Event|0|||
162646577|NCT04690751|587422819|FG004|Overall Study|Adverse Event|0|||
162646578|NCT04690751|587422820|FG005|Overall Study|Adverse Event|0|||
163030383|NCT00191282|588813857|FG001|Overall Study|Protocol Violation|12|||
163030384|NCT00191282|588813856|FG000|Overall Study|Severity of outcome|2|||
163030385|NCT00191282|588813857|FG001|Overall Study|Severity of outcome|5|||
163030386|NCT00191282|588813856|FG000|Overall Study|Sponsor's decision|2|||
163030387|NCT00191282|588813857|FG001|Overall Study|Sponsor's decision|2|||
163030388|NCT00191282|588813856|FG000|Overall Study|Lost to Follow-up|24|||
163030389|NCT00191282|588813857|FG001|Overall Study|Lost to Follow-up|31|||
163030390|NCT00102531|588813858|FG000|Overall Study|Adverse Event|0|||
163030391|NCT00102531|588813859|FG001|Overall Study|Adverse Event|1|||
163030392|NCT00102531|588813858|FG000|Overall Study|Disease Progression|5|||
163030393|NCT00102531|588813859|FG001|Overall Study|Disease Progression|9|||
163030394|NCT00102531|588813858|FG000|Overall Study|Physician Decision|0|||
163030395|NCT00102531|588813859|FG001|Overall Study|Physician Decision|1|||
163030396|NCT04756154|588813860|FG000|Overall Study|Did not meet treatment day baseline|30|||
163030397|NCT04756154|588813861|FG001|Overall Study|Did not meet treatment day baseline|28|||
163030398|NCT04756154|588813862|FG002|Overall Study|Did not meet treatment day baseline|7|||
163030399|NCT04756154|588813860|FG000|Overall Study|Did not return for final sample collection|1|||
163030400|NCT04756154|588813861|FG001|Overall Study|Did not return for final sample collection|1|||
163030401|NCT04756154|588813862|FG002|Overall Study|Did not return for final sample collection|0|||
163030402|NCT01790828|588813863|FG000|Overall Study|Other|34|||
163030403|NCT02089334|588813865|FG000|Overall Study|Withdrawal by Subject|0|||
163030404|NCT02089334|588813866|FG001|Overall Study|Withdrawal by Subject|0|||
163030405|NCT02089334|588813867|FG002|Overall Study|Withdrawal by Subject|0|||
163030406|NCT02089334|588813868|FG003|Overall Study|Withdrawal by Subject|2|||
163030407|NCT02089334|588813865|FG000|Overall Study|Adverse Event|0|||
163030408|NCT02089334|588813866|FG001|Overall Study|Adverse Event|0|||
163030409|NCT02089334|588813867|FG002|Overall Study|Adverse Event|0|||
163030410|NCT02089334|588813868|FG003|Overall Study|Adverse Event|2|||
163030411|NCT02089334|588813865|FG000|Overall Study|Progressive disease|0|||
163030412|NCT02089334|588813866|FG001|Overall Study|Progressive disease|0|||
163030413|NCT02089334|588813867|FG002|Overall Study|Progressive disease|0|||
163030414|NCT02089334|588813868|FG003|Overall Study|Progressive disease|2|||
163030415|NCT02089334|588813865|FG000|Overall Study|Physician Decision|0|||
163030416|NCT02089334|588813866|FG001|Overall Study|Physician Decision|0|||
163030417|NCT02089334|588813867|FG002|Overall Study|Physician Decision|1|||
163030418|NCT02089334|588813868|FG003|Overall Study|Physician Decision|1|||
163030419|NCT02824562|588815893|FG000|Overall Study|Lost to Follow-up|3|||
163030420|NCT02824562|588815894|FG001|Overall Study|Lost to Follow-up|4|||
163030421|NCT02824562|588815893|FG000|Overall Study|Death|0|||
163030422|NCT02824562|588815894|FG001|Overall Study|Death|1|||
163030423|NCT02921750|588815895|FG000|Overall Study|Adverse Event|1|||
163030424|NCT02921750|588815896|FG001|Overall Study|Adverse Event|2|||
163030425|NCT02921750|588815895|FG000|Overall Study|Withdrawal by Subject|1|||
163030426|NCT02921750|588815896|FG001|Overall Study|Withdrawal by Subject|1|||
163030427|NCT02921750|588815895|FG000|Overall Study|Lost to Follow-up|3|||
163030428|NCT02921750|588815896|FG001|Overall Study|Lost to Follow-up|3|||
163030429|NCT02921750|588815895|FG000|Overall Study|Wound healed|3|||
163030430|NCT02921750|588815896|FG001|Overall Study|Wound healed|3|||
163030431|NCT02921750|588815895|FG000|Overall Study|Serious Adverse Event|1|||
163030432|NCT02921750|588815896|FG001|Overall Study|Serious Adverse Event|2|||
163030433|NCT04676412|588815897|FG000|Overall Study|Death|28|||
163030434|NCT04676412|588815898|FG001|Overall Study|Death|31|||
163030435|NCT04676412|588815897|FG000|Overall Study|Lost to Follow-up|1|||
163030436|NCT04676412|588815898|FG001|Overall Study|Lost to Follow-up|2|||
163030437|NCT04676412|588815897|FG000|Overall Study|Sponsor Decision|20|||
163030438|NCT04676412|588815898|FG001|Overall Study|Sponsor Decision|23|||
162646579|NCT04690751|587422815|FG000|Overall Study|Positive urine drug screen test|0|||
162646580|NCT04690751|587422816|FG001|Overall Study|Positive urine drug screen test|0|||
162646581|NCT04690751|587422817|FG002|Overall Study|Positive urine drug screen test|0|||
162646582|NCT04690751|587422818|FG003|Overall Study|Positive urine drug screen test|0|||
162646583|NCT04690751|587422819|FG004|Overall Study|Positive urine drug screen test|1|||
163030439|NCT04676412|588815897|FG000|Overall Study|Withdrawal by Subject|0|||
163030440|NCT04676412|588815898|FG001|Overall Study|Withdrawal by Subject|2|||
163030441|NCT04550832|588815899|FG000|Overall Study|Adverse Event|0|||
163030442|NCT04550832|588815900|FG001|Overall Study|Adverse Event|0|||
163030443|NCT04550832|588815901|FG002|Overall Study|Adverse Event|2|||
163030444|NCT04550832|588815902|FG003|Overall Study|Adverse Event|0|||
163030445|NCT04550832|588815903|FG004|Overall Study|Adverse Event|1|||
163030446|NCT01458951|588815907|FG000|Overall Study|Other|1|||
163030447|NCT01458951|588815908|FG001|Overall Study|Other|0|||
163030448|NCT01458951|588815909|FG002|Overall Study|Other|0|||
163030449|NCT01458951|588815907|FG000|Overall Study|Protocol Violation|5|||
163030450|NCT01458951|588815908|FG001|Overall Study|Protocol Violation|1|||
163030451|NCT01458951|588815909|FG002|Overall Study|Protocol Violation|0|||
163030452|NCT01458951|588815907|FG000|Overall Study|Withdrawal by Subject|2|||
163030453|NCT01458951|588815908|FG001|Overall Study|Withdrawal by Subject|0|||
163030454|NCT01458951|588815909|FG002|Overall Study|Withdrawal by Subject|2|||
163030455|NCT01458951|588815907|FG000|Overall Study|Adverse Event|7|||
163030456|NCT01458951|588815908|FG001|Overall Study|Adverse Event|0|||
163030457|NCT01458951|588815909|FG002|Overall Study|Adverse Event|2|||
163030458|NCT01458951|588815907|FG000|Overall Study|Insufficient Clinical Response|17|||
163030459|NCT01458951|588815908|FG001|Overall Study|Insufficient Clinical Response|0|||
163030460|NCT01458951|588815909|FG002|Overall Study|Insufficient Clinical Response|11|||
163030461|NCT04392167|588815912|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
163030462|NCT03309696|588815913|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
163030463|NCT03309696|588815914|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
163030464|NCT03309696|588815915|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
163030465|NCT03309696|588815916|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
163030466|NCT02638129|588815917|FG000|Overall Study|Study terminated|28|||
163030467|NCT02638129|588815918|FG001|Overall Study|Study terminated|30|||
163030468|NCT03117881|588815919|FG000|Baseline|Withdrawal by Subject|21|||
163030469|NCT03117881|588815920|FG001|Baseline|Withdrawal by Subject|10|||
163030470|NCT03117881|588815921|FG002|Baseline|Withdrawal by Subject|0|||
163030471|NCT03117881|588815919|FG000|Baseline|Lost to Follow-up|22|||
163030472|NCT03117881|588815920|FG001|Baseline|Lost to Follow-up|25|||
163030473|NCT03117881|588815921|FG002|Baseline|Lost to Follow-up|0|||
163030474|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
163030475|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
163030476|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
163030477|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
163030478|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
163030479|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
163030480|NCT03117881|588815919|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
163030481|NCT03117881|588815920|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
163030482|NCT03117881|588815921|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
163030483|NCT03117881|588815919|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
163030484|NCT03117881|588815920|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
163030485|NCT03117881|588815921|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
163030486|NCT03117881|588815919|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
163030487|NCT03117881|588815920|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
163030488|NCT03117881|588815921|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
163030489|NCT03117881|588815919|FG000|6-Month Follow-Up|Did not complete test|53|||
163030490|NCT03117881|588815920|FG001|6-Month Follow-Up|Did not complete test|25|||
163030491|NCT03117881|588815921|FG002|6-Month Follow-Up|Did not complete test|7|||
163030492|NCT03117881|588815919|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
163030493|NCT03117881|588815920|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
163030494|NCT03117881|588815921|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
163030495|NCT03117881|588815919|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
163030496|NCT03117881|588815920|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
163030497|NCT03117881|588815921|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
163030498|NCT03117881|588815919|FG000|12-Month Follow-Up|Did not complete test|40|||
163030499|NCT03117881|588815920|FG001|12-Month Follow-Up|Did not complete test|0|||
163030500|NCT03117881|588815921|FG002|12-Month Follow-Up|Did not complete test|0|||
163030501|NCT00577005|588815924|FG000|Overall Study|Lost to Follow-up|3|||
163030502|NCT00577005|588815925|FG001|Overall Study|Lost to Follow-up|2|||
163030503|NCT00577005|588815924|FG000|Overall Study|Withdrawal by Subject|2|||
163030504|NCT00577005|588815925|FG001|Overall Study|Withdrawal by Subject|1|||
163030505|NCT02667626|588815926|FG000|Overall Study|Withdrawal by Subject|0|||
163030506|NCT02667626|588815927|FG001|Overall Study|Withdrawal by Subject|1|||
163030507|NCT02309723|588815928|FG000|Overall Study|Withdrawal by Subject|24|||
163030508|NCT02309723|588815929|FG001|Overall Study|Withdrawal by Subject|23|||
163030509|NCT02309723|588815930|FG002|Overall Study|Withdrawal by Subject|24|||
163030510|NCT02560623|588815931|FG000|Overall Study|Unable to swallow sponge|0|||
163030511|NCT02560623|588815932|FG001|Overall Study|Unable to swallow sponge|1|||
163030512|NCT02560623|588815933|FG002|Overall Study|Unable to swallow sponge|0|||
163030513|NCT02560623|588815934|FG003|Overall Study|Unable to swallow sponge|0|||
163030514|NCT02560623|588815931|FG000|Overall Study|Intervention prior to sponge administration|0|||
163030515|NCT02560623|588815932|FG001|Overall Study|Intervention prior to sponge administration|1|||
163030516|NCT02560623|588815933|FG002|Overall Study|Intervention prior to sponge administration|0|||
163030517|NCT02560623|588815934|FG003|Overall Study|Intervention prior to sponge administration|0|||
163030518|NCT02453282|588815935|FG000|Overall Study|Death|275|||
163030519|NCT02453282|588815936|FG001|Overall Study|Death|277|||
163030520|NCT02453282|588815937|FG002|Overall Study|Death|296|||
162646584|NCT04690751|587422820|FG005|Overall Study|Positive urine drug screen test|0|||
162646585|NCT01344161|587422821|FG000|Overall Study|Lost to Follow-up|4|||
162646586|NCT01344161|587422822|FG001|Overall Study|Lost to Follow-up|1|||
163030521|NCT02453282|588815935|FG000|Overall Study|Lost to Follow-up|1|||
163030522|NCT02453282|588815936|FG001|Overall Study|Lost to Follow-up|0|||
163030523|NCT02453282|588815937|FG002|Overall Study|Lost to Follow-up|2|||
163030524|NCT02453282|588815935|FG000|Overall Study|Withdrawal by Subject|12|||
163030525|NCT02453282|588815936|FG001|Overall Study|Withdrawal by Subject|10|||
163030526|NCT02453282|588815937|FG002|Overall Study|Withdrawal by Subject|11|||
163030527|NCT02453282|588815935|FG000|Overall Study|Participants ongoing at data cut-off|85|||
163030528|NCT02453282|588815936|FG001|Overall Study|Participants ongoing at data cut-off|84|||
163030529|NCT02453282|588815937|FG002|Overall Study|Participants ongoing at data cut-off|62|||
163030530|NCT02453282|588815935|FG000|Overall Study|Other|1|||
163030531|NCT02453282|588815936|FG001|Overall Study|Other|1|||
163030532|NCT02453282|588815937|FG002|Overall Study|Other|1|||
163030533|NCT01143064|588815938|FG000|Overall Study|Death|109|||
163030534|NCT01143064|588815939|FG001|Overall Study|Death|91|||
163030535|NCT01143064|588815938|FG000|Overall Study|Adverse Event|0|||
163030536|NCT01143064|588815939|FG001|Overall Study|Adverse Event|1|||
163030537|NCT01143064|588815938|FG000|Overall Study|Withdrawal by Subject|7|||
163030538|NCT01143064|588815939|FG001|Overall Study|Withdrawal by Subject|5|||
163030539|NCT01143064|588815938|FG000|Overall Study|Lost to Follow-up|17|||
163030540|NCT01143064|588815939|FG001|Overall Study|Lost to Follow-up|14|||
163030541|NCT01143064|588815938|FG000|Overall Study|Physician Decision|0|||
163030542|NCT01143064|588815939|FG001|Overall Study|Physician Decision|4|||
163030543|NCT00985426|588815940|FG000|Overall Study|Adverse Event|0|||
163030544|NCT00985426|588815941|FG001|Overall Study|Adverse Event|1|||
163030545|NCT00985426|588815940|FG000|Overall Study|Subject Non-Compliance|3|||
163030546|NCT00985426|588815941|FG001|Overall Study|Subject Non-Compliance|3|||
163030547|NCT00985426|588815940|FG000|Overall Study|Withdrawal by Subject|12|||
163030548|NCT00985426|588815941|FG001|Overall Study|Withdrawal by Subject|16|||
163030549|NCT00985426|588815940|FG000|Overall Study|Lost to Follow-up|8|||
163030550|NCT00985426|588815941|FG001|Overall Study|Lost to Follow-up|10|||
163030551|NCT00985426|588815940|FG000|Overall Study|Death|7|||
163030552|NCT00985426|588815941|FG001|Overall Study|Death|3|||
163030553|NCT00985426|588815940|FG000|Overall Study|Protocol Violation|2|||
163030554|NCT00985426|588815941|FG001|Overall Study|Protocol Violation|0|||
163030555|NCT00985426|588815940|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
163030556|NCT00985426|588815941|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
163030557|NCT02327013|588815944|FG000|Overall Study|Adverse Event|4|||
163030558|NCT02327013|588815945|FG001|Overall Study|Adverse Event|4|||
163030559|NCT02327013|588815946|FG002|Overall Study|Adverse Event|3|||
163030560|NCT02327013|588815947|FG003|Overall Study|Adverse Event|0|||
163030561|NCT02327013|588815948|FG004|Overall Study|Adverse Event|1|||
163030562|NCT02327013|588815944|FG000|Overall Study|Lack of Efficacy|2|||
163030563|NCT02327013|588815945|FG001|Overall Study|Lack of Efficacy|0|||
163030564|NCT02327013|588815946|FG002|Overall Study|Lack of Efficacy|5|||
163030565|NCT02327013|588815947|FG003|Overall Study|Lack of Efficacy|0|||
163030566|NCT02327013|588815948|FG004|Overall Study|Lack of Efficacy|1|||
163030567|NCT02327013|588815944|FG000|Overall Study|Non-compliance with IMP|1|||
163030568|NCT02327013|588815945|FG001|Overall Study|Non-compliance with IMP|2|||
163030569|NCT02327013|588815946|FG002|Overall Study|Non-compliance with IMP|7|||
163030570|NCT02327013|588815947|FG003|Overall Study|Non-compliance with IMP|0|||
163030571|NCT02327013|588815948|FG004|Overall Study|Non-compliance with IMP|0|||
163030572|NCT02327013|588815944|FG000|Overall Study|Withdrawal of Consent|1|||
163030573|NCT02327013|588815945|FG001|Overall Study|Withdrawal of Consent|0|||
163030574|NCT02327013|588815946|FG002|Overall Study|Withdrawal of Consent|3|||
163030575|NCT02327013|588815947|FG003|Overall Study|Withdrawal of Consent|0|||
163030576|NCT02327013|588815948|FG004|Overall Study|Withdrawal of Consent|0|||
163030577|NCT02327013|588815944|FG000|Overall Study|Lost to Follow-up|2|||
163030578|NCT02327013|588815945|FG001|Overall Study|Lost to Follow-up|4|||
163030579|NCT02327013|588815946|FG002|Overall Study|Lost to Follow-up|5|||
162646587|NCT01344161|587422821|FG000|Overall Study|Pregnancy|0|||
163030580|NCT02327013|588815947|FG003|Overall Study|Lost to Follow-up|0|||
163030581|NCT02327013|588815948|FG004|Overall Study|Lost to Follow-up|0|||
163030582|NCT02327013|588815944|FG000|Overall Study|Administrative or other reason(s)|1|||
163030583|NCT02327013|588815945|FG001|Overall Study|Administrative or other reason(s)|5|||
163030584|NCT02327013|588815946|FG002|Overall Study|Administrative or other reason(s)|11|||
163030585|NCT02327013|588815947|FG003|Overall Study|Administrative or other reason(s)|1|||
163030586|NCT02327013|588815948|FG004|Overall Study|Administrative or other reason(s)|1|||
163030587|NCT02327013|588815944|FG000|Overall Study|Protocol Violation|0|||
163030588|NCT02327013|588815945|FG001|Overall Study|Protocol Violation|0|||
163030589|NCT02327013|588815946|FG002|Overall Study|Protocol Violation|3|||
163030590|NCT02327013|588815947|FG003|Overall Study|Protocol Violation|0|||
163030591|NCT02327013|588815948|FG004|Overall Study|Protocol Violation|1|||
163030592|NCT02327013|588815944|FG000|Overall Study|Withdrawal before treatment|2|||
162646588|NCT01344161|587422822|FG001|Overall Study|Pregnancy|1|||
162646589|NCT01344161|587422821|FG000|Overall Study|Protocol Violation|1|||
163030593|NCT02327013|588815945|FG001|Overall Study|Withdrawal before treatment|1|||
163030594|NCT02327013|588815946|FG002|Overall Study|Withdrawal before treatment|5|||
163030595|NCT02327013|588815947|FG003|Overall Study|Withdrawal before treatment|0|||
163030596|NCT02327013|588815948|FG004|Overall Study|Withdrawal before treatment|0|||
163030597|NCT02380859|588815949|FG000|Overall Study|Withdrawal by Subject|2|||
163030598|NCT02380859|588815950|FG001|Overall Study|Withdrawal by Subject|0|||
163030599|NCT01661933|588815951|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
163030600|NCT01661933|588815951|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
163030601|NCT03385304|588815952|FG000|Overall Study|Death|19|||
163030602|NCT03385304|588815953|FG001|Overall Study|Death|7|||
163030603|NCT03385304|588815952|FG000|Overall Study|Lost to Follow-up|17|||
163030604|NCT03385304|588815953|FG001|Overall Study|Lost to Follow-up|14|||
163030605|NCT03385304|588815952|FG000|Overall Study|Withdrawal by Subject|3|||
163030606|NCT03385304|588815953|FG001|Overall Study|Withdrawal by Subject|2|||
163030607|NCT03385304|588815952|FG000|Overall Study|Incarceration|2|||
163030608|NCT03385304|588815953|FG001|Overall Study|Incarceration|3|||
163030609|NCT01565668|588815954|FG000|Overall Study|Death|2|||
163030610|NCT01565668|588815955|FG001|Overall Study|Death|1|||
163030611|NCT01565668|588815954|FG000|Overall Study|Lack of Efficacy|4|||
163030612|NCT01565668|588815955|FG001|Overall Study|Lack of Efficacy|2|||
163030613|NCT01565668|588815954|FG000|Overall Study|Participant went on Hospice Care|1|||
163030614|NCT01565668|588815955|FG001|Overall Study|Participant went on Hospice Care|0|||
163030615|NCT01565668|588815954|FG000|Overall Study|Adverse Event|6|||
163030616|NCT01565668|588815955|FG001|Overall Study|Adverse Event|1|||
163030617|NCT01565668|588815954|FG000|Overall Study|Randomized, but never received drug|0|||
163030618|NCT01565668|588815955|FG001|Overall Study|Randomized, but never received drug|2|||
163030619|NCT01565668|588815954|FG000|Overall Study|Progressive disease|13|||
163030620|NCT01565668|588815955|FG001|Overall Study|Progressive disease|14|||
163030621|NCT01565668|588815954|FG000|Overall Study|Withdrawal by Subject|1|||
163030622|NCT01565668|588815955|FG001|Overall Study|Withdrawal by Subject|3|||
163030623|NCT01565668|588815954|FG000|Overall Study|HSCT Transplant|11|||
163030624|NCT01565668|588815955|FG001|Overall Study|HSCT Transplant|15|||
163030625|NCT01097421|588815956|FG000|Overall Study|Adverse Event|8|||
163030626|NCT01097421|588815956|FG000|Overall Study|Protocol Violation|2|||
163030627|NCT01097421|588815956|FG000|Overall Study|Lost to Follow-up|1|||
163030628|NCT01097421|588815956|FG000|Overall Study|Withdrawal by Subject|3|||
163030629|NCT04258254|588815957|FG000|Overall Study|Withdrawal by Subject|0|||
163030630|NCT04258254|588815958|FG001|Overall Study|Withdrawal by Subject|1|||
163030631|NCT04258254|588815959|FG002|Overall Study|Withdrawal by Subject|0|||
163030632|NCT01120249|588815960|FG000|Overall Study|No protocol treatment received|21|||
163030633|NCT01120249|588815961|FG001|Overall Study|No protocol treatment received|15|||
163030634|NCT01120249|588815960|FG000|Overall Study|Disease recurrence|107|||
163030635|NCT01120249|588815961|FG001|Overall Study|Disease recurrence|57|||
163030636|NCT01120249|588815960|FG000|Overall Study|Death|1|||
163030637|NCT01120249|588815961|FG001|Overall Study|Death|0|||
163030638|NCT01120249|588815960|FG000|Overall Study|Adverse Event|40|||
163030639|NCT01120249|588815961|FG001|Overall Study|Adverse Event|276|||
163030640|NCT01120249|588815960|FG000|Overall Study|Participant refusal|34|||
163030641|NCT01120249|588815961|FG001|Overall Study|Participant refusal|42|||
163030642|NCT01120249|588815960|FG000|Overall Study|Other reasons, not protocol specified|29|||
163030643|NCT01120249|588815961|FG001|Overall Study|Other reasons, not protocol specified|22|||
163030644|NCT00723190|588815966|FG000|Overall Study|Withdrawal by Subject|45|||
163030645|NCT00723190|588815966|FG000|Overall Study|Lost to Follow-up|37|||
163030646|NCT00723190|588815966|FG000|Overall Study|Adverse Event|18|||
163030647|NCT00723190|588815966|FG000|Overall Study|Lack of Efficacy|16|||
163030648|NCT00723190|588815966|FG000|Overall Study|Protocol Violation|15|||
163030649|NCT00723190|588815966|FG000|Overall Study|Other-Premature Discontinuation|9|||
163030650|NCT00723190|588815966|FG000|Overall Study|Other-Not included in safety population|2|||
163030651|NCT04472026|588815972|FG000|Overall Study|Lost to Follow-up|5|||
163030652|NCT01404208|588815973|FG000|Overall Study|Discontinued|3|||
163030653|NCT01404208|588815974|FG001|Overall Study|Discontinued|0|||
163030654|NCT02772276|588815977|FG000|Overall Study|Lost to Follow-up|0|||
163030655|NCT02772276|588815978|FG001|Overall Study|Lost to Follow-up|0|||
163030656|NCT02772276|588815979|FG002|Overall Study|Lost to Follow-up|0|||
163030657|NCT02772276|588815980|FG003|Overall Study|Lost to Follow-up|0|||
163030658|NCT02772276|588815981|FG004|Overall Study|Lost to Follow-up|0|||
163030659|NCT02772276|588815982|FG005|Overall Study|Lost to Follow-up|0|||
163030660|NCT02772276|588815983|FG006|Overall Study|Lost to Follow-up|1|||
163030661|NCT02772276|588815984|FG007|Overall Study|Lost to Follow-up|0|||
163030662|NCT02772276|588815985|FG008|Overall Study|Lost to Follow-up|0|||
163030663|NCT02772276|588815986|FG009|Overall Study|Lost to Follow-up|0|||
163030664|NCT02772276|588815987|FG010|Overall Study|Lost to Follow-up|0|||
163030665|NCT02772276|588815988|FG011|Overall Study|Lost to Follow-up|0|||
163030666|NCT02772276|588815989|FG012|Overall Study|Lost to Follow-up|0|||
163030667|NCT02772276|588815977|FG000|Overall Study|Withdrew consent|0|||
163030668|NCT02772276|588815978|FG001|Overall Study|Withdrew consent|0|||
163030669|NCT02772276|588815979|FG002|Overall Study|Withdrew consent|0|||
163030670|NCT02772276|588815980|FG003|Overall Study|Withdrew consent|0|||
163030671|NCT02772276|588815981|FG004|Overall Study|Withdrew consent|0|||
163030672|NCT02772276|588815982|FG005|Overall Study|Withdrew consent|0|||
163030673|NCT02772276|588815983|FG006|Overall Study|Withdrew consent|0|||
163030674|NCT02772276|588815984|FG007|Overall Study|Withdrew consent|1|||
163030675|NCT02772276|588815985|FG008|Overall Study|Withdrew consent|0|||
163030676|NCT02772276|588815986|FG009|Overall Study|Withdrew consent|0|||
163030677|NCT02772276|588815987|FG010|Overall Study|Withdrew consent|0|||
163030678|NCT02772276|588815988|FG011|Overall Study|Withdrew consent|0|||
163030679|NCT02772276|588815989|FG012|Overall Study|Withdrew consent|0|||
163030680|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
163030681|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
163030682|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
163030683|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
163030684|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
163030685|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
163030686|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030687|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
163030688|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030689|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
163030690|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030691|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030692|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
163030693|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030694|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
163030695|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030696|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030697|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
163030698|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030699|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
163030700|NCT00550862|588815990|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030701|NCT00550862|588815991|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
163030702|NCT00550862|588815992|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030703|NCT00550862|588815993|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030704|NCT00550862|588815994|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
163030705|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030706|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030707|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030708|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
163030709|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
163030710|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030711|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030712|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030713|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
163030714|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
163030715|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030716|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030717|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030718|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
163030719|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
163030720|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
163030721|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
163030722|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
163030723|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
163030724|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
163030725|NCT00550862|588815990|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030726|NCT00550862|588815991|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030727|NCT00550862|588815992|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163084998|NCT03559556|589020356|FG000|Overall Study|Withdrawal by Subject|1|||
163084999|NCT02496000|589020357|FG000|Overall Study|Withdrawal by Subject|1|||
162646590|NCT01344161|587422822|FG001|Overall Study|Protocol Violation|1|||
162646591|NCT04364620|587422823|FG000|Overall Study|Disease Progression|20|||
162646592|NCT04364620|587422823|FG000|Overall Study|Adverse Event|5|||
162646593|NCT04364620|587422823|FG000|Overall Study|Physician Decision|4|||
162646594|NCT04364620|587422823|FG000|Overall Study|Death|3|||
162646595|NCT04364620|587422823|FG000|Overall Study|Other|2|||
163030728|NCT00550862|588815993|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
163030729|NCT00550862|588815994|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
163030730|NCT02248974|588815995|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
163030731|NCT02248974|588815996|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
163030732|NCT02248974|588815995|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
163030733|NCT02248974|588815996|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
163030734|NCT02248974|588815995|FG000|1-Day Follow-Up|Enrolled in another study|1|||
163030735|NCT02248974|588815996|FG001|1-Day Follow-Up|Enrolled in another study|0|||
163030736|NCT02248974|588815995|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
163030737|NCT02248974|588815996|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
163030738|NCT02248974|588815995|FG000|1-Week Follow-Up|Enrolled in another study|1|||
163030739|NCT02248974|588815996|FG001|1-Week Follow-Up|Enrolled in another study|1|||
163030740|NCT02248974|588815995|FG000|1-Week Follow-Up|Transferred to another facility|1|||
163030741|NCT02248974|588815996|FG001|1-Week Follow-Up|Transferred to another facility|0|||
163030742|NCT02248974|588815995|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
163030743|NCT02248974|588815996|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
163030744|NCT02248974|588815995|FG000|1-Week Follow-Up|Death|1|||
163030745|NCT02248974|588815996|FG001|1-Week Follow-Up|Death|1|||
163030746|NCT02248974|588815995|FG000|1-Week Follow-Up|Excluded because of age|0|||
163030747|NCT02248974|588815996|FG001|1-Week Follow-Up|Excluded because of age|1|||
163030748|NCT02248974|588815995|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
163030749|NCT02248974|588815996|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
163030750|NCT02248974|588815995|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
163030751|NCT02248974|588815996|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
163030752|NCT02248974|588815995|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
163030753|NCT02248974|588815996|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
163030754|NCT02248974|588815995|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
163030755|NCT02248974|588815996|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
163030756|NCT02248974|588815995|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
163030757|NCT02248974|588815996|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
163030758|NCT03488225|588815997|FG000|Overall Study|Off Protocol Therapy|2|||
163030759|NCT03488225|588815997|FG000|Overall Study|Stem Cell Transplant|2|||
163030760|NCT03436199|588816000|FG000|Overall Study|Adverse Event|15|||
163030761|NCT03436199|588816001|FG001|Overall Study|Adverse Event|40|||
163030762|NCT03436199|588816002|FG002|Overall Study|Adverse Event|7|||
163030763|NCT03436199|588816000|FG000|Overall Study|Withdrawal by Subject|4|||
163030764|NCT03436199|588816001|FG001|Overall Study|Withdrawal by Subject|10|||
163030765|NCT03436199|588816002|FG002|Overall Study|Withdrawal by Subject|3|||
163030766|NCT03436199|588816000|FG000|Overall Study|Lost to Follow-up|1|||
163030767|NCT03436199|588816001|FG001|Overall Study|Lost to Follow-up|0|||
163030768|NCT03436199|588816002|FG002|Overall Study|Lost to Follow-up|2|||
163030769|NCT03436199|588816000|FG000|Overall Study|Protocol Violation|1|||
163030770|NCT03436199|588816001|FG001|Overall Study|Protocol Violation|1|||
163030771|NCT03436199|588816002|FG002|Overall Study|Protocol Violation|0|||
163030772|NCT03436199|588816000|FG000|Overall Study|Physician Decision|0|||
163030773|NCT03436199|588816001|FG001|Overall Study|Physician Decision|1|||
163030774|NCT03436199|588816002|FG002|Overall Study|Physician Decision|0|||
163030775|NCT03436199|588816000|FG000|Overall Study|Could not return to clinic|1|||
163030776|NCT03436199|588816001|FG001|Overall Study|Could not return to clinic|0|||
163030777|NCT03436199|588816002|FG002|Overall Study|Could not return to clinic|0|||
163030778|NCT03436199|588816000|FG000|Overall Study|Withdrawn per physician|0|||
163030779|NCT03436199|588816001|FG001|Overall Study|Withdrawn per physician|1|||
163030780|NCT03436199|588816002|FG002|Overall Study|Withdrawn per physician|0|||
162646596|NCT04364620|587422823|FG000|Overall Study|Withdrawal by Subject|1|||
162646597|NCT01541969|587424810|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
162646598|NCT01541969|587424811|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
163030781|NCT00085098|588816003|FG000|Overall Study|Withdrawal by Subject|0|||
163030782|NCT00085098|588816004|FG001|Overall Study|Withdrawal by Subject|1|||
163030783|NCT00085098|588816003|FG000|Overall Study|Ineligible|1|||
163030784|NCT00085098|588816004|FG001|Overall Study|Ineligible|1|||
163030785|NCT00926536|588816006|FG000|Overall Study|Physician Decision|1|||
163030786|NCT00926536|588816007|FG001|Overall Study|Physician Decision|2|||
163030787|NCT00435487|588816008|FG000|Overall Study|Death|3|||
163030788|NCT00435487|588816009|FG001|Overall Study|Death|4|||
163030789|NCT00435487|588816008|FG000|Overall Study|Adverse Event|0|||
163030790|NCT00435487|588816009|FG001|Overall Study|Adverse Event|3|||
163030791|NCT00435487|588816008|FG000|Overall Study|Lost to Follow-up|2|||
163030792|NCT00435487|588816009|FG001|Overall Study|Lost to Follow-up|2|||
163030793|NCT00435487|588816008|FG000|Overall Study|Other|5|||
163030794|NCT00435487|588816009|FG001|Overall Study|Other|2|||
163030795|NCT00435487|588816008|FG000|Overall Study|Withdrawal by Subject|2|||
163030796|NCT00435487|588816009|FG001|Overall Study|Withdrawal by Subject|1|||
163030797|NCT00435487|588816008|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
163030798|NCT00435487|588816009|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
163030799|NCT00435487|588816008|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
163030800|NCT00435487|588816009|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
163030801|NCT05087966|588816010|FG000|Overall Study|Lost to Follow-up|1|||
163030802|NCT05087966|588816010|FG000|Overall Study|Withdrawal by Subject|5|||
163030803|NCT00954512|588816025|FG000|Overall Study|Withdrawal by Subject|0|||
163030804|NCT00954512|588816026|FG001|Overall Study|Withdrawal by Subject|0|||
163030805|NCT00954512|588816027|FG002|Overall Study|Withdrawal by Subject|0|||
163030806|NCT00954512|588816028|FG003|Overall Study|Withdrawal by Subject|0|||
163030807|NCT00954512|588816029|FG004|Overall Study|Withdrawal by Subject|0|||
163030808|NCT00954512|588816030|FG005|Overall Study|Withdrawal by Subject|1|||
163030809|NCT00954512|588816025|FG000|Overall Study|Adverse Event|0|||
163030810|NCT00954512|588816026|FG001|Overall Study|Adverse Event|0|||
163030811|NCT00954512|588816027|FG002|Overall Study|Adverse Event|0|||
163030812|NCT00954512|588816028|FG003|Overall Study|Adverse Event|0|||
163030813|NCT00954512|588816029|FG004|Overall Study|Adverse Event|1|||
163030814|NCT00954512|588816030|FG005|Overall Study|Adverse Event|2|||
163030815|NCT00954512|588816025|FG000|Overall Study|Physician Decision|0|||
163030816|NCT00954512|588816026|FG001|Overall Study|Physician Decision|1|||
163030817|NCT00954512|588816027|FG002|Overall Study|Physician Decision|0|||
163030818|NCT00954512|588816028|FG003|Overall Study|Physician Decision|1|||
163030819|NCT00954512|588816029|FG004|Overall Study|Physician Decision|0|||
163030820|NCT00954512|588816030|FG005|Overall Study|Physician Decision|0|||
163030821|NCT00954512|588816025|FG000|Overall Study|Symptomatic Deterioration|0|||
163030822|NCT00954512|588816026|FG001|Overall Study|Symptomatic Deterioration|1|||
163030823|NCT00954512|588816027|FG002|Overall Study|Symptomatic Deterioration|0|||
163030824|NCT00954512|588816028|FG003|Overall Study|Symptomatic Deterioration|0|||
163030825|NCT00954512|588816029|FG004|Overall Study|Symptomatic Deterioration|2|||
163030826|NCT00954512|588816030|FG005|Overall Study|Symptomatic Deterioration|0|||
163030827|NCT00954512|588816025|FG000|Overall Study|Progression of Disease|2|||
163030828|NCT00954512|588816026|FG001|Overall Study|Progression of Disease|1|||
163030829|NCT00954512|588816027|FG002|Overall Study|Progression of Disease|0|||
163030830|NCT00954512|588816028|FG003|Overall Study|Progression of Disease|1|||
163030831|NCT00954512|588816029|FG004|Overall Study|Progression of Disease|1|||
163030832|NCT00954512|588816030|FG005|Overall Study|Progression of Disease|1|||
163030833|NCT04814368|588816035|FG000|Overall Study|Study Terminated by Sponsor|0|||
163030834|NCT04814368|588816036|FG001|Overall Study|Study Terminated by Sponsor|3|||
163030835|NCT04814368|588816037|FG002|Overall Study|Study Terminated by Sponsor|0|||
163030836|NCT04814368|588816038|FG003|Overall Study|Study Terminated by Sponsor|2|||
163030837|NCT04814368|588816035|FG000|Overall Study|Subject Decision|1|||
163030838|NCT04814368|588816036|FG001|Overall Study|Subject Decision|2|||
162646599|NCT01541969|587424810|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
162646600|NCT01541969|587424811|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
163030839|NCT04814368|588816037|FG002|Overall Study|Subject Decision|0|||
162646601|NCT01541969|587424810|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
163030840|NCT04814368|588816038|FG003|Overall Study|Subject Decision|0|||
162646602|NCT01541969|587424811|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
163030841|NCT01173055|588816039|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
163030842|NCT01173055|588816040|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
163030843|NCT01173055|588816039|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
163030844|NCT01173055|588816040|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
163030845|NCT04216589|588816042|FG000|Overall Study|Withdrawal by Subject|2|||
163030846|NCT04216589|588816042|FG000|Overall Study|Protocol Violation|1|||
163030847|NCT04216589|588816042|FG000|Overall Study|Incarceration|1|||
163030848|NCT02987972|588816045|FG000|Overall Study|Adverse Event|1|||
163030849|NCT02987972|588816046|FG001|Overall Study|Adverse Event|1|||
163030850|NCT02987972|588816047|FG002|Overall Study|Adverse Event|0|||
163030851|NCT02987972|588816045|FG000|Overall Study|Death|1|||
162646603|NCT01541969|587424810|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
162646604|NCT01541969|587424811|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
163030852|NCT02987972|588816046|FG001|Overall Study|Death|0|||
163030853|NCT02987972|588816047|FG002|Overall Study|Death|0|||
163030854|NCT02987972|588816045|FG000|Overall Study|Lack of Efficacy|9|||
163030855|NCT02987972|588816046|FG001|Overall Study|Lack of Efficacy|12|||
163030856|NCT02987972|588816047|FG002|Overall Study|Lack of Efficacy|12|||
163030857|NCT02987972|588816045|FG000|Overall Study|Lost to Follow-up|7|||
163030858|NCT02987972|588816046|FG001|Overall Study|Lost to Follow-up|8|||
163030859|NCT02987972|588816047|FG002|Overall Study|Lost to Follow-up|4|||
163030860|NCT02987972|588816045|FG000|Overall Study|Physician Decision|1|||
163030861|NCT02987972|588816046|FG001|Overall Study|Physician Decision|6|||
163030862|NCT02987972|588816047|FG002|Overall Study|Physician Decision|0|||
163030863|NCT02987972|588816045|FG000|Overall Study|Protocol Violation|2|||
163030864|NCT02987972|588816046|FG001|Overall Study|Protocol Violation|1|||
163030865|NCT02987972|588816047|FG002|Overall Study|Protocol Violation|5|||
163030866|NCT02987972|588816045|FG000|Overall Study|Withdrawal by Subject|22|||
163030867|NCT02987972|588816046|FG001|Overall Study|Withdrawal by Subject|17|||
163030868|NCT02987972|588816047|FG002|Overall Study|Withdrawal by Subject|21|||
163030869|NCT02342548|588816048|FG000|Overall Study|Adverse Event|12|||
163030870|NCT02342548|588816049|FG001|Overall Study|Adverse Event|17|||
163030871|NCT02342548|588816050|FG002|Overall Study|Adverse Event|13|||
163030872|NCT02342548|588816048|FG000|Overall Study|Lost to Follow-up|0|||
163030873|NCT02342548|588816049|FG001|Overall Study|Lost to Follow-up|1|||
163030874|NCT02342548|588816050|FG002|Overall Study|Lost to Follow-up|0|||
163030875|NCT02342548|588816048|FG000|Overall Study|Study terminated by sponsor|20|||
163030876|NCT02342548|588816049|FG001|Overall Study|Study terminated by sponsor|39|||
163030877|NCT02342548|588816050|FG002|Overall Study|Study terminated by sponsor|25|||
163030878|NCT02342548|588816048|FG000|Overall Study|Protocol Violation|0|||
163030879|NCT02342548|588816049|FG001|Overall Study|Protocol Violation|1|||
163030880|NCT02342548|588816050|FG002|Overall Study|Protocol Violation|0|||
163030881|NCT02342548|588816048|FG000|Overall Study|Withdrawal by Subject|1|||
163030882|NCT02342548|588816049|FG001|Overall Study|Withdrawal by Subject|3|||
163030883|NCT02342548|588816050|FG002|Overall Study|Withdrawal by Subject|4|||
163030884|NCT02342548|588816048|FG000|Overall Study|Other|1|||
163030885|NCT02342548|588816049|FG001|Overall Study|Other|1|||
163030886|NCT02342548|588816050|FG002|Overall Study|Other|1|||
163030887|NCT01047332|588816053|FG000|Overall Study|SEMS Obstruction|11|||
163030888|NCT01047332|588816054|FG001|Overall Study|SEMS Obstruction|20|||
163030889|NCT01047332|588816053|FG000|Overall Study|Died Unobstructed|38|||
163030890|NCT01047332|588816054|FG001|Overall Study|Died Unobstructed|41|||
163030891|NCT01047332|588816053|FG000|Overall Study|Lost to Follow-up|8|||
163030892|NCT01047332|588816054|FG001|Overall Study|Lost to Follow-up|3|||
163030893|NCT03521817|588816055|FG000|Overall Study|Protocol Violation|0|||
163030894|NCT03521817|588816056|FG001|Overall Study|Protocol Violation|1|||
163030895|NCT00787917|588816057|FG000|Blinded Treatment|Adverse Event|1|||
163030896|NCT00787917|588816058|FG001|Blinded Treatment|Adverse Event|0|||
163030897|NCT00787917|588816057|FG000|Blinded Treatment|Lack of Efficacy|1|||
163030898|NCT00787917|588816058|FG001|Blinded Treatment|Lack of Efficacy|0|||
163030899|NCT00787917|588816057|FG000|Blinded Treatment|Administrative problems|3|||
163030900|NCT00787917|588816058|FG001|Blinded Treatment|Administrative problems|2|||
163030901|NCT00787917|588816057|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
163030902|NCT00787917|588816058|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
163030903|NCT00787917|588816057|FG000|Open Label|Administrative problems|3|||
163030904|NCT00787917|588816058|FG001|Open Label|Administrative problems|0|||
163030905|NCT05685732|588816060|FG000|Overall Study|Withdrawal by Subject|2|||
163030906|NCT05685732|588816061|FG001|Overall Study|Withdrawal by Subject|0|||
163030907|NCT05685732|588816062|FG002|Overall Study|Withdrawal by Subject|2|||
163030908|NCT05685732|588816063|FG003|Overall Study|Withdrawal by Subject|3|||
163030909|NCT05685732|588816060|FG000|Overall Study|Protocol Violation|1|||
163030910|NCT05685732|588816061|FG001|Overall Study|Protocol Violation|2|||
163030911|NCT05685732|588816062|FG002|Overall Study|Protocol Violation|4|||
163030912|NCT05685732|588816063|FG003|Overall Study|Protocol Violation|1|||
163030913|NCT05685732|588816060|FG000|Overall Study|Lost to Follow-up|5|||
163030914|NCT05685732|588816061|FG001|Overall Study|Lost to Follow-up|1|||
162646605|NCT01541969|587424810|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
162646606|NCT01541969|587424811|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
162646607|NCT01541969|587424810|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
163030915|NCT05685732|588816062|FG002|Overall Study|Lost to Follow-up|3|||
163030916|NCT05685732|588816063|FG003|Overall Study|Lost to Follow-up|1|||
163030917|NCT05685732|588816060|FG000|Overall Study|Adverse Event|2|||
163030918|NCT05685732|588816061|FG001|Overall Study|Adverse Event|1|||
163030919|NCT05685732|588816062|FG002|Overall Study|Adverse Event|0|||
163030920|NCT05685732|588816063|FG003|Overall Study|Adverse Event|0|||
163030921|NCT05685732|588816060|FG000|Overall Study|Physician Decision|1|||
163030922|NCT05685732|588816061|FG001|Overall Study|Physician Decision|0|||
163030923|NCT05685732|588816062|FG002|Overall Study|Physician Decision|0|||
162646608|NCT01541969|587424811|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
162646609|NCT01541969|587424810|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
162646610|NCT01541969|587424811|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
162646611|NCT01541969|587424810|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
162646612|NCT01541969|587424811|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
162646613|NCT01541969|587424810|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
162646614|NCT01541969|587424811|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
162646615|NCT01541969|587424810|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
162646616|NCT01541969|587424811|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
163030924|NCT05685732|588816063|FG003|Overall Study|Physician Decision|0|||
163030925|NCT02640404|588816064|FG000|Overall Study|Protocol Violation|1|||
163030926|NCT02640404|588816065|FG001|Overall Study|Protocol Violation|0|||
163030927|NCT02640404|588816064|FG000|Overall Study|Withdrawal by Subject|1|||
163030928|NCT02640404|588816065|FG001|Overall Study|Withdrawal by Subject|0|||
163030929|NCT00778102|588816066|FG000|Overall Study|Adverse Event|8|||
163030930|NCT00778102|588816067|FG001|Overall Study|Adverse Event|5|||
163030931|NCT00778102|588816066|FG000|Overall Study|Death|1|||
163030932|NCT00778102|588816067|FG001|Overall Study|Death|1|||
163030933|NCT00778102|588816066|FG000|Overall Study|Lost to Follow-up|1|||
163030934|NCT00778102|588816067|FG001|Overall Study|Lost to Follow-up|0|||
163030935|NCT00778102|588816066|FG000|Overall Study|Violation of Selection Criteria|1|||
163030936|NCT00778102|588816067|FG001|Overall Study|Violation of Selection Criteria|1|||
163030937|NCT00778102|588816066|FG000|Overall Study|Protocol Violation|0|||
163030938|NCT00778102|588816067|FG001|Overall Study|Protocol Violation|1|||
163030939|NCT00778102|588816066|FG000|Overall Study|Refused Treatment|2|||
163030940|NCT00778102|588816067|FG001|Overall Study|Refused Treatment|3|||
163030941|NCT00778102|588816066|FG000|Overall Study|Withdrawal by Subject|1|||
163030942|NCT00778102|588816067|FG001|Overall Study|Withdrawal by Subject|1|||
163030943|NCT00778102|588816066|FG000|Overall Study|Administrative Reason|7|||
163030944|NCT00778102|588816067|FG001|Overall Study|Administrative Reason|10|||
163030945|NCT05397171|588816068|FG000|Overall Study|Death|2|||
163030946|NCT05397171|588816069|FG001|Overall Study|Death|3|||
163030947|NCT05397171|588816070|FG002|Overall Study|Death|3|||
163030948|NCT05397171|588816068|FG000|Overall Study|Study Terminated By Sponsor|1|||
163030949|NCT05397171|588816069|FG001|Overall Study|Study Terminated By Sponsor|2|||
163030950|NCT05397171|588816070|FG002|Overall Study|Study Terminated By Sponsor|3|||
163030951|NCT05397171|588816068|FG000|Overall Study|Withdrawal by Subject|0|||
163030952|NCT05397171|588816069|FG001|Overall Study|Withdrawal by Subject|1|||
162646617|NCT01365507|587424812|FG000|Overall Study|Withdrawal Criteria|8|||
162646618|NCT01365507|587424813|FG001|Overall Study|Withdrawal Criteria|5|||
162646619|NCT01365507|587424812|FG000|Overall Study|Unclassified|1|||
162646620|NCT01365507|587424813|FG001|Overall Study|Unclassified|4|||
162646621|NCT01614990|587424814|FG000|Overall Study|Protocol Violation|1|||
162646622|NCT01614990|587424815|FG001|Overall Study|Protocol Violation|1|||
162646623|NCT02255500|587424820|FG000|Overall Study|Withdrawal by Subject|1|||
162646624|NCT02255500|587424821|FG001|Overall Study|Withdrawal by Subject|0|||
162646625|NCT04254978|587424827|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
162646626|NCT04254978|587424827|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
162646627|NCT04254978|587424827|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
162646628|NCT04254978|587424827|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
162646629|NCT04254978|587424827|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
162646630|NCT04254978|587424827|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
162646631|NCT02449239|587424828|FG000|Induction Phase|Lack of Efficacy|64|||
162646632|NCT02449239|587424828|FG000|Induction Phase|Adverse Event|1|||
162646633|NCT02449239|587424828|FG000|Induction Phase|Lost to Follow-up|1|||
162646634|NCT02449239|587424828|FG000|Induction Phase|Protocol Violation|1|||
162646635|NCT02449239|587424828|FG000|Induction Phase|Physician Decision|1|||
163030953|NCT05397171|588816070|FG002|Overall Study|Withdrawal by Subject|1|||
162646636|NCT02449239|587424828|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
162646637|NCT02449239|587424828|FG000|Induction Phase|Withdrawal by Subject|1|||
162646638|NCT02449239|587424828|FG000|Maintenance Month 3|Lack of Efficacy|14|||
163030954|NCT01328548|588816071|FG000|Overall Study|Death|3|||
163030955|NCT01328548|588816072|FG001|Overall Study|Death|0|||
163030956|NCT01328548|588816071|FG000|Overall Study|Protocol Violation|1|||
163030957|NCT01328548|588816072|FG001|Overall Study|Protocol Violation|0|||
162646639|NCT02449239|587424828|FG000|Maintenance Month 6|Lack of Efficacy|10|||
162646640|NCT02449239|587424828|FG000|Maintenance Month 6|Adverse Event|2|||
163030958|NCT04643964|588818353|FG000|Overall Study|Lost to Follow-up|55|||
163030959|NCT04643964|588818354|FG001|Overall Study|Lost to Follow-up|59|||
163030960|NCT04643964|588818355|FG002|Overall Study|Lost to Follow-up|54|||
163030961|NCT04643964|588818356|FG003|Overall Study|Lost to Follow-up|129|||
163030962|NCT04643964|588818357|FG004|Overall Study|Lost to Follow-up|48|||
163030963|NCT04643964|588818353|FG000|Overall Study|Failed attention check|1|||
163030964|NCT04643964|588818354|FG001|Overall Study|Failed attention check|8|||
163030965|NCT04643964|588818355|FG002|Overall Study|Failed attention check|2|||
163030966|NCT04643964|588818356|FG003|Overall Study|Failed attention check|14|||
163030967|NCT04643964|588818357|FG004|Overall Study|Failed attention check|11|||
163030968|NCT02368210|588818358|FG000|Overall Study|Withdrawal by Subject|1|||
163030969|NCT02368210|588818359|FG001|Overall Study|Withdrawal by Subject|0|||
163030970|NCT02368210|588818358|FG000|Overall Study|Adverse Event|0|||
163030971|NCT02368210|588818359|FG001|Overall Study|Adverse Event|1|||
163030972|NCT00078949|588818360|FG000|Overall Study|No treated|4|||
163030973|NCT00078949|588818361|FG001|Overall Study|No treated|5|||
163030974|NCT00078949|588818362|FG002|Overall Study|No treated|3|||
163030975|NCT00078949|588818363|FG003|Overall Study|No treated|3|||
163030976|NCT00590538|588818364|FG000|Overall Study|Study terminated before completed|2|||
163030977|NCT01125813|588818365|FG000|Overall Study|Death|1|||
163030978|NCT01125813|588818365|FG000|Overall Study|Withdrawal by Subject|1|||
163030979|NCT01125813|588818365|FG000|Overall Study|Screen Failures|4|||
163030980|NCT02539134|588818368|FG000|Overall Study|Lost to Follow-up|1|||
163030981|NCT02539134|588818369|FG001|Overall Study|Lost to Follow-up|0|||
163030982|NCT02539134|588818370|FG002|Overall Study|Lost to Follow-up|0|||
163030983|NCT02539134|588818371|FG003|Overall Study|Lost to Follow-up|0|||
163030984|NCT02539134|588818372|FG004|Overall Study|Lost to Follow-up|0|||
163030985|NCT02539134|588818373|FG005|Overall Study|Lost to Follow-up|0|||
163030986|NCT02255552|588818374|FG000|Overall Study|Participants enrolled into another study|0|||
163030987|NCT02255552|588818375|FG001|Overall Study|Participants enrolled into another study|11|||
163030988|NCT02255552|588818374|FG000|Overall Study|Withdrawal by Subject|1|||
163030989|NCT02255552|588818375|FG001|Overall Study|Withdrawal by Subject|4|||
163030990|NCT00558896|588818376|FG000|Overall Study|Adverse Event|1|||
163030991|NCT00558896|588818377|FG001|Overall Study|Adverse Event|1|||
163030992|NCT00558896|588818378|FG002|Overall Study|Adverse Event|1|||
163030993|NCT00558896|588818379|FG003|Overall Study|Adverse Event|3|||
163030994|NCT00558896|588818380|FG004|Overall Study|Adverse Event|4|||
163030995|NCT00558896|588818381|FG005|Overall Study|Adverse Event|10|||
163030996|NCT00558896|588818382|FG006|Overall Study|Adverse Event|3|||
163030997|NCT00558896|588818376|FG000|Overall Study|Death|3|||
163030998|NCT00558896|588818377|FG001|Overall Study|Death|0|||
163030999|NCT00558896|588818378|FG002|Overall Study|Death|2|||
163031000|NCT00558896|588818379|FG003|Overall Study|Death|3|||
163031001|NCT00558896|588818380|FG004|Overall Study|Death|2|||
163031002|NCT00558896|588818381|FG005|Overall Study|Death|2|||
163031003|NCT00558896|588818382|FG006|Overall Study|Death|6|||
163031004|NCT00558896|588818376|FG000|Overall Study|Withdrawal by Subject|2|||
163031005|NCT00558896|588818377|FG001|Overall Study|Withdrawal by Subject|1|||
163031006|NCT00558896|588818378|FG002|Overall Study|Withdrawal by Subject|1|||
163031007|NCT00558896|588818379|FG003|Overall Study|Withdrawal by Subject|1|||
163031008|NCT00558896|588818380|FG004|Overall Study|Withdrawal by Subject|1|||
163031009|NCT00558896|588818381|FG005|Overall Study|Withdrawal by Subject|5|||
163031010|NCT00558896|588818382|FG006|Overall Study|Withdrawal by Subject|5|||
163031011|NCT00558896|588818376|FG000|Overall Study|Alternative Treatment|2|||
163031012|NCT00558896|588818377|FG001|Overall Study|Alternative Treatment|2|||
163031013|NCT00558896|588818378|FG002|Overall Study|Alternative Treatment|0|||
163031014|NCT00558896|588818379|FG003|Overall Study|Alternative Treatment|2|||
163031015|NCT00558896|588818380|FG004|Overall Study|Alternative Treatment|6|||
163031016|NCT00558896|588818381|FG005|Overall Study|Alternative Treatment|7|||
163031017|NCT00558896|588818382|FG006|Overall Study|Alternative Treatment|1|||
163031018|NCT00558896|588818376|FG000|Overall Study|Physician discretion|3|||
163031019|NCT00558896|588818377|FG001|Overall Study|Physician discretion|2|||
163031020|NCT00558896|588818378|FG002|Overall Study|Physician discretion|1|||
163031021|NCT00558896|588818379|FG003|Overall Study|Physician discretion|2|||
163031022|NCT00558896|588818380|FG004|Overall Study|Physician discretion|1|||
163031023|NCT00558896|588818381|FG005|Overall Study|Physician discretion|3|||
163031024|NCT00558896|588818382|FG006|Overall Study|Physician discretion|3|||
163031025|NCT00558896|588818376|FG000|Overall Study|Continues on treatment|10|||
163031026|NCT00558896|588818377|FG001|Overall Study|Continues on treatment|1|||
163031027|NCT00558896|588818378|FG002|Overall Study|Continues on treatment|0|||
163031028|NCT00558896|588818379|FG003|Overall Study|Continues on treatment|1|||
163031029|NCT00558896|588818380|FG004|Overall Study|Continues on treatment|9|||
163031030|NCT00558896|588818381|FG005|Overall Study|Continues on treatment|25|||
163031031|NCT00558896|588818382|FG006|Overall Study|Continues on treatment|6|||
163031032|NCT03181503|588818383|FG000|Overall Study|Adverse Event|2|||
163031033|NCT03181503|588818384|FG001|Overall Study|Adverse Event|2|||
163031034|NCT03181503|588818383|FG000|Overall Study|Protocol Violation|1|||
163031035|NCT03181503|588818384|FG001|Overall Study|Protocol Violation|0|||
163031036|NCT03181503|588818383|FG000|Overall Study|Withdrawal by Subject|3|||
163031037|NCT03181503|588818384|FG001|Overall Study|Withdrawal by Subject|0|||
163031038|NCT03181503|588818383|FG000|Overall Study|Lost to Follow-up|1|||
163031039|NCT03181503|588818384|FG001|Overall Study|Lost to Follow-up|1|||
163031040|NCT02382796|588818387|FG000|Overall Study|Global deterioration of health status|1|||
163031041|NCT02382796|588818387|FG000|Overall Study|Objective progression or relapse|3|||
163031042|NCT02382796|588818387|FG000|Overall Study|Commercial dacomitinib became available|3|||
163031043|NCT03077659|588818388|FG000|Overall Study|Withdrawal by Subject|0|||
163085000|NCT02496000|589020358|FG001|Overall Study|Withdrawal by Subject|2|||
163085001|NCT02496000|589020359|FG002|Overall Study|Withdrawal by Subject|0|||
163085002|NCT02496000|589020357|FG000|Overall Study|Lost to Follow-up|1|||
163085003|NCT02496000|589020358|FG001|Overall Study|Lost to Follow-up|0|||
163085004|NCT02496000|589020359|FG002|Overall Study|Lost to Follow-up|1|||
163085005|NCT02496000|589020357|FG000|Overall Study|Protocol Violation|0|||
163085006|NCT02496000|589020358|FG001|Overall Study|Protocol Violation|0|||
163085007|NCT02496000|589020359|FG002|Overall Study|Protocol Violation|1|||
163085008|NCT02496000|589020357|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
163085009|NCT02496000|589020358|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
163085010|NCT02496000|589020359|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
163085011|NCT02496000|589020357|FG000|Overall Study|undetermined|0|||
163085012|NCT02496000|589020358|FG001|Overall Study|undetermined|1|||
163085013|NCT02496000|589020359|FG002|Overall Study|undetermined|0|||
163085014|NCT01877278|589020360|FG000|Overall Study|Lost to Follow-up|3|||
163085015|NCT01877278|589020361|FG001|Overall Study|Lost to Follow-up|3|||
163085016|NCT01969058|589020362|FG000|Overall Study|Withdrawal by Subject|2|||
163085017|NCT01969058|589020363|FG001|Overall Study|Withdrawal by Subject|0|||
163085018|NCT01969058|589020362|FG000|Overall Study|Adverse Event|1|||
163085019|NCT01969058|589020363|FG001|Overall Study|Adverse Event|0|||
163085020|NCT04090749|589020364|FG000|Open Label Pilot|Lost to Follow-up|1|||
163085021|NCT04090749|589020365|FG001|Open Label Pilot|Lost to Follow-up|0|||
163085022|NCT04090749|589020366|FG002|Open Label Pilot|Lost to Follow-up|0|||
163085023|NCT04090749|589020364|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
163085024|NCT04090749|589020365|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
163085025|NCT04090749|589020366|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
163085026|NCT04090749|589020364|FG000|Pilot Trial|Lost to Follow-up|0|||
163085027|NCT04090749|589020365|FG001|Pilot Trial|Lost to Follow-up|1|||
162646641|NCT02449239|587424828|FG000|Maintenance Month 6|Physician Decision|1|||
162646642|NCT02449239|587424828|FG000|Maintenance Month 9|Lack of Efficacy|2|||
162646643|NCT02449239|587424828|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
162646644|NCT02449239|587424828|FG000|Maintenance Month 12|Lack of Efficacy|5|||
162646645|NCT02449239|587424828|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
162646646|NCT02449239|587424828|FG000|Maintenance Month 12|Subject moved from area|1|||
163031044|NCT03077659|588818389|FG001|Overall Study|Withdrawal by Subject|0|||
163031045|NCT03077659|588818390|FG002|Overall Study|Withdrawal by Subject|1|||
163031046|NCT02258542|588818397|FG000|Overall Study|eg. not made to the visit|7|||
163031047|NCT02258542|588818398|FG001|Overall Study|eg. not made to the visit|4|||
163031048|NCT02258542|588818399|FG002|Overall Study|eg. not made to the visit|0|||
163031049|NCT02258542|588818400|FG003|Overall Study|eg. not made to the visit|1|||
163031050|NCT02258542|588818397|FG000|Overall Study|study specific discount. criteria|1|||
163031051|NCT02258542|588818398|FG001|Overall Study|study specific discount. criteria|1|||
163031052|NCT02258542|588818399|FG002|Overall Study|study specific discount. criteria|0|||
163031053|NCT02258542|588818400|FG003|Overall Study|study specific discount. criteria|0|||
163031054|NCT02258542|588818397|FG000|Overall Study|Withdrawal by Subject|20|||
163031055|NCT02258542|588818398|FG001|Overall Study|Withdrawal by Subject|20|||
163031056|NCT02258542|588818399|FG002|Overall Study|Withdrawal by Subject|7|||
163031057|NCT02258542|588818400|FG003|Overall Study|Withdrawal by Subject|1|||
163031058|NCT02258542|588818397|FG000|Overall Study|Lost to Follow-up|5|||
163031059|NCT02258542|588818398|FG001|Overall Study|Lost to Follow-up|12|||
163031060|NCT02258542|588818399|FG002|Overall Study|Lost to Follow-up|1|||
163031061|NCT02258542|588818400|FG003|Overall Study|Lost to Follow-up|2|||
163031062|NCT02258542|588818397|FG000|Overall Study|Death|5|||
163031063|NCT02258542|588818398|FG001|Overall Study|Death|4|||
163031064|NCT02258542|588818399|FG002|Overall Study|Death|0|||
163031065|NCT02258542|588818400|FG003|Overall Study|Death|1|||
163031066|NCT02258542|588818397|FG000|Overall Study|Adverse Event|3|||
163031067|NCT02258542|588818398|FG001|Overall Study|Adverse Event|4|||
163031068|NCT02258542|588818399|FG002|Overall Study|Adverse Event|0|||
163031069|NCT02258542|588818400|FG003|Overall Study|Adverse Event|0|||
163031070|NCT02258542|588818397|FG000|Overall Study|Protocol Violation|1|||
163031071|NCT02258542|588818398|FG001|Overall Study|Protocol Violation|2|||
163031072|NCT02258542|588818399|FG002|Overall Study|Protocol Violation|0|||
163031073|NCT02258542|588818400|FG003|Overall Study|Protocol Violation|0|||
163085028|NCT04090749|589020366|FG002|Pilot Trial|Lost to Follow-up|1|||
163085029|NCT03510715|589020367|FG000|Overall Study|Adverse Event|1|||
163085030|NCT03510715|589020368|FG001|Overall Study|Adverse Event|0|||
163085031|NCT01972659|589020370|FG000|Overall Study|Protocol Violation|2|||
163085032|NCT01972659|589020371|FG001|Overall Study|Protocol Violation|2|||
163085033|NCT01972659|589020370|FG000|Overall Study|problems realted to acceleromyograph|2|||
163085034|NCT01972659|589020371|FG001|Overall Study|problems realted to acceleromyograph|1|||
163031074|NCT02258542|588818397|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163031075|NCT02258542|588818398|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
163031076|NCT02258542|588818399|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163031077|NCT02258542|588818400|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
162646647|NCT02449239|587424828|FG000|Maintenance Month 15|Lack of Efficacy|1|||
162717922|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163031078|NCT04068688|588818401|FG000|Overall Study|Lost to Follow-up|1|||
163031079|NCT04068688|588818402|FG001|Overall Study|Lost to Follow-up|1|||
163031080|NCT04068688|588818403|FG002|Overall Study|Lost to Follow-up|0|||
163031081|NCT04068688|588818404|FG003|Overall Study|Lost to Follow-up|0|||
163031082|NCT04068688|588818405|FG004|Overall Study|Lost to Follow-up|5|||
163031083|NCT04068688|588818406|FG005|Overall Study|Lost to Follow-up|5|||
163031084|NCT04068688|588818407|FG006|Overall Study|Lost to Follow-up|0|||
163031085|NCT04068688|588818408|FG007|Overall Study|Lost to Follow-up|0|||
163031086|NCT04068688|588818409|FG008|Overall Study|Lost to Follow-up|1|||
163031087|NCT04068688|588818410|FG009|Overall Study|Lost to Follow-up|0|||
163031088|NCT04068688|588818401|FG000|Overall Study|Withdrawal by Subject|1|||
163031089|NCT04068688|588818402|FG001|Overall Study|Withdrawal by Subject|1|||
163031090|NCT04068688|588818403|FG002|Overall Study|Withdrawal by Subject|0|||
163031091|NCT04068688|588818404|FG003|Overall Study|Withdrawal by Subject|0|||
163031092|NCT04068688|588818405|FG004|Overall Study|Withdrawal by Subject|0|||
163031093|NCT04068688|588818406|FG005|Overall Study|Withdrawal by Subject|0|||
163031094|NCT04068688|588818407|FG006|Overall Study|Withdrawal by Subject|0|||
163031095|NCT04068688|588818408|FG007|Overall Study|Withdrawal by Subject|0|||
163031096|NCT04068688|588818409|FG008|Overall Study|Withdrawal by Subject|0|||
163031097|NCT04068688|588818410|FG009|Overall Study|Withdrawal by Subject|0|||
163031098|NCT04068688|588818401|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
163031099|NCT04068688|588818402|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
163031100|NCT04068688|588818403|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031101|NCT04068688|588818404|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031102|NCT04068688|588818405|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031103|NCT04068688|588818406|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031104|NCT04068688|588818407|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031105|NCT04068688|588818408|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031106|NCT04068688|588818409|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031107|NCT04068688|588818410|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
163031108|NCT04679051|588818411|FG000|Overall Study|felt tired after restricted time in bed|3|||
163031109|NCT04679051|588818412|FG001|Overall Study|felt tired after restricted time in bed|0|||
163031110|NCT04679051|588818411|FG000|Overall Study|discomfort with blood pressure cuff|2|||
163031111|NCT04679051|588818412|FG001|Overall Study|discomfort with blood pressure cuff|0|||
163031112|NCT04679051|588818411|FG000|Overall Study|scheduling conflict|1|||
163031113|NCT04679051|588818412|FG001|Overall Study|scheduling conflict|1|||
163031114|NCT04679051|588818411|FG000|Overall Study|Protocol Violation|0|||
163031115|NCT04679051|588818412|FG001|Overall Study|Protocol Violation|4|||
163031116|NCT00980018|588818419|FG000|Overall Study|Adverse Event|8|||
163031117|NCT00980018|588818419|FG000|Overall Study|Patient withdrew consent|3|||
163031118|NCT00980018|588818419|FG000|Overall Study|Lost to Follow-up|1|||
163031119|NCT00772005|588818422|FG000|Overall Study|Adverse Event|9|||
163031120|NCT00772005|588818423|FG001|Overall Study|Adverse Event|14|||
163031121|NCT00772005|588818424|FG002|Overall Study|Adverse Event|10|||
163031122|NCT00772005|588818425|FG003|Overall Study|Adverse Event|13|||
163031123|NCT00772005|588818422|FG000|Overall Study|Lack of Efficacy|0|||
163031124|NCT00772005|588818423|FG001|Overall Study|Lack of Efficacy|1|||
163031125|NCT00772005|588818424|FG002|Overall Study|Lack of Efficacy|0|||
163031126|NCT00772005|588818425|FG003|Overall Study|Lack of Efficacy|0|||
163031127|NCT00772005|588818422|FG000|Overall Study|Withdrawal by Subject|3|||
163031128|NCT00772005|588818423|FG001|Overall Study|Withdrawal by Subject|7|||
163031129|NCT00772005|588818424|FG002|Overall Study|Withdrawal by Subject|10|||
163031130|NCT00772005|588818425|FG003|Overall Study|Withdrawal by Subject|2|||
163031131|NCT00772005|588818422|FG000|Overall Study|Protocol Violation|2|||
163031132|NCT00772005|588818423|FG001|Overall Study|Protocol Violation|4|||
163031133|NCT00772005|588818424|FG002|Overall Study|Protocol Violation|1|||
163031134|NCT00772005|588818425|FG003|Overall Study|Protocol Violation|6|||
163031135|NCT00772005|588818422|FG000|Overall Study|Lost to Follow-up|7|||
163031136|NCT00772005|588818423|FG001|Overall Study|Lost to Follow-up|3|||
163031137|NCT00772005|588818424|FG002|Overall Study|Lost to Follow-up|6|||
163031138|NCT00772005|588818425|FG003|Overall Study|Lost to Follow-up|3|||
163031139|NCT00772005|588818422|FG000|Overall Study|Non-compliance with study procedures|1|||
163031140|NCT00772005|588818423|FG001|Overall Study|Non-compliance with study procedures|1|||
163031141|NCT00772005|588818424|FG002|Overall Study|Non-compliance with study procedures|0|||
163031142|NCT00772005|588818425|FG003|Overall Study|Non-compliance with study procedures|1|||
163031143|NCT00772005|588818422|FG000|Overall Study|Non-compliance with drug administration|3|||
163031144|NCT00772005|588818423|FG001|Overall Study|Non-compliance with drug administration|0|||
163031145|NCT00772005|588818424|FG002|Overall Study|Non-compliance with drug administration|1|||
163031146|NCT00772005|588818425|FG003|Overall Study|Non-compliance with drug administration|1|||
163031147|NCT01273155|588818429|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
163031148|NCT01273155|588818430|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
162646648|NCT02449239|587424828|FG000|Maintenance Month 21|Lack of Efficacy|1|||
162646649|NCT02449239|587424828|FG000|Maintenance Month 21|Sponsor decision|1|||
162646650|NCT03257631|587424829|FG000|Overall Study|Death|1|||
162646651|NCT03257631|587424830|FG001|Overall Study|Death|0|||
163031149|NCT01273155|588818431|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
163031150|NCT01273155|588818432|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
163031151|NCT01273155|588818433|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
163031152|NCT01273155|588818434|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
163031153|NCT01273155|588818435|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
163031154|NCT01273155|588818429|FG000|Overall Study|Change in liver function/no longer eval.|0|||
163031155|NCT01273155|588818430|FG001|Overall Study|Change in liver function/no longer eval.|1|||
163031156|NCT01273155|588818431|FG002|Overall Study|Change in liver function/no longer eval.|0|||
163031157|NCT01273155|588818432|FG003|Overall Study|Change in liver function/no longer eval.|0|||
163031158|NCT01273155|588818433|FG004|Overall Study|Change in liver function/no longer eval.|1|||
163031159|NCT01273155|588818434|FG005|Overall Study|Change in liver function/no longer eval.|0|||
163031160|NCT01273155|588818435|FG006|Overall Study|Change in liver function/no longer eval.|0|||
163031161|NCT01273155|588818429|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
163031162|NCT01273155|588818430|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
163031163|NCT01273155|588818431|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
163031164|NCT01273155|588818432|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
163031165|NCT01273155|588818433|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
163031166|NCT01273155|588818434|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
163031167|NCT01273155|588818435|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
163031168|NCT01273155|588818429|FG000|Overall Study|Died during Cycle 1|0|||
163031169|NCT01273155|588818430|FG001|Overall Study|Died during Cycle 1|0|||
163031170|NCT01273155|588818431|FG002|Overall Study|Died during Cycle 1|1|||
163031171|NCT01273155|588818432|FG003|Overall Study|Died during Cycle 1|1|||
163031172|NCT01273155|588818433|FG004|Overall Study|Died during Cycle 1|0|||
163031173|NCT01273155|588818434|FG005|Overall Study|Died during Cycle 1|2|||
163031174|NCT01273155|588818435|FG006|Overall Study|Died during Cycle 1|2|||
163031175|NCT01273155|588818429|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
163031176|NCT01273155|588818430|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
163031177|NCT01273155|588818431|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
163031178|NCT01273155|588818432|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
163031179|NCT01273155|588818433|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
163031180|NCT01273155|588818434|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
163031181|NCT01273155|588818435|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
163031182|NCT01256385|588818436|FG000|Overall Study|Physician Decision|1|||
163031183|NCT01256385|588818437|FG001|Overall Study|Physician Decision|1|||
163031184|NCT01256385|588818436|FG000|Overall Study|Withdrawal by Subject|2|||
163031185|NCT01256385|588818437|FG001|Overall Study|Withdrawal by Subject|2|||
163031186|NCT01440569|588818438|FG000|Main Study|Enrolled but not treated|1|||
163031187|NCT01440569|588818439|FG001|Main Study|Enrolled but not treated|0|||
163031188|NCT01440569|588818438|FG000|Main Study|Adverse Event|9|||
163031189|NCT01440569|588818439|FG001|Main Study|Adverse Event|0|||
163031190|NCT01440569|588818438|FG000|Main Study|Pregnancy|1|||
163031191|NCT01440569|588818439|FG001|Main Study|Pregnancy|0|||
163031192|NCT01440569|588818438|FG000|Main Study|Investigator's Discretion|1|||
163031193|NCT01440569|588818439|FG001|Main Study|Investigator's Discretion|1|||
163031194|NCT01440569|588818438|FG000|Main Study|Withdrew Consent|7|||
163031195|NCT01440569|588818439|FG001|Main Study|Withdrew Consent|1|||
163031196|NCT01440569|588818438|FG000|Main Study|Lost to Follow-up|13|||
163031197|NCT01440569|588818439|FG001|Main Study|Lost to Follow-up|2|||
163031198|NCT01440569|588818438|FG000|Main Study|Subject Non-Compliance|3|||
163031199|NCT01440569|588818439|FG001|Main Study|Subject Non-Compliance|0|||
163031200|NCT01440569|588818438|FG000|Main Study|Protocol Violation|1|||
163031201|NCT01440569|588818439|FG001|Main Study|Protocol Violation|0|||
163031202|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Adverse Event|3|||
163031203|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Adverse Event|0|||
163031204|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Pregnancy|1|||
163031205|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Pregnancy|0|||
163031206|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
163031207|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
163031208|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
163031209|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
162646652|NCT03257631|587424831|FG002|Overall Study|Death|1|||
162646653|NCT03257631|587424832|FG003|Overall Study|Death|1|||
162646654|NCT03257631|587424829|FG000|Overall Study|Progressive Disease|10|||
162646655|NCT03257631|587424830|FG001|Overall Study|Progressive Disease|9|||
163031210|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
163031211|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
162646656|NCT03257631|587424831|FG002|Overall Study|Progressive Disease|17|||
162646657|NCT03257631|587424832|FG003|Overall Study|Progressive Disease|8|||
163031212|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
163031213|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
163031214|NCT01440569|588818438|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
163031215|NCT01440569|588818439|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
163031216|NCT03887117|588818447|FG000|Overall Study|Discontinued prematurely|0|||
163031217|NCT03887117|588818448|FG001|Overall Study|Discontinued prematurely|1|||
163031218|NCT03887117|588818449|FG002|Overall Study|Discontinued prematurely|1|||
163031219|NCT03887117|588818450|FG003|Overall Study|Discontinued prematurely|2|||
163031220|NCT02584959|588818451|FG000|Period 1|Withdrawn from study|3|||
163031221|NCT02584959|588818452|FG001|Period 1|Withdrawn from study|4|||
163031222|NCT02584959|588818453|FG002|Period 1|Withdrawn from study|0|||
163031223|NCT02584959|588818451|FG000|Period 2|Withdrawn from study|6|||
163031224|NCT02584959|588818452|FG001|Period 2|Withdrawn from study|1|||
163031225|NCT02584959|588818453|FG002|Period 2|Withdrawn from study|2|||
163031226|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
163031227|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031228|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031229|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031230|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031231|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163031232|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
163031233|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031234|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031235|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031236|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031237|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
163031238|NCT04908475|588818454|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
162646658|NCT03257631|587424829|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162646659|NCT03257631|587424830|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163031239|NCT04908475|588818455|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031240|NCT04908475|588818456|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031241|NCT04908475|588818457|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031242|NCT04908475|588818458|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031243|NCT04908475|588818459|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
163031244|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031245|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
163031246|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
163031247|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
163031248|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031249|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163031250|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
163031251|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
163031252|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
163031253|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
163031254|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
163031255|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
163031256|NCT04908475|588818454|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
163031257|NCT04908475|588818455|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
163031258|NCT04908475|588818456|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
163031259|NCT04908475|588818457|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
163031260|NCT04908475|588818458|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
162646660|NCT03257631|587424831|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
162646661|NCT03257631|587424832|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
162646662|NCT03257631|587424829|FG000|Overall Study|Adverse Event|0|||
162646663|NCT03257631|587424830|FG001|Overall Study|Adverse Event|0|||
162646664|NCT03257631|587424831|FG002|Overall Study|Adverse Event|2|||
162646665|NCT03257631|587424832|FG003|Overall Study|Adverse Event|0|||
162646666|NCT03509675|587424836|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
162646667|NCT03509675|587424837|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
162646668|NCT03509675|587424836|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
162646669|NCT03509675|587424837|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
162646670|NCT03509675|587424836|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
162646671|NCT03509675|587424837|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
163031261|NCT04908475|588818459|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
163031262|NCT01267201|588818465|FG000|First Intervention Period|Withdrawal by Subject|1|||
163031263|NCT01267201|588818466|FG001|First Intervention Period|Withdrawal by Subject|0|||
163031264|NCT01267201|588818467|FG002|First Intervention Period|Withdrawal by Subject|0|||
163031265|NCT01267201|588818468|FG003|First Intervention Period|Withdrawal by Subject|0|||
163031266|NCT01267201|588818469|FG004|First Intervention Period|Withdrawal by Subject|0|||
163085035|NCT02457793|589020373|FG000|Overall Study|Reason not specified|0|||
163031267|NCT01267201|588818470|FG005|First Intervention Period|Withdrawal by Subject|0|||
163031268|NCT01267201|588818465|FG000|Second Intervention Period|Withdrawal by Subject|0|||
163031269|NCT01267201|588818466|FG001|Second Intervention Period|Withdrawal by Subject|1|||
163031270|NCT01267201|588818467|FG002|Second Intervention Period|Withdrawal by Subject|0|||
163031271|NCT01267201|588818468|FG003|Second Intervention Period|Withdrawal by Subject|0|||
163031272|NCT01267201|588818469|FG004|Second Intervention Period|Withdrawal by Subject|0|||
163031273|NCT01267201|588818470|FG005|Second Intervention Period|Withdrawal by Subject|0|||
162646672|NCT03509675|587424836|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
162646673|NCT03509675|587424837|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
162646674|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
163031274|NCT00483704|588818471|FG000|Randomization|Withdrawal by Subject|19|||
163031275|NCT00483704|588818472|FG001|Randomization|Withdrawal by Subject|28|||
163031276|NCT00483704|588818473|FG002|Randomization|Withdrawal by Subject|18|||
163031277|NCT00483704|588818471|FG000|Randomization|Protocol Violation|14|||
163031278|NCT00483704|588818472|FG001|Randomization|Protocol Violation|25|||
163031279|NCT00483704|588818473|FG002|Randomization|Protocol Violation|22|||
163031280|NCT00483704|588818471|FG000|Randomization|Lost to Follow-up|14|||
163031281|NCT00483704|588818472|FG001|Randomization|Lost to Follow-up|14|||
163031282|NCT00483704|588818473|FG002|Randomization|Lost to Follow-up|19|||
163031283|NCT00483704|588818471|FG000|Randomization|Pregnancy|1|||
163031284|NCT00483704|588818472|FG001|Randomization|Pregnancy|0|||
163031285|NCT00483704|588818473|FG002|Randomization|Pregnancy|0|||
163031286|NCT00483704|588818471|FG000|Randomization|Physician Decision|2|||
163031287|NCT00483704|588818472|FG001|Randomization|Physician Decision|4|||
163031288|NCT00483704|588818473|FG002|Randomization|Physician Decision|0|||
163031289|NCT00483704|588818471|FG000|Randomization|Progressive disease|0|||
163031290|NCT00483704|588818472|FG001|Randomization|Progressive disease|0|||
163031291|NCT00483704|588818473|FG002|Randomization|Progressive disease|1|||
163031292|NCT00483704|588818471|FG000|Randomization|Lack of qualifying migraines|21|||
163031293|NCT00483704|588818472|FG001|Randomization|Lack of qualifying migraines|25|||
162646675|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
162646676|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
162646677|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
163031294|NCT00483704|588818473|FG002|Randomization|Lack of qualifying migraines|31|||
163031295|NCT00483704|588818471|FG000|Treatment|Lack of qualifying migraines|101|||
163031296|NCT00483704|588818472|FG001|Treatment|Lack of qualifying migraines|99|||
163031297|NCT00483704|588818473|FG002|Treatment|Lack of qualifying migraines|116|||
163031298|NCT00483704|588818471|FG000|Treatment|Adverse Event|3|||
163031299|NCT00483704|588818472|FG001|Treatment|Adverse Event|5|||
163031300|NCT00483704|588818473|FG002|Treatment|Adverse Event|4|||
163031301|NCT00483704|588818471|FG000|Treatment|Withdrawal by Subject|16|||
163031302|NCT00483704|588818472|FG001|Treatment|Withdrawal by Subject|12|||
163031303|NCT00483704|588818473|FG002|Treatment|Withdrawal by Subject|21|||
163031304|NCT00483704|588818471|FG000|Treatment|Protocol Violation|6|||
163031305|NCT00483704|588818472|FG001|Treatment|Protocol Violation|3|||
163031306|NCT00483704|588818473|FG002|Treatment|Protocol Violation|5|||
163031307|NCT00483704|588818471|FG000|Treatment|Lost to Follow-up|2|||
163031308|NCT00483704|588818472|FG001|Treatment|Lost to Follow-up|7|||
163031309|NCT00483704|588818473|FG002|Treatment|Lost to Follow-up|5|||
163031310|NCT00483704|588818471|FG000|Treatment|Lack of Efficacy|1|||
163031311|NCT00483704|588818472|FG001|Treatment|Lack of Efficacy|1|||
163031312|NCT00483704|588818473|FG002|Treatment|Lack of Efficacy|1|||
163031313|NCT00483704|588818471|FG000|Treatment|Pregnancy|0|||
163031314|NCT00483704|588818472|FG001|Treatment|Pregnancy|1|||
163031315|NCT00483704|588818473|FG002|Treatment|Pregnancy|0|||
163031316|NCT00483704|588818471|FG000|Treatment|Physician Decision|0|||
163031317|NCT00483704|588818472|FG001|Treatment|Physician Decision|1|||
163031318|NCT00483704|588818473|FG002|Treatment|Physician Decision|4|||
163031319|NCT04272606|588818474|FG000|Overall Study|Protocol Violation|1|||
162646678|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
163031320|NCT04272606|588818475|FG001|Overall Study|Protocol Violation|1|||
163031321|NCT04272606|588818474|FG000|Overall Study|Physician Decision|0|||
163031322|NCT04272606|588818475|FG001|Overall Study|Physician Decision|1|||
163031323|NCT03912428|588818476|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031324|NCT03912428|588818477|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
163031325|NCT03912428|588818478|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031326|NCT03912428|588818479|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
163031327|NCT03912428|588818476|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
163031328|NCT03912428|588818477|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
163031329|NCT03912428|588818478|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
163031330|NCT03912428|588818479|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
163031331|NCT03912428|588818476|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031332|NCT03912428|588818477|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031333|NCT03912428|588818478|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
163031334|NCT03912428|588818479|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
163031335|NCT02537431|588818480|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
162646679|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
162646680|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
162646681|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
162646682|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
162646683|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
162646684|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
162646685|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
162646686|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
162646687|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
162646688|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
162717923|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717924|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717925|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717926|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717927|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717928|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
162717929|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
162717930|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162717931|NCT02914522|587673489|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717932|NCT02914522|587673490|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717933|NCT02914522|587673491|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717934|NCT02914522|587673492|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717935|NCT02914522|587673493|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717936|NCT02914522|587673494|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717937|NCT02914522|587673495|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717938|NCT02914522|587673496|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717939|NCT02914522|587673497|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717940|NCT02914522|587673498|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
162717941|NCT02914522|587673499|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162717942|NCT00639002|587673500|FG000|Overall Study|Death|1|||
162717943|NCT00639002|587673500|FG000|Overall Study|Adverse Event|1|||
162717944|NCT00639002|587673500|FG000|Overall Study|Protocol Violation|1|||
162717945|NCT00639002|587673500|FG000|Overall Study|Disease progression|3|||
162717946|NCT00639002|587673500|FG000|Overall Study|Physician Decision|6|||
162717947|NCT00639002|587673500|FG000|Overall Study|Lack of Efficacy|1|||
163031336|NCT01037127|588818487|FG000|Overall Study|Lost to Follow-up|2|||
163031337|NCT01037127|588818488|FG001|Overall Study|Lost to Follow-up|4|||
163031338|NCT01037127|588818487|FG000|Overall Study|Physician Decision|1|||
163031339|NCT01037127|588818488|FG001|Overall Study|Physician Decision|0|||
163031340|NCT01037127|588818487|FG000|Overall Study|Study Closed Terminated|2|||
163031341|NCT01037127|588818488|FG001|Overall Study|Study Closed Terminated|17|||
163031342|NCT04325698|588818489|FG000|Overall Study|Study Terminated By Sponsor|1|||
162717948|NCT00597519|587673504|FG000|Overall Study|Death|1|||
163031343|NCT04325698|588818490|FG001|Overall Study|Study Terminated By Sponsor|1|||
163031344|NCT04325698|588818489|FG000|Overall Study|Withdrawal by Subject|0|||
163031345|NCT04325698|588818490|FG001|Overall Study|Withdrawal by Subject|2|||
163031346|NCT04253782|588818491|FG000|Overall Study|Death|2|||
163031347|NCT04253782|588818492|FG001|Overall Study|Death|0|||
163031348|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031349|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031350|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
163031351|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031352|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031353|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031354|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031355|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031356|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031357|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031358|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031359|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031360|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162646689|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
162646690|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
162717949|NCT03098030|587673505|FG000|Overall Study|Death|10|||
162717950|NCT03098030|587673506|FG001|Overall Study|Death|156|||
162717951|NCT03098030|587673507|FG002|Overall Study|Death|156|||
162646691|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
163031361|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
163031362|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
163031363|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031364|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031365|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031366|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031367|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031368|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031369|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031370|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031371|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031372|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031373|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031374|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031375|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
163031376|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163031377|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
163031378|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031379|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031380|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031381|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031382|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031383|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031384|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
162646692|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
162646693|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
162646694|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
162646695|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
162646696|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
162646697|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
162646698|NCT00277212|587424838|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
162646699|NCT00277212|587424839|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
162646700|NCT00277212|587424840|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
162646701|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
162646702|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
162646703|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
162646704|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
162646705|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
162646706|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
162646707|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
162646708|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
162646709|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
162646710|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
162646711|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
162646712|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
162646713|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
162646714|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
162646715|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
162646716|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
162646717|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
162646718|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
162646719|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
162646720|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
162646721|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
162646722|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
162646723|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
162646724|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
162646725|NCT00277212|587424838|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
162646726|NCT00277212|587424839|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
162646727|NCT00277212|587424840|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
162646728|NCT03336216|587424843|FG000|Randomization|Not reported|2|||
162646729|NCT03336216|587424844|FG001|Randomization|Not reported|0|||
163031385|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031386|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
162646730|NCT03336216|587424845|FG002|Randomization|Not reported|1|||
162646731|NCT03336216|587424846|FG003|Randomization|Not reported|0|||
162646732|NCT03336216|587424843|FG000|Randomization|Other reasons|1|||
163031387|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031388|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031389|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
163031390|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
163031391|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
163031392|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031393|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031394|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031395|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031396|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031397|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031398|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031399|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031400|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031401|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031402|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031403|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163031404|NCT02326298|588818497|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031405|NCT02326298|588818498|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031406|NCT02326298|588818499|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
163031407|NCT02326298|588818500|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031408|NCT02326298|588818501|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031409|NCT02326298|588818502|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031410|NCT02326298|588818503|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031411|NCT02326298|588818504|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031412|NCT02326298|588818505|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031413|NCT02326298|588818506|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031414|NCT02326298|588818507|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031415|NCT02326298|588818508|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031416|NCT02326298|588818509|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031417|NCT02326298|588818510|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
163031418|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031419|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031420|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031421|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031422|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031423|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031424|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
163031425|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031426|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031427|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
163031428|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031429|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031430|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031431|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163031432|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031433|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031434|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031435|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031436|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031437|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
163031438|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
163031439|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031440|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
163031441|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031442|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031443|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163085036|NCT02457793|589020374|FG001|Overall Study|Reason not specified|0|||
163085037|NCT02457793|589020375|FG002|Overall Study|Reason not specified|0|||
163085038|NCT02457793|589020376|FG003|Overall Study|Reason not specified|1|||
163085039|NCT02457793|589020377|FG004|Overall Study|Reason not specified|1|||
163031444|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031445|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
163031446|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031447|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031448|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031449|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031450|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031451|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
163031452|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031453|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031454|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031455|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031456|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031457|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031458|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031459|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
163031460|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031461|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031462|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031463|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031464|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031465|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031466|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
163031467|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031468|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031469|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031470|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031471|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031472|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031473|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
163031474|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031475|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031476|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031477|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031478|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031479|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031480|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031481|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
163031482|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031483|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031484|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031485|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031486|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031487|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
163031488|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031489|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031490|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031491|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031492|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031493|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031494|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
163031495|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
163031496|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031497|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031498|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162646733|NCT03336216|587424844|FG001|Randomization|Other reasons|1|||
162646734|NCT03336216|587424845|FG002|Randomization|Other reasons|1|||
162646735|NCT03336216|587424846|FG003|Randomization|Other reasons|0|||
163031499|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031500|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163031501|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162646736|NCT03336216|587424843|FG000|Randomization|Participant no longer meets study criteria|0|||
163031502|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031503|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031504|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031505|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031506|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031507|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031508|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031509|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
163031510|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031511|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031512|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031513|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031514|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031515|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163031516|NCT02326298|588818497|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031517|NCT02326298|588818498|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031518|NCT02326298|588818499|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031519|NCT02326298|588818500|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031520|NCT02326298|588818501|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031521|NCT02326298|588818502|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
163031522|NCT02326298|588818503|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031523|NCT02326298|588818504|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031524|NCT02326298|588818505|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031525|NCT02326298|588818506|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031526|NCT02326298|588818507|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031527|NCT02326298|588818508|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031528|NCT02326298|588818509|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031529|NCT02326298|588818510|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
163031530|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
163031531|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
163031532|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
163031533|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
163031534|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
163031535|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
163031536|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
163031537|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
163031538|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
163031539|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
163031540|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
163031541|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
163031542|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
163031543|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
163031544|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031545|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031546|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031547|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031548|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031549|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031550|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031551|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031552|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031553|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031554|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031555|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163085040|NCT02457793|589020378|FG005|Overall Study|Reason not specified|1|||
162646737|NCT03336216|587424844|FG001|Randomization|Participant no longer meets study criteria|2|||
162646738|NCT03336216|587424845|FG002|Randomization|Participant no longer meets study criteria|4|||
162646739|NCT03336216|587424846|FG003|Randomization|Participant no longer meets study criteria|1|||
163085041|NCT02457793|589020373|FG000|Overall Study|Withdrawal by Subject|0|||
163085042|NCT02457793|589020374|FG001|Overall Study|Withdrawal by Subject|4|||
163085043|NCT02457793|589020375|FG002|Overall Study|Withdrawal by Subject|2|||
162646740|NCT03336216|587424843|FG000|Randomization|Lost to Follow-up|1|||
162646741|NCT03336216|587424844|FG001|Randomization|Lost to Follow-up|0|||
162646742|NCT03336216|587424845|FG002|Randomization|Lost to Follow-up|0|||
162646743|NCT03336216|587424846|FG003|Randomization|Lost to Follow-up|0|||
162646744|NCT03336216|587424843|FG000|Randomization|Participant withdrew consent|9|||
162646745|NCT03336216|587424844|FG001|Randomization|Participant withdrew consent|1|||
162646746|NCT03336216|587424845|FG002|Randomization|Participant withdrew consent|0|||
162646747|NCT03336216|587424846|FG003|Randomization|Participant withdrew consent|0|||
162646748|NCT03336216|587424843|FG000|Randomization|Adverse Event|1|||
162646749|NCT03336216|587424844|FG001|Randomization|Adverse Event|1|||
162646750|NCT03336216|587424845|FG002|Randomization|Adverse Event|0|||
162646751|NCT03336216|587424846|FG003|Randomization|Adverse Event|0|||
162646752|NCT03336216|587424843|FG000|Treatment|Adverse Event|2|||
162646753|NCT03336216|587424844|FG001|Treatment|Adverse Event|3|||
162646754|NCT03336216|587424845|FG002|Treatment|Adverse Event|4|||
162646755|NCT03336216|587424846|FG003|Treatment|Adverse Event|4|||
162646756|NCT03336216|587424843|FG000|Treatment|Participant request to discontinue treatment|2|||
162646757|NCT03336216|587424844|FG001|Treatment|Participant request to discontinue treatment|1|||
162646758|NCT03336216|587424845|FG002|Treatment|Participant request to discontinue treatment|2|||
162646759|NCT03336216|587424846|FG003|Treatment|Participant request to discontinue treatment|2|||
162646760|NCT03336216|587424843|FG000|Treatment|Participant withdrew consent|7|||
162646761|NCT03336216|587424844|FG001|Treatment|Participant withdrew consent|2|||
162646762|NCT03336216|587424845|FG002|Treatment|Participant withdrew consent|3|||
162646763|NCT03336216|587424846|FG003|Treatment|Participant withdrew consent|2|||
162646764|NCT03336216|587424843|FG000|Treatment|Death|2|||
162646765|NCT03336216|587424844|FG001|Treatment|Death|3|||
162646766|NCT03336216|587424845|FG002|Treatment|Death|3|||
162646767|NCT03336216|587424846|FG003|Treatment|Death|4|||
162646768|NCT03336216|587424843|FG000|Treatment|Participant no longer meets study criteria|0|||
162646769|NCT03336216|587424844|FG001|Treatment|Participant no longer meets study criteria|1|||
162646770|NCT03336216|587424845|FG002|Treatment|Participant no longer meets study criteria|0|||
162646771|NCT03336216|587424846|FG003|Treatment|Participant no longer meets study criteria|0|||
162646772|NCT03336216|587424843|FG000|Treatment|Other reasons|2|||
162646773|NCT03336216|587424844|FG001|Treatment|Other reasons|0|||
162646774|NCT03336216|587424845|FG002|Treatment|Other reasons|0|||
162646775|NCT03336216|587424846|FG003|Treatment|Other reasons|3|||
162646776|NCT03336216|587424843|FG000|Treatment|Disease progression|23|||
162717952|NCT03098030|587673508|FG003|Overall Study|Death|82|||
163031556|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
163031557|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
163031558|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031559|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031560|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031561|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031562|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031563|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031564|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031565|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031566|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031567|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031568|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031569|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163031570|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
163031571|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163031572|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031573|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031574|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031575|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031576|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031577|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031578|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031579|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031580|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031581|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
162646777|NCT03336216|587424844|FG001|Treatment|Disease progression|34|||
162646778|NCT03336216|587424845|FG002|Treatment|Disease progression|33|||
162646779|NCT03336216|587424846|FG003|Treatment|Disease progression|26|||
162646780|NCT03336216|587424843|FG000|Treatment|Study drug toxicity|0|||
162646781|NCT03336216|587424844|FG001|Treatment|Study drug toxicity|3|||
162646782|NCT03336216|587424845|FG002|Treatment|Study drug toxicity|2|||
163085044|NCT02457793|589020376|FG003|Overall Study|Withdrawal by Subject|2|||
163085045|NCT02457793|589020377|FG004|Overall Study|Withdrawal by Subject|2|||
163085046|NCT02457793|589020378|FG005|Overall Study|Withdrawal by Subject|2|||
163085047|NCT02457793|589020373|FG000|Overall Study|Adverse Event|0|||
163085048|NCT02457793|589020374|FG001|Overall Study|Adverse Event|0|||
163085049|NCT02457793|589020375|FG002|Overall Study|Adverse Event|0|||
163085050|NCT02457793|589020376|FG003|Overall Study|Adverse Event|1|||
163085051|NCT02457793|589020377|FG004|Overall Study|Adverse Event|0|||
163085052|NCT02457793|589020378|FG005|Overall Study|Adverse Event|0|||
163085053|NCT02457793|589020373|FG000|Overall Study|Physician Decision|1|||
163085054|NCT02457793|589020374|FG001|Overall Study|Physician Decision|0|||
162646783|NCT03336216|587424846|FG003|Treatment|Study drug toxicity|0|||
162646784|NCT03336216|587424843|FG000|Treatment|Adverse Event unrelated to study drug|1|||
162646785|NCT03336216|587424844|FG001|Treatment|Adverse Event unrelated to study drug|1|||
162646786|NCT03336216|587424845|FG002|Treatment|Adverse Event unrelated to study drug|1|||
162646787|NCT03336216|587424846|FG003|Treatment|Adverse Event unrelated to study drug|0|||
162646788|NCT03336216|587424843|FG000|Treatment|Disease Recurrence|1|||
163031582|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031583|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031584|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
163031585|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
163031586|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031587|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031588|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031589|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031590|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031591|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031592|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031593|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031594|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031595|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031596|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163031597|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
163031598|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
163031599|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
163031600|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031601|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031602|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031603|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031604|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031605|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031606|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031607|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031608|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031609|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031610|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
163031611|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
163031612|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
163031613|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
163031614|NCT02326298|588818497|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031615|NCT02326298|588818498|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031616|NCT02326298|588818499|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031617|NCT02326298|588818500|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031618|NCT02326298|588818501|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031619|NCT02326298|588818502|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031620|NCT02326298|588818503|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031621|NCT02326298|588818504|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031622|NCT02326298|588818505|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031623|NCT02326298|588818506|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031624|NCT02326298|588818507|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163031625|NCT02326298|588818508|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
163031626|NCT02326298|588818509|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
163085055|NCT02457793|589020375|FG002|Overall Study|Physician Decision|1|||
163085056|NCT02457793|589020376|FG003|Overall Study|Physician Decision|1|||
163085057|NCT02457793|589020377|FG004|Overall Study|Physician Decision|1|||
162646789|NCT03336216|587424844|FG001|Treatment|Disease Recurrence|0|||
162646790|NCT03336216|587424845|FG002|Treatment|Disease Recurrence|0|||
163031627|NCT02326298|588818510|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
163031628|NCT02889835|588818511|FG000|Overall Study|Lost to Follow-up|13|||
163031629|NCT02889835|588818512|FG001|Overall Study|Lost to Follow-up|13|||
163031630|NCT02889835|588818513|FG002|Overall Study|Lost to Follow-up|13|||
163031631|NCT02889835|588818511|FG000|Overall Study|Withdrawal by Subject|2|||
163031632|NCT02889835|588818512|FG001|Overall Study|Withdrawal by Subject|2|||
163031633|NCT02889835|588818513|FG002|Overall Study|Withdrawal by Subject|2|||
163031634|NCT02889835|588818511|FG000|Overall Study|Protocol Violation|1|||
163031635|NCT02889835|588818512|FG001|Overall Study|Protocol Violation|1|||
163031636|NCT02889835|588818513|FG002|Overall Study|Protocol Violation|1|||
163031637|NCT02889835|588818511|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
163031638|NCT02889835|588818512|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
163031639|NCT02889835|588818513|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
163031640|NCT02889835|588818511|FG000|Overall Study|Death|1|||
163031641|NCT02889835|588818512|FG001|Overall Study|Death|1|||
163031642|NCT02889835|588818513|FG002|Overall Study|Death|1|||
163031643|NCT01709864|588820257|FG000|Overall Study|Physician Decision|0|||
163031644|NCT01709864|588820258|FG001|Overall Study|Physician Decision|1|||
163031645|NCT01709864|588820257|FG000|Overall Study|subject/guardian decision|5|||
163031646|NCT01709864|588820258|FG001|Overall Study|subject/guardian decision|6|||
163031647|NCT01709864|588820257|FG000|Overall Study|Lost to Follow-up|1|||
163031648|NCT01709864|588820258|FG001|Overall Study|Lost to Follow-up|0|||
163031649|NCT01709864|588820257|FG000|Overall Study|non-compliance with study treatment|1|||
163031650|NCT01709864|588820258|FG001|Overall Study|non-compliance with study treatment|1|||
163031651|NCT01709864|588820257|FG000|Overall Study|Adverse Event|0|||
163031652|NCT01709864|588820258|FG001|Overall Study|Adverse Event|2|||
163031653|NCT01709864|588820257|FG000|Overall Study|Death|0|||
163031654|NCT01709864|588820258|FG001|Overall Study|Death|1|||
163031655|NCT01066793|588820259|FG000|Overall Study|Death|4|||
163031656|NCT01066793|588820260|FG001|Overall Study|Death|1|||
163031657|NCT01066793|588820261|FG002|Overall Study|Death|1|||
163031658|NCT01066793|588820262|FG003|Overall Study|Death|0|||
163031659|NCT01066793|588820263|FG004|Overall Study|Death|0|||
163031660|NCT01066793|588820264|FG005|Overall Study|Death|0|||
163031661|NCT01066793|588820259|FG000|Overall Study|Lack of Efficacy|2|||
163031662|NCT01066793|588820260|FG001|Overall Study|Lack of Efficacy|1|||
163031663|NCT01066793|588820261|FG002|Overall Study|Lack of Efficacy|0|||
163031664|NCT01066793|588820262|FG003|Overall Study|Lack of Efficacy|0|||
163031665|NCT01066793|588820263|FG004|Overall Study|Lack of Efficacy|0|||
163031666|NCT01066793|588820264|FG005|Overall Study|Lack of Efficacy|0|||
163031667|NCT01066793|588820259|FG000|Overall Study|Lost to Follow-up|180|||
163031668|NCT01066793|588820260|FG001|Overall Study|Lost to Follow-up|39|||
163031669|NCT01066793|588820261|FG002|Overall Study|Lost to Follow-up|82|||
163031670|NCT01066793|588820262|FG003|Overall Study|Lost to Follow-up|16|||
163031671|NCT01066793|588820263|FG004|Overall Study|Lost to Follow-up|0|||
163031672|NCT01066793|588820264|FG005|Overall Study|Lost to Follow-up|1|||
163031673|NCT01066793|588820259|FG000|Overall Study|Physician Decision|3|||
162646791|NCT03336216|587424846|FG003|Treatment|Disease Recurrence|0|||
162646792|NCT03239470|587424849|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
162646793|NCT03239470|587424850|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
162646794|NCT01023581|587424851|FG000|Overall Study|Adverse Event|4|||
162646795|NCT01023581|587424852|FG001|Overall Study|Adverse Event|4|||
162646796|NCT01023581|587424853|FG002|Overall Study|Adverse Event|7|||
162646797|NCT01023581|587424854|FG003|Overall Study|Adverse Event|3|||
163031674|NCT01066793|588820260|FG001|Overall Study|Physician Decision|0|||
163031675|NCT01066793|588820261|FG002|Overall Study|Physician Decision|0|||
163031676|NCT01066793|588820262|FG003|Overall Study|Physician Decision|0|||
163031677|NCT01066793|588820263|FG004|Overall Study|Physician Decision|0|||
163031678|NCT01066793|588820264|FG005|Overall Study|Physician Decision|0|||
163031679|NCT01066793|588820259|FG000|Overall Study|Protocol Violation|3|||
163031680|NCT01066793|588820260|FG001|Overall Study|Protocol Violation|2|||
163085058|NCT02457793|589020378|FG005|Overall Study|Physician Decision|3|||
163031681|NCT01066793|588820261|FG002|Overall Study|Protocol Violation|2|||
163031682|NCT01066793|588820262|FG003|Overall Study|Protocol Violation|0|||
163031683|NCT01066793|588820263|FG004|Overall Study|Protocol Violation|0|||
162646798|NCT01023581|587424855|FG004|Overall Study|Adverse Event|2|||
163031684|NCT01066793|588820264|FG005|Overall Study|Protocol Violation|0|||
163031685|NCT01066793|588820259|FG000|Overall Study|Withdrawal by Subject|7|||
163031686|NCT01066793|588820260|FG001|Overall Study|Withdrawal by Subject|4|||
163031687|NCT01066793|588820261|FG002|Overall Study|Withdrawal by Subject|1|||
163031688|NCT01066793|588820262|FG003|Overall Study|Withdrawal by Subject|0|||
163031689|NCT01066793|588820263|FG004|Overall Study|Withdrawal by Subject|0|||
163031690|NCT01066793|588820264|FG005|Overall Study|Withdrawal by Subject|0|||
163031691|NCT01066793|588820259|FG000|Overall Study|Early Termination|3|||
163031692|NCT01066793|588820260|FG001|Overall Study|Early Termination|0|||
163031693|NCT01066793|588820261|FG002|Overall Study|Early Termination|0|||
163031694|NCT01066793|588820262|FG003|Overall Study|Early Termination|0|||
163031695|NCT01066793|588820263|FG004|Overall Study|Early Termination|0|||
162646799|NCT01023581|587424856|FG005|Overall Study|Adverse Event|5|||
162646800|NCT01023581|587424857|FG006|Overall Study|Adverse Event|11|||
162646801|NCT01023581|587424851|FG000|Overall Study|Major protocol deviation|2|||
162646802|NCT01023581|587424852|FG001|Overall Study|Major protocol deviation|0|||
162646803|NCT01023581|587424853|FG002|Overall Study|Major protocol deviation|3|||
162646804|NCT01023581|587424854|FG003|Overall Study|Major protocol deviation|0|||
162646805|NCT01023581|587424855|FG004|Overall Study|Major protocol deviation|0|||
162646806|NCT01023581|587424856|FG005|Overall Study|Major protocol deviation|0|||
162646807|NCT01023581|587424857|FG006|Overall Study|Major protocol deviation|0|||
162646808|NCT01023581|587424851|FG000|Overall Study|Lost to Follow-up|4|||
162646809|NCT01023581|587424852|FG001|Overall Study|Lost to Follow-up|8|||
162646810|NCT01023581|587424853|FG002|Overall Study|Lost to Follow-up|7|||
162646811|NCT01023581|587424854|FG003|Overall Study|Lost to Follow-up|2|||
163031696|NCT01066793|588820264|FG005|Overall Study|Early Termination|0|||
163031697|NCT01066793|588820259|FG000|Overall Study|Lab test not done|7|||
163031698|NCT01066793|588820260|FG001|Overall Study|Lab test not done|0|||
162646812|NCT01023581|587424855|FG004|Overall Study|Lost to Follow-up|5|||
163031699|NCT01066793|588820261|FG002|Overall Study|Lab test not done|0|||
163031700|NCT01066793|588820262|FG003|Overall Study|Lab test not done|1|||
163031701|NCT01066793|588820263|FG004|Overall Study|Lab test not done|0|||
163031702|NCT01066793|588820264|FG005|Overall Study|Lab test not done|0|||
163031703|NCT01066793|588820259|FG000|Overall Study|Miscellaneous|4|||
163031704|NCT01066793|588820260|FG001|Overall Study|Miscellaneous|5|||
163031705|NCT01066793|588820261|FG002|Overall Study|Miscellaneous|6|||
163031706|NCT01066793|588820262|FG003|Overall Study|Miscellaneous|0|||
163031707|NCT01066793|588820263|FG004|Overall Study|Miscellaneous|0|||
163031708|NCT01066793|588820264|FG005|Overall Study|Miscellaneous|0|||
163031709|NCT01066793|588820259|FG000|Overall Study|Non-responders|104|||
163031710|NCT01066793|588820260|FG001|Overall Study|Non-responders|5|||
163031711|NCT01066793|588820261|FG002|Overall Study|Non-responders|11|||
163031712|NCT01066793|588820262|FG003|Overall Study|Non-responders|25|||
163031713|NCT01066793|588820263|FG004|Overall Study|Non-responders|0|||
163031714|NCT01066793|588820264|FG005|Overall Study|Non-responders|0|||
163031715|NCT01066793|588820259|FG000|Overall Study|Other|15|||
163031716|NCT01066793|588820260|FG001|Overall Study|Other|5|||
163031717|NCT01066793|588820261|FG002|Overall Study|Other|6|||
163031718|NCT01066793|588820262|FG003|Overall Study|Other|2|||
163031719|NCT01066793|588820263|FG004|Overall Study|Other|0|||
163031720|NCT01066793|588820264|FG005|Overall Study|Other|0|||
163031721|NCT01066793|588820259|FG000|Overall Study|Relapse|20|||
163031722|NCT01066793|588820260|FG001|Overall Study|Relapse|8|||
163031723|NCT01066793|588820261|FG002|Overall Study|Relapse|2|||
163031724|NCT01066793|588820262|FG003|Overall Study|Relapse|3|||
163031725|NCT01066793|588820263|FG004|Overall Study|Relapse|0|||
163031726|NCT01066793|588820264|FG005|Overall Study|Relapse|0|||
163031727|NCT01066793|588820259|FG000|Overall Study|Result Not Available|1|||
163031728|NCT01066793|588820260|FG001|Overall Study|Result Not Available|0|||
163031729|NCT01066793|588820261|FG002|Overall Study|Result Not Available|0|||
163031730|NCT01066793|588820262|FG003|Overall Study|Result Not Available|0|||
163031731|NCT01066793|588820263|FG004|Overall Study|Result Not Available|0|||
163031732|NCT01066793|588820264|FG005|Overall Study|Result Not Available|0|||
163031733|NCT01066793|588820259|FG000|Overall Study|Treatment Interrupted|1|||
163031734|NCT01066793|588820260|FG001|Overall Study|Treatment Interrupted|1|||
163031735|NCT01066793|588820261|FG002|Overall Study|Treatment Interrupted|0|||
163031736|NCT01066793|588820262|FG003|Overall Study|Treatment Interrupted|0|||
163031737|NCT01066793|588820263|FG004|Overall Study|Treatment Interrupted|0|||
163031738|NCT01066793|588820264|FG005|Overall Study|Treatment Interrupted|0|||
163031739|NCT01066793|588820259|FG000|Overall Study|Treatment Never Started|18|||
163031740|NCT01066793|588820260|FG001|Overall Study|Treatment Never Started|5|||
163031741|NCT01066793|588820261|FG002|Overall Study|Treatment Never Started|4|||
163031742|NCT01066793|588820262|FG003|Overall Study|Treatment Never Started|1|||
163031743|NCT01066793|588820263|FG004|Overall Study|Treatment Never Started|0|||
163031744|NCT01066793|588820264|FG005|Overall Study|Treatment Never Started|0|||
163031745|NCT01066793|588820259|FG000|Overall Study|Treatment Stopped|2|||
162646813|NCT01023581|587424856|FG005|Overall Study|Lost to Follow-up|2|||
162646814|NCT01023581|587424857|FG006|Overall Study|Lost to Follow-up|2|||
162646815|NCT01023581|587424851|FG000|Overall Study|Withdrawal by Subject|13|||
162646816|NCT01023581|587424852|FG001|Overall Study|Withdrawal by Subject|8|||
163031746|NCT01066793|588820260|FG001|Overall Study|Treatment Stopped|1|||
163031747|NCT01066793|588820261|FG002|Overall Study|Treatment Stopped|0|||
163031748|NCT01066793|588820262|FG003|Overall Study|Treatment Stopped|1|||
163031749|NCT01066793|588820263|FG004|Overall Study|Treatment Stopped|0|||
163031750|NCT01066793|588820264|FG005|Overall Study|Treatment Stopped|0|||
163031751|NCT02697916|588820265|FG000|Overall Study|Death|357|||
163031752|NCT02697916|588820266|FG001|Overall Study|Death|315|||
163031753|NCT02697916|588820265|FG000|Overall Study|Withdrawal by Subject|221|||
163031754|NCT02697916|588820266|FG001|Overall Study|Withdrawal by Subject|393|||
163031755|NCT02864316|588820267|FG000|Overall Study|Progressive Disease|2|||
163031756|NCT02864316|588820268|FG001|Overall Study|Progressive Disease|1|||
163031757|NCT02864316|588820267|FG000|Overall Study|Adverse Event|0|||
163031758|NCT02864316|588820268|FG001|Overall Study|Adverse Event|1|||
163031759|NCT02607280|588820270|FG000|Overall Study|Adverse Event|4|||
163031760|NCT02607280|588820271|FG001|Overall Study|Adverse Event|0|||
163031761|NCT02607280|588820270|FG000|Overall Study|Decrease in CrCl <15|0|||
163031762|NCT02607280|588820271|FG001|Overall Study|Decrease in CrCl <15|1|||
163031763|NCT01447446|588820272|FG000|Overall Study|Death|6|||
163031764|NCT01447446|588820273|FG001|Overall Study|Death|3|||
163031765|NCT01447446|588820274|FG002|Overall Study|Death|2|||
163031766|NCT01447446|588820275|FG003|Overall Study|Death|1|||
163031767|NCT01447446|588820276|FG004|Overall Study|Death|7|||
163031768|NCT01447446|588820277|FG005|Overall Study|Death|0|||
163031769|NCT01447446|588820272|FG000|Overall Study|Adverse Event|3|||
163031770|NCT01447446|588820273|FG001|Overall Study|Adverse Event|0|||
163031771|NCT01447446|588820274|FG002|Overall Study|Adverse Event|1|||
163031772|NCT01447446|588820275|FG003|Overall Study|Adverse Event|0|||
163031773|NCT01447446|588820276|FG004|Overall Study|Adverse Event|2|||
163031774|NCT01447446|588820277|FG005|Overall Study|Adverse Event|0|||
163031775|NCT01447446|588820272|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
163031776|NCT01447446|588820273|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
163031777|NCT01447446|588820274|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
163031778|NCT01447446|588820275|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
163031779|NCT01447446|588820276|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
163031780|NCT01447446|588820277|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
163031781|NCT01447446|588820272|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
163031782|NCT01447446|588820273|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
163031783|NCT01447446|588820274|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
163031784|NCT01447446|588820275|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
163031785|NCT01447446|588820276|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
163031786|NCT01447446|588820277|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
163031787|NCT01447446|588820272|FG000|Overall Study|Administrative/Other|34|||
163031788|NCT01447446|588820273|FG001|Overall Study|Administrative/Other|9|||
163031789|NCT01447446|588820274|FG002|Overall Study|Administrative/Other|10|||
163031790|NCT01447446|588820275|FG003|Overall Study|Administrative/Other|2|||
163031791|NCT01447446|588820276|FG004|Overall Study|Administrative/Other|33|||
163031792|NCT01447446|588820277|FG005|Overall Study|Administrative/Other|4|||
163031793|NCT01447446|588820272|FG000|Overall Study|SVR12 Assessment|13|||
163031794|NCT01447446|588820273|FG001|Overall Study|SVR12 Assessment|1|||
163031795|NCT01447446|588820274|FG002|Overall Study|SVR12 Assessment|2|||
163031796|NCT01447446|588820275|FG003|Overall Study|SVR12 Assessment|1|||
163031797|NCT01447446|588820276|FG004|Overall Study|SVR12 Assessment|5|||
163031798|NCT01447446|588820277|FG005|Overall Study|SVR12 Assessment|5|||
163031799|NCT01447446|588820272|FG000|Overall Study|New Treatment Started|8|||
163031800|NCT01447446|588820273|FG001|Overall Study|New Treatment Started|2|||
163031801|NCT01447446|588820274|FG002|Overall Study|New Treatment Started|1|||
163031802|NCT01447446|588820275|FG003|Overall Study|New Treatment Started|0|||
163031803|NCT01447446|588820276|FG004|Overall Study|New Treatment Started|2|||
163031804|NCT01447446|588820277|FG005|Overall Study|New Treatment Started|0|||
163031805|NCT01447446|588820272|FG000|Overall Study|Reason not Specified|1|||
163031806|NCT01447446|588820273|FG001|Overall Study|Reason not Specified|1|||
163031807|NCT01447446|588820274|FG002|Overall Study|Reason not Specified|1|||
163031808|NCT01447446|588820275|FG003|Overall Study|Reason not Specified|1|||
163031809|NCT01447446|588820276|FG004|Overall Study|Reason not Specified|1|||
163031810|NCT01447446|588820277|FG005|Overall Study|Reason not Specified|0|||
163085059|NCT00791648|589022209|FG000|Overall Study|Physician Decision|0|||
163085060|NCT00791648|589022210|FG001|Overall Study|Physician Decision|1|||
163085061|NCT00791648|589022209|FG000|Overall Study|Withdrawal by Subject|0|||
162646817|NCT01023581|587424853|FG002|Overall Study|Withdrawal by Subject|16|||
162646818|NCT01023581|587424854|FG003|Overall Study|Withdrawal by Subject|10|||
162646819|NCT01023581|587424855|FG004|Overall Study|Withdrawal by Subject|6|||
162646820|NCT01023581|587424856|FG005|Overall Study|Withdrawal by Subject|8|||
162646821|NCT01023581|587424857|FG006|Overall Study|Withdrawal by Subject|5|||
163085062|NCT00791648|589022210|FG001|Overall Study|Withdrawal by Subject|1|||
163085063|NCT03396445|589022211|FG000|Treatment Period|Death|2|||
163085064|NCT03396445|589022212|FG001|Treatment Period|Death|2|||
163085065|NCT03396445|589022213|FG002|Treatment Period|Death|1|||
163085066|NCT03396445|589022214|FG003|Treatment Period|Death|1|||
162646822|NCT01023581|587424851|FG000|Overall Study|Pregnancy|0|||
162646823|NCT01023581|587424852|FG001|Overall Study|Pregnancy|0|||
162646824|NCT01023581|587424853|FG002|Overall Study|Pregnancy|0|||
163031811|NCT02052596|588820278|FG000|Active Phase|Adverse Event|3|||
163031812|NCT02052596|588820279|FG001|Active Phase|Adverse Event|2|||
162646825|NCT01023581|587424854|FG003|Overall Study|Pregnancy|2|||
162646826|NCT01023581|587424855|FG004|Overall Study|Pregnancy|0|||
162646827|NCT01023581|587424856|FG005|Overall Study|Pregnancy|1|||
163031813|NCT02052596|588820278|FG000|Active Phase|Lost to Follow-up|8|||
163031814|NCT02052596|588820279|FG001|Active Phase|Lost to Follow-up|11|||
163085067|NCT03396445|589022215|FG004|Treatment Period|Death|3|||
163085068|NCT03396445|589022216|FG005|Treatment Period|Death|2|||
163085069|NCT03396445|589022217|FG006|Treatment Period|Death|5|||
163085070|NCT03396445|589022218|FG007|Treatment Period|Death|3|||
163085071|NCT03396445|589022219|FG008|Treatment Period|Death|3|||
163085072|NCT03396445|589022220|FG009|Treatment Period|Death|3|||
163085073|NCT03396445|589022221|FG010|Treatment Period|Death|7|||
163085074|NCT03396445|589022222|FG011|Treatment Period|Death|12|||
163085075|NCT03396445|589022223|FG012|Treatment Period|Death|28|||
163031815|NCT02052596|588820278|FG000|Active Phase|Protocol Violation|1|||
163031816|NCT02052596|588820279|FG001|Active Phase|Protocol Violation|2|||
163031817|NCT02052596|588820278|FG000|Active Phase|Withdrawal by Subject|3|||
163031818|NCT02052596|588820279|FG001|Active Phase|Withdrawal by Subject|4|||
163031819|NCT02052596|588820278|FG000|Active Phase|Enrolled in error|1|||
163031820|NCT02052596|588820279|FG001|Active Phase|Enrolled in error|0|||
163031821|NCT02052596|588820278|FG000|Active Phase|Lost due to Crohn's disease|0|||
163031822|NCT02052596|588820279|FG001|Active Phase|Lost due to Crohn's disease|1|||
163031823|NCT02052596|588820278|FG000|Safety Phase|Adverse Event|6|||
163031824|NCT02052596|588820279|FG001|Safety Phase|Adverse Event|3|||
163031825|NCT02052596|588820278|FG000|Safety Phase|Lost to Follow-up|11|||
163031826|NCT02052596|588820279|FG001|Safety Phase|Lost to Follow-up|18|||
163031827|NCT02052596|588820278|FG000|Safety Phase|Protocol Violation|1|||
163031828|NCT02052596|588820279|FG001|Safety Phase|Protocol Violation|2|||
163031829|NCT02052596|588820278|FG000|Safety Phase|Withdrawal by Subject|8|||
163031830|NCT02052596|588820279|FG001|Safety Phase|Withdrawal by Subject|11|||
163031831|NCT02052596|588820278|FG000|Safety Phase|Enrolled in error|1|||
163031832|NCT02052596|588820279|FG001|Safety Phase|Enrolled in error|0|||
163031833|NCT02052596|588820278|FG000|Safety Phase|Lost due to Crohn's disease|0|||
163031834|NCT02052596|588820279|FG001|Safety Phase|Lost due to Crohn's disease|1|||
163031835|NCT04829331|588820282|FG000|Overall Study|Lost to Follow-up|1|||
163031836|NCT04829331|588820283|FG001|Overall Study|Lost to Follow-up|0|||
163031837|NCT04526574|588820287|FG000|Overall Study|Protocol Violation|3|||
163031838|NCT04526574|588820288|FG001|Overall Study|Protocol Violation|1|||
163031839|NCT04526574|588820287|FG000|Overall Study|Withdrawal by Subject|12|||
163031840|NCT04526574|588820288|FG001|Overall Study|Withdrawal by Subject|9|||
163031841|NCT04526574|588820287|FG000|Overall Study|Other|1|||
163031842|NCT04526574|588820288|FG001|Overall Study|Other|2|||
163031843|NCT04526574|588820287|FG000|Overall Study|Adverse Event|1|||
163031844|NCT04526574|588820288|FG001|Overall Study|Adverse Event|1|||
163031845|NCT04526574|588820287|FG000|Overall Study|Death|2|||
163031846|NCT04526574|588820288|FG001|Overall Study|Death|3|||
163031847|NCT04526574|588820287|FG000|Overall Study|Lost to Follow-up|9|||
163031848|NCT04526574|588820288|FG001|Overall Study|Lost to Follow-up|9|||
163031849|NCT04526574|588820287|FG000|Overall Study|No longer meets eligibility criteria|8|||
163031850|NCT04526574|588820288|FG001|Overall Study|No longer meets eligibility criteria|8|||
163031851|NCT01032070|588820289|FG000|Overall Study|Disease progression|13|||
163031852|NCT01032070|588820290|FG001|Overall Study|Disease progression|8|||
163031853|NCT01032070|588820289|FG000|Overall Study|Medical or ethical reasons|0|||
163031854|NCT01032070|588820290|FG001|Overall Study|Medical or ethical reasons|2|||
163031855|NCT01032070|588820289|FG000|Overall Study|Withdrawal by Subject|0|||
163031856|NCT01032070|588820290|FG001|Overall Study|Withdrawal by Subject|2|||
163031857|NCT02554318|588820291|FG000|Overall Study|Withdrawal by Subject|10|||
163031858|NCT02554318|588820292|FG001|Overall Study|Withdrawal by Subject|8|||
163031859|NCT01472965|588820295|FG000|Overall Study|Withdrawal by Subject|1|||
163031860|NCT01472965|588820296|FG001|Overall Study|Withdrawal by Subject|0|||
163031861|NCT00396877|588820300|FG000|Overall Study|Lost to Follow-up|2|||
163031862|NCT00396877|588820301|FG001|Overall Study|Lost to Follow-up|1|||
163031863|NCT00396877|588820300|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
163031864|NCT00396877|588820301|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
163031865|NCT00334802|588820302|FG000|Overall Study|Progressive Disease|2|||
163031866|NCT00334802|588820303|FG001|Overall Study|Progressive Disease|24|||
163031867|NCT00334802|588820302|FG000|Overall Study|Toxicity|1|||
163031868|NCT00334802|588820303|FG001|Overall Study|Toxicity|5|||
163031869|NCT00334802|588820302|FG000|Overall Study|Lack of Efficacy|1|||
163031870|NCT00334802|588820303|FG001|Overall Study|Lack of Efficacy|3|||
163031871|NCT00334802|588820302|FG000|Overall Study|Patient Condition Aggrevated|1|||
163031872|NCT00334802|588820303|FG001|Overall Study|Patient Condition Aggrevated|0|||
163031873|NCT00334802|588820302|FG000|Overall Study|Physician Decision|1|||
163031874|NCT00334802|588820303|FG001|Overall Study|Physician Decision|0|||
163031875|NCT00334802|588820302|FG000|Overall Study|Withdrawal by Subject|0|||
163031876|NCT00334802|588820303|FG001|Overall Study|Withdrawal by Subject|4|||
163031877|NCT00334802|588820302|FG000|Overall Study|Adverse Event|0|||
163031878|NCT00334802|588820303|FG001|Overall Study|Adverse Event|3|||
163031879|NCT00334802|588820302|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
163031880|NCT00334802|588820303|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
163031881|NCT01886781|588820307|FG000|Overall Study|Protocol Violation|5|||
163085076|NCT03396445|589022224|FG013|Treatment Period|Death|14|||
163085077|NCT03396445|589022225|FG014|Treatment Period|Death|10|||
163085078|NCT03396445|589022226|FG015|Treatment Period|Death|8|||
163085079|NCT03396445|589022227|FG016|Treatment Period|Death|18|||
163031882|NCT01886781|588820308|FG001|Overall Study|Protocol Violation|0|||
163031883|NCT01886781|588820307|FG000|Overall Study|Adverse Event|1|||
163031884|NCT01886781|588820308|FG001|Overall Study|Adverse Event|0|||
163031885|NCT01886781|588820307|FG000|Overall Study|Lost to Follow-up|5|||
163031886|NCT01886781|588820308|FG001|Overall Study|Lost to Follow-up|0|||
163031887|NCT01886781|588820307|FG000|Overall Study|Withdrawal by Subject|2|||
163031888|NCT01886781|588820308|FG001|Overall Study|Withdrawal by Subject|1|||
163031889|NCT01886781|588820307|FG000|Overall Study|Worsening of symptoms|1|||
163031890|NCT01886781|588820308|FG001|Overall Study|Worsening of symptoms|1|||
163031891|NCT00551161|588820309|FG000|Overall Study|Withdrawal by Subject|1|||
163031892|NCT00934856|588820310|FG000|Feasibility Part|Progressive disease|4|||
163031893|NCT00934856|588820311|FG001|Feasibility Part|Progressive disease|4|||
163031894|NCT00934856|588820312|FG002|Feasibility Part|Progressive disease|2|||
163031895|NCT00934856|588820313|FG003|Feasibility Part|Progressive disease|3|||
163031896|NCT00934856|588820314|FG004|Feasibility Part|Progressive disease|0|||
163031897|NCT00934856|588820315|FG005|Feasibility Part|Progressive disease|0|||
163031898|NCT00934856|588820310|FG000|Feasibility Part|Physician Decision|0|||
163031899|NCT00934856|588820311|FG001|Feasibility Part|Physician Decision|0|||
163031900|NCT00934856|588820312|FG002|Feasibility Part|Physician Decision|1|||
163031901|NCT00934856|588820313|FG003|Feasibility Part|Physician Decision|0|||
163031902|NCT00934856|588820314|FG004|Feasibility Part|Physician Decision|0|||
163031903|NCT00934856|588820315|FG005|Feasibility Part|Physician Decision|0|||
163031904|NCT00934856|588820310|FG000|Feasibility Part|Adverse Event|1|||
163031905|NCT00934856|588820311|FG001|Feasibility Part|Adverse Event|1|||
163031906|NCT00934856|588820312|FG002|Feasibility Part|Adverse Event|0|||
163031907|NCT00934856|588820313|FG003|Feasibility Part|Adverse Event|1|||
163031908|NCT00934856|588820314|FG004|Feasibility Part|Adverse Event|0|||
163031909|NCT00934856|588820315|FG005|Feasibility Part|Adverse Event|2|||
163031910|NCT00934856|588820310|FG000|Feasibility Part|Withdrawal by Subject|0|||
163031911|NCT00934856|588820311|FG001|Feasibility Part|Withdrawal by Subject|0|||
163031912|NCT00934856|588820312|FG002|Feasibility Part|Withdrawal by Subject|0|||
163031913|NCT00934856|588820313|FG003|Feasibility Part|Withdrawal by Subject|1|||
163031914|NCT00934856|588820314|FG004|Feasibility Part|Withdrawal by Subject|0|||
163031915|NCT00934856|588820315|FG005|Feasibility Part|Withdrawal by Subject|1|||
163031916|NCT00934856|588820310|FG000|Extension Part|Adverse Event|0|||
163031917|NCT00934856|588820311|FG001|Extension Part|Adverse Event|0|||
163031918|NCT00934856|588820312|FG002|Extension Part|Adverse Event|0|||
163031919|NCT00934856|588820313|FG003|Extension Part|Adverse Event|1|||
163031920|NCT00934856|588820314|FG004|Extension Part|Adverse Event|4|||
163031921|NCT00934856|588820315|FG005|Extension Part|Adverse Event|4|||
163031922|NCT00934856|588820310|FG000|Extension Part|Progressive disease|0|||
163031923|NCT00934856|588820311|FG001|Extension Part|Progressive disease|0|||
163031924|NCT00934856|588820312|FG002|Extension Part|Progressive disease|0|||
163031925|NCT00934856|588820313|FG003|Extension Part|Progressive disease|1|||
163031926|NCT00934856|588820314|FG004|Extension Part|Progressive disease|0|||
163031927|NCT00934856|588820315|FG005|Extension Part|Progressive disease|0|||
163031928|NCT00934856|588820310|FG000|Extension Part|Non-compliance with drug|0|||
163031929|NCT00934856|588820311|FG001|Extension Part|Non-compliance with drug|0|||
163031930|NCT00934856|588820312|FG002|Extension Part|Non-compliance with drug|0|||
163031931|NCT00934856|588820313|FG003|Extension Part|Non-compliance with drug|0|||
163031932|NCT00934856|588820314|FG004|Extension Part|Non-compliance with drug|0|||
163031933|NCT00934856|588820315|FG005|Extension Part|Non-compliance with drug|1|||
163031934|NCT02273908|588820318|FG000|Overall Study|Adverse Event|16|||
163031935|NCT02273908|588820319|FG001|Overall Study|Adverse Event|0|||
163031936|NCT02273908|588820318|FG000|Overall Study|Lost to Follow-up|10|||
163031937|NCT02273908|588820319|FG001|Overall Study|Lost to Follow-up|1|||
163031938|NCT02273908|588820318|FG000|Overall Study|Did not meet entrance criteria|3|||
163031939|NCT02273908|588820319|FG001|Overall Study|Did not meet entrance criteria|2|||
163031940|NCT02273908|588820318|FG000|Overall Study|Withdrawal by Subject|4|||
163031941|NCT02273908|588820319|FG001|Overall Study|Withdrawal by Subject|2|||
163031942|NCT00422422|588820320|FG000|Overall Study|Lack of Efficacy|1|||
163031943|NCT00422422|588820320|FG000|Overall Study|Protocol Violation|1|||
163031944|NCT00422422|588820320|FG000|Overall Study|Withdrawal by Subject|2|||
163031945|NCT00422422|588820320|FG000|Overall Study|SAE, non-fatal|1|||
163031946|NCT00422422|588820320|FG000|Overall Study|AE, non-serious non-fatal|5|||
163031947|NCT03301844|588820321|FG000|Overall Study|suspected colon cancer|1|||
163031948|NCT03301844|588820322|FG001|Overall Study|suspected colon cancer|1|||
163031949|NCT00501059|588820323|FG000|Overall Study|Protocol Violation|80|||
163031950|NCT00501059|588820324|FG001|Overall Study|Protocol Violation|69|||
163031951|NCT00501059|588820323|FG000|Overall Study|Death|140|||
163031952|NCT00501059|588820324|FG001|Overall Study|Death|137|||
163031953|NCT00501059|588820323|FG000|Overall Study|Other|236|||
163031954|NCT00501059|588820324|FG001|Overall Study|Other|239|||
163031955|NCT00501059|588820323|FG000|Overall Study|Missing end-of-study page|91|||
162646828|NCT01023581|587424857|FG006|Overall Study|Pregnancy|0|||
163031956|NCT00501059|588820324|FG001|Overall Study|Missing end-of-study page|92|||
163031957|NCT00501059|588820323|FG000|Overall Study|Clinical endpoint reached|110|||
163031958|NCT00501059|588820324|FG001|Overall Study|Clinical endpoint reached|123|||
163031959|NCT00501059|588820323|FG000|Overall Study|Insufficient therapeutic effect|4|||
163031960|NCT00501059|588820324|FG001|Overall Study|Insufficient therapeutic effect|5|||
163031961|NCT00501059|588820323|FG000|Overall Study|Consent withdrawn by subject|817|||
163031962|NCT00501059|588820324|FG001|Overall Study|Consent withdrawn by subject|873|||
163031963|NCT00501059|588820323|FG000|Overall Study|Non-compliant with study treatment|23|||
163031964|NCT00501059|588820324|FG001|Overall Study|Non-compliant with study treatment|16|||
163031965|NCT00501059|588820323|FG000|Overall Study|Reason not given|3|||
163031966|NCT00501059|588820324|FG001|Overall Study|Reason not given|1|||
163031967|NCT00501059|588820323|FG000|Overall Study|Adverse Event|129|||
163031968|NCT00501059|588820324|FG001|Overall Study|Adverse Event|122|||
163031969|NCT00501059|588820323|FG000|Overall Study|Lost to Follow-up|210|||
163031970|NCT00501059|588820324|FG001|Overall Study|Lost to Follow-up|198|||
163031971|NCT00501059|588820323|FG000|Overall Study|Not treated|25|||
163031972|NCT00501059|588820324|FG001|Overall Study|Not treated|17|||
163031973|NCT02124759|588820325|FG000|Overall Study|Withdrawal by Subject|3|||
163031974|NCT02124759|588820326|FG001|Overall Study|Withdrawal by Subject|1|||
163031975|NCT02124759|588820327|FG002|Overall Study|Withdrawal by Subject|1|||
163031976|NCT02124759|588820325|FG000|Overall Study|Screen Fail|2|||
163031977|NCT02124759|588820326|FG001|Overall Study|Screen Fail|2|||
163031978|NCT02124759|588820327|FG002|Overall Study|Screen Fail|3|||
163031979|NCT02968433|588820329|FG000|Overall Study|Withdrawal by Subject|1|||
163031980|NCT00875433|588820330|FG000|Overall Study|Progressive disease|41|||
163031981|NCT00875433|588820330|FG000|Overall Study|Other Adverse Event|14|||
163031982|NCT00875433|588820330|FG000|Overall Study|Withdrawal by Subject|2|||
163031983|NCT00875433|588820330|FG000|Overall Study|Other|3|||
163031984|NCT00725101|588820331|FG000|Overall Study|Death|3|||
163031985|NCT00725101|588820331|FG000|Overall Study|Lost to Follow-up|353|||
163031986|NCT00725101|588820331|FG000|Overall Study|Protocol Violation|1|||
163031987|NCT00725101|588820331|FG000|Overall Study|Withdrawal by Subject|127|||
163031988|NCT00725101|588820331|FG000|Overall Study|not specified/no reason given|11|||
163031989|NCT03325894|588820332|FG000|Overall Study|Adverse Event|2|||
163031990|NCT03325894|588820333|FG001|Overall Study|Adverse Event|3|||
163031991|NCT03325894|588820332|FG000|Overall Study|Protocol Violation|1|||
163031992|NCT03325894|588820333|FG001|Overall Study|Protocol Violation|2|||
163031993|NCT03325894|588820332|FG000|Overall Study|Withdrawal by Subject|10|||
163031994|NCT03325894|588820333|FG001|Overall Study|Withdrawal by Subject|6|||
163031995|NCT03325894|588820332|FG000|Overall Study|Lost to Follow-up|4|||
163031996|NCT03325894|588820333|FG001|Overall Study|Lost to Follow-up|9|||
163031997|NCT03325894|588820332|FG000|Overall Study|Lack of Efficacy|8|||
163031998|NCT03325894|588820333|FG001|Overall Study|Lack of Efficacy|14|||
163031999|NCT03325894|588820332|FG000|Overall Study|Study Terminated by Sponsor|38|||
163032000|NCT03325894|588820333|FG001|Overall Study|Study Terminated by Sponsor|43|||
163032001|NCT03325894|588820332|FG000|Overall Study|Other (Not received Treatment)|1|||
163032002|NCT03325894|588820333|FG001|Overall Study|Other (Not received Treatment)|0|||
163032003|NCT03482167|588820336|FG000|Allocated to Intervention|Physician Decision|1|||
163032004|NCT03482167|588820337|FG001|Allocated to Intervention|Physician Decision|2|||
163032005|NCT03482167|588820336|FG000|Received Intervention|Adverse Event|3|||
163032006|NCT03482167|588820337|FG001|Received Intervention|Adverse Event|1|||
163085080|NCT03396445|589022228|FG017|Treatment Period|Death|0|||
163085081|NCT03396445|589022229|FG018|Treatment Period|Death|0|||
163085082|NCT03396445|589022230|FG019|Treatment Period|Death|0|||
163085083|NCT03396445|589022231|FG020|Treatment Period|Death|0|||
163085084|NCT03396445|589022232|FG021|Treatment Period|Death|0|||
163085085|NCT03396445|589022233|FG022|Treatment Period|Death|0|||
163085086|NCT03396445|589022234|FG023|Treatment Period|Death|0|||
163085087|NCT03396445|589022235|FG024|Treatment Period|Death|0|||
163085088|NCT03396445|589022236|FG025|Treatment Period|Death|0|||
163085089|NCT03396445|589022211|FG000|Treatment Period|Lost to Follow-up|0|||
163085090|NCT03396445|589022212|FG001|Treatment Period|Lost to Follow-up|0|||
163085091|NCT03396445|589022213|FG002|Treatment Period|Lost to Follow-up|0|||
163085092|NCT03396445|589022214|FG003|Treatment Period|Lost to Follow-up|0|||
163085093|NCT03396445|589022215|FG004|Treatment Period|Lost to Follow-up|0|||
163085094|NCT03396445|589022216|FG005|Treatment Period|Lost to Follow-up|0|||
163085095|NCT03396445|589022217|FG006|Treatment Period|Lost to Follow-up|0|||
163085096|NCT03396445|589022218|FG007|Treatment Period|Lost to Follow-up|0|||
163085097|NCT03396445|589022219|FG008|Treatment Period|Lost to Follow-up|0|||
163032007|NCT03482167|588820336|FG000|Received Intervention|Physician Decision|1|||
163032008|NCT03482167|588820337|FG001|Received Intervention|Physician Decision|1|||
163032009|NCT03482167|588820336|FG000|Received Intervention|Withdrawal by Subject|1|||
163032010|NCT03482167|588820337|FG001|Received Intervention|Withdrawal by Subject|0|||
163032011|NCT00819780|588820339|FG000|Overall Study|Did not receive study drug|3|||
163032012|NCT00819780|588820340|FG001|Overall Study|Did not receive study drug|4|||
163032013|NCT00819780|588820339|FG000|Overall Study|Still in treatment|25|||
163032014|NCT00819780|588820340|FG001|Overall Study|Still in treatment|17|||
163032015|NCT00622336|588820341|FG000|Treatment Phase|Progression of Disease|181|||
163032016|NCT00622336|588820341|FG000|Treatment Phase|Adverse Event|46|||
163032017|NCT00622336|588820341|FG000|Treatment Phase|Other|40|||
163032018|NCT00622336|588820341|FG000|Treatment Phase|Death|14|||
163085098|NCT03396445|589022220|FG009|Treatment Period|Lost to Follow-up|0|||
163032019|NCT00622336|588820341|FG000|Treatment Phase|Lack of therapeutic effect|13|||
163032020|NCT00622336|588820341|FG000|Treatment Phase|Withdrawal by Subject|13|||
163032021|NCT00622336|588820341|FG000|Treatment Phase|Lost to Follow-up|2|||
163032022|NCT00622336|588820341|FG000|Extension Phase|Adverse Event|2|||
163032023|NCT00622336|588820341|FG000|Extension Phase|Progressive Disease|6|||
163032024|NCT00622336|588820341|FG000|Extension Phase|Lack of therapeutic effect|2|||
163032025|NCT00622336|588820341|FG000|Extension Phase|Withdrawal by Subject|1|||
163032026|NCT00622336|588820341|FG000|Extension Phase|Lost to Follow-up|1|||
163032027|NCT00622336|588820341|FG000|Extension Phase|Other|9|||
163032028|NCT04148287|588820346|FG000|Overall Study|Death|2|||
163032029|NCT03430895|588820348|FG000|Overall Study|Not Treated|2|||
163032030|NCT01645891|588820352|FG000|Overall Study|Adverse Event|6|||
163032031|NCT01645891|588820353|FG001|Overall Study|Adverse Event|10|||
163032032|NCT01645891|588820352|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
163032033|NCT01645891|588820353|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
163032034|NCT01645891|588820352|FG000|Overall Study|Withdrawal by Subject|3|||
163032035|NCT01645891|588820353|FG001|Overall Study|Withdrawal by Subject|3|||
163032036|NCT01645891|588820352|FG000|Overall Study|Protocol Violation|4|||
163032037|NCT01645891|588820353|FG001|Overall Study|Protocol Violation|0|||
163032038|NCT01645891|588820352|FG000|Overall Study|Lost to Follow-up|4|||
163032039|NCT01645891|588820353|FG001|Overall Study|Lost to Follow-up|1|||
163032040|NCT01645891|588820352|FG000|Overall Study|Death|0|||
163032041|NCT01645891|588820353|FG001|Overall Study|Death|2|||
163032042|NCT00138073|588820356|FG000|Overall Study|lack of resources|55|||
163032043|NCT03301740|588820357|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
163032044|NCT03301740|588820358|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
163032045|NCT03301740|588820357|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
163032046|NCT03301740|588820358|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
163032047|NCT02847182|588820359|FG000|Overall Study|Withdrawal by Subject|0|||
163032048|NCT02847182|588820360|FG001|Overall Study|Withdrawal by Subject|1|||
163032049|NCT00962091|588820361|FG000|Overall Study|Withdrawal by Subject|1|||
163032050|NCT00962091|588820362|FG001|Overall Study|Withdrawal by Subject|2|||
163032051|NCT00962091|588820363|FG002|Overall Study|Withdrawal by Subject|1|||
163032052|NCT00962091|588820364|FG003|Overall Study|Withdrawal by Subject|1|||
163032053|NCT00962091|588820365|FG004|Overall Study|Withdrawal by Subject|0|||
163032054|NCT00962091|588820366|FG005|Overall Study|Withdrawal by Subject|1|||
163032055|NCT00962091|588820367|FG006|Overall Study|Withdrawal by Subject|0|||
163032056|NCT00962091|588820361|FG000|Overall Study|Adverse Event|0|||
163032057|NCT00962091|588820362|FG001|Overall Study|Adverse Event|0|||
163032058|NCT00962091|588820363|FG002|Overall Study|Adverse Event|0|||
163032059|NCT00962091|588820364|FG003|Overall Study|Adverse Event|0|||
163032060|NCT00962091|588820365|FG004|Overall Study|Adverse Event|0|||
163032061|NCT00962091|588820366|FG005|Overall Study|Adverse Event|0|||
163032062|NCT00962091|588820367|FG006|Overall Study|Adverse Event|1|||
163032063|NCT01306045|588820370|FG000|Met General Eligibility Criteria|Screen failures|193|||
163032064|NCT01306045|588820371|FG001|Met General Eligibility Criteria|Screen failures|11|||
163032065|NCT01306045|588820372|FG002|Met General Eligibility Criteria|Screen failures|8|||
163032066|NCT05072964|588820373|FG000|Overall Study|Withdrawal by Subject|4|||
163032067|NCT05072964|588820373|FG000|Overall Study|Death|1|||
163032068|NCT02172040|588820375|FG000|Overall Study|Adverse Event|0|||
163032069|NCT02172040|588820376|FG001|Overall Study|Adverse Event|2|||
163032070|NCT02172040|588820377|FG002|Overall Study|Adverse Event|0|||
163032071|NCT02172040|588820378|FG003|Overall Study|Adverse Event|0|||
163032072|NCT02172040|588820375|FG000|Overall Study|Protocol Violation|0|||
163032073|NCT02172040|588820376|FG001|Overall Study|Protocol Violation|1|||
163032074|NCT02172040|588820377|FG002|Overall Study|Protocol Violation|0|||
163032075|NCT02172040|588820378|FG003|Overall Study|Protocol Violation|0|||
163032076|NCT02172040|588820375|FG000|Overall Study|Withdrawal by Subject|0|||
163032077|NCT02172040|588820376|FG001|Overall Study|Withdrawal by Subject|0|||
163032078|NCT02172040|588820377|FG002|Overall Study|Withdrawal by Subject|1|||
163032079|NCT02172040|588820378|FG003|Overall Study|Withdrawal by Subject|0|||
163032080|NCT02172040|588820375|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
163032081|NCT02172040|588820376|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
163085099|NCT03396445|589022221|FG010|Treatment Period|Lost to Follow-up|0|||
163085100|NCT03396445|589022222|FG011|Treatment Period|Lost to Follow-up|0|||
163032082|NCT02172040|588820377|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
163032083|NCT02172040|588820378|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
163032084|NCT02172040|588820375|FG000|Overall Study|Family emergency abroad|0|||
163032085|NCT02172040|588820376|FG001|Overall Study|Family emergency abroad|0|||
163032086|NCT02172040|588820377|FG002|Overall Study|Family emergency abroad|0|||
162646829|NCT01023581|587424851|FG000|Overall Study|Lack of Efficacy|9|||
162646830|NCT01023581|587424852|FG001|Overall Study|Lack of Efficacy|3|||
163032087|NCT02172040|588820378|FG003|Overall Study|Family emergency abroad|1|||
162646831|NCT01023581|587424853|FG002|Overall Study|Lack of Efficacy|6|||
163032088|NCT04908202|588820383|FG000|Pre-Treatment Period|OTHER REASONS|3|||
163032089|NCT04908202|588820384|FG001|Pre-Treatment Period|OTHER REASONS|1|||
163032090|NCT04908202|588820385|FG002|Pre-Treatment Period|OTHER REASONS|0|||
163032091|NCT04908202|588820386|FG003|Pre-Treatment Period|OTHER REASONS|0|||
163032092|NCT04908202|588820383|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
163032093|NCT04908202|588820384|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032094|NCT04908202|588820385|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032095|NCT04908202|588820386|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032096|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
163032097|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
163032098|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163032099|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163032100|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
163032101|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
163032102|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
163032103|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
163032104|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
162646832|NCT01023581|587424854|FG003|Overall Study|Lack of Efficacy|2|||
162646833|NCT01023581|587424855|FG004|Overall Study|Lack of Efficacy|1|||
162646834|NCT01023581|587424856|FG005|Overall Study|Lack of Efficacy|2|||
162646835|NCT01023581|587424857|FG006|Overall Study|Lack of Efficacy|1|||
162646836|NCT01023581|587424851|FG000|Overall Study|Physician Decision|2|||
162646837|NCT01023581|587424852|FG001|Overall Study|Physician Decision|0|||
162646838|NCT01023581|587424853|FG002|Overall Study|Physician Decision|2|||
162646839|NCT01023581|587424854|FG003|Overall Study|Physician Decision|1|||
162646840|NCT01023581|587424855|FG004|Overall Study|Physician Decision|1|||
162646841|NCT01023581|587424856|FG005|Overall Study|Physician Decision|1|||
162646842|NCT01023581|587424857|FG006|Overall Study|Physician Decision|1|||
162646843|NCT01023581|587424851|FG000|Overall Study|Other|1|||
162646844|NCT01023581|587424852|FG001|Overall Study|Other|0|||
162646845|NCT01023581|587424853|FG002|Overall Study|Other|1|||
162646846|NCT01023581|587424854|FG003|Overall Study|Other|0|||
162646847|NCT01023581|587424855|FG004|Overall Study|Other|1|||
162646848|NCT01023581|587424856|FG005|Overall Study|Other|0|||
162646849|NCT01023581|587424857|FG006|Overall Study|Other|0|||
162646850|NCT00922766|587424858|FG000|Overall Study|Death|3|||
162646851|NCT00922766|587424858|FG000|Overall Study|Withdrawal by Subject|2|||
162646852|NCT00922766|587424858|FG000|Overall Study|Other|1|||
162646853|NCT00922766|587424858|FG000|Overall Study|Adverse Event|1|||
162646854|NCT02658890|587424867|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646855|NCT02658890|587424868|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646856|NCT02658890|587424869|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646857|NCT02658890|587424870|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646858|NCT02658890|587424871|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646859|NCT02658890|587424872|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646860|NCT02658890|587424873|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646861|NCT02658890|587424874|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646862|NCT02658890|587424875|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162646863|NCT02658890|587424876|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646864|NCT02658890|587424877|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646865|NCT02658890|587424878|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646866|NCT02658890|587424879|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646867|NCT02658890|587424880|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646868|NCT02658890|587424881|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646869|NCT02658890|587424882|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646870|NCT02658890|587424883|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646871|NCT02658890|587424884|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646872|NCT02658890|587424885|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646873|NCT02658890|587424886|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646874|NCT02658890|587424887|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646875|NCT02658890|587424888|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162717953|NCT03098030|587673505|FG000|Overall Study|Withdrawal by Subject|0|||
163032105|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163032106|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032107|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032108|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
163032109|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
163032110|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
162646876|NCT02658890|587424889|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646877|NCT02658890|587424890|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163032111|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032112|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032113|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
163032114|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032115|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
163032116|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032117|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032118|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032119|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032120|NCT04908202|588820383|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
163032121|NCT04908202|588820384|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
163032122|NCT04908202|588820385|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
163032123|NCT04908202|588820386|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
163032124|NCT04908202|588820383|FG000|Active Treatment Period|OTHER REASONS|0|||
163032125|NCT04908202|588820384|FG001|Active Treatment Period|OTHER REASONS|0|||
163032126|NCT04908202|588820385|FG002|Active Treatment Period|OTHER REASONS|1|||
163032127|NCT04908202|588820386|FG003|Active Treatment Period|OTHER REASONS|3|||
163032128|NCT04908202|588820383|FG000|Active Treatment Period|Lack of Efficacy|0|||
163032129|NCT04908202|588820384|FG001|Active Treatment Period|Lack of Efficacy|0|||
163032130|NCT04908202|588820385|FG002|Active Treatment Period|Lack of Efficacy|4|||
163032131|NCT04908202|588820386|FG003|Active Treatment Period|Lack of Efficacy|5|||
163032132|NCT04908202|588820383|FG000|Active Treatment Period|Adverse Event|0|||
163032133|NCT04908202|588820384|FG001|Active Treatment Period|Adverse Event|0|||
163032134|NCT04908202|588820385|FG002|Active Treatment Period|Adverse Event|5|||
163032135|NCT04908202|588820386|FG003|Active Treatment Period|Adverse Event|8|||
163032136|NCT04908202|588820383|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032137|NCT04908202|588820384|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163032138|NCT04908202|588820385|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163032139|NCT04908202|588820386|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163032140|NCT04908202|588820383|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032141|NCT04908202|588820384|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
163032142|NCT04908202|588820385|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
163032143|NCT04908202|588820386|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
163032144|NCT04908202|588820383|FG000|Active Treatment Period|Lost to Follow-up|0|||
163032145|NCT04908202|588820384|FG001|Active Treatment Period|Lost to Follow-up|0|||
163032146|NCT04908202|588820385|FG002|Active Treatment Period|Lost to Follow-up|2|||
163032147|NCT04908202|588820386|FG003|Active Treatment Period|Lost to Follow-up|2|||
163032148|NCT04908202|588820383|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032149|NCT04908202|588820384|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032150|NCT04908202|588820385|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
163032151|NCT04908202|588820386|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
163032152|NCT04908202|588820383|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032153|NCT04908202|588820384|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
163032154|NCT04908202|588820385|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032155|NCT04908202|588820386|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
163032156|NCT04908202|588820383|FG000|Active Treatment Period|ONGOING Treatment|0|||
163032157|NCT04908202|588820384|FG001|Active Treatment Period|ONGOING Treatment|0|||
163032158|NCT04908202|588820385|FG002|Active Treatment Period|ONGOING Treatment|117|||
163032159|NCT04908202|588820386|FG003|Active Treatment Period|ONGOING Treatment|114|||
163032160|NCT04506905|588820389|FG000|Overall Study|Lost to Follow-up|1|||
163032161|NCT04506905|588820390|FG001|Overall Study|Lost to Follow-up|0|||
163032162|NCT04506905|588820391|FG002|Overall Study|Lost to Follow-up|0|||
163032163|NCT04506905|588820392|FG003|Overall Study|Lost to Follow-up|1|||
163032164|NCT04506905|588820393|FG004|Overall Study|Lost to Follow-up|0|||
163032165|NCT04506905|588820394|FG005|Overall Study|Lost to Follow-up|0|||
163032166|NCT04506905|588820395|FG006|Overall Study|Lost to Follow-up|0|||
163032167|NCT04506905|588820396|FG007|Overall Study|Lost to Follow-up|0|||
163032168|NCT04506905|588820397|FG008|Overall Study|Lost to Follow-up|0|||
163032169|NCT04506905|588820389|FG000|Overall Study|Withdrawal by Subject|0|||
163032170|NCT04506905|588820390|FG001|Overall Study|Withdrawal by Subject|0|||
163032171|NCT04506905|588820391|FG002|Overall Study|Withdrawal by Subject|0|||
163032172|NCT04506905|588820392|FG003|Overall Study|Withdrawal by Subject|2|||
163032173|NCT04506905|588820393|FG004|Overall Study|Withdrawal by Subject|0|||
163032174|NCT04506905|588820394|FG005|Overall Study|Withdrawal by Subject|0|||
163032175|NCT04506905|588820395|FG006|Overall Study|Withdrawal by Subject|0|||
163032176|NCT04506905|588820396|FG007|Overall Study|Withdrawal by Subject|0|||
163032177|NCT04506905|588820397|FG008|Overall Study|Withdrawal by Subject|0|||
163032178|NCT03030118|588822128|FG000|Overall Study|Achieved SLE Diagnosis|11|||
163032179|NCT03030118|588822129|FG001|Overall Study|Achieved SLE Diagnosis|10|||
163032180|NCT03030118|588822128|FG000|Overall Study|Adverse Event|1|||
163032181|NCT03030118|588822129|FG001|Overall Study|Adverse Event|1|||
163032182|NCT03030118|588822128|FG000|Overall Study|Pregnancy|2|||
163032183|NCT03030118|588822129|FG001|Overall Study|Pregnancy|2|||
163032184|NCT03030118|588822128|FG000|Overall Study|Lost to Follow-up|5|||
163032185|NCT03030118|588822129|FG001|Overall Study|Lost to Follow-up|6|||
163032186|NCT03030118|588822128|FG000|Overall Study|Concomitant Medications|1|||
163032187|NCT03030118|588822129|FG001|Overall Study|Concomitant Medications|1|||
163032188|NCT03030118|588822128|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
163032189|NCT03030118|588822129|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
163032190|NCT03030118|588822128|FG000|Overall Study|Other|2|||
163032191|NCT03030118|588822129|FG001|Overall Study|Other|0|||
163032192|NCT03030118|588822128|FG000|Overall Study|Withdrawal by Subject|26|||
163032193|NCT03030118|588822129|FG001|Overall Study|Withdrawal by Subject|21|||
163032194|NCT03030118|588822128|FG000|Overall Study|Protocol Violation|1|||
163032195|NCT03030118|588822129|FG001|Overall Study|Protocol Violation|6|||
163032196|NCT02949908|588822130|FG000|Overall Study|Study termination|2|||
163032197|NCT05323994|588822131|FG000|Overall Study|Protocol Violation|1|||
163032198|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
163032199|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032200|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032201|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163085101|NCT03396445|589022223|FG012|Treatment Period|Lost to Follow-up|1|||
163085102|NCT03396445|589022224|FG013|Treatment Period|Lost to Follow-up|0|||
163085103|NCT03396445|589022225|FG014|Treatment Period|Lost to Follow-up|1|||
163085104|NCT03396445|589022226|FG015|Treatment Period|Lost to Follow-up|0|||
163085105|NCT03396445|589022227|FG016|Treatment Period|Lost to Follow-up|0|||
163085106|NCT03396445|589022228|FG017|Treatment Period|Lost to Follow-up|0|||
163085107|NCT03396445|589022229|FG018|Treatment Period|Lost to Follow-up|0|||
162646878|NCT02658890|587424891|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646879|NCT02658890|587424892|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646880|NCT02658890|587424893|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162646881|NCT02658890|587424867|FG000|Treatment Phase|Adverse Event|0|||
162646882|NCT02658890|587424868|FG001|Treatment Phase|Adverse Event|1|||
162646883|NCT02658890|587424869|FG002|Treatment Phase|Adverse Event|2|||
162646884|NCT02658890|587424870|FG003|Treatment Phase|Adverse Event|2|||
162646885|NCT02658890|587424871|FG004|Treatment Phase|Adverse Event|1|||
162646886|NCT02658890|587424872|FG005|Treatment Phase|Adverse Event|0|||
162646887|NCT02658890|587424873|FG006|Treatment Phase|Adverse Event|0|||
162646888|NCT02658890|587424874|FG007|Treatment Phase|Adverse Event|2|||
162646889|NCT02658890|587424875|FG008|Treatment Phase|Adverse Event|1|||
162646890|NCT02658890|587424876|FG009|Treatment Phase|Adverse Event|2|||
162646891|NCT02658890|587424877|FG010|Treatment Phase|Adverse Event|3|||
162646892|NCT02658890|587424878|FG011|Treatment Phase|Adverse Event|0|||
162646893|NCT02658890|587424879|FG012|Treatment Phase|Adverse Event|1|||
162646894|NCT02658890|587424880|FG013|Treatment Phase|Adverse Event|4|||
162646895|NCT02658890|587424881|FG014|Treatment Phase|Adverse Event|0|||
162646896|NCT02658890|587424882|FG015|Treatment Phase|Adverse Event|0|||
162646897|NCT02658890|587424883|FG016|Treatment Phase|Adverse Event|0|||
162646898|NCT02658890|587424884|FG017|Treatment Phase|Adverse Event|0|||
162646899|NCT02658890|587424885|FG018|Treatment Phase|Adverse Event|5|||
162646900|NCT02658890|587424886|FG019|Treatment Phase|Adverse Event|1|||
162646901|NCT02658890|587424887|FG020|Treatment Phase|Adverse Event|3|||
162646902|NCT02658890|587424888|FG021|Treatment Phase|Adverse Event|0|||
162646903|NCT02658890|587424889|FG022|Treatment Phase|Adverse Event|5|||
162646904|NCT02658890|587424890|FG023|Treatment Phase|Adverse Event|0|||
162646905|NCT02658890|587424891|FG024|Treatment Phase|Adverse Event|0|||
162646906|NCT02658890|587424892|FG025|Treatment Phase|Adverse Event|2|||
162646907|NCT02658890|587424893|FG026|Treatment Phase|Adverse Event|1|||
162646908|NCT02658890|587424867|FG000|Treatment Phase|Death|0|||
162646909|NCT02658890|587424868|FG001|Treatment Phase|Death|0|||
162646910|NCT02658890|587424869|FG002|Treatment Phase|Death|0|||
162646911|NCT02658890|587424870|FG003|Treatment Phase|Death|0|||
162646912|NCT02658890|587424871|FG004|Treatment Phase|Death|0|||
163032202|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
163032203|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Death|0|||
163085108|NCT03396445|589022230|FG019|Treatment Period|Lost to Follow-up|0|||
163085109|NCT03396445|589022231|FG020|Treatment Period|Lost to Follow-up|0|||
162646913|NCT02658890|587424872|FG005|Treatment Phase|Death|0|||
162646914|NCT02658890|587424873|FG006|Treatment Phase|Death|0|||
162646915|NCT02658890|587424874|FG007|Treatment Phase|Death|0|||
162646916|NCT02658890|587424875|FG008|Treatment Phase|Death|0|||
162646917|NCT02658890|587424876|FG009|Treatment Phase|Death|0|||
162646918|NCT02658890|587424877|FG010|Treatment Phase|Death|0|||
162646919|NCT02658890|587424878|FG011|Treatment Phase|Death|0|||
162646920|NCT02658890|587424879|FG012|Treatment Phase|Death|0|||
162646921|NCT02658890|587424880|FG013|Treatment Phase|Death|0|||
162646922|NCT02658890|587424881|FG014|Treatment Phase|Death|0|||
162646923|NCT02658890|587424882|FG015|Treatment Phase|Death|0|||
163032204|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Death|1|||
163032205|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Death|0|||
163085110|NCT03396445|589022232|FG021|Treatment Period|Lost to Follow-up|0|||
163085111|NCT03396445|589022233|FG022|Treatment Period|Lost to Follow-up|0|||
163085112|NCT03396445|589022234|FG023|Treatment Period|Lost to Follow-up|0|||
163085113|NCT03396445|589022235|FG024|Treatment Period|Lost to Follow-up|0|||
163085114|NCT03396445|589022236|FG025|Treatment Period|Lost to Follow-up|0|||
163085115|NCT03396445|589022211|FG000|Treatment Period|Physician Decision|0|||
163085116|NCT03396445|589022212|FG001|Treatment Period|Physician Decision|0|||
163085117|NCT03396445|589022213|FG002|Treatment Period|Physician Decision|0|||
163085118|NCT03396445|589022214|FG003|Treatment Period|Physician Decision|0|||
163085119|NCT03396445|589022215|FG004|Treatment Period|Physician Decision|1|||
163032206|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Death|0|||
163032207|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Death|0|||
163032208|NCT00454818|588822134|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032209|NCT00454818|588822135|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032210|NCT00454818|588822136|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
163032211|NCT00454818|588822137|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
163032212|NCT00454818|588822138|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
163032213|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032214|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
163032215|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032216|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
163032217|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
163032218|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Death|0|||
163032219|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Death|1|||
163032220|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Death|0|||
163032221|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Death|0|||
163032222|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Death|1|||
163032223|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032224|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032225|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
163032226|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
163032227|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
163032228|NCT00454818|588822134|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032229|NCT00454818|588822135|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032230|NCT00454818|588822136|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
163032231|NCT00454818|588822137|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
163032232|NCT00454818|588822138|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
163032233|NCT00766467|588822140|FG000|Overall Study|Withdrawal by Subject|7|||
163032234|NCT00766467|588822141|FG001|Overall Study|Withdrawal by Subject|2|||
163032235|NCT00766467|588822140|FG000|Overall Study|Adverse Event|1|||
163032236|NCT00766467|588822141|FG001|Overall Study|Adverse Event|1|||
163032237|NCT00766467|588822140|FG000|Overall Study|Protocol Violation|2|||
163032238|NCT00766467|588822141|FG001|Overall Study|Protocol Violation|4|||
163032239|NCT00766467|588822140|FG000|Overall Study|Tumor Progression on Study|0|||
163032240|NCT00766467|588822141|FG001|Overall Study|Tumor Progression on Study|1|||
163032241|NCT00766467|588822140|FG000|Overall Study|Physician Decision|1|||
163032242|NCT00766467|588822141|FG001|Overall Study|Physician Decision|0|||
163032243|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
163032244|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
163032245|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
163032246|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
163032247|NCT00943670|588822143|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
163032248|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
163032249|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
163032250|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
163032251|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
163032252|NCT00943670|588822143|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
163032253|NCT02604550|588822144|FG000|Overall Study|Lost to Follow-up|7|||
163032254|NCT02604550|588822145|FG001|Overall Study|Lost to Follow-up|6|||
163032255|NCT02604550|588822144|FG000|Overall Study|Withdrawal by Subject|0|||
163032256|NCT02604550|588822145|FG001|Overall Study|Withdrawal by Subject|1|||
163032257|NCT02604550|588822144|FG000|Overall Study|Incomplete data using paper journal|18|||
163085120|NCT03396445|589022216|FG005|Treatment Period|Physician Decision|0|||
163085121|NCT03396445|589022217|FG006|Treatment Period|Physician Decision|0|||
163085122|NCT03396445|589022218|FG007|Treatment Period|Physician Decision|0|||
162646924|NCT02658890|587424883|FG016|Treatment Phase|Death|0|||
162646925|NCT02658890|587424884|FG017|Treatment Phase|Death|0|||
162646926|NCT02658890|587424885|FG018|Treatment Phase|Death|1|||
162646927|NCT02658890|587424886|FG019|Treatment Phase|Death|0|||
163032258|NCT02604550|588822145|FG001|Overall Study|Incomplete data using paper journal|19|||
163032259|NCT00908076|588822146|FG000|Overall Study|Lack of Efficacy|1|||
163032260|NCT00908076|588822147|FG001|Overall Study|Lack of Efficacy|1|||
163032261|NCT02332239|588822148|FG000|Overall Study|Lost to Follow-up|4|||
163032262|NCT02332239|588822149|FG001|Overall Study|Lost to Follow-up|6|||
163032263|NCT00894790|588822150|FG000|Overall Study|Protocol Violation|0|||
163032264|NCT00894790|588822151|FG001|Overall Study|Protocol Violation|1|||
163032265|NCT00894790|588822150|FG000|Overall Study|Lost to Follow-up|0|||
163032266|NCT00894790|588822151|FG001|Overall Study|Lost to Follow-up|1|||
163032267|NCT00894790|588822150|FG000|Overall Study|Did not meet entrance criteria|1|||
163032268|NCT00894790|588822151|FG001|Overall Study|Did not meet entrance criteria|0|||
163032269|NCT00662558|588822152|FG000|Overall Study|Adverse Event|21|||
163032270|NCT00662558|588822153|FG001|Overall Study|Adverse Event|59|||
163032271|NCT00662558|588822152|FG000|Overall Study|Lack of Efficacy|4|||
163032272|NCT00662558|588822153|FG001|Overall Study|Lack of Efficacy|7|||
163032273|NCT00662558|588822152|FG000|Overall Study|Lost to Follow-up|13|||
163032274|NCT00662558|588822153|FG001|Overall Study|Lost to Follow-up|10|||
163032275|NCT00662558|588822152|FG000|Overall Study|Other|9|||
163032276|NCT00662558|588822153|FG001|Overall Study|Other|14|||
163032277|NCT00662558|588822152|FG000|Overall Study|Withdrawal by Subject|7|||
163032278|NCT00662558|588822153|FG001|Overall Study|Withdrawal by Subject|12|||
163032279|NCT00662558|588822152|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
163032280|NCT00662558|588822153|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
163032281|NCT03329248|588822163|FG000|Overall Study|Progressive Disease|6|||
163032282|NCT00987402|588822164|FG000|Overall Study|Insufficient data entry|86|||
163032283|NCT00987402|588822165|FG001|Overall Study|Insufficient data entry|98|||
163032284|NCT03000530|588822166|FG000|Overall Study|Adverse Event|0|||
163032285|NCT03000530|588822167|FG001|Overall Study|Adverse Event|0|||
163032286|NCT03000530|588822168|FG002|Overall Study|Adverse Event|2|||
163032287|NCT03000530|588822166|FG000|Overall Study|Lost to Follow-up|0|||
163032288|NCT03000530|588822167|FG001|Overall Study|Lost to Follow-up|3|||
163032289|NCT03000530|588822168|FG002|Overall Study|Lost to Follow-up|1|||
163032290|NCT03000530|588822166|FG000|Overall Study|Withdrawal by Subject|0|||
163032291|NCT03000530|588822167|FG001|Overall Study|Withdrawal by Subject|2|||
163032292|NCT03000530|588822168|FG002|Overall Study|Withdrawal by Subject|1|||
163032293|NCT01672294|588822172|FG000|Overall Study|Withdrawal by Subject|4|||
163032294|NCT01672294|588822173|FG001|Overall Study|Withdrawal by Subject|4|||
163032295|NCT01672294|588822174|FG002|Overall Study|Withdrawal by Subject|4|||
163032296|NCT01672294|588822175|FG003|Overall Study|Withdrawal by Subject|4|||
163032297|NCT01672294|588822172|FG000|Overall Study|Excluded by study|1|||
163032298|NCT01672294|588822173|FG001|Overall Study|Excluded by study|1|||
163085123|NCT03396445|589022219|FG008|Treatment Period|Physician Decision|0|||
162646928|NCT02658890|587424887|FG020|Treatment Phase|Death|0|||
163032299|NCT01672294|588822174|FG002|Overall Study|Excluded by study|0|||
163032300|NCT01672294|588822175|FG003|Overall Study|Excluded by study|0|||
163032301|NCT01672294|588822172|FG000|Overall Study|Lost to Follow-up|1|||
163032302|NCT01672294|588822173|FG001|Overall Study|Lost to Follow-up|16|||
163032303|NCT01672294|588822174|FG002|Overall Study|Lost to Follow-up|7|||
163032304|NCT01672294|588822175|FG003|Overall Study|Lost to Follow-up|9|||
163032305|NCT01285492|588822176|FG000|Overall Study|Adverse Event|11|||
163032306|NCT01285492|588822177|FG001|Overall Study|Adverse Event|0|||
163032307|NCT01285492|588822176|FG000|Overall Study|Protocol Violation|3|||
163032308|NCT01285492|588822177|FG001|Overall Study|Protocol Violation|0|||
163032309|NCT01285492|588822176|FG000|Overall Study|Withdrawal by Subject|2|||
163032310|NCT01285492|588822177|FG001|Overall Study|Withdrawal by Subject|1|||
163032311|NCT01285492|588822176|FG000|Overall Study|Death|1|||
163032312|NCT01285492|588822177|FG001|Overall Study|Death|0|||
163032313|NCT03379792|588822178|FG000|Overall Study|Physician Decision|0|||
163032314|NCT03379792|588822179|FG001|Overall Study|Physician Decision|0|||
163032315|NCT03379792|588822180|FG002|Overall Study|Physician Decision|0|||
163032316|NCT03379792|588822181|FG003|Overall Study|Physician Decision|1|||
163032317|NCT03379792|588822182|FG004|Overall Study|Physician Decision|0|||
163032318|NCT03379792|588822183|FG005|Overall Study|Physician Decision|0|||
163032319|NCT03379792|588822178|FG000|Overall Study|Withdrawal by Subject|0|||
163032320|NCT03379792|588822179|FG001|Overall Study|Withdrawal by Subject|0|||
163032321|NCT03379792|588822180|FG002|Overall Study|Withdrawal by Subject|0|||
163032322|NCT03379792|588822181|FG003|Overall Study|Withdrawal by Subject|0|||
163032323|NCT03379792|588822182|FG004|Overall Study|Withdrawal by Subject|1|||
163032324|NCT03379792|588822183|FG005|Overall Study|Withdrawal by Subject|1|||
163032325|NCT01121536|588822185|FG000|Overall Study|Adverse Event|63|||
163032326|NCT01121536|588822185|FG000|Overall Study|Lack of Efficacy|35|||
163032327|NCT01121536|588822185|FG000|Overall Study|Withdrawal by Subject|65|||
163032328|NCT01121536|588822185|FG000|Overall Study|Protocol Violation|20|||
163032329|NCT01121536|588822185|FG000|Overall Study|Noncompliance with study medication|12|||
163032330|NCT01121536|588822185|FG000|Overall Study|Noncompliance with study procedures|9|||
163032331|NCT01121536|588822185|FG000|Overall Study|Lost to Follow-up|39|||
163085124|NCT03396445|589022220|FG009|Treatment Period|Physician Decision|1|||
163085125|NCT03396445|589022221|FG010|Treatment Period|Physician Decision|0|||
163085126|NCT03396445|589022222|FG011|Treatment Period|Physician Decision|0|||
163085127|NCT03396445|589022223|FG012|Treatment Period|Physician Decision|0|||
163085128|NCT03396445|589022224|FG013|Treatment Period|Physician Decision|0|||
163085129|NCT03396445|589022225|FG014|Treatment Period|Physician Decision|0|||
162717954|NCT03098030|587673506|FG001|Overall Study|Withdrawal by Subject|7|||
163032332|NCT01121536|588822185|FG000|Overall Study|Other|118|||
163032333|NCT02649426|588822186|FG000|Overall Study|Follow-up on going|1|||
163032334|NCT02649426|588822187|FG001|Overall Study|Follow-up on going|26|||
163032335|NCT02649426|588822188|FG002|Overall Study|Follow-up on going|28|||
163032336|NCT02649426|588822189|FG003|Overall Study|Follow-up on going|31|||
163032337|NCT00306787|588822190|FG000|Overall Study|Discontinued without taking study drug|208|||
163032338|NCT00306787|588822191|FG001|Overall Study|Discontinued without taking study drug|215|||
163032339|NCT00306787|588822190|FG000|Overall Study|Adverse Event|1|||
163032340|NCT00306787|588822191|FG001|Overall Study|Adverse Event|1|||
163032341|NCT00306787|588822190|FG000|Overall Study|Lack of Efficacy|1|||
163032342|NCT00306787|588822191|FG001|Overall Study|Lack of Efficacy|0|||
163032343|NCT00306787|588822190|FG000|Overall Study|Protocol Violation|8|||
163032344|NCT00306787|588822191|FG001|Overall Study|Protocol Violation|10|||
163032345|NCT00306787|588822190|FG000|Overall Study|Withdrawal by Subject|2|||
163032346|NCT00306787|588822191|FG001|Overall Study|Withdrawal by Subject|9|||
163032347|NCT00306787|588822190|FG000|Overall Study|Lost to Follow-up|9|||
163032348|NCT00306787|588822191|FG001|Overall Study|Lost to Follow-up|6|||
163032349|NCT00306787|588822190|FG000|Overall Study|Administrative problems|4|||
163032350|NCT00306787|588822191|FG001|Overall Study|Administrative problems|0|||
163032351|NCT00306787|588822190|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163032352|NCT00306787|588822191|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163032353|NCT00369161|588822197|FG000|Overall Study|Adverse Event|15|||
163032354|NCT00369161|588822198|FG001|Overall Study|Adverse Event|13|||
163032355|NCT00369161|588822197|FG000|Overall Study|Abnormal laboratory value|0|||
163032356|NCT00369161|588822198|FG001|Overall Study|Abnormal laboratory value|1|||
163032357|NCT00369161|588822197|FG000|Overall Study|Lack of Efficacy|3|||
163032358|NCT00369161|588822198|FG001|Overall Study|Lack of Efficacy|1|||
163032359|NCT00369161|588822197|FG000|Overall Study|Protocol Violation|0|||
163032360|NCT00369161|588822198|FG001|Overall Study|Protocol Violation|2|||
163032361|NCT00369161|588822197|FG000|Overall Study|Withdrawal by Subject|2|||
163032362|NCT00369161|588822198|FG001|Overall Study|Withdrawal by Subject|3|||
163032363|NCT00369161|588822197|FG000|Overall Study|Death|1|||
163032364|NCT00369161|588822198|FG001|Overall Study|Death|2|||
163032365|NCT00369161|588822197|FG000|Overall Study|Graft loss|4|||
163032366|NCT00369161|588822198|FG001|Overall Study|Graft loss|0|||
163032367|NCT00369161|588822197|FG000|Overall Study|Administrative Problem|2|||
163032368|NCT00369161|588822198|FG001|Overall Study|Administrative Problem|2|||
163032369|NCT01870297|588822201|FG000|Overall Study|Adverse Event|0|||
163032370|NCT01870297|588822202|FG001|Overall Study|Adverse Event|0|||
163032371|NCT01870297|588822203|FG002|Overall Study|Adverse Event|0|||
163085130|NCT03396445|589022226|FG015|Treatment Period|Physician Decision|0|||
162717955|NCT03098030|587673507|FG002|Overall Study|Withdrawal by Subject|8|||
163032372|NCT01870297|588822204|FG003|Overall Study|Adverse Event|0|||
163032373|NCT01870297|588822205|FG004|Overall Study|Adverse Event|2|||
163032374|NCT01870297|588822206|FG005|Overall Study|Adverse Event|0|||
163032375|NCT01870297|588822207|FG006|Overall Study|Adverse Event|0|||
163032376|NCT01870297|588822201|FG000|Overall Study|Lost to Follow-up|0|||
163085131|NCT03396445|589022227|FG016|Treatment Period|Physician Decision|0|||
163032377|NCT01870297|588822202|FG001|Overall Study|Lost to Follow-up|1|||
163032378|NCT01870297|588822203|FG002|Overall Study|Lost to Follow-up|1|||
163032379|NCT01870297|588822204|FG003|Overall Study|Lost to Follow-up|0|||
163032380|NCT01870297|588822205|FG004|Overall Study|Lost to Follow-up|0|||
163032381|NCT01870297|588822206|FG005|Overall Study|Lost to Follow-up|0|||
163032382|NCT01870297|588822207|FG006|Overall Study|Lost to Follow-up|0|||
163032383|NCT01870297|588822201|FG000|Overall Study|Withdrawal by Subject|0|||
163032384|NCT01870297|588822202|FG001|Overall Study|Withdrawal by Subject|0|||
163032385|NCT01870297|588822203|FG002|Overall Study|Withdrawal by Subject|0|||
163032386|NCT01870297|588822204|FG003|Overall Study|Withdrawal by Subject|0|||
163032387|NCT01870297|588822205|FG004|Overall Study|Withdrawal by Subject|1|||
163032388|NCT01870297|588822206|FG005|Overall Study|Withdrawal by Subject|1|||
163032389|NCT01870297|588822207|FG006|Overall Study|Withdrawal by Subject|1|||
163032390|NCT01870297|588822201|FG000|Overall Study|Sponsor Decision|0|||
163032391|NCT01870297|588822202|FG001|Overall Study|Sponsor Decision|6|||
163032392|NCT01870297|588822203|FG002|Overall Study|Sponsor Decision|0|||
163032393|NCT01870297|588822204|FG003|Overall Study|Sponsor Decision|0|||
163032394|NCT01870297|588822205|FG004|Overall Study|Sponsor Decision|0|||
163032395|NCT01870297|588822206|FG005|Overall Study|Sponsor Decision|0|||
163032396|NCT01870297|588822207|FG006|Overall Study|Sponsor Decision|1|||
163032397|NCT04249622|588822210|FG000|Overall Study|Withdrawal by Subject|1|||
163032398|NCT04249622|588822211|FG001|Overall Study|Withdrawal by Subject|1|||
163032399|NCT04249622|588822210|FG000|Overall Study|Alternative therapy|1|||
163032400|NCT04249622|588822211|FG001|Overall Study|Alternative therapy|0|||
163032401|NCT04249622|588822210|FG000|Overall Study|Discontinuation of pertuzumab|1|||
163032402|NCT04249622|588822211|FG001|Overall Study|Discontinuation of pertuzumab|0|||
163032403|NCT03689543|588822213|FG000|Overall Study|Adverse Event|0|||
163032404|NCT03689543|588822214|FG001|Overall Study|Adverse Event|0|||
163032405|NCT03689543|588822215|FG002|Overall Study|Adverse Event|1|||
163032406|NCT00586508|588822216|FG000|Overall Study|Progressive disease|52|||
163032407|NCT00586508|588822217|FG001|Overall Study|Progressive disease|8|||
163032408|NCT00586508|588822216|FG000|Overall Study|Death|0|||
163032409|NCT00586508|588822217|FG001|Overall Study|Death|1|||
163032410|NCT00586508|588822216|FG000|Overall Study|Adverse Event|12|||
163032411|NCT00586508|588822217|FG001|Overall Study|Adverse Event|4|||
163032412|NCT00586508|588822216|FG000|Overall Study|Withdrawal by Subject|4|||
163032413|NCT00586508|588822217|FG001|Overall Study|Withdrawal by Subject|0|||
163032414|NCT01294371|588822218|FG000|Overall Study|Adverse Event|1|||
163032415|NCT01294371|588822218|FG000|Overall Study|Withdrawal by Subject|12|||
163032416|NCT01294371|588822218|FG000|Overall Study|Lost to Follow-up|6|||
163032417|NCT01294371|588822218|FG000|Overall Study|Administrative Reason|1|||
163032418|NCT01294371|588822218|FG000|Overall Study|Other|14|||
163032419|NCT05619536|588822219|FG000|Overall Study|Withdrawal by Subject|0|||
163032420|NCT05619536|588822220|FG001|Overall Study|Withdrawal by Subject|1|||
163032421|NCT05619536|588822221|FG002|Overall Study|Withdrawal by Subject|0|||
163032422|NCT05619536|588822222|FG003|Overall Study|Withdrawal by Subject|1|||
163032423|NCT05619536|588822219|FG000|Overall Study|Lost to Follow-up|0|||
163032424|NCT05619536|588822220|FG001|Overall Study|Lost to Follow-up|1|||
163032425|NCT05619536|588822221|FG002|Overall Study|Lost to Follow-up|1|||
163032426|NCT05619536|588822222|FG003|Overall Study|Lost to Follow-up|0|||
163032427|NCT00106639|588822223|FG000|Overall Study|Adverse Event|3|||
163032428|NCT00106639|588822224|FG001|Overall Study|Adverse Event|4|||
163032429|NCT00106639|588822225|FG002|Overall Study|Adverse Event|1|||
163032430|NCT00106639|588822223|FG000|Overall Study|Protocol Violation|0|||
163032431|NCT00106639|588822224|FG001|Overall Study|Protocol Violation|1|||
163032432|NCT00106639|588822225|FG002|Overall Study|Protocol Violation|0|||
163032433|NCT00106639|588822223|FG000|Overall Study|Withdrawal by Subject|0|||
163032434|NCT00106639|588822224|FG001|Overall Study|Withdrawal by Subject|1|||
163032435|NCT00106639|588822225|FG002|Overall Study|Withdrawal by Subject|0|||
163032436|NCT00106639|588822223|FG000|Overall Study|Participant defaulted|0|||
163032437|NCT00106639|588822224|FG001|Overall Study|Participant defaulted|1|||
163032438|NCT00106639|588822225|FG002|Overall Study|Participant defaulted|1|||
163032439|NCT02637713|588822233|FG000|Overall Study|Screen Failure|2|||
163032440|NCT02345889|588822234|FG000|Overall Study|Inadequate Bowel Prep|17|||
163032441|NCT02345889|588822235|FG001|Overall Study|Inadequate Bowel Prep|16|||
163032442|NCT02345889|588822236|FG002|Overall Study|Inadequate Bowel Prep|18|||
163032443|NCT02345889|588822237|FG003|Overall Study|Inadequate Bowel Prep|14|||
163032444|NCT02345889|588822234|FG000|Overall Study|Polyposis identified during procedure|1|||
163032445|NCT02345889|588822235|FG001|Overall Study|Polyposis identified during procedure|1|||
163032446|NCT02345889|588822236|FG002|Overall Study|Polyposis identified during procedure|0|||
163032447|NCT02345889|588822237|FG003|Overall Study|Polyposis identified during procedure|1|||
163032448|NCT02345889|588822234|FG000|Overall Study|Recognized ineligible post-randomization|1|||
163032449|NCT02345889|588822235|FG001|Overall Study|Recognized ineligible post-randomization|0|||
163032450|NCT02345889|588822236|FG002|Overall Study|Recognized ineligible post-randomization|2|||
163032451|NCT02345889|588822237|FG003|Overall Study|Recognized ineligible post-randomization|1|||
163032452|NCT02345889|588822234|FG000|Overall Study|Ulcerative Colitis identified|1|||
163032453|NCT02345889|588822235|FG001|Overall Study|Ulcerative Colitis identified|0|||
163032454|NCT02345889|588822236|FG002|Overall Study|Ulcerative Colitis identified|0|||
163032455|NCT02345889|588822237|FG003|Overall Study|Ulcerative Colitis identified|0|||
163032456|NCT02345889|588822234|FG000|Overall Study|Cecum not intubated|1|||
163032457|NCT02345889|588822235|FG001|Overall Study|Cecum not intubated|0|||
163032458|NCT02345889|588822236|FG002|Overall Study|Cecum not intubated|0|||
163032459|NCT02345889|588822237|FG003|Overall Study|Cecum not intubated|0|||
163032460|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032461|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032462|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032463|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032464|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
163032465|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
163032466|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032467|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032468|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032469|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032470|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
163032471|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
163032472|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Adverse Event|0|||
163032473|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Adverse Event|0|||
163032474|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Adverse Event|0|||
163032475|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Adverse Event|0|||
163032476|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Adverse Event|0|||
163032477|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Adverse Event|2|||
163032478|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032479|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032480|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032481|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032482|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
163032483|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
163032484|NCT03191864|588822239|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032485|NCT03191864|588822240|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032486|NCT03191864|588822241|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032487|NCT03191864|588822242|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032488|NCT03191864|588822243|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
163032489|NCT03191864|588822244|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
163032490|NCT03191864|588822239|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032491|NCT03191864|588822240|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032492|NCT03191864|588822241|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
163032493|NCT03191864|588822242|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032494|NCT03191864|588822243|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
163032495|NCT03191864|588822244|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
163032496|NCT03191864|588822239|FG000|Part 1 - Induction|Adverse Event|0|||
163032497|NCT03191864|588822240|FG001|Part 1 - Induction|Adverse Event|2|||
163032498|NCT03191864|588822241|FG002|Part 1 - Induction|Adverse Event|0|||
163032499|NCT03191864|588822242|FG003|Part 1 - Induction|Adverse Event|1|||
163032500|NCT03191864|588822243|FG004|Part 1 - Induction|Adverse Event|0|||
163032501|NCT03191864|588822244|FG005|Part 1 - Induction|Adverse Event|2|||
163032502|NCT03191864|588822239|FG000|Part 1 - Induction|Randomized but never dosed|0|||
163032503|NCT03191864|588822240|FG001|Part 1 - Induction|Randomized but never dosed|0|||
163032504|NCT03191864|588822241|FG002|Part 1 - Induction|Randomized but never dosed|1|||
163032505|NCT03191864|588822242|FG003|Part 1 - Induction|Randomized but never dosed|0|||
163032506|NCT03191864|588822243|FG004|Part 1 - Induction|Randomized but never dosed|0|||
163032507|NCT03191864|588822244|FG005|Part 1 - Induction|Randomized but never dosed|0|||
163032508|NCT03191864|588822239|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
163032509|NCT03191864|588822240|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
163032510|NCT03191864|588822241|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
162646929|NCT02658890|587424888|FG021|Treatment Phase|Death|0|||
162646930|NCT02658890|587424889|FG022|Treatment Phase|Death|0|||
162646931|NCT02658890|587424890|FG023|Treatment Phase|Death|0|||
162646932|NCT02658890|587424891|FG024|Treatment Phase|Death|0|||
162646933|NCT02658890|587424892|FG025|Treatment Phase|Death|0|||
162646934|NCT02658890|587424893|FG026|Treatment Phase|Death|0|||
162717956|NCT03098030|587673508|FG003|Overall Study|Withdrawal by Subject|2|||
162717957|NCT03098030|587673505|FG000|Overall Study|Lost to Follow-up|0|||
163032511|NCT03191864|588822242|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
163032512|NCT03191864|588822243|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
163032513|NCT03191864|588822244|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
162646935|NCT02658890|587424867|FG000|Treatment Phase|Lost to Follow-up|0|||
162646936|NCT02658890|587424868|FG001|Treatment Phase|Lost to Follow-up|0|||
162646937|NCT02658890|587424869|FG002|Treatment Phase|Lost to Follow-up|0|||
162646938|NCT02658890|587424870|FG003|Treatment Phase|Lost to Follow-up|0|||
163032514|NCT03191864|588822239|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032515|NCT03191864|588822240|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032516|NCT03191864|588822241|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
163032517|NCT03191864|588822242|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032518|NCT03191864|588822243|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032519|NCT03191864|588822244|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
163032520|NCT03191864|588822239|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
163032521|NCT03191864|588822240|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032522|NCT03191864|588822241|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032523|NCT03191864|588822242|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032524|NCT03191864|588822243|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032525|NCT03191864|588822244|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
163032526|NCT03191864|588822239|FG000|Part 2 - Maintenance|Physician Decision|1|||
163032527|NCT03191864|588822240|FG001|Part 2 - Maintenance|Physician Decision|0|||
163032528|NCT03191864|588822241|FG002|Part 2 - Maintenance|Physician Decision|0|||
163032529|NCT03191864|588822242|FG003|Part 2 - Maintenance|Physician Decision|0|||
163032530|NCT03191864|588822243|FG004|Part 2 - Maintenance|Physician Decision|0|||
163032531|NCT03191864|588822244|FG005|Part 2 - Maintenance|Physician Decision|0|||
163032532|NCT03191864|588822239|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
163032533|NCT03191864|588822240|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
163032534|NCT03191864|588822241|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
163032535|NCT03191864|588822242|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
163032536|NCT03191864|588822243|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
163032537|NCT03191864|588822244|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
163032538|NCT03191864|588822239|FG000|Part 2 - Maintenance|Adverse Event|0|||
163032539|NCT03191864|588822240|FG001|Part 2 - Maintenance|Adverse Event|0|||
163032540|NCT03191864|588822241|FG002|Part 2 - Maintenance|Adverse Event|0|||
163032541|NCT03191864|588822242|FG003|Part 2 - Maintenance|Adverse Event|0|||
163032542|NCT03191864|588822243|FG004|Part 2 - Maintenance|Adverse Event|1|||
163032543|NCT03191864|588822244|FG005|Part 2 - Maintenance|Adverse Event|0|||
163032544|NCT03191864|588822239|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
163032545|NCT03191864|588822240|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032546|NCT03191864|588822241|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032547|NCT03191864|588822242|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032548|NCT03191864|588822243|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
163032549|NCT03191864|588822244|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
163032550|NCT03191864|588822239|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032551|NCT03191864|588822240|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032552|NCT03191864|588822241|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032553|NCT03191864|588822242|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032554|NCT03191864|588822243|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
163032555|NCT03191864|588822244|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
163032556|NCT02044874|588822247|FG000|Overall Study|Adverse Event|5|||
163032557|NCT02044874|588822248|FG001|Overall Study|Adverse Event|6|||
163032558|NCT02044874|588822249|FG002|Overall Study|Adverse Event|6|||
163032559|NCT02044874|588822247|FG000|Overall Study|Withdrawal by Subject|8|||
163032560|NCT02044874|588822248|FG001|Overall Study|Withdrawal by Subject|16|||
163032561|NCT02044874|588822249|FG002|Overall Study|Withdrawal by Subject|23|||
163032562|NCT02044874|588822247|FG000|Overall Study|Physician Decision|0|||
163032563|NCT02044874|588822248|FG001|Overall Study|Physician Decision|2|||
163032564|NCT02044874|588822249|FG002|Overall Study|Physician Decision|1|||
163032565|NCT02044874|588822247|FG000|Overall Study|Lost to Follow-up|10|||
162646939|NCT02658890|587424871|FG004|Treatment Phase|Lost to Follow-up|0|||
162646940|NCT02658890|587424872|FG005|Treatment Phase|Lost to Follow-up|0|||
162646941|NCT02658890|587424873|FG006|Treatment Phase|Lost to Follow-up|1|||
162646942|NCT02658890|587424874|FG007|Treatment Phase|Lost to Follow-up|0|||
162646943|NCT02658890|587424875|FG008|Treatment Phase|Lost to Follow-up|0|||
162646944|NCT02658890|587424876|FG009|Treatment Phase|Lost to Follow-up|0|||
162646945|NCT02658890|587424877|FG010|Treatment Phase|Lost to Follow-up|0|||
162646946|NCT02658890|587424878|FG011|Treatment Phase|Lost to Follow-up|0|||
162646947|NCT02658890|587424879|FG012|Treatment Phase|Lost to Follow-up|0|||
162646948|NCT02658890|587424880|FG013|Treatment Phase|Lost to Follow-up|0|||
163032566|NCT02044874|588822248|FG001|Overall Study|Lost to Follow-up|27|||
163032567|NCT02044874|588822249|FG002|Overall Study|Lost to Follow-up|21|||
163085132|NCT03396445|589022228|FG017|Treatment Period|Physician Decision|0|||
162646949|NCT02658890|587424881|FG014|Treatment Phase|Lost to Follow-up|0|||
162646950|NCT02658890|587424882|FG015|Treatment Phase|Lost to Follow-up|0|||
162646951|NCT02658890|587424883|FG016|Treatment Phase|Lost to Follow-up|0|||
162646952|NCT02658890|587424884|FG017|Treatment Phase|Lost to Follow-up|0|||
162646953|NCT02658890|587424885|FG018|Treatment Phase|Lost to Follow-up|0|||
163032568|NCT02044874|588822247|FG000|Overall Study|Sponsor Decision|0|||
163032569|NCT02044874|588822248|FG001|Overall Study|Sponsor Decision|1|||
163032570|NCT02044874|588822249|FG002|Overall Study|Sponsor Decision|1|||
163032571|NCT02044874|588822247|FG000|Overall Study|Other|7|||
163032572|NCT02044874|588822248|FG001|Overall Study|Other|3|||
163032573|NCT02044874|588822249|FG002|Overall Study|Other|8|||
163032574|NCT00415597|588822250|FG000|Enrollment|Withdrawal by Subject|1|||
163032575|NCT00415597|588822250|FG000|Enrollment|Protocol Violation|1|||
163032576|NCT00415597|588822250|FG000|Treatment|Adverse Event|110|||
163032577|NCT00415597|588822250|FG000|Treatment|Lack of Efficacy|39|||
163032578|NCT00415597|588822250|FG000|Treatment|Protocol Violation|67|||
163032579|NCT00415597|588822250|FG000|Treatment|Physician Decision|3|||
163032580|NCT00415597|588822250|FG000|Treatment|Withdrawal by Subject|51|||
163032581|NCT00415597|588822250|FG000|Treatment|Lost to Follow-up|28|||
163032582|NCT00415597|588822250|FG000|Treatment|Drug Screen|2|||
163032583|NCT00415597|588822250|FG000|Treatment|Administrative|3|||
163032584|NCT00415597|588822250|FG000|Treatment|Sponsor Decision|1|||
163032585|NCT00415597|588822250|FG000|Treatment|Multiple Reasons|1|||
163032586|NCT02093390|588822253|FG000|Overall Study|Withdrawal by Subject|0|||
163032587|NCT02093390|588822254|FG001|Overall Study|Withdrawal by Subject|1|||
163032588|NCT00073983|588822255|FG000|Overall Study|not evaluable|1|||
163032589|NCT03976323|588822258|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
163032590|NCT03976323|588822259|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163032591|NCT03976323|588822260|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
163032592|NCT03976323|588822258|FG000|Induction Phase|Death|80|||
163032593|NCT03976323|588822259|FG001|Induction Phase|Death|0|||
163032594|NCT03976323|588822260|FG002|Induction Phase|Death|0|||
163032595|NCT03976323|588822258|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
163032596|NCT03976323|588822259|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
163032597|NCT03976323|588822260|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
163032598|NCT03976323|588822258|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163032599|NCT03976323|588822259|FG001|Maintenance Phase|Withdrawal by Subject|9|||
163032600|NCT03976323|588822260|FG002|Maintenance Phase|Withdrawal by Subject|3|||
163032601|NCT03976323|588822258|FG000|Maintenance Phase|Physician Decision|0|||
163032602|NCT03976323|588822259|FG001|Maintenance Phase|Physician Decision|0|||
163032603|NCT03976323|588822260|FG002|Maintenance Phase|Physician Decision|1|||
163032604|NCT03976323|588822258|FG000|Maintenance Phase|Death|0|||
163032605|NCT03976323|588822259|FG001|Maintenance Phase|Death|228|||
163032606|NCT03976323|588822260|FG002|Maintenance Phase|Death|234|||
163032607|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
163032608|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
163032609|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
163032610|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
163032611|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
163032612|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
163032613|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
163032614|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
163032615|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
163032616|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
163032617|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
163032618|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
163032619|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
163032620|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
163032621|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
163032622|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
163032623|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
163032624|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
163032625|NCT02294461|588822261|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
163032626|NCT02294461|588822262|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
163032627|NCT02294461|588822263|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
163032628|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
163032629|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
163032630|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
163032631|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
163032632|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
163032633|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
163032634|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
163032635|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
163032636|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
163032637|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
163032638|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
163032639|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
163032640|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
163032641|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
163032642|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
163032643|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
163032644|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
162646954|NCT02658890|587424886|FG019|Treatment Phase|Lost to Follow-up|0|||
162646955|NCT02658890|587424887|FG020|Treatment Phase|Lost to Follow-up|0|||
162646956|NCT02658890|587424888|FG021|Treatment Phase|Lost to Follow-up|0|||
162646957|NCT02658890|587424889|FG022|Treatment Phase|Lost to Follow-up|0|||
162646958|NCT02658890|587424890|FG023|Treatment Phase|Lost to Follow-up|0|||
162646959|NCT02658890|587424891|FG024|Treatment Phase|Lost to Follow-up|0|||
162646960|NCT02658890|587424892|FG025|Treatment Phase|Lost to Follow-up|0|||
162646961|NCT02658890|587424893|FG026|Treatment Phase|Lost to Follow-up|0|||
162646962|NCT02658890|587424867|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
162646963|NCT02658890|587424868|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
162646964|NCT02658890|587424869|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
162646965|NCT02658890|587424870|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
162646966|NCT02658890|587424871|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
162646967|NCT02658890|587424872|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
162646968|NCT02658890|587424873|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
162646969|NCT02658890|587424874|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
162646970|NCT02658890|587424875|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
162646971|NCT02658890|587424876|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
162646972|NCT02658890|587424877|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
162646973|NCT02658890|587424878|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
162646974|NCT02658890|587424879|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
162646975|NCT02658890|587424880|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
162646976|NCT02658890|587424881|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
162646977|NCT02658890|587424882|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
162646978|NCT02658890|587424883|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
162646979|NCT02658890|587424884|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
162646980|NCT02658890|587424885|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
162646981|NCT02658890|587424886|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
162646982|NCT02658890|587424887|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
162646983|NCT02658890|587424888|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
162646984|NCT02658890|587424889|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
162646985|NCT02658890|587424890|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
162646986|NCT02658890|587424891|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
163032645|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
163032646|NCT02294461|588822261|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
163032647|NCT02294461|588822262|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
163032648|NCT02294461|588822263|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
163032649|NCT03800836|588822264|FG000|Overall Study|Other|2|||
163032650|NCT03800836|588822265|FG001|Overall Study|Other|1|||
163032651|NCT03800836|588822266|FG002|Overall Study|Other|0|||
162646987|NCT02658890|587424892|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
163085133|NCT03396445|589022229|FG018|Treatment Period|Physician Decision|0|||
162646988|NCT02658890|587424893|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
162646989|NCT02658890|587424867|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
162646990|NCT02658890|587424868|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
162646991|NCT02658890|587424869|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
162646992|NCT02658890|587424870|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
163032652|NCT03800836|588822267|FG003|Overall Study|Other|2|||
163032653|NCT03800836|588822268|FG004|Overall Study|Other|0|||
163032654|NCT03800836|588822269|FG005|Overall Study|Other|1|||
163032655|NCT03800836|588822264|FG000|Overall Study|Lost to Follow-up|2|||
163032656|NCT03800836|588822265|FG001|Overall Study|Lost to Follow-up|0|||
163032657|NCT03800836|588822266|FG002|Overall Study|Lost to Follow-up|1|||
163032658|NCT03800836|588822267|FG003|Overall Study|Lost to Follow-up|1|||
163032659|NCT03800836|588822268|FG004|Overall Study|Lost to Follow-up|3|||
163032660|NCT03800836|588822269|FG005|Overall Study|Lost to Follow-up|0|||
163032661|NCT03800836|588822264|FG000|Overall Study|Withdrawal by Subject|1|||
163032662|NCT03800836|588822265|FG001|Overall Study|Withdrawal by Subject|0|||
163032663|NCT03800836|588822266|FG002|Overall Study|Withdrawal by Subject|0|||
163032664|NCT03800836|588822267|FG003|Overall Study|Withdrawal by Subject|0|||
163032665|NCT03800836|588822268|FG004|Overall Study|Withdrawal by Subject|0|||
163032666|NCT03800836|588822269|FG005|Overall Study|Withdrawal by Subject|0|||
163032667|NCT03800836|588822264|FG000|Overall Study|Physician Decision|31|||
163032668|NCT03800836|588822265|FG001|Overall Study|Physician Decision|3|||
163032669|NCT03800836|588822266|FG002|Overall Study|Physician Decision|6|||
163032670|NCT03800836|588822267|FG003|Overall Study|Physician Decision|4|||
163032671|NCT03800836|588822268|FG004|Overall Study|Physician Decision|4|||
163032672|NCT03800836|588822269|FG005|Overall Study|Physician Decision|5|||
163032673|NCT03800836|588822264|FG000|Overall Study|Death|34|||
163032674|NCT03800836|588822265|FG001|Overall Study|Death|16|||
163032675|NCT03800836|588822266|FG002|Overall Study|Death|5|||
163032676|NCT03800836|588822267|FG003|Overall Study|Death|5|||
163032677|NCT03800836|588822268|FG004|Overall Study|Death|10|||
163032678|NCT03800836|588822269|FG005|Overall Study|Death|0|||
163032679|NCT03800836|588822264|FG000|Overall Study|Symptomatic Deterioration|1|||
163032680|NCT03800836|588822265|FG001|Overall Study|Symptomatic Deterioration|0|||
163032681|NCT03800836|588822266|FG002|Overall Study|Symptomatic Deterioration|1|||
163032682|NCT03800836|588822267|FG003|Overall Study|Symptomatic Deterioration|0|||
163032683|NCT03800836|588822268|FG004|Overall Study|Symptomatic Deterioration|0|||
163032684|NCT03800836|588822269|FG005|Overall Study|Symptomatic Deterioration|0|||
163032685|NCT00441363|588824412|FG000|Overall Study|Adverse Event|4|||
163032686|NCT00441363|588824413|FG001|Overall Study|Adverse Event|2|||
163032687|NCT00441363|588824412|FG000|Overall Study|Withdrawal by Subject|3|||
163032688|NCT00441363|588824413|FG001|Overall Study|Withdrawal by Subject|4|||
163032689|NCT00441363|588824412|FG000|Overall Study|Physician Decision|6|||
163032690|NCT00441363|588824413|FG001|Overall Study|Physician Decision|7|||
163032691|NCT00441363|588824412|FG000|Overall Study|Lost to Follow-up|2|||
163032692|NCT00441363|588824413|FG001|Overall Study|Lost to Follow-up|2|||
163032693|NCT00441363|588824412|FG000|Overall Study|Other|2|||
163032694|NCT00441363|588824413|FG001|Overall Study|Other|0|||
163032695|NCT03774394|588824416|FG000|Overall Study|Withdrawal by Subject|2|||
163032696|NCT03774394|588824417|FG001|Overall Study|Withdrawal by Subject|0|||
163032697|NCT03334422|588824418|FG000|Overall Study|Adverse Event|1|||
163032698|NCT03334422|588824419|FG001|Overall Study|Adverse Event|3|||
163032699|NCT03334422|588824420|FG002|Overall Study|Adverse Event|2|||
163032700|NCT03334422|588824421|FG003|Overall Study|Adverse Event|2|||
162646993|NCT02658890|587424871|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
162646994|NCT02658890|587424872|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
162646995|NCT02658890|587424873|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
163032701|NCT03334422|588824418|FG000|Overall Study|Lack of Efficacy|10|||
163032702|NCT03334422|588824419|FG001|Overall Study|Lack of Efficacy|2|||
163032703|NCT03334422|588824420|FG002|Overall Study|Lack of Efficacy|7|||
163032704|NCT03334422|588824421|FG003|Overall Study|Lack of Efficacy|3|||
163032705|NCT03334422|588824418|FG000|Overall Study|Withdrawal by Subject|8|||
163032706|NCT03334422|588824419|FG001|Overall Study|Withdrawal by Subject|3|||
163032707|NCT03334422|588824420|FG002|Overall Study|Withdrawal by Subject|1|||
163032708|NCT03334422|588824421|FG003|Overall Study|Withdrawal by Subject|0|||
163032709|NCT03334422|588824418|FG000|Overall Study|Lost to Follow-up|0|||
163032710|NCT03334422|588824419|FG001|Overall Study|Lost to Follow-up|0|||
162646996|NCT02658890|587424874|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
163032711|NCT03334422|588824420|FG002|Overall Study|Lost to Follow-up|0|||
163032712|NCT03334422|588824421|FG003|Overall Study|Lost to Follow-up|1|||
163032713|NCT03334422|588824418|FG000|Overall Study|Inability to obtain laboratory samples|0|||
163032714|NCT03334422|588824419|FG001|Overall Study|Inability to obtain laboratory samples|1|||
163032715|NCT03334422|588824420|FG002|Overall Study|Inability to obtain laboratory samples|0|||
163032716|NCT03334422|588824421|FG003|Overall Study|Inability to obtain laboratory samples|0|||
163032717|NCT03334422|588824418|FG000|Overall Study|Pregnancy|0|||
163032718|NCT03334422|588824419|FG001|Overall Study|Pregnancy|1|||
163032719|NCT03334422|588824420|FG002|Overall Study|Pregnancy|0|||
163032720|NCT03334422|588824421|FG003|Overall Study|Pregnancy|0|||
163032721|NCT01313221|588824422|FG000|Overall Study|Protocol Violation|0|||
163032722|NCT01313221|588824423|FG001|Overall Study|Protocol Violation|1|||
163032723|NCT01313221|588824424|FG002|Overall Study|Protocol Violation|1|||
163032724|NCT01313221|588824422|FG000|Overall Study|Non-compliance|3|||
163032725|NCT01313221|588824423|FG001|Overall Study|Non-compliance|0|||
163032726|NCT01313221|588824424|FG002|Overall Study|Non-compliance|2|||
163032727|NCT01313221|588824422|FG000|Overall Study|Withdrawal by Subject|2|||
163032728|NCT01313221|588824423|FG001|Overall Study|Withdrawal by Subject|3|||
163032729|NCT01313221|588824424|FG002|Overall Study|Withdrawal by Subject|5|||
163032730|NCT01313221|588824422|FG000|Overall Study|Requirement for alternative therapy|0|||
163032731|NCT01313221|588824423|FG001|Overall Study|Requirement for alternative therapy|1|||
163032732|NCT01313221|588824424|FG002|Overall Study|Requirement for alternative therapy|1|||
163032733|NCT01313221|588824422|FG000|Overall Study|Lost to Follow-up|6|||
163085134|NCT03396445|589022230|FG019|Treatment Period|Physician Decision|0|||
163085135|NCT03396445|589022231|FG020|Treatment Period|Physician Decision|0|||
163085136|NCT03396445|589022232|FG021|Treatment Period|Physician Decision|0|||
162646997|NCT02658890|587424875|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
162646998|NCT02658890|587424876|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
162646999|NCT02658890|587424877|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
162647000|NCT02658890|587424878|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
162647001|NCT02658890|587424879|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
162647002|NCT02658890|587424880|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
162647003|NCT02658890|587424881|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
162647004|NCT02658890|587424882|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
162647005|NCT02658890|587424883|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
162647006|NCT02658890|587424884|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
162647007|NCT02658890|587424885|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
162647008|NCT02658890|587424886|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
162647009|NCT02658890|587424887|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
162647010|NCT02658890|587424888|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
162647011|NCT02658890|587424889|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
162647012|NCT02658890|587424890|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
162647013|NCT02658890|587424891|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
162647014|NCT02658890|587424892|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
162647015|NCT02658890|587424893|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
162647016|NCT02658890|587424867|FG000|Treatment Phase|Other Reasons|0|||
162647017|NCT02658890|587424868|FG001|Treatment Phase|Other Reasons|0|||
162647018|NCT02658890|587424869|FG002|Treatment Phase|Other Reasons|0|||
162647019|NCT02658890|587424870|FG003|Treatment Phase|Other Reasons|0|||
162647020|NCT02658890|587424871|FG004|Treatment Phase|Other Reasons|0|||
162647021|NCT02658890|587424872|FG005|Treatment Phase|Other Reasons|0|||
162647022|NCT02658890|587424873|FG006|Treatment Phase|Other Reasons|1|||
162647023|NCT02658890|587424874|FG007|Treatment Phase|Other Reasons|0|||
162647024|NCT02658890|587424875|FG008|Treatment Phase|Other Reasons|1|||
162647025|NCT02658890|587424876|FG009|Treatment Phase|Other Reasons|0|||
162647026|NCT02658890|587424877|FG010|Treatment Phase|Other Reasons|0|||
162647027|NCT02658890|587424878|FG011|Treatment Phase|Other Reasons|0|||
162647028|NCT02658890|587424879|FG012|Treatment Phase|Other Reasons|0|||
162647029|NCT02658890|587424880|FG013|Treatment Phase|Other Reasons|2|||
162647030|NCT02658890|587424881|FG014|Treatment Phase|Other Reasons|0|||
162647031|NCT02658890|587424882|FG015|Treatment Phase|Other Reasons|0|||
162647032|NCT02658890|587424883|FG016|Treatment Phase|Other Reasons|0|||
162647033|NCT02658890|587424884|FG017|Treatment Phase|Other Reasons|0|||
162647034|NCT02658890|587424885|FG018|Treatment Phase|Other Reasons|1|||
162647035|NCT02658890|587424886|FG019|Treatment Phase|Other Reasons|0|||
162647036|NCT02658890|587424887|FG020|Treatment Phase|Other Reasons|0|||
163032734|NCT01313221|588824423|FG001|Overall Study|Lost to Follow-up|3|||
163032735|NCT01313221|588824424|FG002|Overall Study|Lost to Follow-up|1|||
163085137|NCT03396445|589022233|FG022|Treatment Period|Physician Decision|0|||
162647037|NCT02658890|587424888|FG021|Treatment Phase|Other Reasons|0|||
162647038|NCT02658890|587424889|FG022|Treatment Phase|Other Reasons|0|||
162647039|NCT02658890|587424890|FG023|Treatment Phase|Other Reasons|0|||
162647040|NCT02658890|587424891|FG024|Treatment Phase|Other Reasons|1|||
162647041|NCT02658890|587424892|FG025|Treatment Phase|Other Reasons|0|||
162647042|NCT02658890|587424893|FG026|Treatment Phase|Other Reasons|1|||
162647043|NCT02658890|587424867|FG000|Treatment Phase|Progressive Disease|6|||
162717958|NCT03098030|587673506|FG001|Overall Study|Lost to Follow-up|0|||
163032736|NCT01313221|588824422|FG000|Overall Study|Other|1|||
163032737|NCT01313221|588824423|FG001|Overall Study|Other|0|||
163032738|NCT01313221|588824424|FG002|Overall Study|Other|0|||
163032739|NCT01313221|588824422|FG000|Overall Study|Adverse Event|0|||
163032740|NCT01313221|588824423|FG001|Overall Study|Adverse Event|0|||
163032741|NCT01313221|588824424|FG002|Overall Study|Adverse Event|7|||
163032742|NCT01313221|588824422|FG000|Overall Study|Disease progression|0|||
163032743|NCT01313221|588824423|FG001|Overall Study|Disease progression|0|||
163032744|NCT01313221|588824424|FG002|Overall Study|Disease progression|2|||
163032745|NCT01313221|588824422|FG000|Overall Study|Physician Decision|0|||
163032746|NCT01313221|588824423|FG001|Overall Study|Physician Decision|0|||
163032747|NCT01313221|588824424|FG002|Overall Study|Physician Decision|2|||
163032748|NCT01313221|588824422|FG000|Overall Study|Pregnancy|0|||
163032749|NCT01313221|588824423|FG001|Overall Study|Pregnancy|0|||
163032750|NCT01313221|588824424|FG002|Overall Study|Pregnancy|2|||
163032751|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032752|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
163032753|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032754|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
163032755|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032756|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032757|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
163032758|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
163032759|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
163032760|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032761|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032762|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
163032763|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
163032764|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
163032765|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
163032766|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
163032767|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032768|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032769|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
163032770|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
163032771|NCT00994214|588824425|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
163032772|NCT00994214|588824426|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
163032773|NCT00994214|588824427|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
163032774|NCT00994214|588824428|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
163032775|NCT03246061|588824429|FG000|Overall Study|Still in follow-up|15|||
163032776|NCT03246061|588824430|FG001|Overall Study|Still in follow-up|21|||
163032777|NCT04710368|588824435|FG000|Overall Study|Withdrawal by Subject|9|||
163032778|NCT04710368|588824435|FG000|Overall Study|Lost to Follow-up|4|||
163032779|NCT04710368|588824435|FG000|Overall Study|Death|2|||
163032780|NCT04710368|588824435|FG000|Overall Study|Patient preference|11|||
163032781|NCT04710368|588824435|FG000|Overall Study|Treatment discontinuation|1|||
163032782|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
163032783|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
163032784|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
163032785|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
163032786|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
163032787|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
163032788|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
163032789|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
163032790|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
163032791|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
163032792|NCT01777139|588824438|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
163032793|NCT01777139|588824439|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
163032794|NCT01777139|588824438|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
163032795|NCT01777139|588824439|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
163032796|NCT01777139|588824438|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
163032797|NCT01777139|588824439|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
163032798|NCT01887288|588824441|FG000|Overall Study|The study was terminated and the PI has|16|||
163032799|NCT00290693|588824442|FG000|Overall Study|Withdrawal by Subject|2|||
163032800|NCT05625477|588824443|FG000|Overall Study|Lost to Follow-up|2|||
163032801|NCT05625477|588824444|FG001|Overall Study|Lost to Follow-up|2|||
163032802|NCT05625477|588824445|FG002|Overall Study|Lost to Follow-up|1|||
163032803|NCT05625477|588824446|FG003|Overall Study|Lost to Follow-up|1|||
163032804|NCT05625477|588824447|FG004|Overall Study|Lost to Follow-up|0|||
163032805|NCT05625477|588824443|FG000|Overall Study|Covid quarantine|1|||
163032806|NCT05625477|588824444|FG001|Overall Study|Covid quarantine|0|||
162717959|NCT03098030|587673507|FG002|Overall Study|Lost to Follow-up|2|||
162717960|NCT03098030|587673508|FG003|Overall Study|Lost to Follow-up|1|||
162717961|NCT03368001|587673509|FG000|Allocation|Lost to Pretest|16|||
162717962|NCT03368001|587673510|FG001|Allocation|Lost to Pretest|25|||
162717963|NCT03368001|587673509|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
162717964|NCT03368001|587673510|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
162717965|NCT03368001|587673509|FG000|Posttest|Lost to Posttest|7|||
162717966|NCT03368001|587673510|FG001|Posttest|Lost to Posttest|11|||
162717967|NCT03368001|587673509|FG000|Posttest|Discontinued Intervention|6|||
162717968|NCT03368001|587673510|FG001|Posttest|Discontinued Intervention|19|||
162717969|NCT03368001|587673509|FG000|Follow-up|Lost to Follow-up|6|||
162717970|NCT03368001|587673510|FG001|Follow-up|Lost to Follow-up|3|||
162717971|NCT03612804|587673511|FG000|Overall Study|Death|0|||
162717972|NCT03612804|587673512|FG001|Overall Study|Death|7|||
162717973|NCT03612804|587673513|FG002|Overall Study|Death|0|||
162717974|NCT03612804|587673514|FG003|Overall Study|Death|8|||
162717975|NCT03612804|587673511|FG000|Overall Study|Medication copay coverage issues|0|||
162717976|NCT03612804|587673512|FG001|Overall Study|Medication copay coverage issues|0|||
162717977|NCT03612804|587673513|FG002|Overall Study|Medication copay coverage issues|0|||
162717978|NCT03612804|587673514|FG003|Overall Study|Medication copay coverage issues|17|||
162717979|NCT03612804|587673511|FG000|Overall Study|Not current smoker at time of screening|0|||
162717980|NCT03612804|587673512|FG001|Overall Study|Not current smoker at time of screening|1|||
162717981|NCT03612804|587673513|FG002|Overall Study|Not current smoker at time of screening|0|||
162717982|NCT03612804|587673514|FG003|Overall Study|Not current smoker at time of screening|3|||
162717983|NCT03612804|587673511|FG000|Overall Study|Non-veteran status|0|||
162717984|NCT03612804|587673512|FG001|Overall Study|Non-veteran status|1|||
162717985|NCT03612804|587673513|FG002|Overall Study|Non-veteran status|0|||
162717986|NCT03612804|587673514|FG003|Overall Study|Non-veteran status|0|||
162717987|NCT03612804|587673511|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
162717988|NCT03612804|587673512|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
162717989|NCT03612804|587673513|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
162717990|NCT03612804|587673514|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
162717991|NCT03612804|587673511|FG000|Overall Study|Provider retired from VA|0|||
162717992|NCT03612804|587673512|FG001|Overall Study|Provider retired from VA|0|||
162717993|NCT03612804|587673513|FG002|Overall Study|Provider retired from VA|2|||
162717994|NCT03612804|587673514|FG003|Overall Study|Provider retired from VA|0|||
162717995|NCT03612804|587673511|FG000|Overall Study|Withdrawal by Subject|0|||
162717996|NCT03612804|587673512|FG001|Overall Study|Withdrawal by Subject|0|||
162717997|NCT03612804|587673513|FG002|Overall Study|Withdrawal by Subject|7|||
162717998|NCT03612804|587673514|FG003|Overall Study|Withdrawal by Subject|0|||
162717999|NCT03612804|587673511|FG000|Overall Study|Provider involved with study activities|1|||
162718000|NCT03612804|587673512|FG001|Overall Study|Provider involved with study activities|0|||
162718001|NCT03612804|587673513|FG002|Overall Study|Provider involved with study activities|0|||
162718002|NCT03612804|587673514|FG003|Overall Study|Provider involved with study activities|0|||
162718003|NCT05484726|587673515|FG000|Overall Study|Protocol Violation|3|||
162718004|NCT05484726|587673516|FG001|Overall Study|Protocol Violation|3|||
162718005|NCT05484726|587673515|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
163032807|NCT05625477|588824445|FG002|Overall Study|Covid quarantine|0|||
163032808|NCT05625477|588824446|FG003|Overall Study|Covid quarantine|0|||
163032809|NCT05625477|588824447|FG004|Overall Study|Covid quarantine|0|||
163032810|NCT04849416|588824450|FG000|Overall Study|Ongoing Treatment|12|||
163032811|NCT04849416|588824451|FG001|Overall Study|Ongoing Treatment|5|||
163032812|NCT04849416|588824452|FG002|Overall Study|Ongoing Treatment|3|||
162718006|NCT05484726|587673516|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
162718007|NCT05484726|587673515|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
162718008|NCT05484726|587673516|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
162718009|NCT05484726|587673515|FG000|Overall Study|continued need of mechanical ventilation|2|||
162718010|NCT05484726|587673516|FG001|Overall Study|continued need of mechanical ventilation|3|||
163032813|NCT04849416|588824450|FG000|Overall Study|On Post-Treatment Follow-up|8|||
163032814|NCT04849416|588824451|FG001|Overall Study|On Post-Treatment Follow-up|9|||
163032815|NCT04849416|588824452|FG002|Overall Study|On Post-Treatment Follow-up|10|||
163032816|NCT04849416|588824450|FG000|Overall Study|Withdrawal by Subject|0|||
163032817|NCT04849416|588824451|FG001|Overall Study|Withdrawal by Subject|0|||
163085138|NCT03396445|589022234|FG023|Treatment Period|Physician Decision|0|||
163085139|NCT03396445|589022235|FG024|Treatment Period|Physician Decision|0|||
163085140|NCT03396445|589022236|FG025|Treatment Period|Physician Decision|0|||
163032818|NCT04849416|588824452|FG002|Overall Study|Withdrawal by Subject|1|||
163085141|NCT03396445|589022211|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085142|NCT03396445|589022212|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162718011|NCT05484726|587673515|FG000|Overall Study|Withdrawal by Subject|2|||
162718012|NCT05484726|587673516|FG001|Overall Study|Withdrawal by Subject|3|||
162718013|NCT05484726|587673515|FG000|Overall Study|IVH (G III & IV)|2|||
163032819|NCT04849416|588824450|FG000|Overall Study|Lost to Follow-up|1|||
163032820|NCT04849416|588824451|FG001|Overall Study|Lost to Follow-up|0|||
163032821|NCT04849416|588824452|FG002|Overall Study|Lost to Follow-up|0|||
163032822|NCT01092637|588824453|FG000|Overall Study|Death|47|||
163032823|NCT01092637|588824454|FG001|Overall Study|Death|49|||
163032824|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163032825|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032826|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032827|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032828|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032829|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
163032830|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032831|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032832|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
163032833|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032834|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032835|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032836|NCT01716520|588824455|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032837|NCT01716520|588824456|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163032838|NCT01716520|588824457|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032839|NCT01716520|588824458|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032840|NCT01716520|588824459|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032841|NCT01716520|588824460|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163032842|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032843|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
163032844|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032845|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032846|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032847|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
163032848|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032849|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032850|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032851|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032852|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163032853|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
163032854|NCT01716520|588824455|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032855|NCT01716520|588824456|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032856|NCT01716520|588824457|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
163032857|NCT01716520|588824458|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032858|NCT01716520|588824459|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
163032859|NCT01716520|588824460|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
163032860|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032861|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032862|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032863|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032864|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
163032865|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
163032866|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032867|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032868|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032869|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032870|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163032871|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163032872|NCT01716520|588824455|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032873|NCT01716520|588824456|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032874|NCT01716520|588824457|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032875|NCT01716520|588824458|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
163032876|NCT01716520|588824459|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032877|NCT01716520|588824460|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
163032878|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032879|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032880|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032881|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032882|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
163032883|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
163032884|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
163032885|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032886|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032887|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
162647044|NCT02658890|587424868|FG001|Treatment Phase|Progressive Disease|7|||
162647045|NCT02658890|587424869|FG002|Treatment Phase|Progressive Disease|6|||
162647046|NCT02658890|587424870|FG003|Treatment Phase|Progressive Disease|12|||
162647047|NCT02658890|587424871|FG004|Treatment Phase|Progressive Disease|6|||
162647048|NCT02658890|587424872|FG005|Treatment Phase|Progressive Disease|18|||
162647049|NCT02658890|587424873|FG006|Treatment Phase|Progressive Disease|12|||
163085143|NCT03396445|589022213|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085144|NCT03396445|589022214|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085145|NCT03396445|589022215|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085146|NCT03396445|589022216|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085147|NCT03396445|589022217|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085148|NCT03396445|589022218|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085149|NCT03396445|589022219|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085150|NCT03396445|589022220|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085151|NCT03396445|589022221|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085152|NCT03396445|589022222|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085153|NCT03396445|589022223|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
163085154|NCT03396445|589022224|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085155|NCT03396445|589022225|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
163085156|NCT03396445|589022226|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162647050|NCT02658890|587424874|FG007|Treatment Phase|Progressive Disease|19|||
162647051|NCT02658890|587424875|FG008|Treatment Phase|Progressive Disease|26|||
162647052|NCT02658890|587424876|FG009|Treatment Phase|Progressive Disease|8|||
162647053|NCT02658890|587424877|FG010|Treatment Phase|Progressive Disease|7|||
162647054|NCT02658890|587424878|FG011|Treatment Phase|Progressive Disease|9|||
162647055|NCT02658890|587424879|FG012|Treatment Phase|Progressive Disease|8|||
162647056|NCT02658890|587424880|FG013|Treatment Phase|Progressive Disease|29|||
162647057|NCT02658890|587424881|FG014|Treatment Phase|Progressive Disease|6|||
162647058|NCT02658890|587424882|FG015|Treatment Phase|Progressive Disease|2|||
162647059|NCT02658890|587424883|FG016|Treatment Phase|Progressive Disease|32|||
162647060|NCT02658890|587424884|FG017|Treatment Phase|Progressive Disease|14|||
162647061|NCT02658890|587424885|FG018|Treatment Phase|Progressive Disease|40|||
162647062|NCT02658890|587424886|FG019|Treatment Phase|Progressive Disease|32|||
162647063|NCT02658890|587424887|FG020|Treatment Phase|Progressive Disease|19|||
162647064|NCT02658890|587424888|FG021|Treatment Phase|Progressive Disease|30|||
162647065|NCT02658890|587424889|FG022|Treatment Phase|Progressive Disease|15|||
162647066|NCT02658890|587424890|FG023|Treatment Phase|Progressive Disease|0|||
162647067|NCT02658890|587424891|FG024|Treatment Phase|Progressive Disease|0|||
162647068|NCT02658890|587424892|FG025|Treatment Phase|Progressive Disease|14|||
162647069|NCT02658890|587424893|FG026|Treatment Phase|Progressive Disease|11|||
162647070|NCT02658890|587424867|FG000|Treatment Phase|Study Drug Toxicity|0|||
162647071|NCT02658890|587424868|FG001|Treatment Phase|Study Drug Toxicity|0|||
162647072|NCT02658890|587424869|FG002|Treatment Phase|Study Drug Toxicity|2|||
162647073|NCT02658890|587424870|FG003|Treatment Phase|Study Drug Toxicity|0|||
162647074|NCT02658890|587424871|FG004|Treatment Phase|Study Drug Toxicity|0|||
162647075|NCT02658890|587424872|FG005|Treatment Phase|Study Drug Toxicity|0|||
162647076|NCT02658890|587424873|FG006|Treatment Phase|Study Drug Toxicity|0|||
162647077|NCT02658890|587424874|FG007|Treatment Phase|Study Drug Toxicity|0|||
162647078|NCT02658890|587424875|FG008|Treatment Phase|Study Drug Toxicity|3|||
162647079|NCT02658890|587424876|FG009|Treatment Phase|Study Drug Toxicity|0|||
162647080|NCT02658890|587424877|FG010|Treatment Phase|Study Drug Toxicity|1|||
162647081|NCT02658890|587424878|FG011|Treatment Phase|Study Drug Toxicity|1|||
162647082|NCT02658890|587424879|FG012|Treatment Phase|Study Drug Toxicity|2|||
162647083|NCT02658890|587424880|FG013|Treatment Phase|Study Drug Toxicity|9|||
162647084|NCT02658890|587424881|FG014|Treatment Phase|Study Drug Toxicity|0|||
162647085|NCT02658890|587424882|FG015|Treatment Phase|Study Drug Toxicity|1|||
162647086|NCT02658890|587424883|FG016|Treatment Phase|Study Drug Toxicity|1|||
162647087|NCT02658890|587424884|FG017|Treatment Phase|Study Drug Toxicity|0|||
162647088|NCT02658890|587424885|FG018|Treatment Phase|Study Drug Toxicity|8|||
162647089|NCT02658890|587424886|FG019|Treatment Phase|Study Drug Toxicity|3|||
162647090|NCT02658890|587424887|FG020|Treatment Phase|Study Drug Toxicity|2|||
162647091|NCT02658890|587424888|FG021|Treatment Phase|Study Drug Toxicity|0|||
162647092|NCT02658890|587424889|FG022|Treatment Phase|Study Drug Toxicity|8|||
162647093|NCT02658890|587424890|FG023|Treatment Phase|Study Drug Toxicity|0|||
162647094|NCT02658890|587424891|FG024|Treatment Phase|Study Drug Toxicity|0|||
162647095|NCT02658890|587424892|FG025|Treatment Phase|Study Drug Toxicity|2|||
162647096|NCT02658890|587424893|FG026|Treatment Phase|Study Drug Toxicity|0|||
162647097|NCT02658890|587424867|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647098|NCT02658890|587424868|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647099|NCT02658890|587424869|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647100|NCT02658890|587424870|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162647101|NCT02658890|587424871|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647102|NCT02658890|587424872|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647103|NCT02658890|587424873|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647104|NCT02658890|587424874|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647105|NCT02658890|587424875|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647106|NCT02658890|587424876|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162647107|NCT02658890|587424877|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647108|NCT02658890|587424878|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647109|NCT02658890|587424879|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647110|NCT02658890|587424880|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647111|NCT02658890|587424881|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647112|NCT02658890|587424882|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647113|NCT02658890|587424883|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647114|NCT02658890|587424884|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163085157|NCT03396445|589022227|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085158|NCT03396445|589022228|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162647115|NCT02658890|587424885|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162647116|NCT02658890|587424886|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647117|NCT02658890|587424887|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162718014|NCT05484726|587673516|FG001|Overall Study|IVH (G III & IV)|1|||
163085159|NCT03396445|589022229|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085160|NCT03396445|589022230|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085161|NCT03396445|589022231|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085162|NCT03396445|589022232|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162647118|NCT02658890|587424888|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647119|NCT02658890|587424889|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162647120|NCT02658890|587424890|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647121|NCT02658890|587424891|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
163085163|NCT03396445|589022233|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085164|NCT03396445|589022234|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085165|NCT03396445|589022235|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162718015|NCT05484726|587673515|FG000|Overall Study|NEC (stage II & III)|2|||
162718016|NCT05484726|587673516|FG001|Overall Study|NEC (stage II & III)|3|||
162718017|NCT04550039|587673524|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
162718018|NCT04550039|587673525|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
162718019|NCT04550039|587673524|FG000|Overall Study|patient self-withdrew from study|0|||
162718020|NCT04550039|587673525|FG001|Overall Study|patient self-withdrew from study|1|||
162718021|NCT04391309|587673526|FG000|Overall Study|Death|1|||
162718022|NCT04391309|587673527|FG001|Overall Study|Death|1|||
162718023|NCT04391309|587673526|FG000|Overall Study|Lost to Follow-up|3|||
162718024|NCT04391309|587673527|FG001|Overall Study|Lost to Follow-up|2|||
162718025|NCT04391309|587673526|FG000|Overall Study|Withdrawal by Subject|2|||
162718026|NCT04391309|587673527|FG001|Overall Study|Withdrawal by Subject|2|||
162718027|NCT05826431|587673528|FG000|Overall Study|Withdrawal by Subject|1|||
162718028|NCT01697319|587673531|FG000|Primary Phase|Withdrawal by Subject|1|||
162718029|NCT01697319|587673531|FG000|Extension Phase|Terminated by Sponsor|15|||
162718030|NCT04222959|587673534|FG000|Overall Study|Lost to Follow-up|76|||
162718031|NCT04222959|587673535|FG001|Overall Study|Lost to Follow-up|28|||
162718032|NCT03254394|587673538|FG000|Overall Study|Withdrawal by Subject|0|||
162718033|NCT03254394|587673539|FG001|Overall Study|Withdrawal by Subject|2|||
163085166|NCT03396445|589022236|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163085167|NCT03396445|589022211|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
163085168|NCT03396445|589022212|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
163085169|NCT03396445|589022213|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
163085170|NCT03396445|589022214|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
163085171|NCT03396445|589022215|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
163085172|NCT03396445|589022216|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085173|NCT03396445|589022217|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
162647122|NCT02658890|587424892|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647123|NCT02658890|587424893|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162647124|NCT02658890|587424867|FG000|Treatment Phase|Withdrawal by Subject|0|||
162647125|NCT02658890|587424868|FG001|Treatment Phase|Withdrawal by Subject|1|||
162647126|NCT02658890|587424869|FG002|Treatment Phase|Withdrawal by Subject|0|||
162647127|NCT02658890|587424870|FG003|Treatment Phase|Withdrawal by Subject|0|||
162647128|NCT02658890|587424871|FG004|Treatment Phase|Withdrawal by Subject|0|||
162647129|NCT02658890|587424872|FG005|Treatment Phase|Withdrawal by Subject|0|||
162647130|NCT02658890|587424873|FG006|Treatment Phase|Withdrawal by Subject|1|||
162647131|NCT02658890|587424874|FG007|Treatment Phase|Withdrawal by Subject|0|||
162647132|NCT02658890|587424875|FG008|Treatment Phase|Withdrawal by Subject|0|||
162647133|NCT02658890|587424876|FG009|Treatment Phase|Withdrawal by Subject|1|||
162647134|NCT02658890|587424877|FG010|Treatment Phase|Withdrawal by Subject|0|||
162647135|NCT02658890|587424878|FG011|Treatment Phase|Withdrawal by Subject|0|||
162647136|NCT02658890|587424879|FG012|Treatment Phase|Withdrawal by Subject|1|||
162647137|NCT02658890|587424880|FG013|Treatment Phase|Withdrawal by Subject|3|||
162647138|NCT02658890|587424881|FG014|Treatment Phase|Withdrawal by Subject|0|||
162647139|NCT02658890|587424882|FG015|Treatment Phase|Withdrawal by Subject|0|||
162647140|NCT02658890|587424883|FG016|Treatment Phase|Withdrawal by Subject|1|||
162647141|NCT02658890|587424884|FG017|Treatment Phase|Withdrawal by Subject|0|||
162647142|NCT02658890|587424885|FG018|Treatment Phase|Withdrawal by Subject|4|||
162647143|NCT02658890|587424886|FG019|Treatment Phase|Withdrawal by Subject|3|||
162647144|NCT02658890|587424887|FG020|Treatment Phase|Withdrawal by Subject|0|||
162647145|NCT02658890|587424888|FG021|Treatment Phase|Withdrawal by Subject|4|||
162647146|NCT02658890|587424889|FG022|Treatment Phase|Withdrawal by Subject|1|||
162647147|NCT02658890|587424890|FG023|Treatment Phase|Withdrawal by Subject|1|||
162647148|NCT02658890|587424891|FG024|Treatment Phase|Withdrawal by Subject|0|||
162647149|NCT02658890|587424892|FG025|Treatment Phase|Withdrawal by Subject|0|||
162718034|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
162718035|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
162718036|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
162647150|NCT02658890|587424893|FG026|Treatment Phase|Withdrawal by Subject|0|||
162647151|NCT02404311|587424894|FG000|Part A: Month 0-18|Death|2|||
162647152|NCT02404311|587424895|FG001|Part A: Month 0-18|Death|0|||
162647153|NCT02404311|587424896|FG002|Part A: Month 0-18|Death|0|||
162647154|NCT02404311|587424897|FG003|Part A: Month 0-18|Death|0|||
162647155|NCT02404311|587424898|FG004|Part A: Month 0-18|Death|0|||
162647156|NCT02404311|587424894|FG000|Part A: Month 0-18|Physician Decision|1|||
162647157|NCT02404311|587424895|FG001|Part A: Month 0-18|Physician Decision|0|||
162718037|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718038|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718039|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718040|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718041|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718042|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162718043|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
162718044|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
162718045|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
162718046|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718047|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718048|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718049|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718050|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718051|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162718052|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
162718053|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
162718054|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
162718055|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718056|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718057|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718058|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718059|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718060|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162718061|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
162718062|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718063|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
162718064|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718065|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718066|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718067|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718068|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718069|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162718070|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162718071|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162718072|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
162718073|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718074|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718075|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718076|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718077|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718078|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162718079|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718080|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162718081|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162718082|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718083|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718084|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718085|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718086|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718087|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162718088|NCT01212757|587673540|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
162718089|NCT01212757|587673541|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
162718090|NCT01212757|587673542|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718091|NCT01212757|587673543|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718092|NCT01212757|587673544|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163032888|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032889|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
163032890|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032891|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032892|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032893|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032894|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
163032895|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
162647158|NCT02404311|587424896|FG002|Part A: Month 0-18|Physician Decision|0|||
162647159|NCT02404311|587424897|FG003|Part A: Month 0-18|Physician Decision|0|||
163032896|NCT01716520|588824455|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032897|NCT01716520|588824456|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
163032898|NCT01716520|588824457|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032899|NCT01716520|588824458|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032900|NCT01716520|588824459|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032901|NCT01716520|588824460|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
163032902|NCT01716520|588824455|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032903|NCT01716520|588824456|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032904|NCT01716520|588824457|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032905|NCT01716520|588824458|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032906|NCT01716520|588824459|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163032907|NCT01716520|588824460|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
163032908|NCT01716520|588824455|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032909|NCT01716520|588824456|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032910|NCT01716520|588824457|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
163032911|NCT01716520|588824458|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032912|NCT01716520|588824459|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163085174|NCT03396445|589022218|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085175|NCT03396445|589022219|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085176|NCT03396445|589022220|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085177|NCT03396445|589022221|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085178|NCT03396445|589022222|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085179|NCT03396445|589022223|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085180|NCT03396445|589022224|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085181|NCT03396445|589022225|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085182|NCT03396445|589022226|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085183|NCT03396445|589022227|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085184|NCT03396445|589022228|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085185|NCT03396445|589022229|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085186|NCT03396445|589022230|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085187|NCT03396445|589022231|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085188|NCT03396445|589022232|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163032913|NCT01716520|588824460|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163032914|NCT05916131|588824465|FG000|Overall Study|Lost to Follow-up|0|||
163032915|NCT05916131|588824466|FG001|Overall Study|Lost to Follow-up|0|||
163032916|NCT05916131|588824467|FG002|Overall Study|Lost to Follow-up|1|||
163032917|NCT05916131|588824468|FG003|Overall Study|Lost to Follow-up|0|||
163032918|NCT02278367|588824469|FG000|Overall Study|Physician Decision|5|||
163032919|NCT02278367|588824470|FG001|Overall Study|Physician Decision|0|||
163032920|NCT02278367|588824469|FG000|Overall Study|Withdrawal by Subject|5|||
163032921|NCT02278367|588824470|FG001|Overall Study|Withdrawal by Subject|0|||
163032922|NCT04105010|588824471|FG000|Overall Study|Death|3|||
163032923|NCT04105010|588824472|FG001|Overall Study|Death|1|||
163032924|NCT04105010|588824473|FG002|Overall Study|Death|1|||
163032925|NCT04105010|588824474|FG003|Overall Study|Death|54|||
163032926|NCT04105010|588824471|FG000|Overall Study|Lost to Follow-up|0|||
163032927|NCT04105010|588824472|FG001|Overall Study|Lost to Follow-up|0|||
163032928|NCT04105010|588824473|FG002|Overall Study|Lost to Follow-up|0|||
163032929|NCT04105010|588824474|FG003|Overall Study|Lost to Follow-up|4|||
163032930|NCT04105010|588824471|FG000|Overall Study|Withdrawal by Subject|8|||
163032931|NCT04105010|588824472|FG001|Overall Study|Withdrawal by Subject|1|||
163032932|NCT04105010|588824473|FG002|Overall Study|Withdrawal by Subject|1|||
163032933|NCT04105010|588824474|FG003|Overall Study|Withdrawal by Subject|4|||
163032934|NCT04105010|588824471|FG000|Overall Study|Other reason|4|||
163032935|NCT04105010|588824472|FG001|Overall Study|Other reason|7|||
163032936|NCT04105010|588824473|FG002|Overall Study|Other reason|0|||
163032937|NCT04105010|588824474|FG003|Overall Study|Other reason|19|||
162647160|NCT02404311|587424898|FG004|Part A: Month 0-18|Physician Decision|0|||
162647161|NCT02404311|587424894|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
162647162|NCT02404311|587424895|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
162647163|NCT02404311|587424896|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
162647164|NCT02404311|587424897|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
162647165|NCT02404311|587424898|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
162647166|NCT02404311|587424894|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
162647167|NCT02404311|587424895|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
162647168|NCT02404311|587424896|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
162647169|NCT02404311|587424897|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
162647170|NCT02404311|587424898|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
162647171|NCT02404311|587424894|FG000|Part A: Month 0-18|HIV Infection|6|||
162647172|NCT02404311|587424895|FG001|Part A: Month 0-18|HIV Infection|2|||
162647173|NCT02404311|587424896|FG002|Part A: Month 0-18|HIV Infection|0|||
162647174|NCT02404311|587424897|FG003|Part A: Month 0-18|HIV Infection|0|||
162647175|NCT02404311|587424898|FG004|Part A: Month 0-18|HIV Infection|0|||
162647176|NCT02404311|587424894|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
162647177|NCT02404311|587424895|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
162647178|NCT02404311|587424896|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
162647179|NCT02404311|587424897|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
162647180|NCT02404311|587424898|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
162647181|NCT00159588|587424899|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
162647182|NCT00159588|587424900|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
162647183|NCT00159588|587424901|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
162647184|NCT03314584|587424908|FG000|Overall Study|Withdrawal by Subject|3|||
162647185|NCT03314584|587424909|FG001|Overall Study|Withdrawal by Subject|3|||
162647186|NCT03314584|587424908|FG000|Overall Study|Lost to Follow-up|4|||
162647187|NCT03314584|587424909|FG001|Overall Study|Lost to Follow-up|0|||
162647188|NCT06134817|587424910|FG000|Overall Study|Physician Departure - termination of study|1|||
162647189|NCT03506373|587424915|FG000|Overall Study|Adverse Event|6|||
162647190|NCT03506373|587424915|FG000|Overall Study|Withdrawal by Subject|2|||
162647191|NCT03506373|587424915|FG000|Overall Study|Disease progression|5|||
162647192|NCT03506373|587424915|FG000|Overall Study|Other|3|||
162647193|NCT00107198|587424922|FG000|Overall Study|Lack of Efficacy|28|||
162647194|NCT00107198|587424922|FG000|Overall Study|Lost to Follow-up|12|||
162647195|NCT00107198|587424922|FG000|Overall Study|Protocol Violation|1|||
162647196|NCT00107198|587424922|FG000|Overall Study|Withdrawal by Subject|6|||
162647197|NCT00107198|587424922|FG000|Overall Study|Ineligible|5|||
162647198|NCT02532647|587424925|FG000|Overall Study|Did not receive trial medication|1|||
162647199|NCT02532647|587424926|FG001|Overall Study|Did not receive trial medication|0|||
162647200|NCT02532647|587424927|FG002|Overall Study|Did not receive trial medication|1|||
162647201|NCT03897179|587424937|FG000|Overall Study|Withdrawal by Subject|1|||
162647202|NCT01480076|587424938|FG000|Overall Study|Run-in Failure|52|||
162647203|NCT01480076|587424938|FG000|Overall Study|Adverse Event|39|||
162647204|NCT01480076|587424938|FG000|Overall Study|Death|2|||
162647205|NCT01480076|587424938|FG000|Overall Study|Disease Progression|5|||
162647206|NCT01480076|587424938|FG000|Overall Study|Non-compliance With Study Protocol|15|||
162647207|NCT01480076|587424938|FG000|Overall Study|Withdrawal by Subject|105|||
162647208|NCT01480076|587424938|FG000|Overall Study|Lost to Follow-up|7|||
163032938|NCT01211483|588824475|FG000|Phase 1b|Death|6|||
163032939|NCT01211483|588824476|FG001|Phase 1b|Death|0|||
163032940|NCT01211483|588824477|FG002|Phase 1b|Death|0|||
163032941|NCT01211483|588824478|FG003|Phase 1b|Death|0|||
162718093|NCT01212757|587673545|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718094|NCT01212757|587673546|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718095|NCT01212757|587673547|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718096|NCT01212757|587673548|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162718097|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163085189|NCT03396445|589022233|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085190|NCT03396445|589022234|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085191|NCT03396445|589022235|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
162647209|NCT01480076|587424938|FG000|Overall Study|Investigator Decision|13|||
162647210|NCT01480076|587424938|FG000|Overall Study|Other|52|||
162647211|NCT02503332|587424940|FG000|Overall Study|Adverse Event|17|||
162647212|NCT02503332|587424941|FG001|Overall Study|Adverse Event|5|||
162647213|NCT02503332|587424942|FG002|Overall Study|Adverse Event|3|||
162647214|NCT02503332|587424943|FG003|Overall Study|Adverse Event|1|||
162647215|NCT02503332|587424940|FG000|Overall Study|Investigator's Decision|5|||
162647216|NCT02503332|587424941|FG001|Overall Study|Investigator's Decision|1|||
162647217|NCT02503332|587424942|FG002|Overall Study|Investigator's Decision|0|||
162647218|NCT02503332|587424943|FG003|Overall Study|Investigator's Decision|0|||
162647219|NCT02503332|587424940|FG000|Overall Study|Sponsor's Decision|1|||
162647220|NCT02503332|587424941|FG001|Overall Study|Sponsor's Decision|0|||
162647221|NCT02503332|587424942|FG002|Overall Study|Sponsor's Decision|0|||
162647222|NCT02503332|587424943|FG003|Overall Study|Sponsor's Decision|1|||
162647223|NCT02503332|587424940|FG000|Overall Study|Subject Request|6|||
162647224|NCT02503332|587424941|FG001|Overall Study|Subject Request|5|||
162647225|NCT02503332|587424942|FG002|Overall Study|Subject Request|2|||
162647226|NCT02503332|587424943|FG003|Overall Study|Subject Request|1|||
162647227|NCT02503332|587424940|FG000|Overall Study|Death|0|||
162647228|NCT02503332|587424941|FG001|Overall Study|Death|2|||
162647229|NCT02503332|587424942|FG002|Overall Study|Death|2|||
162647230|NCT02503332|587424943|FG003|Overall Study|Death|0|||
162647231|NCT02503332|587424940|FG000|Overall Study|Other|5|||
162647232|NCT02503332|587424941|FG001|Overall Study|Other|6|||
162647233|NCT02503332|587424942|FG002|Overall Study|Other|1|||
162647234|NCT02503332|587424943|FG003|Overall Study|Other|1|||
162647235|NCT05694546|587424944|FG000|Overall Study|Lost to Follow-up|11|||
162647236|NCT02120950|587424945|FG000|Overall Study|Adverse Event|5|||
162647237|NCT02120950|587424946|FG001|Overall Study|Adverse Event|4|||
162647238|NCT02120950|587424947|FG002|Overall Study|Adverse Event|3|||
162647239|NCT02120950|587424945|FG000|Overall Study|Death|3|||
162647240|NCT02120950|587424946|FG001|Overall Study|Death|0|||
162647241|NCT02120950|587424947|FG002|Overall Study|Death|1|||
162647242|NCT02120950|587424945|FG000|Overall Study|Withdrawal by Subject|6|||
162647243|NCT02120950|587424946|FG001|Overall Study|Withdrawal by Subject|3|||
162647244|NCT02120950|587424947|FG002|Overall Study|Withdrawal by Subject|2|||
162647245|NCT02120950|587424945|FG000|Overall Study|Protocol Violation|1|||
162647246|NCT02120950|587424946|FG001|Overall Study|Protocol Violation|1|||
162647247|NCT02120950|587424947|FG002|Overall Study|Protocol Violation|7|||
162647248|NCT02120950|587424945|FG000|Overall Study|Other reasons|5|||
162647249|NCT02120950|587424946|FG001|Overall Study|Other reasons|4|||
162647250|NCT02120950|587424947|FG002|Overall Study|Other reasons|1|||
162647251|NCT02120950|587424945|FG000|Overall Study|Lost to Follow-up|0|||
162647252|NCT02120950|587424946|FG001|Overall Study|Lost to Follow-up|2|||
162647253|NCT02120950|587424947|FG002|Overall Study|Lost to Follow-up|1|||
162647254|NCT02424383|587424948|FG000|Overall Study|Withdrawal by Subject|32|||
162647255|NCT02424383|587424948|FG000|Overall Study|Death|170|||
162647256|NCT02424383|587424948|FG000|Overall Study|Sponsor's decision|3|||
162647257|NCT02424383|587424948|FG000|Overall Study|Investigator's decision|44|||
162647258|NCT02424383|587424948|FG000|Overall Study|Lost to Follow-up|81|||
162647259|NCT02424383|587424948|FG000|Overall Study|Other|7|||
162647260|NCT02424383|587424948|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
162647261|NCT03412084|587424952|FG000|Overall Study|Withdrawal by Subject|2|||
162647262|NCT03412084|587424953|FG001|Overall Study|Withdrawal by Subject|0|||
162647263|NCT03412084|587424952|FG000|Overall Study|Participant moved|1|||
162647264|NCT03412084|587424953|FG001|Overall Study|Participant moved|0|||
162647265|NCT03412084|587424952|FG000|Overall Study|Lost to Follow-up|1|||
162718098|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
162647266|NCT03412084|587424953|FG001|Overall Study|Lost to Follow-up|1|||
162647267|NCT01928862|587424957|FG000|Overall Study|Lost to Follow-up|1|||
162647268|NCT01928862|587424958|FG001|Overall Study|Lost to Follow-up|0|||
162647269|NCT01928862|587424959|FG002|Overall Study|Lost to Follow-up|0|||
162647270|NCT01928862|587424960|FG003|Overall Study|Lost to Follow-up|0|||
162647271|NCT01928862|587424961|FG004|Overall Study|Lost to Follow-up|1|||
162647272|NCT01752855|587424965|FG000|Overall Study|Adverse Event|1|||
162647273|NCT01752855|587424966|FG001|Overall Study|Adverse Event|0|||
162647274|NCT01752855|587424965|FG000|Overall Study|Withdrew Consent|0|||
162647275|NCT01752855|587424966|FG001|Overall Study|Withdrew Consent|2|||
162647276|NCT01752855|587424965|FG000|Overall Study|Lack of Efficacy|0|||
162647277|NCT01752855|587424966|FG001|Overall Study|Lack of Efficacy|2|||
162647278|NCT01478321|587424968|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
162647279|NCT01478321|587424968|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
162647280|NCT01478321|587424968|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
162647281|NCT01478321|587424968|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
163032942|NCT01211483|588824475|FG000|Phase 1b|Withdrawal by Subject|1|||
163032943|NCT01211483|588824476|FG001|Phase 1b|Withdrawal by Subject|0|||
163032944|NCT01211483|588824477|FG002|Phase 1b|Withdrawal by Subject|0|||
163032945|NCT01211483|588824478|FG003|Phase 1b|Withdrawal by Subject|0|||
163032946|NCT01211483|588824475|FG000|Phase 2|Lost to Follow-up|0|||
163032947|NCT01211483|588824476|FG001|Phase 2|Lost to Follow-up|1|||
163032948|NCT01211483|588824477|FG002|Phase 2|Lost to Follow-up|1|||
163032949|NCT01211483|588824478|FG003|Phase 2|Lost to Follow-up|2|||
163032950|NCT01211483|588824475|FG000|Phase 2|Death|0|||
163032951|NCT01211483|588824476|FG001|Phase 2|Death|64|||
163032952|NCT01211483|588824477|FG002|Phase 2|Death|53|||
163032953|NCT01211483|588824478|FG003|Phase 2|Death|53|||
163032954|NCT01211483|588824475|FG000|Phase 2|Withdrawal by Subject|0|||
163032955|NCT01211483|588824476|FG001|Phase 2|Withdrawal by Subject|1|||
163032956|NCT01211483|588824477|FG002|Phase 2|Withdrawal by Subject|10|||
163032957|NCT01211483|588824478|FG003|Phase 2|Withdrawal by Subject|5|||
163032958|NCT01211483|588824475|FG000|Phase 2|Study terminated by Sponsor|0|||
163032959|NCT01211483|588824476|FG001|Phase 2|Study terminated by Sponsor|6|||
163032960|NCT01211483|588824477|FG002|Phase 2|Study terminated by Sponsor|8|||
163032961|NCT01211483|588824478|FG003|Phase 2|Study terminated by Sponsor|11|||
163032962|NCT01675154|588824479|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032963|NCT01675154|588824480|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
163032964|NCT01675154|588824481|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032965|NCT01675154|588824482|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
163032966|NCT02971800|588824485|FG000|Overall Study|Protocol Violation|1|||
163032967|NCT02971800|588824485|FG000|Overall Study|Withdrawal by Subject|1|||
163032968|NCT02971800|588824485|FG000|Overall Study|Exclusion criteria prior intervention|1|||
163032969|NCT02971800|588824485|FG000|Overall Study|Number evaluable participant already reached|4|||
163032970|NCT00616603|588824486|FG000|Overall Study|Physician Decision|2|||
163032971|NCT00616603|588824487|FG001|Overall Study|Physician Decision|0|||
163032972|NCT00616603|588824488|FG002|Overall Study|Physician Decision|2|||
163032973|NCT00006305|588824493|FG000|Overall Study|Withdrawal by Subject|17|||
163032974|NCT00006305|588824494|FG001|Overall Study|Withdrawal by Subject|10|||
163032975|NCT00006305|588824495|FG002|Overall Study|Withdrawal by Subject|15|||
163032976|NCT00006305|588824496|FG003|Overall Study|Withdrawal by Subject|14|||
163032977|NCT00329641|588824497|FG000|Overall Study|Did not start treatment|1|||
163032978|NCT00329641|588824497|FG000|Overall Study|Not eligible|1|||
163032979|NCT00329641|588824497|FG000|Overall Study|Adverse Event|3|||
163032980|NCT00329641|588824497|FG000|Overall Study|Other reason, not protocol specified|1|||
163032981|NCT00115037|588824498|FG000|Phase1|Lost to Follow-up|16|||
163032982|NCT00115037|588824499|FG001|Phase1|Lost to Follow-up|23|||
163032983|NCT00115037|588824500|FG002|Phase1|Lost to Follow-up|0|||
163032984|NCT00115037|588824501|FG003|Phase1|Lost to Follow-up|0|||
163032985|NCT00115037|588824502|FG004|Phase1|Lost to Follow-up|0|||
163032986|NCT00115037|588824503|FG005|Phase1|Lost to Follow-up|0|||
163032987|NCT00115037|588824498|FG000|Phase1|Withdrawal by Subject|9|||
163032988|NCT00115037|588824499|FG001|Phase1|Withdrawal by Subject|4|||
163032989|NCT00115037|588824500|FG002|Phase1|Withdrawal by Subject|0|||
163032990|NCT00115037|588824501|FG003|Phase1|Withdrawal by Subject|0|||
163032991|NCT00115037|588824502|FG004|Phase1|Withdrawal by Subject|0|||
163032992|NCT00115037|588824503|FG005|Phase1|Withdrawal by Subject|0|||
163032993|NCT00115037|588824498|FG000|Phase2|Death|0|||
163032994|NCT00115037|588824499|FG001|Phase2|Death|0|||
163032995|NCT00115037|588824500|FG002|Phase2|Death|1|||
163032996|NCT00115037|588824501|FG003|Phase2|Death|0|||
163032997|NCT00115037|588824502|FG004|Phase2|Death|0|||
163032998|NCT00115037|588824503|FG005|Phase2|Death|1|||
163032999|NCT00115037|588824498|FG000|Phase2|Withdrawal by Subject|0|||
163033000|NCT00115037|588824499|FG001|Phase2|Withdrawal by Subject|0|||
163033001|NCT00115037|588824500|FG002|Phase2|Withdrawal by Subject|2|||
163033002|NCT00115037|588824501|FG003|Phase2|Withdrawal by Subject|1|||
163033003|NCT00115037|588824502|FG004|Phase2|Withdrawal by Subject|2|||
163033004|NCT00115037|588824503|FG005|Phase2|Withdrawal by Subject|1|||
163033005|NCT00115037|588824498|FG000|Phase2|Lost to Follow-up|0|||
163033006|NCT00115037|588824499|FG001|Phase2|Lost to Follow-up|0|||
163033007|NCT00115037|588824500|FG002|Phase2|Lost to Follow-up|12|||
163033008|NCT00115037|588824501|FG003|Phase2|Lost to Follow-up|14|||
163033009|NCT00115037|588824502|FG004|Phase2|Lost to Follow-up|4|||
163033010|NCT00115037|588824503|FG005|Phase2|Lost to Follow-up|10|||
163033011|NCT01398410|588824504|FG000|Overall Study|Adverse Event|12|||
163033012|NCT01398410|588824505|FG001|Overall Study|Adverse Event|16|||
163033013|NCT01398410|588824504|FG000|Overall Study|Participants Choice|8|||
163033014|NCT01398410|588824505|FG001|Overall Study|Participants Choice|11|||
162647282|NCT01478321|587424968|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
163033015|NCT01398410|588824504|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
163033016|NCT01398410|588824505|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
163033017|NCT01398410|588824504|FG000|Overall Study|Other|36|||
163033018|NCT01398410|588824505|FG001|Overall Study|Other|29|||
163033019|NCT02470403|588824506|FG000|Overall Study|Adverse Event|1|||
163033020|NCT02470403|588824507|FG001|Overall Study|Adverse Event|0|||
163033021|NCT02470403|588824508|FG002|Overall Study|Adverse Event|0|||
163033022|NCT02470403|588824509|FG003|Overall Study|Adverse Event|0|||
163033023|NCT02470403|588824510|FG004|Overall Study|Adverse Event|0|||
163033024|NCT02470403|588824506|FG000|Overall Study|Lost to Follow-up|0|||
163033025|NCT02470403|588824507|FG001|Overall Study|Lost to Follow-up|1|||
163033026|NCT02470403|588824508|FG002|Overall Study|Lost to Follow-up|0|||
163033027|NCT02470403|588824509|FG003|Overall Study|Lost to Follow-up|0|||
163033028|NCT02470403|588824510|FG004|Overall Study|Lost to Follow-up|0|||
163033029|NCT02470403|588824506|FG000|Overall Study|Subject/guardian decision|1|||
163033030|NCT02470403|588824507|FG001|Overall Study|Subject/guardian decision|0|||
163033031|NCT02470403|588824508|FG002|Overall Study|Subject/guardian decision|0|||
163033032|NCT02470403|588824509|FG003|Overall Study|Subject/guardian decision|4|||
163033033|NCT02470403|588824510|FG004|Overall Study|Subject/guardian decision|0|||
163033034|NCT02631070|588824511|FG000|Overall Study|Withdrawal by Subject|35|||
163033035|NCT02631070|588824512|FG001|Overall Study|Withdrawal by Subject|13|||
163033036|NCT02631070|588824511|FG000|Overall Study|Death|45|||
163033037|NCT02631070|588824512|FG001|Overall Study|Death|24|||
163033038|NCT02631070|588824511|FG000|Overall Study|Lost to Follow-up|5|||
163033039|NCT02631070|588824512|FG001|Overall Study|Lost to Follow-up|1|||
163033040|NCT02631070|588824511|FG000|Overall Study|Transition to rollover protocol|52|||
163033041|NCT02631070|588824512|FG001|Overall Study|Transition to rollover protocol|21|||
163033042|NCT02631070|588824511|FG000|Overall Study|Other reasons|12|||
163033043|NCT02631070|588824512|FG001|Overall Study|Other reasons|5|||
163033044|NCT03515629|588824513|FG000|Overall Study|Death|0|||
163033045|NCT03515629|588824514|FG001|Overall Study|Death|1|||
163033046|NCT03515629|588824515|FG002|Overall Study|Death|1|||
163033047|NCT03515629|588824513|FG000|Overall Study|Progressive disease|0|||
163033048|NCT03515629|588824514|FG001|Overall Study|Progressive disease|1|||
163033049|NCT03515629|588824515|FG002|Overall Study|Progressive disease|0|||
163033050|NCT03597022|588824518|FG000|Overall Study|Premature termination of the study|7|||
163033051|NCT03597022|588824519|FG001|Overall Study|Premature termination of the study|7|||
163033052|NCT03597022|588824520|FG002|Overall Study|Premature termination of the study|8|||
163033053|NCT03597022|588824518|FG000|Overall Study|Serious adverse event|1|||
163033054|NCT03597022|588824519|FG001|Overall Study|Serious adverse event|1|||
163033055|NCT03597022|588824520|FG002|Overall Study|Serious adverse event|0|||
163033056|NCT01430624|588824521|FG000|Overall Study|Lost to Follow-up|23|||
163033057|NCT01430624|588824522|FG001|Overall Study|Lost to Follow-up|29|||
163033058|NCT01430624|588824523|FG002|Overall Study|Lost to Follow-up|27|||
163033059|NCT01430624|588824521|FG000|Overall Study|technical or eligibility|5|||
163033060|NCT01430624|588824522|FG001|Overall Study|technical or eligibility|5|||
163033061|NCT01430624|588824523|FG002|Overall Study|technical or eligibility|2|||
163033062|NCT00401960|588824528|FG000|Overall Study|Lost to Follow-up|3|||
163033063|NCT00401960|588824529|FG001|Overall Study|Lost to Follow-up|0|||
163033064|NCT00401960|588824528|FG000|Overall Study|Death|2|||
163033065|NCT00401960|588824529|FG001|Overall Study|Death|0|||
163033066|NCT01606202|588824530|FG000|Overall Study|Adverse Event|5|||
163033067|NCT01606202|588824531|FG001|Overall Study|Adverse Event|0|||
163033068|NCT01606202|588824530|FG000|Overall Study|Withdrawal by Subject|2|||
163033069|NCT01606202|588824531|FG001|Overall Study|Withdrawal by Subject|1|||
163033070|NCT01606202|588824530|FG000|Overall Study|Personal problems|0|||
163033071|NCT01606202|588824531|FG001|Overall Study|Personal problems|1|||
163085192|NCT03396445|589022236|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
163085193|NCT03396445|589022211|FG000|Treatment Period|Withdrawal by Subject|0|||
163085194|NCT03396445|589022212|FG001|Treatment Period|Withdrawal by Subject|0|||
163085195|NCT03396445|589022213|FG002|Treatment Period|Withdrawal by Subject|0|||
163085196|NCT03396445|589022214|FG003|Treatment Period|Withdrawal by Subject|0|||
163085197|NCT03396445|589022215|FG004|Treatment Period|Withdrawal by Subject|0|||
163085198|NCT03396445|589022216|FG005|Treatment Period|Withdrawal by Subject|0|||
163033072|NCT01606202|588824530|FG000|Overall Study|Problems with administration|0|||
163085199|NCT03396445|589022217|FG006|Treatment Period|Withdrawal by Subject|0|||
163085200|NCT03396445|589022218|FG007|Treatment Period|Withdrawal by Subject|0|||
163085201|NCT03396445|589022219|FG008|Treatment Period|Withdrawal by Subject|0|||
163085202|NCT03396445|589022220|FG009|Treatment Period|Withdrawal by Subject|0|||
163085203|NCT03396445|589022221|FG010|Treatment Period|Withdrawal by Subject|0|||
163085204|NCT03396445|589022222|FG011|Treatment Period|Withdrawal by Subject|0|||
163085205|NCT03396445|589022223|FG012|Treatment Period|Withdrawal by Subject|0|||
163085206|NCT03396445|589022224|FG013|Treatment Period|Withdrawal by Subject|0|||
163085207|NCT03396445|589022225|FG014|Treatment Period|Withdrawal by Subject|1|||
163085208|NCT03396445|589022226|FG015|Treatment Period|Withdrawal by Subject|0|||
163085209|NCT03396445|589022227|FG016|Treatment Period|Withdrawal by Subject|1|||
163085210|NCT03396445|589022228|FG017|Treatment Period|Withdrawal by Subject|0|||
163033073|NCT01606202|588824531|FG001|Overall Study|Problems with administration|1|||
163085211|NCT03396445|589022229|FG018|Treatment Period|Withdrawal by Subject|0|||
163033074|NCT01593254|588824537|FG000|Overall Study|Disease progression|2|||
163033075|NCT01593254|588824538|FG001|Overall Study|Disease progression|7|||
163033076|NCT01593254|588824537|FG000|Overall Study|Study drug toxicity|6|||
163033077|NCT01593254|588824538|FG001|Overall Study|Study drug toxicity|20|||
163033078|NCT01593254|588824537|FG000|Overall Study|Death|3|||
163033079|NCT01593254|588824538|FG001|Overall Study|Death|3|||
163033080|NCT01593254|588824537|FG000|Overall Study|AE unrelated to study drug|0|||
163033081|NCT01593254|588824538|FG001|Overall Study|AE unrelated to study drug|1|||
163033082|NCT01593254|588824537|FG000|Overall Study|participant request to discontinue study treatment|1|||
163033083|NCT01593254|588824538|FG001|Overall Study|participant request to discontinue study treatment|3|||
163033084|NCT01593254|588824537|FG000|Overall Study|participant withdrew consent|0|||
163033085|NCT01593254|588824538|FG001|Overall Study|participant withdrew consent|9|||
163033086|NCT01593254|588824537|FG000|Overall Study|lost to follow up|1|||
163033087|NCT01593254|588824538|FG001|Overall Study|lost to follow up|6|||
163033088|NCT01593254|588824537|FG000|Overall Study|maximum clinical benefit|1|||
163033089|NCT01593254|588824538|FG001|Overall Study|maximum clinical benefit|2|||
163033090|NCT01593254|588824537|FG000|Overall Study|Poor/non compliance|1|||
163033091|NCT01593254|588824538|FG001|Overall Study|Poor/non compliance|1|||
163033092|NCT01593254|588824537|FG000|Overall Study|Pregnancy|0|||
163033093|NCT01593254|588824538|FG001|Overall Study|Pregnancy|3|||
163033094|NCT01593254|588824537|FG000|Overall Study|participant no longer meets study criteria|1|||
163033095|NCT01593254|588824538|FG001|Overall Study|participant no longer meets study criteria|1|||
163033096|NCT01593254|588824537|FG000|Overall Study|Admin reason by sponsor|7|||
163033097|NCT01593254|588824538|FG001|Overall Study|Admin reason by sponsor|3|||
163033098|NCT01593254|588824537|FG000|Overall Study|Imatinib treatment failure|2|||
163033099|NCT01593254|588824538|FG001|Overall Study|Imatinib treatment failure|0|||
163033100|NCT01593254|588824537|FG000|Overall Study|Other Reasons|61|||
163033101|NCT01593254|588824538|FG001|Overall Study|Other Reasons|115|||
163033102|NCT00932451|588824539|FG000|Overall Study|Withdrawal by Subject|69|||
163033103|NCT00932451|588824539|FG000|Overall Study|Lost to Follow-up|22|||
163033104|NCT00932451|588824539|FG000|Overall Study|Death|726|||
163033105|NCT00932451|588824539|FG000|Overall Study|Other reasons|5|||
163033106|NCT03627416|588824540|FG000|Overall Study|Adverse Event|0|||
163033107|NCT03627416|588824541|FG001|Overall Study|Adverse Event|1|||
163033108|NCT02079636|588824542|FG000|Overall Study|Death|2|||
163033109|NCT02079636|588824543|FG001|Overall Study|Death|1|||
163033110|NCT02079636|588824544|FG002|Overall Study|Death|0|||
163033111|NCT02079636|588824545|FG003|Overall Study|Death|5|||
163033112|NCT02079636|588824546|FG004|Overall Study|Death|1|||
163033113|NCT02079636|588824547|FG005|Overall Study|Death|2|||
163033114|NCT02079636|588824548|FG006|Overall Study|Death|1|||
163033115|NCT02079636|588824549|FG007|Overall Study|Death|0|||
163033116|NCT02079636|588824550|FG008|Overall Study|Death|0|||
163033117|NCT02079636|588824551|FG009|Overall Study|Death|0|||
163033118|NCT02079636|588824552|FG010|Overall Study|Death|0|||
163033119|NCT02079636|588824553|FG011|Overall Study|Death|1|||
163033120|NCT02079636|588824554|FG012|Overall Study|Death|1|||
163033121|NCT02079636|588824555|FG013|Overall Study|Death|0|||
163033122|NCT02079636|588824556|FG014|Overall Study|Death|2|||
163033123|NCT02079636|588824542|FG000|Overall Study|Adverse Event|1|||
163033124|NCT02079636|588824543|FG001|Overall Study|Adverse Event|1|||
163033125|NCT02079636|588824544|FG002|Overall Study|Adverse Event|0|||
163033126|NCT02079636|588824545|FG003|Overall Study|Adverse Event|1|||
163033127|NCT02079636|588824546|FG004|Overall Study|Adverse Event|1|||
163033128|NCT02079636|588824547|FG005|Overall Study|Adverse Event|2|||
163033129|NCT02079636|588824548|FG006|Overall Study|Adverse Event|0|||
163033130|NCT02079636|588824549|FG007|Overall Study|Adverse Event|0|||
163033131|NCT02079636|588824550|FG008|Overall Study|Adverse Event|0|||
163033132|NCT02079636|588824551|FG009|Overall Study|Adverse Event|0|||
163033133|NCT02079636|588824552|FG010|Overall Study|Adverse Event|0|||
163033134|NCT02079636|588824553|FG011|Overall Study|Adverse Event|0|||
163033135|NCT02079636|588824554|FG012|Overall Study|Adverse Event|0|||
163033136|NCT02079636|588824555|FG013|Overall Study|Adverse Event|0|||
163033137|NCT02079636|588824556|FG014|Overall Study|Adverse Event|0|||
163033138|NCT02079636|588824542|FG000|Overall Study|Progressive disease|0|||
163033139|NCT02079636|588824543|FG001|Overall Study|Progressive disease|0|||
163033140|NCT02079636|588824544|FG002|Overall Study|Progressive disease|0|||
163033141|NCT02079636|588824545|FG003|Overall Study|Progressive disease|2|||
163033142|NCT02079636|588824546|FG004|Overall Study|Progressive disease|0|||
163033143|NCT02079636|588824547|FG005|Overall Study|Progressive disease|0|||
163033144|NCT02079636|588824548|FG006|Overall Study|Progressive disease|0|||
163033145|NCT02079636|588824549|FG007|Overall Study|Progressive disease|0|||
163033146|NCT02079636|588824550|FG008|Overall Study|Progressive disease|0|||
163033147|NCT02079636|588824551|FG009|Overall Study|Progressive disease|0|||
163033148|NCT02079636|588824552|FG010|Overall Study|Progressive disease|0|||
163033149|NCT02079636|588824553|FG011|Overall Study|Progressive disease|0|||
163033150|NCT02079636|588824554|FG012|Overall Study|Progressive disease|1|||
163033151|NCT02079636|588824555|FG013|Overall Study|Progressive disease|0|||
163033152|NCT02079636|588824556|FG014|Overall Study|Progressive disease|0|||
163085212|NCT03396445|589022230|FG019|Treatment Period|Withdrawal by Subject|0|||
162647283|NCT01478321|587424968|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
162647284|NCT01478321|587424968|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
162647285|NCT01478321|587424968|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
162647286|NCT02053753|587424969|FG000|Overall Study|Withdrawal by Subject|2|||
162647287|NCT02053753|587424970|FG001|Overall Study|Withdrawal by Subject|4|||
162647288|NCT02053753|587424969|FG000|Overall Study|Decision by Sponsor|1|||
162647289|NCT02053753|587424970|FG001|Overall Study|Decision by Sponsor|1|||
162647290|NCT02053753|587424969|FG000|Overall Study|Lost to Follow-up|4|||
162647291|NCT02053753|587424970|FG001|Overall Study|Lost to Follow-up|3|||
162647292|NCT02439320|587424971|FG000|Overall Study|Adverse Event|0|||
162647293|NCT02439320|587424972|FG001|Overall Study|Adverse Event|2|||
162647294|NCT02439320|587424973|FG002|Overall Study|Adverse Event|0|||
162647295|NCT02439320|587424971|FG000|Overall Study|Lost to Follow-up|37|||
162647296|NCT02439320|587424972|FG001|Overall Study|Lost to Follow-up|34|||
162647297|NCT02439320|587424973|FG002|Overall Study|Lost to Follow-up|42|||
162647298|NCT02439320|587424971|FG000|Overall Study|Death|0|||
162647299|NCT02439320|587424972|FG001|Overall Study|Death|1|||
162647300|NCT02439320|587424973|FG002|Overall Study|Death|0|||
162647301|NCT02439320|587424971|FG000|Overall Study|Noncompliance with Protocol|10|||
162647302|NCT02439320|587424972|FG001|Overall Study|Noncompliance with Protocol|11|||
162647303|NCT02439320|587424973|FG002|Overall Study|Noncompliance with Protocol|7|||
162647304|NCT02439320|587424971|FG000|Overall Study|Pregnancy|0|||
162647305|NCT02439320|587424972|FG001|Overall Study|Pregnancy|1|||
162647306|NCT02439320|587424973|FG002|Overall Study|Pregnancy|1|||
162647307|NCT02439320|587424971|FG000|Overall Study|Withdrawal by Subject|12|||
162647308|NCT02439320|587424972|FG001|Overall Study|Withdrawal by Subject|16|||
162647309|NCT02439320|587424973|FG002|Overall Study|Withdrawal by Subject|14|||
162647310|NCT02439320|587424971|FG000|Overall Study|Physician Decision|2|||
162647311|NCT02439320|587424972|FG001|Overall Study|Physician Decision|1|||
162647312|NCT02439320|587424973|FG002|Overall Study|Physician Decision|0|||
162647313|NCT02439320|587424971|FG000|Overall Study|Sponsor Request|0|||
162647314|NCT02439320|587424972|FG001|Overall Study|Sponsor Request|2|||
162647315|NCT02439320|587424973|FG002|Overall Study|Sponsor Request|1|||
162718099|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
162718100|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
163033153|NCT02079636|588824542|FG000|Overall Study|Withdrawal by Subject|0|||
163033154|NCT02079636|588824543|FG001|Overall Study|Withdrawal by Subject|0|||
163033155|NCT02079636|588824544|FG002|Overall Study|Withdrawal by Subject|0|||
163033156|NCT02079636|588824545|FG003|Overall Study|Withdrawal by Subject|4|||
163033157|NCT02079636|588824546|FG004|Overall Study|Withdrawal by Subject|0|||
163033158|NCT02079636|588824547|FG005|Overall Study|Withdrawal by Subject|1|||
163033159|NCT02079636|588824548|FG006|Overall Study|Withdrawal by Subject|0|||
163033160|NCT02079636|588824549|FG007|Overall Study|Withdrawal by Subject|0|||
163033161|NCT02079636|588824550|FG008|Overall Study|Withdrawal by Subject|0|||
163033162|NCT02079636|588824551|FG009|Overall Study|Withdrawal by Subject|2|||
163033163|NCT02079636|588824552|FG010|Overall Study|Withdrawal by Subject|1|||
163033164|NCT02079636|588824553|FG011|Overall Study|Withdrawal by Subject|1|||
163033165|NCT02079636|588824554|FG012|Overall Study|Withdrawal by Subject|1|||
163033166|NCT02079636|588824555|FG013|Overall Study|Withdrawal by Subject|0|||
163033167|NCT02079636|588824556|FG014|Overall Study|Withdrawal by Subject|2|||
163033168|NCT02079636|588824542|FG000|Overall Study|Physician Decision|0|||
163033169|NCT02079636|588824543|FG001|Overall Study|Physician Decision|0|||
163033170|NCT02079636|588824544|FG002|Overall Study|Physician Decision|0|||
163033171|NCT02079636|588824545|FG003|Overall Study|Physician Decision|0|||
163033172|NCT02079636|588824546|FG004|Overall Study|Physician Decision|0|||
163033173|NCT02079636|588824547|FG005|Overall Study|Physician Decision|1|||
163033174|NCT02079636|588824548|FG006|Overall Study|Physician Decision|0|||
163033175|NCT02079636|588824549|FG007|Overall Study|Physician Decision|0|||
163033176|NCT02079636|588824550|FG008|Overall Study|Physician Decision|0|||
163033177|NCT02079636|588824551|FG009|Overall Study|Physician Decision|1|||
163033178|NCT02079636|588824552|FG010|Overall Study|Physician Decision|1|||
163033179|NCT02079636|588824553|FG011|Overall Study|Physician Decision|0|||
163033180|NCT02079636|588824554|FG012|Overall Study|Physician Decision|0|||
163033181|NCT02079636|588824555|FG013|Overall Study|Physician Decision|0|||
163033182|NCT02079636|588824556|FG014|Overall Study|Physician Decision|1|||
163033183|NCT02079636|588824542|FG000|Overall Study|Lost to Follow-up|0|||
163033184|NCT02079636|588824543|FG001|Overall Study|Lost to Follow-up|0|||
163033185|NCT02079636|588824544|FG002|Overall Study|Lost to Follow-up|0|||
163033186|NCT02079636|588824545|FG003|Overall Study|Lost to Follow-up|0|||
163033187|NCT02079636|588824546|FG004|Overall Study|Lost to Follow-up|0|||
162647316|NCT02439320|587424971|FG000|Overall Study|Randomization Failure|35|||
162647317|NCT02439320|587424972|FG001|Overall Study|Randomization Failure|46|||
163033188|NCT02079636|588824547|FG005|Overall Study|Lost to Follow-up|0|||
163033189|NCT02079636|588824548|FG006|Overall Study|Lost to Follow-up|0|||
163033190|NCT02079636|588824549|FG007|Overall Study|Lost to Follow-up|1|||
163033191|NCT02079636|588824550|FG008|Overall Study|Lost to Follow-up|0|||
162647318|NCT02439320|587424973|FG002|Overall Study|Randomization Failure|34|||
163033192|NCT02079636|588824551|FG009|Overall Study|Lost to Follow-up|0|||
163085213|NCT03396445|589022231|FG020|Treatment Period|Withdrawal by Subject|0|||
163085214|NCT03396445|589022232|FG021|Treatment Period|Withdrawal by Subject|0|||
163085215|NCT03396445|589022233|FG022|Treatment Period|Withdrawal by Subject|0|||
163085216|NCT03396445|589022234|FG023|Treatment Period|Withdrawal by Subject|0|||
163085217|NCT03396445|589022235|FG024|Treatment Period|Withdrawal by Subject|0|||
163085218|NCT03396445|589022236|FG025|Treatment Period|Withdrawal by Subject|0|||
163085219|NCT03396445|589022211|FG000|Switch-over Period|Death|0|||
163085220|NCT03396445|589022212|FG001|Switch-over Period|Death|0|||
163085221|NCT03396445|589022213|FG002|Switch-over Period|Death|0|||
163085222|NCT03396445|589022214|FG003|Switch-over Period|Death|0|||
163085223|NCT03396445|589022215|FG004|Switch-over Period|Death|0|||
163085224|NCT03396445|589022216|FG005|Switch-over Period|Death|0|||
163085225|NCT03396445|589022217|FG006|Switch-over Period|Death|0|||
163085226|NCT03396445|589022218|FG007|Switch-over Period|Death|0|||
163085227|NCT03396445|589022219|FG008|Switch-over Period|Death|0|||
163085228|NCT03396445|589022220|FG009|Switch-over Period|Death|0|||
163085229|NCT03396445|589022221|FG010|Switch-over Period|Death|0|||
163085230|NCT03396445|589022222|FG011|Switch-over Period|Death|0|||
163085231|NCT03396445|589022223|FG012|Switch-over Period|Death|0|||
163085232|NCT03396445|589022224|FG013|Switch-over Period|Death|0|||
163085233|NCT03396445|589022225|FG014|Switch-over Period|Death|0|||
163085234|NCT03396445|589022226|FG015|Switch-over Period|Death|0|||
163085235|NCT03396445|589022227|FG016|Switch-over Period|Death|0|||
163085236|NCT03396445|589022228|FG017|Switch-over Period|Death|0|||
163085237|NCT03396445|589022229|FG018|Switch-over Period|Death|1|||
163085238|NCT03396445|589022230|FG019|Switch-over Period|Death|2|||
163085239|NCT03396445|589022231|FG020|Switch-over Period|Death|2|||
163085240|NCT03396445|589022232|FG021|Switch-over Period|Death|1|||
163085241|NCT03396445|589022233|FG022|Switch-over Period|Death|2|||
163085242|NCT03396445|589022234|FG023|Switch-over Period|Death|0|||
163085243|NCT03396445|589022235|FG024|Switch-over Period|Death|1|||
163085244|NCT03396445|589022236|FG025|Switch-over Period|Death|6|||
163085245|NCT03396445|589022211|FG000|Switch-over Period|Lost to Follow-up|0|||
163085246|NCT03396445|589022212|FG001|Switch-over Period|Lost to Follow-up|0|||
163085247|NCT03396445|589022213|FG002|Switch-over Period|Lost to Follow-up|0|||
163085248|NCT03396445|589022214|FG003|Switch-over Period|Lost to Follow-up|0|||
163085249|NCT03396445|589022215|FG004|Switch-over Period|Lost to Follow-up|0|||
163085250|NCT03396445|589022216|FG005|Switch-over Period|Lost to Follow-up|0|||
163085251|NCT03396445|589022217|FG006|Switch-over Period|Lost to Follow-up|0|||
163085252|NCT03396445|589022218|FG007|Switch-over Period|Lost to Follow-up|0|||
163085253|NCT03396445|589022219|FG008|Switch-over Period|Lost to Follow-up|0|||
163085254|NCT03396445|589022220|FG009|Switch-over Period|Lost to Follow-up|0|||
163085255|NCT03396445|589022221|FG010|Switch-over Period|Lost to Follow-up|0|||
163085256|NCT03396445|589022222|FG011|Switch-over Period|Lost to Follow-up|0|||
163085257|NCT03396445|589022223|FG012|Switch-over Period|Lost to Follow-up|0|||
163085258|NCT03396445|589022224|FG013|Switch-over Period|Lost to Follow-up|0|||
163085259|NCT03396445|589022225|FG014|Switch-over Period|Lost to Follow-up|0|||
163085260|NCT03396445|589022226|FG015|Switch-over Period|Lost to Follow-up|0|||
163085261|NCT03396445|589022227|FG016|Switch-over Period|Lost to Follow-up|0|||
163085262|NCT03396445|589022228|FG017|Switch-over Period|Lost to Follow-up|0|||
163085263|NCT03396445|589022229|FG018|Switch-over Period|Lost to Follow-up|0|||
163085264|NCT03396445|589022230|FG019|Switch-over Period|Lost to Follow-up|0|||
163085265|NCT03396445|589022231|FG020|Switch-over Period|Lost to Follow-up|0|||
163085266|NCT03396445|589022232|FG021|Switch-over Period|Lost to Follow-up|0|||
163085267|NCT03396445|589022233|FG022|Switch-over Period|Lost to Follow-up|0|||
163085268|NCT03396445|589022234|FG023|Switch-over Period|Lost to Follow-up|1|||
163085269|NCT03396445|589022235|FG024|Switch-over Period|Lost to Follow-up|0|||
163085270|NCT03396445|589022236|FG025|Switch-over Period|Lost to Follow-up|0|||
163085271|NCT04123704|589022240|FG000|Overall Study|Disease progression|2|||
163085272|NCT00836706|589022241|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
163085273|NCT00836706|589022242|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
163085274|NCT02989857|589022243|FG000|Randomization Phase|Not Treated|3|||
163085275|NCT02989857|589022244|FG001|Randomization Phase|Not Treated|2|||
163085276|NCT02989857|589022245|FG002|Randomization Phase|Not Treated|0|||
163085277|NCT01992757|589022246|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
163085278|NCT01344356|589022253|FG000|Overall Study|Physician Decision|0|||
163085279|NCT01344356|589022254|FG001|Overall Study|Physician Decision|3|||
163085280|NCT01344356|589022253|FG000|Overall Study|Lost to Follow-up|0|||
163085281|NCT01344356|589022254|FG001|Overall Study|Lost to Follow-up|6|||
163085282|NCT00366457|589022262|FG000|Overall Study|never began study therapy|2|||
163085283|NCT02829996|589022263|FG000|Overall Study|Withdrawal by Subject|1|||
163085284|NCT02829996|589022264|FG001|Overall Study|Withdrawal by Subject|0|||
163085285|NCT02829996|589022265|FG002|Overall Study|Withdrawal by Subject|0|||
162647319|NCT01505608|587424974|FG000|Phase I|Lack of Efficacy|0|||
163085286|NCT02829996|589022266|FG003|Overall Study|Withdrawal by Subject|0|||
163085287|NCT02829996|589022267|FG004|Overall Study|Withdrawal by Subject|0|||
163085288|NCT02390076|589022276|FG000|Overall Study|Lost to Follow-up|2|||
163085289|NCT02390076|589022277|FG001|Overall Study|Lost to Follow-up|1|||
163085290|NCT02390076|589022278|FG002|Overall Study|Lost to Follow-up|4|||
163085291|NCT02095106|589022281|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163085292|NCT02095106|589022282|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163085293|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Adverse Event|20|||
163085294|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Adverse Event|10|||
163085295|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Adverse Event|5|||
163085296|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Adverse Event|0|||
163085297|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Adverse Event|0|||
163085298|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Adverse Event|0|||
163085299|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Adverse Event|0|||
163085300|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Adverse Event|0|||
163085301|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Adverse Event|0|||
163085302|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Adverse Event|0|||
163085303|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Adverse Event|0|||
162647320|NCT01505608|587424975|FG001|Phase I|Lack of Efficacy|4|||
162647321|NCT01505608|587424974|FG000|Phase I|Adverse Event|0|||
162647322|NCT01505608|587424975|FG001|Phase I|Adverse Event|1|||
162647323|NCT01505608|587424974|FG000|Phase I|Withdrawal by Subject|0|||
162647324|NCT01505608|587424975|FG001|Phase I|Withdrawal by Subject|1|||
162647325|NCT01505608|587424974|FG000|Phase II|Lack of Efficacy|2|||
162647326|NCT01505608|587424975|FG001|Phase II|Lack of Efficacy|1|||
162647327|NCT01505608|587424974|FG000|Phase II|Protocol Violation|0|||
162647328|NCT01505608|587424975|FG001|Phase II|Protocol Violation|1|||
162647329|NCT01251380|587424978|FG000|Overall Study|Other (Not otherwise specified)|12|||
162647330|NCT01251380|587424978|FG000|Overall Study|Withdrawal by Subject|6|||
162647331|NCT01251380|587424978|FG000|Overall Study|Lack of Efficacy|1|||
162647332|NCT01251380|587424978|FG000|Overall Study|Adverse Event|1|||
162647333|NCT01251380|587424978|FG000|Overall Study|Lost to Follow-up|2|||
162647334|NCT02404350|587424982|FG000|Overall Study|Adverse Event|2|||
162647335|NCT02404350|587424983|FG001|Overall Study|Adverse Event|2|||
162647336|NCT02404350|587424984|FG002|Overall Study|Adverse Event|3|||
162647337|NCT02404350|587424985|FG003|Overall Study|Adverse Event|9|||
162647338|NCT02404350|587424982|FG000|Overall Study|Lack of Efficacy|3|||
162647339|NCT02404350|587424983|FG001|Overall Study|Lack of Efficacy|1|||
162647340|NCT02404350|587424984|FG002|Overall Study|Lack of Efficacy|0|||
162647341|NCT02404350|587424985|FG003|Overall Study|Lack of Efficacy|3|||
162647342|NCT02404350|587424982|FG000|Overall Study|Lost to Follow-up|2|||
162647343|NCT02404350|587424983|FG001|Overall Study|Lost to Follow-up|0|||
162647344|NCT02404350|587424984|FG002|Overall Study|Lost to Follow-up|0|||
162647345|NCT02404350|587424985|FG003|Overall Study|Lost to Follow-up|1|||
162647346|NCT02404350|587424982|FG000|Overall Study|Physician Decision|1|||
162647347|NCT02404350|587424983|FG001|Overall Study|Physician Decision|0|||
162647348|NCT02404350|587424984|FG002|Overall Study|Physician Decision|0|||
162647349|NCT02404350|587424985|FG003|Overall Study|Physician Decision|2|||
162647350|NCT02404350|587424982|FG000|Overall Study|Pregnancy|0|||
162647351|NCT02404350|587424983|FG001|Overall Study|Pregnancy|0|||
162647352|NCT02404350|587424984|FG002|Overall Study|Pregnancy|0|||
162647353|NCT02404350|587424985|FG003|Overall Study|Pregnancy|1|||
162647354|NCT02404350|587424982|FG000|Overall Study|Withdrawal by Subject|7|||
162647355|NCT02404350|587424983|FG001|Overall Study|Withdrawal by Subject|3|||
162647356|NCT02404350|587424984|FG002|Overall Study|Withdrawal by Subject|3|||
162647357|NCT02404350|587424985|FG003|Overall Study|Withdrawal by Subject|19|||
162647358|NCT02404350|587424982|FG000|Overall Study|Due to Non-compliance with treatment|0|||
162647359|NCT02404350|587424983|FG001|Overall Study|Due to Non-compliance with treatment|0|||
162647360|NCT02404350|587424984|FG002|Overall Study|Due to Non-compliance with treatment|0|||
162647361|NCT02404350|587424985|FG003|Overall Study|Due to Non-compliance with treatment|1|||
162647362|NCT02404350|587424982|FG000|Overall Study|Due to Technical problems|0|||
162647363|NCT02404350|587424983|FG001|Overall Study|Due to Technical problems|0|||
162647364|NCT02404350|587424984|FG002|Overall Study|Due to Technical problems|0|||
162647365|NCT02404350|587424985|FG003|Overall Study|Due to Technical problems|1|||
162647366|NCT05389657|587424986|FG000|Overall Study|Lost to Follow-up|7|||
162647367|NCT05389657|587424987|FG001|Overall Study|Lost to Follow-up|8|||
162647368|NCT05237206|587424989|FG000|Overall Study|screen failure-did not receive treatment|8|||
162647369|NCT05237206|587424989|FG000|Overall Study|did not receive treatment|3|||
162647370|NCT02154581|587424993|FG000|Overall Study|Lost to Follow-up|7|||
162647371|NCT02154581|587424994|FG001|Overall Study|Lost to Follow-up|8|||
162647372|NCT00076011|587426777|FG000|Overall Study|Death|1|||
162647373|NCT00076011|587426777|FG000|Overall Study|Adverse Event|10|||
162647374|NCT00076011|587426777|FG000|Overall Study|Lack of Efficacy|25|||
162647375|NCT00076011|587426777|FG000|Overall Study|Withdrawal by Subject|1|||
162647376|NCT00076011|587426777|FG000|Overall Study|Study terminated by sponsor|3|||
162647377|NCT00076011|587426777|FG000|Overall Study|Other|11|||
162647378|NCT00076011|587426777|FG000|Overall Study|Ongoing|1|||
162647379|NCT02864251|587426784|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
162647380|NCT02864251|587426785|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
162647381|NCT02864251|587426786|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
162647382|NCT02864251|587426784|FG000|Pre-Treatment|Withdrawal by Participant|0|||
162647383|NCT02864251|587426785|FG001|Pre-Treatment|Withdrawal by Participant|0|||
162647384|NCT02864251|587426786|FG002|Pre-Treatment|Withdrawal by Participant|4|||
162718101|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162718102|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
162718103|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163085304|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Adverse Event|0|||
162647385|NCT02864251|587426784|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
162647386|NCT02864251|587426785|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
162647387|NCT02864251|587426786|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
162647388|NCT02864251|587426784|FG000|Pre-Treatment|Other Reasons|0|||
162647389|NCT02864251|587426785|FG001|Pre-Treatment|Other Reasons|1|||
162647390|NCT02864251|587426786|FG002|Pre-Treatment|Other Reasons|1|||
162647391|NCT02864251|587426784|FG000|Treatment|Disease Progression|109|||
162647392|NCT02864251|587426785|FG001|Treatment|Disease Progression|52|||
162647393|NCT02864251|587426786|FG002|Treatment|Disease Progression|101|||
162647394|NCT02864251|587426784|FG000|Treatment|Study Drug Toxicity|9|||
162647395|NCT02864251|587426785|FG001|Treatment|Study Drug Toxicity|4|||
162647396|NCT02864251|587426786|FG002|Treatment|Study Drug Toxicity|10|||
162647397|NCT02864251|587426784|FG000|Treatment|Death|0|||
162647398|NCT02864251|587426785|FG001|Treatment|Death|2|||
162647399|NCT02864251|587426786|FG002|Treatment|Death|3|||
162647400|NCT02864251|587426784|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
162647401|NCT02864251|587426785|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
162647402|NCT02864251|587426786|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
162647403|NCT02864251|587426784|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
162647404|NCT02864251|587426785|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
162647405|NCT02864251|587426786|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
162647406|NCT02864251|587426784|FG000|Treatment|Withdrawal by Participant|8|||
162647407|NCT02864251|587426785|FG001|Treatment|Withdrawal by Participant|5|||
162647408|NCT02864251|587426786|FG002|Treatment|Withdrawal by Participant|13|||
162647409|NCT02864251|587426784|FG000|Treatment|Maximum Clinical Benefit|1|||
162647410|NCT02864251|587426785|FG001|Treatment|Maximum Clinical Benefit|0|||
162647411|NCT02864251|587426786|FG002|Treatment|Maximum Clinical Benefit|1|||
162647412|NCT02864251|587426784|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
162647413|NCT02864251|587426785|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
162647414|NCT02864251|587426786|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
162718104|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162718105|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162718106|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162718107|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
162718108|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
162718109|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
162718110|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162718111|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
162718112|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162718113|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162718114|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162718115|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718116|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718117|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
162718118|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718119|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718120|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718121|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718122|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718123|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162718124|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162718125|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162718126|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
162718127|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162718128|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
162718129|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162718130|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162718131|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162718132|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162718133|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163085305|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
162647415|NCT02864251|587426784|FG000|Treatment|Other Reasons|1|||
162647416|NCT02864251|587426785|FG001|Treatment|Other Reasons|1|||
162647417|NCT02864251|587426786|FG002|Treatment|Other Reasons|4|||
163085306|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085307|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
163085308|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085309|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085310|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085311|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085312|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085313|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085314|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085315|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085316|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
163085317|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
163085318|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
163085319|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
163085320|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
163085321|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
163085322|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
163085323|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
163085324|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
163085325|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
163085326|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
163085327|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
163085328|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
163085329|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
163085330|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
163085331|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
163085332|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
163085333|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
163085334|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
163085335|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
163033193|NCT02079636|588824552|FG010|Overall Study|Lost to Follow-up|0|||
163033194|NCT02079636|588824553|FG011|Overall Study|Lost to Follow-up|0|||
163033195|NCT02079636|588824554|FG012|Overall Study|Lost to Follow-up|0|||
163033196|NCT02079636|588824555|FG013|Overall Study|Lost to Follow-up|0|||
163033197|NCT02079636|588824556|FG014|Overall Study|Lost to Follow-up|0|||
163033198|NCT00561470|588824557|FG000|Overall Study|Adverse Event|74|||
163033199|NCT00561470|588824558|FG001|Overall Study|Adverse Event|163|||
163033200|NCT00561470|588824557|FG000|Overall Study|Disease progression|437|||
163033201|NCT00561470|588824558|FG001|Overall Study|Disease progression|305|||
163033202|NCT00561470|588824557|FG000|Overall Study|poor compliance to protocol|4|||
163033203|NCT00561470|588824558|FG001|Overall Study|poor compliance to protocol|4|||
163033204|NCT00561470|588824557|FG000|Overall Study|Lost to Follow-up|2|||
163033205|NCT00561470|588824558|FG001|Overall Study|Lost to Follow-up|0|||
163033206|NCT00561470|588824557|FG000|Overall Study|Physician Decision|21|||
163033207|NCT00561470|588824558|FG001|Overall Study|Physician Decision|20|||
163033208|NCT00561470|588824557|FG000|Overall Study|Consent Withdrawn|2|||
163033209|NCT00561470|588824558|FG001|Overall Study|Consent Withdrawn|6|||
163033210|NCT00561470|588824557|FG000|Overall Study|Subject request|43|||
163033211|NCT00561470|588824558|FG001|Overall Study|Subject request|77|||
163033212|NCT00561470|588824557|FG000|Overall Study|Metastatic surgery|10|||
163033213|NCT00561470|588824558|FG001|Overall Study|Metastatic surgery|12|||
163033214|NCT00561470|588824557|FG000|Overall Study|Unauthorized procedure|3|||
163033215|NCT00561470|588824558|FG001|Overall Study|Unauthorized procedure|1|||
163033216|NCT00561470|588824557|FG000|Overall Study|Randomized but not treated|5|||
163033217|NCT00561470|588824558|FG001|Overall Study|Randomized but not treated|5|||
163033218|NCT00561470|588824557|FG000|Overall Study|Missed visit window|1|||
163033219|NCT00561470|588824558|FG001|Overall Study|Missed visit window|4|||
163033220|NCT00561470|588824557|FG000|Overall Study|Planning surgery|1|||
163033221|NCT00561470|588824558|FG001|Overall Study|Planning surgery|1|||
163033222|NCT00561470|588824557|FG000|Overall Study|Ongoing Treatment|11|||
163033223|NCT00561470|588824558|FG001|Overall Study|Ongoing Treatment|14|||
163033224|NCT00637806|588824559|FG000|Double-blind Phase|Study Discontinued|2|||
162647418|NCT02864251|587426784|FG000|Treatment|Administrative Reason by Sponsor|1|||
162647419|NCT02864251|587426785|FG001|Treatment|Administrative Reason by Sponsor|0|||
163033225|NCT00637806|588824560|FG001|Double-blind Phase|Study Discontinued|0|||
163085336|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
163085337|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
162647420|NCT02864251|587426786|FG002|Treatment|Administrative Reason by Sponsor|0|||
163085338|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
163033226|NCT00637806|588824561|FG002|Double-blind Phase|Study Discontinued|1|||
163033227|NCT00637806|588824562|FG003|Double-blind Phase|Study Discontinued|0|||
163033228|NCT00637806|588824559|FG000|Extension Phase|Study Discontinued|0|||
163033229|NCT00637806|588824560|FG001|Extension Phase|Study Discontinued|0|||
163033230|NCT00637806|588824561|FG002|Extension Phase|Study Discontinued|0|||
162647421|NCT04343521|587426787|FG000|Overall Study|Adverse Event|0|||
162647422|NCT04343521|587426788|FG001|Overall Study|Adverse Event|2|||
162647423|NCT04343521|587426787|FG000|Overall Study|Death|1|||
162647424|NCT04343521|587426788|FG001|Overall Study|Death|2|||
162647425|NCT04343521|587426787|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
162647426|NCT04343521|587426788|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
162647427|NCT04343521|587426787|FG000|Overall Study|Withdrawal by Subject|70|||
162647428|NCT04343521|587426788|FG001|Overall Study|Withdrawal by Subject|95|||
162647429|NCT04343521|587426787|FG000|Overall Study|Withdrawal by study team|6|||
162647430|NCT04343521|587426788|FG001|Overall Study|Withdrawal by study team|12|||
162647431|NCT00314574|587426789|FG000|Overall Study|Death|3|||
162647432|NCT00314574|587426790|FG001|Overall Study|Death|0|||
162647433|NCT00314574|587426789|FG000|Overall Study|Adverse Event|11|||
162647434|NCT00314574|587426790|FG001|Overall Study|Adverse Event|16|||
163033231|NCT00637806|588824562|FG003|Extension Phase|Study Discontinued|1|||
163033232|NCT01592292|588824563|FG000|Overall Study|Follow-up loss|3|||
163033233|NCT01592292|588824564|FG001|Overall Study|Follow-up loss|3|||
163033234|NCT01592292|588824565|FG002|Overall Study|Follow-up loss|1|||
163033235|NCT01592292|588824566|FG003|Overall Study|Follow-up loss|0|||
163033236|NCT01592292|588824563|FG000|Overall Study|Withdrew consent|2|||
163033237|NCT01592292|588824564|FG001|Overall Study|Withdrew consent|1|||
163033238|NCT01592292|588824565|FG002|Overall Study|Withdrew consent|0|||
163033239|NCT01592292|588824566|FG003|Overall Study|Withdrew consent|0|||
163033240|NCT01592292|588824563|FG000|Overall Study|Other|1|||
163033241|NCT01592292|588824564|FG001|Overall Study|Other|1|||
163033242|NCT01592292|588824565|FG002|Overall Study|Other|2|||
163033243|NCT01592292|588824566|FG003|Overall Study|Other|1|||
163033244|NCT02923245|588824570|FG000|Overall Study|ultrasound order was cancelled|2|||
163033245|NCT02923245|588824571|FG001|Overall Study|ultrasound order was cancelled|1|||
163033246|NCT02680834|588824572|FG000|Overall Study|Physician Decision|5|||
163033247|NCT02680834|588824573|FG001|Overall Study|Physician Decision|2|||
163033248|NCT02680834|588824572|FG000|Overall Study|Withdrawal by Subject|6|||
163033249|NCT02680834|588824573|FG001|Overall Study|Withdrawal by Subject|0|||
163033250|NCT02680834|588824572|FG000|Overall Study|Lost to Follow-up|0|||
163033251|NCT02680834|588824573|FG001|Overall Study|Lost to Follow-up|1|||
163033252|NCT02520427|588824574|FG000|Overall Study|Decision by sponsor|0|||
163033253|NCT02520427|588824575|FG001|Overall Study|Decision by sponsor|0|||
163033254|NCT02520427|588824576|FG002|Overall Study|Decision by sponsor|0|||
163033255|NCT02520427|588824577|FG003|Overall Study|Decision by sponsor|0|||
163033256|NCT02520427|588824578|FG004|Overall Study|Decision by sponsor|0|||
163033257|NCT02520427|588824579|FG005|Overall Study|Decision by sponsor|0|||
163033258|NCT02520427|588824580|FG006|Overall Study|Decision by sponsor|0|||
163033259|NCT02520427|588824581|FG007|Overall Study|Decision by sponsor|0|||
163033260|NCT02520427|588824582|FG008|Overall Study|Decision by sponsor|1|||
163033261|NCT02520427|588824583|FG009|Overall Study|Decision by sponsor|1|||
163033262|NCT02520427|588824584|FG010|Overall Study|Decision by sponsor|0|||
163033263|NCT02520427|588824585|FG011|Overall Study|Decision by sponsor|0|||
163033264|NCT02520427|588824586|FG012|Overall Study|Decision by sponsor|0|||
163033265|NCT02520427|588824587|FG013|Overall Study|Decision by sponsor|0|||
163033266|NCT02520427|588824588|FG014|Overall Study|Decision by sponsor|0|||
163033267|NCT02520427|588824589|FG015|Overall Study|Decision by sponsor|0|||
163033268|NCT02520427|588824590|FG016|Overall Study|Decision by sponsor|0|||
163033269|NCT02520427|588824591|FG017|Overall Study|Decision by sponsor|0|||
163033270|NCT02520427|588824592|FG018|Overall Study|Decision by sponsor|0|||
163033271|NCT02520427|588824593|FG019|Overall Study|Decision by sponsor|0|||
163033272|NCT02520427|588824594|FG020|Overall Study|Decision by sponsor|0|||
163033273|NCT02520427|588824595|FG021|Overall Study|Decision by sponsor|0|||
162647435|NCT00314574|587426789|FG000|Overall Study|Lost to Follow-up|19|||
162647436|NCT00314574|587426790|FG001|Overall Study|Lost to Follow-up|25|||
163033274|NCT02520427|588824596|FG022|Overall Study|Decision by sponsor|0|||
163033275|NCT02520427|588824597|FG023|Overall Study|Decision by sponsor|0|||
163033276|NCT02520427|588824598|FG024|Overall Study|Decision by sponsor|0|||
163033277|NCT02520427|588824599|FG025|Overall Study|Decision by sponsor|0|||
163033278|NCT02520427|588824574|FG000|Overall Study|Withdrawal by Subject|0|||
163033279|NCT02520427|588824575|FG001|Overall Study|Withdrawal by Subject|0|||
163033280|NCT02520427|588824576|FG002|Overall Study|Withdrawal by Subject|1|||
163033281|NCT02520427|588824577|FG003|Overall Study|Withdrawal by Subject|0|||
163033282|NCT02520427|588824578|FG004|Overall Study|Withdrawal by Subject|0|||
163033283|NCT02520427|588824579|FG005|Overall Study|Withdrawal by Subject|0|||
163033284|NCT02520427|588824580|FG006|Overall Study|Withdrawal by Subject|0|||
163033285|NCT02520427|588824581|FG007|Overall Study|Withdrawal by Subject|0|||
163033286|NCT02520427|588824582|FG008|Overall Study|Withdrawal by Subject|0|||
163033287|NCT02520427|588824583|FG009|Overall Study|Withdrawal by Subject|0|||
163033288|NCT02520427|588824584|FG010|Overall Study|Withdrawal by Subject|0|||
163033289|NCT02520427|588824585|FG011|Overall Study|Withdrawal by Subject|0|||
163033290|NCT02520427|588824586|FG012|Overall Study|Withdrawal by Subject|1|||
163033291|NCT02520427|588824587|FG013|Overall Study|Withdrawal by Subject|1|||
163033292|NCT02520427|588824588|FG014|Overall Study|Withdrawal by Subject|1|||
163085339|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
163085340|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
163085341|NCT00725985|589022283|FG000|ITP- Treatment Disposition|Other|50|||
163085342|NCT00725985|589022284|FG001|ITP- Treatment Disposition|Other|38|||
163085343|NCT00725985|589022285|FG002|ITP- Treatment Disposition|Other|24|||
163085344|NCT00725985|589022286|FG003|ITP- Treatment Disposition|Other|0|||
163085345|NCT00725985|589022287|FG004|ITP- Treatment Disposition|Other|0|||
163085346|NCT00725985|589022288|FG005|ITP- Treatment Disposition|Other|0|||
163085347|NCT00725985|589022289|FG006|ITP- Treatment Disposition|Other|0|||
163085348|NCT00725985|589022290|FG007|ITP- Treatment Disposition|Other|0|||
163085349|NCT00725985|589022291|FG008|ITP- Treatment Disposition|Other|0|||
163085350|NCT00725985|589022292|FG009|ITP- Treatment Disposition|Other|0|||
163085351|NCT00725985|589022293|FG010|ITP- Treatment Disposition|Other|0|||
163085352|NCT00725985|589022294|FG011|ITP- Treatment Disposition|Other|0|||
163085353|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085354|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085355|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085356|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
163085357|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
163085358|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
163085359|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085360|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085361|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085362|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085363|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085364|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
163085365|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Death|0|||
163085366|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Death|0|||
163085367|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Death|0|||
163085368|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Death|0|||
163085369|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Death|1|||
163085370|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Death|0|||
163085371|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Death|0|||
163085372|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Death|0|||
163085373|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Death|0|||
163085374|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Death|0|||
163085375|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Death|0|||
163085376|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Death|0|||
163085377|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085378|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085379|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085380|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
163085381|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085382|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085383|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085384|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085385|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085386|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085387|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085388|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
163085389|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085390|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085391|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085392|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085393|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085394|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
163085395|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085396|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085397|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085398|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085399|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085400|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
163085401|NCT00725985|589022283|FG000|OLMP (Up to 96 Weeks)|Other|0|||
163085402|NCT00725985|589022284|FG001|OLMP (Up to 96 Weeks)|Other|0|||
163085403|NCT00725985|589022285|FG002|OLMP (Up to 96 Weeks)|Other|0|||
163085404|NCT00725985|589022286|FG003|OLMP (Up to 96 Weeks)|Other|15|||
163085405|NCT00725985|589022287|FG004|OLMP (Up to 96 Weeks)|Other|20|||
163085406|NCT00725985|589022288|FG005|OLMP (Up to 96 Weeks)|Other|44|||
163085407|NCT00725985|589022289|FG006|OLMP (Up to 96 Weeks)|Other|0|||
163085408|NCT00725985|589022290|FG007|OLMP (Up to 96 Weeks)|Other|0|||
163085409|NCT00725985|589022291|FG008|OLMP (Up to 96 Weeks)|Other|0|||
163085410|NCT00725985|589022292|FG009|OLMP (Up to 96 Weeks)|Other|0|||
163085411|NCT00725985|589022293|FG010|OLMP (Up to 96 Weeks)|Other|0|||
163085412|NCT00725985|589022294|FG011|OLMP (Up to 96 Weeks)|Other|0|||
163085413|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085414|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085415|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
162718134|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
162718135|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718136|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718137|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
162718138|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718139|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718140|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718141|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162718142|NCT01212757|587673540|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718143|NCT01212757|587673541|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
162718144|NCT01212757|587673542|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
162718145|NCT01212757|587673543|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718146|NCT01212757|587673544|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718147|NCT01212757|587673545|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718148|NCT01212757|587673546|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718149|NCT01212757|587673547|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718150|NCT01212757|587673548|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162718151|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163033293|NCT02520427|588824589|FG015|Overall Study|Withdrawal by Subject|0|||
163033294|NCT02520427|588824590|FG016|Overall Study|Withdrawal by Subject|1|||
163033295|NCT02520427|588824591|FG017|Overall Study|Withdrawal by Subject|0|||
163033296|NCT02520427|588824592|FG018|Overall Study|Withdrawal by Subject|0|||
163033297|NCT02520427|588824593|FG019|Overall Study|Withdrawal by Subject|3|||
163033298|NCT02520427|588824594|FG020|Overall Study|Withdrawal by Subject|2|||
163033299|NCT02520427|588824595|FG021|Overall Study|Withdrawal by Subject|0|||
163033300|NCT02520427|588824596|FG022|Overall Study|Withdrawal by Subject|0|||
163033301|NCT02520427|588824597|FG023|Overall Study|Withdrawal by Subject|0|||
163033302|NCT02520427|588824598|FG024|Overall Study|Withdrawal by Subject|0|||
163033303|NCT02520427|588824599|FG025|Overall Study|Withdrawal by Subject|0|||
163033304|NCT02520427|588824574|FG000|Overall Study|Death|1|||
163033305|NCT02520427|588824575|FG001|Overall Study|Death|0|||
163033306|NCT02520427|588824576|FG002|Overall Study|Death|0|||
163033307|NCT02520427|588824577|FG003|Overall Study|Death|0|||
163033308|NCT02520427|588824578|FG004|Overall Study|Death|0|||
163033309|NCT02520427|588824579|FG005|Overall Study|Death|0|||
163033310|NCT02520427|588824580|FG006|Overall Study|Death|0|||
163033311|NCT02520427|588824581|FG007|Overall Study|Death|0|||
163033312|NCT02520427|588824582|FG008|Overall Study|Death|0|||
163033313|NCT02520427|588824583|FG009|Overall Study|Death|0|||
163033314|NCT02520427|588824584|FG010|Overall Study|Death|0|||
163033315|NCT02520427|588824585|FG011|Overall Study|Death|0|||
163033316|NCT02520427|588824586|FG012|Overall Study|Death|0|||
163033317|NCT02520427|588824587|FG013|Overall Study|Death|0|||
163033318|NCT02520427|588824588|FG014|Overall Study|Death|0|||
163033319|NCT02520427|588824589|FG015|Overall Study|Death|0|||
163033320|NCT02520427|588824590|FG016|Overall Study|Death|2|||
163033321|NCT02520427|588824591|FG017|Overall Study|Death|1|||
163033322|NCT02520427|588824592|FG018|Overall Study|Death|3|||
163033323|NCT02520427|588824593|FG019|Overall Study|Death|2|||
163033324|NCT02520427|588824594|FG020|Overall Study|Death|0|||
163033325|NCT02520427|588824595|FG021|Overall Study|Death|0|||
163033326|NCT02520427|588824596|FG022|Overall Study|Death|1|||
163033327|NCT02520427|588824597|FG023|Overall Study|Death|0|||
163033328|NCT02520427|588824598|FG024|Overall Study|Death|1|||
163033329|NCT02520427|588824599|FG025|Overall Study|Death|0|||
163033330|NCT00793624|588824600|FG000|Overall Study|Adverse Event|18|||
163033331|NCT00793624|588824601|FG001|Overall Study|Adverse Event|16|||
163033332|NCT00793624|588824602|FG002|Overall Study|Adverse Event|15|||
163033333|NCT00793624|588824603|FG003|Overall Study|Adverse Event|20|||
163033334|NCT00793624|588824600|FG000|Overall Study|Lost to Follow-up|2|||
163033335|NCT00793624|588824601|FG001|Overall Study|Lost to Follow-up|2|||
163033336|NCT00793624|588824602|FG002|Overall Study|Lost to Follow-up|4|||
163033337|NCT00793624|588824603|FG003|Overall Study|Lost to Follow-up|0|||
163033338|NCT00793624|588824600|FG000|Overall Study|Withdrawal by Subject|20|||
163033339|NCT00793624|588824601|FG001|Overall Study|Withdrawal by Subject|9|||
163033340|NCT00793624|588824602|FG002|Overall Study|Withdrawal by Subject|11|||
163085416|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085417|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163033341|NCT00793624|588824603|FG003|Overall Study|Withdrawal by Subject|14|||
163033342|NCT00793624|588824600|FG000|Overall Study|Lack of Efficacy|9|||
163033343|NCT00793624|588824601|FG001|Overall Study|Lack of Efficacy|2|||
163033344|NCT00793624|588824602|FG002|Overall Study|Lack of Efficacy|1|||
163033345|NCT00793624|588824603|FG003|Overall Study|Lack of Efficacy|3|||
163033346|NCT00793624|588824600|FG000|Overall Study|Non compliance with protocol|2|||
163033347|NCT00793624|588824601|FG001|Overall Study|Non compliance with protocol|3|||
163033348|NCT00793624|588824602|FG002|Overall Study|Non compliance with protocol|2|||
163033349|NCT00793624|588824603|FG003|Overall Study|Non compliance with protocol|3|||
163085418|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085419|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085420|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
163085421|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085422|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085423|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
162647437|NCT00314574|587426789|FG000|Overall Study|Withdrawal by Subject|33|||
162647438|NCT00314574|587426790|FG001|Overall Study|Withdrawal by Subject|22|||
162647439|NCT00314574|587426789|FG000|Overall Study|Physician Decision|22|||
162647440|NCT00314574|587426790|FG001|Overall Study|Physician Decision|15|||
162647441|NCT00314574|587426789|FG000|Overall Study|Pregnancy|6|||
162647442|NCT00314574|587426790|FG001|Overall Study|Pregnancy|4|||
162647443|NCT00314574|587426789|FG000|Overall Study|Data unknown at database lock|0|||
162647444|NCT00314574|587426790|FG001|Overall Study|Data unknown at database lock|1|||
162647445|NCT03144180|587426794|FG000|Overall Study|STAT Delivery|1|||
162647446|NCT03144180|587426795|FG001|Overall Study|STAT Delivery|1|||
162647447|NCT03144180|587426794|FG000|Overall Study|Provider forgot to fill out forms|1|||
162647448|NCT03144180|587426795|FG001|Overall Study|Provider forgot to fill out forms|3|||
162647449|NCT03144180|587426794|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
162647450|NCT03144180|587426795|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
162647451|NCT03144180|587426794|FG000|Overall Study|Scrub tech removed tube cap|0|||
162647452|NCT03144180|587426795|FG001|Overall Study|Scrub tech removed tube cap|1|||
162647453|NCT00751348|587426800|FG000|Overall Study|Withdrawal by Subject|5|||
162647454|NCT00751348|587426801|FG001|Overall Study|Withdrawal by Subject|2|||
162647455|NCT00751348|587426800|FG000|Overall Study|Migration from study area|1|||
162647456|NCT00751348|587426801|FG001|Overall Study|Migration from study area|0|||
162647457|NCT00743652|587426803|FG000|Overall Study|Parent/Legal Guardian Request|3|||
162647458|NCT00743652|587426804|FG001|Overall Study|Parent/Legal Guardian Request|2|||
162647459|NCT00743652|587426805|FG002|Overall Study|Parent/Legal Guardian Request|2|||
162647460|NCT00743652|587426806|FG003|Overall Study|Parent/Legal Guardian Request|2|||
162647461|NCT00743652|587426807|FG004|Overall Study|Parent/Legal Guardian Request|0|||
162647462|NCT00743652|587426803|FG000|Overall Study|Adverse Event|3|||
162647463|NCT00743652|587426804|FG001|Overall Study|Adverse Event|0|||
162647464|NCT00743652|587426805|FG002|Overall Study|Adverse Event|0|||
163085424|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
163085425|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085426|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085427|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085428|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085429|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085430|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085431|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085432|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085433|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
163085434|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085435|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
163085436|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
162647465|NCT00743652|587426806|FG003|Overall Study|Adverse Event|0|||
162647466|NCT00743652|587426807|FG004|Overall Study|Adverse Event|0|||
162647467|NCT00743652|587426803|FG000|Overall Study|Death|2|||
162647468|NCT00743652|587426804|FG001|Overall Study|Death|0|||
162647469|NCT00743652|587426805|FG002|Overall Study|Death|0|||
162647470|NCT00743652|587426806|FG003|Overall Study|Death|0|||
162647471|NCT00743652|587426807|FG004|Overall Study|Death|0|||
162647472|NCT00743652|587426803|FG000|Overall Study|Investigator Request|0|||
162647473|NCT00743652|587426804|FG001|Overall Study|Investigator Request|0|||
162647474|NCT00743652|587426805|FG002|Overall Study|Investigator Request|0|||
162647475|NCT00743652|587426806|FG003|Overall Study|Investigator Request|2|||
162647476|NCT00743652|587426807|FG004|Overall Study|Investigator Request|0|||
162647477|NCT00743652|587426803|FG000|Overall Study|Other|1|||
162647478|NCT00743652|587426804|FG001|Overall Study|Other|1|||
162647479|NCT00743652|587426805|FG002|Overall Study|Other|0|||
162647480|NCT00743652|587426806|FG003|Overall Study|Other|0|||
162647481|NCT00743652|587426807|FG004|Overall Study|Other|0|||
162647482|NCT00743652|587426803|FG000|Overall Study|Lost to Follow-up|1|||
162647483|NCT00743652|587426804|FG001|Overall Study|Lost to Follow-up|0|||
162647484|NCT00743652|587426805|FG002|Overall Study|Lost to Follow-up|0|||
162647485|NCT00743652|587426806|FG003|Overall Study|Lost to Follow-up|0|||
162647486|NCT00743652|587426807|FG004|Overall Study|Lost to Follow-up|0|||
162647487|NCT03261947|587426808|FG000|Overall Study|Death|10|||
162647488|NCT03261947|587426809|FG001|Overall Study|Death|13|||
162647489|NCT03261947|587426810|FG002|Overall Study|Death|17|||
162647490|NCT03261947|587426811|FG003|Overall Study|Death|12|||
162647491|NCT03261947|587426812|FG004|Overall Study|Death|8|||
162647492|NCT03261947|587426808|FG000|Overall Study|Lost to Follow-up|0|||
162647493|NCT03261947|587426809|FG001|Overall Study|Lost to Follow-up|0|||
162647494|NCT03261947|587426810|FG002|Overall Study|Lost to Follow-up|2|||
162647495|NCT03261947|587426811|FG003|Overall Study|Lost to Follow-up|1|||
162647496|NCT03261947|587426812|FG004|Overall Study|Lost to Follow-up|0|||
162647497|NCT03261947|587426808|FG000|Overall Study|Withdrawal by Subject|0|||
162647498|NCT03261947|587426809|FG001|Overall Study|Withdrawal by Subject|0|||
162647499|NCT03261947|587426810|FG002|Overall Study|Withdrawal by Subject|3|||
162647500|NCT03261947|587426811|FG003|Overall Study|Withdrawal by Subject|0|||
162647501|NCT03261947|587426812|FG004|Overall Study|Withdrawal by Subject|1|||
162647502|NCT03261947|587426808|FG000|Overall Study|Site Terminated by Sponsor|0|||
162647503|NCT03261947|587426809|FG001|Overall Study|Site Terminated by Sponsor|0|||
162647504|NCT03261947|587426810|FG002|Overall Study|Site Terminated by Sponsor|4|||
162647505|NCT03261947|587426811|FG003|Overall Study|Site Terminated by Sponsor|7|||
162647506|NCT03261947|587426812|FG004|Overall Study|Site Terminated by Sponsor|5|||
162647507|NCT03261947|587426808|FG000|Overall Study|Reason not Specified|2|||
162647508|NCT03261947|587426809|FG001|Overall Study|Reason not Specified|0|||
162647509|NCT03261947|587426810|FG002|Overall Study|Reason not Specified|4|||
162647510|NCT03261947|587426811|FG003|Overall Study|Reason not Specified|1|||
162647511|NCT03261947|587426812|FG004|Overall Study|Reason not Specified|3|||
162647512|NCT03969992|587426813|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
162647513|NCT03969992|587426814|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
162647514|NCT03969992|587426815|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
162647515|NCT03969992|587426813|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
162647516|NCT03969992|587426814|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
162647517|NCT03969992|587426815|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
162647518|NCT03969992|587426813|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
162647519|NCT03969992|587426814|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
162647520|NCT03969992|587426815|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
162647521|NCT03969992|587426813|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
163033350|NCT00793624|588824600|FG000|Overall Study|Other reason not described above|6|||
163033351|NCT00793624|588824601|FG001|Overall Study|Other reason not described above|4|||
163033352|NCT00793624|588824602|FG002|Overall Study|Other reason not described above|6|||
163033353|NCT00793624|588824603|FG003|Overall Study|Other reason not described above|3|||
163033354|NCT00157248|588824604|FG000|Overall Study|Adverse Event|36|||
163033355|NCT00157248|588824605|FG001|Overall Study|Adverse Event|25|||
163033356|NCT00157248|588824606|FG002|Overall Study|Adverse Event|13|||
163033357|NCT00157248|588824607|FG003|Overall Study|Adverse Event|33|||
163033358|NCT00157248|588824604|FG000|Overall Study|Protocol Violation|4|||
163033359|NCT00157248|588824605|FG001|Overall Study|Protocol Violation|0|||
163033360|NCT00157248|588824606|FG002|Overall Study|Protocol Violation|2|||
163033361|NCT00157248|588824607|FG003|Overall Study|Protocol Violation|2|||
163033362|NCT00157248|588824604|FG000|Overall Study|Lost to Follow-up|0|||
163033363|NCT00157248|588824605|FG001|Overall Study|Lost to Follow-up|1|||
163033364|NCT00157248|588824606|FG002|Overall Study|Lost to Follow-up|0|||
163033365|NCT00157248|588824607|FG003|Overall Study|Lost to Follow-up|0|||
163033366|NCT00157248|588824604|FG000|Overall Study|Withdrawal by Subject|1|||
163033367|NCT00157248|588824605|FG001|Overall Study|Withdrawal by Subject|4|||
163033368|NCT00157248|588824606|FG002|Overall Study|Withdrawal by Subject|3|||
163033369|NCT00157248|588824607|FG003|Overall Study|Withdrawal by Subject|3|||
163033370|NCT00157248|588824604|FG000|Overall Study|site closures, subject moving|7|||
163033371|NCT00157248|588824605|FG001|Overall Study|site closures, subject moving|7|||
163033372|NCT00157248|588824606|FG002|Overall Study|site closures, subject moving|3|||
163033373|NCT00157248|588824607|FG003|Overall Study|site closures, subject moving|9|||
163033374|NCT01712334|588824608|FG000|Treatment Period 1|Randomized in Error|0|||
163033375|NCT01712334|588824609|FG001|Treatment Period 1|Randomized in Error|2|||
163033376|NCT00232596|588824610|FG000|6-Week Titration Phase|Adverse Event|6|||
163033377|NCT00232596|588824611|FG001|6-Week Titration Phase|Adverse Event|19|||
163033378|NCT00232596|588824610|FG000|6-Week Titration Phase|Failed to Return|2|||
163033379|NCT00232596|588824611|FG001|6-Week Titration Phase|Failed to Return|1|||
163033380|NCT00232596|588824610|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
163033381|NCT00232596|588824611|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
163033382|NCT00232596|588824610|FG000|6-Week Titration Phase|Protocol Violation|1|||
163033383|NCT00232596|588824611|FG001|6-Week Titration Phase|Protocol Violation|3|||
163033384|NCT00232596|588824610|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
163033385|NCT00232596|588824611|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
163033386|NCT00232596|588824610|FG000|6-Week Titration Phase|Other|3|||
163033387|NCT00232596|588824611|FG001|6-Week Titration Phase|Other|3|||
163033388|NCT00232596|588824610|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
163033389|NCT00232596|588824611|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
163033390|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Adverse Event|7|||
163033391|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Adverse Event|22|||
163033392|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
163033393|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
162647522|NCT03969992|587426814|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
162647523|NCT03969992|587426815|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
162647524|NCT03969992|587426813|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
162647525|NCT03969992|587426814|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
162647526|NCT03969992|587426815|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
162647527|NCT00228917|587426816|FG000|Overall Study|Migrated/moved from study area|0|||
162647528|NCT00228917|587426817|FG001|Overall Study|Migrated/moved from study area|0|||
162647529|NCT00228917|587426818|FG002|Overall Study|Migrated/moved from study area|0|||
162647530|NCT00228917|587426819|FG003|Overall Study|Migrated/moved from study area|0|||
162647531|NCT00228917|587426820|FG004|Overall Study|Migrated/moved from study area|0|||
162647532|NCT00228917|587426821|FG005|Overall Study|Migrated/moved from study area|2|||
162647533|NCT00228917|587426822|FG006|Overall Study|Migrated/moved from study area|0|||
162647534|NCT00228917|587426823|FG007|Overall Study|Migrated/moved from study area|0|||
162647535|NCT02063737|587426826|FG000|Overall Study|Lost to Follow-up|11|||
162647536|NCT02063737|587426827|FG001|Overall Study|Lost to Follow-up|4|||
162647537|NCT04372602|587426830|FG000|Overall Study|Withdrawal by Subject|1|||
162647538|NCT04372602|587426831|FG001|Overall Study|Withdrawal by Subject|1|||
162647539|NCT04372602|587426830|FG000|Overall Study|Adverse Event|0|||
162647540|NCT04372602|587426831|FG001|Overall Study|Adverse Event|1|||
162647541|NCT04372602|587426830|FG000|Overall Study|Transitioned to comfort care|0|||
162647542|NCT04372602|587426831|FG001|Overall Study|Transitioned to comfort care|1|||
162647543|NCT01085097|587426832|FG000|Overall Study|Adverse Event|0|||
162647544|NCT01085097|587426833|FG001|Overall Study|Adverse Event|0|||
162647545|NCT01085097|587426834|FG002|Overall Study|Adverse Event|2|||
162647546|NCT01085097|587426832|FG000|Overall Study|Treatment failure|2|||
162647547|NCT01085097|587426833|FG001|Overall Study|Treatment failure|0|||
162647548|NCT01085097|587426834|FG002|Overall Study|Treatment failure|0|||
162647549|NCT04120974|587426835|FG000|Overall Study|Death|1|||
162647550|NCT04120974|587426835|FG000|Overall Study|Physician Decision|1|||
162647551|NCT04120974|587426835|FG000|Overall Study|Lost to Follow-up|6|||
162647552|NCT06049043|587426836|FG000|Overall Study|Lost to Follow-up|11|||
162647553|NCT06049043|587426837|FG001|Overall Study|Lost to Follow-up|9|||
162647554|NCT00129129|587426838|FG000|Primary Phase|Adverse Event|2|||
162647555|NCT00129129|587426839|FG001|Primary Phase|Adverse Event|1|||
162647556|NCT00129129|587426840|FG002|Primary Phase|Adverse Event|0|||
162647557|NCT00129129|587426841|FG003|Primary Phase|Adverse Event|0|||
162647558|NCT00129129|587426842|FG004|Primary Phase|Adverse Event|0|||
162647559|NCT00129129|587426838|FG000|Primary Phase|Withdrawal by Subject|12|||
162647560|NCT00129129|587426839|FG001|Primary Phase|Withdrawal by Subject|10|||
162647561|NCT00129129|587426840|FG002|Primary Phase|Withdrawal by Subject|0|||
163085437|NCT00725985|589022283|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085438|NCT00725985|589022284|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085439|NCT00725985|589022285|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085440|NCT00725985|589022286|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085441|NCT00725985|589022287|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085442|NCT00725985|589022288|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085443|NCT00725985|589022289|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
163085444|NCT00725985|589022290|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
163085445|NCT00725985|589022291|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
163085446|NCT00725985|589022292|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085447|NCT00725985|589022293|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085448|NCT00725985|589022294|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
163085449|NCT00725985|589022283|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085450|NCT00725985|589022284|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085451|NCT00725985|589022285|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085452|NCT00725985|589022286|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085453|NCT00725985|589022287|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085454|NCT00725985|589022288|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085455|NCT00725985|589022289|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085456|NCT00725985|589022290|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
163085457|NCT00725985|589022291|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
162647562|NCT00129129|587426841|FG003|Primary Phase|Withdrawal by Subject|0|||
162647563|NCT00129129|587426842|FG004|Primary Phase|Withdrawal by Subject|0|||
163085458|NCT00725985|589022292|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
163085459|NCT00725985|589022293|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
163085460|NCT00725985|589022294|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
163085461|NCT02546323|589022295|FG000|Overall Study|Withdrawal by Subject|36|||
162647564|NCT00129129|587426838|FG000|Primary Phase|Migration from study area|1|||
162647565|NCT00129129|587426839|FG001|Primary Phase|Migration from study area|3|||
162647566|NCT00129129|587426840|FG002|Primary Phase|Migration from study area|0|||
162647567|NCT00129129|587426841|FG003|Primary Phase|Migration from study area|0|||
162647568|NCT00129129|587426842|FG004|Primary Phase|Migration from study area|0|||
163085462|NCT02546323|589022296|FG001|Overall Study|Withdrawal by Subject|33|||
163085463|NCT02546323|589022295|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
162647569|NCT00129129|587426838|FG000|Primary Phase|Lost to Follow-up|8|||
162647570|NCT00129129|587426839|FG001|Primary Phase|Lost to Follow-up|6|||
162647571|NCT00129129|587426840|FG002|Primary Phase|Lost to Follow-up|0|||
162647572|NCT00129129|587426841|FG003|Primary Phase|Lost to Follow-up|0|||
162647573|NCT00129129|587426842|FG004|Primary Phase|Lost to Follow-up|0|||
162647574|NCT00129129|587426838|FG000|Primary Phase|Other|2|||
162647575|NCT00129129|587426839|FG001|Primary Phase|Other|5|||
162647576|NCT00129129|587426840|FG002|Primary Phase|Other|0|||
162647577|NCT00129129|587426841|FG003|Primary Phase|Other|0|||
162647578|NCT00129129|587426842|FG004|Primary Phase|Other|0|||
162647579|NCT00129129|587426838|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
162647580|NCT00129129|587426839|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
162647581|NCT00129129|587426840|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
162647582|NCT00129129|587426841|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
162647583|NCT00129129|587426842|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
162647584|NCT00129129|587426838|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
162647585|NCT00129129|587426839|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
162647586|NCT00129129|587426840|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
162647587|NCT00129129|587426841|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
162647588|NCT00129129|587426842|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
162647589|NCT00129129|587426838|FG000|Fourth Dose Phase|Migration from study area|0|||
162647590|NCT00129129|587426839|FG001|Fourth Dose Phase|Migration from study area|0|||
162647591|NCT00129129|587426840|FG002|Fourth Dose Phase|Migration from study area|0|||
162647592|NCT00129129|587426841|FG003|Fourth Dose Phase|Migration from study area|0|||
162647593|NCT00129129|587426842|FG004|Fourth Dose Phase|Migration from study area|2|||
162647594|NCT00129129|587426838|FG000|Fourth Dose Phase|Other|0|||
162647595|NCT00129129|587426839|FG001|Fourth Dose Phase|Other|0|||
162647596|NCT00129129|587426840|FG002|Fourth Dose Phase|Other|0|||
162647597|NCT00129129|587426841|FG003|Fourth Dose Phase|Other|1|||
162647598|NCT00129129|587426842|FG004|Fourth Dose Phase|Other|1|||
162647599|NCT00129129|587426838|FG000|Fourth Dose Phase|Protocol Violation|0|||
162647600|NCT00129129|587426839|FG001|Fourth Dose Phase|Protocol Violation|0|||
162647601|NCT00129129|587426840|FG002|Fourth Dose Phase|Protocol Violation|0|||
162647602|NCT00129129|587426841|FG003|Fourth Dose Phase|Protocol Violation|1|||
162647603|NCT00129129|587426842|FG004|Fourth Dose Phase|Protocol Violation|0|||
162647604|NCT03089606|587426845|FG000|Overall Study|Progression after Cycle 1|1|||
162647605|NCT00335972|587426846|FG000|Overall Study|not given treatments|0|||
162647606|NCT00335972|587426847|FG001|Overall Study|not given treatments|3|||
162647607|NCT03965962|587426849|FG000|Overall Study|Adverse Event|1|||
162647608|NCT03965962|587426850|FG001|Overall Study|Adverse Event|0|||
162647609|NCT03965962|587426851|FG002|Overall Study|Adverse Event|0|||
162647610|NCT03965962|587426852|FG003|Overall Study|Adverse Event|0|||
162647611|NCT03965962|587426849|FG000|Overall Study|Protocol Violation|21|||
162647612|NCT03965962|587426850|FG001|Overall Study|Protocol Violation|4|||
162647613|NCT03965962|587426851|FG002|Overall Study|Protocol Violation|10|||
162647614|NCT03965962|587426852|FG003|Overall Study|Protocol Violation|5|||
162647615|NCT03965962|587426849|FG000|Overall Study|Lost to Follow-up|0|||
162647616|NCT03965962|587426850|FG001|Overall Study|Lost to Follow-up|1|||
162647617|NCT03965962|587426851|FG002|Overall Study|Lost to Follow-up|0|||
162647618|NCT03965962|587426852|FG003|Overall Study|Lost to Follow-up|0|||
162647619|NCT03965962|587426849|FG000|Overall Study|Withdrawal by Subject|3|||
162647620|NCT03965962|587426850|FG001|Overall Study|Withdrawal by Subject|0|||
162718152|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162718153|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162647621|NCT03965962|587426851|FG002|Overall Study|Withdrawal by Subject|0|||
162647622|NCT03965962|587426852|FG003|Overall Study|Withdrawal by Subject|1|||
162647623|NCT03190889|587426857|FG000|Overall Study|Lost to Follow-up|7|||
162647624|NCT03190889|587426858|FG001|Overall Study|Lost to Follow-up|7|||
162647625|NCT03190889|587426859|FG002|Overall Study|Lost to Follow-up|3|||
162647626|NCT03190889|587426857|FG000|Overall Study|Withdrawal by Subject|1|||
162647627|NCT03190889|587426858|FG001|Overall Study|Withdrawal by Subject|1|||
162647628|NCT03190889|587426859|FG002|Overall Study|Withdrawal by Subject|2|||
162647629|NCT03190889|587426857|FG000|Overall Study|Did not complete protocol|4|||
162718154|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162718155|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163085464|NCT02546323|589022296|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
162647630|NCT03190889|587426858|FG001|Overall Study|Did not complete protocol|9|||
162647631|NCT03190889|587426859|FG002|Overall Study|Did not complete protocol|0|||
162647632|NCT03190889|587426857|FG000|Overall Study|COVID-19|1|||
162647633|NCT03190889|587426858|FG001|Overall Study|COVID-19|0|||
162647634|NCT03190889|587426859|FG002|Overall Study|COVID-19|2|||
162647635|NCT02140567|587426861|FG000|Overall Study|Problems with recording equipment|6|||
162647636|NCT02882854|587426864|FG000|Overall Study|Lost to Follow-up|1|||
162647637|NCT02882854|587426865|FG001|Overall Study|Lost to Follow-up|2|||
162647638|NCT02882854|587426864|FG000|Overall Study|Physician Decision|0|||
162647639|NCT02882854|587426865|FG001|Overall Study|Physician Decision|1|||
162647640|NCT02039674|587426866|FG000|Overall Study|Adverse Event|0|||
162647641|NCT02039674|587426867|FG001|Overall Study|Adverse Event|0|||
163085465|NCT02546323|589022295|FG000|Overall Study|Adverse Event|17|||
163085466|NCT02546323|589022296|FG001|Overall Study|Adverse Event|11|||
163085467|NCT02546323|589022295|FG000|Overall Study|Patient Specific Reasons|1|||
163085468|NCT02546323|589022296|FG001|Overall Study|Patient Specific Reasons|2|||
163085469|NCT02546323|589022295|FG000|Overall Study|Lost to Follow-up|2|||
163085470|NCT02546323|589022296|FG001|Overall Study|Lost to Follow-up|3|||
163085471|NCT02546323|589022295|FG000|Overall Study|Non-compliance with Study Drug|2|||
163085472|NCT02546323|589022296|FG001|Overall Study|Non-compliance with Study Drug|2|||
163085473|NCT02546323|589022295|FG000|Overall Study|Met Withdrawal Criteria|2|||
163085474|NCT02546323|589022296|FG001|Overall Study|Met Withdrawal Criteria|14|||
163085475|NCT04476784|589022297|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
163085476|NCT04476784|589022298|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
163085477|NCT00863304|589022305|FG000|Overall Study|Adverse Event|10|||
163085478|NCT00863304|589022306|FG001|Overall Study|Adverse Event|4|||
163085479|NCT00863304|589022307|FG002|Overall Study|Adverse Event|14|||
163085480|NCT00863304|589022308|FG003|Overall Study|Adverse Event|16|||
163085481|NCT00863304|589022305|FG000|Overall Study|Lost to Follow-up|1|||
163085482|NCT00863304|589022306|FG001|Overall Study|Lost to Follow-up|5|||
163085483|NCT00863304|589022307|FG002|Overall Study|Lost to Follow-up|4|||
163085484|NCT00863304|589022308|FG003|Overall Study|Lost to Follow-up|2|||
163085485|NCT00863304|589022305|FG000|Overall Study|Lack of Efficacy|57|||
163085486|NCT00863304|589022306|FG001|Overall Study|Lack of Efficacy|26|||
163085487|NCT00863304|589022307|FG002|Overall Study|Lack of Efficacy|30|||
163085488|NCT00863304|589022308|FG003|Overall Study|Lack of Efficacy|28|||
163085489|NCT00863304|589022305|FG000|Overall Study|Withdrawal by Subject|19|||
163085490|NCT00863304|589022306|FG001|Overall Study|Withdrawal by Subject|14|||
163085491|NCT00863304|589022307|FG002|Overall Study|Withdrawal by Subject|20|||
163085492|NCT00863304|589022308|FG003|Overall Study|Withdrawal by Subject|18|||
163085493|NCT00863304|589022305|FG000|Overall Study|Other|1|||
163085494|NCT00863304|589022306|FG001|Overall Study|Other|0|||
163085495|NCT00863304|589022307|FG002|Overall Study|Other|0|||
163085496|NCT00863304|589022308|FG003|Overall Study|Other|1|||
163085497|NCT00863304|589022305|FG000|Overall Study|Protocol Violation|2|||
163085498|NCT00863304|589022306|FG001|Overall Study|Protocol Violation|6|||
163085499|NCT00863304|589022307|FG002|Overall Study|Protocol Violation|2|||
163085500|NCT00863304|589022308|FG003|Overall Study|Protocol Violation|0|||
163085501|NCT00863304|589022305|FG000|Overall Study|Randomized, but not Treated|3|||
163085502|NCT00863304|589022306|FG001|Overall Study|Randomized, but not Treated|1|||
163085503|NCT00863304|589022307|FG002|Overall Study|Randomized, but not Treated|4|||
163033394|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
163033395|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
163033396|NCT00232596|588824610|FG000|12-Week Maintenance Phase|Other|1|||
163033397|NCT00232596|588824611|FG001|12-Week Maintenance Phase|Other|3|||
163033398|NCT03467763|588824614|FG000|Overall Study|Lost to Follow-up|1|||
163033399|NCT03467763|588824614|FG000|Overall Study|Protocol Violation|2|||
163033400|NCT02073565|588824615|FG000|Cohort A|Withdrawal by Subject|1|||
163033401|NCT02073565|588824616|FG001|Cohort A|Withdrawal by Subject|0|||
163033402|NCT02073565|588824615|FG000|Cohort B|Withdrawal by Subject|1|||
163033403|NCT02073565|588824616|FG001|Cohort B|Withdrawal by Subject|2|||
163033404|NCT02073565|588824615|FG000|Cohort C|Withdrawal by Subject|0|||
163033405|NCT02073565|588824616|FG001|Cohort C|Withdrawal by Subject|2|||
163033406|NCT02073565|588824615|FG000|Cohort C|Lost to Follow-up|0|||
163033407|NCT02073565|588824616|FG001|Cohort C|Lost to Follow-up|2|||
163033408|NCT04102865|588824617|FG000|Overall Study|Adverse Event|4|||
163033409|NCT04102865|588824618|FG001|Overall Study|Adverse Event|0|||
163033410|NCT04102865|588824617|FG000|Overall Study|Lost to Follow-up|1|||
163033411|NCT04102865|588824618|FG001|Overall Study|Lost to Follow-up|0|||
162647642|NCT02039674|587426868|FG002|Overall Study|Adverse Event|0|||
162647643|NCT02039674|587426869|FG003|Overall Study|Adverse Event|1|||
162647644|NCT02039674|587426870|FG004|Overall Study|Adverse Event|0|||
162647645|NCT02039674|587426871|FG005|Overall Study|Adverse Event|0|||
162647646|NCT02039674|587426872|FG006|Overall Study|Adverse Event|0|||
162647647|NCT02039674|587426873|FG007|Overall Study|Adverse Event|0|||
162647648|NCT02039674|587426874|FG008|Overall Study|Adverse Event|2|||
163033412|NCT04102865|588824617|FG000|Overall Study|Withdrawal by Subject|2|||
163033413|NCT04102865|588824618|FG001|Overall Study|Withdrawal by Subject|0|||
163033414|NCT01764997|588824623|FG000|Run-in Period|Adverse Event|15|||
163033415|NCT01764997|588824624|FG001|Run-in Period|Adverse Event|0|||
163033416|NCT01764997|588824625|FG002|Run-in Period|Adverse Event|0|||
163033417|NCT01764997|588824626|FG003|Run-in Period|Adverse Event|0|||
163033418|NCT01764997|588824627|FG004|Run-in Period|Adverse Event|0|||
163033419|NCT01764997|588824623|FG000|Run-in Period|Lack of Efficacy|5|||
163033420|NCT01764997|588824624|FG001|Run-in Period|Lack of Efficacy|0|||
163085504|NCT00863304|589022308|FG003|Overall Study|Randomized, but not Treated|1|||
162647649|NCT02039674|587426875|FG009|Overall Study|Adverse Event|1|||
163033421|NCT01764997|588824625|FG002|Run-in Period|Lack of Efficacy|0|||
163033422|NCT01764997|588824626|FG003|Run-in Period|Lack of Efficacy|0|||
163033423|NCT01764997|588824627|FG004|Run-in Period|Lack of Efficacy|0|||
163033424|NCT01764997|588824623|FG000|Run-in Period|Poor compliance to protocol|1|||
163033425|NCT01764997|588824624|FG001|Run-in Period|Poor compliance to protocol|0|||
163033426|NCT01764997|588824625|FG002|Run-in Period|Poor compliance to protocol|0|||
163033427|NCT01764997|588824626|FG003|Run-in Period|Poor compliance to protocol|0|||
163033428|NCT01764997|588824627|FG004|Run-in Period|Poor compliance to protocol|0|||
163033429|NCT01764997|588824623|FG000|Run-in Period|Other than specified above|17|||
163033430|NCT01764997|588824624|FG001|Run-in Period|Other than specified above|0|||
163033431|NCT01764997|588824625|FG002|Run-in Period|Other than specified above|0|||
162647650|NCT02039674|587426876|FG010|Overall Study|Adverse Event|0|||
162647651|NCT02039674|587426877|FG011|Overall Study|Adverse Event|2|||
162647652|NCT02039674|587426878|FG012|Overall Study|Adverse Event|3|||
162647653|NCT02039674|587426879|FG013|Overall Study|Adverse Event|1|||
162647654|NCT02039674|587426866|FG000|Overall Study|Death|2|||
162647655|NCT02039674|587426867|FG001|Overall Study|Death|0|||
162647656|NCT02039674|587426868|FG002|Overall Study|Death|2|||
162647657|NCT02039674|587426869|FG003|Overall Study|Death|3|||
162647658|NCT02039674|587426870|FG004|Overall Study|Death|0|||
162647659|NCT02039674|587426871|FG005|Overall Study|Death|0|||
162647660|NCT02039674|587426872|FG006|Overall Study|Death|1|||
162647661|NCT02039674|587426873|FG007|Overall Study|Death|0|||
162647662|NCT02039674|587426874|FG008|Overall Study|Death|2|||
162647663|NCT02039674|587426875|FG009|Overall Study|Death|0|||
162647664|NCT02039674|587426876|FG010|Overall Study|Death|1|||
162647665|NCT02039674|587426877|FG011|Overall Study|Death|3|||
162647666|NCT02039674|587426878|FG012|Overall Study|Death|2|||
162647667|NCT02039674|587426879|FG013|Overall Study|Death|8|||
162647668|NCT02039674|587426866|FG000|Overall Study|Excluded Medication|1|||
162647669|NCT02039674|587426867|FG001|Overall Study|Excluded Medication|1|||
162647670|NCT02039674|587426868|FG002|Overall Study|Excluded Medication|0|||
162647671|NCT02039674|587426869|FG003|Overall Study|Excluded Medication|1|||
162647672|NCT02039674|587426870|FG004|Overall Study|Excluded Medication|0|||
162647673|NCT02039674|587426871|FG005|Overall Study|Excluded Medication|1|||
162647674|NCT02039674|587426872|FG006|Overall Study|Excluded Medication|0|||
162647675|NCT02039674|587426873|FG007|Overall Study|Excluded Medication|0|||
162647676|NCT02039674|587426874|FG008|Overall Study|Excluded Medication|2|||
162647677|NCT02039674|587426875|FG009|Overall Study|Excluded Medication|3|||
162647678|NCT02039674|587426876|FG010|Overall Study|Excluded Medication|5|||
162647679|NCT02039674|587426877|FG011|Overall Study|Excluded Medication|6|||
162647680|NCT02039674|587426878|FG012|Overall Study|Excluded Medication|8|||
162647681|NCT02039674|587426879|FG013|Overall Study|Excluded Medication|3|||
162647682|NCT02039674|587426866|FG000|Overall Study|Lost to Follow-up|0|||
162647683|NCT02039674|587426867|FG001|Overall Study|Lost to Follow-up|0|||
162647684|NCT02039674|587426868|FG002|Overall Study|Lost to Follow-up|0|||
162647685|NCT02039674|587426869|FG003|Overall Study|Lost to Follow-up|0|||
162647686|NCT02039674|587426870|FG004|Overall Study|Lost to Follow-up|1|||
162647687|NCT02039674|587426871|FG005|Overall Study|Lost to Follow-up|1|||
163033432|NCT01764997|588824626|FG003|Run-in Period|Other than specified above|0|||
163033433|NCT01764997|588824627|FG004|Run-in Period|Other than specified above|0|||
163033434|NCT01764997|588824623|FG000|Study Drug Treatment Period|Adverse Event|0|||
163033435|NCT01764997|588824624|FG001|Study Drug Treatment Period|Adverse Event|1|||
163033436|NCT01764997|588824625|FG002|Study Drug Treatment Period|Adverse Event|0|||
163033437|NCT01764997|588824626|FG003|Study Drug Treatment Period|Adverse Event|0|||
163033438|NCT01764997|588824627|FG004|Study Drug Treatment Period|Adverse Event|24|||
163033439|NCT01764997|588824623|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
163033440|NCT01764997|588824624|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
163033441|NCT01764997|588824625|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
163033442|NCT01764997|588824626|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
163033443|NCT01764997|588824627|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
163033444|NCT01764997|588824623|FG000|Study Drug Treatment Period|Other than specified above|0|||
163033445|NCT01764997|588824624|FG001|Study Drug Treatment Period|Other than specified above|0|||
163033446|NCT01764997|588824625|FG002|Study Drug Treatment Period|Other than specified above|0|||
163033447|NCT01764997|588824626|FG003|Study Drug Treatment Period|Other than specified above|0|||
163033448|NCT01764997|588824627|FG004|Study Drug Treatment Period|Other than specified above|10|||
163033449|NCT02913105|588826589|FG000|Overall Study|Adverse Event|11|||
163033450|NCT02913105|588826590|FG001|Overall Study|Adverse Event|0|||
163033451|NCT02913105|588826591|FG002|Overall Study|Adverse Event|4|||
163033452|NCT02913105|588826589|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163033453|NCT02913105|588826590|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163033454|NCT02913105|588826591|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163033455|NCT02913105|588826589|FG000|Overall Study|Reason Not Specified|3|||
163033456|NCT02913105|588826590|FG001|Overall Study|Reason Not Specified|1|||
163033457|NCT02913105|588826591|FG002|Overall Study|Reason Not Specified|1|||
163033458|NCT02913105|588826589|FG000|Overall Study|Physician Decision|1|||
163033459|NCT02913105|588826590|FG001|Overall Study|Physician Decision|1|||
163033460|NCT02913105|588826591|FG002|Overall Study|Physician Decision|0|||
163033461|NCT02913105|588826589|FG000|Overall Study|Withdrawal by Subject|0|||
163033462|NCT02913105|588826590|FG001|Overall Study|Withdrawal by Subject|3|||
162647688|NCT02039674|587426872|FG006|Overall Study|Lost to Follow-up|0|||
162647689|NCT02039674|587426873|FG007|Overall Study|Lost to Follow-up|0|||
163033463|NCT02913105|588826591|FG002|Overall Study|Withdrawal by Subject|1|||
163085505|NCT00863304|589022305|FG000|Overall Study|Entered extension study|101|||
163085506|NCT00863304|589022306|FG001|Overall Study|Entered extension study|129|||
163085507|NCT00863304|589022307|FG002|Overall Study|Entered extension study|113|||
163085508|NCT00863304|589022308|FG003|Overall Study|Entered extension study|125|||
163085509|NCT01182350|589022310|FG000|Overall Study|Adverse Event|5|||
163085510|NCT01182350|589022311|FG001|Overall Study|Adverse Event|0|||
163085511|NCT01182350|589022312|FG002|Overall Study|Adverse Event|0|||
163085512|NCT01182350|589022313|FG003|Overall Study|Adverse Event|0|||
163085513|NCT01182350|589022314|FG004|Overall Study|Adverse Event|0|||
163085514|NCT01182350|589022310|FG000|Overall Study|Disease Progression|15|||
163085515|NCT01182350|589022311|FG001|Overall Study|Disease Progression|12|||
163085516|NCT01182350|589022312|FG002|Overall Study|Disease Progression|0|||
163085517|NCT01182350|589022313|FG003|Overall Study|Disease Progression|1|||
163033464|NCT02168777|588826592|FG000|Overall Study|Withdrawal by Subject|1|||
163033465|NCT02168777|588826593|FG001|Overall Study|Withdrawal by Subject|0|||
163085518|NCT01182350|589022314|FG004|Overall Study|Disease Progression|0|||
163085519|NCT01182350|589022310|FG000|Overall Study|Death|0|||
163085520|NCT01182350|589022311|FG001|Overall Study|Death|1|||
163085521|NCT01182350|589022312|FG002|Overall Study|Death|1|||
163085522|NCT01182350|589022313|FG003|Overall Study|Death|0|||
163033466|NCT02168777|588826594|FG002|Overall Study|Withdrawal by Subject|2|||
163033467|NCT02168777|588826592|FG000|Overall Study|Adverse Event|1|||
163085523|NCT01182350|589022314|FG004|Overall Study|Death|0|||
163085524|NCT01182350|589022310|FG000|Overall Study|Withdrawal by Subject|3|||
163085525|NCT01182350|589022311|FG001|Overall Study|Withdrawal by Subject|1|||
163085526|NCT01182350|589022312|FG002|Overall Study|Withdrawal by Subject|0|||
163085527|NCT01182350|589022313|FG003|Overall Study|Withdrawal by Subject|1|||
163085528|NCT01182350|589022314|FG004|Overall Study|Withdrawal by Subject|0|||
163085529|NCT01182350|589022310|FG000|Overall Study|Alternative Therapy|2|||
163085530|NCT01182350|589022311|FG001|Overall Study|Alternative Therapy|0|||
163085531|NCT01182350|589022312|FG002|Overall Study|Alternative Therapy|1|||
163085532|NCT01182350|589022313|FG003|Overall Study|Alternative Therapy|0|||
163085533|NCT01182350|589022314|FG004|Overall Study|Alternative Therapy|0|||
163085534|NCT01182350|589022310|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
163085535|NCT01182350|589022311|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
163085536|NCT01182350|589022312|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
163085537|NCT01182350|589022313|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
163085538|NCT01182350|589022314|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
163085539|NCT01182350|589022310|FG000|Overall Study|Unevaluable for Biopsy|0|||
163085540|NCT01182350|589022311|FG001|Overall Study|Unevaluable for Biopsy|0|||
163085541|NCT01182350|589022312|FG002|Overall Study|Unevaluable for Biopsy|0|||
163085542|NCT01182350|589022313|FG003|Overall Study|Unevaluable for Biopsy|0|||
163085543|NCT01182350|589022314|FG004|Overall Study|Unevaluable for Biopsy|3|||
163085544|NCT04023487|589022315|FG000|Overall Study|Lost to Follow-up|5|||
163033468|NCT02168777|588826593|FG001|Overall Study|Adverse Event|0|||
163033469|NCT02168777|588826594|FG002|Overall Study|Adverse Event|1|||
163033470|NCT02168777|588826592|FG000|Overall Study|Disease recurrence|0|||
163033471|NCT02168777|588826593|FG001|Overall Study|Disease recurrence|0|||
163033472|NCT02168777|588826594|FG002|Overall Study|Disease recurrence|1|||
163033473|NCT02168777|588826592|FG000|Overall Study|Radiological disease progression|0|||
163033474|NCT02168777|588826593|FG001|Overall Study|Radiological disease progression|5|||
163033475|NCT02168777|588826594|FG002|Overall Study|Radiological disease progression|5|||
163033476|NCT02168777|588826592|FG000|Overall Study|Clinical disease progression|0|||
163033477|NCT02168777|588826593|FG001|Overall Study|Clinical disease progression|1|||
163033478|NCT02168777|588826594|FG002|Overall Study|Clinical disease progression|2|||
163033479|NCT02168777|588826592|FG000|Overall Study|Other reason|0|||
163033480|NCT02168777|588826593|FG001|Overall Study|Other reason|1|||
163033481|NCT02168777|588826594|FG002|Overall Study|Other reason|0|||
163033482|NCT05243563|588826595|FG000|Overall Study|Withdrawal by Subject|1|||
163033483|NCT05243563|588826596|FG001|Overall Study|Withdrawal by Subject|0|||
163033484|NCT05243563|588826595|FG000|Overall Study|Physician Decision|1|||
163085545|NCT04023487|589022316|FG001|Overall Study|Lost to Follow-up|4|||
163085546|NCT04023487|589022315|FG000|Overall Study|Pregnancy|1|||
163085547|NCT04023487|589022316|FG001|Overall Study|Pregnancy|2|||
163085548|NCT04023487|589022315|FG000|Overall Study|Withdrawal by Subject|4|||
163085549|NCT04023487|589022316|FG001|Overall Study|Withdrawal by Subject|5|||
163085550|NCT04023487|589022315|FG000|Overall Study|Partially completed testing|8|||
163085551|NCT04023487|589022316|FG001|Overall Study|Partially completed testing|4|||
163085552|NCT00605189|589022317|FG000|Overall Study|Adverse Event|1|||
163085553|NCT00605189|589022318|FG001|Overall Study|Adverse Event|0|||
163085554|NCT00605189|589022319|FG002|Overall Study|Adverse Event|0|||
163085555|NCT00605189|589022317|FG000|Overall Study|Other|2|||
163085556|NCT00605189|589022318|FG001|Overall Study|Other|2|||
163085557|NCT00605189|589022319|FG002|Overall Study|Other|0|||
163033485|NCT05243563|588826596|FG001|Overall Study|Physician Decision|0|||
163085558|NCT03898180|589022320|FG000|Overall Study|Death|178|||
163085559|NCT03898180|589022321|FG001|Overall Study|Death|173|||
163085560|NCT03898180|589022320|FG000|Overall Study|Physician Decision|1|||
163085561|NCT03898180|589022321|FG001|Overall Study|Physician Decision|0|||
163085562|NCT03898180|589022320|FG000|Overall Study|Sponsor Decision|3|||
163085563|NCT03898180|589022321|FG001|Overall Study|Sponsor Decision|0|||
163085564|NCT03898180|589022320|FG000|Overall Study|Lost to Follow-up|1|||
163085565|NCT03898180|589022321|FG001|Overall Study|Lost to Follow-up|0|||
163085566|NCT03898180|589022320|FG000|Overall Study|Withdrawal by Subject|5|||
163085567|NCT03898180|589022321|FG001|Overall Study|Withdrawal by Subject|4|||
163085568|NCT05030766|589022323|FG000|Phase 1 Participants|Lost to Follow-up|12|||
163085569|NCT05030766|589022324|FG001|Phase 1 Participants|Lost to Follow-up|22|||
163085570|NCT05030766|589022325|FG002|Phase 1 Participants|Lost to Follow-up|0|||
163085571|NCT05030766|589022326|FG003|Phase 1 Participants|Lost to Follow-up|0|||
163085572|NCT05030766|589022323|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
163033486|NCT02437188|588826599|FG000|Overall Study|Randomized but did not receive surgery|4|||
163033487|NCT02437188|588826600|FG001|Overall Study|Randomized but did not receive surgery|8|||
163033488|NCT02437188|588826599|FG000|Overall Study|Adverse Event|0|||
163033489|NCT02437188|588826600|FG001|Overall Study|Adverse Event|1|||
163033490|NCT01663857|588826601|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
163033491|NCT01663857|588826602|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
163033492|NCT01663857|588826603|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
163033493|NCT01663857|588826604|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
163033494|NCT01663857|588826601|FG000|Overall Study|Lost to Follow-up|0|||
163033495|NCT01663857|588826602|FG001|Overall Study|Lost to Follow-up|0|||
163033496|NCT01663857|588826603|FG002|Overall Study|Lost to Follow-up|3|||
163033497|NCT01663857|588826604|FG003|Overall Study|Lost to Follow-up|1|||
163033498|NCT01172808|588826607|FG000|Overall Study|Adverse Event|8|||
163033499|NCT01172808|588826608|FG001|Overall Study|Adverse Event|4|||
163033500|NCT01172808|588826609|FG002|Overall Study|Adverse Event|8|||
163033501|NCT01172808|588826610|FG003|Overall Study|Adverse Event|3|||
163033502|NCT01172808|588826607|FG000|Overall Study|Lack of Efficacy|1|||
163033503|NCT01172808|588826608|FG001|Overall Study|Lack of Efficacy|0|||
163033504|NCT01172808|588826609|FG002|Overall Study|Lack of Efficacy|0|||
163033505|NCT01172808|588826610|FG003|Overall Study|Lack of Efficacy|0|||
163033506|NCT01172808|588826607|FG000|Overall Study|Protocol Violation|2|||
163033507|NCT01172808|588826608|FG001|Overall Study|Protocol Violation|2|||
163033508|NCT01172808|588826609|FG002|Overall Study|Protocol Violation|2|||
163033509|NCT01172808|588826610|FG003|Overall Study|Protocol Violation|0|||
163033510|NCT01172808|588826607|FG000|Overall Study|Lost to Follow-up|0|||
163033511|NCT01172808|588826608|FG001|Overall Study|Lost to Follow-up|1|||
163033512|NCT01172808|588826609|FG002|Overall Study|Lost to Follow-up|1|||
163033513|NCT01172808|588826610|FG003|Overall Study|Lost to Follow-up|3|||
163033514|NCT01172808|588826607|FG000|Overall Study|Withdrawal by Subject|4|||
163033515|NCT01172808|588826608|FG001|Overall Study|Withdrawal by Subject|1|||
163033516|NCT01172808|588826609|FG002|Overall Study|Withdrawal by Subject|3|||
163033517|NCT01172808|588826610|FG003|Overall Study|Withdrawal by Subject|2|||
163033518|NCT01172808|588826607|FG000|Overall Study|Other|6|||
163033519|NCT01172808|588826608|FG001|Overall Study|Other|5|||
163033520|NCT01172808|588826609|FG002|Overall Study|Other|9|||
163033521|NCT01172808|588826610|FG003|Overall Study|Other|7|||
163033522|NCT02578940|588826615|FG000|Overall Study|Screening failure|5|||
163033523|NCT02578940|588826615|FG000|Overall Study|Lost to Follow-up|1|||
163033524|NCT01911793|588826616|FG000|Overall Study|Physician Decision|1|||
163033525|NCT01911793|588826617|FG001|Overall Study|Physician Decision|5|||
163033526|NCT03959488|588826624|FG000|Season 1|Other|6|||
163033527|NCT03959488|588826625|FG001|Season 1|Other|7|||
163033528|NCT03959488|588826626|FG002|Season 1|Other|0|||
163033529|NCT03959488|588826627|FG003|Season 1|Other|0|||
163033530|NCT03959488|588826628|FG004|Season 1|Other|0|||
163033531|NCT03959488|588826624|FG000|Season 1|Withdrawal by parent/guardian|43|||
163033532|NCT03959488|588826625|FG001|Season 1|Withdrawal by parent/guardian|28|||
163033533|NCT03959488|588826626|FG002|Season 1|Withdrawal by parent/guardian|0|||
163033534|NCT03959488|588826627|FG003|Season 1|Withdrawal by parent/guardian|0|||
163033535|NCT03959488|588826628|FG004|Season 1|Withdrawal by parent/guardian|0|||
163033536|NCT03959488|588826624|FG000|Season 1|Due to COVID-19 pandemic|2|||
163033537|NCT03959488|588826625|FG001|Season 1|Due to COVID-19 pandemic|3|||
163033538|NCT03959488|588826626|FG002|Season 1|Due to COVID-19 pandemic|0|||
163033539|NCT03959488|588826627|FG003|Season 1|Due to COVID-19 pandemic|0|||
163033540|NCT03959488|588826628|FG004|Season 1|Due to COVID-19 pandemic|0|||
163033541|NCT03959488|588826624|FG000|Season 1|Lost to Follow-up|17|||
163033542|NCT03959488|588826625|FG001|Season 1|Lost to Follow-up|7|||
163033543|NCT03959488|588826626|FG002|Season 1|Lost to Follow-up|0|||
163033544|NCT03959488|588826627|FG003|Season 1|Lost to Follow-up|0|||
163085573|NCT05030766|589022324|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
163033545|NCT03959488|588826628|FG004|Season 1|Lost to Follow-up|0|||
163033546|NCT03959488|588826624|FG000|Season 1|Death|5|||
163033547|NCT03959488|588826625|FG001|Season 1|Death|1|||
163033548|NCT03959488|588826626|FG002|Season 1|Death|0|||
163033549|NCT03959488|588826627|FG003|Season 1|Death|0|||
163033550|NCT03959488|588826628|FG004|Season 1|Death|0|||
163033551|NCT03959488|588826624|FG000|Season 2|Other|0|||
163033552|NCT03959488|588826625|FG001|Season 2|Other|0|||
163033553|NCT03959488|588826626|FG002|Season 2|Other|2|||
163033554|NCT03959488|588826627|FG003|Season 2|Other|0|||
163033555|NCT03959488|588826628|FG004|Season 2|Other|0|||
163033556|NCT03959488|588826624|FG000|Season 2|Withdrawal by parent/guardian|0|||
163033557|NCT03959488|588826625|FG001|Season 2|Withdrawal by parent/guardian|0|||
163033558|NCT03959488|588826626|FG002|Season 2|Withdrawal by parent/guardian|3|||
163033559|NCT03959488|588826627|FG003|Season 2|Withdrawal by parent/guardian|1|||
163033560|NCT03959488|588826628|FG004|Season 2|Withdrawal by parent/guardian|1|||
163033561|NCT03959488|588826624|FG000|Season 2|Lost to Follow-up|0|||
163033562|NCT03959488|588826625|FG001|Season 2|Lost to Follow-up|0|||
163033563|NCT03959488|588826626|FG002|Season 2|Lost to Follow-up|1|||
163033564|NCT03959488|588826627|FG003|Season 2|Lost to Follow-up|0|||
163033565|NCT03959488|588826628|FG004|Season 2|Lost to Follow-up|1|||
163033566|NCT03341936|588826629|FG000|Overall Study|Ineligible|1|||
163033567|NCT03341936|588826629|FG000|Overall Study|Disease Progression|2|||
163033568|NCT03341936|588826629|FG000|Overall Study|Withdrew Consent|4|||
163033569|NCT03341936|588826629|FG000|Overall Study|Non-Compliance|1|||
163033570|NCT03341936|588826629|FG000|Overall Study|Physician Decision|1|||
163033571|NCT03341936|588826629|FG000|Overall Study|Withdrawal by Subject|1|||
163033572|NCT03341936|588826629|FG000|Overall Study|Other|1|||
163033573|NCT02542293|588826630|FG000|Overall Study|Death|367|||
163033574|NCT02542293|588826631|FG001|Overall Study|Death|377|||
163033575|NCT02542293|588826630|FG000|Overall Study|Withdrawal by Subject|8|||
163033576|NCT02542293|588826631|FG001|Overall Study|Withdrawal by Subject|19|||
163033577|NCT04529850|588826632|FG000|Overall Study|Death|2|||
163033578|NCT04529850|588826632|FG000|Overall Study|Physician Decision|1|||
163033579|NCT04529850|588826632|FG000|Overall Study|Withdrawal by Subject|2|||
163033580|NCT00593606|588826635|FG000|Overall Study|Adverse Event|13|||
163033581|NCT00593606|588826635|FG000|Overall Study|Withdrawal by Subject|1|||
163033582|NCT00593606|588826635|FG000|Overall Study|Protocol Violation|3|||
163033583|NCT00593606|588826635|FG000|Overall Study|Lost to Follow-up|2|||
163033584|NCT00593606|588826635|FG000|Overall Study|Run-In Failure|5|||
163033585|NCT00593606|588826635|FG000|Overall Study|Screen Failure|3|||
163033586|NCT00869557|588826638|FG000|Randomized Phase|Lost to Follow-up|2|||
163033587|NCT00869557|588826639|FG001|Randomized Phase|Lost to Follow-up|1|||
163033588|NCT00869557|588826638|FG000|Randomized Phase|Investigator's Discretion|1|||
163033589|NCT00869557|588826639|FG001|Randomized Phase|Investigator's Discretion|0|||
163033590|NCT00869557|588826638|FG000|Randomized Phase|Withdrew Consent|0|||
163033591|NCT00869557|588826639|FG001|Randomized Phase|Withdrew Consent|1|||
163033592|NCT00869557|588826638|FG000|Extension Phase|Adverse Event|2|||
163033593|NCT00869557|588826639|FG001|Extension Phase|Adverse Event|2|||
163033594|NCT00869557|588826638|FG000|Extension Phase|Lack of Efficacy|1|||
163033595|NCT00869557|588826639|FG001|Extension Phase|Lack of Efficacy|0|||
163033596|NCT00869557|588826638|FG000|Extension Phase|Lost to Follow-up|3|||
163033597|NCT00869557|588826639|FG001|Extension Phase|Lost to Follow-up|1|||
163033598|NCT00869557|588826638|FG000|Extension Phase|Investigator's Discretion|2|||
163033599|NCT00869557|588826639|FG001|Extension Phase|Investigator's Discretion|0|||
163033600|NCT00869557|588826638|FG000|Extension Phase|Withdrew Consent|2|||
163033601|NCT00869557|588826639|FG001|Extension Phase|Withdrew Consent|0|||
163033602|NCT01472939|588826640|FG000|Overall Study|Adverse Event|3|||
163033603|NCT01472939|588826641|FG001|Overall Study|Adverse Event|7|||
163033604|NCT01472939|588826642|FG002|Overall Study|Adverse Event|7|||
163033605|NCT01472939|588826643|FG003|Overall Study|Adverse Event|14|||
163033606|NCT01472939|588826640|FG000|Overall Study|Lack of Efficacy|1|||
163033607|NCT01472939|588826641|FG001|Overall Study|Lack of Efficacy|0|||
163033608|NCT01472939|588826642|FG002|Overall Study|Lack of Efficacy|0|||
163033609|NCT01472939|588826643|FG003|Overall Study|Lack of Efficacy|1|||
163033610|NCT01472939|588826640|FG000|Overall Study|Lost to Follow-up|3|||
163033611|NCT01472939|588826641|FG001|Overall Study|Lost to Follow-up|0|||
163033612|NCT01472939|588826642|FG002|Overall Study|Lost to Follow-up|2|||
163033613|NCT01472939|588826643|FG003|Overall Study|Lost to Follow-up|0|||
163033614|NCT01472939|588826640|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033615|NCT01472939|588826641|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033616|NCT01472939|588826642|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
163033617|NCT01472939|588826643|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
163033618|NCT01472939|588826640|FG000|Overall Study|Prohibited Medication|0|||
163033619|NCT01472939|588826641|FG001|Overall Study|Prohibited Medication|1|||
163033620|NCT01472939|588826642|FG002|Overall Study|Prohibited Medication|0|||
163033621|NCT01472939|588826643|FG003|Overall Study|Prohibited Medication|0|||
163033622|NCT01472939|588826640|FG000|Overall Study|Withdrawal By PI|1|||
163033623|NCT01472939|588826641|FG001|Overall Study|Withdrawal By PI|0|||
163033624|NCT01472939|588826642|FG002|Overall Study|Withdrawal By PI|0|||
163033625|NCT01472939|588826643|FG003|Overall Study|Withdrawal By PI|0|||
163033626|NCT01472939|588826640|FG000|Overall Study|Protocol Violation|3|||
163033627|NCT01472939|588826641|FG001|Overall Study|Protocol Violation|3|||
163033628|NCT01472939|588826642|FG002|Overall Study|Protocol Violation|0|||
163033629|NCT01472939|588826643|FG003|Overall Study|Protocol Violation|1|||
163033630|NCT01472939|588826640|FG000|Overall Study|Withdrawal by Subject|9|||
163033631|NCT01472939|588826641|FG001|Overall Study|Withdrawal by Subject|3|||
163033632|NCT01472939|588826642|FG002|Overall Study|Withdrawal by Subject|1|||
163033633|NCT01472939|588826643|FG003|Overall Study|Withdrawal by Subject|4|||
163033634|NCT00114738|588826644|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
163033635|NCT00114738|588826645|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
163033636|NCT00114738|588826646|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
163033637|NCT00114738|588826644|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
163033638|NCT00114738|588826645|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
163033639|NCT00114738|588826646|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
163033640|NCT00114738|588826644|FG000|Screening for Randomization|Neuropathy|17|||
163033641|NCT00114738|588826645|FG001|Screening for Randomization|Neuropathy|0|||
163033642|NCT00114738|588826646|FG002|Screening for Randomization|Neuropathy|0|||
163033643|NCT00114738|588826644|FG000|Screening for Randomization|Progressive disease|2|||
163033644|NCT00114738|588826645|FG001|Screening for Randomization|Progressive disease|0|||
163033645|NCT00114738|588826646|FG002|Screening for Randomization|Progressive disease|0|||
163033646|NCT00114738|588826644|FG000|Screening for Randomization|CNS Hemorrhage|1|||
163033647|NCT00114738|588826645|FG001|Screening for Randomization|CNS Hemorrhage|0|||
163033648|NCT00114738|588826646|FG002|Screening for Randomization|CNS Hemorrhage|0|||
163033649|NCT00114738|588826644|FG000|Screening for Randomization|Other|1|||
163033650|NCT00114738|588826645|FG001|Screening for Randomization|Other|0|||
163033651|NCT00114738|588826646|FG002|Screening for Randomization|Other|0|||
163033652|NCT05940077|588826647|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
163033653|NCT01492101|588826648|FG000|Overall Study|Death|323|||
163033654|NCT01492101|588826649|FG001|Overall Study|Death|322|||
163033655|NCT01492101|588826648|FG000|Overall Study|Withdrawal by Subject|14|||
163033656|NCT01492101|588826649|FG001|Overall Study|Withdrawal by Subject|18|||
163033657|NCT01492101|588826648|FG000|Overall Study|Lost to Follow-up|0|||
163033658|NCT01492101|588826649|FG001|Overall Study|Lost to Follow-up|2|||
163033659|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
163033660|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033661|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033662|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033663|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
163033664|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
162647690|NCT02039674|587426874|FG008|Overall Study|Lost to Follow-up|0|||
162647691|NCT02039674|587426875|FG009|Overall Study|Lost to Follow-up|0|||
162647692|NCT02039674|587426876|FG010|Overall Study|Lost to Follow-up|0|||
162647693|NCT02039674|587426877|FG011|Overall Study|Lost to Follow-up|2|||
162647694|NCT02039674|587426878|FG012|Overall Study|Lost to Follow-up|2|||
162647695|NCT02039674|587426879|FG013|Overall Study|Lost to Follow-up|1|||
162647696|NCT02039674|587426866|FG000|Overall Study|Physician Decision|0|||
162647697|NCT02039674|587426867|FG001|Overall Study|Physician Decision|0|||
162647698|NCT02039674|587426868|FG002|Overall Study|Physician Decision|0|||
162647699|NCT02039674|587426869|FG003|Overall Study|Physician Decision|0|||
162647700|NCT02039674|587426870|FG004|Overall Study|Physician Decision|0|||
162647701|NCT02039674|587426871|FG005|Overall Study|Physician Decision|0|||
162647702|NCT02039674|587426872|FG006|Overall Study|Physician Decision|0|||
162647703|NCT02039674|587426873|FG007|Overall Study|Physician Decision|0|||
162647704|NCT02039674|587426874|FG008|Overall Study|Physician Decision|0|||
162647705|NCT02039674|587426875|FG009|Overall Study|Physician Decision|0|||
162647706|NCT02039674|587426876|FG010|Overall Study|Physician Decision|0|||
162647707|NCT02039674|587426877|FG011|Overall Study|Physician Decision|1|||
162647708|NCT02039674|587426878|FG012|Overall Study|Physician Decision|1|||
162647709|NCT02039674|587426879|FG013|Overall Study|Physician Decision|0|||
163033665|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033666|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033667|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033668|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
163033669|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
163033670|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
162647710|NCT02039674|587426866|FG000|Overall Study|Progressive Disease|8|||
162647711|NCT02039674|587426867|FG001|Overall Study|Progressive Disease|8|||
162647712|NCT02039674|587426868|FG002|Overall Study|Progressive Disease|6|||
162647713|NCT02039674|587426869|FG003|Overall Study|Progressive Disease|7|||
162647714|NCT02039674|587426870|FG004|Overall Study|Progressive Disease|9|||
162647715|NCT02039674|587426871|FG005|Overall Study|Progressive Disease|10|||
162647716|NCT02039674|587426872|FG006|Overall Study|Progressive Disease|1|||
162647717|NCT02039674|587426873|FG007|Overall Study|Progressive Disease|3|||
163033671|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163085574|NCT05030766|589022325|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
163033672|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
162647718|NCT02039674|587426874|FG008|Overall Study|Progressive Disease|6|||
162647719|NCT02039674|587426875|FG009|Overall Study|Progressive Disease|4|||
162647720|NCT02039674|587426876|FG010|Overall Study|Progressive Disease|0|||
162647721|NCT02039674|587426877|FG011|Overall Study|Progressive Disease|34|||
162647722|NCT02039674|587426878|FG012|Overall Study|Progressive Disease|34|||
162647723|NCT02039674|587426879|FG013|Overall Study|Progressive Disease|18|||
162647724|NCT02039674|587426866|FG000|Overall Study|Withdrawal by Subject|1|||
162647725|NCT02039674|587426867|FG001|Overall Study|Withdrawal by Subject|2|||
162647726|NCT02039674|587426868|FG002|Overall Study|Withdrawal by Subject|3|||
162647727|NCT02039674|587426869|FG003|Overall Study|Withdrawal by Subject|0|||
162647728|NCT02039674|587426870|FG004|Overall Study|Withdrawal by Subject|1|||
162647729|NCT02039674|587426871|FG005|Overall Study|Withdrawal by Subject|0|||
162647730|NCT02039674|587426872|FG006|Overall Study|Withdrawal by Subject|0|||
162647731|NCT02039674|587426873|FG007|Overall Study|Withdrawal by Subject|0|||
162647732|NCT02039674|587426874|FG008|Overall Study|Withdrawal by Subject|0|||
162647733|NCT02039674|587426875|FG009|Overall Study|Withdrawal by Subject|1|||
162647734|NCT02039674|587426876|FG010|Overall Study|Withdrawal by Subject|1|||
162647735|NCT02039674|587426877|FG011|Overall Study|Withdrawal by Subject|4|||
162647736|NCT02039674|587426878|FG012|Overall Study|Withdrawal by Subject|6|||
162647737|NCT02039674|587426879|FG013|Overall Study|Withdrawal by Subject|2|||
162647738|NCT02039674|587426866|FG000|Overall Study|Clinical Progression|0|||
162647739|NCT02039674|587426867|FG001|Overall Study|Clinical Progression|0|||
162647740|NCT02039674|587426868|FG002|Overall Study|Clinical Progression|0|||
162647741|NCT02039674|587426869|FG003|Overall Study|Clinical Progression|0|||
162647742|NCT02039674|587426870|FG004|Overall Study|Clinical Progression|0|||
162647743|NCT02039674|587426871|FG005|Overall Study|Clinical Progression|0|||
162647744|NCT02039674|587426872|FG006|Overall Study|Clinical Progression|1|||
162647745|NCT02039674|587426873|FG007|Overall Study|Clinical Progression|0|||
162647746|NCT02039674|587426874|FG008|Overall Study|Clinical Progression|0|||
162647747|NCT02039674|587426875|FG009|Overall Study|Clinical Progression|0|||
162647748|NCT02039674|587426876|FG010|Overall Study|Clinical Progression|0|||
162647749|NCT02039674|587426877|FG011|Overall Study|Clinical Progression|0|||
162647750|NCT02039674|587426878|FG012|Overall Study|Clinical Progression|1|||
162647751|NCT02039674|587426879|FG013|Overall Study|Clinical Progression|0|||
162647752|NCT02039674|587426866|FG000|Overall Study|Sponsor Decision|1|||
162647753|NCT02039674|587426867|FG001|Overall Study|Sponsor Decision|1|||
162647754|NCT02039674|587426868|FG002|Overall Study|Sponsor Decision|1|||
162647755|NCT02039674|587426869|FG003|Overall Study|Sponsor Decision|1|||
162647756|NCT02039674|587426870|FG004|Overall Study|Sponsor Decision|1|||
162647757|NCT02039674|587426871|FG005|Overall Study|Sponsor Decision|0|||
162647758|NCT02039674|587426872|FG006|Overall Study|Sponsor Decision|0|||
162647759|NCT02039674|587426873|FG007|Overall Study|Sponsor Decision|0|||
162647760|NCT02039674|587426874|FG008|Overall Study|Sponsor Decision|0|||
162647761|NCT02039674|587426875|FG009|Overall Study|Sponsor Decision|3|||
162647762|NCT02039674|587426876|FG010|Overall Study|Sponsor Decision|0|||
162647763|NCT02039674|587426877|FG011|Overall Study|Sponsor Decision|8|||
162647764|NCT02039674|587426878|FG012|Overall Study|Sponsor Decision|5|||
162647765|NCT02039674|587426879|FG013|Overall Study|Sponsor Decision|0|||
162647766|NCT02039674|587426866|FG000|Overall Study|Other|0|||
162647767|NCT02039674|587426867|FG001|Overall Study|Other|0|||
162647768|NCT02039674|587426868|FG002|Overall Study|Other|0|||
162647769|NCT02039674|587426869|FG003|Overall Study|Other|0|||
162647770|NCT02039674|587426870|FG004|Overall Study|Other|0|||
162647771|NCT02039674|587426871|FG005|Overall Study|Other|0|||
162647772|NCT02039674|587426872|FG006|Overall Study|Other|0|||
162647773|NCT02039674|587426873|FG007|Overall Study|Other|0|||
162647774|NCT02039674|587426874|FG008|Overall Study|Other|0|||
162647775|NCT02039674|587426875|FG009|Overall Study|Other|0|||
162647776|NCT02039674|587426876|FG010|Overall Study|Other|0|||
162647777|NCT02039674|587426877|FG011|Overall Study|Other|0|||
162647778|NCT02039674|587426878|FG012|Overall Study|Other|1|||
162647779|NCT02039674|587426879|FG013|Overall Study|Other|0|||
162647780|NCT01358357|587426880|FG000|Open Label Phase|Adverse Event|0|||
163033673|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
163033674|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
163033675|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163033676|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
162647781|NCT01358357|587426881|FG001|Open Label Phase|Adverse Event|0|||
162647782|NCT01358357|587426882|FG002|Open Label Phase|Adverse Event|59|||
162647783|NCT01358357|587426880|FG000|Open Label Phase|Lack of Efficacy|0|||
162647784|NCT01358357|587426881|FG001|Open Label Phase|Lack of Efficacy|0|||
162647785|NCT01358357|587426882|FG002|Open Label Phase|Lack of Efficacy|107|||
162647786|NCT01358357|587426880|FG000|Open Label Phase|Lost to Follow-up|0|||
162647787|NCT01358357|587426881|FG001|Open Label Phase|Lost to Follow-up|0|||
163033677|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
162647788|NCT01358357|587426882|FG002|Open Label Phase|Lost to Follow-up|76|||
162647789|NCT01358357|587426880|FG000|Open Label Phase|Protocol Violation|0|||
162647790|NCT01358357|587426881|FG001|Open Label Phase|Protocol Violation|0|||
162647791|NCT01358357|587426882|FG002|Open Label Phase|Protocol Violation|45|||
162647792|NCT01358357|587426880|FG000|Open Label Phase|Withdrawal by Subject|0|||
163033678|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
163033679|NCT01004432|588826650|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
163033680|NCT01004432|588826651|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
162647793|NCT01358357|587426881|FG001|Open Label Phase|Withdrawal by Subject|0|||
162647794|NCT01358357|587426882|FG002|Open Label Phase|Withdrawal by Subject|112|||
162647795|NCT01358357|587426880|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
162647796|NCT01358357|587426881|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
162647797|NCT01358357|587426882|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
162647798|NCT01358357|587426880|FG000|Open Label Phase|Terminated at study completion|0|||
162647799|NCT01358357|587426881|FG001|Open Label Phase|Terminated at study completion|0|||
162647800|NCT01358357|587426882|FG002|Open Label Phase|Terminated at study completion|5|||
162647801|NCT01358357|587426880|FG000|Open Label Phase|Mood episode|0|||
162647802|NCT01358357|587426881|FG001|Open Label Phase|Mood episode|0|||
162647803|NCT01358357|587426882|FG002|Open Label Phase|Mood episode|42|||
162647804|NCT01358357|587426880|FG000|Double-Blind Phase|Adverse Event|8|||
162647805|NCT01358357|587426881|FG001|Double-Blind Phase|Adverse Event|5|||
162647806|NCT01358357|587426882|FG002|Double-Blind Phase|Adverse Event|0|||
162647807|NCT01358357|587426880|FG000|Double-Blind Phase|Lost to Follow-up|5|||
162647808|NCT01358357|587426881|FG001|Double-Blind Phase|Lost to Follow-up|7|||
162647809|NCT01358357|587426882|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162647810|NCT01358357|587426880|FG000|Double-Blind Phase|Protocol Violation|1|||
162647811|NCT01358357|587426881|FG001|Double-Blind Phase|Protocol Violation|11|||
162647812|NCT01358357|587426882|FG002|Double-Blind Phase|Protocol Violation|0|||
162647813|NCT01358357|587426880|FG000|Double-Blind Phase|Protocol Violation|16|||
162647814|NCT01358357|587426881|FG001|Double-Blind Phase|Protocol Violation|12|||
162647815|NCT01358357|587426882|FG002|Double-Blind Phase|Protocol Violation|0|||
162647816|NCT01358357|587426880|FG000|Double-Blind Phase|Terminated at study completion|2|||
162647817|NCT01358357|587426881|FG001|Double-Blind Phase|Terminated at study completion|0|||
162647818|NCT01358357|587426882|FG002|Double-Blind Phase|Terminated at study completion|0|||
162647819|NCT01358357|587426880|FG000|Double-Blind Phase|Recurrence of mood event|48|||
162647820|NCT01358357|587426881|FG001|Double-Blind Phase|Recurrence of mood event|64|||
162647821|NCT01358357|587426882|FG002|Double-Blind Phase|Recurrence of mood event|0|||
162647822|NCT01358357|587426880|FG000|Double-Blind Phase|Administrative|0|||
162647823|NCT01358357|587426881|FG001|Double-Blind Phase|Administrative|1|||
162647824|NCT01358357|587426882|FG002|Double-Blind Phase|Administrative|0|||
162647825|NCT03774433|587426887|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
162647826|NCT00108160|587426888|FG000|Overall Study|Lost to Follow-up|25|||
162647827|NCT00108160|587426889|FG001|Overall Study|Lost to Follow-up|12|||
162647828|NCT00108160|587426888|FG000|Overall Study|Death|1|||
162647829|NCT00108160|587426889|FG001|Overall Study|Death|2|||
162647830|NCT00108160|587426888|FG000|Overall Study|Withdrawal by Subject|4|||
162647831|NCT00108160|587426889|FG001|Overall Study|Withdrawal by Subject|2|||
162647832|NCT00108160|587426888|FG000|Overall Study|Protocol Violation|9|||
162647833|NCT00108160|587426889|FG001|Overall Study|Protocol Violation|5|||
162647834|NCT02081079|587426890|FG000|Overall Study|Lack of Efficacy|3|||
162647835|NCT02081079|587426891|FG001|Overall Study|Lack of Efficacy|2|||
162647836|NCT02081079|587426890|FG000|Overall Study|Lost to Follow-up|1|||
162647837|NCT02081079|587426891|FG001|Overall Study|Lost to Follow-up|0|||
162647838|NCT01712854|587426892|FG000|Overall Study|Physician Decision|1|||
162647839|NCT00768144|587426893|FG000|Overall Study|Adverse Event|13|||
162647840|NCT00768144|587426893|FG000|Overall Study|Progressive Disease|21|||
162647841|NCT00768144|587426893|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
162647842|NCT00768144|587426893|FG000|Overall Study|Pt Withdrew Consent|1|||
162647843|NCT01150123|587426894|FG000|Overall Study|Withdrawal by Subject|1|||
162647844|NCT01150123|587426895|FG001|Overall Study|Withdrawal by Subject|1|||
162647845|NCT01150123|587426896|FG002|Overall Study|Withdrawal by Subject|2|||
162647846|NCT01150123|587426897|FG003|Overall Study|Withdrawal by Subject|1|||
162647847|NCT01150123|587426898|FG004|Overall Study|Withdrawal by Subject|1|||
162647848|NCT01150123|587426899|FG005|Overall Study|Withdrawal by Subject|1|||
162647849|NCT01150123|587426900|FG006|Overall Study|Withdrawal by Subject|0|||
162647850|NCT01150123|587426901|FG007|Overall Study|Withdrawal by Subject|3|||
162647851|NCT01150123|587426902|FG008|Overall Study|Withdrawal by Subject|2|||
162647852|NCT01150123|587426903|FG009|Overall Study|Withdrawal by Subject|0|||
162647853|NCT01150123|587426904|FG010|Overall Study|Withdrawal by Subject|1|||
162647854|NCT01150123|587426905|FG011|Overall Study|Withdrawal by Subject|0|||
162647855|NCT01150123|587426906|FG012|Overall Study|Withdrawal by Subject|1|||
162647856|NCT01150123|587426907|FG013|Overall Study|Withdrawal by Subject|0|||
162647857|NCT01150123|587426908|FG014|Overall Study|Withdrawal by Subject|0|||
163033681|NCT01004432|588826652|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
162647858|NCT01150123|587426909|FG015|Overall Study|Withdrawal by Subject|1|||
162647859|NCT01150123|587426910|FG016|Overall Study|Withdrawal by Subject|0|||
162647860|NCT01150123|587426911|FG017|Overall Study|Withdrawal by Subject|1|||
162647861|NCT01150123|587426894|FG000|Overall Study|Lost to Follow-up|2|||
162647862|NCT01150123|587426895|FG001|Overall Study|Lost to Follow-up|1|||
162647863|NCT01150123|587426896|FG002|Overall Study|Lost to Follow-up|2|||
163033682|NCT01004432|588826653|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163033683|NCT01004432|588826654|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
163033684|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
163033685|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
163033686|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
163033687|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
163033688|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
163033689|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
163033690|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
163033691|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
163033692|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
163033693|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
163033694|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
163033695|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
163033696|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
163033697|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
163033698|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
163033699|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033700|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033701|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033702|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
163033703|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
163033704|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
163033705|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
163033706|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
163033707|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
163033708|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
163033709|NCT01004432|588826650|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
163033710|NCT01004432|588826651|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
163033711|NCT01004432|588826652|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
163033712|NCT01004432|588826653|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
163033713|NCT01004432|588826654|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
163033714|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033715|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033716|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033717|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
163033718|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
163033719|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033720|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033721|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033722|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
163033723|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
163033724|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033725|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033726|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033727|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
163033728|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
163033729|NCT01004432|588826650|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033730|NCT01004432|588826651|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033731|NCT01004432|588826652|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033732|NCT01004432|588826653|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
163033733|NCT01004432|588826654|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
163033734|NCT01149421|588826656|FG000|Overall Study|Adverse Event|22|||
162647864|NCT01150123|587426897|FG003|Overall Study|Lost to Follow-up|2|||
163033735|NCT01149421|588826657|FG001|Overall Study|Adverse Event|6|||
163033736|NCT01149421|588826658|FG002|Overall Study|Adverse Event|11|||
163033737|NCT01149421|588826656|FG000|Overall Study|Withdrawal by Subject|20|||
163033738|NCT01149421|588826657|FG001|Overall Study|Withdrawal by Subject|12|||
163033739|NCT01149421|588826658|FG002|Overall Study|Withdrawal by Subject|13|||
163033740|NCT01149421|588826656|FG000|Overall Study|Sponsor Decision|0|||
163033741|NCT01149421|588826657|FG001|Overall Study|Sponsor Decision|1|||
163033742|NCT01149421|588826658|FG002|Overall Study|Sponsor Decision|1|||
163033743|NCT01149421|588826656|FG000|Overall Study|Lost to Follow-up|2|||
163033744|NCT01149421|588826657|FG001|Overall Study|Lost to Follow-up|4|||
163033745|NCT01149421|588826658|FG002|Overall Study|Lost to Follow-up|5|||
162647865|NCT01150123|587426898|FG004|Overall Study|Lost to Follow-up|2|||
162647866|NCT01150123|587426899|FG005|Overall Study|Lost to Follow-up|5|||
162647867|NCT01150123|587426900|FG006|Overall Study|Lost to Follow-up|0|||
162647868|NCT01150123|587426901|FG007|Overall Study|Lost to Follow-up|0|||
162647869|NCT01150123|587426902|FG008|Overall Study|Lost to Follow-up|3|||
162647870|NCT01150123|587426903|FG009|Overall Study|Lost to Follow-up|1|||
162647871|NCT01150123|587426904|FG010|Overall Study|Lost to Follow-up|1|||
162647872|NCT01150123|587426905|FG011|Overall Study|Lost to Follow-up|1|||
163033746|NCT01149421|588826656|FG000|Overall Study|Physician Decision|5|||
163033747|NCT01149421|588826657|FG001|Overall Study|Physician Decision|3|||
163033748|NCT01149421|588826658|FG002|Overall Study|Physician Decision|6|||
163033749|NCT01149421|588826656|FG000|Overall Study|Entry Criteria Not Met|1|||
163033750|NCT01149421|588826657|FG001|Overall Study|Entry Criteria Not Met|1|||
163033751|NCT01149421|588826658|FG002|Overall Study|Entry Criteria Not Met|2|||
163033752|NCT01149421|588826656|FG000|Overall Study|Protocol Violation|2|||
163033753|NCT01149421|588826657|FG001|Overall Study|Protocol Violation|2|||
163033754|NCT01149421|588826658|FG002|Overall Study|Protocol Violation|6|||
163033755|NCT03738800|588826661|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
163033756|NCT03738800|588826662|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163033757|NCT03738800|588826663|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163033758|NCT03738800|588826661|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
163033759|NCT03738800|588826662|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
163033760|NCT03738800|588826663|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
163033761|NCT03738800|588826661|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
163033762|NCT03738800|588826662|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163033763|NCT03738800|588826663|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163033764|NCT02223819|588826666|FG000|Overall Study|Lost to Follow-up|2|||
163033765|NCT01917344|588826668|FG000|Overall Study|Withdrawal by Subject|1|||
163033766|NCT03435224|588826669|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
163033767|NCT00367484|588826670|FG000|Overall Study|Adverse Event|7|||
163033768|NCT00367484|588826670|FG000|Overall Study|Withdrew informed consent|5|||
163033769|NCT00367484|588826670|FG000|Overall Study|Travel to USA|1|||
163033770|NCT00367484|588826670|FG000|Overall Study|Lost to Follow-up|1|||
163033771|NCT00367484|588826670|FG000|Overall Study|Protocol Violation|1|||
163033772|NCT00367484|588826670|FG000|Overall Study|The choice of the patient|1|||
163033773|NCT00367484|588826670|FG000|Overall Study|Lack of Efficacy|1|||
163033774|NCT01777295|588826671|FG000|Overall Study|Withdrawal by Subject|2|||
163033775|NCT01777295|588826672|FG001|Overall Study|Withdrawal by Subject|2|||
163033776|NCT01777295|588826671|FG000|Overall Study|Pregnancy|0|||
163033777|NCT01777295|588826672|FG001|Overall Study|Pregnancy|1|||
163033778|NCT01777295|588826671|FG000|Overall Study|Personal problem|1|||
163033779|NCT01777295|588826672|FG001|Overall Study|Personal problem|0|||
163033780|NCT01777295|588826671|FG000|Overall Study|Investigator call for AEs check|1|||
163033781|NCT01777295|588826672|FG001|Overall Study|Investigator call for AEs check|0|||
163033782|NCT00412217|588826673|FG000|Overall Study|Insufficient Data Available|8|||
163033783|NCT00412217|588826674|FG001|Overall Study|Insufficient Data Available|3|||
163033784|NCT00412217|588826673|FG000|Overall Study|Death|5|||
163033785|NCT00412217|588826674|FG001|Overall Study|Death|4|||
163033786|NCT00412217|588826673|FG000|Overall Study|Disease Progression|2|||
163033787|NCT00412217|588826674|FG001|Overall Study|Disease Progression|3|||
163033788|NCT00412217|588826673|FG000|Overall Study|Investigator Decision|1|||
163033789|NCT00412217|588826674|FG001|Overall Study|Investigator Decision|0|||
163033790|NCT00412217|588826673|FG000|Overall Study|Withdrawal by Subject|2|||
163033791|NCT00412217|588826674|FG001|Overall Study|Withdrawal by Subject|0|||
163033792|NCT00412217|588826673|FG000|Overall Study|Lost to Follow-up|1|||
163033793|NCT00412217|588826674|FG001|Overall Study|Lost to Follow-up|4|||
163033794|NCT00412217|588826673|FG000|Overall Study|Study Terminated by Sponsor|26|||
163033795|NCT00412217|588826674|FG001|Overall Study|Study Terminated by Sponsor|33|||
163033796|NCT00412217|588826673|FG000|Overall Study|Other|1|||
163033797|NCT00412217|588826674|FG001|Overall Study|Other|1|||
163033798|NCT02609724|588826675|FG000|Overall Study|Death|2|||
163033799|NCT02609724|588826676|FG001|Overall Study|Death|0|||
163033800|NCT02609724|588826677|FG002|Overall Study|Death|1|||
163033801|NCT02609724|588826675|FG000|Overall Study|Withdrawal by Subject|1|||
163033802|NCT02609724|588826676|FG001|Overall Study|Withdrawal by Subject|2|||
163033803|NCT02609724|588826677|FG002|Overall Study|Withdrawal by Subject|3|||
163033804|NCT02609724|588826675|FG000|Overall Study|Illness|2|||
163033805|NCT02609724|588826676|FG001|Overall Study|Illness|1|||
163033806|NCT02609724|588826677|FG002|Overall Study|Illness|0|||
163033807|NCT04007107|588826682|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033808|NCT04007107|588826683|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
163154806|NCT04123470|589281443|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
162647873|NCT01150123|587426906|FG012|Overall Study|Lost to Follow-up|2|||
162647874|NCT01150123|587426907|FG013|Overall Study|Lost to Follow-up|0|||
162647875|NCT01150123|587426908|FG014|Overall Study|Lost to Follow-up|0|||
163033809|NCT04007107|588826684|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033810|NCT04007107|588826685|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
163033811|NCT00426660|588826691|FG000|Overall Study|Death|14|||
163033812|NCT00426660|588826691|FG000|Overall Study|Adverse Event|23|||
163033813|NCT00426660|588826691|FG000|Overall Study|Insufficient Clinical Response|22|||
162647876|NCT01150123|587426909|FG015|Overall Study|Lost to Follow-up|0|||
162647877|NCT01150123|587426910|FG016|Overall Study|Lost to Follow-up|0|||
162647878|NCT01150123|587426911|FG017|Overall Study|Lost to Follow-up|0|||
162647879|NCT02171260|587426914|FG000|Overall Study|Death|0|||
162647880|NCT02171260|587426915|FG001|Overall Study|Death|0|||
162647881|NCT02171260|587426916|FG002|Overall Study|Death|0|||
162647882|NCT02171260|587426917|FG003|Overall Study|Death|1|||
162647883|NCT02171260|587426914|FG000|Overall Study|Physician Decision|1|||
162647884|NCT02171260|587426915|FG001|Overall Study|Physician Decision|0|||
162647885|NCT02171260|587426916|FG002|Overall Study|Physician Decision|1|||
162647886|NCT02171260|587426917|FG003|Overall Study|Physician Decision|0|||
162647887|NCT02171260|587426914|FG000|Overall Study|Withdrawal by Subject|1|||
162647888|NCT02171260|587426915|FG001|Overall Study|Withdrawal by Subject|0|||
162647889|NCT02171260|587426916|FG002|Overall Study|Withdrawal by Subject|0|||
162647890|NCT02171260|587426917|FG003|Overall Study|Withdrawal by Subject|0|||
162647891|NCT02171260|587426914|FG000|Overall Study|Evidence of progressive disease|4|||
162647892|NCT02171260|587426915|FG001|Overall Study|Evidence of progressive disease|6|||
162647893|NCT02171260|587426916|FG002|Overall Study|Evidence of progressive disease|4|||
162647894|NCT02171260|587426917|FG003|Overall Study|Evidence of progressive disease|4|||
162647895|NCT00322842|587426920|FG000|Overall Study|Withdrawal by Subject|0|||
162647896|NCT00322842|587426921|FG001|Overall Study|Withdrawal by Subject|1|||
162647897|NCT00322842|587426920|FG000|Overall Study|Lost to Follow-up|0|||
162647898|NCT00322842|587426921|FG001|Overall Study|Lost to Follow-up|1|||
162647899|NCT00322842|587426920|FG000|Overall Study|Refused transplant|1|||
162647900|NCT00322842|587426921|FG001|Overall Study|Refused transplant|0|||
162647901|NCT00322842|587426920|FG000|Overall Study|Death|1|||
162647902|NCT00322842|587426921|FG001|Overall Study|Death|0|||
162647903|NCT00323492|587426922|FG000|Study Phase 1|Adverse Event|2|||
162647904|NCT00323492|587426923|FG001|Study Phase 1|Adverse Event|0|||
162647905|NCT00323492|587426924|FG002|Study Phase 1|Adverse Event|0|||
162647906|NCT00323492|587426922|FG000|Study Phase 2|Adverse Event|1|||
162647907|NCT00323492|587426923|FG001|Study Phase 2|Adverse Event|0|||
162647908|NCT00323492|587426924|FG002|Study Phase 2|Adverse Event|0|||
162647909|NCT00323492|587426922|FG000|Study Phase 2|Physician Decision|1|||
162647910|NCT00323492|587426923|FG001|Study Phase 2|Physician Decision|0|||
162647911|NCT00323492|587426924|FG002|Study Phase 2|Physician Decision|0|||
162647912|NCT00323492|587426922|FG000|Study Phase 2|Lost to Follow-up|1|||
162647913|NCT00323492|587426923|FG001|Study Phase 2|Lost to Follow-up|0|||
162647914|NCT00323492|587426924|FG002|Study Phase 2|Lost to Follow-up|0|||
162647915|NCT00323492|587426922|FG000|Study Phase 2|Withdrawal by Subject|0|||
162647916|NCT00323492|587426923|FG001|Study Phase 2|Withdrawal by Subject|1|||
162647917|NCT00323492|587426924|FG002|Study Phase 2|Withdrawal by Subject|0|||
162647918|NCT00323492|587426922|FG000|Study Phase 2|Noncompliance with study schedule|0|||
162647919|NCT00323492|587426923|FG001|Study Phase 2|Noncompliance with study schedule|0|||
162647920|NCT00323492|587426924|FG002|Study Phase 2|Noncompliance with study schedule|1|||
162647921|NCT00323492|587426922|FG000|Study Phase 2|Protocol Violation|1|||
162647922|NCT00323492|587426923|FG001|Study Phase 2|Protocol Violation|0|||
162647923|NCT00323492|587426924|FG002|Study Phase 2|Protocol Violation|0|||
162647924|NCT03082599|587426925|FG000|Overall Study|Lost to Follow-up|1|||
162647925|NCT03082599|587426926|FG001|Overall Study|Lost to Follow-up|0|||
162647926|NCT02486042|587426927|FG000|Overall Study|Physician Decision|1|||
162647927|NCT02486042|587426928|FG001|Overall Study|Physician Decision|7|||
162647928|NCT02486042|587426927|FG000|Overall Study|Hospital transfer|2|||
163033814|NCT00426660|588826691|FG000|Overall Study|Lost to Follow-up|15|||
162647929|NCT02486042|587426928|FG001|Overall Study|Hospital transfer|2|||
162647930|NCT02486042|587426927|FG000|Overall Study|Withdrawal by Subject|0|||
162647931|NCT02486042|587426928|FG001|Overall Study|Withdrawal by Subject|2|||
162647932|NCT01466387|587426929|FG000|Overall Study|Adverse Event|0|||
162647933|NCT01466387|587426930|FG001|Overall Study|Adverse Event|0|||
162647934|NCT01466387|587426931|FG002|Overall Study|Adverse Event|1|||
162647935|NCT01466387|587426932|FG003|Overall Study|Adverse Event|1|||
162647936|NCT01466387|587426933|FG004|Overall Study|Adverse Event|0|||
162647937|NCT01466387|587426934|FG005|Overall Study|Adverse Event|0|||
162647938|NCT01466387|587426929|FG000|Overall Study|Lost to Follow-up|0|||
162718156|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162647939|NCT01466387|587426930|FG001|Overall Study|Lost to Follow-up|0|||
162647940|NCT01466387|587426931|FG002|Overall Study|Lost to Follow-up|0|||
162647941|NCT01466387|587426932|FG003|Overall Study|Lost to Follow-up|0|||
162718157|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163033815|NCT00426660|588826691|FG000|Overall Study|Other|23|||
163033816|NCT00426660|588826691|FG000|Overall Study|Withdrawal by Subject|18|||
163033817|NCT00426660|588826691|FG000|Overall Study|Protocol Violation|1|||
163033818|NCT00426660|588826691|FG000|Overall Study|Enrolled Not Treated|15|||
162647942|NCT01466387|587426933|FG004|Overall Study|Lost to Follow-up|0|||
162647943|NCT01466387|587426934|FG005|Overall Study|Lost to Follow-up|1|||
162647944|NCT01466387|587426929|FG000|Overall Study|Protocol Violation|1|||
162647945|NCT01466387|587426930|FG001|Overall Study|Protocol Violation|0|||
163033819|NCT03114657|588826692|FG000|Overall Study|Adverse Event|9|||
163033820|NCT03114657|588826693|FG001|Overall Study|Adverse Event|6|||
163033821|NCT03114657|588826692|FG000|Overall Study|Death|4|||
162647946|NCT01466387|587426931|FG002|Overall Study|Protocol Violation|0|||
162647947|NCT01466387|587426932|FG003|Overall Study|Protocol Violation|1|||
162647948|NCT01466387|587426933|FG004|Overall Study|Protocol Violation|0|||
162647949|NCT01466387|587426934|FG005|Overall Study|Protocol Violation|0|||
162647950|NCT00832585|587426945|FG000|Overall Study|Withdrawal by Subject|1|||
162647951|NCT00832585|587426945|FG000|Overall Study|Lost to Follow-up|1|||
162647952|NCT00673179|587426947|FG000|Overall Study|Toxicity/Complications|3|||
162647953|NCT00673179|587426948|FG001|Overall Study|Toxicity/Complications|0|||
162647954|NCT00352846|587426949|FG000|Overall Study|Disease progression|0|||
162647955|NCT00352846|587426950|FG001|Overall Study|Disease progression|2|||
162647956|NCT00352846|587426949|FG000|Overall Study|Withdrawal by Subject|3|||
162647957|NCT00352846|587426950|FG001|Overall Study|Withdrawal by Subject|8|||
162647958|NCT00352846|587426949|FG000|Overall Study|Ineligible|3|||
162647959|NCT00352846|587426950|FG001|Overall Study|Ineligible|2|||
162647960|NCT00352846|587426949|FG000|Overall Study|Non-compliance|2|||
162647961|NCT00352846|587426950|FG001|Overall Study|Non-compliance|0|||
162647962|NCT00352846|587426949|FG000|Overall Study|Death|0|||
162647963|NCT00352846|587426950|FG001|Overall Study|Death|1|||
162647964|NCT00281684|587426951|FG000|Overall Study|Lost to Follow-up|0|||
162647965|NCT00281684|587426952|FG001|Overall Study|Lost to Follow-up|0|||
162647966|NCT00281684|587426953|FG002|Overall Study|Lost to Follow-up|1|||
162647967|NCT00281684|587426954|FG003|Overall Study|Lost to Follow-up|0|||
162647968|NCT00281684|587426951|FG000|Overall Study|Withdrawal by Subject|1|||
162647969|NCT00281684|587426952|FG001|Overall Study|Withdrawal by Subject|0|||
162647970|NCT00281684|587426953|FG002|Overall Study|Withdrawal by Subject|0|||
162647971|NCT00281684|587426954|FG003|Overall Study|Withdrawal by Subject|0|||
162647972|NCT01531387|587426958|FG000|Overall Study|Early termination of study|11|||
162647973|NCT01531387|587426959|FG001|Overall Study|Early termination of study|11|||
162647974|NCT00578942|587426960|FG000|Overall Study|Lost to Follow-up|1|||
162647975|NCT01124643|587426963|FG000|Overall Study|Death|1|||
162647976|NCT04220411|587426964|FG000|Overall Study|Adverse Event|0|||
162647977|NCT04220411|587426965|FG001|Overall Study|Adverse Event|0|||
162647978|NCT04220411|587426966|FG002|Overall Study|Adverse Event|0|||
162647979|NCT04220411|587426967|FG003|Overall Study|Adverse Event|1|||
162647980|NCT00403273|587428340|FG000|Overall Study|Lost to Follow-up|3|||
162647981|NCT00403273|587428341|FG001|Overall Study|Lost to Follow-up|2|||
162647982|NCT00403273|587428340|FG000|Overall Study|Physician Decision|0|||
162647983|NCT00403273|587428341|FG001|Overall Study|Physician Decision|1|||
162647984|NCT00403273|587428340|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
162647985|NCT00403273|587428341|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
162647986|NCT03256552|587428346|FG000|Overall Study|Protocol Violation|1|||
162647987|NCT03256552|587428346|FG000|Overall Study|Physician Decision|1|||
162647988|NCT03256552|587428346|FG000|Overall Study|Adverse Event|1|||
163033822|NCT03114657|588826693|FG001|Overall Study|Death|0|||
163033823|NCT03114657|588826692|FG000|Overall Study|Multiple Reasons|1|||
163033824|NCT03114657|588826693|FG001|Overall Study|Multiple Reasons|2|||
163033825|NCT03114657|588826692|FG000|Overall Study|Physician Decision|2|||
163033826|NCT03114657|588826693|FG001|Overall Study|Physician Decision|2|||
163033827|NCT03114657|588826692|FG000|Overall Study|Study Terminated By Sponsor|355|||
163033828|NCT03114657|588826693|FG001|Overall Study|Study Terminated By Sponsor|374|||
163033829|NCT03114657|588826692|FG000|Overall Study|Symptomatic Deterioration|0|||
163033830|NCT03114657|588826693|FG001|Overall Study|Symptomatic Deterioration|1|||
163033831|NCT03114657|588826692|FG000|Overall Study|Withdrawal by Subject|28|||
163033832|NCT03114657|588826693|FG001|Overall Study|Withdrawal by Subject|22|||
163033833|NCT04245202|588826694|FG000|Overall Study|Lack of Efficacy|10|||
163033834|NCT04245202|588826695|FG001|Overall Study|Lack of Efficacy|1|||
163033835|NCT00717275|588826696|FG000|Overall Study|Premature study termination.|3|||
163033836|NCT01522235|588826700|FG000|Overall Study|Physician Decision|1|||
163033837|NCT01522235|588826701|FG001|Overall Study|Physician Decision|1|||
163033838|NCT03769194|588826702|FG000|Overall Study|Withdrawal by Subject|0|||
163033839|NCT03769194|588826703|FG001|Overall Study|Withdrawal by Subject|7|||
163033840|NCT03769194|588826704|FG002|Overall Study|Withdrawal by Subject|4|||
163033841|NCT03769194|588826705|FG003|Overall Study|Withdrawal by Subject|1|||
163033842|NCT03769194|588826702|FG000|Overall Study|moved from study area|0|||
163033843|NCT03769194|588826703|FG001|Overall Study|moved from study area|2|||
163033844|NCT03769194|588826704|FG002|Overall Study|moved from study area|1|||
162647989|NCT03256552|587428346|FG000|Overall Study|Withdrawal by Subject|2|||
162647990|NCT01012622|587428347|FG000|Overall Study|Withdrawal by Subject|6|||
162647991|NCT01012622|587428347|FG000|Overall Study|Lost to Follow-up|5|||
163033845|NCT03769194|588826705|FG003|Overall Study|moved from study area|1|||
163033846|NCT03769194|588826702|FG000|Overall Study|Lost to Follow-up|3|||
163033847|NCT03769194|588826703|FG001|Overall Study|Lost to Follow-up|6|||
163033848|NCT03769194|588826704|FG002|Overall Study|Lost to Follow-up|3|||
163033849|NCT03769194|588826705|FG003|Overall Study|Lost to Follow-up|6|||
163033850|NCT03769194|588826702|FG000|Overall Study|other|1|||
163033851|NCT03769194|588826703|FG001|Overall Study|other|3|||
163033852|NCT03769194|588826704|FG002|Overall Study|other|0|||
163033853|NCT03769194|588826705|FG003|Overall Study|other|1|||
163033854|NCT00312572|588826707|FG000|Overall Study|Adverse Event|10|||
163033855|NCT00312572|588826708|FG001|Overall Study|Adverse Event|16|||
163033856|NCT00312572|588826707|FG000|Overall Study|Lost to Follow-up|1|||
163033857|NCT00312572|588826708|FG001|Overall Study|Lost to Follow-up|1|||
163033858|NCT00312572|588826707|FG000|Overall Study|Administrative|4|||
163033859|NCT00312572|588826708|FG001|Overall Study|Administrative|2|||
163033860|NCT00312572|588826707|FG000|Overall Study|Lack of Efficacy|1|||
163033861|NCT00312572|588826708|FG001|Overall Study|Lack of Efficacy|2|||
163033862|NCT05385224|588826709|FG000|Overall Study|Unable to swallow capsule|2|||
163033863|NCT05385224|588826709|FG000|Overall Study|Withdrawal by Subject|2|||
163033864|NCT05385224|588826709|FG000|Overall Study|Did not meet study criteria|1|||
163033865|NCT04521114|588826716|FG000|Overall Study|Lost to Follow-up|1|||
163033866|NCT04521114|588826717|FG001|Overall Study|Lost to Follow-up|2|||
163033867|NCT04521114|588826718|FG002|Overall Study|Lost to Follow-up|0|||
163033868|NCT04521114|588826716|FG000|Overall Study|Withdrawal by Subject|1|||
163033869|NCT04521114|588826717|FG001|Overall Study|Withdrawal by Subject|2|||
163033870|NCT04521114|588826718|FG002|Overall Study|Withdrawal by Subject|2|||
163033871|NCT04521114|588826716|FG000|Overall Study|Adverse Event|1|||
163033872|NCT04521114|588826717|FG001|Overall Study|Adverse Event|0|||
163033873|NCT04521114|588826718|FG002|Overall Study|Adverse Event|0|||
162647992|NCT01012622|587428347|FG000|Overall Study|Adverse Event|7|||
162647993|NCT01012622|587428347|FG000|Overall Study|non-compliance with the drug|9|||
163033874|NCT04521114|588826716|FG000|Overall Study|Sponsor Wish|1|||
163033875|NCT04521114|588826717|FG001|Overall Study|Sponsor Wish|0|||
163033876|NCT04521114|588826718|FG002|Overall Study|Sponsor Wish|0|||
163033877|NCT04521114|588826716|FG000|Overall Study|Withdrawal of Consent|2|||
163033878|NCT04521114|588826717|FG001|Overall Study|Withdrawal of Consent|2|||
163033879|NCT04521114|588826718|FG002|Overall Study|Withdrawal of Consent|0|||
163033880|NCT01362517|588826719|FG000|Overall Study|Protocol Violation|1|||
163033881|NCT01362517|588826719|FG000|Overall Study|Lost to Follow-up|1|||
163033882|NCT01133288|588826722|FG000|Eligibility Assessment|met exclusion criteria|5|||
163033883|NCT01133288|588826722|FG000|Intervention Allocation|study terminated|2|||
163033884|NCT02614131|588826723|FG000|Overall Study|Withdrawal by Subject|1|||
163033885|NCT02614131|588826724|FG001|Overall Study|Withdrawal by Subject|0|||
163033886|NCT02614131|588826725|FG002|Overall Study|Withdrawal by Subject|0|||
163033887|NCT02614131|588826726|FG003|Overall Study|Withdrawal by Subject|0|||
163033888|NCT02614131|588826727|FG004|Overall Study|Withdrawal by Subject|0|||
163033889|NCT02614131|588826728|FG005|Overall Study|Withdrawal by Subject|0|||
163033890|NCT02614131|588826729|FG006|Overall Study|Withdrawal by Subject|0|||
163033891|NCT02614131|588826723|FG000|Overall Study|Adverse Event|0|||
163033892|NCT02614131|588826724|FG001|Overall Study|Adverse Event|0|||
163033893|NCT02614131|588826725|FG002|Overall Study|Adverse Event|0|||
163033894|NCT02614131|588826726|FG003|Overall Study|Adverse Event|0|||
163033895|NCT02614131|588826727|FG004|Overall Study|Adverse Event|0|||
163033896|NCT02614131|588826728|FG005|Overall Study|Adverse Event|0|||
163033897|NCT02614131|588826729|FG006|Overall Study|Adverse Event|1|||
163033898|NCT03209518|588826730|FG000|Overall Study|Case Report Forms Uncollected|1|||
163033899|NCT03209518|588826730|FG000|Overall Study|Protocol Deviation|1|||
163033900|NCT00337779|588826731|FG000|Overall Study|Withdrawal by Subject|10|||
163033901|NCT00337779|588826732|FG001|Overall Study|Withdrawal by Subject|12|||
163033902|NCT00337779|588826731|FG000|Overall Study|Sponsor decision|1|||
163033903|NCT00337779|588826732|FG001|Overall Study|Sponsor decision|1|||
163033904|NCT00337779|588826731|FG000|Overall Study|Physician Decision|3|||
163033905|NCT00337779|588826732|FG001|Overall Study|Physician Decision|6|||
163033906|NCT00337779|588826731|FG000|Overall Study|Protocol Violation|1|||
163033907|NCT00337779|588826732|FG001|Overall Study|Protocol Violation|1|||
163033908|NCT00337779|588826731|FG000|Overall Study|Lost to Follow-up|6|||
163033909|NCT00337779|588826732|FG001|Overall Study|Lost to Follow-up|5|||
163154807|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
163033910|NCT00337779|588826731|FG000|Overall Study|Adverse Event|28|||
163033911|NCT00337779|588826732|FG001|Overall Study|Adverse Event|51|||
163033912|NCT00337779|588826731|FG000|Overall Study|Pregnancy|3|||
163033913|NCT00337779|588826732|FG001|Overall Study|Pregnancy|2|||
163033914|NCT00337779|588826731|FG000|Overall Study|Death|0|||
163033915|NCT00337779|588826732|FG001|Overall Study|Death|1|||
163033916|NCT02028169|588826745|FG000|Overall Study|Lost to Follow-up|21|||
163033917|NCT02028169|588826745|FG000|Overall Study|Lack of Efficacy|2|||
163033918|NCT02028169|588826745|FG000|Overall Study|Withdrawal by Subject|2|||
163033919|NCT02028169|588826745|FG000|Overall Study|Adverse Event|1|||
163033920|NCT02028169|588826745|FG000|Overall Study|Cessation of Drug|1|||
163033921|NCT02028169|588826745|FG000|Overall Study|Concomitant Medication Usage|1|||
163033922|NCT02240069|588826750|FG000|Overall Study|Withdrawal by Subject|5|||
163033923|NCT02240069|588826751|FG001|Overall Study|Withdrawal by Subject|5|||
163033924|NCT02240069|588826752|FG002|Overall Study|Withdrawal by Subject|2|||
163033925|NCT01876979|588826753|FG000|Overall Study|Physician Decision|2|||
163033926|NCT01876979|588826754|FG001|Overall Study|Physician Decision|3|||
163033927|NCT01096589|588826755|FG000|Overall Study|Adverse Event|2|||
163033928|NCT01096589|588826756|FG001|Overall Study|Adverse Event|1|||
163033929|NCT01096589|588826757|FG002|Overall Study|Adverse Event|2|||
162647994|NCT01012622|587428347|FG000|Overall Study|Other|1|||
162647995|NCT01012622|587428347|FG000|Overall Study|screening failure|1|||
162647996|NCT01012622|587428347|FG000|Overall Study|withdrawal of consent by a parent|2|||
162647997|NCT01176292|587428348|FG000|Overall Study|Lost to Follow-up|2|||
162647998|NCT01176292|587428349|FG001|Overall Study|Lost to Follow-up|4|||
162647999|NCT01176292|587428348|FG000|Overall Study|Adverse Event|1|||
162648000|NCT01176292|587428349|FG001|Overall Study|Adverse Event|1|||
162648001|NCT01176292|587428348|FG000|Overall Study|Physician Decision|0|||
162648002|NCT01176292|587428349|FG001|Overall Study|Physician Decision|2|||
162648003|NCT01176292|587428348|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
162648004|NCT01176292|587428349|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
162648005|NCT00380393|587428350|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
162648006|NCT00380393|587428351|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
162648007|NCT00380393|587428350|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
162648008|NCT00380393|587428351|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
162648009|NCT00380393|587428350|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
162648010|NCT00380393|587428351|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
162648011|NCT00380393|587428350|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
162648012|NCT00380393|587428351|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
162648013|NCT00380393|587428350|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
162648014|NCT00380393|587428351|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
162648015|NCT00380393|587428350|FG000|Month 14|Withdrawal by Subject|9|||
162648016|NCT00380393|587428351|FG001|Month 14|Withdrawal by Subject|7|||
162648017|NCT00380393|587428350|FG000|Month 14|Death|1|||
162648018|NCT00380393|587428351|FG001|Month 14|Death|0|||
162648019|NCT00380393|587428350|FG000|Month 14|Lost to Follow-up|0|||
162648020|NCT00380393|587428351|FG001|Month 14|Lost to Follow-up|1|||
162648021|NCT00380393|587428350|FG000|Month 14|Migrated/moved from study area|39|||
162648022|NCT00380393|587428351|FG001|Month 14|Migrated/moved from study area|42|||
162648023|NCT00380393|587428350|FG000|Month 14|Protocol Violation|2|||
162648024|NCT00380393|587428351|FG001|Month 14|Protocol Violation|0|||
162648025|NCT00380393|587428350|FG000|Month 14|Others|6|||
162648026|NCT00380393|587428351|FG001|Month 14|Others|6|||
162648027|NCT00278954|587428362|FG000|Overall Study|Adverse Event|3|||
162648028|NCT00278954|587428362|FG000|Overall Study|Lost to Follow-up|1|||
162648029|NCT00278954|587428362|FG000|Overall Study|Withdrawal by Subject|1|||
162648030|NCT02211131|587428366|FG000|Overall Study|Death|26|||
162648031|NCT02211131|587428367|FG001|Overall Study|Death|16|||
162648032|NCT02211131|587428366|FG000|Overall Study|Lost to Follow-up|4|||
162648033|NCT02211131|587428367|FG001|Overall Study|Lost to Follow-up|3|||
162648034|NCT02211131|587428366|FG000|Overall Study|Decision by Sponsor|1|||
162648035|NCT02211131|587428367|FG001|Overall Study|Decision by Sponsor|1|||
162648036|NCT02211131|587428366|FG000|Overall Study|Withdrawal by Subject|3|||
162648037|NCT02211131|587428367|FG001|Overall Study|Withdrawal by Subject|8|||
162648038|NCT05664490|587428368|FG000|Overall Study|Withdrawal by Subject|0|||
162648039|NCT05664490|587428369|FG001|Overall Study|Withdrawal by Subject|1|||
162648040|NCT05664490|587428368|FG000|Overall Study|Lost to Follow-up|14|||
162648041|NCT05664490|587428369|FG001|Overall Study|Lost to Follow-up|22|||
162648042|NCT01589445|587428372|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
162648043|NCT01589445|587428372|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
162648044|NCT01589445|587428372|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
162648045|NCT01589445|587428372|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
162648046|NCT01589445|587428372|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
162648047|NCT01589445|587428372|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
162648048|NCT01589445|587428372|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
162648049|NCT01589445|587428372|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
162648050|NCT01589445|587428372|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
162648051|NCT01589445|587428372|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
162648052|NCT00481195|587428384|FG000|Overall Study|Adverse Event|16|||
162648053|NCT00481195|587428385|FG001|Overall Study|Adverse Event|11|||
162648054|NCT00481195|587428384|FG000|Overall Study|Lack of Efficacy|1|||
163033930|NCT01096589|588826758|FG003|Overall Study|Adverse Event|1|||
163033931|NCT01096589|588826755|FG000|Overall Study|Withdrawal by Subject|2|||
162648055|NCT00481195|587428385|FG001|Overall Study|Lack of Efficacy|3|||
162648056|NCT00481195|587428384|FG000|Overall Study|Lost to Follow-up|4|||
162648057|NCT00481195|587428385|FG001|Overall Study|Lost to Follow-up|6|||
162648058|NCT00481195|587428384|FG000|Overall Study|Physician Decision|3|||
162648059|NCT00481195|587428385|FG001|Overall Study|Physician Decision|1|||
162648060|NCT00481195|587428384|FG000|Overall Study|Protocol Violation|10|||
162648061|NCT00481195|587428385|FG001|Overall Study|Protocol Violation|7|||
162648062|NCT00481195|587428384|FG000|Overall Study|Withdrawal by Subject|3|||
162648063|NCT00481195|587428385|FG001|Overall Study|Withdrawal by Subject|9|||
162648064|NCT00481195|587428384|FG000|Overall Study|Miscellaneous|2|||
162648065|NCT00481195|587428385|FG001|Overall Study|Miscellaneous|2|||
162648066|NCT02932904|587428386|FG000|Overall Study|Reason not Specified|1|||
162648067|NCT02932904|587428387|FG001|Overall Study|Reason not Specified|0|||
162648068|NCT02932904|587428388|FG002|Overall Study|Reason not Specified|2|||
162648069|NCT02932904|587428389|FG003|Overall Study|Reason not Specified|2|||
162648070|NCT02932904|587428386|FG000|Overall Study|Noncompliance with Study Drug|2|||
162648071|NCT02932904|587428387|FG001|Overall Study|Noncompliance with Study Drug|3|||
162648072|NCT02932904|587428388|FG002|Overall Study|Noncompliance with Study Drug|3|||
162648073|NCT02932904|587428389|FG003|Overall Study|Noncompliance with Study Drug|4|||
162648074|NCT02932904|587428386|FG000|Overall Study|Pregnancy|0|||
162648075|NCT02932904|587428387|FG001|Overall Study|Pregnancy|1|||
162648076|NCT02932904|587428388|FG002|Overall Study|Pregnancy|1|||
162648077|NCT02932904|587428389|FG003|Overall Study|Pregnancy|0|||
162648078|NCT02932904|587428386|FG000|Overall Study|Study Termination|0|||
162648079|NCT02932904|587428387|FG001|Overall Study|Study Termination|1|||
162648080|NCT02932904|587428388|FG002|Overall Study|Study Termination|0|||
162648081|NCT02932904|587428389|FG003|Overall Study|Study Termination|0|||
162648082|NCT02932904|587428386|FG000|Overall Study|Voluntary Withdrawal|2|||
162648083|NCT02932904|587428387|FG001|Overall Study|Voluntary Withdrawal|1|||
162648084|NCT02932904|587428388|FG002|Overall Study|Voluntary Withdrawal|4|||
162648085|NCT02932904|587428389|FG003|Overall Study|Voluntary Withdrawal|2|||
162648086|NCT02932904|587428386|FG000|Overall Study|Lost to Follow-up|5|||
162648087|NCT02932904|587428387|FG001|Overall Study|Lost to Follow-up|3|||
162648088|NCT02932904|587428388|FG002|Overall Study|Lost to Follow-up|6|||
162648089|NCT02932904|587428389|FG003|Overall Study|Lost to Follow-up|0|||
162648090|NCT02932904|587428386|FG000|Overall Study|Significant Protocol Deviation|2|||
162648091|NCT02932904|587428387|FG001|Overall Study|Significant Protocol Deviation|3|||
162648092|NCT02932904|587428388|FG002|Overall Study|Significant Protocol Deviation|6|||
162648093|NCT02932904|587428389|FG003|Overall Study|Significant Protocol Deviation|1|||
162648094|NCT02932904|587428386|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162648095|NCT02932904|587428387|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
162648096|NCT02932904|587428388|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
162648097|NCT02932904|587428389|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
162648098|NCT02932904|587428386|FG000|Overall Study|Randomized But Not Treated|1|||
162648099|NCT02932904|587428387|FG001|Overall Study|Randomized But Not Treated|1|||
162648100|NCT02932904|587428388|FG002|Overall Study|Randomized But Not Treated|0|||
162718158|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162718159|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
162718160|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162718161|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163033932|NCT01096589|588826756|FG001|Overall Study|Withdrawal by Subject|1|||
163033933|NCT01096589|588826757|FG002|Overall Study|Withdrawal by Subject|1|||
163033934|NCT01096589|588826758|FG003|Overall Study|Withdrawal by Subject|1|||
163033935|NCT01096589|588826755|FG000|Overall Study|Compliance with protocol|0|||
163033936|NCT01096589|588826756|FG001|Overall Study|Compliance with protocol|0|||
163033937|NCT01096589|588826757|FG002|Overall Study|Compliance with protocol|1|||
163033938|NCT01096589|588826758|FG003|Overall Study|Compliance with protocol|0|||
163033939|NCT01096589|588826755|FG000|Overall Study|found treatment exhausting|0|||
163033940|NCT01096589|588826756|FG001|Overall Study|found treatment exhausting|0|||
163033941|NCT01096589|588826757|FG002|Overall Study|found treatment exhausting|0|||
163033942|NCT01096589|588826758|FG003|Overall Study|found treatment exhausting|1|||
163033943|NCT00948506|588826759|FG000|Overall Study|Withdrawal by Subject|3|||
163033944|NCT00948506|588826760|FG001|Overall Study|Withdrawal by Subject|1|||
163033945|NCT03233204|588826762|FG000|Overall Study|Adverse Event|1|||
163033946|NCT03233204|588826762|FG000|Overall Study|Death|1|||
163033947|NCT03233204|588826762|FG000|Overall Study|Withdrawal by Subject|1|||
163033948|NCT03233204|588826762|FG000|Overall Study|Progressive Disease|3|||
163033949|NCT02227368|588828412|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
163033950|NCT02227368|588828413|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
163033951|NCT02227368|588828412|FG000|Overall Study|Lost to Follow-up|1|||
163033952|NCT02227368|588828413|FG001|Overall Study|Lost to Follow-up|0|||
163033953|NCT02227368|588828412|FG000|Overall Study|Adverse Event|1|||
163033954|NCT02227368|588828413|FG001|Overall Study|Adverse Event|0|||
162718162|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163033955|NCT03046056|588828415|FG000|Overall Study|Non-responder at Week 10|6|||
163033956|NCT03046056|588828416|FG001|Overall Study|Non-responder at Week 10|6|||
163033957|NCT03046056|588828417|FG002|Overall Study|Non-responder at Week 10|4|||
163033958|NCT03046056|588828415|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
163033959|NCT03046056|588828416|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
162648101|NCT02932904|587428389|FG003|Overall Study|Randomized But Not Treated|2|||
162648102|NCT01476696|587428394|FG000|Overall Study|Sponsor decision|2|||
163033960|NCT03046056|588828417|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
163033961|NCT03046056|588828415|FG000|Overall Study|Adverse Event|1|||
163085575|NCT05030766|589022326|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
162648103|NCT01476696|587428395|FG001|Overall Study|Sponsor decision|1|||
162648104|NCT01476696|587428396|FG002|Overall Study|Sponsor decision|0|||
162648105|NCT01476696|587428394|FG000|Overall Study|Withdrawal by Subject|1|||
162648106|NCT01476696|587428395|FG001|Overall Study|Withdrawal by Subject|0|||
162648107|NCT01476696|587428396|FG002|Overall Study|Withdrawal by Subject|0|||
162648108|NCT01498640|587428400|FG000|Overall Study|Lost to Follow-up|1|||
162648109|NCT01498640|587428400|FG000|Overall Study|Death|1|||
162648110|NCT01498640|587428400|FG000|Overall Study|Other|3|||
163033962|NCT03046056|588828416|FG001|Overall Study|Adverse Event|5|||
163033963|NCT03046056|588828417|FG002|Overall Study|Adverse Event|0|||
162648111|NCT02590939|587428401|FG000|Overall Study|Withdrawal by Subject|3|||
162648112|NCT02590939|587428402|FG001|Overall Study|Withdrawal by Subject|1|||
162648113|NCT02590939|587428401|FG000|Overall Study|Failed the nociceptive test|2|||
162648114|NCT02590939|587428402|FG001|Overall Study|Failed the nociceptive test|1|||
162648115|NCT02225743|587428403|FG000|Overall Study|Withdrawal by Subject|18|||
162648116|NCT01319877|587428408|FG000|Overall Study|Lost to Follow-up|100|||
162648117|NCT01319877|587428409|FG001|Overall Study|Lost to Follow-up|37|||
162648118|NCT01319877|587428408|FG000|Overall Study|Physician Decision|2|||
162648119|NCT01319877|587428409|FG001|Overall Study|Physician Decision|0|||
162648120|NCT01319877|587428408|FG000|Overall Study|Disease Progression|2|||
162648121|NCT01319877|587428409|FG001|Overall Study|Disease Progression|2|||
162648122|NCT01319877|587428408|FG000|Overall Study|Withdrawal by Subject|0|||
162648123|NCT01319877|587428409|FG001|Overall Study|Withdrawal by Subject|1|||
162648124|NCT01319877|587428408|FG000|Overall Study|Reason Not Specified|4|||
162648125|NCT01319877|587428409|FG001|Overall Study|Reason Not Specified|5|||
162648126|NCT02347189|587428413|FG000|Overall Study|No implant attempted of study device|9|||
162648127|NCT02347189|587428413|FG000|Overall Study|No primary outcome data available|2|||
162648128|NCT02677987|587428414|FG000|Overall Study|Withdrawal by Subject|3|||
162648129|NCT02677987|587428415|FG001|Overall Study|Withdrawal by Subject|0|||
162648130|NCT02677987|587428414|FG000|Overall Study|Lost to Follow-up|1|||
162648131|NCT02677987|587428415|FG001|Overall Study|Lost to Follow-up|0|||
162648132|NCT03320564|587428416|FG000|Overall Study|Protocol Violation|1|||
162648133|NCT01527682|587428417|FG000|Overall Study|Protocol Violation|8|||
162648134|NCT04668950|587428418|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
162648135|NCT04668950|587428419|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
162648136|NCT04668950|587428418|FG000|Overall Study|Could not confirm started study medication|15|||
162648137|NCT04668950|587428419|FG001|Overall Study|Could not confirm started study medication|15|||
162648138|NCT04668950|587428418|FG000|Overall Study|Could not confirm baseline status|6|||
162648139|NCT04668950|587428419|FG001|Overall Study|Could not confirm baseline status|2|||
162648140|NCT04668950|587428418|FG000|Overall Study|Drop out and did not start medication|15|||
162648141|NCT04668950|587428419|FG001|Overall Study|Drop out and did not start medication|17|||
162648142|NCT04668950|587428418|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
162648143|NCT04668950|587428419|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
162648144|NCT04668950|587428418|FG000|Overall Study|Other|2|||
162648145|NCT04668950|587428419|FG001|Overall Study|Other|4|||
162648146|NCT03979638|587428420|FG000|Period 1|Physician Decision|1|||
162648147|NCT03979638|587428421|FG001|Period 1|Physician Decision|1|||
162648148|NCT03979638|587428420|FG000|Period 1|Withdrawal by Subject|4|||
162648149|NCT03979638|587428421|FG001|Period 1|Withdrawal by Subject|3|||
162648150|NCT03979638|587428420|FG000|Period 1|Study terminated by Sponsor|1|||
162648151|NCT03979638|587428421|FG001|Period 1|Study terminated by Sponsor|3|||
162648152|NCT03979638|587428420|FG000|Period 1|Protocol Violation|1|||
162648153|NCT03979638|587428421|FG001|Period 1|Protocol Violation|0|||
162648154|NCT03979638|587428420|FG000|Period 2|Study terminated by Sponsor|1|||
162648155|NCT03979638|587428421|FG001|Period 2|Study terminated by Sponsor|1|||
162648156|NCT00600938|587428422|FG000|Core Study|Abnormal test procedure result(s)|3|||
162648157|NCT00600938|587428423|FG001|Core Study|Abnormal test procedure result(s)|2|||
162648158|NCT00600938|587428424|FG002|Core Study|Abnormal test procedure result(s)|0|||
162648159|NCT00600938|587428425|FG003|Core Study|Abnormal test procedure result(s)|0|||
162648160|NCT00600938|587428422|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
162648161|NCT00600938|587428423|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
162648162|NCT00600938|587428424|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
162648163|NCT00600938|587428425|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
162648164|NCT00600938|587428422|FG000|Core Study|Patient withdrew consent|7|||
162648165|NCT00600938|587428423|FG001|Core Study|Patient withdrew consent|12|||
162648166|NCT00600938|587428424|FG002|Core Study|Patient withdrew consent|0|||
162648167|NCT00600938|587428425|FG003|Core Study|Patient withdrew consent|0|||
163033964|NCT03046056|588828415|FG000|Overall Study|Non-compliance With Study Drug|0|||
163033965|NCT03046056|588828416|FG001|Overall Study|Non-compliance With Study Drug|0|||
162648168|NCT00600938|587428422|FG000|Core Study|Lost to Follow-up|3|||
162648169|NCT00600938|587428423|FG001|Core Study|Lost to Follow-up|2|||
163033966|NCT03046056|588828417|FG002|Overall Study|Non-compliance With Study Drug|2|||
162648170|NCT00600938|587428424|FG002|Core Study|Lost to Follow-up|0|||
162648171|NCT00600938|587428425|FG003|Core Study|Lost to Follow-up|0|||
162648172|NCT00600938|587428422|FG000|Core Study|Death|1|||
163033967|NCT03046056|588828415|FG000|Overall Study|Protocol Violation|1|||
163033968|NCT03046056|588828416|FG001|Overall Study|Protocol Violation|1|||
163033969|NCT03046056|588828417|FG002|Overall Study|Protocol Violation|0|||
163033970|NCT03046056|588828415|FG000|Overall Study|Investigator's Discretion|0|||
162648173|NCT00600938|587428423|FG001|Core Study|Death|1|||
162648174|NCT00600938|587428424|FG002|Core Study|Death|0|||
162648175|NCT00600938|587428425|FG003|Core Study|Death|0|||
162648176|NCT00600938|587428422|FG000|Core Study|Protocol Violation|1|||
162648177|NCT00600938|587428423|FG001|Core Study|Protocol Violation|2|||
162648178|NCT00600938|587428424|FG002|Core Study|Protocol Violation|0|||
162648179|NCT00600938|587428425|FG003|Core Study|Protocol Violation|0|||
162648180|NCT00600938|587428422|FG000|Extension Study|Adverse Event|1|||
162648181|NCT00600938|587428423|FG001|Extension Study|Adverse Event|0|||
162648182|NCT00600938|587428424|FG002|Extension Study|Adverse Event|2|||
162648183|NCT00600938|587428425|FG003|Extension Study|Adverse Event|0|||
162648184|NCT00600938|587428422|FG000|Extension Study|Abnormal test procedure results|0|||
162648185|NCT00600938|587428423|FG001|Extension Study|Abnormal test procedure results|1|||
162648186|NCT00600938|587428424|FG002|Extension Study|Abnormal test procedure results|1|||
162648187|NCT00600938|587428425|FG003|Extension Study|Abnormal test procedure results|1|||
162648188|NCT00600938|587428422|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
162648189|NCT00600938|587428423|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
162648190|NCT00600938|587428424|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
162648191|NCT00600938|587428425|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
162648192|NCT00600938|587428422|FG000|Extension Study|Withdrawal by Subject|2|||
162648193|NCT00600938|587428423|FG001|Extension Study|Withdrawal by Subject|2|||
162648194|NCT00600938|587428424|FG002|Extension Study|Withdrawal by Subject|3|||
162648195|NCT00600938|587428425|FG003|Extension Study|Withdrawal by Subject|0|||
162648196|NCT00600938|587428422|FG000|Extension Study|Lost to Follow-up|1|||
162648197|NCT00600938|587428423|FG001|Extension Study|Lost to Follow-up|1|||
162648198|NCT00600938|587428424|FG002|Extension Study|Lost to Follow-up|2|||
162648199|NCT00600938|587428425|FG003|Extension Study|Lost to Follow-up|0|||
162648200|NCT00600938|587428422|FG000|Extension Study|Death|1|||
162648201|NCT00600938|587428423|FG001|Extension Study|Death|0|||
162648202|NCT00600938|587428424|FG002|Extension Study|Death|0|||
162648203|NCT00600938|587428425|FG003|Extension Study|Death|0|||
162648204|NCT02680639|587428426|FG000|Screening Period|Screen Failure|7|||
162648205|NCT02680639|587428427|FG001|Screening Period|Screen Failure|0|||
162648206|NCT02680639|587428428|FG002|Screening Period|Screen Failure|0|||
162648207|NCT02678676|587428429|FG000|Overall Study|Death|619|||
162648208|NCT02678676|587428430|FG001|Overall Study|Death|649|||
162648209|NCT02678676|587428429|FG000|Overall Study|Withdrawal by Subject|13|||
162648210|NCT02678676|587428430|FG001|Overall Study|Withdrawal by Subject|5|||
162648211|NCT02678676|587428429|FG000|Overall Study|Lost to Follow-up|171|||
162648212|NCT02678676|587428430|FG001|Overall Study|Lost to Follow-up|151|||
162648213|NCT02678676|587428429|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
162648214|NCT02678676|587428430|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
162648215|NCT03200899|587428431|FG000|Overall Study|Lost to Follow-up|10|||
162648216|NCT03200899|587428432|FG001|Overall Study|Lost to Follow-up|23|||
162648217|NCT01342510|587428447|FG000|Overall Study|Protocol Violation|12|||
162648218|NCT01342510|587428448|FG001|Overall Study|Protocol Violation|6|||
162648219|NCT01342510|587428449|FG002|Overall Study|Protocol Violation|13|||
162648220|NCT01342510|587428450|FG003|Overall Study|Protocol Violation|11|||
162648221|NCT01400516|587428452|FG000|Primary Trial|Withdrawal by Subject|0|||
162648222|NCT01400516|587428453|FG001|Primary Trial|Withdrawal by Subject|2|||
162648223|NCT00549562|587428454|FG000|Overall Study|Adverse Event|1|||
162648224|NCT00549562|587428454|FG000|Overall Study|Lack of Efficacy|1|||
163033971|NCT03046056|588828416|FG001|Overall Study|Investigator's Discretion|1|||
163033972|NCT03046056|588828417|FG002|Overall Study|Investigator's Discretion|0|||
163033973|NCT03046056|588828415|FG000|Overall Study|Withdrew Consent|1|||
163033974|NCT03046056|588828416|FG001|Overall Study|Withdrew Consent|0|||
163085576|NCT05030766|589022323|FG000|Phase 2 Participants|Lost to Follow-up|0|||
163085577|NCT05030766|589022324|FG001|Phase 2 Participants|Lost to Follow-up|0|||
163085578|NCT05030766|589022325|FG002|Phase 2 Participants|Lost to Follow-up|6|||
163085579|NCT05030766|589022326|FG003|Phase 2 Participants|Lost to Follow-up|2|||
163033975|NCT03046056|588828417|FG002|Overall Study|Withdrew Consent|0|||
163033976|NCT03089853|588828418|FG000|Overall Study|Lost to Follow-up|2|||
163033977|NCT03089853|588828419|FG001|Overall Study|Lost to Follow-up|1|||
162648225|NCT00323115|587428460|FG000|Vaccine Administration|Adverse Event|1|||
162648226|NCT00323115|587428460|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
162648227|NCT02496533|587428461|FG000|Overall Study|Lack of data on outcome|3|||
162648228|NCT02496533|587428462|FG001|Overall Study|Lack of data on outcome|0|||
163033978|NCT01317004|588828420|FG000|Overall Study|Withdrawal by Subject|1|||
163033979|NCT01317004|588828421|FG001|Overall Study|Withdrawal by Subject|4|||
163033980|NCT01317004|588828420|FG000|Overall Study|Protocol Violation|0|||
162648229|NCT02496533|587428461|FG000|Overall Study|Patient did not complete all measures|0|||
162648230|NCT02496533|587428462|FG001|Overall Study|Patient did not complete all measures|4|||
162648231|NCT02496533|587428461|FG000|Overall Study|Late for radiologic testing|0|||
162648232|NCT02496533|587428462|FG001|Overall Study|Late for radiologic testing|2|||
163085580|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
162648233|NCT05756790|587428463|FG000|Overall Study|Withdrawal by Subject|1|||
162648234|NCT05756790|587428464|FG001|Overall Study|Withdrawal by Subject|1|||
163033981|NCT01317004|588828421|FG001|Overall Study|Protocol Violation|2|||
162648235|NCT05756790|587428465|FG002|Overall Study|Withdrawal by Subject|1|||
162648236|NCT05756790|587428466|FG003|Overall Study|Withdrawal by Subject|1|||
162648237|NCT05756790|587428467|FG004|Overall Study|Withdrawal by Subject|0|||
162648238|NCT05756790|587428468|FG005|Overall Study|Withdrawal by Subject|0|||
162648239|NCT05756790|587428463|FG000|Overall Study|Protocol Violation|0|||
162648240|NCT05756790|587428464|FG001|Overall Study|Protocol Violation|0|||
162648241|NCT05756790|587428465|FG002|Overall Study|Protocol Violation|1|||
162648242|NCT05756790|587428466|FG003|Overall Study|Protocol Violation|1|||
162648243|NCT05756790|587428467|FG004|Overall Study|Protocol Violation|0|||
162648244|NCT05756790|587428468|FG005|Overall Study|Protocol Violation|0|||
162648245|NCT05756790|587428463|FG000|Overall Study|Ineligible|0|||
162648246|NCT05756790|587428464|FG001|Overall Study|Ineligible|0|||
162648247|NCT05756790|587428465|FG002|Overall Study|Ineligible|0|||
162648248|NCT05756790|587428466|FG003|Overall Study|Ineligible|0|||
162648249|NCT05756790|587428467|FG004|Overall Study|Ineligible|2|||
162648250|NCT05756790|587428468|FG005|Overall Study|Ineligible|2|||
162648251|NCT00502697|587429796|FG000|Overall Study|Withdrawal by Subject|3|||
162648252|NCT00502697|587429797|FG001|Overall Study|Withdrawal by Subject|1|||
162648253|NCT00502697|587429796|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
162648254|NCT00502697|587429797|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
162648255|NCT00502697|587429796|FG000|Overall Study|found not to meet eligibility criteria|3|||
162648256|NCT00502697|587429797|FG001|Overall Study|found not to meet eligibility criteria|4|||
162648257|NCT00502697|587429796|FG000|Overall Study|did not meet assignment criteria|4|||
162648258|NCT00502697|587429797|FG001|Overall Study|did not meet assignment criteria|2|||
162648259|NCT00589108|587429801|FG000|Overall Study|Lost to Follow-up|1|||
162648260|NCT00589108|587429802|FG001|Overall Study|Lost to Follow-up|1|||
162648261|NCT00589108|587429803|FG002|Overall Study|Lost to Follow-up|1|||
162648262|NCT00589108|587429801|FG000|Overall Study|Death|3|||
162648263|NCT00589108|587429802|FG001|Overall Study|Death|3|||
162648264|NCT00589108|587429803|FG002|Overall Study|Death|4|||
162648265|NCT02268409|587429812|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
162648266|NCT02268409|587429812|FG000|Overall Study|Death|1|||
162648267|NCT02268409|587429812|FG000|Overall Study|Lost to Follow-up|1|||
162648268|NCT02268409|587429812|FG000|Overall Study|Protocol Violation|3|||
162648269|NCT02268409|587429812|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
162648270|NCT02268409|587429812|FG000|Overall Study|Withdrawal by Subject|5|||
162648271|NCT03026257|587429814|FG000|Overall Study|Adverse Event|3|||
163033982|NCT01317004|588828420|FG000|Overall Study|Adverse Event|3|||
163033983|NCT01317004|588828421|FG001|Overall Study|Adverse Event|3|||
163033984|NCT01980628|588828424|FG000|Overall Study|Adverse Event|12|||
163033985|NCT01980628|588828424|FG000|Overall Study|Physician Decision|5|||
163033986|NCT01980628|588828424|FG000|Overall Study|Withdrawal by Subject|4|||
163033987|NCT01980628|588828424|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
163033988|NCT05437640|588828427|FG000|Washout (1 Week)|Adverse Event|1|||
163033989|NCT05437640|588828428|FG001|Washout (1 Week)|Adverse Event|0|||
163033990|NCT02474355|588828429|FG000|Overall Study|Other|43|||
163033991|NCT02474355|588828429|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
163033992|NCT02474355|588828429|FG000|Overall Study|Lost to Follow-up|98|||
163033993|NCT02474355|588828429|FG000|Overall Study|Withdrawal by Subject|124|||
163033994|NCT02474355|588828429|FG000|Overall Study|Death|1361|||
163033995|NCT03015194|588828431|FG000|Overall Study|Death|10|||
163033996|NCT03015194|588828431|FG000|Overall Study|Withdrawal by Subject|2|||
163033997|NCT01698268|588828435|FG000|Overall Study|Physician Decision|2|||
163033998|NCT01698268|588828436|FG001|Overall Study|Physician Decision|1|||
163033999|NCT02263729|588828437|FG000|Overall Study|Lost to Follow-up|1|||
163034000|NCT02263729|588828438|FG001|Overall Study|Lost to Follow-up|1|||
163034001|NCT04591015|588828439|FG000|Overall Study|Death|6|||
163034002|NCT04591015|588828440|FG001|Overall Study|Death|4|||
163034003|NCT04591015|588828439|FG000|Overall Study|Withdrawal by Subject|6|||
163034004|NCT04591015|588828440|FG001|Overall Study|Withdrawal by Subject|3|||
163034005|NCT04591015|588828439|FG000|Overall Study|Lost to Follow-up|16|||
163034006|NCT04591015|588828440|FG001|Overall Study|Lost to Follow-up|11|||
163034007|NCT02509078|588828441|FG000|Overall Study|Protocol Violation|1|||
163034008|NCT02509078|588828442|FG001|Overall Study|Protocol Violation|1|||
163034009|NCT00981058|588828454|FG000|Overall Study|Progressive Disease|38|||
162648272|NCT03026257|587429815|FG001|Overall Study|Adverse Event|0|||
162648273|NCT03026257|587429816|FG002|Overall Study|Adverse Event|0|||
162648274|NCT03026257|587429817|FG003|Overall Study|Adverse Event|0|||
162648275|NCT03026257|587429818|FG004|Overall Study|Adverse Event|0|||
162648276|NCT03026257|587429819|FG005|Overall Study|Adverse Event|0|||
162648277|NCT03026257|587429814|FG000|Overall Study|Lost to Follow-up|1|||
162648278|NCT03026257|587429815|FG001|Overall Study|Lost to Follow-up|0|||
162648279|NCT03026257|587429816|FG002|Overall Study|Lost to Follow-up|0|||
162648280|NCT03026257|587429817|FG003|Overall Study|Lost to Follow-up|0|||
162648281|NCT03026257|587429818|FG004|Overall Study|Lost to Follow-up|0|||
163034010|NCT00981058|588828455|FG001|Overall Study|Progressive Disease|31|||
163034011|NCT00981058|588828454|FG000|Overall Study|Lost to Follow-up|3|||
163034012|NCT00981058|588828455|FG001|Overall Study|Lost to Follow-up|2|||
163034013|NCT00981058|588828454|FG000|Overall Study|Physician Decision|4|||
162648282|NCT03026257|587429819|FG005|Overall Study|Lost to Follow-up|0|||
162648283|NCT03026257|587429814|FG000|Overall Study|Protocol Violation|1|||
162648284|NCT03026257|587429815|FG001|Overall Study|Protocol Violation|0|||
162648285|NCT03026257|587429816|FG002|Overall Study|Protocol Violation|0|||
162648286|NCT03026257|587429817|FG003|Overall Study|Protocol Violation|1|||
162648287|NCT03026257|587429818|FG004|Overall Study|Protocol Violation|1|||
162648288|NCT03026257|587429819|FG005|Overall Study|Protocol Violation|0|||
162648289|NCT03026257|587429814|FG000|Overall Study|Withdrawal by Subject|1|||
162648290|NCT03026257|587429815|FG001|Overall Study|Withdrawal by Subject|1|||
162648291|NCT03026257|587429816|FG002|Overall Study|Withdrawal by Subject|0|||
162648292|NCT03026257|587429817|FG003|Overall Study|Withdrawal by Subject|0|||
162648293|NCT03026257|587429818|FG004|Overall Study|Withdrawal by Subject|0|||
162648294|NCT03026257|587429819|FG005|Overall Study|Withdrawal by Subject|0|||
162648295|NCT02181556|587429820|FG000|Overall Study|Withdrawal by Subject|1|||
162648296|NCT00427635|587429821|FG000|Treatment Phase|Withdrawal by Subject|1|||
162648297|NCT00427635|587429822|FG001|Treatment Phase|Withdrawal by Subject|0|||
162648298|NCT00427635|587429821|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
162648299|NCT00427635|587429822|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
162648300|NCT00838201|587429825|FG000|Overall Study|Investigator decision, or other reasons|2|||
162648301|NCT00838201|587429826|FG001|Overall Study|Investigator decision, or other reasons|3|||
162648302|NCT00838201|587429825|FG000|Overall Study|Noncompliance|0|||
162648303|NCT00838201|587429826|FG001|Overall Study|Noncompliance|1|||
162648304|NCT00838201|587429825|FG000|Overall Study|Administrative decision|1|||
162648305|NCT00838201|587429826|FG001|Overall Study|Administrative decision|2|||
162648306|NCT00838201|587429825|FG000|Overall Study|Disease progression|3|||
162648307|NCT00838201|587429826|FG001|Overall Study|Disease progression|3|||
162648308|NCT00838201|587429825|FG000|Overall Study|Consent withdrawn|16|||
162718163|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162718164|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162718165|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162718166|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162718167|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
162718168|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
163034014|NCT00981058|588828455|FG001|Overall Study|Physician Decision|5|||
163034015|NCT00981058|588828454|FG000|Overall Study|Randomization Error|0|||
163034016|NCT00981058|588828455|FG001|Overall Study|Randomization Error|1|||
163034017|NCT00981058|588828454|FG000|Overall Study|Withdrawal by Subject|24|||
163034018|NCT00981058|588828455|FG001|Overall Study|Withdrawal by Subject|22|||
163034019|NCT02667587|588828456|FG000|Pre-Treatment|Not reported|1|||
163034020|NCT02667587|588828457|FG001|Pre-Treatment|Not reported|0|||
163034021|NCT02667587|588828456|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163034022|NCT02667587|588828457|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
163034023|NCT02667587|588828456|FG000|Pre-Treatment|Participant withdrew consent|0|||
163034024|NCT02667587|588828457|FG001|Pre-Treatment|Participant withdrew consent|1|||
163034025|NCT02667587|588828456|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
163034026|NCT02667587|588828457|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
163034027|NCT02667587|588828456|FG000|End of Treatment|Disease Progression|193|||
163034028|NCT02667587|588828457|FG001|End of Treatment|Disease Progression|226|||
163034029|NCT02667587|588828456|FG000|End of Treatment|Study Drug Toxicity|75|||
163085581|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
163085582|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
163085583|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
163085584|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
163085585|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
163085586|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
163085587|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
163085588|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
163085589|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
163085590|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
163085591|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
163085592|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
162648309|NCT00838201|587429826|FG001|Overall Study|Consent withdrawn|19|||
162648310|NCT00838201|587429825|FG000|Overall Study|Lost to Follow-up|4|||
162718169|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163034030|NCT02667587|588828457|FG001|End of Treatment|Study Drug Toxicity|19|||
163034031|NCT02667587|588828456|FG000|End of Treatment|Death|2|||
162648311|NCT00838201|587429826|FG001|Overall Study|Lost to Follow-up|3|||
162648312|NCT00838201|587429825|FG000|Overall Study|Adverse Event|5|||
162648313|NCT00838201|587429826|FG001|Overall Study|Adverse Event|9|||
162648314|NCT00838201|587429825|FG000|Overall Study|Death|11|||
163034032|NCT02667587|588828457|FG001|End of Treatment|Death|1|||
163034033|NCT02667587|588828456|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
162648315|NCT00838201|587429826|FG001|Overall Study|Death|13|||
162648316|NCT00489853|587429827|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
162648317|NCT00489853|587429828|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
162648318|NCT00489853|587429829|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
162648319|NCT00489853|587429827|FG000|Wash-out Period 1|Adverse Event|0|||
162648320|NCT00489853|587429828|FG001|Wash-out Period 1|Adverse Event|1|||
162648321|NCT00489853|587429829|FG002|Wash-out Period 1|Adverse Event|1|||
162648322|NCT00489853|587429827|FG000|Wash-out Period 1|Protocol Violation|0|||
162648323|NCT00489853|587429828|FG001|Wash-out Period 1|Protocol Violation|1|||
162648324|NCT00489853|587429829|FG002|Wash-out Period 1|Protocol Violation|1|||
162648325|NCT00489853|587429827|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
163034034|NCT02667587|588828457|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
163034035|NCT02667587|588828456|FG000|End of Treatment|participant request to discontinue treatment|33|||
163034036|NCT02667587|588828457|FG001|End of Treatment|participant request to discontinue treatment|35|||
163034037|NCT02667587|588828456|FG000|End of Treatment|participant withdrew consent|5|||
163034038|NCT02667587|588828457|FG001|End of Treatment|participant withdrew consent|6|||
163034039|NCT02667587|588828456|FG000|End of Treatment|Lost to Follow-up|1|||
163034040|NCT02667587|588828457|FG001|End of Treatment|Lost to Follow-up|2|||
163034041|NCT02667587|588828456|FG000|End of Treatment|maximum clinical benefit|4|||
163034042|NCT02667587|588828457|FG001|End of Treatment|maximum clinical benefit|4|||
163034043|NCT02667587|588828456|FG000|End of Treatment|poor or non compliant|0|||
163034044|NCT02667587|588828457|FG001|End of Treatment|poor or non compliant|1|||
163034045|NCT02667587|588828456|FG000|End of Treatment|participant no longer meets study criteria|1|||
163034046|NCT02667587|588828457|FG001|End of Treatment|participant no longer meets study criteria|1|||
163034047|NCT02667587|588828456|FG000|End of Treatment|administrative reason by sponsor|1|||
163034048|NCT02667587|588828457|FG001|End of Treatment|administrative reason by sponsor|29|||
163034049|NCT02667587|588828456|FG000|End of Treatment|other reasonse|21|||
163034050|NCT02667587|588828457|FG001|End of Treatment|other reasonse|10|||
163034051|NCT02696434|588828461|FG000|Overall Study|Adverse Event|3|||
163034052|NCT02696434|588828462|FG001|Overall Study|Adverse Event|1|||
163034053|NCT02696434|588828461|FG000|Overall Study|Lost to Follow-up|5|||
163034054|NCT02696434|588828462|FG001|Overall Study|Lost to Follow-up|4|||
163034055|NCT02696434|588828461|FG000|Overall Study|Withdrawal by Subject|14|||
163034056|NCT02696434|588828462|FG001|Overall Study|Withdrawal by Subject|12|||
163034057|NCT02696434|588828461|FG000|Overall Study|Physician Decision|0|||
163034058|NCT02696434|588828462|FG001|Overall Study|Physician Decision|1|||
163034059|NCT03570554|588828468|FG000|Overall Study|Non-compliance with study drug|0|||
163034060|NCT03570554|588828469|FG001|Overall Study|Non-compliance with study drug|0|||
163034061|NCT03570554|588828470|FG002|Overall Study|Non-compliance with study drug|1|||
163034062|NCT03570554|588828471|FG003|Overall Study|Non-compliance with study drug|0|||
163034063|NCT03570554|588828468|FG000|Overall Study|Adverse Event|0|||
163085593|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
163085594|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
163085595|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
163085596|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
163085597|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
163085598|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
163085599|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
163085600|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
163085601|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
163085602|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
163085603|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
163085604|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
162648326|NCT00489853|587429828|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
163034064|NCT03570554|588828469|FG001|Overall Study|Adverse Event|0|||
163034065|NCT03570554|588828470|FG002|Overall Study|Adverse Event|0|||
163034066|NCT03570554|588828471|FG003|Overall Study|Adverse Event|1|||
163034067|NCT02719353|588828474|FG000|First Intervention|Physician Decision|0|||
162648327|NCT00489853|587429829|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
162648328|NCT00489853|587429827|FG000|Wash-out Period 2|Adverse Event|1|||
163034068|NCT02719353|588828475|FG001|First Intervention|Physician Decision|1|||
163034069|NCT00980174|588828477|FG000|Overall Study|Withdrawal by Subject|1|||
163034070|NCT00980174|588828478|FG001|Overall Study|Withdrawal by Subject|4|||
163034071|NCT00980174|588828477|FG000|Overall Study|Adverse Event|0|||
163034072|NCT00980174|588828478|FG001|Overall Study|Adverse Event|3|||
163034073|NCT00980174|588828477|FG000|Overall Study|Ineligibility determined|2|||
163034074|NCT00980174|588828478|FG001|Overall Study|Ineligibility determined|1|||
163034075|NCT00980174|588828477|FG000|Overall Study|Death|1|||
163034076|NCT00980174|588828478|FG001|Overall Study|Death|1|||
163034077|NCT00980174|588828477|FG000|Overall Study|Other|0|||
163034078|NCT00980174|588828478|FG001|Overall Study|Other|1|||
163034079|NCT01546038|588828480|FG000|Overall Study|Death|15|||
163034080|NCT01546038|588828481|FG001|Overall Study|Death|6|||
163034081|NCT01546038|588828482|FG002|Overall Study|Death|4|||
163034082|NCT01546038|588828483|FG003|Overall Study|Death|2|||
163034083|NCT01546038|588828484|FG004|Overall Study|Death|9|||
163034084|NCT01546038|588828485|FG005|Overall Study|Death|3|||
163034085|NCT01546038|588828486|FG006|Overall Study|Death|46|||
163034086|NCT01546038|588828487|FG007|Overall Study|Death|76|||
163034087|NCT01546038|588828488|FG008|Overall Study|Death|39|||
163034088|NCT01546038|588828480|FG000|Overall Study|Lost to Follow-up|0|||
163034089|NCT01546038|588828481|FG001|Overall Study|Lost to Follow-up|0|||
163034090|NCT01546038|588828482|FG002|Overall Study|Lost to Follow-up|0|||
163034091|NCT01546038|588828483|FG003|Overall Study|Lost to Follow-up|0|||
163034092|NCT01546038|588828484|FG004|Overall Study|Lost to Follow-up|1|||
163034093|NCT01546038|588828485|FG005|Overall Study|Lost to Follow-up|0|||
163034094|NCT01546038|588828486|FG006|Overall Study|Lost to Follow-up|2|||
163034095|NCT01546038|588828487|FG007|Overall Study|Lost to Follow-up|1|||
163034096|NCT01546038|588828488|FG008|Overall Study|Lost to Follow-up|0|||
163034097|NCT01546038|588828480|FG000|Overall Study|Withdrawal by Subject|1|||
163034098|NCT01546038|588828481|FG001|Overall Study|Withdrawal by Subject|0|||
163034099|NCT01546038|588828482|FG002|Overall Study|Withdrawal by Subject|0|||
163034100|NCT01546038|588828483|FG003|Overall Study|Withdrawal by Subject|1|||
163034101|NCT01546038|588828484|FG004|Overall Study|Withdrawal by Subject|0|||
163034102|NCT01546038|588828485|FG005|Overall Study|Withdrawal by Subject|1|||
163034103|NCT01546038|588828486|FG006|Overall Study|Withdrawal by Subject|3|||
163034104|NCT01546038|588828487|FG007|Overall Study|Withdrawal by Subject|3|||
163034105|NCT01546038|588828488|FG008|Overall Study|Withdrawal by Subject|1|||
163034106|NCT01546038|588828480|FG000|Overall Study|: Randomized, not treated|0|||
163034107|NCT01546038|588828481|FG001|Overall Study|: Randomized, not treated|0|||
163034108|NCT01546038|588828482|FG002|Overall Study|: Randomized, not treated|0|||
163034109|NCT01546038|588828483|FG003|Overall Study|: Randomized, not treated|0|||
163034110|NCT01546038|588828484|FG004|Overall Study|: Randomized, not treated|0|||
163034111|NCT01546038|588828485|FG005|Overall Study|: Randomized, not treated|0|||
163034112|NCT01546038|588828486|FG006|Overall Study|: Randomized, not treated|2|||
163034113|NCT01546038|588828487|FG007|Overall Study|: Randomized, not treated|4|||
163034114|NCT01546038|588828488|FG008|Overall Study|: Randomized, not treated|3|||
163034115|NCT00424021|588828489|FG000|NCT00046319 Study Period|Adverse Event|1|||
163034116|NCT00424021|588828490|FG001|NCT00046319 Study Period|Adverse Event|0|||
163034117|NCT00424021|588828491|FG002|NCT00046319 Study Period|Adverse Event|1|||
163034118|NCT00424021|588828492|FG003|NCT00046319 Study Period|Adverse Event|1|||
163034119|NCT00424021|588828489|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034120|NCT00424021|588828490|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
163034121|NCT00424021|588828491|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034122|NCT00424021|588828492|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
163034123|NCT00424021|588828489|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
163034124|NCT00424021|588828490|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
163034125|NCT00424021|588828491|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
163034126|NCT00424021|588828492|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
163034127|NCT00424021|588828489|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
163034128|NCT00424021|588828490|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
163034129|NCT00424021|588828491|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
162648329|NCT00489853|587429828|FG001|Wash-out Period 2|Adverse Event|1|||
162648330|NCT00489853|587429829|FG002|Wash-out Period 2|Adverse Event|0|||
162648331|NCT00489853|587429827|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
162648332|NCT00489853|587429828|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
162648333|NCT00489853|587429829|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
162648334|NCT00489853|587429827|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
162648335|NCT00489853|587429828|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
162648336|NCT00489853|587429829|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
163034130|NCT00424021|588828492|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
163034131|NCT00424021|588828489|FG000|AMB-220-E Study Period|Adverse Event|1|||
163034132|NCT00424021|588828490|FG001|AMB-220-E Study Period|Adverse Event|1|||
163034133|NCT00424021|588828491|FG002|AMB-220-E Study Period|Adverse Event|3|||
163034134|NCT00424021|588828492|FG003|AMB-220-E Study Period|Adverse Event|7|||
163034135|NCT00424021|588828489|FG000|AMB-220-E Study Period|Death|0|||
163034136|NCT00424021|588828490|FG001|AMB-220-E Study Period|Death|0|||
163034137|NCT00424021|588828491|FG002|AMB-220-E Study Period|Death|1|||
163034138|NCT00424021|588828492|FG003|AMB-220-E Study Period|Death|1|||
163034139|NCT00424021|588828489|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
163034140|NCT00424021|588828490|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
163034141|NCT00424021|588828491|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
163034142|NCT00424021|588828492|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
163034143|NCT00424021|588828489|FG000|AMB-220-E Study Period|Physician Decision|0|||
163034144|NCT00424021|588828490|FG001|AMB-220-E Study Period|Physician Decision|0|||
163034145|NCT00424021|588828491|FG002|AMB-220-E Study Period|Physician Decision|0|||
163034146|NCT00424021|588828492|FG003|AMB-220-E Study Period|Physician Decision|1|||
163034147|NCT01832818|588828493|FG000|Overall Study|Lost to Follow-up|6|||
162648337|NCT03265249|587429834|FG000|Overall Study|Withdrawal by Subject|0|||
162648338|NCT03265249|587429835|FG001|Overall Study|Withdrawal by Subject|1|||
162648339|NCT02520011|587429840|FG000|Overall Study|Adverse Event|0|||
162648340|NCT02520011|587429841|FG001|Overall Study|Adverse Event|1|||
162648341|NCT02520011|587429842|FG002|Overall Study|Adverse Event|2|||
162648342|NCT02520011|587429840|FG000|Overall Study|Death|0|||
162648343|NCT02520011|587429841|FG001|Overall Study|Death|8|||
162648344|NCT02520011|587429842|FG002|Overall Study|Death|1|||
162648345|NCT02520011|587429840|FG000|Overall Study|Lack of Efficacy|4|||
162648346|NCT02520011|587429841|FG001|Overall Study|Lack of Efficacy|26|||
162648347|NCT02520011|587429842|FG002|Overall Study|Lack of Efficacy|4|||
162648348|NCT02520011|587429840|FG000|Overall Study|Physician Decision|0|||
162648349|NCT02520011|587429841|FG001|Overall Study|Physician Decision|2|||
162648350|NCT02520011|587429842|FG002|Overall Study|Physician Decision|0|||
162648351|NCT02520011|587429840|FG000|Overall Study|Withdrawal by Subject|1|||
162648352|NCT02520011|587429841|FG001|Overall Study|Withdrawal by Subject|3|||
162648353|NCT02520011|587429842|FG002|Overall Study|Withdrawal by Subject|0|||
162648354|NCT02520011|587429840|FG000|Overall Study|Protocol Deviation|0|||
162648355|NCT02520011|587429841|FG001|Overall Study|Protocol Deviation|1|||
162648356|NCT02520011|587429842|FG002|Overall Study|Protocol Deviation|0|||
162648357|NCT02520011|587429840|FG000|Overall Study|Patient went to hospice|0|||
162648358|NCT02520011|587429841|FG001|Overall Study|Patient went to hospice|1|||
162648359|NCT02520011|587429842|FG002|Overall Study|Patient went to hospice|0|||
162648360|NCT02520011|587429840|FG000|Overall Study|Progressive disease following response|0|||
162648361|NCT02520011|587429841|FG001|Overall Study|Progressive disease following response|4|||
162648362|NCT02520011|587429842|FG002|Overall Study|Progressive disease following response|2|||
162648363|NCT00644969|587429843|FG000|Treatment Phase|Randomized, not treated|1|||
162648364|NCT00644969|587429844|FG001|Treatment Phase|Randomized, not treated|0|||
162648365|NCT00644969|587429843|FG000|Treatment Phase|Adverse Event|3|||
162648366|NCT00644969|587429844|FG001|Treatment Phase|Adverse Event|0|||
162648367|NCT00644969|587429843|FG000|Treatment Phase|Withdrawal by Subject|4|||
162648368|NCT00644969|587429844|FG001|Treatment Phase|Withdrawal by Subject|0|||
162648369|NCT00644969|587429843|FG000|Treatment Phase|Lost to Follow-up|2|||
162648370|NCT00644969|587429844|FG001|Treatment Phase|Lost to Follow-up|2|||
162648371|NCT00644969|587429843|FG000|Treatment Phase|Other|4|||
162648372|NCT00644969|587429844|FG001|Treatment Phase|Other|1|||
162648373|NCT00644969|587429843|FG000|Post Treatment Phase|Death|1|||
162648374|NCT00644969|587429844|FG001|Post Treatment Phase|Death|0|||
162648375|NCT00644969|587429843|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
162648376|NCT00644969|587429844|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
162648377|NCT00644969|587429843|FG000|Post Treatment Phase|Lost to Follow-up|4|||
162648378|NCT00644969|587429844|FG001|Post Treatment Phase|Lost to Follow-up|1|||
162648379|NCT00644969|587429843|FG000|Post Treatment Phase|Other|1|||
162648380|NCT00644969|587429844|FG001|Post Treatment Phase|Other|0|||
162648381|NCT01933048|587429845|FG000|Overall Study|Lost to Follow-up|15|||
162648382|NCT01933048|587429846|FG001|Overall Study|Lost to Follow-up|18|||
162648383|NCT01933048|587429845|FG000|Overall Study|personal reasons|1|||
162648384|NCT01933048|587429846|FG001|Overall Study|personal reasons|1|||
162648385|NCT01933048|587429845|FG000|Overall Study|Protocol Violation|7|||
162648386|NCT01933048|587429846|FG001|Overall Study|Protocol Violation|8|||
162648387|NCT01933048|587429845|FG000|Overall Study|Physician Decision|1|||
162648388|NCT01933048|587429846|FG001|Overall Study|Physician Decision|0|||
162648389|NCT01933048|587429845|FG000|Overall Study|unknown reasons|1|||
162648390|NCT01933048|587429846|FG001|Overall Study|unknown reasons|1|||
162648391|NCT02780804|587429847|FG000|Overall Study|Death|1|||
162648392|NCT02780804|587429848|FG001|Overall Study|Death|0|||
162648393|NCT02780804|587429849|FG002|Overall Study|Death|0|||
162648394|NCT02780804|587429847|FG000|Overall Study|Lack of Efficacy|5|||
162648395|NCT02780804|587429848|FG001|Overall Study|Lack of Efficacy|8|||
162648396|NCT02780804|587429849|FG002|Overall Study|Lack of Efficacy|4|||
162648397|NCT02780804|587429847|FG000|Overall Study|Physician Decision|0|||
162648398|NCT02780804|587429848|FG001|Overall Study|Physician Decision|0|||
162648399|NCT02780804|587429849|FG002|Overall Study|Physician Decision|2|||
162648400|NCT02780804|587429847|FG000|Overall Study|Withdrawal by Subject|0|||
163034148|NCT00236899|588828494|FG000|Overall Study|Adverse Event (Study Related)|1|||
162648401|NCT02780804|587429848|FG001|Overall Study|Withdrawal by Subject|1|||
162648402|NCT02780804|587429849|FG002|Overall Study|Withdrawal by Subject|0|||
163034149|NCT00236899|588828495|FG001|Overall Study|Adverse Event (Study Related)|1|||
162648403|NCT02476968|587429850|FG000|Overall Study|Other|0|||
162648404|NCT02476968|587429851|FG001|Overall Study|Other|2|||
162648405|NCT02476968|587429852|FG002|Overall Study|Other|0|||
162648406|NCT02476968|587429850|FG000|Overall Study|Lost to Follow-up|10|||
162648407|NCT02476968|587429851|FG001|Overall Study|Lost to Follow-up|0|||
162648408|NCT02476968|587429852|FG002|Overall Study|Lost to Follow-up|1|||
162648409|NCT02476968|587429850|FG000|Overall Study|Death|48|||
162648410|NCT02476968|587429851|FG001|Overall Study|Death|8|||
162648411|NCT02476968|587429852|FG002|Overall Study|Death|1|||
163034150|NCT00236899|588828496|FG002|Overall Study|Adverse Event (Study Related)|2|||
162648412|NCT02476968|587429850|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162648413|NCT02476968|587429851|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162648414|NCT02476968|587429852|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
163034151|NCT00236899|588828497|FG003|Overall Study|Adverse Event (Study Related)|1|||
163034152|NCT00236899|588828494|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
163034153|NCT00236899|588828495|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
163034154|NCT00236899|588828496|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
163034155|NCT00236899|588828497|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
163034156|NCT00236899|588828494|FG000|Overall Study|Death (Study Disease)|1|||
163034157|NCT00236899|588828495|FG001|Overall Study|Death (Study Disease)|4|||
163034158|NCT00236899|588828496|FG002|Overall Study|Death (Study Disease)|0|||
163034159|NCT00236899|588828497|FG003|Overall Study|Death (Study Disease)|0|||
163034160|NCT00236899|588828494|FG000|Overall Study|Death (Not Study Related)|2|||
163034161|NCT00236899|588828495|FG001|Overall Study|Death (Not Study Related)|0|||
163034162|NCT00236899|588828496|FG002|Overall Study|Death (Not Study Related)|0|||
163034163|NCT00236899|588828497|FG003|Overall Study|Death (Not Study Related)|0|||
163034164|NCT00236899|588828494|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
163034165|NCT00236899|588828495|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
163034166|NCT00236899|588828496|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
163034167|NCT00236899|588828497|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
163034168|NCT00236899|588828494|FG000|Overall Study|Lost to Follow-up|0|||
163034169|NCT00236899|588828495|FG001|Overall Study|Lost to Follow-up|1|||
163034170|NCT00236899|588828496|FG002|Overall Study|Lost to Follow-up|0|||
163034171|NCT00236899|588828497|FG003|Overall Study|Lost to Follow-up|0|||
163034172|NCT00236899|588828494|FG000|Overall Study|Entry Criteria Exclusion|0|||
163034173|NCT00236899|588828495|FG001|Overall Study|Entry Criteria Exclusion|1|||
163034174|NCT00236899|588828496|FG002|Overall Study|Entry Criteria Exclusion|1|||
163034175|NCT00236899|588828497|FG003|Overall Study|Entry Criteria Exclusion|0|||
163034176|NCT00236899|588828494|FG000|Overall Study|Protocol Violation|1|||
163034177|NCT00236899|588828495|FG001|Overall Study|Protocol Violation|0|||
163034178|NCT00236899|588828496|FG002|Overall Study|Protocol Violation|0|||
163034179|NCT00236899|588828497|FG003|Overall Study|Protocol Violation|0|||
163034180|NCT00236899|588828494|FG000|Overall Study|Withdrawal by Subject|6|||
163034181|NCT00236899|588828495|FG001|Overall Study|Withdrawal by Subject|4|||
163034182|NCT00236899|588828496|FG002|Overall Study|Withdrawal by Subject|5|||
163034183|NCT00236899|588828497|FG003|Overall Study|Withdrawal by Subject|2|||
163034184|NCT00236899|588828494|FG000|Overall Study|Physician Decision|7|||
163034185|NCT00236899|588828495|FG001|Overall Study|Physician Decision|8|||
163034186|NCT00236899|588828496|FG002|Overall Study|Physician Decision|7|||
163034187|NCT00236899|588828497|FG003|Overall Study|Physician Decision|6|||
163034188|NCT00236899|588828494|FG000|Overall Study|Satisfactory Response|2|||
163034189|NCT00236899|588828495|FG001|Overall Study|Satisfactory Response|0|||
162648415|NCT02476968|587429850|FG000|Overall Study|Patient decision|37|||
162648416|NCT02476968|587429851|FG001|Overall Study|Patient decision|8|||
162648417|NCT02476968|587429852|FG002|Overall Study|Patient decision|0|||
162648418|NCT04171414|587429857|FG000|Overall Study|Death|1|||
162648419|NCT04171414|587429857|FG000|Overall Study|Withdrawal by Subject|1|||
162648420|NCT01714310|587429858|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
162648421|NCT01714310|587429859|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
162648422|NCT01714310|587429860|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
162648423|NCT01714310|587429858|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
162648424|NCT01714310|587429859|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
163034190|NCT00236899|588828496|FG002|Overall Study|Satisfactory Response|0|||
162648425|NCT01714310|587429860|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
162648426|NCT01714310|587429858|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
162648427|NCT01714310|587429859|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
162648428|NCT01714310|587429860|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
162648429|NCT01714310|587429858|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
162648430|NCT01714310|587429859|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
162648431|NCT01714310|587429860|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
163034191|NCT00236899|588828497|FG003|Overall Study|Satisfactory Response|1|||
163034192|NCT00236899|588828494|FG000|Overall Study|Lack of Efficacy|18|||
163034193|NCT00236899|588828495|FG001|Overall Study|Lack of Efficacy|18|||
163034194|NCT00236899|588828496|FG002|Overall Study|Lack of Efficacy|25|||
163034195|NCT00236899|588828497|FG003|Overall Study|Lack of Efficacy|23|||
163034196|NCT02565706|588828502|FG000|Overall Study|Withdrawal by Subject|5|||
163034197|NCT02565706|588828503|FG001|Overall Study|Withdrawal by Subject|7|||
163034198|NCT02565706|588828504|FG002|Overall Study|Withdrawal by Subject|7|||
163034199|NCT02565706|588828505|FG003|Overall Study|Withdrawal by Subject|11|||
163034200|NCT02565706|588828502|FG000|Overall Study|Lost to Follow-up|72|||
163034201|NCT02565706|588828503|FG001|Overall Study|Lost to Follow-up|75|||
163034202|NCT02565706|588828504|FG002|Overall Study|Lost to Follow-up|82|||
163034203|NCT02565706|588828505|FG003|Overall Study|Lost to Follow-up|74|||
163034204|NCT00568334|588828506|FG000|Overall Study|Withdrawal by Subject|0|||
163034205|NCT00568334|588828507|FG001|Overall Study|Withdrawal by Subject|1|||
163034206|NCT00568334|588828506|FG000|Overall Study|Lost to Follow-up|1|||
163034207|NCT00568334|588828507|FG001|Overall Study|Lost to Follow-up|0|||
163034208|NCT01897571|588828508|FG000|Overall Study|Lost to Follow-up|3|||
163034209|NCT01897571|588828509|FG001|Overall Study|Lost to Follow-up|0|||
163034210|NCT01897571|588828510|FG002|Overall Study|Lost to Follow-up|0|||
163034211|NCT01897571|588828511|FG003|Overall Study|Lost to Follow-up|0|||
163034212|NCT01897571|588828512|FG004|Overall Study|Lost to Follow-up|2|||
163034213|NCT01897571|588828513|FG005|Overall Study|Lost to Follow-up|0|||
163034214|NCT01897571|588828514|FG006|Overall Study|Lost to Follow-up|0|||
163034215|NCT01897571|588828515|FG007|Overall Study|Lost to Follow-up|0|||
163034216|NCT01897571|588828516|FG008|Overall Study|Lost to Follow-up|1|||
163034217|NCT01897571|588828517|FG009|Overall Study|Lost to Follow-up|2|||
163034218|NCT01897571|588828518|FG010|Overall Study|Lost to Follow-up|4|||
163034219|NCT01897571|588828508|FG000|Overall Study|Withdrawal by Subject|0|||
163034220|NCT01897571|588828509|FG001|Overall Study|Withdrawal by Subject|0|||
163034221|NCT01897571|588828510|FG002|Overall Study|Withdrawal by Subject|0|||
163034222|NCT01897571|588828511|FG003|Overall Study|Withdrawal by Subject|0|||
163034223|NCT01897571|588828512|FG004|Overall Study|Withdrawal by Subject|0|||
163034224|NCT01897571|588828513|FG005|Overall Study|Withdrawal by Subject|0|||
163034225|NCT01897571|588828514|FG006|Overall Study|Withdrawal by Subject|0|||
163034226|NCT01897571|588828515|FG007|Overall Study|Withdrawal by Subject|1|||
163034227|NCT01897571|588828516|FG008|Overall Study|Withdrawal by Subject|4|||
163034228|NCT01897571|588828517|FG009|Overall Study|Withdrawal by Subject|3|||
163034229|NCT01897571|588828518|FG010|Overall Study|Withdrawal by Subject|1|||
163034230|NCT01897571|588828508|FG000|Overall Study|Other|1|||
163034231|NCT01897571|588828509|FG001|Overall Study|Other|0|||
163034232|NCT01897571|588828510|FG002|Overall Study|Other|0|||
163034233|NCT01897571|588828511|FG003|Overall Study|Other|3|||
163034234|NCT01897571|588828512|FG004|Overall Study|Other|3|||
163034235|NCT01897571|588828513|FG005|Overall Study|Other|4|||
163034236|NCT01897571|588828514|FG006|Overall Study|Other|7|||
163034237|NCT01897571|588828515|FG007|Overall Study|Other|0|||
163034238|NCT01897571|588828516|FG008|Overall Study|Other|0|||
163034239|NCT01897571|588828517|FG009|Overall Study|Other|0|||
163034240|NCT01897571|588828518|FG010|Overall Study|Other|0|||
163034241|NCT01897571|588828508|FG000|Overall Study|Enrolled in rollover study|0|||
163034242|NCT01897571|588828509|FG001|Overall Study|Enrolled in rollover study|0|||
163034243|NCT01897571|588828510|FG002|Overall Study|Enrolled in rollover study|0|||
163034244|NCT01897571|588828511|FG003|Overall Study|Enrolled in rollover study|0|||
163034245|NCT01897571|588828512|FG004|Overall Study|Enrolled in rollover study|0|||
163034246|NCT01897571|588828513|FG005|Overall Study|Enrolled in rollover study|0|||
163034247|NCT01897571|588828514|FG006|Overall Study|Enrolled in rollover study|0|||
163034248|NCT01897571|588828515|FG007|Overall Study|Enrolled in rollover study|9|||
163034249|NCT01897571|588828516|FG008|Overall Study|Enrolled in rollover study|7|||
163034250|NCT01897571|588828517|FG009|Overall Study|Enrolled in rollover study|9|||
163034251|NCT01897571|588828518|FG010|Overall Study|Enrolled in rollover study|1|||
163034252|NCT01897571|588828508|FG000|Overall Study|Death|2|||
163034253|NCT01897571|588828509|FG001|Overall Study|Death|2|||
163034254|NCT01897571|588828510|FG002|Overall Study|Death|3|||
163034255|NCT01897571|588828511|FG003|Overall Study|Death|6|||
163034256|NCT01897571|588828512|FG004|Overall Study|Death|7|||
163034257|NCT01897571|588828513|FG005|Overall Study|Death|9|||
163034258|NCT01897571|588828514|FG006|Overall Study|Death|5|||
163034259|NCT01897571|588828515|FG007|Overall Study|Death|22|||
163034260|NCT01897571|588828516|FG008|Overall Study|Death|23|||
163034261|NCT01897571|588828517|FG009|Overall Study|Death|129|||
163034262|NCT01897571|588828518|FG010|Overall Study|Death|59|||
163034263|NCT01797094|588828519|FG000|Overall Study|Adverse Event|1|||
163034264|NCT01797094|588828520|FG001|Overall Study|Adverse Event|1|||
163034265|NCT01797094|588828519|FG000|Overall Study|Personal Reasons|4|||
163034266|NCT01797094|588828520|FG001|Overall Study|Personal Reasons|0|||
163034267|NCT01797094|588828519|FG000|Overall Study|Protocol Violation|0|||
163034268|NCT01797094|588828520|FG001|Overall Study|Protocol Violation|1|||
163034269|NCT01797094|588828519|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163034270|NCT01797094|588828520|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163034271|NCT03217968|588828523|FG000|Overall Study|Withdrawal by Subject|4|||
163034272|NCT03217968|588828523|FG000|Overall Study|Lost to Follow-up|1|||
163034273|NCT03217968|588828523|FG000|Overall Study|Protocol Violation|6|||
163034274|NCT03008278|588828524|FG000|Overall Study|Progressive Disease|0|||
163034275|NCT03008278|588828525|FG001|Overall Study|Progressive Disease|0|||
163034276|NCT03008278|588828526|FG002|Overall Study|Progressive Disease|32|||
163034277|NCT03008278|588828524|FG000|Overall Study|Adverse Event|0|||
163034278|NCT03008278|588828525|FG001|Overall Study|Adverse Event|0|||
163034279|NCT03008278|588828526|FG002|Overall Study|Adverse Event|4|||
163034280|NCT03008278|588828524|FG000|Overall Study|Withdrawal by Subject|0|||
163034281|NCT03008278|588828525|FG001|Overall Study|Withdrawal by Subject|0|||
163034282|NCT03008278|588828526|FG002|Overall Study|Withdrawal by Subject|3|||
163034283|NCT03008278|588828524|FG000|Overall Study|Physician Decision|0|||
163034284|NCT03008278|588828525|FG001|Overall Study|Physician Decision|2|||
163034285|NCT03008278|588828526|FG002|Overall Study|Physician Decision|0|||
163034286|NCT01074255|588828527|FG000|Overall Study|Did not receive EMEND|2|||
162648432|NCT02487394|587429861|FG000|Phase 1|Withdrawal by Subject|0|||
162648433|NCT02487394|587429862|FG001|Phase 1|Withdrawal by Subject|1|||
162648434|NCT00704535|587429863|FG000|Overall Study|Adverse Event|2|||
162648435|NCT00704535|587429863|FG000|Overall Study|Death|2|||
162648436|NCT00704535|587429863|FG000|Overall Study|Lost to Follow-up|8|||
162648437|NCT00704535|587429863|FG000|Overall Study|Protocol Violation|10|||
162648438|NCT00704535|587429863|FG000|Overall Study|Completed status not on Case Report Form|124|||
162648439|NCT03161483|587429878|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162648440|NCT03161483|587429879|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
162648441|NCT03161483|587429880|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162648442|NCT03161483|587429881|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162648443|NCT03161483|587429878|FG000|Treatment Period|Death|1|||
162648444|NCT03161483|587429879|FG001|Treatment Period|Death|0|||
162648445|NCT03161483|587429880|FG002|Treatment Period|Death|0|||
162648446|NCT03161483|587429881|FG003|Treatment Period|Death|0|||
162648447|NCT03161483|587429878|FG000|Treatment Period|Adverse Event|5|||
162648448|NCT03161483|587429879|FG001|Treatment Period|Adverse Event|2|||
162648449|NCT03161483|587429880|FG002|Treatment Period|Adverse Event|1|||
162648450|NCT03161483|587429881|FG003|Treatment Period|Adverse Event|11|||
162648451|NCT03161483|587429878|FG000|Treatment Period|Pregnancy|1|||
162648452|NCT03161483|587429879|FG001|Treatment Period|Pregnancy|0|||
162648453|NCT03161483|587429880|FG002|Treatment Period|Pregnancy|0|||
162648454|NCT03161483|587429881|FG003|Treatment Period|Pregnancy|0|||
162648455|NCT03161483|587429878|FG000|Treatment Period|Lack of Efficacy|0|||
162648456|NCT03161483|587429879|FG001|Treatment Period|Lack of Efficacy|0|||
162648457|NCT03161483|587429880|FG002|Treatment Period|Lack of Efficacy|0|||
162648458|NCT03161483|587429881|FG003|Treatment Period|Lack of Efficacy|1|||
162648459|NCT03161483|587429878|FG000|Treatment Period|Withdrawal by Subject|2|||
162648460|NCT03161483|587429879|FG001|Treatment Period|Withdrawal by Subject|5|||
162648461|NCT03161483|587429880|FG002|Treatment Period|Withdrawal by Subject|2|||
162648462|NCT03161483|587429881|FG003|Treatment Period|Withdrawal by Subject|6|||
162648463|NCT03161483|587429878|FG000|Treatment Period|Lost to Follow-up|0|||
162648464|NCT03161483|587429879|FG001|Treatment Period|Lost to Follow-up|0|||
162648465|NCT03161483|587429880|FG002|Treatment Period|Lost to Follow-up|0|||
162648466|NCT03161483|587429881|FG003|Treatment Period|Lost to Follow-up|1|||
162648467|NCT03161483|587429878|FG000|Treatment Period|Protocol Violation|0|||
162648468|NCT03161483|587429879|FG001|Treatment Period|Protocol Violation|0|||
162648469|NCT03161483|587429880|FG002|Treatment Period|Protocol Violation|0|||
162648470|NCT03161483|587429881|FG003|Treatment Period|Protocol Violation|1|||
162648471|NCT03161483|587429878|FG000|Treatment Period|Other reasons|1|||
162648472|NCT03161483|587429879|FG001|Treatment Period|Other reasons|1|||
162648473|NCT03161483|587429880|FG002|Treatment Period|Other reasons|0|||
162648474|NCT03161483|587429881|FG003|Treatment Period|Other reasons|0|||
162648475|NCT00600756|587429884|FG000|Analysis After 6 Months|Adverse Event|43|||
162648476|NCT00600756|587429885|FG001|Analysis After 6 Months|Adverse Event|33|||
162648477|NCT00600756|587429884|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
162648478|NCT00600756|587429885|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
162648479|NCT00600756|587429884|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
162648480|NCT00600756|587429885|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
162648481|NCT00600756|587429884|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
162648482|NCT00600756|587429885|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
162648483|NCT00600756|587429884|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
162718170|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
162718171|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
162718172|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162718173|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162718174|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162648484|NCT00600756|587429885|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
162648485|NCT00600756|587429884|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
162648486|NCT00600756|587429885|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
162648487|NCT00600756|587429884|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
162648488|NCT00600756|587429885|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
162648489|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
162648490|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
162648491|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
162648492|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
162648493|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
162648494|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
162718175|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162648495|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
162648496|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
162648497|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
163034287|NCT01389258|588828528|FG000|Overall Study|Lost to Follow-up|5|||
162648498|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
162648499|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
162648500|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
162648501|NCT00600756|587429884|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
162648502|NCT00600756|587429885|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
162648503|NCT04753164|587429886|FG000|Overall Study|Adverse Event|0|||
162648504|NCT04753164|587429887|FG001|Overall Study|Adverse Event|2|||
162648505|NCT04753164|587429886|FG000|Overall Study|Withdrawal by Subject|9|||
162648506|NCT04753164|587429887|FG001|Overall Study|Withdrawal by Subject|7|||
162648507|NCT04753164|587429886|FG000|Overall Study|Lost to Follow-up|6|||
162648508|NCT04753164|587429887|FG001|Overall Study|Lost to Follow-up|6|||
162648509|NCT04753164|587429886|FG000|Overall Study|Other|12|||
162648510|NCT04753164|587429887|FG001|Overall Study|Other|5|||
162648511|NCT00694369|587429888|FG000|Overall Study|Adverse Event|0|||
162648512|NCT00694369|587429889|FG001|Overall Study|Adverse Event|1|||
162648513|NCT00694369|587429890|FG002|Overall Study|Adverse Event|0|||
162648514|NCT00694369|587429891|FG003|Overall Study|Adverse Event|1|||
162648515|NCT00694369|587429892|FG004|Overall Study|Adverse Event|3|||
162648516|NCT00694369|587429888|FG000|Overall Study|Lost to Follow-up|0|||
162648517|NCT00694369|587429889|FG001|Overall Study|Lost to Follow-up|0|||
162648518|NCT00694369|587429890|FG002|Overall Study|Lost to Follow-up|1|||
162648519|NCT00694369|587429891|FG003|Overall Study|Lost to Follow-up|1|||
162648520|NCT00694369|587429892|FG004|Overall Study|Lost to Follow-up|0|||
162648521|NCT00694369|587429888|FG000|Overall Study|Physician Decision|0|||
162648522|NCT00694369|587429889|FG001|Overall Study|Physician Decision|0|||
162648523|NCT00694369|587429890|FG002|Overall Study|Physician Decision|0|||
162648524|NCT00694369|587429891|FG003|Overall Study|Physician Decision|0|||
162648525|NCT00694369|587429892|FG004|Overall Study|Physician Decision|1|||
162648526|NCT00694369|587429888|FG000|Overall Study|Protocol Violation|0|||
162648527|NCT00694369|587429889|FG001|Overall Study|Protocol Violation|1|||
162648528|NCT00694369|587429890|FG002|Overall Study|Protocol Violation|0|||
162648529|NCT00694369|587429891|FG003|Overall Study|Protocol Violation|0|||
162648530|NCT00694369|587429892|FG004|Overall Study|Protocol Violation|0|||
162648531|NCT00694369|587429888|FG000|Overall Study|Withdrawal by Subject|1|||
162648532|NCT00694369|587429889|FG001|Overall Study|Withdrawal by Subject|1|||
162648533|NCT00694369|587429890|FG002|Overall Study|Withdrawal by Subject|1|||
162648534|NCT00694369|587429891|FG003|Overall Study|Withdrawal by Subject|1|||
162648535|NCT00694369|587429892|FG004|Overall Study|Withdrawal by Subject|2|||
162648536|NCT00439556|587429893|FG000|Overall Study|Patient was taken off study for non-comp|0|||
162648537|NCT00439556|587429894|FG001|Overall Study|Patient was taken off study for non-comp|1|||
162648538|NCT00439556|587429895|FG002|Overall Study|Patient was taken off study for non-comp|0|||
162648539|NCT02871739|587429896|FG000|Overall Study|Lost to Follow-up|3|||
162648540|NCT02871739|587429897|FG001|Overall Study|Lost to Follow-up|2|||
162648541|NCT02871739|587429898|FG002|Overall Study|Lost to Follow-up|0|||
162648542|NCT02871739|587429899|FG003|Overall Study|Lost to Follow-up|2|||
162648543|NCT01324388|587429902|FG000|Part 1 of Study|Adverse Event|2|||
162648544|NCT01324388|587429903|FG001|Part 1 of Study|Adverse Event|0|||
162648545|NCT01324388|587429904|FG002|Part 1 of Study|Adverse Event|0|||
162648546|NCT01324388|587429905|FG003|Part 1 of Study|Adverse Event|0|||
162648547|NCT01324388|587429902|FG000|Part 1 of Study|Protocol Violation|1|||
162648548|NCT01324388|587429903|FG001|Part 1 of Study|Protocol Violation|2|||
162648549|NCT01324388|587429904|FG002|Part 1 of Study|Protocol Violation|0|||
162648550|NCT01324388|587429905|FG003|Part 1 of Study|Protocol Violation|0|||
162648551|NCT01324388|587429902|FG000|Part 1 of Study|Physician Decision|1|||
162648552|NCT01324388|587429903|FG001|Part 1 of Study|Physician Decision|0|||
162648553|NCT01324388|587429904|FG002|Part 1 of Study|Physician Decision|0|||
162648554|NCT01324388|587429905|FG003|Part 1 of Study|Physician Decision|0|||
162648555|NCT01324388|587429902|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
162648556|NCT01324388|587429903|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
162648557|NCT01324388|587429904|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
162648558|NCT01324388|587429905|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
162648559|NCT01324388|587429902|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162718176|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
163034288|NCT03313310|588828530|FG000|Phase 2|Lost to Follow-up|4|||
163034289|NCT03313310|588828531|FG001|Phase 2|Lost to Follow-up|0|||
162648560|NCT01324388|587429903|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162648561|NCT01324388|587429904|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
162648562|NCT01324388|587429905|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162648563|NCT01405963|587429906|FG000|Overall Study|Moved Away|2|||
162648564|NCT01405963|587429907|FG001|Overall Study|Moved Away|0|||
162648565|NCT01405963|587429906|FG000|Overall Study|Adverse Event|0|||
162648566|NCT01405963|587429907|FG001|Overall Study|Adverse Event|1|||
162648567|NCT01405963|587429906|FG000|Overall Study|Lost to Follow-up|0|||
162648568|NCT01405963|587429907|FG001|Overall Study|Lost to Follow-up|1|||
162648569|NCT00850395|587429914|FG000|Overall Study|Death|1|||
163034290|NCT03313310|588828530|FG000|Phase 3|Lost to Follow-up|0|||
162718177|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162718178|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162718179|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
162718180|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
162718181|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162718182|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162718183|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162718184|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162718185|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162718186|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
162718187|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718188|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718189|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
162718190|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718191|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718192|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718193|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718194|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718195|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162718196|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718197|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
162718198|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
162718199|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718200|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718201|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718202|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718203|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
162718204|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162718205|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163034291|NCT03313310|588828531|FG001|Phase 3|Lost to Follow-up|1|||
163034292|NCT01281956|588828534|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
163034293|NCT01281956|588828535|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
163034294|NCT03677934|588828538|FG000|Overall Study|Adverse Event|1|||
163034295|NCT03677934|588828539|FG001|Overall Study|Adverse Event|1|||
163034296|NCT03677934|588828538|FG000|Overall Study|Death|8|||
163034297|NCT03677934|588828539|FG001|Overall Study|Death|4|||
163034298|NCT03677934|588828538|FG000|Overall Study|Lost to Follow-up|3|||
163034299|NCT03677934|588828539|FG001|Overall Study|Lost to Follow-up|0|||
163034300|NCT03677934|588828538|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163034301|NCT03677934|588828539|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163034302|NCT03677934|588828538|FG000|Overall Study|Physician Decision|0|||
163034303|NCT03677934|588828539|FG001|Overall Study|Physician Decision|1|||
163034304|NCT03677934|588828538|FG000|Overall Study|Withdrawal by Subject|1|||
163034305|NCT03677934|588828539|FG001|Overall Study|Withdrawal by Subject|7|||
163034306|NCT04769739|588828540|FG000|Overall Study|Colorectal cancer obstruction|2|||
163034307|NCT04769739|588828541|FG001|Overall Study|Colorectal cancer obstruction|0|||
163034308|NCT04769739|588828542|FG002|Overall Study|Colorectal cancer obstruction|0|||
163034309|NCT04769739|588828543|FG003|Overall Study|Colorectal cancer obstruction|0|||
163034310|NCT04769739|588828540|FG000|Overall Study|Failed cecal intubation|1|||
163034311|NCT04769739|588828541|FG001|Overall Study|Failed cecal intubation|0|||
163034312|NCT04769739|588828542|FG002|Overall Study|Failed cecal intubation|0|||
163034313|NCT04769739|588828543|FG003|Overall Study|Failed cecal intubation|1|||
163034314|NCT04769739|588828540|FG000|Overall Study|Poor bowel preparation|0|||
163034315|NCT04769739|588828541|FG001|Overall Study|Poor bowel preparation|0|||
163034316|NCT04769739|588828542|FG002|Overall Study|Poor bowel preparation|0|||
163034317|NCT04769739|588828543|FG003|Overall Study|Poor bowel preparation|1|||
163034318|NCT02407054|588828565|FG000|Overall Study|Adverse Event|1|||
163034319|NCT02407054|588828566|FG001|Overall Study|Adverse Event|4|||
163034320|NCT02407054|588828567|FG002|Overall Study|Adverse Event|1|||
163034321|NCT02407054|588828565|FG000|Overall Study|Non-compliance with Study|0|||
163034322|NCT02407054|588828566|FG001|Overall Study|Non-compliance with Study|2|||
163034323|NCT02407054|588828567|FG002|Overall Study|Non-compliance with Study|1|||
163034324|NCT02407054|588828565|FG000|Overall Study|Physician Decision|1|||
163034325|NCT02407054|588828566|FG001|Overall Study|Physician Decision|3|||
163034326|NCT02407054|588828567|FG002|Overall Study|Physician Decision|3|||
163034327|NCT02407054|588828565|FG000|Overall Study|Withdrawal by Subject|5|||
163034328|NCT02407054|588828566|FG001|Overall Study|Withdrawal by Subject|9|||
163034329|NCT02407054|588828567|FG002|Overall Study|Withdrawal by Subject|2|||
163034330|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
163034331|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034332|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034333|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034334|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
163034335|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
163034336|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
163034337|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034338|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034339|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034340|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
163034341|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034342|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034343|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034344|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034345|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034346|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034347|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
163034348|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034349|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034350|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034351|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
163034352|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
163034353|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
163034354|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
163034355|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
163034356|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
163034357|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
163034358|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
163034359|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
163034360|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
163034361|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
163034362|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
163034363|NCT00932698|588828570|FG000|Part 1 (Dose Escalation)|Other|0|||
163034364|NCT00932698|588828571|FG001|Part 1 (Dose Escalation)|Other|0|||
163034365|NCT00932698|588828572|FG002|Part 1 (Dose Escalation)|Other|1|||
163034366|NCT00932698|588828573|FG003|Part 1 (Dose Escalation)|Other|0|||
163034367|NCT00932698|588828574|FG004|Part 1 (Dose Escalation)|Other|0|||
163034368|NCT00932698|588828575|FG005|Part 1 (Dose Escalation)|Other|0|||
163034369|NCT00932698|588828576|FG006|Part 1 (Dose Escalation)|Other|1|||
163034370|NCT00932698|588828577|FG007|Part 1 (Dose Escalation)|Other|0|||
163034371|NCT00932698|588828578|FG008|Part 1 (Dose Escalation)|Other|0|||
163034372|NCT00932698|588828579|FG009|Part 1 (Dose Escalation)|Other|0|||
163034373|NCT00932698|588828580|FG010|Part 1 (Dose Escalation)|Other|0|||
163034374|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034375|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034376|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034377|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034378|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034379|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034380|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
163034381|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
163034382|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
163034383|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
163034384|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
163034385|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
162648570|NCT00850395|587429914|FG000|Overall Study|Adverse Event|1|||
162648571|NCT00850395|587429914|FG000|Overall Study|Insufficient clinical response|3|||
162648572|NCT00850395|587429914|FG000|Overall Study|Other|5|||
162648573|NCT01737047|587429915|FG000|Overall Study|Death|10|||
162648574|NCT01737047|587429916|FG001|Overall Study|Death|0|||
162648575|NCT01737047|587429917|FG002|Overall Study|Death|1|||
162648576|NCT01737047|587429915|FG000|Overall Study|Withdrawal by Subject|17|||
162648577|NCT01737047|587429916|FG001|Overall Study|Withdrawal by Subject|11|||
162648578|NCT01737047|587429917|FG002|Overall Study|Withdrawal by Subject|4|||
162718206|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
162648579|NCT02802592|587429918|FG000|Overall Study|Study terminated due to loss of funding|4|||
162648580|NCT04007523|587429919|FG000|Overall Study|Withdrawal by Subject|0|||
162718207|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
162718208|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162718209|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162718210|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162718211|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163034386|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034387|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034388|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034389|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034390|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
162648581|NCT04007523|587429920|FG001|Overall Study|Withdrawal by Subject|1|||
162648582|NCT04007523|587429921|FG002|Overall Study|Withdrawal by Subject|1|||
162648583|NCT04007523|587429922|FG003|Overall Study|Withdrawal by Subject|0|||
162648584|NCT04007523|587429919|FG000|Overall Study|ICU Transfer|0|||
162648585|NCT04007523|587429920|FG001|Overall Study|ICU Transfer|1|||
162648586|NCT04007523|587429921|FG002|Overall Study|ICU Transfer|0|||
162648587|NCT04007523|587429922|FG003|Overall Study|ICU Transfer|0|||
163034391|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034392|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
163034393|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
163034394|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
163034395|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
163034396|NCT00932698|588828570|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
162648588|NCT04007523|587429919|FG000|Overall Study|COVID hospital closure|0|||
163034397|NCT00932698|588828571|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
163034398|NCT00932698|588828572|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
163034399|NCT00932698|588828573|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
163034400|NCT00932698|588828574|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
163034401|NCT00932698|588828575|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
163034402|NCT00932698|588828576|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
163034403|NCT00932698|588828577|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
163034404|NCT00932698|588828578|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
163034405|NCT00932698|588828579|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
163034406|NCT00932698|588828580|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
163034407|NCT01447927|588828581|FG000|Overall Study|Adverse Event|4|||
163034408|NCT01447927|588828582|FG001|Overall Study|Adverse Event|3|||
163034409|NCT01447927|588828581|FG000|Overall Study|Withdrawal by Subject|1|||
163034410|NCT01447927|588828582|FG001|Overall Study|Withdrawal by Subject|0|||
163034411|NCT00642954|588830368|FG000|Overall Study|Progressive Disease|3|||
163034412|NCT00642954|588830369|FG001|Overall Study|Progressive Disease|3|||
163085605|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
163085606|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
163085607|NCT03093415|589022327|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
163085608|NCT03093415|589022328|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
163085609|NCT03093415|589022329|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
163085610|NCT03093415|589022327|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
163085611|NCT03093415|589022328|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
163085612|NCT03093415|589022329|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
163085613|NCT03559530|589022330|FG000|Overall Study|non-location of medical records|44|||
163085614|NCT03559530|589022331|FG001|Overall Study|non-location of medical records|0|||
163034413|NCT00642954|588830370|FG002|Overall Study|Progressive Disease|3|||
163034414|NCT00642954|588830371|FG003|Overall Study|Progressive Disease|3|||
163034415|NCT00642954|588830372|FG004|Overall Study|Progressive Disease|9|||
163034416|NCT00642954|588830368|FG000|Overall Study|Withdrawal by Subject|0|||
163034417|NCT00642954|588830369|FG001|Overall Study|Withdrawal by Subject|0|||
163034418|NCT00642954|588830370|FG002|Overall Study|Withdrawal by Subject|0|||
163034419|NCT00642954|588830371|FG003|Overall Study|Withdrawal by Subject|0|||
163034420|NCT00642954|588830372|FG004|Overall Study|Withdrawal by Subject|1|||
163034421|NCT00642954|588830368|FG000|Overall Study|Adverse Event|1|||
163034422|NCT00642954|588830369|FG001|Overall Study|Adverse Event|1|||
163034423|NCT00642954|588830370|FG002|Overall Study|Adverse Event|0|||
163034424|NCT00642954|588830371|FG003|Overall Study|Adverse Event|0|||
163034425|NCT00642954|588830372|FG004|Overall Study|Adverse Event|6|||
163034426|NCT01344759|588830373|FG000|Overall Study|Patients failed to reach sedation level|0|||
163034427|NCT01344759|588830374|FG001|Overall Study|Patients failed to reach sedation level|2|||
163034428|NCT01890759|588830375|FG000|Overall Study|Protocol Violation|0|||
163034429|NCT01890759|588830376|FG001|Overall Study|Protocol Violation|2|||
163034430|NCT01890759|588830375|FG000|Overall Study|Lost to Follow-up|0|||
162648589|NCT04007523|587429920|FG001|Overall Study|COVID hospital closure|0|||
162648590|NCT04007523|587429921|FG002|Overall Study|COVID hospital closure|1|||
162648591|NCT04007523|587429922|FG003|Overall Study|COVID hospital closure|2|||
163034431|NCT01890759|588830376|FG001|Overall Study|Lost to Follow-up|2|||
163034432|NCT01890759|588830375|FG000|Overall Study|Withdrawal by Subject|2|||
163034433|NCT01890759|588830376|FG001|Overall Study|Withdrawal by Subject|8|||
163034434|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
162648592|NCT04007523|587429919|FG000|Overall Study|Surgery cancelled|0|||
162648593|NCT04007523|587429920|FG001|Overall Study|Surgery cancelled|0|||
163034435|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
163034436|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
163034437|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
163034438|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
163034439|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
162648594|NCT04007523|587429921|FG002|Overall Study|Surgery cancelled|1|||
162648595|NCT04007523|587429922|FG003|Overall Study|Surgery cancelled|1|||
162648596|NCT01826487|587429923|FG000|Overall Study|Adverse Event|1|||
162648597|NCT01826487|587429924|FG001|Overall Study|Adverse Event|1|||
162648598|NCT01826487|587429923|FG000|Overall Study|Lost to Follow-up|1|||
162648599|NCT01826487|587429924|FG001|Overall Study|Lost to Follow-up|0|||
162648600|NCT01826487|587429923|FG000|Overall Study|Withdrawal by Subject|1|||
162648601|NCT01826487|587429924|FG001|Overall Study|Withdrawal by Subject|3|||
163034440|NCT04114656|588830379|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
163034441|NCT04114656|588830380|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
163034442|NCT04114656|588830379|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
163034443|NCT04114656|588830380|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
163034444|NCT00703326|588830381|FG000|Overall Study|Lost to Follow-up|47|||
163034445|NCT00703326|588830382|FG001|Overall Study|Lost to Follow-up|18|||
163034446|NCT00703326|588830381|FG000|Overall Study|Withdrawal by Subject|54|||
163034447|NCT00703326|588830382|FG001|Overall Study|Withdrawal by Subject|20|||
163034448|NCT00703326|588830381|FG000|Overall Study|Adverse Event|1|||
163034449|NCT00703326|588830382|FG001|Overall Study|Adverse Event|0|||
163034450|NCT02661061|588830383|FG000|Overall Study|Lack of Efficacy|1|||
163034451|NCT02661061|588830384|FG001|Overall Study|Lack of Efficacy|1|||
163034452|NCT02661061|588830383|FG000|Overall Study|Withdrawal by Subject|1|||
163034453|NCT02661061|588830384|FG001|Overall Study|Withdrawal by Subject|1|||
163034454|NCT02732015|588830385|FG000|Overall Study|Lost to Follow-up|0|||
163034455|NCT02732015|588830386|FG001|Overall Study|Lost to Follow-up|1|||
163034456|NCT03052920|588830387|FG000|Overall Study|Withdrawal by Subject|1|||
163034457|NCT01937715|588830388|FG000|Overall Study|Death|0|||
163034458|NCT01937715|588830389|FG001|Overall Study|Death|0|||
163034459|NCT01937715|588830390|FG002|Overall Study|Death|0|||
163034460|NCT01937715|588830391|FG003|Overall Study|Death|1|||
163034461|NCT01937715|588830392|FG004|Overall Study|Death|0|||
163034462|NCT01937715|588830388|FG000|Overall Study|Withdrawal by Subject|0|||
163034463|NCT01937715|588830389|FG001|Overall Study|Withdrawal by Subject|1|||
163034464|NCT01937715|588830390|FG002|Overall Study|Withdrawal by Subject|0|||
163034465|NCT01937715|588830391|FG003|Overall Study|Withdrawal by Subject|0|||
163034466|NCT01937715|588830392|FG004|Overall Study|Withdrawal by Subject|2|||
163034467|NCT01937715|588830388|FG000|Overall Study|Other|0|||
163034468|NCT01937715|588830389|FG001|Overall Study|Other|0|||
163034469|NCT01937715|588830390|FG002|Overall Study|Other|0|||
163034470|NCT01937715|588830391|FG003|Overall Study|Other|3|||
163034471|NCT01937715|588830392|FG004|Overall Study|Other|0|||
163034472|NCT00433017|588830395|FG000|Overall Study|Adverse Event|5|||
163034473|NCT00433017|588830396|FG001|Overall Study|Adverse Event|3|||
163034474|NCT00433017|588830395|FG000|Overall Study|Withdrawal by Subject|4|||
163034475|NCT00433017|588830396|FG001|Overall Study|Withdrawal by Subject|5|||
163034476|NCT00433017|588830395|FG000|Overall Study|Lost to Follow-up|3|||
163034477|NCT00433017|588830396|FG001|Overall Study|Lost to Follow-up|4|||
163034478|NCT00433017|588830395|FG000|Overall Study|Administrative problems|80|||
163034479|NCT00433017|588830396|FG001|Overall Study|Administrative problems|86|||
163034480|NCT00433017|588830395|FG000|Overall Study|Protocol Violation|1|||
163034481|NCT00433017|588830396|FG001|Overall Study|Protocol Violation|0|||
163034482|NCT00433017|588830395|FG000|Overall Study|Death|2|||
163034483|NCT00433017|588830396|FG001|Overall Study|Death|2|||
163034484|NCT00433017|588830395|FG000|Overall Study|Subject no longer requires study drug|1|||
163034485|NCT00433017|588830396|FG001|Overall Study|Subject no longer requires study drug|1|||
163034486|NCT00153816|588830397|FG000|Overall Study|Death|6|||
163034487|NCT00153816|588830398|FG001|Overall Study|Death|5|||
163034488|NCT00153816|588830399|FG002|Overall Study|Death|4|||
163034489|NCT00153816|588830400|FG003|Overall Study|Death|6|||
163034490|NCT00153816|588830401|FG004|Overall Study|Death|0|||
163034491|NCT00153816|588830402|FG005|Overall Study|Death|2|||
163034492|NCT00153816|588830397|FG000|Overall Study|Lost to Follow-up|7|||
163034493|NCT00153816|588830398|FG001|Overall Study|Lost to Follow-up|8|||
162648602|NCT01826487|587429923|FG000|Overall Study|Protocol Violation|1|||
162648603|NCT01826487|587429924|FG001|Overall Study|Protocol Violation|1|||
162648604|NCT01408030|587429925|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
162648605|NCT01408030|587429926|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
163034494|NCT00153816|588830399|FG002|Overall Study|Lost to Follow-up|5|||
163034495|NCT00153816|588830400|FG003|Overall Study|Lost to Follow-up|8|||
163034496|NCT00153816|588830401|FG004|Overall Study|Lost to Follow-up|7|||
163034497|NCT00153816|588830402|FG005|Overall Study|Lost to Follow-up|9|||
163034498|NCT00153816|588830397|FG000|Overall Study|Withdrawal by Subject|9|||
163085615|NCT03559530|589022330|FG000|Overall Study|culture results not considered for treat|29|||
162648606|NCT01408030|587429927|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
162648607|NCT01408030|587429928|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
163034499|NCT00153816|588830398|FG001|Overall Study|Withdrawal by Subject|9|||
163034500|NCT00153816|588830399|FG002|Overall Study|Withdrawal by Subject|9|||
163034501|NCT00153816|588830400|FG003|Overall Study|Withdrawal by Subject|4|||
163034502|NCT00153816|588830401|FG004|Overall Study|Withdrawal by Subject|1|||
162648608|NCT01408030|587429925|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
162648609|NCT01408030|587429926|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
162648610|NCT01408030|587429927|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
162648611|NCT01408030|587429928|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
162648612|NCT01408030|587429925|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
162648613|NCT01408030|587429926|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
162648614|NCT01408030|587429927|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
162648615|NCT01408030|587429928|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
162648616|NCT01408030|587429925|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
162648617|NCT01408030|587429926|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
162648618|NCT01408030|587429927|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
162648619|NCT01408030|587429928|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
162648620|NCT01408030|587429925|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
162648621|NCT01408030|587429926|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
162648622|NCT01408030|587429927|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
162648623|NCT01408030|587429928|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
162648624|NCT01408030|587429925|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
162648625|NCT01408030|587429926|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
162648626|NCT01408030|587429927|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
162648627|NCT01408030|587429928|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
162648628|NCT01408030|587429925|FG000|Observation Phase (Off Drug)|Other|1|||
163034503|NCT00153816|588830402|FG005|Overall Study|Withdrawal by Subject|5|||
163034504|NCT00153816|588830397|FG000|Overall Study|Follow-up exam not done|8|||
163034505|NCT00153816|588830398|FG001|Overall Study|Follow-up exam not done|7|||
163034506|NCT00153816|588830399|FG002|Overall Study|Follow-up exam not done|11|||
163034507|NCT00153816|588830400|FG003|Overall Study|Follow-up exam not done|10|||
163034508|NCT00153816|588830401|FG004|Overall Study|Follow-up exam not done|8|||
163034509|NCT00153816|588830402|FG005|Overall Study|Follow-up exam not done|9|||
163034510|NCT00153816|588830397|FG000|Overall Study|Follow-up exam done, histology missing|2|||
163034511|NCT00153816|588830398|FG001|Overall Study|Follow-up exam done, histology missing|3|||
163034512|NCT00153816|588830399|FG002|Overall Study|Follow-up exam done, histology missing|3|||
163034513|NCT00153816|588830400|FG003|Overall Study|Follow-up exam done, histology missing|3|||
163034514|NCT00153816|588830401|FG004|Overall Study|Follow-up exam done, histology missing|1|||
163034515|NCT00153816|588830402|FG005|Overall Study|Follow-up exam done, histology missing|2|||
163034516|NCT03594955|588830406|FG000|Overall Study|Adverse Event|1|||
163034517|NCT03594955|588830406|FG000|Overall Study|Progressive disease|5|||
163034518|NCT03594955|588830406|FG000|Overall Study|Sponsor's decision|1|||
163034519|NCT03539484|588830408|FG000|Overall Study|Death|1|||
163034520|NCT03539484|588830409|FG001|Overall Study|Death|0|||
163034521|NCT03539484|588830410|FG002|Overall Study|Death|0|||
163034522|NCT03539484|588830411|FG003|Overall Study|Death|2|||
163034523|NCT03539484|588830412|FG004|Overall Study|Death|8|||
163034524|NCT03539484|588830413|FG005|Overall Study|Death|3|||
163034525|NCT03539484|588830414|FG006|Overall Study|Death|0|||
163034526|NCT03539484|588830408|FG000|Overall Study|Lost to Follow-up|0|||
163034527|NCT03539484|588830409|FG001|Overall Study|Lost to Follow-up|1|||
163034528|NCT03539484|588830410|FG002|Overall Study|Lost to Follow-up|0|||
163034529|NCT03539484|588830411|FG003|Overall Study|Lost to Follow-up|0|||
163034530|NCT03539484|588830412|FG004|Overall Study|Lost to Follow-up|1|||
163034531|NCT03539484|588830413|FG005|Overall Study|Lost to Follow-up|0|||
163034532|NCT03539484|588830414|FG006|Overall Study|Lost to Follow-up|0|||
163034533|NCT03539484|588830408|FG000|Overall Study|Withdrawal by Subject|0|||
163034534|NCT03539484|588830409|FG001|Overall Study|Withdrawal by Subject|0|||
163034535|NCT03539484|588830410|FG002|Overall Study|Withdrawal by Subject|0|||
163034536|NCT03539484|588830411|FG003|Overall Study|Withdrawal by Subject|0|||
163034537|NCT03539484|588830412|FG004|Overall Study|Withdrawal by Subject|2|||
163034538|NCT03539484|588830413|FG005|Overall Study|Withdrawal by Subject|0|||
163034539|NCT03539484|588830414|FG006|Overall Study|Withdrawal by Subject|1|||
163034540|NCT03539484|588830408|FG000|Overall Study|Study Terminated by Sponsor|0|||
163034541|NCT03539484|588830409|FG001|Overall Study|Study Terminated by Sponsor|0|||
163034542|NCT03539484|588830410|FG002|Overall Study|Study Terminated by Sponsor|1|||
163034543|NCT03539484|588830411|FG003|Overall Study|Study Terminated by Sponsor|1|||
163034544|NCT03539484|588830412|FG004|Overall Study|Study Terminated by Sponsor|2|||
163034545|NCT03539484|588830413|FG005|Overall Study|Study Terminated by Sponsor|2|||
163034546|NCT03539484|588830414|FG006|Overall Study|Study Terminated by Sponsor|1|||
163034547|NCT02131636|588830420|FG000|Overall Study|Personal Reasons|4|||
163034548|NCT02131636|588830421|FG001|Overall Study|Personal Reasons|4|||
163034549|NCT02131636|588830420|FG000|Overall Study|Lost to Follow-up|4|||
163034550|NCT02131636|588830421|FG001|Overall Study|Lost to Follow-up|0|||
163034551|NCT02131636|588830420|FG000|Overall Study|Adverse Event|4|||
163034552|NCT02131636|588830421|FG001|Overall Study|Adverse Event|1|||
163034553|NCT02173379|588830422|FG000|Overall Study|Lost to Follow-up|89|||
162648629|NCT01408030|587429926|FG001|Observation Phase (Off Drug)|Other|1|||
163034554|NCT02173379|588830423|FG001|Overall Study|Lost to Follow-up|81|||
163034555|NCT02173379|588830422|FG000|Overall Study|Withdrawal by Subject|24|||
162718212|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
162718213|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
162718214|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718215|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718216|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
162718217|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718218|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718219|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718220|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718221|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718222|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162718223|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162718224|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
162718225|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162718226|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162718227|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162718228|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162718229|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162718230|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162718231|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162718232|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718233|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718234|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718235|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718236|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718237|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718238|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718239|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162718240|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
162718241|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718242|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
162718243|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718244|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718245|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718246|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718247|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718248|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718249|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162718250|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718251|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718252|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
162718253|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718254|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718255|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718256|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718257|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162718258|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
162718259|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163034556|NCT02173379|588830423|FG001|Overall Study|Withdrawal by Subject|29|||
163034557|NCT02173379|588830422|FG000|Overall Study|Physician Decision|8|||
163034558|NCT02173379|588830423|FG001|Overall Study|Physician Decision|8|||
163034559|NCT02173379|588830422|FG000|Overall Study|Death|75|||
163034560|NCT02173379|588830423|FG001|Overall Study|Death|72|||
163034561|NCT02173379|588830422|FG000|Overall Study|Other Reason|1|||
163034562|NCT02173379|588830423|FG001|Overall Study|Other Reason|0|||
163034563|NCT06226649|588830425|FG000|Overall Study|Withdrawal by Subject|4|||
163034564|NCT06226649|588830426|FG001|Overall Study|Withdrawal by Subject|1|||
163034565|NCT00631163|588830431|FG000|Number of Participants in Year 1|Adverse Event|12|||
162718260|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
162718261|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718262|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718263|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718264|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718265|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718266|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162718267|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
162718268|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162718269|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163034566|NCT00631163|588830431|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
163034567|NCT00631163|588830431|FG000|Number of Participants in Year 1|Death|6|||
163034568|NCT00631163|588830431|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
163034569|NCT00631163|588830431|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
163034570|NCT00631163|588830431|FG000|Number of Participants in Year 1|Administrative problems|6|||
163034571|NCT00631163|588830431|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
163034572|NCT00631163|588830431|FG000|Number of Participants in Year 2|Adverse Event|1|||
163034573|NCT00631163|588830431|FG000|Number of Participants in Year 2|Protocol Violation|1|||
163034574|NCT00631163|588830431|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
163034575|NCT02290925|588830432|FG000|First Period of Three Months|Lost to Follow-up|2|||
163034576|NCT02290925|588830433|FG001|First Period of Three Months|Lost to Follow-up|1|||
163034577|NCT02290925|588830432|FG000|First Period of Three Months|Death|1|||
163034578|NCT02290925|588830433|FG001|First Period of Three Months|Death|0|||
163034579|NCT02290925|588830432|FG000|First Period of Three Months|Insulin Started|1|||
163034580|NCT02290925|588830433|FG001|First Period of Three Months|Insulin Started|1|||
163034581|NCT02290925|588830432|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
163034582|NCT02290925|588830433|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
163034583|NCT02290925|588830432|FG000|Second Period of 3 Months|insulin started|0|||
163034584|NCT02290925|588830433|FG001|Second Period of 3 Months|insulin started|1|||
163034585|NCT02305446|588830441|FG000|Overall Study|Adverse Event|1|||
163034586|NCT01636947|588830443|FG000|Overall Study|Not Treated|2|||
163034587|NCT01636947|588830444|FG001|Overall Study|Not Treated|2|||
163034588|NCT01636947|588830443|FG000|Overall Study|Lost to Follow-up|4|||
163034589|NCT01636947|588830444|FG001|Overall Study|Lost to Follow-up|0|||
163085616|NCT03559530|589022331|FG001|Overall Study|culture results not considered for treat|0|||
163085617|NCT03559530|589022330|FG000|Overall Study|duplicate cases|8|||
163085618|NCT03559530|589022331|FG001|Overall Study|duplicate cases|0|||
163085619|NCT03559530|589022330|FG000|Overall Study|other species of Acinetobacte|7|||
163085620|NCT03559530|589022331|FG001|Overall Study|other species of Acinetobacte|0|||
163034590|NCT01636947|588830443|FG000|Overall Study|Protocol Violation|1|||
163034591|NCT01636947|588830444|FG001|Overall Study|Protocol Violation|1|||
163034592|NCT01636947|588830443|FG000|Overall Study|Withdrawal by Subject|3|||
163034593|NCT01636947|588830444|FG001|Overall Study|Withdrawal by Subject|3|||
163034594|NCT01636947|588830443|FG000|Overall Study|Adverse Event|1|||
163034595|NCT01636947|588830444|FG001|Overall Study|Adverse Event|1|||
163034596|NCT01636947|588830443|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163034597|NCT01636947|588830444|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
163034598|NCT00388297|588830447|FG000|Overall Study|Lost to Follow-up|16|||
163034599|NCT00388297|588830448|FG001|Overall Study|Lost to Follow-up|12|||
163034600|NCT00388297|588830449|FG002|Overall Study|Lost to Follow-up|11|||
163034601|NCT00388297|588830450|FG003|Overall Study|Lost to Follow-up|8|||
163034602|NCT00316914|588830452|FG000|Overall Study|Withdrawal by Subject|5|||
163034603|NCT00316914|588830453|FG001|Overall Study|Withdrawal by Subject|3|||
163034604|NCT00316914|588830452|FG000|Overall Study|Adverse Event|8|||
163034605|NCT00316914|588830453|FG001|Overall Study|Adverse Event|7|||
163034606|NCT00316914|588830452|FG000|Overall Study|Other Problems|6|||
163034607|NCT00316914|588830453|FG001|Overall Study|Other Problems|11|||
163034608|NCT00316914|588830452|FG000|Overall Study|Missing end of treatment documentation|14|||
163034609|NCT00316914|588830453|FG001|Overall Study|Missing end of treatment documentation|15|||
163034610|NCT00427999|588830458|FG000|Overall Study|Adverse Event|6|||
163034611|NCT00427999|588830458|FG000|Overall Study|Abnormal laboratory values|1|||
163034612|NCT00427999|588830458|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
163034613|NCT00427999|588830458|FG000|Overall Study|Protocol Violation|2|||
163034614|NCT00427999|588830458|FG000|Overall Study|Withdrawal by Subject|9|||
163034615|NCT00427999|588830458|FG000|Overall Study|Death|1|||
163034616|NCT02284568|588830459|FG000|Overall Study|Adverse Event|2|||
163085621|NCT03559530|589022330|FG000|Overall Study|contamination / colonization|3|||
163085622|NCT03559530|589022331|FG001|Overall Study|contamination / colonization|0|||
163034617|NCT02284568|588830460|FG001|Overall Study|Adverse Event|9|||
163034618|NCT02284568|588830461|FG002|Overall Study|Adverse Event|4|||
163034619|NCT02284568|588830459|FG000|Overall Study|Withdrawal by Subject|22|||
163034620|NCT02284568|588830460|FG001|Overall Study|Withdrawal by Subject|21|||
163034621|NCT02284568|588830461|FG002|Overall Study|Withdrawal by Subject|1|||
163034622|NCT02284568|588830459|FG000|Overall Study|Noncompliance with study drug admin|1|||
163034623|NCT02284568|588830460|FG001|Overall Study|Noncompliance with study drug admin|2|||
163034624|NCT02284568|588830461|FG002|Overall Study|Noncompliance with study drug admin|0|||
163034625|NCT02284568|588830459|FG000|Overall Study|Noncompliance|1|||
163034626|NCT02284568|588830460|FG001|Overall Study|Noncompliance|0|||
163034627|NCT02284568|588830461|FG002|Overall Study|Noncompliance|0|||
163034628|NCT02284568|588830459|FG000|Overall Study|Protocol Violation|0|||
163034629|NCT02284568|588830460|FG001|Overall Study|Protocol Violation|1|||
163034630|NCT02284568|588830461|FG002|Overall Study|Protocol Violation|0|||
163034631|NCT02284568|588830459|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
163034632|NCT02284568|588830460|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
163034633|NCT02284568|588830461|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
163034634|NCT02284568|588830459|FG000|Overall Study|Lost to Follow-up|0|||
163034635|NCT02284568|588830460|FG001|Overall Study|Lost to Follow-up|3|||
163034636|NCT02284568|588830461|FG002|Overall Study|Lost to Follow-up|0|||
163034637|NCT02284568|588830459|FG000|Overall Study|Lack of Efficacy|4|||
163034638|NCT02284568|588830460|FG001|Overall Study|Lack of Efficacy|7|||
163034639|NCT02284568|588830461|FG002|Overall Study|Lack of Efficacy|0|||
163034640|NCT02284568|588830459|FG000|Overall Study|Other|1|||
163085623|NCT01472185|589022332|FG000|Overall Study|Randomized but Not Treated|0|||
163085624|NCT01472185|589022333|FG001|Overall Study|Randomized but Not Treated|1|||
163085625|NCT01472185|589022332|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
163085626|NCT01472185|589022333|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
163085627|NCT01472185|589022332|FG000|Overall Study|Hyperglycemia|5|||
163085628|NCT01472185|589022333|FG001|Overall Study|Hyperglycemia|2|||
163085629|NCT01472185|589022332|FG000|Overall Study|Investigator's Discretion|3|||
163085630|NCT01472185|589022333|FG001|Overall Study|Investigator's Discretion|1|||
163085631|NCT01472185|589022332|FG000|Overall Study|Lost to Follow-up|4|||
163085632|NCT01472185|589022333|FG001|Overall Study|Lost to Follow-up|1|||
163085633|NCT01472185|589022332|FG000|Overall Study|Protocol Violation|5|||
163085634|NCT01472185|589022333|FG001|Overall Study|Protocol Violation|1|||
163085635|NCT01472185|589022332|FG000|Overall Study|Subject Noncompliance|8|||
163085636|NCT01472185|589022333|FG001|Overall Study|Subject Noncompliance|15|||
163085637|NCT01472185|589022332|FG000|Overall Study|Subject Withdrew Consent|6|||
163085638|NCT01472185|589022333|FG001|Overall Study|Subject Withdrew Consent|3|||
163085639|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085640|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
163085641|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085642|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
163034641|NCT02284568|588830460|FG001|Overall Study|Other|2|||
163034642|NCT02284568|588830461|FG002|Overall Study|Other|0|||
163034643|NCT02284568|588830459|FG000|Overall Study|Withdrew before taking study drug|0|||
163034644|NCT02284568|588830460|FG001|Overall Study|Withdrew before taking study drug|1|||
163034645|NCT02284568|588830461|FG002|Overall Study|Withdrew before taking study drug|0|||
163034646|NCT00460265|588830462|FG000|Overall Study|Lost to Follow-up|14|||
163034647|NCT00460265|588830463|FG001|Overall Study|Lost to Follow-up|15|||
163034648|NCT00460265|588830462|FG000|Overall Study|Physician Decision|1|||
163034649|NCT00460265|588830463|FG001|Overall Study|Physician Decision|2|||
163034650|NCT00460265|588830462|FG000|Overall Study|Withdrawal by Subject|10|||
163034651|NCT00460265|588830463|FG001|Overall Study|Withdrawal by Subject|25|||
163034652|NCT00460265|588830462|FG000|Overall Study|Ongoing|60|||
163034653|NCT00460265|588830463|FG001|Overall Study|Ongoing|47|||
163034654|NCT02956057|588830477|FG000|Overall Study|Discontinued intervention|14|||
163034655|NCT02956057|588830478|FG001|Overall Study|Discontinued intervention|10|||
163034656|NCT02956057|588830479|FG002|Overall Study|Discontinued intervention|7|||
163034657|NCT02956057|588830480|FG003|Overall Study|Discontinued intervention|14|||
163034658|NCT02956057|588830481|FG004|Overall Study|Discontinued intervention|4|||
163034659|NCT02956057|588830482|FG005|Overall Study|Discontinued intervention|17|||
163034660|NCT02956057|588830477|FG000|Overall Study|Lost to Follow-up|0|||
163034661|NCT02956057|588830478|FG001|Overall Study|Lost to Follow-up|2|||
163085643|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
163085644|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
163034662|NCT02956057|588830479|FG002|Overall Study|Lost to Follow-up|1|||
163034663|NCT02956057|588830480|FG003|Overall Study|Lost to Follow-up|1|||
163034664|NCT02956057|588830481|FG004|Overall Study|Lost to Follow-up|1|||
163034665|NCT02956057|588830482|FG005|Overall Study|Lost to Follow-up|0|||
163034666|NCT01420679|588830487|FG000|Overall Study|Disease Progression|3|||
163034667|NCT01420679|588830488|FG001|Overall Study|Disease Progression|2|||
163034668|NCT01420679|588830487|FG000|Overall Study|Adverse Event|4|||
163034669|NCT01420679|588830488|FG001|Overall Study|Adverse Event|0|||
163034670|NCT01420679|588830487|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
163034671|NCT01420679|588830488|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
163034672|NCT01420679|588830487|FG000|Overall Study|Patient Decision|1|||
163085645|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
163085646|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085647|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
162648630|NCT01408030|587429927|FG002|Observation Phase (Off Drug)|Other|1|||
163034673|NCT01420679|588830488|FG001|Overall Study|Patient Decision|0|||
163085648|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085649|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085650|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085651|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163034674|NCT01420679|588830487|FG000|Overall Study|Investigator Decision|1|||
163034675|NCT01420679|588830488|FG001|Overall Study|Investigator Decision|2|||
163034676|NCT01420679|588830487|FG000|Overall Study|Sponsor Decision|3|||
163034677|NCT01420679|588830488|FG001|Overall Study|Sponsor Decision|3|||
163034678|NCT01420679|588830487|FG000|Overall Study|Other|1|||
163034679|NCT01420679|588830488|FG001|Overall Study|Other|0|||
163034680|NCT03956615|588830489|FG000|Overall Study|No multiple myeloma confirmed|2|||
163034681|NCT03956615|588830489|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
163034682|NCT03956615|588830489|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
163034683|NCT03956615|588830489|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
163034684|NCT01069419|588830490|FG000|Overall Study|Adverse Event|233|||
162648631|NCT01408030|587429928|FG003|Observation Phase (Off Drug)|Other|1|||
162648632|NCT03608774|587429930|FG000|Overall Study|Lost to Follow-up|5|||
162648633|NCT03608774|587429931|FG001|Overall Study|Lost to Follow-up|5|||
162648634|NCT03608774|587429930|FG000|Overall Study|Withdrawal by Subject|1|||
162648635|NCT03608774|587429931|FG001|Overall Study|Withdrawal by Subject|0|||
162648636|NCT03608774|587429930|FG000|Overall Study|Protocol Violation|1|||
162648637|NCT03608774|587429931|FG001|Overall Study|Protocol Violation|0|||
162648638|NCT03608774|587429930|FG000|Overall Study|Not eligible at enrollment|0|||
162648639|NCT03608774|587429931|FG001|Overall Study|Not eligible at enrollment|1|||
162648640|NCT03608774|587429930|FG000|Overall Study|Health related event|0|||
162648641|NCT03608774|587429931|FG001|Overall Study|Health related event|1|||
162648642|NCT01586819|587429932|FG000|Overall Study|Withdrawal by Subject|1|||
162648643|NCT01586819|587429933|FG001|Overall Study|Withdrawal by Subject|0|||
162648644|NCT01359254|587429934|FG000|Overall Study|Death|1|||
162648645|NCT01359254|587429935|FG001|Overall Study|Death|0|||
162648646|NCT04837131|587429936|FG000|Overall Study|Death|1|||
162648647|NCT04837131|587429936|FG000|Overall Study|Withdrawal by Subject|1|||
162648648|NCT04837131|587429936|FG000|Overall Study|Adverse Event|1|||
162648649|NCT04837131|587429936|FG000|Overall Study|Protocol Violation|1|||
162648650|NCT03873987|587431184|FG000|Overall Study|Adverse Event|1|||
162648651|NCT03873987|587431185|FG001|Overall Study|Adverse Event|0|||
162648652|NCT03873987|587431184|FG000|Overall Study|staff was unable to start a new IV line|1|||
162648653|NCT03873987|587431185|FG001|Overall Study|staff was unable to start a new IV line|0|||
162648654|NCT03873987|587431184|FG000|Overall Study|Lost to Follow-up|0|||
162648655|NCT03873987|587431185|FG001|Overall Study|Lost to Follow-up|1|||
162648656|NCT01465022|587431186|FG000|Overall Study|Lost to Follow-up|15|||
162648657|NCT01465022|587431187|FG001|Overall Study|Lost to Follow-up|14|||
162648658|NCT01465022|587431188|FG002|Overall Study|Lost to Follow-up|0|||
162648659|NCT01465022|587431186|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
162648660|NCT01465022|587431187|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
162648661|NCT01465022|587431188|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
162648662|NCT01465022|587431186|FG000|Overall Study|Not Randomized|0|||
162648663|NCT01465022|587431187|FG001|Overall Study|Not Randomized|0|||
162648664|NCT01465022|587431188|FG002|Overall Study|Not Randomized|70|||
162648665|NCT00004888|587431189|FG000|Overall Study|Adverse Event|5|||
162648666|NCT00004888|587431190|FG001|Overall Study|Adverse Event|10|||
162648667|NCT00004888|587431189|FG000|Overall Study|Withdrawal by Subject|0|||
162648668|NCT00004888|587431190|FG001|Overall Study|Withdrawal by Subject|3|||
162648669|NCT00004888|587431189|FG000|Overall Study|Physician Decision|1|||
162648670|NCT00004888|587431190|FG001|Overall Study|Physician Decision|1|||
162648671|NCT00004888|587431189|FG000|Overall Study|Progressive Disease|4|||
162648672|NCT00004888|587431190|FG001|Overall Study|Progressive Disease|9|||
162648673|NCT00004888|587431189|FG000|Overall Study|Death without progressive disease|0|||
162648674|NCT00004888|587431190|FG001|Overall Study|Death without progressive disease|1|||
162648675|NCT00004888|587431189|FG000|Overall Study|Toxic death|1|||
162648676|NCT00004888|587431190|FG001|Overall Study|Toxic death|0|||
162648677|NCT00136084|587431191|FG000|Overall Study|Death|12|||
162648678|NCT00136084|587431192|FG001|Overall Study|Death|5|||
162648679|NCT00136084|587431191|FG000|Overall Study|Unacceptable toxicity|8|||
162648680|NCT00136084|587431192|FG001|Overall Study|Unacceptable toxicity|11|||
162648681|NCT00136084|587431191|FG000|Overall Study|Relapse|20|||
162648682|NCT00136084|587431192|FG001|Overall Study|Relapse|23|||
162648683|NCT00136084|587431191|FG000|Overall Study|Lost to Follow-up|2|||
162648684|NCT00136084|587431192|FG001|Overall Study|Lost to Follow-up|0|||
162648685|NCT00136084|587431191|FG000|Overall Study|No Response|1|||
162648686|NCT00136084|587431192|FG001|Overall Study|No Response|2|||
162648687|NCT00136084|587431191|FG000|Overall Study|Withdrawal by Subject|5|||
162648688|NCT00136084|587431192|FG001|Overall Study|Withdrawal by Subject|1|||
162648689|NCT02579265|587431193|FG000|Overall Study|Weaned off earlier than 28 days|44|||
162648690|NCT02579265|587431194|FG001|Overall Study|Weaned off earlier than 28 days|43|||
162648691|NCT02579265|587431193|FG000|Overall Study|Adverse Event|2|||
162648692|NCT02579265|587431194|FG001|Overall Study|Adverse Event|0|||
162648693|NCT02579265|587431193|FG000|Overall Study|Any other reason not specified|0|||
162648694|NCT02579265|587431194|FG001|Overall Study|Any other reason not specified|2|||
162648695|NCT02579265|587431193|FG000|Overall Study|Withdrawal by Subject|2|||
162648696|NCT02579265|587431194|FG001|Overall Study|Withdrawal by Subject|0|||
162648697|NCT02579265|587431193|FG000|Overall Study|Physician Decision|1|||
162648698|NCT02579265|587431194|FG001|Overall Study|Physician Decision|0|||
162648699|NCT02579265|587431193|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
162648700|NCT02579265|587431194|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
163034685|NCT01069419|588830490|FG000|Overall Study|Lack of Efficacy|332|||
163034686|NCT01069419|588830490|FG000|Overall Study|Lost to Follow-up|49|||
163034687|NCT01069419|588830490|FG000|Overall Study|Remission of disease|11|||
163034688|NCT01069419|588830490|FG000|Overall Study|Withdrawal by Subject|34|||
163034689|NCT01069419|588830490|FG000|Overall Study|Other Reason|43|||
163034690|NCT01069419|588830490|FG000|Overall Study|Missing termination information|13|||
163034691|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
163034692|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
163034693|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
163034694|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
163034695|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
163034696|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034697|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034698|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
163034699|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
163034700|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
163034701|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
163034702|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
163034703|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Death|0|||
163034704|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Death|0|||
163034705|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Death|1|||
163034706|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Death|0|||
163034707|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034708|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
163034709|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034710|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
163034711|NCT01179737|588830493|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
163034712|NCT01179737|588830494|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034713|NCT01179737|588830495|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034714|NCT01179737|588830496|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
163034715|NCT01179737|588830493|FG000|Extension|The study was terminated|3|||
163034716|NCT01179737|588830494|FG001|Extension|The study was terminated|0|||
163034717|NCT01179737|588830495|FG002|Extension|The study was terminated|0|||
163034718|NCT01179737|588830496|FG003|Extension|The study was terminated|0|||
163034719|NCT01254721|588830497|FG000|Overall Study|Lost to Follow-up|0|||
163034720|NCT01254721|588830498|FG001|Overall Study|Lost to Follow-up|4|||
163034721|NCT01254721|588830497|FG000|Overall Study|Lack of Efficacy|4|||
163034722|NCT01254721|588830498|FG001|Overall Study|Lack of Efficacy|2|||
163034723|NCT01254721|588830497|FG000|Overall Study|Death|0|||
163034724|NCT01254721|588830498|FG001|Overall Study|Death|1|||
163034725|NCT01254721|588830497|FG000|Overall Study|technical problum|1|||
163034726|NCT01254721|588830498|FG001|Overall Study|technical problum|0|||
163034727|NCT01254721|588830497|FG000|Overall Study|Adverse Event|2|||
163034728|NCT01254721|588830498|FG001|Overall Study|Adverse Event|3|||
163034729|NCT01254721|588830497|FG000|Overall Study|Withdrawal by Subject|8|||
163034730|NCT01254721|588830498|FG001|Overall Study|Withdrawal by Subject|11|||
163034731|NCT01254721|588830497|FG000|Overall Study|Wrongly randomization|0|||
163034732|NCT01254721|588830498|FG001|Overall Study|Wrongly randomization|1|||
163034733|NCT00904839|588830499|FG000|Overall Study|Adverse Event|0|||
163034734|NCT00904839|588830500|FG001|Overall Study|Adverse Event|5|||
163034735|NCT00904839|588830501|FG002|Overall Study|Adverse Event|4|||
163034736|NCT00904839|588830499|FG000|Overall Study|Protocol Violation|0|||
163034737|NCT00904839|588830500|FG001|Overall Study|Protocol Violation|1|||
163034738|NCT00904839|588830501|FG002|Overall Study|Protocol Violation|1|||
163034739|NCT00904839|588830499|FG000|Overall Study|Lost to Follow-up|0|||
163034740|NCT00904839|588830500|FG001|Overall Study|Lost to Follow-up|1|||
163034741|NCT00904839|588830501|FG002|Overall Study|Lost to Follow-up|2|||
163034742|NCT00904839|588830499|FG000|Overall Study|Withdrawal by Subject|0|||
163034743|NCT00904839|588830500|FG001|Overall Study|Withdrawal by Subject|2|||
163034744|NCT00904839|588830501|FG002|Overall Study|Withdrawal by Subject|0|||
163034745|NCT00904839|588830499|FG000|Overall Study|Not treated|1|||
163034746|NCT00904839|588830500|FG001|Overall Study|Not treated|0|||
163034747|NCT00904839|588830501|FG002|Overall Study|Not treated|1|||
163034748|NCT00904839|588830499|FG000|Overall Study|Other than above|0|||
163034749|NCT00904839|588830500|FG001|Overall Study|Other than above|9|||
163034750|NCT00904839|588830501|FG002|Overall Study|Other than above|7|||
163034751|NCT01904903|588830505|FG000|Overall Study|Withdrawal by Subject|1|||
163034752|NCT01634659|588830507|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
163034753|NCT01634659|588830508|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
163034754|NCT01634659|588830507|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
163034755|NCT01634659|588830508|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
163034756|NCT04395274|588830509|FG000|Overall Study|Lost to Follow-up|20|||
163034757|NCT04395274|588830510|FG001|Overall Study|Lost to Follow-up|11|||
163034758|NCT04395274|588830509|FG000|Overall Study|Withdrawal by Subject|13|||
163034759|NCT04395274|588830510|FG001|Overall Study|Withdrawal by Subject|10|||
163034760|NCT04395274|588830509|FG000|Overall Study|Moved Abroad|0|||
163034761|NCT04395274|588830510|FG001|Overall Study|Moved Abroad|1|||
163034762|NCT00335959|588830511|FG000|Overall Study|Adverse Event|2|||
163034763|NCT00335959|588830511|FG000|Overall Study|Ineligible|1|||
163034764|NCT00824382|588830514|FG000|Overall Study|Adverse Event|4|||
163034765|NCT00824382|588830515|FG001|Overall Study|Adverse Event|1|||
163034766|NCT00824382|588830516|FG002|Overall Study|Adverse Event|1|||
163034767|NCT00824382|588830517|FG003|Overall Study|Adverse Event|4|||
163034768|NCT00824382|588830514|FG000|Overall Study|Protocol Violation|1|||
163085652|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085653|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085654|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
163085655|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
163085656|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
163085657|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
163085658|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
163085659|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
163034769|NCT00824382|588830515|FG001|Overall Study|Protocol Violation|0|||
163034770|NCT00824382|588830516|FG002|Overall Study|Protocol Violation|0|||
163034771|NCT00824382|588830517|FG003|Overall Study|Protocol Violation|1|||
163034772|NCT00824382|588830514|FG000|Overall Study|Investigator's decision|0|||
163034773|NCT00824382|588830515|FG001|Overall Study|Investigator's decision|1|||
163034774|NCT00824382|588830516|FG002|Overall Study|Investigator's decision|2|||
163034775|NCT00824382|588830517|FG003|Overall Study|Investigator's decision|0|||
163034776|NCT02908074|588830519|FG000|Overall Study|sponsor/ICON decision|0|||
163034777|NCT02908074|588830520|FG001|Overall Study|sponsor/ICON decision|0|||
163034778|NCT02908074|588830521|FG002|Overall Study|sponsor/ICON decision|1|||
163034779|NCT02908074|588830522|FG003|Overall Study|sponsor/ICON decision|0|||
163034780|NCT02908074|588830523|FG004|Overall Study|sponsor/ICON decision|0|||
163034781|NCT02908074|588830524|FG005|Overall Study|sponsor/ICON decision|0|||
163034782|NCT02908074|588830519|FG000|Overall Study|Protocol Violation|0|||
163034783|NCT02908074|588830520|FG001|Overall Study|Protocol Violation|1|||
163034784|NCT02908074|588830521|FG002|Overall Study|Protocol Violation|0|||
163034785|NCT02908074|588830522|FG003|Overall Study|Protocol Violation|0|||
163034786|NCT02908074|588830523|FG004|Overall Study|Protocol Violation|0|||
163034787|NCT02908074|588830524|FG005|Overall Study|Protocol Violation|0|||
163034788|NCT02908074|588830519|FG000|Overall Study|Adverse Event|5|||
163034789|NCT02908074|588830520|FG001|Overall Study|Adverse Event|2|||
163034790|NCT02908074|588830521|FG002|Overall Study|Adverse Event|0|||
163034791|NCT02908074|588830522|FG003|Overall Study|Adverse Event|0|||
163034792|NCT02908074|588830523|FG004|Overall Study|Adverse Event|1|||
163034793|NCT02908074|588830524|FG005|Overall Study|Adverse Event|0|||
163034794|NCT02908074|588830519|FG000|Overall Study|AESI|1|||
163034795|NCT02908074|588830520|FG001|Overall Study|AESI|0|||
163034796|NCT02908074|588830521|FG002|Overall Study|AESI|1|||
163034797|NCT02908074|588830522|FG003|Overall Study|AESI|0|||
163034798|NCT02908074|588830523|FG004|Overall Study|AESI|1|||
163034799|NCT02908074|588830524|FG005|Overall Study|AESI|0|||
163034800|NCT02908074|588830519|FG000|Overall Study|Discontinuation criteria per protocol|0|||
163034801|NCT02908074|588830520|FG001|Overall Study|Discontinuation criteria per protocol|0|||
163034802|NCT02908074|588830521|FG002|Overall Study|Discontinuation criteria per protocol|1|||
162648701|NCT02174848|587431195|FG000|Overall Study|Adverse Event|2|||
162648702|NCT02174848|587431196|FG001|Overall Study|Adverse Event|1|||
162648703|NCT02174848|587431195|FG000|Overall Study|Withdrawal by Subject|3|||
162648704|NCT02174848|587431196|FG001|Overall Study|Withdrawal by Subject|3|||
162648705|NCT02174848|587431195|FG000|Overall Study|Lost to Follow-up|0|||
162648706|NCT02174848|587431196|FG001|Overall Study|Lost to Follow-up|1|||
162648707|NCT02174848|587431195|FG000|Overall Study|Worsening of disease|1|||
162648708|NCT02174848|587431196|FG001|Overall Study|Worsening of disease|1|||
162648709|NCT02174848|587431195|FG000|Overall Study|Unable to comply with study requirements|1|||
162648710|NCT02174848|587431196|FG001|Overall Study|Unable to comply with study requirements|0|||
162648711|NCT00997503|587431202|FG000|Overall Study|Death|53|||
163034803|NCT02908074|588830522|FG003|Overall Study|Discontinuation criteria per protocol|0|||
163034804|NCT02908074|588830523|FG004|Overall Study|Discontinuation criteria per protocol|0|||
163034805|NCT02908074|588830524|FG005|Overall Study|Discontinuation criteria per protocol|1|||
163034806|NCT02908074|588830519|FG000|Overall Study|Withdrawal by Subject|3|||
163034807|NCT02908074|588830520|FG001|Overall Study|Withdrawal by Subject|2|||
163034808|NCT02908074|588830521|FG002|Overall Study|Withdrawal by Subject|2|||
163034809|NCT02908074|588830522|FG003|Overall Study|Withdrawal by Subject|2|||
163034810|NCT02908074|588830523|FG004|Overall Study|Withdrawal by Subject|2|||
163034811|NCT02908074|588830524|FG005|Overall Study|Withdrawal by Subject|2|||
163034812|NCT02908074|588830519|FG000|Overall Study|Lost to Follow-up|0|||
163034813|NCT02908074|588830520|FG001|Overall Study|Lost to Follow-up|1|||
163034814|NCT02908074|588830521|FG002|Overall Study|Lost to Follow-up|1|||
163034815|NCT02908074|588830522|FG003|Overall Study|Lost to Follow-up|1|||
162648712|NCT00997503|587431202|FG000|Overall Study|Withdrawal by Subject|76|||
162648713|NCT00997503|587431202|FG000|Overall Study|Lost to Follow-up|33|||
162648714|NCT00997503|587431202|FG000|Overall Study|Adverse Event|3|||
163034816|NCT02908074|588830523|FG004|Overall Study|Lost to Follow-up|0|||
163034817|NCT02908074|588830524|FG005|Overall Study|Lost to Follow-up|1|||
163034818|NCT01393106|588831973|FG000|Overall Study|Adverse Event|3|||
163034819|NCT01393106|588831973|FG000|Overall Study|Withdrawal by Subject|1|||
163034820|NCT01393106|588831973|FG000|Overall Study|Lack of Efficacy|1|||
163034821|NCT01955109|588831975|FG000|Overall Study|Adverse Event|2|||
163034822|NCT01955109|588831976|FG001|Overall Study|Adverse Event|0|||
163034823|NCT01955109|588831975|FG000|Overall Study|Participant unwilling to continue|35|||
163034824|NCT01955109|588831976|FG001|Overall Study|Participant unwilling to continue|7|||
163034825|NCT01955109|588831975|FG000|Overall Study|Physician Decision|2|||
163034826|NCT01955109|588831976|FG001|Overall Study|Physician Decision|0|||
163034827|NCT01955109|588831975|FG000|Overall Study|Lost to Follow-up|3|||
163034828|NCT01955109|588831976|FG001|Overall Study|Lost to Follow-up|1|||
163034829|NCT01955109|588831975|FG000|Overall Study|Non-compliance|3|||
163034830|NCT01955109|588831976|FG001|Overall Study|Non-compliance|1|||
163034831|NCT01853696|588831977|FG000|Overall Study|Withdrawal by Subject|1|||
163034832|NCT01853696|588831978|FG001|Overall Study|Withdrawal by Subject|1|||
163034833|NCT01853696|588831977|FG000|Overall Study|Lost to Follow-up|5|||
163034834|NCT01853696|588831978|FG001|Overall Study|Lost to Follow-up|4|||
163034835|NCT03003000|588831979|FG000|Overall Study|Adverse Event|1|||
163034836|NCT03003000|588831980|FG001|Overall Study|Adverse Event|2|||
163034837|NCT03003000|588831981|FG002|Overall Study|Adverse Event|3|||
163034838|NCT03003000|588831979|FG000|Overall Study|Lack of Efficacy|1|||
163034839|NCT03003000|588831980|FG001|Overall Study|Lack of Efficacy|0|||
163034840|NCT03003000|588831981|FG002|Overall Study|Lack of Efficacy|0|||
163034841|NCT03003000|588831979|FG000|Overall Study|Non-compliant with protocol|0|||
163034842|NCT03003000|588831980|FG001|Overall Study|Non-compliant with protocol|1|||
163034843|NCT03003000|588831981|FG002|Overall Study|Non-compliant with protocol|1|||
163034844|NCT03003000|588831979|FG000|Overall Study|Refused to continue medication|2|||
163034845|NCT03003000|588831980|FG001|Overall Study|Refused to continue medication|0|||
163034846|NCT03003000|588831981|FG002|Overall Study|Refused to continue medication|0|||
163034847|NCT03003000|588831979|FG000|Overall Study|Other than listed|1|||
163034848|NCT03003000|588831980|FG001|Overall Study|Other than listed|1|||
163034849|NCT03003000|588831981|FG002|Overall Study|Other than listed|1|||
163034850|NCT04933617|588831982|FG000|Dose Escalation|Early closure of study|0|||
163034851|NCT04933617|588831983|FG001|Dose Escalation|Early closure of study|3|||
163034852|NCT04933617|588831984|FG002|Dose Escalation|Early closure of study|0|||
163034853|NCT04933617|588831985|FG003|Dose Escalation|Early closure of study|0|||
163034854|NCT04933617|588831986|FG004|Dose Escalation|Early closure of study|0|||
163034855|NCT02191046|588831987|FG000|Overall Study|low compliance|5|||
163034856|NCT02191046|588831988|FG001|Overall Study|low compliance|1|||
163034857|NCT02147067|588831989|FG000|Overall Study|Withdrawal by Subject|2|||
163034858|NCT02147067|588831990|FG001|Overall Study|Withdrawal by Subject|2|||
163034859|NCT00089635|588831991|FG000|Overall Study|Adverse Event|2|||
163034860|NCT00089635|588831991|FG000|Overall Study|Death|17|||
163034861|NCT00089635|588831991|FG000|Overall Study|Disease Progression|12|||
163034862|NCT00089635|588831991|FG000|Overall Study|Lost to Follow-up|3|||
163034863|NCT00089635|588831991|FG000|Overall Study|Withdrawal by Subject|6|||
163034864|NCT00089635|588831991|FG000|Overall Study|Ineligibility determined|1|||
163034865|NCT00089635|588831991|FG000|Overall Study|Other|2|||
163034866|NCT02943785|588831992|FG000|Overall Study|Adverse Event|112|||
163034867|NCT02943785|588831993|FG001|Overall Study|Adverse Event|97|||
163034868|NCT02943785|588831992|FG000|Overall Study|Withdrawal by Subject|63|||
163034869|NCT02943785|588831993|FG001|Overall Study|Withdrawal by Subject|126|||
163034870|NCT02943785|588831992|FG000|Overall Study|Physician Decision|23|||
163034871|NCT02943785|588831993|FG001|Overall Study|Physician Decision|47|||
163034872|NCT02943785|588831992|FG000|Overall Study|Death|46|||
163034873|NCT02943785|588831993|FG001|Overall Study|Death|46|||
163034874|NCT02943785|588831992|FG000|Overall Study|Lost to Follow-up|1|||
163034875|NCT02943785|588831993|FG001|Overall Study|Lost to Follow-up|0|||
163034876|NCT02943785|588831992|FG000|Overall Study|Other|16|||
163034877|NCT02943785|588831993|FG001|Overall Study|Other|19|||
163034878|NCT02943785|588831992|FG000|Overall Study|Did not receive any study medication|21|||
163034879|NCT02943785|588831993|FG001|Overall Study|Did not receive any study medication|28|||
163034880|NCT02603107|588831994|FG000|Randomized Phase|Withdrew consent|8|||
163034881|NCT02603107|588831995|FG001|Randomized Phase|Withdrew consent|15|||
163034882|NCT02603107|588831994|FG000|Randomized Phase|Lost to Follow-up|1|||
163034883|NCT02603107|588831995|FG001|Randomized Phase|Lost to Follow-up|3|||
163034884|NCT02603107|588831994|FG000|Randomized Phase|Adverse Event|2|||
163034885|NCT02603107|588831995|FG001|Randomized Phase|Adverse Event|0|||
163034886|NCT02603107|588831994|FG000|Randomized Phase|Death|1|||
163034887|NCT02603107|588831995|FG001|Randomized Phase|Death|1|||
163034888|NCT02603107|588831994|FG000|Randomized Phase|Non-compliance with study drug|1|||
163034889|NCT02603107|588831995|FG001|Randomized Phase|Non-compliance with study drug|1|||
163034890|NCT02603107|588831994|FG000|Randomized Phase|Investigator's discretion|0|||
163034891|NCT02603107|588831995|FG001|Randomized Phase|Investigator's discretion|1|||
163034892|NCT02603107|588831994|FG000|Randomized Phase|Lack of Efficacy|1|||
163034893|NCT02603107|588831995|FG001|Randomized Phase|Lack of Efficacy|0|||
163034894|NCT02603107|588831994|FG000|Randomized Phase|Protocol Violation|1|||
163034895|NCT02603107|588831995|FG001|Randomized Phase|Protocol Violation|0|||
163034896|NCT02603107|588831994|FG000|Optional Extension Phase|Lost to Follow-up|3|||
163034897|NCT02603107|588831995|FG001|Optional Extension Phase|Lost to Follow-up|3|||
163034898|NCT02603107|588831994|FG000|Optional Extension Phase|Withdrew consent|3|||
163034899|NCT02603107|588831995|FG001|Optional Extension Phase|Withdrew consent|2|||
163034900|NCT02603107|588831994|FG000|Optional Extension Phase|Investigator's discretion|2|||
163034901|NCT02603107|588831995|FG001|Optional Extension Phase|Investigator's discretion|2|||
163034902|NCT02603107|588831994|FG000|Optional Extension Phase|Pregnancy|0|||
163034903|NCT02603107|588831995|FG001|Optional Extension Phase|Pregnancy|3|||
163034904|NCT02603107|588831994|FG000|Optional Extension Phase|Adverse Event|0|||
163034905|NCT02603107|588831995|FG001|Optional Extension Phase|Adverse Event|2|||
163034906|NCT02603107|588831994|FG000|Optional Extension Phase|Not treated in extension phase|0|||
163034907|NCT02603107|588831995|FG001|Optional Extension Phase|Not treated in extension phase|1|||
163034908|NCT02603107|588831994|FG000|Optional Extension Phase|Protocol Violation|1|||
163034909|NCT02603107|588831995|FG001|Optional Extension Phase|Protocol Violation|0|||
163034910|NCT00821015|588831996|FG000|Overall Study|Lost to Follow-up|12|||
163034911|NCT03170609|588831999|FG000|Overall Study|Death|0|||
163034912|NCT03170609|588832000|FG001|Overall Study|Death|0|||
163034913|NCT03170609|588832001|FG002|Overall Study|Death|1|||
163034914|NCT03170609|588832002|FG003|Overall Study|Death|0|||
163034915|NCT03170609|588832003|FG004|Overall Study|Death|0|||
163034916|NCT03170609|588832004|FG005|Overall Study|Death|0|||
163034917|NCT03170609|588832005|FG006|Overall Study|Death|0|||
163034918|NCT03170609|588831999|FG000|Overall Study|Withdrawal by Subject|1|||
163034919|NCT03170609|588832000|FG001|Overall Study|Withdrawal by Subject|2|||
163034920|NCT03170609|588832001|FG002|Overall Study|Withdrawal by Subject|0|||
163034921|NCT03170609|588832002|FG003|Overall Study|Withdrawal by Subject|0|||
163034922|NCT03170609|588832003|FG004|Overall Study|Withdrawal by Subject|0|||
163034923|NCT03170609|588832004|FG005|Overall Study|Withdrawal by Subject|0|||
163034924|NCT03170609|588832005|FG006|Overall Study|Withdrawal by Subject|1|||
163034925|NCT03170609|588831999|FG000|Overall Study|Lost to Follow-up|1|||
163034926|NCT03170609|588832000|FG001|Overall Study|Lost to Follow-up|0|||
163034927|NCT03170609|588832001|FG002|Overall Study|Lost to Follow-up|5|||
163034928|NCT03170609|588832002|FG003|Overall Study|Lost to Follow-up|2|||
163034929|NCT03170609|588832003|FG004|Overall Study|Lost to Follow-up|1|||
163034930|NCT03170609|588832004|FG005|Overall Study|Lost to Follow-up|1|||
163034931|NCT03170609|588832005|FG006|Overall Study|Lost to Follow-up|0|||
163034932|NCT03170609|588831999|FG000|Overall Study|Other|1|||
163034933|NCT03170609|588832000|FG001|Overall Study|Other|0|||
163034934|NCT03170609|588832001|FG002|Overall Study|Other|0|||
163034935|NCT03170609|588832002|FG003|Overall Study|Other|0|||
163034936|NCT03170609|588832003|FG004|Overall Study|Other|0|||
163034937|NCT03170609|588832004|FG005|Overall Study|Other|1|||
163034938|NCT03170609|588832005|FG006|Overall Study|Other|0|||
163034939|NCT01887678|588832012|FG000|Overall Study|Adverse Event|4|||
163034940|NCT01887678|588832013|FG001|Overall Study|Adverse Event|6|||
163034941|NCT01887678|588832012|FG000|Overall Study|Exceeded rescue medication dosage|4|||
163034942|NCT01887678|588832013|FG001|Overall Study|Exceeded rescue medication dosage|5|||
163034943|NCT01887678|588832012|FG000|Overall Study|Withdrawal of consent|3|||
163034944|NCT01887678|588832013|FG001|Overall Study|Withdrawal of consent|4|||
162648715|NCT00997503|587431202|FG000|Overall Study|Physician Decision|10|||
162648716|NCT00997503|587431202|FG000|Overall Study|Missed 12-month follow-up|85|||
162648717|NCT00997503|587431202|FG000|Overall Study|Other reason|13|||
162648718|NCT01641367|587431211|FG000|Cohorts|Death|18|||
162648719|NCT01641367|587431212|FG001|Cohorts|Death|1|||
162648720|NCT01641367|587431213|FG002|Cohorts|Death|2|||
162648721|NCT01641367|587431214|FG003|Cohorts|Death|0|||
162648722|NCT01641367|587431215|FG004|Cohorts|Death|1|||
163034945|NCT01887678|588832012|FG000|Overall Study|Lost to Follow-up|4|||
163085660|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
162648723|NCT01641367|587431216|FG005|Cohorts|Death|1|||
162648724|NCT01641367|587431217|FG006|Cohorts|Death|0|||
162648725|NCT01641367|587431218|FG007|Cohorts|Death|0|||
162648726|NCT01641367|587431211|FG000|Cohorts|Lost to Follow-up|16|||
162648727|NCT01641367|587431212|FG001|Cohorts|Lost to Follow-up|0|||
162648728|NCT01641367|587431213|FG002|Cohorts|Lost to Follow-up|2|||
162648729|NCT01641367|587431214|FG003|Cohorts|Lost to Follow-up|0|||
162648730|NCT01641367|587431215|FG004|Cohorts|Lost to Follow-up|2|||
162648731|NCT01641367|587431216|FG005|Cohorts|Lost to Follow-up|0|||
162648732|NCT01641367|587431217|FG006|Cohorts|Lost to Follow-up|0|||
162648733|NCT01641367|587431218|FG007|Cohorts|Lost to Follow-up|0|||
162648734|NCT01641367|587431211|FG000|Randomized Adherence Intervention|Death|0|||
162648735|NCT01641367|587431212|FG001|Randomized Adherence Intervention|Death|0|||
162648736|NCT01641367|587431213|FG002|Randomized Adherence Intervention|Death|0|||
162648737|NCT01641367|587431214|FG003|Randomized Adherence Intervention|Death|0|||
163034946|NCT01887678|588832013|FG001|Overall Study|Lost to Follow-up|2|||
163034947|NCT01887678|588832012|FG000|Overall Study|Deterioration of clinical condition|0|||
163034948|NCT01887678|588832013|FG001|Overall Study|Deterioration of clinical condition|4|||
163034949|NCT01887678|588832012|FG000|Overall Study|Lack of Efficacy|1|||
163034950|NCT01887678|588832013|FG001|Overall Study|Lack of Efficacy|2|||
163085661|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
163085662|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
163085663|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
163085664|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
163085665|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
163085666|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
163085667|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
163085668|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
163085669|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
163085670|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
163034951|NCT01887678|588832012|FG000|Overall Study|Non-compliance|0|||
163085671|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
163034952|NCT01887678|588832013|FG001|Overall Study|Non-compliance|3|||
163034953|NCT01887678|588832012|FG000|Overall Study|Specified|1|||
163034954|NCT01887678|588832013|FG001|Overall Study|Specified|2|||
163034955|NCT00791492|588832016|FG000|Overall Study|Withdrawal by Subject|1|||
163034956|NCT00791492|588832017|FG001|Overall Study|Withdrawal by Subject|2|||
163034957|NCT00791492|588832016|FG000|Overall Study|Liver transplantation|5|||
163034958|NCT00791492|588832017|FG001|Overall Study|Liver transplantation|1|||
163034959|NCT00090987|588832018|FG000|Overall Study|Adverse Event|5|||
163034960|NCT00090987|588832018|FG000|Overall Study|Lack of Efficacy|7|||
163034961|NCT00090987|588832018|FG000|Overall Study|Withdrawal by Subject|3|||
163034962|NCT00090987|588832018|FG000|Overall Study|alternative therapy|1|||
163034963|NCT00090987|588832018|FG000|Overall Study|Non-compliance|4|||
163034964|NCT00090987|588832018|FG000|Overall Study|Incarcerated|1|||
163034965|NCT00990665|588832023|FG000|Overall Study|Unsuccessful Implant|8|||
163034966|NCT00990665|588832023|FG000|Overall Study|Death|29|||
163034967|NCT00990665|588832023|FG000|Overall Study|Heart Transplant|1|||
163034968|NCT00990665|588832023|FG000|Overall Study|Withdrawal by Subject|6|||
163034969|NCT00990665|588832023|FG000|Overall Study|Lost to Follow-up|1|||
163034970|NCT00990665|588832023|FG000|Overall Study|System Explant|3|||
163034971|NCT02603562|588832024|FG000|Overall Study|Lost to Follow-up|1|||
163034972|NCT00270231|588832025|FG000|First Intervention|Lost to Follow-up|1|||
163034973|NCT00270231|588832026|FG001|First Intervention|Lost to Follow-up|1|||
163034974|NCT00270231|588832025|FG000|Washout Period|Lost to Follow-up|1|||
163034975|NCT00270231|588832026|FG001|Washout Period|Lost to Follow-up|0|||
163034976|NCT00270231|588832025|FG000|Second Intervention|Lost to Follow-up|0|||
163034977|NCT00270231|588832026|FG001|Second Intervention|Lost to Follow-up|1|||
163034978|NCT00574795|588832028|FG000|Infant Series|Withdrawal by Subject|2|||
163034979|NCT00574795|588832028|FG000|Infant Series|Protocol Violation|2|||
163034980|NCT00574795|588832028|FG000|Infant Series|Adverse Event|1|||
163034981|NCT00574795|588832028|FG000|After Infant Series|Withdrawal by Subject|1|||
163034982|NCT00574795|588832028|FG000|After Infant Series|Adverse Event|2|||
163034983|NCT00574795|588832028|FG000|Toddler Dose|Withdrawal by Subject|1|||
163034984|NCT02638259|588832029|FG000|Treatment Period 1|Adverse Event|1|||
163034985|NCT02638259|588832030|FG001|Treatment Period 1|Adverse Event|5|||
163034986|NCT02638259|588832029|FG000|Treatment Period 1|Death|0|||
163034987|NCT02638259|588832030|FG001|Treatment Period 1|Death|1|||
163034988|NCT02638259|588832029|FG000|Treatment Period 1|Lack of Efficacy|0|||
163034989|NCT02638259|588832030|FG001|Treatment Period 1|Lack of Efficacy|1|||
163034990|NCT02638259|588832029|FG000|Treatment Period 1|Protocol Violation|0|||
163034991|NCT02638259|588832030|FG001|Treatment Period 1|Protocol Violation|3|||
163034992|NCT02638259|588832029|FG000|Treatment Period 1|Withdrawal by Subject|4|||
163034993|NCT02638259|588832030|FG001|Treatment Period 1|Withdrawal by Subject|6|||
163034994|NCT02638259|588832029|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
163034995|NCT02638259|588832030|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
163034996|NCT02638259|588832029|FG000|Treatment Period 2|Adverse Event|5|||
163034997|NCT02638259|588832030|FG001|Treatment Period 2|Adverse Event|4|||
163034998|NCT02638259|588832029|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163034999|NCT02638259|588832030|FG001|Treatment Period 2|Withdrawal by Subject|7|||
163035000|NCT04299048|588832031|FG000|Overall Study|Death|1|||
163035001|NCT04299048|588832031|FG000|Overall Study|Global deterioration of health status|2|||
163085672|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
163085673|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085674|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085675|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085676|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163035002|NCT04299048|588832031|FG000|Overall Study|Enrolled and not treated|1|||
163035003|NCT00314132|588832032|FG000|Overall Study|Lost to Follow-up|3|||
163035004|NCT00314132|588832033|FG001|Overall Study|Lost to Follow-up|13|||
163035005|NCT00314132|588832032|FG000|Overall Study|Withdrawal by Subject|3|||
163035006|NCT00314132|588832033|FG001|Overall Study|Withdrawal by Subject|5|||
163035007|NCT00314132|588832032|FG000|Overall Study|Adverse Event|1|||
163035008|NCT00314132|588832033|FG001|Overall Study|Adverse Event|0|||
163035009|NCT00314132|588832032|FG000|Overall Study|Physician Decision|1|||
163035010|NCT00314132|588832033|FG001|Overall Study|Physician Decision|0|||
163035011|NCT00957905|588832034|FG000|Part B|Not Treated|0|||
162648738|NCT01641367|587431215|FG004|Randomized Adherence Intervention|Death|0|||
162648739|NCT01641367|587431216|FG005|Randomized Adherence Intervention|Death|0|||
162648740|NCT01641367|587431217|FG006|Randomized Adherence Intervention|Death|11|||
162648741|NCT01641367|587431218|FG007|Randomized Adherence Intervention|Death|12|||
162648742|NCT01641367|587431211|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648743|NCT01641367|587431212|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648744|NCT01641367|587431213|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648745|NCT01641367|587431214|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648746|NCT01641367|587431215|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648747|NCT01641367|587431216|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
162648748|NCT01641367|587431217|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
162648749|NCT01641367|587431218|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
162648750|NCT00218296|587431221|FG000|Overall Study|Lost to Follow-up|9|||
162648751|NCT00218296|587431222|FG001|Overall Study|Lost to Follow-up|7|||
162648752|NCT00218296|587431221|FG000|Overall Study|Withdrawal by Subject|36|||
162648753|NCT00218296|587431222|FG001|Overall Study|Withdrawal by Subject|47|||
162648754|NCT00218296|587431221|FG000|Overall Study|Randomized but did not enter treatment|66|||
162648755|NCT00218296|587431222|FG001|Overall Study|Randomized but did not enter treatment|67|||
162718270|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
162718271|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163035012|NCT00957905|588832035|FG001|Part B|Not Treated|1|||
163035013|NCT00957905|588832034|FG000|Part B|Physician Decision|0|||
163035014|NCT00957905|588832035|FG001|Part B|Physician Decision|1|||
163035015|NCT00957905|588832034|FG000|Part B|Death|0|||
163035016|NCT00957905|588832035|FG001|Part B|Death|1|||
163035017|NCT00957905|588832034|FG000|Part B|Protocol Violation|0|||
163035018|NCT00957905|588832035|FG001|Part B|Protocol Violation|1|||
163035019|NCT01260584|588832052|FG000|Period 1|Protocol Violation|0|||
163035020|NCT01260584|588832053|FG001|Period 1|Protocol Violation|0|||
163035021|NCT01260584|588832054|FG002|Period 1|Protocol Violation|1|||
163035022|NCT01260584|588832055|FG003|Period 1|Protocol Violation|1|||
163035023|NCT01260584|588832052|FG000|Period 1|Adverse Event|0|||
163035024|NCT01260584|588832053|FG001|Period 1|Adverse Event|0|||
163035025|NCT01260584|588832054|FG002|Period 1|Adverse Event|1|||
163035026|NCT01260584|588832055|FG003|Period 1|Adverse Event|0|||
163035027|NCT01260584|588832052|FG000|Period 2|Protocol Violation|0|||
163035028|NCT01260584|588832053|FG001|Period 2|Protocol Violation|2|||
163035029|NCT01260584|588832054|FG002|Period 2|Protocol Violation|3|||
163035030|NCT01260584|588832055|FG003|Period 2|Protocol Violation|1|||
163035031|NCT01260584|588832052|FG000|Period 2|Adverse Event|1|||
163035032|NCT01260584|588832053|FG001|Period 2|Adverse Event|0|||
163035033|NCT01260584|588832054|FG002|Period 2|Adverse Event|2|||
163035034|NCT01260584|588832055|FG003|Period 2|Adverse Event|0|||
163035035|NCT01260584|588832052|FG000|Period 2|Withdrawal by Subject|0|||
163035036|NCT01260584|588832053|FG001|Period 2|Withdrawal by Subject|1|||
163035037|NCT01260584|588832054|FG002|Period 2|Withdrawal by Subject|0|||
163035038|NCT01260584|588832055|FG003|Period 2|Withdrawal by Subject|0|||
163035039|NCT00045734|588832056|FG000|Overall Study|Protocol Violation|1|||
163035040|NCT02069093|588832057|FG000|Overall Study|Disease progression|14|||
163035041|NCT02069093|588832057|FG000|Overall Study|New cancer therapy|1|||
163035042|NCT02069093|588832057|FG000|Overall Study|Death|1|||
163035043|NCT02069093|588832057|FG000|Overall Study|Administrative problems|1|||
163035044|NCT02069093|588832057|FG000|Overall Study|Withdrawal by Subject|2|||
163035045|NCT02069093|588832057|FG000|Overall Study|Abnormal laboratory values|1|||
163035046|NCT02069093|588832057|FG000|Overall Study|Adverse Event|10|||
163035047|NCT03434249|588832060|FG000|Overall Study|Adverse Event|1|||
163035048|NCT03434249|588832061|FG001|Overall Study|Adverse Event|0|||
163035049|NCT03434249|588832060|FG000|Overall Study|Lost to Follow-up|0|||
163035050|NCT03434249|588832061|FG001|Overall Study|Lost to Follow-up|1|||
163035051|NCT03434249|588832060|FG000|Overall Study|Non-compliance of family|2|||
163035052|NCT03434249|588832061|FG001|Overall Study|Non-compliance of family|1|||
163035053|NCT03434249|588832060|FG000|Overall Study|Difficulties in completing daily diary|2|||
163035054|NCT03434249|588832061|FG001|Overall Study|Difficulties in completing daily diary|1|||
163035055|NCT02918552|588832062|FG000|Overall Study|Failed Pharmacokinetics|1|||
163035056|NCT02918552|588832063|FG001|Overall Study|Failed Pharmacokinetics|0|||
163035057|NCT02918552|588832062|FG000|Overall Study|Withdrawal by Subject|0|||
163035058|NCT02918552|588832063|FG001|Overall Study|Withdrawal by Subject|1|||
163035059|NCT02918552|588832062|FG000|Overall Study|Lost to Follow-up|0|||
163035060|NCT02918552|588832063|FG001|Overall Study|Lost to Follow-up|1|||
163035061|NCT01001598|588832064|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
163035062|NCT01001598|588832064|FG000|Overall Study|Adverse Event|1|||
163035063|NCT01969084|588832069|FG000|Overall Study|Adverse Event|0|||
163035064|NCT01969084|588832070|FG001|Overall Study|Adverse Event|1|||
163035065|NCT02920177|588832071|FG000|Overall Study|Withdrawal by Subject|1|||
163035066|NCT02920177|588832072|FG001|Overall Study|Withdrawal by Subject|1|||
163035067|NCT02920177|588832071|FG000|Overall Study|Physician Decision|1|||
163035068|NCT02920177|588832072|FG001|Overall Study|Physician Decision|0|||
163035069|NCT02920177|588832071|FG000|Overall Study|Lost to Follow-up|0|||
163085677|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085678|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085679|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085680|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085681|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085682|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085683|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085684|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085685|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085686|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
163085687|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
163085688|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085689|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
163085690|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085691|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085692|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085693|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
163085694|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085695|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085696|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085697|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085698|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085699|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085700|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085701|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085702|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163085703|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085704|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085705|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085706|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
163085707|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085708|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085709|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
163085710|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085711|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085712|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085713|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085714|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085715|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085716|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085717|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085718|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
163085719|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085720|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085721|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
163085722|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085723|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085724|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085725|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163035070|NCT02920177|588832072|FG001|Overall Study|Lost to Follow-up|1|||
163035071|NCT03164265|588832073|FG000|Overall Study|Physician Decision|3|||
163035072|NCT04907227|588832074|FG000|Overall Study|Death|12|||
163035073|NCT04907227|588832075|FG001|Overall Study|Death|8|||
162648756|NCT04064294|587431229|FG000|Overall Study|Adverse Event|1|||
162648757|NCT04064294|587431230|FG001|Overall Study|Adverse Event|0|||
162648758|NCT04064294|587431231|FG002|Overall Study|Adverse Event|0|||
162648759|NCT01289847|587431233|FG000|Overall Study|Patient could not comply with visits|1|||
162648760|NCT00006478|587431234|FG000|Overall Study|Vaccine could not be produced|1|||
163035074|NCT04907227|588832074|FG000|Overall Study|Withdrawal by Subject|2|||
163035075|NCT04907227|588832075|FG001|Overall Study|Withdrawal by Subject|2|||
163035076|NCT04907227|588832074|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
163035077|NCT04907227|588832075|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
163035078|NCT04907227|588832074|FG000|Overall Study|Sponsor Decision|25|||
163035079|NCT04907227|588832075|FG001|Overall Study|Sponsor Decision|30|||
163035080|NCT04907227|588832074|FG000|Overall Study|Physician Decision|1|||
162648761|NCT00006478|587431234|FG000|Overall Study|Physician Decision|6|||
163035081|NCT04907227|588832075|FG001|Overall Study|Physician Decision|0|||
163035082|NCT03673345|588832076|FG000|Overall Study|Lost to Follow-up|1|||
163035083|NCT03673345|588832077|FG001|Overall Study|Lost to Follow-up|0|||
163035084|NCT03673345|588832078|FG002|Overall Study|Lost to Follow-up|3|||
163035085|NCT03673345|588832079|FG003|Overall Study|Lost to Follow-up|3|||
163035086|NCT03673345|588832080|FG004|Overall Study|Lost to Follow-up|2|||
163035087|NCT03673345|588832081|FG005|Overall Study|Lost to Follow-up|1|||
163035088|NCT03673345|588832082|FG006|Overall Study|Lost to Follow-up|0|||
163035089|NCT03673345|588832083|FG007|Overall Study|Lost to Follow-up|0|||
163035090|NCT03673345|588832076|FG000|Overall Study|Withdrawal by Subject|1|||
163035091|NCT03673345|588832077|FG001|Overall Study|Withdrawal by Subject|0|||
163035092|NCT03673345|588832078|FG002|Overall Study|Withdrawal by Subject|4|||
163035093|NCT03673345|588832079|FG003|Overall Study|Withdrawal by Subject|2|||
163035094|NCT03673345|588832080|FG004|Overall Study|Withdrawal by Subject|0|||
163035095|NCT03673345|588832081|FG005|Overall Study|Withdrawal by Subject|0|||
163035096|NCT03673345|588832082|FG006|Overall Study|Withdrawal by Subject|0|||
163035097|NCT03673345|588832083|FG007|Overall Study|Withdrawal by Subject|0|||
163035098|NCT03673345|588832076|FG000|Overall Study|Physician Decision|0|||
163035099|NCT03673345|588832077|FG001|Overall Study|Physician Decision|0|||
163035100|NCT03673345|588832078|FG002|Overall Study|Physician Decision|2|||
163035101|NCT03673345|588832079|FG003|Overall Study|Physician Decision|0|||
163035102|NCT03673345|588832080|FG004|Overall Study|Physician Decision|0|||
163035103|NCT03673345|588832081|FG005|Overall Study|Physician Decision|0|||
163085726|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085727|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085728|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085729|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085730|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085731|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085732|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085733|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085734|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
163085735|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085736|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085737|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163085738|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085739|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085740|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085741|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085742|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085743|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085744|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085745|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162648762|NCT00409617|587431244|FG000|Overall Study|Adverse Event|57|||
162648763|NCT00409617|587431244|FG000|Overall Study|Lack of Efficacy|54|||
162648764|NCT00409617|587431244|FG000|Overall Study|Lost to Follow-up|2|||
162648765|NCT00409617|587431244|FG000|Overall Study|Protocol Violation|24|||
162648766|NCT00409617|587431244|FG000|Overall Study|Withdrawal by Subject|8|||
162648767|NCT00409617|587431244|FG000|Overall Study|Administrative reasons|1|||
162648768|NCT00409617|587431244|FG000|Overall Study|Not described|14|||
162648769|NCT02159521|587431245|FG000|Overall Study|Enrolled but not treated|3|||
162648770|NCT02159521|587431245|FG000|Overall Study|Withdrawal by Subject|7|||
162648771|NCT02159521|587431245|FG000|Overall Study|Lost to Follow-up|6|||
162648772|NCT02159521|587431245|FG000|Overall Study|Death|1|||
162648773|NCT02159521|587431245|FG000|Overall Study|Other than specified|1|||
162648774|NCT00907374|587431248|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
162648775|NCT00907374|587431249|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
162648776|NCT03818516|587431250|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
162718272|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163035104|NCT03673345|588832082|FG006|Overall Study|Physician Decision|0|||
163085746|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085747|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085748|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163035105|NCT03673345|588832083|FG007|Overall Study|Physician Decision|0|||
163035106|NCT01362244|588832084|FG000|Overall Study|Adverse Event|3|||
163035107|NCT01362244|588832085|FG001|Overall Study|Adverse Event|5|||
163035108|NCT01362244|588832084|FG000|Overall Study|Lack of Efficacy|5|||
162648777|NCT01524692|587431254|FG000|Overall Study|Withdrawal by Subject|3|||
162648778|NCT01709695|587431255|FG000|Overall Study|Withdrawal by Subject|1|||
162648779|NCT01709695|587431256|FG001|Overall Study|Withdrawal by Subject|1|||
163035109|NCT01362244|588832085|FG001|Overall Study|Lack of Efficacy|11|||
163035110|NCT01362244|588832084|FG000|Overall Study|Lost to Follow-up|0|||
163035111|NCT01362244|588832085|FG001|Overall Study|Lost to Follow-up|2|||
163035112|NCT01362244|588832084|FG000|Overall Study|Protocol Violation|5|||
163035113|NCT01362244|588832085|FG001|Overall Study|Protocol Violation|1|||
163035114|NCT01362244|588832084|FG000|Overall Study|Withdrawal by Subject|2|||
163035115|NCT01362244|588832085|FG001|Overall Study|Withdrawal by Subject|1|||
163035116|NCT01362244|588832084|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
163035117|NCT01362244|588832085|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
163035118|NCT01362244|588832084|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
163035119|NCT01362244|588832085|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
163035120|NCT01253174|588832086|FG000|Period 1|Randomized but not treated|0|||
163035121|NCT01253174|588832087|FG001|Period 1|Randomized but not treated|1|||
163035122|NCT01253174|588832088|FG002|Period 1|Randomized but not treated|1|||
163035123|NCT01253174|588832089|FG003|Period 1|Randomized but not treated|0|||
163035124|NCT01253174|588832090|FG004|Period 1|Randomized but not treated|1|||
163035125|NCT01253174|588832091|FG005|Period 1|Randomized but not treated|0|||
163035126|NCT01253174|588832086|FG000|Period 2|Adverse Event|0|||
163035127|NCT01253174|588832087|FG001|Period 2|Adverse Event|0|||
163035128|NCT01253174|588832088|FG002|Period 2|Adverse Event|1|||
163035129|NCT01253174|588832089|FG003|Period 2|Adverse Event|0|||
163035130|NCT01253174|588832090|FG004|Period 2|Adverse Event|0|||
163035131|NCT01253174|588832091|FG005|Period 2|Adverse Event|0|||
163035132|NCT01253174|588832086|FG000|Period 3|Withdrawal by Subject|0|||
163035133|NCT01253174|588832087|FG001|Period 3|Withdrawal by Subject|1|||
163035134|NCT01253174|588832088|FG002|Period 3|Withdrawal by Subject|0|||
162648780|NCT03065244|587431259|FG000|Overall Study|Lost to Follow-up|1|||
162648781|NCT03065244|587431260|FG001|Overall Study|Lost to Follow-up|1|||
162648782|NCT03065244|587431259|FG000|Overall Study|Diagnosed with a different disease|1|||
163035135|NCT01253174|588832089|FG003|Period 3|Withdrawal by Subject|0|||
163035136|NCT01253174|588832090|FG004|Period 3|Withdrawal by Subject|1|||
163035137|NCT01253174|588832091|FG005|Period 3|Withdrawal by Subject|0|||
163035138|NCT01253174|588832086|FG000|Period 3|Pregnancy|0|||
163035139|NCT01253174|588832087|FG001|Period 3|Pregnancy|0|||
163035140|NCT01253174|588832088|FG002|Period 3|Pregnancy|1|||
163035141|NCT01253174|588832089|FG003|Period 3|Pregnancy|0|||
163035142|NCT01253174|588832090|FG004|Period 3|Pregnancy|0|||
163035143|NCT01253174|588832091|FG005|Period 3|Pregnancy|0|||
163035144|NCT02267135|588832092|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
163035145|NCT02267135|588832093|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
163035146|NCT02267135|588832092|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
163035147|NCT02267135|588832093|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
163035148|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
163035149|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
163035150|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
163035151|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
163035152|NCT02267135|588832092|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
163035153|NCT02267135|588832093|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
163035154|NCT03806231|588832094|FG000|Overall Study|Physician Decision|1|||
163035155|NCT03806231|588832095|FG001|Overall Study|Physician Decision|0|||
163035156|NCT03806231|588832094|FG000|Overall Study|Withdrawal by Subject|1|||
163035157|NCT03806231|588832095|FG001|Overall Study|Withdrawal by Subject|0|||
163035158|NCT02919267|588832096|FG000|Overall Study|Protocol Violation|0|||
163035159|NCT02919267|588832097|FG001|Overall Study|Protocol Violation|3|||
163035160|NCT02919267|588832098|FG002|Overall Study|Protocol Violation|3|||
163035161|NCT02919267|588832099|FG003|Overall Study|Protocol Violation|4|||
163035162|NCT04608344|588832100|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
163035163|NCT04608344|588832101|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
163035164|NCT04608344|588832100|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
163035165|NCT04608344|588832101|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
163035166|NCT00467961|588832102|FG000|Overall Study|Technical Failures|5|||
163035167|NCT00467961|588832102|FG000|Overall Study|Disease Progression|2|||
163035168|NCT02429310|588832104|FG000|Overall Study|Lost to Follow-up|1|||
162648783|NCT03065244|587431260|FG001|Overall Study|Diagnosed with a different disease|1|||
162648784|NCT03065244|587431259|FG000|Overall Study|Protocol Violation|0|||
163035169|NCT02429310|588832105|FG001|Overall Study|Lost to Follow-up|2|||
163035170|NCT02429310|588832104|FG000|Overall Study|Protocol Violation|1|||
163035171|NCT02429310|588832105|FG001|Overall Study|Protocol Violation|1|||
163035172|NCT00394433|588832106|FG000|Overall Study|Adverse Event|2|||
163035173|NCT00394433|588832106|FG000|Overall Study|Alternative Therapy|1|||
162648785|NCT03065244|587431260|FG001|Overall Study|Protocol Violation|1|||
163035174|NCT03646305|588832107|FG000|Overall Study|Lost to Follow-up|4|||
163035175|NCT03646305|588832108|FG001|Overall Study|Lost to Follow-up|2|||
163035176|NCT03646305|588832109|FG002|Overall Study|Lost to Follow-up|2|||
163035177|NCT03646305|588832110|FG003|Overall Study|Lost to Follow-up|1|||
163035178|NCT03646305|588832107|FG000|Overall Study|Withdrawal by Subject|1|||
163035179|NCT03646305|588832108|FG001|Overall Study|Withdrawal by Subject|0|||
162648786|NCT03065244|587431259|FG000|Overall Study|Withdrawal by Subject|1|||
162648787|NCT03065244|587431260|FG001|Overall Study|Withdrawal by Subject|1|||
163035180|NCT03646305|588832109|FG002|Overall Study|Withdrawal by Subject|0|||
163035181|NCT03646305|588832110|FG003|Overall Study|Withdrawal by Subject|1|||
162648788|NCT01894152|587431261|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
162648789|NCT02965703|587431266|FG000|Overall Study|Withdrawal by Subject|6|||
162648790|NCT02965703|587431267|FG001|Overall Study|Withdrawal by Subject|3|||
162648791|NCT02965703|587431268|FG002|Overall Study|Withdrawal by Subject|1|||
162648792|NCT02965703|587431266|FG000|Overall Study|Protocol Violation|1|||
162648793|NCT02965703|587431267|FG001|Overall Study|Protocol Violation|0|||
163035182|NCT01554176|588832111|FG000|Treatment Phase|Protocol Violation|1|||
163035183|NCT01554176|588832112|FG001|Treatment Phase|Protocol Violation|2|||
163035184|NCT01554176|588832113|FG002|Treatment Phase|Protocol Violation|0|||
163035185|NCT01554176|588832114|FG003|Treatment Phase|Protocol Violation|0|||
163035186|NCT01554176|588832115|FG004|Treatment Phase|Protocol Violation|0|||
163035187|NCT01554176|588832111|FG000|Treatment Phase|Physician Decision|1|||
163035188|NCT01554176|588832112|FG001|Treatment Phase|Physician Decision|1|||
163035189|NCT01554176|588832113|FG002|Treatment Phase|Physician Decision|0|||
163035190|NCT01554176|588832114|FG003|Treatment Phase|Physician Decision|0|||
163035191|NCT01554176|588832115|FG004|Treatment Phase|Physician Decision|0|||
163035192|NCT01554176|588832111|FG000|Treatment Phase|Lack of Efficacy|0|||
163035193|NCT01554176|588832112|FG001|Treatment Phase|Lack of Efficacy|1|||
163035194|NCT01554176|588832113|FG002|Treatment Phase|Lack of Efficacy|0|||
163035195|NCT01554176|588832114|FG003|Treatment Phase|Lack of Efficacy|0|||
163035196|NCT01554176|588832115|FG004|Treatment Phase|Lack of Efficacy|0|||
163035197|NCT01554176|588832111|FG000|Treatment Phase|Adverse event, non-fatal|1|||
163035198|NCT01554176|588832112|FG001|Treatment Phase|Adverse event, non-fatal|1|||
163035199|NCT01554176|588832113|FG002|Treatment Phase|Adverse event, non-fatal|0|||
163035200|NCT01554176|588832114|FG003|Treatment Phase|Adverse event, non-fatal|0|||
163035201|NCT01554176|588832115|FG004|Treatment Phase|Adverse event, non-fatal|0|||
163035202|NCT01554176|588832111|FG000|Treatment Phase|Non-compliance with study drug|1|||
163035203|NCT01554176|588832112|FG001|Treatment Phase|Non-compliance with study drug|0|||
163035204|NCT01554176|588832113|FG002|Treatment Phase|Non-compliance with study drug|0|||
163035205|NCT01554176|588832114|FG003|Treatment Phase|Non-compliance with study drug|0|||
163035206|NCT01554176|588832115|FG004|Treatment Phase|Non-compliance with study drug|0|||
163035207|NCT01554176|588832111|FG000|Treatment Phase|Withdrawal by Subject|1|||
163035208|NCT01554176|588832112|FG001|Treatment Phase|Withdrawal by Subject|0|||
163035209|NCT01554176|588832113|FG002|Treatment Phase|Withdrawal by Subject|0|||
163035210|NCT01554176|588832114|FG003|Treatment Phase|Withdrawal by Subject|0|||
163035211|NCT01554176|588832115|FG004|Treatment Phase|Withdrawal by Subject|0|||
163035212|NCT01554176|588832111|FG000|Treatment Phase|Lost to Follow-up|3|||
163035213|NCT01554176|588832112|FG001|Treatment Phase|Lost to Follow-up|0|||
163035214|NCT01554176|588832113|FG002|Treatment Phase|Lost to Follow-up|0|||
163035215|NCT01554176|588832114|FG003|Treatment Phase|Lost to Follow-up|0|||
163035216|NCT01554176|588832115|FG004|Treatment Phase|Lost to Follow-up|0|||
163035217|NCT01554176|588832111|FG000|Run-out Phase|Protocol Violation|0|||
163035218|NCT01554176|588832112|FG001|Run-out Phase|Protocol Violation|0|||
163035219|NCT01554176|588832113|FG002|Run-out Phase|Protocol Violation|0|||
163035220|NCT01554176|588832114|FG003|Run-out Phase|Protocol Violation|1|||
163035221|NCT01554176|588832115|FG004|Run-out Phase|Protocol Violation|0|||
163035222|NCT02678000|588832118|FG000|PART 2|Adverse Event|0|||
163035223|NCT02678000|588832119|FG001|PART 2|Adverse Event|0|||
163035224|NCT02678000|588832120|FG002|PART 2|Adverse Event|2|||
163035225|NCT02678000|588832121|FG003|PART 2|Adverse Event|1|||
163035226|NCT02678000|588832122|FG004|PART 2|Adverse Event|0|||
163035227|NCT02678000|588832118|FG000|PART 2|Withdrawal by Subject|0|||
163035228|NCT02678000|588832119|FG001|PART 2|Withdrawal by Subject|0|||
163035229|NCT02678000|588832120|FG002|PART 2|Withdrawal by Subject|1|||
163035230|NCT02678000|588832121|FG003|PART 2|Withdrawal by Subject|0|||
163035231|NCT02678000|588832122|FG004|PART 2|Withdrawal by Subject|0|||
163035232|NCT02190721|588834246|FG000|Overall Study|Patient was out of the city|0|||
163035233|NCT02190721|588834247|FG001|Overall Study|Patient was out of the city|1|||
163035234|NCT02190721|588834248|FG002|Overall Study|Patient was out of the city|0|||
163035235|NCT01760447|588834249|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
163035236|NCT01760447|588834250|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
163035237|NCT01760447|588834251|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
163035238|NCT01760447|588834252|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
163035239|NCT01760447|588834249|FG000|Weeks 0-20|Withdrawal by Subject|2|||
163035240|NCT01760447|588834250|FG001|Weeks 0-20|Withdrawal by Subject|0|||
163035241|NCT01760447|588834251|FG002|Weeks 0-20|Withdrawal by Subject|1|||
163035242|NCT01760447|588834252|FG003|Weeks 0-20|Withdrawal by Subject|0|||
163035243|NCT01760447|588834249|FG000|Weeks 0-20|Lost to Follow-up|1|||
163035244|NCT01760447|588834250|FG001|Weeks 0-20|Lost to Follow-up|0|||
163035245|NCT01760447|588834251|FG002|Weeks 0-20|Lost to Follow-up|1|||
163035246|NCT01760447|588834252|FG003|Weeks 0-20|Lost to Follow-up|1|||
163035247|NCT01760447|588834249|FG000|Weeks 0-20|Randomized but not treated|0|||
163035248|NCT01760447|588834250|FG001|Weeks 0-20|Randomized but not treated|0|||
163035249|NCT01760447|588834251|FG002|Weeks 0-20|Randomized but not treated|2|||
163035250|NCT01760447|588834252|FG003|Weeks 0-20|Randomized but not treated|0|||
163035251|NCT01760447|588834249|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
163035252|NCT01760447|588834250|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
162648794|NCT02965703|587431268|FG002|Overall Study|Protocol Violation|0|||
162648795|NCT02965703|587431266|FG000|Overall Study|Adverse Event|1|||
162648796|NCT02965703|587431267|FG001|Overall Study|Adverse Event|1|||
162648797|NCT02965703|587431268|FG002|Overall Study|Adverse Event|0|||
162648798|NCT02965703|587431266|FG000|Overall Study|Lost to Follow-up|2|||
162648799|NCT02965703|587431267|FG001|Overall Study|Lost to Follow-up|1|||
163035253|NCT01760447|588834251|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
163035254|NCT01760447|588834252|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
163035255|NCT01760447|588834249|FG000|Weeks 20-54|Withdrawal by Subject|2|||
163035256|NCT01760447|588834250|FG001|Weeks 20-54|Withdrawal by Subject|1|||
163035257|NCT01760447|588834251|FG002|Weeks 20-54|Withdrawal by Subject|1|||
163035258|NCT01760447|588834252|FG003|Weeks 20-54|Withdrawal by Subject|2|||
163035259|NCT01760447|588834249|FG000|Weeks 20-54|Lost to Follow-up|0|||
163035260|NCT01760447|588834250|FG001|Weeks 20-54|Lost to Follow-up|0|||
163035261|NCT01760447|588834251|FG002|Weeks 20-54|Lost to Follow-up|1|||
163035262|NCT01760447|588834252|FG003|Weeks 20-54|Lost to Follow-up|2|||
163035263|NCT01214668|588834253|FG000|Overall Study|Adverse Event|0|||
163035264|NCT01214668|588834254|FG001|Overall Study|Adverse Event|1|||
163035265|NCT01214668|588834255|FG002|Overall Study|Adverse Event|0|||
163035266|NCT01214668|588834256|FG003|Overall Study|Adverse Event|2|||
163035267|NCT01214668|588834257|FG004|Overall Study|Adverse Event|1|||
163035268|NCT01214668|588834258|FG005|Overall Study|Adverse Event|1|||
163035269|NCT01214668|588834253|FG000|Overall Study|Death|0|||
163035270|NCT01214668|588834254|FG001|Overall Study|Death|0|||
163035271|NCT01214668|588834255|FG002|Overall Study|Death|1|||
163035272|NCT01214668|588834256|FG003|Overall Study|Death|0|||
163035273|NCT01214668|588834257|FG004|Overall Study|Death|0|||
163035274|NCT01214668|588834258|FG005|Overall Study|Death|0|||
163035275|NCT01214668|588834253|FG000|Overall Study|Progressive Disease|4|||
163035276|NCT01214668|588834254|FG001|Overall Study|Progressive Disease|2|||
163035277|NCT01214668|588834255|FG002|Overall Study|Progressive Disease|5|||
163035278|NCT01214668|588834256|FG003|Overall Study|Progressive Disease|4|||
163035279|NCT01214668|588834257|FG004|Overall Study|Progressive Disease|4|||
163035280|NCT01214668|588834258|FG005|Overall Study|Progressive Disease|5|||
163035281|NCT01214668|588834253|FG000|Overall Study|Withdrawal by Subject|0|||
163035282|NCT01214668|588834254|FG001|Overall Study|Withdrawal by Subject|0|||
163035283|NCT01214668|588834255|FG002|Overall Study|Withdrawal by Subject|0|||
163035284|NCT01214668|588834256|FG003|Overall Study|Withdrawal by Subject|0|||
163035285|NCT01214668|588834257|FG004|Overall Study|Withdrawal by Subject|1|||
163035286|NCT01214668|588834258|FG005|Overall Study|Withdrawal by Subject|0|||
163035287|NCT02907619|588834259|FG000|Overall Study|Study terminated by sponsor|18|||
163035288|NCT02907619|588834260|FG001|Overall Study|Study terminated by sponsor|18|||
163035289|NCT02907619|588834261|FG002|Overall Study|Study terminated by sponsor|19|||
163035290|NCT02907619|588834259|FG000|Overall Study|Death|0|||
163035291|NCT02907619|588834260|FG001|Overall Study|Death|0|||
163035292|NCT02907619|588834261|FG002|Overall Study|Death|1|||
163035293|NCT02907619|588834259|FG000|Overall Study|Withdrawal by Subject|1|||
163035294|NCT02907619|588834260|FG001|Overall Study|Withdrawal by Subject|1|||
163035295|NCT02907619|588834261|FG002|Overall Study|Withdrawal by Subject|0|||
163035296|NCT02907619|588834259|FG000|Overall Study|Other|0|||
163035297|NCT02907619|588834260|FG001|Overall Study|Other|1|||
163035298|NCT02907619|588834261|FG002|Overall Study|Other|0|||
163035299|NCT03326518|588834262|FG000|Overall Study|Protocol Violation|1|||
163035300|NCT03326518|588834263|FG001|Overall Study|Protocol Violation|0|||
163035301|NCT03326518|588834264|FG002|Overall Study|Protocol Violation|0|||
163035302|NCT03326518|588834262|FG000|Overall Study|Withdrawal by Subject|1|||
163035303|NCT03326518|588834263|FG001|Overall Study|Withdrawal by Subject|0|||
163035304|NCT03326518|588834264|FG002|Overall Study|Withdrawal by Subject|0|||
163035305|NCT03326518|588834262|FG000|Overall Study|Lost to Follow-up|1|||
163035306|NCT03326518|588834263|FG001|Overall Study|Lost to Follow-up|0|||
163035307|NCT03326518|588834264|FG002|Overall Study|Lost to Follow-up|1|||
163035308|NCT06439095|588834265|FG000|Overall Study|Lost to Follow-up|2|||
163035309|NCT03484403|588834267|FG000|Overall Study|Withdrawal by Subject|6|||
163035310|NCT03484403|588834268|FG001|Overall Study|Withdrawal by Subject|4|||
163035311|NCT01937884|588834269|FG000|Overall Study|Withdrawal by Subject|1|||
163035312|NCT01937884|588834270|FG001|Overall Study|Withdrawal by Subject|0|||
163035313|NCT01167634|588834275|FG000|Overall Study|Lost to Follow-up|1|||
163035314|NCT01167634|588834276|FG001|Overall Study|Lost to Follow-up|3|||
163035315|NCT01167634|588834277|FG002|Overall Study|Lost to Follow-up|3|||
163035316|NCT01167634|588834278|FG003|Overall Study|Lost to Follow-up|4|||
163035317|NCT01167634|588834275|FG000|Overall Study|Withdrawal by Subject|1|||
162648800|NCT02965703|587431268|FG002|Overall Study|Lost to Follow-up|1|||
162648801|NCT00788827|587431273|FG000|Overall Study|Lack of Efficacy|2|||
162648802|NCT02818777|587431285|FG000|Overall Study|Adverse Event|3|||
163035318|NCT01167634|588834276|FG001|Overall Study|Withdrawal by Subject|1|||
163035319|NCT01167634|588834277|FG002|Overall Study|Withdrawal by Subject|0|||
163035320|NCT01167634|588834278|FG003|Overall Study|Withdrawal by Subject|0|||
163035321|NCT00553358|588834279|FG000|Overall Study|Randomized but did not receive treatment|3|||
163035322|NCT00553358|588834280|FG001|Overall Study|Randomized but did not receive treatment|3|||
163035323|NCT00553358|588834281|FG002|Overall Study|Randomized but did not receive treatment|1|||
163035324|NCT00553358|588834279|FG000|Overall Study|Lost to Follow-up|22|||
163035325|NCT00553358|588834280|FG001|Overall Study|Lost to Follow-up|26|||
163035326|NCT00553358|588834281|FG002|Overall Study|Lost to Follow-up|18|||
163035327|NCT00553358|588834279|FG000|Overall Study|Withdrew completely|23|||
163035328|NCT00553358|588834280|FG001|Overall Study|Withdrew completely|33|||
163035329|NCT00553358|588834281|FG002|Overall Study|Withdrew completely|34|||
163035330|NCT00553358|588834279|FG000|Overall Study|Died during clinical follow-up|25|||
163035331|NCT00553358|588834280|FG001|Overall Study|Died during clinical follow-up|29|||
163035332|NCT00553358|588834281|FG002|Overall Study|Died during clinical follow-up|32|||
163035333|NCT00553358|588834279|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
163035334|NCT00553358|588834280|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
163035335|NCT00553358|588834281|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
163035336|NCT00553358|588834279|FG000|Overall Study|Died after clinical follow-up ended|1|||
163035337|NCT00553358|588834280|FG001|Overall Study|Died after clinical follow-up ended|2|||
163035338|NCT00553358|588834281|FG002|Overall Study|Died after clinical follow-up ended|0|||
163035339|NCT00553358|588834279|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035340|NCT00553358|588834280|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035341|NCT00553358|588834281|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
163035342|NCT02854605|588834286|FG000|Overall Study|Adverse Event|1|||
163035343|NCT02854605|588834287|FG001|Overall Study|Adverse Event|5|||
163035344|NCT02854605|588834288|FG002|Overall Study|Adverse Event|2|||
163035345|NCT02854605|588834286|FG000|Overall Study|Lost to Follow-up|0|||
163035346|NCT02854605|588834287|FG001|Overall Study|Lost to Follow-up|2|||
163035347|NCT02854605|588834288|FG002|Overall Study|Lost to Follow-up|0|||
163035348|NCT02854605|588834286|FG000|Overall Study|Withdrew Consent|1|||
163035349|NCT02854605|588834287|FG001|Overall Study|Withdrew Consent|0|||
163035350|NCT02854605|588834288|FG002|Overall Study|Withdrew Consent|1|||
163035351|NCT02854605|588834286|FG000|Overall Study|Investigator's Discretion|1|||
163035352|NCT02854605|588834287|FG001|Overall Study|Investigator's Discretion|0|||
163035353|NCT02854605|588834288|FG002|Overall Study|Investigator's Discretion|0|||
163035354|NCT02854605|588834286|FG000|Overall Study|Protocol Violation|0|||
163035355|NCT02854605|588834287|FG001|Overall Study|Protocol Violation|0|||
163035356|NCT02854605|588834288|FG002|Overall Study|Protocol Violation|1|||
163035357|NCT05268016|588834289|FG000|Overall Study|Unacceptable toxicity or AE|2|||
163035358|NCT05268016|588834290|FG001|Overall Study|Unacceptable toxicity or AE|2|||
163035359|NCT05268016|588834291|FG002|Overall Study|Unacceptable toxicity or AE|4|||
163035360|NCT05268016|588834292|FG003|Overall Study|Unacceptable toxicity or AE|3|||
163035361|NCT05268016|588834293|FG004|Overall Study|Unacceptable toxicity or AE|1|||
163035362|NCT05268016|588834289|FG000|Overall Study|Withdrawal by Subject|1|||
163035363|NCT05268016|588834290|FG001|Overall Study|Withdrawal by Subject|3|||
163035364|NCT05268016|588834291|FG002|Overall Study|Withdrawal by Subject|2|||
163035365|NCT05268016|588834292|FG003|Overall Study|Withdrawal by Subject|2|||
163035366|NCT05268016|588834293|FG004|Overall Study|Withdrawal by Subject|1|||
163035367|NCT05268016|588834289|FG000|Overall Study|Lost to Follow-up|4|||
163035368|NCT05268016|588834290|FG001|Overall Study|Lost to Follow-up|7|||
163035369|NCT05268016|588834291|FG002|Overall Study|Lost to Follow-up|1|||
163035370|NCT05268016|588834292|FG003|Overall Study|Lost to Follow-up|3|||
163035371|NCT05268016|588834293|FG004|Overall Study|Lost to Follow-up|5|||
163035372|NCT05268016|588834289|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
163035373|NCT05268016|588834290|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035374|NCT05268016|588834291|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035375|NCT05268016|588834292|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
163035376|NCT05268016|588834293|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
163035377|NCT05268016|588834289|FG000|Overall Study|Lack of Efficacy|0|||
163035378|NCT05268016|588834290|FG001|Overall Study|Lack of Efficacy|0|||
163035379|NCT05268016|588834291|FG002|Overall Study|Lack of Efficacy|0|||
163035380|NCT05268016|588834292|FG003|Overall Study|Lack of Efficacy|0|||
163035381|NCT05268016|588834293|FG004|Overall Study|Lack of Efficacy|4|||
163035382|NCT05268016|588834289|FG000|Overall Study|Physician Decision|0|||
163035383|NCT05268016|588834290|FG001|Overall Study|Physician Decision|0|||
163035384|NCT05268016|588834291|FG002|Overall Study|Physician Decision|0|||
163035385|NCT05268016|588834292|FG003|Overall Study|Physician Decision|1|||
163035386|NCT05268016|588834293|FG004|Overall Study|Physician Decision|0|||
163035387|NCT05268016|588834289|FG000|Overall Study|Other|1|||
163035388|NCT05268016|588834290|FG001|Overall Study|Other|0|||
163035389|NCT05268016|588834291|FG002|Overall Study|Other|1|||
163035390|NCT05268016|588834292|FG003|Overall Study|Other|2|||
163035391|NCT05268016|588834293|FG004|Overall Study|Other|0|||
163035392|NCT01964716|588834294|FG000|Overall Study|Withdrawal by Subject|2|||
163085749|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163035393|NCT01964716|588834295|FG001|Overall Study|Withdrawal by Subject|3|||
163035394|NCT01964716|588834294|FG000|Overall Study|Lost to Follow-up|1|||
162648803|NCT02028988|587431286|FG000|Overall Study|Withdrawal by Subject|2|||
162648804|NCT00747435|587431289|FG000|Overall Study|Lost to Follow-up|2|||
162648805|NCT00747435|587431289|FG000|Overall Study|Withdrawal by Subject|3|||
162648806|NCT00747435|587431289|FG000|Overall Study|Still undergoing follow up|1|||
162648807|NCT01324349|587431290|FG000|Overall Study|Death|1|||
162648808|NCT01324349|587431291|FG001|Overall Study|Death|1|||
162648809|NCT01324349|587431290|FG000|Overall Study|Withdrawal by Subject|0|||
162648810|NCT01324349|587431291|FG001|Overall Study|Withdrawal by Subject|1|||
162648811|NCT00851799|587431292|FG000|Overall Study|Death|1|||
162648812|NCT00851799|587431293|FG001|Overall Study|Death|0|||
162648813|NCT00851799|587431294|FG002|Overall Study|Death|1|||
162648814|NCT00851799|587431292|FG000|Overall Study|Lost to Follow-up|5|||
162648815|NCT00851799|587431293|FG001|Overall Study|Lost to Follow-up|3|||
162648816|NCT00851799|587431294|FG002|Overall Study|Lost to Follow-up|10|||
162648817|NCT00851799|587431292|FG000|Overall Study|Not able to get to clinic|8|||
162648818|NCT00851799|587431293|FG001|Overall Study|Not able to get to clinic|5|||
162648819|NCT00851799|587431294|FG002|Overall Study|Not able to get to clinic|9|||
162648820|NCT00851799|587431292|FG000|Overall Study|Not willing to adhere to requirements|1|||
162648821|NCT00851799|587431293|FG001|Overall Study|Not willing to adhere to requirements|2|||
162648822|NCT00851799|587431294|FG002|Overall Study|Not willing to adhere to requirements|2|||
162648823|NCT00851799|587431292|FG000|Overall Study|Withdrew consent prior study completion|1|||
162648824|NCT00851799|587431293|FG001|Overall Study|Withdrew consent prior study completion|2|||
162648825|NCT00851799|587431294|FG002|Overall Study|Withdrew consent prior study completion|1|||
162648826|NCT00851799|587431292|FG000|Overall Study|Severe Debilitation|0|||
162648827|NCT00851799|587431293|FG001|Overall Study|Severe Debilitation|1|||
162648828|NCT00851799|587431294|FG002|Overall Study|Severe Debilitation|0|||
163035395|NCT01964716|588834295|FG001|Overall Study|Lost to Follow-up|2|||
163035396|NCT01964716|588834294|FG000|Overall Study|No longer met eligibility criteria|1|||
163035397|NCT01964716|588834295|FG001|Overall Study|No longer met eligibility criteria|1|||
163035398|NCT01964716|588834294|FG000|Overall Study|Death|1|||
163035399|NCT01964716|588834295|FG001|Overall Study|Death|0|||
163035400|NCT03013985|588834296|FG000|Overall Study|Protocol Violation|2|||
163035401|NCT03013985|588834297|FG001|Overall Study|Protocol Violation|2|||
163035402|NCT03013985|588834296|FG000|Overall Study|Withdrawal by Subject|14|||
163035403|NCT03013985|588834297|FG001|Overall Study|Withdrawal by Subject|17|||
163035404|NCT01370616|588834298|FG000|Overall Study|Adverse Event|11|||
163035405|NCT01370616|588834299|FG001|Overall Study|Adverse Event|16|||
163035406|NCT01370616|588834298|FG000|Overall Study|Death|1|||
163035407|NCT01370616|588834299|FG001|Overall Study|Death|0|||
163035408|NCT01370616|588834298|FG000|Overall Study|Lack of Efficacy|6|||
163035409|NCT01370616|588834299|FG001|Overall Study|Lack of Efficacy|2|||
163035410|NCT01370616|588834298|FG000|Overall Study|Lost to Follow-up|0|||
163035411|NCT01370616|588834299|FG001|Overall Study|Lost to Follow-up|3|||
163035412|NCT01370616|588834298|FG000|Overall Study|Physician Decision|6|||
163035413|NCT01370616|588834299|FG001|Overall Study|Physician Decision|6|||
163035414|NCT01370616|588834298|FG000|Overall Study|Progressive Disease|0|||
163035415|NCT01370616|588834299|FG001|Overall Study|Progressive Disease|1|||
163035416|NCT01370616|588834298|FG000|Overall Study|Recovery|1|||
163035417|NCT01370616|588834299|FG001|Overall Study|Recovery|0|||
163035418|NCT01370616|588834298|FG000|Overall Study|Technical Problems|3|||
163035419|NCT01370616|588834299|FG001|Overall Study|Technical Problems|5|||
163035420|NCT01370616|588834298|FG000|Overall Study|Withdrawal by Subject|34|||
163035421|NCT01370616|588834299|FG001|Overall Study|Withdrawal by Subject|34|||
163035422|NCT00076999|588834304|FG000|Overall Study|Adverse Event|2|||
163035423|NCT00076999|588834305|FG001|Overall Study|Adverse Event|8|||
163035424|NCT00076999|588834306|FG002|Overall Study|Adverse Event|6|||
163035425|NCT00076999|588834307|FG003|Overall Study|Adverse Event|0|||
163035426|NCT00076999|588834308|FG004|Overall Study|Adverse Event|2|||
163035427|NCT00076999|588834304|FG000|Overall Study|Protocol Violation|0|||
163035428|NCT00076999|588834305|FG001|Overall Study|Protocol Violation|3|||
163035429|NCT00076999|588834306|FG002|Overall Study|Protocol Violation|4|||
163035430|NCT00076999|588834307|FG003|Overall Study|Protocol Violation|0|||
163035431|NCT00076999|588834308|FG004|Overall Study|Protocol Violation|9|||
163035432|NCT00076999|588834304|FG000|Overall Study|Lost to Follow-up|2|||
163035433|NCT00076999|588834305|FG001|Overall Study|Lost to Follow-up|1|||
163035434|NCT00076999|588834306|FG002|Overall Study|Lost to Follow-up|0|||
163035435|NCT00076999|588834307|FG003|Overall Study|Lost to Follow-up|0|||
163035436|NCT00076999|588834308|FG004|Overall Study|Lost to Follow-up|0|||
163035437|NCT00076999|588834304|FG000|Overall Study|Withdrawal by Subject|0|||
163035438|NCT00076999|588834305|FG001|Overall Study|Withdrawal by Subject|4|||
163035439|NCT00076999|588834306|FG002|Overall Study|Withdrawal by Subject|3|||
163035440|NCT00076999|588834307|FG003|Overall Study|Withdrawal by Subject|0|||
163035441|NCT00076999|588834308|FG004|Overall Study|Withdrawal by Subject|1|||
163035442|NCT00076999|588834304|FG000|Overall Study|Other reason (not specified)|8|||
163035443|NCT00076999|588834305|FG001|Overall Study|Other reason (not specified)|8|||
163035444|NCT00076999|588834306|FG002|Overall Study|Other reason (not specified)|4|||
163035445|NCT00076999|588834307|FG003|Overall Study|Other reason (not specified)|1|||
163035446|NCT00076999|588834308|FG004|Overall Study|Other reason (not specified)|13|||
163035447|NCT01217385|588834310|FG000|Overall Study|Withdrawal by Subject|3|||
163035448|NCT01217385|588834310|FG000|Overall Study|DOSI not performed/not eval|12|||
163035449|NCT01217385|588834310|FG000|Overall Study|Central Path not Available|1|||
163035450|NCT01217385|588834310|FG000|Overall Study|Normal Breast TOI not available|10|||
163035451|NCT01534208|588834311|FG000|Overall Study|Lost to Follow-up|19|||
163035452|NCT01534208|588834312|FG001|Overall Study|Lost to Follow-up|14|||
163035453|NCT01534208|588834311|FG000|Overall Study|Withdrawal by Subject|6|||
163035454|NCT01534208|588834312|FG001|Overall Study|Withdrawal by Subject|20|||
163035455|NCT01534208|588834311|FG000|Overall Study|Adverse Event|15|||
163035456|NCT01534208|588834312|FG001|Overall Study|Adverse Event|8|||
163035457|NCT01534208|588834311|FG000|Overall Study|Physician Decision|2|||
163035458|NCT01534208|588834312|FG001|Overall Study|Physician Decision|0|||
163035459|NCT01534208|588834311|FG000|Overall Study|Lack of Efficacy|0|||
163035460|NCT01534208|588834312|FG001|Overall Study|Lack of Efficacy|3|||
163035461|NCT01534208|588834311|FG000|Overall Study|Protocol Violation|2|||
163035462|NCT01534208|588834312|FG001|Overall Study|Protocol Violation|2|||
163035463|NCT01534208|588834311|FG000|Overall Study|Sponsor decision|4|||
163035464|NCT01534208|588834312|FG001|Overall Study|Sponsor decision|1|||
163035465|NCT01534208|588834311|FG000|Overall Study|Subject relocation|2|||
163035466|NCT01534208|588834312|FG001|Overall Study|Subject relocation|0|||
163035467|NCT01534208|588834311|FG000|Overall Study|Lab assessment|2|||
163035468|NCT01534208|588834312|FG001|Overall Study|Lab assessment|1|||
163035469|NCT01534208|588834311|FG000|Overall Study|Eligibility error|3|||
163035470|NCT01534208|588834312|FG001|Overall Study|Eligibility error|0|||
163035471|NCT01534208|588834311|FG000|Overall Study|PCP decision|1|||
163035472|NCT01534208|588834312|FG001|Overall Study|PCP decision|0|||
163035473|NCT01534208|588834311|FG000|Overall Study|Needed prohibited meds|1|||
163035474|NCT01534208|588834312|FG001|Overall Study|Needed prohibited meds|0|||
163035475|NCT02117713|588834323|FG000|Week 48|Adverse Event|4|||
163035476|NCT02117713|588834323|FG000|Week 48|Withdrawal by caregiver|2|||
163035477|NCT02117713|588834323|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
163035478|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
163035479|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
163035480|NCT02117713|588834323|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
163035481|NCT00672841|588834324|FG000|Overall Study|Comfort care|1|||
163035482|NCT00672841|588834325|FG001|Overall Study|Comfort care|4|||
163035483|NCT00672841|588834324|FG000|Overall Study|icteric specimens|0|||
163035484|NCT00672841|588834325|FG001|Overall Study|icteric specimens|3|||
163035485|NCT00672841|588834324|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
163035486|NCT00672841|588834325|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
163035487|NCT00672841|588834324|FG000|Overall Study|Adverse Event|0|||
163035488|NCT00672841|588834325|FG001|Overall Study|Adverse Event|3|||
163035489|NCT00672841|588834324|FG000|Overall Study|Pregnancy|0|||
163035490|NCT00672841|588834325|FG001|Overall Study|Pregnancy|1|||
163035491|NCT03578146|588834326|FG000|Overall Study|Did Not Receive Treatment|1|||
163035492|NCT03578146|588834327|FG001|Overall Study|Did Not Receive Treatment|0|||
163035493|NCT03578146|588834328|FG002|Overall Study|Did Not Receive Treatment|0|||
163035494|NCT03578146|588834329|FG003|Overall Study|Did Not Receive Treatment|0|||
163035495|NCT03578146|588834330|FG004|Overall Study|Did Not Receive Treatment|0|||
163035496|NCT03578146|588834331|FG005|Overall Study|Did Not Receive Treatment|2|||
162648829|NCT00851799|587431292|FG000|Overall Study|Completed protocol due to pregnancy|0|||
163035497|NCT03578146|588834326|FG000|Overall Study|Lost to Follow-up|0|||
163035498|NCT03578146|588834327|FG001|Overall Study|Lost to Follow-up|1|||
163035499|NCT03578146|588834328|FG002|Overall Study|Lost to Follow-up|1|||
163035500|NCT03578146|588834329|FG003|Overall Study|Lost to Follow-up|0|||
163035501|NCT03578146|588834330|FG004|Overall Study|Lost to Follow-up|0|||
163035502|NCT03578146|588834331|FG005|Overall Study|Lost to Follow-up|1|||
163035503|NCT01094782|588834333|FG000|Overall Study|Withdrawal by Subject|5|||
163035504|NCT01094782|588834334|FG001|Overall Study|Withdrawal by Subject|5|||
163035505|NCT01094782|588834335|FG002|Overall Study|Withdrawal by Subject|1|||
163035506|NCT01094782|588834336|FG003|Overall Study|Withdrawal by Subject|5|||
163035507|NCT01094782|588834337|FG004|Overall Study|Withdrawal by Subject|5|||
163035508|NCT01094782|588834338|FG005|Overall Study|Withdrawal by Subject|0|||
163035509|NCT01094782|588834333|FG000|Overall Study|Lost to Follow-up|1|||
163035510|NCT01094782|588834334|FG001|Overall Study|Lost to Follow-up|0|||
163035511|NCT01094782|588834335|FG002|Overall Study|Lost to Follow-up|0|||
163035512|NCT01094782|588834336|FG003|Overall Study|Lost to Follow-up|2|||
163035513|NCT01094782|588834337|FG004|Overall Study|Lost to Follow-up|1|||
163035514|NCT01094782|588834338|FG005|Overall Study|Lost to Follow-up|4|||
163035515|NCT01094782|588834333|FG000|Overall Study|Positive Drug Screen|2|||
163035516|NCT01094782|588834334|FG001|Overall Study|Positive Drug Screen|2|||
163035517|NCT01094782|588834335|FG002|Overall Study|Positive Drug Screen|1|||
163035518|NCT01094782|588834336|FG003|Overall Study|Positive Drug Screen|1|||
163035519|NCT01094782|588834337|FG004|Overall Study|Positive Drug Screen|3|||
163035520|NCT01094782|588834338|FG005|Overall Study|Positive Drug Screen|2|||
163035521|NCT01094782|588834333|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
163035522|NCT01094782|588834334|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
163035523|NCT01094782|588834335|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
163035524|NCT01094782|588834336|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
163035525|NCT01094782|588834337|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
163085750|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163085751|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
163085752|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
163035526|NCT01094782|588834338|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
163035527|NCT01094782|588834333|FG000|Overall Study|Unable to Complete Questionnaires|0|||
163035528|NCT01094782|588834334|FG001|Overall Study|Unable to Complete Questionnaires|1|||
163035529|NCT01094782|588834335|FG002|Overall Study|Unable to Complete Questionnaires|0|||
163035530|NCT01094782|588834336|FG003|Overall Study|Unable to Complete Questionnaires|0|||
163035531|NCT01094782|588834337|FG004|Overall Study|Unable to Complete Questionnaires|0|||
163035532|NCT01094782|588834338|FG005|Overall Study|Unable to Complete Questionnaires|0|||
163035533|NCT01094782|588834333|FG000|Overall Study|Healthy Subject Had Pain|0|||
163035534|NCT01094782|588834334|FG001|Overall Study|Healthy Subject Had Pain|1|||
163035535|NCT01094782|588834335|FG002|Overall Study|Healthy Subject Had Pain|0|||
163035536|NCT01094782|588834336|FG003|Overall Study|Healthy Subject Had Pain|0|||
163035537|NCT01094782|588834337|FG004|Overall Study|Healthy Subject Had Pain|0|||
163035538|NCT01094782|588834338|FG005|Overall Study|Healthy Subject Had Pain|0|||
163035539|NCT01094782|588834333|FG000|Overall Study|Hypertension|0|||
163035540|NCT01094782|588834334|FG001|Overall Study|Hypertension|0|||
163035541|NCT01094782|588834335|FG002|Overall Study|Hypertension|1|||
163035542|NCT01094782|588834336|FG003|Overall Study|Hypertension|0|||
163035543|NCT01094782|588834337|FG004|Overall Study|Hypertension|0|||
163035544|NCT01094782|588834338|FG005|Overall Study|Hypertension|0|||
163035545|NCT01094782|588834333|FG000|Overall Study|Wrong Pain Condition|0|||
163035546|NCT01094782|588834334|FG001|Overall Study|Wrong Pain Condition|0|||
163035547|NCT01094782|588834335|FG002|Overall Study|Wrong Pain Condition|0|||
163035548|NCT01094782|588834336|FG003|Overall Study|Wrong Pain Condition|2|||
163035549|NCT01094782|588834337|FG004|Overall Study|Wrong Pain Condition|1|||
163035550|NCT01094782|588834338|FG005|Overall Study|Wrong Pain Condition|1|||
163035551|NCT01094782|588834333|FG000|Overall Study|Recent Interventional Injection|0|||
163035552|NCT01094782|588834334|FG001|Overall Study|Recent Interventional Injection|0|||
163035553|NCT01094782|588834335|FG002|Overall Study|Recent Interventional Injection|0|||
163035554|NCT01094782|588834336|FG003|Overall Study|Recent Interventional Injection|0|||
163035555|NCT01094782|588834337|FG004|Overall Study|Recent Interventional Injection|0|||
163035556|NCT01094782|588834338|FG005|Overall Study|Recent Interventional Injection|1|||
163035557|NCT01094782|588834333|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035558|NCT01094782|588834334|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035559|NCT01094782|588834335|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035560|NCT01094782|588834336|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163035561|NCT01094782|588834337|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
163035562|NCT01094782|588834338|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
163085753|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
163085754|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
163085755|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
163085756|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
163085757|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
163085758|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
163085759|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
163085760|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
163085761|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
163085762|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
163085763|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
163085764|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
163085765|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
163085766|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
163085767|NCT02958865|589022334|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085768|NCT02958865|589022335|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085769|NCT02958865|589022336|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085770|NCT02958865|589022337|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085771|NCT02958865|589022338|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
163085772|NCT02958865|589022339|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085773|NCT02958865|589022340|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085774|NCT02958865|589022341|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085775|NCT02958865|589022342|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163035563|NCT01094782|588834333|FG000|Overall Study|Noncompliance With Study Schedule|0|||
163035564|NCT01094782|588834334|FG001|Overall Study|Noncompliance With Study Schedule|0|||
163035565|NCT01094782|588834335|FG002|Overall Study|Noncompliance With Study Schedule|0|||
163035566|NCT01094782|588834336|FG003|Overall Study|Noncompliance With Study Schedule|1|||
163035567|NCT01094782|588834337|FG004|Overall Study|Noncompliance With Study Schedule|0|||
163035568|NCT01094782|588834338|FG005|Overall Study|Noncompliance With Study Schedule|0|||
163035569|NCT00634049|588834339|FG000|Overall Study|Never received study drug|1|||
163035570|NCT00634049|588834339|FG000|Overall Study|Died prior to receiving study drug|1|||
163035571|NCT00634049|588834339|FG000|Overall Study|Screening failure|1|||
163035572|NCT01717391|588834340|FG000|Overall Study|Withdrawal by Subject|5|||
163035573|NCT01717391|588834340|FG000|Overall Study|Physician Decision|1|||
163035574|NCT01717391|588834340|FG000|Overall Study|FLT technical failure|3|||
163035575|NCT02450552|588834344|FG000|Overall Study|Withdrawal by Subject|4|||
163035576|NCT02450552|588834345|FG001|Overall Study|Withdrawal by Subject|0|||
163035577|NCT02450552|588834346|FG002|Overall Study|Withdrawal by Subject|4|||
163035578|NCT02450552|588834344|FG000|Overall Study|Physician Decision|1|||
163035579|NCT02450552|588834345|FG001|Overall Study|Physician Decision|0|||
163035580|NCT02450552|588834346|FG002|Overall Study|Physician Decision|1|||
163035581|NCT01524783|588834347|FG000|Blinded Period|Adverse Event|64|||
163035582|NCT01524783|588834348|FG001|Blinded Period|Adverse Event|7|||
163035583|NCT01524783|588834349|FG002|Blinded Period|Adverse Event|0|||
163035584|NCT01524783|588834347|FG000|Blinded Period|Disease Progression|89|||
163035585|NCT01524783|588834348|FG001|Blinded Period|Disease Progression|75|||
163035586|NCT01524783|588834349|FG002|Blinded Period|Disease Progression|0|||
163035587|NCT01524783|588834347|FG000|Blinded Period|Withdrawal by Subject|19|||
163035588|NCT01524783|588834348|FG001|Blinded Period|Withdrawal by Subject|6|||
163035589|NCT01524783|588834349|FG002|Blinded Period|Withdrawal by Subject|0|||
163035590|NCT01524783|588834347|FG000|Blinded Period|Protocol deviation|2|||
163035591|NCT01524783|588834348|FG001|Blinded Period|Protocol deviation|1|||
163035592|NCT01524783|588834349|FG002|Blinded Period|Protocol deviation|0|||
163035593|NCT01524783|588834347|FG000|Blinded Period|Death|5|||
163035594|NCT01524783|588834348|FG001|Blinded Period|Death|2|||
163035595|NCT01524783|588834349|FG002|Blinded Period|Death|0|||
163035596|NCT01524783|588834347|FG000|Open-label Period|Disease progression|13|||
163035597|NCT01524783|588834348|FG001|Open-label Period|Disease progression|0|||
163035598|NCT01524783|588834349|FG002|Open-label Period|Disease progression|2|||
163035599|NCT01524783|588834347|FG000|Open-label Period|Administrative problems|5|||
163035600|NCT01524783|588834348|FG001|Open-label Period|Administrative problems|0|||
163035601|NCT01524783|588834349|FG002|Open-label Period|Administrative problems|2|||
163035602|NCT01524783|588834347|FG000|Open-label Period|Adverse Event|5|||
163035603|NCT01524783|588834348|FG001|Open-label Period|Adverse Event|0|||
163035604|NCT01524783|588834349|FG002|Open-label Period|Adverse Event|1|||
163035605|NCT01524783|588834347|FG000|Open-label Period|Withdrawal by Subject|2|||
163035606|NCT01524783|588834348|FG001|Open-label Period|Withdrawal by Subject|0|||
163035607|NCT01524783|588834349|FG002|Open-label Period|Withdrawal by Subject|1|||
163035608|NCT01524783|588834347|FG000|Open-label Period|Protocol deviation|1|||
163035609|NCT01524783|588834348|FG001|Open-label Period|Protocol deviation|0|||
163035610|NCT01524783|588834349|FG002|Open-label Period|Protocol deviation|0|||
163035611|NCT01625689|588834350|FG000|Overall Study|Migration|2|||
163035612|NCT01625689|588834351|FG001|Overall Study|Migration|1|||
163035613|NCT03723070|588834356|FG000|Overall Study|Lost to Follow-up|2|||
163035614|NCT03723070|588834356|FG000|Overall Study|Physician Decision|1|||
163035615|NCT03723070|588834356|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
163035616|NCT02208050|588834357|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
163035617|NCT02208050|588834358|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
163035618|NCT00721279|588834362|FG000|Overall Study|Lack of Efficacy|6|||
163035619|NCT00721279|588834363|FG001|Overall Study|Lack of Efficacy|3|||
163035620|NCT00721279|588834362|FG000|Overall Study|Tolerability insufficient|5|||
163035621|NCT00721279|588834363|FG001|Overall Study|Tolerability insufficient|2|||
163035622|NCT00721279|588834362|FG000|Overall Study|Withdrawal by Subject|13|||
163035623|NCT00721279|588834363|FG001|Overall Study|Withdrawal by Subject|3|||
163035624|NCT00721279|588834362|FG000|Overall Study|Other|12|||
163035625|NCT00721279|588834363|FG001|Overall Study|Other|16|||
163035626|NCT05153148|588834364|FG000|Overall Study|Adverse Event|1|||
163035627|NCT05153148|588834365|FG001|Overall Study|Adverse Event|0|||
163035628|NCT05153148|588834366|FG002|Overall Study|Adverse Event|3|||
163035629|NCT05153148|588834367|FG003|Overall Study|Adverse Event|5|||
163035630|NCT05153148|588834364|FG000|Overall Study|Lost to Follow-up|1|||
163035631|NCT05153148|588834365|FG001|Overall Study|Lost to Follow-up|1|||
163085776|NCT02958865|589022343|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162648830|NCT00851799|587431293|FG001|Overall Study|Completed protocol due to pregnancy|0|||
162648831|NCT00851799|587431294|FG002|Overall Study|Completed protocol due to pregnancy|1|||
162648832|NCT02276612|587431297|FG000|Overall Study|Death|1|||
162648833|NCT02276612|587431298|FG001|Overall Study|Death|0|||
163085777|NCT02958865|589022344|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085778|NCT02958865|589022345|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085779|NCT02958865|589022346|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085780|NCT02958865|589022347|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162648834|NCT02276612|587431297|FG000|Overall Study|Pregnancy|1|||
162648835|NCT02276612|587431298|FG001|Overall Study|Pregnancy|0|||
163035632|NCT05153148|588834366|FG002|Overall Study|Lost to Follow-up|2|||
163035633|NCT05153148|588834367|FG003|Overall Study|Lost to Follow-up|0|||
163035634|NCT05153148|588834364|FG000|Overall Study|Withdrawal by Subject|6|||
163035635|NCT05153148|588834365|FG001|Overall Study|Withdrawal by Subject|8|||
163035636|NCT05153148|588834366|FG002|Overall Study|Withdrawal by Subject|6|||
163035637|NCT05153148|588834367|FG003|Overall Study|Withdrawal by Subject|8|||
163035638|NCT05153148|588834364|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035639|NCT05153148|588834365|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035640|NCT05153148|588834366|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
163035641|NCT05153148|588834367|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163035642|NCT05153148|588834364|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035643|NCT05153148|588834365|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035644|NCT05153148|588834366|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
163035645|NCT05153148|588834367|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
163035646|NCT05153148|588834364|FG000|Overall Study|Reason not Specified|1|||
163035647|NCT05153148|588834365|FG001|Overall Study|Reason not Specified|1|||
163035648|NCT05153148|588834366|FG002|Overall Study|Reason not Specified|1|||
163035649|NCT05153148|588834367|FG003|Overall Study|Reason not Specified|1|||
163035650|NCT01732471|588834368|FG000|Overall Study|Withdrawal by Subject|1|||
163035651|NCT00474786|588834369|FG000|Overall Study|Not Meeting Study Criteria|0|||
163035652|NCT00474786|588834370|FG001|Overall Study|Not Meeting Study Criteria|1|||
163035653|NCT00474786|588834369|FG000|Overall Study|Investigator Request|2|||
163035654|NCT00474786|588834370|FG001|Overall Study|Investigator Request|1|||
163035655|NCT00474786|588834369|FG000|Overall Study|Death|189|||
163035656|NCT00474786|588834370|FG001|Overall Study|Death|170|||
163035657|NCT00474786|588834369|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
163035658|NCT00474786|588834370|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
163035659|NCT00474786|588834369|FG000|Overall Study|Lost to Follow-up|4|||
163035660|NCT00474786|588834370|FG001|Overall Study|Lost to Follow-up|7|||
163035661|NCT00474786|588834369|FG000|Overall Study|Protocol Violation|2|||
163035662|NCT00474786|588834370|FG001|Overall Study|Protocol Violation|0|||
163035663|NCT00474786|588834369|FG000|Overall Study|Withdrawal by Subject|15|||
163035664|NCT00474786|588834370|FG001|Overall Study|Withdrawal by Subject|15|||
163035665|NCT00474786|588834369|FG000|Overall Study|Other|5|||
163035666|NCT00474786|588834370|FG001|Overall Study|Other|0|||
163035667|NCT02892513|588834371|FG000|Overall Study|Withdrawal by Subject|0|||
163035668|NCT02892513|588834372|FG001|Overall Study|Withdrawal by Subject|1|||
163035669|NCT00900731|588834373|FG000|Overall Study|Adverse Event|31|||
163035670|NCT00900731|588834374|FG001|Overall Study|Adverse Event|27|||
163035671|NCT00900731|588834373|FG000|Overall Study|Withdrawal by Subject|8|||
163035672|NCT00900731|588834374|FG001|Overall Study|Withdrawal by Subject|7|||
163035673|NCT00900731|588834373|FG000|Overall Study|Protocol Deviation|8|||
163035674|NCT00900731|588834374|FG001|Overall Study|Protocol Deviation|11|||
163035675|NCT00900731|588834373|FG000|Overall Study|Administrative Problems|5|||
163035676|NCT00900731|588834374|FG001|Overall Study|Administrative Problems|4|||
163035677|NCT00900731|588834373|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
163035678|NCT00900731|588834374|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163035679|NCT00900731|588834373|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
163035680|NCT00900731|588834374|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
163035681|NCT00900731|588834373|FG000|Overall Study|Lost to Follow-up|2|||
163035682|NCT00900731|588834374|FG001|Overall Study|Lost to Follow-up|3|||
163035683|NCT00900731|588834373|FG000|Overall Study|Lack of Efficacy|1|||
163035684|NCT00900731|588834374|FG001|Overall Study|Lack of Efficacy|3|||
163035685|NCT00900731|588834373|FG000|Overall Study|Death|0|||
163035686|NCT00900731|588834374|FG001|Overall Study|Death|2|||
163035687|NCT00131365|588834375|FG000|Overall Study|Withdrawal by Subject|1|||
163035688|NCT00131365|588834375|FG000|Overall Study|Alternative treatment|3|||
163035689|NCT05249127|588834376|FG000|Overall Study|Protocol Violation|13|||
163035690|NCT05249127|588834376|FG000|Overall Study|Physician Decision|4|||
163035691|NCT05249127|588834376|FG000|Overall Study|Withdrawal by Subject|2|||
163035692|NCT05249127|588834376|FG000|Overall Study|Participant Non-compliance|1|||
163035693|NCT03053427|588834377|FG000|Overall Study|Adverse Event|4|||
163035694|NCT03053427|588834378|FG001|Overall Study|Adverse Event|4|||
163035695|NCT03053427|588834377|FG000|Overall Study|Lack of Efficacy|1|||
163035696|NCT03053427|588834378|FG001|Overall Study|Lack of Efficacy|3|||
163035697|NCT03053427|588834377|FG000|Overall Study|Lost to Follow-up|2|||
163035698|NCT03053427|588834378|FG001|Overall Study|Lost to Follow-up|2|||
163035699|NCT03053427|588834377|FG000|Overall Study|Worsening of the target disease|0|||
163035700|NCT03053427|588834378|FG001|Overall Study|Worsening of the target disease|1|||
163035701|NCT03053427|588834377|FG000|Overall Study|Protocol Deviation|3|||
163035702|NCT03053427|588834378|FG001|Overall Study|Protocol Deviation|3|||
163035703|NCT03053427|588834377|FG000|Overall Study|Withdrawal by Subject|3|||
163035704|NCT03053427|588834378|FG001|Overall Study|Withdrawal by Subject|2|||
163035705|NCT03053427|588834377|FG000|Overall Study|Miscellaneous|0|||
163035706|NCT03053427|588834378|FG001|Overall Study|Miscellaneous|1|||
163035707|NCT01324570|588834381|FG000|Overall Study|Adverse Event|4|||
163035708|NCT01324570|588834382|FG001|Overall Study|Adverse Event|7|||
163035709|NCT01324570|588834381|FG000|Overall Study|Withdrawal by Subject|0|||
163035710|NCT01324570|588834382|FG001|Overall Study|Withdrawal by Subject|3|||
163035711|NCT01324570|588834381|FG000|Overall Study|Lack of Efficacy|0|||
162718273|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162718274|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162718275|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
162718276|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
162718277|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162718278|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
162718279|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
162718280|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162718281|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162718282|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162718283|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162718284|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
162718285|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
162718286|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162718287|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
162718288|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
162718289|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163085781|NCT02958865|589022348|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163085782|NCT02958865|589022349|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163035712|NCT01324570|588834382|FG001|Overall Study|Lack of Efficacy|1|||
163035713|NCT01324570|588834381|FG000|Overall Study|Confirmed or suspected diversion|0|||
163035714|NCT01324570|588834382|FG001|Overall Study|Confirmed or suspected diversion|1|||
163035715|NCT01324570|588834381|FG000|Overall Study|Administrative|0|||
163035716|NCT01324570|588834382|FG001|Overall Study|Administrative|2|||
163035717|NCT02607306|588834383|FG000|Overall Study|Adverse Event|8|||
163035718|NCT02607306|588834384|FG001|Overall Study|Adverse Event|6|||
163035719|NCT02607306|588834385|FG002|Overall Study|Adverse Event|6|||
163035720|NCT02607306|588834383|FG000|Overall Study|Unclassified|1|||
163035721|NCT02607306|588834384|FG001|Overall Study|Unclassified|4|||
163035722|NCT02607306|588834385|FG002|Overall Study|Unclassified|0|||
163035723|NCT02607306|588834383|FG000|Overall Study|Withdrawal by Subject|8|||
163035724|NCT02607306|588834384|FG001|Overall Study|Withdrawal by Subject|10|||
163035725|NCT02607306|588834385|FG002|Overall Study|Withdrawal by Subject|2|||
163035726|NCT02607306|588834383|FG000|Overall Study|Lack of Efficacy|0|||
163035727|NCT02607306|588834384|FG001|Overall Study|Lack of Efficacy|1|||
163035728|NCT02607306|588834385|FG002|Overall Study|Lack of Efficacy|1|||
163035729|NCT02607306|588834383|FG000|Overall Study|Protocol Violation|4|||
163035730|NCT02607306|588834384|FG001|Overall Study|Protocol Violation|2|||
163035731|NCT02607306|588834385|FG002|Overall Study|Protocol Violation|1|||
163035732|NCT02360475|588834388|FG000|Overall Study|Lost to Follow-up|4|||
163035733|NCT02360475|588834389|FG001|Overall Study|Lost to Follow-up|12|||
163035734|NCT02360475|588834390|FG002|Overall Study|Lost to Follow-up|6|||
163035735|NCT02360475|588834391|FG003|Overall Study|Lost to Follow-up|4|||
163035736|NCT02360475|588834388|FG000|Overall Study|Withdrawal by Subject|0|||
163035737|NCT02360475|588834389|FG001|Overall Study|Withdrawal by Subject|1|||
163035738|NCT02360475|588834390|FG002|Overall Study|Withdrawal by Subject|2|||
163035739|NCT02360475|588834391|FG003|Overall Study|Withdrawal by Subject|0|||
163035740|NCT02360475|588834388|FG000|Overall Study|Migrated/moved from study area|0|||
163035741|NCT02360475|588834389|FG001|Overall Study|Migrated/moved from study area|0|||
163035742|NCT02360475|588834390|FG002|Overall Study|Migrated/moved from study area|0|||
163035743|NCT02360475|588834391|FG003|Overall Study|Migrated/moved from study area|1|||
163035744|NCT02510820|588836056|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163035745|NCT02510820|588836057|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163035746|NCT02510820|588836056|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163035747|NCT02510820|588836057|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
163035748|NCT01859949|588836058|FG000|Overall Study|Family Matters|0|||
163035749|NCT01859949|588836059|FG001|Overall Study|Family Matters|1|||
163035750|NCT01859949|588836058|FG000|Overall Study|Physician Decision|2|||
163035751|NCT01859949|588836059|FG001|Overall Study|Physician Decision|4|||
163035752|NCT01859949|588836058|FG000|Overall Study|Withdrawal by Subject|11|||
163035753|NCT01859949|588836059|FG001|Overall Study|Withdrawal by Subject|10|||
163035754|NCT01859949|588836058|FG000|Overall Study|Protocol Violation|1|||
163035755|NCT01859949|588836059|FG001|Overall Study|Protocol Violation|1|||
163035756|NCT01859949|588836058|FG000|Overall Study|Adverse Event|0|||
163035757|NCT01859949|588836059|FG001|Overall Study|Adverse Event|1|||
163035758|NCT01153009|588836060|FG000|Overall Study|Adverse Event|4|||
163035759|NCT01153009|588836061|FG001|Overall Study|Adverse Event|14|||
163035760|NCT01153009|588836062|FG002|Overall Study|Adverse Event|14|||
163035761|NCT01153009|588836063|FG003|Overall Study|Adverse Event|10|||
162718290|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162718291|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162718292|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162718293|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
163035762|NCT01153009|588836060|FG000|Overall Study|Lack of Efficacy|9|||
163035763|NCT01153009|588836061|FG001|Overall Study|Lack of Efficacy|0|||
163035764|NCT01153009|588836062|FG002|Overall Study|Lack of Efficacy|2|||
163035765|NCT01153009|588836063|FG003|Overall Study|Lack of Efficacy|1|||
163035766|NCT01153009|588836060|FG000|Overall Study|Noncompliance with Study Medication|1|||
163035767|NCT01153009|588836061|FG001|Overall Study|Noncompliance with Study Medication|3|||
163035768|NCT01153009|588836062|FG002|Overall Study|Noncompliance with Study Medication|4|||
163035769|NCT01153009|588836063|FG003|Overall Study|Noncompliance with Study Medication|1|||
163035770|NCT01153009|588836060|FG000|Overall Study|Protocol Deviations|4|||
163035771|NCT01153009|588836061|FG001|Overall Study|Protocol Deviations|3|||
163035772|NCT01153009|588836062|FG002|Overall Study|Protocol Deviations|3|||
163035773|NCT01153009|588836063|FG003|Overall Study|Protocol Deviations|2|||
163035774|NCT01153009|588836060|FG000|Overall Study|Withdrawal of Consent|5|||
163035775|NCT01153009|588836061|FG001|Overall Study|Withdrawal of Consent|5|||
163035776|NCT01153009|588836062|FG002|Overall Study|Withdrawal of Consent|4|||
163035777|NCT01153009|588836063|FG003|Overall Study|Withdrawal of Consent|6|||
163035778|NCT01153009|588836060|FG000|Overall Study|Lost to Follow-up|8|||
163035779|NCT01153009|588836061|FG001|Overall Study|Lost to Follow-up|8|||
163035780|NCT01153009|588836062|FG002|Overall Study|Lost to Follow-up|11|||
163035781|NCT01153009|588836063|FG003|Overall Study|Lost to Follow-up|15|||
163035782|NCT01153009|588836060|FG000|Overall Study|Other|1|||
163035783|NCT01153009|588836061|FG001|Overall Study|Other|1|||
163035784|NCT01153009|588836062|FG002|Overall Study|Other|3|||
163035785|NCT01153009|588836063|FG003|Overall Study|Other|2|||
163035786|NCT03307837|588836068|FG000|Overall Study|Withdrawal by Subject|0|||
163035787|NCT03307837|588836069|FG001|Overall Study|Withdrawal by Subject|0|||
163035788|NCT03307837|588836070|FG002|Overall Study|Withdrawal by Subject|1|||
163035789|NCT03307837|588836071|FG003|Overall Study|Withdrawal by Subject|0|||
163035790|NCT03307837|588836072|FG004|Overall Study|Withdrawal by Subject|0|||
163035791|NCT03307837|588836073|FG005|Overall Study|Withdrawal by Subject|1|||
163035792|NCT03307837|588836068|FG000|Overall Study|Lost to Follow-up|1|||
163035793|NCT03307837|588836069|FG001|Overall Study|Lost to Follow-up|1|||
163035794|NCT03307837|588836070|FG002|Overall Study|Lost to Follow-up|0|||
163035795|NCT03307837|588836071|FG003|Overall Study|Lost to Follow-up|0|||
163035796|NCT03307837|588836072|FG004|Overall Study|Lost to Follow-up|0|||
163035797|NCT03307837|588836073|FG005|Overall Study|Lost to Follow-up|1|||
163035798|NCT01744483|588836074|FG000|Overall Study|Death|9|||
163035799|NCT01744483|588836075|FG001|Overall Study|Death|4|||
163035800|NCT01744483|588836076|FG002|Overall Study|Death|11|||
163035801|NCT01744483|588836074|FG000|Overall Study|Lost to Follow-up|8|||
163035802|NCT01744483|588836075|FG001|Overall Study|Lost to Follow-up|9|||
163035803|NCT01744483|588836076|FG002|Overall Study|Lost to Follow-up|11|||
163035804|NCT01744483|588836074|FG000|Overall Study|Protocol Violation|1|||
163035805|NCT01744483|588836075|FG001|Overall Study|Protocol Violation|2|||
163035806|NCT01744483|588836076|FG002|Overall Study|Protocol Violation|1|||
163035807|NCT01744483|588836074|FG000|Overall Study|Withdrawal by Subject|4|||
163035808|NCT01744483|588836075|FG001|Overall Study|Withdrawal by Subject|6|||
163035809|NCT01744483|588836076|FG002|Overall Study|Withdrawal by Subject|2|||
163035810|NCT01744483|588836074|FG000|Overall Study|No ICU Admit|5|||
163035811|NCT01744483|588836075|FG001|Overall Study|No ICU Admit|1|||
163035812|NCT01744483|588836076|FG002|Overall Study|No ICU Admit|2|||
163035813|NCT01744483|588836074|FG000|Overall Study|Routed to OSH|2|||
163035814|NCT01744483|588836075|FG001|Overall Study|Routed to OSH|0|||
163035815|NCT01744483|588836076|FG002|Overall Study|Routed to OSH|1|||
163035816|NCT03041467|588836077|FG000|Overall Study|Death|46|||
163035817|NCT03041467|588836078|FG001|Overall Study|Death|39|||
163035818|NCT03041467|588836077|FG000|Overall Study|Withdrawal by Subject|36|||
163035819|NCT03041467|588836078|FG001|Overall Study|Withdrawal by Subject|37|||
163035820|NCT03041467|588836077|FG000|Overall Study|Lost to Follow-up|6|||
163035821|NCT03041467|588836078|FG001|Overall Study|Lost to Follow-up|8|||
163035822|NCT03041467|588836077|FG000|Overall Study|Declined consent for study extension|21|||
163035823|NCT03041467|588836078|FG001|Overall Study|Declined consent for study extension|33|||
163035824|NCT03041467|588836077|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
163035825|NCT03041467|588836078|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
163035826|NCT02469168|588836083|FG000|Overall Study|Trial closed|1|||
163035827|NCT02469168|588836084|FG001|Overall Study|Trial closed|0|||
163035828|NCT00298363|588836085|FG000|Overall Study|Lost to Follow-up|0|||
163035829|NCT00298363|588836086|FG001|Overall Study|Lost to Follow-up|0|||
163035830|NCT00298363|588836087|FG002|Overall Study|Lost to Follow-up|1|||
163035831|NCT00298363|588836085|FG000|Overall Study|Physician Decision|4|||
163035832|NCT00298363|588836086|FG001|Overall Study|Physician Decision|1|||
163035833|NCT00298363|588836087|FG002|Overall Study|Physician Decision|0|||
163035834|NCT00298363|588836085|FG000|Overall Study|Protocol Violation|1|||
163035835|NCT00298363|588836086|FG001|Overall Study|Protocol Violation|1|||
163035836|NCT00298363|588836087|FG002|Overall Study|Protocol Violation|0|||
163035837|NCT00298363|588836085|FG000|Overall Study|Withdrawal by Subject|5|||
163035838|NCT00298363|588836086|FG001|Overall Study|Withdrawal by Subject|1|||
163035839|NCT00298363|588836087|FG002|Overall Study|Withdrawal by Subject|3|||
163035840|NCT00298363|588836085|FG000|Overall Study|Adverse Event|5|||
163035841|NCT00298363|588836086|FG001|Overall Study|Adverse Event|2|||
163035842|NCT00298363|588836087|FG002|Overall Study|Adverse Event|2|||
163035843|NCT00298363|588836085|FG000|Overall Study|Lack of Efficacy|2|||
163035844|NCT00298363|588836086|FG001|Overall Study|Lack of Efficacy|3|||
163035845|NCT00298363|588836087|FG002|Overall Study|Lack of Efficacy|0|||
163035846|NCT00135356|588836088|FG000|Overall Study|Adverse Event|6|||
163035847|NCT00135356|588836089|FG001|Overall Study|Adverse Event|2|||
163035848|NCT00135356|588836088|FG000|Overall Study|Lack of Efficacy|2|||
163035849|NCT00135356|588836089|FG001|Overall Study|Lack of Efficacy|0|||
163035850|NCT00135356|588836088|FG000|Overall Study|Lost to Follow-up|3|||
163035851|NCT00135356|588836089|FG001|Overall Study|Lost to Follow-up|1|||
163035852|NCT00135356|588836088|FG000|Overall Study|Surgery for abdominal fat|1|||
163035853|NCT00135356|588836089|FG001|Overall Study|Surgery for abdominal fat|0|||
163035854|NCT00135356|588836088|FG000|Overall Study|Change in antiviral regimen|0|||
163035855|NCT00135356|588836089|FG001|Overall Study|Change in antiviral regimen|1|||
163035856|NCT00135356|588836088|FG000|Overall Study|Poor/noncompliance|1|||
163035857|NCT00135356|588836089|FG001|Overall Study|Poor/noncompliance|1|||
163035858|NCT00135356|588836088|FG000|Overall Study|No longer meets study criteria|2|||
163035859|NCT00135356|588836089|FG001|Overall Study|No longer meets study criteria|0|||
163035860|NCT00135356|588836088|FG000|Overall Study|Withdrawal by Subject|2|||
163035861|NCT00135356|588836089|FG001|Overall Study|Withdrawal by Subject|4|||
163035862|NCT01533688|588836090|FG000|Overall Study|Withdrawal by Subject|5|||
163035863|NCT01533688|588836091|FG001|Overall Study|Withdrawal by Subject|4|||
163035864|NCT01533688|588836092|FG002|Overall Study|Withdrawal by Subject|3|||
163035865|NCT01533688|588836090|FG000|Overall Study|Medically unstable|1|||
163035866|NCT01533688|588836091|FG001|Overall Study|Medically unstable|3|||
163035867|NCT01533688|588836092|FG002|Overall Study|Medically unstable|3|||
163035868|NCT01533688|588836090|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
163035869|NCT01533688|588836091|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
163035870|NCT01533688|588836092|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
163035871|NCT01306214|588836094|FG000|Overall Study|Death|0|||
163035872|NCT01306214|588836095|FG001|Overall Study|Death|0|||
163035873|NCT01306214|588836096|FG002|Overall Study|Death|1|||
163035874|NCT01306214|588836094|FG000|Overall Study|Lost to Follow-up|3|||
163035875|NCT01306214|588836095|FG001|Overall Study|Lost to Follow-up|5|||
163035876|NCT01306214|588836096|FG002|Overall Study|Lost to Follow-up|4|||
163035877|NCT01306214|588836094|FG000|Overall Study|Withdrawal by Subject|24|||
163035878|NCT01306214|588836095|FG001|Overall Study|Withdrawal by Subject|22|||
163035879|NCT01306214|588836096|FG002|Overall Study|Withdrawal by Subject|16|||
163035880|NCT01306214|588836094|FG000|Overall Study|Not treated|1|||
163035881|NCT01306214|588836095|FG001|Overall Study|Not treated|1|||
163035882|NCT01306214|588836096|FG002|Overall Study|Not treated|1|||
163035883|NCT02686814|588836097|FG000|Overall Study|Physician Decision|14|||
163035884|NCT02686814|588836097|FG000|Overall Study|Withdrawal by Subject|4|||
163035885|NCT02686814|588836097|FG000|Overall Study|Death|1|||
163035886|NCT02065518|588836098|FG000|Overall Study|Lost to Follow-up|3|||
163035887|NCT02065518|588836099|FG001|Overall Study|Lost to Follow-up|4|||
163035888|NCT02065518|588836100|FG002|Overall Study|Lost to Follow-up|0|||
163035889|NCT02065518|588836101|FG003|Overall Study|Lost to Follow-up|3|||
163035890|NCT02065518|588836098|FG000|Overall Study|Withdrawal by Subject|3|||
163035891|NCT02065518|588836099|FG001|Overall Study|Withdrawal by Subject|4|||
163035892|NCT02065518|588836100|FG002|Overall Study|Withdrawal by Subject|9|||
163035893|NCT02065518|588836101|FG003|Overall Study|Withdrawal by Subject|2|||
163035894|NCT01090050|588836103|FG000|Overall Study|Lost to Follow-up|0|||
163035895|NCT01090050|588836104|FG001|Overall Study|Lost to Follow-up|1|||
163035896|NCT01090050|588836103|FG000|Overall Study|Lack of Efficacy|1|||
163035897|NCT01090050|588836104|FG001|Overall Study|Lack of Efficacy|5|||
163035898|NCT01090050|588836103|FG000|Overall Study|Physician Decision|0|||
163035899|NCT01090050|588836104|FG001|Overall Study|Physician Decision|1|||
163035900|NCT00571103|588836105|FG000|Overall Study|Withdrawal by Subject|1|||
163035901|NCT00571103|588836105|FG000|Overall Study|Lost to Follow-up|1|||
163035902|NCT02368886|588836106|FG000|Overall Study|Cancel|1|||
163035903|NCT02368886|588836107|FG001|Overall Study|Cancel|1|||
163035904|NCT02368886|588836108|FG002|Overall Study|Cancel|1|||
163035905|NCT02368886|588836109|FG003|Overall Study|Cancel|3|||
163035906|NCT02368886|588836106|FG000|Overall Study|Ineligible|0|||
163035907|NCT02368886|588836107|FG001|Overall Study|Ineligible|0|||
163035908|NCT02368886|588836108|FG002|Overall Study|Ineligible|0|||
163035909|NCT02368886|588836109|FG003|Overall Study|Ineligible|1|||
163035910|NCT04767529|588836110|FG000|Overall Study|Adverse Event|0|||
163035911|NCT04767529|588836111|FG001|Overall Study|Adverse Event|4|||
163035912|NCT04767529|588836112|FG002|Overall Study|Adverse Event|3|||
163035913|NCT04767529|588836110|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
163035914|NCT04767529|588836111|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
163035915|NCT04767529|588836112|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
163035916|NCT04767529|588836110|FG000|Overall Study|Required use of a prohibited medication|0|||
163035917|NCT04767529|588836111|FG001|Overall Study|Required use of a prohibited medication|1|||
163035918|NCT04767529|588836112|FG002|Overall Study|Required use of a prohibited medication|0|||
163085783|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085784|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085785|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085786|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085787|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085788|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085789|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085790|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085791|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085792|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
163085793|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
163085794|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085795|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
163085796|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085797|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
163085798|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
163085799|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085800|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085801|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085802|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085803|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085804|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085805|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085806|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085807|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
163085808|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
163085809|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085810|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
163085811|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085812|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
163085813|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
163085814|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
163085815|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085816|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085817|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085818|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085819|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085820|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085821|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085822|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085823|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085824|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
163085825|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085826|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085827|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085828|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085829|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
163085830|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
163085831|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085832|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085833|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
162648836|NCT02276612|587431297|FG000|Overall Study|Withdrew Consent|1|||
162648837|NCT02276612|587431298|FG001|Overall Study|Withdrew Consent|0|||
162648838|NCT02276612|587431297|FG000|Overall Study|Lost to Follow-up|1|||
162648839|NCT02276612|587431298|FG001|Overall Study|Lost to Follow-up|0|||
162648840|NCT04365556|587431299|FG000|Overall Study|No longer eligible due to treatment plan|1|||
162648841|NCT04365556|587431300|FG001|Overall Study|No longer eligible due to treatment plan|0|||
162648842|NCT04365556|587431299|FG000|Overall Study|Lost to Follow-up|3|||
162648843|NCT04365556|587431300|FG001|Overall Study|Lost to Follow-up|2|||
162648844|NCT04439318|587431301|FG000|Overall Study|Ineligible|1|||
162648845|NCT04439318|587431301|FG000|Overall Study|Never Started Treatment|3|||
162648846|NCT04439318|587431301|FG000|Overall Study|Adverse Event|10|||
162648847|NCT04439318|587431301|FG000|Overall Study|Death|2|||
162648848|NCT04439318|587431301|FG000|Overall Study|Disease Progression|25|||
163085834|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085835|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085836|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085837|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
162648849|NCT04439318|587431301|FG000|Overall Study|Other Complicating Disease|2|||
162648850|NCT04439318|587431301|FG000|Overall Study|Withdrawal by Subject|4|||
163085838|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085839|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085840|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085841|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
163085842|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
163085843|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
163085844|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
163085845|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
163085846|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
163085847|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
163085848|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
163085849|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
163085850|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
163085851|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
163085852|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
163085853|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
163085854|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
163085855|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
163085856|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
163085857|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
163085858|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
163085859|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
163085860|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
163085861|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
163085862|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
163085863|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085864|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085865|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085866|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085867|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085868|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085869|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085870|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085871|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085872|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085873|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085874|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085875|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085876|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
163085877|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085878|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
163085879|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085880|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085881|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085882|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085883|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085884|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085885|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085886|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085887|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085888|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085889|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085890|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085891|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085892|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
163085893|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085894|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
163085895|NCT02958865|589022334|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085896|NCT02958865|589022335|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085897|NCT02958865|589022336|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085898|NCT02958865|589022337|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085899|NCT02958865|589022338|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085900|NCT02958865|589022339|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085901|NCT02958865|589022340|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085902|NCT02958865|589022341|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
162718294|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
162718295|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
162718296|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
162718297|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
162718298|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
162718299|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
162718300|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
162718301|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
162718302|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
162718303|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
162718304|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718305|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718306|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718307|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718308|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718309|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718310|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162718311|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
162718312|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163035919|NCT04767529|588836110|FG000|Overall Study|Withdrawal by Subject|7|||
163035920|NCT04767529|588836111|FG001|Overall Study|Withdrawal by Subject|5|||
163085903|NCT02958865|589022342|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085904|NCT02958865|589022343|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
163085905|NCT02958865|589022344|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085906|NCT02958865|589022345|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085907|NCT02958865|589022346|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085908|NCT02958865|589022347|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085909|NCT02958865|589022348|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085910|NCT02958865|589022349|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
163085911|NCT01309230|589022350|FG000|Overall Study|Withdrawal by Subject|0|||
163085912|NCT01309230|589022351|FG001|Overall Study|Withdrawal by Subject|2|||
163085913|NCT01309230|589022350|FG000|Overall Study|Observation arm closed|0|||
163085914|NCT01309230|589022351|FG001|Overall Study|Observation arm closed|2|||
163085915|NCT02661815|589022352|FG000|Overall Study|Withdrawal by Subject|1|||
163085916|NCT02661815|589022353|FG001|Overall Study|Withdrawal by Subject|0|||
163085917|NCT02661815|589022354|FG002|Overall Study|Withdrawal by Subject|0|||
163085918|NCT02661815|589022355|FG003|Overall Study|Withdrawal by Subject|0|||
163085919|NCT00635050|589022358|FG000|Overall Study|Withdrawal by Subject|1|||
163085920|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Adverse Event|3|||
163085921|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Adverse Event|0|||
163085922|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Adverse Event|0|||
163085923|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
163085924|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
163085925|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
163085926|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
163085927|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
163085928|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
163085929|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
163035921|NCT04767529|588836112|FG002|Overall Study|Withdrawal by Subject|4|||
163035922|NCT04767529|588836110|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
163035923|NCT04767529|588836111|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
163035924|NCT04767529|588836112|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
163035925|NCT04767529|588836110|FG000|Overall Study|Lost to Follow-up|0|||
163035926|NCT04767529|588836111|FG001|Overall Study|Lost to Follow-up|2|||
163035927|NCT04767529|588836112|FG002|Overall Study|Lost to Follow-up|3|||
163035928|NCT00004088|588836114|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
163035929|NCT00004088|588836114|FG000|Overall Study|Withdrawal by Subject|1|||
163035930|NCT00004088|588836114|FG000|Overall Study|Protocol Violation|3|||
163035931|NCT00004088|588836114|FG000|Overall Study|Physician Decision|1|||
163035932|NCT02636699|588836115|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
163035933|NCT02636699|588836116|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
163085930|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
163085931|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
162718313|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162718314|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
162718315|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
162718316|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162718317|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162718318|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162648851|NCT04439318|587431301|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
162648852|NCT04439318|587431301|FG000|Overall Study|Non-Compliance|1|||
162648853|NCT04439318|587431301|FG000|Overall Study|Still on Treatment|1|||
162648854|NCT04920123|587433242|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162648855|NCT04920123|587433243|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162648856|NCT04920123|587433244|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162648857|NCT00826267|587433245|FG000|Overall Study|Other Adverse Event|1|||
162648858|NCT00826267|587433246|FG001|Overall Study|Other Adverse Event|0|||
162648859|NCT00826267|587433247|FG002|Overall Study|Other Adverse Event|0|||
162648860|NCT02586493|587433260|FG000|Overall Study|Adverse Event|4|||
162648861|NCT02586493|587433260|FG000|Overall Study|Protocol Violation|6|||
162648862|NCT02586493|587433260|FG000|Overall Study|Lost to Follow-up|1|||
162648863|NCT02586493|587433260|FG000|Overall Study|Withdrawal by Subject|1|||
162648864|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
162648865|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
162648866|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
162648867|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
162648868|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
162648869|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
162648870|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
162648871|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
162648872|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
163035934|NCT02636699|588836117|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
162648873|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
162648874|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
162648875|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
162648876|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
162648877|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
162648878|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
162648879|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Death|5|||
162648880|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Death|0|||
163035935|NCT02636699|588836115|FG000|Screening Period|Withdrawal by Subject|0|||
163035936|NCT02636699|588836116|FG001|Screening Period|Withdrawal by Subject|0|||
163035937|NCT02636699|588836117|FG002|Screening Period|Withdrawal by Subject|23|||
163035938|NCT02636699|588836115|FG000|Screening Period|Adverse Event|0|||
163035939|NCT02636699|588836116|FG001|Screening Period|Adverse Event|0|||
163035940|NCT02636699|588836117|FG002|Screening Period|Adverse Event|1|||
163035941|NCT02636699|588836115|FG000|Screening Period|Other not specified|0|||
163035942|NCT02636699|588836116|FG001|Screening Period|Other not specified|0|||
163035943|NCT02636699|588836117|FG002|Screening Period|Other not specified|3|||
163035944|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
163035945|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
163035946|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
163035947|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
163035948|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
163035949|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
163035950|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
163035951|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
163035952|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
163035953|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
163035954|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
163035955|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
163035956|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
163035957|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
163035958|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
163035959|NCT02636699|588836115|FG000|Treatment and Follow-up Periods|Other|3|||
163035960|NCT02636699|588836116|FG001|Treatment and Follow-up Periods|Other|1|||
163035961|NCT02636699|588836117|FG002|Treatment and Follow-up Periods|Other|0|||
163035962|NCT03624569|588836118|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163035963|NCT03624569|588836119|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
163035964|NCT03624569|588836118|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
163035965|NCT03624569|588836119|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
163035966|NCT03004924|588836146|FG000|Overall Study|Adverse Event|6|||
163035967|NCT03004924|588836147|FG001|Overall Study|Adverse Event|5|||
163035968|NCT03004924|588836148|FG002|Overall Study|Adverse Event|10|||
163035969|NCT03004924|588836146|FG000|Overall Study|Protocol Violation|4|||
163035970|NCT03004924|588836147|FG001|Overall Study|Protocol Violation|0|||
163035971|NCT03004924|588836148|FG002|Overall Study|Protocol Violation|1|||
163035972|NCT03004924|588836146|FG000|Overall Study|Withdrawal by Subject|5|||
163035973|NCT03004924|588836147|FG001|Overall Study|Withdrawal by Subject|3|||
163035974|NCT03004924|588836148|FG002|Overall Study|Withdrawal by Subject|5|||
163035975|NCT03004924|588836146|FG000|Overall Study|Lost to Follow-up|6|||
163035976|NCT03004924|588836147|FG001|Overall Study|Lost to Follow-up|1|||
163035977|NCT03004924|588836148|FG002|Overall Study|Lost to Follow-up|4|||
163035978|NCT03004924|588836146|FG000|Overall Study|Lack of Efficacy|2|||
163035979|NCT03004924|588836147|FG001|Overall Study|Lack of Efficacy|4|||
163035980|NCT03004924|588836148|FG002|Overall Study|Lack of Efficacy|2|||
163035981|NCT03004924|588836146|FG000|Overall Study|Physician Decision|1|||
163035982|NCT03004924|588836147|FG001|Overall Study|Physician Decision|0|||
163035983|NCT03004924|588836148|FG002|Overall Study|Physician Decision|1|||
163035984|NCT03004924|588836146|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163035985|NCT03004924|588836147|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163035986|NCT03004924|588836148|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163035987|NCT03004924|588836146|FG000|Overall Study|Screen Failure|1|||
163035988|NCT03004924|588836147|FG001|Overall Study|Screen Failure|0|||
163035989|NCT03004924|588836148|FG002|Overall Study|Screen Failure|0|||
163035990|NCT03004924|588836146|FG000|Overall Study|Pregnancy|0|||
163035991|NCT03004924|588836147|FG001|Overall Study|Pregnancy|1|||
163035992|NCT03004924|588836148|FG002|Overall Study|Pregnancy|0|||
163035993|NCT03004924|588836146|FG000|Overall Study|Terminated by Sponsor|0|||
163035994|NCT03004924|588836147|FG001|Overall Study|Terminated by Sponsor|0|||
163035995|NCT03004924|588836148|FG002|Overall Study|Terminated by Sponsor|1|||
163035996|NCT03004924|588836146|FG000|Overall Study|Missed Study Visit|0|||
163035997|NCT03004924|588836147|FG001|Overall Study|Missed Study Visit|0|||
163035998|NCT03004924|588836148|FG002|Overall Study|Missed Study Visit|2|||
163035999|NCT03004924|588836146|FG000|Overall Study|HSV1 Positive|1|||
163036000|NCT03004924|588836147|FG001|Overall Study|HSV1 Positive|0|||
163036001|NCT03004924|588836148|FG002|Overall Study|HSV1 Positive|0|||
163036002|NCT03411902|588836164|FG000|Overall Study|Lost to Follow-up|3|||
163036003|NCT03411902|588836165|FG001|Overall Study|Lost to Follow-up|0|||
163036004|NCT01693185|588836168|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
163036005|NCT01693185|588836169|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
163036006|NCT00419159|588836170|FG000|Overall Study|Adverse Event|7|||
163036007|NCT00419159|588836171|FG001|Overall Study|Adverse Event|15|||
163036008|NCT00419159|588836170|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163036009|NCT00419159|588836171|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163036010|NCT00419159|588836170|FG000|Overall Study|Subject's no longer requires study drug|0|||
163036011|NCT00419159|588836171|FG001|Overall Study|Subject's no longer requires study drug|1|||
163036012|NCT00419159|588836170|FG000|Overall Study|Protocol Violation|1|||
163036013|NCT00419159|588836171|FG001|Overall Study|Protocol Violation|0|||
163085932|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
163085933|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
163085934|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
163085935|NCT04380142|589022363|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
163085936|NCT04380142|589022364|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
163085937|NCT04380142|589022365|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
163085938|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163085939|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163085940|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Adverse Event|14|||
163085941|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
163085942|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
163085943|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
163085944|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163085945|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
163085946|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
163085947|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
163036014|NCT00419159|588836170|FG000|Overall Study|Withdrawal by Subject|10|||
163036015|NCT00419159|588836171|FG001|Overall Study|Withdrawal by Subject|3|||
163085948|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
163085949|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
163036016|NCT00419159|588836170|FG000|Overall Study|Lost to Follow-up|0|||
163036017|NCT00419159|588836171|FG001|Overall Study|Lost to Follow-up|1|||
163036018|NCT00419159|588836170|FG000|Overall Study|Death|2|||
163036019|NCT00419159|588836171|FG001|Overall Study|Death|2|||
163036020|NCT00419159|588836170|FG000|Overall Study|Disease progression|79|||
163036021|NCT00419159|588836171|FG001|Overall Study|Disease progression|76|||
163036022|NCT01017601|588836172|FG000|Overall Study|Disease Progression|12|||
163085950|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
163085951|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
162648881|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Death|2|||
163036023|NCT01017601|588836173|FG001|Overall Study|Disease Progression|12|||
163036024|NCT01017601|588836172|FG000|Overall Study|Withdrawal by Subject|0|||
163036025|NCT01017601|588836173|FG001|Overall Study|Withdrawal by Subject|1|||
163036026|NCT00803205|588836175|FG000|Overall Study|Adverse Event|7|||
163085952|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
163085953|NCT04380142|589022363|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
163085954|NCT04380142|589022364|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
163085955|NCT04380142|589022365|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
163085956|NCT00209131|589022366|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
163085957|NCT00209131|589022367|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
163085958|NCT04875533|589022368|FG000|Overall Study|Adverse Event|6|||
163085959|NCT04875533|589022369|FG001|Overall Study|Adverse Event|4|||
163085960|NCT04875533|589022368|FG000|Overall Study|Protocol Violation|4|||
163085961|NCT04875533|589022369|FG001|Overall Study|Protocol Violation|0|||
163085962|NCT04875533|589022368|FG000|Overall Study|Withdrawal by Subject|8|||
163085963|NCT04875533|589022369|FG001|Overall Study|Withdrawal by Subject|5|||
163085964|NCT04875533|589022368|FG000|Overall Study|No longer meets eligibility criteria|1|||
163085965|NCT04875533|589022369|FG001|Overall Study|No longer meets eligibility criteria|0|||
163085966|NCT04875533|589022368|FG000|Overall Study|Other|0|||
163085967|NCT04875533|589022369|FG001|Overall Study|Other|2|||
163085968|NCT01299961|589022370|FG000|Overall Study|Adverse Event|3|||
163085969|NCT01299961|589022370|FG000|Overall Study|Lack of Efficacy|2|||
163085970|NCT01299961|589022370|FG000|Overall Study|Lost to Follow-up|1|||
163085971|NCT02904096|589022371|FG000|Overall Study|Adverse Event|1|||
163085972|NCT02904096|589022372|FG001|Overall Study|Adverse Event|0|||
163085973|NCT02904096|589022371|FG000|Overall Study|Withdrawal by Subject|4|||
163085974|NCT02904096|589022372|FG001|Overall Study|Withdrawal by Subject|3|||
163085975|NCT02904096|589022371|FG000|Overall Study|Lost to Follow-up|10|||
163085976|NCT02904096|589022372|FG001|Overall Study|Lost to Follow-up|17|||
163085977|NCT02904096|589022371|FG000|Overall Study|Non-compliant|3|||
163085978|NCT02904096|589022372|FG001|Overall Study|Non-compliant|1|||
163085979|NCT02904096|589022371|FG000|Overall Study|Sponsor instructed|1|||
163085980|NCT02904096|589022372|FG001|Overall Study|Sponsor instructed|0|||
163085981|NCT00980798|589022373|FG000|Overall Study|Adverse Event|7|||
163085982|NCT00980798|589022374|FG001|Overall Study|Adverse Event|36|||
163085983|NCT00980798|589022373|FG000|Overall Study|Lack of Efficacy|16|||
163085984|NCT00980798|589022374|FG001|Overall Study|Lack of Efficacy|5|||
163085985|NCT00980798|589022373|FG000|Overall Study|Lost to Follow-up|0|||
163085986|NCT00980798|589022374|FG001|Overall Study|Lost to Follow-up|1|||
163085987|NCT00980798|589022373|FG000|Overall Study|Physician Decision|2|||
163085988|NCT00980798|589022374|FG001|Overall Study|Physician Decision|1|||
163085989|NCT00980798|589022373|FG000|Overall Study|Withdrawal by Subject|8|||
163036027|NCT00803205|588836176|FG001|Overall Study|Adverse Event|2|||
163036028|NCT00803205|588836175|FG000|Overall Study|Lost to Follow-up|1|||
163036029|NCT00803205|588836176|FG001|Overall Study|Lost to Follow-up|0|||
163036030|NCT00803205|588836175|FG000|Overall Study|Withdrawal by Subject|9|||
163036031|NCT00803205|588836176|FG001|Overall Study|Withdrawal by Subject|9|||
163036032|NCT00803205|588836175|FG000|Overall Study|Physician Decision|1|||
163036033|NCT00803205|588836176|FG001|Overall Study|Physician Decision|0|||
163036034|NCT00803205|588836175|FG000|Overall Study|Protocol Violation|1|||
163036035|NCT00803205|588836176|FG001|Overall Study|Protocol Violation|1|||
163036036|NCT00803205|588836175|FG000|Overall Study|Medical Monitor Decision|1|||
163036037|NCT00803205|588836176|FG001|Overall Study|Medical Monitor Decision|0|||
163036038|NCT00803205|588836175|FG000|Overall Study|Acquired a Lung Infection|0|||
163036039|NCT00803205|588836176|FG001|Overall Study|Acquired a Lung Infection|1|||
163036040|NCT00803205|588836175|FG000|Overall Study|Sponsor Decision|0|||
163036041|NCT00803205|588836176|FG001|Overall Study|Sponsor Decision|1|||
163036042|NCT01857102|588836177|FG000|Period 1|No longer meets Eligibility Criteria|0|||
163036043|NCT01857102|588836178|FG001|Period 1|No longer meets Eligibility Criteria|2|||
163036044|NCT01857102|588836177|FG000|Period 1|Lost to Follow-up|0|||
163036045|NCT01857102|588836178|FG001|Period 1|Lost to Follow-up|3|||
163036046|NCT01857102|588836177|FG000|Period 1|Unsatisfactory Lens Fit|1|||
163036047|NCT01857102|588836178|FG001|Period 1|Unsatisfactory Lens Fit|0|||
163036048|NCT01857102|588836177|FG000|Period 1|Unsatisfactory Visual Response|1|||
163036049|NCT01857102|588836178|FG001|Period 1|Unsatisfactory Visual Response|0|||
163036050|NCT01857102|588836177|FG000|Period 1|Physician Decision|1|||
163036051|NCT01857102|588836178|FG001|Period 1|Physician Decision|0|||
163036052|NCT01857102|588836177|FG000|Period 2|Lens Discomfort|1|||
163036053|NCT01857102|588836178|FG001|Period 2|Lens Discomfort|0|||
163036054|NCT01857102|588836177|FG000|Period 2|Unsatisfactory Lens Fit|1|||
163036055|NCT01857102|588836178|FG001|Period 2|Unsatisfactory Lens Fit|0|||
163036056|NCT02735096|588836184|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
163036057|NCT01080391|588836192|FG000|Overall Study|Randomized but not treated|7|||
163036058|NCT01080391|588836193|FG001|Overall Study|Randomized but not treated|4|||
163036059|NCT02083653|588836199|FG000|Overall Study|Randomized but not Treated|0|||
163036060|NCT02083653|588836200|FG001|Overall Study|Randomized but not Treated|2|||
163036061|NCT02083653|588836201|FG002|Overall Study|Randomized but not Treated|7|||
163036062|NCT02083653|588836199|FG000|Overall Study|Adverse Event|12|||
163036063|NCT02083653|588836200|FG001|Overall Study|Adverse Event|5|||
163036064|NCT02083653|588836201|FG002|Overall Study|Adverse Event|4|||
163036065|NCT02083653|588836199|FG000|Overall Study|Lost to Follow-up|1|||
163036066|NCT02083653|588836200|FG001|Overall Study|Lost to Follow-up|0|||
163036067|NCT02083653|588836201|FG002|Overall Study|Lost to Follow-up|0|||
163036068|NCT02083653|588836199|FG000|Overall Study|Death|2|||
163036069|NCT02083653|588836200|FG001|Overall Study|Death|2|||
163036070|NCT02083653|588836201|FG002|Overall Study|Death|2|||
163036071|NCT02083653|588836199|FG000|Overall Study|Progressive Disease|65|||
163036072|NCT02083653|588836200|FG001|Overall Study|Progressive Disease|73|||
163036073|NCT02083653|588836201|FG002|Overall Study|Progressive Disease|63|||
163036074|NCT02083653|588836199|FG000|Overall Study|Withdrawal by Subject|2|||
163036075|NCT02083653|588836200|FG001|Overall Study|Withdrawal by Subject|1|||
163036076|NCT02083653|588836201|FG002|Overall Study|Withdrawal by Subject|2|||
163036077|NCT02083653|588836199|FG000|Overall Study|Other Events|0|||
163036078|NCT02083653|588836200|FG001|Overall Study|Other Events|2|||
163036079|NCT02083653|588836201|FG002|Overall Study|Other Events|2|||
163036080|NCT02083653|588836199|FG000|Overall Study|Reason Missing|0|||
163036081|NCT02083653|588836200|FG001|Overall Study|Reason Missing|0|||
163036082|NCT02083653|588836201|FG002|Overall Study|Reason Missing|4|||
163036083|NCT02073656|588836202|FG000|Primary Study|Lost to Follow-up|6|||
163036084|NCT02073656|588836202|FG000|Primary Study|Death|1|||
163036085|NCT02073656|588836202|FG000|Primary Study|Withdrew Consent|1|||
163036086|NCT02536781|588836205|FG000|Overall Study|Lost to Follow-up|2|||
163036087|NCT02536781|588836206|FG001|Overall Study|Lost to Follow-up|0|||
163036088|NCT03423147|588836207|FG000|Overall Study|Lost to Follow-up|5|||
163036089|NCT03423147|588836208|FG001|Overall Study|Lost to Follow-up|8|||
163036090|NCT03423147|588836207|FG000|Overall Study|Withdrawal by Subject|1|||
163036091|NCT03423147|588836208|FG001|Overall Study|Withdrawal by Subject|0|||
163036092|NCT03423147|588836207|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
163036093|NCT03423147|588836208|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
163036094|NCT03423147|588836207|FG000|Overall Study|Age < 18|1|||
163036095|NCT03423147|588836208|FG001|Overall Study|Age < 18|0|||
163036096|NCT03423147|588836207|FG000|Overall Study|No Trial of Labor|0|||
163036097|NCT03423147|588836208|FG001|Overall Study|No Trial of Labor|1|||
163036098|NCT00539032|588836210|FG000|Overall Study|Withdrawal by Subject|2|||
163036099|NCT00539032|588836211|FG001|Overall Study|Withdrawal by Subject|1|||
163036100|NCT03611582|588836212|FG000|Overall Study|Adverse Event|26|||
163036101|NCT03611582|588836213|FG001|Overall Study|Adverse Event|6|||
163036102|NCT03611582|588836212|FG000|Overall Study|Protocol Violation|0|||
163036103|NCT03611582|588836213|FG001|Overall Study|Protocol Violation|1|||
163036104|NCT03611582|588836212|FG000|Overall Study|Pregnancy|1|||
163036105|NCT03611582|588836213|FG001|Overall Study|Pregnancy|2|||
163036106|NCT03611582|588836212|FG000|Overall Study|Lack of Efficacy|0|||
163036107|NCT03611582|588836213|FG001|Overall Study|Lack of Efficacy|1|||
163036108|NCT03611582|588836212|FG000|Overall Study|At the discretion of the investigator|1|||
163036109|NCT03611582|588836213|FG001|Overall Study|At the discretion of the investigator|0|||
163036110|NCT03611582|588836212|FG000|Overall Study|Safety concern as judged by the investigator|1|||
163036111|NCT03611582|588836213|FG001|Overall Study|Safety concern as judged by the investigator|2|||
163036112|NCT03611582|588836212|FG000|Overall Study|Withdrawal by Subject|4|||
163036113|NCT03611582|588836213|FG001|Overall Study|Withdrawal by Subject|3|||
163036114|NCT03611582|588836212|FG000|Overall Study|Lost to Follow-up|18|||
163036115|NCT03611582|588836213|FG001|Overall Study|Lost to Follow-up|7|||
163036116|NCT03611582|588836212|FG000|Overall Study|other|17|||
163036117|NCT03611582|588836213|FG001|Overall Study|other|16|||
163036118|NCT04438499|588836214|FG000|Overall Study|Lack of Efficacy|3|||
163036119|NCT04494425|588837839|FG000|Overall Study|Death|160|||
163036120|NCT04494425|588837840|FG001|Overall Study|Death|166|||
163036121|NCT04494425|588837839|FG000|Overall Study|Withdrawal by Subject|10|||
163036122|NCT04494425|588837840|FG001|Overall Study|Withdrawal by Subject|40|||
163036123|NCT04494425|588837839|FG000|Overall Study|Other|1|||
163036124|NCT04494425|588837840|FG001|Overall Study|Other|1|||
163036125|NCT04494425|588837839|FG000|Overall Study|Ongoing at the time of PCD|265|||
163036126|NCT04494425|588837840|FG001|Overall Study|Ongoing at the time of PCD|223|||
163036127|NCT01270321|588837842|FG000|Overall Study|Death|3|||
163036128|NCT01270321|588837843|FG001|Overall Study|Death|1|||
163036129|NCT01270321|588837844|FG002|Overall Study|Death|4|||
163036130|NCT01270321|588837842|FG000|Overall Study|Adverse Event|7|||
163036131|NCT01270321|588837843|FG001|Overall Study|Adverse Event|9|||
163036132|NCT01270321|588837844|FG002|Overall Study|Adverse Event|5|||
163036133|NCT04003623|588837848|FG000|Overall Study|Withdrawal by Subject|1|||
163036134|NCT04003623|588837849|FG001|Overall Study|Withdrawal by Subject|0|||
163036135|NCT01190189|588837853|FG000|Overall Study|Lost to Follow-up|4|||
163036136|NCT01190189|588837853|FG000|Overall Study|Withdrawal by Subject|1|||
163036137|NCT01190189|588837853|FG000|Overall Study|Migrated/moved from study area|1|||
163036138|NCT00762034|588837857|FG000|Induction Period|Protocol Violation|1|||
163036139|NCT00762034|588837858|FG001|Induction Period|Protocol Violation|2|||
163036140|NCT00762034|588837857|FG000|Induction Period|Entry Criterion Not Met|12|||
163085990|NCT00980798|589022374|FG001|Overall Study|Withdrawal by Subject|11|||
163085991|NCT00980798|589022373|FG000|Overall Study|Other|0|||
163085992|NCT00980798|589022374|FG001|Overall Study|Other|1|||
163085993|NCT00526799|589022375|FG000|Overall Study|Withdrawal by Subject|1|||
163085994|NCT00526799|589022376|FG001|Overall Study|Withdrawal by Subject|0|||
163085995|NCT00526799|589022375|FG000|Overall Study|Intercurrent Complicating Disease|0|||
163085996|NCT00526799|589022376|FG001|Overall Study|Intercurrent Complicating Disease|1|||
163085997|NCT03633058|589022377|FG000|Overall Study|Adverse Event|0|||
163085998|NCT03633058|589022378|FG001|Overall Study|Adverse Event|0|||
163085999|NCT03633058|589022379|FG002|Overall Study|Adverse Event|1|||
163086000|NCT03633058|589022380|FG003|Overall Study|Adverse Event|0|||
163086001|NCT02757768|589022381|FG000|Overall Study|Randomized Never Received Study Drug|3|||
163086002|NCT02757768|589022382|FG001|Overall Study|Randomized Never Received Study Drug|4|||
163086003|NCT02757768|589022381|FG000|Overall Study|Adverse Event|5|||
163086004|NCT02757768|589022382|FG001|Overall Study|Adverse Event|3|||
163086005|NCT02757768|589022381|FG000|Overall Study|Lack of Efficacy|2|||
163086006|NCT02757768|589022382|FG001|Overall Study|Lack of Efficacy|1|||
163086007|NCT02757768|589022381|FG000|Overall Study|Lost to Follow-up|1|||
163086008|NCT02757768|589022382|FG001|Overall Study|Lost to Follow-up|0|||
163086009|NCT02757768|589022381|FG000|Overall Study|Protocol Deviation|2|||
163086010|NCT02757768|589022382|FG001|Overall Study|Protocol Deviation|9|||
163086011|NCT02757768|589022381|FG000|Overall Study|Withdrawal by Subject|16|||
163086012|NCT02757768|589022382|FG001|Overall Study|Withdrawal by Subject|9|||
163086013|NCT02757768|589022381|FG000|Overall Study|Miscellaneous|4|||
163086014|NCT02757768|589022382|FG001|Overall Study|Miscellaneous|2|||
163086015|NCT00835367|589022383|FG000|Washout|Adverse Event|2|||
163086016|NCT00835367|589022384|FG001|Washout|Adverse Event|0|||
163086017|NCT00835367|589022383|FG000|Washout|Withdrawal by Subject|1|||
163086018|NCT00835367|589022384|FG001|Washout|Withdrawal by Subject|0|||
163086019|NCT00835367|589022383|FG000|Second Intervention|Adverse Event|1|||
163086020|NCT00835367|589022384|FG001|Second Intervention|Adverse Event|1|||
163086021|NCT00835172|589022385|FG000|Washout|Protocol Violation|0|||
163086022|NCT00835172|589022386|FG001|Washout|Protocol Violation|1|||
163086023|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
163086024|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
163086025|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
163086026|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
163086027|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
163086028|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
163086029|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
163086030|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
163086031|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
163086032|NCT04734210|589024265|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
163086033|NCT04734210|589024266|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
163086034|NCT04734210|589024267|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
163086035|NCT00573768|589024268|FG000|Overall Study|Adverse Event|1|||
163086036|NCT00573768|589024269|FG001|Overall Study|Adverse Event|1|||
163086037|NCT00573768|589024270|FG002|Overall Study|Adverse Event|2|||
163086038|NCT00573768|589024268|FG000|Overall Study|Protocol Violation|1|||
163086039|NCT00573768|589024269|FG001|Overall Study|Protocol Violation|0|||
163086040|NCT00573768|589024270|FG002|Overall Study|Protocol Violation|1|||
163086041|NCT00573768|589024268|FG000|Overall Study|Withdrawal by Subject|0|||
163086042|NCT00573768|589024269|FG001|Overall Study|Withdrawal by Subject|1|||
163086043|NCT00573768|589024270|FG002|Overall Study|Withdrawal by Subject|0|||
163086044|NCT00573768|589024268|FG000|Overall Study|Lost to Follow-up|0|||
163086045|NCT00573768|589024269|FG001|Overall Study|Lost to Follow-up|0|||
163086046|NCT00573768|589024270|FG002|Overall Study|Lost to Follow-up|1|||
163086047|NCT00553254|589024278|FG000|Overall Study|Death|3|||
163086048|NCT00553254|589024279|FG001|Overall Study|Death|6|||
163086049|NCT00553254|589024280|FG002|Overall Study|Death|25|||
163086050|NCT00553254|589024278|FG000|Overall Study|Lost to Follow-up|0|||
163086051|NCT00553254|589024279|FG001|Overall Study|Lost to Follow-up|0|||
163036141|NCT00762034|588837858|FG001|Induction Period|Entry Criterion Not Met|11|||
163036142|NCT00762034|588837857|FG000|Induction Period|Adverse Event|27|||
163036143|NCT00762034|588837858|FG001|Induction Period|Adverse Event|38|||
163036144|NCT00762034|588837857|FG000|Induction Period|Lost to Follow-up|1|||
163036145|NCT00762034|588837858|FG001|Induction Period|Lost to Follow-up|1|||
163036146|NCT00762034|588837857|FG000|Induction Period|Progressive Disease|73|||
163036147|NCT00762034|588837858|FG001|Induction Period|Progressive Disease|55|||
163036148|NCT00762034|588837857|FG000|Induction Period|Physician Decision|21|||
163036149|NCT00762034|588837858|FG001|Induction Period|Physician Decision|20|||
163036150|NCT00762034|588837857|FG000|Induction Period|Withdrawal by Subject|15|||
163086052|NCT00553254|589024280|FG002|Overall Study|Lost to Follow-up|2|||
163086053|NCT00553254|589024278|FG000|Overall Study|Withdrawal by Subject|2|||
163086054|NCT00553254|589024279|FG001|Overall Study|Withdrawal by Subject|0|||
163086055|NCT00553254|589024280|FG002|Overall Study|Withdrawal by Subject|2|||
163086056|NCT00553254|589024278|FG000|Overall Study|Study terminated by Sponsor|0|||
163086057|NCT00553254|589024279|FG001|Overall Study|Study terminated by Sponsor|0|||
163086058|NCT00553254|589024280|FG002|Overall Study|Study terminated by Sponsor|1|||
163086059|NCT00553254|589024278|FG000|Overall Study|Other|1|||
163086060|NCT00553254|589024279|FG001|Overall Study|Other|0|||
163086061|NCT00553254|589024280|FG002|Overall Study|Other|13|||
163086062|NCT02314923|589024283|FG000|Overall Study|Death|0|||
163086063|NCT02314923|589024284|FG001|Overall Study|Death|0|||
163086064|NCT02314923|589024285|FG002|Overall Study|Death|0|||
163086065|NCT02314923|589024286|FG003|Overall Study|Death|1|||
163086066|NCT02314923|589024287|FG004|Overall Study|Death|0|||
163086067|NCT02314923|589024288|FG005|Overall Study|Death|0|||
163086068|NCT02314923|589024289|FG006|Overall Study|Death|0|||
163086069|NCT02314923|589024290|FG007|Overall Study|Death|0|||
163086070|NCT02314923|589024291|FG008|Overall Study|Death|0|||
163086071|NCT02314923|589024292|FG009|Overall Study|Death|0|||
163086072|NCT02314923|589024283|FG000|Overall Study|Lost to Follow-up|2|||
163086073|NCT02314923|589024284|FG001|Overall Study|Lost to Follow-up|3|||
163086074|NCT02314923|589024285|FG002|Overall Study|Lost to Follow-up|1|||
163086075|NCT02314923|589024286|FG003|Overall Study|Lost to Follow-up|0|||
163086076|NCT02314923|589024287|FG004|Overall Study|Lost to Follow-up|0|||
163086077|NCT02314923|589024288|FG005|Overall Study|Lost to Follow-up|0|||
163086078|NCT02314923|589024289|FG006|Overall Study|Lost to Follow-up|3|||
163086079|NCT02314923|589024290|FG007|Overall Study|Lost to Follow-up|4|||
163086080|NCT02314923|589024291|FG008|Overall Study|Lost to Follow-up|2|||
163086081|NCT02314923|589024292|FG009|Overall Study|Lost to Follow-up|0|||
163086082|NCT02314923|589024283|FG000|Overall Study|Withdrawal by Subject|0|||
163086083|NCT02314923|589024284|FG001|Overall Study|Withdrawal by Subject|0|||
163086084|NCT02314923|589024285|FG002|Overall Study|Withdrawal by Subject|1|||
163086085|NCT02314923|589024286|FG003|Overall Study|Withdrawal by Subject|0|||
163086086|NCT02314923|589024287|FG004|Overall Study|Withdrawal by Subject|1|||
163086087|NCT02314923|589024288|FG005|Overall Study|Withdrawal by Subject|0|||
163086088|NCT02314923|589024289|FG006|Overall Study|Withdrawal by Subject|1|||
163086089|NCT02314923|589024290|FG007|Overall Study|Withdrawal by Subject|0|||
163086090|NCT02314923|589024291|FG008|Overall Study|Withdrawal by Subject|0|||
163086091|NCT02314923|589024292|FG009|Overall Study|Withdrawal by Subject|0|||
163086092|NCT02314923|589024283|FG000|Overall Study|Physician Decision|0|||
163086093|NCT02314923|589024284|FG001|Overall Study|Physician Decision|1|||
163086094|NCT02314923|589024285|FG002|Overall Study|Physician Decision|0|||
163086095|NCT02314923|589024286|FG003|Overall Study|Physician Decision|0|||
163086096|NCT02314923|589024287|FG004|Overall Study|Physician Decision|0|||
163086097|NCT02314923|589024288|FG005|Overall Study|Physician Decision|0|||
163086098|NCT02314923|589024289|FG006|Overall Study|Physician Decision|0|||
163086099|NCT02314923|589024290|FG007|Overall Study|Physician Decision|0|||
163086100|NCT02314923|589024291|FG008|Overall Study|Physician Decision|0|||
163086101|NCT02314923|589024292|FG009|Overall Study|Physician Decision|0|||
163086102|NCT02314923|589024283|FG000|Overall Study|Participant unavailable|0|||
163086103|NCT02314923|589024284|FG001|Overall Study|Participant unavailable|0|||
163086104|NCT02314923|589024285|FG002|Overall Study|Participant unavailable|0|||
163086105|NCT02314923|589024286|FG003|Overall Study|Participant unavailable|0|||
163086106|NCT02314923|589024287|FG004|Overall Study|Participant unavailable|0|||
163086107|NCT02314923|589024288|FG005|Overall Study|Participant unavailable|1|||
162648882|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Death|0|||
162648883|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Death|4|||
162648884|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
162648885|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
162648886|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
162648887|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
162648888|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
163086108|NCT02314923|589024289|FG006|Overall Study|Participant unavailable|0|||
163086109|NCT02314923|589024290|FG007|Overall Study|Participant unavailable|0|||
163086110|NCT02314923|589024291|FG008|Overall Study|Participant unavailable|0|||
163086111|NCT02314923|589024292|FG009|Overall Study|Participant unavailable|0|||
163086112|NCT02314923|589024283|FG000|Overall Study|Screen failure|0|||
163086113|NCT02314923|589024284|FG001|Overall Study|Screen failure|0|||
163086114|NCT02314923|589024285|FG002|Overall Study|Screen failure|0|||
163086115|NCT02314923|589024286|FG003|Overall Study|Screen failure|0|||
163086116|NCT02314923|589024287|FG004|Overall Study|Screen failure|0|||
163086117|NCT02314923|589024288|FG005|Overall Study|Screen failure|0|||
163086118|NCT02314923|589024289|FG006|Overall Study|Screen failure|1|||
163086119|NCT02314923|589024290|FG007|Overall Study|Screen failure|0|||
163086120|NCT02314923|589024291|FG008|Overall Study|Screen failure|0|||
163086121|NCT02314923|589024292|FG009|Overall Study|Screen failure|0|||
163086122|NCT02314923|589024283|FG000|Overall Study|Participant relocation|1|||
163086123|NCT02314923|589024284|FG001|Overall Study|Participant relocation|0|||
163036151|NCT00762034|588837858|FG001|Induction Period|Withdrawal by Subject|19|||
163036152|NCT00762034|588837857|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
163036153|NCT00762034|588837858|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
163036154|NCT00762034|588837857|FG000|Induction Period|Deaths Due to Study Disease|9|||
163036155|NCT00762034|588837858|FG001|Induction Period|Deaths Due to Study Disease|9|||
163036156|NCT00762034|588837857|FG000|Maintenance Period|Protocol Violation|1|||
163036157|NCT00762034|588837858|FG001|Maintenance Period|Protocol Violation|3|||
163036158|NCT00762034|588837857|FG000|Maintenance Period|Entry Criterion Not Met|0|||
163036159|NCT00762034|588837858|FG001|Maintenance Period|Entry Criterion Not Met|2|||
163036160|NCT00762034|588837857|FG000|Maintenance Period|Adverse Event|42|||
163036161|NCT00762034|588837858|FG001|Maintenance Period|Adverse Event|26|||
163036162|NCT00762034|588837857|FG000|Maintenance Period|Progressive Disease|186|||
163036163|NCT00762034|588837858|FG001|Maintenance Period|Progressive Disease|224|||
163036164|NCT00762034|588837857|FG000|Maintenance Period|Physician Decision|25|||
163036165|NCT00762034|588837858|FG001|Maintenance Period|Physician Decision|20|||
163036166|NCT00762034|588837857|FG000|Maintenance Period|Withdrawal by Subject|34|||
163036167|NCT00762034|588837858|FG001|Maintenance Period|Withdrawal by Subject|14|||
163036168|NCT00762034|588837857|FG000|Maintenance Period|Death not due to study disease|2|||
163036169|NCT00762034|588837858|FG001|Maintenance Period|Death not due to study disease|5|||
163036170|NCT00762034|588837857|FG000|Maintenance Period|Death due to study disease|3|||
163036171|NCT00762034|588837858|FG001|Maintenance Period|Death due to study disease|3|||
163036172|NCT00762034|588837857|FG000|Maintenance Period|Other|1|||
163036173|NCT00762034|588837858|FG001|Maintenance Period|Other|1|||
163036174|NCT00734656|588837859|FG000|Lab Session 1|Withdrawal by Subject|2|||
163036175|NCT00734656|588837860|FG001|Lab Session 1|Withdrawal by Subject|0|||
163036176|NCT00734656|588837861|FG002|Lab Session 1|Withdrawal by Subject|0|||
163036177|NCT00734656|588837862|FG003|Lab Session 1|Withdrawal by Subject|0|||
163036178|NCT00734656|588837859|FG000|Washout 1|Withdrawal by Subject|1|||
163036179|NCT00734656|588837860|FG001|Washout 1|Withdrawal by Subject|5|||
163036180|NCT00734656|588837861|FG002|Washout 1|Withdrawal by Subject|2|||
163036181|NCT00734656|588837862|FG003|Washout 1|Withdrawal by Subject|3|||
163036182|NCT00734656|588837859|FG000|Lab Session 2|Withdrawal by Subject|1|||
163036183|NCT00734656|588837860|FG001|Lab Session 2|Withdrawal by Subject|0|||
163036184|NCT00734656|588837861|FG002|Lab Session 2|Withdrawal by Subject|0|||
163036185|NCT00734656|588837862|FG003|Lab Session 2|Withdrawal by Subject|1|||
163036186|NCT00734656|588837859|FG000|Washout 2|Withdrawal by Subject|1|||
163036187|NCT00734656|588837860|FG001|Washout 2|Withdrawal by Subject|1|||
163036188|NCT00734656|588837861|FG002|Washout 2|Withdrawal by Subject|1|||
163036189|NCT00734656|588837862|FG003|Washout 2|Withdrawal by Subject|0|||
163036190|NCT00734656|588837859|FG000|Washout 3|Withdrawal by Subject|1|||
163036191|NCT00734656|588837860|FG001|Washout 3|Withdrawal by Subject|0|||
163036192|NCT00734656|588837861|FG002|Washout 3|Withdrawal by Subject|0|||
163036193|NCT00734656|588837862|FG003|Washout 3|Withdrawal by Subject|1|||
163036194|NCT00734656|588837859|FG000|Lab Session 4|Withdrawal by Subject|0|||
163036195|NCT00734656|588837860|FG001|Lab Session 4|Withdrawal by Subject|0|||
163036196|NCT00734656|588837861|FG002|Lab Session 4|Withdrawal by Subject|0|||
163036197|NCT00734656|588837862|FG003|Lab Session 4|Withdrawal by Subject|1|||
163036198|NCT03214679|588837865|FG000|Overall Study|Lost to Follow-up|12|||
163036199|NCT03214679|588837866|FG001|Overall Study|Lost to Follow-up|14|||
163036200|NCT03214679|588837865|FG000|Overall Study|not eligible|2|||
163036201|NCT03214679|588837866|FG001|Overall Study|not eligible|0|||
163036202|NCT01754766|588837874|FG000|Overall Study|Personal reasons|1|||
163036203|NCT01754766|588837875|FG001|Overall Study|Personal reasons|1|||
163036204|NCT01754766|588837876|FG002|Overall Study|Personal reasons|0|||
163036205|NCT02412878|588837877|FG000|Overall Study|Withdrawal by Subject|19|||
163036206|NCT02412878|588837878|FG001|Overall Study|Withdrawal by Subject|10|||
163036207|NCT02412878|588837877|FG000|Overall Study|Lost to Follow-up|2|||
163036208|NCT02412878|588837878|FG001|Overall Study|Lost to Follow-up|3|||
163036209|NCT04676152|588837879|FG000|Overall Study|screen fail|9|||
163036210|NCT01026818|588837887|FG000|Screening Period|Entry Criteria Not Met|105|||
163036211|NCT01026818|588837888|FG001|Screening Period|Entry Criteria Not Met|0|||
163036212|NCT01026818|588837889|FG002|Screening Period|Entry Criteria Not Met|0|||
163036213|NCT01026818|588837890|FG003|Screening Period|Entry Criteria Not Met|0|||
163036214|NCT01026818|588837887|FG000|Screening Period|Withdrawal by Subject|49|||
163036215|NCT01026818|588837888|FG001|Screening Period|Withdrawal by Subject|0|||
163036216|NCT01026818|588837889|FG002|Screening Period|Withdrawal by Subject|0|||
163036217|NCT01026818|588837890|FG003|Screening Period|Withdrawal by Subject|0|||
163036218|NCT01026818|588837887|FG000|Screening Period|Protocol Deviation|3|||
163036219|NCT01026818|588837888|FG001|Screening Period|Protocol Deviation|0|||
163036220|NCT01026818|588837889|FG002|Screening Period|Protocol Deviation|0|||
163036221|NCT01026818|588837890|FG003|Screening Period|Protocol Deviation|0|||
163036222|NCT01026818|588837887|FG000|Screening Period|Adverse Event|2|||
163036223|NCT01026818|588837888|FG001|Screening Period|Adverse Event|0|||
163036224|NCT01026818|588837889|FG002|Screening Period|Adverse Event|0|||
163036225|NCT01026818|588837890|FG003|Screening Period|Adverse Event|0|||
163036226|NCT01026818|588837887|FG000|Screening Period|Physician Decision|1|||
162718319|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162718320|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162718321|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162718322|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718323|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162718324|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162718325|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718326|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718327|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718328|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718329|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162718330|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162718331|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162718332|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
162718333|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
162718334|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162718335|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162718336|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162718337|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162718338|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
162718339|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
162718340|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718341|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
162718342|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718343|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718344|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718345|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718346|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718347|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718348|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162718349|NCT01212757|587673540|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718350|NCT01212757|587673541|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
162718351|NCT01212757|587673542|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
162718352|NCT01212757|587673543|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718353|NCT01212757|587673544|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718354|NCT01212757|587673545|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718355|NCT01212757|587673546|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718356|NCT01212757|587673547|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718357|NCT01212757|587673548|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162718358|NCT03141788|587673549|FG000|Overall Study|Lost to Follow-up|1|||
162718359|NCT03141788|587673549|FG000|Overall Study|Protocol Violation|3|||
162718360|NCT03141788|587673549|FG000|Overall Study|Withdrawal by Subject|4|||
162718361|NCT01049503|587676555|FG000|Overall Study|Lost to Follow-up|11|||
162718362|NCT01049503|587676556|FG001|Overall Study|Lost to Follow-up|12|||
162718363|NCT01049503|587676557|FG002|Overall Study|Lost to Follow-up|24|||
162718364|NCT01049503|587676558|FG003|Overall Study|Lost to Follow-up|26|||
162718365|NCT01049503|587676559|FG004|Overall Study|Lost to Follow-up|27|||
162718366|NCT01049503|587676560|FG005|Overall Study|Lost to Follow-up|8|||
162718367|NCT02525796|587676564|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162718368|NCT02525796|587676565|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162718369|NCT02525796|587676566|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162718370|NCT02525796|587676564|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
162718371|NCT02525796|587676565|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
162718372|NCT02525796|587676566|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
162718373|NCT02525796|587676564|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
162718374|NCT02525796|587676565|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
163036227|NCT01026818|588837888|FG001|Screening Period|Physician Decision|0|||
163036228|NCT01026818|588837889|FG002|Screening Period|Physician Decision|0|||
162718375|NCT02525796|587676566|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
162718376|NCT02525796|587676564|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
162718377|NCT02525796|587676565|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
162718378|NCT02525796|587676566|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
162718379|NCT02525796|587676564|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
163036229|NCT01026818|588837890|FG003|Screening Period|Physician Decision|0|||
163036230|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
163036231|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
163036232|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
163036233|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
162718380|NCT02525796|587676565|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
163086124|NCT02314923|589024285|FG002|Overall Study|Participant relocation|0|||
163086125|NCT02314923|589024286|FG003|Overall Study|Participant relocation|0|||
163086126|NCT02314923|589024287|FG004|Overall Study|Participant relocation|0|||
163086127|NCT02314923|589024288|FG005|Overall Study|Participant relocation|0|||
163086128|NCT02314923|589024289|FG006|Overall Study|Participant relocation|0|||
163086129|NCT02314923|589024290|FG007|Overall Study|Participant relocation|1|||
163086130|NCT02314923|589024291|FG008|Overall Study|Participant relocation|0|||
163086131|NCT02314923|589024292|FG009|Overall Study|Participant relocation|0|||
163086132|NCT00976456|589024295|FG000|Overall Study|Adverse Event|17|||
163086133|NCT00976456|589024296|FG001|Overall Study|Adverse Event|22|||
163086134|NCT00976456|589024295|FG000|Overall Study|Death|7|||
163086135|NCT00976456|589024296|FG001|Overall Study|Death|9|||
163086136|NCT00976456|589024295|FG000|Overall Study|Lack of Efficacy|5|||
163086137|NCT00976456|589024296|FG001|Overall Study|Lack of Efficacy|2|||
163086138|NCT00976456|589024295|FG000|Overall Study|Withdrawal by Subject|3|||
163086139|NCT00976456|589024296|FG001|Overall Study|Withdrawal by Subject|1|||
163086140|NCT00976456|589024295|FG000|Overall Study|screening failure, unknown|11|||
163086141|NCT00976456|589024296|FG001|Overall Study|screening failure, unknown|4|||
163086142|NCT00478257|589024297|FG000|Overall Study|Withdrawal by Subject|8|||
163086143|NCT00478257|589024298|FG001|Overall Study|Withdrawal by Subject|3|||
163086144|NCT00806585|589024299|FG000|Overall Study|Study terminated by Sponsor|0|||
163086145|NCT00806585|589024300|FG001|Overall Study|Study terminated by Sponsor|0|||
163086146|NCT00806585|589024301|FG002|Overall Study|Study terminated by Sponsor|1|||
163086147|NCT00806585|589024302|FG003|Overall Study|Study terminated by Sponsor|2|||
163086148|NCT00806585|589024303|FG004|Overall Study|Study terminated by Sponsor|0|||
163086149|NCT00806585|589024299|FG000|Overall Study|Protocol Violation|3|||
163086150|NCT00806585|589024300|FG001|Overall Study|Protocol Violation|1|||
163086151|NCT00806585|589024301|FG002|Overall Study|Protocol Violation|2|||
163086152|NCT00806585|589024302|FG003|Overall Study|Protocol Violation|0|||
163086153|NCT00806585|589024303|FG004|Overall Study|Protocol Violation|0|||
163086154|NCT00806585|589024299|FG000|Overall Study|Physician Decision|0|||
163086155|NCT00806585|589024300|FG001|Overall Study|Physician Decision|2|||
163086156|NCT00806585|589024301|FG002|Overall Study|Physician Decision|3|||
163086157|NCT00806585|589024302|FG003|Overall Study|Physician Decision|0|||
163086158|NCT00806585|589024303|FG004|Overall Study|Physician Decision|1|||
163086159|NCT00806585|589024299|FG000|Overall Study|Lost to Follow-up|2|||
163086160|NCT00806585|589024300|FG001|Overall Study|Lost to Follow-up|1|||
163086161|NCT00806585|589024301|FG002|Overall Study|Lost to Follow-up|2|||
163086162|NCT00806585|589024302|FG003|Overall Study|Lost to Follow-up|2|||
163086163|NCT00806585|589024303|FG004|Overall Study|Lost to Follow-up|5|||
163086164|NCT00806585|589024299|FG000|Overall Study|Lack of Efficacy|1|||
163086165|NCT00806585|589024300|FG001|Overall Study|Lack of Efficacy|0|||
163086166|NCT00806585|589024301|FG002|Overall Study|Lack of Efficacy|0|||
163086167|NCT00806585|589024302|FG003|Overall Study|Lack of Efficacy|0|||
163086168|NCT00806585|589024303|FG004|Overall Study|Lack of Efficacy|0|||
163086169|NCT00806585|589024299|FG000|Overall Study|Adverse Event|1|||
163086170|NCT00806585|589024300|FG001|Overall Study|Adverse Event|5|||
163086171|NCT00806585|589024301|FG002|Overall Study|Adverse Event|3|||
163086172|NCT00806585|589024302|FG003|Overall Study|Adverse Event|4|||
163086173|NCT00806585|589024303|FG004|Overall Study|Adverse Event|2|||
163086174|NCT00806585|589024299|FG000|Overall Study|Withdrawal by Subject|10|||
163086175|NCT00806585|589024300|FG001|Overall Study|Withdrawal by Subject|8|||
163086176|NCT00806585|589024301|FG002|Overall Study|Withdrawal by Subject|9|||
163086177|NCT00806585|589024302|FG003|Overall Study|Withdrawal by Subject|3|||
163086178|NCT00806585|589024303|FG004|Overall Study|Withdrawal by Subject|11|||
163086179|NCT00806585|589024299|FG000|Overall Study|Completion status unknown|15|||
163086180|NCT00806585|589024300|FG001|Overall Study|Completion status unknown|14|||
163086181|NCT00806585|589024301|FG002|Overall Study|Completion status unknown|12|||
163086182|NCT00806585|589024302|FG003|Overall Study|Completion status unknown|4|||
163086183|NCT00806585|589024303|FG004|Overall Study|Completion status unknown|12|||
163086184|NCT02507934|589024304|FG000|Overall Study|Lost to Follow-up|2|||
163086185|NCT02507934|589024305|FG001|Overall Study|Lost to Follow-up|0|||
163086186|NCT02507934|589024304|FG000|Overall Study|Withdrawal by Subject|2|||
163086187|NCT02507934|589024305|FG001|Overall Study|Withdrawal by Subject|0|||
163086188|NCT03766399|589024306|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086189|NCT03766399|589024307|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086190|NCT03766399|589024308|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
162648889|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
163086191|NCT03766399|589024309|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086192|NCT03766399|589024310|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086193|NCT03766399|589024311|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086194|NCT03766399|589024312|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086195|NCT03766399|589024313|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086196|NCT03766399|589024314|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086197|NCT03766399|589024315|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086198|NCT03766399|589024316|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086199|NCT03766399|589024317|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086200|NCT03766399|589024318|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086201|NCT03766399|589024319|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
163086202|NCT03766399|589024320|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086203|NCT03766399|589024321|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086204|NCT03766399|589024322|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086205|NCT03766399|589024323|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
163086206|NCT03331354|589024324|FG000|Overall Study|Withdrawal by Subject|1|||
163086207|NCT03331354|589024325|FG001|Overall Study|Withdrawal by Subject|3|||
163086208|NCT03331354|589024324|FG000|Overall Study|Lost to Follow-up|3|||
163086209|NCT03331354|589024325|FG001|Overall Study|Lost to Follow-up|3|||
163086210|NCT03331354|589024324|FG000|Overall Study|Found employment before initiated active intervention|0|||
163086211|NCT03331354|589024325|FG001|Overall Study|Found employment before initiated active intervention|4|||
163086212|NCT05889468|589024328|FG000|Overall Study|Lost to Follow-up|9|||
163086213|NCT05889468|589024329|FG001|Overall Study|Lost to Follow-up|2|||
163086214|NCT05889468|589024328|FG000|Overall Study|Withdrawal by Subject|2|||
163086215|NCT05889468|589024329|FG001|Overall Study|Withdrawal by Subject|2|||
163086216|NCT01767987|589024332|FG000|Overall Study|Physician Decision|4|||
163086217|NCT01767987|589024333|FG001|Overall Study|Physician Decision|1|||
163086218|NCT01153516|589024334|FG000|Overall Study|Both subjects refused surgery|2|||
163086219|NCT01153516|589024335|FG001|Overall Study|Both subjects refused surgery|0|||
163086220|NCT01605097|589024344|FG000|Overall Study|Protocol Violation|1|||
163086221|NCT02284893|589024352|FG000|26 Week (Short Term)|Adverse Event|1|||
163086222|NCT02284893|589024353|FG001|26 Week (Short Term)|Adverse Event|9|||
163086223|NCT02284893|589024352|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
163086224|NCT02284893|589024353|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
163086225|NCT02284893|589024352|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
163086226|NCT02284893|589024353|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
163086227|NCT02284893|589024352|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
163086228|NCT02284893|589024353|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
163086229|NCT02284893|589024352|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
163086230|NCT02284893|589024353|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
163086231|NCT02284893|589024352|FG000|26 Week (Short Term)|Other|1|||
163086232|NCT02284893|589024353|FG001|26 Week (Short Term)|Other|1|||
163086233|NCT02284893|589024352|FG000|52 Week (Long Term)|Adverse Event|3|||
163086234|NCT02284893|589024353|FG001|52 Week (Long Term)|Adverse Event|1|||
163086235|NCT02284893|589024352|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
163086236|NCT02284893|589024353|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
163086237|NCT02284893|589024352|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
163086238|NCT02284893|589024353|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
163086239|NCT02284893|589024352|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
163086240|NCT02284893|589024353|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
163086241|NCT02284893|589024352|FG000|52 Week (Long Term)|Non-Compliance|2|||
163086242|NCT02284893|589024353|FG001|52 Week (Long Term)|Non-Compliance|3|||
163086243|NCT03038620|589024356|FG000|Overall Study|Lost to Follow-up|18|||
163086244|NCT03038620|589024357|FG001|Overall Study|Lost to Follow-up|23|||
163086245|NCT03038620|589024356|FG000|Overall Study|Withdrawal by Subject|0|||
162648890|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
162648891|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
162648892|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
162648893|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
162648894|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
162648895|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
163086246|NCT03038620|589024357|FG001|Overall Study|Withdrawal by Subject|15|||
163086247|NCT03038620|589024356|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
163086248|NCT03038620|589024357|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
163086249|NCT00539500|589024363|FG000|Overall Study|Disease Progression|1|||
163086250|NCT00539500|589024363|FG000|Overall Study|Lost to Follow-up|2|||
163086251|NCT02011542|589024365|FG000|Overall Study|Physician Decision|1|||
163086252|NCT03261505|589024366|FG000|Overall Study|Withdrawal by Subject|2|||
163086253|NCT03261505|589024367|FG001|Overall Study|Withdrawal by Subject|3|||
163086254|NCT03261505|589024368|FG002|Overall Study|Withdrawal by Subject|4|||
163086255|NCT03261505|589024369|FG003|Overall Study|Withdrawal by Subject|3|||
163086256|NCT03261505|589024366|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086257|NCT03261505|589024367|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086258|NCT03261505|589024368|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
163086259|NCT03261505|589024369|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
163086260|NCT03261505|589024366|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163086261|NCT03261505|589024367|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163086262|NCT03261505|589024368|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
163086263|NCT03261505|589024369|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
163086264|NCT03261505|589024366|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
163086265|NCT03261505|589024367|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086266|NCT03261505|589024368|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086267|NCT03261505|589024369|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
163086268|NCT00663260|589024371|FG000|Overall Study|Lack of Efficacy|2|||
163086269|NCT00663260|589024372|FG001|Overall Study|Lack of Efficacy|0|||
163086270|NCT00663260|589024373|FG002|Overall Study|Lack of Efficacy|0|||
163086271|NCT00663260|589024371|FG000|Overall Study|Adverse Event|12|||
163086272|NCT00663260|589024372|FG001|Overall Study|Adverse Event|7|||
163086273|NCT00663260|589024373|FG002|Overall Study|Adverse Event|6|||
163086274|NCT00663260|589024371|FG000|Overall Study|Withdrawal by Subject|3|||
163086275|NCT00663260|589024372|FG001|Overall Study|Withdrawal by Subject|1|||
163086276|NCT00663260|589024373|FG002|Overall Study|Withdrawal by Subject|6|||
163086277|NCT00663260|589024371|FG000|Overall Study|Death|1|||
163086278|NCT00663260|589024372|FG001|Overall Study|Death|0|||
163086279|NCT00663260|589024373|FG002|Overall Study|Death|1|||
163086280|NCT00663260|589024371|FG000|Overall Study|Lost to Follow-up|0|||
163086281|NCT00663260|589024372|FG001|Overall Study|Lost to Follow-up|1|||
163086282|NCT00663260|589024373|FG002|Overall Study|Lost to Follow-up|0|||
163086283|NCT00663260|589024371|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
163086284|NCT00663260|589024372|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
163086285|NCT00663260|589024373|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
163086286|NCT00522379|589024374|FG000|Overall Study|Adverse Event|12|||
163086287|NCT00522379|589024375|FG001|Overall Study|Adverse Event|15|||
163086288|NCT00522379|589024376|FG002|Overall Study|Adverse Event|12|||
163086289|NCT00522379|589024377|FG003|Overall Study|Adverse Event|5|||
163086290|NCT00522379|589024378|FG004|Overall Study|Adverse Event|17|||
163086291|NCT00522379|589024374|FG000|Overall Study|Lack of Efficacy|3|||
163086292|NCT00522379|589024375|FG001|Overall Study|Lack of Efficacy|0|||
163086293|NCT00522379|589024376|FG002|Overall Study|Lack of Efficacy|2|||
163086294|NCT00522379|589024377|FG003|Overall Study|Lack of Efficacy|2|||
163086295|NCT00522379|589024378|FG004|Overall Study|Lack of Efficacy|7|||
163086296|NCT00522379|589024374|FG000|Overall Study|Withdrawal by Subject|2|||
163086297|NCT00522379|589024375|FG001|Overall Study|Withdrawal by Subject|3|||
163086298|NCT00522379|589024376|FG002|Overall Study|Withdrawal by Subject|1|||
163086299|NCT00522379|589024377|FG003|Overall Study|Withdrawal by Subject|2|||
163086300|NCT00522379|589024378|FG004|Overall Study|Withdrawal by Subject|0|||
163086301|NCT00522379|589024374|FG000|Overall Study|Protocol Violation|1|||
163086302|NCT00522379|589024375|FG001|Overall Study|Protocol Violation|1|||
163086303|NCT00522379|589024376|FG002|Overall Study|Protocol Violation|2|||
163086304|NCT00522379|589024377|FG003|Overall Study|Protocol Violation|0|||
163086305|NCT00522379|589024378|FG004|Overall Study|Protocol Violation|0|||
163086306|NCT00522379|589024374|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
163086307|NCT00522379|589024375|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
163086308|NCT00522379|589024376|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
163086309|NCT00522379|589024377|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
163086310|NCT00522379|589024378|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
163086311|NCT00522379|589024374|FG000|Overall Study|Lost to Follow-up|1|||
163086312|NCT00522379|589024375|FG001|Overall Study|Lost to Follow-up|0|||
163086313|NCT00522379|589024376|FG002|Overall Study|Lost to Follow-up|4|||
163086314|NCT00522379|589024377|FG003|Overall Study|Lost to Follow-up|2|||
163086315|NCT00522379|589024378|FG004|Overall Study|Lost to Follow-up|2|||
163086316|NCT00522379|589024374|FG000|Overall Study|Randomization error|0|||
163086317|NCT00522379|589024375|FG001|Overall Study|Randomization error|0|||
163086318|NCT00522379|589024376|FG002|Overall Study|Randomization error|0|||
163086319|NCT00522379|589024377|FG003|Overall Study|Randomization error|0|||
163086320|NCT00522379|589024378|FG004|Overall Study|Randomization error|1|||
163086321|NCT00522379|589024374|FG000|Overall Study|Dispensing error|1|||
163086322|NCT00522379|589024375|FG001|Overall Study|Dispensing error|0|||
163086323|NCT00522379|589024376|FG002|Overall Study|Dispensing error|0|||
163086324|NCT00522379|589024377|FG003|Overall Study|Dispensing error|1|||
163086325|NCT00522379|589024378|FG004|Overall Study|Dispensing error|0|||
162648896|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
162648897|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
162648898|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
162648899|NCT01604343|587433268|FG000|Prior to W52 Administration(Through W52)|Other|15|||
162648900|NCT01604343|587433269|FG001|Prior to W52 Administration(Through W52)|Other|0|||
162648901|NCT01604343|587433270|FG002|Prior to W52 Administration(Through W52)|Other|10|||
163086326|NCT00522379|589024374|FG000|Overall Study|Subject Moved|1|||
163086327|NCT00522379|589024375|FG001|Overall Study|Subject Moved|1|||
163086328|NCT00522379|589024376|FG002|Overall Study|Subject Moved|0|||
163086329|NCT00522379|589024377|FG003|Overall Study|Subject Moved|0|||
163086330|NCT00522379|589024378|FG004|Overall Study|Subject Moved|0|||
163086331|NCT00522379|589024374|FG000|Overall Study|Sponsor Request|0|||
163086332|NCT00522379|589024375|FG001|Overall Study|Sponsor Request|1|||
163086333|NCT00522379|589024376|FG002|Overall Study|Sponsor Request|0|||
163086334|NCT00522379|589024377|FG003|Overall Study|Sponsor Request|0|||
163086335|NCT00522379|589024378|FG004|Overall Study|Sponsor Request|0|||
163086336|NCT00522379|589024374|FG000|Overall Study|Family Problem|0|||
163086337|NCT00522379|589024375|FG001|Overall Study|Family Problem|0|||
163086338|NCT00522379|589024376|FG002|Overall Study|Family Problem|1|||
163086339|NCT00522379|589024377|FG003|Overall Study|Family Problem|0|||
163086340|NCT00522379|589024378|FG004|Overall Study|Family Problem|0|||
163086341|NCT00522379|589024374|FG000|Overall Study|Site Closed|0|||
163086342|NCT00522379|589024375|FG001|Overall Study|Site Closed|0|||
163086343|NCT00522379|589024376|FG002|Overall Study|Site Closed|0|||
163086344|NCT00522379|589024377|FG003|Overall Study|Site Closed|1|||
163086345|NCT00522379|589024378|FG004|Overall Study|Site Closed|0|||
163086346|NCT00522379|589024374|FG000|Overall Study|Subject Withdrawal|0|||
163086347|NCT00522379|589024375|FG001|Overall Study|Subject Withdrawal|0|||
163086348|NCT00522379|589024376|FG002|Overall Study|Subject Withdrawal|0|||
163086349|NCT00522379|589024377|FG003|Overall Study|Subject Withdrawal|1|||
163086350|NCT00522379|589024378|FG004|Overall Study|Subject Withdrawal|0|||
163086351|NCT03213509|589024379|FG000|Overall Study|Did not consent for verbal autopsy|4|||
163086352|NCT03213509|589024380|FG001|Overall Study|Did not consent for verbal autopsy|5|||
163086353|NCT04562090|589024381|FG000|Overall Study|Withdrawal by Subject|3|||
163086354|NCT04562090|589024382|FG001|Overall Study|Withdrawal by Subject|4|||
163086355|NCT04562090|589024381|FG000|Overall Study|Protocol Violation|2|||
163086356|NCT04562090|589024382|FG001|Overall Study|Protocol Violation|0|||
163086357|NCT04562090|589024381|FG000|Overall Study|Lack of Efficacy|0|||
163086358|NCT04562090|589024382|FG001|Overall Study|Lack of Efficacy|1|||
163086359|NCT04562090|589024381|FG000|Overall Study|Adverse Event|1|||
163086360|NCT04562090|589024382|FG001|Overall Study|Adverse Event|4|||
163086361|NCT04562090|589024381|FG000|Overall Study|Miscellaneous|0|||
163086362|NCT04562090|589024382|FG001|Overall Study|Miscellaneous|3|||
163086363|NCT00847730|589024383|FG000|Overall Study|Multiple interruptions in therapy|8|||
163086364|NCT00432965|589024384|FG000|Overall Study|Lost to Follow-up|22|||
163086365|NCT00432965|589024385|FG001|Overall Study|Lost to Follow-up|19|||
163086366|NCT00432965|589024384|FG000|Overall Study|Withdrawal by Subject|13|||
163086367|NCT00432965|589024385|FG001|Overall Study|Withdrawal by Subject|13|||
163086368|NCT00432965|589024384|FG000|Overall Study|Physician Decision|14|||
163086369|NCT00432965|589024385|FG001|Overall Study|Physician Decision|13|||
163086370|NCT00432965|589024384|FG000|Overall Study|Lack of Efficacy|8|||
163086371|NCT00432965|589024385|FG001|Overall Study|Lack of Efficacy|13|||
163086372|NCT00432965|589024384|FG000|Overall Study|Non-compliance|7|||
163086373|NCT00432965|589024385|FG001|Overall Study|Non-compliance|0|||
163086374|NCT00432965|589024384|FG000|Overall Study|Adverse Event|22|||
163086375|NCT00432965|589024385|FG001|Overall Study|Adverse Event|19|||
163086376|NCT00432965|589024384|FG000|Overall Study|Death|3|||
163086377|NCT00432965|589024385|FG001|Overall Study|Death|4|||
163086378|NCT00432965|589024384|FG000|Overall Study|Exclusionary Methods|1|||
163086379|NCT00432965|589024385|FG001|Overall Study|Exclusionary Methods|2|||
163086380|NCT00432965|589024384|FG000|Overall Study|Incomplete Data|4|||
163086381|NCT00432965|589024385|FG001|Overall Study|Incomplete Data|3|||
163086382|NCT01889251|589024386|FG000|Overall Study|Adverse Event|1|||
163086383|NCT01889251|589024387|FG001|Overall Study|Adverse Event|0|||
163086384|NCT01903863|589024388|FG000|Overall Study|Physician Decision|2|||
163086385|NCT01903863|589024389|FG001|Overall Study|Physician Decision|0|||
163086386|NCT01722669|589024396|FG000|Overall Study|Withdrawal by Subject|0|||
163086387|NCT01722669|589024397|FG001|Overall Study|Withdrawal by Subject|0|||
163086388|NCT01722669|589024398|FG002|Overall Study|Withdrawal by Subject|0|||
163086389|NCT01722669|589024399|FG003|Overall Study|Withdrawal by Subject|0|||
163086390|NCT01722669|589024400|FG004|Overall Study|Withdrawal by Subject|0|||
163086391|NCT01722669|589024401|FG005|Overall Study|Withdrawal by Subject|2|||
163086392|NCT01344226|589024402|FG000|Overall Study|Protocol Violation|2|||
163086393|NCT01344226|589024402|FG000|Overall Study|Withdrawal by Subject|3|||
163086394|NCT01344226|589024402|FG000|Overall Study|Lack of Efficacy|3|||
163086395|NCT03909971|589024409|FG000|Overall Study|Participant transition to rollover study|26|||
163086396|NCT03909971|589024410|FG001|Overall Study|Participant transition to rollover study|9|||
163086397|NCT03909971|589024409|FG000|Overall Study|Global Deterioration of Health Status|2|||
163086398|NCT03909971|589024410|FG001|Overall Study|Global Deterioration of Health Status|2|||
163086399|NCT03909971|589024409|FG000|Overall Study|Progressive Disease|28|||
163086400|NCT03909971|589024410|FG001|Overall Study|Progressive Disease|21|||
163086401|NCT03909971|589024409|FG000|Overall Study|Death|6|||
163086402|NCT03909971|589024410|FG001|Overall Study|Death|6|||
163086403|NCT03909971|589024409|FG000|Overall Study|Adverse Event|1|||
163086404|NCT03909971|589024410|FG001|Overall Study|Adverse Event|2|||
163086405|NCT03909971|589024409|FG000|Overall Study|Withdrawal by Subject|2|||
163086406|NCT03909971|589024410|FG001|Overall Study|Withdrawal by Subject|1|||
163086407|NCT03909971|589024409|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
163086408|NCT03909971|589024410|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
163036234|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
163036235|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
163036236|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
163036237|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
163036238|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
163036239|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
163036240|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
163036241|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
163036242|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
163036243|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
163036244|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
163036245|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
163036246|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
163036247|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
163036248|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
163036249|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
163036250|NCT01026818|588837887|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
163036251|NCT01026818|588837888|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
163036252|NCT01026818|588837889|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
163036253|NCT01026818|588837890|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
163036254|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
163036255|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
163036256|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
163036257|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
163036258|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
163036259|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
163036260|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
163036261|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
163036262|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036263|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
163036264|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036265|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
163036266|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
163036267|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
163036268|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
163036269|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
163036270|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
163036271|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
163036272|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
163036273|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
163036274|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036275|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
163036276|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036277|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
163036278|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
163036279|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
163036280|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
163036281|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
163036282|NCT01026818|588837887|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036283|NCT01026818|588837888|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036284|NCT01026818|588837889|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
163036285|NCT01026818|588837890|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
163036286|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036287|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
163036288|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036289|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
163036290|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036291|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
163036292|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036293|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
163036294|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
163036295|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
163036296|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
163036297|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
163036298|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
163036299|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
163086409|NCT03909971|589024409|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
163086410|NCT03909971|589024410|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
163086411|NCT04727151|589024414|FG000|Overall Study|Death|0|||
163086412|NCT04727151|589024415|FG001|Overall Study|Death|0|||
163086413|NCT04727151|589024416|FG002|Overall Study|Death|0|||
163086414|NCT04727151|589024417|FG003|Overall Study|Death|0|||
163086415|NCT04727151|589024418|FG004|Overall Study|Death|3|||
163086416|NCT04727151|589024414|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086417|NCT04727151|589024415|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086418|NCT04727151|589024416|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086419|NCT04727151|589024417|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
163086420|NCT04727151|589024418|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
163086421|NCT01587196|589024419|FG000|Overall Study|Lost to Follow-up|50|||
163086422|NCT01587196|589024419|FG000|Overall Study|Withdrawal by Subject|4|||
163086423|NCT00642759|589024420|FG000|Overall Study|Protocol Violation|1|||
163086424|NCT03612570|589024424|FG000|Overall Study|Lost to Follow-up|1|||
163086425|NCT05318287|589024429|FG000|Overall Study|Lost to Follow-up|8|||
163086426|NCT05185453|589024430|FG000|Overall Study|Lost to Follow-up|13|||
163086427|NCT05185453|589024431|FG001|Overall Study|Lost to Follow-up|3|||
163086428|NCT03537508|589024444|FG000|Overall Study|Adverse Event|2|||
163086429|NCT03537508|589024445|FG001|Overall Study|Adverse Event|1|||
163086430|NCT03537508|589024444|FG000|Overall Study|Protocol Violation|65|||
163086431|NCT03537508|589024445|FG001|Overall Study|Protocol Violation|48|||
163086432|NCT03537508|589024444|FG000|Overall Study|Lost to Follow-up|86|||
163086433|NCT03537508|589024445|FG001|Overall Study|Lost to Follow-up|60|||
163086434|NCT03537508|589024444|FG000|Overall Study|Withdrawal by parent/guardian|263|||
163086435|NCT03537508|589024445|FG001|Overall Study|Withdrawal by parent/guardian|149|||
163086436|NCT03814044|589024453|FG000|Overall Study|Protocol deviation|1|||
163086437|NCT02495883|589024465|FG000|Overall Study|Excessive head motion|1|||
163086438|NCT02495883|589024466|FG001|Overall Study|Excessive head motion|0|||
163086439|NCT00964678|589024470|FG000|Overall Study|Physician Decision|4|||
163086440|NCT03359395|589024471|FG000|First Intervention A / B|Withdrawal by Subject|1|||
163086441|NCT03359395|589024472|FG001|First Intervention A / B|Withdrawal by Subject|0|||
163086442|NCT03359395|589024471|FG000|First Intervention A / B|Lost to Follow-up|2|||
163086443|NCT03359395|589024472|FG001|First Intervention A / B|Lost to Follow-up|3|||
163086444|NCT03359395|589024471|FG000|Second Intervention B/A|Exclusion criteria|0|||
163086445|NCT03359395|589024472|FG001|Second Intervention B/A|Exclusion criteria|1|||
163086446|NCT03359395|589024471|FG000|Second Intervention B/A|Lost to Follow-up|3|||
163086447|NCT03359395|589024472|FG001|Second Intervention B/A|Lost to Follow-up|2|||
163086448|NCT01323192|589025943|FG000|Overall Study|Adverse Event|6|||
163086449|NCT01323192|589025944|FG001|Overall Study|Adverse Event|1|||
163086450|NCT01323192|589025943|FG000|Overall Study|Withdrawal by Subject|3|||
163086451|NCT01323192|589025944|FG001|Overall Study|Withdrawal by Subject|1|||
163086452|NCT01323192|589025943|FG000|Overall Study|Noncompliance with study medication|0|||
163086453|NCT01323192|589025944|FG001|Overall Study|Noncompliance with study medication|3|||
163086454|NCT01323192|589025943|FG000|Overall Study|Nonmedical reasons|0|||
163086455|NCT01323192|589025944|FG001|Overall Study|Nonmedical reasons|1|||
163086456|NCT03552029|589025945|FG000|Overall Study|Death|3|||
163086457|NCT03552029|589025946|FG001|Overall Study|Death|0|||
163086458|NCT03552029|589025945|FG000|Overall Study|Adverse Event|1|||
163086459|NCT03552029|589025946|FG001|Overall Study|Adverse Event|0|||
163086460|NCT03552029|589025945|FG000|Overall Study|Lack of Efficacy|0|||
163086461|NCT03552029|589025946|FG001|Overall Study|Lack of Efficacy|2|||
163086462|NCT03552029|589025945|FG000|Overall Study|Physician Decision|0|||
163086463|NCT03552029|589025946|FG001|Overall Study|Physician Decision|1|||
163086464|NCT03552029|589025945|FG000|Overall Study|Study terminated by Sponsor|0|||
163086465|NCT03552029|589025946|FG001|Overall Study|Study terminated by Sponsor|1|||
163086466|NCT03552029|589025945|FG000|Overall Study|Other|0|||
163086467|NCT03552029|589025946|FG001|Overall Study|Other|2|||
163086468|NCT01168596|589025949|FG000|Overall Study|Withdrawal by Subject|3|||
163086469|NCT01168596|589025950|FG001|Overall Study|Withdrawal by Subject|1|||
163086470|NCT01276704|589025951|FG000|Overall Study|Lost to Follow-up|2|||
163086471|NCT01276704|589025952|FG001|Overall Study|Lost to Follow-up|3|||
163086472|NCT01276704|589025951|FG000|Overall Study|Non-compliant|2|||
163086473|NCT01276704|589025952|FG001|Overall Study|Non-compliant|2|||
163086474|NCT01276704|589025951|FG000|Overall Study|Withdrawal by Subject|7|||
163086475|NCT01276704|589025952|FG001|Overall Study|Withdrawal by Subject|1|||
163086476|NCT01276704|589025951|FG000|Overall Study|Physician Decision|3|||
163086477|NCT01276704|589025952|FG001|Overall Study|Physician Decision|5|||
163086478|NCT00710593|589025953|FG000|Overall Study|Incarceration|1|||
163086479|NCT00710593|589025954|FG001|Overall Study|Incarceration|0|||
163086480|NCT00710593|589025953|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
163086481|NCT00710593|589025954|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
163086482|NCT00710593|589025953|FG000|Overall Study|Lost to Follow-up|3|||
163086483|NCT00710593|589025954|FG001|Overall Study|Lost to Follow-up|1|||
163086484|NCT00710593|589025953|FG000|Overall Study|Moved out of area|1|||
163086485|NCT00710593|589025954|FG001|Overall Study|Moved out of area|0|||
162718381|NCT02525796|587676566|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
162718382|NCT00726999|587676569|FG000|Overall Study|Physician Decision|0|||
162718383|NCT00726999|587676570|FG001|Overall Study|Physician Decision|1|||
162718384|NCT00726999|587676569|FG000|Overall Study|Withdrawal by Subject|2|||
162718385|NCT00726999|587676570|FG001|Overall Study|Withdrawal by Subject|0|||
162718386|NCT00726999|587676569|FG000|Overall Study|Protocol Violation|1|||
162718387|NCT00726999|587676570|FG001|Overall Study|Protocol Violation|0|||
162718388|NCT01198275|587676571|FG000|Overall Study|Adverse Event|2|||
162718389|NCT01198275|587676572|FG001|Overall Study|Adverse Event|3|||
162718390|NCT01198275|587676571|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
162718391|NCT01198275|587676572|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
162718392|NCT00391846|587676573|FG000|Overall Study|Adverse Event|4|||
162718393|NCT00391846|587676574|FG001|Overall Study|Adverse Event|1|||
162718394|NCT00391846|587676573|FG000|Overall Study|Did not meet the required elig. crit|2|||
162718395|NCT00391846|587676574|FG001|Overall Study|Did not meet the required elig. crit|2|||
162718396|NCT00391846|587676573|FG000|Overall Study|Withdrawal by Subject|2|||
162718397|NCT00391846|587676574|FG001|Overall Study|Withdrawal by Subject|3|||
162718398|NCT00391846|587676573|FG000|Overall Study|Developed study specific DC criteria|0|||
162718399|NCT00391846|587676574|FG001|Overall Study|Developed study specific DC criteria|1|||
162718400|NCT02477670|587676578|FG000|Stage 1|Adverse Event|2|||
162718401|NCT02477670|587676579|FG001|Stage 1|Adverse Event|7|||
162718402|NCT02477670|587676580|FG002|Stage 1|Adverse Event|0|||
162718403|NCT02477670|587676581|FG003|Stage 1|Adverse Event|0|||
162718404|NCT02477670|587676582|FG004|Stage 1|Adverse Event|0|||
162718405|NCT02477670|587676583|FG005|Stage 1|Adverse Event|0|||
162718406|NCT02477670|587676584|FG006|Stage 1|Adverse Event|0|||
162718407|NCT02477670|587676578|FG000|Stage 1|Lost to Follow-up|0|||
162718408|NCT02477670|587676579|FG001|Stage 1|Lost to Follow-up|2|||
162718409|NCT02477670|587676580|FG002|Stage 1|Lost to Follow-up|0|||
162718410|NCT02477670|587676581|FG003|Stage 1|Lost to Follow-up|0|||
162718411|NCT02477670|587676582|FG004|Stage 1|Lost to Follow-up|0|||
162718412|NCT02477670|587676583|FG005|Stage 1|Lost to Follow-up|0|||
162718413|NCT02477670|587676584|FG006|Stage 1|Lost to Follow-up|0|||
162718414|NCT02477670|587676578|FG000|Stage 1|Withdrawal by Subject|1|||
162718415|NCT02477670|587676579|FG001|Stage 1|Withdrawal by Subject|2|||
162718416|NCT02477670|587676580|FG002|Stage 1|Withdrawal by Subject|0|||
162718417|NCT02477670|587676581|FG003|Stage 1|Withdrawal by Subject|0|||
162718418|NCT02477670|587676582|FG004|Stage 1|Withdrawal by Subject|0|||
162718419|NCT02477670|587676583|FG005|Stage 1|Withdrawal by Subject|0|||
162718420|NCT02477670|587676584|FG006|Stage 1|Withdrawal by Subject|0|||
163036300|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
163036301|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
163036302|NCT01026818|588837887|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
163036303|NCT01026818|588837888|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
163036304|NCT01026818|588837889|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
163036305|NCT01026818|588837890|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
163036306|NCT01375374|588837891|FG000|Overall Study|Adverse Event|1|||
163036307|NCT01908582|588837892|FG000|Period 2|Physician Decision|1|||
163036308|NCT01908582|588837892|FG000|Period 2|Withdrawal by Subject|1|||
163036309|NCT00424593|588837893|FG000|Acute Double-Blind Period|Adverse Event|16|||
163036310|NCT00424593|588837894|FG001|Acute Double-Blind Period|Adverse Event|7|||
163036311|NCT00424593|588837893|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
163036312|NCT00424593|588837894|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
163036313|NCT00424593|588837893|FG000|Acute Double-Blind Period|Protocol Violation|2|||
163036314|NCT00424593|588837894|FG001|Acute Double-Blind Period|Protocol Violation|2|||
163036315|NCT00424593|588837893|FG000|Acute Double-Blind Period|Physician Decision|1|||
163036316|NCT00424593|588837894|FG001|Acute Double-Blind Period|Physician Decision|2|||
163036317|NCT00424593|588837893|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
163036318|NCT00424593|588837894|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
163036319|NCT00424593|588837893|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
163036320|NCT00424593|588837894|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
163036321|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
162718421|NCT02477670|587676578|FG000|Stage 1|Non-compliance with Study Drug|1|||
162718422|NCT02477670|587676579|FG001|Stage 1|Non-compliance with Study Drug|2|||
162718423|NCT02477670|587676580|FG002|Stage 1|Non-compliance with Study Drug|0|||
162718424|NCT02477670|587676581|FG003|Stage 1|Non-compliance with Study Drug|0|||
162718425|NCT02477670|587676582|FG004|Stage 1|Non-compliance with Study Drug|0|||
162718426|NCT02477670|587676583|FG005|Stage 1|Non-compliance with Study Drug|0|||
162718427|NCT02477670|587676584|FG006|Stage 1|Non-compliance with Study Drug|0|||
162718428|NCT02477670|587676578|FG000|Stage 2|Adverse Event|0|||
162718429|NCT02477670|587676579|FG001|Stage 2|Adverse Event|0|||
162718430|NCT02477670|587676580|FG002|Stage 2|Adverse Event|1|||
162718431|NCT02477670|587676581|FG003|Stage 2|Adverse Event|0|||
162718432|NCT02477670|587676582|FG004|Stage 2|Adverse Event|0|||
162718433|NCT02477670|587676583|FG005|Stage 2|Adverse Event|0|||
163036322|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
163036323|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Adverse Event|18|||
163086486|NCT00710593|589025953|FG000|Overall Study|Failure to adhere or complete study eval|1|||
163086487|NCT00710593|589025954|FG001|Overall Study|Failure to adhere or complete study eval|1|||
163086488|NCT00710593|589025953|FG000|Overall Study|Protocol Violation|1|||
163086489|NCT00710593|589025954|FG001|Overall Study|Protocol Violation|1|||
163086490|NCT00710593|589025953|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
163086491|NCT00710593|589025954|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
163086492|NCT04490278|589025955|FG000|Overall Study|Lost to Follow-up|6|||
163086493|NCT00183248|589025965|FG000|Overall Study|Lost to Follow-up|0|||
163086494|NCT00183248|589025966|FG001|Overall Study|Lost to Follow-up|1|||
163086495|NCT00183248|589025965|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
163086496|NCT00183248|589025966|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
163086497|NCT03801525|589025967|FG000|Overall Study|Adverse Event|17|||
163086498|NCT03801525|589025968|FG001|Overall Study|Adverse Event|1|||
163086499|NCT03801525|589025969|FG002|Overall Study|Adverse Event|0|||
163086500|NCT03801525|589025967|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
163086501|NCT03801525|589025968|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
163086502|NCT03801525|589025969|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
163036324|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Adverse Event|0|||
163036325|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
163036326|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
163036327|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
163036328|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
163036329|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
163036330|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
163036331|NCT00424593|588837893|FG000|Dose-Blind Extension Period|Physician Decision|3|||
163036332|NCT00424593|588837894|FG001|Dose-Blind Extension Period|Physician Decision|0|||
163036333|NCT01066663|588837895|FG000|Overall Study|Adverse Event|0|||
163086503|NCT03801525|589025967|FG000|Overall Study|Death|29|||
163086504|NCT03801525|589025968|FG001|Overall Study|Death|1|||
163086505|NCT03801525|589025969|FG002|Overall Study|Death|4|||
163086506|NCT03801525|589025967|FG000|Overall Study|Disease Progression|6|||
163036334|NCT01066663|588837896|FG001|Overall Study|Adverse Event|0|||
163036335|NCT01066663|588837897|FG002|Overall Study|Adverse Event|1|||
163086507|NCT03801525|589025968|FG001|Overall Study|Disease Progression|0|||
163086508|NCT03801525|589025969|FG002|Overall Study|Disease Progression|1|||
163086509|NCT03801525|589025967|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
163086510|NCT03801525|589025968|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
163086511|NCT03801525|589025969|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
163086512|NCT03801525|589025967|FG000|Overall Study|Investigator Decision|18|||
163086513|NCT03801525|589025968|FG001|Overall Study|Investigator Decision|1|||
163086514|NCT03801525|589025969|FG002|Overall Study|Investigator Decision|0|||
163086515|NCT03801525|589025967|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
163086516|NCT03801525|589025968|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
163086517|NCT03801525|589025969|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
163086518|NCT03801525|589025967|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
163086519|NCT03801525|589025968|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
163086520|NCT03801525|589025969|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
163086521|NCT03801525|589025967|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
163086522|NCT03801525|589025968|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
163086523|NCT03801525|589025969|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
163086524|NCT03801525|589025967|FG000|Overall Study|Withdrawal of Subject Consent|38|||
163086525|NCT03801525|589025968|FG001|Overall Study|Withdrawal of Subject Consent|2|||
163086526|NCT03801525|589025969|FG002|Overall Study|Withdrawal of Subject Consent|1|||
163036336|NCT02232061|588837898|FG000|Overall Study|Administrative problems|1|||
163036337|NCT02232061|588837898|FG000|Overall Study|Withdrawal by Subject|1|||
163036338|NCT03297021|588837899|FG000|Overall Study|Incomplete/illegible data sheet|4|||
163036339|NCT03297021|588837900|FG001|Overall Study|Incomplete/illegible data sheet|2|||
163036340|NCT03297021|588837901|FG002|Overall Study|Incomplete/illegible data sheet|3|||
163036341|NCT03297021|588837899|FG000|Overall Study|Missing Post-Op Data|1|||
163036342|NCT03297021|588837900|FG001|Overall Study|Missing Post-Op Data|2|||
163036343|NCT03297021|588837901|FG002|Overall Study|Missing Post-Op Data|1|||
163036344|NCT02784288|588837902|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
163086527|NCT03801525|589025967|FG000|Overall Study|Reason not Specified|4|||
163086528|NCT03801525|589025968|FG001|Overall Study|Reason not Specified|0|||
163036345|NCT00560703|588837903|FG000|Overall Study|Adverse Event|0|||
163036346|NCT00560703|588837904|FG001|Overall Study|Adverse Event|2|||
163036347|NCT00560703|588837903|FG000|Overall Study|Protocol Violation|0|||
163036348|NCT00560703|588837904|FG001|Overall Study|Protocol Violation|2|||
163036349|NCT00560703|588837903|FG000|Overall Study|Withdrawal by Subject|0|||
163036350|NCT00560703|588837904|FG001|Overall Study|Withdrawal by Subject|1|||
162648902|NCT01604343|587433271|FG003|Prior to W52 Administration(Through W52)|Other|0|||
163086529|NCT03801525|589025969|FG002|Overall Study|Reason not Specified|4|||
163086530|NCT03309202|589025970|FG000|Overall Study|Lost to Follow-up|1|||
163086531|NCT03309202|589025971|FG001|Overall Study|Lost to Follow-up|0|||
163086532|NCT03309202|589025972|FG002|Overall Study|Lost to Follow-up|0|||
163086533|NCT03309202|589025973|FG003|Overall Study|Lost to Follow-up|0|||
163086534|NCT03243084|589025975|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
163086535|NCT03243084|589025976|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
163086536|NCT01500317|589025982|FG000|Overall Study|Withdrawal by Subject|3|||
163086537|NCT01500317|589025983|FG001|Overall Study|Withdrawal by Subject|2|||
163086538|NCT01500317|589025984|FG002|Overall Study|Withdrawal by Subject|0|||
163086539|NCT00335829|589025985|FG000|Overall Study|Withdrawal by Subject|1|||
162648903|NCT01604343|587433272|FG004|Prior to W52 Administration(Through W52)|Other|6|||
162648904|NCT01604343|587433268|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
162648905|NCT01604343|587433269|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
162648906|NCT01604343|587433270|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
162648907|NCT01604343|587433271|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
162648908|NCT01604343|587433272|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
162648909|NCT01604343|587433268|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
162648910|NCT01604343|587433269|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
162648911|NCT01604343|587433270|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
162648912|NCT01604343|587433271|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
162648913|NCT01604343|587433272|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
162648914|NCT01604343|587433268|FG000|Week 52 to Week 104|Adverse Event|0|||
162648915|NCT01604343|587433269|FG001|Week 52 to Week 104|Adverse Event|12|||
162648916|NCT01604343|587433270|FG002|Week 52 to Week 104|Adverse Event|26|||
162648917|NCT01604343|587433271|FG003|Week 52 to Week 104|Adverse Event|21|||
162648918|NCT01604343|587433272|FG004|Week 52 to Week 104|Adverse Event|27|||
162648919|NCT01604343|587433268|FG000|Week 52 to Week 104|Death|0|||
162648920|NCT01604343|587433269|FG001|Week 52 to Week 104|Death|4|||
162648921|NCT01604343|587433270|FG002|Week 52 to Week 104|Death|2|||
162648922|NCT01604343|587433271|FG003|Week 52 to Week 104|Death|5|||
162648923|NCT01604343|587433272|FG004|Week 52 to Week 104|Death|0|||
162648924|NCT01604343|587433268|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
162648925|NCT01604343|587433269|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
162648926|NCT01604343|587433270|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
162648927|NCT01604343|587433271|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
162648928|NCT01604343|587433272|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
162648929|NCT01604343|587433268|FG000|Week 52 to Week 104|Physician Decision|0|||
162648930|NCT01604343|587433269|FG001|Week 52 to Week 104|Physician Decision|1|||
162648931|NCT01604343|587433270|FG002|Week 52 to Week 104|Physician Decision|0|||
162648932|NCT01604343|587433271|FG003|Week 52 to Week 104|Physician Decision|0|||
162648933|NCT01604343|587433272|FG004|Week 52 to Week 104|Physician Decision|2|||
162648934|NCT01604343|587433268|FG000|Week 52 to Week 104|Pregnancy|0|||
162648935|NCT01604343|587433269|FG001|Week 52 to Week 104|Pregnancy|0|||
162648936|NCT01604343|587433270|FG002|Week 52 to Week 104|Pregnancy|1|||
162648937|NCT01604343|587433271|FG003|Week 52 to Week 104|Pregnancy|2|||
162648938|NCT01604343|587433272|FG004|Week 52 to Week 104|Pregnancy|1|||
162648939|NCT01604343|587433268|FG000|Week 52 to Week 104|Other|0|||
162648940|NCT01604343|587433269|FG001|Week 52 to Week 104|Other|11|||
162648941|NCT01604343|587433270|FG002|Week 52 to Week 104|Other|11|||
162648942|NCT01604343|587433271|FG003|Week 52 to Week 104|Other|6|||
162648943|NCT01604343|587433272|FG004|Week 52 to Week 104|Other|3|||
162648944|NCT01604343|587433268|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
162648945|NCT01604343|587433269|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162648946|NCT01604343|587433270|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
162648947|NCT01604343|587433271|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162648948|NCT01604343|587433272|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162648949|NCT01604343|587433268|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
163086540|NCT00335829|589025985|FG000|Overall Study|Lost to Follow-up|1|||
162648950|NCT01604343|587433269|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
162648951|NCT01604343|587433270|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
162648952|NCT01604343|587433271|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
162648953|NCT01604343|587433272|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
162648954|NCT01604343|587433268|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
162648955|NCT01604343|587433269|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
162648956|NCT01604343|587433270|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
162648957|NCT01604343|587433271|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
162648958|NCT01604343|587433272|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
162648959|NCT00436748|587433273|FG000|Overall Study|Ineligibility Determined|1|||
162648960|NCT00436748|587433274|FG001|Overall Study|Ineligibility Determined|1|||
162648961|NCT00436748|587433273|FG000|Overall Study|Adverse Event|0|||
163086541|NCT00335829|589025985|FG000|Overall Study|Adverse Event|1|||
163086542|NCT04562116|589025986|FG000|Overall Study|Lost to Follow-up|1|||
163086543|NCT04562116|589025986|FG000|Overall Study|Withdrawal by Subject|3|||
163086544|NCT01559935|589025987|FG000|Car Phase|Toxicity|4|||
162718434|NCT02477670|587676584|FG006|Stage 2|Adverse Event|0|||
163036351|NCT00560703|588837903|FG000|Overall Study|non-compliance|0|||
163036352|NCT00560703|588837904|FG001|Overall Study|non-compliance|1|||
163036353|NCT02095197|588837905|FG000|Overall Study|Lost to Follow-up|0|||
163036354|NCT02095197|588837906|FG001|Overall Study|Lost to Follow-up|3|||
163036355|NCT04278924|588837908|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
163036356|NCT04278924|588837909|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
163036357|NCT04278924|588837910|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036358|NCT04278924|588837911|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
163036359|NCT04278924|588837912|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036360|NCT04278924|588837913|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036361|NCT04278924|588837914|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
163036362|NCT04278924|588837908|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036363|NCT04278924|588837909|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
163036364|NCT04278924|588837910|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036365|NCT04278924|588837911|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036366|NCT04278924|588837912|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036367|NCT04278924|588837913|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036368|NCT04278924|588837914|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
163036369|NCT04847232|588837915|FG000|Overall Study|Death|123|||
163036370|NCT04847232|588837916|FG001|Overall Study|Death|115|||
163036371|NCT04847232|588837915|FG000|Overall Study|Lost to Follow-up|3|||
163036372|NCT04847232|588837916|FG001|Overall Study|Lost to Follow-up|10|||
163036373|NCT04847232|588837915|FG000|Overall Study|Withdrawal by Subject|73|||
163036374|NCT04847232|588837916|FG001|Overall Study|Withdrawal by Subject|101|||
163036375|NCT04847232|588837915|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
163036376|NCT04847232|588837916|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
163036377|NCT02476916|588837917|FG000|Core Period|Adverse Event|2|||
163036378|NCT02476916|588837918|FG001|Core Period|Adverse Event|2|||
163036379|NCT02476916|588837917|FG000|Core Period|Investigator decision|1|||
163036380|NCT02476916|588837918|FG001|Core Period|Investigator decision|1|||
163036381|NCT02476916|588837917|FG000|Core Period|Withdrawal by Subject|3|||
163036382|NCT02476916|588837918|FG001|Core Period|Withdrawal by Subject|0|||
163036383|NCT02476916|588837917|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
163036384|NCT02476916|588837918|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
163036385|NCT02476916|588837917|FG000|Extension Period|On Treatment|12|||
163036386|NCT02476916|588837918|FG001|Extension Period|On Treatment|17|||
163036387|NCT06010732|588837919|FG000|Crossover Period 1|Protocol Violation|0|||
163036388|NCT06010732|588837920|FG001|Crossover Period 1|Protocol Violation|0|||
163036389|NCT06010732|588837921|FG002|Crossover Period 1|Protocol Violation|1|||
163036390|NCT06010732|588837922|FG003|Crossover Period 1|Protocol Violation|0|||
163036391|NCT06010732|588837923|FG004|Crossover Period 1|Protocol Violation|1|||
163036392|NCT06010732|588837924|FG005|Crossover Period 1|Protocol Violation|0|||
163036393|NCT06010732|588837919|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036394|NCT06010732|588837920|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
163036395|NCT06010732|588837921|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036396|NCT06010732|588837922|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036397|NCT06010732|588837923|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036398|NCT06010732|588837924|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
163036399|NCT06010732|588837919|FG000|Crossover Period 2|Adverse Event|0|||
163036400|NCT06010732|588837920|FG001|Crossover Period 2|Adverse Event|1|||
163036401|NCT06010732|588837921|FG002|Crossover Period 2|Adverse Event|0|||
163036402|NCT06010732|588837922|FG003|Crossover Period 2|Adverse Event|0|||
163036403|NCT06010732|588837923|FG004|Crossover Period 2|Adverse Event|0|||
163036404|NCT06010732|588837924|FG005|Crossover Period 2|Adverse Event|0|||
163036405|NCT06010732|588837919|FG000|Crossover Period 2|broken denture|0|||
163036406|NCT06010732|588837920|FG001|Crossover Period 2|broken denture|0|||
163036407|NCT06010732|588837921|FG002|Crossover Period 2|broken denture|1|||
163036408|NCT06010732|588837922|FG003|Crossover Period 2|broken denture|0|||
163036409|NCT06010732|588837923|FG004|Crossover Period 2|broken denture|0|||
163036410|NCT06010732|588837924|FG005|Crossover Period 2|broken denture|0|||
163036411|NCT00253370|588837926|FG000|Overall Study|Adverse Event|18|||
163036412|NCT00253370|588837926|FG000|Overall Study|Disease progression|13|||
163036413|NCT00253370|588837926|FG000|Overall Study|Death|2|||
163036414|NCT00253370|588837926|FG000|Overall Study|Withdrawal by Subject|6|||
163036415|NCT00253370|588837926|FG000|Overall Study|Non-protocol therapy|1|||
163036416|NCT00253370|588837926|FG000|Overall Study|Physician Decision|1|||
163036417|NCT00253370|588837926|FG000|Overall Study|Protocol Violation|1|||
163036418|NCT00253370|588837926|FG000|Overall Study|Abdominal pain due to disease|1|||
163036419|NCT03699540|588837927|FG000|Overall Study|Lost to Follow-up|1|||
163036420|NCT02697591|588837928|FG000|Overall Study|Lost to Follow-up|0|||
163036421|NCT02697591|588837929|FG001|Overall Study|Lost to Follow-up|0|||
163036422|NCT02697591|588837930|FG002|Overall Study|Lost to Follow-up|0|||
163036423|NCT02697591|588837931|FG003|Overall Study|Lost to Follow-up|0|||
163036424|NCT02697591|588837932|FG004|Overall Study|Lost to Follow-up|0|||
163036425|NCT02697591|588837933|FG005|Overall Study|Lost to Follow-up|1|||
163036426|NCT02697591|588837934|FG006|Overall Study|Lost to Follow-up|1|||
163036427|NCT02697591|588837935|FG007|Overall Study|Lost to Follow-up|0|||
163036428|NCT02697591|588837936|FG008|Overall Study|Lost to Follow-up|0|||
163036429|NCT02697591|588837937|FG009|Overall Study|Lost to Follow-up|1|||
163036430|NCT02697591|588837928|FG000|Overall Study|Withdrawal by Subject|1|||
163036431|NCT02697591|588837929|FG001|Overall Study|Withdrawal by Subject|1|||
163036432|NCT02697591|588837930|FG002|Overall Study|Withdrawal by Subject|2|||
163036433|NCT02697591|588837931|FG003|Overall Study|Withdrawal by Subject|1|||
163036434|NCT02697591|588837932|FG004|Overall Study|Withdrawal by Subject|7|||
163036435|NCT02697591|588837933|FG005|Overall Study|Withdrawal by Subject|6|||
163036436|NCT02697591|588837934|FG006|Overall Study|Withdrawal by Subject|9|||
163036437|NCT02697591|588837935|FG007|Overall Study|Withdrawal by Subject|1|||
163036438|NCT02697591|588837936|FG008|Overall Study|Withdrawal by Subject|6|||
163036439|NCT02697591|588837937|FG009|Overall Study|Withdrawal by Subject|10|||
163036440|NCT02697591|588837928|FG000|Overall Study|Physician Decision|1|||
163036441|NCT02697591|588837929|FG001|Overall Study|Physician Decision|0|||
163036442|NCT02697591|588837930|FG002|Overall Study|Physician Decision|0|||
163036443|NCT02697591|588837931|FG003|Overall Study|Physician Decision|0|||
163036444|NCT02697591|588837932|FG004|Overall Study|Physician Decision|1|||
163036445|NCT02697591|588837933|FG005|Overall Study|Physician Decision|2|||
163036446|NCT02697591|588837934|FG006|Overall Study|Physician Decision|0|||
163036447|NCT02697591|588837935|FG007|Overall Study|Physician Decision|0|||
163036448|NCT02697591|588837936|FG008|Overall Study|Physician Decision|1|||
163036449|NCT02697591|588837937|FG009|Overall Study|Physician Decision|1|||
163036450|NCT02697591|588837928|FG000|Overall Study|Death|2|||
163036451|NCT02697591|588837929|FG001|Overall Study|Death|3|||
163036452|NCT02697591|588837930|FG002|Overall Study|Death|1|||
163036453|NCT02697591|588837931|FG003|Overall Study|Death|1|||
163036454|NCT02697591|588837932|FG004|Overall Study|Death|4|||
163036455|NCT02697591|588837933|FG005|Overall Study|Death|5|||
163036456|NCT02697591|588837934|FG006|Overall Study|Death|3|||
163036457|NCT02697591|588837935|FG007|Overall Study|Death|1|||
163036458|NCT02697591|588837936|FG008|Overall Study|Death|1|||
163036459|NCT02697591|588837937|FG009|Overall Study|Death|5|||
163036460|NCT02697591|588837928|FG000|Overall Study|Reason not Specified|0|||
163036461|NCT02697591|588837929|FG001|Overall Study|Reason not Specified|0|||
163036462|NCT02697591|588837930|FG002|Overall Study|Reason not Specified|0|||
163036463|NCT02697591|588837931|FG003|Overall Study|Reason not Specified|1|||
163036464|NCT02697591|588837932|FG004|Overall Study|Reason not Specified|1|||
163036465|NCT02697591|588837933|FG005|Overall Study|Reason not Specified|2|||
163036466|NCT02697591|588837934|FG006|Overall Study|Reason not Specified|3|||
163036467|NCT02697591|588837935|FG007|Overall Study|Reason not Specified|1|||
163036468|NCT02697591|588837936|FG008|Overall Study|Reason not Specified|1|||
163036469|NCT02697591|588837937|FG009|Overall Study|Reason not Specified|3|||
163036470|NCT00624832|588837938|FG000|Overall Study|Adverse Event|0|||
163036471|NCT00624832|588837939|FG001|Overall Study|Adverse Event|1|||
163036472|NCT00624832|588837940|FG002|Overall Study|Adverse Event|0|||
163036473|NCT00624832|588837941|FG003|Overall Study|Adverse Event|1|||
163036474|NCT00624832|588837938|FG000|Overall Study|Abnormal Laboratory Value|2|||
163036475|NCT00624832|588837939|FG001|Overall Study|Abnormal Laboratory Value|0|||
163036476|NCT00624832|588837940|FG002|Overall Study|Abnormal Laboratory Value|0|||
163036477|NCT00624832|588837941|FG003|Overall Study|Abnormal Laboratory Value|0|||
163036478|NCT01939223|588837942|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
163036479|NCT01939223|588837943|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
163036480|NCT01939223|588837942|FG000|Overall Study|Disease recurrence (radiological)|1|||
163036481|NCT01939223|588837943|FG001|Overall Study|Disease recurrence (radiological)|3|||
163036482|NCT01939223|588837942|FG000|Overall Study|Study stopped by Sponsor|5|||
163036483|NCT01939223|588837943|FG001|Overall Study|Study stopped by Sponsor|7|||
163036484|NCT01939223|588837942|FG000|Overall Study|Withdrawal by Subject|6|||
163036485|NCT01939223|588837943|FG001|Overall Study|Withdrawal by Subject|0|||
163036486|NCT04379700|588837944|FG000|Overall Study|Withdrawal by Subject|10|||
163036487|NCT04379700|588837944|FG000|Overall Study|Screen Fail|4|||
163036488|NCT04379700|588837944|FG000|Overall Study|Lost to Follow-up|3|||
163036489|NCT01464619|588837948|FG000|Overall Study|Lost to Follow-up|3|||
163036490|NCT01464619|588837949|FG001|Overall Study|Lost to Follow-up|4|||
163036491|NCT01048099|588837956|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
163036492|NCT01048099|588837956|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
163036493|NCT01731470|588837958|FG000|Overall Study|Withdrawal by Subject|1|||
163036494|NCT01731470|588837958|FG000|Overall Study|Did not meet study criteria|1|||
163036495|NCT02258334|588837961|FG000|Overall Study|Adverse Event|1|||
163036496|NCT02258334|588837962|FG001|Overall Study|Adverse Event|0|||
163036497|NCT02258334|588837963|FG002|Overall Study|Adverse Event|0|||
163036498|NCT02258334|588837964|FG003|Overall Study|Adverse Event|0|||
163036499|NCT03564795|588837971|FG000|Overall Study|Withdrawal by Subject|3|||
163036500|NCT03564795|588837971|FG000|Overall Study|Lost to Follow-up|6|||
163036501|NCT03564795|588837971|FG000|Overall Study|Physician Decision|2|||
163036502|NCT05079230|588837972|FG000|Overall Study|Study Terminated by Sponsor|101|||
162718435|NCT02477670|587676578|FG000|Stage 2|Antipsychotic Medication Changed|0|||
162718436|NCT02477670|587676579|FG001|Stage 2|Antipsychotic Medication Changed|0|||
162718437|NCT02477670|587676580|FG002|Stage 2|Antipsychotic Medication Changed|1|||
162718438|NCT02477670|587676581|FG003|Stage 2|Antipsychotic Medication Changed|0|||
162718439|NCT02477670|587676582|FG004|Stage 2|Antipsychotic Medication Changed|0|||
162718440|NCT02477670|587676583|FG005|Stage 2|Antipsychotic Medication Changed|0|||
162718441|NCT02477670|587676584|FG006|Stage 2|Antipsychotic Medication Changed|0|||
162718442|NCT02477670|587676578|FG000|Stage 2|Withdrawal by Subject|0|||
162718443|NCT02477670|587676579|FG001|Stage 2|Withdrawal by Subject|0|||
162718444|NCT02477670|587676580|FG002|Stage 2|Withdrawal by Subject|0|||
162718445|NCT02477670|587676581|FG003|Stage 2|Withdrawal by Subject|1|||
162718446|NCT02477670|587676582|FG004|Stage 2|Withdrawal by Subject|0|||
162718447|NCT02477670|587676583|FG005|Stage 2|Withdrawal by Subject|0|||
162718448|NCT02477670|587676584|FG006|Stage 2|Withdrawal by Subject|0|||
162718449|NCT00970307|587676585|FG000|Overall Study|Serious Adverse Event|1|||
162718450|NCT00970307|587676586|FG001|Overall Study|Serious Adverse Event|0|||
162718451|NCT00970307|587676587|FG002|Overall Study|Serious Adverse Event|0|||
162718452|NCT00970307|587676585|FG000|Overall Study|Withdrawal by Subject|2|||
162718453|NCT00970307|587676586|FG001|Overall Study|Withdrawal by Subject|3|||
162718454|NCT00970307|587676587|FG002|Overall Study|Withdrawal by Subject|2|||
162718455|NCT02810080|587676588|FG000|Overall Study|Adverse Event|3|||
162718456|NCT02810080|587676589|FG001|Overall Study|Adverse Event|0|||
162718457|NCT02810080|587676588|FG000|Overall Study|Death|0|||
162718458|NCT02810080|587676589|FG001|Overall Study|Death|2|||
162718459|NCT02810080|587676588|FG000|Overall Study|Physician Decision|4|||
162718460|NCT02810080|587676589|FG001|Overall Study|Physician Decision|0|||
162718461|NCT02810080|587676588|FG000|Overall Study|Withdrawal by Subject|0|||
162718462|NCT02810080|587676589|FG001|Overall Study|Withdrawal by Subject|2|||
162718463|NCT01759264|587676590|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
162718464|NCT01759264|587676590|FG000|Overall Study|Adverse Event|1|||
162718465|NCT01759264|587676590|FG000|Overall Study|Other|2|||
163086545|NCT01559935|589025987|FG000|Car Phase|Death|1|||
163086546|NCT01559935|589025987|FG000|Car Phase|Lack of Efficacy|2|||
163086547|NCT01559935|589025987|FG000|Car Phase|Lost to Follow-up|1|||
163086548|NCT01559935|589025987|FG000|Car Phase|Physician Decision|1|||
163086549|NCT01559935|589025987|FG000|Car Phase|Withdrawal by Subject|2|||
163086550|NCT01559935|589025987|FG000|Car Phase|Per protocol|1|||
163086551|NCT01559935|589025987|FG000|Car Phase|Insurance|1|||
163086552|NCT01559935|589025987|FG000|Car Phase|non-compliance|1|||
163086553|NCT01559935|589025987|FG000|BiRD Phase|Toxicity|1|||
163086554|NCT01559935|589025987|FG000|BiRD Phase|Lack of Efficacy|1|||
163086555|NCT01559935|589025987|FG000|BiRD Phase|Withdrawal by Subject|2|||
163086556|NCT01559935|589025987|FG000|Maintenance Phase|Remains on study|28|||
163086557|NCT01559935|589025987|FG000|Maintenance Phase|Toxicity|1|||
163086558|NCT01559935|589025987|FG000|Maintenance Phase|Lack of Efficacy|18|||
163086559|NCT01559935|589025987|FG000|Maintenance Phase|Withdrawal by Subject|5|||
163086560|NCT01559935|589025987|FG000|Maintenance Phase|Non-compliance|2|||
163086561|NCT03078868|589025989|FG000|Overall Study|Physician Decision|3|||
163086562|NCT00105066|589025993|FG000|Overall Study|Adverse Event|2|||
163086563|NCT00105066|589025994|FG001|Overall Study|Adverse Event|5|||
163086564|NCT01506726|589025999|FG000|Overall Study|Adverse Event|1|||
163086565|NCT01506726|589026000|FG001|Overall Study|Adverse Event|2|||
163086566|NCT02231580|589026007|FG000|Overall Study|Adverse Event|5|||
163086567|NCT02231580|589026008|FG001|Overall Study|Adverse Event|0|||
163086568|NCT04079738|589026010|FG000|Study Treatment|Death|1|||
163086569|NCT04079738|589026011|FG001|Study Treatment|Death|0|||
163086570|NCT04079738|589026012|FG002|Study Treatment|Death|0|||
163086571|NCT04079738|589026013|FG003|Study Treatment|Death|0|||
163086572|NCT04079738|589026010|FG000|Study Treatment|Adverse Event|2|||
163086573|NCT04079738|589026011|FG001|Study Treatment|Adverse Event|0|||
163086574|NCT04079738|589026012|FG002|Study Treatment|Adverse Event|0|||
163086575|NCT04079738|589026013|FG003|Study Treatment|Adverse Event|0|||
163086576|NCT04079738|589026010|FG000|Study Treatment|withdrawal before treatment|1|||
163086577|NCT04079738|589026011|FG001|Study Treatment|withdrawal before treatment|0|||
163086578|NCT04079738|589026012|FG002|Study Treatment|withdrawal before treatment|0|||
163086579|NCT04079738|589026013|FG003|Study Treatment|withdrawal before treatment|0|||
163086580|NCT04079738|589026010|FG000|Study Treatment|symptomatic deterioration|2|||
162718466|NCT01759264|587676590|FG000|Overall Study|Lost to Follow-up|2|||
162718467|NCT01759264|587676590|FG000|Overall Study|Withdrawal by Subject|3|||
162718468|NCT01759264|587676590|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
162718469|NCT05174013|587676595|FG000|Overall Study|Lost to Follow-up|0|||
162718470|NCT05174013|587676596|FG001|Overall Study|Lost to Follow-up|0|||
162718471|NCT05174013|587676597|FG002|Overall Study|Lost to Follow-up|0|||
162718472|NCT05174013|587676598|FG003|Overall Study|Lost to Follow-up|1|||
162718473|NCT05174013|587676599|FG004|Overall Study|Lost to Follow-up|0|||
162718474|NCT05174013|587676600|FG005|Overall Study|Lost to Follow-up|0|||
162718475|NCT05174013|587676595|FG000|Overall Study|Withdrawal by Subject|0|||
163086581|NCT04079738|589026011|FG001|Study Treatment|symptomatic deterioration|0|||
163086582|NCT04079738|589026012|FG002|Study Treatment|symptomatic deterioration|0|||
163086583|NCT04079738|589026013|FG003|Study Treatment|symptomatic deterioration|0|||
163086584|NCT04079738|589026010|FG000|Study Treatment|Disease Progression|1|||
163086585|NCT04079738|589026011|FG001|Study Treatment|Disease Progression|0|||
163086586|NCT04079738|589026012|FG002|Study Treatment|Disease Progression|0|||
163086587|NCT04079738|589026013|FG003|Study Treatment|Disease Progression|0|||
163086588|NCT04079738|589026010|FG000|Study Treatment|withdrawal after treatment|1|||
163086589|NCT04079738|589026011|FG001|Study Treatment|withdrawal after treatment|0|||
163086590|NCT04079738|589026012|FG002|Study Treatment|withdrawal after treatment|0|||
163086591|NCT04079738|589026013|FG003|Study Treatment|withdrawal after treatment|0|||
163086592|NCT04079738|589026010|FG000|Follow up|Withdrawal by Subject|3|||
163086593|NCT04079738|589026011|FG001|Follow up|Withdrawal by Subject|0|||
163086594|NCT04079738|589026012|FG002|Follow up|Withdrawal by Subject|0|||
163086595|NCT04079738|589026013|FG003|Follow up|Withdrawal by Subject|0|||
163086596|NCT04079738|589026010|FG000|Follow up|Death|5|||
163086597|NCT04079738|589026011|FG001|Follow up|Death|0|||
163086598|NCT04079738|589026012|FG002|Follow up|Death|0|||
163086599|NCT04079738|589026013|FG003|Follow up|Death|0|||
163086600|NCT05552859|589026016|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
163086601|NCT05552859|589026017|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
163086602|NCT01380080|589026018|FG000|Overall Study|Death|36|||
163086603|NCT01380080|589026019|FG001|Overall Study|Death|44|||
163086604|NCT01380080|589026018|FG000|Overall Study|Site is closing|28|||
163086605|NCT01380080|589026019|FG001|Overall Study|Site is closing|31|||
163086606|NCT01380080|589026018|FG000|Overall Study|Not able to get to clinic|7|||
163086607|NCT01380080|589026019|FG001|Overall Study|Not able to get to clinic|1|||
163086608|NCT01380080|589026018|FG000|Overall Study|Not willing to adhere to requirements|6|||
163086609|NCT01380080|589026019|FG001|Overall Study|Not willing to adhere to requirements|2|||
163086610|NCT01380080|589026018|FG000|Overall Study|Withdrawal by Subject|5|||
163086611|NCT01380080|589026019|FG001|Overall Study|Withdrawal by Subject|2|||
163086612|NCT01380080|589026018|FG000|Overall Study|Lost to Follow-up|3|||
163086613|NCT01380080|589026019|FG001|Overall Study|Lost to Follow-up|3|||
163086614|NCT02303821|589026022|FG000|Overall Study|Withdrawal by Subject|0|||
163086615|NCT02303821|589026023|FG001|Overall Study|Withdrawal by Subject|0|||
163086616|NCT02303821|589026024|FG002|Overall Study|Withdrawal by Subject|0|||
163086617|NCT02303821|589026025|FG003|Overall Study|Withdrawal by Subject|0|||
163086618|NCT02303821|589026026|FG004|Overall Study|Withdrawal by Subject|0|||
163086619|NCT02303821|589026027|FG005|Overall Study|Withdrawal by Subject|0|||
163086620|NCT02303821|589026028|FG006|Overall Study|Withdrawal by Subject|0|||
163086621|NCT02303821|589026029|FG007|Overall Study|Withdrawal by Subject|2|||
163086622|NCT02303821|589026022|FG000|Overall Study|Death|0|||
163086623|NCT02303821|589026023|FG001|Overall Study|Death|2|||
163086624|NCT02303821|589026024|FG002|Overall Study|Death|0|||
163086625|NCT02303821|589026025|FG003|Overall Study|Death|0|||
163086626|NCT02303821|589026026|FG004|Overall Study|Death|0|||
163086627|NCT02303821|589026027|FG005|Overall Study|Death|3|||
163086628|NCT02303821|589026028|FG006|Overall Study|Death|41|||
163086629|NCT02303821|589026029|FG007|Overall Study|Death|29|||
163086630|NCT02303821|589026022|FG000|Overall Study|Lost to Follow-up|0|||
163086631|NCT02303821|589026023|FG001|Overall Study|Lost to Follow-up|0|||
163086632|NCT02303821|589026024|FG002|Overall Study|Lost to Follow-up|0|||
163086633|NCT02303821|589026025|FG003|Overall Study|Lost to Follow-up|0|||
163086634|NCT02303821|589026026|FG004|Overall Study|Lost to Follow-up|0|||
163086635|NCT02303821|589026027|FG005|Overall Study|Lost to Follow-up|0|||
163086636|NCT02303821|589026028|FG006|Overall Study|Lost to Follow-up|1|||
163086637|NCT02303821|589026029|FG007|Overall Study|Lost to Follow-up|0|||
163086638|NCT02303821|589026022|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086639|NCT02303821|589026023|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086640|NCT02303821|589026024|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086641|NCT02303821|589026025|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086642|NCT02303821|589026026|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
162648962|NCT00436748|587433274|FG001|Overall Study|Adverse Event|2|||
162648963|NCT00436748|587433273|FG000|Overall Study|Consent Withdrawn|1|||
162648964|NCT00436748|587433274|FG001|Overall Study|Consent Withdrawn|4|||
162648965|NCT00436748|587433273|FG000|Overall Study|Administrative Decision|1|||
162648966|NCT00436748|587433274|FG001|Overall Study|Administrative Decision|0|||
162648967|NCT00436748|587433273|FG000|Overall Study|Lost to Follow-up|0|||
162648968|NCT00436748|587433274|FG001|Overall Study|Lost to Follow-up|1|||
163086643|NCT02303821|589026027|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086644|NCT02303821|589026028|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
163086645|NCT02303821|589026029|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
163086646|NCT02303821|589026022|FG000|Overall Study|Decision by sponsor|0|||
163086647|NCT02303821|589026023|FG001|Overall Study|Decision by sponsor|0|||
163086648|NCT02303821|589026024|FG002|Overall Study|Decision by sponsor|0|||
163086649|NCT02303821|589026025|FG003|Overall Study|Decision by sponsor|0|||
163086650|NCT02303821|589026026|FG004|Overall Study|Decision by sponsor|0|||
163086651|NCT02303821|589026027|FG005|Overall Study|Decision by sponsor|1|||
163086652|NCT02303821|589026028|FG006|Overall Study|Decision by sponsor|0|||
163086653|NCT02303821|589026029|FG007|Overall Study|Decision by sponsor|0|||
163086654|NCT02303821|589026022|FG000|Overall Study|Protocol-specified criteria|0|||
163086655|NCT02303821|589026023|FG001|Overall Study|Protocol-specified criteria|1|||
163086656|NCT02303821|589026024|FG002|Overall Study|Protocol-specified criteria|0|||
163086657|NCT02303821|589026025|FG003|Overall Study|Protocol-specified criteria|0|||
163086658|NCT02303821|589026026|FG004|Overall Study|Protocol-specified criteria|0|||
163086659|NCT02303821|589026027|FG005|Overall Study|Protocol-specified criteria|1|||
163086660|NCT02303821|589026028|FG006|Overall Study|Protocol-specified criteria|0|||
163086661|NCT02303821|589026029|FG007|Overall Study|Protocol-specified criteria|0|||
163086662|NCT00210132|589026030|FG000|Overall Study|Protocol Violation|1|||
163086663|NCT00210132|589026031|FG001|Overall Study|Protocol Violation|4|||
163086664|NCT02711202|589026034|FG000|Overall Study|Adverse Event|3|||
163086665|NCT02711202|589026035|FG001|Overall Study|Adverse Event|0|||
163086666|NCT02711202|589026034|FG000|Overall Study|graft loss|1|||
163086667|NCT02711202|589026035|FG001|Overall Study|graft loss|0|||
163086668|NCT02255656|589026043|FG000|Overall Study|Adverse Event|11|||
163086669|NCT02255656|589026043|FG000|Overall Study|Poor compliance to protocol|3|||
163086670|NCT02255656|589026043|FG000|Overall Study|Lost to Follow-up|30|||
163086671|NCT02255656|589026043|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
163086672|NCT02255656|589026043|FG000|Overall Study|Other|126|||
163086673|NCT03734536|589026044|FG000|Overall Study|Withdrew Consent|1|||
163086674|NCT03734536|589026045|FG001|Overall Study|Withdrew Consent|5|||
163086675|NCT03734536|589026044|FG000|Overall Study|Lost to Follow-up|10|||
163086676|NCT03734536|589026045|FG001|Overall Study|Lost to Follow-up|7|||
163086677|NCT03448393|589026046|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086678|NCT03448393|589026047|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086679|NCT03448393|589026048|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
163086680|NCT03448393|589026049|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086681|NCT03448393|589026050|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086682|NCT03448393|589026051|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086683|NCT03448393|589026052|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086684|NCT03448393|589026053|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
163086685|NCT03448393|589026054|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
163086686|NCT03448393|589026046|FG000|Dose Expansion|Not treated - screen failure|0|||
163086687|NCT03448393|589026047|FG001|Dose Expansion|Not treated - screen failure|0|||
163086688|NCT03448393|589026048|FG002|Dose Expansion|Not treated - screen failure|0|||
163086689|NCT03448393|589026049|FG003|Dose Expansion|Not treated - screen failure|0|||
163086690|NCT03448393|589026050|FG004|Dose Expansion|Not treated - screen failure|0|||
163086691|NCT03448393|589026051|FG005|Dose Expansion|Not treated - screen failure|0|||
163086692|NCT03448393|589026052|FG006|Dose Expansion|Not treated - screen failure|0|||
163086693|NCT03448393|589026053|FG007|Dose Expansion|Not treated - screen failure|0|||
163086694|NCT03448393|589026054|FG008|Dose Expansion|Not treated - screen failure|7|||
163086695|NCT04144517|589026068|FG000|Overall Study|Physician Decision|0|||
163086696|NCT04144517|589026069|FG001|Overall Study|Physician Decision|1|||
163086697|NCT04144517|589026068|FG000|Overall Study|Other|2|||
163086698|NCT04144517|589026069|FG001|Overall Study|Other|2|||
163086699|NCT04144517|589026068|FG000|Overall Study|Death|6|||
163086700|NCT04144517|589026069|FG001|Overall Study|Death|3|||
163086701|NCT05929326|589026074|FG000|Overall Study|unqualified sample|2|||
163086702|NCT05929326|589026075|FG001|Overall Study|unqualified sample|3|||
163086703|NCT05929326|589026076|FG002|Overall Study|unqualified sample|7|||
163086704|NCT05212168|589026086|FG000|Overall Study|Lost to Follow-up|0|||
163086705|NCT05212168|589026087|FG001|Overall Study|Lost to Follow-up|3|||
163086706|NCT05212168|589026086|FG000|Overall Study|Study terminated by sponsor|30|||
163086707|NCT05212168|589026087|FG001|Overall Study|Study terminated by sponsor|27|||
163086708|NCT05212168|589026086|FG000|Overall Study|Other|4|||
163086709|NCT05212168|589026087|FG001|Overall Study|Other|7|||
163086710|NCT03941093|589026089|FG000|Overall Study|Protocol Violation|0|||
163086711|NCT03941093|589026090|FG001|Overall Study|Protocol Violation|1|||
163086712|NCT03941093|589026089|FG000|Overall Study|Withdrawal by Subject|9|||
163086713|NCT03941093|589026090|FG001|Overall Study|Withdrawal by Subject|6|||
163086714|NCT02333799|589027829|FG000|Treatment Period|Withdrawal by Subject|1|||
163086715|NCT02333799|589027829|FG000|Treatment Period|Death|6|||
163086716|NCT02333799|589027829|FG000|6 Month Follow Up Period|Physician Decision|1|||
163086717|NCT02333799|589027829|FG000|6 Month Follow Up Period|Death|1|||
163086718|NCT02333799|589027829|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
163086719|NCT02333799|589027829|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
163086720|NCT05847686|589027830|FG000|Overall Study|Withdrawal by Subject|3|||
163086721|NCT05484895|589027831|FG000|Overall Study|Lost to Follow-up|63|||
163086722|NCT05484895|589027832|FG001|Overall Study|Lost to Follow-up|64|||
163086723|NCT04795531|589027834|FG000|Overall Study|Withdrawal by Subject|4|||
163086724|NCT04795531|589027835|FG001|Overall Study|Withdrawal by Subject|4|||
163086725|NCT04795531|589027834|FG000|Overall Study|Lost to Follow-up|0|||
163086726|NCT04795531|589027835|FG001|Overall Study|Lost to Follow-up|1|||
163086727|NCT04795531|589027834|FG000|Overall Study|Physician Decision|0|||
163036503|NCT05079230|588837973|FG001|Overall Study|Study Terminated by Sponsor|102|||
163036504|NCT05079230|588837972|FG000|Overall Study|Death|72|||
163036505|NCT05079230|588837973|FG001|Overall Study|Death|66|||
163036506|NCT05079230|588837972|FG000|Overall Study|Withdrew Consent|16|||
163036507|NCT05079230|588837973|FG001|Overall Study|Withdrew Consent|18|||
163036508|NCT05079230|588837972|FG000|Overall Study|Lost to Follow-up|0|||
163036509|NCT05079230|588837973|FG001|Overall Study|Lost to Follow-up|3|||
163036510|NCT00564395|588837978|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
163036511|NCT00564395|588837979|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
163036512|NCT00564395|588837978|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
163036513|NCT00564395|588837979|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
163036514|NCT02054910|588837981|FG000|Overall Study|Lost to Follow-up|4|||
163036515|NCT02054910|588837982|FG001|Overall Study|Lost to Follow-up|1|||
163036516|NCT00477607|588837987|FG000|Overall Study|Lost to Follow-up|7|||
163036517|NCT00477607|588837988|FG001|Overall Study|Lost to Follow-up|7|||
163036518|NCT00432276|588837989|FG000|Overall Study|Hyperglycemic Rescue|44|||
163036519|NCT00432276|588837990|FG001|Overall Study|Hyperglycemic Rescue|87|||
163036520|NCT00432276|588837989|FG000|Overall Study|Adverse Event|13|||
163036521|NCT00432276|588837990|FG001|Overall Study|Adverse Event|16|||
163036522|NCT00432276|588837989|FG000|Overall Study|Protocol Violation|25|||
163036523|NCT00432276|588837990|FG001|Overall Study|Protocol Violation|20|||
163036524|NCT00432276|588837989|FG000|Overall Study|Lost to Follow-up|6|||
163036525|NCT00432276|588837990|FG001|Overall Study|Lost to Follow-up|2|||
163036526|NCT00432276|588837989|FG000|Overall Study|Withdrawal by Subject|25|||
163036527|NCT00432276|588837990|FG001|Overall Study|Withdrawal by Subject|20|||
163036528|NCT00432276|588837989|FG000|Overall Study|Physician Decision|6|||
163036529|NCT00432276|588837990|FG001|Overall Study|Physician Decision|8|||
163036530|NCT00432276|588837989|FG000|Overall Study|Other|2|||
163036531|NCT00432276|588837990|FG001|Overall Study|Other|3|||
163036532|NCT00594386|588837991|FG000|Overall Study|Major protocol violation|2|||
163036533|NCT00594386|588837991|FG000|Overall Study|Lack of Efficacy|12|||
163036534|NCT00594386|588837991|FG000|Overall Study|Adverse Event|68|||
163036535|NCT00594386|588837991|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
163036536|NCT00594386|588837991|FG000|Overall Study|Subject withdrew consent|35|||
163036537|NCT00594386|588837991|FG000|Overall Study|Study ended per sponsor|115|||
163036538|NCT00594386|588837991|FG000|Overall Study|Lost to Follow-up|6|||
163036539|NCT00594386|588837991|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
163036540|NCT00594386|588837991|FG000|Overall Study|Other: Subject moved to Seattle|1|||
163036541|NCT00594386|588837991|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
163036542|NCT00594386|588837991|FG000|Overall Study|Other: Study terminated per investigator|2|||
163036543|NCT00594386|588837991|FG000|Overall Study|Other: Sponsor closure of study|1|||
163036544|NCT00594386|588837991|FG000|Overall Study|Other: Site terminated participation|1|||
163036545|NCT00594386|588837991|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
163036546|NCT00594386|588837991|FG000|Overall Study|Other: Loss of drivers license|1|||
163036547|NCT01210144|588837995|FG000|Overall Study|Lack of ovarian response|1|||
163036548|NCT01210144|588837996|FG001|Overall Study|Lack of ovarian response|0|||
163036549|NCT01210144|588837995|FG000|Overall Study|No fertilization|1|||
163036550|NCT01210144|588837996|FG001|Overall Study|No fertilization|0|||
163036551|NCT01210144|588837995|FG000|Overall Study|No transfer|1|||
163036552|NCT01210144|588837996|FG001|Overall Study|No transfer|0|||
163036553|NCT00207727|588838001|FG000|Overall Study|Withdrawal by Subject|0|||
163036554|NCT00207727|588838002|FG001|Overall Study|Withdrawal by Subject|0|||
163036555|NCT00207727|588838003|FG002|Overall Study|Withdrawal by Subject|0|||
163036556|NCT00207727|588838004|FG003|Overall Study|Withdrawal by Subject|0|||
163036557|NCT00207727|588838005|FG004|Overall Study|Withdrawal by Subject|1|||
163036558|NCT00207727|588838001|FG000|Overall Study|Lost to Follow-up|0|||
163036559|NCT00207727|588838002|FG001|Overall Study|Lost to Follow-up|1|||
163036560|NCT00207727|588838003|FG002|Overall Study|Lost to Follow-up|0|||
163036561|NCT00207727|588838004|FG003|Overall Study|Lost to Follow-up|0|||
163036562|NCT00207727|588838005|FG004|Overall Study|Lost to Follow-up|0|||
163036563|NCT00207727|588838001|FG000|Overall Study|Other|38|||
163036564|NCT00207727|588838002|FG001|Overall Study|Other|41|||
163036565|NCT00207727|588838003|FG002|Overall Study|Other|41|||
163036566|NCT00207727|588838004|FG003|Overall Study|Other|37|||
163036567|NCT00207727|588838005|FG004|Overall Study|Other|33|||
163036568|NCT03759366|588838006|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
163036569|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
163036570|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
163036571|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
163036572|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
163036573|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
163036574|NCT03759366|588838006|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
163036575|NCT00505661|588838011|FG000|Overall Study|Not Eligible|4|||
163036576|NCT01573754|588838015|FG000|Overall Study|Noncompliance or remission not achieved|3|||
163036577|NCT01573754|588838016|FG001|Overall Study|Noncompliance or remission not achieved|15|||
163086728|NCT04795531|589027835|FG001|Overall Study|Physician Decision|2|||
163086729|NCT04795531|589027834|FG000|Overall Study|Death|2|||
163086730|NCT04795531|589027835|FG001|Overall Study|Death|1|||
163086731|NCT03698279|589027836|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163086732|NCT03698279|589027837|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163086733|NCT03698279|589027838|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163086734|NCT03698279|589027839|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163086735|NCT03698279|589027840|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163086736|NCT03698279|589027841|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163086737|NCT03698279|589027836|FG000|Overall Study|Protocol deviation|1|||
163086738|NCT03698279|589027837|FG001|Overall Study|Protocol deviation|0|||
163086739|NCT03698279|589027838|FG002|Overall Study|Protocol deviation|1|||
163086740|NCT03698279|589027839|FG003|Overall Study|Protocol deviation|0|||
163086741|NCT03698279|589027840|FG004|Overall Study|Protocol deviation|0|||
163086742|NCT03698279|589027841|FG005|Overall Study|Protocol deviation|0|||
163086743|NCT03698279|589027836|FG000|Overall Study|Withdrawal by Subject|0|||
163086744|NCT03698279|589027837|FG001|Overall Study|Withdrawal by Subject|0|||
163086745|NCT03698279|589027838|FG002|Overall Study|Withdrawal by Subject|1|||
163086746|NCT03698279|589027839|FG003|Overall Study|Withdrawal by Subject|0|||
163086747|NCT03698279|589027840|FG004|Overall Study|Withdrawal by Subject|0|||
163086748|NCT03698279|589027841|FG005|Overall Study|Withdrawal by Subject|0|||
163086749|NCT03698279|589027836|FG000|Overall Study|Lost to Follow-up|3|||
163086750|NCT03698279|589027837|FG001|Overall Study|Lost to Follow-up|1|||
163086751|NCT03698279|589027838|FG002|Overall Study|Lost to Follow-up|4|||
163086752|NCT03698279|589027839|FG003|Overall Study|Lost to Follow-up|5|||
163086753|NCT03698279|589027840|FG004|Overall Study|Lost to Follow-up|0|||
163086754|NCT03698279|589027841|FG005|Overall Study|Lost to Follow-up|0|||
163086755|NCT02552225|589027842|FG000|Overall Study|Withdrawal by Subject|1|||
163086756|NCT02552225|589027843|FG001|Overall Study|Withdrawal by Subject|0|||
163086757|NCT03122184|589027844|FG000|Overall Study|Lost to Follow-up|4|||
163086758|NCT03122184|589027845|FG001|Overall Study|Lost to Follow-up|6|||
163086759|NCT03122184|589027844|FG000|Overall Study|Withdrawal by Subject|3|||
163086760|NCT03122184|589027845|FG001|Overall Study|Withdrawal by Subject|0|||
163086761|NCT03122184|589027844|FG000|Overall Study|Terminated due to cognitive problem|1|||
163086762|NCT03122184|589027845|FG001|Overall Study|Terminated due to cognitive problem|0|||
163086763|NCT00633126|589027846|FG000|Overall Study|Did not receive full dose|1|||
163086764|NCT00876447|589027847|FG000|Overall Study|Other miscellaneous reasons|3|||
163086765|NCT00876447|589027848|FG001|Overall Study|Other miscellaneous reasons|8|||
163086766|NCT00876447|589027847|FG000|Overall Study|Site closure|19|||
163086767|NCT00876447|589027848|FG001|Overall Study|Site closure|14|||
163086768|NCT00876447|589027847|FG000|Overall Study|Protocol Violation|9|||
163086769|NCT00876447|589027848|FG001|Overall Study|Protocol Violation|3|||
163086770|NCT00876447|589027847|FG000|Overall Study|Personal reasons|30|||
163086771|NCT00876447|589027848|FG001|Overall Study|Personal reasons|28|||
163086772|NCT00876447|589027847|FG000|Overall Study|Lost to Follow-up|6|||
163086773|NCT00876447|589027848|FG001|Overall Study|Lost to Follow-up|15|||
163086774|NCT00876447|589027847|FG000|Overall Study|Pregnancy|4|||
163086775|NCT00876447|589027848|FG001|Overall Study|Pregnancy|2|||
163086776|NCT00876447|589027847|FG000|Overall Study|Lack of Efficacy|5|||
163086777|NCT00876447|589027848|FG001|Overall Study|Lack of Efficacy|3|||
163086778|NCT00876447|589027847|FG000|Overall Study|Adverse Event|4|||
163086779|NCT00876447|589027848|FG001|Overall Study|Adverse Event|8|||
163086780|NCT00567502|589027849|FG000|Overall Study|Lost to Follow-up|91|||
163086781|NCT00567502|589027850|FG001|Overall Study|Lost to Follow-up|14|||
163086782|NCT00567502|589027851|FG002|Overall Study|Lost to Follow-up|351|||
163086783|NCT00567502|589027852|FG003|Overall Study|Lost to Follow-up|2|||
163086784|NCT00567502|589027849|FG000|Overall Study|Death|65|||
163086785|NCT00567502|589027850|FG001|Overall Study|Death|16|||
163086786|NCT00567502|589027851|FG002|Overall Study|Death|360|||
163086787|NCT00567502|589027852|FG003|Overall Study|Death|5|||
163086788|NCT00567502|589027849|FG000|Overall Study|Other|64|||
163086789|NCT00567502|589027850|FG001|Overall Study|Other|2|||
163086790|NCT00567502|589027851|FG002|Overall Study|Other|134|||
163086791|NCT00567502|589027852|FG003|Overall Study|Other|6|||
163086792|NCT00567502|589027849|FG000|Overall Study|Participant request|12|||
163086793|NCT00567502|589027850|FG001|Overall Study|Participant request|1|||
163086794|NCT00567502|589027851|FG002|Overall Study|Participant request|33|||
163086795|NCT00567502|589027852|FG003|Overall Study|Participant request|1|||
163086796|NCT00567502|589027849|FG000|Overall Study|Sponsor request|9|||
163086797|NCT00567502|589027850|FG001|Overall Study|Sponsor request|0|||
163086798|NCT00567502|589027851|FG002|Overall Study|Sponsor request|30|||
163086799|NCT00567502|589027852|FG003|Overall Study|Sponsor request|1|||
163086800|NCT00567502|589027849|FG000|Overall Study|Never Initiated Treatment|0|||
163086801|NCT00567502|589027850|FG001|Overall Study|Never Initiated Treatment|0|||
163086802|NCT00567502|589027851|FG002|Overall Study|Never Initiated Treatment|0|||
163086803|NCT00567502|589027852|FG003|Overall Study|Never Initiated Treatment|72|||
163086804|NCT02297516|589027853|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
163086805|NCT02297516|589027854|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
163086806|NCT02297516|589027853|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
162718476|NCT05174013|587676596|FG001|Overall Study|Withdrawal by Subject|0|||
162718477|NCT05174013|587676597|FG002|Overall Study|Withdrawal by Subject|1|||
162718478|NCT05174013|587676598|FG003|Overall Study|Withdrawal by Subject|0|||
162718479|NCT05174013|587676599|FG004|Overall Study|Withdrawal by Subject|0|||
162718480|NCT05174013|587676600|FG005|Overall Study|Withdrawal by Subject|0|||
162718481|NCT02034916|587676601|FG000|Overall Study|Death|39|||
162718482|NCT02034916|587676602|FG001|Overall Study|Death|28|||
162718483|NCT02034916|587676601|FG000|Overall Study|Withdrawal by Subject|2|||
162718484|NCT02034916|587676602|FG001|Overall Study|Withdrawal by Subject|1|||
162718485|NCT02034916|587676601|FG000|Overall Study|Lost to Follow-up|4|||
162718486|NCT02034916|587676602|FG001|Overall Study|Lost to Follow-up|1|||
162718487|NCT02034916|587676601|FG000|Overall Study|Study terminated by sponsor|4|||
162718488|NCT02034916|587676602|FG001|Overall Study|Study terminated by sponsor|5|||
162718489|NCT00753012|587676606|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
162718490|NCT00753012|587676607|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
162718491|NCT00753012|587676606|FG000|Overall Study|Adverse Event|2|||
162718492|NCT00753012|587676607|FG001|Overall Study|Adverse Event|0|||
162718493|NCT00753012|587676606|FG000|Overall Study|Withdrawal by Subject|0|||
162718494|NCT00753012|587676607|FG001|Overall Study|Withdrawal by Subject|1|||
162718495|NCT00753012|587676606|FG000|Overall Study|Lost to Follow-up|4|||
162718496|NCT00753012|587676607|FG001|Overall Study|Lost to Follow-up|0|||
162718497|NCT00753012|587676606|FG000|Overall Study|Confounded endpoint data|1|||
162718498|NCT00753012|587676607|FG001|Overall Study|Confounded endpoint data|0|||
162718499|NCT01930045|587676608|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163036578|NCT00463840|588838018|FG000|Overall Study|Disease progression|7|||
163036579|NCT00463840|588838018|FG000|Overall Study|Withdrawal by Subject|2|||
163036580|NCT00463840|588838018|FG000|Overall Study|Adverse Event|3|||
163036581|NCT04228965|588840165|FG000|Overall Study|Lost to Follow-up|26|||
163036582|NCT04228965|588840166|FG001|Overall Study|Lost to Follow-up|11|||
163036583|NCT04228965|588840165|FG000|Overall Study|Withdrawal by Subject|18|||
163036584|NCT04228965|588840166|FG001|Overall Study|Withdrawal by Subject|5|||
163036585|NCT02442206|588840167|FG000|Period 1|Adverse Event|1|||
163036586|NCT02442206|588840168|FG001|Period 1|Adverse Event|1|||
163036587|NCT02442206|588840167|FG000|Period 1|withdrew consent|0|||
163036588|NCT02442206|588840168|FG001|Period 1|withdrew consent|1|||
163036589|NCT02442206|588840167|FG000|Period 1|COPD exacerbation|0|||
163036590|NCT02442206|588840168|FG001|Period 1|COPD exacerbation|1|||
163036591|NCT02442206|588840167|FG000|Period 2|Adverse Event|1|||
163036592|NCT02442206|588840168|FG001|Period 2|Adverse Event|0|||
163036593|NCT01471444|588840169|FG000|Overall Study|Physician Decision|3|||
163036594|NCT01471444|588840170|FG001|Overall Study|Physician Decision|2|||
163036595|NCT01471444|588840169|FG000|Overall Study|Withdrawal by Subject|0|||
163036596|NCT01471444|588840170|FG001|Overall Study|Withdrawal by Subject|1|||
163036597|NCT03915626|588840171|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
163036598|NCT01709409|588840174|FG000|Overall Study|Protocol Violation|1|||
163036599|NCT01709409|588840175|FG001|Overall Study|Protocol Violation|0|||
163036600|NCT04571385|588840176|FG000|Overall Study|Participant non-compliance|1|||
163036601|NCT04571385|588840177|FG001|Overall Study|Participant non-compliance|0|||
163036602|NCT04571385|588840178|FG002|Overall Study|Participant non-compliance|0|||
163036603|NCT04571385|588840176|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
163036604|NCT04571385|588840177|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
163036605|NCT04571385|588840178|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
163036606|NCT04571385|588840176|FG000|Overall Study|Screen failure|0|||
163036607|NCT04571385|588840177|FG001|Overall Study|Screen failure|0|||
163036608|NCT04571385|588840178|FG002|Overall Study|Screen failure|1|||
163036609|NCT01928199|588840181|FG000|Overall Study|Lost to Follow-up|2|||
163036610|NCT01928199|588840182|FG001|Overall Study|Lost to Follow-up|1|||
163036611|NCT01928199|588840181|FG000|Overall Study|Withdrawal by Subject|3|||
163036612|NCT01928199|588840182|FG001|Overall Study|Withdrawal by Subject|5|||
163036613|NCT01641471|588840183|FG000|Overall Study|Withdrawal by Subject|19|||
163036614|NCT01641471|588840184|FG001|Overall Study|Withdrawal by Subject|19|||
163036615|NCT01641471|588840183|FG000|Overall Study|Lost to Follow-up|2|||
163036616|NCT01641471|588840184|FG001|Overall Study|Lost to Follow-up|4|||
163036617|NCT01641471|588840183|FG000|Overall Study|Protocol Violation|2|||
163036618|NCT01641471|588840184|FG001|Overall Study|Protocol Violation|4|||
163036619|NCT03300050|588840187|FG000|Overall Study|Lost to Follow-up|2|||
163036620|NCT03300050|588840188|FG001|Overall Study|Lost to Follow-up|1|||
163036621|NCT03300050|588840189|FG002|Overall Study|Lost to Follow-up|0|||
163036622|NCT03300050|588840190|FG003|Overall Study|Lost to Follow-up|0|||
163036623|NCT03300050|588840191|FG004|Overall Study|Lost to Follow-up|1|||
163036624|NCT03300050|588840187|FG000|Overall Study|Withdrawal by Subject|1|||
163036625|NCT03300050|588840188|FG001|Overall Study|Withdrawal by Subject|1|||
162718500|NCT01930045|587676609|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162718501|NCT01930045|587676610|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162718502|NCT01930045|587676611|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163036626|NCT03300050|588840189|FG002|Overall Study|Withdrawal by Subject|1|||
163036627|NCT03300050|588840190|FG003|Overall Study|Withdrawal by Subject|0|||
163086807|NCT02297516|589027854|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
163086808|NCT02297516|589027853|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
163086809|NCT02297516|589027854|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
163086810|NCT00582907|589027857|FG000|1st Course|Withdrawal by Subject|1|||
163086811|NCT00582907|589027858|FG001|1st Course|Withdrawal by Subject|0|||
163086812|NCT00582907|589027859|FG002|1st Course|Withdrawal by Subject|0|||
163086813|NCT00582907|589027860|FG003|1st Course|Withdrawal by Subject|0|||
163086814|NCT00582907|589027857|FG000|1st Course|Lost to Follow-up|0|||
163086815|NCT00582907|589027858|FG001|1st Course|Lost to Follow-up|0|||
163086816|NCT00582907|589027859|FG002|1st Course|Lost to Follow-up|0|||
163086817|NCT00582907|589027860|FG003|1st Course|Lost to Follow-up|1|||
163086818|NCT00582907|589027857|FG000|2nd Course|Lack of Efficacy|1|||
163086819|NCT00582907|589027858|FG001|2nd Course|Lack of Efficacy|0|||
163086820|NCT00582907|589027859|FG002|2nd Course|Lack of Efficacy|0|||
163086821|NCT00582907|589027860|FG003|2nd Course|Lack of Efficacy|0|||
163086822|NCT02538614|589027861|FG000|Overall Study|Progressive Disease|2|||
163086823|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
163086824|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
163086825|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
163086826|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
163086827|NCT01441960|589027863|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
163086828|NCT01441960|589027864|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
163086829|NCT00189423|589027865|FG000|Overall Study|Death|746|||
163086830|NCT00189423|589027866|FG001|Overall Study|Death|747|||
163086831|NCT00189423|589027865|FG000|Overall Study|Withdrawal by Subject|9|||
163086832|NCT00189423|589027866|FG001|Overall Study|Withdrawal by Subject|9|||
163086833|NCT00189423|589027865|FG000|Overall Study|Lost to Follow-up|10|||
163086834|NCT00189423|589027866|FG001|Overall Study|Lost to Follow-up|10|||
163086835|NCT00415636|589027867|FG000|Overall Study|Symptomatic deterioration|1|||
163086836|NCT00415636|589027868|FG001|Overall Study|Symptomatic deterioration|0|||
163086837|NCT00415636|589027869|FG002|Overall Study|Symptomatic deterioration|1|||
163086838|NCT00415636|589027870|FG003|Overall Study|Symptomatic deterioration|2|||
163086839|NCT00415636|589027871|FG004|Overall Study|Symptomatic deterioration|0|||
163086840|NCT00415636|589027872|FG005|Overall Study|Symptomatic deterioration|1|||
163086841|NCT00415636|589027867|FG000|Overall Study|Adverse Event|0|||
163086842|NCT00415636|589027868|FG001|Overall Study|Adverse Event|0|||
163086843|NCT00415636|589027869|FG002|Overall Study|Adverse Event|0|||
163086844|NCT00415636|589027870|FG003|Overall Study|Adverse Event|1|||
163086845|NCT00415636|589027871|FG004|Overall Study|Adverse Event|1|||
163086846|NCT00415636|589027872|FG005|Overall Study|Adverse Event|0|||
163086847|NCT00415636|589027867|FG000|Overall Study|Withdrawal by Subject|0|||
163086848|NCT00415636|589027868|FG001|Overall Study|Withdrawal by Subject|0|||
163086849|NCT00415636|589027869|FG002|Overall Study|Withdrawal by Subject|0|||
163086850|NCT00415636|589027870|FG003|Overall Study|Withdrawal by Subject|0|||
163086851|NCT00415636|589027871|FG004|Overall Study|Withdrawal by Subject|1|||
163086852|NCT00415636|589027872|FG005|Overall Study|Withdrawal by Subject|0|||
163086853|NCT00415636|589027867|FG000|Overall Study|Disease progression|0|||
163086854|NCT00415636|589027868|FG001|Overall Study|Disease progression|0|||
163086855|NCT00415636|589027869|FG002|Overall Study|Disease progression|0|||
163086856|NCT00415636|589027870|FG003|Overall Study|Disease progression|3|||
163086857|NCT00415636|589027871|FG004|Overall Study|Disease progression|0|||
163086858|NCT00415636|589027872|FG005|Overall Study|Disease progression|1|||
163086859|NCT01263119|589027873|FG000|Period 1|Protocol Violation|2|||
163086860|NCT01263119|589027873|FG000|Period 2|Adverse Event|2|||
163086861|NCT02138825|589027874|FG000|Main Study Treatment|Adverse Event|11|||
163086862|NCT02138825|589027875|FG001|Main Study Treatment|Adverse Event|3|||
163086863|NCT02138825|589027874|FG000|Main Study Treatment|Death|1|||
163086864|NCT02138825|589027875|FG001|Main Study Treatment|Death|2|||
163086865|NCT02138825|589027874|FG000|Main Study Treatment|Protocol Violation|2|||
163086866|NCT02138825|589027875|FG001|Main Study Treatment|Protocol Violation|2|||
163086867|NCT02138825|589027874|FG000|Main Study Treatment|Sponsor decision|12|||
163086868|NCT02138825|589027875|FG001|Main Study Treatment|Sponsor decision|18|||
163086869|NCT02138825|589027874|FG000|Main Study Treatment|Study terminated by sponsor|10|||
163086870|NCT02138825|589027875|FG001|Main Study Treatment|Study terminated by sponsor|9|||
163086871|NCT02138825|589027874|FG000|Main Study Treatment|Withdrawal by Subject|3|||
163086872|NCT02138825|589027875|FG001|Main Study Treatment|Withdrawal by Subject|1|||
163086873|NCT02138825|589027874|FG000|Main Study Treatment|Medical decision|1|||
163086874|NCT02138825|589027875|FG001|Main Study Treatment|Medical decision|0|||
163086875|NCT02138825|589027874|FG000|Long-term Extension|Study termination by sponsor|32|||
163086876|NCT02138825|589027875|FG001|Long-term Extension|Study termination by sponsor|38|||
163086877|NCT02138825|589027874|FG000|Safety Follow-up|Adverse Event|4|||
163086878|NCT02138825|589027875|FG001|Safety Follow-up|Adverse Event|3|||
163086879|NCT02138825|589027874|FG000|Safety Follow-up|Death|11|||
163086880|NCT02138825|589027875|FG001|Safety Follow-up|Death|5|||
163086881|NCT02138825|589027874|FG000|Safety Follow-up|Withdrawal by Subject|5|||
163086882|NCT02138825|589027875|FG001|Safety Follow-up|Withdrawal by Subject|3|||
163086883|NCT02138825|589027874|FG000|Safety Follow-up|clinic worsening|1|||
163086884|NCT02138825|589027875|FG001|Safety Follow-up|clinic worsening|0|||
163086885|NCT02138825|589027874|FG000|Safety Follow-up|withdrawal by PI|1|||
163086886|NCT02138825|589027875|FG001|Safety Follow-up|withdrawal by PI|0|||
163086887|NCT02138825|589027874|FG000|Safety Follow-up|logistical difficulties|0|||
163086888|NCT02138825|589027875|FG001|Safety Follow-up|logistical difficulties|1|||
163086889|NCT02138825|589027874|FG000|Safety Follow-up|progressive disease|0|||
163086890|NCT02138825|589027875|FG001|Safety Follow-up|progressive disease|2|||
163086891|NCT02138825|589027874|FG000|Safety Follow-up|too unwell to attend the visit|0|||
163086892|NCT02138825|589027875|FG001|Safety Follow-up|too unwell to attend the visit|1|||
163086893|NCT02138825|589027874|FG000|Safety Follow-up|treatment unblinded|0|||
163086894|NCT02138825|589027875|FG001|Safety Follow-up|treatment unblinded|1|||
163086895|NCT02138825|589027874|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
163086896|NCT02138825|589027875|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
163086897|NCT01702298|589027881|FG000|Overall Study|Withdrawal by Subject|1|||
163086898|NCT01822925|589027887|FG000|Overall Study|Adverse Event|1|||
163086899|NCT01822925|589027888|FG001|Overall Study|Adverse Event|1|||
163086900|NCT01822925|589027889|FG002|Overall Study|Adverse Event|1|||
163086901|NCT01822925|589027890|FG003|Overall Study|Adverse Event|1|||
163086902|NCT01822925|589027887|FG000|Overall Study|Lost to Follow-up|0|||
163086903|NCT01822925|589027888|FG001|Overall Study|Lost to Follow-up|1|||
163086904|NCT01822925|589027889|FG002|Overall Study|Lost to Follow-up|0|||
163086905|NCT01822925|589027890|FG003|Overall Study|Lost to Follow-up|0|||
163086906|NCT01822925|589027887|FG000|Overall Study|Protocol Violation|1|||
163086907|NCT01822925|589027888|FG001|Overall Study|Protocol Violation|0|||
163086908|NCT01822925|589027889|FG002|Overall Study|Protocol Violation|0|||
163086909|NCT01822925|589027890|FG003|Overall Study|Protocol Violation|1|||
163086910|NCT01822925|589027887|FG000|Overall Study|Withdrawal by Subject|2|||
163086911|NCT01822925|589027888|FG001|Overall Study|Withdrawal by Subject|0|||
163086912|NCT01822925|589027889|FG002|Overall Study|Withdrawal by Subject|2|||
163086913|NCT01822925|589027890|FG003|Overall Study|Withdrawal by Subject|2|||
163086914|NCT01822925|589027887|FG000|Overall Study|Taking prohibited medication|2|||
163086915|NCT01822925|589027888|FG001|Overall Study|Taking prohibited medication|0|||
163086916|NCT01822925|589027889|FG002|Overall Study|Taking prohibited medication|0|||
163086917|NCT01822925|589027890|FG003|Overall Study|Taking prohibited medication|1|||
163086918|NCT03847519|589027893|FG000|Overall Study|Death|5|||
163086919|NCT03847519|589027894|FG001|Overall Study|Death|8|||
163086920|NCT03847519|589027895|FG002|Overall Study|Death|1|||
163086921|NCT03847519|589027893|FG000|Overall Study|Lost to Follow-up|1|||
163086922|NCT03847519|589027894|FG001|Overall Study|Lost to Follow-up|2|||
163086923|NCT03847519|589027895|FG002|Overall Study|Lost to Follow-up|0|||
163086924|NCT03847519|589027893|FG000|Overall Study|Study Terminated by Sponsor|0|||
163086925|NCT03847519|589027894|FG001|Overall Study|Study Terminated by Sponsor|3|||
163086926|NCT03847519|589027895|FG002|Overall Study|Study Terminated by Sponsor|2|||
163086927|NCT02090764|589027896|FG000|Overall Study|Adverse Event|1|||
163086928|NCT02090764|589027897|FG001|Overall Study|Adverse Event|3|||
163086929|NCT02090764|589027896|FG000|Overall Study|Lack of Efficacy|0|||
163086930|NCT02090764|589027897|FG001|Overall Study|Lack of Efficacy|13|||
163086931|NCT02090764|589027896|FG000|Overall Study|Withdrawal by Subject|2|||
163086932|NCT02090764|589027897|FG001|Overall Study|Withdrawal by Subject|1|||
163086933|NCT02090764|589027896|FG000|Overall Study|Intercurrent illness and other|1|||
163086934|NCT02090764|589027897|FG001|Overall Study|Intercurrent illness and other|1|||
163086935|NCT02090764|589027896|FG000|Overall Study|Lost to Follow-up|2|||
163086936|NCT02090764|589027897|FG001|Overall Study|Lost to Follow-up|2|||
163086937|NCT02300233|589027900|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
162648969|NCT00436748|587433273|FG000|Overall Study|Protocol-specified Criteria|5|||
162648970|NCT00436748|587433274|FG001|Overall Study|Protocol-specified Criteria|4|||
162648971|NCT00436748|587433273|FG000|Overall Study|Other|3|||
162648972|NCT00436748|587433274|FG001|Overall Study|Other|0|||
162648973|NCT00850200|587433275|FG000|Overall Study|Physician Decision|2|||
163086938|NCT02300233|589027901|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
162648974|NCT00850200|587433275|FG000|Overall Study|Did not recieve treatment|2|||
163086939|NCT02300233|589027902|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
163086940|NCT02300233|589027900|FG000|Overall Study|Withdrawal by Subject|1|||
163086941|NCT02300233|589027901|FG001|Overall Study|Withdrawal by Subject|0|||
163086942|NCT02300233|589027902|FG002|Overall Study|Withdrawal by Subject|3|||
163086943|NCT02300233|589027900|FG000|Overall Study|Investigator Judgement|0|||
163086944|NCT02300233|589027901|FG001|Overall Study|Investigator Judgement|0|||
163086945|NCT02300233|589027902|FG002|Overall Study|Investigator Judgement|1|||
163086946|NCT02300233|589027900|FG000|Overall Study|Reason Not Specified|0|||
163086947|NCT02300233|589027901|FG001|Overall Study|Reason Not Specified|0|||
163086948|NCT02300233|589027902|FG002|Overall Study|Reason Not Specified|5|||
163086949|NCT00833690|589027903|FG000|Overall Study|Withdrawal by Subject|1|||
163086950|NCT00833690|589027904|FG001|Overall Study|Withdrawal by Subject|0|||
162648975|NCT00850200|587433275|FG000|Overall Study|Withdrawal by Subject|1|||
162648976|NCT02711800|587433276|FG000|Overall Study|Lost to Follow-up|1|||
163086951|NCT00833690|589027905|FG002|Overall Study|Withdrawal by Subject|0|||
163086952|NCT00833690|589027903|FG000|Overall Study|Discontinued study drug|3|||
163086953|NCT00833690|589027904|FG001|Overall Study|Discontinued study drug|2|||
163086954|NCT00833690|589027905|FG002|Overall Study|Discontinued study drug|0|||
163086955|NCT00744861|589027906|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
163086956|NCT00744861|589027907|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
163086957|NCT00744861|589027908|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
163086958|NCT00744861|589027909|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
163086959|NCT00744861|589027906|FG000|Feasibility Stage 1|Pregnancy|0|||
163086960|NCT00744861|589027907|FG001|Feasibility Stage 1|Pregnancy|1|||
163086961|NCT00744861|589027908|FG002|Feasibility Stage 1|Pregnancy|0|||
163086962|NCT00744861|589027909|FG003|Feasibility Stage 1|Pregnancy|0|||
163086963|NCT00744861|589027906|FG000|Pivotal Stage 2|Adverse Event|0|||
163086964|NCT00744861|589027907|FG001|Pivotal Stage 2|Adverse Event|0|||
163086965|NCT00744861|589027908|FG002|Pivotal Stage 2|Adverse Event|6|||
163086966|NCT00744861|589027909|FG003|Pivotal Stage 2|Adverse Event|11|||
163086967|NCT00744861|589027906|FG000|Pivotal Stage 2|Death|0|||
163086968|NCT00744861|589027907|FG001|Pivotal Stage 2|Death|0|||
163086969|NCT00744861|589027908|FG002|Pivotal Stage 2|Death|0|||
163086970|NCT00744861|589027909|FG003|Pivotal Stage 2|Death|1|||
163086971|NCT00744861|589027906|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
163086972|NCT00744861|589027907|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
163086973|NCT00744861|589027908|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
163086974|NCT00744861|589027909|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
163086975|NCT00744861|589027906|FG000|Pivotal Stage 2|Physician Decision|0|||
163086976|NCT00744861|589027907|FG001|Pivotal Stage 2|Physician Decision|0|||
163086977|NCT00744861|589027908|FG002|Pivotal Stage 2|Physician Decision|3|||
163086978|NCT00744861|589027909|FG003|Pivotal Stage 2|Physician Decision|1|||
163086979|NCT00744861|589027906|FG000|Pivotal Stage 2|Protocol Violation|0|||
163086980|NCT00744861|589027907|FG001|Pivotal Stage 2|Protocol Violation|0|||
163086981|NCT00744861|589027908|FG002|Pivotal Stage 2|Protocol Violation|0|||
163086982|NCT00744861|589027909|FG003|Pivotal Stage 2|Protocol Violation|1|||
163086983|NCT00744861|589027906|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
163086984|NCT00744861|589027907|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
163086985|NCT00744861|589027908|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
163086986|NCT00744861|589027909|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
163086987|NCT00744861|589027906|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
163086988|NCT00744861|589027907|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
163086989|NCT00744861|589027908|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
163086990|NCT00744861|589027909|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
163086991|NCT04856527|589027910|FG000|Overall Study|Unable to complete experimental task|2|||
163086992|NCT04856527|589027911|FG001|Overall Study|Unable to complete experimental task|0|||
163086993|NCT03605693|589027914|FG000|Overall Study|Lost to Follow-up|4|||
163086994|NCT03605693|589027915|FG001|Overall Study|Lost to Follow-up|0|||
163086995|NCT03605693|589027914|FG000|Overall Study|Physician Decision|1|||
163086996|NCT03605693|589027915|FG001|Overall Study|Physician Decision|0|||
163086997|NCT04752566|589027916|FG000|Overall Study|Protocol Violation|0|||
163086998|NCT04752566|589027917|FG001|Overall Study|Protocol Violation|1|||
163086999|NCT04752566|589027916|FG000|Overall Study|Death|1|||
163087000|NCT04752566|589027917|FG001|Overall Study|Death|0|||
163087001|NCT04752566|589027916|FG000|Overall Study|Adverse Event|1|||
163087002|NCT04752566|589027917|FG001|Overall Study|Adverse Event|0|||
163087003|NCT04752566|589027916|FG000|Overall Study|Withdrawal by Subject|2|||
163087004|NCT04752566|589027917|FG001|Overall Study|Withdrawal by Subject|0|||
163087005|NCT04752566|589027916|FG000|Overall Study|Physician Decision|1|||
163087006|NCT04752566|589027917|FG001|Overall Study|Physician Decision|1|||
163087007|NCT05134649|589027918|FG000|Overall Study|Lost to Follow-up|12|||
163087008|NCT05134649|589027918|FG000|Overall Study|Withdrawal by Subject|14|||
163087009|NCT05134649|589027918|FG000|Overall Study|Pregnancy|1|||
163087010|NCT05134649|589027918|FG000|Overall Study|Other, not specified|3|||
163087011|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
163087012|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
163087013|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
163087014|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
163087015|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087016|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
163087017|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087018|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
163087019|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
163087020|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
163087021|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
163087022|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
163087023|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
163087024|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
163087025|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
163087026|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
163036628|NCT03300050|588840191|FG004|Overall Study|Withdrawal by Subject|0|||
163087027|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
163087028|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
163087029|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
163087030|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
163087031|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
163087032|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
163087033|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
163087034|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
163087035|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
163087036|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
163087037|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
163087038|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
163087039|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
163087040|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
163087041|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
163087042|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
163087043|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
163087044|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
163087045|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
163087046|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
163087047|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
163087048|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
163087049|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
163087050|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
163087051|NCT04392154|589027921|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087052|NCT04392154|589027922|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
163087053|NCT04392154|589027923|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087054|NCT04392154|589027924|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
163087055|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087056|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087057|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
163087058|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
163087059|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087060|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087061|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
163087062|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
163087063|NCT04392154|589027921|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087064|NCT04392154|589027922|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087065|NCT04392154|589027923|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
163087066|NCT04392154|589027924|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
163087067|NCT02038647|589027926|FG000|Overall Study|Progressive Disease|50|||
163036629|NCT03300050|588840187|FG000|Overall Study|Death|0|||
163036630|NCT03300050|588840188|FG001|Overall Study|Death|0|||
163036631|NCT03300050|588840189|FG002|Overall Study|Death|1|||
163036632|NCT03300050|588840190|FG003|Overall Study|Death|0|||
163036633|NCT03300050|588840191|FG004|Overall Study|Death|0|||
163036634|NCT03300050|588840187|FG000|Overall Study|Not Eligible at Randomization|0|||
163036635|NCT03300050|588840188|FG001|Overall Study|Not Eligible at Randomization|0|||
163036636|NCT03300050|588840189|FG002|Overall Study|Not Eligible at Randomization|1|||
163036637|NCT03300050|588840190|FG003|Overall Study|Not Eligible at Randomization|1|||
163036638|NCT03300050|588840191|FG004|Overall Study|Not Eligible at Randomization|0|||
163036639|NCT02499263|588840192|FG000|Overall Study|Lost to Follow-up|9|||
163036640|NCT02499263|588840192|FG000|Overall Study|Participant's withdrawal of consent|4|||
163036641|NCT02499263|588840192|FG000|Overall Study|Lack of Efficacy|22|||
163036642|NCT02499263|588840192|FG000|Overall Study|investigator's judgment|12|||
163036643|NCT02499263|588840192|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
163036644|NCT02499263|588840192|FG000|Overall Study|Participant's decision|3|||
163036645|NCT02499263|588840192|FG000|Overall Study|Pregnancy|1|||
163036646|NCT01108237|588840193|FG000|Overall Study|No alignment data|2|||
163036647|NCT01108237|588840194|FG001|Overall Study|No alignment data|15|||
163036648|NCT01108237|588840193|FG000|Overall Study|Did not meet criteria for analysis|7|||
163036649|NCT01108237|588840194|FG001|Overall Study|Did not meet criteria for analysis|0|||
163036650|NCT02734862|588840196|FG000|Part A|Death|3|||
163036651|NCT02734862|588840197|FG001|Part A|Death|4|||
163036652|NCT02734862|588840198|FG002|Part A|Death|6|||
163036653|NCT02734862|588840196|FG000|Part A|Lost to Follow-up|2|||
163036654|NCT02734862|588840197|FG001|Part A|Lost to Follow-up|1|||
163036655|NCT02734862|588840198|FG002|Part A|Lost to Follow-up|1|||
163036656|NCT02734862|588840196|FG000|Part A|Withdrawal by Subject|1|||
162648977|NCT02711800|587433276|FG000|Overall Study|Withdrawal by Subject|1|||
163087068|NCT02038647|589027927|FG001|Overall Study|Progressive Disease|59|||
163087069|NCT02038647|589027926|FG000|Overall Study|Adverse Event|18|||
163087070|NCT02038647|589027927|FG001|Overall Study|Adverse Event|10|||
163087071|NCT02038647|589027926|FG000|Overall Study|Symptomatic Deterioration|7|||
163087072|NCT02038647|589027927|FG001|Overall Study|Symptomatic Deterioration|7|||
163087073|NCT02038647|589027926|FG000|Overall Study|Withdrawal by Subject|5|||
163087074|NCT02038647|589027927|FG001|Overall Study|Withdrawal by Subject|2|||
163087075|NCT02038647|589027926|FG000|Overall Study|Not Reported|0|||
163087076|NCT02038647|589027927|FG001|Overall Study|Not Reported|1|||
163087077|NCT02038647|589027926|FG000|Overall Study|Ongoing at Datacut|9|||
163087078|NCT02038647|589027927|FG001|Overall Study|Ongoing at Datacut|10|||
163087079|NCT02757430|589027928|FG000|Overall Study|Physician Decision|6|||
163087080|NCT02757430|589027928|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
163087081|NCT02757430|589027928|FG000|Overall Study|No informed consent|1|||
163087082|NCT02757430|589027928|FG000|Overall Study|No procedure performed|2|||
163087083|NCT01983111|589027931|FG000|Overall Study|Withdrawal by Subject|8|||
163087084|NCT01983111|589027932|FG001|Overall Study|Withdrawal by Subject|6|||
163087085|NCT01983111|589027931|FG000|Overall Study|Adverse Event|4|||
163087086|NCT01983111|589027932|FG001|Overall Study|Adverse Event|0|||
163087087|NCT01983111|589027931|FG000|Overall Study|Protocol Violation|0|||
163087088|NCT01983111|589027932|FG001|Overall Study|Protocol Violation|1|||
163087089|NCT03502200|589027933|FG000|Overall Study|Adverse Event|1|||
163087090|NCT03502200|589027934|FG001|Overall Study|Adverse Event|0|||
163087091|NCT03502200|589027933|FG000|Overall Study|Lost to Follow-up|36|||
163087092|NCT03502200|589027934|FG001|Overall Study|Lost to Follow-up|38|||
163087093|NCT03502200|589027933|FG000|Overall Study|Study Team Decision|1|||
163087094|NCT03502200|589027934|FG001|Overall Study|Study Team Decision|1|||
163087095|NCT03502200|589027933|FG000|Overall Study|Withdrawal by Subject|5|||
163087096|NCT03502200|589027934|FG001|Overall Study|Withdrawal by Subject|7|||
163087097|NCT03502200|589027933|FG000|Overall Study|Death|0|||
163087098|NCT03502200|589027934|FG001|Overall Study|Death|2|||
163087099|NCT00855335|589027935|FG000|Overall Study|Lost to Follow-up|0|||
163087100|NCT00855335|589027936|FG001|Overall Study|Lost to Follow-up|0|||
163087101|NCT00855335|589027937|FG002|Overall Study|Lost to Follow-up|3|||
163087102|NCT00855335|589027938|FG003|Overall Study|Lost to Follow-up|1|||
163087103|NCT00855335|589027939|FG004|Overall Study|Lost to Follow-up|0|||
163087104|NCT00855335|589027935|FG000|Overall Study|Withdrawal by Subject|0|||
163087105|NCT00855335|589027936|FG001|Overall Study|Withdrawal by Subject|0|||
163087106|NCT00855335|589027937|FG002|Overall Study|Withdrawal by Subject|0|||
163087107|NCT00855335|589027938|FG003|Overall Study|Withdrawal by Subject|1|||
163087108|NCT00855335|589027939|FG004|Overall Study|Withdrawal by Subject|0|||
163087109|NCT00855335|589027935|FG000|Overall Study|Adverse Event|2|||
163087110|NCT00855335|589027936|FG001|Overall Study|Adverse Event|0|||
163087111|NCT00855335|589027937|FG002|Overall Study|Adverse Event|0|||
163087112|NCT00855335|589027938|FG003|Overall Study|Adverse Event|0|||
163087113|NCT00855335|589027939|FG004|Overall Study|Adverse Event|0|||
163087114|NCT00855335|589027935|FG000|Overall Study|Physician Decision|1|||
163087115|NCT00855335|589027936|FG001|Overall Study|Physician Decision|1|||
163087116|NCT00855335|589027937|FG002|Overall Study|Physician Decision|0|||
163087117|NCT00855335|589027938|FG003|Overall Study|Physician Decision|0|||
163087118|NCT00855335|589027939|FG004|Overall Study|Physician Decision|0|||
163087119|NCT00855335|589027935|FG000|Overall Study|Other|2|||
163087120|NCT00855335|589027936|FG001|Overall Study|Other|1|||
163087121|NCT00855335|589027937|FG002|Overall Study|Other|2|||
163087122|NCT00855335|589027938|FG003|Overall Study|Other|5|||
163087123|NCT00855335|589027939|FG004|Overall Study|Other|1|||
163087124|NCT03097289|589027941|FG000|Overall Study|Adverse Event|1|||
163087125|NCT03097289|589027941|FG000|Overall Study|Equipment failure|2|||
163087126|NCT03097289|589027941|FG000|Overall Study|Collected platelet product unusable|3|||
163087127|NCT02526290|589027944|FG000|Overall Study|Adverse Event|3|||
162648978|NCT05442554|587433279|FG000|Overall Study|Adverse Event|1|||
162648979|NCT01990495|587433291|FG000|Overall Study|Physician Decision|5|||
163087128|NCT02526290|589027944|FG000|Overall Study|Withdrawal by Subject|4|||
163087129|NCT02526290|589027944|FG000|Overall Study|Physician Decision|1|||
163087130|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
163087131|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
163087132|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
163087133|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
163087134|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
163087135|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
163087136|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
163087137|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
163087138|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
163087139|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
163087140|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
162648980|NCT01990495|587433292|FG001|Overall Study|Physician Decision|4|||
163087141|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087142|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087143|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087144|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087145|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087146|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087147|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
163087148|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087149|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
163087150|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087151|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087152|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087153|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087154|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087155|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
163087156|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087157|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087158|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087159|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
163087160|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087161|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087162|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087163|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087164|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087165|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087166|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
163087167|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
163087168|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
163087169|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
163087170|NCT02082977|589027947|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087171|NCT02082977|589027948|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087172|NCT02082977|589027949|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087173|NCT02082977|589027950|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087174|NCT02082977|589027951|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087175|NCT02082977|589027952|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087176|NCT02082977|589027953|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087177|NCT02082977|589027954|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
163087178|NCT02082977|589027955|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087179|NCT02082977|589027956|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
163087180|NCT00049543|589027957|FG000|Overall Study|still on treatment|2|||
163087181|NCT00049543|589027958|FG001|Overall Study|still on treatment|9|||
163087182|NCT02402647|589027968|FG000|Overall Study|Lost to Follow-up|13|||
163087183|NCT02402647|589027969|FG001|Overall Study|Lost to Follow-up|7|||
163087184|NCT02402647|589027968|FG000|Overall Study|Protocol Violation|1|||
163087185|NCT02402647|589027969|FG001|Overall Study|Protocol Violation|1|||
163087186|NCT02402647|589027968|FG000|Overall Study|scheduled and timed out|2|||
163087187|NCT02402647|589027969|FG001|Overall Study|scheduled and timed out|1|||
163087188|NCT02402647|589027968|FG000|Overall Study|medical illness|2|||
163087189|NCT02402647|589027969|FG001|Overall Study|medical illness|4|||
163087190|NCT02402647|589027968|FG000|Overall Study|Moved|2|||
163036657|NCT02734862|588840197|FG001|Part A|Withdrawal by Subject|1|||
163036658|NCT02734862|588840198|FG002|Part A|Withdrawal by Subject|2|||
163036659|NCT02734862|588840196|FG000|Part A|Physician Decision|2|||
163036660|NCT02734862|588840197|FG001|Part A|Physician Decision|0|||
163036661|NCT02734862|588840198|FG002|Part A|Physician Decision|1|||
163036662|NCT02734862|588840196|FG000|Part A|Adverse Event|2|||
163036663|NCT02734862|588840197|FG001|Part A|Adverse Event|0|||
163036664|NCT02734862|588840198|FG002|Part A|Adverse Event|1|||
163036665|NCT02734862|588840196|FG000|Part A|Noncompliance|1|||
163036666|NCT02734862|588840197|FG001|Part A|Noncompliance|1|||
163036667|NCT02734862|588840198|FG002|Part A|Noncompliance|0|||
163036668|NCT02734862|588840196|FG000|Part A|Other|1|||
163036669|NCT02734862|588840197|FG001|Part A|Other|1|||
162648981|NCT00097721|587433293|FG000|Overall Study|Adverse Event|8|||
163036670|NCT02734862|588840198|FG002|Part A|Other|3|||
163036671|NCT02734862|588840196|FG000|Part B|Death|8|||
163087191|NCT02402647|589027969|FG001|Overall Study|Moved|0|||
163087192|NCT02402647|589027968|FG000|Overall Study|loved one illness|1|||
163087193|NCT02402647|589027969|FG001|Overall Study|loved one illness|0|||
163087194|NCT02402647|589027968|FG000|Overall Study|deceased preexisting condition|2|||
163087195|NCT02402647|589027969|FG001|Overall Study|deceased preexisting condition|0|||
163087196|NCT02402647|589027968|FG000|Overall Study|Other|2|||
162648982|NCT00097721|587433294|FG001|Overall Study|Adverse Event|1|||
163036672|NCT02734862|588840197|FG001|Part B|Death|3|||
163087197|NCT02402647|589027969|FG001|Overall Study|Other|1|||
163036673|NCT02734862|588840198|FG002|Part B|Death|5|||
163036674|NCT02734862|588840196|FG000|Part B|Lost to Follow-up|2|||
163036675|NCT02734862|588840197|FG001|Part B|Lost to Follow-up|2|||
163036676|NCT02734862|588840198|FG002|Part B|Lost to Follow-up|0|||
162648983|NCT00097721|587433293|FG000|Overall Study|Withdrawal by Subject|6|||
163087198|NCT03557502|589027973|FG000|Protocol 2|Withdrawal by Subject|1|||
163087199|NCT03557502|589027974|FG001|Protocol 2|Withdrawal by Subject|1|||
163087200|NCT03557502|589027973|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
163087201|NCT03557502|589027974|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
163087202|NCT00618787|589027978|FG000|Overall Study|Adverse Event|0|||
163087203|NCT00618787|589027979|FG001|Overall Study|Adverse Event|1|||
163087204|NCT00618787|589027978|FG000|Overall Study|Withdrawal by Subject|2|||
163087205|NCT00618787|589027979|FG001|Overall Study|Withdrawal by Subject|1|||
163087206|NCT00618787|589027978|FG000|Overall Study|Lost to Follow-up|1|||
163087207|NCT00618787|589027979|FG001|Overall Study|Lost to Follow-up|0|||
163087208|NCT01994876|589027980|FG000|Test Period 1|Withdrawal by Subject|0|||
163087209|NCT01994876|589027981|FG001|Test Period 1|Withdrawal by Subject|1|||
163087210|NCT01994876|589027980|FG000|Test Period 1|Adverse Event|0|||
163087211|NCT01994876|589027981|FG001|Test Period 1|Adverse Event|1|||
163087212|NCT01994876|589027980|FG000|Test Period 2|Adverse Event|1|||
163087213|NCT01994876|589027981|FG001|Test Period 2|Adverse Event|0|||
163087214|NCT01994876|589027980|FG000|Test Period 2|Protocol Violation|0|||
163087215|NCT01994876|589027981|FG001|Test Period 2|Protocol Violation|1|||
163087216|NCT05819398|589027982|FG000|Overall Study|Withdrawal by Subject|11|||
163087217|NCT05819398|589027983|FG001|Overall Study|Withdrawal by Subject|7|||
163087218|NCT05819398|589027984|FG002|Overall Study|Withdrawal by Subject|6|||
163087219|NCT05819398|589027985|FG003|Overall Study|Withdrawal by Subject|6|||
163087220|NCT05819398|589027982|FG000|Overall Study|Lost to Follow-up|0|||
163087221|NCT05819398|589027983|FG001|Overall Study|Lost to Follow-up|2|||
163087222|NCT05819398|589027984|FG002|Overall Study|Lost to Follow-up|0|||
163087223|NCT05819398|589027985|FG003|Overall Study|Lost to Follow-up|1|||
163087224|NCT05819398|589027982|FG000|Overall Study|Adverse Event|1|||
163087225|NCT05819398|589027983|FG001|Overall Study|Adverse Event|3|||
163087226|NCT05819398|589027984|FG002|Overall Study|Adverse Event|4|||
163087227|NCT05819398|589027985|FG003|Overall Study|Adverse Event|5|||
163087228|NCT05819398|589027982|FG000|Overall Study|Other than listed|0|||
163087229|NCT05819398|589027983|FG001|Overall Study|Other than listed|2|||
163087230|NCT05819398|589027984|FG002|Overall Study|Other than listed|2|||
163087231|NCT05819398|589027985|FG003|Overall Study|Other than listed|0|||
163087232|NCT05819398|589027982|FG000|Overall Study|Lack of Efficacy|0|||
163087233|NCT05819398|589027983|FG001|Overall Study|Lack of Efficacy|1|||
163087234|NCT05819398|589027984|FG002|Overall Study|Lack of Efficacy|0|||
163087235|NCT05819398|589027985|FG003|Overall Study|Lack of Efficacy|0|||
163087236|NCT05819398|589027982|FG000|Overall Study|Study terminated by sponsor|20|||
163087237|NCT05819398|589027983|FG001|Overall Study|Study terminated by sponsor|18|||
163087238|NCT05819398|589027984|FG002|Overall Study|Study terminated by sponsor|20|||
163087239|NCT05819398|589027985|FG003|Overall Study|Study terminated by sponsor|22|||
163087240|NCT02520154|589027986|FG000|Overall Study|Death|1|||
163087241|NCT02520154|589027986|FG000|Overall Study|Withdrawal by Subject|2|||
163087242|NCT02520154|589027986|FG000|Overall Study|Physician Decision|2|||
163087243|NCT06022107|589027987|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
163087244|NCT06022107|589027987|FG000|Overall Study|Dropped out of study for higher level of care|1|||
163087245|NCT06022107|589027987|FG000|Overall Study|Lost to Follow-up|2|||
163087246|NCT03716830|589030275|FG000|Overall Study|Withdrawal by Subject|2|||
163087247|NCT03716830|589030276|FG001|Overall Study|Withdrawal by Subject|2|||
163087248|NCT03716830|589030277|FG002|Overall Study|Withdrawal by Subject|6|||
163087249|NCT03716830|589030278|FG003|Overall Study|Withdrawal by Subject|5|||
163087250|NCT03716830|589030275|FG000|Overall Study|Adverse Event|1|||
163087251|NCT03716830|589030276|FG001|Overall Study|Adverse Event|2|||
163087252|NCT03716830|589030277|FG002|Overall Study|Adverse Event|0|||
163087253|NCT03716830|589030278|FG003|Overall Study|Adverse Event|1|||
163087254|NCT03716830|589030275|FG000|Overall Study|Lost to Follow-up|1|||
163087255|NCT03716830|589030276|FG001|Overall Study|Lost to Follow-up|1|||
163087256|NCT03716830|589030277|FG002|Overall Study|Lost to Follow-up|0|||
163087257|NCT03716830|589030278|FG003|Overall Study|Lost to Follow-up|0|||
163087258|NCT04887831|589030279|FG000|Overall Study|Death|26|||
163087259|NCT04887831|589030280|FG001|Overall Study|Death|26|||
163087260|NCT04887831|589030279|FG000|Overall Study|Lost to Follow-up|0|||
163087261|NCT04887831|589030280|FG001|Overall Study|Lost to Follow-up|1|||
163087262|NCT04887831|589030279|FG000|Overall Study|Withdrawal by Subject|2|||
163087263|NCT04887831|589030280|FG001|Overall Study|Withdrawal by Subject|1|||
163087264|NCT04887831|589030279|FG000|Overall Study|Study Terminated by Sponsor|18|||
163087265|NCT04887831|589030280|FG001|Overall Study|Study Terminated by Sponsor|17|||
163087266|NCT04887831|589030279|FG000|Overall Study|Other|1|||
163087267|NCT04887831|589030280|FG001|Overall Study|Other|0|||
163087268|NCT02276040|589030286|FG000|Overall Study|Physician Decision|15|||
163087269|NCT02835690|589030287|FG000|Overall Study|Death|12|||
163087270|NCT02835690|589030288|FG001|Overall Study|Death|11|||
163087271|NCT02835690|589030289|FG002|Overall Study|Death|13|||
163087272|NCT02835690|589030287|FG000|Overall Study|Transferred to Extension Study|2|||
163087273|NCT02835690|589030288|FG001|Overall Study|Transferred to Extension Study|2|||
163087274|NCT02835690|589030289|FG002|Overall Study|Transferred to Extension Study|1|||
163087275|NCT02835690|589030287|FG000|Overall Study|Did Not Continue on Extension Study|0|||
163087276|NCT02835690|589030288|FG001|Overall Study|Did Not Continue on Extension Study|0|||
163087277|NCT02835690|589030289|FG002|Overall Study|Did Not Continue on Extension Study|1|||
163087278|NCT02835690|589030287|FG000|Overall Study|Not Treated|0|||
163087279|NCT02835690|589030288|FG001|Overall Study|Not Treated|2|||
163087280|NCT02835690|589030289|FG002|Overall Study|Not Treated|0|||
163087281|NCT03728933|589030290|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163087282|NCT03728933|589030291|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163087283|NCT03728933|589030292|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163087284|NCT03728933|589030290|FG000|Overall Study|Withdrawal by Subject|0|||
163087285|NCT03728933|589030291|FG001|Overall Study|Withdrawal by Subject|0|||
163087286|NCT03728933|589030292|FG002|Overall Study|Withdrawal by Subject|1|||
163087287|NCT03728933|589030290|FG000|Overall Study|Lost to Follow-up|0|||
163087288|NCT03728933|589030291|FG001|Overall Study|Lost to Follow-up|1|||
163087289|NCT03728933|589030292|FG002|Overall Study|Lost to Follow-up|0|||
163087290|NCT03728933|589030290|FG000|Overall Study|Adverse Event|1|||
163087291|NCT03728933|589030291|FG001|Overall Study|Adverse Event|0|||
162648984|NCT00097721|587433294|FG001|Overall Study|Withdrawal by Subject|1|||
162648985|NCT00097721|587433293|FG000|Overall Study|Progressive Disease|55|||
162648986|NCT00097721|587433294|FG001|Overall Study|Progressive Disease|27|||
162648987|NCT00097721|587433293|FG000|Overall Study|Physician Decision|1|||
162648988|NCT00097721|587433294|FG001|Overall Study|Physician Decision|3|||
162648989|NCT00097721|587433293|FG000|Overall Study|Reason not given|1|||
162648990|NCT00097721|587433294|FG001|Overall Study|Reason not given|1|||
162648991|NCT00449956|587433295|FG000|Overall Study|Adverse Event|7|||
162648992|NCT00449956|587433296|FG001|Overall Study|Adverse Event|1|||
162648993|NCT00449956|587433297|FG002|Overall Study|Adverse Event|6|||
162648994|NCT00449956|587433295|FG000|Overall Study|Lack of Efficacy|0|||
162648995|NCT00449956|587433296|FG001|Overall Study|Lack of Efficacy|0|||
162648996|NCT00449956|587433297|FG002|Overall Study|Lack of Efficacy|1|||
162648997|NCT00449956|587433295|FG000|Overall Study|Protocol Violation|1|||
162648998|NCT00449956|587433296|FG001|Overall Study|Protocol Violation|1|||
162648999|NCT00449956|587433297|FG002|Overall Study|Protocol Violation|1|||
162649000|NCT00449956|587433295|FG000|Overall Study|Withdrawal by Subject|0|||
162649001|NCT00449956|587433296|FG001|Overall Study|Withdrawal by Subject|1|||
162649002|NCT00449956|587433297|FG002|Overall Study|Withdrawal by Subject|0|||
162649003|NCT00449956|587433295|FG000|Overall Study|Physician Decision|2|||
162649004|NCT00449956|587433296|FG001|Overall Study|Physician Decision|1|||
162649005|NCT00449956|587433297|FG002|Overall Study|Physician Decision|1|||
162649006|NCT02972632|587433307|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162649007|NCT02972632|587433307|FG000|Overall Study|Lost to Follow-up|4|||
162649008|NCT02972632|587433307|FG000|Overall Study|Voluntary Withdrawal|10|||
162649009|NCT02126969|587433308|FG000|Overall Study|Withdrawal by Subject|1|||
162649010|NCT02126969|587433309|FG001|Overall Study|Withdrawal by Subject|2|||
162649011|NCT00354172|587433310|FG000|Overall Study|Did not receive transplant|1|||
162649012|NCT01828034|587433311|FG000|Overall Study|Withdrawal by Subject|0|||
162649013|NCT01828034|587433312|FG001|Overall Study|Withdrawal by Subject|0|||
162649014|NCT01828034|587433313|FG002|Overall Study|Withdrawal by Subject|0|||
162649015|NCT01828034|587433314|FG003|Overall Study|Withdrawal by Subject|1|||
162649016|NCT02023151|587433315|FG000|Overall Study|Lost to Follow-up|4|||
162649017|NCT03450707|587433316|FG000|Overall Study|Outside enrollment window|4|||
162649018|NCT03450707|587433317|FG001|Overall Study|Outside enrollment window|1|||
162649019|NCT03450707|587433316|FG000|Overall Study|Death|1|||
162649020|NCT03450707|587433317|FG001|Overall Study|Death|0|||
162649021|NCT03450707|587433316|FG000|Overall Study|Indication for thiamine|1|||
162649022|NCT03450707|587433317|FG001|Overall Study|Indication for thiamine|1|||
162649023|NCT03450707|587433316|FG000|Overall Study|Evidence of traumatic brain injury|1|||
162649024|NCT03450707|587433317|FG001|Overall Study|Evidence of traumatic brain injury|0|||
162649025|NCT03450707|587433316|FG000|Overall Study|Following commands|0|||
162649026|NCT03450707|587433317|FG001|Overall Study|Following commands|3|||
162649027|NCT03450707|587433316|FG000|Overall Study|Lactate < 3.5|0|||
162649028|NCT03450707|587433317|FG001|Overall Study|Lactate < 3.5|2|||
162649029|NCT03450707|587433316|FG000|Overall Study|Rearrest with ECMO|0|||
162649030|NCT03450707|587433317|FG001|Overall Study|Rearrest with ECMO|1|||
162649031|NCT03450707|587433316|FG000|Overall Study|Indication for thiamine + head CT results|0|||
162649032|NCT03450707|587433317|FG001|Overall Study|Indication for thiamine + head CT results|1|||
163087292|NCT03728933|589030292|FG002|Overall Study|Adverse Event|0|||
163087293|NCT03674281|589030293|FG000|Overall Study|screen failure|2|||
163087294|NCT03674281|589030294|FG001|Overall Study|screen failure|0|||
163087295|NCT03674281|589030295|FG002|Overall Study|screen failure|0|||
162649033|NCT03450707|587433316|FG000|Overall Study|Family/patient goals of care|0|||
162649034|NCT03450707|587433317|FG001|Overall Study|Family/patient goals of care|1|||
162649035|NCT02871375|587433318|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
162649036|NCT02871375|587433319|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
162649037|NCT01988571|587433322|FG000|Overall Study|Death|3|||
162649038|NCT01988571|587433323|FG001|Overall Study|Death|1|||
162649039|NCT01988571|587433322|FG000|Overall Study|Physician Decision|2|||
163087296|NCT03674281|589030293|FG000|Overall Study|Withdrawal by Subject|1|||
163087297|NCT03674281|589030294|FG001|Overall Study|Withdrawal by Subject|3|||
163087298|NCT03674281|589030295|FG002|Overall Study|Withdrawal by Subject|3|||
163087299|NCT04622592|589030301|FG000|Overall Study|Death|0|||
163087300|NCT04622592|589030302|FG001|Overall Study|Death|0|||
163087301|NCT04622592|589030303|FG002|Overall Study|Death|1|||
163087302|NCT04622592|589030304|FG003|Overall Study|Death|0|||
163087303|NCT04622592|589030305|FG004|Overall Study|Death|0|||
163087304|NCT04622592|589030306|FG005|Overall Study|Death|0|||
163087305|NCT04622592|589030307|FG006|Overall Study|Death|0|||
163087306|NCT04622592|589030308|FG007|Overall Study|Death|1|||
163087307|NCT04622592|589030301|FG000|Overall Study|Lost to Follow-up|0|||
163087308|NCT04622592|589030302|FG001|Overall Study|Lost to Follow-up|0|||
163036677|NCT02734862|588840196|FG000|Part B|Withdrawal by Subject|3|||
163036678|NCT02734862|588840197|FG001|Part B|Withdrawal by Subject|1|||
163036679|NCT02734862|588840198|FG002|Part B|Withdrawal by Subject|0|||
163036680|NCT02734862|588840196|FG000|Part B|Other|0|||
163036681|NCT02734862|588840197|FG001|Part B|Other|1|||
163036682|NCT02734862|588840198|FG002|Part B|Other|0|||
163036683|NCT02757625|588840199|FG000|Overall Study|Investigator's discretion|0|||
163036684|NCT02757625|588840200|FG001|Overall Study|Investigator's discretion|0|||
163036685|NCT02757625|588840201|FG002|Overall Study|Investigator's discretion|1|||
163036686|NCT02757625|588840202|FG003|Overall Study|Investigator's discretion|0|||
163036687|NCT02757625|588840199|FG000|Overall Study|Adverse Event|0|||
163036688|NCT02757625|588840200|FG001|Overall Study|Adverse Event|0|||
163036689|NCT02757625|588840201|FG002|Overall Study|Adverse Event|1|||
163036690|NCT02757625|588840202|FG003|Overall Study|Adverse Event|0|||
163036691|NCT00564278|588840203|FG000|Overall Study|Lost to Follow-up|35|||
163036692|NCT00564278|588840204|FG001|Overall Study|Lost to Follow-up|33|||
163036693|NCT00564278|588840203|FG000|Overall Study|Physician Decision|1|||
163036694|NCT00564278|588840204|FG001|Overall Study|Physician Decision|2|||
163036695|NCT00564278|588840203|FG000|Overall Study|Withdrawal by Subject|11|||
163036696|NCT00564278|588840204|FG001|Overall Study|Withdrawal by Subject|7|||
163036697|NCT02779075|588840205|FG000|Overall Study|Withdrawal by Subject|1|||
163036698|NCT02779075|588840206|FG001|Overall Study|Withdrawal by Subject|3|||
163036699|NCT02779075|588840205|FG000|Overall Study|IV lost during 2nd study|1|||
163036700|NCT02779075|588840206|FG001|Overall Study|IV lost during 2nd study|0|||
163036701|NCT00790556|588840207|FG000|Treatment Period 1|Physician Decision|1|||
163036702|NCT00790556|588840208|FG001|Treatment Period 1|Physician Decision|0|||
163036703|NCT00790556|588840207|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163036704|NCT00790556|588840208|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163036705|NCT03077607|588840209|FG000|Period 1 (15 Days)|Adverse Event|1|||
163036706|NCT03077607|588840210|FG001|Period 1 (15 Days)|Adverse Event|0|||
163036707|NCT03077607|588840209|FG000|Period 1 (15 Days)|Death|1|||
163036708|NCT03077607|588840210|FG001|Period 1 (15 Days)|Death|0|||
163036709|NCT03077607|588840209|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
163036710|NCT03077607|588840210|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
163036711|NCT03077607|588840209|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
163036712|NCT03077607|588840210|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
163036713|NCT04401202|588840212|FG000|Overall Study|Lost to Follow-up|2|||
163036714|NCT04401202|588840213|FG001|Overall Study|Lost to Follow-up|2|||
163036715|NCT04401202|588840212|FG000|Overall Study|Adverse Event|0|||
163036716|NCT04401202|588840213|FG001|Overall Study|Adverse Event|1|||
163036717|NCT04401202|588840212|FG000|Overall Study|Hospitalized|4|||
163036718|NCT04401202|588840213|FG001|Overall Study|Hospitalized|1|||
163036719|NCT02714036|588840214|FG000|Overall Study|Adverse Event|9|||
163036720|NCT02714036|588840215|FG001|Overall Study|Adverse Event|2|||
163036721|NCT02714036|588840214|FG000|Overall Study|Withdrawal by Subject|3|||
163036722|NCT02714036|588840215|FG001|Overall Study|Withdrawal by Subject|2|||
163036723|NCT05697627|588840219|FG000|Overall Study|Adverse Event|1|||
163036724|NCT04122625|588840220|FG000|Part A (up to 2.92 Years)|Death|2|||
163036725|NCT04122625|588840221|FG001|Part A (up to 2.92 Years)|Death|4|||
163036726|NCT04122625|588840222|FG002|Part A (up to 2.92 Years)|Death|0|||
163036727|NCT04122625|588840223|FG003|Part A (up to 2.92 Years)|Death|0|||
163036728|NCT04122625|588840224|FG004|Part A (up to 2.92 Years)|Death|0|||
163087309|NCT04622592|589030303|FG002|Overall Study|Lost to Follow-up|0|||
163036729|NCT04122625|588840225|FG005|Part A (up to 2.92 Years)|Death|0|||
163036730|NCT04122625|588840220|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036731|NCT04122625|588840221|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036732|NCT04122625|588840222|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
163036733|NCT04122625|588840223|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
163036734|NCT04122625|588840224|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
163036735|NCT04122625|588840225|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
163036736|NCT04122625|588840220|FG000|Part B (up to 2.33 Years)|Death|0|||
163036737|NCT04122625|588840221|FG001|Part B (up to 2.33 Years)|Death|0|||
163036738|NCT04122625|588840222|FG002|Part B (up to 2.33 Years)|Death|5|||
163087310|NCT04622592|589030304|FG003|Overall Study|Lost to Follow-up|3|||
163087311|NCT04622592|589030305|FG004|Overall Study|Lost to Follow-up|1|||
163087312|NCT04622592|589030306|FG005|Overall Study|Lost to Follow-up|0|||
163087313|NCT04622592|589030307|FG006|Overall Study|Lost to Follow-up|2|||
162649040|NCT01988571|587433323|FG001|Overall Study|Physician Decision|1|||
162649041|NCT01988571|587433322|FG000|Overall Study|Lost to Follow-up|3|||
162649042|NCT01988571|587433323|FG001|Overall Study|Lost to Follow-up|0|||
162649043|NCT01988571|587433322|FG000|Overall Study|Withdrawal by Subject|31|||
162649044|NCT01988571|587433323|FG001|Overall Study|Withdrawal by Subject|33|||
162649045|NCT00004412|587433324|FG000|Randomized Period|Moved to Crossover Period|3|||
162649046|NCT00004412|587433325|FG001|Randomized Period|Moved to Crossover Period|0|||
162649047|NCT00004412|587433326|FG002|Randomized Period|Moved to Crossover Period|0|||
163087314|NCT04622592|589030308|FG007|Overall Study|Lost to Follow-up|2|||
163087315|NCT04622592|589030301|FG000|Overall Study|Physician Decision|0|||
163087316|NCT04622592|589030302|FG001|Overall Study|Physician Decision|0|||
163087317|NCT04622592|589030303|FG002|Overall Study|Physician Decision|0|||
163087318|NCT04622592|589030304|FG003|Overall Study|Physician Decision|0|||
163087319|NCT04622592|589030305|FG004|Overall Study|Physician Decision|1|||
163087320|NCT04622592|589030306|FG005|Overall Study|Physician Decision|0|||
163087321|NCT04622592|589030307|FG006|Overall Study|Physician Decision|0|||
163087322|NCT04622592|589030308|FG007|Overall Study|Physician Decision|0|||
163087323|NCT04622592|589030301|FG000|Overall Study|Withdrawal by Subject|1|||
163087324|NCT04622592|589030302|FG001|Overall Study|Withdrawal by Subject|0|||
163087325|NCT04622592|589030303|FG002|Overall Study|Withdrawal by Subject|2|||
163087326|NCT04622592|589030304|FG003|Overall Study|Withdrawal by Subject|0|||
162649048|NCT00337103|587433327|FG000|Overall Study|Progressive Disease|414|||
162649049|NCT00337103|587433328|FG001|Overall Study|Progressive Disease|410|||
162649050|NCT00337103|587433327|FG000|Overall Study|Adverse Event|45|||
162649051|NCT00337103|587433328|FG001|Overall Study|Adverse Event|59|||
162649052|NCT00337103|587433327|FG000|Overall Study|Subject Choice|34|||
162649053|NCT00337103|587433328|FG001|Overall Study|Subject Choice|27|||
162649054|NCT00337103|587433327|FG000|Overall Study|Clinical Progression|27|||
162649055|NCT00337103|587433328|FG001|Overall Study|Clinical Progression|24|||
162649056|NCT00337103|587433327|FG000|Overall Study|Physician Decision|15|||
162649057|NCT00337103|587433328|FG001|Overall Study|Physician Decision|14|||
162649058|NCT00337103|587433327|FG000|Overall Study|Withdrawal by Subject|8|||
162649059|NCT00337103|587433328|FG001|Overall Study|Withdrawal by Subject|5|||
162649060|NCT00337103|587433327|FG000|Overall Study|Other|5|||
162649061|NCT00337103|587433328|FG001|Overall Study|Other|6|||
162649062|NCT00337103|587433327|FG000|Overall Study|Entry Criteria Not Met|4|||
162649063|NCT00337103|587433328|FG001|Overall Study|Entry Criteria Not Met|1|||
162649064|NCT00337103|587433327|FG000|Overall Study|Lost to Follow-up|1|||
162649065|NCT00337103|587433328|FG001|Overall Study|Lost to Follow-up|2|||
162649066|NCT00337103|587433327|FG000|Overall Study|Death|1|||
162649067|NCT00337103|587433328|FG001|Overall Study|Death|0|||
162649068|NCT00149747|587433343|FG000|Overall Study|Death|1|||
162649069|NCT00149747|587433344|FG001|Overall Study|Death|0|||
162649070|NCT00149747|587433343|FG000|Overall Study|Withdrawal by Subject|3|||
162649071|NCT00149747|587433344|FG001|Overall Study|Withdrawal by Subject|3|||
162649072|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
163087327|NCT04622592|589030305|FG004|Overall Study|Withdrawal by Subject|0|||
163087328|NCT04622592|589030306|FG005|Overall Study|Withdrawal by Subject|0|||
163087329|NCT04622592|589030307|FG006|Overall Study|Withdrawal by Subject|1|||
163087330|NCT04622592|589030308|FG007|Overall Study|Withdrawal by Subject|4|||
163087331|NCT04622592|589030301|FG000|Overall Study|Other than specified above|0|||
163087332|NCT04622592|589030302|FG001|Overall Study|Other than specified above|0|||
163087333|NCT04622592|589030303|FG002|Overall Study|Other than specified above|1|||
163087334|NCT04622592|589030304|FG003|Overall Study|Other than specified above|0|||
163087335|NCT04622592|589030305|FG004|Overall Study|Other than specified above|0|||
163087336|NCT04622592|589030306|FG005|Overall Study|Other than specified above|0|||
163087337|NCT04622592|589030307|FG006|Overall Study|Other than specified above|0|||
163087338|NCT04622592|589030308|FG007|Overall Study|Other than specified above|0|||
163087339|NCT00560508|589030311|FG000|12 Week Double-blind Period|Adverse Event|3|||
163087340|NCT00560508|589030312|FG001|12 Week Double-blind Period|Adverse Event|2|||
163087341|NCT00560508|589030311|FG000|12 Week Double-blind Period|Protocol Violation|1|||
163087342|NCT00560508|589030312|FG001|12 Week Double-blind Period|Protocol Violation|0|||
163087343|NCT00560508|589030311|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
162649073|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
162649074|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
162649075|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
162649076|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
163087344|NCT00560508|589030312|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
163087345|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
163087346|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
163087347|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
163087348|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
162649077|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
162649078|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
163087349|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
162649079|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162649080|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162649081|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162649082|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
162649083|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
162649084|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
162649085|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
162649086|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
162649087|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
162649088|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162649089|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162649090|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162649091|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162649092|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
162649093|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162649094|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
162649095|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162649096|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162649097|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162649098|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
162649099|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162649100|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162649101|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162649102|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
162649103|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
162649104|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
162649105|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
162649106|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
162649107|NCT03373383|587433345|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
162649108|NCT03373383|587433346|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
162649109|NCT03373383|587433347|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
162649110|NCT03373383|587433348|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
162649111|NCT03373383|587433349|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
162649112|NCT03373383|587433345|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
162649113|NCT03373383|587433346|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162649114|NCT03373383|587433347|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162649115|NCT03373383|587433348|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162649116|NCT03373383|587433349|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162649117|NCT02689258|587433350|FG000|Overall Study|Subject Non-Compliance|0|||
162649118|NCT02689258|587433351|FG001|Overall Study|Subject Non-Compliance|1|||
162649119|NCT02689258|587433352|FG002|Overall Study|Subject Non-Compliance|0|||
162649120|NCT02689258|587433353|FG003|Overall Study|Subject Non-Compliance|0|||
162649121|NCT02689258|587433354|FG004|Overall Study|Subject Non-Compliance|0|||
162649122|NCT02689258|587433355|FG005|Overall Study|Subject Non-Compliance|0|||
162649123|NCT02689258|587433356|FG006|Overall Study|Subject Non-Compliance|0|||
162649124|NCT02689258|587433357|FG007|Overall Study|Subject Non-Compliance|0|||
162649125|NCT02689258|587433358|FG008|Overall Study|Subject Non-Compliance|0|||
162649126|NCT02689258|587433359|FG009|Overall Study|Subject Non-Compliance|0|||
162649127|NCT02689258|587433360|FG010|Overall Study|Subject Non-Compliance|0|||
162649128|NCT02689258|587433361|FG011|Overall Study|Subject Non-Compliance|0|||
162649129|NCT02689258|587433350|FG000|Overall Study|Subject Refusal to Continue|0|||
162649130|NCT02689258|587433351|FG001|Overall Study|Subject Refusal to Continue|1|||
163036739|NCT04122625|588840223|FG003|Part B (up to 2.33 Years)|Death|7|||
163036740|NCT04122625|588840224|FG004|Part B (up to 2.33 Years)|Death|6|||
163036741|NCT04122625|588840225|FG005|Part B (up to 2.33 Years)|Death|7|||
163036742|NCT04165135|588840228|FG000|Overall Study|Protocol Violation|10|||
163036743|NCT04165135|588840228|FG000|Overall Study|Participants withdrawal of consent|5|||
163036744|NCT00530790|588840229|FG000|Overall Study|Adverse Event|2|||
163036745|NCT00530790|588840229|FG000|Overall Study|Withdrawal by Subject|2|||
163036746|NCT00530790|588840229|FG000|Overall Study|Physician Decision|1|||
163036747|NCT01618916|588840234|FG000|Overall Study|Adverse Event|1|||
163036748|NCT01618916|588840235|FG001|Overall Study|Adverse Event|0|||
163036749|NCT01618916|588840236|FG002|Overall Study|Adverse Event|0|||
163036750|NCT01618916|588840237|FG003|Overall Study|Adverse Event|0|||
163036751|NCT01618916|588840238|FG004|Overall Study|Adverse Event|0|||
163036752|NCT01618916|588840239|FG005|Overall Study|Adverse Event|0|||
162649131|NCT02689258|587433352|FG002|Overall Study|Subject Refusal to Continue|0|||
162649132|NCT02689258|587433353|FG003|Overall Study|Subject Refusal to Continue|0|||
162649133|NCT02689258|587433354|FG004|Overall Study|Subject Refusal to Continue|0|||
162649134|NCT02689258|587433355|FG005|Overall Study|Subject Refusal to Continue|0|||
163036753|NCT01618916|588840234|FG000|Overall Study|Withdrawal by Subject|0|||
163036754|NCT01618916|588840235|FG001|Overall Study|Withdrawal by Subject|1|||
162718503|NCT01930045|587676612|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162718504|NCT01930045|587676613|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
162718505|NCT01930045|587676608|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
162718506|NCT01930045|587676609|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
162718507|NCT01930045|587676610|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
162718508|NCT01930045|587676611|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
162718509|NCT01930045|587676612|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
162718510|NCT01930045|587676613|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
162718511|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
162718512|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
162718513|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
162718514|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
162718515|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
162718516|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
162718517|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
162718518|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
162718519|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
162718520|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
162718521|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
162718522|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
162718523|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
162718524|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
162718525|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
162718526|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
162718527|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
162718528|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
162718529|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
162718530|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
162718531|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
162718532|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
162718533|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
162718534|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
162718535|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162718536|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162718537|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
162718538|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162718539|NCT00241644|587676614|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
162718540|NCT00241644|587676615|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
162718541|NCT00241644|587676616|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
162718542|NCT00241644|587676617|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
162718543|NCT00241644|587676614|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
162718544|NCT00241644|587676615|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
162718545|NCT00241644|587676616|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
162718546|NCT00241644|587676617|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
162718547|NCT00241644|587676614|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162718548|NCT00241644|587676615|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
162718549|NCT00241644|587676616|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162718550|NCT00241644|587676617|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
162718551|NCT00241644|587676614|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
162718552|NCT00241644|587676615|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
162718553|NCT00241644|587676616|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
162718554|NCT00241644|587676617|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
162718555|NCT00241644|587676614|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
163087350|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
163087351|NCT00560508|589030311|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
163087352|NCT00560508|589030312|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
162718556|NCT00241644|587676615|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
163087353|NCT02448381|589030315|FG000|Overall Study|Adverse Event|2|||
163087354|NCT02448381|589030316|FG001|Overall Study|Adverse Event|0|||
163087355|NCT02448381|589030315|FG000|Overall Study|Lost to Follow-up|16|||
163087356|NCT02448381|589030316|FG001|Overall Study|Lost to Follow-up|9|||
163087357|NCT02448381|589030315|FG000|Overall Study|Physician Decision|1|||
163087358|NCT02448381|589030316|FG001|Overall Study|Physician Decision|1|||
163087359|NCT02448381|589030315|FG000|Overall Study|Pregnancy|1|||
163087360|NCT02448381|589030316|FG001|Overall Study|Pregnancy|0|||
163087361|NCT02448381|589030315|FG000|Overall Study|Withdrawal by Subject|13|||
163087362|NCT02448381|589030316|FG001|Overall Study|Withdrawal by Subject|9|||
163087363|NCT02448381|589030315|FG000|Overall Study|Noncompliance with Study Procedures|2|||
163087364|NCT02448381|589030316|FG001|Overall Study|Noncompliance with Study Procedures|0|||
162718557|NCT00241644|587676616|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
162718558|NCT00241644|587676617|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
162718559|NCT00241644|587676614|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
162718560|NCT00241644|587676615|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
162718561|NCT00241644|587676616|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
162718562|NCT00241644|587676617|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
162718563|NCT01370694|587676621|FG000|Overall Study|Switched to rituximab|4|||
162718564|NCT01370694|587676621|FG000|Overall Study|Progressive disease|2|||
162718565|NCT04842604|587676625|FG000|Overall Study|Death|1|||
162718566|NCT04842604|587676626|FG001|Overall Study|Death|0|||
162718567|NCT04842604|587676625|FG000|Overall Study|Other|4|||
162718568|NCT04842604|587676626|FG001|Overall Study|Other|4|||
162718569|NCT04842604|587676625|FG000|Overall Study|Randomized but not treated|1|||
162718570|NCT04842604|587676626|FG001|Overall Study|Randomized but not treated|0|||
162718571|NCT01193153|587676627|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
162718572|NCT01193153|587676628|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
162718573|NCT01193153|587676627|FG000|Open-label Lead in Period|Pregnancy|1|||
162718574|NCT01193153|587676628|FG001|Open-label Lead in Period|Pregnancy|0|||
162718575|NCT01193153|587676627|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
162718576|NCT01193153|587676628|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
162718577|NCT01193153|587676627|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
162718578|NCT01193153|587676628|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
162718579|NCT01193153|587676627|FG000|Open-label Lead in Period|Other|14|||
163087365|NCT04617860|589030319|FG000|Overall Study|Adverse Event|0|||
163087366|NCT04617860|589030320|FG001|Overall Study|Adverse Event|2|||
163087367|NCT04617860|589030321|FG002|Overall Study|Adverse Event|2|||
163087368|NCT04617860|589030319|FG000|Overall Study|Withdrawal by Subject|0|||
163087369|NCT04617860|589030320|FG001|Overall Study|Withdrawal by Subject|0|||
163087370|NCT04617860|589030321|FG002|Overall Study|Withdrawal by Subject|2|||
163087371|NCT04617860|589030319|FG000|Overall Study|Physician Decision|0|||
163087372|NCT04617860|589030320|FG001|Overall Study|Physician Decision|1|||
163087373|NCT04617860|589030321|FG002|Overall Study|Physician Decision|0|||
163087374|NCT04617860|589030319|FG000|Overall Study|Sponsor Decision|0|||
163087375|NCT04617860|589030320|FG001|Overall Study|Sponsor Decision|3|||
163087376|NCT04617860|589030321|FG002|Overall Study|Sponsor Decision|1|||
163087377|NCT04617860|589030319|FG000|Overall Study|Termination of Study by Sponsor|8|||
163087378|NCT04617860|589030320|FG001|Overall Study|Termination of Study by Sponsor|4|||
163087379|NCT04617860|589030321|FG002|Overall Study|Termination of Study by Sponsor|13|||
163087380|NCT02735200|589030326|FG000|Overall Study|Lost to Follow-up|0|||
163087381|NCT02735200|589030327|FG001|Overall Study|Lost to Follow-up|5|||
163087382|NCT02735200|589030326|FG000|Overall Study|Withdrawal by Subject|8|||
163087383|NCT02735200|589030327|FG001|Overall Study|Withdrawal by Subject|0|||
163087384|NCT02115321|589030331|FG000|Overall Study|Death|1|||
163087385|NCT02115321|589030332|FG001|Overall Study|Death|0|||
163087386|NCT04403919|589030333|FG000|Overall Study|Lost to Follow-up|0|||
163087387|NCT04403919|589030334|FG001|Overall Study|Lost to Follow-up|0|||
163087388|NCT04403919|589030335|FG002|Overall Study|Lost to Follow-up|0|||
163087389|NCT04403919|589030336|FG003|Overall Study|Lost to Follow-up|1|||
163087390|NCT00023595|589030339|FG000|5 Year Follow up|Lost to Follow-up|2|||
163087391|NCT00023595|589030340|FG001|5 Year Follow up|Lost to Follow-up|2|||
163087392|NCT00023595|589030341|FG002|5 Year Follow up|Lost to Follow-up|1|||
163087393|NCT00023595|589030342|FG003|5 Year Follow up|Lost to Follow-up|7|||
163087394|NCT00023595|589030343|FG004|5 Year Follow up|Lost to Follow-up|3|||
163087395|NCT00023595|589030339|FG000|10 Year Follow up|Lost to Follow-up|12|||
163087396|NCT00023595|589030340|FG001|10 Year Follow up|Lost to Follow-up|10|||
163087397|NCT00023595|589030341|FG002|10 Year Follow up|Lost to Follow-up|3|||
163087398|NCT00023595|589030342|FG003|10 Year Follow up|Lost to Follow-up|0|||
163087399|NCT00023595|589030343|FG004|10 Year Follow up|Lost to Follow-up|0|||
163087400|NCT02106832|589030346|FG000|Overall Study|Adverse Event|1|||
163087401|NCT02106832|589030347|FG001|Overall Study|Adverse Event|2|||
163087402|NCT02106832|589030348|FG002|Overall Study|Adverse Event|3|||
163087403|NCT02106832|589030349|FG003|Overall Study|Adverse Event|0|||
162718580|NCT01193153|587676628|FG001|Open-label Lead in Period|Other|0|||
162718581|NCT01193153|587676627|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
163087404|NCT02106832|589030346|FG000|Overall Study|Death|4|||
163087405|NCT02106832|589030347|FG001|Overall Study|Death|4|||
163087406|NCT02106832|589030348|FG002|Overall Study|Death|1|||
163087407|NCT02106832|589030349|FG003|Overall Study|Death|4|||
163087408|NCT02106832|589030346|FG000|Overall Study|Deterioration of general conditions|0|||
163087409|NCT02106832|589030347|FG001|Overall Study|Deterioration of general conditions|0|||
162718582|NCT01193153|587676628|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
163087410|NCT02106832|589030348|FG002|Overall Study|Deterioration of general conditions|1|||
163087411|NCT02106832|589030349|FG003|Overall Study|Deterioration of general conditions|0|||
163087412|NCT02106832|589030346|FG000|Overall Study|Lost to Follow-up|0|||
163087413|NCT02106832|589030347|FG001|Overall Study|Lost to Follow-up|1|||
163087414|NCT02106832|589030348|FG002|Overall Study|Lost to Follow-up|1|||
163087415|NCT02106832|589030349|FG003|Overall Study|Lost to Follow-up|3|||
163087416|NCT02106832|589030346|FG000|Overall Study|Physician Decision|1|||
163087417|NCT02106832|589030347|FG001|Overall Study|Physician Decision|0|||
163087418|NCT02106832|589030348|FG002|Overall Study|Physician Decision|0|||
163087419|NCT02106832|589030349|FG003|Overall Study|Physician Decision|0|||
163087420|NCT02106832|589030346|FG000|Overall Study|Protocol Violation|0|||
163087421|NCT02106832|589030347|FG001|Overall Study|Protocol Violation|0|||
163087422|NCT02106832|589030348|FG002|Overall Study|Protocol Violation|0|||
163087423|NCT02106832|589030349|FG003|Overall Study|Protocol Violation|1|||
163087424|NCT02106832|589030346|FG000|Overall Study|Withdrawal by Subject|17|||
163087425|NCT02106832|589030347|FG001|Overall Study|Withdrawal by Subject|17|||
163087426|NCT02106832|589030348|FG002|Overall Study|Withdrawal by Subject|10|||
163087427|NCT02106832|589030349|FG003|Overall Study|Withdrawal by Subject|7|||
163087428|NCT02106832|589030346|FG000|Overall Study|Technical problems|0|||
163087429|NCT02106832|589030347|FG001|Overall Study|Technical problems|1|||
163087430|NCT02106832|589030348|FG002|Overall Study|Technical problems|0|||
163087431|NCT02106832|589030349|FG003|Overall Study|Technical problems|0|||
163087432|NCT00619866|589030366|FG000|Weeks 1 - 12|Adverse Event|0|||
163087433|NCT00619866|589030367|FG001|Weeks 1 - 12|Adverse Event|1|||
163087434|NCT00619866|589030368|FG002|Weeks 1 - 12|Adverse Event|2|||
163087435|NCT00619866|589030369|FG003|Weeks 1 - 12|Adverse Event|0|||
163087436|NCT00619866|589030370|FG004|Weeks 1 - 12|Adverse Event|0|||
163087437|NCT00619866|589030366|FG000|Weeks 1 - 12|Non-compliance|0|||
163087438|NCT00619866|589030367|FG001|Weeks 1 - 12|Non-compliance|0|||
163087439|NCT00619866|589030368|FG002|Weeks 1 - 12|Non-compliance|1|||
163087440|NCT00619866|589030369|FG003|Weeks 1 - 12|Non-compliance|0|||
163087441|NCT00619866|589030370|FG004|Weeks 1 - 12|Non-compliance|0|||
163087442|NCT00619866|589030366|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
163087443|NCT00619866|589030367|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
163087444|NCT00619866|589030368|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
163087445|NCT00619866|589030369|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
163087446|NCT00619866|589030370|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
163087447|NCT00619866|589030366|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
163087448|NCT00619866|589030367|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
163087449|NCT00619866|589030368|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
163087450|NCT00619866|589030369|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
163087451|NCT00619866|589030370|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
163087452|NCT00619866|589030366|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
163087453|NCT00619866|589030367|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
163087454|NCT00619866|589030368|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
163087455|NCT00619866|589030369|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
163087456|NCT00619866|589030370|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
163087457|NCT00619866|589030366|FG000|Weeks 1 - 12|Sponsor Decision|0|||
163087458|NCT00619866|589030367|FG001|Weeks 1 - 12|Sponsor Decision|1|||
163087459|NCT00619866|589030368|FG002|Weeks 1 - 12|Sponsor Decision|0|||
163087460|NCT00619866|589030369|FG003|Weeks 1 - 12|Sponsor Decision|0|||
163087461|NCT00619866|589030370|FG004|Weeks 1 - 12|Sponsor Decision|0|||
163087462|NCT00619866|589030366|FG000|Weeks 13 - 24|Adverse Event|0|||
163087463|NCT00619866|589030367|FG001|Weeks 13 - 24|Adverse Event|0|||
163087464|NCT00619866|589030368|FG002|Weeks 13 - 24|Adverse Event|2|||
163087465|NCT00619866|589030369|FG003|Weeks 13 - 24|Adverse Event|1|||
163087466|NCT00619866|589030370|FG004|Weeks 13 - 24|Adverse Event|0|||
163087467|NCT00619866|589030366|FG000|Weeks 13 - 24|Protocol Deviation|0|||
163087468|NCT00619866|589030367|FG001|Weeks 13 - 24|Protocol Deviation|0|||
163087469|NCT00619866|589030368|FG002|Weeks 13 - 24|Protocol Deviation|0|||
163087470|NCT00619866|589030369|FG003|Weeks 13 - 24|Protocol Deviation|1|||
163087471|NCT00619866|589030370|FG004|Weeks 13 - 24|Protocol Deviation|0|||
163087472|NCT00619866|589030366|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
163036755|NCT01618916|588840236|FG002|Overall Study|Withdrawal by Subject|1|||
163036756|NCT01618916|588840237|FG003|Overall Study|Withdrawal by Subject|0|||
163036757|NCT01618916|588840238|FG004|Overall Study|Withdrawal by Subject|1|||
163036758|NCT01618916|588840239|FG005|Overall Study|Withdrawal by Subject|0|||
163036759|NCT01618916|588840234|FG000|Overall Study|Lost to Follow-up|1|||
163036760|NCT01618916|588840235|FG001|Overall Study|Lost to Follow-up|0|||
163036761|NCT01618916|588840236|FG002|Overall Study|Lost to Follow-up|0|||
163036762|NCT01618916|588840237|FG003|Overall Study|Lost to Follow-up|2|||
163036763|NCT01618916|588840238|FG004|Overall Study|Lost to Follow-up|0|||
163036764|NCT01618916|588840239|FG005|Overall Study|Lost to Follow-up|0|||
163036765|NCT00849290|588840246|FG000|Overall Study|Adverse Event|3|||
163036766|NCT00849290|588840246|FG000|Overall Study|Death|14|||
163087473|NCT00619866|589030367|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
163087474|NCT00619866|589030368|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
163087475|NCT00619866|589030369|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
163087476|NCT00619866|589030370|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
163087477|NCT00619866|589030366|FG000|Weeks 13 - 24|Non-compliance|0|||
163087478|NCT00619866|589030367|FG001|Weeks 13 - 24|Non-compliance|1|||
163087479|NCT00619866|589030368|FG002|Weeks 13 - 24|Non-compliance|1|||
163087480|NCT00619866|589030369|FG003|Weeks 13 - 24|Non-compliance|0|||
163087481|NCT00619866|589030370|FG004|Weeks 13 - 24|Non-compliance|0|||
163036767|NCT00849290|588840246|FG000|Overall Study|Withdrawal by Subject|11|||
163087482|NCT00619866|589030366|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
163087483|NCT00619866|589030367|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
163087484|NCT00619866|589030368|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
163087485|NCT00619866|589030369|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
163087486|NCT00619866|589030370|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
163087487|NCT01656161|589030371|FG000|Overall Study|Death|3|||
163087488|NCT01656161|589030371|FG000|Overall Study|Adverse Event|2|||
163087489|NCT01656161|589030371|FG000|Overall Study|Protocol Violation|1|||
163087490|NCT01656161|589030371|FG000|Overall Study|Withdrawal by Subject|1|||
163087491|NCT03510273|589030376|FG000|Overall Study|Withdrawal by Subject|2|||
163087492|NCT03510273|589030376|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
163087493|NCT03510273|589030376|FG000|Overall Study|Moved away from study area|4|||
163087494|NCT02589938|589030380|FG000|Overall Study|Withdrawal by Subject|11|||
163087495|NCT02589938|589030381|FG001|Overall Study|Withdrawal by Subject|5|||
163087496|NCT02589938|589030382|FG002|Overall Study|Withdrawal by Subject|6|||
163087497|NCT02589938|589030380|FG000|Overall Study|Lost to Follow-up|3|||
163087498|NCT02589938|589030381|FG001|Overall Study|Lost to Follow-up|3|||
163087499|NCT02589938|589030382|FG002|Overall Study|Lost to Follow-up|3|||
163087500|NCT02589938|589030380|FG000|Overall Study|Death|1|||
163087501|NCT02589938|589030381|FG001|Overall Study|Death|0|||
163087502|NCT02589938|589030382|FG002|Overall Study|Death|1|||
163087503|NCT02589938|589030380|FG000|Overall Study|Protocol Violation|6|||
163087504|NCT02589938|589030381|FG001|Overall Study|Protocol Violation|2|||
163087505|NCT02589938|589030382|FG002|Overall Study|Protocol Violation|3|||
163087506|NCT02589938|589030380|FG000|Overall Study|Physician Decision|1|||
163087507|NCT02589938|589030381|FG001|Overall Study|Physician Decision|0|||
163087508|NCT02589938|589030382|FG002|Overall Study|Physician Decision|0|||
163087509|NCT02589938|589030380|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
163087510|NCT02589938|589030381|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
163087511|NCT02589938|589030382|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
163087512|NCT04716894|589030383|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
163087513|NCT04716894|589030383|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
163087514|NCT05205616|589030390|FG000|Overall Study|Lost to Follow-up|4|||
163087515|NCT05205616|589030391|FG001|Overall Study|Lost to Follow-up|4|||
163087516|NCT01467466|589030393|FG000|Overall Study|Withdrawal by Subject|15|||
163087517|NCT01467466|589030394|FG001|Overall Study|Withdrawal by Subject|18|||
163087518|NCT01467466|589030395|FG002|Overall Study|Withdrawal by Subject|13|||
163087519|NCT01467466|589030396|FG003|Overall Study|Withdrawal by Subject|11|||
163087520|NCT01467466|589030393|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
163087521|NCT01467466|589030394|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
163087522|NCT01467466|589030395|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
163087523|NCT01467466|589030396|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
163087524|NCT01467466|589030393|FG000|Overall Study|Procedure Cancelled|46|||
163087525|NCT01467466|589030394|FG001|Overall Study|Procedure Cancelled|45|||
163087526|NCT01467466|589030395|FG002|Overall Study|Procedure Cancelled|25|||
163087527|NCT01467466|589030396|FG003|Overall Study|Procedure Cancelled|29|||
163087528|NCT01467466|589030393|FG000|Overall Study|No Endpoint Blood Draw|38|||
163087529|NCT01467466|589030394|FG001|Overall Study|No Endpoint Blood Draw|32|||
163087530|NCT01467466|589030395|FG002|Overall Study|No Endpoint Blood Draw|51|||
163087531|NCT01467466|589030396|FG003|Overall Study|No Endpoint Blood Draw|43|||
163087532|NCT00787150|589030397|FG000|Overall Study|Adverse Event|4|||
163087533|NCT00787150|589030398|FG001|Overall Study|Adverse Event|4|||
163087534|NCT00787150|589030399|FG002|Overall Study|Adverse Event|4|||
163087535|NCT00787150|589030397|FG000|Overall Study|Physician Decision|1|||
163087536|NCT00787150|589030398|FG001|Overall Study|Physician Decision|2|||
163087537|NCT00787150|589030399|FG002|Overall Study|Physician Decision|1|||
163087538|NCT00787150|589030397|FG000|Overall Study|Withdrawal by Subject|2|||
163087539|NCT00787150|589030398|FG001|Overall Study|Withdrawal by Subject|1|||
163087540|NCT00787150|589030399|FG002|Overall Study|Withdrawal by Subject|0|||
163087541|NCT00787150|589030397|FG000|Overall Study|Dosing incorrect study durg|2|||
163087542|NCT00787150|589030398|FG001|Overall Study|Dosing incorrect study durg|0|||
163087543|NCT00787150|589030399|FG002|Overall Study|Dosing incorrect study durg|0|||
163087544|NCT00982280|589030407|FG000|Observation Period|Not eligible to be dosed|19|||
163087545|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
163087546|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
162718583|NCT01193153|587676627|FG000|Open-label Lead in Period|Adverse Event|41|||
163087547|NCT00982280|589030407|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
163087548|NCT00982280|589030407|FG000|Maintenance Period|Adverse Event|1|||
163087549|NCT01979185|589030413|FG000|Period 2|Other|0|||
163087550|NCT01979185|589030414|FG001|Period 2|Other|1|||
163087551|NCT01121757|589030415|FG000|First Drug|Death|1|||
163087552|NCT01121757|589030416|FG001|First Drug|Death|0|||
163087553|NCT01121757|589030415|FG000|First Drug|Disease Progression|0|||
163087554|NCT01121757|589030416|FG001|First Drug|Disease Progression|2|||
163087555|NCT01121757|589030415|FG000|Combination|Physician Decision|0|||
163087556|NCT01121757|589030416|FG001|Combination|Physician Decision|1|||
162649135|NCT02689258|587433356|FG006|Overall Study|Subject Refusal to Continue|0|||
162649136|NCT02689258|587433357|FG007|Overall Study|Subject Refusal to Continue|0|||
162649137|NCT02689258|587433358|FG008|Overall Study|Subject Refusal to Continue|1|||
162649138|NCT02689258|587433359|FG009|Overall Study|Subject Refusal to Continue|0|||
162649139|NCT02689258|587433360|FG010|Overall Study|Subject Refusal to Continue|0|||
162649140|NCT02689258|587433361|FG011|Overall Study|Subject Refusal to Continue|1|||
162649141|NCT02689258|587433350|FG000|Overall Study|Other|0|||
162649142|NCT02689258|587433351|FG001|Overall Study|Other|2|||
162649143|NCT02689258|587433352|FG002|Overall Study|Other|0|||
162649144|NCT02689258|587433353|FG003|Overall Study|Other|0|||
162649145|NCT02689258|587433354|FG004|Overall Study|Other|1|||
162649146|NCT02689258|587433355|FG005|Overall Study|Other|0|||
162649147|NCT02689258|587433356|FG006|Overall Study|Other|0|||
162649148|NCT02689258|587433357|FG007|Overall Study|Other|0|||
162649149|NCT02689258|587433358|FG008|Overall Study|Other|1|||
162649150|NCT02689258|587433359|FG009|Overall Study|Other|0|||
162649151|NCT02689258|587433360|FG010|Overall Study|Other|0|||
162649152|NCT02689258|587433361|FG011|Overall Study|Other|0|||
162649153|NCT00594464|587433363|FG000|Overall Study|Withdrawal by Subject|1|||
162649154|NCT00594464|587433363|FG000|Overall Study|Delay in operation|2|||
162649155|NCT00785486|587433364|FG000|Midazolam Alone|Withdrawal by Subject|1|||
162649156|NCT02907359|587433371|FG000|Overall Study|Death|234|||
162649157|NCT02907359|587433372|FG001|Overall Study|Death|117|||
162649158|NCT02907359|587433371|FG000|Overall Study|Withdrawal by Subject|6|||
162649159|NCT02907359|587433372|FG001|Overall Study|Withdrawal by Subject|11|||
162649160|NCT02907359|587433371|FG000|Overall Study|Lost to Follow-up|1|||
162649161|NCT02907359|587433372|FG001|Overall Study|Lost to Follow-up|0|||
162649162|NCT03131440|587433373|FG000|Overall Study|Withdrawal by Subject|1|||
162649163|NCT03131440|587433374|FG001|Overall Study|Withdrawal by Subject|3|||
162649164|NCT03131440|587433375|FG002|Overall Study|Withdrawal by Subject|0|||
162649165|NCT03131440|587433376|FG003|Overall Study|Withdrawal by Subject|0|||
162649166|NCT03131440|587433377|FG004|Overall Study|Withdrawal by Subject|1|||
162649167|NCT03131440|587433378|FG005|Overall Study|Withdrawal by Subject|0|||
162649168|NCT03131440|587433379|FG006|Overall Study|Withdrawal by Subject|0|||
162649169|NCT03131440|587433380|FG007|Overall Study|Withdrawal by Subject|1|||
162649170|NCT03131440|587433381|FG008|Overall Study|Withdrawal by Subject|1|||
162649171|NCT03131440|587433382|FG009|Overall Study|Withdrawal by Subject|1|||
162649172|NCT03131440|587433383|FG010|Overall Study|Withdrawal by Subject|0|||
162649173|NCT03131440|587433384|FG011|Overall Study|Withdrawal by Subject|1|||
162649174|NCT03131440|587433385|FG012|Overall Study|Withdrawal by Subject|1|||
162649175|NCT03131440|587433386|FG013|Overall Study|Withdrawal by Subject|0|||
162649176|NCT03131440|587433387|FG014|Overall Study|Withdrawal by Subject|1|||
162649177|NCT03131440|587433388|FG015|Overall Study|Withdrawal by Subject|0|||
162649178|NCT03131440|587433389|FG016|Overall Study|Withdrawal by Subject|0|||
162649179|NCT03131440|587433390|FG017|Overall Study|Withdrawal by Subject|0|||
162649180|NCT03131440|587433391|FG018|Overall Study|Withdrawal by Subject|1|||
162649181|NCT03131440|587433392|FG019|Overall Study|Withdrawal by Subject|0|||
163036768|NCT00849290|588840246|FG000|Overall Study|Lost to Follow-up|2|||
163036769|NCT00849290|588840246|FG000|Overall Study|Protocol Violation|5|||
163036770|NCT00849290|588840246|FG000|Overall Study|Disease Progression|20|||
163036771|NCT00938587|588840247|FG000|Overall Study|Adverse Event|2|||
163036772|NCT00938587|588840248|FG001|Overall Study|Adverse Event|0|||
163036773|NCT00938587|588840249|FG002|Overall Study|Adverse Event|0|||
163036774|NCT00938587|588840250|FG003|Overall Study|Adverse Event|2|||
163036775|NCT00938587|588840247|FG000|Overall Study|Did not meet entrance criteria|0|||
163036776|NCT00938587|588840248|FG001|Overall Study|Did not meet entrance criteria|0|||
163036777|NCT00938587|588840249|FG002|Overall Study|Did not meet entrance criteria|1|||
163036778|NCT00938587|588840250|FG003|Overall Study|Did not meet entrance criteria|0|||
163036779|NCT00938587|588840247|FG000|Overall Study|Withdrawal by Subject|1|||
163036780|NCT00938587|588840248|FG001|Overall Study|Withdrawal by Subject|1|||
163036781|NCT00938587|588840249|FG002|Overall Study|Withdrawal by Subject|0|||
163036782|NCT00938587|588840250|FG003|Overall Study|Withdrawal by Subject|0|||
163036783|NCT02819440|588840255|FG000|Overall Study|Adverse Event|3|||
163036784|NCT02819440|588840256|FG001|Overall Study|Adverse Event|1|||
163036785|NCT02819440|588840255|FG000|Overall Study|Lost to Follow-up|1|||
163036786|NCT02819440|588840256|FG001|Overall Study|Lost to Follow-up|3|||
163036787|NCT02819440|588840255|FG000|Overall Study|Withdrawal by Subject|9|||
163036788|NCT02819440|588840256|FG001|Overall Study|Withdrawal by Subject|8|||
163036789|NCT02334384|588840264|FG000|Overall Study|Lost to Follow-up|1|||
163036790|NCT02334384|588840265|FG001|Overall Study|Lost to Follow-up|1|||
163036791|NCT00055497|588840266|FG000|Overall Study|Adverse Event|1|||
163036792|NCT00055497|588840267|FG001|Overall Study|Adverse Event|1|||
163036793|NCT00055497|588840268|FG002|Overall Study|Adverse Event|1|||
163036794|NCT00055497|588840269|FG003|Overall Study|Adverse Event|28|||
163036795|NCT00055497|588840266|FG000|Overall Study|Withdrawal by Subject|3|||
163036796|NCT00055497|588840267|FG001|Overall Study|Withdrawal by Subject|1|||
163036797|NCT00055497|588840268|FG002|Overall Study|Withdrawal by Subject|1|||
163087557|NCT01121757|589030415|FG000|Combination|Disease Progression|2|||
163087558|NCT01121757|589030416|FG001|Combination|Disease Progression|0|||
163087559|NCT03620981|589030427|FG000|Overall Study|Adverse Event|14|||
163087560|NCT03620981|589030428|FG001|Overall Study|Adverse Event|38|||
163087561|NCT03620981|589030429|FG002|Overall Study|Adverse Event|25|||
163087562|NCT03620981|589030427|FG000|Overall Study|Lack of Efficacy|2|||
163087563|NCT03620981|589030428|FG001|Overall Study|Lack of Efficacy|1|||
163087564|NCT03620981|589030429|FG002|Overall Study|Lack of Efficacy|1|||
163087565|NCT03620981|589030427|FG000|Overall Study|Physician Decision|7|||
163087566|NCT03620981|589030428|FG001|Overall Study|Physician Decision|4|||
163087567|NCT03620981|589030429|FG002|Overall Study|Physician Decision|4|||
163087568|NCT03620981|589030427|FG000|Overall Study|Protocol Violation|1|||
163087569|NCT03620981|589030428|FG001|Overall Study|Protocol Violation|2|||
163087570|NCT03620981|589030429|FG002|Overall Study|Protocol Violation|1|||
163087571|NCT03620981|589030427|FG000|Overall Study|Withdrawal by Legal Representative|2|||
163087572|NCT03620981|589030428|FG001|Overall Study|Withdrawal by Legal Representative|1|||
163087573|NCT03620981|589030429|FG002|Overall Study|Withdrawal by Legal Representative|1|||
163087574|NCT03620981|589030427|FG000|Overall Study|Withdrawal by Care Giver|2|||
163087575|NCT03620981|589030428|FG001|Overall Study|Withdrawal by Care Giver|0|||
163087576|NCT03620981|589030429|FG002|Overall Study|Withdrawal by Care Giver|1|||
163087577|NCT03620981|589030427|FG000|Overall Study|Non-compliance with Study Drug|1|||
163087578|NCT03620981|589030428|FG001|Overall Study|Non-compliance with Study Drug|1|||
163087579|NCT03620981|589030429|FG002|Overall Study|Non-compliance with Study Drug|0|||
163087580|NCT05852470|589030436|FG000|Overall Study|Withdrawal by Subject|0|||
163087581|NCT05852470|589030437|FG001|Overall Study|Withdrawal by Subject|1|||
163087582|NCT06071104|589030438|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
163087583|NCT04116489|589030443|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
163087584|NCT04116489|589030443|FG000|Overall Study|Withdrawal by Subject|1|||
163087585|NCT03781570|589030444|FG000|Overall Study|Technical Issues (equipment failure)|31|||
163087586|NCT03781570|589030444|FG000|Overall Study|Withdrawal by Subject|7|||
163087587|NCT03781570|589030444|FG000|Overall Study|Physical Constraints|11|||
163087588|NCT06028464|589030448|FG000|Washout|Positive drug test.|1|||
163087589|NCT03636022|589030449|FG000|Overall Study|Withdrawal by Subject|1|||
163087590|NCT03636022|589030450|FG001|Overall Study|Withdrawal by Subject|3|||
163087591|NCT03330847|589030451|FG000|Overall Study|Patients ongoing study|62|||
163087592|NCT03330847|589030452|FG001|Overall Study|Patients ongoing study|65|||
163087593|NCT03330847|589030453|FG002|Overall Study|Patients ongoing study|15|||
163087594|NCT01346592|589030456|FG000|Overall Study|Lost to Follow-up|62|||
163087595|NCT01346592|589030457|FG001|Overall Study|Lost to Follow-up|29|||
163087596|NCT01346592|589030458|FG002|Overall Study|Lost to Follow-up|29|||
163087597|NCT01346592|589030456|FG000|Overall Study|Protocol Violation|2|||
163087598|NCT01346592|589030457|FG001|Overall Study|Protocol Violation|1|||
163087599|NCT01346592|589030458|FG002|Overall Study|Protocol Violation|0|||
163087600|NCT01346592|589030456|FG000|Overall Study|Death|1|||
163087601|NCT01346592|589030457|FG001|Overall Study|Death|3|||
163087602|NCT01346592|589030458|FG002|Overall Study|Death|4|||
163087603|NCT01346592|589030456|FG000|Overall Study|Adverse Event|0|||
163087604|NCT01346592|589030457|FG001|Overall Study|Adverse Event|1|||
163087605|NCT01346592|589030458|FG002|Overall Study|Adverse Event|0|||
163087606|NCT01346592|589030456|FG000|Overall Study|Withdrawal by Subject|77|||
163087607|NCT01346592|589030457|FG001|Overall Study|Withdrawal by Subject|51|||
163087608|NCT01346592|589030458|FG002|Overall Study|Withdrawal by Subject|38|||
163087609|NCT01346592|589030456|FG000|Overall Study|Inappropriate enrollment|3|||
163087610|NCT01346592|589030457|FG001|Overall Study|Inappropriate enrollment|1|||
163087611|NCT01346592|589030458|FG002|Overall Study|Inappropriate enrollment|1|||
162718584|NCT01193153|587676628|FG001|Open-label Lead in Period|Adverse Event|0|||
162718585|NCT01193153|587676627|FG000|Open-label Lead in Period|Death|1|||
162718586|NCT01193153|587676628|FG001|Open-label Lead in Period|Death|0|||
162718587|NCT01193153|587676627|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
162718588|NCT01193153|587676628|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
162718589|NCT01193153|587676627|FG000|Open-label Stabilization Period|Adverse Event|9|||
162718590|NCT01193153|587676628|FG001|Open-label Stabilization Period|Adverse Event|0|||
162718591|NCT01193153|587676627|FG000|Open-label Stabilization Period|Death|2|||
162718592|NCT01193153|587676628|FG001|Open-label Stabilization Period|Death|0|||
163087612|NCT01346592|589030456|FG000|Overall Study|Administrative reason|1|||
163087613|NCT01346592|589030457|FG001|Overall Study|Administrative reason|0|||
163087614|NCT01346592|589030458|FG002|Overall Study|Administrative reason|0|||
163087615|NCT01346592|589030456|FG000|Overall Study|Unable to Classify|7|||
163087616|NCT01346592|589030457|FG001|Overall Study|Unable to Classify|3|||
163087617|NCT01346592|589030458|FG002|Overall Study|Unable to Classify|6|||
163087618|NCT05943990|589030459|FG000|Overall Study|Study Terminated by Sponsor|0|||
163087619|NCT05943990|589030460|FG001|Overall Study|Study Terminated by Sponsor|0|||
163087620|NCT05943990|589030461|FG002|Overall Study|Study Terminated by Sponsor|1|||
163087621|NCT04696146|589031919|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
163087622|NCT04696146|589031920|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
163087623|NCT04696146|589031919|FG000|Overall Study|Off hours issue with product|1|||
163087624|NCT04696146|589031920|FG001|Overall Study|Off hours issue with product|0|||
163087625|NCT00276419|589031925|FG000|First Intervention|Adverse Event|1|||
163087626|NCT00276419|589031926|FG001|First Intervention|Adverse Event|0|||
163087627|NCT00276419|589031925|FG000|First Intervention|Withdrawal by Subject|0|||
163087628|NCT00276419|589031926|FG001|First Intervention|Withdrawal by Subject|2|||
163087629|NCT03493958|589031927|FG000|Overall Study|Withdrawal by Subject|6|||
163087630|NCT03493958|589031927|FG000|Overall Study|Lost to Follow-up|7|||
163087631|NCT03493958|589031927|FG000|Overall Study|Did not complete all required study procedures|2|||
163087632|NCT02367456|589031928|FG000|Overall Study|Death|8|||
163087633|NCT02367456|589031929|FG001|Overall Study|Death|24|||
163087634|NCT02367456|589031930|FG002|Overall Study|Death|17|||
163087635|NCT02367456|589031928|FG000|Overall Study|Lost to Follow-up|1|||
163087636|NCT02367456|589031929|FG001|Overall Study|Lost to Follow-up|3|||
163087637|NCT02367456|589031930|FG002|Overall Study|Lost to Follow-up|1|||
163087638|NCT02367456|589031928|FG000|Overall Study|Other reason|3|||
163087639|NCT02367456|589031929|FG001|Overall Study|Other reason|3|||
163087640|NCT02367456|589031930|FG002|Overall Study|Other reason|9|||
163087641|NCT02367456|589031928|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
163087642|NCT02367456|589031929|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
163087643|NCT02367456|589031930|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
163087644|NCT01645176|589031935|FG000|Overall Study|Lack of Efficacy|4|||
163087645|NCT01645176|589031935|FG000|Overall Study|did not complete final MRI|1|||
163087646|NCT02569853|589031936|FG000|Overall Study|Adverse Event|2|||
163087647|NCT02569853|589031937|FG001|Overall Study|Adverse Event|0|||
163087648|NCT02569853|589031936|FG000|Overall Study|Withdrawal by Subject|3|||
163087649|NCT02569853|589031937|FG001|Overall Study|Withdrawal by Subject|2|||
163087650|NCT02569853|589031936|FG000|Overall Study|Lost to Follow-up|3|||
163087651|NCT02569853|589031937|FG001|Overall Study|Lost to Follow-up|3|||
163087652|NCT02569853|589031936|FG000|Overall Study|Protocol Violation|1|||
163087653|NCT02569853|589031937|FG001|Overall Study|Protocol Violation|1|||
163087654|NCT02569853|589031936|FG000|Overall Study|Did not experience migraine attack|10|||
163087655|NCT02569853|589031937|FG001|Overall Study|Did not experience migraine attack|7|||
163087656|NCT02569853|589031936|FG000|Overall Study|Physician Decision|1|||
163087657|NCT02569853|589031937|FG001|Overall Study|Physician Decision|1|||
163087658|NCT00402987|589031938|FG000|Overall Study|Lack of Efficacy|0|||
163087659|NCT00402987|589031939|FG001|Overall Study|Lack of Efficacy|0|||
163087660|NCT00402987|589031940|FG002|Overall Study|Lack of Efficacy|1|||
163087661|NCT00402987|589031941|FG003|Overall Study|Lack of Efficacy|0|||
163087662|NCT01668004|589031942|FG000|Overall Study|Adverse Event|7|||
163087663|NCT01668004|589031942|FG000|Overall Study|Withdrawal by Subject|2|||
163087664|NCT01668004|589031942|FG000|Overall Study|Lost to Follow-up|5|||
163087665|NCT01668004|589031942|FG000|Overall Study|Lack of Efficacy|9|||
163087666|NCT01668004|589031942|FG000|Overall Study|Non-compliance with treatment|2|||
163087667|NCT01493414|589031947|FG000|Overall Study|Adverse Event|405|||
163087668|NCT01493414|589031947|FG000|Overall Study|Disease progression|204|||
163087669|NCT01493414|589031947|FG000|Overall Study|Death|101|||
163087670|NCT01493414|589031947|FG000|Overall Study|Physician Decision|93|||
163087671|NCT01493414|589031947|FG000|Overall Study|Withdrawal by Subject|79|||
163087672|NCT01493414|589031947|FG000|Overall Study|Protocol deviation|27|||
163087673|NCT01493414|589031947|FG000|Overall Study|Administrative problems|25|||
163087674|NCT01493414|589031947|FG000|Overall Study|Lost to Follow-up|16|||
163087675|NCT03773484|589031972|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
163087676|NCT04724837|589031973|FG000|Overall Study|Other|4|||
163087677|NCT04724837|589031974|FG001|Overall Study|Other|16|||
163087678|NCT04724837|589031975|FG002|Overall Study|Other|0|||
163087679|NCT04724837|589031973|FG000|Overall Study|Withdrawal by Subject|2|||
163087680|NCT04724837|589031974|FG001|Overall Study|Withdrawal by Subject|9|||
163087681|NCT04724837|589031975|FG002|Overall Study|Withdrawal by Subject|9|||
163087682|NCT04724837|589031973|FG000|Overall Study|Adverse Event|2|||
163087683|NCT04724837|589031974|FG001|Overall Study|Adverse Event|7|||
163087684|NCT04724837|589031975|FG002|Overall Study|Adverse Event|4|||
163087685|NCT04724837|589031973|FG000|Overall Study|Lost to Follow-up|0|||
163087686|NCT04724837|589031974|FG001|Overall Study|Lost to Follow-up|1|||
163087687|NCT04724837|589031975|FG002|Overall Study|Lost to Follow-up|3|||
163087688|NCT04724837|589031973|FG000|Overall Study|Physician Decision|1|||
163087689|NCT04724837|589031974|FG001|Overall Study|Physician Decision|2|||
163087690|NCT04724837|589031975|FG002|Overall Study|Physician Decision|0|||
163087691|NCT04724837|589031973|FG000|Overall Study|Death|0|||
163087692|NCT04724837|589031974|FG001|Overall Study|Death|0|||
163087693|NCT04724837|589031975|FG002|Overall Study|Death|1|||
163087694|NCT04724837|589031973|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163087695|NCT04724837|589031974|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163087696|NCT04724837|589031975|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
163087697|NCT04724837|589031973|FG000|Overall Study|Study Terminated by Sponsor|0|||
163087698|NCT04724837|589031974|FG001|Overall Study|Study Terminated by Sponsor|1|||
163087699|NCT04724837|589031975|FG002|Overall Study|Study Terminated by Sponsor|0|||
163087700|NCT04222673|589031976|FG000|Overall Study|Lost to Follow-up|5|||
163087701|NCT02420717|589031981|FG000|Overall Study|Did not receive all study medication|2|||
163087702|NCT02420717|589031982|FG001|Overall Study|Did not receive all study medication|0|||
163087703|NCT02420717|589031983|FG002|Overall Study|Did not receive all study medication|0|||
163087704|NCT03138564|589031984|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
163087705|NCT03138564|589031985|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
163087706|NCT03138564|589031984|FG000|Overall Study|Lost to Follow-up|16|||
163087707|NCT03138564|589031985|FG001|Overall Study|Lost to Follow-up|2|||
163087708|NCT03138564|589031984|FG000|Overall Study|Withdrawal by Subject|48|||
163087709|NCT03138564|589031985|FG001|Overall Study|Withdrawal by Subject|4|||
163087710|NCT03138564|589031984|FG000|Overall Study|No longer met eligibility criteria|2|||
163087711|NCT03138564|589031985|FG001|Overall Study|No longer met eligibility criteria|0|||
163087712|NCT03138564|589031984|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
163087713|NCT03138564|589031985|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
163087714|NCT03138564|589031984|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
163087715|NCT03138564|589031985|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
163087716|NCT03138564|589031984|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
163087717|NCT03138564|589031985|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
163087718|NCT03138564|589031984|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
163087719|NCT03138564|589031985|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
163087720|NCT05177354|589031987|FG000|Implant to 30-day Visit|Physician Decision|1|||
163087721|NCT05177354|589031987|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
163087722|NCT05177354|589031987|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
163087723|NCT05177354|589031987|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
163087724|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087725|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087726|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087727|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087728|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087729|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
163087730|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087731|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087732|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087733|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
163087734|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Death|2|||
163087735|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Death|1|||
163087736|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Death|3|||
163087737|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Death|1|||
163087738|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Death|2|||
163087739|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Death|3|||
163087740|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Death|3|||
163087741|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Death|0|||
163087742|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Death|0|||
163087743|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Death|0|||
163087744|NCT02936323|589031988|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087745|NCT02936323|589031989|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087746|NCT02936323|589031990|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087747|NCT02936323|589031991|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087748|NCT02936323|589031992|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087749|NCT02936323|589031993|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
163087750|NCT02936323|589031994|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087751|NCT02936323|589031995|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087752|NCT02936323|589031996|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087753|NCT02936323|589031997|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
163087754|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087755|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087756|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087757|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087758|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087759|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087760|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
163087761|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
163087762|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
163087763|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
163087764|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
163087765|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
163087766|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
163087767|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
163087768|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
163087769|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
163087770|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
163087771|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
163087772|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
163087773|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
163087774|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087775|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087776|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087777|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087778|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087779|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087780|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087781|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
163087782|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
162649182|NCT03131440|587433393|FG020|Overall Study|Withdrawal by Subject|1|||
162649183|NCT03131440|587433394|FG021|Overall Study|Withdrawal by Subject|1|||
162649184|NCT03131440|587433395|FG022|Overall Study|Withdrawal by Subject|1|||
162649185|NCT03131440|587433396|FG023|Overall Study|Withdrawal by Subject|0|||
162649186|NCT03131440|587433397|FG024|Overall Study|Withdrawal by Subject|0|||
162649187|NCT03131440|587433398|FG025|Overall Study|Withdrawal by Subject|0|||
163036798|NCT00055497|588840269|FG003|Overall Study|Withdrawal by Subject|15|||
163036799|NCT00055497|588840266|FG000|Overall Study|Lost to Follow-up|0|||
163036800|NCT00055497|588840267|FG001|Overall Study|Lost to Follow-up|1|||
163036801|NCT00055497|588840268|FG002|Overall Study|Lost to Follow-up|0|||
163036802|NCT00055497|588840269|FG003|Overall Study|Lost to Follow-up|5|||
163036803|NCT00055497|588840266|FG000|Overall Study|Protocol Violation|0|||
163036804|NCT00055497|588840267|FG001|Overall Study|Protocol Violation|0|||
163036805|NCT00055497|588840268|FG002|Overall Study|Protocol Violation|0|||
163036806|NCT00055497|588840269|FG003|Overall Study|Protocol Violation|3|||
163036807|NCT00055497|588840266|FG000|Overall Study|Lack of Efficacy|1|||
163036808|NCT00055497|588840267|FG001|Overall Study|Lack of Efficacy|0|||
163036809|NCT00055497|588840268|FG002|Overall Study|Lack of Efficacy|0|||
163036810|NCT00055497|588840269|FG003|Overall Study|Lack of Efficacy|27|||
163036811|NCT00055497|588840266|FG000|Overall Study|Administrative Reasons|0|||
163036812|NCT00055497|588840267|FG001|Overall Study|Administrative Reasons|0|||
163036813|NCT00055497|588840268|FG002|Overall Study|Administrative Reasons|0|||
163036814|NCT00055497|588840269|FG003|Overall Study|Administrative Reasons|1|||
163036815|NCT00055497|588840266|FG000|Overall Study|Other|0|||
163036816|NCT00055497|588840267|FG001|Overall Study|Other|0|||
163036817|NCT00055497|588840268|FG002|Overall Study|Other|0|||
163036818|NCT00055497|588840269|FG003|Overall Study|Other|11|||
163036819|NCT00048165|588840270|FG000|Completed 6 Months Study|Administration/Other|8|||
163036820|NCT00048165|588840271|FG001|Completed 6 Months Study|Administration/Other|8|||
163036821|NCT00048165|588840270|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
163036822|NCT00048165|588840271|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
163036823|NCT00048165|588840270|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
163036824|NCT00048165|588840271|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
163036825|NCT00048165|588840270|FG000|Completed 6 Months Study|Death|12|||
163036826|NCT00048165|588840271|FG001|Completed 6 Months Study|Death|6|||
163036827|NCT00048165|588840270|FG000|Completed 6 Months Study|Insufficient therapy|1|||
163036828|NCT00048165|588840271|FG001|Completed 6 Months Study|Insufficient therapy|4|||
163036829|NCT00048165|588840270|FG000|Completed 6 Months Study|Other violation|4|||
163036830|NCT00048165|588840271|FG001|Completed 6 Months Study|Other violation|6|||
163036831|NCT00048165|588840270|FG000|Completed 6 Months Study|Refused treatment|5|||
163036832|NCT00048165|588840271|FG001|Completed 6 Months Study|Refused treatment|5|||
163036833|NCT00048165|588840270|FG000|Completed 6 Months Study|Violation criteria|0|||
163036834|NCT00048165|588840271|FG001|Completed 6 Months Study|Violation criteria|2|||
163036835|NCT00048165|588840270|FG000|Completed 6 Months Study|Did not receive study drug|6|||
163036836|NCT00048165|588840271|FG001|Completed 6 Months Study|Did not receive study drug|6|||
163036837|NCT00048165|588840270|FG000|Completed 12 Months Study|Administration/Other|0|||
163036838|NCT00048165|588840271|FG001|Completed 12 Months Study|Administration/Other|2|||
163036839|NCT00048165|588840270|FG000|Completed 12 Months Study|Death|2|||
163036840|NCT00048165|588840271|FG001|Completed 12 Months Study|Death|1|||
163036841|NCT00048165|588840270|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
163036842|NCT00048165|588840271|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
163036843|NCT00731731|588840272|FG000|Overall Study|Protocol Violation|0|||
163036844|NCT00731731|588840273|FG001|Overall Study|Protocol Violation|0|||
163036845|NCT00731731|588840274|FG002|Overall Study|Protocol Violation|1|||
163036846|NCT00731731|588840272|FG000|Overall Study|Cancel prior to treatment|0|||
163036847|NCT00731731|588840273|FG001|Overall Study|Cancel prior to treatment|0|||
163036848|NCT00731731|588840274|FG002|Overall Study|Cancel prior to treatment|2|||
163036849|NCT01084538|588840275|FG000|Overall Study|Drug not available|30|||
163036850|NCT01084538|588840275|FG000|Overall Study|Adverse Event|9|||
163036851|NCT01084538|588840275|FG000|Overall Study|Kidney transplant|6|||
163036852|NCT01084538|588840275|FG000|Overall Study|Serious Adverse Event|3|||
163087783|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
163087784|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087785|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087786|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087787|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087788|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087789|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087790|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087791|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087792|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
163087793|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
163087794|NCT02936323|589031988|FG000|Phase 2a Dose Expansion|Death|0|||
163087795|NCT02936323|589031989|FG001|Phase 2a Dose Expansion|Death|0|||
163087796|NCT02936323|589031990|FG002|Phase 2a Dose Expansion|Death|0|||
163087797|NCT02936323|589031991|FG003|Phase 2a Dose Expansion|Death|0|||
163087798|NCT02936323|589031992|FG004|Phase 2a Dose Expansion|Death|0|||
163087799|NCT02936323|589031993|FG005|Phase 2a Dose Expansion|Death|0|||
163087800|NCT02936323|589031994|FG006|Phase 2a Dose Expansion|Death|0|||
163087801|NCT02936323|589031995|FG007|Phase 2a Dose Expansion|Death|4|||
163087802|NCT02936323|589031996|FG008|Phase 2a Dose Expansion|Death|8|||
163087803|NCT02936323|589031997|FG009|Phase 2a Dose Expansion|Death|10|||
163087804|NCT06272383|589031998|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
163087805|NCT06272383|589031999|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
163087806|NCT05715827|589032000|FG000|Overall Study|Physician Decision|0|||
163087807|NCT05715827|589032001|FG001|Overall Study|Physician Decision|1|||
163087808|NCT05715827|589032000|FG000|Overall Study|console communication error|0|||
163087809|NCT05715827|589032001|FG001|Overall Study|console communication error|1|||
163087810|NCT04846868|589032002|FG000|Overall Study|Adverse Event|12|||
163087811|NCT04846868|589032003|FG001|Overall Study|Adverse Event|11|||
163087812|NCT04846868|589032002|FG000|Overall Study|Protocol deviation|6|||
163087813|NCT04846868|589032003|FG001|Overall Study|Protocol deviation|2|||
163087814|NCT04846868|589032002|FG000|Overall Study|Perceived lack of efficacy|3|||
163087815|NCT04846868|589032003|FG001|Overall Study|Perceived lack of efficacy|2|||
163087816|NCT04846868|589032002|FG000|Overall Study|Change of residence|2|||
163087817|NCT04846868|589032003|FG001|Overall Study|Change of residence|3|||
163087818|NCT04846868|589032002|FG000|Overall Study|Burden of study procedures|1|||
163087819|NCT04846868|589032003|FG001|Overall Study|Burden of study procedures|1|||
163087820|NCT04846868|589032002|FG000|Overall Study|No reason available|2|||
163087821|NCT04846868|589032003|FG001|Overall Study|No reason available|5|||
163087822|NCT04846868|589032002|FG000|Overall Study|Other reason listed|20|||
163087823|NCT04846868|589032003|FG001|Overall Study|Other reason listed|10|||
163087824|NCT04846868|589032002|FG000|Overall Study|Not treated|0|||
163087825|NCT04846868|589032003|FG001|Overall Study|Not treated|1|||
163087826|NCT04398706|589032004|FG000|Overall Study|Adverse Event|0|||
163087827|NCT04398706|589032005|FG001|Overall Study|Adverse Event|0|||
163087828|NCT04398706|589032006|FG002|Overall Study|Adverse Event|0|||
163087829|NCT04398706|589032007|FG003|Overall Study|Adverse Event|0|||
163087830|NCT04398706|589032008|FG004|Overall Study|Adverse Event|0|||
163036853|NCT01084538|588840275|FG000|Overall Study|Lack of effectiveness|2|||
163036854|NCT01084538|588840275|FG000|Overall Study|Patient noncompliance|2|||
163036855|NCT01084538|588840275|FG000|Overall Study|Hyperphosphatemia|2|||
163036856|NCT01084538|588840275|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
163036857|NCT01084538|588840275|FG000|Overall Study|Change of residence|2|||
163036858|NCT01084538|588840275|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
163036859|NCT01084538|588840275|FG000|Overall Study|Reason unknown|8|||
163036860|NCT03742258|588840276|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
163036861|NCT03742258|588840277|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
163036862|NCT03742258|588840278|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
163036863|NCT03742258|588840276|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
163036864|NCT03742258|588840277|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
163036865|NCT03742258|588840278|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
163036866|NCT03742258|588840276|FG000|Survival Follow-Up|Still in Follow-up|0|||
163036867|NCT03742258|588840277|FG001|Survival Follow-Up|Still in Follow-up|0|||
163036868|NCT03742258|588840278|FG002|Survival Follow-Up|Still in Follow-up|2|||
163036869|NCT00508157|588840282|FG000|Overall Study|Adverse Event|0|||
163036870|NCT00508157|588840283|FG001|Overall Study|Adverse Event|1|||
163036871|NCT00508157|588840282|FG000|Overall Study|Subject Withdrew Consent|1|||
163087831|NCT04398706|589032009|FG005|Overall Study|Adverse Event|1|||
163087832|NCT04398706|589032010|FG006|Overall Study|Adverse Event|1|||
163036872|NCT00508157|588840283|FG001|Overall Study|Subject Withdrew Consent|0|||
163036873|NCT00508157|588840282|FG000|Overall Study|Lost to Follow-up|1|||
163036874|NCT00508157|588840283|FG001|Overall Study|Lost to Follow-up|0|||
163036875|NCT00508157|588840282|FG000|Overall Study|Subject no longer met study criteria|0|||
162649188|NCT03131440|587433399|FG026|Overall Study|Withdrawal by Subject|0|||
163087833|NCT04398706|589032011|FG007|Overall Study|Adverse Event|0|||
163087834|NCT04398706|589032004|FG000|Overall Study|Lost to Follow-up|0|||
163087835|NCT04398706|589032005|FG001|Overall Study|Lost to Follow-up|1|||
163087836|NCT04398706|589032006|FG002|Overall Study|Lost to Follow-up|2|||
163087837|NCT04398706|589032007|FG003|Overall Study|Lost to Follow-up|1|||
163087838|NCT04398706|589032008|FG004|Overall Study|Lost to Follow-up|6|||
163087839|NCT04398706|589032009|FG005|Overall Study|Lost to Follow-up|3|||
163087840|NCT04398706|589032010|FG006|Overall Study|Lost to Follow-up|8|||
163087841|NCT04398706|589032011|FG007|Overall Study|Lost to Follow-up|2|||
163087842|NCT04398706|589032004|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163087843|NCT04398706|589032005|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163087844|NCT04398706|589032006|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163087845|NCT04398706|589032007|FG003|Overall Study|Withdrawal by parent/guardian|2|||
163087846|NCT04398706|589032008|FG004|Overall Study|Withdrawal by parent/guardian|19|||
163087847|NCT04398706|589032009|FG005|Overall Study|Withdrawal by parent/guardian|23|||
163087848|NCT04398706|589032010|FG006|Overall Study|Withdrawal by parent/guardian|13|||
163087849|NCT04398706|589032011|FG007|Overall Study|Withdrawal by parent/guardian|11|||
163087850|NCT04398706|589032004|FG000|Overall Study|Protocol deviation|0|||
163087851|NCT04398706|589032005|FG001|Overall Study|Protocol deviation|1|||
163087852|NCT04398706|589032006|FG002|Overall Study|Protocol deviation|0|||
163087853|NCT04398706|589032007|FG003|Overall Study|Protocol deviation|0|||
163087854|NCT04398706|589032008|FG004|Overall Study|Protocol deviation|6|||
163087855|NCT04398706|589032009|FG005|Overall Study|Protocol deviation|4|||
163087856|NCT04398706|589032010|FG006|Overall Study|Protocol deviation|6|||
163087857|NCT04398706|589032011|FG007|Overall Study|Protocol deviation|3|||
163087858|NCT04890509|589032012|FG000|Overall Study|Death|4|||
163087859|NCT04890509|589032013|FG001|Overall Study|Death|4|||
163087860|NCT04116853|589032014|FG000|Overall Study|Adverse Event|1|||
163087861|NCT04116853|589032015|FG001|Overall Study|Adverse Event|3|||
163087862|NCT04116853|589032014|FG000|Overall Study|Lost to Follow-up|2|||
163087863|NCT04116853|589032015|FG001|Overall Study|Lost to Follow-up|0|||
163087864|NCT04116853|589032014|FG000|Overall Study|Incarceration|0|||
163087865|NCT04116853|589032015|FG001|Overall Study|Incarceration|1|||
163087866|NCT04116853|589032014|FG000|Overall Study|Pregnancy|1|||
163087867|NCT04116853|589032015|FG001|Overall Study|Pregnancy|1|||
163087868|NCT04116853|589032014|FG000|Overall Study|Began Other Weight Loss program|4|||
163087869|NCT04116853|589032015|FG001|Overall Study|Began Other Weight Loss program|8|||
163087870|NCT04116853|589032014|FG000|Overall Study|Began Anti-Obesity Medication|3|||
163087871|NCT04116853|589032015|FG001|Overall Study|Began Anti-Obesity Medication|3|||
163087872|NCT04116853|589032014|FG000|Overall Study|Protocol Violation|0|||
162649189|NCT03131440|587433400|FG027|Overall Study|Withdrawal by Subject|0|||
162649190|NCT03131440|587433401|FG028|Overall Study|Withdrawal by Subject|0|||
162649191|NCT03131440|587433402|FG029|Overall Study|Withdrawal by Subject|0|||
162649192|NCT03131440|587433403|FG030|Overall Study|Withdrawal by Subject|1|||
162649193|NCT03131440|587433404|FG031|Overall Study|Withdrawal by Subject|0|||
162649194|NCT03131440|587433373|FG000|Overall Study|Lost to Follow-up|0|||
162649195|NCT03131440|587433374|FG001|Overall Study|Lost to Follow-up|0|||
162649196|NCT03131440|587433375|FG002|Overall Study|Lost to Follow-up|0|||
162649197|NCT03131440|587433376|FG003|Overall Study|Lost to Follow-up|0|||
162649198|NCT03131440|587433377|FG004|Overall Study|Lost to Follow-up|0|||
162649199|NCT03131440|587433378|FG005|Overall Study|Lost to Follow-up|1|||
162649200|NCT03131440|587433379|FG006|Overall Study|Lost to Follow-up|0|||
162649201|NCT03131440|587433380|FG007|Overall Study|Lost to Follow-up|0|||
162649202|NCT03131440|587433381|FG008|Overall Study|Lost to Follow-up|0|||
162649203|NCT03131440|587433382|FG009|Overall Study|Lost to Follow-up|0|||
162649204|NCT03131440|587433383|FG010|Overall Study|Lost to Follow-up|0|||
162649205|NCT03131440|587433384|FG011|Overall Study|Lost to Follow-up|0|||
162649206|NCT03131440|587433385|FG012|Overall Study|Lost to Follow-up|0|||
163087873|NCT04116853|589032015|FG001|Overall Study|Protocol Violation|1|||
163087874|NCT03274466|589032016|FG000|Overall Study|Withdrawal by Subject|7|||
163087875|NCT03274466|589032017|FG001|Overall Study|Withdrawal by Subject|3|||
163087876|NCT03274466|589032016|FG000|Overall Study|Protocol Specified Withdrawal|5|||
163087877|NCT03274466|589032017|FG001|Overall Study|Protocol Specified Withdrawal|11|||
163087878|NCT03274466|589032016|FG000|Overall Study|Lost to Follow-up|5|||
162649207|NCT03131440|587433386|FG013|Overall Study|Lost to Follow-up|0|||
162649208|NCT03131440|587433387|FG014|Overall Study|Lost to Follow-up|0|||
163087879|NCT03274466|589032017|FG001|Overall Study|Lost to Follow-up|7|||
163087880|NCT03274466|589032016|FG000|Overall Study|Subject Non-compliance|0|||
163087881|NCT03274466|589032017|FG001|Overall Study|Subject Non-compliance|1|||
163087882|NCT03274466|589032016|FG000|Overall Study|Adverse Event|3|||
163087883|NCT03274466|589032017|FG001|Overall Study|Adverse Event|3|||
163087884|NCT03274466|589032016|FG000|Overall Study|Physician Decision|0|||
163087885|NCT03274466|589032017|FG001|Overall Study|Physician Decision|1|||
163087886|NCT03274466|589032016|FG000|Overall Study|Protocol Violation|3|||
163087887|NCT03274466|589032017|FG001|Overall Study|Protocol Violation|3|||
162649209|NCT03131440|587433388|FG015|Overall Study|Lost to Follow-up|0|||
162649210|NCT03131440|587433389|FG016|Overall Study|Lost to Follow-up|0|||
162718593|NCT01193153|587676627|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
162718594|NCT01193153|587676628|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
162718595|NCT01193153|587676627|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
162718596|NCT01193153|587676628|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
162718597|NCT01193153|587676627|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
162718598|NCT01193153|587676628|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
162718599|NCT01193153|587676627|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
162718600|NCT01193153|587676628|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
162718601|NCT01193153|587676627|FG000|Open-label Stabilization Period|Other|8|||
162718602|NCT01193153|587676628|FG001|Open-label Stabilization Period|Other|0|||
162718603|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Other|2|||
162718604|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Other|3|||
162718605|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
162718606|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
162718607|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Death|2|||
162718608|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Death|0|||
162718609|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
162718610|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
162718611|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
162718612|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
162718613|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
162718614|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
162718615|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
162718616|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
162718617|NCT01193153|587676627|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
162718618|NCT01193153|587676628|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
162718619|NCT00344019|587676629|FG000|Overall Study|did not meet final inclusion criteria|0|||
162718620|NCT00344019|587676630|FG001|Overall Study|did not meet final inclusion criteria|0|||
162718621|NCT00344019|587676631|FG002|Overall Study|did not meet final inclusion criteria|74|||
162718622|NCT01119950|587676634|FG000|Overall Study|Adverse Event|25|||
162718623|NCT01119950|587676634|FG000|Overall Study|Withdrawal by Subject|9|||
162718624|NCT01119950|587676634|FG000|Overall Study|Protocol Violation|5|||
162718625|NCT01119950|587676634|FG000|Overall Study|Lost to Follow-up|4|||
162718626|NCT01119950|587676634|FG000|Overall Study|Administrative|2|||
162718627|NCT01119950|587676634|FG000|Overall Study|Abnormal lab value|1|||
162718628|NCT01119950|587676634|FG000|Overall Study|Death|1|||
162718629|NCT01988233|587676637|FG000|Overall Study|Lost to Follow-up|64|||
162718630|NCT01988233|587676638|FG001|Overall Study|Lost to Follow-up|51|||
162718631|NCT01591616|587676641|FG000|Overall Study|Withdrawal by Subject|1|||
162718632|NCT00758602|587676642|FG000|Overall Study|Adverse Event|11|||
162718633|NCT00758602|587676643|FG001|Overall Study|Adverse Event|10|||
162718634|NCT00758602|587676642|FG000|Overall Study|Lost to Follow-up|4|||
162718635|NCT00758602|587676643|FG001|Overall Study|Lost to Follow-up|3|||
162718636|NCT00758602|587676642|FG000|Overall Study|Withdrawal by Subject|1|||
162718637|NCT00758602|587676643|FG001|Overall Study|Withdrawal by Subject|3|||
162718638|NCT00758602|587676642|FG000|Overall Study|Protocol Violation|0|||
163036876|NCT00508157|588840283|FG001|Overall Study|Subject no longer met study criteria|1|||
163036877|NCT00508157|588840282|FG000|Overall Study|Other known cause|0|||
163036878|NCT00508157|588840283|FG001|Overall Study|Other known cause|1|||
163036879|NCT01952080|588840285|FG000|Overall Study|Withdrawal by Subject|0|||
163036880|NCT01952080|588840286|FG001|Overall Study|Withdrawal by Subject|0|||
163036881|NCT01952080|588840287|FG002|Overall Study|Withdrawal by Subject|0|||
163036882|NCT01952080|588840288|FG003|Overall Study|Withdrawal by Subject|1|||
163036883|NCT01952080|588840285|FG000|Overall Study|Protocol Non-compliance|0|||
163036884|NCT01952080|588840286|FG001|Overall Study|Protocol Non-compliance|1|||
163036885|NCT01952080|588840287|FG002|Overall Study|Protocol Non-compliance|0|||
163036886|NCT01952080|588840288|FG003|Overall Study|Protocol Non-compliance|0|||
163036887|NCT02134353|588840289|FG000|Overall Study|Adverse Event|10|||
163036888|NCT02134353|588840290|FG001|Overall Study|Adverse Event|6|||
163036889|NCT02134353|588840289|FG000|Overall Study|Lost to Follow-up|1|||
163036890|NCT02134353|588840290|FG001|Overall Study|Lost to Follow-up|1|||
163036891|NCT02134353|588840289|FG000|Overall Study|Lack of Efficacy|2|||
163036892|NCT02134353|588840290|FG001|Overall Study|Lack of Efficacy|1|||
163036893|NCT02134353|588840289|FG000|Overall Study|Withdrawal by Subject|12|||
163036894|NCT02134353|588840290|FG001|Overall Study|Withdrawal by Subject|13|||
163036895|NCT02134353|588840289|FG000|Overall Study|Death|0|||
163036896|NCT02134353|588840290|FG001|Overall Study|Death|1|||
163036897|NCT02134353|588840289|FG000|Overall Study|Pregnancy|0|||
163036898|NCT02134353|588840290|FG001|Overall Study|Pregnancy|1|||
163036899|NCT02134353|588840289|FG000|Overall Study|Relocation|1|||
163036900|NCT02134353|588840290|FG001|Overall Study|Relocation|0|||
163036901|NCT02134353|588840289|FG000|Overall Study|Other - Patient's Choice|0|||
163036902|NCT02134353|588840290|FG001|Overall Study|Other - Patient's Choice|1|||
163087888|NCT01107886|589032023|FG000|Overall Study|Lost to Follow-up|15|||
163087889|NCT01107886|589032024|FG001|Overall Study|Lost to Follow-up|13|||
163087890|NCT01107886|589032023|FG000|Overall Study|Withdrawal by Subject|180|||
163087891|NCT01107886|589032024|FG001|Overall Study|Withdrawal by Subject|196|||
163087892|NCT01107886|589032023|FG000|Overall Study|Administrative withdrawal of consent|7|||
163087893|NCT01107886|589032024|FG001|Overall Study|Administrative withdrawal of consent|5|||
163087894|NCT01346176|589032025|FG000|Recruited|Protocol Violation|1|||
163087895|NCT01346176|589032026|FG001|Recruited|Protocol Violation|0|||
163087896|NCT01346176|589032027|FG002|Recruited|Protocol Violation|0|||
163087897|NCT01346176|589032025|FG000|Completed Advance Directive|Death|3|||
163087898|NCT01346176|589032026|FG001|Completed Advance Directive|Death|2|||
163087899|NCT01346176|589032027|FG002|Completed Advance Directive|Death|2|||
163087900|NCT01346176|589032025|FG000|Completed Advance Directive|Became Ineligible|3|||
163087901|NCT01346176|589032026|FG001|Completed Advance Directive|Became Ineligible|0|||
163087902|NCT01346176|589032027|FG002|Completed Advance Directive|Became Ineligible|1|||
163087903|NCT01346176|589032025|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
163087904|NCT01346176|589032026|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
163087905|NCT01346176|589032027|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
163087906|NCT01346176|589032025|FG000|Completed Satisfaction Survey|Death|3|||
163087907|NCT01346176|589032026|FG001|Completed Satisfaction Survey|Death|0|||
163087908|NCT01346176|589032027|FG002|Completed Satisfaction Survey|Death|2|||
163087909|NCT01346176|589032025|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
163087910|NCT01346176|589032026|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
163087911|NCT01346176|589032027|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
163087912|NCT02581930|589032040|FG000|Overall Study|Withdrawal by Subject|1|||
163087913|NCT02581930|589032040|FG000|Overall Study|patient declined further treatment|1|||
163087914|NCT02776735|589032041|FG000|Overall Study|Adverse Event|0|||
163087915|NCT02776735|589032042|FG001|Overall Study|Adverse Event|0|||
163036903|NCT00655681|588840293|FG000|Overall Study|Lost to Follow-up|1|||
163036904|NCT00655681|588840294|FG001|Overall Study|Lost to Follow-up|1|||
163036905|NCT01783821|588840298|FG000|Overall Study|Screen Failure|1|||
163036906|NCT01783821|588840299|FG001|Overall Study|Screen Failure|1|||
163036907|NCT01653327|588840306|FG000|Overall Study|Withdrawal by Subject|1|||
163036908|NCT00422292|588840307|FG000|Overall Study|Serious adverse events|1|||
162649211|NCT03131440|587433390|FG017|Overall Study|Lost to Follow-up|0|||
162649212|NCT03131440|587433391|FG018|Overall Study|Lost to Follow-up|0|||
162649213|NCT03131440|587433392|FG019|Overall Study|Lost to Follow-up|2|||
162649214|NCT03131440|587433393|FG020|Overall Study|Lost to Follow-up|1|||
162649215|NCT03131440|587433394|FG021|Overall Study|Lost to Follow-up|0|||
162649216|NCT03131440|587433395|FG022|Overall Study|Lost to Follow-up|1|||
162649217|NCT03131440|587433396|FG023|Overall Study|Lost to Follow-up|0|||
162649218|NCT03131440|587433397|FG024|Overall Study|Lost to Follow-up|1|||
162649219|NCT03131440|587433398|FG025|Overall Study|Lost to Follow-up|0|||
162649220|NCT03131440|587433399|FG026|Overall Study|Lost to Follow-up|0|||
162649221|NCT03131440|587433400|FG027|Overall Study|Lost to Follow-up|2|||
162649222|NCT03131440|587433401|FG028|Overall Study|Lost to Follow-up|0|||
162649223|NCT03131440|587433402|FG029|Overall Study|Lost to Follow-up|2|||
162649224|NCT03131440|587433403|FG030|Overall Study|Lost to Follow-up|0|||
162649225|NCT03131440|587433404|FG031|Overall Study|Lost to Follow-up|0|||
162649226|NCT03131440|587433373|FG000|Overall Study|Death|0|||
162649227|NCT03131440|587433374|FG001|Overall Study|Death|0|||
162649228|NCT03131440|587433375|FG002|Overall Study|Death|0|||
162649229|NCT03131440|587433376|FG003|Overall Study|Death|0|||
162649230|NCT03131440|587433377|FG004|Overall Study|Death|0|||
162649231|NCT03131440|587433378|FG005|Overall Study|Death|0|||
162649232|NCT03131440|587433379|FG006|Overall Study|Death|0|||
162649233|NCT03131440|587433380|FG007|Overall Study|Death|0|||
162649234|NCT03131440|587433381|FG008|Overall Study|Death|0|||
162649235|NCT03131440|587433382|FG009|Overall Study|Death|0|||
162649236|NCT03131440|587433383|FG010|Overall Study|Death|0|||
162649237|NCT03131440|587433384|FG011|Overall Study|Death|0|||
162649238|NCT03131440|587433385|FG012|Overall Study|Death|0|||
162649239|NCT03131440|587433386|FG013|Overall Study|Death|0|||
162649240|NCT03131440|587433387|FG014|Overall Study|Death|0|||
162649241|NCT03131440|587433388|FG015|Overall Study|Death|0|||
162649242|NCT03131440|587433389|FG016|Overall Study|Death|0|||
162649243|NCT03131440|587433390|FG017|Overall Study|Death|0|||
162649244|NCT03131440|587433391|FG018|Overall Study|Death|0|||
163036909|NCT00422292|588840308|FG001|Overall Study|Serious adverse events|4|||
163087916|NCT02776735|589032043|FG002|Overall Study|Adverse Event|0|||
163087917|NCT02776735|589032044|FG003|Overall Study|Adverse Event|1|||
163087918|NCT02776735|589032045|FG004|Overall Study|Adverse Event|0|||
163036910|NCT00422292|588840309|FG002|Overall Study|Serious adverse events|0|||
162649245|NCT03131440|587433392|FG019|Overall Study|Death|0|||
163036911|NCT00422292|588840310|FG003|Overall Study|Serious adverse events|0|||
162649246|NCT03131440|587433393|FG020|Overall Study|Death|0|||
162649247|NCT03131440|587433394|FG021|Overall Study|Death|0|||
162649248|NCT03131440|587433395|FG022|Overall Study|Death|0|||
162649249|NCT03131440|587433396|FG023|Overall Study|Death|0|||
163087919|NCT02776735|589032046|FG005|Overall Study|Adverse Event|1|||
163087920|NCT02776735|589032041|FG000|Overall Study|Lost to Follow-up|0|||
163087921|NCT02776735|589032042|FG001|Overall Study|Lost to Follow-up|0|||
163087922|NCT02776735|589032043|FG002|Overall Study|Lost to Follow-up|0|||
163087923|NCT02776735|589032044|FG003|Overall Study|Lost to Follow-up|1|||
163087924|NCT02776735|589032045|FG004|Overall Study|Lost to Follow-up|0|||
163087925|NCT02776735|589032046|FG005|Overall Study|Lost to Follow-up|0|||
163087926|NCT02776735|589032041|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163087927|NCT02776735|589032042|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163087928|NCT02776735|589032043|FG002|Overall Study|Withdrawal by parent/guardian|2|||
163087929|NCT02776735|589032044|FG003|Overall Study|Withdrawal by parent/guardian|2|||
163087930|NCT02776735|589032045|FG004|Overall Study|Withdrawal by parent/guardian|0|||
163087931|NCT02776735|589032046|FG005|Overall Study|Withdrawal by parent/guardian|0|||
163087932|NCT02776735|589032041|FG000|Overall Study|Withdrawal by Subject|1|||
163087933|NCT02776735|589032042|FG001|Overall Study|Withdrawal by Subject|0|||
163087934|NCT02776735|589032043|FG002|Overall Study|Withdrawal by Subject|0|||
163087935|NCT02776735|589032044|FG003|Overall Study|Withdrawal by Subject|0|||
163087936|NCT02776735|589032045|FG004|Overall Study|Withdrawal by Subject|0|||
163087937|NCT02776735|589032046|FG005|Overall Study|Withdrawal by Subject|1|||
163087938|NCT02776735|589032041|FG000|Overall Study|Other|0|||
163087939|NCT02776735|589032042|FG001|Overall Study|Other|0|||
163087940|NCT02776735|589032043|FG002|Overall Study|Other|3|||
163087941|NCT02776735|589032044|FG003|Overall Study|Other|0|||
163087942|NCT02776735|589032045|FG004|Overall Study|Other|0|||
163087943|NCT02776735|589032046|FG005|Overall Study|Other|0|||
163087944|NCT01576783|589033315|FG000|Overall Study|Change in Medical Care|1|||
163087945|NCT01576783|589033316|FG001|Overall Study|Change in Medical Care|0|||
163087946|NCT01576783|589033315|FG000|Overall Study|Lost to Follow-up|14|||
163087947|NCT01576783|589033316|FG001|Overall Study|Lost to Follow-up|16|||
163087948|NCT01576783|589033315|FG000|Overall Study|Withdrawal by Subject|5|||
163087949|NCT01576783|589033316|FG001|Overall Study|Withdrawal by Subject|1|||
163087950|NCT05489328|589033317|FG000|Overall Study|Lost to Follow-up|0|||
163087951|NCT05489328|589033318|FG001|Overall Study|Lost to Follow-up|0|||
163087952|NCT05489328|589033319|FG002|Overall Study|Lost to Follow-up|1|||
163087953|NCT05489328|589033320|FG003|Overall Study|Lost to Follow-up|0|||
163087954|NCT05489328|589033321|FG004|Overall Study|Lost to Follow-up|2|||
163087955|NCT05489328|589033322|FG005|Overall Study|Lost to Follow-up|0|||
163087956|NCT05489328|589033323|FG006|Overall Study|Lost to Follow-up|0|||
163087957|NCT05489328|589033324|FG007|Overall Study|Lost to Follow-up|1|||
163087958|NCT05489328|589033325|FG008|Overall Study|Lost to Follow-up|0|||
163087959|NCT05489328|589033317|FG000|Overall Study|Withdrawal by Subject|0|||
163087960|NCT05489328|589033318|FG001|Overall Study|Withdrawal by Subject|0|||
163087961|NCT05489328|589033319|FG002|Overall Study|Withdrawal by Subject|0|||
163087962|NCT05489328|589033320|FG003|Overall Study|Withdrawal by Subject|0|||
163087963|NCT05489328|589033321|FG004|Overall Study|Withdrawal by Subject|0|||
163087964|NCT05489328|589033322|FG005|Overall Study|Withdrawal by Subject|0|||
163087965|NCT05489328|589033323|FG006|Overall Study|Withdrawal by Subject|1|||
163087966|NCT05489328|589033324|FG007|Overall Study|Withdrawal by Subject|1|||
163087967|NCT05489328|589033325|FG008|Overall Study|Withdrawal by Subject|0|||
163087968|NCT05489328|589033317|FG000|Overall Study|Other|0|||
163087969|NCT05489328|589033318|FG001|Overall Study|Other|0|||
163087970|NCT05489328|589033319|FG002|Overall Study|Other|0|||
163087971|NCT05489328|589033320|FG003|Overall Study|Other|0|||
163087972|NCT05489328|589033321|FG004|Overall Study|Other|0|||
163087973|NCT05489328|589033322|FG005|Overall Study|Other|0|||
163087974|NCT05489328|589033323|FG006|Overall Study|Other|0|||
163087975|NCT05489328|589033324|FG007|Overall Study|Other|1|||
163087976|NCT05489328|589033325|FG008|Overall Study|Other|1|||
163087977|NCT01083602|589033326|FG000|Overall Study|Adverse Event|11|||
163087978|NCT01083602|589033326|FG000|Overall Study|New Cancer Therapy|2|||
163087979|NCT01083602|589033326|FG000|Overall Study|Death|1|||
163087980|NCT01083602|589033326|FG000|Overall Study|Withdrawal by Subject|5|||
163087981|NCT01083602|589033326|FG000|Overall Study|Lack of Efficacy|36|||
163087982|NCT03021486|589033328|FG000|Overall Study|Withdrawal by Subject|1|||
163087983|NCT03021486|589033329|FG001|Overall Study|Withdrawal by Subject|1|||
163087984|NCT03021486|589033330|FG002|Overall Study|Withdrawal by Subject|3|||
163087985|NCT03021486|589033328|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
163087986|NCT03021486|589033329|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
163087987|NCT03021486|589033330|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
163087988|NCT04043286|589033331|FG000|Overall Study|Withdrawal by Subject|2|||
163087989|NCT04043286|589033332|FG001|Overall Study|Withdrawal by Subject|2|||
163087990|NCT01732536|589033333|FG000|Overall Study|Withdrawal by Subject|1|||
163087991|NCT01732536|589033334|FG001|Overall Study|Withdrawal by Subject|1|||
163087992|NCT02986074|589033335|FG000|First Trial Period|Adverse Event|1|||
163087993|NCT02986074|589033336|FG001|First Trial Period|Adverse Event|0|||
163087994|NCT02986074|589033337|FG002|First Trial Period|Adverse Event|0|||
163087995|NCT02986074|589033338|FG003|First Trial Period|Adverse Event|0|||
163087996|NCT02986074|589033335|FG000|Follow up Period|system explant|0|||
163087997|NCT02986074|589033336|FG001|Follow up Period|system explant|0|||
163087998|NCT02986074|589033337|FG002|Follow up Period|system explant|1|||
163087999|NCT02986074|589033338|FG003|Follow up Period|system explant|2|||
163088000|NCT02986074|589033335|FG000|Follow up Period|Physician Decision|0|||
163088001|NCT02986074|589033336|FG001|Follow up Period|Physician Decision|0|||
163088002|NCT02986074|589033337|FG002|Follow up Period|Physician Decision|0|||
163088003|NCT02986074|589033338|FG003|Follow up Period|Physician Decision|1|||
163088004|NCT03186638|589033339|FG000|Overall Study|Withdrawal by Subject|4|||
163088005|NCT03186638|589033340|FG001|Overall Study|Withdrawal by Subject|4|||
163088006|NCT03186638|589033339|FG000|Overall Study|Withdrawn due to medical problem|3|||
163088007|NCT03186638|589033340|FG001|Overall Study|Withdrawn due to medical problem|2|||
163088008|NCT03186638|589033339|FG000|Overall Study|Lost to Follow-up|1|||
163088009|NCT03186638|589033340|FG001|Overall Study|Lost to Follow-up|0|||
163088010|NCT04099277|589033341|FG000|Overall Study|Physician Decision|1|||
163088011|NCT04099277|589033341|FG000|Overall Study|Withdrawal by Subject|1|||
163088012|NCT00524121|589033342|FG000|Overall Study|Disease progression|6|||
163088013|NCT00524121|589033342|FG000|Overall Study|Adverse Event|4|||
163088014|NCT00524121|589033342|FG000|Overall Study|Patient refused|2|||
163088015|NCT00524121|589033342|FG000|Overall Study|Other|1|||
163088016|NCT00524121|589033342|FG000|Overall Study|Death|1|||
163088017|NCT00524121|589033342|FG000|Overall Study|Not treated (became ineligible)|4|||
163088018|NCT00524121|589033342|FG000|Overall Study|Not treated (changed mind)|1|||
163088019|NCT02410772|589033345|FG000|Overall Study|Death|3|||
163088020|NCT02410772|589033346|FG001|Overall Study|Death|4|||
163088021|NCT02410772|589033347|FG002|Overall Study|Death|8|||
163088022|NCT02410772|589033345|FG000|Overall Study|Lost to Follow-up|31|||
163088023|NCT02410772|589033346|FG001|Overall Study|Lost to Follow-up|23|||
163088024|NCT02410772|589033347|FG002|Overall Study|Lost to Follow-up|22|||
163088025|NCT02410772|589033345|FG000|Overall Study|Pregnancy|8|||
163088026|NCT02410772|589033346|FG001|Overall Study|Pregnancy|4|||
163088027|NCT02410772|589033347|FG002|Overall Study|Pregnancy|5|||
163088028|NCT02410772|589033345|FG000|Overall Study|Protocol Violation|8|||
163088029|NCT02410772|589033346|FG001|Overall Study|Protocol Violation|8|||
163088030|NCT02410772|589033347|FG002|Overall Study|Protocol Violation|4|||
163088031|NCT02410772|589033345|FG000|Overall Study|Baseline Drug Resistance|49|||
163088032|NCT02410772|589033346|FG001|Overall Study|Baseline Drug Resistance|40|||
163088033|NCT02410772|589033347|FG002|Overall Study|Baseline Drug Resistance|51|||
163088034|NCT02410772|589033345|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
163088035|NCT02410772|589033346|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
163088036|NCT02410772|589033347|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
163088037|NCT02410772|589033345|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
163088038|NCT02410772|589033346|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
163088039|NCT02410772|589033347|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
163088040|NCT00904371|589033350|FG000|Overall Study|Adverse Event|2|||
163088041|NCT00904371|589033350|FG000|Overall Study|Lost to Follow-up|4|||
163088042|NCT00904371|589033350|FG000|Overall Study|Discontinued at target blood pressure|2|||
163088043|NCT00904371|589033350|FG000|Overall Study|Continued with Tritace|1|||
163088044|NCT00754572|589033355|FG000|Overall Study|Adverse Event|19|||
163088045|NCT00754572|589033355|FG000|Overall Study|Other|39|||
163088046|NCT00754572|589033355|FG000|Overall Study|Protocol Violation|3|||
163088047|NCT00754572|589033355|FG000|Overall Study|Withdrawal by Subject|3|||
163088048|NCT00754572|589033355|FG000|Overall Study|Lack of Efficacy|2|||
163088049|NCT00754572|589033355|FG000|Overall Study|Death|1|||
163088050|NCT00754572|589033355|FG000|Overall Study|Administrative Reason|3|||
163088051|NCT00754572|589033355|FG000|Overall Study|Lost to Follow-up|1|||
163088052|NCT02493764|589033357|FG000|Overall Study|Adverse Event|2|||
163088053|NCT02493764|589033358|FG001|Overall Study|Adverse Event|2|||
163088054|NCT02493764|589033357|FG000|Overall Study|Death|44|||
163088055|NCT02493764|589033358|FG001|Overall Study|Death|58|||
163088056|NCT02493764|589033357|FG000|Overall Study|Lost to Follow-up|2|||
163088057|NCT02493764|589033358|FG001|Overall Study|Lost to Follow-up|1|||
162649250|NCT03131440|587433397|FG024|Overall Study|Death|0|||
162649251|NCT03131440|587433398|FG025|Overall Study|Death|1|||
162649252|NCT03131440|587433399|FG026|Overall Study|Death|0|||
162649253|NCT03131440|587433400|FG027|Overall Study|Death|0|||
163088058|NCT02493764|589033357|FG000|Overall Study|Protocol Violation|6|||
163088059|NCT02493764|589033358|FG001|Overall Study|Protocol Violation|7|||
163088060|NCT02493764|589033357|FG000|Overall Study|Physician Decision|1|||
163088061|NCT02493764|589033358|FG001|Overall Study|Physician Decision|1|||
163088062|NCT02493764|589033357|FG000|Overall Study|Participant moved|17|||
163088063|NCT02493764|589033358|FG001|Overall Study|Participant moved|5|||
163088064|NCT02493764|589033357|FG000|Overall Study|Withdrawal parent/guardian|0|||
163088065|NCT02493764|589033358|FG001|Overall Study|Withdrawal parent/guardian|1|||
163088066|NCT02493764|589033357|FG000|Overall Study|Withdrawal by Subject|11|||
163088067|NCT02493764|589033358|FG001|Overall Study|Withdrawal by Subject|7|||
163088068|NCT04846231|589033364|FG000|Overall Study|Lost to Follow-up|1|||
163088069|NCT04846231|589033365|FG001|Overall Study|Lost to Follow-up|0|||
163088070|NCT04846231|589033366|FG002|Overall Study|Lost to Follow-up|0|||
163088071|NCT04846231|589033367|FG003|Overall Study|Lost to Follow-up|0|||
163088072|NCT04846231|589033368|FG004|Overall Study|Lost to Follow-up|0|||
162718639|NCT00758602|587676643|FG001|Overall Study|Protocol Violation|2|||
162718640|NCT00758602|587676642|FG000|Overall Study|Death|0|||
162718641|NCT00758602|587676643|FG001|Overall Study|Death|1|||
162718642|NCT00758602|587676642|FG000|Overall Study|Reason not specified|3|||
162718643|NCT00758602|587676643|FG001|Overall Study|Reason not specified|3|||
162718644|NCT02148133|587676656|FG000|Overall Study|Investigator discretion|1|||
162718645|NCT02148133|587676656|FG000|Overall Study|Lack of Efficacy|1|||
163088073|NCT04846231|589033369|FG005|Overall Study|Lost to Follow-up|0|||
163088074|NCT04846231|589033370|FG006|Overall Study|Lost to Follow-up|0|||
163088075|NCT04846231|589033371|FG007|Overall Study|Lost to Follow-up|1|||
163088076|NCT04846231|589033364|FG000|Overall Study|Withdrawal by Subject|0|||
163088077|NCT04846231|589033365|FG001|Overall Study|Withdrawal by Subject|1|||
163088078|NCT04846231|589033366|FG002|Overall Study|Withdrawal by Subject|2|||
163088079|NCT04846231|589033367|FG003|Overall Study|Withdrawal by Subject|1|||
163088080|NCT04846231|589033368|FG004|Overall Study|Withdrawal by Subject|0|||
163088081|NCT04846231|589033369|FG005|Overall Study|Withdrawal by Subject|0|||
163088082|NCT04846231|589033370|FG006|Overall Study|Withdrawal by Subject|0|||
163088083|NCT04846231|589033371|FG007|Overall Study|Withdrawal by Subject|0|||
163088084|NCT04846231|589033364|FG000|Overall Study|Protocol Violation|0|||
163088085|NCT04846231|589033365|FG001|Overall Study|Protocol Violation|1|||
163088086|NCT04846231|589033366|FG002|Overall Study|Protocol Violation|0|||
163088087|NCT04846231|589033367|FG003|Overall Study|Protocol Violation|0|||
163088088|NCT04846231|589033368|FG004|Overall Study|Protocol Violation|0|||
163088089|NCT04846231|589033369|FG005|Overall Study|Protocol Violation|0|||
163088090|NCT04846231|589033370|FG006|Overall Study|Protocol Violation|0|||
163088091|NCT04846231|589033371|FG007|Overall Study|Protocol Violation|0|||
163088092|NCT04846231|589033364|FG000|Overall Study|Adverse Event|0|||
163088093|NCT04846231|589033365|FG001|Overall Study|Adverse Event|0|||
163088094|NCT04846231|589033366|FG002|Overall Study|Adverse Event|0|||
163088095|NCT04846231|589033367|FG003|Overall Study|Adverse Event|0|||
163088096|NCT04846231|589033368|FG004|Overall Study|Adverse Event|0|||
163088097|NCT04846231|589033369|FG005|Overall Study|Adverse Event|0|||
163088098|NCT04846231|589033370|FG006|Overall Study|Adverse Event|1|||
163088099|NCT04846231|589033371|FG007|Overall Study|Adverse Event|1|||
163088100|NCT05448950|589033372|FG000|Overall Study|Death|2|||
163088101|NCT05448950|589033372|FG000|Overall Study|Withdrawal by Subject|1|||
163088102|NCT05448950|589033372|FG000|Overall Study|AVG abandoned|4|||
163088103|NCT01646827|589033373|FG000|Overall Study|Lost to Follow-up|0|||
163088104|NCT01646827|589033374|FG001|Overall Study|Lost to Follow-up|3|||
163088105|NCT01646827|589033373|FG000|Overall Study|Physician Decision|1|||
163088106|NCT01646827|589033374|FG001|Overall Study|Physician Decision|2|||
163088107|NCT01646827|589033373|FG000|Overall Study|Withdrawal by Subject|1|||
163088108|NCT01646827|589033374|FG001|Overall Study|Withdrawal by Subject|0|||
163088109|NCT01143402|589033377|FG000|Overall Study|Rapid clinical decline|1|||
163088110|NCT01143402|589033378|FG001|Overall Study|Rapid clinical decline|1|||
163088111|NCT01143402|589033379|FG002|Overall Study|Rapid clinical decline|0|||
163088112|NCT01143402|589033377|FG000|Overall Study|Not Treated|0|||
163088113|NCT01143402|589033378|FG001|Overall Study|Not Treated|0|||
163088114|NCT01143402|589033379|FG002|Overall Study|Not Treated|1|||
163088115|NCT04462471|589033380|FG000|Overall Study|Adverse Event|0|||
163088116|NCT04462471|589033381|FG001|Overall Study|Adverse Event|1|||
163088117|NCT04462471|589033382|FG002|Overall Study|Adverse Event|0|||
163088118|NCT04462471|589033383|FG003|Overall Study|Adverse Event|0|||
163088119|NCT04462471|589033380|FG000|Overall Study|Disease progression|1|||
163088120|NCT04462471|589033381|FG001|Overall Study|Disease progression|0|||
163088121|NCT04462471|589033382|FG002|Overall Study|Disease progression|0|||
163088122|NCT04462471|589033383|FG003|Overall Study|Disease progression|0|||
163088123|NCT02706392|589033384|FG000|Overall Study|Death|1|||
163088124|NCT02706392|589033385|FG001|Overall Study|Death|0|||
163088125|NCT02706392|589033386|FG002|Overall Study|Death|2|||
162718646|NCT02148133|587676656|FG000|Overall Study|Protocol deviation|1|||
162718647|NCT02148133|587676656|FG000|Overall Study|Protocol-defined stopping criteria|2|||
163088126|NCT02706392|589033387|FG003|Overall Study|Death|2|||
163088127|NCT02706392|589033388|FG004|Overall Study|Death|5|||
163088128|NCT02706392|589033389|FG005|Overall Study|Death|2|||
163088129|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088130|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088131|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
163088132|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
163088133|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
163088134|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
163088135|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
163088136|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
162718648|NCT03808883|587676657|FG000|Overall Study|Withdrawal by Subject|2|||
162718649|NCT03808883|587676658|FG001|Overall Study|Withdrawal by Subject|0|||
163088137|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088138|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
163088139|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088140|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
163088141|NCT00265122|589033394|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088142|NCT00265122|589033395|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
163088143|NCT00265122|589033396|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
163088144|NCT00265122|589033397|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
162649254|NCT03131440|587433401|FG028|Overall Study|Death|0|||
162649255|NCT03131440|587433402|FG029|Overall Study|Death|0|||
162649256|NCT03131440|587433403|FG030|Overall Study|Death|0|||
162649257|NCT03131440|587433404|FG031|Overall Study|Death|0|||
162649258|NCT00746941|587433407|FG000|Overall Study|Death|2|||
162649259|NCT00746941|587433408|FG001|Overall Study|Death|0|||
162649260|NCT00746941|587433409|FG002|Overall Study|Death|0|||
162649261|NCT00746941|587433410|FG003|Overall Study|Death|6|||
162649262|NCT00746941|587433407|FG000|Overall Study|Physician Decision|0|||
162649263|NCT00746941|587433408|FG001|Overall Study|Physician Decision|0|||
162649264|NCT00746941|587433409|FG002|Overall Study|Physician Decision|2|||
162649265|NCT00746941|587433410|FG003|Overall Study|Physician Decision|0|||
162649266|NCT00746941|587433407|FG000|Overall Study|Withdrawal by Subject|3|||
162649267|NCT00746941|587433408|FG001|Overall Study|Withdrawal by Subject|0|||
162649268|NCT00746941|587433409|FG002|Overall Study|Withdrawal by Subject|0|||
162649269|NCT00746941|587433410|FG003|Overall Study|Withdrawal by Subject|2|||
162649270|NCT00746941|587433407|FG000|Overall Study|Other, reason not provided|2|||
162649271|NCT00746941|587433408|FG001|Overall Study|Other, reason not provided|4|||
162649272|NCT00746941|587433409|FG002|Overall Study|Other, reason not provided|0|||
162649273|NCT00746941|587433410|FG003|Overall Study|Other, reason not provided|4|||
162649274|NCT00746941|587433407|FG000|Overall Study|Adverse Event|0|||
162649275|NCT00746941|587433408|FG001|Overall Study|Adverse Event|0|||
162649276|NCT00746941|587433409|FG002|Overall Study|Adverse Event|0|||
162649277|NCT00746941|587433410|FG003|Overall Study|Adverse Event|1|||
162649278|NCT03742141|587433417|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
162649279|NCT01354496|587433423|FG000|Period 1|Adverse Event|0|||
162649280|NCT01354496|587433424|FG001|Period 1|Adverse Event|0|||
162649281|NCT01354496|587433425|FG002|Period 1|Adverse Event|1|||
163088145|NCT00265122|589033398|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088146|NCT00265122|589033399|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
163088147|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
163088148|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
163088149|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
163088150|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
163088151|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
163088152|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
163088153|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
163088154|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
163088155|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
163088156|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
163088157|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
163088158|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
163088159|NCT00265122|589033394|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
163088160|NCT00265122|589033395|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088161|NCT00265122|589033396|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
163088162|NCT00265122|589033397|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
163088163|NCT00265122|589033398|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088164|NCT00265122|589033399|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
163088165|NCT01276106|589033400|FG000|Overall Study|Adverse Event|3|||
163088166|NCT01276106|589033401|FG001|Overall Study|Adverse Event|3|||
163088167|NCT01276106|589033402|FG002|Overall Study|Adverse Event|11|||
163088168|NCT01276106|589033403|FG003|Overall Study|Adverse Event|3|||
163088169|NCT01276106|589033400|FG000|Overall Study|Withdrawal by Subject|6|||
163088170|NCT01276106|589033401|FG001|Overall Study|Withdrawal by Subject|3|||
163088171|NCT01276106|589033402|FG002|Overall Study|Withdrawal by Subject|1|||
163088172|NCT01276106|589033403|FG003|Overall Study|Withdrawal by Subject|6|||
163088173|NCT01276106|589033400|FG000|Overall Study|Lack of Efficacy|0|||
163088174|NCT01276106|589033401|FG001|Overall Study|Lack of Efficacy|1|||
163088175|NCT01276106|589033402|FG002|Overall Study|Lack of Efficacy|0|||
163088176|NCT01276106|589033403|FG003|Overall Study|Lack of Efficacy|1|||
163088177|NCT01276106|589033400|FG000|Overall Study|Lost to Follow-up|2|||
163088178|NCT01276106|589033401|FG001|Overall Study|Lost to Follow-up|1|||
162649282|NCT01354496|587433426|FG003|Period 1|Adverse Event|0|||
162649283|NCT01354496|587433427|FG004|Period 1|Adverse Event|0|||
162649284|NCT01354496|587433428|FG005|Period 1|Adverse Event|0|||
162649285|NCT01354496|587433423|FG000|Period 1|Physician Decision|0|||
162649286|NCT01354496|587433424|FG001|Period 1|Physician Decision|0|||
162649287|NCT01354496|587433425|FG002|Period 1|Physician Decision|1|||
162649288|NCT01354496|587433426|FG003|Period 1|Physician Decision|0|||
162649289|NCT01354496|587433427|FG004|Period 1|Physician Decision|0|||
162649290|NCT01354496|587433428|FG005|Period 1|Physician Decision|0|||
162649291|NCT01354496|587433423|FG000|Period 2|Adverse Event|0|||
162649292|NCT01354496|587433424|FG001|Period 2|Adverse Event|0|||
162649293|NCT01354496|587433425|FG002|Period 2|Adverse Event|0|||
162649294|NCT01354496|587433426|FG003|Period 2|Adverse Event|1|||
162649295|NCT01354496|587433427|FG004|Period 2|Adverse Event|0|||
162649296|NCT01354496|587433428|FG005|Period 2|Adverse Event|0|||
162649297|NCT01354496|587433423|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162649298|NCT01354496|587433424|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
162649299|NCT01354496|587433425|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162649300|NCT01354496|587433426|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
162649301|NCT01354496|587433427|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162649302|NCT01354496|587433428|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162649303|NCT00500292|587433432|FG000|Overall Study|Adverse Event|3|||
162649304|NCT00500292|587433433|FG001|Overall Study|Adverse Event|6|||
162718650|NCT03808883|587676657|FG000|Overall Study|Did not complete pre test or post test survey|4|||
162718651|NCT03808883|587676658|FG001|Overall Study|Did not complete pre test or post test survey|3|||
163088179|NCT01276106|589033402|FG002|Overall Study|Lost to Follow-up|1|||
163088180|NCT01276106|589033403|FG003|Overall Study|Lost to Follow-up|0|||
163088181|NCT01276106|589033400|FG000|Overall Study|Physician Decision|0|||
163088182|NCT01276106|589033401|FG001|Overall Study|Physician Decision|0|||
163088183|NCT01276106|589033402|FG002|Overall Study|Physician Decision|1|||
163088184|NCT01276106|589033403|FG003|Overall Study|Physician Decision|1|||
163088185|NCT01276106|589033400|FG000|Overall Study|Protocol Violation|1|||
163088186|NCT01276106|589033401|FG001|Overall Study|Protocol Violation|1|||
163088187|NCT01276106|589033402|FG002|Overall Study|Protocol Violation|0|||
163088188|NCT01276106|589033403|FG003|Overall Study|Protocol Violation|2|||
163088189|NCT01276106|589033400|FG000|Overall Study|Insufficient therapeutic effects|0|||
163088190|NCT01276106|589033401|FG001|Overall Study|Insufficient therapeutic effects|0|||
163088191|NCT01276106|589033402|FG002|Overall Study|Insufficient therapeutic effects|2|||
163088192|NCT01276106|589033403|FG003|Overall Study|Insufficient therapeutic effects|0|||
163088193|NCT00862940|589033407|FG000|Overall Study|Adverse Event|15|||
163088194|NCT00862940|589033408|FG001|Overall Study|Adverse Event|12|||
163088195|NCT00862940|589033407|FG000|Overall Study|Lack of Efficacy|1|||
163088196|NCT00862940|589033408|FG001|Overall Study|Lack of Efficacy|3|||
163088197|NCT00862940|589033407|FG000|Overall Study|Protocol Violation|2|||
163088198|NCT00862940|589033408|FG001|Overall Study|Protocol Violation|5|||
163088199|NCT00862940|589033407|FG000|Overall Study|Withdrawal by Subject|4|||
163088200|NCT00862940|589033408|FG001|Overall Study|Withdrawal by Subject|6|||
163088201|NCT00862940|589033407|FG000|Overall Study|Non-compliance|4|||
163088202|NCT00862940|589033408|FG001|Overall Study|Non-compliance|0|||
163088203|NCT00862940|589033407|FG000|Overall Study|Lost to Follow-up|0|||
163088204|NCT00862940|589033408|FG001|Overall Study|Lost to Follow-up|1|||
163088205|NCT00862940|589033407|FG000|Overall Study|Administrative or other reason(s)|4|||
163088206|NCT00862940|589033408|FG001|Overall Study|Administrative or other reason(s)|3|||
163088207|NCT00485173|589033409|FG000|Overall Study|Death|4|||
163088208|NCT00485173|589033410|FG001|Overall Study|Death|3|||
163088209|NCT00485173|589033409|FG000|Overall Study|Lost to Follow-up|32|||
163088210|NCT00485173|589033410|FG001|Overall Study|Lost to Follow-up|61|||
163088211|NCT00879398|589033413|FG000|Overall Study|Visit Stop|399|||
163088212|NCT00879398|589033413|FG000|Overall Study|Lack of Efficacy|64|||
163088213|NCT00879398|589033413|FG000|Overall Study|Adverse Event|41|||
163088214|NCT00879398|589033413|FG000|Overall Study|Other Reasons|171|||
163088215|NCT00829244|589033414|FG000|Overall Study|Adverse Event|1|||
163088216|NCT00829244|589033415|FG001|Overall Study|Adverse Event|3|||
163088217|NCT00829244|589033414|FG000|Overall Study|Protocol Violation|1|||
163088218|NCT00829244|589033415|FG001|Overall Study|Protocol Violation|0|||
163088219|NCT00829244|589033414|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
163088220|NCT00829244|589033415|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
163088221|NCT00829244|589033414|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
163088222|NCT00829244|589033415|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
163088223|NCT00829244|589033414|FG000|Overall Study|No fertilization|2|||
163088224|NCT00829244|589033415|FG001|Overall Study|No fertilization|2|||
163088225|NCT00829244|589033414|FG000|Overall Study|All embryos discarded|0|||
163088226|NCT00829244|589033415|FG001|Overall Study|All embryos discarded|3|||
163088227|NCT00829244|589033414|FG000|Overall Study|No embryo cleavage|0|||
163088228|NCT00829244|589033415|FG001|Overall Study|No embryo cleavage|2|||
163088229|NCT04251533|589033422|FG000|Overall Study|Progressive disease|33|||
163088230|NCT04251533|589033423|FG001|Overall Study|Progressive disease|29|||
163088231|NCT04251533|589033424|FG002|Overall Study|Progressive disease|22|||
163088232|NCT04251533|589033422|FG000|Overall Study|Death|5|||
163088233|NCT04251533|589033423|FG001|Overall Study|Death|1|||
163088234|NCT04251533|589033424|FG002|Overall Study|Death|3|||
163088235|NCT04251533|589033422|FG000|Overall Study|Physician Decision|3|||
163088236|NCT04251533|589033423|FG001|Overall Study|Physician Decision|2|||
163088237|NCT04251533|589033424|FG002|Overall Study|Physician Decision|4|||
163088238|NCT04251533|589033422|FG000|Overall Study|Participant decision|1|||
162649305|NCT00500292|587433434|FG002|Overall Study|Adverse Event|4|||
163088239|NCT04251533|589033423|FG001|Overall Study|Participant decision|3|||
163088240|NCT04251533|589033424|FG002|Overall Study|Participant decision|1|||
163088241|NCT04251533|589033422|FG000|Overall Study|Adverse Event|2|||
163088242|NCT04251533|589033423|FG001|Overall Study|Adverse Event|1|||
163088243|NCT04251533|589033424|FG002|Overall Study|Adverse Event|1|||
163088244|NCT04583618|589033432|FG000|Overall Study|Adverse Event|0|||
163088245|NCT04583618|589033433|FG001|Overall Study|Adverse Event|0|||
163088246|NCT04583618|589033434|FG002|Overall Study|Adverse Event|1|||
163088247|NCT04583618|589033435|FG003|Overall Study|Adverse Event|0|||
163088248|NCT04583618|589033436|FG004|Overall Study|Adverse Event|0|||
163088249|NCT04583618|589033432|FG000|Overall Study|Protocol deviation|1|||
163088250|NCT04583618|589033433|FG001|Overall Study|Protocol deviation|1|||
163088251|NCT04583618|589033434|FG002|Overall Study|Protocol deviation|1|||
163088252|NCT04583618|589033435|FG003|Overall Study|Protocol deviation|0|||
163088253|NCT04583618|589033436|FG004|Overall Study|Protocol deviation|0|||
163088254|NCT04583618|589033432|FG000|Overall Study|Withdrawal by Subject|2|||
163088255|NCT04583618|589033433|FG001|Overall Study|Withdrawal by Subject|1|||
163088256|NCT04583618|589033434|FG002|Overall Study|Withdrawal by Subject|3|||
163088257|NCT04583618|589033435|FG003|Overall Study|Withdrawal by Subject|1|||
163088258|NCT04583618|589033436|FG004|Overall Study|Withdrawal by Subject|1|||
163088259|NCT04583618|589033432|FG000|Overall Study|Lost to Follow-up|0|||
163088260|NCT04583618|589033433|FG001|Overall Study|Lost to Follow-up|1|||
163088261|NCT04583618|589033434|FG002|Overall Study|Lost to Follow-up|3|||
163088262|NCT04583618|589033435|FG003|Overall Study|Lost to Follow-up|1|||
163088263|NCT04583618|589033436|FG004|Overall Study|Lost to Follow-up|1|||
163088264|NCT02302222|589033439|FG000|Overall Study|Physician Decision|0|||
163088265|NCT02302222|589033440|FG001|Overall Study|Physician Decision|4|||
163088266|NCT02302222|589033439|FG000|Overall Study|Lost to Follow-up|1|||
163088267|NCT02302222|589033440|FG001|Overall Study|Lost to Follow-up|0|||
163088268|NCT02302222|589033439|FG000|Overall Study|Treatment discontinued before day 5|0|||
163088269|NCT02302222|589033440|FG001|Overall Study|Treatment discontinued before day 5|1|||
163088270|NCT02302222|589033439|FG000|Overall Study|Withdrawn prior to any treatment|0|||
163088271|NCT02302222|589033440|FG001|Overall Study|Withdrawn prior to any treatment|1|||
163088272|NCT00016354|589033441|FG000|Overall Study|Lack of Efficacy|0|||
163088273|NCT00016354|589033442|FG001|Overall Study|Lack of Efficacy|0|||
163088274|NCT00016354|589033443|FG002|Overall Study|Lack of Efficacy|0|||
163088275|NCT00016354|589033444|FG003|Overall Study|Lack of Efficacy|0|||
163088276|NCT00016354|589033445|FG004|Overall Study|Lack of Efficacy|0|||
163088277|NCT00016354|589033446|FG005|Overall Study|Lack of Efficacy|0|||
163088278|NCT00016354|589033447|FG006|Overall Study|Lack of Efficacy|0|||
163088279|NCT00016354|589033448|FG007|Overall Study|Lack of Efficacy|1|||
163088280|NCT03110562|589033449|FG000|Initial Treatment Period|Disease Progression|1|||
163088281|NCT03110562|589033450|FG001|Initial Treatment Period|Disease Progression|1|||
163088282|NCT03110562|589033451|FG002|Initial Treatment Period|Disease Progression|0|||
163088283|NCT03110562|589033452|FG003|Initial Treatment Period|Disease Progression|0|||
163088284|NCT03110562|589033449|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
163088285|NCT03110562|589033450|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
163088286|NCT03110562|589033451|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
163088287|NCT03110562|589033452|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
163088288|NCT03110562|589033449|FG000|Initial Treatment Period|Adverse Event|1|||
163088289|NCT03110562|589033450|FG001|Initial Treatment Period|Adverse Event|0|||
163088290|NCT03110562|589033451|FG002|Initial Treatment Period|Adverse Event|0|||
163088291|NCT03110562|589033452|FG003|Initial Treatment Period|Adverse Event|0|||
163088292|NCT03110562|589033449|FG000|Initial Treatment Period|Death|74|||
163088293|NCT03110562|589033450|FG001|Initial Treatment Period|Death|82|||
163088294|NCT03110562|589033451|FG002|Initial Treatment Period|Death|0|||
163088295|NCT03110562|589033452|FG003|Initial Treatment Period|Death|0|||
163088296|NCT03110562|589033449|FG000|Initial Treatment Period|Lost to Follow-up|13|||
163088297|NCT03110562|589033450|FG001|Initial Treatment Period|Lost to Follow-up|8|||
163088298|NCT03110562|589033451|FG002|Initial Treatment Period|Lost to Follow-up|0|||
163088299|NCT03110562|589033452|FG003|Initial Treatment Period|Lost to Follow-up|0|||
163088300|NCT03110562|589033449|FG000|Initial Treatment Period|Protocol Deviation|1|||
163088301|NCT03110562|589033450|FG001|Initial Treatment Period|Protocol Deviation|0|||
163088302|NCT03110562|589033451|FG002|Initial Treatment Period|Protocol Deviation|0|||
163088303|NCT03110562|589033452|FG003|Initial Treatment Period|Protocol Deviation|0|||
163088304|NCT03110562|589033449|FG000|Initial Treatment Period|Physician Decision|2|||
163088305|NCT03110562|589033450|FG001|Initial Treatment Period|Physician Decision|1|||
163088306|NCT03110562|589033451|FG002|Initial Treatment Period|Physician Decision|0|||
163088307|NCT03110562|589033452|FG003|Initial Treatment Period|Physician Decision|0|||
163088308|NCT03110562|589033449|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
163088309|NCT03110562|589033450|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
163088310|NCT03110562|589033451|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
163088311|NCT03110562|589033452|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
163088312|NCT03110562|589033449|FG000|Initial Treatment Period|Other|5|||
163088313|NCT03110562|589033450|FG001|Initial Treatment Period|Other|4|||
163088314|NCT03110562|589033451|FG002|Initial Treatment Period|Other|0|||
163088315|NCT03110562|589033452|FG003|Initial Treatment Period|Other|0|||
163088316|NCT03110562|589033449|FG000|Initial Treatment Period|Randomized but never treated|0|||
163088317|NCT03110562|589033450|FG001|Initial Treatment Period|Randomized but never treated|3|||
163088318|NCT03110562|589033451|FG002|Initial Treatment Period|Randomized but never treated|0|||
163088319|NCT03110562|589033452|FG003|Initial Treatment Period|Randomized but never treated|0|||
163088320|NCT03110562|589033449|FG000|Crossover Period|Disease Progression|0|||
163088321|NCT03110562|589033450|FG001|Crossover Period|Disease Progression|0|||
163088322|NCT03110562|589033451|FG002|Crossover Period|Disease Progression|1|||
163088323|NCT03110562|589033452|FG003|Crossover Period|Disease Progression|0|||
163088324|NCT03110562|589033449|FG000|Crossover Period|Withdrawal by Subject|0|||
163088325|NCT03110562|589033450|FG001|Crossover Period|Withdrawal by Subject|0|||
163088326|NCT03110562|589033451|FG002|Crossover Period|Withdrawal by Subject|8|||
163088327|NCT03110562|589033452|FG003|Crossover Period|Withdrawal by Subject|6|||
163088328|NCT03110562|589033449|FG000|Crossover Period|Death|0|||
163088329|NCT03110562|589033450|FG001|Crossover Period|Death|0|||
163088330|NCT03110562|589033451|FG002|Crossover Period|Death|37|||
163088331|NCT03110562|589033452|FG003|Crossover Period|Death|3|||
163088332|NCT03110562|589033449|FG000|Crossover Period|Lost to Follow-up|0|||
163088333|NCT03110562|589033450|FG001|Crossover Period|Lost to Follow-up|0|||
163088334|NCT03110562|589033451|FG002|Crossover Period|Lost to Follow-up|0|||
163088335|NCT03110562|589033452|FG003|Crossover Period|Lost to Follow-up|1|||
163088336|NCT03110562|589033449|FG000|Crossover Period|Other|0|||
163088337|NCT03110562|589033450|FG001|Crossover Period|Other|0|||
163088338|NCT03110562|589033451|FG002|Crossover Period|Other|1|||
163088339|NCT03110562|589033452|FG003|Crossover Period|Other|1|||
163088340|NCT03110562|589033449|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
163088341|NCT03110562|589033450|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
163088342|NCT03110562|589033451|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
163088343|NCT03110562|589033452|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
163088344|NCT02769481|589033456|FG000|Overall Study|Protocol Violation|1|||
163088345|NCT02769481|589033457|FG001|Overall Study|Protocol Violation|0|||
163088346|NCT02769481|589033456|FG000|Overall Study|Adverse Event|3|||
163088347|NCT02769481|589033457|FG001|Overall Study|Adverse Event|6|||
163088348|NCT02769481|589033456|FG000|Overall Study|Entry Criteria Not Met|1|||
163088349|NCT02769481|589033457|FG001|Overall Study|Entry Criteria Not Met|2|||
163088350|NCT02769481|589033456|FG000|Overall Study|Withdrawal by Subject|14|||
163088351|NCT02769481|589033457|FG001|Overall Study|Withdrawal by Subject|16|||
163088352|NCT02769481|589033456|FG000|Overall Study|Lost to Follow-up|9|||
163088353|NCT02769481|589033457|FG001|Overall Study|Lost to Follow-up|9|||
163088354|NCT02769481|589033456|FG000|Overall Study|Physician Decision|0|||
163088355|NCT02769481|589033457|FG001|Overall Study|Physician Decision|1|||
163088356|NCT02769481|589033456|FG000|Overall Study|Terminated by Sponsor|1|||
163088357|NCT02769481|589033457|FG001|Overall Study|Terminated by Sponsor|0|||
163088358|NCT02769481|589033456|FG000|Overall Study|Death|0|||
163088359|NCT02769481|589033457|FG001|Overall Study|Death|1|||
163088360|NCT02769481|589033456|FG000|Overall Study|Undefined|4|||
163088361|NCT02769481|589033457|FG001|Overall Study|Undefined|1|||
163088362|NCT02781558|589033458|FG000|Overall Study|Lost to Follow-up|2|||
163088363|NCT02781558|589033459|FG001|Overall Study|Lost to Follow-up|2|||
163088364|NCT02781558|589033458|FG000|Overall Study|Adverse Event|1|||
163088365|NCT02781558|589033459|FG001|Overall Study|Adverse Event|0|||
163088366|NCT00643279|589033462|FG000|Overall Study|Death|13|||
163088367|NCT00643279|589033463|FG001|Overall Study|Death|11|||
163088368|NCT00643279|589033462|FG000|Overall Study|Withdrawal by Subject|3|||
163088369|NCT00643279|589033463|FG001|Overall Study|Withdrawal by Subject|0|||
163088370|NCT00643279|589033462|FG000|Overall Study|Lost to Follow-up|0|||
163088371|NCT00643279|589033463|FG001|Overall Study|Lost to Follow-up|1|||
163088372|NCT00643279|589033462|FG000|Overall Study|Physician Decision|0|||
162718652|NCT00855465|587676660|FG000|Treatment Period|Adverse Event|4|||
163088373|NCT00643279|589033463|FG001|Overall Study|Physician Decision|1|||
163088374|NCT01334918|589035806|FG000|Overall Study|Did not receive study drug|6|||
163088375|NCT01334918|589035807|FG001|Overall Study|Did not receive study drug|0|||
163088376|NCT01334918|589035806|FG000|Overall Study|Adverse Event|2|||
163088377|NCT01334918|589035807|FG001|Overall Study|Adverse Event|0|||
163088378|NCT01334918|589035806|FG000|Overall Study|Withdrawal by Subject|0|||
163088379|NCT01334918|589035807|FG001|Overall Study|Withdrawal by Subject|1|||
163088380|NCT01657370|589035813|FG000|Overall Study|Withdrawal by Subject|0|||
163088381|NCT01657370|589035814|FG001|Overall Study|Withdrawal by Subject|0|||
163088382|NCT01657370|589035815|FG002|Overall Study|Withdrawal by Subject|1|||
163088383|NCT01657370|589035816|FG003|Overall Study|Withdrawal by Subject|0|||
163088384|NCT01657370|589035817|FG004|Overall Study|Withdrawal by Subject|0|||
163088385|NCT01657370|589035818|FG005|Overall Study|Withdrawal by Subject|1|||
163088386|NCT01657370|589035813|FG000|Overall Study|Physician Decision|2|||
162649306|NCT00500292|587433432|FG000|Overall Study|Condition under investigation worsened|21|||
162649307|NCT00500292|587433433|FG001|Overall Study|Condition under investigation worsened|23|||
162649308|NCT00500292|587433434|FG002|Overall Study|Condition under investigation worsened|19|||
162649309|NCT00500292|587433432|FG000|Overall Study|Withdrawal by Subject|0|||
162649310|NCT00500292|587433433|FG001|Overall Study|Withdrawal by Subject|1|||
162649311|NCT00500292|587433434|FG002|Overall Study|Withdrawal by Subject|0|||
162649312|NCT00500292|587433432|FG000|Overall Study|Other|1|||
162649313|NCT00500292|587433433|FG001|Overall Study|Other|1|||
162649314|NCT00500292|587433434|FG002|Overall Study|Other|4|||
162649315|NCT03717480|587433435|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
162649316|NCT02741700|587433436|FG000|Overall Study|Lost to Follow-up|17|||
162649317|NCT02741700|587433437|FG001|Overall Study|Lost to Follow-up|8|||
162649318|NCT02741700|587433436|FG000|Overall Study|Withdrawal by Subject|2|||
162649319|NCT02741700|587433437|FG001|Overall Study|Withdrawal by Subject|5|||
162649320|NCT02741700|587433436|FG000|Overall Study|Physician Decision|3|||
162649321|NCT02741700|587433437|FG001|Overall Study|Physician Decision|0|||
162649322|NCT02741700|587433436|FG000|Overall Study|Moved out of State|0|||
162649323|NCT02741700|587433437|FG001|Overall Study|Moved out of State|1|||
162649324|NCT02741700|587433436|FG000|Overall Study|Death|4|||
162649325|NCT02741700|587433437|FG001|Overall Study|Death|5|||
162649326|NCT01774786|587433439|FG000|Overall Study|Death|300|||
163088387|NCT01657370|589035814|FG001|Overall Study|Physician Decision|3|||
163088388|NCT01657370|589035815|FG002|Overall Study|Physician Decision|1|||
163088389|NCT01657370|589035816|FG003|Overall Study|Physician Decision|2|||
163088390|NCT01657370|589035817|FG004|Overall Study|Physician Decision|5|||
163088391|NCT01657370|589035818|FG005|Overall Study|Physician Decision|0|||
163088392|NCT01657370|589035813|FG000|Overall Study|Lack of Qualifying Event|1|||
163088393|NCT01657370|589035814|FG001|Overall Study|Lack of Qualifying Event|0|||
163088394|NCT01657370|589035815|FG002|Overall Study|Lack of Qualifying Event|3|||
163088395|NCT01657370|589035816|FG003|Overall Study|Lack of Qualifying Event|2|||
163088396|NCT01657370|589035817|FG004|Overall Study|Lack of Qualifying Event|1|||
163088397|NCT01657370|589035818|FG005|Overall Study|Lack of Qualifying Event|2|||
163088398|NCT01657370|589035813|FG000|Overall Study|Adverse Event|0|||
163088399|NCT01657370|589035814|FG001|Overall Study|Adverse Event|0|||
163088400|NCT01657370|589035815|FG002|Overall Study|Adverse Event|0|||
163088401|NCT01657370|589035816|FG003|Overall Study|Adverse Event|0|||
163088402|NCT01657370|589035817|FG004|Overall Study|Adverse Event|1|||
163088403|NCT01657370|589035818|FG005|Overall Study|Adverse Event|0|||
163088404|NCT01657370|589035813|FG000|Overall Study|Protocol Violation|1|||
163088405|NCT01657370|589035814|FG001|Overall Study|Protocol Violation|1|||
163088406|NCT01657370|589035815|FG002|Overall Study|Protocol Violation|1|||
163088407|NCT01657370|589035816|FG003|Overall Study|Protocol Violation|1|||
163088408|NCT01657370|589035817|FG004|Overall Study|Protocol Violation|0|||
163088409|NCT01657370|589035818|FG005|Overall Study|Protocol Violation|0|||
163088410|NCT01657370|589035813|FG000|Overall Study|Lost to Follow-up|2|||
163088411|NCT01657370|589035814|FG001|Overall Study|Lost to Follow-up|0|||
163088412|NCT01657370|589035815|FG002|Overall Study|Lost to Follow-up|1|||
163088413|NCT01657370|589035816|FG003|Overall Study|Lost to Follow-up|0|||
163088414|NCT01657370|589035817|FG004|Overall Study|Lost to Follow-up|0|||
163088415|NCT01657370|589035818|FG005|Overall Study|Lost to Follow-up|1|||
163088416|NCT02777086|589035819|FG000|Overall Study|Lost to Follow-up|96|||
163088417|NCT02777086|589035820|FG001|Overall Study|Lost to Follow-up|99|||
163088418|NCT01133665|589035821|FG000|Overall Study|Physician Decision|2|||
163088419|NCT01819272|589035822|FG000|Overall Study|Adverse Event|1|||
163088420|NCT01819272|589035823|FG001|Overall Study|Adverse Event|0|||
163088421|NCT01819272|589035824|FG002|Overall Study|Adverse Event|0|||
163088422|NCT01819272|589035825|FG003|Overall Study|Adverse Event|2|||
163088423|NCT01819272|589035826|FG004|Overall Study|Adverse Event|0|||
163088424|NCT01819272|589035827|FG005|Overall Study|Adverse Event|0|||
162649327|NCT01774786|587433440|FG001|Overall Study|Death|319|||
162649328|NCT01774786|587433439|FG000|Overall Study|Lost to Follow-up|6|||
162649329|NCT01774786|587433440|FG001|Overall Study|Lost to Follow-up|7|||
162649330|NCT01774786|587433439|FG000|Overall Study|Withdrawal by Subject|18|||
162649331|NCT01774786|587433440|FG001|Overall Study|Withdrawal by Subject|14|||
162649332|NCT01774786|587433439|FG000|Overall Study|Physician Decision|2|||
162649333|NCT01774786|587433440|FG001|Overall Study|Physician Decision|0|||
163088425|NCT01819272|589035822|FG000|Overall Study|Lost to Follow-up|3|||
163088426|NCT01819272|589035823|FG001|Overall Study|Lost to Follow-up|0|||
163088427|NCT01819272|589035824|FG002|Overall Study|Lost to Follow-up|1|||
163088428|NCT01819272|589035825|FG003|Overall Study|Lost to Follow-up|0|||
163088429|NCT01819272|589035826|FG004|Overall Study|Lost to Follow-up|0|||
163088430|NCT01819272|589035827|FG005|Overall Study|Lost to Follow-up|3|||
163088431|NCT01819272|589035822|FG000|Overall Study|Protocol Violation|0|||
163088432|NCT01819272|589035823|FG001|Overall Study|Protocol Violation|0|||
163088433|NCT01819272|589035824|FG002|Overall Study|Protocol Violation|0|||
163088434|NCT01819272|589035825|FG003|Overall Study|Protocol Violation|1|||
163088435|NCT01819272|589035826|FG004|Overall Study|Protocol Violation|2|||
163088436|NCT01819272|589035827|FG005|Overall Study|Protocol Violation|3|||
163088437|NCT01819272|589035822|FG000|Overall Study|Physician Decision|0|||
163088438|NCT01819272|589035823|FG001|Overall Study|Physician Decision|1|||
163088439|NCT01819272|589035824|FG002|Overall Study|Physician Decision|0|||
163036912|NCT00422292|588840307|FG000|Overall Study|Adverse Event|1|||
163036913|NCT00422292|588840308|FG001|Overall Study|Adverse Event|0|||
163036914|NCT00422292|588840309|FG002|Overall Study|Adverse Event|1|||
163088440|NCT01819272|589035825|FG003|Overall Study|Physician Decision|0|||
163088441|NCT01819272|589035826|FG004|Overall Study|Physician Decision|0|||
163088442|NCT01819272|589035827|FG005|Overall Study|Physician Decision|0|||
163088443|NCT01819272|589035822|FG000|Overall Study|Withdrawal of Consent|0|||
163088444|NCT01819272|589035823|FG001|Overall Study|Withdrawal of Consent|1|||
163036915|NCT00422292|588840310|FG003|Overall Study|Adverse Event|0|||
163036916|NCT00422292|588840307|FG000|Overall Study|Protocol Violation|4|||
163036917|NCT00422292|588840308|FG001|Overall Study|Protocol Violation|25|||
163036918|NCT00422292|588840309|FG002|Overall Study|Protocol Violation|8|||
163036919|NCT00422292|588840310|FG003|Overall Study|Protocol Violation|5|||
163036920|NCT00422292|588840307|FG000|Overall Study|Lost to Follow-up|6|||
163036921|NCT00422292|588840308|FG001|Overall Study|Lost to Follow-up|12|||
163036922|NCT00422292|588840309|FG002|Overall Study|Lost to Follow-up|6|||
163036923|NCT00422292|588840310|FG003|Overall Study|Lost to Follow-up|6|||
163036924|NCT00422292|588840307|FG000|Overall Study|Withdrawal by Subject|6|||
163036925|NCT00422292|588840308|FG001|Overall Study|Withdrawal by Subject|25|||
163036926|NCT00422292|588840309|FG002|Overall Study|Withdrawal by Subject|7|||
163036927|NCT00422292|588840310|FG003|Overall Study|Withdrawal by Subject|13|||
163036928|NCT02440854|588840311|FG000|Overall Study|Relocation of patient|1|||
163036929|NCT02440854|588840311|FG000|Overall Study|Death|6|||
163036930|NCT02440854|588840311|FG000|Overall Study|Lost to Follow-up|10|||
163036931|NCT02440854|588840311|FG000|Overall Study|Afatinib discontinuation|46|||
163036932|NCT02440854|588840311|FG000|Overall Study|stopped study at earlier timepoint|14|||
163036933|NCT02440854|588840311|FG000|Overall Study|Study medication not received|1|||
163036934|NCT02440854|588840311|FG000|Overall Study|Violation of inclusion criteria|2|||
163036935|NCT02243046|588840312|FG000|Overall Study|Lost to Follow-up|1|||
163036936|NCT02243046|588840313|FG001|Overall Study|Lost to Follow-up|1|||
163036937|NCT02243046|588840314|FG002|Overall Study|Lost to Follow-up|4|||
163036938|NCT02669082|588840315|FG000|Overall Study|Adverse Event|1|||
163036939|NCT04918355|588840316|FG000|Overall Study|no qualifying health encounter|497|||
163036940|NCT04918355|588840317|FG001|Overall Study|no qualifying health encounter|192|||
163036941|NCT04918355|588840318|FG002|Overall Study|no qualifying health encounter|438|||
163036942|NCT04918355|588840319|FG003|Overall Study|no qualifying health encounter|424|||
163036943|NCT04683939|588840323|FG000|Overall Study|Study termination by the sponsor|0|||
163036944|NCT04683939|588840324|FG001|Overall Study|Study termination by the sponsor|1|||
163036945|NCT04683939|588840325|FG002|Overall Study|Study termination by the sponsor|2|||
163036946|NCT04683939|588840326|FG003|Overall Study|Study termination by the sponsor|2|||
163036947|NCT04683939|588840323|FG000|Overall Study|Death|1|||
163036948|NCT04683939|588840324|FG001|Overall Study|Death|1|||
163036949|NCT04683939|588840325|FG002|Overall Study|Death|2|||
163036950|NCT04683939|588840326|FG003|Overall Study|Death|1|||
163036951|NCT04683939|588840323|FG000|Overall Study|Withdrawal by Subject|1|||
163036952|NCT04683939|588840324|FG001|Overall Study|Withdrawal by Subject|0|||
163036953|NCT04683939|588840325|FG002|Overall Study|Withdrawal by Subject|0|||
163036954|NCT04683939|588840326|FG003|Overall Study|Withdrawal by Subject|0|||
163036955|NCT04683939|588840323|FG000|Overall Study|Physician Decision|1|||
163036956|NCT04683939|588840324|FG001|Overall Study|Physician Decision|0|||
163036957|NCT04683939|588840325|FG002|Overall Study|Physician Decision|0|||
163036958|NCT04683939|588840326|FG003|Overall Study|Physician Decision|0|||
163036959|NCT04683939|588840323|FG000|Overall Study|Lost to Follow-up|0|||
163036960|NCT04683939|588840324|FG001|Overall Study|Lost to Follow-up|1|||
163036961|NCT04683939|588840325|FG002|Overall Study|Lost to Follow-up|0|||
163036962|NCT04683939|588840326|FG003|Overall Study|Lost to Follow-up|0|||
163036963|NCT04852276|588840327|FG000|Overall Study|Death|2|||
163036964|NCT04852276|588840328|FG001|Overall Study|Death|0|||
163036965|NCT04852276|588840327|FG000|Overall Study|Lost to Follow-up|15|||
163036966|NCT04852276|588840328|FG001|Overall Study|Lost to Follow-up|9|||
162649334|NCT01774786|587433439|FG000|Overall Study|Non-compliance|0|||
163036967|NCT04852276|588840327|FG000|Overall Study|Withdrawal by Subject|26|||
163036968|NCT04852276|588840328|FG001|Overall Study|Withdrawal by Subject|6|||
163036969|NCT01687283|588842320|FG000|Overall Study|Adverse Event|11|||
163036970|NCT01687283|588842321|FG001|Overall Study|Adverse Event|4|||
163036971|NCT01687283|588842320|FG000|Overall Study|Lack of Efficacy|3|||
163036972|NCT01687283|588842321|FG001|Overall Study|Lack of Efficacy|1|||
163036973|NCT01687283|588842320|FG000|Overall Study|Protocol Violation|1|||
163036974|NCT01687283|588842321|FG001|Overall Study|Protocol Violation|3|||
163036975|NCT01687283|588842320|FG000|Overall Study|protocol defined stopping criteria|8|||
163036976|NCT01687283|588842321|FG001|Overall Study|protocol defined stopping criteria|10|||
163036977|NCT01687283|588842320|FG000|Overall Study|Lost to Follow-up|1|||
163036978|NCT01687283|588842321|FG001|Overall Study|Lost to Follow-up|1|||
163036979|NCT01687283|588842320|FG000|Overall Study|Investigator discretion|2|||
163088445|NCT01819272|589035824|FG002|Overall Study|Withdrawal of Consent|2|||
162649335|NCT01774786|587433440|FG001|Overall Study|Non-compliance|1|||
162649336|NCT01774786|587433439|FG000|Overall Study|Reason Not Specified|2|||
162649337|NCT01774786|587433440|FG001|Overall Study|Reason Not Specified|5|||
162649338|NCT00075582|587433441|FG000|Overall Study|Adverse Event|3|||
162649339|NCT00075582|587433442|FG001|Overall Study|Adverse Event|1|||
162649340|NCT00075582|587433441|FG000|Overall Study|Lack of Efficacy|4|||
162649341|NCT00075582|587433442|FG001|Overall Study|Lack of Efficacy|8|||
162649342|NCT00075582|587433441|FG000|Overall Study|Physician Decision|5|||
162649343|NCT00075582|587433442|FG001|Overall Study|Physician Decision|8|||
162649344|NCT00075582|587433441|FG000|Overall Study|Withdrawal by Subject|2|||
162649345|NCT00075582|587433442|FG001|Overall Study|Withdrawal by Subject|2|||
162649346|NCT00075582|587433441|FG000|Overall Study|Ineligible for study|36|||
162649347|NCT00075582|587433442|FG001|Overall Study|Ineligible for study|16|||
162649348|NCT05045144|587433443|FG000|Overall Study|Lost to Follow-up|3|||
162649349|NCT05045144|587433444|FG001|Overall Study|Lost to Follow-up|2|||
162649350|NCT05045144|587433445|FG002|Overall Study|Lost to Follow-up|3|||
162649351|NCT05045144|587433446|FG003|Overall Study|Lost to Follow-up|5|||
162649352|NCT05045144|587433447|FG004|Overall Study|Lost to Follow-up|13|||
162649353|NCT05045144|587433443|FG000|Overall Study|Withdrawal by Subject|0|||
162649354|NCT05045144|587433444|FG001|Overall Study|Withdrawal by Subject|1|||
162649355|NCT05045144|587433445|FG002|Overall Study|Withdrawal by Subject|0|||
162649356|NCT05045144|587433446|FG003|Overall Study|Withdrawal by Subject|0|||
162649357|NCT05045144|587433447|FG004|Overall Study|Withdrawal by Subject|0|||
162649358|NCT05045144|587433443|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162649359|NCT05045144|587433444|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162649360|NCT05045144|587433445|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162649361|NCT05045144|587433446|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162649362|NCT05045144|587433447|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162649363|NCT04544293|587433448|FG000|Double-blind|Adverse Event|2|||
162649364|NCT04544293|587433449|FG001|Double-blind|Adverse Event|1|||
162649365|NCT04544293|587433448|FG000|Double-blind|Pregnancy|0|||
162649366|NCT04544293|587433449|FG001|Double-blind|Pregnancy|1|||
162649367|NCT04544293|587433448|FG000|Double-blind|Lost to Follow-up|0|||
162649368|NCT04544293|587433449|FG001|Double-blind|Lost to Follow-up|1|||
162649369|NCT04544293|587433448|FG000|Open-Label Extension|Study ongoing|79|||
162649370|NCT04544293|587433449|FG001|Open-Label Extension|Study ongoing|81|||
162649371|NCT02385084|587433450|FG000|Period 2|Protocol Violation|0|||
162649372|NCT02385084|587433451|FG001|Period 2|Protocol Violation|0|||
162649373|NCT02385084|587433452|FG002|Period 2|Protocol Violation|1|||
162649374|NCT02385084|587433453|FG003|Period 2|Protocol Violation|0|||
162649375|NCT02385084|587433454|FG004|Period 2|Protocol Violation|0|||
163036980|NCT01687283|588842321|FG001|Overall Study|Investigator discretion|0|||
163036981|NCT01687283|588842320|FG000|Overall Study|Withdrawal by Subject|9|||
163036982|NCT01687283|588842321|FG001|Overall Study|Withdrawal by Subject|8|||
163036983|NCT00497146|588842322|FG000|Treatment Period|Adverse Event|6|||
163036984|NCT00497146|588842323|FG001|Treatment Period|Adverse Event|2|||
163036985|NCT00497146|588842322|FG000|Treatment Period|Withdrawal by Subject|5|||
163036986|NCT00497146|588842323|FG001|Treatment Period|Withdrawal by Subject|9|||
163036987|NCT00497146|588842322|FG000|Treatment Period|Lost to Follow-up|1|||
163036988|NCT00497146|588842323|FG001|Treatment Period|Lost to Follow-up|3|||
163036989|NCT00497146|588842322|FG000|Treatment Period|Required dialysis|4|||
163036990|NCT00497146|588842323|FG001|Treatment Period|Required dialysis|1|||
163036991|NCT00497146|588842322|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
163036992|NCT00497146|588842323|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
163036993|NCT00497146|588842322|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
163036994|NCT00497146|588842323|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
163036995|NCT00497146|588842322|FG000|Treatment Period|Other Reason|2|||
163036996|NCT00497146|588842323|FG001|Treatment Period|Other Reason|3|||
163036997|NCT00497146|588842322|FG000|Long-term Follow-up Period|Adverse Event|2|||
163036998|NCT00497146|588842323|FG001|Long-term Follow-up Period|Adverse Event|2|||
163036999|NCT00497146|588842322|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
163037000|NCT00497146|588842323|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
163037001|NCT00497146|588842322|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
163037002|NCT00497146|588842323|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
163037003|NCT00497146|588842322|FG000|Long-term Follow-up Period|Other|0|||
163037004|NCT00497146|588842323|FG001|Long-term Follow-up Period|Other|1|||
163037005|NCT04575584|588842324|FG000|Overall Study|Death|6|||
162649376|NCT02385084|587433455|FG005|Period 2|Protocol Violation|0|||
162649377|NCT00744627|587433456|FG000|Overall Study|Adverse Event|6|||
162649378|NCT00744627|587433457|FG001|Overall Study|Adverse Event|9|||
162649379|NCT00744627|587433456|FG000|Overall Study|Lack of Efficacy|7|||
162649380|NCT00744627|587433457|FG001|Overall Study|Lack of Efficacy|3|||
162649381|NCT00744627|587433456|FG000|Overall Study|Noncompliance|0|||
162649382|NCT00744627|587433457|FG001|Overall Study|Noncompliance|1|||
162649383|NCT00744627|587433456|FG000|Overall Study|Protocol Deviations|0|||
162649384|NCT00744627|587433457|FG001|Overall Study|Protocol Deviations|2|||
162649385|NCT00744627|587433456|FG000|Overall Study|Voluntary Withdrawal|9|||
162718653|NCT00855465|587676661|FG001|Treatment Period|Adverse Event|2|||
162718654|NCT00855465|587676660|FG000|Treatment Period|Death|2|||
163037006|NCT04575584|588842325|FG001|Overall Study|Death|4|||
163037007|NCT04575584|588842326|FG002|Overall Study|Death|6|||
163037008|NCT04575584|588842327|FG003|Overall Study|Death|2|||
163037009|NCT04575584|588842328|FG004|Overall Study|Death|0|||
163037010|NCT04575584|588842329|FG005|Overall Study|Death|0|||
163037011|NCT04575584|588842324|FG000|Overall Study|Lost to Follow-up|1|||
163037012|NCT04575584|588842325|FG001|Overall Study|Lost to Follow-up|1|||
163037013|NCT04575584|588842326|FG002|Overall Study|Lost to Follow-up|1|||
163037014|NCT04575584|588842327|FG003|Overall Study|Lost to Follow-up|1|||
163037015|NCT04575584|588842328|FG004|Overall Study|Lost to Follow-up|0|||
163037016|NCT04575584|588842329|FG005|Overall Study|Lost to Follow-up|0|||
163037017|NCT04575584|588842324|FG000|Overall Study|Physician Decision|0|||
163037018|NCT04575584|588842325|FG001|Overall Study|Physician Decision|1|||
163037019|NCT04575584|588842326|FG002|Overall Study|Physician Decision|1|||
163037020|NCT04575584|588842327|FG003|Overall Study|Physician Decision|1|||
163037021|NCT04575584|588842328|FG004|Overall Study|Physician Decision|0|||
163037022|NCT04575584|588842329|FG005|Overall Study|Physician Decision|0|||
163037023|NCT04575584|588842324|FG000|Overall Study|Withdrawal by Subject|7|||
163037024|NCT04575584|588842325|FG001|Overall Study|Withdrawal by Subject|9|||
163037025|NCT04575584|588842326|FG002|Overall Study|Withdrawal by Subject|5|||
163037026|NCT04575584|588842327|FG003|Overall Study|Withdrawal by Subject|3|||
163037027|NCT04575584|588842328|FG004|Overall Study|Withdrawal by Subject|0|||
163037028|NCT04575584|588842329|FG005|Overall Study|Withdrawal by Subject|0|||
163037029|NCT04575584|588842324|FG000|Overall Study|Not recorded|0|||
163037030|NCT04575584|588842325|FG001|Overall Study|Not recorded|0|||
163037031|NCT04575584|588842326|FG002|Overall Study|Not recorded|0|||
163037032|NCT04575584|588842327|FG003|Overall Study|Not recorded|1|||
163037033|NCT04575584|588842328|FG004|Overall Study|Not recorded|0|||
163037034|NCT04575584|588842329|FG005|Overall Study|Not recorded|0|||
163037035|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
163037036|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
163037037|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
163037038|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
163037039|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
163037040|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
163037041|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
163037042|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
163037043|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
163037044|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
163037045|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
163037046|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
163037047|NCT02634801|588842330|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
163037048|NCT02634801|588842331|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
163037049|NCT02634801|588842332|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
163037050|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
163037051|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
163037052|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
163037053|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
163037054|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
163037055|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
163037056|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037057|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037058|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
163037059|NCT02634801|588842330|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
163037060|NCT02634801|588842331|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
163037061|NCT02634801|588842332|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
163037062|NCT02634801|588842330|FG000|Follow-up Period|Lost to Follow-up|3|||
163037063|NCT02634801|588842331|FG001|Follow-up Period|Lost to Follow-up|1|||
163037064|NCT02634801|588842332|FG002|Follow-up Period|Lost to Follow-up|2|||
163037065|NCT02634801|588842330|FG000|Follow-up Period|Physician Decision|0|||
163037066|NCT02634801|588842331|FG001|Follow-up Period|Physician Decision|0|||
163037067|NCT02634801|588842332|FG002|Follow-up Period|Physician Decision|1|||
163037068|NCT02634801|588842330|FG000|Follow-up Period|Withdrawal by Subject|1|||
163037069|NCT02634801|588842331|FG001|Follow-up Period|Withdrawal by Subject|2|||
163037070|NCT02634801|588842332|FG002|Follow-up Period|Withdrawal by Subject|5|||
163037071|NCT02634801|588842330|FG000|Follow-up Period|Adverse Event|1|||
163037072|NCT02634801|588842331|FG001|Follow-up Period|Adverse Event|5|||
163037073|NCT02634801|588842332|FG002|Follow-up Period|Adverse Event|0|||
163037074|NCT00199849|588842333|FG000|Overall Study|Unrelated illness or complication|0|||
163037075|NCT00199849|588842334|FG001|Overall Study|Unrelated illness or complication|1|||
163037076|NCT00199849|588842335|FG002|Overall Study|Unrelated illness or complication|0|||
163037077|NCT00199849|588842333|FG000|Overall Study|Progressive disease requiring intervention|0|||
163037078|NCT00199849|588842334|FG001|Overall Study|Progressive disease requiring intervention|0|||
163037079|NCT00199849|588842335|FG002|Overall Study|Progressive disease requiring intervention|1|||
163037080|NCT00199849|588842333|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
163037081|NCT00199849|588842334|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
163037082|NCT00199849|588842335|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
163037083|NCT01548768|588842336|FG000|Overall Study|Withdrawal by Subject|0|||
162649386|NCT00744627|587433457|FG001|Overall Study|Voluntary Withdrawal|6|||
162649387|NCT00744627|587433456|FG000|Overall Study|Lost to Follow-up|2|||
162649388|NCT00744627|587433457|FG001|Overall Study|Lost to Follow-up|1|||
162649389|NCT00744627|587433456|FG000|Overall Study|Other|1|||
162649390|NCT00744627|587433457|FG001|Overall Study|Other|0|||
162649391|NCT02268786|587433458|FG000|Overall Study|No Euploid Embryos available|42|||
162649392|NCT02268786|587433459|FG001|Overall Study|No Euploid Embryos available|0|||
162649393|NCT02268786|587433458|FG000|Overall Study|Withdrawal by Subject|7|||
162649394|NCT02268786|587433459|FG001|Overall Study|Withdrawal by Subject|14|||
162649395|NCT02268786|587433458|FG000|Overall Study|Thaw Failure|6|||
162649396|NCT02268786|587433459|FG001|Overall Study|Thaw Failure|4|||
162649397|NCT02268786|587433458|FG000|Overall Study|Protocol Violation|1|||
162649398|NCT02268786|587433459|FG001|Overall Study|Protocol Violation|0|||
162649399|NCT04809220|587433462|FG000|Overall Study|Adverse Event|4|||
162649400|NCT04809220|587433463|FG001|Overall Study|Adverse Event|0|||
162649401|NCT04809220|587433462|FG000|Overall Study|Death|1|||
162649402|NCT04809220|587433463|FG001|Overall Study|Death|0|||
162649403|NCT04809220|587433462|FG000|Overall Study|Lost to Follow-up|3|||
162649404|NCT04809220|587433463|FG001|Overall Study|Lost to Follow-up|0|||
162649405|NCT04809220|587433462|FG000|Overall Study|Physician Decision|0|||
162649406|NCT04809220|587433463|FG001|Overall Study|Physician Decision|1|||
162649407|NCT04809220|587433462|FG000|Overall Study|Withdrawal by Subject|9|||
162649408|NCT04809220|587433463|FG001|Overall Study|Withdrawal by Subject|5|||
162649409|NCT04809220|587433462|FG000|Overall Study|Due to long-term overseas business trips|1|||
162649410|NCT04809220|587433463|FG001|Overall Study|Due to long-term overseas business trips|0|||
162649411|NCT01062555|587433468|FG000|Phase 1|Death|10|||
162649412|NCT01062555|587433469|FG001|Phase 1|Death|17|||
162649413|NCT01062555|587433470|FG002|Phase 1|Death|0|||
162649414|NCT01062555|587433471|FG003|Phase 1|Death|0|||
162649415|NCT01062555|587433468|FG000|Phase 1|Graft Failure|12|||
162649416|NCT01062555|587433469|FG001|Phase 1|Graft Failure|8|||
162649417|NCT01062555|587433470|FG002|Phase 1|Graft Failure|0|||
162649418|NCT01062555|587433471|FG003|Phase 1|Graft Failure|0|||
162649419|NCT01062555|587433468|FG000|Phase 1|Withdrawal by Subject|1|||
162649420|NCT01062555|587433469|FG001|Phase 1|Withdrawal by Subject|1|||
162649421|NCT01062555|587433470|FG002|Phase 1|Withdrawal by Subject|0|||
162649422|NCT01062555|587433471|FG003|Phase 1|Withdrawal by Subject|0|||
162649423|NCT01062555|587433468|FG000|Phase 2|Death|0|||
162649424|NCT01062555|587433469|FG001|Phase 2|Death|0|||
162649425|NCT01062555|587433470|FG002|Phase 2|Death|8|||
162649426|NCT01062555|587433471|FG003|Phase 2|Death|3|||
162649427|NCT01062555|587433468|FG000|Phase 2|Graft failure|0|||
162649428|NCT01062555|587433469|FG001|Phase 2|Graft failure|0|||
162649429|NCT01062555|587433470|FG002|Phase 2|Graft failure|7|||
162649430|NCT01062555|587433471|FG003|Phase 2|Graft failure|4|||
162649431|NCT01062555|587433468|FG000|Phase 2|Withdrawal by Subject|0|||
162649432|NCT01062555|587433469|FG001|Phase 2|Withdrawal by Subject|0|||
162649433|NCT01062555|587433470|FG002|Phase 2|Withdrawal by Subject|0|||
162649434|NCT01062555|587433471|FG003|Phase 2|Withdrawal by Subject|7|||
162649435|NCT01062555|587433468|FG000|Phase 2|Protocol Violation|0|||
162649436|NCT01062555|587433469|FG001|Phase 2|Protocol Violation|0|||
162649437|NCT01062555|587433470|FG002|Phase 2|Protocol Violation|0|||
162649438|NCT01062555|587433471|FG003|Phase 2|Protocol Violation|3|||
162649439|NCT01062555|587433468|FG000|Phase 2|Physician Decision|0|||
162649440|NCT01062555|587433469|FG001|Phase 2|Physician Decision|0|||
162649441|NCT01062555|587433470|FG002|Phase 2|Physician Decision|0|||
162649442|NCT01062555|587433471|FG003|Phase 2|Physician Decision|17|||
162649443|NCT03560531|587433472|FG000|Overall Study|Death|4|||
162649444|NCT03560531|587433473|FG001|Overall Study|Death|1|||
162649445|NCT03560531|587433474|FG002|Overall Study|Death|1|||
162649446|NCT03560531|587433475|FG003|Overall Study|Death|2|||
162649447|NCT03560531|587433476|FG004|Overall Study|Death|6|||
162649448|NCT03560531|587433477|FG005|Overall Study|Death|1|||
162649449|NCT03560531|587433478|FG006|Overall Study|Death|4|||
162649450|NCT03560531|587433479|FG007|Overall Study|Death|8|||
162649451|NCT03560531|587433480|FG008|Overall Study|Death|1|||
162649452|NCT03560531|587433481|FG009|Overall Study|Death|3|||
162649453|NCT03560531|587433482|FG010|Overall Study|Death|2|||
162649454|NCT03560531|587433483|FG011|Overall Study|Death|0|||
162649455|NCT03560531|587433484|FG012|Overall Study|Death|4|||
162649456|NCT03560531|587433485|FG013|Overall Study|Death|1|||
162649457|NCT03560531|587433472|FG000|Overall Study|Lost to Follow-up|1|||
162649458|NCT03560531|587433473|FG001|Overall Study|Lost to Follow-up|1|||
162649459|NCT03560531|587433474|FG002|Overall Study|Lost to Follow-up|0|||
162649460|NCT03560531|587433475|FG003|Overall Study|Lost to Follow-up|0|||
162649461|NCT03560531|587433476|FG004|Overall Study|Lost to Follow-up|0|||
163037084|NCT01548768|588842337|FG001|Overall Study|Withdrawal by Subject|2|||
163037085|NCT01548768|588842338|FG002|Overall Study|Withdrawal by Subject|1|||
163037086|NCT01548768|588842339|FG003|Overall Study|Withdrawal by Subject|0|||
163037087|NCT01548768|588842336|FG000|Overall Study|Physician Decision|1|||
163037088|NCT01548768|588842337|FG001|Overall Study|Physician Decision|0|||
163037089|NCT01548768|588842338|FG002|Overall Study|Physician Decision|0|||
163037090|NCT01548768|588842339|FG003|Overall Study|Physician Decision|0|||
163037091|NCT01548768|588842336|FG000|Overall Study|Adverse Event|0|||
163037092|NCT01548768|588842337|FG001|Overall Study|Adverse Event|0|||
163037093|NCT01548768|588842338|FG002|Overall Study|Adverse Event|0|||
163037094|NCT01548768|588842339|FG003|Overall Study|Adverse Event|1|||
163037095|NCT01548768|588842336|FG000|Overall Study|Non-Compliance|0|||
163037096|NCT01548768|588842337|FG001|Overall Study|Non-Compliance|0|||
163037097|NCT01548768|588842338|FG002|Overall Study|Non-Compliance|0|||
163037098|NCT01548768|588842339|FG003|Overall Study|Non-Compliance|3|||
163037099|NCT02178358|588842342|FG000|Overall Study|Withdrawal by Subject|0|||
163037100|NCT02178358|588842343|FG001|Overall Study|Withdrawal by Subject|2|||
163037101|NCT02178358|588842344|FG002|Overall Study|Withdrawal by Subject|2|||
163037102|NCT02178358|588842342|FG000|Overall Study|Lost to Follow-up|1|||
163037103|NCT02178358|588842343|FG001|Overall Study|Lost to Follow-up|0|||
163037104|NCT02178358|588842344|FG002|Overall Study|Lost to Follow-up|0|||
163037105|NCT00645671|588842346|FG000|Overall Study|Protocol Violation|1|||
163037106|NCT00645671|588842347|FG001|Overall Study|Protocol Violation|0|||
163037107|NCT00645671|588842346|FG000|Overall Study|Withdrawal by Subject|0|||
163037108|NCT00645671|588842347|FG001|Overall Study|Withdrawal by Subject|4|||
163037109|NCT00645671|588842346|FG000|Overall Study|Adverse Event|0|||
163037110|NCT00645671|588842347|FG001|Overall Study|Adverse Event|1|||
163037111|NCT00645671|588842346|FG000|Overall Study|Physician Decision|0|||
163037112|NCT00645671|588842347|FG001|Overall Study|Physician Decision|1|||
163037113|NCT00493311|588842348|FG000|Overall Study|Need for rescue medication|2|||
163037114|NCT00493311|588842349|FG001|Overall Study|Need for rescue medication|2|||
163037115|NCT05600036|588842350|FG000|Overall Study|Adverse Event|0|||
163037116|NCT05600036|588842351|FG001|Overall Study|Adverse Event|2|||
163037117|NCT05600036|588842352|FG002|Overall Study|Adverse Event|1|||
163037118|NCT05600036|588842353|FG003|Overall Study|Adverse Event|0|||
163037119|NCT05600036|588842354|FG004|Overall Study|Adverse Event|1|||
163037120|NCT05600036|588842355|FG005|Overall Study|Adverse Event|0|||
163037121|NCT05600036|588842350|FG000|Overall Study|Lost to Follow-up|0|||
163037122|NCT05600036|588842351|FG001|Overall Study|Lost to Follow-up|2|||
163037123|NCT05600036|588842352|FG002|Overall Study|Lost to Follow-up|1|||
163037124|NCT05600036|588842353|FG003|Overall Study|Lost to Follow-up|1|||
163037125|NCT05600036|588842354|FG004|Overall Study|Lost to Follow-up|0|||
163037126|NCT05600036|588842355|FG005|Overall Study|Lost to Follow-up|0|||
163037127|NCT05600036|588842350|FG000|Overall Study|Protocol Violation|0|||
163037128|NCT05600036|588842351|FG001|Overall Study|Protocol Violation|0|||
163037129|NCT05600036|588842352|FG002|Overall Study|Protocol Violation|2|||
163037130|NCT05600036|588842353|FG003|Overall Study|Protocol Violation|0|||
163037131|NCT05600036|588842354|FG004|Overall Study|Protocol Violation|0|||
163037132|NCT05600036|588842355|FG005|Overall Study|Protocol Violation|0|||
163037133|NCT05600036|588842350|FG000|Overall Study|Withdrawal by Subject|0|||
163037134|NCT05600036|588842351|FG001|Overall Study|Withdrawal by Subject|1|||
163037135|NCT05600036|588842352|FG002|Overall Study|Withdrawal by Subject|2|||
163037136|NCT05600036|588842353|FG003|Overall Study|Withdrawal by Subject|0|||
163037137|NCT05600036|588842354|FG004|Overall Study|Withdrawal by Subject|3|||
163037138|NCT05600036|588842355|FG005|Overall Study|Withdrawal by Subject|5|||
163037139|NCT05600036|588842350|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037140|NCT05600036|588842351|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037141|NCT05600036|588842352|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037142|NCT05600036|588842353|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
163037143|NCT05600036|588842354|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037144|NCT05600036|588842355|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
163037145|NCT05600036|588842350|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037146|NCT05600036|588842351|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
163037147|NCT05600036|588842352|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
162649462|NCT03560531|587433477|FG005|Overall Study|Lost to Follow-up|0|||
163037148|NCT05600036|588842353|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037149|NCT05600036|588842354|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037150|NCT05600036|588842355|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
163037151|NCT05600036|588842350|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037152|NCT05600036|588842351|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037153|NCT05600036|588842352|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037154|NCT05600036|588842353|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
163037155|NCT05600036|588842354|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037156|NCT05600036|588842355|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
163037157|NCT04348500|588842356|FG000|Overall Study|Death|2|||
163037158|NCT04348500|588842357|FG001|Overall Study|Death|2|||
163037159|NCT04348500|588842356|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
163037160|NCT04348500|588842357|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
163037161|NCT02722746|588842358|FG000|Overall Study|Withdrawal by Subject|0|||
163037162|NCT02722746|588842359|FG001|Overall Study|Withdrawal by Subject|1|||
163037163|NCT02722746|588842360|FG002|Overall Study|Withdrawal by Subject|0|||
163037164|NCT02722746|588842358|FG000|Overall Study|Protocol Violation|8|||
163037165|NCT02722746|588842359|FG001|Overall Study|Protocol Violation|4|||
163037166|NCT02722746|588842360|FG002|Overall Study|Protocol Violation|6|||
163037167|NCT01038752|588842365|FG000|Overall Study|Tumor Progression|2|||
163037168|NCT01038752|588842366|FG001|Overall Study|Tumor Progression|2|||
163037169|NCT01038752|588842365|FG000|Overall Study|Lost to Follow-up|3|||
163037170|NCT01038752|588842366|FG001|Overall Study|Lost to Follow-up|3|||
163037171|NCT02700698|588842373|FG000|Overall Study|Withdrawal by Subject|1|||
163037172|NCT02700698|588842374|FG001|Overall Study|Withdrawal by Subject|0|||
163037173|NCT00703118|588842375|FG000|Overall Study|Adverse Event|1|||
163037174|NCT00703118|588842376|FG001|Overall Study|Adverse Event|2|||
163037175|NCT00703118|588842377|FG002|Overall Study|Adverse Event|2|||
163037176|NCT00703118|588842375|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
163037177|NCT00703118|588842376|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
163037178|NCT00703118|588842377|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
163037179|NCT00703118|588842375|FG000|Overall Study|Lost to Follow-up|6|||
163037180|NCT00703118|588842376|FG001|Overall Study|Lost to Follow-up|4|||
163088446|NCT01819272|589035825|FG003|Overall Study|Withdrawal of Consent|1|||
163088447|NCT01819272|589035826|FG004|Overall Study|Withdrawal of Consent|0|||
163088448|NCT01819272|589035827|FG005|Overall Study|Withdrawal of Consent|1|||
163088449|NCT01819272|589035822|FG000|Overall Study|Loss of Glucose Control|2|||
163088450|NCT01819272|589035823|FG001|Overall Study|Loss of Glucose Control|1|||
163088451|NCT01819272|589035824|FG002|Overall Study|Loss of Glucose Control|0|||
163088452|NCT01819272|589035825|FG003|Overall Study|Loss of Glucose Control|1|||
163088453|NCT01819272|589035826|FG004|Overall Study|Loss of Glucose Control|2|||
163088454|NCT01819272|589035827|FG005|Overall Study|Loss of Glucose Control|0|||
163088455|NCT00805389|589035828|FG000|Overall Study|Adverse Event|0|||
163088456|NCT00805389|589035829|FG001|Overall Study|Adverse Event|0|||
163088457|NCT00805389|589035830|FG002|Overall Study|Adverse Event|1|||
163088458|NCT00805389|589035831|FG003|Overall Study|Adverse Event|2|||
163088459|NCT00805389|589035832|FG004|Overall Study|Adverse Event|0|||
163088460|NCT00805389|589035828|FG000|Overall Study|Lost to Follow-up|4|||
163088461|NCT00805389|589035829|FG001|Overall Study|Lost to Follow-up|3|||
163088462|NCT00805389|589035830|FG002|Overall Study|Lost to Follow-up|6|||
163088463|NCT00805389|589035831|FG003|Overall Study|Lost to Follow-up|10|||
163088464|NCT00805389|589035832|FG004|Overall Study|Lost to Follow-up|9|||
163088465|NCT00805389|589035828|FG000|Overall Study|Protocol Violation|0|||
163088466|NCT00805389|589035829|FG001|Overall Study|Protocol Violation|0|||
163088467|NCT00805389|589035830|FG002|Overall Study|Protocol Violation|1|||
163088468|NCT00805389|589035831|FG003|Overall Study|Protocol Violation|0|||
163088469|NCT00805389|589035832|FG004|Overall Study|Protocol Violation|0|||
163088470|NCT00805389|589035828|FG000|Overall Study|Withdrawal by Subject|3|||
163088471|NCT00805389|589035829|FG001|Overall Study|Withdrawal by Subject|2|||
163088472|NCT00805389|589035830|FG002|Overall Study|Withdrawal by Subject|4|||
163088473|NCT00805389|589035831|FG003|Overall Study|Withdrawal by Subject|5|||
163088474|NCT00805389|589035832|FG004|Overall Study|Withdrawal by Subject|4|||
163088475|NCT01246960|589035833|FG000|Overall Study|Lost to Follow-up|3|||
163088476|NCT01246960|589035834|FG001|Overall Study|Lost to Follow-up|1|||
163088477|NCT01246960|589035833|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
163088478|NCT01246960|589035834|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
163088479|NCT03376516|589035839|FG000|Overall Study|Not treated|1|||
163088480|NCT03376516|589035839|FG000|Overall Study|Consent withdrawn|1|||
163088481|NCT01581684|589035840|FG000|Overall Study|Other reason not defined|0|||
163037181|NCT00703118|588842377|FG002|Overall Study|Lost to Follow-up|4|||
163037182|NCT00703118|588842375|FG000|Overall Study|Withdrawal by Subject|8|||
163037183|NCT00703118|588842376|FG001|Overall Study|Withdrawal by Subject|7|||
163037184|NCT00703118|588842377|FG002|Overall Study|Withdrawal by Subject|13|||
163037185|NCT00703118|588842375|FG000|Overall Study|Other|0|||
163037186|NCT00703118|588842376|FG001|Overall Study|Other|0|||
163088482|NCT01581684|589035841|FG001|Overall Study|Other reason not defined|0|||
163088483|NCT01581684|589035842|FG002|Overall Study|Other reason not defined|0|||
163088484|NCT01581684|589035843|FG003|Overall Study|Other reason not defined|0|||
163088485|NCT01581684|589035844|FG004|Overall Study|Other reason not defined|0|||
162649463|NCT03560531|587433478|FG006|Overall Study|Lost to Follow-up|1|||
163088486|NCT01581684|589035845|FG005|Overall Study|Other reason not defined|0|||
163088487|NCT01581684|589035846|FG006|Overall Study|Other reason not defined|0|||
163088488|NCT01581684|589035847|FG007|Overall Study|Other reason not defined|0|||
163088489|NCT01581684|589035848|FG008|Overall Study|Other reason not defined|1|||
163088490|NCT01581684|589035849|FG009|Overall Study|Other reason not defined|0|||
163088491|NCT02239926|589035852|FG000|Overall Study|Withdrawal by Subject|0|||
163088492|NCT02239926|589035853|FG001|Overall Study|Withdrawal by Subject|1|||
163088493|NCT00598650|589035856|FG000|Overall Study|Withdrawal by Subject|3|||
163088494|NCT00598650|589035856|FG000|Overall Study|Adverse Event|18|||
163088495|NCT00598650|589035856|FG000|Overall Study|No treatment for 3 weeks|1|||
163088496|NCT00598650|589035856|FG000|Overall Study|Not eligible|1|||
163088497|NCT00598650|589035856|FG000|Overall Study|Prohibited Concomitant Medication|2|||
163088498|NCT00598650|589035856|FG000|Overall Study|Physician Decision|2|||
163088499|NCT01628913|589035857|FG000|Overall Study|Adverse Event|12|||
163088500|NCT01628913|589035858|FG001|Overall Study|Adverse Event|5|||
163088501|NCT01628913|589035857|FG000|Overall Study|Disease Progression|11|||
163088502|NCT01628913|589035858|FG001|Overall Study|Disease Progression|14|||
163088503|NCT01628913|589035857|FG000|Overall Study|Protocol Violation|1|||
163088504|NCT01628913|589035858|FG001|Overall Study|Protocol Violation|0|||
163088505|NCT01628913|589035857|FG000|Overall Study|Death|1|||
163088506|NCT01628913|589035858|FG001|Overall Study|Death|0|||
163088507|NCT01628913|589035857|FG000|Overall Study|study terminated by Sponsor|4|||
163088508|NCT01628913|589035858|FG001|Overall Study|study terminated by Sponsor|9|||
163088509|NCT01628913|589035857|FG000|Overall Study|Withdrawal by Subject|1|||
163088510|NCT01628913|589035858|FG001|Overall Study|Withdrawal by Subject|0|||
163088511|NCT01628913|589035857|FG000|Overall Study|Physician Decision|1|||
163088512|NCT01628913|589035858|FG001|Overall Study|Physician Decision|3|||
163088513|NCT05201807|589035862|FG000|Overall Study|Adverse Event|1|||
163088514|NCT05201807|589035862|FG000|Overall Study|COVID-19 Related|1|||
163088515|NCT01664624|589035865|FG000|Overall Study|Adverse Event|0|||
163088516|NCT01664624|589035866|FG001|Overall Study|Adverse Event|1|||
163088517|NCT01664624|589035867|FG002|Overall Study|Adverse Event|0|||
163088518|NCT01664624|589035868|FG003|Overall Study|Adverse Event|0|||
163088519|NCT01029535|589035871|FG000|Overall Study|Lost to Follow-up|24|||
163088520|NCT01029535|589035871|FG000|Overall Study|Protocol Violation|2|||
163088521|NCT01029535|589035871|FG000|Overall Study|Participant Withdrew Consent|2|||
163088522|NCT01029535|589035871|FG000|Overall Study|Adverse Event|1|||
163088523|NCT01029535|589035871|FG000|Overall Study|Use of Another Treatment|1|||
163088524|NCT01029535|589035871|FG000|Overall Study|Death|1|||
163088525|NCT01146613|589035878|FG000|Overall Study|Lost to Follow-up|3|||
162649464|NCT03560531|587433479|FG007|Overall Study|Lost to Follow-up|0|||
163037187|NCT00703118|588842377|FG002|Overall Study|Other|1|||
163037188|NCT05053035|588842380|FG000|Overall Study|Withdrawal by Subject|1|||
163037189|NCT05053035|588842381|FG001|Overall Study|Withdrawal by Subject|0|||
163037190|NCT00438256|588842382|FG000|Overall Study|Ineligible for Resection|2|||
163037191|NCT00438256|588842383|FG001|Overall Study|Ineligible for Resection|1|||
163037192|NCT00438256|588842384|FG002|Overall Study|Ineligible for Resection|1|||
163037193|NCT00438256|588842385|FG003|Overall Study|Ineligible for Resection|7|||
163037194|NCT00438256|588842382|FG000|Overall Study|Excluded final Diagnosis|0|||
163037195|NCT00438256|588842383|FG001|Overall Study|Excluded final Diagnosis|0|||
163037196|NCT00438256|588842384|FG002|Overall Study|Excluded final Diagnosis|0|||
163037197|NCT00438256|588842385|FG003|Overall Study|Excluded final Diagnosis|2|||
163037198|NCT02005627|588842389|FG000|Overall Study|Lost to Follow-up|1|||
163037199|NCT02005627|588842390|FG001|Overall Study|Lost to Follow-up|2|||
163037200|NCT02005627|588842389|FG000|Overall Study|Withdrawal by Subject|1|||
163037201|NCT02005627|588842390|FG001|Overall Study|Withdrawal by Subject|2|||
163037202|NCT03760458|588842393|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
163037203|NCT03760458|588842394|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
163037204|NCT03760458|588842395|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037205|NCT03760458|588842396|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037206|NCT03760458|588842397|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
163037207|NCT00750919|588842398|FG000|Overall Study|Adverse Event|9|||
163037208|NCT00750919|588842398|FG000|Overall Study|Withdrawal by Subject|1|||
163037209|NCT00750919|588842398|FG000|Overall Study|Lack of Efficacy|8|||
163037210|NCT00750919|588842398|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
163037211|NCT00750919|588842398|FG000|Overall Study|Other|36|||
163037212|NCT00048997|588842403|FG000|Overall Study|Protocol Violation|7|||
163037213|NCT00048997|588842404|FG001|Overall Study|Protocol Violation|2|||
163037214|NCT00048997|588842403|FG000|Overall Study|Withdrawal by Subject|6|||
163037215|NCT00048997|588842404|FG001|Overall Study|Withdrawal by Subject|1|||
163037216|NCT00002525|588842411|FG000|Overall Study|Adverse Event|36|||
163037217|NCT00002525|588842412|FG001|Overall Study|Adverse Event|0|||
163037218|NCT00002525|588842411|FG000|Overall Study|Death|5|||
163037219|NCT00002525|588842412|FG001|Overall Study|Death|0|||
163088526|NCT01146613|589035879|FG001|Overall Study|Lost to Follow-up|8|||
162649465|NCT03560531|587433480|FG008|Overall Study|Lost to Follow-up|0|||
163088527|NCT01146613|589035878|FG000|Overall Study|Lack of Efficacy|0|||
163088528|NCT01146613|589035879|FG001|Overall Study|Lack of Efficacy|1|||
163088529|NCT01146613|589035878|FG000|Overall Study|Death|1|||
163088530|NCT01146613|589035879|FG001|Overall Study|Death|0|||
163088531|NCT01146613|589035878|FG000|Overall Study|Physician Decision|1|||
163088532|NCT01146613|589035879|FG001|Overall Study|Physician Decision|0|||
163088533|NCT01146613|589035878|FG000|Overall Study|Withdrawal by Subject|0|||
163088534|NCT01146613|589035879|FG001|Overall Study|Withdrawal by Subject|3|||
163088535|NCT01146613|589035878|FG000|Overall Study|schedule conflict|1|||
162718655|NCT00855465|587676661|FG001|Treatment Period|Death|2|||
163037220|NCT00002525|588842411|FG000|Overall Study|Withdrawal by Subject|11|||
163037221|NCT00002525|588842412|FG001|Overall Study|Withdrawal by Subject|0|||
163037222|NCT00002525|588842411|FG000|Overall Study|Start non-protocol therapy|1|||
163037223|NCT00002525|588842412|FG001|Overall Study|Start non-protocol therapy|0|||
163037224|NCT00002525|588842411|FG000|Overall Study|Other complicating disease|1|||
163037225|NCT00002525|588842412|FG001|Overall Study|Other complicating disease|0|||
163037226|NCT00002525|588842411|FG000|Overall Study|Duke's A, B1, D disease|92|||
163037227|NCT00002525|588842412|FG001|Overall Study|Duke's A, B1, D disease|0|||
163037228|NCT00002525|588842411|FG000|Overall Study|Error|6|||
163037229|NCT00002525|588842412|FG001|Overall Study|Error|0|||
163037230|NCT00002525|588842411|FG000|Overall Study|Other|26|||
163037231|NCT00002525|588842412|FG001|Overall Study|Other|0|||
163037232|NCT00002525|588842411|FG000|Overall Study|Never start protocol therapy|8|||
163037233|NCT00002525|588842412|FG001|Overall Study|Never start protocol therapy|0|||
163037234|NCT03304184|588842413|FG000|Overall Study|Withdrawal by Subject|1|||
163037235|NCT03304184|588842414|FG001|Overall Study|Withdrawal by Subject|2|||
163037236|NCT04527978|588842418|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163037237|NCT04527978|588842419|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163037238|NCT02112877|588842421|FG000|Overall Study|Withdrawal by Subject|1|||
163037239|NCT02112877|588842422|FG001|Overall Study|Withdrawal by Subject|7|||
163037240|NCT02112877|588842421|FG000|Overall Study|Visit Missed|1|||
163037241|NCT02112877|588842422|FG001|Overall Study|Visit Missed|6|||
163037242|NCT01490697|588842433|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
163037243|NCT01490697|588842434|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
163037244|NCT00090584|588842435|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
163037245|NCT00090584|588842436|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
163037246|NCT00090584|588842435|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
163037247|NCT00090584|588842436|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
163037248|NCT00379808|588842437|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
163037249|NCT00379808|588842438|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
163037250|NCT01578499|588842439|FG000|Overall Study|Reason not Specified|0|||
163037251|NCT01578499|588842440|FG001|Overall Study|Reason not Specified|1|||
163037252|NCT01578499|588842439|FG000|Overall Study|Lost to Follow-up|2|||
163037253|NCT01578499|588842440|FG001|Overall Study|Lost to Follow-up|1|||
163037254|NCT01578499|588842439|FG000|Overall Study|Withdrawal by Subject|10|||
163037255|NCT01578499|588842440|FG001|Overall Study|Withdrawal by Subject|16|||
163037256|NCT01578499|588842439|FG000|Overall Study|Death|20|||
163037257|NCT01578499|588842440|FG001|Overall Study|Death|25|||
163037258|NCT01578499|588842439|FG000|Overall Study|Died and End of Study Page not Completed|2|||
163037259|NCT01578499|588842440|FG001|Overall Study|Died and End of Study Page not Completed|0|||
163037260|NCT01987232|588842441|FG000|Overall Study|Ongoing in Study|0|||
163037261|NCT01987232|588842442|FG001|Overall Study|Ongoing in Study|0|||
163037262|NCT01987232|588842443|FG002|Overall Study|Ongoing in Study|0|||
163037263|NCT01987232|588842444|FG003|Overall Study|Ongoing in Study|1|||
163037264|NCT01987232|588842445|FG004|Overall Study|Ongoing in Study|0|||
163037265|NCT02791438|588842446|FG000|Treatment Period|Adverse Event|1|||
163037266|NCT02791438|588842447|FG001|Treatment Period|Adverse Event|0|||
163037267|NCT02791438|588842446|FG000|Treatment Period|Withdrawal by Subject|0|||
163037268|NCT02791438|588842447|FG001|Treatment Period|Withdrawal by Subject|1|||
163037269|NCT02791438|588842446|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
163037270|NCT02791438|588842447|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
163037271|NCT01603394|588842448|FG000|Overall Study|Adverse Event|1|||
163037272|NCT00862459|588842449|FG000|Overall Study|Lost to Follow-up|1|||
163037273|NCT00862459|588842450|FG001|Overall Study|Lost to Follow-up|2|||
163037274|NCT00862459|588842451|FG002|Overall Study|Lost to Follow-up|2|||
163037275|NCT00862459|588842449|FG000|Overall Study|Protocol Violation|1|||
163037276|NCT00862459|588842450|FG001|Overall Study|Protocol Violation|0|||
163037277|NCT00862459|588842451|FG002|Overall Study|Protocol Violation|0|||
163037278|NCT00862459|588842449|FG000|Overall Study|Withdrawal by Subject|1|||
163037279|NCT00862459|588842450|FG001|Overall Study|Withdrawal by Subject|1|||
163037280|NCT00862459|588842451|FG002|Overall Study|Withdrawal by Subject|3|||
163037281|NCT00862459|588842449|FG000|Overall Study|Adverse Event|0|||
163037282|NCT00862459|588842450|FG001|Overall Study|Adverse Event|1|||
163037283|NCT00862459|588842451|FG002|Overall Study|Adverse Event|0|||
163037284|NCT00862459|588842449|FG000|Overall Study|Personal reasons|1|||
163037285|NCT00862459|588842450|FG001|Overall Study|Personal reasons|0|||
163037286|NCT00862459|588842451|FG002|Overall Study|Personal reasons|0|||
163037287|NCT00862459|588842449|FG000|Overall Study|Operation|1|||
163037288|NCT00862459|588842450|FG001|Overall Study|Operation|1|||
163037289|NCT00862459|588842451|FG002|Overall Study|Operation|0|||
163037290|NCT00862459|588842449|FG000|Overall Study|Intravenous (IV) site problems|1|||
163037291|NCT00862459|588842450|FG001|Overall Study|Intravenous (IV) site problems|0|||
163037292|NCT00862459|588842451|FG002|Overall Study|Intravenous (IV) site problems|1|||
163088536|NCT01146613|589035879|FG001|Overall Study|schedule conflict|0|||
163088537|NCT01146613|589035878|FG000|Overall Study|Outpatient detox|1|||
163088538|NCT01146613|589035879|FG001|Overall Study|Outpatient detox|0|||
163088539|NCT00949533|589035880|FG000|Overall Study|Lost to Follow-up|0|||
163088540|NCT00949533|589035881|FG001|Overall Study|Lost to Follow-up|1|||
163088541|NCT01493089|589035882|FG000|Overall Study|Protocol Violation|2|||
163088542|NCT01493089|589035883|FG001|Overall Study|Protocol Violation|2|||
163088543|NCT01493089|589035882|FG000|Overall Study|Withdrawal by Subject|1|||
163088544|NCT01493089|589035883|FG001|Overall Study|Withdrawal by Subject|0|||
163088545|NCT01493089|589035882|FG000|Overall Study|Physician Decision|0|||
163088546|NCT01493089|589035883|FG001|Overall Study|Physician Decision|1|||
163088547|NCT02234362|589035884|FG000|Overall Study|Not eligible after first screening visit|17|||
163088548|NCT02234362|589035884|FG000|Overall Study|Lost to Follow-up|6|||
163088549|NCT02234362|589035884|FG000|Overall Study|Withdrawal by Subject|3|||
163088550|NCT02164864|589035885|FG000|Overall Study|Trial disease worsening|7|||
163088551|NCT02164864|589035886|FG001|Overall Study|Trial disease worsening|5|||
163088552|NCT02164864|589035887|FG002|Overall Study|Trial disease worsening|1|||
163088553|NCT02164864|589035885|FG000|Overall Study|Other pre-existing disease worsening|6|||
163088554|NCT02164864|589035886|FG001|Overall Study|Other pre-existing disease worsening|4|||
163088555|NCT02164864|589035887|FG002|Overall Study|Other pre-existing disease worsening|9|||
163088556|NCT02164864|589035885|FG000|Overall Study|Other Adverse Event (AE)|52|||
163088557|NCT02164864|589035886|FG001|Overall Study|Other Adverse Event (AE)|32|||
163088558|NCT02164864|589035887|FG002|Overall Study|Other Adverse Event (AE)|49|||
163088559|NCT02164864|589035885|FG000|Overall Study|Protocol Violation|2|||
163088560|NCT02164864|589035886|FG001|Overall Study|Protocol Violation|4|||
163088561|NCT02164864|589035887|FG002|Overall Study|Protocol Violation|1|||
163088562|NCT02164864|589035885|FG000|Overall Study|Lost to Follow-up|4|||
163088563|NCT02164864|589035886|FG001|Overall Study|Lost to Follow-up|3|||
163088564|NCT02164864|589035887|FG002|Overall Study|Lost to Follow-up|2|||
163088565|NCT02164864|589035885|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
163088566|NCT02164864|589035886|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
163088567|NCT02164864|589035887|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
163088568|NCT02164864|589035885|FG000|Overall Study|Other than stated|3|||
163088569|NCT02164864|589035886|FG001|Overall Study|Other than stated|4|||
163088570|NCT02164864|589035887|FG002|Overall Study|Other than stated|14|||
163088571|NCT01870869|589035888|FG000|Overall Study|Implanted with nonstudy device|1|||
163088572|NCT01870869|589035889|FG001|Overall Study|Implanted with nonstudy device|3|||
163088573|NCT01870869|589035890|FG002|Overall Study|Implanted with nonstudy device|14|||
163088574|NCT01870869|589035891|FG003|Overall Study|Implanted with nonstudy device|4|||
163088575|NCT01870869|589035888|FG000|Overall Study|Death|0|||
163088576|NCT01870869|589035889|FG001|Overall Study|Death|0|||
163088577|NCT01870869|589035890|FG002|Overall Study|Death|7|||
163088578|NCT01870869|589035891|FG003|Overall Study|Death|1|||
163088579|NCT01870869|589035888|FG000|Overall Study|Subject choice|6|||
163088580|NCT01870869|589035889|FG001|Overall Study|Subject choice|2|||
163088581|NCT01870869|589035890|FG002|Overall Study|Subject choice|22|||
163088582|NCT01870869|589035891|FG003|Overall Study|Subject choice|8|||
163088583|NCT01870869|589035888|FG000|Overall Study|Lost to Follow-up|10|||
163088584|NCT01870869|589035889|FG001|Overall Study|Lost to Follow-up|2|||
163088585|NCT01870869|589035890|FG002|Overall Study|Lost to Follow-up|25|||
163088586|NCT01870869|589035891|FG003|Overall Study|Lost to Follow-up|3|||
163088587|NCT01870869|589035888|FG000|Overall Study|Reason not Specified|1|||
163088588|NCT01870869|589035889|FG001|Overall Study|Reason not Specified|2|||
163088589|NCT01870869|589035890|FG002|Overall Study|Reason not Specified|20|||
163088590|NCT01870869|589035891|FG003|Overall Study|Reason not Specified|4|||
163088591|NCT01870869|589035888|FG000|Overall Study|Not evaluable|10|||
163088592|NCT01870869|589035889|FG001|Overall Study|Not evaluable|5|||
163088593|NCT01870869|589035890|FG002|Overall Study|Not evaluable|42|||
163088594|NCT01870869|589035891|FG003|Overall Study|Not evaluable|10|||
163088595|NCT00261833|589035892|FG000|Overall Study|Death|1|||
163088596|NCT00261833|589035893|FG001|Overall Study|Death|3|||
163088597|NCT00261833|589035892|FG000|Overall Study|Adverse Event|1|||
163088598|NCT00261833|589035893|FG001|Overall Study|Adverse Event|4|||
163088599|NCT00261833|589035892|FG000|Overall Study|Withdrawal by Subject|5|||
163088600|NCT00261833|589035893|FG001|Overall Study|Withdrawal by Subject|7|||
163088601|NCT00261833|589035892|FG000|Overall Study|Protocol Violation|0|||
163088602|NCT00261833|589035893|FG001|Overall Study|Protocol Violation|1|||
163088603|NCT00261833|589035892|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
163088604|NCT00261833|589035893|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
163088605|NCT00261833|589035892|FG000|Overall Study|Lung transplantation|1|||
163088606|NCT00261833|589035893|FG001|Overall Study|Lung transplantation|1|||
163088607|NCT00261833|589035892|FG000|Overall Study|Missing reason|1|||
163088608|NCT00261833|589035893|FG001|Overall Study|Missing reason|0|||
163088609|NCT00261833|589035892|FG000|Overall Study|Not interested in being participant|0|||
163088610|NCT00261833|589035893|FG001|Overall Study|Not interested in being participant|1|||
163088611|NCT02131766|589035895|FG000|Overall Study|Withdrawal by Subject|4|||
163088612|NCT02271880|589035897|FG000|Overall Study|Premature discontinuation of study|3|||
163088613|NCT02271880|589035898|FG001|Overall Study|Premature discontinuation of study|4|||
163088614|NCT00474903|589035900|FG000|Overall Study|Protocol Violation|1|||
163088615|NCT00474903|589035901|FG001|Overall Study|Protocol Violation|5|||
163088616|NCT00474903|589035902|FG002|Overall Study|Protocol Violation|2|||
163088617|NCT02006927|589035903|FG000|Overall Study|Adverse Event|2|||
163088618|NCT02006927|589035903|FG000|Overall Study|Withdrawal by Subject|1|||
163088619|NCT00673920|589035906|FG000|Baseline up to Week 48|Withdrew consent|1|||
163088620|NCT00673920|589035907|FG001|Baseline up to Week 48|Withdrew consent|0|||
163088621|NCT00673920|589035908|FG002|Baseline up to Week 48|Withdrew consent|2|||
163088622|NCT00673920|589035909|FG003|Baseline up to Week 48|Withdrew consent|0|||
163088623|NCT00673920|589035910|FG004|Baseline up to Week 48|Withdrew consent|0|||
163088624|NCT00673920|589035911|FG005|Baseline up to Week 48|Withdrew consent|0|||
163088625|NCT00673920|589035912|FG006|Baseline up to Week 48|Withdrew consent|0|||
163088626|NCT00673920|589035913|FG007|Baseline up to Week 48|Withdrew consent|0|||
163088627|NCT00673920|589035906|FG000|Baseline up to Week 48|Refused treatment|1|||
163088628|NCT00673920|589035907|FG001|Baseline up to Week 48|Refused treatment|0|||
163088629|NCT00673920|589035908|FG002|Baseline up to Week 48|Refused treatment|0|||
163088630|NCT00673920|589035909|FG003|Baseline up to Week 48|Refused treatment|0|||
163088631|NCT00673920|589035910|FG004|Baseline up to Week 48|Refused treatment|0|||
163088632|NCT00673920|589035911|FG005|Baseline up to Week 48|Refused treatment|0|||
163088633|NCT00673920|589035912|FG006|Baseline up to Week 48|Refused treatment|0|||
163088634|NCT00673920|589035913|FG007|Baseline up to Week 48|Refused treatment|0|||
163088635|NCT00673920|589035906|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
163088636|NCT00673920|589035907|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
163088637|NCT00673920|589035908|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088638|NCT00673920|589035909|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088639|NCT00673920|589035910|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088640|NCT00673920|589035911|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088641|NCT00673920|589035912|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088642|NCT00673920|589035913|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
163088643|NCT00673920|589035906|FG000|Baseline up to Week 48|Protocol Violation|0|||
163088644|NCT00673920|589035907|FG001|Baseline up to Week 48|Protocol Violation|0|||
163088645|NCT00673920|589035908|FG002|Baseline up to Week 48|Protocol Violation|1|||
163088646|NCT00673920|589035909|FG003|Baseline up to Week 48|Protocol Violation|0|||
163088647|NCT00673920|589035910|FG004|Baseline up to Week 48|Protocol Violation|0|||
163088648|NCT00673920|589035911|FG005|Baseline up to Week 48|Protocol Violation|0|||
163088649|NCT00673920|589035912|FG006|Baseline up to Week 48|Protocol Violation|0|||
163088650|NCT00673920|589035913|FG007|Baseline up to Week 48|Protocol Violation|0|||
163088651|NCT00673920|589035906|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088652|NCT00673920|589035907|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088653|NCT00673920|589035908|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
163088654|NCT00673920|589035909|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088655|NCT00673920|589035910|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088656|NCT00673920|589035911|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088657|NCT00673920|589035912|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088658|NCT00673920|589035913|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
163088659|NCT00673920|589035906|FG000|Baseline up to Week 48|Administrative/Other|0|||
162649466|NCT03560531|587433481|FG009|Overall Study|Lost to Follow-up|0|||
162649467|NCT03560531|587433482|FG010|Overall Study|Lost to Follow-up|0|||
162649468|NCT03560531|587433483|FG011|Overall Study|Lost to Follow-up|0|||
162649469|NCT03560531|587433484|FG012|Overall Study|Lost to Follow-up|0|||
162649470|NCT03560531|587433485|FG013|Overall Study|Lost to Follow-up|0|||
162649471|NCT03560531|587433472|FG000|Overall Study|Withdrawal by Subject|1|||
162649472|NCT03560531|587433473|FG001|Overall Study|Withdrawal by Subject|0|||
162649473|NCT03560531|587433474|FG002|Overall Study|Withdrawal by Subject|0|||
162649474|NCT03560531|587433475|FG003|Overall Study|Withdrawal by Subject|0|||
162649475|NCT03560531|587433476|FG004|Overall Study|Withdrawal by Subject|0|||
162649476|NCT03560531|587433477|FG005|Overall Study|Withdrawal by Subject|0|||
162649477|NCT03560531|587433478|FG006|Overall Study|Withdrawal by Subject|0|||
162649478|NCT03560531|587433479|FG007|Overall Study|Withdrawal by Subject|3|||
162649479|NCT03560531|587433480|FG008|Overall Study|Withdrawal by Subject|2|||
162649480|NCT03560531|587433481|FG009|Overall Study|Withdrawal by Subject|0|||
162649481|NCT03560531|587433482|FG010|Overall Study|Withdrawal by Subject|0|||
162649482|NCT03560531|587433483|FG011|Overall Study|Withdrawal by Subject|0|||
162649483|NCT03560531|587433484|FG012|Overall Study|Withdrawal by Subject|2|||
162649484|NCT03560531|587433485|FG013|Overall Study|Withdrawal by Subject|0|||
162649485|NCT03560531|587433472|FG000|Overall Study|Study end per-protocol|1|||
162649486|NCT03560531|587433473|FG001|Overall Study|Study end per-protocol|1|||
162649487|NCT03560531|587433474|FG002|Overall Study|Study end per-protocol|2|||
162649488|NCT03560531|587433475|FG003|Overall Study|Study end per-protocol|0|||
162649489|NCT03560531|587433476|FG004|Overall Study|Study end per-protocol|1|||
162649490|NCT03560531|587433477|FG005|Overall Study|Study end per-protocol|0|||
162649491|NCT03560531|587433478|FG006|Overall Study|Study end per-protocol|0|||
162649492|NCT03560531|587433479|FG007|Overall Study|Study end per-protocol|0|||
162649493|NCT03560531|587433480|FG008|Overall Study|Study end per-protocol|0|||
162649494|NCT03560531|587433481|FG009|Overall Study|Study end per-protocol|0|||
162649495|NCT03560531|587433482|FG010|Overall Study|Study end per-protocol|0|||
162649496|NCT03560531|587433483|FG011|Overall Study|Study end per-protocol|0|||
162649497|NCT03560531|587433484|FG012|Overall Study|Study end per-protocol|0|||
162649498|NCT03560531|587433485|FG013|Overall Study|Study end per-protocol|0|||
162649499|NCT03560531|587433472|FG000|Overall Study|Early study termination by sponsor|9|||
162649500|NCT03560531|587433473|FG001|Overall Study|Early study termination by sponsor|0|||
162649501|NCT03560531|587433474|FG002|Overall Study|Early study termination by sponsor|0|||
162649502|NCT03560531|587433475|FG003|Overall Study|Early study termination by sponsor|4|||
162718656|NCT00855465|587676660|FG000|Treatment Period|Lack of Efficacy|2|||
163088660|NCT00673920|589035907|FG001|Baseline up to Week 48|Administrative/Other|1|||
163088661|NCT00673920|589035908|FG002|Baseline up to Week 48|Administrative/Other|2|||
163088662|NCT00673920|589035909|FG003|Baseline up to Week 48|Administrative/Other|0|||
163088663|NCT00673920|589035910|FG004|Baseline up to Week 48|Administrative/Other|0|||
163088664|NCT00673920|589035911|FG005|Baseline up to Week 48|Administrative/Other|0|||
163088665|NCT00673920|589035912|FG006|Baseline up to Week 48|Administrative/Other|0|||
163088666|NCT00673920|589035913|FG007|Baseline up to Week 48|Administrative/Other|0|||
163088667|NCT00673920|589035906|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088668|NCT00673920|589035907|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
163088669|NCT00673920|589035908|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
163088670|NCT00673920|589035909|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088671|NCT00673920|589035910|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088672|NCT00673920|589035911|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088673|NCT00673920|589035912|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088674|NCT00673920|589035913|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
163088675|NCT00673920|589035906|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088676|NCT00673920|589035907|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088677|NCT00673920|589035908|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088678|NCT00673920|589035909|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088679|NCT00673920|589035910|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088680|NCT00673920|589035911|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088681|NCT00673920|589035912|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
163088682|NCT00673920|589035913|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163088683|NCT00673920|589035906|FG000|Week 24 to Week 48|Failure to return|0|||
163088684|NCT00673920|589035907|FG001|Week 24 to Week 48|Failure to return|0|||
163088685|NCT00673920|589035908|FG002|Week 24 to Week 48|Failure to return|0|||
163088686|NCT00673920|589035909|FG003|Week 24 to Week 48|Failure to return|0|||
163088687|NCT00673920|589035910|FG004|Week 24 to Week 48|Failure to return|0|||
163088688|NCT00673920|589035911|FG005|Week 24 to Week 48|Failure to return|1|||
163088689|NCT00673920|589035912|FG006|Week 24 to Week 48|Failure to return|0|||
163088690|NCT00673920|589035913|FG007|Week 24 to Week 48|Failure to return|0|||
163088691|NCT00673920|589035906|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088692|NCT00673920|589035907|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088693|NCT00673920|589035908|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088694|NCT00673920|589035909|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088695|NCT00673920|589035910|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088696|NCT00673920|589035911|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
163088697|NCT00673920|589035912|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088698|NCT00673920|589035913|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
163088699|NCT00673920|589035906|FG000|Week 24 to Week 48|Death|0|||
163088700|NCT00673920|589035907|FG001|Week 24 to Week 48|Death|0|||
163088701|NCT00673920|589035908|FG002|Week 24 to Week 48|Death|0|||
163088702|NCT00673920|589035909|FG003|Week 24 to Week 48|Death|0|||
163088703|NCT00673920|589035910|FG004|Week 24 to Week 48|Death|0|||
163088704|NCT00673920|589035911|FG005|Week 24 to Week 48|Death|1|||
163088705|NCT00673920|589035912|FG006|Week 24 to Week 48|Death|0|||
163088706|NCT00673920|589035913|FG007|Week 24 to Week 48|Death|0|||
162718657|NCT00855465|587676661|FG001|Treatment Period|Lack of Efficacy|1|||
162718658|NCT00855465|587676660|FG000|Treatment Period|Non-compliance|1|||
163088707|NCT00673920|589035906|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
163088708|NCT00673920|589035907|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
163088709|NCT00673920|589035908|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
163088710|NCT00673920|589035909|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
163088711|NCT00673920|589035910|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
162649503|NCT03560531|587433476|FG004|Overall Study|Early study termination by sponsor|8|||
162649504|NCT03560531|587433477|FG005|Overall Study|Early study termination by sponsor|2|||
162649505|NCT03560531|587433478|FG006|Overall Study|Early study termination by sponsor|5|||
162718659|NCT00855465|587676661|FG001|Treatment Period|Non-compliance|0|||
163088712|NCT00673920|589035911|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
163088713|NCT00673920|589035912|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
163088714|NCT00673920|589035913|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
163088715|NCT02519842|589035914|FG000|Base Study: Cycle 1|Screening Failure|1|||
162649506|NCT03560531|587433479|FG007|Overall Study|Early study termination by sponsor|64|||
162649507|NCT03560531|587433480|FG008|Overall Study|Early study termination by sponsor|7|||
162649508|NCT03560531|587433481|FG009|Overall Study|Early study termination by sponsor|2|||
162649509|NCT03560531|587433482|FG010|Overall Study|Early study termination by sponsor|16|||
162649510|NCT03560531|587433483|FG011|Overall Study|Early study termination by sponsor|2|||
162649511|NCT03560531|587433484|FG012|Overall Study|Early study termination by sponsor|6|||
162649512|NCT03560531|587433485|FG013|Overall Study|Early study termination by sponsor|2|||
162649513|NCT02968979|587433486|FG000|Overall Study|Protocol Violation|7|||
162649514|NCT02968979|587433486|FG000|Overall Study|Withdrawal by Subject|1|||
162649515|NCT01471379|587433487|FG000|Overall Study|Adverse Event|1|||
162649516|NCT01471379|587433488|FG001|Overall Study|Adverse Event|0|||
162649517|NCT01471379|587433489|FG002|Overall Study|Adverse Event|0|||
162649518|NCT01471379|587433487|FG000|Overall Study|Study terminated|0|||
162649519|NCT01471379|587433488|FG001|Overall Study|Study terminated|1|||
162649520|NCT01471379|587433489|FG002|Overall Study|Study terminated|0|||
162649521|NCT00729183|587433490|FG000|Overall Study|Adverse Event|11|||
162649522|NCT00729183|587433491|FG001|Overall Study|Adverse Event|5|||
162649523|NCT00729183|587433490|FG000|Overall Study|Lack of Efficacy|0|||
162649524|NCT00729183|587433491|FG001|Overall Study|Lack of Efficacy|1|||
162649525|NCT00729183|587433490|FG000|Overall Study|Lost to Follow-up|3|||
162649526|NCT00729183|587433491|FG001|Overall Study|Lost to Follow-up|1|||
162649527|NCT00729183|587433490|FG000|Overall Study|Physician Decision|1|||
162649528|NCT00729183|587433491|FG001|Overall Study|Physician Decision|1|||
162649529|NCT00729183|587433490|FG000|Overall Study|Protocol Violation|1|||
162649530|NCT00729183|587433491|FG001|Overall Study|Protocol Violation|0|||
162649531|NCT00729183|587433490|FG000|Overall Study|Withdrawal by Subject|9|||
162649532|NCT00729183|587433491|FG001|Overall Study|Withdrawal by Subject|7|||
162649533|NCT04380857|587435272|FG000|Overall Study|Lost to Follow-up|3|||
162649534|NCT04380857|587435273|FG001|Overall Study|Lost to Follow-up|3|||
162649535|NCT02558790|587435274|FG000|Overall Study|Lost to Follow-up|2|||
162649536|NCT02558790|587435274|FG000|Overall Study|Physician Decision|1|||
162649537|NCT02558790|587435274|FG000|Overall Study|Withdrawal by Subject|1|||
162649538|NCT02558790|587435274|FG000|Overall Study|Screen Fail|3|||
162649539|NCT05083442|587435275|FG000|Overall Study|Lost to Follow-up|1|||
162649540|NCT05083442|587435276|FG001|Overall Study|Lost to Follow-up|0|||
162649541|NCT05083442|587435275|FG000|Overall Study|Lack of Efficacy|0|||
162649542|NCT05083442|587435276|FG001|Overall Study|Lack of Efficacy|1|||
162649543|NCT05083442|587435275|FG000|Overall Study|Withdrawal by Subject|1|||
162649544|NCT05083442|587435276|FG001|Overall Study|Withdrawal by Subject|3|||
162649545|NCT05083442|587435275|FG000|Overall Study|scheduling difficulties|1|||
162649546|NCT05083442|587435276|FG001|Overall Study|scheduling difficulties|2|||
162649547|NCT04865354|587435284|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
162649548|NCT04865354|587435285|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
162649549|NCT04865354|587435284|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
162649550|NCT04865354|587435285|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
162649551|NCT04865354|587435284|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
162649552|NCT04865354|587435285|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
162649553|NCT02945410|587435286|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162649554|NCT02945410|587435287|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
162649555|NCT02945410|587435288|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162649556|NCT02945410|587435289|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162649557|NCT02945410|587435290|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162649558|NCT02945410|587435291|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162649559|NCT02945410|587435286|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
162649560|NCT02945410|587435287|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
162649561|NCT02945410|587435288|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
162649562|NCT02945410|587435289|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
162649563|NCT02945410|587435290|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
162649564|NCT02945410|587435291|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
162649565|NCT02945410|587435286|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162649566|NCT02945410|587435287|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162649567|NCT02945410|587435288|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
162649568|NCT02945410|587435289|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
163088716|NCT02519842|589035915|FG001|Base Study: Cycle 1|Screening Failure|1|||
162649569|NCT02945410|587435290|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
162649570|NCT02945410|587435291|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162649571|NCT00110812|587435292|FG000|Main Study|Death|0|||
162649572|NCT00110812|587435293|FG001|Main Study|Death|0|||
162649573|NCT00110812|587435294|FG002|Main Study|Death|2|||
162649574|NCT00110812|587435292|FG000|Main Study|Withdrawal by Subject|0|||
162649575|NCT00110812|587435293|FG001|Main Study|Withdrawal by Subject|0|||
162649576|NCT00110812|587435294|FG002|Main Study|Withdrawal by Subject|1|||
163088717|NCT02519842|589035916|FG002|Base Study: Cycle 1|Screening Failure|0|||
163088718|NCT02519842|589035914|FG000|Base Study: Cycle 1|Adverse Event|1|||
163088719|NCT02519842|589035915|FG001|Base Study: Cycle 1|Adverse Event|0|||
163088720|NCT02519842|589035916|FG002|Base Study: Cycle 1|Adverse Event|0|||
163088721|NCT02519842|589035914|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
163088722|NCT02519842|589035915|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
163088723|NCT02519842|589035916|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
163088724|NCT02519842|589035914|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
163088725|NCT02519842|589035915|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
163088726|NCT02519842|589035916|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
163088727|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
163088728|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
163088729|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
163088730|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
163088731|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
163088732|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
163088733|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163088734|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
163088735|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
163088736|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
163088737|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
163088738|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
163088739|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Death|0|||
163088740|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Death|0|||
163088741|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Death|1|||
163088742|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
163088743|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
163088744|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
163088745|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
163088746|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
163088747|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
163088748|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
163088749|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
163088750|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
163088751|NCT02519842|589035914|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
163088752|NCT02519842|589035915|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
163088753|NCT02519842|589035916|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
163088754|NCT02639390|589035918|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
163088755|NCT02639390|589035919|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
163088756|NCT01561976|589035920|FG000|Period 1|Adverse Event|0|||
163088757|NCT01561976|589035921|FG001|Period 1|Adverse Event|0|||
163088758|NCT01561976|589035922|FG002|Period 1|Adverse Event|1|||
163088759|NCT01561976|589035923|FG003|Period 1|Adverse Event|0|||
163088760|NCT01561976|589035924|FG004|Period 1|Adverse Event|0|||
163088761|NCT01561976|589035925|FG005|Period 1|Adverse Event|0|||
163088762|NCT01561976|589035920|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163088763|NCT01561976|589035921|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
163088764|NCT01561976|589035922|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163088765|NCT01561976|589035923|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
163088766|NCT01561976|589035924|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
163088767|NCT01561976|589035925|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
163088768|NCT01561976|589035920|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088769|NCT01561976|589035921|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088770|NCT01561976|589035922|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088771|NCT01561976|589035923|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088772|NCT01561976|589035924|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163088773|NCT01561976|589035925|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163088774|NCT01561976|589035920|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
163088775|NCT01561976|589035921|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
163088776|NCT01561976|589035922|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
163088777|NCT01561976|589035923|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
163088778|NCT01561976|589035924|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
163088779|NCT01561976|589035925|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
163088780|NCT01463527|589035926|FG000|Overall Study|Protocol Violation|1|||
163088781|NCT01463527|589035927|FG001|Overall Study|Protocol Violation|1|||
163088782|NCT01463527|589035926|FG000|Overall Study|Crying >20% of sedation|5|||
163088783|NCT01463527|589035927|FG001|Overall Study|Crying >20% of sedation|6|||
163088784|NCT01977222|589035930|FG000|Overall Study|Withdrawal by Subject|1|||
163088785|NCT02980107|589035931|FG000|Overall Study|Withdrawal by Subject|51|||
163088786|NCT02980107|589035932|FG001|Overall Study|Withdrawal by Subject|62|||
163088787|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163037293|NCT00862459|588842449|FG000|Overall Study|Unable to hold still for imaging|0|||
163037294|NCT00862459|588842450|FG001|Overall Study|Unable to hold still for imaging|1|||
163037295|NCT00862459|588842451|FG002|Overall Study|Unable to hold still for imaging|0|||
163037296|NCT00862459|588842449|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
163037297|NCT00862459|588842450|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
163037298|NCT00862459|588842451|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
163037299|NCT00862459|588842449|FG000|Overall Study|Administrative problems|0|||
163037300|NCT00862459|588842450|FG001|Overall Study|Administrative problems|1|||
163037301|NCT00862459|588842451|FG002|Overall Study|Administrative problems|0|||
163037302|NCT01333956|588842462|FG000|Overall Study|Lost to Follow-up|1|||
163037303|NCT01333956|588842463|FG001|Overall Study|Lost to Follow-up|2|||
163037304|NCT01333956|588842464|FG002|Overall Study|Lost to Follow-up|0|||
163037305|NCT01333956|588842465|FG003|Overall Study|Lost to Follow-up|1|||
163037306|NCT01333956|588842462|FG000|Overall Study|Unable to complete study procedure|1|||
163037307|NCT01333956|588842463|FG001|Overall Study|Unable to complete study procedure|0|||
163037308|NCT01333956|588842464|FG002|Overall Study|Unable to complete study procedure|0|||
163037309|NCT01333956|588842465|FG003|Overall Study|Unable to complete study procedure|1|||
163037310|NCT01333956|588842462|FG000|Overall Study|Withdrawal by Subject|0|||
163037311|NCT01333956|588842463|FG001|Overall Study|Withdrawal by Subject|2|||
163037312|NCT01333956|588842464|FG002|Overall Study|Withdrawal by Subject|1|||
163037313|NCT01333956|588842465|FG003|Overall Study|Withdrawal by Subject|0|||
163037314|NCT03426436|588842466|FG000|Overall Study|Incorrect lead placement|12|||
163037315|NCT03426436|588842466|FG000|Overall Study|Withdrawal by Subject|2|||
163037316|NCT03426436|588842466|FG000|Overall Study|Consent issue|1|||
163037317|NCT03426436|588842466|FG000|Overall Study|ECGs not saved|4|||
163037318|NCT03168919|588842467|FG000|Overall Study|Withdrawal by Subject|2|||
163037319|NCT01085136|588842468|FG000|Part A|Other Adverse event|223|||
163037320|NCT01085136|588842469|FG001|Part A|Other Adverse event|0|||
163037321|NCT01085136|588842470|FG002|Part A|Other Adverse event|0|||
163037322|NCT01085136|588842468|FG000|Part A|Protocol Violation|3|||
163037323|NCT01085136|588842469|FG001|Part A|Protocol Violation|0|||
163037324|NCT01085136|588842470|FG002|Part A|Protocol Violation|0|||
163037325|NCT01085136|588842468|FG000|Part A|Lost to Follow-up|3|||
163037326|NCT01085136|588842469|FG001|Part A|Lost to Follow-up|0|||
163037327|NCT01085136|588842470|FG002|Part A|Lost to Follow-up|0|||
163037328|NCT01085136|588842468|FG000|Part A|Refusal to continue trial medication|64|||
163037329|NCT01085136|588842469|FG001|Part A|Refusal to continue trial medication|0|||
163037330|NCT01085136|588842470|FG002|Part A|Refusal to continue trial medication|0|||
163037331|NCT01085136|588842468|FG000|Part A|Other reason not defined above|30|||
163037332|NCT01085136|588842469|FG001|Part A|Other reason not defined above|0|||
163037333|NCT01085136|588842470|FG002|Part A|Other reason not defined above|0|||
163037334|NCT01085136|588842468|FG000|Part B|Other AE|0|||
163037335|NCT01085136|588842469|FG001|Part B|Other AE|29|||
163037336|NCT01085136|588842470|FG002|Part B|Other AE|8|||
163037337|NCT01085136|588842468|FG000|Part B|Refusal to continue trial medication|0|||
163037338|NCT01085136|588842469|FG001|Part B|Refusal to continue trial medication|12|||
163037339|NCT01085136|588842470|FG002|Part B|Refusal to continue trial medication|7|||
163037340|NCT01085136|588842468|FG000|Part B|Not treated|0|||
163037341|NCT01085136|588842469|FG001|Part B|Not treated|4|||
163037342|NCT01085136|588842470|FG002|Part B|Not treated|8|||
163037343|NCT01085136|588842468|FG000|Part B|Other reason not defined above|0|||
163037344|NCT01085136|588842469|FG001|Part B|Other reason not defined above|6|||
163037345|NCT01085136|588842470|FG002|Part B|Other reason not defined above|3|||
163037346|NCT02655419|588842471|FG000|Overall Study|Enrolled but not treated|1|||
163037347|NCT02655419|588842472|FG001|Overall Study|Enrolled but not treated|5|||
163037348|NCT02655419|588842471|FG000|Overall Study|Withdrawal by Subject|4|||
163037349|NCT02655419|588842472|FG001|Overall Study|Withdrawal by Subject|1|||
163037350|NCT02655419|588842471|FG000|Overall Study|Other|0|||
163037351|NCT02655419|588842472|FG001|Overall Study|Other|1|||
163037352|NCT04226495|588842476|FG000|Overall Study|Withdrawal by Subject|3|||
163037353|NCT04226495|588842477|FG001|Overall Study|Withdrawal by Subject|3|||
163037354|NCT04226495|588842476|FG000|Overall Study|PI discretion|3|||
163037355|NCT04226495|588842477|FG001|Overall Study|PI discretion|4|||
163037356|NCT02333383|588842479|FG000|Overall Study|Adalimumab discontinuation|21|||
163037357|NCT02333383|588842479|FG000|Overall Study|Lost to Follow-up|15|||
163037358|NCT02333383|588842479|FG000|Overall Study|Withdrawal by Subject|3|||
163037359|NCT02333383|588842479|FG000|Overall Study|Transfer to another hospital|2|||
163037360|NCT04459598|588842480|FG000|Overall Study|Adverse Event|1|||
163037361|NCT04459598|588842481|FG001|Overall Study|Adverse Event|1|||
163037362|NCT00866333|588842482|FG000|Overall Study|Withdrawal of consent|0|||
163037363|NCT00866333|588842483|FG001|Overall Study|Withdrawal of consent|1|||
163037364|NCT00866333|588842484|FG002|Overall Study|Withdrawal of consent|2|||
163037365|NCT00866333|588842482|FG000|Overall Study|Reason not Specified|3|||
163037366|NCT00866333|588842483|FG001|Overall Study|Reason not Specified|1|||
163037367|NCT00866333|588842484|FG002|Overall Study|Reason not Specified|1|||
163037368|NCT00866333|588842482|FG000|Overall Study|Study Terminated by Sponsor|2|||
163037369|NCT00866333|588842483|FG001|Overall Study|Study Terminated by Sponsor|5|||
162649577|NCT00110812|587435292|FG000|Main Study|Lost to Follow-up|8|||
162649578|NCT00110812|587435293|FG001|Main Study|Lost to Follow-up|11|||
162649579|NCT00110812|587435294|FG002|Main Study|Lost to Follow-up|10|||
162649580|NCT00110812|587435292|FG000|Extended Follow-up|Death|1|||
162649581|NCT00110812|587435293|FG001|Extended Follow-up|Death|0|||
162649582|NCT00110812|587435294|FG002|Extended Follow-up|Death|3|||
162649583|NCT00110812|587435292|FG000|Extended Follow-up|Withdrawal by Subject|0|||
162649584|NCT00110812|587435293|FG001|Extended Follow-up|Withdrawal by Subject|1|||
162649585|NCT00110812|587435294|FG002|Extended Follow-up|Withdrawal by Subject|0|||
163037370|NCT00866333|588842484|FG002|Overall Study|Study Terminated by Sponsor|9|||
163037371|NCT01854879|588842485|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
163037372|NCT01854879|588842485|FG000|Overall Study|screen fail|3|||
163037373|NCT01854879|588842485|FG000|Overall Study|incomplete data set|1|||
163037374|NCT00385827|588844158|FG000|Part 1|Adverse Event|1|||
163037375|NCT00385827|588844159|FG001|Part 1|Adverse Event|0|||
163037376|NCT00385827|588844160|FG002|Part 1|Adverse Event|0|||
163037377|NCT00385827|588844158|FG000|Part 1|Death|2|||
163037378|NCT00385827|588844159|FG001|Part 1|Death|0|||
163037379|NCT00385827|588844160|FG002|Part 1|Death|0|||
163037380|NCT00385827|588844158|FG000|Part 1|Lack of Efficacy|5|||
163037381|NCT00385827|588844159|FG001|Part 1|Lack of Efficacy|0|||
163037382|NCT00385827|588844160|FG002|Part 1|Lack of Efficacy|0|||
163037383|NCT00385827|588844158|FG000|Part 1|Other|1|||
163037384|NCT00385827|588844159|FG001|Part 1|Other|0|||
163037385|NCT00385827|588844160|FG002|Part 1|Other|0|||
163037386|NCT00385827|588844158|FG000|Part 2|Adverse Event|0|||
163037387|NCT00385827|588844159|FG001|Part 2|Adverse Event|6|||
163037388|NCT00385827|588844160|FG002|Part 2|Adverse Event|10|||
163037389|NCT00385827|588844158|FG000|Part 2|Death|0|||
163037390|NCT00385827|588844159|FG001|Part 2|Death|0|||
163037391|NCT00385827|588844160|FG002|Part 2|Death|2|||
163037392|NCT00385827|588844158|FG000|Part 2|Lack of Efficacy|0|||
163037393|NCT00385827|588844159|FG001|Part 2|Lack of Efficacy|14|||
163037394|NCT00385827|588844160|FG002|Part 2|Lack of Efficacy|13|||
163037395|NCT00385827|588844158|FG000|Part 2|Randomized but not treated|0|||
163037396|NCT00385827|588844159|FG001|Part 2|Randomized but not treated|2|||
163037397|NCT00385827|588844160|FG002|Part 2|Randomized but not treated|2|||
163037398|NCT00385827|588844158|FG000|Part 2|Other|0|||
163037399|NCT00385827|588844159|FG001|Part 2|Other|11|||
163037400|NCT00385827|588844160|FG002|Part 2|Other|21|||
163037401|NCT00410072|588844161|FG000|Day 1 to Week 48|Adverse Event|1|||
163037402|NCT00410072|588844162|FG001|Day 1 to Week 48|Adverse Event|2|||
163037403|NCT00410072|588844161|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
163037404|NCT00410072|588844162|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
163037405|NCT00410072|588844161|FG000|Day 1 to Week 48|Other|0|||
163037406|NCT00410072|588844162|FG001|Day 1 to Week 48|Other|1|||
163037407|NCT00410072|588844161|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
163037408|NCT00410072|588844162|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
163037409|NCT00410072|588844161|FG000|Day 1 to Week 48|Pregnancy|0|||
163037410|NCT00410072|588844162|FG001|Day 1 to Week 48|Pregnancy|2|||
163037411|NCT00410072|588844161|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
163037412|NCT00410072|588844162|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
163037413|NCT00410072|588844161|FG000|After Week 48 to Week 96|Adverse Event|1|||
163037414|NCT00410072|588844162|FG001|After Week 48 to Week 96|Adverse Event|2|||
163037415|NCT00410072|588844161|FG000|After Week 48 to Week 96|Death|0|||
163037416|NCT00410072|588844162|FG001|After Week 48 to Week 96|Death|1|||
163037417|NCT00410072|588844161|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
163037418|NCT00410072|588844162|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
163037419|NCT00410072|588844161|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
163037420|NCT00410072|588844162|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
163037421|NCT00410072|588844161|FG000|After Week 48 to Week 96|Other|2|||
163037422|NCT00410072|588844162|FG001|After Week 48 to Week 96|Other|0|||
163037423|NCT00410072|588844161|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
163037424|NCT00410072|588844162|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
163037425|NCT00410072|588844161|FG000|After Week 48 to Week 96|Pregnancy|0|||
163037426|NCT00410072|588844162|FG001|After Week 48 to Week 96|Pregnancy|2|||
163037427|NCT00410072|588844161|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
163037428|NCT00410072|588844162|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
163037429|NCT01421147|588844163|FG000|Treatment Period|Adverse Event|2|||
163037430|NCT01421147|588844164|FG001|Treatment Period|Adverse Event|3|||
163037431|NCT01421147|588844163|FG000|Treatment Period|Lost to Follow-up|2|||
163037432|NCT01421147|588844164|FG001|Treatment Period|Lost to Follow-up|1|||
163037433|NCT01421147|588844163|FG000|Treatment Period|Physician Decision|2|||
163037434|NCT01421147|588844164|FG001|Treatment Period|Physician Decision|2|||
162649586|NCT00110812|587435292|FG000|Extended Follow-up|Lost to Follow-up|1|||
163037435|NCT01421147|588844163|FG000|Treatment Period|Withdrawal by Subject|10|||
163037436|NCT01421147|588844164|FG001|Treatment Period|Withdrawal by Subject|5|||
163037437|NCT01421147|588844163|FG000|Extension Period|Adverse Event|0|||
163037438|NCT01421147|588844164|FG001|Extension Period|Adverse Event|2|||
163037439|NCT01421147|588844163|FG000|Extension Period|Death|0|||
163037440|NCT01421147|588844164|FG001|Extension Period|Death|1|||
163088788|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
163037441|NCT01421147|588844163|FG000|Extension Period|Lost to Follow-up|2|||
163037442|NCT01421147|588844164|FG001|Extension Period|Lost to Follow-up|5|||
163037443|NCT01421147|588844163|FG000|Extension Period|Physician Decision|1|||
163037444|NCT01421147|588844164|FG001|Extension Period|Physician Decision|0|||
163037445|NCT01421147|588844163|FG000|Extension Period|Withdrawal by Subject|5|||
163037446|NCT01421147|588844164|FG001|Extension Period|Withdrawal by Subject|3|||
163037447|NCT00904917|588844167|FG000|Overall Study|Lost to Follow-up|2|||
163037448|NCT00904917|588844168|FG001|Overall Study|Lost to Follow-up|2|||
163037449|NCT00904917|588844169|FG002|Overall Study|Lost to Follow-up|2|||
163037450|NCT00904917|588844170|FG003|Overall Study|Lost to Follow-up|2|||
163037451|NCT05025332|588844173|FG000|Screening|Screen failure|12|||
163037452|NCT05025332|588844173|FG000|Treatment & Follow Up|Protocol Violation|1|||
163037453|NCT05025332|588844173|FG000|Treatment & Follow Up|Adverse Event|4|||
163037454|NCT02107313|588844174|FG000|Overall Study|One participant did not do the FED cohor|0|||
163037455|NCT02107313|588844175|FG001|Overall Study|One participant did not do the FED cohor|1|||
163037456|NCT01031004|588844178|FG000|Overall Study|Protocol Violation|0|||
163037457|NCT01031004|588844179|FG001|Overall Study|Protocol Violation|1|||
163037458|NCT01031004|588844178|FG000|Overall Study|Lost to Follow-up|1|||
163037459|NCT01031004|588844179|FG001|Overall Study|Lost to Follow-up|0|||
163037460|NCT00582426|588844187|FG000|Overall Study|Lost to Follow-up|0|||
163037461|NCT00582426|588844188|FG001|Overall Study|Lost to Follow-up|2|||
163037462|NCT00582426|588844187|FG000|Overall Study|Adverse Event|4|||
163037463|NCT00582426|588844188|FG001|Overall Study|Adverse Event|2|||
163037464|NCT00582426|588844187|FG000|Overall Study|Protocol Violation|6|||
163037465|NCT00582426|588844188|FG001|Overall Study|Protocol Violation|2|||
163037466|NCT00582426|588844187|FG000|Overall Study|Death|4|||
163037467|NCT00582426|588844188|FG001|Overall Study|Death|3|||
163037468|NCT00582426|588844187|FG000|Overall Study|Withdrawal by Subject|3|||
163037469|NCT00582426|588844188|FG001|Overall Study|Withdrawal by Subject|2|||
163037470|NCT00582426|588844187|FG000|Overall Study|Disease Progression|2|||
163037471|NCT00582426|588844188|FG001|Overall Study|Disease Progression|2|||
163037472|NCT00582426|588844187|FG000|Overall Study|Use of illicit drugs|1|||
163037473|NCT00582426|588844188|FG001|Overall Study|Use of illicit drugs|0|||
163037474|NCT02164318|588844191|FG000|Overall Study|Withdrawal by Subject|0|||
163037475|NCT02164318|588844192|FG001|Overall Study|Withdrawal by Subject|1|||
163037476|NCT02164318|588844193|FG002|Overall Study|Withdrawal by Subject|0|||
163037477|NCT02164318|588844194|FG003|Overall Study|Withdrawal by Subject|1|||
163037478|NCT00662311|588844195|FG000|Overall Study|Respiratory Infection|1|||
163037479|NCT00662311|588844196|FG001|Overall Study|Respiratory Infection|0|||
163037480|NCT00662311|588844197|FG002|Overall Study|Respiratory Infection|0|||
163037481|NCT04727528|588844198|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
163037482|NCT04727528|588844199|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
163037483|NCT04727528|588844198|FG000|Open-label Period|Randomized who did not receive treatment|1|||
163037484|NCT04727528|588844199|FG001|Open-label Period|Randomized who did not receive treatment|0|||
163037485|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163037486|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Adverse Event|1|||
163037487|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Death|0|||
163037488|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Death|1|||
163037489|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
163037490|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
163037491|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
163037492|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
163037493|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Physician Decision|0|||
163037494|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Physician Decision|1|||
163037495|NCT04727528|588844198|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
163037496|NCT04727528|588844199|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163037497|NCT02335346|588844203|FG000|Overall Study|Adverse Event|11|||
163037498|NCT02335346|588844203|FG000|Overall Study|Withdrawal by Subject|1|||
163037499|NCT01964989|588844204|FG000|Overall Study|Protocol Violation|3|||
163037500|NCT01964989|588844205|FG001|Overall Study|Protocol Violation|4|||
163037501|NCT01964989|588844204|FG000|Overall Study|Administrative Reason|103|||
163037502|NCT01964989|588844205|FG001|Overall Study|Administrative Reason|95|||
163037503|NCT01964989|588844204|FG000|Overall Study|Adverse Event|0|||
163037504|NCT01964989|588844205|FG001|Overall Study|Adverse Event|1|||
163037505|NCT01964989|588844204|FG000|Overall Study|Death|1|||
163037506|NCT01964989|588844205|FG001|Overall Study|Death|3|||
163037507|NCT01964989|588844204|FG000|Overall Study|Withdrawal by Subject|156|||
163088789|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163088790|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163037508|NCT01964989|588844205|FG001|Overall Study|Withdrawal by Subject|160|||
163037509|NCT01964989|588844204|FG000|Overall Study|Lost to Follow-up|254|||
163037510|NCT01964989|588844205|FG001|Overall Study|Lost to Follow-up|232|||
163037511|NCT01964989|588844204|FG000|Overall Study|Other|267|||
162649587|NCT00110812|587435293|FG001|Extended Follow-up|Lost to Follow-up|3|||
162649588|NCT00110812|587435294|FG002|Extended Follow-up|Lost to Follow-up|1|||
162649589|NCT01886833|587435295|FG000|Overall Study|IgA not available from both periods|204|||
162649590|NCT04200248|587435296|FG000|Overall Study|Personal reasons|0|||
162649591|NCT04200248|587435297|FG001|Overall Study|Personal reasons|0|||
162649592|NCT04200248|587435298|FG002|Overall Study|Personal reasons|1|||
162649593|NCT04200248|587435296|FG000|Overall Study|Discontinued prior to treatment|3|||
162649594|NCT04200248|587435297|FG001|Overall Study|Discontinued prior to treatment|3|||
162649595|NCT04200248|587435298|FG002|Overall Study|Discontinued prior to treatment|2|||
162649596|NCT01454726|587435299|FG000|Overall Study|Withdrawal by Subject|0|||
162649597|NCT01454726|587435300|FG001|Overall Study|Withdrawal by Subject|1|||
162649598|NCT04476030|587435301|FG000|Overall Study|Withdrawal by Subject|20|||
162649599|NCT04476030|587435302|FG001|Overall Study|Withdrawal by Subject|16|||
162649600|NCT04476030|587435301|FG000|Overall Study|Adverse Event|10|||
162649601|NCT04476030|587435302|FG001|Overall Study|Adverse Event|11|||
162649602|NCT04476030|587435301|FG000|Overall Study|Lost to Follow-up|7|||
162649603|NCT04476030|587435302|FG001|Overall Study|Lost to Follow-up|4|||
162649604|NCT04476030|587435301|FG000|Overall Study|Physician Decision|1|||
162649605|NCT04476030|587435302|FG001|Overall Study|Physician Decision|1|||
162649606|NCT04476030|587435301|FG000|Overall Study|Protocol Deviation|2|||
162649607|NCT04476030|587435302|FG001|Overall Study|Protocol Deviation|0|||
162649608|NCT04476030|587435301|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
162649609|NCT04476030|587435302|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
162649610|NCT04476030|587435301|FG000|Overall Study|Randomized but not Dosed|2|||
162649611|NCT04476030|587435302|FG001|Overall Study|Randomized but not Dosed|8|||
162649612|NCT02342704|587435303|FG000|Overall Study|Physician Decision|0|||
162649613|NCT02342704|587435304|FG001|Overall Study|Physician Decision|3|||
162649614|NCT02342704|587435303|FG000|Overall Study|Sponsor Termination|49|||
162649615|NCT02342704|587435304|FG001|Overall Study|Sponsor Termination|43|||
162649616|NCT02342704|587435303|FG000|Overall Study|Other|0|||
162649617|NCT02342704|587435304|FG001|Overall Study|Other|1|||
162649618|NCT02342704|587435303|FG000|Overall Study|Withdrawal by Subject|1|||
162649619|NCT02342704|587435304|FG001|Overall Study|Withdrawal by Subject|0|||
162649620|NCT02342704|587435303|FG000|Overall Study|Lost to Follow-up|2|||
162649621|NCT02342704|587435304|FG001|Overall Study|Lost to Follow-up|1|||
162649622|NCT02342704|587435303|FG000|Overall Study|Adverse Event|1|||
162649623|NCT02342704|587435304|FG001|Overall Study|Adverse Event|3|||
162649624|NCT00302003|587435305|FG000|Overall Study|Lack of Efficacy|62|||
162649625|NCT00302003|587435305|FG000|Overall Study|Lost to Follow-up|1|||
162649626|NCT00302003|587435305|FG000|Overall Study|Physician Decision|2|||
162649627|NCT00302003|587435305|FG000|Overall Study|Withdrawal by Subject|5|||
162649628|NCT00302003|587435305|FG000|Overall Study|Ineligible|9|||
162649629|NCT00302003|587435305|FG000|Overall Study|Protocol Violation|1|||
162649630|NCT02042924|587435306|FG000|Overall Study|Early Death|1|||
162649631|NCT04033003|587435307|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
162649632|NCT04033003|587435308|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
162649633|NCT04033003|587435307|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
163088791|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
163088792|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
163088793|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
163088794|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
163088795|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
163088796|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
163088797|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
163088798|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
163088799|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088800|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163088801|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088802|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163088803|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
163088804|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
163088805|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
163088806|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
162649634|NCT04033003|587435308|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
162649635|NCT04033003|587435307|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
162649636|NCT04033003|587435308|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
162649637|NCT04033003|587435307|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
162649638|NCT04033003|587435308|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
162649639|NCT04033003|587435307|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
162649640|NCT04033003|587435308|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
162649641|NCT04033003|587435307|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
162649642|NCT04033003|587435308|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
162649643|NCT04033003|587435307|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
162649644|NCT04033003|587435308|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
162649645|NCT04033003|587435307|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
162649646|NCT04033003|587435308|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
162649647|NCT04033003|587435307|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
163037512|NCT01964989|588844205|FG001|Overall Study|Other|252|||
163037513|NCT02769312|588844206|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
163037514|NCT02769312|588844207|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
163037515|NCT02769312|588844206|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
163037516|NCT02769312|588844207|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
163037517|NCT02769312|588844206|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
163037518|NCT02769312|588844207|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
163037519|NCT02769312|588844206|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
163037520|NCT02769312|588844207|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
163037521|NCT02769312|588844206|FG000|Follow-up|Lost to Follow-up|1|||
163037522|NCT02769312|588844207|FG001|Follow-up|Lost to Follow-up|1|||
163037523|NCT01148459|588844210|FG000|Overall Study|Serious Adverse Event|5|||
163037524|NCT01148459|588844211|FG001|Overall Study|Serious Adverse Event|4|||
163037525|NCT01148459|588844210|FG000|Overall Study|Withdrawal by Subject|1|||
163037526|NCT01148459|588844211|FG001|Overall Study|Withdrawal by Subject|0|||
163037527|NCT01148459|588844210|FG000|Overall Study|Migrated/moved from study area|3|||
163037528|NCT01148459|588844211|FG001|Overall Study|Migrated/moved from study area|6|||
163037529|NCT01148459|588844210|FG000|Overall Study|Lost to Follow-up|2|||
163037530|NCT01148459|588844211|FG001|Overall Study|Lost to Follow-up|0|||
163037531|NCT01148459|588844210|FG000|Overall Study|Refusal|1|||
163037532|NCT01148459|588844211|FG001|Overall Study|Refusal|0|||
163037533|NCT01148459|588844210|FG000|Overall Study|Failure to comply with study procedures|0|||
163037534|NCT01148459|588844211|FG001|Overall Study|Failure to comply with study procedures|1|||
163037535|NCT02496039|588844212|FG000|Overall Study|Adverse Event|3|||
163037536|NCT02496039|588844212|FG000|Overall Study|Protocol Violation|1|||
163037537|NCT00948922|588844213|FG000|Overall Study|Did not start study treatment|2|||
163037538|NCT00948922|588844214|FG001|Overall Study|Did not start study treatment|5|||
163037539|NCT00948922|588844215|FG002|Overall Study|Did not start study treatment|0|||
163037540|NCT00948922|588844213|FG000|Overall Study|Withdrawal by Subject|0|||
163037541|NCT00948922|588844214|FG001|Overall Study|Withdrawal by Subject|2|||
163037542|NCT00948922|588844215|FG002|Overall Study|Withdrawal by Subject|1|||
163037543|NCT00948922|588844213|FG000|Overall Study|Death|3|||
163037544|NCT00948922|588844214|FG001|Overall Study|Death|0|||
163037545|NCT00948922|588844215|FG002|Overall Study|Death|0|||
163037546|NCT00948922|588844213|FG000|Overall Study|Disease progression|0|||
163037547|NCT00948922|588844214|FG001|Overall Study|Disease progression|1|||
163037548|NCT00948922|588844215|FG002|Overall Study|Disease progression|0|||
163037549|NCT00948922|588844213|FG000|Overall Study|Insurance issues|1|||
163037550|NCT00948922|588844214|FG001|Overall Study|Insurance issues|0|||
163037551|NCT00948922|588844215|FG002|Overall Study|Insurance issues|0|||
163037552|NCT00948922|588844213|FG000|Overall Study|Transplant eligibility issues|2|||
163037553|NCT00948922|588844214|FG001|Overall Study|Transplant eligibility issues|3|||
163037554|NCT00948922|588844215|FG002|Overall Study|Transplant eligibility issues|0|||
163037555|NCT00948922|588844213|FG000|Overall Study|Not evaluable at time of analysis|0|||
163037556|NCT00948922|588844214|FG001|Overall Study|Not evaluable at time of analysis|3|||
163037557|NCT00948922|588844215|FG002|Overall Study|Not evaluable at time of analysis|0|||
163037558|NCT04854057|588844216|FG000|Overall Study|Adverse Event|0|||
163037559|NCT04854057|588844217|FG001|Overall Study|Adverse Event|1|||
163037560|NCT02131233|588844218|FG000|Overall Study|Not Treated|2|||
163037561|NCT02131233|588844219|FG001|Overall Study|Not Treated|3|||
163037562|NCT02131233|588844218|FG000|Overall Study|Adverse Event|7|||
163037563|NCT02131233|588844219|FG001|Overall Study|Adverse Event|6|||
163037564|NCT02131233|588844218|FG000|Overall Study|Death|0|||
163037565|NCT02131233|588844219|FG001|Overall Study|Death|1|||
163037566|NCT02131233|588844218|FG000|Overall Study|Lack of Efficacy|6|||
163037567|NCT02131233|588844219|FG001|Overall Study|Lack of Efficacy|3|||
163037568|NCT02131233|588844218|FG000|Overall Study|Lost to Follow-up|14|||
163037569|NCT02131233|588844219|FG001|Overall Study|Lost to Follow-up|13|||
163037570|NCT02131233|588844218|FG000|Overall Study|Non-Compliance With Study Drug|8|||
163037571|NCT02131233|588844219|FG001|Overall Study|Non-Compliance With Study Drug|5|||
163037572|NCT02131233|588844218|FG000|Overall Study|Physician Decision|7|||
163037573|NCT02131233|588844219|FG001|Overall Study|Physician Decision|0|||
163037574|NCT02131233|588844218|FG000|Overall Study|Pregnancy|4|||
163037575|NCT02131233|588844219|FG001|Overall Study|Pregnancy|0|||
163037576|NCT02131233|588844218|FG000|Overall Study|Withdrawal by Subject|18|||
163037577|NCT02131233|588844219|FG001|Overall Study|Withdrawal by Subject|11|||
163037578|NCT05114564|588844221|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
163037579|NCT05114564|588844222|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
163037580|NCT05114564|588844221|FG000|First Intervention|Adverse Event|0|||
163037581|NCT05114564|588844222|FG001|First Intervention|Adverse Event|1|||
163037582|NCT00255840|588844223|FG000|Overall Study|Lost to Follow-up|10|||
163037583|NCT00255840|588844224|FG001|Overall Study|Lost to Follow-up|14|||
163088807|NCT02836249|589035935|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
163088808|NCT02836249|589035936|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088809|NCT02836249|589035937|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088810|NCT02836249|589035938|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163088811|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163088812|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
163088813|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
163088814|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
163088815|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163088816|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
163088817|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
163088818|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
163088819|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Death|0|||
163088820|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Death|0|||
163088821|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Death|1|||
163088822|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Death|0|||
163088823|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088824|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088825|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
163088826|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
163088827|NCT02836249|589035935|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088828|NCT02836249|589035936|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088829|NCT02836249|589035937|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
163088830|NCT02836249|589035938|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
163088831|NCT00928668|589035939|FG000|Overall Study|Adverse Event|1|||
163088832|NCT00928668|589035940|FG001|Overall Study|Adverse Event|0|||
163088833|NCT00928668|589035941|FG002|Overall Study|Adverse Event|0|||
163088834|NCT00928668|589035942|FG003|Overall Study|Adverse Event|0|||
163088835|NCT00928668|589035943|FG004|Overall Study|Adverse Event|0|||
163088836|NCT00928668|589035939|FG000|Overall Study|Protocol Violation|0|||
163088837|NCT00928668|589035940|FG001|Overall Study|Protocol Violation|0|||
163088838|NCT00928668|589035941|FG002|Overall Study|Protocol Violation|0|||
163088839|NCT00928668|589035942|FG003|Overall Study|Protocol Violation|0|||
163088840|NCT00928668|589035943|FG004|Overall Study|Protocol Violation|1|||
163088841|NCT00928668|589035939|FG000|Overall Study|Withdrawal by Subject|0|||
163088842|NCT00928668|589035940|FG001|Overall Study|Withdrawal by Subject|1|||
163088843|NCT00928668|589035941|FG002|Overall Study|Withdrawal by Subject|1|||
163088844|NCT00928668|589035942|FG003|Overall Study|Withdrawal by Subject|0|||
163088845|NCT00928668|589035943|FG004|Overall Study|Withdrawal by Subject|0|||
163088846|NCT00928668|589035939|FG000|Overall Study|Other reasons not listed above|0|||
163088847|NCT00928668|589035940|FG001|Overall Study|Other reasons not listed above|0|||
163088848|NCT00928668|589035941|FG002|Overall Study|Other reasons not listed above|0|||
163088849|NCT00928668|589035942|FG003|Overall Study|Other reasons not listed above|1|||
163088850|NCT00928668|589035943|FG004|Overall Study|Other reasons not listed above|0|||
163088851|NCT02943473|589035948|FG000|Overall Study|enrolled but not dosed|1|||
163088852|NCT02943473|589035948|FG000|Overall Study|screen failure|1|||
163088853|NCT02943473|589035948|FG000|Overall Study|Physician Decision|4|||
163088854|NCT04138056|589035949|FG000|Primary Study|Lost to Follow-up|3|||
163088855|NCT04138056|589035950|FG001|Primary Study|Lost to Follow-up|4|||
163088856|NCT04138056|589035951|FG002|Primary Study|Lost to Follow-up|1|||
163088857|NCT04138056|589035952|FG003|Primary Study|Lost to Follow-up|1|||
163088858|NCT04138056|589035953|FG004|Primary Study|Lost to Follow-up|4|||
163088859|NCT04138056|589035949|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
163088860|NCT04138056|589035950|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
163088861|NCT04138056|589035951|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
163088862|NCT04138056|589035952|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
163088863|NCT04138056|589035953|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
163088864|NCT04138056|589035949|FG000|Extension Study|Lost to Follow-up|1|||
163088865|NCT04138056|589035950|FG001|Extension Study|Lost to Follow-up|2|||
163088866|NCT04138056|589035951|FG002|Extension Study|Lost to Follow-up|1|||
162649648|NCT04033003|587435308|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
162649649|NCT04033003|587435307|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
163088867|NCT04138056|589035952|FG003|Extension Study|Lost to Follow-up|0|||
163088868|NCT04138056|589035953|FG004|Extension Study|Lost to Follow-up|1|||
163088869|NCT01968980|589035957|FG000|Overall Study|Death|0|||
163088870|NCT01968980|589035958|FG001|Overall Study|Death|1|||
163088871|NCT01968980|589035957|FG000|Overall Study|Adverse Event|1|||
162649650|NCT04033003|587435308|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
162649651|NCT04033003|587435307|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
163088872|NCT01968980|589035958|FG001|Overall Study|Adverse Event|3|||
163088873|NCT01968980|589035957|FG000|Overall Study|Does not meet entry criteria|1|||
163088874|NCT01968980|589035958|FG001|Overall Study|Does not meet entry criteria|3|||
162649652|NCT04033003|587435308|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
162649653|NCT04033003|587435307|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
162649654|NCT04033003|587435308|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
163088875|NCT01968980|589035957|FG000|Overall Study|Withdrawal by Subject|13|||
163088876|NCT01968980|589035958|FG001|Overall Study|Withdrawal by Subject|5|||
163088877|NCT01968980|589035957|FG000|Overall Study|Other unspecified|1|||
163088878|NCT01968980|589035958|FG001|Overall Study|Other unspecified|2|||
163088879|NCT01242514|589035959|FG000|Overall Study|e.g., project closure|1042|||
163088880|NCT01242514|589035960|FG001|Overall Study|e.g., project closure|305|||
163088881|NCT01242514|589035961|FG002|Overall Study|e.g., project closure|171|||
163088882|NCT01242514|589035959|FG000|Overall Study|Subject decision|33|||
163088883|NCT01242514|589035960|FG001|Overall Study|Subject decision|8|||
163088884|NCT01242514|589035961|FG002|Overall Study|Subject decision|2|||
163088885|NCT01242514|589035959|FG000|Overall Study|Severe non-compliance to protocol|5|||
163088886|NCT01242514|589035960|FG001|Overall Study|Severe non-compliance to protocol|2|||
163088887|NCT01242514|589035961|FG002|Overall Study|Severe non-compliance to protocol|1|||
163088888|NCT01242514|589035959|FG000|Overall Study|Lack of therapeutic response|99|||
163088889|NCT01242514|589035960|FG001|Overall Study|Lack of therapeutic response|16|||
163088890|NCT01242514|589035961|FG002|Overall Study|Lack of therapeutic response|10|||
163088891|NCT01242514|589035959|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
163088892|NCT01242514|589035960|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
163088893|NCT01242514|589035961|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
163088894|NCT01242514|589035959|FG000|Overall Study|Lost to Follow-up|14|||
163088895|NCT01242514|589035960|FG001|Overall Study|Lost to Follow-up|5|||
163088896|NCT01242514|589035961|FG002|Overall Study|Lost to Follow-up|4|||
163088897|NCT01242514|589035959|FG000|Overall Study|Adverse Event|129|||
163088898|NCT01242514|589035960|FG001|Overall Study|Adverse Event|18|||
163088899|NCT01242514|589035961|FG002|Overall Study|Adverse Event|19|||
163088900|NCT05901636|589035965|FG000|Overall Study|Lost to Follow-up|0|||
163088901|NCT05901636|589035966|FG001|Overall Study|Lost to Follow-up|1|||
163088902|NCT05901636|589035967|FG002|Overall Study|Lost to Follow-up|0|||
163088903|NCT05901636|589035968|FG003|Overall Study|Lost to Follow-up|1|||
163088904|NCT05901636|589035969|FG004|Overall Study|Lost to Follow-up|1|||
163088905|NCT05901636|589035970|FG005|Overall Study|Lost to Follow-up|3|||
163088906|NCT05901636|589035971|FG006|Overall Study|Lost to Follow-up|1|||
163088907|NCT05901636|589035965|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
163088908|NCT05901636|589035966|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
163088909|NCT05901636|589035967|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
163088910|NCT05901636|589035968|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
163088911|NCT05901636|589035969|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
163088912|NCT05901636|589035970|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
163088913|NCT05901636|589035971|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
163088914|NCT05901636|589035965|FG000|Overall Study|Withdrawal by Subject|1|||
163088915|NCT05901636|589035966|FG001|Overall Study|Withdrawal by Subject|1|||
163088916|NCT05901636|589035967|FG002|Overall Study|Withdrawal by Subject|0|||
163088917|NCT05901636|589035968|FG003|Overall Study|Withdrawal by Subject|0|||
163088918|NCT05901636|589035969|FG004|Overall Study|Withdrawal by Subject|1|||
163088919|NCT05901636|589035970|FG005|Overall Study|Withdrawal by Subject|1|||
163088920|NCT05901636|589035971|FG006|Overall Study|Withdrawal by Subject|0|||
163088921|NCT05901636|589035965|FG000|Overall Study|Other|0|||
163088922|NCT05901636|589035966|FG001|Overall Study|Other|0|||
163088923|NCT05901636|589035967|FG002|Overall Study|Other|1|||
163088924|NCT05901636|589035968|FG003|Overall Study|Other|1|||
163088925|NCT05901636|589035969|FG004|Overall Study|Other|0|||
163088926|NCT05901636|589035970|FG005|Overall Study|Other|0|||
163088927|NCT05901636|589035971|FG006|Overall Study|Other|0|||
163088928|NCT03193801|589035972|FG000|Overall Study|Physician Decision|2|||
163088929|NCT03193801|589035972|FG000|Overall Study|Withdrawal by Subject|1|||
163088930|NCT05239221|589035977|FG000|Overall Study|Adverse Event|0|||
163088931|NCT05239221|589035978|FG001|Overall Study|Adverse Event|0|||
163088932|NCT05239221|589035979|FG002|Overall Study|Adverse Event|0|||
163088933|NCT05239221|589035980|FG003|Overall Study|Adverse Event|0|||
163088934|NCT05239221|589035981|FG004|Overall Study|Adverse Event|0|||
163088935|NCT05239221|589035982|FG005|Overall Study|Adverse Event|0|||
163088936|NCT05239221|589035983|FG006|Overall Study|Adverse Event|1|||
163088937|NCT05239221|589035984|FG007|Overall Study|Adverse Event|0|||
163088938|NCT05239221|589035985|FG008|Overall Study|Adverse Event|0|||
162649655|NCT04033003|587435307|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
163088939|NCT05239221|589035986|FG009|Overall Study|Adverse Event|0|||
163088940|NCT05239221|589035987|FG010|Overall Study|Adverse Event|1|||
163088941|NCT05239221|589035988|FG011|Overall Study|Adverse Event|1|||
163088942|NCT05239221|589035989|FG012|Overall Study|Adverse Event|0|||
163088943|NCT05239221|589035990|FG013|Overall Study|Adverse Event|0|||
162649656|NCT04033003|587435308|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
163088944|NCT05239221|589035991|FG014|Overall Study|Adverse Event|0|||
163088945|NCT05239221|589035992|FG015|Overall Study|Adverse Event|0|||
163088946|NCT05239221|589035977|FG000|Overall Study|Withdrawal by Subject|0|||
163088947|NCT05239221|589035978|FG001|Overall Study|Withdrawal by Subject|0|||
163088948|NCT05239221|589035979|FG002|Overall Study|Withdrawal by Subject|0|||
163088949|NCT05239221|589035980|FG003|Overall Study|Withdrawal by Subject|0|||
163088950|NCT05239221|589035981|FG004|Overall Study|Withdrawal by Subject|0|||
163088951|NCT05239221|589035982|FG005|Overall Study|Withdrawal by Subject|0|||
163088952|NCT05239221|589035983|FG006|Overall Study|Withdrawal by Subject|0|||
163088953|NCT05239221|589035984|FG007|Overall Study|Withdrawal by Subject|0|||
163088954|NCT05239221|589035985|FG008|Overall Study|Withdrawal by Subject|0|||
163088955|NCT05239221|589035986|FG009|Overall Study|Withdrawal by Subject|0|||
163088956|NCT05239221|589035987|FG010|Overall Study|Withdrawal by Subject|1|||
163088957|NCT05239221|589035988|FG011|Overall Study|Withdrawal by Subject|0|||
163088958|NCT05239221|589035989|FG012|Overall Study|Withdrawal by Subject|0|||
163088959|NCT05239221|589035990|FG013|Overall Study|Withdrawal by Subject|0|||
163088960|NCT05239221|589035991|FG014|Overall Study|Withdrawal by Subject|0|||
163088961|NCT05239221|589035992|FG015|Overall Study|Withdrawal by Subject|1|||
163088962|NCT02114177|589037525|FG000|Overall Study|Lost to Follow-up|1|||
163088963|NCT02114177|589037526|FG001|Overall Study|Lost to Follow-up|2|||
163088964|NCT02114177|589037525|FG000|Overall Study|Withdrawal by Subject|6|||
163088965|NCT02114177|589037526|FG001|Overall Study|Withdrawal by Subject|1|||
163088966|NCT02114177|589037525|FG000|Overall Study|Other|2|||
163088967|NCT02114177|589037526|FG001|Overall Study|Other|1|||
163088968|NCT01897493|589037528|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
163088969|NCT05111145|589037531|FG000|Overall Study|Commercial drug is available for participant|76|||
163088970|NCT05111145|589037531|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
163088971|NCT02336815|589037532|FG000|Overall Study|Disease Progression|45|||
163088972|NCT02336815|589037533|FG001|Overall Study|Disease Progression|70|||
163088973|NCT02336815|589037532|FG000|Overall Study|Adverse Event|18|||
163088974|NCT02336815|589037533|FG001|Overall Study|Adverse Event|39|||
163088975|NCT02336815|589037532|FG000|Overall Study|Physician Decision|11|||
162649657|NCT02919670|587435309|FG000|Overall Study|Only 17 participants met compliance|43|||
162649658|NCT02919670|587435310|FG001|Overall Study|Only 17 participants met compliance|39|||
162649659|NCT02256891|587435311|FG000|Overall Study|Death|0|||
162649660|NCT02256891|587435312|FG001|Overall Study|Death|2|||
162649661|NCT02256891|587435311|FG000|Overall Study|Lost to Follow-up|0|||
162649662|NCT02256891|587435312|FG001|Overall Study|Lost to Follow-up|3|||
162649663|NCT02256891|587435311|FG000|Overall Study|Physician Decision|7|||
162649664|NCT02256891|587435312|FG001|Overall Study|Physician Decision|3|||
162649665|NCT02256891|587435311|FG000|Overall Study|Screen Fail|5|||
162649666|NCT02256891|587435312|FG001|Overall Study|Screen Fail|4|||
162649667|NCT02256891|587435311|FG000|Overall Study|Equipment Malfunction|0|||
162649668|NCT02256891|587435312|FG001|Overall Study|Equipment Malfunction|1|||
162649669|NCT01675882|587435315|FG000|Overall Study|Adverse Event|0|||
162649670|NCT01675882|587435316|FG001|Overall Study|Adverse Event|2|||
162649671|NCT01675882|587435317|FG002|Overall Study|Adverse Event|1|||
162649672|NCT01675882|587435318|FG003|Overall Study|Adverse Event|0|||
162649673|NCT01675882|587435315|FG000|Overall Study|Participant unwilling to continue|2|||
162649674|NCT01675882|587435316|FG001|Overall Study|Participant unwilling to continue|4|||
162649675|NCT01675882|587435317|FG002|Overall Study|Participant unwilling to continue|2|||
162649676|NCT01675882|587435318|FG003|Overall Study|Participant unwilling to continue|1|||
162649677|NCT01675882|587435315|FG000|Overall Study|Lost to Follow-up|0|||
162649678|NCT01675882|587435316|FG001|Overall Study|Lost to Follow-up|1|||
162649679|NCT01675882|587435317|FG002|Overall Study|Lost to Follow-up|0|||
162649680|NCT01675882|587435318|FG003|Overall Study|Lost to Follow-up|0|||
162649681|NCT01675882|587435315|FG000|Overall Study|Non-compliance|0|||
162649682|NCT01675882|587435316|FG001|Overall Study|Non-compliance|0|||
162649683|NCT01675882|587435317|FG002|Overall Study|Non-compliance|0|||
162649684|NCT01675882|587435318|FG003|Overall Study|Non-compliance|1|||
162649685|NCT01446965|587435321|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
162649686|NCT01446965|587435322|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
162649687|NCT01446965|587435321|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
162649688|NCT01446965|587435322|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
162649689|NCT02016482|587435332|FG000|Period A|Adverse Event|3|||
162649690|NCT02016482|587435333|FG001|Period A|Adverse Event|5|||
162649691|NCT02016482|587435332|FG000|Period A|Withdrawal by Subject|3|||
162649692|NCT02016482|587435333|FG001|Period A|Withdrawal by Subject|4|||
162649693|NCT02016482|587435332|FG000|Period A|Lost to Follow-up|3|||
162649694|NCT02016482|587435333|FG001|Period A|Lost to Follow-up|3|||
162649695|NCT02016482|587435332|FG000|Period A|Lack of Efficacy|2|||
162649696|NCT02016482|587435333|FG001|Period A|Lack of Efficacy|1|||
163088976|NCT02336815|589037533|FG001|Overall Study|Physician Decision|4|||
163088977|NCT02336815|589037532|FG000|Overall Study|Withdrawal by Subject|3|||
163088978|NCT02336815|589037533|FG001|Overall Study|Withdrawal by Subject|2|||
162649697|NCT02016482|587435332|FG000|Period A|Other|3|||
162649698|NCT02016482|587435333|FG001|Period A|Other|0|||
162649699|NCT02016482|587435332|FG000|Period A|Protocol Violation|0|||
162649700|NCT02016482|587435333|FG001|Period A|Protocol Violation|1|||
163088979|NCT02336815|589037532|FG000|Overall Study|Lost to Follow-up|1|||
163088980|NCT02336815|589037533|FG001|Overall Study|Lost to Follow-up|3|||
163088981|NCT02336815|589037532|FG000|Overall Study|Other|1|||
163088982|NCT02336815|589037533|FG001|Overall Study|Other|5|||
163088983|NCT01359956|589037534|FG000|Overall Study|Death|58|||
163088984|NCT01359956|589037535|FG001|Overall Study|Death|60|||
163088985|NCT01359956|589037536|FG002|Overall Study|Death|66|||
163088986|NCT01359956|589037537|FG003|Overall Study|Death|57|||
163088987|NCT01359956|589037534|FG000|Overall Study|Lost to Follow-up|3|||
163088988|NCT01359956|589037535|FG001|Overall Study|Lost to Follow-up|4|||
163088989|NCT01359956|589037536|FG002|Overall Study|Lost to Follow-up|1|||
163088990|NCT01359956|589037537|FG003|Overall Study|Lost to Follow-up|1|||
163088991|NCT01784029|589037538|FG000|Overall Study|Lost to Follow-up|19|||
163088992|NCT01784029|589037539|FG001|Overall Study|Lost to Follow-up|20|||
163088993|NCT01784029|589037540|FG002|Overall Study|Lost to Follow-up|22|||
163088994|NCT03235050|589037543|FG000|Overall Study|Adverse Event|0|||
163088995|NCT03235050|589037544|FG001|Overall Study|Adverse Event|0|||
163088996|NCT03235050|589037545|FG002|Overall Study|Adverse Event|1|||
163088997|NCT03235050|589037546|FG003|Overall Study|Adverse Event|4|||
163088998|NCT03235050|589037547|FG004|Overall Study|Adverse Event|1|||
163088999|NCT03235050|589037543|FG000|Overall Study|Death|0|||
163089000|NCT03235050|589037544|FG001|Overall Study|Death|0|||
163089001|NCT03235050|589037545|FG002|Overall Study|Death|0|||
163089002|NCT03235050|589037546|FG003|Overall Study|Death|2|||
163089003|NCT03235050|589037547|FG004|Overall Study|Death|1|||
163089004|NCT03235050|589037543|FG000|Overall Study|Lost to Follow-up|1|||
163089005|NCT03235050|589037544|FG001|Overall Study|Lost to Follow-up|2|||
163089006|NCT03235050|589037545|FG002|Overall Study|Lost to Follow-up|1|||
163089007|NCT03235050|589037546|FG003|Overall Study|Lost to Follow-up|2|||
163089008|NCT03235050|589037547|FG004|Overall Study|Lost to Follow-up|0|||
163089009|NCT03235050|589037543|FG000|Overall Study|Withdrawal by Subject|3|||
163089010|NCT03235050|589037544|FG001|Overall Study|Withdrawal by Subject|2|||
163089011|NCT03235050|589037545|FG002|Overall Study|Withdrawal by Subject|2|||
163089012|NCT03235050|589037546|FG003|Overall Study|Withdrawal by Subject|5|||
163089013|NCT03235050|589037547|FG004|Overall Study|Withdrawal by Subject|7|||
163089014|NCT03235050|589037543|FG000|Overall Study|Other reasons|0|||
163089015|NCT03235050|589037544|FG001|Overall Study|Other reasons|1|||
163089016|NCT03235050|589037545|FG002|Overall Study|Other reasons|0|||
163089017|NCT03235050|589037546|FG003|Overall Study|Other reasons|1|||
163089018|NCT03235050|589037547|FG004|Overall Study|Other reasons|2|||
163089019|NCT00370292|589037548|FG000|Overall Study|Disease Progression|4|||
163089020|NCT00370292|589037548|FG000|Overall Study|Adverse Event|7|||
163089021|NCT00370292|589037548|FG000|Overall Study|Physician Decision|2|||
163089022|NCT03545672|589037549|FG000|Overall Study|Uncertain diagnosis|2|||
163089023|NCT03545672|589037550|FG001|Overall Study|Uncertain diagnosis|1|||
163089024|NCT03545672|589037549|FG000|Overall Study|Protocol Violation|2|||
163089025|NCT03545672|589037550|FG001|Overall Study|Protocol Violation|2|||
163089026|NCT02415556|589037551|FG000|Overall Study|Adverse Event|3|||
163089027|NCT02415556|589037552|FG001|Overall Study|Adverse Event|4|||
163089028|NCT02415556|589037553|FG002|Overall Study|Adverse Event|2|||
163089029|NCT02415556|589037554|FG003|Overall Study|Adverse Event|4|||
163089030|NCT02415556|589037551|FG000|Overall Study|Lost to Follow-up|4|||
163089031|NCT02415556|589037552|FG001|Overall Study|Lost to Follow-up|5|||
163089032|NCT02415556|589037553|FG002|Overall Study|Lost to Follow-up|4|||
163089033|NCT02415556|589037554|FG003|Overall Study|Lost to Follow-up|1|||
163089034|NCT02415556|589037551|FG000|Overall Study|Withdrawal by Subject|13|||
163089035|NCT02415556|589037552|FG001|Overall Study|Withdrawal by Subject|4|||
163089036|NCT02415556|589037553|FG002|Overall Study|Withdrawal by Subject|14|||
163089037|NCT02415556|589037554|FG003|Overall Study|Withdrawal by Subject|12|||
163089038|NCT02415556|589037551|FG000|Overall Study|Physician Decision|1|||
163089039|NCT02415556|589037552|FG001|Overall Study|Physician Decision|3|||
163089040|NCT02415556|589037553|FG002|Overall Study|Physician Decision|1|||
163089041|NCT02415556|589037554|FG003|Overall Study|Physician Decision|2|||
163089042|NCT02415556|589037551|FG000|Overall Study|Censored - study completion|4|||
163089043|NCT02415556|589037552|FG001|Overall Study|Censored - study completion|5|||
163089044|NCT02415556|589037553|FG002|Overall Study|Censored - study completion|1|||
162649701|NCT02016482|587435332|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
162649702|NCT02016482|587435333|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
163089045|NCT02415556|589037554|FG003|Overall Study|Censored - study completion|0|||
163089046|NCT02415556|589037551|FG000|Overall Study|Family-related issues|0|||
163089047|NCT02415556|589037552|FG001|Overall Study|Family-related issues|0|||
163089048|NCT02415556|589037553|FG002|Overall Study|Family-related issues|0|||
162649703|NCT02016482|587435332|FG000|Period B|Withdrawal by Subject|1|||
162649704|NCT02016482|587435333|FG001|Period B|Withdrawal by Subject|1|||
163089049|NCT02415556|589037554|FG003|Overall Study|Family-related issues|1|||
163089050|NCT01209767|589037555|FG000|Overall Study|Withdrawal by Subject|1|||
163089051|NCT01209767|589037555|FG000|Overall Study|Lost to Follow-up|3|||
163089052|NCT00105534|589037556|FG000|Overall Study|Adverse Event|2|||
163089053|NCT00105534|589037557|FG001|Overall Study|Adverse Event|5|||
163089054|NCT00105534|589037556|FG000|Overall Study|Protocol Violation|1|||
163089055|NCT00105534|589037557|FG001|Overall Study|Protocol Violation|4|||
163089056|NCT00105534|589037556|FG000|Overall Study|Withdrawal by Subject|6|||
163089057|NCT00105534|589037557|FG001|Overall Study|Withdrawal by Subject|6|||
162649705|NCT02016482|587435332|FG000|Period B|Lost to Follow-up|2|||
162649706|NCT02016482|587435333|FG001|Period B|Lost to Follow-up|0|||
162649707|NCT02016482|587435332|FG000|Period B|Lack of Efficacy|6|||
162649708|NCT02016482|587435333|FG001|Period B|Lack of Efficacy|4|||
162649709|NCT02016482|587435332|FG000|Period B|Other|4|||
162649710|NCT02016482|587435333|FG001|Period B|Other|0|||
162649711|NCT02016482|587435332|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
162649712|NCT02016482|587435333|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
162649713|NCT03387813|587435334|FG000|Overall Study|Death|40|||
162649714|NCT03387813|587435335|FG001|Overall Study|Death|37|||
162649715|NCT03387813|587435336|FG002|Overall Study|Death|190|||
162649716|NCT03387813|587435334|FG000|Overall Study|Withdrawal by Subject|9|||
162649717|NCT03387813|587435335|FG001|Overall Study|Withdrawal by Subject|19|||
162649718|NCT03387813|587435336|FG002|Overall Study|Withdrawal by Subject|32|||
162649719|NCT03387813|587435334|FG000|Overall Study|Lost to Follow-up|3|||
162649720|NCT03387813|587435335|FG001|Overall Study|Lost to Follow-up|9|||
162649721|NCT03387813|587435336|FG002|Overall Study|Lost to Follow-up|15|||
162649722|NCT03387813|587435334|FG000|Overall Study|Non-Compliance|6|||
162649723|NCT03387813|587435335|FG001|Overall Study|Non-Compliance|6|||
162649724|NCT03387813|587435336|FG002|Overall Study|Non-Compliance|31|||
162649725|NCT03387813|587435334|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
162649726|NCT03387813|587435335|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
162649727|NCT03387813|587435336|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
162649728|NCT00606892|587435337|FG000|First Intervention|Protocol Violation|1|||
162649729|NCT00606892|587435338|FG001|First Intervention|Protocol Violation|4|||
162649730|NCT00855309|587435340|FG000|Overall Study|patient never recieved drug|1|||
162649731|NCT00855309|587435341|FG001|Overall Study|patient never recieved drug|0|||
162649732|NCT00829296|587435342|FG000|Overall Study|Adverse Event|5|||
163089058|NCT00105534|589037556|FG000|Overall Study|Lost to Follow-up|5|||
163089059|NCT00105534|589037557|FG001|Overall Study|Lost to Follow-up|1|||
163089060|NCT00105534|589037556|FG000|Overall Study|Lack of Efficacy|7|||
163089061|NCT00105534|589037557|FG001|Overall Study|Lack of Efficacy|15|||
163089062|NCT00105534|589037556|FG000|Overall Study|Treatment unmasked|1|||
163089063|NCT00105534|589037557|FG001|Overall Study|Treatment unmasked|0|||
163089064|NCT00105534|589037556|FG000|Overall Study|Other Reason|0|||
163089065|NCT00105534|589037557|FG001|Overall Study|Other Reason|2|||
163089066|NCT01621178|589037558|FG000|Overall Study|Adverse Event|5|||
163089067|NCT01621178|589037559|FG001|Overall Study|Adverse Event|2|||
163089068|NCT01621178|589037560|FG002|Overall Study|Adverse Event|8|||
163089069|NCT01621178|589037558|FG000|Overall Study|Death|6|||
163089070|NCT01621178|589037559|FG001|Overall Study|Death|7|||
163089071|NCT01621178|589037560|FG002|Overall Study|Death|2|||
163089072|NCT01621178|589037558|FG000|Overall Study|Lost to Follow-up|1|||
163089073|NCT01621178|589037559|FG001|Overall Study|Lost to Follow-up|2|||
163089074|NCT01621178|589037560|FG002|Overall Study|Lost to Follow-up|1|||
163089075|NCT01621178|589037558|FG000|Overall Study|Withdrawal by Subject|14|||
163089076|NCT01621178|589037559|FG001|Overall Study|Withdrawal by Subject|17|||
163089077|NCT01621178|589037560|FG002|Overall Study|Withdrawal by Subject|18|||
163089078|NCT01621178|589037558|FG000|Overall Study|Physician Decision|5|||
163089079|NCT01621178|589037559|FG001|Overall Study|Physician Decision|2|||
163089080|NCT01621178|589037560|FG002|Overall Study|Physician Decision|7|||
163089081|NCT02465931|589037561|FG000|Overall Study|Lost to Follow-up|9|||
163089082|NCT02465931|589037562|FG001|Overall Study|Lost to Follow-up|11|||
163089083|NCT02465931|589037561|FG000|Overall Study|Protocol Violation|1|||
163089084|NCT02465931|589037562|FG001|Overall Study|Protocol Violation|0|||
163089085|NCT02465931|589037561|FG000|Overall Study|Withdrawal by Subject|1|||
163089086|NCT02465931|589037562|FG001|Overall Study|Withdrawal by Subject|0|||
163089087|NCT03423121|589037564|FG000|Overall Study|Lost to Follow-up|2|||
163089088|NCT03423121|589037565|FG001|Overall Study|Lost to Follow-up|6|||
163089089|NCT03423121|589037564|FG000|Overall Study|Adverse Event|1|||
163089090|NCT03423121|589037565|FG001|Overall Study|Adverse Event|0|||
163089091|NCT04102007|589037570|FG000|Overall Study|Adverse Event|4|||
162649733|NCT00829296|587435343|FG001|Overall Study|Adverse Event|4|||
162649734|NCT04960228|587435349|FG000|Overall Study|Withdrawal by Subject|216|||
162649735|NCT04960228|587435350|FG001|Overall Study|Withdrawal by Subject|35|||
162649736|NCT04960228|587435349|FG000|Overall Study|Failed attention check|69|||
162649737|NCT04960228|587435350|FG001|Overall Study|Failed attention check|148|||
163089092|NCT04102007|589037570|FG000|Overall Study|Lost to Follow-up|3|||
163089093|NCT04102007|589037570|FG000|Overall Study|Withdrawal by Subject|12|||
163089094|NCT04102007|589037570|FG000|Overall Study|Eligibility Violation|5|||
163089095|NCT04102007|589037570|FG000|Overall Study|Lack of Efficacy|6|||
163089096|NCT04102007|589037570|FG000|Overall Study|Protocol Deviation|5|||
163089097|NCT04102007|589037570|FG000|Overall Study|Protocol Compliance|1|||
163089098|NCT04102007|589037570|FG000|Overall Study|Withdrew Treatment|2|||
163089099|NCT04102007|589037570|FG000|Overall Study|Pregnancy|1|||
163089100|NCT03289143|589037571|FG000|Overall Study|Caregiver Unavailability|1|||
163089101|NCT03289143|589037572|FG001|Overall Study|Caregiver Unavailability|1|||
163089102|NCT03289143|589037573|FG002|Overall Study|Caregiver Unavailability|0|||
163089103|NCT03289143|589037574|FG003|Overall Study|Caregiver Unavailability|0|||
163089104|NCT03289143|589037571|FG000|Overall Study|Research Department Closure|0|||
163089105|NCT03289143|589037572|FG001|Overall Study|Research Department Closure|0|||
163089106|NCT03289143|589037573|FG002|Overall Study|Research Department Closure|1|||
163089107|NCT03289143|589037574|FG003|Overall Study|Research Department Closure|0|||
163089108|NCT03289143|589037571|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089109|NCT03289143|589037572|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089110|NCT03289143|589037573|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
163089111|NCT03289143|589037574|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
163089112|NCT03289143|589037571|FG000|Overall Study|Medical Monitor Decision|1|||
163089113|NCT03289143|589037572|FG001|Overall Study|Medical Monitor Decision|0|||
163089114|NCT03289143|589037573|FG002|Overall Study|Medical Monitor Decision|0|||
163089115|NCT03289143|589037574|FG003|Overall Study|Medical Monitor Decision|0|||
163089116|NCT03289143|589037571|FG000|Overall Study|Participant Non-Compliance|0|||
163089117|NCT03289143|589037572|FG001|Overall Study|Participant Non-Compliance|0|||
163089118|NCT03289143|589037573|FG002|Overall Study|Participant Non-Compliance|1|||
163089119|NCT03289143|589037574|FG003|Overall Study|Participant Non-Compliance|0|||
163089120|NCT03289143|589037571|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089121|NCT03289143|589037572|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089122|NCT03289143|589037573|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
163089123|NCT03289143|589037574|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
163089124|NCT03289143|589037571|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089125|NCT03289143|589037572|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089126|NCT03289143|589037573|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
163089127|NCT03289143|589037574|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
163089128|NCT03289143|589037571|FG000|Overall Study|Caregiver Passed Away|1|||
163089129|NCT03289143|589037572|FG001|Overall Study|Caregiver Passed Away|0|||
163089130|NCT03289143|589037573|FG002|Overall Study|Caregiver Passed Away|0|||
163089131|NCT03289143|589037574|FG003|Overall Study|Caregiver Passed Away|0|||
163089132|NCT03289143|589037571|FG000|Overall Study|Physician Decision|0|||
163089133|NCT03289143|589037572|FG001|Overall Study|Physician Decision|2|||
163089134|NCT03289143|589037573|FG002|Overall Study|Physician Decision|2|||
163089135|NCT03289143|589037574|FG003|Overall Study|Physician Decision|2|||
163089136|NCT03289143|589037571|FG000|Overall Study|Protocol Deviation|2|||
163089137|NCT03289143|589037572|FG001|Overall Study|Protocol Deviation|1|||
163089138|NCT03289143|589037573|FG002|Overall Study|Protocol Deviation|3|||
163089139|NCT03289143|589037574|FG003|Overall Study|Protocol Deviation|1|||
163089140|NCT03289143|589037571|FG000|Overall Study|Study Terminated By Sponsor|101|||
163089141|NCT03289143|589037572|FG001|Overall Study|Study Terminated By Sponsor|75|||
163089142|NCT03289143|589037573|FG002|Overall Study|Study Terminated By Sponsor|100|||
163089143|NCT03289143|589037574|FG003|Overall Study|Study Terminated By Sponsor|69|||
163089144|NCT03289143|589037571|FG000|Overall Study|Withdrawal by Subject|14|||
163089145|NCT03289143|589037572|FG001|Overall Study|Withdrawal by Subject|6|||
163089146|NCT03289143|589037573|FG002|Overall Study|Withdrawal by Subject|14|||
163089147|NCT03289143|589037574|FG003|Overall Study|Withdrawal by Subject|12|||
163089148|NCT03289143|589037571|FG000|Overall Study|Adverse Event|10|||
163089149|NCT03289143|589037572|FG001|Overall Study|Adverse Event|7|||
163089150|NCT03289143|589037573|FG002|Overall Study|Adverse Event|6|||
163089151|NCT03289143|589037574|FG003|Overall Study|Adverse Event|5|||
163089152|NCT03289143|589037571|FG000|Overall Study|Death|2|||
163089153|NCT03289143|589037572|FG001|Overall Study|Death|0|||
163089154|NCT03289143|589037573|FG002|Overall Study|Death|2|||
163089155|NCT03289143|589037574|FG003|Overall Study|Death|1|||
163089156|NCT03289143|589037571|FG000|Overall Study|Lost to Follow-up|2|||
163089157|NCT03289143|589037572|FG001|Overall Study|Lost to Follow-up|1|||
163089158|NCT03289143|589037573|FG002|Overall Study|Lost to Follow-up|1|||
163089159|NCT03289143|589037574|FG003|Overall Study|Lost to Follow-up|0|||
163089160|NCT03289143|589037571|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
163089161|NCT03289143|589037572|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
163089162|NCT03289143|589037573|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
163089163|NCT03289143|589037574|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
163089164|NCT03289143|589037571|FG000|Overall Study|Withdrawal by Caregiver|0|||
163089165|NCT03289143|589037572|FG001|Overall Study|Withdrawal by Caregiver|1|||
163089166|NCT03289143|589037573|FG002|Overall Study|Withdrawal by Caregiver|0|||
163089167|NCT03289143|589037574|FG003|Overall Study|Withdrawal by Caregiver|0|||
163089168|NCT03289143|589037571|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163089169|NCT03289143|589037572|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163089170|NCT03289143|589037573|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
163089171|NCT03289143|589037574|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163089172|NCT03289143|589037571|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089173|NCT03289143|589037572|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089174|NCT03289143|589037573|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163089175|NCT03289143|589037574|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
163089176|NCT00948688|589037575|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
163089177|NCT00948688|589037576|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
163089178|NCT00948688|589037575|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
163089179|NCT00948688|589037576|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
163089180|NCT00948688|589037575|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
163089181|NCT00948688|589037576|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
163089182|NCT00730756|589037577|FG000|Overall Study|Adverse Event|2|||
163089183|NCT00730756|589037578|FG001|Overall Study|Adverse Event|0|||
163089184|NCT00730756|589037577|FG000|Overall Study|Lack of Efficacy|1|||
163089185|NCT00730756|589037578|FG001|Overall Study|Lack of Efficacy|1|||
163089186|NCT00730756|589037577|FG000|Overall Study|Protocol Deviation|1|||
163089187|NCT00730756|589037578|FG001|Overall Study|Protocol Deviation|2|||
163089188|NCT00730756|589037577|FG000|Overall Study|Lost to Follow-up|0|||
163089189|NCT00730756|589037578|FG001|Overall Study|Lost to Follow-up|1|||
163089190|NCT00730756|589037577|FG000|Overall Study|Withdrew Consent|0|||
163089191|NCT00730756|589037578|FG001|Overall Study|Withdrew Consent|1|||
163089192|NCT04388826|589037579|FG000|Overall Study|Lost to Follow-up|3|||
163089193|NCT04388826|589037580|FG001|Overall Study|Lost to Follow-up|2|||
163089194|NCT04388826|589037579|FG000|Overall Study|Adverse Event|1|||
163089195|NCT04388826|589037580|FG001|Overall Study|Adverse Event|0|||
163089196|NCT01840943|589037581|FG000|Overall Study|Withdrawal by Subject|5|||
163089197|NCT01840943|589037582|FG001|Overall Study|Withdrawal by Subject|6|||
163089198|NCT01840943|589037581|FG000|Overall Study|Physician Decision|4|||
163089199|NCT01840943|589037582|FG001|Overall Study|Physician Decision|2|||
163089200|NCT01840943|589037581|FG000|Overall Study|Lost to Follow-up|4|||
163089201|NCT01840943|589037582|FG001|Overall Study|Lost to Follow-up|4|||
163089202|NCT02862574|589037583|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163089203|NCT02862574|589037584|FG001|Double-Blind Treatment Period|Adverse Event|1|||
163089204|NCT02862574|589037585|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163089205|NCT02862574|589037583|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
163089206|NCT02862574|589037584|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
163089207|NCT02862574|589037585|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
162649738|NCT04960228|587435349|FG000|Overall Study|Flagged for response quality by Dynata|3|||
162649739|NCT04960228|587435350|FG001|Overall Study|Flagged for response quality by Dynata|3|||
162649740|NCT02547129|587435351|FG000|Overall Study|Difficulty with ongoing infection|1|||
163037584|NCT00255840|588844223|FG000|Overall Study|Discontinued intervention|53|||
163037585|NCT00255840|588844224|FG001|Overall Study|Discontinued intervention|56|||
163037586|NCT01005901|588844227|FG000|Overall Study|Withdrawal by Subject|38|||
163037587|NCT01005901|588844228|FG001|Overall Study|Withdrawal by Subject|14|||
163037588|NCT01005901|588844227|FG000|Overall Study|Adverse Event|30|||
163037589|NCT01005901|588844228|FG001|Overall Study|Adverse Event|16|||
163037590|NCT01005901|588844227|FG000|Overall Study|Administrative problems|21|||
163037591|NCT01005901|588844228|FG001|Overall Study|Administrative problems|13|||
163037592|NCT01005901|588844227|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163037593|NCT01005901|588844228|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
163037594|NCT01005901|588844227|FG000|Overall Study|Protocol Violation|4|||
163037595|NCT01005901|588844228|FG001|Overall Study|Protocol Violation|3|||
163037596|NCT01005901|588844227|FG000|Overall Study|Death|2|||
163037597|NCT01005901|588844228|FG001|Overall Study|Death|3|||
163037598|NCT01005901|588844227|FG000|Overall Study|Lost to Follow-up|1|||
163037599|NCT01005901|588844228|FG001|Overall Study|Lost to Follow-up|2|||
163037600|NCT01005901|588844227|FG000|Overall Study|Patient's inability to use the device|1|||
163037601|NCT01005901|588844228|FG001|Overall Study|Patient's inability to use the device|1|||
163037602|NCT01005901|588844227|FG000|Overall Study|No longer requires study drug|0|||
163037603|NCT01005901|588844228|FG001|Overall Study|No longer requires study drug|1|||
163037604|NCT00715520|588844233|FG000|Overall Study|Screen failure|8|||
163037605|NCT00715520|588844234|FG001|Overall Study|Screen failure|1|||
163037606|NCT00715520|588844235|FG002|Overall Study|Screen failure|1|||
163037607|NCT00715520|588844233|FG000|Overall Study|Withdrawal by Subject|2|||
163037608|NCT00715520|588844234|FG001|Overall Study|Withdrawal by Subject|0|||
163037609|NCT00715520|588844235|FG002|Overall Study|Withdrawal by Subject|1|||
163037610|NCT01006590|588844236|FG000|Overall Study|Adverse Event|2|||
163089208|NCT02862574|589037583|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
163089209|NCT02862574|589037584|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
163089210|NCT02862574|589037585|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
163089211|NCT01446874|589037586|FG000|Overall Study|Not eligible|1|||
163089212|NCT01446874|589037587|FG001|Overall Study|Not eligible|0|||
163089213|NCT01446874|589037588|FG002|Overall Study|Not eligible|0|||
163089214|NCT01446874|589037586|FG000|Overall Study|No surgery/No qualifying surgery|1|||
163089215|NCT01446874|589037587|FG001|Overall Study|No surgery/No qualifying surgery|0|||
163089216|NCT01446874|589037588|FG002|Overall Study|No surgery/No qualifying surgery|12|||
163089217|NCT01446874|589037586|FG000|Overall Study|Non-compliance|0|||
163089218|NCT01446874|589037587|FG001|Overall Study|Non-compliance|4|||
163089219|NCT01446874|589037588|FG002|Overall Study|Non-compliance|0|||
163089220|NCT01446874|589037586|FG000|Overall Study|Antibiotics for pre-op infection|0|||
163089221|NCT01446874|589037587|FG001|Overall Study|Antibiotics for pre-op infection|0|||
163089222|NCT01446874|589037588|FG002|Overall Study|Antibiotics for pre-op infection|2|||
163089223|NCT01446874|589037586|FG000|Overall Study|Withdrawal by Subject|0|||
163089224|NCT01446874|589037587|FG001|Overall Study|Withdrawal by Subject|0|||
163089225|NCT01446874|589037588|FG002|Overall Study|Withdrawal by Subject|4|||
163089226|NCT03639610|589037592|FG000|Overall Study|Adverse Event|7|||
163037611|NCT01006590|588844237|FG001|Overall Study|Adverse Event|3|||
163037612|NCT01006590|588844236|FG000|Overall Study|Death|1|||
163037613|NCT01006590|588844237|FG001|Overall Study|Death|1|||
163037614|NCT01006590|588844236|FG000|Overall Study|Lost to Follow-up|1|||
163037615|NCT01006590|588844237|FG001|Overall Study|Lost to Follow-up|1|||
163037616|NCT01006590|588844236|FG000|Overall Study|Protocol Violation|1|||
163037617|NCT01006590|588844237|FG001|Overall Study|Protocol Violation|0|||
163037618|NCT01006590|588844236|FG000|Overall Study|Withdrawal by Subject|4|||
163037619|NCT01006590|588844237|FG001|Overall Study|Withdrawal by Subject|2|||
163037620|NCT01006590|588844236|FG000|Overall Study|Study specific discontinuation criteria|16|||
163037621|NCT01006590|588844237|FG001|Overall Study|Study specific discontinuation criteria|23|||
163037622|NCT01006590|588844236|FG000|Overall Study|Other|3|||
163037623|NCT01006590|588844237|FG001|Overall Study|Other|2|||
163037624|NCT03332095|588844238|FG000|Overall Study|Lost to Follow-up|1|||
163037625|NCT03332095|588844239|FG001|Overall Study|Lost to Follow-up|0|||
163037626|NCT03332095|588844238|FG000|Overall Study|Pregnancy|0|||
163037627|NCT03332095|588844239|FG001|Overall Study|Pregnancy|1|||
163037628|NCT04942210|588844243|FG000|Overall Study|Adverse Event|0|||
163037629|NCT04942210|588844244|FG001|Overall Study|Adverse Event|1|||
163037630|NCT04942210|588844243|FG000|Overall Study|Protocol Deviation|4|||
163037631|NCT04942210|588844244|FG001|Overall Study|Protocol Deviation|1|||
163037632|NCT04942210|588844243|FG000|Overall Study|Withdrawal by Subject|5|||
163037633|NCT04942210|588844244|FG001|Overall Study|Withdrawal by Subject|2|||
163037634|NCT04942210|588844243|FG000|Overall Study|Lost to Follow-up|16|||
163037635|NCT04942210|588844244|FG001|Overall Study|Lost to Follow-up|7|||
163037636|NCT04942210|588844243|FG000|Overall Study|Ongoing at the time of DBL date|60|||
163037637|NCT04942210|588844244|FG001|Overall Study|Ongoing at the time of DBL date|25|||
163037638|NCT04942210|588844243|FG000|Overall Study|Randomized but did not receive vaccination|3|||
163037639|NCT04942210|588844244|FG001|Overall Study|Randomized but did not receive vaccination|0|||
163037640|NCT02776670|588844245|FG000|Overall Study|Adverse Event|0|||
163037641|NCT02776670|588844246|FG001|Overall Study|Adverse Event|2|||
163037642|NCT02776670|588844245|FG000|Overall Study|Protocol Violation|0|||
163037643|NCT02776670|588844246|FG001|Overall Study|Protocol Violation|2|||
163037644|NCT02776670|588844245|FG000|Overall Study|Withdrawal by Subject|0|||
163037645|NCT02776670|588844246|FG001|Overall Study|Withdrawal by Subject|1|||
163037646|NCT02776670|588844245|FG000|Overall Study|Other - Reason not given|0|||
163037647|NCT02776670|588844246|FG001|Overall Study|Other - Reason not given|1|||
163037648|NCT00957424|588844251|FG000|Overall Study|Lost to Follow-up|19|||
163037649|NCT00957424|588844251|FG000|Overall Study|Protocol Violation|3|||
163037650|NCT00957424|588844251|FG000|Overall Study|Withdrawal by Subject|1|||
163037651|NCT03913104|588844260|FG000|Overall Study|Lost to Follow-up|20|||
163037652|NCT03913104|588844260|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
163037653|NCT03913104|588844260|FG000|Overall Study|Withdrawal by Subject|2|||
163037654|NCT01119846|588844261|FG000|Overall Study|Adverse Event|1|||
163037655|NCT01119846|588844262|FG001|Overall Study|Adverse Event|0|||
163037656|NCT01119846|588844263|FG002|Overall Study|Adverse Event|6|||
163037657|NCT01119846|588844261|FG000|Overall Study|Physician Decision|1|||
163037658|NCT01119846|588844262|FG001|Overall Study|Physician Decision|0|||
163037659|NCT01119846|588844263|FG002|Overall Study|Physician Decision|0|||
163037660|NCT01119846|588844261|FG000|Overall Study|Protocol Violation|0|||
163037661|NCT01119846|588844262|FG001|Overall Study|Protocol Violation|0|||
163037662|NCT01119846|588844263|FG002|Overall Study|Protocol Violation|1|||
163037663|NCT01119846|588844261|FG000|Overall Study|Withdrawal by Subject|0|||
163037664|NCT01119846|588844262|FG001|Overall Study|Withdrawal by Subject|0|||
163037665|NCT01119846|588844263|FG002|Overall Study|Withdrawal by Subject|4|||
163037666|NCT03420222|588844264|FG000|Overall Study|Withdrawal by Subject|5|||
163037667|NCT03420222|588844265|FG001|Overall Study|Withdrawal by Subject|0|||
163037668|NCT03420222|588844264|FG000|Overall Study|Physician Decision|0|||
163037669|NCT03420222|588844265|FG001|Overall Study|Physician Decision|1|||
163037670|NCT00187278|588844270|FG000|Overall Study|Protocol Violation|10|||
163037671|NCT00187278|588844271|FG001|Overall Study|Protocol Violation|13|||
163037672|NCT01380691|588844276|FG000|Washout (7 Days)|Protocol Violation|0|||
163037673|NCT01380691|588844277|FG001|Washout (7 Days)|Protocol Violation|0|||
163037674|NCT01380691|588844278|FG002|Washout (7 Days)|Protocol Violation|0|||
163089227|NCT03639610|589037593|FG001|Overall Study|Adverse Event|1|||
163089228|NCT03639610|589037594|FG002|Overall Study|Adverse Event|0|||
163089229|NCT03639610|589037592|FG000|Overall Study|Physician Decision|3|||
162649741|NCT02547129|587435352|FG001|Overall Study|Difficulty with ongoing infection|0|||
162649742|NCT00794196|587435353|FG000|Overall Study|Lost to Follow-up|5|||
162649743|NCT00794196|587435354|FG001|Overall Study|Lost to Follow-up|23|||
162649744|NCT01640366|587435355|FG000|Overall Study|Withdrawal by Subject|1|||
162649745|NCT01640366|587435355|FG000|Overall Study|Protocol Violation|16|||
162649746|NCT01640366|587435355|FG000|Overall Study|Lost to Follow-up|5|||
162649747|NCT01200797|587435358|FG000|Overall Study|symptomatic deterioration|2|||
162649748|NCT01200797|587435358|FG000|Overall Study|Adverse Event|4|||
162649749|NCT01200797|587435358|FG000|Overall Study|Disease Progression|13|||
162649750|NCT03745144|587435361|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
162649751|NCT03745144|587435362|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
162649752|NCT03745144|587435363|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
162649753|NCT03745144|587435361|FG000|Period 1|Other|0|||
162649754|NCT03745144|587435362|FG001|Period 1|Other|0|||
162649755|NCT03745144|587435363|FG002|Period 1|Other|1|||
162649756|NCT00642668|587435368|FG000|Overall Study|Lost to Follow-up|1|||
162649757|NCT00642668|587435368|FG000|Overall Study|Adverse Event|2|||
162649758|NCT00642668|587435368|FG000|Overall Study|Death|2|||
162649759|NCT00642668|587435368|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162649760|NCT00642668|587435368|FG000|Overall Study|Failure to Return|1|||
162649761|NCT00642668|587435368|FG000|Overall Study|Dialysis Initiation|5|||
162649762|NCT00642668|587435368|FG000|Overall Study|Blood Transfusion|2|||
162649763|NCT00896337|587435369|FG000|Overall Study|Death|7|||
162649764|NCT00896337|587435369|FG000|Overall Study|Withdrawal by Subject|7|||
162649765|NCT00896337|587435369|FG000|Overall Study|Lost to Follow-up|11|||
162649766|NCT01070316|587435371|FG000|Extension Phase|Lack of Efficacy|3|||
162649767|NCT01070316|587435371|FG000|Extension Phase|Withdrawal by Subject|1|||
162649768|NCT01113879|587435376|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
162649769|NCT01113879|587435377|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
162649770|NCT04151290|587435378|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
162649771|NCT00082433|587435382|FG000|Overall Study|Adverse Event|12|||
162649772|NCT00082433|587435383|FG001|Overall Study|Adverse Event|17|||
162649773|NCT00082433|587435382|FG000|Overall Study|Death|8|||
162649774|NCT00082433|587435383|FG001|Overall Study|Death|18|||
162649775|NCT00082433|587435382|FG000|Overall Study|Disease Progression/Relapse|270|||
162649776|NCT00082433|587435383|FG001|Overall Study|Disease Progression/Relapse|388|||
162649777|NCT00082433|587435382|FG000|Overall Study|Physician Decision|50|||
162649778|NCT00082433|587435383|FG001|Overall Study|Physician Decision|61|||
162649779|NCT00082433|587435382|FG000|Overall Study|Lost to Follow-up|1|||
162649780|NCT00082433|587435383|FG001|Overall Study|Lost to Follow-up|2|||
162649781|NCT00082433|587435382|FG000|Overall Study|Study Drug Toxicity|179|||
162649782|NCT00082433|587435383|FG001|Overall Study|Study Drug Toxicity|66|||
162649783|NCT00082433|587435382|FG000|Overall Study|Withdrawal by Subject|55|||
162649784|NCT00082433|587435383|FG001|Overall Study|Withdrawal by Subject|30|||
162649785|NCT00082433|587435382|FG000|Overall Study|Still On Treatment|2|||
162649786|NCT00082433|587435383|FG001|Overall Study|Still On Treatment|1|||
162649787|NCT00082433|587435382|FG000|Overall Study|Not Treated|12|||
162649788|NCT00082433|587435383|FG001|Overall Study|Not Treated|11|||
162649789|NCT00082433|587435382|FG000|Overall Study|Ineligible|2|||
162649790|NCT00082433|587435383|FG001|Overall Study|Ineligible|1|||
162649791|NCT00082433|587435382|FG000|Overall Study|Noncompliance|2|||
162649792|NCT00082433|587435383|FG001|Overall Study|Noncompliance|1|||
162649793|NCT00082433|587435382|FG000|Overall Study|New primary cancer|1|||
162649794|NCT00082433|587435383|FG001|Overall Study|New primary cancer|0|||
162649795|NCT00082433|587435382|FG000|Overall Study|Impending surgery|0|||
162649796|NCT00082433|587435383|FG001|Overall Study|Impending surgery|1|||
162649797|NCT01796197|587435386|FG000|Overall Study|Lost to Follow-up|1|||
162649798|NCT01796197|587435386|FG000|Overall Study|Lack of Efficacy|1|||
162649799|NCT04097821|587435387|FG000|Overall Study|Subject Decision|0|||
162649800|NCT04097821|587435388|FG001|Overall Study|Subject Decision|0|||
162649801|NCT04097821|587435389|FG002|Overall Study|Subject Decision|0|||
162649802|NCT04097821|587435390|FG003|Overall Study|Subject Decision|1|||
162649803|NCT04097821|587435391|FG004|Overall Study|Subject Decision|2|||
162649804|NCT04097821|587435392|FG005|Overall Study|Subject Decision|2|||
162649805|NCT04097821|587435393|FG006|Overall Study|Subject Decision|0|||
162649806|NCT04097821|587435394|FG007|Overall Study|Subject Decision|1|||
162649807|NCT04097821|587435387|FG000|Overall Study|Death|0|||
162649808|NCT04097821|587435388|FG001|Overall Study|Death|0|||
162649809|NCT04097821|587435389|FG002|Overall Study|Death|3|||
162649810|NCT04097821|587435390|FG003|Overall Study|Death|1|||
162649811|NCT04097821|587435391|FG004|Overall Study|Death|0|||
162718660|NCT00855465|587676660|FG000|Treatment Period|Protocol Violation|2|||
163037675|NCT01380691|588844279|FG003|Washout (7 Days)|Protocol Violation|1|||
162649812|NCT04097821|587435392|FG005|Overall Study|Death|0|||
162649813|NCT04097821|587435393|FG006|Overall Study|Death|0|||
162649814|NCT04097821|587435394|FG007|Overall Study|Death|0|||
162649815|NCT04097821|587435387|FG000|Overall Study|Physician Decision|1|||
162649816|NCT04097821|587435388|FG001|Overall Study|Physician Decision|2|||
162649817|NCT04097821|587435389|FG002|Overall Study|Physician Decision|0|||
162649818|NCT04097821|587435390|FG003|Overall Study|Physician Decision|0|||
162649819|NCT04097821|587435391|FG004|Overall Study|Physician Decision|0|||
163037676|NCT01380691|588844276|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
163037677|NCT01380691|588844277|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
163037678|NCT01380691|588844278|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
163037679|NCT01380691|588844279|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
163037680|NCT03084315|588844284|FG000|Overall Study|Lost to Follow-up|8|||
163037681|NCT03084315|588844285|FG001|Overall Study|Lost to Follow-up|7|||
163037682|NCT03084315|588844284|FG000|Overall Study|Withdrawal by Subject|2|||
163037683|NCT03084315|588844285|FG001|Overall Study|Withdrawal by Subject|2|||
163037684|NCT04424914|588844286|FG000|Overall Study|Other|0|||
163037685|NCT04424914|588844287|FG001|Overall Study|Other|0|||
163037686|NCT04424914|588844288|FG002|Overall Study|Other|28|||
163037687|NCT04424914|588844286|FG000|Overall Study|Withdrawal by Subject|3|||
163037688|NCT04424914|588844287|FG001|Overall Study|Withdrawal by Subject|0|||
163037689|NCT04424914|588844288|FG002|Overall Study|Withdrawal by Subject|0|||
163037690|NCT04424914|588844286|FG000|Overall Study|Study terminated by sponsor|23|||
163037691|NCT04424914|588844287|FG001|Overall Study|Study terminated by sponsor|7|||
163037692|NCT04424914|588844288|FG002|Overall Study|Study terminated by sponsor|0|||
163037693|NCT04424914|588844286|FG000|Overall Study|Lost to Follow-up|0|||
163037694|NCT04424914|588844287|FG001|Overall Study|Lost to Follow-up|0|||
163037695|NCT04424914|588844288|FG002|Overall Study|Lost to Follow-up|1|||
163037696|NCT04424914|588844286|FG000|Overall Study|Death|3|||
163037697|NCT04424914|588844287|FG001|Overall Study|Death|1|||
163037698|NCT04424914|588844288|FG002|Overall Study|Death|0|||
163037699|NCT00460746|588844291|FG000|Overall Study|Adverse Event|1|||
163037700|NCT00460746|588844291|FG000|Overall Study|Lost to Follow-up|1|||
163037701|NCT02195427|588844294|FG000|Overall Study|Did not consent to study extension|13|||
163037702|NCT02195427|588844295|FG001|Overall Study|Did not consent to study extension|9|||
163037703|NCT02195427|588844294|FG000|Overall Study|Withdrawal by Subject|4|||
163037704|NCT02195427|588844295|FG001|Overall Study|Withdrawal by Subject|2|||
163037705|NCT02195427|588844294|FG000|Overall Study|Lost to Follow-up|0|||
163037706|NCT02195427|588844295|FG001|Overall Study|Lost to Follow-up|1|||
163037707|NCT02195427|588844294|FG000|Overall Study|Protocol Violation|7|||
163037708|NCT02195427|588844295|FG001|Overall Study|Protocol Violation|14|||
163037709|NCT02195427|588844294|FG000|Overall Study|Conditional re-treatment at W52|2|||
163037710|NCT02195427|588844295|FG001|Overall Study|Conditional re-treatment at W52|1|||
163037711|NCT03782974|588844298|FG000|Overall Study|Withdrawal by Subject|7|||
163037712|NCT03782974|588844299|FG001|Overall Study|Withdrawal by Subject|7|||
163037713|NCT03782974|588844298|FG000|Overall Study|Pregnancy|1|||
163089230|NCT03639610|589037593|FG001|Overall Study|Physician Decision|1|||
163089231|NCT03639610|589037594|FG002|Overall Study|Physician Decision|0|||
162649820|NCT04097821|587435392|FG005|Overall Study|Physician Decision|0|||
162649821|NCT04097821|587435393|FG006|Overall Study|Physician Decision|0|||
162649822|NCT04097821|587435394|FG007|Overall Study|Physician Decision|0|||
162649823|NCT04097821|587435387|FG000|Overall Study|Adverse Event|0|||
162649824|NCT04097821|587435388|FG001|Overall Study|Adverse Event|0|||
162649825|NCT04097821|587435389|FG002|Overall Study|Adverse Event|1|||
162649826|NCT04097821|587435390|FG003|Overall Study|Adverse Event|1|||
162649827|NCT04097821|587435391|FG004|Overall Study|Adverse Event|0|||
162649828|NCT04097821|587435392|FG005|Overall Study|Adverse Event|0|||
162649829|NCT04097821|587435393|FG006|Overall Study|Adverse Event|0|||
162649830|NCT04097821|587435394|FG007|Overall Study|Adverse Event|0|||
162649831|NCT04097821|587435387|FG000|Overall Study|New Therapy For Study Indication|0|||
162649832|NCT04097821|587435388|FG001|Overall Study|New Therapy For Study Indication|0|||
162649833|NCT04097821|587435389|FG002|Overall Study|New Therapy For Study Indication|0|||
162649834|NCT04097821|587435390|FG003|Overall Study|New Therapy For Study Indication|0|||
162649835|NCT04097821|587435391|FG004|Overall Study|New Therapy For Study Indication|0|||
162649836|NCT04097821|587435392|FG005|Overall Study|New Therapy For Study Indication|0|||
162649837|NCT04097821|587435393|FG006|Overall Study|New Therapy For Study Indication|1|||
162649838|NCT04097821|587435394|FG007|Overall Study|New Therapy For Study Indication|0|||
162649839|NCT00244712|587435398|FG000|Overall Study|Adverse Event|20|||
162649840|NCT00244712|587435399|FG001|Overall Study|Adverse Event|21|||
162649841|NCT00244712|587435398|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
162649842|NCT00244712|587435399|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
162649843|NCT00244712|587435398|FG000|Overall Study|Lack of Compliance|10|||
162649844|NCT00244712|587435399|FG001|Overall Study|Lack of Compliance|11|||
162649845|NCT00244712|587435398|FG000|Overall Study|Lost to Follow-up|45|||
162649846|NCT00244712|587435399|FG001|Overall Study|Lost to Follow-up|52|||
162649847|NCT00244712|587435398|FG000|Overall Study|Withdrawal by Subject|13|||
162649848|NCT00244712|587435399|FG001|Overall Study|Withdrawal by Subject|23|||
162649849|NCT00244712|587435398|FG000|Overall Study|Protocol Violation, disease progression|13|||
162649850|NCT00244712|587435399|FG001|Overall Study|Protocol Violation, disease progression|11|||
162649851|NCT01077804|587435402|FG000|Overall Study|Unreachable|102|||
162649852|NCT01077804|587435402|FG000|Overall Study|Refused to continue|79|||
162649853|NCT01077804|587435402|FG000|Overall Study|Other|18|||
162649854|NCT02776917|587435403|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
162649855|NCT00560950|587435406|FG000|Overall Study|Lost to Follow-up|1|||
163089232|NCT03639610|589037592|FG000|Overall Study|Disease progression|8|||
163089233|NCT03639610|589037593|FG001|Overall Study|Disease progression|5|||
163089234|NCT03639610|589037594|FG002|Overall Study|Disease progression|3|||
163089235|NCT03639610|589037592|FG000|Overall Study|Study terminated by sponsor|2|||
163089236|NCT03639610|589037593|FG001|Overall Study|Study terminated by sponsor|1|||
163089237|NCT03639610|589037594|FG002|Overall Study|Study terminated by sponsor|1|||
162649856|NCT00560950|587435407|FG001|Overall Study|Lost to Follow-up|0|||
162649857|NCT02970968|587436962|FG000|Overall Study|Withdrawal by Subject|3|||
162649858|NCT02970968|587436963|FG001|Overall Study|Withdrawal by Subject|3|||
162649859|NCT02970968|587436962|FG000|Overall Study|Adverse Event|1|||
162649860|NCT02970968|587436963|FG001|Overall Study|Adverse Event|2|||
162649861|NCT02970968|587436962|FG000|Overall Study|Lost to Follow-up|1|||
162649862|NCT02970968|587436963|FG001|Overall Study|Lost to Follow-up|1|||
162649863|NCT02970968|587436962|FG000|Overall Study|Non-Compliance|0|||
162649864|NCT02970968|587436963|FG001|Overall Study|Non-Compliance|1|||
162649865|NCT03003520|587436964|FG000|Overall Study|Adverse Event|9|||
162649866|NCT03003520|587436965|FG001|Overall Study|Adverse Event|0|||
162649867|NCT03003520|587436964|FG000|Overall Study|Death|1|||
162649868|NCT03003520|587436965|FG001|Overall Study|Death|0|||
162649869|NCT03003520|587436964|FG000|Overall Study|Other reasons|4|||
162649870|NCT03003520|587436965|FG001|Overall Study|Other reasons|0|||
162649871|NCT03003520|587436964|FG000|Overall Study|Withdrawal by Subject|6|||
162649872|NCT03003520|587436965|FG001|Overall Study|Withdrawal by Subject|0|||
162649873|NCT03003520|587436964|FG000|Overall Study|Progressive disease|9|||
162649874|NCT03003520|587436965|FG001|Overall Study|Progressive disease|1|||
162649875|NCT01332149|587436966|FG000|Overall Study|Adverse Event|11|||
162649876|NCT01332149|587436967|FG001|Overall Study|Adverse Event|9|||
162649877|NCT01332149|587436966|FG000|Overall Study|Other unspecified|5|||
162649878|NCT01332149|587436967|FG001|Overall Study|Other unspecified|7|||
162649879|NCT01332149|587436966|FG000|Overall Study|Protocol Violation|1|||
162649880|NCT01332149|587436967|FG001|Overall Study|Protocol Violation|3|||
162649881|NCT01332149|587436966|FG000|Overall Study|Withdrawal by Subject|4|||
162649882|NCT01332149|587436967|FG001|Overall Study|Withdrawal by Subject|5|||
162649883|NCT01332149|587436966|FG000|Overall Study|Lost to Follow-up|1|||
162649884|NCT01332149|587436967|FG001|Overall Study|Lost to Follow-up|1|||
162649885|NCT01332149|587436966|FG000|Overall Study|Insufficient clinical response|4|||
162649886|NCT01332149|587436967|FG001|Overall Study|Insufficient clinical response|7|||
162649887|NCT01332149|587436966|FG000|Overall Study|Did not meet entrance criteria|3|||
162649888|NCT01332149|587436967|FG001|Overall Study|Did not meet entrance criteria|4|||
162649889|NCT01332149|587436966|FG000|Overall Study|Randomized but not treated|1|||
162649890|NCT01332149|587436967|FG001|Overall Study|Randomized but not treated|2|||
162649891|NCT04982029|587436968|FG000|Overall Study|Lost to Follow-up|2|||
162649892|NCT04982029|587436969|FG001|Overall Study|Lost to Follow-up|3|||
162649893|NCT03264404|587436970|FG000|Overall Study|Death|2|||
162649894|NCT03264404|587436970|FG000|Overall Study|Physician Decision|1|||
162649895|NCT03264404|587436970|FG000|Overall Study|Disease Progression|28|||
162649896|NCT03264404|587436970|FG000|Overall Study|Adverse Event|1|||
162649897|NCT03264404|587436970|FG000|Overall Study|Off study prior to treatment|2|||
162649898|NCT02565381|587436971|FG000|Overall Study|Lost to Follow-up|1|||
162649899|NCT02565381|587436972|FG001|Overall Study|Lost to Follow-up|0|||
162649900|NCT02565381|587436973|FG002|Overall Study|Lost to Follow-up|1|||
162649901|NCT04615949|587436976|FG000|Overall Study|Withdrawal by Subject|2|||
162649902|NCT04615949|587436977|FG001|Overall Study|Withdrawal by Subject|4|||
162649903|NCT04615949|587436976|FG000|Overall Study|Lost to Follow-up|2|||
162649904|NCT04615949|587436977|FG001|Overall Study|Lost to Follow-up|2|||
162649905|NCT04615949|587436976|FG000|Overall Study|Death|0|||
162649906|NCT04615949|587436977|FG001|Overall Study|Death|2|||
162649907|NCT03036566|587436978|FG000|Overall Study|Lost to Follow-up|3|||
162649908|NCT05458856|587436979|FG000|Overall Study|Withdrawal by Subject|5|||
162649909|NCT05458856|587436979|FG000|Overall Study|Death|4|||
162649910|NCT05458856|587436979|FG000|Overall Study|Protocol Deviation|3|||
162649911|NCT05458856|587436979|FG000|Overall Study|Physician Decision|1|||
162649912|NCT03299842|587436983|FG000|Overall Study|Caregiver withdrew consent|2|||
162649913|NCT03299842|587436983|FG000|Overall Study|Child would not keep the watch on|3|||
162649914|NCT00071812|587436984|FG000|24-Week Double-Blind Period|Adverse Event|2|||
162649915|NCT00071812|587436985|FG001|24-Week Double-Blind Period|Adverse Event|3|||
162649916|NCT00071812|587436986|FG002|24-Week Double-Blind Period|Adverse Event|4|||
162649917|NCT00071812|587436987|FG003|24-Week Double-Blind Period|Adverse Event|4|||
162649918|NCT00071812|587436984|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
162649919|NCT00071812|587436985|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
162649920|NCT00071812|587436986|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
162649921|NCT00071812|587436987|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
162649922|NCT00071812|587436984|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
162649923|NCT00071812|587436985|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
162649924|NCT00071812|587436986|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
162649925|NCT00071812|587436987|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163089238|NCT03639610|589037592|FG000|Overall Study|Patient request to stop treatment|1|||
163089239|NCT03639610|589037593|FG001|Overall Study|Patient request to stop treatment|2|||
163089240|NCT03639610|589037594|FG002|Overall Study|Patient request to stop treatment|0|||
163089241|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
163089242|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
163089243|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
162649926|NCT00071812|587436984|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
162649927|NCT00071812|587436985|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
162649928|NCT00071812|587436986|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
162649929|NCT00071812|587436987|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
162649930|NCT00071812|587436984|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
162649931|NCT00071812|587436985|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
162649932|NCT00071812|587436986|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
162649933|NCT00071812|587436987|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
162649934|NCT00071812|587436984|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
162649935|NCT00071812|587436985|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
162649936|NCT00071812|587436986|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
162649937|NCT00071812|587436987|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
162649938|NCT00071812|587436984|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162649939|NCT00071812|587436985|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162649940|NCT00071812|587436986|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162649941|NCT00071812|587436987|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
162649942|NCT00071812|587436984|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162649943|NCT00071812|587436985|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162649944|NCT00071812|587436986|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162649945|NCT00071812|587436987|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
162649946|NCT00071812|587436984|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162649947|NCT00071812|587436985|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162649948|NCT00071812|587436986|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162649949|NCT00071812|587436987|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
162649950|NCT00071812|587436984|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162649951|NCT00071812|587436985|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162649952|NCT00071812|587436986|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
162649953|NCT00071812|587436987|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
162649954|NCT01940120|587436990|FG000|Overall Study|Death|40|||
162649955|NCT01940120|587436990|FG000|Overall Study|Withdrawal by Subject|8|||
162649956|NCT03711162|587436992|FG000|Overall Study|Adverse Event|5|||
162649957|NCT03711162|587436993|FG001|Overall Study|Adverse Event|2|||
162649958|NCT03711162|587436994|FG002|Overall Study|Adverse Event|4|||
162649959|NCT03711162|587436992|FG000|Overall Study|Death|11|||
162649960|NCT03711162|587436993|FG001|Overall Study|Death|7|||
162649961|NCT03711162|587436994|FG002|Overall Study|Death|8|||
162649962|NCT03711162|587436992|FG000|Overall Study|Lost to Follow-up|1|||
162649963|NCT03711162|587436993|FG001|Overall Study|Lost to Follow-up|0|||
162649964|NCT03711162|587436994|FG002|Overall Study|Lost to Follow-up|1|||
162649965|NCT03711162|587436992|FG000|Overall Study|Study Terminated by Sponsor|139|||
162649966|NCT03711162|587436993|FG001|Overall Study|Study Terminated by Sponsor|152|||
162649967|NCT03711162|587436994|FG002|Overall Study|Study Terminated by Sponsor|146|||
162649968|NCT03711162|587436992|FG000|Overall Study|Withdrawal by Subject|17|||
162649969|NCT03711162|587436993|FG001|Overall Study|Withdrawal by Subject|10|||
162649970|NCT03711162|587436994|FG002|Overall Study|Withdrawal by Subject|10|||
162649971|NCT03711162|587436992|FG000|Overall Study|Miscellaneous|1|||
162649972|NCT03711162|587436993|FG001|Overall Study|Miscellaneous|2|||
162649973|NCT03711162|587436994|FG002|Overall Study|Miscellaneous|2|||
162649974|NCT03711162|587436992|FG000|Overall Study|Not Treated|1|||
162649975|NCT03711162|587436993|FG001|Overall Study|Not Treated|0|||
162649976|NCT03711162|587436994|FG002|Overall Study|Not Treated|1|||
162649977|NCT03711162|587436992|FG000|Overall Study|Physician Decision|0|||
162649978|NCT03711162|587436993|FG001|Overall Study|Physician Decision|2|||
163089244|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
163089245|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
163089246|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
162649979|NCT03711162|587436994|FG002|Overall Study|Physician Decision|0|||
162649980|NCT03711162|587436992|FG000|Overall Study|Lack of Efficacy|0|||
162649981|NCT03711162|587436993|FG001|Overall Study|Lack of Efficacy|0|||
162649982|NCT03711162|587436994|FG002|Overall Study|Lack of Efficacy|2|||
162649983|NCT03711162|587436992|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
162649984|NCT03711162|587436993|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
162649985|NCT03711162|587436994|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162649986|NCT01275066|587436997|FG000|Overall Study|Withdrawal by Subject|0|||
162649987|NCT01275066|587436998|FG001|Overall Study|Withdrawal by Subject|0|||
162649988|NCT01275066|587436999|FG002|Overall Study|Withdrawal by Subject|1|||
162649989|NCT01275066|587436997|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
162649990|NCT01275066|587436998|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
163089247|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
163089248|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
163089249|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
163089250|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
163089251|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
163089252|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
163089253|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
163089254|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089255|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089256|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
163089257|NCT05067335|589037598|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089258|NCT05067335|589037599|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
163089259|NCT05067335|589037600|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089260|NCT05067335|589037601|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
163089261|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
163089262|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
163089263|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
163089264|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
163089265|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089266|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089267|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
163089268|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
163089269|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089270|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089271|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
163089272|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
163089273|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089274|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089275|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
163089276|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
163089277|NCT05067335|589037598|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089278|NCT05067335|589037599|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089279|NCT05067335|589037600|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
163089280|NCT05067335|589037601|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
163089281|NCT03610048|589037602|FG000|Overall Study|Study terminated by sponsor|84|||
163089282|NCT03610048|589037602|FG000|Overall Study|Adverse Event|32|||
163089283|NCT03610048|589037602|FG000|Overall Study|Withdrawal by Subject|31|||
163089284|NCT03610048|589037602|FG000|Overall Study|Lost to Follow-up|8|||
163089285|NCT03610048|589037602|FG000|Overall Study|Other|4|||
163089286|NCT03610048|589037602|FG000|Overall Study|Physician Decision|1|||
163089287|NCT03610048|589037602|FG000|Overall Study|Pregnancy|1|||
163089288|NCT02136914|589037603|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
163089289|NCT02136914|589037604|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
163089290|NCT02136914|589037603|FG000|Overall Study|Withdrawal by Subject|3|||
163089291|NCT02136914|589037604|FG001|Overall Study|Withdrawal by Subject|10|||
163089292|NCT02136914|589037603|FG000|Overall Study|Subject Unwilling to Proceed|7|||
163089293|NCT02136914|589037604|FG001|Overall Study|Subject Unwilling to Proceed|2|||
163089294|NCT02136914|589037603|FG000|Overall Study|Lost to Follow-up|1|||
163089295|NCT02136914|589037604|FG001|Overall Study|Lost to Follow-up|1|||
163089296|NCT02136914|589037603|FG000|Overall Study|Did Not Receive Study Drug|2|||
163089297|NCT02136914|589037604|FG001|Overall Study|Did Not Receive Study Drug|0|||
163089298|NCT02136914|589037603|FG000|Overall Study|Lack of Efficacy|1|||
163037714|NCT03782974|588844299|FG001|Overall Study|Pregnancy|0|||
163037715|NCT04985942|588845586|FG000|Overall Study|Adverse Event|14|||
163037716|NCT04985942|588845587|FG001|Overall Study|Adverse Event|2|||
163037717|NCT04985942|588845586|FG000|Overall Study|Lack of Efficacy|0|||
163037718|NCT04985942|588845587|FG001|Overall Study|Lack of Efficacy|3|||
163037719|NCT04985942|588845586|FG000|Overall Study|Lost to Follow-up|1|||
163037720|NCT04985942|588845587|FG001|Overall Study|Lost to Follow-up|1|||
163037721|NCT04985942|588845586|FG000|Overall Study|Protocol Violation|1|||
163037722|NCT04985942|588845587|FG001|Overall Study|Protocol Violation|1|||
163037723|NCT04985942|588845586|FG000|Overall Study|Withdrawal by Subject|5|||
163037724|NCT04985942|588845587|FG001|Overall Study|Withdrawal by Subject|4|||
163037725|NCT00171158|588845588|FG000|Core Study|Death|27|||
163037726|NCT00171158|588845588|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
163037727|NCT00171158|588845588|FG000|Core Study|Protocol Violation|4|||
162649991|NCT01275066|587436999|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
162649992|NCT03240133|587437000|FG000|Overall Study|Withdrawal by Subject|0|||
162649993|NCT03240133|587437001|FG001|Overall Study|Withdrawal by Subject|1|||
162649994|NCT03240133|587437002|FG002|Overall Study|Withdrawal by Subject|0|||
162649995|NCT03240133|587437000|FG000|Overall Study|Adverse Event|1|||
162649996|NCT03240133|587437001|FG001|Overall Study|Adverse Event|1|||
162649997|NCT03240133|587437002|FG002|Overall Study|Adverse Event|0|||
162649998|NCT03240133|587437000|FG000|Overall Study|Rash|1|||
162649999|NCT03240133|587437001|FG001|Overall Study|Rash|0|||
162650000|NCT03240133|587437002|FG002|Overall Study|Rash|0|||
162650001|NCT03240133|587437000|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
162650002|NCT03240133|587437001|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
162650003|NCT03240133|587437002|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
162650004|NCT03240133|587437000|FG000|Overall Study|Intercurrent illness.|0|||
162650005|NCT03240133|587437001|FG001|Overall Study|Intercurrent illness.|1|||
162650006|NCT03240133|587437002|FG002|Overall Study|Intercurrent illness.|0|||
162650007|NCT03240133|587437000|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
162650008|NCT03240133|587437001|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
162650009|NCT03240133|587437002|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
162650010|NCT00749463|587437003|FG000|Overall Study|Adverse Event|0|||
162650011|NCT00749463|587437004|FG001|Overall Study|Adverse Event|4|||
162650012|NCT00749463|587437005|FG002|Overall Study|Adverse Event|1|||
163037728|NCT00171158|588845588|FG000|Core Study|Administrative problems|1|||
163037729|NCT00171158|588845588|FG000|Core Study|Adverse event, non-fatal|21|||
163037730|NCT00171158|588845588|FG000|Core Study|Consent withdrawn by subject|6|||
163037731|NCT00171158|588845588|FG000|Core Study|No longer required drug (BMT)|14|||
163037732|NCT00171158|588845588|FG000|Core Study|Abnormal Laboratory Values|2|||
163037733|NCT00171158|588845588|FG000|Core Study|Lost to Follow-up|1|||
163037734|NCT00171158|588845588|FG000|E2 Extension|Other|7|||
163037735|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
163037736|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037737|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
163037738|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037739|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037740|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037741|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037742|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037743|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037744|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
163037745|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037746|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037747|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
163037748|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037749|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037750|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037751|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037752|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037753|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037754|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
163037755|NCT02757352|588845589|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
163037756|NCT02757352|588845590|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
163037757|NCT02757352|588845591|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
163037758|NCT02757352|588845592|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037759|NCT02757352|588845593|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037760|NCT02757352|588845594|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037761|NCT02757352|588845595|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037762|NCT02757352|588845596|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037763|NCT02757352|588845597|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037764|NCT02757352|588845598|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
163037765|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037766|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
163037767|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037768|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037769|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037770|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037771|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037772|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037773|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163089299|NCT02136914|589037604|FG001|Overall Study|Lack of Efficacy|0|||
163089300|NCT02136914|589037603|FG000|Overall Study|Death|0|||
163089301|NCT02136914|589037604|FG001|Overall Study|Death|1|||
163089302|NCT05878067|589037605|FG000|Overall Study|Lost to Follow-up|2|||
163089303|NCT00329030|589037610|FG000|Overall Study|Withdrawal by Subject|1|||
163089304|NCT00329030|589037611|FG001|Overall Study|Withdrawal by Subject|3|||
163089305|NCT00329030|589037610|FG000|Overall Study|Progressive Disease|6|||
163089306|NCT00329030|589037611|FG001|Overall Study|Progressive Disease|2|||
163089307|NCT00329030|589037610|FG000|Overall Study|Ineligible Pathology|1|||
163089308|NCT00329030|589037611|FG001|Overall Study|Ineligible Pathology|1|||
162650013|NCT00749463|587437003|FG000|Overall Study|Withdrawal by Subject|1|||
162650014|NCT00749463|587437004|FG001|Overall Study|Withdrawal by Subject|0|||
162650015|NCT00749463|587437005|FG002|Overall Study|Withdrawal by Subject|0|||
162650016|NCT00116831|587437006|FG000|Overall Study|Adverse Event|14|||
163089309|NCT00560417|589037612|FG000|Overall Study|Adverse Event|3|||
163089310|NCT00560417|589037613|FG001|Overall Study|Adverse Event|2|||
163089311|NCT00560417|589037612|FG000|Overall Study|Entry Criteria Not Met|1|||
163089312|NCT00560417|589037613|FG001|Overall Study|Entry Criteria Not Met|0|||
163089313|NCT00560417|589037612|FG000|Overall Study|Lost to Follow-up|0|||
163089314|NCT00560417|589037613|FG001|Overall Study|Lost to Follow-up|1|||
163089315|NCT00560417|589037612|FG000|Overall Study|Physician Decision|2|||
163089316|NCT00560417|589037613|FG001|Overall Study|Physician Decision|6|||
163089317|NCT00560417|589037612|FG000|Overall Study|Protocol Violation|6|||
163089318|NCT00560417|589037613|FG001|Overall Study|Protocol Violation|5|||
163089319|NCT00560417|589037612|FG000|Overall Study|Sponsor Decision|2|||
163089320|NCT00560417|589037613|FG001|Overall Study|Sponsor Decision|0|||
163089321|NCT00560417|589037612|FG000|Overall Study|Withdrawal by Subject|3|||
163089322|NCT00560417|589037613|FG001|Overall Study|Withdrawal by Subject|3|||
163089323|NCT00419744|589037614|FG000|Overall Study|Adverse Event|39|||
163089324|NCT00419744|589037615|FG001|Overall Study|Adverse Event|40|||
163089325|NCT00419744|589037616|FG002|Overall Study|Adverse Event|50|||
163089326|NCT00419744|589037614|FG000|Overall Study|Withdrawal by Subject|45|||
163089327|NCT00419744|589037615|FG001|Overall Study|Withdrawal by Subject|49|||
163089328|NCT00419744|589037616|FG002|Overall Study|Withdrawal by Subject|52|||
163089329|NCT00419744|589037614|FG000|Overall Study|Lost to Follow-up|8|||
163089330|NCT00419744|589037615|FG001|Overall Study|Lost to Follow-up|10|||
163089331|NCT00419744|589037616|FG002|Overall Study|Lost to Follow-up|6|||
163089332|NCT00419744|589037614|FG000|Overall Study|Protocol Violation|4|||
163089333|NCT00419744|589037615|FG001|Overall Study|Protocol Violation|7|||
163089334|NCT00419744|589037616|FG002|Overall Study|Protocol Violation|8|||
163089335|NCT00419744|589037614|FG000|Overall Study|Randomized in error|9|||
163089336|NCT00419744|589037615|FG001|Overall Study|Randomized in error|6|||
163089337|NCT00419744|589037616|FG002|Overall Study|Randomized in error|7|||
163089338|NCT00419744|589037614|FG000|Overall Study|Moving out of state|2|||
163089339|NCT00419744|589037615|FG001|Overall Study|Moving out of state|0|||
163089340|NCT00419744|589037616|FG002|Overall Study|Moving out of state|1|||
163089341|NCT00419744|589037614|FG000|Overall Study|Physician Decision|10|||
163089342|NCT00419744|589037615|FG001|Overall Study|Physician Decision|5|||
163089343|NCT00419744|589037616|FG002|Overall Study|Physician Decision|6|||
162650017|NCT00116831|587437007|FG001|Overall Study|Adverse Event|16|||
162650018|NCT00116831|587437006|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
162650019|NCT00116831|587437007|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
162650020|NCT00116831|587437006|FG000|Overall Study|Lost to Follow-up|8|||
162650021|NCT00116831|587437007|FG001|Overall Study|Lost to Follow-up|6|||
162650022|NCT00116831|587437006|FG000|Overall Study|Protocol Violation|3|||
162650023|NCT00116831|587437007|FG001|Overall Study|Protocol Violation|6|||
162650024|NCT00116831|587437006|FG000|Overall Study|Hypoglycaemic events|1|||
162650025|NCT00116831|587437007|FG001|Overall Study|Hypoglycaemic events|0|||
162650026|NCT00116831|587437006|FG000|Overall Study|Low haemoglobin on screening|1|||
162650027|NCT00116831|587437007|FG001|Overall Study|Low haemoglobin on screening|0|||
163089344|NCT00419744|589037614|FG000|Overall Study|Spirometry mouthpiece issues|0|||
163089345|NCT00419744|589037615|FG001|Overall Study|Spirometry mouthpiece issues|1|||
163089346|NCT00419744|589037616|FG002|Overall Study|Spirometry mouthpiece issues|2|||
163089347|NCT00419744|589037614|FG000|Overall Study|Incorrect medication kit dispensed|0|||
163089348|NCT00419744|589037615|FG001|Overall Study|Incorrect medication kit dispensed|0|||
163089349|NCT00419744|589037616|FG002|Overall Study|Incorrect medication kit dispensed|1|||
163089350|NCT00583219|589037619|FG000|Phase 2|Withdrawal by Subject|1|||
163089351|NCT02037529|589037620|FG000|Overall Study|Withdrawal by Subject|1|||
163089352|NCT02037529|589037621|FG001|Overall Study|Withdrawal by Subject|3|||
163089353|NCT02037529|589037620|FG000|Overall Study|Adverse Event|0|||
163089354|NCT02037529|589037621|FG001|Overall Study|Adverse Event|1|||
162650028|NCT00116831|587437006|FG000|Overall Study|Withdrawn investigational product|1|||
163089355|NCT00718315|589037623|FG000|Overall Study|Adverse Event|1|||
163089356|NCT00718315|589037624|FG001|Overall Study|Adverse Event|2|||
162650029|NCT00116831|587437007|FG001|Overall Study|Withdrawn investigational product|0|||
162650030|NCT00116831|587437006|FG000|Overall Study|Withdrawal by Subject|32|||
163089357|NCT00718315|589037625|FG002|Overall Study|Adverse Event|3|||
163089358|NCT00718315|589037623|FG000|Overall Study|Death|6|||
163089359|NCT00718315|589037624|FG001|Overall Study|Death|6|||
163089360|NCT00718315|589037625|FG002|Overall Study|Death|5|||
163089361|NCT00718315|589037623|FG000|Overall Study|Lost to Follow-up|2|||
163089362|NCT00718315|589037624|FG001|Overall Study|Lost to Follow-up|3|||
162650031|NCT00116831|587437007|FG001|Overall Study|Withdrawal by Subject|32|||
162650032|NCT00116831|587437006|FG000|Overall Study|Insufficient therapeutic effect|0|||
162650033|NCT00116831|587437007|FG001|Overall Study|Insufficient therapeutic effect|1|||
162650034|NCT00116831|587437006|FG000|Overall Study|Missing data for participant|1|||
162650035|NCT00116831|587437007|FG001|Overall Study|Missing data for participant|0|||
162650036|NCT04904185|587437008|FG000|Overall Study|Expansion failure|1|||
162650037|NCT04904185|587437009|FG001|Overall Study|Expansion failure|0|||
162650038|NCT04904185|587437008|FG000|Overall Study|Late response on prior treatment|1|||
162650039|NCT04904185|587437009|FG001|Overall Study|Late response on prior treatment|0|||
162650040|NCT01344369|587437012|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
162650041|NCT01344369|587437013|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
162650042|NCT01344369|587437012|FG000|Washout of 28 Days|Physician Decision|0|||
162650043|NCT01344369|587437013|FG001|Washout of 28 Days|Physician Decision|1|||
162650044|NCT01344369|587437012|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
162650045|NCT01344369|587437013|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
162650046|NCT00735371|587437025|FG000|Overall Study|Adverse Event|3|||
162650047|NCT00735371|587437026|FG001|Overall Study|Adverse Event|3|||
162650048|NCT00735371|587437027|FG002|Overall Study|Adverse Event|4|||
162650049|NCT00735371|587437028|FG003|Overall Study|Adverse Event|1|||
162650050|NCT00735371|587437025|FG000|Overall Study|Protocol Violation|2|||
162650051|NCT00735371|587437026|FG001|Overall Study|Protocol Violation|2|||
162650052|NCT00735371|587437027|FG002|Overall Study|Protocol Violation|0|||
162650053|NCT00735371|587437028|FG003|Overall Study|Protocol Violation|3|||
162650054|NCT00735371|587437025|FG000|Overall Study|Withdrawal by Subject|0|||
162650055|NCT00735371|587437026|FG001|Overall Study|Withdrawal by Subject|2|||
162650056|NCT00735371|587437027|FG002|Overall Study|Withdrawal by Subject|2|||
162650057|NCT00735371|587437028|FG003|Overall Study|Withdrawal by Subject|0|||
162650058|NCT00735371|587437025|FG000|Overall Study|Lost to Follow-up|1|||
162650059|NCT00735371|587437026|FG001|Overall Study|Lost to Follow-up|1|||
162650060|NCT00735371|587437027|FG002|Overall Study|Lost to Follow-up|3|||
162650061|NCT00735371|587437028|FG003|Overall Study|Lost to Follow-up|1|||
162650062|NCT00735371|587437025|FG000|Overall Study|Lack of Efficacy|4|||
162650063|NCT00735371|587437026|FG001|Overall Study|Lack of Efficacy|2|||
162650064|NCT00735371|587437027|FG002|Overall Study|Lack of Efficacy|0|||
162650065|NCT00735371|587437028|FG003|Overall Study|Lack of Efficacy|4|||
162650066|NCT00735371|587437025|FG000|Overall Study|Sponsor Decision|3|||
162650067|NCT00735371|587437026|FG001|Overall Study|Sponsor Decision|1|||
162650068|NCT00735371|587437027|FG002|Overall Study|Sponsor Decision|0|||
162650069|NCT00735371|587437028|FG003|Overall Study|Sponsor Decision|1|||
162650070|NCT00735371|587437025|FG000|Overall Study|Protocol Violation|0|||
162650071|NCT00735371|587437026|FG001|Overall Study|Protocol Violation|1|||
162650072|NCT00735371|587437027|FG002|Overall Study|Protocol Violation|2|||
162650073|NCT00735371|587437028|FG003|Overall Study|Protocol Violation|0|||
162650074|NCT00735371|587437025|FG000|Overall Study|Prior Vyvanse Exposure|1|||
162650075|NCT00735371|587437026|FG001|Overall Study|Prior Vyvanse Exposure|1|||
162650076|NCT00735371|587437027|FG002|Overall Study|Prior Vyvanse Exposure|0|||
162650077|NCT00735371|587437028|FG003|Overall Study|Prior Vyvanse Exposure|0|||
162650078|NCT00735371|587437025|FG000|Overall Study|Exclusion criteria|1|||
162650079|NCT00735371|587437026|FG001|Overall Study|Exclusion criteria|0|||
162650080|NCT00735371|587437027|FG002|Overall Study|Exclusion criteria|0|||
162650081|NCT00735371|587437028|FG003|Overall Study|Exclusion criteria|0|||
163089363|NCT00718315|589037625|FG002|Overall Study|Lost to Follow-up|4|||
163089364|NCT00718315|589037623|FG000|Overall Study|Protocol Violation|5|||
163089365|NCT00718315|589037624|FG001|Overall Study|Protocol Violation|5|||
162650082|NCT01533246|587437029|FG000|Overall Study|Adverse Event|1|||
162650083|NCT01533246|587437029|FG000|Overall Study|Withdrawal by Subject|1|||
162650084|NCT01987427|587437035|FG000|Overall Study|Adverse Event|4|||
162650085|NCT01987427|587437036|FG001|Overall Study|Adverse Event|2|||
162650086|NCT01987427|587437037|FG002|Overall Study|Adverse Event|8|||
163089366|NCT00718315|589037625|FG002|Overall Study|Protocol Violation|3|||
163089367|NCT00718315|589037623|FG000|Overall Study|Erlotinib dose decreased|4|||
162650087|NCT01987427|587437035|FG000|Overall Study|Lost to Follow-up|6|||
162650088|NCT01987427|587437036|FG001|Overall Study|Lost to Follow-up|6|||
162650089|NCT01987427|587437037|FG002|Overall Study|Lost to Follow-up|9|||
162650090|NCT01987427|587437035|FG000|Overall Study|Withdrawal by Subject|2|||
162650091|NCT01987427|587437036|FG001|Overall Study|Withdrawal by Subject|1|||
162650092|NCT01987427|587437037|FG002|Overall Study|Withdrawal by Subject|3|||
162650093|NCT01987427|587437035|FG000|Overall Study|Lack of Efficacy|1|||
162650094|NCT01987427|587437036|FG001|Overall Study|Lack of Efficacy|0|||
162650095|NCT01987427|587437037|FG002|Overall Study|Lack of Efficacy|0|||
162650096|NCT01987427|587437035|FG000|Overall Study|Other|1|||
162650097|NCT01987427|587437036|FG001|Overall Study|Other|1|||
162650098|NCT01987427|587437037|FG002|Overall Study|Other|0|||
162650099|NCT02129803|587437045|FG000|Overall Study|Protocol Violation|4|||
163089368|NCT00718315|589037624|FG001|Overall Study|Erlotinib dose decreased|3|||
163089369|NCT00718315|589037625|FG002|Overall Study|Erlotinib dose decreased|1|||
163089370|NCT00718315|589037623|FG000|Overall Study|Use of Minocyclin|1|||
163089371|NCT00718315|589037624|FG001|Overall Study|Use of Minocyclin|1|||
163089372|NCT00718315|589037625|FG002|Overall Study|Use of Minocyclin|1|||
163089373|NCT00718315|589037623|FG000|Overall Study|Disease progression|0|||
163089374|NCT00718315|589037624|FG001|Overall Study|Disease progression|1|||
163089375|NCT00718315|589037625|FG002|Overall Study|Disease progression|1|||
163089376|NCT00718315|589037623|FG000|Overall Study|Other|0|||
163089377|NCT00718315|589037624|FG001|Overall Study|Other|0|||
163089378|NCT00718315|589037625|FG002|Overall Study|Other|1|||
163089379|NCT00718315|589037623|FG000|Overall Study|Use of ATB and Corticoids|0|||
163089380|NCT00718315|589037624|FG001|Overall Study|Use of ATB and Corticoids|1|||
163089381|NCT00718315|589037625|FG002|Overall Study|Use of ATB and Corticoids|2|||
163089382|NCT00399529|589037626|FG000|Overall Study|Off Study Prior to Treatment|2|||
163089383|NCT01164007|589037627|FG000|Overall Study|Adverse Event|5|||
163089384|NCT01164007|589037627|FG000|Overall Study|Progression of Disease|30|||
163089385|NCT01164007|589037627|FG000|Overall Study|Protocol Violation|1|||
163089386|NCT01164007|589037627|FG000|Overall Study|Withdrawal by Subject|1|||
163089387|NCT01164007|589037627|FG000|Overall Study|Medical Decision|3|||
163089388|NCT03746015|589037632|FG000|Overall Study|Withdrawal of Consent|1|||
163089389|NCT03746015|589037633|FG001|Overall Study|Withdrawal of Consent|0|||
163089390|NCT03746015|589037634|FG002|Overall Study|Withdrawal of Consent|0|||
163089391|NCT05200845|589037636|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
163089392|NCT05200845|589037637|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
163089393|NCT05200845|589037638|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
163089394|NCT05200845|589037639|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
163089395|NCT05200845|589037636|FG000|Overall Study|Withdrawal by Subject|0|||
163089396|NCT05200845|589037637|FG001|Overall Study|Withdrawal by Subject|1|||
163089397|NCT05200845|589037638|FG002|Overall Study|Withdrawal by Subject|1|||
163089398|NCT05200845|589037639|FG003|Overall Study|Withdrawal by Subject|0|||
163089399|NCT02303262|589037642|FG000|Overall Study|Withdrawal by Subject|2|||
163089400|NCT02412670|589037643|FG000|Overall Study|Adverse Event|4|||
163089401|NCT02412670|589037644|FG001|Overall Study|Adverse Event|1|||
163089402|NCT02412670|589037643|FG000|Overall Study|Physician Decision|1|||
163089403|NCT02412670|589037644|FG001|Overall Study|Physician Decision|0|||
163089404|NCT02412670|589037643|FG000|Overall Study|Withdrawal by Subject|1|||
163089405|NCT02412670|589037644|FG001|Overall Study|Withdrawal by Subject|0|||
163089406|NCT02412670|589037643|FG000|Overall Study|Ineligible|1|||
163089407|NCT02412670|589037644|FG001|Overall Study|Ineligible|0|||
163089408|NCT01728246|589037650|FG000|Overall Study|Participant needed rescue medication|1|||
163089409|NCT01728246|589037651|FG001|Overall Study|Participant needed rescue medication|5|||
163089410|NCT01728246|589037650|FG000|Overall Study|Protocol Violation|1|||
163089411|NCT01728246|589037651|FG001|Overall Study|Protocol Violation|0|||
163089412|NCT01728246|589037650|FG000|Overall Study|Withdrawal by Subject|2|||
163089413|NCT01728246|589037651|FG001|Overall Study|Withdrawal by Subject|3|||
163089414|NCT01728246|589037650|FG000|Overall Study|Lost to Follow-up|23|||
163089415|NCT01728246|589037651|FG001|Overall Study|Lost to Follow-up|22|||
163089416|NCT01728246|589037650|FG000|Overall Study|Lack of Efficacy|1|||
163089417|NCT01728246|589037651|FG001|Overall Study|Lack of Efficacy|1|||
163089418|NCT01728246|589037650|FG000|Overall Study|Adverse Event|8|||
163089419|NCT01728246|589037651|FG001|Overall Study|Adverse Event|5|||
163089420|NCT05805150|589037652|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
163089421|NCT05805150|589037653|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
163089422|NCT00431964|589037656|FG000|Overall Study|Adverse Event|1|||
163089423|NCT00431964|589037657|FG001|Overall Study|Adverse Event|0|||
163089424|NCT00431964|589037656|FG000|Overall Study|Lost to Follow-up|1|||
163089425|NCT00431964|589037657|FG001|Overall Study|Lost to Follow-up|2|||
163089426|NCT00431964|589037656|FG000|Overall Study|Physician Decision|2|||
163089427|NCT00431964|589037657|FG001|Overall Study|Physician Decision|2|||
163089428|NCT00431964|589037656|FG000|Overall Study|Withdrawal by Subject|2|||
163089429|NCT00431964|589037657|FG001|Overall Study|Withdrawal by Subject|1|||
163089430|NCT00431964|589037656|FG000|Overall Study|Parental Consent Withdrawn|0|||
163089431|NCT00431964|589037657|FG001|Overall Study|Parental Consent Withdrawn|2|||
163089432|NCT00431964|589037656|FG000|Overall Study|Due to Unstable Health|0|||
163089433|NCT00431964|589037657|FG001|Overall Study|Due to Unstable Health|1|||
163089434|NCT03189719|589037658|FG000|Overall Study|Death|325|||
163089435|NCT03189719|589037659|FG001|Overall Study|Death|361|||
163089436|NCT03189719|589037658|FG000|Overall Study|Physician Decision|1|||
163089437|NCT03189719|589037659|FG001|Overall Study|Physician Decision|0|||
163089438|NCT03189719|589037658|FG000|Overall Study|Sponsor Decision|40|||
163089439|NCT03189719|589037659|FG001|Overall Study|Sponsor Decision|12|||
163089440|NCT03189719|589037658|FG000|Overall Study|Withdrawal by Subject|7|||
163089441|NCT03189719|589037659|FG001|Overall Study|Withdrawal by Subject|3|||
163089442|NCT03012880|589037660|FG000|Overall Study|Withdrawal by Subject|1|||
163089443|NCT03012880|589037661|FG001|Overall Study|Withdrawal by Subject|0|||
162650100|NCT02129803|587437046|FG001|Overall Study|Protocol Violation|0|||
162650101|NCT02129803|587437045|FG000|Overall Study|Physician Decision|0|||
162650102|NCT02129803|587437046|FG001|Overall Study|Physician Decision|1|||
162650103|NCT02129803|587437045|FG000|Overall Study|Difficulty sleeping|1|||
162650104|NCT02129803|587437046|FG001|Overall Study|Difficulty sleeping|0|||
162650105|NCT02129803|587437045|FG000|Overall Study|Morning headache|0|||
162650106|NCT02129803|587437046|FG001|Overall Study|Morning headache|1|||
162650107|NCT02129803|587437045|FG000|Overall Study|Withdrawal by Subject|1|||
162650108|NCT02129803|587437046|FG001|Overall Study|Withdrawal by Subject|1|||
162650109|NCT02319031|587437047|FG000|Treatment Period|Death|1|||
162650110|NCT02319031|587437048|FG001|Treatment Period|Death|0|||
162650111|NCT01465464|587437059|FG000|Overall Study|Adverse Event|96|||
162650112|NCT01465464|587437060|FG001|Overall Study|Adverse Event|49|||
162650113|NCT01465464|587437059|FG000|Overall Study|Lack of Efficacy|139|||
162650114|NCT01465464|587437060|FG001|Overall Study|Lack of Efficacy|190|||
162650115|NCT01465464|587437059|FG000|Overall Study|Physician Decision|13|||
162650116|NCT01465464|587437060|FG001|Overall Study|Physician Decision|5|||
162650117|NCT01465464|587437059|FG000|Overall Study|Protocol Violation|1|||
162650118|NCT01465464|587437060|FG001|Overall Study|Protocol Violation|1|||
162650119|NCT01465464|587437059|FG000|Overall Study|Withdrawal by Subject|46|||
162650120|NCT01465464|587437060|FG001|Overall Study|Withdrawal by Subject|30|||
162650121|NCT01465464|587437059|FG000|Overall Study|Other|9|||
162650122|NCT01465464|587437060|FG001|Overall Study|Other|3|||
162650123|NCT01465464|587437059|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
162650124|NCT01465464|587437060|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
162718661|NCT00855465|587676661|FG001|Treatment Period|Protocol Violation|0|||
163037774|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
163037775|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037776|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163037777|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037778|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037779|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037780|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037781|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037782|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037783|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037784|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037785|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037786|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037787|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
163037788|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037789|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037790|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037791|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037792|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037793|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037794|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037795|NCT02757352|588845589|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
163037796|NCT02757352|588845590|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
163037797|NCT02757352|588845591|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
163037798|NCT02757352|588845592|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037799|NCT02757352|588845593|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037800|NCT02757352|588845594|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037801|NCT02757352|588845595|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037802|NCT02757352|588845596|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037803|NCT02757352|588845597|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037804|NCT02757352|588845598|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
163037805|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037806|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037807|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037808|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
163037809|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037810|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
163037811|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037812|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037813|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
163037814|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
162650125|NCT01183975|587437063|FG000|Overall Study|Lost to Follow-up|73|||
162650126|NCT02739269|587437071|FG000|Overall Study|Protocol Violation|5|||
162650127|NCT02739269|587437072|FG001|Overall Study|Protocol Violation|0|||
162650128|NCT02739269|587437071|FG000|Overall Study|Cycle cancellation|2|||
163037815|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037816|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037817|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037818|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
163037819|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
163037820|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
163037821|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037822|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037823|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037824|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
163037825|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037826|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037827|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037828|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037829|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
163037830|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037831|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037832|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037833|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037834|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
163037835|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037836|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037837|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037838|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037839|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037840|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
163037841|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037842|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037843|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037844|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
163037845|NCT02757352|588845589|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037846|NCT02757352|588845590|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037847|NCT02757352|588845591|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037848|NCT02757352|588845592|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
163037849|NCT02757352|588845593|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037850|NCT02757352|588845594|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
163037851|NCT02757352|588845595|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037852|NCT02757352|588845596|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037853|NCT02757352|588845597|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037854|NCT02757352|588845598|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
163037855|NCT02757352|588845589|FG000|Follow-Up Period|Adverse Event|0|||
163037856|NCT02757352|588845590|FG001|Follow-Up Period|Adverse Event|0|||
163037857|NCT02757352|588845591|FG002|Follow-Up Period|Adverse Event|0|||
163037858|NCT02757352|588845592|FG003|Follow-Up Period|Adverse Event|0|||
163037859|NCT02757352|588845593|FG004|Follow-Up Period|Adverse Event|0|||
163037860|NCT02757352|588845594|FG005|Follow-Up Period|Adverse Event|0|||
163037861|NCT02757352|588845595|FG006|Follow-Up Period|Adverse Event|1|||
163037862|NCT02757352|588845596|FG007|Follow-Up Period|Adverse Event|0|||
163037863|NCT02757352|588845597|FG008|Follow-Up Period|Adverse Event|2|||
163037864|NCT02757352|588845598|FG009|Follow-Up Period|Adverse Event|0|||
163037865|NCT02757352|588845589|FG000|Follow-Up Period|Lost to Follow-up|0|||
163037866|NCT02757352|588845590|FG001|Follow-Up Period|Lost to Follow-up|0|||
163037867|NCT02757352|588845591|FG002|Follow-Up Period|Lost to Follow-up|0|||
163037868|NCT02757352|588845592|FG003|Follow-Up Period|Lost to Follow-up|0|||
163037869|NCT02757352|588845593|FG004|Follow-Up Period|Lost to Follow-up|0|||
163037870|NCT02757352|588845594|FG005|Follow-Up Period|Lost to Follow-up|0|||
163037871|NCT02757352|588845595|FG006|Follow-Up Period|Lost to Follow-up|0|||
163037872|NCT02757352|588845596|FG007|Follow-Up Period|Lost to Follow-up|0|||
163037873|NCT02757352|588845597|FG008|Follow-Up Period|Lost to Follow-up|1|||
163037874|NCT02757352|588845598|FG009|Follow-Up Period|Lost to Follow-up|0|||
163037875|NCT02757352|588845589|FG000|Follow-Up Period|Lack of Efficacy|0|||
163037876|NCT02757352|588845590|FG001|Follow-Up Period|Lack of Efficacy|0|||
162650129|NCT02739269|587437072|FG001|Overall Study|Cycle cancellation|2|||
163037877|NCT02757352|588845591|FG002|Follow-Up Period|Lack of Efficacy|0|||
163037878|NCT02757352|588845592|FG003|Follow-Up Period|Lack of Efficacy|0|||
163037879|NCT02757352|588845593|FG004|Follow-Up Period|Lack of Efficacy|0|||
163089444|NCT03012880|589037660|FG000|Overall Study|Ineligible|1|||
163089445|NCT03012880|589037661|FG001|Overall Study|Ineligible|0|||
163089446|NCT05211596|589037662|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
163089447|NCT05211596|589037662|FG000|Baseline to 6 Months|Death|1|||
163089448|NCT05211596|589037662|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
163089449|NCT05211596|589037662|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
163089450|NCT02293551|589037663|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
163089451|NCT02293551|589037664|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
163089452|NCT02293551|589037665|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
163089453|NCT02293551|589037666|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
163089454|NCT02293551|589037667|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
163089455|NCT02293551|589037668|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
163089456|NCT02293551|589037663|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
163089457|NCT02293551|589037664|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
163089458|NCT02293551|589037665|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
163089459|NCT02293551|589037666|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
163089460|NCT02293551|589037667|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
163089461|NCT02293551|589037668|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
163089462|NCT02293551|589037663|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089463|NCT02293551|589037664|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089464|NCT02293551|589037665|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089465|NCT02293551|589037666|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
163089466|NCT02293551|589037667|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
163089467|NCT02293551|589037668|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
163089468|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
163089469|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
163089470|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
163089471|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
163089472|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
163089473|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
163089474|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
163089475|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
163089476|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
163089477|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
163089478|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
163089479|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
163089480|NCT04532749|589037669|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
163089481|NCT04532749|589037670|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
163089482|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
163089483|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
163089484|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
163089485|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
163089486|NCT04532749|589037669|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
163089487|NCT04532749|589037670|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
163089488|NCT00529633|589039481|FG000|Overall Study|Withdrawal by Subject|1|||
163089489|NCT00529633|589039482|FG001|Overall Study|Withdrawal by Subject|1|||
163089490|NCT00069641|589039483|FG000|Overall Study|Death|1|||
163089491|NCT00069641|589039484|FG001|Overall Study|Death|0|||
162650130|NCT02739269|587437071|FG000|Overall Study|Withdrawal by Subject|0|||
162650131|NCT02739269|587437072|FG001|Overall Study|Withdrawal by Subject|2|||
162650132|NCT02244580|587437073|FG000|Overall Study|No cancer tissues available|241|||
162650133|NCT02136576|587437075|FG000|Overall Study|Lost to Follow-up|2|||
162650134|NCT02136576|587437076|FG001|Overall Study|Lost to Follow-up|0|||
162650135|NCT02136576|587437077|FG002|Overall Study|Lost to Follow-up|0|||
162650136|NCT01708174|587437078|FG000|Treatment Period|Withdrawal by Subject|1|||
163037880|NCT02757352|588845594|FG005|Follow-Up Period|Lack of Efficacy|0|||
163037881|NCT02757352|588845595|FG006|Follow-Up Period|Lack of Efficacy|0|||
163037882|NCT02757352|588845596|FG007|Follow-Up Period|Lack of Efficacy|0|||
163037883|NCT02757352|588845597|FG008|Follow-Up Period|Lack of Efficacy|1|||
163037884|NCT02757352|588845598|FG009|Follow-Up Period|Lack of Efficacy|1|||
163037885|NCT02757352|588845589|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163037886|NCT02757352|588845590|FG001|Follow-Up Period|Withdrawal by Subject|0|||
163037887|NCT02757352|588845591|FG002|Follow-Up Period|Withdrawal by Subject|0|||
163037888|NCT02757352|588845592|FG003|Follow-Up Period|Withdrawal by Subject|0|||
163037889|NCT02757352|588845593|FG004|Follow-Up Period|Withdrawal by Subject|0|||
163037890|NCT02757352|588845594|FG005|Follow-Up Period|Withdrawal by Subject|0|||
163037891|NCT02757352|588845595|FG006|Follow-Up Period|Withdrawal by Subject|0|||
163037892|NCT02757352|588845596|FG007|Follow-Up Period|Withdrawal by Subject|1|||
163037893|NCT02757352|588845597|FG008|Follow-Up Period|Withdrawal by Subject|6|||
163037894|NCT02757352|588845598|FG009|Follow-Up Period|Withdrawal by Subject|2|||
163037895|NCT04750278|588845599|FG000|Overall Study|Death|9|||
163037896|NCT04750278|588845600|FG001|Overall Study|Death|10|||
163037897|NCT04750278|588845601|FG002|Overall Study|Death|10|||
163089492|NCT00069641|589039485|FG002|Overall Study|Death|1|||
163089493|NCT02704208|589039486|FG000|Overall Study|Lost to Follow-up|42|||
163089494|NCT02704208|589039487|FG001|Overall Study|Lost to Follow-up|37|||
163089495|NCT02935192|589039488|FG000|Overall Study|Withdrawal by Subject|8|||
163089496|NCT02935192|589039489|FG001|Overall Study|Withdrawal by Subject|4|||
163089497|NCT00492557|589039491|FG000|Overall Study|Subject request|12|||
163089498|NCT00492557|589039492|FG001|Overall Study|Subject request|11|||
163089499|NCT00492557|589039491|FG000|Overall Study|Protocol Violation|7|||
163089500|NCT00492557|589039492|FG001|Overall Study|Protocol Violation|8|||
163089501|NCT00492557|589039491|FG000|Overall Study|Other|2|||
163089502|NCT00492557|589039492|FG001|Overall Study|Other|2|||
163089503|NCT00492557|589039491|FG000|Overall Study|Death|1|||
163089504|NCT00492557|589039492|FG001|Overall Study|Death|1|||
163089505|NCT00492557|589039491|FG000|Overall Study|Adverse Event|1|||
163089506|NCT00492557|589039492|FG001|Overall Study|Adverse Event|0|||
163089507|NCT00492557|589039491|FG000|Overall Study|Failed to return|1|||
163089508|NCT00492557|589039492|FG001|Overall Study|Failed to return|0|||
163089509|NCT00492557|589039491|FG000|Overall Study|Lost to Follow-up|0|||
163089510|NCT00492557|589039492|FG001|Overall Study|Lost to Follow-up|1|||
163089511|NCT04778592|589039496|FG000|Overall Study|Adverse Event|1|||
163089512|NCT04778592|589039497|FG001|Overall Study|Adverse Event|2|||
163089513|NCT04778592|589039496|FG000|Overall Study|Withdrawal by Subject|1|||
163089514|NCT04778592|589039497|FG001|Overall Study|Withdrawal by Subject|2|||
163089515|NCT01354223|589039499|FG000|Overall Study|Withdrawal by Subject|3|||
163089516|NCT01354223|589039500|FG001|Overall Study|Withdrawal by Subject|1|||
163089517|NCT05173974|589039504|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089518|NCT05173974|589039505|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089519|NCT05173974|589039506|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
163089520|NCT05173974|589039507|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
163089521|NCT05173974|589039504|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089522|NCT05173974|589039505|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
163089523|NCT05173974|589039506|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089524|NCT05173974|589039507|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
163089525|NCT04047446|589039508|FG000|Overall Study|Physician Decision|1|||
163089526|NCT04047446|589039509|FG001|Overall Study|Physician Decision|0|||
163089527|NCT00329420|589039510|FG000|Re-induction Phase|Lack of Efficacy|0|||
163089528|NCT00329420|589039511|FG001|Re-induction Phase|Lack of Efficacy|1|||
163089529|NCT00329420|589039512|FG002|Re-induction Phase|Lack of Efficacy|0|||
163089530|NCT00329420|589039510|FG000|Re-induction Phase|Withdrawal of Consent|0|||
163089531|NCT00329420|589039511|FG001|Re-induction Phase|Withdrawal of Consent|0|||
163089532|NCT00329420|589039512|FG002|Re-induction Phase|Withdrawal of Consent|1|||
163089533|NCT00329420|589039510|FG000|Re-induction Phase|Did not respond to re-induction|6|||
163089534|NCT00329420|589039511|FG001|Re-induction Phase|Did not respond to re-induction|5|||
163089535|NCT00329420|589039512|FG002|Re-induction Phase|Did not respond to re-induction|7|||
163089536|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
163089537|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
163089538|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
163089539|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
163089540|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
163089541|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
163089542|NCT00329420|589039510|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
163089543|NCT00329420|589039511|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
163089544|NCT00329420|589039512|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
163089545|NCT01135992|589039513|FG000|Overall Study|Adverse Event|1|||
163089546|NCT01135992|589039513|FG000|Overall Study|Lack of Efficacy|1|||
163089547|NCT01135992|589039513|FG000|Overall Study|Protocol Violation|2|||
163089548|NCT01135992|589039513|FG000|Overall Study|Withdrawal criteria|10|||
163089549|NCT01135992|589039513|FG000|Overall Study|Unclassified|7|||
163089550|NCT03983421|589039515|FG000|Overall Study|Lost to Follow-up|1|||
163089551|NCT02660229|589039516|FG000|Overall Study|Adverse Event|2|||
163089552|NCT02660229|589039517|FG001|Overall Study|Adverse Event|0|||
163089553|NCT02660229|589039516|FG000|Overall Study|Withdrawal by Subject|0|||
163089554|NCT02660229|589039517|FG001|Overall Study|Withdrawal by Subject|1|||
163089555|NCT02727322|589039521|FG000|Overall Study|Withdrawal by Subject|1|||
163089556|NCT02727322|589039522|FG001|Overall Study|Withdrawal by Subject|1|||
163089557|NCT02727322|589039521|FG000|Overall Study|Protocol Violation|1|||
163089558|NCT02727322|589039522|FG001|Overall Study|Protocol Violation|0|||
162650137|NCT01708174|587437079|FG001|Treatment Period|Withdrawal by Subject|0|||
162650138|NCT01708174|587437080|FG002|Treatment Period|Withdrawal by Subject|0|||
163089559|NCT01517984|589039523|FG000|Overall Study|Lost to Follow-up|0|||
163089560|NCT01517984|589039524|FG001|Overall Study|Lost to Follow-up|1|||
163089561|NCT01517984|589039525|FG002|Overall Study|Lost to Follow-up|0|||
163089562|NCT01517984|589039526|FG003|Overall Study|Lost to Follow-up|0|||
163089563|NCT01517984|589039523|FG000|Overall Study|Withdrawal by Subject|1|||
163089564|NCT01517984|589039524|FG001|Overall Study|Withdrawal by Subject|8|||
163089565|NCT01517984|589039525|FG002|Overall Study|Withdrawal by Subject|4|||
163089566|NCT01517984|589039526|FG003|Overall Study|Withdrawal by Subject|1|||
163089567|NCT01517984|589039523|FG000|Overall Study|Screen Failure|4|||
163089568|NCT01517984|589039524|FG001|Overall Study|Screen Failure|0|||
163089569|NCT01517984|589039525|FG002|Overall Study|Screen Failure|0|||
163089570|NCT01517984|589039526|FG003|Overall Study|Screen Failure|0|||
163089571|NCT01517984|589039523|FG000|Overall Study|Ineligible for randomization|0|||
163089572|NCT01517984|589039524|FG001|Overall Study|Ineligible for randomization|14|||
163089573|NCT01517984|589039525|FG002|Overall Study|Ineligible for randomization|0|||
163089574|NCT01517984|589039526|FG003|Overall Study|Ineligible for randomization|0|||
163089575|NCT02724839|589039529|FG000|Overall Study|Withdrawal by Subject|1|||
163089576|NCT02724839|589039530|FG001|Overall Study|Withdrawal by Subject|1|||
163089577|NCT02724839|589039531|FG002|Overall Study|Withdrawal by Subject|0|||
163089578|NCT02724839|589039529|FG000|Overall Study|Lost to Follow-up|0|||
163089579|NCT02724839|589039530|FG001|Overall Study|Lost to Follow-up|3|||
163089580|NCT02724839|589039531|FG002|Overall Study|Lost to Follow-up|2|||
163089581|NCT02724839|589039529|FG000|Overall Study|Physician Decision|0|||
163089582|NCT02724839|589039530|FG001|Overall Study|Physician Decision|0|||
163089583|NCT02724839|589039531|FG002|Overall Study|Physician Decision|3|||
163089584|NCT01155050|589039532|FG000|Overall Study|Lost to Follow-up|15|||
163089585|NCT01155050|589039533|FG001|Overall Study|Lost to Follow-up|20|||
163089586|NCT01155050|589039534|FG002|Overall Study|Lost to Follow-up|19|||
163089587|NCT01155050|589039535|FG003|Overall Study|Lost to Follow-up|22|||
163089588|NCT01496287|589039536|FG000|Overall Study|Lost to Follow-up|1|||
163089589|NCT01496287|589039536|FG000|Overall Study|Incomplete anesthesia|5|||
163089590|NCT01959529|589039537|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
163089591|NCT01959529|589039538|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
163089592|NCT01959529|589039537|FG000|Overall Study|Lost to Follow-up|4|||
163089593|NCT01959529|589039538|FG001|Overall Study|Lost to Follow-up|1|||
163089594|NCT01959529|589039537|FG000|Overall Study|Other|70|||
163037898|NCT04750278|588845599|FG000|Overall Study|Withdrawal by Subject|4|||
163037899|NCT04750278|588845600|FG001|Overall Study|Withdrawal by Subject|1|||
163037900|NCT04750278|588845601|FG002|Overall Study|Withdrawal by Subject|2|||
163037901|NCT04750278|588845599|FG000|Overall Study|Lost to Follow-up|1|||
163037902|NCT04750278|588845600|FG001|Overall Study|Lost to Follow-up|1|||
163037903|NCT04750278|588845601|FG002|Overall Study|Lost to Follow-up|1|||
163037904|NCT04750278|588845599|FG000|Overall Study|Pregnancy|1|||
163037905|NCT04750278|588845600|FG001|Overall Study|Pregnancy|0|||
163037906|NCT04750278|588845601|FG002|Overall Study|Pregnancy|0|||
163037907|NCT04750278|588845599|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
163037908|NCT04750278|588845600|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
163037909|NCT04750278|588845601|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
163037910|NCT04750278|588845599|FG000|Overall Study|Non-compliance|0|||
163037911|NCT04750278|588845600|FG001|Overall Study|Non-compliance|0|||
163037912|NCT04750278|588845601|FG002|Overall Study|Non-compliance|1|||
163037913|NCT04750278|588845599|FG000|Overall Study|Transfer to Outside Facility|0|||
163037914|NCT04750278|588845600|FG001|Overall Study|Transfer to Outside Facility|2|||
163037915|NCT04750278|588845601|FG002|Overall Study|Transfer to Outside Facility|1|||
163037916|NCT04750278|588845599|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
163037917|NCT04750278|588845600|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
163037918|NCT04750278|588845601|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
163037919|NCT04750278|588845599|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
163037920|NCT04750278|588845600|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
163037921|NCT04750278|588845601|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
163037922|NCT01212159|588845602|FG000|Overall Study|Withdrawal by Subject|12|||
163037923|NCT01212159|588845603|FG001|Overall Study|Withdrawal by Subject|12|||
163037924|NCT01299896|588845604|FG000|Overall Study|Withdrawal by Subject|1|||
163037925|NCT01299896|588845605|FG001|Overall Study|Withdrawal by Subject|7|||
163037926|NCT01299896|588845604|FG000|Overall Study|Lost to Follow-up|0|||
163037927|NCT01299896|588845605|FG001|Overall Study|Lost to Follow-up|11|||
163037928|NCT01467271|588845608|FG000|Overall Study|Death|84|||
163037929|NCT01467271|588845608|FG000|Overall Study|Lost to Follow-up|83|||
163037930|NCT01467271|588845608|FG000|Overall Study|Retraction of patient's consent|21|||
163037931|NCT01467271|588845608|FG000|Overall Study|Other reason|14|||
163037932|NCT01411319|588845632|FG000|Overall Study|Lost to Follow-up|1|||
163037933|NCT02815267|588845633|FG000|Double-Blind Phase|Adverse Event|0|||
163037934|NCT02815267|588845634|FG001|Double-Blind Phase|Adverse Event|3|||
163037935|NCT02815267|588845633|FG000|Double-Blind Phase|Lost to Follow-up|17|||
163037936|NCT02815267|588845634|FG001|Double-Blind Phase|Lost to Follow-up|9|||
163037937|NCT02815267|588845633|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
163037938|NCT02815267|588845634|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
163089595|NCT01959529|589039538|FG001|Overall Study|Other|68|||
163089596|NCT01959529|589039537|FG000|Overall Study|Hypoglycaemia|1|||
163089597|NCT01959529|589039538|FG001|Overall Study|Hypoglycaemia|1|||
163089598|NCT01959529|589039537|FG000|Overall Study|Lack of glycaemic control|1|||
162718662|NCT00855465|587676660|FG000|Treatment Period|Withdrawal by Subject|2|||
162718663|NCT00855465|587676661|FG001|Treatment Period|Withdrawal by Subject|0|||
162718664|NCT00855465|587676660|FG000|Treatment Period|Not treated|1|||
162718665|NCT00855465|587676661|FG001|Treatment Period|Not treated|0|||
162718666|NCT00855465|587676660|FG000|Follow-up Period (FUP)|Adverse Event|0|||
162718667|NCT00855465|587676661|FG001|Follow-up Period (FUP)|Adverse Event|1|||
162718668|NCT00855465|587676660|FG000|Follow-up Period (FUP)|Death|0|||
162718669|NCT00855465|587676661|FG001|Follow-up Period (FUP)|Death|1|||
162718670|NCT00855465|587676660|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
162718671|NCT00855465|587676661|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
162718672|NCT00855465|587676660|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
162718673|NCT00855465|587676661|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
162718674|NCT00855465|587676660|FG000|Follow-up Period (FUP)|Missing|1|||
162718675|NCT00855465|587676661|FG001|Follow-up Period (FUP)|Missing|0|||
162718676|NCT00612586|587676672|FG000|Overall Study|Adverse Event|6|||
162718677|NCT00612586|587676673|FG001|Overall Study|Adverse Event|2|||
162718678|NCT00612586|587676672|FG000|Overall Study|Death|1|||
162718679|NCT00612586|587676673|FG001|Overall Study|Death|0|||
162718680|NCT00612586|587676672|FG000|Overall Study|Entry Criteria Not Met|0|||
162718681|NCT00612586|587676673|FG001|Overall Study|Entry Criteria Not Met|2|||
162718682|NCT00612586|587676672|FG000|Overall Study|Withdrawal by Subject|7|||
162718683|NCT00612586|587676673|FG001|Overall Study|Withdrawal by Subject|9|||
162718684|NCT00612586|587676672|FG000|Overall Study|Physician Decision|1|||
162718685|NCT00612586|587676673|FG001|Overall Study|Physician Decision|2|||
162718686|NCT00612586|587676672|FG000|Overall Study|Sponsor Decision|1|||
162718687|NCT00612586|587676673|FG001|Overall Study|Sponsor Decision|1|||
162718688|NCT00612586|587676672|FG000|Overall Study|Progressive Disease|26|||
162718689|NCT00612586|587676673|FG001|Overall Study|Progressive Disease|24|||
162718690|NCT00612586|587676672|FG000|Overall Study|Randomized and Not Treated|1|||
162718691|NCT00612586|587676673|FG001|Overall Study|Randomized and Not Treated|1|||
162718692|NCT02613364|587676674|FG000|Overall Study|Other|19|||
162718693|NCT02613364|587676675|FG001|Overall Study|Other|29|||
162718694|NCT02613364|587676676|FG002|Overall Study|Other|17|||
162718695|NCT02613364|587676674|FG000|Overall Study|Too time consuming|21|||
162718696|NCT02613364|587676675|FG001|Overall Study|Too time consuming|26|||
162718697|NCT02613364|587676676|FG002|Overall Study|Too time consuming|26|||
162718698|NCT02613364|587676674|FG000|Overall Study|Withdrawal by Subject|13|||
162718699|NCT02613364|587676675|FG001|Overall Study|Withdrawal by Subject|18|||
162718700|NCT02613364|587676676|FG002|Overall Study|Withdrawal by Subject|17|||
162718701|NCT02613364|587676674|FG000|Overall Study|Medical|12|||
162718702|NCT02613364|587676675|FG001|Overall Study|Medical|13|||
162718703|NCT02613364|587676676|FG002|Overall Study|Medical|9|||
162718704|NCT02613364|587676674|FG000|Overall Study|Disliked Study Procedure|1|||
162718705|NCT02613364|587676675|FG001|Overall Study|Disliked Study Procedure|1|||
162718706|NCT02613364|587676676|FG002|Overall Study|Disliked Study Procedure|4|||
162718707|NCT02613364|587676674|FG000|Overall Study|Disliked Intervention|0|||
162718708|NCT02613364|587676675|FG001|Overall Study|Disliked Intervention|3|||
162718709|NCT02613364|587676676|FG002|Overall Study|Disliked Intervention|3|||
162650139|NCT01708174|587437078|FG000|Treatment Period|Progressive disease|0|||
162650140|NCT01708174|587437079|FG001|Treatment Period|Progressive disease|1|||
162650141|NCT01708174|587437080|FG002|Treatment Period|Progressive disease|0|||
162650142|NCT01708174|587437078|FG000|Treatment Period|Death|0|||
162650143|NCT01708174|587437079|FG001|Treatment Period|Death|0|||
162650144|NCT01708174|587437080|FG002|Treatment Period|Death|1|||
162650145|NCT01708174|587437078|FG000|Treatment Period|Adverse Event|0|||
162650146|NCT01708174|587437079|FG001|Treatment Period|Adverse Event|1|||
162650147|NCT01708174|587437080|FG002|Treatment Period|Adverse Event|0|||
162650148|NCT00923559|587437081|FG000|Overall Study|Lost to Follow-up|2|||
162650149|NCT00923559|587437082|FG001|Overall Study|Lost to Follow-up|3|||
162718710|NCT01909336|587676677|FG000|Overall Study|Lost to Follow-up|4|||
162718711|NCT01909336|587676678|FG001|Overall Study|Lost to Follow-up|2|||
162650150|NCT02268812|587437083|FG000|Overall Study|Adverse Event|8|||
162718712|NCT01909336|587676679|FG002|Overall Study|Lost to Follow-up|2|||
162718713|NCT01909336|587676677|FG000|Overall Study|Physician Decision|0|||
162718714|NCT01909336|587676678|FG001|Overall Study|Physician Decision|1|||
162718715|NCT01909336|587676679|FG002|Overall Study|Physician Decision|1|||
162718716|NCT01235949|587676680|FG000|Primary Phase|Migrated/moved from study area|1|||
162718717|NCT01235949|587676681|FG001|Primary Phase|Migrated/moved from study area|1|||
162718718|NCT01235949|587676682|FG002|Primary Phase|Migrated/moved from study area|0|||
163089599|NCT01959529|589039538|FG001|Overall Study|Lack of glycaemic control|1|||
162650151|NCT02268812|587437084|FG001|Overall Study|Adverse Event|26|||
162650152|NCT02268812|587437085|FG002|Overall Study|Adverse Event|7|||
162718719|NCT01235949|587676683|FG003|Primary Phase|Migrated/moved from study area|0|||
162718720|NCT01235949|587676684|FG004|Primary Phase|Migrated/moved from study area|1|||
162718721|NCT01235949|587676685|FG005|Primary Phase|Migrated/moved from study area|2|||
162718722|NCT01235949|587676686|FG006|Primary Phase|Migrated/moved from study area|0|||
162718723|NCT01235949|587676687|FG007|Primary Phase|Migrated/moved from study area|0|||
162650153|NCT02268812|587437086|FG003|Overall Study|Adverse Event|10|||
163089600|NCT00557193|589039546|FG000|Induction|Adverse Event|2|||
163089601|NCT00557193|589039547|FG001|Induction|Adverse Event|0|||
163089602|NCT00557193|589039548|FG002|Induction|Adverse Event|0|||
163089603|NCT00557193|589039549|FG003|Induction|Adverse Event|0|||
163089604|NCT00557193|589039550|FG004|Induction|Adverse Event|0|||
163089605|NCT00557193|589039551|FG005|Induction|Adverse Event|0|||
163089606|NCT00557193|589039546|FG000|Induction|Death|6|||
163089607|NCT00557193|589039547|FG001|Induction|Death|0|||
163089608|NCT00557193|589039548|FG002|Induction|Death|0|||
163089609|NCT00557193|589039549|FG003|Induction|Death|0|||
163089610|NCT00557193|589039550|FG004|Induction|Death|0|||
163089611|NCT00557193|589039551|FG005|Induction|Death|0|||
163089612|NCT00557193|589039546|FG000|Induction|Physician Decision|3|||
163089613|NCT00557193|589039547|FG001|Induction|Physician Decision|0|||
163089614|NCT00557193|589039548|FG002|Induction|Physician Decision|0|||
163089615|NCT00557193|589039549|FG003|Induction|Physician Decision|0|||
163089616|NCT00557193|589039550|FG004|Induction|Physician Decision|0|||
163089617|NCT00557193|589039551|FG005|Induction|Physician Decision|0|||
163089618|NCT00557193|589039546|FG000|Induction|Withdrawal by Subject|1|||
163089619|NCT00557193|589039547|FG001|Induction|Withdrawal by Subject|0|||
163089620|NCT00557193|589039548|FG002|Induction|Withdrawal by Subject|0|||
163089621|NCT00557193|589039549|FG003|Induction|Withdrawal by Subject|0|||
163089622|NCT00557193|589039550|FG004|Induction|Withdrawal by Subject|0|||
163089623|NCT00557193|589039551|FG005|Induction|Withdrawal by Subject|0|||
163089624|NCT00557193|589039546|FG000|Induction|Refusal of Further Protocol Therapy|2|||
163089625|NCT00557193|589039547|FG001|Induction|Refusal of Further Protocol Therapy|0|||
163089626|NCT00557193|589039548|FG002|Induction|Refusal of Further Protocol Therapy|0|||
163089627|NCT00557193|589039549|FG003|Induction|Refusal of Further Protocol Therapy|0|||
163089628|NCT00557193|589039550|FG004|Induction|Refusal of Further Protocol Therapy|0|||
163089629|NCT00557193|589039551|FG005|Induction|Refusal of Further Protocol Therapy|0|||
163089630|NCT00557193|589039546|FG000|Induction|Ineligible|8|||
163089631|NCT00557193|589039547|FG001|Induction|Ineligible|0|||
163089632|NCT00557193|589039548|FG002|Induction|Ineligible|0|||
163089633|NCT00557193|589039549|FG003|Induction|Ineligible|0|||
163089634|NCT00557193|589039550|FG004|Induction|Ineligible|0|||
163089635|NCT00557193|589039551|FG005|Induction|Ineligible|0|||
163089636|NCT00557193|589039546|FG000|Induction|Inevaluable for post Induction|2|||
163089637|NCT00557193|589039547|FG001|Induction|Inevaluable for post Induction|0|||
163089638|NCT00557193|589039548|FG002|Induction|Inevaluable for post Induction|0|||
163089639|NCT00557193|589039549|FG003|Induction|Inevaluable for post Induction|0|||
163089640|NCT00557193|589039550|FG004|Induction|Inevaluable for post Induction|0|||
163089641|NCT00557193|589039551|FG005|Induction|Inevaluable for post Induction|0|||
163089642|NCT00557193|589039546|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
163089643|NCT00557193|589039547|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089644|NCT00557193|589039548|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089645|NCT00557193|589039549|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089646|NCT00557193|589039550|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089647|NCT00557193|589039551|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
163089648|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163089649|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
163089650|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
163089651|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
163089652|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
163089653|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
163089654|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
163089655|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
163089656|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
163089657|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
163089658|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
163089659|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
163089660|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
163089661|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
163089662|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
163089663|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
163089664|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
163089665|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
163089666|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
163089667|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
163089668|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
163089669|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
163089670|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
163089671|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
163089672|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
162650154|NCT02268812|587437083|FG000|Overall Study|Protocol deviation|0|||
162650155|NCT02268812|587437084|FG001|Overall Study|Protocol deviation|0|||
162650156|NCT02268812|587437085|FG002|Overall Study|Protocol deviation|1|||
162650157|NCT02268812|587437086|FG003|Overall Study|Protocol deviation|0|||
162650158|NCT02268812|587437083|FG000|Overall Study|Withdrawal by Subject|0|||
162650159|NCT02268812|587437084|FG001|Overall Study|Withdrawal by Subject|1|||
162650160|NCT02268812|587437085|FG002|Overall Study|Withdrawal by Subject|0|||
162650161|NCT02268812|587437086|FG003|Overall Study|Withdrawal by Subject|0|||
162650162|NCT02268812|587437083|FG000|Overall Study|Physician Decision|3|||
162650163|NCT02268812|587437084|FG001|Overall Study|Physician Decision|1|||
162650164|NCT02268812|587437085|FG002|Overall Study|Physician Decision|0|||
162650165|NCT02268812|587437086|FG003|Overall Study|Physician Decision|1|||
162650166|NCT02268812|587437083|FG000|Overall Study|Other|5|||
162650167|NCT02268812|587437084|FG001|Overall Study|Other|4|||
162650168|NCT02268812|587437085|FG002|Overall Study|Other|1|||
162650169|NCT02268812|587437086|FG003|Overall Study|Other|3|||
162650170|NCT01951157|587437088|FG000|Overall Study|Progressive Disease|12|||
162650171|NCT01951157|587437089|FG001|Overall Study|Progressive Disease|13|||
162650172|NCT01951157|587437090|FG002|Overall Study|Progressive Disease|10|||
162650173|NCT01951157|587437088|FG000|Overall Study|Treatment-unrelated AE|1|||
162650174|NCT01951157|587437089|FG001|Overall Study|Treatment-unrelated AE|0|||
162650175|NCT01951157|587437090|FG002|Overall Study|Treatment-unrelated AE|3|||
162650176|NCT01951157|587437088|FG000|Overall Study|Study Termination|0|||
162650177|NCT01951157|587437089|FG001|Overall Study|Study Termination|0|||
162650178|NCT01951157|587437090|FG002|Overall Study|Study Termination|1|||
162650179|NCT01951157|587437088|FG000|Overall Study|Physician Decision|5|||
162650180|NCT01951157|587437089|FG001|Overall Study|Physician Decision|3|||
162650181|NCT01951157|587437090|FG002|Overall Study|Physician Decision|2|||
162650182|NCT01951157|587437088|FG000|Overall Study|Non-treatmentrelated death|2|||
162650183|NCT01951157|587437089|FG001|Overall Study|Non-treatmentrelated death|2|||
162650184|NCT01951157|587437090|FG002|Overall Study|Non-treatmentrelated death|2|||
162650185|NCT01951157|587437088|FG000|Overall Study|No treated|0|||
162650186|NCT01951157|587437089|FG001|Overall Study|No treated|1|||
162650187|NCT01951157|587437090|FG002|Overall Study|No treated|0|||
162650188|NCT01951157|587437088|FG000|Overall Study|Treatment-related AE|2|||
162650189|NCT01951157|587437089|FG001|Overall Study|Treatment-related AE|0|||
162650190|NCT01951157|587437090|FG002|Overall Study|Treatment-related AE|4|||
162650191|NCT01951157|587437088|FG000|Overall Study|Consent withdrawn by subject|0|||
162650192|NCT01951157|587437089|FG001|Overall Study|Consent withdrawn by subject|1|||
162650193|NCT01951157|587437090|FG002|Overall Study|Consent withdrawn by subject|3|||
162650194|NCT01951157|587437088|FG000|Overall Study|Treatment-related death|0|||
162650195|NCT01951157|587437089|FG001|Overall Study|Treatment-related death|2|||
162650196|NCT01951157|587437090|FG002|Overall Study|Treatment-related death|0|||
162650197|NCT04964128|587437093|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
162650198|NCT04964128|587437093|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
162650199|NCT00994240|587437095|FG000|Overall Study|Lost to Follow-up|3|||
162650200|NCT00994240|587437096|FG001|Overall Study|Lost to Follow-up|2|||
162650201|NCT00994240|587437095|FG000|Overall Study|Withdrawal by Subject|1|||
162650202|NCT00994240|587437096|FG001|Overall Study|Withdrawal by Subject|0|||
162650203|NCT00994240|587437095|FG000|Overall Study|study termination|2|||
162650204|NCT00994240|587437096|FG001|Overall Study|study termination|3|||
162650205|NCT01177540|587437097|FG000|Overall Study|Adverse Event|1|||
162650206|NCT01177540|587437098|FG001|Overall Study|Adverse Event|0|||
162650207|NCT00748215|587437109|FG000|Overall Study|Withdrawal by Subject|7|||
162650208|NCT00748215|587437110|FG001|Overall Study|Withdrawal by Subject|7|||
162650209|NCT00748215|587437109|FG000|Overall Study|Treatment change|2|||
162650210|NCT00748215|587437110|FG001|Overall Study|Treatment change|1|||
162650211|NCT00748215|587437109|FG000|Overall Study|Change in patient condition|0|||
162650212|NCT00748215|587437110|FG001|Overall Study|Change in patient condition|3|||
162650213|NCT00748215|587437109|FG000|Overall Study|Non-compliant|0|||
162650214|NCT00748215|587437110|FG001|Overall Study|Non-compliant|2|||
163089673|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
163089674|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
163089675|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
162650215|NCT00748215|587437109|FG000|Overall Study|Adverse Event|0|||
162650216|NCT00748215|587437110|FG001|Overall Study|Adverse Event|5|||
162650217|NCT02013167|587437111|FG000|Overall Study|Withdrawal by Subject|15|||
162650218|NCT02013167|587437112|FG001|Overall Study|Withdrawal by Subject|14|||
162650219|NCT02013167|587437111|FG000|Overall Study|Sponsor Decision|1|||
162650220|NCT02013167|587437112|FG001|Overall Study|Sponsor Decision|3|||
162650221|NCT02013167|587437111|FG000|Overall Study|Lost to Follow-up|0|||
162650222|NCT02013167|587437112|FG001|Overall Study|Lost to Follow-up|1|||
162650223|NCT02013167|587437111|FG000|Overall Study|Death|85|||
163089676|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
162650224|NCT02013167|587437112|FG001|Overall Study|Death|160|||
162650225|NCT02620046|587437117|FG000|Overall Study|Adverse Event|22|||
162650226|NCT02620046|587437118|FG001|Overall Study|Adverse Event|42|||
162650227|NCT02620046|587437117|FG000|Overall Study|Lost to Follow-up|4|||
162650228|NCT02620046|587437118|FG001|Overall Study|Lost to Follow-up|10|||
162650229|NCT02620046|587437117|FG000|Overall Study|Withdrawal by Subject|36|||
162650230|NCT02620046|587437118|FG001|Overall Study|Withdrawal by Subject|66|||
162650231|NCT02620046|587437117|FG000|Overall Study|Site Termination|3|||
162650232|NCT02620046|587437118|FG001|Overall Study|Site Termination|3|||
162650233|NCT02620046|587437117|FG000|Overall Study|Pregnancy|3|||
162650234|NCT02620046|587437118|FG001|Overall Study|Pregnancy|7|||
162650235|NCT02620046|587437117|FG000|Overall Study|Lack of Efficacy|81|||
162650236|NCT02620046|587437118|FG001|Overall Study|Lack of Efficacy|146|||
162650237|NCT02620046|587437117|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
162650238|NCT02620046|587437118|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
162650239|NCT02620046|587437117|FG000|Overall Study|Reason Not Specified|13|||
162650240|NCT02620046|587437118|FG001|Overall Study|Reason Not Specified|21|||
162650241|NCT02620046|587437117|FG000|Overall Study|Significant Protocol Deviation|0|||
162650242|NCT02620046|587437118|FG001|Overall Study|Significant Protocol Deviation|1|||
162650243|NCT00574405|587438748|FG000|Overall Study|Withdrawal by Subject|3|||
162650244|NCT00574405|587438749|FG001|Overall Study|Withdrawal by Subject|2|||
162650245|NCT01336738|587438750|FG000|Overall Study|Adverse Event|0|||
162650246|NCT01336738|587438751|FG001|Overall Study|Adverse Event|3|||
162650247|NCT01336738|587438752|FG002|Overall Study|Adverse Event|2|||
162650248|NCT01336738|587438753|FG003|Overall Study|Adverse Event|1|||
162650249|NCT01336738|587438754|FG004|Overall Study|Adverse Event|3|||
162650250|NCT01336738|587438750|FG000|Overall Study|Lost to Follow-up|2|||
162650251|NCT01336738|587438751|FG001|Overall Study|Lost to Follow-up|1|||
162650252|NCT01336738|587438752|FG002|Overall Study|Lost to Follow-up|2|||
162650253|NCT01336738|587438753|FG003|Overall Study|Lost to Follow-up|2|||
162650254|NCT01336738|587438754|FG004|Overall Study|Lost to Follow-up|2|||
162650255|NCT01336738|587438750|FG000|Overall Study|Did not meet entrance criteria|0|||
162650256|NCT01336738|587438751|FG001|Overall Study|Did not meet entrance criteria|1|||
162650257|NCT01336738|587438752|FG002|Overall Study|Did not meet entrance criteria|0|||
162650258|NCT01336738|587438753|FG003|Overall Study|Did not meet entrance criteria|0|||
162650259|NCT01336738|587438754|FG004|Overall Study|Did not meet entrance criteria|0|||
162650260|NCT01336738|587438750|FG000|Overall Study|Protocol Violation|0|||
162650261|NCT01336738|587438751|FG001|Overall Study|Protocol Violation|1|||
162650262|NCT01336738|587438752|FG002|Overall Study|Protocol Violation|0|||
162650263|NCT01336738|587438753|FG003|Overall Study|Protocol Violation|0|||
162650264|NCT01336738|587438754|FG004|Overall Study|Protocol Violation|0|||
162650265|NCT01336738|587438750|FG000|Overall Study|Withdrawal by Subject|2|||
162650266|NCT01336738|587438751|FG001|Overall Study|Withdrawal by Subject|0|||
162650267|NCT01336738|587438752|FG002|Overall Study|Withdrawal by Subject|2|||
162650268|NCT01336738|587438753|FG003|Overall Study|Withdrawal by Subject|1|||
162650269|NCT01336738|587438754|FG004|Overall Study|Withdrawal by Subject|1|||
162650270|NCT01336738|587438750|FG000|Overall Study|Other|3|||
163089677|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
163089678|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089679|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089680|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
163089681|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089682|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089683|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
163089684|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089685|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089686|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
163089687|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089688|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089689|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
163089690|NCT00557193|589039546|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089691|NCT00557193|589039547|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089692|NCT00557193|589039548|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
163089693|NCT00557193|589039549|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
162650271|NCT01336738|587438751|FG001|Overall Study|Other|3|||
162650272|NCT01336738|587438752|FG002|Overall Study|Other|2|||
162650273|NCT01336738|587438753|FG003|Overall Study|Other|3|||
162650274|NCT01336738|587438754|FG004|Overall Study|Other|4|||
162650275|NCT01083433|587438755|FG000|Overall Study|Lost to Follow-up|2|||
162650276|NCT01083433|587438756|FG001|Overall Study|Lost to Follow-up|1|||
162650277|NCT01083433|587438757|FG002|Overall Study|Lost to Follow-up|1|||
162650278|NCT01083433|587438755|FG000|Overall Study|Withdrawal by Subject|0|||
162650279|NCT01083433|587438756|FG001|Overall Study|Withdrawal by Subject|5|||
162650280|NCT01083433|587438757|FG002|Overall Study|Withdrawal by Subject|3|||
162650281|NCT01083433|587438755|FG000|Overall Study|Pregnancy|0|||
162650282|NCT01083433|587438756|FG001|Overall Study|Pregnancy|0|||
162650283|NCT01083433|587438757|FG002|Overall Study|Pregnancy|1|||
162650284|NCT01852292|587438759|FG000|Overall Study|Untreated - did not receive study drug|3|||
162650285|NCT01852292|587438760|FG001|Overall Study|Untreated - did not receive study drug|1|||
162650286|NCT01852292|587438759|FG000|Overall Study|Death|9|||
162650287|NCT01852292|587438760|FG001|Overall Study|Death|8|||
162650288|NCT01852292|587438759|FG000|Overall Study|Patient/guardian decision|8|||
162650289|NCT01852292|587438760|FG001|Overall Study|Patient/guardian decision|4|||
162650290|NCT01852292|587438759|FG000|Overall Study|Adverse Event|8|||
162650291|NCT01852292|587438760|FG001|Overall Study|Adverse Event|11|||
162650292|NCT01852292|587438759|FG000|Overall Study|Physician Decision|6|||
162650293|NCT01852292|587438760|FG001|Overall Study|Physician Decision|2|||
162650294|NCT01852292|587438759|FG000|Overall Study|Protocol Violation|2|||
162650295|NCT01852292|587438760|FG001|Overall Study|Protocol Violation|0|||
162650296|NCT01852292|587438759|FG000|Overall Study|Non-compliance with study treatment|1|||
162650297|NCT01852292|587438760|FG001|Overall Study|Non-compliance with study treatment|0|||
162650298|NCT01852292|587438759|FG000|Overall Study|Study terminated by Sponsor|0|||
162650299|NCT01852292|587438760|FG001|Overall Study|Study terminated by Sponsor|1|||
162650300|NCT01852292|587438759|FG000|Overall Study|Progressive disease|42|||
162650301|NCT01852292|587438760|FG001|Overall Study|Progressive disease|52|||
162650302|NCT01914666|587438763|FG000|Treatment Period|Lack of Efficacy|0|||
162650303|NCT01914666|587438764|FG001|Treatment Period|Lack of Efficacy|0|||
162650304|NCT01914666|587438765|FG002|Treatment Period|Lack of Efficacy|2|||
162650305|NCT01914666|587438763|FG000|Treatment Period|Adverse Event|10|||
162650306|NCT01914666|587438764|FG001|Treatment Period|Adverse Event|4|||
162650307|NCT01914666|587438765|FG002|Treatment Period|Adverse Event|2|||
162650308|NCT01914666|587438763|FG000|Treatment Period|Withdrawal by Subject|3|||
162650309|NCT01914666|587438764|FG001|Treatment Period|Withdrawal by Subject|2|||
162650310|NCT01914666|587438765|FG002|Treatment Period|Withdrawal by Subject|2|||
162650311|NCT01914666|587438763|FG000|Treatment Period|Physician Decision|0|||
162650312|NCT01914666|587438764|FG001|Treatment Period|Physician Decision|0|||
162650313|NCT01914666|587438765|FG002|Treatment Period|Physician Decision|2|||
162650314|NCT02388737|587438767|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
162650315|NCT02388737|587438768|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
162650316|NCT02388737|587438769|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
162650317|NCT02388737|587438767|FG000|Overall Study|Major Protocol Deviation|18|||
162650318|NCT02388737|587438768|FG001|Overall Study|Major Protocol Deviation|25|||
162650319|NCT02388737|587438769|FG002|Overall Study|Major Protocol Deviation|22|||
162650320|NCT02388737|587438767|FG000|Overall Study|Lost to Follow-up|5|||
162650321|NCT02388737|587438768|FG001|Overall Study|Lost to Follow-up|1|||
162650322|NCT02388737|587438769|FG002|Overall Study|Lost to Follow-up|4|||
162650323|NCT02388737|587438767|FG000|Overall Study|Voluntary Withdrawal|10|||
162650324|NCT02388737|587438768|FG001|Overall Study|Voluntary Withdrawal|18|||
162650325|NCT02388737|587438769|FG002|Overall Study|Voluntary Withdrawal|17|||
162650326|NCT02388737|587438767|FG000|Overall Study|Lack of Efficacy|3|||
162650327|NCT02388737|587438768|FG001|Overall Study|Lack of Efficacy|0|||
162650328|NCT02388737|587438769|FG002|Overall Study|Lack of Efficacy|3|||
162650329|NCT02388737|587438767|FG000|Overall Study|Reason Not Specified|5|||
162650330|NCT02388737|587438768|FG001|Overall Study|Reason Not Specified|5|||
162650331|NCT02388737|587438769|FG002|Overall Study|Reason Not Specified|4|||
162650332|NCT03252522|587438770|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
162650333|NCT03252522|587438771|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
163089694|NCT00557193|589039550|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
163089695|NCT00557193|589039551|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
163089696|NCT00652834|589039552|FG000|Overall Study|Withdrawal by Subject|3|||
163089697|NCT00652834|589039552|FG000|Overall Study|Lost to Follow-up|2|||
163089698|NCT00320606|589039553|FG000|Overall Study|Adverse Event|1|||
163089699|NCT00320606|589039553|FG000|Overall Study|Protocol Violation|1|||
163089700|NCT00320606|589039553|FG000|Overall Study|Withdrawal by Subject|1|||
163089701|NCT01948427|589039558|FG000|Overall Study|Serious Adverse Event|3|||
162650334|NCT03252522|587438772|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
162650335|NCT03252522|587438770|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
162650336|NCT03252522|587438771|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
162650337|NCT03252522|587438772|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
162650338|NCT03252522|587438770|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
162650339|NCT03252522|587438771|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
162650340|NCT03252522|587438772|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
162650341|NCT03252522|587438770|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
162650342|NCT03252522|587438771|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
162650343|NCT03252522|587438772|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
162650344|NCT03252522|587438770|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
162650345|NCT03252522|587438771|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
162650346|NCT03252522|587438772|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
162650347|NCT03252522|587438770|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
162650348|NCT03252522|587438771|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
163089702|NCT01948427|589039559|FG001|Overall Study|Serious Adverse Event|0|||
163089703|NCT01948427|589039560|FG002|Overall Study|Serious Adverse Event|0|||
163089704|NCT01948427|589039561|FG003|Overall Study|Serious Adverse Event|0|||
163089705|NCT01948427|589039562|FG004|Overall Study|Serious Adverse Event|1|||
163089706|NCT01948427|589039558|FG000|Overall Study|Investigator Request|0|||
163089707|NCT01948427|589039559|FG001|Overall Study|Investigator Request|8|||
163089708|NCT01948427|589039560|FG002|Overall Study|Investigator Request|0|||
163089709|NCT01948427|589039561|FG003|Overall Study|Investigator Request|0|||
163089710|NCT01948427|589039562|FG004|Overall Study|Investigator Request|6|||
163089711|NCT01948427|589039558|FG000|Overall Study|Lost to Follow-up|1|||
163089712|NCT01948427|589039559|FG001|Overall Study|Lost to Follow-up|0|||
163089713|NCT01948427|589039560|FG002|Overall Study|Lost to Follow-up|0|||
163089714|NCT01948427|589039561|FG003|Overall Study|Lost to Follow-up|0|||
163089715|NCT01948427|589039562|FG004|Overall Study|Lost to Follow-up|4|||
163089716|NCT01948427|589039558|FG000|Overall Study|Withdrawal by Subject|2|||
163089717|NCT01948427|589039559|FG001|Overall Study|Withdrawal by Subject|0|||
163089718|NCT01948427|589039560|FG002|Overall Study|Withdrawal by Subject|0|||
163089719|NCT01948427|589039561|FG003|Overall Study|Withdrawal by Subject|0|||
163089720|NCT01948427|589039562|FG004|Overall Study|Withdrawal by Subject|1|||
163089721|NCT01948427|589039558|FG000|Overall Study|Other, Not Specified|1|||
163089722|NCT01948427|589039559|FG001|Overall Study|Other, Not Specified|9|||
163089723|NCT01948427|589039560|FG002|Overall Study|Other, Not Specified|0|||
163089724|NCT01948427|589039561|FG003|Overall Study|Other, Not Specified|0|||
163089725|NCT01948427|589039562|FG004|Overall Study|Other, Not Specified|2|||
163089726|NCT00256126|589039563|FG000|Overall Study|Adverse Event|1|||
163089727|NCT00256126|589039564|FG001|Overall Study|Adverse Event|0|||
163089728|NCT00256126|589039563|FG000|Overall Study|Other|1|||
163089729|NCT00256126|589039564|FG001|Overall Study|Other|2|||
163089730|NCT02434081|589039565|FG000|Overall Study|Death (never started treatment)|2|||
163089731|NCT02434081|589039565|FG000|Overall Study|Death|2|||
163089732|NCT02434081|589039565|FG000|Overall Study|Progression|20|||
163089733|NCT02434081|589039565|FG000|Overall Study|Adverse Event|20|||
163089734|NCT02434081|589039565|FG000|Overall Study|Physician Decision|2|||
163089735|NCT02434081|589039565|FG000|Overall Study|Withdrawal by Subject|1|||
163089736|NCT02434081|589039565|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
163089737|NCT00854360|589039574|FG000|Overall Study|Adverse Event|0|||
163089738|NCT00854360|589039575|FG001|Overall Study|Adverse Event|1|||
163089739|NCT00854360|589039576|FG002|Overall Study|Adverse Event|2|||
163089740|NCT00854360|589039577|FG003|Overall Study|Adverse Event|6|||
163089741|NCT00854360|589039574|FG000|Overall Study|Withdrawal by Subject|0|||
163089742|NCT00854360|589039575|FG001|Overall Study|Withdrawal by Subject|0|||
163089743|NCT00854360|589039576|FG002|Overall Study|Withdrawal by Subject|0|||
163089744|NCT00854360|589039577|FG003|Overall Study|Withdrawal by Subject|1|||
163089745|NCT00854360|589039574|FG000|Overall Study|Pregnancy|0|||
163089746|NCT00854360|589039575|FG001|Overall Study|Pregnancy|1|||
163089747|NCT00854360|589039576|FG002|Overall Study|Pregnancy|0|||
163089748|NCT00854360|589039577|FG003|Overall Study|Pregnancy|0|||
163089749|NCT00854360|589039574|FG000|Overall Study|Lack of Efficacy|2|||
163089750|NCT00854360|589039575|FG001|Overall Study|Lack of Efficacy|1|||
163089751|NCT00854360|589039576|FG002|Overall Study|Lack of Efficacy|0|||
163089752|NCT00854360|589039577|FG003|Overall Study|Lack of Efficacy|0|||
163089753|NCT00854360|589039574|FG000|Overall Study|Other|0|||
163089754|NCT00854360|589039575|FG001|Overall Study|Other|0|||
163089755|NCT00854360|589039576|FG002|Overall Study|Other|0|||
163089756|NCT00854360|589039577|FG003|Overall Study|Other|3|||
163089757|NCT03435380|589039578|FG000|Overall Study|Death|1|||
163089758|NCT03435380|589039579|FG001|Overall Study|Death|2|||
163089759|NCT03435380|589039580|FG002|Overall Study|Death|1|||
163089760|NCT03435380|589039578|FG000|Overall Study|Lost to Follow-up|12|||
163089761|NCT03435380|589039579|FG001|Overall Study|Lost to Follow-up|8|||
163089762|NCT03435380|589039580|FG002|Overall Study|Lost to Follow-up|6|||
163089763|NCT03435380|589039578|FG000|Overall Study|Physician Decision|1|||
163089764|NCT03435380|589039579|FG001|Overall Study|Physician Decision|0|||
163089765|NCT03435380|589039580|FG002|Overall Study|Physician Decision|0|||
163089766|NCT03435380|589039578|FG000|Overall Study|Withdrawal by Subject|0|||
163089767|NCT03435380|589039579|FG001|Overall Study|Withdrawal by Subject|1|||
163089768|NCT03435380|589039580|FG002|Overall Study|Withdrawal by Subject|1|||
163089769|NCT03435380|589039578|FG000|Overall Study|Ineligible|0|||
163089770|NCT03435380|589039579|FG001|Overall Study|Ineligible|1|||
163089771|NCT03435380|589039580|FG002|Overall Study|Ineligible|1|||
163089772|NCT03218917|589039581|FG000|Overall Study|Adverse Event|3|||
163089773|NCT03218917|589039582|FG001|Overall Study|Adverse Event|3|||
163089774|NCT03218917|589039583|FG002|Overall Study|Adverse Event|2|||
163089775|NCT03218917|589039581|FG000|Overall Study|Subject withdrew consent|2|||
163089776|NCT03218917|589039582|FG001|Overall Study|Subject withdrew consent|4|||
163089777|NCT03218917|589039583|FG002|Overall Study|Subject withdrew consent|10|||
163089778|NCT03218917|589039581|FG000|Overall Study|Physician Decision|0|||
163089779|NCT03218917|589039582|FG001|Overall Study|Physician Decision|1|||
163089780|NCT03218917|589039583|FG002|Overall Study|Physician Decision|1|||
163089781|NCT03218917|589039581|FG000|Overall Study|Lost to Follow-up|1|||
163089782|NCT03218917|589039582|FG001|Overall Study|Lost to Follow-up|0|||
162650349|NCT03252522|587438772|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
162650350|NCT03252522|587438770|FG000|Phase 2: Open Label|Adverse Event|0|||
162650351|NCT03252522|587438771|FG001|Phase 2: Open Label|Adverse Event|0|||
162650352|NCT03252522|587438772|FG002|Phase 2: Open Label|Adverse Event|2|||
162650353|NCT03252522|587438770|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
162650354|NCT03252522|587438771|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
162650355|NCT03252522|587438772|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
162650356|NCT04152447|587438774|FG000|Overall Study|Lost to Follow-up|1|||
162650357|NCT04152447|587438775|FG001|Overall Study|Lost to Follow-up|0|||
162650358|NCT04152447|587438774|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
162650359|NCT04152447|587438775|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
162650360|NCT04152447|587438774|FG000|Overall Study|Withdrawal by Subject|0|||
162650361|NCT04152447|587438775|FG001|Overall Study|Withdrawal by Subject|1|||
162650362|NCT04152447|587438774|FG000|Overall Study|Found ineligible after enrolling|1|||
162650363|NCT04152447|587438775|FG001|Overall Study|Found ineligible after enrolling|1|||
162650364|NCT04152447|587438774|FG000|Overall Study|Did not receive VR headset in time.|0|||
162650365|NCT04152447|587438775|FG001|Overall Study|Did not receive VR headset in time.|2|||
162650366|NCT03240575|587438776|FG000|Overall Study|Adverse Event|0|||
162650367|NCT03240575|587438777|FG001|Overall Study|Adverse Event|2|||
162650368|NCT03240575|587438778|FG002|Overall Study|Adverse Event|0|||
162650369|NCT03240575|587438779|FG003|Overall Study|Adverse Event|1|||
162650370|NCT03240575|587438776|FG000|Overall Study|Withdrawal by Subject|2|||
162650371|NCT03240575|587438777|FG001|Overall Study|Withdrawal by Subject|11|||
162650372|NCT03240575|587438778|FG002|Overall Study|Withdrawal by Subject|0|||
162650373|NCT03240575|587438779|FG003|Overall Study|Withdrawal by Subject|1|||
162650374|NCT03240575|587438776|FG000|Overall Study|Other|0|||
162650375|NCT03240575|587438777|FG001|Overall Study|Other|1|||
162650376|NCT03240575|587438778|FG002|Overall Study|Other|0|||
162650377|NCT03240575|587438779|FG003|Overall Study|Other|0|||
162650378|NCT04482179|587438780|FG000|Overall Study|Death|1|||
162650379|NCT04482179|587438781|FG001|Overall Study|Death|0|||
162650380|NCT04482179|587438780|FG000|Overall Study|Withdrawal by Subject|1|||
162650381|NCT04482179|587438781|FG001|Overall Study|Withdrawal by Subject|0|||
162650382|NCT03034954|587438784|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
162650383|NCT03034954|587438785|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
162650384|NCT03568942|587438788|FG000|Overall Study|Family emergency|1|||
162650385|NCT03568942|587438788|FG000|Overall Study|Lost to Follow-up|1|||
162650386|NCT04145895|587438792|FG000|Overall Study|Physician Decision|2|||
162650387|NCT04145895|587438793|FG001|Overall Study|Physician Decision|0|||
162650388|NCT04145895|587438792|FG000|Overall Study|Withdrawal by Subject|0|||
162650389|NCT04145895|587438793|FG001|Overall Study|Withdrawal by Subject|2|||
162650390|NCT00913744|587438794|FG000|Overall Study|Adverse Event|2|||
162650391|NCT00913744|587438795|FG001|Overall Study|Adverse Event|0|||
162650392|NCT00913744|587438794|FG000|Overall Study|Withdrawal by Subject|2|||
162650393|NCT00913744|587438795|FG001|Overall Study|Withdrawal by Subject|1|||
162650394|NCT00913744|587438794|FG000|Overall Study|Death|1|||
162650395|NCT00913744|587438795|FG001|Overall Study|Death|0|||
162650396|NCT00805935|587438796|FG000|Overall Study|Stimulation Failure|1|||
162650397|NCT00805935|587438797|FG001|Overall Study|Stimulation Failure|5|||
162650398|NCT00805935|587438798|FG002|Overall Study|Stimulation Failure|2|||
162650399|NCT00805935|587438799|FG003|Overall Study|Stimulation Failure|2|||
162650400|NCT00805935|587438796|FG000|Overall Study|Cycle cancelled|0|||
162650401|NCT00805935|587438797|FG001|Overall Study|Cycle cancelled|0|||
162650402|NCT00805935|587438798|FG002|Overall Study|Cycle cancelled|2|||
162650403|NCT00805935|587438799|FG003|Overall Study|Cycle cancelled|0|||
162650404|NCT00805935|587438796|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
163037939|NCT02815267|588845633|FG000|Double-Blind Phase|Protocol Violation|3|||
162650405|NCT00805935|587438797|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
162650406|NCT00805935|587438798|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
162650407|NCT00805935|587438799|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
162650408|NCT00805935|587438796|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162650409|NCT00805935|587438797|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162650410|NCT00805935|587438798|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162650411|NCT00805935|587438799|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
162650412|NCT00805935|587438796|FG000|Overall Study|Lost to Follow-up|1|||
162650413|NCT00805935|587438797|FG001|Overall Study|Lost to Follow-up|0|||
162650414|NCT00805935|587438798|FG002|Overall Study|Lost to Follow-up|0|||
162650415|NCT00805935|587438799|FG003|Overall Study|Lost to Follow-up|0|||
163037940|NCT02815267|588845634|FG001|Double-Blind Phase|Protocol Violation|2|||
163037941|NCT02815267|588845633|FG000|Double-Blind Phase|Site withdrawal|1|||
163037942|NCT02815267|588845634|FG001|Double-Blind Phase|Site withdrawal|6|||
163037943|NCT02815267|588845633|FG000|Double-Blind Phase|Received a disallowed medication|1|||
163037944|NCT02815267|588845634|FG001|Double-Blind Phase|Received a disallowed medication|1|||
163037945|NCT02815267|588845633|FG000|Open-Label Phase|Adverse Event|1|||
163037946|NCT02815267|588845634|FG001|Open-Label Phase|Adverse Event|1|||
163037947|NCT02815267|588845633|FG000|Open-Label Phase|Lost to Follow-up|23|||
162650416|NCT00805935|587438796|FG000|Overall Study|No positive serum pregnancy|8|||
162650417|NCT00805935|587438797|FG001|Overall Study|No positive serum pregnancy|7|||
162650418|NCT00805935|587438798|FG002|Overall Study|No positive serum pregnancy|6|||
162650419|NCT00805935|587438799|FG003|Overall Study|No positive serum pregnancy|5|||
162650420|NCT00805935|587438796|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162650421|NCT00805935|587438797|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162650422|NCT00805935|587438798|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162650423|NCT00805935|587438799|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
162650424|NCT00805935|587438796|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
162650425|NCT00805935|587438797|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
162650426|NCT00805935|587438798|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
162650427|NCT00805935|587438799|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
162650428|NCT00805935|587438796|FG000|Overall Study|Biochemical pregnancy|0|||
162650429|NCT00805935|587438797|FG001|Overall Study|Biochemical pregnancy|1|||
162650430|NCT00805935|587438798|FG002|Overall Study|Biochemical pregnancy|0|||
162650431|NCT00805935|587438799|FG003|Overall Study|Biochemical pregnancy|0|||
162650432|NCT00805935|587438796|FG000|Overall Study|Chemical pregnancy|0|||
162650433|NCT00805935|587438797|FG001|Overall Study|Chemical pregnancy|5|||
162650434|NCT00805935|587438798|FG002|Overall Study|Chemical pregnancy|3|||
162650435|NCT00805935|587438799|FG003|Overall Study|Chemical pregnancy|2|||
163089783|NCT03218917|589039583|FG002|Overall Study|Lost to Follow-up|0|||
163089784|NCT03218917|589039581|FG000|Overall Study|Reason Missing|0|||
163089785|NCT03218917|589039582|FG001|Overall Study|Reason Missing|2|||
163089786|NCT03218917|589039583|FG002|Overall Study|Reason Missing|0|||
163089787|NCT03218917|589039581|FG000|Overall Study|Death|0|||
163089788|NCT03218917|589039582|FG001|Overall Study|Death|1|||
163089789|NCT03218917|589039583|FG002|Overall Study|Death|0|||
163089790|NCT03218917|589039581|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163089791|NCT03218917|589039582|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163089792|NCT03218917|589039583|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163089793|NCT01908140|589039584|FG000|Overall Study|Other or Progressive Disease|5|||
163089794|NCT01908140|589039585|FG001|Overall Study|Other or Progressive Disease|12|||
163089795|NCT01908140|589039584|FG000|Overall Study|Lack of Efficacy|7|||
163089796|NCT01908140|589039585|FG001|Overall Study|Lack of Efficacy|5|||
163089797|NCT01908140|589039584|FG000|Overall Study|Withdrawal by Subject|23|||
163089798|NCT01908140|589039585|FG001|Overall Study|Withdrawal by Subject|24|||
163089799|NCT01908140|589039584|FG000|Overall Study|Lost to Follow-up|1|||
163089800|NCT01908140|589039585|FG001|Overall Study|Lost to Follow-up|6|||
163089801|NCT01908140|589039584|FG000|Overall Study|Protocol Violation|8|||
163089802|NCT01908140|589039585|FG001|Overall Study|Protocol Violation|9|||
163089803|NCT01908140|589039584|FG000|Overall Study|Adverse Event|22|||
163089804|NCT01908140|589039585|FG001|Overall Study|Adverse Event|23|||
163089805|NCT02581891|589039590|FG000|Overall Study|Adverse Event|4|||
163089806|NCT02581891|589039591|FG001|Overall Study|Adverse Event|6|||
163089807|NCT02581891|589039590|FG000|Overall Study|Death|3|||
163089808|NCT02581891|589039591|FG001|Overall Study|Death|4|||
163089809|NCT02581891|589039590|FG000|Overall Study|Lost to Follow-up|1|||
163089810|NCT02581891|589039591|FG001|Overall Study|Lost to Follow-up|2|||
163089811|NCT02581891|589039590|FG000|Overall Study|Physician Decision|0|||
163089812|NCT02581891|589039591|FG001|Overall Study|Physician Decision|1|||
163089813|NCT02581891|589039590|FG000|Overall Study|Withdrawal by Subject|4|||
163089814|NCT02581891|589039591|FG001|Overall Study|Withdrawal by Subject|5|||
163089815|NCT02581891|589039590|FG000|Overall Study|Other Reasons|3|||
163089816|NCT02581891|589039591|FG001|Overall Study|Other Reasons|1|||
163089817|NCT02581891|589039590|FG000|Overall Study|Discontinued during followup|1|||
162650436|NCT00805935|587438796|FG000|Overall Study|Ectopic pregnancy|0|||
162650437|NCT00805935|587438797|FG001|Overall Study|Ectopic pregnancy|0|||
162650438|NCT00805935|587438798|FG002|Overall Study|Ectopic pregnancy|1|||
162650439|NCT00805935|587438799|FG003|Overall Study|Ectopic pregnancy|0|||
162650440|NCT00805935|587438796|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162650441|NCT00805935|587438797|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
162650442|NCT00805935|587438798|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162650443|NCT00805935|587438799|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162650444|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
163089818|NCT02581891|589039591|FG001|Overall Study|Discontinued during followup|0|||
163089819|NCT01076010|589039592|FG000|Overall Study|Death|15|||
163089820|NCT01076010|589039593|FG001|Overall Study|Death|1|||
163089821|NCT01076010|589039594|FG002|Overall Study|Death|0|||
163089822|NCT01076010|589039592|FG000|Overall Study|Adverse Event|7|||
163089823|NCT01076010|589039593|FG001|Overall Study|Adverse Event|2|||
163089824|NCT01076010|589039594|FG002|Overall Study|Adverse Event|0|||
163089825|NCT01076010|589039592|FG000|Overall Study|Progressive disease|90|||
163089826|NCT01076010|589039593|FG001|Overall Study|Progressive disease|30|||
163089827|NCT01076010|589039594|FG002|Overall Study|Progressive disease|1|||
163089828|NCT01076010|589039592|FG000|Overall Study|Lack of Efficacy|4|||
163089829|NCT01076010|589039593|FG001|Overall Study|Lack of Efficacy|0|||
163089830|NCT01076010|589039594|FG002|Overall Study|Lack of Efficacy|0|||
163089831|NCT01076010|589039592|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
163089832|NCT01076010|589039593|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
163089833|NCT01076010|589039594|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
163089834|NCT01076010|589039592|FG000|Overall Study|Significant Surgical Procedure|0|||
163089835|NCT01076010|589039593|FG001|Overall Study|Significant Surgical Procedure|1|||
163089836|NCT01076010|589039594|FG002|Overall Study|Significant Surgical Procedure|0|||
163089837|NCT01076010|589039592|FG000|Overall Study|Protocol Violation|0|||
163089838|NCT01076010|589039593|FG001|Overall Study|Protocol Violation|1|||
163089839|NCT01076010|589039594|FG002|Overall Study|Protocol Violation|0|||
163089840|NCT01076010|589039592|FG000|Overall Study|Noncompliance|1|||
163089841|NCT01076010|589039593|FG001|Overall Study|Noncompliance|1|||
163089842|NCT01076010|589039594|FG002|Overall Study|Noncompliance|0|||
163089843|NCT01076010|589039592|FG000|Overall Study|Withdrawal by Subject|3|||
163089844|NCT01076010|589039593|FG001|Overall Study|Withdrawal by Subject|0|||
163089845|NCT01076010|589039594|FG002|Overall Study|Withdrawal by Subject|1|||
163089846|NCT01076010|589039592|FG000|Overall Study|Other|5|||
163089847|NCT01076010|589039593|FG001|Overall Study|Other|2|||
163089848|NCT01076010|589039594|FG002|Overall Study|Other|0|||
163089849|NCT01612676|589039595|FG000|Overall Study|Adverse Event|2|||
163089850|NCT01612676|589039596|FG001|Overall Study|Adverse Event|3|||
163089851|NCT01612676|589039597|FG002|Overall Study|Adverse Event|1|||
163089852|NCT01612676|589039598|FG003|Overall Study|Adverse Event|3|||
163089853|NCT01612676|589039595|FG000|Overall Study|Protocol Violation|0|||
163089854|NCT01612676|589039596|FG001|Overall Study|Protocol Violation|1|||
163089855|NCT01612676|589039597|FG002|Overall Study|Protocol Violation|0|||
163089856|NCT01612676|589039598|FG003|Overall Study|Protocol Violation|0|||
163089857|NCT00181844|589039605|FG000|Signed Consent|Withdrawal by Subject|5|||
163089858|NCT00181844|589039605|FG000|Signed Consent|Did not meet entrance criteria|7|||
163089859|NCT00181844|589039605|FG000|Exposed to Study Medication|Adverse Event|10|||
163089860|NCT00181844|589039605|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
163089861|NCT00181844|589039605|FG000|Exposed to Study Medication|Non-compliance|2|||
163089862|NCT00181844|589039605|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
163089863|NCT00181844|589039605|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
163089864|NCT01959932|589039609|FG000|Overall Study|Withdrawal by Subject|1|||
163089865|NCT01959932|589039610|FG001|Overall Study|Withdrawal by Subject|0|||
163089866|NCT01959932|589039611|FG002|Overall Study|Withdrawal by Subject|0|||
163089867|NCT00397540|589039612|FG000|Overall Study|short follow-up duration < 12 months|1|||
163089868|NCT00397540|589039613|FG001|Overall Study|short follow-up duration < 12 months|0|||
163089869|NCT00060944|589039616|FG000|Overall Study|Adverse Event|12|||
163089870|NCT00060944|589039617|FG001|Overall Study|Adverse Event|10|||
163089871|NCT00060944|589039616|FG000|Overall Study|Death|2|||
163089872|NCT00060944|589039617|FG001|Overall Study|Death|3|||
163089873|NCT00060944|589039616|FG000|Overall Study|Withdrawal by Subject|18|||
163089874|NCT00060944|589039617|FG001|Overall Study|Withdrawal by Subject|5|||
163089875|NCT00060944|589039616|FG000|Overall Study|Disease Progression|93|||
163089876|NCT00060944|589039617|FG001|Overall Study|Disease Progression|94|||
163089877|NCT00060944|589039616|FG000|Overall Study|Lost to Follow-up|1|||
163089878|NCT00060944|589039617|FG001|Overall Study|Lost to Follow-up|0|||
163089879|NCT00060944|589039616|FG000|Overall Study|Subject Ineligible To Continue|2|||
163089880|NCT00060944|589039617|FG001|Overall Study|Subject Ineligible To Continue|1|||
163089881|NCT00060944|589039616|FG000|Overall Study|Treatment Switch|0|||
163089882|NCT00060944|589039617|FG001|Overall Study|Treatment Switch|13|||
163089883|NCT00060944|589039616|FG000|Overall Study|Other|2|||
163089884|NCT00060944|589039617|FG001|Overall Study|Other|4|||
163089885|NCT00060944|589039616|FG000|Overall Study|randomized but not treated|6|||
163089886|NCT00060944|589039617|FG001|Overall Study|randomized but not treated|4|||
163089887|NCT00776230|589039622|FG000|Overall Study|Lost to Follow-up|2|||
163089888|NCT00776230|589039623|FG001|Overall Study|Lost to Follow-up|1|||
163089889|NCT00776230|589039624|FG002|Overall Study|Lost to Follow-up|5|||
163089890|NCT00776230|589039622|FG000|Overall Study|Not vaccinated at Day 0|1|||
163089891|NCT00776230|589039623|FG001|Overall Study|Not vaccinated at Day 0|0|||
163089892|NCT00776230|589039624|FG002|Overall Study|Not vaccinated at Day 0|0|||
163089893|NCT00776230|589039622|FG000|Overall Study|Withdrawal by Subject|0|||
163089894|NCT00776230|589039623|FG001|Overall Study|Withdrawal by Subject|1|||
163089895|NCT00776230|589039624|FG002|Overall Study|Withdrawal by Subject|0|||
163089896|NCT00776230|589039622|FG000|Overall Study|Subject missed Visit 4|0|||
163089897|NCT00776230|589039623|FG001|Overall Study|Subject missed Visit 4|1|||
163089898|NCT00776230|589039624|FG002|Overall Study|Subject missed Visit 4|0|||
163089899|NCT01215851|589039625|FG000|Treatment Period|Adverse Event|1|||
163089900|NCT01215851|589039626|FG001|Treatment Period|Adverse Event|1|||
163089901|NCT01215851|589039627|FG002|Treatment Period|Adverse Event|1|||
163089902|NCT01215851|589039628|FG003|Treatment Period|Adverse Event|3|||
163089903|NCT01215851|589039629|FG004|Treatment Period|Adverse Event|0|||
163089904|NCT01215851|589039630|FG005|Treatment Period|Adverse Event|1|||
163089905|NCT01215851|589039625|FG000|Follow up Period|Lost to Follow-up|0|||
163089906|NCT01215851|589039626|FG001|Follow up Period|Lost to Follow-up|0|||
163089907|NCT01215851|589039627|FG002|Follow up Period|Lost to Follow-up|0|||
163089908|NCT01215851|589039628|FG003|Follow up Period|Lost to Follow-up|0|||
163089909|NCT01215851|589039629|FG004|Follow up Period|Lost to Follow-up|0|||
163089910|NCT01215851|589039630|FG005|Follow up Period|Lost to Follow-up|1|||
163089911|NCT03961308|589039631|FG000|Overall Study|Withdrawal by Subject|1|||
163089912|NCT03961308|589039632|FG001|Overall Study|Withdrawal by Subject|0|||
163089913|NCT03961308|589039631|FG000|Overall Study|Other|1|||
163089914|NCT03961308|589039632|FG001|Overall Study|Other|0|||
163089915|NCT03961308|589039631|FG000|Overall Study|Lost to Follow-up|0|||
163089916|NCT03961308|589039632|FG001|Overall Study|Lost to Follow-up|1|||
163089917|NCT03961308|589039631|FG000|Overall Study|Adverse Event|0|||
163089918|NCT03961308|589039632|FG001|Overall Study|Adverse Event|1|||
163089919|NCT02297412|589039638|FG000|Overall Study|Canceled|1|||
163089920|NCT02297412|589039639|FG001|Overall Study|Canceled|1|||
163089921|NCT04549454|589039645|FG000|T1 to T2|Lost to Follow-up|22|||
163089922|NCT04549454|589039646|FG001|T1 to T2|Lost to Follow-up|26|||
163089923|NCT04549454|589039645|FG000|T1 to T3|Lost to Follow-up|31|||
163089924|NCT04549454|589039646|FG001|T1 to T3|Lost to Follow-up|36|||
163089925|NCT01355627|589039652|FG000|Overall Study|Request By the Patient to Discontinue|5|||
163089926|NCT01355627|589039653|FG001|Overall Study|Request By the Patient to Discontinue|7|||
163089927|NCT01355627|589039652|FG000|Overall Study|Lost to Follow-up|8|||
163089928|NCT01355627|589039653|FG001|Overall Study|Lost to Follow-up|7|||
163089929|NCT01355627|589039652|FG000|Overall Study|Fatal Adverse Event|19|||
163089930|NCT01355627|589039653|FG001|Overall Study|Fatal Adverse Event|23|||
163089931|NCT01355627|589039652|FG000|Overall Study|Other|1|||
163089932|NCT01355627|589039653|FG001|Overall Study|Other|1|||
163089933|NCT00545779|589039656|FG000|Overall Study|Violation of selection criteria at entry|8|||
163089934|NCT00545779|589039656|FG000|Overall Study|Other protocol violation|1|||
163089935|NCT00545779|589039656|FG000|Overall Study|Did not cooperate|7|||
163089936|NCT00545779|589039656|FG000|Overall Study|Withdrawal by Subject|20|||
163089937|NCT00545779|589039656|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
163089938|NCT00545779|589039656|FG000|Overall Study|Failure to return|3|||
163089939|NCT01405196|589039657|FG000|Overall Study|Study Terminated by Sponsor|0|||
163089940|NCT01405196|589039658|FG001|Overall Study|Study Terminated by Sponsor|0|||
163089941|NCT01405196|589039659|FG002|Overall Study|Study Terminated by Sponsor|9|||
163089942|NCT01405196|589039660|FG003|Overall Study|Study Terminated by Sponsor|0|||
163089943|NCT01405196|589039657|FG000|Overall Study|Other|2|||
163089944|NCT01405196|589039658|FG001|Overall Study|Other|2|||
163089945|NCT01405196|589039659|FG002|Overall Study|Other|5|||
163089946|NCT01405196|589039660|FG003|Overall Study|Other|0|||
163089947|NCT01405196|589039657|FG000|Overall Study|Withdrawal by Subject|4|||
163089948|NCT01405196|589039658|FG001|Overall Study|Withdrawal by Subject|6|||
163089949|NCT01405196|589039659|FG002|Overall Study|Withdrawal by Subject|3|||
163089950|NCT01405196|589039660|FG003|Overall Study|Withdrawal by Subject|6|||
163089951|NCT01405196|589039657|FG000|Overall Study|Adverse Event|2|||
163089952|NCT01405196|589039658|FG001|Overall Study|Adverse Event|2|||
163089953|NCT01405196|589039659|FG002|Overall Study|Adverse Event|0|||
163089954|NCT01405196|589039660|FG003|Overall Study|Adverse Event|2|||
163089955|NCT01405196|589039657|FG000|Overall Study|Death|1|||
163089956|NCT01405196|589039658|FG001|Overall Study|Death|0|||
163089957|NCT01405196|589039659|FG002|Overall Study|Death|3|||
163089958|NCT01405196|589039660|FG003|Overall Study|Death|0|||
163089959|NCT01405196|589039657|FG000|Overall Study|Lost to Follow-up|2|||
163089960|NCT01405196|589039658|FG001|Overall Study|Lost to Follow-up|2|||
163089961|NCT01405196|589039659|FG002|Overall Study|Lost to Follow-up|3|||
163089962|NCT01405196|589039660|FG003|Overall Study|Lost to Follow-up|1|||
163089963|NCT01542788|589039661|FG000|Overall Study|Randomized but Not Treated|2|||
163089964|NCT01542788|589039662|FG001|Overall Study|Randomized but Not Treated|0|||
163089965|NCT01542788|589039661|FG000|Overall Study|Lack of Efficacy|41|||
163089966|NCT01542788|589039662|FG001|Overall Study|Lack of Efficacy|71|||
163089967|NCT01542788|589039661|FG000|Overall Study|Lost to Follow-up|5|||
163089968|NCT01542788|589039662|FG001|Overall Study|Lost to Follow-up|0|||
163089969|NCT01542788|589039661|FG000|Overall Study|Death|3|||
163089970|NCT01542788|589039662|FG001|Overall Study|Death|0|||
163089971|NCT01542788|589039661|FG000|Overall Study|Protocol Violation|2|||
163089972|NCT01542788|589039662|FG001|Overall Study|Protocol Violation|0|||
163089973|NCT01542788|589039661|FG000|Overall Study|Physician Decision|1|||
163089974|NCT01542788|589039662|FG001|Overall Study|Physician Decision|0|||
163089975|NCT01542788|589039661|FG000|Overall Study|Withdrawal by Subject|1|||
163089976|NCT01542788|589039662|FG001|Overall Study|Withdrawal by Subject|0|||
163089977|NCT01400412|589039663|FG000|Overall Study|Lost to Follow-up|4|||
163089978|NCT01400412|589039664|FG001|Overall Study|Lost to Follow-up|7|||
163089979|NCT01400412|589039663|FG000|Overall Study|Withdrawal by Subject|3|||
163089980|NCT01400412|589039664|FG001|Overall Study|Withdrawal by Subject|4|||
163089981|NCT01400412|589039663|FG000|Overall Study|Unable to complete|3|||
163089982|NCT01400412|589039664|FG001|Overall Study|Unable to complete|3|||
162650445|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
162650446|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
162650447|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
162650448|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162650449|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
162650450|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162650451|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162650452|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
162650453|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
162650454|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
162650455|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
162650456|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
162650457|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162650458|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162650459|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162650460|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
162650461|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
162650462|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
162650463|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
162650464|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162650465|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
162650466|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162650467|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162650468|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162650469|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
162650470|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162650471|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162650472|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162650473|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
162650474|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162650475|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162650476|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
162650477|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
162650478|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
162650479|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
163089983|NCT01400412|589039663|FG000|Overall Study|Never started study treatment|0|||
163089984|NCT01400412|589039664|FG001|Overall Study|Never started study treatment|3|||
163089985|NCT01649869|589039665|FG000|Overall Study|Family member illness|1|||
163089986|NCT01649869|589039666|FG001|Overall Study|Family member illness|0|||
163089987|NCT01649869|589039665|FG000|Overall Study|Required treatment outside protocol|1|||
163089988|NCT01649869|589039666|FG001|Overall Study|Required treatment outside protocol|0|||
163089989|NCT01649869|589039665|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
163089990|NCT01649869|589039666|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
163089991|NCT01126190|589041018|FG000|Double-Blind Phase|Death|0|||
163089992|NCT01126190|589041019|FG001|Double-Blind Phase|Death|1|||
163089993|NCT01126190|589041020|FG002|Double-Blind Phase|Death|0|||
163089994|NCT01126190|589041018|FG000|Double-Blind Phase|Adverse Event|1|||
163089995|NCT01126190|589041019|FG001|Double-Blind Phase|Adverse Event|2|||
163089996|NCT01126190|589041020|FG002|Double-Blind Phase|Adverse Event|0|||
163089997|NCT01126190|589041018|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163089998|NCT01126190|589041019|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
163089999|NCT01126190|589041020|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163090000|NCT01126190|589041018|FG000|Double-Blind Phase|Request of Investigator|1|||
163090001|NCT01126190|589041019|FG001|Double-Blind Phase|Request of Investigator|0|||
163090002|NCT01126190|589041020|FG002|Double-Blind Phase|Request of Investigator|0|||
163090003|NCT01126190|589041018|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
163090004|NCT01126190|589041019|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
163090005|NCT01126190|589041020|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
163090006|NCT01126190|589041018|FG000|Double-Blind Phase|Non-compliance|1|||
163090007|NCT01126190|589041019|FG001|Double-Blind Phase|Non-compliance|0|||
163090008|NCT01126190|589041020|FG002|Double-Blind Phase|Non-compliance|0|||
163090009|NCT01126190|589041018|FG000|Double-Blind Phase|Lost to Follow-up|1|||
163090010|NCT01126190|589041019|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162650480|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
162650481|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
162650482|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
163090011|NCT01126190|589041020|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163090012|NCT01126190|589041018|FG000|Open-Label Phase|Death|0|||
163090013|NCT01126190|589041019|FG001|Open-Label Phase|Death|0|||
163090014|NCT01126190|589041020|FG002|Open-Label Phase|Death|1|||
163090015|NCT01126190|589041018|FG000|Open-Label Phase|Adverse Event|0|||
163090016|NCT01126190|589041019|FG001|Open-Label Phase|Adverse Event|0|||
163090017|NCT01126190|589041020|FG002|Open-Label Phase|Adverse Event|4|||
163090018|NCT01126190|589041018|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163090019|NCT01126190|589041019|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163090020|NCT01126190|589041020|FG002|Open-Label Phase|Withdrawal by Subject|6|||
163090021|NCT01977898|589041021|FG000|Overall Study|Non functioning catheter|1|||
163090022|NCT01977898|589041022|FG001|Overall Study|Non functioning catheter|1|||
163090023|NCT03386773|589041023|FG000|Overall Study|Lost to Follow-up|24|||
163090024|NCT03386773|589041024|FG001|Overall Study|Lost to Follow-up|33|||
163090025|NCT03386773|589041023|FG000|Overall Study|Withdrawal by Subject|3|||
163090026|NCT03386773|589041024|FG001|Overall Study|Withdrawal by Subject|2|||
163090027|NCT01049373|589041025|FG000|Overall Study|Protocol Violation|9|||
163090028|NCT01049373|589041026|FG001|Overall Study|Protocol Violation|9|||
163090029|NCT01049373|589041025|FG000|Overall Study|Withdrawal by Subject|8|||
163090030|NCT01049373|589041026|FG001|Overall Study|Withdrawal by Subject|5|||
163090031|NCT01049373|589041025|FG000|Overall Study|Adverse Event|3|||
163090032|NCT01049373|589041026|FG001|Overall Study|Adverse Event|3|||
163090033|NCT01049373|589041025|FG000|Overall Study|Lost to Follow-up|9|||
163090034|NCT01049373|589041026|FG001|Overall Study|Lost to Follow-up|4|||
163090035|NCT01049373|589041025|FG000|Overall Study|no evaluable study values|9|||
163090036|NCT01049373|589041026|FG001|Overall Study|no evaluable study values|21|||
163090037|NCT01049373|589041025|FG000|Overall Study|Other|1|||
163090038|NCT01049373|589041026|FG001|Overall Study|Other|1|||
163090039|NCT01049373|589041025|FG000|Overall Study|Non-cooperation|0|||
163090040|NCT01049373|589041026|FG001|Overall Study|Non-cooperation|1|||
163090041|NCT04573972|589041027|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
163090042|NCT04573972|589041028|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
163090043|NCT01198587|589041031|FG000|Overall Study|Lost to Follow-up|8|||
163090044|NCT01198587|589041032|FG001|Overall Study|Lost to Follow-up|0|||
163090045|NCT01198587|589041033|FG002|Overall Study|Lost to Follow-up|9|||
163090046|NCT01198587|589041034|FG003|Overall Study|Lost to Follow-up|0|||
163090047|NCT03036852|589041037|FG000|Overall Study|Death|2|||
163090048|NCT03036852|589041037|FG000|Overall Study|Lack of Efficacy|2|||
163090049|NCT03036852|589041037|FG000|Overall Study|Adverse Event|1|||
163090050|NCT03036852|589041037|FG000|Overall Study|Lost to Follow-up|1|||
163090051|NCT03984825|589041038|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
163090052|NCT03984825|589041038|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
163090053|NCT03984825|589041038|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
163090054|NCT00622726|589041039|FG000|March, 2008 to August, 2010|Death|5|||
163090055|NCT00622726|589041040|FG001|March, 2008 to August, 2010|Death|2|||
163090056|NCT00622726|589041039|FG000|August, 2010 to April, 2013|Death|1|||
163090057|NCT00622726|589041040|FG001|August, 2010 to April, 2013|Death|5|||
163090058|NCT00742625|589041041|FG000|Remission Induction|Progression|6|||
163090059|NCT00742625|589041041|FG000|Remission Induction|Failed induction|8|||
163090060|NCT00742625|589041041|FG000|Remission Induction|Adverse Event|3|||
163090061|NCT00742625|589041041|FG000|Remission Induction|Death|10|||
163090062|NCT00742625|589041041|FG000|Remission Induction|Refusal|5|||
163090063|NCT00742625|589041041|FG000|Remission Induction|Non protocol treatment|17|||
163090064|NCT00742625|589041041|FG000|Remission Induction|Other, not specified|5|||
163090065|NCT00742625|589041041|FG000|Consolidation|Progression|5|||
163090066|NCT00742625|589041041|FG000|Consolidation|Adverse Event|1|||
163090067|NCT00742625|589041041|FG000|Consolidation|Death|1|||
163090068|NCT00742625|589041041|FG000|Consolidation|Refused|1|||
163090069|NCT00742625|589041041|FG000|Consolidation|Non protocol therapy|13|||
163090070|NCT01865487|589041042|FG000|Overall Study|Lost to Follow-up|0|||
163090071|NCT01865487|589041043|FG001|Overall Study|Lost to Follow-up|0|||
162650483|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
163090072|NCT01865487|589041044|FG002|Overall Study|Lost to Follow-up|0|||
163090073|NCT01865487|589041045|FG003|Overall Study|Lost to Follow-up|1|||
163090074|NCT01865487|589041046|FG004|Overall Study|Lost to Follow-up|0|||
163090075|NCT01865487|589041047|FG005|Overall Study|Lost to Follow-up|0|||
163090076|NCT01865487|589041048|FG006|Overall Study|Lost to Follow-up|1|||
163090077|NCT01865487|589041049|FG007|Overall Study|Lost to Follow-up|0|||
163090078|NCT01865487|589041050|FG008|Overall Study|Lost to Follow-up|0|||
163090079|NCT01865487|589041051|FG009|Overall Study|Lost to Follow-up|0|||
163090080|NCT01865487|589041042|FG000|Overall Study|Withdrawal by Subject|0|||
163090081|NCT01865487|589041043|FG001|Overall Study|Withdrawal by Subject|0|||
163090082|NCT01865487|589041044|FG002|Overall Study|Withdrawal by Subject|0|||
163090083|NCT01865487|589041045|FG003|Overall Study|Withdrawal by Subject|0|||
163090084|NCT01865487|589041046|FG004|Overall Study|Withdrawal by Subject|1|||
163090085|NCT01865487|589041047|FG005|Overall Study|Withdrawal by Subject|0|||
163090086|NCT01865487|589041048|FG006|Overall Study|Withdrawal by Subject|0|||
162718724|NCT01235949|587676688|FG008|Primary Phase|Migrated/moved from study area|0|||
162718725|NCT01235949|587676689|FG009|Primary Phase|Migrated/moved from study area|0|||
162718726|NCT01235949|587676690|FG010|Primary Phase|Migrated/moved from study area|0|||
162718727|NCT01235949|587676691|FG011|Primary Phase|Migrated/moved from study area|0|||
162718728|NCT01235949|587676692|FG012|Primary Phase|Migrated/moved from study area|0|||
162718729|NCT01235949|587676693|FG013|Primary Phase|Migrated/moved from study area|0|||
162718730|NCT01235949|587676694|FG014|Primary Phase|Migrated/moved from study area|0|||
162718731|NCT01235949|587676695|FG015|Primary Phase|Migrated/moved from study area|0|||
162718732|NCT01235949|587676696|FG016|Primary Phase|Migrated/moved from study area|0|||
162718733|NCT01235949|587676697|FG017|Primary Phase|Migrated/moved from study area|0|||
162718734|NCT01235949|587676680|FG000|Primary Phase|Adverse Event|0|||
162718735|NCT01235949|587676681|FG001|Primary Phase|Adverse Event|0|||
162718736|NCT01235949|587676682|FG002|Primary Phase|Adverse Event|0|||
162718737|NCT01235949|587676683|FG003|Primary Phase|Adverse Event|1|||
162718738|NCT01235949|587676684|FG004|Primary Phase|Adverse Event|0|||
162718739|NCT01235949|587676685|FG005|Primary Phase|Adverse Event|0|||
162718740|NCT01235949|587676686|FG006|Primary Phase|Adverse Event|0|||
162718741|NCT01235949|587676687|FG007|Primary Phase|Adverse Event|0|||
162718742|NCT01235949|587676688|FG008|Primary Phase|Adverse Event|0|||
162718743|NCT01235949|587676689|FG009|Primary Phase|Adverse Event|0|||
162718744|NCT01235949|587676690|FG010|Primary Phase|Adverse Event|0|||
162718745|NCT01235949|587676691|FG011|Primary Phase|Adverse Event|0|||
162718746|NCT01235949|587676692|FG012|Primary Phase|Adverse Event|0|||
162718747|NCT01235949|587676693|FG013|Primary Phase|Adverse Event|0|||
162718748|NCT01235949|587676694|FG014|Primary Phase|Adverse Event|0|||
162718749|NCT01235949|587676695|FG015|Primary Phase|Adverse Event|0|||
162718750|NCT01235949|587676696|FG016|Primary Phase|Adverse Event|0|||
162718751|NCT01235949|587676697|FG017|Primary Phase|Adverse Event|0|||
162718752|NCT01235949|587676680|FG000|Primary Phase|Withdrawal by Subject|3|||
162718753|NCT01235949|587676681|FG001|Primary Phase|Withdrawal by Subject|2|||
162718754|NCT01235949|587676682|FG002|Primary Phase|Withdrawal by Subject|2|||
162718755|NCT01235949|587676683|FG003|Primary Phase|Withdrawal by Subject|0|||
162718756|NCT01235949|587676684|FG004|Primary Phase|Withdrawal by Subject|0|||
162718757|NCT01235949|587676685|FG005|Primary Phase|Withdrawal by Subject|3|||
162718758|NCT01235949|587676686|FG006|Primary Phase|Withdrawal by Subject|0|||
162718759|NCT01235949|587676687|FG007|Primary Phase|Withdrawal by Subject|0|||
162718760|NCT01235949|587676688|FG008|Primary Phase|Withdrawal by Subject|0|||
162718761|NCT01235949|587676689|FG009|Primary Phase|Withdrawal by Subject|0|||
162718762|NCT01235949|587676690|FG010|Primary Phase|Withdrawal by Subject|0|||
162718763|NCT01235949|587676691|FG011|Primary Phase|Withdrawal by Subject|0|||
162718764|NCT01235949|587676692|FG012|Primary Phase|Withdrawal by Subject|0|||
162718765|NCT01235949|587676693|FG013|Primary Phase|Withdrawal by Subject|0|||
162718766|NCT01235949|587676694|FG014|Primary Phase|Withdrawal by Subject|0|||
162718767|NCT01235949|587676695|FG015|Primary Phase|Withdrawal by Subject|0|||
162718768|NCT01235949|587676696|FG016|Primary Phase|Withdrawal by Subject|0|||
162718769|NCT01235949|587676697|FG017|Primary Phase|Withdrawal by Subject|0|||
162718770|NCT01235949|587676680|FG000|Primary Phase|Lost to Follow-up|0|||
162718771|NCT01235949|587676681|FG001|Primary Phase|Lost to Follow-up|0|||
162718772|NCT01235949|587676682|FG002|Primary Phase|Lost to Follow-up|1|||
162718773|NCT01235949|587676683|FG003|Primary Phase|Lost to Follow-up|1|||
162718774|NCT01235949|587676684|FG004|Primary Phase|Lost to Follow-up|0|||
162718775|NCT01235949|587676685|FG005|Primary Phase|Lost to Follow-up|2|||
162718776|NCT01235949|587676686|FG006|Primary Phase|Lost to Follow-up|0|||
162718777|NCT01235949|587676687|FG007|Primary Phase|Lost to Follow-up|0|||
162718778|NCT01235949|587676688|FG008|Primary Phase|Lost to Follow-up|0|||
162718779|NCT01235949|587676689|FG009|Primary Phase|Lost to Follow-up|0|||
162718780|NCT01235949|587676690|FG010|Primary Phase|Lost to Follow-up|0|||
162718781|NCT01235949|587676691|FG011|Primary Phase|Lost to Follow-up|0|||
162718782|NCT01235949|587676692|FG012|Primary Phase|Lost to Follow-up|0|||
162718783|NCT01235949|587676693|FG013|Primary Phase|Lost to Follow-up|0|||
162718784|NCT01235949|587676694|FG014|Primary Phase|Lost to Follow-up|0|||
162718785|NCT01235949|587676695|FG015|Primary Phase|Lost to Follow-up|0|||
162718786|NCT01235949|587676696|FG016|Primary Phase|Lost to Follow-up|0|||
162718787|NCT01235949|587676697|FG017|Primary Phase|Lost to Follow-up|0|||
162718788|NCT01235949|587676680|FG000|Booster Phase|Migrated/moved from study area|0|||
162718789|NCT01235949|587676681|FG001|Booster Phase|Migrated/moved from study area|0|||
163037948|NCT02815267|588845634|FG001|Open-Label Phase|Lost to Follow-up|9|||
162718790|NCT01235949|587676682|FG002|Booster Phase|Migrated/moved from study area|0|||
162718791|NCT01235949|587676683|FG003|Booster Phase|Migrated/moved from study area|0|||
162718792|NCT01235949|587676684|FG004|Booster Phase|Migrated/moved from study area|0|||
162718793|NCT01235949|587676685|FG005|Booster Phase|Migrated/moved from study area|0|||
162718794|NCT01235949|587676686|FG006|Booster Phase|Migrated/moved from study area|0|||
162718795|NCT01235949|587676687|FG007|Booster Phase|Migrated/moved from study area|0|||
162718796|NCT01235949|587676688|FG008|Booster Phase|Migrated/moved from study area|0|||
162718797|NCT01235949|587676689|FG009|Booster Phase|Migrated/moved from study area|0|||
163037949|NCT02815267|588845633|FG000|Open-Label Phase|Withdrawal by Subject|24|||
163090087|NCT01865487|589041049|FG007|Overall Study|Withdrawal by Subject|0|||
163090088|NCT01865487|589041050|FG008|Overall Study|Withdrawal by Subject|0|||
163090089|NCT01865487|589041051|FG009|Overall Study|Withdrawal by Subject|0|||
163090090|NCT01627691|589041052|FG000|Overall Study|Death|11|||
163090091|NCT01627691|589041052|FG000|Overall Study|Lost to Follow-up|3|||
163090092|NCT01627691|589041052|FG000|Overall Study|Withdrawal by Subject|1|||
163090093|NCT01627691|589041052|FG000|Overall Study|Missed the visit|3|||
163090094|NCT01307449|589041053|FG000|Overall Study|Adverse Event|1|||
163090095|NCT01307449|589041054|FG001|Overall Study|Adverse Event|0|||
163090096|NCT01307449|589041055|FG002|Overall Study|Adverse Event|0|||
163090097|NCT01307449|589041056|FG003|Overall Study|Adverse Event|0|||
163090098|NCT01531998|589041062|FG000|Overall Study|Withdrawal by Subject|3|||
163090099|NCT02927795|589041063|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
163090100|NCT02927795|589041063|FG000|Overall Study|Not Treated|4|||
163090101|NCT01156844|589041065|FG000|Overall Study|Adverse Event|0|||
163090102|NCT01156844|589041066|FG001|Overall Study|Adverse Event|0|||
163090103|NCT01156844|589041067|FG002|Overall Study|Adverse Event|1|||
163090104|NCT01156844|589041068|FG003|Overall Study|Adverse Event|1|||
163037950|NCT02815267|588845634|FG001|Open-Label Phase|Withdrawal by Subject|13|||
163037951|NCT02815267|588845633|FG000|Open-Label Phase|Protocol Violation|0|||
163037952|NCT02815267|588845634|FG001|Open-Label Phase|Protocol Violation|1|||
163037953|NCT02815267|588845633|FG000|Open-Label Phase|Administrative|21|||
163037954|NCT02815267|588845634|FG001|Open-Label Phase|Administrative|12|||
163037955|NCT02815267|588845633|FG000|Open-Label Phase|Other|2|||
163037956|NCT02815267|588845634|FG001|Open-Label Phase|Other|5|||
163037957|NCT04126317|588845648|FG000|Overall Study|Adverse Event|0|||
163037958|NCT04126317|588845649|FG001|Overall Study|Adverse Event|1|||
163037959|NCT04126317|588845648|FG000|Overall Study|Withdrawal by Subject|4|||
163037960|NCT04126317|588845649|FG001|Overall Study|Withdrawal by Subject|1|||
163037961|NCT00660595|588845652|FG000|Overall Study|Lost to Follow-up|0|||
163037962|NCT00660595|588845653|FG001|Overall Study|Lost to Follow-up|1|||
163037963|NCT00660595|588845652|FG000|Overall Study|Did not consent to participate in study|12|||
163037964|NCT00660595|588845653|FG001|Overall Study|Did not consent to participate in study|8|||
163037965|NCT00660595|588845652|FG000|Overall Study|Participant left hospital|1|||
163037966|NCT00660595|588845653|FG001|Overall Study|Participant left hospital|0|||
163037967|NCT00660595|588845652|FG000|Overall Study|Non Specified reasons|5|||
163037968|NCT00660595|588845653|FG001|Overall Study|Non Specified reasons|0|||
163037969|NCT01204918|588845683|FG000|Overall Study|Withdrawal by Subject|4|||
163037970|NCT01204918|588845684|FG001|Overall Study|Withdrawal by Subject|10|||
163037971|NCT01204918|588845685|FG002|Overall Study|Withdrawal by Subject|5|||
163037972|NCT01280682|588845690|FG000|Overall Study|Lost to Follow-up|0|||
163037973|NCT01280682|588845691|FG001|Overall Study|Lost to Follow-up|6|||
163037974|NCT01280682|588845690|FG000|Overall Study|Withdrawal by Subject|0|||
163037975|NCT01280682|588845691|FG001|Overall Study|Withdrawal by Subject|7|||
163037976|NCT00269477|588845697|FG000|Overall Study|Protocol Violation|5|||
163037977|NCT00269477|588845698|FG001|Overall Study|Protocol Violation|5|||
163037978|NCT00269477|588845699|FG002|Overall Study|Protocol Violation|1|||
163037979|NCT00269477|588845700|FG003|Overall Study|Protocol Violation|0|||
163037980|NCT00269477|588845697|FG000|Overall Study|Missed post-vaccination blood draw|0|||
163037981|NCT00269477|588845698|FG001|Overall Study|Missed post-vaccination blood draw|1|||
163037982|NCT00269477|588845699|FG002|Overall Study|Missed post-vaccination blood draw|0|||
163037983|NCT00269477|588845700|FG003|Overall Study|Missed post-vaccination blood draw|0|||
163037984|NCT00431067|588845701|FG000|Overall Study|Other Adverse Event|9|||
163037985|NCT00431067|588845701|FG000|Overall Study|Progressive disease|30|||
163037986|NCT00431067|588845701|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
163037987|NCT00548249|588845702|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
163037988|NCT00548249|588845703|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037989|NCT00548249|588845704|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037990|NCT00548249|588845705|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
163037991|NCT00548249|588845706|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
163037992|NCT00548249|588845702|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
163037993|NCT00548249|588845703|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
163037994|NCT00548249|588845704|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
163037995|NCT00548249|588845705|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
163037996|NCT00548249|588845706|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
163037997|NCT00548249|588845702|FG000|Overall Study|Protocol Violation|1|||
163090105|NCT01156844|589041065|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163037998|NCT00548249|588845703|FG001|Overall Study|Protocol Violation|1|||
163037999|NCT00548249|588845704|FG002|Overall Study|Protocol Violation|4|||
163038000|NCT00548249|588845705|FG003|Overall Study|Protocol Violation|0|||
163038001|NCT00548249|588845706|FG004|Overall Study|Protocol Violation|3|||
163038002|NCT00548249|588845702|FG000|Overall Study|Miscellaneous|2|||
163038003|NCT00548249|588845703|FG001|Overall Study|Miscellaneous|3|||
163038004|NCT00548249|588845704|FG002|Overall Study|Miscellaneous|2|||
163038005|NCT00548249|588845705|FG003|Overall Study|Miscellaneous|0|||
163090106|NCT01156844|589041066|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163090107|NCT01156844|589041067|FG002|Overall Study|Abnormal test procedure result(s)|2|||
163090108|NCT01156844|589041068|FG003|Overall Study|Abnormal test procedure result(s)|2|||
163090109|NCT01156844|589041065|FG000|Overall Study|Withdrawal by Subject|0|||
163090110|NCT01156844|589041066|FG001|Overall Study|Withdrawal by Subject|0|||
163090111|NCT01156844|589041067|FG002|Overall Study|Withdrawal by Subject|2|||
163090112|NCT01156844|589041068|FG003|Overall Study|Withdrawal by Subject|2|||
163090113|NCT01156844|589041065|FG000|Overall Study|Lost to Follow-up|0|||
163090114|NCT01156844|589041066|FG001|Overall Study|Lost to Follow-up|0|||
163090115|NCT01156844|589041067|FG002|Overall Study|Lost to Follow-up|1|||
163090116|NCT01156844|589041068|FG003|Overall Study|Lost to Follow-up|0|||
163090117|NCT01156844|589041065|FG000|Overall Study|Administrative problems|0|||
163090118|NCT01156844|589041066|FG001|Overall Study|Administrative problems|1|||
163090119|NCT01156844|589041067|FG002|Overall Study|Administrative problems|0|||
163090120|NCT01156844|589041068|FG003|Overall Study|Administrative problems|1|||
163090121|NCT01156844|589041065|FG000|Overall Study|Protocol deviation|2|||
163090122|NCT01156844|589041066|FG001|Overall Study|Protocol deviation|0|||
163090123|NCT01156844|589041067|FG002|Overall Study|Protocol deviation|0|||
163090124|NCT01156844|589041068|FG003|Overall Study|Protocol deviation|0|||
163090125|NCT04661033|589041070|FG000|Overall Study|Adverse Event|0|||
163090126|NCT04661033|589041071|FG001|Overall Study|Adverse Event|0|||
163090127|NCT04661033|589041072|FG002|Overall Study|Adverse Event|1|||
163090128|NCT04661033|589041073|FG003|Overall Study|Adverse Event|0|||
163090129|NCT04661033|589041070|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
163090130|NCT04661033|589041071|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090131|NCT04661033|589041072|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090132|NCT04661033|589041073|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
163090133|NCT04661033|589041070|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
163090134|NCT04661033|589041071|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
163090135|NCT04661033|589041072|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
163090136|NCT04661033|589041073|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
163090137|NCT04661033|589041070|FG000|Overall Study|Early discontinuation as per PI|1|||
163090138|NCT04661033|589041071|FG001|Overall Study|Early discontinuation as per PI|0|||
163090139|NCT04661033|589041072|FG002|Overall Study|Early discontinuation as per PI|0|||
163090140|NCT04661033|589041073|FG003|Overall Study|Early discontinuation as per PI|0|||
163090141|NCT03440008|589041074|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
163090142|NCT03440008|589041075|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
163090143|NCT03440008|589041074|FG000|Overall Study|Withdrawal by Subject|1|||
163090144|NCT03440008|589041075|FG001|Overall Study|Withdrawal by Subject|0|||
163090145|NCT01734902|589041084|FG000|Overall Study|Other than listed|0|||
163090146|NCT01734902|589041085|FG001|Overall Study|Other than listed|2|||
163090147|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
163090148|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
163090149|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
163090150|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Death|0|||
163090151|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Death|0|||
163090152|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Death|1|||
163090153|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
163090154|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
163090155|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
163090156|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
163090157|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
163090158|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
163090159|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
163090160|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
163090161|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
163038006|NCT00548249|588845706|FG004|Overall Study|Miscellaneous|2|||
163038007|NCT00548249|588845702|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
163038008|NCT00548249|588845703|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
163038009|NCT00548249|588845704|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
163038010|NCT00548249|588845705|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
163038011|NCT00548249|588845706|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
163038012|NCT00548249|588845702|FG000|Overall Study|Adverse Event|2|||
163038013|NCT00548249|588845703|FG001|Overall Study|Adverse Event|2|||
163038014|NCT00548249|588845704|FG002|Overall Study|Adverse Event|0|||
163038015|NCT00548249|588845705|FG003|Overall Study|Adverse Event|1|||
163090162|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Graft loss|0|||
163090163|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Graft loss|0|||
163090164|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Graft loss|7|||
163038016|NCT00548249|588845706|FG004|Overall Study|Adverse Event|1|||
163038017|NCT00548249|588845702|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
162650484|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
162650485|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
162650486|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
162650487|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
162650488|NCT01218516|587438800|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
162650489|NCT01218516|587438801|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
162650490|NCT01218516|587438802|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
162650491|NCT01218516|587438803|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
162650492|NCT00283439|587438804|FG000|Overall Study|Adverse Event|0|||
162650493|NCT00283439|587438805|FG001|Overall Study|Adverse Event|0|||
162650494|NCT00283439|587438806|FG002|Overall Study|Adverse Event|0|||
162650495|NCT00283439|587438807|FG003|Overall Study|Adverse Event|1|||
162650496|NCT00283439|587438804|FG000|Overall Study|Death|0|||
162650497|NCT00283439|587438805|FG001|Overall Study|Death|0|||
162650498|NCT00283439|587438806|FG002|Overall Study|Death|1|||
162650499|NCT00283439|587438807|FG003|Overall Study|Death|0|||
162650500|NCT00283439|587438804|FG000|Overall Study|Disease progression|0|||
162650501|NCT00283439|587438805|FG001|Overall Study|Disease progression|1|||
162650502|NCT00283439|587438806|FG002|Overall Study|Disease progression|0|||
162650503|NCT00283439|587438807|FG003|Overall Study|Disease progression|0|||
162650504|NCT00283439|587438804|FG000|Overall Study|Requirement for alternative therapy|1|||
162650505|NCT00283439|587438805|FG001|Overall Study|Requirement for alternative therapy|2|||
162650506|NCT00283439|587438806|FG002|Overall Study|Requirement for alternative therapy|5|||
162650507|NCT00283439|587438807|FG003|Overall Study|Requirement for alternative therapy|2|||
162650508|NCT00283439|587438804|FG000|Overall Study|Stem cell transplant|6|||
162650509|NCT00283439|587438805|FG001|Overall Study|Stem cell transplant|6|||
162650510|NCT00283439|587438806|FG002|Overall Study|Stem cell transplant|4|||
162650511|NCT00283439|587438807|FG003|Overall Study|Stem cell transplant|3|||
162650512|NCT00283439|587438804|FG000|Overall Study|Treatment discontinued|0|||
162650513|NCT00283439|587438805|FG001|Overall Study|Treatment discontinued|2|||
162650514|NCT00283439|587438806|FG002|Overall Study|Treatment discontinued|1|||
162650515|NCT00283439|587438807|FG003|Overall Study|Treatment discontinued|3|||
163038018|NCT00548249|588845703|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
163038019|NCT00548249|588845704|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
163038020|NCT00548249|588845705|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
163038021|NCT00548249|588845706|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
163038022|NCT00548249|588845702|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
163038023|NCT00548249|588845703|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
163038024|NCT00548249|588845704|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
163038025|NCT00548249|588845705|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
163038026|NCT00548249|588845706|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
163038027|NCT00548249|588845702|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038028|NCT00548249|588845703|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038029|NCT00548249|588845704|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038030|NCT00548249|588845705|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
163038031|NCT00548249|588845706|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
163038032|NCT00548249|588845702|FG000|Overall Study|Prolonged hospitalization|0|||
163038033|NCT00548249|588845703|FG001|Overall Study|Prolonged hospitalization|0|||
163038034|NCT00548249|588845704|FG002|Overall Study|Prolonged hospitalization|2|||
163038035|NCT00548249|588845705|FG003|Overall Study|Prolonged hospitalization|1|||
163038036|NCT00548249|588845706|FG004|Overall Study|Prolonged hospitalization|0|||
163038037|NCT00548249|588845702|FG000|Overall Study|Withdrawal by Subject|2|||
163038038|NCT00548249|588845703|FG001|Overall Study|Withdrawal by Subject|0|||
163038039|NCT00548249|588845704|FG002|Overall Study|Withdrawal by Subject|0|||
163038040|NCT00548249|588845705|FG003|Overall Study|Withdrawal by Subject|0|||
163038041|NCT00548249|588845706|FG004|Overall Study|Withdrawal by Subject|0|||
163038042|NCT00548249|588845702|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038043|NCT00548249|588845703|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
163038044|NCT00548249|588845704|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038045|NCT00548249|588845705|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
163038046|NCT00548249|588845706|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
163038047|NCT00548249|588845702|FG000|Overall Study|Sponsor's request|0|||
163038048|NCT00548249|588845703|FG001|Overall Study|Sponsor's request|0|||
163038049|NCT00548249|588845704|FG002|Overall Study|Sponsor's request|0|||
163038050|NCT00548249|588845705|FG003|Overall Study|Sponsor's request|1|||
163038051|NCT00548249|588845706|FG004|Overall Study|Sponsor's request|0|||
163038052|NCT00080483|588845708|FG000|Overall Study|Lost to Follow-up|1|||
163038053|NCT00080483|588845709|FG001|Overall Study|Lost to Follow-up|1|||
163038054|NCT00080483|588845708|FG000|Overall Study|Physician Decision|1|||
162650516|NCT00283439|587438804|FG000|Overall Study|Other|1|||
162650517|NCT00283439|587438805|FG001|Overall Study|Other|0|||
163090165|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
163090166|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
163090167|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
163038055|NCT00080483|588845709|FG001|Overall Study|Physician Decision|1|||
163038056|NCT02007278|588845712|FG000|Overall Study|Failure to comply with an eligibility|0|||
163038057|NCT02007278|588845713|FG001|Overall Study|Failure to comply with an eligibility|1|||
163038058|NCT02007278|588845712|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
163038059|NCT02007278|588845713|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
163038060|NCT02007278|588845712|FG000|Overall Study|Incorrect medication administration|1|||
163038061|NCT02007278|588845713|FG001|Overall Study|Incorrect medication administration|0|||
163038062|NCT02007278|588845712|FG000|Overall Study|Mis-randomization|1|||
163038063|NCT02007278|588845713|FG001|Overall Study|Mis-randomization|1|||
163038064|NCT01404949|588845714|FG000|Overall Study|Not Treated|1|||
163038065|NCT02651688|588845718|FG000|Overall Study|Non-compliance|0|||
163038066|NCT02651688|588845719|FG001|Overall Study|Non-compliance|0|||
163038067|NCT02651688|588845720|FG002|Overall Study|Non-compliance|1|||
163038068|NCT02651688|588845718|FG000|Overall Study|Principal Investigator (PI) decision|0|||
163090168|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
163090169|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
163090170|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
163090171|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
163090172|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
163090173|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
163090174|NCT00956293|589041089|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
163090175|NCT00956293|589041090|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
163090176|NCT00956293|589041091|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
163090177|NCT00956293|589041089|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
163090178|NCT00956293|589041090|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
163090179|NCT00956293|589041091|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
163090180|NCT00956293|589041089|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
163090181|NCT00956293|589041090|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
163090182|NCT00956293|589041091|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
163090183|NCT00956293|589041089|FG000|Main Period (Randomization)|Adverse Event|0|||
163090184|NCT00956293|589041090|FG001|Main Period (Randomization)|Adverse Event|15|||
163090185|NCT00956293|589041091|FG002|Main Period (Randomization)|Adverse Event|0|||
163090186|NCT00956293|589041089|FG000|Follow-up Period|Follow-up period was terminated.|20|||
163090187|NCT00956293|589041090|FG001|Follow-up Period|Follow-up period was terminated.|32|||
163090188|NCT00956293|589041091|FG002|Follow-up Period|Follow-up period was terminated.|0|||
163090189|NCT03383666|589041092|FG000|Overall Study|Withdrawal by Subject|2|||
163090190|NCT03383666|589041092|FG000|Overall Study|Lost to Follow-up|2|||
163090191|NCT02359903|589041093|FG000|Overall Study|Adverse Event|0|||
163090192|NCT02359903|589041094|FG001|Overall Study|Adverse Event|2|||
163090193|NCT02536664|589041095|FG000|Overall Study|Inadequate completion of documentation|2|||
163090194|NCT02536664|589041096|FG001|Overall Study|Inadequate completion of documentation|4|||
163090195|NCT02536664|589041095|FG000|Overall Study|Progression|13|||
163090196|NCT02536664|589041096|FG001|Overall Study|Progression|18|||
163090197|NCT02536664|589041095|FG000|Overall Study|Death due to lymphoma|2|||
163090198|NCT02536664|589041096|FG001|Overall Study|Death due to lymphoma|1|||
163090199|NCT02536664|589041095|FG000|Overall Study|Death due to other reason|3|||
163090200|NCT02536664|589041096|FG001|Overall Study|Death due to other reason|2|||
163090201|NCT02536664|589041095|FG000|Overall Study|Intolerability|8|||
163090202|NCT02536664|589041096|FG001|Overall Study|Intolerability|6|||
163090203|NCT02536664|589041095|FG000|Overall Study|Withdrawal by Subject|8|||
163090204|NCT02536664|589041096|FG001|Overall Study|Withdrawal by Subject|5|||
163090205|NCT02536664|589041095|FG000|Overall Study|Other|18|||
163090206|NCT02536664|589041096|FG001|Overall Study|Other|24|||
163090207|NCT02536664|589041095|FG000|Overall Study|Missing|53|||
163090208|NCT02536664|589041096|FG001|Overall Study|Missing|20|||
163090209|NCT03507127|589041099|FG000|Overall Study|Withdrawal by Subject|1|||
163090210|NCT03507127|589041100|FG001|Overall Study|Withdrawal by Subject|0|||
163090211|NCT03507127|589041099|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
163090212|NCT03507127|589041100|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
163090213|NCT02081586|589041102|FG000|Overall Study|Lost to Follow-up|0|||
163090214|NCT02081586|589041103|FG001|Overall Study|Lost to Follow-up|1|||
163090215|NCT02081586|589041104|FG002|Overall Study|Lost to Follow-up|0|||
163090216|NCT02081586|589041105|FG003|Overall Study|Lost to Follow-up|1|||
163090217|NCT02081586|589041102|FG000|Overall Study|Head injury not related to study|0|||
163090218|NCT02081586|589041103|FG001|Overall Study|Head injury not related to study|0|||
163090219|NCT02081586|589041104|FG002|Overall Study|Head injury not related to study|1|||
163090220|NCT02081586|589041105|FG003|Overall Study|Head injury not related to study|0|||
163038069|NCT02651688|588845719|FG001|Overall Study|Principal Investigator (PI) decision|2|||
163090221|NCT04756531|589041111|FG000|Overall Study|Adverse Event|0|||
163090222|NCT04756531|589041112|FG001|Overall Study|Adverse Event|0|||
163090223|NCT04756531|589041113|FG002|Overall Study|Adverse Event|0|||
162650518|NCT00283439|587438806|FG002|Overall Study|Other|0|||
163090224|NCT04756531|589041114|FG003|Overall Study|Adverse Event|0|||
163090225|NCT04756531|589041115|FG004|Overall Study|Adverse Event|1|||
163090226|NCT04756531|589041116|FG005|Overall Study|Adverse Event|0|||
163090227|NCT04756531|589041117|FG006|Overall Study|Adverse Event|0|||
162650519|NCT00283439|587438807|FG003|Overall Study|Other|0|||
162650520|NCT01539226|587438808|FG000|Overall Study|Withdrawal by Subject|24|||
162650521|NCT01539226|587438809|FG001|Overall Study|Withdrawal by Subject|54|||
162650522|NCT01539226|587438808|FG000|Overall Study|Lost to Follow-up|20|||
162650523|NCT01539226|587438809|FG001|Overall Study|Lost to Follow-up|54|||
162650524|NCT01539226|587438808|FG000|Overall Study|Death|1|||
162650525|NCT01539226|587438809|FG001|Overall Study|Death|2|||
162650526|NCT01539226|587438808|FG000|Overall Study|Adverse Event|2|||
162650527|NCT01539226|587438809|FG001|Overall Study|Adverse Event|0|||
162650528|NCT01539226|587438808|FG000|Overall Study|Pregnancy|13|||
162650529|NCT01539226|587438809|FG001|Overall Study|Pregnancy|29|||
162650530|NCT01539226|587438808|FG000|Overall Study|inappropriate enrollment|0|||
162650531|NCT01539226|587438809|FG001|Overall Study|inappropriate enrollment|1|||
162650532|NCT01539226|587438808|FG000|Overall Study|Multiple Reasons|3|||
162650533|NCT01539226|587438809|FG001|Overall Study|Multiple Reasons|1|||
162650534|NCT01539226|587438808|FG000|Overall Study|not HIV seroconversion-related|93|||
162650535|NCT01539226|587438809|FG001|Overall Study|not HIV seroconversion-related|176|||
163038070|NCT02651688|588845720|FG002|Overall Study|Principal Investigator (PI) decision|0|||
163038071|NCT02651688|588845718|FG000|Overall Study|Lost to Follow-up|1|||
163038072|NCT02651688|588845719|FG001|Overall Study|Lost to Follow-up|3|||
163038073|NCT02651688|588845720|FG002|Overall Study|Lost to Follow-up|0|||
163038074|NCT02651688|588845718|FG000|Overall Study|Withdrawal by Subject|1|||
163038075|NCT02651688|588845719|FG001|Overall Study|Withdrawal by Subject|0|||
163038076|NCT02651688|588845720|FG002|Overall Study|Withdrawal by Subject|2|||
163038077|NCT01429441|588845721|FG000|Overall Study|Adverse Event|5|||
163038078|NCT01429441|588845722|FG001|Overall Study|Adverse Event|1|||
163038079|NCT01429441|588845721|FG000|Overall Study|Death|0|||
163038080|NCT01429441|588845722|FG001|Overall Study|Death|2|||
163038081|NCT01429441|588845721|FG000|Overall Study|Lost to Follow-up|5|||
163038082|NCT01429441|588845722|FG001|Overall Study|Lost to Follow-up|2|||
163038083|NCT01429441|588845721|FG000|Overall Study|Physician Decision|1|||
163038084|NCT01429441|588845722|FG001|Overall Study|Physician Decision|0|||
163038085|NCT01429441|588845721|FG000|Overall Study|Withdrawal by Subject|27|||
163038086|NCT01429441|588845722|FG001|Overall Study|Withdrawal by Subject|18|||
163038087|NCT02670382|588845724|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
163038088|NCT02670382|588845725|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
163038089|NCT00394771|588845727|FG000|Overall Study|Did not meet protocol requirements|1|||
163038090|NCT00394771|588845728|FG001|Overall Study|Did not meet protocol requirements|0|||
163038091|NCT00394771|588845729|FG002|Overall Study|Did not meet protocol requirements|2|||
163038092|NCT00394771|588845730|FG003|Overall Study|Did not meet protocol requirements|0|||
163038093|NCT00394771|588845727|FG000|Overall Study|Protocol Violation|2|||
163038094|NCT00394771|588845728|FG001|Overall Study|Protocol Violation|4|||
163038095|NCT00394771|588845729|FG002|Overall Study|Protocol Violation|9|||
163038096|NCT00394771|588845730|FG003|Overall Study|Protocol Violation|7|||
163038097|NCT00394771|588845727|FG000|Overall Study|Withdrawal by Subject|10|||
163038098|NCT00394771|588845728|FG001|Overall Study|Withdrawal by Subject|6|||
163038099|NCT00394771|588845729|FG002|Overall Study|Withdrawal by Subject|8|||
163038100|NCT00394771|588845730|FG003|Overall Study|Withdrawal by Subject|12|||
163038101|NCT00394771|588845727|FG000|Overall Study|Adverse Event|10|||
163038102|NCT00394771|588845728|FG001|Overall Study|Adverse Event|5|||
163038103|NCT00394771|588845729|FG002|Overall Study|Adverse Event|12|||
163038104|NCT00394771|588845730|FG003|Overall Study|Adverse Event|8|||
163038105|NCT00394771|588845727|FG000|Overall Study|Participant pregnant|0|||
163038106|NCT00394771|588845728|FG001|Overall Study|Participant pregnant|1|||
163038107|NCT00394771|588845729|FG002|Overall Study|Participant pregnant|2|||
163038108|NCT00394771|588845730|FG003|Overall Study|Participant pregnant|2|||
163038109|NCT00394771|588845727|FG000|Overall Study|Lost to Follow-up|15|||
163038110|NCT00394771|588845728|FG001|Overall Study|Lost to Follow-up|15|||
163038111|NCT00394771|588845729|FG002|Overall Study|Lost to Follow-up|13|||
163038112|NCT00394771|588845730|FG003|Overall Study|Lost to Follow-up|10|||
163038113|NCT00394771|588845727|FG000|Overall Study|Other|3|||
163038114|NCT00394771|588845728|FG001|Overall Study|Other|3|||
163038115|NCT00394771|588845729|FG002|Overall Study|Other|1|||
162650536|NCT01539226|587438808|FG000|Overall Study|HIV seroconversion-related|55|||
162650537|NCT01539226|587438809|FG001|Overall Study|HIV seroconversion-related|80|||
162650538|NCT01539226|587438808|FG000|Overall Study|Non-compliance|6|||
162650539|NCT01539226|587438809|FG001|Overall Study|Non-compliance|8|||
162650540|NCT01632891|587438810|FG000|Overall Study|Lost to Follow-up|0|||
163038116|NCT00394771|588845730|FG003|Overall Study|Other|0|||
163038117|NCT02906033|588845732|FG000|Baseline|Protocol Violation|37|||
163038118|NCT02906033|588845733|FG001|Baseline|Protocol Violation|33|||
163090228|NCT04756531|589041118|FG007|Overall Study|Adverse Event|0|||
162650541|NCT01632891|587438811|FG001|Overall Study|Lost to Follow-up|1|||
162650542|NCT01632891|587438810|FG000|Overall Study|Withdrawal by Subject|1|||
162650543|NCT01632891|587438811|FG001|Overall Study|Withdrawal by Subject|0|||
162650544|NCT00333229|587438812|FG000|Overall Study|Lack of Efficacy|0|||
162650545|NCT00333229|587438813|FG001|Overall Study|Lack of Efficacy|1|||
162650546|NCT00240071|587438815|FG000|Overall Study|Withdrawal by Subject|3|||
162650547|NCT04627064|587438823|FG000|Overall Study|Progressive disease|8|||
162650548|NCT04627064|587438824|FG001|Overall Study|Progressive disease|0|||
162650549|NCT04627064|587438823|FG000|Overall Study|Withdrawal by Subject|2|||
162650550|NCT04627064|587438824|FG001|Overall Study|Withdrawal by Subject|0|||
162650551|NCT04627064|587438823|FG000|Overall Study|Physician Decision|1|||
162650552|NCT04627064|587438824|FG001|Overall Study|Physician Decision|0|||
162650553|NCT02086110|587438828|FG000|Overall Study|Withdrawal by Subject|1|||
162650554|NCT02086110|587438829|FG001|Overall Study|Withdrawal by Subject|1|||
162650555|NCT01869192|587438830|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
162650556|NCT01869192|587438831|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
162650557|NCT01869192|587438830|FG000|Postoperative Chemotherapy|Physician Decision|0|||
162650558|NCT01869192|587438831|FG001|Postoperative Chemotherapy|Physician Decision|2|||
162650559|NCT02286193|587438834|FG000|Overall Study|Referred: CRS unable to make contact|62|||
162650560|NCT02286193|587438834|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
162650561|NCT02286193|587438834|FG000|Overall Study|Referred: Declined service|38|||
162650562|NCT00423891|587438835|FG000|Enrolled|Withdrawal by Subject|0|||
162650563|NCT00423891|587438836|FG001|Enrolled|Withdrawal by Subject|0|||
162650564|NCT00423891|587438837|FG002|Enrolled|Withdrawal by Subject|1|||
162650565|NCT00423891|587438835|FG000|Enrolled|Lost to Follow-up|0|||
162650566|NCT00423891|587438836|FG001|Enrolled|Lost to Follow-up|0|||
162650567|NCT00423891|587438837|FG002|Enrolled|Lost to Follow-up|1|||
162650568|NCT00423891|587438835|FG000|Enrolled|No longer met criteria|11|||
162650569|NCT00423891|587438836|FG001|Enrolled|No longer met criteria|2|||
162650570|NCT00423891|587438837|FG002|Enrolled|No longer met criteria|1|||
162650571|NCT00423891|587438835|FG000|Treatment|Withdrawal by Subject|1|||
162650572|NCT00423891|587438836|FG001|Treatment|Withdrawal by Subject|0|||
162650573|NCT00423891|587438837|FG002|Treatment|Withdrawal by Subject|0|||
162650574|NCT00423891|587438835|FG000|Treatment|Lost to Follow-up|1|||
162650575|NCT00423891|587438836|FG001|Treatment|Lost to Follow-up|0|||
162650576|NCT00423891|587438837|FG002|Treatment|Lost to Follow-up|0|||
162650577|NCT00423891|587438835|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
162650578|NCT00423891|587438836|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
162650579|NCT00423891|587438837|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
162650580|NCT00423891|587438835|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
162650581|NCT00423891|587438836|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
162650582|NCT00423891|587438837|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
162650583|NCT01364428|587438854|FG000|Overall Study|Adverse Event|1|||
162650584|NCT01364428|587438855|FG001|Overall Study|Adverse Event|2|||
163090229|NCT04756531|589041119|FG008|Overall Study|Adverse Event|0|||
163090230|NCT04756531|589041120|FG009|Overall Study|Adverse Event|0|||
163090231|NCT04756531|589041121|FG010|Overall Study|Adverse Event|0|||
163090232|NCT04756531|589041122|FG011|Overall Study|Adverse Event|0|||
163090233|NCT04756531|589041123|FG012|Overall Study|Adverse Event|0|||
163090234|NCT04756531|589041124|FG013|Overall Study|Adverse Event|0|||
163090235|NCT04756531|589041125|FG014|Overall Study|Adverse Event|0|||
163090236|NCT04756531|589041126|FG015|Overall Study|Adverse Event|0|||
163090237|NCT04756531|589041127|FG016|Overall Study|Adverse Event|0|||
163090238|NCT04756531|589041128|FG017|Overall Study|Adverse Event|0|||
163090239|NCT04756531|589041111|FG000|Overall Study|Withdrawal by Subject|0|||
163090240|NCT04756531|589041112|FG001|Overall Study|Withdrawal by Subject|0|||
163090241|NCT04756531|589041113|FG002|Overall Study|Withdrawal by Subject|0|||
163090242|NCT04756531|589041114|FG003|Overall Study|Withdrawal by Subject|0|||
163090243|NCT04756531|589041115|FG004|Overall Study|Withdrawal by Subject|0|||
163090244|NCT04756531|589041116|FG005|Overall Study|Withdrawal by Subject|0|||
163090245|NCT04756531|589041117|FG006|Overall Study|Withdrawal by Subject|1|||
163090246|NCT04756531|589041118|FG007|Overall Study|Withdrawal by Subject|0|||
163090247|NCT04756531|589041119|FG008|Overall Study|Withdrawal by Subject|0|||
162650585|NCT01364428|587438854|FG000|Overall Study|Protocol Violation|2|||
162650586|NCT01364428|587438855|FG001|Overall Study|Protocol Violation|0|||
162650587|NCT01364428|587438854|FG000|Overall Study|Withdrawal Criteria|14|||
162650588|NCT01364428|587438855|FG001|Overall Study|Withdrawal Criteria|10|||
162650589|NCT01364428|587438854|FG000|Overall Study|Other|3|||
162650590|NCT01364428|587438855|FG001|Overall Study|Other|3|||
162650591|NCT01585766|587438856|FG000|Overall Study|Withdrawal by Subject|0|||
162650592|NCT01585766|587438857|FG001|Overall Study|Withdrawal by Subject|1|||
162650593|NCT01585766|587438858|FG002|Overall Study|Withdrawal by Subject|1|||
162650594|NCT01585766|587438859|FG003|Overall Study|Withdrawal by Subject|0|||
162650595|NCT01585766|587438860|FG004|Overall Study|Withdrawal by Subject|0|||
163090248|NCT04756531|589041120|FG009|Overall Study|Withdrawal by Subject|0|||
163090249|NCT04756531|589041121|FG010|Overall Study|Withdrawal by Subject|0|||
163090250|NCT04756531|589041122|FG011|Overall Study|Withdrawal by Subject|0|||
163090251|NCT04756531|589041123|FG012|Overall Study|Withdrawal by Subject|0|||
163090252|NCT04756531|589041124|FG013|Overall Study|Withdrawal by Subject|0|||
163090253|NCT04756531|589041125|FG014|Overall Study|Withdrawal by Subject|0|||
163090254|NCT04756531|589041126|FG015|Overall Study|Withdrawal by Subject|0|||
163090255|NCT04756531|589041127|FG016|Overall Study|Withdrawal by Subject|0|||
163090256|NCT04756531|589041128|FG017|Overall Study|Withdrawal by Subject|0|||
163090257|NCT00789555|589041131|FG000|Overall Study|Protocol Amendment|78|||
163090258|NCT00789555|589041132|FG001|Overall Study|Protocol Amendment|76|||
163090259|NCT00789555|589041133|FG002|Overall Study|Protocol Amendment|80|||
163090260|NCT00789555|589041131|FG000|Overall Study|Adverse Event|17|||
163090261|NCT00789555|589041132|FG001|Overall Study|Adverse Event|7|||
163090262|NCT00789555|589041133|FG002|Overall Study|Adverse Event|10|||
163090263|NCT00789555|589041131|FG000|Overall Study|Lost to Follow-up|9|||
163090264|NCT00789555|589041132|FG001|Overall Study|Lost to Follow-up|10|||
163090265|NCT00789555|589041133|FG002|Overall Study|Lost to Follow-up|18|||
163090266|NCT00789555|589041131|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
163090267|NCT00789555|589041132|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
163090268|NCT00789555|589041133|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
163090269|NCT00789555|589041131|FG000|Overall Study|Treatment failure|11|||
163090270|NCT00789555|589041132|FG001|Overall Study|Treatment failure|8|||
163090271|NCT00789555|589041133|FG002|Overall Study|Treatment failure|12|||
163090272|NCT00789555|589041131|FG000|Overall Study|Protocol Violation|6|||
163090273|NCT00789555|589041132|FG001|Overall Study|Protocol Violation|9|||
163090274|NCT00789555|589041133|FG002|Overall Study|Protocol Violation|13|||
163090275|NCT04646005|589041137|FG000|Overall Study|Adverse Event|1|||
163090276|NCT04646005|589041137|FG000|Overall Study|Progressive Disease|71|||
163090277|NCT04646005|589041137|FG000|Overall Study|Death|20|||
163090278|NCT04646005|589041137|FG000|Overall Study|Withdrawal by Subject|12|||
163090279|NCT04646005|589041137|FG000|Overall Study|Sponsor Request|9|||
163090280|NCT04712669|589041139|FG000|Double Blind Phase|Adverse Event|4|||
163090281|NCT04712669|589041140|FG001|Double Blind Phase|Adverse Event|4|||
163090282|NCT04712669|589041141|FG002|Double Blind Phase|Adverse Event|3|||
163090283|NCT04712669|589041142|FG003|Double Blind Phase|Adverse Event|0|||
163090284|NCT04712669|589041143|FG004|Double Blind Phase|Adverse Event|0|||
163090285|NCT04712669|589041144|FG005|Double Blind Phase|Adverse Event|0|||
163090286|NCT04712669|589041145|FG006|Double Blind Phase|Adverse Event|0|||
163090287|NCT04712669|589041146|FG007|Double Blind Phase|Adverse Event|0|||
163090288|NCT04712669|589041139|FG000|Double Blind Phase|Physician Decision|1|||
163090289|NCT04712669|589041140|FG001|Double Blind Phase|Physician Decision|0|||
163090290|NCT04712669|589041141|FG002|Double Blind Phase|Physician Decision|0|||
163090291|NCT04712669|589041142|FG003|Double Blind Phase|Physician Decision|0|||
163090292|NCT04712669|589041143|FG004|Double Blind Phase|Physician Decision|0|||
163090293|NCT04712669|589041144|FG005|Double Blind Phase|Physician Decision|0|||
163090294|NCT04712669|589041145|FG006|Double Blind Phase|Physician Decision|0|||
163090295|NCT04712669|589041146|FG007|Double Blind Phase|Physician Decision|0|||
163090296|NCT04712669|589041139|FG000|Double Blind Phase|Withdrawal by Subject|3|||
163090297|NCT04712669|589041140|FG001|Double Blind Phase|Withdrawal by Subject|6|||
163090298|NCT04712669|589041141|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163090299|NCT04712669|589041142|FG003|Double Blind Phase|Withdrawal by Subject|0|||
163090300|NCT04712669|589041143|FG004|Double Blind Phase|Withdrawal by Subject|0|||
163090301|NCT04712669|589041144|FG005|Double Blind Phase|Withdrawal by Subject|0|||
163090302|NCT04712669|589041145|FG006|Double Blind Phase|Withdrawal by Subject|0|||
163090303|NCT04712669|589041146|FG007|Double Blind Phase|Withdrawal by Subject|0|||
163090304|NCT04712669|589041139|FG000|Double Blind Phase|Termination by Sponsor|0|||
163090305|NCT04712669|589041140|FG001|Double Blind Phase|Termination by Sponsor|0|||
163090306|NCT04712669|589041141|FG002|Double Blind Phase|Termination by Sponsor|1|||
163090307|NCT04712669|589041142|FG003|Double Blind Phase|Termination by Sponsor|0|||
163090308|NCT04712669|589041143|FG004|Double Blind Phase|Termination by Sponsor|0|||
163090309|NCT04712669|589041144|FG005|Double Blind Phase|Termination by Sponsor|0|||
163090310|NCT04712669|589041145|FG006|Double Blind Phase|Termination by Sponsor|0|||
163090311|NCT04712669|589041146|FG007|Double Blind Phase|Termination by Sponsor|0|||
163090312|NCT04712669|589041139|FG000|Open Label Phase|Adverse Event|0|||
163090313|NCT04712669|589041140|FG001|Open Label Phase|Adverse Event|0|||
163090314|NCT04712669|589041141|FG002|Open Label Phase|Adverse Event|0|||
163090315|NCT04712669|589041142|FG003|Open Label Phase|Adverse Event|1|||
163090316|NCT04712669|589041143|FG004|Open Label Phase|Adverse Event|1|||
163090317|NCT04712669|589041144|FG005|Open Label Phase|Adverse Event|3|||
163090318|NCT04712669|589041145|FG006|Open Label Phase|Adverse Event|1|||
163090319|NCT04712669|589041146|FG007|Open Label Phase|Adverse Event|2|||
163090320|NCT04712669|589041139|FG000|Open Label Phase|Death|0|||
163090321|NCT04712669|589041140|FG001|Open Label Phase|Death|0|||
163090322|NCT04712669|589041141|FG002|Open Label Phase|Death|0|||
163090323|NCT04712669|589041142|FG003|Open Label Phase|Death|1|||
163090324|NCT04712669|589041143|FG004|Open Label Phase|Death|0|||
163090325|NCT04712669|589041144|FG005|Open Label Phase|Death|0|||
163090326|NCT04712669|589041145|FG006|Open Label Phase|Death|0|||
163090327|NCT04712669|589041146|FG007|Open Label Phase|Death|0|||
163090328|NCT04712669|589041139|FG000|Open Label Phase|Lack of Efficacy|0|||
163090329|NCT04712669|589041140|FG001|Open Label Phase|Lack of Efficacy|0|||
163090330|NCT04712669|589041141|FG002|Open Label Phase|Lack of Efficacy|0|||
163090331|NCT04712669|589041142|FG003|Open Label Phase|Lack of Efficacy|0|||
163090332|NCT04712669|589041143|FG004|Open Label Phase|Lack of Efficacy|1|||
163090333|NCT04712669|589041144|FG005|Open Label Phase|Lack of Efficacy|0|||
163090334|NCT04712669|589041145|FG006|Open Label Phase|Lack of Efficacy|0|||
163090335|NCT04712669|589041146|FG007|Open Label Phase|Lack of Efficacy|0|||
163090336|NCT04712669|589041139|FG000|Open Label Phase|Lost to Follow-up|0|||
163090337|NCT04712669|589041140|FG001|Open Label Phase|Lost to Follow-up|0|||
163090338|NCT04712669|589041141|FG002|Open Label Phase|Lost to Follow-up|0|||
163090339|NCT04712669|589041142|FG003|Open Label Phase|Lost to Follow-up|0|||
163090340|NCT04712669|589041143|FG004|Open Label Phase|Lost to Follow-up|0|||
163090341|NCT04712669|589041144|FG005|Open Label Phase|Lost to Follow-up|0|||
163090342|NCT04712669|589041145|FG006|Open Label Phase|Lost to Follow-up|1|||
163090343|NCT04712669|589041146|FG007|Open Label Phase|Lost to Follow-up|1|||
163090344|NCT04712669|589041139|FG000|Open Label Phase|Physician Decision|0|||
163090345|NCT04712669|589041140|FG001|Open Label Phase|Physician Decision|0|||
163090346|NCT04712669|589041141|FG002|Open Label Phase|Physician Decision|0|||
163090347|NCT04712669|589041142|FG003|Open Label Phase|Physician Decision|1|||
163090348|NCT04712669|589041143|FG004|Open Label Phase|Physician Decision|0|||
163090349|NCT04712669|589041144|FG005|Open Label Phase|Physician Decision|0|||
163090350|NCT04712669|589041145|FG006|Open Label Phase|Physician Decision|0|||
163090351|NCT04712669|589041146|FG007|Open Label Phase|Physician Decision|0|||
163090352|NCT04712669|589041139|FG000|Open Label Phase|Withdrawal by Subject|0|||
163090353|NCT04712669|589041140|FG001|Open Label Phase|Withdrawal by Subject|0|||
163090354|NCT04712669|589041141|FG002|Open Label Phase|Withdrawal by Subject|0|||
163090355|NCT04712669|589041142|FG003|Open Label Phase|Withdrawal by Subject|1|||
163090356|NCT04712669|589041143|FG004|Open Label Phase|Withdrawal by Subject|5|||
163090357|NCT04712669|589041144|FG005|Open Label Phase|Withdrawal by Subject|5|||
163090358|NCT04712669|589041145|FG006|Open Label Phase|Withdrawal by Subject|0|||
163090359|NCT04712669|589041146|FG007|Open Label Phase|Withdrawal by Subject|4|||
163090360|NCT04712669|589041139|FG000|Open Label Phase|Termination by Sponsor|0|||
163090361|NCT04712669|589041140|FG001|Open Label Phase|Termination by Sponsor|0|||
163090362|NCT04712669|589041141|FG002|Open Label Phase|Termination by Sponsor|0|||
163090363|NCT04712669|589041142|FG003|Open Label Phase|Termination by Sponsor|11|||
162650596|NCT01585766|587438861|FG005|Overall Study|Withdrawal by Subject|0|||
162650597|NCT01585766|587438856|FG000|Overall Study|Death|0|||
162650598|NCT01585766|587438857|FG001|Overall Study|Death|1|||
163090364|NCT04712669|589041143|FG004|Open Label Phase|Termination by Sponsor|9|||
163090365|NCT04712669|589041144|FG005|Open Label Phase|Termination by Sponsor|14|||
162650599|NCT01585766|587438858|FG002|Overall Study|Death|0|||
162650600|NCT01585766|587438859|FG003|Overall Study|Death|0|||
163090366|NCT04712669|589041145|FG006|Open Label Phase|Termination by Sponsor|0|||
163090367|NCT04712669|589041146|FG007|Open Label Phase|Termination by Sponsor|14|||
163090368|NCT00639457|589042839|FG000|Overall Study|Withdrawal by Subject|2|||
163090369|NCT00639457|589042840|FG001|Overall Study|Withdrawal by Subject|3|||
163090370|NCT00892008|589042841|FG000|Overall Study|Death|5|||
163090371|NCT00892008|589042841|FG000|Overall Study|Lack of Efficacy|3|||
163090372|NCT00892008|589042841|FG000|Overall Study|Lost to Follow-up|142|||
163090373|NCT00892008|589042841|FG000|Overall Study|Other|378|||
163090374|NCT00892008|589042841|FG000|Overall Study|Adverse Event|37|||
163090375|NCT00355030|589042842|FG000|Study Period 1 Treatment|Adverse Event|1|||
163090376|NCT00355030|589042843|FG001|Study Period 1 Treatment|Adverse Event|1|||
163090377|NCT00355030|589042842|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
163090378|NCT00355030|589042843|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
162650601|NCT01585766|587438860|FG004|Overall Study|Death|0|||
162650602|NCT01585766|587438861|FG005|Overall Study|Death|0|||
162650603|NCT01585766|587438856|FG000|Overall Study|Physician Decision|0|||
162650604|NCT01585766|587438857|FG001|Overall Study|Physician Decision|0|||
162650605|NCT01585766|587438858|FG002|Overall Study|Physician Decision|1|||
162650606|NCT01585766|587438859|FG003|Overall Study|Physician Decision|0|||
162650607|NCT01585766|587438860|FG004|Overall Study|Physician Decision|0|||
162650608|NCT01585766|587438861|FG005|Overall Study|Physician Decision|0|||
162650609|NCT01073865|587438862|FG000|Overall Study|Reasons other than below|19|||
162718798|NCT01235949|587676690|FG010|Booster Phase|Migrated/moved from study area|0|||
163090379|NCT00355030|589042842|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
163090380|NCT00355030|589042843|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
163090381|NCT00355030|589042842|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
163090382|NCT00355030|589042843|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
163090383|NCT00355030|589042842|FG000|Study Period 1 Treatment|Physician Decision|0|||
163090384|NCT00355030|589042843|FG001|Study Period 1 Treatment|Physician Decision|1|||
163090385|NCT00355030|589042842|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
163090386|NCT00355030|589042843|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
162650610|NCT01073865|587438863|FG001|Overall Study|Reasons other than below|31|||
162650611|NCT01073865|587438862|FG000|Overall Study|Lost to Follow-up|1|||
162650612|NCT01073865|587438863|FG001|Overall Study|Lost to Follow-up|1|||
163090387|NCT00355030|589042842|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
163090388|NCT00355030|589042843|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
163090389|NCT00355030|589042842|FG000|Study Period 1 Treatment|Other|2|||
163090390|NCT00355030|589042843|FG001|Study Period 1 Treatment|Other|6|||
163090391|NCT00355030|589042842|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
163090392|NCT00355030|589042843|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
163090393|NCT00355030|589042842|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
163090394|NCT00355030|589042843|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
163090395|NCT01693367|589042844|FG000|Overall Study|Withdrawal by Subject|1|||
163090396|NCT01693367|589042845|FG001|Overall Study|Withdrawal by Subject|1|||
163090397|NCT01693367|589042844|FG000|Overall Study|Physician Decision|0|||
163090398|NCT01693367|589042845|FG001|Overall Study|Physician Decision|1|||
163090399|NCT00690794|589042846|FG000|Overall Study|Adverse Event|12|||
163090400|NCT00690794|589042847|FG001|Overall Study|Adverse Event|10|||
163090401|NCT00690794|589042846|FG000|Overall Study|Lost to Follow-up|1|||
163090402|NCT00690794|589042847|FG001|Overall Study|Lost to Follow-up|4|||
163090403|NCT00690794|589042846|FG000|Overall Study|Withdrawal by Subject|0|||
163090404|NCT00690794|589042847|FG001|Overall Study|Withdrawal by Subject|9|||
163090405|NCT00690794|589042846|FG000|Overall Study|Protocol Violation|6|||
163090406|NCT00690794|589042847|FG001|Overall Study|Protocol Violation|7|||
163090407|NCT00690794|589042846|FG000|Overall Study|Noncompliance|1|||
163090408|NCT00690794|589042847|FG001|Overall Study|Noncompliance|2|||
163090409|NCT00690794|589042846|FG000|Overall Study|Other not specified|1|||
163090410|NCT00690794|589042847|FG001|Overall Study|Other not specified|3|||
163090411|NCT00325143|589042848|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
163090412|NCT00325143|589042848|FG000|Overall Study|Migrated/moved from study area|1|||
163090413|NCT00325143|589042848|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
163090414|NCT00325143|589042848|FG000|Overall Study|Withdrawal by Subject|8|||
163090415|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
163090416|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
163090417|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
163090418|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
163090419|NCT02286895|589042849|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
163090420|NCT02286895|589042850|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
163090421|NCT00399035|589042852|FG000|Overall Study|Death|289|||
163090422|NCT00399035|589042853|FG001|Overall Study|Death|141|||
163090423|NCT00399035|589042854|FG002|Overall Study|Death|234|||
163090424|NCT00399035|589042852|FG000|Overall Study|Lost to Follow-up|2|||
163090425|NCT00399035|589042853|FG001|Overall Study|Lost to Follow-up|1|||
163090426|NCT00399035|589042854|FG002|Overall Study|Lost to Follow-up|5|||
163090427|NCT00399035|589042852|FG000|Overall Study|Withdrawal by Subject|19|||
163090428|NCT00399035|589042853|FG001|Overall Study|Withdrawal by Subject|15|||
163090429|NCT00399035|589042854|FG002|Overall Study|Withdrawal by Subject|12|||
163090430|NCT00399035|589042852|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
163090431|NCT00399035|589042853|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
163090432|NCT00399035|589042854|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
163090433|NCT00399035|589042852|FG000|Overall Study|Severe non-compliance with protocol|2|||
163090434|NCT00399035|589042853|FG001|Overall Study|Severe non-compliance with protocol|1|||
163090435|NCT00399035|589042854|FG002|Overall Study|Severe non-compliance with protocol|0|||
163090436|NCT02949011|589042857|FG000|Overall Study|Adverse Event|6|||
163090437|NCT02949011|589042858|FG001|Overall Study|Adverse Event|7|||
163090438|NCT02949011|589042859|FG002|Overall Study|Adverse Event|3|||
163090439|NCT02949011|589042857|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
163090440|NCT02949011|589042858|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
163090441|NCT02949011|589042859|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
163090442|NCT02949011|589042857|FG000|Overall Study|Protocol Deviation|5|||
163038119|NCT02906033|588845732|FG000|Follow-up|Lost to Follow-up|46|||
163038120|NCT02906033|588845733|FG001|Follow-up|Lost to Follow-up|62|||
163038121|NCT00358956|588845734|FG000|Overall Study|Adverse Event|3|||
163038122|NCT00358956|588845734|FG000|Overall Study|condition under investigation worsened|4|||
163038123|NCT00358956|588845734|FG000|Overall Study|Withdrawal by Subject|1|||
163038124|NCT03417024|588845737|FG000|Overall Study|Study Termination prior to follow-up|11|||
163038125|NCT03417024|588845737|FG000|Overall Study|Physician Decision|2|||
163090443|NCT02949011|589042858|FG001|Overall Study|Protocol Deviation|3|||
163090444|NCT02949011|589042859|FG002|Overall Study|Protocol Deviation|3|||
163090445|NCT02949011|589042857|FG000|Overall Study|Lack of Efficacy|0|||
163090446|NCT02949011|589042858|FG001|Overall Study|Lack of Efficacy|2|||
163090447|NCT02949011|589042859|FG002|Overall Study|Lack of Efficacy|0|||
163090448|NCT02949011|589042857|FG000|Overall Study|Withdrawal by Subject|13|||
163090449|NCT02949011|589042858|FG001|Overall Study|Withdrawal by Subject|13|||
163090450|NCT02949011|589042859|FG002|Overall Study|Withdrawal by Subject|21|||
163090451|NCT02949011|589042857|FG000|Overall Study|Lost to Follow-up|7|||
163090452|NCT02949011|589042858|FG001|Overall Study|Lost to Follow-up|5|||
163090453|NCT02949011|589042859|FG002|Overall Study|Lost to Follow-up|5|||
163038126|NCT00386425|588845738|FG000|Overall Study|Physician Decision|3|||
162650613|NCT01073865|587438862|FG000|Overall Study|Death|3|||
162650614|NCT01073865|587438863|FG001|Overall Study|Death|2|||
162650615|NCT01073865|587438862|FG000|Overall Study|Withdrawal by Subject|5|||
162650616|NCT01073865|587438863|FG001|Overall Study|Withdrawal by Subject|5|||
162650617|NCT00696137|587438867|FG000|Overall Study|Withdrawal by Subject|2|||
162650618|NCT04371380|587438868|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
162650619|NCT04371380|587438869|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
162650620|NCT04371380|587438870|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
162650621|NCT02376166|587438871|FG000|Overall Study|Adverse Event|1|||
162650622|NCT02376166|587438871|FG000|Overall Study|Discontinued metformin early|2|||
162650623|NCT02197806|587438874|FG000|Overall Study|Adverse Event|0|||
162650624|NCT02197806|587438875|FG001|Overall Study|Adverse Event|1|||
162650625|NCT02197806|587438876|FG002|Overall Study|Adverse Event|0|||
162650626|NCT02197806|587438877|FG003|Overall Study|Adverse Event|1|||
162650627|NCT00680901|587438878|FG000|Overall Study|Ongoing: On Study Treatment|1|||
163090454|NCT02949011|589042857|FG000|Overall Study|Death|0|||
163090455|NCT02949011|589042858|FG001|Overall Study|Death|0|||
163090456|NCT02949011|589042859|FG002|Overall Study|Death|1|||
163090457|NCT02949011|589042857|FG000|Overall Study|Miscellaneous|2|||
163090458|NCT02949011|589042858|FG001|Overall Study|Miscellaneous|4|||
163090459|NCT02949011|589042859|FG002|Overall Study|Miscellaneous|6|||
163090460|NCT00163189|589042860|FG000|Overall Study|Other|6|||
163090461|NCT00163189|589042860|FG000|Overall Study|Lost to Follow-up|1|||
163090462|NCT00163189|589042860|FG000|Overall Study|Protocol Violation|2|||
163090463|NCT00163189|589042860|FG000|Overall Study|Death|3|||
163090464|NCT00163189|589042860|FG000|Overall Study|Adverse Event|6|||
163090465|NCT00163189|589042860|FG000|Overall Study|Lack of Efficacy|7|||
163090466|NCT00163189|589042860|FG000|Overall Study|Study terminated by sponsor|11|||
163090467|NCT00163189|589042860|FG000|Overall Study|Withdrawal by Subject|11|||
163090468|NCT00163189|589042860|FG000|Overall Study|Did not meet continuation criterion|16|||
163090469|NCT01170663|589042861|FG000|Overall Study|Lost to Follow-up|3|||
163090470|NCT01170663|589042862|FG001|Overall Study|Lost to Follow-up|9|||
163090471|NCT01170663|589042861|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
163090472|NCT01170663|589042862|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
163090473|NCT00454116|589042863|FG000|Overall Study|Adverse Event|5|||
163090474|NCT00454116|589042864|FG001|Overall Study|Adverse Event|11|||
163090475|NCT00454116|589042865|FG002|Overall Study|Adverse Event|9|||
163090476|NCT00454116|589042863|FG000|Overall Study|Condition under investigation worsened|17|||
163090477|NCT00454116|589042864|FG001|Overall Study|Condition under investigation worsened|13|||
163090478|NCT00454116|589042865|FG002|Overall Study|Condition under investigation worsened|18|||
163090479|NCT00454116|589042863|FG000|Overall Study|Withdrawal by Subject|3|||
163090480|NCT00454116|589042864|FG001|Overall Study|Withdrawal by Subject|3|||
163090481|NCT00454116|589042865|FG002|Overall Study|Withdrawal by Subject|1|||
163090482|NCT00454116|589042863|FG000|Overall Study|Other|2|||
163090483|NCT00454116|589042864|FG001|Overall Study|Other|2|||
163090484|NCT00454116|589042865|FG002|Overall Study|Other|0|||
162650628|NCT00680901|587438879|FG001|Overall Study|Ongoing: On Study Treatment|0|||
162650629|NCT00680901|587438878|FG000|Overall Study|Ongoing: In Follow Up|1|||
162650630|NCT00680901|587438879|FG001|Overall Study|Ongoing: In Follow Up|0|||
163090485|NCT02746809|589042866|FG000|Enrollment|Inclusion Exclusion not met|9|||
163090486|NCT02746809|589042866|FG000|Enrollment|Withdrawal by Subject|1|||
163090487|NCT02746809|589042866|FG000|Enrollment|Expected Enrollment Met|2|||
163090488|NCT02746809|589042866|FG000|Procedure|Death|1|||
163090489|NCT02746809|589042866|FG000|1-Month|Death|5|||
163090490|NCT02746809|589042866|FG000|6-Month|Death|2|||
163090491|NCT02746809|589042866|FG000|6-Month|Withdrawal by Subject|1|||
163090492|NCT02746809|589042866|FG000|12-Month|Death|3|||
163090493|NCT02746809|589042866|FG000|12-Month|Withdrawal by Subject|2|||
163090494|NCT02746809|589042866|FG000|24-Month|Death|1|||
163090495|NCT02746809|589042866|FG000|24-Month|Withdrawal by Subject|1|||
163090496|NCT02746809|589042866|FG000|36-Month|Death|8|||
163090497|NCT02746809|589042866|FG000|36-Month|Withdrawal by Subject|1|||
163090498|NCT02746809|589042866|FG000|48-Month|Death|7|||
163090499|NCT02746809|589042866|FG000|48-Month|Withdrawal by Subject|1|||
163090500|NCT02746809|589042866|FG000|60-Month|Death|1|||
163090501|NCT02746809|589042866|FG000|60-Month|Lost to Follow-up|2|||
162650631|NCT00680901|587438878|FG000|Overall Study|Adverse Event|1|||
162650632|NCT00680901|587438879|FG001|Overall Study|Adverse Event|1|||
162650633|NCT00680901|587438878|FG000|Overall Study|Lost to Follow-up|3|||
163090502|NCT03500211|589042869|FG000|Overall Study|Withdrawal by Subject|1|||
163090503|NCT03500211|589042870|FG001|Overall Study|Withdrawal by Subject|1|||
163090504|NCT02431325|589042871|FG000|Overall Study|Adverse Event|3|||
163090505|NCT02431325|589042872|FG001|Overall Study|Adverse Event|0|||
163090506|NCT02431325|589042871|FG000|Overall Study|Lost to Follow-up|0|||
163090507|NCT02431325|589042872|FG001|Overall Study|Lost to Follow-up|1|||
163090508|NCT02431325|589042871|FG000|Overall Study|Withdrawal by Subject|1|||
163090509|NCT02431325|589042872|FG001|Overall Study|Withdrawal by Subject|2|||
163090510|NCT02431325|589042871|FG000|Overall Study|Declined to take study medication|1|||
163038127|NCT00386425|588845739|FG001|Overall Study|Physician Decision|0|||
163038128|NCT00386425|588845740|FG002|Overall Study|Physician Decision|0|||
163038129|NCT00386425|588845738|FG000|Overall Study|Withdrawal by Subject|0|||
163038130|NCT00386425|588845739|FG001|Overall Study|Withdrawal by Subject|1|||
163038131|NCT00386425|588845740|FG002|Overall Study|Withdrawal by Subject|0|||
163038132|NCT01907217|588845741|FG000|Overall Study|Withdrawal by Subject|0|||
163038133|NCT01907217|588845742|FG001|Overall Study|Withdrawal by Subject|2|||
163038134|NCT04607980|588845748|FG000|Overall Study|Adverse Event|3|||
163038135|NCT04607980|588845749|FG001|Overall Study|Adverse Event|4|||
163038136|NCT04607980|588845748|FG000|Overall Study|Death|0|||
163038137|NCT04607980|588845749|FG001|Overall Study|Death|1|||
163038138|NCT04607980|588845748|FG000|Overall Study|Withdrawal by Subject|2|||
163038139|NCT04607980|588845749|FG001|Overall Study|Withdrawal by Subject|5|||
163038140|NCT04607980|588845748|FG000|Overall Study|Lost to Follow-up|4|||
163038141|NCT04607980|588845749|FG001|Overall Study|Lost to Follow-up|8|||
163038142|NCT04607980|588845748|FG000|Overall Study|Protocol Violation|0|||
163038143|NCT04607980|588845749|FG001|Overall Study|Protocol Violation|3|||
163038144|NCT04607980|588845748|FG000|Overall Study|Other|3|||
163038145|NCT04607980|588845749|FG001|Overall Study|Other|0|||
163038146|NCT00448812|588845750|FG000|Year 2|Missed visit but remained in study|4|||
163038147|NCT00448812|588845751|FG001|Year 2|Missed visit but remained in study|1|||
163038148|NCT00448812|588845750|FG000|Year 3|Withdrawal by Subject|1|||
163038149|NCT00448812|588845751|FG001|Year 3|Withdrawal by Subject|3|||
163038150|NCT00448812|588845750|FG000|Year 3|Lost to Follow-up|1|||
163038151|NCT00448812|588845751|FG001|Year 3|Lost to Follow-up|0|||
163038152|NCT00448812|588845750|FG000|Year 3|Missed visit but remained in study|2|||
163038153|NCT00448812|588845751|FG001|Year 3|Missed visit but remained in study|0|||
163038154|NCT00448812|588845750|FG000|Year 5|Missed visit but remained in study|1|||
163038155|NCT00448812|588845751|FG001|Year 5|Missed visit but remained in study|0|||
163038156|NCT02012959|588845752|FG000|Treatment Phase A|Adverse Event|2|||
163038157|NCT02012959|588845753|FG001|Treatment Phase A|Adverse Event|0|||
163038158|NCT02012959|588845754|FG002|Treatment Phase A|Adverse Event|0|||
163038159|NCT02012959|588845755|FG003|Treatment Phase A|Adverse Event|0|||
163038160|NCT02012959|588845756|FG004|Treatment Phase A|Adverse Event|0|||
163038161|NCT03396822|588847293|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
163038162|NCT03396822|588847293|FG000|Overall Study|Physician Decision|1|||
163038163|NCT03630705|588847298|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
163038164|NCT03630705|588847299|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
163090511|NCT02431325|589042872|FG001|Overall Study|Declined to take study medication|0|||
163090512|NCT02431325|589042871|FG000|Overall Study|Withdrew before starting study medication|1|||
163090513|NCT02431325|589042872|FG001|Overall Study|Withdrew before starting study medication|0|||
163090514|NCT02431325|589042871|FG000|Overall Study|Placebo shortage|2|||
163090515|NCT02431325|589042872|FG001|Overall Study|Placebo shortage|0|||
163090516|NCT01917318|589042873|FG000|First Treatment|Withdrawal by Subject|0|||
163090517|NCT01917318|589042874|FG001|First Treatment|Withdrawal by Subject|1|||
163090518|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Physician Decision|2|||
163090519|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Physician Decision|0|||
163090520|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Physician Decision|0|||
163090521|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Adverse Event|33|||
163090522|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Adverse Event|0|||
163090523|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Adverse Event|0|||
163090524|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
163090525|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163090526|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163090527|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
163090528|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163090529|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163090530|NCT01008618|589042875|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
163090531|NCT01008618|589042876|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
163090532|NCT01008618|589042877|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
163090533|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
163090534|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
163038165|NCT03630705|588847300|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163038166|NCT03630705|588847301|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163038167|NCT03630705|588847298|FG000|Overall Study|Lost to Follow-up|1|||
163038168|NCT03630705|588847299|FG001|Overall Study|Lost to Follow-up|2|||
163038169|NCT03630705|588847300|FG002|Overall Study|Lost to Follow-up|0|||
163038170|NCT03630705|588847301|FG003|Overall Study|Lost to Follow-up|0|||
163038171|NCT01128400|588847302|FG000|Overall Study|Lost to Follow-up|1|||
163038172|NCT01128400|588847303|FG001|Overall Study|Lost to Follow-up|0|||
163038173|NCT01128400|588847304|FG002|Overall Study|Lost to Follow-up|1|||
163038174|NCT01128400|588847302|FG000|Overall Study|Screening failure|1|||
163038175|NCT01128400|588847303|FG001|Overall Study|Screening failure|0|||
163038176|NCT01128400|588847304|FG002|Overall Study|Screening failure|0|||
163038177|NCT01128400|588847302|FG000|Overall Study|were not invited to participate on taste|0|||
163090535|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
163090536|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
163090537|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
163090538|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163090539|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
163090540|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
163090541|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
163090542|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163090543|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163090544|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
163090545|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163090546|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163090547|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
163090548|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
163090549|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
163090550|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
163090551|NCT01008618|589042875|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
163090552|NCT01008618|589042876|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
163090553|NCT01008618|589042877|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
163090554|NCT01128569|589042881|FG000|Washout Period 1|Adverse Event|0|||
163090555|NCT01128569|589042882|FG001|Washout Period 1|Adverse Event|0|||
163090556|NCT01128569|589042883|FG002|Washout Period 1|Adverse Event|1|||
163090557|NCT01128569|589042884|FG003|Washout Period 1|Adverse Event|0|||
163090558|NCT01128569|589042885|FG004|Washout Period 1|Adverse Event|0|||
163090559|NCT01128569|589042886|FG005|Washout Period 1|Adverse Event|0|||
163090560|NCT01128569|589042881|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163090561|NCT01128569|589042882|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163090562|NCT01128569|589042883|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163090563|NCT01128569|589042884|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163090564|NCT01128569|589042885|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163090565|NCT01128569|589042886|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163090566|NCT00894387|589042887|FG000|Overall Study|Adverse Event|44|||
163090567|NCT00894387|589042888|FG001|Overall Study|Adverse Event|45|||
163090568|NCT00894387|589042887|FG000|Overall Study|Abnormal Laboratory values|2|||
163090569|NCT00894387|589042888|FG001|Overall Study|Abnormal Laboratory values|2|||
163090570|NCT00894387|589042887|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163090571|NCT00894387|589042888|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163090572|NCT00894387|589042887|FG000|Overall Study|Lost to Follow-up|3|||
163090573|NCT00894387|589042888|FG001|Overall Study|Lost to Follow-up|5|||
163090574|NCT00894387|589042887|FG000|Overall Study|Administrative problems|2|||
163090575|NCT00894387|589042888|FG001|Overall Study|Administrative problems|2|||
163090576|NCT00894387|589042887|FG000|Overall Study|Death|77|||
163090577|NCT00894387|589042888|FG001|Overall Study|Death|76|||
163090578|NCT00894387|589042887|FG000|Overall Study|Protocol Deviation|4|||
163090579|NCT00894387|589042888|FG001|Overall Study|Protocol Deviation|0|||
163090580|NCT00894387|589042887|FG000|Overall Study|Patient's request|25|||
163090581|NCT00894387|589042888|FG001|Overall Study|Patient's request|30|||
163090582|NCT00894387|589042887|FG000|Overall Study|Other (Missing)|5|||
163090583|NCT00894387|589042888|FG001|Overall Study|Other (Missing)|3|||
163090584|NCT00894387|589042887|FG000|Overall Study|Mis-randomized|13|||
163090585|NCT00894387|589042888|FG001|Overall Study|Mis-randomized|9|||
163090586|NCT00894387|589042887|FG000|Overall Study|GCP non-compliance|0|||
163090587|NCT00894387|589042888|FG001|Overall Study|GCP non-compliance|2|||
163090588|NCT03338400|589042889|FG000|Overall Study|Lost to Follow-up|1|||
163090589|NCT03338400|589042890|FG001|Overall Study|Lost to Follow-up|2|||
163090590|NCT00487981|589042893|FG000|Overall Study|Hypothyroidism diagnosis|1|||
163090591|NCT01213082|589042897|FG000|Overall Study|Lost to Follow-up|6|||
163090592|NCT01213082|589042898|FG001|Overall Study|Lost to Follow-up|7|||
163090593|NCT01213082|589042899|FG002|Overall Study|Lost to Follow-up|4|||
162650634|NCT00680901|587438879|FG001|Overall Study|Lost to Follow-up|5|||
162650635|NCT00680901|587438878|FG000|Overall Study|Subject decided to withdraw from the study|4|||
162650636|NCT00680901|587438879|FG001|Overall Study|Subject decided to withdraw from the study|15|||
162650637|NCT00680901|587438878|FG000|Overall Study|Sponsor decision|1|||
162650638|NCT00680901|587438879|FG001|Overall Study|Sponsor decision|0|||
162650639|NCT00680901|587438878|FG000|Overall Study|Physician Decision|0|||
162650640|NCT00680901|587438879|FG001|Overall Study|Physician Decision|2|||
162650641|NCT00680901|587438878|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
162650642|NCT00680901|587438879|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
162650643|NCT00680901|587438878|FG000|Overall Study|Other protocol defined stopping criteria|17|||
162650644|NCT00680901|587438879|FG001|Overall Study|Other protocol defined stopping criteria|17|||
162650645|NCT04251221|587438882|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
162650646|NCT04251221|587438883|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
163090594|NCT01213082|589042897|FG000|Overall Study|Physician Decision|0|||
163090595|NCT01213082|589042898|FG001|Overall Study|Physician Decision|0|||
163090596|NCT01213082|589042899|FG002|Overall Study|Physician Decision|1|||
163090597|NCT00698828|589042905|FG000|Overall Study|Adverse Event|3|||
163090598|NCT00698828|589042906|FG001|Overall Study|Adverse Event|4|||
163090599|NCT00698828|589042907|FG002|Overall Study|Adverse Event|4|||
163090600|NCT00698828|589042905|FG000|Overall Study|Death|0|||
163090601|NCT00698828|589042906|FG001|Overall Study|Death|0|||
163090602|NCT00698828|589042907|FG002|Overall Study|Death|1|||
163090603|NCT00698828|589042905|FG000|Overall Study|Exacerbation of COPD|1|||
163090604|NCT00698828|589042906|FG001|Overall Study|Exacerbation of COPD|3|||
163090605|NCT00698828|589042907|FG002|Overall Study|Exacerbation of COPD|0|||
163090606|NCT00698828|589042905|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
163090607|NCT00698828|589042906|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
163090608|NCT00698828|589042907|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
163090609|NCT00698828|589042905|FG000|Overall Study|Investigator/Sponsor decision|1|||
163090610|NCT00698828|589042906|FG001|Overall Study|Investigator/Sponsor decision|0|||
163090611|NCT00698828|589042907|FG002|Overall Study|Investigator/Sponsor decision|2|||
163090612|NCT00698828|589042905|FG000|Overall Study|Lost to Follow-up|1|||
163090613|NCT00698828|589042906|FG001|Overall Study|Lost to Follow-up|1|||
163090614|NCT00698828|589042907|FG002|Overall Study|Lost to Follow-up|0|||
163090615|NCT00698828|589042905|FG000|Overall Study|Withdrew consent|0|||
163090616|NCT00698828|589042906|FG001|Overall Study|Withdrew consent|7|||
163090617|NCT00698828|589042907|FG002|Overall Study|Withdrew consent|4|||
163090618|NCT00698828|589042905|FG000|Overall Study|Withdrew consent (not treated)|2|||
163090619|NCT00698828|589042906|FG001|Overall Study|Withdrew consent (not treated)|0|||
163090620|NCT00698828|589042907|FG002|Overall Study|Withdrew consent (not treated)|0|||
163090621|NCT02013609|589042910|FG000|Overall Study|Withdrawal by Subject|9|||
163090622|NCT02013609|589042910|FG000|Overall Study|Lost to Follow-up|3|||
163090623|NCT02013609|589042910|FG000|Overall Study|Adverse Event|3|||
163090624|NCT02013609|589042910|FG000|Overall Study|Met Withdrawal Criteria|3|||
163090625|NCT01816295|589042911|FG000|Double Blind Phase|Adverse Event|11|||
163090626|NCT01816295|589042912|FG001|Double Blind Phase|Adverse Event|8|||
163090627|NCT01816295|589042911|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
163090628|NCT01816295|589042912|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
163090629|NCT01816295|589042911|FG000|Double Blind Phase|Lost to Follow-up|3|||
163090630|NCT01816295|589042912|FG001|Double Blind Phase|Lost to Follow-up|5|||
163090631|NCT01816295|589042911|FG000|Double Blind Phase|Physician Decision|2|||
163090632|NCT01816295|589042912|FG001|Double Blind Phase|Physician Decision|2|||
163090633|NCT01816295|589042911|FG000|Double Blind Phase|Protocol Violation|17|||
163090634|NCT01816295|589042912|FG001|Double Blind Phase|Protocol Violation|11|||
163090635|NCT01816295|589042911|FG000|Double Blind Phase|Sponsor Decision|8|||
163090636|NCT01816295|589042912|FG001|Double Blind Phase|Sponsor Decision|8|||
163090637|NCT01816295|589042911|FG000|Double Blind Phase|Withdrawal by Subject|22|||
163090638|NCT01816295|589042912|FG001|Double Blind Phase|Withdrawal by Subject|20|||
163090639|NCT01816295|589042911|FG000|OLE Phase|Adverse Event|17|||
163090640|NCT01816295|589042912|FG001|OLE Phase|Adverse Event|15|||
163090641|NCT01816295|589042911|FG000|OLE Phase|Death|1|||
163090642|NCT01816295|589042912|FG001|OLE Phase|Death|0|||
163090643|NCT01816295|589042911|FG000|OLE Phase|Entry Criteria Not Met|3|||
163090644|NCT01816295|589042912|FG001|OLE Phase|Entry Criteria Not Met|5|||
163090645|NCT01816295|589042911|FG000|OLE Phase|Lost to Follow-up|5|||
163090646|NCT01816295|589042912|FG001|OLE Phase|Lost to Follow-up|5|||
163090647|NCT01816295|589042911|FG000|OLE Phase|Physician Decision|3|||
163090648|NCT01816295|589042912|FG001|OLE Phase|Physician Decision|1|||
163090649|NCT01816295|589042911|FG000|OLE Phase|Protocol Violation|4|||
163090650|NCT01816295|589042912|FG001|OLE Phase|Protocol Violation|4|||
163090651|NCT01816295|589042911|FG000|OLE Phase|Sponsor Decision|7|||
163090652|NCT01816295|589042912|FG001|OLE Phase|Sponsor Decision|9|||
163090653|NCT01816295|589042911|FG000|OLE Phase|Withdrawal by Subject|10|||
163090654|NCT01816295|589042912|FG001|OLE Phase|Withdrawal by Subject|10|||
163090655|NCT01816295|589042911|FG000|OLE Phase|Lack of Efficacy|3|||
163090656|NCT01816295|589042912|FG001|OLE Phase|Lack of Efficacy|7|||
163090657|NCT01130337|589042914|FG000|Overall Study|Withdrawal by Subject|3|||
163090658|NCT01130337|589042914|FG000|Overall Study|Principal investigator decision|1|||
163090659|NCT01130337|589042914|FG000|Overall Study|Death|1|||
163090660|NCT01130337|589042914|FG000|Overall Study|Disease progression|1|||
163090661|NCT01130337|589042914|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
163090662|NCT01130337|589042914|FG000|Overall Study|Surgical resection (R2)|1|||
163090663|NCT03886493|589042915|FG000|Overall Study|Adverse Event|1|||
163090664|NCT04067011|589042917|FG000|Overall Study|Not Treated|8|||
163090665|NCT04067011|589042918|FG001|Overall Study|Not Treated|7|||
163090666|NCT04067011|589042919|FG002|Overall Study|Not Treated|5|||
163090667|NCT04067011|589042917|FG000|Overall Study|Adverse Event|2|||
163090668|NCT04067011|589042918|FG001|Overall Study|Adverse Event|1|||
163090669|NCT04067011|589042919|FG002|Overall Study|Adverse Event|0|||
163090670|NCT04067011|589042917|FG000|Overall Study|Withdrawal by Subject|6|||
163090671|NCT04067011|589042918|FG001|Overall Study|Withdrawal by Subject|2|||
163090672|NCT04067011|589042919|FG002|Overall Study|Withdrawal by Subject|1|||
163090673|NCT04067011|589042917|FG000|Overall Study|Lost to Follow-up|0|||
163090674|NCT04067011|589042918|FG001|Overall Study|Lost to Follow-up|0|||
163090675|NCT04067011|589042919|FG002|Overall Study|Lost to Follow-up|1|||
163090676|NCT04067011|589042917|FG000|Overall Study|Physician Decision|1|||
163090677|NCT04067011|589042918|FG001|Overall Study|Physician Decision|1|||
163090678|NCT04067011|589042919|FG002|Overall Study|Physician Decision|0|||
163090679|NCT04067011|589042917|FG000|Overall Study|Other Reasons|2|||
163090680|NCT04067011|589042918|FG001|Overall Study|Other Reasons|0|||
163090681|NCT04067011|589042919|FG002|Overall Study|Other Reasons|1|||
163090682|NCT04067011|589042917|FG000|Overall Study|Missing|0|||
163090683|NCT04067011|589042918|FG001|Overall Study|Missing|2|||
163090684|NCT04067011|589042919|FG002|Overall Study|Missing|0|||
163090685|NCT05209386|589042920|FG000|Overall Study|Withdrawal by Subject|8|||
163090686|NCT05209386|589042920|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
163090687|NCT04436744|589042921|FG000|Overall Study|Adverse Event|1|||
163090688|NCT04436744|589042922|FG001|Overall Study|Adverse Event|1|||
163090689|NCT04436744|589042921|FG000|Overall Study|Death|1|||
163090690|NCT04436744|589042922|FG001|Overall Study|Death|0|||
163090691|NCT04436744|589042921|FG000|Overall Study|Lost to Follow-up|0|||
163090692|NCT04436744|589042922|FG001|Overall Study|Lost to Follow-up|2|||
163090693|NCT04436744|589042921|FG000|Overall Study|Physician Decision|0|||
163090694|NCT04436744|589042922|FG001|Overall Study|Physician Decision|1|||
163090695|NCT04436744|589042921|FG000|Overall Study|Progressive Disease|0|||
163090696|NCT04436744|589042922|FG001|Overall Study|Progressive Disease|4|||
163090697|NCT04436744|589042921|FG000|Overall Study|Protocol Deviation|1|||
163090698|NCT04436744|589042922|FG001|Overall Study|Protocol Deviation|1|||
163090699|NCT04436744|589042921|FG000|Overall Study|Withdrawal by Subject|1|||
163090700|NCT04436744|589042922|FG001|Overall Study|Withdrawal by Subject|2|||
163090701|NCT01463033|589042923|FG000|Overall Study|Lost to Follow-up|4|||
163090702|NCT01463033|589042924|FG001|Overall Study|Lost to Follow-up|4|||
163090703|NCT01463033|589042923|FG000|Overall Study|Death|3|||
163090704|NCT01463033|589042924|FG001|Overall Study|Death|2|||
163090705|NCT01240863|589042926|FG000|Open-label Titration Period|Adverse Event|47|||
163090706|NCT01240863|589042927|FG001|Open-label Titration Period|Adverse Event|0|||
163090707|NCT01240863|589042928|FG002|Open-label Titration Period|Adverse Event|0|||
163090708|NCT01240863|589042926|FG000|Open-label Titration Period|Lack of Efficacy|19|||
163090709|NCT01240863|589042927|FG001|Open-label Titration Period|Lack of Efficacy|0|||
163090710|NCT01240863|589042928|FG002|Open-label Titration Period|Lack of Efficacy|0|||
163090711|NCT01240863|589042926|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
163090712|NCT01240863|589042927|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
163090713|NCT01240863|589042928|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
163090714|NCT01240863|589042926|FG000|Open-label Titration Period|Protocol Violation|7|||
163090715|NCT01240863|589042927|FG001|Open-label Titration Period|Protocol Violation|0|||
163090716|NCT01240863|589042928|FG002|Open-label Titration Period|Protocol Violation|0|||
163090717|NCT01240863|589042926|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
163090718|NCT01240863|589042927|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
163090719|NCT01240863|589042928|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
163090720|NCT01240863|589042926|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
163090721|NCT01240863|589042927|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
163090722|NCT01240863|589042928|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
163090723|NCT01240863|589042926|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
163090724|NCT01240863|589042927|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
163090725|NCT01240863|589042928|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
163090726|NCT01240863|589042926|FG000|Open-label Titration Period|Other|7|||
163090727|NCT01240863|589042927|FG001|Open-label Titration Period|Other|0|||
163090728|NCT01240863|589042928|FG002|Open-label Titration Period|Other|0|||
163090729|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
163090730|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
163090731|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
163090732|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163090733|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
163090734|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
162650647|NCT02120794|587438886|FG000|Overall Study|Withdrawal by Subject|43|||
163090735|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163090736|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
163090737|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163090738|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163090739|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
163090740|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
163090741|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
162650648|NCT02120794|587438886|FG000|Overall Study|Adverse Event|10|||
162650649|NCT02120794|587438886|FG000|Overall Study|Physician Decision|4|||
162718799|NCT01235949|587676691|FG011|Booster Phase|Migrated/moved from study area|1|||
163090742|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
163090743|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
163090744|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
163090745|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
163090746|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
163090747|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
163090748|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
163090749|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
163090750|NCT01240863|589042926|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
163090751|NCT01240863|589042927|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
163090752|NCT01240863|589042928|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
163090753|NCT00746811|589042929|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
163090754|NCT00746811|589042930|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
163090755|NCT01538199|589042931|FG000|Overall Study|Lost to Follow-up|1|||
163090756|NCT01538199|589042932|FG001|Overall Study|Lost to Follow-up|2|||
163090757|NCT01538199|589042933|FG002|Overall Study|Lost to Follow-up|1|||
163090758|NCT01538199|589042934|FG003|Overall Study|Lost to Follow-up|0|||
163090759|NCT01538199|589042931|FG000|Overall Study|participant did not have time|1|||
163090760|NCT01538199|589042932|FG001|Overall Study|participant did not have time|0|||
163090761|NCT01538199|589042933|FG002|Overall Study|participant did not have time|0|||
163090762|NCT01538199|589042934|FG003|Overall Study|participant did not have time|2|||
163090763|NCT01538199|589042931|FG000|Overall Study|Lack of Efficacy|0|||
163090764|NCT01538199|589042932|FG001|Overall Study|Lack of Efficacy|1|||
163090765|NCT01538199|589042933|FG002|Overall Study|Lack of Efficacy|0|||
163090766|NCT01538199|589042934|FG003|Overall Study|Lack of Efficacy|0|||
163090767|NCT03358030|589042935|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
163090768|NCT03358030|589042936|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163090769|NCT03358030|589042937|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
163090770|NCT03358030|589042938|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
163090771|NCT03358030|589042935|FG000|Overall Study|Ineligibility|0|||
163090772|NCT03358030|589042936|FG001|Overall Study|Ineligibility|0|||
163090773|NCT03358030|589042937|FG002|Overall Study|Ineligibility|0|||
163090774|NCT03358030|589042938|FG003|Overall Study|Ineligibility|2|||
163090775|NCT03358030|589042935|FG000|Overall Study|Voluntary Withdrawal|1|||
163090776|NCT03358030|589042936|FG001|Overall Study|Voluntary Withdrawal|1|||
163090777|NCT03358030|589042937|FG002|Overall Study|Voluntary Withdrawal|3|||
163090778|NCT03358030|589042938|FG003|Overall Study|Voluntary Withdrawal|1|||
163090779|NCT03358030|589042935|FG000|Overall Study|Other|0|||
163090780|NCT03358030|589042936|FG001|Overall Study|Other|0|||
163090781|NCT03358030|589042937|FG002|Overall Study|Other|1|||
163090782|NCT03358030|589042938|FG003|Overall Study|Other|0|||
163090783|NCT03342560|589042939|FG000|Overall Study|Lost to Follow-up|2|||
163090784|NCT02604511|589042940|FG000|Overall Study|Adverse Event|3|||
163090785|NCT02604511|589042940|FG000|Overall Study|Disease Progression|4|||
163090786|NCT02604511|589042940|FG000|Overall Study|Withdrawal by Subject|3|||
163090787|NCT02604511|589042940|FG000|Overall Study|Participant ineligible|1|||
163090788|NCT02604511|589042940|FG000|Overall Study|Intercurrent illness|1|||
163090789|NCT03770286|589042941|FG000|Overall Study|Lost to Follow-up|6|||
163090790|NCT03770286|589042942|FG001|Overall Study|Lost to Follow-up|4|||
163090791|NCT03770286|589042943|FG002|Overall Study|Lost to Follow-up|3|||
163090792|NCT03770286|589042941|FG000|Overall Study|Protocol Violation|1|||
163090793|NCT03770286|589042942|FG001|Overall Study|Protocol Violation|0|||
163090794|NCT03770286|589042943|FG002|Overall Study|Protocol Violation|2|||
163090795|NCT02505425|589042944|FG000|Overall Study|Lost to Follow-up|41|||
163090796|NCT02505425|589042945|FG001|Overall Study|Lost to Follow-up|61|||
163090797|NCT02505425|589042946|FG002|Overall Study|Lost to Follow-up|31|||
163090798|NCT02505425|589042947|FG003|Overall Study|Lost to Follow-up|19|||
163090799|NCT02505425|589042944|FG000|Overall Study|Withdrawal by Subject|39|||
163090800|NCT02505425|589042945|FG001|Overall Study|Withdrawal by Subject|9|||
163090801|NCT02505425|589042946|FG002|Overall Study|Withdrawal by Subject|19|||
163090802|NCT02505425|589042947|FG003|Overall Study|Withdrawal by Subject|7|||
163090803|NCT02505425|589042944|FG000|Overall Study|Death|8|||
163090804|NCT02505425|589042945|FG001|Overall Study|Death|12|||
163090805|NCT02505425|589042946|FG002|Overall Study|Death|0|||
163090806|NCT02505425|589042947|FG003|Overall Study|Death|0|||
163090807|NCT05643495|589042954|FG000|Overall Study|Adverse Event|0|||
163090808|NCT05643495|589042955|FG001|Overall Study|Adverse Event|1|||
163090809|NCT05643495|589042954|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163090810|NCT05643495|589042955|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
163090811|NCT02257528|589042956|FG000|Overall Study|Never received study treatment|1|||
163090812|NCT01729039|589042957|FG000|Overall Study|disqualified|2|||
163090813|NCT01729039|589042958|FG001|Overall Study|disqualified|5|||
163090814|NCT01729039|589042957|FG000|Overall Study|Withdrawal by Subject|8|||
163090815|NCT01729039|589042958|FG001|Overall Study|Withdrawal by Subject|7|||
163090816|NCT00404248|589042961|FG000|Overall Study|pts declining status|0|||
163090817|NCT00404248|589042962|FG001|Overall Study|pts declining status|1|||
163090818|NCT00404248|589042963|FG002|Overall Study|pts declining status|0|||
163090819|NCT00404248|589042964|FG003|Overall Study|pts declining status|0|||
163090820|NCT00404248|589042965|FG004|Overall Study|pts declining status|0|||
163090821|NCT00404248|589042966|FG005|Overall Study|pts declining status|0|||
163090822|NCT00404248|589042967|FG006|Overall Study|pts declining status|0|||
163090823|NCT00404248|589042968|FG007|Overall Study|pts declining status|0|||
163090824|NCT00404248|589042969|FG008|Overall Study|pts declining status|0|||
163090825|NCT00698841|589042970|FG000|Overall Study|Withdrawal by Subject|2|||
163090826|NCT00698841|589042970|FG000|Overall Study|Adverse Event|3|||
163090827|NCT00698841|589042970|FG000|Overall Study|Disease progression|7|||
163090828|NCT00698841|589042970|FG000|Overall Study|Failure to meet eligibility criteria|2|||
163090829|NCT00698841|589042970|FG000|Overall Study|Study drug toxicity|2|||
163090830|NCT00698841|589042970|FG000|Overall Study|Other|2|||
163090831|NCT05788991|589042971|FG000|Overall Study|Not treated with study medication|1|||
163090832|NCT05788991|589042972|FG001|Overall Study|Not treated with study medication|3|||
163090833|NCT05788991|589042971|FG000|Overall Study|Withdrawal by Subject|1|||
163090834|NCT05788991|589042972|FG001|Overall Study|Withdrawal by Subject|0|||
163090835|NCT05788991|589042971|FG000|Overall Study|Lack of Efficacy|0|||
163090836|NCT05788991|589042972|FG001|Overall Study|Lack of Efficacy|1|||
163090837|NCT05788991|589042971|FG000|Overall Study|Protocol Violation|1|||
163090838|NCT05788991|589042972|FG001|Overall Study|Protocol Violation|2|||
163090839|NCT04464473|589042973|FG000|Overall Study|New piercing could not be removed for scanning|0|||
163090840|NCT04464473|589042974|FG001|Overall Study|New piercing could not be removed for scanning|0|||
163090841|NCT04464473|589042975|FG002|Overall Study|New piercing could not be removed for scanning|0|||
163090842|NCT04464473|589042976|FG003|Overall Study|New piercing could not be removed for scanning|1|||
163090843|NCT04464473|589042977|FG004|Overall Study|New piercing could not be removed for scanning|0|||
163090844|NCT04464473|589042978|FG005|Overall Study|New piercing could not be removed for scanning|0|||
163090845|NCT04464473|589042973|FG000|Overall Study|Adverse Event|0|||
163090846|NCT04464473|589042974|FG001|Overall Study|Adverse Event|0|||
163090847|NCT04464473|589042975|FG002|Overall Study|Adverse Event|0|||
163090848|NCT04464473|589042976|FG003|Overall Study|Adverse Event|1|||
163090849|NCT04464473|589042977|FG004|Overall Study|Adverse Event|0|||
163090850|NCT04464473|589042978|FG005|Overall Study|Adverse Event|0|||
163090851|NCT04464473|589042973|FG000|Overall Study|Lost to Follow-up|0|||
163090852|NCT04464473|589042974|FG001|Overall Study|Lost to Follow-up|0|||
163090853|NCT04464473|589042975|FG002|Overall Study|Lost to Follow-up|0|||
163090854|NCT04464473|589042976|FG003|Overall Study|Lost to Follow-up|1|||
163090855|NCT04464473|589042977|FG004|Overall Study|Lost to Follow-up|0|||
163090856|NCT04464473|589042978|FG005|Overall Study|Lost to Follow-up|0|||
163090857|NCT03802396|589042979|FG000|Overall Study|Withdrawal by Subject|2|||
163090858|NCT03802396|589042980|FG001|Overall Study|Withdrawal by Subject|0|||
163090859|NCT03802396|589042979|FG000|Overall Study|Surgery Cancelled|1|||
163090860|NCT03802396|589042980|FG001|Overall Study|Surgery Cancelled|0|||
163090861|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
163090862|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
163090863|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
163090864|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
163090865|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090866|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090867|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
163090868|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163090869|NCT04237584|589042991|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090870|NCT04237584|589042992|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090871|NCT04237584|589042993|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
163090872|NCT04237584|589042994|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
163090873|NCT04237584|589042991|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
162650650|NCT02120794|587438886|FG000|Overall Study|Due to insurance coverage|1|||
162650651|NCT01148511|587438887|FG000|Exposed to Study Drug|Protocol Violation|2|||
162650652|NCT01148511|587438888|FG001|Exposed to Study Drug|Protocol Violation|0|||
162650653|NCT01148511|587438889|FG002|Exposed to Study Drug|Protocol Violation|0|||
162650654|NCT01148511|587438887|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
162650655|NCT01148511|587438888|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
162650656|NCT01148511|587438889|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
162650657|NCT01148511|587438887|FG000|Randomized|Adverse Event|0|||
162650658|NCT01148511|587438888|FG001|Randomized|Adverse Event|1|||
162650659|NCT01148511|587438889|FG002|Randomized|Adverse Event|0|||
162650660|NCT01148511|587438887|FG000|Randomized|Protocol Violation|0|||
162650661|NCT01148511|587438888|FG001|Randomized|Protocol Violation|2|||
162718800|NCT01235949|587676692|FG012|Booster Phase|Migrated/moved from study area|1|||
162718801|NCT01235949|587676693|FG013|Booster Phase|Migrated/moved from study area|0|||
163090874|NCT04237584|589042992|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
163090875|NCT04237584|589042993|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
163090876|NCT04237584|589042994|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
163090877|NCT04237584|589042991|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090878|NCT04237584|589042992|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090879|NCT04237584|589042993|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
163090880|NCT04237584|589042994|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
163090881|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
163090882|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
163090883|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
163090884|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
163090885|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
163090886|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
163090887|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
163090888|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
163090889|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
163090890|NCT01150357|589043000|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
163090891|NCT01150357|589043001|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
163090892|NCT01150357|589043002|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
163090893|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
163090894|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
163090895|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
163090896|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
163090897|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
163090898|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
163090899|NCT01150357|589043000|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
163090900|NCT01150357|589043001|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
163090901|NCT01150357|589043002|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
163090902|NCT02661672|589043003|FG000|Overall Study|Lost to Follow-up|1|||
163090903|NCT02661672|589043003|FG000|Overall Study|Death|4|||
163038178|NCT01128400|588847303|FG001|Overall Study|were not invited to participate on taste|0|||
163038179|NCT01128400|588847304|FG002|Overall Study|were not invited to participate on taste|15|||
163038180|NCT01128400|588847302|FG000|Overall Study|Excluded due to sinus problems|0|||
163038181|NCT01128400|588847303|FG001|Overall Study|Excluded due to sinus problems|1|||
163038182|NCT01128400|588847304|FG002|Overall Study|Excluded due to sinus problems|0|||
163038183|NCT03782571|588847310|FG000|Period 1|Withdrawal by Subject|1|||
163038184|NCT03782571|588847311|FG001|Period 1|Withdrawal by Subject|0|||
163038185|NCT03782571|588847312|FG002|Period 1|Withdrawal by Subject|0|||
163038186|NCT03782571|588847313|FG003|Period 1|Withdrawal by Subject|0|||
162650662|NCT01148511|587438889|FG002|Randomized|Protocol Violation|1|||
163090904|NCT03549338|589044601|FG000|Overall Study|Progressive Disease|1|||
163090905|NCT03549338|589044602|FG001|Overall Study|Progressive Disease|0|||
163090906|NCT03549338|589044603|FG002|Overall Study|Progressive Disease|0|||
163090907|NCT03549338|589044601|FG000|Overall Study|Clinical Progression|0|||
163090908|NCT03549338|589044602|FG001|Overall Study|Clinical Progression|1|||
163090909|NCT03549338|589044603|FG002|Overall Study|Clinical Progression|0|||
163090910|NCT01492426|589044604|FG000|Treatment|Death|0|||
163090911|NCT01492426|589044605|FG001|Treatment|Death|1|||
163090912|NCT01492426|589044604|FG000|Treatment|Other|1|||
163090913|NCT01492426|589044605|FG001|Treatment|Other|0|||
163090914|NCT01492426|589044604|FG000|Treatment|Adverse Event|25|||
163090915|NCT01492426|589044605|FG001|Treatment|Adverse Event|25|||
163090916|NCT01492426|589044604|FG000|Treatment|Lack of Efficacy|38|||
163090917|NCT01492426|589044605|FG001|Treatment|Lack of Efficacy|5|||
163090918|NCT01492426|589044604|FG000|Treatment|Participant withdrew consent|1|||
163090919|NCT01492426|589044605|FG001|Treatment|Participant withdrew consent|2|||
163090920|NCT01492426|589044604|FG000|Treatment|Poor compliance/noncompliance|1|||
163090921|NCT01492426|589044605|FG001|Treatment|Poor compliance/noncompliance|0|||
163090922|NCT01492426|589044604|FG000|Treatment|Subject requested discontinue study drug|7|||
163090923|NCT01492426|589044605|FG001|Treatment|Subject requested discontinue study drug|3|||
163090924|NCT01492426|589044604|FG000|Treatment|Lost to Follow-up|9|||
163090925|NCT01492426|589044605|FG001|Treatment|Lost to Follow-up|4|||
163090926|NCT01492426|589044604|FG000|Treatment|Participant does not meet study criteria|1|||
163090927|NCT01492426|589044605|FG001|Treatment|Participant does not meet study criteria|0|||
163090928|NCT01492426|589044604|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
162650663|NCT01148511|587438887|FG000|Randomized|Lost to Follow-up|0|||
163038187|NCT03782571|588847310|FG000|Period 3|Subject Unable to Attend V5|1|||
163038188|NCT03782571|588847311|FG001|Period 3|Subject Unable to Attend V5|0|||
163038189|NCT03782571|588847312|FG002|Period 3|Subject Unable to Attend V5|0|||
163090929|NCT01492426|589044605|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
162650664|NCT01148511|587438888|FG001|Randomized|Lost to Follow-up|1|||
162650665|NCT01148511|587438889|FG002|Randomized|Lost to Follow-up|1|||
163090930|NCT01492426|589044604|FG000|Follow-Up|Death|1|||
163090931|NCT01492426|589044605|FG001|Follow-Up|Death|0|||
163090932|NCT01492426|589044604|FG000|Follow-Up|Other|4|||
163090933|NCT01492426|589044605|FG001|Follow-Up|Other|2|||
163090934|NCT01492426|589044604|FG000|Follow-Up|Participant Withdrew Consent|6|||
163090935|NCT01492426|589044605|FG001|Follow-Up|Participant Withdrew Consent|1|||
163090936|NCT01492426|589044604|FG000|Follow-Up|Lost to Follow-up|12|||
163090937|NCT01492426|589044605|FG001|Follow-Up|Lost to Follow-up|6|||
163090938|NCT00269113|589044606|FG000|Overall Study|Adverse Event|14|||
163090939|NCT00269113|589044607|FG001|Overall Study|Adverse Event|7|||
163090940|NCT00269113|589044606|FG000|Overall Study|Lack of Efficacy|35|||
163090941|NCT00269113|589044607|FG001|Overall Study|Lack of Efficacy|18|||
163090942|NCT00269113|589044606|FG000|Overall Study|Early Improvement|2|||
163090943|NCT00269113|589044607|FG001|Overall Study|Early Improvement|0|||
163090944|NCT00269113|589044606|FG000|Overall Study|Withdrawal by Subject|0|||
163090945|NCT00269113|589044607|FG001|Overall Study|Withdrawal by Subject|2|||
163090946|NCT00269113|589044606|FG000|Overall Study|Death|6|||
163090947|NCT00269113|589044607|FG001|Overall Study|Death|2|||
163090948|NCT00269113|589044606|FG000|Overall Study|Lost to Follow-up|2|||
163090949|NCT00269113|589044607|FG001|Overall Study|Lost to Follow-up|1|||
163090950|NCT00269113|589044606|FG000|Overall Study|Protocol Violation|15|||
163090951|NCT00269113|589044607|FG001|Overall Study|Protocol Violation|5|||
163090952|NCT00269113|589044606|FG000|Overall Study|Other|0|||
163090953|NCT00269113|589044607|FG001|Overall Study|Other|2|||
163090954|NCT00652743|589044608|FG000|Months 12-18|Lost to Follow-up|1|||
163090955|NCT00652743|589044609|FG001|Months 12-18|Lost to Follow-up|2|||
163090956|NCT00652743|589044610|FG002|Months 12-18|Lost to Follow-up|7|||
163090957|NCT00652743|589044608|FG000|Months 24-30|Other|5|||
163090958|NCT00652743|589044609|FG001|Months 24-30|Other|1|||
163090959|NCT00652743|589044610|FG002|Months 24-30|Other|11|||
163090960|NCT00652743|589044608|FG000|Months 36-42|Serious Adverse Events|0|||
163090961|NCT00652743|589044609|FG001|Months 36-42|Serious Adverse Events|1|||
163090962|NCT00652743|589044610|FG002|Months 36-42|Serious Adverse Events|1|||
163090963|NCT00652743|589044608|FG000|Months 36-42|Withdrawal by Subject|1|||
163090964|NCT00652743|589044609|FG001|Months 36-42|Withdrawal by Subject|1|||
163090965|NCT00652743|589044610|FG002|Months 36-42|Withdrawal by Subject|0|||
163090966|NCT00652743|589044608|FG000|Months 36-42|Lost to Follow-up|0|||
163090967|NCT00652743|589044609|FG001|Months 36-42|Lost to Follow-up|1|||
163090968|NCT00652743|589044610|FG002|Months 36-42|Lost to Follow-up|0|||
163090969|NCT00652743|589044608|FG000|Months 36-42|Migrated/moved from study area|1|||
163090970|NCT00652743|589044609|FG001|Months 36-42|Migrated/moved from study area|0|||
163090971|NCT00652743|589044610|FG002|Months 36-42|Migrated/moved from study area|0|||
163090972|NCT00652743|589044608|FG000|Months 36-42|Other|4|||
163090973|NCT00652743|589044609|FG001|Months 36-42|Other|2|||
163090974|NCT00652743|589044610|FG002|Months 36-42|Other|8|||
163090975|NCT00140140|589044611|FG000|Overall Study|Unacceptable toxicity|1|||
163090976|NCT00140140|589044612|FG001|Overall Study|Unacceptable toxicity|1|||
163090977|NCT00140140|589044613|FG002|Overall Study|Unacceptable toxicity|2|||
162718802|NCT01235949|587676694|FG014|Booster Phase|Migrated/moved from study area|0|||
162718803|NCT01235949|587676695|FG015|Booster Phase|Migrated/moved from study area|0|||
162718804|NCT01235949|587676696|FG016|Booster Phase|Migrated/moved from study area|0|||
162718805|NCT01235949|587676697|FG017|Booster Phase|Migrated/moved from study area|1|||
162718806|NCT01235949|587676680|FG000|Booster Phase|Adverse Event|0|||
162718807|NCT01235949|587676681|FG001|Booster Phase|Adverse Event|0|||
162718808|NCT01235949|587676682|FG002|Booster Phase|Adverse Event|0|||
162718809|NCT01235949|587676683|FG003|Booster Phase|Adverse Event|0|||
162718810|NCT01235949|587676684|FG004|Booster Phase|Adverse Event|0|||
162718811|NCT01235949|587676685|FG005|Booster Phase|Adverse Event|0|||
162718812|NCT01235949|587676686|FG006|Booster Phase|Adverse Event|0|||
162718813|NCT01235949|587676687|FG007|Booster Phase|Adverse Event|0|||
162718814|NCT01235949|587676688|FG008|Booster Phase|Adverse Event|0|||
162718815|NCT01235949|587676689|FG009|Booster Phase|Adverse Event|0|||
163090978|NCT00140140|589044611|FG000|Overall Study|Physician Decision|1|||
163090979|NCT00140140|589044612|FG001|Overall Study|Physician Decision|1|||
163090980|NCT00140140|589044613|FG002|Overall Study|Physician Decision|0|||
163090981|NCT01248793|589044614|FG000|Overall Study|Lost to Follow-up|0|||
163090982|NCT01248793|589044615|FG001|Overall Study|Lost to Follow-up|1|||
163090983|NCT01248793|589044614|FG000|Overall Study|Adverse Event|1|||
163090984|NCT01248793|589044615|FG001|Overall Study|Adverse Event|1|||
163090985|NCT01248793|589044614|FG000|Overall Study|Protocol Violation|0|||
163090986|NCT01248793|589044615|FG001|Overall Study|Protocol Violation|1|||
163090987|NCT01248793|589044614|FG000|Overall Study|Withdrawal by Subject|3|||
163090988|NCT01248793|589044615|FG001|Overall Study|Withdrawal by Subject|3|||
163090989|NCT00517699|589044616|FG000|Overall Study|Withdrawal by Subject|1|||
162718816|NCT01235949|587676690|FG010|Booster Phase|Adverse Event|0|||
162718817|NCT01235949|587676691|FG011|Booster Phase|Adverse Event|0|||
162718818|NCT01235949|587676692|FG012|Booster Phase|Adverse Event|0|||
162718819|NCT01235949|587676693|FG013|Booster Phase|Adverse Event|0|||
163090990|NCT00517699|589044616|FG000|Overall Study|Lack of Efficacy|1|||
163090991|NCT00517699|589044616|FG000|Overall Study|Administrative error|1|||
163090992|NCT00517699|589044616|FG000|Overall Study|Study terminated by Sponsor|2|||
163090993|NCT01114737|589044617|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163090994|NCT01114737|589044618|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163090995|NCT01114737|589044617|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
163090996|NCT01114737|589044618|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
163090997|NCT01114737|589044617|FG000|Randomized Treatment Period|Pregnancy|1|||
163090998|NCT01114737|589044618|FG001|Randomized Treatment Period|Pregnancy|0|||
163090999|NCT01114737|589044617|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
163091000|NCT01114737|589044618|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
163091001|NCT01114737|589044617|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
163091002|NCT01114737|589044618|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
163091003|NCT01114737|589044617|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
163091004|NCT01114737|589044618|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
163091005|NCT02580877|589044621|FG000|Overall Study|Withdrawal by Subject|1|||
163091006|NCT02580877|589044622|FG001|Overall Study|Withdrawal by Subject|3|||
163091007|NCT02580877|589044621|FG000|Overall Study|Adverse Event|0|||
163091008|NCT02580877|589044622|FG001|Overall Study|Adverse Event|1|||
163091009|NCT01466491|589044623|FG000|Overall Study|Protocol Violation|0|||
163091010|NCT01466491|589044624|FG001|Overall Study|Protocol Violation|3|||
163091011|NCT01466491|589044625|FG002|Overall Study|Protocol Violation|2|||
163091012|NCT01466491|589044626|FG003|Overall Study|Protocol Violation|0|||
163091013|NCT01466491|589044623|FG000|Overall Study|Missing Data|0|||
163091014|NCT01466491|589044624|FG001|Overall Study|Missing Data|0|||
163091015|NCT01466491|589044625|FG002|Overall Study|Missing Data|1|||
163091016|NCT01466491|589044626|FG003|Overall Study|Missing Data|0|||
163091017|NCT01123148|589044627|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
163091018|NCT01123148|589044627|FG000|Overall Study|Didn't meet milestone criteria|1|||
163091019|NCT04460183|589044631|FG000|Overall Study|Lost to Follow-up|3|||
163091020|NCT04460183|589044632|FG001|Overall Study|Lost to Follow-up|1|||
163091021|NCT04460183|589044631|FG000|Overall Study|Withdrawal by Subject|1|||
163091022|NCT04460183|589044632|FG001|Overall Study|Withdrawal by Subject|0|||
163091023|NCT00856609|589044635|FG000|Overall Study|Adverse Event|1|||
163091024|NCT00856609|589044636|FG001|Overall Study|Adverse Event|0|||
163091025|NCT01788943|589044637|FG000|Overall Study|Withdrawal by Subject|1|||
163091026|NCT01788943|589044638|FG001|Overall Study|Withdrawal by Subject|0|||
163091027|NCT01119287|589044639|FG000|Overall Study|Patient Decision, not related to AE|0|||
163091028|NCT01119287|589044640|FG001|Overall Study|Patient Decision, not related to AE|0|||
163091029|NCT01119287|589044641|FG002|Overall Study|Patient Decision, not related to AE|2|||
163091030|NCT01119287|589044642|FG003|Overall Study|Patient Decision, not related to AE|2|||
163091031|NCT01119287|589044643|FG004|Overall Study|Patient Decision, not related to AE|1|||
163091032|NCT01119287|589044644|FG005|Overall Study|Patient Decision, not related to AE|0|||
163091033|NCT00783432|589044645|FG000|Overall Study|Adverse Event|22|||
163091034|NCT00783432|589044646|FG001|Overall Study|Adverse Event|17|||
163091035|NCT00783432|589044645|FG000|Overall Study|Lack of Efficacy|20|||
163091036|NCT00783432|589044646|FG001|Overall Study|Lack of Efficacy|21|||
163091037|NCT00783432|589044645|FG000|Overall Study|Lost to Follow-up|11|||
163091038|NCT00783432|589044646|FG001|Overall Study|Lost to Follow-up|6|||
163091039|NCT00783432|589044645|FG000|Overall Study|Withdrawal by Subject|23|||
163091040|NCT00783432|589044646|FG001|Overall Study|Withdrawal by Subject|20|||
163091041|NCT00783432|589044645|FG000|Overall Study|subject moved|3|||
163091042|NCT00783432|589044646|FG001|Overall Study|subject moved|5|||
163091043|NCT00783432|589044645|FG000|Overall Study|Protocol Violation|6|||
163091044|NCT00783432|589044646|FG001|Overall Study|Protocol Violation|9|||
163091045|NCT00186628|589044647|FG000|Overall Study|Death|2|||
163091046|NCT00186628|589044647|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
163091047|NCT01331681|589044648|FG000|Overall Study|Adverse Event|10|||
163091048|NCT01331681|589044649|FG001|Overall Study|Adverse Event|13|||
163091049|NCT01331681|589044650|FG002|Overall Study|Adverse Event|10|||
163091050|NCT01331681|589044648|FG000|Overall Study|Death|6|||
163091051|NCT01331681|589044649|FG001|Overall Study|Death|6|||
163091052|NCT01331681|589044650|FG002|Overall Study|Death|2|||
163091053|NCT01331681|589044648|FG000|Overall Study|Lack of Efficacy|0|||
163091054|NCT01331681|589044649|FG001|Overall Study|Lack of Efficacy|1|||
163091055|NCT01331681|589044650|FG002|Overall Study|Lack of Efficacy|0|||
163091056|NCT01331681|589044648|FG000|Overall Study|Withdrawal by Subject|12|||
163091057|NCT01331681|589044649|FG001|Overall Study|Withdrawal by Subject|8|||
163091058|NCT01331681|589044650|FG002|Overall Study|Withdrawal by Subject|15|||
163091059|NCT01331681|589044648|FG000|Overall Study|Protocol Violation|1|||
163091060|NCT01331681|589044649|FG001|Overall Study|Protocol Violation|1|||
162650666|NCT01148511|587438887|FG000|Randomized|Consent withdrawal|0|||
163091061|NCT01331681|589044650|FG002|Overall Study|Protocol Violation|0|||
163091062|NCT01331681|589044648|FG000|Overall Study|Lost to Follow-up|2|||
163091063|NCT01331681|589044649|FG001|Overall Study|Lost to Follow-up|4|||
162650667|NCT01148511|587438888|FG001|Randomized|Consent withdrawal|5|||
163091064|NCT01331681|589044650|FG002|Overall Study|Lost to Follow-up|1|||
163091065|NCT01331681|589044648|FG000|Overall Study|Physician Decision|2|||
163091066|NCT01331681|589044649|FG001|Overall Study|Physician Decision|0|||
163091067|NCT01331681|589044650|FG002|Overall Study|Physician Decision|4|||
163091068|NCT01331681|589044648|FG000|Overall Study|Therapeutic procedure required|1|||
163091069|NCT01331681|589044649|FG001|Overall Study|Therapeutic procedure required|0|||
163091070|NCT01331681|589044650|FG002|Overall Study|Therapeutic procedure required|0|||
163091071|NCT01331681|589044648|FG000|Overall Study|Sponsor decision|1|||
163091072|NCT01331681|589044649|FG001|Overall Study|Sponsor decision|1|||
163091073|NCT01331681|589044650|FG002|Overall Study|Sponsor decision|0|||
163091074|NCT01331681|589044648|FG000|Overall Study|Switching to other therapy|0|||
163091075|NCT01331681|589044649|FG001|Overall Study|Switching to other therapy|0|||
163091076|NCT01331681|589044650|FG002|Overall Study|Switching to other therapy|1|||
163091077|NCT01331681|589044648|FG000|Overall Study|Not Received Study Treatment|0|||
163091078|NCT01331681|589044649|FG001|Overall Study|Not Received Study Treatment|0|||
163091079|NCT01331681|589044650|FG002|Overall Study|Not Received Study Treatment|2|||
163091080|NCT05525910|589044651|FG000|Period 4|Per sponsor due to study timelines|0|||
163091081|NCT05525910|589044652|FG001|Period 4|Per sponsor due to study timelines|0|||
163091082|NCT05525910|589044653|FG002|Period 4|Per sponsor due to study timelines|1|||
163091083|NCT05525910|589044654|FG003|Period 4|Per sponsor due to study timelines|1|||
163091084|NCT05525910|589044655|FG004|Period 4|Per sponsor due to study timelines|1|||
163091085|NCT00107276|589044656|FG000|Overall Study|Progression|46|||
163091086|NCT00107276|589044656|FG000|Overall Study|Adverse Event|6|||
163091087|NCT00107276|589044656|FG000|Overall Study|M.D. decision|2|||
163091088|NCT00107276|589044656|FG000|Overall Study|Patient refusal|1|||
163091089|NCT00107276|589044656|FG000|Overall Study|Death|1|||
163091090|NCT00107276|589044656|FG000|Overall Study|Ineligible|16|||
163091091|NCT03498716|589044666|FG000|Overall Study|Withdrawal by Subject|88|||
163091092|NCT03498716|589044667|FG001|Overall Study|Withdrawal by Subject|73|||
163091093|NCT03498716|589044666|FG000|Overall Study|Study Terminated By Sponsor|933|||
163091094|NCT03498716|589044667|FG001|Overall Study|Study Terminated By Sponsor|927|||
163091095|NCT03498716|589044666|FG000|Overall Study|Lost to Follow-up|15|||
163091096|NCT03498716|589044667|FG001|Overall Study|Lost to Follow-up|26|||
163091097|NCT03498716|589044666|FG000|Overall Study|Disease Relapse|0|||
163091098|NCT03498716|589044667|FG001|Overall Study|Disease Relapse|1|||
163091099|NCT03498716|589044666|FG000|Overall Study|Death|58|||
163091100|NCT03498716|589044667|FG001|Overall Study|Death|72|||
163091101|NCT03498716|589044666|FG000|Overall Study|Physician Decision|4|||
163091102|NCT03498716|589044667|FG001|Overall Study|Physician Decision|2|||
163091103|NCT02284191|589044668|FG000|Overall Study|Withdrawal by Subject|1|||
163091104|NCT02284191|589044669|FG001|Overall Study|Withdrawal by Subject|3|||
163091105|NCT02284191|589044668|FG000|Overall Study|Lost to Follow-up|1|||
163091106|NCT02284191|589044669|FG001|Overall Study|Lost to Follow-up|0|||
163091107|NCT04064905|589044670|FG000|Overall Study|Lost to Follow-up|0|||
163091108|NCT04064905|589044671|FG001|Overall Study|Lost to Follow-up|3|||
163091109|NCT04064905|589044672|FG002|Overall Study|Lost to Follow-up|1|||
163091110|NCT04064905|589044673|FG003|Overall Study|Lost to Follow-up|4|||
163091111|NCT04064905|589044674|FG004|Overall Study|Lost to Follow-up|2|||
163091112|NCT02257684|589044677|FG000|Overall Study|Adverse Event|2|||
163091113|NCT02257684|589044677|FG000|Overall Study|Lack of Efficacy|1|||
163091114|NCT02257684|589044677|FG000|Overall Study|Sponsor's Decision|1|||
163091115|NCT03139448|589044681|FG000|Overall Study|Lack of Efficacy|6|||
163091116|NCT03139448|589044682|FG001|Overall Study|Lack of Efficacy|7|||
163091117|NCT03139448|589044681|FG000|Overall Study|Location of procedure changed|2|||
163091118|NCT03139448|589044682|FG001|Overall Study|Location of procedure changed|8|||
163091119|NCT03139448|589044681|FG000|Overall Study|Withdrawal by Subject|3|||
163091120|NCT03139448|589044682|FG001|Overall Study|Withdrawal by Subject|6|||
163091121|NCT03139448|589044681|FG000|Overall Study|Screen fail|1|||
163091122|NCT03139448|589044682|FG001|Overall Study|Screen fail|3|||
163091123|NCT03139448|589044681|FG000|Overall Study|Physician Decision|0|||
163091124|NCT03139448|589044682|FG001|Overall Study|Physician Decision|2|||
163091125|NCT01987557|589044683|FG000|Overall Study|Protocol Violation|1|||
163091126|NCT01987557|589044684|FG001|Overall Study|Protocol Violation|0|||
163091127|NCT01987557|589044685|FG002|Overall Study|Protocol Violation|1|||
163091128|NCT01987557|589044683|FG000|Overall Study|Withdrawal by Subject|2|||
163091129|NCT01987557|589044684|FG001|Overall Study|Withdrawal by Subject|1|||
163091130|NCT01987557|589044685|FG002|Overall Study|Withdrawal by Subject|2|||
163091131|NCT01987557|589044683|FG000|Overall Study|Adverse Event|0|||
163091132|NCT01987557|589044684|FG001|Overall Study|Adverse Event|2|||
162650668|NCT01148511|587438889|FG002|Randomized|Consent withdrawal|3|||
163091133|NCT01987557|589044685|FG002|Overall Study|Adverse Event|0|||
163091134|NCT00760552|589044686|FG000|Overall Study|Death|2|||
163091135|NCT00760552|589044687|FG001|Overall Study|Death|0|||
163091136|NCT00760552|589044686|FG000|Overall Study|Lost to Follow-up|11|||
163091137|NCT00760552|589044687|FG001|Overall Study|Lost to Follow-up|10|||
163091138|NCT01038323|589044688|FG000|Overall Study|Withdrawal by Subject|3|||
163091139|NCT01038323|589044689|FG001|Overall Study|Withdrawal by Subject|2|||
163091140|NCT01038323|589044690|FG002|Overall Study|Withdrawal by Subject|4|||
163091141|NCT01832727|589044699|FG000|Overall Study|Adverse Event|4|||
163091142|NCT01832727|589044700|FG001|Overall Study|Adverse Event|6|||
163091143|NCT01832727|589044701|FG002|Overall Study|Adverse Event|1|||
163038190|NCT03782571|588847313|FG003|Period 3|Subject Unable to Attend V5|0|||
163038191|NCT03782571|588847310|FG000|Period 3|Adverse Event|1|||
163038192|NCT03782571|588847311|FG001|Period 3|Adverse Event|0|||
163038193|NCT03782571|588847312|FG002|Period 3|Adverse Event|0|||
163038194|NCT03782571|588847313|FG003|Period 3|Adverse Event|0|||
163038195|NCT03504189|588847314|FG000|Overall Study|Withdrawal by Subject|1|||
163091144|NCT01832727|589044702|FG003|Overall Study|Adverse Event|0|||
163091145|NCT01832727|589044703|FG004|Overall Study|Adverse Event|1|||
163091146|NCT01832727|589044704|FG005|Overall Study|Adverse Event|1|||
163091147|NCT01832727|589044705|FG006|Overall Study|Adverse Event|2|||
163091148|NCT01832727|589044706|FG007|Overall Study|Adverse Event|1|||
163091149|NCT01832727|589044707|FG008|Overall Study|Adverse Event|9|||
163091150|NCT01832727|589044699|FG000|Overall Study|Disease progression|3|||
163091151|NCT01832727|589044700|FG001|Overall Study|Disease progression|0|||
163091152|NCT01832727|589044701|FG002|Overall Study|Disease progression|2|||
163091153|NCT01832727|589044702|FG003|Overall Study|Disease progression|1|||
163091154|NCT01832727|589044703|FG004|Overall Study|Disease progression|3|||
163091155|NCT01832727|589044704|FG005|Overall Study|Disease progression|3|||
163091156|NCT01832727|589044705|FG006|Overall Study|Disease progression|6|||
163091157|NCT01832727|589044706|FG007|Overall Study|Disease progression|2|||
163091158|NCT01832727|589044707|FG008|Overall Study|Disease progression|7|||
163091159|NCT01832727|589044699|FG000|Overall Study|Lost to Follow-up|0|||
163091160|NCT01832727|589044700|FG001|Overall Study|Lost to Follow-up|0|||
163091161|NCT01832727|589044701|FG002|Overall Study|Lost to Follow-up|0|||
163091162|NCT01832727|589044702|FG003|Overall Study|Lost to Follow-up|1|||
163038196|NCT03504189|588847314|FG000|Overall Study|Screening Failure|1|||
163038197|NCT03504189|588847314|FG000|Overall Study|Device Failure|2|||
163038198|NCT03488563|588847315|FG000|Overall Study|Lost to Follow-up|7|||
163038199|NCT03488563|588847316|FG001|Overall Study|Lost to Follow-up|6|||
163038200|NCT03488563|588847317|FG002|Overall Study|Lost to Follow-up|7|||
163038201|NCT03488563|588847315|FG000|Overall Study|Withdrawal by Subject|8|||
163038202|NCT03488563|588847316|FG001|Overall Study|Withdrawal by Subject|7|||
163038203|NCT03488563|588847317|FG002|Overall Study|Withdrawal by Subject|7|||
163038204|NCT03488563|588847315|FG000|Overall Study|Physician Decision|0|||
163038205|NCT03488563|588847316|FG001|Overall Study|Physician Decision|0|||
163038206|NCT03488563|588847317|FG002|Overall Study|Physician Decision|1|||
163038207|NCT03488563|588847315|FG000|Overall Study|Protocol Violation|3|||
163038208|NCT03488563|588847316|FG001|Overall Study|Protocol Violation|2|||
163038209|NCT03488563|588847317|FG002|Overall Study|Protocol Violation|6|||
163038210|NCT03488563|588847315|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
163038211|NCT03488563|588847316|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
163038212|NCT03488563|588847317|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
163038213|NCT03488563|588847315|FG000|Overall Study|Use of prohibited medication|2|||
163038214|NCT03488563|588847316|FG001|Overall Study|Use of prohibited medication|0|||
163038215|NCT03488563|588847317|FG002|Overall Study|Use of prohibited medication|0|||
163038216|NCT03488563|588847315|FG000|Overall Study|Adverse Event|1|||
163038217|NCT03488563|588847316|FG001|Overall Study|Adverse Event|0|||
163038218|NCT03488563|588847317|FG002|Overall Study|Adverse Event|1|||
163038219|NCT03488563|588847315|FG000|Overall Study|Subject returned for ET visit|0|||
163038220|NCT03488563|588847316|FG001|Overall Study|Subject returned for ET visit|1|||
163038221|NCT03488563|588847317|FG002|Overall Study|Subject returned for ET visit|0|||
163091163|NCT01832727|589044703|FG004|Overall Study|Lost to Follow-up|0|||
163091164|NCT01832727|589044704|FG005|Overall Study|Lost to Follow-up|0|||
163091165|NCT01832727|589044705|FG006|Overall Study|Lost to Follow-up|0|||
163091166|NCT01832727|589044706|FG007|Overall Study|Lost to Follow-up|0|||
162650669|NCT01148511|587438887|FG000|Randomized|Other|0|||
162650670|NCT01148511|587438888|FG001|Randomized|Other|1|||
162650671|NCT01148511|587438889|FG002|Randomized|Other|1|||
162650672|NCT00969553|587438898|FG000|Overall Study|Progressive disease (PD)|2|||
162650673|NCT00969553|587438899|FG001|Overall Study|Progressive disease (PD)|2|||
162650674|NCT00969553|587438900|FG002|Overall Study|Progressive disease (PD)|6|||
162650675|NCT00969553|587438901|FG003|Overall Study|Progressive disease (PD)|9|||
162650676|NCT00969553|587438902|FG004|Overall Study|Progressive disease (PD)|2|||
162650677|NCT00969553|587438903|FG005|Overall Study|Progressive disease (PD)|4|||
162650678|NCT00969553|587438904|FG006|Overall Study|Progressive disease (PD)|2|||
163038222|NCT03488563|588847315|FG000|Overall Study|Sponsor's decision|0|||
163038223|NCT03488563|588847316|FG001|Overall Study|Sponsor's decision|0|||
163038224|NCT03488563|588847317|FG002|Overall Study|Sponsor's decision|1|||
163038225|NCT02626000|588847334|FG000|Overall Study|Decision by Sponsor|1|||
163038226|NCT02626000|588847334|FG000|Overall Study|Death|29|||
163038227|NCT01796301|588847338|FG000|Overall Study|Withdrawal by Subject|15|||
163038228|NCT01796301|588847339|FG001|Overall Study|Withdrawal by Subject|15|||
163038229|NCT01796301|588847338|FG000|Overall Study|Lost to Follow-up|3|||
163038230|NCT01796301|588847339|FG001|Overall Study|Lost to Follow-up|3|||
163038231|NCT01796301|588847338|FG000|Overall Study|Death|0|||
163038232|NCT01796301|588847339|FG001|Overall Study|Death|1|||
163038233|NCT01796301|588847338|FG000|Overall Study|Decision by Sponsor|0|||
163038234|NCT01796301|588847339|FG001|Overall Study|Decision by Sponsor|1|||
163038235|NCT00339833|588847340|FG000|Overall Study|Withdrawal by Subject|1|||
163038236|NCT00339833|588847341|FG001|Overall Study|Withdrawal by Subject|2|||
163038237|NCT00339833|588847340|FG000|Overall Study|toothache|0|||
163038238|NCT00339833|588847341|FG001|Overall Study|toothache|1|||
163038239|NCT00339833|588847340|FG000|Overall Study|indigestion|0|||
163038240|NCT00339833|588847341|FG001|Overall Study|indigestion|1|||
163038241|NCT00339833|588847340|FG000|Overall Study|Chest pain|0|||
163038242|NCT00339833|588847341|FG001|Overall Study|Chest pain|1|||
163038243|NCT00339833|588847340|FG000|Overall Study|minor infection|0|||
163038244|NCT00339833|588847341|FG001|Overall Study|minor infection|1|||
163038245|NCT00339833|588847340|FG000|Overall Study|Poor venous access|2|||
163038246|NCT00339833|588847341|FG001|Overall Study|Poor venous access|2|||
163038247|NCT00339833|588847340|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
163038248|NCT00339833|588847341|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
163038249|NCT00339833|588847340|FG000|Overall Study|Error in data records|1|||
163038250|NCT00339833|588847341|FG001|Overall Study|Error in data records|0|||
163038251|NCT00217581|588847342|FG000|Overall Study|Withdrawal by Subject|1|||
163038252|NCT02829047|588847343|FG000|Overall Study|Withdrawal by Subject|1|||
163091167|NCT01832727|589044707|FG008|Overall Study|Lost to Follow-up|0|||
163091168|NCT01832727|589044699|FG000|Overall Study|Physician Decision|1|||
163091169|NCT01832727|589044700|FG001|Overall Study|Physician Decision|0|||
163091170|NCT01832727|589044701|FG002|Overall Study|Physician Decision|0|||
163091171|NCT01832727|589044702|FG003|Overall Study|Physician Decision|1|||
163091172|NCT01832727|589044703|FG004|Overall Study|Physician Decision|0|||
163091173|NCT01832727|589044704|FG005|Overall Study|Physician Decision|1|||
163091174|NCT01832727|589044705|FG006|Overall Study|Physician Decision|0|||
163091175|NCT01832727|589044706|FG007|Overall Study|Physician Decision|0|||
163091176|NCT01832727|589044707|FG008|Overall Study|Physician Decision|0|||
163091177|NCT01832727|589044699|FG000|Overall Study|Withdrawal by Subject|1|||
163091178|NCT01832727|589044700|FG001|Overall Study|Withdrawal by Subject|1|||
163091179|NCT01832727|589044701|FG002|Overall Study|Withdrawal by Subject|0|||
163091180|NCT01832727|589044702|FG003|Overall Study|Withdrawal by Subject|1|||
163091181|NCT01832727|589044703|FG004|Overall Study|Withdrawal by Subject|0|||
163091182|NCT01832727|589044704|FG005|Overall Study|Withdrawal by Subject|1|||
163091183|NCT01832727|589044705|FG006|Overall Study|Withdrawal by Subject|0|||
163091184|NCT01832727|589044706|FG007|Overall Study|Withdrawal by Subject|2|||
163091185|NCT01832727|589044707|FG008|Overall Study|Withdrawal by Subject|1|||
163091186|NCT01832727|589044699|FG000|Overall Study|Study terminated by sponsor|0|||
163091187|NCT01832727|589044700|FG001|Overall Study|Study terminated by sponsor|0|||
163091188|NCT01832727|589044701|FG002|Overall Study|Study terminated by sponsor|0|||
163091189|NCT01832727|589044702|FG003|Overall Study|Study terminated by sponsor|0|||
163038253|NCT01597492|588847344|FG000|Overall Study|Withdrawal by Subject|1|||
163038254|NCT01597492|588847345|FG001|Overall Study|Withdrawal by Subject|2|||
163038255|NCT01597492|588847344|FG000|Overall Study|Adverse Event|3|||
163038256|NCT01597492|588847345|FG001|Overall Study|Adverse Event|0|||
163038257|NCT01597492|588847344|FG000|Overall Study|Lost to Follow-up|0|||
163038258|NCT01597492|588847345|FG001|Overall Study|Lost to Follow-up|2|||
163038259|NCT01597492|588847344|FG000|Overall Study|Other Reason|2|||
163038260|NCT01597492|588847345|FG001|Overall Study|Other Reason|0|||
163038261|NCT02570750|588847346|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
163038262|NCT02570750|588847347|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
163038263|NCT02570750|588847346|FG000|Overall Study|Protocol deviation|4|||
163038264|NCT02570750|588847347|FG001|Overall Study|Protocol deviation|2|||
163038265|NCT02570750|588847346|FG000|Overall Study|Withdrawal by Subject|5|||
163038266|NCT02570750|588847347|FG001|Overall Study|Withdrawal by Subject|0|||
162718820|NCT01235949|587676694|FG014|Booster Phase|Adverse Event|0|||
163038267|NCT02570750|588847346|FG000|Overall Study|Lost to Follow-up|2|||
163038268|NCT02570750|588847347|FG001|Overall Study|Lost to Follow-up|2|||
163038269|NCT02570750|588847346|FG000|Overall Study|Adverse Event|2|||
163038270|NCT02570750|588847347|FG001|Overall Study|Adverse Event|1|||
163038271|NCT01884545|588847348|FG000|Overall Study|Lost to Follow-up|6|||
163091190|NCT01832727|589044703|FG004|Overall Study|Study terminated by sponsor|0|||
163091191|NCT01832727|589044704|FG005|Overall Study|Study terminated by sponsor|0|||
163038272|NCT01884545|588847349|FG001|Overall Study|Lost to Follow-up|4|||
163091192|NCT01832727|589044705|FG006|Overall Study|Study terminated by sponsor|0|||
163091193|NCT01832727|589044706|FG007|Overall Study|Study terminated by sponsor|1|||
163091194|NCT01832727|589044707|FG008|Overall Study|Study terminated by sponsor|1|||
163091195|NCT03323164|589044710|FG000|Overall Study|Poor quality imaging/scans|2|||
163091196|NCT03323164|589044711|FG001|Overall Study|Poor quality imaging/scans|2|||
163091197|NCT00461708|589044712|FG000|Overall Study|Adverse Event|17|||
163091198|NCT00461708|589044713|FG001|Overall Study|Adverse Event|7|||
163091199|NCT00461708|589044712|FG000|Overall Study|Lack of Efficacy|68|||
163091200|NCT00461708|589044713|FG001|Overall Study|Lack of Efficacy|20|||
163091201|NCT00461708|589044712|FG000|Overall Study|Physician Decision|10|||
163091202|NCT00461708|589044713|FG001|Overall Study|Physician Decision|4|||
163091203|NCT00461708|589044712|FG000|Overall Study|Withdrawal by Subject|8|||
163091204|NCT00461708|589044713|FG001|Overall Study|Withdrawal by Subject|2|||
163091205|NCT00461708|589044712|FG000|Overall Study|Other|4|||
163091206|NCT00461708|589044713|FG001|Overall Study|Other|4|||
163091207|NCT00461708|589044712|FG000|Overall Study|Death|8|||
163091208|NCT00461708|589044713|FG001|Overall Study|Death|1|||
163091209|NCT00501644|589044714|FG000|Overall Study|Adverse Event|4|||
163091210|NCT00501644|589044714|FG000|Overall Study|Withdrawal by Subject|1|||
163091211|NCT02394561|589044715|FG000|CORE Phase|Adverse Event|7|||
163091212|NCT02394561|589044716|FG001|CORE Phase|Adverse Event|9|||
163091213|NCT02394561|589044715|FG000|CORE Phase|Death|0|||
163091214|NCT02394561|589044716|FG001|CORE Phase|Death|1|||
163091215|NCT02394561|589044715|FG000|CORE Phase|Pregnancy|1|||
163091216|NCT02394561|589044716|FG001|CORE Phase|Pregnancy|0|||
163091217|NCT02394561|589044715|FG000|CORE Phase|Lost to Follow-up|1|||
163091218|NCT02394561|589044716|FG001|CORE Phase|Lost to Follow-up|0|||
163091219|NCT02394561|589044715|FG000|CORE Phase|Physician Decision|1|||
163091220|NCT02394561|589044716|FG001|CORE Phase|Physician Decision|1|||
163091221|NCT02394561|589044715|FG000|CORE Phase|Withdrawal by Subject|2|||
163091222|NCT02394561|589044716|FG001|CORE Phase|Withdrawal by Subject|2|||
163091223|NCT02394561|589044715|FG000|CORE Phase|Lack of Efficacy|1|||
163091224|NCT02394561|589044716|FG001|CORE Phase|Lack of Efficacy|6|||
163091225|NCT02394561|589044715|FG000|Extension Phase|Adverse Event|6|||
163091226|NCT02394561|589044716|FG001|Extension Phase|Adverse Event|1|||
163091227|NCT02394561|589044715|FG000|Extension Phase|Death|0|||
163091228|NCT02394561|589044716|FG001|Extension Phase|Death|1|||
163091229|NCT02394561|589044715|FG000|Extension Phase|Protocol Violation|1|||
163091230|NCT02394561|589044716|FG001|Extension Phase|Protocol Violation|0|||
163091231|NCT02394561|589044715|FG000|Extension Phase|Lost to Follow-up|1|||
163091232|NCT02394561|589044716|FG001|Extension Phase|Lost to Follow-up|0|||
163091233|NCT02394561|589044715|FG000|Extension Phase|Physician Decision|0|||
163091234|NCT02394561|589044716|FG001|Extension Phase|Physician Decision|2|||
163091235|NCT02394561|589044715|FG000|Extension Phase|Withdrawal by Subject|0|||
163091236|NCT02394561|589044716|FG001|Extension Phase|Withdrawal by Subject|5|||
163091237|NCT02394561|589044715|FG000|Extension Phase|Lack of Efficacy|3|||
163091238|NCT02394561|589044716|FG001|Extension Phase|Lack of Efficacy|3|||
163091239|NCT02553629|589044717|FG000|Overall Study|Logistic reasons|3|||
163091240|NCT02553629|589044718|FG001|Overall Study|Logistic reasons|6|||
163091241|NCT03434834|589044719|FG000|Overall Study|unable to swallow OCT probe|16|||
163091242|NCT01823289|589044720|FG000|Overall Study|Lost to Follow-up|5|||
163091243|NCT01823289|589044720|FG000|Overall Study|Adverse Event|5|||
163091244|NCT01823289|589044720|FG000|Overall Study|Lack of Efficacy|1|||
163091245|NCT01823289|589044720|FG000|Overall Study|Physician Decision|9|||
163091246|NCT01823289|589044720|FG000|Overall Study|Administered contraindicated medicine|1|||
163091247|NCT01823289|589044720|FG000|Overall Study|Transaminase increased more than 3 times|1|||
163091248|NCT01823289|589044720|FG000|Overall Study|Drug affected efficacy and safety|1|||
163091249|NCT01823289|589044720|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
163091250|NCT01812057|589044721|FG000|Overall Study|Protocol Violation|1|||
163091251|NCT01812057|589044722|FG001|Overall Study|Protocol Violation|0|||
163091252|NCT01812057|589044721|FG000|Overall Study|Physician Decision|1|||
163091253|NCT01812057|589044722|FG001|Overall Study|Physician Decision|0|||
163091254|NCT01736917|589044723|FG000|Overall Study|Adverse Event|1|||
163091255|NCT01736917|589044723|FG000|Overall Study|Protocol Violation|10|||
163091256|NCT01133847|589044732|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
163091257|NCT01133847|589044733|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
163091258|NCT01133847|589044734|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
163091259|NCT01133847|589044732|FG000|Follow-Up Phase|Lost to Follow-up|1|||
163091260|NCT01133847|589044733|FG001|Follow-Up Phase|Lost to Follow-up|3|||
163091261|NCT01133847|589044734|FG002|Follow-Up Phase|Lost to Follow-up|7|||
163091262|NCT01880957|589044735|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
163091263|NCT01880957|589044736|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
163091264|NCT01880957|589044735|FG000|Overall Study|Lost to Follow-up|11|||
163091265|NCT01880957|589044736|FG001|Overall Study|Lost to Follow-up|0|||
163091266|NCT01880957|589044735|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
163091267|NCT01880957|589044736|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
163091268|NCT01378117|589044737|FG000|Overall Study|withdrawal|2|||
163091269|NCT01378117|589044738|FG001|Overall Study|withdrawal|1|||
163091270|NCT01378117|589044739|FG002|Overall Study|withdrawal|2|||
163091271|NCT01378117|589044737|FG000|Overall Study|discharged before med given|2|||
163091272|NCT01378117|589044738|FG001|Overall Study|discharged before med given|0|||
163091273|NCT01378117|589044739|FG002|Overall Study|discharged before med given|1|||
163091274|NCT01854528|589044740|FG000|Overall Study|Adverse Event|0|||
163091275|NCT01854528|589044741|FG001|Overall Study|Adverse Event|4|||
163091276|NCT01854528|589044740|FG000|Overall Study|Withdrawal by Subject|0|||
163091277|NCT01854528|589044741|FG001|Overall Study|Withdrawal by Subject|2|||
163091278|NCT01854528|589044740|FG000|Overall Study|Virologic Failure|0|||
163091279|NCT01854528|589044741|FG001|Overall Study|Virologic Failure|9|||
163091280|NCT02961244|589044742|FG000|Overall Study|Protocol Violation|0|||
163091281|NCT02961244|589044743|FG001|Overall Study|Protocol Violation|1|||
163091282|NCT02961244|589044742|FG000|Overall Study|Withdrawal by Subject|1|||
163091283|NCT02961244|589044743|FG001|Overall Study|Withdrawal by Subject|2|||
163091284|NCT02961244|589044742|FG000|Overall Study|Surgery plan change after study approval|0|||
163091285|NCT02961244|589044743|FG001|Overall Study|Surgery plan change after study approval|2|||
163091286|NCT02961244|589044742|FG000|Overall Study|Lost to Follow-up|0|||
163091287|NCT02961244|589044743|FG001|Overall Study|Lost to Follow-up|2|||
163091288|NCT02961244|589044742|FG000|Overall Study|İnadequate data|0|||
163091289|NCT02961244|589044743|FG001|Overall Study|İnadequate data|2|||
163091290|NCT01368614|589044744|FG000|Screening Period|Screen Failure|58|||
163091291|NCT01368614|589044745|FG001|Screening Period|Screen Failure|0|||
163091292|NCT01368614|589044746|FG002|Screening Period|Screen Failure|0|||
163091293|NCT01368614|589044747|FG003|Screening Period|Screen Failure|0|||
163091294|NCT01368614|589044744|FG000|Study Period|Withdrawal by Subject|0|||
163091295|NCT01368614|589044745|FG001|Study Period|Withdrawal by Subject|1|||
163091296|NCT01368614|589044746|FG002|Study Period|Withdrawal by Subject|1|||
163091297|NCT01368614|589044747|FG003|Study Period|Withdrawal by Subject|3|||
163091298|NCT01368614|589044744|FG000|Study Period|Lost to Follow-up|0|||
163091299|NCT01368614|589044745|FG001|Study Period|Lost to Follow-up|0|||
163091300|NCT01368614|589044746|FG002|Study Period|Lost to Follow-up|1|||
163091301|NCT01368614|589044747|FG003|Study Period|Lost to Follow-up|0|||
163091302|NCT02561962|589044760|FG000|Overall Study|Withdrawal by Subject|1|||
163091303|NCT02561962|589044761|FG001|Overall Study|Withdrawal by Subject|0|||
163091304|NCT02561962|589044762|FG002|Overall Study|Withdrawal by Subject|0|||
163091305|NCT02561962|589044763|FG003|Overall Study|Withdrawal by Subject|0|||
163091306|NCT02561962|589044764|FG004|Overall Study|Withdrawal by Subject|1|||
163091307|NCT02561962|589044765|FG005|Overall Study|Withdrawal by Subject|1|||
163091308|NCT02561962|589044766|FG006|Overall Study|Withdrawal by Subject|2|||
163091309|NCT02561962|589044767|FG007|Overall Study|Withdrawal by Subject|1|||
163091310|NCT02561962|589044768|FG008|Overall Study|Withdrawal by Subject|0|||
163091311|NCT02561962|589044760|FG000|Overall Study|Decision by sponsor|0|||
163091312|NCT02561962|589044761|FG001|Overall Study|Decision by sponsor|0|||
163091313|NCT02561962|589044762|FG002|Overall Study|Decision by sponsor|0|||
163091314|NCT02561962|589044763|FG003|Overall Study|Decision by sponsor|0|||
163091315|NCT02561962|589044764|FG004|Overall Study|Decision by sponsor|1|||
163091316|NCT02561962|589044765|FG005|Overall Study|Decision by sponsor|1|||
163091317|NCT02561962|589044766|FG006|Overall Study|Decision by sponsor|0|||
163091318|NCT02561962|589044767|FG007|Overall Study|Decision by sponsor|3|||
163091319|NCT02561962|589044768|FG008|Overall Study|Decision by sponsor|0|||
163091320|NCT02561962|589044760|FG000|Overall Study|Lost to Follow-up|0|||
163091321|NCT02561962|589044761|FG001|Overall Study|Lost to Follow-up|0|||
163091322|NCT02561962|589044762|FG002|Overall Study|Lost to Follow-up|0|||
163091323|NCT02561962|589044763|FG003|Overall Study|Lost to Follow-up|0|||
163091324|NCT02561962|589044764|FG004|Overall Study|Lost to Follow-up|0|||
163091325|NCT02561962|589044765|FG005|Overall Study|Lost to Follow-up|1|||
163091326|NCT02561962|589044766|FG006|Overall Study|Lost to Follow-up|0|||
163091327|NCT02561962|589044767|FG007|Overall Study|Lost to Follow-up|0|||
163091328|NCT02561962|589044768|FG008|Overall Study|Lost to Follow-up|0|||
163091329|NCT03586973|589044769|FG000|Overall Study|Death|15|||
163091330|NCT03586973|589044770|FG001|Overall Study|Death|8|||
163091331|NCT03586973|589044769|FG000|Overall Study|Site Terminated by Sponsor|3|||
163091332|NCT03586973|589044770|FG001|Overall Study|Site Terminated by Sponsor|6|||
163091333|NCT03586973|589044769|FG000|Overall Study|Withdrawal by Subject|1|||
163091334|NCT03586973|589044770|FG001|Overall Study|Withdrawal by Subject|0|||
163091335|NCT03586973|589044769|FG000|Overall Study|Lost to Follow-up|1|||
163091336|NCT03586973|589044770|FG001|Overall Study|Lost to Follow-up|0|||
163091337|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
163091338|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
163091339|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
163091340|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
163091341|NCT02735421|589046479|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
163091342|NCT02735421|589046479|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
163091343|NCT02735421|589046479|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
163091344|NCT01978145|589046480|FG000|Treatment Period 1|Adverse Event|1|||
163091345|NCT01978145|589046481|FG001|Treatment Period 1|Adverse Event|9|||
163091346|NCT01978145|589046480|FG000|Treatment Period 1|Physician Decision|1|||
163091347|NCT01978145|589046481|FG001|Treatment Period 1|Physician Decision|0|||
163091348|NCT01978145|589046480|FG000|Treatment Period 1|Withdrawal by Subject|5|||
163091349|NCT01978145|589046481|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163091350|NCT01978145|589046480|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
163091351|NCT01978145|589046481|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
163091352|NCT01978145|589046480|FG000|Washout Period 1|Adverse Event|0|||
163091353|NCT01978145|589046481|FG001|Washout Period 1|Adverse Event|1|||
163091354|NCT01978145|589046480|FG000|Washout Period 1|Withdrawal by Subject|1|||
163091355|NCT01978145|589046481|FG001|Washout Period 1|Withdrawal by Subject|1|||
163091356|NCT01978145|589046480|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
163091357|NCT01978145|589046481|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
163091358|NCT01978145|589046480|FG000|Treatment Period 2|Adverse Event|3|||
163091359|NCT01978145|589046481|FG001|Treatment Period 2|Adverse Event|3|||
163091360|NCT01978145|589046480|FG000|Treatment Period 2|Protocol Violation|0|||
163091361|NCT01978145|589046481|FG001|Treatment Period 2|Protocol Violation|1|||
163091362|NCT01978145|589046480|FG000|Treatment Period 2|Lost to Follow-up|1|||
163091363|NCT01978145|589046481|FG001|Treatment Period 2|Lost to Follow-up|1|||
163091364|NCT01978145|589046480|FG000|Treatment Period 2|Withdrawal by Subject|7|||
163091365|NCT01978145|589046481|FG001|Treatment Period 2|Withdrawal by Subject|4|||
163091366|NCT01978145|589046480|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
163091367|NCT01978145|589046481|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
163091368|NCT00322049|589046482|FG000|Overall Study|Moved out of area|0|||
163091369|NCT00322049|589046483|FG001|Overall Study|Moved out of area|0|||
163091370|NCT00322049|589046484|FG002|Overall Study|Moved out of area|0|||
163091371|NCT00322049|589046485|FG003|Overall Study|Moved out of area|1|||
163091372|NCT00322049|589046482|FG000|Overall Study|Infected with Dengue during study|0|||
163091373|NCT00322049|589046483|FG001|Overall Study|Infected with Dengue during study|1|||
163091374|NCT00322049|589046484|FG002|Overall Study|Infected with Dengue during study|0|||
163091375|NCT00322049|589046485|FG003|Overall Study|Infected with Dengue during study|0|||
163091376|NCT00755807|589046486|FG000|Acute Phase|Adverse Event|16|||
163091377|NCT00755807|589046487|FG001|Acute Phase|Adverse Event|5|||
163091378|NCT00755807|589046486|FG000|Acute Phase|Protocol Violation|1|||
163091379|NCT00755807|589046487|FG001|Acute Phase|Protocol Violation|3|||
163091380|NCT00755807|589046486|FG000|Acute Phase|Withdrawal by Subject|1|||
163091381|NCT00755807|589046487|FG001|Acute Phase|Withdrawal by Subject|2|||
163091382|NCT00755807|589046486|FG000|Acute Phase|Lack of Efficacy|0|||
163091383|NCT00755807|589046487|FG001|Acute Phase|Lack of Efficacy|1|||
163091384|NCT00755807|589046486|FG000|Acute Phase|Physician Decision|0|||
163091385|NCT00755807|589046487|FG001|Acute Phase|Physician Decision|1|||
163091386|NCT00755807|589046486|FG000|Open-label Extension Phase|Adverse Event|7|||
163091387|NCT00755807|589046487|FG001|Open-label Extension Phase|Adverse Event|7|||
163091388|NCT00755807|589046486|FG000|Open-label Extension Phase|Protocol Violation|5|||
163091389|NCT00755807|589046487|FG001|Open-label Extension Phase|Protocol Violation|2|||
163091390|NCT00755807|589046486|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
163091391|NCT00755807|589046487|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
163091392|NCT00755807|589046486|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
163091393|NCT00755807|589046487|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
163091394|NCT00755807|589046486|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
163091395|NCT00755807|589046487|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
163091396|NCT00755807|589046486|FG000|Open-label Extension Phase|Sponsor Decision|0|||
163091397|NCT00755807|589046487|FG001|Open-label Extension Phase|Sponsor Decision|1|||
163091398|NCT01585025|589046496|FG000|Overall Study|Withdrawal by Subject|0|||
163091399|NCT01585025|589046497|FG001|Overall Study|Withdrawal by Subject|3|||
163091400|NCT01585025|589046498|FG002|Overall Study|Withdrawal by Subject|4|||
163091401|NCT00503984|589046499|FG000|Overall Study|Protocol Violation|0|||
163091402|NCT00503984|589046500|FG001|Overall Study|Protocol Violation|1|||
163091403|NCT00503984|589046501|FG002|Overall Study|Protocol Violation|0|||
163091404|NCT00503984|589046502|FG003|Overall Study|Protocol Violation|0|||
163091405|NCT00503984|589046503|FG004|Overall Study|Protocol Violation|0|||
163091406|NCT00503984|589046504|FG005|Overall Study|Protocol Violation|0|||
163091407|NCT00503984|589046499|FG000|Overall Study|Adverse Event|0|||
163091408|NCT00503984|589046500|FG001|Overall Study|Adverse Event|1|||
163091409|NCT00503984|589046501|FG002|Overall Study|Adverse Event|0|||
163091410|NCT00503984|589046502|FG003|Overall Study|Adverse Event|0|||
163091411|NCT00503984|589046503|FG004|Overall Study|Adverse Event|0|||
163091412|NCT00503984|589046504|FG005|Overall Study|Adverse Event|0|||
163091413|NCT00503984|589046499|FG000|Overall Study|Death|0|||
163091414|NCT00503984|589046500|FG001|Overall Study|Death|0|||
163091415|NCT00503984|589046501|FG002|Overall Study|Death|0|||
163091416|NCT00503984|589046502|FG003|Overall Study|Death|0|||
163091417|NCT00503984|589046503|FG004|Overall Study|Death|1|||
163091418|NCT00503984|589046504|FG005|Overall Study|Death|0|||
163091419|NCT02122380|589046507|FG000|First Intervention (30 Days)|Adverse Event|1|||
163091420|NCT02122380|589046508|FG001|First Intervention (30 Days)|Adverse Event|0|||
163091421|NCT02122380|589046507|FG000|First Intervention (30 Days)|Physician Decision|0|||
163091422|NCT02122380|589046508|FG001|First Intervention (30 Days)|Physician Decision|1|||
163091423|NCT02122380|589046507|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
163038273|NCT01884545|588847350|FG002|Overall Study|Lost to Follow-up|9|||
163038274|NCT01884545|588847351|FG003|Overall Study|Lost to Follow-up|4|||
163038275|NCT01884545|588847348|FG000|Overall Study|Patient withdrawn|7|||
163038276|NCT01884545|588847349|FG001|Overall Study|Patient withdrawn|12|||
163038277|NCT01884545|588847350|FG002|Overall Study|Patient withdrawn|5|||
163038278|NCT01884545|588847351|FG003|Overall Study|Patient withdrawn|5|||
163038279|NCT01884545|588847348|FG000|Overall Study|Non-adherence|0|||
163038280|NCT01884545|588847349|FG001|Overall Study|Non-adherence|2|||
163038281|NCT01884545|588847350|FG002|Overall Study|Non-adherence|0|||
163038282|NCT01884545|588847351|FG003|Overall Study|Non-adherence|0|||
163038283|NCT01410240|588847352|FG000|Overall Study|Physician Decision|0|||
163038284|NCT01410240|588847353|FG001|Overall Study|Physician Decision|0|||
163038285|NCT01410240|588847354|FG002|Overall Study|Physician Decision|1|||
163038286|NCT01410240|588847352|FG000|Overall Study|Missed week 6 assessments|1|||
163038287|NCT01410240|588847353|FG001|Overall Study|Missed week 6 assessments|1|||
163038288|NCT01410240|588847354|FG002|Overall Study|Missed week 6 assessments|1|||
163038289|NCT00162097|588847356|FG000|Overall Study|Participant no longer met study criteria|0|||
163038290|NCT00162097|588847357|FG001|Overall Study|Participant no longer met study criteria|0|||
163038291|NCT00162097|588847358|FG002|Overall Study|Participant no longer met study criteria|0|||
163038292|NCT00162097|588847359|FG003|Overall Study|Participant no longer met study criteria|1|||
163038293|NCT02886884|588847362|FG000|Follow-up|Withdrawal by Subject|0|||
163038294|NCT02886884|588847363|FG001|Follow-up|Withdrawal by Subject|0|||
163038295|NCT02886884|588847364|FG002|Follow-up|Withdrawal by Subject|0|||
163038296|NCT02886884|588847365|FG003|Follow-up|Withdrawal by Subject|1|||
163038297|NCT00625183|588847368|FG000|Overall Study|Disease Progression|1|||
163038298|NCT02279745|588847369|FG000|Overall Study|Adverse Event|7|||
163038299|NCT02279745|588847369|FG000|Overall Study|Death|6|||
163038300|NCT02279745|588847369|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
163038301|NCT02279745|588847369|FG000|Overall Study|Withdrawal by Subject|2|||
163038302|NCT02279745|588847369|FG000|Overall Study|Pregnancy|1|||
163038303|NCT02279745|588847369|FG000|Overall Study|Study Non-compliance|1|||
163038304|NCT02279745|588847369|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
163038305|NCT01606748|588847370|FG000|Overall Study|Adverse Event|1|||
163038306|NCT01606748|588847371|FG001|Overall Study|Adverse Event|0|||
163038307|NCT01606748|588847370|FG000|Overall Study|Progressive Disease|1|||
163038308|NCT01606748|588847371|FG001|Overall Study|Progressive Disease|0|||
163038309|NCT01606748|588847370|FG000|Overall Study|Withdrawal by Subject|1|||
163038310|NCT01606748|588847371|FG001|Overall Study|Withdrawal by Subject|0|||
163038311|NCT01706575|588847373|FG000|Overall Study|Participant Withdrew Consent|4|||
163038312|NCT01706575|588847373|FG000|Overall Study|Lost to Follow-up|2|||
163038313|NCT01706575|588847373|FG000|Overall Study|Started but not Treated|6|||
163038314|NCT03244618|588847376|FG000|Overall Study|Lost to Follow-up|3|||
163038315|NCT03244618|588847377|FG001|Overall Study|Lost to Follow-up|4|||
163038316|NCT03244618|588847376|FG000|Overall Study|Protocol Violation|4|||
163038317|NCT03244618|588847377|FG001|Overall Study|Protocol Violation|3|||
163038318|NCT03244618|588847376|FG000|Overall Study|Withdrawal by Subject|0|||
163038319|NCT03244618|588847377|FG001|Overall Study|Withdrawal by Subject|2|||
163038320|NCT03469999|588847378|FG000|Overall Study|Lost to Follow-up|2|||
163038321|NCT02155322|588847382|FG000|Overall Study|Adverse Event|1|||
163038322|NCT02155322|588847382|FG000|Overall Study|Physician Decision|1|||
163038323|NCT02155322|588847382|FG000|Overall Study|Relapse/Recurrence|8|||
163038324|NCT02155322|588847382|FG000|Overall Study|Withdrawal by Subject|4|||
163038325|NCT01215435|588847385|FG000|Overall Study|Adverse Event|1|||
163038326|NCT01215435|588847386|FG001|Overall Study|Adverse Event|0|||
163038327|NCT01215435|588847385|FG000|Overall Study|Protocol Violation|2|||
163038328|NCT01215435|588847386|FG001|Overall Study|Protocol Violation|0|||
162650679|NCT00969553|587438905|FG007|Overall Study|Progressive disease (PD)|12|||
162650680|NCT00969553|587438906|FG008|Overall Study|Progressive disease (PD)|3|||
162650681|NCT00969553|587438898|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650682|NCT00969553|587438899|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650683|NCT00969553|587438900|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650684|NCT00969553|587438901|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
163038329|NCT01215435|588847385|FG000|Overall Study|Withdrawal Criteria|8|||
163038330|NCT01215435|588847386|FG001|Overall Study|Withdrawal Criteria|11|||
163038331|NCT01215435|588847385|FG000|Overall Study|Lost to Follow-up|3|||
163038332|NCT01215435|588847386|FG001|Overall Study|Lost to Follow-up|0|||
163038333|NCT01215435|588847385|FG000|Overall Study|Unclassified|5|||
163038334|NCT01215435|588847386|FG001|Overall Study|Unclassified|5|||
163038335|NCT03383692|588847387|FG000|Overall Study|Progressive disease as per RECIST|3|||
163038336|NCT03383692|588847388|FG001|Overall Study|Progressive disease as per RECIST|3|||
163038337|NCT03383692|588847387|FG000|Overall Study|Clinical progression|0|||
163038338|NCT03383692|588847388|FG001|Overall Study|Clinical progression|1|||
163038339|NCT03383692|588847387|FG000|Overall Study|Adverse Event|3|||
163038340|NCT03383692|588847388|FG001|Overall Study|Adverse Event|0|||
163038341|NCT01810783|588847392|FG000|Overall Study|Adverse Event|32|||
163038342|NCT01810783|588847392|FG000|Overall Study|Withdrawal by Subject|22|||
162650685|NCT00969553|587438902|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
162718821|NCT01235949|587676695|FG015|Booster Phase|Adverse Event|1|||
163091424|NCT02122380|589046508|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
163091425|NCT02122380|589046507|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
163091426|NCT02122380|589046508|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
163091427|NCT02122380|589046507|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
163091428|NCT02122380|589046508|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
163091429|NCT01192126|589046509|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
163091430|NCT01192126|589046510|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
163091431|NCT01192126|589046509|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
163091432|NCT01192126|589046510|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
163091433|NCT00688467|589046511|FG000|Treatment Period 1|Adverse Event|2|||
163091434|NCT00688467|589046512|FG001|Treatment Period 1|Adverse Event|1|||
163091435|NCT00688467|589046511|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
163091436|NCT00688467|589046512|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
163091437|NCT00688467|589046511|FG000|Treatment Period 2|Protocol Violation|0|||
162718822|NCT01235949|587676696|FG016|Booster Phase|Adverse Event|0|||
162718823|NCT01235949|587676697|FG017|Booster Phase|Adverse Event|0|||
162718824|NCT01235949|587676680|FG000|Booster Phase|Withdrawal by Subject|0|||
162718825|NCT01235949|587676681|FG001|Booster Phase|Withdrawal by Subject|0|||
162718826|NCT01235949|587676682|FG002|Booster Phase|Withdrawal by Subject|0|||
162718827|NCT01235949|587676683|FG003|Booster Phase|Withdrawal by Subject|0|||
162718828|NCT01235949|587676684|FG004|Booster Phase|Withdrawal by Subject|0|||
162718829|NCT01235949|587676685|FG005|Booster Phase|Withdrawal by Subject|0|||
162718830|NCT01235949|587676686|FG006|Booster Phase|Withdrawal by Subject|0|||
162718831|NCT01235949|587676687|FG007|Booster Phase|Withdrawal by Subject|1|||
162718832|NCT01235949|587676688|FG008|Booster Phase|Withdrawal by Subject|1|||
162718833|NCT01235949|587676689|FG009|Booster Phase|Withdrawal by Subject|0|||
162718834|NCT01235949|587676690|FG010|Booster Phase|Withdrawal by Subject|1|||
162718835|NCT01235949|587676691|FG011|Booster Phase|Withdrawal by Subject|1|||
162718836|NCT01235949|587676692|FG012|Booster Phase|Withdrawal by Subject|2|||
162718837|NCT01235949|587676693|FG013|Booster Phase|Withdrawal by Subject|0|||
162718838|NCT01235949|587676694|FG014|Booster Phase|Withdrawal by Subject|2|||
162718839|NCT01235949|587676695|FG015|Booster Phase|Withdrawal by Subject|0|||
162718840|NCT01235949|587676696|FG016|Booster Phase|Withdrawal by Subject|0|||
163091438|NCT00688467|589046512|FG001|Treatment Period 2|Protocol Violation|1|||
163091439|NCT00688467|589046511|FG000|Treatment Period 2|Adverse Event|0|||
163091440|NCT00688467|589046512|FG001|Treatment Period 2|Adverse Event|1|||
163091441|NCT00387088|589046513|FG000|Overall Study|Adverse Event|143|||
163091442|NCT00387088|589046514|FG001|Overall Study|Adverse Event|156|||
163091443|NCT00387088|589046513|FG000|Overall Study|Protocol Violation|47|||
163091444|NCT00387088|589046514|FG001|Overall Study|Protocol Violation|35|||
163091445|NCT00387088|589046513|FG000|Overall Study|Withdrawal by Subject|20|||
163091446|NCT00387088|589046514|FG001|Overall Study|Withdrawal by Subject|35|||
163091447|NCT00387088|589046513|FG000|Overall Study|Lack of Efficacy|28|||
162718841|NCT01235949|587676697|FG017|Booster Phase|Withdrawal by Subject|0|||
162718842|NCT01235949|587676680|FG000|Booster Phase|Lost to Follow-up|0|||
162718843|NCT01235949|587676681|FG001|Booster Phase|Lost to Follow-up|0|||
163038343|NCT01810783|588847392|FG000|Overall Study|Lack of Efficacy|12|||
163038344|NCT01810783|588847392|FG000|Overall Study|Lost to Follow-up|10|||
163038345|NCT01810783|588847392|FG000|Overall Study|Protocol Violation|5|||
163038346|NCT01810783|588847392|FG000|Overall Study|Non-compliance with IMP|4|||
163038347|NCT01810783|588847392|FG000|Overall Study|Adminstrative or other reason(s)|23|||
163038348|NCT01810783|588847392|FG000|Overall Study|Enrolled, not treated|1|||
163038349|NCT04776018|588847394|FG000|Overall Study|Death|0|||
163038350|NCT04776018|588847395|FG001|Overall Study|Death|1|||
163038351|NCT04776018|588847396|FG002|Overall Study|Death|4|||
163038352|NCT04776018|588847397|FG003|Overall Study|Death|1|||
163038353|NCT04776018|588847398|FG004|Overall Study|Death|4|||
163038354|NCT04776018|588847399|FG005|Overall Study|Death|0|||
163038355|NCT04776018|588847400|FG006|Overall Study|Death|0|||
163038356|NCT04776018|588847394|FG000|Overall Study|Study terminated by sponsor|2|||
163038357|NCT04776018|588847395|FG001|Overall Study|Study terminated by sponsor|1|||
163038358|NCT04776018|588847396|FG002|Overall Study|Study terminated by sponsor|4|||
163038359|NCT04776018|588847397|FG003|Overall Study|Study terminated by sponsor|0|||
163038360|NCT04776018|588847398|FG004|Overall Study|Study terminated by sponsor|3|||
163038361|NCT04776018|588847399|FG005|Overall Study|Study terminated by sponsor|0|||
163038362|NCT04776018|588847400|FG006|Overall Study|Study terminated by sponsor|0|||
162718844|NCT01235949|587676682|FG002|Booster Phase|Lost to Follow-up|0|||
163038363|NCT04776018|588847394|FG000|Overall Study|Withdrawal by Subject|1|||
163038364|NCT04776018|588847395|FG001|Overall Study|Withdrawal by Subject|0|||
163038365|NCT04776018|588847396|FG002|Overall Study|Withdrawal by Subject|0|||
163038366|NCT04776018|588847397|FG003|Overall Study|Withdrawal by Subject|2|||
163091448|NCT00387088|589046514|FG001|Overall Study|Lack of Efficacy|67|||
162718845|NCT01235949|587676683|FG003|Booster Phase|Lost to Follow-up|0|||
162718846|NCT01235949|587676684|FG004|Booster Phase|Lost to Follow-up|0|||
163038367|NCT04776018|588847398|FG004|Overall Study|Withdrawal by Subject|1|||
162718847|NCT01235949|587676685|FG005|Booster Phase|Lost to Follow-up|0|||
163038368|NCT04776018|588847399|FG005|Overall Study|Withdrawal by Subject|0|||
163038369|NCT04776018|588847400|FG006|Overall Study|Withdrawal by Subject|0|||
163038370|NCT04776018|588847394|FG000|Overall Study|Other|0|||
163038371|NCT04776018|588847395|FG001|Overall Study|Other|1|||
163038372|NCT04776018|588847396|FG002|Overall Study|Other|1|||
163038373|NCT04776018|588847397|FG003|Overall Study|Other|0|||
163038374|NCT04776018|588847398|FG004|Overall Study|Other|0|||
163038375|NCT04776018|588847399|FG005|Overall Study|Other|0|||
163038376|NCT04776018|588847400|FG006|Overall Study|Other|0|||
163038377|NCT04776018|588847394|FG000|Overall Study|Lost to Follow-up|0|||
163038378|NCT04776018|588847395|FG001|Overall Study|Lost to Follow-up|0|||
163038379|NCT04776018|588847396|FG002|Overall Study|Lost to Follow-up|1|||
163038380|NCT04776018|588847397|FG003|Overall Study|Lost to Follow-up|0|||
163038381|NCT04776018|588847398|FG004|Overall Study|Lost to Follow-up|0|||
163038382|NCT04776018|588847399|FG005|Overall Study|Lost to Follow-up|0|||
163038383|NCT04776018|588847400|FG006|Overall Study|Lost to Follow-up|0|||
163038384|NCT00793546|588847401|FG000|Overall Study|Death|3|||
163038385|NCT00793546|588847402|FG001|Overall Study|Death|0|||
163038386|NCT00793546|588847401|FG000|Overall Study|Lost to Follow-up|1|||
163038387|NCT00793546|588847402|FG001|Overall Study|Lost to Follow-up|0|||
163038388|NCT00793546|588847401|FG000|Overall Study|Withdrawal by Subject|1|||
163038389|NCT00793546|588847402|FG001|Overall Study|Withdrawal by Subject|1|||
163038390|NCT00793546|588847401|FG000|Overall Study|Study Terminated by Sponsor|8|||
163038391|NCT00793546|588847402|FG001|Overall Study|Study Terminated by Sponsor|27|||
163038392|NCT00793546|588847401|FG000|Overall Study|Other|1|||
163038393|NCT00793546|588847402|FG001|Overall Study|Other|0|||
163038394|NCT00435019|588847404|FG000|Overall Study|Adverse Event|1|||
163038395|NCT00435019|588847405|FG001|Overall Study|Adverse Event|0|||
163038396|NCT00435019|588847404|FG000|Overall Study|Lack of Efficacy|1|||
163038397|NCT00435019|588847405|FG001|Overall Study|Lack of Efficacy|2|||
163038398|NCT00435019|588847404|FG000|Overall Study|Protocol Violation|3|||
163038399|NCT00435019|588847405|FG001|Overall Study|Protocol Violation|1|||
163038400|NCT00435019|588847404|FG000|Overall Study|Personal reasons for withdrawal|8|||
163038401|NCT00435019|588847405|FG001|Overall Study|Personal reasons for withdrawal|7|||
163038402|NCT04503668|588847406|FG000|Overall Study|Incomplete data|4|||
163038403|NCT04503668|588847407|FG001|Overall Study|Incomplete data|3|||
163038404|NCT04503668|588847406|FG000|Overall Study|Withdrawal by Subject|1|||
163038405|NCT04503668|588847407|FG001|Overall Study|Withdrawal by Subject|1|||
163038406|NCT04503668|588847406|FG000|Overall Study|Adverse Event|2|||
163038407|NCT04503668|588847407|FG001|Overall Study|Adverse Event|0|||
163038408|NCT02306694|588847408|FG000|Overall Study|Withdrawal by Subject|3|||
163038409|NCT02306694|588847408|FG000|Overall Study|Lost to Follow-up|1|||
163038410|NCT00742027|588847411|FG000|Overall Study|Disease Progression|76|||
163038411|NCT00742027|588847411|FG000|Overall Study|New Cancer Therapy|19|||
163038412|NCT00742027|588847411|FG000|Overall Study|Withdrawal by Subject|18|||
163038413|NCT00742027|588847411|FG000|Overall Study|Death|7|||
163038414|NCT00742027|588847411|FG000|Overall Study|Lost to Follow-up|4|||
163038415|NCT00742027|588847411|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
163038416|NCT00742027|588847411|FG000|Overall Study|Missing|2|||
163038417|NCT00742027|588847411|FG000|Overall Study|Administrative Problems|1|||
163038418|NCT01180049|588847412|FG000|Overall Study|Other|9|||
163038419|NCT01180049|588847413|FG001|Overall Study|Other|7|||
163038420|NCT01180049|588847412|FG000|Overall Study|Lost to Follow-up|8|||
163038421|NCT01180049|588847413|FG001|Overall Study|Lost to Follow-up|6|||
163038422|NCT01180049|588847412|FG000|Overall Study|Death|36|||
163038423|NCT01180049|588847413|FG001|Overall Study|Death|35|||
163038424|NCT01764659|588847414|FG000|Overall Study|Death|1|||
163038425|NCT01764659|588847414|FG000|Overall Study|Physician Decision|1|||
163038426|NCT01210352|588847415|FG000|Overall Study|Adverse Event|0|||
163038427|NCT01210352|588847416|FG001|Overall Study|Adverse Event|0|||
163038428|NCT01210352|588847417|FG002|Overall Study|Adverse Event|0|||
163038429|NCT01210352|588847418|FG003|Overall Study|Adverse Event|0|||
163038430|NCT01210352|588847419|FG004|Overall Study|Adverse Event|0|||
163038431|NCT01210352|588847420|FG005|Overall Study|Adverse Event|0|||
163038432|NCT01210352|588847421|FG006|Overall Study|Adverse Event|0|||
163038433|NCT01210352|588847422|FG007|Overall Study|Adverse Event|2|||
163038434|NCT01210352|588847423|FG008|Overall Study|Adverse Event|1|||
163038435|NCT01210352|588847415|FG000|Overall Study|Lack of Efficacy|0|||
163038436|NCT01210352|588847416|FG001|Overall Study|Lack of Efficacy|0|||
163038437|NCT01210352|588847417|FG002|Overall Study|Lack of Efficacy|0|||
163038438|NCT01210352|588847418|FG003|Overall Study|Lack of Efficacy|0|||
163038439|NCT01210352|588847419|FG004|Overall Study|Lack of Efficacy|0|||
163038440|NCT01210352|588847420|FG005|Overall Study|Lack of Efficacy|0|||
163038441|NCT01210352|588847421|FG006|Overall Study|Lack of Efficacy|1|||
163038442|NCT01210352|588847422|FG007|Overall Study|Lack of Efficacy|0|||
163038443|NCT01210352|588847423|FG008|Overall Study|Lack of Efficacy|0|||
163038444|NCT01210352|588847415|FG000|Overall Study|Physician Decision|0|||
163038445|NCT01210352|588847416|FG001|Overall Study|Physician Decision|0|||
163038446|NCT01210352|588847417|FG002|Overall Study|Physician Decision|0|||
163038447|NCT01210352|588847418|FG003|Overall Study|Physician Decision|0|||
162718848|NCT01235949|587676686|FG006|Booster Phase|Lost to Follow-up|0|||
162718849|NCT01235949|587676687|FG007|Booster Phase|Lost to Follow-up|0|||
162718850|NCT01235949|587676688|FG008|Booster Phase|Lost to Follow-up|1|||
162718851|NCT01235949|587676689|FG009|Booster Phase|Lost to Follow-up|1|||
162718852|NCT01235949|587676690|FG010|Booster Phase|Lost to Follow-up|1|||
162718853|NCT01235949|587676691|FG011|Booster Phase|Lost to Follow-up|1|||
162718854|NCT01235949|587676692|FG012|Booster Phase|Lost to Follow-up|0|||
162718855|NCT01235949|587676693|FG013|Booster Phase|Lost to Follow-up|0|||
162718856|NCT01235949|587676694|FG014|Booster Phase|Lost to Follow-up|0|||
162718857|NCT01235949|587676695|FG015|Booster Phase|Lost to Follow-up|0|||
162718858|NCT01235949|587676696|FG016|Booster Phase|Lost to Follow-up|0|||
162718859|NCT01235949|587676697|FG017|Booster Phase|Lost to Follow-up|1|||
162718860|NCT00436644|587676698|FG000|Overall Study|Adverse Event|2|||
162718861|NCT00436644|587676698|FG000|Overall Study|Death|1|||
162718862|NCT03743246|587676699|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162718863|NCT03743246|587676700|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162718864|NCT03743246|587676701|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
162718865|NCT03743246|587676702|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162718866|NCT03743246|587676699|FG000|Pre-Treatment Period|Death|0|||
162718867|NCT03743246|587676700|FG001|Pre-Treatment Period|Death|1|||
162718868|NCT03743246|587676701|FG002|Pre-Treatment Period|Death|0|||
162718869|NCT03743246|587676702|FG003|Pre-Treatment Period|Death|1|||
162718870|NCT03743246|587676699|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
163091449|NCT00387088|589046513|FG000|Overall Study|Lost to Follow-up|22|||
163091450|NCT00387088|589046514|FG001|Overall Study|Lost to Follow-up|28|||
163091451|NCT00387088|589046513|FG000|Overall Study|Other|58|||
163091452|NCT00387088|589046514|FG001|Overall Study|Other|52|||
162650686|NCT00969553|587438903|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650687|NCT00969553|587438904|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650688|NCT00969553|587438905|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650689|NCT00969553|587438906|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
162650690|NCT00969553|587438898|FG000|Overall Study|Other Adverse Event|0|||
162650691|NCT00969553|587438899|FG001|Overall Study|Other Adverse Event|0|||
162650692|NCT00969553|587438900|FG002|Overall Study|Other Adverse Event|0|||
162650693|NCT00969553|587438901|FG003|Overall Study|Other Adverse Event|1|||
162650694|NCT00969553|587438902|FG004|Overall Study|Other Adverse Event|0|||
162650695|NCT00969553|587438903|FG005|Overall Study|Other Adverse Event|0|||
162650696|NCT00969553|587438904|FG006|Overall Study|Other Adverse Event|1|||
162650697|NCT00969553|587438905|FG007|Overall Study|Other Adverse Event|0|||
162650698|NCT00969553|587438906|FG008|Overall Study|Other Adverse Event|0|||
162650699|NCT00969553|587438898|FG000|Overall Study|Refused cont. medication|1|||
162650700|NCT00969553|587438899|FG001|Overall Study|Refused cont. medication|1|||
162650701|NCT00969553|587438900|FG002|Overall Study|Refused cont. medication|0|||
162650702|NCT00969553|587438901|FG003|Overall Study|Refused cont. medication|2|||
162650703|NCT00969553|587438902|FG004|Overall Study|Refused cont. medication|0|||
162650704|NCT00969553|587438903|FG005|Overall Study|Refused cont. medication|0|||
162650705|NCT00969553|587438904|FG006|Overall Study|Refused cont. medication|0|||
162650706|NCT00969553|587438905|FG007|Overall Study|Refused cont. medication|1|||
162650707|NCT00969553|587438906|FG008|Overall Study|Refused cont. medication|0|||
162650708|NCT00969553|587438898|FG000|Overall Study|Not specified above|0|||
162650709|NCT00969553|587438899|FG001|Overall Study|Not specified above|0|||
162650710|NCT00969553|587438900|FG002|Overall Study|Not specified above|0|||
162650711|NCT00969553|587438901|FG003|Overall Study|Not specified above|4|||
162650712|NCT00969553|587438902|FG004|Overall Study|Not specified above|0|||
162650713|NCT00969553|587438903|FG005|Overall Study|Not specified above|0|||
162650714|NCT00969553|587438904|FG006|Overall Study|Not specified above|1|||
162650715|NCT00969553|587438905|FG007|Overall Study|Not specified above|1|||
162650716|NCT00969553|587438906|FG008|Overall Study|Not specified above|0|||
162650717|NCT04243538|587438907|FG000|Overall Study|Withdrawal by Subject|0|||
162718871|NCT03743246|587676700|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
162718872|NCT03743246|587676701|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
162718873|NCT03743246|587676702|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163091453|NCT03604497|589046520|FG000|Overall Study|Protocol Violation|52|||
163091454|NCT00811954|589046521|FG000|Overall Study|Death|10|||
163091455|NCT00811954|589046522|FG001|Overall Study|Death|6|||
162650718|NCT04243538|587438908|FG001|Overall Study|Withdrawal by Subject|2|||
162650719|NCT04243538|587438907|FG000|Overall Study|Lost to Follow-up|0|||
162718874|NCT03743246|587676699|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
162718875|NCT03743246|587676700|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163091456|NCT00811954|589046523|FG002|Overall Study|Death|13|||
162718876|NCT03743246|587676701|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163091457|NCT00811954|589046521|FG000|Overall Study|Lost to Follow-up|29|||
162650720|NCT04243538|587438908|FG001|Overall Study|Lost to Follow-up|3|||
162650721|NCT04536727|587438909|FG000|Overall Study|Lost to Follow-up|1|||
162650722|NCT04536727|587438910|FG001|Overall Study|Lost to Follow-up|1|||
162650723|NCT04536727|587438909|FG000|Overall Study|Death|0|||
162650724|NCT04536727|587438910|FG001|Overall Study|Death|1|||
163091458|NCT00811954|589046522|FG001|Overall Study|Lost to Follow-up|23|||
162718877|NCT03743246|587676702|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
162718878|NCT03743246|587676699|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
162718879|NCT03743246|587676700|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
162718880|NCT03743246|587676701|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
162718881|NCT03743246|587676702|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
162718882|NCT03743246|587676699|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163038448|NCT01210352|588847419|FG004|Overall Study|Physician Decision|0|||
163038449|NCT01210352|588847420|FG005|Overall Study|Physician Decision|0|||
163038450|NCT01210352|588847421|FG006|Overall Study|Physician Decision|0|||
163038451|NCT01210352|588847422|FG007|Overall Study|Physician Decision|1|||
163038452|NCT01210352|588847423|FG008|Overall Study|Physician Decision|2|||
163038453|NCT01210352|588847415|FG000|Overall Study|Withdrawal by Subject|0|||
163038454|NCT01210352|588847416|FG001|Overall Study|Withdrawal by Subject|0|||
163038455|NCT01210352|588847417|FG002|Overall Study|Withdrawal by Subject|1|||
163038456|NCT01210352|588847418|FG003|Overall Study|Withdrawal by Subject|0|||
163038457|NCT01210352|588847419|FG004|Overall Study|Withdrawal by Subject|0|||
163038458|NCT01210352|588847420|FG005|Overall Study|Withdrawal by Subject|0|||
163038459|NCT01210352|588847421|FG006|Overall Study|Withdrawal by Subject|1|||
163038460|NCT01210352|588847422|FG007|Overall Study|Withdrawal by Subject|0|||
163038461|NCT01210352|588847423|FG008|Overall Study|Withdrawal by Subject|1|||
163038462|NCT01210352|588847415|FG000|Overall Study|Patient Discharged Early|0|||
163038463|NCT01210352|588847416|FG001|Overall Study|Patient Discharged Early|0|||
163038464|NCT01210352|588847417|FG002|Overall Study|Patient Discharged Early|1|||
163038465|NCT01210352|588847418|FG003|Overall Study|Patient Discharged Early|0|||
163038466|NCT01210352|588847419|FG004|Overall Study|Patient Discharged Early|0|||
163038467|NCT01210352|588847420|FG005|Overall Study|Patient Discharged Early|0|||
163038468|NCT01210352|588847421|FG006|Overall Study|Patient Discharged Early|0|||
163038469|NCT01210352|588847422|FG007|Overall Study|Patient Discharged Early|0|||
163038470|NCT01210352|588847423|FG008|Overall Study|Patient Discharged Early|0|||
163038471|NCT04227405|588848731|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
163038472|NCT04227405|588848732|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
163038473|NCT04227405|588848731|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
163038474|NCT04227405|588848732|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
163038475|NCT04227405|588848731|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
163038476|NCT04227405|588848732|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
163038477|NCT03536663|588848733|FG000|Endexo|Protocol Violation|1|||
163038478|NCT01502956|588848734|FG000|Overall Study|Death|0|||
163038479|NCT01502956|588848735|FG001|Overall Study|Death|2|||
163038480|NCT01502956|588848734|FG000|Overall Study|Lost to Follow-up|14|||
163038481|NCT01502956|588848735|FG001|Overall Study|Lost to Follow-up|11|||
163038482|NCT01502956|588848734|FG000|Overall Study|Physician Decision|2|||
163038483|NCT01502956|588848735|FG001|Overall Study|Physician Decision|3|||
163038484|NCT01502956|588848734|FG000|Overall Study|Withdrawal by Subject|8|||
163038485|NCT01502956|588848735|FG001|Overall Study|Withdrawal by Subject|10|||
163038486|NCT01616758|588848736|FG000|Overall Study|Adverse Event|1|||
163038487|NCT01616758|588848736|FG000|Overall Study|Withdrawal by Subject|2|||
163038488|NCT01616758|588848736|FG000|Overall Study|Disease progression|18|||
163038489|NCT01616758|588848736|FG000|Overall Study|Study termination by Sponsor|1|||
163038490|NCT02187029|588848737|FG000|Overall Study|Adverse Event|0|||
163038491|NCT02187029|588848738|FG001|Overall Study|Adverse Event|1|||
163038492|NCT02187029|588848739|FG002|Overall Study|Adverse Event|1|||
163038493|NCT02187029|588848740|FG003|Overall Study|Adverse Event|0|||
163038494|NCT02187029|588848737|FG000|Overall Study|Study Terminated by Sponsor|0|||
163038495|NCT02187029|588848738|FG001|Overall Study|Study Terminated by Sponsor|0|||
163038496|NCT02187029|588848739|FG002|Overall Study|Study Terminated by Sponsor|10|||
163038497|NCT02187029|588848740|FG003|Overall Study|Study Terminated by Sponsor|3|||
163038498|NCT02187029|588848737|FG000|Overall Study|Withdrawal by Subject|1|||
163038499|NCT02187029|588848738|FG001|Overall Study|Withdrawal by Subject|0|||
163038500|NCT02187029|588848739|FG002|Overall Study|Withdrawal by Subject|0|||
163038501|NCT02187029|588848740|FG003|Overall Study|Withdrawal by Subject|0|||
163038502|NCT02985021|588848741|FG000|Overall Study|Inability to comply with study procedures|1|||
163038503|NCT04105842|588848742|FG000|Overall Study|Withdrawal by Subject|2|||
163038504|NCT01535443|588848748|FG000|Overall Study|Physician Decision|3|||
163038505|NCT00760487|588848750|FG000|Overall Study|Unilateral implantation|3|||
163038506|NCT00329745|588848751|FG000|Overall Study|Protocol Violation|1|||
163038507|NCT00329745|588848752|FG001|Overall Study|Protocol Violation|0|||
163038508|NCT00329745|588848751|FG000|Overall Study|Withdrawal by Subject|0|||
163038509|NCT00329745|588848752|FG001|Overall Study|Withdrawal by Subject|1|||
163038510|NCT00329745|588848751|FG000|Overall Study|Lost to Follow-up|86|||
163038511|NCT00329745|588848752|FG001|Overall Study|Lost to Follow-up|101|||
163038512|NCT03146741|588848753|FG000|Overall Study|Txp with non-HCV+ heart|4|||
163038513|NCT03146741|588848753|FG000|Overall Study|Listeted for MOT|2|||
163038514|NCT03146741|588848753|FG000|Overall Study|Physician Decision|2|||
163038515|NCT03146741|588848753|FG000|Overall Study|Awaiting txp|2|||
163038516|NCT03224624|588848754|FG000|Overall Study|Lost to Follow-up|9|||
163091459|NCT00811954|589046523|FG002|Overall Study|Lost to Follow-up|34|||
163091460|NCT00811954|589046521|FG000|Overall Study|Not able to get to clinic|28|||
163091461|NCT00811954|589046522|FG001|Overall Study|Not able to get to clinic|35|||
163091462|NCT00811954|589046523|FG002|Overall Study|Not able to get to clinic|30|||
163091463|NCT00811954|589046521|FG000|Overall Study|Not willing to adhere to requirements|12|||
163091464|NCT00811954|589046522|FG001|Overall Study|Not willing to adhere to requirements|2|||
163091465|NCT00811954|589046523|FG002|Overall Study|Not willing to adhere to requirements|16|||
163091466|NCT00811954|589046521|FG000|Overall Study|Withdraw consent prior study completion|4|||
163091467|NCT00811954|589046522|FG001|Overall Study|Withdraw consent prior study completion|6|||
163091468|NCT00811954|589046523|FG002|Overall Study|Withdraw consent prior study completion|5|||
163091469|NCT00811954|589046521|FG000|Overall Study|Site Closure|4|||
163091470|NCT00811954|589046522|FG001|Overall Study|Site Closure|0|||
163091471|NCT00811954|589046523|FG002|Overall Study|Site Closure|1|||
163091472|NCT00811954|589046521|FG000|Overall Study|Severe Debilitation|2|||
163091473|NCT00811954|589046522|FG001|Overall Study|Severe Debilitation|0|||
163091474|NCT00811954|589046523|FG002|Overall Study|Severe Debilitation|1|||
163091475|NCT00811954|589046521|FG000|Overall Study|Complete Protocol: No follow-up|0|||
163091476|NCT00811954|589046522|FG001|Overall Study|Complete Protocol: No follow-up|0|||
163091477|NCT00811954|589046523|FG002|Overall Study|Complete Protocol: No follow-up|1|||
163091478|NCT01534481|589046530|FG000|Overall Study|Lost to Follow-up|29|||
163091479|NCT01534481|589046531|FG001|Overall Study|Lost to Follow-up|24|||
163091480|NCT01534481|589046530|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
163091481|NCT01534481|589046531|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
163091482|NCT00945659|589046535|FG000|Overall Study|Lost to Follow-up|7|||
163091483|NCT00945659|589046536|FG001|Overall Study|Lost to Follow-up|20|||
163091484|NCT00945659|589046537|FG002|Overall Study|Lost to Follow-up|17|||
163091485|NCT00658541|589046538|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091486|NCT00658541|589046539|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091487|NCT00658541|589046538|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163091488|NCT00658541|589046539|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163091489|NCT03179761|589046540|FG000|Overall Study|Death|2|||
163091490|NCT03179761|589046541|FG001|Overall Study|Death|5|||
163091491|NCT03179761|589046540|FG000|Overall Study|Lost to Follow-up|2|||
163091492|NCT03179761|589046541|FG001|Overall Study|Lost to Follow-up|2|||
163091493|NCT03179761|589046540|FG000|Overall Study|Protocol Violation|1|||
163091494|NCT03179761|589046541|FG001|Overall Study|Protocol Violation|0|||
163091495|NCT03179761|589046540|FG000|Overall Study|Withdrawal by Subject|1|||
163091496|NCT03179761|589046541|FG001|Overall Study|Withdrawal by Subject|4|||
163091497|NCT03179761|589046540|FG000|Overall Study|Investigator Request|0|||
163091498|NCT03179761|589046541|FG001|Overall Study|Investigator Request|2|||
163091499|NCT00565409|589046542|FG000|Period 1 Open Label|Adverse Event|17|||
163091500|NCT00565409|589046543|FG001|Period 1 Open Label|Adverse Event|0|||
163091501|NCT00565409|589046544|FG002|Period 1 Open Label|Adverse Event|0|||
163091502|NCT00565409|589046545|FG003|Period 1 Open Label|Adverse Event|0|||
163091503|NCT00565409|589046542|FG000|Period 1 Open Label|Death|2|||
163091504|NCT00565409|589046543|FG001|Period 1 Open Label|Death|0|||
163091505|NCT00565409|589046544|FG002|Period 1 Open Label|Death|0|||
163091506|NCT00565409|589046545|FG003|Period 1 Open Label|Death|0|||
163091507|NCT00565409|589046542|FG000|Period 1 Open Label|Lost to Follow-up|1|||
163091508|NCT00565409|589046543|FG001|Period 1 Open Label|Lost to Follow-up|0|||
163091509|NCT00565409|589046544|FG002|Period 1 Open Label|Lost to Follow-up|0|||
163091510|NCT00565409|589046545|FG003|Period 1 Open Label|Lost to Follow-up|0|||
163091511|NCT00565409|589046542|FG000|Period 1 Open Label|Other|21|||
163091512|NCT00565409|589046543|FG001|Period 1 Open Label|Other|0|||
163091513|NCT00565409|589046544|FG002|Period 1 Open Label|Other|0|||
163091514|NCT00565409|589046545|FG003|Period 1 Open Label|Other|0|||
163091515|NCT00565409|589046542|FG000|Period 1 Open Label|Protocol Violation|14|||
163091516|NCT00565409|589046543|FG001|Period 1 Open Label|Protocol Violation|0|||
163091517|NCT00565409|589046544|FG002|Period 1 Open Label|Protocol Violation|0|||
163091518|NCT00565409|589046545|FG003|Period 1 Open Label|Protocol Violation|0|||
163091519|NCT00565409|589046542|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
163091520|NCT00565409|589046543|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091521|NCT00565409|589046544|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091522|NCT00565409|589046545|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
163091523|NCT00565409|589046542|FG000|Period 1 Open Label|no conclusion of participation record|1|||
162650725|NCT00500370|587438911|FG000|Overall Study|Adverse Event|9|||
163091524|NCT00565409|589046543|FG001|Period 1 Open Label|no conclusion of participation record|0|||
163091525|NCT00565409|589046544|FG002|Period 1 Open Label|no conclusion of participation record|0|||
163091526|NCT00565409|589046545|FG003|Period 1 Open Label|no conclusion of participation record|0|||
163091527|NCT00565409|589046542|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
163091528|NCT00565409|589046543|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091529|NCT00565409|589046544|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091530|NCT00565409|589046545|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
163091531|NCT00565409|589046542|FG000|Period 2 Double-Blind|Adverse Event|0|||
163091532|NCT00565409|589046543|FG001|Period 2 Double-Blind|Adverse Event|7|||
162650726|NCT00500370|587438912|FG001|Overall Study|Adverse Event|3|||
162650727|NCT00500370|587438911|FG000|Overall Study|Lost to Follow-up|10|||
162650728|NCT00500370|587438912|FG001|Overall Study|Lost to Follow-up|10|||
162650729|NCT00500370|587438911|FG000|Overall Study|Protocol Violation|2|||
163038517|NCT03224624|588848755|FG001|Overall Study|Lost to Follow-up|4|||
163038518|NCT03224624|588848754|FG000|Overall Study|Death|1|||
163038519|NCT03224624|588848755|FG001|Overall Study|Death|0|||
163038520|NCT00496587|588848758|FG000|Overall Study|Adverse Event|2|||
163038521|NCT00496587|588848758|FG000|Overall Study|Progressive Disease|24|||
163038522|NCT00496587|588848758|FG000|Overall Study|Withdrawal by Subject|2|||
163038523|NCT00496587|588848758|FG000|Overall Study|Death|1|||
163038524|NCT00496587|588848758|FG000|Overall Study|Complications unrelated|2|||
163038525|NCT00482170|588848760|FG000|Overall Study|Adverse Event|5|||
163038526|NCT00482170|588848761|FG001|Overall Study|Adverse Event|14|||
163038527|NCT00482170|588848760|FG000|Overall Study|Withdrawal by Subject|6|||
162650730|NCT00500370|587438912|FG001|Overall Study|Protocol Violation|4|||
162650731|NCT00500370|587438911|FG000|Overall Study|Sponsor Decision|2|||
163091533|NCT00565409|589046544|FG002|Period 2 Double-Blind|Adverse Event|4|||
163091534|NCT00565409|589046545|FG003|Period 2 Double-Blind|Adverse Event|5|||
163091535|NCT00565409|589046542|FG000|Period 2 Double-Blind|Death|0|||
163091536|NCT00565409|589046543|FG001|Period 2 Double-Blind|Death|2|||
163091537|NCT00565409|589046544|FG002|Period 2 Double-Blind|Death|0|||
163091538|NCT00565409|589046545|FG003|Period 2 Double-Blind|Death|0|||
163091539|NCT00565409|589046542|FG000|Period 2 Double-Blind|Protocol Violation|0|||
163091540|NCT00565409|589046543|FG001|Period 2 Double-Blind|Protocol Violation|4|||
163091541|NCT00565409|589046544|FG002|Period 2 Double-Blind|Protocol Violation|6|||
163091542|NCT00565409|589046545|FG003|Period 2 Double-Blind|Protocol Violation|2|||
163091543|NCT00565409|589046542|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
163091544|NCT00565409|589046543|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
163091545|NCT00565409|589046544|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
163091546|NCT00565409|589046545|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
163091547|NCT00565409|589046542|FG000|Period 2 Double-Blind|Other|0|||
163091548|NCT00565409|589046543|FG001|Period 2 Double-Blind|Other|4|||
163091549|NCT00565409|589046544|FG002|Period 2 Double-Blind|Other|5|||
163091550|NCT00565409|589046545|FG003|Period 2 Double-Blind|Other|9|||
163091551|NCT00565409|589046542|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
163091552|NCT00565409|589046543|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
163091553|NCT00565409|589046544|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
163091554|NCT00565409|589046545|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
163091555|NCT04828707|589046548|FG000|Overall Study|Lost to Follow-up|3|||
163091556|NCT04828707|589046549|FG001|Overall Study|Lost to Follow-up|2|||
163091557|NCT04828707|589046548|FG000|Overall Study|Withdrawal by Subject|2|||
163091558|NCT04828707|589046549|FG001|Overall Study|Withdrawal by Subject|1|||
163091559|NCT01570387|589046556|FG000|Overall Study|Adverse Event|1|||
163091560|NCT01570387|589046557|FG001|Overall Study|Adverse Event|0|||
163091561|NCT01570387|589046558|FG002|Overall Study|Adverse Event|0|||
163091562|NCT01570387|589046559|FG003|Overall Study|Adverse Event|0|||
163091563|NCT01570387|589046556|FG000|Overall Study|Death|0|||
162650732|NCT00500370|587438912|FG001|Overall Study|Sponsor Decision|0|||
162650733|NCT00500370|587438911|FG000|Overall Study|Subject Decision|10|||
162650734|NCT00500370|587438912|FG001|Overall Study|Subject Decision|17|||
162650735|NCT05308901|587440706|FG000|Overall Study|Death|6|||
162650736|NCT02586012|587440707|FG000|Overall Study|Withdrawal by Subject|1|||
162650737|NCT02586012|587440708|FG001|Overall Study|Withdrawal by Subject|1|||
162650738|NCT02586012|587440709|FG002|Overall Study|Withdrawal by Subject|0|||
162650739|NCT02586012|587440710|FG003|Overall Study|Withdrawal by Subject|1|||
162650740|NCT02586012|587440711|FG004|Overall Study|Withdrawal by Subject|0|||
162650741|NCT02586012|587440712|FG005|Overall Study|Withdrawal by Subject|2|||
162650742|NCT02586012|587440707|FG000|Overall Study|Protocol Violation|0|||
162650743|NCT02586012|587440708|FG001|Overall Study|Protocol Violation|0|||
162650744|NCT02586012|587440709|FG002|Overall Study|Protocol Violation|0|||
162650745|NCT02586012|587440710|FG003|Overall Study|Protocol Violation|0|||
162718883|NCT03743246|587676700|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
163038528|NCT00482170|588848761|FG001|Overall Study|Withdrawal by Subject|1|||
163091564|NCT01570387|589046557|FG001|Overall Study|Death|0|||
163091565|NCT01570387|589046558|FG002|Overall Study|Death|0|||
163091566|NCT01570387|589046559|FG003|Overall Study|Death|1|||
163091567|NCT01570387|589046556|FG000|Overall Study|Withdrawal by Subject|0|||
163038529|NCT00482170|588848760|FG000|Overall Study|Protocol Violation|2|||
163091568|NCT01570387|589046557|FG001|Overall Study|Withdrawal by Subject|0|||
163091569|NCT01570387|589046558|FG002|Overall Study|Withdrawal by Subject|0|||
163091570|NCT01570387|589046559|FG003|Overall Study|Withdrawal by Subject|1|||
162650746|NCT02586012|587440711|FG004|Overall Study|Protocol Violation|0|||
162650747|NCT02586012|587440712|FG005|Overall Study|Protocol Violation|1|||
163091571|NCT01876381|589046560|FG000|Overall Study|Lack of Efficacy|5|||
163091572|NCT01876381|589046560|FG000|Overall Study|Physician Decision|1|||
162650748|NCT02586012|587440707|FG000|Overall Study|study terminated|0|||
162650749|NCT02586012|587440708|FG001|Overall Study|study terminated|2|||
163038530|NCT00482170|588848761|FG001|Overall Study|Protocol Violation|3|||
163091573|NCT01876381|589046560|FG000|Overall Study|Withdrawal by Subject|1|||
163091574|NCT02170064|589046561|FG000|Overall Study|Withdrawal by Subject|5|||
163091575|NCT02170064|589046562|FG001|Overall Study|Withdrawal by Subject|1|||
163091576|NCT02170064|589046563|FG002|Overall Study|Withdrawal by Subject|1|||
163091577|NCT02170064|589046561|FG000|Overall Study|Physician Decision|1|||
163091578|NCT02170064|589046562|FG001|Overall Study|Physician Decision|1|||
163091579|NCT02170064|589046563|FG002|Overall Study|Physician Decision|0|||
163091580|NCT04211363|589046564|FG000|Overall Study|Adverse Event|5|||
163091581|NCT04211363|589046565|FG001|Overall Study|Adverse Event|2|||
163091582|NCT04211363|589046564|FG000|Overall Study|Physician Decision|0|||
163091583|NCT04211363|589046565|FG001|Overall Study|Physician Decision|1|||
163091584|NCT04211363|589046564|FG000|Overall Study|Protocol Violation|1|||
163091585|NCT04211363|589046565|FG001|Overall Study|Protocol Violation|0|||
163091586|NCT04211363|589046564|FG000|Overall Study|Pregnancy|1|||
163091587|NCT04211363|589046565|FG001|Overall Study|Pregnancy|0|||
163091588|NCT04211363|589046564|FG000|Overall Study|Lost to Follow-up|12|||
163091589|NCT04211363|589046565|FG001|Overall Study|Lost to Follow-up|4|||
163091590|NCT04211363|589046564|FG000|Overall Study|Withdrawal by Subject|11|||
163091591|NCT04211363|589046565|FG001|Overall Study|Withdrawal by Subject|11|||
163091592|NCT04211363|589046564|FG000|Overall Study|Other|1|||
163091593|NCT04211363|589046565|FG001|Overall Study|Other|2|||
163091594|NCT00654732|589046575|FG000|Overall Study|Adverse Event|4|||
163091595|NCT00654732|589046576|FG001|Overall Study|Adverse Event|6|||
163091596|NCT00518180|589046580|FG000|Overall Study|Withdrawal by Subject|29|||
163091597|NCT00518180|589046581|FG001|Overall Study|Withdrawal by Subject|30|||
163091598|NCT00518180|589046582|FG002|Overall Study|Withdrawal by Subject|42|||
163091599|NCT00518180|589046580|FG000|Overall Study|Lost to Follow-up|30|||
163091600|NCT00518180|589046581|FG001|Overall Study|Lost to Follow-up|28|||
163091601|NCT00518180|589046582|FG002|Overall Study|Lost to Follow-up|34|||
163091602|NCT00518180|589046580|FG000|Overall Study|Administrative reason|0|||
163091603|NCT00518180|589046581|FG001|Overall Study|Administrative reason|2|||
163091604|NCT00518180|589046582|FG002|Overall Study|Administrative reason|2|||
163091605|NCT00518180|589046580|FG000|Overall Study|Protocol Violation|5|||
163091606|NCT00518180|589046581|FG001|Overall Study|Protocol Violation|7|||
163091607|NCT00518180|589046582|FG002|Overall Study|Protocol Violation|4|||
163091608|NCT00518180|589046580|FG000|Overall Study|Unable to classify|0|||
163091609|NCT00518180|589046581|FG001|Overall Study|Unable to classify|2|||
163091610|NCT00518180|589046582|FG002|Overall Study|Unable to classify|0|||
163091611|NCT00518180|589046580|FG000|Overall Study|Adverse Event|1|||
163091612|NCT00518180|589046581|FG001|Overall Study|Adverse Event|0|||
163091613|NCT00518180|589046582|FG002|Overall Study|Adverse Event|0|||
163091614|NCT02347085|589046583|FG000|Overall Study|Adverse Event|2|||
163091615|NCT02347085|589046583|FG000|Overall Study|Lack of Efficacy|1|||
163091616|NCT02347085|589046583|FG000|Overall Study|Withdrawal by Subject|4|||
163091617|NCT02347085|589046583|FG000|Overall Study|Lost to Follow-up|1|||
162650750|NCT02586012|587440709|FG002|Overall Study|study terminated|1|||
162650751|NCT02586012|587440710|FG003|Overall Study|study terminated|1|||
162650752|NCT02586012|587440711|FG004|Overall Study|study terminated|1|||
162650753|NCT02586012|587440712|FG005|Overall Study|study terminated|0|||
162650754|NCT01816139|587440713|FG000|Overall Study|Adverse Event|6|||
162650755|NCT01816139|587440714|FG001|Overall Study|Adverse Event|8|||
162650756|NCT01816139|587440713|FG000|Overall Study|Lack of Efficacy|1|||
162650757|NCT01816139|587440714|FG001|Overall Study|Lack of Efficacy|2|||
162650758|NCT01816139|587440713|FG000|Overall Study|Lost to Follow-up|5|||
162650759|NCT01816139|587440714|FG001|Overall Study|Lost to Follow-up|3|||
162650760|NCT01816139|587440713|FG000|Overall Study|Withdrew Consent|6|||
162650761|NCT01816139|587440714|FG001|Overall Study|Withdrew Consent|4|||
162650762|NCT01816139|587440713|FG000|Overall Study|Protocol Violation|6|||
162650763|NCT01816139|587440714|FG001|Overall Study|Protocol Violation|3|||
162650764|NCT01816139|587440713|FG000|Overall Study|Reason not Specified|4|||
162650765|NCT01816139|587440714|FG001|Overall Study|Reason not Specified|2|||
162650766|NCT01572038|587440715|FG000|Overall Study|Death|648|||
162650767|NCT01572038|587440715|FG000|Overall Study|Withdrawal by Subject|204|||
162650768|NCT01572038|587440715|FG000|Overall Study|Lost to Follow-up|81|||
162650769|NCT01572038|587440715|FG000|Overall Study|Physician Decision|20|||
163091618|NCT02347085|589046583|FG000|Overall Study|Protocol Criteria|2|||
163091619|NCT01957865|589046584|FG000|Overall Study|Found HIV negative|0|||
163091620|NCT01957865|589046585|FG001|Overall Study|Found HIV negative|0|||
163091621|NCT01957865|589046586|FG002|Overall Study|Found HIV negative|1|||
163091622|NCT01957865|589046584|FG000|Overall Study|Lost to Follow-up|0|||
162650770|NCT01572038|587440715|FG000|Overall Study|Patient Decision|14|||
163091623|NCT01957865|589046585|FG001|Overall Study|Lost to Follow-up|2|||
163091624|NCT01957865|589046586|FG002|Overall Study|Lost to Follow-up|2|||
162650771|NCT01572038|587440715|FG000|Overall Study|Progressive Disease|8|||
162650772|NCT01572038|587440715|FG000|Overall Study|Site Closed Before Completing Form|6|||
163091625|NCT01082614|589046587|FG000|Overall Study|Adverse Event|1|||
163091626|NCT01082614|589046588|FG001|Overall Study|Adverse Event|4|||
163091627|NCT01082614|589046587|FG000|Overall Study|Equipment Malfunction|0|||
163091628|NCT01082614|589046588|FG001|Overall Study|Equipment Malfunction|1|||
163091629|NCT01082614|589046587|FG000|Overall Study|Physician Decision|2|||
162650773|NCT01572038|587440715|FG000|Overall Study|Enrolled into Another Trial|3|||
162650774|NCT01572038|587440715|FG000|Overall Study|Participated in Another Trial|3|||
162650775|NCT01572038|587440715|FG000|Overall Study|Termination by Sponsor|2|||
162650776|NCT01572038|587440715|FG000|Overall Study|Patient Deterioration|1|||
162650777|NCT01572038|587440715|FG000|Overall Study|Sponsor Decision|1|||
162650778|NCT02554656|587440716|FG000|Overall Study|Protocol Violation|3|||
162650779|NCT01888497|587440717|FG000|Washout Period 1|Withdrawal by Subject|0|||
162650780|NCT01888497|587440718|FG001|Washout Period 1|Withdrawal by Subject|0|||
162650781|NCT01888497|587440719|FG002|Washout Period 1|Withdrawal by Subject|1|||
162650782|NCT01888497|587440720|FG003|Washout Period 1|Withdrawal by Subject|1|||
162650783|NCT01888497|587440717|FG000|Washout Period 2|Adverse Event|0|||
162650784|NCT01888497|587440718|FG001|Washout Period 2|Adverse Event|0|||
162650785|NCT01888497|587440719|FG002|Washout Period 2|Adverse Event|0|||
162650786|NCT01888497|587440720|FG003|Washout Period 2|Adverse Event|1|||
162650787|NCT01888497|587440717|FG000|Washout Period 2|Withdrawal by Subject|0|||
162650788|NCT01888497|587440718|FG001|Washout Period 2|Withdrawal by Subject|0|||
162650789|NCT01888497|587440719|FG002|Washout Period 2|Withdrawal by Subject|0|||
162650790|NCT01888497|587440720|FG003|Washout Period 2|Withdrawal by Subject|1|||
162650791|NCT01140477|587440723|FG000|Overall Study|Lost to Follow-up|4|||
162650792|NCT01140477|587440724|FG001|Overall Study|Lost to Follow-up|0|||
162650793|NCT01140477|587440723|FG000|Overall Study|Withdrawal by Subject|1|||
162650794|NCT01140477|587440724|FG001|Overall Study|Withdrawal by Subject|4|||
162650795|NCT01140477|587440723|FG000|Overall Study|Surgical complication preventing implant|2|||
162650796|NCT01140477|587440724|FG001|Overall Study|Surgical complication preventing implant|0|||
162650797|NCT01140477|587440723|FG000|Overall Study|Death|1|||
162650798|NCT01140477|587440724|FG001|Overall Study|Death|1|||
162650799|NCT01140477|587440723|FG000|Overall Study|Subject explanted|0|||
162650800|NCT01140477|587440724|FG001|Overall Study|Subject explanted|1|||
162650801|NCT04127786|587440729|FG000|Primary Series|Adverse Event|1|||
162650802|NCT04127786|587440730|FG001|Primary Series|Adverse Event|0|||
162650803|NCT04127786|587440731|FG002|Primary Series|Adverse Event|0|||
162650804|NCT04127786|587440732|FG003|Primary Series|Adverse Event|1|||
162650805|NCT04127786|587440733|FG004|Primary Series|Adverse Event|0|||
162650806|NCT04127786|587440734|FG005|Primary Series|Adverse Event|1|||
162650807|NCT04127786|587440729|FG000|Primary Series|Protocol Violation|5|||
162650808|NCT04127786|587440730|FG001|Primary Series|Protocol Violation|3|||
162650809|NCT04127786|587440731|FG002|Primary Series|Protocol Violation|4|||
162650810|NCT04127786|587440732|FG003|Primary Series|Protocol Violation|3|||
162650811|NCT04127786|587440733|FG004|Primary Series|Protocol Violation|2|||
162650812|NCT04127786|587440734|FG005|Primary Series|Protocol Violation|0|||
162650813|NCT04127786|587440729|FG000|Primary Series|Withdrawal by Subject|0|||
162650814|NCT04127786|587440730|FG001|Primary Series|Withdrawal by Subject|0|||
162650815|NCT04127786|587440731|FG002|Primary Series|Withdrawal by Subject|0|||
162650816|NCT04127786|587440732|FG003|Primary Series|Withdrawal by Subject|1|||
162650817|NCT04127786|587440733|FG004|Primary Series|Withdrawal by Subject|0|||
162650818|NCT04127786|587440734|FG005|Primary Series|Withdrawal by Subject|0|||
162650819|NCT04127786|587440729|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
162650820|NCT04127786|587440730|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
162650821|NCT04127786|587440731|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
162650822|NCT04127786|587440732|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
162650823|NCT04127786|587440733|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
162650824|NCT04127786|587440734|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
162650825|NCT04127786|587440729|FG000|Booster Phase|Withdrawal by Subject|2|||
162650826|NCT04127786|587440730|FG001|Booster Phase|Withdrawal by Subject|0|||
162650827|NCT04127786|587440731|FG002|Booster Phase|Withdrawal by Subject|0|||
162650828|NCT04127786|587440732|FG003|Booster Phase|Withdrawal by Subject|0|||
162650829|NCT04127786|587440733|FG004|Booster Phase|Withdrawal by Subject|0|||
162650830|NCT04127786|587440734|FG005|Booster Phase|Withdrawal by Subject|0|||
162650831|NCT01904604|587440735|FG000|Overall Study|Withdrew before receiving dosing|0|||
162650832|NCT01904604|587440736|FG001|Overall Study|Withdrew before receiving dosing|1|||
162650833|NCT01904604|587440737|FG002|Overall Study|Withdrew before receiving dosing|0|||
162650834|NCT01904604|587440735|FG000|Overall Study|Non-compliance|1|||
162650835|NCT01904604|587440736|FG001|Overall Study|Non-compliance|0|||
162650836|NCT01904604|587440737|FG002|Overall Study|Non-compliance|0|||
162650837|NCT01904604|587440735|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
162650838|NCT01904604|587440736|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
162650839|NCT01904604|587440737|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
162650840|NCT01904604|587440735|FG000|Overall Study|Patch site reactions|1|||
162650841|NCT01904604|587440736|FG001|Overall Study|Patch site reactions|1|||
162650842|NCT01904604|587440737|FG002|Overall Study|Patch site reactions|0|||
162650843|NCT01904604|587440735|FG000|Overall Study|Increased syncope|0|||
162650844|NCT01904604|587440736|FG001|Overall Study|Increased syncope|1|||
162650845|NCT01904604|587440737|FG002|Overall Study|Increased syncope|0|||
162650846|NCT01904604|587440735|FG000|Overall Study|Unrelated illness|0|||
162650847|NCT01904604|587440736|FG001|Overall Study|Unrelated illness|1|||
162650848|NCT01904604|587440737|FG002|Overall Study|Unrelated illness|0|||
162650849|NCT01904604|587440735|FG000|Overall Study|Passed Week 52 OFC|1|||
163091630|NCT01082614|589046588|FG001|Overall Study|Physician Decision|0|||
163091631|NCT00950651|589046592|FG000|Overall Study|Adverse Event|17|||
163091632|NCT00950651|589046593|FG001|Overall Study|Adverse Event|20|||
163091633|NCT00950651|589046592|FG000|Overall Study|Death|1|||
163091634|NCT00950651|589046593|FG001|Overall Study|Death|0|||
163091635|NCT00950651|589046592|FG000|Overall Study|Lack of Efficacy|2|||
163091636|NCT00950651|589046593|FG001|Overall Study|Lack of Efficacy|2|||
163091637|NCT00950651|589046592|FG000|Overall Study|Protocol Violation|3|||
163091638|NCT00950651|589046593|FG001|Overall Study|Protocol Violation|4|||
163091639|NCT00950651|589046592|FG000|Overall Study|Withdrawal by Subject|8|||
163091640|NCT00950651|589046593|FG001|Overall Study|Withdrawal by Subject|9|||
163091641|NCT03783780|589046598|FG000|Overall Study|Withdrawn prior to completion|1|||
162650850|NCT01904604|587440736|FG001|Overall Study|Passed Week 52 OFC|0|||
162650851|NCT01904604|587440737|FG002|Overall Study|Passed Week 52 OFC|0|||
162650852|NCT01904604|587440735|FG000|Overall Study|Withdrawal by Subject|1|||
162650853|NCT01904604|587440736|FG001|Overall Study|Withdrawal by Subject|2|||
162650854|NCT01904604|587440737|FG002|Overall Study|Withdrawal by Subject|0|||
162650855|NCT01904604|587440735|FG000|Overall Study|Participant Relocated|1|||
162650856|NCT01904604|587440736|FG001|Overall Study|Participant Relocated|1|||
162650857|NCT01904604|587440737|FG002|Overall Study|Participant Relocated|1|||
162650858|NCT01904604|587440735|FG000|Overall Study|Lost to Follow-up|0|||
162650859|NCT01904604|587440736|FG001|Overall Study|Lost to Follow-up|0|||
163091642|NCT03768427|589046599|FG000|Overall Study|Death|0|||
163091643|NCT03768427|589046600|FG001|Overall Study|Death|0|||
163091644|NCT03768427|589046601|FG002|Overall Study|Death|1|||
163091645|NCT03768427|589046602|FG003|Overall Study|Death|0|||
162650860|NCT01904604|587440737|FG002|Overall Study|Lost to Follow-up|1|||
162650861|NCT02821962|587440743|FG000|Overall Study|Lost to Follow-up|2|||
162650862|NCT02821962|587440744|FG001|Overall Study|Lost to Follow-up|0|||
162650863|NCT04206293|587440757|FG000|Overall Study|Consent withdrawal|1|||
162650864|NCT03325166|587440759|FG000|Overall Study|Adverse Event|1|||
162650865|NCT00782210|587440761|FG000|Overall Study|Adverse Event|21|||
163091646|NCT03768427|589046599|FG000|Overall Study|Lost to Follow-up|2|||
163091647|NCT03768427|589046600|FG001|Overall Study|Lost to Follow-up|0|||
162650866|NCT00782210|587440762|FG001|Overall Study|Adverse Event|17|||
162650867|NCT00782210|587440763|FG002|Overall Study|Adverse Event|16|||
162650868|NCT00782210|587440761|FG000|Overall Study|Lost to Follow-up|2|||
162650869|NCT00782210|587440762|FG001|Overall Study|Lost to Follow-up|1|||
162650870|NCT00782210|587440763|FG002|Overall Study|Lost to Follow-up|2|||
163091648|NCT03768427|589046601|FG002|Overall Study|Lost to Follow-up|0|||
163091649|NCT03768427|589046602|FG003|Overall Study|Lost to Follow-up|0|||
163091650|NCT03768427|589046599|FG000|Overall Study|Physician Decision|3|||
163091651|NCT03768427|589046600|FG001|Overall Study|Physician Decision|2|||
163091652|NCT03768427|589046601|FG002|Overall Study|Physician Decision|4|||
163091653|NCT03768427|589046602|FG003|Overall Study|Physician Decision|4|||
163091654|NCT03768427|589046599|FG000|Overall Study|Withdrawal by Subject|7|||
163091655|NCT03768427|589046600|FG001|Overall Study|Withdrawal by Subject|2|||
162650871|NCT00782210|587440761|FG000|Overall Study|Withdrawal by Subject|11|||
162650872|NCT00782210|587440762|FG001|Overall Study|Withdrawal by Subject|8|||
162650873|NCT00782210|587440763|FG002|Overall Study|Withdrawal by Subject|11|||
162650874|NCT00782210|587440761|FG000|Overall Study|Non compliance with protocol|0|||
163091656|NCT03768427|589046601|FG002|Overall Study|Withdrawal by Subject|6|||
163091657|NCT03768427|589046602|FG003|Overall Study|Withdrawal by Subject|7|||
163091658|NCT03710889|589046605|FG000|Overall Study|Adverse Event|2|||
163091659|NCT03710889|589046605|FG000|Overall Study|Protocol Deviation|1|||
163091660|NCT00659425|589046607|FG000|Overall Study|Disease progression|1|||
163091661|NCT00659425|589046608|FG001|Overall Study|Disease progression|0|||
163091662|NCT00659425|589046609|FG002|Overall Study|Disease progression|0|||
163091663|NCT00659425|589046610|FG003|Overall Study|Disease progression|1|||
163091664|NCT00659425|589046611|FG004|Overall Study|Disease progression|0|||
163091665|NCT00659425|589046612|FG005|Overall Study|Disease progression|2|||
163091666|NCT00659425|589046613|FG006|Overall Study|Disease progression|4|||
163091667|NCT00659425|589046614|FG007|Overall Study|Disease progression|3|||
162650875|NCT00782210|587440762|FG001|Overall Study|Non compliance with protocol|3|||
162650876|NCT00782210|587440763|FG002|Overall Study|Non compliance with protocol|2|||
162650877|NCT00782210|587440761|FG000|Overall Study|Lack of Efficacy|13|||
162650878|NCT00782210|587440762|FG001|Overall Study|Lack of Efficacy|4|||
162650879|NCT00782210|587440763|FG002|Overall Study|Lack of Efficacy|1|||
162650880|NCT00782210|587440761|FG000|Overall Study|Other reason not described above|3|||
163091668|NCT00659425|589046615|FG008|Overall Study|Disease progression|5|||
163091669|NCT00659425|589046616|FG009|Overall Study|Disease progression|3|||
163091670|NCT00659425|589046607|FG000|Overall Study|Death|0|||
163091671|NCT00659425|589046608|FG001|Overall Study|Death|0|||
163091672|NCT00659425|589046609|FG002|Overall Study|Death|0|||
163091673|NCT00659425|589046610|FG003|Overall Study|Death|1|||
162650881|NCT00782210|587440762|FG001|Overall Study|Other reason not described above|2|||
163091674|NCT00659425|589046611|FG004|Overall Study|Death|0|||
163091675|NCT00659425|589046612|FG005|Overall Study|Death|0|||
163091676|NCT00659425|589046613|FG006|Overall Study|Death|1|||
163091677|NCT00659425|589046614|FG007|Overall Study|Death|0|||
162650882|NCT00782210|587440763|FG002|Overall Study|Other reason not described above|3|||
162650883|NCT01610791|587440768|FG000|Overall Study|Lost to Follow-up|7|||
162650884|NCT01610791|587440768|FG000|Overall Study|Adverse Event|6|||
162650885|NCT01610791|587440768|FG000|Overall Study|Physician Decision|1|||
162650886|NCT01610791|587440768|FG000|Overall Study|Adverse event and Investigator decision|1|||
162650887|NCT01610791|587440768|FG000|Overall Study|Death|1|||
162650888|NCT01610791|587440768|FG000|Overall Study|Not determined|5|||
162650889|NCT05923229|587440769|FG000|Overall Study|Withdrawal by Subject|3|||
162650890|NCT05923229|587440770|FG001|Overall Study|Withdrawal by Subject|0|||
162650891|NCT05923229|587440769|FG000|Overall Study|Health related|2|||
162650892|NCT05923229|587440770|FG001|Overall Study|Health related|1|||
162650893|NCT04304001|587440771|FG000|Overall Study|Lost to Follow-up|13|||
162650894|NCT04304001|587440772|FG001|Overall Study|Lost to Follow-up|9|||
162650895|NCT04164901|587440773|FG000|Overall Study|Withdrawal by Subject|4|||
162650896|NCT04164901|587440774|FG001|Overall Study|Withdrawal by Subject|4|||
162650897|NCT02465528|587440775|FG000|Overall Study|Progressive disease|0|||
162650898|NCT02465528|587440776|FG001|Overall Study|Progressive disease|2|||
162650899|NCT02465528|587440777|FG002|Overall Study|Progressive disease|9|||
162650900|NCT02465528|587440778|FG003|Overall Study|Progressive disease|4|||
162650901|NCT02465528|587440775|FG000|Overall Study|Study terminated by sponsor|1|||
162650902|NCT02465528|587440776|FG001|Overall Study|Study terminated by sponsor|2|||
162650903|NCT02465528|587440777|FG002|Overall Study|Study terminated by sponsor|0|||
162650904|NCT02465528|587440778|FG003|Overall Study|Study terminated by sponsor|0|||
162650905|NCT02465528|587440775|FG000|Overall Study|Withdrawal by Subject|0|||
162650906|NCT02465528|587440776|FG001|Overall Study|Withdrawal by Subject|0|||
162650907|NCT02465528|587440777|FG002|Overall Study|Withdrawal by Subject|2|||
162650908|NCT02465528|587440778|FG003|Overall Study|Withdrawal by Subject|0|||
162650909|NCT02465528|587440775|FG000|Overall Study|Adverse Event|0|||
162650910|NCT02465528|587440776|FG001|Overall Study|Adverse Event|0|||
162650911|NCT02465528|587440777|FG002|Overall Study|Adverse Event|0|||
162650912|NCT02465528|587440778|FG003|Overall Study|Adverse Event|1|||
162650913|NCT02465528|587440775|FG000|Overall Study|Physician Decision|0|||
162650914|NCT02465528|587440776|FG001|Overall Study|Physician Decision|0|||
162650915|NCT02465528|587440777|FG002|Overall Study|Physician Decision|1|||
162650916|NCT02465528|587440778|FG003|Overall Study|Physician Decision|0|||
162650917|NCT05358821|587440779|FG000|Overall Study|Withdrawal by Subject|0|||
162650918|NCT05358821|587440780|FG001|Overall Study|Withdrawal by Subject|1|||
162650919|NCT05358821|587440781|FG002|Overall Study|Withdrawal by Subject|0|||
162650920|NCT05358821|587440779|FG000|Overall Study|Withdrawal of Consent|0|||
162650921|NCT05358821|587440780|FG001|Overall Study|Withdrawal of Consent|0|||
162650922|NCT05358821|587440781|FG002|Overall Study|Withdrawal of Consent|1|||
162650923|NCT04098458|587440788|FG000|Overall Study|Death|1|||
162650924|NCT04098458|587440788|FG000|Overall Study|did not meet study inclusion criteria|3|||
162650925|NCT02272413|587440793|FG000|Randomized Through Treatment Start|Not treated|3|||
162650926|NCT02272413|587440794|FG001|Randomized Through Treatment Start|Not treated|5|||
162650927|NCT02272413|587440793|FG000|Pre-switch Period|Adverse Event|38|||
162650928|NCT02272413|587440794|FG001|Pre-switch Period|Adverse Event|37|||
162650929|NCT02272413|587440793|FG000|Pre-switch Period|Death|26|||
162650930|NCT02272413|587440794|FG001|Pre-switch Period|Death|26|||
162650931|NCT02272413|587440793|FG000|Pre-switch Period|Withdrawal by Subject|27|||
162650932|NCT02272413|587440794|FG001|Pre-switch Period|Withdrawal by Subject|15|||
162650933|NCT02272413|587440793|FG000|Pre-switch Period|Physician Decision|6|||
162650934|NCT02272413|587440794|FG001|Pre-switch Period|Physician Decision|18|||
162650935|NCT02272413|587440793|FG000|Pre-switch Period|Progressive disease|185|||
162650936|NCT02272413|587440794|FG001|Pre-switch Period|Progressive disease|173|||
162650937|NCT02272413|587440793|FG000|Pre-switch Period|Lost to Follow-up|0|||
162650938|NCT02272413|587440794|FG001|Pre-switch Period|Lost to Follow-up|2|||
162650939|NCT02272413|587440793|FG000|Pre-switch Period|Protocol Violation|1|||
162650940|NCT02272413|587440794|FG001|Pre-switch Period|Protocol Violation|0|||
162650941|NCT02272413|587440793|FG000|Pre-switch Period|Other than listed|10|||
162650942|NCT02272413|587440794|FG001|Pre-switch Period|Other than listed|11|||
162650943|NCT02272413|587440793|FG000|Post-switch Period|Adverse Event|4|||
162650944|NCT02272413|587440794|FG001|Post-switch Period|Adverse Event|4|||
162650945|NCT02272413|587440793|FG000|Post-switch Period|Death|3|||
162650946|NCT02272413|587440794|FG001|Post-switch Period|Death|2|||
162650947|NCT02272413|587440793|FG000|Post-switch Period|Withdrawal by Subject|1|||
162650948|NCT02272413|587440794|FG001|Post-switch Period|Withdrawal by Subject|2|||
162650949|NCT02272413|587440793|FG000|Post-switch Period|Physician Decision|1|||
162650950|NCT02272413|587440794|FG001|Post-switch Period|Physician Decision|1|||
162650951|NCT02272413|587440793|FG000|Post-switch Period|Progressive disease|21|||
162718884|NCT03743246|587676701|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
162650952|NCT02272413|587440794|FG001|Post-switch Period|Progressive disease|21|||
162650953|NCT02272413|587440793|FG000|Post-switch Period|Study terminated by sponsor|8|||
162650954|NCT02272413|587440794|FG001|Post-switch Period|Study terminated by sponsor|11|||
162650955|NCT02272413|587440793|FG000|Post-switch Period|Other than listed|4|||
162650956|NCT02272413|587440794|FG001|Post-switch Period|Other than listed|5|||
162650957|NCT04327999|587440795|FG000|Overall Study|Protocol Violation|1|||
162718885|NCT03743246|587676702|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
162718886|NCT03743246|587676699|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
162718887|NCT03743246|587676700|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162718888|NCT03743246|587676701|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162718889|NCT03743246|587676702|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162718890|NCT03743246|587676699|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
162718891|NCT03743246|587676700|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
162718892|NCT03743246|587676701|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
162718893|NCT03743246|587676702|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
162718894|NCT03743246|587676699|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
162718895|NCT03743246|587676700|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162718896|NCT03743246|587676701|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162718897|NCT03743246|587676702|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162718898|NCT04173572|587676703|FG000|Overall Study|Withdrawal by Subject|1|||
162718899|NCT04173572|587676704|FG001|Overall Study|Withdrawal by Subject|5|||
162718900|NCT04173572|587676703|FG000|Overall Study|Lost to Follow-up|3|||
162718901|NCT04173572|587676704|FG001|Overall Study|Lost to Follow-up|1|||
162718902|NCT00395018|587676705|FG000|On-Treatment|Death|4|||
162718903|NCT00395018|587676705|FG000|On-Treatment|Other Reason|2|||
162718904|NCT00395018|587676705|FG000|On-Treatment|Poor/non-compliance|2|||
162718905|NCT00395018|587676705|FG000|On-Treatment|Subject no longer meets study criteria|2|||
162718906|NCT00395018|587676705|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
162718907|NCT00395018|587676705|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
162718908|NCT00395018|587676705|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
162718909|NCT02534350|587676706|FG000|Overall Study|Randomized But Not Treated|1|||
162718910|NCT02534350|587676707|FG001|Overall Study|Randomized But Not Treated|0|||
162718911|NCT02534350|587676706|FG000|Overall Study|Protocol Violation|1|||
162718912|NCT02534350|587676707|FG001|Overall Study|Protocol Violation|0|||
162718913|NCT02534350|587676706|FG000|Overall Study|Withdrew Consent|2|||
162718914|NCT02534350|587676707|FG001|Overall Study|Withdrew Consent|0|||
162718915|NCT03478696|587676723|FG000|Overall Study|Adverse Event|1|||
162718916|NCT03478696|587676724|FG001|Overall Study|Adverse Event|5|||
162718917|NCT03478696|587676723|FG000|Overall Study|Lost to Follow-up|1|||
162718918|NCT03478696|587676724|FG001|Overall Study|Lost to Follow-up|0|||
162718919|NCT03478696|587676723|FG000|Overall Study|Physician Decision|6|||
162718920|NCT03478696|587676724|FG001|Overall Study|Physician Decision|3|||
162718921|NCT03478696|587676723|FG000|Overall Study|Withdrawal by Subject|9|||
162718922|NCT03478696|587676724|FG001|Overall Study|Withdrawal by Subject|4|||
162718923|NCT00716144|587676729|FG000|Overall Study|Withdrawal by Subject|4|||
162718924|NCT00716144|587676730|FG001|Overall Study|Withdrawal by Subject|2|||
162718925|NCT00716144|587676731|FG002|Overall Study|Withdrawal by Subject|6|||
162718926|NCT00716144|587676732|FG003|Overall Study|Withdrawal by Subject|6|||
162718927|NCT00716144|587676729|FG000|Overall Study|Lost to Follow-up|2|||
162718928|NCT00716144|587676730|FG001|Overall Study|Lost to Follow-up|2|||
162718929|NCT00716144|587676731|FG002|Overall Study|Lost to Follow-up|1|||
162718930|NCT00716144|587676732|FG003|Overall Study|Lost to Follow-up|2|||
162718931|NCT00716144|587676729|FG000|Overall Study|Adverse Event|0|||
162718932|NCT00716144|587676730|FG001|Overall Study|Adverse Event|0|||
162650958|NCT02872116|587440796|FG000|Pre-Treatment|Disease Progression|0|||
162650959|NCT02872116|587440797|FG001|Pre-Treatment|Disease Progression|1|||
162650960|NCT02872116|587440798|FG002|Pre-Treatment|Disease Progression|0|||
162650961|NCT02872116|587440796|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
162650962|NCT02872116|587440797|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
162650963|NCT02872116|587440798|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
162650964|NCT02872116|587440796|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
162650965|NCT02872116|587440797|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
162650966|NCT02872116|587440798|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
162718933|NCT00716144|587676731|FG002|Overall Study|Adverse Event|0|||
162718934|NCT00716144|587676732|FG003|Overall Study|Adverse Event|2|||
162718935|NCT00716144|587676729|FG000|Overall Study|Non-compliance|1|||
162718936|NCT00716144|587676730|FG001|Overall Study|Non-compliance|0|||
162718937|NCT00716144|587676731|FG002|Overall Study|Non-compliance|0|||
163091678|NCT00659425|589046615|FG008|Overall Study|Death|0|||
162650967|NCT02872116|587440796|FG000|Pre-Treatment|Participant withdrew consent|2|||
162650968|NCT02872116|587440797|FG001|Pre-Treatment|Participant withdrew consent|20|||
162650969|NCT02872116|587440798|FG002|Pre-Treatment|Participant withdrew consent|3|||
162650970|NCT02872116|587440796|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
162718938|NCT00716144|587676732|FG003|Overall Study|Non-compliance|0|||
162718939|NCT00716144|587676729|FG000|Overall Study|Protocol Violation|2|||
162718940|NCT00716144|587676730|FG001|Overall Study|Protocol Violation|0|||
162718941|NCT00716144|587676731|FG002|Overall Study|Protocol Violation|1|||
162718942|NCT00716144|587676732|FG003|Overall Study|Protocol Violation|0|||
162718943|NCT00716144|587676729|FG000|Overall Study|Physician Decision|0|||
162718944|NCT00716144|587676730|FG001|Overall Study|Physician Decision|1|||
163091679|NCT00659425|589046616|FG009|Overall Study|Death|0|||
163091680|NCT00659425|589046607|FG000|Overall Study|Adverse Event|0|||
163091681|NCT00659425|589046608|FG001|Overall Study|Adverse Event|0|||
163091682|NCT00659425|589046609|FG002|Overall Study|Adverse Event|0|||
163091683|NCT00659425|589046610|FG003|Overall Study|Adverse Event|0|||
163091684|NCT00659425|589046611|FG004|Overall Study|Adverse Event|0|||
163091685|NCT00659425|589046612|FG005|Overall Study|Adverse Event|1|||
163091686|NCT00659425|589046613|FG006|Overall Study|Adverse Event|0|||
163091687|NCT00659425|589046614|FG007|Overall Study|Adverse Event|3|||
163091688|NCT00659425|589046615|FG008|Overall Study|Adverse Event|1|||
163091689|NCT00659425|589046616|FG009|Overall Study|Adverse Event|4|||
163091690|NCT00659425|589046607|FG000|Overall Study|Investigator Discretion|0|||
163091691|NCT00659425|589046608|FG001|Overall Study|Investigator Discretion|0|||
163091692|NCT00659425|589046609|FG002|Overall Study|Investigator Discretion|0|||
163091693|NCT00659425|589046610|FG003|Overall Study|Investigator Discretion|0|||
163091694|NCT00659425|589046611|FG004|Overall Study|Investigator Discretion|0|||
163091695|NCT00659425|589046612|FG005|Overall Study|Investigator Discretion|1|||
163091696|NCT00659425|589046613|FG006|Overall Study|Investigator Discretion|0|||
163091697|NCT00659425|589046614|FG007|Overall Study|Investigator Discretion|3|||
163091698|NCT00659425|589046615|FG008|Overall Study|Investigator Discretion|0|||
163091699|NCT00659425|589046616|FG009|Overall Study|Investigator Discretion|0|||
163091700|NCT00659425|589046607|FG000|Overall Study|Other|0|||
163091701|NCT00659425|589046608|FG001|Overall Study|Other|1|||
163091702|NCT00659425|589046609|FG002|Overall Study|Other|1|||
163091703|NCT00659425|589046610|FG003|Overall Study|Other|2|||
163091704|NCT00659425|589046611|FG004|Overall Study|Other|4|||
163091705|NCT00659425|589046612|FG005|Overall Study|Other|0|||
163091706|NCT00659425|589046613|FG006|Overall Study|Other|3|||
163091707|NCT00659425|589046614|FG007|Overall Study|Other|2|||
163091708|NCT00659425|589046615|FG008|Overall Study|Other|0|||
163091709|NCT00659425|589046616|FG009|Overall Study|Other|6|||
163091710|NCT02121509|589046617|FG000|Washout Period (35 Days)|Adverse Event|1|||
163091711|NCT02121509|589046618|FG001|Washout Period (35 Days)|Adverse Event|1|||
163091712|NCT02121509|589046619|FG002|Washout Period (35 Days)|Adverse Event|0|||
163091713|NCT02121509|589046620|FG003|Washout Period (35 Days)|Adverse Event|0|||
163091714|NCT02121509|589046617|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091715|NCT02121509|589046618|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
163091716|NCT02121509|589046619|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091717|NCT02121509|589046620|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
163091718|NCT02121509|589046617|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
163091719|NCT02121509|589046618|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091720|NCT02121509|589046619|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091721|NCT02121509|589046620|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
163091722|NCT00636181|589046623|FG000|Overall Study|Withdrawal by Subject|8|||
163091723|NCT00636181|589046624|FG001|Overall Study|Withdrawal by Subject|6|||
163091724|NCT00636181|589046625|FG002|Overall Study|Withdrawal by Subject|10|||
163091725|NCT02993263|589046626|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
163091726|NCT00542178|589046627|FG000|Overall Study|did not complete year 4 follow-up|75|||
163091727|NCT00542178|589046628|FG001|Overall Study|did not complete year 4 follow-up|80|||
163091728|NCT00542178|589046629|FG002|Overall Study|did not complete year 4 follow-up|74|||
163091729|NCT00542178|589046630|FG003|Overall Study|did not complete year 4 follow-up|62|||
163091730|NCT00542178|589046631|FG004|Overall Study|did not complete year 4 follow-up|64|||
163091731|NCT00542178|589046632|FG005|Overall Study|did not complete year 4 follow-up|89|||
163091732|NCT00542178|589046633|FG006|Overall Study|did not complete year 4 follow-up|87|||
163091733|NCT00542178|589046634|FG007|Overall Study|did not complete year 4 follow-up|85|||
163091734|NCT00829998|589046635|FG000|Washout|Adverse Event|0|||
163091735|NCT00829998|589046636|FG001|Washout|Adverse Event|1|||
163091736|NCT01173679|589048341|FG000|Overall Study|Death|1|||
163091737|NCT01250054|589048342|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
163091738|NCT01250054|589048343|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
163091739|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
163091740|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
163091741|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
163091742|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
163091743|NCT02026011|589048344|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
163091744|NCT02026011|589048345|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
163091745|NCT02026011|589048344|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
163091746|NCT02026011|589048345|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
163091747|NCT01770743|589048346|FG000|Overall Study|Adverse Event|1|||
163091748|NCT01770743|589048347|FG001|Overall Study|Adverse Event|0|||
163091749|NCT01770743|589048348|FG002|Overall Study|Adverse Event|0|||
163091750|NCT01770743|589048349|FG003|Overall Study|Adverse Event|0|||
163091751|NCT01770743|589048350|FG004|Overall Study|Adverse Event|0|||
163091752|NCT01770743|589048346|FG000|Overall Study|Withdrawal by Subject|0|||
163091753|NCT01770743|589048347|FG001|Overall Study|Withdrawal by Subject|0|||
163091754|NCT01770743|589048348|FG002|Overall Study|Withdrawal by Subject|1|||
163091755|NCT01770743|589048349|FG003|Overall Study|Withdrawal by Subject|1|||
163091756|NCT01770743|589048350|FG004|Overall Study|Withdrawal by Subject|1|||
163091757|NCT01770743|589048346|FG000|Overall Study|Lost to Follow-up|0|||
163091758|NCT01770743|589048347|FG001|Overall Study|Lost to Follow-up|2|||
163091759|NCT01770743|589048348|FG002|Overall Study|Lost to Follow-up|0|||
163091760|NCT01770743|589048349|FG003|Overall Study|Lost to Follow-up|0|||
163091761|NCT01770743|589048350|FG004|Overall Study|Lost to Follow-up|1|||
163091762|NCT01770743|589048346|FG000|Overall Study|Sponsor Terminated Subject|1|||
163091763|NCT01770743|589048347|FG001|Overall Study|Sponsor Terminated Subject|0|||
163091764|NCT01770743|589048348|FG002|Overall Study|Sponsor Terminated Subject|0|||
163091765|NCT01770743|589048349|FG003|Overall Study|Sponsor Terminated Subject|1|||
163091766|NCT01770743|589048350|FG004|Overall Study|Sponsor Terminated Subject|0|||
163091767|NCT01770743|589048346|FG000|Overall Study|Moving Out of State|0|||
163091768|NCT01770743|589048347|FG001|Overall Study|Moving Out of State|1|||
163091769|NCT01770743|589048348|FG002|Overall Study|Moving Out of State|0|||
163091770|NCT01770743|589048349|FG003|Overall Study|Moving Out of State|0|||
163091771|NCT01770743|589048350|FG004|Overall Study|Moving Out of State|0|||
163091772|NCT00939107|589048353|FG000|Overall Study|Lost to Follow-up|14|||
163091773|NCT00939107|589048354|FG001|Overall Study|Lost to Follow-up|12|||
163091774|NCT05010070|589048355|FG000|Overall Study|Lost to Follow-up|1|||
163091775|NCT05010070|589048355|FG000|Overall Study|Withdrawal by Subject|1|||
163091776|NCT00441272|589048357|FG000|Overall Study|Study terminated prior to enrollment|25|||
163091777|NCT00441272|589048358|FG001|Overall Study|Study terminated prior to enrollment|25|||
163091778|NCT00427011|589048359|FG000|Overall Study|Adverse Event|10|||
163091779|NCT00427011|589048359|FG000|Overall Study|Withdrawal by Subject|1|||
163091780|NCT00427011|589048359|FG000|Overall Study|Lack of Efficacy|2|||
163091781|NCT00427011|589048359|FG000|Overall Study|Other|12|||
163091782|NCT00952705|589048360|FG000|Overall Study|Lost to Follow-up|24|||
163091783|NCT00952705|589048361|FG001|Overall Study|Lost to Follow-up|8|||
163091784|NCT00952705|589048362|FG002|Overall Study|Lost to Follow-up|9|||
163091785|NCT00952705|589048360|FG000|Overall Study|Withdrawal by Subject|2|||
163091786|NCT00952705|589048361|FG001|Overall Study|Withdrawal by Subject|1|||
163091787|NCT00952705|589048362|FG002|Overall Study|Withdrawal by Subject|1|||
163091788|NCT00952705|589048360|FG000|Overall Study|Death|2|||
163091789|NCT00952705|589048361|FG001|Overall Study|Death|0|||
163091790|NCT00952705|589048362|FG002|Overall Study|Death|0|||
163091791|NCT00952705|589048360|FG000|Overall Study|Incarcerated post dose|5|||
163091792|NCT00952705|589048361|FG001|Overall Study|Incarcerated post dose|0|||
163091793|NCT00952705|589048362|FG002|Overall Study|Incarcerated post dose|0|||
163091794|NCT00952705|589048360|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
163091795|NCT00952705|589048361|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
163091796|NCT00952705|589048362|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
163091797|NCT02921789|589048363|FG000|Overall Study|Adverse Event|0|||
163091798|NCT02921789|589048364|FG001|Overall Study|Adverse Event|1|||
163091799|NCT02921789|589048363|FG000|Overall Study|Lost to Follow-up|1|||
163091800|NCT02921789|589048364|FG001|Overall Study|Lost to Follow-up|0|||
163091801|NCT02921789|589048363|FG000|Overall Study|Protocol Deviation|2|||
163091802|NCT02921789|589048364|FG001|Overall Study|Protocol Deviation|0|||
163091803|NCT02921789|589048363|FG000|Overall Study|Withdrawal by Subject|2|||
163091804|NCT02921789|589048364|FG001|Overall Study|Withdrawal by Subject|1|||
163091805|NCT02921789|589048363|FG000|Overall Study|Miscellaneous|3|||
163091806|NCT02921789|589048364|FG001|Overall Study|Miscellaneous|2|||
163091807|NCT01944020|589048365|FG000|Overall Study|Withdrawal by Subject|5|||
163091808|NCT01944020|589048366|FG001|Overall Study|Withdrawal by Subject|0|||
163091809|NCT01669902|589048367|FG000|Overall Study|Adverse Event|11|||
163091810|NCT01669902|589048367|FG000|Overall Study|Lack of Efficacy|10|||
162650971|NCT02872116|587440797|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
162650972|NCT02872116|587440798|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
162650973|NCT02872116|587440796|FG000|Pre-Treatment|Other reasons|1|||
162650974|NCT02872116|587440797|FG001|Pre-Treatment|Other reasons|2|||
162650975|NCT02872116|587440798|FG002|Pre-Treatment|Other reasons|2|||
162650976|NCT02872116|587440796|FG000|Treatment|Death|121|||
162650977|NCT02872116|587440797|FG001|Treatment|Death|94|||
163091811|NCT01669902|589048367|FG000|Overall Study|Other|8|||
163091812|NCT02391311|589048370|FG000|Overall Study|Lost to Follow-up|2|||
163091813|NCT02391311|589048371|FG001|Overall Study|Lost to Follow-up|1|||
162650978|NCT02872116|587440798|FG002|Treatment|Death|68|||
163091814|NCT02391311|589048370|FG000|Overall Study|deemed ineligible after baseline|1|||
163091815|NCT02391311|589048371|FG001|Overall Study|deemed ineligible after baseline|1|||
163091816|NCT02808897|589048374|FG000|Overall Study|Lost to Follow-up|9|||
163091817|NCT02808897|589048375|FG001|Overall Study|Lost to Follow-up|11|||
163091818|NCT00305448|589048376|FG000|Overall Study|Protocol Violation|0|||
163091819|NCT00305448|589048377|FG001|Overall Study|Protocol Violation|1|||
163091820|NCT00305448|589048378|FG002|Overall Study|Protocol Violation|0|||
162650979|NCT02872116|587440796|FG000|Treatment|Lost to Follow-up|5|||
163091821|NCT00305448|589048376|FG000|Overall Study|Withdrawal by Subject|2|||
163091822|NCT00305448|589048377|FG001|Overall Study|Withdrawal by Subject|0|||
162650980|NCT02872116|587440797|FG001|Treatment|Lost to Follow-up|7|||
163091823|NCT00305448|589048378|FG002|Overall Study|Withdrawal by Subject|1|||
162650981|NCT02872116|587440798|FG002|Treatment|Lost to Follow-up|3|||
162650982|NCT02872116|587440796|FG000|Treatment|Participant withdrew consent|20|||
162650983|NCT02872116|587440797|FG001|Treatment|Participant withdrew consent|40|||
162650984|NCT02872116|587440798|FG002|Treatment|Participant withdrew consent|8|||
162650985|NCT02872116|587440796|FG000|Treatment|Other reasons|13|||
162650986|NCT02872116|587440797|FG001|Treatment|Other reasons|12|||
162650987|NCT02872116|587440798|FG002|Treatment|Other reasons|5|||
162650988|NCT03792672|587440803|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
162650989|NCT03792672|587440804|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162650990|NCT03792672|587440805|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162650991|NCT03792672|587440806|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
162650992|NCT03792672|587440807|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162650993|NCT03792672|587440808|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162650994|NCT03792672|587440803|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
162650995|NCT03792672|587440804|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
162650996|NCT03792672|587440805|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
162650997|NCT03792672|587440806|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
162650998|NCT03792672|587440807|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
162650999|NCT03792672|587440808|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
162651000|NCT03792672|587440803|FG000|Treatment Period 4 (2 Days)|Other|1|||
162651001|NCT03792672|587440804|FG001|Treatment Period 4 (2 Days)|Other|0|||
162651002|NCT03792672|587440805|FG002|Treatment Period 4 (2 Days)|Other|0|||
162651003|NCT03792672|587440806|FG003|Treatment Period 4 (2 Days)|Other|0|||
162651004|NCT03792672|587440807|FG004|Treatment Period 4 (2 Days)|Other|0|||
162651005|NCT03792672|587440808|FG005|Treatment Period 4 (2 Days)|Other|0|||
162651006|NCT00453999|587440809|FG000|Overall Study|Adverse Event|1|||
162651007|NCT00453999|587440810|FG001|Overall Study|Adverse Event|2|||
162651008|NCT00453999|587440811|FG002|Overall Study|Adverse Event|1|||
162651009|NCT00453999|587440809|FG000|Overall Study|Lost to Follow-up|0|||
162651010|NCT00453999|587440810|FG001|Overall Study|Lost to Follow-up|1|||
162651011|NCT00453999|587440811|FG002|Overall Study|Lost to Follow-up|1|||
162651012|NCT00453999|587440809|FG000|Overall Study|Withdrawal by Subject|2|||
162651013|NCT00453999|587440810|FG001|Overall Study|Withdrawal by Subject|1|||
162651014|NCT00453999|587440811|FG002|Overall Study|Withdrawal by Subject|1|||
162651015|NCT00453999|587440809|FG000|Overall Study|Subject Request|2|||
162651016|NCT00453999|587440810|FG001|Overall Study|Subject Request|1|||
162651017|NCT00453999|587440811|FG002|Overall Study|Subject Request|0|||
162651018|NCT04238728|587440814|FG000|Overall Study|Withdrawal by Subject|1|||
162651019|NCT04238728|587440814|FG000|Overall Study|Lost to Follow-up|2|||
162651020|NCT04225923|587440821|FG000|Overall Study|Protocol Violation|1|||
162651021|NCT04225923|587440822|FG001|Overall Study|Protocol Violation|0|||
162651022|NCT04225923|587440823|FG002|Overall Study|Protocol Violation|1|||
162651023|NCT04225923|587440821|FG000|Overall Study|Withdrawal by Subject|4|||
163091824|NCT00305448|589048376|FG000|Overall Study|Adverse Event|1|||
163091825|NCT00305448|589048377|FG001|Overall Study|Adverse Event|0|||
163091826|NCT00305448|589048378|FG002|Overall Study|Adverse Event|1|||
163091827|NCT00305448|589048376|FG000|Overall Study|Disease Progression|27|||
163091828|NCT00305448|589048377|FG001|Overall Study|Disease Progression|31|||
163091829|NCT00305448|589048378|FG002|Overall Study|Disease Progression|28|||
163091830|NCT00305448|589048376|FG000|Overall Study|Subjective Disease Progression|1|||
163091831|NCT00305448|589048377|FG001|Overall Study|Subjective Disease Progression|2|||
163091832|NCT00305448|589048378|FG002|Overall Study|Subjective Disease Progression|2|||
163091833|NCT00305448|589048376|FG000|Overall Study|Tumor Marker Elevation|0|||
163091834|NCT00305448|589048377|FG001|Overall Study|Tumor Marker Elevation|0|||
163091835|NCT00305448|589048378|FG002|Overall Study|Tumor Marker Elevation|1|||
163091836|NCT00002766|589048379|FG000|Overall Study|Withdrawal by Subject|0|||
163091837|NCT00002766|589048380|FG001|Overall Study|Withdrawal by Subject|1|||
162651024|NCT04225923|587440822|FG001|Overall Study|Withdrawal by Subject|1|||
163091838|NCT00002766|589048379|FG000|Overall Study|Patient Not Treated|1|||
162651025|NCT04225923|587440823|FG002|Overall Study|Withdrawal by Subject|3|||
162651026|NCT04225923|587440821|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
162651027|NCT04225923|587440822|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
162651028|NCT04225923|587440823|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
162651029|NCT01907828|587440829|FG000|Overall Study|Exclusion criteria not met|0|||
162651030|NCT01907828|587440830|FG001|Overall Study|Exclusion criteria not met|1|||
162651031|NCT01907828|587440829|FG000|Overall Study|Withdrawal by Subject|3|||
162651032|NCT01907828|587440830|FG001|Overall Study|Withdrawal by Subject|4|||
163091839|NCT00002766|589048380|FG001|Overall Study|Patient Not Treated|2|||
163091840|NCT00002766|589048379|FG000|Overall Study|Adverse Event|1|||
162651033|NCT01907828|587440829|FG000|Overall Study|Lost to Follow-up|3|||
162651034|NCT01907828|587440830|FG001|Overall Study|Lost to Follow-up|0|||
162651035|NCT01907828|587440829|FG000|Overall Study|Participant refused 24-month follow-up|1|||
162651036|NCT01907828|587440830|FG001|Overall Study|Participant refused 24-month follow-up|0|||
162718945|NCT00716144|587676731|FG002|Overall Study|Physician Decision|2|||
163091841|NCT00002766|589048380|FG001|Overall Study|Adverse Event|1|||
162718946|NCT00716144|587676732|FG003|Overall Study|Physician Decision|2|||
163038531|NCT00482170|588848760|FG000|Overall Study|Lost to Follow-up|2|||
163038532|NCT00482170|588848761|FG001|Overall Study|Lost to Follow-up|0|||
163038533|NCT00482170|588848760|FG000|Overall Study|Unspecified reason|0|||
163038534|NCT00482170|588848761|FG001|Overall Study|Unspecified reason|2|||
163038535|NCT00592592|588848764|FG000|Overall Study|Patient found ineligible upon chart review|1|||
163038536|NCT01134263|588848765|FG000|Overall Study|Serious adverse event|2|||
163038537|NCT01134263|588848766|FG001|Overall Study|Serious adverse event|1|||
163091842|NCT00002766|589048379|FG000|Overall Study|Protocol Violation|1|||
162651037|NCT01907828|587440829|FG000|Overall Study|Participant met exclusion criteria|0|||
162651038|NCT01907828|587440830|FG001|Overall Study|Participant met exclusion criteria|1|||
162651039|NCT03925324|587440831|FG000|Overall Study|Death|1|||
162651040|NCT03925324|587440832|FG001|Overall Study|Death|1|||
162651041|NCT04414553|587440833|FG000|Overall Study|Lost to Follow-up|20|||
162651042|NCT03554291|587440841|FG000|Overall Study|Death|2|||
162651043|NCT03554291|587440842|FG001|Overall Study|Death|1|||
162651044|NCT03554291|587440841|FG000|Overall Study|Lost to Follow-up|1|||
162651045|NCT03554291|587440842|FG001|Overall Study|Lost to Follow-up|0|||
162651046|NCT03554291|587440841|FG000|Overall Study|Withdrawal by Subject|1|||
162651047|NCT03554291|587440842|FG001|Overall Study|Withdrawal by Subject|0|||
162651048|NCT03554291|587440841|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
162651049|NCT03554291|587440842|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
162651050|NCT01228747|587440843|FG000|Overall Study|Adverse Event|8|||
162651051|NCT01228747|587440844|FG001|Overall Study|Adverse Event|4|||
162651052|NCT01228747|587440843|FG000|Overall Study|Lack of Efficacy|40|||
162651053|NCT01228747|587440844|FG001|Overall Study|Lack of Efficacy|27|||
162651054|NCT01228747|587440843|FG000|Overall Study|Protocol Violation|6|||
162651055|NCT01228747|587440844|FG001|Overall Study|Protocol Violation|5|||
162651056|NCT01228747|587440843|FG000|Overall Study|Lost to Follow-up|4|||
162651057|NCT01228747|587440844|FG001|Overall Study|Lost to Follow-up|3|||
162651058|NCT01228747|587440843|FG000|Overall Study|Withdrawal by Subject|5|||
162651059|NCT01228747|587440844|FG001|Overall Study|Withdrawal by Subject|1|||
162651060|NCT01228747|587440843|FG000|Overall Study|Other Reason|2|||
162651061|NCT01228747|587440844|FG001|Overall Study|Other Reason|5|||
162651062|NCT00537381|587440848|FG000|Overall Study|Adverse Event|13|||
163038538|NCT01134263|588848767|FG002|Overall Study|Serious adverse event|1|||
163091843|NCT00002766|589048380|FG001|Overall Study|Protocol Violation|0|||
163091844|NCT04108273|589048391|FG000|Overall Study|COVID Pandemic|1|||
163091845|NCT04108273|589048392|FG001|Overall Study|COVID Pandemic|0|||
163091846|NCT02441218|589048393|FG000|Overall Study|Death|503|||
163091847|NCT02441218|589048394|FG001|Overall Study|Death|553|||
162651063|NCT00537381|587440849|FG001|Overall Study|Adverse Event|9|||
162651064|NCT00537381|587440848|FG000|Overall Study|Death|3|||
162651065|NCT00537381|587440849|FG001|Overall Study|Death|3|||
162651066|NCT00537381|587440848|FG000|Overall Study|Withdrawal by Subject|5|||
162651067|NCT00537381|587440849|FG001|Overall Study|Withdrawal by Subject|14|||
162651068|NCT00537381|587440848|FG000|Overall Study|Physician Decision|7|||
162651069|NCT00537381|587440849|FG001|Overall Study|Physician Decision|6|||
162651070|NCT00537381|587440848|FG000|Overall Study|Disease Progression|9|||
162651071|NCT00537381|587440849|FG001|Overall Study|Disease Progression|18|||
162651072|NCT00537381|587440848|FG000|Overall Study|Sponsor decision|14|||
162651073|NCT00537381|587440849|FG001|Overall Study|Sponsor decision|9|||
162651074|NCT00537381|587440848|FG000|Overall Study|Other|5|||
162651075|NCT00537381|587440849|FG001|Overall Study|Other|3|||
162651076|NCT04258605|587440858|FG000|Overall Study|Death|1|||
162651077|NCT04258605|587440859|FG001|Overall Study|Death|0|||
162651078|NCT04258605|587440858|FG000|Overall Study|Early study termination|21|||
162651079|NCT04258605|587440859|FG001|Overall Study|Early study termination|2|||
163038539|NCT01134263|588848768|FG003|Overall Study|Serious adverse event|1|||
162651080|NCT02910167|587440860|FG000|Overall Study|Adverse Event|1|||
162651081|NCT02910167|587440860|FG000|Overall Study|Lost to Follow-up|18|||
162651082|NCT00842348|587440868|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
162651083|NCT00842348|587440869|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
163038540|NCT01134263|588848769|FG004|Overall Study|Serious adverse event|1|||
163038541|NCT01134263|588848765|FG000|Overall Study|Other adverse event|1|||
163038542|NCT01134263|588848766|FG001|Overall Study|Other adverse event|2|||
163038543|NCT01134263|588848767|FG002|Overall Study|Other adverse event|5|||
163038544|NCT01134263|588848768|FG003|Overall Study|Other adverse event|3|||
163038545|NCT01134263|588848769|FG004|Overall Study|Other adverse event|0|||
163038546|NCT01134263|588848765|FG000|Overall Study|Protocol Violation|8|||
163038547|NCT01134263|588848766|FG001|Overall Study|Protocol Violation|7|||
163038548|NCT01134263|588848767|FG002|Overall Study|Protocol Violation|2|||
163038549|NCT01134263|588848768|FG003|Overall Study|Protocol Violation|4|||
163038550|NCT01134263|588848769|FG004|Overall Study|Protocol Violation|2|||
163038551|NCT01134263|588848765|FG000|Overall Study|Lost to Follow-up|4|||
163038552|NCT01134263|588848766|FG001|Overall Study|Lost to Follow-up|3|||
163038553|NCT01134263|588848767|FG002|Overall Study|Lost to Follow-up|5|||
163038554|NCT01134263|588848768|FG003|Overall Study|Lost to Follow-up|3|||
162651084|NCT00842348|587440868|FG000|Study 729|Disease progression/death|19|||
162718947|NCT00716144|587676729|FG000|Overall Study|Intercurrent illness|0|||
162718948|NCT00716144|587676730|FG001|Overall Study|Intercurrent illness|0|||
162718949|NCT00716144|587676731|FG002|Overall Study|Intercurrent illness|1|||
162718950|NCT00716144|587676732|FG003|Overall Study|Intercurrent illness|0|||
162718951|NCT00716144|587676729|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
162718952|NCT00716144|587676730|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
162718953|NCT00716144|587676731|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
162718954|NCT00716144|587676732|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
162718955|NCT00716144|587676729|FG000|Overall Study|Adverse event: left foot pain|0|||
162718956|NCT00716144|587676730|FG001|Overall Study|Adverse event: left foot pain|1|||
162718957|NCT00716144|587676731|FG002|Overall Study|Adverse event: left foot pain|0|||
162718958|NCT00716144|587676732|FG003|Overall Study|Adverse event: left foot pain|0|||
162718959|NCT00716144|587676729|FG000|Overall Study|Clinical Depression|0|||
162718960|NCT00716144|587676730|FG001|Overall Study|Clinical Depression|1|||
162718961|NCT00716144|587676731|FG002|Overall Study|Clinical Depression|0|||
162718962|NCT00716144|587676732|FG003|Overall Study|Clinical Depression|0|||
162718963|NCT02341625|587676737|FG000|Overall Study|Disease Progression|2|||
162718964|NCT02341625|587676738|FG001|Overall Study|Disease Progression|2|||
162718965|NCT02341625|587676739|FG002|Overall Study|Disease Progression|3|||
162718966|NCT02341625|587676740|FG003|Overall Study|Disease Progression|6|||
162718967|NCT02341625|587676741|FG004|Overall Study|Disease Progression|7|||
162718968|NCT02341625|587676742|FG005|Overall Study|Disease Progression|7|||
162718969|NCT02341625|587676743|FG006|Overall Study|Disease Progression|28|||
162718970|NCT02341625|587676744|FG007|Overall Study|Disease Progression|5|||
162718971|NCT02341625|587676745|FG008|Overall Study|Disease Progression|4|||
162718972|NCT02341625|587676746|FG009|Overall Study|Disease Progression|19|||
162718973|NCT02341625|587676737|FG000|Overall Study|Study Drug Toxicity|0|||
162718974|NCT02341625|587676738|FG001|Overall Study|Study Drug Toxicity|0|||
162718975|NCT02341625|587676739|FG002|Overall Study|Study Drug Toxicity|0|||
162718976|NCT02341625|587676740|FG003|Overall Study|Study Drug Toxicity|1|||
162718977|NCT02341625|587676741|FG004|Overall Study|Study Drug Toxicity|0|||
162718978|NCT02341625|587676742|FG005|Overall Study|Study Drug Toxicity|3|||
162718979|NCT02341625|587676743|FG006|Overall Study|Study Drug Toxicity|10|||
162718980|NCT02341625|587676744|FG007|Overall Study|Study Drug Toxicity|0|||
162718981|NCT02341625|587676745|FG008|Overall Study|Study Drug Toxicity|0|||
162718982|NCT02341625|587676746|FG009|Overall Study|Study Drug Toxicity|3|||
162718983|NCT02341625|587676737|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718984|NCT02341625|587676738|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718985|NCT02341625|587676739|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718986|NCT02341625|587676740|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718987|NCT02341625|587676741|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163038555|NCT01134263|588848769|FG004|Overall Study|Lost to Follow-up|1|||
163038556|NCT01134263|588848765|FG000|Overall Study|Withdrawal by Subject|8|||
163038557|NCT01134263|588848766|FG001|Overall Study|Withdrawal by Subject|6|||
163038558|NCT01134263|588848767|FG002|Overall Study|Withdrawal by Subject|16|||
163038559|NCT01134263|588848768|FG003|Overall Study|Withdrawal by Subject|7|||
163038560|NCT01134263|588848769|FG004|Overall Study|Withdrawal by Subject|5|||
163038561|NCT01134263|588848765|FG000|Overall Study|Enrolled, but not treated|1|||
163038562|NCT01134263|588848766|FG001|Overall Study|Enrolled, but not treated|1|||
163038563|NCT01134263|588848767|FG002|Overall Study|Enrolled, but not treated|0|||
163038564|NCT01134263|588848768|FG003|Overall Study|Enrolled, but not treated|1|||
163038565|NCT01134263|588848769|FG004|Overall Study|Enrolled, but not treated|0|||
163038566|NCT01557517|588848770|FG000|Overall Study|Death|1|||
163038567|NCT01557517|588848771|FG001|Overall Study|Death|0|||
163038568|NCT01557517|588848770|FG000|Overall Study|Refused further treatment|0|||
163038569|NCT01557517|588848771|FG001|Overall Study|Refused further treatment|2|||
163038570|NCT01557517|588848770|FG000|Overall Study|Adverse Event|0|||
163038571|NCT01557517|588848771|FG001|Overall Study|Adverse Event|2|||
163038572|NCT01557517|588848770|FG000|Overall Study|Pt declined before treatment started|1|||
163038573|NCT01557517|588848771|FG001|Overall Study|Pt declined before treatment started|0|||
163038574|NCT00770913|588848772|FG000|Overall Study|Adverse Event|1|||
163038575|NCT00770913|588848773|FG001|Overall Study|Adverse Event|3|||
163038576|NCT00770913|588848774|FG002|Overall Study|Adverse Event|6|||
163038577|NCT00770913|588848772|FG000|Overall Study|Refusal to continue participation|6|||
163038578|NCT00770913|588848773|FG001|Overall Study|Refusal to continue participation|4|||
163038579|NCT00770913|588848774|FG002|Overall Study|Refusal to continue participation|5|||
163038580|NCT00770913|588848772|FG000|Overall Study|Physician Decision|0|||
163038581|NCT00770913|588848773|FG001|Overall Study|Physician Decision|1|||
163038582|NCT00770913|588848774|FG002|Overall Study|Physician Decision|1|||
163038583|NCT00770913|588848772|FG000|Overall Study|Protocol Violation|3|||
163038584|NCT00770913|588848773|FG001|Overall Study|Protocol Violation|0|||
163038585|NCT00770913|588848774|FG002|Overall Study|Protocol Violation|1|||
163038586|NCT00770913|588848772|FG000|Overall Study|Incorrect drug was allocated|1|||
163038587|NCT00770913|588848773|FG001|Overall Study|Incorrect drug was allocated|0|||
163038588|NCT00770913|588848774|FG002|Overall Study|Incorrect drug was allocated|0|||
163038589|NCT02347072|588848775|FG000|Overall Study|Adverse Event|2|||
163091848|NCT02441218|589048393|FG000|Overall Study|Withdrawal by Subject|73|||
163091849|NCT02441218|589048394|FG001|Overall Study|Withdrawal by Subject|58|||
163091850|NCT02441218|589048393|FG000|Overall Study|Lost to Follow-up|2|||
163091851|NCT02441218|589048394|FG001|Overall Study|Lost to Follow-up|1|||
163091852|NCT01541371|589048395|FG000|Overall Study|Withdrawal by Subject|14|||
163091853|NCT01541371|589048395|FG000|Overall Study|Lost to Follow-up|21|||
163091854|NCT01541371|589048395|FG000|Overall Study|Adverse Event|15|||
163091855|NCT01541371|589048395|FG000|Overall Study|Lack of Efficacy|12|||
163091856|NCT01541371|589048395|FG000|Overall Study|Protocol Violation|6|||
162651085|NCT00842348|587440869|FG001|Study 729|Disease progression/death|30|||
162651086|NCT00842348|587440868|FG000|Study 729|Adverse Event|1|||
162651087|NCT00842348|587440869|FG001|Study 729|Adverse Event|1|||
162651088|NCT00842348|587440868|FG000|Study 729|Protocol Violation|1|||
162651089|NCT00842348|587440869|FG001|Study 729|Protocol Violation|1|||
162651090|NCT00842348|587440868|FG000|Study 729|Withdrawal by Subject|2|||
162651091|NCT00842348|587440869|FG001|Study 729|Withdrawal by Subject|4|||
162651092|NCT00842348|587440868|FG000|Study 729|Due to Sponsor stopping the study|1|||
162651093|NCT00842348|587440869|FG001|Study 729|Due to Sponsor stopping the study|1|||
162651094|NCT00842348|587440868|FG000|Study 729|Due to non-availability of IP|0|||
162651095|NCT00842348|587440869|FG001|Study 729|Due to non-availability of IP|1|||
162651096|NCT00842348|587440868|FG000|Study 729|Sponsor's decision|1|||
162651097|NCT00842348|587440869|FG001|Study 729|Sponsor's decision|0|||
162651098|NCT00842348|587440868|FG000|Study 729|Surgical resection|1|||
162651099|NCT00842348|587440869|FG001|Study 729|Surgical resection|0|||
162651100|NCT00026793|587440874|FG000|Overall Study|Death on study due to underlying disease|4|||
162651101|NCT00026793|587440874|FG000|Overall Study|Physician Decision|2|||
162651102|NCT00026793|587440874|FG000|Overall Study|Off study|2|||
162651103|NCT01449526|587440875|FG000|Overall Study|Lost to Follow-up|1|||
163091857|NCT01541371|589048395|FG000|Overall Study|Study medication non-compliance|3|||
163091858|NCT01541371|589048395|FG000|Overall Study|Other|6|||
163091859|NCT02154061|589048396|FG000|Overall Study|Pregnancy|1|||
163091860|NCT02154061|589048397|FG001|Overall Study|Pregnancy|0|||
163091861|NCT02154061|589048396|FG000|Overall Study|enrolled but not vaccinated|1|||
163091862|NCT02154061|589048397|FG001|Overall Study|enrolled but not vaccinated|0|||
163091863|NCT01936831|589048398|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091864|NCT01936831|589048399|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091865|NCT01936831|589048400|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091866|NCT01936831|589048401|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091867|NCT01936831|589048402|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091868|NCT01936831|589048403|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
163091869|NCT01936831|589048404|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091870|NCT01936831|589048405|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091871|NCT01936831|589048406|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
163091872|NCT03848416|589048412|FG000|Overall Study|Withdrawal by Subject|1|||
163091873|NCT03848416|589048413|FG001|Overall Study|Withdrawal by Subject|0|||
163091874|NCT03848416|589048414|FG002|Overall Study|Withdrawal by Subject|0|||
163091875|NCT03848416|589048412|FG000|Overall Study|Death|0|||
163091876|NCT03848416|589048413|FG001|Overall Study|Death|0|||
163091877|NCT03848416|589048414|FG002|Overall Study|Death|1|||
163091878|NCT02808429|589048415|FG000|Overall Study|Lost to Follow-up|1|||
163091879|NCT02808429|589048416|FG001|Overall Study|Lost to Follow-up|0|||
163091880|NCT02808429|589048417|FG002|Overall Study|Lost to Follow-up|0|||
163091881|NCT02808429|589048415|FG000|Overall Study|Protocol Violation|0|||
163091882|NCT02808429|589048416|FG001|Overall Study|Protocol Violation|1|||
163091883|NCT02808429|589048417|FG002|Overall Study|Protocol Violation|0|||
163091884|NCT02808429|589048415|FG000|Overall Study|Premature study termination by sponsor|2|||
163091885|NCT02808429|589048416|FG001|Overall Study|Premature study termination by sponsor|0|||
163091886|NCT02808429|589048417|FG002|Overall Study|Premature study termination by sponsor|1|||
163091887|NCT02808429|589048415|FG000|Overall Study|Relocation|0|||
163091888|NCT02808429|589048416|FG001|Overall Study|Relocation|0|||
162651104|NCT01449526|587440876|FG001|Overall Study|Lost to Follow-up|2|||
162651105|NCT01449526|587440875|FG000|Overall Study|Withdrawal by Subject|1|||
162651106|NCT01449526|587440876|FG001|Overall Study|Withdrawal by Subject|1|||
162651107|NCT01449526|587440875|FG000|Overall Study|Symptoms/complaints|0|||
162651108|NCT01449526|587440876|FG001|Overall Study|Symptoms/complaints|1|||
163091889|NCT02808429|589048417|FG002|Overall Study|Relocation|1|||
163091890|NCT01436110|589048418|FG000|Overall Study|Lack of Efficacy|23|||
163091891|NCT01436110|589048419|FG001|Overall Study|Lack of Efficacy|14|||
163091892|NCT01436110|589048420|FG002|Overall Study|Lack of Efficacy|9|||
163091893|NCT01436110|589048418|FG000|Overall Study|Withdrawal by Subject|6|||
163091894|NCT01436110|589048419|FG001|Overall Study|Withdrawal by Subject|8|||
163091895|NCT01436110|589048420|FG002|Overall Study|Withdrawal by Subject|4|||
163091896|NCT01436110|589048418|FG000|Overall Study|Adverse Event|2|||
162651109|NCT01449526|587440875|FG000|Overall Study|Lack of Motivation|0|||
163091897|NCT01436110|589048419|FG001|Overall Study|Adverse Event|1|||
162651110|NCT01449526|587440876|FG001|Overall Study|Lack of Motivation|1|||
162651111|NCT01449526|587440875|FG000|Overall Study|Cannot maintain visits|0|||
162651112|NCT01449526|587440876|FG001|Overall Study|Cannot maintain visits|1|||
163091898|NCT01436110|589048420|FG002|Overall Study|Adverse Event|2|||
163091899|NCT01436110|589048418|FG000|Overall Study|Physician Decision|3|||
163091900|NCT01436110|589048419|FG001|Overall Study|Physician Decision|1|||
163091901|NCT01436110|589048420|FG002|Overall Study|Physician Decision|1|||
163091902|NCT01436110|589048418|FG000|Overall Study|Lost to Follow-up|1|||
163091903|NCT01436110|589048419|FG001|Overall Study|Lost to Follow-up|1|||
163091904|NCT01436110|589048420|FG002|Overall Study|Lost to Follow-up|3|||
163091905|NCT01436110|589048418|FG000|Overall Study|Protocol Violation|3|||
163091906|NCT01436110|589048419|FG001|Overall Study|Protocol Violation|1|||
163091907|NCT01436110|589048420|FG002|Overall Study|Protocol Violation|1|||
163091908|NCT01436110|589048418|FG000|Overall Study|Did Not Receive Trial Medication|1|||
163091909|NCT01436110|589048419|FG001|Overall Study|Did Not Receive Trial Medication|0|||
163091910|NCT01436110|589048420|FG002|Overall Study|Did Not Receive Trial Medication|3|||
163091911|NCT01088503|589048422|FG000|Overall Study|Withdrawal by Subject|118|||
163091912|NCT01088503|589048423|FG001|Overall Study|Withdrawal by Subject|327|||
163091913|NCT01088503|589048424|FG002|Overall Study|Withdrawal by Subject|10|||
163091914|NCT01088503|589048422|FG000|Overall Study|Death|64|||
163091915|NCT01088503|589048423|FG001|Overall Study|Death|358|||
163091916|NCT01088503|589048424|FG002|Overall Study|Death|7|||
163091917|NCT01847092|589048425|FG000|Overall Study|Adverse Event|12|||
163091918|NCT01847092|589048426|FG001|Overall Study|Adverse Event|3|||
163091919|NCT01847092|589048425|FG000|Overall Study|Withdrawal by Subject|5|||
163091920|NCT01847092|589048426|FG001|Overall Study|Withdrawal by Subject|5|||
163091921|NCT01847092|589048425|FG000|Overall Study|Protocol Specified|8|||
163091922|NCT01847092|589048426|FG001|Overall Study|Protocol Specified|0|||
163091923|NCT01847092|589048425|FG000|Overall Study|Physician Decision|1|||
163091924|NCT01847092|589048426|FG001|Overall Study|Physician Decision|1|||
163091925|NCT01847092|589048425|FG000|Overall Study|Protocol Violation|0|||
163091926|NCT01847092|589048426|FG001|Overall Study|Protocol Violation|2|||
163091927|NCT01664247|589048430|FG000|Overall Study|Adverse Event|5|||
163091928|NCT01664247|589048431|FG001|Overall Study|Adverse Event|3|||
163091929|NCT01664247|589048430|FG000|Overall Study|Protocol Violation|3|||
163091930|NCT01664247|589048431|FG001|Overall Study|Protocol Violation|5|||
163091931|NCT01664247|589048430|FG000|Overall Study|Withdrawal Criteria|1|||
163091932|NCT01664247|589048431|FG001|Overall Study|Withdrawal Criteria|4|||
163091933|NCT01664247|589048430|FG000|Overall Study|Unclassified|5|||
163091934|NCT01664247|589048431|FG001|Overall Study|Unclassified|29|||
163091935|NCT01000506|589048432|FG000|Overall Study|Adverse Event|6|||
163091936|NCT01000506|589048433|FG001|Overall Study|Adverse Event|5|||
163091937|NCT01000506|589048434|FG002|Overall Study|Adverse Event|8|||
162651113|NCT01132495|587440877|FG000|Overall Study|Various reasons|40|||
162651114|NCT01132495|587440878|FG001|Overall Study|Various reasons|38|||
162651115|NCT01132495|587440879|FG002|Overall Study|Various reasons|20|||
162651116|NCT01132495|587440880|FG003|Overall Study|Various reasons|12|||
162651117|NCT03913091|587440881|FG000|Overall Study|Lost to Follow-up|18|||
162651118|NCT03913091|587440882|FG001|Overall Study|Lost to Follow-up|11|||
162651119|NCT03913091|587440881|FG000|Overall Study|Required additional meds/surgery|1|||
162651120|NCT03913091|587440882|FG001|Overall Study|Required additional meds/surgery|2|||
162651121|NCT03913091|587440881|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
162651122|NCT03913091|587440882|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
162651123|NCT00655564|587440883|FG000|Overall Study|Adverse Event|1|||
162651124|NCT00655564|587440883|FG000|Overall Study|Lost to Follow-up|1|||
162651125|NCT00655564|587440883|FG000|Overall Study|Desired Alternate Therapy|1|||
162651126|NCT04144166|587443186|FG000|Overall Study|Discharged before study start|1|||
162651127|NCT04144166|587443186|FG000|Overall Study|Pregnancy|1|||
162651128|NCT04144166|587443186|FG000|Overall Study|Nail polish could not be removed from finger|1|||
162651129|NCT01236755|587443188|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
162651130|NCT01236755|587443188|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
162651131|NCT01236755|587443188|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
163091938|NCT01000506|589048435|FG003|Overall Study|Adverse Event|9|||
163091939|NCT01000506|589048432|FG000|Overall Study|Lack of Efficacy|8|||
163091940|NCT01000506|589048433|FG001|Overall Study|Lack of Efficacy|6|||
163091941|NCT01000506|589048434|FG002|Overall Study|Lack of Efficacy|4|||
163091942|NCT01000506|589048435|FG003|Overall Study|Lack of Efficacy|4|||
163038590|NCT02347072|588848775|FG000|Overall Study|Withdrawal by Subject|6|||
163038591|NCT02347072|588848775|FG000|Overall Study|Physician Decision|1|||
163038592|NCT02347072|588848775|FG000|Overall Study|Lost to Follow-up|2|||
163038593|NCT02347072|588848775|FG000|Overall Study|Protocol Violation|1|||
163038594|NCT02347072|588848775|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
163038595|NCT01134393|588848780|FG000|Overall Study|Adverse Event|18|||
163038596|NCT01134393|588848780|FG000|Overall Study|Lack of Efficacy|2|||
163038597|NCT01134393|588848780|FG000|Overall Study|Protocol Violation|12|||
163038598|NCT01134393|588848780|FG000|Overall Study|Lost to Follow-up|3|||
163038599|NCT01134393|588848780|FG000|Overall Study|Withdrawal by Subject|11|||
163038600|NCT01134393|588848780|FG000|Overall Study|Other|6|||
163038601|NCT03230838|588848783|FG000|Overall Study|Withdrawal by Subject|3|||
163038602|NCT03230838|588848784|FG001|Overall Study|Withdrawal by Subject|0|||
163038603|NCT03230838|588848783|FG000|Overall Study|Temperature excursion|1|||
163038604|NCT03230838|588848784|FG001|Overall Study|Temperature excursion|0|||
163038605|NCT00575510|588848787|FG000|Overall Study|Lost to Follow-up|4|||
163038606|NCT00575510|588848788|FG001|Overall Study|Lost to Follow-up|6|||
163038607|NCT00575510|588848789|FG002|Overall Study|Lost to Follow-up|9|||
163038608|NCT00575510|588848787|FG000|Overall Study|Withdrawal by Subject|1|||
163038609|NCT00575510|588848788|FG001|Overall Study|Withdrawal by Subject|0|||
163038610|NCT00575510|588848789|FG002|Overall Study|Withdrawal by Subject|0|||
163038611|NCT00575510|588848787|FG000|Overall Study|Clinic Called Patient|7|||
163038612|NCT00575510|588848788|FG001|Overall Study|Clinic Called Patient|7|||
163038613|NCT00575510|588848789|FG002|Overall Study|Clinic Called Patient|7|||
163038614|NCT00575510|588848787|FG000|Overall Study|Pregnancy|0|||
163038615|NCT00575510|588848788|FG001|Overall Study|Pregnancy|0|||
163038616|NCT00575510|588848789|FG002|Overall Study|Pregnancy|1|||
163038617|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
163038618|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
163038619|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Adverse Event|1|||
163038620|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Adverse Event|2|||
163038621|NCT02697734|588848790|FG000|Core Phase - up to Week 48|Physician Decision|1|||
163038622|NCT02697734|588848791|FG001|Core Phase - up to Week 48|Physician Decision|0|||
163038623|NCT02697734|588848790|FG000|Optional Extension Phase|Adverse Event|5|||
163038624|NCT02697734|588848791|FG001|Optional Extension Phase|Adverse Event|1|||
163038625|NCT02697734|588848790|FG000|Optional Extension Phase|Physician Decision|0|||
163038626|NCT02697734|588848791|FG001|Optional Extension Phase|Physician Decision|1|||
163038627|NCT02324699|588848792|FG000|Overall Study|study terminated|1|||
163038628|NCT03970200|588848793|FG000|Overall Study|Death|2|||
163038629|NCT03970200|588848794|FG001|Overall Study|Death|2|||
163038630|NCT03970200|588848795|FG002|Overall Study|Death|1|||
163038631|NCT03970200|588848793|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
163038632|NCT03970200|588848794|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
163038633|NCT03970200|588848795|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
163038634|NCT01607346|588848796|FG000|Overall Study|Adverse Event|3|||
163038635|NCT01098162|588848797|FG000|Overall Study|Adverse Event|37|||
163038636|NCT01098162|588848797|FG000|Overall Study|Lack of Efficacy|4|||
163038637|NCT01098162|588848797|FG000|Overall Study|Wish of Patient|7|||
163038638|NCT01098162|588848797|FG000|Overall Study|Lost to Follow-up|9|||
163038639|NCT01098162|588848797|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
163038640|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
163038641|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
163038642|NCT01098162|588848797|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
163038643|NCT01098162|588848797|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
163038644|NCT01098162|588848797|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
163038645|NCT01098162|588848797|FG000|Overall Study|Other Reason|1|||
163038646|NCT01098162|588848797|FG000|Overall Study|Reason Unknown|26|||
163038647|NCT01605825|588848798|FG000|Overall Study|Adverse Event|4|||
163038648|NCT01605825|588848799|FG001|Overall Study|Adverse Event|2|||
163038649|NCT01605825|588848798|FG000|Overall Study|Withdrawal by Subject|0|||
163038650|NCT01605825|588848799|FG001|Overall Study|Withdrawal by Subject|1|||
163038651|NCT01605825|588848798|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
163038652|NCT01605825|588848799|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
163038653|NCT01605825|588848798|FG000|Overall Study|Non-Compliance with Protocol|3|||
163038654|NCT01605825|588848799|FG001|Overall Study|Non-Compliance with Protocol|0|||
163038655|NCT00380718|588848802|FG000|Overall Study|Adverse Event|1|||
163038656|NCT00380718|588848802|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
163038657|NCT04318132|588848808|FG000|Overall Study|Protocol Violation|0|||
163038658|NCT04318132|588848809|FG001|Overall Study|Protocol Violation|0|||
163038659|NCT04318132|588848810|FG002|Overall Study|Protocol Violation|3|||
163038660|NCT04318132|588848811|FG003|Overall Study|Protocol Violation|0|||
163038661|NCT01863732|588848812|FG000|Overall Study|Adverse Event|2|||
163038662|NCT01863732|588848813|FG001|Overall Study|Adverse Event|0|||
163038663|NCT01863732|588848814|FG002|Overall Study|Adverse Event|3|||
163038664|NCT01863732|588848815|FG003|Overall Study|Adverse Event|3|||
163038665|NCT01863732|588848812|FG000|Overall Study|Lack of Efficacy|1|||
163038666|NCT01863732|588848813|FG001|Overall Study|Lack of Efficacy|0|||
163091943|NCT01000506|589048432|FG000|Overall Study|Protocol Violation|1|||
163091944|NCT01000506|589048433|FG001|Overall Study|Protocol Violation|1|||
163091945|NCT01000506|589048434|FG002|Overall Study|Protocol Violation|0|||
163091946|NCT01000506|589048435|FG003|Overall Study|Protocol Violation|0|||
163091947|NCT01000506|589048432|FG000|Overall Study|Lost to Follow-up|1|||
163091948|NCT01000506|589048433|FG001|Overall Study|Lost to Follow-up|1|||
163091949|NCT01000506|589048434|FG002|Overall Study|Lost to Follow-up|4|||
163091950|NCT01000506|589048435|FG003|Overall Study|Lost to Follow-up|0|||
163091951|NCT01000506|589048432|FG000|Overall Study|Physician Decision|1|||
163091952|NCT01000506|589048433|FG001|Overall Study|Physician Decision|3|||
163091953|NCT01000506|589048434|FG002|Overall Study|Physician Decision|3|||
163091954|NCT01000506|589048435|FG003|Overall Study|Physician Decision|3|||
163091955|NCT01000506|589048432|FG000|Overall Study|Withdrawal by Subject|11|||
163091956|NCT01000506|589048433|FG001|Overall Study|Withdrawal by Subject|8|||
163091957|NCT01000506|589048434|FG002|Overall Study|Withdrawal by Subject|2|||
163091958|NCT01000506|589048435|FG003|Overall Study|Withdrawal by Subject|7|||
163091959|NCT03064074|589048436|FG000|Overall Study|Physician Decision|0|||
163091960|NCT03064074|589048437|FG001|Overall Study|Physician Decision|0|||
163091961|NCT03064074|589048438|FG002|Overall Study|Physician Decision|0|||
163091962|NCT03064074|589048439|FG003|Overall Study|Physician Decision|1|||
163091963|NCT00269087|589048440|FG000|Overall Study|Adverse Event|20|||
163091964|NCT00269087|589048440|FG000|Overall Study|Withdrawal by Subject|1|||
163091965|NCT00269087|589048440|FG000|Overall Study|Exacerbation of COPD|13|||
163091966|NCT01188967|589048446|FG000|Overall Study|Withdrawal by Subject|1|||
163091967|NCT01188967|589048447|FG001|Overall Study|Withdrawal by Subject|1|||
163091968|NCT01188967|589048446|FG000|Overall Study|Physician Decision|1|||
163091969|NCT01188967|589048447|FG001|Overall Study|Physician Decision|1|||
163091970|NCT01188967|589048446|FG000|Overall Study|Lost to Follow-up|3|||
163091971|NCT01188967|589048447|FG001|Overall Study|Lost to Follow-up|2|||
163091972|NCT01448616|589048448|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
163091973|NCT01448616|589048449|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091974|NCT01448616|589048450|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091975|NCT01448616|589048451|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163091976|NCT01448616|589048448|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
163091977|NCT01448616|589048449|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091978|NCT01448616|589048450|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091979|NCT01448616|589048451|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
163091980|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
163091981|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
163091982|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
163091983|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
163091984|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
163091985|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
163091986|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
163091987|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
163091988|NCT01448616|589048448|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
163091989|NCT01448616|589048449|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
163038667|NCT01863732|588848814|FG002|Overall Study|Lack of Efficacy|2|||
163038668|NCT01863732|588848815|FG003|Overall Study|Lack of Efficacy|1|||
163038669|NCT01863732|588848812|FG000|Overall Study|Lost to Follow-up|2|||
163038670|NCT01863732|588848813|FG001|Overall Study|Lost to Follow-up|2|||
163038671|NCT01863732|588848814|FG002|Overall Study|Lost to Follow-up|1|||
163038672|NCT01863732|588848815|FG003|Overall Study|Lost to Follow-up|1|||
163038673|NCT01863732|588848812|FG000|Overall Study|Physician Decision|1|||
163038674|NCT01863732|588848813|FG001|Overall Study|Physician Decision|0|||
163038675|NCT01863732|588848814|FG002|Overall Study|Physician Decision|1|||
163038676|NCT01863732|588848815|FG003|Overall Study|Physician Decision|0|||
163038677|NCT01863732|588848812|FG000|Overall Study|Pregnancy|0|||
163038678|NCT01863732|588848813|FG001|Overall Study|Pregnancy|0|||
163091990|NCT01448616|589048450|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
163091991|NCT01448616|589048451|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
163038679|NCT01863732|588848814|FG002|Overall Study|Pregnancy|0|||
162718988|NCT02341625|587676742|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718989|NCT02341625|587676743|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163091992|NCT00523978|589048454|FG000|Overall Study|Withdrawal by Subject|3|||
163091993|NCT00523978|589048455|FG001|Overall Study|Withdrawal by Subject|7|||
163091994|NCT00523978|589048454|FG000|Overall Study|Screen Failures|5|||
163091995|NCT00523978|589048455|FG001|Overall Study|Screen Failures|1|||
163091996|NCT00523978|589048454|FG000|Overall Study|Death|1|||
163038680|NCT01863732|588848815|FG003|Overall Study|Pregnancy|1|||
163038681|NCT01863732|588848812|FG000|Overall Study|Technical problems|0|||
163091997|NCT00523978|589048455|FG001|Overall Study|Death|0|||
163091998|NCT01696643|589048460|FG000|Overall Study|Adverse Event|15|||
163091999|NCT01696643|589048461|FG001|Overall Study|Adverse Event|7|||
163038682|NCT01863732|588848813|FG001|Overall Study|Technical problems|1|||
163038683|NCT01863732|588848814|FG002|Overall Study|Technical problems|1|||
163038684|NCT01863732|588848815|FG003|Overall Study|Technical problems|0|||
163038685|NCT01863732|588848812|FG000|Overall Study|Subject/guardian decision|6|||
163038686|NCT01863732|588848813|FG001|Overall Study|Subject/guardian decision|9|||
163038687|NCT01863732|588848814|FG002|Overall Study|Subject/guardian decision|3|||
163038688|NCT01863732|588848815|FG003|Overall Study|Subject/guardian decision|1|||
163038689|NCT01863732|588848812|FG000|Overall Study|Death|1|||
163038690|NCT01863732|588848813|FG001|Overall Study|Death|0|||
163038691|NCT01863732|588848814|FG002|Overall Study|Death|0|||
163038692|NCT01863732|588848815|FG003|Overall Study|Death|1|||
163038693|NCT00840034|588848819|FG000|Acute Treatment Phase|Adverse Event|6|||
163038694|NCT00840034|588848820|FG001|Acute Treatment Phase|Adverse Event|8|||
163038695|NCT00840034|588848819|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
163038696|NCT00840034|588848820|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
163038697|NCT00840034|588848819|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
163038698|NCT00840034|588848820|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
163038699|NCT00840034|588848819|FG000|Acute Treatment Phase|Physician Decision|0|||
163038700|NCT00840034|588848820|FG001|Acute Treatment Phase|Physician Decision|1|||
163038701|NCT00840034|588848819|FG000|Acute Treatment Phase|Protocol Violation|2|||
163038702|NCT00840034|588848820|FG001|Acute Treatment Phase|Protocol Violation|4|||
163038703|NCT00840034|588848819|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
163038704|NCT00840034|588848820|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
163038705|NCT00840034|588848819|FG000|Taper Phase|Adverse Event|1|||
163038706|NCT00840034|588848820|FG001|Taper Phase|Adverse Event|0|||
163038707|NCT00840034|588848819|FG000|Taper Phase|Lost to Follow-up|1|||
163038708|NCT00840034|588848820|FG001|Taper Phase|Lost to Follow-up|1|||
163038709|NCT00840034|588848819|FG000|Taper Phase|Withdrawal by Subject|1|||
163038710|NCT00840034|588848820|FG001|Taper Phase|Withdrawal by Subject|1|||
163038711|NCT02839876|588848827|FG000|Overall Study|Protocol Violation|10|||
163038712|NCT02839876|588848828|FG001|Overall Study|Protocol Violation|11|||
163038713|NCT01156051|588848830|FG000|Overall Study|Lost to Follow-up|1|||
163038714|NCT01156051|588848831|FG001|Overall Study|Lost to Follow-up|0|||
163038715|NCT01156051|588848830|FG000|Overall Study|patient not compliant with protocol|0|||
163038716|NCT01156051|588848831|FG001|Overall Study|patient not compliant with protocol|1|||
163038717|NCT03816007|588848832|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
163038718|NCT03816007|588848833|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
163038719|NCT03816007|588848832|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
163038720|NCT03816007|588848833|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
163038721|NCT03816007|588848832|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
163038722|NCT03816007|588848833|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
163038723|NCT03628716|588848834|FG000|Overall Study|Adverse Event|1|||
163038724|NCT03628716|588848835|FG001|Overall Study|Adverse Event|1|||
163038725|NCT03628716|588848834|FG000|Overall Study|Death|1|||
163038726|NCT03628716|588848835|FG001|Overall Study|Death|0|||
163038727|NCT03628716|588848834|FG000|Overall Study|Lack of Efficacy|15|||
163038728|NCT03628716|588848835|FG001|Overall Study|Lack of Efficacy|20|||
163038729|NCT03628716|588848834|FG000|Overall Study|Withdrawal by Subject|1|||
163038730|NCT03628716|588848835|FG001|Overall Study|Withdrawal by Subject|2|||
163038731|NCT03628716|588848834|FG000|Overall Study|Study Terminated by Sponsor|1|||
163038732|NCT03628716|588848835|FG001|Overall Study|Study Terminated by Sponsor|0|||
163038733|NCT02179749|588848836|FG000|Overall Study|Adverse Event|0|||
163038734|NCT02179749|588848837|FG001|Overall Study|Adverse Event|0|||
163038735|NCT02179749|588848838|FG002|Overall Study|Adverse Event|1|||
163038736|NCT02179749|588848836|FG000|Overall Study|Withdrawal by Subject|0|||
163038737|NCT02179749|588848837|FG001|Overall Study|Withdrawal by Subject|0|||
163038738|NCT02179749|588848838|FG002|Overall Study|Withdrawal by Subject|1|||
163038739|NCT02620384|588848839|FG000|Overall Study|Adverse Event|2|||
163038740|NCT02620384|588848840|FG001|Overall Study|Adverse Event|1|||
163038741|NCT02620384|588848839|FG000|Overall Study|Discharged prior to 2nd dose|2|||
163038742|NCT02620384|588848840|FG001|Overall Study|Discharged prior to 2nd dose|5|||
163038743|NCT02620384|588848839|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
163038744|NCT02620384|588848840|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
163038745|NCT00094536|588848841|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
163038746|NCT00094536|588848841|FG000|Treatment and Follow-up|Adverse Event|4|||
163038747|NCT00094536|588848841|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
163038748|NCT00094536|588848841|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
163038749|NCT00094536|588848841|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
163038750|NCT00094536|588848841|FG000|Treatment and Follow-up|Subject non-compliance|9|||
163038751|NCT00094536|588848841|FG000|Treatment and Follow-up|Unable to attend visits|1|||
163038752|NCT02071082|588848842|FG000|Overall Study|Enrolled and Never Treated|1|||
163038753|NCT02071082|588848843|FG001|Overall Study|Enrolled and Never Treated|1|||
163038754|NCT02071082|588848842|FG000|Overall Study|Adverse Event|0|||
163038755|NCT02071082|588848843|FG001|Overall Study|Adverse Event|1|||
163038756|NCT02071082|588848842|FG000|Overall Study|Withdrew Consent|0|||
163038757|NCT02071082|588848843|FG001|Overall Study|Withdrew Consent|4|||
163092000|NCT01696643|589048460|FG000|Overall Study|Death|1|||
163092001|NCT01696643|589048461|FG001|Overall Study|Death|2|||
163092002|NCT01696643|589048460|FG000|Overall Study|Lack of Efficacy|3|||
163092003|NCT01696643|589048461|FG001|Overall Study|Lack of Efficacy|0|||
163092004|NCT01696643|589048460|FG000|Overall Study|Lost to Follow-up|67|||
163092005|NCT01696643|589048461|FG001|Overall Study|Lost to Follow-up|67|||
163092006|NCT01696643|589048460|FG000|Overall Study|Physician Decision|3|||
163092007|NCT01696643|589048461|FG001|Overall Study|Physician Decision|2|||
163092008|NCT01696643|589048460|FG000|Overall Study|Pregnancy|0|||
163092009|NCT01696643|589048461|FG001|Overall Study|Pregnancy|1|||
163092010|NCT01696643|589048460|FG000|Overall Study|Protocol Violation|7|||
163092011|NCT01696643|589048461|FG001|Overall Study|Protocol Violation|7|||
163092012|NCT01696643|589048460|FG000|Overall Study|Study Terminated by Sponsor|286|||
163092013|NCT01696643|589048461|FG001|Overall Study|Study Terminated by Sponsor|294|||
163092014|NCT01696643|589048460|FG000|Overall Study|Withdrawal by Subject|142|||
163092015|NCT01696643|589048461|FG001|Overall Study|Withdrawal by Subject|149|||
163092016|NCT01696643|589048460|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
163092017|NCT01696643|589048461|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
163092018|NCT01696643|589048460|FG000|Overall Study|Site Error|2|||
163092019|NCT01696643|589048461|FG001|Overall Study|Site Error|1|||
163092020|NCT01696643|589048460|FG000|Overall Study|Participant Incarcerated|0|||
163092021|NCT01696643|589048461|FG001|Overall Study|Participant Incarcerated|1|||
163092022|NCT01696643|589048460|FG000|Overall Study|Medical Monitor Decision|0|||
163092023|NCT01696643|589048461|FG001|Overall Study|Medical Monitor Decision|2|||
163092024|NCT01696643|589048460|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
163092025|NCT01696643|589048461|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
163092026|NCT02951780|589048465|FG000|Period 1|Adverse Event|0|||
163092027|NCT02951780|589048466|FG001|Period 1|Adverse Event|0|||
163092028|NCT02951780|589048467|FG002|Period 1|Adverse Event|0|||
163092029|NCT02951780|589048468|FG003|Period 1|Adverse Event|1|||
163092030|NCT02951780|589048469|FG004|Period 1|Adverse Event|0|||
163092031|NCT02951780|589048470|FG005|Period 1|Adverse Event|0|||
163092032|NCT02951780|589048471|FG006|Period 1|Adverse Event|0|||
163092033|NCT02951780|589048472|FG007|Period 1|Adverse Event|0|||
163092034|NCT02951780|589048473|FG008|Period 1|Adverse Event|0|||
163092035|NCT02951780|589048465|FG000|Period 1|Scheduling Conflicts|0|||
163092036|NCT02951780|589048466|FG001|Period 1|Scheduling Conflicts|0|||
163092037|NCT02951780|589048467|FG002|Period 1|Scheduling Conflicts|0|||
163092038|NCT02951780|589048468|FG003|Period 1|Scheduling Conflicts|0|||
163092039|NCT02951780|589048469|FG004|Period 1|Scheduling Conflicts|0|||
163092040|NCT02951780|589048470|FG005|Period 1|Scheduling Conflicts|0|||
163092041|NCT02951780|589048471|FG006|Period 1|Scheduling Conflicts|0|||
163092042|NCT02951780|589048472|FG007|Period 1|Scheduling Conflicts|1|||
163092043|NCT02951780|589048473|FG008|Period 1|Scheduling Conflicts|0|||
163092044|NCT02951780|589048465|FG000|Period 2|Scheduling Conflicts|0|||
163092045|NCT02951780|589048466|FG001|Period 2|Scheduling Conflicts|0|||
163092046|NCT02951780|589048467|FG002|Period 2|Scheduling Conflicts|0|||
163092047|NCT02951780|589048468|FG003|Period 2|Scheduling Conflicts|0|||
163092048|NCT02951780|589048469|FG004|Period 2|Scheduling Conflicts|0|||
163092049|NCT02951780|589048470|FG005|Period 2|Scheduling Conflicts|0|||
163092050|NCT02951780|589048471|FG006|Period 2|Scheduling Conflicts|0|||
163092051|NCT02951780|589048472|FG007|Period 2|Scheduling Conflicts|1|||
163092052|NCT02951780|589048473|FG008|Period 2|Scheduling Conflicts|0|||
163092053|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
163092054|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
163092055|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
163092056|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
163092057|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
163092058|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
163092059|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
163092060|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
163092061|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
163092062|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
163092063|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
163092064|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
163092065|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
163092066|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
163092067|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
163092068|NCT00546481|589048474|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
163092069|NCT00546481|589048475|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
163092070|NCT00546481|589048476|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
163092071|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
163092072|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
163092073|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
163092074|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
163092075|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
163092076|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
163092077|NCT00546481|589048474|FG000|Maintenance Phase (CERA)|Other Reason|0|||
163092078|NCT00546481|589048475|FG001|Maintenance Phase (CERA)|Other Reason|0|||
163092079|NCT00546481|589048476|FG002|Maintenance Phase (CERA)|Other Reason|1|||
163092080|NCT00244621|589048477|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163092081|NCT00244621|589048478|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163092082|NCT00244621|589048479|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
163092083|NCT00244621|589048477|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163092084|NCT00244621|589048478|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163092085|NCT00244621|589048479|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162651132|NCT01236755|587443188|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
162651133|NCT01481116|587443189|FG000|Overall Study|Adverse Event|26|||
162651134|NCT01481116|587443190|FG001|Overall Study|Adverse Event|26|||
162651135|NCT01481116|587443191|FG002|Overall Study|Adverse Event|42|||
162651136|NCT01481116|587443189|FG000|Overall Study|Major Protocol Deviation|3|||
162651137|NCT01481116|587443190|FG001|Overall Study|Major Protocol Deviation|7|||
162651138|NCT01481116|587443191|FG002|Overall Study|Major Protocol Deviation|1|||
162651139|NCT01481116|587443189|FG000|Overall Study|Lost to Follow-up|8|||
162651140|NCT01481116|587443190|FG001|Overall Study|Lost to Follow-up|12|||
162651141|NCT01481116|587443191|FG002|Overall Study|Lost to Follow-up|11|||
162651142|NCT01481116|587443189|FG000|Overall Study|Withdrawal by Subject|37|||
162651143|NCT01481116|587443190|FG001|Overall Study|Withdrawal by Subject|33|||
162651144|NCT01481116|587443191|FG002|Overall Study|Withdrawal by Subject|37|||
162651145|NCT01481116|587443189|FG000|Overall Study|Study Termination|730|||
162651146|NCT01481116|587443190|FG001|Overall Study|Study Termination|729|||
162651147|NCT01481116|587443191|FG002|Overall Study|Study Termination|713|||
162651148|NCT01481116|587443189|FG000|Overall Study|Pregnancy|0|||
162651149|NCT01481116|587443190|FG001|Overall Study|Pregnancy|0|||
162651150|NCT01481116|587443191|FG002|Overall Study|Pregnancy|1|||
162651151|NCT01481116|587443189|FG000|Overall Study|Lack of Efficacy|3|||
162651152|NCT01481116|587443190|FG001|Overall Study|Lack of Efficacy|3|||
162651153|NCT01481116|587443191|FG002|Overall Study|Lack of Efficacy|1|||
162651154|NCT01481116|587443189|FG000|Overall Study|Contraindications|1|||
162651155|NCT01481116|587443190|FG001|Overall Study|Contraindications|1|||
162651156|NCT01481116|587443191|FG002|Overall Study|Contraindications|0|||
162651157|NCT01481116|587443189|FG000|Overall Study|Other|1|||
162651158|NCT01481116|587443190|FG001|Overall Study|Other|1|||
162651159|NCT01481116|587443191|FG002|Overall Study|Other|0|||
162651160|NCT01481116|587443189|FG000|Overall Study|Participant Started Taking Glipizide|1|||
162651161|NCT01481116|587443190|FG001|Overall Study|Participant Started Taking Glipizide|0|||
162651162|NCT01481116|587443191|FG002|Overall Study|Participant Started Taking Glipizide|0|||
162651163|NCT01481116|587443189|FG000|Overall Study|Participant Moved Out of Area|2|||
162651164|NCT01481116|587443190|FG001|Overall Study|Participant Moved Out of Area|0|||
162651165|NCT01481116|587443191|FG002|Overall Study|Participant Moved Out of Area|1|||
162651166|NCT01481116|587443189|FG000|Overall Study|Participant Moved Out of Country|1|||
162651167|NCT01481116|587443190|FG001|Overall Study|Participant Moved Out of Country|0|||
162651168|NCT01481116|587443191|FG002|Overall Study|Participant Moved Out of Country|1|||
162651169|NCT01481116|587443189|FG000|Overall Study|Investigator Decision|3|||
162651170|NCT01481116|587443190|FG001|Overall Study|Investigator Decision|2|||
162651171|NCT01481116|587443191|FG002|Overall Study|Investigator Decision|1|||
162651172|NCT01481116|587443189|FG000|Overall Study|Sponsor Decision|0|||
162651173|NCT01481116|587443190|FG001|Overall Study|Sponsor Decision|1|||
162651174|NCT01481116|587443191|FG002|Overall Study|Sponsor Decision|3|||
162651175|NCT01481116|587443189|FG000|Overall Study|Non-Compliant With Study Drug|0|||
162651176|NCT01481116|587443190|FG001|Overall Study|Non-Compliant With Study Drug|1|||
162651177|NCT01481116|587443191|FG002|Overall Study|Non-Compliant With Study Drug|1|||
162651178|NCT01481116|587443189|FG000|Overall Study|Investigator's Discretion|2|||
162651179|NCT01481116|587443190|FG001|Overall Study|Investigator's Discretion|0|||
162651180|NCT01481116|587443191|FG002|Overall Study|Investigator's Discretion|0|||
162651181|NCT01481116|587443189|FG000|Overall Study|Death|2|||
162718990|NCT02341625|587676744|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
162718991|NCT02341625|587676745|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162718992|NCT02341625|587676746|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163092086|NCT00244621|589048477|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
162651182|NCT01481116|587443190|FG001|Overall Study|Death|1|||
163092087|NCT00244621|589048478|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
163092088|NCT00244621|589048479|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162651183|NCT01481116|587443191|FG002|Overall Study|Death|0|||
162651184|NCT01481116|587443189|FG000|Overall Study|Hypoglycemic Event|4|||
162651185|NCT01481116|587443190|FG001|Overall Study|Hypoglycemic Event|0|||
162651186|NCT01481116|587443191|FG002|Overall Study|Hypoglycemic Event|0|||
162651187|NCT03848845|587443192|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
162651188|NCT03848845|587443193|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
162651189|NCT03848845|587443194|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
163038758|NCT02071082|588848842|FG000|Overall Study|Lost to Follow-up|1|||
163038759|NCT02071082|588848843|FG001|Overall Study|Lost to Follow-up|1|||
163038760|NCT02526160|588850549|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
163038761|NCT02526160|588850550|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
163038762|NCT02526160|588850549|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
163038763|NCT02526160|588850550|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
163038764|NCT02526160|588850549|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
163038765|NCT02526160|588850550|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
163038766|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Death|0|||
163038767|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Death|1|||
163038768|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
163038769|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
163038770|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
163038771|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
163038772|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
163038773|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
163038774|NCT02526160|588850549|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
163038775|NCT02526160|588850550|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
163038776|NCT01775787|588850551|FG000|First 7-10 Days|Adverse Event|0|||
163038777|NCT01775787|588850552|FG001|First 7-10 Days|Adverse Event|1|||
163038778|NCT01775787|588850551|FG000|First 7-10 Days|family emergency|0|||
163038779|NCT01775787|588850552|FG001|First 7-10 Days|family emergency|1|||
163038780|NCT01775787|588850551|FG000|First 7-10 Days|time commitment|0|||
163038781|NCT01775787|588850552|FG001|First 7-10 Days|time commitment|2|||
163038782|NCT01775787|588850551|FG000|First 7-10 Days|concerns with using IV|1|||
163038783|NCT01775787|588850552|FG001|First 7-10 Days|concerns with using IV|2|||
163038784|NCT01775787|588850551|FG000|Second 7-10 Days|time commitment|0|||
163038785|NCT01775787|588850552|FG001|Second 7-10 Days|time commitment|1|||
163038786|NCT01775787|588850551|FG000|Second 7-10 Days|concerns with using IV|0|||
163038787|NCT01775787|588850552|FG001|Second 7-10 Days|concerns with using IV|1|||
163038788|NCT04076319|588850557|FG000|Overall Study|Withdrawal by Subject|2|||
163038789|NCT04076319|588850558|FG001|Overall Study|Withdrawal by Subject|0|||
163038790|NCT04076319|588850557|FG000|Overall Study|Death|1|||
163038791|NCT04076319|588850558|FG001|Overall Study|Death|0|||
163038792|NCT01054222|588850559|FG000|Overall Study|Lack of Efficacy|1|||
163038793|NCT01054222|588850559|FG000|Overall Study|Lost to Follow-up|4|||
163038794|NCT01054222|588850559|FG000|Overall Study|Withdrawal by Subject|6|||
163038795|NCT03252145|588850563|FG000|Overall Study|Withdrawal by Subject|1|||
163038796|NCT03252145|588850564|FG001|Overall Study|Withdrawal by Subject|0|||
163038797|NCT03252145|588850563|FG000|Overall Study|Complicating Disease|1|||
163038798|NCT03252145|588850564|FG001|Overall Study|Complicating Disease|2|||
163038799|NCT01763827|588850568|FG000|Overall Study|Withdrawal by Subject|1|||
163038800|NCT01763827|588850569|FG001|Overall Study|Withdrawal by Subject|0|||
163038801|NCT01763827|588850570|FG002|Overall Study|Withdrawal by Subject|0|||
163038802|NCT01763827|588850571|FG003|Overall Study|Withdrawal by Subject|0|||
163038803|NCT01763827|588850572|FG004|Overall Study|Withdrawal by Subject|2|||
163038804|NCT01763827|588850573|FG005|Overall Study|Withdrawal by Subject|0|||
163038805|NCT01763827|588850568|FG000|Overall Study|Decision by sponsor|2|||
163038806|NCT01763827|588850569|FG001|Overall Study|Decision by sponsor|0|||
163038807|NCT01763827|588850570|FG002|Overall Study|Decision by sponsor|3|||
163038808|NCT01763827|588850571|FG003|Overall Study|Decision by sponsor|0|||
163038809|NCT01763827|588850572|FG004|Overall Study|Decision by sponsor|2|||
163038810|NCT01763827|588850573|FG005|Overall Study|Decision by sponsor|1|||
163038811|NCT01763827|588850568|FG000|Overall Study|Lost to Follow-up|0|||
163038812|NCT01763827|588850569|FG001|Overall Study|Lost to Follow-up|1|||
163038813|NCT01763827|588850570|FG002|Overall Study|Lost to Follow-up|1|||
163038814|NCT01763827|588850571|FG003|Overall Study|Lost to Follow-up|1|||
163038815|NCT01763827|588850572|FG004|Overall Study|Lost to Follow-up|2|||
163038816|NCT01763827|588850573|FG005|Overall Study|Lost to Follow-up|1|||
163038817|NCT04446429|588850576|FG000|Overall Study|Lost to Follow-up|6|||
163038818|NCT04446429|588850577|FG001|Overall Study|Lost to Follow-up|0|||
163038819|NCT05205005|588850578|FG000|Overall Study|Withdrawal by Subject|1|||
163038820|NCT05205005|588850579|FG001|Overall Study|Withdrawal by Subject|0|||
163038821|NCT05205005|588850578|FG000|Overall Study|Adverse Event|1|||
163038822|NCT05205005|588850579|FG001|Overall Study|Adverse Event|0|||
163038823|NCT01869777|588850580|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
163038824|NCT01951573|588850581|FG000|Washout Period|Adverse Event|0|||
163038825|NCT01951573|588850582|FG001|Washout Period|Adverse Event|1|||
163038826|NCT04399889|588850583|FG000|Overall Study|Death|5|||
163092089|NCT00244621|589048477|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
163038827|NCT04399889|588850584|FG001|Overall Study|Death|1|||
163038828|NCT04399889|588850585|FG002|Overall Study|Death|1|||
163038829|NCT00707980|588850586|FG000|Overall Study|Adverse Event|49|||
163038830|NCT00707980|588850586|FG000|Overall Study|Lack of Efficacy|35|||
163038831|NCT00707980|588850586|FG000|Overall Study|Non-Compliance with Study Drug|28|||
162651190|NCT03848845|587443195|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
162651191|NCT03848845|587443192|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162651192|NCT03848845|587443193|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162651193|NCT03848845|587443194|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
162651194|NCT03848845|587443195|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162651195|NCT03848845|587443192|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
162651196|NCT03848845|587443193|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
162651197|NCT03848845|587443194|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
162651198|NCT03848845|587443195|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
162651199|NCT03848845|587443192|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162651200|NCT03848845|587443193|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162651201|NCT03848845|587443194|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162651202|NCT03848845|587443195|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
162651203|NCT02433834|587443197|FG000|Overall Study|Protocol-specified criteria|7|||
162651204|NCT02433834|587443197|FG000|Overall Study|Protocol Violation|3|||
162651205|NCT02433834|587443197|FG000|Overall Study|Lost to Follow-up|6|||
162651206|NCT02433834|587443197|FG000|Overall Study|Withdrawal by Subject|14|||
162651207|NCT02433834|587443197|FG000|Overall Study|Adverse Event|6|||
162651208|NCT02433834|587443197|FG000|Overall Study|Physician Decision|1|||
162651209|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
162651210|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
162651211|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
162651212|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
162651213|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
162651214|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
162651215|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
162651216|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
162651217|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
162651218|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
162651219|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
162651220|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
162651221|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
162651222|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
162651223|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
162651224|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
162651225|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
162651226|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
162651227|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
162651228|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
162651229|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
162651230|NCT00934544|587443198|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
162651231|NCT00934544|587443199|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
162651232|NCT00934544|587443200|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
162651233|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
162651234|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
162651235|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
162651236|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
162651237|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
162651238|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
162718993|NCT02341625|587676737|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718994|NCT02341625|587676738|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718995|NCT02341625|587676739|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718996|NCT02341625|587676740|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718997|NCT02341625|587676741|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718998|NCT02341625|587676742|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162718999|NCT02341625|587676743|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
162719000|NCT02341625|587676744|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
162651239|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
162651240|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
162651241|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
162651242|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
162719001|NCT02341625|587676745|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162719002|NCT02341625|587676746|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163092090|NCT00244621|589048478|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
163038832|NCT00707980|588850586|FG000|Overall Study|Protocol Deviations|19|||
163038833|NCT00707980|588850586|FG000|Overall Study|Withdrawal of Consent|81|||
163038834|NCT00707980|588850586|FG000|Overall Study|Lost to Follow-up|59|||
163038835|NCT00707980|588850586|FG000|Overall Study|Other|39|||
163038836|NCT01152996|588850587|FG000|Overall Study|Withdrawal by Subject|142|||
163038837|NCT01152996|588850587|FG000|Overall Study|Adverse Event|115|||
163038838|NCT01152996|588850587|FG000|Overall Study|Lost to Follow-up|112|||
163038839|NCT01152996|588850587|FG000|Overall Study|Lack of Efficacy|68|||
163038840|NCT01152996|588850587|FG000|Overall Study|Noncompliance|41|||
163038841|NCT01152996|588850587|FG000|Overall Study|Other|36|||
163038842|NCT01152996|588850587|FG000|Overall Study|Protocol Violation|22|||
163038843|NCT01152996|588850587|FG000|Overall Study|Elevated liver enzymes|1|||
163038844|NCT02260817|588850591|FG000|Overall Study|Lost to Follow-up|0|||
163092091|NCT00244621|589048479|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
163092092|NCT00244621|589048477|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163092093|NCT00244621|589048478|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
163092094|NCT00244621|589048479|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163092095|NCT00244621|589048477|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
163092096|NCT00244621|589048478|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163092097|NCT00244621|589048479|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163092098|NCT00244621|589048477|FG000|Open-label Treatment Period|Adverse Event|0|||
163092099|NCT00244621|589048478|FG001|Open-label Treatment Period|Adverse Event|0|||
163092100|NCT00244621|589048479|FG002|Open-label Treatment Period|Adverse Event|1|||
163092101|NCT00244621|589048477|FG000|Open-label Treatment Period|Moved abroad|0|||
163092102|NCT00244621|589048478|FG001|Open-label Treatment Period|Moved abroad|0|||
163092103|NCT00244621|589048479|FG002|Open-label Treatment Period|Moved abroad|1|||
163092104|NCT01193101|589048483|FG000|Overall Study|Adverse Event|0|||
163092105|NCT01193101|589048484|FG001|Overall Study|Adverse Event|1|||
163092106|NCT01193101|589048485|FG002|Overall Study|Adverse Event|1|||
163092107|NCT01193101|589048486|FG003|Overall Study|Adverse Event|3|||
163092108|NCT01193101|589048483|FG000|Overall Study|Lack of Efficacy|3|||
163092109|NCT01193101|589048484|FG001|Overall Study|Lack of Efficacy|1|||
163092110|NCT01193101|589048485|FG002|Overall Study|Lack of Efficacy|0|||
163092111|NCT01193101|589048486|FG003|Overall Study|Lack of Efficacy|8|||
163092112|NCT01193101|589048483|FG000|Overall Study|Withdrawal by Subject|2|||
163092113|NCT01193101|589048484|FG001|Overall Study|Withdrawal by Subject|4|||
163092114|NCT01193101|589048485|FG002|Overall Study|Withdrawal by Subject|1|||
163092115|NCT01193101|589048486|FG003|Overall Study|Withdrawal by Subject|1|||
163092116|NCT01193101|589048483|FG000|Overall Study|Administrative problems|0|||
163092117|NCT01193101|589048484|FG001|Overall Study|Administrative problems|0|||
163092118|NCT01193101|589048485|FG002|Overall Study|Administrative problems|1|||
163092119|NCT01193101|589048486|FG003|Overall Study|Administrative problems|0|||
163092120|NCT01193101|589048483|FG000|Overall Study|Abnormal test procedure results|0|||
163092121|NCT01193101|589048484|FG001|Overall Study|Abnormal test procedure results|1|||
163092122|NCT01193101|589048485|FG002|Overall Study|Abnormal test procedure results|0|||
163092123|NCT01193101|589048486|FG003|Overall Study|Abnormal test procedure results|0|||
163092124|NCT02271529|589048487|FG000|Overall Study|Withdrawal by Subject|1|||
163092125|NCT03508050|589048488|FG000|Overall Study|Pleural adhesions|1|||
163092126|NCT03508050|589048489|FG001|Overall Study|Pleural adhesions|0|||
163092127|NCT03508050|589048488|FG000|Overall Study|Mucus plug|1|||
163092128|NCT03508050|589048489|FG001|Overall Study|Mucus plug|0|||
163092129|NCT03508050|589048488|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
163092130|NCT03508050|589048489|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
163092131|NCT03508050|589048488|FG000|Overall Study|Sustained desaturation|0|||
163092132|NCT03508050|589048489|FG001|Overall Study|Sustained desaturation|1|||
163092133|NCT00811720|589048490|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
163092134|NCT00811720|589048491|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
163092135|NCT00811720|589048490|FG000|All Treated Patients|Adverse Event|20|||
163092136|NCT00811720|589048491|FG001|All Treated Patients|Adverse Event|62|||
163092137|NCT00811720|589048490|FG000|All Treated Patients|Lack of Efficacy|22|||
163092138|NCT00811720|589048491|FG001|All Treated Patients|Lack of Efficacy|18|||
163092139|NCT00811720|589048490|FG000|All Treated Patients|Non-compliance|0|||
163092140|NCT00811720|589048491|FG001|All Treated Patients|Non-compliance|14|||
163092141|NCT00811720|589048490|FG000|All Treated Patients|Protocol Violation|9|||
163092142|NCT00811720|589048491|FG001|All Treated Patients|Protocol Violation|16|||
163092143|NCT00811720|589048490|FG000|All Treated Patients|Withdrawal by Subject|28|||
163092144|NCT00811720|589048491|FG001|All Treated Patients|Withdrawal by Subject|34|||
163092145|NCT00811720|589048490|FG000|All Treated Patients|Lost to Follow-up|10|||
163092146|NCT00811720|589048491|FG001|All Treated Patients|Lost to Follow-up|16|||
163092147|NCT00811720|589048490|FG000|All Treated Patients|Other Reason|7|||
163092148|NCT00811720|589048491|FG001|All Treated Patients|Other Reason|4|||
163092149|NCT03894891|589048492|FG000|Overall Study|Withdrawal by Subject|1|||
163038845|NCT02260817|588850592|FG001|Overall Study|Lost to Follow-up|14|||
163092150|NCT03894891|589048492|FG000|Overall Study|Completed protocol treatment per protocol|5|||
163092151|NCT04389866|589048493|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
162651243|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
162651244|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
162651245|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
162651246|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
162651247|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
162651248|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
162651249|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
162719003|NCT02341625|587676737|FG000|Overall Study|Participant Withdrew Consent|0|||
163038846|NCT02260817|588850591|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
163038847|NCT02260817|588850592|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
163038848|NCT02260817|588850591|FG000|Overall Study|Observation, no biopsy|0|||
163038849|NCT02260817|588850592|FG001|Overall Study|Observation, no biopsy|1|||
163038850|NCT02260817|588850591|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
163038851|NCT02260817|588850592|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
163038852|NCT02260817|588850591|FG000|Overall Study|Protocol Violation|0|||
163038853|NCT02260817|588850592|FG001|Overall Study|Protocol Violation|14|||
163038854|NCT03299101|588850593|FG000|Overall Study|Lost to Follow-up|1|||
163038855|NCT03299101|588850593|FG000|Overall Study|Withdrawal by Subject|5|||
163038856|NCT03299101|588850593|FG000|Overall Study|Surgery was changed|3|||
163038857|NCT03299101|588850593|FG000|Overall Study|Not enough time to complete prehab|1|||
163038858|NCT04217317|588850596|FG000|Overall Study|Lack of Efficacy|4|||
163038859|NCT04217317|588850596|FG000|Overall Study|Physician Decision|1|||
163038860|NCT01424241|588850597|FG000|Overall Study|Withdrawal by Subject|1|||
163038861|NCT01424241|588850597|FG000|Overall Study|Time constraints|2|||
163038862|NCT05259917|588850602|FG000|Overall Study|Protocol Violation|0|||
163038863|NCT05259917|588850603|FG001|Overall Study|Protocol Violation|0|||
163038864|NCT05259917|588850604|FG002|Overall Study|Protocol Violation|1|||
163038865|NCT05259917|588850605|FG003|Overall Study|Protocol Violation|0|||
163038866|NCT05259917|588850606|FG004|Overall Study|Protocol Violation|0|||
163038867|NCT05259917|588850607|FG005|Overall Study|Protocol Violation|0|||
163038868|NCT05259917|588850602|FG000|Overall Study|Lost to Follow-up|0|||
163038869|NCT05259917|588850603|FG001|Overall Study|Lost to Follow-up|0|||
163038870|NCT05259917|588850604|FG002|Overall Study|Lost to Follow-up|1|||
163038871|NCT05259917|588850605|FG003|Overall Study|Lost to Follow-up|0|||
163038872|NCT05259917|588850606|FG004|Overall Study|Lost to Follow-up|0|||
163038873|NCT05259917|588850607|FG005|Overall Study|Lost to Follow-up|1|||
163038874|NCT05259917|588850602|FG000|Overall Study|Physician Decision|0|||
163038875|NCT05259917|588850603|FG001|Overall Study|Physician Decision|1|||
163038876|NCT05259917|588850604|FG002|Overall Study|Physician Decision|0|||
163038877|NCT05259917|588850605|FG003|Overall Study|Physician Decision|0|||
163038878|NCT05259917|588850606|FG004|Overall Study|Physician Decision|0|||
163038879|NCT05259917|588850607|FG005|Overall Study|Physician Decision|0|||
163038880|NCT05259917|588850602|FG000|Overall Study|Withdrawal by Subject|0|||
163038881|NCT05259917|588850603|FG001|Overall Study|Withdrawal by Subject|1|||
163038882|NCT05259917|588850604|FG002|Overall Study|Withdrawal by Subject|0|||
163038883|NCT05259917|588850605|FG003|Overall Study|Withdrawal by Subject|0|||
163038884|NCT05259917|588850606|FG004|Overall Study|Withdrawal by Subject|1|||
163038885|NCT05259917|588850607|FG005|Overall Study|Withdrawal by Subject|1|||
163038886|NCT05259917|588850602|FG000|Overall Study|Trial Termination by Sponsor|7|||
163038887|NCT05259917|588850603|FG001|Overall Study|Trial Termination by Sponsor|2|||
163038888|NCT05259917|588850604|FG002|Overall Study|Trial Termination by Sponsor|3|||
163038889|NCT05259917|588850605|FG003|Overall Study|Trial Termination by Sponsor|5|||
163038890|NCT05259917|588850606|FG004|Overall Study|Trial Termination by Sponsor|11|||
163038891|NCT05259917|588850607|FG005|Overall Study|Trial Termination by Sponsor|4|||
163038892|NCT05259917|588850602|FG000|Overall Study|Other|1|||
163038893|NCT05259917|588850603|FG001|Overall Study|Other|0|||
163038894|NCT05259917|588850604|FG002|Overall Study|Other|2|||
163038895|NCT05259917|588850605|FG003|Overall Study|Other|0|||
163038896|NCT05259917|588850606|FG004|Overall Study|Other|0|||
163038897|NCT05259917|588850607|FG005|Overall Study|Other|0|||
163038898|NCT00303472|588850612|FG000|Treatment Period|Adverse Event|0|||
163038899|NCT00303472|588850613|FG001|Treatment Period|Adverse Event|0|||
163038900|NCT00303472|588850614|FG002|Treatment Period|Adverse Event|0|||
163038901|NCT00303472|588850615|FG003|Treatment Period|Adverse Event|0|||
163038902|NCT00303472|588850616|FG004|Treatment Period|Adverse Event|1|||
163038903|NCT00303472|588850617|FG005|Treatment Period|Adverse Event|0|||
163038904|NCT00303472|588850618|FG006|Treatment Period|Adverse Event|0|||
163038905|NCT00303472|588850612|FG000|Treatment Period|Death|0|||
163038906|NCT00303472|588850613|FG001|Treatment Period|Death|0|||
163038907|NCT00303472|588850614|FG002|Treatment Period|Death|0|||
163038908|NCT00303472|588850615|FG003|Treatment Period|Death|1|||
163038909|NCT00303472|588850616|FG004|Treatment Period|Death|0|||
163038910|NCT00303472|588850617|FG005|Treatment Period|Death|0|||
163038911|NCT00303472|588850618|FG006|Treatment Period|Death|1|||
163038912|NCT00303472|588850612|FG000|Treatment Period|Withdrawal by Subject|0|||
163038913|NCT00303472|588850613|FG001|Treatment Period|Withdrawal by Subject|0|||
162651250|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
162651251|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
162651252|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
162651253|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
162651254|NCT00934544|587443198|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
162651255|NCT00934544|587443199|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
162651256|NCT00934544|587443200|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
162651257|NCT02643251|587443201|FG000|Overall Study|Adverse Event|3|||
162651258|NCT02643251|587443202|FG001|Overall Study|Adverse Event|1|||
162651259|NCT02643251|587443201|FG000|Overall Study|Withdrawal by Subject|2|||
162651260|NCT02643251|587443202|FG001|Overall Study|Withdrawal by Subject|0|||
162651261|NCT02643251|587443201|FG000|Overall Study|Lost to Follow-up|4|||
162651262|NCT02643251|587443202|FG001|Overall Study|Lost to Follow-up|1|||
162651263|NCT02643251|587443201|FG000|Overall Study|Protocol Violation|1|||
162651264|NCT02643251|587443202|FG001|Overall Study|Protocol Violation|0|||
162651265|NCT02643251|587443201|FG000|Overall Study|PI Decision to terminate patient|1|||
162651266|NCT02643251|587443202|FG001|Overall Study|PI Decision to terminate patient|0|||
162651267|NCT00348556|587443203|FG000|Overall Study|Adverse Event|1|||
162651268|NCT00192075|587443204|FG000|Overall Study|Disease Progression|23|||
162651269|NCT00192075|587443205|FG001|Overall Study|Disease Progression|6|||
162651270|NCT00192075|587443204|FG000|Overall Study|Adverse Event|1|||
162651271|NCT00192075|587443205|FG001|Overall Study|Adverse Event|3|||
162651272|NCT00192075|587443204|FG000|Overall Study|Death|0|||
162651273|NCT00192075|587443205|FG001|Overall Study|Death|1|||
162651274|NCT00192075|587443204|FG000|Overall Study|Lack of Efficacy|0|||
162651275|NCT00192075|587443205|FG001|Overall Study|Lack of Efficacy|0|||
162651276|NCT00192075|587443204|FG000|Overall Study|Physician Decision|3|||
162651277|NCT00192075|587443205|FG001|Overall Study|Physician Decision|0|||
162651278|NCT00192075|587443204|FG000|Overall Study|Withdrawal by Subject|5|||
162651279|NCT00192075|587443205|FG001|Overall Study|Withdrawal by Subject|5|||
162651280|NCT00192075|587443204|FG000|Overall Study|Patient Non-Compliance|0|||
162651281|NCT00192075|587443205|FG001|Overall Study|Patient Non-Compliance|1|||
162651282|NCT00192075|587443204|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
162651283|NCT00192075|587443205|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
162651284|NCT00192075|587443204|FG000|Overall Study|Other|5|||
162651285|NCT00192075|587443205|FG001|Overall Study|Other|2|||
162651286|NCT00779675|587443206|FG000|Treatment Period|Adverse Event|87|||
162651287|NCT00779675|587443206|FG000|Treatment Period|Treatment Failure|80|||
162651288|NCT00779675|587443206|FG000|Treatment Period|Transferred to Another Study|38|||
162651289|NCT00779675|587443206|FG000|Treatment Period|Lost to Follow-up|23|||
162651290|NCT00779675|587443206|FG000|Treatment Period|Withdrawal by Subject|46|||
162651291|NCT00779675|587443206|FG000|Treatment Period|Protocol Violation|54|||
162651292|NCT00779675|587443206|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
162651293|NCT00779675|587443206|FG000|Treatment Period|Administrative|3|||
162651294|NCT00779675|587443206|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
162651295|NCT00779675|587443206|FG000|Extended Treatment Period|Protocol Violation|13|||
162651296|NCT00779675|587443206|FG000|Extended Treatment Period|Adverse Event|6|||
162651297|NCT00779675|587443206|FG000|Extended Treatment Period|Treatment Failure|11|||
162651298|NCT00779675|587443206|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
162651299|NCT00779675|587443206|FG000|Extended Treatment Period|Lost to Follow-up|6|||
162651300|NCT01944059|587443207|FG000|Overall Study|Lost to Follow-up|1|||
162651301|NCT01944059|587443207|FG000|Overall Study|Physician Decision|3|||
162651302|NCT01944059|587443207|FG000|Overall Study|Withdrawal by Subject|1|||
162651303|NCT01944059|587443207|FG000|Overall Study|Adverse Event|2|||
162651304|NCT00430092|587443214|FG000|Overall Study|Adverse Event|0|||
163038914|NCT00303472|588850614|FG002|Treatment Period|Withdrawal by Subject|0|||
163038915|NCT00303472|588850615|FG003|Treatment Period|Withdrawal by Subject|1|||
163038916|NCT00303472|588850616|FG004|Treatment Period|Withdrawal by Subject|0|||
163038917|NCT00303472|588850617|FG005|Treatment Period|Withdrawal by Subject|1|||
163038918|NCT00303472|588850618|FG006|Treatment Period|Withdrawal by Subject|0|||
163038919|NCT00303472|588850612|FG000|Treatment Period|Other|0|||
163038920|NCT00303472|588850613|FG001|Treatment Period|Other|0|||
163038921|NCT00303472|588850614|FG002|Treatment Period|Other|0|||
163038922|NCT00303472|588850615|FG003|Treatment Period|Other|0|||
163038923|NCT00303472|588850616|FG004|Treatment Period|Other|1|||
163038924|NCT00303472|588850617|FG005|Treatment Period|Other|0|||
163038925|NCT00303472|588850618|FG006|Treatment Period|Other|1|||
163038926|NCT00303472|588850612|FG000|Treatment Period|Disease Progression (to AML)|0|||
163038927|NCT00303472|588850613|FG001|Treatment Period|Disease Progression (to AML)|0|||
163038928|NCT00303472|588850614|FG002|Treatment Period|Disease Progression (to AML)|0|||
163038929|NCT00303472|588850615|FG003|Treatment Period|Disease Progression (to AML)|0|||
163038930|NCT00303472|588850616|FG004|Treatment Period|Disease Progression (to AML)|1|||
163038931|NCT00303472|588850617|FG005|Treatment Period|Disease Progression (to AML)|0|||
163038932|NCT00303472|588850618|FG006|Treatment Period|Disease Progression (to AML)|0|||
163038933|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Adverse Event|1|||
162651305|NCT00430092|587443215|FG001|Overall Study|Adverse Event|0|||
162651306|NCT00430092|587443216|FG002|Overall Study|Adverse Event|1|||
162651307|NCT00430092|587443214|FG000|Overall Study|Lack of Efficacy|5|||
163038934|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Adverse Event|0|||
163038935|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Adverse Event|1|||
163038936|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Adverse Event|0|||
163038937|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Adverse Event|0|||
163038938|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Adverse Event|0|||
163038939|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Adverse Event|0|||
163038940|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Death|2|||
163038941|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Death|0|||
163038942|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Death|1|||
163038943|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Death|0|||
163038944|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Death|0|||
163038945|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Death|0|||
163038946|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Death|0|||
163038947|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038948|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038949|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038950|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
163038951|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038952|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038953|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
163038954|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Physician Decision|0|||
163038955|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Physician Decision|4|||
163038956|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Physician Decision|2|||
163038957|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Physician Decision|3|||
163038958|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Physician Decision|2|||
163038959|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Physician Decision|0|||
163038960|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Physician Decision|0|||
163038961|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038962|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038963|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038964|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
163038965|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
163038966|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038967|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
163038968|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Other|0|||
163038969|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Other|2|||
163038970|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Other|4|||
163038971|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Other|2|||
163038972|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Other|1|||
163038973|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Other|0|||
163038974|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Other|0|||
163038975|NCT00303472|588850612|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
163038976|NCT00303472|588850613|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038977|NCT00303472|588850614|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038978|NCT00303472|588850615|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038979|NCT00303472|588850616|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038980|NCT00303472|588850617|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
163038981|NCT00303472|588850618|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
163038982|NCT03585712|588850626|FG000|Treatment Period 1|Protocol Violation|1|||
163038983|NCT03585712|588850627|FG001|Treatment Period 1|Protocol Violation|0|||
163038984|NCT03585712|588850628|FG002|Treatment Period 1|Protocol Violation|0|||
163038985|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
163038986|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
163038987|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
163038988|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
163038989|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
163038990|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
163038991|NCT03585712|588850626|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
163038992|NCT03585712|588850627|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
163038993|NCT03585712|588850628|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
163038994|NCT03517449|588850629|FG000|Overall Study|Death|184|||
163038995|NCT03517449|588850630|FG001|Overall Study|Death|236|||
163038996|NCT03517449|588850629|FG000|Overall Study|Lost to Follow-up|0|||
163038997|NCT03517449|588850630|FG001|Overall Study|Lost to Follow-up|2|||
163038998|NCT03517449|588850629|FG000|Overall Study|Withdrawal by Subject|7|||
163038999|NCT03517449|588850630|FG001|Overall Study|Withdrawal by Subject|26|||
163039000|NCT03517449|588850629|FG000|Overall Study|Participants Ongoing|220|||
163039001|NCT03517449|588850630|FG001|Overall Study|Participants Ongoing|152|||
163092152|NCT04389866|589048494|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
163092153|NCT00776789|589048502|FG000|Overall Study|Consent refusal|2|||
163092154|NCT00776789|589048503|FG001|Overall Study|Consent refusal|2|||
162651308|NCT00430092|587443215|FG001|Overall Study|Lack of Efficacy|2|||
162651309|NCT00430092|587443216|FG002|Overall Study|Lack of Efficacy|54|||
162651310|NCT00430092|587443214|FG000|Overall Study|Lost to Follow-up|1|||
162651311|NCT00430092|587443215|FG001|Overall Study|Lost to Follow-up|0|||
162651312|NCT00430092|587443216|FG002|Overall Study|Lost to Follow-up|0|||
162651313|NCT00430092|587443214|FG000|Overall Study|Protocol Violation|0|||
162651314|NCT00430092|587443215|FG001|Overall Study|Protocol Violation|1|||
162651315|NCT00430092|587443216|FG002|Overall Study|Protocol Violation|1|||
162651316|NCT00430092|587443214|FG000|Overall Study|Withdrawal by Subject|0|||
162651317|NCT00430092|587443215|FG001|Overall Study|Withdrawal by Subject|1|||
162651318|NCT00430092|587443216|FG002|Overall Study|Withdrawal by Subject|1|||
162651319|NCT01956110|587443217|FG000|Overall Study|Protocol Violation|25|||
162651320|NCT01956110|587443218|FG001|Overall Study|Protocol Violation|11|||
162651321|NCT01956110|587443217|FG000|Overall Study|Adverse Event|9|||
162651322|NCT01956110|587443218|FG001|Overall Study|Adverse Event|10|||
162651323|NCT01956110|587443217|FG000|Overall Study|Personal reasons|1|||
162651324|NCT01956110|587443218|FG001|Overall Study|Personal reasons|1|||
162651325|NCT02118428|587443223|FG000|Overall Study|Physician Decision|0|||
162651326|NCT02118428|587443224|FG001|Overall Study|Physician Decision|1|||
162651327|NCT02118428|587443225|FG002|Overall Study|Physician Decision|0|||
162651328|NCT02118428|587443223|FG000|Overall Study|Withdrawal by Subject|2|||
162651329|NCT02118428|587443224|FG001|Overall Study|Withdrawal by Subject|2|||
162651330|NCT02118428|587443225|FG002|Overall Study|Withdrawal by Subject|0|||
162651331|NCT02118428|587443223|FG000|Overall Study|Death|7|||
162651332|NCT02118428|587443224|FG001|Overall Study|Death|5|||
162651333|NCT02118428|587443225|FG002|Overall Study|Death|0|||
162651334|NCT02118428|587443223|FG000|Overall Study|Lost to Follow-up|3|||
162651335|NCT02118428|587443224|FG001|Overall Study|Lost to Follow-up|1|||
162651336|NCT02118428|587443225|FG002|Overall Study|Lost to Follow-up|0|||
162651337|NCT02118428|587443223|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
162651338|NCT02118428|587443224|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
162651339|NCT02118428|587443225|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
162651340|NCT01633944|587443228|FG000|Open-label Titration Phase|Adverse Event|109|||
162651341|NCT01633944|587443229|FG001|Open-label Titration Phase|Adverse Event|0|||
162651342|NCT01633944|587443230|FG002|Open-label Titration Phase|Adverse Event|0|||
162651343|NCT01633944|587443228|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
162651344|NCT01633944|587443229|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
162651345|NCT01633944|587443230|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
162651346|NCT01633944|587443228|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
162651347|NCT01633944|587443229|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
162651348|NCT01633944|587443230|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
162651349|NCT01633944|587443228|FG000|Open-label Titration Phase|Protocol Violation|24|||
162651350|NCT01633944|587443229|FG001|Open-label Titration Phase|Protocol Violation|0|||
162651351|NCT01633944|587443230|FG002|Open-label Titration Phase|Protocol Violation|0|||
162651352|NCT01633944|587443228|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
162651353|NCT01633944|587443229|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
162651354|NCT01633944|587443230|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
162651355|NCT01633944|587443228|FG000|Open-label Titration Phase|Other|68|||
162651356|NCT01633944|587443229|FG001|Open-label Titration Phase|Other|0|||
162651357|NCT01633944|587443230|FG002|Open-label Titration Phase|Other|0|||
162651358|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Adverse Event|0|||
162651359|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Adverse Event|13|||
162651360|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Adverse Event|7|||
162651361|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
162651362|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
162651363|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
162651364|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162651365|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163092155|NCT00776789|589048502|FG000|Overall Study|Poor quality video|1|||
163092156|NCT00776789|589048503|FG001|Overall Study|Poor quality video|1|||
163092157|NCT04940130|589048504|FG000|Overall Study|Travel|1|||
162651366|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
162651367|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
162651368|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
162651369|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
162651370|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162651371|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
163092158|NCT04940130|589048505|FG001|Overall Study|Travel|0|||
162651372|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
162651373|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
162651374|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
162651375|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
163039002|NCT01808222|588850634|FG000|Overall Study|mpMR scan was not performed|1|||
163092159|NCT04940130|589048506|FG002|Overall Study|Travel|2|||
163092160|NCT04940130|589048504|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
163092161|NCT04940130|589048505|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
163092162|NCT04940130|589048506|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
163092163|NCT04940130|589048504|FG000|Overall Study|Adverse Event|0|||
163092164|NCT04940130|589048505|FG001|Overall Study|Adverse Event|0|||
163092165|NCT04940130|589048506|FG002|Overall Study|Adverse Event|2|||
163092166|NCT04940130|589048504|FG000|Overall Study|Disease progression/treatment failure|0|||
163092167|NCT04940130|589048505|FG001|Overall Study|Disease progression/treatment failure|0|||
163092168|NCT04940130|589048506|FG002|Overall Study|Disease progression/treatment failure|1|||
163092169|NCT04940130|589048504|FG000|Overall Study|Participant refusal|0|||
163092170|NCT04940130|589048505|FG001|Overall Study|Participant refusal|0|||
162651376|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
162651377|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
162651378|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
162651379|NCT01633944|587443228|FG000|Double-blind Treatment Phase|Other|0|||
162651380|NCT01633944|587443229|FG001|Double-blind Treatment Phase|Other|7|||
162651381|NCT01633944|587443230|FG002|Double-blind Treatment Phase|Other|0|||
162651382|NCT00463060|587443231|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
162651383|NCT00463060|587443231|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
162651384|NCT01400841|587443232|FG000|Initial Study Phase (6 Months)|Death|1|||
162651385|NCT01400841|587443232|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
162651386|NCT00701129|587443233|FG000|Overall Study|Death|2|||
162651387|NCT00910715|587443234|FG000|Overall Study|Lost to Follow-up|22|||
162651388|NCT00910715|587443235|FG001|Overall Study|Lost to Follow-up|26|||
162651389|NCT00910715|587443236|FG002|Overall Study|Lost to Follow-up|0|||
162651390|NCT00706966|587443237|FG000|Overall Study|Adverse Event|1|||
163039003|NCT00621517|588850635|FG000|Overall Study|Lost to Follow-up|3|||
163039004|NCT00621517|588850636|FG001|Overall Study|Lost to Follow-up|3|||
163039005|NCT00621517|588850635|FG000|Overall Study|Withdrawal by Subject|3|||
163039006|NCT00621517|588850636|FG001|Overall Study|Withdrawal by Subject|4|||
162651391|NCT02884089|587443238|FG000|Period 1|Dosing error|2|||
162651392|NCT02884089|587443239|FG001|Period 1|Dosing error|2|||
162651393|NCT02884089|587443240|FG002|Period 1|Dosing error|0|||
162651394|NCT02884089|587443241|FG003|Period 1|Dosing error|0|||
162651395|NCT02884089|587443238|FG000|Washout Period 1|Lost to Follow-up|0|||
162651396|NCT02884089|587443239|FG001|Washout Period 1|Lost to Follow-up|1|||
162651397|NCT02884089|587443240|FG002|Washout Period 1|Lost to Follow-up|0|||
162651398|NCT02884089|587443241|FG003|Washout Period 1|Lost to Follow-up|1|||
162651399|NCT02884089|587443238|FG000|Washout Period 1|Withdrawal by Subject|0|||
162651400|NCT02884089|587443239|FG001|Washout Period 1|Withdrawal by Subject|1|||
162651401|NCT02884089|587443240|FG002|Washout Period 1|Withdrawal by Subject|0|||
162651402|NCT02884089|587443241|FG003|Washout Period 1|Withdrawal by Subject|0|||
162651403|NCT02884089|587443238|FG000|Period 2|Adverse Event|1|||
162651404|NCT02884089|587443239|FG001|Period 2|Adverse Event|0|||
162651405|NCT02884089|587443240|FG002|Period 2|Adverse Event|0|||
162651406|NCT02884089|587443241|FG003|Period 2|Adverse Event|0|||
162651407|NCT02884089|587443238|FG000|Period 3|Withdrawal by Subject|0|||
162651408|NCT02884089|587443239|FG001|Period 3|Withdrawal by Subject|0|||
162651409|NCT02884089|587443240|FG002|Period 3|Withdrawal by Subject|1|||
162651410|NCT02884089|587443241|FG003|Period 3|Withdrawal by Subject|0|||
162651411|NCT02884089|587443238|FG000|Washout Period 3|Withdrawal by Subject|0|||
162651412|NCT02884089|587443239|FG001|Washout Period 3|Withdrawal by Subject|0|||
163039007|NCT00621517|588850635|FG000|Overall Study|Adverse Event|1|||
163039008|NCT00621517|588850636|FG001|Overall Study|Adverse Event|0|||
163039009|NCT00856843|588850637|FG000|Overall Study|Withdrawal by Subject|1|||
163039010|NCT00856843|588850638|FG001|Overall Study|Withdrawal by Subject|5|||
163039011|NCT00856843|588850637|FG000|Overall Study|Lack of Efficacy|1|||
163039012|NCT00856843|588850638|FG001|Overall Study|Lack of Efficacy|0|||
163039013|NCT02101359|588850639|FG000|Overall Study|Not included|23|||
163039014|NCT02101359|588850640|FG001|Overall Study|Not included|13|||
163039015|NCT02101359|588850639|FG000|Overall Study|Withdrawal by Subject|5|||
163039016|NCT02101359|588850640|FG001|Overall Study|Withdrawal by Subject|4|||
163039017|NCT02101359|588850639|FG000|Overall Study|Lost to Follow-up|1|||
163039018|NCT02101359|588850640|FG001|Overall Study|Lost to Follow-up|0|||
163039019|NCT02101359|588850639|FG000|Overall Study|Protocol Violation|0|||
163039020|NCT02101359|588850640|FG001|Overall Study|Protocol Violation|2|||
163039021|NCT00494221|588850641|FG000|Overall Study|Death|15|||
163039022|NCT00494221|588850642|FG001|Overall Study|Death|9|||
163039023|NCT00494221|588850643|FG002|Overall Study|Death|14|||
163039024|NCT00494221|588850641|FG000|Overall Study|Withdrawal by Subject|1|||
163039025|NCT00494221|588850642|FG001|Overall Study|Withdrawal by Subject|2|||
163039026|NCT00494221|588850643|FG002|Overall Study|Withdrawal by Subject|0|||
163039027|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
163039028|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
163039029|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
163092171|NCT04940130|589048506|FG002|Overall Study|Participant refusal|1|||
163092172|NCT00363311|589048509|FG000|Overall Study|Adverse Event|6|||
163092173|NCT00363311|589048510|FG001|Overall Study|Adverse Event|4|||
163092174|NCT00363311|589048509|FG000|Overall Study|Lost to Follow-up|3|||
163092175|NCT00363311|589048510|FG001|Overall Study|Lost to Follow-up|0|||
163092176|NCT00363311|589048509|FG000|Overall Study|Protocol Violation|1|||
163092177|NCT00363311|589048510|FG001|Overall Study|Protocol Violation|2|||
163092178|NCT00363311|589048509|FG000|Overall Study|Withdrawal by Subject|12|||
163092179|NCT00363311|589048510|FG001|Overall Study|Withdrawal by Subject|6|||
163092180|NCT00363311|589048509|FG000|Overall Study|Physician Decision|1|||
163092181|NCT00363311|589048510|FG001|Overall Study|Physician Decision|1|||
163092182|NCT00363311|589048509|FG000|Overall Study|Sponsor Terminated Study|2|||
163092183|NCT00363311|589048510|FG001|Overall Study|Sponsor Terminated Study|2|||
163092184|NCT00363311|589048509|FG000|Overall Study|Disease Progression|46|||
163092185|NCT00363311|589048510|FG001|Overall Study|Disease Progression|26|||
163092186|NCT00363311|589048509|FG000|Overall Study|Non-Compliance|1|||
163092187|NCT00363311|589048510|FG001|Overall Study|Non-Compliance|1|||
163092188|NCT00363311|589048509|FG000|Overall Study|Participant Refused Biopsy|1|||
163092189|NCT00363311|589048510|FG001|Overall Study|Participant Refused Biopsy|0|||
163092190|NCT00363311|589048509|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
163092191|NCT00363311|589048510|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
163092192|NCT00363311|589048509|FG000|Overall Study|Participant Opted for Treatment|1|||
163092193|NCT00363311|589048510|FG001|Overall Study|Participant Opted for Treatment|0|||
163092194|NCT00363311|589048509|FG000|Overall Study|Participant Moved to Another Country|1|||
163092195|NCT00363311|589048510|FG001|Overall Study|Participant Moved to Another Country|0|||
163092196|NCT00363311|589048509|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
163092197|NCT00363311|589048510|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
163092198|NCT00363311|589048509|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
163092199|NCT00363311|589048510|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
163092200|NCT00363311|589048509|FG000|Overall Study|Participant Moved to Louisiana|0|||
163092201|NCT00363311|589048510|FG001|Overall Study|Participant Moved to Louisiana|1|||
163092202|NCT00401843|589048511|FG000|Overall Study|Achieved Complete Response|1|||
163092203|NCT00401843|589048512|FG001|Overall Study|Achieved Complete Response|5|||
163092204|NCT00401843|589048513|FG002|Overall Study|Achieved Complete Response|11|||
163092205|NCT00401843|589048511|FG000|Overall Study|Adverse Event|7|||
163092206|NCT00401843|589048512|FG001|Overall Study|Adverse Event|26|||
163092207|NCT00401843|589048513|FG002|Overall Study|Adverse Event|27|||
163092208|NCT00401843|589048511|FG000|Overall Study|Death|0|||
163092209|NCT00401843|589048512|FG001|Overall Study|Death|8|||
163092210|NCT00401843|589048513|FG002|Overall Study|Death|10|||
163092211|NCT00401843|589048511|FG000|Overall Study|Disease progression|10|||
163092212|NCT00401843|589048512|FG001|Overall Study|Disease progression|60|||
163092213|NCT00401843|589048513|FG002|Overall Study|Disease progression|49|||
163092214|NCT00401843|589048511|FG000|Overall Study|End of Study|1|||
162651413|NCT02884089|587443240|FG002|Washout Period 3|Withdrawal by Subject|1|||
162651414|NCT02884089|587443241|FG003|Washout Period 3|Withdrawal by Subject|0|||
162651415|NCT02884089|587443238|FG000|Washout Period 3|Lost to Follow-up|0|||
162651416|NCT02884089|587443239|FG001|Washout Period 3|Lost to Follow-up|0|||
162651417|NCT02884089|587443240|FG002|Washout Period 3|Lost to Follow-up|0|||
162651418|NCT02884089|587443241|FG003|Washout Period 3|Lost to Follow-up|1|||
162651419|NCT02884089|587443238|FG000|Period 4|Withdrawal by Subject|0|||
162651420|NCT02884089|587443239|FG001|Period 4|Withdrawal by Subject|1|||
162651421|NCT02884089|587443240|FG002|Period 4|Withdrawal by Subject|0|||
162651422|NCT02884089|587443241|FG003|Period 4|Withdrawal by Subject|0|||
162651423|NCT02884089|587443238|FG000|Period 4|Lost to Follow-up|1|||
162651424|NCT02884089|587443239|FG001|Period 4|Lost to Follow-up|0|||
162651425|NCT02884089|587443240|FG002|Period 4|Lost to Follow-up|0|||
162651426|NCT02884089|587443241|FG003|Period 4|Lost to Follow-up|0|||
162651427|NCT02884089|587443238|FG000|Follow-up Visit|Withdrawal by Subject|1|||
162651428|NCT02884089|587443239|FG001|Follow-up Visit|Withdrawal by Subject|0|||
163092215|NCT00401843|589048512|FG001|Overall Study|End of Study|1|||
163092216|NCT00401843|589048513|FG002|Overall Study|End of Study|2|||
162719004|NCT02341625|587676738|FG001|Overall Study|Participant Withdrew Consent|0|||
162719005|NCT02341625|587676739|FG002|Overall Study|Participant Withdrew Consent|0|||
162719006|NCT02341625|587676740|FG003|Overall Study|Participant Withdrew Consent|1|||
162719007|NCT02341625|587676741|FG004|Overall Study|Participant Withdrew Consent|0|||
162651429|NCT02884089|587443240|FG002|Follow-up Visit|Withdrawal by Subject|0|||
162651430|NCT02884089|587443241|FG003|Follow-up Visit|Withdrawal by Subject|1|||
162651431|NCT01631474|587443242|FG000|Overall Study|Lost to Follow-up|8|||
162719008|NCT02341625|587676742|FG005|Overall Study|Participant Withdrew Consent|0|||
163092217|NCT00401843|589048511|FG000|Overall Study|Lost to Follow-up|0|||
163092218|NCT00401843|589048512|FG001|Overall Study|Lost to Follow-up|0|||
162651432|NCT01631474|587443243|FG001|Overall Study|Lost to Follow-up|5|||
162651433|NCT01631474|587443244|FG002|Overall Study|Lost to Follow-up|7|||
163092219|NCT00401843|589048513|FG002|Overall Study|Lost to Follow-up|2|||
163092220|NCT00401843|589048511|FG000|Overall Study|Other Unspecified|0|||
163092221|NCT00401843|589048512|FG001|Overall Study|Other Unspecified|3|||
163092222|NCT00401843|589048513|FG002|Overall Study|Other Unspecified|5|||
163092223|NCT00401843|589048511|FG000|Overall Study|Physician Decision|0|||
163092224|NCT00401843|589048512|FG001|Overall Study|Physician Decision|16|||
163092225|NCT00401843|589048513|FG002|Overall Study|Physician Decision|10|||
163092226|NCT00401843|589048511|FG000|Overall Study|Protocol Violation|0|||
163092227|NCT00401843|589048512|FG001|Overall Study|Protocol Violation|0|||
163092228|NCT00401843|589048513|FG002|Overall Study|Protocol Violation|1|||
163092229|NCT00401843|589048511|FG000|Overall Study|Withdrawal by Subject|1|||
163092230|NCT00401843|589048512|FG001|Overall Study|Withdrawal by Subject|5|||
163092231|NCT00401843|589048513|FG002|Overall Study|Withdrawal by Subject|5|||
163092232|NCT00401843|589048511|FG000|Overall Study|Withdrawal of consent to study agent|1|||
163092233|NCT00401843|589048512|FG001|Overall Study|Withdrawal of consent to study agent|15|||
163092234|NCT00401843|589048513|FG002|Overall Study|Withdrawal of consent to study agent|17|||
163092235|NCT00401843|589048511|FG000|Overall Study|Randomized but not Treated|0|||
163092236|NCT00401843|589048512|FG001|Overall Study|Randomized but not Treated|2|||
163092237|NCT00401843|589048513|FG002|Overall Study|Randomized but not Treated|3|||
163092238|NCT00401843|589048511|FG000|Overall Study|Received incorrect treatment|0|||
163092239|NCT00401843|589048512|FG001|Overall Study|Received incorrect treatment|3|||
163092240|NCT00401843|589048513|FG002|Overall Study|Received incorrect treatment|0|||
163092241|NCT04881760|589048516|FG000|Overall Study|Adverse Event|0|||
163092242|NCT04881760|589048517|FG001|Overall Study|Adverse Event|1|||
163092243|NCT04881760|589048518|FG002|Overall Study|Adverse Event|1|||
163092244|NCT04881760|589048519|FG003|Overall Study|Adverse Event|0|||
163092245|NCT04881760|589048520|FG004|Overall Study|Adverse Event|1|||
163092246|NCT04881760|589048521|FG005|Overall Study|Adverse Event|1|||
163092247|NCT04881760|589048522|FG006|Overall Study|Adverse Event|2|||
163092248|NCT04881760|589048516|FG000|Overall Study|Death|0|||
163092249|NCT04881760|589048517|FG001|Overall Study|Death|0|||
163092250|NCT04881760|589048518|FG002|Overall Study|Death|0|||
163092251|NCT04881760|589048519|FG003|Overall Study|Death|1|||
163092252|NCT04881760|589048520|FG004|Overall Study|Death|0|||
163092253|NCT04881760|589048521|FG005|Overall Study|Death|0|||
163092254|NCT04881760|589048522|FG006|Overall Study|Death|0|||
163092255|NCT04881760|589048516|FG000|Overall Study|Lost to Follow-up|5|||
163092256|NCT04881760|589048517|FG001|Overall Study|Lost to Follow-up|7|||
163092257|NCT04881760|589048518|FG002|Overall Study|Lost to Follow-up|5|||
163092258|NCT04881760|589048519|FG003|Overall Study|Lost to Follow-up|1|||
163092259|NCT04881760|589048520|FG004|Overall Study|Lost to Follow-up|2|||
163092260|NCT04881760|589048521|FG005|Overall Study|Lost to Follow-up|4|||
163092261|NCT04881760|589048522|FG006|Overall Study|Lost to Follow-up|4|||
163092262|NCT04881760|589048516|FG000|Overall Study|Withdrawal by Subject|13|||
163092263|NCT04881760|589048517|FG001|Overall Study|Withdrawal by Subject|1|||
163092264|NCT04881760|589048518|FG002|Overall Study|Withdrawal by Subject|1|||
163092265|NCT04881760|589048519|FG003|Overall Study|Withdrawal by Subject|4|||
163092266|NCT04881760|589048520|FG004|Overall Study|Withdrawal by Subject|2|||
163092267|NCT04881760|589048521|FG005|Overall Study|Withdrawal by Subject|1|||
163092268|NCT04881760|589048522|FG006|Overall Study|Withdrawal by Subject|2|||
163092269|NCT04881760|589048516|FG000|Overall Study|Randomized but Never Treated|0|||
163092270|NCT04881760|589048517|FG001|Overall Study|Randomized but Never Treated|0|||
163092271|NCT04881760|589048518|FG002|Overall Study|Randomized but Never Treated|0|||
163092272|NCT04881760|589048519|FG003|Overall Study|Randomized but Never Treated|1|||
163092273|NCT04881760|589048520|FG004|Overall Study|Randomized but Never Treated|0|||
163092274|NCT04881760|589048521|FG005|Overall Study|Randomized but Never Treated|0|||
163092275|NCT04881760|589048522|FG006|Overall Study|Randomized but Never Treated|0|||
163092276|NCT04881760|589048516|FG000|Overall Study|Inadvertent Enrollment|2|||
163092277|NCT04881760|589048517|FG001|Overall Study|Inadvertent Enrollment|0|||
163092278|NCT04881760|589048518|FG002|Overall Study|Inadvertent Enrollment|0|||
163092279|NCT04881760|589048519|FG003|Overall Study|Inadvertent Enrollment|0|||
163092280|NCT04881760|589048520|FG004|Overall Study|Inadvertent Enrollment|0|||
163092281|NCT04881760|589048521|FG005|Overall Study|Inadvertent Enrollment|0|||
163092282|NCT04881760|589048522|FG006|Overall Study|Inadvertent Enrollment|0|||
163092283|NCT04881760|589048516|FG000|Overall Study|Site Closure|0|||
163092284|NCT04881760|589048517|FG001|Overall Study|Site Closure|0|||
163092285|NCT04881760|589048518|FG002|Overall Study|Site Closure|0|||
163092286|NCT04881760|589048519|FG003|Overall Study|Site Closure|1|||
163092287|NCT04881760|589048520|FG004|Overall Study|Site Closure|0|||
163092288|NCT04881760|589048521|FG005|Overall Study|Site Closure|0|||
163092289|NCT04881760|589048522|FG006|Overall Study|Site Closure|0|||
163092290|NCT01182298|589048523|FG000|Overall Study|Lack of Efficacy|4|||
163092291|NCT01182298|589048523|FG000|Overall Study|Withdrawal by Subject|2|||
163092292|NCT01508910|589048524|FG000|Treatment|Death|2|||
163092293|NCT01508910|589048525|FG001|Treatment|Death|3|||
163092294|NCT01508910|589048526|FG002|Treatment|Death|2|||
163092295|NCT01508910|589048527|FG003|Treatment|Death|0|||
163092296|NCT01508910|589048524|FG000|Treatment|Lost to Follow-up|0|||
163092297|NCT01508910|589048525|FG001|Treatment|Lost to Follow-up|0|||
163092298|NCT01508910|589048526|FG002|Treatment|Lost to Follow-up|2|||
163092299|NCT01508910|589048527|FG003|Treatment|Lost to Follow-up|1|||
162651434|NCT01631474|587443245|FG003|Overall Study|Lost to Follow-up|5|||
162651435|NCT01631474|587443246|FG004|Overall Study|Lost to Follow-up|5|||
162651436|NCT01631474|587443242|FG000|Overall Study|Withdrawal by Subject|4|||
162651437|NCT01631474|587443243|FG001|Overall Study|Withdrawal by Subject|4|||
162651438|NCT01631474|587443244|FG002|Overall Study|Withdrawal by Subject|2|||
162651439|NCT01631474|587443245|FG003|Overall Study|Withdrawal by Subject|6|||
162651440|NCT01631474|587443246|FG004|Overall Study|Withdrawal by Subject|5|||
162651441|NCT01631474|587443242|FG000|Overall Study|Lack of Efficacy|2|||
162651442|NCT01631474|587443243|FG001|Overall Study|Lack of Efficacy|2|||
162651443|NCT01631474|587443244|FG002|Overall Study|Lack of Efficacy|0|||
162651444|NCT01631474|587443245|FG003|Overall Study|Lack of Efficacy|0|||
162651445|NCT01631474|587443246|FG004|Overall Study|Lack of Efficacy|2|||
162651446|NCT01631474|587443242|FG000|Overall Study|Noncompliance with Study Drug|0|||
162651447|NCT01631474|587443243|FG001|Overall Study|Noncompliance with Study Drug|0|||
162651448|NCT01631474|587443244|FG002|Overall Study|Noncompliance with Study Drug|0|||
162651449|NCT01631474|587443245|FG003|Overall Study|Noncompliance with Study Drug|0|||
162651450|NCT01631474|587443246|FG004|Overall Study|Noncompliance with Study Drug|1|||
162651451|NCT01631474|587443242|FG000|Overall Study|Adverse Event|0|||
162651452|NCT01631474|587443243|FG001|Overall Study|Adverse Event|1|||
162651453|NCT01631474|587443244|FG002|Overall Study|Adverse Event|0|||
162651454|NCT01631474|587443245|FG003|Overall Study|Adverse Event|0|||
162651455|NCT01631474|587443246|FG004|Overall Study|Adverse Event|0|||
162651456|NCT01467076|587443247|FG000|Overall Study|Lost to Follow-up|1|||
162651457|NCT01467076|587443248|FG001|Overall Study|Lost to Follow-up|0|||
162651458|NCT01467076|587443249|FG002|Overall Study|Lost to Follow-up|0|||
162651459|NCT03354429|587443250|FG000|Overall Study|Withdrawal by Subject|8|||
162651460|NCT03354429|587443251|FG001|Overall Study|Withdrawal by Subject|7|||
162651461|NCT03354429|587443250|FG000|Overall Study|Lost to Follow-up|1|||
162651462|NCT03354429|587443251|FG001|Overall Study|Lost to Follow-up|0|||
162651463|NCT00654381|587443257|FG000|1st Stage|Adverse Event|3|||
162651464|NCT00654381|587443258|FG001|1st Stage|Adverse Event|3|||
162651465|NCT00654381|587443259|FG002|1st Stage|Adverse Event|3|||
162651466|NCT00654381|587443260|FG003|1st Stage|Adverse Event|3|||
162651467|NCT00654381|587443261|FG004|1st Stage|Adverse Event|2|||
162651468|NCT00654381|587443262|FG005|1st Stage|Adverse Event|1|||
162651469|NCT00654381|587443257|FG000|1st Stage|Withdrawal by Subject|0|||
162651470|NCT00654381|587443258|FG001|1st Stage|Withdrawal by Subject|0|||
162651471|NCT00654381|587443259|FG002|1st Stage|Withdrawal by Subject|0|||
162651472|NCT00654381|587443260|FG003|1st Stage|Withdrawal by Subject|1|||
162651473|NCT00654381|587443261|FG004|1st Stage|Withdrawal by Subject|0|||
163039030|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
163039031|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
163039032|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
163039033|NCT01900431|588850647|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
163039034|NCT01900431|588850648|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
163039035|NCT01900431|588850649|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
163039036|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
163039037|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
163039038|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
163039039|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
163039040|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
163039041|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
163039042|NCT01900431|588850647|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
163039043|NCT01900431|588850648|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
163039044|NCT01900431|588850649|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
163039045|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
163039046|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
163039047|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
163039048|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
163039049|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
163039050|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
163039051|NCT01900431|588850647|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
163039052|NCT01900431|588850648|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
163039053|NCT01900431|588850649|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
163039054|NCT01841567|588850650|FG000|Overall Study|Adverse Event|3|||
163039055|NCT03172364|588850651|FG000|Overall Study|Adverse Event|1|||
163039056|NCT03172364|588850652|FG001|Overall Study|Adverse Event|1|||
163039057|NCT03172364|588850651|FG000|Overall Study|Protocol Violation|1|||
163039058|NCT03172364|588850652|FG001|Overall Study|Protocol Violation|0|||
163039059|NCT00630747|588850653|FG000|Overall Study|Death|1|||
163039060|NCT00630747|588850653|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
163039061|NCT00630747|588850653|FG000|Overall Study|Returned to country of origin|1|||
162651474|NCT00654381|587443262|FG005|1st Stage|Withdrawal by Subject|1|||
162651475|NCT00654381|587443257|FG000|1st Stage|Investigator's decision|0|||
162651476|NCT00654381|587443258|FG001|1st Stage|Investigator's decision|0|||
162651477|NCT00654381|587443259|FG002|1st Stage|Investigator's decision|0|||
162651478|NCT00654381|587443260|FG003|1st Stage|Investigator's decision|1|||
162651479|NCT00654381|587443261|FG004|1st Stage|Investigator's decision|0|||
162651480|NCT00654381|587443262|FG005|1st Stage|Investigator's decision|0|||
162651481|NCT00654381|587443257|FG000|2nd Stage|Adverse Event|2|||
162651482|NCT00654381|587443258|FG001|2nd Stage|Adverse Event|0|||
162651483|NCT00654381|587443259|FG002|2nd Stage|Adverse Event|2|||
162651484|NCT00654381|587443260|FG003|2nd Stage|Adverse Event|3|||
162651485|NCT00654381|587443261|FG004|2nd Stage|Adverse Event|7|||
162651486|NCT00654381|587443262|FG005|2nd Stage|Adverse Event|2|||
162651487|NCT00654381|587443257|FG000|2nd Stage|Withdrawal by Subject|0|||
162651488|NCT00654381|587443258|FG001|2nd Stage|Withdrawal by Subject|0|||
162651489|NCT00654381|587443259|FG002|2nd Stage|Withdrawal by Subject|0|||
162651490|NCT00654381|587443260|FG003|2nd Stage|Withdrawal by Subject|0|||
162651491|NCT00654381|587443261|FG004|2nd Stage|Withdrawal by Subject|1|||
162651492|NCT00654381|587443262|FG005|2nd Stage|Withdrawal by Subject|1|||
162651493|NCT00654381|587443257|FG000|2nd Stage|Investigator's decision|0|||
162651494|NCT00654381|587443258|FG001|2nd Stage|Investigator's decision|0|||
162651495|NCT00654381|587443259|FG002|2nd Stage|Investigator's decision|1|||
162651496|NCT00654381|587443260|FG003|2nd Stage|Investigator's decision|1|||
162651497|NCT00654381|587443261|FG004|2nd Stage|Investigator's decision|0|||
162651498|NCT00654381|587443262|FG005|2nd Stage|Investigator's decision|0|||
162651499|NCT00654381|587443257|FG000|Extension Stage|Adverse Event|1|||
162651500|NCT00654381|587443258|FG001|Extension Stage|Adverse Event|2|||
162651501|NCT00654381|587443259|FG002|Extension Stage|Adverse Event|9|||
162651502|NCT00654381|587443260|FG003|Extension Stage|Adverse Event|7|||
162651503|NCT00654381|587443261|FG004|Extension Stage|Adverse Event|1|||
162651504|NCT00654381|587443262|FG005|Extension Stage|Adverse Event|1|||
162651505|NCT00654381|587443257|FG000|Extension Stage|Protocol Violation|0|||
162651506|NCT00654381|587443258|FG001|Extension Stage|Protocol Violation|0|||
162651507|NCT00654381|587443259|FG002|Extension Stage|Protocol Violation|0|||
162651508|NCT00654381|587443260|FG003|Extension Stage|Protocol Violation|1|||
162651509|NCT00654381|587443261|FG004|Extension Stage|Protocol Violation|0|||
162651510|NCT00654381|587443262|FG005|Extension Stage|Protocol Violation|0|||
162651511|NCT00654381|587443257|FG000|Extension Stage|Lack of Efficacy|0|||
162651512|NCT00654381|587443258|FG001|Extension Stage|Lack of Efficacy|0|||
162651513|NCT00654381|587443259|FG002|Extension Stage|Lack of Efficacy|1|||
162651514|NCT00654381|587443260|FG003|Extension Stage|Lack of Efficacy|0|||
162651515|NCT00654381|587443261|FG004|Extension Stage|Lack of Efficacy|0|||
162651516|NCT00654381|587443262|FG005|Extension Stage|Lack of Efficacy|0|||
162651517|NCT00654381|587443257|FG000|Extension Stage|Withdrawal by Subject|0|||
162651518|NCT00654381|587443258|FG001|Extension Stage|Withdrawal by Subject|0|||
162651519|NCT00654381|587443259|FG002|Extension Stage|Withdrawal by Subject|1|||
162651520|NCT00654381|587443260|FG003|Extension Stage|Withdrawal by Subject|1|||
162651521|NCT00654381|587443261|FG004|Extension Stage|Withdrawal by Subject|1|||
162651522|NCT00654381|587443262|FG005|Extension Stage|Withdrawal by Subject|1|||
162651523|NCT00654381|587443257|FG000|Extension Stage|Closure of the trial site|0|||
162651524|NCT00654381|587443258|FG001|Extension Stage|Closure of the trial site|0|||
162651525|NCT00654381|587443259|FG002|Extension Stage|Closure of the trial site|0|||
162651526|NCT00654381|587443260|FG003|Extension Stage|Closure of the trial site|0|||
162651527|NCT00654381|587443261|FG004|Extension Stage|Closure of the trial site|1|||
162651528|NCT00654381|587443262|FG005|Extension Stage|Closure of the trial site|1|||
162651529|NCT05040152|587443268|FG000|Overall Study|Withdrawal by Subject|5|||
162651530|NCT05040152|587443269|FG001|Overall Study|Withdrawal by Subject|0|||
162651531|NCT05040152|587443268|FG000|Overall Study|Lost to Follow-up|0|||
162651532|NCT05040152|587443269|FG001|Overall Study|Lost to Follow-up|2|||
162651533|NCT00006489|587443271|FG000|Overall Study|Adverse Event|3|||
162651534|NCT00006489|587443272|FG001|Overall Study|Adverse Event|2|||
162651535|NCT00006489|587443273|FG002|Overall Study|Adverse Event|4|||
162651536|NCT00006489|587443274|FG003|Overall Study|Adverse Event|3|||
163039062|NCT02732327|588850656|FG000|Overall Study|Protocol Violation|0|||
163039063|NCT02732327|588850657|FG001|Overall Study|Protocol Violation|1|||
162651537|NCT00006489|587443271|FG000|Overall Study|Withdrawal by Subject|10|||
162651538|NCT00006489|587443272|FG001|Overall Study|Withdrawal by Subject|9|||
162719009|NCT02341625|587676743|FG006|Overall Study|Participant Withdrew Consent|0|||
162719010|NCT02341625|587676744|FG007|Overall Study|Participant Withdrew Consent|0|||
162719011|NCT02341625|587676745|FG008|Overall Study|Participant Withdrew Consent|0|||
162719012|NCT02341625|587676746|FG009|Overall Study|Participant Withdrew Consent|0|||
162651539|NCT00006489|587443273|FG002|Overall Study|Withdrawal by Subject|9|||
162651540|NCT00006489|587443274|FG003|Overall Study|Withdrawal by Subject|6|||
162651541|NCT00006489|587443271|FG000|Overall Study|Scheduling Conflict|0|||
162651542|NCT00006489|587443272|FG001|Overall Study|Scheduling Conflict|3|||
162651543|NCT00006489|587443273|FG002|Overall Study|Scheduling Conflict|2|||
162651544|NCT00006489|587443274|FG003|Overall Study|Scheduling Conflict|1|||
162651545|NCT00006489|587443271|FG000|Overall Study|Death|0|||
162651546|NCT00006489|587443272|FG001|Overall Study|Death|0|||
163039064|NCT00603382|588850658|FG000|Overall Study|Adverse Event|0|||
162651547|NCT00006489|587443273|FG002|Overall Study|Death|0|||
163092300|NCT01508910|589048524|FG000|Treatment|Withdrawal by Subject|0|||
163092301|NCT01508910|589048525|FG001|Treatment|Withdrawal by Subject|1|||
163092302|NCT01508910|589048526|FG002|Treatment|Withdrawal by Subject|6|||
163092303|NCT01508910|589048527|FG003|Treatment|Withdrawal by Subject|1|||
163092304|NCT01508910|589048524|FG000|Treatment|Sponsor Decision|0|||
163092305|NCT01508910|589048525|FG001|Treatment|Sponsor Decision|0|||
163092306|NCT01508910|589048526|FG002|Treatment|Sponsor Decision|0|||
163092307|NCT01508910|589048527|FG003|Treatment|Sponsor Decision|1|||
163092308|NCT01595529|589048528|FG000|Overall Study|Adverse Event|2|||
163092309|NCT01595529|589048529|FG001|Overall Study|Adverse Event|0|||
163092310|NCT01595529|589048528|FG000|Overall Study|Subject Non-Compliant|2|||
162651548|NCT00006489|587443274|FG003|Overall Study|Death|1|||
162651549|NCT00578175|587443275|FG000|Overall Study|Adverse Event|0|||
162651550|NCT00578175|587443276|FG001|Overall Study|Adverse Event|1|||
162651551|NCT00578175|587443277|FG002|Overall Study|Adverse Event|1|||
162651552|NCT00578175|587443275|FG000|Overall Study|Other reasons|70|||
162651553|NCT00578175|587443276|FG001|Overall Study|Other reasons|42|||
162651554|NCT00578175|587443277|FG002|Overall Study|Other reasons|23|||
162651555|NCT03029624|587443283|FG000|Overall Study|Adverse Event|1|||
162651556|NCT03029624|587443283|FG000|Overall Study|Withdrawal by Subject|1|||
162651557|NCT03029624|587443283|FG000|Overall Study|Lack of Efficacy|1|||
162651558|NCT03029624|587443283|FG000|Overall Study|MRI need|2|||
162651559|NCT00974571|587443285|FG000|Overall Study|Adverse Event|31|||
162651560|NCT00974571|587443286|FG001|Overall Study|Adverse Event|4|||
162651561|NCT00974571|587443287|FG002|Overall Study|Adverse Event|27|||
162651562|NCT00974571|587443285|FG000|Overall Study|Lack of Efficacy|3|||
162651563|NCT00974571|587443286|FG001|Overall Study|Lack of Efficacy|2|||
162651564|NCT00974571|587443287|FG002|Overall Study|Lack of Efficacy|9|||
162651565|NCT00974571|587443285|FG000|Overall Study|Lost to Follow-up|2|||
162651566|NCT00974571|587443286|FG001|Overall Study|Lost to Follow-up|1|||
162651567|NCT00974571|587443287|FG002|Overall Study|Lost to Follow-up|2|||
162651568|NCT00974571|587443285|FG000|Overall Study|Protocol Violation|13|||
162651569|NCT00974571|587443286|FG001|Overall Study|Protocol Violation|4|||
162651570|NCT00974571|587443287|FG002|Overall Study|Protocol Violation|18|||
162651571|NCT00974571|587443285|FG000|Overall Study|Withdrawal by Subject|14|||
162651572|NCT00974571|587443286|FG001|Overall Study|Withdrawal by Subject|5|||
162651573|NCT00974571|587443287|FG002|Overall Study|Withdrawal by Subject|16|||
162651574|NCT00974571|587443285|FG000|Overall Study|Patient Moved|1|||
163092311|NCT01595529|589048529|FG001|Overall Study|Subject Non-Compliant|0|||
163092312|NCT01595529|589048528|FG000|Overall Study|Lost to Follow-up|8|||
163092313|NCT01595529|589048529|FG001|Overall Study|Lost to Follow-up|14|||
162651575|NCT00974571|587443286|FG001|Overall Study|Patient Moved|0|||
162651576|NCT00974571|587443287|FG002|Overall Study|Patient Moved|1|||
162651577|NCT00974571|587443285|FG000|Overall Study|Other|4|||
162651578|NCT00974571|587443286|FG001|Overall Study|Other|0|||
162651579|NCT00974571|587443287|FG002|Overall Study|Other|10|||
162651580|NCT01371656|587443288|FG000|Overall Study|Death|7|||
162651581|NCT01371656|587443289|FG001|Overall Study|Death|4|||
163092314|NCT01595529|589048528|FG000|Overall Study|Protocol Violation|1|||
163092315|NCT01595529|589048529|FG001|Overall Study|Protocol Violation|2|||
163092316|NCT01595529|589048528|FG000|Overall Study|Physician Decision|1|||
163092317|NCT01595529|589048529|FG001|Overall Study|Physician Decision|0|||
163092318|NCT01595529|589048528|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
163092319|NCT01595529|589048529|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
163092320|NCT01595529|589048528|FG000|Overall Study|Administrative Decision|1|||
163092321|NCT01595529|589048529|FG001|Overall Study|Administrative Decision|0|||
163092322|NCT01595529|589048528|FG000|Overall Study|Entry Failure/Screening Failure|6|||
162651582|NCT01371656|587443288|FG000|Overall Study|Physician Decision|46|||
162651583|NCT01371656|587443289|FG001|Overall Study|Physician Decision|7|||
162651584|NCT01371656|587443288|FG000|Overall Study|Withdrawal by Subject|7|||
162651585|NCT01371656|587443289|FG001|Overall Study|Withdrawal by Subject|0|||
162651586|NCT01371656|587443288|FG000|Overall Study|Ineligible|4|||
162719013|NCT02341625|587676737|FG000|Overall Study|Completed Treatment as per Protocol|0|||
163092323|NCT01595529|589048529|FG001|Overall Study|Entry Failure/Screening Failure|1|||
163092324|NCT04016714|589048530|FG000|Overall Study|Death|1|||
163092325|NCT04016714|589048531|FG001|Overall Study|Death|0|||
162651587|NCT01371656|587443289|FG001|Overall Study|Ineligible|3|||
162651588|NCT04334460|587443302|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
162651589|NCT04334460|587443303|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
162651590|NCT04334460|587443302|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
162651591|NCT04334460|587443303|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
163092326|NCT04016714|589048530|FG000|Overall Study|Lost to Follow-up|3|||
163092327|NCT04016714|589048531|FG001|Overall Study|Lost to Follow-up|1|||
163092328|NCT04016714|589048530|FG000|Overall Study|Physician Decision|3|||
163092329|NCT04016714|589048531|FG001|Overall Study|Physician Decision|3|||
163092330|NCT04016714|589048530|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
163092331|NCT04016714|589048531|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
162651592|NCT03778931|587443304|FG000|Overall Study|Withdrawal by Subject|12|||
162651593|NCT03778931|587443305|FG001|Overall Study|Withdrawal by Subject|25|||
162651594|NCT03778931|587443304|FG000|Overall Study|Physician Decision|1|||
162651595|NCT03778931|587443305|FG001|Overall Study|Physician Decision|3|||
162651596|NCT03778931|587443304|FG000|Overall Study|Participant Noncompliance|1|||
162651597|NCT03778931|587443305|FG001|Overall Study|Participant Noncompliance|1|||
162651598|NCT03778931|587443304|FG000|Overall Study|Lost to Follow-up|4|||
162651599|NCT03778931|587443305|FG001|Overall Study|Lost to Follow-up|1|||
162651600|NCT03778931|587443304|FG000|Overall Study|Death|69|||
163039065|NCT00603382|588850659|FG001|Overall Study|Adverse Event|1|||
163039066|NCT00603382|588850660|FG002|Overall Study|Adverse Event|1|||
163039067|NCT00603382|588850661|FG003|Overall Study|Adverse Event|2|||
163039068|NCT00603382|588850662|FG004|Overall Study|Adverse Event|1|||
163039069|NCT00603382|588850663|FG005|Overall Study|Adverse Event|2|||
163039070|NCT00603382|588850658|FG000|Overall Study|Lack of Efficacy|14|||
163039071|NCT00603382|588850659|FG001|Overall Study|Lack of Efficacy|9|||
163039072|NCT00603382|588850660|FG002|Overall Study|Lack of Efficacy|3|||
163039073|NCT00603382|588850661|FG003|Overall Study|Lack of Efficacy|6|||
163039074|NCT00603382|588850662|FG004|Overall Study|Lack of Efficacy|6|||
163039075|NCT00603382|588850663|FG005|Overall Study|Lack of Efficacy|11|||
163039076|NCT00603382|588850658|FG000|Overall Study|Protocol Violation|1|||
163039077|NCT00603382|588850659|FG001|Overall Study|Protocol Violation|0|||
163039078|NCT00603382|588850660|FG002|Overall Study|Protocol Violation|1|||
163039079|NCT00603382|588850661|FG003|Overall Study|Protocol Violation|2|||
163039080|NCT00603382|588850662|FG004|Overall Study|Protocol Violation|1|||
163039081|NCT00603382|588850663|FG005|Overall Study|Protocol Violation|0|||
163039082|NCT00603382|588850658|FG000|Overall Study|Lost to Follow-up|0|||
163039083|NCT00603382|588850659|FG001|Overall Study|Lost to Follow-up|1|||
163039084|NCT00603382|588850660|FG002|Overall Study|Lost to Follow-up|1|||
163039085|NCT00603382|588850661|FG003|Overall Study|Lost to Follow-up|1|||
163039086|NCT00603382|588850662|FG004|Overall Study|Lost to Follow-up|0|||
163039087|NCT00603382|588850663|FG005|Overall Study|Lost to Follow-up|1|||
163039088|NCT00603382|588850658|FG000|Overall Study|Physician Decision|0|||
163039089|NCT00603382|588850659|FG001|Overall Study|Physician Decision|0|||
163039090|NCT00603382|588850660|FG002|Overall Study|Physician Decision|2|||
163039091|NCT00603382|588850661|FG003|Overall Study|Physician Decision|0|||
163039092|NCT00603382|588850662|FG004|Overall Study|Physician Decision|1|||
163039093|NCT00603382|588850663|FG005|Overall Study|Physician Decision|3|||
163039094|NCT00603382|588850658|FG000|Overall Study|Withdrawal by Subject|3|||
163039095|NCT00603382|588850659|FG001|Overall Study|Withdrawal by Subject|3|||
163039096|NCT00603382|588850660|FG002|Overall Study|Withdrawal by Subject|1|||
163039097|NCT00603382|588850661|FG003|Overall Study|Withdrawal by Subject|1|||
163039098|NCT00603382|588850662|FG004|Overall Study|Withdrawal by Subject|0|||
163039099|NCT00603382|588850663|FG005|Overall Study|Withdrawal by Subject|1|||
163039100|NCT00583102|588850664|FG000|Overall Study|Adverse Event|3|||
163039101|NCT01078298|588850669|FG000|Overall Study|Lost to Follow-up|12|||
163039102|NCT01078298|588850670|FG001|Overall Study|Lost to Follow-up|13|||
163039103|NCT01078298|588850669|FG000|Overall Study|Withdrawal by Subject|31|||
163039104|NCT01078298|588850670|FG001|Overall Study|Withdrawal by Subject|33|||
163039105|NCT01078298|588850669|FG000|Overall Study|Protocol Violation|6|||
163039106|NCT01078298|588850670|FG001|Overall Study|Protocol Violation|6|||
163039107|NCT01078298|588850669|FG000|Overall Study|Adverse Event|6|||
163039108|NCT01078298|588850670|FG001|Overall Study|Adverse Event|5|||
163039109|NCT01078298|588850669|FG000|Overall Study|Death|2|||
163039110|NCT01078298|588850670|FG001|Overall Study|Death|0|||
163039111|NCT01078298|588850669|FG000|Overall Study|Did not meet entrance criteria|0|||
163039112|NCT01078298|588850670|FG001|Overall Study|Did not meet entrance criteria|1|||
163039113|NCT01078298|588850669|FG000|Overall Study|Other|24|||
163039114|NCT01078298|588850670|FG001|Overall Study|Other|32|||
163039115|NCT00628927|588850671|FG000|Overall Study|Problems performing blood draw|6|||
163039116|NCT00628927|588850672|FG001|Overall Study|Problems performing blood draw|0|||
163039117|NCT00628927|588850671|FG000|Overall Study|Lost to Follow-up|1|||
163039118|NCT00628927|588850672|FG001|Overall Study|Lost to Follow-up|0|||
163039119|NCT00628927|588850671|FG000|Overall Study|Equipment failure|1|||
163039120|NCT00628927|588850672|FG001|Overall Study|Equipment failure|0|||
163039121|NCT01298141|588850676|FG000|Overall Study|Adverse Event|3|||
163039122|NCT01298141|588850676|FG000|Overall Study|Refusal of Required Study Procedures|1|||
163039123|NCT01298141|588850676|FG000|Overall Study|Withdrawal by Subject|6|||
163039124|NCT01298141|588850676|FG000|Overall Study|Termination of Study by the Investigator|5|||
163039125|NCT01298141|588850676|FG000|Overall Study|Other|5|||
163039126|NCT01298141|588850676|FG000|Overall Study|Lost to Follow-up|1|||
162651601|NCT03778931|587443305|FG001|Overall Study|Death|79|||
163039127|NCT01298141|588850676|FG000|Overall Study|Death|6|||
163039128|NCT01298141|588850676|FG000|Overall Study|Not treated|4|||
163039129|NCT03338569|588850677|FG000|Overall Study|Physician Decision|8|||
163039130|NCT03338569|588850678|FG001|Overall Study|Physician Decision|3|||
163039131|NCT03338569|588850677|FG000|Overall Study|Withdrawal by Subject|0|||
163039132|NCT03338569|588850678|FG001|Overall Study|Withdrawal by Subject|1|||
163039133|NCT03338569|588850677|FG000|Overall Study|Lost to Follow-up|0|||
163039134|NCT03338569|588850678|FG001|Overall Study|Lost to Follow-up|1|||
163092332|NCT01822665|589048532|FG000|Overall Study|Adverse Event|3|||
163092333|NCT01822665|589048532|FG000|Overall Study|Other Reason|5|||
163092334|NCT00867035|589048533|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
163092335|NCT00867035|589048534|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
163092336|NCT00867035|589048533|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
163092337|NCT00867035|589048534|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
163092338|NCT04592341|589050508|FG000|Overall Study|Physician Decision|5|||
163092339|NCT04592341|589050508|FG000|Overall Study|Study Terminated by Sponsor|5|||
163092340|NCT04592341|589050508|FG000|Overall Study|Withdrawal by Subject|53|||
163092341|NCT04592341|589050508|FG000|Overall Study|Lost to Follow-up|3|||
163092342|NCT04592341|589050508|FG000|Overall Study|Death|1|||
163092343|NCT04592341|589050508|FG000|Overall Study|Adverse Event|5|||
163092344|NCT04592341|589050508|FG000|Overall Study|other|4|||
163092345|NCT01747915|589050509|FG000|Overall Study|Other|1|||
163092346|NCT01747915|589050510|FG001|Overall Study|Other|1|||
163092347|NCT01747915|589050511|FG002|Overall Study|Other|1|||
163092348|NCT01747915|589050509|FG000|Overall Study|Adverse Event|8|||
163092349|NCT01747915|589050510|FG001|Overall Study|Adverse Event|5|||
163092350|NCT01747915|589050511|FG002|Overall Study|Adverse Event|2|||
163092351|NCT01747915|589050509|FG000|Overall Study|Death|0|||
163092352|NCT01747915|589050510|FG001|Overall Study|Death|0|||
163092353|NCT01747915|589050511|FG002|Overall Study|Death|1|||
163092354|NCT01747915|589050509|FG000|Overall Study|Lack of Efficacy|0|||
163092355|NCT01747915|589050510|FG001|Overall Study|Lack of Efficacy|1|||
163092356|NCT01747915|589050511|FG002|Overall Study|Lack of Efficacy|0|||
163092357|NCT01747915|589050509|FG000|Overall Study|Lost to Follow-up|1|||
163092358|NCT01747915|589050510|FG001|Overall Study|Lost to Follow-up|0|||
163092359|NCT01747915|589050511|FG002|Overall Study|Lost to Follow-up|0|||
163092360|NCT01747915|589050509|FG000|Overall Study|Withdrawal by Subject|4|||
163092361|NCT01747915|589050510|FG001|Overall Study|Withdrawal by Subject|4|||
163092362|NCT01747915|589050511|FG002|Overall Study|Withdrawal by Subject|1|||
163092363|NCT01747915|589050509|FG000|Overall Study|Protocol Violation|1|||
163092364|NCT01747915|589050510|FG001|Overall Study|Protocol Violation|0|||
163092365|NCT01747915|589050511|FG002|Overall Study|Protocol Violation|0|||
163092366|NCT01747915|589050509|FG000|Overall Study|Pregnancy|0|||
163092367|NCT01747915|589050510|FG001|Overall Study|Pregnancy|0|||
163092368|NCT01747915|589050511|FG002|Overall Study|Pregnancy|1|||
163092369|NCT06164691|589050517|FG000|Overall Study|Withdrawal by Subject|2|||
163092370|NCT06164691|589050518|FG001|Overall Study|Withdrawal by Subject|0|||
163092371|NCT06164691|589050519|FG002|Overall Study|Withdrawal by Subject|0|||
163092372|NCT00812955|589050520|FG000|Overall Study|Adverse Event|7|||
163092373|NCT00812955|589050521|FG001|Overall Study|Adverse Event|6|||
163092374|NCT00812955|589050522|FG002|Overall Study|Adverse Event|3|||
163092375|NCT00812955|589050523|FG003|Overall Study|Adverse Event|4|||
163092376|NCT00812955|589050520|FG000|Overall Study|Lost to Follow-up|2|||
163092377|NCT00812955|589050521|FG001|Overall Study|Lost to Follow-up|1|||
163092378|NCT00812955|589050522|FG002|Overall Study|Lost to Follow-up|1|||
163092379|NCT00812955|589050523|FG003|Overall Study|Lost to Follow-up|2|||
163092380|NCT00812955|589050520|FG000|Overall Study|Withdrawal by Subject|1|||
163092381|NCT00812955|589050521|FG001|Overall Study|Withdrawal by Subject|0|||
163092382|NCT00812955|589050522|FG002|Overall Study|Withdrawal by Subject|1|||
163092383|NCT00812955|589050523|FG003|Overall Study|Withdrawal by Subject|2|||
163092384|NCT00812955|589050520|FG000|Overall Study|randomized in error|0|||
163092385|NCT00812955|589050521|FG001|Overall Study|randomized in error|0|||
163092386|NCT00812955|589050522|FG002|Overall Study|randomized in error|1|||
163092387|NCT00812955|589050523|FG003|Overall Study|randomized in error|0|||
163092388|NCT03046446|589050524|FG000|Overall Study|Lack of Efficacy|7|||
163039135|NCT00350779|588850679|FG000|Overall Study|Adverse Event|4|||
163039136|NCT00350779|588850680|FG001|Overall Study|Adverse Event|2|||
163039137|NCT00350779|588850679|FG000|Overall Study|Lack of Efficacy|0|||
163039138|NCT00350779|588850680|FG001|Overall Study|Lack of Efficacy|4|||
163039139|NCT00350779|588850679|FG000|Overall Study|Lost to Follow-up|2|||
163039140|NCT00350779|588850680|FG001|Overall Study|Lost to Follow-up|0|||
163039141|NCT00350779|588850679|FG000|Overall Study|Physician Decision|2|||
163092389|NCT03046446|589050524|FG000|Overall Study|Adverse Event|6|||
163092390|NCT03046446|589050524|FG000|Overall Study|Lost to Follow-up|3|||
163092391|NCT03046446|589050524|FG000|Overall Study|Withdrawal by Subject|14|||
163092392|NCT03046446|589050524|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
163092393|NCT03046446|589050524|FG000|Overall Study|Disease Progression (see caveats)|25|||
163092394|NCT03046446|589050524|FG000|Overall Study|Non OA related knee surgery|1|||
163092395|NCT03183063|589050525|FG000|Overall Study|Withdrawal by Subject|2|||
163039142|NCT00350779|588850680|FG001|Overall Study|Physician Decision|4|||
163039143|NCT00350779|588850679|FG000|Overall Study|Protocol Violation|3|||
163092396|NCT03183063|589050526|FG001|Overall Study|Withdrawal by Subject|0|||
163092397|NCT03183063|589050527|FG002|Overall Study|Withdrawal by Subject|0|||
163092398|NCT03183063|589050525|FG000|Overall Study|Physician Decision|3|||
163092399|NCT03183063|589050526|FG001|Overall Study|Physician Decision|4|||
163039144|NCT00350779|588850680|FG001|Overall Study|Protocol Violation|1|||
163092400|NCT03183063|589050527|FG002|Overall Study|Physician Decision|4|||
163092401|NCT00399568|589050528|FG000|Overall Study|Adverse Event|1|||
162651602|NCT00775437|587443306|FG000|Overall Study|Loss of efficacy|2|||
162651603|NCT00775437|587443306|FG000|Overall Study|Withdrawal by Subject|3|||
162651604|NCT00775437|587443306|FG000|Overall Study|Lost to Follow-up|1|||
162651605|NCT04180020|587443315|FG000|Overall Study|missed visit|18|||
162651606|NCT04180020|587443316|FG001|Overall Study|missed visit|16|||
162651607|NCT04180020|587443315|FG000|Overall Study|Death|2|||
162651608|NCT04180020|587443316|FG001|Overall Study|Death|3|||
162651609|NCT04180020|587443315|FG000|Overall Study|Withdrawal by Subject|1|||
162651610|NCT04180020|587443316|FG001|Overall Study|Withdrawal by Subject|5|||
162651611|NCT04180020|587443315|FG000|Overall Study|incarcerated|1|||
162651612|NCT04180020|587443316|FG001|Overall Study|incarcerated|1|||
162651613|NCT04180020|587443315|FG000|Overall Study|Physician Decision|0|||
162651614|NCT04180020|587443316|FG001|Overall Study|Physician Decision|2|||
162651615|NCT03216850|587443321|FG000|Overall Study|Pre-analytical error|6|||
162651616|NCT02357940|587443324|FG000|Overall Study|Adverse Event|0|||
162651617|NCT02357940|587443325|FG001|Overall Study|Adverse Event|1|||
162651618|NCT02357940|587443324|FG000|Overall Study|Investigator's judgement|0|||
162651619|NCT02357940|587443325|FG001|Overall Study|Investigator's judgement|1|||
162651620|NCT02442778|587443326|FG000|Overall Study|Adverse Event|2|||
162651621|NCT02442778|587443327|FG001|Overall Study|Adverse Event|6|||
162651622|NCT02442778|587443328|FG002|Overall Study|Adverse Event|6|||
162651623|NCT02442778|587443326|FG000|Overall Study|Death|0|||
162651624|NCT02442778|587443327|FG001|Overall Study|Death|2|||
162651625|NCT02442778|587443328|FG002|Overall Study|Death|0|||
162651626|NCT02442778|587443326|FG000|Overall Study|Lack of Efficacy|1|||
162651627|NCT02442778|587443327|FG001|Overall Study|Lack of Efficacy|0|||
162651628|NCT02442778|587443328|FG002|Overall Study|Lack of Efficacy|0|||
162651629|NCT02442778|587443326|FG000|Overall Study|Lost to Follow-up|1|||
162651630|NCT02442778|587443327|FG001|Overall Study|Lost to Follow-up|1|||
162651631|NCT02442778|587443328|FG002|Overall Study|Lost to Follow-up|1|||
162651632|NCT02442778|587443326|FG000|Overall Study|Non-compliance with study drug|2|||
162651633|NCT02442778|587443327|FG001|Overall Study|Non-compliance with study drug|0|||
162651634|NCT02442778|587443328|FG002|Overall Study|Non-compliance with study drug|1|||
162651635|NCT02442778|587443326|FG000|Overall Study|Physician Decision|1|||
162651636|NCT02442778|587443327|FG001|Overall Study|Physician Decision|1|||
162651637|NCT02442778|587443328|FG002|Overall Study|Physician Decision|1|||
162651638|NCT02442778|587443326|FG000|Overall Study|Protocol Deviation|3|||
162651639|NCT02442778|587443327|FG001|Overall Study|Protocol Deviation|0|||
162651640|NCT02442778|587443328|FG002|Overall Study|Protocol Deviation|1|||
162651641|NCT02442778|587443326|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
162651642|NCT02442778|587443327|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
162651643|NCT02442778|587443328|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
162651644|NCT02442778|587443326|FG000|Overall Study|Withdrawal by Subject|4|||
162651645|NCT02442778|587443327|FG001|Overall Study|Withdrawal by Subject|4|||
162651646|NCT02442778|587443328|FG002|Overall Study|Withdrawal by Subject|3|||
162651647|NCT02442778|587443326|FG000|Overall Study|Reason not specified|1|||
162651648|NCT02442778|587443327|FG001|Overall Study|Reason not specified|4|||
163092402|NCT00399568|589050529|FG001|Overall Study|Adverse Event|2|||
163092403|NCT00399568|589050528|FG000|Overall Study|Withdrawal by Subject|7|||
163092404|NCT00399568|589050529|FG001|Overall Study|Withdrawal by Subject|3|||
163092405|NCT00399568|589050528|FG000|Overall Study|Protocol non-compliance|2|||
163092406|NCT00399568|589050529|FG001|Overall Study|Protocol non-compliance|2|||
163092407|NCT00399568|589050528|FG000|Overall Study|Lost to Follow-up|2|||
163092408|NCT00399568|589050529|FG001|Overall Study|Lost to Follow-up|2|||
163092409|NCT00925002|589050530|FG000|Overall Study|Other|1|||
163092410|NCT00925002|589050531|FG001|Overall Study|Other|4|||
163092411|NCT00925002|589050532|FG002|Overall Study|Other|0|||
163092412|NCT00925002|589050530|FG000|Overall Study|Death|1|||
163092413|NCT00925002|589050531|FG001|Overall Study|Death|1|||
163092414|NCT00925002|589050532|FG002|Overall Study|Death|5|||
162651649|NCT02442778|587443328|FG002|Overall Study|Reason not specified|0|||
162651650|NCT02641379|587443331|FG000|Overall Study|Exclusion criterion during screening|1|||
162651651|NCT02641379|587443332|FG001|Overall Study|Exclusion criterion during screening|0|||
162651652|NCT02641379|587443333|FG002|Overall Study|Exclusion criterion during screening|0|||
162651653|NCT02641379|587443334|FG003|Overall Study|Exclusion criterion during screening|1|||
162651654|NCT02641379|587443335|FG004|Overall Study|Exclusion criterion during screening|2|||
162651655|NCT02641379|587443336|FG005|Overall Study|Exclusion criterion during screening|0|||
162651656|NCT02641379|587443337|FG006|Overall Study|Exclusion criterion during screening|0|||
162651657|NCT02641379|587443338|FG007|Overall Study|Exclusion criterion during screening|0|||
162651658|NCT02641379|587443339|FG008|Overall Study|Exclusion criterion during screening|0|||
162651659|NCT02641379|587443340|FG009|Overall Study|Exclusion criterion during screening|0|||
162651660|NCT02641379|587443341|FG010|Overall Study|Exclusion criterion during screening|0|||
162651661|NCT02641379|587443331|FG000|Overall Study|Withdrawal of informed consent|0|||
163092415|NCT00925002|589050530|FG000|Overall Study|Adverse Event|3|||
163092416|NCT00925002|589050531|FG001|Overall Study|Adverse Event|1|||
163092417|NCT00925002|589050532|FG002|Overall Study|Adverse Event|2|||
163092418|NCT00925002|589050530|FG000|Overall Study|Participant withdrew consent|1|||
163092419|NCT00925002|589050531|FG001|Overall Study|Participant withdrew consent|3|||
163092420|NCT00925002|589050532|FG002|Overall Study|Participant withdrew consent|3|||
163092421|NCT01343888|589050535|FG000|Overall Study|Adverse Event|12|||
163092422|NCT01343888|589050536|FG001|Overall Study|Adverse Event|22|||
163092423|NCT01343888|589050537|FG002|Overall Study|Adverse Event|5|||
163092424|NCT01343888|589050535|FG000|Overall Study|Lack of Efficacy|9|||
163092425|NCT01343888|589050536|FG001|Overall Study|Lack of Efficacy|9|||
163092426|NCT01343888|589050537|FG002|Overall Study|Lack of Efficacy|13|||
163092427|NCT01343888|589050535|FG000|Overall Study|Lost to Follow-up|0|||
163092428|NCT01343888|589050536|FG001|Overall Study|Lost to Follow-up|2|||
163092429|NCT01343888|589050537|FG002|Overall Study|Lost to Follow-up|1|||
163092430|NCT01343888|589050535|FG000|Overall Study|Protocol Violation|0|||
163092431|NCT01343888|589050536|FG001|Overall Study|Protocol Violation|2|||
163092432|NCT01343888|589050537|FG002|Overall Study|Protocol Violation|0|||
163092433|NCT01343888|589050535|FG000|Overall Study|Withdrawal by Subject|4|||
163092434|NCT01343888|589050536|FG001|Overall Study|Withdrawal by Subject|4|||
163092435|NCT01343888|589050537|FG002|Overall Study|Withdrawal by Subject|2|||
163092436|NCT01343888|589050535|FG000|Overall Study|other than stated above|0|||
163092437|NCT01343888|589050536|FG001|Overall Study|other than stated above|0|||
163092438|NCT01343888|589050537|FG002|Overall Study|other than stated above|1|||
163092439|NCT00558636|589050538|FG000|Treatment|Adverse Event|9|||
163092440|NCT00558636|589050539|FG001|Treatment|Adverse Event|2|||
163092441|NCT00558636|589050538|FG000|Treatment|Withdrawal by Subject|2|||
163092442|NCT00558636|589050539|FG001|Treatment|Withdrawal by Subject|0|||
163092443|NCT00558636|589050538|FG000|Treatment|Premature termination of the study|35|||
163092444|NCT00558636|589050539|FG001|Treatment|Premature termination of the study|37|||
163092445|NCT00558636|589050538|FG000|Treatment|Disease progression|1|||
163092446|NCT00558636|589050539|FG001|Treatment|Disease progression|5|||
163092447|NCT00558636|589050538|FG000|Follow-up|Premature termination of the study|12|||
163092448|NCT00558636|589050539|FG001|Follow-up|Premature termination of the study|7|||
163092449|NCT01990742|589050540|FG000|Overall Study|Withdrawal by facility|407|||
163092450|NCT01990742|589050541|FG001|Overall Study|Withdrawal by facility|1083|||
163092451|NCT01990742|589050540|FG000|Overall Study|Facility closed|0|||
163092452|NCT01990742|589050541|FG001|Overall Study|Facility closed|270|||
163092453|NCT00800735|589050542|FG000|Overall Study|Administrative/Other|2|||
163092454|NCT00800735|589050542|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163092455|NCT00800735|589050542|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
163092456|NCT00800735|589050542|FG000|Overall Study|Withdrew Consent|3|||
163092457|NCT00506142|589050543|FG000|Overall Study|Adverse Event|8|||
163092458|NCT00506142|589050544|FG001|Overall Study|Adverse Event|7|||
163092459|NCT00506142|589050543|FG000|Overall Study|Lack of Efficacy|21|||
163092460|NCT00506142|589050544|FG001|Overall Study|Lack of Efficacy|7|||
163092461|NCT00506142|589050543|FG000|Overall Study|Withdrawal by Subject|4|||
163092462|NCT00506142|589050544|FG001|Overall Study|Withdrawal by Subject|5|||
163092463|NCT00506142|589050543|FG000|Overall Study|Physician Decision|1|||
163092464|NCT00506142|589050544|FG001|Overall Study|Physician Decision|0|||
163092465|NCT00506142|589050543|FG000|Overall Study|New health condition|1|||
163092466|NCT00506142|589050544|FG001|Overall Study|New health condition|0|||
162651662|NCT02641379|587443332|FG001|Overall Study|Withdrawal of informed consent|1|||
162651663|NCT02641379|587443333|FG002|Overall Study|Withdrawal of informed consent|0|||
162651664|NCT02641379|587443334|FG003|Overall Study|Withdrawal of informed consent|0|||
162651665|NCT02641379|587443335|FG004|Overall Study|Withdrawal of informed consent|0|||
163092467|NCT02133573|589050550|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
163092468|NCT02133573|589050551|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
163092469|NCT02133573|589050550|FG000|Overall Study|Child Deaths|3|||
163092470|NCT02133573|589050551|FG001|Overall Study|Child Deaths|5|||
163092471|NCT02133573|589050550|FG000|Overall Study|Child Declined Follow Ups|2|||
163092472|NCT02133573|589050551|FG001|Overall Study|Child Declined Follow Ups|1|||
163092473|NCT02133573|589050550|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
163092474|NCT02133573|589050551|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
163092475|NCT03273907|589050558|FG000|Overall Study|Death|1|||
163092476|NCT03273907|589050558|FG000|Overall Study|Lost to Follow-up|4|||
162651666|NCT02641379|587443336|FG005|Overall Study|Withdrawal of informed consent|0|||
162651667|NCT02641379|587443337|FG006|Overall Study|Withdrawal of informed consent|0|||
163092477|NCT03273907|589050558|FG000|Overall Study|Withdrawal by Subject|2|||
163092478|NCT03273907|589050558|FG000|Overall Study|COVID 19|2|||
163092479|NCT00110214|589050559|FG000|Overall Study|Never started treatment|21|||
163092480|NCT00110214|589050560|FG001|Overall Study|Never started treatment|20|||
163092481|NCT00110214|589050559|FG000|Overall Study|Disease progression or death|260|||
163092482|NCT00110214|589050560|FG001|Overall Study|Disease progression or death|151|||
163092483|NCT00110214|589050559|FG000|Overall Study|Adverse Event|115|||
163092484|NCT00110214|589050560|FG001|Overall Study|Adverse Event|192|||
163092485|NCT00110214|589050559|FG000|Overall Study|Refused further treatment|52|||
163092486|NCT00110214|589050560|FG001|Overall Study|Refused further treatment|65|||
163092487|NCT00110214|589050559|FG000|Overall Study|Other (not specified)|61|||
163092488|NCT00110214|589050560|FG001|Overall Study|Other (not specified)|75|||
163092489|NCT01016067|589050561|FG000|Overall Study|Lost to Follow-up|1|||
163092490|NCT01016067|589050562|FG001|Overall Study|Lost to Follow-up|2|||
163092491|NCT01016067|589050561|FG000|Overall Study|Physician Decision|1|||
163092492|NCT01016067|589050562|FG001|Overall Study|Physician Decision|1|||
163092493|NCT01016067|589050561|FG000|Overall Study|Withdrew due to Relocation|0|||
163092494|NCT01016067|589050562|FG001|Overall Study|Withdrew due to Relocation|1|||
162651668|NCT02641379|587443338|FG007|Overall Study|Withdrawal of informed consent|1|||
162651669|NCT02641379|587443339|FG008|Overall Study|Withdrawal of informed consent|0|||
162651670|NCT02641379|587443340|FG009|Overall Study|Withdrawal of informed consent|0|||
162651671|NCT02641379|587443341|FG010|Overall Study|Withdrawal of informed consent|0|||
162651672|NCT02641379|587443331|FG000|Overall Study|Adverse Event|7|||
162651673|NCT02641379|587443332|FG001|Overall Study|Adverse Event|8|||
162651674|NCT02641379|587443333|FG002|Overall Study|Adverse Event|2|||
162651675|NCT02641379|587443334|FG003|Overall Study|Adverse Event|2|||
162651676|NCT02641379|587443335|FG004|Overall Study|Adverse Event|5|||
162651677|NCT02641379|587443336|FG005|Overall Study|Adverse Event|1|||
162651678|NCT02641379|587443337|FG006|Overall Study|Adverse Event|5|||
162651679|NCT02641379|587443338|FG007|Overall Study|Adverse Event|0|||
162651680|NCT02641379|587443339|FG008|Overall Study|Adverse Event|1|||
162651681|NCT02641379|587443340|FG009|Overall Study|Adverse Event|1|||
162651682|NCT02641379|587443341|FG010|Overall Study|Adverse Event|5|||
162651683|NCT02641379|587443331|FG000|Overall Study|Lack of Efficacy|0|||
162651684|NCT02641379|587443332|FG001|Overall Study|Lack of Efficacy|0|||
162651685|NCT02641379|587443333|FG002|Overall Study|Lack of Efficacy|2|||
162651686|NCT02641379|587443334|FG003|Overall Study|Lack of Efficacy|0|||
162651687|NCT02641379|587443335|FG004|Overall Study|Lack of Efficacy|0|||
162651688|NCT02641379|587443336|FG005|Overall Study|Lack of Efficacy|2|||
162651689|NCT02641379|587443337|FG006|Overall Study|Lack of Efficacy|0|||
162651690|NCT02641379|587443338|FG007|Overall Study|Lack of Efficacy|5|||
162651691|NCT02641379|587443339|FG008|Overall Study|Lack of Efficacy|0|||
162651692|NCT02641379|587443340|FG009|Overall Study|Lack of Efficacy|0|||
162651693|NCT02641379|587443341|FG010|Overall Study|Lack of Efficacy|0|||
162651694|NCT02641379|587443331|FG000|Overall Study|Participant unable to attend study visit|4|||
162651695|NCT02641379|587443332|FG001|Overall Study|Participant unable to attend study visit|10|||
162651696|NCT02641379|587443333|FG002|Overall Study|Participant unable to attend study visit|1|||
162651697|NCT02641379|587443334|FG003|Overall Study|Participant unable to attend study visit|2|||
162651698|NCT02641379|587443335|FG004|Overall Study|Participant unable to attend study visit|5|||
162651699|NCT02641379|587443336|FG005|Overall Study|Participant unable to attend study visit|1|||
162651700|NCT02641379|587443337|FG006|Overall Study|Participant unable to attend study visit|1|||
162651701|NCT02641379|587443338|FG007|Overall Study|Participant unable to attend study visit|1|||
162651702|NCT02641379|587443339|FG008|Overall Study|Participant unable to attend study visit|0|||
162651703|NCT02641379|587443340|FG009|Overall Study|Participant unable to attend study visit|2|||
162651704|NCT02641379|587443341|FG010|Overall Study|Participant unable to attend study visit|0|||
162651705|NCT02641379|587443331|FG000|Overall Study|Participant's compliance|0|||
162651706|NCT02641379|587443332|FG001|Overall Study|Participant's compliance|1|||
162651707|NCT02641379|587443333|FG002|Overall Study|Participant's compliance|0|||
162651708|NCT02641379|587443334|FG003|Overall Study|Participant's compliance|1|||
162651709|NCT02641379|587443335|FG004|Overall Study|Participant's compliance|0|||
162651710|NCT02641379|587443336|FG005|Overall Study|Participant's compliance|2|||
162651711|NCT02641379|587443337|FG006|Overall Study|Participant's compliance|0|||
162651712|NCT02641379|587443338|FG007|Overall Study|Participant's compliance|0|||
162651713|NCT02641379|587443339|FG008|Overall Study|Participant's compliance|1|||
162651714|NCT02641379|587443340|FG009|Overall Study|Participant's compliance|1|||
162651715|NCT02641379|587443341|FG010|Overall Study|Participant's compliance|1|||
162651716|NCT02641379|587443331|FG000|Overall Study|Participant cannot be reached|4|||
162651717|NCT02641379|587443332|FG001|Overall Study|Participant cannot be reached|4|||
162651718|NCT02641379|587443333|FG002|Overall Study|Participant cannot be reached|0|||
163092495|NCT01673646|589050563|FG000|Overall Study|Adverse Event|2|||
162651719|NCT02641379|587443334|FG003|Overall Study|Participant cannot be reached|8|||
162651720|NCT02641379|587443335|FG004|Overall Study|Participant cannot be reached|2|||
162651721|NCT02641379|587443336|FG005|Overall Study|Participant cannot be reached|1|||
163092496|NCT01673646|589050564|FG001|Overall Study|Adverse Event|1|||
163092497|NCT01673646|589050565|FG002|Overall Study|Adverse Event|1|||
162651722|NCT02641379|587443337|FG006|Overall Study|Participant cannot be reached|0|||
162651723|NCT02641379|587443338|FG007|Overall Study|Participant cannot be reached|1|||
162651724|NCT02641379|587443339|FG008|Overall Study|Participant cannot be reached|0|||
162651725|NCT02641379|587443340|FG009|Overall Study|Participant cannot be reached|2|||
162651726|NCT02641379|587443341|FG010|Overall Study|Participant cannot be reached|1|||
162651727|NCT02641379|587443331|FG000|Overall Study|PCR positive at Week 24|15|||
162651728|NCT02641379|587443332|FG001|Overall Study|PCR positive at Week 24|21|||
162651729|NCT02641379|587443333|FG002|Overall Study|PCR positive at Week 24|62|||
162651730|NCT02641379|587443334|FG003|Overall Study|PCR positive at Week 24|0|||
163092498|NCT01673646|589050563|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162651731|NCT02641379|587443335|FG004|Overall Study|PCR positive at Week 24|0|||
162651732|NCT02641379|587443336|FG005|Overall Study|PCR positive at Week 24|6|||
163092499|NCT01673646|589050564|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163092500|NCT01673646|589050565|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163092501|NCT01673646|589050563|FG000|Overall Study|Condition no longer requires study drug|0|||
163092502|NCT01673646|589050564|FG001|Overall Study|Condition no longer requires study drug|1|||
163092503|NCT01673646|589050565|FG002|Overall Study|Condition no longer requires study drug|0|||
163092504|NCT01673646|589050563|FG000|Overall Study|Withdrawal by Subject|0|||
163092505|NCT01673646|589050564|FG001|Overall Study|Withdrawal by Subject|2|||
163092506|NCT01673646|589050565|FG002|Overall Study|Withdrawal by Subject|2|||
163092507|NCT01673646|589050563|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
163092508|NCT01673646|589050564|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
163092509|NCT01673646|589050565|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
163092510|NCT00382174|589050569|FG000|Overall Study|Lost to Follow-up|1|||
163092511|NCT00382174|589050570|FG001|Overall Study|Lost to Follow-up|4|||
163092512|NCT00382174|589050571|FG002|Overall Study|Lost to Follow-up|5|||
163092513|NCT00382174|589050569|FG000|Overall Study|Adverse Event|1|||
163092514|NCT00382174|589050570|FG001|Overall Study|Adverse Event|4|||
163092515|NCT00382174|589050571|FG002|Overall Study|Adverse Event|5|||
163092516|NCT00382174|589050569|FG000|Overall Study|Withdrawal by Subject|1|||
163092517|NCT00382174|589050570|FG001|Overall Study|Withdrawal by Subject|4|||
163092518|NCT00382174|589050571|FG002|Overall Study|Withdrawal by Subject|5|||
163092519|NCT00382174|589050569|FG000|Overall Study|Non compliance|1|||
163092520|NCT00382174|589050570|FG001|Overall Study|Non compliance|0|||
163092521|NCT00382174|589050571|FG002|Overall Study|Non compliance|1|||
163092522|NCT00382174|589050569|FG000|Overall Study|Physician Decision|0|||
163092523|NCT00382174|589050570|FG001|Overall Study|Physician Decision|2|||
163092524|NCT00382174|589050571|FG002|Overall Study|Physician Decision|2|||
163092525|NCT00382174|589050569|FG000|Overall Study|Failed to meet criteria|0|||
163092526|NCT00382174|589050570|FG001|Overall Study|Failed to meet criteria|1|||
163092527|NCT00382174|589050571|FG002|Overall Study|Failed to meet criteria|1|||
163092528|NCT00382174|589050569|FG000|Overall Study|Wounds merged|0|||
163092529|NCT00382174|589050570|FG001|Overall Study|Wounds merged|2|||
163092530|NCT00382174|589050571|FG002|Overall Study|Wounds merged|2|||
163092531|NCT04577781|589050572|FG000|Overall Study|Adverse Event|2|||
163092532|NCT04577781|589050573|FG001|Overall Study|Adverse Event|2|||
163092533|NCT04577781|589050572|FG000|Overall Study|Physician Decision|1|||
163092534|NCT04577781|589050573|FG001|Overall Study|Physician Decision|0|||
163092535|NCT01464879|589050574|FG000|Overall Study|Physician Decision|1|||
163092536|NCT01464879|589050574|FG000|Overall Study|Non-compliance|1|||
163092537|NCT01911260|589050575|FG000|Supplementation Period|transference or evasion of school|7|||
163092538|NCT01911260|589050576|FG001|Supplementation Period|transference or evasion of school|9|||
163092539|NCT01911260|589050577|FG002|Supplementation Period|transference or evasion of school|7|||
163092540|NCT01911260|589050578|FG003|Supplementation Period|transference or evasion of school|6|||
163092541|NCT01911260|589050575|FG000|Supplementation Period|Adverse Event|2|||
163092542|NCT01911260|589050576|FG001|Supplementation Period|Adverse Event|0|||
163092543|NCT01911260|589050577|FG002|Supplementation Period|Adverse Event|1|||
163092544|NCT01911260|589050578|FG003|Supplementation Period|Adverse Event|0|||
163092545|NCT01911260|589050575|FG000|Supplementation Period|refused to receive supplement|1|||
163092546|NCT01911260|589050576|FG001|Supplementation Period|refused to receive supplement|0|||
163092547|NCT01911260|589050577|FG002|Supplementation Period|refused to receive supplement|1|||
163092548|NCT01911260|589050578|FG003|Supplementation Period|refused to receive supplement|0|||
163092549|NCT01911260|589050575|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
163092550|NCT01911260|589050576|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
163092551|NCT01911260|589050577|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
162651733|NCT02641379|587443337|FG006|Overall Study|PCR positive at Week 24|3|||
162651734|NCT02641379|587443338|FG007|Overall Study|PCR positive at Week 24|8|||
162651735|NCT02641379|587443339|FG008|Overall Study|PCR positive at Week 24|0|||
162651736|NCT02641379|587443340|FG009|Overall Study|PCR positive at Week 24|1|||
162651737|NCT02641379|587443341|FG010|Overall Study|PCR positive at Week 24|0|||
162651738|NCT02641379|587443331|FG000|Overall Study|PCR positive at follow up 2|1|||
162651739|NCT02641379|587443332|FG001|Overall Study|PCR positive at follow up 2|0|||
163092552|NCT01911260|589050578|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
163092553|NCT01911260|589050575|FG000|Follow-up Period|transference or evasion of school|13|||
163092554|NCT01911260|589050576|FG001|Follow-up Period|transference or evasion of school|20|||
163092555|NCT01911260|589050577|FG002|Follow-up Period|transference or evasion of school|15|||
163092556|NCT01911260|589050578|FG003|Follow-up Period|transference or evasion of school|12|||
163092557|NCT01657305|589050579|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
162651740|NCT02641379|587443333|FG002|Overall Study|PCR positive at follow up 2|0|||
163092558|NCT01657305|589050579|FG000|Overall Study|Withdrawal by Subject|4|||
163092559|NCT01657305|589050579|FG000|Overall Study|Adverse Event|1|||
163092560|NCT01657305|589050579|FG000|Overall Study|Lost to Follow-up|1|||
163092561|NCT01657305|589050579|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
162651741|NCT02641379|587443334|FG003|Overall Study|PCR positive at follow up 2|0|||
162651742|NCT02641379|587443335|FG004|Overall Study|PCR positive at follow up 2|0|||
163039145|NCT00350779|588850679|FG000|Overall Study|Withdrawal by Subject|9|||
163039146|NCT00350779|588850680|FG001|Overall Study|Withdrawal by Subject|8|||
163039147|NCT00350779|588850679|FG000|Overall Study|Patient Moved|2|||
163039148|NCT00350779|588850680|FG001|Overall Study|Patient Moved|1|||
163039149|NCT00350779|588850679|FG000|Overall Study|Non-compliance with study procedures|0|||
163039150|NCT00350779|588850680|FG001|Overall Study|Non-compliance with study procedures|1|||
163039151|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
163039152|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039153|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039154|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039155|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039156|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039157|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039158|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039159|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
163039160|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039161|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
163039162|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
163039163|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
163039164|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039165|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
163039166|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
163039167|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039168|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
163039169|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
163039170|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
163039171|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
163039172|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
163039173|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
163039174|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
163039175|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
163039176|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
163039177|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
163039178|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
163039179|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
163039180|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039181|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039182|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039183|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039184|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
163039185|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
163039186|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
163039187|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039188|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039189|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039190|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
163039191|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039192|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
163039193|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039194|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039195|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
163039196|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039197|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039198|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039199|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039200|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039201|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
163039202|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163092562|NCT00940602|589050581|FG000|Overall Study|Administrative problems|1|||
163092563|NCT00940602|589050582|FG001|Overall Study|Administrative problems|1|||
163092564|NCT00940602|589050581|FG000|Overall Study|Patient/guardian decision|13|||
163092565|NCT00940602|589050582|FG001|Overall Study|Patient/guardian decision|28|||
163092566|NCT00940602|589050581|FG000|Overall Study|Physician Decision|8|||
163092567|NCT00940602|589050582|FG001|Overall Study|Physician Decision|5|||
163092568|NCT00940602|589050581|FG000|Overall Study|Pregnancy|1|||
163092569|NCT00940602|589050582|FG001|Overall Study|Pregnancy|0|||
163092570|NCT00940602|589050581|FG000|Overall Study|Protocol Deviation (untreated)|1|||
163092571|NCT00940602|589050582|FG001|Overall Study|Protocol Deviation (untreated)|0|||
163092572|NCT00940602|589050581|FG000|Overall Study|Disease progression|8|||
163092573|NCT00940602|589050582|FG001|Overall Study|Disease progression|2|||
163092574|NCT00940602|589050581|FG000|Overall Study|Death|38|||
163092575|NCT00940602|589050582|FG001|Overall Study|Death|19|||
163092576|NCT00940602|589050581|FG000|Overall Study|Lost to Follow-up|3|||
163092577|NCT00940602|589050582|FG001|Overall Study|Lost to Follow-up|1|||
163092578|NCT00940602|589050581|FG000|Overall Study|Patient withdrew consent|26|||
163092579|NCT00940602|589050582|FG001|Overall Study|Patient withdrew consent|13|||
163092580|NCT00940602|589050581|FG000|Overall Study|Adverse Event|7|||
163092581|NCT00940602|589050582|FG001|Overall Study|Adverse Event|2|||
163092582|NCT00940602|589050581|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
163092583|NCT00940602|589050582|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
163092584|NCT00575666|589050583|FG000|Overall Study|Withdrawal by Subject|3|||
163092585|NCT00575666|589050584|FG001|Overall Study|Withdrawal by Subject|2|||
163092586|NCT00575666|589050583|FG000|Overall Study|Physician Decision|1|||
163092587|NCT00575666|589050584|FG001|Overall Study|Physician Decision|1|||
163092588|NCT00508482|589050585|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
163092589|NCT00508482|589050586|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
163092590|NCT00508482|589050587|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
163092591|NCT00508482|589050585|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
163092592|NCT00508482|589050586|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
163092593|NCT00508482|589050587|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
163092594|NCT00508482|589050585|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
163092595|NCT00508482|589050586|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
163092596|NCT00508482|589050587|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
163092597|NCT01374425|589050588|FG000|Overall Study|Radiographic Disease Progression|86|||
163092598|NCT01374425|589050589|FG001|Overall Study|Radiographic Disease Progression|81|||
163092599|NCT01374425|589050588|FG000|Overall Study|Clinical Disease Progression|9|||
163092600|NCT01374425|589050589|FG001|Overall Study|Clinical Disease Progression|6|||
163092601|NCT01374425|589050588|FG000|Overall Study|Adverse Event|29|||
163092602|NCT01374425|589050589|FG001|Overall Study|Adverse Event|18|||
163092603|NCT01374425|589050588|FG000|Overall Study|Death (Progression of Disease)|1|||
163092604|NCT01374425|589050589|FG001|Overall Study|Death (Progression of Disease)|0|||
163092605|NCT01374425|589050588|FG000|Overall Study|Death (Adverse Event)|2|||
163092606|NCT01374425|589050589|FG001|Overall Study|Death (Adverse Event)|4|||
163092607|NCT01374425|589050588|FG000|Overall Study|Withdrawal by Subject|6|||
163092608|NCT01374425|589050589|FG001|Overall Study|Withdrawal by Subject|7|||
163092609|NCT01374425|589050588|FG000|Overall Study|Refused Treatment|10|||
163092610|NCT01374425|589050589|FG001|Overall Study|Refused Treatment|24|||
163092611|NCT01374425|589050588|FG000|Overall Study|Protocol Violation|2|||
163092612|NCT01374425|589050589|FG001|Overall Study|Protocol Violation|3|||
163092613|NCT01374425|589050588|FG000|Overall Study|Sponsor Decision|0|||
163092614|NCT01374425|589050589|FG001|Overall Study|Sponsor Decision|1|||
163092615|NCT01374425|589050588|FG000|Overall Study|Lost to Follow-up|2|||
163092616|NCT01374425|589050589|FG001|Overall Study|Lost to Follow-up|1|||
163092617|NCT01374425|589050588|FG000|Overall Study|Other|41|||
163092618|NCT01374425|589050589|FG001|Overall Study|Other|43|||
163092619|NCT02289469|589050590|FG000|Overall Study|Unable to match a control|6|||
163092620|NCT02289469|589050591|FG001|Overall Study|Unable to match a control|0|||
163092621|NCT02750930|589050598|FG000|Overall Study|Study closed/terminated|8|||
163092622|NCT02761642|589050599|FG000|Overall Study|Did not Receive Study Treatment|3|||
163092623|NCT02761642|589050599|FG000|Overall Study|Adverse Event|13|||
163092624|NCT02761642|589050599|FG000|Overall Study|Withdrawal by Subject|2|||
163092625|NCT02761642|589050599|FG000|Overall Study|Non-compliant|7|||
163092626|NCT02761642|589050599|FG000|Overall Study|Death|3|||
163092627|NCT02761642|589050599|FG000|Overall Study|Lack of Efficacy|20|||
163092628|NCT02761642|589050599|FG000|Overall Study|Physician Decision|1|||
163092629|NCT02761642|589050599|FG000|Overall Study|Reason Unspecified|21|||
163092630|NCT01644643|589050602|FG000|Overall Study|Death|1|||
163092631|NCT01644643|589050603|FG001|Overall Study|Death|0|||
163092632|NCT01644643|589050604|FG002|Overall Study|Death|3|||
163092633|NCT01644643|589050605|FG003|Overall Study|Death|3|||
163092634|NCT01644643|589050602|FG000|Overall Study|Lost to Follow-up|0|||
163092635|NCT01644643|589050603|FG001|Overall Study|Lost to Follow-up|0|||
163092636|NCT01644643|589050604|FG002|Overall Study|Lost to Follow-up|0|||
163092637|NCT01644643|589050605|FG003|Overall Study|Lost to Follow-up|4|||
163092638|NCT01644643|589050602|FG000|Overall Study|Withdrawal by Subject|1|||
163092639|NCT01644643|589050603|FG001|Overall Study|Withdrawal by Subject|0|||
163092640|NCT01644643|589050604|FG002|Overall Study|Withdrawal by Subject|2|||
163092641|NCT01644643|589050605|FG003|Overall Study|Withdrawal by Subject|1|||
163092642|NCT01644643|589050602|FG000|Overall Study|Other Eligibility criteria|0|||
162651743|NCT02641379|587443336|FG005|Overall Study|PCR positive at follow up 2|0|||
162651744|NCT02641379|587443337|FG006|Overall Study|PCR positive at follow up 2|0|||
162651745|NCT02641379|587443338|FG007|Overall Study|PCR positive at follow up 2|0|||
162651746|NCT02641379|587443339|FG008|Overall Study|PCR positive at follow up 2|0|||
162651747|NCT02641379|587443340|FG009|Overall Study|PCR positive at follow up 2|0|||
162651748|NCT02641379|587443341|FG010|Overall Study|PCR positive at follow up 2|0|||
162651749|NCT02641379|587443331|FG000|Overall Study|Participant showed relapse|1|||
162651750|NCT02641379|587443332|FG001|Overall Study|Participant showed relapse|0|||
162651751|NCT02641379|587443333|FG002|Overall Study|Participant showed relapse|0|||
162651752|NCT02641379|587443334|FG003|Overall Study|Participant showed relapse|0|||
162651753|NCT02641379|587443335|FG004|Overall Study|Participant showed relapse|0|||
162651754|NCT02641379|587443336|FG005|Overall Study|Participant showed relapse|0|||
162651755|NCT02641379|587443337|FG006|Overall Study|Participant showed relapse|1|||
163092643|NCT01644643|589050603|FG001|Overall Study|Other Eligibility criteria|0|||
163092644|NCT01644643|589050604|FG002|Overall Study|Other Eligibility criteria|0|||
163092645|NCT01644643|589050605|FG003|Overall Study|Other Eligibility criteria|2|||
163092646|NCT02850978|589050606|FG000|Overall Study|Uncollectable CRF|27|||
163092647|NCT02850978|589050606|FG000|Overall Study|No visit since the first visit|35|||
163092648|NCT02850978|589050606|FG000|Overall Study|Adverse Event|81|||
163092649|NCT02850978|589050606|FG000|Overall Study|Lack of Efficacy|40|||
163092650|NCT02850978|589050606|FG000|Overall Study|Improvement in condition|34|||
163092651|NCT02850978|589050606|FG000|Overall Study|Lost to Follow-up|121|||
163092652|NCT02850978|589050606|FG000|Overall Study|Reason not listed|88|||
163092653|NCT00114127|589050607|FG000|Overall Study|Adverse Event|2|||
163092654|NCT00114127|589050608|FG001|Overall Study|Adverse Event|1|||
163092655|NCT00114127|589050607|FG000|Overall Study|Lost to Follow-up|1|||
163092656|NCT00114127|589050608|FG001|Overall Study|Lost to Follow-up|0|||
163092657|NCT00114127|589050607|FG000|Overall Study|Withdrawal by Subject|1|||
163092658|NCT00114127|589050608|FG001|Overall Study|Withdrawal by Subject|3|||
163092659|NCT00421148|589050609|FG000|Overall Study|Lost to Follow-up|0|||
163092660|NCT00421148|589050610|FG001|Overall Study|Lost to Follow-up|0|||
163092661|NCT00421148|589050611|FG002|Overall Study|Lost to Follow-up|0|||
163092662|NCT00421148|589050612|FG003|Overall Study|Lost to Follow-up|0|||
163092663|NCT00421148|589050613|FG004|Overall Study|Lost to Follow-up|0|||
163092664|NCT00421148|589050614|FG005|Overall Study|Lost to Follow-up|0|||
163092665|NCT00421148|589050615|FG006|Overall Study|Lost to Follow-up|0|||
163092666|NCT00421148|589050616|FG007|Overall Study|Lost to Follow-up|0|||
163092667|NCT00421148|589050617|FG008|Overall Study|Lost to Follow-up|0|||
163092668|NCT00421148|589050618|FG009|Overall Study|Lost to Follow-up|0|||
163092669|NCT00421148|589050619|FG010|Overall Study|Lost to Follow-up|0|||
163092670|NCT00421148|589050620|FG011|Overall Study|Lost to Follow-up|0|||
163092671|NCT00421148|589050621|FG012|Overall Study|Lost to Follow-up|0|||
163092672|NCT00421148|589050622|FG013|Overall Study|Lost to Follow-up|0|||
163092673|NCT00421148|589050623|FG014|Overall Study|Lost to Follow-up|0|||
163092674|NCT00421148|589050624|FG015|Overall Study|Lost to Follow-up|0|||
163092675|NCT00421148|589050625|FG016|Overall Study|Lost to Follow-up|0|||
163092676|NCT00421148|589050626|FG017|Overall Study|Lost to Follow-up|1|||
163092677|NCT00421148|589050627|FG018|Overall Study|Lost to Follow-up|0|||
163092678|NCT00421148|589050628|FG019|Overall Study|Lost to Follow-up|0|||
163092679|NCT00421148|589050609|FG000|Overall Study|Withdrawal by Subject|0|||
163092680|NCT00421148|589050610|FG001|Overall Study|Withdrawal by Subject|0|||
163092681|NCT00421148|589050611|FG002|Overall Study|Withdrawal by Subject|0|||
163092682|NCT00421148|589050612|FG003|Overall Study|Withdrawal by Subject|0|||
162651756|NCT02641379|587443338|FG007|Overall Study|Participant showed relapse|0|||
162651757|NCT02641379|587443339|FG008|Overall Study|Participant showed relapse|0|||
163092683|NCT00421148|589050613|FG004|Overall Study|Withdrawal by Subject|0|||
163092684|NCT00421148|589050614|FG005|Overall Study|Withdrawal by Subject|0|||
163092685|NCT00421148|589050615|FG006|Overall Study|Withdrawal by Subject|0|||
163092686|NCT00421148|589050616|FG007|Overall Study|Withdrawal by Subject|0|||
163092687|NCT00421148|589050617|FG008|Overall Study|Withdrawal by Subject|0|||
163092688|NCT00421148|589050618|FG009|Overall Study|Withdrawal by Subject|0|||
163092689|NCT00421148|589050619|FG010|Overall Study|Withdrawal by Subject|0|||
163092690|NCT00421148|589050620|FG011|Overall Study|Withdrawal by Subject|0|||
163092691|NCT00421148|589050621|FG012|Overall Study|Withdrawal by Subject|0|||
163092692|NCT00421148|589050622|FG013|Overall Study|Withdrawal by Subject|0|||
163092693|NCT00421148|589050623|FG014|Overall Study|Withdrawal by Subject|0|||
163092694|NCT00421148|589050624|FG015|Overall Study|Withdrawal by Subject|0|||
162651758|NCT02641379|587443340|FG009|Overall Study|Participant showed relapse|0|||
162651759|NCT02641379|587443341|FG010|Overall Study|Participant showed relapse|0|||
162651760|NCT02641379|587443331|FG000|Overall Study|Participant stopped study/treatment|1|||
163092695|NCT00421148|589050625|FG016|Overall Study|Withdrawal by Subject|0|||
162651761|NCT02641379|587443332|FG001|Overall Study|Participant stopped study/treatment|3|||
162651762|NCT02641379|587443333|FG002|Overall Study|Participant stopped study/treatment|1|||
163092696|NCT00421148|589050626|FG017|Overall Study|Withdrawal by Subject|1|||
163092697|NCT00421148|589050627|FG018|Overall Study|Withdrawal by Subject|0|||
163092698|NCT00421148|589050628|FG019|Overall Study|Withdrawal by Subject|0|||
163092699|NCT00421148|589050609|FG000|Overall Study|Protocol Violation|0|||
162651763|NCT02641379|587443334|FG003|Overall Study|Participant stopped study/treatment|0|||
162651764|NCT02641379|587443335|FG004|Overall Study|Participant stopped study/treatment|0|||
162651765|NCT02641379|587443336|FG005|Overall Study|Participant stopped study/treatment|1|||
162651766|NCT02641379|587443337|FG006|Overall Study|Participant stopped study/treatment|2|||
162651767|NCT02641379|587443338|FG007|Overall Study|Participant stopped study/treatment|0|||
162651768|NCT02641379|587443339|FG008|Overall Study|Participant stopped study/treatment|1|||
162651769|NCT02641379|587443340|FG009|Overall Study|Participant stopped study/treatment|0|||
162651770|NCT02641379|587443341|FG010|Overall Study|Participant stopped study/treatment|0|||
162651771|NCT02641379|587443331|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
162651772|NCT02641379|587443332|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
162651773|NCT02641379|587443333|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
162651774|NCT02641379|587443334|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
162651775|NCT02641379|587443335|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
162651776|NCT02641379|587443336|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
162651777|NCT02641379|587443337|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
162651778|NCT02641379|587443338|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
162651779|NCT02641379|587443339|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
162651780|NCT02641379|587443340|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
162651781|NCT02641379|587443341|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
162651782|NCT02641379|587443331|FG000|Overall Study|Financial problems|0|||
162651783|NCT02641379|587443332|FG001|Overall Study|Financial problems|1|||
162651784|NCT02641379|587443333|FG002|Overall Study|Financial problems|0|||
162651785|NCT02641379|587443334|FG003|Overall Study|Financial problems|0|||
162651786|NCT02641379|587443335|FG004|Overall Study|Financial problems|0|||
162651787|NCT02641379|587443336|FG005|Overall Study|Financial problems|0|||
162651788|NCT02641379|587443337|FG006|Overall Study|Financial problems|0|||
162651789|NCT02641379|587443338|FG007|Overall Study|Financial problems|0|||
162651790|NCT02641379|587443339|FG008|Overall Study|Financial problems|0|||
162651791|NCT02641379|587443340|FG009|Overall Study|Financial problems|0|||
162651792|NCT02641379|587443341|FG010|Overall Study|Financial problems|0|||
162651793|NCT02641379|587443331|FG000|Overall Study|PCR positive at Week 68|0|||
162651794|NCT02641379|587443332|FG001|Overall Study|PCR positive at Week 68|1|||
162651795|NCT02641379|587443333|FG002|Overall Study|PCR positive at Week 68|0|||
162651796|NCT02641379|587443334|FG003|Overall Study|PCR positive at Week 68|0|||
162651797|NCT02641379|587443335|FG004|Overall Study|PCR positive at Week 68|0|||
162651798|NCT02641379|587443336|FG005|Overall Study|PCR positive at Week 68|0|||
162651799|NCT02641379|587443337|FG006|Overall Study|PCR positive at Week 68|0|||
162651800|NCT02641379|587443338|FG007|Overall Study|PCR positive at Week 68|0|||
162651801|NCT02641379|587443339|FG008|Overall Study|PCR positive at Week 68|0|||
162651802|NCT02641379|587443340|FG009|Overall Study|PCR positive at Week 68|0|||
162651803|NCT02641379|587443341|FG010|Overall Study|PCR positive at Week 68|0|||
162651804|NCT02641379|587443331|FG000|Overall Study|PCR positive at Week 48|0|||
162651805|NCT02641379|587443332|FG001|Overall Study|PCR positive at Week 48|1|||
162651806|NCT02641379|587443333|FG002|Overall Study|PCR positive at Week 48|0|||
162651807|NCT02641379|587443334|FG003|Overall Study|PCR positive at Week 48|0|||
162651808|NCT02641379|587443335|FG004|Overall Study|PCR positive at Week 48|0|||
162651809|NCT02641379|587443336|FG005|Overall Study|PCR positive at Week 48|0|||
162719014|NCT02341625|587676738|FG001|Overall Study|Completed Treatment as per Protocol|0|||
163092700|NCT00421148|589050610|FG001|Overall Study|Protocol Violation|0|||
163092701|NCT00421148|589050611|FG002|Overall Study|Protocol Violation|0|||
163092702|NCT00421148|589050612|FG003|Overall Study|Protocol Violation|0|||
163092703|NCT00421148|589050613|FG004|Overall Study|Protocol Violation|0|||
163092704|NCT00421148|589050614|FG005|Overall Study|Protocol Violation|1|||
163092705|NCT00421148|589050615|FG006|Overall Study|Protocol Violation|0|||
163092706|NCT00421148|589050616|FG007|Overall Study|Protocol Violation|0|||
163092707|NCT00421148|589050617|FG008|Overall Study|Protocol Violation|0|||
163092708|NCT00421148|589050618|FG009|Overall Study|Protocol Violation|0|||
163092709|NCT00421148|589050619|FG010|Overall Study|Protocol Violation|0|||
163092710|NCT00421148|589050620|FG011|Overall Study|Protocol Violation|0|||
163092711|NCT00421148|589050621|FG012|Overall Study|Protocol Violation|0|||
163092712|NCT00421148|589050622|FG013|Overall Study|Protocol Violation|0|||
163092713|NCT00421148|589050623|FG014|Overall Study|Protocol Violation|0|||
163092714|NCT00421148|589050624|FG015|Overall Study|Protocol Violation|0|||
163092715|NCT00421148|589050625|FG016|Overall Study|Protocol Violation|0|||
163092716|NCT00421148|589050626|FG017|Overall Study|Protocol Violation|0|||
163092717|NCT00421148|589050627|FG018|Overall Study|Protocol Violation|1|||
163092718|NCT00421148|589050628|FG019|Overall Study|Protocol Violation|0|||
163092719|NCT00570713|589050629|FG000|Overall Study|Adverse Event|16|||
163092720|NCT00570713|589050630|FG001|Overall Study|Adverse Event|9|||
163092721|NCT00570713|589050629|FG000|Overall Study|Death|7|||
163092722|NCT00570713|589050630|FG001|Overall Study|Death|7|||
162651810|NCT02641379|587443337|FG006|Overall Study|PCR positive at Week 48|0|||
162651811|NCT02641379|587443338|FG007|Overall Study|PCR positive at Week 48|0|||
163092723|NCT00570713|589050629|FG000|Overall Study|Lack of Efficacy|40|||
163092724|NCT00570713|589050630|FG001|Overall Study|Lack of Efficacy|49|||
163092725|NCT00570713|589050629|FG000|Overall Study|Physician Decision|2|||
163092726|NCT00570713|589050630|FG001|Overall Study|Physician Decision|2|||
163092727|NCT00570713|589050629|FG000|Overall Study|Withdrawal by Subject|3|||
163092728|NCT00570713|589050630|FG001|Overall Study|Withdrawal by Subject|3|||
163092729|NCT00570713|589050629|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
163092730|NCT00570713|589050630|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
163092731|NCT00469833|589050631|FG000|Overall Study|No IV access|2|||
163092732|NCT03289533|589050632|FG000|Overall Study|Death|12|||
163092733|NCT03289533|589050632|FG000|Overall Study|Terminated from study by sponsor|10|||
163092734|NCT00539240|589050633|FG000|Overall Study|Withdrawal by Subject|0|||
163092735|NCT00539240|589050634|FG001|Overall Study|Withdrawal by Subject|2|||
163092736|NCT00539240|589050635|FG002|Overall Study|Withdrawal by Subject|0|||
163092737|NCT00539240|589050633|FG000|Overall Study|Protocol Violation|1|||
163092738|NCT00539240|589050634|FG001|Overall Study|Protocol Violation|1|||
163092739|NCT00539240|589050635|FG002|Overall Study|Protocol Violation|4|||
163092740|NCT00539240|589050633|FG000|Overall Study|Lost to Follow-up|2|||
163092741|NCT00539240|589050634|FG001|Overall Study|Lost to Follow-up|3|||
163092742|NCT00539240|589050635|FG002|Overall Study|Lost to Follow-up|1|||
163092743|NCT00539240|589050633|FG000|Overall Study|Adverse Event|3|||
163092744|NCT00539240|589050634|FG001|Overall Study|Adverse Event|1|||
163092745|NCT00539240|589050635|FG002|Overall Study|Adverse Event|10|||
163092746|NCT01284959|589050636|FG000|Overall Study|Withdrawal by Subject|1|||
163092747|NCT01284959|589050637|FG001|Overall Study|Withdrawal by Subject|0|||
163092748|NCT01284959|589050638|FG002|Overall Study|Withdrawal by Subject|0|||
163092749|NCT01284959|589050636|FG000|Overall Study|Adverse Event|0|||
163092750|NCT01284959|589050637|FG001|Overall Study|Adverse Event|0|||
163092751|NCT01284959|589050638|FG002|Overall Study|Adverse Event|1|||
163092752|NCT01055613|589050639|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
163092753|NCT01055613|589050640|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163092754|NCT01055613|589050639|FG000|Overall Study|Unacceptable lens fit|1|||
163092755|NCT01055613|589050640|FG001|Overall Study|Unacceptable lens fit|0|||
163092756|NCT01055613|589050639|FG000|Overall Study|Discomfort|2|||
163092757|NCT01055613|589050640|FG001|Overall Study|Discomfort|1|||
163092758|NCT01055613|589050639|FG000|Overall Study|Lost to Follow-up|1|||
163092759|NCT01055613|589050640|FG001|Overall Study|Lost to Follow-up|1|||
163092760|NCT01055613|589050639|FG000|Overall Study|Protocol Violation|1|||
163092761|NCT01055613|589050640|FG001|Overall Study|Protocol Violation|1|||
163092762|NCT01055613|589050639|FG000|Overall Study|Subject Disinterest|1|||
163092763|NCT01055613|589050640|FG001|Overall Study|Subject Disinterest|1|||
163092764|NCT01677988|589050648|FG000|Overall Study|Lack of Efficacy|2|||
163092765|NCT02629861|589050653|FG000|Overall Study|Adverse Event|7|||
163092766|NCT02629861|589050654|FG001|Overall Study|Adverse Event|5|||
163092767|NCT02629861|589050655|FG002|Overall Study|Adverse Event|4|||
163092768|NCT02629861|589050653|FG000|Overall Study|Withdrawal by Subject|5|||
163092769|NCT02629861|589050654|FG001|Overall Study|Withdrawal by Subject|8|||
163092770|NCT02629861|589050655|FG002|Overall Study|Withdrawal by Subject|13|||
163092771|NCT02629861|589050653|FG000|Overall Study|Protocol Violation|2|||
163092772|NCT02629861|589050654|FG001|Overall Study|Protocol Violation|3|||
163092773|NCT02629861|589050655|FG002|Overall Study|Protocol Violation|7|||
163092774|NCT02629861|589050653|FG000|Overall Study|Lost to Follow-up|12|||
163092775|NCT02629861|589050654|FG001|Overall Study|Lost to Follow-up|9|||
163092776|NCT02629861|589050655|FG002|Overall Study|Lost to Follow-up|4|||
163092777|NCT02629861|589050653|FG000|Overall Study|Other|1|||
163092778|NCT02629861|589050654|FG001|Overall Study|Other|1|||
163092779|NCT02629861|589050655|FG002|Overall Study|Other|0|||
163092780|NCT02629861|589050653|FG000|Overall Study|Pregnancy|2|||
163092781|NCT02629861|589050654|FG001|Overall Study|Pregnancy|1|||
163092782|NCT02629861|589050655|FG002|Overall Study|Pregnancy|0|||
163092783|NCT00271544|589050668|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
163092784|NCT00271544|589050668|FG000|Overall Study|Model 4196 lead not attempted|9|||
163092785|NCT00271544|589050668|FG000|Overall Study|Implant not attempted|4|||
163092786|NCT00902330|589050675|FG000|Overall Study|Too overwhelmed by treatment|2|||
163092787|NCT00902330|589050676|FG001|Overall Study|Too overwhelmed by treatment|5|||
163092788|NCT00902330|589050675|FG000|Overall Study|Adverse Event|1|||
163092789|NCT00902330|589050676|FG001|Overall Study|Adverse Event|0|||
163092790|NCT00902330|589050675|FG000|Overall Study|No post baseline data|1|||
163092791|NCT00902330|589050676|FG001|Overall Study|No post baseline data|0|||
163092792|NCT00165789|589050677|FG000|Overall Study|Adverse Event|0|||
163092793|NCT00165789|589050678|FG001|Overall Study|Adverse Event|3|||
163092794|NCT00165789|589050679|FG002|Overall Study|Adverse Event|0|||
163092795|NCT00165789|589050680|FG003|Overall Study|Adverse Event|12|||
163092796|NCT00165789|589050677|FG000|Overall Study|Withdrawal by Subject|0|||
163092797|NCT00165789|589050678|FG001|Overall Study|Withdrawal by Subject|1|||
163092798|NCT00165789|589050679|FG002|Overall Study|Withdrawal by Subject|1|||
163092799|NCT00165789|589050680|FG003|Overall Study|Withdrawal by Subject|2|||
163092800|NCT03571971|589050681|FG000|Overall Study|Lost to Follow-up|2|||
163092801|NCT03571971|589050682|FG001|Overall Study|Lost to Follow-up|2|||
163092802|NCT03571971|589050681|FG000|Overall Study|Protocol Violation|2|||
163092803|NCT03571971|589050682|FG001|Overall Study|Protocol Violation|3|||
163092804|NCT03571971|589050681|FG000|Overall Study|Withdrawal by Subject|2|||
163092805|NCT03571971|589050682|FG001|Overall Study|Withdrawal by Subject|0|||
163092806|NCT03571971|589050681|FG000|Overall Study|Incomplete primary outcome data|2|||
163092807|NCT03571971|589050682|FG001|Overall Study|Incomplete primary outcome data|0|||
163092808|NCT03950856|589050686|FG000|Overall Study|Death|1|||
163092809|NCT03950856|589050687|FG001|Overall Study|Death|2|||
163092810|NCT03950856|589050688|FG002|Overall Study|Death|0|||
163092811|NCT03950856|589050689|FG003|Overall Study|Death|0|||
163092812|NCT03950856|589050686|FG000|Overall Study|Lost to Follow-up|5|||
163092813|NCT03950856|589050687|FG001|Overall Study|Lost to Follow-up|6|||
163092814|NCT03950856|589050688|FG002|Overall Study|Lost to Follow-up|8|||
163092815|NCT03950856|589050689|FG003|Overall Study|Lost to Follow-up|2|||
163092816|NCT03950856|589050686|FG000|Overall Study|Protocol Violation|2|||
163092817|NCT03950856|589050687|FG001|Overall Study|Protocol Violation|0|||
163092818|NCT03950856|589050688|FG002|Overall Study|Protocol Violation|0|||
163092819|NCT03950856|589050689|FG003|Overall Study|Protocol Violation|1|||
163092820|NCT03950856|589050686|FG000|Overall Study|Withdrawal by Subject|4|||
163092821|NCT03950856|589050687|FG001|Overall Study|Withdrawal by Subject|1|||
163092822|NCT03950856|589050688|FG002|Overall Study|Withdrawal by Subject|3|||
163092823|NCT03950856|589050689|FG003|Overall Study|Withdrawal by Subject|1|||
163092824|NCT03950856|589050686|FG000|Overall Study|Unable to phone|7|||
163092825|NCT03950856|589050687|FG001|Overall Study|Unable to phone|6|||
163092826|NCT03950856|589050688|FG002|Overall Study|Unable to phone|7|||
163092827|NCT03950856|589050689|FG003|Overall Study|Unable to phone|2|||
163092828|NCT01816984|589050690|FG000|Overall Study|declining health status|1|||
163092829|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
163092830|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
163092831|NCT04422431|589050693|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
163092832|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
163092833|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
163092834|NCT04422431|589050693|FG000|Extension Period (48 Weeks)|Other than specified|2|||
163092835|NCT01174563|589050694|FG000|Overall Study|Progressive Disease|45|||
163092836|NCT01174563|589050694|FG000|Overall Study|Death|5|||
163092837|NCT01174563|589050694|FG000|Overall Study|Investigator's Discretion|5|||
163092838|NCT01174563|589050694|FG000|Overall Study|Participant Withdrew Consent|3|||
163092839|NCT01174563|589050694|FG000|Overall Study|Rash Adverse Event|1|||
163092840|NCT01174563|589050694|FG000|Overall Study|Sponsor's decision|1|||
163092841|NCT03402841|589050695|FG000|Overall Study|Withdrawal by Subject|3|||
163092842|NCT03402841|589050695|FG000|Overall Study|Lost to Follow-up|2|||
163092843|NCT03402841|589050695|FG000|Overall Study|Death|146|||
163092844|NCT00444106|589050698|FG000|Overall Study|Lost to Follow-up|2|||
163092845|NCT00444106|589050699|FG001|Overall Study|Lost to Follow-up|1|||
163092846|NCT00444106|589050700|FG002|Overall Study|Lost to Follow-up|0|||
163092847|NCT00444106|589050698|FG000|Overall Study|Abnormal Test Procedure Results|0|||
163092848|NCT00444106|589050699|FG001|Overall Study|Abnormal Test Procedure Results|0|||
163092849|NCT00444106|589050700|FG002|Overall Study|Abnormal Test Procedure Results|1|||
163092850|NCT00810277|589052449|FG000|Overall Study|Adverse Event|1|||
163092851|NCT01856322|589052450|FG000|Overall Study|off study due to lack of accrual|0|||
163092852|NCT01856322|589052451|FG001|Overall Study|off study due to lack of accrual|0|||
163092853|NCT01856322|589052452|FG002|Overall Study|off study due to lack of accrual|3|||
163092854|NCT02896257|589052453|FG000|Providers|Without eligible patients|21|||
163092855|NCT02896257|589052454|FG001|Providers|Without eligible patients|28|||
163092856|NCT02896257|589052453|FG000|Patients|PFT entry criteria not met|43|||
163092857|NCT02896257|589052454|FG001|Patients|PFT entry criteria not met|50|||
163092858|NCT02896257|589052453|FG000|Patients|No capacity to review|8|||
163092859|NCT02896257|589052454|FG001|Patients|No capacity to review|11|||
163092860|NCT02896257|589052453|FG000|Patients|Appointment rescheduled/cancelled|5|||
163092861|NCT02896257|589052454|FG001|Patients|Appointment rescheduled/cancelled|7|||
163092862|NCT02896257|589052453|FG000|Patients|PCP not assigned a clinic|4|||
163092863|NCT02896257|589052454|FG001|Patients|PCP not assigned a clinic|0|||
163092864|NCT02896257|589052453|FG000|Patients|No history of COPD|0|||
163092865|NCT02896257|589052454|FG001|Patients|No history of COPD|1|||
163092866|NCT02896257|589052453|FG000|Patients|Deceased between review and index date|0|||
163092867|NCT02896257|589052454|FG001|Patients|Deceased between review and index date|1|||
163092868|NCT02896257|589052453|FG000|Patients|No ICS Rx upon review|1|||
163092869|NCT02896257|589052454|FG001|Patients|No ICS Rx upon review|1|||
163092870|NCT02896257|589052453|FG000|Patients|Protocol Violation|2|||
163092871|NCT02896257|589052454|FG001|Patients|Protocol Violation|1|||
163092872|NCT02896257|589052453|FG000|Patients|Hospice care|0|||
163092873|NCT02896257|589052454|FG001|Patients|Hospice care|1|||
163092874|NCT03423602|589052459|FG000|Overall Study|Death|1|||
163092875|NCT03423602|589052459|FG000|Overall Study|Lost to Follow-up|6|||
163092876|NCT03423602|589052459|FG000|Overall Study|Protocol Violation|1|||
163092877|NCT03423602|589052459|FG000|Overall Study|Withdrawal by Subject|4|||
163092878|NCT00692003|589052460|FG000|Overall Study|Sponsor Decision|5|||
163092879|NCT00692003|589052461|FG001|Overall Study|Sponsor Decision|1|||
163092880|NCT03257358|589052462|FG000|Overall Study|Adverse Event|25|||
163092881|NCT03257358|589052463|FG001|Overall Study|Adverse Event|12|||
163092882|NCT03257358|589052462|FG000|Overall Study|Lack of Efficacy|1|||
163092883|NCT03257358|589052463|FG001|Overall Study|Lack of Efficacy|1|||
163092884|NCT03257358|589052462|FG000|Overall Study|Lost to Follow-up|12|||
163092885|NCT03257358|589052463|FG001|Overall Study|Lost to Follow-up|4|||
163092886|NCT03257358|589052462|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
163092887|NCT03257358|589052463|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
163092888|NCT03257358|589052462|FG000|Overall Study|Physician Decision|2|||
163092889|NCT03257358|589052463|FG001|Overall Study|Physician Decision|2|||
163092890|NCT03257358|589052462|FG000|Overall Study|Protocol Violation|5|||
163092891|NCT03257358|589052463|FG001|Overall Study|Protocol Violation|3|||
163092892|NCT03257358|589052462|FG000|Overall Study|Technical problems|4|||
163092893|NCT03257358|589052463|FG001|Overall Study|Technical problems|1|||
163092894|NCT03257358|589052462|FG000|Overall Study|Withdrawal by Subject|8|||
163092895|NCT03257358|589052463|FG001|Overall Study|Withdrawal by Subject|3|||
163092896|NCT03257358|589052462|FG000|Overall Study|Withdrawal of informed consent|9|||
163092897|NCT03257358|589052463|FG001|Overall Study|Withdrawal of informed consent|5|||
163092898|NCT03257358|589052462|FG000|Overall Study|New therapy for study indication|1|||
163092899|NCT03257358|589052463|FG001|Overall Study|New therapy for study indication|0|||
162719015|NCT02341625|587676739|FG002|Overall Study|Completed Treatment as per Protocol|0|||
162719016|NCT02341625|587676740|FG003|Overall Study|Completed Treatment as per Protocol|0|||
163092900|NCT03257358|589052462|FG000|Overall Study|No longer requires treatment|0|||
163092901|NCT03257358|589052463|FG001|Overall Study|No longer requires treatment|1|||
163092902|NCT02332187|589052464|FG000|Overall Study|Withdrawal by Subject|2|||
163092903|NCT02332187|589052465|FG001|Overall Study|Withdrawal by Subject|2|||
163092904|NCT02332187|589052464|FG000|Overall Study|Adverse Event|0|||
163092905|NCT02332187|589052465|FG001|Overall Study|Adverse Event|1|||
163092906|NCT02903823|589052466|FG000|Overall Study|Physician Decision|5|||
163092907|NCT02903823|589052466|FG000|Overall Study|Could not advance catheter|1|||
163092908|NCT02903823|589052466|FG000|Overall Study|Catheter dislodgement|1|||
163092909|NCT02852967|589052467|FG000|Overall Study|Adverse Event|3|||
163092910|NCT02852967|589052468|FG001|Overall Study|Adverse Event|1|||
163092911|NCT02852967|589052469|FG002|Overall Study|Adverse Event|0|||
163092912|NCT02852967|589052470|FG003|Overall Study|Adverse Event|1|||
163092913|NCT02852967|589052471|FG004|Overall Study|Adverse Event|0|||
163092914|NCT02852967|589052467|FG000|Overall Study|Death|1|||
163092915|NCT02852967|589052468|FG001|Overall Study|Death|0|||
163092916|NCT02852967|589052469|FG002|Overall Study|Death|0|||
163092917|NCT02852967|589052470|FG003|Overall Study|Death|0|||
163092918|NCT02852967|589052471|FG004|Overall Study|Death|0|||
163092919|NCT02852967|589052467|FG000|Overall Study|Lost to Follow-up|1|||
163092920|NCT02852967|589052468|FG001|Overall Study|Lost to Follow-up|2|||
163092921|NCT02852967|589052469|FG002|Overall Study|Lost to Follow-up|3|||
163092922|NCT02852967|589052470|FG003|Overall Study|Lost to Follow-up|4|||
163092923|NCT02852967|589052471|FG004|Overall Study|Lost to Follow-up|4|||
163092924|NCT02852967|589052467|FG000|Overall Study|Withdrawal by Subject|6|||
163092925|NCT02852967|589052468|FG001|Overall Study|Withdrawal by Subject|12|||
163092926|NCT02852967|589052469|FG002|Overall Study|Withdrawal by Subject|7|||
163092927|NCT02852967|589052470|FG003|Overall Study|Withdrawal by Subject|10|||
163092928|NCT02852967|589052471|FG004|Overall Study|Withdrawal by Subject|10|||
163092929|NCT02852967|589052467|FG000|Overall Study|SAE|0|||
163092930|NCT02852967|589052468|FG001|Overall Study|SAE|0|||
163092931|NCT02852967|589052469|FG002|Overall Study|SAE|0|||
163092932|NCT02852967|589052470|FG003|Overall Study|SAE|3|||
163092933|NCT02852967|589052471|FG004|Overall Study|SAE|0|||
163092934|NCT02852967|589052467|FG000|Overall Study|Elevated Liver Enzymes|2|||
163092935|NCT02852967|589052468|FG001|Overall Study|Elevated Liver Enzymes|0|||
163092936|NCT02852967|589052469|FG002|Overall Study|Elevated Liver Enzymes|0|||
163092937|NCT02852967|589052470|FG003|Overall Study|Elevated Liver Enzymes|2|||
163092938|NCT02852967|589052471|FG004|Overall Study|Elevated Liver Enzymes|2|||
163092939|NCT02852967|589052467|FG000|Overall Study|Physician Decision|0|||
163092940|NCT02852967|589052468|FG001|Overall Study|Physician Decision|0|||
163092941|NCT02852967|589052469|FG002|Overall Study|Physician Decision|0|||
163092942|NCT02852967|589052470|FG003|Overall Study|Physician Decision|1|||
163092943|NCT02852967|589052471|FG004|Overall Study|Physician Decision|0|||
163092944|NCT02852967|589052467|FG000|Overall Study|Lack of Efficacy|0|||
163092945|NCT02852967|589052468|FG001|Overall Study|Lack of Efficacy|1|||
163092946|NCT02852967|589052469|FG002|Overall Study|Lack of Efficacy|0|||
163092947|NCT02852967|589052470|FG003|Overall Study|Lack of Efficacy|0|||
163092948|NCT02852967|589052471|FG004|Overall Study|Lack of Efficacy|0|||
163092949|NCT02852967|589052467|FG000|Overall Study|Non-compliance|0|||
163092950|NCT02852967|589052468|FG001|Overall Study|Non-compliance|0|||
163092951|NCT02852967|589052469|FG002|Overall Study|Non-compliance|1|||
163092952|NCT02852967|589052470|FG003|Overall Study|Non-compliance|1|||
163092953|NCT02852967|589052471|FG004|Overall Study|Non-compliance|0|||
163092954|NCT02852967|589052467|FG000|Overall Study|Dispensing Drug Violation|0|||
163092955|NCT02852967|589052468|FG001|Overall Study|Dispensing Drug Violation|0|||
163092956|NCT02852967|589052469|FG002|Overall Study|Dispensing Drug Violation|1|||
163092957|NCT02852967|589052470|FG003|Overall Study|Dispensing Drug Violation|0|||
163092958|NCT02852967|589052471|FG004|Overall Study|Dispensing Drug Violation|0|||
163092959|NCT02852967|589052467|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
163092960|NCT02852967|589052468|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
163092961|NCT02852967|589052469|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
163092962|NCT02852967|589052470|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
163092963|NCT02852967|589052471|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
163092964|NCT00339040|589052478|FG000|Stage I|Not able to attend clinic|1|||
163092965|NCT00339040|589052479|FG001|Stage I|Not able to attend clinic|0|||
163092966|NCT00339040|589052478|FG000|Stage I|Protocol Violation|1|||
163092967|NCT00339040|589052479|FG001|Stage I|Protocol Violation|1|||
163092968|NCT00339040|589052478|FG000|Stage II|Lost to Follow-up|3|||
163092969|NCT00339040|589052479|FG001|Stage II|Lost to Follow-up|0|||
163092970|NCT00339040|589052478|FG000|Stage II|Withdrawal by Subject|1|||
163092971|NCT00339040|589052479|FG001|Stage II|Withdrawal by Subject|2|||
163092972|NCT00339040|589052478|FG000|Stage II|Protocol Violation|3|||
163092973|NCT00339040|589052479|FG001|Stage II|Protocol Violation|0|||
163092974|NCT00339040|589052478|FG000|Stage II|Not able to attend clinic|1|||
163092975|NCT00339040|589052479|FG001|Stage II|Not able to attend clinic|0|||
163092976|NCT00339040|589052478|FG000|Stage II|Site closing|2|||
163092977|NCT00339040|589052479|FG001|Stage II|Site closing|0|||
163092978|NCT03341637|589052480|FG000|Overall Study|Lost to Follow-up|1|||
163092979|NCT03341637|589052481|FG001|Overall Study|Lost to Follow-up|0|||
163092980|NCT03341637|589052480|FG000|Overall Study|Withdrawal by Subject|3|||
163092981|NCT03341637|589052481|FG001|Overall Study|Withdrawal by Subject|3|||
163092982|NCT03341637|589052480|FG000|Overall Study|Reason not Specified|1|||
163092983|NCT03341637|589052481|FG001|Overall Study|Reason not Specified|1|||
163092984|NCT01462929|589052488|FG000|Overall Study|Adverse Event|3|||
163092985|NCT01462929|589052489|FG001|Overall Study|Adverse Event|3|||
163092986|NCT01462929|589052490|FG002|Overall Study|Adverse Event|4|||
163092987|NCT01462929|589052488|FG000|Overall Study|Withdrawal by Subject|2|||
163092988|NCT01462929|589052489|FG001|Overall Study|Withdrawal by Subject|1|||
163092989|NCT01462929|589052490|FG002|Overall Study|Withdrawal by Subject|0|||
163092990|NCT01462929|589052488|FG000|Overall Study|Lack of Efficacy|0|||
163092991|NCT01462929|589052489|FG001|Overall Study|Lack of Efficacy|0|||
163092992|NCT01462929|589052490|FG002|Overall Study|Lack of Efficacy|1|||
163092993|NCT00887159|589052491|FG000|Overall Study|Disease progression|6|||
163092994|NCT00887159|589052492|FG001|Overall Study|Disease progression|39|||
163092995|NCT00887159|589052493|FG002|Overall Study|Disease progression|33|||
163092996|NCT00887159|589052491|FG000|Overall Study|Adverse Event|3|||
163092997|NCT00887159|589052492|FG001|Overall Study|Adverse Event|4|||
163092998|NCT00887159|589052493|FG002|Overall Study|Adverse Event|17|||
163092999|NCT00887159|589052491|FG000|Overall Study|Death|2|||
163093000|NCT00887159|589052492|FG001|Overall Study|Death|2|||
163093001|NCT00887159|589052493|FG002|Overall Study|Death|0|||
163093002|NCT00887159|589052491|FG000|Overall Study|Withdrawal by Subject|4|||
163093003|NCT00887159|589052492|FG001|Overall Study|Withdrawal by Subject|4|||
163093004|NCT00887159|589052493|FG002|Overall Study|Withdrawal by Subject|2|||
163093005|NCT00887159|589052491|FG000|Overall Study|Alternative therapy|2|||
163093006|NCT00887159|589052492|FG001|Overall Study|Alternative therapy|0|||
163093007|NCT00887159|589052493|FG002|Overall Study|Alternative therapy|0|||
163093008|NCT00887159|589052491|FG000|Overall Study|Physician Decision|1|||
163093009|NCT00887159|589052492|FG001|Overall Study|Physician Decision|1|||
163093010|NCT00887159|589052493|FG002|Overall Study|Physician Decision|0|||
163093011|NCT00887159|589052491|FG000|Overall Study|Sympomatic deterioration|1|||
163093012|NCT00887159|589052492|FG001|Overall Study|Sympomatic deterioration|0|||
163093013|NCT00887159|589052493|FG002|Overall Study|Sympomatic deterioration|0|||
163093014|NCT00887159|589052491|FG000|Overall Study|Treatment delayed|1|||
163093015|NCT00887159|589052492|FG001|Overall Study|Treatment delayed|1|||
163093016|NCT00887159|589052493|FG002|Overall Study|Treatment delayed|0|||
163093017|NCT00887159|589052491|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
163093018|NCT00887159|589052492|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
162651812|NCT02641379|587443339|FG008|Overall Study|PCR positive at Week 48|0|||
162651813|NCT02641379|587443340|FG009|Overall Study|PCR positive at Week 48|0|||
162651814|NCT02641379|587443341|FG010|Overall Study|PCR positive at Week 48|0|||
163093019|NCT00887159|589052493|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
163093020|NCT00887159|589052491|FG000|Overall Study|Received more tx instead of observation|1|||
163093021|NCT00887159|589052492|FG001|Overall Study|Received more tx instead of observation|0|||
163093022|NCT00887159|589052493|FG002|Overall Study|Received more tx instead of observation|0|||
163093023|NCT00887159|589052491|FG000|Overall Study|Ineligible|5|||
163093024|NCT00887159|589052492|FG001|Overall Study|Ineligible|1|||
163093025|NCT00887159|589052493|FG002|Overall Study|Ineligible|0|||
163093026|NCT00887159|589052491|FG000|Overall Study|Never started assigned therapy|3|||
163093027|NCT00887159|589052492|FG001|Overall Study|Never started assigned therapy|3|||
163093028|NCT00887159|589052493|FG002|Overall Study|Never started assigned therapy|4|||
162651815|NCT02641379|587443331|FG000|Overall Study|PCR not performed at Week 12|0|||
163093029|NCT03443687|589052500|FG000|Overall Study|Lost to Follow-up|3|||
163093030|NCT03443687|589052501|FG001|Overall Study|Lost to Follow-up|5|||
162651816|NCT02641379|587443332|FG001|Overall Study|PCR not performed at Week 12|0|||
163093031|NCT03443687|589052500|FG000|Overall Study|Withdrawal by Subject|1|||
163093032|NCT03443687|589052501|FG001|Overall Study|Withdrawal by Subject|0|||
163093033|NCT03443687|589052500|FG000|Overall Study|Discontinued intervention|1|||
163093034|NCT03443687|589052501|FG001|Overall Study|Discontinued intervention|1|||
163093035|NCT02805790|589052502|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
163093036|NCT02805790|589052503|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
163093037|NCT02071771|589052505|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
163093038|NCT02071771|589052506|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
163093039|NCT02071771|589052505|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
163093040|NCT02071771|589052506|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
163093041|NCT02078752|589052507|FG000|Overall Study|Death|0|||
163093042|NCT02078752|589052508|FG001|Overall Study|Death|3|||
163093043|NCT02078752|589052509|FG002|Overall Study|Death|0|||
163093044|NCT02078752|589052510|FG003|Overall Study|Death|0|||
163093045|NCT02078752|589052511|FG004|Overall Study|Death|0|||
163093046|NCT02078752|589052512|FG005|Overall Study|Death|1|||
163093047|NCT02078752|589052513|FG006|Overall Study|Death|0|||
163093048|NCT02078752|589052514|FG007|Overall Study|Death|1|||
163093049|NCT02078752|589052515|FG008|Overall Study|Death|0|||
163093050|NCT02078752|589052516|FG009|Overall Study|Death|4|||
163093051|NCT02078752|589052507|FG000|Overall Study|Lost to Follow-up|1|||
163093052|NCT02078752|589052508|FG001|Overall Study|Lost to Follow-up|0|||
163093053|NCT02078752|589052509|FG002|Overall Study|Lost to Follow-up|0|||
163093054|NCT02078752|589052510|FG003|Overall Study|Lost to Follow-up|1|||
163093055|NCT02078752|589052511|FG004|Overall Study|Lost to Follow-up|0|||
163093056|NCT02078752|589052512|FG005|Overall Study|Lost to Follow-up|0|||
163093057|NCT02078752|589052513|FG006|Overall Study|Lost to Follow-up|0|||
163093058|NCT02078752|589052514|FG007|Overall Study|Lost to Follow-up|0|||
163093059|NCT02078752|589052515|FG008|Overall Study|Lost to Follow-up|0|||
163093060|NCT02078752|589052516|FG009|Overall Study|Lost to Follow-up|0|||
163093061|NCT02078752|589052507|FG000|Overall Study|Withdrawal by Subject|1|||
163093062|NCT02078752|589052508|FG001|Overall Study|Withdrawal by Subject|1|||
163093063|NCT02078752|589052509|FG002|Overall Study|Withdrawal by Subject|1|||
163093064|NCT02078752|589052510|FG003|Overall Study|Withdrawal by Subject|1|||
163093065|NCT02078752|589052511|FG004|Overall Study|Withdrawal by Subject|0|||
163093066|NCT02078752|589052512|FG005|Overall Study|Withdrawal by Subject|3|||
163093067|NCT02078752|589052513|FG006|Overall Study|Withdrawal by Subject|2|||
163093068|NCT02078752|589052514|FG007|Overall Study|Withdrawal by Subject|1|||
163093069|NCT02078752|589052515|FG008|Overall Study|Withdrawal by Subject|0|||
163093070|NCT02078752|589052516|FG009|Overall Study|Withdrawal by Subject|1|||
163093071|NCT02078752|589052507|FG000|Overall Study|Other|0|||
163093072|NCT02078752|589052508|FG001|Overall Study|Other|3|||
163093073|NCT02078752|589052509|FG002|Overall Study|Other|0|||
163093074|NCT02078752|589052510|FG003|Overall Study|Other|0|||
163093075|NCT02078752|589052511|FG004|Overall Study|Other|1|||
163093076|NCT02078752|589052512|FG005|Overall Study|Other|0|||
163093077|NCT02078752|589052513|FG006|Overall Study|Other|0|||
163093078|NCT02078752|589052514|FG007|Overall Study|Other|1|||
163093079|NCT02078752|589052515|FG008|Overall Study|Other|0|||
163093080|NCT02078752|589052516|FG009|Overall Study|Other|0|||
163093081|NCT02078752|589052507|FG000|Overall Study|Study terminated by sponsor|0|||
163093082|NCT02078752|589052508|FG001|Overall Study|Study terminated by sponsor|0|||
163093083|NCT02078752|589052509|FG002|Overall Study|Study terminated by sponsor|0|||
163093084|NCT02078752|589052510|FG003|Overall Study|Study terminated by sponsor|0|||
163093085|NCT02078752|589052511|FG004|Overall Study|Study terminated by sponsor|0|||
163093086|NCT02078752|589052512|FG005|Overall Study|Study terminated by sponsor|0|||
163093087|NCT02078752|589052513|FG006|Overall Study|Study terminated by sponsor|0|||
163093088|NCT02078752|589052514|FG007|Overall Study|Study terminated by sponsor|0|||
163093089|NCT02078752|589052515|FG008|Overall Study|Study terminated by sponsor|0|||
163093090|NCT02078752|589052516|FG009|Overall Study|Study terminated by sponsor|5|||
163093091|NCT00592631|589052517|FG000|Overall Study|Lost to Follow-up|0|||
163093092|NCT00592631|589052518|FG001|Overall Study|Lost to Follow-up|2|||
163093093|NCT00616642|589052521|FG000|Overall Study|Withdrawal by Subject|0|||
163093094|NCT00616642|589052522|FG001|Overall Study|Withdrawal by Subject|1|||
163093095|NCT00570323|589052523|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
163093096|NCT00570323|589052524|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
163093097|NCT00570323|589052523|FG000|Started Treatment After Randomization|Protocol Violation|1|||
163093098|NCT00570323|589052524|FG001|Started Treatment After Randomization|Protocol Violation|0|||
163093099|NCT00570323|589052523|FG000|Started Treatment After Randomization|Physician Decision|1|||
163093100|NCT00570323|589052524|FG001|Started Treatment After Randomization|Physician Decision|0|||
163093101|NCT00570323|589052523|FG000|Complete Study After Start|Lost to Follow-up|0|||
163093102|NCT00570323|589052524|FG001|Complete Study After Start|Lost to Follow-up|1|||
163093103|NCT00570323|589052523|FG000|Complete Study After Start|Withdrawal by Subject|2|||
163093104|NCT00570323|589052524|FG001|Complete Study After Start|Withdrawal by Subject|0|||
163093105|NCT00570323|589052523|FG000|Complete Study After Start|Physician Decision|1|||
163093106|NCT00570323|589052524|FG001|Complete Study After Start|Physician Decision|0|||
163093107|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Physician Decision|0|||
163093108|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Physician Decision|0|||
163093109|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Physician Decision|1|||
163093110|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Physician Decision|0|||
163093111|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
163093112|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
163093113|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
163093114|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
163093115|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
163093116|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
163093117|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
163093118|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
163093119|NCT02266147|589052527|FG000|PART 1: Dose Escalation|Other|1|||
163093120|NCT02266147|589052528|FG001|PART 1: Dose Escalation|Other|1|||
163093121|NCT02266147|589052529|FG002|PART 1: Dose Escalation|Other|0|||
163093122|NCT02266147|589052530|FG003|PART 1: Dose Escalation|Other|0|||
163093123|NCT02266147|589052527|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
163093124|NCT02266147|589052528|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
163093125|NCT02266147|589052529|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
163093126|NCT02266147|589052530|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
163093127|NCT02266147|589052527|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
163093128|NCT02266147|589052528|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
163093129|NCT02266147|589052529|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
163093130|NCT02266147|589052530|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
163093131|NCT01567722|589052537|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
163093132|NCT01567722|589052538|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
163093133|NCT01567722|589052539|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
163093134|NCT01567722|589052537|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
163093135|NCT01567722|589052538|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
163093136|NCT01567722|589052539|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
163093137|NCT01567722|589052537|FG000|Overall Study|Protocol closure by the OCG|2|||
163093138|NCT01567722|589052538|FG001|Overall Study|Protocol closure by the OCG|0|||
163093139|NCT01567722|589052539|FG002|Overall Study|Protocol closure by the OCG|0|||
163093140|NCT01567722|589052537|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
163093141|NCT01567722|589052538|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
163093142|NCT01567722|589052539|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
163093143|NCT02259114|589052541|FG000|Overall Study|Progressive Disease|14|||
163093144|NCT02259114|589052542|FG001|Overall Study|Progressive Disease|2|||
163093145|NCT02259114|589052543|FG002|Overall Study|Progressive Disease|10|||
163093146|NCT02259114|589052544|FG003|Overall Study|Progressive Disease|2|||
163093147|NCT02259114|589052545|FG004|Overall Study|Progressive Disease|5|||
163093148|NCT02259114|589052541|FG000|Overall Study|Adverse Event|2|||
163093149|NCT02259114|589052542|FG001|Overall Study|Adverse Event|1|||
163093150|NCT02259114|589052543|FG002|Overall Study|Adverse Event|0|||
163093151|NCT02259114|589052544|FG003|Overall Study|Adverse Event|0|||
163093152|NCT02259114|589052545|FG004|Overall Study|Adverse Event|1|||
163093153|NCT02259114|589052541|FG000|Overall Study|Death|3|||
163093154|NCT02259114|589052542|FG001|Overall Study|Death|0|||
163093155|NCT02259114|589052543|FG002|Overall Study|Death|1|||
163093156|NCT02259114|589052544|FG003|Overall Study|Death|0|||
163093157|NCT02259114|589052545|FG004|Overall Study|Death|0|||
163093158|NCT02259114|589052541|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093159|NCT02259114|589052542|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093160|NCT02259114|589052543|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
163093161|NCT02259114|589052544|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
162651817|NCT02641379|587443333|FG002|Overall Study|PCR not performed at Week 12|1|||
162651818|NCT02641379|587443334|FG003|Overall Study|PCR not performed at Week 12|0|||
162651819|NCT02641379|587443335|FG004|Overall Study|PCR not performed at Week 12|0|||
163093162|NCT02259114|589052545|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
163093163|NCT02259114|589052541|FG000|Overall Study|Withdrawal by Subject|0|||
163093164|NCT02259114|589052542|FG001|Overall Study|Withdrawal by Subject|0|||
163093165|NCT02259114|589052543|FG002|Overall Study|Withdrawal by Subject|1|||
163093166|NCT02259114|589052544|FG003|Overall Study|Withdrawal by Subject|1|||
163093167|NCT02259114|589052545|FG004|Overall Study|Withdrawal by Subject|0|||
163093168|NCT02259114|589052541|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
163093169|NCT02259114|589052542|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
163093170|NCT02259114|589052543|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093171|NCT02259114|589052544|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093172|NCT02259114|589052545|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
163093173|NCT02259114|589052541|FG000|Overall Study|Not Treated|1|||
163093174|NCT02259114|589052542|FG001|Overall Study|Not Treated|0|||
163093175|NCT02259114|589052543|FG002|Overall Study|Not Treated|0|||
163093176|NCT02259114|589052544|FG003|Overall Study|Not Treated|0|||
163093177|NCT02259114|589052545|FG004|Overall Study|Not Treated|0|||
163093178|NCT03937479|589052546|FG000|Overall Study|Adverse Event|2|||
163093179|NCT03937479|589052547|FG001|Overall Study|Adverse Event|3|||
163093180|NCT03937479|589052548|FG002|Overall Study|Adverse Event|0|||
163093181|NCT03937479|589052549|FG003|Overall Study|Adverse Event|0|||
163093182|NCT03937479|589052550|FG004|Overall Study|Adverse Event|1|||
163093183|NCT03937479|589052546|FG000|Overall Study|Withdrawal by Subject|3|||
163093184|NCT03937479|589052547|FG001|Overall Study|Withdrawal by Subject|5|||
163093185|NCT03937479|589052548|FG002|Overall Study|Withdrawal by Subject|2|||
163093186|NCT03937479|589052549|FG003|Overall Study|Withdrawal by Subject|2|||
163093187|NCT03937479|589052550|FG004|Overall Study|Withdrawal by Subject|1|||
163093188|NCT03937479|589052546|FG000|Overall Study|Protocol Violation|5|||
163093189|NCT03937479|589052547|FG001|Overall Study|Protocol Violation|6|||
163093190|NCT03937479|589052548|FG002|Overall Study|Protocol Violation|4|||
163093191|NCT03937479|589052549|FG003|Overall Study|Protocol Violation|3|||
163093192|NCT03937479|589052550|FG004|Overall Study|Protocol Violation|2|||
163093193|NCT03937479|589052546|FG000|Overall Study|Lost to Follow-up|0|||
163093194|NCT03937479|589052547|FG001|Overall Study|Lost to Follow-up|1|||
163093195|NCT03937479|589052548|FG002|Overall Study|Lost to Follow-up|0|||
163093196|NCT03937479|589052549|FG003|Overall Study|Lost to Follow-up|1|||
163093197|NCT03937479|589052550|FG004|Overall Study|Lost to Follow-up|0|||
163093198|NCT03937479|589052546|FG000|Overall Study|Physician Decision|0|||
163093199|NCT03937479|589052547|FG001|Overall Study|Physician Decision|0|||
163093200|NCT03937479|589052548|FG002|Overall Study|Physician Decision|1|||
163093201|NCT03937479|589052549|FG003|Overall Study|Physician Decision|0|||
163093202|NCT03937479|589052550|FG004|Overall Study|Physician Decision|1|||
163093203|NCT02712788|589052553|FG000|Overall Study|Physician Decision|1|||
163093204|NCT02712788|589052554|FG001|Overall Study|Physician Decision|0|||
163093205|NCT02712788|589052553|FG000|Overall Study|Protocol Violation|1|||
163093206|NCT02712788|589052554|FG001|Overall Study|Protocol Violation|0|||
163093207|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
163093208|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
163093209|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
163093210|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
163093211|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
163093212|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
163093213|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
163093214|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
163093215|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
163093216|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
163093217|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
163093218|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
163093219|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
163093220|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
163093221|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
163093222|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
163093223|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
163093224|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
163093225|NCT03789292|589052556|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
163093226|NCT03789292|589052557|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
163093227|NCT03789292|589052558|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
163093228|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
163093229|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
163093230|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
163093231|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
163093232|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
163093233|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
163093234|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
163093235|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
163093236|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
163093237|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
163093238|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
163093239|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
163093240|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
163093241|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
163093242|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
163093243|NCT03789292|589052556|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
163093244|NCT03789292|589052557|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
163093245|NCT03789292|589052558|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
163093246|NCT01904721|589052561|FG000|Overall Study|Other Reasons|0|||
163093247|NCT01904721|589052562|FG001|Overall Study|Other Reasons|0|||
163093248|NCT01904721|589052563|FG002|Overall Study|Other Reasons|1|||
163093249|NCT01904721|589052564|FG003|Overall Study|Other Reasons|1|||
163093250|NCT01904721|589052565|FG004|Overall Study|Other Reasons|2|||
163093251|NCT01904721|589052566|FG005|Overall Study|Other Reasons|2|||
163093252|NCT01904721|589052567|FG006|Overall Study|Other Reasons|2|||
163093253|NCT01904721|589052561|FG000|Overall Study|Personal Reasons|0|||
163093254|NCT01904721|589052562|FG001|Overall Study|Personal Reasons|0|||
163093255|NCT01904721|589052563|FG002|Overall Study|Personal Reasons|0|||
163093256|NCT01904721|589052564|FG003|Overall Study|Personal Reasons|0|||
163093257|NCT01904721|589052565|FG004|Overall Study|Personal Reasons|2|||
163093258|NCT01904721|589052566|FG005|Overall Study|Personal Reasons|3|||
163093259|NCT01904721|589052567|FG006|Overall Study|Personal Reasons|3|||
162651820|NCT02641379|587443336|FG005|Overall Study|PCR not performed at Week 12|0|||
162651821|NCT02641379|587443337|FG006|Overall Study|PCR not performed at Week 12|0|||
162651822|NCT02641379|587443338|FG007|Overall Study|PCR not performed at Week 12|0|||
162651823|NCT02641379|587443339|FG008|Overall Study|PCR not performed at Week 12|0|||
162651824|NCT02641379|587443340|FG009|Overall Study|PCR not performed at Week 12|0|||
162651825|NCT02641379|587443341|FG010|Overall Study|PCR not performed at Week 12|0|||
162651826|NCT02641379|587443331|FG000|Overall Study|No PCR at baseline|0|||
162651827|NCT02641379|587443332|FG001|Overall Study|No PCR at baseline|0|||
162651828|NCT02641379|587443333|FG002|Overall Study|No PCR at baseline|1|||
162651829|NCT02641379|587443334|FG003|Overall Study|No PCR at baseline|0|||
162651830|NCT02641379|587443335|FG004|Overall Study|No PCR at baseline|0|||
162651831|NCT02641379|587443336|FG005|Overall Study|No PCR at baseline|0|||
162651832|NCT02641379|587443337|FG006|Overall Study|No PCR at baseline|0|||
162651833|NCT02641379|587443338|FG007|Overall Study|No PCR at baseline|0|||
162651834|NCT02641379|587443339|FG008|Overall Study|No PCR at baseline|0|||
162651835|NCT02641379|587443340|FG009|Overall Study|No PCR at baseline|0|||
162651836|NCT02641379|587443341|FG010|Overall Study|No PCR at baseline|0|||
162651837|NCT02641379|587443331|FG000|Overall Study|PCR positive at Week 28|0|||
163093260|NCT01904721|589052561|FG000|Overall Study|Lost to Follow-up|0|||
163093261|NCT01904721|589052562|FG001|Overall Study|Lost to Follow-up|0|||
163093262|NCT01904721|589052563|FG002|Overall Study|Lost to Follow-up|0|||
163093263|NCT01904721|589052564|FG003|Overall Study|Lost to Follow-up|0|||
163093264|NCT01904721|589052565|FG004|Overall Study|Lost to Follow-up|1|||
163093265|NCT01904721|589052566|FG005|Overall Study|Lost to Follow-up|3|||
163093266|NCT01904721|589052567|FG006|Overall Study|Lost to Follow-up|1|||
163093267|NCT01904721|589052561|FG000|Overall Study|Lack of Efficacy|0|||
163093268|NCT01904721|589052562|FG001|Overall Study|Lack of Efficacy|0|||
163093269|NCT01904721|589052563|FG002|Overall Study|Lack of Efficacy|0|||
163093270|NCT01904721|589052564|FG003|Overall Study|Lack of Efficacy|0|||
163093271|NCT01904721|589052565|FG004|Overall Study|Lack of Efficacy|0|||
163093272|NCT01904721|589052566|FG005|Overall Study|Lack of Efficacy|0|||
163093273|NCT01904721|589052567|FG006|Overall Study|Lack of Efficacy|1|||
163093274|NCT01904721|589052561|FG000|Overall Study|Adverse Event|0|||
163093275|NCT01904721|589052562|FG001|Overall Study|Adverse Event|0|||
163093276|NCT01904721|589052563|FG002|Overall Study|Adverse Event|0|||
163093277|NCT01904721|589052564|FG003|Overall Study|Adverse Event|0|||
163093278|NCT01904721|589052565|FG004|Overall Study|Adverse Event|3|||
163093279|NCT01904721|589052566|FG005|Overall Study|Adverse Event|1|||
163093280|NCT01904721|589052567|FG006|Overall Study|Adverse Event|0|||
163093281|NCT00532844|589052569|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
163093282|NCT00532844|589052570|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
163093283|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
163093284|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
163093285|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
163093286|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
163093287|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
163093288|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
163093289|NCT00532844|589052569|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
162651838|NCT02641379|587443332|FG001|Overall Study|PCR positive at Week 28|0|||
162651839|NCT02641379|587443333|FG002|Overall Study|PCR positive at Week 28|1|||
162651840|NCT02641379|587443334|FG003|Overall Study|PCR positive at Week 28|0|||
162651841|NCT02641379|587443335|FG004|Overall Study|PCR positive at Week 28|0|||
162651842|NCT02641379|587443336|FG005|Overall Study|PCR positive at Week 28|0|||
162651843|NCT02641379|587443337|FG006|Overall Study|PCR positive at Week 28|0|||
162651844|NCT02641379|587443338|FG007|Overall Study|PCR positive at Week 28|0|||
162651845|NCT02641379|587443339|FG008|Overall Study|PCR positive at Week 28|0|||
162651846|NCT02641379|587443340|FG009|Overall Study|PCR positive at Week 28|0|||
162651847|NCT02641379|587443341|FG010|Overall Study|PCR positive at Week 28|0|||
163093290|NCT00532844|589052570|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
163093291|NCT01077063|589052571|FG000|Overall Study|Adverse Event|3|||
163093292|NCT01077063|589052572|FG001|Overall Study|Adverse Event|0|||
163093293|NCT01077063|589052571|FG000|Overall Study|Death|1|||
163093294|NCT01077063|589052572|FG001|Overall Study|Death|1|||
163093295|NCT01077063|589052571|FG000|Overall Study|Withdrawal by Subject|0|||
163093296|NCT01077063|589052572|FG001|Overall Study|Withdrawal by Subject|2|||
163093297|NCT00553631|589052574|FG000|Overall Study|Withdrawal by Subject|0|||
163093298|NCT00553631|589052575|FG001|Overall Study|Withdrawal by Subject|1|||
163093299|NCT00553631|589052574|FG000|Overall Study|Lost to Follow-up|1|||
163093300|NCT00553631|589052575|FG001|Overall Study|Lost to Follow-up|0|||
163093301|NCT00251693|589052576|FG000|Overall Study|Adverse Event|17|||
163093302|NCT00251693|589052577|FG001|Overall Study|Adverse Event|9|||
163093303|NCT00251693|589052578|FG002|Overall Study|Adverse Event|9|||
163093304|NCT00251693|589052576|FG000|Overall Study|Protocol Violation|2|||
163093305|NCT00251693|589052577|FG001|Overall Study|Protocol Violation|0|||
163093306|NCT00251693|589052578|FG002|Overall Study|Protocol Violation|2|||
163093307|NCT00251693|589052576|FG000|Overall Study|Lost to Follow-up|12|||
163093308|NCT00251693|589052577|FG001|Overall Study|Lost to Follow-up|7|||
163093309|NCT00251693|589052578|FG002|Overall Study|Lost to Follow-up|8|||
163093310|NCT00251693|589052576|FG000|Overall Study|Withdrawal by Subject|11|||
163093311|NCT00251693|589052577|FG001|Overall Study|Withdrawal by Subject|17|||
163093312|NCT00251693|589052578|FG002|Overall Study|Withdrawal by Subject|14|||
163093313|NCT00251693|589052576|FG000|Overall Study|Lack of Efficacy|0|||
163093314|NCT00251693|589052577|FG001|Overall Study|Lack of Efficacy|1|||
163093315|NCT00251693|589052578|FG002|Overall Study|Lack of Efficacy|0|||
162651848|NCT02641379|587443331|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
162651849|NCT02641379|587443332|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
162651850|NCT02641379|587443333|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
162651851|NCT02641379|587443334|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
162651852|NCT02641379|587443335|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
162651853|NCT02641379|587443336|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
162651854|NCT02641379|587443337|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
163093316|NCT00251693|589052576|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
163093317|NCT00251693|589052577|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
163093318|NCT00251693|589052578|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
163093319|NCT00251693|589052576|FG000|Overall Study|Noncompliant|0|||
163093320|NCT00251693|589052577|FG001|Overall Study|Noncompliant|0|||
163093321|NCT00251693|589052578|FG002|Overall Study|Noncompliant|2|||
163093322|NCT00251693|589052576|FG000|Overall Study|Possible Barrett's esophagus|3|||
163093323|NCT00251693|589052577|FG001|Overall Study|Possible Barrett's esophagus|5|||
163093324|NCT00251693|589052578|FG002|Overall Study|Possible Barrett's esophagus|2|||
163093325|NCT00251693|589052576|FG000|Overall Study|Subject request/subject unavailable|1|||
163093326|NCT00251693|589052577|FG001|Overall Study|Subject request/subject unavailable|2|||
163093327|NCT00251693|589052578|FG002|Overall Study|Subject request/subject unavailable|0|||
163093328|NCT00251693|589052576|FG000|Overall Study|Abnormal laboratory findings|0|||
163093329|NCT00251693|589052577|FG001|Overall Study|Abnormal laboratory findings|0|||
163093330|NCT00251693|589052578|FG002|Overall Study|Abnormal laboratory findings|1|||
163093331|NCT01816048|589052581|FG000|Overall Study|Adverse Event|1|||
163093332|NCT01816048|589052581|FG000|Overall Study|Death|1|||
163093333|NCT01816048|589052581|FG000|Overall Study|Withdrawal by Subject|1|||
163093334|NCT01816048|589052581|FG000|Overall Study|Disease Progression|3|||
163093335|NCT02031302|589052582|FG000|Overall Study|Death|115|||
163093336|NCT02031302|589052583|FG001|Overall Study|Death|0|||
163093337|NCT02031302|589052582|FG000|Overall Study|Not treated with study valve system|18|||
163093338|NCT02031302|589052583|FG001|Overall Study|Not treated with study valve system|0|||
163093339|NCT02031302|589052582|FG000|Overall Study|Missed Follow Up|27|||
163093340|NCT02031302|589052583|FG001|Overall Study|Missed Follow Up|0|||
163093341|NCT02031302|589052582|FG000|Overall Study|Lost to Follow-up|4|||
163093342|NCT02031302|589052583|FG001|Overall Study|Lost to Follow-up|0|||
163093343|NCT01847443|589052584|FG000|Study Period 1|Withdrawal by Subject|0|||
163093344|NCT01847443|589052585|FG001|Study Period 1|Withdrawal by Subject|1|||
163093345|NCT01847443|589052586|FG002|Study Period 1|Withdrawal by Subject|0|||
163093346|NCT01847443|589052587|FG003|Study Period 1|Withdrawal by Subject|0|||
163093347|NCT01847443|589052584|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
163093348|NCT01847443|589052585|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
163093349|NCT01847443|589052586|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
163093350|NCT01847443|589052587|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
163093351|NCT01847443|589052584|FG000|Washout Period Before Study Period 2|Other reason|1|||
163093352|NCT01847443|589052585|FG001|Washout Period Before Study Period 2|Other reason|0|||
163093353|NCT01847443|589052586|FG002|Washout Period Before Study Period 2|Other reason|0|||
163093354|NCT01847443|589052587|FG003|Washout Period Before Study Period 2|Other reason|0|||
163093355|NCT01847443|589052584|FG000|Washout Period Before Study Period 3|Other reason|1|||
162651855|NCT02641379|587443338|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
163093356|NCT01847443|589052585|FG001|Washout Period Before Study Period 3|Other reason|0|||
163093357|NCT01847443|589052586|FG002|Washout Period Before Study Period 3|Other reason|0|||
163093358|NCT01847443|589052587|FG003|Washout Period Before Study Period 3|Other reason|0|||
163093359|NCT01847443|589052584|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
162651856|NCT02641379|587443339|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
162651857|NCT02641379|587443340|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
162651858|NCT02641379|587443341|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
162651859|NCT02641379|587443331|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
162651860|NCT02641379|587443332|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
162651861|NCT02641379|587443333|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
162651862|NCT02641379|587443334|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
162651863|NCT02641379|587443335|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
162651864|NCT02641379|587443336|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
162651865|NCT02641379|587443337|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
162651866|NCT02641379|587443338|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
162651867|NCT02641379|587443339|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
162651868|NCT02641379|587443340|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
162651869|NCT02641379|587443341|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
162651870|NCT02641379|587443331|FG000|Overall Study|Baseline viral load unavailable|0|||
162651871|NCT02641379|587443332|FG001|Overall Study|Baseline viral load unavailable|0|||
162651872|NCT02641379|587443333|FG002|Overall Study|Baseline viral load unavailable|0|||
162651873|NCT02641379|587443334|FG003|Overall Study|Baseline viral load unavailable|1|||
162651874|NCT02641379|587443335|FG004|Overall Study|Baseline viral load unavailable|0|||
162651875|NCT02641379|587443336|FG005|Overall Study|Baseline viral load unavailable|0|||
162651876|NCT02641379|587443337|FG006|Overall Study|Baseline viral load unavailable|0|||
162651877|NCT02641379|587443338|FG007|Overall Study|Baseline viral load unavailable|0|||
162651878|NCT02641379|587443339|FG008|Overall Study|Baseline viral load unavailable|0|||
162651879|NCT02641379|587443340|FG009|Overall Study|Baseline viral load unavailable|0|||
162651880|NCT02641379|587443341|FG010|Overall Study|Baseline viral load unavailable|0|||
162651881|NCT02641379|587443331|FG000|Overall Study|Blood could not be drawn|0|||
162651882|NCT02641379|587443332|FG001|Overall Study|Blood could not be drawn|0|||
162651883|NCT02641379|587443333|FG002|Overall Study|Blood could not be drawn|0|||
162651884|NCT02641379|587443334|FG003|Overall Study|Blood could not be drawn|0|||
162651885|NCT02641379|587443335|FG004|Overall Study|Blood could not be drawn|1|||
162651886|NCT02641379|587443336|FG005|Overall Study|Blood could not be drawn|0|||
162651887|NCT02641379|587443337|FG006|Overall Study|Blood could not be drawn|0|||
162651888|NCT02641379|587443338|FG007|Overall Study|Blood could not be drawn|0|||
162651889|NCT02641379|587443339|FG008|Overall Study|Blood could not be drawn|0|||
162651890|NCT02641379|587443340|FG009|Overall Study|Blood could not be drawn|0|||
162651891|NCT02641379|587443341|FG010|Overall Study|Blood could not be drawn|0|||
162651892|NCT02641379|587443331|FG000|Overall Study|Protocol Violation|0|||
162651893|NCT02641379|587443332|FG001|Overall Study|Protocol Violation|0|||
162651894|NCT02641379|587443333|FG002|Overall Study|Protocol Violation|0|||
162651895|NCT02641379|587443334|FG003|Overall Study|Protocol Violation|0|||
163093360|NCT01847443|589052585|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093361|NCT01847443|589052586|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093362|NCT01847443|589052587|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
163093363|NCT01847443|589052584|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
163093364|NCT01847443|589052585|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093365|NCT01847443|589052586|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093366|NCT01847443|589052587|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
163093367|NCT04067492|589052588|FG000|Overall Study|Lost to Follow-up|0|||
163093368|NCT04067492|589052589|FG001|Overall Study|Lost to Follow-up|0|||
163093369|NCT04067492|589052590|FG002|Overall Study|Lost to Follow-up|0|||
163093370|NCT04067492|589052591|FG003|Overall Study|Lost to Follow-up|0|||
163093371|NCT04067492|589052592|FG004|Overall Study|Lost to Follow-up|0|||
163093372|NCT04067492|589052593|FG005|Overall Study|Lost to Follow-up|1|||
163093373|NCT04067492|589052588|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
162651896|NCT02641379|587443335|FG004|Overall Study|Protocol Violation|2|||
162651897|NCT02641379|587443336|FG005|Overall Study|Protocol Violation|0|||
162651898|NCT02641379|587443337|FG006|Overall Study|Protocol Violation|0|||
162651899|NCT02641379|587443338|FG007|Overall Study|Protocol Violation|0|||
162651900|NCT02641379|587443339|FG008|Overall Study|Protocol Violation|1|||
162651901|NCT02641379|587443340|FG009|Overall Study|Protocol Violation|0|||
162651902|NCT02641379|587443341|FG010|Overall Study|Protocol Violation|0|||
162651903|NCT02641379|587443331|FG000|Overall Study|Participation in sili rescue study|0|||
162651904|NCT02641379|587443332|FG001|Overall Study|Participation in sili rescue study|0|||
162651905|NCT02641379|587443333|FG002|Overall Study|Participation in sili rescue study|0|||
162651906|NCT02641379|587443334|FG003|Overall Study|Participation in sili rescue study|0|||
163093374|NCT04067492|589052589|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
163093375|NCT04067492|589052590|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
162651907|NCT02641379|587443335|FG004|Overall Study|Participation in sili rescue study|0|||
162651908|NCT02641379|587443336|FG005|Overall Study|Participation in sili rescue study|1|||
162651909|NCT02641379|587443337|FG006|Overall Study|Participation in sili rescue study|0|||
162651910|NCT02641379|587443338|FG007|Overall Study|Participation in sili rescue study|0|||
163093376|NCT04067492|589052591|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093377|NCT04067492|589052592|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093378|NCT04067492|589052593|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163093379|NCT04067492|589052588|FG000|Overall Study|COVID-19 epidemiological situation|0|||
163093380|NCT04067492|589052589|FG001|Overall Study|COVID-19 epidemiological situation|0|||
163093381|NCT04067492|589052590|FG002|Overall Study|COVID-19 epidemiological situation|0|||
163093382|NCT04067492|589052591|FG003|Overall Study|COVID-19 epidemiological situation|1|||
163093383|NCT04067492|589052592|FG004|Overall Study|COVID-19 epidemiological situation|0|||
163093384|NCT04067492|589052593|FG005|Overall Study|COVID-19 epidemiological situation|0|||
163093385|NCT05899829|589052600|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
163093386|NCT05899829|589052601|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
163093387|NCT05899829|589052600|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
163093388|NCT05899829|589052601|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
163093389|NCT05076045|589052602|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
163093390|NCT05076045|589052603|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
163093391|NCT00038948|589052608|FG000|Overall Study|Adverse Event|131|||
163093392|NCT00038948|589052609|FG001|Overall Study|Adverse Event|43|||
162651911|NCT02641379|587443339|FG008|Overall Study|Participation in sili rescue study|0|||
162651912|NCT02641379|587443340|FG009|Overall Study|Participation in sili rescue study|0|||
162651913|NCT02641379|587443341|FG010|Overall Study|Participation in sili rescue study|0|||
162651914|NCT02641379|587443331|FG000|Overall Study|Lost to Follow-up|0|||
162651915|NCT02641379|587443332|FG001|Overall Study|Lost to Follow-up|0|||
162651916|NCT02641379|587443333|FG002|Overall Study|Lost to Follow-up|0|||
162651917|NCT02641379|587443334|FG003|Overall Study|Lost to Follow-up|0|||
162651918|NCT02641379|587443335|FG004|Overall Study|Lost to Follow-up|0|||
162651919|NCT02641379|587443336|FG005|Overall Study|Lost to Follow-up|0|||
162651920|NCT02641379|587443337|FG006|Overall Study|Lost to Follow-up|0|||
162651921|NCT02641379|587443338|FG007|Overall Study|Lost to Follow-up|0|||
162651922|NCT02641379|587443339|FG008|Overall Study|Lost to Follow-up|1|||
162651923|NCT02641379|587443340|FG009|Overall Study|Lost to Follow-up|0|||
162651924|NCT02641379|587443341|FG010|Overall Study|Lost to Follow-up|0|||
162651925|NCT02641379|587443331|FG000|Overall Study|Source data not found|0|||
162651926|NCT02641379|587443332|FG001|Overall Study|Source data not found|0|||
162651927|NCT02641379|587443333|FG002|Overall Study|Source data not found|0|||
162651928|NCT02641379|587443334|FG003|Overall Study|Source data not found|0|||
162651929|NCT02641379|587443335|FG004|Overall Study|Source data not found|0|||
162651930|NCT02641379|587443336|FG005|Overall Study|Source data not found|1|||
162651931|NCT02641379|587443337|FG006|Overall Study|Source data not found|0|||
162651932|NCT02641379|587443338|FG007|Overall Study|Source data not found|0|||
162651933|NCT02641379|587443339|FG008|Overall Study|Source data not found|0|||
162651934|NCT02641379|587443340|FG009|Overall Study|Source data not found|0|||
162651935|NCT02641379|587443341|FG010|Overall Study|Source data not found|0|||
162651936|NCT02641379|587443331|FG000|Overall Study|Participant showed weight reduction|0|||
162651937|NCT02641379|587443332|FG001|Overall Study|Participant showed weight reduction|0|||
162651938|NCT02641379|587443333|FG002|Overall Study|Participant showed weight reduction|0|||
162651939|NCT02641379|587443334|FG003|Overall Study|Participant showed weight reduction|0|||
162651940|NCT02641379|587443335|FG004|Overall Study|Participant showed weight reduction|0|||
162651941|NCT02641379|587443336|FG005|Overall Study|Participant showed weight reduction|0|||
162651942|NCT02641379|587443337|FG006|Overall Study|Participant showed weight reduction|0|||
162651943|NCT02641379|587443338|FG007|Overall Study|Participant showed weight reduction|1|||
162651944|NCT02641379|587443339|FG008|Overall Study|Participant showed weight reduction|0|||
162651945|NCT02641379|587443340|FG009|Overall Study|Participant showed weight reduction|0|||
162651946|NCT02641379|587443341|FG010|Overall Study|Participant showed weight reduction|0|||
162651947|NCT02641379|587443331|FG000|Overall Study|Non-response Week 12|0|||
162651948|NCT02641379|587443332|FG001|Overall Study|Non-response Week 12|0|||
162651949|NCT02641379|587443333|FG002|Overall Study|Non-response Week 12|0|||
162651950|NCT02641379|587443334|FG003|Overall Study|Non-response Week 12|0|||
162651951|NCT02641379|587443335|FG004|Overall Study|Non-response Week 12|0|||
163093393|NCT00038948|589052608|FG000|Overall Study|Lost to Follow-up|4|||
162651952|NCT02641379|587443336|FG005|Overall Study|Non-response Week 12|0|||
162651953|NCT02641379|587443337|FG006|Overall Study|Non-response Week 12|0|||
162651954|NCT02641379|587443338|FG007|Overall Study|Non-response Week 12|1|||
162651955|NCT02641379|587443339|FG008|Overall Study|Non-response Week 12|0|||
162651956|NCT02641379|587443340|FG009|Overall Study|Non-response Week 12|0|||
163093394|NCT00038948|589052609|FG001|Overall Study|Lost to Follow-up|4|||
162651957|NCT02641379|587443341|FG010|Overall Study|Non-response Week 12|0|||
162719017|NCT02341625|587676741|FG004|Overall Study|Completed Treatment as per Protocol|0|||
162719018|NCT02341625|587676742|FG005|Overall Study|Completed Treatment as per Protocol|0|||
162719019|NCT02341625|587676743|FG006|Overall Study|Completed Treatment as per Protocol|0|||
162651958|NCT02641379|587443331|FG000|Overall Study|No 2 Log drop at Week 12|0|||
162651959|NCT02641379|587443332|FG001|Overall Study|No 2 Log drop at Week 12|0|||
162651960|NCT02641379|587443333|FG002|Overall Study|No 2 Log drop at Week 12|0|||
163093395|NCT00038948|589052608|FG000|Overall Study|Nonmedical event|5|||
163093396|NCT00038948|589052609|FG001|Overall Study|Nonmedical event|7|||
163093397|NCT00038948|589052608|FG000|Overall Study|Withdrawal by Subject|23|||
163093398|NCT00038948|589052609|FG001|Overall Study|Withdrawal by Subject|10|||
163093399|NCT00038948|589052608|FG000|Overall Study|Protocol Violation|3|||
163093400|NCT00038948|589052609|FG001|Overall Study|Protocol Violation|7|||
163093401|NCT00038948|589052608|FG000|Overall Study|Lack of Efficacy|3|||
163093402|NCT00038948|589052609|FG001|Overall Study|Lack of Efficacy|6|||
163093403|NCT05270863|589052610|FG000|Visit 2 First Intervention|Randomization error|0|||
163093404|NCT05270863|589052611|FG001|Visit 2 First Intervention|Randomization error|0|||
163093405|NCT05270863|589052612|FG002|Visit 2 First Intervention|Randomization error|0|||
163093406|NCT05270863|589052613|FG003|Visit 2 First Intervention|Randomization error|1|||
163093407|NCT05270863|589052614|FG004|Visit 2 First Intervention|Randomization error|0|||
163093408|NCT05270863|589052615|FG005|Visit 2 First Intervention|Randomization error|0|||
163093409|NCT05270863|589052610|FG000|First Washout|Withdrawal by Subject|0|||
163093410|NCT05270863|589052611|FG001|First Washout|Withdrawal by Subject|0|||
163093411|NCT05270863|589052612|FG002|First Washout|Withdrawal by Subject|0|||
163093412|NCT05270863|589052613|FG003|First Washout|Withdrawal by Subject|0|||
163093413|NCT05270863|589052614|FG004|First Washout|Withdrawal by Subject|1|||
163093414|NCT05270863|589052615|FG005|First Washout|Withdrawal by Subject|1|||
163093415|NCT05270863|589052610|FG000|First Washout|Lost to Follow-up|0|||
163093416|NCT05270863|589052611|FG001|First Washout|Lost to Follow-up|0|||
163093417|NCT05270863|589052612|FG002|First Washout|Lost to Follow-up|0|||
163093418|NCT05270863|589052613|FG003|First Washout|Lost to Follow-up|0|||
163093419|NCT05270863|589052614|FG004|First Washout|Lost to Follow-up|0|||
163093420|NCT05270863|589052615|FG005|First Washout|Lost to Follow-up|1|||
163093421|NCT05270863|589052610|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
163093422|NCT05270863|589052611|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093423|NCT05270863|589052612|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
163093424|NCT05270863|589052613|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093425|NCT05270863|589052614|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093426|NCT05270863|589052615|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
163093427|NCT05270863|589052610|FG000|Second Washout|Withdrawal by Subject|1|||
163093428|NCT05270863|589052611|FG001|Second Washout|Withdrawal by Subject|1|||
163093429|NCT05270863|589052612|FG002|Second Washout|Withdrawal by Subject|0|||
163093430|NCT05270863|589052613|FG003|Second Washout|Withdrawal by Subject|0|||
163093431|NCT05270863|589052614|FG004|Second Washout|Withdrawal by Subject|0|||
163093432|NCT05270863|589052615|FG005|Second Washout|Withdrawal by Subject|0|||
163093433|NCT05270863|589052610|FG000|Second Washout|Lost to Follow-up|0|||
163093434|NCT05270863|589052611|FG001|Second Washout|Lost to Follow-up|0|||
163093435|NCT05270863|589052612|FG002|Second Washout|Lost to Follow-up|0|||
163093436|NCT05270863|589052613|FG003|Second Washout|Lost to Follow-up|1|||
163093437|NCT05270863|589052614|FG004|Second Washout|Lost to Follow-up|0|||
163093438|NCT05270863|589052615|FG005|Second Washout|Lost to Follow-up|0|||
163093439|NCT03984188|589052616|FG000|Overall Study|Death|2|||
163093440|NCT03984188|589052617|FG001|Overall Study|Death|4|||
163093441|NCT03984188|589052616|FG000|Overall Study|Physician Decision|0|||
163093442|NCT03984188|589052617|FG001|Overall Study|Physician Decision|2|||
163093443|NCT03984188|589052616|FG000|Overall Study|Lost to Follow-up|3|||
163093444|NCT03984188|589052617|FG001|Overall Study|Lost to Follow-up|2|||
163093445|NCT03984188|589052616|FG000|Overall Study|Withdrawal by Subject|6|||
163093446|NCT03984188|589052617|FG001|Overall Study|Withdrawal by Subject|0|||
163093447|NCT00529243|589054264|FG000|Overall Study|Adverse Event|1|||
163093448|NCT00529243|589054264|FG000|Overall Study|Death|1|||
163093449|NCT00529243|589054264|FG000|Overall Study|Relocated|1|||
163093450|NCT00678288|589054271|FG000|Overall Study|Adverse Event|0|||
162651961|NCT02641379|587443334|FG003|Overall Study|No 2 Log drop at Week 12|0|||
162651962|NCT02641379|587443335|FG004|Overall Study|No 2 Log drop at Week 12|0|||
162651963|NCT02641379|587443336|FG005|Overall Study|No 2 Log drop at Week 12|0|||
162651964|NCT02641379|587443337|FG006|Overall Study|No 2 Log drop at Week 12|0|||
162651965|NCT02641379|587443338|FG007|Overall Study|No 2 Log drop at Week 12|0|||
162651966|NCT02641379|587443339|FG008|Overall Study|No 2 Log drop at Week 12|0|||
162651967|NCT02641379|587443340|FG009|Overall Study|No 2 Log drop at Week 12|0|||
163093451|NCT00678288|589054272|FG001|Overall Study|Adverse Event|2|||
163093452|NCT00678288|589054271|FG000|Overall Study|Withdrawal by Subject|1|||
163093453|NCT00678288|589054272|FG001|Overall Study|Withdrawal by Subject|1|||
162651968|NCT02641379|587443341|FG010|Overall Study|No 2 Log drop at Week 12|1|||
162651969|NCT02641379|587443331|FG000|Overall Study|Negative PCR result|0|||
162651970|NCT02641379|587443332|FG001|Overall Study|Negative PCR result|0|||
163093454|NCT00678288|589054271|FG000|Overall Study|Study terminated by the sponsor|2|||
163093455|NCT00678288|589054272|FG001|Overall Study|Study terminated by the sponsor|0|||
163093456|NCT00678288|589054271|FG000|Overall Study|Not compliant with study medication|0|||
163093457|NCT00678288|589054272|FG001|Overall Study|Not compliant with study medication|1|||
163093458|NCT00678288|589054271|FG000|Overall Study|Switch to commercial drug|0|||
163093459|NCT00678288|589054272|FG001|Overall Study|Switch to commercial drug|1|||
163093460|NCT00678288|589054271|FG000|Overall Study|Reason not reported|1|||
163093461|NCT00678288|589054272|FG001|Overall Study|Reason not reported|0|||
163093462|NCT00678288|589054271|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
163093463|NCT00678288|589054272|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
163093464|NCT04472650|589054283|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
163093465|NCT04472650|589054284|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
163093466|NCT03247829|589054287|FG000|Overall Study|Death|3|||
163093467|NCT03247829|589054288|FG001|Overall Study|Death|4|||
163093468|NCT03247829|589054287|FG000|Overall Study|Enter Hospice Care|1|||
163093469|NCT03247829|589054288|FG001|Overall Study|Enter Hospice Care|0|||
163093470|NCT03247829|589054287|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
163093471|NCT03247829|589054288|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
163093472|NCT03247829|589054287|FG000|Overall Study|LVAD Explant|1|||
163093473|NCT03247829|589054288|FG001|Overall Study|LVAD Explant|1|||
163093474|NCT03247829|589054287|FG000|Overall Study|Transplant|1|||
163093475|NCT03247829|589054288|FG001|Overall Study|Transplant|1|||
163093476|NCT01783444|589054289|FG000|Treatment Phase|Adverse Event|9|||
163093477|NCT01783444|589054290|FG001|Treatment Phase|Adverse Event|20|||
163093478|NCT01783444|589054291|FG002|Treatment Phase|Adverse Event|19|||
163093479|NCT01783444|589054289|FG000|Treatment Phase|Disease Progression|76|||
163093480|NCT01783444|589054290|FG001|Treatment Phase|Disease Progression|66|||
163093481|NCT01783444|589054291|FG002|Treatment Phase|Disease Progression|64|||
163093482|NCT01783444|589054289|FG000|Treatment Phase|Death|2|||
163093483|NCT01783444|589054290|FG001|Treatment Phase|Death|2|||
163093484|NCT01783444|589054291|FG002|Treatment Phase|Death|2|||
163093485|NCT01783444|589054289|FG000|Treatment Phase|Protocol Violation|1|||
163093486|NCT01783444|589054290|FG001|Treatment Phase|Protocol Violation|1|||
163093487|NCT01783444|589054291|FG002|Treatment Phase|Protocol Violation|2|||
163093488|NCT01783444|589054289|FG000|Treatment Phase|Withdrawal by Subject|6|||
163093489|NCT01783444|589054290|FG001|Treatment Phase|Withdrawal by Subject|8|||
163093490|NCT01783444|589054291|FG002|Treatment Phase|Withdrawal by Subject|9|||
163093491|NCT01783444|589054289|FG000|Treatment Phase|Administrative problems|2|||
163093492|NCT01783444|589054290|FG001|Treatment Phase|Administrative problems|0|||
163093493|NCT01783444|589054291|FG002|Treatment Phase|Administrative problems|1|||
163093494|NCT01783444|589054289|FG000|Treatment Phase|Physician Decision|8|||
163093495|NCT01783444|589054290|FG001|Treatment Phase|Physician Decision|6|||
163093496|NCT01783444|589054291|FG002|Treatment Phase|Physician Decision|5|||
163093497|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
163093498|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
163093499|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
163093500|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
163093501|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
163093502|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
163093503|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
163093504|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
163093505|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
163093506|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
163093507|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
163093508|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
163093509|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
163093510|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
163093511|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
163093512|NCT01783444|589054289|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
163093513|NCT01783444|589054290|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
163093514|NCT01783444|589054291|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
163093515|NCT00552071|589054293|FG000|Overall Study|Adverse Event|1|||
163093516|NCT00552071|589054294|FG001|Overall Study|Adverse Event|0|||
163093517|NCT00552071|589054293|FG000|Overall Study|Lack of Efficacy|1|||
163093518|NCT00552071|589054294|FG001|Overall Study|Lack of Efficacy|0|||
163093519|NCT00552071|589054293|FG000|Overall Study|Physician Decision|1|||
163093520|NCT00552071|589054294|FG001|Overall Study|Physician Decision|0|||
163093521|NCT00552071|589054293|FG000|Overall Study|Pregnancy|1|||
163093522|NCT00552071|589054294|FG001|Overall Study|Pregnancy|0|||
163093523|NCT00552071|589054293|FG000|Overall Study|Death|0|||
163093524|NCT00552071|589054294|FG001|Overall Study|Death|1|||
163093525|NCT00552071|589054293|FG000|Overall Study|Withdrawal by Subject|0|||
163093526|NCT00552071|589054294|FG001|Overall Study|Withdrawal by Subject|1|||
163093527|NCT00272792|589054295|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
163093528|NCT00272792|589054296|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
163093529|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
163093530|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
163093531|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
163093532|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
163093533|NCT00272792|589054295|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
163093534|NCT00272792|589054296|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
163093535|NCT00937495|589054301|FG000|Overall Study|Protocol Violation|2|||
163093536|NCT02549989|589054302|FG000|Overall Study|Adverse Event|4|||
163093537|NCT02549989|589054302|FG000|Overall Study|Death|1|||
163093538|NCT02549989|589054302|FG000|Overall Study|Lack of Efficacy|19|||
163093539|NCT02549989|589054302|FG000|Overall Study|Withdrawal by Subject|3|||
163093540|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
163093541|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093542|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093543|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093544|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093545|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093546|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093547|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093548|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
163093549|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093550|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
163093551|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
163093552|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093553|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
162651971|NCT02641379|587443333|FG002|Overall Study|Negative PCR result|0|||
162651972|NCT02641379|587443334|FG003|Overall Study|Negative PCR result|0|||
163093554|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093555|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093556|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093557|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
163093558|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
163093559|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
163093560|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
163093561|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093562|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093563|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093564|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093565|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093566|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093567|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
163093568|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
163093569|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
163093570|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093571|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093572|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093573|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093574|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093575|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
163093576|NCT02628444|589054306|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
163093577|NCT02628444|589054307|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
163093578|NCT02628444|589054308|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
163093579|NCT02628444|589054309|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093580|NCT02628444|589054310|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093581|NCT02628444|589054311|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093582|NCT02628444|589054312|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093583|NCT02628444|589054313|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093584|NCT02628444|589054314|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
163093585|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093586|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093587|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093588|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
163093589|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093590|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093591|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093592|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093593|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163093594|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093595|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093596|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
163093597|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093598|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093599|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
163093600|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
163093601|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
163093602|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
163093603|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093604|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093605|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
163093606|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
162651973|NCT02641379|587443335|FG004|Overall Study|Negative PCR result|0|||
162651974|NCT02641379|587443336|FG005|Overall Study|Negative PCR result|0|||
162651975|NCT02641379|587443337|FG006|Overall Study|Negative PCR result|0|||
162651976|NCT02641379|587443338|FG007|Overall Study|Negative PCR result|0|||
162651977|NCT02641379|587443339|FG008|Overall Study|Negative PCR result|0|||
162651978|NCT02641379|587443340|FG009|Overall Study|Negative PCR result|1|||
162651979|NCT02641379|587443341|FG010|Overall Study|Negative PCR result|0|||
162651980|NCT02641379|587443331|FG000|Overall Study|Participant's PCR high|0|||
162651981|NCT02641379|587443332|FG001|Overall Study|Participant's PCR high|0|||
162651982|NCT02641379|587443333|FG002|Overall Study|Participant's PCR high|0|||
162651983|NCT02641379|587443334|FG003|Overall Study|Participant's PCR high|0|||
162651984|NCT02641379|587443335|FG004|Overall Study|Participant's PCR high|0|||
162651985|NCT02641379|587443336|FG005|Overall Study|Participant's PCR high|0|||
162651986|NCT02641379|587443337|FG006|Overall Study|Participant's PCR high|0|||
162651987|NCT02641379|587443338|FG007|Overall Study|Participant's PCR high|1|||
162651988|NCT02641379|587443339|FG008|Overall Study|Participant's PCR high|0|||
162651989|NCT02641379|587443340|FG009|Overall Study|Participant's PCR high|0|||
162651990|NCT02641379|587443341|FG010|Overall Study|Participant's PCR high|0|||
162719020|NCT02341625|587676744|FG007|Overall Study|Completed Treatment as per Protocol|0|||
163093607|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
163093608|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
163093609|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
163093610|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
163093611|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
163093612|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093613|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093614|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093615|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093616|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
163093617|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093618|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
163093619|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
163093620|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
163093621|NCT02628444|589054306|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093622|NCT02628444|589054307|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093623|NCT02628444|589054308|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
163093624|NCT02628444|589054309|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093625|NCT02628444|589054310|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093626|NCT02628444|589054311|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
163093627|NCT02628444|589054312|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
163093628|NCT02628444|589054313|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
163093629|NCT02628444|589054314|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
163093630|NCT00288015|589054315|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
163093631|NCT00288015|589054315|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
163093632|NCT00288015|589054315|FG000|First Response Assessment|Withdrawal by Subject|1|||
163093633|NCT00288015|589054315|FG000|First Response Assessment|Death|1|||
163093634|NCT00288015|589054315|FG000|First Response Assessment|Physician Decision|2|||
163093635|NCT00288015|589054315|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
163093636|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Death|13|||
162651991|NCT02641379|587443331|FG000|Overall Study|Participant treated after Week 24|0|||
162651992|NCT02641379|587443332|FG001|Overall Study|Participant treated after Week 24|0|||
163093637|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
163093638|NCT00288015|589054315|FG000|Follow up for Survival x 2 Years|Other|9|||
163093639|NCT00443703|589054318|FG000|Overall Study|Never Treated|3|||
163093640|NCT00443703|589054319|FG001|Overall Study|Never Treated|1|||
163093641|NCT00443703|589054318|FG000|Overall Study|Adverse Event|7|||
163093642|NCT00443703|589054319|FG001|Overall Study|Adverse Event|3|||
163093643|NCT00443703|589054318|FG000|Overall Study|Lack of Efficacy|3|||
163093644|NCT00443703|589054319|FG001|Overall Study|Lack of Efficacy|1|||
163093645|NCT00443703|589054318|FG000|Overall Study|Lost to Follow-up|0|||
163093646|NCT00443703|589054319|FG001|Overall Study|Lost to Follow-up|4|||
163093647|NCT00443703|589054318|FG000|Overall Study|Physician Decision|4|||
163093648|NCT00443703|589054319|FG001|Overall Study|Physician Decision|2|||
163093649|NCT00443703|589054318|FG000|Overall Study|Protocol Violation|1|||
163093650|NCT00443703|589054319|FG001|Overall Study|Protocol Violation|1|||
163093651|NCT00443703|589054318|FG000|Overall Study|Withdrawal by Subject|9|||
163093652|NCT00443703|589054319|FG001|Overall Study|Withdrawal by Subject|6|||
163093653|NCT00443703|589054318|FG000|Overall Study|Progressive Disease|1|||
163093654|NCT00443703|589054319|FG001|Overall Study|Progressive Disease|0|||
163093655|NCT01333722|589054320|FG000|Overall Study|Lack of Efficacy|0|||
163093656|NCT01333722|589054321|FG001|Overall Study|Lack of Efficacy|2|||
163093657|NCT01333722|589054320|FG000|Overall Study|Withdrawal by Subject|0|||
163093658|NCT01333722|589054321|FG001|Overall Study|Withdrawal by Subject|1|||
163093659|NCT00784368|589054322|FG000|Overall Study|Physician Decision|0|||
163093660|NCT00784368|589054323|FG001|Overall Study|Physician Decision|0|||
163093661|NCT00784368|589054324|FG002|Overall Study|Physician Decision|6|||
163093662|NCT00784368|589054322|FG000|Overall Study|Lack of Efficacy|2|||
163093663|NCT00784368|589054323|FG001|Overall Study|Lack of Efficacy|0|||
163093664|NCT00784368|589054324|FG002|Overall Study|Lack of Efficacy|1|||
163093665|NCT00784368|589054322|FG000|Overall Study|Adverse Event|6|||
163093666|NCT00784368|589054323|FG001|Overall Study|Adverse Event|9|||
163093667|NCT00784368|589054324|FG002|Overall Study|Adverse Event|2|||
163093668|NCT00784368|589054322|FG000|Overall Study|Diagnosis of fever|0|||
163093669|NCT00784368|589054323|FG001|Overall Study|Diagnosis of fever|0|||
163093670|NCT00784368|589054324|FG002|Overall Study|Diagnosis of fever|1|||
163093671|NCT00784368|589054322|FG000|Overall Study|Worsening of complications|0|||
163093672|NCT00784368|589054323|FG001|Overall Study|Worsening of complications|0|||
163093673|NCT00784368|589054324|FG002|Overall Study|Worsening of complications|1|||
163093674|NCT00784368|589054322|FG000|Overall Study|Worsening of symptoms|0|||
163093675|NCT00784368|589054323|FG001|Overall Study|Worsening of symptoms|1|||
163093676|NCT00784368|589054324|FG002|Overall Study|Worsening of symptoms|0|||
163093677|NCT00784368|589054322|FG000|Overall Study|Withdrawal of informed consent|0|||
163093678|NCT00784368|589054323|FG001|Overall Study|Withdrawal of informed consent|1|||
163093679|NCT00784368|589054324|FG002|Overall Study|Withdrawal of informed consent|0|||
163093680|NCT02079909|589054325|FG000|Overall Study|Adverse Event|23|||
163093681|NCT02079909|589054326|FG001|Overall Study|Adverse Event|23|||
163093682|NCT02079909|589054327|FG002|Overall Study|Adverse Event|7|||
163093683|NCT02079909|589054325|FG000|Overall Study|Withdrawal by Subject|9|||
163093684|NCT02079909|589054326|FG001|Overall Study|Withdrawal by Subject|17|||
163093685|NCT02079909|589054327|FG002|Overall Study|Withdrawal by Subject|4|||
163093686|NCT02079909|589054325|FG000|Overall Study|Lost to Follow-up|2|||
163093687|NCT02079909|589054326|FG001|Overall Study|Lost to Follow-up|3|||
163093688|NCT02079909|589054327|FG002|Overall Study|Lost to Follow-up|1|||
163093689|NCT02079909|589054325|FG000|Overall Study|Death|2|||
163093690|NCT02079909|589054326|FG001|Overall Study|Death|2|||
163093691|NCT02079909|589054327|FG002|Overall Study|Death|0|||
163093692|NCT02079909|589054325|FG000|Overall Study|Lack of Efficacy|0|||
163093693|NCT02079909|589054326|FG001|Overall Study|Lack of Efficacy|0|||
163093694|NCT02079909|589054327|FG002|Overall Study|Lack of Efficacy|1|||
163093695|NCT02079909|589054325|FG000|Overall Study|Protocol Violation|0|||
163093696|NCT02079909|589054326|FG001|Overall Study|Protocol Violation|1|||
163093697|NCT02079909|589054327|FG002|Overall Study|Protocol Violation|1|||
163093698|NCT02079909|589054325|FG000|Overall Study|Physician Decision|0|||
163093699|NCT02079909|589054326|FG001|Overall Study|Physician Decision|1|||
163093700|NCT02079909|589054327|FG002|Overall Study|Physician Decision|1|||
162651993|NCT02641379|587443333|FG002|Overall Study|Participant treated after Week 24|0|||
162651994|NCT02641379|587443334|FG003|Overall Study|Participant treated after Week 24|0|||
163093701|NCT02079909|589054325|FG000|Overall Study|Relocation etc.|2|||
163093702|NCT02079909|589054326|FG001|Overall Study|Relocation etc.|2|||
163093703|NCT02079909|589054327|FG002|Overall Study|Relocation etc.|3|||
163093704|NCT00720356|589054332|FG000|Registration to Study|Determined to have methylated MGMT|67|||
163093705|NCT00720356|589054332|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
163093706|NCT00720356|589054332|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
163093707|NCT00720356|589054332|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
163093708|NCT00720356|589054332|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
163093709|NCT00720356|589054332|FG000|Follow up Until Death|Withdrawal by Subject|1|||
163093710|NCT00720356|589054332|FG000|Follow up Until Death|Alive at last data collection|4|||
163093711|NCT02237001|589054335|FG000|Overall Study|Lost to Follow-up|2|||
163093712|NCT02237001|589054335|FG000|Overall Study|Withdrawal by Subject|1|||
163093713|NCT02237001|589054335|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
163093714|NCT02237001|589054335|FG000|Overall Study|Re-operation|4|||
163093715|NCT02237001|589054335|FG000|Overall Study|Incarceration|1|||
163093716|NCT01047007|589054336|FG000|Overall Study|Adverse Event|0|||
163093717|NCT01047007|589054337|FG001|Overall Study|Adverse Event|2|||
163093718|NCT01047007|589054338|FG002|Overall Study|Adverse Event|1|||
163093719|NCT01047007|589054339|FG003|Overall Study|Adverse Event|0|||
163093720|NCT01047007|589054336|FG000|Overall Study|Progressive Disease|2|||
163093721|NCT01047007|589054337|FG001|Overall Study|Progressive Disease|4|||
163093722|NCT01047007|589054338|FG002|Overall Study|Progressive Disease|1|||
163093723|NCT01047007|589054339|FG003|Overall Study|Progressive Disease|0|||
163093724|NCT03759600|589054342|FG000|Overall Study|Adverse Event|2|||
163093725|NCT03759600|589054342|FG000|Overall Study|Progressive Disease|15|||
163093726|NCT03759600|589054342|FG000|Overall Study|Site Terminated by Sponsor|3|||
163093727|NCT00457392|589054344|FG000|Overall Study|Objective Progression or Relapse|229|||
163093728|NCT00457392|589054345|FG001|Overall Study|Objective Progression or Relapse|296|||
163093729|NCT00457392|589054344|FG000|Overall Study|Death|106|||
163093730|NCT00457392|589054345|FG001|Overall Study|Death|106|||
163093731|NCT00457392|589054344|FG000|Overall Study|Adverse Event|84|||
163093732|NCT00457392|589054345|FG001|Overall Study|Adverse Event|41|||
163093733|NCT00457392|589054344|FG000|Overall Study|Global Deterioration of Health Status|22|||
163093734|NCT00457392|589054345|FG001|Overall Study|Global Deterioration of Health Status|8|||
163093735|NCT00457392|589054344|FG000|Overall Study|Withdrawal by Subject|14|||
163093736|NCT00457392|589054345|FG001|Overall Study|Withdrawal by Subject|8|||
163093737|NCT00457392|589054344|FG000|Overall Study|Lost to Follow-up|6|||
163093738|NCT00457392|589054345|FG001|Overall Study|Lost to Follow-up|7|||
163093739|NCT00457392|589054344|FG000|Overall Study|Protocol Violation|4|||
163093740|NCT00457392|589054345|FG001|Overall Study|Protocol Violation|3|||
163093741|NCT00457392|589054344|FG000|Overall Study|Other|7|||
163093742|NCT00457392|589054345|FG001|Overall Study|Other|4|||
163093743|NCT00457392|589054344|FG000|Overall Study|Study Terminated by Sponsor|1|||
163093744|NCT00457392|589054345|FG001|Overall Study|Study Terminated by Sponsor|4|||
163093745|NCT00457392|589054344|FG000|Overall Study|Randomized, Not Treated|7|||
163093746|NCT00457392|589054345|FG001|Overall Study|Randomized, Not Treated|3|||
163093747|NCT00756275|589054346|FG000|Overall Study|Lost to Follow-up|25|||
163093748|NCT00756275|589054347|FG001|Overall Study|Lost to Follow-up|21|||
163093749|NCT00756275|589054346|FG000|Overall Study|Withdrawal by Subject|4|||
163093750|NCT00756275|589054347|FG001|Overall Study|Withdrawal by Subject|7|||
163093751|NCT00980148|589054348|FG000|Overall Study|Discharged from facility|89|||
163093752|NCT00980148|589054349|FG001|Overall Study|Discharged from facility|96|||
163093753|NCT00980148|589054348|FG000|Overall Study|Received other antichlamydia treatment|20|||
163093754|NCT00980148|589054349|FG001|Overall Study|Received other antichlamydia treatment|14|||
163093755|NCT00980148|589054348|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
163093756|NCT00980148|589054349|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
163093757|NCT00980148|589054348|FG000|Overall Study|Various other reasons|8|||
163093758|NCT00980148|589054349|FG001|Overall Study|Various other reasons|9|||
163093759|NCT00420381|589054352|FG000|Overall Study|Protocol Violation|1|||
163093760|NCT01244035|589054365|FG000|Part 1: Period 1|Adverse Event|0|||
163093761|NCT01244035|589054366|FG001|Part 1: Period 1|Adverse Event|0|||
163093762|NCT01244035|589054367|FG002|Part 1: Period 1|Adverse Event|0|||
163093763|NCT01244035|589054368|FG003|Part 1: Period 1|Adverse Event|0|||
163093764|NCT01244035|589054369|FG004|Part 1: Period 1|Adverse Event|0|||
163093765|NCT01244035|589054370|FG005|Part 1: Period 1|Adverse Event|1|||
163093766|NCT01244035|589054365|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
163093767|NCT01244035|589054366|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
163093768|NCT01244035|589054367|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
163093769|NCT01244035|589054368|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
163093770|NCT01244035|589054369|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
163093771|NCT01244035|589054370|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
163093772|NCT01244035|589054365|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093773|NCT01244035|589054366|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
163093774|NCT01244035|589054367|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
163093775|NCT01244035|589054368|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
163093776|NCT01244035|589054369|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093777|NCT01244035|589054370|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
163093778|NCT01244035|589054365|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093779|NCT01244035|589054366|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093780|NCT01244035|589054367|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
163093781|NCT01244035|589054368|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093782|NCT01244035|589054369|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093783|NCT01244035|589054370|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
163093784|NCT01244035|589054365|FG000|Part 1: Period 3|Adverse Event|0|||
163093785|NCT01244035|589054366|FG001|Part 1: Period 3|Adverse Event|0|||
163093786|NCT01244035|589054367|FG002|Part 1: Period 3|Adverse Event|0|||
163093787|NCT01244035|589054368|FG003|Part 1: Period 3|Adverse Event|0|||
163093788|NCT01244035|589054369|FG004|Part 1: Period 3|Adverse Event|0|||
163093789|NCT01244035|589054370|FG005|Part 1: Period 3|Adverse Event|1|||
163093790|NCT01244035|589054365|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
163093791|NCT01244035|589054366|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
163093792|NCT01244035|589054367|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
163093793|NCT01244035|589054368|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
163093794|NCT01244035|589054369|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
163093795|NCT01244035|589054370|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
162651995|NCT02641379|587443335|FG004|Overall Study|Participant treated after Week 24|0|||
162651996|NCT02641379|587443336|FG005|Overall Study|Participant treated after Week 24|0|||
162651997|NCT02641379|587443337|FG006|Overall Study|Participant treated after Week 24|0|||
162651998|NCT02641379|587443338|FG007|Overall Study|Participant treated after Week 24|0|||
163093796|NCT01244035|589054365|FG000|Part 1: Period 3|Protocol Deviation|0|||
163093797|NCT01244035|589054366|FG001|Part 1: Period 3|Protocol Deviation|1|||
163093798|NCT01244035|589054367|FG002|Part 1: Period 3|Protocol Deviation|0|||
163093799|NCT01244035|589054368|FG003|Part 1: Period 3|Protocol Deviation|0|||
163093800|NCT01244035|589054369|FG004|Part 1: Period 3|Protocol Deviation|0|||
163093801|NCT01244035|589054370|FG005|Part 1: Period 3|Protocol Deviation|0|||
163093802|NCT02776683|589054371|FG000|Pre-switch Period|Protocol Violation|1|||
163093803|NCT02776683|589054372|FG001|Pre-switch Period|Protocol Violation|0|||
163093804|NCT02776683|589054371|FG000|Pre-switch Period|Adverse Event|21|||
163093805|NCT02776683|589054372|FG001|Pre-switch Period|Adverse Event|0|||
163093806|NCT02776683|589054371|FG000|Pre-switch Period|Withdrawal by Subject|9|||
163093807|NCT02776683|589054372|FG001|Pre-switch Period|Withdrawal by Subject|0|||
163093808|NCT02776683|589054371|FG000|Pre-switch Period|Physician Decision|7|||
163093809|NCT02776683|589054372|FG001|Pre-switch Period|Physician Decision|0|||
163093810|NCT02776683|589054371|FG000|Pre-switch Period|Progressive disease|39|||
163093811|NCT02776683|589054372|FG001|Pre-switch Period|Progressive disease|0|||
163093812|NCT02776683|589054371|FG000|Pre-switch Period|Other than listed|3|||
163093813|NCT02776683|589054372|FG001|Pre-switch Period|Other than listed|0|||
163093814|NCT02776683|589054371|FG000|Post-switch Period|Adverse Event|0|||
163093815|NCT02776683|589054372|FG001|Post-switch Period|Adverse Event|3|||
163093816|NCT02776683|589054371|FG000|Post-switch Period|Withdrawal by Subject|0|||
163093817|NCT02776683|589054372|FG001|Post-switch Period|Withdrawal by Subject|2|||
163093818|NCT02776683|589054371|FG000|Post-switch Period|Physician Decision|0|||
163093819|NCT02776683|589054372|FG001|Post-switch Period|Physician Decision|3|||
163093820|NCT02776683|589054371|FG000|Post-switch Period|Progressive disease|0|||
163093821|NCT02776683|589054372|FG001|Post-switch Period|Progressive disease|20|||
163093822|NCT02776683|589054371|FG000|Post-switch Period|Other than listed|0|||
163093823|NCT02776683|589054372|FG001|Post-switch Period|Other than listed|15|||
163093824|NCT03389308|589054373|FG000|Overall Study|Withdrawal by Subject|5|||
163093825|NCT03389308|589054373|FG000|Overall Study|Lost to Follow-up|3|||
163093826|NCT03389308|589054373|FG000|Overall Study|Adverse Event|2|||
163093827|NCT03389308|589054373|FG000|Overall Study|Sponsor Request|2|||
163093828|NCT01023217|589054377|FG000|Overall Study|Withdrawal by Subject|1|||
163093829|NCT01023217|589054378|FG001|Overall Study|Withdrawal by Subject|0|||
163093830|NCT00332696|589054381|FG000|Overall Study|Death|24|||
163093831|NCT00332696|589054382|FG001|Overall Study|Death|14|||
163093832|NCT00332696|589054381|FG000|Overall Study|Insufficient therapeutic effect|4|||
163093833|NCT00332696|589054382|FG001|Overall Study|Insufficient therapeutic effect|11|||
162651999|NCT02641379|587443339|FG008|Overall Study|Participant treated after Week 24|1|||
162652000|NCT02641379|587443340|FG009|Overall Study|Participant treated after Week 24|0|||
162652001|NCT02641379|587443341|FG010|Overall Study|Participant treated after Week 24|0|||
162652002|NCT02641379|587443331|FG000|Overall Study|Missing PCR result at Week 8|0|||
162652003|NCT02641379|587443332|FG001|Overall Study|Missing PCR result at Week 8|0|||
162652004|NCT02641379|587443333|FG002|Overall Study|Missing PCR result at Week 8|0|||
162652005|NCT02641379|587443334|FG003|Overall Study|Missing PCR result at Week 8|0|||
163093834|NCT00332696|589054381|FG000|Overall Study|Adverse Event|1|||
162652006|NCT02641379|587443335|FG004|Overall Study|Missing PCR result at Week 8|0|||
162652007|NCT02641379|587443336|FG005|Overall Study|Missing PCR result at Week 8|0|||
162652008|NCT02641379|587443337|FG006|Overall Study|Missing PCR result at Week 8|0|||
162652009|NCT02641379|587443338|FG007|Overall Study|Missing PCR result at Week 8|0|||
163093835|NCT00332696|589054382|FG001|Overall Study|Adverse Event|2|||
163093836|NCT00332696|589054381|FG000|Overall Study|Condition does not justify treatment|0|||
163093837|NCT00332696|589054382|FG001|Overall Study|Condition does not justify treatment|2|||
163093838|NCT00332696|589054381|FG000|Overall Study|Lost to Follow-up|0|||
162652010|NCT02641379|587443339|FG008|Overall Study|Missing PCR result at Week 8|0|||
163093839|NCT00332696|589054382|FG001|Overall Study|Lost to Follow-up|1|||
163093840|NCT00332696|589054381|FG000|Overall Study|Withdrawal by Subject|1|||
163093841|NCT00332696|589054382|FG001|Overall Study|Withdrawal by Subject|0|||
163093842|NCT02216526|589054383|FG000|Overall Study|Adverse Event|1|||
162652011|NCT02641379|587443340|FG009|Overall Study|Missing PCR result at Week 8|1|||
163093843|NCT02216526|589054384|FG001|Overall Study|Adverse Event|1|||
163093844|NCT02216526|589054385|FG002|Overall Study|Adverse Event|0|||
163093845|NCT02216526|589054383|FG000|Overall Study|Death|0|||
163093846|NCT02216526|589054384|FG001|Overall Study|Death|1|||
163093847|NCT02216526|589054385|FG002|Overall Study|Death|3|||
163093848|NCT02216526|589054383|FG000|Overall Study|Protocol Violation|2|||
163093849|NCT02216526|589054384|FG001|Overall Study|Protocol Violation|0|||
163093850|NCT02216526|589054385|FG002|Overall Study|Protocol Violation|2|||
163093851|NCT02216526|589054383|FG000|Overall Study|Hospitalization|2|||
163093852|NCT02216526|589054384|FG001|Overall Study|Hospitalization|1|||
163093853|NCT02216526|589054385|FG002|Overall Study|Hospitalization|3|||
163093854|NCT00696878|589054390|FG000|Overall Study|Adverse Event|8|||
163093855|NCT00696878|589054390|FG000|Overall Study|Withdrawal by Subject|87|||
163093856|NCT00696878|589054390|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
163093857|NCT00696878|589054390|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
163093858|NCT00696878|589054390|FG000|Overall Study|Trial stopped|32|||
163093859|NCT00696878|589054390|FG000|Overall Study|Other reason (not specified)|55|||
163093860|NCT04103450|589054391|FG000|Overall Study|Adverse Event|4|||
163093861|NCT04103450|589054392|FG001|Overall Study|Adverse Event|2|||
163093862|NCT04103450|589054391|FG000|Overall Study|Lack of Efficacy|3|||
163093863|NCT04103450|589054392|FG001|Overall Study|Lack of Efficacy|0|||
163093864|NCT04103450|589054391|FG000|Overall Study|Withdrawal by Subject|5|||
163093865|NCT04103450|589054392|FG001|Overall Study|Withdrawal by Subject|3|||
163093866|NCT04103450|589054391|FG000|Overall Study|Lost to Follow-up|1|||
163093867|NCT04103450|589054392|FG001|Overall Study|Lost to Follow-up|2|||
163093868|NCT04103450|589054391|FG000|Overall Study|Physician Decision|1|||
163093869|NCT04103450|589054392|FG001|Overall Study|Physician Decision|2|||
163093870|NCT04103450|589054391|FG000|Overall Study|Protocol Violation|1|||
163093871|NCT04103450|589054392|FG001|Overall Study|Protocol Violation|0|||
163093872|NCT04103450|589054391|FG000|Overall Study|Other|1|||
163093873|NCT04103450|589054392|FG001|Overall Study|Other|1|||
163093874|NCT02230189|589054396|FG000|Overall Study|Withdrawal by Subject|3|||
163093875|NCT02230189|589054397|FG001|Overall Study|Withdrawal by Subject|0|||
163093876|NCT02230189|589054398|FG002|Overall Study|Withdrawal by Subject|1|||
163093877|NCT02230189|589054396|FG000|Overall Study|Lost to Follow-up|1|||
163093878|NCT02230189|589054397|FG001|Overall Study|Lost to Follow-up|0|||
163093879|NCT02230189|589054398|FG002|Overall Study|Lost to Follow-up|0|||
163093880|NCT02230189|589054396|FG000|Overall Study|Physician Decision|1|||
163093881|NCT02230189|589054397|FG001|Overall Study|Physician Decision|0|||
163093882|NCT02230189|589054398|FG002|Overall Study|Physician Decision|0|||
163093883|NCT03188263|589054403|FG000|Overall Study|Withdrawal by Subject|3|||
163093884|NCT03188263|589054404|FG001|Overall Study|Withdrawal by Subject|0|||
163093885|NCT03188263|589054403|FG000|Overall Study|Physician Decision|1|||
163093886|NCT03188263|589054404|FG001|Overall Study|Physician Decision|0|||
163093887|NCT00699413|589054405|FG000|Overall Study|Withdrawal by Subject|0|||
163093888|NCT00699413|589054406|FG001|Overall Study|Withdrawal by Subject|2|||
163093889|NCT00699413|589054405|FG000|Overall Study|Study terminated by sponsor|4|||
163093890|NCT00699413|589054406|FG001|Overall Study|Study terminated by sponsor|2|||
163093891|NCT02779777|589054407|FG000|Overall Study|Disease Progression|1|||
163093892|NCT02779777|589054408|FG001|Overall Study|Disease Progression|0|||
163093893|NCT02779777|589054409|FG002|Overall Study|Disease Progression|0|||
163093894|NCT02779777|589054407|FG000|Overall Study|Adverse Event|3|||
163093895|NCT02779777|589054408|FG001|Overall Study|Adverse Event|1|||
163093896|NCT02779777|589054409|FG002|Overall Study|Adverse Event|0|||
163093897|NCT02779777|589054407|FG000|Overall Study|Physician Decision|9|||
163093898|NCT02779777|589054408|FG001|Overall Study|Physician Decision|0|||
163093899|NCT02779777|589054409|FG002|Overall Study|Physician Decision|1|||
163093900|NCT02779777|589054407|FG000|Overall Study|Withdrawal by Subject|1|||
163093901|NCT02779777|589054408|FG001|Overall Study|Withdrawal by Subject|0|||
163093902|NCT02779777|589054409|FG002|Overall Study|Withdrawal by Subject|0|||
163093903|NCT01030822|589054410|FG000|Overall Study|Moved/migrated from study area|6|||
163093904|NCT01030822|589054411|FG001|Overall Study|Moved/migrated from study area|7|||
163093905|NCT01030822|589054412|FG002|Overall Study|Moved/migrated from study area|3|||
163093906|NCT01030822|589054410|FG000|Overall Study|Withdrawal by Subject|16|||
163093907|NCT01030822|589054411|FG001|Overall Study|Withdrawal by Subject|13|||
163093908|NCT01030822|589054412|FG002|Overall Study|Withdrawal by Subject|16|||
163093909|NCT01030822|589054410|FG000|Overall Study|Lost to Follow-up|9|||
163093910|NCT01030822|589054411|FG001|Overall Study|Lost to Follow-up|4|||
163093911|NCT01030822|589054412|FG002|Overall Study|Lost to Follow-up|7|||
163093912|NCT04540367|589054413|FG000|Overall Study|Withdrawal by Subject|0|||
163093913|NCT04540367|589054414|FG001|Overall Study|Withdrawal by Subject|0|||
162652012|NCT02641379|587443341|FG010|Overall Study|Missing PCR result at Week 8|0|||
162652013|NCT02641379|587443331|FG000|Overall Study|PCR positive|0|||
162652014|NCT02641379|587443332|FG001|Overall Study|PCR positive|0|||
163093914|NCT04540367|589054415|FG002|Overall Study|Withdrawal by Subject|0|||
163093915|NCT04540367|589054416|FG003|Overall Study|Withdrawal by Subject|2|||
163093916|NCT04540367|589054413|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
163093917|NCT04540367|589054414|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
163093918|NCT04540367|589054415|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
163093919|NCT04540367|589054416|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
163093920|NCT04540367|589054413|FG000|Overall Study|Adverse Event|0|||
163093921|NCT04540367|589054414|FG001|Overall Study|Adverse Event|0|||
163093922|NCT04540367|589054415|FG002|Overall Study|Adverse Event|1|||
163093923|NCT04540367|589054416|FG003|Overall Study|Adverse Event|1|||
163093924|NCT00730886|589054417|FG000|Overall Study|Lost to Follow-up|1|||
163093925|NCT00730886|589054418|FG001|Overall Study|Lost to Follow-up|0|||
163093926|NCT00730886|589054417|FG000|Overall Study|Physician Decision|1|||
163093927|NCT00730886|589054418|FG001|Overall Study|Physician Decision|0|||
163093928|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
163093929|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
163093930|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
163093931|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
163093932|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
163093933|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
163093934|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
163093935|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
163093936|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
163093937|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
163093938|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
163093939|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
163093940|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
163093941|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
163093942|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
163093943|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
163093944|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
163093945|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
163093946|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
163093947|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
163093948|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
163093949|NCT04021290|589054421|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
163093950|NCT04021290|589054422|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
163093951|NCT04021290|589054423|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
163093952|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
163093953|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
163093954|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
163093955|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
163093956|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
163093957|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
163093958|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
163093959|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
163093960|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
163093961|NCT04021290|589054421|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
163093962|NCT04021290|589054422|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
163093963|NCT04021290|589054423|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
163093964|NCT03391882|589054424|FG000|Study Overall|Adverse Event|3|||
163093965|NCT03391882|589054425|FG001|Study Overall|Adverse Event|6|||
163093966|NCT03391882|589054426|FG002|Study Overall|Adverse Event|1|||
163093967|NCT03391882|589054427|FG003|Study Overall|Adverse Event|1|||
163093968|NCT03391882|589054428|FG004|Study Overall|Adverse Event|3|||
163093969|NCT03391882|589054429|FG005|Study Overall|Adverse Event|1|||
163093970|NCT03391882|589054424|FG000|Study Overall|Lack of Efficacy|13|||
163093971|NCT03391882|589054425|FG001|Study Overall|Lack of Efficacy|9|||
163093972|NCT03391882|589054426|FG002|Study Overall|Lack of Efficacy|0|||
163093973|NCT03391882|589054427|FG003|Study Overall|Lack of Efficacy|0|||
163093974|NCT03391882|589054428|FG004|Study Overall|Lack of Efficacy|0|||
163093975|NCT03391882|589054429|FG005|Study Overall|Lack of Efficacy|0|||
163093976|NCT03391882|589054424|FG000|Study Overall|Withdrawal by Subject|3|||
163093977|NCT03391882|589054425|FG001|Study Overall|Withdrawal by Subject|3|||
163093978|NCT03391882|589054426|FG002|Study Overall|Withdrawal by Subject|2|||
163093979|NCT03391882|589054427|FG003|Study Overall|Withdrawal by Subject|2|||
163093980|NCT03391882|589054428|FG004|Study Overall|Withdrawal by Subject|1|||
163093981|NCT03391882|589054429|FG005|Study Overall|Withdrawal by Subject|3|||
163093982|NCT03391882|589054424|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093983|NCT03391882|589054425|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
163093984|NCT03391882|589054426|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093985|NCT03391882|589054427|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
162719021|NCT02341625|587676745|FG008|Overall Study|Completed Treatment as per Protocol|0|||
163093986|NCT03391882|589054428|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093987|NCT03391882|589054429|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
163093988|NCT03391882|589054424|FG000|Study Overall|Protocol Violation|1|||
163093989|NCT03391882|589054425|FG001|Study Overall|Protocol Violation|0|||
162652015|NCT02641379|587443333|FG002|Overall Study|PCR positive|0|||
162652016|NCT02641379|587443334|FG003|Overall Study|PCR positive|0|||
162652017|NCT02641379|587443335|FG004|Overall Study|PCR positive|0|||
162652018|NCT02641379|587443336|FG005|Overall Study|PCR positive|0|||
162652019|NCT02641379|587443337|FG006|Overall Study|PCR positive|1|||
162652020|NCT02641379|587443338|FG007|Overall Study|PCR positive|0|||
162652021|NCT02641379|587443339|FG008|Overall Study|PCR positive|0|||
162652022|NCT02641379|587443340|FG009|Overall Study|PCR positive|0|||
162652023|NCT02641379|587443341|FG010|Overall Study|PCR positive|0|||
162652024|NCT01165138|587443342|FG000|Overall Study|Adverse Event|0|||
162652025|NCT01165138|587443343|FG001|Overall Study|Adverse Event|1|||
162652026|NCT01165138|587443344|FG002|Overall Study|Adverse Event|0|||
162652027|NCT01165138|587443345|FG003|Overall Study|Adverse Event|2|||
162652028|NCT01165138|587443342|FG000|Overall Study|Lack of Efficacy|0|||
162652029|NCT01165138|587443343|FG001|Overall Study|Lack of Efficacy|32|||
162652030|NCT01165138|587443344|FG002|Overall Study|Lack of Efficacy|6|||
162652031|NCT01165138|587443345|FG003|Overall Study|Lack of Efficacy|7|||
162652032|NCT01165138|587443342|FG000|Overall Study|Protocol Violation|0|||
162652033|NCT01165138|587443343|FG001|Overall Study|Protocol Violation|7|||
162652034|NCT01165138|587443344|FG002|Overall Study|Protocol Violation|0|||
162652035|NCT01165138|587443345|FG003|Overall Study|Protocol Violation|2|||
162652036|NCT01165138|587443342|FG000|Overall Study|Lost to Follow-up|0|||
162652037|NCT01165138|587443343|FG001|Overall Study|Lost to Follow-up|0|||
162652038|NCT01165138|587443344|FG002|Overall Study|Lost to Follow-up|1|||
162652039|NCT01165138|587443345|FG003|Overall Study|Lost to Follow-up|2|||
162652040|NCT01165138|587443342|FG000|Overall Study|Physician Decision|0|||
162652041|NCT01165138|587443343|FG001|Overall Study|Physician Decision|6|||
162652042|NCT01165138|587443344|FG002|Overall Study|Physician Decision|7|||
162652043|NCT01165138|587443345|FG003|Overall Study|Physician Decision|6|||
162652044|NCT01165138|587443342|FG000|Overall Study|Withdrawal by Subject|0|||
162652045|NCT01165138|587443343|FG001|Overall Study|Withdrawal by Subject|6|||
163093990|NCT03391882|589054426|FG002|Study Overall|Protocol Violation|0|||
163093991|NCT03391882|589054427|FG003|Study Overall|Protocol Violation|0|||
163093992|NCT03391882|589054428|FG004|Study Overall|Protocol Violation|0|||
163093993|NCT03391882|589054429|FG005|Study Overall|Protocol Violation|0|||
163093994|NCT03391882|589054424|FG000|Part A - Titration Phase|Adverse Event|3|||
163093995|NCT03391882|589054425|FG001|Part A - Titration Phase|Adverse Event|6|||
162652046|NCT01165138|587443344|FG002|Overall Study|Withdrawal by Subject|6|||
162652047|NCT01165138|587443345|FG003|Overall Study|Withdrawal by Subject|3|||
162652048|NCT01644175|587443348|FG000|Overall Study|Randomized But Not Treated|0|||
162652049|NCT01644175|587443349|FG001|Overall Study|Randomized But Not Treated|2|||
162652050|NCT01644175|587443348|FG000|Overall Study|Adverse Event|8|||
162652051|NCT01644175|587443349|FG001|Overall Study|Adverse Event|13|||
162652052|NCT01644175|587443348|FG000|Overall Study|Death|1|||
162652053|NCT01644175|587443349|FG001|Overall Study|Death|2|||
162652054|NCT01644175|587443348|FG000|Overall Study|Poor compliance to protocol|9|||
162652055|NCT01644175|587443349|FG001|Overall Study|Poor compliance to protocol|10|||
162652056|NCT01644175|587443348|FG000|Overall Study|Physician Decision|1|||
162652057|NCT01644175|587443349|FG001|Overall Study|Physician Decision|2|||
162652058|NCT01644175|587443348|FG000|Overall Study|Participant Moved|1|||
162652059|NCT01644175|587443349|FG001|Overall Study|Participant Moved|2|||
162652060|NCT01644175|587443348|FG000|Overall Study|Consent withdrawn by participant|3|||
162652061|NCT01644175|587443349|FG001|Overall Study|Consent withdrawn by participant|4|||
162652062|NCT01644175|587443348|FG000|Overall Study|Related to Autoinjector Administration|2|||
162652063|NCT01644175|587443349|FG001|Overall Study|Related to Autoinjector Administration|1|||
162652064|NCT01644175|587443348|FG000|Overall Study|Last visit outside protocol visit window|4|||
162652065|NCT01644175|587443349|FG001|Overall Study|Last visit outside protocol visit window|11|||
162719022|NCT02341625|587676746|FG009|Overall Study|Completed Treatment as per Protocol|1|||
163093996|NCT03391882|589054426|FG002|Part A - Titration Phase|Adverse Event|0|||
163093997|NCT03391882|589054427|FG003|Part A - Titration Phase|Adverse Event|0|||
163093998|NCT03391882|589054428|FG004|Part A - Titration Phase|Adverse Event|0|||
163093999|NCT03391882|589054429|FG005|Part A - Titration Phase|Adverse Event|0|||
163094000|NCT03391882|589054424|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
162652066|NCT01644175|587443348|FG000|Overall Study|Selection criteria finally not met|0|||
162652067|NCT01644175|587443349|FG001|Overall Study|Selection criteria finally not met|1|||
162652068|NCT01644175|587443348|FG000|Overall Study|Site closure|2|||
162652069|NCT01644175|587443349|FG001|Overall Study|Site closure|2|||
162652070|NCT01644175|587443348|FG000|Overall Study|Lost to Follow-up|1|||
162652071|NCT01644175|587443349|FG001|Overall Study|Lost to Follow-up|0|||
162652072|NCT01644175|587443348|FG000|Overall Study|Other than specified above|0|||
162652073|NCT01644175|587443349|FG001|Overall Study|Other than specified above|3|||
162652074|NCT01398956|587443353|FG000|Overall Study|Withdrawal by Subject|4|||
162652075|NCT01398956|587443353|FG000|Overall Study|AE, non-serious non-fatal|4|||
162652076|NCT01398956|587443353|FG000|Overall Study|Withdrawal Criteria No.3|1|||
162652077|NCT01398956|587443353|FG000|Overall Study|Subject moved a long distance|1|||
163094001|NCT03391882|589054425|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
162652078|NCT00856908|587443357|FG000|Overall Study|Lost to Follow-up|1|||
162652079|NCT00856908|587443358|FG001|Overall Study|Lost to Follow-up|0|||
162652080|NCT01063595|587443359|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
162652081|NCT01063595|587443360|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
162652082|NCT01063595|587443359|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
162652083|NCT01063595|587443360|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
162652084|NCT01063595|587443359|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
162652085|NCT01063595|587443360|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
162652086|NCT01063595|587443359|FG000|First Intervention|Adverse Event|1|||
162652087|NCT01063595|587443360|FG001|First Intervention|Adverse Event|4|||
162652088|NCT01063595|587443359|FG000|First Intervention|Withdrawal by Subject|1|||
162652089|NCT01063595|587443360|FG001|First Intervention|Withdrawal by Subject|0|||
162652090|NCT01063595|587443359|FG000|First Intervention|Reason not Specified|0|||
162652091|NCT01063595|587443360|FG001|First Intervention|Reason not Specified|1|||
162652092|NCT01623596|587443361|FG000|Overall Study|Abnormal laboratory values|2|||
162652093|NCT01623596|587443362|FG001|Overall Study|Abnormal laboratory values|0|||
162652094|NCT01623596|587443361|FG000|Overall Study|Administrative problems|9|||
162652095|NCT01623596|587443362|FG001|Overall Study|Administrative problems|13|||
162652096|NCT01623596|587443361|FG000|Overall Study|Adverse Event|20|||
162652097|NCT01623596|587443362|FG001|Overall Study|Adverse Event|29|||
162652098|NCT01623596|587443361|FG000|Overall Study|Death|0|||
162652099|NCT01623596|587443362|FG001|Overall Study|Death|2|||
162652100|NCT01623596|587443361|FG000|Overall Study|Lost to Follow-up|12|||
162652101|NCT01623596|587443362|FG001|Overall Study|Lost to Follow-up|16|||
162652102|NCT01623596|587443361|FG000|Overall Study|Withdrawal by Subject|13|||
162652103|NCT01623596|587443362|FG001|Overall Study|Withdrawal by Subject|31|||
162652104|NCT01623596|587443361|FG000|Overall Study|Patient no longer requires study drug|1|||
162652105|NCT01623596|587443362|FG001|Overall Study|Patient no longer requires study drug|0|||
162652106|NCT01623596|587443361|FG000|Overall Study|Protocol Violation|0|||
162652107|NCT01623596|587443362|FG001|Overall Study|Protocol Violation|6|||
162652108|NCT01623596|587443361|FG000|Overall Study|Lack of Efficacy|5|||
162652109|NCT01623596|587443362|FG001|Overall Study|Lack of Efficacy|3|||
162652110|NCT00451035|587443363|FG000|Overall Study|Disease progression|11|||
162652111|NCT00451035|587443363|FG000|Overall Study|Death|3|||
163094002|NCT03391882|589054426|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
163094003|NCT03391882|589054427|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
163094004|NCT03391882|589054428|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
163094005|NCT03391882|589054429|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
163094006|NCT03391882|589054424|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
163094007|NCT03391882|589054425|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
163094008|NCT03391882|589054426|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
163094009|NCT03391882|589054427|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
163094010|NCT03391882|589054428|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
163094011|NCT03391882|589054429|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
163094012|NCT03391882|589054424|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094013|NCT03391882|589054425|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
163094014|NCT03391882|589054426|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094015|NCT03391882|589054427|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094016|NCT03391882|589054428|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094017|NCT03391882|589054429|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
163094018|NCT03391882|589054424|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
163094019|NCT03391882|589054425|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
163094020|NCT03391882|589054426|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094021|NCT03391882|589054427|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094022|NCT03391882|589054428|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094023|NCT03391882|589054429|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
163094024|NCT03391882|589054424|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
163094025|NCT03391882|589054425|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
163094026|NCT03391882|589054426|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
163094027|NCT03391882|589054427|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
163094028|NCT03391882|589054428|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
163094029|NCT03391882|589054429|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
163094030|NCT03391882|589054424|FG000|Part B - Treatment Phase|Adverse Event|0|||
163094031|NCT03391882|589054425|FG001|Part B - Treatment Phase|Adverse Event|0|||
163094032|NCT03391882|589054426|FG002|Part B - Treatment Phase|Adverse Event|1|||
163094033|NCT03391882|589054427|FG003|Part B - Treatment Phase|Adverse Event|1|||
163094034|NCT03391882|589054428|FG004|Part B - Treatment Phase|Adverse Event|3|||
163094035|NCT03391882|589054429|FG005|Part B - Treatment Phase|Adverse Event|1|||
163094036|NCT03391882|589054424|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
163094037|NCT03391882|589054425|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
163094038|NCT03391882|589054426|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
163094039|NCT03391882|589054427|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
163094040|NCT03391882|589054428|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
163094041|NCT03391882|589054429|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
163094042|NCT03913130|589054432|FG000|Overall Study|Sponsor Decision|1|||
163094043|NCT04046939|589054435|FG000|Primary Assessment Period|Adverse Event|1|||
163094044|NCT04046939|589054436|FG001|Primary Assessment Period|Adverse Event|0|||
163094045|NCT04046939|589054437|FG002|Primary Assessment Period|Adverse Event|0|||
163094046|NCT04046939|589054438|FG003|Primary Assessment Period|Adverse Event|0|||
163094047|NCT04046939|589054435|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
163094048|NCT04046939|589054436|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
163094049|NCT04046939|589054437|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
163094050|NCT04046939|589054438|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
163094051|NCT04046939|589054435|FG000|Primary Assessment Period|Physician Decision|0|||
163094052|NCT04046939|589054436|FG001|Primary Assessment Period|Physician Decision|0|||
163094053|NCT04046939|589054437|FG002|Primary Assessment Period|Physician Decision|1|||
163094054|NCT04046939|589054438|FG003|Primary Assessment Period|Physician Decision|0|||
163094055|NCT04046939|589054435|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
163094056|NCT04046939|589054436|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
163094057|NCT04046939|589054437|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
163094058|NCT04046939|589054438|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
163094059|NCT04704193|589054439|FG000|Overall Study|Withdrawal by Subject|1|||
163094060|NCT03384875|589054440|FG000|Overall Study|Death|1|||
163094061|NCT03384875|589054441|FG001|Overall Study|Death|1|||
163094062|NCT03384875|589054442|FG002|Overall Study|Death|0|||
162652112|NCT00451035|587443363|FG000|Overall Study|New anti-neoplastic therapy|3|||
162652113|NCT04059146|587443367|FG000|Overall Study|Withdrawal by Subject|0|||
162652114|NCT04059146|587443368|FG001|Overall Study|Withdrawal by Subject|1|||
162652115|NCT01712256|587443371|FG000|Overall Study|Lost to Follow-up|1|||
162652116|NCT00962104|587443374|FG000|Overall Study|Adverse Event|10|||
162652117|NCT00962104|587443375|FG001|Overall Study|Adverse Event|3|||
162652118|NCT00962104|587443374|FG000|Overall Study|Entry Criteria Not Met|1|||
162652119|NCT00962104|587443375|FG001|Overall Study|Entry Criteria Not Met|2|||
162652120|NCT00962104|587443374|FG000|Overall Study|Lack of Efficacy|0|||
162652121|NCT00962104|587443375|FG001|Overall Study|Lack of Efficacy|1|||
162652122|NCT00962104|587443374|FG000|Overall Study|Lost to Follow-up|10|||
162652123|NCT00962104|587443375|FG001|Overall Study|Lost to Follow-up|4|||
162652124|NCT00962104|587443374|FG000|Overall Study|Physician Decision|1|||
162652125|NCT00962104|587443375|FG001|Overall Study|Physician Decision|0|||
162652126|NCT00962104|587443374|FG000|Overall Study|Protocol Violation|6|||
162652127|NCT00962104|587443375|FG001|Overall Study|Protocol Violation|8|||
162652128|NCT00962104|587443374|FG000|Overall Study|Sponsor Decision|0|||
162652129|NCT00962104|587443375|FG001|Overall Study|Sponsor Decision|1|||
162652130|NCT00962104|587443374|FG000|Overall Study|Withdrawal by Subject|10|||
162652131|NCT00962104|587443375|FG001|Overall Study|Withdrawal by Subject|6|||
162652132|NCT00962104|587443374|FG000|Overall Study|Other|2|||
162652133|NCT00962104|587443375|FG001|Overall Study|Other|0|||
162652134|NCT03274986|587443376|FG000|Overall Study|Withdrawal by Subject|0|||
162652135|NCT03274986|587443377|FG001|Overall Study|Withdrawal by Subject|1|||
162652136|NCT03274986|587443376|FG000|Overall Study|Lost to Follow-up|0|||
162652137|NCT03274986|587443377|FG001|Overall Study|Lost to Follow-up|1|||
162652138|NCT00603746|587443378|FG000|Overall Study|Adverse Event|2|||
163039203|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163094063|NCT03384875|589054440|FG000|Overall Study|Reason not provided|1|||
163094064|NCT03384875|589054441|FG001|Overall Study|Reason not provided|0|||
163094065|NCT03384875|589054442|FG002|Overall Study|Reason not provided|0|||
163094066|NCT04790279|589056772|FG000|Overall Study|Did not meet medication start criteria|27|||
163094067|NCT04790279|589056773|FG001|Overall Study|Did not meet medication start criteria|15|||
163094068|NCT04790279|589056772|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
163094069|NCT04790279|589056773|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
163094070|NCT04790279|589056772|FG000|Overall Study|Protocol Violation|8|||
163094071|NCT04790279|589056773|FG001|Overall Study|Protocol Violation|3|||
163094072|NCT04790279|589056772|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
163094073|NCT04790279|589056773|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
163094074|NCT01713582|589056774|FG000|Overall Study|Disease progression|3|||
163094075|NCT01713582|589056775|FG001|Overall Study|Disease progression|3|||
163094076|NCT01713582|589056776|FG002|Overall Study|Disease progression|3|||
163094077|NCT01713582|589056777|FG003|Overall Study|Disease progression|2|||
162652139|NCT00603746|587443379|FG001|Overall Study|Adverse Event|3|||
162652140|NCT00603746|587443380|FG002|Overall Study|Adverse Event|0|||
162652141|NCT00603746|587443381|FG003|Overall Study|Adverse Event|1|||
162652142|NCT00603746|587443382|FG004|Overall Study|Adverse Event|0|||
162652143|NCT00603746|587443383|FG005|Overall Study|Adverse Event|4|||
163039204|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
163039205|NCT00528372|588850681|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
163039206|NCT00528372|588850682|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039207|NCT00528372|588850683|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039208|NCT00528372|588850684|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
163039209|NCT00528372|588850685|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039210|NCT00528372|588850686|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163094078|NCT01713582|589056778|FG004|Overall Study|Disease progression|3|||
163094079|NCT01713582|589056779|FG005|Overall Study|Disease progression|3|||
163094080|NCT01713582|589056780|FG006|Overall Study|Disease progression|3|||
163094081|NCT01713582|589056781|FG007|Overall Study|Disease progression|3|||
163094082|NCT01713582|589056782|FG008|Overall Study|Disease progression|3|||
163094083|NCT01713582|589056783|FG009|Overall Study|Disease progression|11|||
163094084|NCT01713582|589056784|FG010|Overall Study|Disease progression|10|||
163094085|NCT01713582|589056785|FG011|Overall Study|Disease progression|5|||
163094086|NCT01713582|589056786|FG012|Overall Study|Disease progression|3|||
163094087|NCT01713582|589056787|FG013|Overall Study|Disease progression|3|||
163094088|NCT01713582|589056788|FG014|Overall Study|Disease progression|6|||
163094089|NCT01713582|589056789|FG015|Overall Study|Disease progression|6|||
163094090|NCT01713582|589056790|FG016|Overall Study|Disease progression|5|||
163094091|NCT01713582|589056791|FG017|Overall Study|Disease progression|2|||
163094092|NCT01713582|589056792|FG018|Overall Study|Disease progression|3|||
163094093|NCT01713582|589056793|FG019|Overall Study|Disease progression|5|||
163094094|NCT01713582|589056794|FG020|Overall Study|Disease progression|15|||
163094095|NCT01713582|589056774|FG000|Overall Study|Death|0|||
163094096|NCT01713582|589056775|FG001|Overall Study|Death|0|||
163094097|NCT01713582|589056776|FG002|Overall Study|Death|0|||
163094098|NCT01713582|589056777|FG003|Overall Study|Death|1|||
163094099|NCT01713582|589056778|FG004|Overall Study|Death|1|||
163094100|NCT01713582|589056779|FG005|Overall Study|Death|3|||
163094101|NCT01713582|589056780|FG006|Overall Study|Death|3|||
163094102|NCT01713582|589056781|FG007|Overall Study|Death|2|||
163094103|NCT01713582|589056782|FG008|Overall Study|Death|3|||
163094104|NCT01713582|589056783|FG009|Overall Study|Death|4|||
163094105|NCT01713582|589056784|FG010|Overall Study|Death|3|||
163094106|NCT01713582|589056785|FG011|Overall Study|Death|0|||
163094107|NCT01713582|589056786|FG012|Overall Study|Death|0|||
163094108|NCT01713582|589056787|FG013|Overall Study|Death|0|||
163094109|NCT01713582|589056788|FG014|Overall Study|Death|0|||
163094110|NCT01713582|589056789|FG015|Overall Study|Death|0|||
163094111|NCT01713582|589056790|FG016|Overall Study|Death|0|||
163094112|NCT01713582|589056791|FG017|Overall Study|Death|0|||
163094113|NCT01713582|589056792|FG018|Overall Study|Death|0|||
163094114|NCT01713582|589056793|FG019|Overall Study|Death|0|||
163094115|NCT01713582|589056794|FG020|Overall Study|Death|0|||
163094116|NCT01713582|589056774|FG000|Overall Study|Adverse event-related|0|||
163094117|NCT01713582|589056775|FG001|Overall Study|Adverse event-related|0|||
163094118|NCT01713582|589056776|FG002|Overall Study|Adverse event-related|0|||
163094119|NCT01713582|589056777|FG003|Overall Study|Adverse event-related|0|||
163094120|NCT01713582|589056778|FG004|Overall Study|Adverse event-related|0|||
163094121|NCT01713582|589056779|FG005|Overall Study|Adverse event-related|0|||
163094122|NCT01713582|589056780|FG006|Overall Study|Adverse event-related|0|||
163094123|NCT01713582|589056781|FG007|Overall Study|Adverse event-related|0|||
163094124|NCT01713582|589056782|FG008|Overall Study|Adverse event-related|0|||
163094125|NCT01713582|589056783|FG009|Overall Study|Adverse event-related|1|||
163094126|NCT01713582|589056784|FG010|Overall Study|Adverse event-related|1|||
163094127|NCT01713582|589056785|FG011|Overall Study|Adverse event-related|0|||
163094128|NCT01713582|589056786|FG012|Overall Study|Adverse event-related|0|||
163094129|NCT01713582|589056787|FG013|Overall Study|Adverse event-related|0|||
163094130|NCT01713582|589056788|FG014|Overall Study|Adverse event-related|0|||
163094131|NCT01713582|589056789|FG015|Overall Study|Adverse event-related|0|||
163094132|NCT01713582|589056790|FG016|Overall Study|Adverse event-related|0|||
163094133|NCT01713582|589056791|FG017|Overall Study|Adverse event-related|0|||
163094134|NCT01713582|589056792|FG018|Overall Study|Adverse event-related|1|||
163094135|NCT01713582|589056793|FG019|Overall Study|Adverse event-related|0|||
163094136|NCT01713582|589056794|FG020|Overall Study|Adverse event-related|0|||
163094137|NCT01713582|589056774|FG000|Overall Study|Adverse event-unrelated|0|||
163094138|NCT01713582|589056775|FG001|Overall Study|Adverse event-unrelated|0|||
163094139|NCT01713582|589056776|FG002|Overall Study|Adverse event-unrelated|0|||
163094140|NCT01713582|589056777|FG003|Overall Study|Adverse event-unrelated|0|||
163094141|NCT01713582|589056778|FG004|Overall Study|Adverse event-unrelated|0|||
163094142|NCT01713582|589056779|FG005|Overall Study|Adverse event-unrelated|1|||
163094143|NCT01713582|589056780|FG006|Overall Study|Adverse event-unrelated|1|||
163094144|NCT01713582|589056781|FG007|Overall Study|Adverse event-unrelated|1|||
163094145|NCT01713582|589056782|FG008|Overall Study|Adverse event-unrelated|0|||
163094146|NCT01713582|589056783|FG009|Overall Study|Adverse event-unrelated|0|||
163094147|NCT01713582|589056784|FG010|Overall Study|Adverse event-unrelated|0|||
163094148|NCT01713582|589056785|FG011|Overall Study|Adverse event-unrelated|0|||
163094149|NCT01713582|589056786|FG012|Overall Study|Adverse event-unrelated|0|||
163094150|NCT01713582|589056787|FG013|Overall Study|Adverse event-unrelated|1|||
163094151|NCT01713582|589056788|FG014|Overall Study|Adverse event-unrelated|1|||
163094152|NCT01713582|589056789|FG015|Overall Study|Adverse event-unrelated|0|||
163094153|NCT01713582|589056790|FG016|Overall Study|Adverse event-unrelated|0|||
163094154|NCT01713582|589056791|FG017|Overall Study|Adverse event-unrelated|0|||
163094155|NCT01713582|589056792|FG018|Overall Study|Adverse event-unrelated|0|||
163094156|NCT01713582|589056793|FG019|Overall Study|Adverse event-unrelated|0|||
163094157|NCT01713582|589056794|FG020|Overall Study|Adverse event-unrelated|0|||
163094158|NCT01713582|589056774|FG000|Overall Study|Withdrawal of consent|0|||
163094159|NCT01713582|589056775|FG001|Overall Study|Withdrawal of consent|0|||
163094160|NCT01713582|589056776|FG002|Overall Study|Withdrawal of consent|1|||
163094161|NCT01713582|589056777|FG003|Overall Study|Withdrawal of consent|0|||
163094162|NCT01713582|589056778|FG004|Overall Study|Withdrawal of consent|0|||
163094163|NCT01713582|589056779|FG005|Overall Study|Withdrawal of consent|1|||
163094164|NCT01713582|589056780|FG006|Overall Study|Withdrawal of consent|0|||
163094165|NCT01713582|589056781|FG007|Overall Study|Withdrawal of consent|0|||
163094166|NCT01713582|589056782|FG008|Overall Study|Withdrawal of consent|0|||
163094167|NCT01713582|589056783|FG009|Overall Study|Withdrawal of consent|1|||
163094168|NCT01713582|589056784|FG010|Overall Study|Withdrawal of consent|0|||
163094169|NCT01713582|589056785|FG011|Overall Study|Withdrawal of consent|0|||
163094170|NCT01713582|589056786|FG012|Overall Study|Withdrawal of consent|0|||
163094171|NCT01713582|589056787|FG013|Overall Study|Withdrawal of consent|0|||
163094172|NCT01713582|589056788|FG014|Overall Study|Withdrawal of consent|0|||
163094173|NCT01713582|589056789|FG015|Overall Study|Withdrawal of consent|0|||
163094174|NCT01713582|589056790|FG016|Overall Study|Withdrawal of consent|0|||
163094175|NCT01713582|589056791|FG017|Overall Study|Withdrawal of consent|0|||
163094176|NCT01713582|589056792|FG018|Overall Study|Withdrawal of consent|1|||
163094177|NCT01713582|589056793|FG019|Overall Study|Withdrawal of consent|0|||
163094178|NCT01713582|589056794|FG020|Overall Study|Withdrawal of consent|0|||
163094179|NCT01713582|589056774|FG000|Overall Study|Lack of Efficacy|0|||
163094180|NCT01713582|589056775|FG001|Overall Study|Lack of Efficacy|0|||
163094181|NCT01713582|589056776|FG002|Overall Study|Lack of Efficacy|0|||
163094182|NCT01713582|589056777|FG003|Overall Study|Lack of Efficacy|0|||
163094183|NCT01713582|589056778|FG004|Overall Study|Lack of Efficacy|0|||
163094184|NCT01713582|589056779|FG005|Overall Study|Lack of Efficacy|0|||
163094185|NCT01713582|589056780|FG006|Overall Study|Lack of Efficacy|0|||
163094186|NCT01713582|589056781|FG007|Overall Study|Lack of Efficacy|0|||
163094187|NCT01713582|589056782|FG008|Overall Study|Lack of Efficacy|0|||
163094188|NCT01713582|589056783|FG009|Overall Study|Lack of Efficacy|1|||
163094189|NCT01713582|589056784|FG010|Overall Study|Lack of Efficacy|2|||
163094190|NCT01713582|589056785|FG011|Overall Study|Lack of Efficacy|0|||
163094191|NCT01713582|589056786|FG012|Overall Study|Lack of Efficacy|0|||
163094192|NCT01713582|589056787|FG013|Overall Study|Lack of Efficacy|0|||
163094193|NCT01713582|589056788|FG014|Overall Study|Lack of Efficacy|0|||
163094194|NCT01713582|589056789|FG015|Overall Study|Lack of Efficacy|0|||
163094195|NCT01713582|589056790|FG016|Overall Study|Lack of Efficacy|0|||
163094196|NCT01713582|589056791|FG017|Overall Study|Lack of Efficacy|0|||
163094197|NCT01713582|589056792|FG018|Overall Study|Lack of Efficacy|0|||
163094198|NCT01713582|589056793|FG019|Overall Study|Lack of Efficacy|0|||
163094199|NCT01713582|589056794|FG020|Overall Study|Lack of Efficacy|0|||
163094200|NCT01713582|589056774|FG000|Overall Study|Withdrawal by Subject|0|||
163094201|NCT01713582|589056775|FG001|Overall Study|Withdrawal by Subject|0|||
163094202|NCT01713582|589056776|FG002|Overall Study|Withdrawal by Subject|0|||
163094203|NCT01713582|589056777|FG003|Overall Study|Withdrawal by Subject|0|||
163094204|NCT01713582|589056778|FG004|Overall Study|Withdrawal by Subject|0|||
163094205|NCT01713582|589056779|FG005|Overall Study|Withdrawal by Subject|0|||
163094206|NCT01713582|589056780|FG006|Overall Study|Withdrawal by Subject|0|||
163094207|NCT01713582|589056781|FG007|Overall Study|Withdrawal by Subject|0|||
163094208|NCT01713582|589056782|FG008|Overall Study|Withdrawal by Subject|0|||
163094209|NCT01713582|589056783|FG009|Overall Study|Withdrawal by Subject|0|||
163094210|NCT01713582|589056784|FG010|Overall Study|Withdrawal by Subject|0|||
163094211|NCT01713582|589056785|FG011|Overall Study|Withdrawal by Subject|0|||
163094212|NCT01713582|589056786|FG012|Overall Study|Withdrawal by Subject|0|||
163094213|NCT01713582|589056787|FG013|Overall Study|Withdrawal by Subject|0|||
163094214|NCT01713582|589056788|FG014|Overall Study|Withdrawal by Subject|0|||
163094215|NCT01713582|589056789|FG015|Overall Study|Withdrawal by Subject|0|||
163094216|NCT01713582|589056790|FG016|Overall Study|Withdrawal by Subject|0|||
163094217|NCT01713582|589056791|FG017|Overall Study|Withdrawal by Subject|1|||
163094218|NCT01713582|589056792|FG018|Overall Study|Withdrawal by Subject|0|||
163094219|NCT01713582|589056793|FG019|Overall Study|Withdrawal by Subject|0|||
163094220|NCT01713582|589056794|FG020|Overall Study|Withdrawal by Subject|0|||
163094221|NCT01713582|589056774|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
163094222|NCT01713582|589056775|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
162652144|NCT00603746|587443378|FG000|Overall Study|Lack of Efficacy|34|||
162652145|NCT00603746|587443379|FG001|Overall Study|Lack of Efficacy|11|||
163094223|NCT01713582|589056776|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
163094224|NCT01713582|589056777|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
162652146|NCT00603746|587443380|FG002|Overall Study|Lack of Efficacy|6|||
163094225|NCT01713582|589056778|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
163094226|NCT01713582|589056779|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
163094227|NCT01713582|589056780|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
163094228|NCT01713582|589056781|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
163094229|NCT01713582|589056782|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
162652147|NCT00603746|587443381|FG003|Overall Study|Lack of Efficacy|11|||
162652148|NCT00603746|587443382|FG004|Overall Study|Lack of Efficacy|12|||
162652149|NCT00603746|587443383|FG005|Overall Study|Lack of Efficacy|8|||
162652150|NCT00603746|587443378|FG000|Overall Study|Protocol Violation|0|||
162652151|NCT00603746|587443379|FG001|Overall Study|Protocol Violation|3|||
163094230|NCT01713582|589056783|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
163094231|NCT01713582|589056784|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
163094232|NCT01713582|589056785|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
163094233|NCT01713582|589056786|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
163094234|NCT01713582|589056787|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
163094235|NCT01713582|589056788|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
163094236|NCT01713582|589056789|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
163094237|NCT01713582|589056790|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
163094238|NCT01713582|589056791|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
163094239|NCT01713582|589056792|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
163094240|NCT01713582|589056793|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
163094241|NCT01713582|589056794|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
163094242|NCT01713582|589056774|FG000|Overall Study|Disease progression and adverse event|0|||
163094243|NCT01713582|589056775|FG001|Overall Study|Disease progression and adverse event|0|||
163094244|NCT01713582|589056776|FG002|Overall Study|Disease progression and adverse event|0|||
163094245|NCT01713582|589056777|FG003|Overall Study|Disease progression and adverse event|0|||
163094246|NCT01713582|589056778|FG004|Overall Study|Disease progression and adverse event|0|||
163094247|NCT01713582|589056779|FG005|Overall Study|Disease progression and adverse event|0|||
163094248|NCT01713582|589056780|FG006|Overall Study|Disease progression and adverse event|0|||
163094249|NCT01713582|589056781|FG007|Overall Study|Disease progression and adverse event|0|||
163094250|NCT01713582|589056782|FG008|Overall Study|Disease progression and adverse event|0|||
163094251|NCT01713582|589056783|FG009|Overall Study|Disease progression and adverse event|0|||
163094252|NCT01713582|589056784|FG010|Overall Study|Disease progression and adverse event|0|||
163094253|NCT01713582|589056785|FG011|Overall Study|Disease progression and adverse event|0|||
163094254|NCT01713582|589056786|FG012|Overall Study|Disease progression and adverse event|0|||
163094255|NCT01713582|589056787|FG013|Overall Study|Disease progression and adverse event|0|||
163094256|NCT01713582|589056788|FG014|Overall Study|Disease progression and adverse event|0|||
163094257|NCT01713582|589056789|FG015|Overall Study|Disease progression and adverse event|0|||
163094258|NCT01713582|589056790|FG016|Overall Study|Disease progression and adverse event|1|||
163094259|NCT01713582|589056791|FG017|Overall Study|Disease progression and adverse event|0|||
163094260|NCT01713582|589056792|FG018|Overall Study|Disease progression and adverse event|0|||
163094261|NCT01713582|589056793|FG019|Overall Study|Disease progression and adverse event|0|||
163094262|NCT01713582|589056794|FG020|Overall Study|Disease progression and adverse event|0|||
163094263|NCT04551898|589056795|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
163094264|NCT04551898|589056796|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
163094265|NCT04551898|589056797|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
163094266|NCT04551898|589056798|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
163094267|NCT04551898|589056795|FG000|Overall Study|Withdrawal by Subject|5|||
163094268|NCT04551898|589056796|FG001|Overall Study|Withdrawal by Subject|1|||
163094269|NCT04551898|589056797|FG002|Overall Study|Withdrawal by Subject|2|||
163094270|NCT04551898|589056798|FG003|Overall Study|Withdrawal by Subject|2|||
163094271|NCT04551898|589056795|FG000|Overall Study|Lost to Follow-up|2|||
163094272|NCT04551898|589056796|FG001|Overall Study|Lost to Follow-up|1|||
163094273|NCT04551898|589056797|FG002|Overall Study|Lost to Follow-up|2|||
163094274|NCT04551898|589056798|FG003|Overall Study|Lost to Follow-up|2|||
163094275|NCT04551898|589056795|FG000|Overall Study|Death|1|||
163094276|NCT04551898|589056796|FG001|Overall Study|Death|0|||
163094277|NCT04551898|589056797|FG002|Overall Study|Death|0|||
163094278|NCT04551898|589056798|FG003|Overall Study|Death|0|||
163094279|NCT04551898|589056795|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094280|NCT04551898|589056796|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094281|NCT04551898|589056797|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
163094282|NCT04551898|589056798|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
163094283|NCT03427814|589056799|FG000|Overall Study|Withdrawal by Subject|4|||
163094284|NCT03427814|589056800|FG001|Overall Study|Withdrawal by Subject|4|||
163094285|NCT03427814|589056799|FG000|Overall Study|Lost to Follow-up|0|||
163094286|NCT03427814|589056800|FG001|Overall Study|Lost to Follow-up|2|||
163094287|NCT03427814|589056799|FG000|Overall Study|Death|42|||
162652152|NCT00603746|587443380|FG002|Overall Study|Protocol Violation|1|||
163094288|NCT03427814|589056800|FG001|Overall Study|Death|31|||
163094289|NCT03427814|589056799|FG000|Overall Study|Sponsor's Decision|1|||
163094290|NCT03427814|589056800|FG001|Overall Study|Sponsor's Decision|0|||
163094291|NCT03427814|589056799|FG000|Overall Study|Investigator's Decision|1|||
163094292|NCT03427814|589056800|FG001|Overall Study|Investigator's Decision|2|||
162652153|NCT00603746|587443381|FG003|Overall Study|Protocol Violation|0|||
162652154|NCT00603746|587443382|FG004|Overall Study|Protocol Violation|1|||
162652155|NCT00603746|587443383|FG005|Overall Study|Protocol Violation|0|||
162652156|NCT00603746|587443378|FG000|Overall Study|Lost to Follow-up|0|||
162652157|NCT00603746|587443379|FG001|Overall Study|Lost to Follow-up|1|||
162652158|NCT00603746|587443380|FG002|Overall Study|Lost to Follow-up|1|||
162652159|NCT00603746|587443381|FG003|Overall Study|Lost to Follow-up|0|||
162652160|NCT00603746|587443382|FG004|Overall Study|Lost to Follow-up|0|||
162652161|NCT00603746|587443383|FG005|Overall Study|Lost to Follow-up|0|||
162652162|NCT00603746|587443378|FG000|Overall Study|Physician Decision|1|||
162652163|NCT00603746|587443379|FG001|Overall Study|Physician Decision|0|||
162652164|NCT00603746|587443380|FG002|Overall Study|Physician Decision|0|||
162652165|NCT00603746|587443381|FG003|Overall Study|Physician Decision|0|||
162652166|NCT00603746|587443382|FG004|Overall Study|Physician Decision|1|||
162652167|NCT00603746|587443383|FG005|Overall Study|Physician Decision|0|||
162652168|NCT00603746|587443378|FG000|Overall Study|Withdrawal by Subject|1|||
162652169|NCT00603746|587443379|FG001|Overall Study|Withdrawal by Subject|0|||
163094293|NCT03427814|589056799|FG000|Overall Study|Disease progression|1|||
163094294|NCT03427814|589056800|FG001|Overall Study|Disease progression|0|||
163094295|NCT03427814|589056799|FG000|Overall Study|Treatment Completed|0|||
163094296|NCT03427814|589056800|FG001|Overall Study|Treatment Completed|1|||
163094297|NCT03427814|589056799|FG000|Overall Study|Sponsor's Decision to End study|21|||
163094298|NCT03427814|589056800|FG001|Overall Study|Sponsor's Decision to End study|25|||
163094299|NCT03427814|589056799|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
163094300|NCT03427814|589056800|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
163094301|NCT03846427|589056801|FG000|Overall Study|Death|13|||
163094302|NCT03846427|589056801|FG000|Overall Study|Withdrawal by Subject|3|||
163094303|NCT03846427|589056801|FG000|Overall Study|Physician Decision|1|||
163094304|NCT01334554|589056802|FG000|Overall Study|Adverse Event|4|||
163094305|NCT01334554|589056803|FG001|Overall Study|Adverse Event|2|||
163094306|NCT02393859|589056805|FG000|Overall Study|Decision by Sponsor|2|||
163094307|NCT02393859|589056806|FG001|Overall Study|Decision by Sponsor|4|||
163094308|NCT02393859|589056805|FG000|Overall Study|Withdrawal by Subject|11|||
163094309|NCT02393859|589056806|FG001|Overall Study|Withdrawal by Subject|6|||
163094310|NCT02393859|589056805|FG000|Overall Study|Death|27|||
163094311|NCT02393859|589056806|FG001|Overall Study|Death|10|||
163094312|NCT02393859|589056805|FG000|Overall Study|Lost to Follow-up|1|||
163094313|NCT02393859|589056806|FG001|Overall Study|Lost to Follow-up|1|||
163094314|NCT00954447|589056807|FG000|Overall Study|Adverse Event|33|||
163094315|NCT00954447|589056808|FG001|Overall Study|Adverse Event|25|||
163094316|NCT00954447|589056807|FG000|Overall Study|Lack of Efficacy|17|||
163094317|NCT00954447|589056808|FG001|Overall Study|Lack of Efficacy|3|||
163094318|NCT00954447|589056807|FG000|Overall Study|Protocol Violation|5|||
163094319|NCT00954447|589056808|FG001|Overall Study|Protocol Violation|7|||
163094320|NCT00954447|589056807|FG000|Overall Study|Lost to Follow-up|8|||
163094321|NCT00954447|589056808|FG001|Overall Study|Lost to Follow-up|14|||
163094322|NCT00954447|589056807|FG000|Overall Study|Withdrawal by Subject|26|||
163094323|NCT00954447|589056808|FG001|Overall Study|Withdrawal by Subject|21|||
163094324|NCT00954447|589056807|FG000|Overall Study|Other|21|||
163094325|NCT00954447|589056808|FG001|Overall Study|Other|18|||
163094326|NCT01979614|589056809|FG000|Overall Study|Adverse Event|1|||
163094327|NCT01979614|589056810|FG001|Overall Study|Adverse Event|1|||
163094328|NCT00488514|589056811|FG000|Overall Study|Adverse Event|41|||
163094329|NCT00488514|589056811|FG000|Overall Study|Lost to Follow-up|44|||
163094330|NCT00488514|589056811|FG000|Overall Study|Protocol Violation|32|||
163094331|NCT00488514|589056811|FG000|Overall Study|Withdrawal by Subject|106|||
163094332|NCT00488514|589056811|FG000|Overall Study|Lack of Efficacy|28|||
163094333|NCT00488514|589056811|FG000|Overall Study|Did not meet criteria for treatment|30|||
163094334|NCT00488514|589056811|FG000|Overall Study|Postive drug screen|1|||
163094335|NCT00488514|589056811|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
162652170|NCT00603746|587443380|FG002|Overall Study|Withdrawal by Subject|0|||
162652171|NCT00603746|587443381|FG003|Overall Study|Withdrawal by Subject|1|||
162652172|NCT00603746|587443382|FG004|Overall Study|Withdrawal by Subject|3|||
162652173|NCT00603746|587443383|FG005|Overall Study|Withdrawal by Subject|1|||
162652174|NCT01524627|587443385|FG000|Overall Study|Physician Decision|0|||
162652175|NCT01524627|587443386|FG001|Overall Study|Physician Decision|1|||
162652176|NCT01524627|587443385|FG000|Overall Study|Lost to Follow-up|1|||
163094336|NCT00488514|589056811|FG000|Overall Study|Investigator decision|1|||
163094337|NCT00488514|589056811|FG000|Overall Study|Participant had too few migraines|5|||
163094338|NCT00488514|589056811|FG000|Overall Study|Increase in number of migraines|2|||
163094339|NCT00488514|589056811|FG000|Overall Study|Increased use of concomitant medication|1|||
162652177|NCT01524627|587443386|FG001|Overall Study|Lost to Follow-up|1|||
162652178|NCT05627518|587443387|FG000|Treatment Period 1|Adverse Event|0|||
162652179|NCT05627518|587443388|FG001|Treatment Period 1|Adverse Event|0|||
162652180|NCT05627518|587443389|FG002|Treatment Period 1|Adverse Event|1|||
162652181|NCT05627518|587443390|FG003|Treatment Period 1|Adverse Event|0|||
163094340|NCT01535287|589056812|FG000|Overall Study|drug not prepared in time|5|||
163094341|NCT01535287|589056813|FG001|Overall Study|drug not prepared in time|6|||
163094342|NCT00305877|589056814|FG000|Overall Study|Lack of Efficacy|6|||
163094343|NCT00305877|589056815|FG001|Overall Study|Lack of Efficacy|9|||
162652182|NCT05627518|587443391|FG004|Treatment Period 1|Adverse Event|0|||
162652183|NCT05627518|587443392|FG005|Treatment Period 1|Adverse Event|0|||
162652184|NCT05627518|587443393|FG006|Treatment Period 1|Adverse Event|0|||
163094344|NCT00305877|589056814|FG000|Overall Study|Adverse Event|9|||
163094345|NCT00305877|589056815|FG001|Overall Study|Adverse Event|14|||
163094346|NCT00305877|589056814|FG000|Overall Study|Death|0|||
163094347|NCT00305877|589056815|FG001|Overall Study|Death|1|||
163094348|NCT00305877|589056814|FG000|Overall Study|Withdrawal by Subject|4|||
163094349|NCT00305877|589056815|FG001|Overall Study|Withdrawal by Subject|2|||
163094350|NCT00305877|589056814|FG000|Overall Study|Physician Decision|1|||
163094351|NCT00305877|589056815|FG001|Overall Study|Physician Decision|1|||
163094352|NCT00305877|589056814|FG000|Overall Study|Never start treatment|2|||
163094353|NCT00305877|589056815|FG001|Overall Study|Never start treatment|5|||
163094354|NCT00305877|589056814|FG000|Overall Study|Ineligible|2|||
163094355|NCT00305877|589056815|FG001|Overall Study|Ineligible|1|||
163094356|NCT00305877|589056814|FG000|Overall Study|Transportation issue with daily RT|0|||
163094357|NCT00305877|589056815|FG001|Overall Study|Transportation issue with daily RT|1|||
163094358|NCT00628446|589056818|FG000|Overall Study|Lost to Follow-up|3|||
163094359|NCT00628446|589056818|FG000|Overall Study|Withdrawal by Subject|1|||
163094360|NCT00628446|589056818|FG000|Overall Study|Protocol Violation|3|||
163094361|NCT04971967|589056819|FG000|Overall Study|Lost to Follow-up|6|||
163094362|NCT04971967|589056820|FG001|Overall Study|Lost to Follow-up|7|||
163094363|NCT00682929|589056823|FG000|Overall Study|Adverse Event|4|||
163094364|NCT00682929|589056824|FG001|Overall Study|Adverse Event|1|||
163094365|NCT00682929|589056825|FG002|Overall Study|Adverse Event|1|||
163094366|NCT00682929|589056823|FG000|Overall Study|Withdrawal by Subject|1|||
163094367|NCT00682929|589056824|FG001|Overall Study|Withdrawal by Subject|2|||
163094368|NCT00682929|589056825|FG002|Overall Study|Withdrawal by Subject|1|||
163094369|NCT00682929|589056823|FG000|Overall Study|dosing compliance < 80%|0|||
163094370|NCT00682929|589056824|FG001|Overall Study|dosing compliance < 80%|2|||
163094371|NCT00682929|589056825|FG002|Overall Study|dosing compliance < 80%|0|||
163094372|NCT00682929|589056823|FG000|Overall Study|lag in DEA renewal|1|||
163094373|NCT00682929|589056824|FG001|Overall Study|lag in DEA renewal|0|||
163094374|NCT00682929|589056825|FG002|Overall Study|lag in DEA renewal|0|||
163094375|NCT00938912|589056826|FG000|Overall Study|Withdrawal by Subject|28|||
163094376|NCT00938912|589056826|FG000|Overall Study|Lost to Follow-up|4|||
163094377|NCT00938912|589056826|FG000|Overall Study|Lack of Efficacy|43|||
163094378|NCT00938912|589056826|FG000|Overall Study|Adverse event, non-fatal|24|||
163094379|NCT00938912|589056826|FG000|Overall Study|Adverse event, fatal|1|||
163094380|NCT00938912|589056826|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
163094381|NCT00938912|589056826|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
163094382|NCT00938912|589056826|FG000|Overall Study|Participant needed prohibit medication|1|||
163094383|NCT00938912|589056826|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
163094384|NCT00938912|589056826|FG000|Overall Study|Did not meet Eligibility criteria|1|||
163094385|NCT00938912|589056826|FG000|Overall Study|Participant relocated not related to AE|1|||
163094386|NCT00938912|589056826|FG000|Overall Study|Participant moved to another city|1|||
163094387|NCT00938912|589056826|FG000|Overall Study|Participant experienced break through seizures|1|||
163094388|NCT00938912|589056826|FG000|Overall Study|No longer wished to participate in the study|1|||
163094389|NCT00938912|589056826|FG000|Overall Study|Protocol Deviation|2|||
163094390|NCT00803738|589056832|FG000|Overall Study|Adverse Event|3|||
163094391|NCT00803738|589056833|FG001|Overall Study|Adverse Event|5|||
163094392|NCT00803738|589056832|FG000|Overall Study|Lost to Follow-up|4|||
163094393|NCT00803738|589056833|FG001|Overall Study|Lost to Follow-up|4|||
163094394|NCT00803738|589056832|FG000|Overall Study|Protocol Violation|18|||
163094395|NCT00803738|589056833|FG001|Overall Study|Protocol Violation|10|||
163094396|NCT00803738|589056832|FG000|Overall Study|Withdrawal by Subject|1|||
163094397|NCT00803738|589056833|FG001|Overall Study|Withdrawal by Subject|4|||
163094398|NCT00803738|589056832|FG000|Overall Study|Lack of Efficacy|10|||
163094399|NCT00803738|589056833|FG001|Overall Study|Lack of Efficacy|16|||
163094400|NCT00803738|589056832|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
163094401|NCT00803738|589056833|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
162652185|NCT05627518|587443394|FG007|Treatment Period 1|Adverse Event|1|||
162652186|NCT05627518|587443387|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162652187|NCT05627518|587443388|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163094402|NCT00803738|589056832|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
163094403|NCT00803738|589056833|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
163094404|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
163094405|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094406|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094407|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
163094408|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
162652188|NCT05627518|587443389|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162652189|NCT05627518|587443390|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162652190|NCT05627518|587443391|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162652191|NCT05627518|587443392|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162652192|NCT05627518|587443393|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162652193|NCT05627518|587443394|FG007|Treatment Period 1|Withdrawal by Subject|0|||
162652194|NCT05627518|587443387|FG000|Treatment Period 1|Protocol Violation|0|||
162652195|NCT05627518|587443388|FG001|Treatment Period 1|Protocol Violation|0|||
162652196|NCT05627518|587443389|FG002|Treatment Period 1|Protocol Violation|0|||
162652197|NCT05627518|587443390|FG003|Treatment Period 1|Protocol Violation|0|||
162652198|NCT05627518|587443391|FG004|Treatment Period 1|Protocol Violation|0|||
162652199|NCT05627518|587443392|FG005|Treatment Period 1|Protocol Violation|0|||
162652200|NCT05627518|587443393|FG006|Treatment Period 1|Protocol Violation|6|||
162652201|NCT05627518|587443394|FG007|Treatment Period 1|Protocol Violation|6|||
162652202|NCT05627518|587443387|FG000|Treatment Period 2|Adverse Event|1|||
162652203|NCT05627518|587443388|FG001|Treatment Period 2|Adverse Event|0|||
162652204|NCT05627518|587443389|FG002|Treatment Period 2|Adverse Event|0|||
162652205|NCT05627518|587443390|FG003|Treatment Period 2|Adverse Event|0|||
162652206|NCT05627518|587443391|FG004|Treatment Period 2|Adverse Event|0|||
162652207|NCT05627518|587443392|FG005|Treatment Period 2|Adverse Event|0|||
162652208|NCT05627518|587443393|FG006|Treatment Period 2|Adverse Event|0|||
162652209|NCT05627518|587443394|FG007|Treatment Period 2|Adverse Event|0|||
162652210|NCT05627518|587443387|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162652211|NCT05627518|587443388|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162652212|NCT05627518|587443389|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162652213|NCT05627518|587443390|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162652214|NCT05627518|587443391|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162652215|NCT05627518|587443392|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162652216|NCT05627518|587443393|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162652217|NCT05627518|587443394|FG007|Treatment Period 2|Withdrawal by Subject|0|||
162652218|NCT04013191|587445461|FG000|Overall Study|Adverse Event|1|||
162652219|NCT04013191|587445462|FG001|Overall Study|Adverse Event|0|||
162652220|NCT00588445|587445465|FG000|Overall Study|Protocol Violation|1|||
162652221|NCT00588445|587445465|FG000|Overall Study|Withdrawal by Subject|3|||
162652222|NCT00588445|587445465|FG000|Overall Study|Disease Progression|1|||
162652223|NCT00588445|587445465|FG000|Overall Study|Not Treated|10|||
162652224|NCT00358527|587445466|FG000|Overall Study|Adverse Event|4|||
162652225|NCT00358527|587445467|FG001|Overall Study|Adverse Event|0|||
162652226|NCT00358527|587445466|FG000|Overall Study|Withdrawal by Subject|1|||
162652227|NCT00358527|587445467|FG001|Overall Study|Withdrawal by Subject|1|||
162652228|NCT00358527|587445466|FG000|Overall Study|Non-compliance with protocol|6|||
163094409|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
163094410|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
163094411|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
163094412|NCT02964273|589056834|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
163094413|NCT02964273|589056835|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
163094414|NCT02964273|589056836|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
163094415|NCT02964273|589056837|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
163094416|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094417|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094418|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
163094419|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
163094420|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
163094421|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
163094422|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
163094423|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
163094424|NCT02964273|589056834|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
163094425|NCT02964273|589056835|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
163094426|NCT02964273|589056836|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
163094427|NCT02964273|589056837|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
163094428|NCT03012334|589056838|FG000|Period 1|Withdrawal by Subject|0|||
163094429|NCT03012334|589056839|FG001|Period 1|Withdrawal by Subject|0|||
163094430|NCT03012334|589056840|FG002|Period 1|Withdrawal by Subject|0|||
163094431|NCT03012334|589056841|FG003|Period 1|Withdrawal by Subject|0|||
163094432|NCT03012334|589056842|FG004|Period 1|Withdrawal by Subject|0|||
163094433|NCT03012334|589056843|FG005|Period 1|Withdrawal by Subject|0|||
163094434|NCT03012334|589056844|FG006|Period 1|Withdrawal by Subject|0|||
163094435|NCT03012334|589056845|FG007|Period 1|Withdrawal by Subject|0|||
162652229|NCT00358527|587445467|FG001|Overall Study|Non-compliance with protocol|1|||
162652230|NCT00358527|587445466|FG000|Overall Study|Administrative|2|||
162652231|NCT00358527|587445467|FG001|Overall Study|Administrative|1|||
162652232|NCT00145509|587445470|FG000|Overall Study|Adverse Event|10|||
162652233|NCT00145509|587445471|FG001|Overall Study|Adverse Event|3|||
162652234|NCT00145509|587445470|FG000|Overall Study|Lack of Efficacy|3|||
162652235|NCT00145509|587445471|FG001|Overall Study|Lack of Efficacy|1|||
162652236|NCT00145509|587445470|FG000|Overall Study|Lost to Follow-up|5|||
163094436|NCT03012334|589056846|FG008|Period 1|Withdrawal by Subject|0|||
163094437|NCT03012334|589056847|FG009|Period 1|Withdrawal by Subject|1|||
163094438|NCT03012334|589056838|FG000|Period 2|Withdrawal by Subject|0|||
163094439|NCT03012334|589056839|FG001|Period 2|Withdrawal by Subject|1|||
163094440|NCT03012334|589056840|FG002|Period 2|Withdrawal by Subject|0|||
163094441|NCT03012334|589056841|FG003|Period 2|Withdrawal by Subject|0|||
163094442|NCT03012334|589056842|FG004|Period 2|Withdrawal by Subject|0|||
163094443|NCT03012334|589056843|FG005|Period 2|Withdrawal by Subject|0|||
163094444|NCT03012334|589056844|FG006|Period 2|Withdrawal by Subject|0|||
163094445|NCT03012334|589056845|FG007|Period 2|Withdrawal by Subject|0|||
163094446|NCT03012334|589056846|FG008|Period 2|Withdrawal by Subject|0|||
163094447|NCT03012334|589056847|FG009|Period 2|Withdrawal by Subject|0|||
163094448|NCT03012334|589056838|FG000|Period 2|Protocol Violation|0|||
163094449|NCT03012334|589056839|FG001|Period 2|Protocol Violation|0|||
163094450|NCT03012334|589056840|FG002|Period 2|Protocol Violation|1|||
163094451|NCT03012334|589056841|FG003|Period 2|Protocol Violation|0|||
163094452|NCT03012334|589056842|FG004|Period 2|Protocol Violation|0|||
163094453|NCT03012334|589056843|FG005|Period 2|Protocol Violation|0|||
163094454|NCT03012334|589056844|FG006|Period 2|Protocol Violation|0|||
163094455|NCT03012334|589056845|FG007|Period 2|Protocol Violation|1|||
163094456|NCT03012334|589056846|FG008|Period 2|Protocol Violation|0|||
163094457|NCT03012334|589056847|FG009|Period 2|Protocol Violation|0|||
163094458|NCT03012334|589056838|FG000|Period 4|Non-Compliance|0|||
163094459|NCT03012334|589056839|FG001|Period 4|Non-Compliance|0|||
163094460|NCT03012334|589056840|FG002|Period 4|Non-Compliance|0|||
163094461|NCT03012334|589056841|FG003|Period 4|Non-Compliance|0|||
163094462|NCT03012334|589056842|FG004|Period 4|Non-Compliance|0|||
163094463|NCT03012334|589056843|FG005|Period 4|Non-Compliance|0|||
163094464|NCT03012334|589056844|FG006|Period 4|Non-Compliance|1|||
163094465|NCT03012334|589056845|FG007|Period 4|Non-Compliance|0|||
163094466|NCT03012334|589056846|FG008|Period 4|Non-Compliance|0|||
163094467|NCT03012334|589056847|FG009|Period 4|Non-Compliance|0|||
163094468|NCT03012334|589056838|FG000|Period 4|Adverse Event|0|||
163094469|NCT03012334|589056839|FG001|Period 4|Adverse Event|0|||
163094470|NCT03012334|589056840|FG002|Period 4|Adverse Event|0|||
163094471|NCT03012334|589056841|FG003|Period 4|Adverse Event|0|||
163094472|NCT03012334|589056842|FG004|Period 4|Adverse Event|0|||
163094473|NCT03012334|589056843|FG005|Period 4|Adverse Event|0|||
163094474|NCT03012334|589056844|FG006|Period 4|Adverse Event|0|||
163094475|NCT03012334|589056845|FG007|Period 4|Adverse Event|0|||
163094476|NCT03012334|589056846|FG008|Period 4|Adverse Event|1|||
163094477|NCT03012334|589056847|FG009|Period 4|Adverse Event|0|||
163094478|NCT01823107|589056848|FG000|Overall Study|Withdrawal by Subject|1|||
163094479|NCT00328172|589056851|FG000|Overall Study|Adverse Event|3|||
163094480|NCT00328172|589056852|FG001|Overall Study|Adverse Event|2|||
163094481|NCT00328172|589056853|FG002|Overall Study|Adverse Event|1|||
163094482|NCT00328172|589056854|FG003|Overall Study|Adverse Event|2|||
163094483|NCT00328172|589056855|FG004|Overall Study|Adverse Event|1|||
163094484|NCT00328172|589056851|FG000|Overall Study|Protocol Violation|0|||
163094485|NCT00328172|589056852|FG001|Overall Study|Protocol Violation|1|||
163094486|NCT00328172|589056853|FG002|Overall Study|Protocol Violation|1|||
163094487|NCT00328172|589056854|FG003|Overall Study|Protocol Violation|0|||
163094488|NCT00328172|589056855|FG004|Overall Study|Protocol Violation|0|||
163094489|NCT00328172|589056851|FG000|Overall Study|Lost to Follow-up|1|||
163094490|NCT00328172|589056852|FG001|Overall Study|Lost to Follow-up|1|||
163094491|NCT00328172|589056853|FG002|Overall Study|Lost to Follow-up|2|||
163094492|NCT00328172|589056854|FG003|Overall Study|Lost to Follow-up|1|||
163094493|NCT00328172|589056855|FG004|Overall Study|Lost to Follow-up|1|||
163094494|NCT00328172|589056851|FG000|Overall Study|Withdrawal by Subject|1|||
163094495|NCT00328172|589056852|FG001|Overall Study|Withdrawal by Subject|1|||
163094496|NCT00328172|589056853|FG002|Overall Study|Withdrawal by Subject|1|||
163094497|NCT00328172|589056854|FG003|Overall Study|Withdrawal by Subject|6|||
163094498|NCT00328172|589056855|FG004|Overall Study|Withdrawal by Subject|0|||
163094499|NCT00328172|589056851|FG000|Overall Study|Lack of Efficacy|14|||
163094500|NCT00328172|589056852|FG001|Overall Study|Lack of Efficacy|9|||
163094501|NCT00328172|589056853|FG002|Overall Study|Lack of Efficacy|4|||
163094502|NCT00328172|589056854|FG003|Overall Study|Lack of Efficacy|4|||
163094503|NCT00328172|589056855|FG004|Overall Study|Lack of Efficacy|3|||
163094504|NCT00328172|589056851|FG000|Overall Study|Other reason (not specified)|3|||
163094505|NCT00328172|589056852|FG001|Overall Study|Other reason (not specified)|0|||
163094506|NCT00328172|589056853|FG002|Overall Study|Other reason (not specified)|1|||
163094507|NCT00328172|589056854|FG003|Overall Study|Other reason (not specified)|0|||
163094508|NCT00328172|589056855|FG004|Overall Study|Other reason (not specified)|0|||
163094509|NCT00077974|589056856|FG000|Overall Study|Adverse Event|22|||
163094510|NCT00077974|589056856|FG000|Overall Study|Protocol Violation|1|||
163094511|NCT00077974|589056856|FG000|Overall Study|Withdrawal by Subject|3|||
163094512|NCT00077974|589056856|FG000|Overall Study|Lack of Efficacy|76|||
163094513|NCT00077974|589056856|FG000|Overall Study|Decision of Sponsor|2|||
163094514|NCT02897115|589056859|FG000|Overall Study|Early termination of study by sponsor|11|||
163094515|NCT02897115|589056860|FG001|Overall Study|Early termination of study by sponsor|8|||
163094516|NCT04512001|589056861|FG000|Week 0 to Week 24|Adverse Event|14|||
162652237|NCT00145509|587445471|FG001|Overall Study|Lost to Follow-up|9|||
162652238|NCT00145509|587445470|FG000|Overall Study|Withdrew Consent|2|||
162652239|NCT00145509|587445471|FG001|Overall Study|Withdrew Consent|7|||
162652240|NCT00145509|587445470|FG000|Overall Study|Reason not provided|2|||
162652241|NCT00145509|587445471|FG001|Overall Study|Reason not provided|1|||
162652242|NCT00697346|587445476|FG000|Overall Study|Adverse Event|4|||
162652243|NCT00697346|587445477|FG001|Overall Study|Adverse Event|5|||
162652244|NCT00697346|587445478|FG002|Overall Study|Adverse Event|0|||
162652245|NCT00697346|587445476|FG000|Overall Study|Progressive Disease|19|||
162652246|NCT00697346|587445477|FG001|Overall Study|Progressive Disease|18|||
162652247|NCT00697346|587445478|FG002|Overall Study|Progressive Disease|0|||
162652248|NCT00697346|587445476|FG000|Overall Study|Symptomatic Deterioration|0|||
162652249|NCT00697346|587445477|FG001|Overall Study|Symptomatic Deterioration|1|||
162652250|NCT00697346|587445478|FG002|Overall Study|Symptomatic Deterioration|0|||
162652251|NCT00697346|587445476|FG000|Overall Study|Withdrawal by Subject|2|||
162652252|NCT00697346|587445477|FG001|Overall Study|Withdrawal by Subject|2|||
162652253|NCT00697346|587445478|FG002|Overall Study|Withdrawal by Subject|0|||
162652254|NCT00697346|587445476|FG000|Overall Study|Reason not Specified|3|||
162652255|NCT00697346|587445477|FG001|Overall Study|Reason not Specified|0|||
162652256|NCT00697346|587445478|FG002|Overall Study|Reason not Specified|1|||
162652257|NCT03569371|587445479|FG000|Overall Study|Lack of Efficacy|1|||
162652258|NCT03569371|587445479|FG000|Overall Study|Lost to Follow-up|1|||
162652259|NCT03569371|587445479|FG000|Overall Study|Adverse Event|1|||
162652260|NCT03643562|587445482|FG000|Overall Study|Adverse Event|1|||
162652261|NCT03643562|587445483|FG001|Overall Study|Adverse Event|0|||
162652262|NCT03643562|587445482|FG000|Overall Study|Lack of Efficacy|0|||
163094517|NCT04512001|589056862|FG001|Week 0 to Week 24|Adverse Event|10|||
163094518|NCT04512001|589056863|FG002|Week 0 to Week 24|Adverse Event|0|||
163094519|NCT04512001|589056864|FG003|Week 0 to Week 24|Adverse Event|0|||
163094520|NCT04512001|589056865|FG004|Week 0 to Week 24|Adverse Event|0|||
163094521|NCT04512001|589056861|FG000|Week 0 to Week 24|Death|0|||
163094522|NCT04512001|589056862|FG001|Week 0 to Week 24|Death|2|||
163094523|NCT04512001|589056863|FG002|Week 0 to Week 24|Death|0|||
163094524|NCT04512001|589056864|FG003|Week 0 to Week 24|Death|0|||
163094525|NCT04512001|589056865|FG004|Week 0 to Week 24|Death|0|||
163094526|NCT04512001|589056861|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
163094527|NCT04512001|589056862|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
163094528|NCT04512001|589056863|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
163094529|NCT04512001|589056864|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
163094530|NCT04512001|589056865|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
163094531|NCT04512001|589056861|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
163094532|NCT04512001|589056862|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
163094533|NCT04512001|589056863|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094534|NCT04512001|589056864|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094535|NCT04512001|589056865|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
163094536|NCT04512001|589056861|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
163094537|NCT04512001|589056862|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094538|NCT04512001|589056863|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094539|NCT04512001|589056864|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094540|NCT04512001|589056865|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
163094541|NCT04512001|589056861|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094542|NCT04512001|589056862|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
163094543|NCT04512001|589056863|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094544|NCT04512001|589056864|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094545|NCT04512001|589056865|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
163094546|NCT04512001|589056861|FG000|Week 24 to Week 63|Adverse Event|0|||
163094547|NCT04512001|589056862|FG001|Week 24 to Week 63|Adverse Event|0|||
163094548|NCT04512001|589056863|FG002|Week 24 to Week 63|Adverse Event|13|||
162652263|NCT03643562|587445483|FG001|Overall Study|Lack of Efficacy|1|||
162652264|NCT03643562|587445482|FG000|Overall Study|Physician Decision|0|||
162652265|NCT03643562|587445483|FG001|Overall Study|Physician Decision|1|||
162652266|NCT03643562|587445482|FG000|Overall Study|Study Terminated by Sponsor|2|||
162652267|NCT03643562|587445483|FG001|Overall Study|Study Terminated by Sponsor|10|||
163094549|NCT04512001|589056864|FG003|Week 24 to Week 63|Adverse Event|8|||
163094550|NCT04512001|589056865|FG004|Week 24 to Week 63|Adverse Event|6|||
163094551|NCT04512001|589056861|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
163094552|NCT04512001|589056862|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
163094553|NCT04512001|589056863|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
162652268|NCT03643562|587445482|FG000|Overall Study|Withdrawal by Subject|2|||
162652269|NCT03643562|587445483|FG001|Overall Study|Withdrawal by Subject|2|||
162652270|NCT03643562|587445482|FG000|Overall Study|Other than specified|3|||
162652271|NCT03643562|587445483|FG001|Overall Study|Other than specified|2|||
162652272|NCT01982253|587445484|FG000|Overall Study|Withdrawal by Subject|1|||
162652273|NCT01982253|587445485|FG001|Overall Study|Withdrawal by Subject|0|||
162652274|NCT01982253|587445486|FG002|Overall Study|Withdrawal by Subject|0|||
163094554|NCT04512001|589056864|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
163094555|NCT04512001|589056865|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
163094556|NCT04512001|589056861|FG000|Week 24 to Week 63|Death|0|||
163094557|NCT04512001|589056862|FG001|Week 24 to Week 63|Death|0|||
163094558|NCT04512001|589056863|FG002|Week 24 to Week 63|Death|0|||
163094559|NCT04512001|589056864|FG003|Week 24 to Week 63|Death|1|||
163094560|NCT04512001|589056865|FG004|Week 24 to Week 63|Death|1|||
163094561|NCT04512001|589056861|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
163094562|NCT04512001|589056862|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
163094563|NCT04512001|589056863|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
163094564|NCT04512001|589056864|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
163094565|NCT04512001|589056865|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
163094566|NCT04512001|589056861|FG000|Week 24 to Week 63|Miscellaneous|0|||
163094567|NCT04512001|589056862|FG001|Week 24 to Week 63|Miscellaneous|0|||
163094568|NCT04512001|589056863|FG002|Week 24 to Week 63|Miscellaneous|3|||
163094569|NCT04512001|589056864|FG003|Week 24 to Week 63|Miscellaneous|2|||
163094570|NCT04512001|589056865|FG004|Week 24 to Week 63|Miscellaneous|1|||
163094571|NCT03896477|589056871|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
163094572|NCT03896477|589056872|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
163094573|NCT03896477|589056873|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
163094574|NCT03896477|589056871|FG000|Overall Study|Parent Requested Withdrawal|8|||
163094575|NCT03896477|589056872|FG001|Overall Study|Parent Requested Withdrawal|12|||
163094576|NCT03896477|589056873|FG002|Overall Study|Parent Requested Withdrawal|9|||
163094577|NCT03896477|589056871|FG000|Overall Study|Adverse Event|0|||
163094578|NCT03896477|589056872|FG001|Overall Study|Adverse Event|0|||
163094579|NCT03896477|589056873|FG002|Overall Study|Adverse Event|1|||
163094580|NCT03896477|589056871|FG000|Overall Study|Death|1|||
163094581|NCT03896477|589056872|FG001|Overall Study|Death|0|||
163094582|NCT03896477|589056873|FG002|Overall Study|Death|0|||
163094583|NCT03896477|589056871|FG000|Overall Study|Other|5|||
163094584|NCT03896477|589056872|FG001|Overall Study|Other|6|||
163094585|NCT03896477|589056873|FG002|Overall Study|Other|7|||
163094586|NCT03896477|589056871|FG000|Overall Study|Lost to Follow-up|2|||
163094587|NCT03896477|589056872|FG001|Overall Study|Lost to Follow-up|1|||
163094588|NCT03896477|589056873|FG002|Overall Study|Lost to Follow-up|1|||
163094589|NCT01106157|589056877|FG000|Overall Study|Withdrawal by Subject|1|||
163094590|NCT01106157|589056878|FG001|Overall Study|Withdrawal by Subject|0|||
163094591|NCT02298868|589056882|FG000|Overall Study|Adverse Event|1|||
163094592|NCT02298868|589056882|FG000|Overall Study|Death|1|||
163094593|NCT02298868|589056882|FG000|Overall Study|Patient underwent transplant|1|||
163094594|NCT01063348|589056883|FG000|Overall Study|Lost to Follow-up|3|||
163094595|NCT01063348|589056884|FG001|Overall Study|Lost to Follow-up|10|||
163094596|NCT03824392|589056887|FG000|Overall Study|Adverse Event|1|||
163094597|NCT03824392|589056888|FG001|Overall Study|Adverse Event|0|||
163094598|NCT03824392|589056889|FG002|Overall Study|Adverse Event|0|||
163094599|NCT03824392|589056890|FG003|Overall Study|Adverse Event|0|||
163094600|NCT03824392|589056887|FG000|Overall Study|Investigator Decision|0|||
163094601|NCT03824392|589056888|FG001|Overall Study|Investigator Decision|1|||
163094602|NCT03824392|589056889|FG002|Overall Study|Investigator Decision|0|||
163094603|NCT03824392|589056890|FG003|Overall Study|Investigator Decision|0|||
163094604|NCT03824392|589056887|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
163094605|NCT03824392|589056888|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
163094606|NCT03824392|589056889|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
163094607|NCT03824392|589056890|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
163094608|NCT00967616|589056891|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
163094609|NCT00967616|589056892|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
163094610|NCT00967616|589056891|FG000|Overall Study|Death|0|||
163094611|NCT00967616|589056892|FG001|Overall Study|Death|3|||
163094612|NCT00967616|589056891|FG000|Overall Study|Withdrawal by Subject|8|||
163094613|NCT00967616|589056892|FG001|Overall Study|Withdrawal by Subject|4|||
163094614|NCT00967616|589056891|FG000|Overall Study|Progressive Disease|31|||
163094615|NCT00967616|589056892|FG001|Overall Study|Progressive Disease|18|||
162652275|NCT01982253|587445484|FG000|Overall Study|Study terminated by sponsor|1|||
162652276|NCT01982253|587445485|FG001|Overall Study|Study terminated by sponsor|4|||
163094616|NCT00967616|589056891|FG000|Overall Study|Other|8|||
163094617|NCT00967616|589056892|FG001|Overall Study|Other|8|||
163094618|NCT00967616|589056891|FG000|Overall Study|Protocol Violation|1|||
163094619|NCT00967616|589056892|FG001|Overall Study|Protocol Violation|0|||
162652277|NCT01982253|587445486|FG002|Overall Study|Study terminated by sponsor|4|||
163094620|NCT01847755|589056893|FG000|Overall Study|Adverse Event|2|||
163094621|NCT01847755|589056893|FG000|Overall Study|Withdrawal by Subject|2|||
163094622|NCT01847755|589056893|FG000|Overall Study|Physician Decision|1|||
163094623|NCT00120627|589056907|FG000|Overall Study|Withdrawal by Subject|5|||
163094624|NCT00120627|589056908|FG001|Overall Study|Withdrawal by Subject|5|||
163094625|NCT03386435|589056909|FG000|Overall Study|Protocol Violation|5|||
163094626|NCT03386435|589056910|FG001|Overall Study|Protocol Violation|7|||
163094627|NCT04068922|589056911|FG000|Overall Study|Lost to Follow-up|5|||
163094628|NCT04068922|589056911|FG000|Overall Study|Withdrawal by Subject|7|||
163094629|NCT04068922|589056911|FG000|Overall Study|Adverse Event|1|||
163094630|NCT00907621|589056913|FG000|Overall Study|Lost to Follow-up|6|||
163094631|NCT00907621|589056914|FG001|Overall Study|Lost to Follow-up|3|||
163094632|NCT00907621|589056913|FG000|Overall Study|intercurrent febrile illness|1|||
163094633|NCT00907621|589056914|FG001|Overall Study|intercurrent febrile illness|1|||
163094634|NCT00959907|589056915|FG000|Overall Study|Protocol Violation|0|||
163094635|NCT00959907|589056916|FG001|Overall Study|Protocol Violation|1|||
163094636|NCT00959907|589056915|FG000|Overall Study|Adverse Event|1|||
163094637|NCT00959907|589056916|FG001|Overall Study|Adverse Event|0|||
163094638|NCT00959907|589056915|FG000|Overall Study|Withdrawal by Subject|2|||
163094639|NCT00959907|589056916|FG001|Overall Study|Withdrawal by Subject|0|||
163094640|NCT01261975|589056921|FG000|Overall Study|Surgical complication|1|||
163094641|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
163094642|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094643|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094644|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094645|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094646|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
163094647|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
163094648|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
163094649|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
163094650|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
163094651|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
163094652|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
163094653|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
163094654|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094655|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094656|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094657|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094658|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
163094659|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
163094660|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
163094661|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
163094662|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
163094663|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
163094664|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
163094665|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
163094666|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
163094667|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094668|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094669|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094670|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163094671|NCT00716274|589056923|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094672|NCT00716274|589056924|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
163094673|NCT00716274|589056925|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094674|NCT00716274|589056926|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094675|NCT00716274|589056927|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094676|NCT00716274|589056928|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
163094677|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094678|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094679|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
163094680|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094681|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094682|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
163094683|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
163094684|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
163094685|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
163094686|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
163094687|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
163094688|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
163094689|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094690|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094691|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094692|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
163094693|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
163094694|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163094695|NCT00716274|589056923|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
163094696|NCT00716274|589056924|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
163094697|NCT00716274|589056925|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
163094698|NCT00716274|589056926|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
162652278|NCT02789176|587445490|FG000|Overall Study|Death|0|||
162652279|NCT02789176|587445491|FG001|Overall Study|Death|0|||
162652280|NCT02789176|587445492|FG002|Overall Study|Death|3|||
162652281|NCT02789176|587445493|FG003|Overall Study|Death|0|||
162652282|NCT02789176|587445490|FG000|Overall Study|Withdrawal by Subject|0|||
162652283|NCT02789176|587445491|FG001|Overall Study|Withdrawal by Subject|0|||
162652284|NCT02789176|587445492|FG002|Overall Study|Withdrawal by Subject|1|||
162652285|NCT02789176|587445493|FG003|Overall Study|Withdrawal by Subject|0|||
162652286|NCT02789176|587445490|FG000|Overall Study|Lost to Follow-up|8|||
162652287|NCT02789176|587445491|FG001|Overall Study|Lost to Follow-up|2|||
162652288|NCT02789176|587445492|FG002|Overall Study|Lost to Follow-up|6|||
162652289|NCT02789176|587445493|FG003|Overall Study|Lost to Follow-up|1|||
162652290|NCT02223767|587445494|FG000|Overall Study|Withdrawal by Subject|4|||
162652291|NCT02223767|587445495|FG001|Overall Study|Withdrawal by Subject|4|||
162652292|NCT00770120|587445501|FG000|Overall Study|Progression|31|||
162652293|NCT00770120|587445501|FG000|Overall Study|Adverse Event|11|||
162652294|NCT00770120|587445501|FG000|Overall Study|Not Protocol Specified|11|||
162652295|NCT00770120|587445501|FG000|Overall Study|Death|3|||
162652296|NCT00770120|587445501|FG000|Overall Study|Withdrawal by Subject|2|||
162652297|NCT00770120|587445501|FG000|Overall Study|Ineligible|1|||
162652298|NCT00770120|587445501|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
163094699|NCT00716274|589056927|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
163094700|NCT00716274|589056928|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
163094701|NCT01932788|589056929|FG000|Overall Study|Protocol Violation|18|||
163094702|NCT01932788|589056930|FG001|Overall Study|Protocol Violation|0|||
163094703|NCT01932788|589056929|FG000|Overall Study|Lost to Follow-up|18|||
163094704|NCT01932788|589056930|FG001|Overall Study|Lost to Follow-up|46|||
163094705|NCT01932788|589056929|FG000|Overall Study|Lack of Efficacy|2|||
163094706|NCT01932788|589056930|FG001|Overall Study|Lack of Efficacy|0|||
163094707|NCT01932788|589056929|FG000|Overall Study|Withdrawal by Subject|0|||
163094708|NCT01932788|589056930|FG001|Overall Study|Withdrawal by Subject|5|||
163094709|NCT04290624|589056931|FG000|Overall Study|Adverse Event|1|||
163094710|NCT04290624|589056932|FG001|Overall Study|Adverse Event|0|||
163094711|NCT01171677|589056933|FG000|Overall Study|Withdrawal by Subject|0|||
163094712|NCT01171677|589056934|FG001|Overall Study|Withdrawal by Subject|3|||
163094713|NCT01171677|589056933|FG000|Overall Study|Adverse Event|1|||
163094714|NCT01171677|589056934|FG001|Overall Study|Adverse Event|0|||
163094715|NCT01171677|589056933|FG000|Overall Study|completed <70% IntenSati classes|5|||
163094716|NCT01171677|589056934|FG001|Overall Study|completed <70% IntenSati classes|0|||
163094717|NCT00656370|589056935|FG000|Overall Study|Screen Failures|7|||
163094718|NCT00656370|589056935|FG000|Overall Study|Alternates|3|||
163094719|NCT01342094|589056938|FG000|Overall Study|Adverse Event|5|||
163094720|NCT01342094|589056939|FG001|Overall Study|Adverse Event|0|||
163094721|NCT01342094|589056938|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
163094722|NCT01342094|589056939|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
163094723|NCT01342094|589056938|FG000|Overall Study|Withdrawal by Subject|0|||
163094724|NCT01342094|589056939|FG001|Overall Study|Withdrawal by Subject|2|||
163094725|NCT02806414|589056942|FG000|Overall Study|Lost to Follow-up|2|||
163094726|NCT03092479|589056951|FG000|Overall Study|Lost to Follow-up|3|||
163094727|NCT03092479|589056952|FG001|Overall Study|Lost to Follow-up|2|||
163094728|NCT03092479|589056951|FG000|Overall Study|Withdrawal by Subject|4|||
163094729|NCT03092479|589056952|FG001|Overall Study|Withdrawal by Subject|0|||
163094730|NCT05653700|589056953|FG000|Overall Study|Non Responders|9|||
163094731|NCT05653700|589056954|FG001|Overall Study|Non Responders|0|||
163094732|NCT00543985|589056961|FG000|Overall Study|Withdrawal by Subject|4|||
163094733|NCT01634152|589056962|FG000|Overall Study|Adverse Event|2|||
163094734|NCT01634152|589056963|FG001|Overall Study|Adverse Event|0|||
163094735|NCT01634152|589056964|FG002|Overall Study|Adverse Event|2|||
163094736|NCT01634152|589056962|FG000|Overall Study|Consent withdrawn not due to AE|1|||
163094737|NCT01634152|589056963|FG001|Overall Study|Consent withdrawn not due to AE|0|||
163094738|NCT01634152|589056964|FG002|Overall Study|Consent withdrawn not due to AE|1|||
163094739|NCT01634152|589056962|FG000|Overall Study|Not treated|0|||
163094740|NCT01634152|589056963|FG001|Overall Study|Not treated|1|||
163094741|NCT01634152|589056964|FG002|Overall Study|Not treated|0|||
162652299|NCT00770120|587445501|FG000|Overall Study|Reason under Review|1|||
162652300|NCT02412631|587445502|FG000|Overall Study|Adverse Event|1|||
162652301|NCT02412631|587445503|FG001|Overall Study|Adverse Event|2|||
163094742|NCT01634152|589056962|FG000|Overall Study|Other reason not defined above|1|||
163094743|NCT01634152|589056963|FG001|Overall Study|Other reason not defined above|0|||
163094744|NCT01634152|589056964|FG002|Overall Study|Other reason not defined above|1|||
163094745|NCT01900665|589056969|FG000|Placebo Controlled Period|Death|9|||
163094746|NCT01900665|589056970|FG001|Placebo Controlled Period|Death|16|||
163094747|NCT01900665|589056969|FG000|Placebo Controlled Period|Adverse Event|48|||
163094748|NCT01900665|589056970|FG001|Placebo Controlled Period|Adverse Event|39|||
163094749|NCT01900665|589056969|FG000|Placebo Controlled Period|Protocol Violation|1|||
163094750|NCT01900665|589056970|FG001|Placebo Controlled Period|Protocol Violation|7|||
163094751|NCT01900665|589056969|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
163094752|NCT01900665|589056970|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
163094753|NCT01900665|589056969|FG000|Placebo Controlled Period|Physician Decision|11|||
163094754|NCT01900665|589056970|FG001|Placebo Controlled Period|Physician Decision|7|||
163094755|NCT01900665|589056969|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
163094756|NCT01900665|589056970|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
163094757|NCT01900665|589056969|FG000|Placebo Controlled Period|Caregiver Decision|33|||
163094758|NCT01900665|589056970|FG001|Placebo Controlled Period|Caregiver Decision|41|||
163094759|NCT01900665|589056969|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
163094760|NCT01900665|589056970|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
163094761|NCT01900665|589056969|FG000|Open Label Period|Adverse Event|16|||
163094762|NCT01900665|589056970|FG001|Open Label Period|Adverse Event|20|||
163094763|NCT01900665|589056969|FG000|Open Label Period|Death|5|||
163094764|NCT01900665|589056970|FG001|Open Label Period|Death|6|||
163094765|NCT01900665|589056969|FG000|Open Label Period|Lost to Follow-up|1|||
163094766|NCT01900665|589056970|FG001|Open Label Period|Lost to Follow-up|1|||
163094767|NCT01900665|589056969|FG000|Open Label Period|Parent/Caregiver Decision|33|||
163094768|NCT01900665|589056970|FG001|Open Label Period|Parent/Caregiver Decision|34|||
163094769|NCT01900665|589056969|FG000|Open Label Period|Physician Decision|4|||
163094770|NCT01900665|589056970|FG001|Open Label Period|Physician Decision|4|||
163094771|NCT01900665|589056969|FG000|Open Label Period|Protocol Violation|0|||
163094772|NCT01900665|589056970|FG001|Open Label Period|Protocol Violation|1|||
163094773|NCT01900665|589056969|FG000|Open Label Period|Sponsor Decision|802|||
163094774|NCT01900665|589056970|FG001|Open Label Period|Sponsor Decision|765|||
163094775|NCT01900665|589056969|FG000|Open Label Period|Withdrawal by Subject|20|||
163094776|NCT01900665|589056970|FG001|Open Label Period|Withdrawal by Subject|28|||
163094777|NCT02317627|589056974|FG000|Overall Study|Withdrawal by Subject|0|||
163094778|NCT02317627|589056975|FG001|Overall Study|Withdrawal by Subject|1|||
163094779|NCT02317627|589056976|FG002|Overall Study|Withdrawal by Subject|1|||
163094780|NCT02317627|589056974|FG000|Overall Study|Lost to Follow-up|2|||
163094781|NCT02317627|589056975|FG001|Overall Study|Lost to Follow-up|0|||
163094782|NCT02317627|589056976|FG002|Overall Study|Lost to Follow-up|0|||
163094783|NCT02317627|589056974|FG000|Overall Study|Stopped by Investigator|0|||
163094784|NCT02317627|589056975|FG001|Overall Study|Stopped by Investigator|1|||
163094785|NCT02317627|589056976|FG002|Overall Study|Stopped by Investigator|0|||
163094786|NCT02317627|589056974|FG000|Overall Study|Adverse Event|0|||
163094787|NCT02317627|589056975|FG001|Overall Study|Adverse Event|2|||
163094788|NCT02317627|589056976|FG002|Overall Study|Adverse Event|3|||
163094789|NCT02317627|589056974|FG000|Overall Study|Non-compliance with study drug|0|||
163094790|NCT02317627|589056975|FG001|Overall Study|Non-compliance with study drug|1|||
163094791|NCT02317627|589056976|FG002|Overall Study|Non-compliance with study drug|0|||
163094792|NCT00279214|589056977|FG000|Overall Study|Physician Decision|3|||
163094793|NCT00279214|589056978|FG001|Overall Study|Physician Decision|2|||
163094794|NCT04749914|589056979|FG000|Period 1|Adverse Event|1|||
163094795|NCT04749914|589056980|FG001|Period 1|Adverse Event|0|||
163094796|NCT04749914|589056981|FG002|Period 1|Adverse Event|0|||
163094797|NCT04749914|589056982|FG003|Period 1|Adverse Event|0|||
163094798|NCT04749914|589056979|FG000|Period 1|Withdrawal by Subject|1|||
163094799|NCT04749914|589056980|FG001|Period 1|Withdrawal by Subject|0|||
163094800|NCT04749914|589056981|FG002|Period 1|Withdrawal by Subject|1|||
163094801|NCT04749914|589056982|FG003|Period 1|Withdrawal by Subject|0|||
163094802|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Not Eligible|3|||
163094803|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
163094804|NCT00403130|589056983|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
163094805|NCT00403130|589056983|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
163094806|NCT01280968|589056984|FG000|Overall Study|Lost to Follow-up|8|||
163094807|NCT01280968|589056985|FG001|Overall Study|Lost to Follow-up|2|||
163094808|NCT01280968|589056984|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
163094809|NCT01280968|589056985|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
163094810|NCT01280968|589056984|FG000|Overall Study|Commuting Problems|2|||
163094811|NCT01280968|589056985|FG001|Overall Study|Commuting Problems|0|||
163094812|NCT01280968|589056984|FG000|Overall Study|Anxiety|2|||
163094813|NCT01280968|589056985|FG001|Overall Study|Anxiety|0|||
163094814|NCT01280968|589056984|FG000|Overall Study|Adverse Event|1|||
163094815|NCT01280968|589056985|FG001|Overall Study|Adverse Event|0|||
163094816|NCT01280968|589056984|FG000|Overall Study|Scheduling Conflicts|1|||
163094817|NCT01280968|589056985|FG001|Overall Study|Scheduling Conflicts|1|||
162652302|NCT02412631|587445502|FG000|Overall Study|Lost to Follow-up|5|||
163094818|NCT01280968|589056984|FG000|Overall Study|Pre-existing Neurological Condition|1|||
163094819|NCT01280968|589056985|FG001|Overall Study|Pre-existing Neurological Condition|0|||
163094820|NCT01280968|589056984|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
163094821|NCT01280968|589056985|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
163094822|NCT00342628|589058505|FG000|Overall Study|Withdrawal by Subject|19|||
163094823|NCT00342628|589058506|FG001|Overall Study|Withdrawal by Subject|19|||
163094824|NCT00342628|589058507|FG002|Overall Study|Withdrawal by Subject|18|||
163094825|NCT00342628|589058505|FG000|Overall Study|Death|1|||
163094826|NCT00342628|589058506|FG001|Overall Study|Death|1|||
163094827|NCT00342628|589058507|FG002|Overall Study|Death|0|||
162652303|NCT02412631|587445503|FG001|Overall Study|Lost to Follow-up|9|||
162652304|NCT02412631|587445502|FG000|Overall Study|Withdrawal by Subject|9|||
162652305|NCT02412631|587445503|FG001|Overall Study|Withdrawal by Subject|3|||
162652306|NCT02412631|587445502|FG000|Overall Study|Early stop by FDA|5|||
162652307|NCT02412631|587445503|FG001|Overall Study|Early stop by FDA|2|||
162652308|NCT02412631|587445502|FG000|Overall Study|Unspecified reason|6|||
162652309|NCT02412631|587445503|FG001|Overall Study|Unspecified reason|8|||
162652310|NCT03100825|587445508|FG000|Overall Study|Participant/Guardian Decision|7|||
162652311|NCT03100825|587445508|FG000|Overall Study|Physician Decision|1|||
162652312|NCT00994448|587445509|FG000|Overall Study|Adverse Event|1|||
162652313|NCT00994448|587445510|FG001|Overall Study|Adverse Event|0|||
162652314|NCT00994448|587445509|FG000|Overall Study|Lost to Follow-up|5|||
162652315|NCT00994448|587445510|FG001|Overall Study|Lost to Follow-up|1|||
162652316|NCT00994448|587445509|FG000|Overall Study|Withdrawal by Subject|1|||
162652317|NCT00994448|587445510|FG001|Overall Study|Withdrawal by Subject|1|||
162652318|NCT00994448|587445509|FG000|Overall Study|Physician Decision|1|||
162652319|NCT00994448|587445510|FG001|Overall Study|Physician Decision|0|||
162652320|NCT05288556|587445512|FG000|Overall Study|Protocol Violation|1|||
162652321|NCT05288556|587445512|FG000|Overall Study|Withdrawal by Subject|1|||
162652322|NCT02704364|587445513|FG000|Overall Study|Adverse Event|1|||
162652323|NCT02704364|587445514|FG001|Overall Study|Adverse Event|1|||
162652324|NCT02704364|587445515|FG002|Overall Study|Adverse Event|0|||
162652325|NCT02704364|587445513|FG000|Overall Study|Noncompliance with study drug|1|||
162652326|NCT02704364|587445514|FG001|Overall Study|Noncompliance with study drug|1|||
162652327|NCT02704364|587445515|FG002|Overall Study|Noncompliance with study drug|0|||
162652328|NCT02704364|587445513|FG000|Overall Study|Other|0|||
162652329|NCT02704364|587445514|FG001|Overall Study|Other|1|||
162652330|NCT02704364|587445515|FG002|Overall Study|Other|1|||
162652331|NCT01232296|587445516|FG000|Overall Study|Adverse Event|24|||
162652332|NCT01232296|587445517|FG001|Overall Study|Adverse Event|12|||
162652333|NCT01232296|587445516|FG000|Overall Study|Physician Decision|1|||
162652334|NCT01232296|587445517|FG001|Overall Study|Physician Decision|1|||
162652335|NCT01232296|587445516|FG000|Overall Study|Progressive disease|43|||
162652336|NCT01232296|587445517|FG001|Overall Study|Progressive disease|61|||
162652337|NCT01232296|587445516|FG000|Overall Study|Study terminated by sponsor|0|||
162652338|NCT01232296|587445517|FG001|Overall Study|Study terminated by sponsor|1|||
163039211|NCT00528372|588850687|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039212|NCT00528372|588850688|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
162652339|NCT01232296|587445516|FG000|Overall Study|Technical problems|3|||
162652340|NCT01232296|587445517|FG001|Overall Study|Technical problems|0|||
162652341|NCT01232296|587445516|FG000|Overall Study|Subject/guardian decision|10|||
162652342|NCT01232296|587445517|FG001|Overall Study|Subject/guardian decision|2|||
162652343|NCT01232296|587445516|FG000|Overall Study|Death|1|||
162652344|NCT01232296|587445517|FG001|Overall Study|Death|6|||
162652345|NCT01461096|587445519|FG000|Overall Study|Death|3|||
162652346|NCT01461096|587445520|FG001|Overall Study|Death|6|||
163039213|NCT00528372|588850689|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
163039214|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
163039215|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
163039216|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
163039217|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039218|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039219|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
163039220|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
163039221|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
163039222|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
163039223|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
163039224|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
163039225|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
163039226|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039227|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
163039228|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
163039229|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
163039230|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039231|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
163039232|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
163039233|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
163039234|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
163039235|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
163039236|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
163039237|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
163039238|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
163039239|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
163094828|NCT00342628|589058505|FG000|Overall Study|moved residence|0|||
163094829|NCT00342628|589058506|FG001|Overall Study|moved residence|1|||
163094830|NCT00342628|589058507|FG002|Overall Study|moved residence|1|||
163094831|NCT00456755|589058510|FG000|Overall Study|Lost to Follow-up|2|||
163094832|NCT00456755|589058511|FG001|Overall Study|Lost to Follow-up|1|||
163094833|NCT01475721|589058514|FG000|Overall Study|Death|3|||
163094834|NCT01475721|589058515|FG001|Overall Study|Death|6|||
163094835|NCT01475721|589058514|FG000|Overall Study|Withdrawal by Subject|8|||
163094836|NCT01475721|589058515|FG001|Overall Study|Withdrawal by Subject|8|||
163094837|NCT01048242|589058516|FG000|Overall Study|See study flow chart|4|||
163094838|NCT01048242|589058517|FG001|Overall Study|See study flow chart|2|||
163094839|NCT01772550|589058519|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
163094840|NCT01772550|589058520|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
163094841|NCT01772550|589058521|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
163094842|NCT01772550|589058519|FG000|Overall Study|Adverse Event|0|||
163094843|NCT01772550|589058520|FG001|Overall Study|Adverse Event|0|||
163094844|NCT01772550|589058521|FG002|Overall Study|Adverse Event|1|||
163094845|NCT00559104|589058523|FG000|Overall Study|Lack of Efficacy|9|||
163094846|NCT00559104|589058524|FG001|Overall Study|Lack of Efficacy|0|||
163094847|NCT01815424|589058525|FG000|Week 0 to 16|Adverse Event|1|||
163094848|NCT01815424|589058526|FG001|Week 0 to 16|Adverse Event|3|||
162652347|NCT01461096|587445519|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162652348|NCT01461096|587445520|FG001|Overall Study|Severe debilitation, unable to continue|1|||
162652349|NCT01461096|587445519|FG000|Overall Study|Subj not able to get to clinic|15|||
162652350|NCT01461096|587445520|FG001|Overall Study|Subj not able to get to clinic|13|||
163094849|NCT01815424|589058527|FG002|Week 0 to 16|Adverse Event|3|||
163094850|NCT01815424|589058528|FG003|Week 0 to 16|Adverse Event|0|||
163094851|NCT01815424|589058529|FG004|Week 0 to 16|Adverse Event|0|||
163094852|NCT01815424|589058525|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
163094853|NCT01815424|589058526|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094854|NCT01815424|589058527|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094855|NCT01815424|589058528|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094856|NCT01815424|589058529|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
163094857|NCT01815424|589058525|FG000|Week 0 to 16|Lost to Follow-up|0|||
163094858|NCT01815424|589058526|FG001|Week 0 to 16|Lost to Follow-up|1|||
163094859|NCT01815424|589058527|FG002|Week 0 to 16|Lost to Follow-up|0|||
163094860|NCT01815424|589058528|FG003|Week 0 to 16|Lost to Follow-up|0|||
163094861|NCT01815424|589058529|FG004|Week 0 to 16|Lost to Follow-up|0|||
163094862|NCT01815424|589058525|FG000|Week 0 to 16|Withdrawal by Subject|0|||
163094863|NCT01815424|589058526|FG001|Week 0 to 16|Withdrawal by Subject|0|||
163094864|NCT01815424|589058527|FG002|Week 0 to 16|Withdrawal by Subject|1|||
163094865|NCT01815424|589058528|FG003|Week 0 to 16|Withdrawal by Subject|0|||
163094866|NCT01815424|589058529|FG004|Week 0 to 16|Withdrawal by Subject|0|||
163094867|NCT01815424|589058525|FG000|Week 0 to 16|Other|1|||
163094868|NCT01815424|589058526|FG001|Week 0 to 16|Other|0|||
163094869|NCT01815424|589058527|FG002|Week 0 to 16|Other|3|||
163094870|NCT01815424|589058528|FG003|Week 0 to 16|Other|0|||
163094871|NCT01815424|589058529|FG004|Week 0 to 16|Other|0|||
163094872|NCT01815424|589058525|FG000|Week 0 to 16|Protocol Violation|1|||
163094873|NCT01815424|589058526|FG001|Week 0 to 16|Protocol Violation|0|||
163094874|NCT01815424|589058527|FG002|Week 0 to 16|Protocol Violation|0|||
163094875|NCT01815424|589058528|FG003|Week 0 to 16|Protocol Violation|0|||
163094876|NCT01815424|589058529|FG004|Week 0 to 16|Protocol Violation|0|||
163094877|NCT01815424|589058525|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
163094878|NCT01815424|589058526|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
163094879|NCT01815424|589058527|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
163094880|NCT01815424|589058528|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
163094881|NCT01815424|589058529|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
163094882|NCT01815424|589058525|FG000|Week 16 to 52|Other|0|||
163094883|NCT01815424|589058526|FG001|Week 16 to 52|Other|1|||
163094884|NCT01815424|589058527|FG002|Week 16 to 52|Other|0|||
163094885|NCT01815424|589058528|FG003|Week 16 to 52|Other|0|||
163094886|NCT01815424|589058529|FG004|Week 16 to 52|Other|0|||
163094887|NCT01815424|589058525|FG000|Week 16 to 52|Adverse Event|0|||
163094888|NCT01815424|589058526|FG001|Week 16 to 52|Adverse Event|0|||
163094889|NCT01815424|589058527|FG002|Week 16 to 52|Adverse Event|0|||
163094890|NCT01815424|589058528|FG003|Week 16 to 52|Adverse Event|0|||
163094891|NCT01815424|589058529|FG004|Week 16 to 52|Adverse Event|1|||
163094892|NCT01815424|589058525|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
163094893|NCT01815424|589058526|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
163094894|NCT01815424|589058527|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
163094895|NCT01815424|589058528|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
163094896|NCT01815424|589058529|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
163094897|NCT01815424|589058525|FG000|Week 16 to 52|Lost to Follow-up|0|||
163094898|NCT01815424|589058526|FG001|Week 16 to 52|Lost to Follow-up|2|||
163094899|NCT01815424|589058527|FG002|Week 16 to 52|Lost to Follow-up|0|||
163094900|NCT01815424|589058528|FG003|Week 16 to 52|Lost to Follow-up|2|||
163094901|NCT01815424|589058529|FG004|Week 16 to 52|Lost to Follow-up|1|||
163094902|NCT01815424|589058525|FG000|Week 16 to 52|Withdrawal by Subject|1|||
163094903|NCT01815424|589058526|FG001|Week 16 to 52|Withdrawal by Subject|2|||
163094904|NCT01815424|589058527|FG002|Week 16 to 52|Withdrawal by Subject|0|||
163094905|NCT01815424|589058528|FG003|Week 16 to 52|Withdrawal by Subject|0|||
163094906|NCT01815424|589058529|FG004|Week 16 to 52|Withdrawal by Subject|0|||
163094907|NCT01309204|589058530|FG000|Overall Study|Adverse Event|48|||
163094908|NCT01309204|589058531|FG001|Overall Study|Adverse Event|58|||
163094909|NCT01309204|589058530|FG000|Overall Study|Lost to Follow-up|2|||
163094910|NCT01309204|589058531|FG001|Overall Study|Lost to Follow-up|2|||
163094911|NCT01309204|589058530|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
163094912|NCT01309204|589058531|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
163094913|NCT01309204|589058530|FG000|Overall Study|Inadequate control of IOP|4|||
163094914|NCT01309204|589058531|FG001|Overall Study|Inadequate control of IOP|4|||
163094915|NCT01309204|589058530|FG000|Overall Study|Other|4|||
163094916|NCT01309204|589058531|FG001|Overall Study|Other|1|||
163094917|NCT04723355|589058532|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
163094918|NCT04723355|589058532|FG000|Overall Study|Errors in the informed consent form|2|||
163094919|NCT03374358|589058534|FG000|Overall Study|Withdrawal by Subject|0|||
163094920|NCT03374358|589058535|FG001|Overall Study|Withdrawal by Subject|2|||
163094921|NCT01127633|589058536|FG000|Overall Study|Adverse Event|74|||
163094922|NCT01127633|589058537|FG001|Overall Study|Adverse Event|73|||
163094923|NCT01127633|589058536|FG000|Overall Study|Death|40|||
162652351|NCT01461096|587445519|FG000|Overall Study|Site is closing|27|||
163094924|NCT01127633|589058537|FG001|Overall Study|Death|43|||
163094925|NCT01127633|589058536|FG000|Overall Study|Lost to Follow-up|4|||
163094926|NCT01127633|589058537|FG001|Overall Study|Lost to Follow-up|0|||
163094927|NCT01127633|589058536|FG000|Overall Study|Parent/Caregiver Decision|246|||
163094928|NCT01127633|589058537|FG001|Overall Study|Parent/Caregiver Decision|228|||
163094929|NCT01127633|589058536|FG000|Overall Study|Physician Decision|60|||
163094930|NCT01127633|589058537|FG001|Overall Study|Physician Decision|45|||
163094931|NCT01127633|589058536|FG000|Overall Study|Withdrawal by Subject|57|||
163094932|NCT01127633|589058537|FG001|Overall Study|Withdrawal by Subject|72|||
163094933|NCT01127633|589058536|FG000|Overall Study|Sponsor Decision|163|||
163094934|NCT01127633|589058537|FG001|Overall Study|Sponsor Decision|195|||
163094935|NCT01127633|589058536|FG000|Overall Study|Protocol Violation|8|||
163094936|NCT01127633|589058537|FG001|Overall Study|Protocol Violation|16|||
163094937|NCT01127633|589058536|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
163094938|NCT01127633|589058537|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
163094939|NCT01127633|589058536|FG000|Overall Study|Not treated|1|||
162652352|NCT01461096|587445520|FG001|Overall Study|Site is closing|30|||
162652353|NCT01461096|587445519|FG000|Overall Study|Withdrawal by Subject|5|||
162652354|NCT01461096|587445520|FG001|Overall Study|Withdrawal by Subject|3|||
162652355|NCT01461096|587445519|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
162652356|NCT01461096|587445520|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
162652357|NCT01461096|587445519|FG000|Overall Study|Lost to Follow-up|8|||
162652358|NCT01461096|587445520|FG001|Overall Study|Lost to Follow-up|4|||
162652359|NCT04889625|587445522|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
162652360|NCT04889625|587445523|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
162652361|NCT04889625|587445522|FG000|Period 1|Subject out of window|0|||
162652362|NCT04889625|587445523|FG001|Period 1|Subject out of window|1|||
162652363|NCT04889625|587445522|FG000|Period 1|Wrong add power dispensed|0|||
162652364|NCT04889625|587445523|FG001|Period 1|Wrong add power dispensed|1|||
162652365|NCT04889625|587445522|FG000|Period 1|Discontinued due to fitting guide error|1|||
162652366|NCT04889625|587445523|FG001|Period 1|Discontinued due to fitting guide error|1|||
162652367|NCT04889625|587445522|FG000|Period 2|Test article no longer available|1|||
162652368|NCT04889625|587445523|FG001|Period 2|Test article no longer available|0|||
162652369|NCT04889625|587445522|FG000|Period 2|Incorrect lens dispensed|1|||
162652370|NCT04889625|587445523|FG001|Period 2|Incorrect lens dispensed|0|||
162652371|NCT04889625|587445522|FG000|Period 2|Wrong add power dispensed|0|||
162652372|NCT04889625|587445523|FG001|Period 2|Wrong add power dispensed|1|||
162652373|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
162652374|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
163094940|NCT01127633|589058537|FG001|Overall Study|Not treated|0|||
163094941|NCT01073293|589058539|FG000|Overall Study|Lost to Follow-up|0|||
163094942|NCT01073293|589058540|FG001|Overall Study|Lost to Follow-up|1|||
163094943|NCT01073293|589058539|FG000|Overall Study|Withdrawal by Subject|5|||
162652375|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
162652376|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
163094944|NCT01073293|589058540|FG001|Overall Study|Withdrawal by Subject|10|||
163094945|NCT00775268|589058550|FG000|Baseline|Drug not synthesize dose|1|||
163094946|NCT00775268|589058551|FG001|Baseline|Drug not synthesize dose|0|||
163094947|NCT00775268|589058550|FG000|Baseline|Not treated-ineligible per CT|0|||
163094948|NCT00775268|589058551|FG001|Baseline|Not treated-ineligible per CT|1|||
163094949|NCT00775268|589058550|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
162652377|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
163094950|NCT00775268|589058551|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
163094951|NCT00775268|589058550|FG000|After Completion|Participant missed scan appointment|1|||
163094952|NCT00775268|589058551|FG001|After Completion|Participant missed scan appointment|0|||
163094953|NCT03745768|589058553|FG000|Overall Study|discontinued study|2|||
163094954|NCT03745768|589058554|FG001|Overall Study|discontinued study|0|||
163094955|NCT00443118|589058555|FG000|Overall Study|unknown primary outcome|3|||
163094956|NCT00443118|589058556|FG001|Overall Study|unknown primary outcome|1|||
163094957|NCT00443118|589058557|FG002|Overall Study|unknown primary outcome|0|||
163094958|NCT00443118|589058555|FG000|Overall Study|Withdrawal by Subject|1|||
163094959|NCT00443118|589058556|FG001|Overall Study|Withdrawal by Subject|0|||
163094960|NCT00443118|589058557|FG002|Overall Study|Withdrawal by Subject|0|||
163094961|NCT00506779|589058560|FG000|Overall Study|Withdrawal by Subject|1|||
163094962|NCT00506779|589058561|FG001|Overall Study|Withdrawal by Subject|0|||
163094963|NCT00506779|589058562|FG002|Overall Study|Withdrawal by Subject|1|||
163094964|NCT00506779|589058563|FG003|Overall Study|Withdrawal by Subject|0|||
163094965|NCT00506779|589058560|FG000|Overall Study|Adverse Event|0|||
163094966|NCT00506779|589058561|FG001|Overall Study|Adverse Event|1|||
163094967|NCT00506779|589058562|FG002|Overall Study|Adverse Event|1|||
163094968|NCT00506779|589058563|FG003|Overall Study|Adverse Event|1|||
163094969|NCT04263766|589058564|FG000|Overall Study|Withdrawal by Subject|6|||
163094970|NCT04263766|589058565|FG001|Overall Study|Withdrawal by Subject|4|||
163094971|NCT04263766|589058564|FG000|Overall Study|Lack of Efficacy|1|||
163094972|NCT04263766|589058565|FG001|Overall Study|Lack of Efficacy|3|||
163094973|NCT04232943|589058566|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
163094974|NCT04232943|589058567|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
163094975|NCT04232943|589058568|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
163094976|NCT04232943|589058566|FG000|Overall Study|Withdrawal by Subject|1|||
163094977|NCT04232943|589058567|FG001|Overall Study|Withdrawal by Subject|1|||
163094978|NCT04232943|589058568|FG002|Overall Study|Withdrawal by Subject|0|||
163094979|NCT02639247|589058569|FG000|Overall Study|Lost to Follow-up|2|||
163094980|NCT02639247|589058570|FG001|Overall Study|Lost to Follow-up|1|||
163094981|NCT02639247|589058569|FG000|Overall Study|Death|2|||
163094982|NCT02639247|589058570|FG001|Overall Study|Death|0|||
163094983|NCT02639247|589058569|FG000|Overall Study|Withdrew Consent|0|||
163094984|NCT02639247|589058570|FG001|Overall Study|Withdrew Consent|1|||
163094985|NCT02639247|589058569|FG000|Overall Study|Protocol Violation|1|||
163094986|NCT02639247|589058570|FG001|Overall Study|Protocol Violation|0|||
163094987|NCT01891396|589058571|FG000|Overall Study|Withdrawal by Subject|4|||
163094988|NCT01891396|589058572|FG001|Overall Study|Withdrawal by Subject|4|||
163094989|NCT01891396|589058573|FG002|Overall Study|Withdrawal by Subject|3|||
163094990|NCT01891396|589058571|FG000|Overall Study|Lost to Follow-up|0|||
163094991|NCT01891396|589058572|FG001|Overall Study|Lost to Follow-up|1|||
163094992|NCT01891396|589058573|FG002|Overall Study|Lost to Follow-up|0|||
163094993|NCT00573391|589058574|FG000|Overall Study|study stopped|2|||
163094994|NCT00573391|589058575|FG001|Overall Study|study stopped|2|||
163094995|NCT00573391|589058574|FG000|Overall Study|Death|1|||
163094996|NCT00573391|589058575|FG001|Overall Study|Death|0|||
163094997|NCT02168101|589058576|FG000|Overall Study|Death|2|||
163094998|NCT02168101|589058577|FG001|Overall Study|Death|2|||
163094999|NCT02168101|589058578|FG002|Overall Study|Death|1|||
163095000|NCT00400517|589058579|FG000|Overall Study|Withdrawal by Subject|1|||
163095001|NCT00400517|589058579|FG000|Overall Study|Physician Decision|1|||
163095002|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
163095003|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095004|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095005|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095006|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
163095007|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
163095008|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095009|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095010|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095011|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
163095012|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
163095013|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095014|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095015|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095016|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
163095017|NCT01194245|589058580|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
163095018|NCT01194245|589058581|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095019|NCT01194245|589058582|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095020|NCT01194245|589058583|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095021|NCT01194245|589058584|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
163095022|NCT01194245|589058580|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095023|NCT01194245|589058581|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095024|NCT01194245|589058582|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095025|NCT01194245|589058583|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163095026|NCT01194245|589058584|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163095027|NCT01194245|589058580|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163095028|NCT01194245|589058581|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163095029|NCT01194245|589058582|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095030|NCT01194245|589058583|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095031|NCT01194245|589058584|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
163095032|NCT05518461|589058585|FG000|Overall Study|Lost to Follow-up|25|||
163095033|NCT02457247|589058586|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
163095034|NCT02457247|589058587|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
163095035|NCT02457247|589058588|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
163095036|NCT02457247|589058589|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
163095037|NCT02457247|589058586|FG000|Period 1|Significant Protocol Deviation|1|||
163095038|NCT02457247|589058587|FG001|Period 1|Significant Protocol Deviation|1|||
163095039|NCT02457247|589058588|FG002|Period 1|Significant Protocol Deviation|0|||
163095040|NCT02457247|589058589|FG003|Period 1|Significant Protocol Deviation|0|||
163095041|NCT02457247|589058586|FG000|Period 1|Voluntary Withdrawal|1|||
163095042|NCT02457247|589058587|FG001|Period 1|Voluntary Withdrawal|0|||
163095043|NCT02457247|589058588|FG002|Period 1|Voluntary Withdrawal|0|||
163095044|NCT02457247|589058589|FG003|Period 1|Voluntary Withdrawal|0|||
163095045|NCT02457247|589058586|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
163095046|NCT02457247|589058587|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
163095047|NCT02457247|589058588|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
163095048|NCT02457247|589058589|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
163095049|NCT02457247|589058586|FG000|Period 2|Significant Protocol Deviation|1|||
163095050|NCT02457247|589058587|FG001|Period 2|Significant Protocol Deviation|0|||
163095051|NCT02457247|589058588|FG002|Period 2|Significant Protocol Deviation|0|||
163095052|NCT02457247|589058589|FG003|Period 2|Significant Protocol Deviation|0|||
163095053|NCT02457247|589058586|FG000|Period 2|Lost to Follow-up|0|||
163095054|NCT02457247|589058587|FG001|Period 2|Lost to Follow-up|1|||
163095055|NCT02457247|589058588|FG002|Period 2|Lost to Follow-up|0|||
163095056|NCT02457247|589058589|FG003|Period 2|Lost to Follow-up|0|||
163095057|NCT02457247|589058586|FG000|Period 2|Voluntary Withdrawal|1|||
163095058|NCT02457247|589058587|FG001|Period 2|Voluntary Withdrawal|1|||
163095059|NCT02457247|589058588|FG002|Period 2|Voluntary Withdrawal|0|||
163095060|NCT02457247|589058589|FG003|Period 2|Voluntary Withdrawal|0|||
163095061|NCT00739310|589058590|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
163095062|NCT00739310|589058590|FG000|Overall Study|Withdrawal by Subject|1|||
163095063|NCT00739310|589058590|FG000|Overall Study|Lost to Follow-up|2|||
163095064|NCT02954887|589058591|FG000|Overall Study|Withdrawal by Subject|3|||
163095065|NCT02954887|589058591|FG000|Overall Study|Lack of Efficacy|3|||
163095066|NCT02954887|589058591|FG000|Overall Study|Other|1|||
163095067|NCT01882465|589058593|FG000|Period 1|Lens Discomfort|0|||
163095068|NCT01882465|589058594|FG001|Period 1|Lens Discomfort|0|||
163095069|NCT01882465|589058595|FG002|Period 1|Lens Discomfort|0|||
163095070|NCT01882465|589058596|FG003|Period 1|Lens Discomfort|1|||
163095071|NCT01882465|589058597|FG004|Period 1|Lens Discomfort|0|||
163095072|NCT01882465|589058598|FG005|Period 1|Lens Discomfort|0|||
163095073|NCT01882465|589058599|FG006|Period 1|Lens Discomfort|0|||
163095074|NCT01882465|589058593|FG000|Period 1|Withdrawal by Subject|0|||
163095075|NCT01882465|589058594|FG001|Period 1|Withdrawal by Subject|0|||
163095076|NCT01882465|589058595|FG002|Period 1|Withdrawal by Subject|0|||
163095077|NCT01882465|589058596|FG003|Period 1|Withdrawal by Subject|0|||
163095078|NCT01882465|589058597|FG004|Period 1|Withdrawal by Subject|0|||
163095079|NCT01882465|589058598|FG005|Period 1|Withdrawal by Subject|0|||
163095080|NCT01882465|589058599|FG006|Period 1|Withdrawal by Subject|1|||
163095081|NCT01882465|589058593|FG000|Period 2|Protocol Violation|0|||
163095082|NCT01882465|589058594|FG001|Period 2|Protocol Violation|0|||
163095083|NCT01882465|589058595|FG002|Period 2|Protocol Violation|0|||
163095084|NCT01882465|589058596|FG003|Period 2|Protocol Violation|0|||
163095085|NCT01882465|589058597|FG004|Period 2|Protocol Violation|1|||
163095086|NCT01882465|589058598|FG005|Period 2|Protocol Violation|0|||
163095087|NCT01882465|589058599|FG006|Period 2|Protocol Violation|0|||
163095088|NCT00800982|589058602|FG000|Overall Study|Lost to Follow-up|1|||
163095089|NCT00800982|589058603|FG001|Overall Study|Lost to Follow-up|2|||
163095090|NCT00800982|589058602|FG000|Overall Study|Withdrawal by Subject|0|||
163095091|NCT00800982|589058603|FG001|Overall Study|Withdrawal by Subject|1|||
163095092|NCT00800982|589058602|FG000|Overall Study|Patient moved out of state|1|||
163095093|NCT00800982|589058603|FG001|Overall Study|Patient moved out of state|0|||
163095094|NCT01824290|589058604|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
163095095|NCT01824290|589058605|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095096|NCT01824290|589058606|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095097|NCT01824290|589058607|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
163095098|NCT01824290|589058604|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
163095099|NCT01824290|589058605|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
162652378|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
162652379|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
162652380|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
162652381|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
162652382|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
162652383|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
162652384|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
162652385|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
162652386|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
162652387|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
162652388|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
162652389|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
162652390|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
162652391|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Death|0|||
162652392|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Death|0|||
162652393|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Death|1|||
162652394|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Death|0|||
162652395|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Death|0|||
162652396|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Death|0|||
162652397|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Death|0|||
162652398|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Death|0|||
162652399|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Death|0|||
162652400|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
162652401|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
162652402|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
162652403|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652404|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652405|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652406|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652407|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652408|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162652409|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
162652410|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
162652411|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
162652412|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652413|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652414|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652415|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652416|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652417|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162652418|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
162652419|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
162652420|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
162652421|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
163095100|NCT01824290|589058606|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
163095101|NCT01824290|589058607|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
163095102|NCT01824290|589058604|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
163095103|NCT01824290|589058605|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
163095104|NCT01824290|589058606|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
163095105|NCT01824290|589058607|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
163095106|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
163095107|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
163095108|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
163095109|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
163095110|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
162652422|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
162652423|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
162652424|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
162652425|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
162652426|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
162652427|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
162652428|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
162652429|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
163095111|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
163095112|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
163095113|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
162652430|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
162652431|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
163095114|NCT01824290|589058604|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
163095115|NCT01824290|589058605|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
163095116|NCT01824290|589058606|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
163095117|NCT01824290|589058607|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
163095118|NCT01490918|589058608|FG000|Overall Study|Lost to Follow-up|2|||
163095119|NCT01490918|589058609|FG001|Overall Study|Lost to Follow-up|1|||
163095120|NCT01490918|589058610|FG002|Overall Study|Lost to Follow-up|0|||
163095121|NCT01490918|589058608|FG000|Overall Study|Withdrawal by Subject|7|||
163095122|NCT01490918|589058609|FG001|Overall Study|Withdrawal by Subject|8|||
163095123|NCT01490918|589058610|FG002|Overall Study|Withdrawal by Subject|3|||
163095124|NCT01490918|589058608|FG000|Overall Study|Adverse Event|0|||
163095125|NCT01490918|589058609|FG001|Overall Study|Adverse Event|0|||
163095126|NCT01490918|589058610|FG002|Overall Study|Adverse Event|1|||
163095127|NCT01490918|589058608|FG000|Overall Study|other cause|4|||
163095128|NCT01490918|589058609|FG001|Overall Study|other cause|5|||
163095129|NCT01490918|589058610|FG002|Overall Study|other cause|8|||
163095130|NCT00003631|589058624|FG000|Overall Study|Patient not treated|1|||
163095131|NCT00003631|589058625|FG001|Overall Study|Patient not treated|0|||
163095132|NCT00003631|589058626|FG002|Overall Study|Patient not treated|1|||
163095133|NCT00003631|589058624|FG000|Overall Study|Protocol Violation|1|||
163095134|NCT00003631|589058625|FG001|Overall Study|Protocol Violation|0|||
163095135|NCT00003631|589058626|FG002|Overall Study|Protocol Violation|0|||
163095136|NCT00003631|589058624|FG000|Overall Study|Adverse Event|1|||
163095137|NCT00003631|589058625|FG001|Overall Study|Adverse Event|1|||
163095138|NCT00003631|589058626|FG002|Overall Study|Adverse Event|5|||
163095139|NCT00003631|589058624|FG000|Overall Study|Death|0|||
163095140|NCT00003631|589058625|FG001|Overall Study|Death|0|||
163095141|NCT00003631|589058626|FG002|Overall Study|Death|1|||
163095142|NCT00003631|589058624|FG000|Overall Study|Evaluable for toxicity only|0|||
163095143|NCT00003631|589058625|FG001|Overall Study|Evaluable for toxicity only|0|||
163095144|NCT00003631|589058626|FG002|Overall Study|Evaluable for toxicity only|2|||
163095145|NCT00806260|589058636|FG000|Period 1 (1 Day)|Adverse Event|0|||
163095146|NCT00806260|589058637|FG001|Period 1 (1 Day)|Adverse Event|0|||
163095147|NCT00806260|589058638|FG002|Period 1 (1 Day)|Adverse Event|0|||
163095148|NCT00806260|589058639|FG003|Period 1 (1 Day)|Adverse Event|0|||
162652432|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
162652433|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
162652434|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
162652435|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
162652436|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
162652437|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
163095149|NCT00806260|589058640|FG004|Period 1 (1 Day)|Adverse Event|3|||
163095150|NCT00806260|589058641|FG005|Period 1 (1 Day)|Adverse Event|0|||
163095151|NCT00806260|589058636|FG000|Period 2|Adverse Event|0|||
163095152|NCT00806260|589058637|FG001|Period 2|Adverse Event|0|||
163095153|NCT00806260|589058638|FG002|Period 2|Adverse Event|0|||
163095154|NCT00806260|589058639|FG003|Period 2|Adverse Event|1|||
163095155|NCT00806260|589058640|FG004|Period 2|Adverse Event|0|||
163095156|NCT00806260|589058641|FG005|Period 2|Adverse Event|0|||
163095157|NCT00806260|589058636|FG000|Period 2|Protocol Violation|1|||
163095158|NCT00806260|589058637|FG001|Period 2|Protocol Violation|0|||
163095159|NCT00806260|589058638|FG002|Period 2|Protocol Violation|1|||
163095160|NCT00806260|589058639|FG003|Period 2|Protocol Violation|0|||
163095161|NCT00806260|589058640|FG004|Period 2|Protocol Violation|0|||
163095162|NCT00806260|589058641|FG005|Period 2|Protocol Violation|0|||
163095163|NCT00806260|589058636|FG000|Period 2|Need to take concomitant medication|1|||
163095164|NCT00806260|589058637|FG001|Period 2|Need to take concomitant medication|0|||
163095165|NCT00806260|589058638|FG002|Period 2|Need to take concomitant medication|0|||
163095166|NCT00806260|589058639|FG003|Period 2|Need to take concomitant medication|0|||
163095167|NCT00806260|589058640|FG004|Period 2|Need to take concomitant medication|0|||
163095168|NCT00806260|589058641|FG005|Period 2|Need to take concomitant medication|0|||
163095169|NCT00806260|589058636|FG000|Period 2|sponsor request|0|||
163095170|NCT00806260|589058637|FG001|Period 2|sponsor request|0|||
163095171|NCT00806260|589058638|FG002|Period 2|sponsor request|1|||
163095172|NCT00806260|589058639|FG003|Period 2|sponsor request|1|||
163095173|NCT00806260|589058640|FG004|Period 2|sponsor request|0|||
163095174|NCT00806260|589058641|FG005|Period 2|sponsor request|0|||
163095175|NCT00806260|589058636|FG000|Period 3|Protocol Violation|0|||
163095176|NCT00806260|589058637|FG001|Period 3|Protocol Violation|1|||
163095177|NCT00806260|589058638|FG002|Period 3|Protocol Violation|1|||
163095178|NCT00806260|589058639|FG003|Period 3|Protocol Violation|0|||
163095179|NCT00806260|589058640|FG004|Period 3|Protocol Violation|0|||
163095180|NCT00806260|589058641|FG005|Period 3|Protocol Violation|0|||
163095181|NCT00806260|589058636|FG000|Period 3|Pregnancy|1|||
163095182|NCT00806260|589058637|FG001|Period 3|Pregnancy|0|||
163095183|NCT00806260|589058638|FG002|Period 3|Pregnancy|0|||
163095184|NCT00806260|589058639|FG003|Period 3|Pregnancy|0|||
163095185|NCT00806260|589058640|FG004|Period 3|Pregnancy|0|||
163095186|NCT00806260|589058641|FG005|Period 3|Pregnancy|0|||
163095187|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
163095188|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
162652438|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
162652439|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652440|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652441|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652442|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652443|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652444|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162652445|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652446|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
162652447|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652448|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652449|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652450|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652451|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652452|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652453|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162652454|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
162652455|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
162652456|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
162652457|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
162652458|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
162652459|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
162652460|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
162652461|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
162652462|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
162652463|NCT00404352|587445524|FG000|Double Blind (up to 24 Month)|Other|0|||
162652464|NCT00404352|587445525|FG001|Double Blind (up to 24 Month)|Other|1|||
162652465|NCT00404352|587445526|FG002|Double Blind (up to 24 Month)|Other|0|||
162652466|NCT00404352|587445527|FG003|Double Blind (up to 24 Month)|Other|0|||
162652467|NCT00404352|587445528|FG004|Double Blind (up to 24 Month)|Other|0|||
162652468|NCT00404352|587445529|FG005|Double Blind (up to 24 Month)|Other|0|||
162652469|NCT00404352|587445530|FG006|Double Blind (up to 24 Month)|Other|0|||
162652470|NCT00404352|587445531|FG007|Double Blind (up to 24 Month)|Other|0|||
162652471|NCT00404352|587445532|FG008|Double Blind (up to 24 Month)|Other|0|||
162652472|NCT00404352|587445524|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
162652473|NCT00404352|587445525|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
162652474|NCT00404352|587445526|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
162652475|NCT00404352|587445527|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
162652476|NCT00404352|587445528|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
162652477|NCT00404352|587445529|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
162652478|NCT00404352|587445530|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
162652479|NCT00404352|587445531|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
162652480|NCT00404352|587445532|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
162652481|NCT00404352|587445524|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
162652482|NCT00404352|587445525|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
162652483|NCT00404352|587445526|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
162652484|NCT00404352|587445527|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
162652485|NCT00404352|587445528|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
162652486|NCT00404352|587445529|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
162652487|NCT00404352|587445530|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
162652488|NCT00404352|587445531|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
162652489|NCT00404352|587445532|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
162652490|NCT00404352|587445524|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652491|NCT00404352|587445525|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652492|NCT00404352|587445526|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
163095189|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
163095190|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
163095191|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
162652493|NCT00404352|587445527|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652494|NCT00404352|587445528|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
162652495|NCT00404352|587445529|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652496|NCT00404352|587445530|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652497|NCT00404352|587445531|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652498|NCT00404352|587445532|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162652499|NCT00404352|587445524|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652500|NCT00404352|587445525|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652501|NCT00404352|587445526|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652502|NCT00404352|587445527|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163095192|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
163095193|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
163095194|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
163095195|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095196|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
163095197|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095198|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
163095199|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095200|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
163095201|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095202|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
163095203|NCT00953706|589058645|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095204|NCT00953706|589058646|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
163095205|NCT00953706|589058647|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095206|NCT00953706|589058648|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
163095207|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095208|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095209|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
163095210|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
163095211|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095212|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095213|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
163095214|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
163095215|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095216|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095217|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
163095218|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
163095219|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
163095220|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
163095221|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
163095222|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
163095223|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
163095224|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
163095225|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
163095226|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
163095227|NCT00953706|589058645|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
163095228|NCT00953706|589058646|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
163095229|NCT00953706|589058647|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
163095230|NCT00953706|589058648|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
163095231|NCT02670473|589058649|FG000|Overall Study|Withdrawal by Subject|1|||
163095232|NCT01404234|589058650|FG000|Overall Study|Withdrawal by Subject|2|||
163095233|NCT01214837|589058651|FG000|Overall Study|Death|0|||
163095234|NCT01214837|589058652|FG001|Overall Study|Death|0|||
163095235|NCT01214837|589058653|FG002|Overall Study|Death|1|||
163095236|NCT01214837|589058651|FG000|Overall Study|Adverse Event|1|||
163095237|NCT01214837|589058652|FG001|Overall Study|Adverse Event|2|||
163095238|NCT01214837|589058653|FG002|Overall Study|Adverse Event|1|||
163095239|NCT01214837|589058651|FG000|Overall Study|Withdrawal by Subject|27|||
163095240|NCT01214837|589058652|FG001|Overall Study|Withdrawal by Subject|36|||
163095241|NCT01214837|589058653|FG002|Overall Study|Withdrawal by Subject|28|||
163095242|NCT01214837|589058651|FG000|Overall Study|Lost to Follow-up|20|||
163095243|NCT01214837|589058652|FG001|Overall Study|Lost to Follow-up|15|||
163095244|NCT01214837|589058653|FG002|Overall Study|Lost to Follow-up|21|||
163095245|NCT01214837|589058651|FG000|Overall Study|Inappropriate Enrolment|0|||
163095246|NCT01214837|589058652|FG001|Overall Study|Inappropriate Enrolment|1|||
163095247|NCT01214837|589058653|FG002|Overall Study|Inappropriate Enrolment|2|||
163095248|NCT01214837|589058651|FG000|Overall Study|Administrative Reason|2|||
163095249|NCT01214837|589058652|FG001|Overall Study|Administrative Reason|6|||
162652503|NCT00404352|587445528|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
163095250|NCT01214837|589058653|FG002|Overall Study|Administrative Reason|4|||
163095251|NCT01214837|589058651|FG000|Overall Study|Protocol Violation|3|||
163095252|NCT01214837|589058652|FG001|Overall Study|Protocol Violation|1|||
163095253|NCT01214837|589058653|FG002|Overall Study|Protocol Violation|5|||
163095254|NCT01214837|589058651|FG000|Overall Study|Unable to Classify|1|||
163095255|NCT01214837|589058652|FG001|Overall Study|Unable to Classify|3|||
163095256|NCT01214837|589058653|FG002|Overall Study|Unable to Classify|0|||
163095257|NCT05414175|589058654|FG000|Overall Study|Withdrawal by Subject|1|||
163095258|NCT05414175|589058654|FG000|Overall Study|Other Reasons|1|||
163095259|NCT00027560|589058657|FG000|Overall Study|Withdrawal by Subject|1|||
163095260|NCT03559270|589058661|FG000|Overall Study|Adverse Event|6|||
163095261|NCT03559270|589058662|FG001|Overall Study|Adverse Event|5|||
163095262|NCT03559270|589058663|FG002|Overall Study|Adverse Event|3|||
163095263|NCT03559270|589058664|FG003|Overall Study|Adverse Event|0|||
163095264|NCT03559270|589058661|FG000|Overall Study|Lack of Efficacy|34|||
163095265|NCT03559270|589058662|FG001|Overall Study|Lack of Efficacy|52|||
163095266|NCT03559270|589058663|FG002|Overall Study|Lack of Efficacy|37|||
163095267|NCT03559270|589058664|FG003|Overall Study|Lack of Efficacy|2|||
163095268|NCT03559270|589058661|FG000|Overall Study|Death|0|||
163095269|NCT03559270|589058662|FG001|Overall Study|Death|2|||
163095270|NCT03559270|589058663|FG002|Overall Study|Death|0|||
163095271|NCT03559270|589058664|FG003|Overall Study|Death|0|||
163095272|NCT03559270|589058661|FG000|Overall Study|Lost to Follow-up|16|||
163095273|NCT03559270|589058662|FG001|Overall Study|Lost to Follow-up|4|||
163095274|NCT03559270|589058663|FG002|Overall Study|Lost to Follow-up|12|||
163095275|NCT03559270|589058664|FG003|Overall Study|Lost to Follow-up|3|||
163095276|NCT03559270|589058661|FG000|Overall Study|Sponsor Decision|38|||
163095277|NCT03559270|589058662|FG001|Overall Study|Sponsor Decision|31|||
163095278|NCT03559270|589058663|FG002|Overall Study|Sponsor Decision|35|||
163095279|NCT03559270|589058664|FG003|Overall Study|Sponsor Decision|18|||
163095280|NCT03559270|589058661|FG000|Overall Study|Withdrawal by Subject|19|||
163095281|NCT03559270|589058662|FG001|Overall Study|Withdrawal by Subject|21|||
163095282|NCT03559270|589058663|FG002|Overall Study|Withdrawal by Subject|18|||
163095283|NCT03559270|589058664|FG003|Overall Study|Withdrawal by Subject|7|||
163095284|NCT03559270|589058661|FG000|Overall Study|Physician Decision|3|||
163095285|NCT03559270|589058662|FG001|Overall Study|Physician Decision|2|||
163095286|NCT03559270|589058663|FG002|Overall Study|Physician Decision|1|||
163095287|NCT03559270|589058664|FG003|Overall Study|Physician Decision|0|||
163095288|NCT03559270|589058661|FG000|Overall Study|Pregnancy|0|||
163095289|NCT03559270|589058662|FG001|Overall Study|Pregnancy|1|||
163095290|NCT03559270|589058663|FG002|Overall Study|Pregnancy|0|||
163095291|NCT03559270|589058664|FG003|Overall Study|Pregnancy|0|||
163095292|NCT03559270|589058661|FG000|Overall Study|Protocol Violation|1|||
163095293|NCT03559270|589058662|FG001|Overall Study|Protocol Violation|0|||
163095294|NCT03559270|589058663|FG002|Overall Study|Protocol Violation|2|||
163095295|NCT03559270|589058664|FG003|Overall Study|Protocol Violation|0|||
163095296|NCT04776161|589060058|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
163095297|NCT04776161|589060059|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
163095298|NCT04776161|589060060|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
163095299|NCT04776161|589060058|FG000|Overall Study|Withdrawal by Subject|1|||
163095300|NCT04776161|589060059|FG001|Overall Study|Withdrawal by Subject|0|||
163095301|NCT04776161|589060060|FG002|Overall Study|Withdrawal by Subject|1|||
163095302|NCT04776161|589060058|FG000|Overall Study|Adverse Event|0|||
163095303|NCT04776161|589060059|FG001|Overall Study|Adverse Event|1|||
163095304|NCT04776161|589060060|FG002|Overall Study|Adverse Event|1|||
163095305|NCT04567524|589060065|FG000|Overall Study|Adverse Event|1|||
163095306|NCT04567524|589060066|FG001|Overall Study|Adverse Event|1|||
163095307|NCT04567524|589060067|FG002|Overall Study|Adverse Event|0|||
163095308|NCT04567524|589060068|FG003|Overall Study|Adverse Event|0|||
163095309|NCT04567524|589060065|FG000|Overall Study|Withdrawal by Subject|2|||
163095310|NCT04567524|589060066|FG001|Overall Study|Withdrawal by Subject|0|||
163095311|NCT04567524|589060067|FG002|Overall Study|Withdrawal by Subject|0|||
163095312|NCT04567524|589060068|FG003|Overall Study|Withdrawal by Subject|1|||
163095313|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
163095314|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
163095315|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Adverse Event|2|||
163095316|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Adverse Event|1|||
163095317|NCT02848092|589060069|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
163095318|NCT02848092|589060070|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
163095319|NCT02848092|589060069|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
163095320|NCT02848092|589060070|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
163095321|NCT02848092|589060069|FG000|1-month Post-training Follow-up|fatigue|0|||
163095322|NCT02848092|589060070|FG001|1-month Post-training Follow-up|fatigue|1|||
163095323|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
163095324|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
163095325|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Adverse Event|1|||
163095326|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Adverse Event|1|||
163095327|NCT02848092|589060069|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
163095328|NCT02848092|589060070|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
163095329|NCT02848092|589060069|FG000|6-month Post-training Follow-up|frustrated with task|1|||
163095330|NCT02848092|589060070|FG001|6-month Post-training Follow-up|frustrated with task|0|||
163095331|NCT02848092|589060069|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
163095332|NCT02848092|589060070|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
163095333|NCT02848092|589060069|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
163095334|NCT02848092|589060070|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
163095335|NCT01147393|589060076|FG000|Dose Level 1|Dose limiting Toxicity|2|||
162652504|NCT00404352|587445529|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
162652505|NCT00404352|587445530|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652506|NCT00404352|587445531|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652507|NCT00404352|587445532|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162652508|NCT00404352|587445524|FG000|Open Label (up to 24 Month)|Disease progression|0|||
162652509|NCT00404352|587445525|FG001|Open Label (up to 24 Month)|Disease progression|0|||
162652510|NCT00404352|587445526|FG002|Open Label (up to 24 Month)|Disease progression|0|||
162652511|NCT00404352|587445527|FG003|Open Label (up to 24 Month)|Disease progression|1|||
162652512|NCT00404352|587445528|FG004|Open Label (up to 24 Month)|Disease progression|0|||
162652513|NCT00404352|587445529|FG005|Open Label (up to 24 Month)|Disease progression|0|||
162652514|NCT00404352|587445530|FG006|Open Label (up to 24 Month)|Disease progression|0|||
162652515|NCT00404352|587445531|FG007|Open Label (up to 24 Month)|Disease progression|0|||
162652516|NCT00404352|587445532|FG008|Open Label (up to 24 Month)|Disease progression|0|||
162652517|NCT00404352|587445524|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652518|NCT00404352|587445525|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652519|NCT00404352|587445526|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652520|NCT00404352|587445527|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
163095336|NCT01147393|589060076|FG000|Dose Level -1|Dose Limited Toxicity|1|||
163095337|NCT03432494|589060079|FG000|Overall Study|Death|1|||
163095338|NCT03432494|589060079|FG000|Overall Study|Noncompliance|1|||
163095339|NCT00825994|589060080|FG000|Overall Study|Withdrawal by Subject|2|||
163095340|NCT00825994|589060080|FG000|Overall Study|Lost to Follow-up|1|||
163095341|NCT00825994|589060080|FG000|Overall Study|Protocol Violation|1|||
163095342|NCT00825994|589060080|FG000|Overall Study|Placebo Responder at V2|1|||
163095343|NCT01833494|589060082|FG000|Overall Study|Adverse Event|24|||
163095344|NCT01833494|589060082|FG000|Overall Study|Physician Decision|6|||
163095345|NCT01833494|589060082|FG000|Overall Study|Withdrawal by Subject|6|||
163095346|NCT01833494|589060082|FG000|Overall Study|Decrease in serum phosphorus|4|||
163095347|NCT01833494|589060082|FG000|Overall Study|Decrease in serum calcium|4|||
163095348|NCT01833494|589060082|FG000|Overall Study|Increase in serum ferritin|1|||
163095349|NCT04011735|589060091|FG000|Overall Study|Withdrawal by Subject|1|||
163095350|NCT04011735|589060092|FG001|Overall Study|Withdrawal by Subject|0|||
163095351|NCT04011735|589060093|FG002|Overall Study|Withdrawal by Subject|1|||
163095352|NCT04011735|589060091|FG000|Overall Study|Met exclusion criteria after study entry|0|||
163095353|NCT04011735|589060092|FG001|Overall Study|Met exclusion criteria after study entry|1|||
163095354|NCT04011735|589060093|FG002|Overall Study|Met exclusion criteria after study entry|0|||
163095355|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
163095356|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
163095357|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
163095358|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
163095359|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
163095360|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
163095361|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
163095362|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095363|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095364|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
163095365|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
163095366|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
163095367|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
163095368|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
163095369|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
163095370|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
163095371|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
163095372|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
163095373|NCT02831855|589060094|FG000|Open Label Phase (24 Weeks)|Other|4|||
163095374|NCT02831855|589060095|FG001|Open Label Phase (24 Weeks)|Other|0|||
163095375|NCT02831855|589060096|FG002|Open Label Phase (24 Weeks)|Other|0|||
163095376|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
163095377|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
163095378|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
163095379|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Death|0|||
163095380|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Death|0|||
163095381|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Death|2|||
163095382|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
163095383|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
163095384|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
163095385|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
163095386|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
163095387|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
163095388|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
163095389|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
162652521|NCT00404352|587445528|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652522|NCT00404352|587445529|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652523|NCT00404352|587445530|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
162652524|NCT00404352|587445531|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
162652525|NCT00404352|587445532|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162652526|NCT00404352|587445524|FG000|Open Label Extension (up to 36 Months)|Other|0|||
162652527|NCT00404352|587445525|FG001|Open Label Extension (up to 36 Months)|Other|0|||
162652528|NCT00404352|587445526|FG002|Open Label Extension (up to 36 Months)|Other|0|||
162652529|NCT00404352|587445527|FG003|Open Label Extension (up to 36 Months)|Other|0|||
162652530|NCT00404352|587445528|FG004|Open Label Extension (up to 36 Months)|Other|0|||
162652531|NCT00404352|587445529|FG005|Open Label Extension (up to 36 Months)|Other|0|||
162652532|NCT00404352|587445530|FG006|Open Label Extension (up to 36 Months)|Other|0|||
162652533|NCT00404352|587445531|FG007|Open Label Extension (up to 36 Months)|Other|0|||
162652534|NCT00404352|587445532|FG008|Open Label Extension (up to 36 Months)|Other|2|||
162652535|NCT01479621|587445535|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
162652536|NCT01479621|587445536|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652537|NCT01479621|587445537|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652538|NCT01479621|587445538|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652539|NCT01479621|587445539|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652540|NCT01479621|587445540|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652541|NCT01479621|587445541|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162652542|NCT01479621|587445535|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
162652543|NCT01479621|587445536|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652544|NCT01479621|587445537|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652545|NCT01479621|587445538|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652546|NCT01479621|587445539|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652547|NCT01479621|587445540|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652548|NCT01479621|587445541|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162652549|NCT01479621|587445535|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
162652550|NCT01479621|587445536|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652551|NCT01479621|587445537|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652552|NCT01479621|587445538|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652553|NCT01479621|587445539|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652554|NCT01479621|587445540|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652555|NCT01479621|587445541|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162652556|NCT01479621|587445535|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
162652557|NCT01479621|587445536|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162652558|NCT01479621|587445537|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162652559|NCT01479621|587445538|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163095390|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
163095391|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Other|0|||
163095392|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Other|2|||
163095393|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Other|5|||
163095394|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
163095395|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
163095396|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
163095397|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
163095398|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
163095399|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
162652560|NCT01479621|587445539|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162652561|NCT01479621|587445540|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162652562|NCT01479621|587445541|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162652563|NCT01479621|587445535|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
162652564|NCT01479621|587445536|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162652565|NCT01479621|587445537|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162652566|NCT01479621|587445538|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162652567|NCT01479621|587445539|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162652568|NCT01479621|587445540|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162652569|NCT01479621|587445541|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163095400|NCT02831855|589060094|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
163095401|NCT02831855|589060095|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
163095402|NCT02831855|589060096|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
163095403|NCT01118780|589060098|FG000|Overall Study|Adverse Event|15|||
163095404|NCT01118780|589060099|FG001|Overall Study|Adverse Event|15|||
163095405|NCT01118780|589060098|FG000|Overall Study|Death|1|||
162652570|NCT01479621|587445535|FG000|Treatment Period|Adverse Event|0|||
162652571|NCT01479621|587445536|FG001|Treatment Period|Adverse Event|0|||
162652572|NCT01479621|587445537|FG002|Treatment Period|Adverse Event|0|||
162652573|NCT01479621|587445538|FG003|Treatment Period|Adverse Event|0|||
162652574|NCT01479621|587445539|FG004|Treatment Period|Adverse Event|1|||
162652575|NCT01479621|587445540|FG005|Treatment Period|Adverse Event|2|||
162652576|NCT01479621|587445541|FG006|Treatment Period|Adverse Event|2|||
162652577|NCT01479621|587445535|FG000|Treatment Period|Withdrawal by Subject|0|||
162652578|NCT01479621|587445536|FG001|Treatment Period|Withdrawal by Subject|4|||
162652579|NCT01479621|587445537|FG002|Treatment Period|Withdrawal by Subject|2|||
162652580|NCT01479621|587445538|FG003|Treatment Period|Withdrawal by Subject|2|||
162652581|NCT01479621|587445539|FG004|Treatment Period|Withdrawal by Subject|5|||
162652582|NCT01479621|587445540|FG005|Treatment Period|Withdrawal by Subject|5|||
162652583|NCT01479621|587445541|FG006|Treatment Period|Withdrawal by Subject|1|||
162652584|NCT01479621|587445535|FG000|Treatment Period|Physician Decision|0|||
162652585|NCT01479621|587445536|FG001|Treatment Period|Physician Decision|0|||
162652586|NCT01479621|587445537|FG002|Treatment Period|Physician Decision|0|||
162652587|NCT01479621|587445538|FG003|Treatment Period|Physician Decision|0|||
162652588|NCT01479621|587445539|FG004|Treatment Period|Physician Decision|1|||
162652589|NCT01479621|587445540|FG005|Treatment Period|Physician Decision|1|||
162652590|NCT01479621|587445541|FG006|Treatment Period|Physician Decision|0|||
162652591|NCT01479621|587445535|FG000|Treatment Period|Non-compliance to study drug|0|||
162652592|NCT01479621|587445536|FG001|Treatment Period|Non-compliance to study drug|1|||
162652593|NCT01479621|587445537|FG002|Treatment Period|Non-compliance to study drug|0|||
162652594|NCT01479621|587445538|FG003|Treatment Period|Non-compliance to study drug|0|||
162652595|NCT01479621|587445539|FG004|Treatment Period|Non-compliance to study drug|0|||
162652596|NCT01479621|587445540|FG005|Treatment Period|Non-compliance to study drug|0|||
162652597|NCT01479621|587445541|FG006|Treatment Period|Non-compliance to study drug|1|||
162652598|NCT01479621|587445535|FG000|Treatment Period|Protocol Violation|0|||
162652599|NCT01479621|587445536|FG001|Treatment Period|Protocol Violation|9|||
162652600|NCT01479621|587445537|FG002|Treatment Period|Protocol Violation|6|||
162652601|NCT01479621|587445538|FG003|Treatment Period|Protocol Violation|5|||
162652602|NCT01479621|587445539|FG004|Treatment Period|Protocol Violation|2|||
163095406|NCT01118780|589060099|FG001|Overall Study|Death|0|||
163095407|NCT01118780|589060098|FG000|Overall Study|Lack of Efficacy|2|||
163095408|NCT01118780|589060099|FG001|Overall Study|Lack of Efficacy|6|||
163095409|NCT01118780|589060098|FG000|Overall Study|Physician Decision|2|||
163095410|NCT01118780|589060099|FG001|Overall Study|Physician Decision|0|||
163095411|NCT01118780|589060098|FG000|Overall Study|Protocol Violation|3|||
163095412|NCT01118780|589060099|FG001|Overall Study|Protocol Violation|6|||
163095413|NCT01118780|589060098|FG000|Overall Study|Withdrawal by Subject|13|||
163095414|NCT01118780|589060099|FG001|Overall Study|Withdrawal by Subject|8|||
163095415|NCT03962855|589060100|FG000|Overall Study|Death|0|||
163095416|NCT03962855|589060101|FG001|Overall Study|Death|1|||
163095417|NCT03962855|589060100|FG000|Overall Study|Lost to Follow-up|0|||
163095418|NCT03962855|589060101|FG001|Overall Study|Lost to Follow-up|1|||
163095419|NCT03962855|589060100|FG000|Overall Study|Adverse Event|0|||
163095420|NCT03962855|589060101|FG001|Overall Study|Adverse Event|1|||
163095421|NCT03962855|589060100|FG000|Overall Study|Physician Decision|0|||
163095422|NCT03962855|589060101|FG001|Overall Study|Physician Decision|2|||
163095423|NCT03326063|589060102|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
162652603|NCT01479621|587445540|FG005|Treatment Period|Protocol Violation|10|||
162652604|NCT01479621|587445541|FG006|Treatment Period|Protocol Violation|6|||
162652605|NCT01479621|587445535|FG000|Treatment Period|Pregnancy|0|||
162652606|NCT01479621|587445536|FG001|Treatment Period|Pregnancy|0|||
162652607|NCT01479621|587445537|FG002|Treatment Period|Pregnancy|2|||
162652608|NCT01479621|587445538|FG003|Treatment Period|Pregnancy|0|||
162652609|NCT01479621|587445539|FG004|Treatment Period|Pregnancy|0|||
162652610|NCT01479621|587445540|FG005|Treatment Period|Pregnancy|0|||
162652611|NCT01479621|587445541|FG006|Treatment Period|Pregnancy|0|||
163095424|NCT03326063|589060103|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
163095425|NCT02750514|589060104|FG000|Track 1|Disease progression|20|||
163095426|NCT02750514|589060105|FG001|Track 1|Disease progression|1|||
163095427|NCT02750514|589060106|FG002|Track 1|Disease progression|0|||
162652612|NCT01479621|587445535|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
162652613|NCT01479621|587445536|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
162652614|NCT01479621|587445537|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
163095428|NCT02750514|589060107|FG003|Track 1|Disease progression|1|||
163095429|NCT02750514|589060108|FG004|Track 1|Disease progression|0|||
163095430|NCT02750514|589060104|FG000|Track 1|Adverse event unrelated to study drug|1|||
162652615|NCT01479621|587445538|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
163095431|NCT02750514|589060105|FG001|Track 1|Adverse event unrelated to study drug|0|||
163095432|NCT02750514|589060106|FG002|Track 1|Adverse event unrelated to study drug|0|||
163095433|NCT02750514|589060107|FG003|Track 1|Adverse event unrelated to study drug|0|||
163095434|NCT02750514|589060108|FG004|Track 1|Adverse event unrelated to study drug|0|||
162652616|NCT01479621|587445539|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
162652617|NCT01479621|587445540|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
162652618|NCT01479621|587445541|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
162652619|NCT01479621|587445535|FG000|Treatment Period|Lost to Follow-up|0|||
162652620|NCT01479621|587445536|FG001|Treatment Period|Lost to Follow-up|0|||
162652621|NCT01479621|587445537|FG002|Treatment Period|Lost to Follow-up|1|||
162652622|NCT01479621|587445538|FG003|Treatment Period|Lost to Follow-up|0|||
162652623|NCT01479621|587445539|FG004|Treatment Period|Lost to Follow-up|2|||
162652624|NCT01479621|587445540|FG005|Treatment Period|Lost to Follow-up|2|||
162652625|NCT01479621|587445541|FG006|Treatment Period|Lost to Follow-up|1|||
162652626|NCT01479621|587445535|FG000|Treatment Period|Met stopping criteria|0|||
162652627|NCT01479621|587445536|FG001|Treatment Period|Met stopping criteria|8|||
162652628|NCT01479621|587445537|FG002|Treatment Period|Met stopping criteria|7|||
162652629|NCT01479621|587445538|FG003|Treatment Period|Met stopping criteria|4|||
162652630|NCT01479621|587445539|FG004|Treatment Period|Met stopping criteria|9|||
162652631|NCT01479621|587445540|FG005|Treatment Period|Met stopping criteria|20|||
162652632|NCT01479621|587445541|FG006|Treatment Period|Met stopping criteria|6|||
162652633|NCT02308735|587445544|FG000|Overall Study|Physician Decision|2|||
162652634|NCT02308735|587445545|FG001|Overall Study|Physician Decision|0|||
162652635|NCT02308735|587445546|FG002|Overall Study|Physician Decision|0|||
162652636|NCT02308735|587445547|FG003|Overall Study|Physician Decision|2|||
162652637|NCT01417481|587445551|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162652638|NCT01417481|587445552|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162652639|NCT00582933|587445555|FG000|Overall Study|Physician Decision|3|||
162652640|NCT01736696|587445564|FG000|Overall Study|Withdrawal by Subject|0|||
162652641|NCT01736696|587445565|FG001|Overall Study|Withdrawal by Subject|0|||
162652642|NCT01736696|587445566|FG002|Overall Study|Withdrawal by Subject|1|||
162652643|NCT01736696|587445567|FG003|Overall Study|Withdrawal by Subject|0|||
162652644|NCT01736696|587445568|FG004|Overall Study|Withdrawal by Subject|0|||
162652645|NCT01736696|587445569|FG005|Overall Study|Withdrawal by Subject|0|||
162652646|NCT01736696|587445570|FG006|Overall Study|Withdrawal by Subject|0|||
162652647|NCT00405548|587445571|FG000|Overall Study|Cognitive Memory problems on study day|1|||
162652648|NCT00405548|587445572|FG001|Overall Study|Cognitive Memory problems on study day|0|||
162652649|NCT00405548|587445571|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
162652650|NCT00405548|587445572|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
162652651|NCT00405548|587445571|FG000|Overall Study|Unable to self-administer shots|1|||
162652652|NCT00405548|587445572|FG001|Overall Study|Unable to self-administer shots|0|||
162652653|NCT00405548|587445571|FG000|Overall Study|Venous access failed during study day|1|||
162652654|NCT00405548|587445572|FG001|Overall Study|Venous access failed during study day|0|||
162652655|NCT00405548|587445571|FG000|Overall Study|Withdrawal by Subject|1|||
162652656|NCT00405548|587445572|FG001|Overall Study|Withdrawal by Subject|0|||
162652657|NCT01116232|587445573|FG000|Overall Study|Progressive diease|4|||
162652658|NCT02036502|587445574|FG000|Part 1:Dose Determination/Escalation|Death|3|||
162652659|NCT02036502|587445575|FG001|Part 1:Dose Determination/Escalation|Death|2|||
162652660|NCT02036502|587445576|FG002|Part 1:Dose Determination/Escalation|Death|0|||
162652661|NCT02036502|587445577|FG003|Part 1:Dose Determination/Escalation|Death|0|||
162652662|NCT02036502|587445578|FG004|Part 1:Dose Determination/Escalation|Death|0|||
162652663|NCT02036502|587445579|FG005|Part 1:Dose Determination/Escalation|Death|0|||
162652664|NCT02036502|587445580|FG006|Part 1:Dose Determination/Escalation|Death|0|||
163095435|NCT02750514|589060104|FG000|Track 1|Study drug toxicity|4|||
163095436|NCT02750514|589060105|FG001|Track 1|Study drug toxicity|1|||
163095437|NCT02750514|589060106|FG002|Track 1|Study drug toxicity|0|||
163095438|NCT02750514|589060107|FG003|Track 1|Study drug toxicity|1|||
163095439|NCT02750514|589060108|FG004|Track 1|Study drug toxicity|0|||
163095440|NCT02750514|589060104|FG000|Track 1|Participant request to discontinue|1|||
163095441|NCT02750514|589060105|FG001|Track 1|Participant request to discontinue|0|||
163095442|NCT02750514|589060106|FG002|Track 1|Participant request to discontinue|0|||
163095443|NCT02750514|589060107|FG003|Track 1|Participant request to discontinue|0|||
163095444|NCT02750514|589060108|FG004|Track 1|Participant request to discontinue|0|||
163095445|NCT02750514|589060104|FG000|Track 1|Other reasons|1|||
163095446|NCT02750514|589060105|FG001|Track 1|Other reasons|0|||
163095447|NCT02750514|589060106|FG002|Track 1|Other reasons|0|||
163095448|NCT02750514|589060107|FG003|Track 1|Other reasons|0|||
163095449|NCT02750514|589060108|FG004|Track 1|Other reasons|0|||
163095450|NCT02750514|589060104|FG000|Track 2|Disease progression|4|||
163095451|NCT02750514|589060105|FG001|Track 2|Disease progression|5|||
163095452|NCT02750514|589060106|FG002|Track 2|Disease progression|2|||
163095453|NCT02750514|589060107|FG003|Track 2|Disease progression|5|||
163095454|NCT02750514|589060108|FG004|Track 2|Disease progression|0|||
163095455|NCT02750514|589060104|FG000|Track 2|Adverse event unrelated to study drug|1|||
163095456|NCT02750514|589060105|FG001|Track 2|Adverse event unrelated to study drug|0|||
163095457|NCT02750514|589060106|FG002|Track 2|Adverse event unrelated to study drug|0|||
163095458|NCT02750514|589060107|FG003|Track 2|Adverse event unrelated to study drug|0|||
163095459|NCT02750514|589060108|FG004|Track 2|Adverse event unrelated to study drug|0|||
163095460|NCT02750514|589060104|FG000|Track 2|Study drug toxicity|1|||
162652665|NCT02036502|587445581|FG007|Part 1:Dose Determination/Escalation|Death|0|||
162652666|NCT02036502|587445574|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
162652667|NCT02036502|587445575|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162652668|NCT02036502|587445576|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162652669|NCT02036502|587445577|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162652670|NCT02036502|587445578|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162652671|NCT02036502|587445579|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162719023|NCT02341625|587676737|FG000|Overall Study|Other Reasons|0|||
162719024|NCT02341625|587676738|FG001|Overall Study|Other Reasons|0|||
163095461|NCT02750514|589060105|FG001|Track 2|Study drug toxicity|2|||
163095462|NCT02750514|589060106|FG002|Track 2|Study drug toxicity|0|||
163095463|NCT02750514|589060107|FG003|Track 2|Study drug toxicity|2|||
163095464|NCT02750514|589060108|FG004|Track 2|Study drug toxicity|0|||
163095465|NCT02750514|589060104|FG000|Track 2|Participant withdrew consent|0|||
163095466|NCT02750514|589060105|FG001|Track 2|Participant withdrew consent|1|||
163095467|NCT02750514|589060106|FG002|Track 2|Participant withdrew consent|0|||
163095468|NCT02750514|589060107|FG003|Track 2|Participant withdrew consent|0|||
163095469|NCT02750514|589060108|FG004|Track 2|Participant withdrew consent|0|||
163095470|NCT02750514|589060104|FG000|Track 3|Disease progression|0|||
163095471|NCT02750514|589060105|FG001|Track 3|Disease progression|24|||
163095472|NCT02750514|589060106|FG002|Track 3|Disease progression|13|||
163095473|NCT02750514|589060107|FG003|Track 3|Disease progression|14|||
163095474|NCT02750514|589060108|FG004|Track 3|Disease progression|0|||
163095475|NCT02750514|589060104|FG000|Track 3|Adverse event unrelated to study drug|0|||
163095476|NCT02750514|589060105|FG001|Track 3|Adverse event unrelated to study drug|1|||
163095477|NCT02750514|589060106|FG002|Track 3|Adverse event unrelated to study drug|1|||
163095478|NCT02750514|589060107|FG003|Track 3|Adverse event unrelated to study drug|1|||
163095479|NCT02750514|589060108|FG004|Track 3|Adverse event unrelated to study drug|0|||
163095480|NCT02750514|589060104|FG000|Track 3|Study drug toxicity|0|||
163095481|NCT02750514|589060105|FG001|Track 3|Study drug toxicity|3|||
163095482|NCT02750514|589060106|FG002|Track 3|Study drug toxicity|0|||
163095483|NCT02750514|589060107|FG003|Track 3|Study drug toxicity|1|||
163095484|NCT02750514|589060108|FG004|Track 3|Study drug toxicity|0|||
163095485|NCT02750514|589060104|FG000|Track 3|Participant request to discontinue|0|||
163095486|NCT02750514|589060105|FG001|Track 3|Participant request to discontinue|2|||
163095487|NCT02750514|589060106|FG002|Track 3|Participant request to discontinue|0|||
163095488|NCT02750514|589060107|FG003|Track 3|Participant request to discontinue|0|||
163095489|NCT02750514|589060108|FG004|Track 3|Participant request to discontinue|0|||
163095490|NCT02750514|589060104|FG000|Track 3|Participant withdrew consent|0|||
163095491|NCT02750514|589060105|FG001|Track 3|Participant withdrew consent|3|||
163095492|NCT02750514|589060106|FG002|Track 3|Participant withdrew consent|1|||
163095493|NCT02750514|589060107|FG003|Track 3|Participant withdrew consent|0|||
163095494|NCT02750514|589060108|FG004|Track 3|Participant withdrew consent|0|||
163095495|NCT02750514|589060104|FG000|Track 3|Other reasons|0|||
163095496|NCT02750514|589060105|FG001|Track 3|Other reasons|3|||
163095497|NCT02750514|589060106|FG002|Track 3|Other reasons|0|||
163095498|NCT02750514|589060107|FG003|Track 3|Other reasons|0|||
163095499|NCT02750514|589060108|FG004|Track 3|Other reasons|0|||
163095500|NCT02750514|589060104|FG000|Track 4|Study drug toxicity|0|||
163095501|NCT02750514|589060105|FG001|Track 4|Study drug toxicity|6|||
163095502|NCT02750514|589060106|FG002|Track 4|Study drug toxicity|0|||
163095503|NCT02750514|589060107|FG003|Track 4|Study drug toxicity|5|||
163095504|NCT02750514|589060108|FG004|Track 4|Study drug toxicity|0|||
163095505|NCT02750514|589060104|FG000|Track 4|Participant request to discontinue|0|||
163095506|NCT02750514|589060105|FG001|Track 4|Participant request to discontinue|1|||
163095507|NCT02750514|589060106|FG002|Track 4|Participant request to discontinue|0|||
163095508|NCT02750514|589060107|FG003|Track 4|Participant request to discontinue|1|||
163095509|NCT02750514|589060108|FG004|Track 4|Participant request to discontinue|0|||
163095510|NCT02750514|589060104|FG000|Track 4|Participant withdrew consent|0|||
163095511|NCT02750514|589060105|FG001|Track 4|Participant withdrew consent|1|||
163095512|NCT02750514|589060106|FG002|Track 4|Participant withdrew consent|0|||
163095513|NCT02750514|589060107|FG003|Track 4|Participant withdrew consent|0|||
163095514|NCT02750514|589060108|FG004|Track 4|Participant withdrew consent|0|||
163095515|NCT02750514|589060104|FG000|Track 4|Other reasons|0|||
163095516|NCT02750514|589060105|FG001|Track 4|Other reasons|5|||
163095517|NCT02750514|589060106|FG002|Track 4|Other reasons|0|||
163095518|NCT02750514|589060107|FG003|Track 4|Other reasons|3|||
163095519|NCT02750514|589060108|FG004|Track 4|Other reasons|0|||
163095520|NCT02750514|589060104|FG000|Track 4|Disease progression|0|||
163095521|NCT02750514|589060105|FG001|Track 4|Disease progression|33|||
163095522|NCT02750514|589060106|FG002|Track 4|Disease progression|0|||
163095523|NCT02750514|589060107|FG003|Track 4|Disease progression|32|||
163095524|NCT02750514|589060108|FG004|Track 4|Disease progression|0|||
163095525|NCT02750514|589060104|FG000|Track 4|Adverse event unrelated to study drug|0|||
163095526|NCT02750514|589060105|FG001|Track 4|Adverse event unrelated to study drug|5|||
162719025|NCT02341625|587676739|FG002|Overall Study|Other Reasons|0|||
163095527|NCT02750514|589060106|FG002|Track 4|Adverse event unrelated to study drug|0|||
163095528|NCT02750514|589060107|FG003|Track 4|Adverse event unrelated to study drug|0|||
163095529|NCT02750514|589060108|FG004|Track 4|Adverse event unrelated to study drug|0|||
163095530|NCT02750514|589060104|FG000|Track 4|Death|0|||
163095531|NCT02750514|589060105|FG001|Track 4|Death|0|||
163095532|NCT02750514|589060106|FG002|Track 4|Death|0|||
163095533|NCT02750514|589060107|FG003|Track 4|Death|1|||
163095534|NCT02750514|589060108|FG004|Track 4|Death|0|||
163095535|NCT02750514|589060104|FG000|Track 5|Disease progression|0|||
163095536|NCT02750514|589060105|FG001|Track 5|Disease progression|0|||
163095537|NCT02750514|589060106|FG002|Track 5|Disease progression|0|||
163095538|NCT02750514|589060107|FG003|Track 5|Disease progression|0|||
163095539|NCT02750514|589060108|FG004|Track 5|Disease progression|34|||
163095540|NCT02750514|589060104|FG000|Track 5|Adverse event unrelated to study drug|0|||
163095541|NCT02750514|589060105|FG001|Track 5|Adverse event unrelated to study drug|0|||
163095542|NCT02750514|589060106|FG002|Track 5|Adverse event unrelated to study drug|0|||
163095543|NCT02750514|589060107|FG003|Track 5|Adverse event unrelated to study drug|0|||
163095544|NCT02750514|589060108|FG004|Track 5|Adverse event unrelated to study drug|2|||
163095545|NCT02750514|589060104|FG000|Track 5|Study drug toxicity|0|||
163095546|NCT02750514|589060105|FG001|Track 5|Study drug toxicity|0|||
163095547|NCT02750514|589060106|FG002|Track 5|Study drug toxicity|0|||
163095548|NCT02750514|589060107|FG003|Track 5|Study drug toxicity|0|||
163095549|NCT02750514|589060108|FG004|Track 5|Study drug toxicity|2|||
163095550|NCT02750514|589060104|FG000|Track 5|Participant request to discontinue|0|||
163095551|NCT02750514|589060105|FG001|Track 5|Participant request to discontinue|0|||
163095552|NCT02750514|589060106|FG002|Track 5|Participant request to discontinue|0|||
163095553|NCT02750514|589060107|FG003|Track 5|Participant request to discontinue|0|||
163095554|NCT02750514|589060108|FG004|Track 5|Participant request to discontinue|3|||
163095555|NCT02750514|589060104|FG000|Track 5|Other reasons|0|||
163095556|NCT02750514|589060105|FG001|Track 5|Other reasons|0|||
163095557|NCT02750514|589060106|FG002|Track 5|Other reasons|0|||
163095558|NCT02750514|589060107|FG003|Track 5|Other reasons|0|||
163095559|NCT02750514|589060108|FG004|Track 5|Other reasons|2|||
163095560|NCT02756403|589060110|FG000|Overall Study|Unable to swallow medication|0|||
163095561|NCT02756403|589060111|FG001|Overall Study|Unable to swallow medication|1|||
163095562|NCT02756403|589060112|FG002|Overall Study|Unable to swallow medication|1|||
163095563|NCT02756403|589060113|FG003|Overall Study|Unable to swallow medication|1|||
163095564|NCT02756403|589060110|FG000|Overall Study|Did not complete Procedure|0|||
163095565|NCT02756403|589060111|FG001|Overall Study|Did not complete Procedure|1|||
163095566|NCT02756403|589060112|FG002|Overall Study|Did not complete Procedure|0|||
163095567|NCT02756403|589060113|FG003|Overall Study|Did not complete Procedure|0|||
163095568|NCT02756403|589060110|FG000|Overall Study|Changed Mind About Procedure|0|||
163095569|NCT02756403|589060111|FG001|Overall Study|Changed Mind About Procedure|0|||
163095570|NCT02756403|589060112|FG002|Overall Study|Changed Mind About Procedure|1|||
163095571|NCT02756403|589060113|FG003|Overall Study|Changed Mind About Procedure|0|||
163095572|NCT02756403|589060110|FG000|Overall Study|Protocol Violation|0|||
163095573|NCT02756403|589060111|FG001|Overall Study|Protocol Violation|1|||
163095574|NCT02756403|589060112|FG002|Overall Study|Protocol Violation|0|||
163095575|NCT02756403|589060113|FG003|Overall Study|Protocol Violation|1|||
163095576|NCT00527618|589060114|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
163095577|NCT00527618|589060115|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
163095578|NCT00527618|589060114|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
163095579|NCT00527618|589060115|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
163095580|NCT00527618|589060114|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
163095581|NCT00527618|589060115|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
163095582|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
163095583|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
163095584|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
163095585|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
163095586|NCT00527618|589060114|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
163095587|NCT00527618|589060115|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
163095588|NCT02240121|589060120|FG000|Overall Study|Protocol Violation|1|||
163095589|NCT02240121|589060121|FG001|Overall Study|Protocol Violation|2|||
163095590|NCT02240121|589060120|FG000|Overall Study|Physician Decision|0|||
163095591|NCT02240121|589060121|FG001|Overall Study|Physician Decision|1|||
163095592|NCT02240121|589060120|FG000|Overall Study|Change in protocol interpretation|1|||
163095593|NCT02240121|589060121|FG001|Overall Study|Change in protocol interpretation|0|||
163095594|NCT02240121|589060120|FG000|Overall Study|Lack of Efficacy|2|||
163095595|NCT02240121|589060121|FG001|Overall Study|Lack of Efficacy|3|||
163095596|NCT02240121|589060120|FG000|Overall Study|Site closed|1|||
163095597|NCT02240121|589060121|FG001|Overall Study|Site closed|1|||
163095598|NCT02240121|589060120|FG000|Overall Study|Pregnancy|1|||
163095599|NCT02240121|589060121|FG001|Overall Study|Pregnancy|0|||
163095600|NCT02240121|589060120|FG000|Overall Study|Adverse Event|2|||
163095601|NCT02240121|589060121|FG001|Overall Study|Adverse Event|4|||
163095602|NCT02240121|589060120|FG000|Overall Study|Withdrawal by Subject|6|||
163095603|NCT02240121|589060121|FG001|Overall Study|Withdrawal by Subject|2|||
163095604|NCT02240121|589060120|FG000|Overall Study|Lost to Follow-up|3|||
163095605|NCT02240121|589060121|FG001|Overall Study|Lost to Follow-up|4|||
163095606|NCT02240121|589060120|FG000|Overall Study|Other than specified|1|||
163095607|NCT02240121|589060121|FG001|Overall Study|Other than specified|3|||
163095608|NCT01151020|589060122|FG000|Overall Study|Death|25|||
163095609|NCT01151020|589060122|FG000|Overall Study|Conversion to open repair|1|||
163095610|NCT01151020|589060122|FG000|Overall Study|Lost to Follow-up|4|||
163095611|NCT01151020|589060122|FG000|Overall Study|Withdrawal by Subject|22|||
163095612|NCT01151020|589060122|FG000|Overall Study|Patients did not receive the device|2|||
163095613|NCT00648037|589060123|FG000|Overall Study|Not Treated|1|||
163095614|NCT00648037|589060123|FG000|Overall Study|Withdrawal by Subject|1|||
163095615|NCT00648037|589060123|FG000|Overall Study|Adverse Event|11|||
163095616|NCT00648037|589060123|FG000|Overall Study|Relapse|2|||
163095617|NCT00648037|589060123|FG000|Overall Study|Other|1|||
163095618|NCT01635998|589060124|FG000|Overall Study|Death|1|||
163095619|NCT01635998|589060125|FG001|Overall Study|Death|1|||
163095620|NCT01635998|589060124|FG000|Overall Study|Lost to Follow-up|2|||
163095621|NCT01635998|589060125|FG001|Overall Study|Lost to Follow-up|1|||
163095622|NCT01635998|589060124|FG000|Overall Study|Withdrawal by Subject|1|||
163095623|NCT01635998|589060125|FG001|Overall Study|Withdrawal by Subject|5|||
163095624|NCT00846846|589060126|FG000|Overall Study|Death|56|||
163095625|NCT00846846|589060126|FG000|Overall Study|Withdrawal by Subject|19|||
163095626|NCT04419467|589060127|FG000|Overall Study|Not treated with IP|0|||
163095627|NCT04419467|589060128|FG001|Overall Study|Not treated with IP|0|||
163095628|NCT04419467|589060129|FG002|Overall Study|Not treated with IP|2|||
163095629|NCT04419467|589060127|FG000|Overall Study|Adverse Event|0|||
163095630|NCT04419467|589060128|FG001|Overall Study|Adverse Event|2|||
163095631|NCT04419467|589060129|FG002|Overall Study|Adverse Event|0|||
163095632|NCT04419467|589060127|FG000|Overall Study|Death|1|||
163095633|NCT04419467|589060128|FG001|Overall Study|Death|0|||
163095634|NCT04419467|589060129|FG002|Overall Study|Death|0|||
163095635|NCT04419467|589060127|FG000|Overall Study|Lost to Follow-up|0|||
163095636|NCT04419467|589060128|FG001|Overall Study|Lost to Follow-up|1|||
163095637|NCT04419467|589060129|FG002|Overall Study|Lost to Follow-up|2|||
163095638|NCT04419467|589060127|FG000|Overall Study|Withdrawal by Subject|0|||
163095639|NCT04419467|589060128|FG001|Overall Study|Withdrawal by Subject|0|||
163095640|NCT04419467|589060129|FG002|Overall Study|Withdrawal by Subject|4|||
163095641|NCT04419467|589060127|FG000|Overall Study|Pandemic related|0|||
163095642|NCT04419467|589060128|FG001|Overall Study|Pandemic related|0|||
163095643|NCT04419467|589060129|FG002|Overall Study|Pandemic related|1|||
163095644|NCT04419467|589060127|FG000|Overall Study|Reason not known|1|||
163095645|NCT04419467|589060128|FG001|Overall Study|Reason not known|0|||
163095646|NCT04419467|589060129|FG002|Overall Study|Reason not known|0|||
163095647|NCT02967679|589060132|FG000|Overall Study|Adverse Event|1|||
163095648|NCT00600067|589060135|FG000|Overall Study|Adverse Event|0|||
163095649|NCT00600067|589060136|FG001|Overall Study|Adverse Event|1|||
163095650|NCT00600067|589060135|FG000|Overall Study|Lost to Follow-up|2|||
163095651|NCT00600067|589060136|FG001|Overall Study|Lost to Follow-up|3|||
163095652|NCT00600067|589060135|FG000|Overall Study|protocol non-compliance|0|||
163095653|NCT00600067|589060136|FG001|Overall Study|protocol non-compliance|3|||
163095654|NCT00600067|589060135|FG000|Overall Study|Lack of Efficacy|1|||
163095655|NCT00600067|589060136|FG001|Overall Study|Lack of Efficacy|0|||
163095656|NCT04571060|589060140|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
163095657|NCT04571060|589060141|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
163095658|NCT04571060|589060140|FG000|Overall Study|Never treated migraine|47|||
163095659|NCT04571060|589060141|FG001|Overall Study|Never treated migraine|36|||
163095660|NCT04571060|589060140|FG000|Overall Study|Protocol Violation|4|||
163095661|NCT04571060|589060141|FG001|Overall Study|Protocol Violation|2|||
163095662|NCT04571060|589060140|FG000|Overall Study|Withdrawal by Subject|6|||
163095663|NCT04571060|589060141|FG001|Overall Study|Withdrawal by Subject|2|||
163095664|NCT04571060|589060140|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
163095665|NCT04571060|589060141|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
162652672|NCT02036502|587445580|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162652673|NCT02036502|587445581|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162719026|NCT02341625|587676740|FG003|Overall Study|Other Reasons|0|||
163095666|NCT01253369|589060142|FG000|Overall Study|Adverse Event|4|||
163095667|NCT01253369|589060142|FG000|Overall Study|Withdrawal by Subject|2|||
163095668|NCT01253369|589060142|FG000|Overall Study|Death|1|||
163095669|NCT01253369|589060142|FG000|Overall Study|Progressive disease|23|||
163095670|NCT01253369|589060142|FG000|Overall Study|Not Evaluable|3|||
163095671|NCT01220401|589060147|FG000|Overall Study|Withdrawal by Subject|2|||
163095672|NCT01220401|589060147|FG000|Overall Study|Protocol Violation|1|||
163095673|NCT01853462|589060148|FG000|Overall Study|Withdrawal by Subject|1|||
163095674|NCT01853462|589060149|FG001|Overall Study|Withdrawal by Subject|1|||
163095675|NCT02765399|589060151|FG000|Overall Study|Nausea|1|||
163095676|NCT02765399|589060152|FG001|Overall Study|Nausea|0|||
163095677|NCT02103062|589060153|FG000|Overall Study|Adverse Event|1|||
162652674|NCT02036502|587445574|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163095678|NCT02103062|589060154|FG001|Overall Study|Adverse Event|2|||
163095679|NCT02103062|589060153|FG000|Overall Study|Progressive Disease|17|||
163095680|NCT02103062|589060154|FG001|Overall Study|Progressive Disease|20|||
163095681|NCT02103062|589060153|FG000|Overall Study|Death|0|||
163095682|NCT02103062|589060154|FG001|Overall Study|Death|1|||
163095683|NCT03958331|589060155|FG000|Overall Study|Withdrawal by Subject|3|||
163095684|NCT03958331|589060156|FG001|Overall Study|Withdrawal by Subject|1|||
163095685|NCT03958331|589060157|FG002|Overall Study|Withdrawal by Subject|5|||
163095686|NCT03958331|589060155|FG000|Overall Study|Weaned from medicine|2|||
163095687|NCT03958331|589060156|FG001|Overall Study|Weaned from medicine|0|||
163095688|NCT03958331|589060157|FG002|Overall Study|Weaned from medicine|0|||
163095689|NCT03958331|589060155|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
163095690|NCT03958331|589060156|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
163095691|NCT03958331|589060157|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
163095692|NCT01991483|589060158|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
163095693|NCT01991483|589060159|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
163095694|NCT01991483|589060160|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
163095695|NCT01991483|589060161|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
163095696|NCT01991483|589060158|FG000|Dose Level 600 mg|Physician Decision|0|||
163095697|NCT01991483|589060159|FG001|Dose Level 600 mg|Physician Decision|0|||
163095698|NCT01991483|589060160|FG002|Dose Level 600 mg|Physician Decision|1|||
163095699|NCT01991483|589060161|FG003|Dose Level 600 mg|Physician Decision|0|||
163095700|NCT01991483|589060158|FG000|Dose Level 1000 mg|Protocol Violation|0|||
163095701|NCT01991483|589060159|FG001|Dose Level 1000 mg|Protocol Violation|0|||
163095702|NCT01991483|589060160|FG002|Dose Level 1000 mg|Protocol Violation|0|||
163095703|NCT01991483|589060161|FG003|Dose Level 1000 mg|Protocol Violation|1|||
163095704|NCT02030821|589060162|FG000|Overall Study|Physician Decision|2|||
163095705|NCT02030821|589060163|FG001|Overall Study|Physician Decision|2|||
163095706|NCT02030821|589060164|FG002|Overall Study|Physician Decision|5|||
163095707|NCT02030821|589060165|FG003|Overall Study|Physician Decision|2|||
163095708|NCT03192137|589060166|FG000|Overall Study|Adverse Event|10|||
163095709|NCT03192137|589060167|FG001|Overall Study|Adverse Event|11|||
163095710|NCT03192137|589060166|FG000|Overall Study|Physician Decision|1|||
163095711|NCT03192137|589060167|FG001|Overall Study|Physician Decision|0|||
163095712|NCT03192137|589060166|FG000|Overall Study|Lack of Efficacy|20|||
163095713|NCT03192137|589060167|FG001|Overall Study|Lack of Efficacy|37|||
163095714|NCT03192137|589060166|FG000|Overall Study|Withdrawal by Subject|3|||
163095715|NCT03192137|589060167|FG001|Overall Study|Withdrawal by Subject|3|||
163095716|NCT03192137|589060166|FG000|Overall Study|Protocol Violation|4|||
163095717|NCT03192137|589060167|FG001|Overall Study|Protocol Violation|3|||
163095718|NCT03192137|589060166|FG000|Overall Study|Surgery Cancelled|4|||
163095719|NCT03192137|589060167|FG001|Overall Study|Surgery Cancelled|1|||
163095720|NCT03192137|589060166|FG000|Overall Study|Other - Various Administrative Reasons|8|||
163095721|NCT03192137|589060167|FG001|Overall Study|Other - Various Administrative Reasons|3|||
163095722|NCT01152437|589060168|FG000|Overall Study|Other Adverse Event|8|||
163095723|NCT01152437|589060169|FG001|Overall Study|Other Adverse Event|1|||
163095724|NCT01152437|589060170|FG002|Overall Study|Other Adverse Event|7|||
163095725|NCT01152437|589060168|FG000|Overall Study|Not treated|0|||
163095726|NCT01152437|589060169|FG001|Overall Study|Not treated|1|||
163095727|NCT01152437|589060170|FG002|Overall Study|Not treated|2|||
163095728|NCT01152437|589060168|FG000|Overall Study|Progressive disease|27|||
163095729|NCT01152437|589060169|FG001|Overall Study|Progressive disease|13|||
163095730|NCT01152437|589060170|FG002|Overall Study|Progressive disease|32|||
163095731|NCT01152437|589060168|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
163095732|NCT01152437|589060169|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
162652675|NCT02036502|587445575|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
163095733|NCT01152437|589060170|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
163095734|NCT02015039|589060171|FG000|Overall Study|Not eligible|0|||
163095735|NCT02015039|589060172|FG001|Overall Study|Not eligible|1|||
163095736|NCT01897532|589060173|FG000|Discontinuation From Treatment|Not Treated|7|||
163095737|NCT01897532|589060174|FG001|Discontinuation From Treatment|Not Treated|5|||
163095738|NCT01897532|589060173|FG000|Discontinuation From Treatment|Other reason than specified|196|||
163095739|NCT01897532|589060174|FG001|Discontinuation From Treatment|Other reason than specified|176|||
163095740|NCT01897532|589060173|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
163095741|NCT01897532|589060174|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
163095742|NCT01897532|589060173|FG000|Discontinuation From Treatment|Non compliance|24|||
163095743|NCT01897532|589060174|FG001|Discontinuation From Treatment|Non compliance|15|||
163095744|NCT01897532|589060173|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
162652676|NCT02036502|587445576|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163095745|NCT01897532|589060174|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
163095746|NCT01897532|589060173|FG000|Discontinuation From Trial|Not Treated|7|||
163095747|NCT01897532|589060174|FG001|Discontinuation From Trial|Not Treated|5|||
162652677|NCT02036502|587445577|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
163095748|NCT01897532|589060173|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
163095749|NCT01897532|589060174|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
163095750|NCT01074931|589060180|FG000|Overall Study|Economic reasons|1|||
163095751|NCT01074931|589060180|FG000|Overall Study|Death|5|||
163095752|NCT03132467|589060181|FG000|Overall Study|Adverse Event|2|||
163095753|NCT03132467|589060181|FG000|Overall Study|Withdrawal by Subject|2|||
163095754|NCT01088906|589060182|FG000|Overall Study|Inclusion error|1|||
163095755|NCT01088906|589060182|FG000|Overall Study|Did not receive study treatment|3|||
163095756|NCT01088906|589060182|FG000|Overall Study|Missing data|1|||
163095757|NCT00457626|589060185|FG000|Overall Study|Adverse Event|3|||
163095758|NCT00457626|589060185|FG000|Overall Study|Administrative Problems|2|||
163095759|NCT00457626|589060185|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
163095760|NCT03965403|589060186|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
163095761|NCT02364037|589061098|FG000|Overall Study|Withdrawal by Subject|7|||
163095762|NCT02364037|589061099|FG001|Overall Study|Withdrawal by Subject|4|||
163095763|NCT02364037|589061098|FG000|Overall Study|Lost to Follow-up|37|||
163095764|NCT02364037|589061099|FG001|Overall Study|Lost to Follow-up|49|||
163095765|NCT01453036|589061100|FG000|Overall Study|Lost to Follow-up|26|||
163095766|NCT01453036|589061101|FG001|Overall Study|Lost to Follow-up|115|||
163095767|NCT01453036|589061102|FG002|Overall Study|Lost to Follow-up|31|||
163095768|NCT04072835|589061103|FG000|Overall Study|Overall trial ended|603|||
163095769|NCT04072835|589061103|FG000|Overall Study|Ablation|97|||
163095770|NCT04072835|589061103|FG000|Overall Study|Withdrawal of consent|66|||
163095771|NCT04072835|589061103|FG000|Overall Study|Physician Decision|50|||
163095772|NCT04072835|589061103|FG000|Overall Study|Lost to Follow-up|39|||
163095773|NCT04072835|589061103|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
163095774|NCT04072835|589061103|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
163095775|NCT04072835|589061103|FG000|Overall Study|Adverse Event|25|||
163095776|NCT04072835|589061103|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
163095777|NCT04072835|589061103|FG000|Overall Study|Death|11|||
163095778|NCT04072835|589061103|FG000|Overall Study|Participant felt the drug did not work|8|||
163095779|NCT04072835|589061103|FG000|Overall Study|Participant tolerability|5|||
163095780|NCT04072835|589061103|FG000|Overall Study|Missing|5|||
163095781|NCT04072835|589061103|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
163095782|NCT04072835|589061103|FG000|Overall Study|Pregnancy|3|||
163095783|NCT01336712|589061104|FG000|Overall Study|Death|2|||
163095784|NCT01336712|589061104|FG000|Overall Study|Lack of Efficacy|1|||
163095785|NCT00841776|589061105|FG000|Overall Study|Lack of Efficacy|0|||
163095786|NCT00841776|589061106|FG001|Overall Study|Lack of Efficacy|1|||
163095787|NCT00841776|589061105|FG000|Overall Study|Lost to Follow-up|2|||
163095788|NCT00841776|589061106|FG001|Overall Study|Lost to Follow-up|1|||
163095789|NCT00841776|589061105|FG000|Overall Study|Withdrawal by Subject|0|||
163095790|NCT00841776|589061106|FG001|Overall Study|Withdrawal by Subject|1|||
163095791|NCT00856323|589061107|FG000|Overall Study|Withdrawal by Subject|2|||
163095792|NCT01639469|589061108|FG000|Overall Study|Death|4|||
163095793|NCT01639469|589061109|FG001|Overall Study|Death|2|||
163095794|NCT01639469|589061108|FG000|Overall Study|Lost to Follow-up|1|||
163095795|NCT01639469|589061109|FG001|Overall Study|Lost to Follow-up|1|||
163095796|NCT01119443|589061112|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
163095797|NCT01119443|589061113|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
163095798|NCT02329743|589061114|FG000|Overall Study|Adverse Event|1|||
163095799|NCT02329743|589061115|FG001|Overall Study|Adverse Event|1|||
163095800|NCT02329743|589061116|FG002|Overall Study|Adverse Event|3|||
163095801|NCT02329743|589061114|FG000|Overall Study|Lost to Follow-up|1|||
163095802|NCT02329743|589061115|FG001|Overall Study|Lost to Follow-up|0|||
163095803|NCT02329743|589061116|FG002|Overall Study|Lost to Follow-up|1|||
163095804|NCT02329743|589061114|FG000|Overall Study|Withdrawal by Subject|4|||
163095805|NCT02329743|589061115|FG001|Overall Study|Withdrawal by Subject|4|||
163095806|NCT02329743|589061116|FG002|Overall Study|Withdrawal by Subject|1|||
163095807|NCT02329743|589061114|FG000|Overall Study|Other|0|||
163095808|NCT02329743|589061115|FG001|Overall Study|Other|2|||
163095809|NCT02329743|589061116|FG002|Overall Study|Other|3|||
163095810|NCT01428219|589061127|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
163095811|NCT00355368|589061128|FG000|Overall Study|Protocol Violation|8|||
163095812|NCT00355368|589061129|FG001|Overall Study|Protocol Violation|7|||
163095813|NCT00355368|589061128|FG000|Overall Study|cardiac arrest prior to intubation|2|||
163095814|NCT00355368|589061129|FG001|Overall Study|cardiac arrest prior to intubation|2|||
163095815|NCT01694433|589061131|FG000|Overall Study|Adverse Event|7|||
163095816|NCT01694433|589061132|FG001|Overall Study|Adverse Event|0|||
163095817|NCT01694433|589061131|FG000|Overall Study|Physician Decision|1|||
163095818|NCT01694433|589061132|FG001|Overall Study|Physician Decision|0|||
163095819|NCT01694433|589061131|FG000|Overall Study|Withdrawal by Subject|3|||
163095820|NCT01694433|589061132|FG001|Overall Study|Withdrawal by Subject|4|||
163095821|NCT00374595|589061135|FG000|Overall Study|Death|23|||
163095822|NCT00374595|589061135|FG000|Overall Study|Withdrawal by Subject|39|||
163095823|NCT00374595|589061135|FG000|Overall Study|Lost to Follow-up|3|||
163095824|NCT00374595|589061135|FG000|Overall Study|too much time commitment|1|||
163095825|NCT00374595|589061135|FG000|Overall Study|transfer care to other clinical site|1|||
163095826|NCT00374595|589061135|FG000|Overall Study|relocation|3|||
163095827|NCT01665911|589061139|FG000|Overall Study|Protocol Violation|4|||
163095828|NCT01665911|589061139|FG000|Overall Study|Withdrawal by Subject|1|||
163095829|NCT01665911|589061139|FG000|Overall Study|Adverse Event|1|||
163095830|NCT00347932|589061140|FG000|Overall Study|Adverse Event|4|||
163095831|NCT00347932|589061141|FG001|Overall Study|Adverse Event|5|||
162652678|NCT02036502|587445578|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162652679|NCT02036502|587445579|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162652680|NCT02036502|587445580|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162652681|NCT02036502|587445581|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162652682|NCT02036502|587445574|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
162652683|NCT02036502|587445575|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
162652684|NCT02036502|587445576|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
162652685|NCT02036502|587445577|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
162652686|NCT02036502|587445578|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
162652687|NCT02036502|587445579|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
162652688|NCT02036502|587445580|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
162652689|NCT02036502|587445581|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
162652690|NCT02036502|587445574|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162652691|NCT02036502|587445575|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162652692|NCT02036502|587445576|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
162652693|NCT02036502|587445577|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
163095832|NCT00347932|589061140|FG000|Overall Study|Lack of Efficacy|3|||
163095833|NCT00347932|589061141|FG001|Overall Study|Lack of Efficacy|14|||
163095834|NCT00347932|589061140|FG000|Overall Study|Lost to Follow-up|10|||
163095835|NCT00347932|589061141|FG001|Overall Study|Lost to Follow-up|9|||
163095836|NCT00347932|589061140|FG000|Overall Study|Withdrawal by Subject|10|||
163095837|NCT00347932|589061141|FG001|Overall Study|Withdrawal by Subject|16|||
163095838|NCT00347932|589061140|FG000|Overall Study|Did not meet inclusion criteria|4|||
163095839|NCT00347932|589061141|FG001|Overall Study|Did not meet inclusion criteria|8|||
163095840|NCT01881009|589061143|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
163095841|NCT01881009|589061144|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
163095842|NCT01492088|589061146|FG000|Overall Study|Withdrawal by Patient|0|||
163095843|NCT01492088|589061147|FG001|Overall Study|Withdrawal by Patient|2|||
163095844|NCT01492088|589061148|FG002|Overall Study|Withdrawal by Patient|0|||
163095845|NCT01492088|589061146|FG000|Overall Study|Death|1|||
163095846|NCT01492088|589061147|FG001|Overall Study|Death|6|||
163095847|NCT01492088|589061148|FG002|Overall Study|Death|2|||
163095848|NCT01492088|589061146|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
163095849|NCT01492088|589061147|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
163095850|NCT01492088|589061148|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
163095851|NCT01492088|589061146|FG000|Overall Study|Alive at Last Follow-up|0|||
163095852|NCT01492088|589061147|FG001|Overall Study|Alive at Last Follow-up|6|||
163095853|NCT01492088|589061148|FG002|Overall Study|Alive at Last Follow-up|11|||
163095854|NCT00889707|589061149|FG000|Overall Study|Adverse Event|1|||
163095855|NCT00889707|589061150|FG001|Overall Study|Adverse Event|0|||
163095856|NCT00889707|589061149|FG000|Overall Study|Withdrawal by Subject|4|||
163095857|NCT00889707|589061150|FG001|Overall Study|Withdrawal by Subject|3|||
163095858|NCT00889707|589061149|FG000|Overall Study|Lost to Follow-up|0|||
163095859|NCT00889707|589061150|FG001|Overall Study|Lost to Follow-up|2|||
163095860|NCT00889707|589061149|FG000|Overall Study|Lack of Efficacy|2|||
163095861|NCT00889707|589061150|FG001|Overall Study|Lack of Efficacy|5|||
163095862|NCT00881894|589061154|FG000|Overall Study|Consent withdrawn|0|||
163095863|NCT00881894|589061155|FG001|Overall Study|Consent withdrawn|1|||
163095864|NCT00881894|589061154|FG000|Overall Study|Other reasons for premature termination|1|||
163095865|NCT00881894|589061155|FG001|Overall Study|Other reasons for premature termination|2|||
162652694|NCT02036502|587445578|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
163095866|NCT03943290|589061157|FG000|Overall Study|Sponsor Terminated Study|6|||
163095867|NCT03943290|589061158|FG001|Overall Study|Sponsor Terminated Study|1|||
163095868|NCT03943290|589061159|FG002|Overall Study|Sponsor Terminated Study|11|||
163095869|NCT03943290|589061160|FG003|Overall Study|Sponsor Terminated Study|6|||
163095870|NCT03943290|589061161|FG004|Overall Study|Sponsor Terminated Study|7|||
163095871|NCT03943290|589061162|FG005|Overall Study|Sponsor Terminated Study|6|||
163095872|NCT03943290|589061163|FG006|Overall Study|Sponsor Terminated Study|6|||
162652695|NCT02036502|587445579|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162652696|NCT02036502|587445580|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162719027|NCT02341625|587676741|FG004|Overall Study|Other Reasons|1|||
163095873|NCT03943290|589061164|FG007|Overall Study|Sponsor Terminated Study|7|||
163095874|NCT03943290|589061165|FG008|Overall Study|Sponsor Terminated Study|8|||
163095875|NCT03943290|589061157|FG000|Overall Study|Lost to Follow-up|1|||
163095876|NCT03943290|589061158|FG001|Overall Study|Lost to Follow-up|0|||
163095877|NCT03943290|589061159|FG002|Overall Study|Lost to Follow-up|1|||
163095878|NCT03943290|589061160|FG003|Overall Study|Lost to Follow-up|0|||
163095879|NCT03943290|589061161|FG004|Overall Study|Lost to Follow-up|0|||
163095880|NCT03943290|589061162|FG005|Overall Study|Lost to Follow-up|0|||
163095881|NCT03943290|589061163|FG006|Overall Study|Lost to Follow-up|0|||
163095882|NCT03943290|589061164|FG007|Overall Study|Lost to Follow-up|1|||
163095883|NCT03943290|589061165|FG008|Overall Study|Lost to Follow-up|0|||
163095884|NCT03943290|589061157|FG000|Overall Study|Withdrawal by Subject|0|||
163095885|NCT03943290|589061158|FG001|Overall Study|Withdrawal by Subject|0|||
163095886|NCT03943290|589061159|FG002|Overall Study|Withdrawal by Subject|1|||
163095887|NCT03943290|589061160|FG003|Overall Study|Withdrawal by Subject|0|||
163095888|NCT03943290|589061161|FG004|Overall Study|Withdrawal by Subject|0|||
163095889|NCT03943290|589061162|FG005|Overall Study|Withdrawal by Subject|0|||
163095890|NCT03943290|589061163|FG006|Overall Study|Withdrawal by Subject|0|||
163095891|NCT03943290|589061164|FG007|Overall Study|Withdrawal by Subject|0|||
163095892|NCT03943290|589061165|FG008|Overall Study|Withdrawal by Subject|0|||
163095893|NCT01070979|589061166|FG000|Overall Study|Adverse Event|2|||
163095894|NCT01070979|589061167|FG001|Overall Study|Adverse Event|3|||
163095895|NCT01070979|589061168|FG002|Overall Study|Adverse Event|3|||
163095896|NCT01070979|589061166|FG000|Overall Study|Lost to Follow-up|2|||
163095897|NCT01070979|589061167|FG001|Overall Study|Lost to Follow-up|1|||
163095898|NCT01070979|589061168|FG002|Overall Study|Lost to Follow-up|1|||
163095899|NCT01070979|589061166|FG000|Overall Study|Protocol Violation|0|||
163095900|NCT01070979|589061167|FG001|Overall Study|Protocol Violation|2|||
163095901|NCT01070979|589061168|FG002|Overall Study|Protocol Violation|6|||
163095902|NCT01070979|589061166|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
163095903|NCT01070979|589061167|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
163095904|NCT01070979|589061168|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
163095905|NCT01070979|589061166|FG000|Overall Study|Withdrawal by Subject|3|||
163095906|NCT01070979|589061167|FG001|Overall Study|Withdrawal by Subject|1|||
163095907|NCT01070979|589061168|FG002|Overall Study|Withdrawal by Subject|1|||
163095908|NCT01070979|589061166|FG000|Overall Study|No study drug taken|0|||
163095909|NCT01070979|589061167|FG001|Overall Study|No study drug taken|1|||
163095910|NCT01070979|589061168|FG002|Overall Study|No study drug taken|0|||
163095911|NCT00437268|589061169|FG000|Overall Study|Adverse Event|1|||
163095912|NCT00437268|589061170|FG001|Overall Study|Adverse Event|1|||
163095913|NCT00437268|589061169|FG000|Overall Study|Withdrawal by Subject|2|||
163095914|NCT00437268|589061170|FG001|Overall Study|Withdrawal by Subject|2|||
163095915|NCT00437268|589061169|FG000|Overall Study|Progressive disease|9|||
163095916|NCT00437268|589061170|FG001|Overall Study|Progressive disease|9|||
163095917|NCT00437268|589061169|FG000|Overall Study|Physician Decision|1|||
163095918|NCT00437268|589061170|FG001|Overall Study|Physician Decision|0|||
163095919|NCT00437268|589061169|FG000|Overall Study|Death|0|||
163095920|NCT00437268|589061170|FG001|Overall Study|Death|1|||
163095921|NCT04417257|589061175|FG000|Pilot Phase 2|Adverse Event|2|||
163095922|NCT04417257|589061176|FG001|Pilot Phase 2|Adverse Event|0|||
163095923|NCT04417257|589061175|FG000|Pilot Phase 2|Death|14|||
163095924|NCT04417257|589061176|FG001|Pilot Phase 2|Death|11|||
163095925|NCT04417257|589061175|FG000|Pilot Phase 2|Lost to Follow-up|3|||
163095926|NCT04417257|589061176|FG001|Pilot Phase 2|Lost to Follow-up|5|||
163095927|NCT04417257|589061175|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
163095928|NCT04417257|589061176|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
163095929|NCT04417257|589061175|FG000|Pilot Phase 2|Hepatic impairment|1|||
163095930|NCT04417257|589061176|FG001|Pilot Phase 2|Hepatic impairment|0|||
163095931|NCT04417257|589061175|FG000|Pilot Phase 2|Unblinding|1|||
163095932|NCT04417257|589061176|FG001|Pilot Phase 2|Unblinding|0|||
163095933|NCT04417257|589061175|FG000|Pilot Phase 2|All other|0|||
163095934|NCT04417257|589061176|FG001|Pilot Phase 2|All other|2|||
163095935|NCT04417257|589061175|FG000|Phase 3 Extension|Death|3|||
163095936|NCT04417257|589061176|FG001|Phase 3 Extension|Death|1|||
163095937|NCT04417257|589061175|FG000|Phase 3 Extension|Lost to Follow-up|4|||
163095938|NCT04417257|589061176|FG001|Phase 3 Extension|Lost to Follow-up|2|||
163095939|NCT04417257|589061175|FG000|Phase 3 Extension|Patient withdrawal|2|||
163095940|NCT04417257|589061176|FG001|Phase 3 Extension|Patient withdrawal|2|||
163095941|NCT04417257|589061175|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
163095942|NCT04417257|589061176|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
163095943|NCT03484429|589061180|FG000|Overall Study|Withdrawal by Subject|1|||
163095944|NCT03484429|589061181|FG001|Overall Study|Withdrawal by Subject|0|||
163095945|NCT03484429|589061180|FG000|Overall Study|Adverse Event|2|||
163095946|NCT03484429|589061181|FG001|Overall Study|Adverse Event|0|||
163095947|NCT04466384|589061182|FG000|First Phase|Protocol Violation|1|||
163095948|NCT04466384|589061183|FG001|First Phase|Protocol Violation|0|||
163095949|NCT04466384|589061182|FG000|First Phase|Missing data|1|||
163095950|NCT04466384|589061183|FG001|First Phase|Missing data|0|||
163095951|NCT04466384|589061182|FG000|Cross Over Phase|Physician Decision|1|||
163095952|NCT04466384|589061183|FG001|Cross Over Phase|Physician Decision|0|||
163095953|NCT04466384|589061182|FG000|Cross Over Phase|Withdrawal by Subject|0|||
163095954|NCT04466384|589061183|FG001|Cross Over Phase|Withdrawal by Subject|1|||
163095955|NCT00972023|589062593|FG000|Overall Study|Withdrawal by Subject|1|||
163095956|NCT00532129|589062594|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
162652697|NCT02036502|587445581|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162652698|NCT02036502|587445574|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652699|NCT02036502|587445575|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652700|NCT02036502|587445576|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
162652701|NCT02036502|587445577|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652702|NCT02036502|587445578|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652703|NCT02036502|587445579|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652704|NCT02036502|587445580|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652705|NCT02036502|587445581|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162652706|NCT02036502|587445574|FG000|Part 2:Dose Confirmation|Death|0|||
162652707|NCT02036502|587445575|FG001|Part 2:Dose Confirmation|Death|0|||
162652708|NCT02036502|587445576|FG002|Part 2:Dose Confirmation|Death|1|||
162652709|NCT02036502|587445577|FG003|Part 2:Dose Confirmation|Death|0|||
162652710|NCT02036502|587445578|FG004|Part 2:Dose Confirmation|Death|0|||
162652711|NCT02036502|587445579|FG005|Part 2:Dose Confirmation|Death|0|||
162652712|NCT02036502|587445580|FG006|Part 2:Dose Confirmation|Death|0|||
162652713|NCT02036502|587445581|FG007|Part 2:Dose Confirmation|Death|0|||
162652714|NCT02036502|587445574|FG000|Part 2:Dose Confirmation|Not treated|0|||
162652715|NCT02036502|587445575|FG001|Part 2:Dose Confirmation|Not treated|0|||
162652716|NCT02036502|587445576|FG002|Part 2:Dose Confirmation|Not treated|0|||
162652717|NCT02036502|587445577|FG003|Part 2:Dose Confirmation|Not treated|1|||
162652718|NCT02036502|587445578|FG004|Part 2:Dose Confirmation|Not treated|0|||
162652719|NCT02036502|587445579|FG005|Part 2:Dose Confirmation|Not treated|0|||
162652720|NCT02036502|587445580|FG006|Part 2:Dose Confirmation|Not treated|0|||
162652721|NCT02036502|587445581|FG007|Part 2:Dose Confirmation|Not treated|0|||
162652722|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Adverse Event|0|||
162652723|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Adverse Event|0|||
162652724|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Adverse Event|0|||
162652725|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Adverse Event|0|||
162652726|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Adverse Event|0|||
162652727|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Adverse Event|4|||
162652728|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Adverse Event|0|||
162652729|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Adverse Event|2|||
162652730|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Death|0|||
162652731|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Death|0|||
162652732|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Death|0|||
162652733|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Death|0|||
162652734|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Death|0|||
162652735|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Death|24|||
162652736|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Death|0|||
162652737|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Death|3|||
162652738|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
163095957|NCT00532129|589062594|FG000|Treatment Period|Physician Decision|15|||
163095958|NCT00532129|589062594|FG000|Treatment Period|Disease progression|3|||
163095959|NCT00532129|589062594|FG000|Treatment Period|Protocol Violation|1|||
163095960|NCT00532129|589062594|FG000|Treatment Period|Other|5|||
163095961|NCT00532129|589062594|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
163095962|NCT00532129|589062594|FG000|Follow-up Period|Disease progression|57|||
163095963|NCT00532129|589062594|FG000|Follow-up Period|Lost to Follow-up|1|||
163095964|NCT00532129|589062594|FG000|Follow-up Period|Other|6|||
163095965|NCT03052608|589062595|FG000|Treatment Phase|Adverse Event|10|||
163095966|NCT03052608|589062596|FG001|Treatment Phase|Adverse Event|12|||
163095967|NCT03052608|589062595|FG000|Treatment Phase|Death|6|||
163095968|NCT03052608|589062596|FG001|Treatment Phase|Death|4|||
163095969|NCT03052608|589062595|FG000|Treatment Phase|Withdrawal by Subject|4|||
163095970|NCT03052608|589062596|FG001|Treatment Phase|Withdrawal by Subject|12|||
163095971|NCT03052608|589062595|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
163095972|NCT03052608|589062596|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
163095973|NCT03052608|589062595|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
162652739|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652740|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652741|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652742|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652743|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652744|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
162652745|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
162652746|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Physician Decision|0|||
162652747|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Physician Decision|0|||
162652748|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Physician Decision|0|||
162652749|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Physician Decision|0|||
162652750|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Physician Decision|0|||
163095974|NCT03052608|589062596|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
162652751|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Physician Decision|1|||
162652752|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Physician Decision|0|||
163095975|NCT03052608|589062595|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
163095976|NCT03052608|589062596|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
163095977|NCT03052608|589062595|FG000|Treatment Phase|Ongoing|103|||
163095978|NCT03052608|589062596|FG001|Treatment Phase|Ongoing|31|||
163095979|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Death|23|||
163095980|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Death|28|||
163095981|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
163095982|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
163095983|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
163095984|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
163095985|NCT03052608|589062595|FG000|Long-Term Follow-up Phase|Ongoing|122|||
163095986|NCT03052608|589062596|FG001|Long-Term Follow-up Phase|Ongoing|99|||
163095987|NCT00551031|589062597|FG000|Overall Study|Adverse Event|0|||
163095988|NCT00551031|589062598|FG001|Overall Study|Adverse Event|1|||
163095989|NCT00551031|589062599|FG002|Overall Study|Adverse Event|0|||
163095990|NCT00551031|589062600|FG003|Overall Study|Adverse Event|0|||
163095991|NCT00551031|589062601|FG004|Overall Study|Adverse Event|0|||
163095992|NCT00551031|589062597|FG000|Overall Study|Protocol Violation|1|||
163095993|NCT00551031|589062598|FG001|Overall Study|Protocol Violation|1|||
163095994|NCT00551031|589062599|FG002|Overall Study|Protocol Violation|0|||
163095995|NCT00551031|589062600|FG003|Overall Study|Protocol Violation|0|||
163095996|NCT00551031|589062601|FG004|Overall Study|Protocol Violation|0|||
163095997|NCT00551031|589062597|FG000|Overall Study|Lost to Follow-up|0|||
163095998|NCT00551031|589062598|FG001|Overall Study|Lost to Follow-up|1|||
163095999|NCT00551031|589062599|FG002|Overall Study|Lost to Follow-up|0|||
163096000|NCT00551031|589062600|FG003|Overall Study|Lost to Follow-up|1|||
163096001|NCT00551031|589062601|FG004|Overall Study|Lost to Follow-up|1|||
163096002|NCT00551031|589062597|FG000|Overall Study|Withdrawal by Subject|0|||
163096003|NCT00551031|589062598|FG001|Overall Study|Withdrawal by Subject|4|||
163096004|NCT00551031|589062599|FG002|Overall Study|Withdrawal by Subject|1|||
163096005|NCT00551031|589062600|FG003|Overall Study|Withdrawal by Subject|2|||
163096006|NCT00551031|589062601|FG004|Overall Study|Withdrawal by Subject|0|||
163096007|NCT00551031|589062597|FG000|Overall Study|Serious Adverse Event|0|||
163096008|NCT00551031|589062598|FG001|Overall Study|Serious Adverse Event|2|||
163096009|NCT00551031|589062599|FG002|Overall Study|Serious Adverse Event|1|||
163096010|NCT00551031|589062600|FG003|Overall Study|Serious Adverse Event|0|||
163096011|NCT00551031|589062601|FG004|Overall Study|Serious Adverse Event|0|||
163096012|NCT00551031|589062597|FG000|Overall Study|Did not receive vaccine|1|||
163096013|NCT00551031|589062598|FG001|Overall Study|Did not receive vaccine|2|||
163096014|NCT00551031|589062599|FG002|Overall Study|Did not receive vaccine|0|||
163096015|NCT00551031|589062600|FG003|Overall Study|Did not receive vaccine|0|||
163096016|NCT00551031|589062601|FG004|Overall Study|Did not receive vaccine|0|||
163096017|NCT05554146|589062602|FG000|Overall Study|Adverse Event|0|||
163096018|NCT05554146|589062603|FG001|Overall Study|Adverse Event|1|||
163096019|NCT05554146|589062604|FG002|Overall Study|Adverse Event|0|||
163096020|NCT05554146|589062605|FG003|Overall Study|Adverse Event|0|||
163096021|NCT05554146|589062602|FG000|Overall Study|Protocol Violation|0|||
163096022|NCT05554146|589062603|FG001|Overall Study|Protocol Violation|1|||
163096023|NCT05554146|589062604|FG002|Overall Study|Protocol Violation|0|||
163096024|NCT05554146|589062605|FG003|Overall Study|Protocol Violation|0|||
163096025|NCT05554146|589062602|FG000|Overall Study|No longer interested in participating|0|||
163096026|NCT05554146|589062603|FG001|Overall Study|No longer interested in participating|0|||
163096027|NCT05554146|589062604|FG002|Overall Study|No longer interested in participating|1|||
163096028|NCT05554146|589062605|FG003|Overall Study|No longer interested in participating|0|||
163096029|NCT05554146|589062602|FG000|Overall Study|Lost to Follow-up|1|||
163096030|NCT05554146|589062603|FG001|Overall Study|Lost to Follow-up|0|||
163096031|NCT05554146|589062604|FG002|Overall Study|Lost to Follow-up|0|||
163096032|NCT05554146|589062605|FG003|Overall Study|Lost to Follow-up|0|||
163096033|NCT03073525|589062608|FG000|Overall Study|Withdrawal by Subject|0|||
163096034|NCT03073525|589062609|FG001|Overall Study|Withdrawal by Subject|0|||
163096035|NCT03073525|589062610|FG002|Overall Study|Withdrawal by Subject|3|||
163096036|NCT01976299|589062611|FG000|Overall Study|Withdrawal by Subject|3|||
163096037|NCT01976299|589062612|FG001|Overall Study|Withdrawal by Subject|1|||
163096038|NCT01976299|589062611|FG000|Overall Study|Death|4|||
163096039|NCT01976299|589062612|FG001|Overall Study|Death|2|||
163096040|NCT01976299|589062611|FG000|Overall Study|Lost to Follow-up|7|||
163096041|NCT01976299|589062612|FG001|Overall Study|Lost to Follow-up|1|||
163096042|NCT01976299|589062611|FG000|Overall Study|See clarification above in comments|9|||
163096043|NCT01976299|589062612|FG001|Overall Study|See clarification above in comments|2|||
163096044|NCT01484496|589062614|FG000|Period 1|Protocol Violation|3|||
163096045|NCT01484496|589062615|FG001|Period 1|Protocol Violation|4|||
163096046|NCT01484496|589062616|FG002|Period 1|Protocol Violation|0|||
163096047|NCT01484496|589062617|FG003|Period 1|Protocol Violation|0|||
163096048|NCT01484496|589062614|FG000|Period 1|Physician Decision|5|||
163096049|NCT01484496|589062615|FG001|Period 1|Physician Decision|1|||
163096050|NCT01484496|589062616|FG002|Period 1|Physician Decision|0|||
163096051|NCT01484496|589062617|FG003|Period 1|Physician Decision|0|||
163096052|NCT01484496|589062614|FG000|Period 1|Lack of Efficacy|10|||
163096053|NCT01484496|589062615|FG001|Period 1|Lack of Efficacy|15|||
163096054|NCT01484496|589062616|FG002|Period 1|Lack of Efficacy|0|||
163096055|NCT01484496|589062617|FG003|Period 1|Lack of Efficacy|0|||
163096056|NCT01484496|589062614|FG000|Period 1|Adverse Event|25|||
163096057|NCT01484496|589062615|FG001|Period 1|Adverse Event|40|||
163096058|NCT01484496|589062616|FG002|Period 1|Adverse Event|0|||
163096059|NCT01484496|589062617|FG003|Period 1|Adverse Event|0|||
163096060|NCT01484496|589062614|FG000|Period 1|Withdrawal by Subject|15|||
163096061|NCT01484496|589062615|FG001|Period 1|Withdrawal by Subject|12|||
163096062|NCT01484496|589062616|FG002|Period 1|Withdrawal by Subject|0|||
163096063|NCT01484496|589062617|FG003|Period 1|Withdrawal by Subject|0|||
163096064|NCT01484496|589062614|FG000|Period 1|Lost to Follow-up|2|||
163096065|NCT01484496|589062615|FG001|Period 1|Lost to Follow-up|6|||
163096066|NCT01484496|589062616|FG002|Period 1|Lost to Follow-up|0|||
163096067|NCT01484496|589062617|FG003|Period 1|Lost to Follow-up|0|||
163096068|NCT01484496|589062614|FG000|Period 1|Positive Pregnancy|1|||
163096069|NCT01484496|589062615|FG001|Period 1|Positive Pregnancy|6|||
163096070|NCT01484496|589062616|FG002|Period 1|Positive Pregnancy|0|||
163096071|NCT01484496|589062617|FG003|Period 1|Positive Pregnancy|0|||
163096072|NCT01484496|589062614|FG000|Period 1|Treatment Failure|3|||
163096073|NCT01484496|589062615|FG001|Period 1|Treatment Failure|6|||
163096074|NCT01484496|589062616|FG002|Period 1|Treatment Failure|0|||
163096075|NCT01484496|589062617|FG003|Period 1|Treatment Failure|0|||
163096076|NCT01484496|589062614|FG000|Period 1|Lack of Compliance|2|||
163096077|NCT01484496|589062615|FG001|Period 1|Lack of Compliance|1|||
163096078|NCT01484496|589062616|FG002|Period 1|Lack of Compliance|0|||
163096079|NCT01484496|589062617|FG003|Period 1|Lack of Compliance|0|||
163096080|NCT01484496|589062614|FG000|Period 1|Unable to Visit Site|0|||
163096081|NCT01484496|589062615|FG001|Period 1|Unable to Visit Site|2|||
163096082|NCT01484496|589062616|FG002|Period 1|Unable to Visit Site|0|||
163096083|NCT01484496|589062617|FG003|Period 1|Unable to Visit Site|0|||
163096084|NCT01484496|589062614|FG000|Period 2|Lack of Efficacy|0|||
163096085|NCT01484496|589062615|FG001|Period 2|Lack of Efficacy|0|||
163096086|NCT01484496|589062616|FG002|Period 2|Lack of Efficacy|1|||
163096087|NCT01484496|589062617|FG003|Period 2|Lack of Efficacy|3|||
163096088|NCT01484496|589062614|FG000|Period 2|Adverse Event|0|||
163096089|NCT01484496|589062615|FG001|Period 2|Adverse Event|0|||
163096090|NCT01484496|589062616|FG002|Period 2|Adverse Event|5|||
163096091|NCT01484496|589062617|FG003|Period 2|Adverse Event|13|||
163096092|NCT01484496|589062614|FG000|Period 2|Other|0|||
163096093|NCT01484496|589062615|FG001|Period 2|Other|0|||
163096094|NCT01484496|589062616|FG002|Period 2|Other|9|||
163096095|NCT01484496|589062617|FG003|Period 2|Other|6|||
163096096|NCT01645735|589062618|FG000|Overall Study|Physician Decision|2|||
163096097|NCT01645735|589062619|FG001|Overall Study|Physician Decision|0|||
163096098|NCT01645735|589062618|FG000|Overall Study|Withdrawal by Subject|1|||
163096099|NCT01645735|589062619|FG001|Overall Study|Withdrawal by Subject|0|||
163096100|NCT01645735|589062618|FG000|Overall Study|Protocol Violation|1|||
163096101|NCT01645735|589062619|FG001|Overall Study|Protocol Violation|0|||
163096102|NCT01645735|589062618|FG000|Overall Study|Adverse Event|0|||
163096103|NCT01645735|589062619|FG001|Overall Study|Adverse Event|1|||
163096104|NCT01791517|589062622|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
163096105|NCT01791517|589062623|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
163096106|NCT01791517|589062624|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
163096107|NCT01791517|589062625|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
163096108|NCT01791517|589062626|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
163096109|NCT01791517|589062627|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
163096110|NCT01791517|589062628|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
162652753|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Physician Decision|0|||
163096111|NCT01791517|589062629|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
163096112|NCT01791517|589062630|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
163096113|NCT01791517|589062631|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
163096114|NCT01791517|589062632|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
163096115|NCT01791517|589062633|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
163096116|NCT01791517|589062622|FG000|Phase I: Period 1|Adverse Event|0|||
163096117|NCT01791517|589062623|FG001|Phase I: Period 1|Adverse Event|0|||
162652754|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
163096118|NCT01791517|589062624|FG002|Phase I: Period 1|Adverse Event|1|||
163096119|NCT01791517|589062625|FG003|Phase I: Period 1|Adverse Event|1|||
163096120|NCT01791517|589062626|FG004|Phase I: Period 1|Adverse Event|0|||
163096121|NCT01791517|589062627|FG005|Phase I: Period 1|Adverse Event|0|||
163096122|NCT01791517|589062628|FG006|Phase I: Period 1|Adverse Event|0|||
163096123|NCT01791517|589062629|FG007|Phase I: Period 1|Adverse Event|0|||
163096124|NCT01791517|589062630|FG008|Phase I: Period 1|Adverse Event|0|||
163096125|NCT01791517|589062631|FG009|Phase I: Period 1|Adverse Event|0|||
163096126|NCT01791517|589062632|FG010|Phase I: Period 1|Adverse Event|0|||
163096127|NCT01791517|589062633|FG011|Phase I: Period 1|Adverse Event|0|||
163096128|NCT01791517|589062622|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
162652755|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
163096129|NCT01791517|589062623|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096130|NCT01791517|589062624|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096131|NCT01791517|589062625|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096132|NCT01791517|589062626|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096133|NCT01791517|589062627|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096134|NCT01791517|589062628|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096135|NCT01791517|589062629|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096136|NCT01791517|589062630|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096137|NCT01791517|589062631|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096138|NCT01791517|589062632|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096139|NCT01791517|589062633|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
163096140|NCT01791517|589062622|FG000|Phase I: Period 1|Protocol Violation|0|||
163096141|NCT01791517|589062623|FG001|Phase I: Period 1|Protocol Violation|1|||
163096142|NCT01791517|589062624|FG002|Phase I: Period 1|Protocol Violation|0|||
163096143|NCT01791517|589062625|FG003|Phase I: Period 1|Protocol Violation|0|||
163096144|NCT01791517|589062626|FG004|Phase I: Period 1|Protocol Violation|0|||
162652756|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
162652757|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
162652758|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
162652759|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
162652760|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
162652761|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
162652762|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652763|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652764|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652765|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652766|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652767|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
162652768|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162652769|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
162652770|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162652771|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162652772|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162652773|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162652774|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162652775|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
163096145|NCT01791517|589062627|FG005|Phase I: Period 1|Protocol Violation|0|||
163096146|NCT01791517|589062628|FG006|Phase I: Period 1|Protocol Violation|0|||
163096147|NCT01791517|589062629|FG007|Phase I: Period 1|Protocol Violation|0|||
162652776|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
162652777|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
162652778|NCT02036502|587445574|FG000|Part 3:Dose Expansion|Not Treated|0|||
162652779|NCT02036502|587445575|FG001|Part 3:Dose Expansion|Not Treated|0|||
162652780|NCT02036502|587445576|FG002|Part 3:Dose Expansion|Not Treated|0|||
162652781|NCT02036502|587445577|FG003|Part 3:Dose Expansion|Not Treated|0|||
162652782|NCT02036502|587445578|FG004|Part 3:Dose Expansion|Not Treated|0|||
162652783|NCT02036502|587445579|FG005|Part 3:Dose Expansion|Not Treated|2|||
162652784|NCT02036502|587445580|FG006|Part 3:Dose Expansion|Not Treated|0|||
162652785|NCT02036502|587445581|FG007|Part 3:Dose Expansion|Not Treated|0|||
162652786|NCT00811577|587445587|FG000|Overall Study|Lost to Follow-up|7|||
162652787|NCT00811577|587445588|FG001|Overall Study|Lost to Follow-up|1|||
162652788|NCT00811577|587445587|FG000|Overall Study|Withdrawal by Subject|3|||
162652789|NCT00811577|587445588|FG001|Overall Study|Withdrawal by Subject|0|||
162652790|NCT04011410|587445589|FG000|Overall Study|Withdrawal by Subject|1|||
162652791|NCT01068509|587445590|FG000|Overall Study|Death|0|||
162652792|NCT01068509|587445591|FG001|Overall Study|Death|0|||
162652793|NCT01068509|587445592|FG002|Overall Study|Death|1|||
162652794|NCT01068509|587445590|FG000|Overall Study|Disease Progression|5|||
162652795|NCT01068509|587445591|FG001|Overall Study|Disease Progression|20|||
162652796|NCT01068509|587445592|FG002|Overall Study|Disease Progression|18|||
162652797|NCT01068509|587445590|FG000|Overall Study|Lost to Follow-up|1|||
163096148|NCT01791517|589062630|FG008|Phase I: Period 1|Protocol Violation|0|||
163096149|NCT01791517|589062631|FG009|Phase I: Period 1|Protocol Violation|0|||
162652798|NCT01068509|587445591|FG001|Overall Study|Lost to Follow-up|0|||
162652799|NCT01068509|587445592|FG002|Overall Study|Lost to Follow-up|0|||
162652800|NCT01068509|587445590|FG000|Overall Study|Withdrew Consent|0|||
163096150|NCT01791517|589062632|FG010|Phase I: Period 1|Protocol Violation|0|||
162652801|NCT01068509|587445591|FG001|Overall Study|Withdrew Consent|1|||
162652802|NCT01068509|587445592|FG002|Overall Study|Withdrew Consent|2|||
162652803|NCT01068509|587445590|FG000|Overall Study|Reason Not Specified|0|||
162652804|NCT01068509|587445591|FG001|Overall Study|Reason Not Specified|1|||
162652805|NCT01068509|587445592|FG002|Overall Study|Reason Not Specified|0|||
162652806|NCT01455012|587445593|FG000|Overall Study|Adverse Event|0|||
162652807|NCT01455012|587445594|FG001|Overall Study|Adverse Event|2|||
162652808|NCT01455012|587445593|FG000|Overall Study|Lack of Efficacy|6|||
162652809|NCT01455012|587445594|FG001|Overall Study|Lack of Efficacy|1|||
163096151|NCT01791517|589062633|FG011|Phase I: Period 1|Protocol Violation|0|||
163096152|NCT01791517|589062622|FG000|Phase I: Period 1|Lost to Follow-up|0|||
163096153|NCT01791517|589062623|FG001|Phase I: Period 1|Lost to Follow-up|0|||
163096154|NCT01791517|589062624|FG002|Phase I: Period 1|Lost to Follow-up|0|||
163096155|NCT01791517|589062625|FG003|Phase I: Period 1|Lost to Follow-up|1|||
163096156|NCT01791517|589062626|FG004|Phase I: Period 1|Lost to Follow-up|0|||
163096157|NCT01791517|589062627|FG005|Phase I: Period 1|Lost to Follow-up|0|||
163096158|NCT01791517|589062628|FG006|Phase I: Period 1|Lost to Follow-up|1|||
163096159|NCT01791517|589062629|FG007|Phase I: Period 1|Lost to Follow-up|0|||
163096160|NCT01791517|589062630|FG008|Phase I: Period 1|Lost to Follow-up|1|||
163096161|NCT01791517|589062631|FG009|Phase I: Period 1|Lost to Follow-up|1|||
163096162|NCT01791517|589062632|FG010|Phase I: Period 1|Lost to Follow-up|0|||
163096163|NCT01791517|589062633|FG011|Phase I: Period 1|Lost to Follow-up|0|||
163096164|NCT01791517|589062622|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096165|NCT01791517|589062623|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096166|NCT01791517|589062624|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096167|NCT01791517|589062625|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096168|NCT01791517|589062626|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096169|NCT01791517|589062627|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096170|NCT01791517|589062628|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096171|NCT01791517|589062629|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096172|NCT01791517|589062630|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096173|NCT01791517|589062631|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096174|NCT01791517|589062632|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
163096175|NCT01791517|589062633|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
163096176|NCT01791517|589062622|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
163096177|NCT01791517|589062623|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096178|NCT01791517|589062624|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096179|NCT01791517|589062625|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096180|NCT01791517|589062626|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096181|NCT01791517|589062627|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096182|NCT01791517|589062628|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096183|NCT01791517|589062629|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096184|NCT01791517|589062630|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096185|NCT01791517|589062631|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096186|NCT01791517|589062632|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096187|NCT01791517|589062633|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
163096188|NCT01791517|589062622|FG000|Phase I: Period 2|Protocol Violation|0|||
163096189|NCT01791517|589062623|FG001|Phase I: Period 2|Protocol Violation|0|||
163096190|NCT01791517|589062624|FG002|Phase I: Period 2|Protocol Violation|0|||
163096191|NCT01791517|589062625|FG003|Phase I: Period 2|Protocol Violation|1|||
163096192|NCT01791517|589062626|FG004|Phase I: Period 2|Protocol Violation|0|||
163096193|NCT01791517|589062627|FG005|Phase I: Period 2|Protocol Violation|0|||
163096194|NCT01791517|589062628|FG006|Phase I: Period 2|Protocol Violation|0|||
163096195|NCT01791517|589062629|FG007|Phase I: Period 2|Protocol Violation|0|||
163096196|NCT01791517|589062630|FG008|Phase I: Period 2|Protocol Violation|0|||
162652810|NCT01455012|587445593|FG000|Overall Study|Withdrawal by Subject|3|||
162652811|NCT01455012|587445594|FG001|Overall Study|Withdrawal by Subject|1|||
162652812|NCT01455012|587445593|FG000|Overall Study|Unknown reason|2|||
162652813|NCT01455012|587445594|FG001|Overall Study|Unknown reason|0|||
162652814|NCT01418937|587445597|FG000|Overall Study|Lost to Follow-up|5|||
162652815|NCT01418937|587445597|FG000|Overall Study|Protocol Violation|1|||
162652816|NCT01418937|587445597|FG000|Overall Study|Pregnancy|1|||
162652817|NCT01418937|587445597|FG000|Overall Study|Withdrawal by Subject|1|||
162652818|NCT03323658|587445618|FG000|Overall Study|Adverse Event|0|||
162652819|NCT03323658|587445619|FG001|Overall Study|Adverse Event|1|||
162652820|NCT03323658|587445620|FG002|Overall Study|Adverse Event|0|||
162652821|NCT00615056|587445621|FG000|Overall Study|Death|31|||
162652822|NCT00615056|587445622|FG001|Overall Study|Death|31|||
162652823|NCT00615056|587445623|FG002|Overall Study|Death|21|||
162652824|NCT00615056|587445624|FG003|Overall Study|Death|23|||
162652825|NCT00615056|587445621|FG000|Overall Study|Lost to Follow-up|1|||
163096197|NCT01791517|589062631|FG009|Phase I: Period 2|Protocol Violation|0|||
163096198|NCT01791517|589062632|FG010|Phase I: Period 2|Protocol Violation|0|||
162652826|NCT00615056|587445622|FG001|Overall Study|Lost to Follow-up|2|||
162652827|NCT00615056|587445623|FG002|Overall Study|Lost to Follow-up|4|||
162652828|NCT00615056|587445624|FG003|Overall Study|Lost to Follow-up|5|||
162652829|NCT00615056|587445621|FG000|Overall Study|Other|13|||
162652830|NCT00615056|587445622|FG001|Overall Study|Other|15|||
163096199|NCT01791517|589062633|FG011|Phase I: Period 2|Protocol Violation|0|||
163096200|NCT01791517|589062622|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
163096201|NCT01791517|589062623|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
163096202|NCT01791517|589062624|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
162652831|NCT00615056|587445623|FG002|Overall Study|Other|10|||
163096203|NCT01791517|589062625|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
162652832|NCT00615056|587445624|FG003|Overall Study|Other|7|||
162652833|NCT00615056|587445621|FG000|Overall Study|Objective progression or relapse|0|||
163096204|NCT01791517|589062626|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
163096205|NCT01791517|589062627|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
163096206|NCT01791517|589062628|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
163096207|NCT01791517|589062629|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
163096208|NCT01791517|589062630|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
163096209|NCT01791517|589062631|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
163096210|NCT01791517|589062632|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
163096211|NCT01791517|589062633|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
163096212|NCT01791517|589062622|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096213|NCT01791517|589062623|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096214|NCT01791517|589062624|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096215|NCT01791517|589062625|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096216|NCT01791517|589062626|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096217|NCT01791517|589062627|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096218|NCT01791517|589062628|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096219|NCT01791517|589062629|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096220|NCT01791517|589062630|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096221|NCT01791517|589062631|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096222|NCT01791517|589062632|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
163096223|NCT01791517|589062633|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
163096224|NCT01791517|589062622|FG000|Phase I: Period 2|Lens Discomfort|0|||
163096225|NCT01791517|589062623|FG001|Phase I: Period 2|Lens Discomfort|0|||
163096226|NCT01791517|589062624|FG002|Phase I: Period 2|Lens Discomfort|0|||
163096227|NCT01791517|589062625|FG003|Phase I: Period 2|Lens Discomfort|0|||
163096228|NCT01791517|589062626|FG004|Phase I: Period 2|Lens Discomfort|0|||
163096229|NCT01791517|589062627|FG005|Phase I: Period 2|Lens Discomfort|1|||
163096230|NCT01791517|589062628|FG006|Phase I: Period 2|Lens Discomfort|0|||
163096231|NCT01791517|589062629|FG007|Phase I: Period 2|Lens Discomfort|0|||
163096232|NCT01791517|589062630|FG008|Phase I: Period 2|Lens Discomfort|0|||
163096233|NCT01791517|589062631|FG009|Phase I: Period 2|Lens Discomfort|0|||
163096234|NCT01791517|589062632|FG010|Phase I: Period 2|Lens Discomfort|0|||
163096235|NCT01791517|589062633|FG011|Phase I: Period 2|Lens Discomfort|0|||
163096236|NCT01791517|589062622|FG000|Phase I: Period 2|Lost to Follow-up|0|||
163096237|NCT01791517|589062623|FG001|Phase I: Period 2|Lost to Follow-up|3|||
163096238|NCT01791517|589062624|FG002|Phase I: Period 2|Lost to Follow-up|2|||
163096239|NCT01791517|589062625|FG003|Phase I: Period 2|Lost to Follow-up|0|||
163096240|NCT01791517|589062626|FG004|Phase I: Period 2|Lost to Follow-up|0|||
163096241|NCT01791517|589062627|FG005|Phase I: Period 2|Lost to Follow-up|0|||
163096242|NCT01791517|589062628|FG006|Phase I: Period 2|Lost to Follow-up|0|||
163096243|NCT01791517|589062629|FG007|Phase I: Period 2|Lost to Follow-up|0|||
163096244|NCT01791517|589062630|FG008|Phase I: Period 2|Lost to Follow-up|0|||
163096245|NCT01791517|589062631|FG009|Phase I: Period 2|Lost to Follow-up|0|||
163096246|NCT01791517|589062632|FG010|Phase I: Period 2|Lost to Follow-up|0|||
163096247|NCT01791517|589062633|FG011|Phase I: Period 2|Lost to Follow-up|0|||
163096248|NCT01791517|589062622|FG000|Phase I: Period 3|Lens Discomfort|0|||
163096249|NCT01791517|589062623|FG001|Phase I: Period 3|Lens Discomfort|0|||
163096250|NCT01791517|589062624|FG002|Phase I: Period 3|Lens Discomfort|0|||
163096251|NCT01791517|589062625|FG003|Phase I: Period 3|Lens Discomfort|0|||
163096252|NCT01791517|589062626|FG004|Phase I: Period 3|Lens Discomfort|0|||
163096253|NCT01791517|589062627|FG005|Phase I: Period 3|Lens Discomfort|0|||
163096254|NCT01791517|589062628|FG006|Phase I: Period 3|Lens Discomfort|0|||
163096255|NCT01791517|589062629|FG007|Phase I: Period 3|Lens Discomfort|0|||
163096256|NCT01791517|589062630|FG008|Phase I: Period 3|Lens Discomfort|0|||
163096257|NCT01791517|589062631|FG009|Phase I: Period 3|Lens Discomfort|0|||
163096258|NCT01791517|589062632|FG010|Phase I: Period 3|Lens Discomfort|0|||
162652834|NCT00615056|587445622|FG001|Overall Study|Objective progression or relapse|2|||
162652835|NCT00615056|587445623|FG002|Overall Study|Objective progression or relapse|0|||
162652836|NCT00615056|587445624|FG003|Overall Study|Objective progression or relapse|0|||
162652837|NCT00615056|587445621|FG000|Overall Study|Withdrawal by Subject|0|||
162652838|NCT00615056|587445622|FG001|Overall Study|Withdrawal by Subject|1|||
162652839|NCT00615056|587445623|FG002|Overall Study|Withdrawal by Subject|1|||
163096259|NCT01791517|589062633|FG011|Phase I: Period 3|Lens Discomfort|1|||
163096260|NCT01791517|589062622|FG000|Phase I: Period 3|Lost to Follow-up|0|||
163096261|NCT01791517|589062623|FG001|Phase I: Period 3|Lost to Follow-up|1|||
163096262|NCT01791517|589062624|FG002|Phase I: Period 3|Lost to Follow-up|0|||
163096263|NCT01791517|589062625|FG003|Phase I: Period 3|Lost to Follow-up|0|||
163096264|NCT01791517|589062626|FG004|Phase I: Period 3|Lost to Follow-up|1|||
163096265|NCT01791517|589062627|FG005|Phase I: Period 3|Lost to Follow-up|0|||
163096266|NCT01791517|589062628|FG006|Phase I: Period 3|Lost to Follow-up|0|||
163096267|NCT01791517|589062629|FG007|Phase I: Period 3|Lost to Follow-up|0|||
163096268|NCT01791517|589062630|FG008|Phase I: Period 3|Lost to Follow-up|0|||
163096269|NCT01791517|589062631|FG009|Phase I: Period 3|Lost to Follow-up|0|||
163096270|NCT01791517|589062632|FG010|Phase I: Period 3|Lost to Follow-up|0|||
163096271|NCT01791517|589062633|FG011|Phase I: Period 3|Lost to Follow-up|0|||
163096272|NCT01791517|589062622|FG000|Phase I: Period 3|Adverse Event|0|||
163096273|NCT01791517|589062623|FG001|Phase I: Period 3|Adverse Event|0|||
163096274|NCT01791517|589062624|FG002|Phase I: Period 3|Adverse Event|0|||
163096275|NCT01791517|589062625|FG003|Phase I: Period 3|Adverse Event|1|||
163096276|NCT01791517|589062626|FG004|Phase I: Period 3|Adverse Event|0|||
163096277|NCT01791517|589062627|FG005|Phase I: Period 3|Adverse Event|0|||
163096278|NCT01791517|589062628|FG006|Phase I: Period 3|Adverse Event|0|||
163096279|NCT01791517|589062629|FG007|Phase I: Period 3|Adverse Event|0|||
163096280|NCT01791517|589062630|FG008|Phase I: Period 3|Adverse Event|0|||
163096281|NCT01791517|589062631|FG009|Phase I: Period 3|Adverse Event|0|||
163096282|NCT01791517|589062632|FG010|Phase I: Period 3|Adverse Event|0|||
163096283|NCT01791517|589062633|FG011|Phase I: Period 3|Adverse Event|0|||
163096284|NCT01791517|589062622|FG000|Phase II|Lost to Follow-up|1|||
163096285|NCT01791517|589062623|FG001|Phase II|Lost to Follow-up|0|||
163096286|NCT01791517|589062624|FG002|Phase II|Lost to Follow-up|1|||
163096287|NCT01791517|589062625|FG003|Phase II|Lost to Follow-up|0|||
163096288|NCT01791517|589062626|FG004|Phase II|Lost to Follow-up|1|||
163096289|NCT01791517|589062627|FG005|Phase II|Lost to Follow-up|2|||
163096290|NCT01791517|589062628|FG006|Phase II|Lost to Follow-up|0|||
163096291|NCT01791517|589062629|FG007|Phase II|Lost to Follow-up|1|||
163096292|NCT01791517|589062630|FG008|Phase II|Lost to Follow-up|1|||
162652840|NCT00615056|587445624|FG003|Overall Study|Withdrawal by Subject|0|||
163096293|NCT01791517|589062631|FG009|Phase II|Lost to Follow-up|1|||
163096294|NCT01791517|589062632|FG010|Phase II|Lost to Follow-up|0|||
163096295|NCT01791517|589062633|FG011|Phase II|Lost to Follow-up|0|||
163096296|NCT01791517|589062622|FG000|Phase II|Withdrawal by Subject|1|||
163096297|NCT01791517|589062623|FG001|Phase II|Withdrawal by Subject|0|||
162652841|NCT00615056|587445621|FG000|Overall Study|Discontinued by Sponsor|1|||
162652842|NCT00615056|587445622|FG001|Overall Study|Discontinued by Sponsor|0|||
162652843|NCT00615056|587445623|FG002|Overall Study|Discontinued by Sponsor|0|||
162652844|NCT00615056|587445624|FG003|Overall Study|Discontinued by Sponsor|0|||
162652845|NCT00615056|587445621|FG000|Overall Study|Randomized but not treated|3|||
162652846|NCT00615056|587445622|FG001|Overall Study|Randomized but not treated|0|||
162652847|NCT00615056|587445623|FG002|Overall Study|Randomized but not treated|0|||
163096298|NCT01791517|589062624|FG002|Phase II|Withdrawal by Subject|0|||
163096299|NCT01791517|589062625|FG003|Phase II|Withdrawal by Subject|0|||
163096300|NCT01791517|589062626|FG004|Phase II|Withdrawal by Subject|0|||
163096301|NCT01791517|589062627|FG005|Phase II|Withdrawal by Subject|2|||
163096302|NCT01791517|589062628|FG006|Phase II|Withdrawal by Subject|0|||
163096303|NCT01791517|589062629|FG007|Phase II|Withdrawal by Subject|1|||
163096304|NCT01791517|589062630|FG008|Phase II|Withdrawal by Subject|0|||
163096305|NCT01791517|589062631|FG009|Phase II|Withdrawal by Subject|0|||
163096306|NCT01791517|589062632|FG010|Phase II|Withdrawal by Subject|1|||
163096307|NCT01791517|589062633|FG011|Phase II|Withdrawal by Subject|0|||
163096308|NCT01791517|589062622|FG000|Phase II|Lack of Efficacy|0|||
163096309|NCT01791517|589062623|FG001|Phase II|Lack of Efficacy|0|||
163096310|NCT01791517|589062624|FG002|Phase II|Lack of Efficacy|0|||
163096311|NCT01791517|589062625|FG003|Phase II|Lack of Efficacy|0|||
163096312|NCT01791517|589062626|FG004|Phase II|Lack of Efficacy|1|||
163096313|NCT01791517|589062627|FG005|Phase II|Lack of Efficacy|0|||
163096314|NCT01791517|589062628|FG006|Phase II|Lack of Efficacy|0|||
163096315|NCT01791517|589062629|FG007|Phase II|Lack of Efficacy|0|||
163096316|NCT01791517|589062630|FG008|Phase II|Lack of Efficacy|0|||
163096317|NCT01791517|589062631|FG009|Phase II|Lack of Efficacy|0|||
163096318|NCT01791517|589062632|FG010|Phase II|Lack of Efficacy|0|||
163096319|NCT01791517|589062633|FG011|Phase II|Lack of Efficacy|0|||
163096320|NCT01791517|589062622|FG000|Phase II|Adverse Event|0|||
163096321|NCT01791517|589062623|FG001|Phase II|Adverse Event|0|||
163096322|NCT01791517|589062624|FG002|Phase II|Adverse Event|0|||
163096323|NCT01791517|589062625|FG003|Phase II|Adverse Event|0|||
162719028|NCT02341625|587676742|FG005|Overall Study|Other Reasons|0|||
163096324|NCT01791517|589062626|FG004|Phase II|Adverse Event|0|||
163096325|NCT01791517|589062627|FG005|Phase II|Adverse Event|0|||
163096326|NCT01791517|589062628|FG006|Phase II|Adverse Event|2|||
163096327|NCT01791517|589062629|FG007|Phase II|Adverse Event|1|||
163096328|NCT01791517|589062630|FG008|Phase II|Adverse Event|0|||
163096329|NCT01791517|589062631|FG009|Phase II|Adverse Event|1|||
163096330|NCT01791517|589062632|FG010|Phase II|Adverse Event|0|||
162652848|NCT00615056|587445624|FG003|Overall Study|Randomized but not treated|0|||
162652849|NCT00717769|587445625|FG000|Overall Study|Adverse Event|9|||
162652850|NCT00717769|587445626|FG001|Overall Study|Adverse Event|6|||
163096331|NCT01791517|589062633|FG011|Phase II|Adverse Event|0|||
163096332|NCT01791517|589062622|FG000|Phase II|Lens Handling Difficulties|0|||
163096333|NCT01791517|589062623|FG001|Phase II|Lens Handling Difficulties|0|||
163096334|NCT01791517|589062624|FG002|Phase II|Lens Handling Difficulties|0|||
163096335|NCT01791517|589062625|FG003|Phase II|Lens Handling Difficulties|0|||
163096336|NCT01791517|589062626|FG004|Phase II|Lens Handling Difficulties|0|||
163096337|NCT01791517|589062627|FG005|Phase II|Lens Handling Difficulties|0|||
163096338|NCT01791517|589062628|FG006|Phase II|Lens Handling Difficulties|0|||
163096339|NCT01791517|589062629|FG007|Phase II|Lens Handling Difficulties|0|||
163096340|NCT01791517|589062630|FG008|Phase II|Lens Handling Difficulties|1|||
163096341|NCT01791517|589062631|FG009|Phase II|Lens Handling Difficulties|0|||
163096342|NCT01791517|589062632|FG010|Phase II|Lens Handling Difficulties|0|||
162652851|NCT00717769|587445627|FG002|Overall Study|Adverse Event|1|||
162652852|NCT00717769|587445625|FG000|Overall Study|Lack of compliance|0|||
162652853|NCT00717769|587445626|FG001|Overall Study|Lack of compliance|2|||
162652854|NCT00717769|587445627|FG002|Overall Study|Lack of compliance|0|||
162652855|NCT00717769|587445625|FG000|Overall Study|Lost to Follow-up|3|||
162652856|NCT00717769|587445626|FG001|Overall Study|Lost to Follow-up|4|||
162652857|NCT00717769|587445627|FG002|Overall Study|Lost to Follow-up|0|||
162652858|NCT00717769|587445625|FG000|Overall Study|Lack of Efficacy|1|||
162652859|NCT00717769|587445626|FG001|Overall Study|Lack of Efficacy|2|||
162652860|NCT00717769|587445627|FG002|Overall Study|Lack of Efficacy|0|||
162652861|NCT00717769|587445625|FG000|Overall Study|Protocol Violation|0|||
162652862|NCT00717769|587445626|FG001|Overall Study|Protocol Violation|2|||
162652863|NCT00717769|587445627|FG002|Overall Study|Protocol Violation|0|||
162652864|NCT00717769|587445625|FG000|Overall Study|Sponsor decision|1|||
162652865|NCT00717769|587445626|FG001|Overall Study|Sponsor decision|0|||
162652866|NCT00717769|587445627|FG002|Overall Study|Sponsor decision|10|||
162652867|NCT00717769|587445625|FG000|Overall Study|Withdrew consent|2|||
162652868|NCT00717769|587445626|FG001|Overall Study|Withdrew consent|2|||
162652869|NCT00717769|587445627|FG002|Overall Study|Withdrew consent|0|||
162652870|NCT01380184|587445630|FG000|Part 1 (19 Days)|Adverse Event|1|||
162652871|NCT01380184|587445630|FG000|Part 2|Adverse Event|5|||
162652872|NCT01380184|587445630|FG000|Part 2|Disease Progression|8|||
162652873|NCT01380184|587445630|FG000|Part 2|Lost to Follow-up|1|||
162652874|NCT04327986|587445633|FG000|Overall Study|Physician Decision|2|||
162652875|NCT04327986|587445634|FG001|Overall Study|Physician Decision|0|||
162652876|NCT04327986|587445635|FG002|Overall Study|Physician Decision|0|||
162652877|NCT04327986|587445633|FG000|Overall Study|Death|1|||
162652878|NCT04327986|587445634|FG001|Overall Study|Death|0|||
162652879|NCT04327986|587445635|FG002|Overall Study|Death|0|||
162652880|NCT03350503|587445636|FG000|Overall Study|Adverse Event|5|||
162652881|NCT03350503|587445636|FG000|Overall Study|Withdrawal by Subject|5|||
162652882|NCT03350503|587445636|FG000|Overall Study|Continuation impossible due to move|4|||
162652883|NCT03350503|587445636|FG000|Overall Study|Physician Decision|3|||
162652884|NCT03829046|587445641|FG000|Overall Study|Withdrawal by Subject|1|||
162652885|NCT03829046|587445642|FG001|Overall Study|Withdrawal by Subject|0|||
162652886|NCT00262067|587445643|FG000|Overall Study|Death|190|||
162652887|NCT00262067|587445644|FG001|Overall Study|Death|89|||
162652888|NCT00262067|587445645|FG002|Overall Study|Death|186|||
162652889|NCT00262067|587445646|FG003|Overall Study|Death|99|||
162652890|NCT00262067|587445643|FG000|Overall Study|Lost to Follow-up|5|||
162652891|NCT00262067|587445644|FG001|Overall Study|Lost to Follow-up|4|||
162652892|NCT00262067|587445645|FG002|Overall Study|Lost to Follow-up|7|||
162652893|NCT00262067|587445646|FG003|Overall Study|Lost to Follow-up|5|||
162652894|NCT00262067|587445643|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
162652895|NCT00262067|587445644|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
162652896|NCT00262067|587445645|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
162652897|NCT00262067|587445646|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
162652898|NCT00262067|587445643|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
162652899|NCT00262067|587445644|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
162652900|NCT00262067|587445645|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
162652901|NCT00262067|587445646|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
162652902|NCT04804813|587445649|FG000|Overall Study|Protocol Violation|2|||
162652903|NCT04804813|587445650|FG001|Overall Study|Protocol Violation|0|||
162652904|NCT04804813|587445649|FG000|Overall Study|Withdrawal by Subject|1|||
163096343|NCT01791517|589062633|FG011|Phase II|Lens Handling Difficulties|0|||
163096344|NCT01791517|589062622|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
163096345|NCT01791517|589062623|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
163096346|NCT01791517|589062624|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
163096347|NCT01791517|589062625|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
163096348|NCT01791517|589062626|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
162652905|NCT04804813|587445650|FG001|Overall Study|Withdrawal by Subject|0|||
162652906|NCT01581593|587447456|FG000|Overall Study|Withdrawal by Subject|1|||
162652907|NCT01101841|587447457|FG000|Overall Study|Adverse Event|15|||
162652908|NCT01101841|587447458|FG001|Overall Study|Adverse Event|15|||
163096349|NCT01791517|589062627|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
163096350|NCT01791517|589062628|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
162652909|NCT01101841|587447457|FG000|Overall Study|Lost to Follow-up|9|||
162652910|NCT01101841|587447458|FG001|Overall Study|Lost to Follow-up|3|||
162652911|NCT01101841|587447457|FG000|Overall Study|Withdrawal by Subject|21|||
162652912|NCT01101841|587447458|FG001|Overall Study|Withdrawal by Subject|40|||
162652913|NCT01101841|587447457|FG000|Overall Study|Protocol Violation|1|||
162652914|NCT01101841|587447458|FG001|Overall Study|Protocol Violation|1|||
162652915|NCT01101841|587447457|FG000|Overall Study|Physician Decision|0|||
162652916|NCT01101841|587447458|FG001|Overall Study|Physician Decision|2|||
162652917|NCT01101841|587447457|FG000|Overall Study|Lack of Efficacy|0|||
162652918|NCT01101841|587447458|FG001|Overall Study|Lack of Efficacy|2|||
162652919|NCT01101841|587447457|FG000|Overall Study|Other|0|||
162652920|NCT01101841|587447458|FG001|Overall Study|Other|1|||
162652921|NCT01101841|587447457|FG000|Overall Study|Suicidality Tracking Scale|3|||
162652922|NCT01101841|587447458|FG001|Overall Study|Suicidality Tracking Scale|1|||
162652923|NCT01101841|587447457|FG000|Overall Study|Eligibility Criteria|1|||
163096351|NCT01791517|589062629|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
163096352|NCT01791517|589062630|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
163096353|NCT01791517|589062631|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
163096354|NCT01791517|589062632|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
163096355|NCT01791517|589062633|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
163096356|NCT01791517|589062622|FG000|Phase II|Pre-Existing Ocular Issue|0|||
163096357|NCT01791517|589062623|FG001|Phase II|Pre-Existing Ocular Issue|0|||
163096358|NCT01791517|589062624|FG002|Phase II|Pre-Existing Ocular Issue|0|||
163096359|NCT01791517|589062625|FG003|Phase II|Pre-Existing Ocular Issue|0|||
163096360|NCT01791517|589062626|FG004|Phase II|Pre-Existing Ocular Issue|0|||
163096361|NCT01791517|589062627|FG005|Phase II|Pre-Existing Ocular Issue|0|||
163096362|NCT01791517|589062628|FG006|Phase II|Pre-Existing Ocular Issue|0|||
163096363|NCT01791517|589062629|FG007|Phase II|Pre-Existing Ocular Issue|0|||
163096364|NCT01791517|589062630|FG008|Phase II|Pre-Existing Ocular Issue|0|||
163096365|NCT01791517|589062631|FG009|Phase II|Pre-Existing Ocular Issue|0|||
163096366|NCT01791517|589062632|FG010|Phase II|Pre-Existing Ocular Issue|0|||
163096367|NCT01791517|589062633|FG011|Phase II|Pre-Existing Ocular Issue|1|||
163096368|NCT00589797|589062634|FG000|Overall Study|Death|1|||
163096369|NCT00589797|589062635|FG001|Overall Study|Death|0|||
163096370|NCT00589797|589062634|FG000|Overall Study|Lost to Follow-up|12|||
163096371|NCT00589797|589062635|FG001|Overall Study|Lost to Follow-up|9|||
163096372|NCT00589797|589062634|FG000|Overall Study|Physician Decision|8|||
163096373|NCT00589797|589062635|FG001|Overall Study|Physician Decision|3|||
163096374|NCT00589797|589062634|FG000|Overall Study|Withdrawal by Subject|6|||
163096375|NCT00589797|589062635|FG001|Overall Study|Withdrawal by Subject|5|||
163096376|NCT00589797|589062634|FG000|Overall Study|Non-Randomized Training Subjects|46|||
163096377|NCT00589797|589062635|FG001|Overall Study|Non-Randomized Training Subjects|6|||
163096378|NCT02141672|589062637|FG000|Overall Study|Adverse Event|0|||
163096379|NCT02141672|589062638|FG001|Overall Study|Adverse Event|1|||
163096380|NCT02141672|589062639|FG002|Overall Study|Adverse Event|0|||
163096381|NCT02141672|589062637|FG000|Overall Study|Death|10|||
163096382|NCT02141672|589062638|FG001|Overall Study|Death|2|||
163096383|NCT02141672|589062639|FG002|Overall Study|Death|1|||
163096384|NCT02141672|589062637|FG000|Overall Study|Lack of Efficacy|0|||
163096385|NCT02141672|589062638|FG001|Overall Study|Lack of Efficacy|0|||
163096386|NCT02141672|589062639|FG002|Overall Study|Lack of Efficacy|2|||
163096387|NCT02141672|589062637|FG000|Overall Study|Lost to Follow-up|1|||
163096388|NCT02141672|589062638|FG001|Overall Study|Lost to Follow-up|1|||
163096389|NCT02141672|589062639|FG002|Overall Study|Lost to Follow-up|3|||
163096390|NCT02141672|589062637|FG000|Overall Study|Physician Decision|1|||
163096391|NCT02141672|589062638|FG001|Overall Study|Physician Decision|2|||
163096392|NCT02141672|589062639|FG002|Overall Study|Physician Decision|5|||
163096393|NCT02141672|589062637|FG000|Overall Study|Protocol Violation|0|||
163096394|NCT02141672|589062638|FG001|Overall Study|Protocol Violation|0|||
163096395|NCT02141672|589062639|FG002|Overall Study|Protocol Violation|1|||
163096396|NCT02141672|589062637|FG000|Overall Study|Withdrawal by Subject|3|||
163096397|NCT02141672|589062638|FG001|Overall Study|Withdrawal by Subject|2|||
163096398|NCT02141672|589062639|FG002|Overall Study|Withdrawal by Subject|5|||
163096399|NCT02141672|589062637|FG000|Overall Study|refused to follow-up|1|||
163096400|NCT02141672|589062638|FG001|Overall Study|refused to follow-up|0|||
163096401|NCT02141672|589062639|FG002|Overall Study|refused to follow-up|1|||
163096402|NCT02688192|589062640|FG000|Overall Study|Lost to Follow-up|11|||
163096403|NCT02688192|589062641|FG001|Overall Study|Lost to Follow-up|5|||
163096404|NCT02688192|589062640|FG000|Overall Study|Physician Decision|1|||
163096405|NCT02688192|589062641|FG001|Overall Study|Physician Decision|0|||
163096406|NCT01773967|589062642|FG000|Overall Study|Lost to Follow-up|15|||
163096407|NCT01773967|589062643|FG001|Overall Study|Lost to Follow-up|13|||
163096408|NCT00579553|589062647|FG000|Overall Study|Lost to Follow-up|16|||
163096409|NCT00579553|589062648|FG001|Overall Study|Lost to Follow-up|13|||
163096410|NCT04860869|589062653|FG000|Overall Study|Withdrawal by Subject|1|||
163096411|NCT04860869|589062654|FG001|Overall Study|Withdrawal by Subject|0|||
163096412|NCT01775553|589062655|FG000|Overall Study|Adverse Event|1|||
163096413|NCT01775553|589062655|FG000|Overall Study|Disease Progression|12|||
163096414|NCT00590967|589062665|FG000|Overall Study|Withdrawal by Subject|1|||
162652924|NCT01101841|587447458|FG001|Overall Study|Eligibility Criteria|2|||
162652925|NCT00653224|587447459|FG000|Overall Study|Adverse Event|2|||
163096415|NCT00590967|589062666|FG001|Overall Study|Withdrawal by Subject|1|||
163096416|NCT00590967|589062665|FG000|Overall Study|Ineligible|1|||
163096417|NCT00590967|589062666|FG001|Overall Study|Ineligible|0|||
163096418|NCT00590967|589062665|FG000|Overall Study|Poor performance status|0|||
163096419|NCT00590967|589062666|FG001|Overall Study|Poor performance status|1|||
163096420|NCT00590967|589062665|FG000|Overall Study|Non-compliant|0|||
163096421|NCT00590967|589062666|FG001|Overall Study|Non-compliant|2|||
163096422|NCT00590967|589062665|FG000|Overall Study|Did not sign consent form|0|||
163096423|NCT00590967|589062666|FG001|Overall Study|Did not sign consent form|1|||
163096424|NCT00590967|589062665|FG000|Overall Study|Did not receive chemo per protocol|1|||
162652926|NCT00653224|587447460|FG001|Overall Study|Adverse Event|1|||
162652927|NCT00653224|587447459|FG000|Overall Study|Lack of Efficacy|1|||
162652928|NCT00653224|587447460|FG001|Overall Study|Lack of Efficacy|2|||
162652929|NCT00653224|587447459|FG000|Overall Study|Loss of efficacy|1|||
162652930|NCT00653224|587447460|FG001|Overall Study|Loss of efficacy|0|||
162652931|NCT00653224|587447459|FG000|Overall Study|Lost to Follow-up|1|||
162652932|NCT00653224|587447460|FG001|Overall Study|Lost to Follow-up|0|||
162652933|NCT00653224|587447459|FG000|Overall Study|Other|2|||
162652934|NCT00653224|587447460|FG001|Overall Study|Other|4|||
162652935|NCT03756558|587447461|FG000|Overall Study|Death|1|||
162652936|NCT03756558|587447461|FG000|Overall Study|Lost to Follow-up|2|||
162652937|NCT03756558|587447461|FG000|Overall Study|Withdrawal by Subject|2|||
162652938|NCT02896400|587447462|FG000|1 Month Follow-up|Lost to Follow-up|7|||
162652939|NCT02896400|587447463|FG001|1 Month Follow-up|Lost to Follow-up|7|||
162652940|NCT02896400|587447464|FG002|1 Month Follow-up|Lost to Follow-up|5|||
163096425|NCT00590967|589062666|FG001|Overall Study|Did not receive chemo per protocol|0|||
162652941|NCT02896400|587447465|FG003|1 Month Follow-up|Lost to Follow-up|8|||
162652942|NCT02896400|587447466|FG004|1 Month Follow-up|Lost to Follow-up|9|||
162652943|NCT02896400|587447467|FG005|1 Month Follow-up|Lost to Follow-up|6|||
162652944|NCT02896400|587447468|FG006|1 Month Follow-up|Lost to Follow-up|5|||
162652945|NCT02896400|587447469|FG007|1 Month Follow-up|Lost to Follow-up|6|||
162652946|NCT02896400|587447470|FG008|1 Month Follow-up|Lost to Follow-up|4|||
162652947|NCT02896400|587447471|FG009|1 Month Follow-up|Lost to Follow-up|7|||
162652948|NCT02896400|587447472|FG010|1 Month Follow-up|Lost to Follow-up|5|||
163096426|NCT01881789|589062667|FG000|Overall Study|Withdrawal by Subject|0|||
163096427|NCT01881789|589062668|FG001|Overall Study|Withdrawal by Subject|2|||
163096428|NCT01881789|589062669|FG002|Overall Study|Withdrawal by Subject|1|||
162652949|NCT02896400|587447473|FG011|1 Month Follow-up|Lost to Follow-up|5|||
162652950|NCT02896400|587447474|FG012|1 Month Follow-up|Lost to Follow-up|3|||
162652951|NCT02896400|587447475|FG013|1 Month Follow-up|Lost to Follow-up|4|||
162652952|NCT02896400|587447476|FG014|1 Month Follow-up|Lost to Follow-up|1|||
162652953|NCT02896400|587447477|FG015|1 Month Follow-up|Lost to Follow-up|2|||
162652954|NCT02896400|587447462|FG000|1 Month Follow-up|Death|0|||
162652955|NCT02896400|587447463|FG001|1 Month Follow-up|Death|0|||
162652956|NCT02896400|587447464|FG002|1 Month Follow-up|Death|0|||
162652957|NCT02896400|587447465|FG003|1 Month Follow-up|Death|0|||
162652958|NCT02896400|587447466|FG004|1 Month Follow-up|Death|0|||
162652959|NCT02896400|587447467|FG005|1 Month Follow-up|Death|0|||
162652960|NCT02896400|587447468|FG006|1 Month Follow-up|Death|0|||
162652961|NCT02896400|587447469|FG007|1 Month Follow-up|Death|0|||
162652962|NCT02896400|587447470|FG008|1 Month Follow-up|Death|0|||
162652963|NCT02896400|587447471|FG009|1 Month Follow-up|Death|0|||
162652964|NCT02896400|587447472|FG010|1 Month Follow-up|Death|0|||
162652965|NCT02896400|587447473|FG011|1 Month Follow-up|Death|0|||
162652966|NCT02896400|587447474|FG012|1 Month Follow-up|Death|0|||
162652967|NCT02896400|587447475|FG013|1 Month Follow-up|Death|0|||
163096429|NCT01881789|589062670|FG003|Overall Study|Withdrawal by Subject|0|||
163096430|NCT01881789|589062671|FG004|Overall Study|Withdrawal by Subject|1|||
163096431|NCT01881789|589062672|FG005|Overall Study|Withdrawal by Subject|1|||
163096432|NCT01881789|589062667|FG000|Overall Study|Study Terminated by Sponsor|0|||
163096433|NCT01881789|589062668|FG001|Overall Study|Study Terminated by Sponsor|0|||
163096434|NCT01881789|589062669|FG002|Overall Study|Study Terminated by Sponsor|0|||
163096435|NCT01881789|589062670|FG003|Overall Study|Study Terminated by Sponsor|0|||
163096436|NCT01881789|589062671|FG004|Overall Study|Study Terminated by Sponsor|0|||
163096437|NCT01881789|589062672|FG005|Overall Study|Study Terminated by Sponsor|1|||
163096438|NCT01881789|589062667|FG000|Overall Study|Other|3|||
163096439|NCT01881789|589062668|FG001|Overall Study|Other|5|||
163096440|NCT01881789|589062669|FG002|Overall Study|Other|2|||
163096441|NCT01881789|589062670|FG003|Overall Study|Other|3|||
163096442|NCT01881789|589062671|FG004|Overall Study|Other|1|||
163096443|NCT01881789|589062672|FG005|Overall Study|Other|1|||
163096444|NCT00920556|589062673|FG000|Overall Study|Adverse Event|16|||
163096445|NCT00920556|589062673|FG000|Overall Study|Physician Decision|7|||
163096446|NCT00920556|589062673|FG000|Overall Study|Withdrawal by Subject|1|||
163096447|NCT01299389|589062674|FG000|Double-blind|Adverse Event|45|||
162652968|NCT02896400|587447476|FG014|1 Month Follow-up|Death|0|||
162652969|NCT02896400|587447477|FG015|1 Month Follow-up|Death|1|||
162652970|NCT02896400|587447462|FG000|3 Month Follow-up|Lost to Follow-up|6|||
162652971|NCT02896400|587447463|FG001|3 Month Follow-up|Lost to Follow-up|3|||
162652972|NCT02896400|587447464|FG002|3 Month Follow-up|Lost to Follow-up|6|||
162652973|NCT02896400|587447465|FG003|3 Month Follow-up|Lost to Follow-up|11|||
162652974|NCT02896400|587447466|FG004|3 Month Follow-up|Lost to Follow-up|12|||
162652975|NCT02896400|587447467|FG005|3 Month Follow-up|Lost to Follow-up|6|||
162652976|NCT02896400|587447468|FG006|3 Month Follow-up|Lost to Follow-up|4|||
163096448|NCT01299389|589062675|FG001|Double-blind|Adverse Event|27|||
163096449|NCT01299389|589062676|FG002|Double-blind|Adverse Event|0|||
163096450|NCT01299389|589062677|FG003|Double-blind|Adverse Event|0|||
163096451|NCT01299389|589062674|FG000|Double-blind|Lack of Efficacy|45|||
163096452|NCT01299389|589062675|FG001|Double-blind|Lack of Efficacy|21|||
163096453|NCT01299389|589062676|FG002|Double-blind|Lack of Efficacy|0|||
163096454|NCT01299389|589062677|FG003|Double-blind|Lack of Efficacy|0|||
163096455|NCT01299389|589062674|FG000|Double-blind|Lost to Follow-up|2|||
163096456|NCT01299389|589062675|FG001|Double-blind|Lost to Follow-up|1|||
163096457|NCT01299389|589062676|FG002|Double-blind|Lost to Follow-up|0|||
163096458|NCT01299389|589062677|FG003|Double-blind|Lost to Follow-up|0|||
163096459|NCT01299389|589062674|FG000|Double-blind|Withdrawal by Subject|16|||
163096460|NCT01299389|589062675|FG001|Double-blind|Withdrawal by Subject|13|||
163096461|NCT01299389|589062676|FG002|Double-blind|Withdrawal by Subject|0|||
163096462|NCT01299389|589062677|FG003|Double-blind|Withdrawal by Subject|0|||
163096463|NCT01299389|589062674|FG000|Double-blind|Other|1|||
163096464|NCT01299389|589062675|FG001|Double-blind|Other|1|||
163096465|NCT01299389|589062676|FG002|Double-blind|Other|0|||
163096466|NCT01299389|589062677|FG003|Double-blind|Other|0|||
163096467|NCT01299389|589062674|FG000|Double-blind|"fail to meet study population criteria"|0|||
163096468|NCT01299389|589062675|FG001|Double-blind|"fail to meet study population criteria"|1|||
163096469|NCT01299389|589062676|FG002|Double-blind|"fail to meet study population criteria"|0|||
163096470|NCT01299389|589062677|FG003|Double-blind|"fail to meet study population criteria"|0|||
163096471|NCT01299389|589062674|FG000|Post-observational|Other|0|||
163096472|NCT01299389|589062675|FG001|Post-observational|Other|0|||
163096473|NCT01299389|589062676|FG002|Post-observational|Other|12|||
163096474|NCT01299389|589062677|FG003|Post-observational|Other|6|||
163096475|NCT02834819|589062678|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
163096476|NCT02834819|589062679|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
163096477|NCT03637491|589062680|FG000|Overall Study|Death|9|||
163096478|NCT03637491|589062681|FG001|Overall Study|Death|9|||
163096479|NCT03637491|589062682|FG002|Overall Study|Death|5|||
163096480|NCT03637491|589062683|FG003|Overall Study|Death|3|||
163096481|NCT03637491|589062680|FG000|Overall Study|Lost to Follow-up|0|||
163096482|NCT03637491|589062681|FG001|Overall Study|Lost to Follow-up|1|||
163096483|NCT03637491|589062682|FG002|Overall Study|Lost to Follow-up|0|||
163096484|NCT03637491|589062683|FG003|Overall Study|Lost to Follow-up|1|||
163096485|NCT03637491|589062680|FG000|Overall Study|Study Terminated By Sponsor|0|||
163096486|NCT03637491|589062681|FG001|Overall Study|Study Terminated By Sponsor|2|||
163096487|NCT03637491|589062682|FG002|Overall Study|Study Terminated By Sponsor|1|||
163096488|NCT03637491|589062683|FG003|Overall Study|Study Terminated By Sponsor|0|||
163096489|NCT03637491|589062680|FG000|Overall Study|Withdrawal by Subject|1|||
163096490|NCT03637491|589062681|FG001|Overall Study|Withdrawal by Subject|0|||
163096491|NCT03637491|589062682|FG002|Overall Study|Withdrawal by Subject|1|||
163096492|NCT03637491|589062683|FG003|Overall Study|Withdrawal by Subject|2|||
163096493|NCT02185534|589062684|FG000|First Period|Withdrawal by Subject|0|||
163096494|NCT02185534|589062685|FG001|First Period|Withdrawal by Subject|0|||
163096495|NCT02185534|589062686|FG002|First Period|Withdrawal by Subject|0|||
163096496|NCT02185534|589062687|FG003|First Period|Withdrawal by Subject|1|||
163096497|NCT02185534|589062688|FG004|First Period|Withdrawal by Subject|0|||
163096498|NCT02185534|589062689|FG005|First Period|Withdrawal by Subject|0|||
163096499|NCT02185534|589062684|FG000|First Washout Period|Withdrawal by Subject|1|||
163096500|NCT02185534|589062685|FG001|First Washout Period|Withdrawal by Subject|0|||
163096501|NCT02185534|589062686|FG002|First Washout Period|Withdrawal by Subject|0|||
162652977|NCT02896400|587447469|FG007|3 Month Follow-up|Lost to Follow-up|3|||
162652978|NCT02896400|587447470|FG008|3 Month Follow-up|Lost to Follow-up|6|||
162652979|NCT02896400|587447471|FG009|3 Month Follow-up|Lost to Follow-up|5|||
162652980|NCT02896400|587447472|FG010|3 Month Follow-up|Lost to Follow-up|6|||
162652981|NCT02896400|587447473|FG011|3 Month Follow-up|Lost to Follow-up|6|||
162652982|NCT02896400|587447474|FG012|3 Month Follow-up|Lost to Follow-up|3|||
162652983|NCT02896400|587447475|FG013|3 Month Follow-up|Lost to Follow-up|5|||
162652984|NCT02896400|587447476|FG014|3 Month Follow-up|Lost to Follow-up|3|||
162652985|NCT02896400|587447477|FG015|3 Month Follow-up|Lost to Follow-up|2|||
162652986|NCT02896400|587447462|FG000|3 Month Follow-up|Death|0|||
162652987|NCT02896400|587447463|FG001|3 Month Follow-up|Death|0|||
162652988|NCT02896400|587447464|FG002|3 Month Follow-up|Death|0|||
162652989|NCT02896400|587447465|FG003|3 Month Follow-up|Death|0|||
163096502|NCT02185534|589062687|FG003|First Washout Period|Withdrawal by Subject|0|||
163096503|NCT02185534|589062688|FG004|First Washout Period|Withdrawal by Subject|1|||
163096504|NCT02185534|589062689|FG005|First Washout Period|Withdrawal by Subject|0|||
163096505|NCT02185534|589062684|FG000|First Washout Period|Protocol Violation|0|||
163096506|NCT02185534|589062685|FG001|First Washout Period|Protocol Violation|0|||
163096507|NCT02185534|589062686|FG002|First Washout Period|Protocol Violation|0|||
163096508|NCT02185534|589062687|FG003|First Washout Period|Protocol Violation|0|||
163096509|NCT02185534|589062688|FG004|First Washout Period|Protocol Violation|0|||
163096510|NCT02185534|589062689|FG005|First Washout Period|Protocol Violation|1|||
163096511|NCT04179305|589062697|FG000|Overall Study|Death|1|||
163096512|NCT04179305|589062698|FG001|Overall Study|Death|1|||
163096513|NCT04179305|589062699|FG002|Overall Study|Death|0|||
163096514|NCT04179305|589062700|FG003|Overall Study|Death|0|||
162652990|NCT02896400|587447466|FG004|3 Month Follow-up|Death|0|||
163096515|NCT04179305|589062697|FG000|Overall Study|Lost to Follow-up|1|||
162652991|NCT02896400|587447467|FG005|3 Month Follow-up|Death|0|||
163096516|NCT04179305|589062698|FG001|Overall Study|Lost to Follow-up|1|||
163096517|NCT04179305|589062699|FG002|Overall Study|Lost to Follow-up|0|||
163096518|NCT04179305|589062700|FG003|Overall Study|Lost to Follow-up|0|||
163096519|NCT04179305|589062697|FG000|Overall Study|Withdrawal by Subject|0|||
163096520|NCT04179305|589062698|FG001|Overall Study|Withdrawal by Subject|1|||
163096521|NCT04179305|589062699|FG002|Overall Study|Withdrawal by Subject|0|||
163096522|NCT04179305|589062700|FG003|Overall Study|Withdrawal by Subject|0|||
163096523|NCT04179305|589062697|FG000|Overall Study|Did not have scan|1|||
163096524|NCT04179305|589062698|FG001|Overall Study|Did not have scan|0|||
163096525|NCT04179305|589062699|FG002|Overall Study|Did not have scan|0|||
162652992|NCT02896400|587447468|FG006|3 Month Follow-up|Death|0|||
162652993|NCT02896400|587447469|FG007|3 Month Follow-up|Death|0|||
162652994|NCT02896400|587447470|FG008|3 Month Follow-up|Death|0|||
162652995|NCT02896400|587447471|FG009|3 Month Follow-up|Death|0|||
162652996|NCT02896400|587447472|FG010|3 Month Follow-up|Death|0|||
162652997|NCT02896400|587447473|FG011|3 Month Follow-up|Death|0|||
162652998|NCT02896400|587447474|FG012|3 Month Follow-up|Death|0|||
162652999|NCT02896400|587447475|FG013|3 Month Follow-up|Death|1|||
162653000|NCT02896400|587447476|FG014|3 Month Follow-up|Death|1|||
162653001|NCT02896400|587447477|FG015|3 Month Follow-up|Death|0|||
162653002|NCT02896400|587447462|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653003|NCT02896400|587447463|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162653004|NCT02896400|587447464|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653005|NCT02896400|587447465|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653006|NCT02896400|587447466|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162653007|NCT02896400|587447467|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653008|NCT02896400|587447468|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
162653009|NCT02896400|587447469|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
162653010|NCT02896400|587447470|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653011|NCT02896400|587447471|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653012|NCT02896400|587447472|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162653013|NCT02896400|587447473|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162653014|NCT02896400|587447474|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653015|NCT02896400|587447475|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162653016|NCT02896400|587447476|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
162653017|NCT02896400|587447477|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162653018|NCT02896400|587447462|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
162653019|NCT02896400|587447463|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162653020|NCT02896400|587447464|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
162653021|NCT02896400|587447465|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
162653022|NCT02896400|587447466|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
162653023|NCT02896400|587447467|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162653024|NCT02896400|587447468|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162653025|NCT02896400|587447469|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
162653026|NCT02896400|587447470|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
162653027|NCT02896400|587447471|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
163096526|NCT04179305|589062700|FG003|Overall Study|Did not have scan|0|||
163096527|NCT04179305|589062697|FG000|Overall Study|In hospice care|3|||
163096528|NCT04179305|589062698|FG001|Overall Study|In hospice care|0|||
163096529|NCT04179305|589062699|FG002|Overall Study|In hospice care|0|||
163096530|NCT04179305|589062700|FG003|Overall Study|In hospice care|0|||
163096531|NCT01737762|589062703|FG000|Overall Study|Adverse Event|2|||
163096532|NCT01737762|589062704|FG001|Overall Study|Adverse Event|2|||
163096533|NCT01737762|589062703|FG000|Overall Study|Lost to Follow-up|1|||
163096534|NCT01737762|589062704|FG001|Overall Study|Lost to Follow-up|0|||
163096535|NCT01737762|589062703|FG000|Overall Study|Withdrawal by Subject|2|||
163096536|NCT01737762|589062704|FG001|Overall Study|Withdrawal by Subject|2|||
163096537|NCT01737762|589062703|FG000|Overall Study|Progressive disease|1|||
163096538|NCT01737762|589062704|FG001|Overall Study|Progressive disease|2|||
163096539|NCT01737762|589062703|FG000|Overall Study|Physician Decision|1|||
163096540|NCT01737762|589062704|FG001|Overall Study|Physician Decision|1|||
163096541|NCT01737762|589062703|FG000|Overall Study|Moved from area|2|||
163096542|NCT01737762|589062704|FG001|Overall Study|Moved from area|1|||
162653028|NCT02896400|587447472|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
162653029|NCT02896400|587447473|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
163096543|NCT01737762|589062703|FG000|Overall Study|Trial termination|11|||
163096544|NCT01737762|589062704|FG001|Overall Study|Trial termination|9|||
163096545|NCT00326599|589062705|FG000|Overall Study|Withdrawal by Subject|1|||
163096546|NCT00326599|589062706|FG001|Overall Study|Withdrawal by Subject|0|||
163096547|NCT00326599|589062707|FG002|Overall Study|Withdrawal by Subject|5|||
163096548|NCT00326599|589062708|FG003|Overall Study|Withdrawal by Subject|2|||
163096549|NCT00326599|589062705|FG000|Overall Study|Adverse Event|1|||
163096550|NCT00326599|589062706|FG001|Overall Study|Adverse Event|0|||
163096551|NCT00326599|589062707|FG002|Overall Study|Adverse Event|32|||
163096552|NCT00326599|589062708|FG003|Overall Study|Adverse Event|3|||
163096553|NCT00326599|589062705|FG000|Overall Study|Disease Progression|3|||
163096554|NCT00326599|589062706|FG001|Overall Study|Disease Progression|1|||
163096555|NCT00326599|589062707|FG002|Overall Study|Disease Progression|13|||
163096556|NCT00326599|589062708|FG003|Overall Study|Disease Progression|11|||
163096557|NCT00326599|589062705|FG000|Overall Study|Alternate Treatment|1|||
163096558|NCT00326599|589062706|FG001|Overall Study|Alternate Treatment|0|||
163096559|NCT00326599|589062707|FG002|Overall Study|Alternate Treatment|0|||
163096560|NCT00326599|589062708|FG003|Overall Study|Alternate Treatment|0|||
163096561|NCT00326599|589062705|FG000|Overall Study|Death|0|||
163096562|NCT00326599|589062706|FG001|Overall Study|Death|0|||
163096563|NCT00326599|589062707|FG002|Overall Study|Death|1|||
163096564|NCT00326599|589062708|FG003|Overall Study|Death|2|||
163096565|NCT00326599|589062705|FG000|Overall Study|Other Unspecified Reason|0|||
163096566|NCT00326599|589062706|FG001|Overall Study|Other Unspecified Reason|0|||
163096567|NCT00326599|589062707|FG002|Overall Study|Other Unspecified Reason|2|||
163096568|NCT00326599|589062708|FG003|Overall Study|Other Unspecified Reason|1|||
163096569|NCT00625586|589062709|FG000|Overall Study|Adverse Event|1|||
163096570|NCT00625586|589062709|FG000|Overall Study|Progressive disease|1|||
163096571|NCT02737501|589062718|FG000|Randomized Phase|Died|41|||
163096572|NCT02737501|589062719|FG001|Randomized Phase|Died|29|||
163096573|NCT02737501|589062720|FG002|Randomized Phase|Died|0|||
163096574|NCT02737501|589062718|FG000|Randomized Phase|Withdrawal by Subject|16|||
163096575|NCT02737501|589062719|FG001|Randomized Phase|Withdrawal by Subject|6|||
163096576|NCT02737501|589062720|FG002|Randomized Phase|Withdrawal by Subject|0|||
163096577|NCT02737501|589062718|FG000|Randomized Phase|Lost to Follow-up|0|||
163096578|NCT02737501|589062719|FG001|Randomized Phase|Lost to Follow-up|1|||
163096579|NCT02737501|589062720|FG002|Randomized Phase|Lost to Follow-up|0|||
163096580|NCT02737501|589062718|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
163096581|NCT02737501|589062719|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
163096582|NCT02737501|589062720|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
163096583|NCT02737501|589062718|FG000|Randomized Phase|Reason not Specified|1|||
163096584|NCT02737501|589062719|FG001|Randomized Phase|Reason not Specified|1|||
163096585|NCT02737501|589062720|FG002|Randomized Phase|Reason not Specified|0|||
163096586|NCT02737501|589062718|FG000|Randomized Phase|Never Treated|1|||
163096587|NCT02737501|589062719|FG001|Randomized Phase|Never Treated|1|||
163096588|NCT02737501|589062720|FG002|Randomized Phase|Never Treated|0|||
163096589|NCT02737501|589062718|FG000|Crossover Phase|Died|0|||
163096590|NCT02737501|589062719|FG001|Crossover Phase|Died|0|||
163096591|NCT02737501|589062720|FG002|Crossover Phase|Died|22|||
163096592|NCT02737501|589062718|FG000|Crossover Phase|Withdrew Consent|0|||
163096593|NCT02737501|589062719|FG001|Crossover Phase|Withdrew Consent|0|||
163096594|NCT02737501|589062720|FG002|Crossover Phase|Withdrew Consent|9|||
163096595|NCT02737501|589062718|FG000|Crossover Phase|Physician Decision|0|||
163096596|NCT02737501|589062719|FG001|Crossover Phase|Physician Decision|0|||
163096597|NCT02737501|589062720|FG002|Crossover Phase|Physician Decision|1|||
163096598|NCT02737501|589062718|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
163096599|NCT02737501|589062719|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
163096600|NCT02737501|589062720|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
163096601|NCT02012218|589062721|FG000|Overall Study|Withdrawal by Subject|1|||
163096602|NCT02012218|589062722|FG001|Overall Study|Withdrawal by Subject|0|||
163096603|NCT02012218|589062723|FG002|Overall Study|Withdrawal by Subject|1|||
163096604|NCT02012218|589062724|FG003|Overall Study|Withdrawal by Subject|1|||
163096605|NCT02012218|589062725|FG004|Overall Study|Withdrawal by Subject|1|||
163096606|NCT02012218|589062721|FG000|Overall Study|Adverse Event|1|||
163096607|NCT02012218|589062722|FG001|Overall Study|Adverse Event|0|||
163096608|NCT02012218|589062723|FG002|Overall Study|Adverse Event|0|||
163096609|NCT02012218|589062724|FG003|Overall Study|Adverse Event|1|||
162653030|NCT02896400|587447474|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
162653031|NCT02896400|587447475|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162653032|NCT02896400|587447476|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
162653033|NCT02896400|587447477|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
162653034|NCT01700179|587447478|FG000|Overall Study|Physician Decision|2|||
162653035|NCT01207778|587447479|FG000|Overall Study|Lost to Follow-up|0|||
162653036|NCT01207778|587447480|FG001|Overall Study|Lost to Follow-up|3|||
163096610|NCT02012218|589062725|FG004|Overall Study|Adverse Event|0|||
163096611|NCT02012218|589062721|FG000|Overall Study|Lost to Follow-up|0|||
163096612|NCT02012218|589062722|FG001|Overall Study|Lost to Follow-up|1|||
163096613|NCT02012218|589062723|FG002|Overall Study|Lost to Follow-up|1|||
163096614|NCT02012218|589062724|FG003|Overall Study|Lost to Follow-up|0|||
163096615|NCT02012218|589062725|FG004|Overall Study|Lost to Follow-up|0|||
163096616|NCT02012218|589062721|FG000|Overall Study|Protocol Specified|1|||
163096617|NCT02012218|589062722|FG001|Overall Study|Protocol Specified|0|||
163096618|NCT02012218|589062723|FG002|Overall Study|Protocol Specified|0|||
163096619|NCT02012218|589062724|FG003|Overall Study|Protocol Specified|0|||
163096620|NCT02012218|589062725|FG004|Overall Study|Protocol Specified|0|||
163096621|NCT02012218|589062721|FG000|Overall Study|Protocol Deviation|1|||
163096622|NCT02012218|589062722|FG001|Overall Study|Protocol Deviation|0|||
163096623|NCT02012218|589062723|FG002|Overall Study|Protocol Deviation|0|||
163096624|NCT02012218|589062724|FG003|Overall Study|Protocol Deviation|0|||
163096625|NCT02012218|589062725|FG004|Overall Study|Protocol Deviation|0|||
163096626|NCT04819113|589062726|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163096627|NCT04819113|589062726|FG000|Overall Study|Lost to Follow-up|1|||
163096628|NCT04819113|589062726|FG000|Overall Study|Withdrawn before vaccination|2|||
163096629|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Death|2|||
163096630|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
163096631|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
163096632|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Physician Decision|1|||
163096633|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
163096634|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
163096635|NCT00786422|589062727|FG000|Rivaroxaban Treatment|Adverse Event|2|||
163096636|NCT00786422|589062727|FG000|Follow-up Period|Death|1|||
163096637|NCT00786422|589062727|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
163096638|NCT01085214|589062728|FG000|Overall Study|Alternate treatment required|1|||
163096639|NCT01985022|589062742|FG000|Overall Study|Lost to Follow-up|0|||
163096640|NCT01985022|589062743|FG001|Overall Study|Lost to Follow-up|1|||
163096641|NCT01985022|589062742|FG000|Overall Study|Protocol Violation|0|||
163096642|NCT01985022|589062743|FG001|Overall Study|Protocol Violation|1|||
163096643|NCT01985022|589062742|FG000|Overall Study|Withdrawal by Subject|4|||
163096644|NCT01985022|589062743|FG001|Overall Study|Withdrawal by Subject|1|||
163096645|NCT03761056|589062748|FG000|Overall Study|Death|8|||
163096646|NCT03761056|589062748|FG000|Overall Study|Enrolled but never treated|2|||
163096647|NCT03761056|589062748|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
163096648|NCT03761056|589062748|FG000|Overall Study|Investigator decision|1|||
163096649|NCT00996658|589062749|FG000|Overall Study|Adverse Event|2|||
163096650|NCT00996658|589062750|FG001|Overall Study|Adverse Event|5|||
163096651|NCT00996658|589062749|FG000|Overall Study|Protocol Violation|0|||
163096652|NCT00996658|589062750|FG001|Overall Study|Protocol Violation|1|||
163096653|NCT00996658|589062749|FG000|Overall Study|Lost to Follow-up|2|||
163096654|NCT00996658|589062750|FG001|Overall Study|Lost to Follow-up|5|||
163096655|NCT00996658|589062749|FG000|Overall Study|Non-compliance issues|3|||
163096656|NCT00996658|589062750|FG001|Overall Study|Non-compliance issues|3|||
163096657|NCT00996658|589062749|FG000|Overall Study|Other|9|||
163096658|NCT00996658|589062750|FG001|Overall Study|Other|7|||
163096659|NCT04749745|589062751|FG000|Overall Study|Withdrawal by Subject|1|||
163096660|NCT04749745|589062752|FG001|Overall Study|Withdrawal by Subject|0|||
163096661|NCT01365455|589062756|FG000|Induction Period|Adverse Event|5|||
163096662|NCT01365455|589062757|FG001|Induction Period|Adverse Event|3|||
163096663|NCT01365455|589062758|FG002|Induction Period|Adverse Event|4|||
163096664|NCT01365455|589062759|FG003|Induction Period|Adverse Event|0|||
163096665|NCT01365455|589062760|FG004|Induction Period|Adverse Event|0|||
163096666|NCT01365455|589062756|FG000|Induction Period|Lack of Efficacy|1|||
163096667|NCT01365455|589062757|FG001|Induction Period|Lack of Efficacy|1|||
163096668|NCT01365455|589062758|FG002|Induction Period|Lack of Efficacy|0|||
163096669|NCT01365455|589062759|FG003|Induction Period|Lack of Efficacy|0|||
163096670|NCT01365455|589062760|FG004|Induction Period|Lack of Efficacy|0|||
163096671|NCT01365455|589062756|FG000|Induction Period|Pregnancy|0|||
163096672|NCT01365455|589062757|FG001|Induction Period|Pregnancy|1|||
163096673|NCT01365455|589062758|FG002|Induction Period|Pregnancy|0|||
163096674|NCT01365455|589062759|FG003|Induction Period|Pregnancy|0|||
163096675|NCT01365455|589062760|FG004|Induction Period|Pregnancy|0|||
163096676|NCT01365455|589062756|FG000|Induction Period|Protocol deviation|0|||
163096677|NCT01365455|589062757|FG001|Induction Period|Protocol deviation|1|||
163096678|NCT01365455|589062758|FG002|Induction Period|Protocol deviation|1|||
163096679|NCT01365455|589062759|FG003|Induction Period|Protocol deviation|0|||
163096680|NCT01365455|589062760|FG004|Induction Period|Protocol deviation|0|||
163096681|NCT01365455|589062756|FG000|Induction Period|Subject/guardian decision|9|||
163096682|NCT01365455|589062757|FG001|Induction Period|Subject/guardian decision|1|||
163096683|NCT01365455|589062758|FG002|Induction Period|Subject/guardian decision|8|||
163096684|NCT01365455|589062759|FG003|Induction Period|Subject/guardian decision|0|||
163096685|NCT01365455|589062760|FG004|Induction Period|Subject/guardian decision|0|||
163096686|NCT01365455|589062756|FG000|Induction Period|Lost to Follow-up|0|||
163096687|NCT01365455|589062757|FG001|Induction Period|Lost to Follow-up|0|||
163096688|NCT01365455|589062758|FG002|Induction Period|Lost to Follow-up|3|||
163096689|NCT01365455|589062759|FG003|Induction Period|Lost to Follow-up|0|||
163096690|NCT01365455|589062760|FG004|Induction Period|Lost to Follow-up|0|||
163096691|NCT01365455|589062756|FG000|Maintenance Period|Adverse Event|12|||
163096692|NCT01365455|589062757|FG001|Maintenance Period|Adverse Event|5|||
163096693|NCT01365455|589062758|FG002|Maintenance Period|Adverse Event|1|||
163096694|NCT01365455|589062759|FG003|Maintenance Period|Adverse Event|2|||
163096695|NCT01365455|589062760|FG004|Maintenance Period|Adverse Event|4|||
163096696|NCT01365455|589062756|FG000|Maintenance Period|Lack of Efficacy|10|||
163096697|NCT01365455|589062757|FG001|Maintenance Period|Lack of Efficacy|2|||
163096698|NCT01365455|589062758|FG002|Maintenance Period|Lack of Efficacy|0|||
163096699|NCT01365455|589062759|FG003|Maintenance Period|Lack of Efficacy|2|||
163096700|NCT01365455|589062760|FG004|Maintenance Period|Lack of Efficacy|2|||
163096701|NCT01365455|589062756|FG000|Maintenance Period|Lost to Follow-up|2|||
163096702|NCT01365455|589062757|FG001|Maintenance Period|Lost to Follow-up|4|||
163096703|NCT01365455|589062758|FG002|Maintenance Period|Lost to Follow-up|0|||
163096704|NCT01365455|589062759|FG003|Maintenance Period|Lost to Follow-up|0|||
163096705|NCT01365455|589062760|FG004|Maintenance Period|Lost to Follow-up|3|||
163096706|NCT01365455|589062756|FG000|Maintenance Period|Non-compliance with study treatment|0|||
163096707|NCT01365455|589062757|FG001|Maintenance Period|Non-compliance with study treatment|0|||
163096708|NCT01365455|589062758|FG002|Maintenance Period|Non-compliance with study treatment|0|||
163096709|NCT01365455|589062759|FG003|Maintenance Period|Non-compliance with study treatment|1|||
163096710|NCT01365455|589062760|FG004|Maintenance Period|Non-compliance with study treatment|0|||
163096711|NCT01365455|589062756|FG000|Maintenance Period|Physician Decision|0|||
163096712|NCT01365455|589062757|FG001|Maintenance Period|Physician Decision|1|||
163096713|NCT01365455|589062758|FG002|Maintenance Period|Physician Decision|0|||
163096714|NCT01365455|589062759|FG003|Maintenance Period|Physician Decision|0|||
163096715|NCT01365455|589062760|FG004|Maintenance Period|Physician Decision|1|||
163096716|NCT01365455|589062756|FG000|Maintenance Period|Pregnancy|0|||
163096717|NCT01365455|589062757|FG001|Maintenance Period|Pregnancy|4|||
163096718|NCT01365455|589062758|FG002|Maintenance Period|Pregnancy|0|||
163096719|NCT01365455|589062759|FG003|Maintenance Period|Pregnancy|0|||
163096720|NCT01365455|589062760|FG004|Maintenance Period|Pregnancy|2|||
163096721|NCT01365455|589062756|FG000|Maintenance Period|Protocol deviation|1|||
163096722|NCT01365455|589062757|FG001|Maintenance Period|Protocol deviation|1|||
163096723|NCT01365455|589062758|FG002|Maintenance Period|Protocol deviation|0|||
163096724|NCT01365455|589062759|FG003|Maintenance Period|Protocol deviation|0|||
163096725|NCT01365455|589062760|FG004|Maintenance Period|Protocol deviation|0|||
163096726|NCT01365455|589062756|FG000|Maintenance Period|Subject/guardian decision|4|||
163096727|NCT01365455|589062757|FG001|Maintenance Period|Subject/guardian decision|6|||
163096728|NCT01365455|589062758|FG002|Maintenance Period|Subject/guardian decision|2|||
163096729|NCT01365455|589062759|FG003|Maintenance Period|Subject/guardian decision|4|||
162653037|NCT01207778|587447481|FG002|Overall Study|Lost to Follow-up|3|||
162653038|NCT00503841|587447490|FG000|Overall Study|All screen failures|44|||
162653039|NCT01302964|587447491|FG000|Overall Study|Adverse Event|1|||
163096730|NCT01365455|589062760|FG004|Maintenance Period|Subject/guardian decision|1|||
163096731|NCT04267926|589064656|FG000|Overall Study|abnormal labs. No longer eligible|0|||
163096732|NCT04267926|589064657|FG001|Overall Study|abnormal labs. No longer eligible|0|||
163096733|NCT04267926|589064658|FG002|Overall Study|abnormal labs. No longer eligible|1|||
163096734|NCT04267926|589064656|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
163096735|NCT04267926|589064657|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
163096736|NCT04267926|589064658|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
163096737|NCT03145064|589064659|FG000|Overall Study|Death|24|||
163096738|NCT03145064|589064659|FG000|Overall Study|Lost to Follow-up|3|||
163096739|NCT03145064|589064659|FG000|Overall Study|Withdrawal by Subject|6|||
163096740|NCT03145064|589064659|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
163096741|NCT03145064|589064659|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
163096742|NCT00661830|589064660|FG000|Overall Study|Death|37|||
163096743|NCT00661830|589064661|FG001|Overall Study|Death|33|||
163096744|NCT00661830|589064660|FG000|Overall Study|Lost to Follow-up|1|||
163096745|NCT00661830|589064661|FG001|Overall Study|Lost to Follow-up|3|||
163096746|NCT00661830|589064660|FG000|Overall Study|Withdrawal by Subject|1|||
163096747|NCT00661830|589064661|FG001|Overall Study|Withdrawal by Subject|1|||
163096748|NCT00661830|589064660|FG000|Overall Study|Other reason|1|||
163096749|NCT00661830|589064661|FG001|Overall Study|Other reason|5|||
163096750|NCT01396187|589064662|FG000|Overall Study|Adverse Event|0|||
163096751|NCT01396187|589064663|FG001|Overall Study|Adverse Event|1|||
163096752|NCT01396187|589064664|FG002|Overall Study|Adverse Event|0|||
163096753|NCT01396187|589064665|FG003|Overall Study|Adverse Event|0|||
163096754|NCT01396187|589064666|FG004|Overall Study|Adverse Event|0|||
163096755|NCT01396187|589064662|FG000|Overall Study|Withdrawal by Subject|0|||
163096756|NCT01396187|589064663|FG001|Overall Study|Withdrawal by Subject|1|||
163096757|NCT01396187|589064664|FG002|Overall Study|Withdrawal by Subject|1|||
163096758|NCT01396187|589064665|FG003|Overall Study|Withdrawal by Subject|0|||
163096759|NCT01396187|589064666|FG004|Overall Study|Withdrawal by Subject|0|||
163096760|NCT01396187|589064662|FG000|Overall Study|Other|1|||
163096761|NCT01396187|589064663|FG001|Overall Study|Other|1|||
163096762|NCT01396187|589064664|FG002|Overall Study|Other|0|||
163096763|NCT01396187|589064665|FG003|Overall Study|Other|0|||
163096764|NCT01396187|589064666|FG004|Overall Study|Other|1|||
163096765|NCT01650831|589064667|FG000|Overall Study|Screen failure|1|||
163096766|NCT01897727|589064670|FG000|Overall Study|Exclusion: central sleep apnea|0|||
163096767|NCT01897727|589064671|FG001|Overall Study|Exclusion: central sleep apnea|1|||
163096768|NCT04245449|589064672|FG000|Overall Study|COVID shutdown|7|||
163096769|NCT01273038|589064673|FG000|Second Intervention (14 Days)|Adverse Event|0|||
163096770|NCT01273038|589064674|FG001|Second Intervention (14 Days)|Adverse Event|1|||
163096771|NCT01273038|589064673|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163096772|NCT01273038|589064674|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163096773|NCT02477527|589064675|FG000|Overall Study|Lost to Follow-up|2|||
163096774|NCT02477527|589064675|FG000|Overall Study|Withdrawal by Subject|1|||
163096775|NCT02477527|589064675|FG000|Overall Study|Screen Failure|3|||
162653040|NCT01302964|587447492|FG001|Overall Study|Adverse Event|0|||
162653041|NCT01945489|587447493|FG000|Cycle 1|Adverse Event|2|||
163096776|NCT03692403|589064676|FG000|Overall Study|Withdrawal by Subject|1|||
163096777|NCT03692403|589064677|FG001|Overall Study|Withdrawal by Subject|0|||
163096778|NCT03692403|589064678|FG002|Overall Study|Withdrawal by Subject|1|||
163096779|NCT03692403|589064679|FG003|Overall Study|Withdrawal by Subject|0|||
163096780|NCT03692403|589064676|FG000|Overall Study|Adverse Event|0|||
163096781|NCT03692403|589064677|FG001|Overall Study|Adverse Event|0|||
163096782|NCT03692403|589064678|FG002|Overall Study|Adverse Event|0|||
163096783|NCT03692403|589064679|FG003|Overall Study|Adverse Event|1|||
163096784|NCT03692403|589064676|FG000|Overall Study|Pregnancy|0|||
163096785|NCT03692403|589064677|FG001|Overall Study|Pregnancy|1|||
163096786|NCT03692403|589064678|FG002|Overall Study|Pregnancy|0|||
163096787|NCT03692403|589064679|FG003|Overall Study|Pregnancy|0|||
163096788|NCT03692403|589064676|FG000|Overall Study|Other|0|||
163096789|NCT03692403|589064677|FG001|Overall Study|Other|0|||
163096790|NCT03692403|589064678|FG002|Overall Study|Other|1|||
163096791|NCT03692403|589064679|FG003|Overall Study|Other|0|||
163096792|NCT02479880|589064680|FG000|Overall Study|Study Terminated by Sponsor|13|||
163096793|NCT02479880|589064681|FG001|Overall Study|Study Terminated by Sponsor|12|||
163096794|NCT02479880|589064680|FG000|Overall Study|Pregnancy|0|||
163096795|NCT02479880|589064681|FG001|Overall Study|Pregnancy|1|||
163096796|NCT02840253|589064682|FG000|Overall Study|Unsuccessful block|4|||
163096797|NCT00856635|589064683|FG000|Overall Study|Lost to Follow-up|2|||
163096798|NCT00856635|589064684|FG001|Overall Study|Lost to Follow-up|5|||
163096799|NCT00856635|589064683|FG000|Overall Study|Pregnancy|1|||
162653042|NCT01945489|587447494|FG001|Cycle 1|Adverse Event|0|||
162653043|NCT01945489|587447493|FG000|Cycle 1|Lost to Follow-up|4|||
163096800|NCT00856635|589064684|FG001|Overall Study|Pregnancy|0|||
163096801|NCT00856635|589064683|FG000|Overall Study|Withdrawal by Subject|3|||
163096802|NCT00856635|589064684|FG001|Overall Study|Withdrawal by Subject|1|||
163096803|NCT00856635|589064683|FG000|Overall Study|Serious Adverse Event|1|||
162653044|NCT01945489|587447494|FG001|Cycle 1|Lost to Follow-up|0|||
163096804|NCT00856635|589064684|FG001|Overall Study|Serious Adverse Event|0|||
163096805|NCT00856635|589064683|FG000|Overall Study|Other|1|||
163096806|NCT00856635|589064684|FG001|Overall Study|Other|0|||
163096807|NCT00856635|589064683|FG000|Overall Study|Discontinued at Randomization|2|||
163096808|NCT00856635|589064684|FG001|Overall Study|Discontinued at Randomization|2|||
163096809|NCT01349673|589064685|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
163096810|NCT01349673|589064685|FG000|Overall Study|No Longer Qualified For Study|1|||
163096811|NCT01349673|589064685|FG000|Overall Study|Site Closure|10|||
163096812|NCT01349673|589064685|FG000|Overall Study|Withdrawal by Subject|21|||
163096813|NCT01349673|589064685|FG000|Overall Study|Lost to Follow-up|6|||
163096814|NCT01349673|589064685|FG000|Overall Study|Adverse Event|17|||
163096815|NCT01349673|589064685|FG000|Overall Study|Study Terminated By Sponsor|50|||
163096816|NCT01349673|589064685|FG000|Overall Study|Lack of Efficacy|8|||
163096817|NCT00564733|589064686|FG000|Overall Study|Withdrawal by Subject|4|||
163096818|NCT00564733|589064686|FG000|Overall Study|Ineligible|5|||
163096819|NCT03198767|589064691|FG000|Overall Study|Protocol Violation|0|||
163096820|NCT03198767|589064692|FG001|Overall Study|Protocol Violation|0|||
163096821|NCT03198767|589064693|FG002|Overall Study|Protocol Violation|0|||
163096822|NCT03198767|589064694|FG003|Overall Study|Protocol Violation|6|||
163096823|NCT03198767|589064695|FG004|Overall Study|Protocol Violation|0|||
163096824|NCT03198767|589064696|FG005|Overall Study|Protocol Violation|0|||
163096825|NCT03198767|589064697|FG006|Overall Study|Protocol Violation|0|||
163096826|NCT03462758|589064698|FG000|Overall Study|Chose no or other method of contraception|20|||
163096827|NCT03462758|589064699|FG001|Overall Study|Chose no or other method of contraception|23|||
163096828|NCT03462758|589064698|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
163096829|NCT03462758|589064699|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
163096830|NCT03462758|589064698|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
163096831|NCT03462758|589064699|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
163096832|NCT03462758|589064698|FG000|Overall Study|Medical contraindication|2|||
163096833|NCT03462758|589064699|FG001|Overall Study|Medical contraindication|2|||
163096834|NCT03462758|589064698|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
163096835|NCT03462758|589064699|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
163096836|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
163096837|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
163096838|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096839|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096840|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096841|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
163096842|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
163096843|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
163096844|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096845|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096846|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096847|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163096848|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096849|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
163096850|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096851|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096852|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096853|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
163096854|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
163096855|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
163096856|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096857|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096858|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096859|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
163096860|NCT02820844|589064700|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
163096861|NCT02820844|589064701|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096862|NCT02820844|589064702|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096863|NCT02820844|589064703|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096864|NCT02820844|589064704|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096865|NCT02820844|589064705|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
163096866|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096867|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096868|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
163096869|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
163096870|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096871|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
163096872|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
162653045|NCT01945489|587447493|FG000|Cycle 1|Personal Reasons|4|||
163096873|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096874|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
163096875|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096876|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096877|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
163096878|NCT02820844|589064700|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096879|NCT02820844|589064701|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096880|NCT02820844|589064702|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
163096881|NCT02820844|589064703|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
163096882|NCT02820844|589064704|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096883|NCT02820844|589064705|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096884|NCT02820844|589064700|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096885|NCT02820844|589064701|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096886|NCT02820844|589064702|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096887|NCT02820844|589064703|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096888|NCT02820844|589064704|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
163096889|NCT02820844|589064705|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163096890|NCT02820844|589064700|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096891|NCT02820844|589064701|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096892|NCT02820844|589064702|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096893|NCT02820844|589064703|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096894|NCT02820844|589064704|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
163096895|NCT02820844|589064705|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
163096896|NCT00413660|589064707|FG000|Up To Week 12|Adverse Event|1|||
163096897|NCT00413660|589064708|FG001|Up To Week 12|Adverse Event|3|||
163096898|NCT00413660|589064709|FG002|Up To Week 12|Adverse Event|1|||
163096899|NCT00413660|589064710|FG003|Up To Week 12|Adverse Event|4|||
163096900|NCT00413660|589064711|FG004|Up To Week 12|Adverse Event|6|||
163096901|NCT00413660|589064712|FG005|Up To Week 12|Adverse Event|4|||
163096902|NCT00413660|589064713|FG006|Up To Week 12|Adverse Event|1|||
163096903|NCT00413660|589064714|FG007|Up To Week 12|Adverse Event|0|||
163096904|NCT00413660|589064715|FG008|Up To Week 12|Adverse Event|0|||
163096905|NCT00413660|589064716|FG009|Up To Week 12|Adverse Event|0|||
163096906|NCT00413660|589064717|FG010|Up To Week 12|Adverse Event|0|||
163096907|NCT00413660|589064707|FG000|Up To Week 12|Lack of Efficacy|2|||
163096908|NCT00413660|589064708|FG001|Up To Week 12|Lack of Efficacy|0|||
163096909|NCT00413660|589064709|FG002|Up To Week 12|Lack of Efficacy|0|||
163096910|NCT00413660|589064710|FG003|Up To Week 12|Lack of Efficacy|0|||
163096911|NCT00413660|589064711|FG004|Up To Week 12|Lack of Efficacy|0|||
163096912|NCT00413660|589064712|FG005|Up To Week 12|Lack of Efficacy|0|||
163096913|NCT00413660|589064713|FG006|Up To Week 12|Lack of Efficacy|5|||
163096914|NCT00413660|589064714|FG007|Up To Week 12|Lack of Efficacy|0|||
163096915|NCT00413660|589064715|FG008|Up To Week 12|Lack of Efficacy|0|||
163096916|NCT00413660|589064716|FG009|Up To Week 12|Lack of Efficacy|0|||
163096917|NCT00413660|589064717|FG010|Up To Week 12|Lack of Efficacy|0|||
163096918|NCT00413660|589064707|FG000|Up To Week 12|Lost to Follow-up|0|||
163096919|NCT00413660|589064708|FG001|Up To Week 12|Lost to Follow-up|1|||
163096920|NCT00413660|589064709|FG002|Up To Week 12|Lost to Follow-up|0|||
163096921|NCT00413660|589064710|FG003|Up To Week 12|Lost to Follow-up|0|||
163096922|NCT00413660|589064711|FG004|Up To Week 12|Lost to Follow-up|1|||
163096923|NCT00413660|589064712|FG005|Up To Week 12|Lost to Follow-up|0|||
163096924|NCT00413660|589064713|FG006|Up To Week 12|Lost to Follow-up|0|||
163096925|NCT00413660|589064714|FG007|Up To Week 12|Lost to Follow-up|0|||
163096926|NCT00413660|589064715|FG008|Up To Week 12|Lost to Follow-up|0|||
163096927|NCT00413660|589064716|FG009|Up To Week 12|Lost to Follow-up|0|||
163096928|NCT00413660|589064717|FG010|Up To Week 12|Lost to Follow-up|0|||
163096929|NCT00413660|589064707|FG000|Up To Week 12|Withdrawal by Subject|0|||
163096930|NCT00413660|589064708|FG001|Up To Week 12|Withdrawal by Subject|2|||
163096931|NCT00413660|589064709|FG002|Up To Week 12|Withdrawal by Subject|0|||
163096932|NCT00413660|589064710|FG003|Up To Week 12|Withdrawal by Subject|2|||
163096933|NCT00413660|589064711|FG004|Up To Week 12|Withdrawal by Subject|0|||
162653046|NCT01945489|587447494|FG001|Cycle 1|Personal Reasons|2|||
163096934|NCT00413660|589064712|FG005|Up To Week 12|Withdrawal by Subject|2|||
163096935|NCT00413660|589064713|FG006|Up To Week 12|Withdrawal by Subject|2|||
163096936|NCT00413660|589064714|FG007|Up To Week 12|Withdrawal by Subject|0|||
163096937|NCT00413660|589064715|FG008|Up To Week 12|Withdrawal by Subject|0|||
163096938|NCT00413660|589064716|FG009|Up To Week 12|Withdrawal by Subject|0|||
163096939|NCT00413660|589064717|FG010|Up To Week 12|Withdrawal by Subject|0|||
163096940|NCT00413660|589064707|FG000|Up To Week 12|Randomized, Not Treated|1|||
163096941|NCT00413660|589064708|FG001|Up To Week 12|Randomized, Not Treated|0|||
163096942|NCT00413660|589064709|FG002|Up To Week 12|Randomized, Not Treated|0|||
163096943|NCT00413660|589064710|FG003|Up To Week 12|Randomized, Not Treated|1|||
163096944|NCT00413660|589064711|FG004|Up To Week 12|Randomized, Not Treated|0|||
163096945|NCT00413660|589064712|FG005|Up To Week 12|Randomized, Not Treated|0|||
163096946|NCT00413660|589064713|FG006|Up To Week 12|Randomized, Not Treated|0|||
163096947|NCT00413660|589064714|FG007|Up To Week 12|Randomized, Not Treated|0|||
163096948|NCT00413660|589064715|FG008|Up To Week 12|Randomized, Not Treated|0|||
163096949|NCT00413660|589064716|FG009|Up To Week 12|Randomized, Not Treated|0|||
163096950|NCT00413660|589064717|FG010|Up To Week 12|Randomized, Not Treated|0|||
163096951|NCT00413660|589064707|FG000|Up To Week 12|Other|3|||
163096952|NCT00413660|589064708|FG001|Up To Week 12|Other|1|||
163096953|NCT00413660|589064709|FG002|Up To Week 12|Other|6|||
163096954|NCT00413660|589064710|FG003|Up To Week 12|Other|1|||
163096955|NCT00413660|589064711|FG004|Up To Week 12|Other|2|||
163096956|NCT00413660|589064712|FG005|Up To Week 12|Other|4|||
163096957|NCT00413660|589064713|FG006|Up To Week 12|Other|3|||
163096958|NCT00413660|589064714|FG007|Up To Week 12|Other|0|||
163096959|NCT00413660|589064715|FG008|Up To Week 12|Other|0|||
163096960|NCT00413660|589064716|FG009|Up To Week 12|Other|0|||
163096961|NCT00413660|589064717|FG010|Up To Week 12|Other|0|||
163096962|NCT00413660|589064707|FG000|Post Week 12|Adverse Event|2|||
163096963|NCT00413660|589064708|FG001|Post Week 12|Adverse Event|0|||
163096964|NCT00413660|589064709|FG002|Post Week 12|Adverse Event|2|||
163096965|NCT00413660|589064710|FG003|Post Week 12|Adverse Event|1|||
163096966|NCT00413660|589064711|FG004|Post Week 12|Adverse Event|4|||
163096967|NCT00413660|589064712|FG005|Post Week 12|Adverse Event|2|||
163096968|NCT00413660|589064713|FG006|Post Week 12|Adverse Event|2|||
163096969|NCT00413660|589064714|FG007|Post Week 12|Adverse Event|0|||
163096970|NCT00413660|589064715|FG008|Post Week 12|Adverse Event|0|||
163096971|NCT00413660|589064716|FG009|Post Week 12|Adverse Event|0|||
163096972|NCT00413660|589064717|FG010|Post Week 12|Adverse Event|0|||
163096973|NCT00413660|589064707|FG000|Post Week 12|Lack of Efficacy|0|||
163096974|NCT00413660|589064708|FG001|Post Week 12|Lack of Efficacy|0|||
163096975|NCT00413660|589064709|FG002|Post Week 12|Lack of Efficacy|1|||
163096976|NCT00413660|589064710|FG003|Post Week 12|Lack of Efficacy|0|||
163096977|NCT00413660|589064711|FG004|Post Week 12|Lack of Efficacy|0|||
163096978|NCT00413660|589064712|FG005|Post Week 12|Lack of Efficacy|0|||
163096979|NCT00413660|589064713|FG006|Post Week 12|Lack of Efficacy|0|||
163096980|NCT00413660|589064714|FG007|Post Week 12|Lack of Efficacy|0|||
163096981|NCT00413660|589064715|FG008|Post Week 12|Lack of Efficacy|0|||
163096982|NCT00413660|589064716|FG009|Post Week 12|Lack of Efficacy|1|||
163096983|NCT00413660|589064717|FG010|Post Week 12|Lack of Efficacy|0|||
163096984|NCT00413660|589064707|FG000|Post Week 12|Lost to Follow-up|0|||
163096985|NCT00413660|589064708|FG001|Post Week 12|Lost to Follow-up|1|||
163096986|NCT00413660|589064709|FG002|Post Week 12|Lost to Follow-up|1|||
163096987|NCT00413660|589064710|FG003|Post Week 12|Lost to Follow-up|0|||
163096988|NCT00413660|589064711|FG004|Post Week 12|Lost to Follow-up|0|||
163096989|NCT00413660|589064712|FG005|Post Week 12|Lost to Follow-up|0|||
163096990|NCT00413660|589064713|FG006|Post Week 12|Lost to Follow-up|0|||
163096991|NCT00413660|589064714|FG007|Post Week 12|Lost to Follow-up|0|||
163096992|NCT00413660|589064715|FG008|Post Week 12|Lost to Follow-up|0|||
163096993|NCT00413660|589064716|FG009|Post Week 12|Lost to Follow-up|0|||
163096994|NCT00413660|589064717|FG010|Post Week 12|Lost to Follow-up|0|||
163096995|NCT00413660|589064707|FG000|Post Week 12|Withdrawal by Subject|0|||
163096996|NCT00413660|589064708|FG001|Post Week 12|Withdrawal by Subject|1|||
163096997|NCT00413660|589064709|FG002|Post Week 12|Withdrawal by Subject|1|||
163096998|NCT00413660|589064710|FG003|Post Week 12|Withdrawal by Subject|0|||
163096999|NCT00413660|589064711|FG004|Post Week 12|Withdrawal by Subject|1|||
163097000|NCT00413660|589064712|FG005|Post Week 12|Withdrawal by Subject|0|||
162719029|NCT02341625|587676743|FG006|Overall Study|Other Reasons|5|||
162719030|NCT02341625|587676744|FG007|Overall Study|Other Reasons|0|||
162719031|NCT02341625|587676745|FG008|Overall Study|Other Reasons|0|||
162719032|NCT02341625|587676746|FG009|Overall Study|Other Reasons|2|||
163097001|NCT00413660|589064713|FG006|Post Week 12|Withdrawal by Subject|0|||
163097002|NCT00413660|589064714|FG007|Post Week 12|Withdrawal by Subject|0|||
163097003|NCT00413660|589064715|FG008|Post Week 12|Withdrawal by Subject|0|||
163097004|NCT00413660|589064716|FG009|Post Week 12|Withdrawal by Subject|0|||
163097005|NCT00413660|589064717|FG010|Post Week 12|Withdrawal by Subject|1|||
163097006|NCT00413660|589064707|FG000|Post Week 12|Other|1|||
163097007|NCT00413660|589064708|FG001|Post Week 12|Other|2|||
163097008|NCT00413660|589064709|FG002|Post Week 12|Other|3|||
163097009|NCT00413660|589064710|FG003|Post Week 12|Other|0|||
163097010|NCT00413660|589064711|FG004|Post Week 12|Other|1|||
163097011|NCT00413660|589064712|FG005|Post Week 12|Other|1|||
163097012|NCT00413660|589064713|FG006|Post Week 12|Other|1|||
163097013|NCT00413660|589064714|FG007|Post Week 12|Other|0|||
163097014|NCT00413660|589064715|FG008|Post Week 12|Other|0|||
163097015|NCT00413660|589064716|FG009|Post Week 12|Other|0|||
163097016|NCT00413660|589064717|FG010|Post Week 12|Other|0|||
163097017|NCT02817594|589064721|FG000|Overall Study|Withdrawal by Subject|1|||
163097018|NCT02817594|589064721|FG000|Overall Study|Other|1|||
163097019|NCT02817594|589064721|FG000|Overall Study|Did Not Receive Treatment|1|||
163097020|NCT02010593|589064722|FG000|Overall Study|Lost to Follow-up|1|||
163097021|NCT02010593|589064723|FG001|Overall Study|Lost to Follow-up|0|||
163097022|NCT02010593|589064722|FG000|Overall Study|Physician Decision|1|||
163097023|NCT02010593|589064723|FG001|Overall Study|Physician Decision|0|||
163097024|NCT02010593|589064722|FG000|Overall Study|Unable to adhere to visit schedule|0|||
163097025|NCT02010593|589064723|FG001|Overall Study|Unable to adhere to visit schedule|2|||
163097026|NCT01135459|589064724|FG000|Overall Study|Adverse Event|8|||
163097027|NCT01135459|589064725|FG001|Overall Study|Adverse Event|10|||
163097028|NCT01135459|589064724|FG000|Overall Study|Lack of Efficacy|3|||
163097029|NCT01135459|589064725|FG001|Overall Study|Lack of Efficacy|1|||
163097030|NCT01135459|589064724|FG000|Overall Study|Withdrawal by Subject|2|||
163097031|NCT01135459|589064725|FG001|Overall Study|Withdrawal by Subject|3|||
163097032|NCT01135459|589064724|FG000|Overall Study|Protocol Violation|5|||
163097033|NCT01135459|589064725|FG001|Overall Study|Protocol Violation|3|||
163097034|NCT01135459|589064724|FG000|Overall Study|Lost to Follow-up|2|||
163097035|NCT01135459|589064725|FG001|Overall Study|Lost to Follow-up|1|||
163097036|NCT01135459|589064724|FG000|Overall Study|Non-compliance to study procedures|0|||
163097037|NCT01135459|589064725|FG001|Overall Study|Non-compliance to study procedures|1|||
163097038|NCT01135459|589064724|FG000|Overall Study|Other than specified|1|||
163097039|NCT01135459|589064725|FG001|Overall Study|Other than specified|1|||
163097040|NCT01803880|589064726|FG000|Overall Study|Adverse Event|1|||
163097041|NCT01803880|589064727|FG001|Overall Study|Adverse Event|0|||
163097042|NCT01803880|589064728|FG002|Overall Study|Adverse Event|0|||
163097043|NCT01803880|589064726|FG000|Overall Study|Withdrawal by Subject|1|||
163097044|NCT01803880|589064727|FG001|Overall Study|Withdrawal by Subject|1|||
163097045|NCT01803880|589064728|FG002|Overall Study|Withdrawal by Subject|4|||
163097046|NCT01803880|589064726|FG000|Overall Study|Physician Decision|0|||
163097047|NCT01803880|589064727|FG001|Overall Study|Physician Decision|0|||
163097048|NCT01803880|589064728|FG002|Overall Study|Physician Decision|1|||
163097049|NCT01803880|589064726|FG000|Overall Study|Unable to return for follow-up visits|0|||
163097050|NCT01803880|589064727|FG001|Overall Study|Unable to return for follow-up visits|1|||
163097051|NCT01803880|589064728|FG002|Overall Study|Unable to return for follow-up visits|2|||
163097052|NCT01803880|589064726|FG000|Overall Study|Lost to Follow-up|1|||
163097053|NCT01803880|589064727|FG001|Overall Study|Lost to Follow-up|2|||
163097054|NCT01803880|589064728|FG002|Overall Study|Lost to Follow-up|3|||
163097055|NCT01803880|589064726|FG000|Overall Study|Protocol Violation|1|||
163097056|NCT01803880|589064727|FG001|Overall Study|Protocol Violation|0|||
163097057|NCT01803880|589064728|FG002|Overall Study|Protocol Violation|0|||
163097058|NCT01803880|589064726|FG000|Overall Study|Early study termination|0|||
163097059|NCT01803880|589064727|FG001|Overall Study|Early study termination|6|||
163097060|NCT01803880|589064728|FG002|Overall Study|Early study termination|5|||
163097061|NCT01803880|589064726|FG000|Overall Study|Incomplete data entry by sites|2|||
163097062|NCT01803880|589064727|FG001|Overall Study|Incomplete data entry by sites|0|||
163097063|NCT01803880|589064728|FG002|Overall Study|Incomplete data entry by sites|0|||
163097064|NCT02651116|589064736|FG000|Overall Study|Adverse Event|0|||
163097065|NCT02651116|589064737|FG001|Overall Study|Adverse Event|1|||
162653047|NCT01945489|587447493|FG000|Cycle 1|Protocol Violation|0|||
162653048|NCT01945489|587447494|FG001|Cycle 1|Protocol Violation|1|||
162653049|NCT01945489|587447493|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
162653050|NCT01945489|587447494|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
162653051|NCT01945489|587447493|FG000|Cycle 2|Adverse Event|1|||
162653052|NCT01945489|587447494|FG001|Cycle 2|Adverse Event|0|||
162653053|NCT01945489|587447493|FG000|Cycle 2|Lost to Follow-up|0|||
162653054|NCT01945489|587447494|FG001|Cycle 2|Lost to Follow-up|1|||
162653055|NCT00394212|587447497|FG000|Overall Study|Lost to Follow-up|3|||
162653056|NCT00394212|587447498|FG001|Overall Study|Lost to Follow-up|0|||
162653057|NCT00394212|587447497|FG000|Overall Study|Withdrawal by Subject|4|||
162653058|NCT00394212|587447498|FG001|Overall Study|Withdrawal by Subject|1|||
162653059|NCT02347527|587447500|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
162653060|NCT02347527|587447501|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
162653061|NCT02347527|587447502|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
162653062|NCT02347527|587447503|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
163097066|NCT02651116|589064736|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
163097067|NCT02651116|589064737|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
163097068|NCT02803203|589064738|FG000|Overall Study|Adverse Event|4|||
163097069|NCT02803203|589064738|FG000|Overall Study|Death|4|||
162653063|NCT02347527|587447500|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
163097070|NCT02803203|589064738|FG000|Overall Study|Progressive disease|29|||
163097071|NCT02803203|589064738|FG000|Overall Study|Withdrawal by Subject|8|||
163097072|NCT02803203|589064738|FG000|Overall Study|Complete resection of target disease|2|||
163097073|NCT02803203|589064738|FG000|Overall Study|Switched to commercial Osi|1|||
162653064|NCT02347527|587447501|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
162653065|NCT02347527|587447502|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
163097074|NCT02803203|589064738|FG000|Overall Study|Participant moved away|1|||
163097075|NCT01887717|589064739|FG000|Overall Study|Withdrawal by Subject|1|||
162653066|NCT02347527|587447503|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
163097076|NCT01887717|589064740|FG001|Overall Study|Withdrawal by Subject|7|||
163097077|NCT01887717|589064739|FG000|Overall Study|Physician Decision|0|||
163097078|NCT01887717|589064740|FG001|Overall Study|Physician Decision|2|||
163097079|NCT01887717|589064739|FG000|Overall Study|Administrative reasons|5|||
163097080|NCT01887717|589064740|FG001|Overall Study|Administrative reasons|2|||
163097081|NCT02041299|589064746|FG000|Overall Study|Adverse Event|9|||
163097082|NCT02041299|589064747|FG001|Overall Study|Adverse Event|3|||
163097083|NCT02041299|589064746|FG000|Overall Study|Lost to Follow-up|4|||
163097084|NCT02041299|589064747|FG001|Overall Study|Lost to Follow-up|1|||
163097085|NCT02041299|589064746|FG000|Overall Study|Physician Decision|1|||
163097086|NCT02041299|589064747|FG001|Overall Study|Physician Decision|1|||
163097087|NCT02041299|589064746|FG000|Overall Study|Withdrawal by Subject|13|||
163097088|NCT02041299|589064747|FG001|Overall Study|Withdrawal by Subject|7|||
163097089|NCT02041299|589064746|FG000|Overall Study|Protocol Violation|11|||
163097090|NCT02041299|589064747|FG001|Overall Study|Protocol Violation|4|||
163097091|NCT02041299|589064746|FG000|Overall Study|Termination of the study|7|||
163097092|NCT02041299|589064747|FG001|Overall Study|Termination of the study|3|||
163097093|NCT02041299|589064746|FG000|Overall Study|Required bone marrow transplant|0|||
163097094|NCT02041299|589064747|FG001|Overall Study|Required bone marrow transplant|1|||
163097095|NCT02041299|589064746|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
163097096|NCT02041299|589064747|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
163097097|NCT02389465|589064748|FG000|Overall Study|Lost to Follow-up|1|||
163097098|NCT02389465|589064749|FG001|Overall Study|Lost to Follow-up|3|||
163097099|NCT02389465|589064750|FG002|Overall Study|Lost to Follow-up|3|||
163097100|NCT02389465|589064751|FG003|Overall Study|Lost to Follow-up|0|||
163097101|NCT02389465|589064748|FG000|Overall Study|Physician Decision|0|||
163097102|NCT02389465|589064749|FG001|Overall Study|Physician Decision|0|||
163097103|NCT02389465|589064750|FG002|Overall Study|Physician Decision|0|||
163097104|NCT02389465|589064751|FG003|Overall Study|Physician Decision|1|||
163097105|NCT02389465|589064748|FG000|Overall Study|Withdrawal by Subject|0|||
163097106|NCT02389465|589064749|FG001|Overall Study|Withdrawal by Subject|1|||
163097107|NCT02389465|589064750|FG002|Overall Study|Withdrawal by Subject|2|||
163097108|NCT02389465|589064751|FG003|Overall Study|Withdrawal by Subject|2|||
163097109|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163097110|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163097111|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163097112|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
163097113|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
163097114|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
163097115|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163097116|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
163097117|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
163097118|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163097119|NCT01925768|589064752|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
163097120|NCT01925768|589064753|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
163097121|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
163097122|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
163097123|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
163097124|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
163097125|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
163097126|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
163097127|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
163097128|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
163097129|NCT01925768|589064752|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
163097130|NCT01925768|589064753|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
163097131|NCT00087698|589064756|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
163097132|NCT00087698|589064756|FG000|Overall Study|Death from Other Causes|3|||
163097133|NCT00087698|589064756|FG000|Overall Study|Adverse Event|4|||
163097134|NCT00087698|589064756|FG000|Overall Study|Withdrawal by Subject|4|||
163097135|NCT00087698|589064756|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
163097136|NCT00087698|589064756|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
163097137|NCT00087698|589064756|FG000|Overall Study|Clinical Relapse|1|||
163097138|NCT00087698|589064756|FG000|Overall Study|Death from Study Disease|2|||
163097139|NCT00087698|589064756|FG000|Overall Study|Death from Study Drug Toxicity|2|||
163097140|NCT00087698|589064756|FG000|Overall Study|Protocol Violation|1|||
163097141|NCT03542266|589064757|FG000|Treatment Phase|Withdrawal by Subject|1|||
163097142|NCT03542266|589064757|FG000|Treatment Phase|Adverse Event|1|||
163097143|NCT03542266|589064757|FG000|Treatment Phase|PD|1|||
163097144|NCT04721158|589064765|FG000|Overall Study|Lost to Follow-up|4|||
163097145|NCT04721158|589064765|FG000|Overall Study|Device did not connect|1|||
163097146|NCT00444925|589064767|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
163097147|NCT00444925|589064768|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
163097148|NCT00444925|589064769|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
163097149|NCT00444925|589064767|FG000|Double-blind Treatment Period|Death|2|||
163097150|NCT00444925|589064768|FG001|Double-blind Treatment Period|Death|0|||
163097151|NCT00444925|589064769|FG002|Double-blind Treatment Period|Death|0|||
163097152|NCT00444925|589064767|FG000|Double-blind Treatment Period|Adverse Event|6|||
163097153|NCT00444925|589064768|FG001|Double-blind Treatment Period|Adverse Event|28|||
163097154|NCT00444925|589064769|FG002|Double-blind Treatment Period|Adverse Event|44|||
163097155|NCT00444925|589064767|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
163097156|NCT00444925|589064768|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
163097157|NCT00444925|589064769|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
163097158|NCT00444925|589064767|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
163097159|NCT00444925|589064768|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
163097160|NCT00444925|589064769|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
163097161|NCT00444925|589064767|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
163097162|NCT00444925|589064768|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
163097163|NCT00444925|589064769|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
163097164|NCT00444925|589064767|FG000|Double-blind Treatment Period|Other|7|||
163097165|NCT00444925|589064768|FG001|Double-blind Treatment Period|Other|7|||
163097166|NCT00444925|589064769|FG002|Double-blind Treatment Period|Other|12|||
163097167|NCT00833027|589064770|FG000|Overall Study|Adverse Event|33|||
163097168|NCT00833027|589064770|FG000|Overall Study|Death|1|||
163097169|NCT00833027|589064770|FG000|Overall Study|Lack of Efficacy|12|||
163097170|NCT00833027|589064770|FG000|Overall Study|Lost to Follow-up|24|||
163097171|NCT00833027|589064770|FG000|Overall Study|Protocol Violation|115|||
163097172|NCT00833027|589064770|FG000|Overall Study|Withdrawal by Subject|16|||
163097173|NCT00833027|589064770|FG000|Overall Study|Missing|10|||
163097174|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
163097175|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
163097176|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
163097177|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
163097178|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
163097179|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
163097180|NCT03069716|589064774|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
163097181|NCT03069716|589064775|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
163097182|NCT03069716|589064776|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
163097183|NCT03069716|589064774|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163097184|NCT03069716|589064775|FG001|Randomized Treatment|Withdrawal by Subject|2|||
163097185|NCT03069716|589064776|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163097186|NCT00714948|589064777|FG000|Overall Study|Adverse Event|2|||
163097187|NCT01673126|589064778|FG000|Overall Study|change of diagnosis|4|||
163097188|NCT01673126|589064779|FG001|Overall Study|change of diagnosis|3|||
163097189|NCT00237042|589064782|FG000|Treatment|Became ineligible post-randomization|0|||
163097190|NCT00237042|589064783|FG001|Treatment|Became ineligible post-randomization|1|||
163097191|NCT00237042|589064784|FG002|Treatment|Became ineligible post-randomization|16|||
163097192|NCT00237042|589064782|FG000|Treatment|Moved out of state|1|||
163097193|NCT00237042|589064783|FG001|Treatment|Moved out of state|1|||
163097194|NCT00237042|589064784|FG002|Treatment|Moved out of state|1|||
163097195|NCT00237042|589064782|FG000|Treatment|Completed no treatment|5|||
163097196|NCT00237042|589064783|FG001|Treatment|Completed no treatment|5|||
163097197|NCT00237042|589064784|FG002|Treatment|Completed no treatment|21|||
163097198|NCT00237042|589064782|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
163097199|NCT00237042|589064783|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
163097200|NCT00237042|589064784|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
163097201|NCT00237042|589064782|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
163097202|NCT00237042|589064783|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
163097203|NCT00237042|589064784|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
162653067|NCT02347527|587447500|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
162653068|NCT02347527|587447501|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
162653069|NCT02347527|587447502|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
162653070|NCT02347527|587447503|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
162653071|NCT02347527|587447500|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
162653072|NCT02347527|587447501|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
162653073|NCT02347527|587447502|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
162653074|NCT02347527|587447503|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
162653075|NCT02347527|587447500|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163097204|NCT01913327|589064791|FG000|Overall Study|Withdrawal by Subject|0|||
163097205|NCT01913327|589064792|FG001|Overall Study|Withdrawal by Subject|1|||
163097206|NCT02151786|589064793|FG000|Overall Study|Unavailability of Case Report Form|26|||
163097207|NCT02151786|589064793|FG000|Overall Study|Outside the Contract Period|1|||
163097208|NCT02151786|589064793|FG000|Overall Study|Randomized, not Treated|1|||
163097209|NCT02151786|589064793|FG000|Overall Study|Unavailability of Information|8|||
163097210|NCT02112656|589064794|FG000|Overall Study|Death|78|||
163097211|NCT02112656|589064795|FG001|Overall Study|Death|82|||
163097212|NCT02112656|589064794|FG000|Overall Study|Withdrawal by Subject|9|||
163097213|NCT02112656|589064795|FG001|Overall Study|Withdrawal by Subject|11|||
163097214|NCT02112656|589064794|FG000|Overall Study|Lost to Follow-up|2|||
163097215|NCT02112656|589064795|FG001|Overall Study|Lost to Follow-up|4|||
163097216|NCT02112656|589064794|FG000|Overall Study|Noncompliance|1|||
163097217|NCT02112656|589064795|FG001|Overall Study|Noncompliance|2|||
163097218|NCT01234480|589065999|FG000|Overall Study|Pregnancy|88|||
163097219|NCT01234480|589065999|FG000|Overall Study|>36/Normal History|50|||
163097220|NCT01234480|589065999|FG000|Overall Study|Age|3|||
163097221|NCT01234480|589065999|FG000|Overall Study|HPV Vaccine History|28|||
163097222|NCT01234480|589065999|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
163097223|NCT01234480|589065999|FG000|Overall Study|Hysterectomy|2|||
163097224|NCT01234480|589065999|FG000|Overall Study|Hysterectomy post enrollment|1|||
163097225|NCT01234480|589065999|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
163097226|NCT01234480|589065999|FG000|Overall Study|Informed Consent Form Violation|30|||
163097227|NCT01234480|589065999|FG000|Overall Study|Incorrect Visit|3|||
163097228|NCT01234480|589065999|FG000|Overall Study|No Florida Lab License|20|||
163097229|NCT01234480|589065999|FG000|Overall Study|Out of Window|42|||
163097230|NCT01234480|589065999|FG000|Overall Study|Sample Processing/Storage|92|||
163097231|NCT01234480|589065999|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
163097232|NCT01234480|589065999|FG000|Overall Study|Site/Subject non-compliance|44|||
163097233|NCT01234480|589065999|FG000|Overall Study|Missing Sample|9|||
163097234|NCT03370419|589066000|FG000|Overall Study|Lost to Follow-up|16|||
163097235|NCT02595879|589066006|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
163097236|NCT02595879|589066007|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
163097237|NCT01898286|589066008|FG000|Overall Study|Withdrawal by Subject|1|||
163097238|NCT01898286|589066008|FG000|Overall Study|Protocol Violation|1|||
163097239|NCT01898286|589066008|FG000|Overall Study|Lost to Follow-up|1|||
163097240|NCT02197572|589066009|FG000|Overall Study|Progressive Disease|28|||
163097241|NCT02197572|589066009|FG000|Overall Study|Withdrawal by Subject|9|||
163097242|NCT02197572|589066009|FG000|Overall Study|Adverse Event|3|||
163097243|NCT02197572|589066009|FG000|Overall Study|Reason Not Specified|4|||
163097244|NCT02383862|589066010|FG000|3 Month Follow up|Lost to Follow-up|23|||
163097245|NCT02383862|589066011|FG001|3 Month Follow up|Lost to Follow-up|21|||
163097246|NCT03801928|589066012|FG000|Overall Study|Adverse Event|1|||
163097247|NCT03801928|589066013|FG001|Overall Study|Adverse Event|0|||
163097248|NCT03801928|589066014|FG002|Overall Study|Adverse Event|1|||
163097249|NCT03801928|589066015|FG003|Overall Study|Adverse Event|2|||
163097250|NCT03801928|589066016|FG004|Overall Study|Adverse Event|0|||
163097251|NCT03801928|589066017|FG005|Overall Study|Adverse Event|2|||
163097252|NCT03801928|589066012|FG000|Overall Study|Lack of Efficacy|0|||
163097253|NCT03801928|589066013|FG001|Overall Study|Lack of Efficacy|0|||
163097254|NCT03801928|589066014|FG002|Overall Study|Lack of Efficacy|1|||
163097255|NCT03801928|589066015|FG003|Overall Study|Lack of Efficacy|0|||
163097256|NCT03801928|589066016|FG004|Overall Study|Lack of Efficacy|0|||
163097257|NCT03801928|589066017|FG005|Overall Study|Lack of Efficacy|0|||
163097258|NCT03801928|589066012|FG000|Overall Study|Lost to Follow-up|5|||
163097259|NCT03801928|589066013|FG001|Overall Study|Lost to Follow-up|1|||
163097260|NCT03801928|589066014|FG002|Overall Study|Lost to Follow-up|1|||
163097261|NCT03801928|589066015|FG003|Overall Study|Lost to Follow-up|4|||
163097262|NCT03801928|589066016|FG004|Overall Study|Lost to Follow-up|4|||
163097263|NCT03801928|589066017|FG005|Overall Study|Lost to Follow-up|2|||
163097264|NCT03801928|589066012|FG000|Overall Study|Withdrawal by Subject|0|||
163097265|NCT03801928|589066013|FG001|Overall Study|Withdrawal by Subject|0|||
163097266|NCT03801928|589066014|FG002|Overall Study|Withdrawal by Subject|2|||
163097267|NCT03801928|589066015|FG003|Overall Study|Withdrawal by Subject|1|||
163097268|NCT03801928|589066016|FG004|Overall Study|Withdrawal by Subject|0|||
163097269|NCT03801928|589066017|FG005|Overall Study|Withdrawal by Subject|0|||
163097270|NCT03801928|589066012|FG000|Overall Study|Other|0|||
163097271|NCT03801928|589066013|FG001|Overall Study|Other|2|||
162653076|NCT02347527|587447501|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
162653077|NCT02347527|587447502|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163097272|NCT03801928|589066014|FG002|Overall Study|Other|0|||
163097273|NCT03801928|589066015|FG003|Overall Study|Other|1|||
163097274|NCT03801928|589066016|FG004|Overall Study|Other|0|||
162653078|NCT02347527|587447503|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
163097275|NCT03801928|589066017|FG005|Overall Study|Other|1|||
163097276|NCT02763059|589066018|FG000|Overall Study|Lost to Follow-up|4|||
163097277|NCT02763059|589066019|FG001|Overall Study|Lost to Follow-up|1|||
163097278|NCT02763059|589066020|FG002|Overall Study|Lost to Follow-up|6|||
163097279|NCT02763059|589066018|FG000|Overall Study|Withdrawal by Subject|1|||
163097280|NCT02763059|589066019|FG001|Overall Study|Withdrawal by Subject|0|||
163097281|NCT02763059|589066020|FG002|Overall Study|Withdrawal by Subject|3|||
163097282|NCT03688919|589066021|FG000|Overall Study|Lost to Follow-up|2|||
163097283|NCT03688919|589066022|FG001|Overall Study|Lost to Follow-up|1|||
163097284|NCT03688919|589066021|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
163097285|NCT03688919|589066022|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
163097286|NCT04423939|589066027|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
163097287|NCT04423939|589066028|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
163097288|NCT04423939|589066027|FG000|Overall Study|Death|3|||
163097289|NCT04423939|589066028|FG001|Overall Study|Death|0|||
163097290|NCT04423939|589066027|FG000|Overall Study|Withdrawal by Subject|3|||
163097291|NCT04423939|589066028|FG001|Overall Study|Withdrawal by Subject|0|||
163097292|NCT04423939|589066027|FG000|Overall Study|Caregiver to patient who died|0|||
163097293|NCT04423939|589066028|FG001|Overall Study|Caregiver to patient who died|3|||
163097294|NCT04423939|589066027|FG000|Overall Study|Caregiver to patient who withdrew|0|||
163097295|NCT04423939|589066028|FG001|Overall Study|Caregiver to patient who withdrew|3|||
163097296|NCT01722994|589066032|FG000|Overall Study|Missing data|25|||
163097297|NCT01722994|589066033|FG001|Overall Study|Missing data|17|||
163097298|NCT01206140|589066037|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
163097299|NCT01206140|589066038|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
163097300|NCT00075764|589066039|FG000|Overall Study|Adverse Event|5|||
163097301|NCT00075764|589066040|FG001|Overall Study|Adverse Event|12|||
163097302|NCT00075764|589066039|FG000|Overall Study|Death|4|||
163097303|NCT00075764|589066040|FG001|Overall Study|Death|8|||
163097304|NCT00075764|589066039|FG000|Overall Study|Withdrawal by Subject|28|||
163097305|NCT00075764|589066040|FG001|Overall Study|Withdrawal by Subject|18|||
163097306|NCT00075764|589066039|FG000|Overall Study|Progression|269|||
163097307|NCT00075764|589066040|FG001|Overall Study|Progression|274|||
163097308|NCT00075764|589066039|FG000|Overall Study|Still on treatment|8|||
163097309|NCT00075764|589066040|FG001|Overall Study|Still on treatment|15|||
163097310|NCT00075764|589066039|FG000|Overall Study|Delinquent|4|||
163097311|NCT00075764|589066040|FG001|Overall Study|Delinquent|2|||
163097312|NCT00075764|589066039|FG000|Overall Study|Not protocol specified|27|||
163097313|NCT00075764|589066040|FG001|Overall Study|Not protocol specified|19|||
163097314|NCT00075764|589066039|FG000|Overall Study|Under review|0|||
163097315|NCT00075764|589066040|FG001|Overall Study|Under review|1|||
163097316|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
163097317|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
163097318|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
163097319|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
163097320|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
163097321|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
163097322|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
163097323|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
163097324|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
163097325|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
163097326|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
162653079|NCT00596011|587447504|FG000|Overall Study|Withdrawal by Subject|2|||
163097327|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
163097328|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
163097329|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
163097330|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
163097331|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
163097332|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
163097333|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
163097334|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
163097335|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
163097336|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
163097337|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
163097338|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
163097339|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
163097340|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Other|6|||
163097341|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Other|0|||
163097342|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Other|0|||
163097343|NCT05615220|589066047|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
163097344|NCT05615220|589066048|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
163097345|NCT05615220|589066049|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
163097346|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
163097347|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
163097348|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
163097349|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
163097350|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
163097351|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
163097352|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
163097353|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
163097354|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
163097355|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
163097356|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
163097357|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
163097358|NCT05615220|589066047|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
163097359|NCT05615220|589066048|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
163097360|NCT05615220|589066049|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
163097361|NCT00533429|589066051|FG000|Overall Study|Adverse Event|3|||
163097362|NCT00533429|589066052|FG001|Overall Study|Adverse Event|1|||
163097363|NCT00533429|589066051|FG000|Overall Study|Death|1|||
163097364|NCT00533429|589066052|FG001|Overall Study|Death|0|||
163097365|NCT00533429|589066051|FG000|Overall Study|Withdrawal by Subject|2|||
163097366|NCT00533429|589066052|FG001|Overall Study|Withdrawal by Subject|0|||
163097367|NCT00533429|589066051|FG000|Overall Study|Progressive Disease|12|||
163097368|NCT00533429|589066052|FG001|Overall Study|Progressive Disease|13|||
163097369|NCT00533429|589066051|FG000|Overall Study|Symptomatic deterioration|1|||
163097370|NCT00533429|589066052|FG001|Overall Study|Symptomatic deterioration|2|||
163097371|NCT02655887|589066053|FG000|Overall Study|Lost to Follow-up|3|||
163097372|NCT02655887|589066053|FG000|Overall Study|Death|4|||
163097373|NCT02655887|589066053|FG000|Overall Study|Withdrawal by Subject|3|||
163097374|NCT02655887|589066053|FG000|Overall Study|Missed 12-month follow-up visit|4|||
163097375|NCT04245709|589066056|FG000|Overall Study|Adverse Event|13|||
163097376|NCT04245709|589066056|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
163097377|NCT04339413|589066060|FG000|Overall Study|Reason Not Specified|2|||
163097378|NCT04339413|589066061|FG001|Overall Study|Reason Not Specified|7|||
163097379|NCT04339413|589066060|FG000|Overall Study|Study Terminated by Sponsor|30|||
163097380|NCT04339413|589066061|FG001|Overall Study|Study Terminated by Sponsor|33|||
163097381|NCT04339413|589066060|FG000|Overall Study|Progressive Disease|9|||
163097382|NCT04339413|589066061|FG001|Overall Study|Progressive Disease|6|||
163097383|NCT04339413|589066060|FG000|Overall Study|Withdrawal by Subject|9|||
163097384|NCT04339413|589066061|FG001|Overall Study|Withdrawal by Subject|10|||
163097385|NCT04339413|589066060|FG000|Overall Study|Physician Decision|3|||
163097386|NCT04339413|589066061|FG001|Overall Study|Physician Decision|1|||
163097387|NCT04339413|589066060|FG000|Overall Study|Death|2|||
163097388|NCT04339413|589066061|FG001|Overall Study|Death|0|||
162653080|NCT00596011|587447505|FG001|Overall Study|Withdrawal by Subject|3|||
162653081|NCT00596011|587447504|FG000|Overall Study|Adverse Event|11|||
162653082|NCT00596011|587447505|FG001|Overall Study|Adverse Event|7|||
163097389|NCT04339413|589066060|FG000|Overall Study|Adverse Event|3|||
163097390|NCT04339413|589066061|FG001|Overall Study|Adverse Event|0|||
163097391|NCT01964378|589066065|FG000|Overall Study|Disc. due to death before first dosing|0|||
162653083|NCT01466270|587447510|FG000|Overall Study|Withdrawal by Subject|4|||
162653084|NCT01466270|587447511|FG001|Overall Study|Withdrawal by Subject|1|||
163097392|NCT01964378|589066066|FG001|Overall Study|Disc. due to death before first dosing|1|||
163097393|NCT01964378|589066065|FG000|Overall Study|Disc. due to AE before first dosing|1|||
163097394|NCT01964378|589066066|FG001|Overall Study|Disc. due to AE before first dosing|0|||
163097395|NCT01964378|589066065|FG000|Overall Study|Death|3|||
163097396|NCT01964378|589066066|FG001|Overall Study|Death|2|||
163097397|NCT01964378|589066065|FG000|Overall Study|Adverse Event|12|||
163097398|NCT01964378|589066066|FG001|Overall Study|Adverse Event|5|||
163097399|NCT01964378|589066065|FG000|Overall Study|Lack of Efficacy|0|||
163097400|NCT01964378|589066066|FG001|Overall Study|Lack of Efficacy|1|||
163097401|NCT01964378|589066065|FG000|Overall Study|Protocol Violation|0|||
163097402|NCT01964378|589066066|FG001|Overall Study|Protocol Violation|1|||
163097403|NCT01964378|589066065|FG000|Overall Study|Lost to Follow-up|0|||
163097404|NCT01964378|589066066|FG001|Overall Study|Lost to Follow-up|1|||
163097405|NCT01964378|589066065|FG000|Overall Study|Withdrawal by Subject|7|||
163097406|NCT01964378|589066066|FG001|Overall Study|Withdrawal by Subject|5|||
163097407|NCT01964378|589066065|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
163097408|NCT01964378|589066066|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
163097409|NCT01964378|589066065|FG000|Overall Study|Other|1|||
163097410|NCT01964378|589066066|FG001|Overall Study|Other|2|||
163097411|NCT00657267|589066074|FG000|Overall Study|Progressive disease|45|||
163097412|NCT00657267|589066074|FG000|Overall Study|Adverse Event|9|||
163097413|NCT00142792|589066077|FG000|Overall Study|Death|0|||
163097414|NCT00142792|589066078|FG001|Overall Study|Death|0|||
163097415|NCT00142792|589066079|FG002|Overall Study|Death|1|||
163097416|NCT00142792|589066077|FG000|Overall Study|Withdrawal by Subject|3|||
163097417|NCT00142792|589066078|FG001|Overall Study|Withdrawal by Subject|2|||
163097418|NCT00142792|589066079|FG002|Overall Study|Withdrawal by Subject|3|||
163097419|NCT00142792|589066077|FG000|Overall Study|Lost to Follow-up|8|||
163097420|NCT00142792|589066078|FG001|Overall Study|Lost to Follow-up|11|||
163097421|NCT00142792|589066079|FG002|Overall Study|Lost to Follow-up|7|||
163097422|NCT00142792|589066077|FG000|Overall Study|No category|1|||
163097423|NCT00142792|589066078|FG001|Overall Study|No category|2|||
163097424|NCT00142792|589066079|FG002|Overall Study|No category|1|||
163097425|NCT04872569|589066080|FG000|Overall Study|Withdrawal by Subject|2|||
163097426|NCT02382991|589066086|FG000|Overall Study|Adverse Event|1|||
163097427|NCT02382991|589066087|FG001|Overall Study|Adverse Event|2|||
163097428|NCT02382991|589066086|FG000|Overall Study|Lost to Follow-up|1|||
163097429|NCT02382991|589066087|FG001|Overall Study|Lost to Follow-up|0|||
163097430|NCT02382991|589066086|FG000|Overall Study|Withdrawal by Subject|0|||
163097431|NCT02382991|589066087|FG001|Overall Study|Withdrawal by Subject|1|||
163097432|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
163097433|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
163097434|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097435|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097436|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
163097437|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
163097438|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
163097439|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
162653085|NCT01466270|587447510|FG000|Overall Study|Physician Decision|1|||
163097440|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
163097441|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
163097442|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
163097443|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
163097444|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097445|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097446|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
163097447|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097448|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
163097449|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097450|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097451|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
163097452|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
163097453|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
163097454|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097455|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097456|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
163097457|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097458|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
163097459|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097460|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
162653086|NCT01466270|587447511|FG001|Overall Study|Physician Decision|0|||
162653087|NCT01466270|587447510|FG000|Overall Study|Lost to Follow-up|1|||
163097461|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
163097462|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
163097463|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097464|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097465|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097466|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
163097467|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
163097468|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097469|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097470|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097471|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
163097472|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
163097473|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097474|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097475|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097476|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
163097477|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097478|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
163097479|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097480|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097481|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
163097482|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
163097483|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097484|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097485|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097486|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
163097487|NCT04951622|589066088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097488|NCT04951622|589066089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
163097489|NCT04951622|589066090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097490|NCT04951622|589066091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097491|NCT04951622|589066092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
163097492|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097493|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097494|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
163097495|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
163097496|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
163097497|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097498|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097499|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
163097500|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
163097501|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
163097502|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
163097503|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
163097504|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
163097505|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
162653088|NCT01466270|587447511|FG001|Overall Study|Lost to Follow-up|3|||
162653089|NCT01466270|587447510|FG000|Overall Study|Progression|1|||
162653090|NCT01466270|587447511|FG001|Overall Study|Progression|0|||
162653091|NCT01466270|587447510|FG000|Overall Study|Toxicity|4|||
162653092|NCT01466270|587447511|FG001|Overall Study|Toxicity|1|||
162653093|NCT01466270|587447510|FG000|Overall Study|Multiple|1|||
162653094|NCT01466270|587447511|FG001|Overall Study|Multiple|1|||
162653095|NCT00749775|587447518|FG000|Overall Study|Protocol Violation|24|||
162653096|NCT00749775|587447518|FG000|Overall Study|Lost to Follow-up|36|||
162653097|NCT00749775|587447518|FG000|Overall Study|No visit after first day of treatment|44|||
163097506|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
163097507|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097508|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097509|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
163097510|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
163097511|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
163097512|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097513|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097514|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
163097515|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097516|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
163097517|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
162653098|NCT00749775|587447518|FG000|Overall Study|No drug administration|3|||
162653099|NCT03364049|587447528|FG000|Overall Study|Death|6|||
163097518|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
163097519|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
163097520|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
163097521|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
163097522|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
163097523|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
163097524|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
163097525|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
163097526|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
163097527|NCT04951622|589066088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097528|NCT04951622|589066089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097529|NCT04951622|589066090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097530|NCT04951622|589066091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
163097531|NCT04951622|589066092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
163097532|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
163097533|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
163097534|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
163097535|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097536|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097537|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097538|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097539|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097540|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097541|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097542|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097543|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097544|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097545|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097546|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097547|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
163097548|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163097549|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
163097550|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097551|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097552|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097553|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097554|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097555|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097556|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097557|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097558|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097559|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097560|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097561|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097562|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097563|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163097564|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097565|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097566|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097567|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
163097568|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097569|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097570|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097571|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097572|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097573|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097574|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097575|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097576|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
162719033|NCT02341625|587676737|FG000|Overall Study|Not Reported|0|||
162719034|NCT02341625|587676738|FG001|Overall Study|Not Reported|0|||
163097577|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097578|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097579|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
163097580|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097581|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097582|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
163097583|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097584|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097585|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097586|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097587|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097588|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097589|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097590|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097591|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097592|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097593|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097594|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097595|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
163097596|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097597|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097598|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097599|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
163097600|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097601|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097602|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097603|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097604|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097605|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097606|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097607|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097608|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097609|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097610|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097611|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163097612|NCT02891226|589066097|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097613|NCT02891226|589066098|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097614|NCT02891226|589066099|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097615|NCT02891226|589066100|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
163097616|NCT02891226|589066101|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097617|NCT02891226|589066102|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097618|NCT02891226|589066103|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097619|NCT02891226|589066104|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097620|NCT02891226|589066105|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097621|NCT02891226|589066106|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097622|NCT02891226|589066107|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097623|NCT02891226|589066108|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097624|NCT02891226|589066109|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097625|NCT02891226|589066110|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097626|NCT02891226|589066111|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097627|NCT02891226|589066112|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
163097628|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097629|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097630|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097631|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097632|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097633|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097634|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
163097635|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
163097636|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
163097637|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
163097638|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097639|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097640|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097641|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097642|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097643|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
163097644|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097645|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097646|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097647|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097648|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097649|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
163097650|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097651|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097652|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097653|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
163097654|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097655|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097656|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097657|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097658|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097659|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
163097660|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097661|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097662|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097663|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097664|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097665|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097666|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
163097667|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
163097668|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
163097669|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
163097670|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097671|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097672|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097673|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097674|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097675|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163097676|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097677|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097678|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097679|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097680|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
163097681|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097682|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097683|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097684|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097685|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097686|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097687|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097688|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097689|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097690|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097691|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163097692|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097693|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097694|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097695|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097696|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097697|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097698|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
163097699|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097700|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097701|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097702|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097703|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097704|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097705|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097706|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097707|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
163097708|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097709|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097710|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097711|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097712|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097713|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097714|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097715|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097716|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097717|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
163097718|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097719|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
162653100|NCT03364049|587447529|FG001|Overall Study|Death|4|||
163097720|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097721|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097722|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097723|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163097724|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097725|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097726|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097727|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097728|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097729|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097730|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097731|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
163097732|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097733|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097734|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097735|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097736|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097737|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097738|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097739|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
163097740|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097741|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097742|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097743|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097744|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097745|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097746|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097747|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097748|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
163097749|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097750|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097751|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097752|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097753|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097754|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097755|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
163097756|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097757|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097758|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097759|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097760|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097761|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097762|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097763|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097764|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097765|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
163097766|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097767|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097768|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097769|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097770|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097771|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
163097772|NCT02891226|589066097|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097773|NCT02891226|589066098|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097774|NCT02891226|589066099|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097775|NCT02891226|589066100|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097776|NCT02891226|589066101|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097777|NCT02891226|589066102|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
162653101|NCT03364049|587447530|FG002|Overall Study|Death|5|||
163097778|NCT02891226|589066103|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097779|NCT02891226|589066104|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
162653102|NCT03364049|587447531|FG003|Overall Study|Death|14|||
163097780|NCT02891226|589066105|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097781|NCT02891226|589066106|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
163097782|NCT02891226|589066107|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097783|NCT02891226|589066108|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097784|NCT02891226|589066109|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097785|NCT02891226|589066110|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097786|NCT02891226|589066111|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097787|NCT02891226|589066112|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
163097788|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097789|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097790|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097791|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097792|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097793|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097794|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097795|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097796|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097797|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097798|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
163097799|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097800|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097801|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097802|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097803|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163097804|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097805|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097806|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097807|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097808|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097809|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097810|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097811|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097812|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097813|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097814|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
163097815|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097816|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097817|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097818|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097819|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
163097820|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097821|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097822|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097823|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097824|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097825|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097826|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097827|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097828|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097829|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097830|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
163097831|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097832|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097833|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097834|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097835|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
163097836|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097837|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097838|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097839|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097840|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097841|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097842|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097843|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097844|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097845|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097846|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
163097847|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097848|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097849|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097850|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097851|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163097852|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097853|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097854|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097855|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097856|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097857|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097858|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097859|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097860|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097861|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097862|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
163097863|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097864|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097865|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097866|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097867|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163097868|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097869|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097870|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097871|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097872|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097873|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097874|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097875|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097876|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097877|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097878|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
163097879|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097880|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097881|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097882|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097883|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
163097884|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097885|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097886|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097887|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097888|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097889|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097890|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097891|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097892|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097893|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097894|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
163097895|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097896|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097897|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097898|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097899|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
163097900|NCT02891226|589066097|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097901|NCT02891226|589066098|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097902|NCT02891226|589066099|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097903|NCT02891226|589066100|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097904|NCT02891226|589066101|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097905|NCT02891226|589066102|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097906|NCT02891226|589066103|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097907|NCT02891226|589066104|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097908|NCT02891226|589066105|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097909|NCT02891226|589066106|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097910|NCT02891226|589066107|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
163097911|NCT02891226|589066108|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097912|NCT02891226|589066109|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097913|NCT02891226|589066110|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097914|NCT02891226|589066111|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097915|NCT02891226|589066112|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
163097916|NCT02891226|589066097|FG000|Follow-up Period|Withdrawal by Subject|0|||
163097917|NCT02891226|589066098|FG001|Follow-up Period|Withdrawal by Subject|0|||
163097918|NCT02891226|589066099|FG002|Follow-up Period|Withdrawal by Subject|0|||
163097919|NCT02891226|589066100|FG003|Follow-up Period|Withdrawal by Subject|0|||
163097920|NCT02891226|589066101|FG004|Follow-up Period|Withdrawal by Subject|0|||
163097921|NCT02891226|589066102|FG005|Follow-up Period|Withdrawal by Subject|0|||
163097922|NCT02891226|589066103|FG006|Follow-up Period|Withdrawal by Subject|0|||
163097923|NCT02891226|589066104|FG007|Follow-up Period|Withdrawal by Subject|0|||
163097924|NCT02891226|589066105|FG008|Follow-up Period|Withdrawal by Subject|0|||
163097925|NCT02891226|589066106|FG009|Follow-up Period|Withdrawal by Subject|0|||
163097926|NCT02891226|589066107|FG010|Follow-up Period|Withdrawal by Subject|0|||
163097927|NCT02891226|589066108|FG011|Follow-up Period|Withdrawal by Subject|1|||
163097928|NCT02891226|589066109|FG012|Follow-up Period|Withdrawal by Subject|0|||
163097929|NCT02891226|589066110|FG013|Follow-up Period|Withdrawal by Subject|0|||
163097930|NCT02891226|589066111|FG014|Follow-up Period|Withdrawal by Subject|1|||
163097931|NCT02891226|589066112|FG015|Follow-up Period|Withdrawal by Subject|1|||
163097932|NCT01445847|589066115|FG000|Overall Study|Protocol Violation|13|||
163097933|NCT01445847|589066116|FG001|Overall Study|Protocol Violation|14|||
163097934|NCT01445847|589066115|FG000|Overall Study|Missed Data|1|||
163097935|NCT01445847|589066116|FG001|Overall Study|Missed Data|0|||
163097936|NCT04570384|589066117|FG000|Overall Study|Adverse Event|2|||
163097937|NCT04570384|589066118|FG001|Overall Study|Adverse Event|1|||
163097938|NCT04570384|589066117|FG000|Overall Study|Death|2|||
163097939|NCT04570384|589066118|FG001|Overall Study|Death|5|||
163097940|NCT04570384|589066117|FG000|Overall Study|Lost to Follow-up|1|||
163097941|NCT04570384|589066118|FG001|Overall Study|Lost to Follow-up|0|||
163097942|NCT04570384|589066117|FG000|Overall Study|Other|1|||
163097943|NCT04570384|589066118|FG001|Overall Study|Other|0|||
163097944|NCT04570384|589066117|FG000|Overall Study|Protocol Violation|0|||
163097945|NCT04570384|589066118|FG001|Overall Study|Protocol Violation|1|||
163097946|NCT04570384|589066117|FG000|Overall Study|Sponsor Decision|1|||
163097947|NCT04570384|589066118|FG001|Overall Study|Sponsor Decision|0|||
163097948|NCT04570384|589066117|FG000|Overall Study|Withdrawal by Subject|4|||
163097949|NCT04570384|589066118|FG001|Overall Study|Withdrawal by Subject|2|||
163097950|NCT03654274|589066119|FG000|Overall Study|Adverse Event|19|||
163097951|NCT03654274|589066120|FG001|Overall Study|Adverse Event|23|||
163097952|NCT03654274|589066121|FG002|Overall Study|Adverse Event|24|||
163097953|NCT03654274|589066119|FG000|Overall Study|Protocol Deviation|0|||
163097954|NCT03654274|589066120|FG001|Overall Study|Protocol Deviation|2|||
163097955|NCT03654274|589066121|FG002|Overall Study|Protocol Deviation|0|||
163097956|NCT03654274|589066119|FG000|Overall Study|Lost to Follow-up|8|||
163097957|NCT03654274|589066120|FG001|Overall Study|Lost to Follow-up|6|||
163097958|NCT03654274|589066121|FG002|Overall Study|Lost to Follow-up|5|||
163097959|NCT03654274|589066119|FG000|Overall Study|Withdrawal by Subject|46|||
163097960|NCT03654274|589066120|FG001|Overall Study|Withdrawal by Subject|25|||
163097961|NCT03654274|589066121|FG002|Overall Study|Withdrawal by Subject|33|||
163097962|NCT03654274|589066119|FG000|Overall Study|Lack of Efficacy|4|||
163097963|NCT03654274|589066120|FG001|Overall Study|Lack of Efficacy|5|||
163097964|NCT03654274|589066121|FG002|Overall Study|Lack of Efficacy|7|||
163097965|NCT03654274|589066119|FG000|Overall Study|Pregnancy|2|||
163097966|NCT03654274|589066120|FG001|Overall Study|Pregnancy|2|||
163097967|NCT03654274|589066121|FG002|Overall Study|Pregnancy|1|||
163097968|NCT03654274|589066119|FG000|Overall Study|Other|27|||
163097969|NCT03654274|589066120|FG001|Overall Study|Other|29|||
163097970|NCT03654274|589066121|FG002|Overall Study|Other|32|||
163097971|NCT03654274|589066119|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
163097972|NCT03654274|589066120|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
163097973|NCT03654274|589066121|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
163097974|NCT02454530|589066122|FG000|Overall Study|Other|8|||
163097975|NCT02454530|589066123|FG001|Overall Study|Other|13|||
163097976|NCT02454530|589066122|FG000|Overall Study|Missing information|56|||
163097977|NCT02454530|589066123|FG001|Overall Study|Missing information|69|||
163097978|NCT02454530|589066122|FG000|Overall Study|Death|2|||
163097979|NCT02454530|589066123|FG001|Overall Study|Death|41|||
163097980|NCT02454530|589066122|FG000|Overall Study|Lost to Follow-up|4|||
163097981|NCT02454530|589066123|FG001|Overall Study|Lost to Follow-up|4|||
163097982|NCT00326001|589066124|FG000|Overall Study|Adverse Event|4|||
163097983|NCT00326001|589066125|FG001|Overall Study|Adverse Event|5|||
163097984|NCT00326001|589066124|FG000|Overall Study|Physician Decision|3|||
163097985|NCT00326001|589066125|FG001|Overall Study|Physician Decision|3|||
163097986|NCT03265145|589066126|FG000|Overall Study|Protocol Violation|2|||
163097987|NCT03265145|589066127|FG001|Overall Study|Protocol Violation|0|||
163097988|NCT03265145|589066126|FG000|Overall Study|Adverse Event|1|||
163097989|NCT03265145|589066127|FG001|Overall Study|Adverse Event|0|||
163097990|NCT03265145|589066126|FG000|Overall Study|Withdrawal by Subject|23|||
163097991|NCT03265145|589066127|FG001|Overall Study|Withdrawal by Subject|19|||
163097992|NCT03265145|589066126|FG000|Overall Study|Death|12|||
163097993|NCT03265145|589066127|FG001|Overall Study|Death|12|||
163097994|NCT03265145|589066126|FG000|Overall Study|Lost to Follow-up|13|||
163097995|NCT03265145|589066127|FG001|Overall Study|Lost to Follow-up|9|||
163097996|NCT03265145|589066126|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
163097997|NCT03265145|589066127|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
163097998|NCT03265145|589066126|FG000|Overall Study|Switched back to previous medication|1|||
163097999|NCT03265145|589066127|FG001|Overall Study|Switched back to previous medication|0|||
163098000|NCT03265145|589066126|FG000|Overall Study|Did not want to take medication|1|||
163098001|NCT03265145|589066127|FG001|Overall Study|Did not want to take medication|0|||
163098002|NCT03265145|589066126|FG000|Overall Study|Subject could not afford medication|0|||
163098003|NCT03265145|589066127|FG001|Overall Study|Subject could not afford medication|1|||
163098004|NCT03265145|589066126|FG000|Overall Study|Site closed|2|||
163098005|NCT03265145|589066127|FG001|Overall Study|Site closed|3|||
163098006|NCT03265145|589066126|FG000|Overall Study|Incorrectly randomized|16|||
163098007|NCT03265145|589066127|FG001|Overall Study|Incorrectly randomized|6|||
163098008|NCT03265145|589066126|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
163098009|NCT03265145|589066127|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
163098010|NCT03265145|589066126|FG000|Overall Study|Physician Decision|0|||
163098011|NCT03265145|589066127|FG001|Overall Study|Physician Decision|3|||
163098012|NCT03265145|589066126|FG000|Overall Study|Subject transferred to another facility|0|||
163098013|NCT03265145|589066127|FG001|Overall Study|Subject transferred to another facility|1|||
163098014|NCT02137070|589066128|FG000|Overall Study|Adverse Event|12|||
163098015|NCT02137070|589066129|FG001|Overall Study|Adverse Event|3|||
163098016|NCT02137070|589066128|FG000|Overall Study|Death|2|||
163098017|NCT02137070|589066129|FG001|Overall Study|Death|0|||
163098018|NCT02137070|589066128|FG000|Overall Study|Lost to Follow-up|24|||
163098019|NCT02137070|589066129|FG001|Overall Study|Lost to Follow-up|9|||
163098020|NCT02137070|589066128|FG000|Overall Study|Physician Decision|0|||
163098021|NCT02137070|589066129|FG001|Overall Study|Physician Decision|1|||
163098022|NCT02137070|589066128|FG000|Overall Study|Protocol Violation|18|||
163098023|NCT02137070|589066129|FG001|Overall Study|Protocol Violation|4|||
163098024|NCT02137070|589066128|FG000|Overall Study|Withdrawal by Subject|18|||
163098025|NCT02137070|589066129|FG001|Overall Study|Withdrawal by Subject|1|||
163154808|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
163154809|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
163154810|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
163154811|NCT04123470|589281442|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
163154812|NCT04123470|589281443|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
163154813|NCT03818256|589281444|FG000|Overall Study|Withdrawal by Subject|2|||
163154814|NCT03818256|589281445|FG001|Overall Study|Withdrawal by Subject|2|||
163154815|NCT03818256|589281444|FG000|Overall Study|Adverse Event|3|||
163154816|NCT03818256|589281445|FG001|Overall Study|Adverse Event|1|||
163154817|NCT03818256|589281444|FG000|Overall Study|Lost to Follow-up|0|||
163154818|NCT03818256|589281445|FG001|Overall Study|Lost to Follow-up|5|||
163154819|NCT03818256|589281444|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
163154820|NCT03818256|589281445|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
163154821|NCT03818256|589281444|FG000|Overall Study|Not reporting for scheduled visits|1|||
163154822|NCT03818256|589281445|FG001|Overall Study|Not reporting for scheduled visits|0|||
163154823|NCT03818256|589281444|FG000|Overall Study|Non-compliant with investigational product|1|||
163154824|NCT03818256|589281445|FG001|Overall Study|Non-compliant with investigational product|0|||
163154825|NCT02749422|589281446|FG000|Overall Study|Lost to Follow-up|0|||
163154826|NCT02749422|589281447|FG001|Overall Study|Lost to Follow-up|2|||
163154827|NCT02749422|589281446|FG000|Overall Study|Ineligible|0|||
163154828|NCT02749422|589281447|FG001|Overall Study|Ineligible|1|||
163154829|NCT00911170|589281448|FG000|Treatment Period|Randomized in error|1|||
163154830|NCT00911170|589281449|FG001|Treatment Period|Randomized in error|1|||
163154831|NCT00911170|589281448|FG000|Treatment Period|Ineligibility determined|1|||
163154832|NCT00911170|589281449|FG001|Treatment Period|Ineligibility determined|3|||
163154833|NCT00911170|589281448|FG000|Treatment Period|Protocol deviation|1|||
163154834|NCT00911170|589281449|FG001|Treatment Period|Protocol deviation|2|||
163154835|NCT00911170|589281448|FG000|Treatment Period|Adverse Event|9|||
163154836|NCT00911170|589281449|FG001|Treatment Period|Adverse Event|10|||
162653103|NCT03364049|587447528|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
163154837|NCT00911170|589281448|FG000|Treatment Period|Withdrawal by Subject|4|||
163154838|NCT00911170|589281449|FG001|Treatment Period|Withdrawal by Subject|4|||
163154839|NCT00911170|589281448|FG000|Treatment Period|Disease progression|0|||
162653104|NCT03364049|587447529|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
162653105|NCT03364049|587447530|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
162653106|NCT03364049|587447531|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
162653107|NCT03364049|587447528|FG000|Overall Study|Withdrawal by Subject|0|||
162653108|NCT03364049|587447529|FG001|Overall Study|Withdrawal by Subject|1|||
162653109|NCT03364049|587447530|FG002|Overall Study|Withdrawal by Subject|1|||
162653110|NCT03364049|587447531|FG003|Overall Study|Withdrawal by Subject|1|||
162653111|NCT01340976|587447532|FG000|Overall Study|Physician Decision|2|||
162653112|NCT01340976|587447533|FG001|Overall Study|Physician Decision|0|||
162653113|NCT01340976|587447534|FG002|Overall Study|Physician Decision|1|||
162653114|NCT01340976|587447535|FG003|Overall Study|Physician Decision|1|||
162653115|NCT01340976|587447536|FG004|Overall Study|Physician Decision|1|||
162653116|NCT01340976|587447537|FG005|Overall Study|Physician Decision|0|||
162653117|NCT01340976|587447532|FG000|Overall Study|Death|0|||
162653118|NCT01340976|587447533|FG001|Overall Study|Death|1|||
162653119|NCT01340976|587447534|FG002|Overall Study|Death|0|||
162653120|NCT01340976|587447535|FG003|Overall Study|Death|0|||
162653121|NCT01340976|587447536|FG004|Overall Study|Death|0|||
162653122|NCT01340976|587447537|FG005|Overall Study|Death|0|||
162653123|NCT01340976|587447532|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
162653124|NCT01340976|587447533|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162653125|NCT01340976|587447534|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162653126|NCT01340976|587447535|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162653127|NCT01340976|587447536|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162653128|NCT01340976|587447537|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162653129|NCT01340976|587447532|FG000|Overall Study|Withdrawal by Subject|0|||
162653130|NCT01340976|587447533|FG001|Overall Study|Withdrawal by Subject|0|||
162653131|NCT01340976|587447534|FG002|Overall Study|Withdrawal by Subject|0|||
162653132|NCT01340976|587447535|FG003|Overall Study|Withdrawal by Subject|1|||
162653133|NCT01340976|587447536|FG004|Overall Study|Withdrawal by Subject|1|||
162653134|NCT01340976|587447537|FG005|Overall Study|Withdrawal by Subject|0|||
162653135|NCT01340976|587447532|FG000|Overall Study|Other anemia treatment|1|||
162653136|NCT01340976|587447533|FG001|Overall Study|Other anemia treatment|0|||
162653137|NCT01340976|587447534|FG002|Overall Study|Other anemia treatment|2|||
162653138|NCT01340976|587447535|FG003|Overall Study|Other anemia treatment|1|||
162653139|NCT01340976|587447536|FG004|Overall Study|Other anemia treatment|0|||
162653140|NCT01340976|587447537|FG005|Overall Study|Other anemia treatment|1|||
162653141|NCT01340976|587447532|FG000|Overall Study|Adverse Event|0|||
162653142|NCT01340976|587447533|FG001|Overall Study|Adverse Event|1|||
162653143|NCT01340976|587447534|FG002|Overall Study|Adverse Event|0|||
162653144|NCT01340976|587447535|FG003|Overall Study|Adverse Event|0|||
162653145|NCT01340976|587447536|FG004|Overall Study|Adverse Event|0|||
162653146|NCT01340976|587447537|FG005|Overall Study|Adverse Event|0|||
162653147|NCT02953821|587447538|FG000|Overall Study|Adverse Event|0|||
162653148|NCT02953821|587447539|FG001|Overall Study|Adverse Event|4|||
162653149|NCT02953821|587447538|FG000|Overall Study|Death|1|||
162653150|NCT02953821|587447539|FG001|Overall Study|Death|0|||
162653151|NCT02953821|587447538|FG000|Overall Study|Progressive Disease|5|||
162653152|NCT02953821|587447539|FG001|Overall Study|Progressive Disease|1|||
162653153|NCT02953821|587447538|FG000|Overall Study|Lost to Follow-up|2|||
162653154|NCT02953821|587447539|FG001|Overall Study|Lost to Follow-up|0|||
162653155|NCT02953821|587447538|FG000|Overall Study|Physician Decision|1|||
162653156|NCT02953821|587447539|FG001|Overall Study|Physician Decision|1|||
162653157|NCT02953821|587447538|FG000|Overall Study|Withdrawal by Subject|3|||
162653158|NCT02953821|587447539|FG001|Overall Study|Withdrawal by Subject|3|||
162653159|NCT02953821|587447538|FG000|Overall Study|Change of address|0|||
162653160|NCT02953821|587447539|FG001|Overall Study|Change of address|1|||
162653161|NCT02953821|587447538|FG000|Overall Study|Lack of Efficacy|1|||
162653162|NCT02953821|587447539|FG001|Overall Study|Lack of Efficacy|0|||
162653163|NCT02953821|587447538|FG000|Overall Study|Out of state for indeterminate time|0|||
162653164|NCT02953821|587447539|FG001|Overall Study|Out of state for indeterminate time|1|||
162653165|NCT02953821|587447538|FG000|Overall Study|No improvement|0|||
162653166|NCT02953821|587447539|FG001|Overall Study|No improvement|1|||
162653167|NCT02953821|587447538|FG000|Overall Study|Refused follow-up visit|2|||
162653168|NCT02953821|587447539|FG001|Overall Study|Refused follow-up visit|1|||
162653169|NCT03064126|587447540|FG000|Overall Study|Death|40|||
162653170|NCT03064126|587447541|FG001|Overall Study|Death|16|||
162653171|NCT03064126|587447542|FG002|Overall Study|Death|4|||
162653172|NCT03064126|587447543|FG003|Overall Study|Death|2|||
162653173|NCT03064126|587447540|FG000|Overall Study|Withdrawal by Subject|17|||
162653174|NCT03064126|587447541|FG001|Overall Study|Withdrawal by Subject|9|||
162653175|NCT03064126|587447542|FG002|Overall Study|Withdrawal by Subject|0|||
162719035|NCT02341625|587676739|FG002|Overall Study|Not Reported|0|||
162653176|NCT03064126|587447543|FG003|Overall Study|Withdrawal by Subject|2|||
162653177|NCT03064126|587447540|FG000|Overall Study|Lost to Follow-up|7|||
162653178|NCT03064126|587447541|FG001|Overall Study|Lost to Follow-up|3|||
162653179|NCT03064126|587447542|FG002|Overall Study|Lost to Follow-up|0|||
162653180|NCT03064126|587447543|FG003|Overall Study|Lost to Follow-up|0|||
162653181|NCT03064126|587447540|FG000|Overall Study|Adverse Event|2|||
162653182|NCT03064126|587447541|FG001|Overall Study|Adverse Event|0|||
162653183|NCT03064126|587447542|FG002|Overall Study|Adverse Event|0|||
162653184|NCT03064126|587447543|FG003|Overall Study|Adverse Event|0|||
162653185|NCT03064126|587447540|FG000|Overall Study|Physician Decision|3|||
162653186|NCT03064126|587447541|FG001|Overall Study|Physician Decision|0|||
162653187|NCT03064126|587447542|FG002|Overall Study|Physician Decision|0|||
162653188|NCT03064126|587447543|FG003|Overall Study|Physician Decision|0|||
162653189|NCT03064126|587447540|FG000|Overall Study|Other reason for early termination|3|||
162653190|NCT03064126|587447541|FG001|Overall Study|Other reason for early termination|2|||
162653191|NCT03064126|587447542|FG002|Overall Study|Other reason for early termination|0|||
162653192|NCT03064126|587447543|FG003|Overall Study|Other reason for early termination|0|||
162653193|NCT03064126|587447540|FG000|Overall Study|Missed Visit|3|||
162653194|NCT03064126|587447541|FG001|Overall Study|Missed Visit|1|||
162653195|NCT03064126|587447542|FG002|Overall Study|Missed Visit|0|||
162653196|NCT03064126|587447543|FG003|Overall Study|Missed Visit|0|||
162653197|NCT03907683|587447549|FG000|Overall Study|Pregnancy|1|||
162653198|NCT03907683|587447549|FG000|Overall Study|Withdrawal by Subject|1|||
162653199|NCT03400332|587447550|FG000|Pre-Treatment|Other reasons|0|||
162653200|NCT03400332|587447551|FG001|Pre-Treatment|Other reasons|0|||
162653201|NCT03400332|587447552|FG002|Pre-Treatment|Other reasons|0|||
162653202|NCT03400332|587447553|FG003|Pre-Treatment|Other reasons|0|||
163098026|NCT03640325|589067774|FG000|Overall Study|Withdrawal by Subject|4|||
163098027|NCT03640325|589067775|FG001|Overall Study|Withdrawal by Subject|1|||
163098028|NCT03640325|589067776|FG002|Overall Study|Withdrawal by Subject|0|||
163098029|NCT03640325|589067774|FG000|Overall Study|Lost to Follow-up|4|||
163098030|NCT03640325|589067775|FG001|Overall Study|Lost to Follow-up|5|||
163098031|NCT03640325|589067776|FG002|Overall Study|Lost to Follow-up|21|||
163098032|NCT03640325|589067774|FG000|Overall Study|Death|5|||
163098033|NCT03640325|589067775|FG001|Overall Study|Death|5|||
163098034|NCT03640325|589067776|FG002|Overall Study|Death|0|||
163098035|NCT01566149|589067779|FG000|Overall Study|Adverse Event|0|||
163098036|NCT01566149|589067780|FG001|Overall Study|Adverse Event|1|||
163098037|NCT01566149|589067779|FG000|Overall Study|Non-compliance with study medication|2|||
163098038|NCT01566149|589067780|FG001|Overall Study|Non-compliance with study medication|0|||
163098039|NCT01566149|589067779|FG000|Overall Study|Protocol Violation|0|||
163098040|NCT01566149|589067780|FG001|Overall Study|Protocol Violation|1|||
163098041|NCT01566149|589067779|FG000|Overall Study|Withdrawal by Subject|1|||
163098042|NCT01566149|589067780|FG001|Overall Study|Withdrawal by Subject|0|||
163098043|NCT03718325|589067785|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
163098044|NCT03718325|589067786|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
163098045|NCT03718325|589067787|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
163098046|NCT03718325|589067785|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
163098047|NCT03718325|589067786|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
163098048|NCT03718325|589067787|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
163098049|NCT03687957|589067788|FG000|Overall Study|Withdrawal by Subject|0|||
163098050|NCT03687957|589067789|FG001|Overall Study|Withdrawal by Subject|0|||
163098051|NCT03687957|589067790|FG002|Overall Study|Withdrawal by Subject|0|||
163098052|NCT03687957|589067791|FG003|Overall Study|Withdrawal by Subject|2|||
163098053|NCT03687957|589067792|FG004|Overall Study|Withdrawal by Subject|0|||
163098054|NCT03687957|589067793|FG005|Overall Study|Withdrawal by Subject|0|||
163098055|NCT03687957|589067794|FG006|Overall Study|Withdrawal by Subject|3|||
163098056|NCT03687957|589067795|FG007|Overall Study|Withdrawal by Subject|1|||
163098057|NCT03687957|589067796|FG008|Overall Study|Withdrawal by Subject|1|||
163098058|NCT03687957|589067797|FG009|Overall Study|Withdrawal by Subject|0|||
163098059|NCT03687957|589067788|FG000|Overall Study|Disease progression|0|||
162653203|NCT03400332|587447554|FG004|Pre-Treatment|Other reasons|0|||
162653204|NCT03400332|587447555|FG005|Pre-Treatment|Other reasons|0|||
162653205|NCT03400332|587447556|FG006|Pre-Treatment|Other reasons|0|||
162653206|NCT03400332|587447557|FG007|Pre-Treatment|Other reasons|0|||
162653207|NCT03400332|587447558|FG008|Pre-Treatment|Other reasons|1|||
162653208|NCT03400332|587447550|FG000|Pre-Treatment|No longer met study criteria|0|||
162653209|NCT03400332|587447551|FG001|Pre-Treatment|No longer met study criteria|0|||
162653210|NCT03400332|587447552|FG002|Pre-Treatment|No longer met study criteria|0|||
162653211|NCT03400332|587447553|FG003|Pre-Treatment|No longer met study criteria|0|||
162653212|NCT03400332|587447554|FG004|Pre-Treatment|No longer met study criteria|0|||
162653213|NCT03400332|587447555|FG005|Pre-Treatment|No longer met study criteria|0|||
162653214|NCT03400332|587447556|FG006|Pre-Treatment|No longer met study criteria|0|||
162653215|NCT03400332|587447557|FG007|Pre-Treatment|No longer met study criteria|0|||
162653216|NCT03400332|587447558|FG008|Pre-Treatment|No longer met study criteria|1|||
162719036|NCT02341625|587676740|FG003|Overall Study|Not Reported|0|||
162653217|NCT03400332|587447550|FG000|Pre-Treatment|Withdrawal by Subject|0|||
163098060|NCT03687957|589067789|FG001|Overall Study|Disease progression|1|||
163098061|NCT03687957|589067790|FG002|Overall Study|Disease progression|1|||
163098062|NCT03687957|589067791|FG003|Overall Study|Disease progression|2|||
163098063|NCT03687957|589067792|FG004|Overall Study|Disease progression|2|||
163098064|NCT03687957|589067793|FG005|Overall Study|Disease progression|0|||
163098065|NCT03687957|589067794|FG006|Overall Study|Disease progression|2|||
163098066|NCT03687957|589067795|FG007|Overall Study|Disease progression|1|||
163098067|NCT03687957|589067796|FG008|Overall Study|Disease progression|0|||
163098068|NCT03687957|589067797|FG009|Overall Study|Disease progression|0|||
163098069|NCT03687957|589067788|FG000|Overall Study|Physician Decision|0|||
163098070|NCT03687957|589067789|FG001|Overall Study|Physician Decision|0|||
163098071|NCT03687957|589067790|FG002|Overall Study|Physician Decision|0|||
163098072|NCT03687957|589067791|FG003|Overall Study|Physician Decision|2|||
163098073|NCT03687957|589067792|FG004|Overall Study|Physician Decision|1|||
163098074|NCT03687957|589067793|FG005|Overall Study|Physician Decision|0|||
163098075|NCT03687957|589067794|FG006|Overall Study|Physician Decision|1|||
163098076|NCT03687957|589067795|FG007|Overall Study|Physician Decision|0|||
163098077|NCT03687957|589067796|FG008|Overall Study|Physician Decision|0|||
163098078|NCT03687957|589067797|FG009|Overall Study|Physician Decision|0|||
163098079|NCT03687957|589067788|FG000|Overall Study|New malignancy|0|||
163098080|NCT03687957|589067789|FG001|Overall Study|New malignancy|0|||
163098081|NCT03687957|589067790|FG002|Overall Study|New malignancy|0|||
163098082|NCT03687957|589067791|FG003|Overall Study|New malignancy|0|||
163098083|NCT03687957|589067792|FG004|Overall Study|New malignancy|1|||
163098084|NCT03687957|589067793|FG005|Overall Study|New malignancy|0|||
163098085|NCT03687957|589067794|FG006|Overall Study|New malignancy|0|||
163098086|NCT03687957|589067795|FG007|Overall Study|New malignancy|0|||
163098087|NCT03687957|589067796|FG008|Overall Study|New malignancy|0|||
163098088|NCT03687957|589067797|FG009|Overall Study|New malignancy|0|||
163098089|NCT03687957|589067788|FG000|Overall Study|Adverse Event|0|||
163098090|NCT03687957|589067789|FG001|Overall Study|Adverse Event|0|||
163098091|NCT03687957|589067790|FG002|Overall Study|Adverse Event|0|||
163098092|NCT03687957|589067791|FG003|Overall Study|Adverse Event|0|||
163098093|NCT03687957|589067792|FG004|Overall Study|Adverse Event|0|||
163098094|NCT03687957|589067793|FG005|Overall Study|Adverse Event|2|||
163098095|NCT03687957|589067794|FG006|Overall Study|Adverse Event|0|||
163098096|NCT03687957|589067795|FG007|Overall Study|Adverse Event|3|||
163098097|NCT03687957|589067796|FG008|Overall Study|Adverse Event|0|||
163098098|NCT03687957|589067797|FG009|Overall Study|Adverse Event|0|||
163098099|NCT03687957|589067788|FG000|Overall Study|Patient went on hospice|0|||
163098100|NCT03687957|589067789|FG001|Overall Study|Patient went on hospice|0|||
163098101|NCT03687957|589067790|FG002|Overall Study|Patient went on hospice|0|||
163098102|NCT03687957|589067791|FG003|Overall Study|Patient went on hospice|0|||
163098103|NCT03687957|589067792|FG004|Overall Study|Patient went on hospice|0|||
163098104|NCT03687957|589067793|FG005|Overall Study|Patient went on hospice|0|||
163098105|NCT03687957|589067794|FG006|Overall Study|Patient went on hospice|1|||
163098106|NCT03687957|589067795|FG007|Overall Study|Patient went on hospice|0|||
163098107|NCT03687957|589067796|FG008|Overall Study|Patient went on hospice|0|||
163098108|NCT03687957|589067797|FG009|Overall Study|Patient went on hospice|0|||
163098109|NCT03687957|589067788|FG000|Overall Study|Death|0|||
162653218|NCT03400332|587447551|FG001|Pre-Treatment|Withdrawal by Subject|0|||
162653219|NCT03400332|587447552|FG002|Pre-Treatment|Withdrawal by Subject|0|||
162653220|NCT03400332|587447553|FG003|Pre-Treatment|Withdrawal by Subject|0|||
163098110|NCT03687957|589067789|FG001|Overall Study|Death|0|||
163098111|NCT03687957|589067790|FG002|Overall Study|Death|0|||
163098112|NCT03687957|589067791|FG003|Overall Study|Death|0|||
163098113|NCT03687957|589067792|FG004|Overall Study|Death|0|||
163098114|NCT03687957|589067793|FG005|Overall Study|Death|0|||
163098115|NCT03687957|589067794|FG006|Overall Study|Death|0|||
162653221|NCT03400332|587447554|FG004|Pre-Treatment|Withdrawal by Subject|0|||
162653222|NCT03400332|587447555|FG005|Pre-Treatment|Withdrawal by Subject|0|||
163098116|NCT03687957|589067795|FG007|Overall Study|Death|1|||
163098117|NCT03687957|589067796|FG008|Overall Study|Death|0|||
163098118|NCT03687957|589067797|FG009|Overall Study|Death|0|||
163098119|NCT01147965|589067803|FG000|Overall Study|Progressive Disease|3|||
163098120|NCT01147965|589067804|FG001|Overall Study|Progressive Disease|3|||
163098121|NCT01147965|589067805|FG002|Overall Study|Progressive Disease|5|||
163098122|NCT01147965|589067806|FG003|Overall Study|Progressive Disease|9|||
163098123|NCT01147965|589067807|FG004|Overall Study|Progressive Disease|5|||
163098124|NCT01147965|589067808|FG005|Overall Study|Progressive Disease|5|||
163098125|NCT01147965|589067803|FG000|Overall Study|Death|0|||
163098126|NCT01147965|589067804|FG001|Overall Study|Death|0|||
163098127|NCT01147965|589067805|FG002|Overall Study|Death|1|||
163098128|NCT01147965|589067806|FG003|Overall Study|Death|1|||
163098129|NCT01147965|589067807|FG004|Overall Study|Death|0|||
162653223|NCT03400332|587447556|FG006|Pre-Treatment|Withdrawal by Subject|0|||
163098130|NCT01147965|589067808|FG005|Overall Study|Death|2|||
163098131|NCT01147965|589067803|FG000|Overall Study|Withdrawal by Subject|0|||
163098132|NCT01147965|589067804|FG001|Overall Study|Withdrawal by Subject|0|||
163098133|NCT01147965|589067805|FG002|Overall Study|Withdrawal by Subject|1|||
163098134|NCT01147965|589067806|FG003|Overall Study|Withdrawal by Subject|1|||
163098135|NCT01147965|589067807|FG004|Overall Study|Withdrawal by Subject|0|||
163098136|NCT01147965|589067808|FG005|Overall Study|Withdrawal by Subject|0|||
163098137|NCT01147965|589067803|FG000|Overall Study|Administration Of Alternative Therapy|0|||
163098138|NCT01147965|589067804|FG001|Overall Study|Administration Of Alternative Therapy|0|||
163098139|NCT01147965|589067805|FG002|Overall Study|Administration Of Alternative Therapy|0|||
163098140|NCT01147965|589067806|FG003|Overall Study|Administration Of Alternative Therapy|0|||
163098141|NCT01147965|589067807|FG004|Overall Study|Administration Of Alternative Therapy|0|||
163098142|NCT01147965|589067808|FG005|Overall Study|Administration Of Alternative Therapy|1|||
163098143|NCT01147965|589067803|FG000|Overall Study|Other|0|||
163098144|NCT01147965|589067804|FG001|Overall Study|Other|0|||
163098145|NCT01147965|589067805|FG002|Overall Study|Other|0|||
163098146|NCT01147965|589067806|FG003|Overall Study|Other|3|||
163098147|NCT01147965|589067807|FG004|Overall Study|Other|1|||
163098148|NCT01147965|589067808|FG005|Overall Study|Other|0|||
163098149|NCT00620373|589067809|FG000|Overall Study|Unverified cancer status|33|||
163098150|NCT01465386|589067814|FG000|Overall Study|Lack of Efficacy|3|||
163098151|NCT01465386|589067814|FG000|Overall Study|Adverse Event|1|||
163098152|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
163098153|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
163098154|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
163098155|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
163098156|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
163098157|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
163098158|NCT01279044|589067815|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
163098159|NCT01279044|589067816|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
163098160|NCT01279044|589067817|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
163098161|NCT01408277|589067820|FG000|Overall Study|Adverse Event|3|||
163098162|NCT01408277|589067821|FG001|Overall Study|Adverse Event|4|||
163098163|NCT01408277|589067820|FG000|Overall Study|Lost to Follow-up|1|||
163098164|NCT01408277|589067821|FG001|Overall Study|Lost to Follow-up|0|||
163098165|NCT01408277|589067820|FG000|Overall Study|Withdrawal by Subject|2|||
163098166|NCT01408277|589067821|FG001|Overall Study|Withdrawal by Subject|0|||
163098167|NCT01408277|589067820|FG000|Overall Study|Protocol Violation|2|||
163098168|NCT01408277|589067821|FG001|Overall Study|Protocol Violation|0|||
163098169|NCT02630693|589067828|FG000|Overall Study|No receive treatment|0|||
163098170|NCT02630693|589067829|FG001|Overall Study|No receive treatment|1|||
163098171|NCT01724216|589067830|FG000|Overall Study|Scan was not completed|1|||
163098172|NCT00175916|589067831|FG000|Overall Study|Death|19|||
163098173|NCT00175916|589067831|FG000|Overall Study|Adverse Event|81|||
163098174|NCT00175916|589067831|FG000|Overall Study|Lack of Efficacy|354|||
163098175|NCT00175916|589067831|FG000|Overall Study|Lost to Follow-up|17|||
163098176|NCT00175916|589067831|FG000|Overall Study|Subject Choice|98|||
163098177|NCT00175916|589067831|FG000|Overall Study|Lack of compliance|8|||
163098178|NCT00175916|589067831|FG000|Overall Study|Patient cannot record seizures|1|||
163098179|NCT00175916|589067831|FG000|Overall Study|Sponsor decision|17|||
163098180|NCT00175916|589067831|FG000|Overall Study|Vigabatrin intake|1|||
163098181|NCT00175916|589067831|FG000|Overall Study|Suicidal behaviour|1|||
163098182|NCT00175916|589067831|FG000|Overall Study|Withdrawal by Subject|1|||
163098183|NCT00175916|589067831|FG000|Overall Study|Seizure - free|4|||
163098184|NCT00175916|589067831|FG000|Overall Study|Administrative reason|1|||
163098185|NCT00175916|589067831|FG000|Overall Study|Pregnancy|1|||
163098186|NCT00175916|589067831|FG000|Overall Study|Patient's request|2|||
163098187|NCT00175916|589067831|FG000|Overall Study|Treating physiciant's choice|1|||
163098188|NCT00175916|589067831|FG000|Overall Study|Moved overseas|1|||
163098189|NCT00175916|589067831|FG000|Overall Study|Loss of job and economic burden|1|||
163098190|NCT00175916|589067831|FG000|Overall Study|Site was closed|9|||
163098191|NCT00175916|589067831|FG000|Overall Study|Patient went to prison|1|||
163098192|NCT01456130|589067833|FG000|Overall Study|Adverse Event|4|||
163098193|NCT01456130|589067833|FG000|Overall Study|Voluntary Withdrawal|1|||
163098194|NCT01456130|589067833|FG000|Overall Study|Lack of Efficacy|4|||
163098195|NCT01456130|589067833|FG000|Overall Study|Other|1|||
163098196|NCT03369665|589067838|FG000|Overall Study|Adverse Event|3|||
163098197|NCT03369665|589067838|FG000|Overall Study|Lost to Follow-up|7|||
163098198|NCT03369665|589067838|FG000|Overall Study|Withdrawal by Subject|15|||
162653224|NCT03400332|587447557|FG007|Pre-Treatment|Withdrawal by Subject|0|||
162653225|NCT03400332|587447558|FG008|Pre-Treatment|Withdrawal by Subject|1|||
163098199|NCT03369665|589067838|FG000|Overall Study|Progression Disease|2|||
163098200|NCT03369665|589067838|FG000|Overall Study|Not classified|3|||
162653226|NCT03400332|587447550|FG000|Treatment|Participant withdrew consent|2|||
163098201|NCT03230318|589067839|FG000|Overall Study|Radiographic disease progression|72|||
163098202|NCT03230318|589067840|FG001|Overall Study|Radiographic disease progression|19|||
163098203|NCT03230318|589067839|FG000|Overall Study|Clinical progression|17|||
163098204|NCT03230318|589067840|FG001|Overall Study|Clinical progression|7|||
163098205|NCT03230318|589067839|FG000|Overall Study|Adverse Event|5|||
163098206|NCT03230318|589067840|FG001|Overall Study|Adverse Event|3|||
163098207|NCT03230318|589067839|FG000|Overall Study|Physician Decision|2|||
162653227|NCT03400332|587447551|FG001|Treatment|Participant withdrew consent|2|||
163098208|NCT03230318|589067840|FG001|Overall Study|Physician Decision|3|||
163098209|NCT03230318|589067839|FG000|Overall Study|Death|3|||
163098210|NCT03230318|589067840|FG001|Overall Study|Death|2|||
163098211|NCT03230318|589067839|FG000|Overall Study|Lost to Follow-up|1|||
163098212|NCT03230318|589067840|FG001|Overall Study|Lost to Follow-up|0|||
163098213|NCT03230318|589067839|FG000|Overall Study|Withdrawal by Subject|1|||
163098214|NCT03230318|589067840|FG001|Overall Study|Withdrawal by Subject|3|||
163098215|NCT03230318|589067839|FG000|Overall Study|Other|3|||
163098216|NCT03230318|589067840|FG001|Overall Study|Other|7|||
163098217|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
163098218|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
163098219|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
163098220|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
163098221|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
163098222|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
163098223|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
163098224|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
163098225|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
163098226|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
163098227|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
163098228|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
163098229|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
163098230|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
163098231|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
163098232|NCT01057693|589067842|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
163098233|NCT01057693|589067843|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
163098234|NCT01057693|589067844|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
163098235|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
163098236|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
163098237|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
163098238|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
163098239|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
163098240|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
163098241|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
163098242|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
163098243|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
163098244|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
163098245|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
163098246|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
163098247|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
163098248|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
163098249|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
163098250|NCT01057693|589067842|FG000|Between Single-Blind and Double-Blind|Other|6|||
163098251|NCT01057693|589067843|FG001|Between Single-Blind and Double-Blind|Other|0|||
163098252|NCT01057693|589067844|FG002|Between Single-Blind and Double-Blind|Other|0|||
163098253|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
163098254|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
163098255|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
163098256|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
163098257|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
163098258|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
163098259|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
162653228|NCT03400332|587447552|FG002|Treatment|Participant withdrew consent|0|||
162653229|NCT03400332|587447553|FG003|Treatment|Participant withdrew consent|0|||
162653230|NCT03400332|587447554|FG004|Treatment|Participant withdrew consent|3|||
162653231|NCT03400332|587447555|FG005|Treatment|Participant withdrew consent|3|||
162653232|NCT03400332|587447556|FG006|Treatment|Participant withdrew consent|1|||
162653233|NCT03400332|587447557|FG007|Treatment|Participant withdrew consent|1|||
162653234|NCT03400332|587447558|FG008|Treatment|Participant withdrew consent|1|||
162653235|NCT03400332|587447550|FG000|Treatment|Other reasons|0|||
162653236|NCT03400332|587447551|FG001|Treatment|Other reasons|1|||
163098260|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
163098261|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
163098262|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
163098263|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
163098264|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
163098265|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
162653237|NCT03400332|587447552|FG002|Treatment|Other reasons|1|||
163098266|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
162653238|NCT03400332|587447553|FG003|Treatment|Other reasons|0|||
162653239|NCT03400332|587447554|FG004|Treatment|Other reasons|3|||
162653240|NCT03400332|587447555|FG005|Treatment|Other reasons|1|||
162653241|NCT03400332|587447556|FG006|Treatment|Other reasons|2|||
162653242|NCT03400332|587447557|FG007|Treatment|Other reasons|0|||
162653243|NCT03400332|587447558|FG008|Treatment|Other reasons|1|||
162653244|NCT03400332|587447550|FG000|Treatment|Lost to Follow-up|0|||
163098267|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
163098268|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
163098269|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
163098270|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
162653245|NCT03400332|587447551|FG001|Treatment|Lost to Follow-up|1|||
162653246|NCT03400332|587447552|FG002|Treatment|Lost to Follow-up|0|||
162653247|NCT03400332|587447553|FG003|Treatment|Lost to Follow-up|0|||
162653248|NCT03400332|587447554|FG004|Treatment|Lost to Follow-up|0|||
162653249|NCT03400332|587447555|FG005|Treatment|Lost to Follow-up|0|||
162653250|NCT03400332|587447556|FG006|Treatment|Lost to Follow-up|0|||
162653251|NCT03400332|587447557|FG007|Treatment|Lost to Follow-up|0|||
162653252|NCT03400332|587447558|FG008|Treatment|Lost to Follow-up|0|||
162653253|NCT03400332|587447550|FG000|Treatment|Death|3|||
162653254|NCT03400332|587447551|FG001|Treatment|Death|1|||
162653255|NCT03400332|587447552|FG002|Treatment|Death|2|||
162653256|NCT03400332|587447553|FG003|Treatment|Death|3|||
162653257|NCT03400332|587447554|FG004|Treatment|Death|6|||
162653258|NCT03400332|587447555|FG005|Treatment|Death|2|||
162653259|NCT03400332|587447556|FG006|Treatment|Death|1|||
162653260|NCT03400332|587447557|FG007|Treatment|Death|3|||
162653261|NCT03400332|587447558|FG008|Treatment|Death|6|||
163098271|NCT01057693|589067842|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
163098272|NCT01057693|589067843|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
163098273|NCT01057693|589067844|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
163098274|NCT02959463|589067845|FG000|Overall Study|Adverse Event|1|||
163098275|NCT02959463|589067846|FG001|Overall Study|Adverse Event|1|||
163098276|NCT02959463|589067845|FG000|Overall Study|Death|1|||
163098277|NCT02959463|589067846|FG001|Overall Study|Death|0|||
163098278|NCT02959463|589067845|FG000|Overall Study|Withdrawal by Subject|1|||
163098279|NCT02959463|589067846|FG001|Overall Study|Withdrawal by Subject|0|||
163098280|NCT02413996|589067847|FG000|Overall Study|not comfortable with the intervention|9|||
163098281|NCT02413996|589067848|FG001|Overall Study|not comfortable with the intervention|2|||
163098282|NCT00709319|589067849|FG000|Overall Study|Death|4|||
163098283|NCT00709319|589067849|FG000|Overall Study|Withdrawal by Subject|2|||
163098284|NCT00090779|589067850|FG000|Step 1|Withdrawal by Subject|4|||
163098285|NCT00090779|589067851|FG001|Step 1|Withdrawal by Subject|2|||
163098286|NCT00090779|589067850|FG000|Step 1|Lost to Follow-up|3|||
163098287|NCT00090779|589067851|FG001|Step 1|Lost to Follow-up|2|||
163098288|NCT00090779|589067850|FG000|Step 1|Death|0|||
163098289|NCT00090779|589067851|FG001|Step 1|Death|2|||
163098290|NCT00090779|589067850|FG000|Step 1|Physician Decision|1|||
163098291|NCT00090779|589067851|FG001|Step 1|Physician Decision|0|||
163098292|NCT00090779|589067850|FG000|Step 1|Pregnancy|1|||
163098293|NCT00090779|589067851|FG001|Step 1|Pregnancy|0|||
163098294|NCT00090779|589067850|FG000|Step 1|Non-compliance to study requirements|0|||
163098295|NCT00090779|589067851|FG001|Step 1|Non-compliance to study requirements|1|||
163098296|NCT00090779|589067850|FG000|Step 1|Subject relocated|2|||
163098297|NCT00090779|589067851|FG001|Step 1|Subject relocated|8|||
163098298|NCT00090779|589067850|FG000|Step 2|Off study per study closure|6|||
163098299|NCT00090779|589067851|FG001|Step 2|Off study per study closure|16|||
163098300|NCT00090779|589067850|FG000|Step 2|Subject relocated|0|||
163098301|NCT00090779|589067851|FG001|Step 2|Subject relocated|1|||
163098302|NCT00090779|589067850|FG000|Step 2|Non-compliance to study requirements|0|||
162653262|NCT00048542|587447559|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162653263|NCT00048542|587447560|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
162653264|NCT00048542|587447561|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
162653265|NCT00048542|587447562|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162653266|NCT00048542|587447563|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
162653267|NCT00048542|587447564|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
162653268|NCT00048542|587447565|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
162653269|NCT00048542|587447566|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
163098303|NCT00090779|589067851|FG001|Step 2|Non-compliance to study requirements|1|||
163098304|NCT00090779|589067850|FG000|Step 3|Initiation of ART and off extended study|3|||
163098305|NCT00090779|589067851|FG001|Step 3|Initiation of ART and off extended study|2|||
163098306|NCT00090779|589067850|FG000|Step 3|Off extended study due to study closure|4|||
162653270|NCT00048542|587447559|FG000|Double-Blind Phase|Protocol Violation|0|||
162653271|NCT00048542|587447560|FG001|Double-Blind Phase|Protocol Violation|0|||
162653272|NCT00048542|587447561|FG002|Double-Blind Phase|Protocol Violation|1|||
162653273|NCT00048542|587447562|FG003|Double-Blind Phase|Protocol Violation|0|||
162653274|NCT00048542|587447563|FG004|Double-Blind Phase|Protocol Violation|0|||
163098307|NCT00090779|589067851|FG001|Step 3|Off extended study due to study closure|3|||
162653275|NCT00048542|587447564|FG005|Double-Blind Phase|Protocol Violation|0|||
162653276|NCT00048542|587447565|FG006|Double-Blind Phase|Protocol Violation|0|||
162653277|NCT00048542|587447566|FG007|Double-Blind Phase|Protocol Violation|0|||
162653278|NCT00048542|587447559|FG000|Double-Blind Phase|Sponsor request or decision|2|||
162653279|NCT00048542|587447560|FG001|Double-Blind Phase|Sponsor request or decision|0|||
162653280|NCT00048542|587447561|FG002|Double-Blind Phase|Sponsor request or decision|0|||
162653281|NCT00048542|587447562|FG003|Double-Blind Phase|Sponsor request or decision|0|||
162653282|NCT00048542|587447563|FG004|Double-Blind Phase|Sponsor request or decision|0|||
162653283|NCT00048542|587447564|FG005|Double-Blind Phase|Sponsor request or decision|0|||
162653284|NCT00048542|587447565|FG006|Double-Blind Phase|Sponsor request or decision|0|||
162653285|NCT00048542|587447566|FG007|Double-Blind Phase|Sponsor request or decision|0|||
162653286|NCT00048542|587447559|FG000|Double-Blind Phase|Randomized in error|1|||
162653287|NCT00048542|587447560|FG001|Double-Blind Phase|Randomized in error|0|||
162653288|NCT00048542|587447561|FG002|Double-Blind Phase|Randomized in error|0|||
162653289|NCT00048542|587447562|FG003|Double-Blind Phase|Randomized in error|0|||
162653290|NCT00048542|587447563|FG004|Double-Blind Phase|Randomized in error|0|||
162653291|NCT00048542|587447564|FG005|Double-Blind Phase|Randomized in error|0|||
162653292|NCT00048542|587447565|FG006|Double-Blind Phase|Randomized in error|0|||
162653293|NCT00048542|587447566|FG007|Double-Blind Phase|Randomized in error|0|||
162653294|NCT00048542|587447559|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653295|NCT00048542|587447560|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653296|NCT00048542|587447561|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653297|NCT00048542|587447562|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653298|NCT00048542|587447563|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
162653299|NCT00048542|587447564|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
162653300|NCT00048542|587447565|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653301|NCT00048542|587447566|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162653302|NCT00048542|587447559|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653303|NCT00048542|587447560|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653304|NCT00048542|587447561|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653305|NCT00048542|587447562|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653306|NCT00048542|587447563|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653307|NCT00048542|587447564|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
162653308|NCT00048542|587447565|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653309|NCT00048542|587447566|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
162653310|NCT00048542|587447559|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653311|NCT00048542|587447560|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653312|NCT00048542|587447561|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653313|NCT00048542|587447562|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653314|NCT00048542|587447563|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
162653315|NCT00048542|587447564|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
162653316|NCT00048542|587447565|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653317|NCT00048542|587447566|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162653318|NCT00048542|587447559|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
162653319|NCT00048542|587447560|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
162653320|NCT00048542|587447561|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
163098308|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
163098309|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
163098310|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
163098311|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
163098312|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
162653321|NCT00048542|587447562|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
162653322|NCT00048542|587447563|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
162653323|NCT00048542|587447564|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
162653324|NCT00048542|587447565|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
162653325|NCT00048542|587447566|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
162653326|NCT00048542|587447559|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162653327|NCT00048542|587447560|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
163098313|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
163098314|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
163098315|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
162653328|NCT00048542|587447561|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162653329|NCT00048542|587447562|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162653330|NCT00048542|587447563|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
162653331|NCT00048542|587447564|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
162653332|NCT00048542|587447565|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162653333|NCT00048542|587447566|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162653334|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162719037|NCT02341625|587676741|FG004|Overall Study|Not Reported|0|||
163098316|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
163098317|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
163098318|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
163098319|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
163098320|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
163098321|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
163098322|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
163098323|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
163098324|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
163098325|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
163098326|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
163098327|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
163098328|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
163098329|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
163098330|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
163098331|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
163098332|NCT01672879|589067852|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
163098333|NCT01672879|589067853|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
163098334|NCT01672879|589067854|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
163098335|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
163098336|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
163098337|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
163098338|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
163098339|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
163098340|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
163098341|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
163098342|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
163098343|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
163098344|NCT01672879|589067852|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
163098345|NCT01672879|589067853|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
163098346|NCT01672879|589067854|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
163098347|NCT03951766|589067859|FG000|Treatment Phase|Lost to Follow-up|1|||
163098348|NCT03951766|589067859|FG000|Follow-up Phase|Lost to Follow-up|10|||
163098349|NCT00041470|589067860|FG000|Overall Study|Loss of Funding|38|||
163098350|NCT04158375|589067865|FG000|Overall Study|Withdrawal by Subject|0|||
163098351|NCT04158375|589067866|FG001|Overall Study|Withdrawal by Subject|3|||
163098352|NCT04158375|589067867|FG002|Overall Study|Withdrawal by Subject|0|||
163098353|NCT04847843|589067868|FG000|Overall Study|Scheduling Conflicts|6|||
163098354|NCT04847843|589067869|FG001|Overall Study|Scheduling Conflicts|9|||
163098355|NCT04847843|589067868|FG000|Overall Study|Withdrawal by Subject|1|||
163098356|NCT04847843|589067869|FG001|Overall Study|Withdrawal by Subject|0|||
163098357|NCT04847843|589067868|FG000|Overall Study|Lost to Follow-up|1|||
163098358|NCT04847843|589067869|FG001|Overall Study|Lost to Follow-up|1|||
163098359|NCT04847843|589067868|FG000|Overall Study|Pregnancy|0|||
163098360|NCT04847843|589067869|FG001|Overall Study|Pregnancy|2|||
163098361|NCT04847843|589067868|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
163098362|NCT04847843|589067869|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
163098363|NCT02734004|589067870|FG000|Overall Study|Death|36|||
163098364|NCT02734004|589067871|FG001|Overall Study|Death|24|||
163098365|NCT02734004|589067872|FG002|Overall Study|Death|26|||
163098366|NCT02734004|589067873|FG003|Overall Study|Death|35|||
163098367|NCT02734004|589067874|FG004|Overall Study|Death|13|||
163098368|NCT02734004|589067875|FG005|Overall Study|Death|17|||
163098369|NCT02734004|589067876|FG006|Overall Study|Death|20|||
163098370|NCT02734004|589067870|FG000|Overall Study|Lost to Follow-up|1|||
163098371|NCT02734004|589067871|FG001|Overall Study|Lost to Follow-up|1|||
163098372|NCT02734004|589067872|FG002|Overall Study|Lost to Follow-up|0|||
163098373|NCT02734004|589067873|FG003|Overall Study|Lost to Follow-up|0|||
163098374|NCT02734004|589067874|FG004|Overall Study|Lost to Follow-up|1|||
163098375|NCT02734004|589067875|FG005|Overall Study|Lost to Follow-up|0|||
163098376|NCT02734004|589067876|FG006|Overall Study|Lost to Follow-up|0|||
163098377|NCT02734004|589067870|FG000|Overall Study|Withdrawal by Subject|3|||
163098378|NCT02734004|589067871|FG001|Overall Study|Withdrawal by Subject|1|||
163098379|NCT02734004|589067872|FG002|Overall Study|Withdrawal by Subject|1|||
163098380|NCT02734004|589067873|FG003|Overall Study|Withdrawal by Subject|1|||
163098381|NCT02734004|589067874|FG004|Overall Study|Withdrawal by Subject|3|||
163098382|NCT02734004|589067875|FG005|Overall Study|Withdrawal by Subject|0|||
163098383|NCT02734004|589067876|FG006|Overall Study|Withdrawal by Subject|2|||
163098384|NCT02734004|589067870|FG000|Overall Study|Other|0|||
163098385|NCT02734004|589067871|FG001|Overall Study|Other|8|||
163098386|NCT02734004|589067872|FG002|Overall Study|Other|7|||
163098387|NCT02734004|589067873|FG003|Overall Study|Other|4|||
163098388|NCT02734004|589067874|FG004|Overall Study|Other|34|||
163098389|NCT02734004|589067875|FG005|Overall Study|Other|14|||
163098390|NCT02734004|589067876|FG006|Overall Study|Other|10|||
163098391|NCT01459666|589067878|FG000|Overall Study|PI left institution|5|||
163098392|NCT01459666|589067879|FG001|Overall Study|PI left institution|4|||
163098393|NCT01061385|589067880|FG000|Overall Study|Lost to Follow-up|1|||
163098394|NCT01061385|589067881|FG001|Overall Study|Lost to Follow-up|0|||
163098395|NCT01061385|589067880|FG000|Overall Study|subject decision not related to AE|0|||
163098396|NCT01061385|589067881|FG001|Overall Study|subject decision not related to AE|1|||
163098397|NCT02379052|589067894|FG000|Overall Study|Protocol Violation|0|||
163098398|NCT02379052|589067895|FG001|Overall Study|Protocol Violation|1|||
163098399|NCT02379052|589067894|FG000|Overall Study|Adverse Event|0|||
163098400|NCT02379052|589067895|FG001|Overall Study|Adverse Event|1|||
163098401|NCT02379052|589067894|FG000|Overall Study|Physician Decision|1|||
163098402|NCT02379052|589067895|FG001|Overall Study|Physician Decision|1|||
163098403|NCT02379052|589067894|FG000|Overall Study|Withdrawal by Subject|2|||
163098404|NCT02379052|589067895|FG001|Overall Study|Withdrawal by Subject|0|||
163098405|NCT02379052|589067894|FG000|Overall Study|Lost to Follow-up|2|||
163098406|NCT02379052|589067895|FG001|Overall Study|Lost to Follow-up|1|||
163098407|NCT02379052|589067894|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
163098408|NCT02379052|589067895|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
163098409|NCT02379052|589067894|FG000|Overall Study|Subject was Incarcerated|0|||
163098410|NCT02379052|589067895|FG001|Overall Study|Subject was Incarcerated|1|||
163098411|NCT00127855|589067896|FG000|Primary Vaccination Course|Adverse Event|0|||
163098412|NCT00127855|589067897|FG001|Primary Vaccination Course|Adverse Event|0|||
163098413|NCT00127855|589067898|FG002|Primary Vaccination Course|Adverse Event|1|||
163098414|NCT00127855|589067899|FG003|Primary Vaccination Course|Adverse Event|0|||
163098415|NCT00127855|589067900|FG004|Primary Vaccination Course|Adverse Event|0|||
163098416|NCT00127855|589067896|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
163098417|NCT00127855|589067897|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
163098418|NCT00127855|589067898|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
163098419|NCT00127855|589067899|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
163098420|NCT00127855|589067900|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
163098421|NCT00127855|589067896|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
163098422|NCT00127855|589067897|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
163098423|NCT00127855|589067898|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
163098424|NCT00127855|589067899|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
163098425|NCT00127855|589067900|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
163098426|NCT00127855|589067896|FG000|Primary Vaccination Course|Other|0|||
163098427|NCT00127855|589067897|FG001|Primary Vaccination Course|Other|0|||
163098428|NCT00127855|589067898|FG002|Primary Vaccination Course|Other|0|||
163098429|NCT00127855|589067899|FG003|Primary Vaccination Course|Other|0|||
163098430|NCT00127855|589067900|FG004|Primary Vaccination Course|Other|1|||
163098431|NCT02343302|589067901|FG000|Overall Study|Physician Decision|1|||
163098432|NCT02343302|589067902|FG001|Overall Study|Physician Decision|1|||
163098433|NCT01282866|589067905|FG000|Overall Study|Adverse Event|1|||
163098434|NCT04834726|589067906|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
163098435|NCT04834726|589067907|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
163098436|NCT04834726|589067908|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
163098437|NCT04834726|589067909|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
163098438|NCT04834726|589067910|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
163098439|NCT04834726|589067911|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
163098440|NCT04834726|589067912|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
163098441|NCT04834726|589067913|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
163098442|NCT04834726|589067914|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
163098443|NCT02948582|589067921|FG000|Washout Period 1|Adverse Event|0|||
163098444|NCT02948582|589067922|FG001|Washout Period 1|Adverse Event|2|||
163098445|NCT02948582|589067923|FG002|Washout Period 1|Adverse Event|0|||
163098446|NCT02948582|589067924|FG003|Washout Period 1|Adverse Event|0|||
163098447|NCT02948582|589067925|FG004|Washout Period 1|Adverse Event|0|||
163098448|NCT02948582|589067926|FG005|Washout Period 1|Adverse Event|0|||
163098449|NCT02948582|589067921|FG000|Washout Period 1|Protocol Violation|0|||
163098450|NCT02948582|589067922|FG001|Washout Period 1|Protocol Violation|0|||
163098451|NCT02948582|589067923|FG002|Washout Period 1|Protocol Violation|0|||
163098452|NCT02948582|589067924|FG003|Washout Period 1|Protocol Violation|0|||
163098453|NCT02948582|589067925|FG004|Washout Period 1|Protocol Violation|0|||
163098454|NCT02948582|589067926|FG005|Washout Period 1|Protocol Violation|1|||
163098455|NCT02948582|589067921|FG000|Washout Period 2|Adverse Event|0|||
163098456|NCT02948582|589067922|FG001|Washout Period 2|Adverse Event|1|||
163098457|NCT02948582|589067923|FG002|Washout Period 2|Adverse Event|0|||
163098458|NCT02948582|589067924|FG003|Washout Period 2|Adverse Event|0|||
163098459|NCT02948582|589067925|FG004|Washout Period 2|Adverse Event|0|||
163098460|NCT02948582|589067926|FG005|Washout Period 2|Adverse Event|0|||
163098461|NCT02948582|589067921|FG000|Washout Period 2|personal reasons|0|||
162719038|NCT02341625|587676742|FG005|Overall Study|Not Reported|0|||
162653335|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162653336|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162653337|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162653338|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162653339|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162653340|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
162653341|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
162653342|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653343|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653344|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653345|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653346|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653347|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162653348|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
162653349|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
162653350|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162653351|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162653352|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162653353|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
163098462|NCT02948582|589067922|FG001|Washout Period 2|personal reasons|0|||
163098463|NCT02948582|589067923|FG002|Washout Period 2|personal reasons|0|||
163098464|NCT02948582|589067924|FG003|Washout Period 2|personal reasons|1|||
163098465|NCT02948582|589067925|FG004|Washout Period 2|personal reasons|0|||
163098466|NCT02948582|589067926|FG005|Washout Period 2|personal reasons|0|||
163098467|NCT02948582|589067921|FG000|Washout Period 4|Adverse Event|1|||
163098468|NCT02948582|589067922|FG001|Washout Period 4|Adverse Event|0|||
163098469|NCT02948582|589067923|FG002|Washout Period 4|Adverse Event|1|||
163098470|NCT02948582|589067924|FG003|Washout Period 4|Adverse Event|0|||
163098471|NCT02948582|589067925|FG004|Washout Period 4|Adverse Event|0|||
163098472|NCT02948582|589067926|FG005|Washout Period 4|Adverse Event|0|||
163098473|NCT03810014|589067932|FG000|Overall Study|Pregnancy|2|||
163098474|NCT03810014|589067933|FG001|Overall Study|Pregnancy|2|||
163098475|NCT03810014|589067934|FG002|Overall Study|Pregnancy|0|||
163098476|NCT03810014|589067935|FG003|Overall Study|Pregnancy|2|||
163098477|NCT03606486|589067936|FG000|Overall Study|Unable to collect sample|5|||
163098478|NCT00442416|589067946|FG000|Overall Study|Adverse Event|4|||
163098479|NCT00442416|589067947|FG001|Overall Study|Adverse Event|1|||
163098480|NCT00442416|589067946|FG000|Overall Study|Death|1|||
163098481|NCT00442416|589067947|FG001|Overall Study|Death|0|||
163098482|NCT00442416|589067946|FG000|Overall Study|Lack of Efficacy|2|||
163098483|NCT00442416|589067947|FG001|Overall Study|Lack of Efficacy|0|||
163098484|NCT00442416|589067946|FG000|Overall Study|Protocol Violation|2|||
163098485|NCT00442416|589067947|FG001|Overall Study|Protocol Violation|3|||
163098486|NCT00442416|589067946|FG000|Overall Study|Withdrew consent|1|||
163098487|NCT00442416|589067947|FG001|Overall Study|Withdrew consent|2|||
163098488|NCT00442416|589067946|FG000|Overall Study|Administrative/Other|27|||
163098489|NCT00442416|589067947|FG001|Overall Study|Administrative/Other|33|||
163098494|NCT01265992|589067954|FG000|Overall Study|Lost to Follow-up|1|||
163098495|NCT01265992|589067954|FG000|Overall Study|Withdrawal by Subject|1|||
163098496|NCT01265992|589067954|FG000|Overall Study|Adverse Event|1|||
163098497|NCT01265992|589067954|FG000|Overall Study|Administrative reasons|2|||
163098498|NCT01265992|589067954|FG000|Overall Study|Stopped treatment|3|||
163098499|NCT01265992|589067954|FG000|Overall Study|Did not receive treatment|1|||
163098500|NCT01102491|589067955|FG000|Overall Study|Protocol Violation|11|||
163098501|NCT01102491|589067956|FG001|Overall Study|Protocol Violation|12|||
163098502|NCT01444430|589067961|FG000|Overall Study|Withdrawal by Subject|53|||
163098503|NCT01444430|589067962|FG001|Overall Study|Withdrawal by Subject|72|||
163098504|NCT01444430|589067961|FG000|Overall Study|Death|6|||
163098505|NCT01444430|589067962|FG001|Overall Study|Death|8|||
163098506|NCT01444430|589067961|FG000|Overall Study|Lost to Follow-up|2|||
163098507|NCT01444430|589067962|FG001|Overall Study|Lost to Follow-up|0|||
163098508|NCT01444430|589067961|FG000|Overall Study|CRF termination module not completed.|0|||
163098509|NCT01444430|589067962|FG001|Overall Study|CRF termination module not completed.|1|||
163098510|NCT01142388|589069667|FG000|Overall Study|Lack of Efficacy|21|||
163098511|NCT01142388|589069668|FG001|Overall Study|Lack of Efficacy|31|||
163098512|NCT01142388|589069667|FG000|Overall Study|Adverse Event|9|||
163098513|NCT01142388|589069668|FG001|Overall Study|Adverse Event|5|||
163098514|NCT01142388|589069667|FG000|Overall Study|Death|3|||
163098515|NCT01142388|589069668|FG001|Overall Study|Death|2|||
163098516|NCT01142388|589069667|FG000|Overall Study|Withdrawal by Subject|5|||
163098517|NCT01142388|589069668|FG001|Overall Study|Withdrawal by Subject|3|||
163098518|NCT01142388|589069667|FG000|Overall Study|Alternative therapy|1|||
163098519|NCT01142388|589069668|FG001|Overall Study|Alternative therapy|0|||
163098520|NCT01142388|589069667|FG000|Overall Study|Other complications|0|||
163098521|NCT01142388|589069668|FG001|Overall Study|Other complications|2|||
163098522|NCT01142388|589069667|FG000|Overall Study|Other|1|||
163098523|NCT01142388|589069668|FG001|Overall Study|Other|1|||
163098524|NCT01142388|589069667|FG000|Overall Study|Never started therapy|7|||
163098525|NCT01142388|589069668|FG001|Overall Study|Never started therapy|3|||
163098526|NCT05265728|589069674|FG000|Overall Study|Adverse Event|1|||
163098527|NCT05265728|589069674|FG000|Overall Study|Study Terminated by Sponsor|5|||
163098528|NCT05265728|589069674|FG000|Overall Study|Withdrawal by Subject|2|||
163098529|NCT03493451|589069675|FG000|Overall Study|Death|11|||
163098530|NCT03493451|589069676|FG001|Overall Study|Death|26|||
163098531|NCT03493451|589069677|FG002|Overall Study|Death|3|||
163098532|NCT03493451|589069675|FG000|Overall Study|Lost to Follow-up|1|||
163098533|NCT03493451|589069676|FG001|Overall Study|Lost to Follow-up|4|||
163098534|NCT03493451|589069677|FG002|Overall Study|Lost to Follow-up|1|||
163098535|NCT03493451|589069675|FG000|Overall Study|Withdrawal by Subject|1|||
163098536|NCT03493451|589069676|FG001|Overall Study|Withdrawal by Subject|1|||
163098537|NCT03493451|589069677|FG002|Overall Study|Withdrawal by Subject|2|||
163098538|NCT03493451|589069675|FG000|Overall Study|Progressive Disease|1|||
163098539|NCT03493451|589069676|FG001|Overall Study|Progressive Disease|0|||
163098540|NCT03493451|589069677|FG002|Overall Study|Progressive Disease|0|||
163098541|NCT03493451|589069675|FG000|Overall Study|Transferred to long term extension study|8|||
163098542|NCT03493451|589069676|FG001|Overall Study|Transferred to long term extension study|13|||
163098543|NCT03493451|589069677|FG002|Overall Study|Transferred to long term extension study|5|||
163098544|NCT01693250|589069678|FG000|Overall Study|Lost to Follow-up|2|||
163098545|NCT01693250|589069679|FG001|Overall Study|Lost to Follow-up|2|||
163098546|NCT02257242|589069680|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
163098547|NCT02257242|589069681|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098548|NCT02257242|589069682|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098549|NCT02257242|589069683|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098550|NCT02257242|589069684|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098551|NCT02257242|589069685|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098552|NCT02257242|589069686|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098553|NCT02257242|589069687|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098554|NCT02257242|589069688|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163098555|NCT00600106|589069689|FG000|Overall Study|Withdrawal by Subject|1|||
163098556|NCT00600106|589069690|FG001|Overall Study|Withdrawal by Subject|1|||
163098557|NCT02213926|589069691|FG000|Overall Study|Death|59|||
163098558|NCT02213926|589069691|FG000|Overall Study|Withdrawal by Subject|10|||
163098559|NCT02213926|589069691|FG000|Overall Study|study terminated by sponsor|51|||
163098560|NCT02213926|589069691|FG000|Overall Study|Lost to Follow-up|3|||
163098561|NCT02213926|589069691|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
163098562|NCT03783962|589069694|FG000|Overall Study|Lost to Follow-up|3|||
163098563|NCT03783962|589069695|FG001|Overall Study|Lost to Follow-up|6|||
163098564|NCT03783962|589069694|FG000|Overall Study|Protocol Violation|0|||
163098565|NCT03783962|589069695|FG001|Overall Study|Protocol Violation|1|||
163098566|NCT02370368|589069696|FG000|Overall Study|Adverse Event|1|||
163098567|NCT02370368|589069697|FG001|Overall Study|Adverse Event|2|||
163098568|NCT02370368|589069696|FG000|Overall Study|Withdrawal by Subject|5|||
163098569|NCT02370368|589069697|FG001|Overall Study|Withdrawal by Subject|4|||
163098570|NCT01169337|589069698|FG000|Overall Study|Lack of Efficacy|5|||
163098571|NCT01169337|589069699|FG001|Overall Study|Lack of Efficacy|7|||
163098572|NCT01169337|589069700|FG002|Overall Study|Lack of Efficacy|0|||
163098573|NCT01169337|589069698|FG000|Overall Study|Adverse Event|12|||
163098574|NCT01169337|589069699|FG001|Overall Study|Adverse Event|18|||
163098575|NCT01169337|589069700|FG002|Overall Study|Adverse Event|0|||
163098576|NCT01169337|589069698|FG000|Overall Study|Death|2|||
163098577|NCT01169337|589069699|FG001|Overall Study|Death|0|||
163098578|NCT01169337|589069700|FG002|Overall Study|Death|0|||
163098579|NCT01169337|589069698|FG000|Overall Study|Withdrawal by Subject|11|||
163098580|NCT01169337|589069699|FG001|Overall Study|Withdrawal by Subject|11|||
163098581|NCT01169337|589069700|FG002|Overall Study|Withdrawal by Subject|6|||
163098582|NCT01169337|589069698|FG000|Overall Study|Noncompliance|2|||
163098583|NCT01169337|589069699|FG001|Overall Study|Noncompliance|0|||
163098584|NCT01169337|589069700|FG002|Overall Study|Noncompliance|0|||
163098585|NCT01169337|589069698|FG000|Overall Study|Other complicating disease|1|||
163098586|NCT01169337|589069699|FG001|Overall Study|Other complicating disease|1|||
163098587|NCT01169337|589069700|FG002|Overall Study|Other complicating disease|0|||
163098588|NCT01169337|589069698|FG000|Overall Study|Physician Decision|1|||
163098589|NCT01169337|589069699|FG001|Overall Study|Physician Decision|5|||
163098590|NCT01169337|589069700|FG002|Overall Study|Physician Decision|0|||
163098591|NCT01169337|589069698|FG000|Overall Study|Alternative therapy|0|||
163098592|NCT01169337|589069699|FG001|Overall Study|Alternative therapy|2|||
163098593|NCT01169337|589069700|FG002|Overall Study|Alternative therapy|0|||
163098594|NCT01169337|589069698|FG000|Overall Study|Changed hospital|0|||
163098595|NCT01169337|589069699|FG001|Overall Study|Changed hospital|1|||
163098596|NCT01169337|589069700|FG002|Overall Study|Changed hospital|0|||
163098597|NCT01169337|589069698|FG000|Overall Study|Never started treatment|0|||
163098598|NCT01169337|589069699|FG001|Overall Study|Never started treatment|2|||
163098599|NCT01169337|589069700|FG002|Overall Study|Never started treatment|0|||
163098600|NCT01169337|589069698|FG000|Overall Study|Reason not reported|1|||
163098601|NCT01169337|589069699|FG001|Overall Study|Reason not reported|0|||
163098602|NCT01169337|589069700|FG002|Overall Study|Reason not reported|0|||
163098603|NCT01169337|589069698|FG000|Overall Study|Continuing lenalidomide|9|||
163098604|NCT01169337|589069699|FG001|Overall Study|Continuing lenalidomide|43|||
163098605|NCT01169337|589069700|FG002|Overall Study|Continuing lenalidomide|0|||
163098606|NCT01643408|589069702|FG000|Overall Study|Adverse Event|12|||
163098607|NCT01643408|589069702|FG000|Overall Study|Other|2|||
163098608|NCT03726658|589069703|FG000|Overall Study|Lost to Follow-up|0|||
163098609|NCT03726658|589069704|FG001|Overall Study|Lost to Follow-up|0|||
163098610|NCT03726658|589069705|FG002|Overall Study|Lost to Follow-up|2|||
163098611|NCT03726658|589069706|FG003|Overall Study|Lost to Follow-up|0|||
163098612|NCT03726658|589069707|FG004|Overall Study|Lost to Follow-up|0|||
163098613|NCT03726658|589069708|FG005|Overall Study|Lost to Follow-up|1|||
163098614|NCT03726658|589069709|FG006|Overall Study|Lost to Follow-up|1|||
163098615|NCT03726658|589069703|FG000|Overall Study|Withdrawal by Subject|1|||
163098616|NCT03726658|589069704|FG001|Overall Study|Withdrawal by Subject|0|||
163098617|NCT03726658|589069705|FG002|Overall Study|Withdrawal by Subject|0|||
163098618|NCT03726658|589069706|FG003|Overall Study|Withdrawal by Subject|0|||
163098619|NCT03726658|589069707|FG004|Overall Study|Withdrawal by Subject|6|||
163098620|NCT03726658|589069708|FG005|Overall Study|Withdrawal by Subject|4|||
163098621|NCT03726658|589069709|FG006|Overall Study|Withdrawal by Subject|2|||
163098622|NCT03726658|589069703|FG000|Overall Study|Pregnancy|0|||
163098623|NCT03726658|589069704|FG001|Overall Study|Pregnancy|0|||
163098624|NCT03726658|589069705|FG002|Overall Study|Pregnancy|0|||
163098625|NCT03726658|589069706|FG003|Overall Study|Pregnancy|0|||
163098626|NCT03726658|589069707|FG004|Overall Study|Pregnancy|0|||
163098627|NCT03726658|589069708|FG005|Overall Study|Pregnancy|0|||
163098628|NCT03726658|589069709|FG006|Overall Study|Pregnancy|1|||
163098629|NCT03726658|589069703|FG000|Overall Study|Not Reported|0|||
163098630|NCT03726658|589069704|FG001|Overall Study|Not Reported|0|||
163098631|NCT03726658|589069705|FG002|Overall Study|Not Reported|0|||
163098632|NCT03726658|589069706|FG003|Overall Study|Not Reported|0|||
163098633|NCT03726658|589069707|FG004|Overall Study|Not Reported|0|||
163098634|NCT03726658|589069708|FG005|Overall Study|Not Reported|0|||
163098635|NCT03726658|589069709|FG006|Overall Study|Not Reported|1|||
163098636|NCT05710640|589069710|FG000|Overall Study|Physician Decision|0|||
163098637|NCT05710640|589069711|FG001|Overall Study|Physician Decision|1|||
163098638|NCT05710640|589069710|FG000|Overall Study|Withdrawal by Subject|1|||
163098639|NCT05710640|589069711|FG001|Overall Study|Withdrawal by Subject|0|||
163098640|NCT05710640|589069710|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
163098641|NCT05710640|589069711|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
163098642|NCT04188509|589069712|FG000|Overall Study|Adverse Event|2|||
163098643|NCT04188509|589069712|FG000|Overall Study|Lost to Follow-up|1|||
163098644|NCT04188509|589069712|FG000|Overall Study|Withdrawal of Consent|1|||
163098645|NCT04188509|589069712|FG000|Overall Study|Discretion of Investigator|1|||
163098646|NCT04188509|589069712|FG000|Overall Study|Noncompliance|3|||
163098647|NCT04188509|589069712|FG000|Overall Study|Sponsor Decision|127|||
163098648|NCT04188509|589069712|FG000|Overall Study|Other|2|||
163098649|NCT00049322|589069717|FG000|Overall Study|disease burden|0|||
163098650|NCT00049322|589069718|FG001|Overall Study|disease burden|3|||
163098651|NCT00049322|589069717|FG000|Overall Study|Adverse Event|1|||
163098652|NCT00049322|589069718|FG001|Overall Study|Adverse Event|0|||
163098653|NCT00049322|589069717|FG000|Overall Study|refused angio|0|||
163098654|NCT00049322|589069718|FG001|Overall Study|refused angio|3|||
163098655|NCT00703963|589069719|FG000|Overall Study|Withdrawal by Subject|7|||
163098656|NCT00703963|589069720|FG001|Overall Study|Withdrawal by Subject|13|||
163098657|NCT00703963|589069719|FG000|Overall Study|Physician Decision|0|||
163098658|NCT00703963|589069720|FG001|Overall Study|Physician Decision|1|||
163098659|NCT03994211|589069721|FG000|Core Phase|Adverse Event|0|||
163098660|NCT03994211|589069722|FG001|Core Phase|Adverse Event|1|||
163098661|NCT03994211|589069723|FG002|Core Phase|Adverse Event|0|||
163098662|NCT03994211|589069721|FG000|Extension Phase|Adverse Event|0|||
163098663|NCT03994211|589069722|FG001|Extension Phase|Adverse Event|0|||
163098664|NCT03994211|589069723|FG002|Extension Phase|Adverse Event|1|||
163098665|NCT03994211|589069721|FG000|Extension Phase|Physician Decision|0|||
163098666|NCT03994211|589069722|FG001|Extension Phase|Physician Decision|0|||
163098667|NCT03994211|589069723|FG002|Extension Phase|Physician Decision|1|||
163098668|NCT03994211|589069721|FG000|Extension Phase|Progressive Disease|0|||
163098669|NCT03994211|589069722|FG001|Extension Phase|Progressive Disease|0|||
163098670|NCT03994211|589069723|FG002|Extension Phase|Progressive Disease|20|||
163098671|NCT03994211|589069721|FG000|Extension Phase|Withdrawal by Subject|0|||
163098672|NCT03994211|589069722|FG001|Extension Phase|Withdrawal by Subject|0|||
163098673|NCT03994211|589069723|FG002|Extension Phase|Withdrawal by Subject|2|||
163098674|NCT00955474|589069727|FG000|Overall Study|Physician Decision|7|||
163098675|NCT00955474|589069728|FG001|Overall Study|Physician Decision|5|||
163098676|NCT02148263|589069730|FG000|Overall Study|Withdrawal by Subject|3|||
163098677|NCT02148263|589069731|FG001|Overall Study|Withdrawal by Subject|2|||
163098678|NCT03900728|589069732|FG000|Overall Study|No text responses|0|||
163098679|NCT03900728|589069733|FG001|Overall Study|No text responses|0|||
163098680|NCT03900728|589069734|FG002|Overall Study|No text responses|4|||
163098681|NCT01272037|589069743|FG000|Overall Study|Death|25|||
163098682|NCT01272037|589069744|FG001|Overall Study|Death|28|||
163098683|NCT01272037|589069743|FG000|Overall Study|Adverse Event|12|||
163098684|NCT01272037|589069744|FG001|Overall Study|Adverse Event|7|||
163098685|NCT01272037|589069743|FG000|Overall Study|Withdrawal by Subject|175|||
163098686|NCT01272037|589069744|FG001|Overall Study|Withdrawal by Subject|93|||
163098687|NCT01272037|589069743|FG000|Overall Study|Disease progression|70|||
163098688|NCT01272037|589069744|FG001|Overall Study|Disease progression|111|||
163098689|NCT01272037|589069743|FG000|Overall Study|Other reason|42|||
163098690|NCT01272037|589069744|FG001|Overall Study|Other reason|41|||
163098691|NCT01272037|589069743|FG000|Overall Study|Delinquent data|24|||
163098692|NCT01272037|589069744|FG001|Overall Study|Delinquent data|19|||
163098693|NCT01272037|589069743|FG000|Overall Study|Reason under review|33|||
163098694|NCT01272037|589069744|FG001|Overall Study|Reason under review|29|||
163098695|NCT01272037|589069743|FG000|Overall Study|On treatment|626|||
163098696|NCT01272037|589069744|FG001|Overall Study|On treatment|632|||
163098697|NCT01393899|589069745|FG000|Overall Study|Study terminated by sponsor|1|||
163098698|NCT01393899|589069746|FG001|Overall Study|Study terminated by sponsor|0|||
163098699|NCT01393899|589069747|FG002|Overall Study|Study terminated by sponsor|1|||
163098700|NCT01393899|589069745|FG000|Overall Study|Other|1|||
163098701|NCT01393899|589069746|FG001|Overall Study|Other|0|||
163098702|NCT01393899|589069747|FG002|Overall Study|Other|0|||
163098703|NCT01393899|589069745|FG000|Overall Study|Withdrawal by Subject|2|||
163098704|NCT01393899|589069746|FG001|Overall Study|Withdrawal by Subject|2|||
163098705|NCT01393899|589069747|FG002|Overall Study|Withdrawal by Subject|1|||
163098706|NCT01393899|589069745|FG000|Overall Study|Lost to Follow-up|0|||
163098707|NCT01393899|589069746|FG001|Overall Study|Lost to Follow-up|0|||
163098708|NCT01393899|589069747|FG002|Overall Study|Lost to Follow-up|1|||
163098709|NCT01393899|589069745|FG000|Overall Study|Does not meet entrance criteria|1|||
163098710|NCT01393899|589069746|FG001|Overall Study|Does not meet entrance criteria|0|||
163098711|NCT01393899|589069747|FG002|Overall Study|Does not meet entrance criteria|1|||
163098712|NCT01393899|589069745|FG000|Overall Study|Lack of Efficacy|26|||
163098713|NCT01393899|589069746|FG001|Overall Study|Lack of Efficacy|21|||
163098714|NCT01393899|589069747|FG002|Overall Study|Lack of Efficacy|16|||
163098715|NCT01393899|589069745|FG000|Overall Study|Adverse Event|1|||
163098716|NCT01393899|589069746|FG001|Overall Study|Adverse Event|5|||
163098717|NCT01393899|589069747|FG002|Overall Study|Adverse Event|3|||
163098718|NCT02503085|589069748|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
163098719|NCT02503085|589069749|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
163098720|NCT02503085|589069750|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
162653354|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162653355|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162653356|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
162653357|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
162653358|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653359|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653360|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653361|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653362|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653363|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162653364|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
162653365|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
162653366|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162653367|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
163098721|NCT02503085|589069751|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
163098722|NCT01162473|589069755|FG000|Overall Study|Adverse Event|2|||
163098723|NCT01162473|589069756|FG001|Overall Study|Adverse Event|1|||
163098724|NCT01162473|589069755|FG000|Overall Study|Withdrawal by Subject|0|||
163098725|NCT01162473|589069756|FG001|Overall Study|Withdrawal by Subject|4|||
163098726|NCT01144416|589069757|FG000|Intervention Period|Adverse Event|5|||
163098727|NCT01144416|589069758|FG001|Intervention Period|Adverse Event|6|||
163098728|NCT01144416|589069757|FG000|Intervention Period|Insufficient ovarian response|11|||
163098729|NCT01144416|589069758|FG001|Intervention Period|Insufficient ovarian response|17|||
163098730|NCT01144416|589069757|FG000|Intervention Period|Risk of OHSS|0|||
162653368|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162653369|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162653370|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162653371|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162653372|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
162653373|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
163098731|NCT01144416|589069758|FG001|Intervention Period|Risk of OHSS|1|||
163098732|NCT01144416|589069757|FG000|Intervention Period|Too high ovarian response|4|||
163098733|NCT01144416|589069758|FG001|Intervention Period|Too high ovarian response|2|||
163098734|NCT01144416|589069757|FG000|Intervention Period|No/too few/bad oocytes|7|||
163098735|NCT01144416|589069758|FG001|Intervention Period|No/too few/bad oocytes|5|||
163098736|NCT01144416|589069757|FG000|Intervention Period|No or abnormal fertilization|25|||
163098737|NCT01144416|589069758|FG001|Intervention Period|No or abnormal fertilization|10|||
163098738|NCT01144416|589069757|FG000|Intervention Period|No/too few/bad quality embryos|3|||
163098739|NCT01144416|589069758|FG001|Intervention Period|No/too few/bad quality embryos|3|||
163098740|NCT01144416|589069757|FG000|Intervention Period|Other|7|||
163098741|NCT01144416|589069758|FG001|Intervention Period|Other|5|||
163098742|NCT02534883|589069760|FG000|Overall Study|Early Termination|8|||
163098743|NCT02534883|589069761|FG001|Overall Study|Early Termination|3|||
163098744|NCT03328832|589069762|FG000|Overall Study|Lost to Follow-up|0|||
163098745|NCT03328832|589069763|FG001|Overall Study|Lost to Follow-up|1|||
163098746|NCT00886769|589069764|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163098747|NCT00886769|589069765|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
163098748|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
163098749|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
163098750|NCT00049257|589069766|FG000|Carboplatin, Paclitaxel|Death|2|||
163098751|NCT00049257|589069766|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
163098752|NCT00132301|589069767|FG000|Overall Study|Death|7|||
163098753|NCT00132301|589069768|FG001|Overall Study|Death|6|||
163098754|NCT00132301|589069767|FG000|Overall Study|Withdrawal by Subject|5|||
163098755|NCT00132301|589069768|FG001|Overall Study|Withdrawal by Subject|2|||
163098756|NCT00132301|589069767|FG000|Overall Study|Physician Decision|1|||
163098757|NCT00132301|589069768|FG001|Overall Study|Physician Decision|1|||
163098758|NCT00132301|589069767|FG000|Overall Study|Lost to Follow-up|5|||
163098759|NCT00132301|589069768|FG001|Overall Study|Lost to Follow-up|3|||
163098760|NCT00132301|589069767|FG000|Overall Study|Other|1|||
163098761|NCT00132301|589069768|FG001|Overall Study|Other|1|||
163098762|NCT00132301|589069767|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
163098763|NCT00132301|589069768|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
163098764|NCT01890265|589069771|FG000|Overall Study|Other (Unspecified reason)|0|||
163098765|NCT01890265|589069772|FG001|Overall Study|Other (Unspecified reason)|1|||
163098766|NCT01890265|589069773|FG002|Overall Study|Other (Unspecified reason)|0|||
163098767|NCT01890265|589069774|FG003|Overall Study|Other (Unspecified reason)|0|||
163098768|NCT01890265|589069775|FG004|Overall Study|Other (Unspecified reason)|0|||
163098769|NCT01890265|589069776|FG005|Overall Study|Other (Unspecified reason)|0|||
163098770|NCT01890265|589069771|FG000|Overall Study|Progressive disease|6|||
163098771|NCT01890265|589069772|FG001|Overall Study|Progressive disease|6|||
163098772|NCT01890265|589069773|FG002|Overall Study|Progressive disease|0|||
163098773|NCT01890265|589069774|FG003|Overall Study|Progressive disease|0|||
163098774|NCT01890265|589069775|FG004|Overall Study|Progressive disease|0|||
163098775|NCT01890265|589069776|FG005|Overall Study|Progressive disease|0|||
163098776|NCT01890265|589069771|FG000|Overall Study|Adverse Event|2|||
163098777|NCT01890265|589069772|FG001|Overall Study|Adverse Event|1|||
163098778|NCT01890265|589069773|FG002|Overall Study|Adverse Event|0|||
163098779|NCT01890265|589069774|FG003|Overall Study|Adverse Event|0|||
163098780|NCT01890265|589069775|FG004|Overall Study|Adverse Event|0|||
163098781|NCT01890265|589069776|FG005|Overall Study|Adverse Event|0|||
163098782|NCT01890265|589069771|FG000|Overall Study|Death|2|||
163098783|NCT01890265|589069772|FG001|Overall Study|Death|3|||
163098784|NCT01890265|589069773|FG002|Overall Study|Death|1|||
163098785|NCT01890265|589069774|FG003|Overall Study|Death|0|||
163098786|NCT01890265|589069775|FG004|Overall Study|Death|0|||
163098787|NCT01890265|589069776|FG005|Overall Study|Death|0|||
163098788|NCT01890265|589069771|FG000|Overall Study|Withdrawal by Subject|0|||
163098789|NCT01890265|589069772|FG001|Overall Study|Withdrawal by Subject|2|||
163098790|NCT01890265|589069773|FG002|Overall Study|Withdrawal by Subject|3|||
163098791|NCT01890265|589069774|FG003|Overall Study|Withdrawal by Subject|0|||
163098792|NCT01890265|589069775|FG004|Overall Study|Withdrawal by Subject|2|||
163098793|NCT01890265|589069776|FG005|Overall Study|Withdrawal by Subject|0|||
163098794|NCT03670355|589069782|FG000|Overall Study|Adverse Event|1|||
163098795|NCT03670355|589069783|FG001|Overall Study|Adverse Event|0|||
163098796|NCT03670355|589069782|FG000|Overall Study|Unable to comply with study procedures|0|||
163098797|NCT03670355|589069783|FG001|Overall Study|Unable to comply with study procedures|1|||
163098798|NCT03670355|589069782|FG000|Overall Study|Participant refused|0|||
163098799|NCT03670355|589069783|FG001|Overall Study|Participant refused|1|||
163098800|NCT03517436|589069784|FG000|Overall Study|Death|3|||
163098801|NCT03517436|589069784|FG000|Overall Study|Withdrawal by Subject|4|||
163098802|NCT03517436|589069784|FG000|Overall Study|Did not receive study valve.|1|||
163098803|NCT04271540|589069785|FG000|Overall Study|Lost to Follow-up|1|||
163098804|NCT04271540|589069785|FG000|Overall Study|Screen Fail|5|||
162653374|NCT00048542|587447559|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162653375|NCT00048542|587447560|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162653376|NCT00048542|587447561|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163098805|NCT04587869|589069788|FG000|Overall Study|Death|1|||
163098806|NCT04587869|589069789|FG001|Overall Study|Death|0|||
163098807|NCT04587869|589069788|FG000|Overall Study|Lost to Follow-up|27|||
163098808|NCT04587869|589069789|FG001|Overall Study|Lost to Follow-up|34|||
163098809|NCT04587869|589069788|FG000|Overall Study|Grant Termination|13|||
163098810|NCT04587869|589069789|FG001|Overall Study|Grant Termination|25|||
163098811|NCT04587869|589069788|FG000|Overall Study|too busy|2|||
163098812|NCT04587869|589069789|FG001|Overall Study|too busy|0|||
163098813|NCT04587869|589069788|FG000|Overall Study|Withdrawal by Subject|2|||
163098814|NCT04587869|589069789|FG001|Overall Study|Withdrawal by Subject|2|||
163098815|NCT04587869|589069788|FG000|Overall Study|Other|1|||
163098816|NCT04587869|589069789|FG001|Overall Study|Other|0|||
163098817|NCT02268383|589069792|FG000|Overall Study|Death|12|||
163098818|NCT02268383|589069792|FG000|Overall Study|Lost to Follow-up|2|||
163098819|NCT02268383|589069792|FG000|Overall Study|Withdrawal by Subject|9|||
163098820|NCT02268383|589069792|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
163098821|NCT02268383|589069792|FG000|Overall Study|Protocol deviation|3|||
163098822|NCT02268383|589069792|FG000|Overall Study|Sponsor decision|22|||
163098823|NCT02268383|589069792|FG000|Overall Study|Not reported|12|||
163098824|NCT00943761|589069793|FG000|Overall Study|Lost to Follow-up|2|||
163098825|NCT00943761|589069794|FG001|Overall Study|Lost to Follow-up|0|||
163098826|NCT00943761|589069793|FG000|Overall Study|Withdrawal by Subject|2|||
163098827|NCT00943761|589069794|FG001|Overall Study|Withdrawal by Subject|1|||
163098828|NCT02708680|589069797|FG000|Overall Study|Withdrawal by Subject|4|||
163098829|NCT02708680|589069798|FG001|Overall Study|Withdrawal by Subject|12|||
163098830|NCT02708680|589069799|FG002|Overall Study|Withdrawal by Subject|12|||
163098831|NCT02708680|589069797|FG000|Overall Study|Death|4|||
163098832|NCT02708680|589069798|FG001|Overall Study|Death|19|||
163098833|NCT02708680|589069799|FG002|Overall Study|Death|21|||
163098834|NCT02708680|589069797|FG000|Overall Study|Lost to Follow-up|0|||
163098835|NCT02708680|589069798|FG001|Overall Study|Lost to Follow-up|3|||
163098836|NCT02708680|589069799|FG002|Overall Study|Lost to Follow-up|3|||
163098837|NCT02708680|589069797|FG000|Overall Study|Study Terminated By Sponsor|0|||
163098838|NCT02708680|589069798|FG001|Overall Study|Study Terminated By Sponsor|5|||
163098839|NCT02708680|589069799|FG002|Overall Study|Study Terminated By Sponsor|4|||
163098840|NCT02708680|589069797|FG000|Overall Study|Other than Specified|0|||
163098841|NCT02708680|589069798|FG001|Overall Study|Other than Specified|0|||
163098842|NCT02708680|589069799|FG002|Overall Study|Other than Specified|1|||
163098843|NCT02708680|589069797|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
163098844|NCT02708680|589069798|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
163098845|NCT02708680|589069799|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
163098846|NCT01342926|589069800|FG000|Overall Study|Adverse Event|5|||
163098847|NCT01342926|589069801|FG001|Overall Study|Adverse Event|8|||
163098848|NCT01342926|589069802|FG002|Overall Study|Adverse Event|10|||
163098849|NCT01342926|589069803|FG003|Overall Study|Adverse Event|7|||
163098850|NCT01342926|589069800|FG000|Overall Study|Lost to Follow-up|0|||
163098851|NCT01342926|589069801|FG001|Overall Study|Lost to Follow-up|1|||
163098852|NCT01342926|589069802|FG002|Overall Study|Lost to Follow-up|1|||
163098853|NCT01342926|589069803|FG003|Overall Study|Lost to Follow-up|0|||
163098854|NCT01342926|589069800|FG000|Overall Study|Investigator Discretion|2|||
163098855|NCT01342926|589069801|FG001|Overall Study|Investigator Discretion|2|||
163098856|NCT01342926|589069802|FG002|Overall Study|Investigator Discretion|0|||
163098857|NCT01342926|589069803|FG003|Overall Study|Investigator Discretion|0|||
163098858|NCT01342926|589069800|FG000|Overall Study|Withdrawal by Subject|2|||
163098859|NCT01342926|589069801|FG001|Overall Study|Withdrawal by Subject|4|||
163098860|NCT01342926|589069802|FG002|Overall Study|Withdrawal by Subject|3|||
163098861|NCT01342926|589069803|FG003|Overall Study|Withdrawal by Subject|5|||
163098862|NCT04162470|589069804|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
163098863|NCT03382912|589069805|FG000|Overall Study|Physician Decision|0|||
162653377|NCT00048542|587447562|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162653378|NCT00048542|587447563|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163098864|NCT03382912|589069806|FG001|Overall Study|Physician Decision|1|||
163098865|NCT03382912|589069805|FG000|Overall Study|Sponsor Decision|6|||
162653379|NCT00048542|587447564|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
163098866|NCT03382912|589069806|FG001|Overall Study|Sponsor Decision|6|||
163098867|NCT03382912|589069805|FG000|Overall Study|Withdrawal by Subject|0|||
163098868|NCT03382912|589069806|FG001|Overall Study|Withdrawal by Subject|5|||
163098869|NCT01402869|589069811|FG000|Overall Study|Required Tooth Extraction|0|||
163098870|NCT01402869|589069812|FG001|Overall Study|Required Tooth Extraction|0|||
163098871|NCT01402869|589069813|FG002|Overall Study|Required Tooth Extraction|1|||
163098872|NCT00642707|589069814|FG000|Overall Study|Adverse Event|0|||
163098873|NCT00642707|589069815|FG001|Overall Study|Adverse Event|0|||
163098874|NCT00642707|589069816|FG002|Overall Study|Adverse Event|0|||
163098875|NCT00642707|589069817|FG003|Overall Study|Adverse Event|2|||
163098876|NCT00642707|589069814|FG000|Overall Study|Withdrawal by Subject|1|||
163098877|NCT00642707|589069815|FG001|Overall Study|Withdrawal by Subject|0|||
163098878|NCT00642707|589069816|FG002|Overall Study|Withdrawal by Subject|0|||
163098879|NCT00642707|589069817|FG003|Overall Study|Withdrawal by Subject|0|||
163098880|NCT02573948|589069818|FG000|Longitudinal Cohort|Death|9|||
163098881|NCT02573948|589069818|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
163098882|NCT02573948|589069818|FG000|Longitudinal Cohort|Incarcerated|25|||
163098883|NCT00707993|589069819|FG000|Overall Study|Adverse Event|16|||
163098884|NCT00707993|589069820|FG001|Overall Study|Adverse Event|20|||
163098885|NCT00707993|589069819|FG000|Overall Study|Protocol Violation|4|||
163098886|NCT00707993|589069820|FG001|Overall Study|Protocol Violation|7|||
163098887|NCT00707993|589069819|FG000|Overall Study|Lost to Follow-up|0|||
163098888|NCT00707993|589069820|FG001|Overall Study|Lost to Follow-up|4|||
163098889|NCT00707993|589069819|FG000|Overall Study|Withdrawal by Subject|12|||
163098890|NCT00707993|589069820|FG001|Overall Study|Withdrawal by Subject|16|||
163098891|NCT00707993|589069819|FG000|Overall Study|Hyperglycemic Rescue|55|||
163098892|NCT00707993|589069820|FG001|Overall Study|Hyperglycemic Rescue|47|||
163098893|NCT00707993|589069819|FG000|Overall Study|Other|2|||
163098894|NCT00707993|589069820|FG001|Overall Study|Other|0|||
163098895|NCT00436436|589069823|FG000|Overall Study|Progression|4|||
163098896|NCT00436436|589069823|FG000|Overall Study|Adverse Event|2|||
163098897|NCT00436436|589069823|FG000|Overall Study|Death|6|||
163098898|NCT01837680|589069824|FG000|Overall Study|Lost to Follow-up|2|||
163098899|NCT01837680|589069825|FG001|Overall Study|Lost to Follow-up|2|||
163098900|NCT01837680|589069824|FG000|Overall Study|lack of insurance|0|||
163098901|NCT01837680|589069825|FG001|Overall Study|lack of insurance|2|||
163098902|NCT01837680|589069824|FG000|Overall Study|allergic reaction|6|||
163098903|NCT01837680|589069825|FG001|Overall Study|allergic reaction|0|||
163098904|NCT01837680|589069824|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
163098905|NCT01837680|589069825|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
163098906|NCT05223673|589069826|FG000|Overall Study|Protocol Violation|1|||
163098907|NCT05223673|589069826|FG000|Overall Study|Study termination|6|||
163098908|NCT03941483|589069827|FG000|Overall Study|Miscellaneous|2|||
163098909|NCT03941483|589069828|FG001|Overall Study|Miscellaneous|3|||
163098910|NCT03941483|589069829|FG002|Overall Study|Miscellaneous|0|||
163098911|NCT03941483|589069827|FG000|Overall Study|Study Terminated by Sponsor|1|||
163098912|NCT03941483|589069828|FG001|Overall Study|Study Terminated by Sponsor|0|||
163098913|NCT03941483|589069829|FG002|Overall Study|Study Terminated by Sponsor|0|||
163098914|NCT03941483|589069827|FG000|Overall Study|Withdrawal by Subject|1|||
163098915|NCT03941483|589069828|FG001|Overall Study|Withdrawal by Subject|4|||
163098916|NCT03941483|589069829|FG002|Overall Study|Withdrawal by Subject|1|||
163098917|NCT03941483|589069827|FG000|Overall Study|Lost to Follow-up|2|||
163098918|NCT03941483|589069828|FG001|Overall Study|Lost to Follow-up|1|||
163098919|NCT03941483|589069829|FG002|Overall Study|Lost to Follow-up|8|||
163098920|NCT03941483|589069827|FG000|Overall Study|Death|3|||
163098921|NCT03941483|589069828|FG001|Overall Study|Death|2|||
163098922|NCT03941483|589069829|FG002|Overall Study|Death|6|||
163098923|NCT03154476|589069830|FG000|Overall Study|Lost to Follow-up|4|||
163098924|NCT03154476|589069831|FG001|Overall Study|Lost to Follow-up|4|||
163098925|NCT02685826|589069832|FG000|Overall Study|Adverse Event|2|||
163098926|NCT02685826|589069833|FG001|Overall Study|Adverse Event|0|||
163098927|NCT02685826|589069834|FG002|Overall Study|Adverse Event|1|||
163098928|NCT02685826|589069832|FG000|Overall Study|Progressive Disease|2|||
163098929|NCT02685826|589069833|FG001|Overall Study|Progressive Disease|1|||
163098930|NCT02685826|589069834|FG002|Overall Study|Progressive Disease|0|||
163098931|NCT02685826|589069832|FG000|Overall Study|Withdrawal by Subject|2|||
163098932|NCT02685826|589069833|FG001|Overall Study|Withdrawal by Subject|0|||
163098933|NCT02685826|589069834|FG002|Overall Study|Withdrawal by Subject|0|||
163098934|NCT02685826|589069832|FG000|Overall Study|Full Clinical Hold by FDA|19|||
163098935|NCT02685826|589069833|FG001|Overall Study|Full Clinical Hold by FDA|9|||
163098936|NCT02685826|589069834|FG002|Overall Study|Full Clinical Hold by FDA|20|||
163098937|NCT05823974|589071654|FG000|Overall Study|Lost to Follow-up|0|||
163098938|NCT05823974|589071655|FG001|Overall Study|Lost to Follow-up|3|||
163098939|NCT05823974|589071656|FG002|Overall Study|Lost to Follow-up|1|||
163098940|NCT05823974|589071657|FG003|Overall Study|Lost to Follow-up|0|||
163098941|NCT05823974|589071658|FG004|Overall Study|Lost to Follow-up|1|||
163098942|NCT05823974|589071659|FG005|Overall Study|Lost to Follow-up|0|||
163098943|NCT05823974|589071660|FG006|Overall Study|Lost to Follow-up|1|||
162653380|NCT00048542|587447565|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
163098944|NCT05823974|589071661|FG007|Overall Study|Lost to Follow-up|0|||
163098945|NCT05823974|589071662|FG008|Overall Study|Lost to Follow-up|0|||
163098946|NCT05823974|589071663|FG009|Overall Study|Lost to Follow-up|1|||
163098947|NCT05823974|589071664|FG010|Overall Study|Lost to Follow-up|1|||
163098948|NCT05823974|589071665|FG011|Overall Study|Lost to Follow-up|0|||
163098949|NCT05823974|589071666|FG012|Overall Study|Lost to Follow-up|1|||
163098950|NCT05823974|589071667|FG013|Overall Study|Lost to Follow-up|2|||
163098951|NCT05823974|589071668|FG014|Overall Study|Lost to Follow-up|1|||
163098952|NCT05823974|589071669|FG015|Overall Study|Lost to Follow-up|1|||
163098953|NCT05823974|589071670|FG016|Overall Study|Lost to Follow-up|1|||
163098954|NCT05823974|589071671|FG017|Overall Study|Lost to Follow-up|0|||
163098955|NCT05823974|589071672|FG018|Overall Study|Lost to Follow-up|0|||
163098956|NCT05823974|589071673|FG019|Overall Study|Lost to Follow-up|2|||
163098957|NCT05823974|589071674|FG020|Overall Study|Lost to Follow-up|0|||
163098958|NCT05823974|589071654|FG000|Overall Study|Physician Decision|0|||
163098959|NCT05823974|589071655|FG001|Overall Study|Physician Decision|0|||
163098960|NCT05823974|589071656|FG002|Overall Study|Physician Decision|0|||
163098961|NCT05823974|589071657|FG003|Overall Study|Physician Decision|0|||
163098962|NCT05823974|589071658|FG004|Overall Study|Physician Decision|0|||
163098963|NCT05823974|589071659|FG005|Overall Study|Physician Decision|0|||
163098964|NCT05823974|589071660|FG006|Overall Study|Physician Decision|0|||
163098965|NCT05823974|589071661|FG007|Overall Study|Physician Decision|0|||
163098966|NCT05823974|589071662|FG008|Overall Study|Physician Decision|0|||
163098967|NCT05823974|589071663|FG009|Overall Study|Physician Decision|0|||
163098968|NCT05823974|589071664|FG010|Overall Study|Physician Decision|0|||
163098969|NCT05823974|589071665|FG011|Overall Study|Physician Decision|0|||
163098970|NCT05823974|589071666|FG012|Overall Study|Physician Decision|0|||
163098971|NCT05823974|589071667|FG013|Overall Study|Physician Decision|0|||
163098972|NCT05823974|589071668|FG014|Overall Study|Physician Decision|0|||
163098973|NCT05823974|589071669|FG015|Overall Study|Physician Decision|1|||
163098974|NCT05823974|589071670|FG016|Overall Study|Physician Decision|0|||
163098975|NCT05823974|589071671|FG017|Overall Study|Physician Decision|1|||
163098976|NCT05823974|589071672|FG018|Overall Study|Physician Decision|1|||
163098977|NCT05823974|589071673|FG019|Overall Study|Physician Decision|0|||
163098978|NCT05823974|589071674|FG020|Overall Study|Physician Decision|0|||
163098979|NCT05823974|589071654|FG000|Overall Study|Withdrawal by Subject|1|||
163098980|NCT05823974|589071655|FG001|Overall Study|Withdrawal by Subject|1|||
163098981|NCT05823974|589071656|FG002|Overall Study|Withdrawal by Subject|2|||
163098982|NCT05823974|589071657|FG003|Overall Study|Withdrawal by Subject|0|||
163098983|NCT05823974|589071658|FG004|Overall Study|Withdrawal by Subject|2|||
163098984|NCT05823974|589071659|FG005|Overall Study|Withdrawal by Subject|3|||
163098985|NCT05823974|589071660|FG006|Overall Study|Withdrawal by Subject|1|||
163098986|NCT05823974|589071661|FG007|Overall Study|Withdrawal by Subject|1|||
163098987|NCT05823974|589071662|FG008|Overall Study|Withdrawal by Subject|2|||
163098988|NCT05823974|589071663|FG009|Overall Study|Withdrawal by Subject|1|||
163098989|NCT05823974|589071664|FG010|Overall Study|Withdrawal by Subject|1|||
163098990|NCT05823974|589071665|FG011|Overall Study|Withdrawal by Subject|0|||
163098991|NCT05823974|589071666|FG012|Overall Study|Withdrawal by Subject|0|||
163098992|NCT05823974|589071667|FG013|Overall Study|Withdrawal by Subject|1|||
163098993|NCT05823974|589071668|FG014|Overall Study|Withdrawal by Subject|1|||
163098994|NCT05823974|589071669|FG015|Overall Study|Withdrawal by Subject|3|||
163098995|NCT05823974|589071670|FG016|Overall Study|Withdrawal by Subject|0|||
163098996|NCT05823974|589071671|FG017|Overall Study|Withdrawal by Subject|2|||
163098997|NCT05823974|589071672|FG018|Overall Study|Withdrawal by Subject|2|||
163098998|NCT05823974|589071673|FG019|Overall Study|Withdrawal by Subject|0|||
163098999|NCT05823974|589071674|FG020|Overall Study|Withdrawal by Subject|1|||
163099000|NCT05823974|589071654|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099001|NCT05823974|589071655|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099002|NCT05823974|589071656|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163099003|NCT05823974|589071657|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099004|NCT05823974|589071658|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099005|NCT05823974|589071659|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099006|NCT05823974|589071660|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099007|NCT05823974|589071661|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099008|NCT05823974|589071662|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099009|NCT05823974|589071663|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099010|NCT05823974|589071664|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099011|NCT05823974|589071665|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099012|NCT05823974|589071666|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099013|NCT05823974|589071667|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099014|NCT05823974|589071668|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163099015|NCT05823974|589071669|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099016|NCT05823974|589071670|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099017|NCT05823974|589071671|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099018|NCT05823974|589071672|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099019|NCT05823974|589071673|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099020|NCT05823974|589071674|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163099021|NCT05823974|589071654|FG000|Overall Study|Other|0|||
163099022|NCT05823974|589071655|FG001|Overall Study|Other|1|||
163099023|NCT05823974|589071656|FG002|Overall Study|Other|1|||
163099024|NCT05823974|589071657|FG003|Overall Study|Other|1|||
163099025|NCT05823974|589071658|FG004|Overall Study|Other|0|||
163099026|NCT05823974|589071659|FG005|Overall Study|Other|1|||
163099027|NCT05823974|589071660|FG006|Overall Study|Other|1|||
163099028|NCT05823974|589071661|FG007|Overall Study|Other|1|||
163099029|NCT05823974|589071662|FG008|Overall Study|Other|1|||
163099030|NCT05823974|589071663|FG009|Overall Study|Other|0|||
163099031|NCT05823974|589071664|FG010|Overall Study|Other|0|||
163099032|NCT05823974|589071665|FG011|Overall Study|Other|0|||
163099033|NCT05823974|589071666|FG012|Overall Study|Other|2|||
163099034|NCT05823974|589071667|FG013|Overall Study|Other|1|||
163099035|NCT05823974|589071668|FG014|Overall Study|Other|0|||
163099036|NCT05823974|589071669|FG015|Overall Study|Other|1|||
163099037|NCT05823974|589071670|FG016|Overall Study|Other|0|||
163099038|NCT05823974|589071671|FG017|Overall Study|Other|0|||
163099039|NCT05823974|589071672|FG018|Overall Study|Other|0|||
163099040|NCT05823974|589071673|FG019|Overall Study|Other|0|||
163099041|NCT05823974|589071674|FG020|Overall Study|Other|0|||
163099042|NCT00316706|589071675|FG000|Overall Study|Lost to Follow-up|38|||
163099043|NCT00316706|589071676|FG001|Overall Study|Lost to Follow-up|48|||
163099044|NCT01133756|589071679|FG000|Overall Study|Adverse Event|1|||
163099045|NCT01133756|589071680|FG001|Overall Study|Adverse Event|2|||
163099046|NCT01133756|589071681|FG002|Overall Study|Adverse Event|1|||
163099047|NCT01133756|589071679|FG000|Overall Study|Investigator Decision|1|||
163099048|NCT01133756|589071680|FG001|Overall Study|Investigator Decision|0|||
163099049|NCT01133756|589071681|FG002|Overall Study|Investigator Decision|0|||
163099050|NCT01133756|589071679|FG000|Overall Study|Withdrawal by Subject|0|||
163099051|NCT01133756|589071680|FG001|Overall Study|Withdrawal by Subject|1|||
163099052|NCT01133756|589071681|FG002|Overall Study|Withdrawal by Subject|0|||
163099053|NCT01133756|589071679|FG000|Overall Study|Progression of Disease|0|||
163099054|NCT01133756|589071680|FG001|Overall Study|Progression of Disease|0|||
163099055|NCT01133756|589071681|FG002|Overall Study|Progression of Disease|1|||
163099056|NCT03941873|589071682|FG000|Overall Study|Death|0|||
163099057|NCT03941873|589071683|FG001|Overall Study|Death|12|||
163099058|NCT03941873|589071684|FG002|Overall Study|Death|2|||
163099059|NCT03941873|589071685|FG003|Overall Study|Death|53|||
163099060|NCT03941873|589071682|FG000|Overall Study|Withdrawal by Subject|1|||
163099061|NCT03941873|589071683|FG001|Overall Study|Withdrawal by Subject|1|||
163099062|NCT03941873|589071684|FG002|Overall Study|Withdrawal by Subject|0|||
163099063|NCT03941873|589071685|FG003|Overall Study|Withdrawal by Subject|5|||
163099064|NCT03941873|589071682|FG000|Overall Study|Lost to Follow-up|1|||
163099065|NCT03941873|589071683|FG001|Overall Study|Lost to Follow-up|2|||
163099066|NCT03941873|589071684|FG002|Overall Study|Lost to Follow-up|0|||
163099067|NCT03941873|589071685|FG003|Overall Study|Lost to Follow-up|0|||
163099068|NCT03941873|589071682|FG000|Overall Study|Sponsor Decision|0|||
163099069|NCT03941873|589071683|FG001|Overall Study|Sponsor Decision|6|||
163099070|NCT03941873|589071684|FG002|Overall Study|Sponsor Decision|0|||
163099071|NCT03941873|589071685|FG003|Overall Study|Sponsor Decision|15|||
163099072|NCT03276728|589071688|FG000|Overall Study|Lost to Follow-up|0|||
163099073|NCT03276728|589071689|FG001|Overall Study|Lost to Follow-up|0|||
163099074|NCT03276728|589071690|FG002|Overall Study|Lost to Follow-up|2|||
163099075|NCT03276728|589071691|FG003|Overall Study|Lost to Follow-up|2|||
163099076|NCT03276728|589071692|FG004|Overall Study|Lost to Follow-up|0|||
163099077|NCT03276728|589071693|FG005|Overall Study|Lost to Follow-up|0|||
163099078|NCT03276728|589071694|FG006|Overall Study|Lost to Follow-up|0|||
163099079|NCT03276728|589071695|FG007|Overall Study|Lost to Follow-up|0|||
163099080|NCT03276728|589071688|FG000|Overall Study|Withdrawal by Subject|0|||
163099081|NCT03276728|589071689|FG001|Overall Study|Withdrawal by Subject|0|||
163099082|NCT03276728|589071690|FG002|Overall Study|Withdrawal by Subject|0|||
163099083|NCT03276728|589071691|FG003|Overall Study|Withdrawal by Subject|3|||
163099084|NCT03276728|589071692|FG004|Overall Study|Withdrawal by Subject|0|||
163099085|NCT03276728|589071693|FG005|Overall Study|Withdrawal by Subject|0|||
163099086|NCT03276728|589071694|FG006|Overall Study|Withdrawal by Subject|0|||
163099087|NCT03276728|589071695|FG007|Overall Study|Withdrawal by Subject|0|||
163099088|NCT03276728|589071688|FG000|Overall Study|Decision by sponsor|0|||
163099089|NCT03276728|589071689|FG001|Overall Study|Decision by sponsor|0|||
163099090|NCT03276728|589071690|FG002|Overall Study|Decision by sponsor|0|||
163099091|NCT03276728|589071691|FG003|Overall Study|Decision by sponsor|0|||
163099092|NCT03276728|589071692|FG004|Overall Study|Decision by sponsor|1|||
163099093|NCT03276728|589071693|FG005|Overall Study|Decision by sponsor|0|||
163099094|NCT03276728|589071694|FG006|Overall Study|Decision by sponsor|2|||
163099095|NCT03276728|589071695|FG007|Overall Study|Decision by sponsor|1|||
163099096|NCT00617084|589071696|FG000|Overall Study|Withdrawal by Subject|5|||
163099097|NCT00617084|589071697|FG001|Overall Study|Withdrawal by Subject|7|||
163099098|NCT00617084|589071696|FG000|Overall Study|Missed 12 Months visit|16|||
163099099|NCT00617084|589071697|FG001|Overall Study|Missed 12 Months visit|19|||
163099100|NCT02222688|589071698|FG000|Overall Study|Withdrawal by Subject|0|||
162719039|NCT02341625|587676743|FG006|Overall Study|Not Reported|0|||
163099101|NCT02222688|589071699|FG001|Overall Study|Withdrawal by Subject|0|||
163099102|NCT02222688|589071700|FG002|Overall Study|Withdrawal by Subject|0|||
163099103|NCT02222688|589071701|FG003|Overall Study|Withdrawal by Subject|2|||
163099104|NCT02222688|589071702|FG004|Overall Study|Withdrawal by Subject|1|||
163099105|NCT02222688|589071703|FG005|Overall Study|Withdrawal by Subject|0|||
163099106|NCT02222688|589071704|FG006|Overall Study|Withdrawal by Subject|1|||
163099107|NCT02222688|589071698|FG000|Overall Study|Disease progression|1|||
163099108|NCT02222688|589071699|FG001|Overall Study|Disease progression|0|||
163099109|NCT02222688|589071700|FG002|Overall Study|Disease progression|0|||
163099110|NCT02222688|589071701|FG003|Overall Study|Disease progression|0|||
163099111|NCT02222688|589071702|FG004|Overall Study|Disease progression|0|||
163099112|NCT02222688|589071703|FG005|Overall Study|Disease progression|0|||
163099113|NCT02222688|589071704|FG006|Overall Study|Disease progression|0|||
163099114|NCT03458325|589071717|FG000|Overall Study|Withdrawal by Subject|1|||
163099115|NCT01134614|589071718|FG000|Overall Study|Still on treatment as of March 2013|21|||
163099116|NCT01134614|589071719|FG001|Overall Study|Still on treatment as of March 2013|13|||
163099117|NCT01134614|589071718|FG000|Overall Study|Progressive disease|60|||
163099118|NCT01134614|589071719|FG001|Overall Study|Progressive disease|54|||
163099119|NCT01134614|589071718|FG000|Overall Study|Adverse Event|26|||
163099120|NCT01134614|589071719|FG001|Overall Study|Adverse Event|39|||
163099121|NCT01134614|589071718|FG000|Overall Study|Death|5|||
163099122|NCT01134614|589071719|FG001|Overall Study|Death|8|||
163099123|NCT01134614|589071718|FG000|Overall Study|Withdrawal by Subject|3|||
163099124|NCT01134614|589071719|FG001|Overall Study|Withdrawal by Subject|2|||
163099125|NCT01134614|589071718|FG000|Overall Study|Alternative therapy|2|||
163099126|NCT01134614|589071719|FG001|Overall Study|Alternative therapy|0|||
163099127|NCT01134614|589071718|FG000|Overall Study|Complicating disease|2|||
163099128|NCT01134614|589071719|FG001|Overall Study|Complicating disease|1|||
163099129|NCT01134614|589071718|FG000|Overall Study|Physician's decision|0|||
163099130|NCT01134614|589071719|FG001|Overall Study|Physician's decision|1|||
163099131|NCT01134614|589071718|FG000|Overall Study|Never started treatment|4|||
163099132|NCT01134614|589071719|FG001|Overall Study|Never started treatment|1|||
163099133|NCT01134614|589071718|FG000|Overall Study|Pt received tx not allowed on study|0|||
163099134|NCT01134614|589071719|FG001|Overall Study|Pt received tx not allowed on study|1|||
163099135|NCT01134614|589071718|FG000|Overall Study|Symptomatic deterioration|0|||
163099136|NCT01134614|589071719|FG001|Overall Study|Symptomatic deterioration|1|||
163099137|NCT01134614|589071718|FG000|Overall Study|Patient in hospice care|0|||
163099138|NCT01134614|589071719|FG001|Overall Study|Patient in hospice care|1|||
163099139|NCT01485796|589071721|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
163099140|NCT01485796|589071721|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
163099141|NCT01485796|589071721|FG000|Period 2: Epoch 2|Adverse Event|3|||
163099142|NCT01485796|589071721|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
163099143|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
163099144|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
163099145|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
163099146|NCT01485796|589071721|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
163099147|NCT01766037|589071723|FG000|Overall Study|Adverse Event|1|||
163099148|NCT01766037|589071724|FG001|Overall Study|Adverse Event|0|||
163099149|NCT01766037|589071723|FG000|Overall Study|Lack of Efficacy|1|||
163099150|NCT01766037|589071724|FG001|Overall Study|Lack of Efficacy|0|||
163099151|NCT01766037|589071723|FG000|Overall Study|Lost to Follow-up|0|||
163099152|NCT01766037|589071724|FG001|Overall Study|Lost to Follow-up|10|||
163099153|NCT01766037|589071723|FG000|Overall Study|Physician Decision|0|||
163099154|NCT01766037|589071724|FG001|Overall Study|Physician Decision|1|||
163099155|NCT01766037|589071723|FG000|Overall Study|Withdrawal by Subject|18|||
163099156|NCT01766037|589071724|FG001|Overall Study|Withdrawal by Subject|16|||
163099157|NCT01766037|589071723|FG000|Overall Study|Moved from area|5|||
163099158|NCT01766037|589071724|FG001|Overall Study|Moved from area|0|||
163099159|NCT01766037|589071723|FG000|Overall Study|medical - unrelated|1|||
163099160|NCT01766037|589071724|FG001|Overall Study|medical - unrelated|2|||
163099161|NCT01766037|589071723|FG000|Overall Study|nausea / discomfort|3|||
163099162|NCT01766037|589071724|FG001|Overall Study|nausea / discomfort|0|||
163099163|NCT00292045|589071728|FG000|Core Study (Through Week 13)|Adverse Event|1|||
163099164|NCT00292045|589071728|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
163099165|NCT02236572|589071729|FG000|Overall Study|Withdrawal by Subject|1|||
163099166|NCT02236572|589071729|FG000|Overall Study|Protocol Violation|1|||
163099167|NCT02236572|589071729|FG000|Overall Study|Lost to Follow-up|1|||
163099168|NCT00606411|589071730|FG000|Overall Study|Adverse Event|1|||
163099169|NCT00606411|589071731|FG001|Overall Study|Adverse Event|2|||
163099170|NCT00606411|589071730|FG000|Overall Study|Lack of Adherence|1|||
163099171|NCT00606411|589071731|FG001|Overall Study|Lack of Adherence|1|||
163099172|NCT00606411|589071730|FG000|Overall Study|Lack of Efficacy|1|||
163099173|NCT00606411|589071731|FG001|Overall Study|Lack of Efficacy|1|||
163099174|NCT00606411|589071730|FG000|Overall Study|Withdrawal by Subject|2|||
163099175|NCT00606411|589071731|FG001|Overall Study|Withdrawal by Subject|0|||
163099176|NCT00606411|589071730|FG000|Overall Study|Lost to Follow-up|1|||
163099177|NCT00606411|589071731|FG001|Overall Study|Lost to Follow-up|2|||
163099178|NCT00606411|589071730|FG000|Overall Study|Move out of state|0|||
163099179|NCT00606411|589071731|FG001|Overall Study|Move out of state|1|||
163099180|NCT00412958|589071732|FG000|Overall Study|Withdrawal by Subject|3|||
163099181|NCT00412958|589071733|FG001|Overall Study|Withdrawal by Subject|0|||
163099182|NCT00412958|589071734|FG002|Overall Study|Withdrawal by Subject|0|||
163099183|NCT00412958|589071735|FG003|Overall Study|Withdrawal by Subject|1|||
163099184|NCT00412958|589071732|FG000|Overall Study|Adverse Event|0|||
163099185|NCT00412958|589071733|FG001|Overall Study|Adverse Event|1|||
163099186|NCT00412958|589071734|FG002|Overall Study|Adverse Event|0|||
163099187|NCT00412958|589071735|FG003|Overall Study|Adverse Event|0|||
163099188|NCT00412958|589071732|FG000|Overall Study|Lost to Follow-up|0|||
163099189|NCT00412958|589071733|FG001|Overall Study|Lost to Follow-up|1|||
163099190|NCT00412958|589071734|FG002|Overall Study|Lost to Follow-up|0|||
163099191|NCT00412958|589071735|FG003|Overall Study|Lost to Follow-up|0|||
163099192|NCT00412958|589071732|FG000|Overall Study|Death|0|||
163099193|NCT00412958|589071733|FG001|Overall Study|Death|1|||
163099194|NCT00412958|589071734|FG002|Overall Study|Death|0|||
163099195|NCT00412958|589071735|FG003|Overall Study|Death|0|||
163099196|NCT00412958|589071732|FG000|Overall Study|Transport issue|0|||
163099197|NCT00412958|589071733|FG001|Overall Study|Transport issue|1|||
163099198|NCT00412958|589071734|FG002|Overall Study|Transport issue|0|||
163099199|NCT00412958|589071735|FG003|Overall Study|Transport issue|0|||
163099200|NCT01318135|589071736|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163099201|NCT01318135|589071737|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099202|NCT01318135|589071738|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099203|NCT01318135|589071739|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099204|NCT01318135|589071740|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099205|NCT01318135|589071741|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099206|NCT01318135|589071742|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099207|NCT01318135|589071743|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163099208|NCT01318135|589071736|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
163099209|NCT01318135|589071737|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099210|NCT01318135|589071738|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099211|NCT01318135|589071739|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099212|NCT01318135|589071740|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099213|NCT01318135|589071741|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099214|NCT01318135|589071742|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099215|NCT01318135|589071743|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
163099216|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
163099217|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
163099218|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
163099219|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
163099220|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
163099221|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
163099222|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
163099223|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
163099224|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099225|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099226|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099227|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099228|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
163099229|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099230|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099231|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
163099232|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099233|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099234|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099235|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163099236|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163099237|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163099238|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163099239|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163099240|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
162653381|NCT00048542|587447566|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
162653382|NCT04033159|587447570|FG000|Washout Period|Physician Decision|0|||
162653383|NCT04033159|587447571|FG001|Washout Period|Physician Decision|1|||
162653384|NCT04033159|587447572|FG002|Washout Period|Physician Decision|0|||
162653385|NCT04033159|587447570|FG000|Washout Period|Study terminated by Sponsor|0|||
162653386|NCT04033159|587447571|FG001|Washout Period|Study terminated by Sponsor|7|||
163099241|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
163099242|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099243|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
163099244|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099245|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
163099246|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163099247|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163099248|NCT01318135|589071736|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099249|NCT01318135|589071737|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099250|NCT01318135|589071738|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099251|NCT01318135|589071739|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099252|NCT01318135|589071740|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099253|NCT01318135|589071741|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099254|NCT01318135|589071742|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
163099255|NCT01318135|589071743|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
163099256|NCT03465722|589071748|FG000|Overall Study|Withdrawal by Subject|21|||
163099257|NCT03465722|589071749|FG001|Overall Study|Withdrawal by Subject|14|||
163099258|NCT03465722|589071748|FG000|Overall Study|Death|89|||
163099259|NCT03465722|589071749|FG001|Overall Study|Death|87|||
163099260|NCT03465722|589071748|FG000|Overall Study|Lost to Follow-up|5|||
163099261|NCT03465722|589071749|FG001|Overall Study|Lost to Follow-up|3|||
163099262|NCT03465722|589071748|FG000|Overall Study|Administrative/Other|33|||
163099263|NCT03465722|589071749|FG001|Overall Study|Administrative/Other|32|||
163099264|NCT03465722|589071748|FG000|Overall Study|Not treated|1|||
163099265|NCT03465722|589071749|FG001|Overall Study|Not treated|2|||
163099266|NCT03465722|589071748|FG000|Overall Study|Sponsor decision|91|||
163099267|NCT03465722|589071749|FG001|Overall Study|Sponsor decision|98|||
163099268|NCT01541865|589071750|FG000|Overall Study|Lost to Follow-up|11|||
163099269|NCT01541865|589071750|FG000|Overall Study|Withdrawal by Subject|9|||
163099270|NCT01541865|589071750|FG000|Overall Study|Adverse Event|1|||
163099271|NCT01541865|589071750|FG000|Overall Study|Protocol Violation|1|||
163099272|NCT01140867|589071753|FG000|Overall Study|Adverse Event|22|||
163099273|NCT01140867|589071753|FG000|Overall Study|Lack of Efficacy|3|||
163099274|NCT01140867|589071753|FG000|Overall Study|Lost to Follow-up|2|||
163099275|NCT01140867|589071753|FG000|Overall Study|Withdrawal by Subject|1|||
163099276|NCT01140867|589071753|FG000|Overall Study|Protocol Violation|1|||
163099277|NCT01140867|589071753|FG000|Overall Study|Uncooperative patient|2|||
163099278|NCT01140867|589071753|FG000|Overall Study|Medication Noncompliance|2|||
163099279|NCT00503425|589071764|FG000|Overall Study|Participant files lost|6|||
163099280|NCT00503425|589071764|FG000|Overall Study|Adverse Event|5|||
163099281|NCT00503425|589071764|FG000|Overall Study|Lack of Efficacy|25|||
163099282|NCT00503425|589071764|FG000|Overall Study|Withdrawal by Subject|8|||
163099283|NCT00503425|589071764|FG000|Overall Study|Lost to Follow-up|3|||
163099284|NCT00503425|589071764|FG000|Overall Study|Death|3|||
163099285|NCT00503425|589071764|FG000|Overall Study|Missing Data/Unknown|4|||
163099286|NCT00881530|589071765|FG000|Overall Study|Adverse Event|5|||
163099287|NCT00881530|589071766|FG001|Overall Study|Adverse Event|1|||
163099288|NCT00881530|589071767|FG002|Overall Study|Adverse Event|1|||
163099289|NCT00881530|589071768|FG003|Overall Study|Adverse Event|4|||
163099290|NCT00881530|589071769|FG004|Overall Study|Adverse Event|10|||
163099291|NCT00881530|589071770|FG005|Overall Study|Adverse Event|2|||
163099292|NCT00881530|589071765|FG000|Overall Study|Lack of Efficacy|1|||
163099293|NCT00881530|589071766|FG001|Overall Study|Lack of Efficacy|0|||
163099294|NCT00881530|589071767|FG002|Overall Study|Lack of Efficacy|0|||
163099295|NCT00881530|589071768|FG003|Overall Study|Lack of Efficacy|0|||
162653387|NCT04033159|587447572|FG002|Washout Period|Study terminated by Sponsor|0|||
162653388|NCT04033159|587447570|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
163099296|NCT00881530|589071769|FG004|Overall Study|Lack of Efficacy|1|||
163099297|NCT00881530|589071770|FG005|Overall Study|Lack of Efficacy|1|||
163099298|NCT00881530|589071765|FG000|Overall Study|Not compliant with the protocol|0|||
163099299|NCT00881530|589071766|FG001|Overall Study|Not compliant with the protocol|0|||
163099300|NCT00881530|589071767|FG002|Overall Study|Not compliant with the protocol|0|||
163099301|NCT00881530|589071768|FG003|Overall Study|Not compliant with the protocol|0|||
163099302|NCT00881530|589071769|FG004|Overall Study|Not compliant with the protocol|2|||
163099303|NCT00881530|589071770|FG005|Overall Study|Not compliant with the protocol|0|||
163099304|NCT00881530|589071765|FG000|Overall Study|Lost to Follow-up|0|||
163099305|NCT00881530|589071766|FG001|Overall Study|Lost to Follow-up|1|||
163099306|NCT00881530|589071767|FG002|Overall Study|Lost to Follow-up|1|||
163099307|NCT00881530|589071768|FG003|Overall Study|Lost to Follow-up|3|||
163099308|NCT00881530|589071769|FG004|Overall Study|Lost to Follow-up|1|||
163099309|NCT00881530|589071770|FG005|Overall Study|Lost to Follow-up|0|||
163099310|NCT00881530|589071765|FG000|Overall Study|Refused to continue medication|7|||
163099311|NCT00881530|589071766|FG001|Overall Study|Refused to continue medication|2|||
163099312|NCT00881530|589071767|FG002|Overall Study|Refused to continue medication|1|||
163099313|NCT00881530|589071768|FG003|Overall Study|Refused to continue medication|2|||
163099314|NCT00881530|589071769|FG004|Overall Study|Refused to continue medication|0|||
163099315|NCT00881530|589071770|FG005|Overall Study|Refused to continue medication|0|||
163099316|NCT00881530|589071765|FG000|Overall Study|Other reason not defined above|1|||
163099317|NCT00881530|589071766|FG001|Overall Study|Other reason not defined above|1|||
163099318|NCT00881530|589071767|FG002|Overall Study|Other reason not defined above|2|||
163099319|NCT00881530|589071768|FG003|Overall Study|Other reason not defined above|0|||
163099320|NCT00881530|589071769|FG004|Overall Study|Other reason not defined above|0|||
163099321|NCT00881530|589071770|FG005|Overall Study|Other reason not defined above|2|||
163099322|NCT00003869|589071772|FG000|Overall Study|Adverse Event|14|||
163099323|NCT00003869|589071773|FG001|Overall Study|Adverse Event|3|||
163099324|NCT00003869|589071772|FG000|Overall Study|Withdrawal by Subject|21|||
163099325|NCT00003869|589071773|FG001|Overall Study|Withdrawal by Subject|3|||
163099326|NCT00003869|589071772|FG000|Overall Study|Death|1|||
163099327|NCT00003869|589071773|FG001|Overall Study|Death|2|||
163099328|NCT00003869|589071772|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
163099329|NCT00003869|589071773|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
163099330|NCT00763256|589071774|FG000|Overall Study|Didn't return for appointments|7|||
163099331|NCT00763256|589071775|FG001|Overall Study|Didn't return for appointments|10|||
163099332|NCT03364231|589071776|FG000|Overall Study|Adverse Event|1|||
163099333|NCT03364231|589071777|FG001|Overall Study|Adverse Event|4|||
163099334|NCT03364231|589071776|FG000|Overall Study|Death|1|||
163099335|NCT03364231|589071777|FG001|Overall Study|Death|0|||
163099336|NCT03364231|589071776|FG000|Overall Study|Investigator Decision|2|||
163099337|NCT03364231|589071777|FG001|Overall Study|Investigator Decision|2|||
163099338|NCT03364231|589071776|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
163099339|NCT03364231|589071777|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
163099340|NCT03364231|589071776|FG000|Overall Study|Withdrawal of Subject Consent|1|||
163099341|NCT03364231|589071777|FG001|Overall Study|Withdrawal of Subject Consent|0|||
163099342|NCT03364231|589071776|FG000|Overall Study|Reason Not Specified|1|||
163099343|NCT03364231|589071777|FG001|Overall Study|Reason Not Specified|0|||
163099344|NCT03364231|589071776|FG000|Overall Study|Disease Progression|0|||
163099345|NCT03364231|589071777|FG001|Overall Study|Disease Progression|6|||
163099346|NCT00124072|589071780|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
163099347|NCT00124072|589071781|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
163099348|NCT00124072|589071782|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
163099349|NCT00124072|589071783|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
163099350|NCT00124072|589071780|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
163099351|NCT00124072|589071781|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
163099352|NCT00124072|589071782|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
163099353|NCT00124072|589071783|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
163099354|NCT00124072|589071780|FG000|Overall Study|Death|499|||
163099355|NCT00124072|589071781|FG001|Overall Study|Death|484|||
163099356|NCT00124072|589071782|FG002|Overall Study|Death|471|||
163099357|NCT00124072|589071783|FG003|Overall Study|Death|480|||
163099358|NCT00414076|589071784|FG000|Overall Study|Progression|1|||
163099359|NCT00414076|589071785|FG001|Overall Study|Progression|2|||
163099360|NCT00414076|589071784|FG000|Overall Study|Withdrawal by Subject|1|||
163099361|NCT00414076|589071785|FG001|Overall Study|Withdrawal by Subject|3|||
163099362|NCT00414076|589071784|FG000|Overall Study|Adverse Event|1|||
163099363|NCT00414076|589071785|FG001|Overall Study|Adverse Event|0|||
163099364|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099365|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099366|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
163099367|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
163099368|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099369|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099370|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
163099371|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
163099372|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099373|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099374|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099375|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099376|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099377|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
163099378|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
163099379|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099380|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
162719040|NCT02341625|587676744|FG007|Overall Study|Not Reported|0|||
163099381|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099382|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099383|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099384|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
163099385|NCT02720523|589071789|FG000|Period 1: Placebo-controlled Period|Other|0|||
163099386|NCT02720523|589071790|FG001|Period 1: Placebo-controlled Period|Other|0|||
163099387|NCT02720523|589071791|FG002|Period 1: Placebo-controlled Period|Other|1|||
163099388|NCT02720523|589071792|FG003|Period 1: Placebo-controlled Period|Other|1|||
163099389|NCT02720523|589071793|FG004|Period 1: Placebo-controlled Period|Other|0|||
162653389|NCT04033159|587447571|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
162653390|NCT04033159|587447572|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
162653391|NCT01452412|587447583|FG000|Overall Study|Withdrawal by Subject|15|||
162653392|NCT01452412|587447584|FG001|Overall Study|Withdrawal by Subject|11|||
163099390|NCT02720523|589071794|FG005|Period 1: Placebo-controlled Period|Other|0|||
163099391|NCT02720523|589071795|FG006|Period 1: Placebo-controlled Period|Other|0|||
163099392|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
163099393|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
163099394|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
163099395|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
163099396|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
163099397|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
163099398|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
163099399|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
163099400|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
163099401|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
163099402|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
163099403|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
163099404|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
163099405|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
163099406|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099407|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099408|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099409|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
163099410|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
163099411|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
163099412|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
163099413|NCT02720523|589071789|FG000|Period 2: Long-term Extension Period|Other|0|||
163099414|NCT02720523|589071790|FG001|Period 2: Long-term Extension Period|Other|0|||
163099415|NCT02720523|589071791|FG002|Period 2: Long-term Extension Period|Other|0|||
163099416|NCT02720523|589071792|FG003|Period 2: Long-term Extension Period|Other|0|||
163099417|NCT02720523|589071793|FG004|Period 2: Long-term Extension Period|Other|2|||
163099418|NCT02720523|589071794|FG005|Period 2: Long-term Extension Period|Other|0|||
163099419|NCT02720523|589071795|FG006|Period 2: Long-term Extension Period|Other|3|||
163099420|NCT03146663|589071796|FG000|Overall Study|Did not receive study treatment|1|||
163099421|NCT03146663|589071797|FG001|Overall Study|Did not receive study treatment|1|||
163099422|NCT05526521|589071798|FG000|Overall Study|Withdrawal by Subject|0|||
163099423|NCT05526521|589071799|FG001|Overall Study|Withdrawal by Subject|1|||
162653393|NCT01452412|587447583|FG000|Overall Study|Adverse Event|4|||
162653394|NCT01452412|587447584|FG001|Overall Study|Adverse Event|3|||
162653395|NCT01452412|587447583|FG000|Overall Study|Lost to Follow-up|5|||
162653396|NCT01452412|587447584|FG001|Overall Study|Lost to Follow-up|3|||
162653397|NCT01452412|587447583|FG000|Overall Study|Death|1|||
162653398|NCT01452412|587447584|FG001|Overall Study|Death|0|||
162653399|NCT01452412|587447583|FG000|Overall Study|Initiated dialysis|1|||
162653400|NCT01452412|587447584|FG001|Overall Study|Initiated dialysis|0|||
162653401|NCT01452412|587447583|FG000|Overall Study|Other|2|||
162653402|NCT01452412|587447584|FG001|Overall Study|Other|0|||
162653403|NCT02346136|587447585|FG000|Overall Study|Withdrawal by Subject|7|||
162653404|NCT02346136|587447586|FG001|Overall Study|Withdrawal by Subject|5|||
162719041|NCT02341625|587676745|FG008|Overall Study|Not Reported|0|||
163099424|NCT05526521|589071800|FG002|Overall Study|Withdrawal by Subject|0|||
163099425|NCT05526521|589071801|FG003|Overall Study|Withdrawal by Subject|0|||
163099426|NCT03929913|589071802|FG000|Overall Study|Death|4|||
163099427|NCT03929913|589071802|FG000|Overall Study|Lost to Follow-up|1|||
163099428|NCT03929913|589071802|FG000|Overall Study|Failed Procedure|2|||
163099429|NCT03919929|589071805|FG000|Overall Study|Withdrawal by Subject|0|||
163099430|NCT03919929|589071806|FG001|Overall Study|Withdrawal by Subject|4|||
163099431|NCT03919929|589071805|FG000|Overall Study|Screen Failure|0|||
163099432|NCT03919929|589071806|FG001|Overall Study|Screen Failure|5|||
162653405|NCT02346136|587447585|FG000|Overall Study|Death|1|||
162653406|NCT02346136|587447586|FG001|Overall Study|Death|0|||
162653407|NCT02346136|587447585|FG000|Overall Study|Study termination|14|||
162653408|NCT02346136|587447586|FG001|Overall Study|Study termination|18|||
162653409|NCT03047135|587447587|FG000|Overall Study|Still being treated|3|||
162653410|NCT00323414|587447588|FG000|Overall Study|Withdrawal by Subject|0|||
162653411|NCT00323414|587447589|FG001|Overall Study|Withdrawal by Subject|1|||
162653412|NCT05619692|587447598|FG000|Overall Study|Adverse Event|2|||
163099433|NCT01544348|589071807|FG000|Overall Study|Lost to Follow-up|1|||
163099434|NCT01544348|589071808|FG001|Overall Study|Lost to Follow-up|0|||
163099435|NCT01544348|589071809|FG002|Overall Study|Lost to Follow-up|0|||
163099436|NCT01544348|589071810|FG003|Overall Study|Lost to Follow-up|0|||
163099437|NCT01544348|589071811|FG004|Overall Study|Lost to Follow-up|0|||
163099438|NCT01544348|589071812|FG005|Overall Study|Lost to Follow-up|0|||
163099439|NCT01544348|589071813|FG006|Overall Study|Lost to Follow-up|1|||
163099440|NCT01544348|589071814|FG007|Overall Study|Lost to Follow-up|0|||
163099441|NCT01544348|589071807|FG000|Overall Study|Withdrawal by Subject|1|||
163099442|NCT01544348|589071808|FG001|Overall Study|Withdrawal by Subject|0|||
163099443|NCT01544348|589071809|FG002|Overall Study|Withdrawal by Subject|0|||
163099444|NCT01544348|589071810|FG003|Overall Study|Withdrawal by Subject|0|||
163099445|NCT01544348|589071811|FG004|Overall Study|Withdrawal by Subject|1|||
163099446|NCT01544348|589071812|FG005|Overall Study|Withdrawal by Subject|2|||
163099447|NCT01544348|589071813|FG006|Overall Study|Withdrawal by Subject|1|||
163099448|NCT01544348|589071814|FG007|Overall Study|Withdrawal by Subject|0|||
163099449|NCT01544348|589071807|FG000|Overall Study|Physician Decision|0|||
163099450|NCT01544348|589071808|FG001|Overall Study|Physician Decision|0|||
163099451|NCT01544348|589071809|FG002|Overall Study|Physician Decision|0|||
163099452|NCT01544348|589071810|FG003|Overall Study|Physician Decision|0|||
163099453|NCT01544348|589071811|FG004|Overall Study|Physician Decision|0|||
163099454|NCT01544348|589071812|FG005|Overall Study|Physician Decision|1|||
163099455|NCT01544348|589071813|FG006|Overall Study|Physician Decision|0|||
163099456|NCT01544348|589071814|FG007|Overall Study|Physician Decision|0|||
163099457|NCT03008070|589071823|FG000|Overall Study|Adverse Event|3|||
163099458|NCT03008070|589071824|FG001|Overall Study|Adverse Event|3|||
163099459|NCT03008070|589071825|FG002|Overall Study|Adverse Event|3|||
163099460|NCT03008070|589071823|FG000|Overall Study|Lost to Follow-up|1|||
163099461|NCT03008070|589071824|FG001|Overall Study|Lost to Follow-up|1|||
163099462|NCT03008070|589071825|FG002|Overall Study|Lost to Follow-up|0|||
163099463|NCT03008070|589071823|FG000|Overall Study|Non compliance|0|||
163099464|NCT03008070|589071824|FG001|Overall Study|Non compliance|1|||
163099465|NCT03008070|589071825|FG002|Overall Study|Non compliance|1|||
163099466|NCT03008070|589071823|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
163099467|NCT03008070|589071824|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
163099468|NCT03008070|589071825|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
163099469|NCT03008070|589071823|FG000|Overall Study|Withdrawal by Subject|2|||
163099470|NCT03008070|589071824|FG001|Overall Study|Withdrawal by Subject|0|||
163099471|NCT03008070|589071825|FG002|Overall Study|Withdrawal by Subject|1|||
163099472|NCT03008070|589071823|FG000|Overall Study|Use of prohibited drug|0|||
163099473|NCT03008070|589071824|FG001|Overall Study|Use of prohibited drug|0|||
163099474|NCT03008070|589071825|FG002|Overall Study|Use of prohibited drug|2|||
163099475|NCT05005273|589071826|FG000|Overall Study|Study Terminated|1|||
163099476|NCT05005273|589071827|FG001|Overall Study|Study Terminated|0|||
163099477|NCT04409834|589071828|FG000|Overall Study|Death|55|||
163099478|NCT04409834|589071829|FG001|Overall Study|Death|62|||
163099479|NCT03960684|589071831|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
163099480|NCT04266912|589071832|FG000|Overall Study|Withdrawal by Subject|1|||
163099481|NCT04266912|589071833|FG001|Overall Study|Withdrawal by Subject|0|||
163099482|NCT04266912|589071834|FG002|Overall Study|Withdrawal by Subject|0|||
163099483|NCT04266912|589071835|FG003|Overall Study|Withdrawal by Subject|0|||
163099484|NCT04266912|589071832|FG000|Overall Study|Progression|6|||
163099485|NCT04266912|589071833|FG001|Overall Study|Progression|6|||
163099486|NCT04266912|589071834|FG002|Overall Study|Progression|0|||
163099487|NCT04266912|589071835|FG003|Overall Study|Progression|10|||
163099488|NCT02574078|589073568|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099489|NCT02574078|589073569|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099490|NCT02574078|589073570|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099491|NCT02574078|589073571|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099492|NCT02574078|589073572|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099493|NCT02574078|589073573|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163099494|NCT02574078|589073574|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
163099495|NCT02574078|589073575|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099496|NCT02574078|589073576|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
163099497|NCT02574078|589073577|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099498|NCT02574078|589073578|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099499|NCT02574078|589073579|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099500|NCT02574078|589073580|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
163099501|NCT02574078|589073568|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
163099502|NCT02574078|589073569|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
163099503|NCT02574078|589073570|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
163099504|NCT02574078|589073571|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
163099505|NCT02574078|589073572|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
163099506|NCT02574078|589073573|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
163099507|NCT02574078|589073574|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
163099508|NCT02574078|589073575|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
163099509|NCT02574078|589073576|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
163099510|NCT02574078|589073577|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
163099511|NCT02574078|589073578|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
163099512|NCT02574078|589073579|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
163099513|NCT02574078|589073580|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
163099514|NCT02574078|589073568|FG000|Pre-Treatment Period|Other reasons|0|||
163099515|NCT02574078|589073569|FG001|Pre-Treatment Period|Other reasons|0|||
163099516|NCT02574078|589073570|FG002|Pre-Treatment Period|Other reasons|0|||
163099517|NCT02574078|589073571|FG003|Pre-Treatment Period|Other reasons|0|||
163099518|NCT02574078|589073572|FG004|Pre-Treatment Period|Other reasons|0|||
163099519|NCT02574078|589073573|FG005|Pre-Treatment Period|Other reasons|0|||
163099520|NCT02574078|589073574|FG006|Pre-Treatment Period|Other reasons|2|||
163099521|NCT02574078|589073575|FG007|Pre-Treatment Period|Other reasons|0|||
163099522|NCT02574078|589073576|FG008|Pre-Treatment Period|Other reasons|0|||
163099523|NCT02574078|589073577|FG009|Pre-Treatment Period|Other reasons|0|||
163099524|NCT02574078|589073578|FG010|Pre-Treatment Period|Other reasons|2|||
163099525|NCT02574078|589073579|FG011|Pre-Treatment Period|Other reasons|0|||
163099526|NCT02574078|589073580|FG012|Pre-Treatment Period|Other reasons|0|||
163099527|NCT02574078|589073568|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
163099528|NCT02574078|589073569|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
163099529|NCT02574078|589073570|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
163099530|NCT02574078|589073571|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
163099531|NCT02574078|589073572|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
163099532|NCT02574078|589073573|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
163099533|NCT02574078|589073574|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
163099534|NCT02574078|589073575|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
163099535|NCT02574078|589073576|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
163099536|NCT02574078|589073577|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
163099537|NCT02574078|589073578|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
163099538|NCT02574078|589073579|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
163099539|NCT02574078|589073580|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
163099540|NCT02574078|589073568|FG000|Treatment Period|Disease progression|6|||
163099541|NCT02574078|589073569|FG001|Treatment Period|Disease progression|4|||
163099542|NCT02574078|589073570|FG002|Treatment Period|Disease progression|7|||
163099543|NCT02574078|589073571|FG003|Treatment Period|Disease progression|18|||
163099544|NCT02574078|589073572|FG004|Treatment Period|Disease progression|16|||
163099545|NCT02574078|589073573|FG005|Treatment Period|Disease progression|26|||
163099546|NCT02574078|589073574|FG006|Treatment Period|Disease progression|5|||
163099547|NCT02574078|589073575|FG007|Treatment Period|Disease progression|9|||
163099548|NCT02574078|589073576|FG008|Treatment Period|Disease progression|8|||
163099549|NCT02574078|589073577|FG009|Treatment Period|Disease progression|5|||
163099550|NCT02574078|589073578|FG010|Treatment Period|Disease progression|20|||
163099551|NCT02574078|589073579|FG011|Treatment Period|Disease progression|29|||
163099552|NCT02574078|589073580|FG012|Treatment Period|Disease progression|2|||
163099553|NCT02574078|589073568|FG000|Treatment Period|Study drug toxicity|1|||
163099554|NCT02574078|589073569|FG001|Treatment Period|Study drug toxicity|1|||
163099555|NCT02574078|589073570|FG002|Treatment Period|Study drug toxicity|0|||
163099556|NCT02574078|589073571|FG003|Treatment Period|Study drug toxicity|5|||
163099557|NCT02574078|589073572|FG004|Treatment Period|Study drug toxicity|3|||
163099558|NCT02574078|589073573|FG005|Treatment Period|Study drug toxicity|1|||
163099559|NCT02574078|589073574|FG006|Treatment Period|Study drug toxicity|2|||
163099560|NCT02574078|589073575|FG007|Treatment Period|Study drug toxicity|0|||
163099561|NCT02574078|589073576|FG008|Treatment Period|Study drug toxicity|2|||
163099562|NCT02574078|589073577|FG009|Treatment Period|Study drug toxicity|1|||
163099563|NCT02574078|589073578|FG010|Treatment Period|Study drug toxicity|16|||
163099564|NCT02574078|589073579|FG011|Treatment Period|Study drug toxicity|2|||
163099565|NCT02574078|589073580|FG012|Treatment Period|Study drug toxicity|4|||
163099566|NCT02574078|589073568|FG000|Treatment Period|Death|2|||
163099567|NCT02574078|589073569|FG001|Treatment Period|Death|0|||
163099568|NCT02574078|589073570|FG002|Treatment Period|Death|0|||
163099569|NCT02574078|589073571|FG003|Treatment Period|Death|0|||
163099570|NCT02574078|589073572|FG004|Treatment Period|Death|1|||
163099571|NCT02574078|589073573|FG005|Treatment Period|Death|1|||
163099572|NCT02574078|589073574|FG006|Treatment Period|Death|1|||
163099573|NCT02574078|589073575|FG007|Treatment Period|Death|1|||
163099574|NCT02574078|589073576|FG008|Treatment Period|Death|7|||
163099575|NCT02574078|589073577|FG009|Treatment Period|Death|1|||
163099576|NCT02574078|589073578|FG010|Treatment Period|Death|0|||
163099577|NCT02574078|589073579|FG011|Treatment Period|Death|2|||
163099578|NCT02574078|589073580|FG012|Treatment Period|Death|1|||
162653413|NCT05619692|587447599|FG001|Overall Study|Adverse Event|2|||
162653414|NCT05619692|587447598|FG000|Overall Study|Withdrawal by Participant|3|||
163099579|NCT02574078|589073568|FG000|Treatment Period|Adverse event unrelated to drug|0|||
163099580|NCT02574078|589073569|FG001|Treatment Period|Adverse event unrelated to drug|0|||
163099581|NCT02574078|589073570|FG002|Treatment Period|Adverse event unrelated to drug|1|||
163099582|NCT02574078|589073571|FG003|Treatment Period|Adverse event unrelated to drug|0|||
163099583|NCT02574078|589073572|FG004|Treatment Period|Adverse event unrelated to drug|2|||
162653415|NCT05619692|587447599|FG001|Overall Study|Withdrawal by Participant|4|||
162653416|NCT05619692|587447598|FG000|Overall Study|Lost to Follow-up|2|||
162653417|NCT05619692|587447599|FG001|Overall Study|Lost to Follow-up|1|||
163099584|NCT02574078|589073573|FG005|Treatment Period|Adverse event unrelated to drug|3|||
163099585|NCT02574078|589073574|FG006|Treatment Period|Adverse event unrelated to drug|0|||
163099586|NCT02574078|589073575|FG007|Treatment Period|Adverse event unrelated to drug|0|||
163099587|NCT02574078|589073576|FG008|Treatment Period|Adverse event unrelated to drug|1|||
163099588|NCT02574078|589073577|FG009|Treatment Period|Adverse event unrelated to drug|2|||
163099589|NCT02574078|589073578|FG010|Treatment Period|Adverse event unrelated to drug|4|||
163099590|NCT02574078|589073579|FG011|Treatment Period|Adverse event unrelated to drug|1|||
163099591|NCT02574078|589073580|FG012|Treatment Period|Adverse event unrelated to drug|0|||
163099592|NCT02574078|589073568|FG000|Treatment Period|Administrative reason by Sponsor|0|||
163099593|NCT02574078|589073569|FG001|Treatment Period|Administrative reason by Sponsor|1|||
163099594|NCT02574078|589073570|FG002|Treatment Period|Administrative reason by Sponsor|0|||
163099595|NCT02574078|589073571|FG003|Treatment Period|Administrative reason by Sponsor|0|||
163099596|NCT02574078|589073572|FG004|Treatment Period|Administrative reason by Sponsor|0|||
163099597|NCT02574078|589073573|FG005|Treatment Period|Administrative reason by Sponsor|0|||
163099598|NCT02574078|589073574|FG006|Treatment Period|Administrative reason by Sponsor|1|||
163099599|NCT02574078|589073575|FG007|Treatment Period|Administrative reason by Sponsor|0|||
163099600|NCT02574078|589073576|FG008|Treatment Period|Administrative reason by Sponsor|0|||
163099601|NCT02574078|589073577|FG009|Treatment Period|Administrative reason by Sponsor|0|||
163099602|NCT02574078|589073578|FG010|Treatment Period|Administrative reason by Sponsor|0|||
163099603|NCT02574078|589073579|FG011|Treatment Period|Administrative reason by Sponsor|0|||
163099604|NCT02574078|589073580|FG012|Treatment Period|Administrative reason by Sponsor|3|||
163099605|NCT02574078|589073568|FG000|Treatment Period|Other reasons|1|||
163099606|NCT02574078|589073569|FG001|Treatment Period|Other reasons|0|||
163099607|NCT02574078|589073570|FG002|Treatment Period|Other reasons|1|||
163099608|NCT02574078|589073571|FG003|Treatment Period|Other reasons|3|||
163099609|NCT02574078|589073572|FG004|Treatment Period|Other reasons|3|||
163099610|NCT02574078|589073573|FG005|Treatment Period|Other reasons|1|||
163099611|NCT02574078|589073574|FG006|Treatment Period|Other reasons|2|||
163099612|NCT02574078|589073575|FG007|Treatment Period|Other reasons|1|||
163099613|NCT02574078|589073576|FG008|Treatment Period|Other reasons|3|||
163099614|NCT02574078|589073577|FG009|Treatment Period|Other reasons|1|||
163099615|NCT02574078|589073578|FG010|Treatment Period|Other reasons|1|||
163099616|NCT02574078|589073579|FG011|Treatment Period|Other reasons|3|||
163099617|NCT02574078|589073580|FG012|Treatment Period|Other reasons|1|||
163099618|NCT02574078|589073568|FG000|Treatment Period|Participant request to stop drug|0|||
163099619|NCT02574078|589073569|FG001|Treatment Period|Participant request to stop drug|0|||
163099620|NCT02574078|589073570|FG002|Treatment Period|Participant request to stop drug|0|||
163099621|NCT02574078|589073571|FG003|Treatment Period|Participant request to stop drug|2|||
163099622|NCT02574078|589073572|FG004|Treatment Period|Participant request to stop drug|4|||
163099623|NCT02574078|589073573|FG005|Treatment Period|Participant request to stop drug|0|||
163099624|NCT02574078|589073574|FG006|Treatment Period|Participant request to stop drug|1|||
163099625|NCT02574078|589073575|FG007|Treatment Period|Participant request to stop drug|0|||
163099626|NCT02574078|589073576|FG008|Treatment Period|Participant request to stop drug|3|||
163099627|NCT02574078|589073577|FG009|Treatment Period|Participant request to stop drug|2|||
163099628|NCT02574078|589073578|FG010|Treatment Period|Participant request to stop drug|2|||
163099629|NCT02574078|589073579|FG011|Treatment Period|Participant request to stop drug|4|||
163099630|NCT02574078|589073580|FG012|Treatment Period|Participant request to stop drug|1|||
163099631|NCT02574078|589073568|FG000|Treatment Period|Participant withdrew consent|0|||
163099632|NCT02574078|589073569|FG001|Treatment Period|Participant withdrew consent|0|||
163099633|NCT02574078|589073570|FG002|Treatment Period|Participant withdrew consent|0|||
163099634|NCT02574078|589073571|FG003|Treatment Period|Participant withdrew consent|0|||
163099635|NCT02574078|589073572|FG004|Treatment Period|Participant withdrew consent|1|||
163099636|NCT02574078|589073573|FG005|Treatment Period|Participant withdrew consent|1|||
163099637|NCT02574078|589073574|FG006|Treatment Period|Participant withdrew consent|0|||
163099638|NCT02574078|589073575|FG007|Treatment Period|Participant withdrew consent|1|||
163099639|NCT02574078|589073576|FG008|Treatment Period|Participant withdrew consent|0|||
163099640|NCT02574078|589073577|FG009|Treatment Period|Participant withdrew consent|2|||
163099641|NCT02574078|589073578|FG010|Treatment Period|Participant withdrew consent|1|||
163099642|NCT02574078|589073579|FG011|Treatment Period|Participant withdrew consent|4|||
163099643|NCT02574078|589073580|FG012|Treatment Period|Participant withdrew consent|1|||
163099644|NCT02574078|589073568|FG000|Treatment Period|Participant no longer meets criteria|0|||
163099645|NCT02574078|589073569|FG001|Treatment Period|Participant no longer meets criteria|0|||
163099646|NCT02574078|589073570|FG002|Treatment Period|Participant no longer meets criteria|0|||
163099647|NCT02574078|589073571|FG003|Treatment Period|Participant no longer meets criteria|0|||
163099648|NCT02574078|589073572|FG004|Treatment Period|Participant no longer meets criteria|1|||
163099649|NCT02574078|589073573|FG005|Treatment Period|Participant no longer meets criteria|0|||
163099650|NCT02574078|589073574|FG006|Treatment Period|Participant no longer meets criteria|0|||
163099651|NCT02574078|589073575|FG007|Treatment Period|Participant no longer meets criteria|0|||
163099652|NCT02574078|589073576|FG008|Treatment Period|Participant no longer meets criteria|0|||
163099653|NCT02574078|589073577|FG009|Treatment Period|Participant no longer meets criteria|1|||
163099654|NCT02574078|589073578|FG010|Treatment Period|Participant no longer meets criteria|1|||
163099655|NCT02574078|589073579|FG011|Treatment Period|Participant no longer meets criteria|1|||
163099656|NCT02574078|589073580|FG012|Treatment Period|Participant no longer meets criteria|0|||
163099657|NCT02574078|589073568|FG000|Treatment Period|Lost to Follow-up|0|||
163099658|NCT02574078|589073569|FG001|Treatment Period|Lost to Follow-up|0|||
163099659|NCT02574078|589073570|FG002|Treatment Period|Lost to Follow-up|0|||
163099660|NCT02574078|589073571|FG003|Treatment Period|Lost to Follow-up|0|||
163099661|NCT02574078|589073572|FG004|Treatment Period|Lost to Follow-up|0|||
163099662|NCT02574078|589073573|FG005|Treatment Period|Lost to Follow-up|0|||
163099663|NCT02574078|589073574|FG006|Treatment Period|Lost to Follow-up|0|||
163099664|NCT02574078|589073575|FG007|Treatment Period|Lost to Follow-up|0|||
163099665|NCT02574078|589073576|FG008|Treatment Period|Lost to Follow-up|0|||
163099666|NCT02574078|589073577|FG009|Treatment Period|Lost to Follow-up|1|||
163099667|NCT02574078|589073578|FG010|Treatment Period|Lost to Follow-up|0|||
163099668|NCT02574078|589073579|FG011|Treatment Period|Lost to Follow-up|1|||
163099669|NCT02574078|589073580|FG012|Treatment Period|Lost to Follow-up|0|||
163099670|NCT02574078|589073568|FG000|Treatment Period|Maximum clinical benefit|0|||
163099671|NCT02574078|589073569|FG001|Treatment Period|Maximum clinical benefit|0|||
163099672|NCT02574078|589073570|FG002|Treatment Period|Maximum clinical benefit|0|||
163099673|NCT02574078|589073571|FG003|Treatment Period|Maximum clinical benefit|0|||
163099674|NCT02574078|589073572|FG004|Treatment Period|Maximum clinical benefit|0|||
163099675|NCT02574078|589073573|FG005|Treatment Period|Maximum clinical benefit|0|||
163099676|NCT02574078|589073574|FG006|Treatment Period|Maximum clinical benefit|0|||
163099677|NCT02574078|589073575|FG007|Treatment Period|Maximum clinical benefit|0|||
163099678|NCT02574078|589073576|FG008|Treatment Period|Maximum clinical benefit|0|||
163099679|NCT02574078|589073577|FG009|Treatment Period|Maximum clinical benefit|1|||
163099680|NCT02574078|589073578|FG010|Treatment Period|Maximum clinical benefit|0|||
163099681|NCT02574078|589073579|FG011|Treatment Period|Maximum clinical benefit|0|||
163099682|NCT02574078|589073580|FG012|Treatment Period|Maximum clinical benefit|0|||
163099683|NCT05935878|589073587|FG000|Overall Study|Death|1|||
163099684|NCT05935878|589073588|FG001|Overall Study|Death|2|||
163099685|NCT05935878|589073587|FG000|Overall Study|Withdrawal by Subject|5|||
163099686|NCT05935878|589073588|FG001|Overall Study|Withdrawal by Subject|5|||
163099687|NCT05935878|589073587|FG000|Overall Study|Revision of implant|1|||
163099688|NCT05935878|589073588|FG001|Overall Study|Revision of implant|1|||
163099689|NCT05935878|589073587|FG000|Overall Study|Mobile bearing dislocation|0|||
163099690|NCT05935878|589073588|FG001|Overall Study|Mobile bearing dislocation|1|||
163099691|NCT02297815|589073604|FG000|Overall Study|Lost to Follow-up|236|||
163099692|NCT02297815|589073605|FG001|Overall Study|Lost to Follow-up|140|||
163099693|NCT00662831|589073606|FG000|Overall Study|Death|4|||
163099694|NCT00662831|589073607|FG001|Overall Study|Death|1|||
163099695|NCT00662831|589073606|FG000|Overall Study|Lack of Efficacy|6|||
163099696|NCT00662831|589073607|FG001|Overall Study|Lack of Efficacy|6|||
163099697|NCT00662831|589073606|FG000|Overall Study|Lost to Follow-up|1|||
163099698|NCT00662831|589073607|FG001|Overall Study|Lost to Follow-up|0|||
163099699|NCT00662831|589073606|FG000|Overall Study|Withdrawal by Subject|2|||
163099700|NCT00662831|589073607|FG001|Overall Study|Withdrawal by Subject|1|||
163099701|NCT00662831|589073606|FG000|Overall Study|Other|62|||
163099702|NCT00662831|589073607|FG001|Overall Study|Other|31|||
163099703|NCT00662831|589073606|FG000|Overall Study|Protocol Violation|8|||
163099704|NCT00662831|589073607|FG001|Overall Study|Protocol Violation|4|||
163099705|NCT00662831|589073606|FG000|Overall Study|Adverse Event|23|||
163099706|NCT00662831|589073607|FG001|Overall Study|Adverse Event|16|||
163099707|NCT01734785|589073609|FG000|Open-Label Period|Adverse Event|0|||
163099708|NCT01734785|589073610|FG001|Open-Label Period|Adverse Event|0|||
163099709|NCT01734785|589073611|FG002|Open-Label Period|Adverse Event|0|||
163099710|NCT01734785|589073612|FG003|Open-Label Period|Adverse Event|9|||
163099711|NCT01734785|589073609|FG000|Open-Label Period|Lack of Efficacy|0|||
163099712|NCT01734785|589073610|FG001|Open-Label Period|Lack of Efficacy|0|||
163099713|NCT01734785|589073611|FG002|Open-Label Period|Lack of Efficacy|0|||
163099714|NCT01734785|589073612|FG003|Open-Label Period|Lack of Efficacy|1|||
163099715|NCT01734785|589073609|FG000|Open-Label Period|Protocol Violation|0|||
163099716|NCT01734785|589073610|FG001|Open-Label Period|Protocol Violation|0|||
163099717|NCT01734785|589073611|FG002|Open-Label Period|Protocol Violation|0|||
163099718|NCT01734785|589073612|FG003|Open-Label Period|Protocol Violation|13|||
163099719|NCT01734785|589073609|FG000|Open-Label Period|Lost to Follow-up|0|||
163099720|NCT01734785|589073610|FG001|Open-Label Period|Lost to Follow-up|0|||
162719042|NCT02341625|587676746|FG009|Overall Study|Not Reported|3|||
163099721|NCT01734785|589073611|FG002|Open-Label Period|Lost to Follow-up|0|||
163099722|NCT01734785|589073612|FG003|Open-Label Period|Lost to Follow-up|14|||
163099723|NCT01734785|589073609|FG000|Open-Label Period|Withdrawal by Subject|0|||
163099724|NCT01734785|589073610|FG001|Open-Label Period|Withdrawal by Subject|0|||
163099725|NCT01734785|589073611|FG002|Open-Label Period|Withdrawal by Subject|0|||
163099726|NCT01734785|589073612|FG003|Open-Label Period|Withdrawal by Subject|12|||
163099727|NCT01734785|589073609|FG000|Open-Label Period|Other Reasons|0|||
163099728|NCT01734785|589073610|FG001|Open-Label Period|Other Reasons|0|||
162719043|NCT03396913|587676747|FG000|Overall Study|Lost to Follow-up|0|||
162719044|NCT03396913|587676748|FG001|Overall Study|Lost to Follow-up|6|||
163099729|NCT01734785|589073611|FG002|Open-Label Period|Other Reasons|0|||
163099730|NCT01734785|589073612|FG003|Open-Label Period|Other Reasons|224|||
163099731|NCT01734785|589073609|FG000|Double-Blind Period|Adverse Event|0|||
163099732|NCT01734785|589073610|FG001|Double-Blind Period|Adverse Event|3|||
163099733|NCT01734785|589073611|FG002|Double-Blind Period|Adverse Event|2|||
163099734|NCT01734785|589073612|FG003|Double-Blind Period|Adverse Event|0|||
163099735|NCT01734785|589073609|FG000|Double-Blind Period|Lack of Efficacy|0|||
163099736|NCT01734785|589073610|FG001|Double-Blind Period|Lack of Efficacy|1|||
163099737|NCT01734785|589073611|FG002|Double-Blind Period|Lack of Efficacy|0|||
163099738|NCT01734785|589073612|FG003|Double-Blind Period|Lack of Efficacy|0|||
163099739|NCT01734785|589073609|FG000|Double-Blind Period|Protocol Violation|0|||
163099740|NCT01734785|589073610|FG001|Double-Blind Period|Protocol Violation|1|||
163099741|NCT01734785|589073611|FG002|Double-Blind Period|Protocol Violation|1|||
163099742|NCT01734785|589073612|FG003|Double-Blind Period|Protocol Violation|0|||
163099743|NCT01734785|589073609|FG000|Double-Blind Period|Lost to Follow-up|2|||
163099744|NCT01734785|589073610|FG001|Double-Blind Period|Lost to Follow-up|4|||
163099745|NCT01734785|589073611|FG002|Double-Blind Period|Lost to Follow-up|2|||
163099746|NCT01734785|589073612|FG003|Double-Blind Period|Lost to Follow-up|0|||
163099747|NCT01734785|589073609|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163099748|NCT01734785|589073610|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163099749|NCT01734785|589073611|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163099750|NCT01734785|589073612|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163099751|NCT01734785|589073609|FG000|Double-Blind Period|Not treated|1|||
163099752|NCT01734785|589073610|FG001|Double-Blind Period|Not treated|0|||
163099753|NCT01734785|589073611|FG002|Double-Blind Period|Not treated|0|||
163099754|NCT01734785|589073612|FG003|Double-Blind Period|Not treated|0|||
163099755|NCT02397915|589073613|FG000|Period 1|Protocol Violation|0|||
163099756|NCT02397915|589073614|FG001|Period 1|Protocol Violation|1|||
163099757|NCT02397915|589073615|FG002|Period 1|Protocol Violation|0|||
163099758|NCT02397915|589073616|FG003|Period 1|Protocol Violation|0|||
163099759|NCT02397915|589073613|FG000|Period 1|Physician Decision|1|||
163099760|NCT02397915|589073614|FG001|Period 1|Physician Decision|0|||
163099761|NCT02397915|589073615|FG002|Period 1|Physician Decision|0|||
163099762|NCT02397915|589073616|FG003|Period 1|Physician Decision|0|||
163099763|NCT00368745|589073617|FG000|Double-blind Treatment Period|Adverse Event|6|||
163099764|NCT00368745|589073618|FG001|Double-blind Treatment Period|Adverse Event|6|||
163099765|NCT00368745|589073617|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
163099766|NCT00368745|589073618|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
163099767|NCT00368745|589073617|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
163099768|NCT00368745|589073618|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163099769|NCT00368745|589073617|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
163099770|NCT00368745|589073618|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
163099771|NCT00368745|589073617|FG000|Double-blind Treatment Period|Other|7|||
163099772|NCT00368745|589073618|FG001|Double-blind Treatment Period|Other|6|||
163099773|NCT00293813|589073622|FG000|Overall Study|Physician Decision|0|||
163099774|NCT00293813|589073623|FG001|Overall Study|Physician Decision|1|||
163099775|NCT00293813|589073624|FG002|Overall Study|Physician Decision|0|||
163099776|NCT00293813|589073622|FG000|Overall Study|Adverse Event|3|||
163099777|NCT00293813|589073623|FG001|Overall Study|Adverse Event|1|||
163099778|NCT00293813|589073624|FG002|Overall Study|Adverse Event|1|||
163099779|NCT00293813|589073622|FG000|Overall Study|Withdrawal by Subject|7|||
163099780|NCT00293813|589073623|FG001|Overall Study|Withdrawal by Subject|4|||
163099781|NCT00293813|589073624|FG002|Overall Study|Withdrawal by Subject|4|||
163099782|NCT00293813|589073622|FG000|Overall Study|Lost to Follow-up|3|||
163099783|NCT00293813|589073623|FG001|Overall Study|Lost to Follow-up|2|||
163099784|NCT00293813|589073624|FG002|Overall Study|Lost to Follow-up|3|||
163099785|NCT00293813|589073622|FG000|Overall Study|Noncompliance|0|||
163099786|NCT00293813|589073623|FG001|Overall Study|Noncompliance|1|||
163099787|NCT00293813|589073624|FG002|Overall Study|Noncompliance|0|||
163099788|NCT01188551|589073625|FG000|Overall Study|Pharmacy issues|1|||
163099789|NCT01188551|589073626|FG001|Overall Study|Pharmacy issues|0|||
163099790|NCT01188551|589073627|FG002|Overall Study|Pharmacy issues|0|||
163099791|NCT01188551|589073628|FG003|Overall Study|Pharmacy issues|0|||
163099792|NCT01306643|589073629|FG000|Overall Study|Adverse Event|5|||
163099793|NCT01306643|589073629|FG000|Overall Study|Disease Progression|7|||
163099794|NCT01306643|589073629|FG000|Overall Study|Other: Change in Eligibility Status|1|||
163099795|NCT01582009|589073631|FG000|Overall Study|Withdrawal by Subject|1|||
163099796|NCT01582009|589073631|FG000|Overall Study|Physician Decision|1|||
163099797|NCT00310375|589073632|FG000|Primary Reporting Phase|Adverse Event|28|||
163099798|NCT00310375|589073633|FG001|Primary Reporting Phase|Adverse Event|22|||
163099799|NCT00310375|589073634|FG002|Primary Reporting Phase|Adverse Event|0|||
163099800|NCT00310375|589073632|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
163099801|NCT00310375|589073633|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
163099802|NCT00310375|589073634|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
163099803|NCT00310375|589073632|FG000|Primary Reporting Phase|Pregnancy|2|||
162719045|NCT01981356|587676758|FG000|Overall Study|Lost to Follow-up|4|||
163099804|NCT00310375|589073633|FG001|Primary Reporting Phase|Pregnancy|2|||
163099805|NCT00310375|589073634|FG002|Primary Reporting Phase|Pregnancy|0|||
163099806|NCT00310375|589073632|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
163099807|NCT00310375|589073633|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
163099808|NCT00310375|589073634|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
163099809|NCT00310375|589073632|FG000|Primary Reporting Phase|Protocol Violation|8|||
163099810|NCT00310375|589073633|FG001|Primary Reporting Phase|Protocol Violation|5|||
163099811|NCT00310375|589073634|FG002|Primary Reporting Phase|Protocol Violation|0|||
163099812|NCT00310375|589073632|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
163099813|NCT00310375|589073633|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
163099814|NCT00310375|589073634|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
163099815|NCT00310375|589073632|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
163099816|NCT00310375|589073633|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
163099817|NCT00310375|589073634|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
163099818|NCT00310375|589073632|FG000|Primary Reporting Phase|Physician Decision|5|||
163099819|NCT00310375|589073633|FG001|Primary Reporting Phase|Physician Decision|3|||
163099820|NCT00310375|589073634|FG002|Primary Reporting Phase|Physician Decision|0|||
163099821|NCT00310375|589073632|FG000|Primary Reporting Phase|Request of the sponsor|2|||
163099822|NCT00310375|589073633|FG001|Primary Reporting Phase|Request of the sponsor|2|||
163099823|NCT00310375|589073634|FG002|Primary Reporting Phase|Request of the sponsor|0|||
163099824|NCT00310375|589073632|FG000|Primary Reporting Phase|Failed to return|1|||
163099825|NCT00310375|589073633|FG001|Primary Reporting Phase|Failed to return|3|||
163099826|NCT00310375|589073634|FG002|Primary Reporting Phase|Failed to return|0|||
163099827|NCT00310375|589073632|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
163099828|NCT00310375|589073633|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
163099829|NCT00310375|589073634|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
163099830|NCT00310375|589073632|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
163099831|NCT00310375|589073633|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
163099832|NCT00310375|589073634|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
163099833|NCT00310375|589073632|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
163099834|NCT00310375|589073633|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
163099835|NCT00310375|589073634|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
163099836|NCT00310375|589073632|FG000|Primary Reporting Phase|Site closure|3|||
163099837|NCT00310375|589073633|FG001|Primary Reporting Phase|Site closure|0|||
163099838|NCT00310375|589073634|FG002|Primary Reporting Phase|Site closure|0|||
163099839|NCT00310375|589073632|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
163099840|NCT00310375|589073633|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
163099841|NCT00310375|589073634|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
163099842|NCT00310375|589073632|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
163099843|NCT00310375|589073633|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
163099844|NCT00310375|589073634|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
163099845|NCT00310375|589073632|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
163099846|NCT00310375|589073633|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
163099847|NCT00310375|589073634|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
163099848|NCT00310375|589073632|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
163099849|NCT00310375|589073633|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
163099850|NCT00310375|589073634|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
163099851|NCT04024436|589073635|FG000|Overall Study|Death|10|||
163099852|NCT04024436|589073636|FG001|Overall Study|Death|14|||
163099853|NCT04024436|589073637|FG002|Overall Study|Death|2|||
163099854|NCT04024436|589073638|FG003|Overall Study|Death|7|||
163099855|NCT04024436|589073635|FG000|Overall Study|Loss to follow up|1|||
163099856|NCT04024436|589073636|FG001|Overall Study|Loss to follow up|0|||
163099857|NCT04024436|589073637|FG002|Overall Study|Loss to follow up|0|||
163099858|NCT04024436|589073638|FG003|Overall Study|Loss to follow up|1|||
163099859|NCT04024436|589073635|FG000|Overall Study|Withdrawal of consent|2|||
163099860|NCT04024436|589073636|FG001|Overall Study|Withdrawal of consent|0|||
163099861|NCT04024436|589073637|FG002|Overall Study|Withdrawal of consent|0|||
163099862|NCT04024436|589073638|FG003|Overall Study|Withdrawal of consent|1|||
163099863|NCT04024436|589073635|FG000|Overall Study|Study termination by sponsor|4|||
163099864|NCT04024436|589073636|FG001|Overall Study|Study termination by sponsor|6|||
163099865|NCT04024436|589073637|FG002|Overall Study|Study termination by sponsor|2|||
163099866|NCT04024436|589073638|FG003|Overall Study|Study termination by sponsor|11|||
163099867|NCT04024436|589073635|FG000|Overall Study|Reason Not Specified|0|||
163099868|NCT04024436|589073636|FG001|Overall Study|Reason Not Specified|1|||
163099869|NCT04024436|589073637|FG002|Overall Study|Reason Not Specified|0|||
163099870|NCT04024436|589073638|FG003|Overall Study|Reason Not Specified|2|||
163099871|NCT02553928|589073639|FG000|Overall Study|Adverse Event|2|||
163099872|NCT02553928|589073640|FG001|Overall Study|Adverse Event|1|||
163099873|NCT02553928|589073639|FG000|Overall Study|Lost to Follow-up|0|||
163099874|NCT02553928|589073640|FG001|Overall Study|Lost to Follow-up|1|||
163099875|NCT02553928|589073639|FG000|Overall Study|Administrative reason(s)|0|||
163099876|NCT02553928|589073640|FG001|Overall Study|Administrative reason(s)|1|||
163099877|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
163099878|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
163099879|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
163099880|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
163099881|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
163099882|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
163099883|NCT05507567|589073641|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
163099884|NCT05507567|589073642|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
163099885|NCT05507567|589073643|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
163099886|NCT05507567|589073641|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
163099887|NCT05507567|589073642|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
163099888|NCT05507567|589073643|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
163099889|NCT04830215|589073644|FG000|Overall Study|Adverse Event|6|||
163099890|NCT04830215|589073644|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
163099891|NCT04830215|589073644|FG000|Overall Study|Withdrawal by Subject|3|||
163099892|NCT04830215|589073644|FG000|Overall Study|Protocol Deviation|1|||
163099893|NCT00770562|589073647|FG000|Overall Study|Did not take treatment|1|||
163099894|NCT00770562|589073648|FG001|Overall Study|Did not take treatment|1|||
163099895|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
163099896|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
163099897|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099898|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099899|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099900|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099901|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099902|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099903|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099904|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163099905|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
163099906|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
163099907|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099908|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099909|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099910|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099911|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099912|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099913|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099914|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
163099915|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
163099916|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099917|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099918|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099919|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099920|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099921|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099922|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099923|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099924|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
163099925|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
163099926|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
163099927|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099928|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099929|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099930|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099931|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099932|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099933|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099934|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
163099935|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099936|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
163099937|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099938|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099939|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099940|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099941|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099942|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099943|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099944|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163099945|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
163099946|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
163099947|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099948|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099949|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099950|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099951|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099952|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099953|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099954|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
163099955|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
163099956|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
163099957|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099958|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099959|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099960|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099961|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099962|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099963|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099964|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
163099965|NCT01194219|589073649|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
163099966|NCT01194219|589073650|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
163099967|NCT01194219|589073651|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099968|NCT01194219|589073652|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099969|NCT01194219|589073653|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099970|NCT01194219|589073654|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099971|NCT01194219|589073655|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099972|NCT01194219|589073656|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099973|NCT01194219|589073657|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099974|NCT01194219|589073658|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
163099975|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099976|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099977|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
163099978|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
163099979|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099980|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099981|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099982|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099983|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099984|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
163099985|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099986|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099987|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
163099988|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
163099989|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099990|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099991|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099992|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099993|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099994|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
163099995|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163099996|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163099997|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
163099998|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
163099999|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100000|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100001|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100002|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100003|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100004|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
163100005|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100006|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100007|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
162653418|NCT05619692|587447598|FG000|Overall Study|Randomized but not treated|1|||
163100008|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
163100009|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100010|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100011|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100012|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100013|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100014|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163100015|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100016|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100017|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
163100018|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100019|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100020|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100021|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100022|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100023|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100024|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163100025|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100026|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100027|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100028|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
163100029|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100030|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100031|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100032|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100033|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100034|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
163100035|NCT01194219|589073649|FG000|Maintenance Phase Weeks16-32|Other|0|||
163100036|NCT01194219|589073650|FG001|Maintenance Phase Weeks16-32|Other|0|||
163100037|NCT01194219|589073651|FG002|Maintenance Phase Weeks16-32|Other|2|||
163100038|NCT01194219|589073652|FG003|Maintenance Phase Weeks16-32|Other|1|||
163100039|NCT01194219|589073653|FG004|Maintenance Phase Weeks16-32|Other|0|||
163100040|NCT01194219|589073654|FG005|Maintenance Phase Weeks16-32|Other|0|||
163100041|NCT01194219|589073655|FG006|Maintenance Phase Weeks16-32|Other|0|||
163100042|NCT01194219|589073656|FG007|Maintenance Phase Weeks16-32|Other|0|||
163100043|NCT01194219|589073657|FG008|Maintenance Phase Weeks16-32|Other|0|||
163100044|NCT01194219|589073658|FG009|Maintenance Phase Weeks16-32|Other|0|||
163100045|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100046|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100047|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100048|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100049|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100050|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
163100051|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
163100052|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
163100053|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100054|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
163100055|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100056|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100057|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100058|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100059|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
163100060|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
163100061|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
163100062|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
163100063|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100064|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
163100065|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100066|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100067|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100068|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100069|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
163100070|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100071|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
163100072|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100073|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100074|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
163100075|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100076|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100077|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100078|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100079|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
163100080|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100081|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
163100082|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
163100083|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100084|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
163100085|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100086|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100087|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100088|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100089|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
163100090|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
163100091|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
163100092|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100093|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100094|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163100095|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100096|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100097|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100098|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100099|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100100|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100101|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100102|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
163100103|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100104|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
163100105|NCT01194219|589073649|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100106|NCT01194219|589073650|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100107|NCT01194219|589073651|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100108|NCT01194219|589073652|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100109|NCT01194219|589073653|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100110|NCT01194219|589073654|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100111|NCT01194219|589073655|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
163100112|NCT01194219|589073656|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100113|NCT01194219|589073657|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100114|NCT01194219|589073658|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
163100115|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100116|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100117|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100118|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100119|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100120|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100121|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100122|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
163100123|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
163100124|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
163100125|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100126|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100127|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100128|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100129|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100130|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100131|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100132|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
163100133|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
163100134|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
163100135|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
162653419|NCT05619692|587447599|FG001|Overall Study|Randomized but not treated|3|||
162653420|NCT02457598|587447600|FG000|Overall Study|Progressive Disease|2|||
163100136|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100137|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100138|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100139|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
162653421|NCT02457598|587447601|FG001|Overall Study|Progressive Disease|2|||
162653422|NCT02457598|587447602|FG002|Overall Study|Progressive Disease|1|||
162653423|NCT02457598|587447603|FG003|Overall Study|Progressive Disease|11|||
163100140|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100141|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100142|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
163100143|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
163100144|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
163100145|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100146|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100147|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100148|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100149|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100150|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100151|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100152|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
163100153|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
163100154|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
163100155|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
163100156|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
163100157|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
163100158|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
163100159|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
163100160|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
163100161|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
163100162|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
163100163|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
163100164|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
163100165|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100166|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100167|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100168|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100169|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100170|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100171|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100172|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
163100173|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
163100174|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
163100175|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100176|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100177|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100178|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100179|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100180|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100181|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100182|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100183|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
163100184|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
163100185|NCT01194219|589073649|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100186|NCT01194219|589073650|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100187|NCT01194219|589073651|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100188|NCT01194219|589073652|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100189|NCT01194219|589073653|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100190|NCT01194219|589073654|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100191|NCT01194219|589073655|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100192|NCT01194219|589073656|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
163100193|NCT01194219|589073657|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
163100194|NCT01194219|589073658|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
163100195|NCT05338710|589073659|FG000|Overall Study|Withdrawal by Subject|3|||
163100196|NCT01081951|589073660|FG000|Overall Study|Death|54|||
163100197|NCT01081951|589073661|FG001|Overall Study|Death|47|||
163100198|NCT01081951|589073660|FG000|Overall Study|Withdrawal by Subject|2|||
163100199|NCT01081951|589073661|FG001|Overall Study|Withdrawal by Subject|6|||
163100200|NCT01081951|589073660|FG000|Overall Study|Allocated treatment but did not take it|0|||
163100201|NCT01081951|589073661|FG001|Overall Study|Allocated treatment but did not take it|1|||
163100202|NCT01081951|589073660|FG000|Overall Study|Lost to Follow-up|0|||
163100203|NCT01081951|589073661|FG001|Overall Study|Lost to Follow-up|1|||
163100204|NCT05226598|589073664|FG000|Overall Study|Death|186|||
162653424|NCT02457598|587447604|FG004|Overall Study|Progressive Disease|7|||
162653425|NCT02457598|587447605|FG005|Overall Study|Progressive Disease|3|||
163100205|NCT05226598|589073665|FG001|Overall Study|Death|191|||
163100206|NCT05226598|589073664|FG000|Overall Study|Withdrawal by Subject|6|||
163100207|NCT05226598|589073665|FG001|Overall Study|Withdrawal by Subject|6|||
163100208|NCT05226598|589073664|FG000|Overall Study|Ongoing|174|||
163100209|NCT05226598|589073665|FG001|Overall Study|Ongoing|176|||
163100210|NCT04503551|589073666|FG000|Overall Study|Withdrawal by Subject|5|||
163100211|NCT04503551|589073667|FG001|Overall Study|Withdrawal by Subject|3|||
163100212|NCT04503551|589073666|FG000|Overall Study|Physician Decision|1|||
163100213|NCT04503551|589073667|FG001|Overall Study|Physician Decision|0|||
163100214|NCT04503551|589073666|FG000|Overall Study|Death|0|||
163100215|NCT04503551|589073667|FG001|Overall Study|Death|1|||
163100216|NCT04503551|589073666|FG000|Overall Study|Lost to Follow-up|1|||
163100217|NCT04503551|589073667|FG001|Overall Study|Lost to Follow-up|2|||
163100218|NCT04503551|589073666|FG000|Overall Study|Ongoing at Week 52|99|||
163100219|NCT04503551|589073667|FG001|Overall Study|Ongoing at Week 52|62|||
163100220|NCT02569476|589073668|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
163100221|NCT02569476|589073668|FG000|Overall Study|Death|33|||
163100222|NCT02569476|589073668|FG000|Overall Study|Withdrawal by Subject|9|||
163100223|NCT02569476|589073668|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
163100224|NCT02569476|589073668|FG000|Overall Study|Palliative care|1|||
163100225|NCT02569476|589073668|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
163100226|NCT02569476|589073668|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
163100227|NCT01152788|589073669|FG000|Overall Study|Withdrawal by Subject|0|||
163100228|NCT01152788|589073670|FG001|Overall Study|Withdrawal by Subject|3|||
163100229|NCT01152788|589073669|FG000|Overall Study|No treatment|0|||
163100230|NCT01152788|589073670|FG001|Overall Study|No treatment|1|||
163100231|NCT00778336|589073671|FG000|Index Procedure-Discharge|Death|6|||
163100232|NCT00778336|589073672|FG001|Index Procedure-Discharge|Death|3|||
163100233|NCT00778336|589073673|FG002|Index Procedure-Discharge|Death|2|||
163100234|NCT00778336|589073674|FG003|Index Procedure-Discharge|Death|0|||
163100235|NCT00778336|589073671|FG000|3 Month Follow Up|Lost to Follow-up|15|||
163100236|NCT00778336|589073672|FG001|3 Month Follow Up|Lost to Follow-up|20|||
163100237|NCT00778336|589073673|FG002|3 Month Follow Up|Lost to Follow-up|3|||
163100238|NCT00778336|589073674|FG003|3 Month Follow Up|Lost to Follow-up|0|||
163100239|NCT00778336|589073671|FG000|3 Month Follow Up|Death|8|||
163100240|NCT00778336|589073672|FG001|3 Month Follow Up|Death|3|||
163100241|NCT00778336|589073673|FG002|3 Month Follow Up|Death|2|||
163100242|NCT00778336|589073674|FG003|3 Month Follow Up|Death|0|||
163100243|NCT04585269|589073675|FG000|Intervention|Withdrawal by Subject|9|||
163100244|NCT04585269|589073676|FG001|Intervention|Withdrawal by Subject|0|||
163100245|NCT04585269|589073675|FG000|Intervention|Unable to schedule|15|||
163100246|NCT04585269|589073676|FG001|Intervention|Unable to schedule|0|||
163100247|NCT04585269|589073675|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
163100248|NCT04585269|589073676|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
163100249|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Death|2|||
163100250|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Death|2|||
163100251|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
163100252|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
163100253|NCT04585269|589073675|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
163100254|NCT04585269|589073676|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
163100255|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
163100256|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
163100257|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
163100258|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
163100259|NCT04585269|589073675|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
163100260|NCT04585269|589073676|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
163100261|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100262|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
163100263|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
163100264|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100265|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100266|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
163100267|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Other|0|||
163100268|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Other|1|||
163100269|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Other|1|||
163100270|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Other|0|||
163100271|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Other|0|||
163100272|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Other|0|||
163100273|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
163100274|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
163100275|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
163100276|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100277|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100278|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
163100279|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100280|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
162653426|NCT02457598|587447606|FG006|Overall Study|Progressive Disease|2|||
163100281|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
163100282|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100283|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100284|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
163100285|NCT03666988|589073679|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
163100286|NCT03666988|589073680|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100287|NCT03666988|589073681|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100288|NCT03666988|589073682|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100289|NCT03666988|589073683|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100290|NCT03666988|589073684|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163100291|NCT02517398|589073685|FG000|Overall Study|Death|2|||
163100292|NCT02517398|589073686|FG001|Overall Study|Death|3|||
163100293|NCT02517398|589073687|FG002|Overall Study|Death|4|||
163100294|NCT02517398|589073688|FG003|Overall Study|Death|2|||
163100295|NCT02517398|589073689|FG004|Overall Study|Death|3|||
163100296|NCT02517398|589073690|FG005|Overall Study|Death|8|||
163100297|NCT02517398|589073691|FG006|Overall Study|Death|3|||
163100298|NCT02517398|589073692|FG007|Overall Study|Death|2|||
163100299|NCT02517398|589073693|FG008|Overall Study|Death|6|||
163100300|NCT02517398|589073694|FG009|Overall Study|Death|24|||
163100301|NCT02517398|589073695|FG010|Overall Study|Death|53|||
163100302|NCT02517398|589073696|FG011|Overall Study|Death|25|||
163100303|NCT02517398|589073697|FG012|Overall Study|Death|73|||
163100304|NCT02517398|589073698|FG013|Overall Study|Death|29|||
163100305|NCT02517398|589073699|FG014|Overall Study|Death|26|||
163100306|NCT02517398|589073700|FG015|Overall Study|Death|23|||
163100307|NCT02517398|589073701|FG016|Overall Study|Death|26|||
163100308|NCT02517398|589073702|FG017|Overall Study|Death|25|||
163100309|NCT02517398|589073703|FG018|Overall Study|Death|22|||
163100310|NCT02517398|589073704|FG019|Overall Study|Death|7|||
163100311|NCT02517398|589073705|FG020|Overall Study|Death|26|||
163100312|NCT02517398|589073706|FG021|Overall Study|Death|30|||
163100313|NCT02517398|589073707|FG022|Overall Study|Death|20|||
163100314|NCT02517398|589073685|FG000|Overall Study|Other|0|||
163100315|NCT02517398|589073686|FG001|Overall Study|Other|0|||
163100316|NCT02517398|589073687|FG002|Overall Study|Other|0|||
163100317|NCT02517398|589073688|FG003|Overall Study|Other|1|||
163100318|NCT02517398|589073689|FG004|Overall Study|Other|0|||
163100319|NCT02517398|589073690|FG005|Overall Study|Other|0|||
163100320|NCT02517398|589073691|FG006|Overall Study|Other|0|||
163100321|NCT02517398|589073692|FG007|Overall Study|Other|0|||
163100322|NCT02517398|589073693|FG008|Overall Study|Other|0|||
163100323|NCT02517398|589073694|FG009|Overall Study|Other|1|||
163100324|NCT02517398|589073695|FG010|Overall Study|Other|0|||
163100325|NCT02517398|589073696|FG011|Overall Study|Other|0|||
163100326|NCT02517398|589073697|FG012|Overall Study|Other|0|||
163100327|NCT02517398|589073698|FG013|Overall Study|Other|1|||
163100328|NCT02517398|589073699|FG014|Overall Study|Other|0|||
163100329|NCT02517398|589073700|FG015|Overall Study|Other|1|||
163100330|NCT02517398|589073701|FG016|Overall Study|Other|1|||
163100331|NCT02517398|589073702|FG017|Overall Study|Other|0|||
163100332|NCT02517398|589073703|FG018|Overall Study|Other|0|||
163100333|NCT02517398|589073704|FG019|Overall Study|Other|1|||
163100334|NCT02517398|589073705|FG020|Overall Study|Other|0|||
163100335|NCT02517398|589073706|FG021|Overall Study|Other|0|||
163100336|NCT02517398|589073707|FG022|Overall Study|Other|0|||
163100337|NCT02517398|589073685|FG000|Overall Study|Lost to Follow-up|0|||
163100338|NCT02517398|589073686|FG001|Overall Study|Lost to Follow-up|0|||
163100339|NCT02517398|589073687|FG002|Overall Study|Lost to Follow-up|0|||
163100340|NCT02517398|589073688|FG003|Overall Study|Lost to Follow-up|0|||
163100341|NCT02517398|589073689|FG004|Overall Study|Lost to Follow-up|0|||
163100342|NCT02517398|589073690|FG005|Overall Study|Lost to Follow-up|0|||
163100343|NCT02517398|589073691|FG006|Overall Study|Lost to Follow-up|0|||
163100344|NCT02517398|589073692|FG007|Overall Study|Lost to Follow-up|0|||
163100345|NCT02517398|589073693|FG008|Overall Study|Lost to Follow-up|0|||
163100346|NCT02517398|589073694|FG009|Overall Study|Lost to Follow-up|1|||
163100347|NCT02517398|589073695|FG010|Overall Study|Lost to Follow-up|0|||
163100348|NCT02517398|589073696|FG011|Overall Study|Lost to Follow-up|2|||
163100349|NCT02517398|589073697|FG012|Overall Study|Lost to Follow-up|2|||
163100350|NCT02517398|589073698|FG013|Overall Study|Lost to Follow-up|0|||
163100351|NCT02517398|589073699|FG014|Overall Study|Lost to Follow-up|1|||
162653427|NCT02457598|587447607|FG007|Overall Study|Progressive Disease|1|||
163100352|NCT02517398|589073700|FG015|Overall Study|Lost to Follow-up|1|||
163100353|NCT02517398|589073701|FG016|Overall Study|Lost to Follow-up|0|||
163100354|NCT02517398|589073702|FG017|Overall Study|Lost to Follow-up|3|||
163100355|NCT02517398|589073703|FG018|Overall Study|Lost to Follow-up|1|||
163100356|NCT02517398|589073704|FG019|Overall Study|Lost to Follow-up|0|||
163100357|NCT02517398|589073705|FG020|Overall Study|Lost to Follow-up|1|||
163100358|NCT02517398|589073706|FG021|Overall Study|Lost to Follow-up|0|||
163100359|NCT02517398|589073707|FG022|Overall Study|Lost to Follow-up|2|||
163100360|NCT02517398|589073685|FG000|Overall Study|Withdrew Consent|0|||
163100361|NCT02517398|589073686|FG001|Overall Study|Withdrew Consent|0|||
163100362|NCT02517398|589073687|FG002|Overall Study|Withdrew Consent|0|||
163100363|NCT02517398|589073688|FG003|Overall Study|Withdrew Consent|0|||
163100364|NCT02517398|589073689|FG004|Overall Study|Withdrew Consent|0|||
163100365|NCT02517398|589073690|FG005|Overall Study|Withdrew Consent|0|||
163100366|NCT02517398|589073691|FG006|Overall Study|Withdrew Consent|1|||
163100367|NCT02517398|589073692|FG007|Overall Study|Withdrew Consent|0|||
163100368|NCT02517398|589073693|FG008|Overall Study|Withdrew Consent|0|||
163100369|NCT02517398|589073694|FG009|Overall Study|Withdrew Consent|2|||
163100370|NCT02517398|589073695|FG010|Overall Study|Withdrew Consent|7|||
163100371|NCT02517398|589073696|FG011|Overall Study|Withdrew Consent|1|||
163100372|NCT02517398|589073697|FG012|Overall Study|Withdrew Consent|5|||
163100373|NCT02517398|589073698|FG013|Overall Study|Withdrew Consent|4|||
163100374|NCT02517398|589073699|FG014|Overall Study|Withdrew Consent|2|||
163100375|NCT02517398|589073700|FG015|Overall Study|Withdrew Consent|5|||
163100376|NCT02517398|589073701|FG016|Overall Study|Withdrew Consent|4|||
163100377|NCT02517398|589073702|FG017|Overall Study|Withdrew Consent|2|||
163100378|NCT02517398|589073703|FG018|Overall Study|Withdrew Consent|3|||
163100379|NCT02517398|589073704|FG019|Overall Study|Withdrew Consent|2|||
163100380|NCT02517398|589073705|FG020|Overall Study|Withdrew Consent|9|||
163100381|NCT02517398|589073706|FG021|Overall Study|Withdrew Consent|3|||
163100382|NCT02517398|589073707|FG022|Overall Study|Withdrew Consent|1|||
163100383|NCT05588440|589073714|FG000|Overall Study|Sponsor Decision|2|||
163100384|NCT05588440|589073715|FG001|Overall Study|Sponsor Decision|0|||
163100385|NCT05588440|589073716|FG002|Overall Study|Sponsor Decision|1|||
163100386|NCT05588440|589073714|FG000|Overall Study|Death|1|||
163100387|NCT05588440|589073715|FG001|Overall Study|Death|1|||
163100388|NCT05588440|589073716|FG002|Overall Study|Death|1|||
163100389|NCT05588440|589073714|FG000|Overall Study|Screen Fail|0|||
163100390|NCT05588440|589073715|FG001|Overall Study|Screen Fail|1|||
163100391|NCT05588440|589073716|FG002|Overall Study|Screen Fail|1|||
163100392|NCT05588440|589073714|FG000|Overall Study|Withdrawal by Subject|0|||
163100393|NCT05588440|589073715|FG001|Overall Study|Withdrawal by Subject|0|||
163100394|NCT05588440|589073716|FG002|Overall Study|Withdrawal by Subject|1|||
163100395|NCT03533660|589073717|FG000|Overall Study|Withdrawal by Subject|2|||
163100396|NCT03533660|589073718|FG001|Overall Study|Withdrawal by Subject|2|||
163100397|NCT03533660|589073717|FG000|Overall Study|Death|2|||
163100398|NCT03533660|589073718|FG001|Overall Study|Death|4|||
163100399|NCT03533660|589073717|FG000|Overall Study|Adverse Event|0|||
163100400|NCT03533660|589073718|FG001|Overall Study|Adverse Event|2|||
163100401|NCT01671956|589073719|FG000|Overall Study|Disease progression|0|||
163100402|NCT01671956|589073720|FG001|Overall Study|Disease progression|1|||
163100403|NCT01671956|589073719|FG000|Overall Study|Withdrawal by Subject|1|||
163100404|NCT01671956|589073720|FG001|Overall Study|Withdrawal by Subject|1|||
163100405|NCT01671956|589073719|FG000|Overall Study|Adverse Event|1|||
163100406|NCT01671956|589073720|FG001|Overall Study|Adverse Event|0|||
163100407|NCT03816176|589073728|FG000|Overall Study|Miscellaneous|5|||
163100408|NCT03816176|589073728|FG000|Overall Study|Lack of Efficacy|4|||
163100409|NCT03816176|589073728|FG000|Overall Study|Adverse Event|3|||
163100410|NCT03581292|589073729|FG000|Overall Study|Physician Decision|9|||
163100411|NCT03581292|589073730|FG001|Overall Study|Physician Decision|5|||
163100412|NCT03581292|589073729|FG000|Overall Study|Withdrawal by Subject|3|||
163100413|NCT03581292|589073730|FG001|Overall Study|Withdrawal by Subject|0|||
163100414|NCT03581292|589073729|FG000|Overall Study|Withdrawal before Therapy Start|1|||
163100415|NCT03581292|589073730|FG001|Overall Study|Withdrawal before Therapy Start|0|||
163100416|NCT05200572|589073731|FG000|Overall Study|Withdrawal by Subject|14|||
163100417|NCT02524145|589073735|FG000|Overall Study|Withdrawal by Subject|2|||
163100418|NCT02524145|589073736|FG001|Overall Study|Withdrawal by Subject|2|||
163100419|NCT02524145|589073737|FG002|Overall Study|Withdrawal by Subject|3|||
163100420|NCT07214935|589073740|FG000|Overall Study|Adverse Event|1|||
163100421|NCT07214935|589073741|FG001|Overall Study|Adverse Event|1|||
163100422|NCT07214935|589073742|FG002|Overall Study|Adverse Event|1|||
163100423|NCT07214935|589073743|FG003|Overall Study|Adverse Event|0|||
163100424|NCT07214935|589073740|FG000|Overall Study|Lost to Follow-up|0|||
163100425|NCT07214935|589073741|FG001|Overall Study|Lost to Follow-up|1|||
163100426|NCT07214935|589073742|FG002|Overall Study|Lost to Follow-up|0|||
163100427|NCT07214935|589073743|FG003|Overall Study|Lost to Follow-up|0|||
163100428|NCT07214935|589073740|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
163100429|NCT07214935|589073741|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100430|NCT07214935|589073742|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100431|NCT07214935|589073743|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
163100432|NCT07214935|589073740|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
163100433|NCT07214935|589073741|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
163100434|NCT07214935|589073742|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
163100435|NCT07214935|589073743|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
163100436|NCT02744612|589076018|FG000|Overall Study|Withdrawal by Subject|0|||
163100437|NCT02744612|589076019|FG001|Overall Study|Withdrawal by Subject|2|||
163100438|NCT00283803|589076020|FG000|Overall Study|Physician Decision|9|||
163100439|NCT00283803|589076020|FG000|Overall Study|Withdrawal by Subject|4|||
163100440|NCT01127607|589076021|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
163100441|NCT01127607|589076022|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
163100442|NCT01127607|589076021|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
163100443|NCT01127607|589076022|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
163100444|NCT03419897|589076023|FG000|Overall Study|Death|180|||
163100445|NCT03419897|589076023|FG000|Overall Study|Lost to Follow-up|1|||
163100446|NCT03419897|589076023|FG000|Overall Study|Withdrawal by Subject|6|||
163100447|NCT03419897|589076023|FG000|Overall Study|Sponsor Decision|61|||
163100448|NCT03419897|589076023|FG000|Overall Study|Physician Decision|1|||
163100449|NCT05730725|589076026|FG000|Overall Study|Withdrawal by Subject|3|||
163100450|NCT05730725|589076027|FG001|Overall Study|Withdrawal by Subject|0|||
163100451|NCT05730725|589076028|FG002|Overall Study|Withdrawal by Subject|0|||
163100452|NCT05730725|589076029|FG003|Overall Study|Withdrawal by Subject|1|||
163100453|NCT05730725|589076026|FG000|Overall Study|Not Reported|1|||
163100454|NCT05730725|589076027|FG001|Overall Study|Not Reported|1|||
163100455|NCT05730725|589076028|FG002|Overall Study|Not Reported|1|||
163100456|NCT05730725|589076029|FG003|Overall Study|Not Reported|1|||
163100457|NCT01945216|589076031|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
163100458|NCT01945216|589076031|FG000|Overall Study|Protocol Violation|42|||
163100459|NCT01945216|589076031|FG000|Overall Study|CRF not assured by investigators|5|||
163100460|NCT02982772|589076033|FG000|Intervention|Lost to Follow-up|19|||
163100461|NCT02982772|589076034|FG001|Intervention|Lost to Follow-up|13|||
163100462|NCT02982772|589076033|FG000|1M Follow-Up|Lost to Follow-up|21|||
163100463|NCT02982772|589076034|FG001|1M Follow-Up|Lost to Follow-up|18|||
163100464|NCT02982772|589076033|FG000|3M Follow-Up|Lost to Follow-up|17|||
163100465|NCT02982772|589076034|FG001|3M Follow-Up|Lost to Follow-up|11|||
163100466|NCT02982772|589076033|FG000|6M Follow-Up|Lost to Follow-up|11|||
163100467|NCT02982772|589076034|FG001|6M Follow-Up|Lost to Follow-up|9|||
163100468|NCT02982772|589076033|FG000|12M Follow-Up|Lost to Follow-up|11|||
163100469|NCT02982772|589076034|FG001|12M Follow-Up|Lost to Follow-up|5|||
163100470|NCT03107052|589076041|FG000|Overall Study|Adverse Event|6|||
163100471|NCT03107052|589076042|FG001|Overall Study|Adverse Event|1|||
163100472|NCT03107052|589076043|FG002|Overall Study|Adverse Event|2|||
163100473|NCT03107052|589076041|FG000|Overall Study|Withdrawal by Subject|9|||
163100474|NCT03107052|589076042|FG001|Overall Study|Withdrawal by Subject|5|||
163100475|NCT03107052|589076043|FG002|Overall Study|Withdrawal by Subject|8|||
163100476|NCT03107052|589076041|FG000|Overall Study|Protocol Violation|6|||
163100477|NCT03107052|589076042|FG001|Overall Study|Protocol Violation|0|||
163100478|NCT03107052|589076043|FG002|Overall Study|Protocol Violation|3|||
163100479|NCT03107052|589076041|FG000|Overall Study|Lost to Follow-up|4|||
163100480|NCT03107052|589076042|FG001|Overall Study|Lost to Follow-up|0|||
163100481|NCT03107052|589076043|FG002|Overall Study|Lost to Follow-up|1|||
163100482|NCT03107052|589076041|FG000|Overall Study|Lack of Efficacy|23|||
163100483|NCT03107052|589076042|FG001|Overall Study|Lack of Efficacy|7|||
163100484|NCT03107052|589076043|FG002|Overall Study|Lack of Efficacy|4|||
163100485|NCT03107052|589076041|FG000|Overall Study|Other than specified|4|||
163100486|NCT03107052|589076042|FG001|Overall Study|Other than specified|2|||
163100487|NCT03107052|589076043|FG002|Overall Study|Other than specified|0|||
162653428|NCT02457598|587447608|FG008|Overall Study|Progressive Disease|1|||
162653429|NCT02457598|587447609|FG009|Overall Study|Progressive Disease|2|||
162653430|NCT02457598|587447610|FG010|Overall Study|Progressive Disease|45|||
162653431|NCT02457598|587447611|FG011|Overall Study|Progressive Disease|6|||
162653432|NCT02457598|587447612|FG012|Overall Study|Progressive Disease|2|||
162653433|NCT02457598|587447613|FG013|Overall Study|Progressive Disease|2|||
162653434|NCT02457598|587447614|FG014|Overall Study|Progressive Disease|10|||
162653435|NCT02457598|587447615|FG015|Overall Study|Progressive Disease|1|||
162653436|NCT02457598|587447616|FG016|Overall Study|Progressive Disease|1|||
162653437|NCT02457598|587447600|FG000|Overall Study|Investigator's Discretion|0|||
162653438|NCT02457598|587447601|FG001|Overall Study|Investigator's Discretion|2|||
162653439|NCT02457598|587447602|FG002|Overall Study|Investigator's Discretion|2|||
162653440|NCT02457598|587447603|FG003|Overall Study|Investigator's Discretion|2|||
162653441|NCT02457598|587447604|FG004|Overall Study|Investigator's Discretion|0|||
162653442|NCT02457598|587447605|FG005|Overall Study|Investigator's Discretion|0|||
162653443|NCT02457598|587447606|FG006|Overall Study|Investigator's Discretion|0|||
162653444|NCT02457598|587447607|FG007|Overall Study|Investigator's Discretion|1|||
162653445|NCT02457598|587447608|FG008|Overall Study|Investigator's Discretion|2|||
162653446|NCT02457598|587447609|FG009|Overall Study|Investigator's Discretion|0|||
163100488|NCT03107052|589076041|FG000|Overall Study|Study terminated due to futility|67|||
163100489|NCT03107052|589076042|FG001|Overall Study|Study terminated due to futility|31|||
162653447|NCT02457598|587447610|FG010|Overall Study|Investigator's Discretion|10|||
163100490|NCT03107052|589076043|FG002|Overall Study|Study terminated due to futility|23|||
163100491|NCT00958360|589076044|FG000|Overall Study|Withdrawal by Subject|3|||
163100492|NCT00958360|589076045|FG001|Overall Study|Withdrawal by Subject|1|||
163100493|NCT00958360|589076044|FG000|Overall Study|Death|6|||
163100494|NCT00958360|589076045|FG001|Overall Study|Death|7|||
163100495|NCT00958360|589076044|FG000|Overall Study|Physician Decision|2|||
163100496|NCT00958360|589076045|FG001|Overall Study|Physician Decision|1|||
163100497|NCT00958360|589076044|FG000|Overall Study|Lost to Follow-up|0|||
163100498|NCT00958360|589076045|FG001|Overall Study|Lost to Follow-up|1|||
163100499|NCT03015363|589076046|FG000|Overall Study|Physician Decision|14|||
163100500|NCT03015363|589076046|FG000|Overall Study|Withdrawal by Subject|3|||
163100501|NCT02263326|589076047|FG000|Overall Study|Lost to Follow-up|1|||
163100502|NCT02263326|589076048|FG001|Overall Study|Lost to Follow-up|1|||
163100503|NCT01061723|589076049|FG000|Overall Study|Adverse Event|0|||
163100504|NCT01061723|589076050|FG001|Overall Study|Adverse Event|2|||
163100505|NCT01061723|589076051|FG002|Overall Study|Adverse Event|5|||
163100506|NCT01061723|589076052|FG003|Overall Study|Adverse Event|5|||
163100507|NCT01061723|589076053|FG004|Overall Study|Adverse Event|2|||
163100508|NCT01061723|589076054|FG005|Overall Study|Adverse Event|6|||
163100509|NCT01061723|589076049|FG000|Overall Study|Lack of Efficacy|2|||
163100510|NCT01061723|589076050|FG001|Overall Study|Lack of Efficacy|3|||
163100511|NCT01061723|589076051|FG002|Overall Study|Lack of Efficacy|4|||
163100512|NCT01061723|589076052|FG003|Overall Study|Lack of Efficacy|2|||
163100513|NCT01061723|589076053|FG004|Overall Study|Lack of Efficacy|1|||
163100514|NCT01061723|589076054|FG005|Overall Study|Lack of Efficacy|1|||
163100515|NCT01061723|589076049|FG000|Overall Study|Randomized but not treated|0|||
163100516|NCT01061723|589076050|FG001|Overall Study|Randomized but not treated|0|||
163100517|NCT01061723|589076051|FG002|Overall Study|Randomized but not treated|0|||
163100518|NCT01061723|589076052|FG003|Overall Study|Randomized but not treated|0|||
163100519|NCT01061723|589076053|FG004|Overall Study|Randomized but not treated|0|||
163100520|NCT01061723|589076054|FG005|Overall Study|Randomized but not treated|1|||
163100521|NCT01061723|589076049|FG000|Overall Study|Other than specified above|2|||
163100522|NCT01061723|589076050|FG001|Overall Study|Other than specified above|1|||
163100523|NCT01061723|589076051|FG002|Overall Study|Other than specified above|1|||
163100524|NCT01061723|589076052|FG003|Overall Study|Other than specified above|1|||
163100525|NCT01061723|589076053|FG004|Overall Study|Other than specified above|0|||
163100526|NCT01061723|589076054|FG005|Overall Study|Other than specified above|1|||
163100527|NCT00500357|589076055|FG000|Overall Study|Death|1|||
163100528|NCT03292874|589076056|FG000|Overall Study|Due to pandemic|5|||
163100529|NCT02482298|589076057|FG000|Overall Study|Withdrawal by Subject|2|||
163100530|NCT02482298|589076058|FG001|Overall Study|Withdrawal by Subject|1|||
163100531|NCT02482298|589076059|FG002|Overall Study|Withdrawal by Subject|2|||
163100532|NCT02482298|589076057|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
163100533|NCT02482298|589076058|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
163100534|NCT02482298|589076059|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
163100535|NCT02482298|589076057|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
163100536|NCT02482298|589076058|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
163100537|NCT02482298|589076059|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
163100538|NCT02482298|589076057|FG000|Overall Study|Lost to Follow-up|0|||
163100539|NCT02482298|589076058|FG001|Overall Study|Lost to Follow-up|1|||
163100540|NCT02482298|589076059|FG002|Overall Study|Lost to Follow-up|0|||
163100541|NCT03592771|589076064|FG000|Overall Study|Adverse Event|2|||
163100542|NCT03592771|589076065|FG001|Overall Study|Adverse Event|0|||
163100543|NCT03592771|589076066|FG002|Overall Study|Adverse Event|1|||
163100544|NCT03592771|589076064|FG000|Overall Study|Death|0|||
163100545|NCT03592771|589076065|FG001|Overall Study|Death|1|||
163100546|NCT03592771|589076066|FG002|Overall Study|Death|1|||
163100547|NCT03592771|589076064|FG000|Overall Study|Lost to Follow-up|5|||
163100548|NCT03592771|589076065|FG001|Overall Study|Lost to Follow-up|11|||
163100549|NCT03592771|589076066|FG002|Overall Study|Lost to Follow-up|15|||
163100550|NCT03592771|589076064|FG000|Overall Study|Withdrawal by Subject|0|||
163100551|NCT03592771|589076065|FG001|Overall Study|Withdrawal by Subject|2|||
163100552|NCT03592771|589076066|FG002|Overall Study|Withdrawal by Subject|0|||
163100553|NCT01642901|589076067|FG000|12-month Follow-up|Withdrawal by Subject|1|||
163100554|NCT01642901|589076068|FG001|12-month Follow-up|Withdrawal by Subject|0|||
163100555|NCT05069597|589076071|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163100556|NCT05069597|589076072|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163100557|NCT03650413|589076073|FG000|Overall Study|Adverse Event|1|||
163100558|NCT03650413|589076073|FG000|Overall Study|Lack of Efficacy|17|||
163100559|NCT03650413|589076073|FG000|Overall Study|Other|9|||
163100560|NCT03650413|589076073|FG000|Overall Study|Physician Decision|2|||
163100561|NCT03650413|589076073|FG000|Overall Study|Study Terminated By Sponsor|16|||
163100562|NCT03650413|589076073|FG000|Overall Study|Withdrawal by Subject|16|||
163100563|NCT03332173|589076076|FG000|Overall Study|Death|7|||
163100564|NCT03332173|589076076|FG000|Overall Study|Withdrawal by Subject|6|||
163100565|NCT03332173|589076076|FG000|Overall Study|Lost to Follow-up|2|||
162653448|NCT02457598|587447611|FG011|Overall Study|Investigator's Discretion|2|||
163100566|NCT03332173|589076076|FG000|Overall Study|Transferred to long-term extension study|29|||
163100567|NCT00540592|589076077|FG000|Overall Study|Adverse Event|0|||
163100568|NCT00540592|589076078|FG001|Overall Study|Adverse Event|1|||
163100569|NCT00540592|589076079|FG002|Overall Study|Adverse Event|0|||
163100570|NCT00540592|589076080|FG003|Overall Study|Adverse Event|0|||
162653449|NCT02457598|587447612|FG012|Overall Study|Investigator's Discretion|2|||
163100571|NCT00540592|589076081|FG004|Overall Study|Adverse Event|1|||
163100572|NCT00540592|589076082|FG005|Overall Study|Adverse Event|0|||
163100573|NCT00540592|589076083|FG006|Overall Study|Adverse Event|0|||
163100574|NCT00540592|589076084|FG007|Overall Study|Adverse Event|1|||
163100575|NCT00540592|589076085|FG008|Overall Study|Adverse Event|1|||
163100576|NCT00540592|589076086|FG009|Overall Study|Adverse Event|2|||
163100577|NCT00540592|589076077|FG000|Overall Study|Lost to Follow-up|2|||
163100578|NCT00540592|589076078|FG001|Overall Study|Lost to Follow-up|0|||
163100579|NCT00540592|589076079|FG002|Overall Study|Lost to Follow-up|0|||
163100580|NCT00540592|589076080|FG003|Overall Study|Lost to Follow-up|0|||
163100581|NCT00540592|589076081|FG004|Overall Study|Lost to Follow-up|0|||
163100582|NCT00540592|589076082|FG005|Overall Study|Lost to Follow-up|0|||
163100583|NCT00540592|589076083|FG006|Overall Study|Lost to Follow-up|0|||
163100584|NCT00540592|589076084|FG007|Overall Study|Lost to Follow-up|0|||
163100585|NCT00540592|589076085|FG008|Overall Study|Lost to Follow-up|0|||
163100586|NCT00540592|589076086|FG009|Overall Study|Lost to Follow-up|0|||
163100587|NCT00540592|589076077|FG000|Overall Study|Withdrawal by Subject|0|||
163100588|NCT00540592|589076078|FG001|Overall Study|Withdrawal by Subject|0|||
163100589|NCT00540592|589076079|FG002|Overall Study|Withdrawal by Subject|1|||
163100590|NCT00540592|589076080|FG003|Overall Study|Withdrawal by Subject|1|||
163100591|NCT00540592|589076081|FG004|Overall Study|Withdrawal by Subject|0|||
163100592|NCT00540592|589076082|FG005|Overall Study|Withdrawal by Subject|0|||
163100593|NCT00540592|589076083|FG006|Overall Study|Withdrawal by Subject|0|||
163100594|NCT00540592|589076084|FG007|Overall Study|Withdrawal by Subject|0|||
163100595|NCT00540592|589076085|FG008|Overall Study|Withdrawal by Subject|0|||
163100596|NCT00540592|589076086|FG009|Overall Study|Withdrawal by Subject|0|||
163100597|NCT00131352|589076087|FG000|Initial Treatment Period|Adverse Event|1|||
163100598|NCT00131352|589076088|FG001|Initial Treatment Period|Adverse Event|3|||
163100599|NCT00131352|589076087|FG000|Initial Treatment Period|Non-compliant|1|||
163100600|NCT00131352|589076088|FG001|Initial Treatment Period|Non-compliant|2|||
163100601|NCT00131352|589076087|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163100602|NCT00131352|589076088|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
163100603|NCT00131352|589076087|FG000|Initial Treatment Period|Lack of Efficacy|6|||
163100604|NCT00131352|589076088|FG001|Initial Treatment Period|Lack of Efficacy|4|||
163100605|NCT00131352|589076087|FG000|Initial Treatment Period|Other|0|||
163100606|NCT00131352|589076088|FG001|Initial Treatment Period|Other|2|||
163100607|NCT00131352|589076087|FG000|Repeat Treatment Period|Adverse Event|1|||
163100608|NCT00131352|589076088|FG001|Repeat Treatment Period|Adverse Event|0|||
163100609|NCT00131352|589076087|FG000|Repeat Treatment Period|Other|1|||
163100610|NCT00131352|589076088|FG001|Repeat Treatment Period|Other|0|||
163100611|NCT04908683|589076089|FG000|Overall Study|Failure to meet continuation criteria|34|||
163100612|NCT04908683|589076090|FG001|Overall Study|Failure to meet continuation criteria|22|||
163100613|NCT04908683|589076089|FG000|Overall Study|Initiated prohibited medication|3|||
163100614|NCT04908683|589076090|FG001|Overall Study|Initiated prohibited medication|0|||
163100615|NCT04908683|589076089|FG000|Overall Study|Randomized by mistake|1|||
163100616|NCT04908683|589076090|FG001|Overall Study|Randomized by mistake|0|||
163100617|NCT04908683|589076089|FG000|Overall Study|Lost to Follow-up|679|||
163100618|NCT04908683|589076090|FG001|Overall Study|Lost to Follow-up|341|||
163100619|NCT04908683|589076089|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
163100620|NCT04908683|589076090|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
163100621|NCT04908683|589076089|FG000|Overall Study|Physician Decision|44|||
163100622|NCT04908683|589076090|FG001|Overall Study|Physician Decision|35|||
163100623|NCT04908683|589076089|FG000|Overall Study|Technical problems|12|||
163100624|NCT04908683|589076090|FG001|Overall Study|Technical problems|9|||
163100625|NCT04908683|589076089|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
163100626|NCT04908683|589076090|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
163100627|NCT04908683|589076089|FG000|Overall Study|Protocol Violation|2|||
163100628|NCT04908683|589076090|FG001|Overall Study|Protocol Violation|0|||
163100629|NCT04908683|589076089|FG000|Overall Study|Withdrawal by Subject|1188|||
163100630|NCT04908683|589076090|FG001|Overall Study|Withdrawal by Subject|570|||
163100631|NCT04908683|589076089|FG000|Overall Study|Site Closure by Sponsor|6|||
163100632|NCT04908683|589076090|FG001|Overall Study|Site Closure by Sponsor|3|||
163100633|NCT04908683|589076089|FG000|Overall Study|Adverse Event|21|||
163100634|NCT04908683|589076090|FG001|Overall Study|Adverse Event|11|||
163100635|NCT04908683|589076089|FG000|Overall Study|Death|101|||
163100636|NCT04908683|589076090|FG001|Overall Study|Death|61|||
163100637|NCT04908683|589076089|FG000|Overall Study|Sponsor's decision|14398|||
163100638|NCT04908683|589076090|FG001|Overall Study|Sponsor's decision|7205|||
163100639|NCT04908683|589076089|FG000|Overall Study|Other|92|||
163100640|NCT04908683|589076090|FG001|Overall Study|Other|50|||
163100641|NCT04908683|589076089|FG000|Overall Study|Randomized not vaccinated|108|||
163100642|NCT04908683|589076090|FG001|Overall Study|Randomized not vaccinated|52|||
163100643|NCT00910910|589076091|FG000|Overall Study|Adverse Event|63|||
163100644|NCT00910910|589076092|FG001|Overall Study|Adverse Event|35|||
163100645|NCT00910910|589076091|FG000|Overall Study|PD without histologic change|27|||
163100646|NCT00910910|589076092|FG001|Overall Study|PD without histologic change|23|||
163100647|NCT00910910|589076091|FG000|Overall Study|PD with histologic change|0|||
163100648|NCT00910910|589076092|FG001|Overall Study|PD with histologic change|2|||
163100649|NCT00910910|589076091|FG000|Overall Study|Withdrawal by Subject|7|||
163100650|NCT00910910|589076092|FG001|Overall Study|Withdrawal by Subject|5|||
163100651|NCT00910910|589076091|FG000|Overall Study|Lost to Follow-up|2|||
163100652|NCT00910910|589076092|FG001|Overall Study|Lost to Follow-up|2|||
163100653|NCT00910910|589076091|FG000|Overall Study|Death|9|||
163100654|NCT00910910|589076092|FG001|Overall Study|Death|3|||
163100655|NCT00910910|589076091|FG000|Overall Study|Protocol Violation|2|||
163100656|NCT00910910|589076092|FG001|Overall Study|Protocol Violation|2|||
163100657|NCT00910910|589076091|FG000|Overall Study|Completed 13 cycles of treatment|0|||
163100658|NCT00910910|589076092|FG001|Overall Study|Completed 13 cycles of treatment|118|||
163100659|NCT00910910|589076091|FG000|Overall Study|Other|114|||
163100660|NCT00910910|589076092|FG001|Overall Study|Other|32|||
163100661|NCT00910910|589076091|FG000|Overall Study|Untreated before cycle 1|1|||
163100662|NCT00910910|589076092|FG001|Overall Study|Untreated before cycle 1|2|||
163100663|NCT00383331|589076093|FG000|Overall Study|Protocol Violation|0|||
163100664|NCT00383331|589076094|FG001|Overall Study|Protocol Violation|1|||
163100665|NCT01973231|589076095|FG000|Overall Study|Protocol Violation|1|||
163100666|NCT01973231|589076096|FG001|Overall Study|Protocol Violation|1|||
163100667|NCT01973231|589076095|FG000|Overall Study|Lost to Follow-up|1|||
163100668|NCT01973231|589076096|FG001|Overall Study|Lost to Follow-up|1|||
163100669|NCT01973231|589076095|FG000|Overall Study|unclassified|2|||
163100670|NCT01973231|589076096|FG001|Overall Study|unclassified|1|||
163100671|NCT01973231|589076095|FG000|Overall Study|Withdrawal by Subject|7|||
163100672|NCT01973231|589076096|FG001|Overall Study|Withdrawal by Subject|9|||
163100673|NCT05384834|589076102|FG000|Overall Study|Lost to Follow-up|43|||
163100674|NCT05384834|589076102|FG000|Overall Study|Withdrawal by Subject|5|||
163100675|NCT01871545|589076103|FG000|Overall Study|Death|2|||
163100676|NCT01871545|589076104|FG001|Overall Study|Death|0|||
163100677|NCT01871545|589076103|FG000|Overall Study|Lack of Efficacy|11|||
163100678|NCT01871545|589076104|FG001|Overall Study|Lack of Efficacy|2|||
163100679|NCT01871545|589076103|FG000|Overall Study|Physician Decision|4|||
163100680|NCT01871545|589076104|FG001|Overall Study|Physician Decision|0|||
163100681|NCT01871545|589076103|FG000|Overall Study|Withdrawal by Subject|0|||
163100682|NCT01871545|589076104|FG001|Overall Study|Withdrawal by Subject|1|||
163100683|NCT01071954|589076105|FG000|Overall Study|Noncompliance|4|||
163100684|NCT01071954|589076105|FG000|Overall Study|Adverse Event|1|||
163100685|NCT01071954|589076105|FG000|Overall Study|Withdrawal by Subject|11|||
163100686|NCT01071954|589076105|FG000|Overall Study|Requirement for Alternative Therapy|5|||
163100687|NCT01071954|589076105|FG000|Overall Study|Administrative Decision|5|||
163100688|NCT01071954|589076105|FG000|Overall Study|Protocol Specified Criteria|1|||
163100689|NCT01926444|589076106|FG000|Overall Study|Colonoscopy not performed|0|||
163100690|NCT01926444|589076107|FG001|Overall Study|Colonoscopy not performed|0|||
163100691|NCT01926444|589076108|FG002|Overall Study|Colonoscopy not performed|4|||
163100692|NCT01926444|589076109|FG003|Overall Study|Colonoscopy not performed|2|||
163100693|NCT02243371|589076119|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
163100694|NCT02243371|589076120|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
163100695|NCT02243371|589076119|FG000|Overall Study|Death (unrelated)|2|||
163100696|NCT02243371|589076120|FG001|Overall Study|Death (unrelated)|4|||
163100697|NCT02243371|589076119|FG000|Overall Study|Adverse Event (unrelated)|0|||
163100698|NCT02243371|589076120|FG001|Overall Study|Adverse Event (unrelated)|1|||
163100699|NCT02243371|589076119|FG000|Overall Study|Lack of Clinical Benefit|0|||
163100700|NCT02243371|589076120|FG001|Overall Study|Lack of Clinical Benefit|1|||
163100701|NCT02243371|589076119|FG000|Overall Study|Withdrawal by Subject|0|||
163100702|NCT02243371|589076120|FG001|Overall Study|Withdrawal by Subject|2|||
163100703|NCT00271856|589076123|FG000|Overall Study|Withdrawal by Subject|1|||
163100704|NCT00271856|589076124|FG001|Overall Study|Withdrawal by Subject|7|||
163100705|NCT00271856|589076123|FG000|Overall Study|Lost to Follow-up|10|||
163100706|NCT00271856|589076124|FG001|Overall Study|Lost to Follow-up|11|||
162653450|NCT02457598|587447613|FG013|Overall Study|Investigator's Discretion|1|||
162719046|NCT01981356|587676759|FG001|Overall Study|Lost to Follow-up|1|||
163100707|NCT04599803|589076125|FG000|Overall Study|Withdrawal by Subject|5|||
163100708|NCT04599803|589076125|FG000|Overall Study|Lost to Follow-up|26|||
163100709|NCT02544750|589076126|FG000|Overall Study|Physician Decision|3|||
163100710|NCT02544750|589076127|FG001|Overall Study|Physician Decision|1|||
163100711|NCT02544750|589076126|FG000|Overall Study|Other reasons|69|||
163100712|NCT02544750|589076127|FG001|Overall Study|Other reasons|39|||
163100713|NCT02544750|589076126|FG000|Overall Study|Met withdrawal criteria|2|||
163100714|NCT02544750|589076127|FG001|Overall Study|Met withdrawal criteria|2|||
163100715|NCT02544750|589076126|FG000|Overall Study|Transition To Commercial Product|1|||
163100716|NCT02544750|589076127|FG001|Overall Study|Transition To Commercial Product|0|||
163100717|NCT02544750|589076126|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
163100718|NCT02544750|589076127|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
163100719|NCT02544750|589076126|FG000|Overall Study|Adverse Event|8|||
163100720|NCT02544750|589076127|FG001|Overall Study|Adverse Event|10|||
163100721|NCT02544750|589076126|FG000|Overall Study|Withdrawal by Subject|10|||
163100722|NCT02544750|589076127|FG001|Overall Study|Withdrawal by Subject|4|||
163100723|NCT02544750|589076126|FG000|Overall Study|Lost to Follow-up|1|||
163100724|NCT02544750|589076127|FG001|Overall Study|Lost to Follow-up|0|||
163100725|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
163100726|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100727|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100728|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100729|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100730|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100731|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100732|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100733|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100734|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100735|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100736|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100737|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
163100738|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
163100739|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
163100740|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100741|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100742|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100743|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100744|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100745|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100746|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100747|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100748|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100749|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100750|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
163100751|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
163100752|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
163100753|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100754|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100755|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100756|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100757|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100758|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100759|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100760|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100761|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100762|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100763|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
163100764|NCT03307785|589076130|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
163100765|NCT03307785|589076131|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
163100766|NCT03307785|589076132|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100767|NCT03307785|589076133|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100768|NCT03307785|589076134|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100769|NCT03307785|589076135|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100770|NCT03307785|589076136|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100771|NCT03307785|589076137|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100772|NCT03307785|589076138|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100773|NCT03307785|589076139|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100774|NCT03307785|589076140|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100775|NCT03307785|589076141|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100776|NCT03307785|589076142|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
163100777|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100778|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100779|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
163100780|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100781|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100782|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100783|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100784|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100785|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100786|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100787|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100788|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100789|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
163100790|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100791|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100792|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
163100793|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100794|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100795|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100796|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100797|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100798|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100799|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100800|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100801|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100802|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
163100803|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100804|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100805|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
163100806|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100807|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100808|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100809|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100810|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100811|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100812|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100813|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100814|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100815|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
163100816|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100817|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100818|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
163100819|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100820|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100821|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100822|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100823|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100824|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100825|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100826|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100827|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100828|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
163100829|NCT03307785|589076130|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100830|NCT03307785|589076131|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100831|NCT03307785|589076132|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
163100832|NCT03307785|589076133|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100833|NCT03307785|589076134|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100834|NCT03307785|589076135|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100835|NCT03307785|589076136|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100836|NCT03307785|589076137|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100837|NCT03307785|589076138|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100838|NCT03307785|589076139|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100839|NCT03307785|589076140|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100840|NCT03307785|589076141|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100841|NCT03307785|589076142|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
163100842|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100843|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100844|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100845|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
162653451|NCT02457598|587447614|FG014|Overall Study|Investigator's Discretion|5|||
162653452|NCT02457598|587447615|FG015|Overall Study|Investigator's Discretion|0|||
162653453|NCT02457598|587447616|FG016|Overall Study|Investigator's Discretion|0|||
163100846|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
163100847|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100848|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100849|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100850|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100851|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100852|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100853|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100854|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
163100855|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100856|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100857|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100858|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
163100859|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
163100860|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100861|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100862|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100863|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100864|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100865|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100866|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100867|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
163100868|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100869|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100870|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100871|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
163100872|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100873|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100874|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100875|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100876|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100877|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100878|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100879|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100880|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
163100881|NCT03307785|589076130|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100882|NCT03307785|589076131|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100883|NCT03307785|589076132|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100884|NCT03307785|589076133|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100885|NCT03307785|589076134|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
163100886|NCT03307785|589076135|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100887|NCT03307785|589076136|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100888|NCT03307785|589076137|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100889|NCT03307785|589076138|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100890|NCT03307785|589076139|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100891|NCT03307785|589076140|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100892|NCT03307785|589076141|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100893|NCT03307785|589076142|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
163100894|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100895|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100896|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100897|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100898|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100899|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
163100900|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100901|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100902|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100903|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100904|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100905|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100906|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
163100907|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100908|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100909|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100910|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100911|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100912|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
163100913|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100914|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100915|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100916|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100917|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100918|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100919|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
163100920|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100921|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100922|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100923|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100924|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100925|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
163100926|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100927|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100928|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100929|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100930|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100931|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100932|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
163100933|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100934|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100935|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100936|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100937|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100938|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
163100939|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100940|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100941|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100942|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100943|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100944|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100945|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
163100946|NCT03307785|589076130|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100947|NCT03307785|589076131|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100948|NCT03307785|589076132|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100949|NCT03307785|589076133|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100950|NCT03307785|589076134|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100951|NCT03307785|589076135|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
163100952|NCT03307785|589076136|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100953|NCT03307785|589076137|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100954|NCT03307785|589076138|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100955|NCT03307785|589076139|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100956|NCT03307785|589076140|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100957|NCT03307785|589076141|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100958|NCT03307785|589076142|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
163100959|NCT03307785|589076130|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100960|NCT03307785|589076131|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100961|NCT03307785|589076132|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100962|NCT03307785|589076133|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100963|NCT03307785|589076134|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100964|NCT03307785|589076135|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100965|NCT03307785|589076136|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
163100966|NCT03307785|589076137|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100967|NCT03307785|589076138|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100968|NCT03307785|589076139|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100969|NCT03307785|589076140|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100970|NCT03307785|589076141|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100971|NCT03307785|589076142|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
163100972|NCT03307785|589076130|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100973|NCT03307785|589076131|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100974|NCT03307785|589076132|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100975|NCT03307785|589076133|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100976|NCT03307785|589076134|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100977|NCT03307785|589076135|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100978|NCT03307785|589076136|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
163100979|NCT03307785|589076137|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100980|NCT03307785|589076138|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100981|NCT03307785|589076139|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100982|NCT03307785|589076140|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100983|NCT03307785|589076141|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100984|NCT03307785|589076142|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163100985|NCT03307785|589076130|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100986|NCT03307785|589076131|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100987|NCT03307785|589076132|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100988|NCT03307785|589076133|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100989|NCT03307785|589076134|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100990|NCT03307785|589076135|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100991|NCT03307785|589076136|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100992|NCT03307785|589076137|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
163100993|NCT03307785|589076138|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100994|NCT03307785|589076139|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100995|NCT03307785|589076140|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100996|NCT03307785|589076141|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100997|NCT03307785|589076142|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
163100998|NCT03307785|589076130|FG000|PACT Phase: Up to 19 Months|Death|0|||
163100999|NCT03307785|589076131|FG001|PACT Phase: Up to 19 Months|Death|0|||
163101000|NCT03307785|589076132|FG002|PACT Phase: Up to 19 Months|Death|0|||
163101001|NCT03307785|589076133|FG003|PACT Phase: Up to 19 Months|Death|0|||
163101002|NCT03307785|589076134|FG004|PACT Phase: Up to 19 Months|Death|0|||
163101003|NCT03307785|589076135|FG005|PACT Phase: Up to 19 Months|Death|0|||
163101004|NCT03307785|589076136|FG006|PACT Phase: Up to 19 Months|Death|0|||
163101005|NCT03307785|589076137|FG007|PACT Phase: Up to 19 Months|Death|0|||
163101006|NCT03307785|589076138|FG008|PACT Phase: Up to 19 Months|Death|0|||
163101007|NCT03307785|589076139|FG009|PACT Phase: Up to 19 Months|Death|0|||
163101008|NCT03307785|589076140|FG010|PACT Phase: Up to 19 Months|Death|0|||
163101009|NCT03307785|589076141|FG011|PACT Phase: Up to 19 Months|Death|0|||
163101010|NCT03307785|589076142|FG012|PACT Phase: Up to 19 Months|Death|1|||
163101011|NCT01154452|589076147|FG000|Phase Ib|Not Treated|1|||
163101012|NCT01154452|589076148|FG001|Phase Ib|Not Treated|0|||
163101013|NCT01154452|589076149|FG002|Phase Ib|Not Treated|0|||
163101014|NCT01154452|589076150|FG003|Phase Ib|Not Treated|0|||
163101015|NCT01154452|589076147|FG000|Phase Ib|Adverse Event|2|||
163101016|NCT01154452|589076148|FG001|Phase Ib|Adverse Event|1|||
163101017|NCT01154452|589076149|FG002|Phase Ib|Adverse Event|0|||
163101018|NCT01154452|589076150|FG003|Phase Ib|Adverse Event|0|||
163101019|NCT01154452|589076147|FG000|Phase II|Withdrawal by Subject|0|||
163101020|NCT01154452|589076148|FG001|Phase II|Withdrawal by Subject|0|||
163101021|NCT01154452|589076149|FG002|Phase II|Withdrawal by Subject|1|||
163101022|NCT01154452|589076150|FG003|Phase II|Withdrawal by Subject|2|||
163101023|NCT01154452|589076147|FG000|Phase II|Adverse Event|0|||
163101024|NCT01154452|589076148|FG001|Phase II|Adverse Event|0|||
163101025|NCT01154452|589076149|FG002|Phase II|Adverse Event|4|||
163101026|NCT01154452|589076150|FG003|Phase II|Adverse Event|4|||
163101027|NCT01392573|589076151|FG000|Overall Study|Adverse Event|1|||
163101028|NCT01392573|589076152|FG001|Overall Study|Adverse Event|3|||
163101029|NCT01392573|589076151|FG000|Overall Study|Lack of Efficacy|1|||
163101030|NCT01392573|589076152|FG001|Overall Study|Lack of Efficacy|2|||
163101031|NCT01392573|589076151|FG000|Overall Study|Protocol Violation|0|||
163101032|NCT01392573|589076152|FG001|Overall Study|Protocol Violation|2|||
163101033|NCT01392573|589076151|FG000|Overall Study|Withdrawal Criteria|13|||
163101034|NCT01392573|589076152|FG001|Overall Study|Withdrawal Criteria|15|||
163101035|NCT01392573|589076151|FG000|Overall Study|Site closure|8|||
163101036|NCT01392573|589076152|FG001|Overall Study|Site closure|7|||
162653454|NCT02457598|587447600|FG000|Overall Study|Study Terminated by Sponsor|0|||
163101037|NCT01392573|589076151|FG000|Overall Study|Unclassified|9|||
163101038|NCT01392573|589076152|FG001|Overall Study|Unclassified|6|||
163101039|NCT00325130|589076188|FG000|Overall Study|Lost to Follow-up|6|||
163101040|NCT00325130|589076189|FG001|Overall Study|Lost to Follow-up|14|||
163101041|NCT00325130|589076188|FG000|Overall Study|Withdrawal by Subject|12|||
163101042|NCT00325130|589076189|FG001|Overall Study|Withdrawal by Subject|14|||
163101043|NCT00325130|589076188|FG000|Overall Study|Protocol Deviation|0|||
163101044|NCT00325130|589076189|FG001|Overall Study|Protocol Deviation|1|||
163101045|NCT00325130|589076188|FG000|Overall Study|Moved|0|||
162653455|NCT02457598|587447601|FG001|Overall Study|Study Terminated by Sponsor|1|||
162653456|NCT02457598|587447602|FG002|Overall Study|Study Terminated by Sponsor|0|||
163101046|NCT00325130|589076189|FG001|Overall Study|Moved|1|||
163101047|NCT00325130|589076188|FG000|Overall Study|Patient Discontinued for Other|1|||
163101048|NCT00325130|589076189|FG001|Overall Study|Patient Discontinued for Other|0|||
163101049|NCT02220855|589077334|FG000|Overall Study|Adverse Event|8|||
163101050|NCT02220855|589077334|FG000|Overall Study|Disease Progression|5|||
163101051|NCT02220855|589077334|FG000|Overall Study|Withdrawal by Subject|1|||
163101052|NCT02974140|589077343|FG000|Overall Study|Adverse Event|2|||
163101053|NCT02974140|589077343|FG000|Overall Study|Lost to Follow-up|1|||
163101054|NCT02974140|589077343|FG000|Overall Study|Study Terminated by Sponsor|36|||
163101055|NCT01905943|589077344|FG000|Overall Study|Withdrawal of consent|90|||
163101056|NCT01905943|589077344|FG000|Overall Study|Lost to Follow-up|16|||
163101057|NCT01905943|589077344|FG000|Overall Study|Investigator discretion|7|||
163101058|NCT01905943|589077344|FG000|Overall Study|Death|186|||
163101059|NCT01905943|589077344|FG000|Overall Study|Adverse Event|3|||
163101060|NCT01905943|589077344|FG000|Overall Study|Other|12|||
163101061|NCT01238991|589077345|FG000|Overall Study|Adverse Event|1|||
163101062|NCT01238991|589077346|FG001|Overall Study|Adverse Event|0|||
163101063|NCT01238991|589077347|FG002|Overall Study|Adverse Event|3|||
163101064|NCT01238991|589077348|FG003|Overall Study|Adverse Event|1|||
163101065|NCT01238991|589077349|FG004|Overall Study|Adverse Event|1|||
163101066|NCT01238991|589077350|FG005|Overall Study|Adverse Event|0|||
163101067|NCT01238991|589077351|FG006|Overall Study|Adverse Event|1|||
163101068|NCT01238991|589077352|FG007|Overall Study|Adverse Event|1|||
163101069|NCT01238991|589077353|FG008|Overall Study|Adverse Event|0|||
163101070|NCT01238991|589077354|FG009|Overall Study|Adverse Event|0|||
163101071|NCT01238991|589077345|FG000|Overall Study|Death|0|||
163101072|NCT01238991|589077346|FG001|Overall Study|Death|0|||
163101073|NCT01238991|589077347|FG002|Overall Study|Death|0|||
163101074|NCT01238991|589077348|FG003|Overall Study|Death|1|||
163101075|NCT01238991|589077349|FG004|Overall Study|Death|0|||
163101076|NCT01238991|589077350|FG005|Overall Study|Death|0|||
163101077|NCT01238991|589077351|FG006|Overall Study|Death|0|||
163101078|NCT01238991|589077352|FG007|Overall Study|Death|0|||
163101079|NCT01238991|589077353|FG008|Overall Study|Death|0|||
163101080|NCT01238991|589077354|FG009|Overall Study|Death|0|||
163101081|NCT01238991|589077345|FG000|Overall Study|Lack of Efficacy|0|||
163101082|NCT01238991|589077346|FG001|Overall Study|Lack of Efficacy|0|||
163101083|NCT01238991|589077347|FG002|Overall Study|Lack of Efficacy|1|||
163101084|NCT01238991|589077348|FG003|Overall Study|Lack of Efficacy|0|||
163101085|NCT01238991|589077349|FG004|Overall Study|Lack of Efficacy|0|||
163101086|NCT01238991|589077350|FG005|Overall Study|Lack of Efficacy|0|||
163101087|NCT01238991|589077351|FG006|Overall Study|Lack of Efficacy|0|||
163101088|NCT01238991|589077352|FG007|Overall Study|Lack of Efficacy|0|||
163101089|NCT01238991|589077353|FG008|Overall Study|Lack of Efficacy|1|||
163101090|NCT01238991|589077354|FG009|Overall Study|Lack of Efficacy|0|||
163101091|NCT01238991|589077345|FG000|Overall Study|Withdrawal by Subject|0|||
163101092|NCT01238991|589077346|FG001|Overall Study|Withdrawal by Subject|0|||
163101093|NCT01238991|589077347|FG002|Overall Study|Withdrawal by Subject|1|||
163101094|NCT01238991|589077348|FG003|Overall Study|Withdrawal by Subject|0|||
163101095|NCT01238991|589077349|FG004|Overall Study|Withdrawal by Subject|0|||
163101096|NCT01238991|589077350|FG005|Overall Study|Withdrawal by Subject|0|||
163101097|NCT01238991|589077351|FG006|Overall Study|Withdrawal by Subject|0|||
163101098|NCT01238991|589077352|FG007|Overall Study|Withdrawal by Subject|0|||
163101099|NCT01238991|589077353|FG008|Overall Study|Withdrawal by Subject|0|||
163101100|NCT01238991|589077354|FG009|Overall Study|Withdrawal by Subject|0|||
163101101|NCT01238991|589077345|FG000|Overall Study|Study Terminated by Sponsor|0|||
163101102|NCT01238991|589077346|FG001|Overall Study|Study Terminated by Sponsor|0|||
163101103|NCT01238991|589077347|FG002|Overall Study|Study Terminated by Sponsor|0|||
163101104|NCT01238991|589077348|FG003|Overall Study|Study Terminated by Sponsor|0|||
163101105|NCT01238991|589077349|FG004|Overall Study|Study Terminated by Sponsor|1|||
163101106|NCT01238991|589077350|FG005|Overall Study|Study Terminated by Sponsor|0|||
163101107|NCT01238991|589077351|FG006|Overall Study|Study Terminated by Sponsor|7|||
163101108|NCT01238991|589077352|FG007|Overall Study|Study Terminated by Sponsor|4|||
163101109|NCT01238991|589077353|FG008|Overall Study|Study Terminated by Sponsor|2|||
163101110|NCT01238991|589077354|FG009|Overall Study|Study Terminated by Sponsor|2|||
163101111|NCT01238991|589077345|FG000|Overall Study|Caregiver's request|0|||
163101112|NCT01238991|589077346|FG001|Overall Study|Caregiver's request|0|||
163101113|NCT01238991|589077347|FG002|Overall Study|Caregiver's request|0|||
163101114|NCT01238991|589077348|FG003|Overall Study|Caregiver's request|0|||
163101115|NCT01238991|589077349|FG004|Overall Study|Caregiver's request|0|||
163101116|NCT01238991|589077350|FG005|Overall Study|Caregiver's request|0|||
163101117|NCT01238991|589077351|FG006|Overall Study|Caregiver's request|0|||
163101118|NCT01238991|589077352|FG007|Overall Study|Caregiver's request|0|||
163101119|NCT01238991|589077353|FG008|Overall Study|Caregiver's request|1|||
163101120|NCT01238991|589077354|FG009|Overall Study|Caregiver's request|0|||
163101121|NCT01238991|589077345|FG000|Overall Study|Admission to a nursing home|1|||
163101122|NCT01238991|589077346|FG001|Overall Study|Admission to a nursing home|0|||
163101123|NCT01238991|589077347|FG002|Overall Study|Admission to a nursing home|1|||
163101124|NCT01238991|589077348|FG003|Overall Study|Admission to a nursing home|0|||
163101125|NCT01238991|589077349|FG004|Overall Study|Admission to a nursing home|0|||
163101126|NCT01238991|589077350|FG005|Overall Study|Admission to a nursing home|0|||
163101127|NCT01238991|589077351|FG006|Overall Study|Admission to a nursing home|0|||
163101128|NCT01238991|589077352|FG007|Overall Study|Admission to a nursing home|0|||
163101129|NCT01238991|589077353|FG008|Overall Study|Admission to a nursing home|0|||
163101130|NCT01238991|589077354|FG009|Overall Study|Admission to a nursing home|0|||
163101131|NCT05959447|589077357|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
163101132|NCT05959447|589077358|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
163101133|NCT05959447|589077357|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
163101134|NCT05959447|589077358|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
163101135|NCT05959447|589077357|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
163101136|NCT05959447|589077358|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
163101137|NCT05959447|589077357|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
163101138|NCT05959447|589077358|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
163101139|NCT02522429|589077359|FG000|Overall Study|Lost to Follow-up|8|||
163101140|NCT02522429|589077359|FG000|Overall Study|Adverse Event|2|||
163101141|NCT02522429|589077359|FG000|Overall Study|Death|1|||
163101142|NCT02522429|589077359|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
163101143|NCT00294671|589077360|FG000|Overall Study|Lack of Efficacy|11|||
163101144|NCT00294671|589077361|FG001|Overall Study|Lack of Efficacy|23|||
163101145|NCT00294671|589077360|FG000|Overall Study|Liver transplant|7|||
163101146|NCT00294671|589077361|FG001|Overall Study|Liver transplant|9|||
163101147|NCT00294671|589077360|FG000|Overall Study|Drug related adverse event (AE)|4|||
163101148|NCT00294671|589077361|FG001|Overall Study|Drug related adverse event (AE)|2|||
163101149|NCT00294671|589077360|FG000|Overall Study|Non-drug related AE|3|||
163101150|NCT00294671|589077361|FG001|Overall Study|Non-drug related AE|2|||
163101151|NCT00294671|589077360|FG000|Overall Study|Lost to Follow-up|1|||
163101152|NCT00294671|589077361|FG001|Overall Study|Lost to Follow-up|3|||
163101153|NCT00294671|589077360|FG000|Overall Study|Non-compliance|1|||
163101154|NCT00294671|589077361|FG001|Overall Study|Non-compliance|0|||
163101155|NCT00294671|589077360|FG000|Overall Study|Death|0|||
163101156|NCT00294671|589077361|FG001|Overall Study|Death|1|||
163101157|NCT01961297|589077366|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
163101158|NCT01961297|589077367|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
163101159|NCT03053440|589077370|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
163101160|NCT03053440|589077371|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
163101161|NCT03053440|589077370|FG000|Overall Study|Death|18|||
163101162|NCT03053440|589077371|FG001|Overall Study|Death|14|||
163101163|NCT03053440|589077370|FG000|Overall Study|Withdrawal by Subject|9|||
163101164|NCT03053440|589077371|FG001|Overall Study|Withdrawal by Subject|8|||
163101165|NCT03053440|589077370|FG000|Overall Study|Lost to Follow-up|1|||
163101166|NCT03053440|589077371|FG001|Overall Study|Lost to Follow-up|0|||
163101167|NCT03053440|589077370|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
163101168|NCT03053440|589077371|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
163101169|NCT03053440|589077370|FG000|Overall Study|Physician Decision|2|||
163101170|NCT03053440|589077371|FG001|Overall Study|Physician Decision|1|||
163101171|NCT03053440|589077370|FG000|Overall Study|Participant Randomized but died before dosing|1|||
163101172|NCT03053440|589077371|FG001|Overall Study|Participant Randomized but died before dosing|0|||
163101173|NCT00391053|589077377|FG000|Overall Study|Serious Adverse Events|1|||
163101174|NCT00391053|589077378|FG001|Overall Study|Serious Adverse Events|0|||
163101175|NCT00391053|589077379|FG002|Overall Study|Serious Adverse Events|1|||
163101176|NCT00391053|589077380|FG003|Overall Study|Serious Adverse Events|4|||
163101177|NCT00391053|589077377|FG000|Overall Study|Protocol Violation|2|||
163101178|NCT00391053|589077378|FG001|Overall Study|Protocol Violation|0|||
163101179|NCT00391053|589077379|FG002|Overall Study|Protocol Violation|0|||
163101180|NCT00391053|589077380|FG003|Overall Study|Protocol Violation|0|||
163101181|NCT00391053|589077377|FG000|Overall Study|Lost to Follow-up|1|||
163101182|NCT00391053|589077378|FG001|Overall Study|Lost to Follow-up|0|||
163101183|NCT00391053|589077379|FG002|Overall Study|Lost to Follow-up|0|||
163101184|NCT00391053|589077380|FG003|Overall Study|Lost to Follow-up|5|||
163101185|NCT00391053|589077377|FG000|Overall Study|Withdrawal by Subject|5|||
163101186|NCT00391053|589077378|FG001|Overall Study|Withdrawal by Subject|1|||
163101187|NCT00391053|589077379|FG002|Overall Study|Withdrawal by Subject|1|||
163101188|NCT00391053|589077380|FG003|Overall Study|Withdrawal by Subject|1|||
162653457|NCT02457598|587447603|FG003|Overall Study|Study Terminated by Sponsor|4|||
162653458|NCT02457598|587447604|FG004|Overall Study|Study Terminated by Sponsor|1|||
163101189|NCT00473889|589077382|FG000|Overall Study|Did not receive study medication|1|||
163101190|NCT00473889|589077383|FG001|Overall Study|Did not receive study medication|4|||
162653459|NCT02457598|587447605|FG005|Overall Study|Study Terminated by Sponsor|0|||
163101191|NCT00473889|589077382|FG000|Overall Study|Adverse Event|30|||
163101192|NCT00473889|589077383|FG001|Overall Study|Adverse Event|17|||
163101193|NCT00473889|589077382|FG000|Overall Study|Protocol Violation|4|||
163101194|NCT00473889|589077383|FG001|Overall Study|Protocol Violation|2|||
163101195|NCT00473889|589077382|FG000|Overall Study|Lack of Efficacy|28|||
163101196|NCT00473889|589077383|FG001|Overall Study|Lack of Efficacy|29|||
162653460|NCT02457598|587447606|FG006|Overall Study|Study Terminated by Sponsor|1|||
162653461|NCT02457598|587447607|FG007|Overall Study|Study Terminated by Sponsor|0|||
162653462|NCT02457598|587447608|FG008|Overall Study|Study Terminated by Sponsor|0|||
162653463|NCT02457598|587447609|FG009|Overall Study|Study Terminated by Sponsor|0|||
162653464|NCT02457598|587447610|FG010|Overall Study|Study Terminated by Sponsor|4|||
162653465|NCT02457598|587447611|FG011|Overall Study|Study Terminated by Sponsor|0|||
163101197|NCT00473889|589077382|FG000|Overall Study|Lost to Follow-up|2|||
163101198|NCT00473889|589077383|FG001|Overall Study|Lost to Follow-up|1|||
163101199|NCT00473889|589077382|FG000|Overall Study|Physician Decision|10|||
163101200|NCT00473889|589077383|FG001|Overall Study|Physician Decision|5|||
163101201|NCT00473889|589077382|FG000|Overall Study|Trial Terminated|3|||
163101202|NCT00473889|589077383|FG001|Overall Study|Trial Terminated|6|||
163101203|NCT00473889|589077382|FG000|Overall Study|Withdrawal by Subject|5|||
163101204|NCT00473889|589077383|FG001|Overall Study|Withdrawal by Subject|0|||
163101205|NCT02140970|589077384|FG000|Overall Study|Lost to Follow-up|1|||
163101206|NCT02140970|589077385|FG001|Overall Study|Lost to Follow-up|2|||
163101207|NCT02140970|589077384|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
163101208|NCT02140970|589077385|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
163101209|NCT02140970|589077384|FG000|Overall Study|Did not meet inclusion criteria|0|||
163101210|NCT02140970|589077385|FG001|Overall Study|Did not meet inclusion criteria|1|||
163101219|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
163101220|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101221|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101222|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163101223|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
163101224|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101225|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101226|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163101227|NCT00460655|589077391|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101228|NCT00460655|589077392|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
163101229|NCT00460655|589077393|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101230|NCT00460655|589077394|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
163101231|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163101232|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163101233|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
163101234|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
163101235|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163101236|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163101237|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
163101238|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
163101239|NCT00460655|589077391|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101240|NCT00460655|589077392|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101241|NCT00460655|589077393|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
163101242|NCT00460655|589077394|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
163101243|NCT03050450|589077395|FG000|Overall Study|Physician Decision|1|||
163101244|NCT03050450|589077396|FG001|Overall Study|Physician Decision|0|||
163101245|NCT03050450|589077397|FG002|Overall Study|Physician Decision|0|||
163101246|NCT03050450|589077398|FG003|Overall Study|Physician Decision|0|||
163101247|NCT03050450|589077399|FG004|Overall Study|Physician Decision|0|||
163101248|NCT00590122|589077400|FG000|Overall Study|swallowed oral dissolving dose|1|||
163101249|NCT00590122|589077401|FG001|Overall Study|swallowed oral dissolving dose|0|||
163101250|NCT00735553|589077405|FG000|Overall Study|Study prematurely terminated|77|||
163101251|NCT02705105|589077406|FG000|Treatment|Objective Disease Progression|1|||
163101252|NCT02705105|589077407|FG001|Treatment|Objective Disease Progression|50|||
163101253|NCT02705105|589077406|FG000|Treatment|Withdrawal by Subject|3|||
163101254|NCT02705105|589077407|FG001|Treatment|Withdrawal by Subject|5|||
163101255|NCT02705105|589077406|FG000|Treatment|Adverse Event|0|||
162653466|NCT02457598|587447612|FG012|Overall Study|Study Terminated by Sponsor|1|||
163101256|NCT02705105|589077407|FG001|Treatment|Adverse Event|17|||
163101257|NCT02705105|589077406|FG000|Treatment|Clinical Disease Progression|0|||
163101258|NCT02705105|589077407|FG001|Treatment|Clinical Disease Progression|32|||
163101259|NCT02705105|589077406|FG000|Treatment|Physician Decision|0|||
163101260|NCT02705105|589077407|FG001|Treatment|Physician Decision|3|||
163101261|NCT02705105|589077406|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
162653467|NCT02457598|587447613|FG013|Overall Study|Study Terminated by Sponsor|0|||
162653468|NCT02457598|587447614|FG014|Overall Study|Study Terminated by Sponsor|8|||
163101262|NCT02705105|589077407|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
163101263|NCT02705105|589077406|FG000|Follow-Up|Death|3|||
163101264|NCT02705105|589077407|FG001|Follow-Up|Death|68|||
163101265|NCT02705105|589077406|FG000|Follow-Up|Withdrawal by Subject|1|||
163101266|NCT02705105|589077407|FG001|Follow-Up|Withdrawal by Subject|14|||
163101267|NCT02705105|589077406|FG000|Follow-Up|Study Terminated|0|||
163101268|NCT02705105|589077407|FG001|Follow-Up|Study Terminated|26|||
163101269|NCT02705105|589077406|FG000|Follow-Up|Discontinued per Amendment 3|0|||
163101270|NCT02705105|589077407|FG001|Follow-Up|Discontinued per Amendment 3|2|||
163101271|NCT00711594|589077409|FG000|Overall Study|Progressive disease|2|||
163101272|NCT00711594|589077410|FG001|Overall Study|Progressive disease|2|||
163101273|NCT00711594|589077411|FG002|Overall Study|Progressive disease|6|||
163101274|NCT00711594|589077412|FG003|Overall Study|Progressive disease|44|||
163101275|NCT00711594|589077409|FG000|Overall Study|Other Adverse Event|1|||
163101276|NCT00711594|589077410|FG001|Overall Study|Other Adverse Event|0|||
163101277|NCT00711594|589077411|FG002|Overall Study|Other Adverse Event|0|||
163101278|NCT00711594|589077412|FG003|Overall Study|Other Adverse Event|16|||
163101279|NCT00711594|589077409|FG000|Overall Study|Withdrawal by Subject|0|||
163101280|NCT00711594|589077410|FG001|Overall Study|Withdrawal by Subject|1|||
163101281|NCT00711594|589077411|FG002|Overall Study|Withdrawal by Subject|0|||
163101282|NCT00711594|589077412|FG003|Overall Study|Withdrawal by Subject|2|||
163101283|NCT00211172|589077415|FG000|Overall Study|Died or lost health plan eligibility|39|||
163101284|NCT00211172|589077416|FG001|Overall Study|Died or lost health plan eligibility|32|||
163101285|NCT02253433|589077420|FG000|Overall Study|Unable to Contact|9|||
163101286|NCT02253433|589077421|FG001|Overall Study|Unable to Contact|16|||
163101287|NCT02253433|589077420|FG000|Overall Study|Death|1|||
163101288|NCT02253433|589077421|FG001|Overall Study|Death|1|||
163101289|NCT02253433|589077420|FG000|Overall Study|No Longer Interested|3|||
163101290|NCT02253433|589077421|FG001|Overall Study|No Longer Interested|15|||
163101291|NCT02253433|589077420|FG000|Overall Study|Out of Study Area|2|||
163101292|NCT02253433|589077421|FG001|Overall Study|Out of Study Area|7|||
163101293|NCT02253433|589077420|FG000|Overall Study|Uncomfortable with home visitors|0|||
163101294|NCT02253433|589077421|FG001|Overall Study|Uncomfortable with home visitors|3|||
163101295|NCT02253433|589077420|FG000|Overall Study|Unstable Housing/Homeless|0|||
163101296|NCT02253433|589077421|FG001|Overall Study|Unstable Housing/Homeless|7|||
163101297|NCT02253433|589077420|FG000|Overall Study|Too Busy|0|||
163101298|NCT02253433|589077421|FG001|Overall Study|Too Busy|4|||
163101299|NCT02253433|589077420|FG000|Overall Study|Medical or Other Concerns|1|||
163101300|NCT02253433|589077421|FG001|Overall Study|Medical or Other Concerns|2|||
163101301|NCT00040742|589077424|FG000|Overall Study|Death|0|||
163101302|NCT00040742|589077425|FG001|Overall Study|Death|0|||
163101303|NCT00040742|589077426|FG002|Overall Study|Death|1|||
163101304|NCT00040742|589077427|FG003|Overall Study|Death|0|||
163101305|NCT00040742|589077424|FG000|Overall Study|Adverse Event|15|||
163101306|NCT00040742|589077425|FG001|Overall Study|Adverse Event|16|||
163101307|NCT00040742|589077426|FG002|Overall Study|Adverse Event|21|||
163101308|NCT00040742|589077427|FG003|Overall Study|Adverse Event|9|||
163101309|NCT00040742|589077424|FG000|Overall Study|Withdrawal by Subject|7|||
163101310|NCT00040742|589077425|FG001|Overall Study|Withdrawal by Subject|15|||
163101311|NCT00040742|589077426|FG002|Overall Study|Withdrawal by Subject|10|||
163101312|NCT00040742|589077427|FG003|Overall Study|Withdrawal by Subject|13|||
163101313|NCT00040742|589077424|FG000|Overall Study|Chemotoxicity|4|||
163101314|NCT00040742|589077425|FG001|Overall Study|Chemotoxicity|3|||
163101315|NCT00040742|589077426|FG002|Overall Study|Chemotoxicity|5|||
163101316|NCT00040742|589077427|FG003|Overall Study|Chemotoxicity|2|||
163101317|NCT00040742|589077424|FG000|Overall Study|Incomplete Forms|6|||
163101318|NCT00040742|589077425|FG001|Overall Study|Incomplete Forms|10|||
163101319|NCT00040742|589077426|FG002|Overall Study|Incomplete Forms|4|||
163101320|NCT00040742|589077427|FG003|Overall Study|Incomplete Forms|5|||
163101321|NCT00040742|589077424|FG000|Overall Study|Other medical|7|||
163101322|NCT00040742|589077425|FG001|Overall Study|Other medical|5|||
163101323|NCT00040742|589077426|FG002|Overall Study|Other medical|5|||
163101324|NCT00040742|589077427|FG003|Overall Study|Other medical|5|||
163101325|NCT00624468|589077428|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
163101326|NCT00624468|589077429|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
163101327|NCT00624468|589077430|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
163101328|NCT00624468|589077431|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
163101329|NCT00624468|589077428|FG000|Double-blind Period|Withdrew Prematurely|1|||
163101330|NCT00624468|589077429|FG001|Double-blind Period|Withdrew Prematurely|1|||
163101331|NCT00624468|589077430|FG002|Double-blind Period|Withdrew Prematurely|0|||
163101332|NCT00624468|589077431|FG003|Double-blind Period|Withdrew Prematurely|0|||
163101333|NCT00624468|589077428|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
163101334|NCT00624468|589077429|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
163101335|NCT00624468|589077430|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
163101336|NCT00624468|589077431|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
163101337|NCT00624468|589077428|FG000|Safety Follow-up (SFU) Period|Other|0|||
163101338|NCT00624468|589077429|FG001|Safety Follow-up (SFU) Period|Other|0|||
163101339|NCT00624468|589077430|FG002|Safety Follow-up (SFU) Period|Other|1|||
163101340|NCT00624468|589077431|FG003|Safety Follow-up (SFU) Period|Other|1|||
163101341|NCT01523743|589077432|FG000|Period 1|Adverse Event|1|||
163101342|NCT01523743|589077433|FG001|Period 1|Adverse Event|0|||
163101343|NCT01523743|589077432|FG000|Period 1|Withdrawal by Subject|6|||
163101344|NCT01523743|589077433|FG001|Period 1|Withdrawal by Subject|2|||
163101345|NCT01523743|589077432|FG000|Period 1|Lost to Follow-up|1|||
163101346|NCT01523743|589077433|FG001|Period 1|Lost to Follow-up|0|||
163101347|NCT01523743|589077432|FG000|Period 1|Lack of Efficacy|1|||
163101348|NCT01523743|589077433|FG001|Period 1|Lack of Efficacy|0|||
163101349|NCT01523743|589077432|FG000|Period 1|Felt unable to empty bladder|1|||
163101350|NCT01523743|589077433|FG001|Period 1|Felt unable to empty bladder|0|||
163101351|NCT01523743|589077432|FG000|Period 2|Withdrawal by Subject|0|||
163101352|NCT01523743|589077433|FG001|Period 2|Withdrawal by Subject|2|||
163101353|NCT01523743|589077432|FG000|Period 2|Adverse Event|1|||
163101354|NCT01523743|589077433|FG001|Period 2|Adverse Event|0|||
163101355|NCT01434654|589077434|FG000|Overall Study|Withdrawal by Subject|1|||
163101356|NCT01434654|589077435|FG001|Overall Study|Withdrawal by Subject|0|||
163101357|NCT01434654|589077434|FG000|Overall Study|Lost to Follow-up|1|||
163101358|NCT01434654|589077435|FG001|Overall Study|Lost to Follow-up|0|||
163101359|NCT00363142|589077436|FG000|Overall Study|Adverse Event|2|||
163101360|NCT00363142|589077437|FG001|Overall Study|Adverse Event|0|||
163101361|NCT00363142|589077436|FG000|Overall Study|Lack of Efficacy|0|||
163101362|NCT00363142|589077437|FG001|Overall Study|Lack of Efficacy|1|||
163101363|NCT00363142|589077436|FG000|Overall Study|Lost to Follow-up|1|||
163101364|NCT00363142|589077437|FG001|Overall Study|Lost to Follow-up|0|||
163101365|NCT00363142|589077436|FG000|Overall Study|Non-compliance|1|||
163101366|NCT00363142|589077437|FG001|Overall Study|Non-compliance|1|||
163101367|NCT00363142|589077436|FG000|Overall Study|Withdrawal by Subject|3|||
163101368|NCT00363142|589077437|FG001|Overall Study|Withdrawal by Subject|1|||
163101369|NCT01340664|589077442|FG000|Overall Study|Adverse Event|0|||
163101370|NCT01340664|589077443|FG001|Overall Study|Adverse Event|1|||
163101371|NCT01340664|589077444|FG002|Overall Study|Adverse Event|7|||
163101372|NCT01340664|589077442|FG000|Overall Study|Lost to Follow-up|2|||
163101373|NCT01340664|589077443|FG001|Overall Study|Lost to Follow-up|0|||
163101374|NCT01340664|589077444|FG002|Overall Study|Lost to Follow-up|2|||
163101375|NCT01340664|589077442|FG000|Overall Study|Withdrawal by Subject|2|||
163101376|NCT01340664|589077443|FG001|Overall Study|Withdrawal by Subject|4|||
163101377|NCT01340664|589077444|FG002|Overall Study|Withdrawal by Subject|0|||
163101378|NCT01340664|589077442|FG000|Overall Study|Glycemic withdrawal criteria|2|||
163101379|NCT01340664|589077443|FG001|Overall Study|Glycemic withdrawal criteria|0|||
163101380|NCT01340664|589077444|FG002|Overall Study|Glycemic withdrawal criteria|0|||
163101381|NCT01340664|589077442|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
163101382|NCT01340664|589077443|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
163101383|NCT01340664|589077444|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
163101384|NCT01340664|589077442|FG000|Overall Study|Other|1|||
163101385|NCT01340664|589077443|FG001|Overall Study|Other|2|||
163101386|NCT01340664|589077444|FG002|Overall Study|Other|2|||
163101387|NCT01823198|589077446|FG000|Overall Study|Physician Decision|0|||
163101388|NCT01823198|589077447|FG001|Overall Study|Physician Decision|1|||
163101389|NCT01823198|589077448|FG002|Overall Study|Physician Decision|0|||
163101390|NCT01823198|589077449|FG003|Overall Study|Physician Decision|0|||
163101391|NCT01823198|589077450|FG004|Overall Study|Physician Decision|0|||
163101392|NCT01823198|589077451|FG005|Overall Study|Physician Decision|3|||
163101393|NCT01823198|589077452|FG006|Overall Study|Physician Decision|3|||
163101394|NCT02441101|589077453|FG000|Overall Study|Withdrawal by Subject|1|||
163101395|NCT02441101|589077454|FG001|Overall Study|Withdrawal by Subject|0|||
163101396|NCT02441101|589077453|FG000|Overall Study|Lost to Follow-up|1|||
163101397|NCT02441101|589077454|FG001|Overall Study|Lost to Follow-up|0|||
163101398|NCT02441101|589077453|FG000|Overall Study|PI relocated and study terminated|1|||
163101399|NCT02441101|589077454|FG001|Overall Study|PI relocated and study terminated|0|||
163101400|NCT02528942|589077455|FG000|Overall Study|Did not meet imaging criteria|9|||
163101401|NCT02528942|589077455|FG000|Overall Study|Lost to Follow-up|25|||
163101402|NCT03035864|589077456|FG000|Treatment Period|Adverse Event|1|||
163101403|NCT03035864|589077457|FG001|Treatment Period|Adverse Event|0|||
163101404|NCT03035864|589077456|FG000|Treatment Period|Other|3|||
163101405|NCT03035864|589077457|FG001|Treatment Period|Other|1|||
163101406|NCT03035864|589077456|FG000|Follow-up Period|Adverse Event|1|||
163101407|NCT03035864|589077457|FG001|Follow-up Period|Adverse Event|0|||
163101408|NCT03035864|589077456|FG000|Follow-up Period|Lost to Follow-up|6|||
163101409|NCT03035864|589077457|FG001|Follow-up Period|Lost to Follow-up|2|||
163101410|NCT03035864|589077456|FG000|Follow-up Period|Physician Decision|1|||
163101411|NCT03035864|589077457|FG001|Follow-up Period|Physician Decision|0|||
163101412|NCT03035864|589077456|FG000|Follow-up Period|Other|3|||
163101413|NCT03035864|589077457|FG001|Follow-up Period|Other|2|||
163101414|NCT00100802|589077460|FG000|Overall Study|Adverse Event|9|||
163101415|NCT00100802|589077460|FG000|Overall Study|Death|1|||
163101416|NCT00100802|589077460|FG000|Overall Study|Lack of Efficacy|47|||
163101417|NCT00100802|589077460|FG000|Overall Study|Physician Decision|5|||
163101418|NCT00100802|589077460|FG000|Overall Study|Protocol Violation|1|||
163101419|NCT00100802|589077460|FG000|Overall Study|Withdrawal by Subject|5|||
163101420|NCT00100802|589077460|FG000|Overall Study|Ineligible|12|||
163101421|NCT03744910|589079223|FG000|Overall Study|Withdrew Consent|1|||
163101422|NCT03744910|589079224|FG001|Overall Study|Withdrew Consent|8|||
163101423|NCT03744910|589079223|FG000|Overall Study|Physician Decision|5|||
163101424|NCT03744910|589079224|FG001|Overall Study|Physician Decision|4|||
163101425|NCT03744910|589079223|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
163101426|NCT03744910|589079224|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
163101427|NCT03744910|589079223|FG000|Overall Study|Lost to Follow-up|0|||
163101428|NCT03744910|589079224|FG001|Overall Study|Lost to Follow-up|1|||
163101429|NCT03744910|589079223|FG000|Overall Study|Other-unspecified|4|||
163101430|NCT03744910|589079224|FG001|Overall Study|Other-unspecified|1|||
163101431|NCT03430843|589079226|FG000|Overall Study|Death|233|||
163101432|NCT03430843|589079227|FG001|Overall Study|Death|233|||
163101433|NCT03430843|589079226|FG000|Overall Study|Sponsor Decision|17|||
163101434|NCT03430843|589079227|FG001|Overall Study|Sponsor Decision|6|||
163101435|NCT03430843|589079226|FG000|Overall Study|Withdrawal by Subject|5|||
163101436|NCT03430843|589079227|FG001|Overall Study|Withdrawal by Subject|14|||
163101437|NCT03430843|589079226|FG000|Overall Study|Lost to Follow-up|1|||
163101438|NCT03430843|589079227|FG001|Overall Study|Lost to Follow-up|3|||
163101439|NCT05360966|589079238|FG000|Overall Study|Adverse Event|5|||
163101440|NCT05360966|589079239|FG001|Overall Study|Adverse Event|5|||
163101441|NCT05360966|589079238|FG000|Overall Study|Withdrawal of Consent|5|||
163101442|NCT05360966|589079239|FG001|Overall Study|Withdrawal of Consent|3|||
163101443|NCT05360966|589079238|FG000|Overall Study|Noncompliance|2|||
163101444|NCT05360966|589079239|FG001|Overall Study|Noncompliance|1|||
163101445|NCT05360966|589079238|FG000|Overall Study|Lost to Follow-up|2|||
163101446|NCT05360966|589079239|FG001|Overall Study|Lost to Follow-up|3|||
163101447|NCT05360966|589079238|FG000|Overall Study|Protocol Deviation|2|||
163101448|NCT05360966|589079239|FG001|Overall Study|Protocol Deviation|1|||
163101449|NCT05360966|589079238|FG000|Overall Study|As specified in the Clinical Study Report|1|||
163101450|NCT05360966|589079239|FG001|Overall Study|As specified in the Clinical Study Report|3|||
163101451|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
163101452|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101453|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101454|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101455|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101456|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101457|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101458|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101459|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101460|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101461|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101462|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101463|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101464|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
163101465|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101466|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101467|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101468|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101469|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101470|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101471|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101472|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101473|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101474|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101475|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101476|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101477|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
163101478|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101479|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101480|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101481|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101482|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101483|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101484|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101485|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101486|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101487|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101488|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101489|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101490|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
163101491|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101492|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101493|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163101494|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
163101495|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101496|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101497|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101498|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101499|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101500|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101501|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101502|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101503|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101504|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101505|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101506|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101507|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
163101508|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101509|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101510|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101511|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101512|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101513|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101514|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101515|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101516|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101517|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101518|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101519|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101520|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
163101521|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101522|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101523|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101524|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101525|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101526|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101527|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101528|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101529|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101530|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101531|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101532|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101533|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
163101534|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101535|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101536|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163101537|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101538|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101539|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101540|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101541|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101542|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101543|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101544|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101545|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101546|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101547|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101548|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101549|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101550|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101551|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101552|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101553|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101554|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101555|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101556|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101557|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101558|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101559|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101560|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101561|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101562|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101563|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
163101564|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101565|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101566|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101567|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101568|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101569|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101570|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101571|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101572|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101573|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101574|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101575|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101576|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
163101577|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101578|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101579|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
163101580|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101581|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101582|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101583|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101584|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101585|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101586|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101587|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101588|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101589|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101590|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101591|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101592|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101593|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101594|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101595|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101596|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101597|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101598|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101599|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101600|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101601|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101602|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101603|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101604|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101605|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101606|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
163101607|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101608|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101609|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101610|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101611|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
162653469|NCT02457598|587447615|FG015|Overall Study|Study Terminated by Sponsor|1|||
162653470|NCT02457598|587447616|FG016|Overall Study|Study Terminated by Sponsor|0|||
162653471|NCT02457598|587447600|FG000|Overall Study|Adverse Event|0|||
163101612|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101613|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101614|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101615|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101616|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101617|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101618|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101619|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
163101620|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101621|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101622|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163101623|NCT05396014|589079240|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101624|NCT05396014|589079241|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101625|NCT05396014|589079242|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101626|NCT05396014|589079243|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101627|NCT05396014|589079244|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101628|NCT05396014|589079245|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101629|NCT05396014|589079246|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101630|NCT05396014|589079247|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101631|NCT05396014|589079248|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101632|NCT05396014|589079249|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101633|NCT05396014|589079250|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101634|NCT05396014|589079251|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101635|NCT05396014|589079252|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101636|NCT05396014|589079253|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101637|NCT05396014|589079254|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101638|NCT05396014|589079255|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101639|NCT05396014|589079256|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101640|NCT05396014|589079257|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101641|NCT05396014|589079258|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101642|NCT05396014|589079259|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101643|NCT05396014|589079260|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101644|NCT05396014|589079261|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101645|NCT05396014|589079262|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101646|NCT05396014|589079263|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101647|NCT05396014|589079264|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101648|NCT05396014|589079265|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101649|NCT05396014|589079266|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
163101650|NCT05396014|589079267|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101651|NCT05396014|589079268|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101652|NCT05396014|589079269|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101653|NCT05396014|589079270|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101654|NCT05396014|589079271|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101655|NCT05396014|589079272|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101656|NCT05396014|589079273|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101657|NCT05396014|589079274|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101658|NCT05396014|589079275|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101659|NCT05396014|589079276|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101660|NCT05396014|589079277|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101661|NCT05396014|589079278|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101662|NCT05396014|589079279|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101663|NCT05396014|589079280|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101664|NCT05396014|589079281|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101665|NCT05396014|589079282|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
163101666|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101667|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101668|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101669|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
162653472|NCT02457598|587447601|FG001|Overall Study|Adverse Event|1|||
163101670|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101671|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
162653473|NCT02457598|587447602|FG002|Overall Study|Adverse Event|1|||
162653474|NCT02457598|587447603|FG003|Overall Study|Adverse Event|4|||
163101672|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101673|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101674|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101675|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101676|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101677|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101678|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101679|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
163101680|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101681|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101682|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101683|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101684|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101685|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101686|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101687|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101688|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101689|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101690|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101691|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101692|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101693|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101694|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101695|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101696|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101697|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101698|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101699|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101700|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101701|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101702|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101703|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101704|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101705|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101706|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101707|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101708|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163101709|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
163101710|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101711|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101712|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101713|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101714|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101715|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101716|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101717|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101718|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101719|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101720|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101721|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101722|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
163101723|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101724|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101725|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101726|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101727|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101728|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101729|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101730|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101731|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101732|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101733|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
162653475|NCT02457598|587447604|FG004|Overall Study|Adverse Event|1|||
162653476|NCT02457598|587447605|FG005|Overall Study|Adverse Event|0|||
162653477|NCT02457598|587447606|FG006|Overall Study|Adverse Event|0|||
163101734|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101735|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101736|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101737|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101738|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101739|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101740|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101741|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101742|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101743|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101744|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101745|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101746|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101747|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101748|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
163101749|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101750|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101751|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
163101752|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
163101753|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101754|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101755|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101756|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101757|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101758|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101759|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101760|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101761|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101762|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101763|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101764|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101765|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101766|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101767|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101768|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101769|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101770|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101771|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101772|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101773|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101774|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101775|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101776|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101777|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101778|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
163101779|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101780|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101781|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101782|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101783|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101784|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101785|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101786|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101787|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101788|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101789|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101790|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101791|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101792|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163101793|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
162653478|NCT02457598|587447607|FG007|Overall Study|Adverse Event|1|||
163101794|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
162653479|NCT02457598|587447608|FG008|Overall Study|Adverse Event|0|||
162653480|NCT02457598|587447609|FG009|Overall Study|Adverse Event|1|||
163101795|NCT05396014|589079240|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101796|NCT05396014|589079241|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101797|NCT05396014|589079242|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101798|NCT05396014|589079243|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101799|NCT05396014|589079244|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101800|NCT05396014|589079245|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101801|NCT05396014|589079246|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101802|NCT05396014|589079247|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101803|NCT05396014|589079248|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101804|NCT05396014|589079249|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101805|NCT05396014|589079250|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101806|NCT05396014|589079251|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101807|NCT05396014|589079252|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101808|NCT05396014|589079253|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
163101809|NCT05396014|589079254|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101810|NCT05396014|589079255|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101811|NCT05396014|589079256|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101812|NCT05396014|589079257|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101813|NCT05396014|589079258|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101814|NCT05396014|589079259|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101815|NCT05396014|589079260|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101816|NCT05396014|589079261|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101817|NCT05396014|589079262|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101818|NCT05396014|589079263|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101819|NCT05396014|589079264|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101820|NCT05396014|589079265|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101821|NCT05396014|589079266|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101822|NCT05396014|589079267|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101823|NCT05396014|589079268|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101824|NCT05396014|589079269|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101825|NCT05396014|589079270|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101826|NCT05396014|589079271|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101827|NCT05396014|589079272|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101828|NCT05396014|589079273|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101829|NCT05396014|589079274|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101830|NCT05396014|589079275|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101831|NCT05396014|589079276|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101832|NCT05396014|589079277|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101833|NCT05396014|589079278|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101834|NCT05396014|589079279|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101835|NCT05396014|589079280|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101836|NCT05396014|589079281|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101837|NCT05396014|589079282|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163101838|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101839|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101840|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101841|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101842|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101843|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101844|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101845|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101846|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101847|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101848|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101849|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101850|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101851|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101852|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101853|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101854|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101855|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101856|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101857|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101858|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101859|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
162653481|NCT02457598|587447610|FG010|Overall Study|Adverse Event|6|||
162653482|NCT02457598|587447611|FG011|Overall Study|Adverse Event|0|||
162653483|NCT02457598|587447612|FG012|Overall Study|Adverse Event|0|||
162653484|NCT02457598|587447613|FG013|Overall Study|Adverse Event|1|||
162653485|NCT02457598|587447614|FG014|Overall Study|Adverse Event|2|||
162653486|NCT02457598|587447615|FG015|Overall Study|Adverse Event|0|||
162719047|NCT01981356|587676758|FG000|Overall Study|Withdrawal by Subject|1|||
162719048|NCT01981356|587676759|FG001|Overall Study|Withdrawal by Subject|1|||
162719049|NCT01981356|587676758|FG000|Overall Study|Protocol Violation|2|||
162653487|NCT02457598|587447616|FG016|Overall Study|Adverse Event|0|||
162653488|NCT02457598|587447600|FG000|Overall Study|Death|0|||
162653489|NCT02457598|587447601|FG001|Overall Study|Death|0|||
162653490|NCT02457598|587447602|FG002|Overall Study|Death|0|||
162719050|NCT01981356|587676759|FG001|Overall Study|Protocol Violation|0|||
162719051|NCT04248829|587676761|FG000|Overall Study|Disease progression|44|||
162719052|NCT04248829|587676762|FG001|Overall Study|Disease progression|109|||
162719053|NCT04248829|587676761|FG000|Overall Study|Adverse Event|19|||
162719054|NCT04248829|587676762|FG001|Overall Study|Adverse Event|18|||
162719055|NCT04248829|587676761|FG000|Overall Study|Withdrawal by Subject|11|||
162719056|NCT04248829|587676762|FG001|Overall Study|Withdrawal by Subject|2|||
163101860|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101861|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101862|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101863|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101864|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101865|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101866|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101867|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101868|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101869|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101870|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101871|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101872|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101873|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101874|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101875|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101876|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101877|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
163101878|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
163101879|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
163101880|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
163101881|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101882|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101883|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101884|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101885|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101886|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101887|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101888|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101889|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
163101890|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101891|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101892|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101893|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101894|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101895|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101896|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101897|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101898|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101899|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101900|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101901|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101902|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101903|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
163101904|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101905|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101906|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101907|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101908|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101909|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101910|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101911|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101912|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101913|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101914|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101915|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
162719057|NCT04248829|587676761|FG000|Overall Study|Lost to Follow-up|0|||
163101916|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
162719058|NCT04248829|587676762|FG001|Overall Study|Lost to Follow-up|1|||
162719059|NCT04248829|587676761|FG000|Overall Study|Death|12|||
162719060|NCT04248829|587676762|FG001|Overall Study|Death|14|||
163101917|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101918|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101919|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101920|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163101921|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101922|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
163101923|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163101924|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101925|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101926|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101927|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101928|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101929|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101930|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101931|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101932|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101933|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101934|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101935|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101936|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101937|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101938|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101939|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101940|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101941|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101942|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101943|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101944|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101945|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101946|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101947|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101948|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101949|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101950|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101951|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101952|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101953|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101954|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101955|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101956|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101957|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101958|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101959|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101960|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101961|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101962|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101963|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101964|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101965|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
163101966|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
163101967|NCT05396014|589079240|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101968|NCT05396014|589079241|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101969|NCT05396014|589079242|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101970|NCT05396014|589079243|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101971|NCT05396014|589079244|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101972|NCT05396014|589079245|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101973|NCT05396014|589079246|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101974|NCT05396014|589079247|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101975|NCT05396014|589079248|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101976|NCT05396014|589079249|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101977|NCT05396014|589079250|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101978|NCT05396014|589079251|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101979|NCT05396014|589079252|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101980|NCT05396014|589079253|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101981|NCT05396014|589079254|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101982|NCT05396014|589079255|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101983|NCT05396014|589079256|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101984|NCT05396014|589079257|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101985|NCT05396014|589079258|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101986|NCT05396014|589079259|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101987|NCT05396014|589079260|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101988|NCT05396014|589079261|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101989|NCT05396014|589079262|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101990|NCT05396014|589079263|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101991|NCT05396014|589079264|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101992|NCT05396014|589079265|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101993|NCT05396014|589079266|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
163101994|NCT05396014|589079267|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101995|NCT05396014|589079268|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101996|NCT05396014|589079269|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101997|NCT05396014|589079270|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101998|NCT05396014|589079271|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163101999|NCT05396014|589079272|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102000|NCT05396014|589079273|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102001|NCT05396014|589079274|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102002|NCT05396014|589079275|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102003|NCT05396014|589079276|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102004|NCT05396014|589079277|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102005|NCT05396014|589079278|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102006|NCT05396014|589079279|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102007|NCT05396014|589079280|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102008|NCT05396014|589079281|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102009|NCT05396014|589079282|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
163102010|NCT05258890|589079284|FG000|Overall Study|Patient withdrawal|6|||
163102011|NCT05258890|589079285|FG001|Overall Study|Patient withdrawal|7|||
163102012|NCT05258890|589079284|FG000|Overall Study|Patient lost to follow-up|10|||
163102013|NCT05258890|589079285|FG001|Overall Study|Patient lost to follow-up|3|||
163102014|NCT05258890|589079284|FG000|Overall Study|Social network member withdrawal|1|||
163102015|NCT05258890|589079285|FG001|Overall Study|Social network member withdrawal|0|||
163102016|NCT05258890|589079284|FG000|Overall Study|Social network member lost to follow-up|5|||
163102017|NCT05258890|589079285|FG001|Overall Study|Social network member lost to follow-up|0|||
163102018|NCT01893411|589079292|FG000|Overall Study|Protocol Violation|1|||
163102019|NCT01893411|589079293|FG001|Overall Study|Protocol Violation|0|||
163102020|NCT01893411|589079294|FG002|Overall Study|Protocol Violation|0|||
163102021|NCT01893411|589079292|FG000|Overall Study|Physician Decision|1|||
163102022|NCT01893411|589079293|FG001|Overall Study|Physician Decision|1|||
163102023|NCT01893411|589079294|FG002|Overall Study|Physician Decision|2|||
163102024|NCT01893411|589079292|FG000|Overall Study|Lack of Efficacy|2|||
163102025|NCT01893411|589079293|FG001|Overall Study|Lack of Efficacy|1|||
163102026|NCT01893411|589079294|FG002|Overall Study|Lack of Efficacy|0|||
163102027|NCT01893411|589079292|FG000|Overall Study|Other|3|||
163102028|NCT01893411|589079293|FG001|Overall Study|Other|1|||
163102029|NCT01893411|589079294|FG002|Overall Study|Other|3|||
163102030|NCT01893411|589079292|FG000|Overall Study|Adverse Event|1|||
163102031|NCT01893411|589079293|FG001|Overall Study|Adverse Event|0|||
163102032|NCT01893411|589079294|FG002|Overall Study|Adverse Event|0|||
163102033|NCT01893411|589079292|FG000|Overall Study|Withdrawal by Subject|7|||
163102034|NCT01893411|589079293|FG001|Overall Study|Withdrawal by Subject|4|||
163102035|NCT01893411|589079294|FG002|Overall Study|Withdrawal by Subject|3|||
163102036|NCT01893411|589079292|FG000|Overall Study|Lost to Follow-up|2|||
163102037|NCT01893411|589079293|FG001|Overall Study|Lost to Follow-up|0|||
163102038|NCT01893411|589079294|FG002|Overall Study|Lost to Follow-up|1|||
163102039|NCT00566982|589079295|FG000|Overall Study|Adverse Event|6|||
163102040|NCT00566982|589079296|FG001|Overall Study|Adverse Event|48|||
163102041|NCT00566982|589079295|FG000|Overall Study|Withdrawal by Subject|1|||
163102042|NCT00566982|589079296|FG001|Overall Study|Withdrawal by Subject|14|||
163102043|NCT00566982|589079295|FG000|Overall Study|Protocol Violation|1|||
163102044|NCT00566982|589079296|FG001|Overall Study|Protocol Violation|4|||
163102045|NCT00566982|589079295|FG000|Overall Study|Lost to Follow-up|0|||
163102046|NCT00566982|589079296|FG001|Overall Study|Lost to Follow-up|1|||
163102047|NCT00566982|589079295|FG000|Overall Study|Other-family problems & doctor's request|0|||
163102048|NCT00566982|589079296|FG001|Overall Study|Other-family problems & doctor's request|2|||
162653491|NCT02457598|587447603|FG003|Overall Study|Death|3|||
163102049|NCT01947283|589079297|FG000|Overall Study|Death|1|||
163102050|NCT01947283|589079298|FG001|Overall Study|Death|1|||
163102051|NCT01947283|589079299|FG002|Overall Study|Death|1|||
163102052|NCT01947283|589079300|FG003|Overall Study|Death|0|||
163102053|NCT01947283|589079301|FG004|Overall Study|Death|0|||
163102054|NCT01947283|589079302|FG005|Overall Study|Death|0|||
163102055|NCT01947283|589079303|FG006|Overall Study|Death|0|||
163102056|NCT01947283|589079297|FG000|Overall Study|Lost to Follow-up|4|||
163102057|NCT01947283|589079298|FG001|Overall Study|Lost to Follow-up|6|||
163102058|NCT01947283|589079299|FG002|Overall Study|Lost to Follow-up|5|||
163102059|NCT01947283|589079300|FG003|Overall Study|Lost to Follow-up|5|||
163102060|NCT01947283|589079301|FG004|Overall Study|Lost to Follow-up|0|||
163102061|NCT01947283|589079302|FG005|Overall Study|Lost to Follow-up|2|||
163102062|NCT01947283|589079303|FG006|Overall Study|Lost to Follow-up|5|||
163102063|NCT01947283|589079297|FG000|Overall Study|Withdrawal by Subject|10|||
163102064|NCT01947283|589079298|FG001|Overall Study|Withdrawal by Subject|8|||
163102065|NCT01947283|589079299|FG002|Overall Study|Withdrawal by Subject|4|||
163102066|NCT01947283|589079300|FG003|Overall Study|Withdrawal by Subject|1|||
163102067|NCT01947283|589079301|FG004|Overall Study|Withdrawal by Subject|0|||
163102068|NCT01947283|589079302|FG005|Overall Study|Withdrawal by Subject|0|||
163102069|NCT01947283|589079303|FG006|Overall Study|Withdrawal by Subject|2|||
163102070|NCT01947283|589079297|FG000|Overall Study|No Clinical Recording|12|||
163102071|NCT01947283|589079298|FG001|Overall Study|No Clinical Recording|6|||
163102072|NCT01947283|589079299|FG002|Overall Study|No Clinical Recording|8|||
163102073|NCT01947283|589079300|FG003|Overall Study|No Clinical Recording|10|||
163102074|NCT01947283|589079301|FG004|Overall Study|No Clinical Recording|0|||
163102075|NCT01947283|589079302|FG005|Overall Study|No Clinical Recording|0|||
163102076|NCT01947283|589079303|FG006|Overall Study|No Clinical Recording|0|||
163102077|NCT01947283|589079297|FG000|Overall Study|Non-coding Clinical Recording language|0|||
163102078|NCT01947283|589079298|FG001|Overall Study|Non-coding Clinical Recording language|0|||
163102079|NCT01947283|589079299|FG002|Overall Study|Non-coding Clinical Recording language|0|||
163102080|NCT01947283|589079300|FG003|Overall Study|Non-coding Clinical Recording language|1|||
163102081|NCT01947283|589079301|FG004|Overall Study|Non-coding Clinical Recording language|0|||
163102082|NCT01947283|589079302|FG005|Overall Study|Non-coding Clinical Recording language|0|||
163102083|NCT01947283|589079303|FG006|Overall Study|Non-coding Clinical Recording language|0|||
163102084|NCT01947283|589079297|FG000|Overall Study|Missing Follow-up Assessment|2|||
163102085|NCT01947283|589079298|FG001|Overall Study|Missing Follow-up Assessment|2|||
163102086|NCT01947283|589079299|FG002|Overall Study|Missing Follow-up Assessment|3|||
163102087|NCT01947283|589079300|FG003|Overall Study|Missing Follow-up Assessment|0|||
163102088|NCT01947283|589079301|FG004|Overall Study|Missing Follow-up Assessment|0|||
163102089|NCT01947283|589079302|FG005|Overall Study|Missing Follow-up Assessment|2|||
163102090|NCT01947283|589079303|FG006|Overall Study|Missing Follow-up Assessment|0|||
163102091|NCT01947283|589079297|FG000|Overall Study|No patients were enrolled in study|0|||
163102092|NCT01947283|589079298|FG001|Overall Study|No patients were enrolled in study|0|||
163102093|NCT01947283|589079299|FG002|Overall Study|No patients were enrolled in study|0|||
163102094|NCT01947283|589079300|FG003|Overall Study|No patients were enrolled in study|0|||
163102095|NCT01947283|589079301|FG004|Overall Study|No patients were enrolled in study|0|||
163102096|NCT01947283|589079302|FG005|Overall Study|No patients were enrolled in study|3|||
163102097|NCT01947283|589079303|FG006|Overall Study|No patients were enrolled in study|1|||
163102098|NCT01498692|589079304|FG000|Overall Study|Death|4|||
162653492|NCT02457598|587447604|FG004|Overall Study|Death|0|||
162653493|NCT02457598|587447605|FG005|Overall Study|Death|1|||
162653494|NCT02457598|587447606|FG006|Overall Study|Death|0|||
163102099|NCT01498692|589079304|FG000|Overall Study|Withdrawal by Subject|1|||
163102100|NCT01498692|589079304|FG000|Overall Study|Missed 12-month visit|3|||
162653495|NCT02457598|587447607|FG007|Overall Study|Death|0|||
162653496|NCT02457598|587447608|FG008|Overall Study|Death|0|||
162653497|NCT02457598|587447609|FG009|Overall Study|Death|0|||
163102101|NCT04729972|589079305|FG000|Overall Study|Adverse Event|1|||
163102102|NCT05002985|589079306|FG000|Overall Study|Withdrawal by Subject|1|||
163102103|NCT03782259|589079307|FG000|Overall Study|Lost to Follow-up|1|||
163102104|NCT03782259|589079308|FG001|Overall Study|Lost to Follow-up|1|||
163102105|NCT03782259|589079307|FG000|Overall Study|Moved out of state|0|||
163102106|NCT03782259|589079308|FG001|Overall Study|Moved out of state|2|||
162653498|NCT02457598|587447610|FG010|Overall Study|Death|3|||
163102107|NCT03782259|589079307|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
163102108|NCT03782259|589079308|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
163102109|NCT03782259|589079307|FG000|Overall Study|Subject discontinued intervention|1|||
163102110|NCT03782259|589079308|FG001|Overall Study|Subject discontinued intervention|0|||
163102111|NCT00603941|589079309|FG000|Overall Study|Disease progression|6|||
163102112|NCT00603941|589079310|FG001|Overall Study|Disease progression|7|||
163102113|NCT00603941|589079311|FG002|Overall Study|Disease progression|1|||
163102114|NCT00603941|589079309|FG000|Overall Study|Adverse Event|1|||
163102115|NCT00603941|589079310|FG001|Overall Study|Adverse Event|0|||
163102116|NCT00603941|589079311|FG002|Overall Study|Adverse Event|1|||
163102117|NCT00603941|589079309|FG000|Overall Study|Physician Decision|0|||
163102118|NCT00603941|589079310|FG001|Overall Study|Physician Decision|1|||
163102119|NCT00603941|589079311|FG002|Overall Study|Physician Decision|0|||
163102120|NCT00603941|589079309|FG000|Overall Study|Withdrawal by Subject|0|||
163102121|NCT00603941|589079310|FG001|Overall Study|Withdrawal by Subject|2|||
163102122|NCT00603941|589079311|FG002|Overall Study|Withdrawal by Subject|0|||
163102123|NCT02707965|589079312|FG000|Overall Study|Withdrawal by Subject|0|||
163102124|NCT02707965|589079313|FG001|Overall Study|Withdrawal by Subject|0|||
163102125|NCT02707965|589079314|FG002|Overall Study|Withdrawal by Subject|1|||
163102126|NCT02707965|589079315|FG003|Overall Study|Withdrawal by Subject|0|||
163102127|NCT02707965|589079316|FG004|Overall Study|Withdrawal by Subject|0|||
163102128|NCT02707965|589079317|FG005|Overall Study|Withdrawal by Subject|0|||
163102129|NCT02707965|589079318|FG006|Overall Study|Withdrawal by Subject|0|||
163102130|NCT02707965|589079319|FG007|Overall Study|Withdrawal by Subject|2|||
163102131|NCT02707965|589079320|FG008|Overall Study|Withdrawal by Subject|0|||
162653499|NCT02457598|587447611|FG011|Overall Study|Death|0|||
162653500|NCT02457598|587447612|FG012|Overall Study|Death|0|||
162653501|NCT02457598|587447613|FG013|Overall Study|Death|1|||
163102132|NCT02707965|589079321|FG009|Overall Study|Withdrawal by Subject|0|||
163102133|NCT02707965|589079322|FG010|Overall Study|Withdrawal by Subject|0|||
163102134|NCT02707965|589079323|FG011|Overall Study|Withdrawal by Subject|0|||
163102135|NCT02707965|589079324|FG012|Overall Study|Withdrawal by Subject|0|||
163102136|NCT02707965|589079325|FG013|Overall Study|Withdrawal by Subject|0|||
163102137|NCT02707965|589079326|FG014|Overall Study|Withdrawal by Subject|0|||
163102138|NCT02707965|589079327|FG015|Overall Study|Withdrawal by Subject|0|||
163102139|NCT02707965|589079312|FG000|Overall Study|PI decisions|0|||
163102140|NCT02707965|589079313|FG001|Overall Study|PI decisions|0|||
163102141|NCT02707965|589079314|FG002|Overall Study|PI decisions|0|||
162653502|NCT02457598|587447614|FG014|Overall Study|Death|2|||
162653503|NCT02457598|587447615|FG015|Overall Study|Death|0|||
162653504|NCT02457598|587447616|FG016|Overall Study|Death|1|||
162653505|NCT02457598|587447600|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
163102142|NCT02707965|589079315|FG003|Overall Study|PI decisions|0|||
163102143|NCT02707965|589079316|FG004|Overall Study|PI decisions|0|||
163102144|NCT02707965|589079317|FG005|Overall Study|PI decisions|0|||
162653506|NCT02457598|587447601|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
162653507|NCT02457598|587447602|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653508|NCT02457598|587447603|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
162653509|NCT02457598|587447604|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653510|NCT02457598|587447605|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
163102145|NCT02707965|589079318|FG006|Overall Study|PI decisions|0|||
163102146|NCT02707965|589079319|FG007|Overall Study|PI decisions|0|||
163102147|NCT02707965|589079320|FG008|Overall Study|PI decisions|0|||
163102148|NCT02707965|589079321|FG009|Overall Study|PI decisions|0|||
163102149|NCT02707965|589079322|FG010|Overall Study|PI decisions|0|||
163102150|NCT02707965|589079323|FG011|Overall Study|PI decisions|0|||
163102151|NCT02707965|589079324|FG012|Overall Study|PI decisions|0|||
163102152|NCT02707965|589079325|FG013|Overall Study|PI decisions|0|||
163102153|NCT02707965|589079326|FG014|Overall Study|PI decisions|2|||
163102154|NCT02707965|589079327|FG015|Overall Study|PI decisions|0|||
163102155|NCT02707965|589079312|FG000|Overall Study|Protocol deviation|1|||
163102156|NCT02707965|589079313|FG001|Overall Study|Protocol deviation|1|||
163102157|NCT02707965|589079314|FG002|Overall Study|Protocol deviation|0|||
163102158|NCT02707965|589079315|FG003|Overall Study|Protocol deviation|0|||
163102159|NCT02707965|589079316|FG004|Overall Study|Protocol deviation|0|||
163102160|NCT02707965|589079317|FG005|Overall Study|Protocol deviation|0|||
163102161|NCT02707965|589079318|FG006|Overall Study|Protocol deviation|0|||
163102162|NCT02707965|589079319|FG007|Overall Study|Protocol deviation|1|||
163102163|NCT02707965|589079320|FG008|Overall Study|Protocol deviation|0|||
163102164|NCT02707965|589079321|FG009|Overall Study|Protocol deviation|0|||
163102165|NCT02707965|589079322|FG010|Overall Study|Protocol deviation|0|||
163102166|NCT02707965|589079323|FG011|Overall Study|Protocol deviation|0|||
163102167|NCT02707965|589079324|FG012|Overall Study|Protocol deviation|0|||
163102168|NCT02707965|589079325|FG013|Overall Study|Protocol deviation|0|||
163102169|NCT02707965|589079326|FG014|Overall Study|Protocol deviation|0|||
163102170|NCT02707965|589079327|FG015|Overall Study|Protocol deviation|0|||
163102171|NCT00249808|589079328|FG000|Overall Study|Other|27|||
163102172|NCT00249808|589079328|FG000|Overall Study|Protocol Violation|3|||
163102173|NCT00249808|589079328|FG000|Overall Study|Lost to Follow-up|8|||
163102174|NCT00249808|589079328|FG000|Overall Study|Adverse Event|81|||
163102175|NCT00249808|589079328|FG000|Overall Study|Lack of Efficacy|52|||
163102176|NCT00249808|589079328|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
163102177|NCT00485758|589079335|FG000|Overall Study|Adverse Event|102|||
163102178|NCT00485758|589079336|FG001|Overall Study|Adverse Event|31|||
163102179|NCT00485758|589079335|FG000|Overall Study|Death|0|||
163102180|NCT00485758|589079336|FG001|Overall Study|Death|1|||
163102181|NCT00485758|589079335|FG000|Overall Study|Lost to Follow-up|5|||
163102182|NCT00485758|589079336|FG001|Overall Study|Lost to Follow-up|1|||
163102183|NCT00485758|589079335|FG000|Overall Study|Physician Decision|3|||
163102184|NCT00485758|589079336|FG001|Overall Study|Physician Decision|3|||
163102185|NCT00485758|589079335|FG000|Overall Study|Protocol Violation|11|||
163102186|NCT00485758|589079336|FG001|Overall Study|Protocol Violation|2|||
163102187|NCT00485758|589079335|FG000|Overall Study|Withdrawal by Subject|32|||
163102188|NCT00485758|589079336|FG001|Overall Study|Withdrawal by Subject|27|||
163102189|NCT00485758|589079335|FG000|Overall Study|Study Terminated by Sponsor|3|||
163102190|NCT00485758|589079336|FG001|Overall Study|Study Terminated by Sponsor|0|||
163102191|NCT04556591|589079337|FG000|Overall Study|Lost to Follow-up|1|||
163102192|NCT04556591|589079338|FG001|Overall Study|Lost to Follow-up|0|||
163102193|NCT04556591|589079337|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
163102194|NCT04556591|589079338|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
163102195|NCT00135330|589079340|FG000|Overall Study|Adverse Event|2|||
163102196|NCT00135330|589079341|FG001|Overall Study|Adverse Event|5|||
163102197|NCT00135330|589079342|FG002|Overall Study|Adverse Event|1|||
163102198|NCT00135330|589079340|FG000|Overall Study|Lost to Follow-up|0|||
163102199|NCT00135330|589079341|FG001|Overall Study|Lost to Follow-up|2|||
163102200|NCT00135330|589079342|FG002|Overall Study|Lost to Follow-up|3|||
163102201|NCT00135330|589079340|FG000|Overall Study|Physician Decision|1|||
163102202|NCT00135330|589079341|FG001|Overall Study|Physician Decision|1|||
163102203|NCT00135330|589079342|FG002|Overall Study|Physician Decision|0|||
163102204|NCT00135330|589079340|FG000|Overall Study|Protocol Violation|4|||
163102205|NCT00135330|589079341|FG001|Overall Study|Protocol Violation|3|||
163102206|NCT00135330|589079342|FG002|Overall Study|Protocol Violation|3|||
163102207|NCT00135330|589079340|FG000|Overall Study|Patient Decision|5|||
163102208|NCT00135330|589079341|FG001|Overall Study|Patient Decision|1|||
163102209|NCT00135330|589079342|FG002|Overall Study|Patient Decision|4|||
163102210|NCT00135330|589079340|FG000|Overall Study|Sponsor Decision|0|||
163102211|NCT00135330|589079341|FG001|Overall Study|Sponsor Decision|1|||
163102212|NCT00135330|589079342|FG002|Overall Study|Sponsor Decision|0|||
163102213|NCT02229825|589079348|FG000|Overall Study|Personal Reasons|0|||
163102214|NCT02229825|589079349|FG001|Overall Study|Personal Reasons|1|||
163102215|NCT02229825|589079348|FG000|Overall Study|Refused continuing medication|7|||
163102216|NCT02229825|589079349|FG001|Overall Study|Refused continuing medication|6|||
163102217|NCT02229825|589079348|FG000|Overall Study|Lost to Follow-up|1|||
162653511|NCT02457598|587447606|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653512|NCT02457598|587447607|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
163102218|NCT02229825|589079349|FG001|Overall Study|Lost to Follow-up|2|||
163102219|NCT02229825|589079348|FG000|Overall Study|Protocol Violation|1|||
163102220|NCT02229825|589079349|FG001|Overall Study|Protocol Violation|1|||
163102221|NCT02229825|589079348|FG000|Overall Study|Lack of Efficacy|4|||
163102222|NCT02229825|589079349|FG001|Overall Study|Lack of Efficacy|10|||
163102223|NCT02229825|589079348|FG000|Overall Study|Adverse Event|11|||
163102224|NCT02229825|589079349|FG001|Overall Study|Adverse Event|9|||
163102225|NCT02229825|589079348|FG000|Overall Study|Not treated|0|||
163102226|NCT02229825|589079349|FG001|Overall Study|Not treated|1|||
163102227|NCT01309997|589079350|FG000|Overall Study|Adverse Event|1|||
163102228|NCT01309997|589079351|FG001|Overall Study|Adverse Event|0|||
163102229|NCT01309997|589079350|FG000|Overall Study|Death|1|||
163102230|NCT01309997|589079351|FG001|Overall Study|Death|3|||
163102231|NCT01309997|589079350|FG000|Overall Study|Lack of Efficacy|2|||
163102232|NCT01309997|589079351|FG001|Overall Study|Lack of Efficacy|2|||
163102233|NCT01309997|589079350|FG000|Overall Study|Withdrawal by Subject|1|||
163102234|NCT01309997|589079351|FG001|Overall Study|Withdrawal by Subject|1|||
163102235|NCT01532921|589079352|FG000|Overall Study|Death|3|||
163102236|NCT01532921|589079352|FG000|Overall Study|Withdrawal by Subject|2|||
163102237|NCT01532921|589079352|FG000|Overall Study|Lost to Follow-up|3|||
163102238|NCT01532921|589079352|FG000|Overall Study|Physician Decision|7|||
163102239|NCT01532921|589079352|FG000|Overall Study|Device was explanted during procedure|1|||
163102240|NCT02526212|589079353|FG000|Overall Study|Incarceration|1|||
162653513|NCT02457598|587447608|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
163102241|NCT02526212|589079354|FG001|Overall Study|Incarceration|0|||
163102242|NCT02526212|589079353|FG000|Overall Study|Lost to Follow-up|1|||
163102243|NCT02526212|589079354|FG001|Overall Study|Lost to Follow-up|0|||
163102244|NCT02526212|589079353|FG000|Overall Study|Death|0|||
163102245|NCT02526212|589079354|FG001|Overall Study|Death|1|||
163102246|NCT02443337|589079356|FG000|Overall Study|Adverse Event|0|||
163102247|NCT02443337|589079357|FG001|Overall Study|Adverse Event|1|||
163102248|NCT02443337|589079356|FG000|Overall Study|Clinical Progressive Disease|3|||
163102249|NCT02443337|589079357|FG001|Overall Study|Clinical Progressive Disease|0|||
163102250|NCT02443337|589079356|FG000|Overall Study|Withdrawal by Subject|2|||
163102251|NCT02443337|589079357|FG001|Overall Study|Withdrawal by Subject|1|||
163102252|NCT02096952|589079364|FG000|Overall Study|Adverse Event|1|||
163102253|NCT03520920|589079365|FG000|Overall Study|Death|13|||
163102254|NCT03520920|589079366|FG001|Overall Study|Death|1|||
163102255|NCT03520920|589079367|FG002|Overall Study|Death|0|||
163102256|NCT03520920|589079365|FG000|Overall Study|Withdrawal by Subject|2|||
163102257|NCT03520920|589079366|FG001|Overall Study|Withdrawal by Subject|1|||
163102258|NCT03520920|589079367|FG002|Overall Study|Withdrawal by Subject|0|||
163102259|NCT03520920|589079365|FG000|Overall Study|Study Terminated by the Sponsor|5|||
163102260|NCT03520920|589079366|FG001|Overall Study|Study Terminated by the Sponsor|14|||
163102261|NCT03520920|589079367|FG002|Overall Study|Study Terminated by the Sponsor|5|||
163102262|NCT00372619|589079369|FG000|Overall Study|Ineligible|0|||
163102263|NCT00372619|589079370|FG001|Overall Study|Ineligible|0|||
163102264|NCT00372619|589079371|FG002|Overall Study|Ineligible|0|||
163102265|NCT00372619|589079372|FG003|Overall Study|Ineligible|0|||
163102266|NCT00372619|589079373|FG004|Overall Study|Ineligible|0|||
163102267|NCT00372619|589079374|FG005|Overall Study|Ineligible|2|||
163102268|NCT00372619|589079375|FG006|Overall Study|Ineligible|0|||
163102269|NCT00372619|589079369|FG000|Overall Study|Inevaluable|0|||
163102270|NCT00372619|589079370|FG001|Overall Study|Inevaluable|0|||
163102271|NCT00372619|589079371|FG002|Overall Study|Inevaluable|0|||
163102272|NCT00372619|589079372|FG003|Overall Study|Inevaluable|0|||
163102273|NCT00372619|589079373|FG004|Overall Study|Inevaluable|0|||
163102274|NCT00372619|589079374|FG005|Overall Study|Inevaluable|1|||
163102275|NCT00372619|589079375|FG006|Overall Study|Inevaluable|0|||
163102276|NCT05420961|589079385|FG000|Overall Study|Withdrawal by Subject|2|||
163102277|NCT05420961|589079386|FG001|Overall Study|Withdrawal by Subject|1|||
163102278|NCT05420961|589079387|FG002|Overall Study|Withdrawal by Subject|1|||
163102279|NCT05420961|589079388|FG003|Overall Study|Withdrawal by Subject|0|||
163102280|NCT05420961|589079389|FG004|Overall Study|Withdrawal by Subject|0|||
163102281|NCT05420961|589079385|FG000|Overall Study|Lost to Follow-up|0|||
163102282|NCT05420961|589079386|FG001|Overall Study|Lost to Follow-up|0|||
163102283|NCT05420961|589079387|FG002|Overall Study|Lost to Follow-up|1|||
163102284|NCT05420961|589079388|FG003|Overall Study|Lost to Follow-up|0|||
163102285|NCT05420961|589079389|FG004|Overall Study|Lost to Follow-up|0|||
163102286|NCT05420961|589079385|FG000|Overall Study|Randomized by mistake without study treatment|0|||
163102287|NCT05420961|589079386|FG001|Overall Study|Randomized by mistake without study treatment|0|||
163102288|NCT05420961|589079387|FG002|Overall Study|Randomized by mistake without study treatment|1|||
163102289|NCT05420961|589079388|FG003|Overall Study|Randomized by mistake without study treatment|0|||
163102290|NCT05420961|589079389|FG004|Overall Study|Randomized by mistake without study treatment|1|||
163102291|NCT04283656|589079390|FG000|Overall Study|Adverse Event|1|||
163102292|NCT04283656|589079391|FG001|Overall Study|Adverse Event|0|||
163102293|NCT04283656|589079390|FG000|Overall Study|Lost to Follow-up|0|||
163102294|NCT04283656|589079391|FG001|Overall Study|Lost to Follow-up|1|||
163102295|NCT00803361|589079392|FG000|Overall Study|Adverse Event|13|||
163102296|NCT00803361|589079393|FG001|Overall Study|Adverse Event|3|||
163102297|NCT00803361|589079392|FG000|Overall Study|Lack of Efficacy|4|||
163102298|NCT00803361|589079393|FG001|Overall Study|Lack of Efficacy|13|||
163102299|NCT00803361|589079392|FG000|Overall Study|Lost to Follow-up|1|||
163102300|NCT00803361|589079393|FG001|Overall Study|Lost to Follow-up|2|||
163102301|NCT00803361|589079392|FG000|Overall Study|Physician Decision|1|||
163102302|NCT00803361|589079393|FG001|Overall Study|Physician Decision|0|||
163102303|NCT00803361|589079392|FG000|Overall Study|Protocol Violation|2|||
163102304|NCT00803361|589079393|FG001|Overall Study|Protocol Violation|4|||
163102305|NCT00803361|589079392|FG000|Overall Study|Withdrawal by Subject|5|||
163102306|NCT00803361|589079393|FG001|Overall Study|Withdrawal by Subject|6|||
163102307|NCT04445519|589079394|FG000|Overall Study|Due to adaptive design|3|||
163102308|NCT04445519|589079395|FG001|Overall Study|Due to adaptive design|0|||
163102309|NCT04445519|589079396|FG002|Overall Study|Due to adaptive design|0|||
163102310|NCT04445519|589079394|FG000|Overall Study|Lost to Follow-up|0|||
163102311|NCT04445519|589079395|FG001|Overall Study|Lost to Follow-up|1|||
163102312|NCT04445519|589079396|FG002|Overall Study|Lost to Follow-up|4|||
163102313|NCT04445519|589079394|FG000|Overall Study|Sponsor or IRB Decision|0|||
163102314|NCT04445519|589079395|FG001|Overall Study|Sponsor or IRB Decision|1|||
163102315|NCT04445519|589079396|FG002|Overall Study|Sponsor or IRB Decision|2|||
163102316|NCT04445519|589079394|FG000|Overall Study|Withdrawal by Subject|0|||
163102317|NCT04445519|589079395|FG001|Overall Study|Withdrawal by Subject|3|||
163102318|NCT04445519|589079396|FG002|Overall Study|Withdrawal by Subject|3|||
163102319|NCT04445519|589079394|FG000|Overall Study|Adverse Event|0|||
163102320|NCT04445519|589079395|FG001|Overall Study|Adverse Event|8|||
163102321|NCT04445519|589079396|FG002|Overall Study|Adverse Event|6|||
163102322|NCT04445519|589079394|FG000|Overall Study|Other Reason|0|||
163102323|NCT04445519|589079395|FG001|Overall Study|Other Reason|1|||
163102324|NCT04445519|589079396|FG002|Overall Study|Other Reason|1|||
163102325|NCT04445519|589079394|FG000|Overall Study|Protocol Violation|0|||
163102326|NCT04445519|589079395|FG001|Overall Study|Protocol Violation|0|||
163102327|NCT04445519|589079396|FG002|Overall Study|Protocol Violation|1|||
162653514|NCT02457598|587447609|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653515|NCT02457598|587447610|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
163102328|NCT03782064|589079397|FG000|Overall Study|Lack of Efficacy|2|||
163102329|NCT03782064|589079397|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
163102330|NCT02446769|589079402|FG000|Screening Period|Screen Failure|11|||
163102331|NCT02446769|589079403|FG001|Screening Period|Screen Failure|0|||
163102332|NCT02446769|589079404|FG002|Screening Period|Screen Failure|0|||
163102333|NCT02446769|589079402|FG000|Study Period|Randomized in Error|0|||
163102334|NCT02446769|589079403|FG001|Study Period|Randomized in Error|2|||
163102335|NCT02446769|589079404|FG002|Study Period|Randomized in Error|0|||
163102336|NCT04482439|589079405|FG000|Overall Study|Lost to Follow-up|1|||
163102337|NCT04482439|589079405|FG000|Overall Study|Unrelated illness|1|||
163102338|NCT03072043|589079406|FG000|Overall Study|Death|0|||
163102339|NCT03072043|589079407|FG001|Overall Study|Death|0|||
163102340|NCT03072043|589079408|FG002|Overall Study|Death|3|||
163102341|NCT03072043|589079406|FG000|Overall Study|Adverse Event|0|||
163102342|NCT03072043|589079407|FG001|Overall Study|Adverse Event|0|||
163102343|NCT03072043|589079408|FG002|Overall Study|Adverse Event|2|||
163102344|NCT03072043|589079406|FG000|Overall Study|Withdrawal by Subject|0|||
163102345|NCT03072043|589079407|FG001|Overall Study|Withdrawal by Subject|0|||
163102346|NCT03072043|589079408|FG002|Overall Study|Withdrawal by Subject|4|||
163102347|NCT00645840|589079409|FG000|Overall Study|Protocol Violation|3|||
163102348|NCT02625220|589079410|FG000|Overall Study|Adverse Event|2|||
163102349|NCT02625220|589079410|FG000|Overall Study|Lost to Follow-up|2|||
163102350|NCT02625220|589079410|FG000|Overall Study|Protocol Violation|1|||
163102351|NCT02625220|589079410|FG000|Overall Study|Study discontinued at site|2|||
163102352|NCT04677543|589079411|FG000|Overall Study|Withdrawal by Subject|4|||
163102353|NCT04677543|589079412|FG001|Overall Study|Withdrawal by Subject|1|||
163102354|NCT04677543|589079411|FG000|Overall Study|Physician Decision|0|||
163102355|NCT04677543|589079412|FG001|Overall Study|Physician Decision|1|||
163102356|NCT04677543|589079411|FG000|Overall Study|Adverse Event|0|||
163102357|NCT04677543|589079412|FG001|Overall Study|Adverse Event|1|||
163102358|NCT00995436|589079413|FG000|Overall Study|Withdrawal by Subject|2|||
163102359|NCT00995436|589079414|FG001|Overall Study|Withdrawal by Subject|5|||
163102360|NCT00995436|589079415|FG002|Overall Study|Withdrawal by Subject|0|||
163102361|NCT02342288|589079417|FG000|Overall Study|no protocol anesthesiologist available|3|||
163102362|NCT02342288|589079418|FG001|Overall Study|no protocol anesthesiologist available|2|||
163102363|NCT02342288|589079417|FG000|Overall Study|anesthesia leak in system|1|||
163102364|NCT02342288|589079418|FG001|Overall Study|anesthesia leak in system|0|||
163102365|NCT02342288|589079417|FG000|Overall Study|Withdrawal by Subject|1|||
163102366|NCT02342288|589079418|FG001|Overall Study|Withdrawal by Subject|0|||
163102367|NCT02342288|589079417|FG000|Overall Study|coordinator contaminated with blood|0|||
163102368|NCT02342288|589079418|FG001|Overall Study|coordinator contaminated with blood|1|||
163102369|NCT02342288|589079417|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
163102370|NCT02342288|589079418|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
163102371|NCT02342288|589079417|FG000|Overall Study|coordinator not available|0|||
163102372|NCT02342288|589079418|FG001|Overall Study|coordinator not available|2|||
163102373|NCT00407602|589079420|FG000|Overall Study|Death - unrelated to device|1|||
163102374|NCT00407602|589079420|FG000|Overall Study|Device explanted|5|||
163102375|NCT00407602|589079420|FG000|Overall Study|Withdrawal by Subject|1|||
163102376|NCT00553436|589079421|FG000|Overall Study|Conversion to another procedure|1|||
163102377|NCT04188834|589079422|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
163102378|NCT02455336|589079423|FG000|Overall Study|Withdrawal by Subject|0|||
163102379|NCT02455336|589079424|FG001|Overall Study|Withdrawal by Subject|2|||
163102380|NCT02455336|589079423|FG000|Overall Study|Adverse Event|3|||
163102381|NCT02455336|589079424|FG001|Overall Study|Adverse Event|0|||
163102382|NCT02455336|589079423|FG000|Overall Study|Non-responder to treatment|2|||
163102383|NCT02455336|589079424|FG001|Overall Study|Non-responder to treatment|0|||
163102384|NCT00391430|589079425|FG000|Overall Study|Withdrawal by Subject|3|||
163102385|NCT00391430|589079426|FG001|Overall Study|Withdrawal by Subject|0|||
163102386|NCT00391430|589079427|FG002|Overall Study|Withdrawal by Subject|12|||
162653516|NCT02457598|587447611|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653517|NCT02457598|587447612|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653518|NCT02457598|587447613|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
162653519|NCT02457598|587447614|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
162653520|NCT02457598|587447615|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
163102387|NCT00577707|589079430|FG000|Overall Study|Withdrawal by Subject|3|||
162653521|NCT02457598|587447616|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
162653522|NCT02457598|587447600|FG000|Overall Study|Withdrew Consent|0|||
162653523|NCT02457598|587447601|FG001|Overall Study|Withdrew Consent|0|||
162653524|NCT02457598|587447602|FG002|Overall Study|Withdrew Consent|0|||
163102388|NCT03299244|589079431|FG000|Overall Study|Withdrawal by Subject|34|||
163102389|NCT03299244|589079432|FG001|Overall Study|Withdrawal by Subject|29|||
163102390|NCT03299244|589079431|FG000|Overall Study|Decision by Sponsor|4|||
163102391|NCT03299244|589079432|FG001|Overall Study|Decision by Sponsor|5|||
163102392|NCT03299244|589079431|FG000|Overall Study|Death|9|||
163102393|NCT03299244|589079432|FG001|Overall Study|Death|4|||
163102394|NCT03706430|589079443|FG000|Overall Study|No A-Line placed|5|||
163102395|NCT03706430|589079443|FG000|Overall Study|Subject had gel nail polish|1|||
163102396|NCT03706430|589079443|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
163102397|NCT03706430|589079443|FG000|Overall Study|Cancelled Case|6|||
163102398|NCT03706430|589079443|FG000|Overall Study|Physician Decision|2|||
163102399|NCT01928433|589079444|FG000|Overall Study|Adverse Event|5|||
163102400|NCT01928433|589079445|FG001|Overall Study|Adverse Event|2|||
163102401|NCT01928433|589079446|FG002|Overall Study|Adverse Event|5|||
163102402|NCT01928433|589079444|FG000|Overall Study|Protocol Violation|0|||
163102403|NCT01928433|589079445|FG001|Overall Study|Protocol Violation|0|||
163102404|NCT01928433|589079446|FG002|Overall Study|Protocol Violation|2|||
163102405|NCT01928433|589079444|FG000|Overall Study|Lack of Efficacy|5|||
163102406|NCT01928433|589079445|FG001|Overall Study|Lack of Efficacy|4|||
163102407|NCT01928433|589079446|FG002|Overall Study|Lack of Efficacy|4|||
163102408|NCT01928433|589079444|FG000|Overall Study|Withdrawal by Subject|0|||
163102409|NCT01928433|589079445|FG001|Overall Study|Withdrawal by Subject|4|||
163102410|NCT01928433|589079446|FG002|Overall Study|Withdrawal by Subject|0|||
163102411|NCT01928433|589079444|FG000|Overall Study|Negative screening urine culture|7|||
163102412|NCT01928433|589079445|FG001|Overall Study|Negative screening urine culture|6|||
163102413|NCT01928433|589079446|FG002|Overall Study|Negative screening urine culture|10|||
163102414|NCT01928433|589079444|FG000|Overall Study|Lost to Follow-up|0|||
163102415|NCT01928433|589079445|FG001|Overall Study|Lost to Follow-up|2|||
163102416|NCT01928433|589079446|FG002|Overall Study|Lost to Follow-up|3|||
163102417|NCT01928433|589079444|FG000|Overall Study|Other reasons|3|||
163102418|NCT01928433|589079445|FG001|Overall Study|Other reasons|3|||
163102419|NCT01928433|589079446|FG002|Overall Study|Other reasons|4|||
163102420|NCT00145626|589079447|FG000|Overall Study|Did not have NK infusions|2|||
163102421|NCT00145626|589079447|FG000|Overall Study|Turned 2 years old before treatment|1|||
163102422|NCT00145626|589079447|FG000|Overall Study|Death|1|||
163102423|NCT00145626|589079447|FG000|Overall Study|Withdrawal by Subject|1|||
163102424|NCT03381287|589079449|FG000|Overall Study|Withdrawal by Subject|0|||
163102425|NCT03381287|589079450|FG001|Overall Study|Withdrawal by Subject|1|||
163102426|NCT03381287|589079451|FG002|Overall Study|Withdrawal by Subject|0|||
163102427|NCT03381287|589079452|FG003|Overall Study|Withdrawal by Subject|0|||
163102428|NCT03381287|589079449|FG000|Overall Study|Adverse Event|0|||
163102429|NCT03381287|589079450|FG001|Overall Study|Adverse Event|0|||
163102430|NCT03381287|589079451|FG002|Overall Study|Adverse Event|0|||
163102431|NCT03381287|589079452|FG003|Overall Study|Adverse Event|1|||
163102432|NCT03381287|589079449|FG000|Overall Study|Physician Decision|0|||
163102433|NCT03381287|589079450|FG001|Overall Study|Physician Decision|0|||
163102434|NCT03381287|589079451|FG002|Overall Study|Physician Decision|0|||
163102435|NCT03381287|589079452|FG003|Overall Study|Physician Decision|1|||
163102436|NCT02709720|589079453|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
163102437|NCT02709720|589079453|FG000|Overall Study|Protocol Violation|1|||
163102438|NCT02709720|589079453|FG000|Overall Study|Not take study medication|1|||
163102439|NCT01198574|589079455|FG000|Overall Study|Resigned from schools|4|||
163102440|NCT01198574|589079456|FG001|Overall Study|Resigned from schools|1|||
163102441|NCT01198574|589079457|FG002|Overall Study|Resigned from schools|1|||
163102442|NCT01198574|589079458|FG003|Overall Study|Resigned from schools|4|||
163102443|NCT02712983|589081475|FG000|Treatment Phase|Adverse Event|3|||
163102444|NCT02712983|589081476|FG001|Treatment Phase|Adverse Event|1|||
163102445|NCT02712983|589081477|FG002|Treatment Phase|Adverse Event|1|||
163102446|NCT02712983|589081478|FG003|Treatment Phase|Adverse Event|4|||
163102447|NCT02712983|589081479|FG004|Treatment Phase|Adverse Event|3|||
163102448|NCT02712983|589081480|FG005|Treatment Phase|Adverse Event|0|||
163102449|NCT02712983|589081481|FG006|Treatment Phase|Adverse Event|6|||
163102450|NCT02712983|589081482|FG007|Treatment Phase|Adverse Event|6|||
163102451|NCT02712983|589081483|FG008|Treatment Phase|Adverse Event|1|||
163102452|NCT02712983|589081475|FG000|Treatment Phase|Protocol Deviation|0|||
163102453|NCT02712983|589081476|FG001|Treatment Phase|Protocol Deviation|0|||
163102454|NCT02712983|589081477|FG002|Treatment Phase|Protocol Deviation|0|||
163102455|NCT02712983|589081478|FG003|Treatment Phase|Protocol Deviation|2|||
163102456|NCT02712983|589081479|FG004|Treatment Phase|Protocol Deviation|0|||
163102457|NCT02712983|589081480|FG005|Treatment Phase|Protocol Deviation|0|||
163102458|NCT02712983|589081481|FG006|Treatment Phase|Protocol Deviation|1|||
163102459|NCT02712983|589081482|FG007|Treatment Phase|Protocol Deviation|0|||
163102460|NCT02712983|589081483|FG008|Treatment Phase|Protocol Deviation|0|||
163102461|NCT02712983|589081475|FG000|Treatment Phase|Technical Problems|0|||
163102462|NCT02712983|589081476|FG001|Treatment Phase|Technical Problems|0|||
163102463|NCT02712983|589081477|FG002|Treatment Phase|Technical Problems|0|||
163102464|NCT02712983|589081478|FG003|Treatment Phase|Technical Problems|0|||
163102465|NCT02712983|589081479|FG004|Treatment Phase|Technical Problems|0|||
163102466|NCT02712983|589081480|FG005|Treatment Phase|Technical Problems|0|||
163102467|NCT02712983|589081481|FG006|Treatment Phase|Technical Problems|1|||
163102468|NCT02712983|589081482|FG007|Treatment Phase|Technical Problems|0|||
163102469|NCT02712983|589081483|FG008|Treatment Phase|Technical Problems|0|||
162719061|NCT04248829|587676761|FG000|Overall Study|Physician Decision|2|||
162719062|NCT04248829|587676762|FG001|Overall Study|Physician Decision|4|||
162719063|NCT04248829|587676761|FG000|Overall Study|Any reason not specifically recorded|0|||
162719064|NCT04248829|587676762|FG001|Overall Study|Any reason not specifically recorded|2|||
163102470|NCT02712983|589081475|FG000|Treatment Phase|Physician Decision|0|||
163102471|NCT02712983|589081476|FG001|Treatment Phase|Physician Decision|0|||
163102472|NCT02712983|589081477|FG002|Treatment Phase|Physician Decision|0|||
163102473|NCT02712983|589081478|FG003|Treatment Phase|Physician Decision|0|||
163102474|NCT02712983|589081479|FG004|Treatment Phase|Physician Decision|0|||
163102475|NCT02712983|589081480|FG005|Treatment Phase|Physician Decision|0|||
163102476|NCT02712983|589081481|FG006|Treatment Phase|Physician Decision|0|||
163102477|NCT02712983|589081482|FG007|Treatment Phase|Physician Decision|1|||
163102478|NCT02712983|589081483|FG008|Treatment Phase|Physician Decision|1|||
163102479|NCT02712983|589081475|FG000|Treatment Phase|Subject Decision|2|||
163102480|NCT02712983|589081476|FG001|Treatment Phase|Subject Decision|0|||
163102481|NCT02712983|589081477|FG002|Treatment Phase|Subject Decision|0|||
163102482|NCT02712983|589081478|FG003|Treatment Phase|Subject Decision|2|||
163102483|NCT02712983|589081479|FG004|Treatment Phase|Subject Decision|1|||
163102484|NCT02712983|589081480|FG005|Treatment Phase|Subject Decision|0|||
163102485|NCT02712983|589081481|FG006|Treatment Phase|Subject Decision|1|||
163102486|NCT02712983|589081482|FG007|Treatment Phase|Subject Decision|2|||
163102487|NCT02712983|589081483|FG008|Treatment Phase|Subject Decision|0|||
163102488|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102489|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163102490|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102491|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102492|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102493|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102494|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163102495|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
163102496|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
163102497|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102498|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102499|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
162653525|NCT02457598|587447603|FG003|Overall Study|Withdrew Consent|0|||
163102500|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
163102501|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102502|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102503|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102504|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102505|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
163102506|NCT02712983|589081475|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102507|NCT02712983|589081476|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102508|NCT02712983|589081477|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102509|NCT02712983|589081478|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102510|NCT02712983|589081479|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
163102511|NCT02712983|589081480|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
163102512|NCT02712983|589081481|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
163102513|NCT02712983|589081482|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
163102514|NCT02712983|589081483|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
163102515|NCT03280303|589081484|FG000|Overall Study|Death|505|||
163102516|NCT03280303|589081484|FG000|Overall Study|Study terminated by sponsor|383|||
163102517|NCT03280303|589081484|FG000|Overall Study|Other|148|||
163102518|NCT03280303|589081484|FG000|Overall Study|No longer willing to participate in study|101|||
163102519|NCT03280303|589081484|FG000|Overall Study|Lost to follow up|39|||
163102520|NCT03280303|589081484|FG000|Overall Study|Adverse Event|20|||
163102521|NCT00064259|589081485|FG000|Overall Study|Adverse Event|1|||
163102522|NCT00064259|589081486|FG001|Overall Study|Adverse Event|0|||
163102523|NCT00064259|589081487|FG002|Overall Study|Adverse Event|0|||
163102524|NCT00064259|589081488|FG003|Overall Study|Adverse Event|1|||
163102525|NCT01132651|589081491|FG000|Overall Study|Lost to Follow-up|1|||
163102526|NCT01132651|589081492|FG001|Overall Study|Lost to Follow-up|1|||
163102527|NCT00948857|589081493|FG000|Overall Study|Lost to Follow-up|1|||
163102528|NCT00948857|589081494|FG001|Overall Study|Lost to Follow-up|0|||
163102529|NCT04439539|589081495|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
163102530|NCT04439539|589081496|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
163102531|NCT04439539|589081497|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
163102532|NCT04439539|589081495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163102533|NCT04439539|589081496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
163102534|NCT04439539|589081497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163102535|NCT04439539|589081495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
163102536|NCT04439539|589081496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
163102537|NCT04439539|589081497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
163102538|NCT02013778|589081498|FG000|Overall Study|Death|4|||
163102539|NCT02013778|589081498|FG000|Overall Study|Withdrawal by Subject|1|||
163102540|NCT02013778|589081498|FG000|Overall Study|Physician Decision|1|||
163102541|NCT02013778|589081498|FG000|Overall Study|Adverse Event|1|||
163102542|NCT02719691|589081499|FG000|Overall Study|Physician Decision|0|||
163102543|NCT02719691|589081500|FG001|Overall Study|Physician Decision|0|||
163102544|NCT02719691|589081501|FG002|Overall Study|Physician Decision|1|||
163102545|NCT02719691|589081502|FG003|Overall Study|Physician Decision|0|||
163102546|NCT02719691|589081503|FG004|Overall Study|Physician Decision|0|||
163102547|NCT02719691|589081504|FG005|Overall Study|Physician Decision|0|||
163102548|NCT02719691|589081505|FG006|Overall Study|Physician Decision|0|||
163102549|NCT02719691|589081499|FG000|Overall Study|Withdrawal by Subject|0|||
163102550|NCT02719691|589081500|FG001|Overall Study|Withdrawal by Subject|0|||
163102551|NCT02719691|589081501|FG002|Overall Study|Withdrawal by Subject|0|||
163102552|NCT02719691|589081502|FG003|Overall Study|Withdrawal by Subject|0|||
163102553|NCT02719691|589081503|FG004|Overall Study|Withdrawal by Subject|0|||
163102554|NCT02719691|589081504|FG005|Overall Study|Withdrawal by Subject|1|||
163102555|NCT02719691|589081505|FG006|Overall Study|Withdrawal by Subject|0|||
163102556|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
163102557|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
163102558|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
162653526|NCT02457598|587447604|FG004|Overall Study|Withdrew Consent|0|||
163102559|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
163102560|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
163102561|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
163102562|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
163102563|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
163102564|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
163102565|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
163102566|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
163102567|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
163102568|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
163102569|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
163102570|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
163102571|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
163102572|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
163102573|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
163102574|NCT03308968|589081506|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
163102575|NCT03308968|589081507|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
163102576|NCT03308968|589081508|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
163102577|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
163102578|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
163102579|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
163102580|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
163102581|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
163102582|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
163102583|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
163102584|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
163102585|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
163102586|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
163102587|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
163102588|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
163102589|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
163102590|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
162653527|NCT02457598|587447605|FG005|Overall Study|Withdrew Consent|0|||
162653528|NCT02457598|587447606|FG006|Overall Study|Withdrew Consent|0|||
162653529|NCT02457598|587447607|FG007|Overall Study|Withdrew Consent|2|||
162653530|NCT02457598|587447608|FG008|Overall Study|Withdrew Consent|0|||
162653531|NCT02457598|587447609|FG009|Overall Study|Withdrew Consent|0|||
162653532|NCT02457598|587447610|FG010|Overall Study|Withdrew Consent|3|||
162653533|NCT02457598|587447611|FG011|Overall Study|Withdrew Consent|0|||
162653534|NCT02457598|587447612|FG012|Overall Study|Withdrew Consent|0|||
162653535|NCT02457598|587447613|FG013|Overall Study|Withdrew Consent|1|||
162653536|NCT02457598|587447614|FG014|Overall Study|Withdrew Consent|0|||
162653537|NCT02457598|587447615|FG015|Overall Study|Withdrew Consent|0|||
162653538|NCT02457598|587447616|FG016|Overall Study|Withdrew Consent|0|||
162653539|NCT02457598|587447600|FG000|Overall Study|Unacceptable Toxicity|0|||
162653540|NCT02457598|587447601|FG001|Overall Study|Unacceptable Toxicity|0|||
162653541|NCT02457598|587447602|FG002|Overall Study|Unacceptable Toxicity|0|||
162719065|NCT01867580|587676765|FG000|Overall Study|Withdrawal by Subject|2|||
163102591|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
163102592|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
163102593|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
163102594|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
163102595|NCT03308968|589081506|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
163102596|NCT03308968|589081507|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
163102597|NCT03308968|589081508|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
163102598|NCT01521923|589081514|FG000|Overall Study|AE, serious fatal|1|||
163102599|NCT01521923|589081515|FG001|Overall Study|AE, serious fatal|0|||
163102600|NCT01521923|589081516|FG002|Overall Study|AE, serious fatal|0|||
163102601|NCT01521923|589081517|FG003|Overall Study|AE, serious fatal|0|||
163102602|NCT01521923|589081514|FG000|Overall Study|SAE, non-fatal|0|||
163102603|NCT01521923|589081515|FG001|Overall Study|SAE, non-fatal|2|||
163102604|NCT01521923|589081516|FG002|Overall Study|SAE, non-fatal|2|||
163102605|NCT01521923|589081517|FG003|Overall Study|SAE, non-fatal|0|||
163102606|NCT01521923|589081514|FG000|Overall Study|AE, non-serious, non-fatal|1|||
163102607|NCT01521923|589081515|FG001|Overall Study|AE, non-serious, non-fatal|3|||
163102608|NCT01521923|589081516|FG002|Overall Study|AE, non-serious, non-fatal|6|||
163102609|NCT01521923|589081517|FG003|Overall Study|AE, non-serious, non-fatal|2|||
163102610|NCT01521923|589081514|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102611|NCT01521923|589081515|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102612|NCT01521923|589081516|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
163102613|NCT01521923|589081517|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
163102614|NCT01521923|589081514|FG000|Overall Study|Lack of Efficacy|1|||
163102615|NCT01521923|589081515|FG001|Overall Study|Lack of Efficacy|1|||
162653542|NCT02457598|587447603|FG003|Overall Study|Unacceptable Toxicity|0|||
162719066|NCT01867580|587676766|FG001|Overall Study|Withdrawal by Subject|3|||
163102616|NCT01521923|589081516|FG002|Overall Study|Lack of Efficacy|0|||
163102617|NCT01521923|589081517|FG003|Overall Study|Lack of Efficacy|0|||
163102618|NCT01521923|589081514|FG000|Overall Study|Protocol Violation|0|||
162653543|NCT02457598|587447604|FG004|Overall Study|Unacceptable Toxicity|0|||
163102619|NCT01521923|589081515|FG001|Overall Study|Protocol Violation|0|||
162653544|NCT02457598|587447605|FG005|Overall Study|Unacceptable Toxicity|0|||
162653545|NCT02457598|587447606|FG006|Overall Study|Unacceptable Toxicity|0|||
162719067|NCT01867580|587676765|FG000|Overall Study|Physician Decision|17|||
163102620|NCT01521923|589081516|FG002|Overall Study|Protocol Violation|1|||
163102621|NCT01521923|589081517|FG003|Overall Study|Protocol Violation|0|||
163102622|NCT01521923|589081514|FG000|Overall Study|Lost to Follow-up|1|||
163102623|NCT01521923|589081515|FG001|Overall Study|Lost to Follow-up|0|||
163102624|NCT01521923|589081516|FG002|Overall Study|Lost to Follow-up|2|||
163102625|NCT01521923|589081517|FG003|Overall Study|Lost to Follow-up|1|||
163102626|NCT01521923|589081514|FG000|Overall Study|Withdrawal by Subject|1|||
163102627|NCT01521923|589081515|FG001|Overall Study|Withdrawal by Subject|1|||
163102628|NCT01521923|589081516|FG002|Overall Study|Withdrawal by Subject|1|||
163102629|NCT01521923|589081517|FG003|Overall Study|Withdrawal by Subject|2|||
163102630|NCT01521923|589081514|FG000|Overall Study|Other|2|||
163102631|NCT01521923|589081515|FG001|Overall Study|Other|1|||
163102632|NCT01521923|589081516|FG002|Overall Study|Other|3|||
163102633|NCT01521923|589081517|FG003|Overall Study|Other|6|||
163102634|NCT01521923|589081514|FG000|Overall Study|AE, captured in Period 1|0|||
163102635|NCT01521923|589081515|FG001|Overall Study|AE, captured in Period 1|1|||
163102636|NCT01521923|589081516|FG002|Overall Study|AE, captured in Period 1|0|||
163102637|NCT01521923|589081517|FG003|Overall Study|AE, captured in Period 1|1|||
163102638|NCT03037476|589081518|FG000|Overall Study|Lost to Follow-up|63|||
163102639|NCT03037476|589081519|FG001|Overall Study|Lost to Follow-up|46|||
163102640|NCT02403817|589081520|FG000|Overall Study|Withdrawal by Subject|5|||
163102641|NCT02403817|589081521|FG001|Overall Study|Withdrawal by Subject|0|||
163102642|NCT01208324|589081527|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
163102643|NCT01208324|589081528|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
163102644|NCT01208324|589081529|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
163102645|NCT01208324|589081530|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
163102646|NCT00984165|589081531|FG000|Overall Study|Death on study|2|||
163102647|NCT00984165|589081532|FG001|Overall Study|Death on study|0|||
163102648|NCT00984165|589081533|FG002|Overall Study|Death on study|0|||
163102649|NCT00984165|589081534|FG003|Overall Study|Death on study|0|||
163102650|NCT00984165|589081531|FG000|Overall Study|Disease progression on study|5|||
163102651|NCT00984165|589081532|FG001|Overall Study|Disease progression on study|1|||
163102652|NCT00984165|589081533|FG002|Overall Study|Disease progression on study|0|||
163102653|NCT00984165|589081534|FG003|Overall Study|Disease progression on study|0|||
163102654|NCT00984165|589081531|FG000|Overall Study|Death of recipient|0|||
163102655|NCT00984165|589081532|FG001|Overall Study|Death of recipient|0|||
163102656|NCT00984165|589081533|FG002|Overall Study|Death of recipient|0|||
163102657|NCT00984165|589081534|FG003|Overall Study|Death of recipient|1|||
163102658|NCT00984165|589081531|FG000|Overall Study|New protocol|0|||
163102659|NCT00984165|589081532|FG001|Overall Study|New protocol|0|||
163102660|NCT00984165|589081533|FG002|Overall Study|New protocol|0|||
163102661|NCT00984165|589081534|FG003|Overall Study|New protocol|1|||
163102662|NCT00984165|589081531|FG000|Overall Study|P+/donor pair removed from protocol|0|||
163102663|NCT00984165|589081532|FG001|Overall Study|P+/donor pair removed from protocol|0|||
163102664|NCT00984165|589081533|FG002|Overall Study|P+/donor pair removed from protocol|0|||
163102665|NCT00984165|589081534|FG003|Overall Study|P+/donor pair removed from protocol|1|||
163102666|NCT00984165|589081531|FG000|Overall Study|removed with a pair recipient|0|||
163102667|NCT00984165|589081532|FG001|Overall Study|removed with a pair recipient|0|||
163102668|NCT00984165|589081533|FG002|Overall Study|removed with a pair recipient|0|||
163102669|NCT00984165|589081534|FG003|Overall Study|removed with a pair recipient|1|||
163102670|NCT04474197|589081535|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102671|NCT04474197|589081536|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
163102672|NCT04474197|589081537|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102673|NCT04474197|589081538|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
163102674|NCT00588237|589081541|FG000|Overall Study|Evaluable for toxicity only|3|||
163102675|NCT00588237|589081541|FG000|Overall Study|Patien not treated|1|||
163102676|NCT01390298|589081542|FG000|Overall Study|Death|1|||
163102677|NCT01390298|589081542|FG000|Overall Study|long term ICU admission|1|||
163102678|NCT01390298|589081542|FG000|Overall Study|Withdrawal by Subject|14|||
163102679|NCT01390298|589081542|FG000|Overall Study|Lost to Follow-up|7|||
163102680|NCT01390298|589081542|FG000|Overall Study|Surgery cancelled|1|||
163102681|NCT00066222|589081547|FG000|Overall Study|No protocol treatment received|1|||
163102682|NCT00635349|589081548|FG000|Overall Study|Other|8|||
163102683|NCT00635349|589081549|FG001|Overall Study|Other|6|||
163102684|NCT00635349|589081548|FG000|Overall Study|Protocol Violation|18|||
163102685|NCT00635349|589081549|FG001|Overall Study|Protocol Violation|22|||
163102686|NCT00635349|589081548|FG000|Overall Study|Withdrawal by Subject|3|||
163102687|NCT00635349|589081549|FG001|Overall Study|Withdrawal by Subject|8|||
163102688|NCT00635349|589081548|FG000|Overall Study|Lost to Follow-up|4|||
163102689|NCT00635349|589081549|FG001|Overall Study|Lost to Follow-up|3|||
163102690|NCT00635349|589081548|FG000|Overall Study|Adverse Event|11|||
162653546|NCT02457598|587447607|FG007|Overall Study|Unacceptable Toxicity|0|||
163102691|NCT00635349|589081549|FG001|Overall Study|Adverse Event|9|||
163102692|NCT01524224|589081553|FG000|Overall Study|Progressive Disease|1|||
163102693|NCT01524224|589081554|FG001|Overall Study|Progressive Disease|0|||
163102694|NCT01524224|589081555|FG002|Overall Study|Progressive Disease|2|||
163102695|NCT01524224|589081556|FG003|Overall Study|Progressive Disease|1|||
163102696|NCT01524224|589081557|FG004|Overall Study|Progressive Disease|2|||
163102697|NCT01524224|589081558|FG005|Overall Study|Progressive Disease|1|||
163102698|NCT01524224|589081559|FG006|Overall Study|Progressive Disease|1|||
163102699|NCT01524224|589081560|FG007|Overall Study|Progressive Disease|5|||
163102700|NCT01524224|589081553|FG000|Overall Study|Withdrawal by Subject|2|||
163102701|NCT01524224|589081554|FG001|Overall Study|Withdrawal by Subject|0|||
163102702|NCT01524224|589081555|FG002|Overall Study|Withdrawal by Subject|0|||
163102703|NCT01524224|589081556|FG003|Overall Study|Withdrawal by Subject|0|||
163102704|NCT01524224|589081557|FG004|Overall Study|Withdrawal by Subject|0|||
163102705|NCT01524224|589081558|FG005|Overall Study|Withdrawal by Subject|0|||
163102706|NCT01524224|589081559|FG006|Overall Study|Withdrawal by Subject|2|||
163102707|NCT01524224|589081560|FG007|Overall Study|Withdrawal by Subject|0|||
163102708|NCT01524224|589081553|FG000|Overall Study|Adverse Event|0|||
163102709|NCT01524224|589081554|FG001|Overall Study|Adverse Event|1|||
163102710|NCT01524224|589081555|FG002|Overall Study|Adverse Event|0|||
163102711|NCT01524224|589081556|FG003|Overall Study|Adverse Event|0|||
163102712|NCT01524224|589081557|FG004|Overall Study|Adverse Event|0|||
163102713|NCT01524224|589081558|FG005|Overall Study|Adverse Event|1|||
163102714|NCT01524224|589081559|FG006|Overall Study|Adverse Event|0|||
163102715|NCT01524224|589081560|FG007|Overall Study|Adverse Event|0|||
163102716|NCT01524224|589081553|FG000|Overall Study|Physician Decision|0|||
163102717|NCT01524224|589081554|FG001|Overall Study|Physician Decision|0|||
163102718|NCT01524224|589081555|FG002|Overall Study|Physician Decision|0|||
163102719|NCT01524224|589081556|FG003|Overall Study|Physician Decision|1|||
163102720|NCT01524224|589081557|FG004|Overall Study|Physician Decision|1|||
163102721|NCT01524224|589081558|FG005|Overall Study|Physician Decision|0|||
163102722|NCT01524224|589081559|FG006|Overall Study|Physician Decision|0|||
163102723|NCT01524224|589081560|FG007|Overall Study|Physician Decision|1|||
163102724|NCT01524224|589081553|FG000|Overall Study|Sponsor Decision|0|||
163102725|NCT01524224|589081554|FG001|Overall Study|Sponsor Decision|0|||
163102726|NCT01524224|589081555|FG002|Overall Study|Sponsor Decision|0|||
163102727|NCT01524224|589081556|FG003|Overall Study|Sponsor Decision|0|||
163102728|NCT01524224|589081557|FG004|Overall Study|Sponsor Decision|1|||
163102729|NCT01524224|589081558|FG005|Overall Study|Sponsor Decision|0|||
163102730|NCT01524224|589081559|FG006|Overall Study|Sponsor Decision|0|||
163102731|NCT01524224|589081560|FG007|Overall Study|Sponsor Decision|0|||
163102732|NCT01119066|589081567|FG000|Overall Study|Withdrawal by Subject|4|||
163102733|NCT01119066|589081568|FG001|Overall Study|Withdrawal by Subject|6|||
163102734|NCT01119066|589081569|FG002|Overall Study|Withdrawal by Subject|0|||
163102735|NCT01119066|589081570|FG003|Overall Study|Withdrawal by Subject|0|||
163102736|NCT01119066|589081567|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
163102737|NCT01119066|589081568|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
162719068|NCT01867580|587676766|FG001|Overall Study|Physician Decision|12|||
163102738|NCT01119066|589081569|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
163102739|NCT01119066|589081570|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
163102740|NCT01119066|589081567|FG000|Overall Study|Relapse identified before transplant|1|||
163102741|NCT01119066|589081568|FG001|Overall Study|Relapse identified before transplant|0|||
163102742|NCT01119066|589081569|FG002|Overall Study|Relapse identified before transplant|0|||
163102743|NCT01119066|589081570|FG003|Overall Study|Relapse identified before transplant|0|||
163102744|NCT01119066|589081567|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102745|NCT01119066|589081568|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
163102746|NCT01119066|589081569|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102747|NCT01119066|589081570|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
163102748|NCT01119066|589081567|FG000|Overall Study|Relapse identified before transplant|0|||
163102749|NCT01119066|589081568|FG001|Overall Study|Relapse identified before transplant|4|||
163102750|NCT01119066|589081569|FG002|Overall Study|Relapse identified before transplant|0|||
163102751|NCT01119066|589081570|FG003|Overall Study|Relapse identified before transplant|0|||
163102752|NCT00783835|589081571|FG000|Overall Study|Adverse Event|3|||
163102753|NCT00783835|589081571|FG000|Overall Study|Medical Criteria|1|||
163102754|NCT00783835|589081571|FG000|Overall Study|Withdrawal by Subject|2|||
163102755|NCT00783835|589081571|FG000|Overall Study|Lost to Follow-up|1|||
163102756|NCT00783835|589081571|FG000|Overall Study|Participant not Adherent|3|||
163102757|NCT00295646|589081572|FG000|Overall Study|Protocol Violation|18|||
163102758|NCT00295646|589081573|FG001|Overall Study|Protocol Violation|20|||
163102759|NCT00295646|589081574|FG002|Overall Study|Protocol Violation|20|||
163102760|NCT00295646|589081575|FG003|Overall Study|Protocol Violation|18|||
163102761|NCT00295646|589081572|FG000|Overall Study|Withdrawal by Subject|8|||
163102762|NCT00295646|589081573|FG001|Overall Study|Withdrawal by Subject|9|||
163102763|NCT00295646|589081574|FG002|Overall Study|Withdrawal by Subject|11|||
163102764|NCT00295646|589081575|FG003|Overall Study|Withdrawal by Subject|14|||
163102765|NCT00295646|589081572|FG000|Overall Study|Lost to Follow-up|0|||
163102766|NCT00295646|589081573|FG001|Overall Study|Lost to Follow-up|5|||
163102767|NCT00295646|589081574|FG002|Overall Study|Lost to Follow-up|1|||
163102768|NCT00295646|589081575|FG003|Overall Study|Lost to Follow-up|5|||
163102769|NCT00295646|589081572|FG000|Overall Study|Death|9|||
163102770|NCT00295646|589081573|FG001|Overall Study|Death|7|||
163102771|NCT00295646|589081574|FG002|Overall Study|Death|18|||
163102772|NCT00295646|589081575|FG003|Overall Study|Death|8|||
163102773|NCT01232127|589081577|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
163102774|NCT01232127|589081578|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
163102775|NCT01232127|589081579|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
163102776|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
163102777|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
163102778|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
163102779|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
163102780|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
163102781|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
163102782|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
163102783|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
163102784|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
163102785|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
163102786|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163102787|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
163102788|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
163102789|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
163102790|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
163102791|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
163102792|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163102793|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
163102794|NCT03162796|589081583|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
163102795|NCT03162796|589081584|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
163102796|NCT03162796|589081585|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
163102797|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
163102798|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
163102799|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
163102800|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
163102801|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
163102802|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
163102803|NCT03162796|589081583|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
163102804|NCT03162796|589081584|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
163102805|NCT03162796|589081585|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
163102806|NCT03162796|589081583|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
163102807|NCT03162796|589081584|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
163102808|NCT03162796|589081585|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
163102809|NCT02623205|589081586|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
163102810|NCT02623205|589081587|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
163102811|NCT02375373|589081591|FG000|Overall Study|Withdrawal by Subject|11|||
163102812|NCT02725476|589081592|FG000|Overall Study|Physician Decision|2|||
163102813|NCT02725476|589081593|FG001|Overall Study|Physician Decision|0|||
163102814|NCT02725476|589081592|FG000|Overall Study|Adverse Event|1|||
163102815|NCT02725476|589081593|FG001|Overall Study|Adverse Event|1|||
163102816|NCT00289289|589081595|FG000|Overall Study|Withdrawal by Subject|5|||
163102817|NCT00289289|589081596|FG001|Overall Study|Withdrawal by Subject|3|||
163102818|NCT00289289|589081597|FG002|Overall Study|Withdrawal by Subject|15|||
163102819|NCT00289289|589081595|FG000|Overall Study|Lost to Follow-up|1|||
163102820|NCT00289289|589081596|FG001|Overall Study|Lost to Follow-up|0|||
163102821|NCT00289289|589081597|FG002|Overall Study|Lost to Follow-up|1|||
163102822|NCT00289289|589081595|FG000|Overall Study|Death|4|||
163102823|NCT00289289|589081596|FG001|Overall Study|Death|2|||
163102824|NCT00289289|589081597|FG002|Overall Study|Death|5|||
163102825|NCT00289289|589081595|FG000|Overall Study|No implant attempted|0|||
163102826|NCT00289289|589081596|FG001|Overall Study|No implant attempted|0|||
163102827|NCT00289289|589081597|FG002|Overall Study|No implant attempted|1|||
163102828|NCT00289289|589081595|FG000|Overall Study|Physician Decision|1|||
163102829|NCT00289289|589081596|FG001|Overall Study|Physician Decision|0|||
163102830|NCT00289289|589081597|FG002|Overall Study|Physician Decision|6|||
163102831|NCT00289289|589081595|FG000|Overall Study|Non-study device implanted|2|||
163102832|NCT00289289|589081596|FG001|Overall Study|Non-study device implanted|1|||
163102833|NCT00289289|589081597|FG002|Overall Study|Non-study device implanted|3|||
163102834|NCT00289289|589081595|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
163102835|NCT00289289|589081596|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
163102836|NCT00289289|589081597|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
163102837|NCT00289289|589081595|FG000|Overall Study|Other Exit Reason|6|||
163102838|NCT00289289|589081596|FG001|Overall Study|Other Exit Reason|4|||
163102839|NCT00289289|589081597|FG002|Overall Study|Other Exit Reason|12|||
163102840|NCT01445613|589081598|FG000|30-day Follow-up|Withdrawal by Subject|6|||
163102841|NCT01445613|589081598|FG000|30-day Follow-up|Physician Decision|3|||
163102842|NCT01445613|589081598|FG000|30-day Follow-up|Missed visit|23|||
163102843|NCT01445613|589081598|FG000|30-day Follow-up|Death|3|||
163102844|NCT01445613|589081598|FG000|1-year Follow-up|Withdrawal by Subject|12|||
163102845|NCT01445613|589081598|FG000|1-year Follow-up|Missed visit|29|||
163102846|NCT01445613|589081598|FG000|1-year Follow-up|Lost to Follow-up|2|||
163102847|NCT01445613|589081598|FG000|1-year Follow-up|Death|30|||
163102848|NCT01445613|589081598|FG000|1-year Follow-up|Physician Decision|2|||
163102849|NCT01445613|589081598|FG000|1-year Follow-up|Received a non-study stent|2|||
163102850|NCT01169701|589081599|FG000|Overall Study|Lost to Follow-up|1|||
163102851|NCT01169701|589081600|FG001|Overall Study|Lost to Follow-up|1|||
163102852|NCT01169701|589081599|FG000|Overall Study|Withdrawal by Subject|1|||
163102853|NCT01169701|589081600|FG001|Overall Study|Withdrawal by Subject|3|||
163102854|NCT01169701|589081599|FG000|Overall Study|Adverse Event|1|||
163102855|NCT01169701|589081600|FG001|Overall Study|Adverse Event|2|||
163102856|NCT01169701|589081599|FG000|Overall Study|Exclusion criteria|2|||
163102857|NCT01169701|589081600|FG001|Overall Study|Exclusion criteria|0|||
163102858|NCT01169701|589081599|FG000|Overall Study|Death|0|||
163102859|NCT01169701|589081600|FG001|Overall Study|Death|1|||
163102860|NCT01169701|589081599|FG000|Overall Study|Administrative problems|0|||
163102861|NCT01169701|589081600|FG001|Overall Study|Administrative problems|1|||
163102862|NCT01169701|589081599|FG000|Overall Study|Serious adverse event|0|||
163102863|NCT01169701|589081600|FG001|Overall Study|Serious adverse event|1|||
163102864|NCT01169701|589081599|FG000|Overall Study|Sponsor decision|0|||
163102865|NCT01169701|589081600|FG001|Overall Study|Sponsor decision|1|||
163102866|NCT00980460|589081609|FG000|Overall Study|Death|0|||
163102867|NCT00980460|589081610|FG001|Overall Study|Death|0|||
163102868|NCT00980460|589081611|FG002|Overall Study|Death|1|||
163102869|NCT00980460|589081612|FG003|Overall Study|Death|2|||
163102870|NCT00980460|589081613|FG004|Overall Study|Death|1|||
163102871|NCT00980460|589081609|FG000|Overall Study|Lack of Efficacy|0|||
163102872|NCT00980460|589081610|FG001|Overall Study|Lack of Efficacy|0|||
163102873|NCT00980460|589081611|FG002|Overall Study|Lack of Efficacy|10|||
163102874|NCT00980460|589081612|FG003|Overall Study|Lack of Efficacy|6|||
163102875|NCT00980460|589081613|FG004|Overall Study|Lack of Efficacy|8|||
163102876|NCT00980460|589081609|FG000|Overall Study|Lost to Follow-up|0|||
163102877|NCT00980460|589081610|FG001|Overall Study|Lost to Follow-up|0|||
163102878|NCT00980460|589081611|FG002|Overall Study|Lost to Follow-up|0|||
163102879|NCT00980460|589081612|FG003|Overall Study|Lost to Follow-up|1|||
163102880|NCT00980460|589081613|FG004|Overall Study|Lost to Follow-up|0|||
163102881|NCT00980460|589081609|FG000|Overall Study|Physician Decision|0|||
163102882|NCT00980460|589081610|FG001|Overall Study|Physician Decision|0|||
163102883|NCT00980460|589081611|FG002|Overall Study|Physician Decision|11|||
163102884|NCT00980460|589081612|FG003|Overall Study|Physician Decision|5|||
163102885|NCT00980460|589081613|FG004|Overall Study|Physician Decision|3|||
163102886|NCT00980460|589081609|FG000|Overall Study|Withdrawal by Subject|0|||
163102887|NCT00980460|589081610|FG001|Overall Study|Withdrawal by Subject|0|||
163102888|NCT00980460|589081611|FG002|Overall Study|Withdrawal by Subject|1|||
163102889|NCT00980460|589081612|FG003|Overall Study|Withdrawal by Subject|0|||
163102890|NCT00980460|589081613|FG004|Overall Study|Withdrawal by Subject|0|||
163102891|NCT00980460|589081609|FG000|Overall Study|Ineligible|0|||
163102892|NCT00980460|589081610|FG001|Overall Study|Ineligible|2|||
163102893|NCT00980460|589081611|FG002|Overall Study|Ineligible|3|||
163102894|NCT00980460|589081612|FG003|Overall Study|Ineligible|1|||
163102895|NCT00980460|589081613|FG004|Overall Study|Ineligible|4|||
163102896|NCT00980460|589081609|FG000|Overall Study|Refusal of further therapy|0|||
163102897|NCT00980460|589081610|FG001|Overall Study|Refusal of further therapy|2|||
163102898|NCT00980460|589081611|FG002|Overall Study|Refusal of further therapy|3|||
163102899|NCT00980460|589081612|FG003|Overall Study|Refusal of further therapy|2|||
163102900|NCT00980460|589081613|FG004|Overall Study|Refusal of further therapy|0|||
163102901|NCT00980460|589081609|FG000|Overall Study|No therapy within 42 days of resection|0|||
163102902|NCT00980460|589081610|FG001|Overall Study|No therapy within 42 days of resection|0|||
162653547|NCT02457598|587447608|FG008|Overall Study|Unacceptable Toxicity|0|||
163102903|NCT00980460|589081611|FG002|Overall Study|No therapy within 42 days of resection|3|||
163102904|NCT00980460|589081612|FG003|Overall Study|No therapy within 42 days of resection|1|||
163102905|NCT00980460|589081613|FG004|Overall Study|No therapy within 42 days of resection|0|||
163102906|NCT00980460|589081609|FG000|Overall Study|No transplant by protocol timepoints|0|||
163102907|NCT00980460|589081610|FG001|Overall Study|No transplant by protocol timepoints|0|||
163102908|NCT00980460|589081611|FG002|Overall Study|No transplant by protocol timepoints|3|||
163102909|NCT00980460|589081612|FG003|Overall Study|No transplant by protocol timepoints|0|||
163102910|NCT00980460|589081613|FG004|Overall Study|No transplant by protocol timepoints|0|||
163102911|NCT02842086|589081614|FG000|Overall Study|Randomized but Never Treated|6|||
163102912|NCT02842086|589081615|FG001|Overall Study|Randomized but Never Treated|6|||
163102913|NCT02842086|589081614|FG000|Overall Study|Still in Double-Blind Phase|7|||
163102914|NCT02842086|589081615|FG001|Overall Study|Still in Double-Blind Phase|3|||
163102915|NCT02842086|589081614|FG000|Overall Study|Adverse Event|18|||
163102916|NCT02842086|589081615|FG001|Overall Study|Adverse Event|20|||
163102917|NCT02842086|589081614|FG000|Overall Study|Death|3|||
163102918|NCT02842086|589081615|FG001|Overall Study|Death|3|||
163102919|NCT02842086|589081614|FG000|Overall Study|Investigator's Discretion|9|||
163102920|NCT02842086|589081615|FG001|Overall Study|Investigator's Discretion|13|||
163102921|NCT02842086|589081614|FG000|Overall Study|Non-Compliance with Study Drug|9|||
163102922|NCT02842086|589081615|FG001|Overall Study|Non-Compliance with Study Drug|8|||
163102923|NCT02842086|589081614|FG000|Overall Study|Protocol Violation|8|||
163102924|NCT02842086|589081615|FG001|Overall Study|Protocol Violation|4|||
163102925|NCT02842086|589081614|FG000|Overall Study|Withdrew Consent|205|||
163102926|NCT02842086|589081615|FG001|Overall Study|Withdrew Consent|194|||
163102927|NCT02842086|589081614|FG000|Overall Study|Lost to Follow-up|274|||
163102928|NCT02842086|589081615|FG001|Overall Study|Lost to Follow-up|236|||
163102929|NCT02842086|589081614|FG000|Overall Study|HIV-1 Infection|5|||
163102930|NCT02842086|589081615|FG001|Overall Study|HIV-1 Infection|6|||
163102931|NCT05696444|589081616|FG000|Treatment|Physician Decision|0|||
163102932|NCT05696444|589081617|FG001|Treatment|Physician Decision|1|||
163102933|NCT05696444|589081618|FG002|Treatment|Physician Decision|0|||
163102934|NCT05696444|589081616|FG000|30 Days|Death|1|||
163102935|NCT05696444|589081617|FG001|30 Days|Death|1|||
163102936|NCT05696444|589081618|FG002|30 Days|Death|0|||
163102937|NCT05696444|589081616|FG000|30 Days|Missed Visit|1|||
163102938|NCT05696444|589081617|FG001|30 Days|Missed Visit|1|||
163102939|NCT05696444|589081618|FG002|30 Days|Missed Visit|1|||
163102940|NCT00078806|589082985|FG000|Part 1A|Adverse Event|2|||
163102941|NCT00078806|589082986|FG001|Part 1A|Adverse Event|0|||
163102942|NCT00078806|589082987|FG002|Part 1A|Adverse Event|0|||
163102943|NCT00078806|589082988|FG003|Part 1A|Adverse Event|0|||
163102944|NCT00078806|589082985|FG000|Part 1A|Lack of Efficacy|7|||
163102945|NCT00078806|589082986|FG001|Part 1A|Lack of Efficacy|0|||
163102946|NCT00078806|589082987|FG002|Part 1A|Lack of Efficacy|0|||
163102947|NCT00078806|589082988|FG003|Part 1A|Lack of Efficacy|0|||
163102948|NCT00078806|589082985|FG000|Part 1A|Other|1|||
163102949|NCT00078806|589082986|FG001|Part 1A|Other|0|||
163102950|NCT00078806|589082987|FG002|Part 1A|Other|0|||
163102951|NCT00078806|589082988|FG003|Part 1A|Other|0|||
163102952|NCT00078806|589082985|FG000|Part 1B|Adverse Event|1|||
163102953|NCT00078806|589082986|FG001|Part 1B|Adverse Event|0|||
163102954|NCT00078806|589082987|FG002|Part 1B|Adverse Event|0|||
163102955|NCT00078806|589082988|FG003|Part 1B|Adverse Event|0|||
163102956|NCT00078806|589082985|FG000|Part 1B|Lack of Efficacy|7|||
163102957|NCT00078806|589082986|FG001|Part 1B|Lack of Efficacy|0|||
163102958|NCT00078806|589082987|FG002|Part 1B|Lack of Efficacy|0|||
163102959|NCT00078806|589082988|FG003|Part 1B|Lack of Efficacy|0|||
163102960|NCT00078806|589082985|FG000|Part 2|Adverse Event|0|||
163102961|NCT00078806|589082986|FG001|Part 2|Adverse Event|1|||
163102962|NCT00078806|589082987|FG002|Part 2|Adverse Event|0|||
163102963|NCT00078806|589082988|FG003|Part 2|Adverse Event|0|||
163102964|NCT00161616|589082989|FG000|Overall Study|Withdrawal by Subject|6|||
163102965|NCT00161616|589082990|FG001|Overall Study|Withdrawal by Subject|5|||
163102966|NCT00161616|589082989|FG000|Overall Study|Physician Decision|1|||
163102967|NCT00161616|589082990|FG001|Overall Study|Physician Decision|0|||
163102968|NCT00161616|589082989|FG000|Overall Study|Death|1|||
163102969|NCT00161616|589082990|FG001|Overall Study|Death|1|||
163102970|NCT00161616|589082989|FG000|Overall Study|Lost to Follow-up|17|||
163102971|NCT00161616|589082990|FG001|Overall Study|Lost to Follow-up|13|||
163102972|NCT00161616|589082989|FG000|Overall Study|Protocol deviation|1|||
163102973|NCT00161616|589082990|FG001|Overall Study|Protocol deviation|0|||
163102974|NCT00861757|589082993|FG000|Overall Study|Adverse Event|1|||
163102975|NCT00861757|589082994|FG001|Overall Study|Adverse Event|5|||
163102976|NCT00861757|589082995|FG002|Overall Study|Adverse Event|7|||
163102977|NCT00861757|589082996|FG003|Overall Study|Adverse Event|2|||
163102978|NCT00861757|589082993|FG000|Overall Study|Entry Criteria Not Met|1|||
163102979|NCT00861757|589082994|FG001|Overall Study|Entry Criteria Not Met|2|||
163102980|NCT00861757|589082995|FG002|Overall Study|Entry Criteria Not Met|1|||
163102981|NCT00861757|589082996|FG003|Overall Study|Entry Criteria Not Met|1|||
162653548|NCT02457598|587447609|FG009|Overall Study|Unacceptable Toxicity|0|||
163102982|NCT00861757|589082993|FG000|Overall Study|Lack of Efficacy|3|||
163102983|NCT00861757|589082994|FG001|Overall Study|Lack of Efficacy|1|||
163102984|NCT00861757|589082995|FG002|Overall Study|Lack of Efficacy|0|||
163102985|NCT00861757|589082996|FG003|Overall Study|Lack of Efficacy|1|||
163102986|NCT00861757|589082993|FG000|Overall Study|Lost to Follow-up|1|||
163102987|NCT00861757|589082994|FG001|Overall Study|Lost to Follow-up|0|||
163102988|NCT00861757|589082995|FG002|Overall Study|Lost to Follow-up|1|||
162653549|NCT02457598|587447610|FG010|Overall Study|Unacceptable Toxicity|1|||
163102989|NCT00861757|589082996|FG003|Overall Study|Lost to Follow-up|1|||
163102990|NCT00861757|589082993|FG000|Overall Study|Physician Decision|0|||
163102991|NCT00861757|589082994|FG001|Overall Study|Physician Decision|0|||
163102992|NCT00861757|589082995|FG002|Overall Study|Physician Decision|0|||
163102993|NCT00861757|589082996|FG003|Overall Study|Physician Decision|1|||
163102994|NCT00861757|589082993|FG000|Overall Study|Protocol Violation|2|||
163102995|NCT00861757|589082994|FG001|Overall Study|Protocol Violation|2|||
163102996|NCT00861757|589082995|FG002|Overall Study|Protocol Violation|4|||
163102997|NCT00861757|589082996|FG003|Overall Study|Protocol Violation|1|||
163102998|NCT00861757|589082993|FG000|Overall Study|Withdrawal by Subject|1|||
163102999|NCT00861757|589082994|FG001|Overall Study|Withdrawal by Subject|5|||
163103000|NCT00861757|589082995|FG002|Overall Study|Withdrawal by Subject|5|||
163103001|NCT00861757|589082996|FG003|Overall Study|Withdrawal by Subject|2|||
163103002|NCT02141633|589082997|FG000|Overall Study|Physician Decision|1|||
163103003|NCT02141633|589082998|FG001|Overall Study|Physician Decision|0|||
163103004|NCT04908384|589082999|FG000|Overall Study|Lost to Follow-up|4|||
163103005|NCT04908384|589083000|FG001|Overall Study|Lost to Follow-up|4|||
163103006|NCT04908384|589083001|FG002|Overall Study|Lost to Follow-up|0|||
163103007|NCT04908384|589083002|FG003|Overall Study|Lost to Follow-up|0|||
163103008|NCT00833469|589083003|FG000|Overall Study|Withdrawal by Subject|1|||
163103009|NCT00833469|589083003|FG000|Overall Study|Lost to Follow-up|1|||
163103010|NCT02943070|589083004|FG000|Overall Study|Physician Decision|1|||
163103011|NCT02943070|589083004|FG000|Overall Study|Adverse Event|2|||
163103012|NCT02943070|589083004|FG000|Overall Study|Death|2|||
163103013|NCT02943070|589083004|FG000|Overall Study|Withdrawal by Subject|3|||
163103014|NCT02943070|589083004|FG000|Overall Study|Lost to Follow-up|4|||
163103015|NCT02943070|589083004|FG000|Overall Study|Retreatment or TURP|13|||
163103016|NCT02943070|589083004|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
163103017|NCT01701362|589083005|FG000|Overall Study|Adverse events not related to study drug|1|||
163103018|NCT01701362|589083006|FG001|Overall Study|Adverse events not related to study drug|6|||
163103019|NCT01701362|589083005|FG000|Overall Study|Adverse events related to study drug|12|||
163103020|NCT01701362|589083006|FG001|Overall Study|Adverse events related to study drug|10|||
163103021|NCT01701362|589083005|FG000|Overall Study|Protocol Violation|5|||
163103022|NCT01701362|589083006|FG001|Overall Study|Protocol Violation|3|||
163103023|NCT01701362|589083005|FG000|Overall Study|No longer willing to participate|8|||
163103024|NCT01701362|589083006|FG001|Overall Study|No longer willing to participate|14|||
163103025|NCT01701362|589083005|FG000|Overall Study|Lost to Follow-up|6|||
163103026|NCT01701362|589083006|FG001|Overall Study|Lost to Follow-up|9|||
163103027|NCT01701362|589083005|FG000|Overall Study|Insufficient clinical response|6|||
163103028|NCT01701362|589083006|FG001|Overall Study|Insufficient clinical response|6|||
163103029|NCT01701362|589083005|FG000|Overall Study|Death|0|||
163103030|NCT01701362|589083006|FG001|Overall Study|Death|1|||
163103031|NCT01701362|589083005|FG000|Overall Study|Randomized but not treated|1|||
163103032|NCT01701362|589083006|FG001|Overall Study|Randomized but not treated|2|||
163103033|NCT01701362|589083005|FG000|Overall Study|Reasons other than those mentioned above|3|||
163103034|NCT01701362|589083006|FG001|Overall Study|Reasons other than those mentioned above|5|||
163103035|NCT00570778|589083007|FG000|Overall Study|Protocol deviation|2|||
163103036|NCT00570778|589083008|FG001|Overall Study|Protocol deviation|1|||
163103037|NCT00570778|589083009|FG002|Overall Study|Protocol deviation|2|||
163103038|NCT00570778|589083010|FG003|Overall Study|Protocol deviation|2|||
163103039|NCT00570778|589083007|FG000|Overall Study|Adverse Event|0|||
163103040|NCT00570778|589083008|FG001|Overall Study|Adverse Event|1|||
163103041|NCT00570778|589083009|FG002|Overall Study|Adverse Event|4|||
163103042|NCT00570778|589083010|FG003|Overall Study|Adverse Event|1|||
163103043|NCT00570778|589083007|FG000|Overall Study|Subject withdrew consent|0|||
163103044|NCT00570778|589083008|FG001|Overall Study|Subject withdrew consent|1|||
163103045|NCT00570778|589083009|FG002|Overall Study|Subject withdrew consent|0|||
163103046|NCT00570778|589083010|FG003|Overall Study|Subject withdrew consent|1|||
163103047|NCT00570778|589083007|FG000|Overall Study|Abnormal test procedure|1|||
163103048|NCT00570778|589083008|FG001|Overall Study|Abnormal test procedure|0|||
163103049|NCT00570778|589083009|FG002|Overall Study|Abnormal test procedure|0|||
163103050|NCT00570778|589083010|FG003|Overall Study|Abnormal test procedure|0|||
163103051|NCT00570778|589083007|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163103052|NCT00570778|589083008|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163103053|NCT00570778|589083009|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163103054|NCT00570778|589083010|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163103055|NCT00570778|589083007|FG000|Overall Study|Lost to Follow-up|0|||
163103056|NCT00570778|589083008|FG001|Overall Study|Lost to Follow-up|0|||
163103057|NCT00570778|589083009|FG002|Overall Study|Lost to Follow-up|1|||
163103058|NCT00570778|589083010|FG003|Overall Study|Lost to Follow-up|0|||
163103059|NCT00570778|589083007|FG000|Overall Study|Subject no longer requires study drug|0|||
163103060|NCT00570778|589083008|FG001|Overall Study|Subject no longer requires study drug|1|||
163103061|NCT00570778|589083009|FG002|Overall Study|Subject no longer requires study drug|0|||
163103062|NCT00570778|589083010|FG003|Overall Study|Subject no longer requires study drug|0|||
163103063|NCT00443872|589083013|FG000|Overall Study|Protocol Violation|7|||
163103064|NCT00443872|589083013|FG000|Overall Study|Lost to Follow-up|2|||
162719069|NCT01867580|587676765|FG000|Overall Study|Lost to Follow-up|3|||
162719070|NCT01867580|587676766|FG001|Overall Study|Lost to Follow-up|5|||
162719071|NCT01867580|587676765|FG000|Overall Study|Sponsor terminated study|1|||
162719072|NCT01867580|587676766|FG001|Overall Study|Sponsor terminated study|0|||
163103065|NCT00443872|589083013|FG000|Overall Study|Adverse Event|8|||
163103066|NCT01014767|589083014|FG000|Overall Study|PI left institution, data unavailable|12|||
163103067|NCT01014767|589083015|FG001|Overall Study|PI left institution, data unavailable|1|||
163103068|NCT01014767|589083016|FG002|Overall Study|PI left institution, data unavailable|4|||
163103069|NCT01014767|589083017|FG003|Overall Study|PI left institution, data unavailable|1|||
163103070|NCT00700622|589083018|FG000|Overall Study|Adverse Event|4|||
163103071|NCT00700622|589083019|FG001|Overall Study|Adverse Event|0|||
163103072|NCT00700622|589083018|FG000|Overall Study|Lost to Follow-up|0|||
163103073|NCT00700622|589083019|FG001|Overall Study|Lost to Follow-up|1|||
163103074|NCT00700622|589083018|FG000|Overall Study|Physician Decision|2|||
163103075|NCT00700622|589083019|FG001|Overall Study|Physician Decision|1|||
163103076|NCT00700622|589083018|FG000|Overall Study|Protocol Violation|0|||
163103077|NCT00700622|589083019|FG001|Overall Study|Protocol Violation|1|||
163103078|NCT00700622|589083018|FG000|Overall Study|Withdrawal by Subject|4|||
163103079|NCT00700622|589083019|FG001|Overall Study|Withdrawal by Subject|1|||
163103080|NCT00700622|589083018|FG000|Overall Study|Other|3|||
163103081|NCT00700622|589083019|FG001|Overall Study|Other|1|||
163103082|NCT00282087|589083020|FG000|Overall Study|Death|1|||
163103083|NCT00405392|589083021|FG000|Overall Study|Adverse Event|15|||
163103084|NCT00405392|589083022|FG001|Overall Study|Adverse Event|14|||
163103085|NCT00405392|589083021|FG000|Overall Study|Did not meet Eligibility criteria|7|||
163103086|NCT00405392|589083022|FG001|Overall Study|Did not meet Eligibility criteria|2|||
163103087|NCT00405392|589083021|FG000|Overall Study|Withdrawal by Subject|4|||
163103088|NCT00405392|589083022|FG001|Overall Study|Withdrawal by Subject|3|||
163103089|NCT00405392|589083021|FG000|Overall Study|Lost to Follow-up|1|||
163103090|NCT00405392|589083022|FG001|Overall Study|Lost to Follow-up|2|||
163103091|NCT00405392|589083021|FG000|Overall Study|Data missing|2|||
163103092|NCT00405392|589083022|FG001|Overall Study|Data missing|0|||
163103093|NCT00405392|589083021|FG000|Overall Study|Non-compliance|0|||
163103094|NCT00405392|589083022|FG001|Overall Study|Non-compliance|1|||
163103095|NCT00405392|589083021|FG000|Overall Study|Other|1|||
163103096|NCT00405392|589083022|FG001|Overall Study|Other|5|||
163103097|NCT01703091|589083025|FG000|Overall Study|Adverse Event|5|||
163103098|NCT01703091|589083026|FG001|Overall Study|Adverse Event|3|||
163103099|NCT01703091|589083025|FG000|Overall Study|Physician Decision|2|||
163103100|NCT01703091|589083026|FG001|Overall Study|Physician Decision|1|||
163103101|NCT01703091|589083025|FG000|Overall Study|Withdrawal by Subject|1|||
163103102|NCT01703091|589083026|FG001|Overall Study|Withdrawal by Subject|0|||
163103103|NCT01703091|589083025|FG000|Overall Study|Sponsor Decision|1|||
163103104|NCT01703091|589083026|FG001|Overall Study|Sponsor Decision|0|||
163103105|NCT02550288|589083027|FG000|Overall Study|Adverse Event|0|||
163103106|NCT02550288|589083028|FG001|Overall Study|Adverse Event|1|||
163103107|NCT02550288|589083029|FG002|Overall Study|Adverse Event|0|||
163103108|NCT02550288|589083030|FG003|Overall Study|Adverse Event|0|||
163103109|NCT02550288|589083031|FG004|Overall Study|Adverse Event|0|||
163103110|NCT02550288|589083027|FG000|Overall Study|Physician Decision|0|||
163103111|NCT02550288|589083028|FG001|Overall Study|Physician Decision|0|||
163103112|NCT02550288|589083029|FG002|Overall Study|Physician Decision|0|||
163103113|NCT02550288|589083030|FG003|Overall Study|Physician Decision|1|||
163103114|NCT02550288|589083031|FG004|Overall Study|Physician Decision|0|||
163103115|NCT02550288|589083027|FG000|Overall Study|Protocol Violation|2|||
162719073|NCT01867580|587676765|FG000|Overall Study|Missed follow-up assessment|2|||
163103116|NCT02550288|589083028|FG001|Overall Study|Protocol Violation|2|||
163103117|NCT02550288|589083029|FG002|Overall Study|Protocol Violation|1|||
163103118|NCT02550288|589083030|FG003|Overall Study|Protocol Violation|0|||
163103119|NCT02550288|589083031|FG004|Overall Study|Protocol Violation|3|||
163103120|NCT02550288|589083027|FG000|Overall Study|Participant moved|0|||
163103121|NCT02550288|589083028|FG001|Overall Study|Participant moved|0|||
163103122|NCT02550288|589083029|FG002|Overall Study|Participant moved|0|||
163103123|NCT02550288|589083030|FG003|Overall Study|Participant moved|1|||
163103124|NCT02550288|589083031|FG004|Overall Study|Participant moved|0|||
163103125|NCT02550288|589083027|FG000|Overall Study|Withdrawal by Subject|0|||
163103126|NCT02550288|589083028|FG001|Overall Study|Withdrawal by Subject|0|||
163103127|NCT02550288|589083029|FG002|Overall Study|Withdrawal by Subject|0|||
163103128|NCT02550288|589083030|FG003|Overall Study|Withdrawal by Subject|1|||
162719074|NCT01867580|587676766|FG001|Overall Study|Missed follow-up assessment|1|||
163103129|NCT02550288|589083031|FG004|Overall Study|Withdrawal by Subject|0|||
162719075|NCT01867580|587676765|FG000|Overall Study|Interruption to therapy|3|||
162719076|NCT01867580|587676766|FG001|Overall Study|Interruption to therapy|0|||
163103130|NCT00988052|589083032|FG000|Overall Study|Missing|1|||
163103131|NCT00988052|589083033|FG001|Overall Study|Missing|0|||
163103132|NCT00988052|589083032|FG000|Overall Study|Teva requested subject withdrawal|3|||
163103133|NCT00988052|589083033|FG001|Overall Study|Teva requested subject withdrawal|1|||
163103134|NCT00988052|589083032|FG000|Overall Study|Death|1|||
163103135|NCT00988052|589083033|FG001|Overall Study|Death|3|||
162653550|NCT02457598|587447611|FG011|Overall Study|Unacceptable Toxicity|0|||
162653551|NCT02457598|587447612|FG012|Overall Study|Unacceptable Toxicity|1|||
162653552|NCT02457598|587447613|FG013|Overall Study|Unacceptable Toxicity|1|||
162653553|NCT02457598|587447614|FG014|Overall Study|Unacceptable Toxicity|1|||
162653554|NCT02457598|587447615|FG015|Overall Study|Unacceptable Toxicity|0|||
162653555|NCT02457598|587447616|FG016|Overall Study|Unacceptable Toxicity|0|||
162653556|NCT02457598|587447600|FG000|Overall Study|Intercurrent Illness|0|||
163103136|NCT00988052|589083032|FG000|Overall Study|Protocol Violation|6|||
163103137|NCT00988052|589083033|FG001|Overall Study|Protocol Violation|5|||
163103138|NCT00988052|589083032|FG000|Overall Study|Pregnancy|6|||
163103139|NCT00988052|589083033|FG001|Overall Study|Pregnancy|6|||
163103140|NCT00988052|589083032|FG000|Overall Study|Lack of Efficacy|8|||
163103141|NCT00988052|589083033|FG001|Overall Study|Lack of Efficacy|7|||
163103142|NCT00988052|589083032|FG000|Overall Study|Lost to Follow-up|6|||
163103143|NCT00988052|589083033|FG001|Overall Study|Lost to Follow-up|11|||
163103144|NCT00988052|589083032|FG000|Overall Study|Physician Decision|27|||
163103145|NCT00988052|589083033|FG001|Overall Study|Physician Decision|28|||
163103146|NCT00988052|589083032|FG000|Overall Study|Adverse Event|35|||
163103147|NCT00988052|589083033|FG001|Overall Study|Adverse Event|28|||
163103148|NCT00988052|589083032|FG000|Overall Study|Withdrawal by Subject|90|||
163103149|NCT00988052|589083033|FG001|Overall Study|Withdrawal by Subject|91|||
163103150|NCT00988052|589083032|FG000|Overall Study|Study terminated by sponsor|240|||
163103151|NCT00988052|589083033|FG001|Overall Study|Study terminated by sponsor|236|||
163103152|NCT00842153|589083034|FG000|Overall Study|Adverse Event|0|||
163103153|NCT00842153|589083035|FG001|Overall Study|Adverse Event|1|||
163103154|NCT00842153|589083034|FG000|Overall Study|Lost to Follow-up|1|||
163103155|NCT00842153|589083035|FG001|Overall Study|Lost to Follow-up|2|||
163103156|NCT05312697|589083037|FG000|Overall Study|Sponsor Terminated Trial|2|||
163103157|NCT02858440|589083038|FG000|Overall Study|Lost to Follow-up|3|||
163103158|NCT02858440|589083038|FG000|Overall Study|Protocol Violation|2|||
163103159|NCT02858440|589083038|FG000|Overall Study|Consent withdrawal|3|||
163103160|NCT02858440|589083038|FG000|Overall Study|Migrated/moved from study area|4|||
163103161|NCT00402324|589083039|FG000|Overall Study|Lost to Follow-up|11|||
163103162|NCT00402324|589083040|FG001|Overall Study|Lost to Follow-up|11|||
163103163|NCT00402324|589083039|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
163103164|NCT00402324|589083040|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
163103165|NCT00402324|589083039|FG000|Overall Study|Protocol Violation|8|||
163103166|NCT00402324|589083040|FG001|Overall Study|Protocol Violation|7|||
163103167|NCT00402324|589083039|FG000|Overall Study|Withdrawal by Subject|5|||
163103168|NCT00402324|589083040|FG001|Overall Study|Withdrawal by Subject|2|||
163103169|NCT00402324|589083039|FG000|Overall Study|Physician Decision|2|||
163103170|NCT00402324|589083040|FG001|Overall Study|Physician Decision|4|||
163103171|NCT00402324|589083039|FG000|Overall Study|Sponsor Decision|4|||
163103172|NCT00402324|589083040|FG001|Overall Study|Sponsor Decision|5|||
163103173|NCT00402324|589083039|FG000|Overall Study|Lack of Efficacy|1|||
163103174|NCT00402324|589083040|FG001|Overall Study|Lack of Efficacy|4|||
163103175|NCT00402324|589083039|FG000|Overall Study|Adverse Event|6|||
163103176|NCT00402324|589083040|FG001|Overall Study|Adverse Event|4|||
163103177|NCT00402324|589083039|FG000|Overall Study|Death|1|||
163103178|NCT00402324|589083040|FG001|Overall Study|Death|0|||
163103179|NCT01277822|589083041|FG000|Overall Study|Adverse Event|2|||
163103180|NCT01277822|589083042|FG001|Overall Study|Adverse Event|1|||
163103181|NCT01277822|589083041|FG000|Overall Study|Withdrawal by Subject|6|||
163103182|NCT01277822|589083042|FG001|Overall Study|Withdrawal by Subject|7|||
163103183|NCT01277822|589083041|FG000|Overall Study|Physician Decision|1|||
163103184|NCT01277822|589083042|FG001|Overall Study|Physician Decision|1|||
163103185|NCT01277822|589083041|FG000|Overall Study|Protocol Violation|1|||
163103186|NCT01277822|589083042|FG001|Overall Study|Protocol Violation|0|||
163103187|NCT01277822|589083041|FG000|Overall Study|Lost to Follow-up|2|||
163103188|NCT01277822|589083042|FG001|Overall Study|Lost to Follow-up|1|||
163103189|NCT01277822|589083041|FG000|Overall Study|Contraindicated medication used|2|||
163103190|NCT01277822|589083042|FG001|Overall Study|Contraindicated medication used|1|||
163103191|NCT01277822|589083041|FG000|Overall Study|Participant moved|1|||
163103192|NCT01277822|589083042|FG001|Overall Study|Participant moved|0|||
162653557|NCT02457598|587447601|FG001|Overall Study|Intercurrent Illness|0|||
162653558|NCT02457598|587447602|FG002|Overall Study|Intercurrent Illness|0|||
162719077|NCT01867580|587676765|FG000|Overall Study|Osteomyelitis|0|||
162719078|NCT01867580|587676766|FG001|Overall Study|Osteomyelitis|1|||
162719079|NCT01867580|587676765|FG000|Overall Study|Continuation of therapy|0|||
162719080|NCT01867580|587676766|FG001|Overall Study|Continuation of therapy|1|||
163103193|NCT00997984|589083043|FG000|Overall Study|Adverse Event|1|||
163103194|NCT00997984|589083044|FG001|Overall Study|Adverse Event|8|||
162719081|NCT01867580|587676765|FG000|Overall Study|Wound recurrence|0|||
163103195|NCT00997984|589083045|FG002|Overall Study|Adverse Event|8|||
163103196|NCT00997984|589083043|FG000|Overall Study|Protocol Violation|1|||
163103197|NCT00997984|589083044|FG001|Overall Study|Protocol Violation|3|||
163103198|NCT00997984|589083045|FG002|Overall Study|Protocol Violation|0|||
163103199|NCT00997984|589083043|FG000|Overall Study|Withdrawal by Subject|6|||
163103200|NCT00997984|589083044|FG001|Overall Study|Withdrawal by Subject|9|||
163103201|NCT00997984|589083045|FG002|Overall Study|Withdrawal by Subject|5|||
163103202|NCT00997984|589083043|FG000|Overall Study|Lost to Follow-up|8|||
163103203|NCT00997984|589083044|FG001|Overall Study|Lost to Follow-up|5|||
163103204|NCT00997984|589083045|FG002|Overall Study|Lost to Follow-up|4|||
163103205|NCT00997984|589083043|FG000|Overall Study|Lack of Efficacy|20|||
163103206|NCT00997984|589083044|FG001|Overall Study|Lack of Efficacy|6|||
163103207|NCT00997984|589083045|FG002|Overall Study|Lack of Efficacy|3|||
163103208|NCT00997984|589083043|FG000|Overall Study|Met exclusion criteria|1|||
163103209|NCT00997984|589083044|FG001|Overall Study|Met exclusion criteria|0|||
163103210|NCT00997984|589083045|FG002|Overall Study|Met exclusion criteria|0|||
163103211|NCT00997984|589083043|FG000|Overall Study|non-compliance|0|||
163103212|NCT00997984|589083044|FG001|Overall Study|non-compliance|2|||
163103213|NCT00997984|589083045|FG002|Overall Study|non-compliance|3|||
163103214|NCT00997984|589083043|FG000|Overall Study|Wrong medication dispensed|0|||
163103215|NCT00997984|589083044|FG001|Overall Study|Wrong medication dispensed|1|||
163103216|NCT00997984|589083045|FG002|Overall Study|Wrong medication dispensed|0|||
163103217|NCT00997984|589083043|FG000|Overall Study|Suicidal ideation|0|||
163103218|NCT00997984|589083044|FG001|Overall Study|Suicidal ideation|0|||
163103219|NCT00997984|589083045|FG002|Overall Study|Suicidal ideation|1|||
163103220|NCT00997984|589083043|FG000|Overall Study|Work schedule|0|||
163103221|NCT00997984|589083044|FG001|Overall Study|Work schedule|0|||
163103222|NCT00997984|589083045|FG002|Overall Study|Work schedule|2|||
163103223|NCT01945996|589083047|FG000|Overall Study|Lost to Follow-up|3|||
163103224|NCT01945996|589083048|FG001|Overall Study|Lost to Follow-up|5|||
163103225|NCT04396795|589083050|FG000|Month 1|Lost to Follow-up|2|||
163103226|NCT04396795|589083051|FG001|Month 1|Lost to Follow-up|3|||
163103227|NCT04396795|589083050|FG000|Month 3|Lost to Follow-up|1|||
163103228|NCT04396795|589083051|FG001|Month 3|Lost to Follow-up|3|||
163103229|NCT04396795|589083050|FG000|Month 6|Lost to Follow-up|3|||
163103230|NCT04396795|589083051|FG001|Month 6|Lost to Follow-up|3|||
163103231|NCT02484443|589083052|FG000|Overall Study|Lack of Efficacy|28|||
163103232|NCT02484443|589083052|FG000|Overall Study|Physician Decision|2|||
163103233|NCT02484443|589083052|FG000|Overall Study|Ineligible|2|||
163103234|NCT01970241|589083053|FG000|Overall Study|Withdrawal by Subject|2|||
163103235|NCT01970241|589083054|FG001|Overall Study|Withdrawal by Subject|0|||
163103236|NCT01970241|589083053|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
163103237|NCT01970241|589083054|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
163103238|NCT02595866|589083055|FG000|Overall Study|Adverse Event|2|||
163103239|NCT02595866|589083056|FG001|Overall Study|Adverse Event|5|||
163103240|NCT02595866|589083055|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
163103241|NCT02595866|589083056|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
163103242|NCT02595866|589083055|FG000|Overall Study|Death|0|||
163103243|NCT02595866|589083056|FG001|Overall Study|Death|1|||
163103244|NCT02595866|589083055|FG000|Overall Study|Incarceration|1|||
163103245|NCT02595866|589083056|FG001|Overall Study|Incarceration|0|||
163103246|NCT02595866|589083055|FG000|Overall Study|Lack of Efficacy|17|||
163103247|NCT02595866|589083056|FG001|Overall Study|Lack of Efficacy|7|||
163103248|NCT02595866|589083055|FG000|Overall Study|Physician Decision|4|||
163103249|NCT02595866|589083056|FG001|Overall Study|Physician Decision|3|||
163103250|NCT02595866|589083055|FG000|Overall Study|Switched to Alternative Treatment|1|||
163103251|NCT02595866|589083056|FG001|Overall Study|Switched to Alternative Treatment|0|||
163103252|NCT02595866|589083055|FG000|Overall Study|Study Terminated|0|||
163103253|NCT02595866|589083056|FG001|Overall Study|Study Terminated|4|||
163103254|NCT02595866|589083055|FG000|Overall Study|Withdrawal by Subject|6|||
163103255|NCT02595866|589083056|FG001|Overall Study|Withdrawal by Subject|1|||
163103256|NCT01107392|589083057|FG000|Overall Study|Adverse Event|2|||
163103257|NCT01107392|589083058|FG001|Overall Study|Adverse Event|0|||
163103258|NCT01107392|589083057|FG000|Overall Study|Personal Reasons|2|||
163103259|NCT01107392|589083058|FG001|Overall Study|Personal Reasons|3|||
163103260|NCT01107392|589083057|FG000|Overall Study|Administrative decision|1|||
163103261|NCT01107392|589083058|FG001|Overall Study|Administrative decision|0|||
163103262|NCT02689206|589083062|FG000|Overall Study|Adverse Event|0|||
163103263|NCT02689206|589083063|FG001|Overall Study|Adverse Event|0|||
163103264|NCT02689206|589083064|FG002|Overall Study|Adverse Event|1|||
163103265|NCT02689206|589083065|FG003|Overall Study|Adverse Event|0|||
163103266|NCT02689206|589083066|FG004|Overall Study|Adverse Event|2|||
163103267|NCT02689206|589083062|FG000|Overall Study|Protocol Violation|1|||
163103268|NCT02689206|589083063|FG001|Overall Study|Protocol Violation|0|||
163103269|NCT02689206|589083064|FG002|Overall Study|Protocol Violation|0|||
163103270|NCT02689206|589083065|FG003|Overall Study|Protocol Violation|1|||
162653559|NCT02457598|587447603|FG003|Overall Study|Intercurrent Illness|0|||
162653560|NCT02457598|587447604|FG004|Overall Study|Intercurrent Illness|0|||
163103271|NCT02689206|589083066|FG004|Overall Study|Protocol Violation|2|||
163103272|NCT02689206|589083062|FG000|Overall Study|Other: Reached stopping criteria|0|||
163103273|NCT02689206|589083063|FG001|Overall Study|Other: Reached stopping criteria|1|||
163103274|NCT02689206|589083064|FG002|Overall Study|Other: Reached stopping criteria|2|||
163103275|NCT02689206|589083065|FG003|Overall Study|Other: Reached stopping criteria|3|||
163103276|NCT02689206|589083066|FG004|Overall Study|Other: Reached stopping criteria|4|||
163103277|NCT02689206|589083062|FG000|Overall Study|Physician Decision|1|||
163103278|NCT02689206|589083063|FG001|Overall Study|Physician Decision|0|||
163103279|NCT02689206|589083064|FG002|Overall Study|Physician Decision|0|||
163103280|NCT02689206|589083065|FG003|Overall Study|Physician Decision|0|||
163103281|NCT02689206|589083066|FG004|Overall Study|Physician Decision|0|||
163103282|NCT02689206|589083062|FG000|Overall Study|Withdrawal by Subject|1|||
163103283|NCT02689206|589083063|FG001|Overall Study|Withdrawal by Subject|0|||
163103284|NCT02689206|589083064|FG002|Overall Study|Withdrawal by Subject|1|||
163103285|NCT02689206|589083065|FG003|Overall Study|Withdrawal by Subject|0|||
163103286|NCT02689206|589083066|FG004|Overall Study|Withdrawal by Subject|0|||
163103287|NCT02520388|589083067|FG000|Overall Study|Physician Decision|1|||
163103288|NCT02520388|589083068|FG001|Overall Study|Physician Decision|0|||
163103289|NCT02520388|589083067|FG000|Overall Study|Subject or parent/guardian request|0|||
163103290|NCT02520388|589083068|FG001|Overall Study|Subject or parent/guardian request|6|||
163103291|NCT02520388|589083067|FG000|Overall Study|Adverse Event|1|||
163103292|NCT02520388|589083068|FG001|Overall Study|Adverse Event|4|||
163103293|NCT02520388|589083067|FG000|Overall Study|Lost to Follow-up|3|||
163103294|NCT02520388|589083068|FG001|Overall Study|Lost to Follow-up|2|||
163103295|NCT02520388|589083067|FG000|Overall Study|Other (reason not defined)|4|||
163103296|NCT02520388|589083068|FG001|Overall Study|Other (reason not defined)|4|||
163103297|NCT02131311|589083069|FG000|Overall Study|Adverse Event|2|||
163103298|NCT02131311|589083069|FG000|Overall Study|Protocol Violation|1|||
163103299|NCT02131311|589083069|FG000|Overall Study|Lost to Follow-up|1|||
163103300|NCT01479764|589083070|FG000|Randomized|Adverse Event|1|||
163103301|NCT01479764|589083071|FG001|Randomized|Adverse Event|1|||
163103302|NCT01479764|589083070|FG000|Randomized|Withdrawal by Subject|1|||
163103303|NCT01479764|589083071|FG001|Randomized|Withdrawal by Subject|0|||
163103304|NCT01479764|589083070|FG000|Treated|Lost to Follow-up|0|||
163103305|NCT01479764|589083071|FG001|Treated|Lost to Follow-up|2|||
163103306|NCT00255723|589083073|FG000|Overall Study|Adverse Event|1|||
163103307|NCT00255723|589083074|FG001|Overall Study|Adverse Event|1|||
163103308|NCT00255723|589083073|FG000|Overall Study|Death|0|||
163103309|NCT00255723|589083074|FG001|Overall Study|Death|1|||
163103310|NCT00255723|589083073|FG000|Overall Study|Response Data Not Available|1|||
163103311|NCT00255723|589083074|FG001|Overall Study|Response Data Not Available|0|||
163103312|NCT03711370|589083075|FG000|Overall Study|Lost to Follow-up|16|||
163103313|NCT03711370|589083076|FG001|Overall Study|Lost to Follow-up|10|||
163103314|NCT03711370|589083075|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
163103315|NCT03711370|589083076|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
163103316|NCT00431444|589083080|FG000|Overall Study|Protocol Violation|1|||
163103317|NCT00431444|589083081|FG001|Overall Study|Protocol Violation|4|||
163103318|NCT00431444|589083080|FG000|Overall Study|Adverse Event|2|||
163103319|NCT00431444|589083081|FG001|Overall Study|Adverse Event|1|||
163103320|NCT00431444|589083080|FG000|Overall Study|Withdrawal by Subject|1|||
163103321|NCT00431444|589083081|FG001|Overall Study|Withdrawal by Subject|1|||
163103322|NCT00431444|589083080|FG000|Overall Study|Lost to Follow-up|1|||
163103323|NCT00431444|589083081|FG001|Overall Study|Lost to Follow-up|0|||
163103324|NCT00431444|589083080|FG000|Overall Study|Administrative Problems|0|||
162653561|NCT02457598|587447605|FG005|Overall Study|Intercurrent Illness|0|||
162653562|NCT02457598|587447606|FG006|Overall Study|Intercurrent Illness|0|||
162653563|NCT02457598|587447607|FG007|Overall Study|Intercurrent Illness|0|||
162653564|NCT02457598|587447608|FG008|Overall Study|Intercurrent Illness|0|||
162653565|NCT02457598|587447609|FG009|Overall Study|Intercurrent Illness|0|||
162653566|NCT02457598|587447610|FG010|Overall Study|Intercurrent Illness|1|||
162653567|NCT02457598|587447611|FG011|Overall Study|Intercurrent Illness|0|||
162653568|NCT02457598|587447612|FG012|Overall Study|Intercurrent Illness|0|||
163103325|NCT00431444|589083081|FG001|Overall Study|Administrative Problems|1|||
163103326|NCT00130039|589083083|FG000|Overall Study|Withdrawal by Subject|15|||
163103327|NCT00130039|589083084|FG001|Overall Study|Withdrawal by Subject|11|||
163103328|NCT00130039|589083083|FG000|Overall Study|Lost to Follow-up|3|||
163103329|NCT00130039|589083084|FG001|Overall Study|Lost to Follow-up|1|||
163103330|NCT00130039|589083083|FG000|Overall Study|Adverse Event|4|||
163103331|NCT00130039|589083084|FG001|Overall Study|Adverse Event|2|||
162653569|NCT02457598|587447613|FG013|Overall Study|Intercurrent Illness|0|||
162653570|NCT02457598|587447614|FG014|Overall Study|Intercurrent Illness|0|||
163103332|NCT00130039|589083083|FG000|Overall Study|Physician Decision|3|||
163103333|NCT00130039|589083084|FG001|Overall Study|Physician Decision|0|||
163103334|NCT00130039|589083083|FG000|Overall Study|clinical events without follow up MRI|5|||
163103335|NCT00130039|589083084|FG001|Overall Study|clinical events without follow up MRI|4|||
163103336|NCT01740687|589083085|FG000|Overall Study|Lost to Follow-up|11|||
163103337|NCT01740687|589083085|FG000|Overall Study|Withdrawal by Subject|2|||
163103338|NCT01740687|589083085|FG000|Overall Study|other reason|22|||
163103339|NCT01740687|589083085|FG000|Overall Study|treatment not received|2|||
163103340|NCT00200967|589083087|FG000|First Treatment Period|Withdrawal by Subject|5|||
163103341|NCT00200967|589083088|FG001|First Treatment Period|Withdrawal by Subject|1|||
163103342|NCT00200967|589083087|FG000|First Treatment Period|Pregnancy|1|||
163103343|NCT00200967|589083088|FG001|First Treatment Period|Pregnancy|0|||
163103344|NCT00200967|589083087|FG000|Wash-out Period|Lost to Follow-up|0|||
163103345|NCT00200967|589083088|FG001|Wash-out Period|Lost to Follow-up|1|||
163103346|NCT00200967|589083087|FG000|Second Treatment Period|Withdrawal by Subject|1|||
163103347|NCT00200967|589083088|FG001|Second Treatment Period|Withdrawal by Subject|2|||
163103348|NCT00200967|589083087|FG000|Run-out Period|Lost to Follow-up|1|||
163103349|NCT00200967|589083088|FG001|Run-out Period|Lost to Follow-up|0|||
163103350|NCT00928187|589083089|FG000|Overall Study|Death|1|||
163103351|NCT00928187|589083090|FG001|Overall Study|Death|2|||
163103352|NCT00928187|589083091|FG002|Overall Study|Death|3|||
163103353|NCT00928187|589083089|FG000|Overall Study|Lost to Follow-up|1|||
163103354|NCT00928187|589083090|FG001|Overall Study|Lost to Follow-up|2|||
163103355|NCT00928187|589083091|FG002|Overall Study|Lost to Follow-up|1|||
163103356|NCT00928187|589083089|FG000|Overall Study|Withdrawal by Subject|0|||
163103357|NCT00928187|589083090|FG001|Overall Study|Withdrawal by Subject|1|||
163103358|NCT00928187|589083091|FG002|Overall Study|Withdrawal by Subject|1|||
163103359|NCT00928187|589083089|FG000|Overall Study|Protocol Violation|0|||
163103360|NCT00928187|589083090|FG001|Overall Study|Protocol Violation|1|||
163103361|NCT00928187|589083091|FG002|Overall Study|Protocol Violation|0|||
163103362|NCT03062280|589084509|FG000|Overall Study|Adverse Event|1|||
163103363|NCT03062280|589084509|FG000|Overall Study|Death|1|||
163103364|NCT03062280|589084509|FG000|Overall Study|Fertility Treatment|2|||
163103365|NCT03062280|589084509|FG000|Overall Study|Physician Decision|2|||
163103366|NCT03062280|589084509|FG000|Overall Study|Pregnancy|5|||
163103367|NCT03062280|589084509|FG000|Overall Study|Withdrawal by Subject|11|||
163103368|NCT00336284|589084510|FG000|Overall Study|Death|52|||
163103369|NCT00336284|589084511|FG001|Overall Study|Death|26|||
163103370|NCT00336284|589084510|FG000|Overall Study|Lost to Follow-up|82|||
163103371|NCT00336284|589084511|FG001|Overall Study|Lost to Follow-up|61|||
163103372|NCT00336284|589084510|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
163103373|NCT00336284|589084511|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
163103374|NCT04123093|589084512|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
163103375|NCT04123093|589084513|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
163103376|NCT04123093|589084512|FG000|Phase 2|Physician Decision|0|||
163103377|NCT04123093|589084513|FG001|Phase 2|Physician Decision|1|||
163103378|NCT04123093|589084512|FG000|Phase 2|Withdrawal by Subject|0|||
163103379|NCT04123093|589084513|FG001|Phase 2|Withdrawal by Subject|1|||
163103380|NCT03462641|589084517|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
163103381|NCT03462641|589084518|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
163103382|NCT03462641|589084517|FG000|Visit 2|Withdrawal by Subject|0|||
163103383|NCT03462641|589084518|FG001|Visit 2|Withdrawal by Subject|1|||
163103384|NCT00022763|589084529|FG000|Overall Study|Adverse Event|1|||
163103385|NCT00022763|589084530|FG001|Overall Study|Adverse Event|2|||
163103386|NCT00022763|589084529|FG000|Overall Study|Injection Site Reactions|0|||
163103387|NCT00022763|589084530|FG001|Overall Study|Injection Site Reactions|2|||
163103388|NCT00022763|589084529|FG000|Overall Study|Death|0|||
163103389|NCT00022763|589084530|FG001|Overall Study|Death|1|||
163103390|NCT00022763|589084529|FG000|Overall Study|Lost to Follow-up|0|||
163103391|NCT00022763|589084530|FG001|Overall Study|Lost to Follow-up|3|||
163103392|NCT00022763|589084529|FG000|Overall Study|Withdrawal by Subject|4|||
163103393|NCT00022763|589084530|FG001|Overall Study|Withdrawal by Subject|7|||
163103394|NCT00022763|589084529|FG000|Overall Study|Insufficient Therapy|1|||
163103395|NCT00022763|589084530|FG001|Overall Study|Insufficient Therapy|0|||
163103396|NCT00022763|589084529|FG000|Overall Study|Admin|3|||
163103397|NCT00022763|589084530|FG001|Overall Study|Admin|2|||
163103398|NCT03248531|589084531|FG000|Overall Study|Adverse Event|0|||
163103399|NCT03248531|589084532|FG001|Overall Study|Adverse Event|0|||
163103400|NCT03248531|589084533|FG002|Overall Study|Adverse Event|1|||
163103401|NCT03248531|589084531|FG000|Overall Study|Lost to Follow-up|1|||
163103402|NCT03248531|589084532|FG001|Overall Study|Lost to Follow-up|0|||
162719082|NCT01867580|587676766|FG001|Overall Study|Wound recurrence|1|||
163103403|NCT03248531|589084533|FG002|Overall Study|Lost to Follow-up|5|||
163103404|NCT03248531|589084531|FG000|Overall Study|Withdrawal by Subject|3|||
163103405|NCT03248531|589084532|FG001|Overall Study|Withdrawal by Subject|3|||
163103406|NCT03248531|589084533|FG002|Overall Study|Withdrawal by Subject|2|||
163103407|NCT03248531|589084531|FG000|Overall Study|Sponsor Request|0|||
163103408|NCT03248531|589084532|FG001|Overall Study|Sponsor Request|2|||
163103409|NCT03248531|589084533|FG002|Overall Study|Sponsor Request|0|||
163103410|NCT02923531|589084534|FG000|Overall Study|Adverse Event|4|||
163103411|NCT02923531|589084534|FG000|Overall Study|Clinical Deterioration|1|||
163103412|NCT02923531|589084534|FG000|Overall Study|Disease Progression|3|||
163103413|NCT02923531|589084534|FG000|Overall Study|Study Termination|1|||
163103414|NCT02201329|589084535|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
163103415|NCT02201329|589084535|FG000|Overall Study|Withdrawal by Subject|2|||
163103416|NCT02997865|589084536|FG000|Overall Study|Death|2|||
163103417|NCT02997865|589084537|FG001|Overall Study|Death|1|||
162719083|NCT01278862|587676767|FG000|Overall Study|Lost to Follow-up|1|||
163103418|NCT02997865|589084536|FG000|Overall Study|Lost to Follow-up|6|||
163103419|NCT02997865|589084537|FG001|Overall Study|Lost to Follow-up|3|||
163103420|NCT02997865|589084536|FG000|Overall Study|Withdrawal by Subject|5|||
163103421|NCT02997865|589084537|FG001|Overall Study|Withdrawal by Subject|0|||
163103422|NCT04660552|589084538|FG000|Overall Study|Withdrawal by Subject|3|||
163103423|NCT04660552|589084539|FG001|Overall Study|Withdrawal by Subject|1|||
163103424|NCT03012828|589084540|FG000|Overall Study|Lost to Follow-up|1|||
163103425|NCT03012828|589084541|FG001|Overall Study|Lost to Follow-up|0|||
163103426|NCT03012828|589084542|FG002|Overall Study|Lost to Follow-up|1|||
163103427|NCT03012828|589084543|FG003|Overall Study|Lost to Follow-up|0|||
163103428|NCT03012828|589084544|FG004|Overall Study|Lost to Follow-up|1|||
163103429|NCT03012828|589084545|FG005|Overall Study|Lost to Follow-up|0|||
163103430|NCT03012828|589084540|FG000|Overall Study|Withdrawal by Subject|0|||
163103431|NCT03012828|589084541|FG001|Overall Study|Withdrawal by Subject|0|||
163103432|NCT03012828|589084542|FG002|Overall Study|Withdrawal by Subject|1|||
163103433|NCT03012828|589084543|FG003|Overall Study|Withdrawal by Subject|0|||
163103434|NCT03012828|589084544|FG004|Overall Study|Withdrawal by Subject|0|||
163103435|NCT03012828|589084545|FG005|Overall Study|Withdrawal by Subject|1|||
163103436|NCT03012828|589084540|FG000|Overall Study|Non-compliance with protocol|0|||
163103437|NCT03012828|589084541|FG001|Overall Study|Non-compliance with protocol|0|||
163103438|NCT03012828|589084542|FG002|Overall Study|Non-compliance with protocol|0|||
163103439|NCT03012828|589084543|FG003|Overall Study|Non-compliance with protocol|0|||
163103440|NCT03012828|589084544|FG004|Overall Study|Non-compliance with protocol|1|||
163103441|NCT03012828|589084545|FG005|Overall Study|Non-compliance with protocol|0|||
163103442|NCT03012828|589084540|FG000|Overall Study|Delay to last visit would delay DBL|0|||
163103443|NCT03012828|589084541|FG001|Overall Study|Delay to last visit would delay DBL|0|||
163103444|NCT03012828|589084542|FG002|Overall Study|Delay to last visit would delay DBL|0|||
163103445|NCT03012828|589084543|FG003|Overall Study|Delay to last visit would delay DBL|0|||
163103446|NCT03012828|589084544|FG004|Overall Study|Delay to last visit would delay DBL|0|||
163103447|NCT03012828|589084545|FG005|Overall Study|Delay to last visit would delay DBL|1|||
163103448|NCT01509846|589084546|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
163103449|NCT01509846|589084547|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163103450|NCT01509846|589084548|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
163103451|NCT01509846|589084549|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163103452|NCT01509846|589084550|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163103453|NCT01509846|589084546|FG000|Received Vaccination 2|Illness|0|||
163103454|NCT01509846|589084547|FG001|Received Vaccination 2|Illness|0|||
163103455|NCT01509846|589084548|FG002|Received Vaccination 2|Illness|0|||
163103456|NCT01509846|589084549|FG003|Received Vaccination 2|Illness|0|||
163103457|NCT01509846|589084550|FG004|Received Vaccination 2|Illness|1|||
163103458|NCT01509846|589084546|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
163103459|NCT01509846|589084547|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
163103460|NCT01509846|589084548|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
163103461|NCT01509846|589084549|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
163103462|NCT01509846|589084550|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
163103463|NCT01509846|589084546|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
163103464|NCT01509846|589084547|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
163103465|NCT01509846|589084548|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
163103466|NCT01509846|589084549|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
163103467|NCT01509846|589084550|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
163103468|NCT01509846|589084546|FG000|Received Vaccination 3|Pregnancy|0|||
163103469|NCT01509846|589084547|FG001|Received Vaccination 3|Pregnancy|0|||
163103470|NCT01509846|589084548|FG002|Received Vaccination 3|Pregnancy|0|||
163103471|NCT01509846|589084549|FG003|Received Vaccination 3|Pregnancy|1|||
163103472|NCT01509846|589084550|FG004|Received Vaccination 3|Pregnancy|0|||
163103473|NCT01509846|589084546|FG000|Received Vaccination 3|Lost to Follow-up|0|||
163103474|NCT01509846|589084547|FG001|Received Vaccination 3|Lost to Follow-up|0|||
163103475|NCT01509846|589084548|FG002|Received Vaccination 3|Lost to Follow-up|1|||
163103476|NCT01509846|589084549|FG003|Received Vaccination 3|Lost to Follow-up|0|||
163103477|NCT01509846|589084550|FG004|Received Vaccination 3|Lost to Follow-up|0|||
163103478|NCT01637584|589084552|FG000|Overall Study|Withdrawal by Subject|1|||
163103479|NCT01637584|589084553|FG001|Overall Study|Withdrawal by Subject|3|||
162719084|NCT01278862|587676768|FG001|Overall Study|Lost to Follow-up|1|||
163103480|NCT02366923|589084554|FG000|Overall Study|Withdrawal by Subject|1|||
163103481|NCT02366923|589084554|FG000|Overall Study|Positive Slit Lamp Findings|2|||
163103482|NCT02366923|589084554|FG000|Overall Study|High Astigmatism|3|||
163103483|NCT00992056|589084557|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
163103484|NCT00992056|589084558|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
163103485|NCT00992056|589084557|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
163103486|NCT00992056|589084558|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
163103487|NCT01001767|589084561|FG000|Overall Study|no baseline study performed|1|||
163103488|NCT01001767|589084562|FG001|Overall Study|no baseline study performed|0|||
163103489|NCT01001767|589084561|FG000|Overall Study|Protocol Violation|1|||
163103490|NCT01001767|589084562|FG001|Overall Study|Protocol Violation|0|||
163103491|NCT01001767|589084561|FG000|Overall Study|Lost to Follow-up|1|||
163103492|NCT01001767|589084562|FG001|Overall Study|Lost to Follow-up|0|||
163103493|NCT01001767|589084561|FG000|Overall Study|Physician Decision|1|||
163103494|NCT01001767|589084562|FG001|Overall Study|Physician Decision|0|||
163103495|NCT00851552|589084563|FG000|Overall Study|Death|2|||
163103496|NCT00851552|589084563|FG000|Overall Study|Adverse Event|1|||
163103497|NCT00851552|589084563|FG000|Overall Study|Disease Progression|4|||
163103498|NCT00177294|589084564|FG000|Overall Study|Withdrawal by Subject|7|||
163103499|NCT00177294|589084565|FG001|Overall Study|Withdrawal by Subject|5|||
163103500|NCT01437111|589084566|FG000|Overall Study|Adverse Event|2|||
163103501|NCT01437111|589084566|FG000|Overall Study|Withdrawal by Subject|4|||
163103502|NCT01437111|589084566|FG000|Overall Study|Not reported|5|||
163103503|NCT01437111|589084566|FG000|Overall Study|Physician Decision|1|||
163103504|NCT01437111|589084566|FG000|Overall Study|Lost to Follow-up|5|||
163103505|NCT01437111|589084566|FG000|Overall Study|Protocol Violation|1|||
163103506|NCT02473471|589084567|FG000|Overall Study|poor oral hygiene|2|||
163103507|NCT02473471|589084567|FG000|Overall Study|Lost to Follow-up|1|||
163103508|NCT03082677|589084568|FG000|Overall Study|Not Treated|2|||
163103509|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
163103510|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
163103511|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
163103512|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
163103513|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
163103514|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
163103515|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
163103516|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
163103517|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
163103518|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
163103519|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
163103520|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
163103521|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103522|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103523|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
163103524|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103525|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103526|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103527|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103528|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103529|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103530|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103531|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103532|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163103533|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
163103534|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
163103535|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
163103536|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
163103537|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
163103538|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
163103539|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
163103540|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
163103541|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
163103542|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
163103543|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
163103544|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
163103545|NCT01667133|589084569|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103546|NCT01667133|589084570|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103547|NCT01667133|589084571|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103548|NCT01667133|589084572|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
163103549|NCT01667133|589084573|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103550|NCT01667133|589084574|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103551|NCT01667133|589084575|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103552|NCT01667133|589084576|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103553|NCT01667133|589084577|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103554|NCT01667133|589084578|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103555|NCT01667133|589084579|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103556|NCT01667133|589084580|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
163103557|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
163103558|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
163103559|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
163103560|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
163103561|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
163103562|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
163103563|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
163103564|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
163103565|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
163103566|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
163103567|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
163103568|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
163103569|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103570|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103571|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103572|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103573|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103574|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103575|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103576|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103577|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103578|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
163103579|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103580|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
163103581|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
163103582|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
163103583|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
163103584|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
163103585|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
163103586|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
163103587|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
163103588|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
163103589|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
163103590|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
163103591|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
163103592|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
163103593|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103594|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103595|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103596|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103597|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103598|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103599|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103600|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103601|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103602|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
163103603|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103604|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
163103605|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Death|0|||
163103606|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Death|0|||
163103607|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Death|0|||
163103608|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Death|0|||
163103609|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Death|0|||
163103610|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Death|0|||
163103611|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Death|0|||
163103612|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Death|0|||
163103613|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Death|0|||
163103614|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Death|1|||
163103615|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Death|0|||
163103616|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Death|0|||
163103617|NCT01667133|589084569|FG000|Phase 2: Dose-expansion|Other|0|||
163103618|NCT01667133|589084570|FG001|Phase 2: Dose-expansion|Other|0|||
163103619|NCT01667133|589084571|FG002|Phase 2: Dose-expansion|Other|0|||
163103620|NCT01667133|589084572|FG003|Phase 2: Dose-expansion|Other|0|||
163103621|NCT01667133|589084573|FG004|Phase 2: Dose-expansion|Other|0|||
163103622|NCT01667133|589084574|FG005|Phase 2: Dose-expansion|Other|0|||
163103623|NCT01667133|589084575|FG006|Phase 2: Dose-expansion|Other|0|||
163103624|NCT01667133|589084576|FG007|Phase 2: Dose-expansion|Other|0|||
163103625|NCT01667133|589084577|FG008|Phase 2: Dose-expansion|Other|0|||
163103626|NCT01667133|589084578|FG009|Phase 2: Dose-expansion|Other|0|||
163103627|NCT01667133|589084579|FG010|Phase 2: Dose-expansion|Other|0|||
163103628|NCT01667133|589084580|FG011|Phase 2: Dose-expansion|Other|1|||
163103629|NCT01916824|589084587|FG000|Overall Study|Lost to Follow-up|3|||
163103630|NCT01916824|589084588|FG001|Overall Study|Lost to Follow-up|6|||
163103631|NCT01916824|589084587|FG000|Overall Study|Physician Decision|2|||
163103632|NCT01916824|589084588|FG001|Overall Study|Physician Decision|0|||
163103633|NCT01916824|589084587|FG000|Overall Study|Withdrawal by Subject|2|||
163103634|NCT01916824|589084588|FG001|Overall Study|Withdrawal by Subject|3|||
163103635|NCT03835481|589084591|FG000|Double-blind Period|Other not stated below|0|||
162719085|NCT02952261|587676770|FG000|Overall Study|Withdrawal by Subject|4|||
162719086|NCT02952261|587676771|FG001|Overall Study|Withdrawal by Subject|5|||
163103636|NCT03835481|589084592|FG001|Double-blind Period|Other not stated below|0|||
163103637|NCT03835481|589084593|FG002|Double-blind Period|Other not stated below|0|||
163103638|NCT03835481|589084594|FG003|Double-blind Period|Other not stated below|1|||
163103639|NCT03835481|589084595|FG004|Double-blind Period|Other not stated below|1|||
163103640|NCT03835481|589084591|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
163103641|NCT03835481|589084592|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
163103642|NCT03835481|589084593|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
163103643|NCT03835481|589084594|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
163103644|NCT03835481|589084595|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
163103645|NCT03835481|589084591|FG000|Double-blind Period|Withdrawal by Subject|0|||
163103646|NCT03835481|589084592|FG001|Double-blind Period|Withdrawal by Subject|0|||
163103647|NCT03835481|589084593|FG002|Double-blind Period|Withdrawal by Subject|1|||
163103648|NCT03835481|589084594|FG003|Double-blind Period|Withdrawal by Subject|0|||
163103649|NCT03835481|589084595|FG004|Double-blind Period|Withdrawal by Subject|5|||
163103650|NCT03835481|589084591|FG000|Double-blind Period|Lost to Follow-up|0|||
163103651|NCT03835481|589084592|FG001|Double-blind Period|Lost to Follow-up|0|||
163103652|NCT03835481|589084593|FG002|Double-blind Period|Lost to Follow-up|0|||
163103653|NCT03835481|589084594|FG003|Double-blind Period|Lost to Follow-up|1|||
163103654|NCT03835481|589084595|FG004|Double-blind Period|Lost to Follow-up|0|||
163103655|NCT03835481|589084591|FG000|Double-blind Period|Protocol Violation|0|||
163103656|NCT03835481|589084592|FG001|Double-blind Period|Protocol Violation|2|||
163103657|NCT03835481|589084593|FG002|Double-blind Period|Protocol Violation|0|||
163103658|NCT03835481|589084594|FG003|Double-blind Period|Protocol Violation|1|||
163103659|NCT03835481|589084595|FG004|Double-blind Period|Protocol Violation|0|||
163103660|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
163103661|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
163103662|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
163103663|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
163103664|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
163103665|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
163103666|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
163103667|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
163103668|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
163103669|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
163103670|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103671|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103672|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
163103673|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
163103674|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163103675|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
163103676|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
163103677|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
163103678|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
163103679|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
163103680|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103681|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103682|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103683|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
163103684|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
163103685|NCT03835481|589084591|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
163103686|NCT03835481|589084592|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
163103687|NCT03835481|589084593|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
163103688|NCT03835481|589084594|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
163103689|NCT03835481|589084595|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
163103690|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
162719087|NCT02952261|587676770|FG000|Overall Study|Protocol Violation|1|||
162719088|NCT02952261|587676771|FG001|Overall Study|Protocol Violation|0|||
163103691|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
163103692|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
163103693|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
163103694|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
163103695|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
163103696|NCT00191945|589084596|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
163103697|NCT00191945|589084597|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
163103698|NCT02063984|589084598|FG000|Overall Study|Lost to Follow-up|6|||
163103699|NCT02063984|589084599|FG001|Overall Study|Lost to Follow-up|5|||
163103700|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
163103701|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
163103702|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
163103703|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
163103704|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
163103705|NCT01536561|589084603|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
163103706|NCT01030952|589084604|FG000|Overall Study|Protocol Violation|0|||
163103707|NCT01030952|589084605|FG001|Overall Study|Protocol Violation|1|||
163103708|NCT01030952|589084604|FG000|Overall Study|Informed consent withdrawal|1|||
163103709|NCT01030952|589084605|FG001|Overall Study|Informed consent withdrawal|0|||
163103710|NCT01030952|589084604|FG000|Overall Study|Lost to Follow-up|0|||
163103711|NCT01030952|589084605|FG001|Overall Study|Lost to Follow-up|1|||
163103712|NCT01030952|589084604|FG000|Overall Study|Unexplained|1|||
163103713|NCT01030952|589084605|FG001|Overall Study|Unexplained|1|||
163103714|NCT01831466|589084611|FG000|Overall Study|Protocol Violation|1|||
163103715|NCT01831466|589084612|FG001|Overall Study|Protocol Violation|1|||
163103716|NCT01831466|589084613|FG002|Overall Study|Protocol Violation|2|||
163103717|NCT01831466|589084614|FG003|Overall Study|Protocol Violation|0|||
163103718|NCT01831466|589084615|FG004|Overall Study|Protocol Violation|0|||
163103719|NCT01831466|589084616|FG005|Overall Study|Protocol Violation|1|||
163103720|NCT01831466|589084617|FG006|Overall Study|Protocol Violation|0|||
163103721|NCT01831466|589084618|FG007|Overall Study|Protocol Violation|0|||
163103722|NCT01831466|589084619|FG008|Overall Study|Protocol Violation|0|||
163103723|NCT01831466|589084620|FG009|Overall Study|Protocol Violation|0|||
163103724|NCT01831466|589084621|FG010|Overall Study|Protocol Violation|0|||
163103725|NCT01831466|589084622|FG011|Overall Study|Protocol Violation|0|||
163103726|NCT01831466|589084611|FG000|Overall Study|Other|2|||
163103727|NCT01831466|589084612|FG001|Overall Study|Other|3|||
163103728|NCT01831466|589084613|FG002|Overall Study|Other|2|||
163103729|NCT01831466|589084614|FG003|Overall Study|Other|2|||
163103730|NCT01831466|589084615|FG004|Overall Study|Other|2|||
163103731|NCT01831466|589084616|FG005|Overall Study|Other|1|||
163103732|NCT01831466|589084617|FG006|Overall Study|Other|0|||
163103733|NCT01831466|589084618|FG007|Overall Study|Other|0|||
163103734|NCT01831466|589084619|FG008|Overall Study|Other|0|||
163103735|NCT01831466|589084620|FG009|Overall Study|Other|0|||
163103736|NCT01831466|589084621|FG010|Overall Study|Other|0|||
163103737|NCT01831466|589084622|FG011|Overall Study|Other|0|||
163103738|NCT01831466|589084611|FG000|Overall Study|Non-compliance with study treatment|2|||
163103739|NCT01831466|589084612|FG001|Overall Study|Non-compliance with study treatment|1|||
163103740|NCT01831466|589084613|FG002|Overall Study|Non-compliance with study treatment|1|||
163103741|NCT01831466|589084614|FG003|Overall Study|Non-compliance with study treatment|0|||
163103742|NCT01831466|589084615|FG004|Overall Study|Non-compliance with study treatment|0|||
163103743|NCT01831466|589084616|FG005|Overall Study|Non-compliance with study treatment|1|||
163103744|NCT01831466|589084617|FG006|Overall Study|Non-compliance with study treatment|0|||
163103745|NCT01831466|589084618|FG007|Overall Study|Non-compliance with study treatment|0|||
163103746|NCT01831466|589084619|FG008|Overall Study|Non-compliance with study treatment|0|||
163103747|NCT01831466|589084620|FG009|Overall Study|Non-compliance with study treatment|0|||
163103748|NCT01831466|589084621|FG010|Overall Study|Non-compliance with study treatment|0|||
162719089|NCT05233085|587676772|FG000|Overall Study|Adverse Event|1|||
163103749|NCT01831466|589084622|FG011|Overall Study|Non-compliance with study treatment|0|||
163103750|NCT01831466|589084611|FG000|Overall Study|Death|0|||
163103751|NCT01831466|589084612|FG001|Overall Study|Death|1|||
163103752|NCT01831466|589084613|FG002|Overall Study|Death|0|||
163103753|NCT01831466|589084614|FG003|Overall Study|Death|0|||
163103754|NCT01831466|589084615|FG004|Overall Study|Death|0|||
163103755|NCT01831466|589084616|FG005|Overall Study|Death|0|||
163103756|NCT01831466|589084617|FG006|Overall Study|Death|0|||
163103757|NCT01831466|589084618|FG007|Overall Study|Death|0|||
163103758|NCT01831466|589084619|FG008|Overall Study|Death|0|||
163103759|NCT01831466|589084620|FG009|Overall Study|Death|0|||
163103760|NCT01831466|589084621|FG010|Overall Study|Death|0|||
163103761|NCT01831466|589084622|FG011|Overall Study|Death|0|||
162719090|NCT05233085|587676773|FG001|Overall Study|Adverse Event|0|||
163103762|NCT01831466|589084611|FG000|Overall Study|Withdrawal by Subject|6|||
163103763|NCT01831466|589084612|FG001|Overall Study|Withdrawal by Subject|3|||
162719091|NCT05233085|587676774|FG002|Overall Study|Adverse Event|0|||
163103764|NCT01831466|589084613|FG002|Overall Study|Withdrawal by Subject|3|||
163103765|NCT01831466|589084614|FG003|Overall Study|Withdrawal by Subject|3|||
163103766|NCT01831466|589084615|FG004|Overall Study|Withdrawal by Subject|3|||
163103767|NCT01831466|589084616|FG005|Overall Study|Withdrawal by Subject|5|||
163103768|NCT01831466|589084617|FG006|Overall Study|Withdrawal by Subject|0|||
163103769|NCT01831466|589084618|FG007|Overall Study|Withdrawal by Subject|0|||
163103770|NCT01831466|589084619|FG008|Overall Study|Withdrawal by Subject|0|||
163103771|NCT01831466|589084620|FG009|Overall Study|Withdrawal by Subject|1|||
163103772|NCT01831466|589084621|FG010|Overall Study|Withdrawal by Subject|0|||
163103773|NCT01831466|589084622|FG011|Overall Study|Withdrawal by Subject|1|||
163103774|NCT01831466|589084611|FG000|Overall Study|Lost to Follow-up|0|||
163103775|NCT01831466|589084612|FG001|Overall Study|Lost to Follow-up|1|||
163103776|NCT01831466|589084613|FG002|Overall Study|Lost to Follow-up|4|||
163103777|NCT01831466|589084614|FG003|Overall Study|Lost to Follow-up|2|||
163103778|NCT01831466|589084615|FG004|Overall Study|Lost to Follow-up|0|||
163103779|NCT01831466|589084616|FG005|Overall Study|Lost to Follow-up|3|||
163103780|NCT01831466|589084617|FG006|Overall Study|Lost to Follow-up|0|||
163103781|NCT01831466|589084618|FG007|Overall Study|Lost to Follow-up|0|||
163103782|NCT01831466|589084619|FG008|Overall Study|Lost to Follow-up|0|||
163103783|NCT01831466|589084620|FG009|Overall Study|Lost to Follow-up|1|||
163103784|NCT01831466|589084621|FG010|Overall Study|Lost to Follow-up|0|||
163103785|NCT01831466|589084622|FG011|Overall Study|Lost to Follow-up|1|||
163103786|NCT01831466|589084611|FG000|Overall Study|Lack of Efficacy|5|||
163103787|NCT01831466|589084612|FG001|Overall Study|Lack of Efficacy|8|||
163103788|NCT01831466|589084613|FG002|Overall Study|Lack of Efficacy|7|||
163103789|NCT01831466|589084614|FG003|Overall Study|Lack of Efficacy|6|||
163103790|NCT01831466|589084615|FG004|Overall Study|Lack of Efficacy|9|||
163103791|NCT01831466|589084616|FG005|Overall Study|Lack of Efficacy|8|||
163103792|NCT01831466|589084617|FG006|Overall Study|Lack of Efficacy|1|||
163103793|NCT01831466|589084618|FG007|Overall Study|Lack of Efficacy|1|||
163103794|NCT01831466|589084619|FG008|Overall Study|Lack of Efficacy|2|||
163103795|NCT01831466|589084620|FG009|Overall Study|Lack of Efficacy|2|||
163103796|NCT01831466|589084621|FG010|Overall Study|Lack of Efficacy|2|||
163103797|NCT01831466|589084622|FG011|Overall Study|Lack of Efficacy|0|||
163103798|NCT01831466|589084611|FG000|Overall Study|Adverse Event|0|||
163103799|NCT01831466|589084612|FG001|Overall Study|Adverse Event|0|||
163103800|NCT01831466|589084613|FG002|Overall Study|Adverse Event|4|||
163103801|NCT01831466|589084614|FG003|Overall Study|Adverse Event|6|||
163103802|NCT01831466|589084615|FG004|Overall Study|Adverse Event|3|||
163103803|NCT01831466|589084616|FG005|Overall Study|Adverse Event|7|||
163103804|NCT01831466|589084617|FG006|Overall Study|Adverse Event|0|||
163103805|NCT01831466|589084618|FG007|Overall Study|Adverse Event|1|||
163103806|NCT01831466|589084619|FG008|Overall Study|Adverse Event|1|||
163103807|NCT01831466|589084620|FG009|Overall Study|Adverse Event|1|||
163103808|NCT01831466|589084621|FG010|Overall Study|Adverse Event|0|||
163103809|NCT01831466|589084622|FG011|Overall Study|Adverse Event|2|||
163103810|NCT03497039|589084623|FG000|Overall Study|Withdrawal by Subject|1|||
163103811|NCT03497039|589084624|FG001|Overall Study|Withdrawal by Subject|0|||
163103812|NCT03497039|589084623|FG000|Overall Study|Protocol Violation|0|||
163103813|NCT03497039|589084624|FG001|Overall Study|Protocol Violation|1|||
163103814|NCT02131662|589084626|FG000|Overall Study|Protocol Violation|1|||
163103815|NCT02131662|589084627|FG001|Overall Study|Protocol Violation|0|||
163103816|NCT02131662|589084628|FG002|Overall Study|Protocol Violation|0|||
163103817|NCT02131662|589084629|FG003|Overall Study|Protocol Violation|0|||
163103818|NCT02131662|589084630|FG004|Overall Study|Protocol Violation|0|||
163103819|NCT02131662|589084626|FG000|Overall Study|Other|2|||
163103820|NCT02131662|589084627|FG001|Overall Study|Other|4|||
163103821|NCT02131662|589084628|FG002|Overall Study|Other|3|||
163103822|NCT02131662|589084629|FG003|Overall Study|Other|3|||
163103823|NCT02131662|589084630|FG004|Overall Study|Other|4|||
163103824|NCT02131662|589084626|FG000|Overall Study|Adverse Event|0|||
163103825|NCT02131662|589084627|FG001|Overall Study|Adverse Event|1|||
163103826|NCT02131662|589084628|FG002|Overall Study|Adverse Event|1|||
163103827|NCT02131662|589084629|FG003|Overall Study|Adverse Event|1|||
163103828|NCT02131662|589084630|FG004|Overall Study|Adverse Event|3|||
163103829|NCT02131662|589084626|FG000|Overall Study|Pregnancy|0|||
163103830|NCT02131662|589084627|FG001|Overall Study|Pregnancy|1|||
163103831|NCT02131662|589084628|FG002|Overall Study|Pregnancy|0|||
163103832|NCT02131662|589084629|FG003|Overall Study|Pregnancy|1|||
163103833|NCT02131662|589084630|FG004|Overall Study|Pregnancy|0|||
163103834|NCT02131662|589084626|FG000|Overall Study|Wish for pregnancy|0|||
163103835|NCT02131662|589084627|FG001|Overall Study|Wish for pregnancy|0|||
163103836|NCT02131662|589084628|FG002|Overall Study|Wish for pregnancy|0|||
163103837|NCT02131662|589084629|FG003|Overall Study|Wish for pregnancy|0|||
163103838|NCT02131662|589084630|FG004|Overall Study|Wish for pregnancy|1|||
163103839|NCT02131662|589084626|FG000|Overall Study|Lack of Efficacy|1|||
163103840|NCT02131662|589084627|FG001|Overall Study|Lack of Efficacy|0|||
163103841|NCT02131662|589084628|FG002|Overall Study|Lack of Efficacy|0|||
163103842|NCT02131662|589084629|FG003|Overall Study|Lack of Efficacy|0|||
163103843|NCT02131662|589084630|FG004|Overall Study|Lack of Efficacy|1|||
163103844|NCT02131662|589084626|FG000|Overall Study|Withdrawal by Subject|1|||
163103845|NCT02131662|589084627|FG001|Overall Study|Withdrawal by Subject|5|||
163103846|NCT02131662|589084628|FG002|Overall Study|Withdrawal by Subject|1|||
163103847|NCT02131662|589084629|FG003|Overall Study|Withdrawal by Subject|5|||
163103848|NCT02131662|589084630|FG004|Overall Study|Withdrawal by Subject|6|||
163103849|NCT02131662|589084626|FG000|Overall Study|Lost to Follow-up|1|||
163103850|NCT02131662|589084627|FG001|Overall Study|Lost to Follow-up|3|||
163103851|NCT02131662|589084628|FG002|Overall Study|Lost to Follow-up|0|||
163103852|NCT02131662|589084629|FG003|Overall Study|Lost to Follow-up|9|||
163103853|NCT02131662|589084630|FG004|Overall Study|Lost to Follow-up|0|||
163103854|NCT02131662|589084626|FG000|Overall Study|Not treated|2|||
163103855|NCT02131662|589084627|FG001|Overall Study|Not treated|0|||
163103856|NCT02131662|589084628|FG002|Overall Study|Not treated|2|||
163103857|NCT02131662|589084629|FG003|Overall Study|Not treated|2|||
163103858|NCT02131662|589084630|FG004|Overall Study|Not treated|3|||
163103859|NCT03554018|589084631|FG000|Overall Study|Lost to Follow-up|3|||
163103860|NCT03554018|589084632|FG001|Overall Study|Lost to Follow-up|7|||
163103861|NCT01016132|589084638|FG000|Overall Study|Discomfort|1|||
163103862|NCT00556439|589084641|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
163103863|NCT00556439|589084642|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
163103864|NCT00556439|589084643|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
163103865|NCT00556439|589084644|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
163103866|NCT00556439|589084641|FG000|Study Entry to Week 12|Physician Decision|1|||
163103867|NCT00556439|589084642|FG001|Study Entry to Week 12|Physician Decision|0|||
163103868|NCT00556439|589084643|FG002|Study Entry to Week 12|Physician Decision|0|||
163103869|NCT00556439|589084644|FG003|Study Entry to Week 12|Physician Decision|0|||
163103870|NCT00556439|589084641|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
163103871|NCT00556439|589084642|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
163103872|NCT00556439|589084643|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
163103873|NCT00556439|589084644|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
163103874|NCT00556439|589084641|FG000|Study Entry to Week 12|Recurrent infection|1|||
163103875|NCT00556439|589084642|FG001|Study Entry to Week 12|Recurrent infection|0|||
163103876|NCT00556439|589084643|FG002|Study Entry to Week 12|Recurrent infection|0|||
163103877|NCT00556439|589084644|FG003|Study Entry to Week 12|Recurrent infection|0|||
163103878|NCT00556439|589084641|FG000|Study Entry to Week 12|Malignancy|0|||
163103879|NCT00556439|589084642|FG001|Study Entry to Week 12|Malignancy|0|||
163103880|NCT00556439|589084643|FG002|Study Entry to Week 12|Malignancy|1|||
163103881|NCT00556439|589084644|FG003|Study Entry to Week 12|Malignancy|0|||
163103882|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
163103883|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
163103884|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
163103885|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
163103886|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
163103887|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103888|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103889|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
163103890|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
163103891|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
163103892|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
163103893|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
163103894|NCT00556439|589084641|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
163103895|NCT00556439|589084642|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103896|NCT00556439|589084643|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103897|NCT00556439|589084644|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
163103898|NCT02100423|589084646|FG000|Overall Study|Death|1|||
163103899|NCT02100423|589084646|FG000|Overall Study|Withdrawal by Subject|3|||
163103900|NCT02100423|589084646|FG000|Overall Study|Adverse Event|1|||
163103901|NCT02100423|589084646|FG000|Overall Study|Physician Decision|1|||
163103902|NCT00703846|589084647|FG000|Overall Study|Adverse Event|8|||
163103903|NCT00703846|589084647|FG000|Overall Study|Lost to Follow-up|55|||
163103904|NCT00703846|589084647|FG000|Overall Study|Lack of Efficacy|15|||
163103905|NCT00703846|589084647|FG000|Overall Study|Noncompliance with Study Treatment|2|||
163103906|NCT00703846|589084647|FG000|Overall Study|Withdrawal by Subject|40|||
163103907|NCT00703846|589084647|FG000|Overall Study|Death|1|||
163103908|NCT00703846|589084647|FG000|Overall Study|Other|14|||
163103909|NCT00703846|589084647|FG000|Overall Study|Did Not Receive Study Drug|2|||
163103910|NCT02195700|589084648|FG000|Overall Study|Protocol Violation|0|||
163103911|NCT02195700|589084649|FG001|Overall Study|Protocol Violation|2|||
163103912|NCT02195700|589084648|FG000|Overall Study|Noncompliance|1|||
163103913|NCT02195700|589084649|FG001|Overall Study|Noncompliance|0|||
163103914|NCT02195700|589084648|FG000|Overall Study|Adverse Event|1|||
163103915|NCT02195700|589084649|FG001|Overall Study|Adverse Event|2|||
163103916|NCT02195700|589084648|FG000|Overall Study|Withdrawal by Subject|3|||
163103917|NCT02195700|589084649|FG001|Overall Study|Withdrawal by Subject|2|||
163103918|NCT02195700|589084648|FG000|Overall Study|Lost to Follow-up|1|||
163103919|NCT02195700|589084649|FG001|Overall Study|Lost to Follow-up|1|||
163103920|NCT04601532|589084650|FG000|Overall Study|Lost to Follow-up|1|||
163103921|NCT04601532|589084651|FG001|Overall Study|Lost to Follow-up|2|||
163103922|NCT04601532|589084650|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
163103923|NCT04601532|589084651|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
163103924|NCT01352221|589084652|FG000|Double-blind Phase|Adverse Event|6|||
163103925|NCT01352221|589084653|FG001|Double-blind Phase|Adverse Event|4|||
163103926|NCT01352221|589084654|FG002|Double-blind Phase|Adverse Event|0|||
163103927|NCT01352221|589084655|FG003|Double-blind Phase|Adverse Event|0|||
163103928|NCT01352221|589084652|FG000|Double-blind Phase|Withdrawal by Subject|3|||
163103929|NCT01352221|589084653|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163103930|NCT01352221|589084654|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163103931|NCT01352221|589084655|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163103932|NCT01352221|589084652|FG000|Double-blind Phase|Lost to Follow-up|0|||
163103933|NCT01352221|589084653|FG001|Double-blind Phase|Lost to Follow-up|1|||
163103934|NCT01352221|589084654|FG002|Double-blind Phase|Lost to Follow-up|0|||
163103935|NCT01352221|589084655|FG003|Double-blind Phase|Lost to Follow-up|0|||
163103936|NCT01352221|589084652|FG000|Double-blind Phase|Protocol Violation|0|||
163103937|NCT01352221|589084653|FG001|Double-blind Phase|Protocol Violation|1|||
163103938|NCT01352221|589084654|FG002|Double-blind Phase|Protocol Violation|0|||
163103939|NCT01352221|589084655|FG003|Double-blind Phase|Protocol Violation|0|||
163103940|NCT01352221|589084652|FG000|Open-label Phase|Physician Decision|0|||
163103941|NCT01352221|589084653|FG001|Open-label Phase|Physician Decision|0|||
163103942|NCT01352221|589084654|FG002|Open-label Phase|Physician Decision|2|||
163103943|NCT01352221|589084655|FG003|Open-label Phase|Physician Decision|1|||
163103944|NCT01352221|589084652|FG000|Open-label Phase|Pregnancy|0|||
163103945|NCT01352221|589084653|FG001|Open-label Phase|Pregnancy|0|||
163103946|NCT01352221|589084654|FG002|Open-label Phase|Pregnancy|1|||
163103947|NCT01352221|589084655|FG003|Open-label Phase|Pregnancy|0|||
163103948|NCT01352221|589084652|FG000|Open-label Phase|Adverse Event|0|||
163103949|NCT01352221|589084653|FG001|Open-label Phase|Adverse Event|0|||
163103950|NCT01352221|589084654|FG002|Open-label Phase|Adverse Event|8|||
163103951|NCT01352221|589084655|FG003|Open-label Phase|Adverse Event|4|||
163103952|NCT01352221|589084652|FG000|Open-label Phase|Withdrawal by Subject|0|||
163103953|NCT01352221|589084653|FG001|Open-label Phase|Withdrawal by Subject|0|||
163103954|NCT01352221|589084654|FG002|Open-label Phase|Withdrawal by Subject|1|||
163103955|NCT01352221|589084655|FG003|Open-label Phase|Withdrawal by Subject|6|||
163103956|NCT01352221|589084652|FG000|Open-label Phase|Worsening of IBD|0|||
163103957|NCT01352221|589084653|FG001|Open-label Phase|Worsening of IBD|0|||
163103958|NCT01352221|589084654|FG002|Open-label Phase|Worsening of IBD|1|||
163103959|NCT01352221|589084655|FG003|Open-label Phase|Worsening of IBD|0|||
163103960|NCT02949024|589084656|FG000|Overall Study|Withdrawal by Subject|0|||
163103961|NCT02949024|589084657|FG001|Overall Study|Withdrawal by Subject|1|||
163103962|NCT01340625|589086390|FG000|First Intervention|Adverse Event|1|||
163103963|NCT01340625|589086391|FG001|First Intervention|Adverse Event|0|||
163103964|NCT01340625|589086390|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
163103965|NCT01340625|589086391|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
163103966|NCT00854724|589086392|FG000|First Intervention|Withdrawal by Subject|1|||
163103967|NCT00854724|589086393|FG001|First Intervention|Withdrawal by Subject|1|||
163103968|NCT00854724|589086392|FG000|Washout|Protocol Violation|1|||
163103969|NCT00854724|589086393|FG001|Washout|Protocol Violation|0|||
163103970|NCT00854724|589086392|FG000|Washout|Withdrawal by Subject|0|||
163103971|NCT00854724|589086393|FG001|Washout|Withdrawal by Subject|1|||
163103972|NCT00854724|589086392|FG000|Second Intervention|Protocol Violation|1|||
163103973|NCT00854724|589086393|FG001|Second Intervention|Protocol Violation|0|||
163103974|NCT00854724|589086392|FG000|Second Intervention|Physician Decision|0|||
163103975|NCT00854724|589086393|FG001|Second Intervention|Physician Decision|1|||
163103976|NCT00576628|589086397|FG000|Overall Study|Adverse Event|11|||
163103977|NCT00576628|589086397|FG000|Overall Study|Death|2|||
163103978|NCT00576628|589086397|FG000|Overall Study|Failure to return|1|||
163103979|NCT00576628|589086397|FG000|Overall Study|Refused Treatment|8|||
163103980|NCT00576628|589086397|FG000|Overall Study|Pregnancy|1|||
163103981|NCT00576628|589086397|FG000|Overall Study|RBC transfusion|1|||
163103982|NCT00576628|589086397|FG000|Overall Study|Progression of Kidney Disease|1|||
163103983|NCT00576628|589086397|FG000|Overall Study|Progression of Renal Failure|1|||
163103984|NCT00576628|589086397|FG000|Overall Study|The patient move into other town|1|||
163103985|NCT00576628|589086397|FG000|Overall Study|Transplantation|1|||
163103986|NCT00576628|589086397|FG000|Overall Study|Dialysis|15|||
163103987|NCT03206970|589086398|FG000|Overall Study|Death|21|||
163103988|NCT03206970|589086398|FG000|Overall Study|Withdrawal by Subject|13|||
163103989|NCT03206970|589086398|FG000|Overall Study|Lost to Follow-up|3|||
163103990|NCT03206970|589086398|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
163103991|NCT03654040|589086405|FG000|Overall Study|Death|1|||
163103992|NCT03654040|589086406|FG001|Overall Study|Death|0|||
163103993|NCT03654040|589086405|FG000|Overall Study|Withdrawal by Subject|1|||
163103994|NCT03654040|589086406|FG001|Overall Study|Withdrawal by Subject|0|||
163103995|NCT03654040|589086405|FG000|Overall Study|Study terminated by sponsor|8|||
163103996|NCT03654040|589086406|FG001|Overall Study|Study terminated by sponsor|2|||
163103997|NCT03654040|589086405|FG000|Overall Study|Failure to initiate study therapy|2|||
163103998|NCT03654040|589086406|FG001|Overall Study|Failure to initiate study therapy|0|||
163103999|NCT03654040|589086405|FG000|Overall Study|Transplanted at another center|2|||
163104000|NCT03654040|589086406|FG001|Overall Study|Transplanted at another center|0|||
163104001|NCT03654040|589086405|FG000|Overall Study|Failure to meet eligibility criteria|14|||
163104002|NCT03654040|589086406|FG001|Overall Study|Failure to meet eligibility criteria|2|||
163104003|NCT03654040|589086405|FG000|Overall Study|No longer transplant candidate|1|||
163104004|NCT03654040|589086406|FG001|Overall Study|No longer transplant candidate|0|||
163104005|NCT03654040|589086405|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
163104006|NCT03654040|589086406|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
163104007|NCT03654040|589086405|FG000|Overall Study|Recipient ineligible|0|||
163104008|NCT03654040|589086406|FG001|Overall Study|Recipient ineligible|2|||
163104009|NCT03654040|589086405|FG000|Overall Study|Received deceased liver|0|||
163104010|NCT03654040|589086406|FG001|Overall Study|Received deceased liver|1|||
163104011|NCT01709110|589086411|FG000|Overall Study|Adverse Event|56|||
163104012|NCT01709110|589086412|FG001|Overall Study|Adverse Event|48|||
163104013|NCT01709110|589086411|FG000|Overall Study|Death|14|||
163104014|NCT01709110|589086412|FG001|Overall Study|Death|6|||
163104015|NCT01709110|589086411|FG000|Overall Study|Lost to Follow-up|7|||
163104016|NCT01709110|589086412|FG001|Overall Study|Lost to Follow-up|5|||
163104017|NCT01709110|589086411|FG000|Overall Study|Protocol Violation|4|||
163104018|NCT01709110|589086412|FG001|Overall Study|Protocol Violation|6|||
163104019|NCT01709110|589086411|FG000|Overall Study|Withdrawal by Subject|96|||
163104020|NCT01709110|589086412|FG001|Overall Study|Withdrawal by Subject|89|||
163104021|NCT01709110|589086411|FG000|Overall Study|Physician Decision|4|||
163104022|NCT01709110|589086412|FG001|Overall Study|Physician Decision|10|||
163104023|NCT01709110|589086411|FG000|Overall Study|Sponsor Decision|2|||
163104024|NCT01709110|589086412|FG001|Overall Study|Sponsor Decision|2|||
163104025|NCT01709110|589086411|FG000|Overall Study|Lack of Efficacy|1|||
163104026|NCT01709110|589086412|FG001|Overall Study|Lack of Efficacy|1|||
163104027|NCT01709110|589086411|FG000|Overall Study|Caregiver Decision|1|||
163104028|NCT01709110|589086412|FG001|Overall Study|Caregiver Decision|1|||
163104029|NCT01951586|589086413|FG000|Overall Study|Death|61|||
163104030|NCT01951586|589086414|FG001|Overall Study|Death|120|||
163104031|NCT01951586|589086413|FG000|Overall Study|Withdrawal by Subject|8|||
163104032|NCT01951586|589086414|FG001|Overall Study|Withdrawal by Subject|17|||
163104033|NCT01951586|589086413|FG000|Overall Study|Lost to Follow-up|0|||
163104034|NCT01951586|589086414|FG001|Overall Study|Lost to Follow-up|1|||
163104035|NCT01951586|589086413|FG000|Overall Study|Sponsor Decision|9|||
163104036|NCT01951586|589086414|FG001|Overall Study|Sponsor Decision|10|||
163104037|NCT02789345|589086415|FG000|Overall Study|Adverse Event|0|||
163104038|NCT02789345|589086416|FG001|Overall Study|Adverse Event|0|||
163104039|NCT02789345|589086417|FG002|Overall Study|Adverse Event|1|||
163104040|NCT02789345|589086415|FG000|Overall Study|Death|0|||
163104041|NCT02789345|589086416|FG001|Overall Study|Death|0|||
163104042|NCT02789345|589086417|FG002|Overall Study|Death|1|||
163104043|NCT02789345|589086415|FG000|Overall Study|Physician Decision|2|||
163104044|NCT02789345|589086416|FG001|Overall Study|Physician Decision|0|||
163104045|NCT02789345|589086417|FG002|Overall Study|Physician Decision|1|||
163104046|NCT02789345|589086415|FG000|Overall Study|Progressive Disease|1|||
163104047|NCT02789345|589086416|FG001|Overall Study|Progressive Disease|3|||
163104048|NCT02789345|589086417|FG002|Overall Study|Progressive Disease|14|||
163104049|NCT03286543|589086423|FG000|Consented|Screen failure before randomization|2|||
163104050|NCT03286543|589086424|FG001|Consented|Screen failure before randomization|0|||
163104051|NCT03286543|589086425|FG002|Consented|Screen failure before randomization|0|||
163104052|NCT03286543|589086423|FG000|Consented|Screen failure before enrollment|4|||
163104053|NCT03286543|589086424|FG001|Consented|Screen failure before enrollment|0|||
163104054|NCT03286543|589086425|FG002|Consented|Screen failure before enrollment|0|||
163104055|NCT03286543|589086423|FG000|Consented|TKA cancelled after enrollment|1|||
163104056|NCT03286543|589086424|FG001|Consented|TKA cancelled after enrollment|0|||
163104057|NCT03286543|589086425|FG002|Consented|TKA cancelled after enrollment|0|||
163104058|NCT03286543|589086423|FG000|Consented|Withdrawn from study|12|||
163104059|NCT03286543|589086424|FG001|Consented|Withdrawn from study|0|||
163104060|NCT03286543|589086425|FG002|Consented|Withdrawn from study|0|||
163104061|NCT03286543|589086423|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
163104062|NCT03286543|589086424|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
163104063|NCT03286543|589086425|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
163104064|NCT03286543|589086423|FG000|Study Enrollment|Withdrawn from study|0|||
163104065|NCT03286543|589086424|FG001|Study Enrollment|Withdrawn from study|6|||
163104066|NCT03286543|589086425|FG002|Study Enrollment|Withdrawn from study|6|||
163104067|NCT02836717|589086429|FG000|Test Phase|Lack of Efficacy|14|||
163104068|NCT02836717|589086430|FG001|Test Phase|Lack of Efficacy|8|||
163104069|NCT02836717|589086431|FG002|Test Phase|Lack of Efficacy|0|||
163104070|NCT02836717|589086429|FG000|Study Phase|Adverse Event|2|||
163104071|NCT02836717|589086430|FG001|Study Phase|Adverse Event|0|||
163104072|NCT02836717|589086431|FG002|Study Phase|Adverse Event|0|||
163104073|NCT02836717|589086429|FG000|Study Phase|Lack of Efficacy|8|||
163104074|NCT02836717|589086430|FG001|Study Phase|Lack of Efficacy|6|||
163104075|NCT02836717|589086431|FG002|Study Phase|Lack of Efficacy|1|||
163104076|NCT02836717|589086429|FG000|Study Phase|Withdrawal by Subject|1|||
163104077|NCT02836717|589086430|FG001|Study Phase|Withdrawal by Subject|0|||
163104078|NCT02836717|589086431|FG002|Study Phase|Withdrawal by Subject|0|||
163104079|NCT02836717|589086429|FG000|Study Phase|Death|1|||
163104080|NCT02836717|589086430|FG001|Study Phase|Death|0|||
163104081|NCT02836717|589086431|FG002|Study Phase|Death|0|||
163104082|NCT02836717|589086429|FG000|Study Phase|abdominal surgeries|2|||
163104083|NCT02836717|589086430|FG001|Study Phase|abdominal surgeries|1|||
163104084|NCT02836717|589086431|FG002|Study Phase|abdominal surgeries|0|||
163104085|NCT00224120|589086432|FG000|Overall Study|Adverse Event|10|||
163104086|NCT00224120|589086433|FG001|Overall Study|Adverse Event|4|||
163104087|NCT00224120|589086432|FG000|Overall Study|Protocol Violation|1|||
163104088|NCT00224120|589086433|FG001|Overall Study|Protocol Violation|0|||
163104089|NCT00224120|589086432|FG000|Overall Study|Withdrawal by Subject|5|||
163104090|NCT00224120|589086433|FG001|Overall Study|Withdrawal by Subject|10|||
163104091|NCT00224120|589086432|FG000|Overall Study|Lack of Efficacy|0|||
163104092|NCT00224120|589086433|FG001|Overall Study|Lack of Efficacy|2|||
163104093|NCT00224120|589086432|FG000|Overall Study|Lost to Follow-up|2|||
163104094|NCT00224120|589086433|FG001|Overall Study|Lost to Follow-up|3|||
163104095|NCT00224120|589086432|FG000|Overall Study|Other|4|||
163104096|NCT00224120|589086433|FG001|Overall Study|Other|5|||
163104097|NCT00104416|589086434|FG000|Double-Blind Phase|Adverse Event|2|||
163104098|NCT00104416|589086435|FG001|Double-Blind Phase|Adverse Event|1|||
163104099|NCT00104416|589086436|FG002|Double-Blind Phase|Adverse Event|0|||
162719092|NCT05233085|587676775|FG003|Overall Study|Adverse Event|0|||
162719093|NCT03284957|587678391|FG000|Overall Study|Adverse Event|0|||
162719094|NCT03284957|587678392|FG001|Overall Study|Adverse Event|0|||
162719095|NCT03284957|587678393|FG002|Overall Study|Adverse Event|0|||
162719096|NCT03284957|587678394|FG003|Overall Study|Adverse Event|0|||
162719097|NCT03284957|587678395|FG004|Overall Study|Adverse Event|0|||
162719098|NCT03284957|587678396|FG005|Overall Study|Adverse Event|1|||
162719099|NCT03284957|587678397|FG006|Overall Study|Adverse Event|1|||
163104100|NCT00104416|589086437|FG003|Double-Blind Phase|Adverse Event|0|||
163104101|NCT00104416|589086438|FG004|Double-Blind Phase|Adverse Event|0|||
163104102|NCT00104416|589086434|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163104103|NCT00104416|589086435|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163104104|NCT00104416|589086436|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163104105|NCT00104416|589086437|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163104106|NCT00104416|589086438|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163104107|NCT00104416|589086434|FG000|Double-Blind Phase|Protocol Violation|0|||
163104108|NCT00104416|589086435|FG001|Double-Blind Phase|Protocol Violation|1|||
163104109|NCT00104416|589086436|FG002|Double-Blind Phase|Protocol Violation|0|||
163104110|NCT00104416|589086437|FG003|Double-Blind Phase|Protocol Violation|0|||
163104111|NCT00104416|589086438|FG004|Double-Blind Phase|Protocol Violation|0|||
163104112|NCT00104416|589086434|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
163104113|NCT00104416|589086435|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
163104114|NCT00104416|589086436|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163104115|NCT00104416|589086437|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163104116|NCT00104416|589086438|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163104117|NCT00104416|589086434|FG000|Double-Blind Phase|Pregnancy|1|||
163104118|NCT00104416|589086435|FG001|Double-Blind Phase|Pregnancy|0|||
163104119|NCT00104416|589086436|FG002|Double-Blind Phase|Pregnancy|0|||
163104120|NCT00104416|589086437|FG003|Double-Blind Phase|Pregnancy|0|||
163104121|NCT00104416|589086438|FG004|Double-Blind Phase|Pregnancy|0|||
163104122|NCT00104416|589086434|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
163104123|NCT00104416|589086435|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
163104124|NCT00104416|589086436|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104125|NCT00104416|589086437|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104126|NCT00104416|589086438|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
163104127|NCT00104416|589086434|FG000|Continuation Phase|Adverse Event|0|||
163104128|NCT00104416|589086435|FG001|Continuation Phase|Adverse Event|0|||
163104129|NCT00104416|589086436|FG002|Continuation Phase|Adverse Event|2|||
163104130|NCT00104416|589086437|FG003|Continuation Phase|Adverse Event|0|||
163104131|NCT00104416|589086438|FG004|Continuation Phase|Adverse Event|2|||
163104132|NCT00104416|589086434|FG000|Continuation Phase|Lost to Follow-up|0|||
163104133|NCT00104416|589086435|FG001|Continuation Phase|Lost to Follow-up|0|||
163104134|NCT00104416|589086436|FG002|Continuation Phase|Lost to Follow-up|1|||
163104135|NCT00104416|589086437|FG003|Continuation Phase|Lost to Follow-up|0|||
163104136|NCT00104416|589086438|FG004|Continuation Phase|Lost to Follow-up|1|||
163104137|NCT00104416|589086434|FG000|Continuation Phase|Withdrawal by Subject|0|||
163104138|NCT00104416|589086435|FG001|Continuation Phase|Withdrawal by Subject|0|||
163104139|NCT00104416|589086436|FG002|Continuation Phase|Withdrawal by Subject|2|||
163104140|NCT00104416|589086437|FG003|Continuation Phase|Withdrawal by Subject|1|||
163104141|NCT00104416|589086438|FG004|Continuation Phase|Withdrawal by Subject|1|||
163104142|NCT00104416|589086434|FG000|Continuation Phase|Pregnancy|0|||
163104143|NCT00104416|589086435|FG001|Continuation Phase|Pregnancy|0|||
163104144|NCT00104416|589086436|FG002|Continuation Phase|Pregnancy|1|||
163104145|NCT00104416|589086437|FG003|Continuation Phase|Pregnancy|1|||
163104146|NCT00104416|589086438|FG004|Continuation Phase|Pregnancy|0|||
163104147|NCT00104416|589086434|FG000|Continuation Phase|Non-compliance|0|||
163104148|NCT00104416|589086435|FG001|Continuation Phase|Non-compliance|0|||
163104149|NCT00104416|589086436|FG002|Continuation Phase|Non-compliance|0|||
163104150|NCT00104416|589086437|FG003|Continuation Phase|Non-compliance|0|||
163104151|NCT00104416|589086438|FG004|Continuation Phase|Non-compliance|1|||
163104152|NCT00438360|589086439|FG000|Overall Study|Adverse Event|6|||
163104153|NCT00438360|589086440|FG001|Overall Study|Adverse Event|1|||
163104154|NCT00438360|589086439|FG000|Overall Study|Lack of Efficacy|42|||
163104155|NCT00438360|589086440|FG001|Overall Study|Lack of Efficacy|27|||
163104156|NCT00438360|589086439|FG000|Overall Study|Other|24|||
163104157|NCT00438360|589086440|FG001|Overall Study|Other|15|||
163104158|NCT00070109|589086441|FG000|Overall Study|Death|1|||
163104159|NCT00070109|589086442|FG001|Overall Study|Death|1|||
163104160|NCT00070109|589086443|FG002|Overall Study|Death|0|||
163104161|NCT00070109|589086444|FG003|Overall Study|Death|0|||
163104162|NCT00070109|589086445|FG004|Overall Study|Death|1|||
162719100|NCT03284957|587678398|FG007|Overall Study|Adverse Event|1|||
163104163|NCT00070109|589086441|FG000|Overall Study|Lack of Efficacy|6|||
163104164|NCT00070109|589086442|FG001|Overall Study|Lack of Efficacy|4|||
163104165|NCT00070109|589086443|FG002|Overall Study|Lack of Efficacy|5|||
163104166|NCT00070109|589086444|FG003|Overall Study|Lack of Efficacy|15|||
162719101|NCT03284957|587678399|FG008|Overall Study|Adverse Event|0|||
162719102|NCT03284957|587678400|FG009|Overall Study|Adverse Event|4|||
163104167|NCT00070109|589086445|FG004|Overall Study|Lack of Efficacy|5|||
163104168|NCT00070109|589086441|FG000|Overall Study|Physician Decision|1|||
163104169|NCT00070109|589086442|FG001|Overall Study|Physician Decision|0|||
163104170|NCT00070109|589086443|FG002|Overall Study|Physician Decision|0|||
163104171|NCT00070109|589086444|FG003|Overall Study|Physician Decision|0|||
163104172|NCT00070109|589086445|FG004|Overall Study|Physician Decision|0|||
163104173|NCT00070109|589086441|FG000|Overall Study|Withdrawal by Subject|0|||
163104174|NCT00070109|589086442|FG001|Overall Study|Withdrawal by Subject|1|||
163104175|NCT00070109|589086443|FG002|Overall Study|Withdrawal by Subject|1|||
163104176|NCT00070109|589086444|FG003|Overall Study|Withdrawal by Subject|0|||
163104177|NCT00070109|589086445|FG004|Overall Study|Withdrawal by Subject|0|||
163104178|NCT00070109|589086441|FG000|Overall Study|Adverse Event|0|||
163104179|NCT00070109|589086442|FG001|Overall Study|Adverse Event|0|||
163104180|NCT00070109|589086443|FG002|Overall Study|Adverse Event|2|||
163104181|NCT00070109|589086444|FG003|Overall Study|Adverse Event|4|||
163104182|NCT00070109|589086445|FG004|Overall Study|Adverse Event|2|||
163104183|NCT00070109|589086441|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
163104184|NCT00070109|589086442|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
163104185|NCT00070109|589086443|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
163104186|NCT00070109|589086444|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
163104187|NCT00070109|589086445|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
163104188|NCT01164891|589086458|FG000|Overall Study|Disease Progression|5|||
163104189|NCT01164891|589086458|FG000|Overall Study|Adverse Event|1|||
163104190|NCT00441142|589086459|FG000|Overall Study|Adverse Event|2|||
163104191|NCT00441142|589086460|FG001|Overall Study|Adverse Event|3|||
162719103|NCT03284957|587678401|FG010|Overall Study|Adverse Event|1|||
163104192|NCT00441142|589086461|FG002|Overall Study|Adverse Event|3|||
163104193|NCT00441142|589086462|FG003|Overall Study|Adverse Event|22|||
163104194|NCT00441142|589086459|FG000|Overall Study|Lack of Efficacy|3|||
163104195|NCT00441142|589086460|FG001|Overall Study|Lack of Efficacy|3|||
163104196|NCT00441142|589086461|FG002|Overall Study|Lack of Efficacy|17|||
163104197|NCT00441142|589086462|FG003|Overall Study|Lack of Efficacy|32|||
163104198|NCT00441142|589086459|FG000|Overall Study|Withdrawal by Subject|0|||
163104199|NCT00441142|589086460|FG001|Overall Study|Withdrawal by Subject|0|||
163104200|NCT00441142|589086461|FG002|Overall Study|Withdrawal by Subject|2|||
163104201|NCT00441142|589086462|FG003|Overall Study|Withdrawal by Subject|10|||
163104202|NCT00441142|589086459|FG000|Overall Study|Patient still receiving active study tx|1|||
163104203|NCT00441142|589086460|FG001|Overall Study|Patient still receiving active study tx|0|||
163104204|NCT00441142|589086461|FG002|Overall Study|Patient still receiving active study tx|0|||
163104205|NCT00441142|589086462|FG003|Overall Study|Patient still receiving active study tx|2|||
163104206|NCT00441142|589086459|FG000|Overall Study|Physician Decision|0|||
163104207|NCT00441142|589086460|FG001|Overall Study|Physician Decision|1|||
163104208|NCT00441142|589086461|FG002|Overall Study|Physician Decision|0|||
163104209|NCT00441142|589086462|FG003|Overall Study|Physician Decision|1|||
163104210|NCT00441142|589086459|FG000|Overall Study|Death|0|||
163104211|NCT00441142|589086460|FG001|Overall Study|Death|0|||
163104212|NCT00441142|589086461|FG002|Overall Study|Death|0|||
163104213|NCT00441142|589086462|FG003|Overall Study|Death|1|||
163104214|NCT00338286|589086463|FG000|Overall Study|Withdrawal by Subject|50|||
163104215|NCT00338286|589086464|FG001|Overall Study|Withdrawal by Subject|54|||
163104216|NCT00338286|589086463|FG000|Overall Study|Lost to Follow-up|80|||
163104217|NCT00338286|589086464|FG001|Overall Study|Lost to Follow-up|66|||
163104218|NCT00338286|589086463|FG000|Overall Study|Other|103|||
163104219|NCT00338286|589086464|FG001|Overall Study|Other|93|||
163104220|NCT01265563|589086465|FG000|Overall Study|Withdrawal by Subject|0|||
163104221|NCT01265563|589086466|FG001|Overall Study|Withdrawal by Subject|1|||
163104222|NCT01265563|589086467|FG002|Overall Study|Withdrawal by Subject|1|||
163104223|NCT01265563|589086468|FG003|Overall Study|Withdrawal by Subject|0|||
163104224|NCT01265563|589086469|FG004|Overall Study|Withdrawal by Subject|2|||
163104225|NCT04908865|589086473|FG000|Overall Study|Adverse Event|2|||
163104226|NCT04908865|589086473|FG000|Overall Study|Lack of Efficacy|5|||
163104227|NCT04908865|589086473|FG000|Overall Study|Lost to Follow-up|1|||
163104228|NCT05286658|589086474|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
163104229|NCT05286658|589086474|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
163104230|NCT01534351|589086477|FG000|Overall Study|Study Terminated Early|1|||
163104231|NCT01534351|589086478|FG001|Overall Study|Study Terminated Early|0|||
163104232|NCT01534351|589086479|FG002|Overall Study|Study Terminated Early|0|||
163104233|NCT00470262|589086480|FG000|Overall Study|Withdrawal by Subject|2|||
163104234|NCT00470262|589086481|FG001|Overall Study|Withdrawal by Subject|0|||
163104235|NCT03248167|589086482|FG000|Overall Study|Withdrawal by Subject|2|||
163104236|NCT03248167|589086483|FG001|Overall Study|Withdrawal by Subject|2|||
163104237|NCT03248167|589086482|FG000|Overall Study|Physician Decision|0|||
163104238|NCT03248167|589086483|FG001|Overall Study|Physician Decision|1|||
163104239|NCT03248167|589086482|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
163104240|NCT03248167|589086483|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
163104241|NCT03248167|589086482|FG000|Overall Study|Lost to Follow-up|1|||
163104242|NCT03248167|589086483|FG001|Overall Study|Lost to Follow-up|0|||
163104243|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Death|0|||
163104244|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Death|1|||
163104245|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Death|1|||
163104246|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Death|0|||
163104247|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Death|0|||
163104248|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Death|0|||
163104249|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Death|0|||
163104250|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Death|0|||
163104251|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104252|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104253|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
163104254|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104255|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
163104256|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104257|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104258|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163104259|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104260|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104261|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104262|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163104263|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104264|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104265|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104266|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163104267|NCT02122146|589086484|FG000|Part 1: Dose Escalation|Other|1|||
163104268|NCT02122146|589086485|FG001|Part 1: Dose Escalation|Other|0|||
163104269|NCT02122146|589086486|FG002|Part 1: Dose Escalation|Other|0|||
163104270|NCT02122146|589086487|FG003|Part 1: Dose Escalation|Other|0|||
163104271|NCT02122146|589086488|FG004|Part 1: Dose Escalation|Other|0|||
163104272|NCT02122146|589086489|FG005|Part 1: Dose Escalation|Other|1|||
163104273|NCT02122146|589086490|FG006|Part 1: Dose Escalation|Other|1|||
163104274|NCT02122146|589086491|FG007|Part 1: Dose Escalation|Other|2|||
163104275|NCT03472495|589086492|FG000|Overall Study|Treatment no longer indicated|1|||
163104276|NCT03472495|589086493|FG001|Overall Study|Treatment no longer indicated|2|||
163104277|NCT03472495|589086492|FG000|Overall Study|Physician Decision|0|||
163104278|NCT03472495|589086493|FG001|Overall Study|Physician Decision|2|||
163104279|NCT02584452|589086496|FG000|Overall Study|Physician Decision|1|||
163104280|NCT02584452|589086497|FG001|Overall Study|Physician Decision|1|||
163104281|NCT02584452|589086496|FG000|Overall Study|Lost to Follow-up|1|||
163104282|NCT02584452|589086497|FG001|Overall Study|Lost to Follow-up|1|||
163104283|NCT02998671|589086498|FG000|Period 1|Study Terminated By Sponsor|2|||
163104284|NCT02998671|589086499|FG001|Period 1|Study Terminated By Sponsor|1|||
163104285|NCT02998671|589086500|FG002|Period 1|Study Terminated By Sponsor|0|||
163104286|NCT02998671|589086501|FG003|Period 1|Study Terminated By Sponsor|0|||
163104287|NCT02998671|589086502|FG004|Period 1|Study Terminated By Sponsor|1|||
163104288|NCT02998671|589086498|FG000|Period 1|Withdrawal by Subject|1|||
163104289|NCT02998671|589086499|FG001|Period 1|Withdrawal by Subject|2|||
163104290|NCT02998671|589086500|FG002|Period 1|Withdrawal by Subject|0|||
163104291|NCT02998671|589086501|FG003|Period 1|Withdrawal by Subject|0|||
163104292|NCT02998671|589086502|FG004|Period 1|Withdrawal by Subject|2|||
163104293|NCT02998671|589086498|FG000|Period 1|Pregnancy|1|||
163104294|NCT02998671|589086499|FG001|Period 1|Pregnancy|0|||
163104295|NCT02998671|589086500|FG002|Period 1|Pregnancy|0|||
163104296|NCT02998671|589086501|FG003|Period 1|Pregnancy|0|||
163104297|NCT02998671|589086502|FG004|Period 1|Pregnancy|0|||
163104298|NCT02998671|589086498|FG000|Period 1|Adverse Event|0|||
163104299|NCT02998671|589086499|FG001|Period 1|Adverse Event|0|||
163104300|NCT02998671|589086500|FG002|Period 1|Adverse Event|0|||
163104301|NCT02998671|589086501|FG003|Period 1|Adverse Event|0|||
163104302|NCT02998671|589086502|FG004|Period 1|Adverse Event|1|||
163104303|NCT02998671|589086498|FG000|Period 2|Adverse Event|0|||
163104304|NCT02998671|589086499|FG001|Period 2|Adverse Event|1|||
163104305|NCT02998671|589086500|FG002|Period 2|Adverse Event|0|||
163104306|NCT02998671|589086501|FG003|Period 2|Adverse Event|0|||
163104307|NCT02998671|589086502|FG004|Period 2|Adverse Event|0|||
163104308|NCT02998671|589086498|FG000|Period 2|Study Terminated By Sponsor|3|||
163104309|NCT02998671|589086499|FG001|Period 2|Study Terminated By Sponsor|5|||
163104310|NCT02998671|589086500|FG002|Period 2|Study Terminated By Sponsor|1|||
163104311|NCT02998671|589086501|FG003|Period 2|Study Terminated By Sponsor|3|||
163104312|NCT02998671|589086502|FG004|Period 2|Study Terminated By Sponsor|0|||
163104313|NCT02998671|589086498|FG000|Period 2|Withdrawal by Subject|0|||
163104314|NCT02998671|589086499|FG001|Period 2|Withdrawal by Subject|1|||
163104315|NCT02998671|589086500|FG002|Period 2|Withdrawal by Subject|0|||
163104316|NCT02998671|589086501|FG003|Period 2|Withdrawal by Subject|0|||
163104317|NCT02998671|589086502|FG004|Period 2|Withdrawal by Subject|0|||
163104318|NCT02998671|589086498|FG000|Period 2|Lost to Follow-up|0|||
163104319|NCT02998671|589086499|FG001|Period 2|Lost to Follow-up|0|||
163104320|NCT02998671|589086500|FG002|Period 2|Lost to Follow-up|0|||
163104321|NCT02998671|589086501|FG003|Period 2|Lost to Follow-up|1|||
163104322|NCT02998671|589086502|FG004|Period 2|Lost to Follow-up|0|||
163104323|NCT01558596|589086504|FG000|Overall Study|Withdrawal by Subject|1|||
163104324|NCT01558596|589086505|FG001|Overall Study|Withdrawal by Subject|0|||
163104325|NCT01558596|589086504|FG000|Overall Study|surgery elsewhere or cancelled|1|||
163104326|NCT01558596|589086505|FG001|Overall Study|surgery elsewhere or cancelled|1|||
163104327|NCT01558596|589086504|FG000|Overall Study|Protocol Violation|1|||
163104328|NCT01558596|589086505|FG001|Overall Study|Protocol Violation|0|||
163104329|NCT04222699|589086513|FG000|Overall Study|Lost to Follow-up|2|||
163104330|NCT03583359|589086533|FG000|Overall Study|Withdrawal by Subject|15|||
163104331|NCT03583359|589086534|FG001|Overall Study|Withdrawal by Subject|6|||
163104332|NCT03583359|589086533|FG000|Overall Study|Lost to Follow-up|12|||
163104333|NCT03583359|589086534|FG001|Overall Study|Lost to Follow-up|3|||
163104334|NCT03583359|589086533|FG000|Overall Study|Adverse Event|0|||
163104335|NCT03583359|589086534|FG001|Overall Study|Adverse Event|1|||
163104336|NCT03583359|589086533|FG000|Overall Study|Protocol Violation|0|||
163104337|NCT03583359|589086534|FG001|Overall Study|Protocol Violation|1|||
163104338|NCT03583359|589086533|FG000|Overall Study|Other|2|||
163104339|NCT03583359|589086534|FG001|Overall Study|Other|1|||
163104340|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Death|1|||
163104341|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Death|0|||
163104342|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Death|0|||
163104343|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
163104344|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
163104345|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
163104346|NCT02567799|589086540|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
163104347|NCT02567799|589086541|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
163104348|NCT02567799|589086542|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
163104349|NCT02567799|589086540|FG000|Follow-up|Death|1|||
163104350|NCT02567799|589086541|FG001|Follow-up|Death|0|||
163104351|NCT02567799|589086542|FG002|Follow-up|Death|1|||
163104352|NCT02567799|589086540|FG000|Follow-up|Progressive Disease|1|||
163104353|NCT02567799|589086541|FG001|Follow-up|Progressive Disease|1|||
163104354|NCT02567799|589086542|FG002|Follow-up|Progressive Disease|3|||
163104355|NCT00790582|589086563|FG000|Overall Study|Death|14|||
163104356|NCT00790582|589086564|FG001|Overall Study|Death|32|||
163104357|NCT00790582|589086563|FG000|Overall Study|Physician Decision|7|||
163104358|NCT00790582|589086564|FG001|Overall Study|Physician Decision|1|||
163104359|NCT00790582|589086563|FG000|Overall Study|Lost to Follow-up|3|||
163104360|NCT00790582|589086564|FG001|Overall Study|Lost to Follow-up|3|||
163104361|NCT00790582|589086563|FG000|Overall Study|Withdrawal by Subject|7|||
162719104|NCT03284957|587678402|FG011|Overall Study|Adverse Event|1|||
163104362|NCT00790582|589086564|FG001|Overall Study|Withdrawal by Subject|51|||
163104363|NCT00803595|589086565|FG000|Overall Study|Adverse Event|3|||
163104364|NCT00803595|589086566|FG001|Overall Study|Adverse Event|4|||
163104365|NCT00803595|589086567|FG002|Overall Study|Adverse Event|1|||
163104366|NCT00803595|589086565|FG000|Overall Study|Protocol Violation|7|||
163104367|NCT00803595|589086566|FG001|Overall Study|Protocol Violation|2|||
163104368|NCT00803595|589086567|FG002|Overall Study|Protocol Violation|12|||
163104369|NCT00803595|589086565|FG000|Overall Study|Withdrawal by Subject|5|||
163104370|NCT00803595|589086566|FG001|Overall Study|Withdrawal by Subject|2|||
163104371|NCT00803595|589086567|FG002|Overall Study|Withdrawal by Subject|3|||
163104372|NCT02566785|589086568|FG000|Overall Study|Lost to Follow-up|0|||
163104373|NCT02566785|589086569|FG001|Overall Study|Lost to Follow-up|2|||
163104374|NCT02566785|589086568|FG000|Overall Study|Worsening condition|1|||
163104375|NCT02566785|589086569|FG001|Overall Study|Worsening condition|1|||
163104376|NCT01597908|589086570|FG000|Randomized Phase|Death|217|||
163104377|NCT01597908|589086571|FG001|Randomized Phase|Death|238|||
163104378|NCT01597908|589086572|FG002|Randomized Phase|Death|0|||
163104379|NCT01597908|589086570|FG000|Randomized Phase|Sponsor Decision|93|||
163104380|NCT01597908|589086571|FG001|Randomized Phase|Sponsor Decision|39|||
163104381|NCT01597908|589086572|FG002|Randomized Phase|Sponsor Decision|0|||
163104382|NCT01597908|589086570|FG000|Randomized Phase|Lost to Follow-up|9|||
163104383|NCT01597908|589086571|FG001|Randomized Phase|Lost to Follow-up|16|||
163104384|NCT01597908|589086572|FG002|Randomized Phase|Lost to Follow-up|0|||
163104385|NCT01597908|589086570|FG000|Randomized Phase|Physician Decision|6|||
163104386|NCT01597908|589086571|FG001|Randomized Phase|Physician Decision|3|||
163104387|NCT01597908|589086572|FG002|Randomized Phase|Physician Decision|0|||
163104388|NCT01597908|589086570|FG000|Randomized Phase|Withdrawal by Subject|26|||
163104389|NCT01597908|589086571|FG001|Randomized Phase|Withdrawal by Subject|22|||
163104390|NCT01597908|589086572|FG002|Randomized Phase|Withdrawal by Subject|0|||
163104391|NCT01597908|589086570|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
163104392|NCT01597908|589086571|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
163104393|NCT01597908|589086572|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
163104394|NCT01597908|589086570|FG000|Crossover Phase|Death|0|||
163104395|NCT01597908|589086571|FG001|Crossover Phase|Death|0|||
163104396|NCT01597908|589086572|FG002|Crossover Phase|Death|11|||
163104397|NCT01597908|589086570|FG000|Crossover Phase|Withdrawal by Subject|0|||
163104398|NCT01597908|589086571|FG001|Crossover Phase|Withdrawal by Subject|0|||
163104399|NCT01597908|589086572|FG002|Crossover Phase|Withdrawal by Subject|3|||
163104400|NCT01597908|589086570|FG000|Crossover Phase|Sponsor Decision|0|||
163104401|NCT01597908|589086571|FG001|Crossover Phase|Sponsor Decision|0|||
163104402|NCT01597908|589086572|FG002|Crossover Phase|Sponsor Decision|20|||
163104403|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Adverse Event|21|||
163104404|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Adverse Event|34|||
163104405|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Adverse Event|14|||
163104406|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Adverse Event|17|||
163104407|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Adverse Event|0|||
163104408|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
163104409|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
163104410|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
163104411|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
163104412|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
163104413|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
163104414|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
163104415|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
163104416|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
163104417|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
163104418|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Physician Decision|2|||
163104419|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Physician Decision|4|||
163104420|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Physician Decision|4|||
163104421|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Physician Decision|4|||
163104422|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Physician Decision|0|||
163104423|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
163104424|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
163104425|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
163104426|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
163104427|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
163104428|NCT00451958|589086575|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
163104429|NCT00451958|589086576|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
163104430|NCT00451958|589086577|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
163104431|NCT00451958|589086578|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
163104432|NCT00451958|589086579|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
163104433|NCT01027650|589086582|FG000|Overall Study|Personal Reasons|0|||
163104434|NCT01027650|589086583|FG001|Overall Study|Personal Reasons|0|||
163104435|NCT01027650|589086584|FG002|Overall Study|Personal Reasons|0|||
163104436|NCT01027650|589086585|FG003|Overall Study|Personal Reasons|0|||
163104437|NCT01027650|589086586|FG004|Overall Study|Personal Reasons|2|||
163104438|NCT01027650|589086587|FG005|Overall Study|Personal Reasons|1|||
163104439|NCT01027650|589086588|FG006|Overall Study|Personal Reasons|0|||
163104440|NCT01027650|589086589|FG007|Overall Study|Personal Reasons|0|||
163104441|NCT01027650|589086582|FG000|Overall Study|Lost to Follow-up|0|||
163104442|NCT01027650|589086583|FG001|Overall Study|Lost to Follow-up|0|||
162653571|NCT02457598|587447615|FG015|Overall Study|Intercurrent Illness|0|||
163104443|NCT01027650|589086584|FG002|Overall Study|Lost to Follow-up|0|||
163104444|NCT01027650|589086585|FG003|Overall Study|Lost to Follow-up|0|||
163104445|NCT01027650|589086586|FG004|Overall Study|Lost to Follow-up|0|||
163104446|NCT01027650|589086587|FG005|Overall Study|Lost to Follow-up|0|||
163104447|NCT01027650|589086588|FG006|Overall Study|Lost to Follow-up|1|||
163104448|NCT01027650|589086589|FG007|Overall Study|Lost to Follow-up|0|||
163104449|NCT01027650|589086582|FG000|Overall Study|Lack of Efficacy|0|||
163104450|NCT01027650|589086583|FG001|Overall Study|Lack of Efficacy|0|||
163104451|NCT01027650|589086584|FG002|Overall Study|Lack of Efficacy|0|||
163104452|NCT01027650|589086585|FG003|Overall Study|Lack of Efficacy|0|||
163104453|NCT01027650|589086586|FG004|Overall Study|Lack of Efficacy|0|||
163104454|NCT01027650|589086587|FG005|Overall Study|Lack of Efficacy|1|||
163104455|NCT01027650|589086588|FG006|Overall Study|Lack of Efficacy|0|||
163104456|NCT01027650|589086589|FG007|Overall Study|Lack of Efficacy|0|||
163104457|NCT00670930|589086590|FG000|Overall Study|Adminstrative Problem|0|||
163104458|NCT00670930|589086591|FG001|Overall Study|Adminstrative Problem|1|||
163104459|NCT00670930|589086590|FG000|Overall Study|Lost to Follow-up|1|||
163104460|NCT00670930|589086591|FG001|Overall Study|Lost to Follow-up|0|||
163104461|NCT00782171|589088187|FG000|Overall Study|Lost to Follow-up|2|||
163104462|NCT00782171|589088188|FG001|Overall Study|Lost to Follow-up|2|||
163104463|NCT00782171|589088187|FG000|Overall Study|Withdrawal by Subject|2|||
163104464|NCT00782171|589088188|FG001|Overall Study|Withdrawal by Subject|1|||
163104465|NCT00782171|589088187|FG000|Overall Study|complications|3|||
163104466|NCT00782171|589088188|FG001|Overall Study|complications|1|||
163104467|NCT00782171|589088187|FG000|Overall Study|others|7|||
163104468|NCT00782171|589088188|FG001|Overall Study|others|9|||
163104469|NCT00782171|589088187|FG000|Overall Study|not eligible|8|||
163104470|NCT00782171|589088188|FG001|Overall Study|not eligible|6|||
163104471|NCT05897242|589088191|FG000|Overall Study|Lost to Follow-up|6|||
163104472|NCT05897242|589088192|FG001|Overall Study|Lost to Follow-up|1|||
163104473|NCT05897242|589088191|FG000|Overall Study|Incomplete|1|||
163104474|NCT05897242|589088192|FG001|Overall Study|Incomplete|0|||
163104475|NCT05897242|589088191|FG000|Overall Study|Withdrawal by Subject|1|||
163104476|NCT05897242|589088192|FG001|Overall Study|Withdrawal by Subject|0|||
163104477|NCT03522246|589088193|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
163104478|NCT03522246|589088194|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
163104479|NCT03522246|589088195|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
163104480|NCT03522246|589088196|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
163104481|NCT03522246|589088197|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
163104482|NCT00814580|589088198|FG000|Overall Study|Adverse Event|6|||
163104483|NCT00814580|589088199|FG001|Overall Study|Adverse Event|15|||
163104484|NCT00814580|589088198|FG000|Overall Study|Lack of Efficacy|18|||
163104485|NCT00814580|589088199|FG001|Overall Study|Lack of Efficacy|25|||
163104486|NCT00814580|589088198|FG000|Overall Study|Protocol Violation|2|||
163104487|NCT00814580|589088199|FG001|Overall Study|Protocol Violation|0|||
163104488|NCT00814580|589088198|FG000|Overall Study|Withdrawal by Subject|2|||
163104489|NCT00814580|589088199|FG001|Overall Study|Withdrawal by Subject|2|||
163104490|NCT00814580|589088198|FG000|Overall Study|Other|1|||
163104491|NCT00814580|589088199|FG001|Overall Study|Other|3|||
163104492|NCT00814580|589088198|FG000|Overall Study|Did Not Take Drug|2|||
163104493|NCT00814580|589088199|FG001|Overall Study|Did Not Take Drug|2|||
163104494|NCT02482428|589088200|FG000|Overall Study|Lost to Follow-up|4|||
163104495|NCT02482428|589088201|FG001|Overall Study|Lost to Follow-up|9|||
163104496|NCT02482428|589088202|FG002|Overall Study|Lost to Follow-up|1|||
163104497|NCT02482428|589088203|FG003|Overall Study|Lost to Follow-up|2|||
163104498|NCT02482428|589088204|FG004|Overall Study|Lost to Follow-up|4|||
163104499|NCT02482428|589088200|FG000|Overall Study|Physician Decision|0|||
163104500|NCT02482428|589088201|FG001|Overall Study|Physician Decision|0|||
162653572|NCT02457598|587447616|FG016|Overall Study|Intercurrent Illness|0|||
162653573|NCT02457598|587447600|FG000|Overall Study|Protocol Violation|0|||
162653574|NCT02457598|587447601|FG001|Overall Study|Protocol Violation|0|||
163104501|NCT02482428|589088202|FG002|Overall Study|Physician Decision|0|||
163104502|NCT02482428|589088203|FG003|Overall Study|Physician Decision|0|||
163104503|NCT02482428|589088204|FG004|Overall Study|Physician Decision|1|||
163104504|NCT02482428|589088200|FG000|Overall Study|protocol deviation|1|||
163104505|NCT02482428|589088201|FG001|Overall Study|protocol deviation|1|||
163104506|NCT02482428|589088202|FG002|Overall Study|protocol deviation|0|||
163104507|NCT02482428|589088203|FG003|Overall Study|protocol deviation|0|||
163104508|NCT02482428|589088204|FG004|Overall Study|protocol deviation|0|||
163104509|NCT02482428|589088200|FG000|Overall Study|subject/guardian decision|4|||
163104510|NCT02482428|589088201|FG001|Overall Study|subject/guardian decision|2|||
163104511|NCT02482428|589088202|FG002|Overall Study|subject/guardian decision|0|||
163104512|NCT02482428|589088203|FG003|Overall Study|subject/guardian decision|0|||
163104513|NCT02482428|589088204|FG004|Overall Study|subject/guardian decision|2|||
163104514|NCT00809835|589088207|FG000|Overall Study|Lost to Follow-up|7|||
163104515|NCT00809835|589088208|FG001|Overall Study|Lost to Follow-up|6|||
163104516|NCT00809835|589088209|FG002|Overall Study|Lost to Follow-up|10|||
163104517|NCT00809835|589088210|FG003|Overall Study|Lost to Follow-up|2|||
163104518|NCT00809835|589088207|FG000|Overall Study|Withdrawal by Subject|1|||
163104519|NCT00809835|589088208|FG001|Overall Study|Withdrawal by Subject|1|||
163104520|NCT00809835|589088209|FG002|Overall Study|Withdrawal by Subject|1|||
163104521|NCT00809835|589088210|FG003|Overall Study|Withdrawal by Subject|0|||
163104522|NCT02547038|589088211|FG000|Overall Study|Lost to Follow-up|3|||
163104523|NCT02547038|589088212|FG001|Overall Study|Lost to Follow-up|2|||
163104524|NCT00516893|589088213|FG000|Overall Study|Lost to Follow-up|4|||
163104525|NCT00516893|589088213|FG000|Overall Study|Adverse Event|3|||
163104526|NCT00516893|589088213|FG000|Overall Study|Withdrawal by Subject|2|||
163104527|NCT00516893|589088213|FG000|Overall Study|Noncompliance|2|||
163104528|NCT00516893|589088213|FG000|Overall Study|Death|1|||
163104529|NCT00516893|589088213|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
163104530|NCT00516893|589088213|FG000|Overall Study|Relocated|1|||
163104531|NCT00516893|589088213|FG000|Overall Study|Pregnancy|1|||
163104532|NCT00516893|589088213|FG000|Overall Study|Received Medication From Another Study|1|||
163104533|NCT05160415|589088216|FG000|Overall Study|Withdrawal by Subject|3|||
163104534|NCT00933608|589088217|FG000|Overall Study|Adverse Event|4|||
163104535|NCT00933608|589088218|FG001|Overall Study|Adverse Event|2|||
163104536|NCT00933608|589088217|FG000|Overall Study|Physician Decision|1|||
163104537|NCT00933608|589088218|FG001|Overall Study|Physician Decision|0|||
163104538|NCT01519791|589088224|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
163104539|NCT01519791|589088225|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
163104540|NCT01519791|589088224|FG000|Overall Study|Protocol Violation|6|||
163104541|NCT01519791|589088225|FG001|Overall Study|Protocol Violation|19|||
163104542|NCT01519791|589088224|FG000|Overall Study|Other Reason|87|||
163104543|NCT01519791|589088225|FG001|Overall Study|Other Reason|222|||
163104544|NCT01519791|589088224|FG000|Overall Study|subjects randomized in error|2|||
163104545|NCT01519791|589088225|FG001|Overall Study|subjects randomized in error|0|||
163104546|NCT01519791|589088224|FG000|Overall Study|Lack of Efficacy|16|||
163104547|NCT01519791|589088225|FG001|Overall Study|Lack of Efficacy|20|||
163104548|NCT01519791|589088224|FG000|Overall Study|SAE, non-fatal|6|||
163104549|NCT01519791|589088225|FG001|Overall Study|SAE, non-fatal|22|||
163104550|NCT01519791|589088224|FG000|Overall Study|AE, serious fatal|0|||
163104551|NCT01519791|589088225|FG001|Overall Study|AE, serious fatal|1|||
163104552|NCT01519791|589088224|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
163104553|NCT01519791|589088225|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
163104554|NCT01519791|589088224|FG000|Overall Study|AE, non-serious non-fatal|12|||
163104555|NCT01519791|589088225|FG001|Overall Study|AE, non-serious non-fatal|31|||
163104556|NCT01519791|589088224|FG000|Overall Study|Withdrawal by Subject|15|||
163104557|NCT01519791|589088225|FG001|Overall Study|Withdrawal by Subject|37|||
163104558|NCT01519791|589088224|FG000|Overall Study|Lost to Follow-up|6|||
163104559|NCT01519791|589088225|FG001|Overall Study|Lost to Follow-up|14|||
163104560|NCT00623233|589088226|FG000|Overall Study|Adverse Event|10|||
163104561|NCT00623233|589088226|FG000|Overall Study|Physician Decision|10|||
163104562|NCT00623233|589088226|FG000|Overall Study|Lost to Follow-up|1|||
163104563|NCT00623233|589088226|FG000|Overall Study|Withdrawal by Subject|3|||
163104564|NCT00559845|589088227|FG000|Overall Study|Withdrew Consent|1|||
163104565|NCT00559845|589088227|FG000|Overall Study|Disease Progression|1|||
163104566|NCT00559845|589088227|FG000|Overall Study|Adverse Event|3|||
163104567|NCT00559845|589088227|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
163104568|NCT00559845|589088227|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
163104569|NCT00459875|589088228|FG000|Overall Study|Ineligible participant|1|||
163104570|NCT00459875|589088228|FG000|Overall Study|Adverse Event|2|||
163104571|NCT03645421|589088234|FG000|Overall Study|Adverse Event|0|||
163104572|NCT03645421|589088235|FG001|Overall Study|Adverse Event|0|||
163104573|NCT03645421|589088236|FG002|Overall Study|Adverse Event|4|||
163104574|NCT03645421|589088237|FG003|Overall Study|Adverse Event|1|||
163104575|NCT03645421|589088234|FG000|Overall Study|Withdrawal by patient|0|||
163104576|NCT03645421|589088235|FG001|Overall Study|Withdrawal by patient|0|||
163104577|NCT03645421|589088236|FG002|Overall Study|Withdrawal by patient|0|||
163104578|NCT03645421|589088237|FG003|Overall Study|Withdrawal by patient|3|||
163104579|NCT03645421|589088234|FG000|Overall Study|Study specific withdrawal criteria|0|||
163104580|NCT03645421|589088235|FG001|Overall Study|Study specific withdrawal criteria|0|||
162653575|NCT02457598|587447602|FG002|Overall Study|Protocol Violation|0|||
162653576|NCT02457598|587447603|FG003|Overall Study|Protocol Violation|0|||
163104581|NCT03645421|589088236|FG002|Overall Study|Study specific withdrawal criteria|1|||
163104582|NCT03645421|589088237|FG003|Overall Study|Study specific withdrawal criteria|0|||
162653577|NCT02457598|587447604|FG004|Overall Study|Protocol Violation|0|||
163104583|NCT02120781|589088238|FG000|Overall Study|Physician Decision|2|||
162653578|NCT02457598|587447605|FG005|Overall Study|Protocol Violation|0|||
163104584|NCT02120781|589088239|FG001|Overall Study|Physician Decision|0|||
163104585|NCT02120781|589088238|FG000|Overall Study|Completion not documented|2|||
163104586|NCT02120781|589088239|FG001|Overall Study|Completion not documented|1|||
163104587|NCT01977729|589088245|FG000|Overall Study|Study terminated|1|||
162653579|NCT02457598|587447606|FG006|Overall Study|Protocol Violation|0|||
163104588|NCT05332392|589088246|FG000|Overall Study|Did not meet inclusion criteria|25|||
163104589|NCT05332392|589088246|FG000|Overall Study|Principal Investigator's decision|17|||
163104590|NCT05332392|589088246|FG000|Overall Study|Adverse Event|1|||
163104591|NCT05332392|589088246|FG000|Overall Study|Subject's decision|1|||
163104592|NCT01268046|589088247|FG000|Overall Study|Withdrawal by Subject|1|||
163104593|NCT01268046|589088248|FG001|Overall Study|Withdrawal by Subject|0|||
163104594|NCT01268046|589088249|FG002|Overall Study|Withdrawal by Subject|0|||
163104595|NCT01268046|589088250|FG003|Overall Study|Withdrawal by Subject|1|||
163104596|NCT01268046|589088247|FG000|Overall Study|Lost to Follow-up|0|||
163104597|NCT01268046|589088248|FG001|Overall Study|Lost to Follow-up|0|||
163104598|NCT01268046|589088249|FG002|Overall Study|Lost to Follow-up|1|||
163104599|NCT01268046|589088250|FG003|Overall Study|Lost to Follow-up|0|||
163104600|NCT03850093|589088251|FG000|Overall Study|Withdrawal by Subject|1|||
163104601|NCT03850093|589088252|FG001|Overall Study|Withdrawal by Subject|0|||
163104602|NCT03850093|589088253|FG002|Overall Study|Withdrawal by Subject|2|||
163104603|NCT03636893|589088254|FG000|Overall Study|Death|0|||
163104604|NCT03636893|589088255|FG001|Overall Study|Death|1|||
163104605|NCT03636893|589088254|FG000|Overall Study|Protocol Violation|0|||
163104606|NCT03636893|589088255|FG001|Overall Study|Protocol Violation|3|||
163104607|NCT03636893|589088254|FG000|Overall Study|Withdrawal by Subject|1|||
163104608|NCT03636893|589088255|FG001|Overall Study|Withdrawal by Subject|2|||
163104609|NCT03636893|589088254|FG000|Overall Study|Refusal to surgery|4|||
163104610|NCT03636893|589088255|FG001|Overall Study|Refusal to surgery|3|||
163104611|NCT03636893|589088254|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
163104612|NCT03636893|589088255|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
163104613|NCT03636893|589088254|FG000|Overall Study|Adverse Event|1|||
163104614|NCT03636893|589088255|FG001|Overall Study|Adverse Event|1|||
163104615|NCT02314156|589088256|FG000|Overall Study|Adverse Event|1|||
163104616|NCT02314156|589088257|FG001|Overall Study|Adverse Event|0|||
163104617|NCT02314156|589088256|FG000|Overall Study|Withdrawal by Subject|1|||
163104618|NCT02314156|589088257|FG001|Overall Study|Withdrawal by Subject|0|||
163104619|NCT00758069|589088262|FG000|Overall Study|Lack of Efficacy|0|||
163104620|NCT00758069|589088263|FG001|Overall Study|Lack of Efficacy|0|||
163104621|NCT00758069|589088264|FG002|Overall Study|Lack of Efficacy|1|||
163104622|NCT00758069|589088262|FG000|Overall Study|Incorrect Study Drug|1|||
163104623|NCT00758069|589088263|FG001|Overall Study|Incorrect Study Drug|0|||
163104624|NCT00758069|589088264|FG002|Overall Study|Incorrect Study Drug|0|||
163104625|NCT04560816|589088265|FG000|Overall Study|Withdrawal by Subject|1|||
163104626|NCT04560816|589088266|FG001|Overall Study|Withdrawal by Subject|1|||
163104627|NCT04560816|589088267|FG002|Overall Study|Withdrawal by Subject|1|||
163104628|NCT04560816|589088268|FG003|Overall Study|Withdrawal by Subject|0|||
163104629|NCT04560816|589088269|FG004|Overall Study|Withdrawal by Subject|3|||
163104630|NCT04560816|589088270|FG005|Overall Study|Withdrawal by Subject|0|||
163104631|NCT04560816|589088265|FG000|Overall Study|Lost to Follow-up|1|||
163104632|NCT04560816|589088266|FG001|Overall Study|Lost to Follow-up|0|||
163104633|NCT04560816|589088267|FG002|Overall Study|Lost to Follow-up|0|||
163104634|NCT04560816|589088268|FG003|Overall Study|Lost to Follow-up|0|||
163104635|NCT04560816|589088269|FG004|Overall Study|Lost to Follow-up|0|||
163104636|NCT04560816|589088270|FG005|Overall Study|Lost to Follow-up|0|||
163104637|NCT04560816|589088265|FG000|Overall Study|Protocol Violation|1|||
163104638|NCT04560816|589088266|FG001|Overall Study|Protocol Violation|0|||
163104639|NCT04560816|589088267|FG002|Overall Study|Protocol Violation|0|||
163104640|NCT04560816|589088268|FG003|Overall Study|Protocol Violation|0|||
163104641|NCT04560816|589088269|FG004|Overall Study|Protocol Violation|0|||
163104642|NCT04560816|589088270|FG005|Overall Study|Protocol Violation|0|||
163104643|NCT03226249|589088271|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
163104644|NCT03226249|589088271|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
163104645|NCT03226249|589088271|FG000|Survival Follow-up|Patients still in follow-up.|30|||
163104646|NCT02277691|589088272|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
163104647|NCT02277691|589088272|FG000|Overall Study|Voluntary Withdrawal|7|||
163104648|NCT02277691|589088272|FG000|Overall Study|Lack of Efficacy|5|||
163104649|NCT02277691|589088272|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
163104650|NCT02846389|589088275|FG000|Overall Study|Withdrawal by Subject|1|||
163104651|NCT02846389|589088276|FG001|Overall Study|Withdrawal by Subject|1|||
163104652|NCT01804049|589088279|FG000|Overall Study|Adverse Event|2|||
163104653|NCT01804049|589088280|FG001|Overall Study|Adverse Event|10|||
163104654|NCT01804049|589088279|FG000|Overall Study|Lost to Follow-up|2|||
163104655|NCT01804049|589088280|FG001|Overall Study|Lost to Follow-up|1|||
163104656|NCT01804049|589088279|FG000|Overall Study|Decreased interest/personal|4|||
163104657|NCT01804049|589088280|FG001|Overall Study|Decreased interest/personal|5|||
163104658|NCT01804049|589088279|FG000|Overall Study|Other health concerns|2|||
163104659|NCT01804049|589088280|FG001|Overall Study|Other health concerns|7|||
163104660|NCT01804049|589088279|FG000|Overall Study|Moved out of area|0|||
163104661|NCT01804049|589088280|FG001|Overall Study|Moved out of area|7|||
162653580|NCT02457598|587447607|FG007|Overall Study|Protocol Violation|0|||
162653581|NCT02457598|587447608|FG008|Overall Study|Protocol Violation|0|||
162653582|NCT02457598|587447609|FG009|Overall Study|Protocol Violation|0|||
163104662|NCT01804049|589088279|FG000|Overall Study|other MD recommended|1|||
163104663|NCT01804049|589088280|FG001|Overall Study|other MD recommended|1|||
163104664|NCT01804049|589088279|FG000|Overall Study|Enrollment in dual studies|0|||
163104665|NCT01804049|589088280|FG001|Overall Study|Enrollment in dual studies|1|||
163104666|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104667|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
163104668|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104669|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104670|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104671|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
163104672|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
163104673|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
163104674|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104675|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104676|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104677|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163104678|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
163104679|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
163104680|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104681|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104682|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104683|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163104684|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
163104685|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
163104686|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104687|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104688|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104689|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
163104690|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104691|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
163104692|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104693|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104694|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104695|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163104696|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
163104697|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
163104698|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104699|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104700|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104701|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163104702|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104703|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
163104704|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104705|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104706|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104707|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
163104708|NCT03985943|589088281|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104709|NCT03985943|589088282|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
163104710|NCT03985943|589088283|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104711|NCT03985943|589088284|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104712|NCT03985943|589088285|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104713|NCT03985943|589088286|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
163104714|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163104715|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163104716|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
163104717|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163104718|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
163104719|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
163104720|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163104721|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163104722|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104723|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163104724|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104725|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
163104726|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
163104727|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
163104728|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
163104729|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
163104730|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
163104731|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
163104732|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
162653583|NCT02457598|587447610|FG010|Overall Study|Protocol Violation|1|||
163104733|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163104734|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163104735|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163104736|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
162653584|NCT02457598|587447611|FG011|Overall Study|Protocol Violation|0|||
162653585|NCT02457598|587447612|FG012|Overall Study|Protocol Violation|0|||
163104737|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163104738|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104739|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104740|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
163104741|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104742|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
163104743|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
163104744|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
163104745|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
163104746|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
163104747|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
163104748|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
163104749|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
163104750|NCT03985943|589088281|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
163104751|NCT03985943|589088282|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
163104752|NCT03985943|589088283|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
163104753|NCT03985943|589088284|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
163104754|NCT03985943|589088285|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
163104755|NCT03985943|589088286|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
163104756|NCT04075513|589088289|FG000|Overall Study|Withdrawal by Subject|2|||
163104757|NCT04075513|589088290|FG001|Overall Study|Withdrawal by Subject|2|||
163104758|NCT04075513|589088289|FG000|Overall Study|Lack of Efficacy|1|||
163104759|NCT04075513|589088290|FG001|Overall Study|Lack of Efficacy|0|||
163104760|NCT04075513|589088289|FG000|Overall Study|Lost to Follow-up|4|||
163104761|NCT04075513|589088290|FG001|Overall Study|Lost to Follow-up|2|||
163104762|NCT04075513|589088289|FG000|Overall Study|Switch to insulin pump|1|||
163104763|NCT04075513|589088290|FG001|Overall Study|Switch to insulin pump|0|||
163104764|NCT05730335|589088291|FG000|Overall Study|Lost to Follow-up|8|||
163104765|NCT05730335|589088291|FG000|Overall Study|Withdrawal by Subject|6|||
163104766|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104767|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104768|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104769|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
163104770|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104771|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
163104772|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104773|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104774|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104775|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
163104776|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104777|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
163104778|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104779|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
163104780|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104781|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104782|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104783|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
163104784|NCT03629223|589088292|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104785|NCT03629223|589088293|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
163104786|NCT03629223|589088294|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104787|NCT03629223|589088295|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104788|NCT03629223|589088296|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104789|NCT03629223|589088297|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
163104790|NCT03629223|589088292|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
163104791|NCT03629223|589088293|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104792|NCT03629223|589088294|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104793|NCT03629223|589088295|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104794|NCT03629223|589088296|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104795|NCT03629223|589088297|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
163104796|NCT01369199|589088300|FG000|Overall Study|Withdrawal by Subject|1|||
163104797|NCT01369199|589088300|FG000|Overall Study|Lost to Follow-up|2|||
163104798|NCT03902392|589088303|FG000|Overall Study|Lost to Follow-up|7|||
163104799|NCT03902392|589088304|FG001|Overall Study|Lost to Follow-up|7|||
163104800|NCT02038946|589088307|FG000|Overall Study|Death|5|||
163104801|NCT02038946|589088307|FG000|Overall Study|Withdrawal by Subject|3|||
163104802|NCT02038946|589088307|FG000|Overall Study|Lost to Follow-up|2|||
163104803|NCT02038946|589088307|FG000|Overall Study|Other reasons|2|||
163104804|NCT00771927|589088310|FG000|Overall Study|Adverse Event|100|||
163104805|NCT00771927|589088311|FG001|Overall Study|Adverse Event|105|||
163104806|NCT00771927|589088310|FG000|Overall Study|Lack of Efficacy|70|||
162719105|NCT03284957|587678403|FG012|Overall Study|Adverse Event|0|||
163104807|NCT00771927|589088311|FG001|Overall Study|Lack of Efficacy|42|||
163104808|NCT00771927|589088310|FG000|Overall Study|Lost to Follow-up|46|||
163104809|NCT00771927|589088311|FG001|Overall Study|Lost to Follow-up|46|||
163104810|NCT00771927|589088310|FG000|Overall Study|Withdrawal by Subject|16|||
163104811|NCT00771927|589088311|FG001|Overall Study|Withdrawal by Subject|17|||
163104812|NCT00771927|589088310|FG000|Overall Study|Other reason|23|||
163104813|NCT00771927|589088311|FG001|Overall Study|Other reason|27|||
163104814|NCT02467192|589088315|FG000|Overall Study|Death|1|||
163104815|NCT02467192|589088315|FG000|Overall Study|revealed to have pneumonia before|2|||
163104816|NCT03213938|589088316|FG000|Overall Study|Lost to Follow-up|4|||
163104817|NCT03213938|589088317|FG001|Overall Study|Lost to Follow-up|3|||
163104818|NCT03213938|589088316|FG000|Overall Study|Lack of Efficacy|1|||
163104819|NCT03213938|589088317|FG001|Overall Study|Lack of Efficacy|0|||
163104820|NCT03213938|589088316|FG000|Overall Study|Decline to participate|5|||
163104821|NCT03213938|589088317|FG001|Overall Study|Decline to participate|4|||
163104822|NCT03213938|589088316|FG000|Overall Study|Without reason|4|||
163104823|NCT03213938|589088317|FG001|Overall Study|Without reason|5|||
163104824|NCT01814046|589088319|FG000|Drug Administration|Death due to complications of RSV|1|||
163104825|NCT01814046|589088320|FG001|Drug Administration|Death due to complications of RSV|0|||
163104826|NCT01814046|589088321|FG002|Drug Administration|Death due to complications of RSV|0|||
163104827|NCT00958347|589088322|FG000|Overall Study|Death|43|||
163104828|NCT00958347|589088322|FG000|Overall Study|Withdrawal by Subject|23|||
163104829|NCT00958347|589088322|FG000|Overall Study|Lost to Follow-up|15|||
163104830|NCT00958347|589088322|FG000|Overall Study|revision/removal|10|||
163104831|NCT00958347|589088322|FG000|Overall Study|study termination|135|||
163104832|NCT04552288|589088323|FG000|Overall Study|Death|3|||
163104833|NCT04552288|589088323|FG000|Overall Study|Lost to Follow-up|6|||
163104834|NCT04552288|589088323|FG000|Overall Study|Physician Decision|3|||
163104835|NCT04552288|589088323|FG000|Overall Study|Protocol Violation|9|||
163104836|NCT04552288|589088323|FG000|Overall Study|Withdrawal by Subject|6|||
163104837|NCT04552288|589088323|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
163104838|NCT00375505|589088324|FG000|Overall Study|Adverse Event|1|||
163104839|NCT00375505|589088325|FG001|Overall Study|Adverse Event|2|||
163104840|NCT00429182|589088326|FG000|Overall Study|Not evaluable, Disease Progression|2|||
163104841|NCT00429182|589088326|FG000|Overall Study|Not eligible|5|||
163104842|NCT03335150|589088329|FG000|Overall Study|Withdrawal by Subject|10|||
163104843|NCT03335150|589088330|FG001|Overall Study|Withdrawal by Subject|4|||
163104844|NCT03335150|589088329|FG000|Overall Study|Adverse Event|0|||
163104845|NCT03335150|589088330|FG001|Overall Study|Adverse Event|1|||
163104846|NCT02218697|589088335|FG000|Overall Study|Adverse Event|0|||
163104847|NCT02218697|589088336|FG001|Overall Study|Adverse Event|2|||
163104848|NCT02218697|589088335|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
163104849|NCT02218697|589088336|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
163104850|NCT02218697|589088335|FG000|Overall Study|Withdrawal by Subject|2|||
163104851|NCT02218697|589088336|FG001|Overall Study|Withdrawal by Subject|3|||
163104852|NCT02142803|589088339|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104853|NCT02142803|589088340|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104854|NCT02142803|589088341|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
163104855|NCT02142803|589088342|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
163104856|NCT05111002|589088345|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
163104857|NCT05111002|589088346|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
163104858|NCT05111002|589088345|FG000|Secondary Outcome|Lost to Follow-up|1|||
163104859|NCT05111002|589088346|FG001|Secondary Outcome|Lost to Follow-up|0|||
163104860|NCT04380753|589088347|FG000|Overall Study|Participants continuing study|4|||
163104861|NCT04380753|589088347|FG000|Overall Study|Death|2|||
163104862|NCT04776720|589088348|FG000|Overall Study|COVID Related|4|||
163104863|NCT04776720|589088349|FG001|Overall Study|COVID Related|2|||
163104864|NCT04776720|589088348|FG000|Overall Study|Adverse Event|2|||
163104865|NCT04776720|589088349|FG001|Overall Study|Adverse Event|0|||
163104866|NCT04776720|589088348|FG000|Overall Study|Serious Adverse Event|0|||
163104867|NCT04776720|589088349|FG001|Overall Study|Serious Adverse Event|1|||
163104868|NCT04776720|589088348|FG000|Overall Study|Too Busy|3|||
163104869|NCT04776720|589088349|FG001|Overall Study|Too Busy|1|||
163104870|NCT04776720|589088348|FG000|Overall Study|Lost to Follow-up|1|||
163104871|NCT04776720|589088349|FG001|Overall Study|Lost to Follow-up|2|||
162653586|NCT02457598|587447613|FG013|Overall Study|Protocol Violation|0|||
163104872|NCT04776720|589088348|FG000|Overall Study|Family|2|||
163104873|NCT04776720|589088349|FG001|Overall Study|Family|2|||
163104874|NCT04776720|589088348|FG000|Overall Study|No remote technology access|0|||
163104875|NCT04776720|589088349|FG001|Overall Study|No remote technology access|1|||
163104876|NCT04776720|589088348|FG000|Overall Study|Withdrawal by Subject|1|||
163104877|NCT04776720|589088349|FG001|Overall Study|Withdrawal by Subject|0|||
163104878|NCT04776720|589088348|FG000|Overall Study|Cannot tolerate intervention|1|||
163104879|NCT04776720|589088349|FG001|Overall Study|Cannot tolerate intervention|0|||
163104880|NCT04776720|589088348|FG000|Overall Study|Incomplete outcome data|6|||
163104881|NCT04776720|589088349|FG001|Overall Study|Incomplete outcome data|1|||
162653587|NCT02457598|587447614|FG014|Overall Study|Protocol Violation|0|||
162653588|NCT02457598|587447615|FG015|Overall Study|Protocol Violation|0|||
162653589|NCT02457598|587447616|FG016|Overall Study|Protocol Violation|0|||
162653590|NCT02703636|587447618|FG000|Overall Study|Adverse Event|14|||
162653591|NCT02703636|587447618|FG000|Overall Study|Study stopped by sponsor|1|||
162653592|NCT02703636|587447618|FG000|Overall Study|Withdrawal by Subject|1|||
162653593|NCT03316885|587447624|FG000|Overall Study|Adverse Event|1|||
162653594|NCT03316885|587447624|FG000|Overall Study|Death|10|||
162653595|NCT03316885|587447624|FG000|Overall Study|Lost to Follow-up|4|||
162653596|NCT03316885|587447624|FG000|Overall Study|Withdrawal by Subject|9|||
162653597|NCT03316885|587447624|FG000|Overall Study|COVID related|8|||
162653598|NCT02196324|587447629|FG000|Overall Study|Withdrawal by Subject|8|||
162653599|NCT02196324|587447630|FG001|Overall Study|Withdrawal by Subject|4|||
162653600|NCT02196324|587447629|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
162653601|NCT02196324|587447630|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
162653602|NCT02196324|587447629|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
162653603|NCT02196324|587447630|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
162653604|NCT02196324|587447629|FG000|Overall Study|Other|1|||
162653605|NCT02196324|587447630|FG001|Overall Study|Other|0|||
162653606|NCT00692770|587447632|FG000|Overall Study|Protocol Violation|2|||
162653607|NCT00692770|587447633|FG001|Overall Study|Protocol Violation|7|||
162653608|NCT00692770|587447632|FG000|Overall Study|Withdrawal by Subject|97|||
162653609|NCT00692770|587447633|FG001|Overall Study|Withdrawal by Subject|36|||
163104882|NCT02311881|589088350|FG000|Overall Study|Did not meet the study criteria|2|||
163104883|NCT02311881|589088351|FG001|Overall Study|Did not meet the study criteria|2|||
163104884|NCT02311881|589088352|FG002|Overall Study|Did not meet the study criteria|0|||
163104885|NCT02311881|589088350|FG000|Overall Study|Adverse Event|7|||
163104886|NCT02311881|589088351|FG001|Overall Study|Adverse Event|15|||
163104887|NCT02311881|589088352|FG002|Overall Study|Adverse Event|8|||
163104888|NCT02311881|589088350|FG000|Overall Study|Lost to Follow-up|3|||
163104889|NCT02311881|589088351|FG001|Overall Study|Lost to Follow-up|3|||
163104890|NCT02311881|589088352|FG002|Overall Study|Lost to Follow-up|2|||
163104891|NCT02311881|589088350|FG000|Overall Study|Protocol Violation|1|||
163104892|NCT02311881|589088351|FG001|Overall Study|Protocol Violation|2|||
163104893|NCT02311881|589088352|FG002|Overall Study|Protocol Violation|3|||
163104894|NCT02311881|589088350|FG000|Overall Study|Withdrawal of consent|14|||
163104895|NCT02311881|589088351|FG001|Overall Study|Withdrawal of consent|16|||
163104896|NCT02311881|589088352|FG002|Overall Study|Withdrawal of consent|17|||
163104897|NCT02311881|589088350|FG000|Overall Study|Other|0|||
163104898|NCT02311881|589088351|FG001|Overall Study|Other|0|||
163104899|NCT02311881|589088352|FG002|Overall Study|Other|1|||
163104900|NCT02311881|589088350|FG000|Overall Study|Lack of Efficacy|1|||
163104901|NCT02311881|589088351|FG001|Overall Study|Lack of Efficacy|2|||
163104902|NCT02311881|589088352|FG002|Overall Study|Lack of Efficacy|0|||
163104903|NCT02311881|589088350|FG000|Overall Study|Subject has border line pregnancy test|1|||
163104904|NCT02311881|589088351|FG001|Overall Study|Subject has border line pregnancy test|0|||
163104905|NCT02311881|589088352|FG002|Overall Study|Subject has border line pregnancy test|0|||
163104906|NCT02311881|589088350|FG000|Overall Study|Withdrawal by Subject|3|||
163104907|NCT02311881|589088351|FG001|Overall Study|Withdrawal by Subject|1|||
163104908|NCT02311881|589088352|FG002|Overall Study|Withdrawal by Subject|4|||
163104909|NCT02311881|589088350|FG000|Overall Study|Sponsor Decision|1|||
163104910|NCT02311881|589088351|FG001|Overall Study|Sponsor Decision|1|||
163104911|NCT02311881|589088352|FG002|Overall Study|Sponsor Decision|1|||
163104912|NCT02311881|589088350|FG000|Overall Study|Protocol Deviation|1|||
163104913|NCT02311881|589088351|FG001|Overall Study|Protocol Deviation|0|||
163104914|NCT02311881|589088352|FG002|Overall Study|Protocol Deviation|0|||
163104915|NCT02311881|589088350|FG000|Overall Study|Non-Compliance|1|||
163104916|NCT02311881|589088351|FG001|Overall Study|Non-Compliance|0|||
163104917|NCT02311881|589088352|FG002|Overall Study|Non-Compliance|2|||
163104918|NCT02311881|589088350|FG000|Overall Study|Physician Decision|0|||
163104919|NCT02311881|589088351|FG001|Overall Study|Physician Decision|0|||
163104920|NCT02311881|589088352|FG002|Overall Study|Physician Decision|1|||
163104921|NCT02311881|589088350|FG000|Overall Study|Medical Monitor Discretion|0|||
163104922|NCT02311881|589088351|FG001|Overall Study|Medical Monitor Discretion|0|||
163104923|NCT02311881|589088352|FG002|Overall Study|Medical Monitor Discretion|1|||
162653610|NCT00692770|587447632|FG000|Overall Study|Adverse Event|136|||
162653611|NCT00692770|587447633|FG001|Overall Study|Adverse Event|41|||
162653612|NCT00692770|587447632|FG000|Overall Study|Death|10|||
162653613|NCT00692770|587447633|FG001|Overall Study|Death|5|||
162653614|NCT00692770|587447632|FG000|Overall Study|Lost to Follow-up|7|||
162653615|NCT00692770|587447633|FG001|Overall Study|Lost to Follow-up|3|||
162653616|NCT00692770|587447632|FG000|Overall Study|Non-compliant with study medication|11|||
162653617|NCT00692770|587447633|FG001|Overall Study|Non-compliant with study medication|5|||
162653618|NCT00692770|587447632|FG000|Overall Study|Progression by clinical judgment|2|||
162653619|NCT00692770|587447633|FG001|Overall Study|Progression by clinical judgment|3|||
162653620|NCT00692770|587447632|FG000|Overall Study|Physician decision not protocol driven|10|||
162653621|NCT00692770|587447633|FG001|Overall Study|Physician decision not protocol driven|14|||
162653622|NCT00692770|587447632|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
162653623|NCT00692770|587447633|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
162653624|NCT00692770|587447632|FG000|Overall Study|Protocol driven decision point|3|||
162653625|NCT00692770|587447633|FG001|Overall Study|Protocol driven decision point|7|||
162653626|NCT00692770|587447632|FG000|Overall Study|Completed all planned assessments|79|||
162653627|NCT00692770|587447633|FG001|Overall Study|Completed all planned assessments|101|||
162653628|NCT00692770|587447632|FG000|Overall Study|Radiological and clinical progression|8|||
162653629|NCT00692770|587447633|FG001|Overall Study|Radiological and clinical progression|8|||
162653630|NCT00692770|587447632|FG000|Overall Study|Clinical endpoint reached|16|||
162653631|NCT00692770|587447633|FG001|Overall Study|Clinical endpoint reached|43|||
162653632|NCT00692770|587447632|FG000|Overall Study|Study terminated by sponsor|2|||
162653633|NCT00692770|587447633|FG001|Overall Study|Study terminated by sponsor|2|||
162653634|NCT00692770|587447632|FG000|Overall Study|Randomized but not treated|3|||
163104924|NCT02311881|589088350|FG000|Overall Study|Participant taking another medication|0|||
163104925|NCT02311881|589088351|FG001|Overall Study|Participant taking another medication|0|||
163104926|NCT02311881|589088352|FG002|Overall Study|Participant taking another medication|1|||
163104927|NCT02311881|589088350|FG000|Overall Study|Serious Adverse Event|0|||
163104928|NCT02311881|589088351|FG001|Overall Study|Serious Adverse Event|1|||
163104929|NCT02311881|589088352|FG002|Overall Study|Serious Adverse Event|0|||
163104930|NCT03306433|589088353|FG000|Overall Study|Lost to Follow-up|3|||
162653635|NCT00692770|587447633|FG001|Overall Study|Randomized but not treated|4|||
162653636|NCT04248816|587447635|FG000|Overall Study|Ineligible post-randomization|7|||
163104931|NCT03306433|589088353|FG000|Overall Study|Patient did not have teeth extracted|1|||
163104932|NCT03306433|589088353|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
163104933|NCT01042158|589088354|FG000|Overall Study|Physician Decision|1|||
163104934|NCT01575808|589088355|FG000|Overall Study|Death|2|||
163104935|NCT01575808|589088356|FG001|Overall Study|Death|0|||
163104936|NCT01575808|589088355|FG000|Overall Study|Withdrawal by Subject|1|||
163104937|NCT01575808|589088356|FG001|Overall Study|Withdrawal by Subject|0|||
163104938|NCT00875485|589090257|FG000|Challenge Dose Epoch|Pregnancy|1|||
163104939|NCT00875485|589090258|FG001|Challenge Dose Epoch|Pregnancy|0|||
163104940|NCT01271010|589090259|FG000|Overall Study|Reason not specified|11|||
163104941|NCT01271010|589090259|FG000|Overall Study|Start of new CLL therapy|1|||
163104942|NCT01271010|589090259|FG000|Overall Study|Protocol Violation|1|||
163104943|NCT01271010|589090259|FG000|Overall Study|Death|2|||
163104944|NCT01271010|589090259|FG000|Overall Study|Progression and relapse of disease|1|||
163104945|NCT01271010|589090259|FG000|Overall Study|Withdrawal by Subject|18|||
163104946|NCT01271010|589090259|FG000|Overall Study|Disease progression|27|||
163104947|NCT01631747|589090260|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
163104948|NCT01631747|589090261|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
163104949|NCT01631747|589090260|FG000|Live Birth|Pregnancy Termination|1|||
163104950|NCT01631747|589090261|FG001|Live Birth|Pregnancy Termination|0|||
163104951|NCT01631747|589090260|FG000|Live Birth|MIscarriage|2|||
163104952|NCT01631747|589090261|FG001|Live Birth|MIscarriage|0|||
163104953|NCT01631747|589090260|FG000|Live Birth|Stillbirth|1|||
163104954|NCT01631747|589090261|FG001|Live Birth|Stillbirth|1|||
163104955|NCT01631747|589090260|FG000|One Year Infant Outcomes|Patient Refused|13|||
163104956|NCT01631747|589090261|FG001|One Year Infant Outcomes|Patient Refused|9|||
163104957|NCT02908685|589090262|FG000|Part 1 OLE|Withdrawal by Subject|0|||
163104958|NCT02908685|589090263|FG001|Part 1 OLE|Withdrawal by Subject|0|||
163104959|NCT02908685|589090264|FG002|Part 1 OLE|Withdrawal by Subject|0|||
163104960|NCT02908685|589090265|FG003|Part 1 OLE|Withdrawal by Subject|0|||
163104961|NCT02908685|589090266|FG004|Part 1 OLE|Withdrawal by Subject|0|||
163104962|NCT02908685|589090267|FG005|Part 1 OLE|Withdrawal by Subject|0|||
163104963|NCT02908685|589090268|FG006|Part 1 OLE|Withdrawal by Subject|0|||
163104964|NCT02908685|589090269|FG007|Part 1 OLE|Withdrawal by Subject|0|||
163104965|NCT02908685|589090270|FG008|Part 1 OLE|Withdrawal by Subject|0|||
163104966|NCT02908685|589090271|FG009|Part 1 OLE|Withdrawal by Subject|0|||
163104967|NCT02908685|589090272|FG010|Part 1 OLE|Withdrawal by Subject|2|||
163104968|NCT02908685|589090273|FG011|Part 1 OLE|Withdrawal by Subject|1|||
163104969|NCT02908685|589090274|FG012|Part 1 OLE|Withdrawal by Subject|0|||
163104970|NCT02908685|589090275|FG013|Part 1 OLE|Withdrawal by Subject|0|||
163104971|NCT02908685|589090262|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104972|NCT02908685|589090263|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104973|NCT02908685|589090264|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104974|NCT02908685|589090265|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104975|NCT02908685|589090266|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104976|NCT02908685|589090267|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104977|NCT02908685|589090268|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104978|NCT02908685|589090269|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104979|NCT02908685|589090270|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104980|NCT02908685|589090271|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104981|NCT02908685|589090272|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104982|NCT02908685|589090273|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
163104983|NCT02908685|589090274|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
163104984|NCT02908685|589090275|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
163104985|NCT02908685|589090262|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104986|NCT02908685|589090263|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104987|NCT02908685|589090264|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104988|NCT02908685|589090265|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104989|NCT02908685|589090266|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104990|NCT02908685|589090267|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104991|NCT02908685|589090268|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104992|NCT02908685|589090269|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104993|NCT02908685|589090270|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104994|NCT02908685|589090271|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104995|NCT02908685|589090272|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104996|NCT02908685|589090273|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104997|NCT02908685|589090274|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
163104998|NCT02908685|589090275|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
163104999|NCT02908685|589090262|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105000|NCT02908685|589090263|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105001|NCT02908685|589090264|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105002|NCT02908685|589090265|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105003|NCT02908685|589090266|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105004|NCT02908685|589090267|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105005|NCT02908685|589090268|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105006|NCT02908685|589090269|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105007|NCT02908685|589090270|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105008|NCT02908685|589090271|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105009|NCT02908685|589090272|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105010|NCT02908685|589090273|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105011|NCT02908685|589090274|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
163105012|NCT02908685|589090275|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
163105013|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Death|0|||
163105014|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Death|0|||
163105015|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Death|0|||
163105016|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Death|0|||
163105017|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Death|0|||
163105018|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Death|0|||
163105019|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Death|0|||
163105020|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Death|0|||
163105021|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Death|0|||
163105022|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Death|0|||
163105023|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Death|0|||
163105024|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Death|0|||
163105025|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Death|1|||
163105026|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Death|0|||
163105027|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
163105028|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
163105029|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
163105030|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
163105031|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
163105032|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
163105033|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
163105034|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
163105035|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
163105036|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
163105037|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
163105038|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
163105039|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
163105040|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
163105041|NCT02908685|589090262|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105042|NCT02908685|589090263|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105043|NCT02908685|589090264|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105044|NCT02908685|589090265|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105045|NCT02908685|589090266|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105046|NCT02908685|589090267|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105047|NCT02908685|589090268|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105048|NCT02908685|589090269|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105049|NCT02908685|589090270|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105050|NCT02908685|589090271|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105051|NCT02908685|589090272|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105052|NCT02908685|589090273|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
163105053|NCT02908685|589090274|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
163105054|NCT02908685|589090275|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
163105055|NCT01691014|589090276|FG000|Overall Study|Premature Termination|1|||
163105056|NCT01691014|589090277|FG001|Overall Study|Premature Termination|6|||
163105057|NCT01691014|589090278|FG002|Overall Study|Premature Termination|0|||
163105058|NCT01691014|589090279|FG003|Overall Study|Premature Termination|3|||
163105059|NCT01691014|589090276|FG000|Overall Study|Other|0|||
163105060|NCT01691014|589090277|FG001|Overall Study|Other|0|||
163105061|NCT01691014|589090278|FG002|Overall Study|Other|2|||
163105062|NCT01691014|589090279|FG003|Overall Study|Other|0|||
163105063|NCT01691014|589090276|FG000|Overall Study|Withdrawal by Subject|0|||
163105064|NCT01691014|589090277|FG001|Overall Study|Withdrawal by Subject|1|||
163105065|NCT01691014|589090278|FG002|Overall Study|Withdrawal by Subject|1|||
163105066|NCT01691014|589090279|FG003|Overall Study|Withdrawal by Subject|1|||
163105067|NCT01691014|589090276|FG000|Overall Study|Adverse Event|0|||
163105068|NCT01691014|589090277|FG001|Overall Study|Adverse Event|5|||
163105069|NCT01691014|589090278|FG002|Overall Study|Adverse Event|1|||
163105070|NCT01691014|589090279|FG003|Overall Study|Adverse Event|1|||
163105071|NCT01691014|589090276|FG000|Overall Study|Lack of Efficacy|2|||
163105072|NCT01691014|589090277|FG001|Overall Study|Lack of Efficacy|3|||
163105073|NCT01691014|589090278|FG002|Overall Study|Lack of Efficacy|7|||
163105074|NCT01691014|589090279|FG003|Overall Study|Lack of Efficacy|0|||
163105075|NCT04308239|589090280|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
163105076|NCT04308239|589090281|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
163105077|NCT04308239|589090280|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
163105078|NCT04308239|589090281|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
163105079|NCT04308239|589090280|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
163105080|NCT04308239|589090281|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
163105081|NCT04308239|589090280|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
163105082|NCT04308239|589090281|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
163105083|NCT05791565|589090284|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
163105084|NCT05791565|589090285|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
163105085|NCT00880269|589090286|FG000|Overall Study|Protocol Violation|1|||
163105086|NCT00880269|589090287|FG001|Overall Study|Protocol Violation|0|||
163105087|NCT00880269|589090286|FG000|Overall Study|Disease Progression|13|||
163105088|NCT00880269|589090287|FG001|Overall Study|Disease Progression|11|||
163105089|NCT00880269|589090286|FG000|Overall Study|New Cancer Therapy|1|||
163105090|NCT00880269|589090287|FG001|Overall Study|New Cancer Therapy|0|||
163105091|NCT00880269|589090286|FG000|Overall Study|Death|4|||
163105092|NCT00880269|589090287|FG001|Overall Study|Death|2|||
163105093|NCT00880269|589090286|FG000|Overall Study|Lost to Follow-up|0|||
163105094|NCT00880269|589090287|FG001|Overall Study|Lost to Follow-up|1|||
163105095|NCT00880269|589090286|FG000|Overall Study|Withdrawal by Subject|3|||
163105096|NCT00880269|589090287|FG001|Overall Study|Withdrawal by Subject|4|||
163105097|NCT00880269|589090286|FG000|Overall Study|Adverse Event|10|||
163105098|NCT00880269|589090287|FG001|Overall Study|Adverse Event|9|||
163105099|NCT02516982|589090288|FG000|Overall Study|Called in to antenatal appointment|32|||
163105100|NCT02516982|589090289|FG001|Overall Study|Called in to antenatal appointment|35|||
163105101|NCT02516982|589090290|FG002|Overall Study|Called in to antenatal appointment|0|||
163105102|NCT02516982|589090291|FG003|Overall Study|Called in to antenatal appointment|0|||
163105103|NCT02516982|589090288|FG000|Overall Study|Withdrawal by Subject|0|||
163105104|NCT02516982|589090289|FG001|Overall Study|Withdrawal by Subject|0|||
163105105|NCT02516982|589090290|FG002|Overall Study|Withdrawal by Subject|1|||
163105106|NCT02516982|589090291|FG003|Overall Study|Withdrawal by Subject|2|||
163105107|NCT02516982|589090288|FG000|Overall Study|Protocol Violation|0|||
163105108|NCT02516982|589090289|FG001|Overall Study|Protocol Violation|0|||
163105109|NCT02516982|589090290|FG002|Overall Study|Protocol Violation|1|||
163105110|NCT02516982|589090291|FG003|Overall Study|Protocol Violation|1|||
163105111|NCT02516982|589090288|FG000|Overall Study|Did not install the app|0|||
163105112|NCT02516982|589090289|FG001|Overall Study|Did not install the app|0|||
163105113|NCT02516982|589090290|FG002|Overall Study|Did not install the app|46|||
163105114|NCT02516982|589090291|FG003|Overall Study|Did not install the app|47|||
163105115|NCT03379259|589090293|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
162653637|NCT04248816|587447636|FG001|Overall Study|Ineligible post-randomization|21|||
162653638|NCT04248816|587447637|FG002|Overall Study|Ineligible post-randomization|25|||
162653639|NCT00344773|587447638|FG000|Overall Study|Adverse Event|2|||
162653640|NCT00344773|587447638|FG000|Overall Study|Objective Disease Progression|16|||
163105116|NCT03379259|589090294|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
163105117|NCT03379259|589090295|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
163105118|NCT03379259|589090296|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
163105119|NCT03379259|589090297|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
163105120|NCT03379259|589090298|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
163105121|NCT03379259|589090293|FG000|Overall Study|Death|0|||
163105122|NCT03379259|589090294|FG001|Overall Study|Death|1|||
163105123|NCT03379259|589090295|FG002|Overall Study|Death|2|||
162653641|NCT00344773|587447638|FG000|Overall Study|Withdrawal by Subject|1|||
162719106|NCT03284957|587678404|FG013|Overall Study|Adverse Event|0|||
162719107|NCT03284957|587678405|FG014|Overall Study|Adverse Event|0|||
162719108|NCT03284957|587678406|FG015|Overall Study|Adverse Event|0|||
162719109|NCT03284957|587678391|FG000|Overall Study|Progressive Disease|3|||
162719110|NCT03284957|587678392|FG001|Overall Study|Progressive Disease|3|||
162719111|NCT03284957|587678393|FG002|Overall Study|Progressive Disease|4|||
162719112|NCT03284957|587678394|FG003|Overall Study|Progressive Disease|3|||
162719113|NCT03284957|587678395|FG004|Overall Study|Progressive Disease|3|||
162719114|NCT03284957|587678396|FG005|Overall Study|Progressive Disease|5|||
162719115|NCT03284957|587678397|FG006|Overall Study|Progressive Disease|45|||
162719116|NCT03284957|587678398|FG007|Overall Study|Progressive Disease|8|||
162719117|NCT03284957|587678399|FG008|Overall Study|Progressive Disease|5|||
162719118|NCT03284957|587678400|FG009|Overall Study|Progressive Disease|18|||
162719119|NCT03284957|587678401|FG010|Overall Study|Progressive Disease|7|||
162719120|NCT03284957|587678402|FG011|Overall Study|Progressive Disease|2|||
162719121|NCT03284957|587678403|FG012|Overall Study|Progressive Disease|3|||
162719122|NCT03284957|587678404|FG013|Overall Study|Progressive Disease|1|||
162719123|NCT03284957|587678405|FG014|Overall Study|Progressive Disease|1|||
163105124|NCT03379259|589090296|FG003|Overall Study|Death|1|||
163105125|NCT03379259|589090297|FG004|Overall Study|Death|4|||
163105126|NCT03379259|589090298|FG005|Overall Study|Death|2|||
163105127|NCT03379259|589090293|FG000|Overall Study|Withdrawal by Subject|0|||
163105128|NCT03379259|589090294|FG001|Overall Study|Withdrawal by Subject|0|||
163105129|NCT03379259|589090295|FG002|Overall Study|Withdrawal by Subject|1|||
163105130|NCT03379259|589090296|FG003|Overall Study|Withdrawal by Subject|0|||
163105131|NCT03379259|589090297|FG004|Overall Study|Withdrawal by Subject|2|||
163105132|NCT03379259|589090298|FG005|Overall Study|Withdrawal by Subject|0|||
163105133|NCT03379259|589090293|FG000|Overall Study|Study terminated by sponsor|0|||
163105134|NCT03379259|589090294|FG001|Overall Study|Study terminated by sponsor|0|||
163105135|NCT03379259|589090295|FG002|Overall Study|Study terminated by sponsor|0|||
163105136|NCT03379259|589090296|FG003|Overall Study|Study terminated by sponsor|1|||
163105137|NCT03379259|589090297|FG004|Overall Study|Study terminated by sponsor|1|||
163105138|NCT03379259|589090298|FG005|Overall Study|Study terminated by sponsor|4|||
163105139|NCT03379259|589090293|FG000|Overall Study|Disease progression|0|||
163105140|NCT03379259|589090294|FG001|Overall Study|Disease progression|0|||
163105141|NCT03379259|589090295|FG002|Overall Study|Disease progression|0|||
163105142|NCT03379259|589090296|FG003|Overall Study|Disease progression|1|||
163105143|NCT03379259|589090297|FG004|Overall Study|Disease progression|0|||
163105144|NCT03379259|589090298|FG005|Overall Study|Disease progression|1|||
163105145|NCT03379259|589090293|FG000|Overall Study|Lost to Follow-up|0|||
163105146|NCT03379259|589090294|FG001|Overall Study|Lost to Follow-up|0|||
163105147|NCT03379259|589090295|FG002|Overall Study|Lost to Follow-up|0|||
163105148|NCT03379259|589090296|FG003|Overall Study|Lost to Follow-up|0|||
163105149|NCT03379259|589090297|FG004|Overall Study|Lost to Follow-up|1|||
163105150|NCT03379259|589090298|FG005|Overall Study|Lost to Follow-up|0|||
163105151|NCT03379259|589090293|FG000|Overall Study|Deteriorating condition|0|||
163105152|NCT03379259|589090294|FG001|Overall Study|Deteriorating condition|0|||
163105153|NCT03379259|589090295|FG002|Overall Study|Deteriorating condition|0|||
163105154|NCT03379259|589090296|FG003|Overall Study|Deteriorating condition|0|||
163105155|NCT03379259|589090297|FG004|Overall Study|Deteriorating condition|1|||
163105156|NCT03379259|589090298|FG005|Overall Study|Deteriorating condition|0|||
163105157|NCT03195660|589090299|FG000|Overall Study|The study was terminated|2|||
163105158|NCT00375427|589090300|FG000|Overall Study|Adverse Event|21|||
163105159|NCT00375427|589090301|FG001|Overall Study|Adverse Event|27|||
163105160|NCT00375427|589090300|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163105161|NCT00375427|589090301|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163105162|NCT00375427|589090300|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163105163|NCT00375427|589090301|FG001|Overall Study|Abnormal laboratory value(s)|2|||
163105164|NCT00375427|589090300|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163105165|NCT00375427|589090301|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163105166|NCT00375427|589090300|FG000|Overall Study|Patient no longer requires study drug|3|||
163105167|NCT00375427|589090301|FG001|Overall Study|Patient no longer requires study drug|7|||
163105168|NCT00375427|589090300|FG000|Overall Study|Protocol Violation|10|||
163105169|NCT00375427|589090301|FG001|Overall Study|Protocol Violation|8|||
163105170|NCT00375427|589090300|FG000|Overall Study|Withdrawal by Subject|9|||
163105171|NCT00375427|589090301|FG001|Overall Study|Withdrawal by Subject|13|||
163105172|NCT00375427|589090300|FG000|Overall Study|Lost to Follow-up|1|||
163105173|NCT00375427|589090301|FG001|Overall Study|Lost to Follow-up|1|||
163105174|NCT00375427|589090300|FG000|Overall Study|Administrative reasons|0|||
163105175|NCT00375427|589090301|FG001|Overall Study|Administrative reasons|1|||
163105176|NCT00375427|589090300|FG000|Overall Study|Death|11|||
163105177|NCT00375427|589090301|FG001|Overall Study|Death|10|||
163105178|NCT03818607|589090307|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
163105179|NCT03818607|589090308|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
163105180|NCT03818607|589090307|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
163105181|NCT03818607|589090308|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
163105182|NCT03818607|589090307|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
163105183|NCT03818607|589090308|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
162653642|NCT00344773|587447638|FG000|Overall Study|Not Eligible for the study|2|||
162653643|NCT02849548|587447646|FG000|Overall Study|Lost to Follow-up|1|||
162653644|NCT02849548|587447647|FG001|Overall Study|Lost to Follow-up|2|||
163105184|NCT01147250|589090312|FG000|Overall Study|Lost to Follow-up|14|||
162653645|NCT02849548|587447646|FG000|Overall Study|Protocol Violation|1|||
163105185|NCT01147250|589090313|FG001|Overall Study|Lost to Follow-up|11|||
163105186|NCT01147250|589090312|FG000|Overall Study|Withdrawal by Subject|83|||
163105187|NCT01147250|589090313|FG001|Overall Study|Withdrawal by Subject|88|||
162653646|NCT02849548|587447647|FG001|Overall Study|Protocol Violation|0|||
163105188|NCT01147250|589090312|FG000|Overall Study|Site termination by sponsor|13|||
163105189|NCT01147250|589090313|FG001|Overall Study|Site termination by sponsor|5|||
163105190|NCT01147250|589090312|FG000|Overall Study|Other than specified|0|||
163105191|NCT01147250|589090313|FG001|Overall Study|Other than specified|1|||
163105192|NCT02249091|589090315|FG000|Overall Study|Lack of Efficacy|8|||
163105193|NCT02249091|589090316|FG001|Overall Study|Lack of Efficacy|3|||
162653647|NCT00714259|587447648|FG000|Overall Study|Death|2|||
162719124|NCT03284957|587678406|FG015|Overall Study|Progressive Disease|2|||
163105194|NCT02249091|589090315|FG000|Overall Study|Physician Decision|4|||
163105195|NCT02249091|589090316|FG001|Overall Study|Physician Decision|1|||
163105196|NCT02249091|589090315|FG000|Overall Study|Withdrawal by Subject|2|||
163105197|NCT02249091|589090316|FG001|Overall Study|Withdrawal by Subject|2|||
163105198|NCT02249091|589090315|FG000|Overall Study|Death|3|||
163105199|NCT02249091|589090316|FG001|Overall Study|Death|4|||
163105200|NCT02249091|589090315|FG000|Overall Study|Adverse Event|1|||
163105201|NCT02249091|589090316|FG001|Overall Study|Adverse Event|0|||
163105202|NCT02249091|589090315|FG000|Overall Study|Stable disease with following SCT|0|||
163105203|NCT02249091|589090316|FG001|Overall Study|Stable disease with following SCT|1|||
163105204|NCT02249091|589090315|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
163105205|NCT02249091|589090316|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
163105206|NCT02249091|589090315|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
163105207|NCT02249091|589090316|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
163105208|NCT02249091|589090315|FG000|Overall Study|Refractory AML|1|||
163105209|NCT02249091|589090316|FG001|Overall Study|Refractory AML|1|||
163105210|NCT00716482|589090320|FG000|Overall Study|Lost to Follow-up|6|||
163105211|NCT00716482|589090320|FG000|Overall Study|Inadequate acquisition or analysis|50|||
163105212|NCT00716482|589090320|FG000|Overall Study|no pathology obtained|10|||
163105213|NCT00716482|589090320|FG000|Overall Study|technical/machine error|28|||
163105214|NCT00716482|589090320|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
163105215|NCT03249909|589090321|FG000|Overall Study|Withdrawal by Subject|3|||
163105216|NCT03249909|589090322|FG001|Overall Study|Withdrawal by Subject|0|||
163105217|NCT03249909|589090323|FG002|Overall Study|Withdrawal by Subject|0|||
163105218|NCT03249909|589090321|FG000|Overall Study|Adverse Event|3|||
163105219|NCT03249909|589090322|FG001|Overall Study|Adverse Event|0|||
163105220|NCT03249909|589090323|FG002|Overall Study|Adverse Event|0|||
163105221|NCT03249909|589090321|FG000|Overall Study|Lost to Follow-up|0|||
163105222|NCT03249909|589090322|FG001|Overall Study|Lost to Follow-up|1|||
163105223|NCT03249909|589090323|FG002|Overall Study|Lost to Follow-up|0|||
163105224|NCT03517371|589090324|FG000|Overall Study|Adverse Event|8|||
163105225|NCT03517371|589090325|FG001|Overall Study|Adverse Event|9|||
163105226|NCT03517371|589090324|FG000|Overall Study|Lost to Follow-up|1|||
163105227|NCT03517371|589090325|FG001|Overall Study|Lost to Follow-up|2|||
163105228|NCT03517371|589090324|FG000|Overall Study|Withdrawal by Subject|4|||
163105229|NCT03517371|589090325|FG001|Overall Study|Withdrawal by Subject|4|||
163105230|NCT03517371|589090324|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
163105231|NCT03517371|589090325|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
163105232|NCT03517371|589090324|FG000|Overall Study|COVID restrictions|2|||
163105233|NCT03517371|589090325|FG001|Overall Study|COVID restrictions|0|||
163105234|NCT03517371|589090324|FG000|Overall Study|Receiving DBS Surgery|0|||
163105235|NCT03517371|589090325|FG001|Overall Study|Receiving DBS Surgery|1|||
163105236|NCT05411822|589090326|FG000|Overall Study|Withdrawal by Subject|2|||
163105237|NCT05411822|589090327|FG001|Overall Study|Withdrawal by Subject|1|||
163105238|NCT01345929|589090328|FG000|Overall Study|Withdrawal by Subject|9|||
163105239|NCT01345929|589090329|FG001|Overall Study|Withdrawal by Subject|8|||
163105240|NCT01345929|589090328|FG000|Overall Study|Lost to Follow-up|9|||
163105241|NCT01345929|589090329|FG001|Overall Study|Lost to Follow-up|9|||
163105242|NCT01345929|589090328|FG000|Overall Study|Adverse Event|0|||
163105243|NCT01345929|589090329|FG001|Overall Study|Adverse Event|1|||
163105244|NCT01345929|589090328|FG000|Overall Study|Didn't meet eligibility criteria|2|||
163105245|NCT01345929|589090329|FG001|Overall Study|Didn't meet eligibility criteria|0|||
163105246|NCT01345929|589090328|FG000|Overall Study|40,000 CFU/ML|1|||
163105247|NCT01345929|589090329|FG001|Overall Study|40,000 CFU/ML|0|||
163105248|NCT01345929|589090328|FG000|Overall Study|Patient withdrawal|0|||
163105249|NCT01345929|589090329|FG001|Overall Study|Patient withdrawal|1|||
163105250|NCT02819297|589090330|FG000|Overall Study|Withdrawal by Subject|25|||
163105251|NCT02819297|589090331|FG001|Overall Study|Withdrawal by Subject|13|||
163105252|NCT02819297|589090330|FG000|Overall Study|Lost to Follow-up|12|||
163105253|NCT02819297|589090331|FG001|Overall Study|Lost to Follow-up|14|||
163105254|NCT02819297|589090330|FG000|Overall Study|Adverse Event|12|||
163105255|NCT02819297|589090331|FG001|Overall Study|Adverse Event|10|||
163105256|NCT02819297|589090330|FG000|Overall Study|Physician Decision|5|||
163105257|NCT02819297|589090331|FG001|Overall Study|Physician Decision|5|||
163105258|NCT02819297|589090330|FG000|Overall Study|Lack of Efficacy|5|||
163105259|NCT02819297|589090331|FG001|Overall Study|Lack of Efficacy|8|||
163105260|NCT02819297|589090330|FG000|Overall Study|Protocol Violation|1|||
163105261|NCT02819297|589090331|FG001|Overall Study|Protocol Violation|2|||
163105262|NCT01670279|589090332|FG000|Overall Study|Adverse Event|0|||
163105263|NCT01670279|589090333|FG001|Overall Study|Adverse Event|1|||
163105264|NCT01670279|589090334|FG002|Overall Study|Adverse Event|0|||
163105265|NCT01670279|589090335|FG003|Overall Study|Adverse Event|0|||
163105266|NCT01670279|589090332|FG000|Overall Study|Physician Decision|0|||
163105267|NCT01670279|589090333|FG001|Overall Study|Physician Decision|1|||
163105268|NCT01670279|589090334|FG002|Overall Study|Physician Decision|0|||
163105269|NCT01670279|589090335|FG003|Overall Study|Physician Decision|0|||
163105270|NCT01670279|589090332|FG000|Overall Study|Participant met withdrawal criteria|0|||
163105271|NCT01670279|589090333|FG001|Overall Study|Participant met withdrawal criteria|0|||
163105272|NCT01670279|589090334|FG002|Overall Study|Participant met withdrawal criteria|0|||
163105273|NCT01670279|589090335|FG003|Overall Study|Participant met withdrawal criteria|1|||
163105274|NCT02318368|589090336|FG000|Overall Study|Withdrawal by Subject|2|||
163105275|NCT02318368|589090337|FG001|Overall Study|Withdrawal by Subject|0|||
163105276|NCT02318368|589090336|FG000|Overall Study|Study terminated by the sponsor|5|||
163105277|NCT02318368|589090337|FG001|Overall Study|Study terminated by the sponsor|2|||
163105278|NCT02318368|589090336|FG000|Overall Study|Death|0|||
163105279|NCT02318368|589090337|FG001|Overall Study|Death|1|||
163105280|NCT01901614|589090338|FG000|Overall Study|Adverse Event|0|||
163105281|NCT01901614|589090339|FG001|Overall Study|Adverse Event|1|||
163105282|NCT01901614|589090338|FG000|Overall Study|Lost to Follow-up|1|||
163105283|NCT01901614|589090339|FG001|Overall Study|Lost to Follow-up|0|||
163105284|NCT01901614|589090338|FG000|Overall Study|Screen Fail|1|||
163105285|NCT01901614|589090339|FG001|Overall Study|Screen Fail|0|||
163105286|NCT02702609|589090340|FG000|Overall Study|Lost to Follow-up|8|||
163105287|NCT02702609|589090341|FG001|Overall Study|Lost to Follow-up|4|||
163105288|NCT02702609|589090340|FG000|Overall Study|Physician Decision|1|||
163105289|NCT02702609|589090341|FG001|Overall Study|Physician Decision|0|||
163105290|NCT02674464|589090342|FG000|Overall Study|Death|10|||
163105291|NCT02674464|589090343|FG001|Overall Study|Death|21|||
163105292|NCT02674464|589090342|FG000|Overall Study|Withdrawal by Subject|24|||
163105293|NCT02674464|589090343|FG001|Overall Study|Withdrawal by Subject|44|||
163105294|NCT02674464|589090342|FG000|Overall Study|Lost to Follow-up|97|||
163105295|NCT02674464|589090343|FG001|Overall Study|Lost to Follow-up|92|||
163105296|NCT02674464|589090342|FG000|Overall Study|Outside survey window|6|||
163105297|NCT02674464|589090343|FG001|Overall Study|Outside survey window|3|||
163105298|NCT04153981|589090344|FG000|Overall Study|Death|1|||
163105299|NCT04153981|589090344|FG000|Overall Study|Withdrawal by Subject|24|||
163105300|NCT04153981|589090344|FG000|Overall Study|Lost to Follow-up|1|||
163105301|NCT04153981|589090344|FG000|Overall Study|Physician Decision|1|||
163105302|NCT04153981|589090344|FG000|Overall Study|Due to Unavailable Glucometer|1|||
163105303|NCT04153981|589090344|FG000|Overall Study|Covid 19|52|||
163105304|NCT04153981|589090344|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
163105305|NCT04153981|589090344|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
163105306|NCT01555073|589090345|FG000|Overall Study|Lost to Follow-up|1|||
163105307|NCT01555073|589090346|FG001|Overall Study|Lost to Follow-up|2|||
163105308|NCT01555073|589090347|FG002|Overall Study|Lost to Follow-up|0|||
163105309|NCT01555073|589090348|FG003|Overall Study|Lost to Follow-up|5|||
163105310|NCT01262638|589090349|FG000|Overall Study|Adverse Event|3|||
163105311|NCT01262638|589090350|FG001|Overall Study|Adverse Event|4|||
163105312|NCT01262638|589090351|FG002|Overall Study|Adverse Event|3|||
163105313|NCT01262638|589090352|FG003|Overall Study|Adverse Event|4|||
163105314|NCT01262638|589090349|FG000|Overall Study|Protocol Violation|1|||
163105315|NCT01262638|589090350|FG001|Overall Study|Protocol Violation|0|||
163105316|NCT01262638|589090351|FG002|Overall Study|Protocol Violation|0|||
163105317|NCT01262638|589090352|FG003|Overall Study|Protocol Violation|1|||
163105318|NCT01262638|589090349|FG000|Overall Study|Withdrawal by Subject|2|||
163105319|NCT01262638|589090350|FG001|Overall Study|Withdrawal by Subject|1|||
163105320|NCT01262638|589090351|FG002|Overall Study|Withdrawal by Subject|0|||
163105321|NCT01262638|589090352|FG003|Overall Study|Withdrawal by Subject|1|||
163105322|NCT01262638|589090349|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105323|NCT01262638|589090350|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105324|NCT01262638|589090351|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
163105325|NCT01262638|589090352|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163105326|NCT01262638|589090349|FG000|Overall Study|Lost to Follow-up|1|||
163105327|NCT01262638|589090350|FG001|Overall Study|Lost to Follow-up|1|||
163105328|NCT01262638|589090351|FG002|Overall Study|Lost to Follow-up|1|||
163105329|NCT01262638|589090352|FG003|Overall Study|Lost to Follow-up|1|||
163105330|NCT01262638|589090349|FG000|Overall Study|Participant Went Out of Town|0|||
163105331|NCT01262638|589090350|FG001|Overall Study|Participant Went Out of Town|0|||
163105332|NCT01262638|589090351|FG002|Overall Study|Participant Went Out of Town|1|||
163105333|NCT01262638|589090352|FG003|Overall Study|Participant Went Out of Town|0|||
163105334|NCT01071252|589090353|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
163105335|NCT01071252|589090354|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
163105336|NCT01071252|589090355|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
163105337|NCT01071252|589090356|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
163105338|NCT01071252|589090357|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
163105339|NCT01071252|589090353|FG000|Overall Study|Withdrawal by Subject|8|||
163105340|NCT01071252|589090354|FG001|Overall Study|Withdrawal by Subject|2|||
163105341|NCT01071252|589090355|FG002|Overall Study|Withdrawal by Subject|1|||
163105342|NCT01071252|589090356|FG003|Overall Study|Withdrawal by Subject|2|||
163105343|NCT01071252|589090357|FG004|Overall Study|Withdrawal by Subject|3|||
163105344|NCT01071252|589090353|FG000|Overall Study|administrative problems|1|||
163105345|NCT01071252|589090354|FG001|Overall Study|administrative problems|1|||
163105346|NCT01071252|589090355|FG002|Overall Study|administrative problems|0|||
163105347|NCT01071252|589090356|FG003|Overall Study|administrative problems|2|||
163105348|NCT01071252|589090357|FG004|Overall Study|administrative problems|1|||
163105349|NCT01071252|589090353|FG000|Overall Study|Lost to Follow-up|1|||
163105350|NCT01071252|589090354|FG001|Overall Study|Lost to Follow-up|0|||
163105351|NCT01071252|589090355|FG002|Overall Study|Lost to Follow-up|1|||
163105352|NCT01071252|589090356|FG003|Overall Study|Lost to Follow-up|2|||
163105353|NCT01071252|589090357|FG004|Overall Study|Lost to Follow-up|0|||
163105354|NCT01071252|589090353|FG000|Overall Study|Adverse Event|1|||
163105355|NCT01071252|589090354|FG001|Overall Study|Adverse Event|1|||
163105356|NCT01071252|589090355|FG002|Overall Study|Adverse Event|0|||
163105357|NCT01071252|589090356|FG003|Overall Study|Adverse Event|1|||
163105358|NCT01071252|589090357|FG004|Overall Study|Adverse Event|0|||
163105359|NCT01071252|589090353|FG000|Overall Study|Death|0|||
163105360|NCT01071252|589090354|FG001|Overall Study|Death|0|||
163105361|NCT01071252|589090355|FG002|Overall Study|Death|0|||
163105362|NCT01071252|589090356|FG003|Overall Study|Death|0|||
163105363|NCT01071252|589090357|FG004|Overall Study|Death|1|||
163105364|NCT01066104|589090358|FG000|Overall Study|Adverse Event|1|||
163105365|NCT01066104|589090359|FG001|Overall Study|Adverse Event|1|||
163105366|NCT01066104|589090358|FG000|Overall Study|Protocol Violation|1|||
163105367|NCT01066104|589090359|FG001|Overall Study|Protocol Violation|0|||
163105368|NCT00260832|589090362|FG000|Overall Study|Adverse Event|26|||
163105369|NCT00260832|589090363|FG001|Overall Study|Adverse Event|19|||
163105370|NCT00260832|589090362|FG000|Overall Study|Progression|116|||
163105371|NCT00260832|589090363|FG001|Overall Study|Progression|96|||
163105372|NCT00260832|589090362|FG000|Overall Study|Withdrawal by Subject|15|||
163105373|NCT00260832|589090363|FG001|Overall Study|Withdrawal by Subject|17|||
163105374|NCT00260832|589090362|FG000|Overall Study|Physician Decision|15|||
163105375|NCT00260832|589090363|FG001|Overall Study|Physician Decision|9|||
163105376|NCT00260832|589090362|FG000|Overall Study|Death|43|||
163105377|NCT00260832|589090363|FG001|Overall Study|Death|62|||
163105378|NCT00260832|589090362|FG000|Overall Study|Other|10|||
163105379|NCT00260832|589090363|FG001|Overall Study|Other|7|||
163105380|NCT00260832|589090362|FG000|Overall Study|Protocol Violation|3|||
163105381|NCT00260832|589090363|FG001|Overall Study|Protocol Violation|1|||
163105382|NCT01104545|589090364|FG000|Overall Study|Adverse Event|0|||
163105383|NCT01104545|589090365|FG001|Overall Study|Adverse Event|1|||
163105384|NCT01104545|589090366|FG002|Overall Study|Adverse Event|2|||
163105385|NCT00564902|589090367|FG000|Overall Study|Withdrawal by Subject|0|||
163105386|NCT00564902|589090368|FG001|Overall Study|Withdrawal by Subject|3|||
163105387|NCT00564902|589090369|FG002|Overall Study|Withdrawal by Subject|4|||
163105388|NCT00564902|589090367|FG000|Overall Study|Death|1|||
163105389|NCT00564902|589090368|FG001|Overall Study|Death|1|||
163105390|NCT00564902|589090369|FG002|Overall Study|Death|0|||
163105391|NCT04532294|589090372|FG000|Overall Study|Withdrawal by Subject|0|||
163105392|NCT04532294|589090373|FG001|Overall Study|Withdrawal by Subject|0|||
163105393|NCT04532294|589090374|FG002|Overall Study|Withdrawal by Subject|1|||
163105394|NCT04532294|589090372|FG000|Overall Study|Participants Not Dosed|0|||
163105395|NCT04532294|589090373|FG001|Overall Study|Participants Not Dosed|0|||
163105396|NCT04532294|589090374|FG002|Overall Study|Participants Not Dosed|2|||
163105397|NCT03089047|589090375|FG000|Overall Study|Lost to Follow-up|1|||
163105398|NCT03089047|589090376|FG001|Overall Study|Lost to Follow-up|0|||
163105399|NCT02146131|589090377|FG000|Overall Study|Physician Decision|61|||
163105400|NCT02146131|589090378|FG001|Overall Study|Physician Decision|56|||
163105401|NCT02097719|589090379|FG000|Overall Study|Subject Withdrew Consent|1|||
163105402|NCT02097719|589090380|FG001|Overall Study|Subject Withdrew Consent|0|||
163105403|NCT02097719|589090379|FG000|Overall Study|Lost to Follow-up|0|||
163105404|NCT02097719|589090380|FG001|Overall Study|Lost to Follow-up|1|||
163105405|NCT02097719|589090379|FG000|Overall Study|Adverse Event|2|||
163105406|NCT02097719|589090380|FG001|Overall Study|Adverse Event|0|||
163105407|NCT00809926|589090382|FG000|Overall Study|Adverse Event|18|||
163105408|NCT00809926|589090383|FG001|Overall Study|Adverse Event|10|||
163105409|NCT00809926|589090382|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163105410|NCT00809926|589090383|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163105411|NCT00809926|589090382|FG000|Overall Study|Patient withdrew consent|8|||
163105412|NCT00809926|589090383|FG001|Overall Study|Patient withdrew consent|6|||
163105413|NCT00809926|589090382|FG000|Overall Study|Lost to Follow-up|2|||
163105414|NCT00809926|589090383|FG001|Overall Study|Lost to Follow-up|1|||
163105415|NCT00809926|589090382|FG000|Overall Study|Administrative Problems|0|||
163105416|NCT00809926|589090383|FG001|Overall Study|Administrative Problems|1|||
163105417|NCT00809926|589090382|FG000|Overall Study|Protocol deviation|0|||
163105418|NCT00809926|589090383|FG001|Overall Study|Protocol deviation|2|||
163105419|NCT01108731|589090390|FG000|Overall Study|Withdrawal by Subject|1|||
163105420|NCT01108731|589090391|FG001|Overall Study|Withdrawal by Subject|1|||
163105421|NCT01108731|589090390|FG000|Overall Study|Adverse Event|3|||
163105422|NCT01108731|589090391|FG001|Overall Study|Adverse Event|3|||
163105423|NCT05356910|589090392|FG000|Overall Study|Lost to Follow-up|10|||
163105424|NCT05356910|589090393|FG001|Overall Study|Lost to Follow-up|19|||
163105425|NCT05356910|589090394|FG002|Overall Study|Lost to Follow-up|0|||
163105426|NCT05356910|589090395|FG003|Overall Study|Lost to Follow-up|0|||
163105427|NCT05356910|589090392|FG000|Overall Study|Withdrawal by Subject|4|||
163105428|NCT05356910|589090393|FG001|Overall Study|Withdrawal by Subject|2|||
163105429|NCT05356910|589090394|FG002|Overall Study|Withdrawal by Subject|0|||
163105430|NCT05356910|589090395|FG003|Overall Study|Withdrawal by Subject|0|||
163105431|NCT02712996|589090399|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
163105432|NCT02712996|589090400|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
163105433|NCT01451749|589090403|FG000|Overall Study|Protocol Violation|14|||
163105434|NCT01451749|589090404|FG001|Overall Study|Protocol Violation|7|||
162653648|NCT02984020|587449541|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
162653649|NCT02984020|587449541|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
162653650|NCT02984020|587449541|FG000|Overall Study|Other significant protocol violation|2|||
163105435|NCT01451749|589090403|FG000|Overall Study|Lost to Follow-up|15|||
163105436|NCT01451749|589090404|FG001|Overall Study|Lost to Follow-up|5|||
163105437|NCT01451749|589090403|FG000|Overall Study|Meet the exclusion criteria,and|1|||
163105438|NCT01451749|589090404|FG001|Overall Study|Meet the exclusion criteria,and|1|||
163105439|NCT01451749|589090403|FG000|Overall Study|Adverse Event|2|||
163105440|NCT01451749|589090404|FG001|Overall Study|Adverse Event|0|||
163105441|NCT01451749|589090403|FG000|Overall Study|Withdrawal by Subject|0|||
163105442|NCT01451749|589090404|FG001|Overall Study|Withdrawal by Subject|1|||
163105443|NCT00972517|589090405|FG000|Overall Study|Adverse Event|0|||
163105444|NCT00972517|589090406|FG001|Overall Study|Adverse Event|0|||
163105445|NCT00972517|589090407|FG002|Overall Study|Adverse Event|0|||
163105446|NCT00972517|589090408|FG003|Overall Study|Adverse Event|1|||
163105447|NCT00972517|589090409|FG004|Overall Study|Adverse Event|0|||
163105448|NCT00972517|589090410|FG005|Overall Study|Adverse Event|0|||
163105449|NCT00972517|589090405|FG000|Overall Study|Withdrawal by Subject|0|||
163105450|NCT00972517|589090406|FG001|Overall Study|Withdrawal by Subject|1|||
163105451|NCT00972517|589090407|FG002|Overall Study|Withdrawal by Subject|0|||
163105452|NCT00972517|589090408|FG003|Overall Study|Withdrawal by Subject|2|||
163105453|NCT00972517|589090409|FG004|Overall Study|Withdrawal by Subject|1|||
163105454|NCT00972517|589090410|FG005|Overall Study|Withdrawal by Subject|0|||
163105455|NCT00819156|589090411|FG000|Overall Study|Adverse Event|1|||
163105456|NCT00819156|589090412|FG001|Overall Study|Adverse Event|4|||
163105457|NCT00819156|589090413|FG002|Overall Study|Adverse Event|2|||
163105458|NCT00819156|589090414|FG003|Overall Study|Adverse Event|1|||
163105459|NCT00819156|589090415|FG004|Overall Study|Adverse Event|2|||
163105460|NCT00819156|589090416|FG005|Overall Study|Adverse Event|3|||
163105461|NCT00819156|589090411|FG000|Overall Study|Withdrawal by Subject|0|||
163105462|NCT00819156|589090412|FG001|Overall Study|Withdrawal by Subject|3|||
163105463|NCT00819156|589090413|FG002|Overall Study|Withdrawal by Subject|2|||
163105464|NCT00819156|589090414|FG003|Overall Study|Withdrawal by Subject|0|||
163105465|NCT00819156|589090415|FG004|Overall Study|Withdrawal by Subject|1|||
163105466|NCT00819156|589090416|FG005|Overall Study|Withdrawal by Subject|0|||
163105467|NCT00819156|589090411|FG000|Overall Study|Protocol Violation|1|||
163105468|NCT00819156|589090412|FG001|Overall Study|Protocol Violation|0|||
163105469|NCT00819156|589090413|FG002|Overall Study|Protocol Violation|1|||
163105470|NCT00819156|589090414|FG003|Overall Study|Protocol Violation|0|||
163105471|NCT00819156|589090415|FG004|Overall Study|Protocol Violation|0|||
163105472|NCT00819156|589090416|FG005|Overall Study|Protocol Violation|1|||
163105473|NCT00819156|589090411|FG000|Overall Study|Lost to Follow-up|0|||
163105474|NCT00819156|589090412|FG001|Overall Study|Lost to Follow-up|1|||
163105475|NCT00819156|589090413|FG002|Overall Study|Lost to Follow-up|0|||
163105476|NCT00819156|589090414|FG003|Overall Study|Lost to Follow-up|0|||
163105477|NCT00819156|589090415|FG004|Overall Study|Lost to Follow-up|0|||
163105478|NCT00819156|589090416|FG005|Overall Study|Lost to Follow-up|2|||
163105479|NCT00819156|589090411|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
163105480|NCT00819156|589090412|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
163105481|NCT00819156|589090413|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105482|NCT00819156|589090414|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105483|NCT00819156|589090415|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
163105484|NCT00819156|589090416|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
163105485|NCT00819156|589090411|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
163105486|NCT00819156|589090412|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105487|NCT00819156|589090413|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105488|NCT00819156|589090414|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105489|NCT00819156|589090415|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
163105490|NCT00819156|589090416|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
163105491|NCT00819156|589090411|FG000|Overall Study|Prostate-specific antigen progression|0|||
163105492|NCT00819156|589090412|FG001|Overall Study|Prostate-specific antigen progression|0|||
163105493|NCT00819156|589090413|FG002|Overall Study|Prostate-specific antigen progression|0|||
163105494|NCT00819156|589090414|FG003|Overall Study|Prostate-specific antigen progression|0|||
163105495|NCT00819156|589090415|FG004|Overall Study|Prostate-specific antigen progression|1|||
163105496|NCT00819156|589090416|FG005|Overall Study|Prostate-specific antigen progression|0|||
163105497|NCT00984594|589090417|FG000|Overall Study|Lost to Follow-up|1|||
163105498|NCT00984594|589090418|FG001|Overall Study|Lost to Follow-up|0|||
163105499|NCT00984594|589090417|FG000|Overall Study|Withdrawal by Subject|0|||
163105500|NCT00984594|589090418|FG001|Overall Study|Withdrawal by Subject|1|||
163105501|NCT01063062|589090419|FG000|Overall Study|Patient withdrew consent|0|||
163105502|NCT01063062|589090420|FG001|Overall Study|Patient withdrew consent|1|||
163105503|NCT01063062|589090419|FG000|Overall Study|Adverse Event|2|||
163105504|NCT01063062|589090420|FG001|Overall Study|Adverse Event|4|||
163105505|NCT01063062|589090419|FG000|Overall Study|Protocol Violation|5|||
163105506|NCT01063062|589090420|FG001|Overall Study|Protocol Violation|4|||
163105507|NCT01063062|589090419|FG000|Overall Study|Investigator's request|1|||
163105508|NCT01063062|589090420|FG001|Overall Study|Investigator's request|0|||
163105509|NCT01063062|589090419|FG000|Overall Study|Lost to Follow-up|0|||
163105510|NCT01063062|589090420|FG001|Overall Study|Lost to Follow-up|2|||
163105511|NCT01063062|589090419|FG000|Overall Study|Miscellaneous reason|0|||
163105512|NCT01063062|589090420|FG001|Overall Study|Miscellaneous reason|1|||
163105513|NCT00281099|589090423|FG000|Overall Study|Death|46|||
163105514|NCT00281099|589090424|FG001|Overall Study|Death|57|||
163105515|NCT00281099|589090423|FG000|Overall Study|Lost to Follow-up|10|||
163105516|NCT00281099|589090424|FG001|Overall Study|Lost to Follow-up|19|||
163105517|NCT00281099|589090423|FG000|Overall Study|Withdrawal by Subject|65|||
163105518|NCT00281099|589090424|FG001|Overall Study|Withdrawal by Subject|70|||
163105519|NCT00281099|589090423|FG000|Overall Study|Physician Decision|79|||
163105520|NCT00281099|589090424|FG001|Overall Study|Physician Decision|72|||
163105521|NCT00281099|589090423|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
163105522|NCT00281099|589090424|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
163105523|NCT02175277|589090425|FG000|Overall Study|Protocol-specified Criteria|1|||
163105524|NCT01082081|589090426|FG000|Overall Study|Lost to Follow-up|0|||
163105525|NCT01082081|589090427|FG001|Overall Study|Lost to Follow-up|0|||
163105526|NCT01082081|589090428|FG002|Overall Study|Lost to Follow-up|1|||
163105527|NCT01082081|589090426|FG000|Overall Study|Withdrawal by Subject|0|||
162719125|NCT03284957|587678391|FG000|Overall Study|Withdrawal by Subject|0|||
163105528|NCT01082081|589090427|FG001|Overall Study|Withdrawal by Subject|0|||
163105529|NCT01082081|589090428|FG002|Overall Study|Withdrawal by Subject|1|||
163105530|NCT01082081|589090426|FG000|Overall Study|Other Reason|0|||
163105531|NCT01082081|589090427|FG001|Overall Study|Other Reason|1|||
163105532|NCT01082081|589090428|FG002|Overall Study|Other Reason|0|||
163105533|NCT03159468|589090429|FG000|Overall Study|Withdrawal by Subject|0|||
163105534|NCT03159468|589090430|FG001|Overall Study|Withdrawal by Subject|0|||
163105535|NCT03159468|589090431|FG002|Overall Study|Withdrawal by Subject|3|||
163105536|NCT03159468|589090432|FG003|Overall Study|Withdrawal by Subject|0|||
163105537|NCT03159468|589090433|FG004|Overall Study|Withdrawal by Subject|0|||
163105538|NCT03159468|589090434|FG005|Overall Study|Withdrawal by Subject|0|||
163105539|NCT02954406|589091982|FG000|Overall Study|Adverse Event|0|||
163105540|NCT02954406|589091983|FG001|Overall Study|Adverse Event|1|||
163105541|NCT02954406|589091984|FG002|Overall Study|Adverse Event|0|||
163105542|NCT02954406|589091985|FG003|Overall Study|Adverse Event|0|||
163105543|NCT02954406|589091986|FG004|Overall Study|Adverse Event|1|||
163105544|NCT02954406|589091987|FG005|Overall Study|Adverse Event|0|||
163105545|NCT02954406|589091988|FG006|Overall Study|Adverse Event|0|||
163105546|NCT02954406|589091989|FG007|Overall Study|Adverse Event|0|||
163105547|NCT02954406|589091990|FG008|Overall Study|Adverse Event|1|||
163105548|NCT02954406|589091991|FG009|Overall Study|Adverse Event|1|||
163105549|NCT02954406|589091992|FG010|Overall Study|Adverse Event|0|||
163105550|NCT02954406|589091982|FG000|Overall Study|Progressive Disease|3|||
163105551|NCT02954406|589091983|FG001|Overall Study|Progressive Disease|4|||
163105552|NCT02954406|589091984|FG002|Overall Study|Progressive Disease|3|||
163105553|NCT02954406|589091985|FG003|Overall Study|Progressive Disease|4|||
163105554|NCT02954406|589091986|FG004|Overall Study|Progressive Disease|3|||
163105555|NCT02954406|589091987|FG005|Overall Study|Progressive Disease|3|||
163105556|NCT02954406|589091988|FG006|Overall Study|Progressive Disease|2|||
163105557|NCT02954406|589091989|FG007|Overall Study|Progressive Disease|2|||
163105558|NCT02954406|589091990|FG008|Overall Study|Progressive Disease|1|||
163105559|NCT02954406|589091991|FG009|Overall Study|Progressive Disease|1|||
163105560|NCT02954406|589091992|FG010|Overall Study|Progressive Disease|0|||
163105561|NCT02954406|589091982|FG000|Overall Study|Symptomatic Deterioration|0|||
163105562|NCT02954406|589091983|FG001|Overall Study|Symptomatic Deterioration|1|||
163105563|NCT02954406|589091984|FG002|Overall Study|Symptomatic Deterioration|0|||
163105564|NCT02954406|589091985|FG003|Overall Study|Symptomatic Deterioration|0|||
163105565|NCT02954406|589091986|FG004|Overall Study|Symptomatic Deterioration|0|||
163105566|NCT02954406|589091987|FG005|Overall Study|Symptomatic Deterioration|0|||
163105567|NCT02954406|589091988|FG006|Overall Study|Symptomatic Deterioration|0|||
163105568|NCT02954406|589091989|FG007|Overall Study|Symptomatic Deterioration|0|||
163105569|NCT02954406|589091990|FG008|Overall Study|Symptomatic Deterioration|0|||
163105570|NCT02954406|589091991|FG009|Overall Study|Symptomatic Deterioration|0|||
163105571|NCT02954406|589091992|FG010|Overall Study|Symptomatic Deterioration|0|||
163105572|NCT02954406|589091982|FG000|Overall Study|Death|0|||
163105573|NCT02954406|589091983|FG001|Overall Study|Death|0|||
163105574|NCT02954406|589091984|FG002|Overall Study|Death|0|||
163105575|NCT02954406|589091985|FG003|Overall Study|Death|0|||
163105576|NCT02954406|589091986|FG004|Overall Study|Death|1|||
163105577|NCT02954406|589091987|FG005|Overall Study|Death|0|||
163105578|NCT02954406|589091988|FG006|Overall Study|Death|0|||
163105579|NCT02954406|589091989|FG007|Overall Study|Death|0|||
163105580|NCT02954406|589091990|FG008|Overall Study|Death|1|||
163105581|NCT02954406|589091991|FG009|Overall Study|Death|1|||
163105582|NCT02954406|589091992|FG010|Overall Study|Death|0|||
163105583|NCT02954406|589091982|FG000|Overall Study|Reason Not Specified|0|||
163105584|NCT02954406|589091983|FG001|Overall Study|Reason Not Specified|0|||
163105585|NCT02954406|589091984|FG002|Overall Study|Reason Not Specified|3|||
163105586|NCT02954406|589091985|FG003|Overall Study|Reason Not Specified|2|||
163105587|NCT02954406|589091986|FG004|Overall Study|Reason Not Specified|2|||
163105588|NCT02954406|589091987|FG005|Overall Study|Reason Not Specified|0|||
163105589|NCT02954406|589091988|FG006|Overall Study|Reason Not Specified|1|||
163105590|NCT02954406|589091989|FG007|Overall Study|Reason Not Specified|0|||
163105591|NCT02954406|589091990|FG008|Overall Study|Reason Not Specified|1|||
163105592|NCT02954406|589091991|FG009|Overall Study|Reason Not Specified|0|||
163105593|NCT02954406|589091992|FG010|Overall Study|Reason Not Specified|0|||
163105594|NCT05924165|589091997|FG000|Overall Study|Physician Decision|2|||
163105595|NCT05924165|589091998|FG001|Overall Study|Physician Decision|3|||
163105596|NCT01681186|589091999|FG000|Washout Period From Second Intervention|Adverse Event|0|||
163105597|NCT01681186|589092000|FG001|Washout Period From Second Intervention|Adverse Event|0|||
163105598|NCT01681186|589092001|FG002|Washout Period From Second Intervention|Adverse Event|0|||
163105599|NCT01681186|589092002|FG003|Washout Period From Second Intervention|Adverse Event|0|||
163105600|NCT01681186|589092003|FG004|Washout Period From Second Intervention|Adverse Event|0|||
163105601|NCT01681186|589092004|FG005|Washout Period From Second Intervention|Adverse Event|0|||
163105602|NCT01681186|589092005|FG006|Washout Period From Second Intervention|Adverse Event|1|||
163105603|NCT01681186|589092006|FG007|Washout Period From Second Intervention|Adverse Event|0|||
163105604|NCT01681186|589091999|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
163105605|NCT01681186|589092000|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
163105606|NCT01681186|589092001|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
163105607|NCT01681186|589092002|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
163105608|NCT01681186|589092003|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
163105609|NCT01681186|589092004|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
163105610|NCT01681186|589092005|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
163105611|NCT01681186|589092006|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
163105612|NCT01681186|589091999|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105613|NCT01681186|589092000|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105614|NCT01681186|589092001|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105615|NCT01681186|589092002|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105616|NCT01681186|589092003|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105617|NCT01681186|589092004|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105618|NCT01681186|589092005|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
163105619|NCT01681186|589092006|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
163105620|NCT01681186|589091999|FG000|Fourth Intervention|Protocol Violation|0|||
163105621|NCT01681186|589092000|FG001|Fourth Intervention|Protocol Violation|0|||
163105622|NCT01681186|589092001|FG002|Fourth Intervention|Protocol Violation|0|||
163105623|NCT01681186|589092002|FG003|Fourth Intervention|Protocol Violation|0|||
163105624|NCT01681186|589092003|FG004|Fourth Intervention|Protocol Violation|0|||
163105625|NCT01681186|589092004|FG005|Fourth Intervention|Protocol Violation|0|||
163105626|NCT01681186|589092005|FG006|Fourth Intervention|Protocol Violation|0|||
163105627|NCT01681186|589092006|FG007|Fourth Intervention|Protocol Violation|1|||
163105628|NCT00606034|589092011|FG000|Overall Study|incarceration|1|||
163105629|NCT01734395|589092012|FG000|Overall Study|Other|65|||
163105630|NCT01734395|589092012|FG000|Overall Study|Lost to Follow-up|287|||
163105631|NCT01734395|589092012|FG000|Overall Study|Lack of Efficacy|5|||
163105632|NCT01734395|589092012|FG000|Overall Study|Adverse Event|40|||
163105633|NCT01734395|589092012|FG000|Overall Study|Withdrawal by Subject|10|||
163105634|NCT01734395|589092012|FG000|Overall Study|Missing the reasons for not completed|3|||
163105635|NCT00765037|589092013|FG000|Overall Study|Lost to Follow-up|5|||
163105636|NCT00765037|589092013|FG000|Overall Study|Adverse Event|1|||
163105637|NCT02125838|589092016|FG000|Overall Study|Lost to Follow-up|4|||
163105638|NCT02125838|589092017|FG001|Overall Study|Lost to Follow-up|4|||
163105639|NCT02565147|589092018|FG000|Overall Study|Withdrawal by Subject|5|||
163105640|NCT02565147|589092019|FG001|Overall Study|Withdrawal by Subject|1|||
163105641|NCT02565147|589092018|FG000|Overall Study|Lost to Follow-up|0|||
163105642|NCT02565147|589092019|FG001|Overall Study|Lost to Follow-up|1|||
163105643|NCT02565147|589092018|FG000|Overall Study|Death|1|||
163105644|NCT02565147|589092019|FG001|Overall Study|Death|1|||
163105645|NCT00787839|589092020|FG000|Overall Study|Failure to have the OGTT was most common|404|||
163105646|NCT00244725|589092028|FG000|Overall Study|Lost to Follow-up|3|||
163105647|NCT00244725|589092029|FG001|Overall Study|Lost to Follow-up|4|||
163105648|NCT00244725|589092030|FG002|Overall Study|Lost to Follow-up|9|||
163105649|NCT00244725|589092031|FG003|Overall Study|Lost to Follow-up|2|||
163105650|NCT00244725|589092028|FG000|Overall Study|Withdrawal by Subject|9|||
163105651|NCT00244725|589092029|FG001|Overall Study|Withdrawal by Subject|7|||
163105652|NCT00244725|589092030|FG002|Overall Study|Withdrawal by Subject|7|||
163105653|NCT00244725|589092031|FG003|Overall Study|Withdrawal by Subject|8|||
163105654|NCT00244725|589092028|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
163105655|NCT00244725|589092029|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
163105656|NCT00244725|589092030|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
163105657|NCT00244725|589092031|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
163105658|NCT00244725|589092028|FG000|Overall Study|Physician Decision|3|||
163105659|NCT00244725|589092029|FG001|Overall Study|Physician Decision|0|||
163105660|NCT00244725|589092030|FG002|Overall Study|Physician Decision|1|||
163105661|NCT00244725|589092031|FG003|Overall Study|Physician Decision|2|||
163105662|NCT00244725|589092028|FG000|Overall Study|Adverse Events|3|||
163105663|NCT00244725|589092029|FG001|Overall Study|Adverse Events|1|||
163105664|NCT00244725|589092030|FG002|Overall Study|Adverse Events|4|||
163105665|NCT00244725|589092031|FG003|Overall Study|Adverse Events|4|||
163105666|NCT00244725|589092028|FG000|Overall Study|Withdrwal by participant|1|||
163105667|NCT00244725|589092029|FG001|Overall Study|Withdrwal by participant|0|||
163105668|NCT00244725|589092030|FG002|Overall Study|Withdrwal by participant|0|||
163105669|NCT00244725|589092031|FG003|Overall Study|Withdrwal by participant|1|||
163105670|NCT00244725|589092028|FG000|Overall Study|Liver function test abnormality|2|||
163105671|NCT00244725|589092029|FG001|Overall Study|Liver function test abnormality|0|||
163105672|NCT00244725|589092030|FG002|Overall Study|Liver function test abnormality|0|||
163105673|NCT00244725|589092031|FG003|Overall Study|Liver function test abnormality|1|||
163105674|NCT00244725|589092028|FG000|Overall Study|Sponsor withdrew the participant|1|||
163105675|NCT00244725|589092029|FG001|Overall Study|Sponsor withdrew the participant|0|||
163105676|NCT00244725|589092030|FG002|Overall Study|Sponsor withdrew the participant|0|||
163105677|NCT00244725|589092031|FG003|Overall Study|Sponsor withdrew the participant|1|||
163105678|NCT00244725|589092028|FG000|Overall Study|Mediciation Error|0|||
163105679|NCT00244725|589092029|FG001|Overall Study|Mediciation Error|1|||
163105680|NCT00244725|589092030|FG002|Overall Study|Mediciation Error|0|||
163105681|NCT00244725|589092031|FG003|Overall Study|Mediciation Error|0|||
163105682|NCT00244725|589092028|FG000|Overall Study|Rehab Refused to allow participantion|0|||
163105683|NCT00244725|589092029|FG001|Overall Study|Rehab Refused to allow participantion|1|||
163105684|NCT00244725|589092030|FG002|Overall Study|Rehab Refused to allow participantion|0|||
163105685|NCT00244725|589092031|FG003|Overall Study|Rehab Refused to allow participantion|0|||
163105686|NCT00244725|589092028|FG000|Overall Study|Headache|0|||
163105687|NCT00244725|589092029|FG001|Overall Study|Headache|1|||
163105688|NCT00244725|589092030|FG002|Overall Study|Headache|0|||
163105689|NCT00244725|589092031|FG003|Overall Study|Headache|0|||
163105690|NCT00244725|589092028|FG000|Overall Study|Received prohibited medication|0|||
163105691|NCT00244725|589092029|FG001|Overall Study|Received prohibited medication|1|||
163105692|NCT00244725|589092030|FG002|Overall Study|Received prohibited medication|0|||
163105693|NCT00244725|589092031|FG003|Overall Study|Received prohibited medication|1|||
163105694|NCT00244725|589092028|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105695|NCT00244725|589092029|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
163105696|NCT00244725|589092030|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105697|NCT00244725|589092031|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
163105698|NCT00244725|589092028|FG000|Overall Study|Administrative reason|0|||
163105699|NCT00244725|589092029|FG001|Overall Study|Administrative reason|0|||
163105700|NCT00244725|589092030|FG002|Overall Study|Administrative reason|1|||
163105701|NCT00244725|589092031|FG003|Overall Study|Administrative reason|0|||
163105702|NCT00244725|589092028|FG000|Overall Study|Vomit|0|||
163105703|NCT00244725|589092029|FG001|Overall Study|Vomit|0|||
163105704|NCT00244725|589092030|FG002|Overall Study|Vomit|1|||
163105705|NCT00244725|589092031|FG003|Overall Study|Vomit|0|||
163105706|NCT00244725|589092028|FG000|Overall Study|Failed to follow-up|0|||
163105707|NCT00244725|589092029|FG001|Overall Study|Failed to follow-up|0|||
163105708|NCT00244725|589092030|FG002|Overall Study|Failed to follow-up|1|||
163105709|NCT00244725|589092031|FG003|Overall Study|Failed to follow-up|1|||
163105710|NCT04004221|589092036|FG000|Overall Study|Death|89|||
163105711|NCT04004221|589092036|FG000|Overall Study|Withdrawal by Subject|5|||
163105712|NCT04004221|589092036|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
163105713|NCT04004221|589092036|FG000|Overall Study|Sponsor Decision|9|||
163105714|NCT04004221|589092036|FG000|Overall Study|Participant refused to enter LTE|1|||
163105715|NCT03423238|589092037|FG000|Overall Study|Lost to Follow-up|1|||
163105716|NCT03423238|589092038|FG001|Overall Study|Lost to Follow-up|0|||
163105717|NCT03423238|589092037|FG000|Overall Study|Withdrawal by Subject|1|||
163105718|NCT03423238|589092038|FG001|Overall Study|Withdrawal by Subject|0|||
163105719|NCT00506454|589092040|FG000|Overall Study|Withdrawal by Subject|1|||
163105720|NCT00506454|589092041|FG001|Overall Study|Withdrawal by Subject|1|||
163105721|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
163105722|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
163105723|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163105724|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105725|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105726|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105727|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163105728|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
163105729|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105730|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105731|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105732|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105733|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105734|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163105735|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163105736|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
163105737|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
163105738|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105739|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105740|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105741|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163105742|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163105743|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163105744|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105745|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105746|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105747|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105748|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163105749|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
163105750|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105751|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105752|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105753|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
162653651|NCT01896895|587449542|FG000|Double-blind MP|Physician Decision|0|||
162653652|NCT01896895|587449543|FG001|Double-blind MP|Physician Decision|0|||
162653653|NCT01896895|587449544|FG002|Double-blind MP|Physician Decision|1|||
162653654|NCT01896895|587449545|FG003|Double-blind MP|Physician Decision|0|||
162653655|NCT01896895|587449542|FG000|Double-blind MP|Withdrawal by Subject|0|||
162653656|NCT01896895|587449543|FG001|Double-blind MP|Withdrawal by Subject|2|||
163105754|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105755|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
163105756|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105757|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
163105758|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105759|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105760|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105761|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105762|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163105763|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
163105764|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
163105765|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
163105766|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105767|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105768|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105769|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163105770|NCT03745638|589092042|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
163105771|NCT03745638|589092043|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
163105772|NCT03745638|589092044|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105773|NCT03745638|589092045|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105774|NCT03745638|589092046|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105775|NCT03745638|589092047|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105776|NCT03745638|589092048|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
163105777|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105778|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105779|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105780|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105781|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163105782|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
163105783|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
163105784|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105785|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105786|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105787|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163105788|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163105789|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163105790|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163105791|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105792|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105793|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163105794|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
163105795|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
163105796|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
163105797|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
163105798|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105799|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105800|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105801|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105802|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
163105803|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
163105804|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163105805|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105806|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105807|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105808|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105809|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105810|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
163105811|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163105812|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105813|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105814|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163105815|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
163105816|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
163105817|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
163105818|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
163105819|NCT03745638|589092042|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105820|NCT03745638|589092043|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105821|NCT03745638|589092044|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105822|NCT03745638|589092045|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105823|NCT03745638|589092046|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
163105824|NCT03745638|589092047|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
163105825|NCT03745638|589092048|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
163105826|NCT00976716|589092049|FG000|Overall Study|Adverse Event|1|||
163105827|NCT02993822|589092057|FG000|Overall Study|Lack of Efficacy|1|||
163105828|NCT02993822|589092058|FG001|Overall Study|Lack of Efficacy|1|||
162719126|NCT03284957|587678392|FG001|Overall Study|Withdrawal by Subject|0|||
162719127|NCT03284957|587678393|FG002|Overall Study|Withdrawal by Subject|0|||
162719128|NCT03284957|587678394|FG003|Overall Study|Withdrawal by Subject|0|||
163105829|NCT02993822|589092059|FG002|Overall Study|Lack of Efficacy|0|||
163105830|NCT02993822|589092060|FG003|Overall Study|Lack of Efficacy|0|||
162719129|NCT03284957|587678395|FG004|Overall Study|Withdrawal by Subject|0|||
162719130|NCT03284957|587678396|FG005|Overall Study|Withdrawal by Subject|0|||
162653657|NCT01896895|587449544|FG002|Double-blind MP|Withdrawal by Subject|1|||
162653658|NCT01896895|587449545|FG003|Double-blind MP|Withdrawal by Subject|0|||
162653659|NCT01896895|587449542|FG000|Double-blind MP|Lost to Follow-up|1|||
162653660|NCT01896895|587449543|FG001|Double-blind MP|Lost to Follow-up|0|||
162653661|NCT01896895|587449544|FG002|Double-blind MP|Lost to Follow-up|1|||
162653662|NCT01896895|587449545|FG003|Double-blind MP|Lost to Follow-up|0|||
162653663|NCT03277846|587449546|FG000|Overall Study|Inpatient stay too brief|12|||
162653664|NCT03277846|587449547|FG001|Overall Study|Inpatient stay too brief|11|||
162653665|NCT05168475|587449548|FG000|Period 1|Protocol Violation|1|||
162653666|NCT05168475|587449548|FG000|Period 1|IMP shortage|2|||
162653667|NCT05168475|587449548|FG000|Period 1|Not randomised|2|||
162653668|NCT05168475|587449548|FG000|Period 2|IMP shortage|1|||
162653669|NCT01589822|587449549|FG000|Overall Study|Withdrawal by Subject|1|||
162653670|NCT01589822|587449550|FG001|Overall Study|Withdrawal by Subject|2|||
162653671|NCT01589822|587449551|FG002|Overall Study|Withdrawal by Subject|0|||
162653672|NCT01589822|587449549|FG000|Overall Study|Death|1|||
162653673|NCT01589822|587449550|FG001|Overall Study|Death|0|||
162653674|NCT01589822|587449551|FG002|Overall Study|Death|0|||
162653675|NCT01589822|587449549|FG000|Overall Study|Missed 90 day visit|2|||
162653676|NCT01589822|587449550|FG001|Overall Study|Missed 90 day visit|1|||
162653677|NCT01589822|587449551|FG002|Overall Study|Missed 90 day visit|1|||
162653678|NCT00646204|587449552|FG000|Overall Study|Adverse Event|3|||
163105831|NCT02993822|589092057|FG000|Overall Study|Protocol Violation|1|||
163105832|NCT02993822|589092058|FG001|Overall Study|Protocol Violation|0|||
163105833|NCT02993822|589092059|FG002|Overall Study|Protocol Violation|0|||
163105834|NCT02993822|589092060|FG003|Overall Study|Protocol Violation|0|||
163105835|NCT02993822|589092057|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
163105836|NCT02993822|589092058|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
163105837|NCT02993822|589092059|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
163105838|NCT02993822|589092060|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
163105839|NCT02993822|589092057|FG000|Overall Study|Adverse Event|3|||
163105840|NCT02993822|589092058|FG001|Overall Study|Adverse Event|1|||
163105841|NCT02993822|589092059|FG002|Overall Study|Adverse Event|7|||
163105842|NCT02993822|589092060|FG003|Overall Study|Adverse Event|0|||
163105843|NCT02993822|589092057|FG000|Overall Study|Withdrawal by Subject|4|||
163105844|NCT02993822|589092058|FG001|Overall Study|Withdrawal by Subject|2|||
163105845|NCT02993822|589092059|FG002|Overall Study|Withdrawal by Subject|2|||
163105846|NCT02993822|589092060|FG003|Overall Study|Withdrawal by Subject|3|||
163105847|NCT02993822|589092057|FG000|Overall Study|Lost to Follow-up|1|||
163105848|NCT02993822|589092058|FG001|Overall Study|Lost to Follow-up|0|||
163105849|NCT02993822|589092059|FG002|Overall Study|Lost to Follow-up|1|||
163105850|NCT02993822|589092060|FG003|Overall Study|Lost to Follow-up|0|||
163105851|NCT01221753|589092064|FG000|Overall Study|Adverse Event|1|||
163105852|NCT01939977|589092068|FG000|Overall Study|Adverse Event|4|||
163105853|NCT01939977|589092069|FG001|Overall Study|Adverse Event|3|||
163105854|NCT01939977|589092068|FG000|Overall Study|Lack of Efficacy|3|||
163105855|NCT01939977|589092069|FG001|Overall Study|Lack of Efficacy|0|||
163105856|NCT01939977|589092068|FG000|Overall Study|Physician Decision|1|||
163105857|NCT01939977|589092069|FG001|Overall Study|Physician Decision|1|||
163105858|NCT01939977|589092068|FG000|Overall Study|Withdrawal by Subject|0|||
163105859|NCT01939977|589092069|FG001|Overall Study|Withdrawal by Subject|2|||
163105860|NCT01939977|589092068|FG000|Overall Study|Did not meet inclusion criteria|1|||
163105861|NCT01939977|589092069|FG001|Overall Study|Did not meet inclusion criteria|0|||
163105862|NCT01939977|589092068|FG000|Overall Study|Did not receive study medication|0|||
163105863|NCT01939977|589092069|FG001|Overall Study|Did not receive study medication|1|||
163105864|NCT01603043|589092073|FG000|Overall Study|Study Futility|7|||
163105865|NCT01603043|589092074|FG001|Overall Study|Study Futility|3|||
163105866|NCT01917929|589092075|FG000|Overall Study|Death|8|||
163105867|NCT01917929|589092075|FG000|Overall Study|Lost to Follow-up|19|||
163105868|NCT01917929|589092075|FG000|Overall Study|Withdrawal by Subject|33|||
163105869|NCT01917929|589092075|FG000|Overall Study|Adverse Event|6|||
163105870|NCT01917929|589092075|FG000|Overall Study|Investigative Site Terminated|35|||
163105871|NCT01917929|589092075|FG000|Overall Study|Censored because study device not implanted|6|||
163105872|NCT01917929|589092075|FG000|Overall Study|Censored because surgery not performed|3|||
163105873|NCT01917929|589092075|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
163105874|NCT01917929|589092075|FG000|Overall Study|Sponsor terminated study|175|||
163105875|NCT01696981|589092076|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
163105876|NCT01696981|589092077|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
163105877|NCT01696981|589092076|FG000|Overall Study|Died Before Randomization|3|||
163105878|NCT01696981|589092077|FG001|Overall Study|Died Before Randomization|8|||
163105879|NCT01696981|589092076|FG000|Overall Study|Died Before ASU (Control)|278|||
163105880|NCT01696981|589092077|FG001|Overall Study|Died Before ASU (Control)|0|||
163105881|NCT01696981|589092076|FG000|Overall Study|Refused ASU (Control)|920|||
163105882|NCT01696981|589092077|FG001|Overall Study|Refused ASU (Control)|0|||
163105883|NCT01696981|589092076|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
163105884|NCT01696981|589092077|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
163105885|NCT03599518|589092078|FG000|Overall Study|Clinical progression|0|||
163105886|NCT03599518|589092079|FG001|Overall Study|Clinical progression|0|||
163105887|NCT03599518|589092080|FG002|Overall Study|Clinical progression|0|||
163105888|NCT03599518|589092081|FG003|Overall Study|Clinical progression|0|||
163105889|NCT03599518|589092082|FG004|Overall Study|Clinical progression|1|||
163105890|NCT03599518|589092078|FG000|Overall Study|Adverse Event|0|||
163105891|NCT03599518|589092079|FG001|Overall Study|Adverse Event|0|||
163105892|NCT03599518|589092080|FG002|Overall Study|Adverse Event|0|||
163105893|NCT03599518|589092081|FG003|Overall Study|Adverse Event|0|||
163105894|NCT03599518|589092082|FG004|Overall Study|Adverse Event|1|||
163105895|NCT03599518|589092078|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
163105896|NCT03599518|589092079|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
163105897|NCT03599518|589092080|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
163105898|NCT03599518|589092081|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
163105899|NCT03599518|589092082|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
163105900|NCT03599518|589092078|FG000|Overall Study|Participant withdrawal from study treatment|0|||
163105901|NCT03599518|589092079|FG001|Overall Study|Participant withdrawal from study treatment|0|||
163105902|NCT03599518|589092080|FG002|Overall Study|Participant withdrawal from study treatment|1|||
163105903|NCT03599518|589092081|FG003|Overall Study|Participant withdrawal from study treatment|0|||
163105904|NCT03599518|589092082|FG004|Overall Study|Participant withdrawal from study treatment|0|||
163105905|NCT02798315|589092085|FG000|Overall Study|Failure to return|1|||
163105906|NCT00005947|589092086|FG000|Overall Study|Death|54|||
163105907|NCT00005947|589092087|FG001|Overall Study|Death|40|||
163105908|NCT00005947|589092086|FG000|Overall Study|Patient Refused to Continue|2|||
163105909|NCT00005947|589092087|FG001|Overall Study|Patient Refused to Continue|1|||
163105910|NCT00005947|589092086|FG000|Overall Study|Site Closure|1|||
163105911|NCT00005947|589092087|FG001|Overall Study|Site Closure|0|||
163105912|NCT00465972|589092088|FG000|Overall Study|Withdrawal by Subject|2|||
163105913|NCT00465972|589092089|FG001|Overall Study|Withdrawal by Subject|1|||
163105914|NCT03292640|589092090|FG000|Overall Study|Withdrawal by Subject|17|||
163105915|NCT03292640|589092091|FG001|Overall Study|Withdrawal by Subject|16|||
163105916|NCT03292640|589092090|FG000|Overall Study|Adverse Event|20|||
163105917|NCT03292640|589092091|FG001|Overall Study|Adverse Event|2|||
163105918|NCT03292640|589092090|FG000|Overall Study|Lost to Follow-up|24|||
163105919|NCT03292640|589092091|FG001|Overall Study|Lost to Follow-up|24|||
163105920|NCT00851890|589092096|FG000|Overall Study|Lost to Follow-up|0|||
163105921|NCT00851890|589092097|FG001|Overall Study|Lost to Follow-up|1|||
163105922|NCT00851890|589092098|FG002|Overall Study|Lost to Follow-up|0|||
163105923|NCT00851890|589092099|FG003|Overall Study|Lost to Follow-up|1|||
163105924|NCT03135431|589092100|FG000|Overall Study|Study Surgeon not available|2|||
163105925|NCT03135431|589092101|FG001|Overall Study|Study Surgeon not available|0|||
163105926|NCT02015481|589092102|FG000|Overall Study|Death|1|||
163105927|NCT03122145|589092104|FG000|Overall Study|Concurrent respiratory disease|3|||
163105928|NCT03122145|589092105|FG001|Overall Study|Concurrent respiratory disease|0|||
163105929|NCT00079391|589092106|FG000|Overall Study|Withdrawal by Subject|1|||
163105930|NCT00837161|589092107|FG000|Overall Study|refused hysterectomy|2|||
163105931|NCT03206918|589092108|FG000|Overall Study|Death|11|||
163105932|NCT03206918|589092108|FG000|Overall Study|Withdrawal by Subject|5|||
163105933|NCT03206918|589092108|FG000|Overall Study|Study terminated by sponsor|12|||
163105934|NCT03206918|589092108|FG000|Overall Study|Lost to Follow-up|3|||
163105935|NCT03206918|589092108|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
163105936|NCT02701764|589092109|FG000|Overall Study|Lost to Follow-up|0|||
163105937|NCT02701764|589092110|FG001|Overall Study|Lost to Follow-up|1|||
163105938|NCT06899737|589092116|FG000|Overall Study|Lost to Follow-up|19|||
163105939|NCT06899737|589092117|FG001|Overall Study|Lost to Follow-up|7|||
163105940|NCT01170273|589092118|FG000|Overall Study|Lost to Follow-up|6|||
163105941|NCT01170273|589092119|FG001|Overall Study|Lost to Follow-up|8|||
163105942|NCT01170273|589092118|FG000|Overall Study|Protocol Violation|1|||
163105943|NCT01170273|589092119|FG001|Overall Study|Protocol Violation|0|||
163105944|NCT01170273|589092118|FG000|Overall Study|Death|1|||
163105945|NCT01170273|589092119|FG001|Overall Study|Death|0|||
163105946|NCT01170273|589092118|FG000|Overall Study|Adverse Event|0|||
163105947|NCT01170273|589092119|FG001|Overall Study|Adverse Event|1|||
163105948|NCT00375674|589092120|FG000|Overall Study|Other|26|||
163105949|NCT00375674|589092121|FG001|Overall Study|Other|18|||
163105950|NCT00375674|589092120|FG000|Overall Study|Death|67|||
163105951|NCT00375674|589092121|FG001|Overall Study|Death|76|||
163105952|NCT00375674|589092120|FG000|Overall Study|Participants refused further follow-up|31|||
163105953|NCT00375674|589092121|FG001|Overall Study|Participants refused further follow-up|30|||
163105954|NCT00375674|589092120|FG000|Overall Study|Lost to Follow-up|17|||
163105955|NCT00375674|589092121|FG001|Overall Study|Lost to Follow-up|15|||
163105956|NCT00375674|589092120|FG000|Overall Study|Enrolled but not treated|3|||
163105957|NCT00375674|589092121|FG001|Overall Study|Enrolled but not treated|2|||
163105958|NCT00912782|589092122|FG000|Overall Study|Death|2|||
163105959|NCT00912782|589092123|FG001|Overall Study|Death|1|||
163105960|NCT00912782|589092122|FG000|Overall Study|Lost to Follow-up|0|||
163105961|NCT00912782|589092123|FG001|Overall Study|Lost to Follow-up|1|||
163105962|NCT00912782|589092122|FG000|Overall Study|Did not receive vascular access type|1|||
163105963|NCT00912782|589092123|FG001|Overall Study|Did not receive vascular access type|2|||
163105964|NCT00912782|589092122|FG000|Overall Study|Relocated before study completion|0|||
163105965|NCT00912782|589092123|FG001|Overall Study|Relocated before study completion|1|||
163105966|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Adverse Event|1|||
163105967|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Adverse Event|0|||
163105968|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
163105969|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
163105970|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
163105971|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
163105972|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
163105973|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
163105974|NCT00301262|589093954|FG000|Double Blind Phase (DB)|Other|1|||
163105975|NCT00301262|589093955|FG001|Double Blind Phase (DB)|Other|4|||
163105976|NCT00301262|589093954|FG000|Open Label Phase (OL)|Adverse Event|1|||
163105977|NCT00301262|589093955|FG001|Open Label Phase (OL)|Adverse Event|0|||
163105978|NCT00301262|589093954|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
163105979|NCT00301262|589093955|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
163105980|NCT00301262|589093954|FG000|Open Label Phase (OL)|Other|2|||
163105981|NCT00301262|589093955|FG001|Open Label Phase (OL)|Other|0|||
163105982|NCT03530995|589093962|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
163105983|NCT03530995|589093963|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
163105984|NCT03530995|589093962|FG000|Part 1 Period 3|Protocol Violation|1|||
163105985|NCT03530995|589093963|FG001|Part 1 Period 3|Protocol Violation|0|||
163105986|NCT03530995|589093962|FG000|Part 1 Period 4|Physician Decision|1|||
163105987|NCT03530995|589093963|FG001|Part 1 Period 4|Physician Decision|0|||
163105988|NCT03530995|589093962|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
163105989|NCT03530995|589093963|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
163105990|NCT01443364|589093965|FG000|Overall Study|Lack of Efficacy|14|||
163105991|NCT01443364|589093965|FG000|Overall Study|Lost to Follow-up|3|||
163105992|NCT01443364|589093965|FG000|Overall Study|Withdrawal by Subject|5|||
163105993|NCT01443364|589093965|FG000|Overall Study|Other Reason|4|||
163105994|NCT01443364|589093965|FG000|Overall Study|SAE, non-fatal|6|||
163105995|NCT01443364|589093965|FG000|Overall Study|AE, non-serious non-fatal|8|||
163105996|NCT01443364|589093965|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
163105997|NCT02650804|589093966|FG000|Overall Study|Adverse Event|3|||
163105998|NCT02650804|589093967|FG001|Overall Study|Adverse Event|2|||
163105999|NCT02650804|589093966|FG000|Overall Study|Death|1|||
163106000|NCT02650804|589093967|FG001|Overall Study|Death|2|||
163106001|NCT02650804|589093966|FG000|Overall Study|Progressive Disease|7|||
163106002|NCT02650804|589093967|FG001|Overall Study|Progressive Disease|10|||
163106003|NCT02650804|589093966|FG000|Overall Study|Physician Decision|0|||
163106004|NCT02650804|589093967|FG001|Overall Study|Physician Decision|2|||
163106005|NCT02650804|589093966|FG000|Overall Study|Withdrawal by Subject|1|||
163106006|NCT02650804|589093967|FG001|Overall Study|Withdrawal by Subject|4|||
163106007|NCT02650804|589093966|FG000|Overall Study|Symptomatic deterioration|5|||
163106008|NCT02650804|589093967|FG001|Overall Study|Symptomatic deterioration|7|||
163106009|NCT02650804|589093966|FG000|Overall Study|Protocol Violation|0|||
163106010|NCT02650804|589093967|FG001|Overall Study|Protocol Violation|1|||
163106011|NCT01986231|589093972|FG000|Overall Study|Adverse Event|1|||
163106012|NCT02150057|589093973|FG000|Overall Study|Lost to Follow-up|6|||
163106013|NCT02150057|589093974|FG001|Overall Study|Lost to Follow-up|4|||
163106014|NCT02388165|589093975|FG000|Overall Study|Study terminated by sponsor|5|||
163106015|NCT02388165|589093976|FG001|Overall Study|Study terminated by sponsor|5|||
163106016|NCT02388165|589093975|FG000|Overall Study|Other|11|||
163106017|NCT02388165|589093976|FG001|Overall Study|Other|13|||
163106018|NCT02388165|589093975|FG000|Overall Study|No longer meet eligibility criteria|40|||
163106019|NCT02388165|589093976|FG001|Overall Study|No longer meet eligibility criteria|43|||
163106020|NCT02388165|589093975|FG000|Overall Study|Withdrawal of consent|31|||
163106021|NCT02388165|589093976|FG001|Overall Study|Withdrawal of consent|32|||
163106022|NCT02388165|589093975|FG000|Overall Study|Lost to Follow-up|19|||
163106023|NCT02388165|589093976|FG001|Overall Study|Lost to Follow-up|20|||
163106024|NCT02388165|589093975|FG000|Overall Study|Death|13|||
163106025|NCT02388165|589093976|FG001|Overall Study|Death|10|||
163106026|NCT02388165|589093975|FG000|Overall Study|Adverse Event|3|||
163106027|NCT02388165|589093976|FG001|Overall Study|Adverse Event|5|||
163106028|NCT02388165|589093975|FG000|Overall Study|Did not meet entrance criteria|5|||
163106029|NCT02388165|589093976|FG001|Overall Study|Did not meet entrance criteria|2|||
163106030|NCT04551963|589093980|FG000|Overall Study|Physician Decision|1|||
163106031|NCT04551963|589093981|FG001|Overall Study|Physician Decision|1|||
163106032|NCT04551963|589093980|FG000|Overall Study|Death|1|||
163106033|NCT04551963|589093981|FG001|Overall Study|Death|0|||
163106034|NCT02974855|589093982|FG000|Overall Study|Adverse Event|0|||
163106035|NCT02974855|589093983|FG001|Overall Study|Adverse Event|1|||
163106036|NCT02974855|589093984|FG002|Overall Study|Adverse Event|0|||
163106037|NCT02974855|589093985|FG003|Overall Study|Adverse Event|1|||
163106038|NCT01474772|589093986|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
163106039|NCT01474772|589093987|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
163106040|NCT01474772|589093986|FG000|Period 1|AE not Related to Study Drug|1|||
163106041|NCT01474772|589093987|FG001|Period 1|AE not Related to Study Drug|0|||
163106042|NCT01474772|589093986|FG000|Period 1|Withdrawal by Subject|3|||
163106043|NCT01474772|589093987|FG001|Period 1|Withdrawal by Subject|1|||
163106044|NCT01474772|589093986|FG000|Period 1|Lost to Follow-up|1|||
163106045|NCT01474772|589093987|FG001|Period 1|Lost to Follow-up|0|||
163106046|NCT01474772|589093986|FG000|Period 1|Reason not Specified|1|||
163106047|NCT01474772|589093987|FG001|Period 1|Reason not Specified|1|||
163106048|NCT01474772|589093986|FG000|Washout|AE not Related to Study Drug|2|||
163106049|NCT01474772|589093987|FG001|Washout|AE not Related to Study Drug|0|||
163106050|NCT01474772|589093986|FG000|Washout|Withdrawal by Subject|1|||
163106051|NCT01474772|589093987|FG001|Washout|Withdrawal by Subject|0|||
163106052|NCT01474772|589093986|FG000|Washout|Lost to Follow-up|0|||
163106053|NCT01474772|589093987|FG001|Washout|Lost to Follow-up|1|||
163106054|NCT01474772|589093986|FG000|Washout|Reason not Specified|0|||
163106055|NCT01474772|589093987|FG001|Washout|Reason not Specified|1|||
163106056|NCT01474772|589093986|FG000|Period 2|Death|0|||
163106057|NCT01474772|589093987|FG001|Period 2|Death|1|||
163106058|NCT01474772|589093986|FG000|Period 2|AE Related to Study Drug|0|||
163106059|NCT01474772|589093987|FG001|Period 2|AE Related to Study Drug|1|||
162653679|NCT00646204|587449553|FG001|Overall Study|Adverse Event|0|||
162653680|NCT00646204|587449552|FG000|Overall Study|Withdrawal by Subject|1|||
162653681|NCT00646204|587449553|FG001|Overall Study|Withdrawal by Subject|0|||
162653682|NCT00773175|587449557|FG000|Overall Study|Adverse Event|2|||
162653683|NCT00773175|587449558|FG001|Overall Study|Adverse Event|0|||
163106060|NCT01474772|589093986|FG000|Period 2|AE not Related to Study Drug|4|||
163106061|NCT01474772|589093987|FG001|Period 2|AE not Related to Study Drug|1|||
163106062|NCT01474772|589093986|FG000|Period 2|Lack of Efficacy|1|||
163106063|NCT01474772|589093987|FG001|Period 2|Lack of Efficacy|0|||
163106064|NCT01474772|589093986|FG000|Period 2|Withdrawal by Subject|3|||
163106065|NCT01474772|589093987|FG001|Period 2|Withdrawal by Subject|4|||
163106066|NCT01474772|589093986|FG000|Period 2|Lost to Follow-up|1|||
163106067|NCT01474772|589093987|FG001|Period 2|Lost to Follow-up|1|||
163106068|NCT01474772|589093986|FG000|Period 2|Reason not Specified|0|||
163106069|NCT01474772|589093987|FG001|Period 2|Reason not Specified|2|||
163106070|NCT01474772|589093986|FG000|Follow-up|AE not Related to Study Drug|0|||
163106071|NCT01474772|589093987|FG001|Follow-up|AE not Related to Study Drug|1|||
163106072|NCT00633074|589093988|FG000|Overall Study|Adverse Event|1|||
163106073|NCT00633074|589093989|FG001|Overall Study|Adverse Event|0|||
163106074|NCT00365105|589093990|FG000|Overall Study|Protocol Violation|5|||
163106075|NCT00365105|589093991|FG001|Overall Study|Protocol Violation|8|||
163106076|NCT00748618|589093992|FG000|Overall Study|Adverse Event|1|||
163106077|NCT00748618|589093993|FG001|Overall Study|Adverse Event|0|||
163106078|NCT06004895|589093994|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
163106079|NCT06004895|589093994|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
163106080|NCT00466947|589093995|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
163106081|NCT00466947|589093996|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
163106082|NCT00466947|589093995|FG000|Study End Analysis Period|Adverse Event|35|||
163106083|NCT00466947|589093996|FG001|Study End Analysis Period|Adverse Event|43|||
163106084|NCT00466947|589093995|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
163106085|NCT00466947|589093996|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
163106086|NCT00466947|589093995|FG000|Study End Analysis Period|Physician Decision|29|||
163106087|NCT00466947|589093996|FG001|Study End Analysis Period|Physician Decision|29|||
163106088|NCT00466947|589093995|FG000|Study End Analysis Period|Protocol Violation|9|||
163106089|NCT00466947|589093996|FG001|Study End Analysis Period|Protocol Violation|17|||
163106090|NCT00466947|589093995|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
163106091|NCT00466947|589093996|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
163106092|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
163106093|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
163106094|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
163106095|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
163106096|NCT00466947|589093995|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
163106097|NCT00466947|589093996|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
163106098|NCT00878254|589093997|FG000|Overall Study|Physician Decision|1|||
163106099|NCT00878254|589093997|FG000|Overall Study|Death|1|||
163106100|NCT00878254|589093997|FG000|Overall Study|Withdrawal by Subject|1|||
163106101|NCT01995526|589093998|FG000|Overall Study|Physician Decision|1|||
163106102|NCT03367403|589094003|FG000|Overall Study|Adverse Event|20|||
163106103|NCT03367403|589094004|FG001|Overall Study|Adverse Event|6|||
163106104|NCT03367403|589094005|FG002|Overall Study|Adverse Event|2|||
163106105|NCT03367403|589094003|FG000|Overall Study|Withdrawal by Subject|12|||
163106106|NCT03367403|589094004|FG001|Overall Study|Withdrawal by Subject|13|||
163106107|NCT03367403|589094005|FG002|Overall Study|Withdrawal by Subject|1|||
163106108|NCT03367403|589094003|FG000|Overall Study|Death|1|||
163106109|NCT03367403|589094004|FG001|Overall Study|Death|2|||
163106110|NCT03367403|589094005|FG002|Overall Study|Death|0|||
163106111|NCT03367403|589094003|FG000|Overall Study|Physician Decision|0|||
163106112|NCT03367403|589094004|FG001|Overall Study|Physician Decision|1|||
163106113|NCT03367403|589094005|FG002|Overall Study|Physician Decision|0|||
163106114|NCT03367403|589094003|FG000|Overall Study|Protocol Violation|1|||
163106115|NCT03367403|589094004|FG001|Overall Study|Protocol Violation|1|||
163106116|NCT03367403|589094005|FG002|Overall Study|Protocol Violation|0|||
163106117|NCT03367403|589094003|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163106118|NCT03367403|589094004|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
163106119|NCT03367403|589094005|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
163106120|NCT03367403|589094003|FG000|Overall Study|COVID-19|3|||
163106121|NCT03367403|589094004|FG001|Overall Study|COVID-19|6|||
163106122|NCT03367403|589094005|FG002|Overall Study|COVID-19|0|||
163106123|NCT03367403|589094003|FG000|Overall Study|Abuse of Alcohol Intake|0|||
163106124|NCT03367403|589094004|FG001|Overall Study|Abuse of Alcohol Intake|1|||
163106125|NCT03367403|589094005|FG002|Overall Study|Abuse of Alcohol Intake|0|||
163106126|NCT03367403|589094003|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
163106127|NCT03367403|589094004|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
163106128|NCT03367403|589094005|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
163106129|NCT02321319|589094010|FG000|Overall Study|Product discontinued|5|||
163106130|NCT03497975|589094013|FG000|Overall Study|Withdrew Consent|34|||
163106131|NCT03497975|589094014|FG001|Overall Study|Withdrew Consent|35|||
163106132|NCT03497975|589094013|FG000|Overall Study|Lost to Follow-up|7|||
163106133|NCT03497975|589094014|FG001|Overall Study|Lost to Follow-up|7|||
163106134|NCT03497975|589094013|FG000|Overall Study|Physician Decision|4|||
163106135|NCT03497975|589094014|FG001|Overall Study|Physician Decision|5|||
163106136|NCT03497975|589094013|FG000|Overall Study|Discontinued|42|||
163106137|NCT03497975|589094014|FG001|Overall Study|Discontinued|39|||
163106138|NCT03497975|589094013|FG000|Overall Study|Reason Not Specified|15|||
163106139|NCT03497975|589094014|FG001|Overall Study|Reason Not Specified|14|||
163106140|NCT02141399|589094015|FG000|Overall Study|Adverse Event|158|||
163106141|NCT02141399|589094015|FG000|Overall Study|Lack of Efficacy|62|||
163106142|NCT02141399|589094015|FG000|Overall Study|Lost to Follow-up|151|||
163106143|NCT02141399|589094015|FG000|Overall Study|Non-compliance with study drug|18|||
163106144|NCT02141399|589094015|FG000|Overall Study|Other|45|||
163106145|NCT02141399|589094015|FG000|Overall Study|Physician Decision|17|||
163106146|NCT02141399|589094015|FG000|Overall Study|Pregnancy|3|||
163106147|NCT02141399|589094015|FG000|Overall Study|Protocol Violation|38|||
163106148|NCT02141399|589094015|FG000|Overall Study|Withdrawal by Subject|238|||
163106149|NCT02141399|589094015|FG000|Overall Study|Failure to meet eligibility criteria|14|||
163106150|NCT00935493|589094021|FG000|Overall Study|Lost to Follow-up|1|||
163106151|NCT00935493|589094022|FG001|Overall Study|Lost to Follow-up|1|||
163106152|NCT00935493|589094023|FG002|Overall Study|Lost to Follow-up|1|||
163106153|NCT00935493|589094021|FG000|Overall Study|Treatment Discontinued|0|||
163106154|NCT00935493|589094022|FG001|Overall Study|Treatment Discontinued|1|||
163106155|NCT00935493|589094023|FG002|Overall Study|Treatment Discontinued|0|||
163106156|NCT03799952|589094029|FG000|Overall Study|Program was too easy, discontinued|1|||
163106157|NCT03799952|589094030|FG001|Overall Study|Program was too easy, discontinued|0|||
163106158|NCT03799952|589094029|FG000|Overall Study|Lost to Follow-up|0|||
163106159|NCT03799952|589094030|FG001|Overall Study|Lost to Follow-up|2|||
163106160|NCT00902850|589094031|FG000|Overall Study|Physician Decision|2|||
163106161|NCT00902850|589094032|FG001|Overall Study|Physician Decision|2|||
163106162|NCT02016716|589094043|FG000|Overall Study|Withdrawal by Subject|5|||
163106163|NCT02016716|589094044|FG001|Overall Study|Withdrawal by Subject|5|||
163106164|NCT02016716|589094045|FG002|Overall Study|Withdrawal by Subject|5|||
163106165|NCT02016716|589094043|FG000|Overall Study|Protocol-specified Criteria|0|||
163106166|NCT02016716|589094044|FG001|Overall Study|Protocol-specified Criteria|1|||
163106167|NCT02016716|589094045|FG002|Overall Study|Protocol-specified Criteria|0|||
163106168|NCT02016716|589094043|FG000|Overall Study|Lost to Follow-up|1|||
163106169|NCT02016716|589094044|FG001|Overall Study|Lost to Follow-up|2|||
163106170|NCT02016716|589094045|FG002|Overall Study|Lost to Follow-up|1|||
163106171|NCT02931838|589094046|FG000|Overall Study|Reason not provided by investigator|1|||
163106172|NCT02931838|589094047|FG001|Overall Study|Reason not provided by investigator|0|||
163106173|NCT02931838|589094048|FG002|Overall Study|Reason not provided by investigator|1|||
163106174|NCT02931838|589094049|FG003|Overall Study|Reason not provided by investigator|0|||
163106175|NCT02931838|589094050|FG004|Overall Study|Reason not provided by investigator|0|||
163106176|NCT02931838|589094051|FG005|Overall Study|Reason not provided by investigator|0|||
163106177|NCT02931838|589094046|FG000|Overall Study|Poor/non-compliance|0|||
163106178|NCT02931838|589094047|FG001|Overall Study|Poor/non-compliance|0|||
163106179|NCT02931838|589094048|FG002|Overall Study|Poor/non-compliance|1|||
163106180|NCT02931838|589094049|FG003|Overall Study|Poor/non-compliance|0|||
163106181|NCT02931838|589094050|FG004|Overall Study|Poor/non-compliance|0|||
163106182|NCT02931838|589094051|FG005|Overall Study|Poor/non-compliance|0|||
163106183|NCT02931838|589094046|FG000|Overall Study|Lack of Efficacy|5|||
163106184|NCT02931838|589094047|FG001|Overall Study|Lack of Efficacy|4|||
163106185|NCT02931838|589094048|FG002|Overall Study|Lack of Efficacy|0|||
163106186|NCT02931838|589094049|FG003|Overall Study|Lack of Efficacy|0|||
163106187|NCT02931838|589094050|FG004|Overall Study|Lack of Efficacy|0|||
163106188|NCT02931838|589094051|FG005|Overall Study|Lack of Efficacy|1|||
163106189|NCT02931838|589094046|FG000|Overall Study|Lost to Follow-up|1|||
163106190|NCT02931838|589094047|FG001|Overall Study|Lost to Follow-up|0|||
163106191|NCT02931838|589094048|FG002|Overall Study|Lost to Follow-up|1|||
163106192|NCT02931838|589094049|FG003|Overall Study|Lost to Follow-up|1|||
163106193|NCT02931838|589094050|FG004|Overall Study|Lost to Follow-up|2|||
163106194|NCT02931838|589094051|FG005|Overall Study|Lost to Follow-up|0|||
163106195|NCT02931838|589094046|FG000|Overall Study|Subject request to discontinue treatment|4|||
163106196|NCT02931838|589094047|FG001|Overall Study|Subject request to discontinue treatment|3|||
163106197|NCT02931838|589094048|FG002|Overall Study|Subject request to discontinue treatment|3|||
163106198|NCT02931838|589094049|FG003|Overall Study|Subject request to discontinue treatment|0|||
162653684|NCT00773175|587449557|FG000|Overall Study|Consent Withdrawn|0|||
163106199|NCT02931838|589094050|FG004|Overall Study|Subject request to discontinue treatment|1|||
163106200|NCT02931838|589094051|FG005|Overall Study|Subject request to discontinue treatment|0|||
163106201|NCT02931838|589094046|FG000|Overall Study|Withdrawal by Subject|1|||
163106202|NCT02931838|589094047|FG001|Overall Study|Withdrawal by Subject|2|||
162653685|NCT00773175|587449558|FG001|Overall Study|Consent Withdrawn|2|||
162653686|NCT03795610|587449562|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
163106203|NCT02931838|589094048|FG002|Overall Study|Withdrawal by Subject|0|||
163106204|NCT02931838|589094049|FG003|Overall Study|Withdrawal by Subject|1|||
163106205|NCT02931838|589094050|FG004|Overall Study|Withdrawal by Subject|0|||
163106206|NCT02931838|589094051|FG005|Overall Study|Withdrawal by Subject|0|||
163106207|NCT02931838|589094046|FG000|Overall Study|Adverse Event|2|||
163106208|NCT02931838|589094047|FG001|Overall Study|Adverse Event|1|||
163106209|NCT02931838|589094048|FG002|Overall Study|Adverse Event|2|||
163106210|NCT02931838|589094049|FG003|Overall Study|Adverse Event|1|||
163106211|NCT02931838|589094050|FG004|Overall Study|Adverse Event|3|||
163106212|NCT02931838|589094051|FG005|Overall Study|Adverse Event|1|||
163106213|NCT00104728|589094052|FG000|Overall Study|screen failures|19|||
163106214|NCT01963767|589094053|FG000|Overall Study|Withdrawal by Subject|4|||
163106215|NCT01963767|589094054|FG001|Overall Study|Withdrawal by Subject|2|||
163106216|NCT01963767|589094053|FG000|Overall Study|Adverse Event|2|||
163106217|NCT01963767|589094054|FG001|Overall Study|Adverse Event|0|||
163106218|NCT01659996|589094055|FG000|Overall Study|Protocol Violation|3|||
163106219|NCT01659996|589094056|FG001|Overall Study|Protocol Violation|3|||
163106220|NCT01659996|589094057|FG002|Overall Study|Protocol Violation|3|||
163106221|NCT01659996|589094055|FG000|Overall Study|Lost to Follow-up|1|||
163106222|NCT01659996|589094056|FG001|Overall Study|Lost to Follow-up|3|||
163106223|NCT01659996|589094057|FG002|Overall Study|Lost to Follow-up|2|||
163106224|NCT01659996|589094055|FG000|Overall Study|Adverse Event|0|||
163106225|NCT01659996|589094056|FG001|Overall Study|Adverse Event|0|||
163106226|NCT01659996|589094057|FG002|Overall Study|Adverse Event|1|||
163106227|NCT01659996|589094055|FG000|Overall Study|Withdrawal by Subject|4|||
163106228|NCT01659996|589094056|FG001|Overall Study|Withdrawal by Subject|1|||
163106229|NCT01659996|589094057|FG002|Overall Study|Withdrawal by Subject|5|||
163106230|NCT02709577|589094058|FG000|Overall Study|non-accommodating anatomy|0|||
163106231|NCT02709577|589094059|FG001|Overall Study|non-accommodating anatomy|1|||
163106232|NCT02709577|589094060|FG002|Overall Study|non-accommodating anatomy|0|||
163106233|NCT02709577|589094061|FG003|Overall Study|non-accommodating anatomy|0|||
163106234|NCT02709577|589094058|FG000|Overall Study|procedural complication|0|||
163106235|NCT02709577|589094059|FG001|Overall Study|procedural complication|1|||
163106236|NCT02709577|589094060|FG002|Overall Study|procedural complication|0|||
163106237|NCT02709577|589094061|FG003|Overall Study|procedural complication|0|||
163106238|NCT02709577|589094058|FG000|Overall Study|Withdrawal by Subject|2|||
163106239|NCT02709577|589094059|FG001|Overall Study|Withdrawal by Subject|3|||
163106240|NCT02709577|589094060|FG002|Overall Study|Withdrawal by Subject|2|||
163106241|NCT02709577|589094061|FG003|Overall Study|Withdrawal by Subject|0|||
163106242|NCT03823287|589094062|FG000|Overall Study|Withdrawal by Subject|25|||
163106243|NCT03823287|589094063|FG001|Overall Study|Withdrawal by Subject|17|||
163106244|NCT03823287|589094062|FG000|Overall Study|Death|13|||
163106245|NCT03823287|589094063|FG001|Overall Study|Death|7|||
163106246|NCT03823287|589094062|FG000|Overall Study|Lost to Follow-up|7|||
163106247|NCT03823287|589094063|FG001|Overall Study|Lost to Follow-up|8|||
163106248|NCT03823287|589094062|FG000|Overall Study|Adverse Event|6|||
163106249|NCT03823287|589094063|FG001|Overall Study|Adverse Event|8|||
163106250|NCT03823287|589094062|FG000|Overall Study|Physician Decision|5|||
163106251|NCT03823287|589094063|FG001|Overall Study|Physician Decision|2|||
163106252|NCT03823287|589094062|FG000|Overall Study|Lack of Efficacy|2|||
163106253|NCT03823287|589094063|FG001|Overall Study|Lack of Efficacy|0|||
163106254|NCT03823287|589094062|FG000|Overall Study|Other|2|||
163106255|NCT03823287|589094063|FG001|Overall Study|Other|4|||
163106256|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Adverse Event|7|||
163106257|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Adverse Event|0|||
163106258|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Adverse Event|0|||
163106259|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
163106260|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
163106261|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
163106262|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
163106263|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
163106264|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
163106265|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
163106266|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
162653687|NCT03795610|587449562|FG000|Overall Study|Withdrawal by Subject|1|||
163106267|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
162653688|NCT03795610|587449562|FG000|Overall Study|Screen Failure (Unknown)|1|||
162653689|NCT02775344|587449563|FG000|Overall Study|No ovarian cyst identified|3|||
163106268|NCT01059864|589094066|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
163106269|NCT01059864|589094067|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
163106270|NCT01059864|589094068|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
163106271|NCT01059864|589094066|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163106272|NCT01059864|589094067|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
163106273|NCT01059864|589094068|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
163106274|NCT03108521|589094069|FG000|Overall Study|Lost to Follow-up|3|||
163106275|NCT03108521|589094070|FG001|Overall Study|Lost to Follow-up|0|||
163106276|NCT03108521|589094069|FG000|Overall Study|Lack of Efficacy|2|||
163106277|NCT03108521|589094070|FG001|Overall Study|Lack of Efficacy|0|||
163106278|NCT03108521|589094069|FG000|Overall Study|Physician Decision|4|||
163106279|NCT03108521|589094070|FG001|Overall Study|Physician Decision|0|||
163106280|NCT03108521|589094069|FG000|Overall Study|Adverse Event|3|||
163106281|NCT03108521|589094070|FG001|Overall Study|Adverse Event|0|||
163106282|NCT03281629|589094076|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
163106283|NCT03281629|589094077|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
163106284|NCT03281629|589094076|FG000|Overall Study|Death|0|||
163106285|NCT03281629|589094077|FG001|Overall Study|Death|1|||
163106286|NCT03281629|589094076|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
163106287|NCT03281629|589094077|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
163106288|NCT01456195|589095860|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163106289|NCT01456195|589095861|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
163106290|NCT01456195|589095862|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163106291|NCT01456195|589095860|FG000|Overall Study|Lost to Follow-up|3|||
163106292|NCT01456195|589095861|FG001|Overall Study|Lost to Follow-up|1|||
163106293|NCT01456195|589095862|FG002|Overall Study|Lost to Follow-up|3|||
163106294|NCT01456195|589095860|FG000|Overall Study|Voluntary Withdrawal|5|||
163106295|NCT01456195|589095861|FG001|Overall Study|Voluntary Withdrawal|3|||
163106296|NCT01456195|589095862|FG002|Overall Study|Voluntary Withdrawal|7|||
163106297|NCT01456195|589095860|FG000|Overall Study|Lack of Efficacy|0|||
163106298|NCT01456195|589095861|FG001|Overall Study|Lack of Efficacy|1|||
163106299|NCT01456195|589095862|FG002|Overall Study|Lack of Efficacy|0|||
163106300|NCT01456195|589095860|FG000|Overall Study|Other Reasons|2|||
163106301|NCT01456195|589095861|FG001|Overall Study|Other Reasons|1|||
163106302|NCT01456195|589095862|FG002|Overall Study|Other Reasons|3|||
163106303|NCT02109432|589095863|FG000|Overall Study|Withdrawal by Subject|1|||
163106304|NCT03372551|589095870|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
163106305|NCT03372551|589095871|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
163106306|NCT04683029|589095881|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
163106307|NCT04683029|589095882|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106308|NCT04683029|589095883|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106309|NCT04683029|589095884|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
163106310|NCT04683029|589095881|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106311|NCT04683029|589095882|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106312|NCT04683029|589095883|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
163106313|NCT04683029|589095884|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
163106314|NCT04683029|589095881|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106315|NCT04683029|589095882|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106316|NCT04683029|589095883|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
163106317|NCT04683029|589095884|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
163106318|NCT04299308|589095885|FG000|Overall Study|Withdrawal by Subject|1|||
163106319|NCT04299308|589095886|FG001|Overall Study|Withdrawal by Subject|0|||
163106320|NCT04299308|589095885|FG000|Overall Study|issue with PET image (1)|1|||
163106321|NCT04299308|589095886|FG001|Overall Study|issue with PET image (1)|0|||
163106322|NCT02920528|589095889|FG000|Overall Study|Incomplete Data|1|||
163106323|NCT02920528|589095890|FG001|Overall Study|Incomplete Data|1|||
163106324|NCT02920528|589095891|FG002|Overall Study|Incomplete Data|1|||
163106325|NCT02920528|589095889|FG000|Overall Study|Adverse Event|0|||
163106326|NCT02920528|589095890|FG001|Overall Study|Adverse Event|0|||
163106327|NCT02920528|589095891|FG002|Overall Study|Adverse Event|3|||
163106328|NCT02920528|589095889|FG000|Overall Study|Did not meet inclusion criteria|2|||
163106329|NCT02920528|589095890|FG001|Overall Study|Did not meet inclusion criteria|0|||
163106330|NCT02920528|589095891|FG002|Overall Study|Did not meet inclusion criteria|1|||
163106331|NCT03596047|589095893|FG000|Overall Study|Withdrawal by Subject|7|||
163106332|NCT03596047|589095894|FG001|Overall Study|Withdrawal by Subject|4|||
163106333|NCT03596047|589095893|FG000|Overall Study|Lost to Follow-up|0|||
163106334|NCT03596047|589095894|FG001|Overall Study|Lost to Follow-up|2|||
163106335|NCT00066703|589095895|FG000|Overall Study|Adverse Event|80|||
163106336|NCT00066703|589095896|FG001|Overall Study|Adverse Event|111|||
163106337|NCT00066703|589095895|FG000|Overall Study|Death|3|||
163106338|NCT00066703|589095896|FG001|Overall Study|Death|0|||
163106339|NCT00066703|589095895|FG000|Overall Study|Lack of Efficacy|114|||
163106340|NCT00066703|589095896|FG001|Overall Study|Lack of Efficacy|69|||
163106341|NCT00066703|589095895|FG000|Overall Study|Lost to Follow-up|31|||
163106342|NCT00066703|589095896|FG001|Overall Study|Lost to Follow-up|28|||
163106343|NCT00066703|589095895|FG000|Overall Study|Withdrawal by Subject|38|||
163106344|NCT00066703|589095896|FG001|Overall Study|Withdrawal by Subject|63|||
163106345|NCT00066703|589095895|FG000|Overall Study|Treatment ongoing|346|||
163106346|NCT00066703|589095896|FG001|Overall Study|Treatment ongoing|311|||
163106347|NCT01696968|589095897|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
163106348|NCT01696968|589095898|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
163106349|NCT01696968|589095897|FG000|Overall Study|Died Before Randomization|3|||
163106350|NCT01696968|589095898|FG001|Overall Study|Died Before Randomization|8|||
163106351|NCT01696968|589095897|FG000|Overall Study|Died Before ASU (Control)|278|||
163106352|NCT01696968|589095898|FG001|Overall Study|Died Before ASU (Control)|0|||
163106353|NCT01696968|589095897|FG000|Overall Study|Refused ASU (Control)|920|||
163106354|NCT01696968|589095898|FG001|Overall Study|Refused ASU (Control)|0|||
163106355|NCT01696968|589095897|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
163106356|NCT01696968|589095898|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
163106357|NCT00734604|589095899|FG000|Overall Study|Adverse Event|0|||
163106358|NCT00734604|589095900|FG001|Overall Study|Adverse Event|2|||
163106359|NCT00734604|589095901|FG002|Overall Study|Adverse Event|0|||
163106360|NCT00734604|589095902|FG003|Overall Study|Adverse Event|2|||
163106361|NCT00734604|589095903|FG004|Overall Study|Adverse Event|1|||
163106362|NCT00734604|589095904|FG005|Overall Study|Adverse Event|1|||
163106363|NCT00734604|589095899|FG000|Overall Study|Serious Adverse Event|1|||
163106364|NCT00734604|589095900|FG001|Overall Study|Serious Adverse Event|0|||
163106365|NCT00734604|589095901|FG002|Overall Study|Serious Adverse Event|1|||
163106366|NCT00734604|589095902|FG003|Overall Study|Serious Adverse Event|2|||
163106367|NCT00734604|589095903|FG004|Overall Study|Serious Adverse Event|0|||
163106368|NCT00734604|589095904|FG005|Overall Study|Serious Adverse Event|1|||
163106369|NCT00734604|589095899|FG000|Overall Study|Lost to Follow-up|1|||
163106370|NCT00734604|589095900|FG001|Overall Study|Lost to Follow-up|2|||
163106371|NCT00734604|589095901|FG002|Overall Study|Lost to Follow-up|2|||
163106372|NCT00734604|589095902|FG003|Overall Study|Lost to Follow-up|4|||
163106373|NCT00734604|589095903|FG004|Overall Study|Lost to Follow-up|2|||
163106374|NCT00734604|589095904|FG005|Overall Study|Lost to Follow-up|3|||
163106375|NCT00734604|589095899|FG000|Overall Study|Physician Decision|0|||
163106376|NCT00734604|589095900|FG001|Overall Study|Physician Decision|1|||
163106377|NCT00734604|589095901|FG002|Overall Study|Physician Decision|1|||
163106378|NCT00734604|589095902|FG003|Overall Study|Physician Decision|0|||
163106379|NCT00734604|589095903|FG004|Overall Study|Physician Decision|0|||
163106380|NCT00734604|589095904|FG005|Overall Study|Physician Decision|0|||
163106381|NCT00734604|589095899|FG000|Overall Study|Protocol Violation|0|||
163106382|NCT00734604|589095900|FG001|Overall Study|Protocol Violation|2|||
163106383|NCT00734604|589095901|FG002|Overall Study|Protocol Violation|0|||
163106384|NCT00734604|589095902|FG003|Overall Study|Protocol Violation|0|||
163106385|NCT00734604|589095903|FG004|Overall Study|Protocol Violation|1|||
163106386|NCT00734604|589095904|FG005|Overall Study|Protocol Violation|0|||
163106387|NCT00734604|589095899|FG000|Overall Study|Sponsor Decision|1|||
163106388|NCT00734604|589095900|FG001|Overall Study|Sponsor Decision|2|||
163106389|NCT00734604|589095901|FG002|Overall Study|Sponsor Decision|1|||
163106390|NCT00734604|589095902|FG003|Overall Study|Sponsor Decision|0|||
163106391|NCT00734604|589095903|FG004|Overall Study|Sponsor Decision|2|||
163106392|NCT00734604|589095904|FG005|Overall Study|Sponsor Decision|0|||
163106393|NCT00734604|589095899|FG000|Overall Study|Withdrawal by Subject|0|||
163106394|NCT00734604|589095900|FG001|Overall Study|Withdrawal by Subject|2|||
163106395|NCT00734604|589095901|FG002|Overall Study|Withdrawal by Subject|0|||
163106396|NCT00734604|589095902|FG003|Overall Study|Withdrawal by Subject|1|||
163106397|NCT00734604|589095903|FG004|Overall Study|Withdrawal by Subject|2|||
163106398|NCT00734604|589095904|FG005|Overall Study|Withdrawal by Subject|1|||
163106399|NCT00734604|589095899|FG000|Overall Study|Lack of Efficacy|0|||
163106400|NCT00734604|589095900|FG001|Overall Study|Lack of Efficacy|1|||
163106401|NCT00734604|589095901|FG002|Overall Study|Lack of Efficacy|1|||
163106402|NCT00734604|589095902|FG003|Overall Study|Lack of Efficacy|0|||
163106403|NCT00734604|589095903|FG004|Overall Study|Lack of Efficacy|0|||
163106404|NCT00734604|589095904|FG005|Overall Study|Lack of Efficacy|0|||
163106405|NCT02199314|589095905|FG000|Overall Study|Withdrawal by Subject|6|||
163106406|NCT02199314|589095905|FG000|Overall Study|Physician Decision|10|||
163106407|NCT04848220|589095906|FG000|Overall Study|Unable to proceed to study procedure|0|||
163106408|NCT04848220|589095907|FG001|Overall Study|Unable to proceed to study procedure|1|||
163106409|NCT04848220|589095908|FG002|Overall Study|Unable to proceed to study procedure|0|||
163106410|NCT04848220|589095906|FG000|Overall Study|Fractional flow not significant|0|||
163106411|NCT04848220|589095907|FG001|Overall Study|Fractional flow not significant|1|||
163106412|NCT04848220|589095908|FG002|Overall Study|Fractional flow not significant|0|||
163106413|NCT02557100|589095913|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
163106414|NCT02557100|589095914|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
163106415|NCT02557100|589095915|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
163106416|NCT02557100|589095913|FG000|Single Blind Treatment Period|Death|0|||
163106417|NCT02557100|589095914|FG001|Single Blind Treatment Period|Death|1|||
163106418|NCT02557100|589095915|FG002|Single Blind Treatment Period|Death|0|||
163106419|NCT02557100|589095913|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
163106420|NCT02557100|589095914|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
163106421|NCT02557100|589095915|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
163106422|NCT02557100|589095913|FG000|Single Blind Treatment Period|Adverse Event|0|||
163106423|NCT02557100|589095914|FG001|Single Blind Treatment Period|Adverse Event|1|||
163106424|NCT02557100|589095915|FG002|Single Blind Treatment Period|Adverse Event|0|||
162719131|NCT03284957|587678397|FG006|Overall Study|Withdrawal by Subject|0|||
162719132|NCT03284957|587678398|FG007|Overall Study|Withdrawal by Subject|0|||
162719133|NCT03284957|587678399|FG008|Overall Study|Withdrawal by Subject|0|||
162719134|NCT03284957|587678400|FG009|Overall Study|Withdrawal by Subject|2|||
162719135|NCT03284957|587678401|FG010|Overall Study|Withdrawal by Subject|0|||
162719136|NCT03284957|587678402|FG011|Overall Study|Withdrawal by Subject|0|||
162719137|NCT03284957|587678403|FG012|Overall Study|Withdrawal by Subject|0|||
162719138|NCT03284957|587678404|FG013|Overall Study|Withdrawal by Subject|0|||
163106425|NCT02557100|589095913|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
163106426|NCT02557100|589095914|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
163106427|NCT02557100|589095915|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
163106428|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Other Reasons|0|||
163106429|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Other Reasons|0|||
163106430|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Other Reasons|1|||
163106431|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
163106432|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
163106433|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
163106434|NCT02557100|589095913|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
163106435|NCT02557100|589095914|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
163106436|NCT02557100|589095915|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
163106437|NCT02513485|589095919|FG000|Overall Study|Adverse Event|1|||
163106438|NCT02513485|589095920|FG001|Overall Study|Adverse Event|0|||
163106439|NCT01406938|589095936|FG000|Induction Period|Subject/guardian decision|6|||
163106440|NCT01406938|589095937|FG001|Induction Period|Subject/guardian decision|8|||
162719139|NCT03284957|587678405|FG014|Overall Study|Withdrawal by Subject|0|||
162719140|NCT03284957|587678406|FG015|Overall Study|Withdrawal by Subject|0|||
162719141|NCT03284957|587678391|FG000|Overall Study|Other|0|||
162719142|NCT03284957|587678392|FG001|Overall Study|Other|0|||
162719143|NCT03284957|587678393|FG002|Overall Study|Other|0|||
162719144|NCT03284957|587678394|FG003|Overall Study|Other|0|||
162719145|NCT03284957|587678395|FG004|Overall Study|Other|0|||
162719146|NCT03284957|587678396|FG005|Overall Study|Other|0|||
163106441|NCT01406938|589095938|FG002|Induction Period|Subject/guardian decision|0|||
163106442|NCT01406938|589095939|FG003|Induction Period|Subject/guardian decision|0|||
163106443|NCT01406938|589095940|FG004|Induction Period|Subject/guardian decision|0|||
163106444|NCT01406938|589095941|FG005|Induction Period|Subject/guardian decision|0|||
162719147|NCT03284957|587678397|FG006|Overall Study|Other|3|||
162719148|NCT03284957|587678398|FG007|Overall Study|Other|0|||
162719149|NCT03284957|587678399|FG008|Overall Study|Other|1|||
162719150|NCT03284957|587678400|FG009|Overall Study|Other|6|||
162719151|NCT03284957|587678401|FG010|Overall Study|Other|0|||
162719152|NCT03284957|587678402|FG011|Overall Study|Other|0|||
162719153|NCT03284957|587678403|FG012|Overall Study|Other|0|||
162719154|NCT03284957|587678404|FG013|Overall Study|Other|0|||
162719155|NCT03284957|587678405|FG014|Overall Study|Other|2|||
162719156|NCT03284957|587678406|FG015|Overall Study|Other|0|||
162719157|NCT03169244|587678416|FG000|Overall Study|Lost to Follow-up|1|||
162719158|NCT03169244|587678417|FG001|Overall Study|Lost to Follow-up|2|||
162719159|NCT03169244|587678416|FG000|Overall Study|Adverse Event|1|||
162719160|NCT03169244|587678417|FG001|Overall Study|Adverse Event|0|||
162719161|NCT03169244|587678416|FG000|Overall Study|Withdrawal by Subject|2|||
162719162|NCT03169244|587678417|FG001|Overall Study|Withdrawal by Subject|2|||
162719163|NCT03169244|587678416|FG000|Overall Study|Physician Decision|1|||
162719164|NCT03169244|587678417|FG001|Overall Study|Physician Decision|0|||
162719165|NCT01070888|587678419|FG000|First Intervention (14 Days)|Adverse Event|0|||
163106445|NCT01406938|589095936|FG000|Induction Period|Protocol deviation|1|||
163106446|NCT01406938|589095937|FG001|Induction Period|Protocol deviation|0|||
163106447|NCT01406938|589095938|FG002|Induction Period|Protocol deviation|0|||
163106448|NCT01406938|589095939|FG003|Induction Period|Protocol deviation|0|||
163106449|NCT01406938|589095940|FG004|Induction Period|Protocol deviation|0|||
163106450|NCT01406938|589095941|FG005|Induction Period|Protocol deviation|0|||
163106451|NCT01406938|589095936|FG000|Induction Period|Adverse Event|8|||
163106452|NCT01406938|589095937|FG001|Induction Period|Adverse Event|9|||
163106453|NCT01406938|589095938|FG002|Induction Period|Adverse Event|0|||
163106454|NCT01406938|589095939|FG003|Induction Period|Adverse Event|0|||
163106455|NCT01406938|589095940|FG004|Induction Period|Adverse Event|0|||
163106456|NCT01406938|589095941|FG005|Induction Period|Adverse Event|0|||
163106457|NCT01406938|589095936|FG000|Induction Period|Lack of Efficacy|1|||
163106458|NCT01406938|589095937|FG001|Induction Period|Lack of Efficacy|0|||
163106459|NCT01406938|589095938|FG002|Induction Period|Lack of Efficacy|0|||
163106460|NCT01406938|589095939|FG003|Induction Period|Lack of Efficacy|0|||
163106461|NCT01406938|589095940|FG004|Induction Period|Lack of Efficacy|0|||
163106462|NCT01406938|589095941|FG005|Induction Period|Lack of Efficacy|0|||
163106463|NCT01406938|589095936|FG000|Induction Period|Lost to Follow-up|2|||
163106464|NCT01406938|589095937|FG001|Induction Period|Lost to Follow-up|3|||
163106465|NCT01406938|589095938|FG002|Induction Period|Lost to Follow-up|0|||
163106466|NCT01406938|589095939|FG003|Induction Period|Lost to Follow-up|0|||
163106467|NCT01406938|589095940|FG004|Induction Period|Lost to Follow-up|0|||
163106468|NCT01406938|589095941|FG005|Induction Period|Lost to Follow-up|0|||
163106469|NCT01406938|589095936|FG000|Maintenance Period|Adverse Event|0|||
163106470|NCT01406938|589095937|FG001|Maintenance Period|Adverse Event|0|||
163106471|NCT01406938|589095938|FG002|Maintenance Period|Adverse Event|2|||
163106472|NCT01406938|589095939|FG003|Maintenance Period|Adverse Event|8|||
163106473|NCT01406938|589095940|FG004|Maintenance Period|Adverse Event|4|||
163106474|NCT01406938|589095941|FG005|Maintenance Period|Adverse Event|2|||
163106475|NCT01406938|589095936|FG000|Maintenance Period|Death|0|||
163106476|NCT01406938|589095937|FG001|Maintenance Period|Death|0|||
163106477|NCT01406938|589095938|FG002|Maintenance Period|Death|0|||
163106478|NCT01406938|589095939|FG003|Maintenance Period|Death|0|||
163106479|NCT01406938|589095940|FG004|Maintenance Period|Death|1|||
163106480|NCT01406938|589095941|FG005|Maintenance Period|Death|0|||
163106481|NCT01406938|589095936|FG000|Maintenance Period|Subject/guardian decision|0|||
163106482|NCT01406938|589095937|FG001|Maintenance Period|Subject/guardian decision|0|||
163106483|NCT01406938|589095938|FG002|Maintenance Period|Subject/guardian decision|11|||
163106484|NCT01406938|589095939|FG003|Maintenance Period|Subject/guardian decision|7|||
163106485|NCT01406938|589095940|FG004|Maintenance Period|Subject/guardian decision|10|||
163106486|NCT01406938|589095941|FG005|Maintenance Period|Subject/guardian decision|7|||
163106487|NCT01406938|589095936|FG000|Maintenance Period|Protocol Violation|0|||
163106488|NCT01406938|589095937|FG001|Maintenance Period|Protocol Violation|0|||
163106489|NCT01406938|589095938|FG002|Maintenance Period|Protocol Violation|2|||
163106490|NCT01406938|589095939|FG003|Maintenance Period|Protocol Violation|2|||
163106491|NCT01406938|589095940|FG004|Maintenance Period|Protocol Violation|2|||
163106492|NCT01406938|589095941|FG005|Maintenance Period|Protocol Violation|2|||
163106493|NCT01406938|589095936|FG000|Maintenance Period|Pregnancy|0|||
163106494|NCT01406938|589095937|FG001|Maintenance Period|Pregnancy|0|||
163106495|NCT01406938|589095938|FG002|Maintenance Period|Pregnancy|0|||
163106496|NCT01406938|589095939|FG003|Maintenance Period|Pregnancy|0|||
163106497|NCT01406938|589095940|FG004|Maintenance Period|Pregnancy|1|||
163106498|NCT01406938|589095941|FG005|Maintenance Period|Pregnancy|0|||
163106499|NCT01406938|589095936|FG000|Maintenance Period|Lost to Follow-up|0|||
163106500|NCT01406938|589095937|FG001|Maintenance Period|Lost to Follow-up|0|||
163106501|NCT01406938|589095938|FG002|Maintenance Period|Lost to Follow-up|0|||
163106502|NCT01406938|589095939|FG003|Maintenance Period|Lost to Follow-up|0|||
163106503|NCT01406938|589095940|FG004|Maintenance Period|Lost to Follow-up|4|||
163106504|NCT01406938|589095941|FG005|Maintenance Period|Lost to Follow-up|0|||
163106505|NCT01406938|589095936|FG000|Maintenance Period|Lack of Efficacy|0|||
163106506|NCT01406938|589095937|FG001|Maintenance Period|Lack of Efficacy|0|||
163106507|NCT01406938|589095938|FG002|Maintenance Period|Lack of Efficacy|2|||
163106508|NCT01406938|589095939|FG003|Maintenance Period|Lack of Efficacy|1|||
163106509|NCT01406938|589095940|FG004|Maintenance Period|Lack of Efficacy|3|||
163106510|NCT01406938|589095941|FG005|Maintenance Period|Lack of Efficacy|5|||
163106511|NCT01406938|589095936|FG000|Follow up|Lack of Efficacy|3|||
163106512|NCT01406938|589095937|FG001|Follow up|Lack of Efficacy|2|||
163106513|NCT01406938|589095938|FG002|Follow up|Lack of Efficacy|1|||
163106514|NCT01406938|589095939|FG003|Follow up|Lack of Efficacy|0|||
163106515|NCT01406938|589095940|FG004|Follow up|Lack of Efficacy|0|||
163106516|NCT01406938|589095941|FG005|Follow up|Lack of Efficacy|0|||
163106517|NCT01406938|589095936|FG000|Follow up|Patient/guardian decision|4|||
163106518|NCT01406938|589095937|FG001|Follow up|Patient/guardian decision|2|||
163106519|NCT01406938|589095938|FG002|Follow up|Patient/guardian decision|4|||
163106520|NCT01406938|589095939|FG003|Follow up|Patient/guardian decision|2|||
163106521|NCT01406938|589095940|FG004|Follow up|Patient/guardian decision|4|||
163106522|NCT01406938|589095941|FG005|Follow up|Patient/guardian decision|1|||
163106523|NCT01406938|589095936|FG000|Follow up|Protocol Violation|0|||
163106524|NCT01406938|589095937|FG001|Follow up|Protocol Violation|0|||
163106525|NCT01406938|589095938|FG002|Follow up|Protocol Violation|1|||
163106526|NCT01406938|589095939|FG003|Follow up|Protocol Violation|0|||
163106527|NCT01406938|589095940|FG004|Follow up|Protocol Violation|0|||
163106528|NCT01406938|589095941|FG005|Follow up|Protocol Violation|0|||
163106529|NCT01406938|589095936|FG000|Follow up|Physician Decision|0|||
163106530|NCT01406938|589095937|FG001|Follow up|Physician Decision|0|||
163106531|NCT01406938|589095938|FG002|Follow up|Physician Decision|2|||
163106532|NCT01406938|589095939|FG003|Follow up|Physician Decision|0|||
163106533|NCT01406938|589095940|FG004|Follow up|Physician Decision|3|||
163106534|NCT01406938|589095941|FG005|Follow up|Physician Decision|1|||
163106535|NCT01406938|589095936|FG000|Follow up|Lost to Follow-up|1|||
163106536|NCT01406938|589095937|FG001|Follow up|Lost to Follow-up|1|||
163106537|NCT01406938|589095938|FG002|Follow up|Lost to Follow-up|0|||
163106538|NCT01406938|589095939|FG003|Follow up|Lost to Follow-up|1|||
163106539|NCT01406938|589095940|FG004|Follow up|Lost to Follow-up|2|||
163106540|NCT01406938|589095941|FG005|Follow up|Lost to Follow-up|1|||
163106541|NCT01576146|589095944|FG000|Extension Period 1|Adverse Event|2|||
163106542|NCT01576146|589095944|FG000|Extension Period 1|Death|2|||
163106543|NCT01576146|589095944|FG000|Extension Period 1|Physician Decision|2|||
163106544|NCT01576146|589095944|FG000|Extension Period 1|Withdrawal by Subject|1|||
163106545|NCT01576146|589095944|FG000|Extension Period 1|Lost to Follow-up|1|||
163106546|NCT01576146|589095944|FG000|Extension Period 1|Parathyroidectomy|1|||
163106547|NCT01576146|589095944|FG000|Extension Period 1|Renal Transplant|1|||
163106548|NCT01576146|589095944|FG000|Extension Period 2|Sponsor Decision|13|||
163106549|NCT01576146|589095944|FG000|Extension Period 2|Death|1|||
163106550|NCT01576146|589095944|FG000|Extension Period 2|Adverse Event|1|||
163106551|NCT01576146|589095944|FG000|Extension Period 2|Renal Transplant|1|||
163106552|NCT01576146|589095944|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
163106553|NCT03654404|589095946|FG000|Overall Study|Death|1|||
163106554|NCT03654404|589095946|FG000|Overall Study|Lost to Follow-up|2|||
163106555|NCT03654404|589095946|FG000|Overall Study|Withdrawal by Subject|5|||
163106556|NCT00654745|589095947|FG000|Overall Study|Adverse Event|12|||
163106557|NCT00654745|589095947|FG000|Overall Study|Lost to Follow-up|7|||
163106558|NCT00654745|589095947|FG000|Overall Study|Protocol Violation|11|||
163106559|NCT00654745|589095947|FG000|Overall Study|Withdrawal by Subject|10|||
163106560|NCT00654745|589095947|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
163106561|NCT00194077|589095950|FG000|Overall Study|Lack of Efficacy|22|||
163106562|NCT00194077|589095951|FG001|Overall Study|Lack of Efficacy|29|||
163106563|NCT00194077|589095950|FG000|Overall Study|Study nonadherence|1|||
163106564|NCT00194077|589095951|FG001|Overall Study|Study nonadherence|0|||
163106565|NCT00194077|589095950|FG000|Overall Study|Withdrawal by Subject|1|||
163106566|NCT00194077|589095951|FG001|Overall Study|Withdrawal by Subject|1|||
162719166|NCT01070888|587678420|FG001|First Intervention (14 Days)|Adverse Event|1|||
162719167|NCT01070888|587678419|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
163106567|NCT03470194|589095952|FG000|Overall Study|Lost to Follow-up|11|||
162719168|NCT01070888|587678420|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
162719169|NCT01070888|587678419|FG000|Washout (14 Days)|Physician Decision|1|||
163106568|NCT03470194|589095953|FG001|Overall Study|Lost to Follow-up|17|||
163106569|NCT01822899|589095954|FG000|Overall Study|Adverse Event|6|||
163106570|NCT01822899|589095955|FG001|Overall Study|Adverse Event|5|||
163106571|NCT01822899|589095954|FG000|Overall Study|Lack of Efficacy|6|||
163106572|NCT01822899|589095955|FG001|Overall Study|Lack of Efficacy|3|||
163106573|NCT01822899|589095954|FG000|Overall Study|Protocol Violation|6|||
163106574|NCT01822899|589095955|FG001|Overall Study|Protocol Violation|3|||
163106575|NCT01822899|589095954|FG000|Overall Study|Lost to Follow-up|1|||
163106576|NCT01822899|589095955|FG001|Overall Study|Lost to Follow-up|0|||
162653690|NCT02775344|587449564|FG001|Overall Study|No ovarian cyst identified|2|||
163106577|NCT01822899|589095954|FG000|Overall Study|Withdrawal by Subject|5|||
163106578|NCT01822899|589095955|FG001|Overall Study|Withdrawal by Subject|7|||
163106579|NCT00759876|589095957|FG000|Overall Study|Sponsor terminated study early|36|||
163106580|NCT01450696|589095958|FG000|Overall Study|Never Treated|1|||
163106581|NCT01450696|589095959|FG001|Overall Study|Never Treated|1|||
163106582|NCT01450696|589095958|FG000|Overall Study|Death|77|||
163106583|NCT01450696|589095959|FG001|Overall Study|Death|84|||
163106584|NCT01450696|589095958|FG000|Overall Study|Lost to Follow-up|3|||
163106585|NCT01450696|589095959|FG001|Overall Study|Lost to Follow-up|3|||
163106586|NCT01450696|589095958|FG000|Overall Study|Non-Compliance|1|||
163106587|NCT01450696|589095959|FG001|Overall Study|Non-Compliance|0|||
163106588|NCT01450696|589095958|FG000|Overall Study|Withdrawal by Subject|13|||
163106589|NCT01450696|589095959|FG001|Overall Study|Withdrawal by Subject|2|||
163106590|NCT01450696|589095958|FG000|Overall Study|Study Terminated by Sponsor|53|||
163106591|NCT01450696|589095959|FG001|Overall Study|Study Terminated by Sponsor|58|||
163106592|NCT02570152|589095960|FG000|Overall Study|Protocol Violation|2|||
163106593|NCT02570152|589095960|FG000|Overall Study|Migrated/moved from study area|13|||
163106594|NCT02684617|589095961|FG000|Overall Study|Adverse Event|1|||
163106595|NCT02684617|589095962|FG001|Overall Study|Adverse Event|0|||
163106596|NCT02684617|589095963|FG002|Overall Study|Adverse Event|1|||
163106597|NCT02684617|589095961|FG000|Overall Study|Death|8|||
163106598|NCT02684617|589095962|FG001|Overall Study|Death|16|||
163106599|NCT02684617|589095963|FG002|Overall Study|Death|28|||
163106600|NCT02684617|589095961|FG000|Overall Study|Withdrawal by Subject|2|||
163106601|NCT02684617|589095962|FG001|Overall Study|Withdrawal by Subject|0|||
163106602|NCT02684617|589095963|FG002|Overall Study|Withdrawal by Subject|4|||
163106603|NCT02684617|589095961|FG000|Overall Study|Screen Failure|1|||
163106604|NCT02684617|589095962|FG001|Overall Study|Screen Failure|0|||
163106605|NCT02684617|589095963|FG002|Overall Study|Screen Failure|2|||
163106606|NCT02684617|589095961|FG000|Overall Study|Study Terminated by Sponsor|6|||
163106607|NCT02684617|589095962|FG001|Overall Study|Study Terminated by Sponsor|1|||
163106608|NCT02684617|589095963|FG002|Overall Study|Study Terminated by Sponsor|5|||
163106609|NCT00853242|589095964|FG000|Overall Study|Adverse Event|0|||
163106610|NCT00853242|589095965|FG001|Overall Study|Adverse Event|1|||
163106611|NCT00853242|589095966|FG002|Overall Study|Adverse Event|1|||
163106612|NCT00853242|589095967|FG003|Overall Study|Adverse Event|0|||
163106613|NCT00853242|589095968|FG004|Overall Study|Adverse Event|3|||
163106614|NCT00853242|589095969|FG005|Overall Study|Adverse Event|1|||
163106615|NCT00853242|589095970|FG006|Overall Study|Adverse Event|1|||
163106616|NCT00853242|589095964|FG000|Overall Study|Noncompliant|0|||
163106617|NCT00853242|589095965|FG001|Overall Study|Noncompliant|0|||
163106618|NCT00853242|589095966|FG002|Overall Study|Noncompliant|0|||
163106619|NCT00853242|589095967|FG003|Overall Study|Noncompliant|0|||
163106620|NCT00853242|589095968|FG004|Overall Study|Noncompliant|1|||
163106621|NCT00853242|589095969|FG005|Overall Study|Noncompliant|0|||
163106622|NCT00853242|589095970|FG006|Overall Study|Noncompliant|0|||
163106623|NCT00853242|589095964|FG000|Overall Study|Withdrawal by Subject|1|||
163106624|NCT00853242|589095965|FG001|Overall Study|Withdrawal by Subject|2|||
163106625|NCT00853242|589095966|FG002|Overall Study|Withdrawal by Subject|0|||
163106626|NCT00853242|589095967|FG003|Overall Study|Withdrawal by Subject|4|||
163106627|NCT00853242|589095968|FG004|Overall Study|Withdrawal by Subject|0|||
163106628|NCT00853242|589095969|FG005|Overall Study|Withdrawal by Subject|0|||
163106629|NCT00853242|589095970|FG006|Overall Study|Withdrawal by Subject|2|||
163106630|NCT00853242|589095964|FG000|Overall Study|Other|2|||
163106631|NCT00853242|589095965|FG001|Overall Study|Other|0|||
163106632|NCT00853242|589095966|FG002|Overall Study|Other|2|||
163106633|NCT00853242|589095967|FG003|Overall Study|Other|0|||
163106634|NCT00853242|589095968|FG004|Overall Study|Other|0|||
163106635|NCT00853242|589095969|FG005|Overall Study|Other|1|||
163106636|NCT00853242|589095970|FG006|Overall Study|Other|2|||
163106637|NCT02516098|589095978|FG000|Period 1|Protocol Violation|1|||
163106638|NCT02516098|589095979|FG001|Period 1|Protocol Violation|0|||
163106639|NCT02516098|589095978|FG000|Washout After Period 1|Adverse Event|0|||
163106640|NCT02516098|589095979|FG001|Washout After Period 1|Adverse Event|1|||
163106641|NCT02516098|589095978|FG000|Period 2|Withdrawal by Subject|0|||
163106642|NCT02516098|589095979|FG001|Period 2|Withdrawal by Subject|1|||
163106643|NCT01092780|589095980|FG000|Washout Period 1|Adverse Event|0|||
163106644|NCT01092780|589095981|FG001|Washout Period 1|Adverse Event|1|||
163106645|NCT01092780|589095982|FG002|Washout Period 1|Adverse Event|0|||
163106646|NCT01092780|589095983|FG003|Washout Period 1|Adverse Event|0|||
163106647|NCT01092780|589095980|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
163106648|NCT01092780|589095981|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
163106649|NCT01092780|589095982|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
163106650|NCT01092780|589095983|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
163106651|NCT01092780|589095980|FG000|Washout Period 2|Adverse Event|0|||
163106652|NCT01092780|589095981|FG001|Washout Period 2|Adverse Event|1|||
163106653|NCT01092780|589095982|FG002|Washout Period 2|Adverse Event|1|||
163106654|NCT01092780|589095983|FG003|Washout Period 2|Adverse Event|0|||
163106655|NCT01257230|589095984|FG000|Overall Study|Not Treated|0|||
163106656|NCT01257230|589095985|FG001|Overall Study|Not Treated|0|||
163106657|NCT01257230|589095986|FG002|Overall Study|Not Treated|1|||
163106658|NCT01257230|589095984|FG000|Overall Study|Adverse Event|2|||
163106659|NCT01257230|589095985|FG001|Overall Study|Adverse Event|0|||
163106660|NCT01257230|589095986|FG002|Overall Study|Adverse Event|0|||
163106661|NCT01257230|589095984|FG000|Overall Study|Lack of Efficacy|0|||
163106662|NCT01257230|589095985|FG001|Overall Study|Lack of Efficacy|1|||
163106663|NCT01257230|589095986|FG002|Overall Study|Lack of Efficacy|0|||
163106664|NCT01257230|589095984|FG000|Overall Study|Protocol Violation|3|||
163106665|NCT01257230|589095985|FG001|Overall Study|Protocol Violation|0|||
163106666|NCT01257230|589095986|FG002|Overall Study|Protocol Violation|1|||
163106667|NCT01257230|589095984|FG000|Overall Study|Withdrawal by Subject|0|||
163106668|NCT01257230|589095985|FG001|Overall Study|Withdrawal by Subject|4|||
163106669|NCT01257230|589095986|FG002|Overall Study|Withdrawal by Subject|1|||
163106670|NCT01257230|589095984|FG000|Overall Study|Other reason not defined above|1|||
163106671|NCT01257230|589095985|FG001|Overall Study|Other reason not defined above|5|||
163106672|NCT01257230|589095986|FG002|Overall Study|Other reason not defined above|3|||
163106673|NCT01205061|589095989|FG000|Overall Study|Adverse Event|4|||
163106674|NCT01205061|589095989|FG000|Overall Study|Withdrawal by Subject|11|||
163106675|NCT01205061|589095989|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
163106676|NCT01205061|589095989|FG000|Overall Study|Lost to Follow-up|9|||
163106677|NCT01205061|589095989|FG000|Overall Study|Other|1|||
163106678|NCT04026009|589095990|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163106679|NCT04026009|589095991|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163106680|NCT04026009|589095992|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163106681|NCT04026009|589095993|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163106682|NCT04026009|589095994|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
163106683|NCT04026009|589095990|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106684|NCT04026009|589095991|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106685|NCT04026009|589095992|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106686|NCT04026009|589095993|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
163106687|NCT04026009|589095994|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
163106688|NCT01988662|589095995|FG000|Overall Study|Subject/guardian decision|1|||
163106689|NCT01988662|589095996|FG001|Overall Study|Subject/guardian decision|1|||
163106690|NCT01988662|589095995|FG000|Overall Study|Adverse Event|3|||
163106691|NCT01988662|589095996|FG001|Overall Study|Adverse Event|1|||
163106692|NCT00615719|589095997|FG000|Overall Study|Physician Decision|5|||
163106693|NCT02300558|589095998|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
163106694|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
163106695|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
163106696|NCT02300558|589095998|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
163106697|NCT01471028|589095999|FG000|VTI-208|Adverse Event|39|||
163106698|NCT01471028|589096000|FG001|VTI-208|Adverse Event|41|||
163106699|NCT01471028|589095999|FG000|VTI-208|Withdrawal by Subject|0|||
163106700|NCT01471028|589096000|FG001|VTI-208|Withdrawal by Subject|2|||
163106701|NCT01471028|589095999|FG000|VTI-208|Lost to Follow-up|1|||
163106702|NCT01471028|589096000|FG001|VTI-208|Lost to Follow-up|1|||
163106703|NCT01471028|589095999|FG000|VTI-208E|Death|7|||
163106704|NCT01471028|589096000|FG001|VTI-208E|Death|10|||
163106705|NCT01471028|589095999|FG000|VTI-208E|Withdrawal by Subject|1|||
163106706|NCT01471028|589096000|FG001|VTI-208E|Withdrawal by Subject|0|||
163106707|NCT01471028|589095999|FG000|VTI-208E|Lost to Follow-up|0|||
163106708|NCT01471028|589096000|FG001|VTI-208E|Lost to Follow-up|2|||
163106709|NCT02957747|589096001|FG000|Overall Study|Withdrawal by Subject|0|||
163106710|NCT02957747|589096002|FG001|Overall Study|Withdrawal by Subject|3|||
163106711|NCT02957747|589096001|FG000|Overall Study|Lost to Follow-up|10|||
163106712|NCT02957747|589096002|FG001|Overall Study|Lost to Follow-up|5|||
163106713|NCT01355679|589096007|FG000|Overall Study|benign tumor types found at biopsy|2|||
163106714|NCT02027311|589096008|FG000|Overall Study|Protocol Violation|3|||
162653691|NCT03909165|587449573|FG000|Overall Study|Physician Decision|0|||
163106715|NCT02027311|589096009|FG001|Overall Study|Protocol Violation|2|||
163106716|NCT00964002|589096010|FG000|Overall Study|Protocol Violation|8|||
162653692|NCT03909165|587449574|FG001|Overall Study|Physician Decision|1|||
162653693|NCT03909165|587449575|FG002|Overall Study|Physician Decision|0|||
162653694|NCT03909165|587449576|FG003|Overall Study|Physician Decision|0|||
163106717|NCT03768089|589096011|FG000|Part A|Lost to Follow-up|0|||
163106718|NCT03768089|589096012|FG001|Part A|Lost to Follow-up|0|||
163106719|NCT03768089|589096013|FG002|Part A|Lost to Follow-up|0|||
163106720|NCT03768089|589096014|FG003|Part A|Lost to Follow-up|0|||
163106721|NCT03768089|589096015|FG004|Part A|Lost to Follow-up|1|||
163106722|NCT03768089|589096016|FG005|Part A|Lost to Follow-up|0|||
163106723|NCT03768089|589096017|FG006|Part A|Lost to Follow-up|0|||
163106724|NCT03768089|589096018|FG007|Part A|Lost to Follow-up|0|||
162653695|NCT03909165|587449577|FG004|Overall Study|Physician Decision|0|||
162653696|NCT03909165|587449573|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162653697|NCT03909165|587449574|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162653698|NCT03909165|587449575|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163106725|NCT03768089|589096019|FG008|Part A|Lost to Follow-up|0|||
163106726|NCT03768089|589096020|FG009|Part A|Lost to Follow-up|0|||
163106727|NCT03768089|589096021|FG010|Part A|Lost to Follow-up|0|||
163106728|NCT03768089|589096022|FG011|Part A|Lost to Follow-up|0|||
163106729|NCT03768089|589096023|FG012|Part A|Lost to Follow-up|0|||
163106730|NCT03768089|589096024|FG013|Part A|Lost to Follow-up|0|||
163106731|NCT03768089|589096025|FG014|Part A|Lost to Follow-up|0|||
163106732|NCT03768089|589096026|FG015|Part A|Lost to Follow-up|0|||
163106733|NCT03768089|589096027|FG016|Part A|Lost to Follow-up|0|||
163106734|NCT03768089|589096028|FG017|Part A|Lost to Follow-up|0|||
163106735|NCT03768089|589096011|FG000|Part C|Randomized, Never Dosed|0|||
163106736|NCT03768089|589096012|FG001|Part C|Randomized, Never Dosed|0|||
163106737|NCT03768089|589096013|FG002|Part C|Randomized, Never Dosed|0|||
163106738|NCT03768089|589096014|FG003|Part C|Randomized, Never Dosed|0|||
163106739|NCT03768089|589096015|FG004|Part C|Randomized, Never Dosed|0|||
163106740|NCT03768089|589096016|FG005|Part C|Randomized, Never Dosed|0|||
163106741|NCT03768089|589096017|FG006|Part C|Randomized, Never Dosed|0|||
163106742|NCT03768089|589096018|FG007|Part C|Randomized, Never Dosed|0|||
163106743|NCT03768089|589096019|FG008|Part C|Randomized, Never Dosed|0|||
163106744|NCT03768089|589096020|FG009|Part C|Randomized, Never Dosed|0|||
163106745|NCT03768089|589096021|FG010|Part C|Randomized, Never Dosed|0|||
163106746|NCT03768089|589096022|FG011|Part C|Randomized, Never Dosed|0|||
163106747|NCT03768089|589096023|FG012|Part C|Randomized, Never Dosed|0|||
163106748|NCT03768089|589096024|FG013|Part C|Randomized, Never Dosed|0|||
163106749|NCT03768089|589096025|FG014|Part C|Randomized, Never Dosed|1|||
163106750|NCT03768089|589096026|FG015|Part C|Randomized, Never Dosed|0|||
163106751|NCT03768089|589096027|FG016|Part C|Randomized, Never Dosed|0|||
163106752|NCT03768089|589096028|FG017|Part C|Randomized, Never Dosed|0|||
163106753|NCT02091362|589096033|FG000|Period 1|Protocol Violation|1|||
163106754|NCT02091362|589096034|FG001|Period 1|Protocol Violation|0|||
163106755|NCT02091362|589096033|FG000|Period 1|Withdrawal by Subject|2|||
163106756|NCT02091362|589096034|FG001|Period 1|Withdrawal by Subject|3|||
163106757|NCT02091362|589096033|FG000|Period 1|Lost to Follow-up|0|||
163106758|NCT02091362|589096034|FG001|Period 1|Lost to Follow-up|1|||
163106759|NCT02091362|589096033|FG000|Period 1|Adverse Event|2|||
163106760|NCT02091362|589096034|FG001|Period 1|Adverse Event|0|||
163106761|NCT02091362|589096033|FG000|Wash-out|Lost to Follow-up|1|||
163106762|NCT02091362|589096034|FG001|Wash-out|Lost to Follow-up|1|||
163106763|NCT02091362|589096033|FG000|Wash-out|Withdrawal by Subject|0|||
163106764|NCT02091362|589096034|FG001|Wash-out|Withdrawal by Subject|2|||
163106765|NCT02091362|589096033|FG000|Period 2|Adverse Event|1|||
163106766|NCT02091362|589096034|FG001|Period 2|Adverse Event|0|||
163106767|NCT02091362|589096033|FG000|Period 2|Lost to Follow-up|0|||
163106768|NCT02091362|589096034|FG001|Period 2|Lost to Follow-up|1|||
163106769|NCT02091362|589096033|FG000|Period 2|Withdrawal by Subject|1|||
163106770|NCT02091362|589096034|FG001|Period 2|Withdrawal by Subject|1|||
163106771|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
163106772|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
163106773|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
163106774|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
163106775|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Death|58|||
163106776|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Death|65|||
163106777|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Adverse Event|28|||
163106778|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Adverse Event|40|||
163106779|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Disease Progression|22|||
163106780|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Disease Progression|35|||
163106781|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Other|25|||
163106782|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Other|33|||
163106783|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
163106784|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
163106785|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Noncompliance|8|||
163106786|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Noncompliance|8|||
163106787|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
163106788|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
163106789|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
163106790|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
163106791|NCT00286091|589096035|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
163106792|NCT00286091|589096036|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
162653699|NCT03909165|587449576|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163106793|NCT00286091|589096035|FG000|Open-label Treatment Phase|Physician Decision|24|||
163106794|NCT00286091|589096036|FG001|Open-label Treatment Phase|Physician Decision|21|||
163106795|NCT00286091|589096035|FG000|Open-label Treatment Phase|Adverse Event|5|||
163106796|NCT00286091|589096036|FG001|Open-label Treatment Phase|Adverse Event|16|||
163106797|NCT00286091|589096035|FG000|Open-label Treatment Phase|Other|11|||
163106798|NCT00286091|589096036|FG001|Open-label Treatment Phase|Other|11|||
163106799|NCT00286091|589096035|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
163106800|NCT00286091|589096036|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
163106801|NCT00286091|589096035|FG000|Open-label Treatment Phase|Death|10|||
163106802|NCT00286091|589096036|FG001|Open-label Treatment Phase|Death|7|||
163106803|NCT00286091|589096035|FG000|Open-label Treatment Phase|Disease Progression|9|||
163106804|NCT00286091|589096036|FG001|Open-label Treatment Phase|Disease Progression|3|||
163106805|NCT00286091|589096035|FG000|Open-label Treatment Phase|Noncompliance|3|||
163106806|NCT00286091|589096036|FG001|Open-label Treatment Phase|Noncompliance|1|||
163106807|NCT00286091|589096035|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
163106808|NCT00286091|589096036|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
163106809|NCT00286091|589096035|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
163106810|NCT00286091|589096036|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
163106811|NCT00286091|589096035|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
163106812|NCT00286091|589096036|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
163106813|NCT02936869|589096037|FG000|Overall Study|Lost to Follow-up|1|||
163106814|NCT02936869|589096038|FG001|Overall Study|Lost to Follow-up|3|||
163106815|NCT02936869|589096037|FG000|Overall Study|Death|0|||
163106816|NCT02936869|589096038|FG001|Overall Study|Death|1|||
163106817|NCT02936869|589096037|FG000|Overall Study|Legal Case|0|||
163106818|NCT02936869|589096038|FG001|Overall Study|Legal Case|1|||
163106819|NCT02936869|589096037|FG000|Overall Study|Protocol Violation|1|||
163106820|NCT02936869|589096038|FG001|Overall Study|Protocol Violation|0|||
163106821|NCT00335738|589096039|FG000|Overall Study|Physician Decision|6|||
163106822|NCT00335738|589096040|FG001|Overall Study|Physician Decision|0|||
163106823|NCT00335738|589096039|FG000|Overall Study|Withdrawal by Subject|2|||
163106824|NCT00335738|589096040|FG001|Overall Study|Withdrawal by Subject|0|||
163106825|NCT00335738|589096039|FG000|Overall Study|Ineligible|3|||
163106826|NCT00335738|589096040|FG001|Overall Study|Ineligible|4|||
163106827|NCT05141175|589096043|FG000|Overall Study|Withdrawal by Subject|1|||
163106828|NCT02036580|589096044|FG000|Overall Study|Withdrawal by Subject|0|||
163106829|NCT02036580|589096045|FG001|Overall Study|Withdrawal by Subject|1|||
163106830|NCT02036580|589096046|FG002|Overall Study|Withdrawal by Subject|0|||
163106831|NCT02036580|589096044|FG000|Overall Study|Adverse Event|1|||
163106832|NCT02036580|589096045|FG001|Overall Study|Adverse Event|0|||
163106833|NCT02036580|589096046|FG002|Overall Study|Adverse Event|0|||
163106834|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Adverse Event|0|||
163106835|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Adverse Event|0|||
163106836|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Adverse Event|0|||
163106837|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Adverse Event|1|||
163106838|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Adverse Event|0|||
163106839|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Adverse Event|0|||
163106840|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Adverse Event|0|||
163106841|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106842|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106843|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106844|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106845|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
163106846|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106847|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
163106848|NCT04470050|589096053|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
163106849|NCT04470050|589096054|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163106850|NCT04470050|589096055|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
163106851|NCT04470050|589096056|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
163106852|NCT04470050|589096057|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
163106853|NCT04470050|589096058|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
163106854|NCT04470050|589096059|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
163106855|NCT03098433|589096060|FG000|Overall Study|Withdrawal by Subject|10|||
163106856|NCT01813058|589096061|FG000|Overall Study|Withdrawal by Subject|5|||
163106857|NCT01813058|589096062|FG001|Overall Study|Withdrawal by Subject|4|||
163106858|NCT03585764|589096063|FG000|Overall Study|Death|3|||
163106859|NCT03585764|589096064|FG001|Overall Study|Death|2|||
163106860|NCT03585764|589096065|FG002|Overall Study|Death|3|||
163106861|NCT03585764|589096066|FG003|Overall Study|Death|0|||
163106862|NCT03585764|589096063|FG000|Overall Study|Lost to Follow-up|0|||
163106863|NCT03585764|589096064|FG001|Overall Study|Lost to Follow-up|1|||
163106864|NCT03585764|589096065|FG002|Overall Study|Lost to Follow-up|0|||
163106865|NCT03585764|589096066|FG003|Overall Study|Lost to Follow-up|0|||
163106866|NCT03585764|589096063|FG000|Overall Study|Physician Decision|0|||
163106867|NCT03585764|589096064|FG001|Overall Study|Physician Decision|0|||
163106868|NCT03585764|589096065|FG002|Overall Study|Physician Decision|2|||
163106869|NCT03585764|589096066|FG003|Overall Study|Physician Decision|0|||
163106870|NCT01581021|589096068|FG000|Overall Study|Lost to Follow-up|4|||
163106871|NCT01581021|589096069|FG001|Overall Study|Lost to Follow-up|6|||
162719170|NCT01070888|587678420|FG001|Washout (14 Days)|Physician Decision|0|||
163106872|NCT01581021|589096068|FG000|Overall Study|More than 2 hooks in thoracic|3|||
163106873|NCT01581021|589096069|FG001|Overall Study|More than 2 hooks in thoracic|0|||
163106874|NCT01581021|589096068|FG000|Overall Study|Neuromuscular|2|||
163106875|NCT01581021|589096069|FG001|Overall Study|Neuromuscular|1|||
163106876|NCT01581021|589096068|FG000|Overall Study|Not Randomized|1|||
163106877|NCT01581021|589096069|FG001|Overall Study|Not Randomized|2|||
163106878|NCT01581021|589096068|FG000|Overall Study|Lenke 6 Classification|0|||
163106879|NCT01581021|589096069|FG001|Overall Study|Lenke 6 Classification|1|||
163106880|NCT01581021|589096068|FG000|Overall Study|Lack of Efficacy|0|||
163106881|NCT01581021|589096069|FG001|Overall Study|Lack of Efficacy|1|||
163106882|NCT03604172|589096070|FG000|Overall Study|Lost to Follow-up|1|||
163106883|NCT03604172|589096071|FG001|Overall Study|Lost to Follow-up|2|||
163106884|NCT00054327|589096072|FG000|Overall Study|Engraftment failure|1|||
163106885|NCT00054327|589096073|FG001|Overall Study|Engraftment failure|0|||
163106886|NCT00054327|589096074|FG002|Overall Study|Engraftment failure|0|||
163106887|NCT00054327|589096075|FG003|Overall Study|Engraftment failure|0|||
163106888|NCT00054327|589096076|FG004|Overall Study|Engraftment failure|0|||
163106889|NCT00054327|589096077|FG005|Overall Study|Engraftment failure|0|||
163106890|NCT03028129|589096080|FG000|Overall Study|Adverse Event|13|||
163106891|NCT03028129|589096081|FG001|Overall Study|Adverse Event|2|||
163106892|NCT03028129|589096080|FG000|Overall Study|Lost to Follow-up|50|||
163106893|NCT03028129|589096081|FG001|Overall Study|Lost to Follow-up|38|||
163106894|NCT03028129|589096080|FG000|Overall Study|Physician Decision|0|||
163106895|NCT03028129|589096081|FG001|Overall Study|Physician Decision|1|||
163106896|NCT03028129|589096080|FG000|Overall Study|Protocol Violation|1|||
163106897|NCT03028129|589096081|FG001|Overall Study|Protocol Violation|1|||
163106898|NCT03028129|589096080|FG000|Overall Study|Withdrawal by Subject|62|||
163106899|NCT03028129|589096081|FG001|Overall Study|Withdrawal by Subject|45|||
163106900|NCT00923351|589096082|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
163106901|NCT00923351|589096083|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
163106902|NCT00923351|589096084|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
163106903|NCT02597452|589096086|FG000|Overall Study|testing incomplete|30|||
163106904|NCT01579565|589098100|FG000|Randomized|Adverse Event|1|||
163106905|NCT01579565|589098101|FG001|Randomized|Adverse Event|3|||
163106906|NCT01579565|589098100|FG000|Randomized|Withdrawal by Subject|3|||
163106907|NCT01579565|589098101|FG001|Randomized|Withdrawal by Subject|0|||
163106908|NCT01579565|589098100|FG000|Randomized|inadequate preoperative pupil dilation|0|||
163106909|NCT01579565|589098101|FG001|Randomized|inadequate preoperative pupil dilation|1|||
163106910|NCT01579565|589098100|FG000|Randomized|prohibited preoperative eating|1|||
163106911|NCT01579565|589098101|FG001|Randomized|prohibited preoperative eating|0|||
163106912|NCT01579565|589098100|FG000|Randomized|prohibited preoperative medication|0|||
163106913|NCT01579565|589098101|FG001|Randomized|prohibited preoperative medication|1|||
163106914|NCT01579565|589098100|FG000|Treated|Physician Decision|0|||
163106915|NCT01579565|589098101|FG001|Treated|Physician Decision|1|||
163106916|NCT01579565|589098100|FG000|Treated|Lost to Follow-up|2|||
163106917|NCT01579565|589098101|FG001|Treated|Lost to Follow-up|1|||
163106918|NCT01579565|589098100|FG000|Treated|declined to return for final visit|0|||
162719171|NCT00178399|587678421|FG000|Overall Study|Physician Decision|4|||
162719172|NCT00178399|587678421|FG000|Overall Study|Withdrawal by Subject|8|||
162719173|NCT00178399|587678421|FG000|Overall Study|Lost to Follow-up|1|||
162719174|NCT02631148|587678422|FG000|Overall Study|8 were ineligible|8|||
162719175|NCT02631148|587678423|FG001|Overall Study|8 were ineligible|0|||
162719176|NCT02631148|587678422|FG000|Overall Study|Withdrawal by Subject|1|||
162719177|NCT02631148|587678423|FG001|Overall Study|Withdrawal by Subject|0|||
162719178|NCT02631148|587678422|FG000|Overall Study|PAH not available to study participant|1|||
162719179|NCT02631148|587678423|FG001|Overall Study|PAH not available to study participant|0|||
162719180|NCT00357396|587678426|FG000|Overall Study|Adverse Event|1|||
162719181|NCT00357396|587678427|FG001|Overall Study|Adverse Event|0|||
162719182|NCT00487578|587678428|FG000|Overall Study|Adverse Event|1|||
162719183|NCT00487578|587678429|FG001|Overall Study|Adverse Event|2|||
162719184|NCT00487578|587678428|FG000|Overall Study|Lack of Efficacy|0|||
162719185|NCT00487578|587678429|FG001|Overall Study|Lack of Efficacy|1|||
162719186|NCT00487578|587678428|FG000|Overall Study|Lost to Follow-up|0|||
163106919|NCT01579565|589098101|FG001|Treated|declined to return for final visit|1|||
163106920|NCT01380535|589098102|FG000|Overall Study|Adverse Event|3|||
163106921|NCT01380535|589098103|FG001|Overall Study|Adverse Event|3|||
162719187|NCT00487578|587678429|FG001|Overall Study|Lost to Follow-up|1|||
163106922|NCT01380535|589098102|FG000|Overall Study|Death|3|||
162719188|NCT00955825|587678430|FG000|Overall Study|Adverse Event|15|||
162719189|NCT00955825|587678431|FG001|Overall Study|Adverse Event|2|||
162719190|NCT00955825|587678430|FG000|Overall Study|Withdrawal by Subject|4|||
162719191|NCT00955825|587678431|FG001|Overall Study|Withdrawal by Subject|6|||
163106923|NCT01380535|589098103|FG001|Overall Study|Death|0|||
163106924|NCT01380535|589098102|FG000|Overall Study|Study site closed|0|||
163106925|NCT01380535|589098103|FG001|Overall Study|Study site closed|5|||
163106926|NCT01380535|589098102|FG000|Overall Study|Withdrawal by Subject|1|||
163106927|NCT01380535|589098103|FG001|Overall Study|Withdrawal by Subject|2|||
163106928|NCT01380535|589098102|FG000|Overall Study|Protocol Violation|0|||
163106929|NCT01380535|589098103|FG001|Overall Study|Protocol Violation|2|||
163106930|NCT01380535|589098102|FG000|Overall Study|Lack of Efficacy|0|||
163106931|NCT01380535|589098103|FG001|Overall Study|Lack of Efficacy|3|||
163106932|NCT00489424|589098109|FG000|Overall Study|Adverse Event|3|||
163106933|NCT00489424|589098110|FG001|Overall Study|Adverse Event|3|||
163106934|NCT00489424|589098111|FG002|Overall Study|Adverse Event|4|||
163106935|NCT00489424|589098109|FG000|Overall Study|Lack of Efficacy|1|||
163106936|NCT00489424|589098110|FG001|Overall Study|Lack of Efficacy|0|||
163106937|NCT00489424|589098111|FG002|Overall Study|Lack of Efficacy|0|||
163106938|NCT00489424|589098109|FG000|Overall Study|Administrative problems|0|||
163106939|NCT00489424|589098110|FG001|Overall Study|Administrative problems|2|||
163106940|NCT00489424|589098111|FG002|Overall Study|Administrative problems|1|||
163106941|NCT00394251|589098112|FG000|Overall Study|Adverse Event|7|||
163106942|NCT00394251|589098113|FG001|Overall Study|Adverse Event|5|||
163106943|NCT00394251|589098112|FG000|Overall Study|Unacceptable Toxicity|20|||
163106944|NCT00394251|589098113|FG001|Overall Study|Unacceptable Toxicity|18|||
163106945|NCT00394251|589098112|FG000|Overall Study|Physician Decision|1|||
163106946|NCT00394251|589098113|FG001|Overall Study|Physician Decision|1|||
163106947|NCT00394251|589098112|FG000|Overall Study|Protocol Violation|0|||
163106948|NCT00394251|589098113|FG001|Overall Study|Protocol Violation|1|||
163106949|NCT00394251|589098112|FG000|Overall Study|Withdrawal by Subject|7|||
163106950|NCT00394251|589098113|FG001|Overall Study|Withdrawal by Subject|11|||
163106951|NCT00394251|589098112|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
163106952|NCT00394251|589098113|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
163106953|NCT01436656|589098114|FG000|Dose Escalation|Death|1|||
163106954|NCT01436656|589098115|FG001|Dose Escalation|Death|3|||
163106955|NCT01436656|589098116|FG002|Dose Escalation|Death|1|||
163106956|NCT01436656|589098117|FG003|Dose Escalation|Death|0|||
163106957|NCT01436656|589098118|FG004|Dose Escalation|Death|2|||
163106958|NCT01436656|589098119|FG005|Dose Escalation|Death|1|||
163106959|NCT01436656|589098120|FG006|Dose Escalation|Death|1|||
163106960|NCT01436656|589098121|FG007|Dose Escalation|Death|1|||
163106961|NCT01436656|589098122|FG008|Dose Escalation|Death|1|||
163106962|NCT01436656|589098123|FG009|Dose Escalation|Death|0|||
163106963|NCT01436656|589098124|FG010|Dose Escalation|Death|0|||
163106964|NCT01436656|589098125|FG011|Dose Escalation|Death|0|||
163106965|NCT01436656|589098126|FG012|Dose Escalation|Death|0|||
163106966|NCT01436656|589098127|FG013|Dose Escalation|Death|0|||
163106967|NCT01436656|589098128|FG014|Dose Escalation|Death|0|||
163106968|NCT01436656|589098129|FG015|Dose Escalation|Death|0|||
163106969|NCT01436656|589098130|FG016|Dose Escalation|Death|0|||
163106970|NCT01436656|589098131|FG017|Dose Escalation|Death|0|||
163106971|NCT01436656|589098114|FG000|Dose Escalation|Protocol Violation|0|||
163106972|NCT01436656|589098115|FG001|Dose Escalation|Protocol Violation|0|||
163106973|NCT01436656|589098116|FG002|Dose Escalation|Protocol Violation|0|||
163106974|NCT01436656|589098117|FG003|Dose Escalation|Protocol Violation|0|||
163106975|NCT01436656|589098118|FG004|Dose Escalation|Protocol Violation|0|||
163106976|NCT01436656|589098119|FG005|Dose Escalation|Protocol Violation|1|||
163106977|NCT01436656|589098120|FG006|Dose Escalation|Protocol Violation|0|||
163106978|NCT01436656|589098121|FG007|Dose Escalation|Protocol Violation|0|||
163106979|NCT01436656|589098122|FG008|Dose Escalation|Protocol Violation|0|||
163106980|NCT01436656|589098123|FG009|Dose Escalation|Protocol Violation|0|||
163106981|NCT01436656|589098124|FG010|Dose Escalation|Protocol Violation|0|||
163106982|NCT01436656|589098125|FG011|Dose Escalation|Protocol Violation|0|||
163106983|NCT01436656|589098126|FG012|Dose Escalation|Protocol Violation|0|||
163106984|NCT01436656|589098127|FG013|Dose Escalation|Protocol Violation|0|||
163106985|NCT01436656|589098128|FG014|Dose Escalation|Protocol Violation|0|||
163106986|NCT01436656|589098129|FG015|Dose Escalation|Protocol Violation|0|||
163106987|NCT01436656|589098130|FG016|Dose Escalation|Protocol Violation|0|||
163106988|NCT01436656|589098131|FG017|Dose Escalation|Protocol Violation|0|||
163106989|NCT01436656|589098114|FG000|Dose Escalation|Withdrawal by Subject|0|||
163106990|NCT01436656|589098115|FG001|Dose Escalation|Withdrawal by Subject|0|||
163106991|NCT01436656|589098116|FG002|Dose Escalation|Withdrawal by Subject|0|||
163106992|NCT01436656|589098117|FG003|Dose Escalation|Withdrawal by Subject|0|||
163106993|NCT01436656|589098118|FG004|Dose Escalation|Withdrawal by Subject|1|||
163106994|NCT01436656|589098119|FG005|Dose Escalation|Withdrawal by Subject|0|||
163106995|NCT01436656|589098120|FG006|Dose Escalation|Withdrawal by Subject|0|||
163106996|NCT01436656|589098121|FG007|Dose Escalation|Withdrawal by Subject|2|||
163106997|NCT01436656|589098122|FG008|Dose Escalation|Withdrawal by Subject|0|||
163106998|NCT01436656|589098123|FG009|Dose Escalation|Withdrawal by Subject|1|||
163106999|NCT01436656|589098124|FG010|Dose Escalation|Withdrawal by Subject|1|||
163107000|NCT01436656|589098125|FG011|Dose Escalation|Withdrawal by Subject|0|||
163107001|NCT01436656|589098126|FG012|Dose Escalation|Withdrawal by Subject|0|||
163107002|NCT01436656|589098127|FG013|Dose Escalation|Withdrawal by Subject|0|||
163107003|NCT01436656|589098128|FG014|Dose Escalation|Withdrawal by Subject|0|||
163107004|NCT01436656|589098129|FG015|Dose Escalation|Withdrawal by Subject|0|||
163107005|NCT01436656|589098130|FG016|Dose Escalation|Withdrawal by Subject|0|||
163107006|NCT01436656|589098131|FG017|Dose Escalation|Withdrawal by Subject|0|||
163107007|NCT01436656|589098114|FG000|Dose Escalation|Administrative problems|0|||
163107008|NCT01436656|589098115|FG001|Dose Escalation|Administrative problems|1|||
163107009|NCT01436656|589098116|FG002|Dose Escalation|Administrative problems|0|||
163107010|NCT01436656|589098117|FG003|Dose Escalation|Administrative problems|0|||
163107011|NCT01436656|589098118|FG004|Dose Escalation|Administrative problems|0|||
163107012|NCT01436656|589098119|FG005|Dose Escalation|Administrative problems|0|||
163107013|NCT01436656|589098120|FG006|Dose Escalation|Administrative problems|0|||
163107014|NCT01436656|589098121|FG007|Dose Escalation|Administrative problems|0|||
163107015|NCT01436656|589098122|FG008|Dose Escalation|Administrative problems|0|||
163107016|NCT01436656|589098123|FG009|Dose Escalation|Administrative problems|0|||
163107017|NCT01436656|589098124|FG010|Dose Escalation|Administrative problems|0|||
163107018|NCT01436656|589098125|FG011|Dose Escalation|Administrative problems|0|||
163107019|NCT01436656|589098126|FG012|Dose Escalation|Administrative problems|0|||
163107020|NCT01436656|589098127|FG013|Dose Escalation|Administrative problems|0|||
163107021|NCT01436656|589098128|FG014|Dose Escalation|Administrative problems|0|||
163107022|NCT01436656|589098129|FG015|Dose Escalation|Administrative problems|0|||
163107023|NCT01436656|589098130|FG016|Dose Escalation|Administrative problems|0|||
163107024|NCT01436656|589098131|FG017|Dose Escalation|Administrative problems|0|||
163107025|NCT01436656|589098114|FG000|Dose Escalation|Lost to Follow-up|1|||
163107026|NCT01436656|589098115|FG001|Dose Escalation|Lost to Follow-up|0|||
163107027|NCT01436656|589098116|FG002|Dose Escalation|Lost to Follow-up|0|||
163107028|NCT01436656|589098117|FG003|Dose Escalation|Lost to Follow-up|0|||
163107029|NCT01436656|589098118|FG004|Dose Escalation|Lost to Follow-up|1|||
163107030|NCT01436656|589098119|FG005|Dose Escalation|Lost to Follow-up|0|||
163107031|NCT01436656|589098120|FG006|Dose Escalation|Lost to Follow-up|0|||
163107032|NCT01436656|589098121|FG007|Dose Escalation|Lost to Follow-up|0|||
163107033|NCT01436656|589098122|FG008|Dose Escalation|Lost to Follow-up|0|||
163107034|NCT01436656|589098123|FG009|Dose Escalation|Lost to Follow-up|0|||
163107035|NCT01436656|589098124|FG010|Dose Escalation|Lost to Follow-up|0|||
163107036|NCT01436656|589098125|FG011|Dose Escalation|Lost to Follow-up|0|||
163107037|NCT01436656|589098126|FG012|Dose Escalation|Lost to Follow-up|0|||
163107038|NCT01436656|589098127|FG013|Dose Escalation|Lost to Follow-up|0|||
163107039|NCT01436656|589098128|FG014|Dose Escalation|Lost to Follow-up|0|||
163107040|NCT01436656|589098129|FG015|Dose Escalation|Lost to Follow-up|0|||
163107041|NCT01436656|589098130|FG016|Dose Escalation|Lost to Follow-up|0|||
163107042|NCT01436656|589098131|FG017|Dose Escalation|Lost to Follow-up|0|||
163107043|NCT01436656|589098114|FG000|Dose Escalation|New anti-cancer therapy|1|||
163107044|NCT01436656|589098115|FG001|Dose Escalation|New anti-cancer therapy|0|||
163107045|NCT01436656|589098116|FG002|Dose Escalation|New anti-cancer therapy|0|||
163107046|NCT01436656|589098117|FG003|Dose Escalation|New anti-cancer therapy|0|||
163107047|NCT01436656|589098118|FG004|Dose Escalation|New anti-cancer therapy|0|||
163107048|NCT01436656|589098119|FG005|Dose Escalation|New anti-cancer therapy|0|||
163107049|NCT01436656|589098120|FG006|Dose Escalation|New anti-cancer therapy|0|||
163107050|NCT01436656|589098121|FG007|Dose Escalation|New anti-cancer therapy|0|||
163107051|NCT01436656|589098122|FG008|Dose Escalation|New anti-cancer therapy|1|||
163107052|NCT01436656|589098123|FG009|Dose Escalation|New anti-cancer therapy|1|||
163107053|NCT01436656|589098124|FG010|Dose Escalation|New anti-cancer therapy|0|||
163107054|NCT01436656|589098125|FG011|Dose Escalation|New anti-cancer therapy|0|||
163107055|NCT01436656|589098126|FG012|Dose Escalation|New anti-cancer therapy|0|||
163107056|NCT01436656|589098127|FG013|Dose Escalation|New anti-cancer therapy|0|||
163107057|NCT01436656|589098128|FG014|Dose Escalation|New anti-cancer therapy|0|||
163107058|NCT01436656|589098129|FG015|Dose Escalation|New anti-cancer therapy|0|||
163107059|NCT01436656|589098130|FG016|Dose Escalation|New anti-cancer therapy|0|||
163107060|NCT01436656|589098131|FG017|Dose Escalation|New anti-cancer therapy|0|||
163107061|NCT01436656|589098114|FG000|Dose Expansion|Adverse Event|0|||
163107062|NCT01436656|589098115|FG001|Dose Expansion|Adverse Event|0|||
163107063|NCT01436656|589098116|FG002|Dose Expansion|Adverse Event|0|||
163107064|NCT01436656|589098117|FG003|Dose Expansion|Adverse Event|0|||
163107065|NCT01436656|589098118|FG004|Dose Expansion|Adverse Event|0|||
163107066|NCT01436656|589098119|FG005|Dose Expansion|Adverse Event|0|||
163107067|NCT01436656|589098120|FG006|Dose Expansion|Adverse Event|0|||
163107068|NCT01436656|589098121|FG007|Dose Expansion|Adverse Event|0|||
163107069|NCT01436656|589098122|FG008|Dose Expansion|Adverse Event|0|||
163107070|NCT01436656|589098123|FG009|Dose Expansion|Adverse Event|0|||
163107071|NCT01436656|589098124|FG010|Dose Expansion|Adverse Event|0|||
163107072|NCT01436656|589098125|FG011|Dose Expansion|Adverse Event|1|||
163107073|NCT01436656|589098126|FG012|Dose Expansion|Adverse Event|0|||
163107074|NCT01436656|589098127|FG013|Dose Expansion|Adverse Event|0|||
163107075|NCT01436656|589098128|FG014|Dose Expansion|Adverse Event|0|||
163107076|NCT01436656|589098129|FG015|Dose Expansion|Adverse Event|0|||
163107077|NCT01436656|589098130|FG016|Dose Expansion|Adverse Event|0|||
163107078|NCT01436656|589098131|FG017|Dose Expansion|Adverse Event|0|||
163107079|NCT01436656|589098114|FG000|Dose Expansion|Withdrawal by Subject|0|||
163107080|NCT01436656|589098115|FG001|Dose Expansion|Withdrawal by Subject|0|||
163107081|NCT01436656|589098116|FG002|Dose Expansion|Withdrawal by Subject|0|||
162719192|NCT00955825|587678430|FG000|Overall Study|Any other reason not above-mentioned|7|||
163107082|NCT01436656|589098117|FG003|Dose Expansion|Withdrawal by Subject|0|||
163107083|NCT01436656|589098118|FG004|Dose Expansion|Withdrawal by Subject|0|||
163107084|NCT01436656|589098119|FG005|Dose Expansion|Withdrawal by Subject|0|||
163107085|NCT01436656|589098120|FG006|Dose Expansion|Withdrawal by Subject|0|||
163107086|NCT01436656|589098121|FG007|Dose Expansion|Withdrawal by Subject|0|||
163107087|NCT01436656|589098122|FG008|Dose Expansion|Withdrawal by Subject|0|||
163107088|NCT01436656|589098123|FG009|Dose Expansion|Withdrawal by Subject|0|||
163107089|NCT01436656|589098124|FG010|Dose Expansion|Withdrawal by Subject|0|||
163107090|NCT01436656|589098125|FG011|Dose Expansion|Withdrawal by Subject|1|||
163107091|NCT01436656|589098126|FG012|Dose Expansion|Withdrawal by Subject|3|||
163107092|NCT01436656|589098127|FG013|Dose Expansion|Withdrawal by Subject|1|||
163107093|NCT01436656|589098128|FG014|Dose Expansion|Withdrawal by Subject|2|||
163107094|NCT01436656|589098129|FG015|Dose Expansion|Withdrawal by Subject|0|||
163107095|NCT01436656|589098130|FG016|Dose Expansion|Withdrawal by Subject|1|||
163107096|NCT01436656|589098131|FG017|Dose Expansion|Withdrawal by Subject|1|||
163107097|NCT01436656|589098114|FG000|Dose Expansion|Death|0|||
163107098|NCT01436656|589098115|FG001|Dose Expansion|Death|0|||
163107099|NCT01436656|589098116|FG002|Dose Expansion|Death|0|||
163107100|NCT01436656|589098117|FG003|Dose Expansion|Death|0|||
163107101|NCT01436656|589098118|FG004|Dose Expansion|Death|0|||
163107102|NCT01436656|589098119|FG005|Dose Expansion|Death|0|||
163107103|NCT01436656|589098120|FG006|Dose Expansion|Death|0|||
163107104|NCT01436656|589098121|FG007|Dose Expansion|Death|0|||
163107105|NCT01436656|589098122|FG008|Dose Expansion|Death|0|||
163107106|NCT01436656|589098123|FG009|Dose Expansion|Death|0|||
163107107|NCT01436656|589098124|FG010|Dose Expansion|Death|0|||
163107108|NCT01436656|589098125|FG011|Dose Expansion|Death|0|||
163107109|NCT01436656|589098126|FG012|Dose Expansion|Death|1|||
163107110|NCT01436656|589098127|FG013|Dose Expansion|Death|0|||
163107111|NCT01436656|589098128|FG014|Dose Expansion|Death|3|||
163107112|NCT01436656|589098129|FG015|Dose Expansion|Death|0|||
163107113|NCT01436656|589098130|FG016|Dose Expansion|Death|3|||
163107114|NCT01436656|589098131|FG017|Dose Expansion|Death|3|||
163107115|NCT01436656|589098114|FG000|Dose Expansion|Lost to Follow-up|0|||
163107116|NCT01436656|589098115|FG001|Dose Expansion|Lost to Follow-up|0|||
163107117|NCT01436656|589098116|FG002|Dose Expansion|Lost to Follow-up|0|||
163107118|NCT01436656|589098117|FG003|Dose Expansion|Lost to Follow-up|0|||
163107119|NCT01436656|589098118|FG004|Dose Expansion|Lost to Follow-up|0|||
163107120|NCT01436656|589098119|FG005|Dose Expansion|Lost to Follow-up|0|||
163107121|NCT01436656|589098120|FG006|Dose Expansion|Lost to Follow-up|0|||
163107122|NCT01436656|589098121|FG007|Dose Expansion|Lost to Follow-up|0|||
163107123|NCT01436656|589098122|FG008|Dose Expansion|Lost to Follow-up|0|||
163107124|NCT01436656|589098123|FG009|Dose Expansion|Lost to Follow-up|0|||
163107125|NCT01436656|589098124|FG010|Dose Expansion|Lost to Follow-up|0|||
163107126|NCT01436656|589098125|FG011|Dose Expansion|Lost to Follow-up|0|||
163107127|NCT01436656|589098126|FG012|Dose Expansion|Lost to Follow-up|0|||
163107128|NCT01436656|589098127|FG013|Dose Expansion|Lost to Follow-up|0|||
163107129|NCT01436656|589098128|FG014|Dose Expansion|Lost to Follow-up|0|||
163107130|NCT01436656|589098129|FG015|Dose Expansion|Lost to Follow-up|0|||
163107131|NCT01436656|589098130|FG016|Dose Expansion|Lost to Follow-up|0|||
163107132|NCT01436656|589098131|FG017|Dose Expansion|Lost to Follow-up|3|||
163107133|NCT01436656|589098114|FG000|Dose Expansion|Disease progression|0|||
163107134|NCT01436656|589098115|FG001|Dose Expansion|Disease progression|0|||
163107135|NCT01436656|589098116|FG002|Dose Expansion|Disease progression|0|||
163107136|NCT01436656|589098117|FG003|Dose Expansion|Disease progression|0|||
163107137|NCT01436656|589098118|FG004|Dose Expansion|Disease progression|0|||
163107138|NCT01436656|589098119|FG005|Dose Expansion|Disease progression|0|||
163107139|NCT01436656|589098120|FG006|Dose Expansion|Disease progression|0|||
163107140|NCT01436656|589098121|FG007|Dose Expansion|Disease progression|0|||
163107141|NCT01436656|589098122|FG008|Dose Expansion|Disease progression|0|||
163107142|NCT01436656|589098123|FG009|Dose Expansion|Disease progression|0|||
163107143|NCT01436656|589098124|FG010|Dose Expansion|Disease progression|0|||
163107144|NCT01436656|589098125|FG011|Dose Expansion|Disease progression|3|||
163107145|NCT01436656|589098126|FG012|Dose Expansion|Disease progression|1|||
163107146|NCT01436656|589098127|FG013|Dose Expansion|Disease progression|0|||
163107147|NCT01436656|589098128|FG014|Dose Expansion|Disease progression|1|||
163107148|NCT01436656|589098129|FG015|Dose Expansion|Disease progression|0|||
163107149|NCT01436656|589098130|FG016|Dose Expansion|Disease progression|0|||
163107150|NCT01436656|589098131|FG017|Dose Expansion|Disease progression|1|||
163107151|NCT01436656|589098114|FG000|Dose Expansion|New cancer therapy|0|||
163107152|NCT01436656|589098115|FG001|Dose Expansion|New cancer therapy|0|||
163107153|NCT01436656|589098116|FG002|Dose Expansion|New cancer therapy|0|||
163107154|NCT01436656|589098117|FG003|Dose Expansion|New cancer therapy|0|||
163107155|NCT01436656|589098118|FG004|Dose Expansion|New cancer therapy|0|||
163107156|NCT01436656|589098119|FG005|Dose Expansion|New cancer therapy|0|||
163107157|NCT01436656|589098120|FG006|Dose Expansion|New cancer therapy|0|||
163107158|NCT01436656|589098121|FG007|Dose Expansion|New cancer therapy|0|||
163107159|NCT01436656|589098122|FG008|Dose Expansion|New cancer therapy|0|||
163107160|NCT01436656|589098123|FG009|Dose Expansion|New cancer therapy|0|||
163107161|NCT01436656|589098124|FG010|Dose Expansion|New cancer therapy|0|||
163107162|NCT01436656|589098125|FG011|Dose Expansion|New cancer therapy|1|||
163107163|NCT01436656|589098126|FG012|Dose Expansion|New cancer therapy|1|||
163107164|NCT01436656|589098127|FG013|Dose Expansion|New cancer therapy|0|||
163107165|NCT01436656|589098128|FG014|Dose Expansion|New cancer therapy|2|||
163107166|NCT01436656|589098129|FG015|Dose Expansion|New cancer therapy|0|||
163107167|NCT01436656|589098130|FG016|Dose Expansion|New cancer therapy|0|||
163107168|NCT01436656|589098131|FG017|Dose Expansion|New cancer therapy|0|||
163107169|NCT01667224|589098133|FG000|Overall Study|Withdrawal by Subject|3|||
163107170|NCT01667224|589098134|FG001|Overall Study|Withdrawal by Subject|1|||
163107171|NCT01667224|589098133|FG000|Overall Study|Protocol Violation|1|||
163107172|NCT01667224|589098134|FG001|Overall Study|Protocol Violation|1|||
163107173|NCT00962741|589098135|FG000|Overall Study|Failed to return|3|||
163107174|NCT00962741|589098135|FG000|Overall Study|Lost to Follow-up|2|||
163107175|NCT00962741|589098135|FG000|Overall Study|Withdrawal by Subject|1|||
163107176|NCT00962741|589098135|FG000|Overall Study|Lack of Efficacy|1|||
163107177|NCT00962741|589098135|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
163107178|NCT03350035|589098136|FG000|Overall Study|Lack of Efficacy|2|||
163107179|NCT03350035|589098137|FG001|Overall Study|Lack of Efficacy|0|||
163107180|NCT03350035|589098138|FG002|Overall Study|Lack of Efficacy|0|||
163107181|NCT03350035|589098136|FG000|Overall Study|Subject discharged to hospice|0|||
163107182|NCT03350035|589098137|FG001|Overall Study|Subject discharged to hospice|0|||
163107183|NCT03350035|589098138|FG002|Overall Study|Subject discharged to hospice|1|||
163107184|NCT01811485|589098139|FG000|Overall Study|Adverse Event|1|||
163107185|NCT01811485|589098140|FG001|Overall Study|Adverse Event|3|||
163107186|NCT01811485|589098141|FG002|Overall Study|Adverse Event|2|||
163107187|NCT01811485|589098139|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163107188|NCT01811485|589098140|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163107189|NCT01811485|589098141|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163107190|NCT01811485|589098139|FG000|Overall Study|Administrative problems|1|||
163107191|NCT01811485|589098140|FG001|Overall Study|Administrative problems|0|||
163107192|NCT01811485|589098141|FG002|Overall Study|Administrative problems|0|||
163107193|NCT01811485|589098139|FG000|Overall Study|Protocol Deviation|0|||
163107194|NCT01811485|589098140|FG001|Overall Study|Protocol Deviation|1|||
163107195|NCT01811485|589098141|FG002|Overall Study|Protocol Deviation|0|||
163107196|NCT01545934|589098142|FG000|Overall Study|Withdrawal by Subject|4|||
163107197|NCT01545934|589098143|FG001|Overall Study|Withdrawal by Subject|3|||
163107198|NCT01545934|589098142|FG000|Overall Study|Lost to Follow-up|1|||
163107199|NCT01545934|589098143|FG001|Overall Study|Lost to Follow-up|0|||
163107200|NCT01843673|589098148|FG000|Overall Study|Lack of Efficacy|2|||
163107201|NCT01843673|589098148|FG000|Overall Study|Withdrawal by Subject|4|||
163107202|NCT00695955|589098155|FG000|Cohort 1|Adverse Event|26|||
163107203|NCT00695955|589098155|FG000|Cohort 1|Protocol Violation|2|||
163107204|NCT00695955|589098155|FG000|Cohort 1|Lost to Follow-up|30|||
163107205|NCT00695955|589098155|FG000|Cohort 1|Withdrawal by Subject|25|||
163107206|NCT00695955|589098155|FG000|Cohort 1|Lack of Efficacy|3|||
163107207|NCT00695955|589098155|FG000|Cohort 1|Other|16|||
163107208|NCT00695955|589098155|FG000|Cohort 2|Adverse Event|24|||
163107209|NCT00695955|589098155|FG000|Cohort 2|Protocol Violation|5|||
163107210|NCT00695955|589098155|FG000|Cohort 2|Lost to Follow-up|38|||
163107211|NCT00695955|589098155|FG000|Cohort 2|Withdrawal by Subject|28|||
162719193|NCT00955825|587678431|FG001|Overall Study|Any other reason not above-mentioned|9|||
163107212|NCT00695955|589098155|FG000|Cohort 2|Lack of Efficacy|4|||
163107213|NCT00695955|589098155|FG000|Cohort 2|Other|5|||
163107214|NCT01177553|589098156|FG000|Overall Study|babies not yet 6 months of age|1|||
163107215|NCT01177553|589098157|FG001|Overall Study|babies not yet 6 months of age|0|||
163107216|NCT00888329|589098159|FG000|Overall Study|Physician Decision|6|||
163107217|NCT00888329|589098160|FG001|Overall Study|Physician Decision|9|||
163107218|NCT04826094|589098161|FG000|Overall Study|Lost to Follow-up|2|||
163107219|NCT04826094|589098162|FG001|Overall Study|Lost to Follow-up|1|||
163107220|NCT04826094|589098163|FG002|Overall Study|Lost to Follow-up|0|||
163107221|NCT04826094|589098164|FG003|Overall Study|Lost to Follow-up|0|||
163107222|NCT04826094|589098165|FG004|Overall Study|Lost to Follow-up|1|||
162719194|NCT00708032|587678432|FG000|Overall Study|Adverse Event|0|||
162719195|NCT00708032|587678433|FG001|Overall Study|Adverse Event|2|||
163107223|NCT04826094|589098166|FG005|Overall Study|Lost to Follow-up|3|||
163107224|NCT04826094|589098167|FG006|Overall Study|Lost to Follow-up|1|||
163107225|NCT04826094|589098168|FG007|Overall Study|Lost to Follow-up|1|||
163107226|NCT04826094|589098161|FG000|Overall Study|Participant withdrew consent|1|||
163107227|NCT04826094|589098162|FG001|Overall Study|Participant withdrew consent|0|||
163107228|NCT04826094|589098163|FG002|Overall Study|Participant withdrew consent|0|||
163107229|NCT04826094|589098164|FG003|Overall Study|Participant withdrew consent|1|||
163107230|NCT04826094|589098165|FG004|Overall Study|Participant withdrew consent|1|||
163107231|NCT04826094|589098166|FG005|Overall Study|Participant withdrew consent|1|||
163107232|NCT04826094|589098167|FG006|Overall Study|Participant withdrew consent|0|||
163107233|NCT04826094|589098168|FG007|Overall Study|Participant withdrew consent|1|||
163107234|NCT04826094|589098161|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
163107235|NCT04826094|589098162|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
163107236|NCT04826094|589098163|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
163107237|NCT04826094|589098164|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
163107238|NCT04826094|589098165|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
163107239|NCT04826094|589098166|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
163107240|NCT04826094|589098167|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
163107241|NCT04826094|589098168|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
163107242|NCT04826094|589098161|FG000|Overall Study|Withdrawn by Investigator|0|||
163107243|NCT04826094|589098162|FG001|Overall Study|Withdrawn by Investigator|0|||
163107244|NCT04826094|589098163|FG002|Overall Study|Withdrawn by Investigator|0|||
163107245|NCT04826094|589098164|FG003|Overall Study|Withdrawn by Investigator|0|||
163107246|NCT04826094|589098165|FG004|Overall Study|Withdrawn by Investigator|0|||
163107247|NCT04826094|589098166|FG005|Overall Study|Withdrawn by Investigator|1|||
163107248|NCT04826094|589098167|FG006|Overall Study|Withdrawn by Investigator|0|||
163107249|NCT04826094|589098168|FG007|Overall Study|Withdrawn by Investigator|1|||
163107250|NCT04826094|589098161|FG000|Overall Study|Other: Moved from area|1|||
163107251|NCT04826094|589098162|FG001|Overall Study|Other: Moved from area|1|||
163107252|NCT04826094|589098163|FG002|Overall Study|Other: Moved from area|1|||
163107253|NCT04826094|589098164|FG003|Overall Study|Other: Moved from area|0|||
163107254|NCT04826094|589098165|FG004|Overall Study|Other: Moved from area|0|||
163107255|NCT04826094|589098166|FG005|Overall Study|Other: Moved from area|0|||
163107256|NCT04826094|589098167|FG006|Overall Study|Other: Moved from area|0|||
162653700|NCT03909165|587449577|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162653701|NCT03909165|587449573|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
162653702|NCT03909165|587449574|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
162653703|NCT03909165|587449575|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162653704|NCT03909165|587449576|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
163107257|NCT04826094|589098168|FG007|Overall Study|Other: Moved from area|0|||
163107258|NCT04826094|589098161|FG000|Overall Study|Other: Declined|0|||
163107259|NCT04826094|589098162|FG001|Overall Study|Other: Declined|0|||
163107260|NCT04826094|589098163|FG002|Overall Study|Other: Declined|0|||
163107261|NCT04826094|589098164|FG003|Overall Study|Other: Declined|0|||
163107262|NCT04826094|589098165|FG004|Overall Study|Other: Declined|1|||
163107263|NCT04826094|589098166|FG005|Overall Study|Other: Declined|0|||
163107264|NCT04826094|589098167|FG006|Overall Study|Other: Declined|0|||
163107265|NCT04826094|589098168|FG007|Overall Study|Other: Declined|0|||
163107266|NCT04826094|589098161|FG000|Overall Study|Other: Vaccine not administered|0|||
163107267|NCT04826094|589098162|FG001|Overall Study|Other: Vaccine not administered|0|||
163107268|NCT04826094|589098163|FG002|Overall Study|Other: Vaccine not administered|1|||
163107269|NCT04826094|589098164|FG003|Overall Study|Other: Vaccine not administered|0|||
163107270|NCT04826094|589098165|FG004|Overall Study|Other: Vaccine not administered|0|||
163107271|NCT04826094|589098166|FG005|Overall Study|Other: Vaccine not administered|1|||
162653705|NCT03909165|587449577|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
162653706|NCT03909165|587449573|FG000|Overall Study|Previous Drug Exposure|0|||
162653707|NCT03909165|587449574|FG001|Overall Study|Previous Drug Exposure|0|||
162653708|NCT03909165|587449575|FG002|Overall Study|Previous Drug Exposure|1|||
162653709|NCT03909165|587449576|FG003|Overall Study|Previous Drug Exposure|0|||
162653710|NCT03909165|587449577|FG004|Overall Study|Previous Drug Exposure|0|||
162653711|NCT03909165|587449573|FG000|Overall Study|Early Discharge|1|||
162653712|NCT03909165|587449574|FG001|Overall Study|Early Discharge|0|||
162653713|NCT03909165|587449575|FG002|Overall Study|Early Discharge|0|||
162653714|NCT03909165|587449576|FG003|Overall Study|Early Discharge|0|||
162653715|NCT03909165|587449577|FG004|Overall Study|Early Discharge|0|||
162653716|NCT06034496|587449578|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
162653717|NCT06034496|587449579|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
162653718|NCT06034496|587449578|FG000|Overall Study|Withdrawal by Subject|5|||
162653719|NCT06034496|587449579|FG001|Overall Study|Withdrawal by Subject|4|||
162653720|NCT03277261|587449584|FG000|Overall Study|Adverse Event|17|||
163107272|NCT04826094|589098167|FG006|Overall Study|Other: Vaccine not administered|1|||
163107273|NCT04826094|589098168|FG007|Overall Study|Other: Vaccine not administered|3|||
163107274|NCT03928418|589098172|FG000|Overall Study|Lost to Follow-up|5|||
163107275|NCT03928418|589098173|FG001|Overall Study|Lost to Follow-up|3|||
163107276|NCT03928418|589098174|FG002|Overall Study|Lost to Follow-up|5|||
163107277|NCT03928418|589098172|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
163107278|NCT03928418|589098173|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
163107279|NCT03928418|589098174|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
162653721|NCT03277261|587449585|FG001|Overall Study|Adverse Event|1|||
162653722|NCT03277261|587449584|FG000|Overall Study|Participant Withdrawal of Consent|6|||
162719196|NCT00708032|587678432|FG000|Overall Study|Lost to Follow-up|1|||
162653723|NCT03277261|587449585|FG001|Overall Study|Participant Withdrawal of Consent|15|||
162653724|NCT03277261|587449584|FG000|Overall Study|Investigator / Sponsor Decision|4|||
162653725|NCT03277261|587449585|FG001|Overall Study|Investigator / Sponsor Decision|2|||
163107280|NCT05319600|589098175|FG000|Overall Study|Withdrawal by Subject|1|||
163107281|NCT05319600|589098176|FG001|Overall Study|Withdrawal by Subject|0|||
163107282|NCT05319600|589098175|FG000|Overall Study|Lost to Follow-up|0|||
163107283|NCT05319600|589098176|FG001|Overall Study|Lost to Follow-up|4|||
163107284|NCT00904670|589098177|FG000|Open Label Phase|Withdrawal by Subject|2|||
163107285|NCT00904670|589098178|FG001|Open Label Phase|Withdrawal by Subject|0|||
163107286|NCT00904670|589098177|FG000|Open Label Phase|Adverse Event|2|||
163107287|NCT00904670|589098178|FG001|Open Label Phase|Adverse Event|0|||
163107288|NCT00904670|589098177|FG000|Open Label Phase|Lack of Efficacy|1|||
163107289|NCT00904670|589098178|FG001|Open Label Phase|Lack of Efficacy|0|||
163107290|NCT00904670|589098177|FG000|Open Label Phase|Lost to Follow-up|1|||
163107291|NCT00904670|589098178|FG001|Open Label Phase|Lost to Follow-up|0|||
163107292|NCT00690430|589098184|FG000|Core Phase|Abnormal Laboratory value|0|||
163107293|NCT00690430|589098185|FG001|Core Phase|Abnormal Laboratory value|1|||
163107294|NCT00690430|589098186|FG002|Core Phase|Abnormal Laboratory value|0|||
163107295|NCT00690430|589098184|FG000|Core Phase|Adverse Event|5|||
163107296|NCT00690430|589098185|FG001|Core Phase|Adverse Event|1|||
163107297|NCT00690430|589098186|FG002|Core Phase|Adverse Event|0|||
163107298|NCT00690430|589098184|FG000|Core Phase|Death|0|||
163107299|NCT00690430|589098185|FG001|Core Phase|Death|2|||
163107300|NCT00690430|589098186|FG002|Core Phase|Death|0|||
163107301|NCT00690430|589098184|FG000|Core Phase|Protocol Violation|1|||
163107302|NCT00690430|589098185|FG001|Core Phase|Protocol Violation|0|||
163107303|NCT00690430|589098186|FG002|Core Phase|Protocol Violation|0|||
163107304|NCT00690430|589098184|FG000|Core Phase|Withdrawal by Subject|3|||
163107305|NCT00690430|589098185|FG001|Core Phase|Withdrawal by Subject|3|||
163107306|NCT00690430|589098186|FG002|Core Phase|Withdrawal by Subject|0|||
163107307|NCT00690430|589098184|FG000|Core Phase|Subject no longer requires study drug|1|||
163107308|NCT00690430|589098185|FG001|Core Phase|Subject no longer requires study drug|0|||
163107309|NCT00690430|589098186|FG002|Core Phase|Subject no longer requires study drug|0|||
163107310|NCT00690430|589098184|FG000|Core Phase|Lack of Efficacy|8|||
163107311|NCT00690430|589098185|FG001|Core Phase|Lack of Efficacy|10|||
163107312|NCT00690430|589098186|FG002|Core Phase|Lack of Efficacy|0|||
163107313|NCT00690430|589098184|FG000|Core Phase|Administrative Problems|0|||
163107314|NCT00690430|589098185|FG001|Core Phase|Administrative Problems|1|||
163107315|NCT00690430|589098186|FG002|Core Phase|Administrative Problems|0|||
163107316|NCT00690430|589098184|FG000|Core Phase|Early Termination|0|||
163107317|NCT00690430|589098185|FG001|Core Phase|Early Termination|5|||
163107318|NCT00690430|589098186|FG002|Core Phase|Early Termination|0|||
163107319|NCT00690430|589098184|FG000|Extension Phase|Lack of Efficacy|3|||
163107320|NCT00690430|589098185|FG001|Extension Phase|Lack of Efficacy|1|||
163107321|NCT00690430|589098186|FG002|Extension Phase|Lack of Efficacy|4|||
163107322|NCT00690430|589098184|FG000|Extension Phase|Abnormal Lab Values|1|||
163107323|NCT00690430|589098185|FG001|Extension Phase|Abnormal Lab Values|0|||
163107324|NCT00690430|589098186|FG002|Extension Phase|Abnormal Lab Values|0|||
163107325|NCT00690430|589098184|FG000|Extension Phase|Abnormal test procedure results|1|||
163107326|NCT00690430|589098185|FG001|Extension Phase|Abnormal test procedure results|0|||
163107327|NCT00690430|589098186|FG002|Extension Phase|Abnormal test procedure results|0|||
163107328|NCT00690430|589098184|FG000|Extension Phase|Administrative Problems|0|||
163107329|NCT00690430|589098185|FG001|Extension Phase|Administrative Problems|1|||
163107330|NCT00690430|589098186|FG002|Extension Phase|Administrative Problems|1|||
163107331|NCT00690430|589098184|FG000|Extension Phase|Adverse Event|2|||
163107332|NCT00690430|589098185|FG001|Extension Phase|Adverse Event|1|||
163107333|NCT00690430|589098186|FG002|Extension Phase|Adverse Event|2|||
163107334|NCT00690430|589098184|FG000|Extension Phase|Death|1|||
163107335|NCT00690430|589098185|FG001|Extension Phase|Death|1|||
163107336|NCT00690430|589098186|FG002|Extension Phase|Death|1|||
163107337|NCT00690430|589098184|FG000|Extension Phase|Withdrawal by Subject|0|||
163107338|NCT00690430|589098185|FG001|Extension Phase|Withdrawal by Subject|0|||
163107339|NCT00690430|589098186|FG002|Extension Phase|Withdrawal by Subject|2|||
163107340|NCT00690430|589098184|FG000|Extension Phase|Early Termination|10|||
163107341|NCT00690430|589098185|FG001|Extension Phase|Early Termination|1|||
163107342|NCT00690430|589098186|FG002|Extension Phase|Early Termination|3|||
163107343|NCT02120300|589098187|FG000|Overall Study|Enrolled but Never Treated|2|||
163107344|NCT02120300|589098188|FG001|Overall Study|Enrolled but Never Treated|0|||
163107345|NCT02120300|589098189|FG002|Overall Study|Enrolled but Never Treated|0|||
163107346|NCT02120300|589098190|FG003|Overall Study|Enrolled but Never Treated|0|||
163107347|NCT02120300|589098187|FG000|Overall Study|Lack of Efficacy|0|||
163107348|NCT02120300|589098188|FG001|Overall Study|Lack of Efficacy|0|||
163107349|NCT02120300|589098189|FG002|Overall Study|Lack of Efficacy|0|||
163107350|NCT02120300|589098190|FG003|Overall Study|Lack of Efficacy|1|||
163107351|NCT02120300|589098187|FG000|Overall Study|Lost to Follow-up|1|||
163107352|NCT02120300|589098188|FG001|Overall Study|Lost to Follow-up|0|||
163107353|NCT02120300|589098189|FG002|Overall Study|Lost to Follow-up|0|||
163107354|NCT02120300|589098190|FG003|Overall Study|Lost to Follow-up|0|||
163107355|NCT01721486|589098193|FG000|Overall Study|Protocol Violation|1|||
163107356|NCT01721486|589098194|FG001|Overall Study|Protocol Violation|0|||
163107357|NCT01721486|589098193|FG000|Overall Study|Physician Decision|0|||
163107358|NCT01721486|589098194|FG001|Overall Study|Physician Decision|1|||
163107359|NCT00182078|589098201|FG000|Overall Study|Withdrawal by Subject|1|||
163107360|NCT00182078|589098202|FG001|Overall Study|Withdrawal by Subject|0|||
163107361|NCT01076205|589098203|FG000|Overall Study|Adverse Drug Reaction|299|||
163107362|NCT01076205|589098203|FG000|Overall Study|Lack of Effectiveness|1423|||
163107363|NCT01076205|589098203|FG000|Overall Study|Other Reason|1075|||
163107364|NCT01076205|589098203|FG000|Overall Study|Unknown Reason|71|||
163107365|NCT01076205|589098203|FG000|Overall Study|Lost to Follow-up|3151|||
163107366|NCT00361231|589098204|FG000|Overall Study|Physician Decision|3|||
163107367|NCT00361231|589098204|FG000|Overall Study|Symptomatic deterioration|5|||
163107368|NCT00361231|589098204|FG000|Overall Study|Radiographic disease progression|16|||
163107369|NCT00361231|589098204|FG000|Overall Study|Withdrawal by Subject|4|||
163107370|NCT00361231|589098204|FG000|Overall Study|Adverse Event|6|||
163107371|NCT01732510|589098205|FG000|Overall Study|Adverse Event|0|||
163107372|NCT01732510|589098206|FG001|Overall Study|Adverse Event|1|||
163107373|NCT01732510|589098207|FG002|Overall Study|Adverse Event|1|||
163107374|NCT01732510|589098208|FG003|Overall Study|Adverse Event|0|||
163107375|NCT01732510|589098209|FG004|Overall Study|Adverse Event|0|||
163107376|NCT01732510|589098210|FG005|Overall Study|Adverse Event|0|||
163107377|NCT01732510|589098211|FG006|Overall Study|Adverse Event|1|||
163107378|NCT01732510|589098205|FG000|Overall Study|Protocol Violation|0|||
163107379|NCT01732510|589098206|FG001|Overall Study|Protocol Violation|0|||
163107380|NCT01732510|589098207|FG002|Overall Study|Protocol Violation|0|||
163107381|NCT01732510|589098208|FG003|Overall Study|Protocol Violation|1|||
163107382|NCT01732510|589098209|FG004|Overall Study|Protocol Violation|0|||
163107383|NCT01732510|589098210|FG005|Overall Study|Protocol Violation|0|||
163107384|NCT01732510|589098211|FG006|Overall Study|Protocol Violation|0|||
163107385|NCT01732510|589098205|FG000|Overall Study|Withdrawal by Subject|1|||
163107386|NCT01732510|589098206|FG001|Overall Study|Withdrawal by Subject|3|||
163107387|NCT01732510|589098207|FG002|Overall Study|Withdrawal by Subject|2|||
163107388|NCT01732510|589098208|FG003|Overall Study|Withdrawal by Subject|1|||
163107389|NCT01732510|589098209|FG004|Overall Study|Withdrawal by Subject|5|||
163107390|NCT01732510|589098210|FG005|Overall Study|Withdrawal by Subject|0|||
163107391|NCT01732510|589098211|FG006|Overall Study|Withdrawal by Subject|1|||
163107392|NCT01732510|589098205|FG000|Overall Study|Lost to Follow-up|0|||
163107393|NCT01732510|589098206|FG001|Overall Study|Lost to Follow-up|0|||
163107394|NCT01732510|589098207|FG002|Overall Study|Lost to Follow-up|1|||
163107395|NCT01732510|589098208|FG003|Overall Study|Lost to Follow-up|1|||
163107396|NCT01732510|589098209|FG004|Overall Study|Lost to Follow-up|0|||
163107397|NCT01732510|589098210|FG005|Overall Study|Lost to Follow-up|1|||
163107398|NCT01732510|589098211|FG006|Overall Study|Lost to Follow-up|0|||
163107399|NCT01732510|589098205|FG000|Overall Study|Physician Decision|0|||
163107400|NCT01732510|589098206|FG001|Overall Study|Physician Decision|1|||
163107401|NCT01732510|589098207|FG002|Overall Study|Physician Decision|0|||
163107402|NCT01732510|589098208|FG003|Overall Study|Physician Decision|0|||
163107403|NCT01732510|589098209|FG004|Overall Study|Physician Decision|0|||
163107404|NCT01732510|589098210|FG005|Overall Study|Physician Decision|0|||
163107405|NCT01732510|589098211|FG006|Overall Study|Physician Decision|0|||
163107406|NCT01732510|589098205|FG000|Overall Study|Pregnancy|0|||
163107407|NCT01732510|589098206|FG001|Overall Study|Pregnancy|0|||
163107408|NCT01732510|589098207|FG002|Overall Study|Pregnancy|0|||
163107409|NCT01732510|589098208|FG003|Overall Study|Pregnancy|1|||
163107410|NCT01732510|589098209|FG004|Overall Study|Pregnancy|0|||
163107411|NCT01732510|589098210|FG005|Overall Study|Pregnancy|0|||
163107412|NCT01732510|589098211|FG006|Overall Study|Pregnancy|0|||
163107413|NCT01732510|589098205|FG000|Overall Study|Study Terminated By Sponsor|0|||
162653726|NCT03277261|587449584|FG000|Overall Study|Pregnancy|2|||
163107414|NCT01732510|589098206|FG001|Overall Study|Study Terminated By Sponsor|0|||
163107415|NCT01732510|589098207|FG002|Overall Study|Study Terminated By Sponsor|0|||
163107416|NCT01732510|589098208|FG003|Overall Study|Study Terminated By Sponsor|1|||
163107417|NCT01732510|589098209|FG004|Overall Study|Study Terminated By Sponsor|0|||
163107418|NCT01732510|589098210|FG005|Overall Study|Study Terminated By Sponsor|12|||
163107419|NCT01732510|589098211|FG006|Overall Study|Study Terminated By Sponsor|6|||
163107420|NCT00313144|589098212|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
163107421|NCT00313144|589098212|FG000|Overall Study|Death|7|||
163107422|NCT00313144|589098212|FG000|Overall Study|Lost to Follow-up|5|||
163107423|NCT00313144|589098212|FG000|Overall Study|Withdrawal by Subject|4|||
163107424|NCT00313144|589098212|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
163107425|NCT00313144|589098212|FG000|Overall Study|Physician Decision|4|||
163107426|NCT00313144|589098212|FG000|Overall Study|Adverse event - transient|5|||
163107427|NCT00313144|589098212|FG000|Overall Study|Liver transplant|1|||
163107428|NCT00313144|589098212|FG000|Overall Study|Insurance (homecare provider) change|1|||
163107429|NCT00313144|589098212|FG000|Overall Study|Change to different product|1|||
163107430|NCT00313144|589098212|FG000|Overall Study|Due to termination of the study|66|||
162653727|NCT03277261|587449585|FG001|Overall Study|Pregnancy|0|||
162653728|NCT03277261|587449584|FG000|Overall Study|Lost to Follow-up|2|||
163107431|NCT03403361|589098213|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
163107432|NCT02487654|589098215|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
163107433|NCT02487654|589098216|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
163107434|NCT02487654|589098215|FG000|Overall Study|Withdrawal by Subject|3|||
163107435|NCT02487654|589098216|FG001|Overall Study|Withdrawal by Subject|7|||
163107436|NCT02443116|589098219|FG000|Part 1|Adverse Event|2|||
163107437|NCT02443116|589098220|FG001|Part 1|Adverse Event|3|||
163107438|NCT02443116|589098221|FG002|Part 1|Adverse Event|0|||
163107439|NCT02443116|589098222|FG003|Part 1|Adverse Event|0|||
163107440|NCT02443116|589098223|FG004|Part 1|Adverse Event|0|||
163107441|NCT02443116|589098224|FG005|Part 1|Adverse Event|0|||
163107442|NCT02443116|589098225|FG006|Part 1|Adverse Event|0|||
163107443|NCT02443116|589098226|FG007|Part 1|Adverse Event|0|||
163107444|NCT02443116|589098227|FG008|Part 1|Adverse Event|0|||
163107445|NCT02443116|589098219|FG000|Part 1|Withdrew informed consent|0|||
163107446|NCT02443116|589098220|FG001|Part 1|Withdrew informed consent|1|||
163107447|NCT02443116|589098221|FG002|Part 1|Withdrew informed consent|0|||
163107448|NCT02443116|589098222|FG003|Part 1|Withdrew informed consent|0|||
163107449|NCT02443116|589098223|FG004|Part 1|Withdrew informed consent|0|||
163107450|NCT02443116|589098224|FG005|Part 1|Withdrew informed consent|0|||
163107451|NCT02443116|589098225|FG006|Part 1|Withdrew informed consent|0|||
163107452|NCT02443116|589098226|FG007|Part 1|Withdrew informed consent|0|||
163107453|NCT02443116|589098227|FG008|Part 1|Withdrew informed consent|0|||
163107454|NCT02443116|589098219|FG000|Part 1|Lost to Follow-up|0|||
163107455|NCT02443116|589098220|FG001|Part 1|Lost to Follow-up|0|||
163107456|NCT02443116|589098221|FG002|Part 1|Lost to Follow-up|2|||
163107457|NCT02443116|589098222|FG003|Part 1|Lost to Follow-up|0|||
163107458|NCT02443116|589098223|FG004|Part 1|Lost to Follow-up|0|||
163107459|NCT02443116|589098224|FG005|Part 1|Lost to Follow-up|0|||
163107460|NCT02443116|589098225|FG006|Part 1|Lost to Follow-up|0|||
163107461|NCT02443116|589098226|FG007|Part 1|Lost to Follow-up|0|||
163107462|NCT02443116|589098227|FG008|Part 1|Lost to Follow-up|0|||
163107463|NCT02443116|589098219|FG000|Part 1|Participant moved out of state|0|||
163107464|NCT02443116|589098220|FG001|Part 1|Participant moved out of state|0|||
163107465|NCT02443116|589098221|FG002|Part 1|Participant moved out of state|1|||
163107466|NCT02443116|589098222|FG003|Part 1|Participant moved out of state|0|||
163107467|NCT02443116|589098223|FG004|Part 1|Participant moved out of state|0|||
163107468|NCT02443116|589098224|FG005|Part 1|Participant moved out of state|0|||
163107469|NCT02443116|589098225|FG006|Part 1|Participant moved out of state|0|||
163107470|NCT02443116|589098226|FG007|Part 1|Participant moved out of state|0|||
163107471|NCT02443116|589098227|FG008|Part 1|Participant moved out of state|0|||
163107472|NCT02443116|589098219|FG000|Part 1|Participant enrolled in another clinical trial|0|||
163107473|NCT02443116|589098220|FG001|Part 1|Participant enrolled in another clinical trial|0|||
163107474|NCT02443116|589098221|FG002|Part 1|Participant enrolled in another clinical trial|1|||
163107475|NCT02443116|589098222|FG003|Part 1|Participant enrolled in another clinical trial|0|||
163107476|NCT02443116|589098223|FG004|Part 1|Participant enrolled in another clinical trial|0|||
163107477|NCT02443116|589098224|FG005|Part 1|Participant enrolled in another clinical trial|0|||
163107478|NCT02443116|589098225|FG006|Part 1|Participant enrolled in another clinical trial|0|||
163107479|NCT02443116|589098226|FG007|Part 1|Participant enrolled in another clinical trial|0|||
163107480|NCT02443116|589098227|FG008|Part 1|Participant enrolled in another clinical trial|0|||
163107481|NCT02443116|589098219|FG000|Part 2|Adverse Event|0|||
163107482|NCT02443116|589098220|FG001|Part 2|Adverse Event|0|||
163107483|NCT02443116|589098221|FG002|Part 2|Adverse Event|0|||
163107484|NCT02443116|589098222|FG003|Part 2|Adverse Event|0|||
163107485|NCT02443116|589098223|FG004|Part 2|Adverse Event|1|||
163107486|NCT02443116|589098224|FG005|Part 2|Adverse Event|1|||
163107487|NCT02443116|589098225|FG006|Part 2|Adverse Event|2|||
163107488|NCT02443116|589098226|FG007|Part 2|Adverse Event|0|||
163107489|NCT02443116|589098227|FG008|Part 2|Adverse Event|0|||
163107490|NCT02443116|589098219|FG000|Part 2|Withdrew informed consent|0|||
162653729|NCT03277261|587449585|FG001|Overall Study|Lost to Follow-up|2|||
162653730|NCT03277261|587449584|FG000|Overall Study|Lack of Efficacy|2|||
162653731|NCT03277261|587449585|FG001|Overall Study|Lack of Efficacy|2|||
162653732|NCT03277261|587449584|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
162653733|NCT03277261|587449585|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
163107491|NCT02443116|589098220|FG001|Part 2|Withdrew informed consent|0|||
163107492|NCT02443116|589098221|FG002|Part 2|Withdrew informed consent|0|||
163107493|NCT02443116|589098222|FG003|Part 2|Withdrew informed consent|0|||
163107494|NCT02443116|589098223|FG004|Part 2|Withdrew informed consent|0|||
163107495|NCT02443116|589098224|FG005|Part 2|Withdrew informed consent|1|||
163107496|NCT02443116|589098225|FG006|Part 2|Withdrew informed consent|1|||
163107497|NCT02443116|589098226|FG007|Part 2|Withdrew informed consent|0|||
163107498|NCT02443116|589098227|FG008|Part 2|Withdrew informed consent|0|||
162653734|NCT03762083|587449586|FG000|Overall Study|Withdrawal by Subject|2|||
163107499|NCT02443116|589098219|FG000|Part 2|Inability to comply with protocol|0|||
163107500|NCT02443116|589098220|FG001|Part 2|Inability to comply with protocol|0|||
163107501|NCT02443116|589098221|FG002|Part 2|Inability to comply with protocol|0|||
163107502|NCT02443116|589098222|FG003|Part 2|Inability to comply with protocol|1|||
163107503|NCT02443116|589098223|FG004|Part 2|Inability to comply with protocol|0|||
163107504|NCT02443116|589098224|FG005|Part 2|Inability to comply with protocol|0|||
163107505|NCT02443116|589098225|FG006|Part 2|Inability to comply with protocol|0|||
163107506|NCT02443116|589098226|FG007|Part 2|Inability to comply with protocol|0|||
163107507|NCT02443116|589098227|FG008|Part 2|Inability to comply with protocol|0|||
163107508|NCT02443116|589098219|FG000|Part 2|Lost to Follow-up|0|||
163107509|NCT02443116|589098220|FG001|Part 2|Lost to Follow-up|0|||
163107510|NCT02443116|589098221|FG002|Part 2|Lost to Follow-up|0|||
163107511|NCT02443116|589098222|FG003|Part 2|Lost to Follow-up|1|||
163107512|NCT02443116|589098223|FG004|Part 2|Lost to Follow-up|0|||
163107513|NCT02443116|589098224|FG005|Part 2|Lost to Follow-up|0|||
163107514|NCT02443116|589098225|FG006|Part 2|Lost to Follow-up|0|||
163107515|NCT02443116|589098226|FG007|Part 2|Lost to Follow-up|0|||
163107516|NCT02443116|589098227|FG008|Part 2|Lost to Follow-up|0|||
163107517|NCT02443116|589098219|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107518|NCT02443116|589098220|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107519|NCT02443116|589098221|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107520|NCT02443116|589098222|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107521|NCT02443116|589098223|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107522|NCT02443116|589098224|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
163107523|NCT02443116|589098225|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107524|NCT02443116|589098226|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107525|NCT02443116|589098227|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
163107526|NCT02443116|589098219|FG000|Part 3|Adverse Event|0|||
163107527|NCT02443116|589098220|FG001|Part 3|Adverse Event|0|||
163107528|NCT02443116|589098221|FG002|Part 3|Adverse Event|0|||
163107529|NCT02443116|589098222|FG003|Part 3|Adverse Event|0|||
163107530|NCT02443116|589098223|FG004|Part 3|Adverse Event|0|||
163107531|NCT02443116|589098224|FG005|Part 3|Adverse Event|0|||
163107532|NCT02443116|589098225|FG006|Part 3|Adverse Event|0|||
163107533|NCT02443116|589098226|FG007|Part 3|Adverse Event|0|||
163107534|NCT02443116|589098227|FG008|Part 3|Adverse Event|1|||
163107535|NCT02443116|589098219|FG000|Part 3|Withdrew informed consent|0|||
163107536|NCT02443116|589098220|FG001|Part 3|Withdrew informed consent|0|||
163107537|NCT02443116|589098221|FG002|Part 3|Withdrew informed consent|0|||
163107538|NCT02443116|589098222|FG003|Part 3|Withdrew informed consent|0|||
163107539|NCT02443116|589098223|FG004|Part 3|Withdrew informed consent|0|||
163107540|NCT02443116|589098224|FG005|Part 3|Withdrew informed consent|0|||
163107541|NCT02443116|589098225|FG006|Part 3|Withdrew informed consent|0|||
163107542|NCT02443116|589098226|FG007|Part 3|Withdrew informed consent|3|||
163107543|NCT02443116|589098227|FG008|Part 3|Withdrew informed consent|2|||
163107544|NCT02443116|589098219|FG000|Part 3|Lost to Follow-up|0|||
163107545|NCT02443116|589098220|FG001|Part 3|Lost to Follow-up|0|||
163107546|NCT02443116|589098221|FG002|Part 3|Lost to Follow-up|0|||
163107547|NCT02443116|589098222|FG003|Part 3|Lost to Follow-up|0|||
163107548|NCT02443116|589098223|FG004|Part 3|Lost to Follow-up|0|||
163107549|NCT02443116|589098224|FG005|Part 3|Lost to Follow-up|0|||
163107550|NCT02443116|589098225|FG006|Part 3|Lost to Follow-up|0|||
163107551|NCT02443116|589098226|FG007|Part 3|Lost to Follow-up|1|||
163107552|NCT02443116|589098227|FG008|Part 3|Lost to Follow-up|2|||
163107553|NCT01932372|589098228|FG000|Overall Study|Not meeting eligibility criteria|33|||
163107554|NCT01932372|589098229|FG001|Overall Study|Not meeting eligibility criteria|179|||
163107555|NCT03594747|589098234|FG000|Overall Study|Death|78|||
163107556|NCT03594747|589098235|FG001|Overall Study|Death|86|||
163107557|NCT03594747|589098236|FG002|Overall Study|Death|87|||
163107558|NCT03594747|589098234|FG000|Overall Study|Withdrawal by Subject|5|||
163107559|NCT03594747|589098235|FG001|Overall Study|Withdrawal by Subject|2|||
163107560|NCT03594747|589098236|FG002|Overall Study|Withdrawal by Subject|11|||
163107561|NCT03594747|589098234|FG000|Overall Study|Lost to Follow-up|4|||
163107562|NCT03594747|589098235|FG001|Overall Study|Lost to Follow-up|1|||
163107563|NCT03594747|589098236|FG002|Overall Study|Lost to Follow-up|1|||
163107564|NCT03594747|589098234|FG000|Overall Study|Physician Decision|0|||
163107565|NCT03594747|589098235|FG001|Overall Study|Physician Decision|1|||
163107566|NCT03594747|589098236|FG002|Overall Study|Physician Decision|0|||
163107567|NCT03594747|589098234|FG000|Overall Study|Sponsor decision|23|||
163107568|NCT03594747|589098235|FG001|Overall Study|Sponsor decision|17|||
163107569|NCT03594747|589098236|FG002|Overall Study|Sponsor decision|16|||
163107570|NCT03594747|589098234|FG000|Overall Study|Did not meet inclusion criteria|0|||
163107571|NCT03594747|589098235|FG001|Overall Study|Did not meet inclusion criteria|0|||
163107572|NCT03594747|589098236|FG002|Overall Study|Did not meet inclusion criteria|1|||
163107573|NCT03594747|589098234|FG000|Overall Study|Transfer to long term extension study|10|||
163107574|NCT03594747|589098235|FG001|Overall Study|Transfer to long term extension study|12|||
163107575|NCT03594747|589098236|FG002|Overall Study|Transfer to long term extension study|5|||
163107576|NCT04382586|589098237|FG000|Overall Study|Death|3|||
163107577|NCT04382586|589098238|FG001|Overall Study|Death|4|||
163107578|NCT04382586|589098237|FG000|Overall Study|Lost to Follow-up|11|||
163107579|NCT04382586|589098238|FG001|Overall Study|Lost to Follow-up|8|||
163107580|NCT04382586|589098237|FG000|Overall Study|Withdrawal by Subject|3|||
163107581|NCT04382586|589098238|FG001|Overall Study|Withdrawal by Subject|1|||
163107582|NCT04382586|589098237|FG000|Overall Study|Physician Decision|0|||
163107583|NCT04382586|589098238|FG001|Overall Study|Physician Decision|3|||
163107584|NCT02265536|589098246|FG000|Overall Study|Adverse Event|1|||
163107585|NCT02265536|589098247|FG001|Overall Study|Adverse Event|0|||
163107586|NCT02265536|589098248|FG002|Overall Study|Adverse Event|0|||
163107587|NCT02265536|589098249|FG003|Overall Study|Adverse Event|0|||
163107588|NCT02265536|589098250|FG004|Overall Study|Adverse Event|1|||
163107589|NCT02265536|589098251|FG005|Overall Study|Adverse Event|0|||
163107590|NCT02265536|589098246|FG000|Overall Study|Physician Decision|0|||
163107591|NCT02265536|589098247|FG001|Overall Study|Physician Decision|0|||
163107592|NCT02265536|589098248|FG002|Overall Study|Physician Decision|0|||
163107593|NCT02265536|589098249|FG003|Overall Study|Physician Decision|0|||
163107594|NCT02265536|589098250|FG004|Overall Study|Physician Decision|2|||
163107595|NCT02265536|589098251|FG005|Overall Study|Physician Decision|0|||
163107596|NCT02265536|589098246|FG000|Overall Study|Withdrawal by Subject|0|||
163107597|NCT02265536|589098247|FG001|Overall Study|Withdrawal by Subject|3|||
163107598|NCT02265536|589098248|FG002|Overall Study|Withdrawal by Subject|0|||
163107599|NCT02265536|589098249|FG003|Overall Study|Withdrawal by Subject|0|||
163107600|NCT02265536|589098250|FG004|Overall Study|Withdrawal by Subject|0|||
163107601|NCT02265536|589098251|FG005|Overall Study|Withdrawal by Subject|0|||
163107602|NCT00349349|589098254|FG000|Overall Study|Adverse Event|5|||
163107603|NCT00349349|589098255|FG001|Overall Study|Adverse Event|6|||
163107604|NCT00349349|589098256|FG002|Overall Study|Adverse Event|2|||
163107605|NCT00349349|589098254|FG000|Overall Study|Withdrawal by Subject|5|||
163107606|NCT00349349|589098255|FG001|Overall Study|Withdrawal by Subject|2|||
163107607|NCT00349349|589098256|FG002|Overall Study|Withdrawal by Subject|1|||
163107608|NCT00349349|589098254|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
163107609|NCT00349349|589098255|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
163107610|NCT00349349|589098256|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
163107611|NCT00349349|589098254|FG000|Overall Study|Death|13|||
163107612|NCT00349349|589098255|FG001|Overall Study|Death|10|||
163107613|NCT00349349|589098256|FG002|Overall Study|Death|1|||
163107614|NCT00349349|589098254|FG000|Overall Study|Other Treatment Selected|2|||
163107615|NCT00349349|589098255|FG001|Overall Study|Other Treatment Selected|0|||
163107616|NCT00349349|589098256|FG002|Overall Study|Other Treatment Selected|0|||
163107617|NCT00349349|589098254|FG000|Overall Study|Participant Reduced General Condition|0|||
163107618|NCT00349349|589098255|FG001|Overall Study|Participant Reduced General Condition|1|||
163107619|NCT00349349|589098256|FG002|Overall Study|Participant Reduced General Condition|0|||
163107620|NCT00349349|589098254|FG000|Overall Study|Physician Decision|1|||
163107621|NCT00349349|589098255|FG001|Overall Study|Physician Decision|2|||
163107622|NCT00349349|589098256|FG002|Overall Study|Physician Decision|1|||
163107623|NCT00349349|589098254|FG000|Overall Study|No Response|0|||
163107624|NCT00349349|589098255|FG001|Overall Study|No Response|3|||
163107625|NCT00349349|589098256|FG002|Overall Study|No Response|0|||
163107626|NCT00349349|589098254|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
163107627|NCT00349349|589098255|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
163107628|NCT00349349|589098256|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
163107629|NCT02907216|589098257|FG000|Overall Study|No benefit to be obtained by continuing|0|||
163107630|NCT02907216|589098258|FG001|Overall Study|No benefit to be obtained by continuing|1|||
163107631|NCT02907216|589098257|FG000|Overall Study|Withdrawal by Subject|1|||
163107632|NCT02907216|589098258|FG001|Overall Study|Withdrawal by Subject|0|||
163107633|NCT02485639|589098261|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
163107634|NCT02485639|589098261|FG000|Overall Study|Early termination|4|||
163107635|NCT02485639|589098261|FG000|Overall Study|Withdrawal by Subject|4|||
163107636|NCT03763656|589098262|FG000|Overall Study|Physician Decision|1|||
163107637|NCT03763656|589098262|FG000|Overall Study|Protocol Violation|1|||
163107638|NCT03763656|589098262|FG000|Overall Study|Withdrawal by Subject|7|||
163107639|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
163107640|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
163107641|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
163107642|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
163107643|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
163107644|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
162653735|NCT03762083|587449586|FG000|Overall Study|Physician Decision|1|||
163107645|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
163107646|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
163107647|NCT03479541|589098263|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
163107648|NCT03479541|589098264|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
163107649|NCT03479541|589098265|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
163107650|NCT03479541|589098266|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
163107651|NCT03479541|589098263|FG000|Home Monitoring|Lost to Follow-up|0|||
163107652|NCT03479541|589098264|FG001|Home Monitoring|Lost to Follow-up|0|||
162653736|NCT01203072|587449587|FG000|Overall Study|Adverse Event|5|||
162653737|NCT01203072|587449588|FG001|Overall Study|Adverse Event|3|||
162653738|NCT01203072|587449589|FG002|Overall Study|Adverse Event|2|||
162653739|NCT01203072|587449590|FG003|Overall Study|Adverse Event|4|||
162653740|NCT01203072|587449591|FG004|Overall Study|Adverse Event|2|||
163107653|NCT03479541|589098265|FG002|Home Monitoring|Lost to Follow-up|8|||
163107654|NCT03479541|589098266|FG003|Home Monitoring|Lost to Follow-up|12|||
163107655|NCT03479541|589098263|FG000|Home Monitoring|Withdrawal by Subject|0|||
163107656|NCT03479541|589098264|FG001|Home Monitoring|Withdrawal by Subject|0|||
163107657|NCT03479541|589098265|FG002|Home Monitoring|Withdrawal by Subject|17|||
163107658|NCT03479541|589098266|FG003|Home Monitoring|Withdrawal by Subject|30|||
163107659|NCT03479541|589098263|FG000|Home Monitoring|Early Termination - PI Decision|0|||
163107660|NCT03479541|589098264|FG001|Home Monitoring|Early Termination - PI Decision|0|||
163107661|NCT03479541|589098265|FG002|Home Monitoring|Early Termination - PI Decision|4|||
163107662|NCT03479541|589098266|FG003|Home Monitoring|Early Termination - PI Decision|6|||
163107663|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
163107664|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
163107665|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
163107666|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
163107667|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
163107668|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
163107669|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
163107670|NCT01673854|589098268|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
163107671|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
163107672|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
163107673|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
163107674|NCT01673854|589098268|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
163107675|NCT00334737|589098269|FG000|Hospital Phase|Death|1|||
163107676|NCT00334737|589098270|FG001|Hospital Phase|Death|2|||
163107677|NCT00334737|589098271|FG002|Hospital Phase|Death|3|||
163107678|NCT00334737|589098269|FG000|Hospital Phase|Withdrawal by Subject|0|||
163107679|NCT00334737|589098270|FG001|Hospital Phase|Withdrawal by Subject|0|||
163107680|NCT00334737|589098271|FG002|Hospital Phase|Withdrawal by Subject|1|||
163107681|NCT00334737|589098269|FG000|Hospital Phase|Did not receive study drug|1|||
163107682|NCT00334737|589098270|FG001|Hospital Phase|Did not receive study drug|0|||
163107683|NCT00334737|589098271|FG002|Hospital Phase|Did not receive study drug|0|||
163107684|NCT00334737|589098269|FG000|Follow up Phase|Lost to Follow-up|5|||
163107685|NCT00334737|589098270|FG001|Follow up Phase|Lost to Follow-up|3|||
163107686|NCT00334737|589098271|FG002|Follow up Phase|Lost to Follow-up|6|||
163107687|NCT02316353|589098272|FG000|Overall Study|Pregnancy|1|||
163107688|NCT02316353|589098273|FG001|Overall Study|Pregnancy|3|||
163107689|NCT02316353|589098272|FG000|Overall Study|Adverse Event|1|||
163107690|NCT02316353|589098273|FG001|Overall Study|Adverse Event|3|||
163107691|NCT02316353|589098272|FG000|Overall Study|Withdrawal by Subject|6|||
163107692|NCT02316353|589098273|FG001|Overall Study|Withdrawal by Subject|2|||
163107693|NCT02640625|589099923|FG000|Overall Study|Adverse Event|1|||
163107694|NCT02013206|589099924|FG000|Overall Study|Progressive disease (PD)|14|||
163107695|NCT02013206|589099925|FG001|Overall Study|Progressive disease (PD)|17|||
163107696|NCT02013206|589099924|FG000|Overall Study|Symptomatic deterioration|3|||
163107697|NCT02013206|589099925|FG001|Overall Study|Symptomatic deterioration|1|||
163107698|NCT02013206|589099924|FG000|Overall Study|Adverse Event|1|||
163107699|NCT02013206|589099925|FG001|Overall Study|Adverse Event|0|||
163107700|NCT02013206|589099924|FG000|Overall Study|Patient refusal|2|||
163107701|NCT02013206|589099925|FG001|Overall Study|Patient refusal|0|||
163107702|NCT02013206|589099924|FG000|Overall Study|Patient non-compliance|1|||
163107703|NCT02013206|589099925|FG001|Overall Study|Patient non-compliance|0|||
163107704|NCT02013206|589099924|FG000|Overall Study|Death|1|||
163107705|NCT02013206|589099925|FG001|Overall Study|Death|2|||
162653741|NCT01203072|587449587|FG000|Overall Study|Lack of Efficacy|1|||
162653742|NCT01203072|587449588|FG001|Overall Study|Lack of Efficacy|0|||
162653743|NCT01203072|587449589|FG002|Overall Study|Lack of Efficacy|0|||
162653744|NCT01203072|587449590|FG003|Overall Study|Lack of Efficacy|0|||
162653745|NCT01203072|587449591|FG004|Overall Study|Lack of Efficacy|0|||
162719197|NCT00708032|587678433|FG001|Overall Study|Lost to Follow-up|2|||
162719198|NCT00708032|587678432|FG000|Overall Study|Pregnancy|0|||
163107706|NCT02013206|589099924|FG000|Overall Study|Other reasons off treatment|5|||
163107707|NCT02013206|589099925|FG001|Overall Study|Other reasons off treatment|2|||
163107708|NCT05425732|589099926|FG000|Overall Study|Death|4|||
163107709|NCT05425732|589099927|FG001|Overall Study|Death|2|||
163107710|NCT05425732|589099928|FG002|Overall Study|Death|0|||
163107711|NCT05425732|589099929|FG003|Overall Study|Death|0|||
163107712|NCT05425732|589099926|FG000|Overall Study|Lost to Follow-up|10|||
163107713|NCT05425732|589099927|FG001|Overall Study|Lost to Follow-up|15|||
163107714|NCT05425732|589099928|FG002|Overall Study|Lost to Follow-up|5|||
163107715|NCT05425732|589099929|FG003|Overall Study|Lost to Follow-up|3|||
162719199|NCT00708032|587678433|FG001|Overall Study|Pregnancy|1|||
162719200|NCT00708032|587678432|FG000|Overall Study|Poor vision|0|||
162719201|NCT00708032|587678433|FG001|Overall Study|Poor vision|6|||
163107716|NCT05425732|589099926|FG000|Overall Study|Physician Decision|0|||
163107717|NCT05425732|589099927|FG001|Overall Study|Physician Decision|2|||
163107718|NCT05425732|589099928|FG002|Overall Study|Physician Decision|0|||
163107719|NCT05425732|589099929|FG003|Overall Study|Physician Decision|0|||
163107720|NCT05425732|589099926|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163107721|NCT05425732|589099927|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
163107722|NCT05425732|589099928|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163107723|NCT05425732|589099929|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163107724|NCT05425732|589099926|FG000|Overall Study|Withdrawal by Subject|4|||
163107725|NCT05425732|589099927|FG001|Overall Study|Withdrawal by Subject|8|||
163107726|NCT05425732|589099928|FG002|Overall Study|Withdrawal by Subject|1|||
163107727|NCT05425732|589099929|FG003|Overall Study|Withdrawal by Subject|1|||
163107728|NCT05425732|589099926|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
163107729|NCT05425732|589099927|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107730|NCT05425732|589099928|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107731|NCT05425732|589099929|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
163107732|NCT02582814|589099930|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163107733|NCT02582814|589099931|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163107734|NCT02582814|589099930|FG000|Overall Study|Withdrawal by Subject|4|||
163107735|NCT02582814|589099931|FG001|Overall Study|Withdrawal by Subject|3|||
163107736|NCT02582814|589099930|FG000|Overall Study|Adverse Event|4|||
163107737|NCT02582814|589099931|FG001|Overall Study|Adverse Event|4|||
163107738|NCT01558115|589099935|FG000|Overall Study|Withdrawal by Subject|3|||
163107739|NCT01558115|589099935|FG000|Overall Study|Study closed due to poor enrollment|4|||
163107740|NCT01696994|589099936|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
163107741|NCT01696994|589099937|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
163107742|NCT01696994|589099936|FG000|Overall Study|Died Before Randomization|1|||
163107743|NCT01696994|589099937|FG001|Overall Study|Died Before Randomization|2|||
163107744|NCT01696994|589099936|FG000|Overall Study|Died Before ASU (Control)|73|||
163107745|NCT01696994|589099937|FG001|Overall Study|Died Before ASU (Control)|0|||
163107746|NCT01696994|589099936|FG000|Overall Study|No Ovaries at Baseline|4807|||
163107747|NCT01696994|589099937|FG001|Overall Study|No Ovaries at Baseline|4851|||
163107748|NCT01696994|589099936|FG000|Overall Study|Refused ASU (Control)|311|||
163107749|NCT01696994|589099937|FG001|Overall Study|Refused ASU (Control)|0|||
163107750|NCT01696994|589099936|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
163107751|NCT01696994|589099937|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
163107752|NCT04644276|589099938|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
163107753|NCT04644276|589099939|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
163107754|NCT04644276|589099940|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
163107755|NCT00705250|589099941|FG000|Overall Study|Withdrawal by Subject|1|||
163107756|NCT00705250|589099941|FG000|Overall Study|Patient died in car accident|1|||
163107757|NCT00316225|589099942|FG000|Overall Study|Adverse Event|2|||
163107758|NCT00316225|589099942|FG000|Overall Study|Physician Decision|3|||
163107759|NCT00316225|589099942|FG000|Overall Study|Progressive Disease|15|||
163107760|NCT00316225|589099942|FG000|Overall Study|Withdrawal by Subject|3|||
163107761|NCT00316225|589099942|FG000|Overall Study|Death|2|||
163107762|NCT01814878|589099943|FG000|Overall Study|Adverse Event|16|||
163107763|NCT01814878|589099944|FG001|Overall Study|Adverse Event|5|||
163107764|NCT01814878|589099943|FG000|Overall Study|Withdrawal by Subject|20|||
163107765|NCT01814878|589099944|FG001|Overall Study|Withdrawal by Subject|16|||
163107766|NCT01814878|589099943|FG000|Overall Study|Protocol Violation|5|||
163107767|NCT01814878|589099944|FG001|Overall Study|Protocol Violation|5|||
163107768|NCT01814878|589099943|FG000|Overall Study|Physician Decision|3|||
163107769|NCT01814878|589099944|FG001|Overall Study|Physician Decision|1|||
163107770|NCT01814878|589099943|FG000|Overall Study|Screening failure (drop-out)|0|||
163107771|NCT01814878|589099944|FG001|Overall Study|Screening failure (drop-out)|3|||
163107772|NCT01814878|589099943|FG000|Overall Study|Other|2|||
163107773|NCT01814878|589099944|FG001|Overall Study|Other|0|||
162719202|NCT00708032|587678432|FG000|Overall Study|Visit out of range at month 12|4|||
163107774|NCT01200407|589099947|FG000|Overall Study|Lost to Follow-up|56|||
163107775|NCT01200407|589099947|FG000|Overall Study|Adverse Event|3|||
163107776|NCT01200407|589099947|FG000|Overall Study|Withdrawal by Subject|4|||
163107777|NCT01200407|589099947|FG000|Overall Study|Other|19|||
163107778|NCT00425698|589099948|FG000|Overall Study|Adverse Event|3|||
163107779|NCT00425698|589099949|FG001|Overall Study|Adverse Event|1|||
163107780|NCT00425698|589099948|FG000|Overall Study|Withdrawal by Subject|0|||
163107781|NCT00425698|589099949|FG001|Overall Study|Withdrawal by Subject|1|||
163107782|NCT01126268|589099953|FG000|Overall Study|Adverse Event|1|||
163107783|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
163107784|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
163107785|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
163107786|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
163107787|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163107788|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
163107789|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
163107790|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
163107791|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
163107792|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
163107793|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
163107794|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
163107795|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
163107796|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
163107797|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
163107798|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
163107799|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
163107800|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107801|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107802|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107803|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107804|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107805|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107806|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107807|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107808|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107809|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107810|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107811|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107812|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163107813|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
163107814|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
163107815|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
163107816|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
163107817|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
163107818|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
163107819|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
163107820|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
163107821|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
163107822|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
163107823|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
163107824|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
163107825|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
163107826|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
163107827|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
163107828|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
163107829|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
163107830|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
163107831|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
163107832|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
163107833|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
163107834|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
163107835|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
163107836|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
163107837|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
163107838|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
163107839|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
163107840|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
163107841|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
163107842|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
163107843|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
163107844|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
163107845|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
163107846|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
163107847|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107848|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107849|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107850|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107851|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107852|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107853|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107854|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107855|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107856|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107857|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163107858|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
163107859|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
163107860|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
163107861|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
163107862|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107863|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107864|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107865|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107866|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107867|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107868|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107869|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107870|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107871|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163107872|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
162653746|NCT01203072|587449587|FG000|Overall Study|Lost to Follow-up|0|||
162653747|NCT01203072|587449588|FG001|Overall Study|Lost to Follow-up|1|||
162653748|NCT01203072|587449589|FG002|Overall Study|Lost to Follow-up|0|||
162653749|NCT01203072|587449590|FG003|Overall Study|Lost to Follow-up|0|||
162653750|NCT01203072|587449591|FG004|Overall Study|Lost to Follow-up|0|||
162653751|NCT01203072|587449587|FG000|Overall Study|Protocol Violation|2|||
162653752|NCT01203072|587449588|FG001|Overall Study|Protocol Violation|0|||
162653753|NCT01203072|587449589|FG002|Overall Study|Protocol Violation|0|||
162653754|NCT01203072|587449590|FG003|Overall Study|Protocol Violation|0|||
162653755|NCT01203072|587449591|FG004|Overall Study|Protocol Violation|1|||
162653756|NCT01203072|587449587|FG000|Overall Study|Withdrawal by Subject|2|||
162653757|NCT01203072|587449588|FG001|Overall Study|Withdrawal by Subject|2|||
162653758|NCT01203072|587449589|FG002|Overall Study|Withdrawal by Subject|1|||
163107873|NCT03831191|589099957|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107874|NCT03831191|589099958|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107875|NCT03831191|589099959|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107876|NCT03831191|589099960|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
163107877|NCT03831191|589099961|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107878|NCT03831191|589099962|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107879|NCT03831191|589099963|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107880|NCT03831191|589099964|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107881|NCT03831191|589099965|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107882|NCT03831191|589099966|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107883|NCT03831191|589099967|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107884|NCT03831191|589099968|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107885|NCT03831191|589099969|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107886|NCT03831191|589099970|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107887|NCT03831191|589099971|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
163107888|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107889|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107890|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107891|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
163107892|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107893|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
163107894|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
163107895|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107896|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
163107897|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107898|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
163107899|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
163107900|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107901|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
163107902|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
163107903|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107904|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107905|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107906|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107907|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107908|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107909|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107910|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107911|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107912|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107913|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107914|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107915|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107916|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163107917|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163107918|NCT03831191|589099957|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107919|NCT03831191|589099958|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107920|NCT03831191|589099959|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107921|NCT03831191|589099960|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107922|NCT03831191|589099961|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107923|NCT03831191|589099962|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107924|NCT03831191|589099963|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107925|NCT03831191|589099964|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107926|NCT03831191|589099965|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107927|NCT03831191|589099966|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107928|NCT03831191|589099967|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107929|NCT03831191|589099968|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107930|NCT03831191|589099969|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107931|NCT03831191|589099970|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163107932|NCT03831191|589099971|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
163107933|NCT01626118|589099972|FG000|Overall Study|Lack of Efficacy|1|||
163107934|NCT01626118|589099973|FG001|Overall Study|Lack of Efficacy|0|||
163107935|NCT01626118|589099974|FG002|Overall Study|Lack of Efficacy|1|||
163107936|NCT01626118|589099975|FG003|Overall Study|Lack of Efficacy|3|||
163107937|NCT01626118|589099972|FG000|Overall Study|Lost to Follow-up|1|||
163107938|NCT01626118|589099973|FG001|Overall Study|Lost to Follow-up|0|||
163107939|NCT01626118|589099974|FG002|Overall Study|Lost to Follow-up|0|||
163107940|NCT01626118|589099975|FG003|Overall Study|Lost to Follow-up|0|||
163107941|NCT01626118|589099972|FG000|Overall Study|Adverse Event|0|||
163107942|NCT01626118|589099973|FG001|Overall Study|Adverse Event|1|||
163107943|NCT01626118|589099974|FG002|Overall Study|Adverse Event|1|||
163107944|NCT01626118|589099975|FG003|Overall Study|Adverse Event|0|||
163107945|NCT01626118|589099972|FG000|Overall Study|Investigator Decision|0|||
163107946|NCT01626118|589099973|FG001|Overall Study|Investigator Decision|1|||
163107947|NCT01626118|589099974|FG002|Overall Study|Investigator Decision|0|||
163107948|NCT01626118|589099975|FG003|Overall Study|Investigator Decision|0|||
163107949|NCT00002540|589099976|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
163107950|NCT00002540|589099977|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
163107951|NCT00002540|589099976|FG000|Overall Study|Died Before Randomization|2|||
163107952|NCT00002540|589099977|FG001|Overall Study|Died Before Randomization|6|||
163107953|NCT00002540|589099976|FG000|Overall Study|Died Before ASU (Control)|202|||
163107954|NCT00002540|589099977|FG001|Overall Study|Died Before ASU (Control)|0|||
163107955|NCT00002540|589099976|FG000|Overall Study|Refused ASU (Control)|597|||
163107956|NCT00002540|589099977|FG001|Overall Study|Refused ASU (Control)|0|||
163107957|NCT00002540|589099976|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
163107958|NCT00002540|589099977|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
163107959|NCT02151903|589099978|FG000|Overall Study|Withdrawal by Subject|1|||
163107960|NCT02151903|589099979|FG001|Overall Study|Withdrawal by Subject|0|||
163107961|NCT02151903|589099978|FG000|Overall Study|Progressive disease|2|||
163107962|NCT02151903|589099979|FG001|Overall Study|Progressive disease|1|||
163107963|NCT01864148|589099980|FG000|Overall Study|Other|2|||
163107964|NCT01864148|589099981|FG001|Overall Study|Other|1|||
163107965|NCT01864148|589099982|FG002|Overall Study|Other|1|||
163107966|NCT01864148|589099983|FG003|Overall Study|Other|3|||
163107967|NCT01864148|589099984|FG004|Overall Study|Other|1|||
163107968|NCT01864148|589099980|FG000|Overall Study|Death|0|||
163107969|NCT01864148|589099981|FG001|Overall Study|Death|0|||
163107970|NCT01864148|589099982|FG002|Overall Study|Death|0|||
163107971|NCT01864148|589099983|FG003|Overall Study|Death|1|||
163107972|NCT01864148|589099984|FG004|Overall Study|Death|0|||
163107973|NCT01864148|589099980|FG000|Overall Study|Investigator Decision|5|||
163107974|NCT01864148|589099981|FG001|Overall Study|Investigator Decision|0|||
163107975|NCT01864148|589099982|FG002|Overall Study|Investigator Decision|0|||
163107976|NCT01864148|589099983|FG003|Overall Study|Investigator Decision|4|||
163107977|NCT01864148|589099984|FG004|Overall Study|Investigator Decision|6|||
163107978|NCT01864148|589099980|FG000|Overall Study|Withdrawal by Subject|9|||
163107979|NCT01864148|589099981|FG001|Overall Study|Withdrawal by Subject|2|||
163107980|NCT01864148|589099982|FG002|Overall Study|Withdrawal by Subject|6|||
163107981|NCT01864148|589099983|FG003|Overall Study|Withdrawal by Subject|8|||
163107982|NCT01864148|589099984|FG004|Overall Study|Withdrawal by Subject|8|||
163107983|NCT01864148|589099980|FG000|Overall Study|Lost to Follow-up|0|||
163107984|NCT01864148|589099981|FG001|Overall Study|Lost to Follow-up|0|||
163107985|NCT01864148|589099982|FG002|Overall Study|Lost to Follow-up|0|||
163107986|NCT01864148|589099983|FG003|Overall Study|Lost to Follow-up|2|||
163107987|NCT01864148|589099984|FG004|Overall Study|Lost to Follow-up|1|||
163107988|NCT01864148|589099980|FG000|Overall Study|Adverse Event|4|||
163107989|NCT01864148|589099981|FG001|Overall Study|Adverse Event|2|||
163107990|NCT01864148|589099982|FG002|Overall Study|Adverse Event|4|||
163107991|NCT01864148|589099983|FG003|Overall Study|Adverse Event|7|||
163107992|NCT01864148|589099984|FG004|Overall Study|Adverse Event|7|||
163107993|NCT01864148|589099980|FG000|Overall Study|Not Dosed|0|||
163107994|NCT01864148|589099981|FG001|Overall Study|Not Dosed|0|||
163107995|NCT01864148|589099982|FG002|Overall Study|Not Dosed|0|||
163107996|NCT01864148|589099983|FG003|Overall Study|Not Dosed|1|||
163107997|NCT01864148|589099984|FG004|Overall Study|Not Dosed|0|||
163107998|NCT00778375|589099985|FG000|Overall Study|Ineligible|3|||
163107999|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
163108000|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
163108001|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
163108002|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
163108003|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
163108004|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
163108005|NCT03490292|589099986|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
163108006|NCT03490292|589099987|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
163108007|NCT03490292|589099986|FG000|1 Year Follow Up Post Last Dose|Death|1|||
163108008|NCT03490292|589099987|FG001|1 Year Follow Up Post Last Dose|Death|1|||
163108009|NCT01421303|589099988|FG000|Overall Study|Lost to Follow-up|13|||
163108010|NCT01421303|589099988|FG000|Overall Study|Non compliance with study procedure|1|||
163108011|NCT01421303|589099988|FG000|Overall Study|Other|7|||
163108012|NCT01421303|589099988|FG000|Overall Study|Withdrawal by Subject|1|||
163108013|NCT00582712|589099997|FG000|Overall Study|Adverse Event|1|||
163108014|NCT00582712|589099997|FG000|Overall Study|Lack of Efficacy|1|||
163108015|NCT00582712|589099997|FG000|Overall Study|Withdrawal by Subject|1|||
163108016|NCT00582712|589099997|FG000|Overall Study|Complicating disease requiring treatment|1|||
163108017|NCT03640507|589100001|FG000|Overall Study|Withdrawal by Subject|0|||
163108018|NCT03640507|589100002|FG001|Overall Study|Withdrawal by Subject|0|||
163108019|NCT03640507|589100003|FG002|Overall Study|Withdrawal by Subject|1|||
163108020|NCT03525600|589100004|FG000|Overall Study|Adverse Event|9|||
163108021|NCT03525600|589100005|FG001|Overall Study|Adverse Event|6|||
163108022|NCT03525600|589100006|FG002|Overall Study|Adverse Event|5|||
163108023|NCT03525600|589100007|FG003|Overall Study|Adverse Event|3|||
163108024|NCT03525600|589100004|FG000|Overall Study|Lost to Follow-up|2|||
163108025|NCT03525600|589100005|FG001|Overall Study|Lost to Follow-up|4|||
163108026|NCT03525600|589100006|FG002|Overall Study|Lost to Follow-up|4|||
163108027|NCT03525600|589100007|FG003|Overall Study|Lost to Follow-up|0|||
163108028|NCT03525600|589100004|FG000|Overall Study|Physician Decision|1|||
163108029|NCT03525600|589100005|FG001|Overall Study|Physician Decision|0|||
163108030|NCT03525600|589100006|FG002|Overall Study|Physician Decision|2|||
163108031|NCT03525600|589100007|FG003|Overall Study|Physician Decision|0|||
163108032|NCT03525600|589100004|FG000|Overall Study|Consent withdrawal|36|||
163108033|NCT03525600|589100005|FG001|Overall Study|Consent withdrawal|20|||
163108034|NCT03525600|589100006|FG002|Overall Study|Consent withdrawal|6|||
163108035|NCT03525600|589100007|FG003|Overall Study|Consent withdrawal|13|||
163108036|NCT03525600|589100004|FG000|Overall Study|Death|7|||
163108037|NCT03525600|589100005|FG001|Overall Study|Death|6|||
163108038|NCT03525600|589100006|FG002|Overall Study|Death|4|||
163108039|NCT03525600|589100007|FG003|Overall Study|Death|3|||
163108040|NCT03525600|589100004|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
163108041|NCT03525600|589100005|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
163108042|NCT03525600|589100006|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
163108043|NCT03525600|589100007|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
163108044|NCT03525600|589100004|FG000|Overall Study|Other|0|||
163108045|NCT03525600|589100005|FG001|Overall Study|Other|1|||
163108046|NCT03525600|589100006|FG002|Overall Study|Other|0|||
163108047|NCT03525600|589100007|FG003|Overall Study|Other|0|||
163108048|NCT02676895|589100008|FG000|Overall Study|Administrative reason|1|||
163108049|NCT02676895|589100009|FG001|Overall Study|Administrative reason|0|||
163108050|NCT02676895|589100010|FG002|Overall Study|Administrative reason|0|||
163108051|NCT02676895|589100008|FG000|Overall Study|Protocol Violation|1|||
163108052|NCT02676895|589100009|FG001|Overall Study|Protocol Violation|0|||
163108053|NCT02676895|589100010|FG002|Overall Study|Protocol Violation|0|||
163108054|NCT02676895|589100008|FG000|Overall Study|Adverse Event|0|||
163108055|NCT02676895|589100009|FG001|Overall Study|Adverse Event|3|||
163108056|NCT02676895|589100010|FG002|Overall Study|Adverse Event|1|||
163108057|NCT02676895|589100008|FG000|Overall Study|Lost to Follow-up|0|||
163108058|NCT02676895|589100009|FG001|Overall Study|Lost to Follow-up|0|||
163108059|NCT02676895|589100010|FG002|Overall Study|Lost to Follow-up|1|||
163108060|NCT02676895|589100008|FG000|Overall Study|Withdrawal by Subject|0|||
163108061|NCT02676895|589100009|FG001|Overall Study|Withdrawal by Subject|0|||
163108062|NCT02676895|589100010|FG002|Overall Study|Withdrawal by Subject|1|||
163108063|NCT01270880|589100014|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
163108064|NCT00613327|589100015|FG000|Overall Study|Adverse Event|38|||
163108065|NCT00613327|589100015|FG000|Overall Study|Lost to Follow-up|8|||
163108066|NCT00613327|589100015|FG000|Overall Study|Withdrawal by Subject|6|||
163108067|NCT00613327|589100015|FG000|Overall Study|Protocol Violation|2|||
163108068|NCT00613327|589100015|FG000|Overall Study|Other|47|||
163108069|NCT00344318|589100016|FG000|Overall Study|Adverse Event|0|||
163108070|NCT00344318|589100017|FG001|Overall Study|Adverse Event|3|||
163108071|NCT00344318|589100018|FG002|Overall Study|Adverse Event|0|||
163108072|NCT00344318|589100019|FG003|Overall Study|Adverse Event|1|||
163108073|NCT00344318|589100016|FG000|Overall Study|Withdrawal by Subject|2|||
163108074|NCT00344318|589100017|FG001|Overall Study|Withdrawal by Subject|2|||
163108075|NCT00344318|589100018|FG002|Overall Study|Withdrawal by Subject|0|||
163108076|NCT00344318|589100019|FG003|Overall Study|Withdrawal by Subject|2|||
163108077|NCT00344318|589100016|FG000|Overall Study|Lost to Follow-up|2|||
163108078|NCT00344318|589100017|FG001|Overall Study|Lost to Follow-up|0|||
163108079|NCT00344318|589100018|FG002|Overall Study|Lost to Follow-up|1|||
162653759|NCT01203072|587449590|FG003|Overall Study|Withdrawal by Subject|2|||
162653760|NCT01203072|587449591|FG004|Overall Study|Withdrawal by Subject|3|||
162653761|NCT00235872|587449592|FG000|Overall Study|Adverse Event|34|||
162653762|NCT00235872|587449592|FG000|Overall Study|Death|1|||
162653763|NCT00235872|587449592|FG000|Overall Study|Lost to Follow-up|1|||
163108080|NCT00344318|589100019|FG003|Overall Study|Lost to Follow-up|0|||
163108081|NCT00395486|589100025|FG000|Overall Study|Adverse Event|1|||
163108082|NCT00395486|589100026|FG001|Overall Study|Adverse Event|2|||
163108083|NCT00395486|589100025|FG000|Overall Study|Withdrawal by Subject|5|||
162653764|NCT00235872|587449592|FG000|Overall Study|Withdrawal by Subject|50|||
163108084|NCT00395486|589100026|FG001|Overall Study|Withdrawal by Subject|2|||
163108085|NCT00395486|589100025|FG000|Overall Study|Lost to Follow-up|0|||
163108086|NCT00395486|589100026|FG001|Overall Study|Lost to Follow-up|1|||
163108087|NCT00290771|589100033|FG000|Overall Study|Disease progression|95|||
163108088|NCT00290771|589100034|FG001|Overall Study|Disease progression|73|||
163108089|NCT00290771|589100033|FG000|Overall Study|Death|11|||
163108090|NCT00290771|589100034|FG001|Overall Study|Death|10|||
163108091|NCT00290771|589100033|FG000|Overall Study|Adverse Event|12|||
163108092|NCT00290771|589100034|FG001|Overall Study|Adverse Event|6|||
163108093|NCT00290771|589100033|FG000|Overall Study|Withdrawal by Subject|5|||
163108094|NCT00290771|589100034|FG001|Overall Study|Withdrawal by Subject|6|||
163108095|NCT00290771|589100033|FG000|Overall Study|Administrative problems|2|||
163108096|NCT00290771|589100034|FG001|Overall Study|Administrative problems|1|||
163108097|NCT00290771|589100033|FG000|Overall Study|Protocol Violation|2|||
163108098|NCT00290771|589100034|FG001|Overall Study|Protocol Violation|0|||
163108099|NCT00290771|589100033|FG000|Overall Study|Lost to Follow-up|0|||
163108100|NCT00290771|589100034|FG001|Overall Study|Lost to Follow-up|1|||
162653765|NCT00235872|587449592|FG000|Overall Study|Administrative reason|61|||
162653766|NCT00116558|587449593|FG000|Overall Study|Death|11|||
162653767|NCT00116558|587449594|FG001|Overall Study|Death|5|||
163108101|NCT04154293|589100037|FG000|Overall Study|Withdrawal by Subject|2|||
162653768|NCT00116558|587449595|FG002|Overall Study|Death|3|||
163108102|NCT04154293|589100038|FG001|Overall Study|Withdrawal by Subject|3|||
163108103|NCT04154293|589100039|FG002|Overall Study|Withdrawal by Subject|1|||
163108104|NCT04154293|589100037|FG000|Overall Study|Physician Decision|0|||
163108105|NCT04154293|589100038|FG001|Overall Study|Physician Decision|0|||
163108106|NCT04154293|589100039|FG002|Overall Study|Physician Decision|1|||
163108107|NCT04731298|589100040|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
163108108|NCT04731298|589100041|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
163108109|NCT01208961|589100042|FG000|High-Fat Period III|Protocol Violation|1|||
163108110|NCT01208961|589100043|FG001|High-Fat Period III|Protocol Violation|0|||
163108111|NCT01262560|589100044|FG000|Overall Study|Protocol Violation|0|||
163108112|NCT01262560|589100045|FG001|Overall Study|Protocol Violation|1|||
163108113|NCT01262560|589100046|FG002|Overall Study|Protocol Violation|2|||
163108114|NCT00350870|589100049|FG000|Overall Study|Withdrawal by Subject|21|||
163108115|NCT00350870|589100050|FG001|Overall Study|Withdrawal by Subject|17|||
163108116|NCT00350870|589100051|FG002|Overall Study|Withdrawal by Subject|15|||
163108117|NCT00350870|589100052|FG003|Overall Study|Withdrawal by Subject|14|||
163108118|NCT00350870|589100049|FG000|Overall Study|Physician Decision|1|||
163108119|NCT00350870|589100050|FG001|Overall Study|Physician Decision|0|||
163108120|NCT00350870|589100051|FG002|Overall Study|Physician Decision|1|||
163108121|NCT00350870|589100052|FG003|Overall Study|Physician Decision|1|||
163108122|NCT02095873|589100055|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163108123|NCT02095873|589100056|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163108124|NCT02095873|589100055|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
163108125|NCT02095873|589100056|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
163108126|NCT02095873|589100055|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
163108127|NCT02095873|589100056|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
163108128|NCT02791516|589100061|FG000|Overall Study|Withdrawal by Subject|1|||
163108129|NCT02791516|589100062|FG001|Overall Study|Withdrawal by Subject|1|||
163108130|NCT02524275|589100063|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
163108131|NCT01439971|589100064|FG000|Overall Study|Required number in cohort dosed|0|||
163108132|NCT01439971|589100065|FG001|Overall Study|Required number in cohort dosed|1|||
163108133|NCT01439971|589100066|FG002|Overall Study|Required number in cohort dosed|2|||
163108134|NCT01439971|589100067|FG003|Overall Study|Required number in cohort dosed|0|||
163108135|NCT01439971|589100068|FG004|Overall Study|Required number in cohort dosed|1|||
163108136|NCT02628600|589100069|FG000|Overall Study|Death|2|||
163108137|NCT02628600|589100070|FG001|Overall Study|Death|1|||
163108138|NCT02628600|589100069|FG000|Overall Study|Adverse Event|3|||
163108139|NCT02628600|589100070|FG001|Overall Study|Adverse Event|20|||
163108140|NCT02628600|589100069|FG000|Overall Study|Protocol Violation|0|||
163108141|NCT02628600|589100070|FG001|Overall Study|Protocol Violation|1|||
163108142|NCT02628600|589100069|FG000|Overall Study|Lack of Efficacy|2|||
163108143|NCT02628600|589100070|FG001|Overall Study|Lack of Efficacy|0|||
163108144|NCT02628600|589100069|FG000|Overall Study|Withdrawal by Subject|13|||
163108145|NCT02628600|589100070|FG001|Overall Study|Withdrawal by Subject|8|||
163108146|NCT02628600|589100069|FG000|Overall Study|Lost to Follow-up|1|||
163108147|NCT02628600|589100070|FG001|Overall Study|Lost to Follow-up|0|||
163108148|NCT02628600|589100069|FG000|Overall Study|Physician Decision|2|||
163108149|NCT02628600|589100070|FG001|Overall Study|Physician Decision|2|||
163108150|NCT02628600|589100069|FG000|Overall Study|Other not specified|1|||
163108151|NCT02628600|589100070|FG001|Overall Study|Other not specified|0|||
163108152|NCT03110029|589100075|FG000|Overall Study|Withdrawal by Subject|1|||
163108153|NCT03110029|589100076|FG001|Overall Study|Withdrawal by Subject|1|||
163108154|NCT00511433|589102931|FG000|Overall Study|Adverse Event|5|||
163108155|NCT00511433|589102932|FG001|Overall Study|Adverse Event|0|||
163108156|NCT00511433|589102931|FG000|Overall Study|Other Reason|1|||
163108157|NCT00511433|589102932|FG001|Overall Study|Other Reason|1|||
163108158|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
163108159|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
163108160|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
163108161|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
163108162|NCT00197145|589102933|FG000|Period 1: Randomized Treatment Phase|Other|2|||
163108163|NCT00197145|589102934|FG001|Period 1: Randomized Treatment Phase|Other|2|||
163108164|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
163108165|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
163108166|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
163108167|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
163108168|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
163108169|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
163108170|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
163108171|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
163108172|NCT00197145|589102933|FG000|Period 2 : Open Label Phase|Other|1|||
163108173|NCT00197145|589102934|FG001|Period 2 : Open Label Phase|Other|0|||
163108174|NCT00790868|589102935|FG000|Overall Study|Withdrawal by Subject|4|||
163108175|NCT00790868|589102936|FG001|Overall Study|Withdrawal by Subject|5|||
163108176|NCT00790868|589102935|FG000|Overall Study|Lost to Follow-up|2|||
163108177|NCT00790868|589102936|FG001|Overall Study|Lost to Follow-up|12|||
163108178|NCT02867813|589102937|FG000|Overall Study|Withdrawal by Subject|57|||
163108179|NCT02867813|589102938|FG001|Overall Study|Withdrawal by Subject|56|||
163108180|NCT02867813|589102937|FG000|Overall Study|Decision by Sponsor|7|||
163108181|NCT02867813|589102938|FG001|Overall Study|Decision by Sponsor|7|||
163108182|NCT02867813|589102937|FG000|Overall Study|Lost to Follow-up|91|||
163108183|NCT02867813|589102938|FG001|Overall Study|Lost to Follow-up|78|||
163108184|NCT02867813|589102937|FG000|Overall Study|Missing|2|||
163108185|NCT02867813|589102938|FG001|Overall Study|Missing|1|||
163108186|NCT02867813|589102937|FG000|Overall Study|Death|294|||
163108187|NCT02867813|589102938|FG001|Overall Study|Death|268|||
163108188|NCT01952665|589102942|FG000|Overall Study|Physician Decision|3|||
163108189|NCT01952665|589102943|FG001|Overall Study|Physician Decision|2|||
163108190|NCT01952665|589102942|FG000|Overall Study|Lost to Follow-up|1|||
163108191|NCT01952665|589102943|FG001|Overall Study|Lost to Follow-up|2|||
163108192|NCT01952665|589102942|FG000|Overall Study|Adverse Event|2|||
163108193|NCT01952665|589102943|FG001|Overall Study|Adverse Event|1|||
163108194|NCT01952665|589102942|FG000|Overall Study|Protocol Violation|0|||
163108195|NCT01952665|589102943|FG001|Overall Study|Protocol Violation|1|||
163108196|NCT02578680|589102944|FG000|Overall Study|Death|329|||
163108197|NCT02578680|589102945|FG001|Overall Study|Death|181|||
163108198|NCT02578680|589102944|FG000|Overall Study|Lost to Follow-up|3|||
163108199|NCT02578680|589102945|FG001|Overall Study|Lost to Follow-up|1|||
163108200|NCT02578680|589102944|FG000|Overall Study|Physician Decision|0|||
163108201|NCT02578680|589102945|FG001|Overall Study|Physician Decision|1|||
163108202|NCT02578680|589102944|FG000|Overall Study|Protocol Violation|1|||
163108203|NCT02578680|589102945|FG001|Overall Study|Protocol Violation|1|||
163108204|NCT02578680|589102944|FG000|Overall Study|Sponsor Decision|64|||
163108205|NCT02578680|589102945|FG001|Overall Study|Sponsor Decision|13|||
163108206|NCT02578680|589102944|FG000|Overall Study|Withdrawal by Subject|13|||
163108207|NCT02578680|589102945|FG001|Overall Study|Withdrawal by Subject|9|||
163108208|NCT02596958|589102947|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
163108209|NCT02596958|589102947|FG000|Overall Study|Cancer Progression|441|||
163108210|NCT02596958|589102947|FG000|Overall Study|Death From Cancer|112|||
163108211|NCT02596958|589102947|FG000|Overall Study|Death From Other Cause|33|||
163108212|NCT02596958|589102947|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
163108213|NCT02596958|589102947|FG000|Overall Study|Administrative Reasons/Other|231|||
163108214|NCT02596958|589102947|FG000|Overall Study|Lost to Follow-up|33|||
163108215|NCT02596958|589102947|FG000|Overall Study|Missing|32|||
163108216|NCT02596958|589102947|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
163108217|NCT01559259|589102948|FG000|Overall Study|Withdrawal by Subject|0|||
163108218|NCT01559259|589102949|FG001|Overall Study|Withdrawal by Subject|0|||
163108219|NCT01559259|589102950|FG002|Overall Study|Withdrawal by Subject|0|||
163108220|NCT01559259|589102951|FG003|Overall Study|Withdrawal by Subject|1|||
163108221|NCT01559259|589102952|FG004|Overall Study|Withdrawal by Subject|0|||
163108222|NCT01559259|589102948|FG000|Overall Study|Adverse Event|0|||
163108223|NCT01559259|589102949|FG001|Overall Study|Adverse Event|1|||
163108224|NCT01559259|589102950|FG002|Overall Study|Adverse Event|1|||
163108225|NCT01559259|589102951|FG003|Overall Study|Adverse Event|0|||
163108226|NCT01559259|589102952|FG004|Overall Study|Adverse Event|0|||
163108227|NCT01995669|589102953|FG000|Overall Study|Progression|2|||
163108228|NCT01995669|589102954|FG001|Overall Study|Progression|1|||
163108229|NCT01995669|589102955|FG002|Overall Study|Progression|1|||
163108230|NCT01995669|589102956|FG003|Overall Study|Progression|13|||
163108231|NCT01995669|589102953|FG000|Overall Study|Adverse Event|0|||
163108232|NCT01995669|589102954|FG001|Overall Study|Adverse Event|0|||
163108233|NCT01995669|589102955|FG002|Overall Study|Adverse Event|0|||
163108234|NCT01995669|589102956|FG003|Overall Study|Adverse Event|3|||
163108235|NCT01995669|589102953|FG000|Overall Study|Death|0|||
163108236|NCT01995669|589102954|FG001|Overall Study|Death|0|||
163108237|NCT01995669|589102955|FG002|Overall Study|Death|0|||
163108238|NCT01995669|589102956|FG003|Overall Study|Death|6|||
163108239|NCT01995669|589102953|FG000|Overall Study|Withdrawal by Subject|0|||
163108240|NCT01995669|589102954|FG001|Overall Study|Withdrawal by Subject|0|||
163108241|NCT01995669|589102955|FG002|Overall Study|Withdrawal by Subject|0|||
163108242|NCT01995669|589102956|FG003|Overall Study|Withdrawal by Subject|6|||
163108243|NCT01995669|589102953|FG000|Overall Study|Insurance Expired|0|||
163108244|NCT01995669|589102954|FG001|Overall Study|Insurance Expired|0|||
163108245|NCT01995669|589102955|FG002|Overall Study|Insurance Expired|0|||
163108246|NCT01995669|589102956|FG003|Overall Study|Insurance Expired|1|||
163108247|NCT03727646|589102957|FG000|Overall Study|Adverse Event|1|||
163108248|NCT03727646|589102958|FG001|Overall Study|Adverse Event|0|||
163108249|NCT05659719|589102959|FG000|Overall Study|At sponsor's request|0|||
163108250|NCT05659719|589102960|FG001|Overall Study|At sponsor's request|0|||
163108251|NCT05659719|589102961|FG002|Overall Study|At sponsor's request|0|||
163108252|NCT05659719|589102962|FG003|Overall Study|At sponsor's request|95|||
163108253|NCT05659719|589102959|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108254|NCT05659719|589102960|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108255|NCT05659719|589102961|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
163108256|NCT05659719|589102962|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
163108257|NCT05659719|589102959|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
163108258|NCT05659719|589102960|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
163108259|NCT05659719|589102961|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
163108260|NCT05659719|589102962|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
163108261|NCT05659719|589102959|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108262|NCT05659719|589102960|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108263|NCT05659719|589102961|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
163108264|NCT05659719|589102962|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
163108265|NCT05659719|589102959|FG000|Overall Study|Lost to Follow-up|0|||
163108266|NCT05659719|589102960|FG001|Overall Study|Lost to Follow-up|0|||
163108267|NCT05659719|589102961|FG002|Overall Study|Lost to Follow-up|0|||
163108268|NCT05659719|589102962|FG003|Overall Study|Lost to Follow-up|2|||
163108269|NCT05659719|589102959|FG000|Overall Study|Moved to another observational study|0|||
163108270|NCT05659719|589102960|FG001|Overall Study|Moved to another observational study|0|||
163108271|NCT05659719|589102961|FG002|Overall Study|Moved to another observational study|0|||
163108272|NCT05659719|589102962|FG003|Overall Study|Moved to another observational study|1|||
163108273|NCT05659719|589102959|FG000|Overall Study|The child was enrolled in an interventional study|0|||
163108274|NCT05659719|589102960|FG001|Overall Study|The child was enrolled in an interventional study|0|||
163108275|NCT05659719|589102961|FG002|Overall Study|The child was enrolled in an interventional study|0|||
163108276|NCT05659719|589102962|FG003|Overall Study|The child was enrolled in an interventional study|55|||
163108277|NCT05659719|589102959|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108278|NCT05659719|589102960|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108279|NCT05659719|589102961|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163108280|NCT05659719|589102962|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
163108281|NCT05659719|589102959|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108282|NCT05659719|589102960|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108283|NCT05659719|589102961|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
163108284|NCT05659719|589102962|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
163108285|NCT02290691|589102966|FG000|Overall Study|Noncompliance|0|||
163108286|NCT02290691|589102967|FG001|Overall Study|Noncompliance|1|||
163108287|NCT02290691|589102966|FG000|Overall Study|Withdrawal by Subject|1|||
163108288|NCT02290691|589102967|FG001|Overall Study|Withdrawal by Subject|1|||
163108289|NCT02290691|589102966|FG000|Overall Study|Lost to Follow-up|7|||
163108290|NCT02290691|589102967|FG001|Overall Study|Lost to Follow-up|7|||
163108291|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
163108292|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
163108293|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
163108294|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
163108295|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
163108296|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
163108297|NCT00306293|589102969|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
163108298|NCT00306293|589102970|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
163108299|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
163108300|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
163108301|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
163108302|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
163108303|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
163108304|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
163108305|NCT00306293|589102969|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
163108306|NCT00306293|589102970|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
163108307|NCT00185380|589102973|FG000|Overall Study|Adverse Event|41|||
163108308|NCT00185380|589102974|FG001|Overall Study|Adverse Event|43|||
163108309|NCT00185380|589102975|FG002|Overall Study|Adverse Event|48|||
163108310|NCT00185380|589102973|FG000|Overall Study|Lost to Follow-up|0|||
163108311|NCT00185380|589102974|FG001|Overall Study|Lost to Follow-up|4|||
163108312|NCT00185380|589102975|FG002|Overall Study|Lost to Follow-up|3|||
163108313|NCT00185380|589102973|FG000|Overall Study|Pregnancy|1|||
163108314|NCT00185380|589102974|FG001|Overall Study|Pregnancy|4|||
163108315|NCT00185380|589102975|FG002|Overall Study|Pregnancy|0|||
163108316|NCT00185380|589102973|FG000|Overall Study|Protocol Violation|2|||
163108317|NCT00185380|589102974|FG001|Overall Study|Protocol Violation|2|||
162653769|NCT00116558|587449593|FG000|Overall Study|Withdrawal by Subject|17|||
163108318|NCT00185380|589102975|FG002|Overall Study|Protocol Violation|1|||
163108319|NCT00185380|589102973|FG000|Overall Study|Withdrawal by Subject|1|||
163108320|NCT00185380|589102974|FG001|Overall Study|Withdrawal by Subject|2|||
163108321|NCT00185380|589102975|FG002|Overall Study|Withdrawal by Subject|0|||
163108322|NCT00185380|589102973|FG000|Overall Study|Failed insertion|1|||
163108323|NCT00185380|589102974|FG001|Overall Study|Failed insertion|1|||
163108324|NCT00185380|589102975|FG002|Overall Study|Failed insertion|2|||
163108325|NCT00185380|589102973|FG000|Overall Study|Planned pregnancy|9|||
163108326|NCT00185380|589102974|FG001|Overall Study|Planned pregnancy|12|||
163108327|NCT00185380|589102975|FG002|Overall Study|Planned pregnancy|12|||
163108328|NCT00185380|589102973|FG000|Overall Study|No need for contraception|3|||
163108329|NCT00185380|589102974|FG001|Overall Study|No need for contraception|3|||
163108330|NCT00185380|589102975|FG002|Overall Study|No need for contraception|3|||
163108331|NCT00185380|589102973|FG000|Overall Study|Could not attend visits|2|||
163108332|NCT00185380|589102974|FG001|Overall Study|Could not attend visits|0|||
163108333|NCT00185380|589102975|FG002|Overall Study|Could not attend visits|4|||
163108334|NCT00185380|589102973|FG000|Overall Study|personal reason|6|||
163108335|NCT00185380|589102974|FG001|Overall Study|personal reason|1|||
163108336|NCT00185380|589102975|FG002|Overall Study|personal reason|1|||
163108337|NCT00218634|589102976|FG000|Overall Study|Lost to Follow-up|8|||
163108338|NCT00218634|589102977|FG001|Overall Study|Lost to Follow-up|15|||
163108339|NCT02589665|589102978|FG000|Induction Period|Did not receive drug|0|||
163108340|NCT02589665|589102979|FG001|Induction Period|Did not receive drug|0|||
163108341|NCT02589665|589102980|FG002|Induction Period|Did not receive drug|0|||
163108342|NCT02589665|589102981|FG003|Induction Period|Did not receive drug|1|||
163108343|NCT02589665|589102982|FG004|Induction Period|Did not receive drug|0|||
163108344|NCT02589665|589102983|FG005|Induction Period|Did not receive drug|0|||
163108345|NCT02589665|589102984|FG006|Induction Period|Did not receive drug|0|||
163108346|NCT02589665|589102985|FG007|Induction Period|Did not receive drug|0|||
163108347|NCT02589665|589102986|FG008|Induction Period|Did not receive drug|0|||
163108348|NCT02589665|589102987|FG009|Induction Period|Did not receive drug|0|||
163108349|NCT02589665|589102978|FG000|Induction Period|Adverse Event|3|||
163108350|NCT02589665|589102979|FG001|Induction Period|Adverse Event|0|||
163108351|NCT02589665|589102980|FG002|Induction Period|Adverse Event|2|||
163108352|NCT02589665|589102981|FG003|Induction Period|Adverse Event|2|||
163108353|NCT02589665|589102982|FG004|Induction Period|Adverse Event|0|||
163108354|NCT02589665|589102983|FG005|Induction Period|Adverse Event|0|||
163108355|NCT02589665|589102984|FG006|Induction Period|Adverse Event|0|||
163108356|NCT02589665|589102985|FG007|Induction Period|Adverse Event|0|||
163108357|NCT02589665|589102986|FG008|Induction Period|Adverse Event|0|||
163108358|NCT02589665|589102987|FG009|Induction Period|Adverse Event|0|||
163108359|NCT02589665|589102978|FG000|Induction Period|Withdrawal by Subject|0|||
163108360|NCT02589665|589102979|FG001|Induction Period|Withdrawal by Subject|1|||
163108361|NCT02589665|589102980|FG002|Induction Period|Withdrawal by Subject|0|||
163108362|NCT02589665|589102981|FG003|Induction Period|Withdrawal by Subject|1|||
163108363|NCT02589665|589102982|FG004|Induction Period|Withdrawal by Subject|0|||
162653770|NCT00116558|587449594|FG001|Overall Study|Withdrawal by Subject|3|||
162653771|NCT00116558|587449595|FG002|Overall Study|Withdrawal by Subject|12|||
162653772|NCT00116558|587449593|FG000|Overall Study|disease progression|3|||
162653773|NCT00116558|587449594|FG001|Overall Study|disease progression|7|||
162653774|NCT00116558|587449595|FG002|Overall Study|disease progression|18|||
162653775|NCT02027844|587449596|FG000|Overall Study|Withdrawal by Subject|3|||
162653776|NCT02027844|587449597|FG001|Overall Study|Withdrawal by Subject|2|||
162653777|NCT02027844|587449598|FG002|Overall Study|Withdrawal by Subject|1|||
162719203|NCT00708032|587678433|FG001|Overall Study|Visit out of range at month 12|1|||
163108364|NCT02589665|589102983|FG005|Induction Period|Withdrawal by Subject|0|||
163108365|NCT02589665|589102984|FG006|Induction Period|Withdrawal by Subject|0|||
163108366|NCT02589665|589102985|FG007|Induction Period|Withdrawal by Subject|0|||
163108367|NCT02589665|589102986|FG008|Induction Period|Withdrawal by Subject|0|||
163108368|NCT02589665|589102987|FG009|Induction Period|Withdrawal by Subject|0|||
163108369|NCT02589665|589102978|FG000|Induction Period|Protocol Violation|0|||
163108370|NCT02589665|589102979|FG001|Induction Period|Protocol Violation|1|||
163108371|NCT02589665|589102980|FG002|Induction Period|Protocol Violation|0|||
162653778|NCT02027844|587449596|FG000|Overall Study|Lost to Follow-up|0|||
163108372|NCT02589665|589102981|FG003|Induction Period|Protocol Violation|0|||
163108373|NCT02589665|589102982|FG004|Induction Period|Protocol Violation|0|||
163108374|NCT02589665|589102983|FG005|Induction Period|Protocol Violation|0|||
163108375|NCT02589665|589102984|FG006|Induction Period|Protocol Violation|0|||
163108376|NCT02589665|589102985|FG007|Induction Period|Protocol Violation|0|||
163108377|NCT02589665|589102986|FG008|Induction Period|Protocol Violation|0|||
163108378|NCT02589665|589102987|FG009|Induction Period|Protocol Violation|0|||
163108379|NCT02589665|589102978|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108380|NCT02589665|589102979|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108381|NCT02589665|589102980|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108382|NCT02589665|589102981|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108383|NCT02589665|589102982|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
163108384|NCT02589665|589102983|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
163108385|NCT02589665|589102984|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
163108386|NCT02589665|589102985|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108387|NCT02589665|589102986|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108388|NCT02589665|589102987|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108389|NCT02589665|589102978|FG000|Maintenance Period|Withdrawal by Subject|0|||
163108390|NCT02589665|589102979|FG001|Maintenance Period|Withdrawal by Subject|0|||
163108391|NCT02589665|589102980|FG002|Maintenance Period|Withdrawal by Subject|0|||
163108392|NCT02589665|589102981|FG003|Maintenance Period|Withdrawal by Subject|0|||
163108393|NCT02589665|589102982|FG004|Maintenance Period|Withdrawal by Subject|4|||
163108394|NCT02589665|589102983|FG005|Maintenance Period|Withdrawal by Subject|2|||
163108395|NCT02589665|589102984|FG006|Maintenance Period|Withdrawal by Subject|4|||
163108396|NCT02589665|589102985|FG007|Maintenance Period|Withdrawal by Subject|0|||
163108397|NCT02589665|589102986|FG008|Maintenance Period|Withdrawal by Subject|0|||
163108398|NCT02589665|589102987|FG009|Maintenance Period|Withdrawal by Subject|0|||
163108399|NCT02589665|589102978|FG000|Maintenance Period|Lack of Efficacy|0|||
163108400|NCT02589665|589102979|FG001|Maintenance Period|Lack of Efficacy|0|||
163108401|NCT02589665|589102980|FG002|Maintenance Period|Lack of Efficacy|0|||
163108402|NCT02589665|589102981|FG003|Maintenance Period|Lack of Efficacy|0|||
163108403|NCT02589665|589102982|FG004|Maintenance Period|Lack of Efficacy|2|||
163108404|NCT02589665|589102983|FG005|Maintenance Period|Lack of Efficacy|1|||
163108405|NCT02589665|589102984|FG006|Maintenance Period|Lack of Efficacy|0|||
163108406|NCT02589665|589102985|FG007|Maintenance Period|Lack of Efficacy|0|||
163108407|NCT02589665|589102986|FG008|Maintenance Period|Lack of Efficacy|0|||
163108408|NCT02589665|589102987|FG009|Maintenance Period|Lack of Efficacy|0|||
163108409|NCT02589665|589102978|FG000|Maintenance Period|Adverse Event|0|||
163108410|NCT02589665|589102979|FG001|Maintenance Period|Adverse Event|0|||
163108411|NCT02589665|589102980|FG002|Maintenance Period|Adverse Event|0|||
163108412|NCT02589665|589102981|FG003|Maintenance Period|Adverse Event|0|||
163108413|NCT02589665|589102982|FG004|Maintenance Period|Adverse Event|0|||
163108414|NCT02589665|589102983|FG005|Maintenance Period|Adverse Event|0|||
163108415|NCT02589665|589102984|FG006|Maintenance Period|Adverse Event|2|||
163108416|NCT02589665|589102985|FG007|Maintenance Period|Adverse Event|0|||
163108417|NCT02589665|589102986|FG008|Maintenance Period|Adverse Event|0|||
163108418|NCT02589665|589102987|FG009|Maintenance Period|Adverse Event|0|||
163108419|NCT02589665|589102978|FG000|Maintenance Period|Lost to Follow-up|0|||
163108420|NCT02589665|589102979|FG001|Maintenance Period|Lost to Follow-up|0|||
163108421|NCT02589665|589102980|FG002|Maintenance Period|Lost to Follow-up|0|||
163108422|NCT02589665|589102981|FG003|Maintenance Period|Lost to Follow-up|0|||
163108423|NCT02589665|589102982|FG004|Maintenance Period|Lost to Follow-up|0|||
163108424|NCT02589665|589102983|FG005|Maintenance Period|Lost to Follow-up|1|||
163108425|NCT02589665|589102984|FG006|Maintenance Period|Lost to Follow-up|0|||
163108426|NCT02589665|589102985|FG007|Maintenance Period|Lost to Follow-up|0|||
163108427|NCT02589665|589102986|FG008|Maintenance Period|Lost to Follow-up|0|||
163108428|NCT02589665|589102987|FG009|Maintenance Period|Lost to Follow-up|0|||
162653779|NCT02027844|587449597|FG001|Overall Study|Lost to Follow-up|2|||
162653780|NCT02027844|587449598|FG002|Overall Study|Lost to Follow-up|1|||
162653781|NCT02027844|587449596|FG000|Overall Study|Protocol Violation|0|||
162653782|NCT02027844|587449597|FG001|Overall Study|Protocol Violation|2|||
162653783|NCT02027844|587449598|FG002|Overall Study|Protocol Violation|0|||
162653784|NCT02027844|587449596|FG000|Overall Study|Incomlete data|2|||
163108429|NCT02589665|589102978|FG000|Maintenance Period|Physician Decision|0|||
163108430|NCT02589665|589102979|FG001|Maintenance Period|Physician Decision|0|||
163108431|NCT02589665|589102980|FG002|Maintenance Period|Physician Decision|0|||
162653785|NCT02027844|587449597|FG001|Overall Study|Incomlete data|0|||
163108432|NCT02589665|589102981|FG003|Maintenance Period|Physician Decision|0|||
163108433|NCT02589665|589102982|FG004|Maintenance Period|Physician Decision|0|||
163108434|NCT02589665|589102983|FG005|Maintenance Period|Physician Decision|1|||
163108435|NCT02589665|589102984|FG006|Maintenance Period|Physician Decision|0|||
163108436|NCT02589665|589102985|FG007|Maintenance Period|Physician Decision|0|||
163108437|NCT02589665|589102986|FG008|Maintenance Period|Physician Decision|0|||
163108438|NCT02589665|589102987|FG009|Maintenance Period|Physician Decision|0|||
163108439|NCT02589665|589102978|FG000|Maintenance Period|Reason Not Collected|0|||
163108440|NCT02589665|589102979|FG001|Maintenance Period|Reason Not Collected|0|||
163108441|NCT02589665|589102980|FG002|Maintenance Period|Reason Not Collected|0|||
163108442|NCT02589665|589102981|FG003|Maintenance Period|Reason Not Collected|0|||
163108443|NCT02589665|589102982|FG004|Maintenance Period|Reason Not Collected|0|||
163108444|NCT02589665|589102983|FG005|Maintenance Period|Reason Not Collected|1|||
163108445|NCT02589665|589102984|FG006|Maintenance Period|Reason Not Collected|1|||
163108446|NCT02589665|589102985|FG007|Maintenance Period|Reason Not Collected|0|||
163108447|NCT02589665|589102986|FG008|Maintenance Period|Reason Not Collected|0|||
163108448|NCT02589665|589102987|FG009|Maintenance Period|Reason Not Collected|0|||
163108449|NCT02589665|589102978|FG000|Induction Extension Period|Adverse Event|0|||
163108450|NCT02589665|589102979|FG001|Induction Extension Period|Adverse Event|0|||
163108451|NCT02589665|589102980|FG002|Induction Extension Period|Adverse Event|0|||
163108452|NCT02589665|589102981|FG003|Induction Extension Period|Adverse Event|0|||
163108453|NCT02589665|589102982|FG004|Induction Extension Period|Adverse Event|0|||
163108454|NCT02589665|589102983|FG005|Induction Extension Period|Adverse Event|0|||
163108455|NCT02589665|589102984|FG006|Induction Extension Period|Adverse Event|0|||
163108456|NCT02589665|589102985|FG007|Induction Extension Period|Adverse Event|0|||
163108457|NCT02589665|589102986|FG008|Induction Extension Period|Adverse Event|4|||
163108458|NCT02589665|589102987|FG009|Induction Extension Period|Adverse Event|0|||
163108459|NCT02589665|589102978|FG000|Induction Extension Period|Lack of Efficacy|0|||
163108460|NCT02589665|589102979|FG001|Induction Extension Period|Lack of Efficacy|0|||
163108461|NCT02589665|589102980|FG002|Induction Extension Period|Lack of Efficacy|0|||
163108462|NCT02589665|589102981|FG003|Induction Extension Period|Lack of Efficacy|0|||
163108463|NCT02589665|589102982|FG004|Induction Extension Period|Lack of Efficacy|0|||
163108464|NCT02589665|589102983|FG005|Induction Extension Period|Lack of Efficacy|0|||
163108465|NCT02589665|589102984|FG006|Induction Extension Period|Lack of Efficacy|0|||
163108466|NCT02589665|589102985|FG007|Induction Extension Period|Lack of Efficacy|0|||
163108467|NCT02589665|589102986|FG008|Induction Extension Period|Lack of Efficacy|3|||
163108468|NCT02589665|589102987|FG009|Induction Extension Period|Lack of Efficacy|0|||
163108469|NCT02589665|589102978|FG000|Induction Extension Period|Withdrawal by Subject|0|||
163108470|NCT02589665|589102979|FG001|Induction Extension Period|Withdrawal by Subject|0|||
163108471|NCT02589665|589102980|FG002|Induction Extension Period|Withdrawal by Subject|0|||
163108472|NCT02589665|589102981|FG003|Induction Extension Period|Withdrawal by Subject|0|||
163108473|NCT02589665|589102982|FG004|Induction Extension Period|Withdrawal by Subject|0|||
163108474|NCT02589665|589102983|FG005|Induction Extension Period|Withdrawal by Subject|0|||
163108475|NCT02589665|589102984|FG006|Induction Extension Period|Withdrawal by Subject|0|||
163108476|NCT02589665|589102985|FG007|Induction Extension Period|Withdrawal by Subject|2|||
163108477|NCT02589665|589102986|FG008|Induction Extension Period|Withdrawal by Subject|3|||
163108478|NCT02589665|589102987|FG009|Induction Extension Period|Withdrawal by Subject|0|||
163108479|NCT02589665|589102978|FG000|Induction Extension Period|Physician Decision|0|||
163108480|NCT02589665|589102979|FG001|Induction Extension Period|Physician Decision|0|||
163108481|NCT02589665|589102980|FG002|Induction Extension Period|Physician Decision|0|||
163108482|NCT02589665|589102981|FG003|Induction Extension Period|Physician Decision|0|||
163108483|NCT02589665|589102982|FG004|Induction Extension Period|Physician Decision|0|||
163108484|NCT02589665|589102983|FG005|Induction Extension Period|Physician Decision|0|||
163108485|NCT02589665|589102984|FG006|Induction Extension Period|Physician Decision|0|||
163108486|NCT02589665|589102985|FG007|Induction Extension Period|Physician Decision|0|||
163108487|NCT02589665|589102986|FG008|Induction Extension Period|Physician Decision|1|||
163108488|NCT02589665|589102987|FG009|Induction Extension Period|Physician Decision|0|||
163108489|NCT02589665|589102978|FG000|Induction Extension Period|Reason Not Collected|0|||
163108490|NCT02589665|589102979|FG001|Induction Extension Period|Reason Not Collected|0|||
163108491|NCT02589665|589102980|FG002|Induction Extension Period|Reason Not Collected|0|||
163108492|NCT02589665|589102981|FG003|Induction Extension Period|Reason Not Collected|0|||
163108493|NCT02589665|589102982|FG004|Induction Extension Period|Reason Not Collected|0|||
163108494|NCT02589665|589102983|FG005|Induction Extension Period|Reason Not Collected|0|||
163108495|NCT02589665|589102984|FG006|Induction Extension Period|Reason Not Collected|0|||
163108496|NCT02589665|589102985|FG007|Induction Extension Period|Reason Not Collected|0|||
163108497|NCT02589665|589102986|FG008|Induction Extension Period|Reason Not Collected|1|||
163108498|NCT02589665|589102987|FG009|Induction Extension Period|Reason Not Collected|0|||
163108499|NCT02589665|589102978|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108500|NCT02589665|589102979|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108501|NCT02589665|589102980|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108502|NCT02589665|589102981|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108503|NCT02589665|589102982|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108504|NCT02589665|589102983|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108505|NCT02589665|589102984|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108506|NCT02589665|589102985|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108507|NCT02589665|589102986|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
163108508|NCT02589665|589102987|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
163108509|NCT02589665|589102978|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
163108510|NCT02589665|589102979|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
163108511|NCT02589665|589102980|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
163108512|NCT02589665|589102981|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
163108513|NCT02589665|589102982|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
163108514|NCT02589665|589102983|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
163108515|NCT02589665|589102984|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
163108516|NCT02589665|589102985|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
163108517|NCT02589665|589102986|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
163108518|NCT02589665|589102987|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
163108519|NCT02589665|589102978|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
163108520|NCT02589665|589102979|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
163108521|NCT02589665|589102980|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
163108522|NCT02589665|589102981|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
163108523|NCT02589665|589102982|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
163108524|NCT02589665|589102983|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
163108525|NCT02589665|589102984|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
163108526|NCT02589665|589102985|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
163108527|NCT02589665|589102986|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
163108528|NCT02589665|589102987|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
163108529|NCT02589665|589102978|FG000|Maintenance Extension Period|Adverse Event|0|||
163108530|NCT02589665|589102979|FG001|Maintenance Extension Period|Adverse Event|0|||
163108531|NCT02589665|589102980|FG002|Maintenance Extension Period|Adverse Event|0|||
163108532|NCT02589665|589102981|FG003|Maintenance Extension Period|Adverse Event|0|||
163108533|NCT02589665|589102982|FG004|Maintenance Extension Period|Adverse Event|0|||
163108534|NCT02589665|589102983|FG005|Maintenance Extension Period|Adverse Event|0|||
163108535|NCT02589665|589102984|FG006|Maintenance Extension Period|Adverse Event|0|||
163108536|NCT02589665|589102985|FG007|Maintenance Extension Period|Adverse Event|0|||
163108537|NCT02589665|589102986|FG008|Maintenance Extension Period|Adverse Event|0|||
163108538|NCT02589665|589102987|FG009|Maintenance Extension Period|Adverse Event|2|||
163108539|NCT02589665|589102978|FG000|Maintenance Extension Period|Non-responder|0|||
163108540|NCT02589665|589102979|FG001|Maintenance Extension Period|Non-responder|0|||
163108541|NCT02589665|589102980|FG002|Maintenance Extension Period|Non-responder|0|||
163108542|NCT02589665|589102981|FG003|Maintenance Extension Period|Non-responder|0|||
163108543|NCT02589665|589102982|FG004|Maintenance Extension Period|Non-responder|0|||
163108544|NCT02589665|589102983|FG005|Maintenance Extension Period|Non-responder|0|||
163108545|NCT02589665|589102984|FG006|Maintenance Extension Period|Non-responder|0|||
163108546|NCT02589665|589102985|FG007|Maintenance Extension Period|Non-responder|0|||
163108547|NCT02589665|589102986|FG008|Maintenance Extension Period|Non-responder|0|||
163108548|NCT02589665|589102987|FG009|Maintenance Extension Period|Non-responder|1|||
163108549|NCT00978380|589102990|FG000|Overall Study|Protocol Violation|2|||
163108550|NCT00978380|589102990|FG000|Overall Study|Withdrawal criteria|9|||
163108551|NCT00978380|589102990|FG000|Overall Study|Unclassified|8|||
163108552|NCT00176488|589102991|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
163108553|NCT00327015|589102992|FG000|Overall Study|Lack of Efficacy|18|||
162719204|NCT00708032|587678432|FG000|Overall Study|Did not meet protocol criteria|1|||
162719205|NCT00708032|587678433|FG001|Overall Study|Did not meet protocol criteria|2|||
163108554|NCT00327015|589102993|FG001|Overall Study|Lack of Efficacy|18|||
163108555|NCT00327015|589102994|FG002|Overall Study|Lack of Efficacy|35|||
163108556|NCT00327015|589102995|FG003|Overall Study|Lack of Efficacy|29|||
163108557|NCT00327015|589102992|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
162719206|NCT00708032|587678432|FG000|Overall Study|Protocol Violation|4|||
162719207|NCT00708032|587678433|FG001|Overall Study|Protocol Violation|1|||
163108558|NCT00327015|589102993|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
163108559|NCT00327015|589102994|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
163108560|NCT00327015|589102995|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
163108561|NCT00327015|589102992|FG000|Overall Study|Lost to Follow-up|22|||
163108562|NCT00327015|589102993|FG001|Overall Study|Lost to Follow-up|23|||
163108563|NCT00327015|589102994|FG002|Overall Study|Lost to Follow-up|29|||
163108564|NCT00327015|589102995|FG003|Overall Study|Lost to Follow-up|22|||
163108565|NCT00327015|589102992|FG000|Overall Study|Adverse Event|14|||
163108566|NCT00327015|589102993|FG001|Overall Study|Adverse Event|10|||
163108567|NCT00327015|589102994|FG002|Overall Study|Adverse Event|14|||
163108568|NCT00327015|589102995|FG003|Overall Study|Adverse Event|14|||
163108569|NCT00327015|589102992|FG000|Overall Study|Subject no longer meets study criteria|4|||
163108570|NCT00327015|589102993|FG001|Overall Study|Subject no longer meets study criteria|2|||
163108571|NCT00327015|589102994|FG002|Overall Study|Subject no longer meets study criteria|8|||
162653786|NCT02027844|587449598|FG002|Overall Study|Incomlete data|0|||
162653787|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
163108572|NCT00327015|589102995|FG003|Overall Study|Subject no longer meets study criteria|7|||
163108573|NCT00327015|589102992|FG000|Overall Study|Poor/Noncompliance|11|||
163108574|NCT00327015|589102993|FG001|Overall Study|Poor/Noncompliance|8|||
163108575|NCT00327015|589102994|FG002|Overall Study|Poor/Noncompliance|4|||
163108576|NCT00327015|589102995|FG003|Overall Study|Poor/Noncompliance|5|||
163108577|NCT00327015|589102992|FG000|Overall Study|Physician Decision|0|||
163108578|NCT00327015|589102993|FG001|Overall Study|Physician Decision|1|||
163108579|NCT00327015|589102994|FG002|Overall Study|Physician Decision|3|||
163108580|NCT00327015|589102995|FG003|Overall Study|Physician Decision|2|||
163108581|NCT00327015|589102992|FG000|Overall Study|Death|1|||
163108582|NCT00327015|589102993|FG001|Overall Study|Death|2|||
163108583|NCT00327015|589102994|FG002|Overall Study|Death|2|||
163108584|NCT00327015|589102995|FG003|Overall Study|Death|3|||
163108585|NCT00327015|589102992|FG000|Overall Study|Pregnancy|0|||
163108586|NCT00327015|589102993|FG001|Overall Study|Pregnancy|2|||
163108587|NCT00327015|589102994|FG002|Overall Study|Pregnancy|1|||
163108588|NCT00327015|589102995|FG003|Overall Study|Pregnancy|1|||
163108589|NCT00327015|589102992|FG000|Overall Study|Administrative Reason by Sponsor|1|||
163108590|NCT00327015|589102993|FG001|Overall Study|Administrative Reason by Sponsor|2|||
163108591|NCT00327015|589102994|FG002|Overall Study|Administrative Reason by Sponsor|2|||
163108592|NCT00327015|589102995|FG003|Overall Study|Administrative Reason by Sponsor|1|||
162653788|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
163108593|NCT02242435|589102996|FG000|Overall Study|Lost to Follow-up|3|||
163108594|NCT02242435|589102997|FG001|Overall Study|Lost to Follow-up|4|||
163108595|NCT02242435|589102996|FG000|Overall Study|Adverse Event|3|||
163108596|NCT02242435|589102997|FG001|Overall Study|Adverse Event|2|||
163108597|NCT02242435|589102996|FG000|Overall Study|Withdrawal by Subject|13|||
163108598|NCT02242435|589102997|FG001|Overall Study|Withdrawal by Subject|8|||
163108599|NCT02242435|589102996|FG000|Overall Study|Death|0|||
163108600|NCT02242435|589102997|FG001|Overall Study|Death|1|||
163108601|NCT02242435|589102996|FG000|Overall Study|Protocol Violation|1|||
163108602|NCT02242435|589102997|FG001|Overall Study|Protocol Violation|0|||
163108603|NCT02242435|589102996|FG000|Overall Study|Physician Decision|0|||
163108604|NCT02242435|589102997|FG001|Overall Study|Physician Decision|1|||
163108605|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
163108606|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
163108607|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
163108608|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
163108609|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
163108610|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
163108611|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
163108612|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
162653789|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Graft loss|1|||
162653790|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Graft loss|2|||
162653791|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Death|5|||
162653792|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Death|3|||
163108613|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
163108614|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
162653793|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
162653794|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
162653795|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
163108615|NCT00510718|589103006|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
162719208|NCT00708032|587678432|FG000|Overall Study|Withdrawal by Subject|0|||
162719209|NCT00708032|587678433|FG001|Overall Study|Withdrawal by Subject|1|||
162719210|NCT00150176|587678434|FG000|Overall Study|Adverse Event|16|||
163108616|NCT00510718|589103007|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
163108617|NCT01089413|589103010|FG000|Overall Study|Lost to Follow-up|1|||
163108618|NCT01089413|589103010|FG000|Overall Study|Progressive Disease|93|||
163108619|NCT01089413|589103010|FG000|Overall Study|Participant Withdrew Consent|1|||
163108620|NCT01089413|589103010|FG000|Overall Study|Unacceptable Toxicity|12|||
163108621|NCT01089413|589103010|FG000|Overall Study|Death|10|||
163108622|NCT01089413|589103010|FG000|Overall Study|Metastasectomy|13|||
163108623|NCT01089413|589103010|FG000|Overall Study|Other|71|||
163108624|NCT01610557|589103015|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108625|NCT01610557|589103016|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
163108626|NCT01610557|589103017|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108627|NCT01610557|589103018|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108628|NCT01610557|589103019|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
163108629|NCT01610557|589103015|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108630|NCT01610557|589103016|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108631|NCT01610557|589103017|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108632|NCT01610557|589103018|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
163108633|NCT01610557|589103019|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
163108634|NCT02003638|589103022|FG000|Overall Study|Withdrawal by Subject|1|||
163108635|NCT02003638|589103023|FG001|Overall Study|Withdrawal by Subject|0|||
163108636|NCT04115748|589103024|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
163108637|NCT04115748|589103025|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
163108638|NCT04115748|589103026|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
163108639|NCT04115748|589103027|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
163108640|NCT04115748|589103028|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108641|NCT04115748|589103029|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108642|NCT04115748|589103030|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108643|NCT04115748|589103031|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108644|NCT04115748|589103032|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108645|NCT04115748|589103033|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
163108646|NCT04115748|589103024|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108647|NCT04115748|589103025|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108648|NCT04115748|589103026|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108649|NCT04115748|589103027|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
163108650|NCT04115748|589103028|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108651|NCT04115748|589103029|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108652|NCT04115748|589103030|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108653|NCT04115748|589103031|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108654|NCT04115748|589103032|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108655|NCT04115748|589103033|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
163108656|NCT04115748|589103024|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108657|NCT04115748|589103025|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108658|NCT04115748|589103026|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108659|NCT04115748|589103027|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
163108660|NCT04115748|589103028|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
163108661|NCT04115748|589103029|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
163108662|NCT04115748|589103030|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108663|NCT04115748|589103031|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108664|NCT04115748|589103032|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
163108665|NCT04115748|589103033|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
163108666|NCT04115748|589103024|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108667|NCT04115748|589103025|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108668|NCT04115748|589103026|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108669|NCT04115748|589103027|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108670|NCT04115748|589103028|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108671|NCT04115748|589103029|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108672|NCT04115748|589103030|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108673|NCT04115748|589103031|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108674|NCT04115748|589103032|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
163108675|NCT04115748|589103033|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
163108676|NCT02752633|589103034|FG000|Overall Study|Withdrawal by Subject|1|||
163108677|NCT00152477|589103036|FG000|Chemotherapy Period|Adverse Event|9|||
163108678|NCT00152477|589103037|FG001|Chemotherapy Period|Adverse Event|4|||
163108679|NCT00152477|589103038|FG002|Chemotherapy Period|Adverse Event|5|||
163108680|NCT00152477|589103036|FG000|Chemotherapy Period|Death|1|||
163108681|NCT00152477|589103037|FG001|Chemotherapy Period|Death|3|||
163108682|NCT00152477|589103038|FG002|Chemotherapy Period|Death|3|||
163108683|NCT00152477|589103036|FG000|Chemotherapy Period|Lack of Efficacy|4|||
163108684|NCT00152477|589103037|FG001|Chemotherapy Period|Lack of Efficacy|5|||
163108685|NCT00152477|589103038|FG002|Chemotherapy Period|Lack of Efficacy|6|||
163108686|NCT00152477|589103036|FG000|Chemotherapy Period|Lost to Follow-up|1|||
163108687|NCT00152477|589103037|FG001|Chemotherapy Period|Lost to Follow-up|0|||
163108688|NCT00152477|589103038|FG002|Chemotherapy Period|Lost to Follow-up|1|||
163108689|NCT00152477|589103036|FG000|Chemotherapy Period|Protocol Violation|1|||
163108690|NCT00152477|589103037|FG001|Chemotherapy Period|Protocol Violation|1|||
163108691|NCT00152477|589103038|FG002|Chemotherapy Period|Protocol Violation|0|||
163108692|NCT00152477|589103036|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
163108693|NCT00152477|589103037|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
162653796|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
162653797|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
163108694|NCT00152477|589103038|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
163108695|NCT00152477|589103036|FG000|Chemotherapy Period|Progression of Disease|6|||
163108696|NCT00152477|589103037|FG001|Chemotherapy Period|Progression of Disease|8|||
163108697|NCT00152477|589103038|FG002|Chemotherapy Period|Progression of Disease|4|||
163108698|NCT00152477|589103036|FG000|Chemotherapy Period|Investigator decision|0|||
163108699|NCT00152477|589103037|FG001|Chemotherapy Period|Investigator decision|0|||
163108700|NCT00152477|589103038|FG002|Chemotherapy Period|Investigator decision|1|||
163108701|NCT00152477|589103036|FG000|Chemotherapy Period|Patient condition worsened|1|||
163108702|NCT00152477|589103037|FG001|Chemotherapy Period|Patient condition worsened|0|||
163108703|NCT00152477|589103038|FG002|Chemotherapy Period|Patient condition worsened|0|||
163108704|NCT00152477|589103036|FG000|Monotherapy Period|Adverse Event|1|||
163108705|NCT00152477|589103037|FG001|Monotherapy Period|Adverse Event|0|||
163108706|NCT00152477|589103038|FG002|Monotherapy Period|Adverse Event|5|||
163108707|NCT00152477|589103036|FG000|Monotherapy Period|Death|2|||
163108708|NCT00152477|589103037|FG001|Monotherapy Period|Death|0|||
163108709|NCT00152477|589103038|FG002|Monotherapy Period|Death|1|||
163108710|NCT00152477|589103036|FG000|Monotherapy Period|Lack of Efficacy|7|||
163108711|NCT00152477|589103037|FG001|Monotherapy Period|Lack of Efficacy|16|||
163108712|NCT00152477|589103038|FG002|Monotherapy Period|Lack of Efficacy|10|||
163108713|NCT00152477|589103036|FG000|Monotherapy Period|Protocol Violation|0|||
163108714|NCT00152477|589103037|FG001|Monotherapy Period|Protocol Violation|1|||
163108715|NCT00152477|589103038|FG002|Monotherapy Period|Protocol Violation|0|||
163108716|NCT00152477|589103036|FG000|Monotherapy Period|Withdrawal by Subject|0|||
163108717|NCT00152477|589103037|FG001|Monotherapy Period|Withdrawal by Subject|0|||
163108718|NCT00152477|589103038|FG002|Monotherapy Period|Withdrawal by Subject|4|||
163108719|NCT00152477|589103036|FG000|Monotherapy Period|Progression of Disease|5|||
163108720|NCT00152477|589103037|FG001|Monotherapy Period|Progression of Disease|11|||
163108721|NCT00152477|589103038|FG002|Monotherapy Period|Progression of Disease|12|||
163108722|NCT00152477|589103036|FG000|Monotherapy Period|Patient decision|0|||
163108723|NCT00152477|589103037|FG001|Monotherapy Period|Patient decision|1|||
163108724|NCT00152477|589103038|FG002|Monotherapy Period|Patient decision|1|||
163108725|NCT00152477|589103036|FG000|Monotherapy Period|Study personel decision|0|||
163108726|NCT00152477|589103037|FG001|Monotherapy Period|Study personel decision|0|||
163108727|NCT00152477|589103038|FG002|Monotherapy Period|Study personel decision|1|||
163108728|NCT00730041|589103041|FG000|Overall Study|Lost to Follow-up|0|||
163108729|NCT00730041|589103042|FG001|Overall Study|Lost to Follow-up|2|||
163108730|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
163108731|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
163108732|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
163108733|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
163108734|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
163108735|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
163108736|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
163108737|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
163108738|NCT00433966|589103045|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
163108739|NCT00433966|589103046|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
163108740|NCT00433966|589103047|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
163108741|NCT00433966|589103048|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
163108742|NCT00433966|589103045|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
163108743|NCT00433966|589103046|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
163108744|NCT00433966|589103047|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
163108745|NCT00433966|589103048|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
163108746|NCT00433966|589103045|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
163108747|NCT00433966|589103046|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
163108748|NCT00433966|589103047|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
163108749|NCT00433966|589103048|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
162653798|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
162653799|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
162653800|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
162653801|NCT00378014|587449599|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
162653802|NCT00378014|587449600|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
162653803|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
163108750|NCT01296711|589103049|FG000|Overall Study|Adverse Event|3|||
163108751|NCT01296711|589103050|FG001|Overall Study|Adverse Event|1|||
163108752|NCT01296711|589103051|FG002|Overall Study|Adverse Event|4|||
163108753|NCT01296711|589103052|FG003|Overall Study|Adverse Event|3|||
163108754|NCT01296711|589103053|FG004|Overall Study|Adverse Event|1|||
162653804|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
163108755|NCT01296711|589103054|FG005|Overall Study|Adverse Event|6|||
163108756|NCT01296711|589103055|FG006|Overall Study|Adverse Event|11|||
163108757|NCT01296711|589103056|FG007|Overall Study|Adverse Event|3|||
163108758|NCT01296711|589103049|FG000|Overall Study|Lack of Efficacy|1|||
163108759|NCT01296711|589103050|FG001|Overall Study|Lack of Efficacy|4|||
163108760|NCT01296711|589103051|FG002|Overall Study|Lack of Efficacy|1|||
163108761|NCT01296711|589103052|FG003|Overall Study|Lack of Efficacy|1|||
163108762|NCT01296711|589103053|FG004|Overall Study|Lack of Efficacy|1|||
163108763|NCT01296711|589103054|FG005|Overall Study|Lack of Efficacy|0|||
163108764|NCT01296711|589103055|FG006|Overall Study|Lack of Efficacy|2|||
163108765|NCT01296711|589103056|FG007|Overall Study|Lack of Efficacy|3|||
163108766|NCT01296711|589103049|FG000|Overall Study|Lost to Follow-up|0|||
163108767|NCT01296711|589103050|FG001|Overall Study|Lost to Follow-up|0|||
163108768|NCT01296711|589103051|FG002|Overall Study|Lost to Follow-up|1|||
163108769|NCT01296711|589103052|FG003|Overall Study|Lost to Follow-up|1|||
163108770|NCT01296711|589103053|FG004|Overall Study|Lost to Follow-up|2|||
163108771|NCT01296711|589103054|FG005|Overall Study|Lost to Follow-up|0|||
163108772|NCT01296711|589103055|FG006|Overall Study|Lost to Follow-up|4|||
163108773|NCT01296711|589103056|FG007|Overall Study|Lost to Follow-up|2|||
163108774|NCT01296711|589103049|FG000|Overall Study|Protocol Violation|0|||
163108775|NCT01296711|589103050|FG001|Overall Study|Protocol Violation|0|||
163108776|NCT01296711|589103051|FG002|Overall Study|Protocol Violation|0|||
163108777|NCT01296711|589103052|FG003|Overall Study|Protocol Violation|1|||
163108778|NCT01296711|589103053|FG004|Overall Study|Protocol Violation|1|||
163108779|NCT01296711|589103054|FG005|Overall Study|Protocol Violation|0|||
163108780|NCT01296711|589103055|FG006|Overall Study|Protocol Violation|0|||
163108781|NCT01296711|589103056|FG007|Overall Study|Protocol Violation|0|||
163108782|NCT01296711|589103049|FG000|Overall Study|Withdrawal by Subject|4|||
163108783|NCT01296711|589103050|FG001|Overall Study|Withdrawal by Subject|2|||
163108784|NCT01296711|589103051|FG002|Overall Study|Withdrawal by Subject|2|||
163108785|NCT01296711|589103052|FG003|Overall Study|Withdrawal by Subject|1|||
163108786|NCT01296711|589103053|FG004|Overall Study|Withdrawal by Subject|1|||
163108787|NCT01296711|589103054|FG005|Overall Study|Withdrawal by Subject|1|||
163108788|NCT01296711|589103055|FG006|Overall Study|Withdrawal by Subject|2|||
163108789|NCT01296711|589103056|FG007|Overall Study|Withdrawal by Subject|1|||
163108790|NCT01296711|589103049|FG000|Overall Study|Study termination|8|||
163108791|NCT01296711|589103050|FG001|Overall Study|Study termination|1|||
163108792|NCT01296711|589103051|FG002|Overall Study|Study termination|5|||
163108793|NCT01296711|589103052|FG003|Overall Study|Study termination|4|||
163108794|NCT01296711|589103053|FG004|Overall Study|Study termination|4|||
163108795|NCT01296711|589103054|FG005|Overall Study|Study termination|4|||
163108796|NCT01296711|589103055|FG006|Overall Study|Study termination|8|||
163108797|NCT01296711|589103056|FG007|Overall Study|Study termination|10|||
163108798|NCT01296711|589103049|FG000|Overall Study|Continued elevated liver enzymes|0|||
163108799|NCT01296711|589103050|FG001|Overall Study|Continued elevated liver enzymes|0|||
163108800|NCT01296711|589103051|FG002|Overall Study|Continued elevated liver enzymes|0|||
163108801|NCT01296711|589103052|FG003|Overall Study|Continued elevated liver enzymes|1|||
163108802|NCT01296711|589103053|FG004|Overall Study|Continued elevated liver enzymes|0|||
163108803|NCT01296711|589103054|FG005|Overall Study|Continued elevated liver enzymes|0|||
163108804|NCT01296711|589103055|FG006|Overall Study|Continued elevated liver enzymes|0|||
163108805|NCT01296711|589103056|FG007|Overall Study|Continued elevated liver enzymes|0|||
163108806|NCT01296711|589103049|FG000|Overall Study|Methotrexate discontinued|0|||
163108807|NCT01296711|589103050|FG001|Overall Study|Methotrexate discontinued|0|||
163108808|NCT01296711|589103051|FG002|Overall Study|Methotrexate discontinued|0|||
163108809|NCT01296711|589103052|FG003|Overall Study|Methotrexate discontinued|1|||
163108810|NCT01296711|589103053|FG004|Overall Study|Methotrexate discontinued|0|||
163108811|NCT01296711|589103054|FG005|Overall Study|Methotrexate discontinued|0|||
163108812|NCT01296711|589103055|FG006|Overall Study|Methotrexate discontinued|0|||
163108813|NCT01296711|589103056|FG007|Overall Study|Methotrexate discontinued|0|||
163108814|NCT01296711|589103049|FG000|Overall Study|Investigator discretion|0|||
163108815|NCT01296711|589103050|FG001|Overall Study|Investigator discretion|0|||
163108816|NCT01296711|589103051|FG002|Overall Study|Investigator discretion|0|||
163108817|NCT01296711|589103052|FG003|Overall Study|Investigator discretion|0|||
163108818|NCT01296711|589103053|FG004|Overall Study|Investigator discretion|0|||
163108819|NCT01296711|589103054|FG005|Overall Study|Investigator discretion|0|||
163108820|NCT01296711|589103055|FG006|Overall Study|Investigator discretion|1|||
163108821|NCT01296711|589103056|FG007|Overall Study|Investigator discretion|0|||
163108822|NCT01296711|589103049|FG000|Overall Study|Other|0|||
163108823|NCT01296711|589103050|FG001|Overall Study|Other|0|||
163108824|NCT01296711|589103051|FG002|Overall Study|Other|0|||
163108825|NCT01296711|589103052|FG003|Overall Study|Other|0|||
163108826|NCT01296711|589103053|FG004|Overall Study|Other|0|||
163108827|NCT01296711|589103054|FG005|Overall Study|Other|0|||
163108828|NCT01296711|589103055|FG006|Overall Study|Other|1|||
163108829|NCT01296711|589103056|FG007|Overall Study|Other|0|||
162719211|NCT00150176|587678435|FG001|Overall Study|Adverse Event|53|||
162719212|NCT00150176|587678434|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
163108830|NCT01296711|589103049|FG000|Overall Study|Required restricted steroid injections|0|||
163108831|NCT01296711|589103050|FG001|Overall Study|Required restricted steroid injections|0|||
163108832|NCT01296711|589103051|FG002|Overall Study|Required restricted steroid injections|0|||
163108833|NCT01296711|589103052|FG003|Overall Study|Required restricted steroid injections|0|||
163108834|NCT01296711|589103053|FG004|Overall Study|Required restricted steroid injections|0|||
163108835|NCT01296711|589103054|FG005|Overall Study|Required restricted steroid injections|0|||
163108836|NCT01296711|589103055|FG006|Overall Study|Required restricted steroid injections|1|||
163108837|NCT01296711|589103056|FG007|Overall Study|Required restricted steroid injections|0|||
163108838|NCT01296711|589103049|FG000|Overall Study|Ongoing missed appointments|0|||
163108839|NCT01296711|589103050|FG001|Overall Study|Ongoing missed appointments|0|||
163108840|NCT01296711|589103051|FG002|Overall Study|Ongoing missed appointments|0|||
163108841|NCT01296711|589103052|FG003|Overall Study|Ongoing missed appointments|0|||
163108842|NCT01296711|589103053|FG004|Overall Study|Ongoing missed appointments|0|||
163108843|NCT01296711|589103054|FG005|Overall Study|Ongoing missed appointments|0|||
163108844|NCT01296711|589103055|FG006|Overall Study|Ongoing missed appointments|1|||
163108845|NCT01296711|589103056|FG007|Overall Study|Ongoing missed appointments|0|||
163108846|NCT01296711|589103049|FG000|Overall Study|Failure to comply with visits|0|||
163108847|NCT01296711|589103050|FG001|Overall Study|Failure to comply with visits|0|||
163108848|NCT01296711|589103051|FG002|Overall Study|Failure to comply with visits|0|||
163108849|NCT01296711|589103052|FG003|Overall Study|Failure to comply with visits|0|||
163108850|NCT01296711|589103053|FG004|Overall Study|Failure to comply with visits|0|||
163108851|NCT01296711|589103054|FG005|Overall Study|Failure to comply with visits|0|||
163108852|NCT01296711|589103055|FG006|Overall Study|Failure to comply with visits|0|||
163108853|NCT01296711|589103056|FG007|Overall Study|Failure to comply with visits|1|||
163108854|NCT01296711|589103049|FG000|Overall Study|Patient decision due to transport|0|||
163108855|NCT01296711|589103050|FG001|Overall Study|Patient decision due to transport|0|||
163108856|NCT01296711|589103051|FG002|Overall Study|Patient decision due to transport|0|||
163108857|NCT01296711|589103052|FG003|Overall Study|Patient decision due to transport|0|||
163108858|NCT01296711|589103053|FG004|Overall Study|Patient decision due to transport|0|||
163108859|NCT01296711|589103054|FG005|Overall Study|Patient decision due to transport|0|||
163108860|NCT01296711|589103055|FG006|Overall Study|Patient decision due to transport|0|||
163108861|NCT01296711|589103056|FG007|Overall Study|Patient decision due to transport|1|||
163108862|NCT01328535|589103057|FG000|Overall Study|Ineligible|1|||
163108863|NCT01035463|589103058|FG000|Overall Study|Adverse Event|0|||
163108864|NCT01035463|589103059|FG001|Overall Study|Adverse Event|0|||
163108865|NCT01035463|589103060|FG002|Overall Study|Adverse Event|4|||
163108866|NCT01035463|589103061|FG003|Overall Study|Adverse Event|1|||
163108867|NCT01035463|589103062|FG004|Overall Study|Adverse Event|5|||
163108868|NCT01035463|589103063|FG005|Overall Study|Adverse Event|7|||
163108869|NCT01035463|589103058|FG000|Overall Study|Withdrawal by Subject|0|||
163108870|NCT01035463|589103059|FG001|Overall Study|Withdrawal by Subject|2|||
163108871|NCT01035463|589103060|FG002|Overall Study|Withdrawal by Subject|1|||
163108872|NCT01035463|589103061|FG003|Overall Study|Withdrawal by Subject|0|||
163108873|NCT01035463|589103062|FG004|Overall Study|Withdrawal by Subject|1|||
163108874|NCT01035463|589103063|FG005|Overall Study|Withdrawal by Subject|4|||
163108875|NCT01035463|589103058|FG000|Overall Study|Disease progression|0|||
163108876|NCT01035463|589103059|FG001|Overall Study|Disease progression|0|||
163108877|NCT01035463|589103060|FG002|Overall Study|Disease progression|0|||
163108878|NCT01035463|589103061|FG003|Overall Study|Disease progression|0|||
163108879|NCT01035463|589103062|FG004|Overall Study|Disease progression|0|||
163108880|NCT01035463|589103063|FG005|Overall Study|Disease progression|3|||
163108881|NCT01035463|589103058|FG000|Overall Study|Other Malignancy|0|||
163108882|NCT01035463|589103059|FG001|Overall Study|Other Malignancy|0|||
163108883|NCT01035463|589103060|FG002|Overall Study|Other Malignancy|0|||
163108884|NCT01035463|589103061|FG003|Overall Study|Other Malignancy|0|||
163108885|NCT01035463|589103062|FG004|Overall Study|Other Malignancy|0|||
163108886|NCT01035463|589103063|FG005|Overall Study|Other Malignancy|2|||
163108887|NCT01035463|589103058|FG000|Overall Study|Other|0|||
163108888|NCT01035463|589103059|FG001|Overall Study|Other|0|||
163108889|NCT01035463|589103060|FG002|Overall Study|Other|0|||
162719213|NCT00150176|587678435|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
162719214|NCT00150176|587678434|FG000|Overall Study|Withdrawal by Subject|19|||
163108890|NCT01035463|589103061|FG003|Overall Study|Other|1|||
163108891|NCT01035463|589103062|FG004|Overall Study|Other|0|||
163108892|NCT01035463|589103063|FG005|Overall Study|Other|2|||
163108893|NCT03425006|589103066|FG000|Overall Study|Withdrawal by Subject|1|||
163108894|NCT03425006|589103066|FG000|Overall Study|Physician Decision|1|||
163108895|NCT03425006|589103066|FG000|Overall Study|Death|1|||
163108896|NCT03748706|589103070|FG000|Overall Study|Lost to Follow-up|1|||
163108897|NCT03070171|589103073|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
163108898|NCT03070171|589103074|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
163108899|NCT03070171|589103073|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
163108900|NCT03070171|589103074|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
163108901|NCT00610857|589103080|FG000|Overall Study|Not evaluable for response|2|||
163108902|NCT03655054|589103083|FG000|Overall Study|Lost to Follow-up|1|||
163108903|NCT03931382|589103084|FG000|Overall Study|Equipment malfunction|2|||
163108904|NCT03931382|589103085|FG001|Overall Study|Equipment malfunction|0|||
163108905|NCT03931382|589103086|FG002|Overall Study|Equipment malfunction|2|||
163108906|NCT03931382|589103084|FG000|Overall Study|Withdrawal by Subject|0|||
163108907|NCT03931382|589103085|FG001|Overall Study|Withdrawal by Subject|1|||
163108908|NCT03931382|589103086|FG002|Overall Study|Withdrawal by Subject|0|||
163108909|NCT01500252|589103089|FG000|Overall Study|Death|4|||
163108910|NCT01500252|589103090|FG001|Overall Study|Death|2|||
163108911|NCT01500252|589103089|FG000|Overall Study|Lost to Follow-up|5|||
163108912|NCT01500252|589103090|FG001|Overall Study|Lost to Follow-up|4|||
163108913|NCT06003777|589103091|FG000|Period 1|Adverse Event|0|||
163108914|NCT06003777|589103092|FG001|Period 1|Adverse Event|0|||
163108915|NCT06003777|589103093|FG002|Period 1|Adverse Event|1|||
163108916|NCT06003777|589103094|FG003|Period 1|Adverse Event|0|||
163108917|NCT06003777|589103095|FG004|Period 1|Adverse Event|0|||
163108918|NCT06003777|589103096|FG005|Period 1|Adverse Event|0|||
163108919|NCT06003777|589103097|FG006|Period 1|Adverse Event|0|||
163108920|NCT06003777|589103098|FG007|Period 1|Adverse Event|0|||
163108921|NCT06003777|589103099|FG008|Period 1|Adverse Event|0|||
163108922|NCT06003777|589103100|FG009|Period 1|Adverse Event|0|||
163108923|NCT06003777|589103101|FG010|Period 1|Adverse Event|0|||
163108924|NCT06003777|589103102|FG011|Period 1|Adverse Event|0|||
163108925|NCT06003777|589103091|FG000|Period 1|Withdrawal by Subject|0|||
163108926|NCT06003777|589103092|FG001|Period 1|Withdrawal by Subject|0|||
163108927|NCT06003777|589103093|FG002|Period 1|Withdrawal by Subject|0|||
163108928|NCT06003777|589103094|FG003|Period 1|Withdrawal by Subject|0|||
163108929|NCT06003777|589103095|FG004|Period 1|Withdrawal by Subject|1|||
163108930|NCT06003777|589103096|FG005|Period 1|Withdrawal by Subject|0|||
163108931|NCT06003777|589103097|FG006|Period 1|Withdrawal by Subject|0|||
163108932|NCT06003777|589103098|FG007|Period 1|Withdrawal by Subject|0|||
163108933|NCT06003777|589103099|FG008|Period 1|Withdrawal by Subject|0|||
163108934|NCT06003777|589103100|FG009|Period 1|Withdrawal by Subject|0|||
163108935|NCT06003777|589103101|FG010|Period 1|Withdrawal by Subject|0|||
163108936|NCT06003777|589103102|FG011|Period 1|Withdrawal by Subject|0|||
163108937|NCT06003777|589103091|FG000|Period 2|Withdrawal by Subject|0|||
163108938|NCT06003777|589103092|FG001|Period 2|Withdrawal by Subject|0|||
163108939|NCT06003777|589103093|FG002|Period 2|Withdrawal by Subject|0|||
163108940|NCT06003777|589103094|FG003|Period 2|Withdrawal by Subject|0|||
163108941|NCT06003777|589103095|FG004|Period 2|Withdrawal by Subject|0|||
163108942|NCT06003777|589103096|FG005|Period 2|Withdrawal by Subject|0|||
163108943|NCT06003777|589103097|FG006|Period 2|Withdrawal by Subject|0|||
163108944|NCT06003777|589103098|FG007|Period 2|Withdrawal by Subject|0|||
163108945|NCT06003777|589103099|FG008|Period 2|Withdrawal by Subject|1|||
163108946|NCT06003777|589103100|FG009|Period 2|Withdrawal by Subject|0|||
163108947|NCT06003777|589103101|FG010|Period 2|Withdrawal by Subject|0|||
163108948|NCT06003777|589103102|FG011|Period 2|Withdrawal by Subject|0|||
163108949|NCT06003777|589103091|FG000|Period 3|Adverse Event|0|||
163108950|NCT06003777|589103092|FG001|Period 3|Adverse Event|0|||
163108951|NCT06003777|589103093|FG002|Period 3|Adverse Event|0|||
163108952|NCT06003777|589103094|FG003|Period 3|Adverse Event|0|||
163108953|NCT06003777|589103095|FG004|Period 3|Adverse Event|0|||
163108954|NCT06003777|589103096|FG005|Period 3|Adverse Event|0|||
163108955|NCT06003777|589103097|FG006|Period 3|Adverse Event|1|||
163108956|NCT06003777|589103098|FG007|Period 3|Adverse Event|0|||
163108957|NCT06003777|589103099|FG008|Period 3|Adverse Event|0|||
163108958|NCT06003777|589103100|FG009|Period 3|Adverse Event|0|||
163108959|NCT06003777|589103101|FG010|Period 3|Adverse Event|0|||
163108960|NCT06003777|589103102|FG011|Period 3|Adverse Event|0|||
163108961|NCT06003777|589103091|FG000|Period 4|No longer met eligibility criteria|0|||
163108962|NCT06003777|589103092|FG001|Period 4|No longer met eligibility criteria|0|||
163108963|NCT06003777|589103093|FG002|Period 4|No longer met eligibility criteria|1|||
163108964|NCT06003777|589103094|FG003|Period 4|No longer met eligibility criteria|0|||
163108965|NCT06003777|589103095|FG004|Period 4|No longer met eligibility criteria|0|||
163108966|NCT06003777|589103096|FG005|Period 4|No longer met eligibility criteria|0|||
163108967|NCT06003777|589103097|FG006|Period 4|No longer met eligibility criteria|0|||
163108968|NCT06003777|589103098|FG007|Period 4|No longer met eligibility criteria|0|||
163108969|NCT06003777|589103099|FG008|Period 4|No longer met eligibility criteria|0|||
163108970|NCT06003777|589103100|FG009|Period 4|No longer met eligibility criteria|0|||
163108971|NCT06003777|589103101|FG010|Period 4|No longer met eligibility criteria|0|||
163108972|NCT06003777|589103102|FG011|Period 4|No longer met eligibility criteria|0|||
163108973|NCT06003777|589103091|FG000|Period 4|Withdrawal by Subject|0|||
163108974|NCT06003777|589103092|FG001|Period 4|Withdrawal by Subject|1|||
163108975|NCT06003777|589103093|FG002|Period 4|Withdrawal by Subject|0|||
163108976|NCT06003777|589103094|FG003|Period 4|Withdrawal by Subject|0|||
163108977|NCT06003777|589103095|FG004|Period 4|Withdrawal by Subject|0|||
163108978|NCT06003777|589103096|FG005|Period 4|Withdrawal by Subject|0|||
163108979|NCT06003777|589103097|FG006|Period 4|Withdrawal by Subject|0|||
163108980|NCT06003777|589103098|FG007|Period 4|Withdrawal by Subject|0|||
163108981|NCT06003777|589103099|FG008|Period 4|Withdrawal by Subject|0|||
163108982|NCT06003777|589103100|FG009|Period 4|Withdrawal by Subject|0|||
163108983|NCT06003777|589103101|FG010|Period 4|Withdrawal by Subject|0|||
163108984|NCT06003777|589103102|FG011|Period 4|Withdrawal by Subject|0|||
163108985|NCT01106651|589103103|FG000|Overall Study|Adverse Event|17|||
163108986|NCT01106651|589103104|FG001|Overall Study|Adverse Event|9|||
163108987|NCT01106651|589103105|FG002|Overall Study|Adverse Event|23|||
163108988|NCT01106651|589103103|FG000|Overall Study|Lost to Follow-up|8|||
163108989|NCT01106651|589103104|FG001|Overall Study|Lost to Follow-up|2|||
163108990|NCT01106651|589103105|FG002|Overall Study|Lost to Follow-up|6|||
163108991|NCT01106651|589103103|FG000|Overall Study|Physician Decision|4|||
163108992|NCT01106651|589103104|FG001|Overall Study|Physician Decision|3|||
163108993|NCT01106651|589103105|FG002|Overall Study|Physician Decision|1|||
163108994|NCT01106651|589103103|FG000|Overall Study|Protocol Violation|1|||
163108995|NCT01106651|589103104|FG001|Overall Study|Protocol Violation|2|||
163108996|NCT01106651|589103105|FG002|Overall Study|Protocol Violation|1|||
163108997|NCT01106651|589103103|FG000|Overall Study|Withdrawal by Subject|14|||
163108998|NCT01106651|589103104|FG001|Overall Study|Withdrawal by Subject|7|||
163108999|NCT01106651|589103105|FG002|Overall Study|Withdrawal by Subject|4|||
163109000|NCT01106651|589103103|FG000|Overall Study|Noncompliance with study drug|1|||
163109001|NCT01106651|589103104|FG001|Overall Study|Noncompliance with study drug|0|||
162653805|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Death|1|||
163109002|NCT01106651|589103105|FG002|Overall Study|Noncompliance with study drug|2|||
163109003|NCT01106651|589103103|FG000|Overall Study|Other|34|||
163109004|NCT01106651|589103104|FG001|Overall Study|Other|31|||
163109005|NCT01106651|589103105|FG002|Overall Study|Other|21|||
163109006|NCT01106651|589103103|FG000|Overall Study|Death|0|||
163109007|NCT01106651|589103104|FG001|Overall Study|Death|3|||
163109008|NCT01106651|589103105|FG002|Overall Study|Death|0|||
163109009|NCT02466425|589103106|FG000|Overall Study|Adverse Event|3|||
163109010|NCT02466425|589103107|FG001|Overall Study|Adverse Event|11|||
163109011|NCT02466425|589103106|FG000|Overall Study|Lack of Efficacy|4|||
163109012|NCT02466425|589103107|FG001|Overall Study|Lack of Efficacy|1|||
163109013|NCT02466425|589103106|FG000|Overall Study|Lost to Follow-up|3|||
163109014|NCT02466425|589103107|FG001|Overall Study|Lost to Follow-up|0|||
163109015|NCT02466425|589103106|FG000|Overall Study|Protocol Violation|1|||
163109016|NCT02466425|589103107|FG001|Overall Study|Protocol Violation|0|||
163109017|NCT02466425|589103106|FG000|Overall Study|Withdrawal by Subject|0|||
163109018|NCT02466425|589103107|FG001|Overall Study|Withdrawal by Subject|1|||
163109019|NCT02466425|589103106|FG000|Overall Study|Other|1|||
163109020|NCT02466425|589103107|FG001|Overall Study|Other|3|||
163109021|NCT02466425|589103106|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163109022|NCT02466425|589103107|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163109023|NCT00712725|589103110|FG000|Overall Study|Adverse Event|1|||
163109024|NCT00712725|589103111|FG001|Overall Study|Adverse Event|0|||
163109025|NCT00712725|589103112|FG002|Overall Study|Adverse Event|0|||
163109026|NCT00712725|589103113|FG003|Overall Study|Adverse Event|1|||
163109027|NCT00712725|589103114|FG004|Overall Study|Adverse Event|0|||
163109028|NCT00712725|589103115|FG005|Overall Study|Adverse Event|0|||
163109029|NCT00712725|589103116|FG006|Overall Study|Adverse Event|0|||
163109030|NCT00712725|589103117|FG007|Overall Study|Adverse Event|0|||
163109031|NCT00712725|589103110|FG000|Overall Study|Lost to Follow-up|3|||
163109032|NCT00712725|589103111|FG001|Overall Study|Lost to Follow-up|2|||
163109033|NCT00712725|589103112|FG002|Overall Study|Lost to Follow-up|1|||
163109034|NCT00712725|589103113|FG003|Overall Study|Lost to Follow-up|1|||
163109035|NCT00712725|589103114|FG004|Overall Study|Lost to Follow-up|2|||
163109036|NCT00712725|589103115|FG005|Overall Study|Lost to Follow-up|2|||
163109037|NCT00712725|589103116|FG006|Overall Study|Lost to Follow-up|3|||
163109038|NCT00712725|589103117|FG007|Overall Study|Lost to Follow-up|1|||
163109039|NCT00712725|589103110|FG000|Overall Study|Physician Decision|2|||
163109040|NCT00712725|589103111|FG001|Overall Study|Physician Decision|0|||
163109041|NCT00712725|589103112|FG002|Overall Study|Physician Decision|0|||
163109042|NCT00712725|589103113|FG003|Overall Study|Physician Decision|0|||
163109043|NCT00712725|589103114|FG004|Overall Study|Physician Decision|1|||
163109044|NCT00712725|589103115|FG005|Overall Study|Physician Decision|0|||
163109045|NCT00712725|589103116|FG006|Overall Study|Physician Decision|2|||
163109046|NCT00712725|589103117|FG007|Overall Study|Physician Decision|0|||
163109047|NCT00712725|589103110|FG000|Overall Study|Pregnancy|0|||
163109048|NCT00712725|589103111|FG001|Overall Study|Pregnancy|1|||
163109049|NCT00712725|589103112|FG002|Overall Study|Pregnancy|0|||
163109050|NCT00712725|589103113|FG003|Overall Study|Pregnancy|0|||
163109051|NCT00712725|589103114|FG004|Overall Study|Pregnancy|1|||
163109052|NCT00712725|589103115|FG005|Overall Study|Pregnancy|0|||
163109053|NCT00712725|589103116|FG006|Overall Study|Pregnancy|2|||
163109054|NCT00712725|589103117|FG007|Overall Study|Pregnancy|0|||
163109055|NCT00712725|589103110|FG000|Overall Study|Protocol Violation|2|||
163109056|NCT00712725|589103111|FG001|Overall Study|Protocol Violation|0|||
163109057|NCT00712725|589103112|FG002|Overall Study|Protocol Violation|1|||
163109058|NCT00712725|589103113|FG003|Overall Study|Protocol Violation|3|||
163109059|NCT00712725|589103114|FG004|Overall Study|Protocol Violation|2|||
163109060|NCT00712725|589103115|FG005|Overall Study|Protocol Violation|0|||
163109061|NCT00712725|589103116|FG006|Overall Study|Protocol Violation|1|||
163109062|NCT00712725|589103117|FG007|Overall Study|Protocol Violation|1|||
163109063|NCT00712725|589103110|FG000|Overall Study|Withdrawal by Subject|2|||
163109064|NCT00712725|589103111|FG001|Overall Study|Withdrawal by Subject|1|||
163109065|NCT00712725|589103112|FG002|Overall Study|Withdrawal by Subject|1|||
163109066|NCT00712725|589103113|FG003|Overall Study|Withdrawal by Subject|2|||
163109067|NCT00712725|589103114|FG004|Overall Study|Withdrawal by Subject|1|||
163109068|NCT00712725|589103115|FG005|Overall Study|Withdrawal by Subject|1|||
163109069|NCT00712725|589103116|FG006|Overall Study|Withdrawal by Subject|1|||
163109070|NCT00712725|589103117|FG007|Overall Study|Withdrawal by Subject|2|||
163109071|NCT00712725|589103110|FG000|Overall Study|Lack of Qualifying Event|16|||
163109072|NCT00712725|589103111|FG001|Overall Study|Lack of Qualifying Event|2|||
163109073|NCT00712725|589103112|FG002|Overall Study|Lack of Qualifying Event|6|||
163109074|NCT00712725|589103113|FG003|Overall Study|Lack of Qualifying Event|8|||
163109075|NCT00712725|589103114|FG004|Overall Study|Lack of Qualifying Event|11|||
163109076|NCT00712725|589103115|FG005|Overall Study|Lack of Qualifying Event|13|||
163109077|NCT00712725|589103116|FG006|Overall Study|Lack of Qualifying Event|11|||
163109078|NCT00712725|589103117|FG007|Overall Study|Lack of Qualifying Event|6|||
163109079|NCT00712725|589103110|FG000|Overall Study|Protocol Specified Criteria|3|||
163109080|NCT00712725|589103111|FG001|Overall Study|Protocol Specified Criteria|0|||
163109081|NCT00712725|589103112|FG002|Overall Study|Protocol Specified Criteria|1|||
163109082|NCT00712725|589103113|FG003|Overall Study|Protocol Specified Criteria|2|||
163109083|NCT00712725|589103114|FG004|Overall Study|Protocol Specified Criteria|1|||
163109084|NCT00712725|589103115|FG005|Overall Study|Protocol Specified Criteria|0|||
163109085|NCT00712725|589103116|FG006|Overall Study|Protocol Specified Criteria|2|||
163109086|NCT00712725|589103117|FG007|Overall Study|Protocol Specified Criteria|1|||
163109087|NCT01901289|589103118|FG000|Overall Study|Death|32|||
163109088|NCT01901289|589103118|FG000|Overall Study|Lost to Follow-up|16|||
163109089|NCT01901289|589103118|FG000|Overall Study|Withdrawal by Subject|35|||
163109090|NCT01901289|589103118|FG000|Overall Study|Other type of endpoint met|2|||
163109091|NCT00889603|589103119|FG000|Overall Study|Adverse Event|7|||
163109092|NCT00889603|589103119|FG000|Overall Study|Death|3|||
163109093|NCT00889603|589103119|FG000|Overall Study|Lost to Follow-up|19|||
163109094|NCT00889603|589103119|FG000|Overall Study|No longer willing to participant in stud|4|||
163109095|NCT00889603|589103119|FG000|Overall Study|Other|4|||
163109096|NCT00700882|589103123|FG000|Overall Study|Never received treatment|6|||
163109097|NCT00700882|589103123|FG000|Overall Study|Ineligible|2|||
163109098|NCT00700882|589103123|FG000|Overall Study|No KIT mutation|51|||
163109099|NCT01606176|589103124|FG000|Overall Study|Adverse Event|2|||
163109100|NCT01606176|589103125|FG001|Overall Study|Adverse Event|3|||
163109101|NCT01606176|589103124|FG000|Overall Study|Disease progression|1|||
163109102|NCT01606176|589103125|FG001|Overall Study|Disease progression|0|||
163109103|NCT01606176|589103124|FG000|Overall Study|Withdrawal by Subject|1|||
163109104|NCT01606176|589103125|FG001|Overall Study|Withdrawal by Subject|0|||
163109105|NCT01832493|589103126|FG000|Overall Study|Physician Decision|2|||
163109106|NCT01832493|589103126|FG000|Overall Study|Protocol Violation|4|||
163109107|NCT01832493|589103126|FG000|Overall Study|Unable to place LV lead|2|||
163109108|NCT01814397|589103129|FG000|Overall Study|Adverse Event|7|||
163109109|NCT01814397|589103129|FG000|Overall Study|Withdrawal by Subject|7|||
163109110|NCT02247011|589103133|FG000|Overall Study|Poor quality of radiological results|125|||
163109111|NCT01818258|589103135|FG000|Overall Study|Death|3|||
163109112|NCT01818258|589103136|FG001|Overall Study|Death|0|||
163109113|NCT01818258|589103135|FG000|Overall Study|Withdrawal by Subject|0|||
163109114|NCT01818258|589103136|FG001|Overall Study|Withdrawal by Subject|1|||
163109115|NCT01818258|589103135|FG000|Overall Study|Lost to Follow-up|0|||
163109116|NCT01818258|589103136|FG001|Overall Study|Lost to Follow-up|1|||
163109117|NCT01818258|589103135|FG000|Overall Study|Unable to Travel to Clinic|0|||
163109118|NCT01818258|589103136|FG001|Overall Study|Unable to Travel to Clinic|1|||
163109119|NCT02839720|589103137|FG000|Overall Study|Adverse Event|2|||
163109120|NCT02839720|589103137|FG000|Overall Study|Non-compliance|2|||
163109121|NCT02839720|589103137|FG000|Overall Study|Intercurrent Illness|1|||
163109122|NCT02839720|589103137|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
163109123|NCT00349921|589103138|FG000|First Spinal Injection|Physician Decision|1|||
163109124|NCT00349921|589103139|FG001|First Spinal Injection|Physician Decision|0|||
163109125|NCT00349921|589103140|FG002|First Spinal Injection|Physician Decision|0|||
163109126|NCT00349921|589103141|FG003|First Spinal Injection|Physician Decision|0|||
163109127|NCT00349921|589103138|FG000|First Spinal Injection|Adverse Event|0|||
163109128|NCT00349921|589103139|FG001|First Spinal Injection|Adverse Event|0|||
163109129|NCT00349921|589103140|FG002|First Spinal Injection|Adverse Event|1|||
163109130|NCT00349921|589103141|FG003|First Spinal Injection|Adverse Event|0|||
163109131|NCT00792740|589103147|FG000|Overall Study|Disease Worsening|3|||
163109132|NCT00792740|589103148|FG001|Overall Study|Disease Worsening|2|||
163109133|NCT00792740|589103147|FG000|Overall Study|Personal Reason|1|||
163109134|NCT00792740|589103148|FG001|Overall Study|Personal Reason|0|||
163109135|NCT00792740|589103147|FG000|Overall Study|Adverse Event|1|||
163109136|NCT00792740|589103148|FG001|Overall Study|Adverse Event|3|||
163109137|NCT00792740|589103147|FG000|Overall Study|Patient's withdrawal of consent|0|||
163109138|NCT00792740|589103148|FG001|Overall Study|Patient's withdrawal of consent|1|||
163109139|NCT00792740|589103147|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
163109140|NCT00792740|589103148|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
163109141|NCT00792740|589103147|FG000|Overall Study|Other reasons|0|||
163109142|NCT00792740|589103148|FG001|Overall Study|Other reasons|1|||
163109143|NCT00107900|589103149|FG000|Overall Study|Adverse Event|3|||
163109144|NCT00107900|589103150|FG001|Overall Study|Adverse Event|2|||
163109145|NCT00107900|589103151|FG002|Overall Study|Adverse Event|10|||
163109146|NCT00107900|589103152|FG003|Overall Study|Adverse Event|3|||
163109147|NCT00107900|589103153|FG004|Overall Study|Adverse Event|5|||
163109148|NCT00107900|589103154|FG005|Overall Study|Adverse Event|3|||
163109149|NCT00107900|589103149|FG000|Overall Study|Death|0|||
163109150|NCT00107900|589103150|FG001|Overall Study|Death|0|||
163109151|NCT00107900|589103151|FG002|Overall Study|Death|0|||
162653806|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Death|2|||
162653807|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
162653808|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
163109152|NCT00107900|589103152|FG003|Overall Study|Death|0|||
163109153|NCT00107900|589103153|FG004|Overall Study|Death|1|||
162653809|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
163109154|NCT00107900|589103154|FG005|Overall Study|Death|0|||
163109155|NCT00107900|589103149|FG000|Overall Study|Lost to Follow-up|4|||
163109156|NCT00107900|589103150|FG001|Overall Study|Lost to Follow-up|1|||
163109157|NCT00107900|589103151|FG002|Overall Study|Lost to Follow-up|3|||
163109158|NCT00107900|589103152|FG003|Overall Study|Lost to Follow-up|2|||
163109159|NCT00107900|589103153|FG004|Overall Study|Lost to Follow-up|5|||
163109160|NCT00107900|589103154|FG005|Overall Study|Lost to Follow-up|5|||
163109161|NCT00107900|589103149|FG000|Overall Study|Protocol Violation|1|||
163109162|NCT00107900|589103150|FG001|Overall Study|Protocol Violation|0|||
163109163|NCT00107900|589103151|FG002|Overall Study|Protocol Violation|5|||
163109164|NCT00107900|589103152|FG003|Overall Study|Protocol Violation|5|||
163109165|NCT00107900|589103153|FG004|Overall Study|Protocol Violation|7|||
163109166|NCT00107900|589103154|FG005|Overall Study|Protocol Violation|0|||
163109167|NCT00107900|589103149|FG000|Overall Study|Withdrawal by Subject|1|||
163109168|NCT00107900|589103150|FG001|Overall Study|Withdrawal by Subject|0|||
163109169|NCT00107900|589103151|FG002|Overall Study|Withdrawal by Subject|5|||
163109170|NCT00107900|589103152|FG003|Overall Study|Withdrawal by Subject|0|||
163109171|NCT00107900|589103153|FG004|Overall Study|Withdrawal by Subject|1|||
163109172|NCT00107900|589103154|FG005|Overall Study|Withdrawal by Subject|1|||
163109173|NCT00107900|589103149|FG000|Overall Study|Administrative Reasons|1|||
163109174|NCT00107900|589103150|FG001|Overall Study|Administrative Reasons|0|||
163109175|NCT00107900|589103151|FG002|Overall Study|Administrative Reasons|2|||
163109176|NCT00107900|589103152|FG003|Overall Study|Administrative Reasons|2|||
163109177|NCT00107900|589103153|FG004|Overall Study|Administrative Reasons|2|||
163109178|NCT00107900|589103154|FG005|Overall Study|Administrative Reasons|0|||
163109179|NCT03724981|589106433|FG000|First Device|Protocol Violation|1|||
163109180|NCT03724981|589106434|FG001|First Device|Protocol Violation|1|||
163109181|NCT01740089|589106436|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
163109182|NCT01740089|589106437|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
163109183|NCT01740089|589106438|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
163109184|NCT01740089|589106436|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
163109185|NCT01740089|589106437|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
163109186|NCT01740089|589106438|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
163109187|NCT01740089|589106436|FG000|After 12 Weeks|Lack of Efficacy|3|||
163109188|NCT01740089|589106437|FG001|After 12 Weeks|Lack of Efficacy|1|||
163109189|NCT01740089|589106438|FG002|After 12 Weeks|Lack of Efficacy|4|||
163109190|NCT01740089|589106436|FG000|After 12 Weeks|Adverse Event|2|||
163109191|NCT01740089|589106437|FG001|After 12 Weeks|Adverse Event|0|||
163109192|NCT01740089|589106438|FG002|After 12 Weeks|Adverse Event|5|||
163109193|NCT01740089|589106436|FG000|After 12 Weeks|Protocol Violation|1|||
163109194|NCT01740089|589106437|FG001|After 12 Weeks|Protocol Violation|1|||
163109195|NCT01740089|589106438|FG002|After 12 Weeks|Protocol Violation|1|||
163109196|NCT01740089|589106436|FG000|After 12 Weeks|Withdrawal by Subject|1|||
163109197|NCT01740089|589106437|FG001|After 12 Weeks|Withdrawal by Subject|1|||
163109198|NCT01740089|589106438|FG002|After 12 Weeks|Withdrawal by Subject|1|||
163109199|NCT02791191|589106441|FG000|Overall Study|Adverse Event|2|||
163109200|NCT02791191|589106442|FG001|Overall Study|Adverse Event|4|||
163109201|NCT02791191|589106443|FG002|Overall Study|Adverse Event|5|||
163109202|NCT02791191|589106441|FG000|Overall Study|Lack of Efficacy|0|||
163109203|NCT02791191|589106442|FG001|Overall Study|Lack of Efficacy|1|||
163109204|NCT02791191|589106443|FG002|Overall Study|Lack of Efficacy|0|||
163109205|NCT02791191|589106441|FG000|Overall Study|Study Drug Non-Compliance|0|||
163109206|NCT02791191|589106442|FG001|Overall Study|Study Drug Non-Compliance|2|||
163109207|NCT02791191|589106443|FG002|Overall Study|Study Drug Non-Compliance|0|||
163109208|NCT02791191|589106441|FG000|Overall Study|Site Closed by Sponsor|1|||
163109209|NCT02791191|589106442|FG001|Overall Study|Site Closed by Sponsor|1|||
163109210|NCT02791191|589106443|FG002|Overall Study|Site Closed by Sponsor|3|||
163109211|NCT02791191|589106441|FG000|Overall Study|Progressive Disease|1|||
163109212|NCT02791191|589106442|FG001|Overall Study|Progressive Disease|0|||
163109213|NCT02791191|589106443|FG002|Overall Study|Progressive Disease|0|||
163109214|NCT02791191|589106441|FG000|Overall Study|Study Terminated by Sponsor|29|||
163109215|NCT02791191|589106442|FG001|Overall Study|Study Terminated by Sponsor|101|||
163109216|NCT02791191|589106443|FG002|Overall Study|Study Terminated by Sponsor|109|||
163109217|NCT02791191|589106441|FG000|Overall Study|Withdrawal by Subject|3|||
163109218|NCT02791191|589106442|FG001|Overall Study|Withdrawal by Subject|1|||
163109219|NCT02791191|589106443|FG002|Overall Study|Withdrawal by Subject|3|||
163109220|NCT02791191|589106441|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
163109221|NCT02791191|589106442|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
163109222|NCT02791191|589106443|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
163109223|NCT02370537|589106444|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
163109224|NCT02370537|589106445|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
163109225|NCT02370537|589106446|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
163109226|NCT02370537|589106444|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
162653810|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
162653811|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
162653812|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
162653813|NCT00378014|587449599|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
162653814|NCT00378014|587449600|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
163109227|NCT02370537|589106445|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
163109228|NCT02370537|589106446|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
163109229|NCT02370537|589106444|FG000|Part B|Not randomised to receive treatment|1|||
162653815|NCT00414661|587449601|FG000|Overall Study|Death|2|||
163109230|NCT02370537|589106445|FG001|Part B|Not randomised to receive treatment|2|||
163109231|NCT02370537|589106446|FG002|Part B|Not randomised to receive treatment|259|||
163109232|NCT02370537|589106444|FG000|Part B|Withdrawal by Subject|0|||
163109233|NCT02370537|589106445|FG001|Part B|Withdrawal by Subject|1|||
163109234|NCT02370537|589106446|FG002|Part B|Withdrawal by Subject|0|||
163109235|NCT03100539|589106455|FG000|Overall Study|Lost to Follow-up|60|||
163109236|NCT03100539|589106456|FG001|Overall Study|Lost to Follow-up|54|||
163109237|NCT03100539|589106457|FG002|Overall Study|Lost to Follow-up|17|||
163109238|NCT03100539|589106455|FG000|Overall Study|Uncollected|8|||
163109239|NCT03100539|589106456|FG001|Overall Study|Uncollected|8|||
163109240|NCT03100539|589106457|FG002|Overall Study|Uncollected|0|||
163109241|NCT03100539|589106455|FG000|Overall Study|Ally Health|0|||
163109242|NCT03100539|589106456|FG001|Overall Study|Ally Health|0|||
162653816|NCT00414661|587449602|FG001|Overall Study|Death|5|||
162653817|NCT00414661|587449603|FG002|Overall Study|Death|0|||
163109243|NCT03100539|589106457|FG002|Overall Study|Ally Health|3|||
163109244|NCT03100539|589106455|FG000|Overall Study|Disinterest|0|||
162653818|NCT00414661|587449604|FG003|Overall Study|Death|0|||
162653819|NCT00414661|587449601|FG000|Overall Study|Lost to Follow-up|1|||
162653820|NCT00414661|587449602|FG001|Overall Study|Lost to Follow-up|4|||
163109245|NCT03100539|589106456|FG001|Overall Study|Disinterest|0|||
163109246|NCT03100539|589106457|FG002|Overall Study|Disinterest|22|||
162653821|NCT00414661|587449603|FG002|Overall Study|Lost to Follow-up|0|||
162653822|NCT00414661|587449604|FG003|Overall Study|Lost to Follow-up|1|||
163109247|NCT03100539|589106455|FG000|Overall Study|Veteran Health|0|||
162653823|NCT00414661|587449601|FG000|Overall Study|Withdrawal by Subject|5|||
163109248|NCT03100539|589106456|FG001|Overall Study|Veteran Health|0|||
163109249|NCT03100539|589106457|FG002|Overall Study|Veteran Health|8|||
163109250|NCT03100539|589106455|FG000|Overall Study|Moved|0|||
163109251|NCT03100539|589106456|FG001|Overall Study|Moved|0|||
163109252|NCT03100539|589106457|FG002|Overall Study|Moved|1|||
163109253|NCT03100539|589106455|FG000|Overall Study|Scheduling Conflicts|0|||
163109254|NCT03100539|589106456|FG001|Overall Study|Scheduling Conflicts|0|||
163109255|NCT03100539|589106457|FG002|Overall Study|Scheduling Conflicts|12|||
163109256|NCT04753658|589106467|FG000|Overall Study|Progressive disease|7|||
163109257|NCT04753658|589106467|FG000|Overall Study|Other|7|||
163109258|NCT04753658|589106467|FG000|Overall Study|Adverse Event|1|||
163109259|NCT01892436|589106468|FG000|Overall Study|Withdrawal by Subject|8|||
163109260|NCT01892436|589106469|FG001|Overall Study|Withdrawal by Subject|15|||
163109261|NCT01892436|589106470|FG002|Overall Study|Withdrawal by Subject|4|||
163109262|NCT01892436|589106471|FG003|Overall Study|Withdrawal by Subject|4|||
163109263|NCT01892436|589106468|FG000|Overall Study|Death|1|||
163109264|NCT01892436|589106469|FG001|Overall Study|Death|1|||
163109265|NCT01892436|589106470|FG002|Overall Study|Death|0|||
163109266|NCT01892436|589106471|FG003|Overall Study|Death|0|||
163109267|NCT01892436|589106468|FG000|Overall Study|Physician Decision|2|||
163109268|NCT01892436|589106469|FG001|Overall Study|Physician Decision|1|||
163109269|NCT01892436|589106470|FG002|Overall Study|Physician Decision|0|||
163109270|NCT01892436|589106471|FG003|Overall Study|Physician Decision|1|||
163109271|NCT01892436|589106468|FG000|Overall Study|Pregnancy|0|||
163109272|NCT01892436|589106469|FG001|Overall Study|Pregnancy|2|||
163109273|NCT01892436|589106470|FG002|Overall Study|Pregnancy|1|||
163109274|NCT01892436|589106471|FG003|Overall Study|Pregnancy|0|||
163109275|NCT01892436|589106468|FG000|Overall Study|Technical problems|2|||
163109276|NCT01892436|589106469|FG001|Overall Study|Technical problems|1|||
163109277|NCT01892436|589106470|FG002|Overall Study|Technical problems|1|||
163109278|NCT01892436|589106471|FG003|Overall Study|Technical problems|1|||
163109279|NCT01892436|589106468|FG000|Overall Study|Lack of Efficacy|1|||
163109280|NCT01892436|589106469|FG001|Overall Study|Lack of Efficacy|2|||
163109281|NCT01892436|589106470|FG002|Overall Study|Lack of Efficacy|2|||
163109282|NCT01892436|589106471|FG003|Overall Study|Lack of Efficacy|2|||
163109283|NCT01892436|589106468|FG000|Overall Study|Lost to Follow-up|1|||
163109284|NCT01892436|589106469|FG001|Overall Study|Lost to Follow-up|1|||
163109285|NCT01892436|589106470|FG002|Overall Study|Lost to Follow-up|1|||
163109286|NCT01892436|589106471|FG003|Overall Study|Lost to Follow-up|3|||
163109287|NCT01892436|589106468|FG000|Overall Study|non-compliance with treatment|1|||
163109288|NCT01892436|589106469|FG001|Overall Study|non-compliance with treatment|0|||
163109289|NCT01892436|589106470|FG002|Overall Study|non-compliance with treatment|0|||
163109290|NCT01892436|589106471|FG003|Overall Study|non-compliance with treatment|0|||
163109291|NCT01892436|589106468|FG000|Overall Study|Adverse Event|7|||
163109292|NCT01892436|589106469|FG001|Overall Study|Adverse Event|6|||
163109293|NCT01892436|589106470|FG002|Overall Study|Adverse Event|2|||
163109294|NCT01892436|589106471|FG003|Overall Study|Adverse Event|3|||
163109295|NCT02923830|589106475|FG000|Overall Study|Physician Decision|13|||
163109296|NCT02923830|589106476|FG001|Overall Study|Physician Decision|15|||
163109297|NCT00837265|589106477|FG000|Pilot Phase|Withdrawal by Subject|0|||
163109298|NCT00837265|589106478|FG001|Pilot Phase|Withdrawal by Subject|2|||
163109299|NCT00837265|589106479|FG002|Pilot Phase|Withdrawal by Subject|3|||
163109300|NCT00837265|589106480|FG003|Pilot Phase|Withdrawal by Subject|2|||
163109301|NCT00837265|589106481|FG004|Pilot Phase|Withdrawal by Subject|0|||
163109302|NCT00837265|589106482|FG005|Pilot Phase|Withdrawal by Subject|0|||
163109303|NCT00837265|589106483|FG006|Pilot Phase|Withdrawal by Subject|0|||
163109304|NCT00837265|589106477|FG000|Pilot Phase|Decision of the investigator|2|||
163109305|NCT00837265|589106478|FG001|Pilot Phase|Decision of the investigator|1|||
163109306|NCT00837265|589106479|FG002|Pilot Phase|Decision of the investigator|0|||
163109307|NCT00837265|589106480|FG003|Pilot Phase|Decision of the investigator|0|||
163109308|NCT00837265|589106481|FG004|Pilot Phase|Decision of the investigator|0|||
163109309|NCT00837265|589106482|FG005|Pilot Phase|Decision of the investigator|0|||
163109310|NCT00837265|589106483|FG006|Pilot Phase|Decision of the investigator|0|||
163109311|NCT00837265|589106477|FG000|Pilot Phase|Adverse Event|1|||
163109312|NCT00837265|589106478|FG001|Pilot Phase|Adverse Event|0|||
163109313|NCT00837265|589106479|FG002|Pilot Phase|Adverse Event|0|||
163109314|NCT00837265|589106480|FG003|Pilot Phase|Adverse Event|0|||
163109315|NCT00837265|589106481|FG004|Pilot Phase|Adverse Event|0|||
163109316|NCT00837265|589106482|FG005|Pilot Phase|Adverse Event|0|||
163109317|NCT00837265|589106483|FG006|Pilot Phase|Adverse Event|0|||
163109318|NCT00837265|589106477|FG000|Pilot Phase|Disease progression|0|||
163109319|NCT00837265|589106478|FG001|Pilot Phase|Disease progression|0|||
163109320|NCT00837265|589106479|FG002|Pilot Phase|Disease progression|0|||
163109321|NCT00837265|589106480|FG003|Pilot Phase|Disease progression|1|||
163109322|NCT00837265|589106481|FG004|Pilot Phase|Disease progression|0|||
163109323|NCT00837265|589106482|FG005|Pilot Phase|Disease progression|0|||
163109324|NCT00837265|589106483|FG006|Pilot Phase|Disease progression|0|||
163109325|NCT00837265|589106477|FG000|Pilot Phase|Participant left the city|0|||
163109326|NCT00837265|589106478|FG001|Pilot Phase|Participant left the city|0|||
163109327|NCT00837265|589106479|FG002|Pilot Phase|Participant left the city|0|||
163109328|NCT00837265|589106480|FG003|Pilot Phase|Participant left the city|1|||
163109329|NCT00837265|589106481|FG004|Pilot Phase|Participant left the city|0|||
163109330|NCT00837265|589106482|FG005|Pilot Phase|Participant left the city|0|||
163109331|NCT00837265|589106483|FG006|Pilot Phase|Participant left the city|0|||
163109332|NCT00837265|589106477|FG000|Main Phase|Withdrawal by Subject|0|||
163109333|NCT00837265|589106478|FG001|Main Phase|Withdrawal by Subject|0|||
163109334|NCT00837265|589106479|FG002|Main Phase|Withdrawal by Subject|0|||
163109335|NCT00837265|589106480|FG003|Main Phase|Withdrawal by Subject|0|||
163109336|NCT00837265|589106481|FG004|Main Phase|Withdrawal by Subject|4|||
163109337|NCT00837265|589106482|FG005|Main Phase|Withdrawal by Subject|2|||
163109338|NCT00837265|589106483|FG006|Main Phase|Withdrawal by Subject|1|||
163109339|NCT00837265|589106477|FG000|Main Phase|Decision of the investigator|0|||
163109340|NCT00837265|589106478|FG001|Main Phase|Decision of the investigator|0|||
163109341|NCT00837265|589106479|FG002|Main Phase|Decision of the investigator|0|||
163109342|NCT00837265|589106480|FG003|Main Phase|Decision of the investigator|0|||
163109343|NCT00837265|589106481|FG004|Main Phase|Decision of the investigator|0|||
163109344|NCT00837265|589106482|FG005|Main Phase|Decision of the investigator|2|||
163109345|NCT00837265|589106483|FG006|Main Phase|Decision of the investigator|1|||
163109346|NCT00837265|589106477|FG000|Main Phase|Adverse Event|0|||
163109347|NCT00837265|589106478|FG001|Main Phase|Adverse Event|0|||
163109348|NCT00837265|589106479|FG002|Main Phase|Adverse Event|0|||
162653824|NCT00414661|587449602|FG001|Overall Study|Withdrawal by Subject|2|||
162653825|NCT00414661|587449603|FG002|Overall Study|Withdrawal by Subject|2|||
162653826|NCT00414661|587449604|FG003|Overall Study|Withdrawal by Subject|2|||
162653827|NCT00414661|587449601|FG000|Overall Study|Other|6|||
162653828|NCT00414661|587449602|FG001|Overall Study|Other|3|||
162653829|NCT00414661|587449603|FG002|Overall Study|Other|0|||
162653830|NCT00414661|587449604|FG003|Overall Study|Other|0|||
162653831|NCT02852265|587449605|FG000|3-month Follow-up|Lost to Follow-up|1|||
162653832|NCT02852265|587449606|FG001|3-month Follow-up|Lost to Follow-up|1|||
162719215|NCT00150176|587678435|FG001|Overall Study|Withdrawal by Subject|12|||
163109349|NCT00837265|589106480|FG003|Main Phase|Adverse Event|0|||
163109350|NCT00837265|589106481|FG004|Main Phase|Adverse Event|0|||
163109351|NCT00837265|589106482|FG005|Main Phase|Adverse Event|1|||
163109352|NCT00837265|589106483|FG006|Main Phase|Adverse Event|0|||
163109353|NCT00837265|589106477|FG000|Main Phase|Death|0|||
163109354|NCT00837265|589106478|FG001|Main Phase|Death|0|||
163109355|NCT00837265|589106479|FG002|Main Phase|Death|0|||
163109356|NCT00837265|589106480|FG003|Main Phase|Death|0|||
163109357|NCT00837265|589106481|FG004|Main Phase|Death|2|||
163109358|NCT00837265|589106482|FG005|Main Phase|Death|0|||
163109359|NCT00837265|589106483|FG006|Main Phase|Death|1|||
163109360|NCT00837265|589106477|FG000|Main Phase|Lost to Follow-up|0|||
163109361|NCT00837265|589106478|FG001|Main Phase|Lost to Follow-up|0|||
163109362|NCT00837265|589106479|FG002|Main Phase|Lost to Follow-up|0|||
163109363|NCT00837265|589106480|FG003|Main Phase|Lost to Follow-up|0|||
163109364|NCT00837265|589106481|FG004|Main Phase|Lost to Follow-up|1|||
163109365|NCT00837265|589106482|FG005|Main Phase|Lost to Follow-up|0|||
163109366|NCT00837265|589106483|FG006|Main Phase|Lost to Follow-up|0|||
163109367|NCT00837265|589106477|FG000|Main Phase|Principal investigator resignation|0|||
163109368|NCT00837265|589106478|FG001|Main Phase|Principal investigator resignation|0|||
163109369|NCT00837265|589106479|FG002|Main Phase|Principal investigator resignation|0|||
163109370|NCT00837265|589106480|FG003|Main Phase|Principal investigator resignation|0|||
163109371|NCT00837265|589106481|FG004|Main Phase|Principal investigator resignation|2|||
163109372|NCT00837265|589106482|FG005|Main Phase|Principal investigator resignation|0|||
163109373|NCT00837265|589106483|FG006|Main Phase|Principal investigator resignation|0|||
163109374|NCT00837265|589106477|FG000|Main Phase|Participant's personal reason|0|||
163109375|NCT00837265|589106478|FG001|Main Phase|Participant's personal reason|0|||
163109376|NCT00837265|589106479|FG002|Main Phase|Participant's personal reason|0|||
163109377|NCT00837265|589106480|FG003|Main Phase|Participant's personal reason|0|||
163109378|NCT00837265|589106481|FG004|Main Phase|Participant's personal reason|1|||
163109379|NCT00837265|589106482|FG005|Main Phase|Participant's personal reason|0|||
163109380|NCT00837265|589106483|FG006|Main Phase|Participant's personal reason|0|||
163109381|NCT00733291|589106485|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
163109382|NCT00733291|589106486|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109383|NCT00733291|589106487|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109384|NCT00733291|589106488|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
163109385|NCT01751906|589106495|FG000|Overall Study|Lost to Follow-up|151|||
163109386|NCT01751906|589106496|FG001|Overall Study|Lost to Follow-up|68|||
163109387|NCT01751906|589106495|FG000|Overall Study|Withdrawal by Subject|22|||
163109388|NCT01751906|589106496|FG001|Overall Study|Withdrawal by Subject|18|||
163109389|NCT01751906|589106495|FG000|Overall Study|Physician Decision|5|||
163109390|NCT01751906|589106496|FG001|Overall Study|Physician Decision|2|||
163109391|NCT01751906|589106495|FG000|Overall Study|Death|84|||
163109392|NCT01751906|589106496|FG001|Overall Study|Death|43|||
162653833|NCT01143090|587449607|FG000|Overall Study|Lack of Efficacy|2|||
162653834|NCT01143090|587449607|FG000|Overall Study|Adverse Event|17|||
162653835|NCT01143090|587449607|FG000|Overall Study|Lost to Follow-up|9|||
162653836|NCT01143090|587449607|FG000|Overall Study|Protocol Violation|2|||
162653837|NCT01143090|587449607|FG000|Overall Study|Withdrawal by Subject|18|||
163109393|NCT01751906|589106495|FG000|Overall Study|Denied on premises for follow-up by law|1|||
163109394|NCT01751906|589106496|FG001|Overall Study|Denied on premises for follow-up by law|0|||
163109395|NCT01110330|589106501|FG000|Overall Study|Adverse Event|0|||
163109396|NCT01110330|589106502|FG001|Overall Study|Adverse Event|4|||
163109397|NCT01110330|589106503|FG002|Overall Study|Adverse Event|3|||
163109398|NCT01110330|589106501|FG000|Overall Study|Lack of Efficacy|3|||
163109399|NCT01110330|589106502|FG001|Overall Study|Lack of Efficacy|1|||
163109400|NCT01110330|589106503|FG002|Overall Study|Lack of Efficacy|1|||
163109401|NCT01110330|589106501|FG000|Overall Study|Lost to Follow-up|9|||
163109402|NCT01110330|589106502|FG001|Overall Study|Lost to Follow-up|10|||
163109403|NCT01110330|589106503|FG002|Overall Study|Lost to Follow-up|15|||
163109404|NCT01110330|589106501|FG000|Overall Study|Physician Decision|0|||
163109405|NCT01110330|589106502|FG001|Overall Study|Physician Decision|1|||
163109406|NCT01110330|589106503|FG002|Overall Study|Physician Decision|0|||
163109407|NCT01110330|589106501|FG000|Overall Study|Protocol Violation|2|||
163109408|NCT01110330|589106502|FG001|Overall Study|Protocol Violation|0|||
163109409|NCT01110330|589106503|FG002|Overall Study|Protocol Violation|4|||
162653838|NCT01143090|587449607|FG000|Overall Study|Non-compliance with study drug|1|||
162719216|NCT00150176|587678434|FG000|Overall Study|Lost to Follow-up|3|||
163109410|NCT01110330|589106501|FG000|Overall Study|Withdrawal by Subject|0|||
163109411|NCT01110330|589106502|FG001|Overall Study|Withdrawal by Subject|6|||
163109412|NCT01110330|589106503|FG002|Overall Study|Withdrawal by Subject|2|||
163109413|NCT01110330|589106501|FG000|Overall Study|Other|1|||
163109414|NCT01110330|589106502|FG001|Overall Study|Other|1|||
163109415|NCT01110330|589106503|FG002|Overall Study|Other|1|||
163109416|NCT02759107|589106504|FG000|Overall Study|Adverse Event|0|||
163109417|NCT02759107|589106505|FG001|Overall Study|Adverse Event|0|||
163109418|NCT02759107|589106506|FG002|Overall Study|Adverse Event|0|||
163109419|NCT02759107|589106507|FG003|Overall Study|Adverse Event|0|||
163109420|NCT02759107|589106508|FG004|Overall Study|Adverse Event|0|||
163109421|NCT02759107|589106509|FG005|Overall Study|Adverse Event|0|||
163109422|NCT02759107|589106510|FG006|Overall Study|Adverse Event|0|||
163109423|NCT02759107|589106511|FG007|Overall Study|Adverse Event|0|||
163109424|NCT02759107|589106512|FG008|Overall Study|Adverse Event|0|||
163109425|NCT02759107|589106513|FG009|Overall Study|Adverse Event|0|||
163109426|NCT02759107|589106514|FG010|Overall Study|Adverse Event|0|||
163109427|NCT02759107|589106515|FG011|Overall Study|Adverse Event|0|||
163109428|NCT02759107|589106516|FG012|Overall Study|Adverse Event|2|||
163109429|NCT02759107|589106517|FG013|Overall Study|Adverse Event|0|||
163109430|NCT02759107|589106518|FG014|Overall Study|Adverse Event|0|||
163109431|NCT02759107|589106519|FG015|Overall Study|Adverse Event|1|||
163109432|NCT02759107|589106520|FG016|Overall Study|Adverse Event|0|||
163109433|NCT02759107|589106521|FG017|Overall Study|Adverse Event|2|||
163109434|NCT02759107|589106504|FG000|Overall Study|Scheduling Conflict|0|||
163109435|NCT02759107|589106505|FG001|Overall Study|Scheduling Conflict|0|||
163109436|NCT02759107|589106506|FG002|Overall Study|Scheduling Conflict|0|||
163109437|NCT02759107|589106507|FG003|Overall Study|Scheduling Conflict|0|||
163109438|NCT02759107|589106508|FG004|Overall Study|Scheduling Conflict|0|||
163109439|NCT02759107|589106509|FG005|Overall Study|Scheduling Conflict|0|||
163109440|NCT02759107|589106510|FG006|Overall Study|Scheduling Conflict|0|||
163109441|NCT02759107|589106511|FG007|Overall Study|Scheduling Conflict|0|||
163109442|NCT02759107|589106512|FG008|Overall Study|Scheduling Conflict|0|||
163109443|NCT02759107|589106513|FG009|Overall Study|Scheduling Conflict|1|||
163109444|NCT02759107|589106514|FG010|Overall Study|Scheduling Conflict|0|||
163109445|NCT02759107|589106515|FG011|Overall Study|Scheduling Conflict|0|||
163109446|NCT02759107|589106516|FG012|Overall Study|Scheduling Conflict|0|||
163109447|NCT02759107|589106517|FG013|Overall Study|Scheduling Conflict|0|||
163109448|NCT02759107|589106518|FG014|Overall Study|Scheduling Conflict|0|||
163109449|NCT02759107|589106519|FG015|Overall Study|Scheduling Conflict|0|||
163109450|NCT02759107|589106520|FG016|Overall Study|Scheduling Conflict|0|||
163109451|NCT02759107|589106521|FG017|Overall Study|Scheduling Conflict|0|||
163109452|NCT00420004|589106527|FG000|Overall Study|Adverse Event|4|||
163109453|NCT00420004|589106528|FG001|Overall Study|Adverse Event|1|||
163109454|NCT00420004|589106529|FG002|Overall Study|Adverse Event|1|||
163109455|NCT00420004|589106527|FG000|Overall Study|Lack of Efficacy|5|||
163109456|NCT00420004|589106528|FG001|Overall Study|Lack of Efficacy|4|||
163109457|NCT00420004|589106529|FG002|Overall Study|Lack of Efficacy|1|||
163109458|NCT00420004|589106527|FG000|Overall Study|Lost to Follow-up|31|||
163109459|NCT00420004|589106528|FG001|Overall Study|Lost to Follow-up|12|||
163109460|NCT00420004|589106529|FG002|Overall Study|Lost to Follow-up|10|||
162653839|NCT01143090|587449607|FG000|Overall Study|Failure to meet eligibility criteria|1|||
162653840|NCT01143090|587449607|FG000|Overall Study|Administrative|1|||
162653841|NCT01800916|587449610|FG000|Test Period 1 (1 Week)|Convex product user|0|||
162653842|NCT01800916|587449611|FG001|Test Period 1 (1 Week)|Convex product user|0|||
162653843|NCT01800916|587449612|FG002|Test Period 1 (1 Week)|Convex product user|0|||
162653844|NCT01800916|587449613|FG003|Test Period 1 (1 Week)|Convex product user|1|||
162653845|NCT01800916|587449614|FG004|Test Period 1 (1 Week)|Convex product user|0|||
163109461|NCT00420004|589106527|FG000|Overall Study|Entry Criteria Not Met|0|||
163109462|NCT00420004|589106528|FG001|Overall Study|Entry Criteria Not Met|1|||
163109463|NCT00420004|589106529|FG002|Overall Study|Entry Criteria Not Met|0|||
163109464|NCT00420004|589106527|FG000|Overall Study|Physician Decision|14|||
163109465|NCT00420004|589106528|FG001|Overall Study|Physician Decision|4|||
163109466|NCT00420004|589106529|FG002|Overall Study|Physician Decision|2|||
163109467|NCT00420004|589106527|FG000|Overall Study|Protocol Violation|5|||
163109468|NCT00420004|589106528|FG001|Overall Study|Protocol Violation|4|||
163109469|NCT00420004|589106529|FG002|Overall Study|Protocol Violation|3|||
163109470|NCT00420004|589106527|FG000|Overall Study|Withdrawal by Subject|67|||
163109471|NCT00420004|589106528|FG001|Overall Study|Withdrawal by Subject|42|||
163109472|NCT00420004|589106529|FG002|Overall Study|Withdrawal by Subject|14|||
163109473|NCT00420004|589106527|FG000|Overall Study|Sponsor Decision|3|||
163109474|NCT00420004|589106528|FG001|Overall Study|Sponsor Decision|3|||
163109475|NCT00420004|589106529|FG002|Overall Study|Sponsor Decision|1|||
163109476|NCT00591149|589106530|FG000|Overall Study|Adverse Event|4|||
163109477|NCT00591149|589106530|FG000|Overall Study|Withdrawal by Subject|1|||
163109478|NCT03002818|589106531|FG000|Overall Study|Decision of the investigator|1|||
163109479|NCT01606787|589106533|FG000|Overall Study|Withdrawal by Subject|4|||
162653846|NCT01800916|587449615|FG005|Test Period 1 (1 Week)|Convex product user|0|||
163109480|NCT01606787|589106534|FG001|Overall Study|Withdrawal by Subject|5|||
162719217|NCT00150176|587678435|FG001|Overall Study|Lost to Follow-up|3|||
162719218|NCT00150176|587678434|FG000|Overall Study|OTHER|11|||
162719219|NCT00150176|587678435|FG001|Overall Study|OTHER|13|||
162719220|NCT04035668|587678439|FG000|Overall Study|Adverse Event|3|||
162719221|NCT04035668|587678440|FG001|Overall Study|Adverse Event|4|||
162719222|NCT04035668|587678441|FG002|Overall Study|Adverse Event|2|||
162719223|NCT04035668|587678439|FG000|Overall Study|Lost to Follow-up|0|||
162719224|NCT04035668|587678440|FG001|Overall Study|Lost to Follow-up|1|||
162719225|NCT04035668|587678441|FG002|Overall Study|Lost to Follow-up|0|||
162719226|NCT04035668|587678439|FG000|Overall Study|Physician Decision|2|||
162719227|NCT04035668|587678440|FG001|Overall Study|Physician Decision|1|||
162719228|NCT04035668|587678441|FG002|Overall Study|Physician Decision|1|||
162719229|NCT04035668|587678439|FG000|Overall Study|Subject Decision|2|||
162719230|NCT04035668|587678440|FG001|Overall Study|Subject Decision|2|||
162719231|NCT04035668|587678441|FG002|Overall Study|Subject Decision|0|||
162719232|NCT02385669|587678443|FG000|Overall Study|Adverse Event|2|||
162719233|NCT00004124|587678444|FG000|Overall Study|Received no protocol therapy|12|||
162719234|NCT00004124|587678445|FG001|Overall Study|Received no protocol therapy|20|||
163109481|NCT01606787|589106533|FG000|Overall Study|Surgery canceled|0|||
162719235|NCT02937831|587678446|FG000|Overall Study|Protocol Violation|4|||
162719236|NCT00114244|587678449|FG000|Overall Study|Adverse Event|2|||
162719237|NCT00114244|587678450|FG001|Overall Study|Adverse Event|5|||
162719238|NCT00114244|587678449|FG000|Overall Study|Withdrawal by Subject|0|||
162719239|NCT00114244|587678450|FG001|Overall Study|Withdrawal by Subject|2|||
162719240|NCT03262935|587678457|FG000|Overall Study|Withdrawal by Subject|6|||
162719241|NCT03262935|587678458|FG001|Overall Study|Withdrawal by Subject|7|||
162719242|NCT03262935|587678457|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
162719243|NCT03262935|587678458|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
162719244|NCT03262935|587678457|FG000|Overall Study|Death|181|||
162719245|NCT03262935|587678458|FG001|Overall Study|Death|94|||
163109482|NCT01606787|589106534|FG001|Overall Study|Surgery canceled|2|||
163109483|NCT00713349|589106541|FG000|Overall Study|Protocol Violation|1|||
163109484|NCT03299881|589106542|FG000|Overall Study|Study Termination|17|||
163109485|NCT03299881|589106543|FG001|Overall Study|Study Termination|13|||
163109486|NCT01289353|589106544|FG000|Overall Study|Lost to Follow-up|2|||
163109487|NCT00473668|589106547|FG000|Overall Study|Withdrawal by Subject|0|||
163109488|NCT00473668|589106548|FG001|Overall Study|Withdrawal by Subject|2|||
163109489|NCT00473668|589106549|FG002|Overall Study|Withdrawal by Subject|0|||
163109490|NCT00473668|589106547|FG000|Overall Study|Migrated/moved from study area|3|||
163109491|NCT00473668|589106548|FG001|Overall Study|Migrated/moved from study area|2|||
163109492|NCT00473668|589106549|FG002|Overall Study|Migrated/moved from study area|0|||
163109493|NCT00473668|589106547|FG000|Overall Study|Lost to Follow-up|0|||
163109494|NCT00473668|589106548|FG001|Overall Study|Lost to Follow-up|4|||
163109495|NCT00473668|589106549|FG002|Overall Study|Lost to Follow-up|6|||
163109496|NCT00473668|589106547|FG000|Overall Study|Other|2|||
163109497|NCT00473668|589106548|FG001|Overall Study|Other|3|||
163109498|NCT00473668|589106549|FG002|Overall Study|Other|4|||
163109499|NCT02226562|589106550|FG000|Overall Study|Lost to Follow-up|0|||
163109500|NCT02226562|589106551|FG001|Overall Study|Lost to Follow-up|1|||
163109501|NCT04569136|589106552|FG000|Overall Study|Lost to Follow-up|2|||
163109502|NCT04569136|589106553|FG001|Overall Study|Lost to Follow-up|0|||
163109503|NCT04569136|589106554|FG002|Overall Study|Lost to Follow-up|1|||
163109504|NCT01466660|589106560|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
163109505|NCT01466660|589106561|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
163109506|NCT01466660|589106560|FG000|Overall Study|Worsening of underlying cancer disease|5|||
163109507|NCT01466660|589106561|FG001|Overall Study|Worsening of underlying cancer disease|2|||
162719246|NCT03262935|587678457|FG000|Overall Study|Lost to Follow-up|9|||
162719247|NCT03262935|587678458|FG001|Overall Study|Lost to Follow-up|4|||
162719248|NCT03262935|587678457|FG000|Overall Study|Other reason|5|||
162719249|NCT03262935|587678458|FG001|Overall Study|Other reason|0|||
162719250|NCT03557008|587678459|FG000|Overall Study|Withdrawal by Subject|2|||
163109508|NCT01466660|589106560|FG000|Overall Study|Other adverse event|19|||
163109509|NCT01466660|589106561|FG001|Overall Study|Other adverse event|18|||
163109510|NCT01466660|589106560|FG000|Overall Study|Protocol Violation|2|||
163109511|NCT01466660|589106561|FG001|Overall Study|Protocol Violation|1|||
163109512|NCT01466660|589106560|FG000|Overall Study|Refused continuation of trial medication|4|||
163109513|NCT01466660|589106561|FG001|Overall Study|Refused continuation of trial medication|3|||
163109514|NCT01466660|589106560|FG000|Overall Study|Other reason not defined above|10|||
163109515|NCT01466660|589106561|FG001|Overall Study|Other reason not defined above|8|||
163109516|NCT03576066|589106562|FG000|Overall Study|Noncompliance with study drug|0|||
163109517|NCT03576066|589106563|FG001|Overall Study|Noncompliance with study drug|1|||
162719251|NCT03557008|587678460|FG001|Overall Study|Withdrawal by Subject|2|||
162719252|NCT03557008|587678459|FG000|Overall Study|Early termination from study|3|||
162719253|NCT03557008|587678460|FG001|Overall Study|Early termination from study|1|||
163109518|NCT00129701|589106564|FG000|Overall Study|Withdrawal by Subject|33|||
163109519|NCT02750345|589106565|FG000|Intervention 1|Adverse Event|0|||
163109520|NCT02750345|589106566|FG001|Intervention 1|Adverse Event|0|||
163109521|NCT02750345|589106567|FG002|Intervention 1|Adverse Event|0|||
163109522|NCT02750345|589106568|FG003|Intervention 1|Adverse Event|0|||
163109523|NCT02750345|589106569|FG004|Intervention 1|Adverse Event|1|||
163109524|NCT02750345|589106570|FG005|Intervention 1|Adverse Event|0|||
163109525|NCT00006164|589106571|FG000|Overall Study|Withdrew or lost to follow-up|70|||
163109526|NCT00006164|589106572|FG001|Overall Study|Withdrew or lost to follow-up|81|||
163109527|NCT00223808|589106573|FG000|Overall Study|<5 hrs therapy before discharge|3|||
163109528|NCT00223808|589106574|FG001|Overall Study|<5 hrs therapy before discharge|5|||
163109529|NCT00223808|589106575|FG002|Overall Study|<5 hrs therapy before discharge|5|||
163109530|NCT00191724|589106578|FG000|Overall Study|Adverse Event|0|||
163109531|NCT00191724|589106579|FG001|Overall Study|Adverse Event|0|||
163109532|NCT00191724|589106580|FG002|Overall Study|Adverse Event|1|||
163109533|NCT00191724|589106581|FG003|Overall Study|Adverse Event|0|||
163109534|NCT00191724|589106582|FG004|Overall Study|Adverse Event|0|||
163109535|NCT00191724|589106578|FG000|Overall Study|Lost to Follow-up|1|||
163109536|NCT00191724|589106579|FG001|Overall Study|Lost to Follow-up|1|||
163109537|NCT00191724|589106580|FG002|Overall Study|Lost to Follow-up|0|||
163109538|NCT00191724|589106581|FG003|Overall Study|Lost to Follow-up|2|||
163109539|NCT00191724|589106582|FG004|Overall Study|Lost to Follow-up|3|||
163109540|NCT00191724|589106578|FG000|Overall Study|Withdrawal by Subject|0|||
163109541|NCT00191724|589106579|FG001|Overall Study|Withdrawal by Subject|0|||
163109542|NCT00191724|589106580|FG002|Overall Study|Withdrawal by Subject|0|||
163109543|NCT00191724|589106581|FG003|Overall Study|Withdrawal by Subject|1|||
163109544|NCT00191724|589106582|FG004|Overall Study|Withdrawal by Subject|0|||
163109545|NCT00608023|589106583|FG000|Overall Study|Withdrawal by Subject|8|||
163109546|NCT00608023|589106584|FG001|Overall Study|Withdrawal by Subject|10|||
163109547|NCT00608023|589106585|FG002|Overall Study|Withdrawal by Subject|7|||
163109548|NCT00608023|589106583|FG000|Overall Study|Adverse Event|1|||
163109549|NCT00608023|589106584|FG001|Overall Study|Adverse Event|4|||
163109550|NCT00608023|589106585|FG002|Overall Study|Adverse Event|5|||
163109551|NCT00608023|589106583|FG000|Overall Study|Lost to Follow-up|2|||
163109552|NCT00608023|589106584|FG001|Overall Study|Lost to Follow-up|2|||
163109553|NCT00608023|589106585|FG002|Overall Study|Lost to Follow-up|1|||
163109554|NCT00608023|589106583|FG000|Overall Study|Protocol Violation|1|||
163109555|NCT00608023|589106584|FG001|Overall Study|Protocol Violation|3|||
163109556|NCT00608023|589106585|FG002|Overall Study|Protocol Violation|1|||
163109557|NCT00608023|589106583|FG000|Overall Study|Unknown reason|0|||
163109558|NCT00608023|589106584|FG001|Overall Study|Unknown reason|3|||
163109559|NCT00608023|589106585|FG002|Overall Study|Unknown reason|0|||
163109560|NCT01231321|589106588|FG000|Overall Study|Adverse Event|3|||
163109561|NCT01231321|589106588|FG000|Overall Study|Lack of Efficacy|2|||
163109562|NCT00489736|589106589|FG000|Overall Study|Lack of Efficacy|53|||
163109563|NCT00489736|589106590|FG001|Overall Study|Lack of Efficacy|14|||
163109564|NCT00489736|589106589|FG000|Overall Study|Adverse Event|32|||
163109565|NCT00489736|589106590|FG001|Overall Study|Adverse Event|45|||
163109566|NCT00489736|589106589|FG000|Overall Study|Poor compliance|6|||
163109567|NCT00489736|589106590|FG001|Overall Study|Poor compliance|2|||
163109568|NCT00489736|589106589|FG000|Overall Study|Not coded/ Not pre-specified|5|||
163109569|NCT00489736|589106590|FG001|Overall Study|Not coded/ Not pre-specified|8|||
163109570|NCT04021524|589106591|FG000|Overall Study|Change in surgical intervention|0|||
163109571|NCT04021524|589106592|FG001|Overall Study|Change in surgical intervention|1|||
163109572|NCT06422364|589106593|FG000|Overall Study|Withdrawn due to study closure|0|||
163109573|NCT06422364|589106594|FG001|Overall Study|Withdrawn due to study closure|2|||
163109574|NCT05260073|589106596|FG000|Overall Study|Physician Decision|1|||
163109575|NCT05260073|589106596|FG000|Overall Study|Withdrawal by Subject|6|||
163109576|NCT05260073|589106596|FG000|Overall Study|Lost to Follow-up|14|||
163109577|NCT03458910|589106597|FG000|Overall Study|Withdrawal by Subject|7|||
163109578|NCT03458910|589106598|FG001|Overall Study|Withdrawal by Subject|8|||
163109579|NCT03458910|589106599|FG002|Overall Study|Withdrawal by Subject|6|||
163109580|NCT03458910|589106600|FG003|Overall Study|Withdrawal by Subject|4|||
163109581|NCT03458910|589106597|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
163109582|NCT03458910|589106598|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
163109583|NCT03458910|589106599|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
163109584|NCT03458910|589106600|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
163109585|NCT05275010|589106601|FG000|Overall Study|Reason Not Specified|4|||
163109586|NCT05275010|589106602|FG001|Overall Study|Reason Not Specified|1|||
163109587|NCT05275010|589106601|FG000|Overall Study|Withdrawal by Subject|1|||
163109588|NCT05275010|589106602|FG001|Overall Study|Withdrawal by Subject|0|||
163109589|NCT05275010|589106601|FG000|Overall Study|Lost to Follow-up|0|||
163109590|NCT05275010|589106602|FG001|Overall Study|Lost to Follow-up|1|||
163109591|NCT04484649|589106603|FG000|Overall Study|Lost to Follow-up|2|||
163109592|NCT04484649|589106604|FG001|Overall Study|Lost to Follow-up|1|||
163109593|NCT04484649|589106603|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
163109594|NCT04484649|589106604|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
163109595|NCT00245050|589106609|FG000|Overall Study|Adverse Event|3|||
163109596|NCT00245050|589106610|FG001|Overall Study|Adverse Event|2|||
163109597|NCT03275246|589106613|FG000|Overall Study|Protocol Violation|5|||
163109598|NCT03275246|589106613|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
163109599|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
163109600|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
163109601|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
163109602|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
163109603|NCT02301546|589106614|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
163109604|NCT02301546|589106615|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
163109605|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
163109606|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
163109607|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
163109608|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
163109609|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
163109610|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
163109611|NCT02301546|589106614|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
163109612|NCT02301546|589106615|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
163109613|NCT05059301|589106616|FG000|Overall Study|Adverse Event|0|||
163109614|NCT05059301|589106617|FG001|Overall Study|Adverse Event|2|||
163109615|NCT05059301|589106618|FG002|Overall Study|Adverse Event|2|||
163109616|NCT05059301|589106616|FG000|Overall Study|Lost to Follow-up|2|||
163109617|NCT05059301|589106617|FG001|Overall Study|Lost to Follow-up|3|||
163109618|NCT05059301|589106618|FG002|Overall Study|Lost to Follow-up|3|||
163109619|NCT04952597|589106620|FG000|Overall Study|Death|12|||
163109620|NCT04952597|589106621|FG001|Overall Study|Death|13|||
163109621|NCT04952597|589106622|FG002|Overall Study|Death|14|||
163109622|NCT04952597|589106620|FG000|Overall Study|Withdrawal by Subject|1|||
163109623|NCT04952597|589106621|FG001|Overall Study|Withdrawal by Subject|0|||
163109624|NCT04952597|589106622|FG002|Overall Study|Withdrawal by Subject|3|||
163109625|NCT04952597|589106620|FG000|Overall Study|Lost to Follow-up|0|||
163109626|NCT04952597|589106621|FG001|Overall Study|Lost to Follow-up|1|||
163109627|NCT04952597|589106622|FG002|Overall Study|Lost to Follow-up|1|||
163109628|NCT04238481|589106638|FG000|Overall Study|Miscellaneous|0|||
163109629|NCT04238481|589106639|FG001|Overall Study|Miscellaneous|1|||
163109630|NCT04238481|589106640|FG002|Overall Study|Miscellaneous|0|||
163109631|NCT04238481|589106641|FG003|Overall Study|Miscellaneous|0|||
163109632|NCT02152371|589106642|FG000|Overall Study|Adverse Event|6|||
163109633|NCT02152371|589106643|FG001|Overall Study|Adverse Event|2|||
163109634|NCT02152371|589106642|FG000|Overall Study|Withdrawal by Subject|3|||
163109635|NCT02152371|589106643|FG001|Overall Study|Withdrawal by Subject|7|||
163109636|NCT02152371|589106642|FG000|Overall Study|Protocol Violation|2|||
163109637|NCT02152371|589106643|FG001|Overall Study|Protocol Violation|3|||
163109638|NCT02152371|589106642|FG000|Overall Study|Lost to Follow-up|1|||
163109639|NCT02152371|589106643|FG001|Overall Study|Lost to Follow-up|0|||
163109640|NCT02152371|589106642|FG000|Overall Study|Lack of Efficacy|0|||
163109641|NCT02152371|589106643|FG001|Overall Study|Lack of Efficacy|1|||
163109642|NCT02152371|589106642|FG000|Overall Study|Physician Decision|0|||
163109643|NCT02152371|589106643|FG001|Overall Study|Physician Decision|2|||
163109644|NCT02152371|589106642|FG000|Overall Study|Reason Not Given|0|||
163109645|NCT02152371|589106643|FG001|Overall Study|Reason Not Given|1|||
163109646|NCT00656058|589106645|FG000|Overall Study|Withdrawal by Subject|2|||
163109647|NCT00656058|589106645|FG000|Overall Study|Withdrawal by Subject|4|||
163109648|NCT03194568|589106646|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
163109649|NCT05285644|589106647|FG000|Overall Study|Adverse Event|3|||
163109650|NCT05285644|589106648|FG001|Overall Study|Adverse Event|3|||
163109651|NCT05285644|589106647|FG000|Overall Study|Withdrawal of Consent|2|||
163109652|NCT05285644|589106648|FG001|Overall Study|Withdrawal of Consent|5|||
163109653|NCT05285644|589106647|FG000|Overall Study|Noncompliance|0|||
163109654|NCT05285644|589106648|FG001|Overall Study|Noncompliance|4|||
163109655|NCT05285644|589106647|FG000|Overall Study|Lost to Follow-up|4|||
163109656|NCT05285644|589106648|FG001|Overall Study|Lost to Follow-up|6|||
163109657|NCT05285644|589106647|FG000|Overall Study|Disallowed Concurrent Medication|1|||
163109658|NCT05285644|589106648|FG001|Overall Study|Disallowed Concurrent Medication|1|||
163109659|NCT05285644|589106647|FG000|Overall Study|Investigator Decision|2|||
163109660|NCT05285644|589106648|FG001|Overall Study|Investigator Decision|0|||
163109661|NCT05285644|589106647|FG000|Overall Study|Protocol Deviation|1|||
163109662|NCT05285644|589106648|FG001|Overall Study|Protocol Deviation|0|||
163109663|NCT05285644|589106647|FG000|Overall Study|As specified in the Clinical Study Report|7|||
163109664|NCT05285644|589106648|FG001|Overall Study|As specified in the Clinical Study Report|3|||
163109665|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109666|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
162719254|NCT01811706|587678461|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
162719255|NCT01811706|587678462|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
162719256|NCT02224924|587678465|FG000|Overall Study|Withdrawal by Subject|7|||
162719257|NCT02224924|587678466|FG001|Overall Study|Withdrawal by Subject|6|||
162719258|NCT02224924|587678465|FG000|Overall Study|Biopsy cancelled|20|||
162719259|NCT02224924|587678466|FG001|Overall Study|Biopsy cancelled|14|||
162719260|NCT02224924|587678465|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
162719261|NCT02224924|587678466|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
162719262|NCT02224924|587678465|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
162719263|NCT02224924|587678466|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
162719264|NCT00943735|587678469|FG000|Overall Study|Adverse Event|12|||
162719265|NCT00943735|587678469|FG000|Overall Study|Withdrawal by Subject|8|||
162719266|NCT00943735|587678469|FG000|Overall Study|Death|1|||
162719267|NCT00943735|587678469|FG000|Overall Study|Other|8|||
162719268|NCT00943735|587678469|FG000|Overall Study|Other|3|||
162719269|NCT00545844|587678470|FG000|Overall Study|Lost to Follow-up|9|||
162719270|NCT00545844|587678470|FG000|Overall Study|Protocol Violation|1|||
162719271|NCT00545844|587678470|FG000|Overall Study|Withdrawal by Subject|2|||
162719272|NCT01329328|587678471|FG000|Overall Study|Withdrawal by Subject|2|||
162719273|NCT01329328|587678472|FG001|Overall Study|Withdrawal by Subject|4|||
162719274|NCT01329328|587678473|FG002|Overall Study|Withdrawal by Subject|3|||
162719275|NCT02503202|587678475|FG000|Base Study: Up to Month 6|Death|1|||
162719276|NCT02503202|587678476|FG001|Base Study: Up to Month 6|Death|1|||
162719277|NCT02503202|587678477|FG002|Base Study: Up to Month 6|Death|0|||
162719278|NCT02503202|587678478|FG003|Base Study: Up to Month 6|Death|0|||
162719279|NCT02503202|587678479|FG004|Base Study: Up to Month 6|Death|0|||
163109667|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109668|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109669|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109670|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109671|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
163109672|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
163109673|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109674|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109675|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109676|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
163109677|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
163109678|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
163109679|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109680|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
163109681|NCT01448824|589108330|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109682|NCT01448824|589108331|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109683|NCT01448824|589108332|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109684|NCT01448824|589108333|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109685|NCT01448824|589108334|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109686|NCT01448824|589108335|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
163109687|NCT01448824|589108336|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109688|NCT01448824|589108337|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
163109689|NCT01448824|589108330|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
163109690|NCT01448824|589108331|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
163109691|NCT01448824|589108332|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
162719280|NCT02503202|587678475|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
162719281|NCT02503202|587678476|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
162719282|NCT02503202|587678477|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
162719283|NCT02503202|587678478|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
162719284|NCT02503202|587678479|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
162719285|NCT02503202|587678475|FG000|Base Study: Up to Month 6|Physician Decision|0|||
162719286|NCT02503202|587678476|FG001|Base Study: Up to Month 6|Physician Decision|0|||
162719287|NCT02503202|587678477|FG002|Base Study: Up to Month 6|Physician Decision|0|||
162719288|NCT02503202|587678478|FG003|Base Study: Up to Month 6|Physician Decision|0|||
162719289|NCT02503202|587678479|FG004|Base Study: Up to Month 6|Physician Decision|1|||
162719290|NCT02503202|587678475|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
162719291|NCT02503202|587678476|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
162719292|NCT02503202|587678477|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163109692|NCT01448824|589108333|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
162719293|NCT02503202|587678478|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163109693|NCT01448824|589108334|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
163109694|NCT01448824|589108335|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
163109695|NCT01448824|589108336|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
163109696|NCT01448824|589108337|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
163109697|NCT01448824|589108330|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109698|NCT01448824|589108331|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109699|NCT01448824|589108332|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109700|NCT01448824|589108333|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109701|NCT01448824|589108334|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109702|NCT01448824|589108335|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109703|NCT01448824|589108336|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163109704|NCT01448824|589108337|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
163109705|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109706|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109707|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109708|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109709|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109710|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109711|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
163109712|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
163109713|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109714|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109715|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109716|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109717|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109718|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109719|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
163109720|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
163109721|NCT01448824|589108330|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109722|NCT01448824|589108331|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109723|NCT01448824|589108332|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109724|NCT01448824|589108333|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109725|NCT01448824|589108334|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109726|NCT01448824|589108335|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109727|NCT01448824|589108336|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
163109728|NCT01448824|589108337|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
163109729|NCT01537081|589108340|FG000|Overall Study|Adverse Event|5|||
163109730|NCT01537081|589108341|FG001|Overall Study|Adverse Event|2|||
163109731|NCT01537081|589108342|FG002|Overall Study|Adverse Event|2|||
163109732|NCT01537081|589108340|FG000|Overall Study|Lack of Efficacy|2|||
163109733|NCT01537081|589108341|FG001|Overall Study|Lack of Efficacy|1|||
163109734|NCT01537081|589108342|FG002|Overall Study|Lack of Efficacy|0|||
163109735|NCT01537081|589108340|FG000|Overall Study|Lost to Follow-up|17|||
163109736|NCT01537081|589108341|FG001|Overall Study|Lost to Follow-up|15|||
163109737|NCT01537081|589108342|FG002|Overall Study|Lost to Follow-up|9|||
163109738|NCT01537081|589108340|FG000|Overall Study|Protocol Violation|3|||
163109739|NCT01537081|589108341|FG001|Overall Study|Protocol Violation|2|||
163109740|NCT01537081|589108342|FG002|Overall Study|Protocol Violation|2|||
163109741|NCT01537081|589108340|FG000|Overall Study|Withdrawal by Subject|6|||
163109742|NCT01537081|589108341|FG001|Overall Study|Withdrawal by Subject|11|||
163109743|NCT01537081|589108342|FG002|Overall Study|Withdrawal by Subject|3|||
163109744|NCT01537081|589108340|FG000|Overall Study|Physician Decision|5|||
163109745|NCT01537081|589108341|FG001|Overall Study|Physician Decision|6|||
163109746|NCT01537081|589108342|FG002|Overall Study|Physician Decision|0|||
163109747|NCT01537081|589108340|FG000|Overall Study|Sponsor decision|0|||
163109748|NCT01537081|589108341|FG001|Overall Study|Sponsor decision|1|||
162653847|NCT01800916|587449616|FG006|Test Period 1 (1 Week)|Convex product user|0|||
163109749|NCT01537081|589108342|FG002|Overall Study|Sponsor decision|0|||
163109750|NCT01537081|589108340|FG000|Overall Study|Assigned but never dosed|1|||
162653848|NCT01800916|587449617|FG007|Test Period 1 (1 Week)|Convex product user|0|||
163109751|NCT01537081|589108341|FG001|Overall Study|Assigned but never dosed|0|||
163109752|NCT01537081|589108342|FG002|Overall Study|Assigned but never dosed|0|||
163109753|NCT01463111|589108343|FG000|Overall Study|Withdrawal by Subject|2|||
163109754|NCT01463111|589108343|FG000|Overall Study|Lost to Follow-up|5|||
163109755|NCT01463111|589108343|FG000|Overall Study|Physician Decision|2|||
163109756|NCT00882583|589108344|FG000|Overall Study|Physician Decision|1|||
163109757|NCT00882583|589108345|FG001|Overall Study|Physician Decision|0|||
163109758|NCT00882583|589108344|FG000|Overall Study|Adverse Event|0|||
163109759|NCT00882583|589108345|FG001|Overall Study|Adverse Event|1|||
163109760|NCT00983515|589108346|FG000|Ritonavir Alone|liver panel out of range|6|||
163109761|NCT00983515|589108346|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
163109762|NCT02526524|589108349|FG000|Overall Study|Withdrawal by Subject|3|||
163109763|NCT02526524|589108350|FG001|Overall Study|Withdrawal by Subject|3|||
163109764|NCT02526524|589108351|FG002|Overall Study|Withdrawal by Subject|6|||
163109765|NCT02526524|589108352|FG003|Overall Study|Withdrawal by Subject|1|||
163109766|NCT02526524|589108353|FG004|Overall Study|Withdrawal by Subject|9|||
163109767|NCT02526524|589108354|FG005|Overall Study|Withdrawal by Subject|5|||
163109768|NCT02526524|589108349|FG000|Overall Study|Adverse Event|3|||
163109769|NCT02526524|589108350|FG001|Overall Study|Adverse Event|2|||
163109770|NCT02526524|589108351|FG002|Overall Study|Adverse Event|4|||
163109771|NCT02526524|589108352|FG003|Overall Study|Adverse Event|2|||
163109772|NCT02526524|589108353|FG004|Overall Study|Adverse Event|6|||
163109773|NCT02526524|589108354|FG005|Overall Study|Adverse Event|8|||
163109774|NCT02526524|589108349|FG000|Overall Study|Lost to Follow-up|2|||
163109775|NCT02526524|589108350|FG001|Overall Study|Lost to Follow-up|3|||
163109776|NCT02526524|589108351|FG002|Overall Study|Lost to Follow-up|8|||
163109777|NCT02526524|589108352|FG003|Overall Study|Lost to Follow-up|1|||
163109778|NCT02526524|589108353|FG004|Overall Study|Lost to Follow-up|2|||
163109779|NCT02526524|589108354|FG005|Overall Study|Lost to Follow-up|5|||
163109780|NCT02526524|589108349|FG000|Overall Study|Protocol Violation|3|||
163109781|NCT02526524|589108350|FG001|Overall Study|Protocol Violation|1|||
163109782|NCT02526524|589108351|FG002|Overall Study|Protocol Violation|5|||
163109783|NCT02526524|589108352|FG003|Overall Study|Protocol Violation|3|||
163109784|NCT02526524|589108353|FG004|Overall Study|Protocol Violation|4|||
163109785|NCT02526524|589108354|FG005|Overall Study|Protocol Violation|3|||
163109786|NCT02526524|589108349|FG000|Overall Study|Loss of Glucose Control|0|||
163109787|NCT02526524|589108350|FG001|Overall Study|Loss of Glucose Control|0|||
163109788|NCT02526524|589108351|FG002|Overall Study|Loss of Glucose Control|3|||
163109789|NCT02526524|589108352|FG003|Overall Study|Loss of Glucose Control|0|||
163109790|NCT02526524|589108353|FG004|Overall Study|Loss of Glucose Control|2|||
163109791|NCT02526524|589108354|FG005|Overall Study|Loss of Glucose Control|0|||
163109792|NCT02526524|589108349|FG000|Overall Study|Physician Decision|0|||
163109793|NCT02526524|589108350|FG001|Overall Study|Physician Decision|0|||
163109794|NCT02526524|589108351|FG002|Overall Study|Physician Decision|0|||
163109795|NCT02526524|589108352|FG003|Overall Study|Physician Decision|0|||
163109796|NCT02526524|589108353|FG004|Overall Study|Physician Decision|1|||
163109797|NCT02526524|589108354|FG005|Overall Study|Physician Decision|0|||
163109798|NCT02526524|589108349|FG000|Overall Study|Sponsor Decision|1|||
163109799|NCT02526524|589108350|FG001|Overall Study|Sponsor Decision|0|||
163109800|NCT02526524|589108351|FG002|Overall Study|Sponsor Decision|0|||
163109801|NCT02526524|589108352|FG003|Overall Study|Sponsor Decision|0|||
163109802|NCT02526524|589108353|FG004|Overall Study|Sponsor Decision|0|||
163109803|NCT02526524|589108354|FG005|Overall Study|Sponsor Decision|0|||
163109804|NCT03764631|589108361|FG000|Overall Study|Personal Reasons|3|||
163109805|NCT03764631|589108362|FG001|Overall Study|Personal Reasons|2|||
163109806|NCT03764631|589108361|FG000|Overall Study|Switching Therapy|3|||
163109807|NCT03764631|589108362|FG001|Overall Study|Switching Therapy|3|||
163109808|NCT03764631|589108361|FG000|Overall Study|Adverse Event|0|||
163109809|NCT03764631|589108362|FG001|Overall Study|Adverse Event|1|||
163109810|NCT03764631|589108361|FG000|Overall Study|Lost to Follow-up|33|||
163109811|NCT03764631|589108362|FG001|Overall Study|Lost to Follow-up|41|||
163109812|NCT03764631|589108361|FG000|Overall Study|No data as study site was closed|2|||
163109813|NCT03764631|589108362|FG001|Overall Study|No data as study site was closed|6|||
163109814|NCT01549886|589108363|FG000|Overall Study|Sponsor's decision|2|||
163109815|NCT01549886|589108364|FG001|Overall Study|Sponsor's decision|3|||
163109816|NCT02039219|589108365|FG000|Treatment|Withdrawal by Subject|1|||
163109817|NCT02039219|589108366|FG001|Treatment|Withdrawal by Subject|0|||
163109818|NCT02039219|589108365|FG000|Treatment|Adverse Event|0|||
163109819|NCT02039219|589108366|FG001|Treatment|Adverse Event|1|||
163109820|NCT02039219|589108365|FG000|Treatment|Physician Decision|1|||
163109821|NCT02039219|589108366|FG001|Treatment|Physician Decision|0|||
163109822|NCT02039219|589108365|FG000|Treatment|Lost to Follow-up|0|||
163109823|NCT02039219|589108366|FG001|Treatment|Lost to Follow-up|1|||
163109824|NCT02039219|589108365|FG000|Treatment|Protocol Violation|1|||
163109825|NCT02039219|589108366|FG001|Treatment|Protocol Violation|0|||
163109826|NCT02039219|589108365|FG000|Treatment|Death|1|||
163109827|NCT02039219|589108366|FG001|Treatment|Death|0|||
163109828|NCT02039219|589108365|FG000|Follow up|Adverse Event|0|||
163109829|NCT02039219|589108366|FG001|Follow up|Adverse Event|1|||
163109830|NCT01681069|589108377|FG000|Overall Study|Withdrawal by Subject|4|||
163109831|NCT01681069|589108378|FG001|Overall Study|Withdrawal by Subject|5|||
163109832|NCT01681069|589108377|FG000|Overall Study|Protocol Violation|1|||
163109833|NCT01681069|589108378|FG001|Overall Study|Protocol Violation|1|||
163109834|NCT01681069|589108377|FG000|Overall Study|Adverse Event|0|||
163109835|NCT01681069|589108378|FG001|Overall Study|Adverse Event|1|||
163109836|NCT01463696|589108379|FG000|Overall Study|Adverse Event|0|||
163109837|NCT01463696|589108380|FG001|Overall Study|Adverse Event|1|||
163109838|NCT01463696|589108381|FG002|Overall Study|Adverse Event|0|||
163109839|NCT01463696|589108382|FG003|Overall Study|Adverse Event|2|||
163109840|NCT01463696|589108383|FG004|Overall Study|Adverse Event|0|||
163109841|NCT01463696|589108384|FG005|Overall Study|Adverse Event|1|||
163109842|NCT01463696|589108385|FG006|Overall Study|Adverse Event|3|||
163109843|NCT01463696|589108386|FG007|Overall Study|Adverse Event|2|||
163109844|NCT01463696|589108379|FG000|Overall Study|Lost to Follow-up|0|||
163109845|NCT01463696|589108380|FG001|Overall Study|Lost to Follow-up|0|||
163109846|NCT01463696|589108381|FG002|Overall Study|Lost to Follow-up|1|||
163109847|NCT01463696|589108382|FG003|Overall Study|Lost to Follow-up|0|||
163109848|NCT01463696|589108383|FG004|Overall Study|Lost to Follow-up|0|||
163109849|NCT01463696|589108384|FG005|Overall Study|Lost to Follow-up|0|||
163109850|NCT01463696|589108385|FG006|Overall Study|Lost to Follow-up|0|||
163109851|NCT01463696|589108386|FG007|Overall Study|Lost to Follow-up|0|||
163109852|NCT01463696|589108379|FG000|Overall Study|Progressive Disease|0|||
163109853|NCT01463696|589108380|FG001|Overall Study|Progressive Disease|1|||
163109854|NCT01463696|589108381|FG002|Overall Study|Progressive Disease|0|||
163109855|NCT01463696|589108382|FG003|Overall Study|Progressive Disease|1|||
163109856|NCT01463696|589108383|FG004|Overall Study|Progressive Disease|0|||
163109857|NCT01463696|589108384|FG005|Overall Study|Progressive Disease|1|||
163109858|NCT01463696|589108385|FG006|Overall Study|Progressive Disease|4|||
163109859|NCT01463696|589108386|FG007|Overall Study|Progressive Disease|2|||
163109860|NCT01463696|589108379|FG000|Overall Study|Withdrawal by Subject|0|||
163109861|NCT01463696|589108380|FG001|Overall Study|Withdrawal by Subject|0|||
163109862|NCT01463696|589108381|FG002|Overall Study|Withdrawal by Subject|0|||
163109863|NCT01463696|589108382|FG003|Overall Study|Withdrawal by Subject|1|||
163109864|NCT01463696|589108383|FG004|Overall Study|Withdrawal by Subject|1|||
163109865|NCT01463696|589108384|FG005|Overall Study|Withdrawal by Subject|1|||
163109866|NCT01463696|589108385|FG006|Overall Study|Withdrawal by Subject|2|||
163109867|NCT01463696|589108386|FG007|Overall Study|Withdrawal by Subject|0|||
163109868|NCT01463696|589108379|FG000|Overall Study|Not Treated|0|||
163109869|NCT01463696|589108380|FG001|Overall Study|Not Treated|0|||
163109870|NCT01463696|589108381|FG002|Overall Study|Not Treated|0|||
163109871|NCT01463696|589108382|FG003|Overall Study|Not Treated|0|||
163109872|NCT01463696|589108383|FG004|Overall Study|Not Treated|0|||
163109873|NCT01463696|589108384|FG005|Overall Study|Not Treated|0|||
163109874|NCT01463696|589108385|FG006|Overall Study|Not Treated|1|||
163109875|NCT01463696|589108386|FG007|Overall Study|Not Treated|0|||
163109876|NCT03883165|589108388|FG000|Overall Study|Withdrawal by Subject|4|||
163109877|NCT03883165|589108389|FG001|Overall Study|Withdrawal by Subject|3|||
163109878|NCT00967694|589108390|FG000|Overall Study|Withdrawal by Subject|6|||
163109879|NCT05526781|589108392|FG000|Overall Study|Lost to Follow-up|1|||
163109880|NCT03905265|589108393|FG000|Overall Study|Withdrawal by Subject|1|||
163109881|NCT03905265|589108394|FG001|Overall Study|Withdrawal by Subject|1|||
163109882|NCT03905265|589108395|FG002|Overall Study|Withdrawal by Subject|0|||
163109883|NCT03905265|589108396|FG003|Overall Study|Withdrawal by Subject|0|||
163109884|NCT03632993|589108399|FG000|Overall Study|Withdrawal by Subject|1|||
163109885|NCT03632993|589108400|FG001|Overall Study|Withdrawal by Subject|0|||
163109886|NCT03632993|589108401|FG002|Overall Study|Withdrawal by Subject|0|||
163109887|NCT03632993|589108402|FG003|Overall Study|Withdrawal by Subject|0|||
163109888|NCT03632993|589108403|FG004|Overall Study|Withdrawal by Subject|0|||
163109889|NCT03632993|589108404|FG005|Overall Study|Withdrawal by Subject|0|||
163109890|NCT03632993|589108405|FG006|Overall Study|Withdrawal by Subject|0|||
163109891|NCT03632993|589108406|FG007|Overall Study|Withdrawal by Subject|0|||
163109892|NCT03632993|589108407|FG008|Overall Study|Withdrawal by Subject|0|||
163109893|NCT03632993|589108408|FG009|Overall Study|Withdrawal by Subject|1|||
163109894|NCT03632993|589108399|FG000|Overall Study|Protocol Non-compliance|0|||
163109895|NCT03632993|589108400|FG001|Overall Study|Protocol Non-compliance|1|||
163109896|NCT03632993|589108401|FG002|Overall Study|Protocol Non-compliance|0|||
163109897|NCT03632993|589108402|FG003|Overall Study|Protocol Non-compliance|0|||
163109898|NCT03632993|589108403|FG004|Overall Study|Protocol Non-compliance|0|||
163109899|NCT03632993|589108404|FG005|Overall Study|Protocol Non-compliance|0|||
163109900|NCT03632993|589108405|FG006|Overall Study|Protocol Non-compliance|0|||
163109901|NCT03632993|589108406|FG007|Overall Study|Protocol Non-compliance|0|||
163109902|NCT03632993|589108407|FG008|Overall Study|Protocol Non-compliance|0|||
163109903|NCT03632993|589108408|FG009|Overall Study|Protocol Non-compliance|0|||
163109904|NCT03632993|589108399|FG000|Overall Study|Lost to Follow-up|0|||
163109905|NCT03632993|589108400|FG001|Overall Study|Lost to Follow-up|0|||
163109906|NCT03632993|589108401|FG002|Overall Study|Lost to Follow-up|0|||
163109907|NCT03632993|589108402|FG003|Overall Study|Lost to Follow-up|0|||
163109908|NCT03632993|589108403|FG004|Overall Study|Lost to Follow-up|0|||
163109909|NCT03632993|589108404|FG005|Overall Study|Lost to Follow-up|1|||
163109910|NCT03632993|589108405|FG006|Overall Study|Lost to Follow-up|0|||
163109911|NCT03632993|589108406|FG007|Overall Study|Lost to Follow-up|1|||
163109912|NCT03632993|589108407|FG008|Overall Study|Lost to Follow-up|0|||
163109913|NCT03632993|589108408|FG009|Overall Study|Lost to Follow-up|0|||
163109914|NCT03632993|589108399|FG000|Overall Study|Adverse Event|0|||
163109915|NCT03632993|589108400|FG001|Overall Study|Adverse Event|0|||
163109916|NCT03632993|589108401|FG002|Overall Study|Adverse Event|0|||
163109917|NCT03632993|589108402|FG003|Overall Study|Adverse Event|0|||
163109918|NCT03632993|589108403|FG004|Overall Study|Adverse Event|0|||
163109919|NCT03632993|589108404|FG005|Overall Study|Adverse Event|1|||
163109920|NCT03632993|589108405|FG006|Overall Study|Adverse Event|0|||
163109921|NCT03632993|589108406|FG007|Overall Study|Adverse Event|1|||
163109922|NCT03632993|589108407|FG008|Overall Study|Adverse Event|0|||
163109923|NCT03632993|589108408|FG009|Overall Study|Adverse Event|0|||
163109924|NCT01005316|589108409|FG000|Overall Study|Adverse Event|0|||
163109925|NCT01005316|589108410|FG001|Overall Study|Adverse Event|0|||
163109926|NCT01005316|589108411|FG002|Overall Study|Adverse Event|0|||
163109927|NCT01005316|589108412|FG003|Overall Study|Adverse Event|1|||
163109928|NCT01005316|589108409|FG000|Overall Study|Death|20|||
163109929|NCT01005316|589108410|FG001|Overall Study|Death|5|||
163109930|NCT01005316|589108411|FG002|Overall Study|Death|1|||
163109931|NCT01005316|589108412|FG003|Overall Study|Death|15|||
163109932|NCT01005316|589108409|FG000|Overall Study|Study Termination|5|||
163109933|NCT01005316|589108410|FG001|Overall Study|Study Termination|63|||
163109934|NCT01005316|589108411|FG002|Overall Study|Study Termination|9|||
163109935|NCT01005316|589108412|FG003|Overall Study|Study Termination|85|||
163109936|NCT01005316|589108409|FG000|Overall Study|Lost to Follow-up|1|||
163109937|NCT01005316|589108410|FG001|Overall Study|Lost to Follow-up|3|||
163109938|NCT01005316|589108411|FG002|Overall Study|Lost to Follow-up|0|||
163109939|NCT01005316|589108412|FG003|Overall Study|Lost to Follow-up|2|||
163109940|NCT01005316|589108409|FG000|Overall Study|Physician Decision|6|||
163109941|NCT01005316|589108410|FG001|Overall Study|Physician Decision|0|||
163109942|NCT01005316|589108411|FG002|Overall Study|Physician Decision|0|||
163109943|NCT01005316|589108412|FG003|Overall Study|Physician Decision|0|||
163109944|NCT01005316|589108409|FG000|Overall Study|Sponsor Decision|6|||
163109945|NCT01005316|589108410|FG001|Overall Study|Sponsor Decision|3|||
163109946|NCT01005316|589108411|FG002|Overall Study|Sponsor Decision|0|||
163109947|NCT01005316|589108412|FG003|Overall Study|Sponsor Decision|0|||
163109948|NCT01005316|589108409|FG000|Overall Study|Withdrawal by Subject|1|||
163109949|NCT01005316|589108410|FG001|Overall Study|Withdrawal by Subject|1|||
163109950|NCT01005316|589108411|FG002|Overall Study|Withdrawal by Subject|0|||
163109951|NCT01005316|589108412|FG003|Overall Study|Withdrawal by Subject|2|||
163109952|NCT01005316|589108409|FG000|Overall Study|Consented to Another Study|2|||
163109953|NCT01005316|589108410|FG001|Overall Study|Consented to Another Study|0|||
162653849|NCT01800916|587449618|FG008|Test Period 1 (1 Week)|Convex product user|0|||
163109954|NCT01005316|589108411|FG002|Overall Study|Consented to Another Study|0|||
163109955|NCT01005316|589108412|FG003|Overall Study|Consented to Another Study|0|||
163109956|NCT01005316|589108409|FG000|Overall Study|Delisted|8|||
163109957|NCT01005316|589108410|FG001|Overall Study|Delisted|0|||
163109958|NCT01005316|589108411|FG002|Overall Study|Delisted|0|||
162653850|NCT01800916|587449610|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
162653851|NCT01800916|587449611|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
163109959|NCT01005316|589108412|FG003|Overall Study|Delisted|0|||
163109960|NCT01005316|589108409|FG000|Overall Study|Transferred Care|1|||
163109961|NCT01005316|589108410|FG001|Overall Study|Transferred Care|0|||
163109962|NCT01005316|589108411|FG002|Overall Study|Transferred Care|1|||
163109963|NCT01005316|589108412|FG003|Overall Study|Transferred Care|3|||
163109964|NCT01005316|589108409|FG000|Overall Study|Retransplanted|0|||
163109965|NCT01005316|589108410|FG001|Overall Study|Retransplanted|1|||
163109966|NCT01005316|589108411|FG002|Overall Study|Retransplanted|0|||
163109967|NCT01005316|589108412|FG003|Overall Study|Retransplanted|0|||
163109968|NCT00632827|589108413|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
163109969|NCT00632827|589108413|FG000|Overall Study|Death|2|||
163109970|NCT00632827|589108413|FG000|Overall Study|Adverse Event|5|||
163109971|NCT00632827|589108413|FG000|Overall Study|Lost to Follow-up|1|||
163109972|NCT00368836|589108414|FG000|Phase II|Screen Failure|1|||
163109973|NCT00368836|589108414|FG000|Phase II|Withdrawal by Subject|1|||
163109974|NCT00368836|589108414|FG000|Phase II|unable to collect blood and/or breath|17|||
163109975|NCT00368836|589108414|FG000|Phase II|Protocol Violation|2|||
163109976|NCT03272828|589108417|FG000|Overall Study|Lost to Follow-up|7|||
163109977|NCT03272828|589108418|FG001|Overall Study|Lost to Follow-up|7|||
163109978|NCT03272828|589108417|FG000|Overall Study|Withdrawal by Subject|2|||
163109979|NCT03272828|589108418|FG001|Overall Study|Withdrawal by Subject|0|||
163109980|NCT03272828|589108417|FG000|Overall Study|Deceased|1|||
163109981|NCT03272828|589108418|FG001|Overall Study|Deceased|1|||
163109982|NCT03272828|589108417|FG000|Overall Study|Failed implant|1|||
163109983|NCT03272828|589108418|FG001|Overall Study|Failed implant|2|||
163109984|NCT03888235|589108422|FG000|Overall Study|Lost to Follow-up|1|||
163109985|NCT03888235|589108423|FG001|Overall Study|Lost to Follow-up|1|||
163109986|NCT03888235|589108424|FG002|Overall Study|Lost to Follow-up|0|||
163109987|NCT01054560|589108425|FG000|Overall Study|Death|10|||
163109988|NCT01054560|589108426|FG001|Overall Study|Death|21|||
163109989|NCT01054560|589108425|FG000|Overall Study|Lost to Follow-up|2|||
163109990|NCT01054560|589108426|FG001|Overall Study|Lost to Follow-up|5|||
163109991|NCT01054560|589108425|FG000|Overall Study|Withdrawal by Subject|0|||
163109992|NCT01054560|589108426|FG001|Overall Study|Withdrawal by Subject|2|||
163109993|NCT01054560|589108425|FG000|Overall Study|Physician Decision|1|||
163109994|NCT01054560|589108426|FG001|Overall Study|Physician Decision|0|||
162653852|NCT01800916|587449612|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
162653853|NCT01800916|587449613|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
162653854|NCT01800916|587449614|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
162653855|NCT01800916|587449615|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
162653856|NCT01800916|587449616|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
162653857|NCT01800916|587449617|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
162653858|NCT01800916|587449618|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
162653859|NCT00559962|587449626|FG000|Overall Study|Adverse Event|1|||
162653860|NCT00559962|587449627|FG001|Overall Study|Adverse Event|7|||
162653861|NCT00559962|587449628|FG002|Overall Study|Adverse Event|8|||
162653862|NCT00559962|587449629|FG003|Overall Study|Adverse Event|5|||
162653863|NCT00559962|587449630|FG004|Overall Study|Adverse Event|11|||
162653864|NCT00559962|587449631|FG005|Overall Study|Adverse Event|4|||
162653865|NCT00559962|587449632|FG006|Overall Study|Adverse Event|4|||
162653866|NCT00559962|587449633|FG007|Overall Study|Adverse Event|2|||
162653867|NCT00559962|587449626|FG000|Overall Study|Lost to Follow-up|0|||
162653868|NCT00559962|587449627|FG001|Overall Study|Lost to Follow-up|1|||
162653869|NCT00559962|587449628|FG002|Overall Study|Lost to Follow-up|0|||
162653870|NCT00559962|587449629|FG003|Overall Study|Lost to Follow-up|0|||
162653871|NCT00559962|587449630|FG004|Overall Study|Lost to Follow-up|0|||
162653872|NCT00559962|587449631|FG005|Overall Study|Lost to Follow-up|0|||
162653873|NCT00559962|587449632|FG006|Overall Study|Lost to Follow-up|0|||
162653874|NCT00559962|587449633|FG007|Overall Study|Lost to Follow-up|0|||
162653875|NCT00559962|587449626|FG000|Overall Study|Withdrawal by Subject|1|||
162653876|NCT00559962|587449627|FG001|Overall Study|Withdrawal by Subject|1|||
162653877|NCT00559962|587449628|FG002|Overall Study|Withdrawal by Subject|2|||
162653878|NCT00559962|587449629|FG003|Overall Study|Withdrawal by Subject|0|||
162653879|NCT00559962|587449630|FG004|Overall Study|Withdrawal by Subject|3|||
162653880|NCT00559962|587449631|FG005|Overall Study|Withdrawal by Subject|1|||
162653881|NCT00559962|587449632|FG006|Overall Study|Withdrawal by Subject|0|||
162653882|NCT00559962|587449633|FG007|Overall Study|Withdrawal by Subject|2|||
163109995|NCT00244933|589108434|FG000|Overall Study|Not response evaluable|2|||
163109996|NCT03703817|589108435|FG000|Overall Study|Not meeting eligibility criteria|7|||
163109997|NCT03703817|589108436|FG001|Overall Study|Not meeting eligibility criteria|4|||
163109998|NCT05129449|589108439|FG000|Overall Study|Protocol Violation|1|||
163109999|NCT02901054|589108443|FG000|Overall Study|Physician Decision|1|||
163110000|NCT02901054|589108443|FG000|Overall Study|Withdrawal by Subject|3|||
163110001|NCT00616018|589108447|FG000|Overall Study|Protocol Violation|3|||
162653883|NCT00559962|587449626|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
162653884|NCT00559962|587449627|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
162653885|NCT00559962|587449628|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
162653886|NCT00559962|587449629|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
163110002|NCT05145322|589108448|FG000|Overall Study|Lost to Follow-up|4|||
163110003|NCT05145322|589108449|FG001|Overall Study|Lost to Follow-up|5|||
163110004|NCT06359028|589108450|FG000|Overall Study|Adverse Event|1|||
163110005|NCT06359028|589108451|FG001|Overall Study|Adverse Event|0|||
162653887|NCT00559962|587449630|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
162653888|NCT00559962|587449631|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
163110006|NCT06359028|589108450|FG000|Overall Study|Withdrawal by Subject|1|||
163110007|NCT06359028|589108451|FG001|Overall Study|Withdrawal by Subject|0|||
162653889|NCT00559962|587449632|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
163110008|NCT04700540|589108452|FG000|Overall Study|Withdrawal by Subject|12|||
162653890|NCT00559962|587449633|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
163110009|NCT04700540|589108453|FG001|Overall Study|Withdrawal by Subject|8|||
163110010|NCT04700540|589108452|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
163110011|NCT04700540|589108453|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
163110012|NCT05248997|589108454|FG000|Overall Study|Lost to Follow-up|1|||
163110013|NCT05248997|589108455|FG001|Overall Study|Lost to Follow-up|1|||
163110014|NCT05248997|589108454|FG000|Overall Study|Randomized but not treated|32|||
163110015|NCT05248997|589108455|FG001|Overall Study|Randomized but not treated|25|||
163110016|NCT03515551|589108456|FG000|Overall Study|Death|4|||
163110017|NCT03515551|589108457|FG001|Overall Study|Death|1|||
163110018|NCT03515551|589108458|FG002|Overall Study|Death|2|||
163110019|NCT03515551|589108459|FG003|Overall Study|Death|2|||
163110020|NCT03515551|589108460|FG004|Overall Study|Death|2|||
163110021|NCT03515551|589108461|FG005|Overall Study|Death|4|||
163110022|NCT03515551|589108462|FG006|Overall Study|Death|1|||
163110023|NCT03515551|589108456|FG000|Overall Study|Lost to Follow-up|0|||
163110024|NCT03515551|589108457|FG001|Overall Study|Lost to Follow-up|0|||
163110025|NCT03515551|589108458|FG002|Overall Study|Lost to Follow-up|1|||
163110026|NCT03515551|589108459|FG003|Overall Study|Lost to Follow-up|0|||
163110027|NCT03515551|589108460|FG004|Overall Study|Lost to Follow-up|0|||
163110028|NCT03515551|589108461|FG005|Overall Study|Lost to Follow-up|0|||
163110029|NCT03515551|589108462|FG006|Overall Study|Lost to Follow-up|0|||
163110030|NCT03515551|589108456|FG000|Overall Study|Withdrawal by Subject|0|||
163110031|NCT03515551|589108457|FG001|Overall Study|Withdrawal by Subject|1|||
163110032|NCT03515551|589108458|FG002|Overall Study|Withdrawal by Subject|0|||
163110033|NCT03515551|589108459|FG003|Overall Study|Withdrawal by Subject|0|||
163110034|NCT03515551|589108460|FG004|Overall Study|Withdrawal by Subject|0|||
163110035|NCT03515551|589108461|FG005|Overall Study|Withdrawal by Subject|0|||
163110036|NCT03515551|589108462|FG006|Overall Study|Withdrawal by Subject|1|||
163110037|NCT03515551|589108456|FG000|Overall Study|Study ended by sponsor|0|||
163110038|NCT03515551|589108457|FG001|Overall Study|Study ended by sponsor|0|||
163110039|NCT03515551|589108458|FG002|Overall Study|Study ended by sponsor|2|||
163110040|NCT03515551|589108459|FG003|Overall Study|Study ended by sponsor|1|||
163110041|NCT03515551|589108460|FG004|Overall Study|Study ended by sponsor|3|||
163110042|NCT03515551|589108461|FG005|Overall Study|Study ended by sponsor|0|||
163110043|NCT03515551|589108462|FG006|Overall Study|Study ended by sponsor|3|||
163110044|NCT03515551|589108456|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110045|NCT03515551|589108457|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
163110046|NCT03515551|589108458|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110047|NCT03515551|589108459|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110048|NCT03515551|589108460|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110049|NCT03515551|589108461|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110050|NCT03515551|589108462|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
163110051|NCT00673231|589108463|FG000|Overall Study|Withdrawal by Subject|14|||
163110052|NCT00673231|589108464|FG001|Overall Study|Withdrawal by Subject|10|||
163110053|NCT00673231|589108465|FG002|Overall Study|Withdrawal by Subject|8|||
163110054|NCT00673231|589108466|FG003|Overall Study|Withdrawal by Subject|6|||
163110055|NCT00673231|589108463|FG000|Overall Study|Adverse Event|6|||
163110056|NCT00673231|589108464|FG001|Overall Study|Adverse Event|5|||
163110057|NCT00673231|589108465|FG002|Overall Study|Adverse Event|9|||
163110058|NCT00673231|589108466|FG003|Overall Study|Adverse Event|6|||
163110059|NCT00673231|589108463|FG000|Overall Study|Lost to Follow-up|1|||
163110060|NCT00673231|589108464|FG001|Overall Study|Lost to Follow-up|2|||
162653891|NCT01639040|587449643|FG000|Overall Study|Adverse Event|1|||
162653892|NCT01639040|587449644|FG001|Overall Study|Adverse Event|0|||
163110061|NCT00673231|589108465|FG002|Overall Study|Lost to Follow-up|1|||
163110062|NCT00673231|589108466|FG003|Overall Study|Lost to Follow-up|2|||
163110063|NCT00673231|589108463|FG000|Overall Study|Death|0|||
163110064|NCT00673231|589108464|FG001|Overall Study|Death|0|||
163110065|NCT00673231|589108465|FG002|Overall Study|Death|1|||
163110066|NCT00673231|589108466|FG003|Overall Study|Death|0|||
163110067|NCT00673231|589108463|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
163110068|NCT00673231|589108464|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
163110069|NCT00673231|589108465|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
163110070|NCT00673231|589108466|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
163110071|NCT02952313|589108467|FG000|Primary Endpoint|Lost to Follow-up|4|||
163110072|NCT02952313|589108467|FG000|Primary Endpoint|Withdrawal by Subject|1|||
163110073|NCT02952313|589108467|FG000|Primary Endpoint|Lack of Efficacy|1|||
163110074|NCT02952313|589108467|FG000|Primary Endpoint|Missed visit|1|||
163110075|NCT02952313|589108467|FG000|Long-term Follow-up|Lost to Follow-up|12|||
163110076|NCT02952313|589108467|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
163110077|NCT02952313|589108467|FG000|Long-term Follow-up|Lack of Efficacy|6|||
163110078|NCT02952313|589108467|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
163110079|NCT02952313|589108467|FG000|Long-term Follow-up|Physician Decision|1|||
163110080|NCT02952313|589108467|FG000|Long-term Follow-up|Death|1|||
162719294|NCT02503202|587678479|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
162719295|NCT02503202|587678475|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162719296|NCT02503202|587678476|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162719297|NCT02503202|587678477|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
162719298|NCT02503202|587678478|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
162719299|NCT02503202|587678479|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162719300|NCT02503202|587678475|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
162719301|NCT02503202|587678476|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
162719302|NCT02503202|587678477|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
162719303|NCT02503202|587678478|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
162719304|NCT02503202|587678479|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
162719305|NCT02503202|587678475|FG000|Extension: Month 6 to 24|Death|1|||
163110081|NCT00920387|589108470|FG000|Stage 1|Adverse Event|1|||
163110082|NCT00920387|589108471|FG001|Stage 1|Adverse Event|0|||
163110083|NCT00920387|589108472|FG002|Stage 1|Adverse Event|0|||
163110084|NCT04470908|589108473|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
163110085|NCT02470585|589108477|FG000|Overall Study|Death|224|||
163110086|NCT02470585|589108478|FG001|Overall Study|Death|227|||
163110087|NCT02470585|589108479|FG002|Overall Study|Death|199|||
163110088|NCT02470585|589108477|FG000|Overall Study|Withdrew consent|21|||
163110089|NCT02470585|589108478|FG001|Overall Study|Withdrew consent|22|||
163110090|NCT02470585|589108479|FG002|Overall Study|Withdrew consent|31|||
163110091|NCT02470585|589108477|FG000|Overall Study|Lost to Follow-up|8|||
163110092|NCT02470585|589108478|FG001|Overall Study|Lost to Follow-up|15|||
163110093|NCT02470585|589108479|FG002|Overall Study|Lost to Follow-up|13|||
163110094|NCT02470585|589108477|FG000|Overall Study|Sponsor discontinued study|117|||
163110095|NCT02470585|589108478|FG001|Overall Study|Sponsor discontinued study|110|||
163110096|NCT02470585|589108479|FG002|Overall Study|Sponsor discontinued study|122|||
163110097|NCT02470585|589108477|FG000|Overall Study|Other, not specified|5|||
163110098|NCT02470585|589108478|FG001|Overall Study|Other, not specified|7|||
163110099|NCT02470585|589108479|FG002|Overall Study|Other, not specified|14|||
163110100|NCT02470585|589108477|FG000|Overall Study|Missing due to site non-compliance|0|||
163110101|NCT02470585|589108478|FG001|Overall Study|Missing due to site non-compliance|2|||
163110102|NCT02470585|589108479|FG002|Overall Study|Missing due to site non-compliance|3|||
163110103|NCT03028415|589108480|FG000|Overall Study|Lost to Follow-up|6|||
163110104|NCT03028415|589108481|FG001|Overall Study|Lost to Follow-up|3|||
163110105|NCT03028415|589108480|FG000|Overall Study|Withdrawal by Subject|1|||
163110106|NCT03028415|589108481|FG001|Overall Study|Withdrawal by Subject|0|||
163110107|NCT03028415|589108480|FG000|Overall Study|Discontinued due to COVID-19|1|||
163110108|NCT03028415|589108481|FG001|Overall Study|Discontinued due to COVID-19|0|||
163110109|NCT05005013|589108484|FG000|Overall Study|Withdrawal by Subject|5|||
163110110|NCT05005013|589108485|FG001|Overall Study|Withdrawal by Subject|1|||
163110111|NCT05005013|589108484|FG000|Overall Study|Lost to Follow-up|3|||
163110112|NCT05005013|589108485|FG001|Overall Study|Lost to Follow-up|1|||
163110113|NCT05005013|589108484|FG000|Overall Study|Ineligibility|1|||
163110114|NCT05005013|589108485|FG001|Overall Study|Ineligibility|1|||
163110115|NCT04283994|589108488|FG000|Overall Study|Death|11|||
163110116|NCT04283994|589108489|FG001|Overall Study|Death|20|||
163110117|NCT04283994|589108490|FG002|Overall Study|Death|11|||
163110118|NCT04283994|589108491|FG003|Overall Study|Death|0|||
163110119|NCT04283994|589108492|FG004|Overall Study|Death|0|||
163110120|NCT04283994|589108493|FG005|Overall Study|Death|0|||
163110121|NCT04283994|589108494|FG006|Overall Study|Death|0|||
163110122|NCT04283994|589108488|FG000|Overall Study|Withdrawal by Subject|16|||
163110123|NCT04283994|589108489|FG001|Overall Study|Withdrawal by Subject|4|||
163110124|NCT04283994|589108490|FG002|Overall Study|Withdrawal by Subject|6|||
163110125|NCT04283994|589108491|FG003|Overall Study|Withdrawal by Subject|1|||
162719306|NCT02503202|587678476|FG001|Extension: Month 6 to 24|Death|0|||
162719307|NCT02503202|587678477|FG002|Extension: Month 6 to 24|Death|0|||
162719308|NCT02503202|587678478|FG003|Extension: Month 6 to 24|Death|0|||
163110126|NCT04283994|589108492|FG004|Overall Study|Withdrawal by Subject|0|||
162719309|NCT02503202|587678479|FG004|Extension: Month 6 to 24|Death|0|||
163110127|NCT04283994|589108493|FG005|Overall Study|Withdrawal by Subject|1|||
163110128|NCT04283994|589108494|FG006|Overall Study|Withdrawal by Subject|0|||
163110129|NCT03315793|589108495|FG000|Overall Study|Adverse Event|4|||
163110130|NCT03315793|589108496|FG001|Overall Study|Adverse Event|2|||
163110131|NCT03315793|589108495|FG000|Overall Study|Protocol Deviation|1|||
163110132|NCT03315793|589108496|FG001|Overall Study|Protocol Deviation|0|||
163110133|NCT03315793|589108495|FG000|Overall Study|Difficult for regular visit|0|||
163110134|NCT03315793|589108496|FG001|Overall Study|Difficult for regular visit|1|||
163110135|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Adverse Event|76|||
163110136|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Adverse Event|0|||
163110137|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Adverse Event|0|||
163110138|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Death|3|||
163110139|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Death|0|||
163110140|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Death|0|||
163110141|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
162653893|NCT04370691|587449645|FG000|Overall Study|Pending visit|48|||
162653894|NCT04370691|587449645|FG000|Overall Study|Have Not Reached Lower Window|15|||
162653895|NCT04370691|587449645|FG000|Overall Study|Termination|14|||
162653896|NCT04370691|587449645|FG000|Overall Study|Missed or Overdue|10|||
162653897|NCT00486265|587449646|FG000|Overall Study|Adverse Event|1|||
162653898|NCT00486265|587449646|FG000|Overall Study|Lack of Efficacy|8|||
162653899|NCT03013543|587449647|FG000|Overall Study|Withdrawal by Subject|0|||
162653900|NCT03013543|587449648|FG001|Overall Study|Withdrawal by Subject|2|||
162653901|NCT03013543|587449649|FG002|Overall Study|Withdrawal by Subject|0|||
162653902|NCT03013543|587449650|FG003|Overall Study|Withdrawal by Subject|5|||
162653903|NCT03013543|587449651|FG004|Overall Study|Withdrawal by Subject|6|||
162653904|NCT03013543|587449652|FG005|Overall Study|Withdrawal by Subject|2|||
162653905|NCT03013543|587449653|FG006|Overall Study|Withdrawal by Subject|3|||
162719310|NCT02503202|587678475|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
162653906|NCT03013543|587449654|FG007|Overall Study|Withdrawal by Subject|1|||
162653907|NCT03013543|587449655|FG008|Overall Study|Withdrawal by Subject|0|||
162653908|NCT03013543|587449656|FG009|Overall Study|Withdrawal by Subject|4|||
162719311|NCT02503202|587678476|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
162653909|NCT03013543|587449647|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
162653910|NCT03013543|587449648|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
162719312|NCT02503202|587678477|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
163110142|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
163110143|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
163110144|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Physician Decision|9|||
163110145|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Physician Decision|0|||
163110146|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Physician Decision|0|||
163110147|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
163110148|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
163110149|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
163110150|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Disease progression|45|||
163110151|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Disease progression|0|||
163110152|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Disease progression|0|||
163110153|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
163110154|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
163110155|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
163110156|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
163110157|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
163110158|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
163110159|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
163110160|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
163110161|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
163110162|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
163110163|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
163110164|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
163110165|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
163110166|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
163110167|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
163110168|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
163110169|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
163110170|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
162653911|NCT03013543|587449649|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162653912|NCT03013543|587449650|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
162653913|NCT03013543|587449651|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
162653914|NCT03013543|587449652|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
162653915|NCT03013543|587449653|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
162653916|NCT03013543|587449654|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
162653917|NCT03013543|587449655|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
162653918|NCT03013543|587449656|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
163110171|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
163110172|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
163110173|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
163110174|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
163110175|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
163110176|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
163110177|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
163110178|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
163110179|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
163110180|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Promotor request|1|||
163110181|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Promotor request|0|||
163110182|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Promotor request|0|||
163110183|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
163110184|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
163110185|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
163110186|NCT01461928|589110120|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
163110187|NCT01461928|589110121|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
163110188|NCT01461928|589110122|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
163110189|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Death|3|||
163110190|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Death|0|||
163110191|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Death|0|||
163110192|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
163110193|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
163110194|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
163110195|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
163110196|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
163110197|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
163110198|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Diseases progression|91|||
163110199|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Diseases progression|0|||
163110200|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Diseases progression|0|||
163110201|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Adverse Event|70|||
163110202|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Adverse Event|0|||
163110203|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Adverse Event|0|||
163110204|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Physician Decision|9|||
163110205|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Physician Decision|0|||
163110206|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Physician Decision|0|||
163110207|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
163110208|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
163110209|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
163110210|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
163110211|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
163110212|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
163110213|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
163110214|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
163110215|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
163110216|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Not compliant|1|||
163110217|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Not compliant|0|||
163110218|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Not compliant|0|||
163110219|NCT01461928|589110120|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
163110220|NCT01461928|589110121|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
163110221|NCT01461928|589110122|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
163110222|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Adverse Event|0|||
163110223|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Adverse Event|2|||
163110224|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Adverse Event|0|||
163110225|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Death|0|||
163110226|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Death|10|||
163110227|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Death|8|||
163110228|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Physician Decision|0|||
163110229|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Physician Decision|0|||
163110230|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Physician Decision|4|||
163110231|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
162719313|NCT02503202|587678478|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
162719314|NCT02503202|587678479|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
163110232|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
163110233|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
163110234|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Moved to another town|0|||
163110235|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Moved to another town|1|||
163110236|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Moved to another town|0|||
163110237|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Disease progression|0|||
163110238|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Disease progression|0|||
163110239|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Disease progression|3|||
163110240|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
163110241|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
163110242|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
163110243|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
163110244|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
163110245|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
163110246|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
163110247|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
163110248|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
163110249|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
163110250|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
163110251|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
163110252|NCT01461928|589110120|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
163110253|NCT01461928|589110121|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
163110254|NCT01461928|589110122|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
163110255|NCT00539513|589110126|FG000|Overall Study|Withdrawal by Subject|2|||
163110256|NCT00539513|589110127|FG001|Overall Study|Withdrawal by Subject|1|||
163110257|NCT00539513|589110126|FG000|Overall Study|Lost to Follow-up|0|||
163110258|NCT00539513|589110127|FG001|Overall Study|Lost to Follow-up|1|||
163110259|NCT01801436|589110134|FG000|Overall Study|Withdrawal by Subject|3|||
163110260|NCT01801436|589110134|FG000|Overall Study|Adverse Event|2|||
163110261|NCT01801436|589110134|FG000|Overall Study|Progressive disease|4|||
163110262|NCT04085458|589110137|FG000|Overall Study|Other|1|||
163110263|NCT04085458|589110137|FG000|Overall Study|Withdrawal by Subject|2|||
163110264|NCT04085458|589110137|FG000|Overall Study|Adverse Event|2|||
163110265|NCT02447250|589110138|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
163110266|NCT02447250|589110138|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
163110267|NCT02447250|589110138|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
163110268|NCT01921218|589110139|FG000|Overall Study|Death|2|||
163110269|NCT01921218|589110140|FG001|Overall Study|Death|1|||
163110270|NCT01921218|589110139|FG000|Overall Study|Withdrawal by Subject|0|||
163110271|NCT01921218|589110140|FG001|Overall Study|Withdrawal by Subject|2|||
163110272|NCT01921218|589110139|FG000|Overall Study|Kidney transplant|1|||
163110273|NCT01921218|589110140|FG001|Overall Study|Kidney transplant|1|||
163110274|NCT03389555|589110141|FG000|Overall Study|Protocol Violation|1|||
163110275|NCT03389555|589110142|FG001|Overall Study|Protocol Violation|3|||
163110276|NCT03389555|589110141|FG000|Overall Study|Death|1|||
163110277|NCT03389555|589110142|FG001|Overall Study|Death|0|||
163110278|NCT01885208|589110143|FG000|Overall Study|Unclassified|32|||
163110279|NCT01885208|589110144|FG001|Overall Study|Unclassified|38|||
163110280|NCT00920218|589110149|FG000|Overall Study|Serious Adverse Event|2|||
163110281|NCT00920218|589110150|FG001|Overall Study|Serious Adverse Event|0|||
163110282|NCT00920218|589110151|FG002|Overall Study|Serious Adverse Event|2|||
163110283|NCT00920218|589110152|FG003|Overall Study|Serious Adverse Event|1|||
163110284|NCT00920218|589110149|FG000|Overall Study|Withdrawal by Subject|0|||
163110285|NCT00920218|589110150|FG001|Overall Study|Withdrawal by Subject|3|||
163110286|NCT00920218|589110151|FG002|Overall Study|Withdrawal by Subject|2|||
163110287|NCT00920218|589110152|FG003|Overall Study|Withdrawal by Subject|0|||
163110288|NCT00920218|589110149|FG000|Overall Study|Migrated/moved from study area|0|||
163110289|NCT00920218|589110150|FG001|Overall Study|Migrated/moved from study area|0|||
163110290|NCT00920218|589110151|FG002|Overall Study|Migrated/moved from study area|1|||
163110291|NCT00920218|589110152|FG003|Overall Study|Migrated/moved from study area|0|||
163110292|NCT00920218|589110149|FG000|Overall Study|Lost to Follow-up|0|||
163110293|NCT00920218|589110150|FG001|Overall Study|Lost to Follow-up|1|||
163110294|NCT00920218|589110151|FG002|Overall Study|Lost to Follow-up|0|||
163110295|NCT00920218|589110152|FG003|Overall Study|Lost to Follow-up|3|||
163110296|NCT00920218|589110149|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
163110297|NCT00920218|589110150|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
163110298|NCT00920218|589110151|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
163110299|NCT00920218|589110152|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
163110300|NCT00920218|589110149|FG000|Overall Study|Other|0|||
163110301|NCT00920218|589110150|FG001|Overall Study|Other|0|||
163110302|NCT00920218|589110151|FG002|Overall Study|Other|1|||
163110303|NCT00920218|589110152|FG003|Overall Study|Other|0|||
163110304|NCT00923975|589110153|FG000|Overall Study|Did not meet inclusion criteria|1|||
163110305|NCT00960011|589110156|FG000|Overall Study|Death|5|||
163110306|NCT00960011|589110157|FG001|Overall Study|Death|0|||
163110307|NCT00960011|589110156|FG000|Overall Study|Lost to Follow-up|6|||
163110308|NCT00960011|589110157|FG001|Overall Study|Lost to Follow-up|2|||
163110309|NCT04417218|589110161|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
163110310|NCT04417218|589110162|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
163110311|NCT00873041|589110163|FG000|Core Study|Adverse Event|2|||
163110312|NCT00873041|589110164|FG001|Core Study|Adverse Event|3|||
163110313|NCT00873041|589110165|FG002|Core Study|Adverse Event|1|||
163110314|NCT00873041|589110163|FG000|Core Study|Withdrawal by Subject|1|||
163110315|NCT00873041|589110164|FG001|Core Study|Withdrawal by Subject|2|||
163110316|NCT00873041|589110165|FG002|Core Study|Withdrawal by Subject|2|||
163110317|NCT00873041|589110163|FG000|Core Study|Lost to Follow-up|3|||
163110318|NCT00873041|589110164|FG001|Core Study|Lost to Follow-up|1|||
163110319|NCT00873041|589110165|FG002|Core Study|Lost to Follow-up|0|||
163110320|NCT00873041|589110163|FG000|Core Study|Abnormal laboratory value|0|||
163110321|NCT00873041|589110164|FG001|Core Study|Abnormal laboratory value|0|||
163110322|NCT00873041|589110165|FG002|Core Study|Abnormal laboratory value|1|||
163110323|NCT00873041|589110163|FG000|Core Study|Protocol deviation|1|||
163110324|NCT00873041|589110164|FG001|Core Study|Protocol deviation|0|||
163110325|NCT00873041|589110165|FG002|Core Study|Protocol deviation|1|||
163110326|NCT00873041|589110163|FG000|Extension Study|Adverse Event|1|||
163110327|NCT00873041|589110164|FG001|Extension Study|Adverse Event|0|||
163110328|NCT00873041|589110165|FG002|Extension Study|Adverse Event|1|||
163110329|NCT00873041|589110163|FG000|Extension Study|Administrative reasons|0|||
163110330|NCT00873041|589110164|FG001|Extension Study|Administrative reasons|0|||
163110331|NCT00873041|589110165|FG002|Extension Study|Administrative reasons|1|||
163110332|NCT02449889|589110168|FG000|Overall Study|Adverse Event|1|||
163110333|NCT02449889|589110169|FG001|Overall Study|Adverse Event|2|||
163110334|NCT02449889|589110170|FG002|Overall Study|Adverse Event|0|||
163110335|NCT02449889|589110168|FG000|Overall Study|Protocol Violation|0|||
163110336|NCT02449889|589110169|FG001|Overall Study|Protocol Violation|4|||
163110337|NCT02449889|589110170|FG002|Overall Study|Protocol Violation|1|||
163110338|NCT00758264|589110171|FG000|Active Phase|Withdrawal by Subject|0|||
163110339|NCT00758264|589110172|FG001|Active Phase|Withdrawal by Subject|0|||
163110340|NCT00758264|589110173|FG002|Active Phase|Withdrawal by Subject|1|||
163110341|NCT00758264|589110171|FG000|Active Phase|Lost to Follow-up|1|||
163110342|NCT00758264|589110172|FG001|Active Phase|Lost to Follow-up|0|||
163110343|NCT00758264|589110173|FG002|Active Phase|Lost to Follow-up|0|||
163110344|NCT00758264|589110171|FG000|Active Phase|Other|0|||
163110345|NCT00758264|589110172|FG001|Active Phase|Other|0|||
163110346|NCT00758264|589110173|FG002|Active Phase|Other|4|||
163110347|NCT01082874|589110179|FG000|Overall Study|Lost to Follow-up|10|||
163110348|NCT01082874|589110180|FG001|Overall Study|Lost to Follow-up|10|||
163110349|NCT01082874|589110181|FG002|Overall Study|Lost to Follow-up|6|||
163110350|NCT01082874|589110182|FG003|Overall Study|Lost to Follow-up|10|||
163110351|NCT01082874|589110179|FG000|Overall Study|Withdrawal by Subject|1|||
163110352|NCT01082874|589110180|FG001|Overall Study|Withdrawal by Subject|2|||
163110353|NCT01082874|589110181|FG002|Overall Study|Withdrawal by Subject|5|||
163110354|NCT01082874|589110182|FG003|Overall Study|Withdrawal by Subject|3|||
163110355|NCT03176472|589110189|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
163110356|NCT03176472|589110190|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
163110357|NCT03176472|589110189|FG000|Double Blind Treatment Period|Adverse Event|0|||
163110358|NCT03176472|589110190|FG001|Double Blind Treatment Period|Adverse Event|5|||
163110359|NCT03176472|589110189|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
163110360|NCT03176472|589110190|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163110361|NCT03176472|589110189|FG000|Double Blind Treatment Period|Physician Decision|0|||
163110362|NCT03176472|589110190|FG001|Double Blind Treatment Period|Physician Decision|1|||
163110363|NCT03176472|589110189|FG000|Double Blind Treatment Period|Protocol Violation|1|||
163110364|NCT03176472|589110190|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163110365|NCT03176472|589110189|FG000|Double Blind Treatment Period|Not Provided|1|||
163110366|NCT03176472|589110190|FG001|Double Blind Treatment Period|Not Provided|0|||
163110367|NCT03176472|589110189|FG000|Open Label Extension|Withdrawal by Subject|3|||
163110368|NCT03176472|589110190|FG001|Open Label Extension|Withdrawal by Subject|4|||
163110369|NCT03176472|589110189|FG000|Open Label Extension|Adverse Event|2|||
163110370|NCT03176472|589110190|FG001|Open Label Extension|Adverse Event|4|||
163110371|NCT03176472|589110189|FG000|Open Label Extension|Lost to Follow-up|1|||
163110372|NCT03176472|589110190|FG001|Open Label Extension|Lost to Follow-up|2|||
163110373|NCT03176472|589110189|FG000|Open Label Extension|Protocol Violation|0|||
163110374|NCT03176472|589110190|FG001|Open Label Extension|Protocol Violation|1|||
163110375|NCT03176472|589110189|FG000|Open Label Extension|Not Provided|2|||
163110376|NCT03176472|589110190|FG001|Open Label Extension|Not Provided|1|||
163110377|NCT01846663|589110191|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
163110378|NCT01846663|589110192|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
163110379|NCT01846663|589110191|FG000|Overall Study|Withdrawal by Subject|1|||
163110380|NCT01846663|589110192|FG001|Overall Study|Withdrawal by Subject|0|||
163110381|NCT01846663|589110191|FG000|Overall Study|Adverse Event|1|||
163110382|NCT01846663|589110192|FG001|Overall Study|Adverse Event|2|||
163110383|NCT04295681|589110206|FG000|Overall Study|Eligibility error|1|||
163110384|NCT04295681|589110207|FG001|Overall Study|Eligibility error|3|||
163110385|NCT02210689|589110214|FG000|Overall Study|Withdrawal by Subject|7|||
163110386|NCT02210689|589110215|FG001|Overall Study|Withdrawal by Subject|4|||
163110387|NCT02210689|589110216|FG002|Overall Study|Withdrawal by Subject|2|||
163110388|NCT02210689|589110214|FG000|Overall Study|Adverse Event|0|||
163110389|NCT02210689|589110215|FG001|Overall Study|Adverse Event|1|||
163110390|NCT02210689|589110216|FG002|Overall Study|Adverse Event|0|||
163110391|NCT02210689|589110214|FG000|Overall Study|Protocol Violation|1|||
163110392|NCT02210689|589110215|FG001|Overall Study|Protocol Violation|0|||
163110393|NCT02210689|589110216|FG002|Overall Study|Protocol Violation|0|||
163110394|NCT02210689|589110214|FG000|Overall Study|Lost to Follow-up|11|||
163110395|NCT02210689|589110215|FG001|Overall Study|Lost to Follow-up|9|||
163110396|NCT02210689|589110216|FG002|Overall Study|Lost to Follow-up|5|||
163110397|NCT02210689|589110214|FG000|Overall Study|Pregnancy|0|||
163110398|NCT02210689|589110215|FG001|Overall Study|Pregnancy|1|||
163110399|NCT02210689|589110216|FG002|Overall Study|Pregnancy|0|||
163110400|NCT02210689|589110214|FG000|Overall Study|Lack of Efficacy|0|||
163110401|NCT02210689|589110215|FG001|Overall Study|Lack of Efficacy|1|||
163110402|NCT02210689|589110216|FG002|Overall Study|Lack of Efficacy|5|||
163110403|NCT02210689|589110214|FG000|Overall Study|Prohibited medication|2|||
163110404|NCT02210689|589110215|FG001|Overall Study|Prohibited medication|8|||
163110405|NCT02210689|589110216|FG002|Overall Study|Prohibited medication|1|||
163110406|NCT02210689|589110214|FG000|Overall Study|Negative Nugent score at baseline|6|||
163110407|NCT02210689|589110215|FG001|Overall Study|Negative Nugent score at baseline|2|||
163110408|NCT02210689|589110216|FG002|Overall Study|Negative Nugent score at baseline|2|||
163110409|NCT02210689|589110214|FG000|Overall Study|Other|25|||
163110410|NCT02210689|589110215|FG001|Overall Study|Other|21|||
163110411|NCT02210689|589110216|FG002|Overall Study|Other|8|||
163110412|NCT00675441|589110217|FG000|Overall Study|Withdrawal by Subject|2|||
163110413|NCT00675441|589110217|FG000|Overall Study|Death|1|||
163110414|NCT01923363|589110218|FG000|Overall Study|Protocol Violation|1|||
163110415|NCT00866047|589110220|FG000|Treatment Period|Progressive disease|13|||
163110416|NCT00866047|589110220|FG000|Treatment Period|Adverse Event|16|||
163110417|NCT00866047|589110220|FG000|Treatment Period|Physician Decision|14|||
163110418|NCT00866047|589110220|FG000|Treatment Period|Withdrawal by Subject|5|||
163110419|NCT00866047|589110220|FG000|Follow-up Period|Lost to Follow-up|5|||
163110420|NCT02928029|589110221|FG000|Overall Study|Withdrawal by Subject|0|||
163110421|NCT02928029|589110222|FG001|Overall Study|Withdrawal by Subject|1|||
163110422|NCT02928029|589110221|FG000|Overall Study|Radiological progression|1|||
163110423|NCT02928029|589110222|FG001|Overall Study|Radiological progression|0|||
163110424|NCT02928029|589110221|FG000|Overall Study|Clinical progression|1|||
163110425|NCT02928029|589110222|FG001|Overall Study|Clinical progression|2|||
163110426|NCT02928029|589110221|FG000|Overall Study|AE not related to clinical progression|1|||
163110427|NCT02928029|589110222|FG001|Overall Study|AE not related to clinical progression|1|||
163110428|NCT05427539|589110224|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163110429|NCT05427539|589110225|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163110430|NCT05427539|589110224|FG000|Period 1|Withdrawal by Subject|1|||
163110431|NCT05427539|589110225|FG001|Period 1|Withdrawal by Subject|0|||
163110432|NCT03718884|589110226|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
163110433|NCT03718884|589110227|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
162653919|NCT03013543|587449647|FG000|Overall Study|Other|0|||
163110434|NCT03718884|589110226|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
163110435|NCT03718884|589110227|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
163110436|NCT02099344|589110228|FG000|Overall Study|Physician Decision|1|||
163110437|NCT02099344|589110229|FG001|Overall Study|Physician Decision|0|||
163110438|NCT00404755|589110234|FG000|Phase I (Bupropion)|Adverse Event|3|||
163110439|NCT00404755|589110234|FG000|Phase I (Bupropion)|Other|1|||
163110440|NCT00404755|589110234|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
163110441|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
163110442|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
163110443|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
163110444|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
163110445|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
163110446|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
163110447|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
163110448|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
163110449|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
163110450|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
163110451|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
163110452|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
163110453|NCT04376684|589110237|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
163110454|NCT04376684|589110238|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
163110455|NCT04376684|589110239|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
163110456|NCT04376684|589110240|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
163110457|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
163110458|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
163110459|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
163110460|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
163110461|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
163110462|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
163110463|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
163110464|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
163110465|NCT04376684|589110237|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
163110466|NCT04376684|589110238|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
163110467|NCT04376684|589110239|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
163110468|NCT04376684|589110240|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
163110469|NCT01666119|589110241|FG000|Overall Study|Adverse Event|6|||
163110470|NCT01666119|589110241|FG000|Overall Study|Withdrawal by Subject|16|||
163110471|NCT01666119|589110241|FG000|Overall Study|Lost to Follow-up|7|||
163110472|NCT01666119|589110241|FG000|Overall Study|non compliance with study medication, pa|18|||
163110473|NCT01666119|589110241|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
163110474|NCT02602275|589110254|FG000|Day 1|Physician Decision|0|||
163110475|NCT02602275|589110255|FG001|Day 1|Physician Decision|1|||
163110476|NCT02241733|589110257|FG000|Overall Study|Lost to Follow-up|9|||
163110477|NCT02241733|589110258|FG001|Overall Study|Lost to Follow-up|4|||
163110478|NCT02241733|589110257|FG000|Overall Study|Physician Decision|6|||
163110479|NCT02241733|589110258|FG001|Overall Study|Physician Decision|2|||
163110480|NCT02241733|589110257|FG000|Overall Study|Withdrawal by Subject|0|||
163110481|NCT02241733|589110258|FG001|Overall Study|Withdrawal by Subject|2|||
163110482|NCT02241733|589110257|FG000|Overall Study|Death|0|||
163110483|NCT02241733|589110258|FG001|Overall Study|Death|2|||
163110484|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
163110485|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
163110486|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
163110487|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
163110488|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
163110489|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
163110490|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
163110491|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
163110492|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
162653920|NCT03013543|587449648|FG001|Overall Study|Other|0|||
163110493|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
163110494|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
163110495|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
163110496|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
163110497|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
163110498|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
163110499|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
162653921|NCT03013543|587449649|FG002|Overall Study|Other|2|||
162653922|NCT03013543|587449650|FG003|Overall Study|Other|0|||
163110500|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163110501|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163110502|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
163110503|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
163110504|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
163110505|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110506|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110507|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
163110508|NCT01866111|589110263|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
163110509|NCT01866111|589110264|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
163110510|NCT01866111|589110265|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
163110511|NCT01866111|589110266|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
163110512|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
163110513|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
163110514|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
163110515|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
163110516|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
163110517|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
163110518|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
163110519|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
163110520|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
163110521|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
163110522|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
163110523|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
163110524|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
163110525|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
163110526|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
163110527|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
163110528|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Death|1|||
163110529|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Death|1|||
163110530|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Death|3|||
163110531|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Death|2|||
163110532|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
163110533|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
163110534|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
163110535|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
163110536|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
163110537|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
163110538|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
163110539|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
163110540|NCT01866111|589110263|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110541|NCT01866111|589110264|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110542|NCT01866111|589110265|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
163110543|NCT01866111|589110266|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
163110544|NCT00516906|589110269|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
163110545|NCT00516906|589110270|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
163110546|NCT01974206|589110271|FG000|Overall Study|Did Not Take Study Drug|0|||
163110547|NCT01974206|589110272|FG001|Overall Study|Did Not Take Study Drug|1|||
163110548|NCT01974206|589110271|FG000|Overall Study|Physician Decision|1|||
163110549|NCT01974206|589110272|FG001|Overall Study|Physician Decision|0|||
163110550|NCT01974206|589110271|FG000|Overall Study|Withdrawal by Subject|3|||
163110551|NCT01974206|589110272|FG001|Overall Study|Withdrawal by Subject|0|||
163110552|NCT01974206|589110271|FG000|Overall Study|Lost to Follow-up|1|||
163110553|NCT01974206|589110272|FG001|Overall Study|Lost to Follow-up|0|||
163110554|NCT01974206|589110271|FG000|Overall Study|Death|1|||
163110555|NCT01974206|589110272|FG001|Overall Study|Death|0|||
163110556|NCT04113018|589110273|FG000|Overall Study|Death|2|||
163110557|NCT04113018|589110273|FG000|Overall Study|Lost to Follow-up|1|||
163110558|NCT04113018|589110273|FG000|Overall Study|Still On Study (on study treatment)|24|||
163110559|NCT04113018|589110273|FG000|Overall Study|Still On Study (in follow up)|12|||
163110560|NCT03802630|589110274|FG000|Overall Study|Study terminated by sponsor|130|||
163110561|NCT03802630|589110275|FG001|Overall Study|Study terminated by sponsor|134|||
163110562|NCT03802630|589110274|FG000|Overall Study|Subject decision|16|||
163110563|NCT03802630|589110275|FG001|Overall Study|Subject decision|9|||
163110564|NCT03802630|589110274|FG000|Overall Study|Adverse Event|3|||
163110565|NCT03802630|589110275|FG001|Overall Study|Adverse Event|1|||
163110566|NCT03802630|589110274|FG000|Overall Study|Lost to Follow-up|2|||
163110567|NCT03802630|589110275|FG001|Overall Study|Lost to Follow-up|2|||
162719315|NCT02503202|587678475|FG000|Extension: Month 6 to 24|Physician Decision|1|||
163110568|NCT03802630|589110274|FG000|Overall Study|Physician Decision|2|||
163110569|NCT03802630|589110275|FG001|Overall Study|Physician Decision|0|||
163110570|NCT03802630|589110274|FG000|Overall Study|Death|0|||
163110571|NCT03802630|589110275|FG001|Overall Study|Death|2|||
163110572|NCT00157196|589110276|FG000|Overall Study|Ongoing at data cut-off|9|||
163110573|NCT06099223|589110277|FG000|Overall Study|Preoperative surveys missed|0|||
163110574|NCT06099223|589110278|FG001|Overall Study|Preoperative surveys missed|1|||
163110575|NCT00583752|589110279|FG000|Overall Study|Lost to Follow-up|5|||
163110576|NCT00583752|589110280|FG001|Overall Study|Lost to Follow-up|5|||
163110577|NCT00526656|589110281|FG000|Overall Study|Death|1|||
163110578|NCT00526656|589110281|FG000|Overall Study|Refused surgery|1|||
163110579|NCT04091581|589110282|FG000|Overall Study|Lost to Follow-up|0|||
163110580|NCT04091581|589110283|FG001|Overall Study|Lost to Follow-up|1|||
163110581|NCT01795495|589110284|FG000|Overall Study|Protocol Violation|1|||
163110582|NCT01795495|589110285|FG001|Overall Study|Protocol Violation|0|||
163110583|NCT01795495|589110286|FG002|Overall Study|Protocol Violation|1|||
163110584|NCT01795495|589110284|FG000|Overall Study|Physician Decision|0|||
163110585|NCT01795495|589110285|FG001|Overall Study|Physician Decision|0|||
163110586|NCT01795495|589110286|FG002|Overall Study|Physician Decision|1|||
163110587|NCT01331837|589110287|FG000|Overall Study|Death|30|||
163110588|NCT01331837|589110288|FG001|Overall Study|Death|34|||
163110589|NCT01331837|589110287|FG000|Overall Study|Lost to Follow-up|3|||
163110590|NCT01331837|589110288|FG001|Overall Study|Lost to Follow-up|1|||
163110591|NCT01331837|589110287|FG000|Overall Study|Info not recorded|10|||
163110592|NCT01331837|589110288|FG001|Overall Study|Info not recorded|16|||
163110593|NCT01331837|589110287|FG000|Overall Study|Withdrawal by Subject|13|||
163110594|NCT01331837|589110288|FG001|Overall Study|Withdrawal by Subject|16|||
163110595|NCT00711113|589112196|FG000|Overall Study|Lost to Follow-up|9|||
163110596|NCT00711113|589112196|FG000|Overall Study|Implant lost|2|||
163110597|NCT02456636|589112197|FG000|Overall Study|Death|0|||
163110598|NCT02456636|589112198|FG001|Overall Study|Death|3|||
163110599|NCT02456636|589112199|FG002|Overall Study|Death|0|||
163110600|NCT02456636|589112197|FG000|Overall Study|Pregnancy|1|||
163110601|NCT02456636|589112198|FG001|Overall Study|Pregnancy|3|||
163110602|NCT02456636|589112199|FG002|Overall Study|Pregnancy|5|||
163110603|NCT02456636|589112197|FG000|Overall Study|Physician Decision|4|||
163110604|NCT02456636|589112198|FG001|Overall Study|Physician Decision|5|||
163110605|NCT02456636|589112199|FG002|Overall Study|Physician Decision|4|||
163110606|NCT02456636|589112197|FG000|Overall Study|Withdrawal by Subject|13|||
163110607|NCT02456636|589112198|FG001|Overall Study|Withdrawal by Subject|14|||
163110608|NCT02456636|589112199|FG002|Overall Study|Withdrawal by Subject|16|||
163110609|NCT02456636|589112197|FG000|Overall Study|Lost to Follow-up|50|||
163110610|NCT02456636|589112198|FG001|Overall Study|Lost to Follow-up|44|||
163110611|NCT02456636|589112199|FG002|Overall Study|Lost to Follow-up|50|||
163110612|NCT05312632|589112202|FG000|Overall Study|Adverse Event|12|||
163110613|NCT05312632|589112202|FG000|Overall Study|Withdrawal by Subject|10|||
163110614|NCT05312632|589112202|FG000|Overall Study|Lack of Efficacy|4|||
163110615|NCT05312632|589112202|FG000|Overall Study|Non-compliance with study procedures|9|||
163110616|NCT05312632|589112202|FG000|Overall Study|Other|4|||
163110617|NCT02379221|589112203|FG000|Overall Study|Lost to Follow-up|1|||
163110618|NCT00519376|589112204|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110619|NCT00519376|589112205|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110620|NCT00519376|589112206|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110621|NCT00519376|589112207|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110622|NCT00519376|589112208|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110623|NCT00519376|589112209|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110624|NCT00519376|589112210|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110625|NCT00519376|589112211|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110626|NCT00519376|589112212|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110627|NCT00519376|589112213|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110628|NCT00519376|589112214|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110629|NCT00519376|589112215|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110630|NCT00519376|589112216|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
163110631|NCT00519376|589112217|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110632|NCT00519376|589112218|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
162719316|NCT02503202|587678476|FG001|Extension: Month 6 to 24|Physician Decision|0|||
163110633|NCT00519376|589112219|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
163110634|NCT00519376|589112204|FG000|Treatment Period 4|Lost to Follow-up|0|||
163110635|NCT00519376|589112205|FG001|Treatment Period 4|Lost to Follow-up|0|||
163110636|NCT00519376|589112206|FG002|Treatment Period 4|Lost to Follow-up|1|||
163110637|NCT00519376|589112207|FG003|Treatment Period 4|Lost to Follow-up|0|||
163110638|NCT00519376|589112208|FG004|Treatment Period 4|Lost to Follow-up|0|||
163110639|NCT00519376|589112209|FG005|Treatment Period 4|Lost to Follow-up|0|||
163110640|NCT00519376|589112210|FG006|Treatment Period 4|Lost to Follow-up|0|||
162653923|NCT03013543|587449651|FG004|Overall Study|Other|2|||
162653924|NCT03013543|587449652|FG005|Overall Study|Other|0|||
162653925|NCT03013543|587449653|FG006|Overall Study|Other|0|||
162653926|NCT03013543|587449654|FG007|Overall Study|Other|0|||
162653927|NCT03013543|587449655|FG008|Overall Study|Other|1|||
162653928|NCT03013543|587449656|FG009|Overall Study|Other|0|||
162653929|NCT03013543|587449647|FG000|Overall Study|Adverse Event|0|||
162653930|NCT03013543|587449648|FG001|Overall Study|Adverse Event|0|||
162653931|NCT03013543|587449649|FG002|Overall Study|Adverse Event|0|||
162653932|NCT03013543|587449650|FG003|Overall Study|Adverse Event|3|||
162653933|NCT03013543|587449651|FG004|Overall Study|Adverse Event|2|||
162653934|NCT03013543|587449652|FG005|Overall Study|Adverse Event|1|||
162653935|NCT03013543|587449653|FG006|Overall Study|Adverse Event|3|||
162653936|NCT03013543|587449654|FG007|Overall Study|Adverse Event|8|||
162653937|NCT03013543|587449655|FG008|Overall Study|Adverse Event|0|||
162653938|NCT03013543|587449656|FG009|Overall Study|Adverse Event|2|||
162653939|NCT03013543|587449647|FG000|Overall Study|Death|0|||
163110641|NCT00519376|589112211|FG007|Treatment Period 4|Lost to Follow-up|0|||
163110642|NCT00519376|589112212|FG008|Treatment Period 4|Lost to Follow-up|0|||
163110643|NCT00519376|589112213|FG009|Treatment Period 4|Lost to Follow-up|0|||
163110644|NCT00519376|589112214|FG010|Treatment Period 4|Lost to Follow-up|0|||
163110645|NCT00519376|589112215|FG011|Treatment Period 4|Lost to Follow-up|0|||
163110646|NCT00519376|589112216|FG012|Treatment Period 4|Lost to Follow-up|0|||
163110647|NCT00519376|589112217|FG013|Treatment Period 4|Lost to Follow-up|0|||
163110648|NCT00519376|589112218|FG014|Treatment Period 4|Lost to Follow-up|0|||
163110649|NCT00519376|589112219|FG015|Treatment Period 4|Lost to Follow-up|0|||
163110650|NCT03812185|589112223|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
163110651|NCT02743949|589112231|FG000|Overall Study|Adverse Event|0|||
163110652|NCT02743949|589112232|FG001|Overall Study|Adverse Event|0|||
163110653|NCT02743949|589112233|FG002|Overall Study|Adverse Event|2|||
163110654|NCT02743949|589112231|FG000|Overall Study|Significant Protocol Deviation|2|||
163110655|NCT02743949|589112232|FG001|Overall Study|Significant Protocol Deviation|0|||
163110656|NCT02743949|589112233|FG002|Overall Study|Significant Protocol Deviation|1|||
163110657|NCT02743949|589112231|FG000|Overall Study|Voluntary Withdrawal|2|||
163110658|NCT02743949|589112232|FG001|Overall Study|Voluntary Withdrawal|1|||
163110659|NCT02743949|589112233|FG002|Overall Study|Voluntary Withdrawal|0|||
163110660|NCT01498575|589112234|FG000|Overall Sample|Withdrawal by Subject|60|||
163110661|NCT01498575|589112235|FG001|Overall Sample|Withdrawal by Subject|14|||
163110662|NCT01498575|589112234|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
163110663|NCT01498575|589112235|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
163110664|NCT01498575|589112234|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
163110665|NCT01498575|589112235|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
163110666|NCT00090142|589112239|FG000|Treatment Period I|Lost to Follow-up|1|||
163110667|NCT00090142|589112240|FG001|Treatment Period I|Lost to Follow-up|2|||
163110668|NCT00090142|589112239|FG000|Treatment Period I|Protocol Violation|2|||
163110669|NCT00090142|589112240|FG001|Treatment Period I|Protocol Violation|0|||
163110670|NCT00090142|589112239|FG000|Treatment Period I|Withdrawal by Subject|2|||
163110671|NCT00090142|589112240|FG001|Treatment Period I|Withdrawal by Subject|0|||
163110672|NCT00090142|589112239|FG000|Treatment Period I|Other|0|||
163110673|NCT00090142|589112240|FG001|Treatment Period I|Other|1|||
163110674|NCT00090142|589112239|FG000|Treatment Period II|Other|1|||
163110675|NCT00090142|589112240|FG001|Treatment Period II|Other|0|||
163110676|NCT01126437|589112241|FG000|Overall Study|Not treated|11|||
163110677|NCT01126437|589112242|FG001|Overall Study|Not treated|18|||
163110678|NCT01126437|589112243|FG002|Overall Study|Not treated|19|||
163110679|NCT01126437|589112241|FG000|Overall Study|Sites with data irregularities/fraud|6|||
163110680|NCT01126437|589112242|FG001|Overall Study|Sites with data irregularities/fraud|6|||
163110681|NCT01126437|589112243|FG002|Overall Study|Sites with data irregularities/fraud|7|||
163110682|NCT01126437|589112241|FG000|Overall Study|Adverse Event|602|||
163110683|NCT01126437|589112242|FG001|Overall Study|Adverse Event|606|||
163110684|NCT01126437|589112243|FG002|Overall Study|Adverse Event|635|||
163110685|NCT01126437|589112241|FG000|Overall Study|Lack of Efficacy|65|||
163110686|NCT01126437|589112242|FG001|Overall Study|Lack of Efficacy|60|||
163110687|NCT01126437|589112243|FG002|Overall Study|Lack of Efficacy|59|||
163110688|NCT01126437|589112241|FG000|Overall Study|Protocol Violation|64|||
163110689|NCT01126437|589112242|FG001|Overall Study|Protocol Violation|66|||
163110690|NCT01126437|589112243|FG002|Overall Study|Protocol Violation|41|||
163110691|NCT01126437|589112241|FG000|Overall Study|Lost to Follow-up|52|||
163110692|NCT01126437|589112242|FG001|Overall Study|Lost to Follow-up|63|||
163110693|NCT01126437|589112243|FG002|Overall Study|Lost to Follow-up|55|||
163110694|NCT01126437|589112241|FG000|Overall Study|Withdrawal by Subject|331|||
163110695|NCT01126437|589112242|FG001|Overall Study|Withdrawal by Subject|335|||
163110696|NCT01126437|589112243|FG002|Overall Study|Withdrawal by Subject|319|||
163110697|NCT01126437|589112241|FG000|Overall Study|Other reason not specified|210|||
163110698|NCT01126437|589112242|FG001|Overall Study|Other reason not specified|176|||
163110699|NCT01126437|589112243|FG002|Overall Study|Other reason not specified|178|||
163110700|NCT00006046|589112249|FG000|Overall Study|Adverse Event|3|||
163110701|NCT00006046|589112250|FG001|Overall Study|Adverse Event|0|||
163110702|NCT00006046|589112251|FG002|Overall Study|Adverse Event|0|||
163110703|NCT00006046|589112252|FG003|Overall Study|Adverse Event|0|||
163110704|NCT00006046|589112253|FG004|Overall Study|Adverse Event|0|||
163110705|NCT00006046|589112249|FG000|Overall Study|Disease Progression|2|||
163110706|NCT00006046|589112250|FG001|Overall Study|Disease Progression|0|||
163110707|NCT00006046|589112251|FG002|Overall Study|Disease Progression|0|||
163110708|NCT00006046|589112252|FG003|Overall Study|Disease Progression|0|||
163110709|NCT00006046|589112253|FG004|Overall Study|Disease Progression|0|||
163110710|NCT00596154|589112254|FG000|Overall Study|Not Evaluable|2|||
163110711|NCT00642369|589112264|FG000|Overall Study|Adverse Event|2|||
163110712|NCT00642369|589112265|FG001|Overall Study|Adverse Event|3|||
163110713|NCT00642369|589112264|FG000|Overall Study|Withdrawal by Subject|1|||
163110714|NCT00642369|589112265|FG001|Overall Study|Withdrawal by Subject|0|||
163110715|NCT00642369|589112264|FG000|Overall Study|misdiagnosis|0|||
162719317|NCT02503202|587678477|FG002|Extension: Month 6 to 24|Physician Decision|1|||
163110716|NCT00642369|589112265|FG001|Overall Study|misdiagnosis|1|||
163110717|NCT00642369|589112264|FG000|Overall Study|Lack of Efficacy|2|||
163110718|NCT00642369|589112265|FG001|Overall Study|Lack of Efficacy|2|||
163110719|NCT00996281|589112273|FG000|Overall Study|Adverse Event|75|||
163110720|NCT00996281|589112274|FG001|Overall Study|Adverse Event|37|||
163110721|NCT00996281|589112273|FG000|Overall Study|Major Protocol Deviation|6|||
163110722|NCT00996281|589112274|FG001|Overall Study|Major Protocol Deviation|7|||
163110723|NCT00996281|589112273|FG000|Overall Study|Lost to Follow-up|14|||
163110724|NCT00996281|589112274|FG001|Overall Study|Lost to Follow-up|16|||
163110725|NCT00996281|589112273|FG000|Overall Study|Withdrawal by Subject|31|||
163110726|NCT00996281|589112274|FG001|Overall Study|Withdrawal by Subject|20|||
163110727|NCT00996281|589112273|FG000|Overall Study|Lack of Efficacy|0|||
163110728|NCT00996281|589112274|FG001|Overall Study|Lack of Efficacy|2|||
163110729|NCT00996281|589112273|FG000|Overall Study|Other|5|||
163110730|NCT00996281|589112274|FG001|Overall Study|Other|7|||
163110731|NCT05593913|589112277|FG000|Overall Study|Insufficient image quality|39|||
163110732|NCT01453205|589112278|FG000|Overall Study|Lost to Follow-up|3|||
163110733|NCT01453205|589112279|FG001|Overall Study|Lost to Follow-up|0|||
163110734|NCT01453205|589112280|FG002|Overall Study|Lost to Follow-up|1|||
163110735|NCT01453205|589112278|FG000|Overall Study|Withdrawal by Subject|8|||
163110736|NCT01453205|589112279|FG001|Overall Study|Withdrawal by Subject|3|||
163110737|NCT01453205|589112280|FG002|Overall Study|Withdrawal by Subject|0|||
163110738|NCT01453205|589112278|FG000|Overall Study|Death|24|||
163110739|NCT01453205|589112279|FG001|Overall Study|Death|22|||
163110740|NCT01453205|589112280|FG002|Overall Study|Death|18|||
163110741|NCT01453205|589112278|FG000|Overall Study|Other|45|||
163110742|NCT01453205|589112279|FG001|Overall Study|Other|27|||
163110743|NCT01453205|589112280|FG002|Overall Study|Other|35|||
163110744|NCT04934800|589112283|FG000|Overall Study|Other|1|||
163110745|NCT04934800|589112283|FG000|Overall Study|Withdrawal by Subject|5|||
163110746|NCT04934800|589112283|FG000|Overall Study|Lack of Efficacy|1|||
163110747|NCT04934800|589112283|FG000|Overall Study|Adverse Event|9|||
163110748|NCT04934800|589112283|FG000|Overall Study|Lost to Follow-up|5|||
163110749|NCT04934800|589112283|FG000|Overall Study|Enrolled but not treated|1|||
163110750|NCT05596734|589112284|FG000|Substudy A|Withdrawal by Subject|1|||
163110751|NCT05596734|589112285|FG001|Substudy A|Withdrawal by Subject|0|||
163110752|NCT05596734|589112286|FG002|Substudy A|Withdrawal by Subject|0|||
163110753|NCT05596734|589112287|FG003|Substudy A|Withdrawal by Subject|0|||
163110754|NCT05596734|589112288|FG004|Substudy A|Withdrawal by Subject|0|||
162653940|NCT03013543|587449648|FG001|Overall Study|Death|0|||
162653941|NCT03013543|587449649|FG002|Overall Study|Death|0|||
162653942|NCT03013543|587449650|FG003|Overall Study|Death|1|||
162653943|NCT03013543|587449651|FG004|Overall Study|Death|0|||
162653944|NCT03013543|587449652|FG005|Overall Study|Death|0|||
162653945|NCT03013543|587449653|FG006|Overall Study|Death|0|||
163110755|NCT05596734|589112289|FG005|Substudy A|Withdrawal by Subject|0|||
163110756|NCT05596734|589112290|FG006|Substudy A|Withdrawal by Subject|1|||
163110757|NCT05596734|589112291|FG007|Substudy A|Withdrawal by Subject|0|||
163110758|NCT05596734|589112292|FG008|Substudy A|Withdrawal by Subject|0|||
163110759|NCT05596734|589112293|FG009|Substudy A|Withdrawal by Subject|0|||
163110760|NCT05596734|589112294|FG010|Substudy A|Withdrawal by Subject|0|||
163110761|NCT05596734|589112295|FG011|Substudy A|Withdrawal by Subject|0|||
163110762|NCT05596734|589112296|FG012|Substudy A|Withdrawal by Subject|0|||
163110763|NCT05596734|589112297|FG013|Substudy A|Withdrawal by Subject|0|||
163110764|NCT05596734|589112298|FG014|Substudy A|Withdrawal by Subject|0|||
163110765|NCT05596734|589112299|FG015|Substudy A|Withdrawal by Subject|0|||
163110766|NCT05596734|589112300|FG016|Substudy A|Withdrawal by Subject|0|||
163110767|NCT05596734|589112301|FG017|Substudy A|Withdrawal by Subject|0|||
163110768|NCT05596734|589112302|FG018|Substudy A|Withdrawal by Subject|0|||
163110769|NCT05596734|589112303|FG019|Substudy A|Withdrawal by Subject|0|||
163110770|NCT05596734|589112304|FG020|Substudy A|Withdrawal by Subject|0|||
163110771|NCT05596734|589112305|FG021|Substudy A|Withdrawal by Subject|0|||
163110772|NCT05596734|589112306|FG022|Substudy A|Withdrawal by Subject|0|||
163110773|NCT05596734|589112307|FG023|Substudy A|Withdrawal by Subject|0|||
163110774|NCT05596734|589112284|FG000|Substudy A|Lost to Follow-up|1|||
163110775|NCT05596734|589112285|FG001|Substudy A|Lost to Follow-up|0|||
163110776|NCT05596734|589112286|FG002|Substudy A|Lost to Follow-up|1|||
163110777|NCT05596734|589112287|FG003|Substudy A|Lost to Follow-up|0|||
163110778|NCT05596734|589112288|FG004|Substudy A|Lost to Follow-up|0|||
162653946|NCT03013543|587449654|FG007|Overall Study|Death|0|||
163110779|NCT05596734|589112289|FG005|Substudy A|Lost to Follow-up|0|||
163110780|NCT05596734|589112290|FG006|Substudy A|Lost to Follow-up|0|||
163110781|NCT05596734|589112291|FG007|Substudy A|Lost to Follow-up|0|||
163110782|NCT05596734|589112292|FG008|Substudy A|Lost to Follow-up|0|||
163110783|NCT05596734|589112293|FG009|Substudy A|Lost to Follow-up|0|||
163110784|NCT05596734|589112294|FG010|Substudy A|Lost to Follow-up|0|||
163110785|NCT05596734|589112295|FG011|Substudy A|Lost to Follow-up|0|||
162653947|NCT03013543|587449655|FG008|Overall Study|Death|0|||
162653948|NCT03013543|587449656|FG009|Overall Study|Death|0|||
163110786|NCT05596734|589112296|FG012|Substudy A|Lost to Follow-up|0|||
163110787|NCT05596734|589112297|FG013|Substudy A|Lost to Follow-up|0|||
163110788|NCT05596734|589112298|FG014|Substudy A|Lost to Follow-up|0|||
163110789|NCT05596734|589112299|FG015|Substudy A|Lost to Follow-up|0|||
163110790|NCT05596734|589112300|FG016|Substudy A|Lost to Follow-up|0|||
163110791|NCT05596734|589112301|FG017|Substudy A|Lost to Follow-up|0|||
163110792|NCT05596734|589112302|FG018|Substudy A|Lost to Follow-up|0|||
163110793|NCT05596734|589112303|FG019|Substudy A|Lost to Follow-up|0|||
163110794|NCT05596734|589112304|FG020|Substudy A|Lost to Follow-up|0|||
163110795|NCT05596734|589112305|FG021|Substudy A|Lost to Follow-up|0|||
163110796|NCT05596734|589112306|FG022|Substudy A|Lost to Follow-up|0|||
163110797|NCT05596734|589112307|FG023|Substudy A|Lost to Follow-up|0|||
163110798|NCT05596734|589112284|FG000|Substudy B|Withdrawal by Subject|0|||
163110799|NCT05596734|589112285|FG001|Substudy B|Withdrawal by Subject|0|||
163110800|NCT05596734|589112286|FG002|Substudy B|Withdrawal by Subject|0|||
163110801|NCT05596734|589112287|FG003|Substudy B|Withdrawal by Subject|0|||
163110802|NCT05596734|589112288|FG004|Substudy B|Withdrawal by Subject|0|||
163110803|NCT05596734|589112289|FG005|Substudy B|Withdrawal by Subject|0|||
163110804|NCT05596734|589112290|FG006|Substudy B|Withdrawal by Subject|0|||
163110805|NCT05596734|589112291|FG007|Substudy B|Withdrawal by Subject|0|||
163110806|NCT05596734|589112292|FG008|Substudy B|Withdrawal by Subject|0|||
163110807|NCT05596734|589112293|FG009|Substudy B|Withdrawal by Subject|0|||
163110808|NCT05596734|589112294|FG010|Substudy B|Withdrawal by Subject|0|||
163110809|NCT05596734|589112295|FG011|Substudy B|Withdrawal by Subject|0|||
163110810|NCT05596734|589112296|FG012|Substudy B|Withdrawal by Subject|1|||
163110811|NCT05596734|589112297|FG013|Substudy B|Withdrawal by Subject|0|||
163110812|NCT05596734|589112298|FG014|Substudy B|Withdrawal by Subject|1|||
163110813|NCT05596734|589112299|FG015|Substudy B|Withdrawal by Subject|2|||
163110814|NCT05596734|589112300|FG016|Substudy B|Withdrawal by Subject|2|||
163110815|NCT05596734|589112301|FG017|Substudy B|Withdrawal by Subject|1|||
163110816|NCT05596734|589112302|FG018|Substudy B|Withdrawal by Subject|2|||
163110817|NCT05596734|589112303|FG019|Substudy B|Withdrawal by Subject|0|||
163110818|NCT05596734|589112304|FG020|Substudy B|Withdrawal by Subject|0|||
163110819|NCT05596734|589112305|FG021|Substudy B|Withdrawal by Subject|0|||
163110820|NCT05596734|589112306|FG022|Substudy B|Withdrawal by Subject|0|||
163110821|NCT05596734|589112307|FG023|Substudy B|Withdrawal by Subject|1|||
163110822|NCT05596734|589112284|FG000|Substudy B|Physician Decision|0|||
163110823|NCT05596734|589112285|FG001|Substudy B|Physician Decision|0|||
163110824|NCT05596734|589112286|FG002|Substudy B|Physician Decision|0|||
163110825|NCT05596734|589112287|FG003|Substudy B|Physician Decision|0|||
163110826|NCT05596734|589112288|FG004|Substudy B|Physician Decision|0|||
163110827|NCT05596734|589112289|FG005|Substudy B|Physician Decision|0|||
163110828|NCT05596734|589112290|FG006|Substudy B|Physician Decision|0|||
163110829|NCT05596734|589112291|FG007|Substudy B|Physician Decision|0|||
163110830|NCT05596734|589112292|FG008|Substudy B|Physician Decision|0|||
163110831|NCT05596734|589112293|FG009|Substudy B|Physician Decision|0|||
163110832|NCT05596734|589112294|FG010|Substudy B|Physician Decision|0|||
163110833|NCT05596734|589112295|FG011|Substudy B|Physician Decision|0|||
163110834|NCT05596734|589112296|FG012|Substudy B|Physician Decision|0|||
163110835|NCT05596734|589112297|FG013|Substudy B|Physician Decision|0|||
163110836|NCT05596734|589112298|FG014|Substudy B|Physician Decision|0|||
163110837|NCT05596734|589112299|FG015|Substudy B|Physician Decision|1|||
163110838|NCT05596734|589112300|FG016|Substudy B|Physician Decision|0|||
163110839|NCT05596734|589112301|FG017|Substudy B|Physician Decision|0|||
163110840|NCT05596734|589112302|FG018|Substudy B|Physician Decision|0|||
163110841|NCT05596734|589112303|FG019|Substudy B|Physician Decision|0|||
163110842|NCT05596734|589112304|FG020|Substudy B|Physician Decision|0|||
163110843|NCT05596734|589112305|FG021|Substudy B|Physician Decision|0|||
163110844|NCT05596734|589112306|FG022|Substudy B|Physician Decision|0|||
163110845|NCT05596734|589112307|FG023|Substudy B|Physician Decision|0|||
163110846|NCT05596734|589112284|FG000|Substudy B|Lost to Follow-up|0|||
163110847|NCT05596734|589112285|FG001|Substudy B|Lost to Follow-up|0|||
163110848|NCT05596734|589112286|FG002|Substudy B|Lost to Follow-up|0|||
163110849|NCT05596734|589112287|FG003|Substudy B|Lost to Follow-up|0|||
163110850|NCT05596734|589112288|FG004|Substudy B|Lost to Follow-up|0|||
163110851|NCT05596734|589112289|FG005|Substudy B|Lost to Follow-up|0|||
162653949|NCT03013543|587449647|FG000|Overall Study|Lack of Efficacy|0|||
162653950|NCT03013543|587449648|FG001|Overall Study|Lack of Efficacy|0|||
162653951|NCT03013543|587449649|FG002|Overall Study|Lack of Efficacy|0|||
163110852|NCT05596734|589112290|FG006|Substudy B|Lost to Follow-up|0|||
163110853|NCT05596734|589112291|FG007|Substudy B|Lost to Follow-up|0|||
163110854|NCT05596734|589112292|FG008|Substudy B|Lost to Follow-up|0|||
163110855|NCT05596734|589112293|FG009|Substudy B|Lost to Follow-up|0|||
163110856|NCT05596734|589112294|FG010|Substudy B|Lost to Follow-up|0|||
163110857|NCT05596734|589112295|FG011|Substudy B|Lost to Follow-up|0|||
163110858|NCT05596734|589112296|FG012|Substudy B|Lost to Follow-up|1|||
163110859|NCT05596734|589112297|FG013|Substudy B|Lost to Follow-up|0|||
163110860|NCT05596734|589112298|FG014|Substudy B|Lost to Follow-up|1|||
163110861|NCT05596734|589112299|FG015|Substudy B|Lost to Follow-up|1|||
163110862|NCT05596734|589112300|FG016|Substudy B|Lost to Follow-up|0|||
163110863|NCT05596734|589112301|FG017|Substudy B|Lost to Follow-up|0|||
163110864|NCT05596734|589112302|FG018|Substudy B|Lost to Follow-up|0|||
163110865|NCT05596734|589112303|FG019|Substudy B|Lost to Follow-up|0|||
163110866|NCT05596734|589112304|FG020|Substudy B|Lost to Follow-up|0|||
163110867|NCT05596734|589112305|FG021|Substudy B|Lost to Follow-up|0|||
163110868|NCT05596734|589112306|FG022|Substudy B|Lost to Follow-up|0|||
163110869|NCT05596734|589112307|FG023|Substudy B|Lost to Follow-up|0|||
163110870|NCT02059499|589112313|FG000|Upto Week 20|Lost to Follow-up|2|||
163110871|NCT02059499|589112314|FG001|Upto Week 20|Lost to Follow-up|6|||
163110872|NCT02059499|589112315|FG002|Upto Week 20|Lost to Follow-up|0|||
163110873|NCT02059499|589112313|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
163110874|NCT02059499|589112314|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
163110875|NCT02059499|589112315|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
163110876|NCT02059499|589112313|FG000|Upto Week 20|Withdrawal by Subject|1|||
163110877|NCT02059499|589112314|FG001|Upto Week 20|Withdrawal by Subject|1|||
163110878|NCT02059499|589112315|FG002|Upto Week 20|Withdrawal by Subject|0|||
163110879|NCT02059499|589112313|FG000|Upto Week 20|No treatment per protocol criteria|0|||
163110880|NCT02059499|589112314|FG001|Upto Week 20|No treatment per protocol criteria|0|||
163110881|NCT02059499|589112315|FG002|Upto Week 20|No treatment per protocol criteria|5|||
163110882|NCT02059499|589112313|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
163110883|NCT02059499|589112314|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
163110884|NCT02059499|589112315|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
163110885|NCT02059499|589112313|FG000|Post-week 20|Lost to Follow-up|0|||
163110886|NCT02059499|589112314|FG001|Post-week 20|Lost to Follow-up|2|||
163110887|NCT02059499|589112315|FG002|Post-week 20|Lost to Follow-up|0|||
163110888|NCT02059499|589112313|FG000|Post-week 20|Withdrawal by Subject|0|||
163110889|NCT02059499|589112314|FG001|Post-week 20|Withdrawal by Subject|1|||
163110890|NCT02059499|589112315|FG002|Post-week 20|Withdrawal by Subject|0|||
163110891|NCT02059499|589112313|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
163110892|NCT02059499|589112314|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
163110893|NCT02059499|589112315|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
163110894|NCT04210245|589112316|FG000|Overall Study|Adverse Event|0|||
163110895|NCT04210245|589112317|FG001|Overall Study|Adverse Event|3|||
163110896|NCT04210245|589112318|FG002|Overall Study|Adverse Event|6|||
163110897|NCT04210245|589112319|FG003|Overall Study|Adverse Event|0|||
163110898|NCT04210245|589112316|FG000|Overall Study|Withdrawal by Subject|0|||
163110899|NCT04210245|589112317|FG001|Overall Study|Withdrawal by Subject|1|||
163110900|NCT04210245|589112318|FG002|Overall Study|Withdrawal by Subject|4|||
163110901|NCT04210245|589112319|FG003|Overall Study|Withdrawal by Subject|4|||
163110902|NCT04210245|589112316|FG000|Overall Study|Lost to Follow-up|0|||
163110903|NCT04210245|589112317|FG001|Overall Study|Lost to Follow-up|1|||
163110904|NCT04210245|589112318|FG002|Overall Study|Lost to Follow-up|1|||
163110905|NCT04210245|589112319|FG003|Overall Study|Lost to Follow-up|1|||
163110906|NCT04210245|589112316|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110907|NCT04210245|589112317|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110908|NCT04210245|589112318|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
163110909|NCT04210245|589112319|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
163110910|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
163110911|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110912|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110913|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110914|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110915|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
163110916|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
163110917|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
163110918|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110919|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110920|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110921|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
163110922|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
163110923|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
163110924|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110925|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110926|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110927|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
163110928|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
163110929|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
163110930|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110931|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
162653952|NCT03013543|587449650|FG003|Overall Study|Lack of Efficacy|1|||
162653953|NCT03013543|587449651|FG004|Overall Study|Lack of Efficacy|0|||
163110932|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110933|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
163110934|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
163110935|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
163110936|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110937|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110938|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110939|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
163110940|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
163110941|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110942|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110943|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110944|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110945|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
163110946|NCT03989349|589112324|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
163110947|NCT03989349|589112325|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
163110948|NCT03989349|589112326|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110949|NCT03989349|589112327|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110950|NCT03989349|589112328|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110951|NCT03989349|589112329|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
163110952|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163110953|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
163110954|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
163110955|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
163110956|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163110957|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
163110958|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163110959|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
163110960|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163110961|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
163110962|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
163110963|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
163110964|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163110965|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
163110966|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
163110967|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
163110968|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
163110969|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
163110970|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110971|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110972|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
163110973|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110974|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
163110975|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
163110976|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110977|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110978|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110979|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110980|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
163110981|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
163110982|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
162653954|NCT03013543|587449652|FG005|Overall Study|Lack of Efficacy|0|||
162653955|NCT03013543|587449653|FG006|Overall Study|Lack of Efficacy|0|||
162653956|NCT03013543|587449654|FG007|Overall Study|Lack of Efficacy|0|||
162653957|NCT03013543|587449655|FG008|Overall Study|Lack of Efficacy|0|||
162653958|NCT03013543|587449656|FG009|Overall Study|Lack of Efficacy|0|||
162653959|NCT03013543|587449647|FG000|Overall Study|Lost to Follow-up|0|||
162653960|NCT03013543|587449648|FG001|Overall Study|Lost to Follow-up|0|||
162653961|NCT03013543|587449649|FG002|Overall Study|Lost to Follow-up|0|||
162653962|NCT03013543|587449650|FG003|Overall Study|Lost to Follow-up|1|||
162653963|NCT03013543|587449651|FG004|Overall Study|Lost to Follow-up|0|||
162653964|NCT03013543|587449652|FG005|Overall Study|Lost to Follow-up|0|||
163110983|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
163110984|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
163110985|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
163110986|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
163110987|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
163110988|NCT03989349|589112324|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110989|NCT03989349|589112325|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110990|NCT03989349|589112326|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110991|NCT03989349|589112327|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
163110992|NCT03989349|589112328|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110993|NCT03989349|589112329|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
163110994|NCT02684058|589112330|FG000|Treatment Period|Progressive disease|4|||
163110995|NCT02684058|589112331|FG001|Treatment Period|Progressive disease|10|||
163110996|NCT02684058|589112332|FG002|Treatment Period|Progressive disease|19|||
163110997|NCT02684058|589112330|FG000|Treatment Period|Adverse Event|3|||
163110998|NCT02684058|589112331|FG001|Treatment Period|Adverse Event|8|||
163110999|NCT02684058|589112332|FG002|Treatment Period|Adverse Event|1|||
163111000|NCT02684058|589112330|FG000|Treatment Period|Physician Decision|5|||
163111001|NCT02684058|589112331|FG001|Treatment Period|Physician Decision|1|||
163111002|NCT02684058|589112332|FG002|Treatment Period|Physician Decision|2|||
163111003|NCT02684058|589112330|FG000|Treatment Period|New therapy for study indication|1|||
163111004|NCT02684058|589112331|FG001|Treatment Period|New therapy for study indication|0|||
163111005|NCT02684058|589112332|FG002|Treatment Period|New therapy for study indication|0|||
163111006|NCT02684058|589112330|FG000|Treatment Period|Protocol deviation|0|||
163111007|NCT02684058|589112331|FG001|Treatment Period|Protocol deviation|1|||
163111008|NCT02684058|589112332|FG002|Treatment Period|Protocol deviation|0|||
163111009|NCT02684058|589112330|FG000|Treatment Period|Subject/guardian decision|4|||
163111010|NCT02684058|589112331|FG001|Treatment Period|Subject/guardian decision|3|||
163111011|NCT02684058|589112332|FG002|Treatment Period|Subject/guardian decision|0|||
163111012|NCT02684058|589112330|FG000|Treatment Period|Death|0|||
163111013|NCT02684058|589112331|FG001|Treatment Period|Death|0|||
163111014|NCT02684058|589112332|FG002|Treatment Period|Death|2|||
163111015|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163111016|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163111017|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163111018|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
163111019|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163111020|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
163111021|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163111022|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
163111023|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162653965|NCT03013543|587449653|FG006|Overall Study|Lost to Follow-up|1|||
162653966|NCT03013543|587449654|FG007|Overall Study|Lost to Follow-up|0|||
163111024|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|Death|0|||
163111025|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163111026|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|Death|3|||
163111027|NCT02684058|589112330|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
163111028|NCT02684058|589112331|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
163111029|NCT02684058|589112332|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
163111030|NCT02684058|589112330|FG000|Post-treatment Survival Follow-up|Death|0|||
163111031|NCT02684058|589112331|FG001|Post-treatment Survival Follow-up|Death|0|||
163111032|NCT02684058|589112332|FG002|Post-treatment Survival Follow-up|Death|7|||
163111033|NCT02684058|589112330|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
163111034|NCT02684058|589112331|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
163111035|NCT02684058|589112332|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
163111036|NCT02684058|589112330|FG000|Crossover Treatment Period|Progressive disease|0|||
163111037|NCT02684058|589112331|FG001|Crossover Treatment Period|Progressive disease|1|||
163111038|NCT02684058|589112332|FG002|Crossover Treatment Period|Progressive disease|0|||
163111039|NCT01802580|589112333|FG000|Overall Study|Physician Decision|1|||
163111040|NCT01802580|589112334|FG001|Overall Study|Physician Decision|0|||
163111041|NCT01802580|589112333|FG000|Overall Study|Protocol Violation|2|||
163111042|NCT01802580|589112334|FG001|Overall Study|Protocol Violation|0|||
163111043|NCT01802580|589112333|FG000|Overall Study|Withdrawal by Subject|5|||
163111044|NCT01802580|589112334|FG001|Overall Study|Withdrawal by Subject|6|||
163111045|NCT01802580|589112333|FG000|Overall Study|Other|1|||
163111046|NCT01802580|589112334|FG001|Overall Study|Other|3|||
163111047|NCT01802580|589112333|FG000|Overall Study|Lack of Efficacy|0|||
163111048|NCT01802580|589112334|FG001|Overall Study|Lack of Efficacy|2|||
163111049|NCT03255967|589112335|FG000|Overall Study|Adverse Event|26|||
163111050|NCT03255967|589112336|FG001|Overall Study|Adverse Event|30|||
163111051|NCT03255967|589112335|FG000|Overall Study|Withdrawal by Subject|6|||
163111052|NCT03255967|589112336|FG001|Overall Study|Withdrawal by Subject|6|||
163111053|NCT03255967|589112335|FG000|Overall Study|Schedule conflict|6|||
163111054|NCT03255967|589112336|FG001|Overall Study|Schedule conflict|4|||
163111055|NCT03255967|589112335|FG000|Overall Study|POA did not sign consent form|2|||
163111056|NCT03255967|589112336|FG001|Overall Study|POA did not sign consent form|0|||
163111057|NCT01252186|589112337|FG000|Overall Study|Adverse Event|9|||
163111058|NCT01252186|589112338|FG001|Overall Study|Adverse Event|6|||
163111059|NCT01252186|589112339|FG002|Overall Study|Adverse Event|8|||
163111060|NCT01252186|589112337|FG000|Overall Study|Withdrawal by Subject|2|||
163111061|NCT01252186|589112338|FG001|Overall Study|Withdrawal by Subject|5|||
163111062|NCT01252186|589112339|FG002|Overall Study|Withdrawal by Subject|2|||
163111063|NCT01252186|589112337|FG000|Overall Study|Physician Decision|0|||
163111064|NCT01252186|589112338|FG001|Overall Study|Physician Decision|0|||
163111065|NCT01252186|589112339|FG002|Overall Study|Physician Decision|1|||
163111066|NCT01252186|589112337|FG000|Overall Study|Non-compliance|0|||
163111067|NCT01252186|589112338|FG001|Overall Study|Non-compliance|3|||
163111068|NCT01252186|589112339|FG002|Overall Study|Non-compliance|4|||
163111069|NCT01252186|589112337|FG000|Overall Study|Protocol Violation|0|||
163111070|NCT01252186|589112338|FG001|Overall Study|Protocol Violation|0|||
163111071|NCT01252186|589112339|FG002|Overall Study|Protocol Violation|1|||
163111072|NCT01252186|589112337|FG000|Overall Study|Pregnancy|2|||
163111073|NCT01252186|589112338|FG001|Overall Study|Pregnancy|2|||
163111074|NCT01252186|589112339|FG002|Overall Study|Pregnancy|0|||
163111075|NCT01252186|589112337|FG000|Overall Study|Sponsor Request|2|||
163111076|NCT01252186|589112338|FG001|Overall Study|Sponsor Request|1|||
163111077|NCT01252186|589112339|FG002|Overall Study|Sponsor Request|0|||
163111078|NCT01252186|589112337|FG000|Overall Study|Lost to Follow-up|10|||
163111079|NCT01252186|589112338|FG001|Overall Study|Lost to Follow-up|10|||
163111080|NCT01252186|589112339|FG002|Overall Study|Lost to Follow-up|11|||
163111081|NCT01252186|589112337|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
163111082|NCT01252186|589112338|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
163111083|NCT01252186|589112339|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
163111084|NCT01327053|589112348|FG000|Overall Study|Adverse Event|23|||
163111085|NCT01327053|589112349|FG001|Overall Study|Adverse Event|57|||
163111086|NCT01327053|589112348|FG000|Overall Study|Patient/guardian decision|11|||
163111087|NCT01327053|589112349|FG001|Overall Study|Patient/guardian decision|35|||
163111088|NCT01327053|589112348|FG000|Overall Study|Physician Decision|10|||
163111089|NCT01327053|589112349|FG001|Overall Study|Physician Decision|14|||
163111090|NCT01327053|589112348|FG000|Overall Study|Death|1|||
163111091|NCT01327053|589112349|FG001|Overall Study|Death|5|||
163111092|NCT01327053|589112348|FG000|Overall Study|Lost to Follow-up|2|||
163111093|NCT01327053|589112349|FG001|Overall Study|Lost to Follow-up|4|||
163111094|NCT01327053|589112348|FG000|Overall Study|Non-compliance with study treatment|0|||
163111095|NCT01327053|589112349|FG001|Overall Study|Non-compliance with study treatment|5|||
163111096|NCT01327053|589112348|FG000|Overall Study|Study terminated by Sponsor|1|||
163111097|NCT01327053|589112349|FG001|Overall Study|Study terminated by Sponsor|3|||
163111098|NCT01327053|589112348|FG000|Overall Study|Progressive disease|31|||
163111099|NCT01327053|589112349|FG001|Overall Study|Progressive disease|26|||
163111100|NCT01327053|589112348|FG000|Overall Study|Protocol Violation|0|||
162719318|NCT02503202|587678478|FG003|Extension: Month 6 to 24|Physician Decision|3|||
163111101|NCT01327053|589112349|FG001|Overall Study|Protocol Violation|1|||
163111102|NCT01327053|589112348|FG000|Overall Study|Untreated|0|||
163111103|NCT01327053|589112349|FG001|Overall Study|Untreated|1|||
163111104|NCT00778258|589112350|FG000|Overall Study|Adverse Event|1|||
163111105|NCT00778258|589112351|FG001|Overall Study|Adverse Event|0|||
163111106|NCT00778258|589112352|FG002|Overall Study|Adverse Event|0|||
163111107|NCT00778258|589112353|FG003|Overall Study|Adverse Event|0|||
163111108|NCT00778258|589112354|FG004|Overall Study|Adverse Event|0|||
163111109|NCT00778258|589112355|FG005|Overall Study|Adverse Event|1|||
163111110|NCT00778258|589112356|FG006|Overall Study|Adverse Event|0|||
163111111|NCT00778258|589112357|FG007|Overall Study|Adverse Event|0|||
163111112|NCT00778258|589112358|FG008|Overall Study|Adverse Event|0|||
163111113|NCT00778258|589112350|FG000|Overall Study|Lost to Follow-up|0|||
163111114|NCT00778258|589112351|FG001|Overall Study|Lost to Follow-up|0|||
163111115|NCT00778258|589112352|FG002|Overall Study|Lost to Follow-up|2|||
163111116|NCT00778258|589112353|FG003|Overall Study|Lost to Follow-up|0|||
163111117|NCT00778258|589112354|FG004|Overall Study|Lost to Follow-up|0|||
163111118|NCT00778258|589112355|FG005|Overall Study|Lost to Follow-up|3|||
163111119|NCT00778258|589112356|FG006|Overall Study|Lost to Follow-up|2|||
163111120|NCT00778258|589112357|FG007|Overall Study|Lost to Follow-up|2|||
163111121|NCT00778258|589112358|FG008|Overall Study|Lost to Follow-up|0|||
163111122|NCT00778258|589112350|FG000|Overall Study|Withdrawal by Subject|6|||
163111123|NCT00778258|589112351|FG001|Overall Study|Withdrawal by Subject|2|||
163111124|NCT00778258|589112352|FG002|Overall Study|Withdrawal by Subject|8|||
163111125|NCT00778258|589112353|FG003|Overall Study|Withdrawal by Subject|2|||
163111126|NCT00778258|589112354|FG004|Overall Study|Withdrawal by Subject|0|||
163111127|NCT00778258|589112355|FG005|Overall Study|Withdrawal by Subject|6|||
163111128|NCT00778258|589112356|FG006|Overall Study|Withdrawal by Subject|12|||
163111129|NCT00778258|589112357|FG007|Overall Study|Withdrawal by Subject|12|||
163111130|NCT00778258|589112358|FG008|Overall Study|Withdrawal by Subject|4|||
163111131|NCT00778258|589112350|FG000|Overall Study|New Contraindication|0|||
163111132|NCT00778258|589112351|FG001|Overall Study|New Contraindication|0|||
163111133|NCT00778258|589112352|FG002|Overall Study|New Contraindication|0|||
163111134|NCT00778258|589112353|FG003|Overall Study|New Contraindication|0|||
163111135|NCT00778258|589112354|FG004|Overall Study|New Contraindication|0|||
163111136|NCT00778258|589112355|FG005|Overall Study|New Contraindication|0|||
163111137|NCT00778258|589112356|FG006|Overall Study|New Contraindication|0|||
163111138|NCT00778258|589112357|FG007|Overall Study|New Contraindication|1|||
163111139|NCT00778258|589112358|FG008|Overall Study|New Contraindication|0|||
163111140|NCT00778258|589112350|FG000|Overall Study|Non-compliance|0|||
163111141|NCT00778258|589112351|FG001|Overall Study|Non-compliance|0|||
163111142|NCT00778258|589112352|FG002|Overall Study|Non-compliance|0|||
163111143|NCT00778258|589112353|FG003|Overall Study|Non-compliance|1|||
163111144|NCT00778258|589112354|FG004|Overall Study|Non-compliance|0|||
163111145|NCT00778258|589112355|FG005|Overall Study|Non-compliance|0|||
163111146|NCT00778258|589112356|FG006|Overall Study|Non-compliance|0|||
163111147|NCT00778258|589112357|FG007|Overall Study|Non-compliance|0|||
163111148|NCT00778258|589112358|FG008|Overall Study|Non-compliance|0|||
163111149|NCT00778258|589112350|FG000|Overall Study|Other|0|||
163111150|NCT00778258|589112351|FG001|Overall Study|Other|0|||
163111151|NCT00778258|589112352|FG002|Overall Study|Other|0|||
163111152|NCT00778258|589112353|FG003|Overall Study|Other|0|||
163111153|NCT00778258|589112354|FG004|Overall Study|Other|0|||
163111154|NCT00778258|589112355|FG005|Overall Study|Other|0|||
163111155|NCT00778258|589112356|FG006|Overall Study|Other|1|||
163111156|NCT00778258|589112357|FG007|Overall Study|Other|0|||
163111157|NCT00778258|589112358|FG008|Overall Study|Other|0|||
163111158|NCT01221623|589112359|FG000|Overall Study|Withdrawal by Subject|19|||
163111159|NCT01221623|589112360|FG001|Overall Study|Withdrawal by Subject|8|||
163111160|NCT01221623|589112359|FG000|Overall Study|Lost to Follow-up|7|||
163111161|NCT01221623|589112360|FG001|Overall Study|Lost to Follow-up|1|||
162653967|NCT03013543|587449655|FG008|Overall Study|Lost to Follow-up|0|||
162653968|NCT03013543|587449656|FG009|Overall Study|Lost to Follow-up|2|||
162653969|NCT03013543|587449647|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162653970|NCT03013543|587449648|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163111162|NCT01221623|589112359|FG000|Overall Study|Adverse Event|6|||
163111163|NCT01221623|589112360|FG001|Overall Study|Adverse Event|3|||
163111164|NCT01221623|589112359|FG000|Overall Study|Death|1|||
163111165|NCT01221623|589112360|FG001|Overall Study|Death|0|||
163111166|NCT01221623|589112359|FG000|Overall Study|Other|5|||
163111167|NCT01221623|589112360|FG001|Overall Study|Other|2|||
163111168|NCT00661726|589112361|FG000|Overall Study|Adverse Event|1|||
163111169|NCT02644096|589112362|FG000|Overall Study|Withdrawal by Subject|28|||
163111170|NCT02644096|589112363|FG001|Overall Study|Withdrawal by Subject|25|||
163111171|NCT02147197|589112364|FG000|Overall Study|Adverse Event|1|||
163111172|NCT02147197|589112365|FG001|Overall Study|Adverse Event|0|||
163111173|NCT02147197|589112366|FG002|Overall Study|Adverse Event|0|||
163111174|NCT02147197|589112364|FG000|Overall Study|Withdrawal of Consent|4|||
163111175|NCT02147197|589112365|FG001|Overall Study|Withdrawal of Consent|3|||
163111176|NCT02147197|589112366|FG002|Overall Study|Withdrawal of Consent|2|||
163111177|NCT02147197|589112364|FG000|Overall Study|Lost to Follow-up|2|||
163111178|NCT02147197|589112365|FG001|Overall Study|Lost to Follow-up|3|||
163111179|NCT02147197|589112366|FG002|Overall Study|Lost to Follow-up|1|||
163111180|NCT02147197|589112364|FG000|Overall Study|Protocol Violation|1|||
163111181|NCT02147197|589112365|FG001|Overall Study|Protocol Violation|0|||
163111182|NCT02147197|589112366|FG002|Overall Study|Protocol Violation|3|||
163111183|NCT02147197|589112364|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163111184|NCT02147197|589112365|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163111185|NCT02147197|589112366|FG002|Overall Study|Other Miscellaneous Reasons|3|||
163111186|NCT00830375|589112367|FG000|Overall Study|Lost to Follow-up|1|||
163111187|NCT01700959|589112368|FG000|Overall Study|Adverse Event|0|||
163111188|NCT01700959|589112369|FG001|Overall Study|Adverse Event|1|||
163111189|NCT01700959|589112370|FG002|Overall Study|Adverse Event|1|||
163111190|NCT01700959|589112371|FG003|Overall Study|Adverse Event|2|||
163111191|NCT01700959|589112372|FG004|Overall Study|Adverse Event|0|||
163111192|NCT01700959|589112373|FG005|Overall Study|Adverse Event|2|||
163111193|NCT01700959|589112368|FG000|Overall Study|Withdrawal by Subject|15|||
163111194|NCT01700959|589112369|FG001|Overall Study|Withdrawal by Subject|9|||
163111195|NCT01700959|589112370|FG002|Overall Study|Withdrawal by Subject|12|||
163111196|NCT01700959|589112371|FG003|Overall Study|Withdrawal by Subject|11|||
163111197|NCT01700959|589112372|FG004|Overall Study|Withdrawal by Subject|8|||
163111198|NCT01700959|589112373|FG005|Overall Study|Withdrawal by Subject|12|||
163111199|NCT01700959|589112368|FG000|Overall Study|Ineligible|2|||
163111200|NCT01700959|589112369|FG001|Overall Study|Ineligible|1|||
163111201|NCT01700959|589112370|FG002|Overall Study|Ineligible|2|||
163111202|NCT01700959|589112371|FG003|Overall Study|Ineligible|0|||
163111203|NCT01700959|589112372|FG004|Overall Study|Ineligible|0|||
163111204|NCT01700959|589112373|FG005|Overall Study|Ineligible|1|||
163111205|NCT01700959|589112368|FG000|Overall Study|Noncompliant|9|||
163111206|NCT01700959|589112369|FG001|Overall Study|Noncompliant|9|||
163111207|NCT01700959|589112370|FG002|Overall Study|Noncompliant|17|||
163111208|NCT01700959|589112371|FG003|Overall Study|Noncompliant|18|||
163111209|NCT01700959|589112372|FG004|Overall Study|Noncompliant|15|||
163111210|NCT01700959|589112373|FG005|Overall Study|Noncompliant|9|||
163111211|NCT01700959|589112368|FG000|Overall Study|Side effects|1|||
163111212|NCT01700959|589112369|FG001|Overall Study|Side effects|4|||
163111213|NCT01700959|589112370|FG002|Overall Study|Side effects|8|||
163111214|NCT01700959|589112371|FG003|Overall Study|Side effects|4|||
163111215|NCT01700959|589112372|FG004|Overall Study|Side effects|4|||
163111216|NCT01700959|589112373|FG005|Overall Study|Side effects|1|||
163111217|NCT00322452|589112374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163111218|NCT00322452|589112375|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163111219|NCT00322452|589112374|FG000|Overall Study|Lost to Follow-up|5|||
163111220|NCT00322452|589112375|FG001|Overall Study|Lost to Follow-up|2|||
163111221|NCT00322452|589112374|FG000|Overall Study|Withdrawal by Subject|19|||
163111222|NCT00322452|589112375|FG001|Overall Study|Withdrawal by Subject|46|||
163111223|NCT00322452|589112374|FG000|Overall Study|Death|223|||
163111224|NCT00322452|589112375|FG001|Overall Study|Death|227|||
163111225|NCT02438384|589112376|FG000|Overall Study|Lost to Follow-up|8|||
163111226|NCT02438384|589112377|FG001|Overall Study|Lost to Follow-up|6|||
163111227|NCT02438384|589112378|FG002|Overall Study|Lost to Follow-up|4|||
163111228|NCT02650128|589112379|FG000|Overall Study|Death|2|||
163111229|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
163111230|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
163111231|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
163111232|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
163111233|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
163111234|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
163111235|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
163111236|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
163111237|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
163111238|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
163111239|NCT01263015|589114040|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
163111240|NCT01263015|589114041|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
163111241|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
163111242|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
163111243|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
163111244|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
163111245|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
163111246|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
163111247|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
163111248|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
163111249|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
163111250|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
163111251|NCT01263015|589114040|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
163111252|NCT01263015|589114041|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
163111253|NCT05599451|589114042|FG000|Overall Study|Not randomized|11|||
163111254|NCT05599451|589114043|FG001|Overall Study|Not randomized|0|||
163111255|NCT05599451|589114044|FG002|Overall Study|Not randomized|0|||
163111256|NCT05599451|589114045|FG003|Overall Study|Not randomized|0|||
163111257|NCT05599451|589114046|FG004|Overall Study|Not randomized|0|||
163111258|NCT05599451|589114042|FG000|Overall Study|Physician Decision|0|||
163111259|NCT05599451|589114043|FG001|Overall Study|Physician Decision|0|||
163111260|NCT05599451|589114044|FG002|Overall Study|Physician Decision|0|||
163111261|NCT05599451|589114045|FG003|Overall Study|Physician Decision|1|||
163111262|NCT05599451|589114046|FG004|Overall Study|Physician Decision|0|||
163111263|NCT02723006|589114047|FG000|Overall Study|Withdrawal by Subject|0|||
163111264|NCT02723006|589114048|FG001|Overall Study|Withdrawal by Subject|1|||
163111265|NCT02723006|589114049|FG002|Overall Study|Withdrawal by Subject|1|||
163111266|NCT02723006|589114047|FG000|Overall Study|Study Terminated by Sponsor|1|||
163111267|NCT02723006|589114048|FG001|Overall Study|Study Terminated by Sponsor|6|||
163111268|NCT02723006|589114049|FG002|Overall Study|Study Terminated by Sponsor|6|||
163111269|NCT00303446|589114050|FG000|Overall Study|Withdrawal by Subject|2|||
163111270|NCT00303446|589114051|FG001|Overall Study|Withdrawal by Subject|2|||
163111271|NCT00303446|589114050|FG000|Overall Study|Death|0|||
163111272|NCT00303446|589114051|FG001|Overall Study|Death|1|||
163111273|NCT00303446|589114050|FG000|Overall Study|Physician Decision|0|||
163111274|NCT00303446|589114051|FG001|Overall Study|Physician Decision|1|||
163111275|NCT03116828|589114053|FG000|Overall Study|Adverse Event|1|||
163111276|NCT03116828|589114054|FG001|Overall Study|Adverse Event|10|||
163111277|NCT03116828|589114053|FG000|Overall Study|Withdrawal by Subject|4|||
163111278|NCT03116828|589114054|FG001|Overall Study|Withdrawal by Subject|8|||
163111279|NCT03116828|589114053|FG000|Overall Study|OTHER|3|||
163111280|NCT03116828|589114054|FG001|Overall Study|OTHER|3|||
163111281|NCT05243745|589114057|FG000|Overall Study|Withdrawal by Subject|0|||
163111282|NCT05243745|589114058|FG001|Overall Study|Withdrawal by Subject|0|||
163111283|NCT05243745|589114059|FG002|Overall Study|Withdrawal by Subject|0|||
163111284|NCT05243745|589114060|FG003|Overall Study|Withdrawal by Subject|1|||
163111285|NCT05243745|589114057|FG000|Overall Study|Unable to Attend Visit 6|0|||
163111286|NCT05243745|589114058|FG001|Overall Study|Unable to Attend Visit 6|0|||
163111287|NCT05243745|589114059|FG002|Overall Study|Unable to Attend Visit 6|1|||
163111288|NCT05243745|589114060|FG003|Overall Study|Unable to Attend Visit 6|0|||
163111289|NCT02998203|589114061|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
163111290|NCT02998203|589114062|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
163111291|NCT02998203|589114061|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
163111292|NCT02998203|589114062|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
163111293|NCT04187144|589114075|FG000|Overall Study|Lost to Follow-up|12|||
163111294|NCT04187144|589114076|FG001|Overall Study|Lost to Follow-up|11|||
163111295|NCT04187144|589114075|FG000|Overall Study|Withdrawal by Subject|20|||
163111296|NCT04187144|589114076|FG001|Overall Study|Withdrawal by Subject|18|||
163111297|NCT04187144|589114075|FG000|Overall Study|Adverse Event|19|||
163111298|NCT04187144|589114076|FG001|Overall Study|Adverse Event|4|||
163111299|NCT04187144|589114075|FG000|Overall Study|Physician Decision|5|||
162653971|NCT03013543|587449649|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162653972|NCT03013543|587449650|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163111300|NCT04187144|589114076|FG001|Overall Study|Physician Decision|3|||
163111301|NCT04187144|589114075|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
163111302|NCT04187144|589114076|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
163111303|NCT04187144|589114075|FG000|Overall Study|Protocol Deviation|1|||
163111304|NCT04187144|589114076|FG001|Overall Study|Protocol Deviation|4|||
163111305|NCT03842969|589114077|FG000|Overall Study|Participant declined follow-up visit|0|||
163111306|NCT03842969|589114078|FG001|Overall Study|Participant declined follow-up visit|1|||
163111307|NCT03842969|589114079|FG002|Overall Study|Participant declined follow-up visit|0|||
163111308|NCT03842969|589114077|FG000|Overall Study|Sponsor's decision|12|||
163111309|NCT03842969|589114078|FG001|Overall Study|Sponsor's decision|99|||
163111310|NCT03842969|589114079|FG002|Overall Study|Sponsor's decision|61|||
163111311|NCT03842969|589114077|FG000|Overall Study|Pregnancy|0|||
163111312|NCT03842969|589114078|FG001|Overall Study|Pregnancy|0|||
163111313|NCT03842969|589114079|FG002|Overall Study|Pregnancy|1|||
163111314|NCT03842969|589114077|FG000|Overall Study|Death|1|||
163111315|NCT03842969|589114078|FG001|Overall Study|Death|0|||
163111316|NCT03842969|589114079|FG002|Overall Study|Death|1|||
163111317|NCT03842969|589114077|FG000|Overall Study|Withdrawal by Subject|3|||
163111318|NCT03842969|589114078|FG001|Overall Study|Withdrawal by Subject|30|||
163111319|NCT03842969|589114079|FG002|Overall Study|Withdrawal by Subject|18|||
163111320|NCT03842969|589114077|FG000|Overall Study|Protocol Violation|1|||
163111321|NCT03842969|589114078|FG001|Overall Study|Protocol Violation|1|||
163111322|NCT03842969|589114079|FG002|Overall Study|Protocol Violation|0|||
163111323|NCT03842969|589114077|FG000|Overall Study|Physician Decision|0|||
163111324|NCT03842969|589114078|FG001|Overall Study|Physician Decision|3|||
163111325|NCT03842969|589114079|FG002|Overall Study|Physician Decision|0|||
163111326|NCT03842969|589114077|FG000|Overall Study|Lost to Follow-up|0|||
163111327|NCT03842969|589114078|FG001|Overall Study|Lost to Follow-up|2|||
163111328|NCT03842969|589114079|FG002|Overall Study|Lost to Follow-up|0|||
163111329|NCT03842969|589114077|FG000|Overall Study|Adverse Event|0|||
163111330|NCT03842969|589114078|FG001|Overall Study|Adverse Event|2|||
163111331|NCT03842969|589114079|FG002|Overall Study|Adverse Event|0|||
163111332|NCT01044745|589114080|FG000|Overall Study|Ineiligible|2|||
163111333|NCT01159171|589114083|FG000|Overall Study|Adverse Event|11|||
163111334|NCT01159171|589114083|FG000|Overall Study|Progression of Disease|28|||
163111335|NCT01159171|589114083|FG000|Overall Study|Protocol Violation|1|||
163111336|NCT01159171|589114083|FG000|Overall Study|Need for Surgery|5|||
163111337|NCT01159171|589114083|FG000|Overall Study|Medical Decision|4|||
163111338|NCT01159171|589114083|FG000|Overall Study|Death|1|||
163111339|NCT01962987|589114084|FG000|Overall Study|Adverse Event|4|||
163111340|NCT01962987|589114085|FG001|Overall Study|Adverse Event|4|||
163111341|NCT01962987|589114086|FG002|Overall Study|Adverse Event|0|||
163111342|NCT01962987|589114084|FG000|Overall Study|Lost to Follow-up|0|||
163111343|NCT01962987|589114085|FG001|Overall Study|Lost to Follow-up|0|||
163111344|NCT01962987|589114086|FG002|Overall Study|Lost to Follow-up|1|||
163111345|NCT01962987|589114084|FG000|Overall Study|Non compliance with dosing requirements|4|||
163111346|NCT01962987|589114085|FG001|Overall Study|Non compliance with dosing requirements|2|||
163111347|NCT01962987|589114086|FG002|Overall Study|Non compliance with dosing requirements|0|||
163111348|NCT01962987|589114084|FG000|Overall Study|Miscellaneous|1|||
163111349|NCT01962987|589114085|FG001|Overall Study|Miscellaneous|9|||
163111350|NCT01962987|589114086|FG002|Overall Study|Miscellaneous|2|||
163111351|NCT01962987|589114084|FG000|Overall Study|Restricted medication|5|||
163111352|NCT01962987|589114085|FG001|Overall Study|Restricted medication|1|||
163111353|NCT01962987|589114086|FG002|Overall Study|Restricted medication|1|||
163111354|NCT01962987|589114084|FG000|Overall Study|Serious Adverse Event|1|||
163111355|NCT01962987|589114085|FG001|Overall Study|Serious Adverse Event|0|||
163111356|NCT01962987|589114086|FG002|Overall Study|Serious Adverse Event|0|||
163111357|NCT01962987|589114084|FG000|Overall Study|Withdrawal by Subject|11|||
163111358|NCT01962987|589114085|FG001|Overall Study|Withdrawal by Subject|10|||
163111359|NCT01962987|589114086|FG002|Overall Study|Withdrawal by Subject|6|||
162653973|NCT03013543|587449651|FG004|Overall Study|Non-Compliance With Study Drug|0|||
162653974|NCT03013543|587449652|FG005|Overall Study|Non-Compliance With Study Drug|0|||
162653975|NCT03013543|587449653|FG006|Overall Study|Non-Compliance With Study Drug|0|||
162653976|NCT03013543|587449654|FG007|Overall Study|Non-Compliance With Study Drug|0|||
163111360|NCT01962987|589114084|FG000|Overall Study|Randomized in Error|4|||
163111361|NCT01962987|589114085|FG001|Overall Study|Randomized in Error|2|||
163111362|NCT01962987|589114086|FG002|Overall Study|Randomized in Error|2|||
163111363|NCT02264665|589114087|FG000|Overall Study|Other|0|||
163111364|NCT02264665|589114088|FG001|Overall Study|Other|0|||
163111365|NCT02264665|589114089|FG002|Overall Study|Other|3|||
163111366|NCT02264665|589114090|FG003|Overall Study|Other|0|||
163111367|NCT02264665|589114091|FG004|Overall Study|Other|0|||
163111368|NCT02264665|589114092|FG005|Overall Study|Other|0|||
163111369|NCT02264665|589114093|FG006|Overall Study|Other|0|||
163111370|NCT02264665|589114087|FG000|Overall Study|Death|9|||
163111371|NCT02264665|589114088|FG001|Overall Study|Death|8|||
163111372|NCT02264665|589114089|FG002|Overall Study|Death|13|||
163111373|NCT02264665|589114090|FG003|Overall Study|Death|5|||
163111374|NCT02264665|589114091|FG004|Overall Study|Death|0|||
163111375|NCT02264665|589114092|FG005|Overall Study|Death|0|||
163111376|NCT02264665|589114093|FG006|Overall Study|Death|1|||
163111377|NCT02264665|589114087|FG000|Overall Study|Lost to Follow-up|1|||
163111378|NCT02264665|589114088|FG001|Overall Study|Lost to Follow-up|0|||
163111379|NCT02264665|589114089|FG002|Overall Study|Lost to Follow-up|2|||
163111380|NCT02264665|589114090|FG003|Overall Study|Lost to Follow-up|1|||
163111381|NCT02264665|589114091|FG004|Overall Study|Lost to Follow-up|0|||
163111382|NCT02264665|589114092|FG005|Overall Study|Lost to Follow-up|0|||
163111383|NCT02264665|589114093|FG006|Overall Study|Lost to Follow-up|0|||
163111384|NCT02264665|589114087|FG000|Overall Study|Participant decision|0|||
162653977|NCT03013543|587449655|FG008|Overall Study|Non-Compliance With Study Drug|1|||
162653978|NCT03013543|587449656|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163111385|NCT02264665|589114088|FG001|Overall Study|Participant decision|0|||
163111386|NCT02264665|589114089|FG002|Overall Study|Participant decision|0|||
163111387|NCT02264665|589114090|FG003|Overall Study|Participant decision|1|||
163111388|NCT02264665|589114091|FG004|Overall Study|Participant decision|0|||
163111389|NCT02264665|589114092|FG005|Overall Study|Participant decision|0|||
163111390|NCT02264665|589114093|FG006|Overall Study|Participant decision|0|||
163111391|NCT02264665|589114087|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
163111392|NCT02264665|589114088|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111393|NCT02264665|589114089|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111394|NCT02264665|589114090|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111395|NCT02264665|589114091|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111396|NCT02264665|589114092|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
163111397|NCT02264665|589114093|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
163111398|NCT02264665|589114087|FG000|Overall Study|Data Missing|0|||
163111399|NCT02264665|589114088|FG001|Overall Study|Data Missing|0|||
163111400|NCT02264665|589114089|FG002|Overall Study|Data Missing|1|||
163111401|NCT02264665|589114090|FG003|Overall Study|Data Missing|0|||
163111402|NCT02264665|589114091|FG004|Overall Study|Data Missing|0|||
163111403|NCT02264665|589114092|FG005|Overall Study|Data Missing|0|||
163111404|NCT02264665|589114093|FG006|Overall Study|Data Missing|0|||
163111405|NCT00789581|589114094|FG000|AC Therapy|Adverse Event|2|||
163111406|NCT00789581|589114095|FG001|AC Therapy|Adverse Event|3|||
163111407|NCT00789581|589114094|FG000|AC Therapy|Withdrawal by Subject|4|||
163111408|NCT00789581|589114095|FG001|AC Therapy|Withdrawal by Subject|7|||
163111409|NCT00789581|589114094|FG000|AC Therapy|Disease recurrence|3|||
163111410|NCT00789581|589114095|FG001|AC Therapy|Disease recurrence|1|||
163111411|NCT00789581|589114094|FG000|AC Therapy|Intercurrent Illness|1|||
163111412|NCT00789581|589114095|FG001|AC Therapy|Intercurrent Illness|0|||
163111413|NCT00789581|589114094|FG000|AC Therapy|Never Treated|1|||
163111414|NCT00789581|589114095|FG001|AC Therapy|Never Treated|4|||
163111415|NCT00789581|589114094|FG000|AC Therapy|Other|0|||
163111416|NCT00789581|589114095|FG001|AC Therapy|Other|2|||
163111417|NCT00789581|589114094|FG000|Adjuvant Therapy|Never treated|2|||
163111418|NCT00789581|589114095|FG001|Adjuvant Therapy|Never treated|2|||
163111419|NCT00789581|589114094|FG000|Adjuvant Therapy|Adverse Event|20|||
163111420|NCT00789581|589114095|FG001|Adjuvant Therapy|Adverse Event|44|||
163111421|NCT00789581|589114094|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
163111422|NCT00789581|589114095|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
163111423|NCT00789581|589114094|FG000|Adjuvant Therapy|Disease recurrence|2|||
163111424|NCT00789581|589114095|FG001|Adjuvant Therapy|Disease recurrence|1|||
163111425|NCT00789581|589114094|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
163111426|NCT00789581|589114095|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
163111427|NCT00789581|589114094|FG000|Adjuvant Therapy|Protocol Violation|1|||
163111428|NCT00789581|589114095|FG001|Adjuvant Therapy|Protocol Violation|1|||
163111429|NCT00789581|589114094|FG000|Adjuvant Therapy|Other|0|||
163111430|NCT00789581|589114095|FG001|Adjuvant Therapy|Other|1|||
163111431|NCT01468207|589114096|FG000|Treatment Period 1|Adverse Event|1|||
163111432|NCT01468207|589114097|FG001|Treatment Period 1|Adverse Event|0|||
163111433|NCT01468207|589114098|FG002|Treatment Period 1|Adverse Event|0|||
163111434|NCT01468207|589114099|FG003|Treatment Period 1|Adverse Event|0|||
163111435|NCT01468207|589114100|FG004|Treatment Period 1|Adverse Event|0|||
163111436|NCT01468207|589114101|FG005|Treatment Period 1|Adverse Event|0|||
163111437|NCT01468207|589114096|FG000|Treatment Period 1|Protocol Violation|1|||
163111438|NCT01468207|589114097|FG001|Treatment Period 1|Protocol Violation|1|||
163111439|NCT01468207|589114098|FG002|Treatment Period 1|Protocol Violation|0|||
163111440|NCT01468207|589114099|FG003|Treatment Period 1|Protocol Violation|0|||
163111441|NCT01468207|589114100|FG004|Treatment Period 1|Protocol Violation|0|||
163111442|NCT01468207|589114101|FG005|Treatment Period 1|Protocol Violation|0|||
163111443|NCT01468207|589114096|FG000|Treatment Period 1|Withdrawal by Subject|5|||
163111444|NCT01468207|589114097|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163111445|NCT01468207|589114098|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163111446|NCT01468207|589114099|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163111447|NCT01468207|589114100|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163111448|NCT01468207|589114101|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163111449|NCT01468207|589114096|FG000|Treatment Period 1|Lost to Follow-up|2|||
163111450|NCT01468207|589114097|FG001|Treatment Period 1|Lost to Follow-up|1|||
163111451|NCT01468207|589114098|FG002|Treatment Period 1|Lost to Follow-up|0|||
163111452|NCT01468207|589114099|FG003|Treatment Period 1|Lost to Follow-up|0|||
163111453|NCT01468207|589114100|FG004|Treatment Period 1|Lost to Follow-up|0|||
163111454|NCT01468207|589114101|FG005|Treatment Period 1|Lost to Follow-up|0|||
163111455|NCT01468207|589114096|FG000|Treatment Period 1|Other|0|||
163111456|NCT01468207|589114097|FG001|Treatment Period 1|Other|2|||
163111457|NCT01468207|589114098|FG002|Treatment Period 1|Other|0|||
163111458|NCT01468207|589114099|FG003|Treatment Period 1|Other|0|||
163111459|NCT01468207|589114100|FG004|Treatment Period 1|Other|0|||
163111460|NCT01468207|589114101|FG005|Treatment Period 1|Other|0|||
163111461|NCT01468207|589114096|FG000|Treatment Period 2|Adverse Event|0|||
163111462|NCT01468207|589114097|FG001|Treatment Period 2|Adverse Event|0|||
163111463|NCT01468207|589114098|FG002|Treatment Period 2|Adverse Event|6|||
163111464|NCT01468207|589114099|FG003|Treatment Period 2|Adverse Event|1|||
163111465|NCT01468207|589114100|FG004|Treatment Period 2|Adverse Event|2|||
163111466|NCT01468207|589114101|FG005|Treatment Period 2|Adverse Event|1|||
163111467|NCT01468207|589114096|FG000|Treatment Period 2|Lack of Efficacy|0|||
163111468|NCT01468207|589114097|FG001|Treatment Period 2|Lack of Efficacy|0|||
163111469|NCT01468207|589114098|FG002|Treatment Period 2|Lack of Efficacy|1|||
163111470|NCT01468207|589114099|FG003|Treatment Period 2|Lack of Efficacy|1|||
163111471|NCT01468207|589114100|FG004|Treatment Period 2|Lack of Efficacy|0|||
163111472|NCT01468207|589114101|FG005|Treatment Period 2|Lack of Efficacy|2|||
163111473|NCT01468207|589114096|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163111474|NCT01468207|589114097|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163111475|NCT01468207|589114098|FG002|Treatment Period 2|Withdrawal by Subject|5|||
163111476|NCT01468207|589114099|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163111477|NCT01468207|589114100|FG004|Treatment Period 2|Withdrawal by Subject|0|||
163111478|NCT01468207|589114101|FG005|Treatment Period 2|Withdrawal by Subject|2|||
163111479|NCT01468207|589114096|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
163111480|NCT01468207|589114097|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
163111481|NCT01468207|589114098|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
163111482|NCT01468207|589114099|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
163111483|NCT01468207|589114100|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
163111484|NCT01468207|589114101|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
163111485|NCT01468207|589114096|FG000|Treatment Period 2|Lost to Follow-up|0|||
163111486|NCT01468207|589114097|FG001|Treatment Period 2|Lost to Follow-up|0|||
163111487|NCT01468207|589114098|FG002|Treatment Period 2|Lost to Follow-up|5|||
163111488|NCT01468207|589114099|FG003|Treatment Period 2|Lost to Follow-up|1|||
163111489|NCT01468207|589114100|FG004|Treatment Period 2|Lost to Follow-up|0|||
163111490|NCT01468207|589114101|FG005|Treatment Period 2|Lost to Follow-up|0|||
163111491|NCT01468207|589114096|FG000|Treatment Period 2|Other|0|||
163111492|NCT01468207|589114097|FG001|Treatment Period 2|Other|0|||
163111493|NCT01468207|589114098|FG002|Treatment Period 2|Other|5|||
163111494|NCT01468207|589114099|FG003|Treatment Period 2|Other|1|||
163111495|NCT01468207|589114100|FG004|Treatment Period 2|Other|1|||
163111496|NCT01468207|589114101|FG005|Treatment Period 2|Other|2|||
163111497|NCT00470093|589114102|FG000|Overall Study|Adverse Event|2|||
163111498|NCT01328041|589114103|FG000|Overall Study|Adverse Event|7|||
163111499|NCT01328041|589114103|FG000|Overall Study|Lack of Efficacy|27|||
163111500|NCT01328041|589114103|FG000|Overall Study|Protocol Violation|7|||
163111501|NCT01328041|589114103|FG000|Overall Study|Lost to Follow-up|7|||
163111502|NCT01328041|589114103|FG000|Overall Study|Physician Decision|2|||
163111503|NCT01328041|589114103|FG000|Overall Study|Withdrawal by Subject|7|||
163111504|NCT00664560|589114104|FG000|Overall Study|Adverse Event|19|||
163111505|NCT00664560|589114105|FG001|Overall Study|Adverse Event|16|||
163111506|NCT00664560|589114106|FG002|Overall Study|Adverse Event|7|||
163111507|NCT00664560|589114104|FG000|Overall Study|Withdrawal by Subject|9|||
163111508|NCT00664560|589114105|FG001|Overall Study|Withdrawal by Subject|13|||
163111509|NCT00664560|589114106|FG002|Overall Study|Withdrawal by Subject|7|||
163111510|NCT00664560|589114104|FG000|Overall Study|Lost to Follow-up|0|||
163111511|NCT00664560|589114105|FG001|Overall Study|Lost to Follow-up|2|||
163111512|NCT00664560|589114106|FG002|Overall Study|Lost to Follow-up|0|||
163111513|NCT00664560|589114104|FG000|Overall Study|Other|11|||
163111514|NCT00664560|589114105|FG001|Overall Study|Other|4|||
163111515|NCT00664560|589114106|FG002|Overall Study|Other|5|||
163111516|NCT03392883|589114107|FG000|Overall Study|Lost to Follow-up|122|||
163111517|NCT03392883|589114108|FG001|Overall Study|Lost to Follow-up|13|||
163111518|NCT03392883|589114109|FG002|Overall Study|Lost to Follow-up|9|||
163111519|NCT03392883|589114107|FG000|Overall Study|Death|4|||
163111520|NCT03392883|589114108|FG001|Overall Study|Death|0|||
163111521|NCT03392883|589114109|FG002|Overall Study|Death|0|||
163111522|NCT03392883|589114107|FG000|Overall Study|Lack of Efficacy|29|||
163111523|NCT03392883|589114108|FG001|Overall Study|Lack of Efficacy|0|||
163111524|NCT03392883|589114109|FG002|Overall Study|Lack of Efficacy|0|||
163111525|NCT03392883|589114107|FG000|Overall Study|Withdrawal by Subject|180|||
163111526|NCT03392883|589114108|FG001|Overall Study|Withdrawal by Subject|0|||
163111527|NCT03392883|589114109|FG002|Overall Study|Withdrawal by Subject|0|||
163111528|NCT03392883|589114107|FG000|Overall Study|Adverse Event|1|||
163111529|NCT03392883|589114108|FG001|Overall Study|Adverse Event|0|||
163111530|NCT03392883|589114109|FG002|Overall Study|Adverse Event|0|||
163111531|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111532|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
163111533|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111534|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
162653979|NCT03013543|587449647|FG000|Overall Study|Physician Decision|0|||
163111535|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
163111536|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111537|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
163111538|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111539|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111540|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
163111541|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111542|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
163111543|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111544|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111545|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
163111546|NCT02688088|589114111|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111547|NCT02688088|589114112|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
163111548|NCT02688088|589114113|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111549|NCT02688088|589114114|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111550|NCT02688088|589114115|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
163111551|NCT02688088|589114111|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111552|NCT02688088|589114112|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111553|NCT02688088|589114113|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
163111554|NCT02688088|589114114|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111555|NCT02688088|589114115|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
163111556|NCT02688088|589114111|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111557|NCT02688088|589114112|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111558|NCT02688088|589114113|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
163111559|NCT02688088|589114114|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111560|NCT02688088|589114115|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
163111561|NCT02688088|589114111|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111562|NCT02688088|589114112|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111563|NCT02688088|589114113|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111564|NCT02688088|589114114|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
163111565|NCT02688088|589114115|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
163111566|NCT02688088|589114111|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111567|NCT02688088|589114112|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111568|NCT02688088|589114113|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111569|NCT02688088|589114114|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
163111570|NCT02688088|589114115|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
163111571|NCT02688088|589114111|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111572|NCT02688088|589114112|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111573|NCT02688088|589114113|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111574|NCT02688088|589114114|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
163111575|NCT02688088|589114115|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
163111576|NCT00313313|589114119|FG000|Overall Study|Lack of Efficacy|14|||
163111577|NCT00313313|589114120|FG001|Overall Study|Lack of Efficacy|9|||
163111578|NCT00313313|589114121|FG002|Overall Study|Lack of Efficacy|20|||
163111579|NCT00313313|589114119|FG000|Overall Study|Withdrawal of consent by subject|18|||
163111580|NCT00313313|589114120|FG001|Overall Study|Withdrawal of consent by subject|17|||
163111581|NCT00313313|589114121|FG002|Overall Study|Withdrawal of consent by subject|31|||
163111582|NCT00313313|589114119|FG000|Overall Study|Lost to Follow-up|10|||
163111583|NCT00313313|589114120|FG001|Overall Study|Lost to Follow-up|7|||
163111584|NCT00313313|589114121|FG002|Overall Study|Lost to Follow-up|9|||
163111585|NCT00313313|589114119|FG000|Overall Study|Adverse Event|15|||
163111586|NCT00313313|589114120|FG001|Overall Study|Adverse Event|16|||
163111587|NCT00313313|589114121|FG002|Overall Study|Adverse Event|12|||
163111588|NCT00313313|589114119|FG000|Overall Study|Physician Decision|2|||
163111589|NCT00313313|589114120|FG001|Overall Study|Physician Decision|6|||
163111590|NCT00313313|589114121|FG002|Overall Study|Physician Decision|4|||
163111591|NCT00313313|589114119|FG000|Overall Study|Poor/Noncompliance|3|||
163111592|NCT00313313|589114120|FG001|Overall Study|Poor/Noncompliance|6|||
163111593|NCT00313313|589114121|FG002|Overall Study|Poor/Noncompliance|2|||
163111594|NCT00313313|589114119|FG000|Overall Study|Pregnancy|1|||
163111595|NCT00313313|589114120|FG001|Overall Study|Pregnancy|2|||
163111596|NCT00313313|589114121|FG002|Overall Study|Pregnancy|0|||
163111597|NCT00313313|589114119|FG000|Overall Study|Death|0|||
163111598|NCT00313313|589114120|FG001|Overall Study|Death|0|||
163111599|NCT00313313|589114121|FG002|Overall Study|Death|2|||
163111600|NCT00313313|589114119|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163111601|NCT00313313|589114120|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
163111602|NCT00313313|589114121|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
163111603|NCT01973387|589114122|FG000|Overall Study|Adverse Event|14|||
162719319|NCT02503202|587678479|FG004|Extension: Month 6 to 24|Physician Decision|0|||
162719320|NCT02503202|587678475|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
162719321|NCT02503202|587678476|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
162719322|NCT02503202|587678477|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
163111604|NCT01973387|589114123|FG001|Overall Study|Adverse Event|4|||
163111605|NCT01973387|589114122|FG000|Overall Study|Withdrawal by Subject|7|||
163111606|NCT01973387|589114123|FG001|Overall Study|Withdrawal by Subject|4|||
163111607|NCT01973387|589114122|FG000|Overall Study|Study terminated by sponsor|63|||
163111608|NCT01973387|589114123|FG001|Overall Study|Study terminated by sponsor|0|||
163111609|NCT01973387|589114122|FG000|Overall Study|Progressive disease or relapse|16|||
163111610|NCT01973387|589114123|FG001|Overall Study|Progressive disease or relapse|5|||
163111611|NCT01973387|589114122|FG000|Overall Study|Death|4|||
163111612|NCT01973387|589114123|FG001|Overall Study|Death|3|||
163111613|NCT01973387|589114122|FG000|Overall Study|Randomized, not treated|2|||
163111614|NCT01973387|589114123|FG001|Overall Study|Randomized, not treated|2|||
163111615|NCT01345591|589114124|FG000|Overall Study|Lost to Follow-up|1|||
163111616|NCT03305419|589114127|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111617|NCT03305419|589114128|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
163111618|NCT03305419|589114129|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111619|NCT03305419|589114130|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111620|NCT03305419|589114131|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111621|NCT03305419|589114132|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111622|NCT03305419|589114133|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111623|NCT03305419|589114134|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163111624|NCT03305419|589114127|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
163111625|NCT03305419|589114128|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111626|NCT03305419|589114129|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111627|NCT03305419|589114130|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111628|NCT03305419|589114131|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111629|NCT03305419|589114132|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111630|NCT03305419|589114133|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111631|NCT03305419|589114134|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
163111632|NCT03305419|589114127|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
163111633|NCT03305419|589114128|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111634|NCT03305419|589114129|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111635|NCT03305419|589114130|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111636|NCT03305419|589114131|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111637|NCT03305419|589114132|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111638|NCT03305419|589114133|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111639|NCT03305419|589114134|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163111640|NCT03305419|589114127|FG000|Part B (14 Days)|Adverse Event|0|||
163111641|NCT03305419|589114128|FG001|Part B (14 Days)|Adverse Event|0|||
163111642|NCT03305419|589114129|FG002|Part B (14 Days)|Adverse Event|0|||
163111643|NCT03305419|589114130|FG003|Part B (14 Days)|Adverse Event|0|||
163111644|NCT03305419|589114131|FG004|Part B (14 Days)|Adverse Event|1|||
163111645|NCT03305419|589114132|FG005|Part B (14 Days)|Adverse Event|2|||
163111646|NCT03305419|589114133|FG006|Part B (14 Days)|Adverse Event|4|||
163111647|NCT03305419|589114134|FG007|Part B (14 Days)|Adverse Event|0|||
163111648|NCT03305419|589114127|FG000|Part B (14 Days)|Physician Decision|0|||
163111649|NCT03305419|589114128|FG001|Part B (14 Days)|Physician Decision|0|||
162719323|NCT02503202|587678478|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
162719324|NCT02503202|587678479|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
163111650|NCT03305419|589114129|FG002|Part B (14 Days)|Physician Decision|0|||
163111651|NCT03305419|589114130|FG003|Part B (14 Days)|Physician Decision|0|||
163111652|NCT03305419|589114131|FG004|Part B (14 Days)|Physician Decision|2|||
163111653|NCT03305419|589114132|FG005|Part B (14 Days)|Physician Decision|8|||
163111654|NCT03305419|589114133|FG006|Part B (14 Days)|Physician Decision|1|||
163111655|NCT03305419|589114134|FG007|Part B (14 Days)|Physician Decision|0|||
163111656|NCT00223977|589114138|FG000|Overall Study|Adverse Event|7|||
163111657|NCT00223977|589114139|FG001|Overall Study|Adverse Event|10|||
163111658|NCT00223977|589114140|FG002|Overall Study|Adverse Event|0|||
163111659|NCT00223977|589114138|FG000|Overall Study|Protocol Violation|0|||
163111660|NCT00223977|589114139|FG001|Overall Study|Protocol Violation|0|||
163111661|NCT00223977|589114140|FG002|Overall Study|Protocol Violation|1|||
163111662|NCT00223977|589114138|FG000|Overall Study|Withdrawal by Subject|1|||
163111663|NCT00223977|589114139|FG001|Overall Study|Withdrawal by Subject|1|||
163111664|NCT00223977|589114140|FG002|Overall Study|Withdrawal by Subject|2|||
163111665|NCT00223977|589114138|FG000|Overall Study|Other|1|||
163111666|NCT00223977|589114139|FG001|Overall Study|Other|0|||
163111667|NCT00223977|589114140|FG002|Overall Study|Other|0|||
163111668|NCT02359045|589114141|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
163111669|NCT02359045|589114142|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163111670|NCT02359045|589114141|FG000|Overall Study|Lost to Follow-up|1|||
163111671|NCT02359045|589114142|FG001|Overall Study|Lost to Follow-up|1|||
163111672|NCT02359045|589114141|FG000|Overall Study|Adverse Event|0|||
163111673|NCT02359045|589114142|FG001|Overall Study|Adverse Event|1|||
163111674|NCT02118766|589114148|FG000|Overall Study|Adverse Event|7|||
163111675|NCT02118766|589114149|FG001|Overall Study|Adverse Event|2|||
163111676|NCT02118766|589114148|FG000|Overall Study|Withdrawal by Subject|3|||
163111677|NCT02118766|589114149|FG001|Overall Study|Withdrawal by Subject|6|||
163111678|NCT02118766|589114148|FG000|Overall Study|Lost to Follow-up|5|||
163111679|NCT02118766|589114149|FG001|Overall Study|Lost to Follow-up|4|||
163111680|NCT02118766|589114148|FG000|Overall Study|Withdrawal by parent/guardian|12|||
163111681|NCT02118766|589114149|FG001|Overall Study|Withdrawal by parent/guardian|18|||
163111682|NCT02118766|589114148|FG000|Overall Study|Other|3|||
163111683|NCT02118766|589114149|FG001|Overall Study|Other|1|||
163111684|NCT02248649|589114152|FG000|Overall Study|Death|7|||
163111685|NCT02248649|589114153|FG001|Overall Study|Death|11|||
163111686|NCT02248649|589114152|FG000|Overall Study|Lost to Follow-up|14|||
163111687|NCT02248649|589114153|FG001|Overall Study|Lost to Follow-up|10|||
163111688|NCT04621240|589114155|FG000|Overall Study|Withdrawal by Subject|36|||
163111689|NCT00780143|589114156|FG000|Overall Study|Progressive disease|1|||
163111690|NCT00780143|589114156|FG000|Overall Study|Toxicity|1|||
163111691|NCT00780143|589114156|FG000|Overall Study|Adverse Event|1|||
163111692|NCT01457014|589114161|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
163111693|NCT01457014|589114162|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111694|NCT01457014|589114163|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111695|NCT01457014|589114164|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
163111696|NCT01457014|589114161|FG000|First Night|Withdrawal by Subject|3|||
163111697|NCT01457014|589114162|FG001|First Night|Withdrawal by Subject|0|||
163111698|NCT01457014|589114163|FG002|First Night|Withdrawal by Subject|0|||
163111699|NCT01457014|589114164|FG003|First Night|Withdrawal by Subject|0|||
163111700|NCT02461290|589114165|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
163111701|NCT02461290|589114165|FG000|Overall Study|Lost to Follow-up|3|||
163111702|NCT03319953|589114166|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
163111703|NCT03319953|589114167|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111704|NCT03319953|589114168|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111705|NCT03319953|589114169|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
163111706|NCT03319953|589114166|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
163111707|NCT03319953|589114167|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
163111708|NCT03319953|589114168|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
163111709|NCT03319953|589114169|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
163111710|NCT04027049|589114173|FG000|Overall Study|Withdrawn by family|1|||
163111711|NCT04027049|589114174|FG001|Overall Study|Withdrawn by family|0|||
163111712|NCT04027049|589114173|FG000|Overall Study|Participant safety|1|||
163111713|NCT04027049|589114174|FG001|Overall Study|Participant safety|0|||
163111714|NCT02226198|589115530|FG000|Lead-in Phase|Protocol Violation|1|||
163111715|NCT02226198|589115531|FG001|Lead-in Phase|Protocol Violation|0|||
163111716|NCT02226198|589115532|FG002|Lead-in Phase|Protocol Violation|0|||
163111717|NCT02226198|589115530|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
163111718|NCT02226198|589115531|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
163111719|NCT02226198|589115532|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
163111720|NCT01440517|589115536|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
163111721|NCT01288612|589115537|FG000|Overall Study|Unable to contact|11|||
163111722|NCT01288612|589115538|FG001|Overall Study|Unable to contact|16|||
163111723|NCT01288612|589115539|FG002|Overall Study|Unable to contact|20|||
163111724|NCT01288612|589115537|FG000|Overall Study|Declined|78|||
163111725|NCT01288612|589115538|FG001|Overall Study|Declined|63|||
163111726|NCT01288612|589115539|FG002|Overall Study|Declined|62|||
163111727|NCT01288612|589115537|FG000|Overall Study|Unable to intubate|0|||
163111728|NCT01288612|589115538|FG001|Overall Study|Unable to intubate|3|||
163111729|NCT01288612|589115539|FG002|Overall Study|Unable to intubate|0|||
163111730|NCT00871923|589115540|FG000|Overall Study|Death|1|||
163111731|NCT00871923|589115540|FG000|Overall Study|Withdrawal by Subject|1|||
163111732|NCT00496483|589115546|FG000|Overall Study|Not dosed|9|||
163111733|NCT00496483|589115546|FG000|Overall Study|Adverse Event|2|||
163111734|NCT00496483|589115546|FG000|Overall Study|Lack of Efficacy|1|||
163111735|NCT04258995|589115548|FG000|Overall Study|Lost to Follow-up|1|||
163111736|NCT04258995|589115549|FG001|Overall Study|Lost to Follow-up|1|||
163111737|NCT03285958|589115551|FG000|Overall Study|Lost to Follow-up|1|||
163111738|NCT03285958|589115552|FG001|Overall Study|Lost to Follow-up|1|||
163111739|NCT03285958|589115551|FG000|Overall Study|Withdrawal by Subject|1|||
163111740|NCT03285958|589115552|FG001|Overall Study|Withdrawal by Subject|0|||
163111741|NCT03285958|589115551|FG000|Overall Study|Not able to attend required orientation|3|||
163111742|NCT03285958|589115552|FG001|Overall Study|Not able to attend required orientation|0|||
163111743|NCT00316693|589115555|FG000|Overall Study|Adverse Event|6|||
163111744|NCT00316693|589115556|FG001|Overall Study|Adverse Event|1|||
163111745|NCT00316693|589115555|FG000|Overall Study|Protocol Violation|1|||
163111746|NCT00316693|589115556|FG001|Overall Study|Protocol Violation|0|||
163111747|NCT00316693|589115555|FG000|Overall Study|Withdrawal by Subject|6|||
163111748|NCT00316693|589115556|FG001|Overall Study|Withdrawal by Subject|6|||
163111749|NCT00316693|589115555|FG000|Overall Study|Lost to Follow-up|26|||
163111750|NCT00316693|589115556|FG001|Overall Study|Lost to Follow-up|34|||
163111751|NCT00316693|589115555|FG000|Overall Study|Other|38|||
163111752|NCT00316693|589115556|FG001|Overall Study|Other|44|||
163111753|NCT01967823|589115557|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
163111754|NCT00413894|589115562|FG000|Overall Study|Withdrawal by Subject|10|||
163111755|NCT00413894|589115562|FG000|Overall Study|Administrative Reasons|1|||
163111756|NCT00413894|589115562|FG000|Overall Study|Hb <10 grams/deciliter|12|||
163111757|NCT00413894|589115562|FG000|Overall Study|Adverse Event|28|||
163111758|NCT00413894|589115562|FG000|Overall Study|Protocol Violation|11|||
163111759|NCT00413894|589115562|FG000|Overall Study|Other|18|||
163111760|NCT04225676|589115563|FG000|Overall Study|Physician Decision|1|||
163111761|NCT04225676|589115563|FG000|Overall Study|Lack of Efficacy|1|||
163111762|NCT04225676|589115563|FG000|Overall Study|Study terminated by sponsor|3|||
163111763|NCT05289271|589115566|FG000|Overall Study|Mistakenly allocated, untreated|1|||
163111764|NCT05289271|589115567|FG001|Overall Study|Mistakenly allocated, untreated|0|||
163111765|NCT02019108|589115568|FG000|Overall Study|Lost to Follow-up|5|||
163111766|NCT02019108|589115569|FG001|Overall Study|Lost to Follow-up|7|||
163111767|NCT00908115|589115580|FG000|Overall Study|Other|14|||
163111768|NCT02442310|589115590|FG000|Overall Study|Adverse Event|2|||
163111769|NCT02442310|589115590|FG000|Overall Study|Withdrawal by Subject|1|||
163111770|NCT02851797|589115591|FG000|Overall Study|Withdrawal by Subject|4|||
163111771|NCT02851797|589115592|FG001|Overall Study|Withdrawal by Subject|2|||
163111772|NCT02851797|589115591|FG000|Overall Study|Adverse Event|3|||
163111773|NCT02851797|589115592|FG001|Overall Study|Adverse Event|0|||
163111774|NCT03077438|589115593|FG000|Overall Study|Protocol Violation|3|||
163111775|NCT03077438|589115594|FG001|Overall Study|Protocol Violation|5|||
163111776|NCT03077438|589115593|FG000|Overall Study|Withdrawal by Subject|3|||
163111777|NCT03077438|589115594|FG001|Overall Study|Withdrawal by Subject|6|||
163111778|NCT03077438|589115593|FG000|Overall Study|Lost to Follow-up|6|||
163111779|NCT03077438|589115594|FG001|Overall Study|Lost to Follow-up|3|||
163111780|NCT03466099|589115596|FG000|Overall Study|Adverse Event|1|||
163111781|NCT03466099|589115597|FG001|Overall Study|Adverse Event|1|||
163111782|NCT03466099|589115598|FG002|Overall Study|Adverse Event|1|||
163111783|NCT03466099|589115596|FG000|Overall Study|Withdrawal by Subject|2|||
163111784|NCT03466099|589115597|FG001|Overall Study|Withdrawal by Subject|3|||
163111785|NCT03466099|589115598|FG002|Overall Study|Withdrawal by Subject|1|||
163111786|NCT03466099|589115596|FG000|Overall Study|Use of rescue medication|8|||
163111787|NCT03466099|589115597|FG001|Overall Study|Use of rescue medication|9|||
163111788|NCT03466099|589115598|FG002|Overall Study|Use of rescue medication|13|||
163111789|NCT03466099|589115596|FG000|Overall Study|Rescued without meeting criteria|4|||
163111790|NCT03466099|589115597|FG001|Overall Study|Rescued without meeting criteria|1|||
163111791|NCT03466099|589115598|FG002|Overall Study|Rescued without meeting criteria|1|||
163111792|NCT03466099|589115596|FG000|Overall Study|Subject compliance|2|||
163111793|NCT03466099|589115597|FG001|Overall Study|Subject compliance|0|||
163111794|NCT03466099|589115598|FG002|Overall Study|Subject compliance|0|||
163111795|NCT03466099|589115596|FG000|Overall Study|Worsening disease|0|||
162653980|NCT03013543|587449648|FG001|Overall Study|Physician Decision|0|||
162653981|NCT03013543|587449649|FG002|Overall Study|Physician Decision|0|||
162653982|NCT03013543|587449650|FG003|Overall Study|Physician Decision|0|||
162653983|NCT03013543|587449651|FG004|Overall Study|Physician Decision|1|||
162653984|NCT03013543|587449652|FG005|Overall Study|Physician Decision|0|||
163111796|NCT03466099|589115597|FG001|Overall Study|Worsening disease|0|||
163111797|NCT03466099|589115598|FG002|Overall Study|Worsening disease|1|||
163111798|NCT03622112|589115599|FG000|Overall Study|Withdrawal by Subject|6|||
163111799|NCT03622112|589115600|FG001|Overall Study|Withdrawal by Subject|2|||
163111800|NCT03622112|589115601|FG002|Overall Study|Withdrawal by Subject|4|||
163111801|NCT03622112|589115602|FG003|Overall Study|Withdrawal by Subject|2|||
163111802|NCT03622112|589115603|FG004|Overall Study|Withdrawal by Subject|1|||
163111803|NCT03622112|589115604|FG005|Overall Study|Withdrawal by Subject|2|||
163111804|NCT03622112|589115605|FG006|Overall Study|Withdrawal by Subject|2|||
163111805|NCT03622112|589115599|FG000|Overall Study|Death|0|||
163111806|NCT03622112|589115600|FG001|Overall Study|Death|0|||
163111807|NCT03622112|589115601|FG002|Overall Study|Death|0|||
163111808|NCT03622112|589115602|FG003|Overall Study|Death|1|||
163111809|NCT03622112|589115603|FG004|Overall Study|Death|0|||
163111810|NCT03622112|589115604|FG005|Overall Study|Death|0|||
163111811|NCT03622112|589115605|FG006|Overall Study|Death|0|||
163111812|NCT03622112|589115599|FG000|Overall Study|Lost to Follow-up|1|||
163111813|NCT03622112|589115600|FG001|Overall Study|Lost to Follow-up|1|||
163111814|NCT03622112|589115601|FG002|Overall Study|Lost to Follow-up|0|||
163111815|NCT03622112|589115602|FG003|Overall Study|Lost to Follow-up|0|||
163111816|NCT03622112|589115603|FG004|Overall Study|Lost to Follow-up|0|||
163111817|NCT03622112|589115604|FG005|Overall Study|Lost to Follow-up|0|||
163111818|NCT03622112|589115605|FG006|Overall Study|Lost to Follow-up|0|||
163111819|NCT03622112|589115599|FG000|Overall Study|Study-specific withdrawal criteria|10|||
163111820|NCT03622112|589115600|FG001|Overall Study|Study-specific withdrawal criteria|8|||
163111821|NCT03622112|589115601|FG002|Overall Study|Study-specific withdrawal criteria|7|||
163111822|NCT03622112|589115602|FG003|Overall Study|Study-specific withdrawal criteria|6|||
163111823|NCT03622112|589115603|FG004|Overall Study|Study-specific withdrawal criteria|4|||
163111824|NCT03622112|589115604|FG005|Overall Study|Study-specific withdrawal criteria|18|||
163111825|NCT03622112|589115605|FG006|Overall Study|Study-specific withdrawal criteria|4|||
163111826|NCT03622112|589115599|FG000|Overall Study|Protocol Violation|2|||
163111827|NCT03622112|589115600|FG001|Overall Study|Protocol Violation|0|||
163111828|NCT03622112|589115601|FG002|Overall Study|Protocol Violation|1|||
163111829|NCT03622112|589115602|FG003|Overall Study|Protocol Violation|1|||
163111830|NCT03622112|589115603|FG004|Overall Study|Protocol Violation|0|||
163111831|NCT03622112|589115604|FG005|Overall Study|Protocol Violation|0|||
163111832|NCT03622112|589115605|FG006|Overall Study|Protocol Violation|0|||
163111833|NCT03622112|589115599|FG000|Overall Study|Adverse Event|6|||
163111834|NCT03622112|589115600|FG001|Overall Study|Adverse Event|8|||
163111835|NCT03622112|589115601|FG002|Overall Study|Adverse Event|4|||
163111836|NCT03622112|589115602|FG003|Overall Study|Adverse Event|11|||
163111837|NCT03622112|589115603|FG004|Overall Study|Adverse Event|4|||
163111838|NCT03622112|589115604|FG005|Overall Study|Adverse Event|20|||
163111839|NCT03622112|589115605|FG006|Overall Study|Adverse Event|2|||
163111840|NCT03622112|589115599|FG000|Overall Study|Reason not specified|0|||
163111841|NCT03622112|589115600|FG001|Overall Study|Reason not specified|1|||
163111842|NCT03622112|589115601|FG002|Overall Study|Reason not specified|0|||
163111843|NCT03622112|589115602|FG003|Overall Study|Reason not specified|1|||
163111844|NCT03622112|589115603|FG004|Overall Study|Reason not specified|1|||
163111845|NCT03622112|589115604|FG005|Overall Study|Reason not specified|2|||
163111846|NCT03622112|589115605|FG006|Overall Study|Reason not specified|1|||
163111847|NCT01165320|589115606|FG000|Overall Study|Clinical adverse experience|2|||
163111848|NCT01165320|589115607|FG001|Overall Study|Clinical adverse experience|1|||
163111849|NCT01165320|589115608|FG002|Overall Study|Clinical adverse experience|0|||
163111850|NCT01165320|589115606|FG000|Overall Study|Laboratory adverse experience|1|||
163111851|NCT01165320|589115607|FG001|Overall Study|Laboratory adverse experience|0|||
163111852|NCT01165320|589115608|FG002|Overall Study|Laboratory adverse experience|0|||
163111853|NCT01165320|589115606|FG000|Overall Study|Lack of Efficacy|0|||
163111854|NCT01165320|589115607|FG001|Overall Study|Lack of Efficacy|2|||
163111855|NCT01165320|589115608|FG002|Overall Study|Lack of Efficacy|0|||
163111856|NCT01165320|589115606|FG000|Overall Study|Reason unknown|0|||
163111857|NCT01165320|589115607|FG001|Overall Study|Reason unknown|1|||
163111858|NCT01165320|589115608|FG002|Overall Study|Reason unknown|0|||
163111859|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
163111860|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
163111861|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
163111862|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
163111863|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
163111864|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
163111865|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
163111866|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
163111867|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
163111868|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
163111869|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Other|1|||
163111870|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Other|1|||
163111871|NCT02075047|589115614|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
163111872|NCT02075047|589115615|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
163111873|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
163111874|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
163111875|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
163111876|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
163111877|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
163111878|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
163111879|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
163111880|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
163111881|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
163111882|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
163111883|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Other|1|||
163111884|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Other|2|||
163111885|NCT02075047|589115614|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
163111886|NCT02075047|589115615|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
163111887|NCT01155466|589115616|FG000|Overall Study|Adverse Event|13|||
163111888|NCT01155466|589115617|FG001|Overall Study|Adverse Event|15|||
163111889|NCT01155466|589115618|FG002|Overall Study|Adverse Event|6|||
163111890|NCT01155466|589115619|FG003|Overall Study|Adverse Event|17|||
163111891|NCT01155466|589115620|FG004|Overall Study|Adverse Event|18|||
163111892|NCT01155466|589115616|FG000|Overall Study|Lost to Follow-up|0|||
163111893|NCT01155466|589115617|FG001|Overall Study|Lost to Follow-up|0|||
163111894|NCT01155466|589115618|FG002|Overall Study|Lost to Follow-up|0|||
163111895|NCT01155466|589115619|FG003|Overall Study|Lost to Follow-up|0|||
163111896|NCT01155466|589115620|FG004|Overall Study|Lost to Follow-up|2|||
163111897|NCT01155466|589115616|FG000|Overall Study|Withdrawal by Subject|7|||
163111898|NCT01155466|589115617|FG001|Overall Study|Withdrawal by Subject|5|||
163111899|NCT01155466|589115618|FG002|Overall Study|Withdrawal by Subject|9|||
163111900|NCT01155466|589115619|FG003|Overall Study|Withdrawal by Subject|4|||
163111901|NCT01155466|589115620|FG004|Overall Study|Withdrawal by Subject|4|||
163111902|NCT01155466|589115616|FG000|Overall Study|Protocol Violation|0|||
163111903|NCT01155466|589115617|FG001|Overall Study|Protocol Violation|0|||
163111904|NCT01155466|589115618|FG002|Overall Study|Protocol Violation|2|||
163111905|NCT01155466|589115619|FG003|Overall Study|Protocol Violation|0|||
163111906|NCT01155466|589115620|FG004|Overall Study|Protocol Violation|1|||
163111907|NCT01155466|589115616|FG000|Overall Study|Administrative|0|||
163111908|NCT01155466|589115617|FG001|Overall Study|Administrative|3|||
163111909|NCT01155466|589115618|FG002|Overall Study|Administrative|0|||
163111910|NCT01155466|589115619|FG003|Overall Study|Administrative|0|||
163111911|NCT01155466|589115620|FG004|Overall Study|Administrative|0|||
163111912|NCT01155466|589115616|FG000|Overall Study|Randomized not treated|2|||
163111913|NCT01155466|589115617|FG001|Overall Study|Randomized not treated|2|||
163111914|NCT01155466|589115618|FG002|Overall Study|Randomized not treated|3|||
163111915|NCT01155466|589115619|FG003|Overall Study|Randomized not treated|0|||
163111916|NCT01155466|589115620|FG004|Overall Study|Randomized not treated|2|||
163111917|NCT00075946|589115621|FG000|Overall Study|Path ineligible: undetermined histology|0|||
163111918|NCT00075946|589115622|FG001|Overall Study|Path ineligible: undetermined histology|0|||
163111919|NCT00075946|589115623|FG002|Overall Study|Path ineligible: undetermined histology|0|||
163111920|NCT00075946|589115624|FG003|Overall Study|Path ineligible: undetermined histology|0|||
163111921|NCT00075946|589115625|FG004|Overall Study|Path ineligible: undetermined histology|6|||
163111922|NCT00075946|589115621|FG000|Overall Study|Did not achieve response after induction|0|||
163111923|NCT00075946|589115622|FG001|Overall Study|Did not achieve response after induction|0|||
163111924|NCT00075946|589115623|FG002|Overall Study|Did not achieve response after induction|0|||
163111925|NCT00075946|589115624|FG003|Overall Study|Did not achieve response after induction|0|||
163111926|NCT00075946|589115625|FG004|Overall Study|Did not achieve response after induction|182|||
163111927|NCT00075946|589115621|FG000|Overall Study|Incorrectly randomized (no response)|5|||
163111928|NCT00075946|589115622|FG001|Overall Study|Incorrectly randomized (no response)|5|||
163111929|NCT00075946|589115623|FG002|Overall Study|Incorrectly randomized (no response)|5|||
163111930|NCT00075946|589115624|FG003|Overall Study|Incorrectly randomized (no response)|1|||
163111931|NCT00075946|589115625|FG004|Overall Study|Incorrectly randomized (no response)|0|||
163111932|NCT00075946|589115621|FG000|Overall Study|Adverse Event|2|||
163111933|NCT00075946|589115622|FG001|Overall Study|Adverse Event|10|||
163111934|NCT00075946|589115623|FG002|Overall Study|Adverse Event|0|||
163111935|NCT00075946|589115624|FG003|Overall Study|Adverse Event|2|||
163111936|NCT00075946|589115625|FG004|Overall Study|Adverse Event|0|||
163111937|NCT00075946|589115621|FG000|Overall Study|Death|0|||
163111938|NCT00075946|589115622|FG001|Overall Study|Death|1|||
163111939|NCT00075946|589115623|FG002|Overall Study|Death|0|||
163111940|NCT00075946|589115624|FG003|Overall Study|Death|0|||
163111941|NCT00075946|589115625|FG004|Overall Study|Death|0|||
163111942|NCT00075946|589115621|FG000|Overall Study|Withdrawal by Subject|23|||
163111943|NCT00075946|589115622|FG001|Overall Study|Withdrawal by Subject|58|||
163111944|NCT00075946|589115623|FG002|Overall Study|Withdrawal by Subject|4|||
163111945|NCT00075946|589115624|FG003|Overall Study|Withdrawal by Subject|9|||
163111946|NCT00075946|589115625|FG004|Overall Study|Withdrawal by Subject|0|||
163111947|NCT00075946|589115621|FG000|Overall Study|Alternative therapy|16|||
163111948|NCT00075946|589115622|FG001|Overall Study|Alternative therapy|2|||
163111949|NCT00075946|589115623|FG002|Overall Study|Alternative therapy|5|||
163111950|NCT00075946|589115624|FG003|Overall Study|Alternative therapy|0|||
163111951|NCT00075946|589115625|FG004|Overall Study|Alternative therapy|0|||
163111952|NCT00075946|589115621|FG000|Overall Study|Other complicating disease|7|||
163111953|NCT00075946|589115622|FG001|Overall Study|Other complicating disease|13|||
163111954|NCT00075946|589115623|FG002|Overall Study|Other complicating disease|1|||
163111955|NCT00075946|589115624|FG003|Overall Study|Other complicating disease|4|||
163111956|NCT00075946|589115625|FG004|Overall Study|Other complicating disease|0|||
163111957|NCT00075946|589115621|FG000|Overall Study|No response to retreatment|23|||
163111958|NCT00075946|589115622|FG001|Overall Study|No response to retreatment|0|||
163111959|NCT00075946|589115623|FG002|Overall Study|No response to retreatment|2|||
163111960|NCT00075946|589115624|FG003|Overall Study|No response to retreatment|0|||
163111961|NCT00075946|589115625|FG004|Overall Study|No response to retreatment|0|||
163111962|NCT00075946|589115621|FG000|Overall Study|Time to progression less than 6 months|15|||
163111963|NCT00075946|589115622|FG001|Overall Study|Time to progression less than 6 months|30|||
163111964|NCT00075946|589115623|FG002|Overall Study|Time to progression less than 6 months|8|||
163111965|NCT00075946|589115624|FG003|Overall Study|Time to progression less than 6 months|3|||
163111966|NCT00075946|589115625|FG004|Overall Study|Time to progression less than 6 months|0|||
163111967|NCT00075946|589115621|FG000|Overall Study|Other|57|||
163111968|NCT00075946|589115622|FG001|Overall Study|Other|32|||
163111969|NCT00075946|589115623|FG002|Overall Study|Other|3|||
163111970|NCT00075946|589115624|FG003|Overall Study|Other|11|||
163111971|NCT00075946|589115625|FG004|Overall Study|Other|0|||
163111972|NCT04154605|589115630|FG000|Overall Study|Procedure Canceled|1|||
163111973|NCT04154605|589115631|FG001|Overall Study|Procedure Canceled|1|||
163111974|NCT04154605|589115630|FG000|Overall Study|Missed follow up|1|||
163111975|NCT04154605|589115631|FG001|Overall Study|Missed follow up|1|||
163111976|NCT04154605|589115630|FG000|Overall Study|Withdrawal by Subject|1|||
163111977|NCT04154605|589115631|FG001|Overall Study|Withdrawal by Subject|0|||
163111978|NCT01229254|589115632|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
163111979|NCT01229254|589115633|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
163111980|NCT01229254|589115634|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
163111981|NCT01229254|589115632|FG000|Overall Study|Adverse Event|4|||
163111982|NCT01229254|589115633|FG001|Overall Study|Adverse Event|5|||
163111983|NCT01229254|589115634|FG002|Overall Study|Adverse Event|3|||
163111984|NCT01229254|589115632|FG000|Overall Study|Lost to Follow-up|3|||
163111985|NCT01229254|589115633|FG001|Overall Study|Lost to Follow-up|0|||
163111986|NCT01229254|589115634|FG002|Overall Study|Lost to Follow-up|1|||
163111987|NCT01229254|589115632|FG000|Overall Study|Physician Decision|0|||
163111988|NCT01229254|589115633|FG001|Overall Study|Physician Decision|3|||
163111989|NCT01229254|589115634|FG002|Overall Study|Physician Decision|0|||
163111990|NCT01229254|589115632|FG000|Overall Study|Protocol Violation|4|||
163111991|NCT01229254|589115633|FG001|Overall Study|Protocol Violation|6|||
163111992|NCT01229254|589115634|FG002|Overall Study|Protocol Violation|5|||
163111993|NCT01229254|589115632|FG000|Overall Study|Withdrawal by Subject|1|||
163111994|NCT01229254|589115633|FG001|Overall Study|Withdrawal by Subject|0|||
163111995|NCT01229254|589115634|FG002|Overall Study|Withdrawal by Subject|1|||
163111996|NCT01229254|589115632|FG000|Overall Study|Non-compliance with Study Drug|0|||
163111997|NCT01229254|589115633|FG001|Overall Study|Non-compliance with Study Drug|1|||
163111998|NCT01229254|589115634|FG002|Overall Study|Non-compliance with Study Drug|1|||
163111999|NCT02231892|589115635|FG000|Overall Study|Lost to Follow-up|1|||
163112000|NCT02231892|589115636|FG001|Overall Study|Lost to Follow-up|0|||
163112001|NCT02231892|589115637|FG002|Overall Study|Lost to Follow-up|3|||
163112002|NCT02231892|589115635|FG000|Overall Study|Withdrawal by Subject|4|||
163112003|NCT02231892|589115636|FG001|Overall Study|Withdrawal by Subject|3|||
163112004|NCT02231892|589115637|FG002|Overall Study|Withdrawal by Subject|15|||
163112005|NCT02231892|589115635|FG000|Overall Study|Physician Decision|0|||
163112006|NCT02231892|589115636|FG001|Overall Study|Physician Decision|2|||
163112007|NCT02231892|589115637|FG002|Overall Study|Physician Decision|4|||
163112008|NCT02231892|589115635|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
163112009|NCT02231892|589115636|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
163112010|NCT02231892|589115637|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
163112011|NCT02231892|589115635|FG000|Overall Study|Participant motor threshold was >83%|0|||
163112012|NCT02231892|589115636|FG001|Overall Study|Participant motor threshold was >83%|0|||
163112013|NCT02231892|589115637|FG002|Overall Study|Participant motor threshold was >83%|9|||
163112014|NCT02231892|589115635|FG000|Overall Study|Could not find motor threshold|2|||
163112015|NCT02231892|589115636|FG001|Overall Study|Could not find motor threshold|0|||
163112016|NCT02231892|589115637|FG002|Overall Study|Could not find motor threshold|1|||
163112017|NCT02231892|589115635|FG000|Overall Study|Could not find reliable motor hotspot|0|||
163112018|NCT02231892|589115636|FG001|Overall Study|Could not find reliable motor hotspot|0|||
163112019|NCT02231892|589115637|FG002|Overall Study|Could not find reliable motor hotspot|1|||
163112020|NCT00515294|589115645|FG000|Overall Study|Lost to Follow-up|3|||
163112021|NCT00515294|589115646|FG001|Overall Study|Lost to Follow-up|2|||
163112022|NCT00515294|589115647|FG002|Overall Study|Lost to Follow-up|3|||
163112023|NCT00515294|589115648|FG003|Overall Study|Lost to Follow-up|1|||
163112024|NCT00515294|589115645|FG000|Overall Study|Driver simulator problems|1|||
163112025|NCT00515294|589115646|FG001|Overall Study|Driver simulator problems|1|||
163112026|NCT00515294|589115647|FG002|Overall Study|Driver simulator problems|1|||
163112027|NCT00515294|589115648|FG003|Overall Study|Driver simulator problems|3|||
163112028|NCT00515294|589115645|FG000|Overall Study|Caffeine amount inaccurate|5|||
163112029|NCT00515294|589115646|FG001|Overall Study|Caffeine amount inaccurate|0|||
163112030|NCT00515294|589115647|FG002|Overall Study|Caffeine amount inaccurate|7|||
163112031|NCT00515294|589115648|FG003|Overall Study|Caffeine amount inaccurate|0|||
163112032|NCT01534260|589115653|FG000|Overall Study|Adverse Event|1|||
163112033|NCT01534260|589115654|FG001|Overall Study|Adverse Event|8|||
163112034|NCT01534260|589115653|FG000|Overall Study|Death|2|||
163112035|NCT01534260|589115654|FG001|Overall Study|Death|0|||
163112036|NCT01534260|589115653|FG000|Overall Study|Lack of Efficacy|1|||
163112037|NCT01534260|589115654|FG001|Overall Study|Lack of Efficacy|1|||
163112038|NCT01534260|589115653|FG000|Overall Study|Withdrawal by Subject|1|||
163112039|NCT01534260|589115654|FG001|Overall Study|Withdrawal by Subject|3|||
163112040|NCT01534260|589115653|FG000|Overall Study|Disease Progression|8|||
163112041|NCT01534260|589115654|FG001|Overall Study|Disease Progression|6|||
163112042|NCT01534260|589115653|FG000|Overall Study|Physician Decision|3|||
163112043|NCT01534260|589115654|FG001|Overall Study|Physician Decision|1|||
163112044|NCT01534260|589115653|FG000|Overall Study|No treatment, per protocol|0|||
163112045|NCT01534260|589115654|FG001|Overall Study|No treatment, per protocol|1|||
163112046|NCT01342965|589115658|FG000|Overall Study|Death|58|||
163112047|NCT01342965|589115659|FG001|Overall Study|Death|57|||
163112048|NCT01342965|589115658|FG000|Overall Study|Lost to Follow-up|5|||
163112049|NCT01342965|589115659|FG001|Overall Study|Lost to Follow-up|3|||
163112050|NCT01342965|589115658|FG000|Overall Study|Other Reasons- Unspecified|44|||
163112051|NCT01342965|589115659|FG001|Overall Study|Other Reasons- Unspecified|38|||
163112052|NCT01342965|589115658|FG000|Overall Study|Withdrawal by Subject|2|||
163112053|NCT01342965|589115659|FG001|Overall Study|Withdrawal by Subject|9|||
163112054|NCT00856206|589115660|FG000|Overall Study|Protocol Violation|6|||
163112055|NCT00856206|589115661|FG001|Overall Study|Protocol Violation|18|||
163112056|NCT00856206|589115660|FG000|Overall Study|Adverse Event|10|||
163112057|NCT00856206|589115661|FG001|Overall Study|Adverse Event|46|||
163112058|NCT00856206|589115660|FG000|Overall Study|Lack of Efficacy|1|||
163112059|NCT00856206|589115661|FG001|Overall Study|Lack of Efficacy|2|||
163112060|NCT00856206|589115660|FG000|Overall Study|Withdrawal by Subject|15|||
163112061|NCT00856206|589115661|FG001|Overall Study|Withdrawal by Subject|36|||
163112062|NCT00856206|589115660|FG000|Overall Study|Lost to Follow-up|13|||
163112063|NCT00856206|589115661|FG001|Overall Study|Lost to Follow-up|39|||
163112064|NCT00856206|589115660|FG000|Overall Study|Death|2|||
163112065|NCT00856206|589115661|FG001|Overall Study|Death|2|||
163112066|NCT00856206|589115660|FG000|Overall Study|Decision by the Sponsor|4|||
163112067|NCT00856206|589115661|FG001|Overall Study|Decision by the Sponsor|8|||
163112068|NCT00856206|589115660|FG000|Overall Study|Other than specified above|3|||
163112069|NCT00856206|589115661|FG001|Overall Study|Other than specified above|10|||
163112070|NCT00503581|589115666|FG000|Overall Study|Study closed|3|||
163112071|NCT00503581|589115667|FG001|Overall Study|Study closed|4|||
163112072|NCT00503581|589115668|FG002|Overall Study|Study closed|2|||
163112073|NCT02780856|589115669|FG000|Overall Study|Lost to Follow-up|1|||
163112074|NCT01301066|589115673|FG000|Overall Study|Lost to Follow-up|5|||
163112075|NCT01301066|589115674|FG001|Overall Study|Lost to Follow-up|11|||
163112076|NCT01301066|589115673|FG000|Overall Study|Protocol Violation|8|||
162719325|NCT04439799|587678480|FG000|Overall Study|Lost to Follow-up|6|||
162719326|NCT04439799|587678481|FG001|Overall Study|Lost to Follow-up|6|||
163112077|NCT01301066|589115674|FG001|Overall Study|Protocol Violation|7|||
163112078|NCT01301066|589115673|FG000|Overall Study|Withdrawal by Subject|4|||
163112079|NCT01301066|589115674|FG001|Overall Study|Withdrawal by Subject|9|||
163112080|NCT01301066|589115673|FG000|Overall Study|Adverse Event|6|||
163112081|NCT01301066|589115674|FG001|Overall Study|Adverse Event|6|||
163112082|NCT01301066|589115673|FG000|Overall Study|Sponsor Decision|2|||
163112083|NCT01301066|589115674|FG001|Overall Study|Sponsor Decision|1|||
163112084|NCT01301066|589115673|FG000|Overall Study|Physician Decision|0|||
163112085|NCT01301066|589115674|FG001|Overall Study|Physician Decision|1|||
163112086|NCT01301066|589115673|FG000|Overall Study|Other|2|||
163112087|NCT01301066|589115674|FG001|Overall Study|Other|0|||
163112088|NCT04003207|589115677|FG000|Overall Study|Protocol Violation|1|||
163112089|NCT01145352|589117704|FG000|Overall Study|Found to have been registered twice|6|||
163112090|NCT01145352|589117704|FG000|Overall Study|Treated before marketing approval|4|||
163112091|NCT01145352|589117704|FG000|Overall Study|Syringe formulation was used|1|||
163112092|NCT01739933|589117707|FG000|Overall Study|Death|89|||
163112093|NCT01739933|589117708|FG001|Overall Study|Death|86|||
163112094|NCT01739933|589117707|FG000|Overall Study|Withdrawal by Subject|10|||
163112095|NCT01739933|589117708|FG001|Overall Study|Withdrawal by Subject|8|||
163112096|NCT01739933|589117707|FG000|Overall Study|Lost to Follow-up|3|||
163112097|NCT01739933|589117708|FG001|Overall Study|Lost to Follow-up|10|||
163112098|NCT01739933|589117707|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
163112099|NCT01739933|589117708|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
163112100|NCT03356977|589117709|FG000|Overall Study|Lost to Follow-up|3|||
163112101|NCT03356977|589117709|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162719327|NCT04439799|587678480|FG000|Overall Study|Withdrawal by Subject|2|||
163112102|NCT01728077|589117710|FG000|Overall Study|Lack of Efficacy|3|||
163112103|NCT01728077|589117711|FG001|Overall Study|Lack of Efficacy|1|||
162719328|NCT04439799|587678481|FG001|Overall Study|Withdrawal by Subject|6|||
163112104|NCT01728077|589117710|FG000|Overall Study|Lost to Follow-up|1|||
163112105|NCT01728077|589117711|FG001|Overall Study|Lost to Follow-up|0|||
162653985|NCT03013543|587449653|FG006|Overall Study|Physician Decision|0|||
162653986|NCT03013543|587449654|FG007|Overall Study|Physician Decision|0|||
162653987|NCT03013543|587449655|FG008|Overall Study|Physician Decision|0|||
162653988|NCT03013543|587449656|FG009|Overall Study|Physician Decision|0|||
163112106|NCT01728077|589117710|FG000|Overall Study|Subject choice|2|||
163112107|NCT01728077|589117711|FG001|Overall Study|Subject choice|3|||
163112108|NCT01728077|589117710|FG000|Overall Study|Death|0|||
163112109|NCT01728077|589117711|FG001|Overall Study|Death|1|||
163112110|NCT01728077|589117710|FG000|Overall Study|Patient moving|1|||
163112111|NCT01728077|589117711|FG001|Overall Study|Patient moving|0|||
163112112|NCT01728077|589117710|FG000|Overall Study|Non compliance|1|||
163112113|NCT01728077|589117711|FG001|Overall Study|Non compliance|0|||
163112114|NCT00378599|589117714|FG000|Overall Study|Adverse Event|38|||
163112115|NCT00378599|589117714|FG000|Overall Study|Protocol Violation|2|||
163112116|NCT00378599|589117714|FG000|Overall Study|Treatment failure|7|||
163112117|NCT00378599|589117714|FG000|Overall Study|Withdrawal by Subject|5|||
163112118|NCT03224507|589117715|FG000|Overall Study|Death|3|||
163112119|NCT03224507|589117716|FG001|Overall Study|Death|0|||
163112120|NCT03224507|589117715|FG000|Overall Study|Lack of Efficacy|6|||
163112121|NCT03224507|589117716|FG001|Overall Study|Lack of Efficacy|0|||
163112122|NCT03224507|589117715|FG000|Overall Study|Withdrawal by Subject|6|||
163112123|NCT03224507|589117716|FG001|Overall Study|Withdrawal by Subject|0|||
163112124|NCT01032291|589117717|FG000|Safety Lead-in|Adverse Event|1|||
163112125|NCT01032291|589117718|FG001|Safety Lead-in|Adverse Event|0|||
163112126|NCT01032291|589117719|FG002|Safety Lead-in|Adverse Event|0|||
163112127|NCT01032291|589117717|FG000|Safety Lead-in|Death|1|||
163112128|NCT01032291|589117718|FG001|Safety Lead-in|Death|0|||
163112129|NCT01032291|589117719|FG002|Safety Lead-in|Death|0|||
163112130|NCT01032291|589117717|FG000|Proof of Concept|Adverse Event|0|||
163112131|NCT01032291|589117718|FG001|Proof of Concept|Adverse Event|5|||
163112132|NCT01032291|589117719|FG002|Proof of Concept|Adverse Event|1|||
163112133|NCT01032291|589117717|FG000|Proof of Concept|Death|0|||
163112134|NCT01032291|589117718|FG001|Proof of Concept|Death|1|||
163112135|NCT01032291|589117719|FG002|Proof of Concept|Death|2|||
163112136|NCT01032291|589117717|FG000|Proof of Concept|Lack of Efficacy|0|||
163112137|NCT01032291|589117718|FG001|Proof of Concept|Lack of Efficacy|1|||
163112138|NCT01032291|589117719|FG002|Proof of Concept|Lack of Efficacy|0|||
163112139|NCT01032291|589117717|FG000|Proof of Concept|Never Received Study Drug|0|||
163112140|NCT01032291|589117718|FG001|Proof of Concept|Never Received Study Drug|1|||
163112141|NCT01032291|589117719|FG002|Proof of Concept|Never Received Study Drug|0|||
163112142|NCT00347438|589117720|FG000|Overall Study|Withdrawal by Subject|1|||
163112143|NCT00347438|589117720|FG000|Overall Study|Physician Decision|1|||
163112144|NCT01529515|589117723|FG000|TRANSITION PHASE|Adverse Event|16|||
163112145|NCT01529515|589117724|FG001|TRANSITION PHASE|Adverse Event|0|||
163112146|NCT01529515|589117725|FG002|TRANSITION PHASE|Adverse Event|0|||
163112147|NCT01529515|589117726|FG003|TRANSITION PHASE|Adverse Event|0|||
163112148|NCT01529515|589117723|FG000|TRANSITION PHASE|Death|1|||
163112149|NCT01529515|589117724|FG001|TRANSITION PHASE|Death|0|||
163112150|NCT01529515|589117725|FG002|TRANSITION PHASE|Death|0|||
162653989|NCT03013543|587449647|FG000|Overall Study|Protocol Violation|0|||
162653990|NCT03013543|587449648|FG001|Overall Study|Protocol Violation|0|||
162653991|NCT03013543|587449649|FG002|Overall Study|Protocol Violation|0|||
162653992|NCT03013543|587449650|FG003|Overall Study|Protocol Violation|0|||
162653993|NCT03013543|587449651|FG004|Overall Study|Protocol Violation|0|||
163112151|NCT01529515|589117726|FG003|TRANSITION PHASE|Death|0|||
163112152|NCT01529515|589117723|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
163112153|NCT01529515|589117724|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
163112154|NCT01529515|589117725|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
163112155|NCT01529515|589117726|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
163112156|NCT01529515|589117723|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
163112157|NCT01529515|589117724|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
163112158|NCT01529515|589117725|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
163112159|NCT01529515|589117726|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
163112160|NCT01529515|589117723|FG000|TRANSITION PHASE|Protocol Violation|4|||
163112161|NCT01529515|589117724|FG001|TRANSITION PHASE|Protocol Violation|0|||
163112162|NCT01529515|589117725|FG002|TRANSITION PHASE|Protocol Violation|0|||
163112163|NCT01529515|589117726|FG003|TRANSITION PHASE|Protocol Violation|0|||
163112164|NCT01529515|589117723|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
163112165|NCT01529515|589117724|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
163112166|NCT01529515|589117725|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
163112167|NCT01529515|589117726|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
163112168|NCT01529515|589117723|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
163112169|NCT01529515|589117724|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
162653994|NCT03013543|587449652|FG005|Overall Study|Protocol Violation|0|||
163112170|NCT01529515|589117725|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
163112171|NCT01529515|589117726|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
163112172|NCT01529515|589117723|FG000|TRANSITION PHASE|Other|9|||
163112173|NCT01529515|589117724|FG001|TRANSITION PHASE|Other|0|||
163112174|NCT01529515|589117725|FG002|TRANSITION PHASE|Other|0|||
163112175|NCT01529515|589117726|FG003|TRANSITION PHASE|Other|0|||
163112176|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Adverse Event|0|||
163112177|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Adverse Event|10|||
163112178|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Adverse Event|0|||
163112179|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Adverse Event|0|||
163112180|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112181|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
163112182|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112183|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
163112184|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112185|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
163112186|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112187|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
163112188|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
163112189|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
163112190|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
163112191|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
163112192|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112193|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
163112194|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112195|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
163112196|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112197|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
163112198|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112199|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
163112200|NCT01529515|589117723|FG000|MAINTENANCE PHASE|Other|0|||
163112201|NCT01529515|589117724|FG001|MAINTENANCE PHASE|Other|10|||
163112202|NCT01529515|589117725|FG002|MAINTENANCE PHASE|Other|0|||
163112203|NCT01529515|589117726|FG003|MAINTENANCE PHASE|Other|0|||
163112204|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
163112205|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
163112206|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
163112207|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
163112208|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
163112209|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
163112210|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
163112211|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
163112212|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
163112213|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
163112214|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
163112215|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
163112216|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
163112217|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
163112218|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
163112219|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
163112220|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112221|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112222|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
163112223|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
163112224|NCT01529515|589117723|FG000|DOUBLE BLIND PHASE|Other|0|||
163112225|NCT01529515|589117724|FG001|DOUBLE BLIND PHASE|Other|0|||
163112226|NCT01529515|589117725|FG002|DOUBLE BLIND PHASE|Other|9|||
163112227|NCT01529515|589117726|FG003|DOUBLE BLIND PHASE|Other|2|||
163112228|NCT00322023|589117728|FG000|Overall Study|various|0|||
163112229|NCT00322023|589117729|FG001|Overall Study|various|2|||
163112230|NCT00322023|589117730|FG002|Overall Study|various|6|||
163112231|NCT03327220|589117731|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
163112232|NCT03327220|589117732|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
163112233|NCT03327220|589117731|FG000|Overall Study|Investigator Decision|2|||
163112234|NCT03327220|589117732|FG001|Overall Study|Investigator Decision|0|||
163112235|NCT03327220|589117731|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
163112236|NCT03327220|589117732|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
163112237|NCT03327220|589117731|FG000|Overall Study|Fungal infection|1|||
163112238|NCT03327220|589117732|FG001|Overall Study|Fungal infection|0|||
163112239|NCT03327220|589117731|FG000|Overall Study|Discharged to Rehabilitation|0|||
163112240|NCT03327220|589117732|FG001|Overall Study|Discharged to Rehabilitation|1|||
163112241|NCT03327220|589117731|FG000|Overall Study|Missing|1|||
163112242|NCT03327220|589117732|FG001|Overall Study|Missing|0|||
163112243|NCT03920293|589117733|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
163112244|NCT03920293|589117734|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
163112245|NCT03920293|589117733|FG000|Randomized-Controlled Period|Physician Decision|1|||
163112246|NCT03920293|589117734|FG001|Randomized-Controlled Period|Physician Decision|2|||
163112247|NCT03920293|589117733|FG000|Randomized-Controlled Period|Adverse Event|0|||
163112248|NCT03920293|589117734|FG001|Randomized-Controlled Period|Adverse Event|2|||
163112249|NCT03920293|589117733|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
163112250|NCT03920293|589117734|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
163112251|NCT03920293|589117733|FG000|Randomized-Controlled Period|Death|2|||
163112252|NCT03920293|589117734|FG001|Randomized-Controlled Period|Death|0|||
163112253|NCT03920293|589117733|FG000|Randomized-Controlled Period|Protocol Violation|1|||
163112254|NCT03920293|589117734|FG001|Randomized-Controlled Period|Protocol Violation|0|||
163112255|NCT03920293|589117733|FG000|Randomized-Controlled Period|Noncompliance|1|||
163112256|NCT03920293|589117734|FG001|Randomized-Controlled Period|Noncompliance|0|||
163112257|NCT03920293|589117733|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
163112258|NCT03920293|589117734|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
163112259|NCT03920293|589117733|FG000|Open- Label Extension Period|Death|3|||
163112260|NCT03920293|589117734|FG001|Open- Label Extension Period|Death|3|||
163112261|NCT03920293|589117733|FG000|Open- Label Extension Period|Physician Decision|5|||
163112262|NCT03920293|589117734|FG001|Open- Label Extension Period|Physician Decision|3|||
163112263|NCT03920293|589117733|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
163112264|NCT03920293|589117734|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
163112265|NCT00523705|589117735|FG000|Overall Study|No time for study.|0|||
163112266|NCT00523705|589117736|FG001|Overall Study|No time for study.|1|||
163112267|NCT00693017|589117737|FG000|Overall Study|Sponsor Decision|2|||
163112268|NCT00693017|589117738|FG001|Overall Study|Sponsor Decision|1|||
163112269|NCT00693017|589117737|FG000|Overall Study|Death|0|||
163112270|NCT00693017|589117738|FG001|Overall Study|Death|1|||
163112271|NCT01691885|589117742|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
163112272|NCT01691885|589117743|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
163112273|NCT01691885|589117742|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
163112274|NCT01691885|589117743|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
163112275|NCT03555981|589117744|FG000|Overall Study|Lost to Follow-up|0|||
163112276|NCT03555981|589117745|FG001|Overall Study|Lost to Follow-up|2|||
163112277|NCT00688324|589117747|FG000|Overall Study|Withdrawal by Subject|2|||
163112278|NCT00688324|589117747|FG000|Overall Study|Physician Decision|5|||
163112279|NCT00688324|589117747|FG000|Overall Study|Lost to Follow-up|1|||
163112280|NCT01972308|589117748|FG000|Overall Study|Withdrawal by Subject|0|||
163112281|NCT01972308|589117749|FG001|Overall Study|Withdrawal by Subject|1|||
163112282|NCT01972308|589117748|FG000|Overall Study|Lost to Follow-up|4|||
163112283|NCT01972308|589117749|FG001|Overall Study|Lost to Follow-up|6|||
163112284|NCT01972308|589117748|FG000|Overall Study|Death|4|||
163112285|NCT01972308|589117749|FG001|Overall Study|Death|1|||
163112286|NCT00585546|589117751|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
163112287|NCT00585546|589117751|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
163112288|NCT01562314|589117752|FG000|Overall Study|Adverse Event|10|||
163112289|NCT01562314|589117753|FG001|Overall Study|Adverse Event|5|||
163112290|NCT01562314|589117752|FG000|Overall Study|Met Withdrawal Criteria|3|||
163112291|NCT01562314|589117753|FG001|Overall Study|Met Withdrawal Criteria|2|||
163112292|NCT01562314|589117752|FG000|Overall Study|Withdrawal by Subject|0|||
163112293|NCT01562314|589117753|FG001|Overall Study|Withdrawal by Subject|1|||
163112294|NCT00813865|589117760|FG000|Overall Study|Failure to Respond|3|||
163112295|NCT00813865|589117760|FG000|Overall Study|Lost to Follow-up|3|||
163112296|NCT00813865|589117760|FG000|Overall Study|Withdrawal by Subject|1|||
163112297|NCT01190475|589117762|FG000|Overall Study|Withdrawal by Subject|0|||
163112298|NCT01190475|589117763|FG001|Overall Study|Withdrawal by Subject|0|||
163112299|NCT01190475|589117764|FG002|Overall Study|Withdrawal by Subject|1|||
163112300|NCT00543803|589117767|FG000|Overall Study|Adverse Event|14|||
163112301|NCT00543803|589117767|FG000|Overall Study|Lack of Efficacy|22|||
163112302|NCT00543803|589117767|FG000|Overall Study|Lost to Follow-up|20|||
163112303|NCT00543803|589117767|FG000|Overall Study|Other|86|||
162653995|NCT03013543|587449653|FG006|Overall Study|Protocol Violation|0|||
163112304|NCT00624585|589117768|FG000|Overall Study|Death|3|||
163112305|NCT00624585|589117768|FG000|Overall Study|Disease Progression|6|||
163112306|NCT00624585|589117768|FG000|Overall Study|Adverse Event|3|||
163112307|NCT04154345|589117772|FG000|Overall Study|Covid-19 pandemic|4|||
163112308|NCT03505788|589117773|FG000|Overall Study|Lost to Follow-up|2|||
163112309|NCT03505788|589117774|FG001|Overall Study|Lost to Follow-up|1|||
163112310|NCT03505788|589117773|FG000|Overall Study|Withdrawal by Subject|1|||
163112311|NCT03505788|589117774|FG001|Overall Study|Withdrawal by Subject|3|||
163112312|NCT03505788|589117773|FG000|Overall Study|Physician Decision|0|||
163112313|NCT03505788|589117774|FG001|Overall Study|Physician Decision|1|||
163112314|NCT01535599|589117776|FG000|Overall Study|Adverse Event|6|||
163112315|NCT01535599|589117777|FG001|Overall Study|Adverse Event|15|||
163112316|NCT01535599|589117776|FG000|Overall Study|Lost to Follow-up|3|||
163112317|NCT01535599|589117777|FG001|Overall Study|Lost to Follow-up|4|||
163112318|NCT01535599|589117776|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
163112319|NCT01535599|589117777|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
163112320|NCT01535599|589117776|FG000|Overall Study|Treatment Failure|33|||
163112321|NCT01535599|589117777|FG001|Overall Study|Treatment Failure|66|||
163112322|NCT01535599|589117776|FG000|Overall Study|BL Culture + for Group A Strep|0|||
163112323|NCT01535599|589117777|FG001|Overall Study|BL Culture + for Group A Strep|1|||
163112324|NCT01535599|589117776|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
163112325|NCT01535599|589117777|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
163112326|NCT01535599|589117776|FG000|Overall Study|Randomized in Error|2|||
163112327|NCT01535599|589117777|FG001|Overall Study|Randomized in Error|4|||
163112328|NCT01535599|589117776|FG000|Overall Study|Did not use product|1|||
163112329|NCT01535599|589117777|FG001|Overall Study|Did not use product|0|||
163112330|NCT01535599|589117776|FG000|Overall Study|Other|1|||
163112331|NCT01535599|589117777|FG001|Overall Study|Other|0|||
163112332|NCT01535599|589117776|FG000|Overall Study|Stopped medication|0|||
163112333|NCT01535599|589117777|FG001|Overall Study|Stopped medication|1|||
163112334|NCT01535599|589117776|FG000|Overall Study|Noncompliance|0|||
163112335|NCT01535599|589117777|FG001|Overall Study|Noncompliance|1|||
163112336|NCT00676520|589117778|FG000|Overall Study|Withdrawal by Subject|163|||
163112337|NCT00676520|589117778|FG000|Overall Study|Lost to Follow-up|162|||
163112338|NCT00676520|589117778|FG000|Overall Study|Death|159|||
163112339|NCT00676520|589117778|FG000|Overall Study|Physician Decision|20|||
163112340|NCT00676520|589117778|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
163112341|NCT00676520|589117778|FG000|Overall Study|Other Reason|18|||
163112342|NCT00590824|589117790|FG000|Overall Study|Disease could not be resected|0|||
163112343|NCT00590824|589117791|FG001|Overall Study|Disease could not be resected|2|||
163112344|NCT00590824|589117792|FG002|Overall Study|Disease could not be resected|1|||
163112345|NCT00590824|589117793|FG003|Overall Study|Disease could not be resected|0|||
163112346|NCT00590824|589117790|FG000|Overall Study|Adverse Event|0|||
163112347|NCT00590824|589117791|FG001|Overall Study|Adverse Event|0|||
163112348|NCT00590824|589117792|FG002|Overall Study|Adverse Event|0|||
163112349|NCT00590824|589117793|FG003|Overall Study|Adverse Event|1|||
163112350|NCT00744978|589117796|FG000|Period 1|Lost to Follow-up|1|||
163112351|NCT00744978|589117797|FG001|Period 1|Lost to Follow-up|0|||
163112352|NCT00744978|589117796|FG000|Period 1|Withdrawal by Subject|0|||
163112353|NCT00744978|589117797|FG001|Period 1|Withdrawal by Subject|2|||
163112354|NCT00744978|589117796|FG000|Period 1|Other|0|||
163112355|NCT00744978|589117797|FG001|Period 1|Other|2|||
163112356|NCT00744978|589117796|FG000|Period 1|Adverse Event|4|||
163112357|NCT00744978|589117797|FG001|Period 1|Adverse Event|0|||
163112358|NCT00744978|589117796|FG000|Period 1|Randomized but not Treated|1|||
163112359|NCT00744978|589117797|FG001|Period 1|Randomized but not Treated|1|||
163112360|NCT00744978|589117796|FG000|Period 2|Adverse Event|0|||
163112361|NCT00744978|589117797|FG001|Period 2|Adverse Event|1|||
163112362|NCT03773133|589117798|FG000|Overall Study|Screen Failure|8|||
163112363|NCT03770728|589117799|FG000|Overall Study|Adverse Event|1|||
163112364|NCT03770728|589117800|FG001|Overall Study|Adverse Event|0|||
163112365|NCT03770728|589117801|FG002|Overall Study|Adverse Event|1|||
163112366|NCT03770728|589117802|FG003|Overall Study|Adverse Event|0|||
163112367|NCT03770728|589117799|FG000|Overall Study|Poor compliance to protocol|0|||
163112368|NCT03770728|589117800|FG001|Overall Study|Poor compliance to protocol|0|||
163112369|NCT03770728|589117801|FG002|Overall Study|Poor compliance to protocol|1|||
163112370|NCT03770728|589117802|FG003|Overall Study|Poor compliance to protocol|0|||
163112371|NCT03770728|589117799|FG000|Overall Study|Withdrawal by Subject|13|||
163112372|NCT03770728|589117800|FG001|Overall Study|Withdrawal by Subject|8|||
163112373|NCT03770728|589117801|FG002|Overall Study|Withdrawal by Subject|9|||
163112374|NCT03770728|589117802|FG003|Overall Study|Withdrawal by Subject|13|||
163112375|NCT03770728|589117799|FG000|Overall Study|Other than specified|24|||
163112376|NCT03770728|589117800|FG001|Overall Study|Other than specified|23|||
162719329|NCT04439799|587678480|FG000|Overall Study|Adverse Event|2|||
163112377|NCT03770728|589117801|FG002|Overall Study|Other than specified|21|||
163112378|NCT03770728|589117802|FG003|Overall Study|Other than specified|22|||
163112379|NCT02778555|589117803|FG000|Overall Study|Withdrawal by Subject|55|||
163112380|NCT02778555|589117804|FG001|Overall Study|Withdrawal by Subject|32|||
163112381|NCT02778555|589117805|FG002|Overall Study|Withdrawal by Subject|107|||
163112382|NCT02379988|589117806|FG000|Overall Study|Not eligible|1|||
163112383|NCT01895543|589117811|FG000|Overall Study|Withdrawal by Subject|43|||
163112384|NCT01895543|589117811|FG000|Overall Study|Lost to Follow-up|25|||
163112385|NCT01895543|589117811|FG000|Overall Study|Adverse Event|28|||
163112386|NCT01895543|589117811|FG000|Overall Study|Subject's substantial non-compliance|6|||
163112387|NCT01895543|589117811|FG000|Overall Study|Protocol Violation|1|||
163112388|NCT01895543|589117811|FG000|Overall Study|Physician Decision|2|||
163112389|NCT01895543|589117811|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
163112390|NCT04262882|589117812|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
163112391|NCT04262882|589117813|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
163112392|NCT04262882|589117812|FG000|Overall Study|Lost to Follow-up|1|||
163112393|NCT04262882|589117813|FG001|Overall Study|Lost to Follow-up|0|||
163112394|NCT00468676|589117818|FG000|Overall Study|Lost to Follow-up|14|||
163112395|NCT00468676|589117819|FG001|Overall Study|Lost to Follow-up|11|||
163112396|NCT00468676|589117818|FG000|Overall Study|Death|2|||
163112397|NCT00468676|589117819|FG001|Overall Study|Death|1|||
163112398|NCT02979093|589117822|FG000|First Scan Session|Scanning data problems|1|||
163112399|NCT02979093|589117823|FG001|First Scan Session|Scanning data problems|2|||
163112400|NCT02979093|589117824|FG002|First Scan Session|Scanning data problems|2|||
163112401|NCT02979093|589117825|FG003|First Scan Session|Scanning data problems|0|||
163112402|NCT02979093|589117822|FG000|Second Scan Session|Scanning data problems|3|||
163112403|NCT02979093|589117823|FG001|Second Scan Session|Scanning data problems|0|||
163112404|NCT02979093|589117824|FG002|Second Scan Session|Scanning data problems|1|||
163112405|NCT02979093|589117825|FG003|Second Scan Session|Scanning data problems|3|||
163112406|NCT00522418|589117826|FG000|Overall Study|Local IRB Consent Violation|5|||
163112407|NCT00522418|589117827|FG001|Overall Study|Local IRB Consent Violation|5|||
163112408|NCT00522418|589117826|FG000|Overall Study|Early Study Termination|46|||
163112409|NCT00522418|589117827|FG001|Overall Study|Early Study Termination|47|||
163112410|NCT00522418|589117826|FG000|Overall Study|Noncompliance|2|||
163112411|NCT00522418|589117827|FG001|Overall Study|Noncompliance|2|||
163112412|NCT00522418|589117826|FG000|Overall Study|Reason Not Specified|3|||
163112413|NCT00522418|589117827|FG001|Overall Study|Reason Not Specified|1|||
163112414|NCT00522418|589117826|FG000|Overall Study|Consent Withdraw|1|||
163112415|NCT00522418|589117827|FG001|Overall Study|Consent Withdraw|2|||
163112416|NCT00522418|589117826|FG000|Overall Study|Lack of Efficacy|0|||
163112417|NCT00522418|589117827|FG001|Overall Study|Lack of Efficacy|1|||
163112418|NCT02438683|589117831|FG000|Overall Study|Adverse Event|1|||
163112419|NCT02438683|589117832|FG001|Overall Study|Adverse Event|0|||
163112420|NCT02438683|589117833|FG002|Overall Study|Adverse Event|0|||
163112421|NCT02438683|589117834|FG003|Overall Study|Adverse Event|0|||
163112422|NCT02438683|589117835|FG004|Overall Study|Adverse Event|0|||
163112423|NCT02438683|589117836|FG005|Overall Study|Adverse Event|0|||
163112424|NCT00721578|589117837|FG000|Overall Study|Death|1|||
163112425|NCT00721578|589117838|FG001|Overall Study|Death|1|||
163112426|NCT00721578|589117837|FG000|Overall Study|Withdrawal by Subject|1|||
163112427|NCT00721578|589117838|FG001|Overall Study|Withdrawal by Subject|1|||
163112428|NCT02256384|589117852|FG000|Overall Study|Withdrawal by Subject|12|||
163112429|NCT02256384|589117852|FG000|Overall Study|Equipment not capturing data|2|||
163112430|NCT05032690|589117859|FG000|Period 1|Adverse Event|0|||
163112431|NCT05032690|589117860|FG001|Period 1|Adverse Event|1|||
163112432|NCT05032690|589117861|FG002|Period 1|Adverse Event|0|||
163112433|NCT05032690|589117862|FG003|Period 1|Adverse Event|0|||
163112434|NCT05032690|589117859|FG000|Period 1|Withdrawal by Subject|1|||
163112435|NCT05032690|589117860|FG001|Period 1|Withdrawal by Subject|0|||
163112436|NCT05032690|589117861|FG002|Period 1|Withdrawal by Subject|0|||
163112437|NCT05032690|589117862|FG003|Period 1|Withdrawal by Subject|0|||
163112438|NCT05032690|589117859|FG000|Period 1|No longer meets eligibility criteria|0|||
163112439|NCT05032690|589117860|FG001|Period 1|No longer meets eligibility criteria|1|||
163112440|NCT05032690|589117861|FG002|Period 1|No longer meets eligibility criteria|0|||
163112441|NCT05032690|589117862|FG003|Period 1|No longer meets eligibility criteria|0|||
163112442|NCT05032690|589117859|FG000|Period 2|Adverse Event|1|||
163112443|NCT05032690|589117860|FG001|Period 2|Adverse Event|0|||
163112444|NCT05032690|589117861|FG002|Period 2|Adverse Event|0|||
163112445|NCT05032690|589117862|FG003|Period 2|Adverse Event|0|||
163112446|NCT05032690|589117859|FG000|Period 2|Withdrawal by Subject|0|||
163112447|NCT05032690|589117860|FG001|Period 2|Withdrawal by Subject|1|||
163112448|NCT05032690|589117861|FG002|Period 2|Withdrawal by Subject|0|||
163112449|NCT05032690|589117862|FG003|Period 2|Withdrawal by Subject|0|||
163112450|NCT05032690|589117859|FG000|Period 2|No longer meets eligibility criteria|0|||
163112451|NCT05032690|589117860|FG001|Period 2|No longer meets eligibility criteria|1|||
163112452|NCT05032690|589117861|FG002|Period 2|No longer meets eligibility criteria|0|||
163112453|NCT05032690|589117862|FG003|Period 2|No longer meets eligibility criteria|0|||
163112454|NCT05032690|589117859|FG000|Period 3|Adverse Event|0|||
163112455|NCT05032690|589117860|FG001|Period 3|Adverse Event|1|||
163112456|NCT05032690|589117861|FG002|Period 3|Adverse Event|0|||
163112457|NCT05032690|589117862|FG003|Period 3|Adverse Event|0|||
163112458|NCT00487942|589117863|FG000|Overall Study|Adverse Event|1|||
163112459|NCT00487942|589117864|FG001|Overall Study|Adverse Event|1|||
163112460|NCT00487942|589117865|FG002|Overall Study|Adverse Event|1|||
163112461|NCT00487942|589117866|FG003|Overall Study|Adverse Event|1|||
163112462|NCT00487942|589117863|FG000|Overall Study|Lost to Follow-up|1|||
163112463|NCT00487942|589117864|FG001|Overall Study|Lost to Follow-up|0|||
163112464|NCT00487942|589117865|FG002|Overall Study|Lost to Follow-up|0|||
162653996|NCT03013543|587449654|FG007|Overall Study|Protocol Violation|0|||
162653997|NCT03013543|587449655|FG008|Overall Study|Protocol Violation|0|||
163112465|NCT00487942|589117866|FG003|Overall Study|Lost to Follow-up|1|||
163112466|NCT00487942|589117863|FG000|Overall Study|Protocol Violation|1|||
163112467|NCT00487942|589117864|FG001|Overall Study|Protocol Violation|1|||
163112468|NCT00487942|589117865|FG002|Overall Study|Protocol Violation|0|||
163112469|NCT00487942|589117866|FG003|Overall Study|Protocol Violation|0|||
163112470|NCT00487942|589117863|FG000|Overall Study|Withdrawal by Subject|0|||
162653998|NCT03013543|587449656|FG009|Overall Study|Protocol Violation|1|||
163112471|NCT00487942|589117864|FG001|Overall Study|Withdrawal by Subject|1|||
163112472|NCT00487942|589117865|FG002|Overall Study|Withdrawal by Subject|2|||
163112473|NCT00487942|589117866|FG003|Overall Study|Withdrawal by Subject|0|||
163112474|NCT00211757|589117867|FG000|Overall Study|Withdrawal by Subject|1|||
163112475|NCT00211757|589117868|FG001|Overall Study|Withdrawal by Subject|1|||
163112476|NCT00211757|589117867|FG000|Overall Study|Lack of Efficacy|0|||
163112477|NCT00211757|589117868|FG001|Overall Study|Lack of Efficacy|1|||
163112478|NCT05151445|589117869|FG000|Overall Study|Withdrawal by Subject|3|||
163112479|NCT02298179|589117870|FG000|Overall Study|Lost to Follow-up|0|||
163112480|NCT02298179|589117871|FG001|Overall Study|Lost to Follow-up|0|||
163112481|NCT02298179|589117872|FG002|Overall Study|Lost to Follow-up|1|||
163112482|NCT02298179|589117873|FG003|Overall Study|Lost to Follow-up|0|||
163112483|NCT02298179|589117874|FG004|Overall Study|Lost to Follow-up|0|||
163112484|NCT02298179|589117875|FG005|Overall Study|Lost to Follow-up|0|||
163112485|NCT02298179|589117876|FG006|Overall Study|Lost to Follow-up|0|||
163112486|NCT02298179|589117877|FG007|Overall Study|Lost to Follow-up|1|||
163112487|NCT02298179|589117878|FG008|Overall Study|Lost to Follow-up|0|||
163112488|NCT02298179|589117879|FG009|Overall Study|Lost to Follow-up|0|||
163112489|NCT02298179|589117880|FG010|Overall Study|Lost to Follow-up|0|||
163112490|NCT02298179|589117881|FG011|Overall Study|Lost to Follow-up|0|||
163112491|NCT00082368|589117882|FG000|Overall Study|Not treated-pt had poor IV access|1|||
163112492|NCT02825420|589117884|FG000|Overall Study|Death|30|||
163112493|NCT02825420|589117885|FG001|Overall Study|Death|12|||
163112494|NCT02825420|589117884|FG000|Overall Study|Progressive disease|6|||
163112495|NCT02825420|589117885|FG001|Overall Study|Progressive disease|1|||
163112496|NCT02825420|589117884|FG000|Overall Study|Lost to Follow-up|2|||
163112497|NCT02825420|589117885|FG001|Overall Study|Lost to Follow-up|2|||
163112498|NCT02825420|589117884|FG000|Overall Study|Withdrawal by Subject|1|||
163112499|NCT02825420|589117885|FG001|Overall Study|Withdrawal by Subject|1|||
163112500|NCT02825420|589117884|FG000|Overall Study|Protocol amendment not signed|1|||
163112501|NCT02825420|589117885|FG001|Overall Study|Protocol amendment not signed|1|||
163112502|NCT02825420|589117884|FG000|Overall Study|Physician Decision|1|||
163112503|NCT02825420|589117885|FG001|Overall Study|Physician Decision|0|||
163112504|NCT02825420|589117884|FG000|Overall Study|Did not receive PLD|2|||
163112505|NCT02825420|589117885|FG001|Overall Study|Did not receive PLD|0|||
163112506|NCT00642174|589119868|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
163112507|NCT00642174|589119869|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
163112508|NCT00896363|589119870|FG000|Overall Study|Adverse Event|3|||
163112509|NCT00896363|589119871|FG001|Overall Study|Adverse Event|4|||
163112510|NCT00896363|589119872|FG002|Overall Study|Adverse Event|2|||
163112511|NCT00896363|589119870|FG000|Overall Study|Lack of Efficacy|0|||
163112512|NCT00896363|589119871|FG001|Overall Study|Lack of Efficacy|2|||
163112513|NCT00896363|589119872|FG002|Overall Study|Lack of Efficacy|1|||
163112514|NCT00896363|589119870|FG000|Overall Study|Withdrawal by Subject|3|||
163112515|NCT00896363|589119871|FG001|Overall Study|Withdrawal by Subject|5|||
163112516|NCT00896363|589119872|FG002|Overall Study|Withdrawal by Subject|5|||
163112517|NCT01730339|589119873|FG000|Overall Study|Withdrawal by Subject|3|||
163112518|NCT01730339|589119874|FG001|Overall Study|Withdrawal by Subject|2|||
163112519|NCT01730339|589119873|FG000|Overall Study|Lost to Follow-up|1|||
163112520|NCT01730339|589119874|FG001|Overall Study|Lost to Follow-up|1|||
163112521|NCT01730339|589119873|FG000|Overall Study|Un-specified|1|||
163112522|NCT01730339|589119874|FG001|Overall Study|Un-specified|0|||
163112523|NCT00847665|589119877|FG000|Overall Study|Withdrawal by Subject|1|||
163112524|NCT00847665|589119878|FG001|Overall Study|Withdrawal by Subject|0|||
163112525|NCT04035564|589119879|FG000|Overall Study|Protocol Violation|1|||
163112526|NCT04035564|589119880|FG001|Overall Study|Protocol Violation|2|||
163112527|NCT04035564|589119879|FG000|Overall Study|No laboratory available|2|||
163112528|NCT04035564|589119880|FG001|Overall Study|No laboratory available|2|||
163112529|NCT04035564|589119879|FG000|Overall Study|Guardian declined consent|1|||
163112530|NCT04035564|589119880|FG001|Overall Study|Guardian declined consent|2|||
163112531|NCT03333252|589119885|FG000|Overall Study|Adverse Event|10|||
163112532|NCT03333252|589119886|FG001|Overall Study|Adverse Event|6|||
163112533|NCT03333252|589119887|FG002|Overall Study|Adverse Event|5|||
163112534|NCT03333252|589119888|FG003|Overall Study|Adverse Event|2|||
163112535|NCT03333252|589119885|FG000|Overall Study|Death|1|||
163112536|NCT03333252|589119886|FG001|Overall Study|Death|3|||
163112537|NCT03333252|589119887|FG002|Overall Study|Death|0|||
163112538|NCT03333252|589119888|FG003|Overall Study|Death|0|||
163112539|NCT03333252|589119885|FG000|Overall Study|Lack of Efficacy|8|||
163112540|NCT03333252|589119886|FG001|Overall Study|Lack of Efficacy|4|||
163112541|NCT03333252|589119887|FG002|Overall Study|Lack of Efficacy|0|||
163112542|NCT03333252|589119888|FG003|Overall Study|Lack of Efficacy|7|||
163112543|NCT03333252|589119885|FG000|Overall Study|Lost to Follow-up|0|||
163112544|NCT03333252|589119886|FG001|Overall Study|Lost to Follow-up|5|||
163112545|NCT03333252|589119887|FG002|Overall Study|Lost to Follow-up|9|||
163112546|NCT03333252|589119888|FG003|Overall Study|Lost to Follow-up|3|||
163112547|NCT03333252|589119885|FG000|Overall Study|Withdrawal by Subject|14|||
163112548|NCT03333252|589119886|FG001|Overall Study|Withdrawal by Subject|24|||
163112549|NCT03333252|589119887|FG002|Overall Study|Withdrawal by Subject|11|||
163112550|NCT03333252|589119888|FG003|Overall Study|Withdrawal by Subject|17|||
163112551|NCT00939029|589119889|FG000|Overall Study|Withdrawal by Subject|3|||
163112552|NCT00939029|589119890|FG001|Overall Study|Withdrawal by Subject|7|||
163112553|NCT00939029|589119889|FG000|Overall Study|Lost to Follow-up|3|||
163112554|NCT00939029|589119890|FG001|Overall Study|Lost to Follow-up|4|||
163112555|NCT00939029|589119889|FG000|Overall Study|Adverse Event|0|||
163112556|NCT00939029|589119890|FG001|Overall Study|Adverse Event|1|||
163112557|NCT04686084|589119891|FG000|Overall Study|Lost to Follow-up|1|||
163112558|NCT01779856|589119892|FG000|Overall Study|Withdrawal by Subject|15|||
163112559|NCT01779856|589119892|FG000|Overall Study|Death|3|||
163112560|NCT01779856|589119892|FG000|Overall Study|Physician Decision|1|||
163112561|NCT01779856|589119892|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
163112562|NCT01779856|589119892|FG000|Overall Study|Delays in scheduling implant|1|||
163112563|NCT01779856|589119892|FG000|Overall Study|Subject ineligible for Implant|2|||
163112564|NCT01425359|589119897|FG000|Overall Study|Randomized but Not Treated|2|||
163112565|NCT01425359|589119898|FG001|Overall Study|Randomized but Not Treated|3|||
163112566|NCT01425359|589119897|FG000|Overall Study|Adverse Event|9|||
163112567|NCT01425359|589119898|FG001|Overall Study|Adverse Event|8|||
163112568|NCT01425359|589119897|FG000|Overall Study|Revascularization|0|||
163112569|NCT01425359|589119898|FG001|Overall Study|Revascularization|1|||
163112570|NCT01425359|589119897|FG000|Overall Study|Death|0|||
163112571|NCT01425359|589119898|FG001|Overall Study|Death|1|||
163112572|NCT01425359|589119897|FG000|Overall Study|Unsatisfactory Response|1|||
163112573|NCT01425359|589119898|FG001|Overall Study|Unsatisfactory Response|0|||
163112574|NCT01425359|589119897|FG000|Overall Study|Protocol Violation|1|||
163112575|NCT01425359|589119898|FG001|Overall Study|Protocol Violation|2|||
163112576|NCT01425359|589119897|FG000|Overall Study|Subject Withdrew Consent|1|||
163112577|NCT01425359|589119898|FG001|Overall Study|Subject Withdrew Consent|2|||
163112578|NCT01425359|589119897|FG000|Overall Study|Investigator's Discretion|2|||
163112579|NCT01425359|589119898|FG001|Overall Study|Investigator's Discretion|0|||
163112580|NCT01425359|589119897|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
163112581|NCT01425359|589119898|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
163112582|NCT03960580|589119899|FG000|Overall Study|Adverse Event|2|||
163112583|NCT03960580|589119900|FG001|Overall Study|Adverse Event|1|||
163112584|NCT03960580|589119901|FG002|Overall Study|Adverse Event|1|||
163112585|NCT03960580|589119899|FG000|Overall Study|Lost to Follow-up|1|||
163112586|NCT03960580|589119900|FG001|Overall Study|Lost to Follow-up|0|||
163112587|NCT03960580|589119901|FG002|Overall Study|Lost to Follow-up|0|||
163112588|NCT03960580|589119899|FG000|Overall Study|Lack of Efficacy|2|||
163112589|NCT03960580|589119900|FG001|Overall Study|Lack of Efficacy|1|||
163112590|NCT03960580|589119901|FG002|Overall Study|Lack of Efficacy|0|||
163112591|NCT03960580|589119899|FG000|Overall Study|Protocol Violation|0|||
163112592|NCT03960580|589119900|FG001|Overall Study|Protocol Violation|0|||
163112593|NCT03960580|589119901|FG002|Overall Study|Protocol Violation|1|||
163112594|NCT03960580|589119899|FG000|Overall Study|Withdrawal by Subject|1|||
163112595|NCT03960580|589119900|FG001|Overall Study|Withdrawal by Subject|1|||
163112596|NCT03960580|589119901|FG002|Overall Study|Withdrawal by Subject|1|||
163112597|NCT03960580|589119899|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
163112598|NCT03960580|589119900|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
163112599|NCT03960580|589119901|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
163112600|NCT02135029|589119909|FG000|Overall Study|Adverse Event|2|||
163112601|NCT02135029|589119910|FG001|Overall Study|Adverse Event|2|||
163112602|NCT02135029|589119911|FG002|Overall Study|Adverse Event|2|||
163112603|NCT02135029|589119909|FG000|Overall Study|Lost to Follow-up|0|||
163112604|NCT02135029|589119910|FG001|Overall Study|Lost to Follow-up|1|||
163112605|NCT02135029|589119911|FG002|Overall Study|Lost to Follow-up|0|||
163112606|NCT02135029|589119909|FG000|Overall Study|Withdrawal by Subject|2|||
163112607|NCT02135029|589119910|FG001|Overall Study|Withdrawal by Subject|0|||
163112608|NCT02135029|589119911|FG002|Overall Study|Withdrawal by Subject|1|||
163112609|NCT02135029|589119909|FG000|Overall Study|Other|0|||
163112610|NCT02135029|589119910|FG001|Overall Study|Other|1|||
162719330|NCT04439799|587678481|FG001|Overall Study|Adverse Event|5|||
162719331|NCT00371566|587678482|FG000|Treatment Phase|Withdrawal by Subject|0|||
163112611|NCT02135029|589119911|FG002|Overall Study|Other|0|||
163112612|NCT02135029|589119909|FG000|Overall Study|Death|0|||
163112613|NCT02135029|589119910|FG001|Overall Study|Death|1|||
163112614|NCT02135029|589119911|FG002|Overall Study|Death|0|||
163112615|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Physician Decision|1|||
163112616|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Physician Decision|0|||
163112617|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Physician Decision|0|||
163112618|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
163112619|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
163112620|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
163112621|NCT00385944|589119917|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
163112622|NCT00385944|589119918|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
163112623|NCT00385944|589119919|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
163112624|NCT00385944|589119917|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
163112625|NCT00385944|589119918|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
163112626|NCT00385944|589119919|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
163112627|NCT03832322|589119921|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
163112628|NCT03832322|589119922|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
163112629|NCT01694121|589119924|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
163112630|NCT01694121|589119925|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
163112631|NCT00521599|589119926|FG000|Overall Study|Adverse Event|5|||
163112632|NCT00521599|589119927|FG001|Overall Study|Adverse Event|7|||
163112633|NCT00521599|589119928|FG002|Overall Study|Adverse Event|6|||
163112634|NCT00521599|589119926|FG000|Overall Study|Treatment Failure|8|||
163112635|NCT00521599|589119927|FG001|Overall Study|Treatment Failure|9|||
163112636|NCT00521599|589119928|FG002|Overall Study|Treatment Failure|22|||
163112637|NCT00521599|589119926|FG000|Overall Study|Lost to Follow-up|2|||
163112638|NCT00521599|589119927|FG001|Overall Study|Lost to Follow-up|1|||
163112639|NCT00521599|589119928|FG002|Overall Study|Lost to Follow-up|2|||
163112640|NCT00521599|589119926|FG000|Overall Study|Withdrawal by Subject|3|||
163112641|NCT00521599|589119927|FG001|Overall Study|Withdrawal by Subject|5|||
163112642|NCT00521599|589119928|FG002|Overall Study|Withdrawal by Subject|1|||
163112643|NCT00521599|589119926|FG000|Overall Study|Withdrawal by subject treatment related|3|||
163112644|NCT00521599|589119927|FG001|Overall Study|Withdrawal by subject treatment related|1|||
163112645|NCT00521599|589119928|FG002|Overall Study|Withdrawal by subject treatment related|2|||
163112646|NCT00521599|589119926|FG000|Overall Study|Protocol Violation|2|||
163112647|NCT00521599|589119927|FG001|Overall Study|Protocol Violation|4|||
163112648|NCT00521599|589119928|FG002|Overall Study|Protocol Violation|2|||
163112649|NCT00521599|589119926|FG000|Overall Study|Did not meet protocol eligibility|2|||
163112650|NCT00521599|589119927|FG001|Overall Study|Did not meet protocol eligibility|2|||
163112651|NCT00521599|589119928|FG002|Overall Study|Did not meet protocol eligibility|1|||
163112652|NCT01778049|589119932|FG000|Open Label Treatment Period|Adverse Event|5|||
163112653|NCT01778049|589119933|FG001|Open Label Treatment Period|Adverse Event|15|||
163112654|NCT01778049|589119934|FG002|Open Label Treatment Period|Adverse Event|0|||
163112655|NCT01778049|589119935|FG003|Open Label Treatment Period|Adverse Event|0|||
163112656|NCT01778049|589119936|FG004|Open Label Treatment Period|Adverse Event|0|||
163112657|NCT01778049|589119937|FG005|Open Label Treatment Period|Adverse Event|0|||
163112658|NCT01778049|589119932|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
163112659|NCT01778049|589119933|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
163112660|NCT01778049|589119934|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
163112661|NCT01778049|589119935|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
163112662|NCT01778049|589119936|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
163112663|NCT01778049|589119937|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
163112664|NCT01778049|589119932|FG000|Open Label Treatment Period|Protocol Violation|5|||
163112665|NCT01778049|589119933|FG001|Open Label Treatment Period|Protocol Violation|5|||
163112666|NCT01778049|589119934|FG002|Open Label Treatment Period|Protocol Violation|0|||
163112667|NCT01778049|589119935|FG003|Open Label Treatment Period|Protocol Violation|0|||
163112668|NCT01778049|589119936|FG004|Open Label Treatment Period|Protocol Violation|0|||
163112669|NCT01778049|589119937|FG005|Open Label Treatment Period|Protocol Violation|0|||
163112670|NCT01778049|589119932|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
163112671|NCT01778049|589119933|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
163112672|NCT01778049|589119934|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
163112673|NCT01778049|589119935|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
163112674|NCT01778049|589119936|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
163112675|NCT01778049|589119937|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
163112676|NCT01778049|589119932|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
163112677|NCT01778049|589119933|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
163112678|NCT01778049|589119934|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
163112679|NCT01778049|589119935|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
163112680|NCT01778049|589119936|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
162653999|NCT02552316|587449658|FG000|Overall Study|Withdrawal by Subject|1|||
163112681|NCT01778049|589119937|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
163112682|NCT01778049|589119932|FG000|Open Label Treatment Period|Not treated|2|||
163112683|NCT01778049|589119933|FG001|Open Label Treatment Period|Not treated|1|||
163112684|NCT01778049|589119934|FG002|Open Label Treatment Period|Not treated|0|||
163112685|NCT01778049|589119935|FG003|Open Label Treatment Period|Not treated|0|||
163112686|NCT01778049|589119936|FG004|Open Label Treatment Period|Not treated|0|||
163112687|NCT01778049|589119937|FG005|Open Label Treatment Period|Not treated|0|||
163112688|NCT01778049|589119932|FG000|Open Label Treatment Period|Other reason not defined above|77|||
163112689|NCT01778049|589119933|FG001|Open Label Treatment Period|Other reason not defined above|94|||
163112690|NCT01778049|589119934|FG002|Open Label Treatment Period|Other reason not defined above|0|||
163112691|NCT01778049|589119935|FG003|Open Label Treatment Period|Other reason not defined above|0|||
163112692|NCT01778049|589119936|FG004|Open Label Treatment Period|Other reason not defined above|0|||
163112693|NCT01778049|589119937|FG005|Open Label Treatment Period|Other reason not defined above|0|||
163112694|NCT01778049|589119932|FG000|Double Blind Treatment Period|Adverse Event|0|||
163112695|NCT01778049|589119933|FG001|Double Blind Treatment Period|Adverse Event|0|||
163112696|NCT01778049|589119934|FG002|Double Blind Treatment Period|Adverse Event|4|||
163112697|NCT01778049|589119935|FG003|Double Blind Treatment Period|Adverse Event|5|||
163112698|NCT01778049|589119936|FG004|Double Blind Treatment Period|Adverse Event|3|||
163112699|NCT01778049|589119937|FG005|Double Blind Treatment Period|Adverse Event|2|||
163112700|NCT01778049|589119932|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
163112701|NCT01778049|589119933|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163112702|NCT01778049|589119934|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163112703|NCT01778049|589119935|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
163112704|NCT01778049|589119936|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163112705|NCT01778049|589119937|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
163112706|NCT01778049|589119932|FG000|Double Blind Treatment Period|Protocol Violation|0|||
163112707|NCT01778049|589119933|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163112708|NCT01778049|589119934|FG002|Double Blind Treatment Period|Protocol Violation|2|||
163112709|NCT01778049|589119935|FG003|Double Blind Treatment Period|Protocol Violation|0|||
163112710|NCT01778049|589119936|FG004|Double Blind Treatment Period|Protocol Violation|0|||
163112711|NCT01778049|589119937|FG005|Double Blind Treatment Period|Protocol Violation|0|||
163112712|NCT01778049|589119932|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
163112713|NCT01778049|589119933|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
163112714|NCT01778049|589119934|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
163112715|NCT01778049|589119935|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
163112716|NCT01778049|589119936|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
163112717|NCT01778049|589119937|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
163112718|NCT01778049|589119932|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112719|NCT01778049|589119933|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112720|NCT01778049|589119934|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
163112721|NCT01778049|589119935|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
163112722|NCT01778049|589119936|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163112723|NCT01778049|589119937|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
163112724|NCT01778049|589119932|FG000|Double Blind Treatment Period|Not treated|0|||
163112725|NCT01778049|589119933|FG001|Double Blind Treatment Period|Not treated|0|||
163112726|NCT01778049|589119934|FG002|Double Blind Treatment Period|Not treated|0|||
163112727|NCT01778049|589119935|FG003|Double Blind Treatment Period|Not treated|2|||
163112728|NCT01778049|589119936|FG004|Double Blind Treatment Period|Not treated|2|||
163112729|NCT01778049|589119937|FG005|Double Blind Treatment Period|Not treated|0|||
163112730|NCT01778049|589119932|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
163112731|NCT01778049|589119933|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
163112732|NCT01778049|589119934|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
163112733|NCT01778049|589119935|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
163112734|NCT01778049|589119936|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
163112735|NCT01778049|589119937|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
163112736|NCT02186652|589119938|FG000|Overall Study|Lost to Follow-up|2|||
163112737|NCT02186652|589119939|FG001|Overall Study|Lost to Follow-up|0|||
163112738|NCT00503776|589119943|FG000|Overall Study|Withdrawal by Subject|1|||
163112739|NCT00503776|589119944|FG001|Overall Study|Withdrawal by Subject|0|||
163112740|NCT00503776|589119945|FG002|Overall Study|Withdrawal by Subject|1|||
163112741|NCT00503776|589119946|FG003|Overall Study|Withdrawal by Subject|1|||
163112742|NCT00503776|589119943|FG000|Overall Study|Physician Decision|0|||
163112743|NCT00503776|589119944|FG001|Overall Study|Physician Decision|0|||
163112744|NCT00503776|589119945|FG002|Overall Study|Physician Decision|1|||
163112745|NCT00503776|589119946|FG003|Overall Study|Physician Decision|1|||
163112746|NCT00107315|589119947|FG000|Overall Study|Disease Progression|9|||
163112747|NCT00107315|589119947|FG000|Overall Study|Adverse Event|4|||
163112748|NCT00107315|589119947|FG000|Overall Study|Withdrawal by Subject|2|||
163112749|NCT02509039|589119952|FG000|Overall Study|Adverse Event|0|||
163112750|NCT02509039|589119953|FG001|Overall Study|Adverse Event|1|||
163112751|NCT02509039|589119954|FG002|Overall Study|Adverse Event|1|||
163112752|NCT02509039|589119955|FG003|Overall Study|Adverse Event|1|||
163112753|NCT02509039|589119952|FG000|Overall Study|Withdrawal by Subject|0|||
163112754|NCT02509039|589119953|FG001|Overall Study|Withdrawal by Subject|0|||
163112755|NCT02509039|589119954|FG002|Overall Study|Withdrawal by Subject|1|||
163112756|NCT02509039|589119955|FG003|Overall Study|Withdrawal by Subject|0|||
163112757|NCT02509039|589119952|FG000|Overall Study|Progressive disease|2|||
163112758|NCT02509039|589119953|FG001|Overall Study|Progressive disease|2|||
163112759|NCT02509039|589119954|FG002|Overall Study|Progressive disease|1|||
163112760|NCT02509039|589119955|FG003|Overall Study|Progressive disease|5|||
163112761|NCT02509039|589119952|FG000|Overall Study|Study terminated by Sponsor|1|||
163112762|NCT02509039|589119953|FG001|Overall Study|Study terminated by Sponsor|0|||
163112763|NCT02509039|589119954|FG002|Overall Study|Study terminated by Sponsor|0|||
163112764|NCT02509039|589119955|FG003|Overall Study|Study terminated by Sponsor|0|||
163112765|NCT03359785|589119956|FG000|Overall Study|Protocol Violation|0|||
163112766|NCT03359785|589119957|FG001|Overall Study|Protocol Violation|1|||
163112767|NCT03359785|589119958|FG002|Overall Study|Protocol Violation|0|||
163112768|NCT03359785|589119959|FG003|Overall Study|Protocol Violation|0|||
163112769|NCT03359785|589119956|FG000|Overall Study|Early study termination due to study pause|0|||
163112770|NCT03359785|589119957|FG001|Overall Study|Early study termination due to study pause|0|||
163112771|NCT03359785|589119958|FG002|Overall Study|Early study termination due to study pause|2|||
163112772|NCT03359785|589119959|FG003|Overall Study|Early study termination due to study pause|0|||
163112773|NCT03359785|589119956|FG000|Overall Study|Withdrawal by Subject|2|||
163112774|NCT03359785|589119957|FG001|Overall Study|Withdrawal by Subject|2|||
163112775|NCT03359785|589119958|FG002|Overall Study|Withdrawal by Subject|0|||
163112776|NCT03359785|589119959|FG003|Overall Study|Withdrawal by Subject|0|||
163112777|NCT03276026|589119963|FG000|Overall Study|Protocol Violation|1|||
163112778|NCT03276026|589119964|FG001|Overall Study|Protocol Violation|0|||
163112779|NCT03650803|589119965|FG000|Overall Study|Lost to Follow-up|6|||
163112780|NCT00367744|589119966|FG000|Overall Study|Lost to Follow-up|4|||
163112781|NCT00367744|589119967|FG001|Overall Study|Lost to Follow-up|5|||
163112782|NCT03664674|589119969|FG000|Overall Study|Adverse Event|1|||
163112783|NCT03664674|589119970|FG001|Overall Study|Adverse Event|1|||
163112784|NCT03664674|589119969|FG000|Overall Study|Physician Decision|0|||
163112785|NCT03664674|589119970|FG001|Overall Study|Physician Decision|1|||
163112786|NCT03664674|589119969|FG000|Overall Study|Withdrawal by Subject|2|||
163112787|NCT03664674|589119970|FG001|Overall Study|Withdrawal by Subject|0|||
163112788|NCT04584346|589119976|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
163112789|NCT04584346|589119977|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
163112790|NCT03894969|589119986|FG000|Overall Study|Adverse Event|0|||
163112791|NCT03894969|589119987|FG001|Overall Study|Adverse Event|2|||
163112792|NCT03894969|589119988|FG002|Overall Study|Adverse Event|0|||
163112793|NCT03894969|589119989|FG003|Overall Study|Adverse Event|1|||
163112794|NCT03894969|589119990|FG004|Overall Study|Adverse Event|2|||
163112795|NCT03894969|589119986|FG000|Overall Study|Lost to Follow-up|3|||
163112796|NCT03894969|589119987|FG001|Overall Study|Lost to Follow-up|1|||
163112797|NCT03894969|589119988|FG002|Overall Study|Lost to Follow-up|1|||
163112798|NCT03894969|589119989|FG003|Overall Study|Lost to Follow-up|0|||
163112799|NCT03894969|589119990|FG004|Overall Study|Lost to Follow-up|0|||
163112800|NCT03894969|589119986|FG000|Overall Study|Withdrawal by Subject|2|||
163112801|NCT03894969|589119987|FG001|Overall Study|Withdrawal by Subject|1|||
163112802|NCT03894969|589119988|FG002|Overall Study|Withdrawal by Subject|3|||
163112803|NCT03894969|589119989|FG003|Overall Study|Withdrawal by Subject|4|||
163112804|NCT03894969|589119990|FG004|Overall Study|Withdrawal by Subject|8|||
163112805|NCT03894969|589119986|FG000|Overall Study|Other|0|||
163112806|NCT03894969|589119987|FG001|Overall Study|Other|0|||
163112807|NCT03894969|589119988|FG002|Overall Study|Other|0|||
163112808|NCT03894969|589119989|FG003|Overall Study|Other|0|||
163112809|NCT03894969|589119990|FG004|Overall Study|Other|3|||
163112810|NCT03894969|589119986|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112811|NCT03894969|589119987|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112812|NCT03894969|589119988|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
163112813|NCT03894969|589119989|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
163112814|NCT03894969|589119990|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
163112815|NCT03894969|589119986|FG000|Overall Study|Solicited Adverse Event|0|||
163112816|NCT03894969|589119987|FG001|Overall Study|Solicited Adverse Event|1|||
163112817|NCT03894969|589119988|FG002|Overall Study|Solicited Adverse Event|0|||
163112818|NCT03894969|589119989|FG003|Overall Study|Solicited Adverse Event|0|||
163112819|NCT03894969|589119990|FG004|Overall Study|Solicited Adverse Event|0|||
163112820|NCT06107803|589119991|FG000|Overall Study|Adverse Event|1|||
163112821|NCT06107803|589119991|FG000|Overall Study|Withdrawal by Subject|2|||
163112822|NCT06107803|589119991|FG000|Overall Study|Protocol Violation|1|||
163112823|NCT03099174|589119992|FG000|Overall Study|Withdrawal by Subject|0|||
163112824|NCT03099174|589119993|FG001|Overall Study|Withdrawal by Subject|0|||
163112825|NCT03099174|589119994|FG002|Overall Study|Withdrawal by Subject|1|||
163112826|NCT03099174|589119995|FG003|Overall Study|Withdrawal by Subject|0|||
163112827|NCT03099174|589119996|FG004|Overall Study|Withdrawal by Subject|2|||
163112828|NCT03099174|589119997|FG005|Overall Study|Withdrawal by Subject|2|||
163112829|NCT03099174|589119998|FG006|Overall Study|Withdrawal by Subject|1|||
163112830|NCT03099174|589119999|FG007|Overall Study|Withdrawal by Subject|4|||
163112831|NCT03099174|589119992|FG000|Overall Study|Adverse Event|0|||
163112832|NCT03099174|589119993|FG001|Overall Study|Adverse Event|1|||
162654000|NCT02552316|587449658|FG000|Overall Study|Withdrawal due to non-compliance|1|||
162654001|NCT04382911|587449659|FG000|Overall Study|unable to be imaged prior to surgery|2|||
162654002|NCT04116710|587449663|FG000|Overall Study|Death|4|||
162654003|NCT04116710|587449664|FG001|Overall Study|Death|6|||
162654004|NCT04116710|587449665|FG002|Overall Study|Death|3|||
162654005|NCT04116710|587449666|FG003|Overall Study|Death|1|||
163112833|NCT03099174|589119994|FG002|Overall Study|Adverse Event|1|||
163112834|NCT03099174|589119995|FG003|Overall Study|Adverse Event|2|||
163112835|NCT03099174|589119996|FG004|Overall Study|Adverse Event|5|||
163112836|NCT03099174|589119997|FG005|Overall Study|Adverse Event|3|||
163112837|NCT03099174|589119998|FG006|Overall Study|Adverse Event|6|||
163112838|NCT03099174|589119999|FG007|Overall Study|Adverse Event|4|||
163112839|NCT03099174|589119992|FG000|Overall Study|Other than listed|6|||
163112840|NCT03099174|589119993|FG001|Overall Study|Other than listed|6|||
163112841|NCT03099174|589119994|FG002|Overall Study|Other than listed|5|||
163112842|NCT03099174|589119995|FG003|Overall Study|Other than listed|6|||
163112843|NCT03099174|589119996|FG004|Overall Study|Other than listed|19|||
163112844|NCT03099174|589119997|FG005|Overall Study|Other than listed|10|||
163112845|NCT03099174|589119998|FG006|Overall Study|Other than listed|26|||
163112846|NCT03099174|589119999|FG007|Overall Study|Other than listed|23|||
163112847|NCT04173260|589120000|FG000|Overall Study|Early termination|4|||
163112848|NCT04730635|589120001|FG000|Overall Study|Lost to Follow-up|1|||
163112849|NCT04730635|589120002|FG001|Overall Study|Lost to Follow-up|0|||
163112850|NCT04730635|589120001|FG000|Overall Study|Withdrawal by Subject|0|||
163112851|NCT04730635|589120002|FG001|Overall Study|Withdrawal by Subject|1|||
163112852|NCT03070223|589120005|FG000|Overall Study|Lost to Follow-up|34|||
163112853|NCT03070223|589120006|FG001|Overall Study|Lost to Follow-up|27|||
163112854|NCT03070223|589120005|FG000|Overall Study|Withdrawal by Subject|12|||
163112855|NCT03070223|589120006|FG001|Overall Study|Withdrawal by Subject|22|||
163112856|NCT03070223|589120005|FG000|Overall Study|Protocol Violation|0|||
163112857|NCT03070223|589120006|FG001|Overall Study|Protocol Violation|1|||
163112858|NCT02308163|589120007|FG000|Overall Study|Not fulfill eligible criteria|1|||
163112859|NCT02308163|589120008|FG001|Overall Study|Not fulfill eligible criteria|2|||
163112860|NCT02308163|589120009|FG002|Overall Study|Not fulfill eligible criteria|0|||
163112861|NCT02308163|589120010|FG003|Overall Study|Not fulfill eligible criteria|1|||
163112862|NCT02308163|589120011|FG004|Overall Study|Not fulfill eligible criteria|1|||
163112863|NCT02308163|589120007|FG000|Overall Study|Adverse Event|9|||
163112864|NCT02308163|589120008|FG001|Overall Study|Adverse Event|5|||
163112865|NCT02308163|589120009|FG002|Overall Study|Adverse Event|2|||
163112866|NCT02308163|589120010|FG003|Overall Study|Adverse Event|2|||
163112867|NCT02308163|589120011|FG004|Overall Study|Adverse Event|11|||
163112868|NCT02308163|589120007|FG000|Overall Study|Lack of Efficacy|11|||
163112869|NCT02308163|589120008|FG001|Overall Study|Lack of Efficacy|3|||
163112870|NCT02308163|589120009|FG002|Overall Study|Lack of Efficacy|8|||
163112871|NCT02308163|589120010|FG003|Overall Study|Lack of Efficacy|4|||
163112872|NCT02308163|589120011|FG004|Overall Study|Lack of Efficacy|6|||
163112873|NCT02308163|589120007|FG000|Overall Study|Withdrawal of consent|2|||
163112874|NCT02308163|589120008|FG001|Overall Study|Withdrawal of consent|3|||
163112875|NCT02308163|589120009|FG002|Overall Study|Withdrawal of consent|0|||
163112876|NCT02308163|589120010|FG003|Overall Study|Withdrawal of consent|2|||
163112877|NCT02308163|589120011|FG004|Overall Study|Withdrawal of consent|6|||
163112878|NCT02308163|589120007|FG000|Overall Study|Protocol Violation|3|||
163112879|NCT02308163|589120008|FG001|Overall Study|Protocol Violation|3|||
163112880|NCT02308163|589120009|FG002|Overall Study|Protocol Violation|3|||
163112881|NCT02308163|589120010|FG003|Overall Study|Protocol Violation|2|||
163112882|NCT02308163|589120011|FG004|Overall Study|Protocol Violation|5|||
163112883|NCT02308163|589120007|FG000|Overall Study|Lab data met discontinuation criteria|3|||
163112884|NCT02308163|589120008|FG001|Overall Study|Lab data met discontinuation criteria|0|||
163112885|NCT02308163|589120009|FG002|Overall Study|Lab data met discontinuation criteria|0|||
162654006|NCT04116710|587449663|FG000|Overall Study|Withdrawal by Subject|0|||
162654007|NCT04116710|587449664|FG001|Overall Study|Withdrawal by Subject|0|||
163112886|NCT02308163|589120010|FG003|Overall Study|Lab data met discontinuation criteria|2|||
163112887|NCT02308163|589120011|FG004|Overall Study|Lab data met discontinuation criteria|0|||
163112888|NCT02308163|589120007|FG000|Overall Study|Miscellaneous|2|||
163112889|NCT02308163|589120008|FG001|Overall Study|Miscellaneous|2|||
163112890|NCT02308163|589120009|FG002|Overall Study|Miscellaneous|1|||
163112891|NCT02308163|589120010|FG003|Overall Study|Miscellaneous|0|||
163112892|NCT02308163|589120011|FG004|Overall Study|Miscellaneous|5|||
163112893|NCT03219034|589120017|FG000|Overall Study|Lost to Follow-up|9|||
163112894|NCT03219034|589120018|FG001|Overall Study|Lost to Follow-up|13|||
163112895|NCT03219034|589120017|FG000|Overall Study|Additional dental work needed|1|||
163112896|NCT03219034|589120018|FG001|Overall Study|Additional dental work needed|0|||
163112897|NCT03219034|589120017|FG000|Overall Study|UPPP Surgery|1|||
163112898|NCT03219034|589120018|FG001|Overall Study|UPPP Surgery|0|||
163112899|NCT03219034|589120017|FG000|Overall Study|Dental sensitivity|0|||
162654008|NCT04116710|587449665|FG002|Overall Study|Withdrawal by Subject|0|||
162654009|NCT04116710|587449666|FG003|Overall Study|Withdrawal by Subject|1|||
163112900|NCT03219034|589120018|FG001|Overall Study|Dental sensitivity|1|||
163112901|NCT03219034|589120017|FG000|Overall Study|Death in family|0|||
163112902|NCT03219034|589120018|FG001|Overall Study|Death in family|1|||
163112903|NCT00118846|589120019|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
163112904|NCT00118846|589120020|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
163112905|NCT00118846|589120019|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
163112906|NCT00118846|589120020|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
163112907|NCT00118846|589120019|FG000|Overall Study|Physician Decision|1|||
163112908|NCT00118846|589120020|FG001|Overall Study|Physician Decision|0|||
163112909|NCT00118846|589120019|FG000|Overall Study|Medical condition|2|||
163112910|NCT00118846|589120020|FG001|Overall Study|Medical condition|2|||
163112911|NCT00118846|589120019|FG000|Overall Study|Lost to Follow-up|0|||
163112912|NCT00118846|589120020|FG001|Overall Study|Lost to Follow-up|2|||
163112913|NCT00118846|589120019|FG000|Overall Study|Personal reason|4|||
163112914|NCT00118846|589120020|FG001|Overall Study|Personal reason|5|||
163112915|NCT00443053|589120022|FG000|Overall Study|Adverse Event|2|||
163112916|NCT00443053|589120023|FG001|Overall Study|Adverse Event|1|||
163112917|NCT00443053|589120022|FG000|Overall Study|Withdrawal by Subject|9|||
163112918|NCT00443053|589120023|FG001|Overall Study|Withdrawal by Subject|18|||
163112919|NCT00443053|589120022|FG000|Overall Study|Lost to Follow-up|4|||
163112920|NCT00443053|589120023|FG001|Overall Study|Lost to Follow-up|5|||
163112921|NCT00443053|589120022|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163112922|NCT00443053|589120023|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
163112923|NCT00443053|589120022|FG000|Overall Study|Noncompliance|2|||
163112924|NCT00443053|589120023|FG001|Overall Study|Noncompliance|1|||
163112925|NCT00443053|589120022|FG000|Overall Study|Other|3|||
163112926|NCT00443053|589120023|FG001|Overall Study|Other|4|||
163112927|NCT00443053|589120022|FG000|Overall Study|Physician Decision|0|||
163112928|NCT00443053|589120023|FG001|Overall Study|Physician Decision|4|||
163112929|NCT00541866|589120024|FG000|Overall Study|Adverse Event|3|||
163112930|NCT00541866|589120025|FG001|Overall Study|Adverse Event|0|||
163112931|NCT00541866|589120026|FG002|Overall Study|Adverse Event|0|||
163112932|NCT00541866|589120027|FG003|Overall Study|Adverse Event|0|||
163112933|NCT00541866|589120028|FG004|Overall Study|Adverse Event|0|||
163112934|NCT00541866|589120024|FG000|Overall Study|Death|1|||
163112935|NCT00541866|589120025|FG001|Overall Study|Death|0|||
163112936|NCT00541866|589120026|FG002|Overall Study|Death|0|||
163112937|NCT00541866|589120027|FG003|Overall Study|Death|0|||
163112938|NCT00541866|589120028|FG004|Overall Study|Death|0|||
163112939|NCT00541866|589120024|FG000|Overall Study|Lack of Efficacy|19|||
163112940|NCT00541866|589120025|FG001|Overall Study|Lack of Efficacy|15|||
163112941|NCT00541866|589120026|FG002|Overall Study|Lack of Efficacy|10|||
163112942|NCT00541866|589120027|FG003|Overall Study|Lack of Efficacy|12|||
163112943|NCT00541866|589120028|FG004|Overall Study|Lack of Efficacy|14|||
163112944|NCT00541866|589120024|FG000|Overall Study|Not Reported or Other|11|||
163112945|NCT00541866|589120025|FG001|Overall Study|Not Reported or Other|3|||
163112946|NCT00541866|589120026|FG002|Overall Study|Not Reported or Other|3|||
163112947|NCT00541866|589120027|FG003|Overall Study|Not Reported or Other|3|||
163112948|NCT00541866|589120028|FG004|Overall Study|Not Reported or Other|1|||
163112949|NCT00541866|589120024|FG000|Overall Study|Physician Decision|0|||
163112950|NCT00541866|589120025|FG001|Overall Study|Physician Decision|0|||
163112951|NCT00541866|589120026|FG002|Overall Study|Physician Decision|2|||
163112952|NCT00541866|589120027|FG003|Overall Study|Physician Decision|1|||
163112953|NCT00541866|589120028|FG004|Overall Study|Physician Decision|0|||
163112954|NCT00578877|589120032|FG000|Overall Study|Lost to Follow-up|8|||
163112955|NCT00578877|589120033|FG001|Overall Study|Lost to Follow-up|10|||
163112956|NCT00578877|589120032|FG000|Overall Study|early discontinue|61|||
163112957|NCT00578877|589120033|FG001|Overall Study|early discontinue|101|||
163112958|NCT00578877|589120032|FG000|Overall Study|did not provide follow-up data|12|||
163112959|NCT00578877|589120033|FG001|Overall Study|did not provide follow-up data|17|||
163112960|NCT03245736|589122016|FG000|Overall Study|Adverse Event|1|||
163112961|NCT03245736|589122016|FG000|Overall Study|Progressive Disease|4|||
163112962|NCT02251717|589122024|FG000|Overall Study|Adverse Event|0|||
163112963|NCT02251717|589122025|FG001|Overall Study|Adverse Event|1|||
163112964|NCT02251717|589122024|FG000|Overall Study|Withdrew Consent|1|||
163112965|NCT02251717|589122025|FG001|Overall Study|Withdrew Consent|0|||
163112966|NCT04098367|589122026|FG000|Overall Study|Adverse Event|0|||
163112967|NCT04098367|589122027|FG001|Overall Study|Adverse Event|0|||
163112968|NCT04098367|589122028|FG002|Overall Study|Adverse Event|1|||
163112969|NCT04098367|589122026|FG000|Overall Study|Lost to Follow-up|1|||
163112970|NCT04098367|589122027|FG001|Overall Study|Lost to Follow-up|5|||
163112971|NCT04098367|589122028|FG002|Overall Study|Lost to Follow-up|2|||
163112972|NCT04098367|589122026|FG000|Overall Study|Withdrawal by Subject|0|||
163112973|NCT04098367|589122027|FG001|Overall Study|Withdrawal by Subject|0|||
163112974|NCT04098367|589122028|FG002|Overall Study|Withdrawal by Subject|1|||
163112975|NCT04098367|589122026|FG000|Overall Study|Sick . Could not attend visit|1|||
163112976|NCT04098367|589122027|FG001|Overall Study|Sick . Could not attend visit|0|||
163112977|NCT04098367|589122028|FG002|Overall Study|Sick . Could not attend visit|0|||
163112978|NCT00445939|589122032|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
163112979|NCT00445939|589122033|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
163112980|NCT00445939|589122034|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
163112981|NCT00445939|589122035|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
163112982|NCT00445939|589122032|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
163112983|NCT00445939|589122033|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
163112984|NCT00445939|589122034|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
163112985|NCT00445939|589122035|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
163112986|NCT00416715|589122036|FG000|Overall Study|Not evaluable for joint aches|7|||
163112987|NCT00416715|589122036|FG000|Overall Study|Vitamin D levels not evaluable|8|||
163112988|NCT01007435|589122049|FG000|Overall Study|Adverse Event|16|||
163112989|NCT01007435|589122050|FG001|Overall Study|Adverse Event|25|||
163112990|NCT01007435|589122051|FG002|Overall Study|Adverse Event|47|||
163112991|NCT01007435|589122052|FG003|Overall Study|Adverse Event|31|||
163112992|NCT01007435|589122049|FG000|Overall Study|Death|2|||
163112993|NCT01007435|589122050|FG001|Overall Study|Death|4|||
163112994|NCT01007435|589122051|FG002|Overall Study|Death|2|||
163112995|NCT01007435|589122052|FG003|Overall Study|Death|1|||
163112996|NCT01007435|589122049|FG000|Overall Study|Insufficient Therapeutic Response|21|||
163112997|NCT01007435|589122050|FG001|Overall Study|Insufficient Therapeutic Response|7|||
163112998|NCT01007435|589122051|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163112999|NCT01007435|589122052|FG003|Overall Study|Insufficient Therapeutic Response|9|||
163113000|NCT01007435|589122049|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
163113001|NCT01007435|589122050|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
163113002|NCT01007435|589122051|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
163113003|NCT01007435|589122052|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
163113004|NCT01007435|589122049|FG000|Overall Study|Other Protocol Violation|2|||
163113005|NCT01007435|589122050|FG001|Overall Study|Other Protocol Violation|0|||
163113006|NCT01007435|589122051|FG002|Overall Study|Other Protocol Violation|1|||
163113007|NCT01007435|589122052|FG003|Overall Study|Other Protocol Violation|0|||
163113008|NCT01007435|589122049|FG000|Overall Study|Refused Treatment|13|||
163113009|NCT01007435|589122050|FG001|Overall Study|Refused Treatment|13|||
163113010|NCT01007435|589122051|FG002|Overall Study|Refused Treatment|5|||
163113011|NCT01007435|589122052|FG003|Overall Study|Refused Treatment|8|||
163113012|NCT01007435|589122049|FG000|Overall Study|Failure to Return|5|||
163113013|NCT01007435|589122050|FG001|Overall Study|Failure to Return|4|||
163113014|NCT01007435|589122051|FG002|Overall Study|Failure to Return|3|||
163113015|NCT01007435|589122052|FG003|Overall Study|Failure to Return|6|||
163113016|NCT01007435|589122049|FG000|Overall Study|Reason not Specified|1|||
163113017|NCT01007435|589122050|FG001|Overall Study|Reason not Specified|1|||
163113018|NCT01007435|589122051|FG002|Overall Study|Reason not Specified|2|||
163113019|NCT01007435|589122052|FG003|Overall Study|Reason not Specified|1|||
163113020|NCT02576535|589122053|FG000|Overall Study|Withdrawal by Subject|2|||
163113021|NCT02545517|589122054|FG000|Overall Study|Death|2|||
163113022|NCT02545517|589122055|FG001|Overall Study|Death|2|||
163113023|NCT02545517|589122056|FG002|Overall Study|Death|1|||
163113024|NCT02545517|589122054|FG000|Overall Study|Lost to Follow-up|14|||
163113025|NCT02545517|589122055|FG001|Overall Study|Lost to Follow-up|13|||
163113026|NCT02545517|589122056|FG002|Overall Study|Lost to Follow-up|17|||
163113027|NCT02545517|589122054|FG000|Overall Study|Protocol Violation|0|||
163113028|NCT02545517|589122055|FG001|Overall Study|Protocol Violation|1|||
163113029|NCT02545517|589122056|FG002|Overall Study|Protocol Violation|1|||
163113030|NCT02545517|589122054|FG000|Overall Study|Withdrawal by Subject|5|||
163113031|NCT02545517|589122055|FG001|Overall Study|Withdrawal by Subject|8|||
163113032|NCT02545517|589122056|FG002|Overall Study|Withdrawal by Subject|9|||
163113033|NCT02545517|589122054|FG000|Overall Study|Administrative reason|5|||
163113034|NCT02545517|589122055|FG001|Overall Study|Administrative reason|6|||
163113035|NCT02545517|589122056|FG002|Overall Study|Administrative reason|10|||
163113036|NCT02545517|589122054|FG000|Overall Study|Other|2|||
163113037|NCT02545517|589122055|FG001|Overall Study|Other|4|||
163113038|NCT02545517|589122056|FG002|Overall Study|Other|3|||
163113039|NCT03334851|589122057|FG000|Overall Study|Other|0|||
163113040|NCT03334851|589122058|FG001|Overall Study|Other|0|||
163113041|NCT03334851|589122059|FG002|Overall Study|Other|0|||
163113042|NCT03334851|589122060|FG003|Overall Study|Other|0|||
163113043|NCT03334851|589122061|FG004|Overall Study|Other|0|||
163113044|NCT03334851|589122062|FG005|Overall Study|Other|0|||
163113045|NCT03334851|589122063|FG006|Overall Study|Other|0|||
163113046|NCT03334851|589122064|FG007|Overall Study|Other|1|||
163113047|NCT03334851|589122065|FG008|Overall Study|Other|0|||
163113048|NCT03334851|589122066|FG009|Overall Study|Other|0|||
163113049|NCT03334851|589122067|FG010|Overall Study|Other|0|||
163113050|NCT03334851|589122068|FG011|Overall Study|Other|0|||
163113051|NCT03334851|589122069|FG012|Overall Study|Other|0|||
163113052|NCT03334851|589122057|FG000|Overall Study|Adverse Event|0|||
163113053|NCT03334851|589122058|FG001|Overall Study|Adverse Event|0|||
163113054|NCT03334851|589122059|FG002|Overall Study|Adverse Event|0|||
163113055|NCT03334851|589122060|FG003|Overall Study|Adverse Event|0|||
163113056|NCT03334851|589122061|FG004|Overall Study|Adverse Event|0|||
163113057|NCT03334851|589122062|FG005|Overall Study|Adverse Event|0|||
163113058|NCT03334851|589122063|FG006|Overall Study|Adverse Event|0|||
163113059|NCT03334851|589122064|FG007|Overall Study|Adverse Event|1|||
163113060|NCT03334851|589122065|FG008|Overall Study|Adverse Event|0|||
163113061|NCT03334851|589122066|FG009|Overall Study|Adverse Event|0|||
163113062|NCT03334851|589122067|FG010|Overall Study|Adverse Event|0|||
163113063|NCT03334851|589122068|FG011|Overall Study|Adverse Event|0|||
163113064|NCT03334851|589122069|FG012|Overall Study|Adverse Event|0|||
163113065|NCT03334851|589122057|FG000|Overall Study|Withdrawal by Subject|0|||
163113066|NCT03334851|589122058|FG001|Overall Study|Withdrawal by Subject|0|||
163113067|NCT03334851|589122059|FG002|Overall Study|Withdrawal by Subject|0|||
163113068|NCT03334851|589122060|FG003|Overall Study|Withdrawal by Subject|0|||
163113069|NCT03334851|589122061|FG004|Overall Study|Withdrawal by Subject|0|||
163113070|NCT03334851|589122062|FG005|Overall Study|Withdrawal by Subject|0|||
163113071|NCT03334851|589122063|FG006|Overall Study|Withdrawal by Subject|0|||
163113072|NCT03334851|589122064|FG007|Overall Study|Withdrawal by Subject|0|||
163113073|NCT03334851|589122065|FG008|Overall Study|Withdrawal by Subject|0|||
163113074|NCT03334851|589122066|FG009|Overall Study|Withdrawal by Subject|0|||
163113075|NCT03334851|589122067|FG010|Overall Study|Withdrawal by Subject|1|||
163113076|NCT03334851|589122068|FG011|Overall Study|Withdrawal by Subject|0|||
163113077|NCT03334851|589122069|FG012|Overall Study|Withdrawal by Subject|1|||
163113078|NCT03334851|589122057|FG000|Overall Study|Lost to Follow-up|0|||
163113079|NCT03334851|589122058|FG001|Overall Study|Lost to Follow-up|0|||
163113080|NCT03334851|589122059|FG002|Overall Study|Lost to Follow-up|0|||
163113081|NCT03334851|589122060|FG003|Overall Study|Lost to Follow-up|0|||
163113082|NCT03334851|589122061|FG004|Overall Study|Lost to Follow-up|0|||
163113083|NCT03334851|589122062|FG005|Overall Study|Lost to Follow-up|0|||
163113084|NCT03334851|589122063|FG006|Overall Study|Lost to Follow-up|0|||
163113085|NCT03334851|589122064|FG007|Overall Study|Lost to Follow-up|0|||
163113086|NCT03334851|589122065|FG008|Overall Study|Lost to Follow-up|0|||
163113087|NCT03334851|589122066|FG009|Overall Study|Lost to Follow-up|0|||
163113088|NCT03334851|589122067|FG010|Overall Study|Lost to Follow-up|2|||
163113089|NCT03334851|589122068|FG011|Overall Study|Lost to Follow-up|1|||
163113090|NCT03334851|589122069|FG012|Overall Study|Lost to Follow-up|0|||
163113091|NCT03575065|589122070|FG000|Overall Study|Death|31|||
163113092|NCT03575065|589122071|FG001|Overall Study|Death|12|||
163113093|NCT03575065|589122070|FG000|Overall Study|Sponsor's Decision|28|||
163113094|NCT03575065|589122071|FG001|Overall Study|Sponsor's Decision|13|||
163113095|NCT03575065|589122070|FG000|Overall Study|Withdrawal by Subject|2|||
163113096|NCT03575065|589122071|FG001|Overall Study|Withdrawal by Subject|1|||
163113097|NCT03575065|589122070|FG000|Overall Study|Lost to Follow-up|1|||
163113098|NCT03575065|589122071|FG001|Overall Study|Lost to Follow-up|0|||
163113099|NCT02323126|589122072|FG000|Overall Study|Patient / guardian decision|0|||
163113100|NCT02323126|589122073|FG001|Overall Study|Patient / guardian decision|1|||
163113101|NCT02323126|589122074|FG002|Overall Study|Patient / guardian decision|2|||
163113102|NCT02323126|589122072|FG000|Overall Study|Progressive disease|14|||
163113103|NCT02323126|589122073|FG001|Overall Study|Progressive disease|8|||
163113104|NCT02323126|589122074|FG002|Overall Study|Progressive disease|14|||
163113105|NCT02323126|589122072|FG000|Overall Study|Physician Decision|0|||
163113106|NCT02323126|589122073|FG001|Overall Study|Physician Decision|1|||
163113107|NCT02323126|589122074|FG002|Overall Study|Physician Decision|3|||
163113108|NCT02323126|589122072|FG000|Overall Study|Death|1|||
163113109|NCT02323126|589122073|FG001|Overall Study|Death|1|||
163113110|NCT02323126|589122074|FG002|Overall Study|Death|4|||
163113111|NCT02323126|589122072|FG000|Overall Study|Adverse Event|3|||
163113112|NCT02323126|589122073|FG001|Overall Study|Adverse Event|5|||
163113113|NCT02323126|589122074|FG002|Overall Study|Adverse Event|7|||
163113114|NCT00396136|589122078|FG000|Overall Study|Death|43|||
163113115|NCT00396136|589122078|FG000|Overall Study|Withdrawal by Subject|59|||
163113116|NCT00396136|589122078|FG000|Overall Study|Lost to Follow-up|15|||
163113117|NCT00396136|589122078|FG000|Overall Study|Study device explanted|8|||
163113118|NCT04043234|589122079|FG000|Overall Study|Lost to Follow-up|1|||
163113119|NCT04043234|589122079|FG000|Overall Study|Withdrawal by Subject|1|||
163113120|NCT03172325|589122080|FG000|Overall Study|Adverse Event|2|||
163113121|NCT03172325|589122081|FG001|Overall Study|Adverse Event|3|||
163113122|NCT03172325|589122080|FG000|Overall Study|Positive PPD|1|||
163113123|NCT03172325|589122081|FG001|Overall Study|Positive PPD|0|||
163113124|NCT03172325|589122080|FG000|Overall Study|Poor Compliance|1|||
163113125|NCT03172325|589122081|FG001|Overall Study|Poor Compliance|1|||
163113126|NCT00496197|589122082|FG000|Overall Study|Discontinued study due to death|43|||
163113127|NCT00496197|589122082|FG000|Overall Study|Adverse Event|13|||
163113128|NCT00496197|589122082|FG000|Overall Study|Does not meet entrance criteria|5|||
163113129|NCT00496197|589122082|FG000|Overall Study|Insufficient clinical response|3|||
163113130|NCT00496197|589122082|FG000|Overall Study|Insufficient bacteriological response|10|||
163113131|NCT00496197|589122082|FG000|Overall Study|Lost to Follow-up|11|||
163113132|NCT00496197|589122082|FG000|Overall Study|Withdrawal by Subject|11|||
163113133|NCT00496197|589122082|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
163113134|NCT00496197|589122082|FG000|Overall Study|Other|14|||
163113135|NCT00496197|589122082|FG000|Overall Study|Protocol Violation|8|||
163113136|NCT00149994|589122083|FG000|Overall Study|Administrative problems:|1|||
163113137|NCT00149994|589122084|FG001|Overall Study|Administrative problems:|0|||
163113138|NCT00149994|589122083|FG000|Overall Study|Protocol Violation|0|||
163113139|NCT00149994|589122084|FG001|Overall Study|Protocol Violation|1|||
163113140|NCT01610713|589122085|FG000|Overall Study|Adverse Event|3|||
163113141|NCT01610713|589122086|FG001|Overall Study|Adverse Event|0|||
163113142|NCT01610713|589122085|FG000|Overall Study|Lack of Efficacy|1|||
163113143|NCT01610713|589122086|FG001|Overall Study|Lack of Efficacy|0|||
163113144|NCT01610713|589122085|FG000|Overall Study|low mood and poor motivation|1|||
163113145|NCT01610713|589122086|FG001|Overall Study|low mood and poor motivation|0|||
163113146|NCT01610713|589122085|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
163113147|NCT01610713|589122086|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
163113148|NCT01610713|589122085|FG000|Overall Study|Lost to Follow-up|0|||
163113149|NCT01610713|589122086|FG001|Overall Study|Lost to Follow-up|1|||
163113150|NCT03943550|589122091|FG000|Overall Study|Adverse Event|0|||
163113151|NCT03943550|589122092|FG001|Overall Study|Adverse Event|0|||
163113152|NCT03943550|589122093|FG002|Overall Study|Adverse Event|1|||
163113153|NCT03943550|589122091|FG000|Overall Study|Lost to Follow-up|0|||
163113154|NCT03943550|589122092|FG001|Overall Study|Lost to Follow-up|0|||
163113155|NCT03943550|589122093|FG002|Overall Study|Lost to Follow-up|1|||
163113156|NCT03943550|589122091|FG000|Overall Study|Progressive Disease|0|||
163113157|NCT03943550|589122092|FG001|Overall Study|Progressive Disease|0|||
163113158|NCT03943550|589122093|FG002|Overall Study|Progressive Disease|2|||
163113159|NCT03943550|589122091|FG000|Overall Study|Participant Moved Out of the Country|0|||
163113160|NCT03943550|589122092|FG001|Overall Study|Participant Moved Out of the Country|1|||
163113161|NCT03943550|589122093|FG002|Overall Study|Participant Moved Out of the Country|0|||
163113162|NCT00543296|589122094|FG000|Overall Study|Physician Decision|7|||
163113163|NCT00934947|589122095|FG000|Overall Study|Adverse Event|0|||
163113164|NCT00934947|589122096|FG001|Overall Study|Adverse Event|2|||
163113165|NCT00252694|589122102|FG000|Overall Study|Withdrawal by Subject|83|||
163113166|NCT00252694|589122103|FG001|Overall Study|Withdrawal by Subject|91|||
163113167|NCT00252694|589122102|FG000|Overall Study|Death|36|||
163113168|NCT00252694|589122103|FG001|Overall Study|Death|34|||
163113169|NCT00252694|589122102|FG000|Overall Study|Mostly Lost to Follow Up|8|||
163113170|NCT00252694|589122103|FG001|Overall Study|Mostly Lost to Follow Up|13|||
163113171|NCT00252694|589122102|FG000|Overall Study|Patient Moving|17|||
163113172|NCT00252694|589122103|FG001|Overall Study|Patient Moving|16|||
163113173|NCT00096226|589122105|FG000|Overall Study|Ineligible|2|||
163113174|NCT00096226|589122105|FG000|Overall Study|Protocol treatment not started|1|||
163113175|NCT02378298|589122108|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
163113176|NCT02378298|589122109|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
163113177|NCT02378298|589122110|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
163113178|NCT02378298|589122108|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
163113179|NCT02378298|589122109|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
163113180|NCT02378298|589122110|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
163113181|NCT02378298|589122108|FG000|Surveillance (19-68 Weeks)|Death|1|||
163113182|NCT02378298|589122109|FG001|Surveillance (19-68 Weeks)|Death|0|||
163113183|NCT02378298|589122110|FG002|Surveillance (19-68 Weeks)|Death|0|||
163113184|NCT03006458|589122112|FG000|First Intervention|Unsatisfied Vision|0|||
163113185|NCT03006458|589122113|FG001|First Intervention|Unsatisfied Vision|3|||
163113186|NCT01468233|589122116|FG000|Treatment Period 1|Adverse Event|5|||
163113187|NCT01468233|589122117|FG001|Treatment Period 1|Adverse Event|3|||
163113188|NCT01468233|589122118|FG002|Treatment Period 1|Adverse Event|0|||
163113189|NCT01468233|589122119|FG003|Treatment Period 1|Adverse Event|0|||
163113190|NCT01468233|589122120|FG004|Treatment Period 1|Adverse Event|0|||
163113191|NCT01468233|589122121|FG005|Treatment Period 1|Adverse Event|0|||
163113192|NCT01468233|589122116|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163113193|NCT01468233|589122117|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163113194|NCT01468233|589122118|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163113195|NCT01468233|589122119|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163113196|NCT01468233|589122120|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163113197|NCT01468233|589122121|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163113198|NCT01468233|589122116|FG000|Treatment Period 1|Lost to Follow-up|3|||
163113199|NCT01468233|589122117|FG001|Treatment Period 1|Lost to Follow-up|0|||
162654010|NCT01256593|587449667|FG000|Overall Study|Protocol Violation|26|||
163113200|NCT01468233|589122118|FG002|Treatment Period 1|Lost to Follow-up|0|||
163113201|NCT01468233|589122119|FG003|Treatment Period 1|Lost to Follow-up|0|||
163113202|NCT01468233|589122120|FG004|Treatment Period 1|Lost to Follow-up|0|||
163113203|NCT01468233|589122121|FG005|Treatment Period 1|Lost to Follow-up|0|||
163113204|NCT01468233|589122116|FG000|Treatment Period 1|Other|1|||
163113205|NCT01468233|589122117|FG001|Treatment Period 1|Other|1|||
163113206|NCT01468233|589122118|FG002|Treatment Period 1|Other|0|||
163113207|NCT01468233|589122119|FG003|Treatment Period 1|Other|0|||
163113208|NCT01468233|589122120|FG004|Treatment Period 1|Other|0|||
163113209|NCT01468233|589122121|FG005|Treatment Period 1|Other|0|||
163113210|NCT01468233|589122116|FG000|Treatment Period 2|Adverse Event|0|||
163113211|NCT01468233|589122117|FG001|Treatment Period 2|Adverse Event|0|||
163113212|NCT01468233|589122118|FG002|Treatment Period 2|Adverse Event|3|||
163113213|NCT01468233|589122119|FG003|Treatment Period 2|Adverse Event|0|||
163113214|NCT01468233|589122120|FG004|Treatment Period 2|Adverse Event|2|||
163113215|NCT01468233|589122121|FG005|Treatment Period 2|Adverse Event|1|||
163113216|NCT01468233|589122116|FG000|Treatment Period 2|Lack of Efficacy|0|||
163113217|NCT01468233|589122117|FG001|Treatment Period 2|Lack of Efficacy|0|||
163113218|NCT01468233|589122118|FG002|Treatment Period 2|Lack of Efficacy|9|||
163113219|NCT01468233|589122119|FG003|Treatment Period 2|Lack of Efficacy|2|||
163113220|NCT01468233|589122120|FG004|Treatment Period 2|Lack of Efficacy|0|||
163113221|NCT01468233|589122121|FG005|Treatment Period 2|Lack of Efficacy|1|||
163113222|NCT01468233|589122116|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163113223|NCT01468233|589122117|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163113224|NCT01468233|589122118|FG002|Treatment Period 2|Withdrawal by Subject|9|||
163113225|NCT01468233|589122119|FG003|Treatment Period 2|Withdrawal by Subject|1|||
163113226|NCT01468233|589122120|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163113227|NCT01468233|589122121|FG005|Treatment Period 2|Withdrawal by Subject|1|||
163113228|NCT01468233|589122116|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
163113229|NCT01468233|589122117|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
163113230|NCT01468233|589122118|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
163113231|NCT01468233|589122119|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
163113232|NCT01468233|589122120|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
163113233|NCT01468233|589122121|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
163113234|NCT01468233|589122116|FG000|Treatment Period 2|Lost to Follow-up|0|||
163113235|NCT01468233|589122117|FG001|Treatment Period 2|Lost to Follow-up|0|||
163113236|NCT01468233|589122118|FG002|Treatment Period 2|Lost to Follow-up|3|||
163113237|NCT01468233|589122119|FG003|Treatment Period 2|Lost to Follow-up|0|||
163113238|NCT01468233|589122120|FG004|Treatment Period 2|Lost to Follow-up|2|||
163113239|NCT01468233|589122121|FG005|Treatment Period 2|Lost to Follow-up|0|||
163113240|NCT01468233|589122116|FG000|Treatment Period 2|Other|0|||
163113241|NCT01468233|589122117|FG001|Treatment Period 2|Other|0|||
163113242|NCT01468233|589122118|FG002|Treatment Period 2|Other|3|||
163113243|NCT01468233|589122119|FG003|Treatment Period 2|Other|0|||
163113244|NCT01468233|589122120|FG004|Treatment Period 2|Other|1|||
163113245|NCT01468233|589122121|FG005|Treatment Period 2|Other|0|||
163113246|NCT01574157|589122122|FG000|Overall Study|Withdrawal by Subject|4|||
163113247|NCT01574157|589122123|FG001|Overall Study|Withdrawal by Subject|5|||
163113248|NCT01574157|589122122|FG000|Overall Study|Lost to Follow-up|0|||
163113249|NCT01574157|589122123|FG001|Overall Study|Lost to Follow-up|3|||
163113250|NCT01944098|589122124|FG000|Overall Study|Physician Decision|1|||
163113251|NCT01944098|589122125|FG001|Overall Study|Physician Decision|0|||
163113252|NCT02136680|589122127|FG000|Overall Study|No Longer Interested|1|||
163113253|NCT02136680|589122128|FG001|Overall Study|No Longer Interested|1|||
163113254|NCT02136680|589122127|FG000|Overall Study|No longer receiving care at clinic|3|||
163113255|NCT02136680|589122128|FG001|Overall Study|No longer receiving care at clinic|5|||
163113256|NCT02136680|589122127|FG000|Overall Study|Moved away|5|||
163113257|NCT02136680|589122128|FG001|Overall Study|Moved away|4|||
163113258|NCT02136680|589122127|FG000|Overall Study|Unable to schedule|17|||
163113259|NCT02136680|589122128|FG001|Overall Study|Unable to schedule|16|||
163113260|NCT02136680|589122127|FG000|Overall Study|Study ended before interview due|6|||
163113261|NCT02136680|589122128|FG001|Overall Study|Study ended before interview due|3|||
163113262|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
163113263|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
162654011|NCT01256593|587449667|FG000|Overall Study|No Drug Administration Information|2|||
162654012|NCT01256593|587449667|FG000|Overall Study|No Visit After Treatment|186|||
162654013|NCT01110915|587449672|FG000|Overall Study|Death|2|||
162654014|NCT01110915|587449673|FG001|Overall Study|Death|1|||
163113264|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
163113265|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
162654015|NCT01110915|587449672|FG000|Overall Study|Lost to Follow-up|1|||
163113266|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
163113267|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
163113268|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
163113269|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
163113270|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
163113271|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
162654016|NCT01110915|587449673|FG001|Overall Study|Lost to Follow-up|0|||
163113272|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
163113273|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
163113274|NCT01632241|589122129|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
163113275|NCT01632241|589122130|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
163113276|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
163113277|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
163113278|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
163113279|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
163113280|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
163113281|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
163113282|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
163113283|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
163113284|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
163113285|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
163113286|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
163113287|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
163113288|NCT01632241|589122129|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
163113289|NCT01632241|589122130|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
163113290|NCT01202188|589122131|FG000|Overall Study|Protocol deviation|14|||
163113291|NCT01202188|589122132|FG001|Overall Study|Protocol deviation|8|||
163113292|NCT01202188|589122133|FG002|Overall Study|Protocol deviation|12|||
163113293|NCT01202188|589122134|FG003|Overall Study|Protocol deviation|10|||
163113294|NCT01202188|589122135|FG004|Overall Study|Protocol deviation|11|||
163113295|NCT01202188|589122131|FG000|Overall Study|Subject withdrew consent|12|||
163113296|NCT01202188|589122132|FG001|Overall Study|Subject withdrew consent|13|||
163113297|NCT01202188|589122133|FG002|Overall Study|Subject withdrew consent|22|||
163113298|NCT01202188|589122134|FG003|Overall Study|Subject withdrew consent|11|||
163113299|NCT01202188|589122135|FG004|Overall Study|Subject withdrew consent|13|||
163113300|NCT01202188|589122131|FG000|Overall Study|Adverse Event|5|||
163113301|NCT01202188|589122132|FG001|Overall Study|Adverse Event|23|||
163113302|NCT01202188|589122133|FG002|Overall Study|Adverse Event|13|||
163113303|NCT01202188|589122134|FG003|Overall Study|Adverse Event|10|||
163113304|NCT01202188|589122135|FG004|Overall Study|Adverse Event|10|||
163113305|NCT01202188|589122131|FG000|Overall Study|Administrative problems|3|||
163113306|NCT01202188|589122132|FG001|Overall Study|Administrative problems|2|||
163113307|NCT01202188|589122133|FG002|Overall Study|Administrative problems|1|||
163113308|NCT01202188|589122134|FG003|Overall Study|Administrative problems|1|||
163113309|NCT01202188|589122135|FG004|Overall Study|Administrative problems|2|||
163113310|NCT01202188|589122131|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163113311|NCT01202188|589122132|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163113312|NCT01202188|589122133|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163113313|NCT01202188|589122134|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
163113314|NCT01202188|589122135|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
163113315|NCT01202188|589122131|FG000|Overall Study|Lost to Follow-up|1|||
163113316|NCT01202188|589122132|FG001|Overall Study|Lost to Follow-up|1|||
163113317|NCT01202188|589122133|FG002|Overall Study|Lost to Follow-up|0|||
163113318|NCT01202188|589122134|FG003|Overall Study|Lost to Follow-up|4|||
163113319|NCT01202188|589122135|FG004|Overall Study|Lost to Follow-up|1|||
163113320|NCT01202188|589122131|FG000|Overall Study|Death|1|||
163113321|NCT01202188|589122132|FG001|Overall Study|Death|1|||
163113322|NCT01202188|589122133|FG002|Overall Study|Death|1|||
163113323|NCT01202188|589122134|FG003|Overall Study|Death|1|||
163113324|NCT01202188|589122135|FG004|Overall Study|Death|0|||
163113325|NCT01202188|589122131|FG000|Overall Study|Abnormal test procedure result (s)|0|||
163113326|NCT01202188|589122132|FG001|Overall Study|Abnormal test procedure result (s)|0|||
163113327|NCT01202188|589122133|FG002|Overall Study|Abnormal test procedure result (s)|2|||
163113328|NCT01202188|589122134|FG003|Overall Study|Abnormal test procedure result (s)|0|||
163113329|NCT01202188|589122135|FG004|Overall Study|Abnormal test procedure result (s)|0|||
163113330|NCT01330628|589122143|FG000|Overall Study|Death|2|||
163113331|NCT01330628|589122144|FG001|Overall Study|Death|3|||
163113332|NCT01330628|589122143|FG000|Overall Study|Lost to Follow-up|5|||
163113333|NCT01330628|589122144|FG001|Overall Study|Lost to Follow-up|6|||
163113334|NCT01330628|589122143|FG000|Overall Study|Adverse Event|44|||
163113335|NCT01330628|589122144|FG001|Overall Study|Adverse Event|25|||
163113336|NCT01330628|589122143|FG000|Overall Study|Withdrawn|18|||
163113337|NCT01330628|589122144|FG001|Overall Study|Withdrawn|6|||
163113338|NCT01330628|589122143|FG000|Overall Study|Didn't receive study treatment|1|||
163113339|NCT01330628|589122144|FG001|Overall Study|Didn't receive study treatment|0|||
163113340|NCT03761394|589122145|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
163113341|NCT03761394|589122146|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
163113342|NCT03761394|589122147|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
162654017|NCT01110915|587449672|FG000|Overall Study|Withdrawal by Subject|7|||
162654018|NCT01110915|587449673|FG001|Overall Study|Withdrawal by Subject|1|||
163113343|NCT03761394|589122148|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
163113344|NCT03761394|589122145|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
163113345|NCT03761394|589122146|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
163113346|NCT03761394|589122147|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
163113347|NCT03761394|589122148|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
163113348|NCT03761394|589122145|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113349|NCT03761394|589122146|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113350|NCT03761394|589122147|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
163113351|NCT03761394|589122148|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
163113352|NCT03761394|589122145|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113353|NCT03761394|589122146|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113354|NCT03761394|589122147|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
163113355|NCT03761394|589122148|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
163113356|NCT01080768|589122158|FG000|Overall Study|Protocol Deviation|2|||
163113357|NCT01080768|589122159|FG001|Overall Study|Protocol Deviation|1|||
163113358|NCT00580034|589122170|FG000|Overall Study|Toxicity|10|||
163113359|NCT00580034|589122171|FG001|Overall Study|Toxicity|0|||
163113360|NCT01939002|589122172|FG000|Overall Study|Adverse Event|13|||
163113361|NCT01939002|589122173|FG001|Overall Study|Adverse Event|13|||
163113362|NCT01939002|589122172|FG000|Overall Study|Withdrawal by Subject|5|||
163113363|NCT01939002|589122173|FG001|Overall Study|Withdrawal by Subject|3|||
163113364|NCT01939002|589122172|FG000|Overall Study|Other|1|||
163113365|NCT01939002|589122173|FG001|Overall Study|Other|2|||
163113366|NCT00098748|589122177|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
163113367|NCT00098748|589122178|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
163113368|NCT00098748|589122179|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
163113369|NCT00098748|589122177|FG000|Received Study Treatment|Death|2|||
163113370|NCT00098748|589122178|FG001|Received Study Treatment|Death|1|||
163113371|NCT00098748|589122179|FG002|Received Study Treatment|Death|2|||
163113372|NCT00098748|589122177|FG000|Received Study Treatment|Adverse Event|1|||
163113373|NCT00098748|589122178|FG001|Received Study Treatment|Adverse Event|2|||
163113374|NCT00098748|589122179|FG002|Received Study Treatment|Adverse Event|5|||
163113375|NCT00098748|589122177|FG000|Received Study Treatment|Lack of Efficacy|40|||
163113376|NCT00098748|589122178|FG001|Received Study Treatment|Lack of Efficacy|27|||
163113377|NCT00098748|589122179|FG002|Received Study Treatment|Lack of Efficacy|27|||
163113378|NCT00098748|589122177|FG000|Received Study Treatment|Other|2|||
163113379|NCT00098748|589122178|FG001|Received Study Treatment|Other|2|||
163113380|NCT00098748|589122179|FG002|Received Study Treatment|Other|6|||
163113381|NCT00098748|589122177|FG000|Received Study Treatment|Subject defaulted|3|||
163113382|NCT00098748|589122178|FG001|Received Study Treatment|Subject defaulted|4|||
163113383|NCT00098748|589122179|FG002|Received Study Treatment|Subject defaulted|4|||
163113384|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
163113385|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
163113386|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
163113387|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
163113388|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
163113389|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
163113390|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
163113391|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
163113392|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
163113393|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
163113394|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
163113395|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
163113396|NCT00098748|589122177|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
163113397|NCT00098748|589122178|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
163113398|NCT00098748|589122179|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
163113399|NCT03095027|589124297|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
163113400|NCT03095027|589124298|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
163113401|NCT02982018|589124299|FG000|Overall Study|Incorrect Lens Dispensed|1|||
163113402|NCT02982018|589124300|FG001|Overall Study|Incorrect Lens Dispensed|0|||
163113403|NCT02982018|589124299|FG000|Overall Study|Protocol Violation|1|||
163113404|NCT02982018|589124300|FG001|Overall Study|Protocol Violation|1|||
163113405|NCT02982018|589124299|FG000|Overall Study|Adverse Event|1|||
163113406|NCT02982018|589124300|FG001|Overall Study|Adverse Event|1|||
163113407|NCT02982018|589124299|FG000|Overall Study|Lens Discomfort|2|||
163113408|NCT02982018|589124300|FG001|Overall Study|Lens Discomfort|0|||
163113409|NCT02982018|589124299|FG000|Overall Study|Withdrawal by Subject|0|||
163113410|NCT02982018|589124300|FG001|Overall Study|Withdrawal by Subject|1|||
163113411|NCT01942161|589124301|FG000|Overall Study|Adverse Event|1|||
163113412|NCT01942161|589124302|FG001|Overall Study|Adverse Event|2|||
163113413|NCT01942161|589124303|FG002|Overall Study|Adverse Event|5|||
163113414|NCT01942161|589124301|FG000|Overall Study|Physician Decision|3|||
163113415|NCT01942161|589124302|FG001|Overall Study|Physician Decision|1|||
163113416|NCT01942161|589124303|FG002|Overall Study|Physician Decision|0|||
163113417|NCT01942161|589124301|FG000|Overall Study|Protocol Violation|1|||
163113418|NCT01942161|589124302|FG001|Overall Study|Protocol Violation|0|||
163113419|NCT01942161|589124303|FG002|Overall Study|Protocol Violation|0|||
163113420|NCT01942161|589124301|FG000|Overall Study|Withdrawal by Subject|3|||
163113421|NCT01942161|589124302|FG001|Overall Study|Withdrawal by Subject|3|||
163113422|NCT01942161|589124303|FG002|Overall Study|Withdrawal by Subject|1|||
163113423|NCT01257568|589124306|FG000|Overall Study|Lost to Follow-up|2|||
163113424|NCT01257568|589124306|FG000|Overall Study|Withdrawal by Subject|6|||
163113425|NCT01257568|589124306|FG000|Overall Study|Terminated|1|||
163113426|NCT01257568|589124306|FG000|Overall Study|Component Revision|24|||
163113427|NCT00132691|589124308|FG000|Overall Study|Lost to Follow-up|5|||
163113428|NCT00132691|589124309|FG001|Overall Study|Lost to Follow-up|8|||
163113429|NCT00132691|589124308|FG000|Overall Study|Missed 2-year visit|4|||
163113430|NCT00132691|589124309|FG001|Overall Study|Missed 2-year visit|4|||
163113431|NCT00132691|589124308|FG000|Overall Study|Death|2|||
163113432|NCT00132691|589124309|FG001|Overall Study|Death|0|||
163113433|NCT00798317|589124310|FG000|Overall Study|Physician Decision|0|||
163113434|NCT00798317|589124311|FG001|Overall Study|Physician Decision|1|||
163113435|NCT00798317|589124310|FG000|Overall Study|Withdrawal by Subject|5|||
163113436|NCT00798317|589124311|FG001|Overall Study|Withdrawal by Subject|4|||
163113437|NCT00798317|589124310|FG000|Overall Study|Lost to Follow-up|2|||
163113438|NCT00798317|589124311|FG001|Overall Study|Lost to Follow-up|2|||
163113439|NCT00798317|589124310|FG000|Overall Study|Adverse Event|2|||
163113440|NCT00798317|589124311|FG001|Overall Study|Adverse Event|0|||
163113441|NCT00798317|589124310|FG000|Overall Study|Death|1|||
163113442|NCT00798317|589124311|FG001|Overall Study|Death|0|||
163113443|NCT00919867|589124312|FG000|First Intervention|Withdrawal by Subject|0|||
163113444|NCT00919867|589124313|FG001|First Intervention|Withdrawal by Subject|0|||
163113445|NCT00919867|589124314|FG002|First Intervention|Withdrawal by Subject|1|||
163113446|NCT00919867|589124315|FG003|First Intervention|Withdrawal by Subject|0|||
163113447|NCT00919867|589124316|FG004|First Intervention|Withdrawal by Subject|0|||
163113448|NCT00919867|589124317|FG005|First Intervention|Withdrawal by Subject|0|||
163113449|NCT00919867|589124312|FG000|First Intervention|Physician Decision|0|||
163113450|NCT00919867|589124313|FG001|First Intervention|Physician Decision|0|||
163113451|NCT00919867|589124314|FG002|First Intervention|Physician Decision|0|||
163113452|NCT00919867|589124315|FG003|First Intervention|Physician Decision|0|||
163113453|NCT00919867|589124316|FG004|First Intervention|Physician Decision|0|||
163113454|NCT00919867|589124317|FG005|First Intervention|Physician Decision|1|||
163113455|NCT03361189|589124325|FG000|Overall Study|Received heart transplant|1|||
163113456|NCT03361189|589124326|FG001|Overall Study|Received heart transplant|0|||
163113457|NCT03361189|589124325|FG000|Overall Study|Pacemake replacement|0|||
163113458|NCT03361189|589124326|FG001|Overall Study|Pacemake replacement|1|||
163113459|NCT03344549|589124327|FG000|Overall Study|Withdrawal by Subject|3|||
163113460|NCT03344549|589124328|FG001|Overall Study|Withdrawal by Subject|2|||
163113461|NCT03344549|589124327|FG000|Overall Study|Dialysis|2|||
163113462|NCT03344549|589124328|FG001|Overall Study|Dialysis|0|||
163113463|NCT03344549|589124327|FG000|Overall Study|Cancer|1|||
163113464|NCT03344549|589124328|FG001|Overall Study|Cancer|0|||
163113465|NCT03344549|589124327|FG000|Overall Study|Lack of electronic device|1|||
163113466|NCT03344549|589124328|FG001|Overall Study|Lack of electronic device|0|||
163113467|NCT03344549|589124327|FG000|Overall Study|Transportation difficulty|0|||
163113468|NCT03344549|589124328|FG001|Overall Study|Transportation difficulty|13|||
163113469|NCT01685801|589124334|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113470|NCT01685801|589124335|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113471|NCT01685801|589124336|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
163113472|NCT01685801|589124337|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
163113473|NCT01685801|589124334|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
163113474|NCT01685801|589124335|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
163113475|NCT01685801|589124336|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
163113476|NCT01685801|589124337|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
163113477|NCT00113399|589124338|FG000|Overall Study|Death|1|||
163113478|NCT00113399|589124339|FG001|Overall Study|Death|1|||
163113479|NCT00113399|589124338|FG000|Overall Study|Withdrawal by Subject|1|||
163113480|NCT00113399|589124339|FG001|Overall Study|Withdrawal by Subject|2|||
163113481|NCT00113399|589124338|FG000|Overall Study|Complete Response|0|||
163113482|NCT00113399|589124339|FG001|Overall Study|Complete Response|1|||
163113483|NCT00113399|589124338|FG000|Overall Study|Other|0|||
163113484|NCT00113399|589124339|FG001|Overall Study|Other|1|||
163113485|NCT03350256|589124340|FG000|Overall Study|Inclusion/exclusion violation|4|||
163113486|NCT03350256|589124340|FG000|Overall Study|Recommended for other therapies|2|||
163113487|NCT03350256|589124340|FG000|Overall Study|Protocol Violation|3|||
163113488|NCT03350256|589124340|FG000|Overall Study|Non compliance|2|||
163113489|NCT03350256|589124340|FG000|Overall Study|Denial by insurance|1|||
163113490|NCT03350256|589124340|FG000|Overall Study|Adverse Event|2|||
163113491|NCT03350256|589124340|FG000|Overall Study|Trial failure|12|||
163113492|NCT03350256|589124340|FG000|Overall Study|Did not proceed to permanent implant|3|||
163113493|NCT03350256|589124340|FG000|Overall Study|Withdrawal by Subject|3|||
163113494|NCT03350256|589124340|FG000|Overall Study|Subject moving out of state|1|||
163113495|NCT03350256|589124340|FG000|Overall Study|Lost to Follow-up|1|||
163113496|NCT03350256|589124340|FG000|Overall Study|Lack of Efficacy|2|||
163113497|NCT00666588|589124341|FG000|Overall Study|ineligible|2|||
163113498|NCT00666588|589124342|FG001|Overall Study|ineligible|0|||
163113499|NCT00666588|589124343|FG002|Overall Study|ineligible|0|||
163113500|NCT00666588|589124344|FG003|Overall Study|ineligible|2|||
163113501|NCT00666588|589124341|FG000|Overall Study|inevaluable|2|||
163113502|NCT00666588|589124342|FG001|Overall Study|inevaluable|0|||
163113503|NCT00666588|589124343|FG002|Overall Study|inevaluable|0|||
163113504|NCT00666588|589124344|FG003|Overall Study|inevaluable|0|||
163113505|NCT01187446|589124347|FG000|Overall Study|Patient started non-protocol therapy|0|||
163113506|NCT01187446|589124348|FG001|Overall Study|Patient started non-protocol therapy|1|||
163113507|NCT00823212|589124350|FG000|Overall Study|Death|8|||
163113508|NCT00823212|589124351|FG001|Overall Study|Death|10|||
163113509|NCT00823212|589124350|FG000|Overall Study|Withdrawal by Subject|6|||
163113510|NCT00823212|589124351|FG001|Overall Study|Withdrawal by Subject|1|||
163113511|NCT00823212|589124350|FG000|Overall Study|Incarcerated|0|||
163113512|NCT00823212|589124351|FG001|Overall Study|Incarcerated|1|||
163113513|NCT00823212|589124350|FG000|Overall Study|Missed 12-month visit|21|||
163113514|NCT00823212|589124351|FG001|Overall Study|Missed 12-month visit|21|||
163113515|NCT00791479|589124356|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113516|NCT00791479|589124357|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113517|NCT00791479|589124358|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113518|NCT00791479|589124359|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113519|NCT00791479|589124360|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
163113520|NCT00791479|589124361|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
163113521|NCT00791479|589124356|FG000|Overall Study|Adverse Event|0|||
163113522|NCT00791479|589124357|FG001|Overall Study|Adverse Event|1|||
163113523|NCT00791479|589124358|FG002|Overall Study|Adverse Event|0|||
163113524|NCT00791479|589124359|FG003|Overall Study|Adverse Event|2|||
163113525|NCT00791479|589124360|FG004|Overall Study|Adverse Event|0|||
163113526|NCT00791479|589124361|FG005|Overall Study|Adverse Event|1|||
163113527|NCT00791479|589124356|FG000|Overall Study|Lost to Follow-up|0|||
163113528|NCT00791479|589124357|FG001|Overall Study|Lost to Follow-up|1|||
163113529|NCT00791479|589124358|FG002|Overall Study|Lost to Follow-up|0|||
163113530|NCT00791479|589124359|FG003|Overall Study|Lost to Follow-up|0|||
163113531|NCT00791479|589124360|FG004|Overall Study|Lost to Follow-up|0|||
163113532|NCT00791479|589124361|FG005|Overall Study|Lost to Follow-up|1|||
163113533|NCT00791479|589124356|FG000|Overall Study|Protocol Violation|2|||
163113534|NCT00791479|589124357|FG001|Overall Study|Protocol Violation|1|||
163113535|NCT00791479|589124358|FG002|Overall Study|Protocol Violation|0|||
163113536|NCT00791479|589124359|FG003|Overall Study|Protocol Violation|1|||
163113537|NCT00791479|589124360|FG004|Overall Study|Protocol Violation|0|||
163113538|NCT00791479|589124361|FG005|Overall Study|Protocol Violation|0|||
163113539|NCT00791479|589124356|FG000|Overall Study|Withdrawal by Subject|0|||
163113540|NCT00791479|589124357|FG001|Overall Study|Withdrawal by Subject|0|||
163113541|NCT00791479|589124358|FG002|Overall Study|Withdrawal by Subject|0|||
163113542|NCT00791479|589124359|FG003|Overall Study|Withdrawal by Subject|1|||
163113543|NCT00791479|589124360|FG004|Overall Study|Withdrawal by Subject|0|||
163113544|NCT00791479|589124361|FG005|Overall Study|Withdrawal by Subject|1|||
163113545|NCT03405935|589124364|FG000|Overall Study|Adverse Event|3|||
163113546|NCT03405935|589124364|FG000|Overall Study|Death|2|||
163113547|NCT03405935|589124364|FG000|Overall Study|Withdrawal by Subject|1|||
163113548|NCT03405935|589124364|FG000|Overall Study|Lost to Follow-up|2|||
163113549|NCT04979897|589124365|FG000|Overall Study|Death|1|||
163113550|NCT04979897|589124366|FG001|Overall Study|Death|8|||
163113551|NCT04979897|589124365|FG000|Overall Study|Lost to Follow-up|111|||
163113552|NCT04979897|589124366|FG001|Overall Study|Lost to Follow-up|56|||
163113553|NCT04979897|589124365|FG000|Overall Study|Withdrawal by Subject|7|||
163113554|NCT04979897|589124366|FG001|Overall Study|Withdrawal by Subject|2|||
163113555|NCT01774097|589124367|FG000|Overall Study|Withdrawal by Subject|1|||
163113556|NCT01774097|589124368|FG001|Overall Study|Withdrawal by Subject|1|||
163113557|NCT01774097|589124367|FG000|Overall Study|Adverse Event|1|||
163113558|NCT01774097|589124368|FG001|Overall Study|Adverse Event|1|||
163113559|NCT04659174|589124374|FG000|Overall Study|Sponsor decision to discontinue study|0|||
163113560|NCT04659174|589124375|FG001|Overall Study|Sponsor decision to discontinue study|2|||
163113561|NCT04659174|589124374|FG000|Overall Study|Lost to Follow-up|9|||
163113562|NCT04659174|589124375|FG001|Overall Study|Lost to Follow-up|11|||
163113563|NCT04659174|589124374|FG000|Overall Study|Adverse Event|8|||
163113564|NCT04659174|589124375|FG001|Overall Study|Adverse Event|5|||
163113565|NCT04659174|589124374|FG000|Overall Study|Withdrawal by Subject|17|||
162654019|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
163113566|NCT04659174|589124375|FG001|Overall Study|Withdrawal by Subject|33|||
163113567|NCT04659174|589124374|FG000|Overall Study|Progressive disease|0|||
163113568|NCT04659174|589124375|FG001|Overall Study|Progressive disease|2|||
163113569|NCT04659174|589124374|FG000|Overall Study|Other reasons|0|||
163113570|NCT04659174|589124375|FG001|Overall Study|Other reasons|2|||
163113571|NCT04659174|589124374|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
163113572|NCT04659174|589124375|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
163113573|NCT04659174|589124374|FG000|Overall Study|Alcohol or illegal drug use|0|||
163113574|NCT04659174|589124375|FG001|Overall Study|Alcohol or illegal drug use|3|||
163113575|NCT04659174|589124374|FG000|Overall Study|Violation of entry criteria|1|||
163113576|NCT04659174|589124375|FG001|Overall Study|Violation of entry criteria|0|||
163113577|NCT04659174|589124374|FG000|Overall Study|Death|0|||
163113578|NCT04659174|589124375|FG001|Overall Study|Death|1|||
163113579|NCT02781792|589124376|FG000|Overall Study|Adverse Event|1|||
163113580|NCT02781792|589124377|FG001|Overall Study|Adverse Event|2|||
163113581|NCT02781792|589124376|FG000|Overall Study|Withdrawal by Subject|3|||
163113582|NCT02781792|589124377|FG001|Overall Study|Withdrawal by Subject|1|||
163113583|NCT02781792|589124376|FG000|Overall Study|Lack of Efficacy|1|||
163113584|NCT02781792|589124377|FG001|Overall Study|Lack of Efficacy|1|||
163113585|NCT02781792|589124376|FG000|Overall Study|Hospice|0|||
163113586|NCT02781792|589124377|FG001|Overall Study|Hospice|1|||
163113587|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
163113588|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
163113589|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113590|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
163113591|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
163113592|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113593|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
163113594|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113595|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113596|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113597|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
163113598|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
163113599|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113600|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113601|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113602|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113603|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113604|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
163113605|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113606|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113607|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113608|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113609|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113610|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113611|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
163113612|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113613|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113614|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113615|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113616|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113617|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113618|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113619|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113620|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113621|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113622|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
163113623|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113624|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113625|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
163113626|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113627|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113628|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113629|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113630|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113631|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113632|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113633|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113634|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113635|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113636|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113637|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113638|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113639|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113640|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
163113641|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113642|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113643|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
163113644|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113645|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113646|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113647|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113648|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113649|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113650|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113651|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113652|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113653|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113654|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113655|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113656|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113657|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113658|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
163113659|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113660|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113661|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113662|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113663|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113664|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113665|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113666|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113667|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113668|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113669|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
163113670|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113671|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113672|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113673|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113674|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113675|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113676|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
163113677|NCT03447314|589124382|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113678|NCT03447314|589124383|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113679|NCT03447314|589124384|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113680|NCT03447314|589124385|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
163113681|NCT03447314|589124386|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113682|NCT03447314|589124387|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
163113683|NCT03447314|589124388|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
162654020|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
162654021|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
162654022|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
162654023|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
162654024|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
162654025|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
162654026|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
162654027|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
162654028|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
163113684|NCT03447314|589124389|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113685|NCT03447314|589124390|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113686|NCT03447314|589124391|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113687|NCT03447314|589124392|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113688|NCT03447314|589124393|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113689|NCT03447314|589124394|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113690|NCT03447314|589124395|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113691|NCT03447314|589124396|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113692|NCT03447314|589124397|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113693|NCT03447314|589124398|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113694|NCT03447314|589124399|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
163113695|NCT01920568|589124401|FG000|Overall Study|Adverse Event|27|||
163113696|NCT01920568|589124402|FG001|Overall Study|Adverse Event|8|||
163113697|NCT01920568|589124401|FG000|Overall Study|Protocol Violation|5|||
163113698|NCT01920568|589124402|FG001|Overall Study|Protocol Violation|3|||
163113699|NCT01920568|589124401|FG000|Overall Study|Lost to Follow-up|2|||
163113700|NCT01920568|589124402|FG001|Overall Study|Lost to Follow-up|2|||
163113701|NCT01920568|589124401|FG000|Overall Study|Physician Decision|13|||
163113702|NCT01920568|589124402|FG001|Overall Study|Physician Decision|4|||
163113703|NCT01920568|589124401|FG000|Overall Study|Withdrawal by Subject|79|||
163113704|NCT01920568|589124402|FG001|Overall Study|Withdrawal by Subject|55|||
163113705|NCT01920568|589124401|FG000|Overall Study|Death due to disease progression|25|||
163113706|NCT01920568|589124402|FG001|Overall Study|Death due to disease progression|12|||
163113707|NCT04049266|589124406|FG000|Overall Study|Adverse Event|16|||
163113708|NCT04049266|589124407|FG001|Overall Study|Adverse Event|9|||
163113709|NCT04049266|589124406|FG000|Overall Study|Non-compliance with study drug|0|||
163113710|NCT04049266|589124407|FG001|Overall Study|Non-compliance with study drug|3|||
163113711|NCT04049266|589124406|FG000|Overall Study|Withdrawal by Subject|6|||
163113712|NCT04049266|589124407|FG001|Overall Study|Withdrawal by Subject|10|||
163113713|NCT04049266|589124406|FG000|Overall Study|Lost to Follow-up|2|||
163113714|NCT04049266|589124407|FG001|Overall Study|Lost to Follow-up|2|||
163113715|NCT04049266|589124406|FG000|Overall Study|Progressive disease|11|||
163113716|NCT04049266|589124407|FG001|Overall Study|Progressive disease|2|||
163113717|NCT04049266|589124406|FG000|Overall Study|Physician Decision|1|||
163113718|NCT04049266|589124407|FG001|Overall Study|Physician Decision|0|||
163113719|NCT04049266|589124406|FG000|Overall Study|Patient moved out of state|1|||
163113720|NCT04049266|589124407|FG001|Overall Study|Patient moved out of state|0|||
163113721|NCT01703208|589124408|FG000|Overall Study|Death|61|||
163113722|NCT01703208|589124409|FG001|Overall Study|Death|48|||
163113723|NCT01703208|589124408|FG000|Overall Study|Lack of Efficacy|1|||
163113724|NCT01703208|589124409|FG001|Overall Study|Lack of Efficacy|2|||
163113725|NCT01703208|589124408|FG000|Overall Study|Lost to Follow-up|68|||
163113726|NCT01703208|589124409|FG001|Overall Study|Lost to Follow-up|62|||
163113727|NCT01703208|589124408|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163113728|NCT01703208|589124409|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163113729|NCT01703208|589124408|FG000|Overall Study|Excluded Medication|1|||
163113730|NCT01703208|589124409|FG001|Overall Study|Excluded Medication|2|||
163113731|NCT01703208|589124408|FG000|Overall Study|Site Discontinued Study Participation|23|||
163113732|NCT01703208|589124409|FG001|Overall Study|Site Discontinued Study Participation|27|||
163113733|NCT01703208|589124408|FG000|Overall Study|Physician Decision|11|||
163113734|NCT01703208|589124409|FG001|Overall Study|Physician Decision|13|||
163113735|NCT01703208|589124408|FG000|Overall Study|Progressive disease|2|||
163113736|NCT01703208|589124409|FG001|Overall Study|Progressive disease|2|||
163113737|NCT01703208|589124408|FG000|Overall Study|Protocol Violation|1|||
163113738|NCT01703208|589124409|FG001|Overall Study|Protocol Violation|1|||
163113739|NCT01703208|589124408|FG000|Overall Study|Study Terminated by Sponsor|1710|||
163113740|NCT01703208|589124409|FG001|Overall Study|Study Terminated by Sponsor|1716|||
163113741|NCT01703208|589124408|FG000|Overall Study|Withdrawal by Subject|205|||
163113742|NCT01703208|589124409|FG001|Overall Study|Withdrawal by Subject|209|||
163113743|NCT01703208|589124408|FG000|Overall Study|Adverse Event|14|||
163113744|NCT01703208|589124409|FG001|Overall Study|Adverse Event|19|||
163113745|NCT01703208|589124408|FG000|Overall Study|Technical Problems|0|||
163113746|NCT01703208|589124409|FG001|Overall Study|Technical Problems|1|||
163113747|NCT01703208|589124408|FG000|Overall Study|Protocol Deviation|2|||
163113748|NCT01703208|589124409|FG001|Overall Study|Protocol Deviation|0|||
163113749|NCT04600076|589124413|FG000|Overall Study|Lost to Follow-up|3|||
163113750|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
163113751|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
163113752|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
163113753|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
163113754|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
163113755|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
163113756|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
163113757|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
163113758|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
163113759|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
163113760|NCT01639339|589124414|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
163113761|NCT01639339|589124415|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
163113762|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
163113763|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
163113764|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
163113765|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
163113766|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
163113767|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
163113768|NCT01639339|589124414|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
163113769|NCT01639339|589124415|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
163113770|NCT02891681|589124416|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
163113771|NCT02891681|589124417|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
163113772|NCT02891681|589124418|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
163113773|NCT02891681|589124416|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
163113774|NCT02891681|589124417|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
163113775|NCT02891681|589124418|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
163113776|NCT02891681|589124416|FG000|Overall Study|Taken off study after first imaging appointment|1|||
163113777|NCT02891681|589124417|FG001|Overall Study|Taken off study after first imaging appointment|0|||
163113778|NCT02891681|589124418|FG002|Overall Study|Taken off study after first imaging appointment|0|||
163113779|NCT01170598|589124419|FG000|Overall Study|Withdrawal by Subject|1|||
163113780|NCT01170598|589124419|FG000|Overall Study|Death|3|||
163113781|NCT01170598|589124419|FG000|Overall Study|Lost to Follow-up|1|||
163113782|NCT01170598|589124419|FG000|Overall Study|Refused|1|||
163113783|NCT01271712|589124420|FG000|Double Blind Treatment|Death|2|||
163113784|NCT01271712|589124421|FG001|Double Blind Treatment|Death|0|||
163113785|NCT01271712|589124420|FG000|Double Blind Treatment|Lack of Efficacy|1|||
163113786|NCT01271712|589124421|FG001|Double Blind Treatment|Lack of Efficacy|0|||
163113787|NCT01271712|589124420|FG000|Double Blind Treatment|Adverse Event|9|||
163113788|NCT01271712|589124421|FG001|Double Blind Treatment|Adverse Event|4|||
163113789|NCT01271712|589124420|FG000|Double Blind Treatment|Progressive disease|23|||
163113790|NCT01271712|589124421|FG001|Double Blind Treatment|Progressive disease|3|||
163113791|NCT01271712|589124420|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
163113792|NCT01271712|589124421|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
163113793|NCT01271712|589124420|FG000|Double Blind Treatment|Non compliance with study drug|2|||
163113794|NCT01271712|589124421|FG001|Double Blind Treatment|Non compliance with study drug|0|||
163113795|NCT01271712|589124420|FG000|Double Blind Treatment|receive no study drug|1|||
163113796|NCT01271712|589124421|FG001|Double Blind Treatment|receive no study drug|0|||
163113797|NCT01271712|589124420|FG000|Open Label Treatment|Death|6|||
163113798|NCT01271712|589124421|FG001|Open Label Treatment|Death|5|||
163113799|NCT01271712|589124420|FG000|Open Label Treatment|Withdrawal by Subject|6|||
163113800|NCT01271712|589124421|FG001|Open Label Treatment|Withdrawal by Subject|11|||
163113801|NCT01271712|589124420|FG000|Open Label Treatment|Physician Decision|2|||
163113802|NCT01271712|589124421|FG001|Open Label Treatment|Physician Decision|0|||
163113803|NCT01271712|589124420|FG000|Open Label Treatment|Adverse Event|14|||
163113804|NCT01271712|589124421|FG001|Open Label Treatment|Adverse Event|8|||
163113805|NCT01271712|589124420|FG000|Open Label Treatment|Progressive disease|59|||
163113806|NCT01271712|589124421|FG001|Open Label Treatment|Progressive disease|32|||
163113807|NCT01271712|589124420|FG000|Open Label Treatment|transferred to rollover study|1|||
163113808|NCT01271712|589124421|FG001|Open Label Treatment|transferred to rollover study|0|||
163113809|NCT01271712|589124420|FG000|Open Label Treatment|Non-compliance with study drug|1|||
163113810|NCT01271712|589124421|FG001|Open Label Treatment|Non-compliance with study drug|0|||
163113811|NCT01271712|589124420|FG000|Open Label Treatment|Protocol Violation|0|||
163113812|NCT01271712|589124421|FG001|Open Label Treatment|Protocol Violation|1|||
163113813|NCT01271712|589124420|FG000|Open Label Treatment|Switching to other therapy|2|||
163113814|NCT01271712|589124421|FG001|Open Label Treatment|Switching to other therapy|1|||
163113815|NCT01271712|589124420|FG000|Safety Follow-up|Death|11|||
163113816|NCT01271712|589124421|FG001|Safety Follow-up|Death|7|||
163113817|NCT01271712|589124420|FG000|Safety Follow-up|Withdrawal by Subject|4|||
163113818|NCT01271712|589124421|FG001|Safety Follow-up|Withdrawal by Subject|2|||
163113819|NCT01271712|589124420|FG000|Safety Follow-up|Protocol Violation|1|||
163113820|NCT01271712|589124421|FG001|Safety Follow-up|Protocol Violation|1|||
163113821|NCT01271712|589124420|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
163113822|NCT01271712|589124421|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
163113823|NCT01271712|589124420|FG000|Safety Follow-up|No follow-up|1|||
163113824|NCT01271712|589124421|FG001|Safety Follow-up|No follow-up|1|||
163113825|NCT01271712|589124420|FG000|Safety Follow-up|Progressive disease|1|||
163113826|NCT01271712|589124421|FG001|Safety Follow-up|Progressive disease|0|||
163113827|NCT01271712|589124420|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
163113828|NCT01271712|589124421|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
163113829|NCT02685748|589124424|FG000|Overall Study|Withdrawal by Subject|3|||
163113830|NCT02685748|589124425|FG001|Overall Study|Withdrawal by Subject|2|||
163113831|NCT04669262|589124435|FG000|Overall Study|Withdrawal by Subject|0|||
163113832|NCT04669262|589124436|FG001|Overall Study|Withdrawal by Subject|0|||
163113833|NCT04669262|589124437|FG002|Overall Study|Withdrawal by Subject|0|||
163113834|NCT04669262|589124438|FG003|Overall Study|Withdrawal by Subject|1|||
163113835|NCT04669262|589124435|FG000|Overall Study|Randomized but Not Treated|0|||
163113836|NCT04669262|589124436|FG001|Overall Study|Randomized but Not Treated|1|||
163113837|NCT04669262|589124437|FG002|Overall Study|Randomized but Not Treated|0|||
163113838|NCT04669262|589124438|FG003|Overall Study|Randomized but Not Treated|0|||
163113839|NCT01638013|589124439|FG000|Overall Study|Adverse Event|36|||
163113840|NCT01638013|589124440|FG001|Overall Study|Adverse Event|29|||
163113841|NCT01638013|589124441|FG002|Overall Study|Adverse Event|48|||
163113842|NCT01638013|589124439|FG000|Overall Study|Lack of Efficacy|39|||
163113843|NCT01638013|589124440|FG001|Overall Study|Lack of Efficacy|11|||
163113844|NCT01638013|589124441|FG002|Overall Study|Lack of Efficacy|14|||
163113845|NCT01638013|589124439|FG000|Overall Study|Protocol Violation|10|||
163113846|NCT01638013|589124440|FG001|Overall Study|Protocol Violation|7|||
163113847|NCT01638013|589124441|FG002|Overall Study|Protocol Violation|11|||
163113848|NCT01638013|589124439|FG000|Overall Study|Met discontinuation criteria|4|||
163113849|NCT01638013|589124440|FG001|Overall Study|Met discontinuation criteria|0|||
163113850|NCT01638013|589124441|FG002|Overall Study|Met discontinuation criteria|7|||
163113851|NCT01638013|589124439|FG000|Overall Study|Subject Lost to Follow up|1|||
163113852|NCT01638013|589124440|FG001|Overall Study|Subject Lost to Follow up|0|||
163113853|NCT01638013|589124441|FG002|Overall Study|Subject Lost to Follow up|1|||
163113854|NCT01638013|589124439|FG000|Overall Study|Miscellaneous|25|||
163113855|NCT01638013|589124440|FG001|Overall Study|Miscellaneous|19|||
163113856|NCT01638013|589124441|FG002|Overall Study|Miscellaneous|23|||
163113857|NCT01638013|589124439|FG000|Overall Study|Withdrawal of Consent|16|||
163113858|NCT01638013|589124440|FG001|Overall Study|Withdrawal of Consent|12|||
163113859|NCT01638013|589124441|FG002|Overall Study|Withdrawal of Consent|16|||
163113860|NCT01638013|589124439|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
163113861|NCT01638013|589124440|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
163113862|NCT01638013|589124441|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
163113863|NCT01846299|589124444|FG000|Overall Study|Physician Decision|4|||
163113864|NCT01846299|589124445|FG001|Overall Study|Physician Decision|2|||
163113865|NCT01846299|589124444|FG000|Overall Study|Protocol deviation|1|||
163113866|NCT01846299|589124445|FG001|Overall Study|Protocol deviation|0|||
163113867|NCT01846299|589124444|FG000|Overall Study|Death|1|||
163113868|NCT01846299|589124445|FG001|Overall Study|Death|2|||
163113869|NCT01846299|589124444|FG000|Overall Study|Lost to Follow-up|3|||
163113870|NCT01846299|589124445|FG001|Overall Study|Lost to Follow-up|0|||
163113871|NCT01846299|589124444|FG000|Overall Study|Withdrawal by Subject|1|||
163113872|NCT01846299|589124445|FG001|Overall Study|Withdrawal by Subject|6|||
163113873|NCT01846299|589124444|FG000|Overall Study|Adverse Event|2|||
163113874|NCT01846299|589124445|FG001|Overall Study|Adverse Event|0|||
163113875|NCT03559517|589124446|FG000|Overall Study|Withdrawal by Subject|1|||
162654029|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
162654030|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
162654031|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
162654032|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
162654033|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
162654034|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
163113876|NCT03559517|589124447|FG001|Overall Study|Withdrawal by Subject|0|||
163113877|NCT03559517|589124448|FG002|Overall Study|Withdrawal by Subject|0|||
163113878|NCT01960998|589124449|FG000|Overall Study|Lost to Follow-up|3|||
163113879|NCT01960998|589124450|FG001|Overall Study|Lost to Follow-up|7|||
163113880|NCT01960998|589124449|FG000|Overall Study|Death|0|||
163113881|NCT01960998|589124450|FG001|Overall Study|Death|1|||
163113882|NCT01960998|589124449|FG000|Overall Study|Withdrawal by Subject|8|||
163113883|NCT01960998|589124450|FG001|Overall Study|Withdrawal by Subject|2|||
163113884|NCT01960998|589124449|FG000|Overall Study|lost computer access|0|||
162654035|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
163113885|NCT01960998|589124450|FG001|Overall Study|lost computer access|1|||
162654036|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
162654037|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
162654038|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
162654039|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
162654040|NCT02161718|587449676|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
162654041|NCT02161718|587449677|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
162654042|NCT02161718|587449678|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
163113886|NCT01774253|589124454|FG000|Overall Study|Lack of Efficacy|4|||
163113887|NCT01774253|589124454|FG000|Overall Study|Physician Decision|2|||
163113888|NCT01774253|589124454|FG000|Overall Study|Withdrawal by Subject|2|||
163113889|NCT01774253|589124454|FG000|Overall Study|Death|1|||
163113890|NCT00772369|589124455|FG000|Overall Study|Did not return record release form|1|||
163113891|NCT03510468|589124456|FG000|Overall Study|Lost to Follow-up|1|||
163113892|NCT03510468|589124456|FG000|Overall Study|Adverse Event|5|||
163113893|NCT03510468|589124456|FG000|Overall Study|Physician Decision|1|||
163113894|NCT03510468|589124456|FG000|Overall Study|non-compliant with treatment|2|||
163113895|NCT03510468|589124456|FG000|Overall Study|Missed visit|1|||
163113896|NCT00840060|589125752|FG000|Overall Study|Withdrawal by Subject|1|||
163113897|NCT00840060|589125753|FG001|Overall Study|Withdrawal by Subject|0|||
163113898|NCT00840060|589125752|FG000|Overall Study|Change in emotional/behavioral status|0|||
163113899|NCT00840060|589125753|FG001|Overall Study|Change in emotional/behavioral status|1|||
163113900|NCT01103063|589125754|FG000|Overall Study|Adverse Event|3|||
163113901|NCT01103063|589125755|FG001|Overall Study|Adverse Event|1|||
163113902|NCT01103063|589125754|FG000|Overall Study|Lost to Follow-up|68|||
163113903|NCT01103063|589125755|FG001|Overall Study|Lost to Follow-up|51|||
163113904|NCT01103063|589125754|FG000|Overall Study|Withdrawal by Subject|60|||
163113905|NCT01103063|589125755|FG001|Overall Study|Withdrawal by Subject|15|||
163113906|NCT01103063|589125754|FG000|Overall Study|Other|16|||
163113907|NCT01103063|589125755|FG001|Overall Study|Other|11|||
163113908|NCT01103063|589125754|FG000|Overall Study|Protocol Violation|1|||
163113909|NCT01103063|589125755|FG001|Overall Study|Protocol Violation|0|||
163113910|NCT01103063|589125754|FG000|Overall Study|Study terminated by Sponsor|326|||
163113911|NCT01103063|589125755|FG001|Overall Study|Study terminated by Sponsor|342|||
163113912|NCT01103063|589125754|FG000|Overall Study|Death|3|||
163113913|NCT01103063|589125755|FG001|Overall Study|Death|1|||
163113914|NCT03899064|589125758|FG000|Overall Study|Lost to Follow-up|1|||
163113915|NCT03899064|589125758|FG000|Overall Study|Protocol Violation|2|||
163113916|NCT03899064|589125758|FG000|Overall Study|Withdrawal by Subject|2|||
163113917|NCT03899064|589125758|FG000|Overall Study|Other|2|||
163113918|NCT03283098|589125759|FG000|Overall Study|Withdrawal by Subject|0|||
163113919|NCT03283098|589125760|FG001|Overall Study|Withdrawal by Subject|1|||
163113920|NCT01069861|589125763|FG000|Overall Study|Death|1|||
163113921|NCT01069861|589125763|FG000|Overall Study|Adverse Event|1|||
163113922|NCT01069861|589125763|FG000|Overall Study|Did not meet entrance criteria|1|||
163113923|NCT00354107|589125764|FG000|Overall Study|Adverse Event|2|||
163113924|NCT00354107|589125764|FG000|Overall Study|Physician Decision|2|||
163113925|NCT00354107|589125764|FG000|Overall Study|Withdrawal by Subject|1|||
163113926|NCT03136497|589125775|FG000|Overall Study|Screen Failure|1|||
163113927|NCT03136497|589125776|FG001|Overall Study|Screen Failure|0|||
163113928|NCT03136497|589125777|FG002|Overall Study|Screen Failure|0|||
163113929|NCT00557310|589125779|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
163113930|NCT00557310|589125779|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
163113931|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
163113932|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
163113933|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
163113934|NCT00557310|589125779|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
163113935|NCT02351349|589125780|FG000|Overall Study|Withdrawal by Subject|2|||
163113936|NCT02351349|589125781|FG001|Overall Study|Withdrawal by Subject|3|||
163113937|NCT02649218|589125782|FG000|Overall Study|Adverse Event|8|||
163113938|NCT02649218|589125782|FG000|Overall Study|Lack of Efficacy|8|||
163113939|NCT02649218|589125782|FG000|Overall Study|Pregnancy|3|||
163113940|NCT02649218|589125782|FG000|Overall Study|Protocol Violation|3|||
163113941|NCT02649218|589125782|FG000|Overall Study|Physician Decision|1|||
163113942|NCT02649218|589125782|FG000|Overall Study|Withdrawal by Subject|2|||
163113943|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
163113944|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
163113945|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
163113946|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
163113947|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
163113948|NCT01224821|589125783|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
163113949|NCT01224821|589125783|FG000|Long-Term Follow-Up|Death|2|||
163113950|NCT01224821|589125783|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
163113951|NCT02174523|589125784|FG000|Overall Study|Withdrawal by Subject|1|||
163113952|NCT02174523|589125785|FG001|Overall Study|Withdrawal by Subject|0|||
163113953|NCT00794365|589125786|FG000|Overall Study|Lost to Follow-up|38|||
163113954|NCT00794365|589125786|FG000|Overall Study|Other|17|||
163113955|NCT00794365|589125786|FG000|Overall Study|Poor Compliance|11|||
163113956|NCT00794365|589125786|FG000|Overall Study|Adverse Event|10|||
163113957|NCT00794365|589125786|FG000|Overall Study|Lack of Efficacy|3|||
163113958|NCT02701777|589125789|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
163113959|NCT02701777|589125790|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
163113960|NCT02701777|589125791|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
163113961|NCT02701777|589125792|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
163113962|NCT02701777|589125789|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
163113963|NCT02701777|589125790|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
163113964|NCT02701777|589125791|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
163113965|NCT02701777|589125792|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
163113966|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
163113967|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
163113968|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
163113969|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
163113970|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
163113971|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
163113972|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
163113973|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
163113974|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
163113975|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
163113976|NCT03549871|589125795|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
163113977|NCT03549871|589125796|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
163113978|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
163113979|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
163113980|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
163113981|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
163113982|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
163113983|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
163113984|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
163113985|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
163113986|NCT03549871|589125795|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
163113987|NCT03549871|589125796|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
163113988|NCT01904149|589125797|FG000|Overall Study|Adverse Event|3|||
163113989|NCT01904149|589125798|FG001|Overall Study|Adverse Event|4|||
163113990|NCT01904149|589125799|FG002|Overall Study|Adverse Event|0|||
163113991|NCT01904149|589125800|FG003|Overall Study|Adverse Event|1|||
163113992|NCT01904149|589125801|FG004|Overall Study|Adverse Event|1|||
163113993|NCT01904149|589125802|FG005|Overall Study|Adverse Event|2|||
163113994|NCT01904149|589125797|FG000|Overall Study|Lack of Efficacy|0|||
163113995|NCT01904149|589125798|FG001|Overall Study|Lack of Efficacy|3|||
163113996|NCT01904149|589125799|FG002|Overall Study|Lack of Efficacy|1|||
163113997|NCT01904149|589125800|FG003|Overall Study|Lack of Efficacy|3|||
163113998|NCT01904149|589125801|FG004|Overall Study|Lack of Efficacy|3|||
163113999|NCT01904149|589125802|FG005|Overall Study|Lack of Efficacy|1|||
163114000|NCT01904149|589125797|FG000|Overall Study|Withdrawal by Subject|1|||
163114001|NCT01904149|589125798|FG001|Overall Study|Withdrawal by Subject|3|||
163114002|NCT01904149|589125799|FG002|Overall Study|Withdrawal by Subject|1|||
163114003|NCT01904149|589125800|FG003|Overall Study|Withdrawal by Subject|0|||
163114004|NCT01904149|589125801|FG004|Overall Study|Withdrawal by Subject|1|||
163114005|NCT01904149|589125802|FG005|Overall Study|Withdrawal by Subject|0|||
163114006|NCT01904149|589125797|FG000|Overall Study|Protocol Violation|0|||
163114007|NCT01904149|589125798|FG001|Overall Study|Protocol Violation|1|||
162654043|NCT02161718|587449676|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
162654044|NCT02161718|587449677|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
162654045|NCT02161718|587449678|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
162654046|NCT02161718|587449676|FG000|Post- Randomization Period|Lost to Follow-up|0|||
162654047|NCT02161718|587449677|FG001|Post- Randomization Period|Lost to Follow-up|9|||
162654048|NCT02161718|587449678|FG002|Post- Randomization Period|Lost to Follow-up|15|||
162654049|NCT02161718|587449676|FG000|Post- Randomization Period|Adverse Event|0|||
162654050|NCT02161718|587449677|FG001|Post- Randomization Period|Adverse Event|9|||
162654051|NCT02161718|587449678|FG002|Post- Randomization Period|Adverse Event|10|||
162654052|NCT02161718|587449676|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
162654053|NCT02161718|587449677|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
163114008|NCT01904149|589125799|FG002|Overall Study|Protocol Violation|0|||
163114009|NCT01904149|589125800|FG003|Overall Study|Protocol Violation|0|||
162654054|NCT02161718|587449678|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
163114010|NCT01904149|589125801|FG004|Overall Study|Protocol Violation|0|||
163114011|NCT01904149|589125802|FG005|Overall Study|Protocol Violation|0|||
163114012|NCT01904149|589125797|FG000|Overall Study|non compliance with study drug|1|||
163114013|NCT01904149|589125798|FG001|Overall Study|non compliance with study drug|0|||
163114014|NCT01904149|589125799|FG002|Overall Study|non compliance with study drug|0|||
163114015|NCT01904149|589125800|FG003|Overall Study|non compliance with study drug|0|||
163114016|NCT01904149|589125801|FG004|Overall Study|non compliance with study drug|0|||
163114017|NCT01904149|589125802|FG005|Overall Study|non compliance with study drug|0|||
163114018|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Death|5|||
163114019|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Death|0|||
163114020|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Death|0|||
163114021|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
163114022|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
163114023|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
163114024|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
163114025|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
163114026|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
163114027|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
163114028|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
163114029|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
163114030|NCT01357161|589125803|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
163114031|NCT01357161|589125804|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
163114032|NCT01357161|589125805|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
163114033|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
163114034|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
163114035|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
163114036|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
163114037|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
163114038|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
163114039|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
163114040|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
163114041|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
163114042|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
163114043|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
163114044|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
163114045|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
163114046|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
163114047|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
163114048|NCT01357161|589125803|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
163114049|NCT01357161|589125804|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
163114050|NCT01357161|589125805|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
163114051|NCT01824823|589125806|FG000|Overall Study|Lack of Efficacy|1|||
163114052|NCT01824823|589125807|FG001|Overall Study|Lack of Efficacy|1|||
163114053|NCT01824823|589125806|FG000|Overall Study|Off-treatment reason not submitted|1|||
163114054|NCT01824823|589125807|FG001|Overall Study|Off-treatment reason not submitted|0|||
163114055|NCT03349645|589125808|FG000|Overall Study|Sponsor Terminated Study|75|||
163114056|NCT03349645|589125808|FG000|Overall Study|Withdrawal by Subject|4|||
163114057|NCT03349645|589125808|FG000|Overall Study|Protocol Violation|1|||
163114058|NCT03349645|589125808|FG000|Overall Study|Other|2|||
163114059|NCT02910401|589125809|FG000|Overall Study|Study closure Study closure|0|||
163114060|NCT02910401|589125810|FG001|Overall Study|Study closure Study closure|0|||
163114061|NCT02910401|589125811|FG002|Overall Study|Study closure Study closure|2|||
163114062|NCT02910401|589125809|FG000|Overall Study|Physician Decision|1|||
163114063|NCT02910401|589125810|FG001|Overall Study|Physician Decision|0|||
163114064|NCT02910401|589125811|FG002|Overall Study|Physician Decision|0|||
163114065|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
163114066|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
163114067|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Death|0|||
163114068|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Death|0|||
163114069|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
163114070|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
163114071|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
163114072|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
163114073|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
163114074|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
163114075|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
163114076|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
162654055|NCT02161718|587449676|FG000|Post- Randomization Period|Physician Decision|0|||
162654056|NCT02161718|587449677|FG001|Post- Randomization Period|Physician Decision|2|||
163114077|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
163114078|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
163114079|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
163114080|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
163114081|NCT00433160|589125813|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
163114082|NCT00433160|589125814|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
163114083|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
163114084|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
163114085|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
163114086|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
163114087|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
163114088|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
163114089|NCT00433160|589125813|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
163114090|NCT00433160|589125814|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
163114091|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
163114092|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
163114093|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
163114094|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
163114095|NCT00433160|589125813|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
163114096|NCT00433160|589125814|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
163114097|NCT02240368|589125815|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
163114098|NCT02240368|589125816|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
163114099|NCT02240368|589125817|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
163114100|NCT02240368|589125815|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
163114101|NCT02240368|589125816|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
163114102|NCT02240368|589125817|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
163114103|NCT03372460|589125821|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
163114104|NCT03372460|589125822|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
163114105|NCT00871117|589125830|FG000|Overall Study|Lost to Follow-up|5|||
163114106|NCT00871117|589125831|FG001|Overall Study|Lost to Follow-up|6|||
163114107|NCT00871117|589125830|FG000|Overall Study|Other|0|||
163114108|NCT00871117|589125831|FG001|Overall Study|Other|4|||
163114109|NCT00916058|589125832|FG000|Phase 1|Screen Failure|0|||
163114110|NCT00916058|589125833|FG001|Phase 1|Screen Failure|0|||
163114111|NCT00916058|589125834|FG002|Phase 1|Screen Failure|0|||
163114112|NCT00916058|589125835|FG003|Phase 1|Screen Failure|0|||
163114113|NCT00916058|589125836|FG004|Phase 1|Screen Failure|0|||
163114114|NCT00916058|589125837|FG005|Phase 1|Screen Failure|1|||
163114115|NCT00916058|589125838|FG006|Phase 1|Screen Failure|0|||
163114116|NCT00916058|589125832|FG000|Phase 2|Screen Failure|0|||
163114117|NCT00916058|589125833|FG001|Phase 2|Screen Failure|0|||
163114118|NCT00916058|589125834|FG002|Phase 2|Screen Failure|0|||
163114119|NCT00916058|589125835|FG003|Phase 2|Screen Failure|0|||
163114120|NCT00916058|589125836|FG004|Phase 2|Screen Failure|0|||
163114121|NCT00916058|589125837|FG005|Phase 2|Screen Failure|0|||
163114122|NCT00916058|589125838|FG006|Phase 2|Screen Failure|3|||
163114123|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
163114124|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163114125|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163114126|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
163114127|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
163114128|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
163114129|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
162654057|NCT02161718|587449678|FG002|Post- Randomization Period|Physician Decision|4|||
162654058|NCT02161718|587449676|FG000|Post- Randomization Period|Protocol Violation|0|||
162654059|NCT02161718|587449677|FG001|Post- Randomization Period|Protocol Violation|2|||
162654060|NCT02161718|587449678|FG002|Post- Randomization Period|Protocol Violation|3|||
162654061|NCT02161718|587449676|FG000|Post- Randomization Period|Lack of Efficacy|0|||
163114130|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
163114131|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
162654062|NCT02161718|587449677|FG001|Post- Randomization Period|Lack of Efficacy|0|||
162654063|NCT02161718|587449678|FG002|Post- Randomization Period|Lack of Efficacy|1|||
162654064|NCT02161718|587449676|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
163114132|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
163114133|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
163114134|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
163114135|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
163114136|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
163114137|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
163114138|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
163114139|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114140|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
163114141|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114142|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
163114143|NCT03222973|589125839|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
163114144|NCT03222973|589125840|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
163114145|NCT03222973|589125841|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
163114146|NCT03222973|589125842|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
163114147|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114148|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114149|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
163114150|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163114151|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
163114152|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
163114153|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
163114154|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
163114155|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
163114156|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
163114157|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
163114158|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
163114159|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
163114160|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
163114161|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
163114162|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
163114163|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
163114164|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
163114165|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
163114166|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
163114167|NCT03222973|589125839|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114168|NCT03222973|589125840|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114169|NCT03222973|589125841|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
163114170|NCT03222973|589125842|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
163114171|NCT02080481|589125843|FG000|Overall Study|Never received a block.|1|||
163114172|NCT02080481|589125844|FG001|Overall Study|Never received a block.|0|||
163114173|NCT02439450|589125846|FG000|Overall Study|Adverse Event|4|||
163114174|NCT02439450|589125847|FG001|Overall Study|Adverse Event|1|||
163114175|NCT02439450|589125848|FG002|Overall Study|Adverse Event|0|||
163114176|NCT02439450|589125849|FG003|Overall Study|Adverse Event|0|||
163114177|NCT02439450|589125846|FG000|Overall Study|Withdrawal by Subject|1|||
163114178|NCT02439450|589125847|FG001|Overall Study|Withdrawal by Subject|2|||
163114179|NCT02439450|589125848|FG002|Overall Study|Withdrawal by Subject|0|||
162654065|NCT02161718|587449677|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
162654066|NCT02161718|587449678|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
162654067|NCT02161718|587449676|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
163114180|NCT02439450|589125849|FG003|Overall Study|Withdrawal by Subject|0|||
162654068|NCT02161718|587449677|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
163114181|NCT02439450|589125846|FG000|Overall Study|Death|3|||
163114182|NCT02439450|589125847|FG001|Overall Study|Death|0|||
163114183|NCT02439450|589125848|FG002|Overall Study|Death|0|||
163114184|NCT02439450|589125849|FG003|Overall Study|Death|1|||
163114185|NCT02439450|589125846|FG000|Overall Study|Progressive Disease|18|||
163114186|NCT02439450|589125847|FG001|Overall Study|Progressive Disease|41|||
163114187|NCT02439450|589125848|FG002|Overall Study|Progressive Disease|2|||
163114188|NCT02439450|589125849|FG003|Overall Study|Progressive Disease|3|||
163114189|NCT03730961|589125854|FG000|Overall Study|Adverse Event|0|||
163114190|NCT03730961|589125855|FG001|Overall Study|Adverse Event|1|||
163114191|NCT04508751|589125860|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
163114192|NCT04508751|589125861|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
163114193|NCT04508751|589125862|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
163114194|NCT01444027|589125873|FG000|Overall Study|Withdrawal by Subject|4|||
163114195|NCT01444027|589125874|FG001|Overall Study|Withdrawal by Subject|10|||
163114196|NCT01444027|589125875|FG002|Overall Study|Withdrawal by Subject|24|||
163114197|NCT01444027|589125873|FG000|Overall Study|Lost to Follow-up|26|||
163114198|NCT01444027|589125874|FG001|Overall Study|Lost to Follow-up|20|||
163114199|NCT01444027|589125875|FG002|Overall Study|Lost to Follow-up|14|||
163114200|NCT03551665|589125877|FG000|Overall Study|Lost to Follow-up|11|||
163114201|NCT03551665|589125878|FG001|Overall Study|Lost to Follow-up|2|||
163114202|NCT03966885|589127428|FG000|Overall Study|Death|1|||
163114203|NCT03966885|589127429|FG001|Overall Study|Death|0|||
163114204|NCT03966885|589127428|FG000|Overall Study|Lost to Follow-up|1|||
163114205|NCT03966885|589127429|FG001|Overall Study|Lost to Follow-up|2|||
163114206|NCT03966885|589127428|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
163114207|NCT03966885|589127429|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
163114208|NCT03966885|589127428|FG000|Overall Study|Moved from study area.|0|||
163114209|NCT03966885|589127429|FG001|Overall Study|Moved from study area.|2|||
163114210|NCT01514240|589127430|FG000|Overall Study|Adverse Event|4|||
163114211|NCT01514240|589127431|FG001|Overall Study|Adverse Event|4|||
163114212|NCT01514240|589127430|FG000|Overall Study|Subject Decision|2|||
163114213|NCT01514240|589127431|FG001|Overall Study|Subject Decision|7|||
163114214|NCT00509093|589127432|FG000|Overall Study|Adverse Event|10|||
163114215|NCT00509093|589127432|FG000|Overall Study|Disease Progression|9|||
163114216|NCT00509093|589127432|FG000|Overall Study|Transformed into MDS|1|||
163114217|NCT00509093|589127432|FG000|Overall Study|Withdrawal by Subject|3|||
163114218|NCT00509093|589127432|FG000|Overall Study|Physician Decision|1|||
163114219|NCT05013424|589127433|FG000|Overall Study|Lost to Follow-up|1|||
163114220|NCT05013424|589127434|FG001|Overall Study|Lost to Follow-up|1|||
163114221|NCT05013424|589127435|FG002|Overall Study|Lost to Follow-up|1|||
163114222|NCT05013424|589127433|FG000|Overall Study|Withdrawal by Subject|0|||
163114223|NCT05013424|589127434|FG001|Overall Study|Withdrawal by Subject|1|||
163114224|NCT05013424|589127435|FG002|Overall Study|Withdrawal by Subject|0|||
163114225|NCT04143217|589127442|FG000|Overall Study|Withdrawal by Subject|42|||
163114226|NCT04143217|589127442|FG000|Overall Study|Adverse Event|29|||
163114227|NCT04143217|589127442|FG000|Overall Study|Lost to Follow-up|29|||
163114228|NCT04143217|589127442|FG000|Overall Study|Lack of Efficacy|15|||
163114229|NCT04143217|589127442|FG000|Overall Study|Physician Decision|1|||
163114230|NCT04143217|589127442|FG000|Overall Study|Non-Compliance With Study Drug|6|||
163114231|NCT04143217|589127442|FG000|Overall Study|Other, Multiple Categories|11|||
163114232|NCT03538444|589127456|FG000|Overall Study|opioid withdrawal|1|||
163114233|NCT03538444|589127457|FG001|Overall Study|opioid withdrawal|0|||
163114234|NCT01451931|589127458|FG000|Overall Study|Lost to Follow-up|17|||
163114235|NCT01451931|589127459|FG001|Overall Study|Lost to Follow-up|36|||
163114236|NCT01451931|589127460|FG002|Overall Study|Lost to Follow-up|21|||
163114237|NCT01451931|589127458|FG000|Overall Study|Withdrawal by Subject|16|||
163114238|NCT01451931|589127459|FG001|Overall Study|Withdrawal by Subject|22|||
163114239|NCT01451931|589127460|FG002|Overall Study|Withdrawal by Subject|22|||
163114240|NCT03640052|589127466|FG000|Overall Study|Lost to Follow-up|0|||
163114241|NCT03640052|589127467|FG001|Overall Study|Lost to Follow-up|1|||
163114242|NCT03640052|589127468|FG002|Overall Study|Lost to Follow-up|0|||
163114243|NCT03640052|589127469|FG003|Overall Study|Lost to Follow-up|0|||
163114244|NCT03640052|589127470|FG004|Overall Study|Lost to Follow-up|0|||
162719332|NCT00371566|587678483|FG001|Treatment Phase|Withdrawal by Subject|1|||
162719333|NCT00371566|587678482|FG000|Treatment Phase|Adverse Event|0|||
162719334|NCT00371566|587678483|FG001|Treatment Phase|Adverse Event|1|||
163114245|NCT04422561|589127471|FG000|Overall Study|Lost to Follow-up|25|||
163114246|NCT04422561|589127472|FG001|Overall Study|Lost to Follow-up|11|||
163114247|NCT05479097|589127478|FG000|Overall Study|Withdrawal by Subject|2|||
163114248|NCT04126564|589127479|FG000|Overall Study|Withdrawal by Subject|0|||
163114249|NCT04126564|589127480|FG001|Overall Study|Withdrawal by Subject|2|||
163114250|NCT04126564|589127479|FG000|Overall Study|Lost to Follow-up|0|||
163114251|NCT04126564|589127480|FG001|Overall Study|Lost to Follow-up|1|||
163114252|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
163114253|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
163114254|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
163114255|NCT00230282|589127484|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
162654069|NCT02161718|587449678|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
162654070|NCT02161718|587449676|FG000|Post- Randomization Period|Relocation|0|||
162654071|NCT02161718|587449677|FG001|Post- Randomization Period|Relocation|3|||
162654072|NCT02161718|587449678|FG002|Post- Randomization Period|Relocation|0|||
162654073|NCT02948842|587449681|FG000|Overall Study|Withdrawal by Subject|4|||
162654074|NCT01537783|587449682|FG000|Overall Study|Lost to Follow-up|11|||
162654075|NCT01537783|587449683|FG001|Overall Study|Lost to Follow-up|2|||
162654076|NCT02350309|587449685|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
162654077|NCT02350309|587449686|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
162654078|NCT02350309|587449687|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
162654079|NCT02350309|587449688|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
162654080|NCT02350309|587449689|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
162654081|NCT02350309|587449690|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
163114256|NCT03941964|589127489|FG000|Overall Study|Adverse Event|1|||
163114257|NCT03941964|589127490|FG001|Overall Study|Adverse Event|8|||
163114258|NCT03941964|589127489|FG000|Overall Study|Progressive disease|7|||
163114259|NCT03941964|589127490|FG001|Overall Study|Progressive disease|3|||
163114260|NCT03941964|589127489|FG000|Overall Study|Lack of Efficacy|0|||
163114261|NCT03941964|589127490|FG001|Overall Study|Lack of Efficacy|1|||
163114262|NCT03941964|589127489|FG000|Overall Study|Death|3|||
163114263|NCT03941964|589127490|FG001|Overall Study|Death|1|||
163114264|NCT03941964|589127489|FG000|Overall Study|Withdrew consent|1|||
163114265|NCT03941964|589127490|FG001|Overall Study|Withdrew consent|3|||
163114266|NCT03941964|589127489|FG000|Overall Study|Physician Decision|9|||
163114267|NCT03941964|589127490|FG001|Overall Study|Physician Decision|2|||
163114268|NCT03941964|589127489|FG000|Overall Study|Other, not specified|2|||
163114269|NCT03941964|589127490|FG001|Overall Study|Other, not specified|1|||
163114270|NCT00457821|589127494|FG000|Part 2|Withdrawal by Subject|0|||
163114271|NCT00457821|589127495|FG001|Part 2|Withdrawal by Subject|0|||
163114272|NCT00457821|589127496|FG002|Part 2|Withdrawal by Subject|0|||
163114273|NCT00457821|589127497|FG003|Part 2|Withdrawal by Subject|0|||
163114274|NCT00457821|589127498|FG004|Part 2|Withdrawal by Subject|0|||
163114275|NCT00457821|589127499|FG005|Part 2|Withdrawal by Subject|0|||
163114276|NCT00457821|589127500|FG006|Part 2|Withdrawal by Subject|0|||
163114277|NCT00457821|589127501|FG007|Part 2|Withdrawal by Subject|1|||
163114278|NCT00790647|589127506|FG000|Overall Study|Adverse Event|1|||
163114279|NCT02437409|589127511|FG000|Overall Study|Withdrawal by Subject|3|||
163114280|NCT02437409|589127511|FG000|Overall Study|Screening failure|12|||
163114281|NCT00027378|589127512|FG000|Overall Study|Physician Decision|0|||
163114282|NCT00027378|589127513|FG001|Overall Study|Physician Decision|3|||
163114283|NCT01369680|589127515|FG000|Overall Study|Lost to Follow-up|0|||
163114284|NCT01369680|589127516|FG001|Overall Study|Lost to Follow-up|0|||
163114285|NCT01369680|589127517|FG002|Overall Study|Lost to Follow-up|1|||
163114286|NCT01369680|589127518|FG003|Overall Study|Lost to Follow-up|2|||
163114287|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
163114288|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
163114289|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
163114290|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
163114291|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
163114292|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
163114293|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
163114294|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
163114295|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
163114296|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
163114297|NCT00737568|589127521|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
163114298|NCT00737568|589127522|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
163114299|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
163114300|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
163114301|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
163114302|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
163114303|NCT00737568|589127521|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
163114304|NCT00737568|589127522|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
163114305|NCT01133626|589127523|FG000|Overall Study|Adverse Event|0|||
163114306|NCT01133626|589127524|FG001|Overall Study|Adverse Event|1|||
163114307|NCT01133626|589127525|FG002|Overall Study|Adverse Event|0|||
163114308|NCT01133626|589127523|FG000|Overall Study|Withdrawal by Subject|1|||
163114309|NCT01133626|589127524|FG001|Overall Study|Withdrawal by Subject|2|||
163114310|NCT01133626|589127525|FG002|Overall Study|Withdrawal by Subject|2|||
163114311|NCT01133626|589127523|FG000|Overall Study|Other|0|||
163114312|NCT01133626|589127524|FG001|Overall Study|Other|2|||
163114313|NCT01133626|589127525|FG002|Overall Study|Other|0|||
163114314|NCT00951080|589127526|FG000|Overall Study|Adverse Event|3|||
163114315|NCT00951080|589127527|FG001|Overall Study|Adverse Event|3|||
163114316|NCT00951080|589127526|FG000|Overall Study|Lost to Follow-up|0|||
163114317|NCT00951080|589127527|FG001|Overall Study|Lost to Follow-up|1|||
163114318|NCT00951080|589127526|FG000|Overall Study|Physician Decision|4|||
163114319|NCT00951080|589127527|FG001|Overall Study|Physician Decision|1|||
163114320|NCT00951080|589127526|FG000|Overall Study|Other|19|||
163114321|NCT00951080|589127527|FG001|Overall Study|Other|22|||
163114322|NCT01713283|589127531|FG000|Overall Study|Lack of Efficacy|10|||
163114323|NCT01713283|589127532|FG001|Overall Study|Lack of Efficacy|2|||
163114324|NCT01713283|589127531|FG000|Overall Study|Lost to Follow-up|1|||
163114325|NCT01713283|589127532|FG001|Overall Study|Lost to Follow-up|1|||
163114326|NCT02585830|589127533|FG000|Overall Study|Withdrawal by Subject|3|||
163114327|NCT00835640|589127534|FG000|Second Intervention|Protocol Violation|1|||
163114328|NCT00835640|589127535|FG001|Second Intervention|Protocol Violation|0|||
163114329|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
163114330|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
163114331|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Death|1|||
163114332|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Death|0|||
163114333|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
163114334|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
163114335|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
163114336|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
163114337|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
163114338|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
163114339|NCT00350272|589127536|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
163114340|NCT00350272|589127537|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
163114341|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
163114342|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
163114343|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
163114344|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
163114345|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
163114346|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
163114347|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
163114348|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
163114349|NCT00350272|589127536|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
163114350|NCT00350272|589127537|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
163114351|NCT00812006|589127538|FG000|Overall Study|Lost to Follow-up|0|||
163114352|NCT00812006|589127539|FG001|Overall Study|Lost to Follow-up|0|||
163114353|NCT00812006|589127540|FG002|Overall Study|Lost to Follow-up|2|||
163114354|NCT00812006|589127538|FG000|Overall Study|Physician Decision|0|||
163114355|NCT00812006|589127539|FG001|Overall Study|Physician Decision|0|||
163114356|NCT00812006|589127540|FG002|Overall Study|Physician Decision|1|||
163114357|NCT00812006|589127538|FG000|Overall Study|Withdrawal by Subject|2|||
163114358|NCT00812006|589127539|FG001|Overall Study|Withdrawal by Subject|1|||
163114359|NCT00812006|589127540|FG002|Overall Study|Withdrawal by Subject|1|||
163114360|NCT00812006|589127538|FG000|Overall Study|Lack of Qualifying Event|4|||
163114361|NCT00812006|589127539|FG001|Overall Study|Lack of Qualifying Event|2|||
163114362|NCT00812006|589127540|FG002|Overall Study|Lack of Qualifying Event|2|||
163114363|NCT00068250|589127541|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
163114364|NCT00068250|589127542|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
163114365|NCT00068250|589127543|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
163114366|NCT00068250|589127544|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
163114367|NCT00235391|589127546|FG000|Overall Study|Adverse Event|4|||
163114368|NCT00235391|589127547|FG001|Overall Study|Adverse Event|5|||
163114369|NCT00235391|589127548|FG002|Overall Study|Adverse Event|10|||
163114370|NCT00235391|589127549|FG003|Overall Study|Adverse Event|72|||
163114371|NCT00235391|589127550|FG004|Overall Study|Adverse Event|5|||
163114372|NCT00235391|589127551|FG005|Overall Study|Adverse Event|2|||
163114373|NCT00235391|589127546|FG000|Overall Study|Abnormal laboratory value(s)|3|||
163114374|NCT00235391|589127547|FG001|Overall Study|Abnormal laboratory value(s)|5|||
163114375|NCT00235391|589127548|FG002|Overall Study|Abnormal laboratory value(s)|4|||
163114376|NCT00235391|589127549|FG003|Overall Study|Abnormal laboratory value(s)|27|||
163114377|NCT00235391|589127550|FG004|Overall Study|Abnormal laboratory value(s)|1|||
163114378|NCT00235391|589127551|FG005|Overall Study|Abnormal laboratory value(s)|2|||
163114379|NCT00235391|589127546|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163114380|NCT00235391|589127547|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163114381|NCT00235391|589127548|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163114382|NCT00235391|589127549|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
163114383|NCT00235391|589127550|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
163114384|NCT00235391|589127551|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
163114385|NCT00235391|589127546|FG000|Overall Study|Condition no longer requires treatment|3|||
163114386|NCT00235391|589127547|FG001|Overall Study|Condition no longer requires treatment|0|||
163114387|NCT00235391|589127548|FG002|Overall Study|Condition no longer requires treatment|0|||
162654082|NCT02350309|587449685|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
162654083|NCT02350309|587449686|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
162654084|NCT02350309|587449687|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
162654085|NCT02350309|587449688|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
162654086|NCT02350309|587449689|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
163114388|NCT00235391|589127549|FG003|Overall Study|Condition no longer requires treatment|11|||
163114389|NCT00235391|589127550|FG004|Overall Study|Condition no longer requires treatment|1|||
163114390|NCT00235391|589127551|FG005|Overall Study|Condition no longer requires treatment|0|||
163114391|NCT00235391|589127546|FG000|Overall Study|Protocol deviation|0|||
163114392|NCT00235391|589127547|FG001|Overall Study|Protocol deviation|0|||
163114393|NCT00235391|589127548|FG002|Overall Study|Protocol deviation|1|||
163114394|NCT00235391|589127549|FG003|Overall Study|Protocol deviation|11|||
163114395|NCT00235391|589127550|FG004|Overall Study|Protocol deviation|0|||
163114396|NCT00235391|589127551|FG005|Overall Study|Protocol deviation|0|||
163114397|NCT00235391|589127546|FG000|Overall Study|Withdrawal by Subject|2|||
163114398|NCT00235391|589127547|FG001|Overall Study|Withdrawal by Subject|3|||
163114399|NCT00235391|589127548|FG002|Overall Study|Withdrawal by Subject|3|||
163114400|NCT00235391|589127549|FG003|Overall Study|Withdrawal by Subject|61|||
163114401|NCT00235391|589127550|FG004|Overall Study|Withdrawal by Subject|5|||
163114402|NCT00235391|589127551|FG005|Overall Study|Withdrawal by Subject|0|||
163114403|NCT00235391|589127546|FG000|Overall Study|Lost to Follow-up|0|||
163114404|NCT00235391|589127547|FG001|Overall Study|Lost to Follow-up|3|||
163114405|NCT00235391|589127548|FG002|Overall Study|Lost to Follow-up|3|||
163114406|NCT00235391|589127549|FG003|Overall Study|Lost to Follow-up|16|||
163114407|NCT00235391|589127550|FG004|Overall Study|Lost to Follow-up|0|||
163114408|NCT00235391|589127551|FG005|Overall Study|Lost to Follow-up|0|||
163114409|NCT00235391|589127546|FG000|Overall Study|Administrative problems|0|||
163114410|NCT00235391|589127547|FG001|Overall Study|Administrative problems|0|||
163114411|NCT00235391|589127548|FG002|Overall Study|Administrative problems|0|||
163114412|NCT00235391|589127549|FG003|Overall Study|Administrative problems|1|||
163114413|NCT00235391|589127550|FG004|Overall Study|Administrative problems|0|||
163114414|NCT00235391|589127551|FG005|Overall Study|Administrative problems|0|||
163114415|NCT00235391|589127546|FG000|Overall Study|Death|0|||
163114416|NCT00235391|589127547|FG001|Overall Study|Death|0|||
163114417|NCT00235391|589127548|FG002|Overall Study|Death|1|||
163114418|NCT00235391|589127549|FG003|Overall Study|Death|4|||
163114419|NCT00235391|589127550|FG004|Overall Study|Death|0|||
163114420|NCT00235391|589127551|FG005|Overall Study|Death|0|||
163114421|NCT02927925|589127554|FG000|Overall Study|Death|16|||
163114422|NCT02927925|589127554|FG000|Overall Study|Physician Decision|1|||
163114423|NCT02927925|589127554|FG000|Overall Study|Withdrawal by Subject|11|||
163114424|NCT02927925|589127554|FG000|Overall Study|Other|3|||
163114425|NCT02927925|589127554|FG000|Overall Study|Disease progression at clinical cutoff|1|||
163114426|NCT00075725|589127557|FG000|Overall Study|Adverse Event|6|||
163114427|NCT00075725|589127558|FG001|Overall Study|Adverse Event|6|||
163114428|NCT00075725|589127559|FG002|Overall Study|Adverse Event|20|||
163114429|NCT00075725|589127560|FG003|Overall Study|Adverse Event|8|||
163114430|NCT00075725|589127561|FG004|Overall Study|Adverse Event|4|||
163114431|NCT00075725|589127562|FG005|Overall Study|Adverse Event|38|||
163114432|NCT00075725|589127563|FG006|Overall Study|Adverse Event|3|||
163114433|NCT00075725|589127564|FG007|Overall Study|Adverse Event|51|||
163114434|NCT00075725|589127565|FG008|Overall Study|Adverse Event|15|||
163114435|NCT00075725|589127566|FG009|Overall Study|Adverse Event|4|||
163114436|NCT00075725|589127567|FG010|Overall Study|Adverse Event|2|||
163114437|NCT00075725|589127568|FG011|Overall Study|Adverse Event|2|||
163114438|NCT00075725|589127557|FG000|Overall Study|Death|3|||
163114439|NCT00075725|589127558|FG001|Overall Study|Death|5|||
163114440|NCT00075725|589127559|FG002|Overall Study|Death|10|||
163114441|NCT00075725|589127560|FG003|Overall Study|Death|2|||
163114442|NCT00075725|589127561|FG004|Overall Study|Death|3|||
163114443|NCT00075725|589127562|FG005|Overall Study|Death|25|||
163114444|NCT00075725|589127563|FG006|Overall Study|Death|4|||
163114445|NCT00075725|589127564|FG007|Overall Study|Death|22|||
163114446|NCT00075725|589127565|FG008|Overall Study|Death|14|||
163114447|NCT00075725|589127566|FG009|Overall Study|Death|4|||
163114448|NCT00075725|589127567|FG010|Overall Study|Death|3|||
163114449|NCT00075725|589127568|FG011|Overall Study|Death|0|||
163114450|NCT00075725|589127557|FG000|Overall Study|Lost to Follow-up|1|||
163114451|NCT00075725|589127558|FG001|Overall Study|Lost to Follow-up|1|||
163114452|NCT00075725|589127559|FG002|Overall Study|Lost to Follow-up|4|||
163114453|NCT00075725|589127560|FG003|Overall Study|Lost to Follow-up|1|||
163114454|NCT00075725|589127561|FG004|Overall Study|Lost to Follow-up|0|||
163114455|NCT00075725|589127562|FG005|Overall Study|Lost to Follow-up|13|||
163114456|NCT00075725|589127563|FG006|Overall Study|Lost to Follow-up|2|||
163114457|NCT00075725|589127564|FG007|Overall Study|Lost to Follow-up|4|||
163114458|NCT00075725|589127565|FG008|Overall Study|Lost to Follow-up|1|||
163114459|NCT00075725|589127566|FG009|Overall Study|Lost to Follow-up|0|||
163114460|NCT00075725|589127567|FG010|Overall Study|Lost to Follow-up|0|||
163114461|NCT00075725|589127568|FG011|Overall Study|Lost to Follow-up|0|||
163114462|NCT00075725|589127557|FG000|Overall Study|Physician Decision|2|||
163114463|NCT00075725|589127558|FG001|Overall Study|Physician Decision|6|||
163114464|NCT00075725|589127559|FG002|Overall Study|Physician Decision|5|||
163114465|NCT00075725|589127560|FG003|Overall Study|Physician Decision|8|||
163114466|NCT00075725|589127561|FG004|Overall Study|Physician Decision|4|||
163114467|NCT00075725|589127562|FG005|Overall Study|Physician Decision|19|||
163114468|NCT00075725|589127563|FG006|Overall Study|Physician Decision|3|||
163114469|NCT00075725|589127564|FG007|Overall Study|Physician Decision|17|||
163114470|NCT00075725|589127565|FG008|Overall Study|Physician Decision|5|||
163114471|NCT00075725|589127566|FG009|Overall Study|Physician Decision|0|||
163114472|NCT00075725|589127567|FG010|Overall Study|Physician Decision|1|||
163114473|NCT00075725|589127568|FG011|Overall Study|Physician Decision|0|||
163114474|NCT00075725|589127557|FG000|Overall Study|Pregnancy|0|||
163114475|NCT00075725|589127558|FG001|Overall Study|Pregnancy|0|||
163114476|NCT00075725|589127559|FG002|Overall Study|Pregnancy|0|||
163114477|NCT00075725|589127560|FG003|Overall Study|Pregnancy|0|||
163114478|NCT00075725|589127561|FG004|Overall Study|Pregnancy|0|||
163114479|NCT00075725|589127562|FG005|Overall Study|Pregnancy|1|||
163114480|NCT00075725|589127563|FG006|Overall Study|Pregnancy|0|||
163114481|NCT00075725|589127564|FG007|Overall Study|Pregnancy|1|||
163114482|NCT00075725|589127565|FG008|Overall Study|Pregnancy|0|||
163114483|NCT00075725|589127566|FG009|Overall Study|Pregnancy|0|||
162654087|NCT02350309|587449690|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
162654088|NCT00207142|587449691|FG000|Induction Phase|Adverse Event|9|||
162654089|NCT00207142|587449692|FG001|Induction Phase|Adverse Event|0|||
162654090|NCT00207142|587449693|FG002|Induction Phase|Adverse Event|0|||
163114484|NCT00075725|589127567|FG010|Overall Study|Pregnancy|0|||
163114485|NCT00075725|589127568|FG011|Overall Study|Pregnancy|0|||
163114486|NCT00075725|589127557|FG000|Overall Study|Protocol Violation|1|||
163114487|NCT00075725|589127558|FG001|Overall Study|Protocol Violation|1|||
163114488|NCT00075725|589127559|FG002|Overall Study|Protocol Violation|0|||
163114489|NCT00075725|589127560|FG003|Overall Study|Protocol Violation|3|||
163114490|NCT00075725|589127561|FG004|Overall Study|Protocol Violation|3|||
163114491|NCT00075725|589127562|FG005|Overall Study|Protocol Violation|2|||
163114492|NCT00075725|589127563|FG006|Overall Study|Protocol Violation|1|||
163114493|NCT00075725|589127564|FG007|Overall Study|Protocol Violation|2|||
163114494|NCT00075725|589127565|FG008|Overall Study|Protocol Violation|3|||
163114495|NCT00075725|589127566|FG009|Overall Study|Protocol Violation|0|||
163114496|NCT00075725|589127567|FG010|Overall Study|Protocol Violation|0|||
163114497|NCT00075725|589127568|FG011|Overall Study|Protocol Violation|1|||
163114498|NCT00075725|589127557|FG000|Overall Study|Withdrawal by Subject|12|||
163114499|NCT00075725|589127558|FG001|Overall Study|Withdrawal by Subject|3|||
163114500|NCT00075725|589127559|FG002|Overall Study|Withdrawal by Subject|6|||
163114501|NCT00075725|589127560|FG003|Overall Study|Withdrawal by Subject|10|||
163114502|NCT00075725|589127561|FG004|Overall Study|Withdrawal by Subject|6|||
163114503|NCT00075725|589127562|FG005|Overall Study|Withdrawal by Subject|27|||
163114504|NCT00075725|589127563|FG006|Overall Study|Withdrawal by Subject|7|||
163114505|NCT00075725|589127564|FG007|Overall Study|Withdrawal by Subject|31|||
163114506|NCT00075725|589127565|FG008|Overall Study|Withdrawal by Subject|10|||
163114507|NCT00075725|589127566|FG009|Overall Study|Withdrawal by Subject|2|||
163114508|NCT00075725|589127567|FG010|Overall Study|Withdrawal by Subject|0|||
163114509|NCT00075725|589127568|FG011|Overall Study|Withdrawal by Subject|0|||
163114510|NCT00075725|589127557|FG000|Overall Study|Disease Progression, all other reasons|17|||
162654091|NCT00207142|587449694|FG003|Induction Phase|Adverse Event|0|||
162654092|NCT00207142|587449691|FG000|Induction Phase|Death|1|||
162654093|NCT00207142|587449692|FG001|Induction Phase|Death|0|||
162654094|NCT00207142|587449693|FG002|Induction Phase|Death|0|||
162654095|NCT00207142|587449694|FG003|Induction Phase|Death|0|||
162654096|NCT00207142|587449691|FG000|Induction Phase|Lack of Efficacy|1|||
162654097|NCT00207142|587449692|FG001|Induction Phase|Lack of Efficacy|0|||
162654098|NCT00207142|587449693|FG002|Induction Phase|Lack of Efficacy|0|||
162654099|NCT00207142|587449694|FG003|Induction Phase|Lack of Efficacy|0|||
162654100|NCT00207142|587449691|FG000|Induction Phase|Lost to Follow-up|5|||
162654101|NCT00207142|587449692|FG001|Induction Phase|Lost to Follow-up|0|||
163114511|NCT00075725|589127558|FG001|Overall Study|Disease Progression, all other reasons|5|||
163114512|NCT00075725|589127559|FG002|Overall Study|Disease Progression, all other reasons|33|||
163114513|NCT00075725|589127560|FG003|Overall Study|Disease Progression, all other reasons|6|||
163114514|NCT00075725|589127561|FG004|Overall Study|Disease Progression, all other reasons|21|||
163114515|NCT00075725|589127562|FG005|Overall Study|Disease Progression, all other reasons|59|||
162654102|NCT00207142|587449693|FG002|Induction Phase|Lost to Follow-up|0|||
162654103|NCT00207142|587449694|FG003|Induction Phase|Lost to Follow-up|0|||
162654104|NCT00207142|587449691|FG000|Induction Phase|Physician Decision|2|||
162654105|NCT00207142|587449692|FG001|Induction Phase|Physician Decision|0|||
163114516|NCT00075725|589127563|FG006|Overall Study|Disease Progression, all other reasons|20|||
163114517|NCT00075725|589127564|FG007|Overall Study|Disease Progression, all other reasons|46|||
163114518|NCT00075725|589127565|FG008|Overall Study|Disease Progression, all other reasons|21|||
163114519|NCT00075725|589127566|FG009|Overall Study|Disease Progression, all other reasons|4|||
163114520|NCT00075725|589127567|FG010|Overall Study|Disease Progression, all other reasons|0|||
163114521|NCT00075725|589127568|FG011|Overall Study|Disease Progression, all other reasons|5|||
163114522|NCT00075725|589127557|FG000|Overall Study|Patient off treatment|0|||
163114523|NCT00075725|589127558|FG001|Overall Study|Patient off treatment|0|||
163114524|NCT00075725|589127559|FG002|Overall Study|Patient off treatment|1|||
163114525|NCT00075725|589127560|FG003|Overall Study|Patient off treatment|2|||
163114526|NCT00075725|589127561|FG004|Overall Study|Patient off treatment|1|||
163114527|NCT00075725|589127562|FG005|Overall Study|Patient off treatment|0|||
163114528|NCT00075725|589127563|FG006|Overall Study|Patient off treatment|0|||
163114529|NCT00075725|589127564|FG007|Overall Study|Patient off treatment|2|||
163114530|NCT00075725|589127565|FG008|Overall Study|Patient off treatment|1|||
163114531|NCT00075725|589127566|FG009|Overall Study|Patient off treatment|0|||
163114532|NCT00075725|589127567|FG010|Overall Study|Patient off treatment|0|||
163114533|NCT00075725|589127568|FG011|Overall Study|Patient off treatment|0|||
163114534|NCT00075725|589127557|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
163114535|NCT00075725|589127558|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
163114536|NCT00075725|589127559|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
163114537|NCT00075725|589127560|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
163114538|NCT00075725|589127561|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
163114539|NCT00075725|589127562|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
163114540|NCT00075725|589127563|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
163114541|NCT00075725|589127564|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
163114542|NCT00075725|589127565|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
163114543|NCT00075725|589127566|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
163114544|NCT00075725|589127567|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
163114545|NCT00075725|589127568|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
163114546|NCT00075725|589127557|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
163114547|NCT00075725|589127558|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
163114548|NCT00075725|589127559|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
163114549|NCT00075725|589127560|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
163114550|NCT00075725|589127561|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
163114551|NCT00075725|589127562|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
163114552|NCT00075725|589127563|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
163114553|NCT00075725|589127564|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
163114554|NCT00075725|589127565|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
163114555|NCT00075725|589127566|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
163114556|NCT00075725|589127567|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
163114557|NCT00075725|589127568|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
163114558|NCT00075725|589127557|FG000|Overall Study|Pt non compliant with therapy|2|||
163114559|NCT00075725|589127558|FG001|Overall Study|Pt non compliant with therapy|1|||
163114560|NCT00075725|589127559|FG002|Overall Study|Pt non compliant with therapy|1|||
163114561|NCT00075725|589127560|FG003|Overall Study|Pt non compliant with therapy|0|||
163114562|NCT00075725|589127561|FG004|Overall Study|Pt non compliant with therapy|2|||
163114563|NCT00075725|589127562|FG005|Overall Study|Pt non compliant with therapy|14|||
163114564|NCT00075725|589127563|FG006|Overall Study|Pt non compliant with therapy|2|||
163114565|NCT00075725|589127564|FG007|Overall Study|Pt non compliant with therapy|5|||
163114566|NCT00075725|589127565|FG008|Overall Study|Pt non compliant with therapy|3|||
163114567|NCT00075725|589127566|FG009|Overall Study|Pt non compliant with therapy|0|||
163114568|NCT00075725|589127567|FG010|Overall Study|Pt non compliant with therapy|0|||
163114569|NCT00075725|589127568|FG011|Overall Study|Pt non compliant with therapy|0|||
163114570|NCT00075725|589127557|FG000|Overall Study|Pt age out of range for treatment|0|||
163114571|NCT00075725|589127558|FG001|Overall Study|Pt age out of range for treatment|1|||
163114572|NCT00075725|589127559|FG002|Overall Study|Pt age out of range for treatment|0|||
163114573|NCT00075725|589127560|FG003|Overall Study|Pt age out of range for treatment|0|||
162654106|NCT00207142|587449693|FG002|Induction Phase|Physician Decision|0|||
162654107|NCT00207142|587449694|FG003|Induction Phase|Physician Decision|0|||
162654108|NCT00207142|587449691|FG000|Induction Phase|Poor/noncompliance|2|||
162654109|NCT00207142|587449692|FG001|Induction Phase|Poor/noncompliance|0|||
163114574|NCT00075725|589127561|FG004|Overall Study|Pt age out of range for treatment|0|||
163114575|NCT00075725|589127562|FG005|Overall Study|Pt age out of range for treatment|1|||
163114576|NCT00075725|589127563|FG006|Overall Study|Pt age out of range for treatment|0|||
162654110|NCT00207142|587449693|FG002|Induction Phase|Poor/noncompliance|0|||
162654111|NCT00207142|587449694|FG003|Induction Phase|Poor/noncompliance|0|||
163114577|NCT00075725|589127564|FG007|Overall Study|Pt age out of range for treatment|1|||
163114578|NCT00075725|589127565|FG008|Overall Study|Pt age out of range for treatment|0|||
163114579|NCT00075725|589127566|FG009|Overall Study|Pt age out of range for treatment|0|||
163114580|NCT00075725|589127567|FG010|Overall Study|Pt age out of range for treatment|0|||
163114581|NCT00075725|589127568|FG011|Overall Study|Pt age out of range for treatment|0|||
163114582|NCT00075725|589127557|FG000|Overall Study|Insurance issues|0|||
163114583|NCT00075725|589127558|FG001|Overall Study|Insurance issues|1|||
163114584|NCT00075725|589127559|FG002|Overall Study|Insurance issues|0|||
163114585|NCT00075725|589127560|FG003|Overall Study|Insurance issues|1|||
163114586|NCT00075725|589127561|FG004|Overall Study|Insurance issues|1|||
163114587|NCT00075725|589127562|FG005|Overall Study|Insurance issues|1|||
163114588|NCT00075725|589127563|FG006|Overall Study|Insurance issues|0|||
163114589|NCT00075725|589127564|FG007|Overall Study|Insurance issues|1|||
163114590|NCT00075725|589127565|FG008|Overall Study|Insurance issues|0|||
163114591|NCT00075725|589127566|FG009|Overall Study|Insurance issues|0|||
163114592|NCT00075725|589127567|FG010|Overall Study|Insurance issues|0|||
163114593|NCT00075725|589127568|FG011|Overall Study|Insurance issues|0|||
163114594|NCT00075725|589127557|FG000|Overall Study|MRD positive after extended ind|0|||
163114595|NCT00075725|589127558|FG001|Overall Study|MRD positive after extended ind|1|||
163114596|NCT00075725|589127559|FG002|Overall Study|MRD positive after extended ind|1|||
163114597|NCT00075725|589127560|FG003|Overall Study|MRD positive after extended ind|0|||
163114598|NCT00075725|589127561|FG004|Overall Study|MRD positive after extended ind|1|||
163114599|NCT00075725|589127562|FG005|Overall Study|MRD positive after extended ind|2|||
163114600|NCT00075725|589127563|FG006|Overall Study|MRD positive after extended ind|0|||
163114601|NCT00075725|589127564|FG007|Overall Study|MRD positive after extended ind|1|||
163114602|NCT00075725|589127565|FG008|Overall Study|MRD positive after extended ind|0|||
163114603|NCT00075725|589127566|FG009|Overall Study|MRD positive after extended ind|0|||
163114604|NCT00075725|589127567|FG010|Overall Study|MRD positive after extended ind|0|||
163114605|NCT00075725|589127568|FG011|Overall Study|MRD positive after extended ind|0|||
163114606|NCT00075725|589127557|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
163114607|NCT00075725|589127558|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
163114608|NCT00075725|589127559|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
163114609|NCT00075725|589127560|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
163114610|NCT00075725|589127561|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
163114611|NCT00075725|589127562|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
163114612|NCT00075725|589127563|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
163114613|NCT00075725|589127564|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
163114614|NCT00075725|589127565|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
163114615|NCT00075725|589127566|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
163114616|NCT00075725|589127567|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
163114617|NCT00075725|589127568|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
163114618|NCT00075725|589127557|FG000|Overall Study|Inevaluable|1|||
163114619|NCT00075725|589127558|FG001|Overall Study|Inevaluable|1|||
163114620|NCT00075725|589127559|FG002|Overall Study|Inevaluable|4|||
163114621|NCT00075725|589127560|FG003|Overall Study|Inevaluable|2|||
163114622|NCT00075725|589127561|FG004|Overall Study|Inevaluable|2|||
163114623|NCT00075725|589127562|FG005|Overall Study|Inevaluable|9|||
163114624|NCT00075725|589127563|FG006|Overall Study|Inevaluable|1|||
163114625|NCT00075725|589127564|FG007|Overall Study|Inevaluable|11|||
163114626|NCT00075725|589127565|FG008|Overall Study|Inevaluable|2|||
163114627|NCT00075725|589127566|FG009|Overall Study|Inevaluable|0|||
163114628|NCT00075725|589127567|FG010|Overall Study|Inevaluable|1|||
163114629|NCT00075725|589127568|FG011|Overall Study|Inevaluable|0|||
163114630|NCT00075725|589127557|FG000|Overall Study|Other|4|||
163114631|NCT00075725|589127558|FG001|Overall Study|Other|2|||
163114632|NCT00075725|589127559|FG002|Overall Study|Other|1|||
163114633|NCT00075725|589127560|FG003|Overall Study|Other|1|||
163114634|NCT00075725|589127561|FG004|Overall Study|Other|1|||
163114635|NCT00075725|589127562|FG005|Overall Study|Other|4|||
163114636|NCT00075725|589127563|FG006|Overall Study|Other|2|||
163114637|NCT00075725|589127564|FG007|Overall Study|Other|9|||
163114638|NCT00075725|589127565|FG008|Overall Study|Other|2|||
163114639|NCT00075725|589127566|FG009|Overall Study|Other|1|||
163114640|NCT00075725|589127567|FG010|Overall Study|Other|0|||
163114641|NCT00075725|589127568|FG011|Overall Study|Other|3|||
163114642|NCT00075725|589127557|FG000|Overall Study|Pt trying to find a BM donor|0|||
163114643|NCT00075725|589127558|FG001|Overall Study|Pt trying to find a BM donor|1|||
163114644|NCT00075725|589127559|FG002|Overall Study|Pt trying to find a BM donor|0|||
163114645|NCT00075725|589127560|FG003|Overall Study|Pt trying to find a BM donor|0|||
163114646|NCT00075725|589127561|FG004|Overall Study|Pt trying to find a BM donor|0|||
163114647|NCT00075725|589127562|FG005|Overall Study|Pt trying to find a BM donor|0|||
163114648|NCT00075725|589127563|FG006|Overall Study|Pt trying to find a BM donor|0|||
163114649|NCT00075725|589127564|FG007|Overall Study|Pt trying to find a BM donor|0|||
163114650|NCT00075725|589127565|FG008|Overall Study|Pt trying to find a BM donor|0|||
163114651|NCT00075725|589127566|FG009|Overall Study|Pt trying to find a BM donor|0|||
163114652|NCT00075725|589127567|FG010|Overall Study|Pt trying to find a BM donor|0|||
163114653|NCT00075725|589127568|FG011|Overall Study|Pt trying to find a BM donor|0|||
163114654|NCT00075725|589127557|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
163114655|NCT00075725|589127558|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
163114656|NCT00075725|589127559|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
163114657|NCT00075725|589127560|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
163114658|NCT00075725|589127561|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
163114659|NCT00075725|589127562|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
163114660|NCT00075725|589127563|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
163114661|NCT00075725|589127564|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
163114662|NCT00075725|589127565|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
163114663|NCT00075725|589127566|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
163114664|NCT00075725|589127567|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
163114665|NCT00075725|589127568|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
163114666|NCT00075725|589127557|FG000|Overall Study|Unsuccessful institutional transfer|0|||
163114667|NCT00075725|589127558|FG001|Overall Study|Unsuccessful institutional transfer|0|||
163114668|NCT00075725|589127559|FG002|Overall Study|Unsuccessful institutional transfer|2|||
163114669|NCT00075725|589127560|FG003|Overall Study|Unsuccessful institutional transfer|0|||
163114670|NCT00075725|589127561|FG004|Overall Study|Unsuccessful institutional transfer|0|||
163114671|NCT00075725|589127562|FG005|Overall Study|Unsuccessful institutional transfer|0|||
163114672|NCT00075725|589127563|FG006|Overall Study|Unsuccessful institutional transfer|0|||
163114673|NCT00075725|589127564|FG007|Overall Study|Unsuccessful institutional transfer|0|||
163114674|NCT00075725|589127565|FG008|Overall Study|Unsuccessful institutional transfer|0|||
163114675|NCT00075725|589127566|FG009|Overall Study|Unsuccessful institutional transfer|1|||
163114676|NCT00075725|589127567|FG010|Overall Study|Unsuccessful institutional transfer|0|||
163114677|NCT00075725|589127568|FG011|Overall Study|Unsuccessful institutional transfer|0|||
163114678|NCT00075725|589127557|FG000|Overall Study|specimen(s) not submitted|0|||
163114679|NCT00075725|589127558|FG001|Overall Study|specimen(s) not submitted|0|||
163114680|NCT00075725|589127559|FG002|Overall Study|specimen(s) not submitted|2|||
163114681|NCT00075725|589127560|FG003|Overall Study|specimen(s) not submitted|0|||
163114682|NCT00075725|589127561|FG004|Overall Study|specimen(s) not submitted|0|||
163114683|NCT00075725|589127562|FG005|Overall Study|specimen(s) not submitted|0|||
163114684|NCT00075725|589127563|FG006|Overall Study|specimen(s) not submitted|0|||
163114685|NCT00075725|589127564|FG007|Overall Study|specimen(s) not submitted|0|||
163114686|NCT00075725|589127565|FG008|Overall Study|specimen(s) not submitted|0|||
163114687|NCT00075725|589127566|FG009|Overall Study|specimen(s) not submitted|0|||
163114688|NCT00075725|589127567|FG010|Overall Study|specimen(s) not submitted|0|||
163114689|NCT00075725|589127568|FG011|Overall Study|specimen(s) not submitted|0|||
163114690|NCT00075725|589127557|FG000|Overall Study|Pt went to transplant|0|||
163114691|NCT00075725|589127558|FG001|Overall Study|Pt went to transplant|0|||
163114692|NCT00075725|589127559|FG002|Overall Study|Pt went to transplant|0|||
163114693|NCT00075725|589127560|FG003|Overall Study|Pt went to transplant|1|||
163114694|NCT00075725|589127561|FG004|Overall Study|Pt went to transplant|0|||
163114695|NCT00075725|589127562|FG005|Overall Study|Pt went to transplant|1|||
163114696|NCT00075725|589127563|FG006|Overall Study|Pt went to transplant|0|||
163114697|NCT00075725|589127564|FG007|Overall Study|Pt went to transplant|0|||
163114698|NCT00075725|589127565|FG008|Overall Study|Pt went to transplant|0|||
163114699|NCT00075725|589127566|FG009|Overall Study|Pt went to transplant|0|||
163114700|NCT00075725|589127567|FG010|Overall Study|Pt went to transplant|0|||
163114701|NCT00075725|589127568|FG011|Overall Study|Pt went to transplant|0|||
163114702|NCT00075725|589127557|FG000|Overall Study|Pt received additional steroids|0|||
163114703|NCT00075725|589127558|FG001|Overall Study|Pt received additional steroids|0|||
163114704|NCT00075725|589127559|FG002|Overall Study|Pt received additional steroids|0|||
163114705|NCT00075725|589127560|FG003|Overall Study|Pt received additional steroids|1|||
163114706|NCT00075725|589127561|FG004|Overall Study|Pt received additional steroids|0|||
163114707|NCT00075725|589127562|FG005|Overall Study|Pt received additional steroids|0|||
163114708|NCT00075725|589127563|FG006|Overall Study|Pt received additional steroids|0|||
163114709|NCT00075725|589127564|FG007|Overall Study|Pt received additional steroids|0|||
163114710|NCT00075725|589127565|FG008|Overall Study|Pt received additional steroids|0|||
163114711|NCT00075725|589127566|FG009|Overall Study|Pt received additional steroids|0|||
163114712|NCT00075725|589127567|FG010|Overall Study|Pt received additional steroids|0|||
163114713|NCT00075725|589127568|FG011|Overall Study|Pt received additional steroids|0|||
163114714|NCT00075725|589127557|FG000|Overall Study|Pt relocated|0|||
163114715|NCT00075725|589127558|FG001|Overall Study|Pt relocated|0|||
163114716|NCT00075725|589127559|FG002|Overall Study|Pt relocated|0|||
163114717|NCT00075725|589127560|FG003|Overall Study|Pt relocated|2|||
163114718|NCT00075725|589127561|FG004|Overall Study|Pt relocated|0|||
163114719|NCT00075725|589127562|FG005|Overall Study|Pt relocated|1|||
163114720|NCT00075725|589127563|FG006|Overall Study|Pt relocated|1|||
163114721|NCT00075725|589127564|FG007|Overall Study|Pt relocated|2|||
163114722|NCT00075725|589127565|FG008|Overall Study|Pt relocated|1|||
163114723|NCT00075725|589127566|FG009|Overall Study|Pt relocated|0|||
163114724|NCT00075725|589127567|FG010|Overall Study|Pt relocated|0|||
163114725|NCT00075725|589127568|FG011|Overall Study|Pt relocated|0|||
163114726|NCT00075725|589127557|FG000|Overall Study|Institution Terminated|0|||
163114727|NCT00075725|589127558|FG001|Overall Study|Institution Terminated|0|||
163114728|NCT00075725|589127559|FG002|Overall Study|Institution Terminated|0|||
163114729|NCT00075725|589127560|FG003|Overall Study|Institution Terminated|0|||
163114730|NCT00075725|589127561|FG004|Overall Study|Institution Terminated|1|||
163114731|NCT00075725|589127562|FG005|Overall Study|Institution Terminated|0|||
163114732|NCT00075725|589127563|FG006|Overall Study|Institution Terminated|0|||
163114733|NCT00075725|589127564|FG007|Overall Study|Institution Terminated|3|||
163114734|NCT00075725|589127565|FG008|Overall Study|Institution Terminated|0|||
163114735|NCT00075725|589127566|FG009|Overall Study|Institution Terminated|0|||
162654112|NCT00207142|587449691|FG000|Induction Phase|Pregnancy|1|||
163114736|NCT00075725|589127567|FG010|Overall Study|Institution Terminated|0|||
163114737|NCT00075725|589127568|FG011|Overall Study|Institution Terminated|0|||
163114738|NCT00075725|589127557|FG000|Overall Study|Study Closure|1|||
163114739|NCT00075725|589127558|FG001|Overall Study|Study Closure|0|||
163114740|NCT00075725|589127559|FG002|Overall Study|Study Closure|0|||
163114741|NCT00075725|589127560|FG003|Overall Study|Study Closure|0|||
163114742|NCT00075725|589127561|FG004|Overall Study|Study Closure|1|||
162654113|NCT00207142|587449692|FG001|Induction Phase|Pregnancy|0|||
163114743|NCT00075725|589127562|FG005|Overall Study|Study Closure|3|||
162654114|NCT00207142|587449693|FG002|Induction Phase|Pregnancy|0|||
163114744|NCT00075725|589127563|FG006|Overall Study|Study Closure|0|||
163114745|NCT00075725|589127564|FG007|Overall Study|Study Closure|1|||
163114746|NCT00075725|589127565|FG008|Overall Study|Study Closure|0|||
163114747|NCT00075725|589127566|FG009|Overall Study|Study Closure|0|||
163114748|NCT00075725|589127567|FG010|Overall Study|Study Closure|0|||
163114749|NCT00075725|589127568|FG011|Overall Study|Study Closure|0|||
163114750|NCT00075725|589127557|FG000|Overall Study|Other complications|0|||
163114751|NCT00075725|589127558|FG001|Overall Study|Other complications|0|||
163114752|NCT00075725|589127559|FG002|Overall Study|Other complications|0|||
163114753|NCT00075725|589127560|FG003|Overall Study|Other complications|0|||
163114754|NCT00075725|589127561|FG004|Overall Study|Other complications|0|||
163114755|NCT00075725|589127562|FG005|Overall Study|Other complications|1|||
163114756|NCT00075725|589127563|FG006|Overall Study|Other complications|0|||
163114757|NCT00075725|589127564|FG007|Overall Study|Other complications|0|||
163114758|NCT00075725|589127565|FG008|Overall Study|Other complications|0|||
163114759|NCT00075725|589127566|FG009|Overall Study|Other complications|0|||
163114760|NCT00075725|589127567|FG010|Overall Study|Other complications|0|||
163114761|NCT00075725|589127568|FG011|Overall Study|Other complications|0|||
163114762|NCT00075725|589127557|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
163114763|NCT00075725|589127558|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
163114764|NCT00075725|589127559|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
163114765|NCT00075725|589127560|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
163114766|NCT00075725|589127561|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
163114767|NCT00075725|589127562|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
163114768|NCT00075725|589127563|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
163114769|NCT00075725|589127564|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
163114770|NCT00075725|589127565|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
163114771|NCT00075725|589127566|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
163114772|NCT00075725|589127567|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
163114773|NCT00075725|589127568|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
163114774|NCT00075725|589127557|FG000|Overall Study|Pt incarcerated|0|||
163114775|NCT00075725|589127558|FG001|Overall Study|Pt incarcerated|0|||
163114776|NCT00075725|589127559|FG002|Overall Study|Pt incarcerated|0|||
163114777|NCT00075725|589127560|FG003|Overall Study|Pt incarcerated|0|||
163114778|NCT00075725|589127561|FG004|Overall Study|Pt incarcerated|0|||
163114779|NCT00075725|589127562|FG005|Overall Study|Pt incarcerated|0|||
163114780|NCT00075725|589127563|FG006|Overall Study|Pt incarcerated|0|||
163114781|NCT00075725|589127564|FG007|Overall Study|Pt incarcerated|1|||
163114782|NCT00075725|589127565|FG008|Overall Study|Pt incarcerated|0|||
163114783|NCT00075725|589127566|FG009|Overall Study|Pt incarcerated|0|||
163114784|NCT00075725|589127567|FG010|Overall Study|Pt incarcerated|0|||
163114785|NCT00075725|589127568|FG011|Overall Study|Pt incarcerated|0|||
163114786|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Death|1|||
163114787|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Death|1|||
163114788|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Death|0|||
163114789|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Death|0|||
163114790|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Death|1|||
163114791|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Death|0|||
163114792|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Death|0|||
163114793|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Death|0|||
163114794|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Death|0|||
163114795|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Death|0|||
163114796|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
163114797|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
163114798|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
163114799|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114800|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
163114801|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114802|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114803|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114804|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114805|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
163114806|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114807|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114808|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114809|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114810|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
163114811|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114812|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114813|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114814|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114815|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
163114816|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
163114817|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114818|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
162654115|NCT00207142|587449694|FG003|Induction Phase|Pregnancy|0|||
162654116|NCT00207142|587449691|FG000|Induction Phase|Subject no longer meets study criteria|3|||
162654117|NCT00207142|587449692|FG001|Induction Phase|Subject no longer meets study criteria|0|||
162654118|NCT00207142|587449693|FG002|Induction Phase|Subject no longer meets study criteria|0|||
162654119|NCT00207142|587449694|FG003|Induction Phase|Subject no longer meets study criteria|0|||
162654120|NCT00207142|587449691|FG000|Induction Phase|Withdrawal by Subject|4|||
162719335|NCT00371566|587678482|FG000|Treatment Phase|Protocol Violation|0|||
163114819|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114820|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114821|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114822|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114823|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114824|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114825|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
163114826|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
163114827|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114828|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114829|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
163114830|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
163114831|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114832|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114833|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114834|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114835|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
163114836|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
163114837|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114838|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114839|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
163114840|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114841|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114842|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114843|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114844|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114845|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
163114846|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
163114847|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114848|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114849|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
163114850|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
163114851|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114852|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114853|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114854|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
162654121|NCT00207142|587449692|FG001|Induction Phase|Withdrawal by Subject|0|||
162719336|NCT00371566|587678483|FG001|Treatment Phase|Protocol Violation|1|||
162654122|NCT00207142|587449693|FG002|Induction Phase|Withdrawal by Subject|0|||
162654123|NCT00207142|587449694|FG003|Induction Phase|Withdrawal by Subject|0|||
162654124|NCT00207142|587449691|FG000|Induction Phase|Incarceration|1|||
162654125|NCT00207142|587449692|FG001|Induction Phase|Incarceration|0|||
162654126|NCT00207142|587449693|FG002|Induction Phase|Incarceration|0|||
162654127|NCT00207142|587449694|FG003|Induction Phase|Incarceration|0|||
162654128|NCT00207142|587449691|FG000|Induction Phase|Missing lab data|1|||
162654129|NCT00207142|587449692|FG001|Induction Phase|Missing lab data|0|||
162654130|NCT00207142|587449693|FG002|Induction Phase|Missing lab data|0|||
162654131|NCT00207142|587449694|FG003|Induction Phase|Missing lab data|0|||
162654132|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
162654133|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
162654134|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
162654135|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
162654136|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
162654137|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
162654138|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
162654139|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
162654140|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162654141|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162654142|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
162654143|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162654144|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
163114855|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
163114856|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
163114857|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163114858|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163114859|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114860|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
163114861|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114862|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114863|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114864|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114865|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163114866|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
163114867|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114868|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114869|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
163114870|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
163114871|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114872|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114873|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114874|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114875|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
163114876|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114877|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114878|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114879|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114880|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163114881|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114882|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114883|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114884|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114885|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163114886|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114887|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114888|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114889|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114890|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114891|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114892|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114893|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114894|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114895|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114896|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
163114897|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
163114898|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
163114899|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
163114900|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
163114901|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114902|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114903|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114904|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114905|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
163114906|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114907|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114908|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114909|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
163114910|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
163114911|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114912|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114913|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114914|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114915|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163114916|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114917|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114918|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114919|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114920|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163114921|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114922|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114923|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114924|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114925|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163114926|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114927|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114928|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114929|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114930|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
163114931|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114932|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114933|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114934|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114935|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
163114936|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114937|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114938|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114939|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114940|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
163114941|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114942|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114943|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114944|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114945|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163114946|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114947|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
163114948|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114949|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114950|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
163114951|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114952|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114953|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
162654145|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
162654146|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
162654147|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
163114954|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114955|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
163114956|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
163114957|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114958|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114959|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114960|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
163114961|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114962|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114963|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114964|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114965|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
163114966|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
163114967|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114968|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
163114969|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114970|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
163114971|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114972|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114973|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114974|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114975|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
163114976|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Other|5|||
163114977|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Other|1|||
163114978|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Other|0|||
163114979|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Other|3|||
163114980|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Other|0|||
163114981|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Other|0|||
163114982|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Other|0|||
163114983|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Other|0|||
163114984|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Other|0|||
163114985|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Other|0|||
163114986|NCT03352557|589127569|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114987|NCT03352557|589127570|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114988|NCT03352557|589127571|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114989|NCT03352557|589127572|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114990|NCT03352557|589127573|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
163114991|NCT03352557|589127574|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114992|NCT03352557|589127575|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114993|NCT03352557|589127576|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114994|NCT03352557|589127577|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114995|NCT03352557|589127578|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
163114996|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Death|0|||
163114997|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Death|0|||
163114998|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Death|0|||
163114999|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Death|0|||
163115000|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Death|0|||
163115001|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Death|1|||
163115002|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Death|0|||
163115003|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Death|1|||
163115004|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Death|1|||
163115005|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Death|1|||
163115006|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115007|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115008|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115009|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115010|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115011|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
163115012|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115013|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115014|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115015|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
163115016|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115017|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115018|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115019|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115020|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115021|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115022|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115023|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115024|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
163115025|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
163115026|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115027|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115028|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115029|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115030|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
163115031|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
163115032|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
163115033|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
163115034|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
163115035|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
163115036|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115037|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115038|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115039|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115040|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115041|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
163115042|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
163115043|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
163115044|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
163115045|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
163115046|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115047|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115048|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115049|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115050|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115051|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115052|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115053|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115054|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
163115055|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
163115056|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115057|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115058|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115059|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115060|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115061|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115062|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
163115063|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115064|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
163115065|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
163115066|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115067|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115068|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
162654148|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
163115069|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115070|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115071|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115072|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115073|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
163115074|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
163115075|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
163115076|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115077|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115078|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115079|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115080|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115081|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115082|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115083|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
163115084|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115085|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163115086|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115087|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115088|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115089|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115090|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115091|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115092|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115093|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
163115094|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115095|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163115096|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115097|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115098|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115099|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115100|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115101|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115102|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115103|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
163115104|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
163115105|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
163115106|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115107|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115108|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115109|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115110|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115111|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
163115112|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115113|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115114|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
163115115|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
163115116|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115117|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115118|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115119|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115120|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115121|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
162719337|NCT00371566|587678482|FG000|Chemoradiation Phase|Physician Decision|2|||
162719338|NCT00371566|587678483|FG001|Chemoradiation Phase|Physician Decision|0|||
163115122|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115123|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115124|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
163115125|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
163115126|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115127|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115128|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115129|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115130|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115131|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115132|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115133|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
163115134|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
163115135|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
163115136|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115137|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115138|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115139|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115140|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115141|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115142|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115143|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
163115144|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
163115145|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
163115146|NCT03352557|589127569|FG000|LTE Period: Week 80 to Week 173|Other|0|||
163115147|NCT03352557|589127570|FG001|LTE Period: Week 80 to Week 173|Other|0|||
163115148|NCT03352557|589127571|FG002|LTE Period: Week 80 to Week 173|Other|0|||
163115149|NCT03352557|589127572|FG003|LTE Period: Week 80 to Week 173|Other|0|||
163115150|NCT03352557|589127573|FG004|LTE Period: Week 80 to Week 173|Other|0|||
163115151|NCT03352557|589127574|FG005|LTE Period: Week 80 to Week 173|Other|0|||
163115152|NCT03352557|589127575|FG006|LTE Period: Week 80 to Week 173|Other|0|||
163115153|NCT03352557|589127576|FG007|LTE Period: Week 80 to Week 173|Other|1|||
163115154|NCT03352557|589127577|FG008|LTE Period: Week 80 to Week 173|Other|0|||
163115155|NCT03352557|589127578|FG009|LTE Period: Week 80 to Week 173|Other|0|||
163115156|NCT04677660|589127579|FG000|Overall Study|Lost to Follow-up|0|||
163115157|NCT04677660|589127580|FG001|Overall Study|Lost to Follow-up|2|||
163115158|NCT04677660|589127579|FG000|Overall Study|Withdrawal by Subject|0|||
163115159|NCT04677660|589127580|FG001|Overall Study|Withdrawal by Subject|1|||
163115160|NCT04677660|589127579|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
163115161|NCT04677660|589127580|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
163115162|NCT03242772|589127581|FG000|Overall Study|Lost to Follow-up|2|||
163115163|NCT03242772|589127582|FG001|Overall Study|Lost to Follow-up|0|||
163115164|NCT03242772|589127581|FG000|Overall Study|Physician Decision|0|||
163115165|NCT03242772|589127582|FG001|Overall Study|Physician Decision|1|||
163115166|NCT03242772|589127581|FG000|Overall Study|Withdrawal by Subject|1|||
163115167|NCT03242772|589127582|FG001|Overall Study|Withdrawal by Subject|0|||
163115168|NCT02499900|589127583|FG000|Core Study Period|Other|1|||
163115169|NCT02499900|589127584|FG001|Core Study Period|Other|4|||
163115170|NCT02499900|589127583|FG000|Core Study Period|Lost to Follow-up|1|||
163115171|NCT02499900|589127584|FG001|Core Study Period|Lost to Follow-up|2|||
163115172|NCT02499900|589127583|FG000|Core Study Period|Per sponsor request|0|||
163115173|NCT02499900|589127584|FG001|Core Study Period|Per sponsor request|1|||
162654149|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
162654150|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
162654151|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
162654152|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162654153|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162654154|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
162654155|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162654156|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
162654157|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
163115174|NCT02499900|589127583|FG000|Core Study Period|Pregnancy|1|||
163115175|NCT02499900|589127584|FG001|Core Study Period|Pregnancy|0|||
163115176|NCT02499900|589127583|FG000|Core Study Period|Protocol Violation|3|||
163115177|NCT02499900|589127584|FG001|Core Study Period|Protocol Violation|0|||
163115178|NCT02499900|589127583|FG000|Core Study Period|Withdrawal by Subject|11|||
163115179|NCT02499900|589127584|FG001|Core Study Period|Withdrawal by Subject|10|||
163115180|NCT02499900|589127583|FG000|Core Study Period|Adverse Event|18|||
163115181|NCT02499900|589127584|FG001|Core Study Period|Adverse Event|14|||
163115182|NCT02499900|589127583|FG000|Core Study Period|Death|0|||
163115183|NCT02499900|589127584|FG001|Core Study Period|Death|1|||
163115184|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
162719339|NCT00371566|587678482|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
162719340|NCT00371566|587678483|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
162719341|NCT00371566|587678482|FG000|Chemoradiation Phase|Non compliant|0|||
162719342|NCT00371566|587678483|FG001|Chemoradiation Phase|Non compliant|1|||
162719343|NCT00371566|587678482|FG000|Chemoradiation Phase|Progressive Disease|1|||
162719344|NCT00371566|587678483|FG001|Chemoradiation Phase|Progressive Disease|1|||
162719345|NCT00371566|587678482|FG000|Chemoradiation Phase|Death|2|||
162719346|NCT00371566|587678483|FG001|Chemoradiation Phase|Death|0|||
162719347|NCT00371566|587678482|FG000|Follow Up Phase|Death|0|||
162719348|NCT00371566|587678483|FG001|Follow Up Phase|Death|5|||
162719349|NCT00371566|587678482|FG000|Follow Up Phase|Disease progression|1|||
162719350|NCT00371566|587678483|FG001|Follow Up Phase|Disease progression|0|||
162719351|NCT00371566|587678482|FG000|Follow Up Phase|Withdrawal by Subject|0|||
162719352|NCT00371566|587678483|FG001|Follow Up Phase|Withdrawal by Subject|1|||
163115185|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
163115186|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
163115187|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
163115188|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
163115189|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
163115190|NCT02499900|589127583|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
163115191|NCT02499900|589127584|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
163115192|NCT02499900|589127583|FG000|Extension Study Period|Adverse Event|2|||
163115193|NCT02499900|589127584|FG001|Extension Study Period|Adverse Event|4|||
163115194|NCT02499900|589127583|FG000|Extension Study Period|Withdrawal by Subject|5|||
163115195|NCT02499900|589127584|FG001|Extension Study Period|Withdrawal by Subject|2|||
163115196|NCT02499900|589127583|FG000|Extension Study Period|Physician Decision|2|||
163115197|NCT02499900|589127584|FG001|Extension Study Period|Physician Decision|5|||
163115198|NCT02499900|589127583|FG000|Extension Study Period|Pregnancy|1|||
163115199|NCT02499900|589127584|FG001|Extension Study Period|Pregnancy|2|||
163115200|NCT02499900|589127583|FG000|Extension Study Period|Lost to Follow-up|2|||
163115201|NCT02499900|589127584|FG001|Extension Study Period|Lost to Follow-up|5|||
163115202|NCT02499900|589127583|FG000|Extension Study Period|Other|0|||
163115203|NCT02499900|589127584|FG001|Extension Study Period|Other|2|||
163115204|NCT01560637|589127585|FG000|Overall Study|Adverse Event|63|||
163115205|NCT01560637|589127585|FG000|Overall Study|Death|69|||
163115206|NCT01560637|589127585|FG000|Overall Study|Lost to Follow-up|8|||
163115207|NCT01560637|589127585|FG000|Overall Study|Protocol Violation|8|||
163115208|NCT01560637|589127585|FG000|Overall Study|Withdrawal by Subject|24|||
163115209|NCT01560637|589127585|FG000|Overall Study|Progressive Disease|20|||
163115210|NCT01560637|589127585|FG000|Overall Study|Other Reason Not Specified|6|||
163115211|NCT01089023|589127590|FG000|Overall Study|Lost to Follow-up|3|||
163115212|NCT01089023|589127590|FG000|Overall Study|Adverse Event|1|||
163115213|NCT01089023|589127590|FG000|Overall Study|Withdrawal by Subject|1|||
163115214|NCT01089023|589127590|FG000|Overall Study|Protocol Violation|1|||
163115215|NCT01089023|589127590|FG000|Overall Study|Lack of Efficacy|1|||
163115216|NCT02434354|589127591|FG000|Overall Study|screen fail|3|||
163115217|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
163115218|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
163115219|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
163115220|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
163115221|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
163115222|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
163115223|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
163115224|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
163115225|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115226|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115227|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
163115228|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
163115229|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Adverse Event|1|||
163115230|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Adverse Event|0|||
163115231|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Adverse Event|2|||
163115232|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Adverse Event|0|||
163115233|NCT01185964|589127595|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
163115234|NCT01185964|589127596|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
163115235|NCT01185964|589127597|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
163115236|NCT01185964|589127598|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
163115237|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
163115238|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
162719353|NCT00371566|587678482|FG000|Follow Up Phase|Physician Decision|1|||
162719354|NCT00371566|587678483|FG001|Follow Up Phase|Physician Decision|1|||
162719355|NCT00371566|587678482|FG000|Follow Up Phase|Lost to Follow-up|1|||
162719356|NCT00371566|587678483|FG001|Follow Up Phase|Lost to Follow-up|0|||
163115239|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
163115240|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
163115241|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115242|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115243|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
163115244|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
163115245|NCT01185964|589127595|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115246|NCT01185964|589127596|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115247|NCT01185964|589127597|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
163115248|NCT01185964|589127598|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
163115249|NCT04962230|589127612|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
163115250|NCT04962230|589127612|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
163115251|NCT03576755|589127613|FG000|Overall Study|Withdrawal by Subject|1|||
163115252|NCT03576755|589127614|FG001|Overall Study|Withdrawal by Subject|0|||
163115253|NCT03576755|589127615|FG002|Overall Study|Withdrawal by Subject|0|||
163115254|NCT03576755|589127616|FG003|Overall Study|Withdrawal by Subject|0|||
163115255|NCT01646645|589127617|FG000|Overall Study|No Treated|1|||
163115256|NCT01646645|589127617|FG000|Overall Study|Inevaluable Donor|29|||
163115257|NCT00717522|589127618|FG000|Overall Study|Disease Progression|5|||
163115258|NCT00717522|589127618|FG000|Overall Study|Adverse Event|1|||
163115259|NCT00717522|589127618|FG000|Overall Study|Death|1|||
163115260|NCT01799239|589127619|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
163115261|NCT01799239|589127620|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
163115262|NCT01799239|589127619|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
163115263|NCT01799239|589127620|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
163115264|NCT01799239|589127619|FG000|Period 1 (7 Days)|Protocol Violation|0|||
163115265|NCT01799239|589127620|FG001|Period 1 (7 Days)|Protocol Violation|1|||
163115266|NCT01799239|589127619|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
163115267|NCT01799239|589127620|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
163115268|NCT01799239|589127619|FG000|Period 2 (7 Days)|Protocol Violation|1|||
163115269|NCT01799239|589127620|FG001|Period 2 (7 Days)|Protocol Violation|0|||
163115270|NCT04209114|589127621|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
163115271|NCT04209114|589127622|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
163115272|NCT04209114|589127623|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
163115273|NCT04209114|589127621|FG000|Pre-Treatment Phase|Other reasons|0|||
163115274|NCT04209114|589127622|FG001|Pre-Treatment Phase|Other reasons|0|||
163115275|NCT04209114|589127623|FG002|Pre-Treatment Phase|Other reasons|1|||
163115276|NCT04209114|589127621|FG000|Pre-Treatment Phase|Death|0|||
163115277|NCT04209114|589127622|FG001|Pre-Treatment Phase|Death|0|||
163115278|NCT04209114|589127623|FG002|Pre-Treatment Phase|Death|1|||
163115279|NCT04209114|589127621|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
163115280|NCT04209114|589127622|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
163115281|NCT04209114|589127623|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
163115282|NCT04209114|589127621|FG000|Treatment Phase|Other reasons|5|||
163115283|NCT04209114|589127622|FG001|Treatment Phase|Other reasons|3|||
163115284|NCT04209114|589127623|FG002|Treatment Phase|Other reasons|0|||
163115285|NCT04209114|589127621|FG000|Treatment Phase|Lost to Follow-up|1|||
163115286|NCT04209114|589127622|FG001|Treatment Phase|Lost to Follow-up|0|||
163115287|NCT04209114|589127623|FG002|Treatment Phase|Lost to Follow-up|0|||
163115288|NCT04209114|589127621|FG000|Treatment Phase|Participant withdrew consent|1|||
163115289|NCT04209114|589127622|FG001|Treatment Phase|Participant withdrew consent|0|||
163115290|NCT04209114|589127623|FG002|Treatment Phase|Participant withdrew consent|0|||
163115291|NCT04209114|589127621|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
163115292|NCT04209114|589127622|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
163115293|NCT04209114|589127623|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
163115294|NCT04209114|589127621|FG000|Treatment Phase|Death|4|||
163115295|NCT04209114|589127622|FG001|Treatment Phase|Death|1|||
163115296|NCT04209114|589127623|FG002|Treatment Phase|Death|0|||
163115297|NCT04209114|589127621|FG000|Treatment Phase|Study drug toxicity|4|||
163115298|NCT04209114|589127622|FG001|Treatment Phase|Study drug toxicity|6|||
163115299|NCT04209114|589127623|FG002|Treatment Phase|Study drug toxicity|0|||
163115300|NCT04209114|589127621|FG000|Treatment Phase|Disease progression|6|||
163115301|NCT04209114|589127622|FG001|Treatment Phase|Disease progression|9|||
163115302|NCT04209114|589127623|FG002|Treatment Phase|Disease progression|0|||
163115303|NCT02210832|589129461|FG000|Overall Study|Pregnancy termination .|3|||
163115304|NCT02210832|589129462|FG001|Overall Study|Pregnancy termination .|4|||
163115305|NCT02210832|589129463|FG002|Overall Study|Pregnancy termination .|1|||
163115306|NCT02210832|589129461|FG000|Overall Study|Lost to Follow-up|26|||
162719357|NCT00530842|587678488|FG000|Overall Study|Adverse Event|10|||
163115307|NCT02210832|589129462|FG001|Overall Study|Lost to Follow-up|32|||
163115308|NCT02210832|589129463|FG002|Overall Study|Lost to Follow-up|17|||
163115309|NCT00471887|589129466|FG000|Overall Study|Adverse Event|9|||
163115310|NCT03710876|589129471|FG000|Overall Study|Death|0|||
163115311|NCT03710876|589129472|FG001|Overall Study|Death|2|||
163115312|NCT03710876|589129471|FG000|Overall Study|Withdrawal by Subject|0|||
163115313|NCT03710876|589129472|FG001|Overall Study|Withdrawal by Subject|2|||
163115314|NCT01278407|589129473|FG000|Confirmatory Phase|Adverse Event|5|||
163115315|NCT01278407|589129474|FG001|Confirmatory Phase|Adverse Event|10|||
163115316|NCT01278407|589129475|FG002|Confirmatory Phase|Adverse Event|1|||
163115317|NCT01278407|589129476|FG003|Confirmatory Phase|Adverse Event|0|||
163115318|NCT01278407|589129477|FG004|Confirmatory Phase|Adverse Event|0|||
163115319|NCT01278407|589129473|FG000|Confirmatory Phase|Participant's Choice|3|||
163115320|NCT01278407|589129474|FG001|Confirmatory Phase|Participant's Choice|5|||
162719358|NCT00530842|587678489|FG001|Overall Study|Adverse Event|6|||
163115321|NCT01278407|589129475|FG002|Confirmatory Phase|Participant's Choice|3|||
162719359|NCT00530842|587678488|FG000|Overall Study|Lack of Efficacy|2|||
163115322|NCT01278407|589129476|FG003|Confirmatory Phase|Participant's Choice|0|||
163115323|NCT01278407|589129477|FG004|Confirmatory Phase|Participant's Choice|0|||
163115324|NCT01278407|589129473|FG000|Confirmatory Phase|Other|1|||
163115325|NCT01278407|589129474|FG001|Confirmatory Phase|Other|1|||
163115326|NCT01278407|589129475|FG002|Confirmatory Phase|Other|2|||
163115327|NCT01278407|589129476|FG003|Confirmatory Phase|Other|0|||
163115328|NCT01278407|589129477|FG004|Confirmatory Phase|Other|0|||
163115329|NCT01278407|589129473|FG000|Extension Phase|Adverse Event|0|||
163115330|NCT01278407|589129474|FG001|Extension Phase|Adverse Event|0|||
163115331|NCT01278407|589129475|FG002|Extension Phase|Adverse Event|0|||
163115332|NCT01278407|589129476|FG003|Extension Phase|Adverse Event|7|||
163115333|NCT01278407|589129477|FG004|Extension Phase|Adverse Event|16|||
163115334|NCT01278407|589129473|FG000|Extension Phase|Participant's Choice|0|||
163115335|NCT01278407|589129474|FG001|Extension Phase|Participant's Choice|0|||
163115336|NCT01278407|589129475|FG002|Extension Phase|Participant's Choice|0|||
163115337|NCT01278407|589129476|FG003|Extension Phase|Participant's Choice|4|||
163115338|NCT01278407|589129477|FG004|Extension Phase|Participant's Choice|11|||
163115339|NCT01278407|589129473|FG000|Extension Phase|Other|0|||
163115340|NCT01278407|589129474|FG001|Extension Phase|Other|0|||
163115341|NCT01278407|589129475|FG002|Extension Phase|Other|0|||
163115342|NCT01278407|589129476|FG003|Extension Phase|Other|1|||
163115343|NCT01278407|589129477|FG004|Extension Phase|Other|3|||
163115344|NCT02534935|589129479|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
163115345|NCT02534935|589129480|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
163115346|NCT02534935|589129481|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
163115347|NCT02534935|589129479|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
163115348|NCT02534935|589129480|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
163115349|NCT02534935|589129481|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
163115350|NCT02534935|589129479|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
163115351|NCT02534935|589129480|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
163115352|NCT02534935|589129481|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
163115353|NCT02534935|589129479|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
163115354|NCT02534935|589129480|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
163115355|NCT02534935|589129481|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
163115356|NCT02534935|589129479|FG000|Stage 1: 24 Months|Adverse Event|0|||
163115357|NCT02534935|589129480|FG001|Stage 1: 24 Months|Adverse Event|2|||
163115358|NCT02534935|589129481|FG002|Stage 1: 24 Months|Adverse Event|0|||
163115359|NCT02534935|589129479|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
163115360|NCT02534935|589129480|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
163115361|NCT02534935|589129481|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
163115362|NCT02534935|589129479|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
163115363|NCT02534935|589129480|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
163115364|NCT02534935|589129481|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
163115365|NCT01460719|589129482|FG000|Overall Study|Adverse Event|1|||
163115366|NCT01460719|589129482|FG000|Overall Study|Withdrawal by Subject|1|||
163115367|NCT03602885|589129488|FG000|Overall Study|Lost to Follow-up|3|||
163115368|NCT03602885|589129489|FG001|Overall Study|Lost to Follow-up|0|||
163115369|NCT01007123|589129494|FG000|Overall Study|Adverse Event|3|||
163115370|NCT01007123|589129495|FG001|Overall Study|Adverse Event|4|||
163115371|NCT01007123|589129496|FG002|Overall Study|Adverse Event|7|||
163115372|NCT01007123|589129497|FG003|Overall Study|Adverse Event|1|||
163115373|NCT01007123|589129494|FG000|Overall Study|Lack of Efficacy|1|||
163115374|NCT01007123|589129495|FG001|Overall Study|Lack of Efficacy|0|||
163115375|NCT01007123|589129496|FG002|Overall Study|Lack of Efficacy|1|||
163115376|NCT01007123|589129497|FG003|Overall Study|Lack of Efficacy|4|||
163115377|NCT01007123|589129494|FG000|Overall Study|Protocol Violation|1|||
163115378|NCT01007123|589129495|FG001|Overall Study|Protocol Violation|1|||
163115379|NCT01007123|589129496|FG002|Overall Study|Protocol Violation|2|||
163115380|NCT01007123|589129497|FG003|Overall Study|Protocol Violation|1|||
163115381|NCT01007123|589129494|FG000|Overall Study|Withdrawal by Subject|1|||
163115382|NCT01007123|589129495|FG001|Overall Study|Withdrawal by Subject|0|||
163115383|NCT01007123|589129496|FG002|Overall Study|Withdrawal by Subject|1|||
163115384|NCT01007123|589129497|FG003|Overall Study|Withdrawal by Subject|0|||
163115385|NCT01007123|589129494|FG000|Overall Study|Lost to Follow-up|0|||
163115386|NCT01007123|589129495|FG001|Overall Study|Lost to Follow-up|1|||
163115387|NCT01007123|589129496|FG002|Overall Study|Lost to Follow-up|0|||
163115388|NCT01007123|589129497|FG003|Overall Study|Lost to Follow-up|0|||
163115389|NCT02838901|589129498|FG000|Overall Study|Withdrawal by Subject|1|||
163115390|NCT02838901|589129499|FG001|Overall Study|Withdrawal by Subject|1|||
163115391|NCT02838901|589129498|FG000|Overall Study|Lost to Follow-up|1|||
163115392|NCT02838901|589129499|FG001|Overall Study|Lost to Follow-up|1|||
163115393|NCT04431713|589129500|FG000|Overall Study|Withdrawal by Subject|2|||
163115394|NCT04431713|589129501|FG001|Overall Study|Withdrawal by Subject|0|||
163115395|NCT04431713|589129500|FG000|Overall Study|Death|2|||
163115396|NCT04431713|589129501|FG001|Overall Study|Death|2|||
163115397|NCT02285114|589129503|FG000|Main Phase|Investigator's Discretion|0|||
163115398|NCT02285114|589129504|FG001|Main Phase|Investigator's Discretion|2|||
163115399|NCT02285114|589129505|FG002|Main Phase|Investigator's Discretion|0|||
163115400|NCT02285114|589129506|FG003|Main Phase|Investigator's Discretion|0|||
163115401|NCT02285114|589129507|FG004|Main Phase|Investigator's Discretion|0|||
163115402|NCT02285114|589129508|FG005|Main Phase|Investigator's Discretion|0|||
163115403|NCT02285114|589129503|FG000|Main Phase|Enrolled but Never Treated|1|||
163115404|NCT02285114|589129504|FG001|Main Phase|Enrolled but Never Treated|0|||
163115405|NCT02285114|589129505|FG002|Main Phase|Enrolled but Never Treated|0|||
163115406|NCT02285114|589129506|FG003|Main Phase|Enrolled but Never Treated|0|||
163115407|NCT02285114|589129507|FG004|Main Phase|Enrolled but Never Treated|0|||
163115408|NCT02285114|589129508|FG005|Main Phase|Enrolled but Never Treated|0|||
163115409|NCT02285114|589129503|FG000|Main Phase|Withdrew Consent|0|||
163115410|NCT02285114|589129504|FG001|Main Phase|Withdrew Consent|0|||
163115411|NCT02285114|589129505|FG002|Main Phase|Withdrew Consent|1|||
163115412|NCT02285114|589129506|FG003|Main Phase|Withdrew Consent|0|||
163115413|NCT02285114|589129507|FG004|Main Phase|Withdrew Consent|0|||
163115414|NCT02285114|589129508|FG005|Main Phase|Withdrew Consent|0|||
163115415|NCT02285114|589129503|FG000|Extension Phase|Investigator's Discretion|0|||
163115416|NCT02285114|589129504|FG001|Extension Phase|Investigator's Discretion|0|||
163115417|NCT02285114|589129505|FG002|Extension Phase|Investigator's Discretion|0|||
163115418|NCT02285114|589129506|FG003|Extension Phase|Investigator's Discretion|14|||
163115419|NCT02285114|589129507|FG004|Extension Phase|Investigator's Discretion|1|||
163115420|NCT02285114|589129508|FG005|Extension Phase|Investigator's Discretion|0|||
163115421|NCT02285114|589129503|FG000|Extension Phase|Lost to Follow-up|0|||
163115422|NCT02285114|589129504|FG001|Extension Phase|Lost to Follow-up|0|||
163115423|NCT02285114|589129505|FG002|Extension Phase|Lost to Follow-up|0|||
163115424|NCT02285114|589129506|FG003|Extension Phase|Lost to Follow-up|1|||
163115425|NCT02285114|589129507|FG004|Extension Phase|Lost to Follow-up|1|||
163115426|NCT02285114|589129508|FG005|Extension Phase|Lost to Follow-up|0|||
163115427|NCT02285114|589129503|FG000|Extension Phase|Non-compliance with Study Drug|0|||
163115428|NCT02285114|589129504|FG001|Extension Phase|Non-compliance with Study Drug|0|||
163115429|NCT02285114|589129505|FG002|Extension Phase|Non-compliance with Study Drug|0|||
163115430|NCT02285114|589129506|FG003|Extension Phase|Non-compliance with Study Drug|2|||
163115431|NCT02285114|589129507|FG004|Extension Phase|Non-compliance with Study Drug|0|||
163115432|NCT02285114|589129508|FG005|Extension Phase|Non-compliance with Study Drug|0|||
163115433|NCT02285114|589129503|FG000|Extension Phase|Pregnancy|0|||
163115434|NCT02285114|589129504|FG001|Extension Phase|Pregnancy|0|||
163115435|NCT02285114|589129505|FG002|Extension Phase|Pregnancy|0|||
163115436|NCT02285114|589129506|FG003|Extension Phase|Pregnancy|1|||
163115437|NCT02285114|589129507|FG004|Extension Phase|Pregnancy|0|||
163115438|NCT02285114|589129508|FG005|Extension Phase|Pregnancy|0|||
163115439|NCT00320255|589129509|FG000|Overall Study|Lack of Efficacy|1|||
163115440|NCT00320255|589129510|FG001|Overall Study|Lack of Efficacy|0|||
163115441|NCT00320255|589129511|FG002|Overall Study|Lack of Efficacy|0|||
163115442|NCT00320255|589129512|FG003|Overall Study|Lack of Efficacy|0|||
163115443|NCT00320255|589129513|FG004|Overall Study|Lack of Efficacy|0|||
163115444|NCT00320255|589129514|FG005|Overall Study|Lack of Efficacy|0|||
163115445|NCT00320255|589129509|FG000|Overall Study|Adverse Event|5|||
163115446|NCT00320255|589129510|FG001|Overall Study|Adverse Event|2|||
163115447|NCT00320255|589129511|FG002|Overall Study|Adverse Event|3|||
163115448|NCT00320255|589129512|FG003|Overall Study|Adverse Event|2|||
163115449|NCT00320255|589129513|FG004|Overall Study|Adverse Event|0|||
163115450|NCT00320255|589129514|FG005|Overall Study|Adverse Event|0|||
163115451|NCT00320255|589129509|FG000|Overall Study|Withdrawal by Subject|1|||
163115452|NCT00320255|589129510|FG001|Overall Study|Withdrawal by Subject|2|||
163115453|NCT00320255|589129511|FG002|Overall Study|Withdrawal by Subject|2|||
163115454|NCT00320255|589129512|FG003|Overall Study|Withdrawal by Subject|4|||
163115455|NCT00320255|589129513|FG004|Overall Study|Withdrawal by Subject|0|||
163115456|NCT00320255|589129514|FG005|Overall Study|Withdrawal by Subject|0|||
163115457|NCT00320255|589129509|FG000|Overall Study|Poor compliance/noncompliance|1|||
163115458|NCT00320255|589129510|FG001|Overall Study|Poor compliance/noncompliance|1|||
163115459|NCT00320255|589129511|FG002|Overall Study|Poor compliance/noncompliance|0|||
163115460|NCT00320255|589129512|FG003|Overall Study|Poor compliance/noncompliance|1|||
163115461|NCT00320255|589129513|FG004|Overall Study|Poor compliance/noncompliance|0|||
163115462|NCT00320255|589129514|FG005|Overall Study|Poor compliance/noncompliance|0|||
163115463|NCT00320255|589129509|FG000|Overall Study|No longer meets study criteria|0|||
163115464|NCT00320255|589129510|FG001|Overall Study|No longer meets study criteria|0|||
163115465|NCT00320255|589129511|FG002|Overall Study|No longer meets study criteria|0|||
163115466|NCT00320255|589129512|FG003|Overall Study|No longer meets study criteria|1|||
163115467|NCT00320255|589129513|FG004|Overall Study|No longer meets study criteria|0|||
163115468|NCT00320255|589129514|FG005|Overall Study|No longer meets study criteria|0|||
163115469|NCT00320255|589129509|FG000|Overall Study|Other|3|||
163115470|NCT00320255|589129510|FG001|Overall Study|Other|2|||
163115471|NCT00320255|589129511|FG002|Overall Study|Other|1|||
163115472|NCT00320255|589129512|FG003|Overall Study|Other|0|||
163115473|NCT00320255|589129513|FG004|Overall Study|Other|0|||
163115474|NCT00320255|589129514|FG005|Overall Study|Other|0|||
163115475|NCT00683917|589129517|FG000|Overall Study|Study prematurely terminated|10|||
163115476|NCT03022097|589129523|FG000|Overall Study|Adverse Event|3|||
163115477|NCT03022097|589129524|FG001|Overall Study|Adverse Event|4|||
163115478|NCT03022097|589129525|FG002|Overall Study|Adverse Event|1|||
163115479|NCT03022097|589129526|FG003|Overall Study|Adverse Event|3|||
163115480|NCT03022097|589129523|FG000|Overall Study|Progressive Disease|2|||
163115481|NCT03022097|589129524|FG001|Overall Study|Progressive Disease|0|||
163115482|NCT03022097|589129525|FG002|Overall Study|Progressive Disease|5|||
163115483|NCT03022097|589129526|FG003|Overall Study|Progressive Disease|2|||
163115484|NCT03022097|589129523|FG000|Overall Study|Lack of Efficacy|0|||
163115485|NCT03022097|589129524|FG001|Overall Study|Lack of Efficacy|0|||
163115486|NCT03022097|589129525|FG002|Overall Study|Lack of Efficacy|3|||
163115487|NCT03022097|589129526|FG003|Overall Study|Lack of Efficacy|3|||
163115488|NCT03022097|589129523|FG000|Overall Study|Protocol Violation|1|||
163115489|NCT03022097|589129524|FG001|Overall Study|Protocol Violation|0|||
163115490|NCT03022097|589129525|FG002|Overall Study|Protocol Violation|1|||
163115491|NCT03022097|589129526|FG003|Overall Study|Protocol Violation|0|||
163115492|NCT03022097|589129523|FG000|Overall Study|Withdrawal by Subject|11|||
163115493|NCT03022097|589129524|FG001|Overall Study|Withdrawal by Subject|13|||
163115494|NCT03022097|589129525|FG002|Overall Study|Withdrawal by Subject|15|||
163115495|NCT03022097|589129526|FG003|Overall Study|Withdrawal by Subject|21|||
163115496|NCT03022097|589129523|FG000|Overall Study|Lost to Follow-up|0|||
163115497|NCT03022097|589129524|FG001|Overall Study|Lost to Follow-up|0|||
163115498|NCT03022097|589129525|FG002|Overall Study|Lost to Follow-up|1|||
163115499|NCT03022097|589129526|FG003|Overall Study|Lost to Follow-up|1|||
163115500|NCT03022097|589129523|FG000|Overall Study|Other|4|||
163115501|NCT03022097|589129524|FG001|Overall Study|Other|1|||
163115502|NCT03022097|589129525|FG002|Overall Study|Other|6|||
163115503|NCT03022097|589129526|FG003|Overall Study|Other|4|||
163115504|NCT03022097|589129523|FG000|Overall Study|Due to COVID-19 pandemic|0|||
163115505|NCT03022097|589129524|FG001|Overall Study|Due to COVID-19 pandemic|1|||
163115506|NCT03022097|589129525|FG002|Overall Study|Due to COVID-19 pandemic|0|||
163115507|NCT03022097|589129526|FG003|Overall Study|Due to COVID-19 pandemic|0|||
163115508|NCT00623545|589129527|FG000|Overall Study|Adverse Event|6|||
163115509|NCT00623545|589129527|FG000|Overall Study|Withdrawal by Subject|4|||
163115510|NCT00445848|589129528|FG000|Overall Study|Adverse Event|14|||
163115511|NCT00445848|589129528|FG000|Overall Study|Withdrawal by Subject|4|||
163115512|NCT00445848|589129528|FG000|Overall Study|Progression|62|||
163115513|NCT00445848|589129528|FG000|Overall Study|Other-Not protocol specified|5|||
163115514|NCT05605691|589129529|FG000|Overall Study|Lost to Follow-up|1|||
163115515|NCT00855933|589129531|FG000|Overall Study|Withdrawal by Subject|0|||
163115516|NCT00855933|589129532|FG001|Overall Study|Withdrawal by Subject|1|||
163115517|NCT05463744|589129533|FG000|Treatment Period|Withdrawal by Subject|19|||
163115518|NCT05463744|589129534|FG001|Treatment Period|Withdrawal by Subject|16|||
163115519|NCT05463744|589129533|FG000|Treatment Period|Adverse Event|4|||
163115520|NCT05463744|589129534|FG001|Treatment Period|Adverse Event|4|||
163115521|NCT05463744|589129533|FG000|Treatment Period|Pregnancy|0|||
163115522|NCT05463744|589129534|FG001|Treatment Period|Pregnancy|3|||
163115523|NCT05463744|589129533|FG000|Treatment Period|Lost to Follow-up|1|||
163115524|NCT05463744|589129534|FG001|Treatment Period|Lost to Follow-up|3|||
163115525|NCT05463744|589129533|FG000|Treatment Period|Inadvertent enrollment|2|||
163115526|NCT05463744|589129534|FG001|Treatment Period|Inadvertent enrollment|1|||
163115527|NCT05463744|589129533|FG000|Treatment Period|Death|0|||
163115528|NCT05463744|589129534|FG001|Treatment Period|Death|1|||
163115529|NCT05463744|589129533|FG000|Treatment Period|Non-compliance with Study Drug|1|||
163115530|NCT05463744|589129534|FG001|Treatment Period|Non-compliance with Study Drug|0|||
163115531|NCT05463744|589129533|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
163115532|NCT05463744|589129534|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
163115533|NCT05463744|589129533|FG000|Treatment Period|Physician Decision|0|||
163115534|NCT05463744|589129534|FG001|Treatment Period|Physician Decision|1|||
163115535|NCT05463744|589129533|FG000|Follow-Up Period|Withdrawal by Subject|3|||
163115536|NCT05463744|589129534|FG001|Follow-Up Period|Withdrawal by Subject|1|||
163115537|NCT05463744|589129533|FG000|Follow-Up Period|Lost to Follow-up|1|||
163115538|NCT05463744|589129534|FG001|Follow-Up Period|Lost to Follow-up|1|||
163115539|NCT02851407|589129535|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163115540|NCT02851407|589129536|FG001|Overall Study|Withdrawal by parent/guardian|7|||
163115541|NCT02851407|589129535|FG000|Overall Study|Protocol deviation|0|||
163115542|NCT02851407|589129536|FG001|Overall Study|Protocol deviation|1|||
163115543|NCT02851407|589129535|FG000|Overall Study|Transferred to another hospital to continue|1|||
163115544|NCT02851407|589129536|FG001|Overall Study|Transferred to another hospital to continue|0|||
163115545|NCT02851407|589129535|FG000|Overall Study|Other Death|30|||
162654158|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
163115546|NCT02851407|589129536|FG001|Overall Study|Other Death|20|||
163115547|NCT02851407|589129535|FG000|Overall Study|Adverse event, serious fatal|6|||
163115548|NCT02851407|589129536|FG001|Overall Study|Adverse event, serious fatal|8|||
163115549|NCT02851407|589129535|FG000|Overall Study|Consent withdrawn by participant|5|||
163115550|NCT02851407|589129536|FG001|Overall Study|Consent withdrawn by participant|3|||
163115551|NCT02851407|589129535|FG000|Overall Study|Screen failure|2|||
163115552|NCT02851407|589129536|FG001|Overall Study|Screen failure|1|||
163115553|NCT02851407|589129535|FG000|Overall Study|Disease relapse|9|||
163115554|NCT02851407|589129536|FG001|Overall Study|Disease relapse|6|||
163115555|NCT02851407|589129535|FG000|Overall Study|Physician Decision|7|||
163115556|NCT02851407|589129536|FG001|Overall Study|Physician Decision|6|||
163115557|NCT02851407|589129535|FG000|Overall Study|Transferred to hospital closer to home|0|||
163115558|NCT02851407|589129536|FG001|Overall Study|Transferred to hospital closer to home|1|||
163115559|NCT02851407|589129535|FG000|Overall Study|Enrolled in an investigational study|0|||
163115560|NCT02851407|589129536|FG001|Overall Study|Enrolled in an investigational study|1|||
163115561|NCT02851407|589129535|FG000|Overall Study|Early recovery|1|||
163115562|NCT02851407|589129536|FG001|Overall Study|Early recovery|0|||
163115563|NCT02851407|589129535|FG000|Overall Study|Adverse event, non-fatal|7|||
163115564|NCT02851407|589129536|FG001|Overall Study|Adverse event, non-fatal|5|||
163115565|NCT02851407|589129535|FG000|Overall Study|Lost to Follow-up|0|||
163115566|NCT02851407|589129536|FG001|Overall Study|Lost to Follow-up|2|||
163115567|NCT03385265|589129540|FG000|Overall Study|Withdrawal by Subject|5|||
163115568|NCT03385265|589129541|FG001|Overall Study|Withdrawal by Subject|2|||
163115569|NCT03385265|589129542|FG002|Overall Study|Withdrawal by Subject|5|||
163115570|NCT03385265|589129543|FG003|Overall Study|Withdrawal by Subject|2|||
163115571|NCT04465877|589129547|FG000|Overall Study|Noncompliant with study requirements|0|||
163115572|NCT04465877|589129548|FG001|Overall Study|Noncompliant with study requirements|0|||
163115573|NCT04465877|589129549|FG002|Overall Study|Noncompliant with study requirements|1|||
163115574|NCT04465877|589129550|FG003|Overall Study|Noncompliant with study requirements|0|||
163115575|NCT03440918|589129551|FG000|Overall Study|Protocol Violation|0|||
163115576|NCT03440918|589129552|FG001|Overall Study|Protocol Violation|16|||
163115577|NCT04346108|589129553|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
163115578|NCT04346108|589129554|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
163115579|NCT04346108|589129555|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
163115580|NCT04346108|589129553|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
163115581|NCT04346108|589129554|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
163115582|NCT04346108|589129555|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
163115583|NCT01598753|589129556|FG000|Overall Study|Adverse Event|1|||
163115584|NCT01598753|589129557|FG001|Overall Study|Adverse Event|9|||
163115585|NCT01598753|589129558|FG002|Overall Study|Adverse Event|1|||
163115586|NCT01598753|589129559|FG003|Overall Study|Adverse Event|7|||
163115587|NCT01598753|589129556|FG000|Overall Study|Lost to Follow-up|4|||
163115588|NCT01598753|589129557|FG001|Overall Study|Lost to Follow-up|3|||
163115589|NCT01598753|589129558|FG002|Overall Study|Lost to Follow-up|7|||
163115590|NCT01598753|589129559|FG003|Overall Study|Lost to Follow-up|5|||
163115591|NCT01598753|589129556|FG000|Overall Study|Physician Decision|0|||
163115592|NCT01598753|589129557|FG001|Overall Study|Physician Decision|1|||
163115593|NCT01598753|589129558|FG002|Overall Study|Physician Decision|0|||
163115594|NCT01598753|589129559|FG003|Overall Study|Physician Decision|2|||
163115595|NCT01598753|589129556|FG000|Overall Study|Withdrawal by Subject|7|||
163115596|NCT01598753|589129557|FG001|Overall Study|Withdrawal by Subject|2|||
163115597|NCT01598753|589129558|FG002|Overall Study|Withdrawal by Subject|0|||
163115598|NCT01598753|589129559|FG003|Overall Study|Withdrawal by Subject|1|||
163115599|NCT02275117|589129560|FG000|Overall Study|Adverse Event|0|||
163115600|NCT02275117|589129561|FG001|Overall Study|Adverse Event|0|||
163115601|NCT02275117|589129562|FG002|Overall Study|Adverse Event|0|||
163115602|NCT02275117|589129563|FG003|Overall Study|Adverse Event|0|||
163115603|NCT02275117|589129564|FG004|Overall Study|Adverse Event|1|||
163115604|NCT02275117|589129560|FG000|Overall Study|Lack of Efficacy|6|||
163115605|NCT02275117|589129561|FG001|Overall Study|Lack of Efficacy|7|||
163115606|NCT02275117|589129562|FG002|Overall Study|Lack of Efficacy|5|||
163115607|NCT02275117|589129563|FG003|Overall Study|Lack of Efficacy|2|||
163115608|NCT02275117|589129564|FG004|Overall Study|Lack of Efficacy|10|||
163115609|NCT02275117|589129560|FG000|Overall Study|Lost to Follow-up|11|||
163115610|NCT02275117|589129561|FG001|Overall Study|Lost to Follow-up|16|||
163115611|NCT02275117|589129562|FG002|Overall Study|Lost to Follow-up|15|||
163115612|NCT02275117|589129563|FG003|Overall Study|Lost to Follow-up|16|||
163115613|NCT02275117|589129564|FG004|Overall Study|Lost to Follow-up|8|||
163115614|NCT02275117|589129560|FG000|Overall Study|Physician Decision|0|||
162719360|NCT00530842|587678489|FG001|Overall Study|Lack of Efficacy|1|||
163115615|NCT02275117|589129561|FG001|Overall Study|Physician Decision|1|||
163115616|NCT02275117|589129562|FG002|Overall Study|Physician Decision|1|||
163115617|NCT02275117|589129563|FG003|Overall Study|Physician Decision|0|||
163115618|NCT02275117|589129564|FG004|Overall Study|Physician Decision|1|||
163115619|NCT02275117|589129560|FG000|Overall Study|Protocol Violation|1|||
163115620|NCT02275117|589129561|FG001|Overall Study|Protocol Violation|0|||
163115621|NCT02275117|589129562|FG002|Overall Study|Protocol Violation|1|||
163115622|NCT02275117|589129563|FG003|Overall Study|Protocol Violation|1|||
163115623|NCT02275117|589129564|FG004|Overall Study|Protocol Violation|0|||
163115624|NCT02275117|589129560|FG000|Overall Study|Withdrawal by Subject|6|||
163115625|NCT02275117|589129561|FG001|Overall Study|Withdrawal by Subject|4|||
163115626|NCT02275117|589129562|FG002|Overall Study|Withdrawal by Subject|7|||
163115627|NCT02275117|589129563|FG003|Overall Study|Withdrawal by Subject|3|||
162719361|NCT00530842|587678488|FG000|Overall Study|Lost to Follow-up|0|||
163115628|NCT02275117|589129564|FG004|Overall Study|Withdrawal by Subject|3|||
163115629|NCT02275117|589129560|FG000|Overall Study|Terminated by Sponsor|4|||
163115630|NCT02275117|589129561|FG001|Overall Study|Terminated by Sponsor|4|||
163115631|NCT02275117|589129562|FG002|Overall Study|Terminated by Sponsor|4|||
163115632|NCT02275117|589129563|FG003|Overall Study|Terminated by Sponsor|6|||
163115633|NCT02275117|589129564|FG004|Overall Study|Terminated by Sponsor|4|||
163115634|NCT02275117|589129560|FG000|Overall Study|Worsening of Study Indication|0|||
163115635|NCT02275117|589129561|FG001|Overall Study|Worsening of Study Indication|1|||
163115636|NCT02275117|589129562|FG002|Overall Study|Worsening of Study Indication|2|||
163115637|NCT02275117|589129563|FG003|Overall Study|Worsening of Study Indication|0|||
163115638|NCT02275117|589129564|FG004|Overall Study|Worsening of Study Indication|0|||
163115639|NCT02275117|589129560|FG000|Overall Study|Study Burden|5|||
163115640|NCT02275117|589129561|FG001|Overall Study|Study Burden|4|||
163115641|NCT02275117|589129562|FG002|Overall Study|Study Burden|7|||
163115642|NCT02275117|589129563|FG003|Overall Study|Study Burden|5|||
163115643|NCT02275117|589129564|FG004|Overall Study|Study Burden|7|||
163115644|NCT02275117|589129560|FG000|Overall Study|Other|1|||
163115645|NCT02275117|589129561|FG001|Overall Study|Other|0|||
163115646|NCT02275117|589129562|FG002|Overall Study|Other|0|||
163115647|NCT02275117|589129563|FG003|Overall Study|Other|0|||
163115648|NCT02275117|589129564|FG004|Overall Study|Other|2|||
163115649|NCT01081301|589129568|FG000|Overall Study|Bereaved|3|||
163115650|NCT01081301|589129568|FG000|Overall Study|Too busy|5|||
163115651|NCT01081301|589129568|FG000|Overall Study|Patient too ill|2|||
163115652|NCT01081301|589129568|FG000|Overall Study|Lost to Follow-up|4|||
163115653|NCT01338610|589129569|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
163115654|NCT01338610|589129570|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
163115655|NCT01338610|589129571|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
163115656|NCT01338610|589129569|FG000|Overall Study|Protocol Violation|1|||
163115657|NCT01338610|589129570|FG001|Overall Study|Protocol Violation|0|||
163115658|NCT01338610|589129571|FG002|Overall Study|Protocol Violation|1|||
163115659|NCT01338610|589129569|FG000|Overall Study|Adverse Event|3|||
163115660|NCT01338610|589129570|FG001|Overall Study|Adverse Event|0|||
163115661|NCT01338610|589129571|FG002|Overall Study|Adverse Event|0|||
163115662|NCT02046226|589129572|FG000|Overall Study|Lost to Follow-up|7|||
163115663|NCT01095653|589129573|FG000|Overall Study|Lack of Efficacy|3|||
163115664|NCT01095653|589129574|FG001|Overall Study|Lack of Efficacy|0|||
163115665|NCT01095653|589129575|FG002|Overall Study|Lack of Efficacy|0|||
163115666|NCT01095653|589129573|FG000|Overall Study|Adverse Event|1|||
163115667|NCT01095653|589129574|FG001|Overall Study|Adverse Event|4|||
163115668|NCT01095653|589129575|FG002|Overall Study|Adverse Event|4|||
163115669|NCT01095653|589129573|FG000|Overall Study|Lost to Follow-up|1|||
163115670|NCT01095653|589129574|FG001|Overall Study|Lost to Follow-up|0|||
163115671|NCT01095653|589129575|FG002|Overall Study|Lost to Follow-up|4|||
163115672|NCT01095653|589129573|FG000|Overall Study|Withdrawal by Subject|4|||
163115673|NCT01095653|589129574|FG001|Overall Study|Withdrawal by Subject|5|||
163115674|NCT01095653|589129575|FG002|Overall Study|Withdrawal by Subject|3|||
163115675|NCT01095653|589129573|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
163115676|NCT01095653|589129574|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
163115677|NCT01095653|589129575|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
163115678|NCT02692040|589129576|FG000|Overall Study|Protocol Violation|0|||
163115679|NCT02692040|589129577|FG001|Overall Study|Protocol Violation|0|||
163115680|NCT02692040|589129578|FG002|Overall Study|Protocol Violation|0|||
163115681|NCT02692040|589129579|FG003|Overall Study|Protocol Violation|0|||
163115682|NCT02692040|589129580|FG004|Overall Study|Protocol Violation|0|||
163115683|NCT02692040|589129581|FG005|Overall Study|Protocol Violation|0|||
163115684|NCT02692040|589129582|FG006|Overall Study|Protocol Violation|0|||
163115685|NCT02692040|589129583|FG007|Overall Study|Protocol Violation|0|||
163115686|NCT02692040|589129584|FG008|Overall Study|Protocol Violation|0|||
163115687|NCT02692040|589129585|FG009|Overall Study|Protocol Violation|0|||
163115688|NCT02692040|589129586|FG010|Overall Study|Protocol Violation|0|||
163115689|NCT02692040|589129587|FG011|Overall Study|Protocol Violation|0|||
163115690|NCT02692040|589129588|FG012|Overall Study|Protocol Violation|1|||
163115691|NCT02692040|589129589|FG013|Overall Study|Protocol Violation|0|||
163115692|NCT02692040|589129590|FG014|Overall Study|Protocol Violation|0|||
163115693|NCT02692040|589129591|FG015|Overall Study|Protocol Violation|0|||
163115694|NCT02692040|589129592|FG016|Overall Study|Protocol Violation|0|||
163115695|NCT02692040|589129576|FG000|Overall Study|Adverse Event|0|||
163115696|NCT02692040|589129577|FG001|Overall Study|Adverse Event|0|||
163115697|NCT02692040|589129578|FG002|Overall Study|Adverse Event|0|||
163115698|NCT02692040|589129579|FG003|Overall Study|Adverse Event|0|||
163115699|NCT02692040|589129580|FG004|Overall Study|Adverse Event|0|||
163115700|NCT02692040|589129581|FG005|Overall Study|Adverse Event|0|||
163115701|NCT02692040|589129582|FG006|Overall Study|Adverse Event|0|||
163115702|NCT02692040|589129583|FG007|Overall Study|Adverse Event|0|||
163115703|NCT02692040|589129584|FG008|Overall Study|Adverse Event|0|||
163115704|NCT02692040|589129585|FG009|Overall Study|Adverse Event|0|||
163115705|NCT02692040|589129586|FG010|Overall Study|Adverse Event|0|||
163115706|NCT02692040|589129587|FG011|Overall Study|Adverse Event|0|||
163115707|NCT02692040|589129588|FG012|Overall Study|Adverse Event|0|||
162719362|NCT00530842|587678489|FG001|Overall Study|Lost to Follow-up|4|||
163115708|NCT02692040|589129589|FG013|Overall Study|Adverse Event|3|||
163115709|NCT02692040|589129590|FG014|Overall Study|Adverse Event|1|||
163115710|NCT02692040|589129591|FG015|Overall Study|Adverse Event|1|||
163115711|NCT02692040|589129592|FG016|Overall Study|Adverse Event|0|||
163115712|NCT00171925|589129596|FG000|Overall Study|Adverse Event|10|||
163115713|NCT00171925|589129597|FG001|Overall Study|Adverse Event|6|||
163115714|NCT00171925|589129596|FG000|Overall Study|Protocol Violation|1|||
163115715|NCT00171925|589129597|FG001|Overall Study|Protocol Violation|1|||
163115716|NCT00171925|589129596|FG000|Overall Study|Withdrawal by Subject|6|||
163115717|NCT00171925|589129597|FG001|Overall Study|Withdrawal by Subject|9|||
163115718|NCT00171925|589129596|FG000|Overall Study|Lost to Follow-up|2|||
163115719|NCT00171925|589129597|FG001|Overall Study|Lost to Follow-up|2|||
163115720|NCT00171925|589129596|FG000|Overall Study|Administrative problems|10|||
163115721|NCT00171925|589129597|FG001|Overall Study|Administrative problems|11|||
163115722|NCT00171925|589129596|FG000|Overall Study|Death|1|||
163115723|NCT00171925|589129597|FG001|Overall Study|Death|2|||
163115724|NCT02836873|589129600|FG000|Overall Study|Protocol Violation|0|||
163115725|NCT02836873|589129601|FG001|Overall Study|Protocol Violation|1|||
163115726|NCT02836873|589129600|FG000|Overall Study|Adverse Event|1|||
163115727|NCT02836873|589129601|FG001|Overall Study|Adverse Event|4|||
163115728|NCT02836873|589129600|FG000|Overall Study|Withdrawal by Subject|2|||
163115729|NCT02836873|589129601|FG001|Overall Study|Withdrawal by Subject|2|||
163115730|NCT02836873|589129600|FG000|Overall Study|Lost to Follow-up|1|||
163115731|NCT02836873|589129601|FG001|Overall Study|Lost to Follow-up|3|||
163115732|NCT02836873|589129600|FG000|Overall Study|Physician Decision|0|||
163115733|NCT02836873|589129601|FG001|Overall Study|Physician Decision|1|||
163115734|NCT02836873|589129600|FG000|Overall Study|Other|1|||
163115735|NCT02836873|589129601|FG001|Overall Study|Other|0|||
163115736|NCT00853125|589129610|FG000|Overall Study|Study participant's donor was CMV +|1|||
163115737|NCT02914548|589129611|FG000|Overall Study|Adverse Event|15|||
163115738|NCT02914548|589129612|FG001|Overall Study|Adverse Event|7|||
163115739|NCT02914548|589129613|FG002|Overall Study|Adverse Event|15|||
163115740|NCT02914548|589129611|FG000|Overall Study|Physician Decision|2|||
163115741|NCT02914548|589129612|FG001|Overall Study|Physician Decision|2|||
163115742|NCT02914548|589129613|FG002|Overall Study|Physician Decision|0|||
163115743|NCT02914548|589129611|FG000|Overall Study|Protocol Violation|1|||
163115744|NCT02914548|589129612|FG001|Overall Study|Protocol Violation|0|||
163115745|NCT02914548|589129613|FG002|Overall Study|Protocol Violation|0|||
163115746|NCT02914548|589129611|FG000|Overall Study|Withdrawal by Subject|3|||
163115747|NCT02914548|589129612|FG001|Overall Study|Withdrawal by Subject|4|||
163115748|NCT02914548|589129613|FG002|Overall Study|Withdrawal by Subject|4|||
163115749|NCT02914548|589129611|FG000|Overall Study|>40% of body surface area|0|||
163115750|NCT02914548|589129612|FG001|Overall Study|>40% of body surface area|1|||
163115751|NCT02914548|589129613|FG002|Overall Study|>40% of body surface area|1|||
163115752|NCT03746600|589129618|FG000|Overall Study|Withdrawal by Subject|3|||
163115753|NCT03746600|589129619|FG001|Overall Study|Withdrawal by Subject|3|||
163115754|NCT03746600|589129618|FG000|Overall Study|dismissed from study|1|||
163115755|NCT03746600|589129619|FG001|Overall Study|dismissed from study|0|||
163115756|NCT03746600|589129618|FG000|Overall Study|Lost to Follow-up|1|||
163115757|NCT03746600|589129619|FG001|Overall Study|Lost to Follow-up|0|||
163115758|NCT02374814|589129627|FG000|Overall Study|Lost to Follow-up|1|||
163115759|NCT02374814|589129628|FG001|Overall Study|Lost to Follow-up|1|||
163115760|NCT02374814|589129629|FG002|Overall Study|Lost to Follow-up|0|||
163115761|NCT02374814|589129630|FG003|Overall Study|Lost to Follow-up|1|||
163115762|NCT02374814|589129631|FG004|Overall Study|Lost to Follow-up|0|||
163115763|NCT02374814|589129632|FG005|Overall Study|Lost to Follow-up|0|||
163115764|NCT02374814|589129627|FG000|Overall Study|Withdrawal by Subject|0|||
163115765|NCT02374814|589129628|FG001|Overall Study|Withdrawal by Subject|0|||
163115766|NCT02374814|589129629|FG002|Overall Study|Withdrawal by Subject|1|||
163115767|NCT02374814|589129630|FG003|Overall Study|Withdrawal by Subject|1|||
163115768|NCT02374814|589129631|FG004|Overall Study|Withdrawal by Subject|0|||
163115769|NCT02374814|589129632|FG005|Overall Study|Withdrawal by Subject|0|||
163115770|NCT00884039|589129633|FG000|Overall Study|Withdrawal by Subject|0|||
163115771|NCT00884039|589129634|FG001|Overall Study|Withdrawal by Subject|1|||
163115772|NCT00884039|589129633|FG000|Overall Study|Lack of Efficacy|2|||
163115773|NCT00884039|589129634|FG001|Overall Study|Lack of Efficacy|0|||
163115774|NCT05291936|589129635|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
163115775|NCT05291936|589129636|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
163115776|NCT05291936|589129635|FG000|Period 1|Withdrew Consent during study|1|||
163115777|NCT05291936|589129636|FG001|Period 1|Withdrew Consent during study|0|||
163115778|NCT05291936|589129635|FG000|Period 2|Adverse Event|0|||
163115779|NCT05291936|589129636|FG001|Period 2|Adverse Event|1|||
163115780|NCT05291936|589129635|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163115781|NCT05291936|589129636|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163115782|NCT01300819|589129637|FG000|Overall Study|Adverse Event|9|||
163115783|NCT01300819|589129638|FG001|Overall Study|Adverse Event|27|||
163115784|NCT01300819|589129637|FG000|Overall Study|Lack of Efficacy|2|||
163115785|NCT01300819|589129638|FG001|Overall Study|Lack of Efficacy|1|||
163115786|NCT01300819|589129637|FG000|Overall Study|Withdrawal by Subject|10|||
163115787|NCT01300819|589129638|FG001|Overall Study|Withdrawal by Subject|12|||
163115788|NCT01300819|589129637|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
163115789|NCT01300819|589129638|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
163115790|NCT01300819|589129637|FG000|Overall Study|Refusal to down titrate study drug|0|||
163115791|NCT01300819|589129638|FG001|Overall Study|Refusal to down titrate study drug|1|||
163115792|NCT01300819|589129637|FG000|Overall Study|Administrative reason|0|||
163115793|NCT01300819|589129638|FG001|Overall Study|Administrative reason|1|||
163115794|NCT01300819|589129637|FG000|Overall Study|Safety follow up not done by mistake|0|||
163115795|NCT01300819|589129638|FG001|Overall Study|Safety follow up not done by mistake|1|||
163115796|NCT01300819|589129637|FG000|Overall Study|Follow up call was not done|1|||
163115797|NCT01300819|589129638|FG001|Overall Study|Follow up call was not done|0|||
163115798|NCT02032407|589132318|FG000|Overall Study|Lost to Follow-up|2|||
163115799|NCT02032407|589132318|FG000|Overall Study|Pregnancy|1|||
163115800|NCT02032407|589132318|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163115801|NCT00428220|589132319|FG000|Overall Study|Participant died|8|||
163115802|NCT00428220|589132319|FG000|Overall Study|Global deterioration of health status|7|||
163115803|NCT00428220|589132319|FG000|Overall Study|Lost to Follow-up|4|||
163115804|NCT00428220|589132319|FG000|Overall Study|Objective progression or relapse|123|||
163115805|NCT00428220|589132319|FG000|Overall Study|Participant refused continued treatment|7|||
163115806|NCT00428220|589132319|FG000|Overall Study|Adverse Event|51|||
163115807|NCT00428220|589132319|FG000|Overall Study|Other|23|||
163115808|NCT00549900|589132320|FG000|Overall Study|Adverse Event|1|||
163115809|NCT01176565|589132327|FG000|Overall Study|Lost to Follow-up|12|||
163115810|NCT01176565|589132328|FG001|Overall Study|Lost to Follow-up|16|||
163115811|NCT01176565|589132327|FG000|Overall Study|Withdrawal by Subject|7|||
163115812|NCT01176565|589132328|FG001|Overall Study|Withdrawal by Subject|1|||
163115813|NCT01176565|589132327|FG000|Overall Study|Not Analyzed (any other reason)|1|||
163115814|NCT01176565|589132328|FG001|Overall Study|Not Analyzed (any other reason)|2|||
163115815|NCT02754141|589132329|FG000|Overall Study|Disease progression|11|||
163115816|NCT02754141|589132330|FG001|Overall Study|Disease progression|7|||
163115817|NCT02754141|589132331|FG002|Overall Study|Disease progression|8|||
163115818|NCT02754141|589132332|FG003|Overall Study|Disease progression|5|||
163115819|NCT02754141|589132333|FG004|Overall Study|Disease progression|7|||
163115820|NCT02754141|589132334|FG005|Overall Study|Disease progression|7|||
163115821|NCT02754141|589132335|FG006|Overall Study|Disease progression|7|||
163115822|NCT02754141|589132336|FG007|Overall Study|Disease progression|6|||
163115823|NCT02754141|589132337|FG008|Overall Study|Disease progression|11|||
163115824|NCT02754141|589132338|FG009|Overall Study|Disease progression|16|||
163115825|NCT02754141|589132339|FG010|Overall Study|Disease progression|18|||
163115826|NCT02754141|589132340|FG011|Overall Study|Disease progression|13|||
163115827|NCT02754141|589132341|FG012|Overall Study|Disease progression|10|||
163115828|NCT02754141|589132342|FG013|Overall Study|Disease progression|12|||
163115829|NCT02754141|589132343|FG014|Overall Study|Disease progression|12|||
163115830|NCT02754141|589132344|FG015|Overall Study|Disease progression|14|||
163115831|NCT02754141|589132345|FG016|Overall Study|Disease progression|0|||
163115832|NCT02754141|589132346|FG017|Overall Study|Disease progression|1|||
163115833|NCT02754141|589132329|FG000|Overall Study|Study drug toxicity|1|||
163115834|NCT02754141|589132330|FG001|Overall Study|Study drug toxicity|1|||
163115835|NCT02754141|589132331|FG002|Overall Study|Study drug toxicity|0|||
163115836|NCT02754141|589132332|FG003|Overall Study|Study drug toxicity|0|||
163115837|NCT02754141|589132333|FG004|Overall Study|Study drug toxicity|0|||
163115838|NCT02754141|589132334|FG005|Overall Study|Study drug toxicity|0|||
163115839|NCT02754141|589132335|FG006|Overall Study|Study drug toxicity|0|||
163115840|NCT02754141|589132336|FG007|Overall Study|Study drug toxicity|0|||
163115841|NCT02754141|589132337|FG008|Overall Study|Study drug toxicity|0|||
163115842|NCT02754141|589132338|FG009|Overall Study|Study drug toxicity|0|||
163115843|NCT02754141|589132339|FG010|Overall Study|Study drug toxicity|2|||
163115844|NCT02754141|589132340|FG011|Overall Study|Study drug toxicity|1|||
162654159|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
162654160|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Death|0|||
163115845|NCT02754141|589132341|FG012|Overall Study|Study drug toxicity|1|||
163115846|NCT02754141|589132342|FG013|Overall Study|Study drug toxicity|0|||
163115847|NCT02754141|589132343|FG014|Overall Study|Study drug toxicity|0|||
162654161|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Death|0|||
163115848|NCT02754141|589132344|FG015|Overall Study|Study drug toxicity|0|||
163115849|NCT02754141|589132345|FG016|Overall Study|Study drug toxicity|0|||
163115850|NCT02754141|589132346|FG017|Overall Study|Study drug toxicity|0|||
163115851|NCT02754141|589132329|FG000|Overall Study|AE unrelated to study drug|1|||
162719363|NCT00530842|587678488|FG000|Overall Study|Protocol Violation|3|||
163115852|NCT02754141|589132330|FG001|Overall Study|AE unrelated to study drug|1|||
163115853|NCT02754141|589132331|FG002|Overall Study|AE unrelated to study drug|0|||
163115854|NCT02754141|589132332|FG003|Overall Study|AE unrelated to study drug|1|||
163115855|NCT02754141|589132333|FG004|Overall Study|AE unrelated to study drug|3|||
163115856|NCT02754141|589132334|FG005|Overall Study|AE unrelated to study drug|2|||
163115857|NCT02754141|589132335|FG006|Overall Study|AE unrelated to study drug|1|||
163115858|NCT02754141|589132336|FG007|Overall Study|AE unrelated to study drug|0|||
163115859|NCT02754141|589132337|FG008|Overall Study|AE unrelated to study drug|0|||
163115860|NCT02754141|589132338|FG009|Overall Study|AE unrelated to study drug|0|||
163115861|NCT02754141|589132339|FG010|Overall Study|AE unrelated to study drug|0|||
163115862|NCT02754141|589132340|FG011|Overall Study|AE unrelated to study drug|0|||
163115863|NCT02754141|589132341|FG012|Overall Study|AE unrelated to study drug|0|||
163115864|NCT02754141|589132342|FG013|Overall Study|AE unrelated to study drug|0|||
163115865|NCT02754141|589132343|FG014|Overall Study|AE unrelated to study drug|0|||
163115866|NCT02754141|589132344|FG015|Overall Study|AE unrelated to study drug|0|||
163115867|NCT02754141|589132345|FG016|Overall Study|AE unrelated to study drug|0|||
163115868|NCT02754141|589132346|FG017|Overall Study|AE unrelated to study drug|0|||
163115869|NCT02754141|589132329|FG000|Overall Study|Request to discontinue|0|||
163115870|NCT02754141|589132330|FG001|Overall Study|Request to discontinue|0|||
163115871|NCT02754141|589132331|FG002|Overall Study|Request to discontinue|0|||
163115872|NCT02754141|589132332|FG003|Overall Study|Request to discontinue|0|||
163115873|NCT02754141|589132333|FG004|Overall Study|Request to discontinue|0|||
163115874|NCT02754141|589132334|FG005|Overall Study|Request to discontinue|0|||
163115875|NCT02754141|589132335|FG006|Overall Study|Request to discontinue|0|||
163115876|NCT02754141|589132336|FG007|Overall Study|Request to discontinue|0|||
163115877|NCT02754141|589132337|FG008|Overall Study|Request to discontinue|1|||
163115878|NCT02754141|589132338|FG009|Overall Study|Request to discontinue|0|||
163115879|NCT02754141|589132339|FG010|Overall Study|Request to discontinue|0|||
163115880|NCT02754141|589132340|FG011|Overall Study|Request to discontinue|0|||
163115881|NCT02754141|589132341|FG012|Overall Study|Request to discontinue|0|||
163115882|NCT02754141|589132342|FG013|Overall Study|Request to discontinue|1|||
163115883|NCT02754141|589132343|FG014|Overall Study|Request to discontinue|1|||
163115884|NCT02754141|589132344|FG015|Overall Study|Request to discontinue|0|||
163115885|NCT02754141|589132345|FG016|Overall Study|Request to discontinue|0|||
163115886|NCT02754141|589132346|FG017|Overall Study|Request to discontinue|0|||
163115887|NCT02754141|589132329|FG000|Overall Study|Withdrew consent|0|||
163115888|NCT02754141|589132330|FG001|Overall Study|Withdrew consent|0|||
163115889|NCT02754141|589132331|FG002|Overall Study|Withdrew consent|0|||
163115890|NCT02754141|589132332|FG003|Overall Study|Withdrew consent|0|||
163115891|NCT02754141|589132333|FG004|Overall Study|Withdrew consent|0|||
163115892|NCT02754141|589132334|FG005|Overall Study|Withdrew consent|0|||
163115893|NCT02754141|589132335|FG006|Overall Study|Withdrew consent|0|||
163115894|NCT02754141|589132336|FG007|Overall Study|Withdrew consent|0|||
163115895|NCT02754141|589132337|FG008|Overall Study|Withdrew consent|0|||
163115896|NCT02754141|589132338|FG009|Overall Study|Withdrew consent|1|||
163115897|NCT02754141|589132339|FG010|Overall Study|Withdrew consent|0|||
163115898|NCT02754141|589132340|FG011|Overall Study|Withdrew consent|0|||
163115899|NCT02754141|589132341|FG012|Overall Study|Withdrew consent|0|||
163115900|NCT02754141|589132342|FG013|Overall Study|Withdrew consent|0|||
163115901|NCT02754141|589132343|FG014|Overall Study|Withdrew consent|0|||
163115902|NCT02754141|589132344|FG015|Overall Study|Withdrew consent|0|||
163115903|NCT02754141|589132345|FG016|Overall Study|Withdrew consent|0|||
163115904|NCT02754141|589132346|FG017|Overall Study|Withdrew consent|0|||
163115905|NCT02754141|589132329|FG000|Overall Study|Maximum clinical benefit|0|||
163115906|NCT02754141|589132330|FG001|Overall Study|Maximum clinical benefit|0|||
163115907|NCT02754141|589132331|FG002|Overall Study|Maximum clinical benefit|0|||
163115908|NCT02754141|589132332|FG003|Overall Study|Maximum clinical benefit|1|||
163115909|NCT02754141|589132333|FG004|Overall Study|Maximum clinical benefit|0|||
163115910|NCT02754141|589132334|FG005|Overall Study|Maximum clinical benefit|0|||
163115911|NCT02754141|589132335|FG006|Overall Study|Maximum clinical benefit|0|||
163115912|NCT02754141|589132336|FG007|Overall Study|Maximum clinical benefit|0|||
162654162|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Death|0|||
162654163|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Death|1|||
162654164|NCT00207142|587449691|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162654165|NCT00207142|587449692|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162654166|NCT00207142|587449693|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162654167|NCT00207142|587449694|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
162719364|NCT00530842|587678489|FG001|Overall Study|Protocol Violation|2|||
163115913|NCT02754141|589132337|FG008|Overall Study|Maximum clinical benefit|0|||
163115914|NCT02754141|589132338|FG009|Overall Study|Maximum clinical benefit|0|||
163115915|NCT02754141|589132339|FG010|Overall Study|Maximum clinical benefit|0|||
163115916|NCT02754141|589132340|FG011|Overall Study|Maximum clinical benefit|0|||
163115917|NCT02754141|589132341|FG012|Overall Study|Maximum clinical benefit|0|||
163115918|NCT02754141|589132342|FG013|Overall Study|Maximum clinical benefit|0|||
163115919|NCT02754141|589132343|FG014|Overall Study|Maximum clinical benefit|0|||
163115920|NCT02754141|589132344|FG015|Overall Study|Maximum clinical benefit|0|||
163115921|NCT02754141|589132345|FG016|Overall Study|Maximum clinical benefit|0|||
162654168|NCT01554618|587449695|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
163115922|NCT02754141|589132346|FG017|Overall Study|Maximum clinical benefit|0|||
163115923|NCT02754141|589132329|FG000|Overall Study|No longer meets study criteria|0|||
163115924|NCT02754141|589132330|FG001|Overall Study|No longer meets study criteria|0|||
163115925|NCT02754141|589132331|FG002|Overall Study|No longer meets study criteria|0|||
163115926|NCT02754141|589132332|FG003|Overall Study|No longer meets study criteria|1|||
163115927|NCT02754141|589132333|FG004|Overall Study|No longer meets study criteria|0|||
163115928|NCT02754141|589132334|FG005|Overall Study|No longer meets study criteria|0|||
163115929|NCT02754141|589132335|FG006|Overall Study|No longer meets study criteria|0|||
163115930|NCT02754141|589132336|FG007|Overall Study|No longer meets study criteria|0|||
163115931|NCT02754141|589132337|FG008|Overall Study|No longer meets study criteria|0|||
163115932|NCT02754141|589132338|FG009|Overall Study|No longer meets study criteria|0|||
163115933|NCT02754141|589132339|FG010|Overall Study|No longer meets study criteria|0|||
163115934|NCT02754141|589132340|FG011|Overall Study|No longer meets study criteria|0|||
163115935|NCT02754141|589132341|FG012|Overall Study|No longer meets study criteria|0|||
163115936|NCT02754141|589132342|FG013|Overall Study|No longer meets study criteria|0|||
163115937|NCT02754141|589132343|FG014|Overall Study|No longer meets study criteria|0|||
163115938|NCT02754141|589132344|FG015|Overall Study|No longer meets study criteria|0|||
163115939|NCT02754141|589132345|FG016|Overall Study|No longer meets study criteria|0|||
163115940|NCT02754141|589132346|FG017|Overall Study|No longer meets study criteria|0|||
163115941|NCT02754141|589132329|FG000|Overall Study|Other reasons|0|||
163115942|NCT02754141|589132330|FG001|Overall Study|Other reasons|0|||
163115943|NCT02754141|589132331|FG002|Overall Study|Other reasons|0|||
163115944|NCT02754141|589132332|FG003|Overall Study|Other reasons|0|||
163115945|NCT02754141|589132333|FG004|Overall Study|Other reasons|0|||
163115946|NCT02754141|589132334|FG005|Overall Study|Other reasons|0|||
163115947|NCT02754141|589132335|FG006|Overall Study|Other reasons|0|||
163115948|NCT02754141|589132336|FG007|Overall Study|Other reasons|1|||
163115949|NCT02754141|589132337|FG008|Overall Study|Other reasons|0|||
163115950|NCT02754141|589132338|FG009|Overall Study|Other reasons|0|||
163115951|NCT02754141|589132339|FG010|Overall Study|Other reasons|0|||
163115952|NCT02754141|589132340|FG011|Overall Study|Other reasons|0|||
163115953|NCT02754141|589132341|FG012|Overall Study|Other reasons|2|||
163115954|NCT02754141|589132342|FG013|Overall Study|Other reasons|0|||
163115955|NCT02754141|589132343|FG014|Overall Study|Other reasons|0|||
163115956|NCT02754141|589132344|FG015|Overall Study|Other reasons|0|||
163115957|NCT02754141|589132345|FG016|Overall Study|Other reasons|0|||
163115958|NCT02754141|589132346|FG017|Overall Study|Other reasons|0|||
163115959|NCT02754141|589132329|FG000|Overall Study|Completed treatment as per protocol|0|||
163115960|NCT02754141|589132330|FG001|Overall Study|Completed treatment as per protocol|1|||
163115961|NCT02754141|589132331|FG002|Overall Study|Completed treatment as per protocol|0|||
163115962|NCT02754141|589132332|FG003|Overall Study|Completed treatment as per protocol|0|||
163115963|NCT02754141|589132333|FG004|Overall Study|Completed treatment as per protocol|0|||
163115964|NCT02754141|589132334|FG005|Overall Study|Completed treatment as per protocol|0|||
163115965|NCT02754141|589132335|FG006|Overall Study|Completed treatment as per protocol|0|||
163115966|NCT02754141|589132336|FG007|Overall Study|Completed treatment as per protocol|0|||
163115967|NCT02754141|589132337|FG008|Overall Study|Completed treatment as per protocol|0|||
163115968|NCT02754141|589132338|FG009|Overall Study|Completed treatment as per protocol|0|||
163115969|NCT02754141|589132339|FG010|Overall Study|Completed treatment as per protocol|0|||
163115970|NCT02754141|589132340|FG011|Overall Study|Completed treatment as per protocol|0|||
163115971|NCT02754141|589132341|FG012|Overall Study|Completed treatment as per protocol|1|||
163115972|NCT02754141|589132342|FG013|Overall Study|Completed treatment as per protocol|0|||
163115973|NCT02754141|589132343|FG014|Overall Study|Completed treatment as per protocol|0|||
163115974|NCT02754141|589132344|FG015|Overall Study|Completed treatment as per protocol|0|||
163115975|NCT02754141|589132345|FG016|Overall Study|Completed treatment as per protocol|0|||
163115976|NCT02754141|589132346|FG017|Overall Study|Completed treatment as per protocol|0|||
163115977|NCT02754141|589132329|FG000|Overall Study|Not completing monotherapy|0|||
163115978|NCT02754141|589132330|FG001|Overall Study|Not completing monotherapy|0|||
163115979|NCT02754141|589132331|FG002|Overall Study|Not completing monotherapy|0|||
163115980|NCT02754141|589132332|FG003|Overall Study|Not completing monotherapy|0|||
163115981|NCT02754141|589132333|FG004|Overall Study|Not completing monotherapy|0|||
163115982|NCT02754141|589132334|FG005|Overall Study|Not completing monotherapy|0|||
163115983|NCT02754141|589132335|FG006|Overall Study|Not completing monotherapy|0|||
163115984|NCT02754141|589132336|FG007|Overall Study|Not completing monotherapy|0|||
163115985|NCT02754141|589132337|FG008|Overall Study|Not completing monotherapy|0|||
163115986|NCT02754141|589132338|FG009|Overall Study|Not completing monotherapy|0|||
163115987|NCT02754141|589132339|FG010|Overall Study|Not completing monotherapy|0|||
163115988|NCT02754141|589132340|FG011|Overall Study|Not completing monotherapy|0|||
163115989|NCT02754141|589132341|FG012|Overall Study|Not completing monotherapy|0|||
163115990|NCT02754141|589132342|FG013|Overall Study|Not completing monotherapy|1|||
163115991|NCT02754141|589132343|FG014|Overall Study|Not completing monotherapy|0|||
163115992|NCT02754141|589132344|FG015|Overall Study|Not completing monotherapy|0|||
163115993|NCT02754141|589132345|FG016|Overall Study|Not completing monotherapy|0|||
163115994|NCT02754141|589132346|FG017|Overall Study|Not completing monotherapy|0|||
163115995|NCT02680041|589132347|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
163115996|NCT02680041|589132347|FG000|Overall Study|Lost to Follow-up|2|||
163115997|NCT02324205|589132348|FG000|Overall Study|Withdrawal by Subject|37|||
163115998|NCT04239222|589132349|FG000|Baseline|Withdrawal by Subject|0|||
163115999|NCT04239222|589132350|FG001|Baseline|Withdrawal by Subject|0|||
163116000|NCT04239222|589132351|FG002|Baseline|Withdrawal by Subject|1|||
163116001|NCT04239222|589132352|FG003|Baseline|Withdrawal by Subject|1|||
163116002|NCT04239222|589132349|FG000|First Foot Assignment|Withdrawal by Subject|0|||
163116003|NCT04239222|589132350|FG001|First Foot Assignment|Withdrawal by Subject|0|||
163116004|NCT04239222|589132351|FG002|First Foot Assignment|Withdrawal by Subject|1|||
163116005|NCT04239222|589132352|FG003|First Foot Assignment|Withdrawal by Subject|0|||
163116006|NCT04239222|589132349|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116007|NCT04239222|589132350|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116008|NCT04239222|589132351|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
163116009|NCT04239222|589132352|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
163116010|NCT00937404|589132355|FG000|Overall Study|Protocol Violation|1|||
163116011|NCT00937404|589132355|FG000|Overall Study|Withdrawal by Subject|1|||
163116012|NCT00090233|589132356|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
163116013|NCT00090233|589132357|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
163116014|NCT00090233|589132356|FG000|Overall Study|Adverse Event|214|||
163116015|NCT00090233|589132357|FG001|Overall Study|Adverse Event|198|||
163116016|NCT00090233|589132356|FG000|Overall Study|Lost to Follow-up|68|||
163116017|NCT00090233|589132357|FG001|Overall Study|Lost to Follow-up|95|||
163116018|NCT00090233|589132356|FG000|Overall Study|Protocol Violation|960|||
163116019|NCT00090233|589132357|FG001|Overall Study|Protocol Violation|1022|||
163116020|NCT00090233|589132356|FG000|Overall Study|Withdrawal by Subject|182|||
163116021|NCT00090233|589132357|FG001|Overall Study|Withdrawal by Subject|211|||
163116022|NCT00090233|589132356|FG000|Overall Study|Moved|203|||
163116023|NCT00090233|589132357|FG001|Overall Study|Moved|189|||
163116024|NCT00090233|589132356|FG000|Overall Study|Other|1211|||
163116025|NCT00090233|589132357|FG001|Overall Study|Other|1160|||
163116026|NCT00090233|589132356|FG000|Overall Study|Data not available at data cut-off point|1552|||
163116027|NCT00090233|589132357|FG001|Overall Study|Data not available at data cut-off point|1563|||
163116028|NCT04863248|589132358|FG000|Overall Study|Sponsor Terminated|4|||
163116029|NCT04863248|589132359|FG001|Overall Study|Sponsor Terminated|1|||
163116030|NCT04863248|589132358|FG000|Overall Study|Death|0|||
163116031|NCT04863248|589132359|FG001|Overall Study|Death|1|||
163116032|NCT04863248|589132358|FG000|Overall Study|Withdrawal by Subject|0|||
163116033|NCT04863248|589132359|FG001|Overall Study|Withdrawal by Subject|1|||
163116034|NCT01779869|589132360|FG000|Overall Study|Physician Decision|2|||
163116035|NCT02536300|589132361|FG000|Overall Study|Investigator's Discretion|17|||
163116036|NCT02536300|589132362|FG001|Overall Study|Investigator's Discretion|11|||
163116037|NCT02536300|589132363|FG002|Overall Study|Investigator's Discretion|2|||
163116038|NCT02536300|589132361|FG000|Overall Study|Progressive Disease|11|||
163116039|NCT02536300|589132362|FG001|Overall Study|Progressive Disease|7|||
163116040|NCT02536300|589132363|FG002|Overall Study|Progressive Disease|6|||
163116041|NCT02536300|589132361|FG000|Overall Study|Study Terminated by Sponsor|6|||
163116042|NCT02536300|589132362|FG001|Overall Study|Study Terminated by Sponsor|4|||
163116043|NCT02536300|589132363|FG002|Overall Study|Study Terminated by Sponsor|7|||
163116044|NCT02536300|589132361|FG000|Overall Study|Death|7|||
163116045|NCT02536300|589132362|FG001|Overall Study|Death|0|||
163116046|NCT02536300|589132363|FG002|Overall Study|Death|5|||
163116047|NCT02536300|589132361|FG000|Overall Study|Withdrew Consent|4|||
163116048|NCT02536300|589132362|FG001|Overall Study|Withdrew Consent|2|||
163116049|NCT02536300|589132363|FG002|Overall Study|Withdrew Consent|0|||
163116050|NCT02536300|589132361|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
163116051|NCT02536300|589132362|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
163116052|NCT02536300|589132363|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
163116053|NCT02536300|589132361|FG000|Overall Study|Enrolled but Never Treated|0|||
163116054|NCT02536300|589132362|FG001|Overall Study|Enrolled but Never Treated|0|||
163116055|NCT02536300|589132363|FG002|Overall Study|Enrolled but Never Treated|1|||
163116056|NCT02536300|589132361|FG000|Overall Study|Non-compliance With Study Drug|1|||
163116057|NCT02536300|589132362|FG001|Overall Study|Non-compliance With Study Drug|0|||
163116058|NCT02536300|589132363|FG002|Overall Study|Non-compliance With Study Drug|0|||
163116059|NCT02536300|589132361|FG000|Overall Study|Protocol Violation|0|||
163116060|NCT02536300|589132362|FG001|Overall Study|Protocol Violation|1|||
162654169|NCT01554618|587449696|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
162654170|NCT01554618|587449695|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
162654171|NCT01554618|587449696|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
163116061|NCT02536300|589132363|FG002|Overall Study|Protocol Violation|0|||
163116062|NCT01691105|589132371|FG000|1 Month Follow-up|Lost to Follow-up|41|||
163116063|NCT01691105|589132372|FG001|1 Month Follow-up|Lost to Follow-up|38|||
163116064|NCT01691105|589132371|FG000|1 Month Follow-up|Death|2|||
163116065|NCT01691105|589132372|FG001|1 Month Follow-up|Death|3|||
163116066|NCT01691105|589132371|FG000|6 Month Follow-up|Lost to Follow-up|39|||
163116067|NCT01691105|589132372|FG001|6 Month Follow-up|Lost to Follow-up|58|||
163116068|NCT01691105|589132371|FG000|6 Month Follow-up|Death|13|||
163116069|NCT01691105|589132372|FG001|6 Month Follow-up|Death|13|||
163116070|NCT01691105|589132371|FG000|12 Month Follow-up|Lost to Follow-up|50|||
163116071|NCT01691105|589132372|FG001|12 Month Follow-up|Lost to Follow-up|71|||
163116072|NCT01691105|589132371|FG000|12 Month Follow-up|Death|22|||
163116073|NCT01691105|589132372|FG001|12 Month Follow-up|Death|30|||
163116074|NCT01691105|589132371|FG000|12 Month Biochemical Verification|Death|22|||
162654172|NCT01554618|587449695|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
162654173|NCT01554618|587449696|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
163116075|NCT01691105|589132372|FG001|12 Month Biochemical Verification|Death|30|||
163116076|NCT01691105|589132371|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
162654174|NCT01554618|587449695|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
163116077|NCT01691105|589132372|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
163116078|NCT01691105|589132371|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
163116079|NCT01691105|589132372|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
163116080|NCT00957944|589132373|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
163116081|NCT00957944|589132374|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
163116082|NCT01482169|589132376|FG000|Overall Study|Physician Decision|2|||
163116083|NCT01777542|589132379|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
163116084|NCT01777542|589132380|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
163116085|NCT01030874|589132383|FG000|Overall Study|Withdrawal by Subject|1|||
163116086|NCT01030874|589132384|FG001|Overall Study|Withdrawal by Subject|0|||
163116087|NCT01030874|589132383|FG000|Overall Study|Discharged in first 2 weeks|17|||
163116088|NCT01030874|589132384|FG001|Overall Study|Discharged in first 2 weeks|16|||
163116089|NCT00869050|589132390|FG000|Overall Study|Screen Failure|3|||
163116090|NCT03298984|589132396|FG000|Overall Study|Physician Decision|1|||
163116091|NCT03298984|589132397|FG001|Overall Study|Physician Decision|0|||
163116092|NCT03298984|589132398|FG002|Overall Study|Physician Decision|0|||
163116093|NCT03298984|589132399|FG003|Overall Study|Physician Decision|6|||
163116094|NCT03298984|589132396|FG000|Overall Study|Lack of Efficacy|0|||
163116095|NCT03298984|589132397|FG001|Overall Study|Lack of Efficacy|1|||
163116096|NCT03298984|589132398|FG002|Overall Study|Lack of Efficacy|1|||
163116097|NCT03298984|589132399|FG003|Overall Study|Lack of Efficacy|4|||
163116098|NCT03298984|589132396|FG000|Overall Study|Relapsed disease (following remission)|0|||
163116099|NCT03298984|589132397|FG001|Overall Study|Relapsed disease (following remission)|0|||
163116100|NCT03298984|589132398|FG002|Overall Study|Relapsed disease (following remission)|1|||
163116101|NCT03298984|589132399|FG003|Overall Study|Relapsed disease (following remission)|1|||
163116102|NCT03298984|589132396|FG000|Overall Study|Adverse Event|0|||
163116103|NCT03298984|589132397|FG001|Overall Study|Adverse Event|0|||
163116104|NCT03298984|589132398|FG002|Overall Study|Adverse Event|0|||
163116105|NCT03298984|589132399|FG003|Overall Study|Adverse Event|1|||
163116106|NCT03298984|589132396|FG000|Overall Study|Death|0|||
163116107|NCT03298984|589132397|FG001|Overall Study|Death|0|||
163116108|NCT03298984|589132398|FG002|Overall Study|Death|0|||
163116109|NCT03298984|589132399|FG003|Overall Study|Death|2|||
163116110|NCT03298984|589132396|FG000|Overall Study|Insurance Company Decision|0|||
163116111|NCT03298984|589132397|FG001|Overall Study|Insurance Company Decision|0|||
163116112|NCT03298984|589132398|FG002|Overall Study|Insurance Company Decision|0|||
163116113|NCT03298984|589132399|FG003|Overall Study|Insurance Company Decision|1|||
163116114|NCT01571284|589132400|FG000|Overall Study|Participant's decision|84|||
163116115|NCT01571284|589132400|FG000|Overall Study|Lost to Follow-up|3|||
163116116|NCT01571284|589132400|FG000|Overall Study|Enrolled but not treated|2|||
163116117|NCT01571284|589132400|FG000|Overall Study|Other than specified above|80|||
163116118|NCT03883113|589132419|FG000|Overall Study|Physician Decision|4|||
163116119|NCT03883113|589132420|FG001|Overall Study|Physician Decision|2|||
163116120|NCT03883113|589132419|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
163116121|NCT03883113|589132420|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
163116122|NCT03883113|589132419|FG000|Overall Study|Pregnancy|1|||
163116123|NCT03883113|589132420|FG001|Overall Study|Pregnancy|0|||
163116124|NCT03883113|589132419|FG000|Overall Study|Adverse Event|0|||
163116125|NCT03883113|589132420|FG001|Overall Study|Adverse Event|1|||
163116126|NCT03883113|589132419|FG000|Overall Study|Withdrawal by Subject|1|||
163116127|NCT03883113|589132420|FG001|Overall Study|Withdrawal by Subject|2|||
163116128|NCT03883113|589132419|FG000|Overall Study|Lost to Follow-up|1|||
163116129|NCT03883113|589132420|FG001|Overall Study|Lost to Follow-up|0|||
163116130|NCT02323204|589132426|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
163116131|NCT02323204|589132427|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
163116132|NCT02323204|589132428|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
163116133|NCT02323204|589132429|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
163116134|NCT02323204|589132426|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
163116135|NCT02323204|589132427|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
163116136|NCT02323204|589132428|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
163116137|NCT02323204|589132429|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
163116138|NCT02323204|589132426|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
163116139|NCT02323204|589132427|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
163116140|NCT02323204|589132428|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
163116141|NCT02323204|589132429|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
163116142|NCT02323204|589132426|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
163116143|NCT02323204|589132427|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
163116144|NCT02323204|589132428|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
163116145|NCT02323204|589132429|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
163116146|NCT02323204|589132426|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
163116147|NCT02323204|589132427|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
163116148|NCT02323204|589132428|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
163116149|NCT02323204|589132429|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
163116150|NCT02323204|589132426|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
163116151|NCT02323204|589132427|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
163116152|NCT02323204|589132428|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
163116153|NCT02323204|589132429|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
163116154|NCT02323204|589132426|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116155|NCT02323204|589132427|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
163116156|NCT02323204|589132428|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116157|NCT02323204|589132429|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
163116158|NCT02323204|589132426|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
163116159|NCT02323204|589132427|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
163116160|NCT02323204|589132428|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
163116161|NCT02323204|589132429|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
163116162|NCT02323204|589132426|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116163|NCT02323204|589132427|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
163116164|NCT02323204|589132428|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
162719365|NCT00530842|587678488|FG000|Overall Study|Withdrawal by Subject|4|||
162719366|NCT00530842|587678489|FG001|Overall Study|Withdrawal by Subject|5|||
163116165|NCT02323204|589132429|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
163116166|NCT02014480|589132430|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116167|NCT02014480|589132431|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116168|NCT02014480|589132432|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163116169|NCT02014480|589132433|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116170|NCT02014480|589132434|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116171|NCT02014480|589132435|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
163116172|NCT02014480|589132430|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116173|NCT02014480|589132431|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163116174|NCT02014480|589132432|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116175|NCT02014480|589132433|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
163116176|NCT02014480|589132434|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163116177|NCT02014480|589132435|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163116178|NCT02014480|589132430|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116179|NCT02014480|589132431|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116180|NCT02014480|589132432|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
163116181|NCT02014480|589132433|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116182|NCT02014480|589132434|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116183|NCT02014480|589132435|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163116184|NCT02014480|589132430|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116185|NCT02014480|589132431|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116186|NCT02014480|589132432|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
163116187|NCT02014480|589132433|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
163116188|NCT02014480|589132434|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163116189|NCT02014480|589132435|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
163116190|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116191|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
163116192|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116193|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116194|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116195|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
163116196|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116197|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116198|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
163116199|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116200|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
163116201|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
163116202|NCT02014480|589132430|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116203|NCT02014480|589132431|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116204|NCT02014480|589132432|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116205|NCT02014480|589132433|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116206|NCT02014480|589132434|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
163116207|NCT02014480|589132435|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
163116208|NCT00724854|589132436|FG000|Overall Study|Lack of Efficacy|187|||
163116209|NCT00724854|589132437|FG001|Overall Study|Lack of Efficacy|13|||
163116210|NCT00724854|589132436|FG000|Overall Study|Lost to Follow-up|87|||
163116211|NCT00724854|589132437|FG001|Overall Study|Lost to Follow-up|10|||
163116212|NCT00724854|589132436|FG000|Overall Study|Adverse Event|62|||
163116213|NCT00724854|589132437|FG001|Overall Study|Adverse Event|4|||
163116214|NCT00724854|589132436|FG000|Overall Study|Other|42|||
163116215|NCT00724854|589132437|FG001|Overall Study|Other|3|||
163116216|NCT00724854|589132436|FG000|Overall Study|Death|11|||
163116217|NCT00724854|589132437|FG001|Overall Study|Death|0|||
163116218|NCT00724854|589132436|FG000|Overall Study|Change of treatment|7|||
163116219|NCT00724854|589132437|FG001|Overall Study|Change of treatment|0|||
163116220|NCT00724854|589132436|FG000|Overall Study|Withdrawal by Subject|5|||
163116221|NCT00724854|589132437|FG001|Overall Study|Withdrawal by Subject|0|||
163116222|NCT00724854|589132436|FG000|Overall Study|Adverse event + lack of efficacy|2|||
163116223|NCT00724854|589132437|FG001|Overall Study|Adverse event + lack of efficacy|1|||
163116224|NCT01865812|589132438|FG000|Primary Treatment Phase|Adverse Event|2|||
163116225|NCT01865812|589132439|FG001|Primary Treatment Phase|Adverse Event|0|||
163116226|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
163116227|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
163116228|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Pruritus|0|||
163116229|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Pruritus|3|||
163116230|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
163116231|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
163116232|NCT01865812|589132438|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
163116233|NCT01865812|589132439|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
163116234|NCT01819129|589132440|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
163116235|NCT01819129|589132441|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
163116236|NCT01819129|589132440|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
163116237|NCT01819129|589132441|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
163116238|NCT01819129|589132440|FG000|Overall Study|Other, Subject moved out of the country|0|||
163116239|NCT01819129|589132441|FG001|Overall Study|Other, Subject moved out of the country|1|||
163116240|NCT01819129|589132440|FG000|Overall Study|Withdrawal by Subject|15|||
163116241|NCT01819129|589132441|FG001|Overall Study|Withdrawal by Subject|15|||
163116242|NCT01819129|589132440|FG000|Overall Study|Lost to Follow-up|5|||
163116243|NCT01819129|589132441|FG001|Overall Study|Lost to Follow-up|2|||
163116244|NCT01819129|589132440|FG000|Overall Study|Lack of Efficacy|0|||
163116245|NCT01819129|589132441|FG001|Overall Study|Lack of Efficacy|1|||
163116246|NCT01819129|589132440|FG000|Overall Study|Adverse Event|1|||
163116247|NCT01819129|589132441|FG001|Overall Study|Adverse Event|4|||
163116248|NCT01819129|589132440|FG000|Overall Study|Death|1|||
163116249|NCT01819129|589132441|FG001|Overall Study|Death|1|||
163116250|NCT01819129|589132440|FG000|Overall Study|Withdrawal Criteria|20|||
163116251|NCT01819129|589132441|FG001|Overall Study|Withdrawal Criteria|15|||
163116252|NCT02752958|589132442|FG000|Overall Study|Adverse Event|3|||
163116253|NCT02752958|589132442|FG000|Overall Study|Lost to Follow-up|1|||
163116254|NCT02752958|589132442|FG000|Overall Study|Protocol Violation|1|||
163116255|NCT02752958|589132442|FG000|Overall Study|Withdrawal by Subject|2|||
163116256|NCT02752958|589132442|FG000|Overall Study|Other (Reason not specified)|2|||
163116257|NCT00054691|589132446|FG000|Overall Study|Unmeasurable Disease|2|||
163116258|NCT00054691|589132446|FG000|Overall Study|Noncompliant|1|||
163116259|NCT03023826|589132448|FG000|Period 1|Withdrawal by Subject|0|||
163116260|NCT03023826|589132449|FG001|Period 1|Withdrawal by Subject|0|||
163116261|NCT03023826|589132450|FG002|Period 1|Withdrawal by Subject|0|||
163116262|NCT03023826|589132451|FG003|Period 1|Withdrawal by Subject|0|||
163116263|NCT03023826|589132452|FG004|Period 1|Withdrawal by Subject|1|||
163116264|NCT03023826|589132453|FG005|Period 1|Withdrawal by Subject|0|||
163116265|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
163116266|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
163116267|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
163116268|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
163116269|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
163116270|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
163116271|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
163116272|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
163116273|NCT00977938|589132454|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
163116274|NCT00977938|589132455|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
163116275|NCT00977938|589132456|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
163116276|NCT00977938|589132457|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
163116277|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
163116278|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
163116279|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
163116280|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
163116281|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
163116282|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
163116283|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
163116284|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
163116285|NCT00977938|589132454|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
163116286|NCT00977938|589132455|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
163116287|NCT00977938|589132456|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
163116288|NCT00977938|589132457|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
162719367|NCT00530842|587678488|FG000|Overall Study|Individual different reasons|4|||
163116289|NCT02142283|589132459|FG000|Overall Study|Death|20|||
163116290|NCT02142283|589132460|FG001|Overall Study|Death|18|||
163116291|NCT02142283|589132459|FG000|Overall Study|Withdrawal by Subject|1|||
163116292|NCT02142283|589132460|FG001|Overall Study|Withdrawal by Subject|3|||
163116293|NCT02460783|589132461|FG000|Overall Study|Withdrawal by Subject|1|||
163116294|NCT02460783|589132462|FG001|Overall Study|Withdrawal by Subject|3|||
163116295|NCT02460783|589132461|FG000|Overall Study|Lost to Follow-up|1|||
163116296|NCT02460783|589132462|FG001|Overall Study|Lost to Follow-up|1|||
163116297|NCT00747344|589132463|FG000|Controlled Period|Adverse Event|3|||
163116298|NCT00747344|589132464|FG001|Controlled Period|Adverse Event|0|||
163116299|NCT00747344|589132465|FG002|Controlled Period|Adverse Event|0|||
163116300|NCT00747344|589132466|FG003|Controlled Period|Adverse Event|0|||
163116301|NCT00747344|589132463|FG000|Controlled Period|Lack of Efficacy|2|||
163116302|NCT00747344|589132464|FG001|Controlled Period|Lack of Efficacy|1|||
163116303|NCT00747344|589132465|FG002|Controlled Period|Lack of Efficacy|0|||
163116304|NCT00747344|589132466|FG003|Controlled Period|Lack of Efficacy|0|||
163116305|NCT00747344|589132463|FG000|Controlled Period|Other|0|||
163116306|NCT00747344|589132464|FG001|Controlled Period|Other|3|||
163116307|NCT00747344|589132465|FG002|Controlled Period|Other|0|||
163116308|NCT00747344|589132466|FG003|Controlled Period|Other|0|||
163116309|NCT00747344|589132463|FG000|After Controlled Period|Adverse Event|0|||
163116310|NCT00747344|589132464|FG001|After Controlled Period|Adverse Event|0|||
163116311|NCT00747344|589132465|FG002|After Controlled Period|Adverse Event|0|||
163116312|NCT00747344|589132466|FG003|After Controlled Period|Adverse Event|1|||
163116313|NCT01484834|589132467|FG000|Overall Study|Lost to Follow-up|5|||
163116314|NCT01484834|589132468|FG001|Overall Study|Lost to Follow-up|8|||
163116315|NCT01484834|589132469|FG002|Overall Study|Lost to Follow-up|1|||
163116316|NCT01484834|589132470|FG003|Overall Study|Lost to Follow-up|4|||
163116317|NCT01371643|589132471|FG000|Overall Study|Withdrawal by Subject|3|||
163116318|NCT01371643|589132472|FG001|Overall Study|Withdrawal by Subject|0|||
163116319|NCT02182440|589132482|FG000|Overall Study|Adverse Event|0|||
163116320|NCT02182440|589132483|FG001|Overall Study|Adverse Event|1|||
163116321|NCT02182440|589132484|FG002|Overall Study|Adverse Event|0|||
163116322|NCT02182440|589132485|FG003|Overall Study|Adverse Event|0|||
163116323|NCT02182440|589132482|FG000|Overall Study|Death|31|||
163116324|NCT02182440|589132483|FG001|Overall Study|Death|8|||
163116325|NCT02182440|589132484|FG002|Overall Study|Death|5|||
163116326|NCT02182440|589132485|FG003|Overall Study|Death|16|||
163116327|NCT02182440|589132482|FG000|Overall Study|Protocol Violation|0|||
162719368|NCT00530842|587678489|FG001|Overall Study|Individual different reasons|3|||
162719369|NCT00530842|587678488|FG000|Period 1|Adverse Event|7|||
162719370|NCT00530842|587678489|FG001|Period 1|Adverse Event|3|||
162719371|NCT00530842|587678488|FG000|Period 1|Lack of Efficacy|1|||
163116328|NCT02182440|589132483|FG001|Overall Study|Protocol Violation|1|||
163116329|NCT02182440|589132484|FG002|Overall Study|Protocol Violation|0|||
163116330|NCT02182440|589132485|FG003|Overall Study|Protocol Violation|0|||
163116331|NCT02182440|589132482|FG000|Overall Study|Physician Decision|1|||
163116332|NCT02182440|589132483|FG001|Overall Study|Physician Decision|0|||
163116333|NCT02182440|589132484|FG002|Overall Study|Physician Decision|0|||
163116334|NCT02182440|589132485|FG003|Overall Study|Physician Decision|0|||
163116335|NCT02182440|589132482|FG000|Overall Study|Withdrawal by Subject|1|||
163116336|NCT02182440|589132483|FG001|Overall Study|Withdrawal by Subject|1|||
163116337|NCT02182440|589132484|FG002|Overall Study|Withdrawal by Subject|3|||
163116338|NCT02182440|589132485|FG003|Overall Study|Withdrawal by Subject|4|||
163116339|NCT02182440|589132482|FG000|Overall Study|different, e.g adm other hospital|12|||
163116340|NCT02182440|589132483|FG001|Overall Study|different, e.g adm other hospital|3|||
163116341|NCT02182440|589132484|FG002|Overall Study|different, e.g adm other hospital|3|||
163116342|NCT02182440|589132485|FG003|Overall Study|different, e.g adm other hospital|10|||
163116343|NCT00072293|589132486|FG000|Overall Study|Lost to Follow-up|1|||
163116344|NCT00072293|589132487|FG001|Overall Study|Lost to Follow-up|1|||
163116345|NCT00072293|589132486|FG000|Overall Study|Withdrawal by Subject|0|||
163116346|NCT00072293|589132487|FG001|Overall Study|Withdrawal by Subject|1|||
163116347|NCT03754582|589132488|FG000|Treatment Phase|Adverse Event|0|||
163116348|NCT03754582|589132489|FG001|Treatment Phase|Adverse Event|1|||
163116349|NCT03754582|589132490|FG002|Treatment Phase|Adverse Event|0|||
163116350|NCT03754582|589132488|FG000|Follow-up Phase|Other|0|||
163116351|NCT03754582|589132489|FG001|Follow-up Phase|Other|0|||
163116352|NCT03754582|589132490|FG002|Follow-up Phase|Other|1|||
163116353|NCT01561755|589132493|FG000|Overall Study|Lost to Follow-up|0|||
163116354|NCT01561755|589132494|FG001|Overall Study|Lost to Follow-up|1|||
163116355|NCT01166958|589132495|FG000|Overall Study|Withdrawal by Subject|1|||
163116356|NCT01166958|589132496|FG001|Overall Study|Withdrawal by Subject|0|||
163116357|NCT01605227|589132497|FG000|Overall Study|Did not receive study treatment|2|||
163116358|NCT01605227|589132498|FG001|Overall Study|Did not receive study treatment|3|||
163116359|NCT01605227|589132497|FG000|Overall Study|Adverse Event|228|||
163116360|NCT01605227|589132498|FG001|Overall Study|Adverse Event|42|||
163116361|NCT01605227|589132497|FG000|Overall Study|Progressive Disease|132|||
163116362|NCT01605227|589132498|FG001|Overall Study|Progressive Disease|128|||
163116363|NCT01605227|589132497|FG000|Overall Study|Clinical Deterioration|227|||
163116364|NCT01605227|589132498|FG001|Overall Study|Clinical Deterioration|133|||
163116365|NCT01605227|589132497|FG000|Overall Study|Lost to Follow-up|1|||
163116366|NCT01605227|589132498|FG001|Overall Study|Lost to Follow-up|0|||
163116367|NCT01605227|589132497|FG000|Overall Study|Protocol Violation|1|||
163116368|NCT01605227|589132498|FG001|Overall Study|Protocol Violation|0|||
163116369|NCT01605227|589132497|FG000|Overall Study|Physician Decision|9|||
163116370|NCT01605227|589132498|FG001|Overall Study|Physician Decision|7|||
163116371|NCT01605227|589132497|FG000|Overall Study|Withdrawal by Subject|18|||
163116372|NCT01605227|589132498|FG001|Overall Study|Withdrawal by Subject|14|||
163116373|NCT01605227|589132497|FG000|Overall Study|Sponsor Decision|2|||
163116374|NCT01605227|589132498|FG001|Overall Study|Sponsor Decision|0|||
163116375|NCT01605227|589132497|FG000|Overall Study|Started New Therapy|1|||
163116376|NCT01605227|589132498|FG001|Overall Study|Started New Therapy|0|||
163116377|NCT01605227|589132497|FG000|Overall Study|Subject Decision|0|||
163116378|NCT01605227|589132498|FG001|Overall Study|Subject Decision|1|||
163116379|NCT01605227|589132497|FG000|Overall Study|Dose Held >6 weeks|0|||
163116380|NCT01605227|589132498|FG001|Overall Study|Dose Held >6 weeks|1|||
163116381|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
163116382|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
163116383|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
163116384|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
163116385|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
163116386|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
163116387|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
163116388|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
163116389|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
163116390|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
163116391|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
163116392|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
163116393|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
163116394|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
163116395|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
163116396|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
163116397|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
163116398|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
163116399|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
163116400|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
163116401|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
163116402|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
163116403|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
163116404|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
163116405|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
163116406|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
163116407|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
163116408|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
163116409|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
163116410|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
163116411|NCT01286987|589132499|FG000|Part 1: Dose Escalation|Physician Decision|0|||
163116412|NCT01286987|589132500|FG001|Part 1: Dose Escalation|Physician Decision|0|||
163116413|NCT01286987|589132501|FG002|Part 1: Dose Escalation|Physician Decision|0|||
163116414|NCT01286987|589132502|FG003|Part 1: Dose Escalation|Physician Decision|0|||
163116415|NCT01286987|589132503|FG004|Part 1: Dose Escalation|Physician Decision|1|||
163116416|NCT01286987|589132504|FG005|Part 1: Dose Escalation|Physician Decision|0|||
163116417|NCT01286987|589132505|FG006|Part 1: Dose Escalation|Physician Decision|0|||
163116418|NCT01286987|589132506|FG007|Part 1: Dose Escalation|Physician Decision|0|||
163116419|NCT01286987|589132507|FG008|Part 1: Dose Escalation|Physician Decision|0|||
163116420|NCT01286987|589132508|FG009|Part 1: Dose Escalation|Physician Decision|0|||
163116421|NCT01286987|589132509|FG010|Part 1: Dose Escalation|Physician Decision|0|||
163116422|NCT01286987|589132510|FG011|Part 1: Dose Escalation|Physician Decision|0|||
163116423|NCT01286987|589132511|FG012|Part 1: Dose Escalation|Physician Decision|0|||
163116424|NCT01286987|589132512|FG013|Part 1: Dose Escalation|Physician Decision|0|||
163116425|NCT01286987|589132513|FG014|Part 1: Dose Escalation|Physician Decision|0|||
163116426|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Death|0|||
163116427|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Death|0|||
163116428|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Death|0|||
163116429|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Death|0|||
163116430|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Death|0|||
163116431|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Death|0|||
163116432|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Death|0|||
163116433|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Death|0|||
163116434|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Death|0|||
163116435|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Death|0|||
163116436|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Death|0|||
163116437|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Death|0|||
163116438|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Death|1|||
163116439|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Death|1|||
163116440|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Death|0|||
163116441|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Physician Decision|0|||
163116442|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Physician Decision|0|||
163116443|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Physician Decision|0|||
163116444|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Physician Decision|0|||
163116445|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Physician Decision|0|||
163116446|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Physician Decision|0|||
163116447|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Physician Decision|0|||
163116448|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Physician Decision|0|||
163116449|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Physician Decision|0|||
163116450|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Physician Decision|0|||
163116451|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Physician Decision|1|||
163116452|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Physician Decision|1|||
163116453|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Physician Decision|0|||
163116454|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Physician Decision|1|||
163116455|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Physician Decision|0|||
163116456|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Other|0|||
163116457|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Other|0|||
163116458|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Other|0|||
163116459|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Other|0|||
163116460|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Other|0|||
163116461|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Other|0|||
163116462|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Other|0|||
163116463|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Other|0|||
163116464|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Other|0|||
163116465|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Other|0|||
163116466|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Other|0|||
163116467|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Other|0|||
163116468|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Other|0|||
163116469|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Other|1|||
163116470|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Other|0|||
163116471|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
163116472|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
163116473|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
163116474|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
163116475|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
163116476|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
163116477|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
163116478|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
163116479|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
163116480|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
163116481|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
163116482|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
162654175|NCT01554618|587449696|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
162654176|NCT01554618|587449695|FG000|Open-Label Extension Period|Physician Decision|0|||
162654177|NCT01554618|587449696|FG001|Open-Label Extension Period|Physician Decision|1|||
162654178|NCT01554618|587449695|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
162654179|NCT01554618|587449696|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
163116483|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
163116484|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
163116485|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
163116486|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
163116487|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
163116488|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
163116489|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
163116490|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
162654180|NCT01857063|587449697|FG000|Period 1 (7 Days)|Adverse Event|0|||
162654181|NCT01857063|587449698|FG001|Period 1 (7 Days)|Adverse Event|1|||
162719372|NCT00530842|587678489|FG001|Period 1|Lack of Efficacy|1|||
163116491|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
162654182|NCT01857063|587449697|FG000|Period 1 (7 Days)|Physician Decision|1|||
162654183|NCT01857063|587449698|FG001|Period 1 (7 Days)|Physician Decision|0|||
162654184|NCT01857063|587449697|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
162654185|NCT01857063|587449698|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
162654186|NCT01857063|587449697|FG000|Period 2 (7 Days)|Adverse Event|2|||
162654187|NCT01857063|587449698|FG001|Period 2 (7 Days)|Adverse Event|1|||
162654188|NCT01857063|587449697|FG000|Period 2 (7 Days)|Physician Decision|1|||
162654189|NCT01857063|587449698|FG001|Period 2 (7 Days)|Physician Decision|1|||
162654190|NCT01857063|587449697|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
163116492|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
163116493|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
163116494|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
163116495|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
163116496|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
163116497|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
163116498|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
163116499|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
163116500|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
163116501|NCT01286987|589132499|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116502|NCT01286987|589132500|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116503|NCT01286987|589132501|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116504|NCT01286987|589132502|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116505|NCT01286987|589132503|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116506|NCT01286987|589132504|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116507|NCT01286987|589132505|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116508|NCT01286987|589132506|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116509|NCT01286987|589132507|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116510|NCT01286987|589132508|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116511|NCT01286987|589132509|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163116512|NCT01286987|589132510|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116513|NCT01286987|589132511|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116514|NCT01286987|589132512|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116515|NCT01286987|589132513|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163116516|NCT00624819|589132514|FG000|Follow-up Period: Year 4|Parents decision|0|||
163116517|NCT00624819|589132515|FG001|Follow-up Period: Year 4|Parents decision|0|||
163116518|NCT00624819|589132516|FG002|Follow-up Period: Year 4|Parents decision|1|||
163116519|NCT00624819|589132517|FG003|Follow-up Period: Year 4|Parents decision|0|||
163116520|NCT00624819|589132514|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
163116521|NCT00624819|589132515|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
163116522|NCT00624819|589132516|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
163116523|NCT00624819|589132517|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
163116524|NCT02847858|589132518|FG000|Overall Study|Lost to Follow-up|401|||
163116525|NCT02847858|589132519|FG001|Overall Study|Lost to Follow-up|269|||
163116526|NCT02826421|589132522|FG000|Overall Study|Adverse Event|1|||
163116527|NCT02826421|589132523|FG001|Overall Study|Adverse Event|0|||
163116528|NCT02826421|589132524|FG002|Overall Study|Adverse Event|0|||
163116529|NCT02826421|589132525|FG003|Overall Study|Adverse Event|1|||
163116530|NCT02826421|589132522|FG000|Overall Study|Withdrawal by Subject|1|||
163116531|NCT02826421|589132523|FG001|Overall Study|Withdrawal by Subject|3|||
163116532|NCT02826421|589132524|FG002|Overall Study|Withdrawal by Subject|1|||
163116533|NCT02826421|589132525|FG003|Overall Study|Withdrawal by Subject|1|||
163116534|NCT02826421|589132522|FG000|Overall Study|Reason not given|1|||
163116535|NCT02826421|589132523|FG001|Overall Study|Reason not given|0|||
163116536|NCT02826421|589132524|FG002|Overall Study|Reason not given|1|||
163116537|NCT02826421|589132525|FG003|Overall Study|Reason not given|0|||
163116538|NCT02210221|589132528|FG000|Overall Study|Lack of Efficacy|7|||
163116539|NCT02210221|589132528|FG000|Overall Study|Withdrawal by Subject|43|||
163116540|NCT00405964|589132533|FG000|Overall Study|Treatment Failure|17|||
163116541|NCT00405964|589132534|FG001|Overall Study|Treatment Failure|45|||
163116542|NCT00405964|589132533|FG000|Overall Study|Adverse Event|7|||
163116543|NCT00405964|589132534|FG001|Overall Study|Adverse Event|16|||
163116544|NCT00405964|589132533|FG000|Overall Study|Lost to Follow-up|5|||
163116545|NCT00405964|589132534|FG001|Overall Study|Lost to Follow-up|5|||
163116546|NCT00405964|589132533|FG000|Overall Study|Withdrawal by Subject|19|||
163116547|NCT00405964|589132534|FG001|Overall Study|Withdrawal by Subject|23|||
163116548|NCT00405964|589132533|FG000|Overall Study|Protocol Violation|11|||
163116549|NCT00405964|589132534|FG001|Overall Study|Protocol Violation|6|||
163116550|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Death|8|||
163116551|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Death|8|||
163116552|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Death|0|||
163116553|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Death|0|||
163116554|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
162719373|NCT00530842|587678488|FG000|Period 1|Protocol Violation|2|||
162654191|NCT01857063|587449698|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
162654192|NCT00058825|587449699|FG000|Overall Study|Relapse|9|||
162654193|NCT00058825|587449699|FG000|Overall Study|Progressive Disease|5|||
162654194|NCT00058825|587449699|FG000|Overall Study|Graft Failure|5|||
162654195|NCT00058825|587449699|FG000|Overall Study|Death|3|||
162654196|NCT01205165|587449700|FG000|Overall Study|Lost to Follow-up|2|||
163116555|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116556|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116557|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
163116558|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116559|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
163116560|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116561|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
163116562|NCT03271047|589132535|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
163116563|NCT03271047|589132536|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
163116564|NCT03271047|589132537|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
163116565|NCT03271047|589132538|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
163116566|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Other|0|||
163116567|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Other|0|||
163116568|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Other|0|||
163116569|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Other|1|||
163116570|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Death|0|||
163116571|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Death|0|||
163116572|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Death|20|||
163116573|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Death|21|||
163116574|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
163116575|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
163116576|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
163116577|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
163116578|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116579|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116580|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
163116581|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
163116582|NCT03271047|589132535|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116583|NCT03271047|589132536|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116584|NCT03271047|589132537|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
163116585|NCT03271047|589132538|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
163116586|NCT00711802|589132539|FG000|Overall Study|Not treated (no further detail)|2|||
163116587|NCT00711802|589132540|FG001|Overall Study|Not treated (no further detail)|1|||
163116588|NCT00711802|589132541|FG002|Overall Study|Not treated (no further detail)|2|||
163116589|NCT00711802|589132542|FG003|Overall Study|Not treated (no further detail)|0|||
163116590|NCT00711802|589132543|FG004|Overall Study|Not treated (no further detail)|2|||
163116591|NCT00711802|589132544|FG005|Overall Study|Not treated (no further detail)|0|||
163116592|NCT00711802|589132545|FG006|Overall Study|Not treated (no further detail)|0|||
163116593|NCT00711802|589132546|FG007|Overall Study|Not treated (no further detail)|0|||
163116594|NCT00711802|589132539|FG000|Overall Study|Adverse Event|0|||
163116595|NCT00711802|589132540|FG001|Overall Study|Adverse Event|0|||
163116596|NCT00711802|589132541|FG002|Overall Study|Adverse Event|0|||
163116597|NCT00711802|589132542|FG003|Overall Study|Adverse Event|0|||
163116598|NCT00711802|589132543|FG004|Overall Study|Adverse Event|1|||
163116599|NCT00711802|589132544|FG005|Overall Study|Adverse Event|1|||
163116600|NCT00711802|589132545|FG006|Overall Study|Adverse Event|0|||
163116601|NCT00711802|589132546|FG007|Overall Study|Adverse Event|0|||
163116602|NCT00711802|589132539|FG000|Overall Study|Microbiological failure|0|||
163116603|NCT00711802|589132540|FG001|Overall Study|Microbiological failure|1|||
163116604|NCT00711802|589132541|FG002|Overall Study|Microbiological failure|0|||
163116605|NCT00711802|589132542|FG003|Overall Study|Microbiological failure|0|||
163116606|NCT00711802|589132543|FG004|Overall Study|Microbiological failure|0|||
163116607|NCT00711802|589132544|FG005|Overall Study|Microbiological failure|1|||
163116608|NCT00711802|589132545|FG006|Overall Study|Microbiological failure|0|||
163116609|NCT00711802|589132546|FG007|Overall Study|Microbiological failure|0|||
163116610|NCT00711802|589132539|FG000|Overall Study|Protocol Violation|0|||
163116611|NCT00711802|589132540|FG001|Overall Study|Protocol Violation|0|||
163116612|NCT00711802|589132541|FG002|Overall Study|Protocol Violation|0|||
163116613|NCT00711802|589132542|FG003|Overall Study|Protocol Violation|1|||
163116614|NCT00711802|589132543|FG004|Overall Study|Protocol Violation|0|||
162654197|NCT00329407|587449708|FG000|Overall Study|Withdrawal by Subject|1|||
162654198|NCT00978068|587449709|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
162654199|NCT00978068|587449710|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
162654200|NCT00978068|587449709|FG000|Overall Study|Death|1|||
162654201|NCT00978068|587449710|FG001|Overall Study|Death|2|||
162654202|NCT00978068|587449709|FG000|Overall Study|Lost to Follow-up|1|||
162654203|NCT00978068|587449710|FG001|Overall Study|Lost to Follow-up|2|||
162654204|NCT00978068|587449709|FG000|Overall Study|Physician Decision|0|||
162654205|NCT00978068|587449710|FG001|Overall Study|Physician Decision|1|||
162654206|NCT00978068|587449709|FG000|Overall Study|Unable to Comply with Study|0|||
162654207|NCT00978068|587449710|FG001|Overall Study|Unable to Comply with Study|2|||
162654208|NCT02275481|587449711|FG000|Overall Study|Death|2|||
162654209|NCT02275481|587449712|FG001|Overall Study|Death|1|||
162654210|NCT02275481|587449711|FG000|Overall Study|Lost to Follow-up|2|||
162654211|NCT02275481|587449712|FG001|Overall Study|Lost to Follow-up|0|||
162654212|NCT02275481|587449711|FG000|Overall Study|Withdrawal by Subject|3|||
162654213|NCT02275481|587449712|FG001|Overall Study|Withdrawal by Subject|0|||
162654214|NCT02275481|587449711|FG000|Overall Study|all other reasons combined|2|||
162654215|NCT02275481|587449712|FG001|Overall Study|all other reasons combined|1|||
162654216|NCT02275481|587449711|FG000|Overall Study|Physician Decision|0|||
162654217|NCT02275481|587449712|FG001|Overall Study|Physician Decision|1|||
162654218|NCT01215227|587449713|FG000|Overall Study|Adverse Event|11|||
163116615|NCT00711802|589132544|FG005|Overall Study|Protocol Violation|0|||
163116616|NCT00711802|589132545|FG006|Overall Study|Protocol Violation|0|||
163116617|NCT00711802|589132546|FG007|Overall Study|Protocol Violation|0|||
163116618|NCT00711802|589132539|FG000|Overall Study|Physician Decision|0|||
163116619|NCT00711802|589132540|FG001|Overall Study|Physician Decision|2|||
163116620|NCT00711802|589132541|FG002|Overall Study|Physician Decision|0|||
163116621|NCT00711802|589132542|FG003|Overall Study|Physician Decision|0|||
163116622|NCT00711802|589132543|FG004|Overall Study|Physician Decision|0|||
163116623|NCT00711802|589132544|FG005|Overall Study|Physician Decision|0|||
163116624|NCT00711802|589132545|FG006|Overall Study|Physician Decision|0|||
163116625|NCT00711802|589132546|FG007|Overall Study|Physician Decision|0|||
163116626|NCT00711802|589132539|FG000|Overall Study|Withdrawal by Subject|0|||
163116627|NCT00711802|589132540|FG001|Overall Study|Withdrawal by Subject|1|||
163116628|NCT00711802|589132541|FG002|Overall Study|Withdrawal by Subject|0|||
163116629|NCT00711802|589132542|FG003|Overall Study|Withdrawal by Subject|1|||
163116630|NCT00711802|589132543|FG004|Overall Study|Withdrawal by Subject|0|||
163116631|NCT00711802|589132544|FG005|Overall Study|Withdrawal by Subject|0|||
163116632|NCT00711802|589132545|FG006|Overall Study|Withdrawal by Subject|0|||
163116633|NCT00711802|589132546|FG007|Overall Study|Withdrawal by Subject|0|||
163116634|NCT00711802|589132539|FG000|Overall Study|Lost to Follow-up|0|||
163116635|NCT00711802|589132540|FG001|Overall Study|Lost to Follow-up|0|||
163116636|NCT00711802|589132541|FG002|Overall Study|Lost to Follow-up|3|||
163116637|NCT00711802|589132542|FG003|Overall Study|Lost to Follow-up|1|||
163116638|NCT00711802|589132543|FG004|Overall Study|Lost to Follow-up|10|||
163116639|NCT00711802|589132544|FG005|Overall Study|Lost to Follow-up|6|||
163116640|NCT00711802|589132545|FG006|Overall Study|Lost to Follow-up|4|||
163116641|NCT00711802|589132546|FG007|Overall Study|Lost to Follow-up|2|||
163116642|NCT00711802|589132539|FG000|Overall Study|Reason not reported|0|||
163116643|NCT00711802|589132540|FG001|Overall Study|Reason not reported|1|||
163116644|NCT00711802|589132541|FG002|Overall Study|Reason not reported|1|||
163116645|NCT00711802|589132542|FG003|Overall Study|Reason not reported|0|||
163116646|NCT00711802|589132543|FG004|Overall Study|Reason not reported|1|||
163116647|NCT00711802|589132544|FG005|Overall Study|Reason not reported|0|||
163116648|NCT00711802|589132545|FG006|Overall Study|Reason not reported|1|||
163116649|NCT00711802|589132546|FG007|Overall Study|Reason not reported|0|||
163116650|NCT00391391|589132547|FG000|Overall Study|Adverse Event|0|||
163116651|NCT00391391|589132548|FG001|Overall Study|Adverse Event|0|||
163116652|NCT00391391|589132549|FG002|Overall Study|Adverse Event|0|||
163116653|NCT00391391|589132550|FG003|Overall Study|Adverse Event|1|||
163116654|NCT00391391|589132547|FG000|Overall Study|Lost to Follow-up|1|||
163116655|NCT00391391|589132548|FG001|Overall Study|Lost to Follow-up|3|||
163116656|NCT00391391|589132549|FG002|Overall Study|Lost to Follow-up|7|||
163116657|NCT00391391|589132550|FG003|Overall Study|Lost to Follow-up|4|||
163116658|NCT00391391|589132547|FG000|Overall Study|Protocol Violation|2|||
163116659|NCT00391391|589132548|FG001|Overall Study|Protocol Violation|3|||
163116660|NCT00391391|589132549|FG002|Overall Study|Protocol Violation|6|||
163116661|NCT00391391|589132550|FG003|Overall Study|Protocol Violation|7|||
163116662|NCT00391391|589132547|FG000|Overall Study|Withdrawal by Subject|6|||
163116663|NCT00391391|589132548|FG001|Overall Study|Withdrawal by Subject|4|||
163116664|NCT00391391|589132549|FG002|Overall Study|Withdrawal by Subject|10|||
163116665|NCT00391391|589132550|FG003|Overall Study|Withdrawal by Subject|7|||
163116666|NCT02649855|589132551|FG000|Overall Study|Refused further treatment|2|||
163116667|NCT02649855|589132552|FG001|Overall Study|Refused further treatment|1|||
163116668|NCT02649855|589132553|FG002|Overall Study|Refused further treatment|1|||
163116669|NCT02649855|589132551|FG000|Overall Study|Withdrew consent|0|||
163116670|NCT02649855|589132552|FG001|Overall Study|Withdrew consent|1|||
163116671|NCT02649855|589132553|FG002|Overall Study|Withdrew consent|0|||
163116672|NCT02649855|589132551|FG000|Overall Study|Switched to alternative treatment|0|||
163116673|NCT02649855|589132552|FG001|Overall Study|Switched to alternative treatment|1|||
163116674|NCT02649855|589132553|FG002|Overall Study|Switched to alternative treatment|1|||
163116675|NCT02649855|589132551|FG000|Overall Study|Principal investigator discretion|0|||
163116676|NCT02649855|589132552|FG001|Overall Study|Principal investigator discretion|1|||
163116677|NCT02649855|589132553|FG002|Overall Study|Principal investigator discretion|1|||
163116678|NCT02649855|589132551|FG000|Overall Study|No treatment, per protocol|1|||
163116679|NCT02649855|589132552|FG001|Overall Study|No treatment, per protocol|0|||
163116680|NCT02649855|589132553|FG002|Overall Study|No treatment, per protocol|0|||
163116681|NCT02649855|589132551|FG000|Overall Study|Initiate new treatment|1|||
163116682|NCT02649855|589132552|FG001|Overall Study|Initiate new treatment|0|||
163116683|NCT02649855|589132553|FG002|Overall Study|Initiate new treatment|0|||
163116684|NCT01344538|589133925|FG000|Overall Study|Adverse Event|1|||
162654219|NCT01215227|587449714|FG001|Overall Study|Adverse Event|11|||
162654220|NCT01215227|587449715|FG002|Overall Study|Adverse Event|4|||
163116685|NCT01344538|589133926|FG001|Overall Study|Adverse Event|1|||
163116686|NCT01344538|589133925|FG000|Overall Study|Lost to Follow-up|1|||
163116687|NCT01344538|589133926|FG001|Overall Study|Lost to Follow-up|0|||
163116688|NCT01655381|589133927|FG000|Overall Study|Investigator Decision|1|||
163116689|NCT01655381|589133927|FG000|Overall Study|Moved to Another City|1|||
163116690|NCT01655381|589133927|FG000|Overall Study|Insufficient Treatment Response|1|||
163116691|NCT04195438|589133928|FG000|Overall Study|Withdrawal by Subject|1|||
163116692|NCT00613925|589133929|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
163116693|NCT00613925|589133930|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
163116694|NCT01156389|589133931|FG000|Overall Study|Elevated liver enzymes|4|||
163116695|NCT01156389|589133932|FG001|Overall Study|Elevated liver enzymes|0|||
163116696|NCT01156389|589133931|FG000|Overall Study|Vomiting|0|||
163116697|NCT01156389|589133932|FG001|Overall Study|Vomiting|1|||
163116698|NCT00350623|589133935|FG000|Overall Study|Lost to Follow-up|8|||
163116699|NCT00350623|589133936|FG001|Overall Study|Lost to Follow-up|3|||
163116700|NCT00350623|589133937|FG002|Overall Study|Lost to Follow-up|4|||
163116701|NCT00350623|589133935|FG000|Overall Study|Withdrawal by Subject|0|||
163116702|NCT00350623|589133936|FG001|Overall Study|Withdrawal by Subject|1|||
163116703|NCT00350623|589133937|FG002|Overall Study|Withdrawal by Subject|1|||
163116704|NCT00350623|589133935|FG000|Overall Study|patient traveling outside the country|0|||
163116705|NCT00350623|589133936|FG001|Overall Study|patient traveling outside the country|0|||
163116706|NCT00350623|589133937|FG002|Overall Study|patient traveling outside the country|1|||
163116707|NCT02279719|589133950|FG000|Overall Study|Patients randomized but never treated|0|||
163116708|NCT02279719|589133951|FG001|Overall Study|Patients randomized but never treated|0|||
163116709|NCT02279719|589133952|FG002|Overall Study|Patients randomized but never treated|0|||
163116710|NCT02279719|589133953|FG003|Overall Study|Patients randomized but never treated|0|||
163116711|NCT02279719|589133954|FG004|Overall Study|Patients randomized but never treated|3|||
163116712|NCT02279719|589133955|FG005|Overall Study|Patients randomized but never treated|0|||
163116713|NCT02279719|589133956|FG006|Overall Study|Patients randomized but never treated|3|||
163116714|NCT04706273|589133957|FG000|Overall Study|Withdrawal by Subject|27|||
163116715|NCT04706273|589133957|FG000|Overall Study|Physician Decision|1|||
163116716|NCT04706273|589133957|FG000|Overall Study|Lost to Follow-up|42|||
163116717|NCT04706273|589133957|FG000|Overall Study|Death|85|||
163116718|NCT04706273|589133957|FG000|Overall Study|Amputation that removes study device|2|||
163116719|NCT04706273|589133957|FG000|Overall Study|Surgical bypass|3|||
163116720|NCT04706273|589133957|FG000|Overall Study|Changing hospital|23|||
163116721|NCT04706273|589133957|FG000|Overall Study|Unable to attend hospital|2|||
163116722|NCT03541187|589133958|FG000|Overall Study|Lost to Follow-up|2|||
163116723|NCT03541187|589133959|FG001|Overall Study|Lost to Follow-up|6|||
163116724|NCT03541187|589133958|FG000|Overall Study|Pregnancy|0|||
163116725|NCT03541187|589133959|FG001|Overall Study|Pregnancy|1|||
163116726|NCT03541187|589133958|FG000|Overall Study|Withdrawal by Subject|6|||
163116727|NCT03541187|589133959|FG001|Overall Study|Withdrawal by Subject|2|||
163116728|NCT03541187|589133958|FG000|Overall Study|Moved out of town|1|||
163116729|NCT03541187|589133959|FG001|Overall Study|Moved out of town|0|||
163116730|NCT03541187|589133958|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
163116731|NCT03541187|589133959|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
163116732|NCT03541187|589133958|FG000|Overall Study|Did not meet randomization criteria|1|||
163116733|NCT03541187|589133959|FG001|Overall Study|Did not meet randomization criteria|1|||
163116734|NCT03541187|589133958|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
163116735|NCT03541187|589133959|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
163116736|NCT03541187|589133958|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
163116737|NCT03541187|589133959|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
163116738|NCT03199053|589133965|FG000|ST Period|Withdrawal by Subject|2|||
163116739|NCT03199053|589133966|FG001|ST Period|Withdrawal by Subject|4|||
163116740|NCT03199053|589133967|FG002|ST Period|Withdrawal by Subject|6|||
163116741|NCT03199053|589133965|FG000|ST Period|Withdrawal by parent/guardian|1|||
163116742|NCT03199053|589133966|FG001|ST Period|Withdrawal by parent/guardian|1|||
163116743|NCT03199053|589133967|FG002|ST Period|Withdrawal by parent/guardian|1|||
163116744|NCT03199053|589133965|FG000|ST Period|Lost to Follow-up|2|||
163116745|NCT03199053|589133966|FG001|ST Period|Lost to Follow-up|0|||
163116746|NCT03199053|589133967|FG002|ST Period|Lost to Follow-up|1|||
163116747|NCT03199053|589133965|FG000|LT Period|Withdrawal by Subject|1|||
163116748|NCT03199053|589133966|FG001|LT Period|Withdrawal by Subject|3|||
163116749|NCT03199053|589133967|FG002|LT Period|Withdrawal by Subject|3|||
163116750|NCT03199053|589133965|FG000|LT Period|Withdrawal by parent/guardian|0|||
163116751|NCT03199053|589133966|FG001|LT Period|Withdrawal by parent/guardian|0|||
163116752|NCT03199053|589133967|FG002|LT Period|Withdrawal by parent/guardian|1|||
163116753|NCT03199053|589133965|FG000|LT Period|Lost to Follow-up|0|||
163116754|NCT03199053|589133966|FG001|LT Period|Lost to Follow-up|1|||
163116755|NCT03199053|589133967|FG002|LT Period|Lost to Follow-up|1|||
163116756|NCT03199053|589133965|FG000|LT Period|Miscellaneous|0|||
163116757|NCT03199053|589133966|FG001|LT Period|Miscellaneous|0|||
163116758|NCT03199053|589133967|FG002|LT Period|Miscellaneous|2|||
163116759|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
163116760|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
163116761|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
163116762|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
162654221|NCT01215227|587449716|FG003|Overall Study|Adverse Event|8|||
162654222|NCT01215227|587449717|FG004|Overall Study|Adverse Event|7|||
162654223|NCT01215227|587449718|FG005|Overall Study|Adverse Event|6|||
162654224|NCT01215227|587449713|FG000|Overall Study|Treatment Failure|8|||
163116763|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
163116764|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
163116765|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
163116766|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
163116767|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
163116768|NCT03199053|589133965|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
163116769|NCT03199053|589133966|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
163116770|NCT03199053|589133967|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
163116771|NCT03263923|589133969|FG000|Overall Study|Withdrawal by Subject|10|||
163116772|NCT03263923|589133970|FG001|Overall Study|Withdrawal by Subject|8|||
163116773|NCT03263923|589133969|FG000|Overall Study|Lost to Follow-up|15|||
163116774|NCT03263923|589133970|FG001|Overall Study|Lost to Follow-up|13|||
163116775|NCT01323270|589133971|FG000|Overall Study|Withdrawal by Subject|19|||
163116776|NCT01323270|589133972|FG001|Overall Study|Withdrawal by Subject|10|||
163116777|NCT01323270|589133971|FG000|Overall Study|Protocol Violation|9|||
163116778|NCT01323270|589133972|FG001|Overall Study|Protocol Violation|7|||
163116779|NCT01323270|589133971|FG000|Overall Study|Lost to Follow-up|4|||
163116780|NCT01323270|589133972|FG001|Overall Study|Lost to Follow-up|6|||
163116781|NCT01323270|589133971|FG000|Overall Study|Adverse Event|8|||
163116782|NCT01323270|589133972|FG001|Overall Study|Adverse Event|0|||
163116783|NCT01323270|589133971|FG000|Overall Study|Other|0|||
163116784|NCT01323270|589133972|FG001|Overall Study|Other|3|||
163116785|NCT01323270|589133971|FG000|Overall Study|Physician Decision|0|||
163116786|NCT01323270|589133972|FG001|Overall Study|Physician Decision|2|||
163116787|NCT01323270|589133971|FG000|Overall Study|Not eligible|1|||
163116788|NCT01323270|589133972|FG001|Overall Study|Not eligible|1|||
163116789|NCT01323270|589133971|FG000|Overall Study|Death|1|||
163116790|NCT01323270|589133972|FG001|Overall Study|Death|0|||
163116791|NCT01323270|589133971|FG000|Overall Study|Randomized, but not vaccinated|1|||
163116792|NCT01323270|589133972|FG001|Overall Study|Randomized, but not vaccinated|0|||
163116793|NCT02229214|589133981|FG000|Overall Study|Adverse Event|2|||
163116794|NCT02229214|589133982|FG001|Overall Study|Adverse Event|0|||
163116795|NCT02229214|589133981|FG000|Overall Study|Withdrawal by Subject|4|||
163116796|NCT02229214|589133982|FG001|Overall Study|Withdrawal by Subject|0|||
163116797|NCT00246025|589133983|FG000|Overall Study|Adverse Event|7|||
163116798|NCT00246025|589133984|FG001|Overall Study|Adverse Event|9|||
163116799|NCT00246025|589133985|FG002|Overall Study|Adverse Event|9|||
163116800|NCT00246025|589133986|FG003|Overall Study|Adverse Event|10|||
163116801|NCT00246025|589133983|FG000|Overall Study|Withdrawal by Subject|3|||
163116802|NCT00246025|589133984|FG001|Overall Study|Withdrawal by Subject|0|||
163116803|NCT00246025|589133985|FG002|Overall Study|Withdrawal by Subject|1|||
163116804|NCT00246025|589133986|FG003|Overall Study|Withdrawal by Subject|2|||
163116805|NCT00246025|589133983|FG000|Overall Study|unsuitable medical history was found|0|||
163116806|NCT00246025|589133984|FG001|Overall Study|unsuitable medical history was found|0|||
163116807|NCT00246025|589133985|FG002|Overall Study|unsuitable medical history was found|0|||
163116808|NCT00246025|589133986|FG003|Overall Study|unsuitable medical history was found|1|||
163116809|NCT03305081|589133989|FG000|Overall Study|Lost to Follow-up|10|||
163116810|NCT03305081|589133990|FG001|Overall Study|Lost to Follow-up|15|||
163116811|NCT01218100|589133991|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116812|NCT01218100|589133992|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116813|NCT01218100|589133993|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
163116814|NCT01218100|589133994|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
163116815|NCT01218100|589133991|FG000|Overall Study|Adverse Event|4|||
163116816|NCT01218100|589133992|FG001|Overall Study|Adverse Event|6|||
163116817|NCT01218100|589133993|FG002|Overall Study|Adverse Event|6|||
163116818|NCT01218100|589133994|FG003|Overall Study|Adverse Event|7|||
162654225|NCT01215227|587449714|FG001|Overall Study|Treatment Failure|4|||
162654226|NCT01215227|587449715|FG002|Overall Study|Treatment Failure|1|||
162654227|NCT01215227|587449716|FG003|Overall Study|Treatment Failure|5|||
162654228|NCT01215227|587449717|FG004|Overall Study|Treatment Failure|1|||
163116819|NCT01218100|589133991|FG000|Overall Study|Lack of Efficacy|9|||
163116820|NCT01218100|589133992|FG001|Overall Study|Lack of Efficacy|6|||
163116821|NCT01218100|589133993|FG002|Overall Study|Lack of Efficacy|5|||
163116822|NCT01218100|589133994|FG003|Overall Study|Lack of Efficacy|12|||
163116823|NCT01218100|589133991|FG000|Overall Study|Protocol Violation|0|||
163116824|NCT01218100|589133992|FG001|Overall Study|Protocol Violation|0|||
163116825|NCT01218100|589133993|FG002|Overall Study|Protocol Violation|1|||
163116826|NCT01218100|589133994|FG003|Overall Study|Protocol Violation|1|||
163116827|NCT01218100|589133991|FG000|Overall Study|Withdrawal by Subject|5|||
163116828|NCT01218100|589133992|FG001|Overall Study|Withdrawal by Subject|2|||
163116829|NCT01218100|589133993|FG002|Overall Study|Withdrawal by Subject|6|||
162654229|NCT01215227|587449718|FG005|Overall Study|Treatment Failure|1|||
163116830|NCT01218100|589133994|FG003|Overall Study|Withdrawal by Subject|7|||
163116831|NCT01218100|589133991|FG000|Overall Study|Lost to Follow-up|3|||
163116832|NCT01218100|589133992|FG001|Overall Study|Lost to Follow-up|8|||
163116833|NCT01218100|589133993|FG002|Overall Study|Lost to Follow-up|2|||
163116834|NCT01218100|589133994|FG003|Overall Study|Lost to Follow-up|1|||
163116835|NCT01218100|589133991|FG000|Overall Study|Other Reason|2|||
163116836|NCT01218100|589133992|FG001|Overall Study|Other Reason|2|||
163116837|NCT01218100|589133993|FG002|Overall Study|Other Reason|6|||
163116838|NCT01218100|589133994|FG003|Overall Study|Other Reason|4|||
163116839|NCT02437305|589133995|FG000|Overall Study|Lost to Follow-up|18|||
163116840|NCT02437305|589133996|FG001|Overall Study|Lost to Follow-up|12|||
163116841|NCT01118520|589133997|FG000|Overall Study|AAA repair|9|||
163116842|NCT01118520|589133998|FG001|Overall Study|AAA repair|7|||
163116843|NCT01118520|589133999|FG002|Overall Study|AAA repair|9|||
163116844|NCT01118520|589133997|FG000|Overall Study|Adverse Event|3|||
163116845|NCT01118520|589133998|FG001|Overall Study|Adverse Event|3|||
163116846|NCT01118520|589133999|FG002|Overall Study|Adverse Event|3|||
163116847|NCT01118520|589133997|FG000|Overall Study|Withdrawal by Subject|8|||
163116848|NCT01118520|589133998|FG001|Overall Study|Withdrawal by Subject|13|||
163116849|NCT01118520|589133999|FG002|Overall Study|Withdrawal by Subject|8|||
163116850|NCT01170065|589134000|FG000|Overall Study|Adverse Event|17|||
163116851|NCT01170065|589134001|FG001|Overall Study|Adverse Event|50|||
163116852|NCT01170065|589134002|FG002|Overall Study|Adverse Event|10|||
163116853|NCT01170065|589134000|FG000|Overall Study|Lost to Follow-up|1|||
163116854|NCT01170065|589134001|FG001|Overall Study|Lost to Follow-up|4|||
163116855|NCT01170065|589134002|FG002|Overall Study|Lost to Follow-up|1|||
163116856|NCT01170065|589134000|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
163116857|NCT01170065|589134001|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
163116858|NCT01170065|589134002|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
163116859|NCT01170065|589134000|FG000|Overall Study|Reason other than specified|3|||
163116860|NCT01170065|589134001|FG001|Overall Study|Reason other than specified|8|||
163116861|NCT01170065|589134002|FG002|Overall Study|Reason other than specified|3|||
163116862|NCT01170065|589134000|FG000|Overall Study|Ongoing after planned observation time|5|||
163116863|NCT01170065|589134001|FG001|Overall Study|Ongoing after planned observation time|26|||
163116864|NCT01170065|589134002|FG002|Overall Study|Ongoing after planned observation time|10|||
163116865|NCT03220581|589134003|FG000|Overall Study|Withdrawal by Subject|0|||
163116866|NCT03220581|589134004|FG001|Overall Study|Withdrawal by Subject|1|||
163116867|NCT03220581|589134003|FG000|Overall Study|Lost to Follow-up|3|||
163116868|NCT03220581|589134004|FG001|Overall Study|Lost to Follow-up|6|||
163116869|NCT01071200|589134005|FG000|Overall Study|Lack of ovarian response|1|||
163116870|NCT01071200|589134006|FG001|Overall Study|Lack of ovarian response|1|||
163116871|NCT01071200|589134005|FG000|Overall Study|No fertilization|4|||
163116872|NCT01071200|589134006|FG001|Overall Study|No fertilization|0|||
162654230|NCT01215227|587449713|FG000|Overall Study|Lost to Follow-up|1|||
162654231|NCT01215227|587449714|FG001|Overall Study|Lost to Follow-up|4|||
162654232|NCT01215227|587449715|FG002|Overall Study|Lost to Follow-up|1|||
162654233|NCT01215227|587449716|FG003|Overall Study|Lost to Follow-up|1|||
162654234|NCT01215227|587449717|FG004|Overall Study|Lost to Follow-up|1|||
162654235|NCT01215227|587449718|FG005|Overall Study|Lost to Follow-up|2|||
162654236|NCT01215227|587449713|FG000|Overall Study|Subject Withdrew Consent|16|||
163116873|NCT01071200|589134005|FG000|Overall Study|No oocytes retrieved|1|||
163116874|NCT01071200|589134006|FG001|Overall Study|No oocytes retrieved|1|||
163116875|NCT01071200|589134005|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
163116876|NCT01071200|589134006|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
163116877|NCT01071200|589134005|FG000|Overall Study|No viable embryos|0|||
163116878|NCT01071200|589134006|FG001|Overall Study|No viable embryos|1|||
163116879|NCT01920893|589134009|FG000|Overall Study|Adverse Event|5|||
163116880|NCT01920893|589134010|FG001|Overall Study|Adverse Event|2|||
163116881|NCT01920893|589134009|FG000|Overall Study|Lack of Efficacy|2|||
163116882|NCT01920893|589134010|FG001|Overall Study|Lack of Efficacy|0|||
163116883|NCT01396265|589134011|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
163116884|NCT01767493|589134012|FG000|Overall Study|screen failures|3|||
163116885|NCT02446418|589134013|FG000|Overall Study|Adverse Event|4|||
163116886|NCT02446418|589134014|FG001|Overall Study|Adverse Event|8|||
163116887|NCT02446418|589134013|FG000|Overall Study|Physician Decision|5|||
163116888|NCT02446418|589134014|FG001|Overall Study|Physician Decision|1|||
163116889|NCT02446418|589134013|FG000|Overall Study|Withdrawal by Subject|3|||
163116890|NCT02446418|589134014|FG001|Overall Study|Withdrawal by Subject|3|||
163116891|NCT02446418|589134013|FG000|Overall Study|Lost to Follow-up|2|||
163116892|NCT02446418|589134014|FG001|Overall Study|Lost to Follow-up|2|||
163116893|NCT02446418|589134013|FG000|Overall Study|Protocol Violation|1|||
163116894|NCT02446418|589134014|FG001|Overall Study|Protocol Violation|2|||
163116895|NCT02446418|589134013|FG000|Overall Study|Lack of Efficacy|2|||
163116896|NCT02446418|589134014|FG001|Overall Study|Lack of Efficacy|0|||
163116897|NCT02446418|589134013|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
163116898|NCT02446418|589134014|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
163116899|NCT03093974|589134017|FG000|Overall Study|Withdrawal by Subject|32|||
163116900|NCT03093974|589134018|FG001|Overall Study|Withdrawal by Subject|27|||
163116901|NCT03093974|589134017|FG000|Overall Study|Adverse Event|17|||
163116902|NCT03093974|589134018|FG001|Overall Study|Adverse Event|24|||
163116903|NCT03093974|589134017|FG000|Overall Study|Death|0|||
163116904|NCT03093974|589134018|FG001|Overall Study|Death|1|||
163116905|NCT03093974|589134017|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163116906|NCT03093974|589134018|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163116907|NCT03093974|589134017|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
162654237|NCT01215227|587449714|FG001|Overall Study|Subject Withdrew Consent|20|||
163116908|NCT03093974|589134018|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
163116909|NCT03093974|589134017|FG000|Overall Study|Lost to Follow-up|0|||
163116910|NCT03093974|589134018|FG001|Overall Study|Lost to Follow-up|1|||
163116911|NCT03093974|589134017|FG000|Overall Study|Other|1|||
163116912|NCT03093974|589134018|FG001|Overall Study|Other|2|||
162654238|NCT01215227|587449715|FG002|Overall Study|Subject Withdrew Consent|7|||
162654239|NCT01215227|587449716|FG003|Overall Study|Subject Withdrew Consent|10|||
163116913|NCT01009346|589134023|FG000|Overall Study|Adverse Event|4|||
163116914|NCT00033540|589134024|FG000|Overall Study|Adverse Event|14|||
163116915|NCT00033540|589134024|FG000|Overall Study|Death|1|||
163116916|NCT00033540|589134024|FG000|Overall Study|Progression|26|||
163116917|NCT00033540|589134024|FG000|Overall Study|Withdrawal by Subject|6|||
162654240|NCT01215227|587449717|FG004|Overall Study|Subject Withdrew Consent|11|||
163116918|NCT00033540|589134024|FG000|Overall Study|Other|5|||
163116919|NCT00033540|589134024|FG000|Overall Study|Ineligible|3|||
163116920|NCT00033540|589134024|FG000|Overall Study|Never received treatment|2|||
163116921|NCT01253265|589134027|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
163116922|NCT01253265|589134028|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116923|NCT01253265|589134029|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116924|NCT01253265|589134030|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116925|NCT01253265|589134031|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
163116926|NCT01253265|589134027|FG000|Overall Study|Withdrawal by Subject|0|||
163116927|NCT01253265|589134028|FG001|Overall Study|Withdrawal by Subject|0|||
163116928|NCT01253265|589134029|FG002|Overall Study|Withdrawal by Subject|0|||
163116929|NCT01253265|589134030|FG003|Overall Study|Withdrawal by Subject|0|||
163116930|NCT01253265|589134031|FG004|Overall Study|Withdrawal by Subject|1|||
162654241|NCT01215227|587449718|FG005|Overall Study|Subject Withdrew Consent|8|||
162654242|NCT01215227|587449713|FG000|Overall Study|Non-Compliance With Protocol|2|||
162654243|NCT01215227|587449714|FG001|Overall Study|Non-Compliance With Protocol|6|||
163116931|NCT00066469|589134034|FG000|Overall Study|Death|3|||
163116932|NCT00066469|589134034|FG000|Overall Study|Lack of Efficacy|9|||
163116933|NCT00066469|589134034|FG000|Overall Study|Lost to Follow-up|1|||
163116934|NCT00066469|589134034|FG000|Overall Study|Physician Decision|1|||
163116935|NCT00066469|589134034|FG000|Overall Study|Withdrawal by Subject|1|||
163116936|NCT00066469|589134034|FG000|Overall Study|ineligible|1|||
163116937|NCT00882908|589134037|FG000|Overall Study|Adverse Event|0|||
163116938|NCT00882908|589134038|FG001|Overall Study|Adverse Event|0|||
163116939|NCT00882908|589134039|FG002|Overall Study|Adverse Event|1|||
163116940|NCT00882908|589134040|FG003|Overall Study|Adverse Event|0|||
163116941|NCT00882908|589134041|FG004|Overall Study|Adverse Event|1|||
163116942|NCT00882908|589134037|FG000|Overall Study|Lost to Follow-up|3|||
163116943|NCT00882908|589134038|FG001|Overall Study|Lost to Follow-up|5|||
163116944|NCT00882908|589134039|FG002|Overall Study|Lost to Follow-up|3|||
163116945|NCT00882908|589134040|FG003|Overall Study|Lost to Follow-up|1|||
163116946|NCT00882908|589134041|FG004|Overall Study|Lost to Follow-up|2|||
163116947|NCT00882908|589134037|FG000|Overall Study|Protocol Violation|0|||
163116948|NCT00882908|589134038|FG001|Overall Study|Protocol Violation|1|||
163116949|NCT00882908|589134039|FG002|Overall Study|Protocol Violation|0|||
163116950|NCT00882908|589134040|FG003|Overall Study|Protocol Violation|0|||
163116951|NCT00882908|589134041|FG004|Overall Study|Protocol Violation|0|||
163116952|NCT00882908|589134037|FG000|Overall Study|Withdrawal by Subject|0|||
163116953|NCT00882908|589134038|FG001|Overall Study|Withdrawal by Subject|0|||
163116954|NCT00882908|589134039|FG002|Overall Study|Withdrawal by Subject|3|||
163116955|NCT00882908|589134040|FG003|Overall Study|Withdrawal by Subject|5|||
163116956|NCT00882908|589134041|FG004|Overall Study|Withdrawal by Subject|2|||
163116957|NCT00882908|589134037|FG000|Overall Study|Subject reached a virologic endpoint|0|||
163116958|NCT00882908|589134038|FG001|Overall Study|Subject reached a virologic endpoint|0|||
163116959|NCT00882908|589134039|FG002|Overall Study|Subject reached a virologic endpoint|0|||
163116960|NCT00882908|589134040|FG003|Overall Study|Subject reached a virologic endpoint|0|||
163116961|NCT00882908|589134041|FG004|Overall Study|Subject reached a virologic endpoint|1|||
163116962|NCT00882908|589134037|FG000|Overall Study|Study terminated in error|0|||
163116963|NCT00882908|589134038|FG001|Overall Study|Study terminated in error|0|||
163116964|NCT00882908|589134039|FG002|Overall Study|Study terminated in error|0|||
163116965|NCT00882908|589134040|FG003|Overall Study|Study terminated in error|1|||
163116966|NCT00882908|589134041|FG004|Overall Study|Study terminated in error|0|||
163116967|NCT03283150|589134042|FG000|Overall Study|Withdrawal by Subject|6|||
163116968|NCT03283150|589134043|FG001|Overall Study|Withdrawal by Subject|0|||
163116969|NCT03283150|589134044|FG002|Overall Study|Withdrawal by Subject|0|||
163116970|NCT00581828|589134045|FG000|Overall Study|Protocol Violation|1|||
163116971|NCT02981407|589134046|FG000|Overall Study|Withdrawal by Subject|2|||
163116972|NCT02981407|589134047|FG001|Overall Study|Withdrawal by Subject|0|||
163116973|NCT02410824|589134050|FG000|First Intervention (One Week)|Headache|0|||
163116974|NCT02410824|589134051|FG001|First Intervention (One Week)|Headache|1|||
163116975|NCT00392808|589134052|FG000|Overall Study|Lost to Follow-up|3|||
163116976|NCT00392808|589134053|FG001|Overall Study|Lost to Follow-up|2|||
163116977|NCT00392808|589134054|FG002|Overall Study|Lost to Follow-up|1|||
163116978|NCT00392808|589134055|FG003|Overall Study|Lost to Follow-up|2|||
163116979|NCT00392808|589134052|FG000|Overall Study|Unable to withdraw blood|3|||
163116980|NCT00392808|589134053|FG001|Overall Study|Unable to withdraw blood|1|||
163116981|NCT00392808|589134054|FG002|Overall Study|Unable to withdraw blood|1|||
163116982|NCT00392808|589134055|FG003|Overall Study|Unable to withdraw blood|2|||
163116983|NCT02084238|589134056|FG000|Overall Study|Lost to Follow-up|2|||
163116984|NCT02436408|589134057|FG000|Overall Study|Death|1|||
163116985|NCT02818036|589134058|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
163116986|NCT02818036|589134059|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
163116987|NCT02818036|589134058|FG000|Overall Study|Withdrawal by Subject|1|||
163116988|NCT02818036|589134059|FG001|Overall Study|Withdrawal by Subject|0|||
163116989|NCT01038713|589134060|FG000|Overall Study|Patient to hospice|1|||
163116990|NCT01038713|589134061|FG001|Overall Study|Patient to hospice|1|||
163116991|NCT01038713|589134062|FG002|Overall Study|Patient to hospice|1|||
163116992|NCT01038713|589134060|FG000|Overall Study|Lost to Follow-up|3|||
163116993|NCT01038713|589134061|FG001|Overall Study|Lost to Follow-up|0|||
163116994|NCT01038713|589134062|FG002|Overall Study|Lost to Follow-up|0|||
163116995|NCT01038713|589134060|FG000|Overall Study|Neuroendocrine Tumor|0|||
163116996|NCT01038713|589134061|FG001|Overall Study|Neuroendocrine Tumor|1|||
163116997|NCT01038713|589134062|FG002|Overall Study|Neuroendocrine Tumor|0|||
163116998|NCT01038713|589134060|FG000|Overall Study|died from PEP|0|||
163116999|NCT01038713|589134061|FG001|Overall Study|died from PEP|1|||
163117000|NCT01038713|589134062|FG002|Overall Study|died from PEP|0|||
163117001|NCT01038713|589134060|FG000|Overall Study|Autoimmune Pancreatitis|1|||
163117002|NCT01038713|589134061|FG001|Overall Study|Autoimmune Pancreatitis|0|||
163117003|NCT01038713|589134062|FG002|Overall Study|Autoimmune Pancreatitis|0|||
163117004|NCT01154283|589134063|FG000|0-6 Weeks|Withdrawal by Subject|7|||
163117005|NCT01154283|589134064|FG001|0-6 Weeks|Withdrawal by Subject|2|||
163117006|NCT01154283|589134063|FG000|0-6 Weeks|Death|0|||
163117007|NCT01154283|589134064|FG001|0-6 Weeks|Death|1|||
163117008|NCT01154283|589134063|FG000|7-12 Weeks|Death|1|||
163117009|NCT01154283|589134064|FG001|7-12 Weeks|Death|0|||
163117010|NCT01154283|589134063|FG000|7-12 Weeks|Withdrawal by Subject|0|||
163117011|NCT01154283|589134064|FG001|7-12 Weeks|Withdrawal by Subject|1|||
163117012|NCT03777917|589134065|FG000|Overall Study|Withdrawal by Subject|1|||
163117013|NCT03777917|589134066|FG001|Overall Study|Withdrawal by Subject|0|||
163117014|NCT03777917|589134065|FG000|Overall Study|Physician Decision|1|||
163117015|NCT03777917|589134066|FG001|Overall Study|Physician Decision|0|||
163117016|NCT03777917|589134065|FG000|Overall Study|Lost to Follow-up|6|||
163117017|NCT03777917|589134066|FG001|Overall Study|Lost to Follow-up|2|||
163117018|NCT03777917|589134065|FG000|Overall Study|Other|1|||
163117019|NCT03777917|589134066|FG001|Overall Study|Other|0|||
163117020|NCT00320372|589134067|FG000|Overall Study|Physician Decision|4|||
163117021|NCT00320372|589134068|FG001|Overall Study|Physician Decision|7|||
163117022|NCT00320372|589134067|FG000|Overall Study|Death|7|||
163117023|NCT00320372|589134068|FG001|Overall Study|Death|8|||
163117024|NCT00320372|589134067|FG000|Overall Study|Withdrawal by Subject|55|||
163117025|NCT00320372|589134068|FG001|Overall Study|Withdrawal by Subject|37|||
163117026|NCT00320372|589134067|FG000|Overall Study|Non-Compliance|40|||
163117027|NCT00320372|589134068|FG001|Overall Study|Non-Compliance|39|||
163117028|NCT00320372|589134067|FG000|Overall Study|Did not Meet (I/E)|3|||
163117029|NCT00320372|589134068|FG001|Overall Study|Did not Meet (I/E)|1|||
163117030|NCT00320372|589134067|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
163117031|NCT00320372|589134068|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
163117032|NCT04063787|589134069|FG000|Overall Study|Inadequate Doppler data|4|||
163117033|NCT04063787|589134069|FG000|Overall Study|Lost to Follow-up|2|||
163117034|NCT04063787|589134069|FG000|Overall Study|Death|3|||
163117035|NCT01416441|589134070|FG000|Overall Study|Lost to Follow-up|5|||
163117036|NCT01416441|589134070|FG000|Overall Study|Adverse Event|6|||
163117037|NCT01416441|589134070|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
163117038|NCT01416441|589134070|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
163117039|NCT01416441|589134070|FG000|Overall Study|Investigator Withdrew Subject|2|||
163117040|NCT01416441|589134070|FG000|Overall Study|Subject Withdrew Consent|12|||
163117041|NCT01416441|589134070|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
163117042|NCT02191605|589135448|FG000|Overall Study|Lost to Follow-up|9|||
163117043|NCT02191605|589135449|FG001|Overall Study|Lost to Follow-up|4|||
163117044|NCT02191605|589135450|FG002|Overall Study|Lost to Follow-up|7|||
163117045|NCT02191605|589135451|FG003|Overall Study|Lost to Follow-up|3|||
163117046|NCT02191605|589135452|FG004|Overall Study|Lost to Follow-up|4|||
163117047|NCT03131596|589135457|FG000|Overall Study|Protocol Violation|3|||
163117048|NCT03131596|589135458|FG001|Overall Study|Protocol Violation|3|||
163117049|NCT03131596|589135457|FG000|Overall Study|Lost to Follow-up|3|||
163117050|NCT03131596|589135458|FG001|Overall Study|Lost to Follow-up|0|||
163117051|NCT00734071|589135459|FG000|Overall Study|Adverse Event|4|||
163117052|NCT00734071|589135460|FG001|Overall Study|Adverse Event|3|||
163117053|NCT00734071|589135459|FG000|Overall Study|Lack of Efficacy|3|||
163117054|NCT00734071|589135460|FG001|Overall Study|Lack of Efficacy|1|||
163117055|NCT00734071|589135459|FG000|Overall Study|Noncompliance|2|||
163117056|NCT00734071|589135460|FG001|Overall Study|Noncompliance|2|||
163117057|NCT00734071|589135459|FG000|Overall Study|Protocol Deviations|3|||
163117058|NCT00734071|589135460|FG001|Overall Study|Protocol Deviations|4|||
163117059|NCT00734071|589135459|FG000|Overall Study|Voluntary Withdrawal|9|||
163117060|NCT00734071|589135460|FG001|Overall Study|Voluntary Withdrawal|7|||
163117061|NCT00734071|589135459|FG000|Overall Study|Lost to Follow-up|16|||
163117062|NCT00734071|589135460|FG001|Overall Study|Lost to Follow-up|8|||
163117063|NCT00734071|589135459|FG000|Overall Study|Other|1|||
163117064|NCT00734071|589135460|FG001|Overall Study|Other|2|||
163117065|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
163117066|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
163117067|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
163117068|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
163117069|NCT03654885|589135461|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
163117070|NCT03654885|589135462|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
163117071|NCT03654885|589135461|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
163117072|NCT03654885|589135462|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
163117073|NCT03654885|589135461|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
162719374|NCT00530842|587678489|FG001|Period 1|Protocol Violation|1|||
162719375|NCT00530842|587678488|FG000|Period 1|Withdrawal by Subject|2|||
162719376|NCT00530842|587678489|FG001|Period 1|Withdrawal by Subject|3|||
162719377|NCT00530842|587678488|FG000|Period 1|Individual different reasons|2|||
162719378|NCT00530842|587678489|FG001|Period 1|Individual different reasons|3|||
163117074|NCT03654885|589135462|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
163117075|NCT03654885|589135461|FG000|Overall Study|Adverse Event in Study Eye|3|||
163117076|NCT03654885|589135462|FG001|Overall Study|Adverse Event in Study Eye|0|||
163117077|NCT03654885|589135461|FG000|Overall Study|Consent Withdrawn|1|||
163117078|NCT03654885|589135462|FG001|Overall Study|Consent Withdrawn|0|||
163117079|NCT03654885|589135461|FG000|Overall Study|Death|3|||
163117080|NCT03654885|589135462|FG001|Overall Study|Death|1|||
163117081|NCT03654885|589135461|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
163117082|NCT03654885|589135462|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
163117083|NCT03654885|589135461|FG000|Overall Study|Lost to Follow-up|3|||
163117084|NCT03654885|589135462|FG001|Overall Study|Lost to Follow-up|3|||
163117085|NCT05275582|589135463|FG000|Overall Study|Lost to Follow-up|1|||
163117086|NCT05275582|589135464|FG001|Overall Study|Lost to Follow-up|0|||
163117087|NCT05275582|589135463|FG000|Overall Study|Withdrawal by Subject|0|||
163117088|NCT05275582|589135464|FG001|Overall Study|Withdrawal by Subject|2|||
163117089|NCT05275582|589135463|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
163117090|NCT05275582|589135464|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
163117091|NCT05275582|589135463|FG000|Overall Study|Death|1|||
163117092|NCT05275582|589135464|FG001|Overall Study|Death|0|||
163117093|NCT05275582|589135463|FG000|Overall Study|Protocol Violation|1|||
163117094|NCT05275582|589135464|FG001|Overall Study|Protocol Violation|0|||
163117095|NCT05320393|589135465|FG000|Overall Study|Withdrawal by Subject|1|||
163117096|NCT05320393|589135466|FG001|Overall Study|Withdrawal by Subject|0|||
163117097|NCT05320393|589135467|FG002|Overall Study|Withdrawal by Subject|2|||
163117098|NCT05320393|589135465|FG000|Overall Study|Lost to Follow-up|1|||
163117099|NCT05320393|589135466|FG001|Overall Study|Lost to Follow-up|2|||
163117100|NCT05320393|589135467|FG002|Overall Study|Lost to Follow-up|1|||
163117101|NCT05320393|589135465|FG000|Overall Study|Moved; too much driving|0|||
163117102|NCT05320393|589135466|FG001|Overall Study|Moved; too much driving|0|||
163117103|NCT05320393|589135467|FG002|Overall Study|Moved; too much driving|2|||
163117104|NCT05320393|589135465|FG000|Overall Study|Did not receive treatment|0|||
163117105|NCT05320393|589135466|FG001|Overall Study|Did not receive treatment|0|||
163117106|NCT05320393|589135467|FG002|Overall Study|Did not receive treatment|1|||
163117107|NCT04411420|589135468|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
163117108|NCT04411420|589135469|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
163117109|NCT04411420|589135468|FG000|Survey Subset|Lost to Follow-up|134|||
163117110|NCT04411420|589135469|FG001|Survey Subset|Lost to Follow-up|120|||
163117111|NCT03187834|589135470|FG000|Overall Study|Lost to Follow-up|0|||
163117112|NCT03187834|589135471|FG001|Overall Study|Lost to Follow-up|1|||
163117113|NCT03187834|589135472|FG002|Overall Study|Lost to Follow-up|2|||
163117114|NCT03187834|589135473|FG003|Overall Study|Lost to Follow-up|2|||
163117115|NCT03187834|589135470|FG000|Overall Study|Had invalid anthropometric measurements|5|||
163117116|NCT03187834|589135471|FG001|Overall Study|Had invalid anthropometric measurements|3|||
163117117|NCT03187834|589135472|FG002|Overall Study|Had invalid anthropometric measurements|4|||
163117118|NCT03187834|589135473|FG003|Overall Study|Had invalid anthropometric measurements|2|||
163117119|NCT03559699|589135474|FG000|Overall Study|Withdrawal by Subject|6|||
163117120|NCT03559699|589135474|FG000|Overall Study|Lost to Follow-up|1|||
163117121|NCT00031460|589135475|FG000|Overall Study|Lost to Follow-up|0|||
163117122|NCT00031460|589135476|FG001|Overall Study|Lost to Follow-up|1|||
163117123|NCT00031460|589135475|FG000|Overall Study|Withdrawal by Subject|1|||
163117124|NCT00031460|589135476|FG001|Overall Study|Withdrawal by Subject|1|||
163117125|NCT00031460|589135475|FG000|Overall Study|Non-Compliant|1|||
163117126|NCT00031460|589135476|FG001|Overall Study|Non-Compliant|1|||
163117127|NCT00031460|589135475|FG000|Overall Study|Death|0|||
163117128|NCT00031460|589135476|FG001|Overall Study|Death|1|||
163117129|NCT00031460|589135475|FG000|Overall Study|Reactivation of Disease|5|||
163117130|NCT00031460|589135476|FG001|Overall Study|Reactivation of Disease|9|||
163117131|NCT00031460|589135475|FG000|Overall Study|Disruption of blinded drug supply|2|||
162654244|NCT01215227|587449715|FG002|Overall Study|Non-Compliance With Protocol|1|||
162654245|NCT01215227|587449716|FG003|Overall Study|Non-Compliance With Protocol|0|||
162654246|NCT01215227|587449717|FG004|Overall Study|Non-Compliance With Protocol|0|||
163117132|NCT00031460|589135476|FG001|Overall Study|Disruption of blinded drug supply|0|||
163117133|NCT00031460|589135475|FG000|Overall Study|Confirmed unevaluable|0|||
163117134|NCT00031460|589135476|FG001|Overall Study|Confirmed unevaluable|1|||
163117135|NCT01930890|589135478|FG000|Overall Study|Study Termination|14|||
163117136|NCT01930890|589135479|FG001|Overall Study|Study Termination|28|||
163117137|NCT01930890|589135480|FG002|Overall Study|Study Termination|13|||
163117138|NCT01930890|589135481|FG003|Overall Study|Study Termination|25|||
163117139|NCT01930890|589135478|FG000|Overall Study|Death|0|||
163117140|NCT01930890|589135479|FG001|Overall Study|Death|0|||
163117141|NCT01930890|589135480|FG002|Overall Study|Death|0|||
162654247|NCT01215227|587449718|FG005|Overall Study|Non-Compliance With Protocol|0|||
162654248|NCT01215227|587449713|FG000|Overall Study|Administrative|83|||
162654249|NCT01215227|587449714|FG001|Overall Study|Administrative|73|||
163117142|NCT01930890|589135481|FG003|Overall Study|Death|1|||
163117143|NCT01930890|589135478|FG000|Overall Study|Investigator Decision|0|||
163117144|NCT01930890|589135479|FG001|Overall Study|Investigator Decision|1|||
163117145|NCT01930890|589135480|FG002|Overall Study|Investigator Decision|0|||
163117146|NCT01930890|589135481|FG003|Overall Study|Investigator Decision|0|||
163117147|NCT01930890|589135478|FG000|Overall Study|Consent Withdrawn|0|||
163117148|NCT01930890|589135479|FG001|Overall Study|Consent Withdrawn|3|||
163117149|NCT01930890|589135480|FG002|Overall Study|Consent Withdrawn|0|||
163117150|NCT01930890|589135481|FG003|Overall Study|Consent Withdrawn|1|||
163117151|NCT01930890|589135478|FG000|Overall Study|Adverse Event|0|||
163117152|NCT01930890|589135479|FG001|Overall Study|Adverse Event|1|||
163117153|NCT01930890|589135480|FG002|Overall Study|Adverse Event|0|||
163117154|NCT01930890|589135481|FG003|Overall Study|Adverse Event|0|||
163117155|NCT01703117|589135490|FG000|Overall Study|Adverse Event|4|||
163117156|NCT01703117|589135491|FG001|Overall Study|Adverse Event|3|||
163117157|NCT01703117|589135490|FG000|Overall Study|Withdrawal by Subject|0|||
163117158|NCT01703117|589135491|FG001|Overall Study|Withdrawal by Subject|1|||
163117159|NCT00330928|589135496|FG000|Overall Study|Lost to Follow-up|6|||
163117160|NCT00330928|589135496|FG000|Overall Study|Physician Decision|9|||
163117161|NCT00330928|589135496|FG000|Overall Study|Death|1|||
163117162|NCT00330928|589135496|FG000|Overall Study|IVUS could not be performed.|1|||
163117163|NCT03028480|589135499|FG000|Overall Study|No revisit after the first prescription date|2|||
163117164|NCT03028480|589135499|FG000|Overall Study|Did not use the drug|1|||
163117165|NCT03028480|589135499|FG000|Overall Study|Violation of the enrollment deadline|10|||
163117166|NCT03028480|589135499|FG000|Overall Study|Case report forms were not collected|21|||
163117167|NCT00759356|589135504|FG000|Overall Study|Adverse Event|0|||
163117168|NCT00759356|589135505|FG001|Overall Study|Adverse Event|1|||
163117169|NCT00759356|589135504|FG000|Overall Study|Withdrawal by Subject|0|||
163117170|NCT00759356|589135505|FG001|Overall Study|Withdrawal by Subject|2|||
163117171|NCT00759356|589135504|FG000|Overall Study|Subject was unable to return|1|||
163117172|NCT00759356|589135505|FG001|Overall Study|Subject was unable to return|0|||
163117173|NCT02403635|589135510|FG000|Overall Study|Not eligible|9|||
163117174|NCT00585221|589135514|FG000|Overall Study|Protocol Violation|8|||
163117175|NCT02509052|589135515|FG000|Overall Study|Non compliance|0|||
163117176|NCT02509052|589135516|FG001|Overall Study|Non compliance|0|||
163117177|NCT02509052|589135517|FG002|Overall Study|Non compliance|1|||
163117178|NCT03554772|589135520|FG000|Overall Study|Lost to Follow-up|0|||
163117179|NCT03554772|589135521|FG001|Overall Study|Lost to Follow-up|0|||
163117180|NCT03554772|589135522|FG002|Overall Study|Lost to Follow-up|0|||
163117181|NCT03554772|589135523|FG003|Overall Study|Lost to Follow-up|2|||
163117182|NCT00241631|589135530|FG000|Run in (2 Weeks)|Physician Decision|3|||
163117183|NCT00241631|589135531|FG001|Run in (2 Weeks)|Physician Decision|3|||
163117184|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|sore throat|1|||
163117185|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|sore throat|0|||
163117186|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
163117187|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
163117188|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
163117189|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
163117190|NCT00241631|589135530|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
163117191|NCT00241631|589135531|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
163117192|NCT03444766|589135533|FG000|Overall Study|Other Reasons|2|||
163117193|NCT03444766|589135533|FG000|Overall Study|Participant Withdrew Consent|5|||
163117194|NCT03444766|589135533|FG000|Overall Study|Lost to Follow-up|2|||
163117195|NCT03444766|589135533|FG000|Overall Study|Death|2|||
163117196|NCT03444766|589135533|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
163117197|NCT03444766|589135533|FG000|Overall Study|Disease Progression|49|||
163117198|NCT03421743|589135536|FG000|Overall Study|Lack of Efficacy|1|||
163117199|NCT03421743|589135537|FG001|Overall Study|Lack of Efficacy|0|||
163117200|NCT03421743|589135536|FG000|Overall Study|Adverse Event|2|||
163117201|NCT03421743|589135537|FG001|Overall Study|Adverse Event|1|||
163117202|NCT03421743|589135536|FG000|Overall Study|Withdrawal by Subject|0|||
163117203|NCT03421743|589135537|FG001|Overall Study|Withdrawal by Subject|1|||
163117204|NCT00435162|589135538|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
163117205|NCT00435162|589135539|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
163117206|NCT00435162|589135540|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
163117207|NCT00435162|589135541|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
163117208|NCT00435162|589135542|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
163117209|NCT00435162|589135543|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
163117210|NCT00694096|589135544|FG000|Overall Study|Withdrawal by Subject|5|||
163117211|NCT02680574|589135550|FG000|Overall Study|Death|137|||
162654250|NCT01215227|587449715|FG002|Overall Study|Administrative|42|||
162654251|NCT01215227|587449716|FG003|Overall Study|Administrative|24|||
162654252|NCT01215227|587449717|FG004|Overall Study|Administrative|28|||
162654253|NCT01215227|587449718|FG005|Overall Study|Administrative|40|||
163117212|NCT02680574|589135551|FG001|Overall Study|Death|137|||
163117213|NCT02680574|589135550|FG000|Overall Study|Withdrawal by Subject|17|||
163117214|NCT02680574|589135551|FG001|Overall Study|Withdrawal by Subject|9|||
163117215|NCT02680574|589135550|FG000|Overall Study|Lost to Follow-up|4|||
163117216|NCT02680574|589135551|FG001|Overall Study|Lost to Follow-up|6|||
163117217|NCT02078102|589135555|FG000|Overall Study|Adverse Event|1|||
163117218|NCT02078102|589135556|FG001|Overall Study|Adverse Event|0|||
163117219|NCT02078102|589135555|FG000|Overall Study|Withdrawal by Subject|1|||
163117220|NCT02078102|589135556|FG001|Overall Study|Withdrawal by Subject|0|||
163117221|NCT02078102|589135555|FG000|Overall Study|Physician Decision|0|||
163117222|NCT02078102|589135556|FG001|Overall Study|Physician Decision|1|||
163117223|NCT02185014|589135559|FG000|Overall Study|Adverse Event|18|||
163117224|NCT02185014|589135559|FG000|Overall Study|Withdrew Consent|8|||
163117225|NCT02185014|589135559|FG000|Overall Study|Lost to Follow-up|4|||
163117226|NCT02185014|589135559|FG000|Overall Study|Lack of Efficacy|14|||
163117227|NCT02185014|589135559|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
163117228|NCT02185014|589135559|FG000|Overall Study|Subject Noncompliance|1|||
163117229|NCT02185014|589135559|FG000|Overall Study|Other|4|||
163117230|NCT02141490|589135562|FG000|Overall Study|Screening failures|4|||
163117231|NCT02141490|589135563|FG001|Overall Study|Screening failures|0|||
163117232|NCT02141490|589135564|FG002|Overall Study|Screening failures|0|||
163117233|NCT01813721|589135565|FG000|Overall Study|Ineligibility determined|63|||
163117234|NCT01813721|589135565|FG000|Overall Study|Withdrawal by Subject|1|||
163117235|NCT02387164|589135566|FG000|Overall Study|Lost to Follow-up|2|||
163117236|NCT02387164|589135567|FG001|Overall Study|Lost to Follow-up|0|||
163117237|NCT02387164|589135566|FG000|Overall Study|Diagnosed|1|||
163117238|NCT02387164|589135567|FG001|Overall Study|Diagnosed|2|||
163117239|NCT02133664|589135570|FG000|Overall Study|Lost to Follow-up|2|||
163117240|NCT02133664|589135571|FG001|Overall Study|Lost to Follow-up|1|||
163117241|NCT02133664|589135570|FG000|Overall Study|Adverse Event|3|||
163117242|NCT02133664|589135571|FG001|Overall Study|Adverse Event|6|||
163117243|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
163117244|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
163117245|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
163117246|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
163117247|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
163117248|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
163117249|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
163117250|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
163117251|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
163117252|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
163117253|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
163117254|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
163117255|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
163117256|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
163117257|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
163117258|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
163117259|NCT03906656|589135572|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
163117260|NCT03906656|589135573|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
163117261|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
163117262|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
163117263|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
162654254|NCT01215227|587449713|FG000|Overall Study|Missing Status|0|||
162654255|NCT01215227|587449714|FG001|Overall Study|Missing Status|1|||
162654256|NCT01215227|587449715|FG002|Overall Study|Missing Status|0|||
163117264|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
163117265|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
163117266|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
163117267|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
163117268|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
163117269|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
163117270|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
163117271|NCT03906656|589135572|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
163117272|NCT03906656|589135573|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
163117273|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
163117274|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
162654257|NCT01215227|587449716|FG003|Overall Study|Missing Status|0|||
162654258|NCT01215227|587449717|FG004|Overall Study|Missing Status|0|||
162654259|NCT01215227|587449718|FG005|Overall Study|Missing Status|0|||
162654260|NCT01215227|587449713|FG000|Overall Study|Randomized but not treated|0|||
162654261|NCT01215227|587449714|FG001|Overall Study|Randomized but not treated|0|||
162654262|NCT01215227|587449715|FG002|Overall Study|Randomized but not treated|1|||
162654263|NCT01215227|587449716|FG003|Overall Study|Randomized but not treated|1|||
162654264|NCT01215227|587449717|FG004|Overall Study|Randomized but not treated|0|||
162654265|NCT01215227|587449718|FG005|Overall Study|Randomized but not treated|1|||
162654266|NCT01393405|587449719|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
162654267|NCT01393405|587449720|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
162654268|NCT01393405|587449721|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
162654269|NCT01393405|587449719|FG000|Induction Period (week1-16)|Adverse Event|16|||
163117275|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
163117276|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
163117277|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Death|2|||
163117278|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Death|0|||
163117279|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
163117280|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
163117281|NCT03906656|589135572|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
163117282|NCT03906656|589135573|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
163117283|NCT01036529|589135574|FG000|Overall Study|Adverse Event|0|||
163117284|NCT01036529|589135575|FG001|Overall Study|Adverse Event|1|||
163117285|NCT01036529|589135574|FG000|Overall Study|Lost to Follow-up|0|||
163117286|NCT01036529|589135575|FG001|Overall Study|Lost to Follow-up|1|||
163117287|NCT01036529|589135574|FG000|Overall Study|Physician Decision|1|||
163117288|NCT01036529|589135575|FG001|Overall Study|Physician Decision|0|||
163117289|NCT01036529|589135574|FG000|Overall Study|Withdrawal by Subject|1|||
163117290|NCT01036529|589135575|FG001|Overall Study|Withdrawal by Subject|1|||
163117291|NCT01036529|589135574|FG000|Overall Study|Sponsor study termination|11|||
163117292|NCT01036529|589135575|FG001|Overall Study|Sponsor study termination|12|||
163117293|NCT00343915|589135577|FG000|Primary Study|Withdrawal by Subject|1|||
163117294|NCT00343915|589135578|FG001|Primary Study|Withdrawal by Subject|0|||
163117295|NCT00343915|589135577|FG000|Primary Study|Lost to Follow-up|2|||
163117296|NCT00343915|589135578|FG001|Primary Study|Lost to Follow-up|3|||
163117297|NCT00343915|589135577|FG000|Primary Study|Other|1|||
163117298|NCT00343915|589135578|FG001|Primary Study|Other|0|||
163117299|NCT02525939|589135579|FG000|Overall Study|Lost to Follow-up|27|||
163117300|NCT02525939|589135580|FG001|Overall Study|Lost to Follow-up|24|||
163117301|NCT02525939|589135579|FG000|Overall Study|Physician Decision|0|||
163117302|NCT02525939|589135580|FG001|Overall Study|Physician Decision|1|||
163117303|NCT02525939|589135579|FG000|Overall Study|Withdrawal by Subject|24|||
163117304|NCT02525939|589135580|FG001|Overall Study|Withdrawal by Subject|39|||
163117305|NCT02525939|589135579|FG000|Overall Study|Death|180|||
163117306|NCT02525939|589135580|FG001|Overall Study|Death|179|||
163117307|NCT00536874|589135581|FG000|Overall Study|Adverse Event|1|||
163117308|NCT00536874|589135581|FG000|Overall Study|Death|2|||
163117309|NCT00536874|589135581|FG000|Overall Study|Withdrawal by Subject|1|||
163117310|NCT01853072|589135582|FG000|Overall Study|Adverse event prior to treatment|0|||
163117311|NCT01853072|589135583|FG001|Overall Study|Adverse event prior to treatment|1|||
163117312|NCT01853072|589135582|FG000|Overall Study|Adverse Event|0|||
163117313|NCT01853072|589135583|FG001|Overall Study|Adverse Event|3|||
163117314|NCT01853072|589135582|FG000|Overall Study|Death|1|||
163117315|NCT01853072|589135583|FG001|Overall Study|Death|4|||
163117316|NCT01853072|589135582|FG000|Overall Study|Lost to Follow-up|0|||
163117317|NCT01853072|589135583|FG001|Overall Study|Lost to Follow-up|3|||
163117318|NCT01853072|589135582|FG000|Overall Study|Non-compliance with study drug|0|||
162654270|NCT01393405|587449720|FG001|Induction Period (week1-16)|Adverse Event|0|||
162654271|NCT01393405|587449721|FG002|Induction Period (week1-16)|Adverse Event|0|||
162654272|NCT01393405|587449719|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
162654273|NCT01393405|587449720|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
162654274|NCT01393405|587449721|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
162654275|NCT01393405|587449719|FG000|Maintenance Period Week|Lack of Efficacy|0|||
162654276|NCT01393405|587449720|FG001|Maintenance Period Week|Lack of Efficacy|22|||
162654277|NCT01393405|587449721|FG002|Maintenance Period Week|Lack of Efficacy|22|||
163117319|NCT01853072|589135583|FG001|Overall Study|Non-compliance with study drug|1|||
163117320|NCT01853072|589135582|FG000|Overall Study|Physician Decision|1|||
162654278|NCT01393405|587449719|FG000|Maintenance Period Week|Adverse Event|0|||
162654279|NCT01393405|587449720|FG001|Maintenance Period Week|Adverse Event|5|||
162654280|NCT01393405|587449721|FG002|Maintenance Period Week|Adverse Event|2|||
163117321|NCT01853072|589135583|FG001|Overall Study|Physician Decision|1|||
163117322|NCT01853072|589135582|FG000|Overall Study|Withdrawal by Subject|1|||
163117323|NCT01853072|589135583|FG001|Overall Study|Withdrawal by Subject|2|||
163117324|NCT01853072|589135582|FG000|Overall Study|Reason not specified|9|||
163117325|NCT01853072|589135583|FG001|Overall Study|Reason not specified|6|||
163117326|NCT01287221|589135584|FG000|Overall Study|Lack of Perceived Benefit|1|||
163117327|NCT01287221|589135585|FG001|Overall Study|Lack of Perceived Benefit|1|||
163117328|NCT01287221|589135584|FG000|Overall Study|Adverse Event|3|||
162654281|NCT01393405|587449719|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
162654282|NCT01393405|587449720|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
162654283|NCT01393405|587449721|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
162654284|NCT01393405|587449719|FG000|Maintenance Period Week|Lost to Follow-up|0|||
162654285|NCT01393405|587449720|FG001|Maintenance Period Week|Lost to Follow-up|1|||
162654286|NCT01393405|587449721|FG002|Maintenance Period Week|Lost to Follow-up|0|||
162654287|NCT02281552|587449722|FG000|Overall Study|Medication error|1|||
162654288|NCT02281552|587449723|FG001|Overall Study|Medication error|0|||
162654289|NCT02281552|587449722|FG000|Overall Study|Insufficient clinical response|0|||
162719379|NCT00530842|587678488|FG000|Period 2|Adverse Event|3|||
162719380|NCT00530842|587678489|FG001|Period 2|Adverse Event|3|||
162719381|NCT00530842|587678488|FG000|Period 2|Lack of Efficacy|1|||
162719382|NCT00530842|587678489|FG001|Period 2|Lack of Efficacy|0|||
163117329|NCT01287221|589135585|FG001|Overall Study|Adverse Event|3|||
163117330|NCT01287221|589135584|FG000|Overall Study|Withdrawal by Subject|0|||
163117331|NCT01287221|589135585|FG001|Overall Study|Withdrawal by Subject|1|||
163117332|NCT00930969|589135586|FG000|Overall Study|Death|5|||
163117333|NCT00930969|589135586|FG000|Overall Study|Lost to Follow-up|1|||
163117334|NCT00930969|589135586|FG000|Overall Study|Physician Decision|13|||
163117335|NCT00930969|589135586|FG000|Overall Study|Withdrawal by Subject|19|||
163117336|NCT03515941|589135587|FG000|Overall Study|Adverse Event|1|||
163117337|NCT03515941|589135588|FG001|Overall Study|Adverse Event|0|||
163117338|NCT03959982|589138032|FG000|Overall Study|Withdrawal by Subject|1|||
163117339|NCT03959982|589138033|FG001|Overall Study|Withdrawal by Subject|0|||
163117340|NCT03959982|589138032|FG000|Overall Study|Physician Decision|2|||
163117341|NCT03959982|589138033|FG001|Overall Study|Physician Decision|0|||
163117342|NCT03959982|589138032|FG000|Overall Study|Lost to Follow-up|1|||
163117343|NCT03959982|589138033|FG001|Overall Study|Lost to Follow-up|0|||
163117344|NCT04030247|589138034|FG000|Overall Study|Withdrawal by Subject|4|||
163117345|NCT04030247|589138034|FG000|Overall Study|Lost to Follow-up|13|||
163117346|NCT01309269|589138037|FG000|Overall Study|Adverse Event|56|||
163117347|NCT01309269|589138037|FG000|Overall Study|Withdrawal by Subject|25|||
163117348|NCT01309269|589138037|FG000|Overall Study|Lack of Acceptance|15|||
163117349|NCT01309269|589138037|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
163117350|NCT01309269|589138037|FG000|Overall Study|Kidney Transplant|25|||
163117351|NCT01309269|589138037|FG000|Overall Study|Administrative Problems|141|||
163117352|NCT01309269|589138037|FG000|Overall Study|Other|256|||
163117353|NCT01309269|589138037|FG000|Overall Study|Other|1|||
163117354|NCT01309269|589138037|FG000|Overall Study|Study Completion Data Not Recorded|95|||
163117355|NCT01309269|589138037|FG000|Overall Study|Enrolled but not Treated|107|||
163117356|NCT03647267|589138054|FG000|Overall Study|Lost to Follow-up|1|||
163117357|NCT03647267|589138055|FG001|Overall Study|Lost to Follow-up|0|||
163117358|NCT05079477|589138056|FG000|Overall Study|Lost to Follow-up|2|||
163117359|NCT05079477|589138057|FG001|Overall Study|Lost to Follow-up|0|||
163117360|NCT05079477|589138056|FG000|Overall Study|Withdrawal by Subject|1|||
163117361|NCT05079477|589138057|FG001|Overall Study|Withdrawal by Subject|0|||
163117362|NCT05079477|589138056|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
163117363|NCT05079477|589138057|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
163117364|NCT05079477|589138056|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
163117365|NCT05079477|589138057|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
163117366|NCT00240110|589138061|FG000|Overall Study|Lost to Follow-up|6|||
163117367|NCT00240110|589138062|FG001|Overall Study|Lost to Follow-up|7|||
163117368|NCT02080260|589138064|FG000|Overall Study|Death|18|||
163117369|NCT02080260|589138064|FG000|Overall Study|Withdrawal by Subject|1|||
163117370|NCT05438602|589138065|FG000|Treatment (15 Days)|Adverse Event|2|||
163117371|NCT05438602|589138066|FG001|Treatment (15 Days)|Adverse Event|1|||
163117372|NCT05438602|589138067|FG002|Treatment (15 Days)|Adverse Event|3|||
163117373|NCT05438602|589138065|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
163117374|NCT05438602|589138066|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
163117375|NCT05438602|589138067|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
163117376|NCT05438602|589138065|FG000|Treatment (15 Days)|Other|0|||
163117377|NCT05438602|589138066|FG001|Treatment (15 Days)|Other|0|||
163117378|NCT05438602|589138067|FG002|Treatment (15 Days)|Other|1|||
163117379|NCT05438602|589138065|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
163117380|NCT05438602|589138066|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
163117381|NCT05438602|589138067|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
163117382|NCT05438602|589138065|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
163117383|NCT05438602|589138066|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
163117384|NCT05438602|589138067|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
163117385|NCT05438602|589138065|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
163117386|NCT05438602|589138066|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
163117387|NCT05438602|589138067|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
163117388|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
163117389|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
163117390|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
163117391|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
163117392|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
162719383|NCT00530842|587678488|FG000|Period 2|Lost to Follow-up|0|||
163117393|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
163117394|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
163117395|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
163117396|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
163117397|NCT05438602|589138065|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
162654290|NCT02281552|587449723|FG001|Overall Study|Insufficient clinical response|1|||
162654291|NCT02281552|587449722|FG000|Overall Study|Adverse Event|3|||
162654292|NCT02281552|587449723|FG001|Overall Study|Adverse Event|9|||
162654293|NCT01434290|587449724|FG000|Overall Study|Protocol Violation|6|||
162654294|NCT01434290|587449725|FG001|Overall Study|Protocol Violation|3|||
162654295|NCT01434290|587449724|FG000|Overall Study|No protocol treatment|2|||
162654296|NCT01434290|587449725|FG001|Overall Study|No protocol treatment|4|||
162654297|NCT01224639|587449726|FG000|Overall Study|Withdrawal by Subject|0|||
162719384|NCT00530842|587678489|FG001|Period 2|Lost to Follow-up|4|||
163117398|NCT05438602|589138066|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
163117399|NCT05438602|589138067|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
163117400|NCT02091284|589138068|FG000|Overall Study|Withdrawal by Subject|2|||
163117401|NCT02091284|589138069|FG001|Overall Study|Withdrawal by Subject|1|||
163117402|NCT02091284|589138068|FG000|Overall Study|unreliable data|1|||
163117403|NCT02091284|589138069|FG001|Overall Study|unreliable data|0|||
163117404|NCT02853435|589138070|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117405|NCT02853435|589138071|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117406|NCT02853435|589138072|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117407|NCT02853435|589138073|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117408|NCT02853435|589138074|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
163117409|NCT02853435|589138075|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
163117410|NCT03747120|589138078|FG000|Overall Study|treatment related toxicity|3|||
163117411|NCT03747120|589138079|FG001|Overall Study|treatment related toxicity|0|||
163117412|NCT03747120|589138080|FG002|Overall Study|treatment related toxicity|0|||
163117413|NCT03747120|589138078|FG000|Overall Study|Withdrawal by Subject|0|||
163117414|NCT03747120|589138079|FG001|Overall Study|Withdrawal by Subject|1|||
163117415|NCT03747120|589138080|FG002|Overall Study|Withdrawal by Subject|2|||
163117416|NCT02317809|589138102|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
163117417|NCT02317809|589138103|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
163117418|NCT02317809|589138102|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
163117419|NCT02317809|589138103|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
163117420|NCT00096174|589138104|FG000|Overall Study|Lack of Efficacy|9|||
163117421|NCT00096174|589138104|FG000|Overall Study|Adverse Event|15|||
163117422|NCT00096174|589138104|FG000|Overall Study|Death|6|||
163117423|NCT00096174|589138104|FG000|Overall Study|Withdrawal by Subject|15|||
163117424|NCT00096174|589138104|FG000|Overall Study|Not started protocol therapy|3|||
163117425|NCT00096174|589138104|FG000|Overall Study|Ineligible|6|||
163117426|NCT00096174|589138104|FG000|Overall Study|other reason|8|||
163117427|NCT00953524|589138105|FG000|Overall Study|Adverse Event|2|||
163117428|NCT00953524|589138106|FG001|Overall Study|Adverse Event|0|||
163117429|NCT00953524|589138107|FG002|Overall Study|Adverse Event|1|||
163117430|NCT00953524|589138108|FG003|Overall Study|Adverse Event|2|||
163117431|NCT00953524|589138105|FG000|Overall Study|Protocol Violation|18|||
163117432|NCT00953524|589138106|FG001|Overall Study|Protocol Violation|10|||
163117433|NCT00953524|589138107|FG002|Overall Study|Protocol Violation|11|||
163117434|NCT00953524|589138108|FG003|Overall Study|Protocol Violation|6|||
163117435|NCT00953524|589138105|FG000|Overall Study|Lost to Follow-up|0|||
163117436|NCT00953524|589138106|FG001|Overall Study|Lost to Follow-up|1|||
163117437|NCT00953524|589138107|FG002|Overall Study|Lost to Follow-up|1|||
163117438|NCT00953524|589138108|FG003|Overall Study|Lost to Follow-up|0|||
163117439|NCT00953524|589138105|FG000|Overall Study|Withdrawal by Subject|2|||
163117440|NCT00953524|589138106|FG001|Overall Study|Withdrawal by Subject|4|||
163117441|NCT00953524|589138107|FG002|Overall Study|Withdrawal by Subject|1|||
163117442|NCT00953524|589138108|FG003|Overall Study|Withdrawal by Subject|0|||
163117443|NCT03362931|589138110|FG000|Overall Study|Adverse Event|1|||
162654298|NCT01224639|587449727|FG001|Overall Study|Withdrawal by Subject|0|||
162654299|NCT01224639|587449728|FG002|Overall Study|Withdrawal by Subject|0|||
162654300|NCT01224639|587449729|FG003|Overall Study|Withdrawal by Subject|0|||
162654301|NCT01224639|587449730|FG004|Overall Study|Withdrawal by Subject|2|||
162654302|NCT01224639|587449731|FG005|Overall Study|Withdrawal by Subject|0|||
162654303|NCT01224639|587449732|FG006|Overall Study|Withdrawal by Subject|1|||
162654304|NCT01224639|587449733|FG007|Overall Study|Withdrawal by Subject|1|||
162654305|NCT01224639|587449726|FG000|Overall Study|Adverse Event|0|||
162654306|NCT01224639|587449727|FG001|Overall Study|Adverse Event|0|||
162654307|NCT01224639|587449728|FG002|Overall Study|Adverse Event|0|||
162654308|NCT01224639|587449729|FG003|Overall Study|Adverse Event|0|||
162654309|NCT01224639|587449730|FG004|Overall Study|Adverse Event|0|||
162654310|NCT01224639|587449731|FG005|Overall Study|Adverse Event|0|||
163117444|NCT03362931|589138110|FG000|Overall Study|Death|2|||
163117445|NCT01998893|589138111|FG000|Overall Study|Adverse Event|2|||
163117446|NCT01998893|589138111|FG000|Overall Study|Death|1|||
163117447|NCT01998893|589138111|FG000|Overall Study|Lost to Follow-up|8|||
163117448|NCT01998893|589138111|FG000|Overall Study|Physician Decision|2|||
163117449|NCT01998893|589138111|FG000|Overall Study|Protocol Violation|2|||
163117450|NCT01998893|589138111|FG000|Overall Study|Withdrawal by Subject|1|||
163117451|NCT01998893|589138111|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
163117452|NCT03276052|589138112|FG000|Overall Study|Withdrawal by Subject|5|||
163117453|NCT03276052|589138112|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
163117454|NCT01994863|589138117|FG000|Period 1|Adverse Event|4|||
163117455|NCT01994863|589138118|FG001|Period 1|Adverse Event|0|||
163117456|NCT01994863|589138117|FG000|Period 1|Withdrawal by Subject|1|||
163117457|NCT01994863|589138118|FG001|Period 1|Withdrawal by Subject|0|||
163117458|NCT01994863|589138117|FG000|Period 1|Trial stopped by sponsor|1|||
163117459|NCT01994863|589138118|FG001|Period 1|Trial stopped by sponsor|3|||
163117460|NCT01994863|589138117|FG000|Period 1|Lack of Efficacy|1|||
163117461|NCT01994863|589138118|FG001|Period 1|Lack of Efficacy|0|||
163117462|NCT01994863|589138117|FG000|Period 2|Adverse Event|0|||
163117463|NCT01994863|589138118|FG001|Period 2|Adverse Event|1|||
163117464|NCT01994863|589138117|FG000|Period 2|Lack of Efficacy|0|||
163117465|NCT01994863|589138118|FG001|Period 2|Lack of Efficacy|2|||
163117466|NCT01994863|589138117|FG000|Period 2|Withdrawal by Subject|1|||
163117467|NCT01994863|589138118|FG001|Period 2|Withdrawal by Subject|1|||
163117468|NCT05136898|589138119|FG000|Overall Study|Adverse Event|2|||
163117469|NCT03784846|589138122|FG000|Pre-COVID Study|Lost to Follow-up|3|||
163117470|NCT03784846|589138123|FG001|Pre-COVID Study|Lost to Follow-up|3|||
163117471|NCT03784846|589138124|FG002|Pre-COVID Study|Lost to Follow-up|2|||
163117472|NCT03784846|589138122|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
163117473|NCT03784846|589138123|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
163117474|NCT03784846|589138124|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
163117475|NCT03784846|589138122|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
163117476|NCT03784846|589138123|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
163117477|NCT03784846|589138124|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
163117478|NCT03784846|589138122|FG000|Post-COVID Study|Lost to Follow-up|3|||
163117479|NCT03784846|589138123|FG001|Post-COVID Study|Lost to Follow-up|5|||
163117480|NCT03784846|589138124|FG002|Post-COVID Study|Lost to Follow-up|1|||
163117481|NCT03784846|589138122|FG000|Post-COVID Study|Withdrawal by Subject|1|||
163117482|NCT03784846|589138123|FG001|Post-COVID Study|Withdrawal by Subject|2|||
163117483|NCT03784846|589138124|FG002|Post-COVID Study|Withdrawal by Subject|0|||
163117484|NCT03054350|589138125|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
163117485|NCT03054350|589138126|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
163117486|NCT03054350|589138127|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
163117487|NCT03054350|589138128|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
163117488|NCT03054350|589138129|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
163117489|NCT03054350|589138130|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
163117490|NCT03054350|589138125|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117491|NCT03054350|589138126|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117492|NCT03054350|589138127|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
163117493|NCT03054350|589138128|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117494|NCT03054350|589138129|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117495|NCT03054350|589138130|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
163117496|NCT03054350|589138125|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
163117497|NCT03054350|589138126|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117498|NCT03054350|589138127|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117499|NCT03054350|589138128|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
163117500|NCT03054350|589138129|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117501|NCT03054350|589138130|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
163117502|NCT03054350|589138125|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117503|NCT03054350|589138126|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117504|NCT03054350|589138127|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
163117505|NCT03054350|589138128|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117506|NCT03054350|589138129|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
162654311|NCT01224639|587449732|FG006|Overall Study|Adverse Event|0|||
162654312|NCT01224639|587449733|FG007|Overall Study|Adverse Event|1|||
162654313|NCT04656132|587449734|FG000|Overall Study|Lost to Follow-up|4|||
162654314|NCT04656132|587449734|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
162654315|NCT04365699|587449735|FG000|Overall Study|Death|2|||
162654316|NCT04365699|587449736|FG001|Overall Study|Death|5|||
162654317|NCT04365699|587449737|FG002|Overall Study|Death|15|||
162654318|NCT00834912|587449739|FG000|Treatment Period 1|Adverse Event|0|||
162654319|NCT00834912|587449740|FG001|Treatment Period 1|Adverse Event|1|||
162654320|NCT00834912|587449741|FG002|Treatment Period 1|Adverse Event|0|||
162654321|NCT00834912|587449742|FG003|Treatment Period 1|Adverse Event|1|||
163117507|NCT03054350|589138130|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
163117508|NCT00931723|589138131|FG000|Overall Study|Withdrawal by Subject|11|||
163117509|NCT00931723|589138132|FG001|Overall Study|Withdrawal by Subject|13|||
163117510|NCT00931723|589138131|FG000|Overall Study|Adverse Event|6|||
163117511|NCT00931723|589138132|FG001|Overall Study|Adverse Event|13|||
163117512|NCT00931723|589138131|FG000|Overall Study|Lithium found in blood|0|||
163117513|NCT00931723|589138132|FG001|Overall Study|Lithium found in blood|1|||
163117514|NCT00931723|589138131|FG000|Overall Study|Condition under investigation worsened|1|||
163117515|NCT00931723|589138132|FG001|Overall Study|Condition under investigation worsened|2|||
163117516|NCT00931723|589138131|FG000|Overall Study|Lost to Follow-up|1|||
163117517|NCT00931723|589138132|FG001|Overall Study|Lost to Follow-up|2|||
163117518|NCT00931723|589138131|FG000|Overall Study|Study-specific discontinuation criteria|1|||
163117519|NCT00931723|589138132|FG001|Overall Study|Study-specific discontinuation criteria|1|||
163117520|NCT00931723|589138131|FG000|Overall Study|Severe non-compliance to protocol|2|||
163117521|NCT00931723|589138132|FG001|Overall Study|Severe non-compliance to protocol|0|||
163117522|NCT00931723|589138131|FG000|Overall Study|Safety reasons|0|||
163117523|NCT00931723|589138132|FG001|Overall Study|Safety reasons|1|||
163117524|NCT00931723|589138131|FG000|Overall Study|Took prohibited concomitant medication|0|||
163117525|NCT00931723|589138132|FG001|Overall Study|Took prohibited concomitant medication|1|||
163117526|NCT00931723|589138131|FG000|Overall Study|Lack or insufficient theraputic response|2|||
163117527|NCT00931723|589138132|FG001|Overall Study|Lack or insufficient theraputic response|5|||
163117528|NCT00931723|589138131|FG000|Overall Study|Sponsor decision|1|||
163117529|NCT00931723|589138132|FG001|Overall Study|Sponsor decision|0|||
163117530|NCT00931723|589138131|FG000|Overall Study|Late hospital discharge|1|||
163117531|NCT00931723|589138132|FG001|Overall Study|Late hospital discharge|0|||
163117532|NCT01643850|589138133|FG000|Overall Study|Withdrawal by Subject|0|||
163117533|NCT01643850|589138134|FG001|Overall Study|Withdrawal by Subject|0|||
163117534|NCT01643850|589138135|FG002|Overall Study|Withdrawal by Subject|0|||
163117535|NCT01643850|589138136|FG003|Overall Study|Withdrawal by Subject|0|||
163117536|NCT01643850|589138137|FG004|Overall Study|Withdrawal by Subject|1|||
163117537|NCT01643850|589138138|FG005|Overall Study|Withdrawal by Subject|0|||
163117538|NCT01643850|589138139|FG006|Overall Study|Withdrawal by Subject|0|||
163117539|NCT01643850|589138140|FG007|Overall Study|Withdrawal by Subject|0|||
162654322|NCT00834912|587449743|FG004|Treatment Period 1|Adverse Event|0|||
162654323|NCT00834912|587449744|FG005|Treatment Period 1|Adverse Event|0|||
163117540|NCT01643850|589138141|FG008|Overall Study|Withdrawal by Subject|0|||
163117541|NCT01643850|589138133|FG000|Overall Study|Lost to Follow-up|0|||
163117542|NCT01643850|589138134|FG001|Overall Study|Lost to Follow-up|0|||
163117543|NCT01643850|589138135|FG002|Overall Study|Lost to Follow-up|0|||
163117544|NCT01643850|589138136|FG003|Overall Study|Lost to Follow-up|0|||
162654324|NCT00834912|587449739|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162654325|NCT00834912|587449740|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162654326|NCT00834912|587449741|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162654327|NCT00834912|587449742|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162654328|NCT00834912|587449743|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162654329|NCT00834912|587449744|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162654330|NCT01399593|587449748|FG000|Overall Study|Physician Decision|1|||
162654331|NCT01399593|587449749|FG001|Overall Study|Physician Decision|0|||
162654332|NCT01399593|587449748|FG000|Overall Study|Adverse Event|1|||
162654333|NCT01399593|587449749|FG001|Overall Study|Adverse Event|0|||
162654334|NCT01399593|587449748|FG000|Overall Study|Death|1|||
162654335|NCT01399593|587449749|FG001|Overall Study|Death|1|||
162654336|NCT01399593|587449748|FG000|Overall Study|Transplantectomy|0|||
162654337|NCT01399593|587449749|FG001|Overall Study|Transplantectomy|1|||
162654338|NCT02357147|587449751|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
162654339|NCT02357147|587449752|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
162654340|NCT02357147|587449751|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
162654341|NCT02357147|587449752|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
162654342|NCT02357147|587449751|FG000|Combination Treatment Phase|Investigator Discretion|1|||
162654343|NCT02357147|587449752|FG001|Combination Treatment Phase|Investigator Discretion|1|||
162654344|NCT02357147|587449751|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
162654345|NCT02357147|587449752|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
162654346|NCT02357147|587449751|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
162654347|NCT02357147|587449752|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
162654348|NCT02357147|587449751|FG000|Combination Treatment Phase|Adverse Event|12|||
162654349|NCT02357147|587449752|FG001|Combination Treatment Phase|Adverse Event|4|||
162654350|NCT02357147|587449751|FG000|Combination Treatment Phase|Death|1|||
162654351|NCT02357147|587449752|FG001|Combination Treatment Phase|Death|1|||
162654352|NCT02357147|587449751|FG000|Combination Treatment Phase|Sponsor Decision|0|||
162654353|NCT02357147|587449752|FG001|Combination Treatment Phase|Sponsor Decision|12|||
162654354|NCT02357147|587449751|FG000|Combination Treatment Phase|Other|1|||
162654355|NCT02357147|587449752|FG001|Combination Treatment Phase|Other|0|||
162654356|NCT02357147|587449751|FG000|Combination Treatment Phase|Not treated|0|||
162654357|NCT02357147|587449752|FG001|Combination Treatment Phase|Not treated|2|||
162654358|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
162654359|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
162654360|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162654361|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
162654362|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
162654363|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
162654364|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162654365|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Adverse Event|3|||
162654366|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
162654367|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
162654368|NCT02357147|587449751|FG000|Maintenance Treatment Phase|Not Treated|1|||
162654369|NCT02357147|587449752|FG001|Maintenance Treatment Phase|Not Treated|0|||
162654370|NCT01012817|587451544|FG000|Overall Study|Withdrawal by Subject|0|||
162654371|NCT01012817|587451545|FG001|Overall Study|Withdrawal by Subject|0|||
162654372|NCT01012817|587451546|FG002|Overall Study|Withdrawal by Subject|0|||
162654373|NCT01012817|587451547|FG003|Overall Study|Withdrawal by Subject|1|||
162654374|NCT01012817|587451548|FG004|Overall Study|Withdrawal by Subject|0|||
163117545|NCT01643850|589138137|FG004|Overall Study|Lost to Follow-up|0|||
163117546|NCT01643850|589138138|FG005|Overall Study|Lost to Follow-up|0|||
163117547|NCT01643850|589138139|FG006|Overall Study|Lost to Follow-up|1|||
163117548|NCT01643850|589138140|FG007|Overall Study|Lost to Follow-up|0|||
163117549|NCT01643850|589138141|FG008|Overall Study|Lost to Follow-up|1|||
163117550|NCT01643850|589138133|FG000|Overall Study|Adverse Event|0|||
163117551|NCT01643850|589138134|FG001|Overall Study|Adverse Event|0|||
163117552|NCT01643850|589138135|FG002|Overall Study|Adverse Event|0|||
163117553|NCT01643850|589138136|FG003|Overall Study|Adverse Event|0|||
163117554|NCT01643850|589138137|FG004|Overall Study|Adverse Event|1|||
163117555|NCT01643850|589138138|FG005|Overall Study|Adverse Event|0|||
163117556|NCT01643850|589138139|FG006|Overall Study|Adverse Event|0|||
163117557|NCT01643850|589138140|FG007|Overall Study|Adverse Event|0|||
163117558|NCT01643850|589138141|FG008|Overall Study|Adverse Event|0|||
162654375|NCT01012817|587451549|FG005|Overall Study|Withdrawal by Subject|0|||
162654376|NCT01012817|587451550|FG006|Overall Study|Withdrawal by Subject|0|||
162654377|NCT01012817|587451551|FG007|Overall Study|Withdrawal by Subject|1|||
162654378|NCT01012817|587451552|FG008|Overall Study|Withdrawal by Subject|0|||
162654379|NCT01012817|587451553|FG009|Overall Study|Withdrawal by Subject|0|||
162654380|NCT01012817|587451554|FG010|Overall Study|Withdrawal by Subject|1|||
162654381|NCT01012817|587451555|FG011|Overall Study|Withdrawal by Subject|1|||
163117559|NCT01643850|589138133|FG000|Overall Study|Administrative Problems|0|||
163117560|NCT01643850|589138134|FG001|Overall Study|Administrative Problems|0|||
163117561|NCT01643850|589138135|FG002|Overall Study|Administrative Problems|1|||
162654382|NCT01012817|587451556|FG012|Overall Study|Withdrawal by Subject|0|||
162654383|NCT01012817|587451557|FG013|Overall Study|Withdrawal by Subject|1|||
162654384|NCT01012817|587451544|FG000|Overall Study|Adverse Event|0|||
162654385|NCT01012817|587451545|FG001|Overall Study|Adverse Event|0|||
162654386|NCT01012817|587451546|FG002|Overall Study|Adverse Event|0|||
162654387|NCT01012817|587451547|FG003|Overall Study|Adverse Event|0|||
162654388|NCT01012817|587451548|FG004|Overall Study|Adverse Event|0|||
162654389|NCT01012817|587451549|FG005|Overall Study|Adverse Event|1|||
162654390|NCT01012817|587451550|FG006|Overall Study|Adverse Event|0|||
162654391|NCT01012817|587451551|FG007|Overall Study|Adverse Event|0|||
163117562|NCT01643850|589138136|FG003|Overall Study|Administrative Problems|0|||
163117563|NCT01643850|589138137|FG004|Overall Study|Administrative Problems|1|||
163117564|NCT01643850|589138138|FG005|Overall Study|Administrative Problems|0|||
163117565|NCT01643850|589138139|FG006|Overall Study|Administrative Problems|0|||
163117566|NCT01643850|589138140|FG007|Overall Study|Administrative Problems|0|||
163117567|NCT01643850|589138141|FG008|Overall Study|Administrative Problems|0|||
163117568|NCT01133405|589138142|FG000|Period 1|Withdrawal by Subject|0|||
163117569|NCT01133405|589138143|FG001|Period 1|Withdrawal by Subject|1|||
163117570|NCT01133405|589138144|FG002|Period 1|Withdrawal by Subject|0|||
163117571|NCT01133405|589138145|FG003|Period 1|Withdrawal by Subject|1|||
163117572|NCT01133405|589138146|FG004|Period 1|Withdrawal by Subject|0|||
163117573|NCT01133405|589138147|FG005|Period 1|Withdrawal by Subject|1|||
163117574|NCT01133405|589138148|FG006|Period 1|Withdrawal by Subject|0|||
163117575|NCT01133405|589138149|FG007|Period 1|Withdrawal by Subject|0|||
163117576|NCT01133405|589138150|FG008|Period 1|Withdrawal by Subject|0|||
163117577|NCT01133405|589138151|FG009|Period 1|Withdrawal by Subject|0|||
163117578|NCT01133405|589138142|FG000|Period 1|Physician Decision|0|||
163117579|NCT01133405|589138143|FG001|Period 1|Physician Decision|0|||
163117580|NCT01133405|589138144|FG002|Period 1|Physician Decision|0|||
163117581|NCT01133405|589138145|FG003|Period 1|Physician Decision|1|||
163117582|NCT01133405|589138146|FG004|Period 1|Physician Decision|0|||
163117583|NCT01133405|589138147|FG005|Period 1|Physician Decision|0|||
163117584|NCT01133405|589138148|FG006|Period 1|Physician Decision|0|||
163117585|NCT01133405|589138149|FG007|Period 1|Physician Decision|0|||
163117586|NCT01133405|589138150|FG008|Period 1|Physician Decision|0|||
163117587|NCT01133405|589138151|FG009|Period 1|Physician Decision|0|||
163117588|NCT01133405|589138142|FG000|Period 1|Discontinued after randomization|1|||
163117589|NCT01133405|589138143|FG001|Period 1|Discontinued after randomization|0|||
163117590|NCT01133405|589138144|FG002|Period 1|Discontinued after randomization|0|||
163117591|NCT01133405|589138145|FG003|Period 1|Discontinued after randomization|0|||
163117592|NCT01133405|589138146|FG004|Period 1|Discontinued after randomization|0|||
163117593|NCT01133405|589138147|FG005|Period 1|Discontinued after randomization|0|||
163117594|NCT01133405|589138148|FG006|Period 1|Discontinued after randomization|1|||
163117595|NCT01133405|589138149|FG007|Period 1|Discontinued after randomization|0|||
163117596|NCT01133405|589138150|FG008|Period 1|Discontinued after randomization|0|||
163117597|NCT01133405|589138151|FG009|Period 1|Discontinued after randomization|0|||
163117598|NCT01133405|589138142|FG000|Period 1|Received drug only in period 2|0|||
163117599|NCT01133405|589138143|FG001|Period 1|Received drug only in period 2|1|||
163117600|NCT01133405|589138144|FG002|Period 1|Received drug only in period 2|0|||
163117601|NCT01133405|589138145|FG003|Period 1|Received drug only in period 2|2|||
163117602|NCT01133405|589138146|FG004|Period 1|Received drug only in period 2|0|||
163117603|NCT01133405|589138147|FG005|Period 1|Received drug only in period 2|1|||
163117604|NCT01133405|589138148|FG006|Period 1|Received drug only in period 2|0|||
163117605|NCT01133405|589138149|FG007|Period 1|Received drug only in period 2|0|||
163117606|NCT01133405|589138150|FG008|Period 1|Received drug only in period 2|0|||
163117607|NCT01133405|589138151|FG009|Period 1|Received drug only in period 2|0|||
163117608|NCT01133405|589138142|FG000|Period 1|Received drug only in period 3|0|||
163117609|NCT01133405|589138143|FG001|Period 1|Received drug only in period 3|1|||
163117610|NCT01133405|589138144|FG002|Period 1|Received drug only in period 3|1|||
163117611|NCT01133405|589138145|FG003|Period 1|Received drug only in period 3|0|||
163117612|NCT01133405|589138146|FG004|Period 1|Received drug only in period 3|0|||
163117613|NCT01133405|589138147|FG005|Period 1|Received drug only in period 3|0|||
163117614|NCT01133405|589138148|FG006|Period 1|Received drug only in period 3|0|||
163117615|NCT01133405|589138149|FG007|Period 1|Received drug only in period 3|0|||
163117616|NCT01133405|589138150|FG008|Period 1|Received drug only in period 3|0|||
163117617|NCT01133405|589138151|FG009|Period 1|Received drug only in period 3|0|||
163117618|NCT01133405|589138142|FG000|Period 2|Adverse Event|0|||
163117619|NCT01133405|589138143|FG001|Period 2|Adverse Event|0|||
163117620|NCT01133405|589138144|FG002|Period 2|Adverse Event|1|||
163117621|NCT01133405|589138145|FG003|Period 2|Adverse Event|0|||
163117622|NCT01133405|589138146|FG004|Period 2|Adverse Event|0|||
162654392|NCT01012817|587451552|FG008|Overall Study|Adverse Event|0|||
163117623|NCT01133405|589138147|FG005|Period 2|Adverse Event|0|||
163117624|NCT01133405|589138148|FG006|Period 2|Adverse Event|0|||
162654393|NCT01012817|587451553|FG009|Overall Study|Adverse Event|0|||
162654394|NCT01012817|587451554|FG010|Overall Study|Adverse Event|1|||
162654395|NCT01012817|587451555|FG011|Overall Study|Adverse Event|0|||
163117625|NCT01133405|589138149|FG007|Period 2|Adverse Event|0|||
163117626|NCT01133405|589138150|FG008|Period 2|Adverse Event|0|||
163117627|NCT01133405|589138151|FG009|Period 2|Adverse Event|0|||
163117628|NCT01133405|589138142|FG000|Period 2|Withdrawal by Subject|0|||
163117629|NCT01133405|589138143|FG001|Period 2|Withdrawal by Subject|0|||
163117630|NCT01133405|589138144|FG002|Period 2|Withdrawal by Subject|0|||
163117631|NCT01133405|589138145|FG003|Period 2|Withdrawal by Subject|1|||
163117632|NCT01133405|589138146|FG004|Period 2|Withdrawal by Subject|0|||
163117633|NCT01133405|589138147|FG005|Period 2|Withdrawal by Subject|1|||
163117634|NCT01133405|589138148|FG006|Period 2|Withdrawal by Subject|0|||
163117635|NCT01133405|589138149|FG007|Period 2|Withdrawal by Subject|0|||
163117636|NCT01133405|589138150|FG008|Period 2|Withdrawal by Subject|0|||
163117637|NCT01133405|589138151|FG009|Period 2|Withdrawal by Subject|0|||
163117638|NCT01133405|589138142|FG000|Period 2|Entry Criteria Not Met|0|||
163117639|NCT01133405|589138143|FG001|Period 2|Entry Criteria Not Met|1|||
163117640|NCT01133405|589138144|FG002|Period 2|Entry Criteria Not Met|0|||
163117641|NCT01133405|589138145|FG003|Period 2|Entry Criteria Not Met|0|||
163117642|NCT01133405|589138146|FG004|Period 2|Entry Criteria Not Met|0|||
163117643|NCT01133405|589138147|FG005|Period 2|Entry Criteria Not Met|0|||
163117644|NCT01133405|589138148|FG006|Period 2|Entry Criteria Not Met|0|||
163117645|NCT01133405|589138149|FG007|Period 2|Entry Criteria Not Met|0|||
163117646|NCT01133405|589138150|FG008|Period 2|Entry Criteria Not Met|0|||
163117647|NCT01133405|589138151|FG009|Period 2|Entry Criteria Not Met|0|||
163117648|NCT01133405|589138142|FG000|Period 2|Physician Decision|0|||
163117649|NCT01133405|589138143|FG001|Period 2|Physician Decision|0|||
163117650|NCT01133405|589138144|FG002|Period 2|Physician Decision|0|||
163117651|NCT01133405|589138145|FG003|Period 2|Physician Decision|0|||
163117652|NCT01133405|589138146|FG004|Period 2|Physician Decision|0|||
163117653|NCT01133405|589138147|FG005|Period 2|Physician Decision|1|||
163117654|NCT01133405|589138148|FG006|Period 2|Physician Decision|0|||
163117655|NCT01133405|589138149|FG007|Period 2|Physician Decision|0|||
163117656|NCT01133405|589138150|FG008|Period 2|Physician Decision|0|||
163117657|NCT01133405|589138151|FG009|Period 2|Physician Decision|0|||
163117658|NCT00867087|589138154|FG000|Overall Study|Other|1|||
163117659|NCT00867087|589138154|FG000|Overall Study|Withdrawal by Subject|4|||
163117660|NCT00867087|589138154|FG000|Overall Study|Death|37|||
163117661|NCT03300024|589138155|FG000|Overall Study|Physician Decision|4|||
163117662|NCT03300024|589138156|FG001|Overall Study|Physician Decision|6|||
163117663|NCT01238835|589138157|FG000|Overall Study|Death|124|||
163117664|NCT01238835|589138157|FG000|Overall Study|Withdrawal by Subject|9|||
163117665|NCT01238835|589138157|FG000|Overall Study|Lost to Follow-up|1|||
163117666|NCT01238835|589138157|FG000|Overall Study|Site early discontinuation|2|||
163117667|NCT02088073|589138158|FG000|Acute Phase|Withdrawal by Subject|5|||
163117668|NCT02088073|589138159|FG001|Acute Phase|Withdrawal by Subject|0|||
163117669|NCT02088073|589138160|FG002|Acute Phase|Withdrawal by Subject|0|||
163117670|NCT02088073|589138161|FG003|Acute Phase|Withdrawal by Subject|0|||
163117671|NCT02088073|589138162|FG004|Acute Phase|Withdrawal by Subject|0|||
163117672|NCT02088073|589138158|FG000|Acute Phase|Hyperkalemia|2|||
163117673|NCT02088073|589138159|FG001|Acute Phase|Hyperkalemia|0|||
163117674|NCT02088073|589138160|FG002|Acute Phase|Hyperkalemia|0|||
163117675|NCT02088073|589138161|FG003|Acute Phase|Hyperkalemia|0|||
163117676|NCT02088073|589138162|FG004|Acute Phase|Hyperkalemia|0|||
163117677|NCT02088073|589138158|FG000|Maintanance Phase|Withdrawal by Subject|0|||
163117678|NCT02088073|589138159|FG001|Maintanance Phase|Withdrawal by Subject|2|||
163117679|NCT02088073|589138160|FG002|Maintanance Phase|Withdrawal by Subject|0|||
163117680|NCT02088073|589138161|FG003|Maintanance Phase|Withdrawal by Subject|0|||
163117681|NCT02088073|589138162|FG004|Maintanance Phase|Withdrawal by Subject|0|||
163117682|NCT02088073|589138158|FG000|Maintanance Phase|Adverse Event|0|||
163117683|NCT02088073|589138159|FG001|Maintanance Phase|Adverse Event|0|||
163117684|NCT02088073|589138160|FG002|Maintanance Phase|Adverse Event|3|||
163117685|NCT02088073|589138161|FG003|Maintanance Phase|Adverse Event|0|||
163117686|NCT02088073|589138162|FG004|Maintanance Phase|Adverse Event|1|||
163117687|NCT02088073|589138158|FG000|Maintanance Phase|Physician Decision|0|||
163117688|NCT02088073|589138159|FG001|Maintanance Phase|Physician Decision|0|||
163117689|NCT02088073|589138160|FG002|Maintanance Phase|Physician Decision|0|||
163117690|NCT02088073|589138161|FG003|Maintanance Phase|Physician Decision|0|||
163117691|NCT02088073|589138162|FG004|Maintanance Phase|Physician Decision|1|||
163117692|NCT02088073|589138158|FG000|Maintanance Phase|Sponsor's decision|0|||
163117693|NCT02088073|589138159|FG001|Maintanance Phase|Sponsor's decision|2|||
163117694|NCT02088073|589138160|FG002|Maintanance Phase|Sponsor's decision|0|||
163117695|NCT02088073|589138161|FG003|Maintanance Phase|Sponsor's decision|2|||
163117696|NCT02088073|589138162|FG004|Maintanance Phase|Sponsor's decision|1|||
163117697|NCT02088073|589138158|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
163117698|NCT02088073|589138159|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
163117699|NCT02088073|589138160|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
163117700|NCT02088073|589138161|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
163117701|NCT02088073|589138162|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
163117702|NCT02088073|589138158|FG000|Maintanance Phase|Miscellaneous|0|||
163117703|NCT02088073|589138159|FG001|Maintanance Phase|Miscellaneous|2|||
163117704|NCT02088073|589138160|FG002|Maintanance Phase|Miscellaneous|1|||
163117705|NCT02088073|589138161|FG003|Maintanance Phase|Miscellaneous|2|||
163117706|NCT02088073|589138162|FG004|Maintanance Phase|Miscellaneous|1|||
163117707|NCT02088073|589138158|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117708|NCT02088073|589138159|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117709|NCT02088073|589138160|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
163117710|NCT02088073|589138161|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
163117711|NCT02088073|589138162|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
163117712|NCT02088073|589138158|FG000|Maintanance Phase|Subject compliance|0|||
163117713|NCT02088073|589138159|FG001|Maintanance Phase|Subject compliance|1|||
163117714|NCT02088073|589138160|FG002|Maintanance Phase|Subject compliance|0|||
163117715|NCT02088073|589138161|FG003|Maintanance Phase|Subject compliance|0|||
162654396|NCT01012817|587451556|FG012|Overall Study|Adverse Event|0|||
163117716|NCT02088073|589138162|FG004|Maintanance Phase|Subject compliance|0|||
163117717|NCT02419131|589138163|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
163117718|NCT02419131|589138164|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
163117719|NCT02419131|589138165|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
163117720|NCT02419131|589138163|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
163117721|NCT02419131|589138164|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
163117722|NCT02419131|589138165|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
163117723|NCT02969590|589138171|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
163117724|NCT02969590|589138172|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
163117725|NCT02969590|589138173|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
163117726|NCT00681564|589138175|FG000|Overall Study|Lost to Follow-up|6|||
163117727|NCT00681564|589138176|FG001|Overall Study|Lost to Follow-up|6|||
163117728|NCT00681564|589138175|FG000|Overall Study|Withdrawal by Subject|0|||
163117729|NCT00681564|589138176|FG001|Overall Study|Withdrawal by Subject|1|||
163117730|NCT00681564|589138175|FG000|Overall Study|Death|0|||
163117731|NCT00681564|589138176|FG001|Overall Study|Death|1|||
163117732|NCT02370641|589138177|FG000|Overall Study|dropped study|4|||
163117733|NCT02370641|589138178|FG001|Overall Study|dropped study|2|||
163117734|NCT01719003|589138180|FG000|Overall Study|Non compliant with protocol|1|||
163117735|NCT01719003|589138181|FG001|Overall Study|Non compliant with protocol|1|||
163117736|NCT01719003|589138182|FG002|Overall Study|Non compliant with protocol|0|||
163117737|NCT01719003|589138183|FG003|Overall Study|Non compliant with protocol|1|||
163117738|NCT01719003|589138184|FG004|Overall Study|Non compliant with protocol|2|||
163117739|NCT01719003|589138185|FG005|Overall Study|Non compliant with protocol|1|||
163117740|NCT01719003|589138186|FG006|Overall Study|Non compliant with protocol|2|||
163117741|NCT01719003|589138187|FG007|Overall Study|Non compliant with protocol|3|||
163117742|NCT01719003|589138188|FG008|Overall Study|Non compliant with protocol|0|||
163117743|NCT01719003|589138180|FG000|Overall Study|Adverse Event|6|||
163117744|NCT01719003|589138181|FG001|Overall Study|Adverse Event|5|||
163117745|NCT01719003|589138182|FG002|Overall Study|Adverse Event|4|||
163117746|NCT01719003|589138183|FG003|Overall Study|Adverse Event|3|||
163117747|NCT01719003|589138184|FG004|Overall Study|Adverse Event|4|||
163117748|NCT01719003|589138185|FG005|Overall Study|Adverse Event|3|||
163117749|NCT01719003|589138186|FG006|Overall Study|Adverse Event|6|||
163117750|NCT01719003|589138187|FG007|Overall Study|Adverse Event|5|||
163117751|NCT01719003|589138188|FG008|Overall Study|Adverse Event|0|||
163117752|NCT01719003|589138180|FG000|Overall Study|Lost to Follow-up|0|||
163117753|NCT01719003|589138181|FG001|Overall Study|Lost to Follow-up|6|||
163117754|NCT01719003|589138182|FG002|Overall Study|Lost to Follow-up|7|||
163117755|NCT01719003|589138183|FG003|Overall Study|Lost to Follow-up|2|||
163117756|NCT01719003|589138184|FG004|Overall Study|Lost to Follow-up|3|||
163117757|NCT01719003|589138185|FG005|Overall Study|Lost to Follow-up|4|||
163117758|NCT01719003|589138186|FG006|Overall Study|Lost to Follow-up|3|||
163117759|NCT01719003|589138187|FG007|Overall Study|Lost to Follow-up|2|||
163117760|NCT01719003|589138188|FG008|Overall Study|Lost to Follow-up|2|||
163117761|NCT01719003|589138180|FG000|Overall Study|Refusal to continue, not due to AE|2|||
162654397|NCT01012817|587451557|FG013|Overall Study|Adverse Event|1|||
162654398|NCT00634647|587451558|FG000|Overall Study|death on study|3|||
162654399|NCT00634647|587451558|FG000|Overall Study|refused further treatment|3|||
162654400|NCT00634647|587451558|FG000|Overall Study|declined to participate before treatment|1|||
162654401|NCT05723770|587451559|FG000|Overall Study|Lost to Follow-up|4|||
162654402|NCT05723770|587451559|FG000|Overall Study|Withdrawal by Subject|2|||
162654403|NCT02365636|587451560|FG000|Overall Study|Adverse Event|3|||
162654404|NCT02365636|587451561|FG001|Overall Study|Adverse Event|3|||
162654405|NCT02365636|587451562|FG002|Overall Study|Adverse Event|2|||
162654406|NCT02365636|587451560|FG000|Overall Study|Protocol Violation|1|||
162654407|NCT02365636|587451561|FG001|Overall Study|Protocol Violation|4|||
162654408|NCT02365636|587451562|FG002|Overall Study|Protocol Violation|0|||
162654409|NCT02365636|587451560|FG000|Overall Study|Lost to Follow-up|0|||
162654410|NCT02365636|587451561|FG001|Overall Study|Lost to Follow-up|0|||
162654411|NCT02365636|587451562|FG002|Overall Study|Lost to Follow-up|1|||
162654412|NCT02365636|587451560|FG000|Overall Study|Other|2|||
162654413|NCT02365636|587451561|FG001|Overall Study|Other|0|||
162654414|NCT02365636|587451562|FG002|Overall Study|Other|0|||
162654415|NCT03912233|587451563|FG000|Overall Study|Adverse Event|1|||
162654416|NCT03912233|587451564|FG001|Overall Study|Adverse Event|0|||
162654417|NCT03912233|587451565|FG002|Overall Study|Adverse Event|0|||
162654418|NCT03912233|587451566|FG003|Overall Study|Adverse Event|0|||
162654419|NCT03912233|587451567|FG004|Overall Study|Adverse Event|0|||
162654420|NCT03912233|587451568|FG005|Overall Study|Adverse Event|0|||
162654421|NCT03912233|587451563|FG000|Overall Study|Physician Decision|1|||
162654422|NCT03912233|587451564|FG001|Overall Study|Physician Decision|0|||
162654423|NCT03912233|587451565|FG002|Overall Study|Physician Decision|0|||
162654424|NCT03912233|587451566|FG003|Overall Study|Physician Decision|0|||
162654425|NCT03912233|587451567|FG004|Overall Study|Physician Decision|0|||
162654426|NCT03912233|587451568|FG005|Overall Study|Physician Decision|0|||
162654427|NCT03912233|587451563|FG000|Overall Study|Other|0|||
162654428|NCT03912233|587451564|FG001|Overall Study|Other|0|||
162654429|NCT03912233|587451565|FG002|Overall Study|Other|0|||
163117762|NCT01719003|589138181|FG001|Overall Study|Refusal to continue, not due to AE|5|||
163117763|NCT01719003|589138182|FG002|Overall Study|Refusal to continue, not due to AE|4|||
163117764|NCT01719003|589138183|FG003|Overall Study|Refusal to continue, not due to AE|4|||
163117765|NCT01719003|589138184|FG004|Overall Study|Refusal to continue, not due to AE|4|||
163117766|NCT01719003|589138185|FG005|Overall Study|Refusal to continue, not due to AE|3|||
163117767|NCT01719003|589138186|FG006|Overall Study|Refusal to continue, not due to AE|8|||
163117768|NCT01719003|589138187|FG007|Overall Study|Refusal to continue, not due to AE|7|||
163117769|NCT01719003|589138188|FG008|Overall Study|Refusal to continue, not due to AE|1|||
163117770|NCT01719003|589138180|FG000|Overall Study|Reason other than those specified|0|||
163117771|NCT01719003|589138181|FG001|Overall Study|Reason other than those specified|0|||
163117772|NCT01719003|589138182|FG002|Overall Study|Reason other than those specified|2|||
163117773|NCT01719003|589138183|FG003|Overall Study|Reason other than those specified|3|||
163117774|NCT01719003|589138184|FG004|Overall Study|Reason other than those specified|4|||
163117775|NCT01719003|589138185|FG005|Overall Study|Reason other than those specified|1|||
163117776|NCT01719003|589138186|FG006|Overall Study|Reason other than those specified|0|||
163117777|NCT01719003|589138187|FG007|Overall Study|Reason other than those specified|3|||
163117778|NCT01719003|589138188|FG008|Overall Study|Reason other than those specified|1|||
163117779|NCT01719003|589138180|FG000|Overall Study|Lack of Efficacy|0|||
163117780|NCT01719003|589138181|FG001|Overall Study|Lack of Efficacy|0|||
163117781|NCT01719003|589138182|FG002|Overall Study|Lack of Efficacy|0|||
163117782|NCT01719003|589138183|FG003|Overall Study|Lack of Efficacy|0|||
163117783|NCT01719003|589138184|FG004|Overall Study|Lack of Efficacy|0|||
163117784|NCT01719003|589138185|FG005|Overall Study|Lack of Efficacy|0|||
163117785|NCT01719003|589138186|FG006|Overall Study|Lack of Efficacy|1|||
163117786|NCT01719003|589138187|FG007|Overall Study|Lack of Efficacy|0|||
163117787|NCT01719003|589138188|FG008|Overall Study|Lack of Efficacy|0|||
163117788|NCT02370095|589138189|FG000|Overall Study|Withdrawal by Subject|0|||
163117789|NCT02370095|589138190|FG001|Overall Study|Withdrawal by Subject|1|||
163117790|NCT00700102|589138191|FG000|Overall Study|Died|394|||
163117791|NCT00700102|589138192|FG001|Overall Study|Died|385|||
163117792|NCT00700102|589138191|FG000|Overall Study|Lost to Follow-up|8|||
163117793|NCT00700102|589138192|FG001|Overall Study|Lost to Follow-up|10|||
163117794|NCT01667562|589138193|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
162654430|NCT03912233|587451566|FG003|Overall Study|Other|0|||
163117795|NCT01667562|589138194|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
163117796|NCT01667562|589138193|FG000|Erlotinib Phase|Lost to Follow-up|0|||
162654431|NCT03912233|587451567|FG004|Overall Study|Other|7|||
162654432|NCT03912233|587451568|FG005|Overall Study|Other|12|||
163117797|NCT01667562|589138194|FG001|Erlotinib Phase|Lost to Follow-up|1|||
163117798|NCT01667562|589138193|FG000|Erlotinib Phase|Adverse Event|0|||
163117799|NCT01667562|589138194|FG001|Erlotinib Phase|Adverse Event|1|||
163117800|NCT01667562|589138193|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
163117801|NCT01667562|589138194|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
163117802|NCT02130986|589138195|FG000|Overall Study|Withdrawal by Subject|4|||
163117803|NCT02130986|589138196|FG001|Overall Study|Withdrawal by Subject|4|||
163117804|NCT02130986|589138195|FG000|Overall Study|Lost to Follow-up|151|||
163117805|NCT02130986|589138196|FG001|Overall Study|Lost to Follow-up|160|||
163117806|NCT01129882|589138197|FG000|Overall Study|Adverse Event|39|||
163117807|NCT01129882|589138197|FG000|Overall Study|Death|6|||
163117808|NCT01129882|589138197|FG000|Overall Study|Lack of Efficacy|5|||
163117809|NCT01129882|589138197|FG000|Overall Study|Lost to Follow-up|13|||
163117810|NCT01129882|589138197|FG000|Overall Study|Physician Decision|27|||
163117811|NCT01129882|589138197|FG000|Overall Study|Protocol Deviation|3|||
163117812|NCT01129882|589138197|FG000|Overall Study|Withdrawal Criteria Met|19|||
163117813|NCT01129882|589138197|FG000|Overall Study|Trial Termination by Sponsor|6|||
163117814|NCT01129882|589138197|FG000|Overall Study|Withdrawal by Subject|160|||
163117815|NCT01028716|589138198|FG000|Overall Study|Physician Decision|1|||
163117816|NCT00762996|589138199|FG000|Period One|Protocol Violation|0|||
163117817|NCT00762996|589138200|FG001|Period One|Protocol Violation|0|||
163117818|NCT00762996|589138201|FG002|Period One|Protocol Violation|1|||
163117819|NCT00762996|589138202|FG003|Period One|Protocol Violation|0|||
163117820|NCT00762996|589138199|FG000|Period One|ineligible|0|||
163117821|NCT00762996|589138200|FG001|Period One|ineligible|0|||
163117822|NCT00762996|589138201|FG002|Period One|ineligible|1|||
163117823|NCT00762996|589138202|FG003|Period One|ineligible|1|||
163117824|NCT00762996|589138199|FG000|Period One|Adverse Event|0|||
163117825|NCT00762996|589138200|FG001|Period One|Adverse Event|0|||
163117826|NCT00762996|589138201|FG002|Period One|Adverse Event|1|||
163117827|NCT00762996|589138202|FG003|Period One|Adverse Event|0|||
163117828|NCT00762996|589138199|FG000|Period One|Withdrawal by Subject|0|||
163117829|NCT00762996|589138200|FG001|Period One|Withdrawal by Subject|0|||
163117830|NCT00762996|589138201|FG002|Period One|Withdrawal by Subject|1|||
163117831|NCT00762996|589138202|FG003|Period One|Withdrawal by Subject|0|||
163117832|NCT00657150|589138204|FG000|Overall Study|Adverse Event|19|||
163117833|NCT00657150|589138205|FG001|Overall Study|Adverse Event|10|||
163117834|NCT00657150|589138204|FG000|Overall Study|Non-compliant with protocol|5|||
163117835|NCT00657150|589138205|FG001|Overall Study|Non-compliant with protocol|9|||
163117836|NCT00657150|589138204|FG000|Overall Study|Lost to Follow-up|2|||
163117837|NCT00657150|589138205|FG001|Overall Study|Lost to Follow-up|0|||
163117838|NCT00657150|589138204|FG000|Overall Study|Withdrawal by Subject|51|||
163117839|NCT00657150|589138205|FG001|Overall Study|Withdrawal by Subject|36|||
163117840|NCT00657150|589138204|FG000|Overall Study|Other|38|||
163117841|NCT00657150|589138205|FG001|Overall Study|Other|38|||
163117842|NCT00657150|589138204|FG000|Treatment|Adverse Event|60|||
163117843|NCT00657150|589138205|FG001|Treatment|Adverse Event|53|||
163117844|NCT00657150|589138204|FG000|Treatment|Non-compliant with protocol|10|||
163117845|NCT00657150|589138205|FG001|Treatment|Non-compliant with protocol|9|||
163117846|NCT00657150|589138204|FG000|Treatment|Lost to Follow-up|1|||
163117847|NCT00657150|589138205|FG001|Treatment|Lost to Follow-up|0|||
163117848|NCT00657150|589138204|FG000|Treatment|Withdrawal by Subject|23|||
163117849|NCT00657150|589138205|FG001|Treatment|Withdrawal by Subject|20|||
163117850|NCT00657150|589138204|FG000|Treatment|Other|13|||
163117851|NCT00657150|589138205|FG001|Treatment|Other|15|||
163117852|NCT01319721|589138213|FG000|Overall Study|Lost to Follow-up|1|||
163117853|NCT01319721|589138214|FG001|Overall Study|Lost to Follow-up|6|||
163117854|NCT02653495|589138215|FG000|Overall Study|Lost to Follow-up|2|||
163117855|NCT02653495|589138216|FG001|Overall Study|Lost to Follow-up|0|||
163117856|NCT02653495|589138215|FG000|Overall Study|Screening Failure|10|||
163117857|NCT02653495|589138216|FG001|Overall Study|Screening Failure|0|||
162654433|NCT02583256|587451571|FG000|Overall Study|Withdrawal by Subject|0|||
162654434|NCT02583256|587451572|FG001|Overall Study|Withdrawal by Subject|1|||
162654435|NCT02583256|587451573|FG002|Overall Study|Withdrawal by Subject|1|||
162654436|NCT02583256|587451574|FG003|Overall Study|Withdrawal by Subject|0|||
162654437|NCT02583256|587451571|FG000|Overall Study|Lost to Follow-up|1|||
163117858|NCT00468845|589138217|FG000|Overall Study|Adverse Event|9|||
163117859|NCT00468845|589138218|FG001|Overall Study|Adverse Event|14|||
163117860|NCT00468845|589138219|FG002|Overall Study|Adverse Event|11|||
163117861|NCT00468845|589138217|FG000|Overall Study|Lost to Follow-up|2|||
163117862|NCT00468845|589138218|FG001|Overall Study|Lost to Follow-up|1|||
163117863|NCT00468845|589138219|FG002|Overall Study|Lost to Follow-up|2|||
163117864|NCT00468845|589138217|FG000|Overall Study|Other|4|||
163117865|NCT00468845|589138218|FG001|Overall Study|Other|9|||
163117866|NCT00468845|589138219|FG002|Overall Study|Other|5|||
163117867|NCT00468845|589138217|FG000|Overall Study|No longer willing to participate|5|||
163117868|NCT00468845|589138218|FG001|Overall Study|No longer willing to participate|6|||
163117869|NCT00468845|589138219|FG002|Overall Study|No longer willing to participate|10|||
163117870|NCT00468845|589138217|FG000|Overall Study|Randomized, not treated|1|||
163117871|NCT00468845|589138218|FG001|Overall Study|Randomized, not treated|4|||
163117872|NCT00468845|589138219|FG002|Overall Study|Randomized, not treated|2|||
163117873|NCT02761694|589138220|FG000|Overall Study|Lack of Efficacy|0|||
163117874|NCT02761694|589138221|FG001|Overall Study|Lack of Efficacy|0|||
163117875|NCT02761694|589138222|FG002|Overall Study|Lack of Efficacy|0|||
163117876|NCT02761694|589138223|FG003|Overall Study|Lack of Efficacy|0|||
163117877|NCT02761694|589138224|FG004|Overall Study|Lack of Efficacy|0|||
163117878|NCT02761694|589138225|FG005|Overall Study|Lack of Efficacy|0|||
163117879|NCT02761694|589138226|FG006|Overall Study|Lack of Efficacy|6|||
163117880|NCT02761694|589138227|FG007|Overall Study|Lack of Efficacy|0|||
163117881|NCT02761694|589138228|FG008|Overall Study|Lack of Efficacy|0|||
163117882|NCT02761694|589138229|FG009|Overall Study|Lack of Efficacy|1|||
163117883|NCT02761694|589138230|FG010|Overall Study|Lack of Efficacy|1|||
163117884|NCT02761694|589138231|FG011|Overall Study|Lack of Efficacy|4|||
163117885|NCT02761694|589138220|FG000|Overall Study|Death|0|||
163117886|NCT02761694|589138221|FG001|Overall Study|Death|0|||
163117887|NCT02761694|589138222|FG002|Overall Study|Death|0|||
163117888|NCT02761694|589138223|FG003|Overall Study|Death|0|||
163117889|NCT02761694|589138224|FG004|Overall Study|Death|0|||
163117890|NCT02761694|589138225|FG005|Overall Study|Death|0|||
163117891|NCT02761694|589138226|FG006|Overall Study|Death|2|||
163117892|NCT02761694|589138227|FG007|Overall Study|Death|0|||
163117893|NCT02761694|589138228|FG008|Overall Study|Death|2|||
163117894|NCT02761694|589138229|FG009|Overall Study|Death|2|||
163117895|NCT02761694|589138230|FG010|Overall Study|Death|1|||
163117896|NCT02761694|589138231|FG011|Overall Study|Death|0|||
162654438|NCT02583256|587451572|FG001|Overall Study|Lost to Follow-up|1|||
162654439|NCT02583256|587451573|FG002|Overall Study|Lost to Follow-up|0|||
163117897|NCT02761694|589138220|FG000|Overall Study|Physician Decision|0|||
163117898|NCT02761694|589138221|FG001|Overall Study|Physician Decision|0|||
163117899|NCT02761694|589138222|FG002|Overall Study|Physician Decision|0|||
163117900|NCT02761694|589138223|FG003|Overall Study|Physician Decision|0|||
163117901|NCT02761694|589138224|FG004|Overall Study|Physician Decision|0|||
163117902|NCT02761694|589138225|FG005|Overall Study|Physician Decision|0|||
163117903|NCT02761694|589138226|FG006|Overall Study|Physician Decision|1|||
163117904|NCT02761694|589138227|FG007|Overall Study|Physician Decision|0|||
163117905|NCT02761694|589138228|FG008|Overall Study|Physician Decision|0|||
163117906|NCT02761694|589138229|FG009|Overall Study|Physician Decision|0|||
163117907|NCT02761694|589138230|FG010|Overall Study|Physician Decision|0|||
163117908|NCT02761694|589138231|FG011|Overall Study|Physician Decision|0|||
163117909|NCT02761694|589138220|FG000|Overall Study|Withdrawal by Subject|0|||
163117910|NCT02761694|589138221|FG001|Overall Study|Withdrawal by Subject|0|||
163117911|NCT02761694|589138222|FG002|Overall Study|Withdrawal by Subject|0|||
163117912|NCT02761694|589138223|FG003|Overall Study|Withdrawal by Subject|1|||
163117913|NCT02761694|589138224|FG004|Overall Study|Withdrawal by Subject|0|||
163117914|NCT02761694|589138225|FG005|Overall Study|Withdrawal by Subject|0|||
163117915|NCT02761694|589138226|FG006|Overall Study|Withdrawal by Subject|4|||
163117916|NCT02761694|589138227|FG007|Overall Study|Withdrawal by Subject|0|||
163117917|NCT02761694|589138228|FG008|Overall Study|Withdrawal by Subject|2|||
163117918|NCT02761694|589138229|FG009|Overall Study|Withdrawal by Subject|1|||
163117919|NCT02761694|589138230|FG010|Overall Study|Withdrawal by Subject|0|||
163117920|NCT02761694|589138231|FG011|Overall Study|Withdrawal by Subject|0|||
163117921|NCT02761694|589138220|FG000|Overall Study|Lost to Follow-up|0|||
163117922|NCT02761694|589138221|FG001|Overall Study|Lost to Follow-up|0|||
163117923|NCT02761694|589138222|FG002|Overall Study|Lost to Follow-up|0|||
163117924|NCT02761694|589138223|FG003|Overall Study|Lost to Follow-up|0|||
163117925|NCT02761694|589138224|FG004|Overall Study|Lost to Follow-up|0|||
163117926|NCT02761694|589138225|FG005|Overall Study|Lost to Follow-up|0|||
163117927|NCT02761694|589138226|FG006|Overall Study|Lost to Follow-up|1|||
163117928|NCT02761694|589138227|FG007|Overall Study|Lost to Follow-up|0|||
163117929|NCT02761694|589138228|FG008|Overall Study|Lost to Follow-up|0|||
163117930|NCT02761694|589138229|FG009|Overall Study|Lost to Follow-up|0|||
163117931|NCT02761694|589138230|FG010|Overall Study|Lost to Follow-up|0|||
163117932|NCT02761694|589138231|FG011|Overall Study|Lost to Follow-up|1|||
163117933|NCT02761694|589138220|FG000|Overall Study|Adverse Event|0|||
163117934|NCT02761694|589138221|FG001|Overall Study|Adverse Event|0|||
163117935|NCT02761694|589138222|FG002|Overall Study|Adverse Event|0|||
163117936|NCT02761694|589138223|FG003|Overall Study|Adverse Event|0|||
163117937|NCT02761694|589138224|FG004|Overall Study|Adverse Event|0|||
162654440|NCT02583256|587451574|FG003|Overall Study|Lost to Follow-up|1|||
163117938|NCT02761694|589138225|FG005|Overall Study|Adverse Event|0|||
163117939|NCT02761694|589138226|FG006|Overall Study|Adverse Event|1|||
163117940|NCT02761694|589138227|FG007|Overall Study|Adverse Event|0|||
163117941|NCT02761694|589138228|FG008|Overall Study|Adverse Event|1|||
163117942|NCT02761694|589138229|FG009|Overall Study|Adverse Event|0|||
163117943|NCT02761694|589138230|FG010|Overall Study|Adverse Event|0|||
163117944|NCT02761694|589138231|FG011|Overall Study|Adverse Event|1|||
163117945|NCT02761694|589138220|FG000|Overall Study|Other|4|||
163117946|NCT02761694|589138221|FG001|Overall Study|Other|4|||
163117947|NCT02761694|589138222|FG002|Overall Study|Other|1|||
163117948|NCT02761694|589138223|FG003|Overall Study|Other|2|||
163117949|NCT02761694|589138224|FG004|Overall Study|Other|3|||
163117950|NCT02761694|589138225|FG005|Overall Study|Other|3|||
163117951|NCT02761694|589138226|FG006|Overall Study|Other|18|||
163117952|NCT02761694|589138227|FG007|Overall Study|Other|8|||
163117953|NCT02761694|589138228|FG008|Overall Study|Other|0|||
163117954|NCT02761694|589138229|FG009|Overall Study|Other|1|||
162654441|NCT02583256|587451571|FG000|Overall Study|Administrative/Other|2|||
162654442|NCT02583256|587451572|FG001|Overall Study|Administrative/Other|0|||
162654443|NCT02583256|587451573|FG002|Overall Study|Administrative/Other|1|||
162654444|NCT02583256|587451574|FG003|Overall Study|Administrative/Other|2|||
162654445|NCT02177266|587451580|FG000|Overall Study|Adverse Event|0|||
162654446|NCT02177266|587451581|FG001|Overall Study|Adverse Event|1|||
162654447|NCT02177266|587451580|FG000|Overall Study|Withdrawal by Subject|1|||
162654448|NCT02177266|587451581|FG001|Overall Study|Withdrawal by Subject|0|||
162654449|NCT01023659|587451582|FG000|Overall Study|Lost to Follow-up|73|||
162654450|NCT01023659|587451583|FG001|Overall Study|Lost to Follow-up|228|||
162654451|NCT01023659|587451584|FG002|Overall Study|Lost to Follow-up|99|||
162654452|NCT04537806|587451585|FG000|Overall Study|Randomized but not treated|1|||
162654453|NCT04537806|587451586|FG001|Overall Study|Randomized but not treated|0|||
162654454|NCT04537806|587451585|FG000|Overall Study|Adverse Event|1|||
162654455|NCT04537806|587451586|FG001|Overall Study|Adverse Event|1|||
162654456|NCT03019627|587451589|FG000|Overall Study|Adverse Event|8|||
162654457|NCT03019627|587451590|FG001|Overall Study|Adverse Event|0|||
162654458|NCT03019627|587451589|FG000|Overall Study|Unrelated to adverse event|1|||
162654459|NCT03019627|587451590|FG001|Overall Study|Unrelated to adverse event|3|||
162654460|NCT03019627|587451589|FG000|Overall Study|Lost to Follow-up|2|||
162654461|NCT03019627|587451590|FG001|Overall Study|Lost to Follow-up|1|||
162654462|NCT03019627|587451589|FG000|Overall Study|not compliance|2|||
162654463|NCT03019627|587451590|FG001|Overall Study|not compliance|2|||
162654464|NCT03019627|587451589|FG000|Overall Study|Other|2|||
162654465|NCT03019627|587451590|FG001|Overall Study|Other|2|||
162654466|NCT01802775|587451593|FG000|Overall Study|Death|0|||
162654467|NCT01802775|587451594|FG001|Overall Study|Death|3|||
162654468|NCT01802775|587451593|FG000|Overall Study|Reason not provided|0|||
162654469|NCT01802775|587451594|FG001|Overall Study|Reason not provided|1|||
162654470|NCT01802775|587451593|FG000|Overall Study|Physician Decision|1|||
162654471|NCT01802775|587451594|FG001|Overall Study|Physician Decision|0|||
162654472|NCT01802775|587451593|FG000|Overall Study|Adverse Event|1|||
162654473|NCT01802775|587451594|FG001|Overall Study|Adverse Event|1|||
162654474|NCT01802775|587451593|FG000|Overall Study|Withdrawal by Subject|3|||
162654475|NCT01802775|587451594|FG001|Overall Study|Withdrawal by Subject|5|||
162654476|NCT01802775|587451593|FG000|Overall Study|Lost to Follow-up|1|||
162654477|NCT01802775|587451594|FG001|Overall Study|Lost to Follow-up|2|||
162654478|NCT00519649|587451595|FG000|Overall Study|Withdrawal by Subject|1|||
162654479|NCT01465802|587451596|FG000|Overall Study|Study terminated by sponsor|1|||
162654480|NCT01465802|587451597|FG001|Overall Study|Study terminated by sponsor|0|||
162654481|NCT01465802|587451598|FG002|Overall Study|Study terminated by sponsor|0|||
162654482|NCT01465802|587451599|FG003|Overall Study|Study terminated by sponsor|1|||
162654483|NCT01465802|587451600|FG004|Overall Study|Study terminated by sponsor|7|||
163117955|NCT02761694|589138230|FG010|Overall Study|Other|1|||
163117956|NCT02761694|589138231|FG011|Overall Study|Other|0|||
163117957|NCT02395055|589138235|FG000|Overall Study|Withdrawal by Subject|7|||
163117958|NCT02395055|589138236|FG001|Overall Study|Withdrawal by Subject|3|||
163117959|NCT00787930|589138237|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
162654484|NCT01465802|587451596|FG000|Overall Study|Withdrawal by Subject|7|||
162654485|NCT01465802|587451597|FG001|Overall Study|Withdrawal by Subject|7|||
162654486|NCT01465802|587451598|FG002|Overall Study|Withdrawal by Subject|0|||
162654487|NCT01465802|587451599|FG003|Overall Study|Withdrawal by Subject|8|||
162654488|NCT01465802|587451600|FG004|Overall Study|Withdrawal by Subject|1|||
162654489|NCT01465802|587451596|FG000|Overall Study|Lost to Follow-up|1|||
162654490|NCT01465802|587451597|FG001|Overall Study|Lost to Follow-up|1|||
162654491|NCT01465802|587451598|FG002|Overall Study|Lost to Follow-up|0|||
162654492|NCT01465802|587451599|FG003|Overall Study|Lost to Follow-up|0|||
162654493|NCT01465802|587451600|FG004|Overall Study|Lost to Follow-up|0|||
162654494|NCT01465802|587451596|FG000|Overall Study|Reason not specified|9|||
162654495|NCT01465802|587451597|FG001|Overall Study|Reason not specified|4|||
162654496|NCT01465802|587451598|FG002|Overall Study|Reason not specified|0|||
162654497|NCT01465802|587451599|FG003|Overall Study|Reason not specified|10|||
162654498|NCT01465802|587451600|FG004|Overall Study|Reason not specified|2|||
162654499|NCT01465802|587451596|FG000|Overall Study|Death|15|||
162654500|NCT01465802|587451597|FG001|Overall Study|Death|12|||
162654501|NCT01465802|587451598|FG002|Overall Study|Death|0|||
162654502|NCT01465802|587451599|FG003|Overall Study|Death|10|||
162654503|NCT01465802|587451600|FG004|Overall Study|Death|2|||
162654504|NCT01067352|587451601|FG000|Overall Study|Withdrawal by Subject|1|||
162654505|NCT01067352|587451602|FG001|Overall Study|Withdrawal by Subject|2|||
162654506|NCT01067352|587451603|FG002|Overall Study|Withdrawal by Subject|1|||
162654507|NCT01067352|587451601|FG000|Overall Study|Physician Decision|0|||
162654508|NCT01067352|587451602|FG001|Overall Study|Physician Decision|1|||
162654509|NCT01067352|587451603|FG002|Overall Study|Physician Decision|0|||
162654510|NCT02103478|587451604|FG000|Overall Study|Adverse Event|0|||
162654511|NCT02103478|587451605|FG001|Overall Study|Adverse Event|0|||
162654512|NCT02103478|587451606|FG002|Overall Study|Adverse Event|1|||
162654513|NCT02103478|587451607|FG003|Overall Study|Adverse Event|1|||
163117960|NCT01896271|589138238|FG000|Overall Study|Physician Decision|10|||
163117961|NCT03002623|589138242|FG000|Overall Study|Lost to Follow-up|1|||
163117962|NCT03002623|589138243|FG001|Overall Study|Lost to Follow-up|0|||
163117963|NCT03002623|589138242|FG000|Overall Study|Physician Decision|1|||
163117964|NCT03002623|589138243|FG001|Overall Study|Physician Decision|1|||
163117965|NCT03762616|589138246|FG000|Overall Study|Protocol Violation|2|||
163117966|NCT00758589|589140414|FG000|Overall Study|Adverse Event|3|||
163117967|NCT00758589|589140415|FG001|Overall Study|Adverse Event|2|||
163117968|NCT00758589|589140416|FG002|Overall Study|Adverse Event|5|||
163117969|NCT00758589|589140417|FG003|Overall Study|Adverse Event|4|||
163117970|NCT00758589|589140414|FG000|Overall Study|Withdrawal by Subject|0|||
163117971|NCT00758589|589140415|FG001|Overall Study|Withdrawal by Subject|1|||
163117972|NCT00758589|589140416|FG002|Overall Study|Withdrawal by Subject|1|||
163117973|NCT00758589|589140417|FG003|Overall Study|Withdrawal by Subject|1|||
163117974|NCT00758589|589140414|FG000|Overall Study|Palm stopped to work|0|||
163117975|NCT00758589|589140415|FG001|Overall Study|Palm stopped to work|0|||
163117976|NCT00758589|589140416|FG002|Overall Study|Palm stopped to work|0|||
163117977|NCT00758589|589140417|FG003|Overall Study|Palm stopped to work|1|||
163117978|NCT00583791|589140419|FG000|Overall Study|Other|67|||
163117979|NCT00583791|589140419|FG000|Overall Study|Death|6|||
163117980|NCT00203021|589140420|FG000|Overall Study|Death|4|||
163117981|NCT00203021|589140421|FG001|Overall Study|Death|1|||
163117982|NCT00203021|589140420|FG000|Overall Study|Adverse Event|10|||
163117983|NCT00203021|589140421|FG001|Overall Study|Adverse Event|5|||
163117984|NCT00203021|589140420|FG000|Overall Study|Withdrawal by Subject|45|||
163117985|NCT00203021|589140421|FG001|Overall Study|Withdrawal by Subject|48|||
163117986|NCT00203021|589140420|FG000|Overall Study|Lost to Follow-up|9|||
163117987|NCT00203021|589140421|FG001|Overall Study|Lost to Follow-up|7|||
163117988|NCT00203021|589140420|FG000|Overall Study|Other than specified|11|||
163117989|NCT00203021|589140421|FG001|Overall Study|Other than specified|16|||
163117990|NCT03204890|589140426|FG000|Overall Study|Withdrawal by Subject|1|||
163117991|NCT04524455|589140437|FG000|Overall Study|Death|3|||
163117992|NCT04524455|589140438|FG001|Overall Study|Death|3|||
163117993|NCT04524455|589140437|FG000|Overall Study|Decision by Sponsor|0|||
163117994|NCT04524455|589140438|FG001|Overall Study|Decision by Sponsor|2|||
163117995|NCT04524455|589140437|FG000|Overall Study|Withdrawal of Consent From Study|1|||
163117996|NCT04524455|589140438|FG001|Overall Study|Withdrawal of Consent From Study|0|||
163117997|NCT04524455|589140437|FG000|Overall Study|Lost to Follow-up|0|||
163117998|NCT04524455|589140438|FG001|Overall Study|Lost to Follow-up|1|||
163117999|NCT01688739|589140439|FG000|Overall Study|Administrative Decision|1|||
163118000|NCT01688739|589140440|FG001|Overall Study|Administrative Decision|0|||
163118001|NCT01688739|589140441|FG002|Overall Study|Administrative Decision|0|||
163118002|NCT01688739|589140442|FG003|Overall Study|Administrative Decision|0|||
163118003|NCT01688739|589140443|FG004|Overall Study|Administrative Decision|0|||
163118004|NCT01688739|589140444|FG005|Overall Study|Administrative Decision|0|||
163118005|NCT01688739|589140445|FG006|Overall Study|Administrative Decision|0|||
163118006|NCT01688739|589140446|FG007|Overall Study|Administrative Decision|0|||
163118007|NCT01688739|589140447|FG008|Overall Study|Administrative Decision|0|||
163118008|NCT01688739|589140448|FG009|Overall Study|Administrative Decision|0|||
163118009|NCT00490776|589140451|FG000|Overall Study|Withdrawal by Subject|1|||
163118010|NCT00490776|589140451|FG000|Overall Study|Administrative Problems|1|||
163118011|NCT00490776|589140451|FG000|Overall Study|Death|1|||
163118012|NCT00490776|589140451|FG000|Overall Study|New Cancer Therapy|1|||
163118013|NCT00490776|589140451|FG000|Overall Study|Disease Progression|5|||
163118014|NCT03383783|589140452|FG000|Overall Study|Withdrawal by Subject|2|||
163118015|NCT01340937|589140454|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
163118016|NCT01340937|589140455|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
163118017|NCT01340937|589140456|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
163118018|NCT01340937|589140457|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
163118019|NCT01340937|589140454|FG000|Period 1: Infant Series|Adverse Event|0|||
163118020|NCT01340937|589140455|FG001|Period 1: Infant Series|Adverse Event|1|||
163118021|NCT01340937|589140456|FG002|Period 1: Infant Series|Adverse Event|4|||
163118022|NCT01340937|589140457|FG003|Period 1: Infant Series|Adverse Event|0|||
163118023|NCT01340937|589140454|FG000|Period 1: Infant Series|Death|2|||
163118024|NCT01340937|589140455|FG001|Period 1: Infant Series|Death|0|||
163118025|NCT01340937|589140456|FG002|Period 1: Infant Series|Death|2|||
163118026|NCT01340937|589140457|FG003|Period 1: Infant Series|Death|0|||
163118027|NCT01340937|589140454|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
163118028|NCT01340937|589140455|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
163118029|NCT01340937|589140456|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
163118030|NCT01340937|589140457|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
163118031|NCT01340937|589140454|FG000|Period 1: Infant Series|Physician Decision|2|||
163118032|NCT01340937|589140455|FG001|Period 1: Infant Series|Physician Decision|3|||
163118033|NCT01340937|589140456|FG002|Period 1: Infant Series|Physician Decision|1|||
163118034|NCT01340937|589140457|FG003|Period 1: Infant Series|Physician Decision|0|||
163118035|NCT01340937|589140454|FG000|Period 1: Infant Series|Protocol Violation|1|||
163118036|NCT01340937|589140455|FG001|Period 1: Infant Series|Protocol Violation|4|||
163118037|NCT01340937|589140456|FG002|Period 1: Infant Series|Protocol Violation|4|||
163118038|NCT01340937|589140457|FG003|Period 1: Infant Series|Protocol Violation|3|||
163118039|NCT01340937|589140454|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
163118040|NCT01340937|589140455|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
163118041|NCT01340937|589140456|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
163118042|NCT01340937|589140457|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
163118043|NCT01340937|589140454|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
163118044|NCT01340937|589140455|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
163118045|NCT01340937|589140456|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
163118046|NCT01340937|589140457|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
163118047|NCT01340937|589140454|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
163118048|NCT01340937|589140455|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
163118049|NCT01340937|589140456|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
163118050|NCT01340937|589140457|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
163118051|NCT01340937|589140454|FG000|Period 2: Interim Period|Adverse Event|1|||
163118052|NCT01340937|589140455|FG001|Period 2: Interim Period|Adverse Event|0|||
163118053|NCT01340937|589140456|FG002|Period 2: Interim Period|Adverse Event|1|||
163118054|NCT01340937|589140457|FG003|Period 2: Interim Period|Adverse Event|0|||
163118055|NCT01340937|589140454|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
163118056|NCT01340937|589140455|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
163118057|NCT01340937|589140456|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
163118058|NCT01340937|589140457|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
163118059|NCT01340937|589140454|FG000|Period 2: Interim Period|Physician Decision|0|||
163118060|NCT01340937|589140455|FG001|Period 2: Interim Period|Physician Decision|1|||
163118061|NCT01340937|589140456|FG002|Period 2: Interim Period|Physician Decision|1|||
163118062|NCT01340937|589140457|FG003|Period 2: Interim Period|Physician Decision|0|||
163118063|NCT01340937|589140454|FG000|Period 2: Interim Period|Protocol Violation|5|||
163118064|NCT01340937|589140455|FG001|Period 2: Interim Period|Protocol Violation|3|||
163118065|NCT01340937|589140456|FG002|Period 2: Interim Period|Protocol Violation|6|||
163118066|NCT01340937|589140457|FG003|Period 2: Interim Period|Protocol Violation|3|||
163118067|NCT01340937|589140454|FG000|Period 2: Interim Period|Technical problems|4|||
163118068|NCT01340937|589140455|FG001|Period 2: Interim Period|Technical problems|4|||
163118069|NCT01340937|589140456|FG002|Period 2: Interim Period|Technical problems|6|||
163118070|NCT01340937|589140457|FG003|Period 2: Interim Period|Technical problems|3|||
163118071|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
163118072|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
163118073|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
163118074|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
163118075|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
163118076|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
163118077|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
163118078|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
163118079|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118080|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118081|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
163118082|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
163118083|NCT01340937|589140454|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
163118084|NCT01340937|589140455|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
163118085|NCT01340937|589140456|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
163118086|NCT01340937|589140457|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
163118087|NCT00046930|589140458|FG000|Overall Study|Ineligible|12|||
163118088|NCT00046930|589140459|FG001|Overall Study|Ineligible|4|||
163118089|NCT00440310|589140460|FG000|Overall Study|Lost to Follow-up|4|||
163118090|NCT00440310|589140461|FG001|Overall Study|Lost to Follow-up|5|||
163118091|NCT00440310|589140460|FG000|Overall Study|Protocol Violation|0|||
163118092|NCT00440310|589140461|FG001|Overall Study|Protocol Violation|1|||
163118093|NCT00440310|589140460|FG000|Overall Study|Withdrawal by Subject|15|||
163118094|NCT00440310|589140461|FG001|Overall Study|Withdrawal by Subject|14|||
163118095|NCT00440310|589140460|FG000|Overall Study|No Reply at EOS|7|||
163118096|NCT00440310|589140461|FG001|Overall Study|No Reply at EOS|7|||
162654514|NCT02103478|587451608|FG004|Overall Study|Adverse Event|2|||
162654515|NCT02103478|587451609|FG005|Overall Study|Adverse Event|1|||
162654516|NCT02103478|587451610|FG006|Overall Study|Adverse Event|0|||
162654517|NCT02103478|587451611|FG007|Overall Study|Adverse Event|0|||
163118097|NCT00440310|589140460|FG000|Overall Study|Other|1|||
163118098|NCT00440310|589140461|FG001|Overall Study|Other|0|||
163118099|NCT00440310|589140460|FG000|Overall Study|Status Unknown|1|||
163118100|NCT00440310|589140461|FG001|Overall Study|Status Unknown|3|||
163118101|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
163118102|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
163118103|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
163118104|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
162654518|NCT02103478|587451612|FG008|Overall Study|Adverse Event|0|||
163118105|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
163118106|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
163118107|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
163118108|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
163118109|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
163118110|NCT02119156|589140464|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
163118111|NCT02119156|589140465|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
163118112|NCT02119156|589140466|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
163118113|NCT02119156|589140464|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
163118114|NCT02119156|589140465|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
163118115|NCT02119156|589140466|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
163118116|NCT01657760|589140467|FG000|Overall Study|Withdrawal by Subject|0|||
163118117|NCT01657760|589140468|FG001|Overall Study|Withdrawal by Subject|0|||
163118118|NCT01657760|589140469|FG002|Overall Study|Withdrawal by Subject|0|||
163118119|NCT01657760|589140470|FG003|Overall Study|Withdrawal by Subject|1|||
163118120|NCT01657760|589140467|FG000|Overall Study|Physician Decision|1|||
163118121|NCT01657760|589140468|FG001|Overall Study|Physician Decision|1|||
163118122|NCT01657760|589140469|FG002|Overall Study|Physician Decision|1|||
163118123|NCT01657760|589140470|FG003|Overall Study|Physician Decision|2|||
163118124|NCT02469415|589140471|FG000|Overall Study|Withdrawal by Subject|1|||
163118125|NCT02469415|589140471|FG000|Overall Study|Investigational agent placed on hold|2|||
163118126|NCT00940485|589140476|FG000|Overall Study|HBeAb positive at Baseline|3|||
163118127|NCT00940485|589140477|FG001|Overall Study|HBeAb positive at Baseline|2|||
163118128|NCT00940485|589140476|FG000|Overall Study|Lost to Follow-up|2|||
163118129|NCT00940485|589140477|FG001|Overall Study|Lost to Follow-up|3|||
163118130|NCT00940485|589140476|FG000|Overall Study|Adverse Event|8|||
163118131|NCT00940485|589140477|FG001|Overall Study|Adverse Event|0|||
163118132|NCT00940485|589140476|FG000|Overall Study|Withdrawal by Subject|1|||
163118133|NCT00940485|589140477|FG001|Overall Study|Withdrawal by Subject|1|||
163118134|NCT00940485|589140476|FG000|Overall Study|Others|1|||
163118135|NCT00940485|589140477|FG001|Overall Study|Others|1|||
163118136|NCT01113580|589140478|FG000|Overall Study|Protocol Violation|1|||
163118137|NCT01113580|589140479|FG001|Overall Study|Protocol Violation|0|||
163118138|NCT04599166|589140485|FG000|Overall Study|Technological failure connecting to study app|80|||
163118139|NCT01974752|589140486|FG000|Overall Study|Death|33|||
163118140|NCT01974752|589140487|FG001|Overall Study|Death|11|||
163118141|NCT01974752|589140486|FG000|Overall Study|Lost to Follow-up|2|||
163118142|NCT01974752|589140487|FG001|Overall Study|Lost to Follow-up|0|||
163118143|NCT01974752|589140486|FG000|Overall Study|Withdrawal by Subject|2|||
163118144|NCT01974752|589140487|FG001|Overall Study|Withdrawal by Subject|3|||
163118145|NCT01974752|589140486|FG000|Overall Study|Other Eligibility Criteria|0|||
163118146|NCT01974752|589140487|FG001|Overall Study|Other Eligibility Criteria|1|||
163118147|NCT02233738|589140488|FG000|Overall Study|Lost to Follow-up|5|||
163118148|NCT02233738|589140489|FG001|Overall Study|Lost to Follow-up|12|||
163118149|NCT02233738|589140488|FG000|Overall Study|Death|0|||
163118150|NCT02233738|589140489|FG001|Overall Study|Death|1|||
163118151|NCT02233738|589140488|FG000|Overall Study|Withdrawal by Subject|0|||
163118152|NCT02233738|589140489|FG001|Overall Study|Withdrawal by Subject|1|||
163118153|NCT02233738|589140488|FG000|Overall Study|Did not return after Baseline|3|||
163118154|NCT02233738|589140489|FG001|Overall Study|Did not return after Baseline|2|||
163118155|NCT02435680|589140490|FG000|Overall Study|Physician Decision|3|||
163118156|NCT02435680|589140491|FG001|Overall Study|Physician Decision|0|||
163118157|NCT02435680|589140492|FG002|Overall Study|Physician Decision|0|||
163118158|NCT02435680|589140490|FG000|Overall Study|subject / guardian decision|0|||
163118159|NCT02435680|589140491|FG001|Overall Study|subject / guardian decision|3|||
163118160|NCT02435680|589140492|FG002|Overall Study|subject / guardian decision|2|||
163118161|NCT02435680|589140490|FG000|Overall Study|Adverse Event|8|||
163118162|NCT02435680|589140491|FG001|Overall Study|Adverse Event|3|||
163118163|NCT02435680|589140492|FG002|Overall Study|Adverse Event|2|||
163118164|NCT02435680|589140490|FG000|Overall Study|progressive disease|10|||
163118165|NCT02435680|589140491|FG001|Overall Study|progressive disease|7|||
163118166|NCT02435680|589140492|FG002|Overall Study|progressive disease|11|||
163118167|NCT02435680|589140490|FG000|Overall Study|not treated|0|||
163118168|NCT02435680|589140491|FG001|Overall Study|not treated|0|||
163118169|NCT02435680|589140492|FG002|Overall Study|not treated|1|||
163118170|NCT00294645|589140493|FG000|Overall Study|Death|10|||
163118171|NCT00294645|589140494|FG001|Overall Study|Death|18|||
163118172|NCT00294645|589140493|FG000|Overall Study|Lost to Follow-up|1|||
163118173|NCT00294645|589140494|FG001|Overall Study|Lost to Follow-up|10|||
163118174|NCT00294645|589140493|FG000|Overall Study|Withdrawal by Subject|18|||
163118175|NCT00294645|589140494|FG001|Overall Study|Withdrawal by Subject|34|||
163118176|NCT00294645|589140493|FG000|Overall Study|Physician Decision|15|||
163118177|NCT00294645|589140494|FG001|Overall Study|Physician Decision|20|||
163118178|NCT00294645|589140493|FG000|Overall Study|Other|4|||
163118179|NCT00294645|589140494|FG001|Overall Study|Other|10|||
163118180|NCT00554619|589140497|FG000|Overall Study|Adverse Event|1|||
163118181|NCT00554619|589140497|FG000|Overall Study|Physician Decision|1|||
163118182|NCT00554619|589140497|FG000|Overall Study|Liver Function Test Abnormality|1|||
163118183|NCT00907803|589140499|FG000|Overall Study|Withdrawal of consent - long commute|1|||
163118184|NCT00907803|589140500|FG001|Overall Study|Withdrawal of consent - long commute|0|||
163118185|NCT00907803|589140501|FG002|Overall Study|Withdrawal of consent - long commute|0|||
163118186|NCT00907803|589140499|FG000|Overall Study|Adverse Event|2|||
163118187|NCT00907803|589140500|FG001|Overall Study|Adverse Event|0|||
163118188|NCT00907803|589140501|FG002|Overall Study|Adverse Event|0|||
163118189|NCT00907803|589140499|FG000|Overall Study|Withdrawal by Subject|0|||
163118190|NCT00907803|589140500|FG001|Overall Study|Withdrawal by Subject|1|||
163118191|NCT00907803|589140501|FG002|Overall Study|Withdrawal by Subject|0|||
163118192|NCT00907803|589140499|FG000|Overall Study|Lost to Follow-up|0|||
163118193|NCT00907803|589140500|FG001|Overall Study|Lost to Follow-up|1|||
163118194|NCT00907803|589140501|FG002|Overall Study|Lost to Follow-up|0|||
163118195|NCT00907803|589140499|FG000|Overall Study|Protocol Violation|0|||
163118196|NCT00907803|589140500|FG001|Overall Study|Protocol Violation|1|||
163118197|NCT00907803|589140501|FG002|Overall Study|Protocol Violation|0|||
163118198|NCT04612842|589140506|FG000|Overall Study|Lost to Follow-up|20|||
163118199|NCT04612842|589140507|FG001|Overall Study|Lost to Follow-up|11|||
163118200|NCT04612842|589140506|FG000|Overall Study|Withdrawal by Subject|26|||
163118201|NCT04612842|589140507|FG001|Overall Study|Withdrawal by Subject|15|||
163118202|NCT04612842|589140506|FG000|Overall Study|Death|2|||
163118203|NCT04612842|589140507|FG001|Overall Study|Death|2|||
163118204|NCT05426031|589140508|FG000|Overall Study|Circulatory Arrest|3|||
163118205|NCT05426031|589140509|FG001|Overall Study|Circulatory Arrest|2|||
163118206|NCT03060512|589140510|FG000|Overall Study|Adverse Event|4|||
163118207|NCT03060512|589140511|FG001|Overall Study|Adverse Event|6|||
163118208|NCT03060512|589140510|FG000|Overall Study|Lost to Follow-up|1|||
163118209|NCT03060512|589140511|FG001|Overall Study|Lost to Follow-up|1|||
163118210|NCT03060512|589140510|FG000|Overall Study|Withdrawal by Subject|1|||
163118211|NCT03060512|589140511|FG001|Overall Study|Withdrawal by Subject|0|||
163118212|NCT03060512|589140510|FG000|Overall Study|Non-compliance with study medication|1|||
163118213|NCT03060512|589140511|FG001|Overall Study|Non-compliance with study medication|2|||
163118214|NCT00089986|589140512|FG000|Overall Study|Adverse Event|6|||
163118215|NCT00089986|589140513|FG001|Overall Study|Adverse Event|9|||
163118216|NCT00089986|589140514|FG002|Overall Study|Adverse Event|6|||
163118217|NCT00089986|589140512|FG000|Overall Study|Lost to Follow-up|3|||
163118218|NCT00089986|589140513|FG001|Overall Study|Lost to Follow-up|1|||
163118219|NCT00089986|589140514|FG002|Overall Study|Lost to Follow-up|1|||
163118220|NCT00089986|589140512|FG000|Overall Study|Protocol Violation|0|||
163118221|NCT00089986|589140513|FG001|Overall Study|Protocol Violation|1|||
163118222|NCT00089986|589140514|FG002|Overall Study|Protocol Violation|0|||
163118223|NCT00089986|589140512|FG000|Overall Study|Patient transferred to another hospital|2|||
163118224|NCT00089986|589140513|FG001|Overall Study|Patient transferred to another hospital|1|||
163118225|NCT00089986|589140514|FG002|Overall Study|Patient transferred to another hospital|0|||
163118226|NCT00089986|589140512|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
163118227|NCT00089986|589140513|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
163118228|NCT00089986|589140514|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
163118229|NCT00089986|589140512|FG000|Overall Study|Hemohlobin stopping rule|0|||
163118230|NCT00089986|589140513|FG001|Overall Study|Hemohlobin stopping rule|1|||
163118231|NCT00089986|589140514|FG002|Overall Study|Hemohlobin stopping rule|0|||
163118232|NCT00089986|589140512|FG000|Overall Study|Investigator decision to withdrew|0|||
163118233|NCT00089986|589140513|FG001|Overall Study|Investigator decision to withdrew|1|||
163118234|NCT00089986|589140514|FG002|Overall Study|Investigator decision to withdrew|0|||
163118235|NCT00089986|589140512|FG000|Overall Study|Enrollment in another study|0|||
163118236|NCT00089986|589140513|FG001|Overall Study|Enrollment in another study|1|||
163118237|NCT00089986|589140514|FG002|Overall Study|Enrollment in another study|0|||
163118238|NCT00089986|589140512|FG000|Overall Study|Family decision|0|||
162654519|NCT02103478|587451604|FG000|Overall Study|Death|2|||
162654520|NCT02103478|587451605|FG001|Overall Study|Death|2|||
162654521|NCT02103478|587451606|FG002|Overall Study|Death|1|||
162654522|NCT02103478|587451607|FG003|Overall Study|Death|1|||
163118239|NCT00089986|589140513|FG001|Overall Study|Family decision|1|||
163118240|NCT00089986|589140514|FG002|Overall Study|Family decision|0|||
163118241|NCT00089986|589140512|FG000|Overall Study|Do not resuscitate (DNR)|0|||
163118242|NCT00089986|589140513|FG001|Overall Study|Do not resuscitate (DNR)|0|||
163118243|NCT00089986|589140514|FG002|Overall Study|Do not resuscitate (DNR)|1|||
163118244|NCT00089986|589140512|FG000|Overall Study|Withdrawal by Subject|3|||
163118245|NCT00089986|589140513|FG001|Overall Study|Withdrawal by Subject|6|||
163118246|NCT00089986|589140514|FG002|Overall Study|Withdrawal by Subject|2|||
163118247|NCT04065074|589140518|FG000|Overall Study|Adverse Event|1|||
163118248|NCT04065074|589140518|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
163118249|NCT02334683|589140519|FG000|First 12 Week Period|Lost to Follow-up|1|||
162654523|NCT02103478|587451608|FG004|Overall Study|Death|5|||
162654524|NCT02103478|587451609|FG005|Overall Study|Death|15|||
163118250|NCT02334683|589140520|FG001|First 12 Week Period|Lost to Follow-up|0|||
163118251|NCT02334683|589140519|FG000|Second 12 Week Period|Adverse Event|0|||
163118252|NCT02334683|589140520|FG001|Second 12 Week Period|Adverse Event|1|||
163118253|NCT01062841|589140521|FG000|Overall Study|Indwelling Device Removed|41|||
163118254|NCT01062841|589140522|FG001|Overall Study|Indwelling Device Removed|48|||
163118255|NCT01062841|589140521|FG000|Overall Study|Death|3|||
163118256|NCT01062841|589140522|FG001|Overall Study|Death|5|||
163118257|NCT01062841|589140521|FG000|Overall Study|Withdrawal by Subject|2|||
163118258|NCT01062841|589140522|FG001|Overall Study|Withdrawal by Subject|0|||
163118259|NCT01062841|589140521|FG000|Overall Study|Withdrawal by Study|3|||
163118260|NCT01062841|589140522|FG001|Overall Study|Withdrawal by Study|0|||
163118261|NCT03958656|589140523|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118262|NCT03958656|589140524|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
163118263|NCT03958656|589140525|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118264|NCT03958656|589140526|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163118265|NCT03958656|589140523|FG000|Overall Study|No longer meets eligibility criteria|0|||
163118266|NCT03958656|589140524|FG001|Overall Study|No longer meets eligibility criteria|0|||
163118267|NCT03958656|589140525|FG002|Overall Study|No longer meets eligibility criteria|1|||
163118268|NCT03958656|589140526|FG003|Overall Study|No longer meets eligibility criteria|0|||
163118269|NCT03958656|589140523|FG000|Overall Study|Started anti-cancer treatment|0|||
163118270|NCT03958656|589140524|FG001|Overall Study|Started anti-cancer treatment|0|||
163118271|NCT03958656|589140525|FG002|Overall Study|Started anti-cancer treatment|1|||
163118272|NCT03958656|589140526|FG003|Overall Study|Started anti-cancer treatment|0|||
163118273|NCT03831880|589140527|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
163118274|NCT03831880|589140528|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
163118275|NCT03831880|589140527|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
163118276|NCT03831880|589140528|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
163118277|NCT03158012|589140531|FG000|Overall Study|Withdrawal by Subject|0|||
163118278|NCT03158012|589140532|FG001|Overall Study|Withdrawal by Subject|1|||
163118279|NCT02788201|589140533|FG000|Overall Study|Death|1|||
163118280|NCT02788201|589140534|FG001|Overall Study|Death|1|||
163118281|NCT02788201|589140535|FG002|Overall Study|Death|1|||
163118282|NCT02788201|589140536|FG003|Overall Study|Death|1|||
163118283|NCT02788201|589140537|FG004|Overall Study|Death|0|||
163118284|NCT02788201|589140538|FG005|Overall Study|Death|1|||
163118285|NCT02788201|589140533|FG000|Overall Study|Ineligible|0|||
163118286|NCT02788201|589140534|FG001|Overall Study|Ineligible|0|||
163118287|NCT02788201|589140535|FG002|Overall Study|Ineligible|0|||
163118288|NCT02788201|589140536|FG003|Overall Study|Ineligible|0|||
163118289|NCT02788201|589140537|FG004|Overall Study|Ineligible|0|||
163118290|NCT02788201|589140538|FG005|Overall Study|Ineligible|1|||
163118291|NCT02788201|589140533|FG000|Overall Study|Withdrawal by Subject|0|||
163118292|NCT02788201|589140534|FG001|Overall Study|Withdrawal by Subject|0|||
163118293|NCT02788201|589140535|FG002|Overall Study|Withdrawal by Subject|0|||
163118294|NCT02788201|589140536|FG003|Overall Study|Withdrawal by Subject|0|||
163118295|NCT02788201|589140537|FG004|Overall Study|Withdrawal by Subject|0|||
163118296|NCT02788201|589140538|FG005|Overall Study|Withdrawal by Subject|1|||
163118297|NCT01414205|589140539|FG000|Overall Study|Death|5|||
163118298|NCT01414205|589140540|FG001|Overall Study|Death|1|||
163118299|NCT01414205|589140539|FG000|Overall Study|Lost to Follow-up|1|||
163118300|NCT01414205|589140540|FG001|Overall Study|Lost to Follow-up|4|||
163118301|NCT01414205|589140539|FG000|Overall Study|Physician Decision|0|||
163118302|NCT01414205|589140540|FG001|Overall Study|Physician Decision|1|||
163118303|NCT01414205|589140539|FG000|Overall Study|Randomized but not Treated|1|||
163118304|NCT01414205|589140540|FG001|Overall Study|Randomized but not Treated|1|||
163118305|NCT01166373|589140541|FG000|Overall Study|Lost to Follow-up|3|||
163118306|NCT01166373|589140542|FG001|Overall Study|Lost to Follow-up|2|||
163118307|NCT01166373|589140543|FG002|Overall Study|Lost to Follow-up|2|||
163118308|NCT01166373|589140544|FG003|Overall Study|Lost to Follow-up|2|||
163118309|NCT01166373|589140541|FG000|Overall Study|Withdrawal by Subject|1|||
163118310|NCT01166373|589140542|FG001|Overall Study|Withdrawal by Subject|2|||
163118311|NCT01166373|589140543|FG002|Overall Study|Withdrawal by Subject|2|||
163118312|NCT01166373|589140544|FG003|Overall Study|Withdrawal by Subject|3|||
163118313|NCT01166373|589140541|FG000|Overall Study|Physician Decision|1|||
163118314|NCT01166373|589140542|FG001|Overall Study|Physician Decision|0|||
163118315|NCT01166373|589140543|FG002|Overall Study|Physician Decision|0|||
163118316|NCT01166373|589140544|FG003|Overall Study|Physician Decision|0|||
162654525|NCT02103478|587451610|FG006|Overall Study|Death|14|||
162654526|NCT02103478|587451611|FG007|Overall Study|Death|10|||
162654527|NCT02103478|587451612|FG008|Overall Study|Death|11|||
162654528|NCT02103478|587451604|FG000|Overall Study|Progressive Disease|2|||
163118317|NCT02498067|589140545|FG000|Overall Study|Lost to Follow-up|22|||
163118318|NCT02498067|589140545|FG000|Overall Study|Did not meet inclusion criteria|11|||
163118319|NCT01874275|589140546|FG000|Overall Study|Lost to Follow-up|1|||
163118320|NCT01874275|589140547|FG001|Overall Study|Lost to Follow-up|0|||
163118321|NCT02214225|589140552|FG000|Overall Study|Lost to Follow-up|46|||
163118322|NCT02214225|589140553|FG001|Overall Study|Lost to Follow-up|18|||
162654529|NCT02103478|587451605|FG001|Overall Study|Progressive Disease|1|||
162654530|NCT02103478|587451606|FG002|Overall Study|Progressive Disease|2|||
163118323|NCT02214225|589140554|FG002|Overall Study|Lost to Follow-up|18|||
163118324|NCT02214225|589140552|FG000|Overall Study|Withdrawal by Subject|2|||
163118325|NCT02214225|589140553|FG001|Overall Study|Withdrawal by Subject|0|||
163118326|NCT02214225|589140554|FG002|Overall Study|Withdrawal by Subject|2|||
163118327|NCT02214225|589140552|FG000|Overall Study|Death|5|||
163118328|NCT02214225|589140553|FG001|Overall Study|Death|0|||
163118329|NCT02214225|589140554|FG002|Overall Study|Death|1|||
163118330|NCT02214225|589140552|FG000|Overall Study|randomized in error, not vaccinated|2|||
163118331|NCT02214225|589140553|FG001|Overall Study|randomized in error, not vaccinated|1|||
163118332|NCT02214225|589140554|FG002|Overall Study|randomized in error, not vaccinated|1|||
163118333|NCT03987932|589140555|FG000|Overall Study|Lost to Follow-up|2|||
163118334|NCT03987932|589140556|FG001|Overall Study|Lost to Follow-up|1|||
163118335|NCT03987932|589140557|FG002|Overall Study|Lost to Follow-up|1|||
163118336|NCT03987932|589140555|FG000|Overall Study|Non-study related elective surgery|0|||
163118337|NCT03987932|589140556|FG001|Overall Study|Non-study related elective surgery|0|||
163118338|NCT03987932|589140557|FG002|Overall Study|Non-study related elective surgery|1|||
163118339|NCT01669421|589140558|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
163118340|NCT01669421|589140558|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
163118341|NCT02813668|589140564|FG000|Overall Study|Death|4|||
163118342|NCT02813668|589140564|FG000|Overall Study|Lost to Follow-up|509|||
163118343|NCT02813668|589140564|FG000|Overall Study|Withdrawal by Subject|148|||
163118344|NCT02813668|589140564|FG000|Overall Study|No longer at worksite|85|||
163118345|NCT02813668|589140564|FG000|Overall Study|Medical reasons not related to the study|4|||
163118346|NCT02961790|589140565|FG000|Overall Study|Canceled|4|||
163118347|NCT02961790|589140566|FG001|Overall Study|Canceled|5|||
163118348|NCT02961790|589140567|FG002|Overall Study|Canceled|1|||
163118349|NCT02961790|589140568|FG003|Overall Study|Canceled|4|||
163118350|NCT02961790|589140565|FG000|Overall Study|without baseline data|4|||
163118351|NCT02961790|589140566|FG001|Overall Study|without baseline data|0|||
163118352|NCT02961790|589140567|FG002|Overall Study|without baseline data|1|||
163118353|NCT02961790|589140568|FG003|Overall Study|without baseline data|0|||
163118354|NCT02961790|589140565|FG000|Overall Study|without post baseline data|7|||
163118355|NCT02961790|589140566|FG001|Overall Study|without post baseline data|6|||
163118356|NCT02961790|589140567|FG002|Overall Study|without post baseline data|4|||
163118357|NCT02961790|589140568|FG003|Overall Study|without post baseline data|1|||
163118358|NCT02594098|589140571|FG000|Overall Study|Lack of Efficacy|17|||
163118359|NCT02594098|589140572|FG001|Overall Study|Lack of Efficacy|6|||
163118360|NCT02594098|589140571|FG000|Overall Study|Withdrawal by Subject|1|||
163118361|NCT02594098|589140572|FG001|Overall Study|Withdrawal by Subject|3|||
163118362|NCT02594098|589140571|FG000|Overall Study|Terminated participation|6|||
163118363|NCT02594098|589140572|FG001|Overall Study|Terminated participation|2|||
163118364|NCT02594098|589140571|FG000|Overall Study|Seek alternative treatment|2|||
163118365|NCT02594098|589140572|FG001|Overall Study|Seek alternative treatment|1|||
163118366|NCT02594098|589140571|FG000|Overall Study|Other|0|||
163118367|NCT02594098|589140572|FG001|Overall Study|Other|1|||
163118368|NCT01866423|589140573|FG000|Overall Study|Lack of Efficacy|3|||
163118369|NCT01866423|589140573|FG000|Overall Study|Sponsor Decision|1|||
163118370|NCT00526110|589140580|FG000|Overall Study|Adverse Event|2|||
163118371|NCT00526110|589140581|FG001|Overall Study|Adverse Event|9|||
163118372|NCT00526110|589140580|FG000|Overall Study|Disease Progression|0|||
163118373|NCT00526110|589140581|FG001|Overall Study|Disease Progression|19|||
163118374|NCT00526110|589140580|FG000|Overall Study|Maximal Response|0|||
163118375|NCT00526110|589140581|FG001|Overall Study|Maximal Response|6|||
163118376|NCT00526110|589140580|FG000|Overall Study|Withdrawal by Subject|0|||
163118377|NCT00526110|589140581|FG001|Overall Study|Withdrawal by Subject|2|||
163118378|NCT00526110|589140580|FG000|Overall Study|Poor Tolerance|0|||
163118379|NCT00526110|589140581|FG001|Overall Study|Poor Tolerance|5|||
163118380|NCT01400243|589140582|FG000|Overall Study|Protocol Violation|8|||
163118381|NCT01400243|589140583|FG001|Overall Study|Protocol Violation|11|||
163118382|NCT00953680|589140584|FG000|Period 1|Withdrawal by Subject|0|||
163118383|NCT00953680|589140585|FG001|Period 1|Withdrawal by Subject|1|||
163118384|NCT00570037|589142551|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
163118385|NCT00570037|589142552|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
163118386|NCT03946124|589142553|FG000|Overall Study|Withdrawal by Subject|19|||
163118387|NCT02118597|589142555|FG000|Overall Study|Sponsor terminated the study|14|||
163118388|NCT02118597|589142555|FG000|Overall Study|Serious Adverse Event|1|||
163118389|NCT02118597|589142555|FG000|Overall Study|Investigator's decision|1|||
163118390|NCT01891344|589142556|FG000|Overall Study|Ongoing|6|||
163118391|NCT01891344|589142557|FG001|Overall Study|Ongoing|2|||
163118392|NCT01891344|589142558|FG002|Overall Study|Ongoing|0|||
163118393|NCT01891344|589142559|FG003|Overall Study|Ongoing|1|||
163118394|NCT01891344|589142560|FG004|Overall Study|Ongoing|4|||
163118395|NCT01891344|589142561|FG005|Overall Study|Ongoing|1|||
163118396|NCT01891344|589142562|FG006|Overall Study|Ongoing|0|||
163118397|NCT01891344|589142563|FG007|Overall Study|Ongoing|0|||
162654531|NCT02103478|587451607|FG003|Overall Study|Progressive Disease|0|||
163118398|NCT01852825|589142564|FG000|Overall Study|Withdrawal by Subject|2|||
163118399|NCT01852825|589142565|FG001|Overall Study|Withdrawal by Subject|0|||
163118400|NCT01852825|589142566|FG002|Overall Study|Withdrawal by Subject|0|||
163118401|NCT01665430|589142567|FG000|Overall Study|Adverse Event|1|||
163118402|NCT01665430|589142567|FG000|Overall Study|Withdrawal by Subject|6|||
163118403|NCT01665430|589142567|FG000|Overall Study|Other Unspecified|2|||
163118404|NCT02310230|589142568|FG000|Overall Study|Physician Decision|1|||
163118405|NCT02310230|589142569|FG001|Overall Study|Physician Decision|3|||
163118406|NCT02310230|589142568|FG000|Overall Study|monitor baseline taken after induction|2|||
163118407|NCT02310230|589142569|FG001|Overall Study|monitor baseline taken after induction|7|||
163118408|NCT02310230|589142568|FG000|Overall Study|Poor signal quality|5|||
163118409|NCT02310230|589142569|FG001|Overall Study|Poor signal quality|8|||
163118410|NCT02310230|589142568|FG000|Overall Study|Case cancelled|1|||
163118411|NCT02310230|589142569|FG001|Overall Study|Case cancelled|0|||
163118412|NCT03593681|589142570|FG000|Overall Study|Inadequate sample collected|12|||
163118413|NCT03593681|589142570|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
163118414|NCT03593681|589142570|FG000|Overall Study|Protocol Violation|3|||
163118415|NCT03593681|589142570|FG000|Overall Study|Withdrawal by Subject|3|||
163118416|NCT03593681|589142570|FG000|Overall Study|Procedure not attempted|3|||
163118417|NCT03593681|589142570|FG000|Overall Study|Adverse Event|2|||
163118418|NCT03593681|589142570|FG000|Overall Study|Physician Decision|1|||
163118419|NCT01149486|589142573|FG000|First Intervention|Adverse Event|0|||
163118420|NCT01149486|589142574|FG001|First Intervention|Adverse Event|1|||
163118421|NCT04662073|589142575|FG000|Overall Study|Withdrawal by Subject|1|||
163118422|NCT04662073|589142576|FG001|Overall Study|Withdrawal by Subject|0|||
163118423|NCT00598078|589142579|FG000|Period 2 (Day 2)|Adverse Event|1|||
163118424|NCT00598078|589142580|FG001|Period 2 (Day 2)|Adverse Event|0|||
163118425|NCT03366103|589142584|FG000|Overall Study|Disease Progression|3|||
163118426|NCT03366103|589142585|FG001|Overall Study|Disease Progression|1|||
163118427|NCT03366103|589142586|FG002|Overall Study|Disease Progression|0|||
163118428|NCT03366103|589142584|FG000|Overall Study|Adverse Event|0|||
163118429|NCT03366103|589142585|FG001|Overall Study|Adverse Event|1|||
163118430|NCT03366103|589142586|FG002|Overall Study|Adverse Event|0|||
163118431|NCT00541099|589142587|FG000|Overall Study|Ineligible|3|||
163118432|NCT05590000|589142594|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
163118433|NCT01174004|589142595|FG000|Overall Study|Adverse Event|2|||
163118434|NCT01174004|589142596|FG001|Overall Study|Adverse Event|10|||
163118435|NCT01174004|589142595|FG000|Overall Study|Withdrawal by Subject|2|||
163118436|NCT01174004|589142596|FG001|Overall Study|Withdrawal by Subject|3|||
163118437|NCT01174004|589142595|FG000|Overall Study|At Discretion of Sponsor|2|||
163118438|NCT01174004|589142596|FG001|Overall Study|At Discretion of Sponsor|2|||
163118439|NCT01174004|589142595|FG000|Overall Study|Protocol Violation|0|||
163118440|NCT01174004|589142596|FG001|Overall Study|Protocol Violation|1|||
163118441|NCT01174004|589142595|FG000|Overall Study|Physician Decision|1|||
163118442|NCT01174004|589142596|FG001|Overall Study|Physician Decision|0|||
163118443|NCT02689076|589142597|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
163118444|NCT02689076|589142598|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
163118445|NCT02689076|589142599|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
163118446|NCT02689076|589142597|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
163118447|NCT02689076|589142598|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
163118448|NCT02689076|589142599|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
163118449|NCT02689076|589142597|FG000|Overall Study|Did not have an HIE match|2|||
163118450|NCT02689076|589142598|FG001|Overall Study|Did not have an HIE match|0|||
163118451|NCT02689076|589142599|FG002|Overall Study|Did not have an HIE match|0|||
163118452|NCT02689076|589142597|FG000|Overall Study|Death during non-VA encounter|2|||
163118453|NCT02689076|589142598|FG001|Overall Study|Death during non-VA encounter|5|||
163118454|NCT02689076|589142599|FG002|Overall Study|Death during non-VA encounter|0|||
163118455|NCT02689076|589142597|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
163118456|NCT02689076|589142598|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
163118457|NCT02689076|589142599|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
163118458|NCT02689076|589142597|FG000|Overall Study|Participant no longer active in VA system|1|||
163118459|NCT02689076|589142598|FG001|Overall Study|Participant no longer active in VA system|0|||
163118460|NCT02689076|589142599|FG002|Overall Study|Participant no longer active in VA system|0|||
163118461|NCT02689076|589142597|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
163118462|NCT02689076|589142598|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
163118463|NCT02689076|589142599|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
163118464|NCT00933244|589142600|FG000|Overall Study|Withdrawal by Subject|5|||
163118465|NCT00933244|589142601|FG001|Overall Study|Withdrawal by Subject|1|||
163118466|NCT00933244|589142602|FG002|Overall Study|Withdrawal by Subject|3|||
163118467|NCT00434759|589142605|FG000|Overall Study|Lack of Efficacy|5|||
163118468|NCT00434759|589142606|FG001|Overall Study|Lack of Efficacy|4|||
163118469|NCT00434759|589142605|FG000|Overall Study|Withdrawal by Subject|17|||
163118470|NCT00434759|589142606|FG001|Overall Study|Withdrawal by Subject|1|||
163118471|NCT00434759|589142605|FG000|Overall Study|family affairs|2|||
163118472|NCT00434759|589142606|FG001|Overall Study|family affairs|0|||
163118473|NCT01143896|589142613|FG000|Overall Study|Did not complete Baseline Interview|5|||
163118474|NCT01143896|589142614|FG001|Overall Study|Did not complete Baseline Interview|4|||
163118475|NCT01143896|589142613|FG000|Overall Study|Lost to Follow-up|18|||
163118476|NCT01143896|589142614|FG001|Overall Study|Lost to Follow-up|13|||
163118477|NCT01143896|589142613|FG000|Overall Study|Withdrawal by Subject|13|||
163118478|NCT01143896|589142614|FG001|Overall Study|Withdrawal by Subject|5|||
163118479|NCT01143896|589142613|FG000|Overall Study|Death|6|||
163118480|NCT01143896|589142614|FG001|Overall Study|Death|3|||
163118481|NCT01318070|589142615|FG000|Overall Study|Adverse Event|1|||
163118482|NCT01318070|589142616|FG001|Overall Study|Adverse Event|1|||
163118483|NCT01318070|589142617|FG002|Overall Study|Adverse Event|5|||
163118484|NCT01318070|589142615|FG000|Overall Study|Withdrawal by Subject|0|||
163118485|NCT01318070|589142616|FG001|Overall Study|Withdrawal by Subject|1|||
163118486|NCT01318070|589142617|FG002|Overall Study|Withdrawal by Subject|1|||
163118487|NCT01318070|589142615|FG000|Overall Study|Lack of Efficacy|0|||
163118488|NCT01318070|589142616|FG001|Overall Study|Lack of Efficacy|0|||
163118489|NCT01318070|589142617|FG002|Overall Study|Lack of Efficacy|1|||
163118490|NCT01318070|589142615|FG000|Overall Study|Principal Investigator Discretion|1|||
163118491|NCT01318070|589142616|FG001|Overall Study|Principal Investigator Discretion|0|||
163118492|NCT01318070|589142617|FG002|Overall Study|Principal Investigator Discretion|0|||
163118493|NCT00693472|589142620|FG000|Part 1|Adverse Event|1|||
163118494|NCT00693472|589142621|FG001|Part 1|Adverse Event|1|||
163118495|NCT00693472|589142622|FG002|Part 1|Adverse Event|0|||
163118496|NCT00693472|589142623|FG003|Part 1|Adverse Event|0|||
163118497|NCT00693472|589142620|FG000|Part 1|Lost to Follow-up|0|||
163118498|NCT00693472|589142621|FG001|Part 1|Lost to Follow-up|1|||
163118499|NCT00693472|589142622|FG002|Part 1|Lost to Follow-up|0|||
163118500|NCT00693472|589142623|FG003|Part 1|Lost to Follow-up|0|||
163118501|NCT00693472|589142620|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
163118502|NCT00693472|589142621|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
163118503|NCT00693472|589142622|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
163118504|NCT00693472|589142623|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
163118505|NCT00693472|589142620|FG000|Part 2|Adverse Event|0|||
163118506|NCT00693472|589142621|FG001|Part 2|Adverse Event|0|||
163118507|NCT00693472|589142622|FG002|Part 2|Adverse Event|1|||
163118508|NCT00693472|589142623|FG003|Part 2|Adverse Event|0|||
163118509|NCT00693472|589142620|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
163118510|NCT00693472|589142621|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
163118511|NCT00693472|589142622|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
163118512|NCT00693472|589142623|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
163118513|NCT00042432|589142624|FG000|Overall Study|Adverse Event|4|||
163118514|NCT00042432|589142625|FG001|Overall Study|Adverse Event|1|||
163118515|NCT00042432|589142624|FG000|Overall Study|Withdrawal by Subject|1|||
163118516|NCT00042432|589142625|FG001|Overall Study|Withdrawal by Subject|3|||
163118517|NCT00042432|589142624|FG000|Overall Study|Death|0|||
163118518|NCT00042432|589142625|FG001|Overall Study|Death|2|||
163118519|NCT00042432|589142624|FG000|Overall Study|Ineligibility determined|1|||
163118520|NCT00042432|589142625|FG001|Overall Study|Ineligibility determined|0|||
163118521|NCT00042432|589142624|FG000|Overall Study|Initiation of maintenance dialysis|1|||
163118522|NCT00042432|589142625|FG001|Overall Study|Initiation of maintenance dialysis|1|||
163118523|NCT00042432|589142624|FG000|Overall Study|Other|2|||
163118524|NCT00042432|589142625|FG001|Overall Study|Other|0|||
163118525|NCT00849875|589142627|FG000|Overall Study|Death|28|||
163118526|NCT00849875|589142627|FG000|Overall Study|Ongoing (unknown completion status)|11|||
163118527|NCT00849875|589142627|FG000|Overall Study|Others|6|||
163118528|NCT00849875|589142627|FG000|Overall Study|Lost to Follow-up|2|||
163118529|NCT02966795|589142629|FG000|Overall Study|Patient Left the Country|0|||
163118530|NCT02966795|589142630|FG001|Overall Study|Patient Left the Country|1|||
163118531|NCT00432744|589142631|FG000|Months 0-6|Withdrawal by Subject|4|||
162654532|NCT02103478|587451608|FG004|Overall Study|Progressive Disease|9|||
163118532|NCT00432744|589142632|FG001|Months 0-6|Withdrawal by Subject|4|||
163118533|NCT00432744|589142631|FG000|Months 0-6|Too disabled to score|1|||
163118534|NCT00432744|589142632|FG001|Months 0-6|Too disabled to score|0|||
163118535|NCT00432744|589142631|FG000|Months 7 - 12|Withdrawal by Subject|1|||
163118536|NCT00432744|589142632|FG001|Months 7 - 12|Withdrawal by Subject|0|||
163118537|NCT00432744|589142631|FG000|Months 7 - 12|Too disabled to score|0|||
163118538|NCT00432744|589142632|FG001|Months 7 - 12|Too disabled to score|1|||
163118539|NCT00461305|589142635|FG000|Treatment|Adverse Event|26|||
163118540|NCT00461305|589142636|FG001|Treatment|Adverse Event|3|||
163118541|NCT00461305|589142635|FG000|Treatment|Lost to Follow-up|4|||
163118542|NCT00461305|589142636|FG001|Treatment|Lost to Follow-up|2|||
163118543|NCT00461305|589142635|FG000|Treatment|Protocol Violation|13|||
163118544|NCT00461305|589142636|FG001|Treatment|Protocol Violation|2|||
163118545|NCT00461305|589142635|FG000|Treatment|Withdrawal by Subject|48|||
163118546|NCT00461305|589142636|FG001|Treatment|Withdrawal by Subject|2|||
163118547|NCT00461305|589142635|FG000|Treatment|Never dispensed|5|||
163118548|NCT00461305|589142636|FG001|Treatment|Never dispensed|0|||
163118549|NCT00461305|589142635|FG000|Treatment|Study drug not taken|1|||
163118550|NCT00461305|589142636|FG001|Treatment|Study drug not taken|0|||
163118551|NCT00461305|589142635|FG000|Treatment|Partially missing diary|2|||
162654533|NCT02103478|587451609|FG005|Overall Study|Progressive Disease|1|||
162654534|NCT02103478|587451610|FG006|Overall Study|Progressive Disease|2|||
162654535|NCT02103478|587451611|FG007|Overall Study|Progressive Disease|0|||
162654536|NCT02103478|587451612|FG008|Overall Study|Progressive Disease|1|||
162654537|NCT02103478|587451604|FG000|Overall Study|Withdrawal by Subject|2|||
162654538|NCT02103478|587451605|FG001|Overall Study|Withdrawal by Subject|0|||
162654539|NCT02103478|587451606|FG002|Overall Study|Withdrawal by Subject|0|||
162654540|NCT02103478|587451607|FG003|Overall Study|Withdrawal by Subject|4|||
162654541|NCT02103478|587451608|FG004|Overall Study|Withdrawal by Subject|0|||
162654542|NCT02103478|587451609|FG005|Overall Study|Withdrawal by Subject|0|||
162654543|NCT02103478|587451610|FG006|Overall Study|Withdrawal by Subject|1|||
162654544|NCT02103478|587451611|FG007|Overall Study|Withdrawal by Subject|1|||
162654545|NCT02103478|587451612|FG008|Overall Study|Withdrawal by Subject|0|||
162654546|NCT02103478|587451604|FG000|Overall Study|Lost to Follow-up|0|||
162654547|NCT02103478|587451605|FG001|Overall Study|Lost to Follow-up|0|||
162654548|NCT02103478|587451606|FG002|Overall Study|Lost to Follow-up|0|||
162654549|NCT02103478|587451607|FG003|Overall Study|Lost to Follow-up|0|||
162654550|NCT02103478|587451608|FG004|Overall Study|Lost to Follow-up|0|||
162654551|NCT02103478|587451609|FG005|Overall Study|Lost to Follow-up|0|||
162654552|NCT02103478|587451610|FG006|Overall Study|Lost to Follow-up|0|||
162654553|NCT02103478|587451611|FG007|Overall Study|Lost to Follow-up|1|||
162654554|NCT02103478|587451612|FG008|Overall Study|Lost to Follow-up|0|||
162654555|NCT02103478|587451604|FG000|Overall Study|Other|1|||
162654556|NCT02103478|587451605|FG001|Overall Study|Other|3|||
162654557|NCT02103478|587451606|FG002|Overall Study|Other|2|||
162654558|NCT02103478|587451607|FG003|Overall Study|Other|0|||
162654559|NCT02103478|587451608|FG004|Overall Study|Other|3|||
162654560|NCT02103478|587451609|FG005|Overall Study|Other|8|||
162654561|NCT02103478|587451610|FG006|Overall Study|Other|8|||
162654562|NCT02103478|587451611|FG007|Overall Study|Other|4|||
162654563|NCT02103478|587451612|FG008|Overall Study|Other|2|||
162654564|NCT03219333|587451613|FG000|Overall Study|Withdrawal by Subject|9|||
162654565|NCT03219333|587451614|FG001|Overall Study|Withdrawal by Subject|4|||
162654566|NCT03219333|587451613|FG000|Overall Study|Lost to Follow-up|1|||
162654567|NCT03219333|587451614|FG001|Overall Study|Lost to Follow-up|1|||
162654568|NCT03219333|587451613|FG000|Overall Study|Death|104|||
162654569|NCT03219333|587451614|FG001|Overall Study|Death|72|||
162654570|NCT03219333|587451613|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
162654571|NCT03219333|587451614|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
162654572|NCT03219333|587451613|FG000|Overall Study|Other|2|||
162654573|NCT03219333|587451614|FG001|Overall Study|Other|2|||
162654574|NCT00723606|587451615|FG000|Overall Study|Adverse Event|2|||
162654575|NCT00723606|587451616|FG001|Overall Study|Adverse Event|5|||
162654576|NCT00723606|587451615|FG000|Overall Study|Other|2|||
162654577|NCT00723606|587451616|FG001|Overall Study|Other|0|||
162654578|NCT00723606|587451615|FG000|Overall Study|Withdrawal by Subject|0|||
162654579|NCT00723606|587451616|FG001|Overall Study|Withdrawal by Subject|2|||
162654580|NCT02566759|587451617|FG000|All Parts|Withdrawal by Subject|0|||
162654581|NCT02566759|587451618|FG001|All Parts|Withdrawal by Subject|1|||
162654582|NCT02566759|587451619|FG002|All Parts|Withdrawal by Subject|0|||
162654583|NCT02566759|587451620|FG003|All Parts|Withdrawal by Subject|0|||
162654584|NCT02566759|587451621|FG004|All Parts|Withdrawal by Subject|0|||
162654585|NCT02566759|587451622|FG005|All Parts|Withdrawal by Subject|0|||
162654586|NCT02566759|587451623|FG006|All Parts|Withdrawal by Subject|0|||
162654587|NCT02566759|587451624|FG007|All Parts|Withdrawal by Subject|0|||
162719385|NCT00530842|587678488|FG000|Period 2|Protocol Violation|1|||
163118552|NCT00461305|589142636|FG001|Treatment|Partially missing diary|0|||
162719386|NCT00530842|587678489|FG001|Period 2|Protocol Violation|0|||
162719387|NCT00530842|587678488|FG000|Period 2|Withdrawal by Subject|1|||
162719388|NCT00530842|587678489|FG001|Period 2|Withdrawal by Subject|2|||
162719389|NCT00530842|587678488|FG000|Period 2|Individual different reasons|2|||
163118553|NCT00461305|589142635|FG000|Treatment|Other (missing drug etc)|2|||
163118554|NCT00461305|589142636|FG001|Treatment|Other (missing drug etc)|0|||
163118555|NCT00461305|589142635|FG000|Continued Treatment|Adverse Event|26|||
163118556|NCT00461305|589142636|FG001|Continued Treatment|Adverse Event|0|||
162654588|NCT02566759|587451625|FG008|All Parts|Withdrawal by Subject|0|||
162654589|NCT02566759|587451626|FG009|All Parts|Withdrawal by Subject|0|||
162654590|NCT02566759|587451627|FG010|All Parts|Withdrawal by Subject|0|||
162654591|NCT02566759|587451628|FG011|All Parts|Withdrawal by Subject|0|||
162654592|NCT02566759|587451629|FG012|All Parts|Withdrawal by Subject|0|||
162654593|NCT02566759|587451630|FG013|All Parts|Withdrawal by Subject|0|||
162654594|NCT02566759|587451631|FG014|All Parts|Withdrawal by Subject|0|||
162654595|NCT02566759|587451632|FG015|All Parts|Withdrawal by Subject|0|||
162654596|NCT02566759|587451633|FG016|All Parts|Withdrawal by Subject|0|||
162654597|NCT02566759|587451617|FG000|All Parts|Adverse Event|0|||
162719390|NCT00530842|587678489|FG001|Period 2|Individual different reasons|0|||
162719391|NCT00082810|587678491|FG000|Overall Study|Adverse Event|3|||
162719392|NCT00082810|587678491|FG000|Overall Study|Progressive disease|24|||
162719393|NCT00082810|587678491|FG000|Overall Study|Withdrawal by Subject|4|||
162719394|NCT00177216|587678492|FG000|Overall Study|Withdrawal by Subject|6|||
162719395|NCT00177216|587678493|FG001|Overall Study|Withdrawal by Subject|3|||
162719396|NCT00177216|587678494|FG002|Overall Study|Withdrawal by Subject|1|||
162719397|NCT01161498|587678497|FG000|Overall Study|Disease Progression|0|||
162719398|NCT01161498|587678498|FG001|Overall Study|Disease Progression|1|||
162719399|NCT03310983|587678504|FG000|Overall Study|Lost to Follow-up|15|||
162719400|NCT03310983|587678505|FG001|Overall Study|Lost to Follow-up|17|||
162719401|NCT01656304|587678506|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
162719402|NCT00823979|587678509|FG000|Overall Study|Lack of Efficacy|13|||
162719403|NCT00823979|587678510|FG001|Overall Study|Lack of Efficacy|16|||
162719404|NCT00823979|587678511|FG002|Overall Study|Lack of Efficacy|9|||
162719405|NCT00823979|587678509|FG000|Overall Study|Lost to Follow-up|2|||
162719406|NCT00823979|587678510|FG001|Overall Study|Lost to Follow-up|1|||
162719407|NCT00823979|587678511|FG002|Overall Study|Lost to Follow-up|0|||
162719408|NCT00823979|587678509|FG000|Overall Study|Withdrawal by Subject|2|||
162719409|NCT00823979|587678510|FG001|Overall Study|Withdrawal by Subject|3|||
162719410|NCT00823979|587678511|FG002|Overall Study|Withdrawal by Subject|2|||
162719411|NCT00823979|587678509|FG000|Overall Study|Protocol Violation|1|||
162719412|NCT00823979|587678510|FG001|Overall Study|Protocol Violation|1|||
162719413|NCT00823979|587678511|FG002|Overall Study|Protocol Violation|0|||
162719414|NCT00823979|587678509|FG000|Overall Study|Pregnancy|0|||
162719415|NCT00823979|587678510|FG001|Overall Study|Pregnancy|1|||
162719416|NCT00823979|587678511|FG002|Overall Study|Pregnancy|0|||
162719417|NCT00823979|587678509|FG000|Overall Study|Adverse Event|0|||
162719418|NCT00823979|587678510|FG001|Overall Study|Adverse Event|2|||
162719419|NCT00823979|587678511|FG002|Overall Study|Adverse Event|4|||
162719420|NCT00823979|587678509|FG000|Overall Study|Other|2|||
162719421|NCT00823979|587678510|FG001|Overall Study|Other|0|||
162719422|NCT00823979|587678511|FG002|Overall Study|Other|1|||
162719423|NCT00823979|587678509|FG000|Overall Study|Randomized but not Treated|4|||
162719424|NCT00823979|587678510|FG001|Overall Study|Randomized but not Treated|3|||
162719425|NCT00823979|587678511|FG002|Overall Study|Randomized but not Treated|1|||
162719426|NCT00823979|587678509|FG000|Overall Study|Study Terminated by Sponsor|5|||
162719427|NCT00823979|587678510|FG001|Overall Study|Study Terminated by Sponsor|5|||
162719428|NCT00823979|587678511|FG002|Overall Study|Study Terminated by Sponsor|7|||
162719429|NCT03523091|587678512|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
162719430|NCT03523091|587678513|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
162719431|NCT03523091|587678512|FG000|Overall Study|Withdrawal by Subject|0|||
162719432|NCT03523091|587678513|FG001|Overall Study|Withdrawal by Subject|3|||
162719433|NCT03523091|587678512|FG000|Overall Study|Increase Botox dose|0|||
162719434|NCT03523091|587678513|FG001|Overall Study|Increase Botox dose|1|||
162719435|NCT01093534|587678514|FG000|Overall Study|Adverse Event|2|||
162719436|NCT01093534|587678515|FG001|Overall Study|Adverse Event|5|||
162719437|NCT01093534|587678516|FG002|Overall Study|Adverse Event|2|||
162719438|NCT01093534|587678514|FG000|Overall Study|Lack of Efficacy|2|||
162719439|NCT01093534|587678515|FG001|Overall Study|Lack of Efficacy|1|||
162719440|NCT01093534|587678516|FG002|Overall Study|Lack of Efficacy|1|||
162719441|NCT01093534|587678514|FG000|Overall Study|Withdrawal by Subject|5|||
162719442|NCT01093534|587678515|FG001|Overall Study|Withdrawal by Subject|7|||
162719443|NCT01093534|587678516|FG002|Overall Study|Withdrawal by Subject|2|||
162719444|NCT01093534|587678514|FG000|Overall Study|Other|1|||
162719445|NCT01093534|587678515|FG001|Overall Study|Other|3|||
162719446|NCT01093534|587678516|FG002|Overall Study|Other|4|||
162719447|NCT00741988|587678520|FG000|Overall Study|Adverse Event|2|||
162719448|NCT00741988|587678521|FG001|Overall Study|Adverse Event|4|||
162719449|NCT00741988|587678520|FG000|Overall Study|Lack of Efficacy|2|||
162719450|NCT00741988|587678521|FG001|Overall Study|Lack of Efficacy|0|||
162719451|NCT03863834|587678528|FG000|Overall Study|Lost to Follow-up|3|||
162719452|NCT02685488|587678529|FG000|Overall Study|Withdrawal by Subject|0|||
162719453|NCT02685488|587678530|FG001|Overall Study|Withdrawal by Subject|1|||
162719454|NCT04436120|587678531|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162719455|NCT04436120|587678532|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162719456|NCT04436120|587678533|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162719457|NCT04436120|587678534|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
162719458|NCT04436120|587678535|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162719459|NCT04436120|587678536|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
162719460|NCT04436120|587678537|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162719461|NCT05147233|587680479|FG000|Overall Study|Adverse Event|0|||
162719462|NCT05147233|587680480|FG001|Overall Study|Adverse Event|1|||
162719463|NCT05147233|587680479|FG000|Overall Study|Lost to Follow-up|1|||
162719464|NCT05147233|587680480|FG001|Overall Study|Lost to Follow-up|1|||
162719465|NCT05147233|587680479|FG000|Overall Study|Protocol Violation|0|||
162719466|NCT05147233|587680480|FG001|Overall Study|Protocol Violation|1|||
162719467|NCT05147233|587680479|FG000|Overall Study|Withdrawal by Subject|2|||
162654598|NCT02566759|587451618|FG001|All Parts|Adverse Event|0|||
162654599|NCT02566759|587451619|FG002|All Parts|Adverse Event|0|||
162654600|NCT02566759|587451620|FG003|All Parts|Adverse Event|0|||
162654601|NCT02566759|587451621|FG004|All Parts|Adverse Event|0|||
163118557|NCT00461305|589142635|FG000|Continued Treatment|Lost to Follow-up|4|||
163118558|NCT00461305|589142636|FG001|Continued Treatment|Lost to Follow-up|0|||
163118559|NCT00461305|589142635|FG000|Continued Treatment|Protocol Violation|13|||
163118560|NCT00461305|589142636|FG001|Continued Treatment|Protocol Violation|0|||
163118561|NCT00461305|589142635|FG000|Continued Treatment|Withdrawal by Subject|48|||
163118562|NCT00461305|589142636|FG001|Continued Treatment|Withdrawal by Subject|0|||
163118563|NCT00461305|589142635|FG000|Continued Treatment|Partially missing diary|2|||
163118564|NCT00461305|589142636|FG001|Continued Treatment|Partially missing diary|0|||
163118565|NCT00461305|589142635|FG000|Continued Treatment|Other (missing drug etc)|2|||
163118566|NCT00461305|589142636|FG001|Continued Treatment|Other (missing drug etc)|0|||
163118567|NCT02513823|589142637|FG000|Overall Study|Lost to Follow-up|4|||
163118568|NCT02513823|589142637|FG000|Overall Study|Physician Decision|1|||
163118569|NCT02743780|589142638|FG000|Part 3 (7 Days)|Adverse Event|0|||
163118570|NCT02743780|589142639|FG001|Part 3 (7 Days)|Adverse Event|0|||
163118571|NCT02743780|589142640|FG002|Part 3 (7 Days)|Adverse Event|1|||
163118572|NCT02743780|589142641|FG003|Part 3 (7 Days)|Adverse Event|0|||
163118573|NCT02743780|589142642|FG004|Part 3 (7 Days)|Adverse Event|0|||
163118574|NCT01294462|589142643|FG000|Overall Study|Lost to Follow-up|1|||
163118575|NCT01294462|589142644|FG001|Overall Study|Lost to Follow-up|0|||
163118576|NCT01294462|589142643|FG000|Overall Study|Withdrawal by Subject|65|||
163118577|NCT01294462|589142644|FG001|Overall Study|Withdrawal by Subject|63|||
163118578|NCT04342689|589142648|FG000|Overall Study|Withdrawal by Subject|32|||
163118579|NCT04342689|589142649|FG001|Overall Study|Withdrawal by Subject|33|||
163118580|NCT04342689|589142648|FG000|Overall Study|Lost to Follow-up|10|||
163118581|NCT04342689|589142649|FG001|Overall Study|Lost to Follow-up|12|||
163118582|NCT01460407|589142650|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
163118583|NCT01460407|589142651|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
163118584|NCT00844805|589142653|FG000|Treatment Phase|Adverse Event|5|||
163118585|NCT00844805|589142654|FG001|Treatment Phase|Adverse Event|1|||
163118586|NCT00844805|589142655|FG002|Treatment Phase|Adverse Event|0|||
163118587|NCT00844805|589142656|FG003|Treatment Phase|Adverse Event|0|||
163118588|NCT00844805|589142653|FG000|Treatment Phase|Withdrawal by Subject|3|||
163118589|NCT00844805|589142654|FG001|Treatment Phase|Withdrawal by Subject|4|||
163118590|NCT00844805|589142655|FG002|Treatment Phase|Withdrawal by Subject|0|||
163118591|NCT00844805|589142656|FG003|Treatment Phase|Withdrawal by Subject|0|||
163118592|NCT00844805|589142653|FG000|Treatment Phase|Noncompliance With Protocol|1|||
163118593|NCT00844805|589142654|FG001|Treatment Phase|Noncompliance With Protocol|0|||
163118594|NCT00844805|589142655|FG002|Treatment Phase|Noncompliance With Protocol|0|||
163118595|NCT00844805|589142656|FG003|Treatment Phase|Noncompliance With Protocol|0|||
163118596|NCT00844805|589142653|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
163118597|NCT00844805|589142654|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
163118598|NCT00844805|589142655|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
163118599|NCT00844805|589142656|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
163118600|NCT00844805|589142653|FG000|Follow-Up Phase|Adverse Event|0|||
163118601|NCT00844805|589142654|FG001|Follow-Up Phase|Adverse Event|0|||
163118602|NCT00844805|589142655|FG002|Follow-Up Phase|Adverse Event|1|||
163118603|NCT00844805|589142656|FG003|Follow-Up Phase|Adverse Event|0|||
163118604|NCT00844805|589142653|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
163118605|NCT00844805|589142654|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163118606|NCT00844805|589142655|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
163118607|NCT00844805|589142656|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
163118608|NCT00844805|589142653|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
163118609|NCT00844805|589142654|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
163118610|NCT00844805|589142655|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
163118611|NCT00844805|589142656|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
163118612|NCT00844805|589142653|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
163118613|NCT00844805|589142654|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
163118614|NCT00844805|589142655|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
163118615|NCT00844805|589142656|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
163118616|NCT00844805|589142653|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118617|NCT00844805|589142654|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118618|NCT00844805|589142655|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163118619|NCT00844805|589142656|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
163118620|NCT00259298|589142660|FG000|Overall Study|Withdrawal by Subject|1|||
163118621|NCT00259298|589142660|FG000|Overall Study|Physician Decision|2|||
163118622|NCT01011933|589142661|FG000|Overall Study|Wrong cell type|1|||
163118623|NCT01011933|589142661|FG000|Overall Study|Improper pre-protocol Rx|1|||
163118624|NCT01011933|589142661|FG000|Overall Study|Inadequate pathology|1|||
163118625|NCT01011933|589142661|FG000|Overall Study|Never treated|1|||
163118626|NCT00475865|589142663|FG000|Overall Study|Adverse Event|0|||
162654602|NCT02566759|587451622|FG005|All Parts|Adverse Event|0|||
162654603|NCT02566759|587451623|FG006|All Parts|Adverse Event|0|||
162654604|NCT02566759|587451624|FG007|All Parts|Adverse Event|0|||
162654605|NCT02566759|587451625|FG008|All Parts|Adverse Event|0|||
162654606|NCT02566759|587451626|FG009|All Parts|Adverse Event|0|||
162654607|NCT02566759|587451627|FG010|All Parts|Adverse Event|0|||
162654608|NCT02566759|587451628|FG011|All Parts|Adverse Event|0|||
162654609|NCT02566759|587451629|FG012|All Parts|Adverse Event|1|||
163118627|NCT00475865|589142664|FG001|Overall Study|Adverse Event|3|||
163118628|NCT00475865|589142665|FG002|Overall Study|Adverse Event|4|||
163118629|NCT00475865|589142663|FG000|Overall Study|Lack of Efficacy|1|||
163118630|NCT00475865|589142664|FG001|Overall Study|Lack of Efficacy|0|||
163118631|NCT00475865|589142665|FG002|Overall Study|Lack of Efficacy|0|||
163118632|NCT00475865|589142663|FG000|Overall Study|Progressive disease|0|||
163118633|NCT00475865|589142664|FG001|Overall Study|Progressive disease|1|||
163118634|NCT00475865|589142665|FG002|Overall Study|Progressive disease|2|||
163118635|NCT00475865|589142663|FG000|Overall Study|Participant did not wish to continue|1|||
163118636|NCT00475865|589142664|FG001|Overall Study|Participant did not wish to continue|0|||
163118637|NCT00475865|589142665|FG002|Overall Study|Participant did not wish to continue|0|||
163118638|NCT00475865|589142663|FG000|Overall Study|Other than above|0|||
163118639|NCT00475865|589142664|FG001|Overall Study|Other than above|1|||
163118640|NCT00475865|589142665|FG002|Overall Study|Other than above|0|||
163118641|NCT02726880|589142666|FG000|Overall Study|Withdrawal by Subject|2|||
163118642|NCT02726880|589142667|FG001|Overall Study|Withdrawal by Subject|0|||
163118643|NCT02726880|589142666|FG000|Overall Study|Lost to Follow-up|1|||
163118644|NCT02726880|589142667|FG001|Overall Study|Lost to Follow-up|3|||
163118645|NCT04316741|589142668|FG000|Baseline Enrollment|Lost to Follow-up|1|||
163118646|NCT04316741|589142669|FG001|Baseline Enrollment|Lost to Follow-up|1|||
163118647|NCT04316741|589142668|FG000|Immediate Post-Test|Lost to Follow-up|5|||
163118648|NCT04316741|589142669|FG001|Immediate Post-Test|Lost to Follow-up|1|||
163118649|NCT04316741|589142668|FG000|1-month Post-test|Lost to Follow-up|7|||
163118650|NCT04316741|589142669|FG001|1-month Post-test|Lost to Follow-up|2|||
163118651|NCT04316741|589142668|FG000|3-month Follow-up|Lost to Follow-up|10|||
163118652|NCT04316741|589142669|FG001|3-month Follow-up|Lost to Follow-up|2|||
163118653|NCT00787202|589142670|FG000|Overall Study|Adverse Event|3|||
163118654|NCT00787202|589142671|FG001|Overall Study|Adverse Event|2|||
163118655|NCT00787202|589142672|FG002|Overall Study|Adverse Event|0|||
163118656|NCT00787202|589142673|FG003|Overall Study|Adverse Event|0|||
163118657|NCT00787202|589142674|FG004|Overall Study|Adverse Event|2|||
163118658|NCT00787202|589142670|FG000|Overall Study|Lack of Efficacy|5|||
163118659|NCT00787202|589142671|FG001|Overall Study|Lack of Efficacy|6|||
163118660|NCT00787202|589142672|FG002|Overall Study|Lack of Efficacy|5|||
163118661|NCT00787202|589142673|FG003|Overall Study|Lack of Efficacy|2|||
163118662|NCT00787202|589142674|FG004|Overall Study|Lack of Efficacy|1|||
163118663|NCT00787202|589142670|FG000|Overall Study|Lost to Follow-up|1|||
163118664|NCT00787202|589142671|FG001|Overall Study|Lost to Follow-up|0|||
163118665|NCT00787202|589142672|FG002|Overall Study|Lost to Follow-up|0|||
163118666|NCT00787202|589142673|FG003|Overall Study|Lost to Follow-up|0|||
163118667|NCT00787202|589142674|FG004|Overall Study|Lost to Follow-up|0|||
163118668|NCT00787202|589142670|FG000|Overall Study|Withdrawal by Subject|2|||
163118669|NCT00787202|589142671|FG001|Overall Study|Withdrawal by Subject|2|||
163118670|NCT00787202|589142672|FG002|Overall Study|Withdrawal by Subject|2|||
163118671|NCT00787202|589142673|FG003|Overall Study|Withdrawal by Subject|0|||
163118672|NCT00787202|589142674|FG004|Overall Study|Withdrawal by Subject|0|||
163118673|NCT00787202|589142670|FG000|Overall Study|Protocol Violation|2|||
163118674|NCT00787202|589142671|FG001|Overall Study|Protocol Violation|1|||
163118675|NCT00787202|589142672|FG002|Overall Study|Protocol Violation|0|||
163118676|NCT00787202|589142673|FG003|Overall Study|Protocol Violation|0|||
163118677|NCT00787202|589142674|FG004|Overall Study|Protocol Violation|1|||
163118678|NCT00787202|589142670|FG000|Overall Study|Randomized, not treated|1|||
163118679|NCT00787202|589142671|FG001|Overall Study|Randomized, not treated|0|||
163118680|NCT00787202|589142672|FG002|Overall Study|Randomized, not treated|0|||
163118681|NCT00787202|589142673|FG003|Overall Study|Randomized, not treated|0|||
163118682|NCT00787202|589142674|FG004|Overall Study|Randomized, not treated|0|||
163118683|NCT01510145|589142675|FG000|Overall Study|Adverse Event|6|||
163118684|NCT01510145|589142675|FG000|Overall Study|Lost to Follow-up|5|||
162654610|NCT02566759|587451630|FG013|All Parts|Adverse Event|3|||
163118685|NCT01510145|589142675|FG000|Overall Study|Withdrawal by Subject|6|||
163118686|NCT01510145|589142675|FG000|Overall Study|Relative reported subject withdrew|1|||
163118687|NCT01442064|589142676|FG000|Overall Study|Adverse Event|2|||
163118688|NCT01442064|589142677|FG001|Overall Study|Adverse Event|2|||
162654611|NCT02566759|587451631|FG014|All Parts|Adverse Event|0|||
163118689|NCT01442064|589142678|FG002|Overall Study|Adverse Event|2|||
163118690|NCT01442064|589142679|FG003|Overall Study|Adverse Event|1|||
163118691|NCT01442064|589142680|FG004|Overall Study|Adverse Event|2|||
163118692|NCT01442064|589142681|FG005|Overall Study|Adverse Event|0|||
163118693|NCT01442064|589142676|FG000|Overall Study|Death|0|||
163118694|NCT01442064|589142677|FG001|Overall Study|Death|1|||
163118695|NCT01442064|589142678|FG002|Overall Study|Death|3|||
162654612|NCT02566759|587451632|FG015|All Parts|Adverse Event|0|||
163118696|NCT01442064|589142679|FG003|Overall Study|Death|3|||
163118697|NCT01442064|589142680|FG004|Overall Study|Death|1|||
162654613|NCT02566759|587451633|FG016|All Parts|Adverse Event|0|||
162654614|NCT02566759|587451617|FG000|All Parts|Other|0|||
162654615|NCT02566759|587451618|FG001|All Parts|Other|0|||
162654616|NCT02566759|587451619|FG002|All Parts|Other|0|||
162654617|NCT02566759|587451620|FG003|All Parts|Other|0|||
162654618|NCT02566759|587451621|FG004|All Parts|Other|0|||
162654619|NCT02566759|587451622|FG005|All Parts|Other|0|||
162654620|NCT02566759|587451623|FG006|All Parts|Other|0|||
162654621|NCT02566759|587451624|FG007|All Parts|Other|0|||
162654622|NCT02566759|587451625|FG008|All Parts|Other|0|||
162654623|NCT02566759|587451626|FG009|All Parts|Other|0|||
162654624|NCT02566759|587451627|FG010|All Parts|Other|0|||
162654625|NCT02566759|587451628|FG011|All Parts|Other|0|||
162654626|NCT02566759|587451629|FG012|All Parts|Other|0|||
162654627|NCT02566759|587451630|FG013|All Parts|Other|2|||
162654628|NCT02566759|587451631|FG014|All Parts|Other|0|||
162654629|NCT02566759|587451632|FG015|All Parts|Other|0|||
162654630|NCT02566759|587451633|FG016|All Parts|Other|0|||
162654631|NCT02566759|587451617|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654632|NCT02566759|587451618|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654633|NCT02566759|587451619|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654634|NCT02566759|587451620|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654635|NCT02566759|587451621|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654636|NCT02566759|587451622|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654637|NCT02566759|587451623|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654638|NCT02566759|587451624|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654639|NCT02566759|587451625|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654640|NCT02566759|587451626|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654641|NCT02566759|587451627|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654642|NCT02566759|587451628|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654643|NCT02566759|587451629|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654644|NCT02566759|587451630|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654645|NCT02566759|587451631|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654646|NCT02566759|587451632|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162654647|NCT02566759|587451633|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
162654648|NCT01096784|587451634|FG000|Overall Study|Withdrawal by Subject|2|||
162654649|NCT01096784|587451635|FG001|Overall Study|Withdrawal by Subject|1|||
162654650|NCT01096784|587451634|FG000|Overall Study|Adverse Event|11|||
162654651|NCT01096784|587451635|FG001|Overall Study|Adverse Event|9|||
162654652|NCT01096784|587451634|FG000|Overall Study|Protocol Deviation|2|||
162654653|NCT01096784|587451635|FG001|Overall Study|Protocol Deviation|2|||
162654654|NCT01096784|587451634|FG000|Overall Study|Administrative Decision|0|||
162654655|NCT01096784|587451635|FG001|Overall Study|Administrative Decision|1|||
162654656|NCT01096784|587451634|FG000|Overall Study|Other Unspecified|0|||
162654657|NCT01096784|587451635|FG001|Overall Study|Other Unspecified|1|||
162654658|NCT00976898|587451636|FG000|Overall Study|Protocol Violation|1|||
162654659|NCT00976898|587451636|FG000|Overall Study|Adverse Event|1|||
162654660|NCT00976898|587451636|FG000|Overall Study|Physician Decision|1|||
162654661|NCT00976898|587451636|FG000|Overall Study|Liver Transplant|1|||
162654662|NCT00976898|587451636|FG000|Overall Study|Progressive Disease|1|||
162654663|NCT05107128|587451637|FG000|Overall Study|Adverse Event|2|||
162654664|NCT05107128|587451638|FG001|Overall Study|Adverse Event|0|||
163118698|NCT01442064|589142681|FG005|Overall Study|Death|3|||
162654665|NCT05107128|587451637|FG000|Overall Study|Withdrawal by Subject|3|||
162654666|NCT05107128|587451638|FG001|Overall Study|Withdrawal by Subject|3|||
162654667|NCT05107128|587451637|FG000|Overall Study|Withdrawal of Consent|0|||
162654668|NCT05107128|587451638|FG001|Overall Study|Withdrawal of Consent|1|||
162654669|NCT05107128|587451637|FG000|Overall Study|Reason Not Specified|2|||
162654670|NCT05107128|587451638|FG001|Overall Study|Reason Not Specified|0|||
162654671|NCT03761628|587451639|FG000|Overall Study|Withdrawal by Subject|3|||
162654672|NCT03761628|587451639|FG000|Overall Study|Physician Decision|1|||
162654673|NCT03761628|587451639|FG000|Overall Study|Pregnancy|1|||
162654674|NCT03761628|587451639|FG000|Overall Study|Lost to Follow-up|1|||
162654675|NCT01470469|587451642|FG000|Overall Study|Withdrawal by Subject|4|||
162654676|NCT01470469|587451643|FG001|Overall Study|Withdrawal by Subject|6|||
162654677|NCT01470469|587451642|FG000|Overall Study|Lack of Efficacy|1|||
162654678|NCT01470469|587451643|FG001|Overall Study|Lack of Efficacy|7|||
163118699|NCT01442064|589142676|FG000|Overall Study|Lost to Follow-up|5|||
162654679|NCT01470469|587451642|FG000|Overall Study|Adverse Event|0|||
162654680|NCT01470469|587451643|FG001|Overall Study|Adverse Event|7|||
162654681|NCT01470469|587451642|FG000|Overall Study|Lost to Follow-up|2|||
162654682|NCT01470469|587451643|FG001|Overall Study|Lost to Follow-up|2|||
162654683|NCT01470469|587451642|FG000|Overall Study|Protocol Violation|1|||
162654684|NCT01470469|587451643|FG001|Overall Study|Protocol Violation|1|||
162654685|NCT01470469|587451642|FG000|Overall Study|Other|2|||
162654686|NCT01470469|587451643|FG001|Overall Study|Other|1|||
162654687|NCT05459129|587451644|FG000|Overall Study|Death|1|||
162654688|NCT05459129|587451645|FG001|Overall Study|Death|0|||
162654689|NCT05459129|587451644|FG000|Overall Study|Study Terminated By Sponsor|5|||
163118700|NCT01442064|589142677|FG001|Overall Study|Lost to Follow-up|5|||
163118701|NCT01442064|589142678|FG002|Overall Study|Lost to Follow-up|1|||
163118702|NCT01442064|589142679|FG003|Overall Study|Lost to Follow-up|1|||
163118703|NCT01442064|589142680|FG004|Overall Study|Lost to Follow-up|3|||
163118704|NCT01442064|589142681|FG005|Overall Study|Lost to Follow-up|3|||
163118705|NCT01442064|589142676|FG000|Overall Study|Physician Decision|1|||
163118706|NCT01442064|589142677|FG001|Overall Study|Physician Decision|1|||
163118707|NCT01442064|589142678|FG002|Overall Study|Physician Decision|2|||
163118708|NCT01442064|589142679|FG003|Overall Study|Physician Decision|3|||
163118709|NCT01442064|589142680|FG004|Overall Study|Physician Decision|3|||
163118710|NCT01442064|589142681|FG005|Overall Study|Physician Decision|1|||
163118711|NCT01442064|589142676|FG000|Overall Study|Withdrawal by Subject|6|||
163118712|NCT01442064|589142677|FG001|Overall Study|Withdrawal by Subject|3|||
163118713|NCT01442064|589142678|FG002|Overall Study|Withdrawal by Subject|2|||
163118714|NCT01442064|589142679|FG003|Overall Study|Withdrawal by Subject|2|||
163118715|NCT01442064|589142680|FG004|Overall Study|Withdrawal by Subject|2|||
163118716|NCT01442064|589142681|FG005|Overall Study|Withdrawal by Subject|1|||
163118717|NCT01442064|589142676|FG000|Overall Study|Sponsor decision|82|||
163118718|NCT01442064|589142677|FG001|Overall Study|Sponsor decision|88|||
163118719|NCT01442064|589142678|FG002|Overall Study|Sponsor decision|92|||
162654690|NCT05459129|587451645|FG001|Overall Study|Study Terminated By Sponsor|6|||
163118720|NCT01442064|589142679|FG003|Overall Study|Sponsor decision|88|||
163118721|NCT01442064|589142680|FG004|Overall Study|Sponsor decision|95|||
163118722|NCT01442064|589142681|FG005|Overall Study|Sponsor decision|87|||
163118723|NCT01442064|589142676|FG000|Overall Study|Subject non-compliance|0|||
163118724|NCT01442064|589142677|FG001|Overall Study|Subject non-compliance|0|||
163118725|NCT01442064|589142678|FG002|Overall Study|Subject non-compliance|0|||
163118726|NCT01442064|589142679|FG003|Overall Study|Subject non-compliance|0|||
163118727|NCT01442064|589142680|FG004|Overall Study|Subject non-compliance|0|||
163118728|NCT01442064|589142681|FG005|Overall Study|Subject non-compliance|2|||
163118729|NCT01442064|589142676|FG000|Overall Study|Condition mandated other intervention|1|||
163118730|NCT01442064|589142677|FG001|Overall Study|Condition mandated other intervention|1|||
163118731|NCT01442064|589142678|FG002|Overall Study|Condition mandated other intervention|2|||
163118732|NCT01442064|589142679|FG003|Overall Study|Condition mandated other intervention|0|||
163118733|NCT01442064|589142680|FG004|Overall Study|Condition mandated other intervention|0|||
163118734|NCT01442064|589142681|FG005|Overall Study|Condition mandated other intervention|2|||
163118735|NCT01360398|589142682|FG000|Overall Study|Withdrawal by Subject|14|||
163118736|NCT01360398|589142682|FG000|Overall Study|Other|7|||
163118737|NCT01360398|589142682|FG000|Overall Study|Migrated/moved from study area|1|||
163118738|NCT02153346|589142683|FG000|Overall Study|Lost to Follow-up|11|||
163118739|NCT01710527|589142684|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
163118740|NCT01710527|589142685|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
163118741|NCT01822535|589142686|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
163118742|NCT01822535|589142687|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
163118743|NCT01822535|589142686|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
163118744|NCT01822535|589142687|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
163118745|NCT01822535|589142686|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
163118746|NCT01822535|589142687|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
163118747|NCT02278614|589142690|FG000|Overall Study|Withdrawal by Subject|3|||
163118748|NCT02278614|589142691|FG001|Overall Study|Withdrawal by Subject|5|||
163118749|NCT02278614|589142690|FG000|Overall Study|Adverse Event|1|||
163118750|NCT02278614|589142691|FG001|Overall Study|Adverse Event|0|||
163118751|NCT02278614|589142690|FG000|Overall Study|left eye was not eligible|1|||
163118752|NCT02278614|589142691|FG001|Overall Study|left eye was not eligible|0|||
163118753|NCT02279498|589142692|FG000|Overall Study|Adverse Event|3|||
163118754|NCT02279498|589142693|FG001|Overall Study|Adverse Event|0|||
163118755|NCT02279498|589142692|FG000|Overall Study|Lack of Efficacy|4|||
163118756|NCT02279498|589142693|FG001|Overall Study|Lack of Efficacy|0|||
163118757|NCT02279498|589142692|FG000|Overall Study|Lost to Follow-up|0|||
163118758|NCT02279498|589142693|FG001|Overall Study|Lost to Follow-up|1|||
163118759|NCT02279498|589142692|FG000|Overall Study|Withdrawal by Subject|9|||
163118760|NCT02279498|589142693|FG001|Overall Study|Withdrawal by Subject|2|||
163118761|NCT02279498|589142692|FG000|Overall Study|Undefined|2|||
163118762|NCT02279498|589142693|FG001|Overall Study|Undefined|1|||
163118763|NCT00737711|589142696|FG000|Overall Study|Adverse Event|2|||
163118764|NCT00737711|589142696|FG000|Overall Study|Death|8|||
163118765|NCT00737711|589142696|FG000|Overall Study|Failure to return|4|||
163118766|NCT00737711|589142696|FG000|Overall Study|Protocol Violation|1|||
163118767|NCT00737711|589142696|FG000|Overall Study|Withdrawal by Subject|5|||
163118768|NCT00737711|589142696|FG000|Overall Study|Blood transfusion|6|||
163118769|NCT00737711|589142696|FG000|Overall Study|Other|5|||
163118770|NCT02739321|589142697|FG000|Overall Study|Lack of Efficacy|1|||
163118771|NCT02739321|589142698|FG001|Overall Study|Lack of Efficacy|1|||
163118772|NCT02739321|589142697|FG000|Overall Study|Lost to Follow-up|1|||
163118773|NCT02739321|589142698|FG001|Overall Study|Lost to Follow-up|1|||
163118774|NCT02739321|589142697|FG000|Overall Study|Withdrawal by Subject|1|||
163118775|NCT02739321|589142698|FG001|Overall Study|Withdrawal by Subject|2|||
163118776|NCT02558400|589142699|FG000|Overall Study|Adverse Event|47|||
163118777|NCT02558400|589142700|FG001|Overall Study|Adverse Event|53|||
163118778|NCT02558400|589142701|FG002|Overall Study|Adverse Event|4|||
163118779|NCT02558400|589142699|FG000|Overall Study|Withdrawal by Subject|13|||
163118780|NCT02558400|589142700|FG001|Overall Study|Withdrawal by Subject|9|||
163118781|NCT02558400|589142701|FG002|Overall Study|Withdrawal by Subject|8|||
163118782|NCT02558400|589142699|FG000|Overall Study|Non-Compliant|0|||
163118783|NCT02558400|589142700|FG001|Overall Study|Non-Compliant|1|||
163118784|NCT02558400|589142701|FG002|Overall Study|Non-Compliant|3|||
163118785|NCT02558400|589142699|FG000|Overall Study|Lost to Follow-up|5|||
163118786|NCT02558400|589142700|FG001|Overall Study|Lost to Follow-up|5|||
163118787|NCT02558400|589142701|FG002|Overall Study|Lost to Follow-up|4|||
163118788|NCT02558400|589142699|FG000|Overall Study|Lack of Efficacy|0|||
163118789|NCT02558400|589142700|FG001|Overall Study|Lack of Efficacy|13|||
163118790|NCT02558400|589142701|FG002|Overall Study|Lack of Efficacy|1|||
163118791|NCT02558400|589142699|FG000|Overall Study|Disallowed Concurrent Medication|6|||
163118792|NCT02558400|589142700|FG001|Overall Study|Disallowed Concurrent Medication|7|||
163118793|NCT02558400|589142701|FG002|Overall Study|Disallowed Concurrent Medication|5|||
163118794|NCT02558400|589142699|FG000|Overall Study|Physician Decision|2|||
163118795|NCT02558400|589142700|FG001|Overall Study|Physician Decision|2|||
163118796|NCT02558400|589142701|FG002|Overall Study|Physician Decision|0|||
163118797|NCT02558400|589142699|FG000|Overall Study|Protocol Violation|6|||
163118798|NCT02558400|589142700|FG001|Overall Study|Protocol Violation|3|||
163118799|NCT02558400|589142701|FG002|Overall Study|Protocol Violation|8|||
163118800|NCT02558400|589142699|FG000|Overall Study|Death|0|||
163118801|NCT02558400|589142700|FG001|Overall Study|Death|1|||
163118802|NCT02558400|589142701|FG002|Overall Study|Death|0|||
163118803|NCT02558400|589142699|FG000|Overall Study|Ineligible for the study|0|||
163118804|NCT02558400|589142700|FG001|Overall Study|Ineligible for the study|2|||
163118805|NCT02558400|589142701|FG002|Overall Study|Ineligible for the study|0|||
163118806|NCT02230683|589142705|FG000|Overall Study|Adverse Event|1|||
163118807|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
163118808|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
163118809|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
163118810|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
163118811|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
163118812|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
163118813|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
163118814|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
163118815|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
163118816|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
163118817|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
163118818|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
163118819|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
163118820|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
163118821|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
163118822|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
163118823|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
163118824|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
163118825|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
163118826|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
163118827|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
163118828|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
163118829|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
163118830|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
163118831|NCT00624780|589142706|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
163118832|NCT00624780|589142707|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
163118833|NCT00624780|589142708|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
163118834|NCT00624780|589142709|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
163118835|NCT00624780|589142710|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
163118836|NCT00624780|589142711|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
163118837|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
163118838|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
163118839|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
163118840|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
163118841|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
163118842|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
163118843|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118844|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
163118845|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118846|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163118847|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163118848|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163118849|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118850|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
163118851|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118852|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
163118853|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118854|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
163118855|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
163118856|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
163118857|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
163118858|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
163118859|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
163118860|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
163118861|NCT00624780|589142706|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
163118862|NCT00624780|589142707|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
162654691|NCT04649151|587451653|FG000|Overall Study|Pregnancy|0|||
162654692|NCT04649151|587451654|FG001|Overall Study|Pregnancy|0|||
162654693|NCT04649151|587451655|FG002|Overall Study|Pregnancy|0|||
162654694|NCT04649151|587451656|FG003|Overall Study|Pregnancy|0|||
162654695|NCT04649151|587451657|FG004|Overall Study|Pregnancy|3|||
162654696|NCT04649151|587451653|FG000|Overall Study|Physician Decision|10|||
162654697|NCT04649151|587451654|FG001|Overall Study|Physician Decision|0|||
162654698|NCT04649151|587451655|FG002|Overall Study|Physician Decision|0|||
162654699|NCT04649151|587451656|FG003|Overall Study|Physician Decision|1|||
162654700|NCT04649151|587451657|FG004|Overall Study|Physician Decision|1|||
162654701|NCT04649151|587451653|FG000|Overall Study|Protocol Deviation|25|||
162654702|NCT04649151|587451654|FG001|Overall Study|Protocol Deviation|3|||
162654703|NCT04649151|587451655|FG002|Overall Study|Protocol Deviation|0|||
162654704|NCT04649151|587451656|FG003|Overall Study|Protocol Deviation|0|||
162654705|NCT04649151|587451657|FG004|Overall Study|Protocol Deviation|0|||
162654706|NCT04649151|587451653|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
162654707|NCT04649151|587451654|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
162654708|NCT04649151|587451655|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
162654709|NCT04649151|587451656|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
163118863|NCT00624780|589142708|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
163118864|NCT00624780|589142709|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
163118865|NCT00624780|589142710|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
163118866|NCT00624780|589142711|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
163118867|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118868|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
162654710|NCT04649151|587451657|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
163118869|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
163118870|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118871|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
163118872|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
163118873|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
163118874|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118875|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118876|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118877|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118878|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
163118879|NCT00624780|589142706|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118880|NCT00624780|589142707|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118881|NCT00624780|589142708|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
163118882|NCT00624780|589142709|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118883|NCT00624780|589142710|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118884|NCT00624780|589142711|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
163118885|NCT00624780|589142706|FG000|Follow-up (Week 26)|Death|0|||
163118886|NCT00624780|589142707|FG001|Follow-up (Week 26)|Death|0|||
163118887|NCT00624780|589142708|FG002|Follow-up (Week 26)|Death|1|||
163118888|NCT00624780|589142709|FG003|Follow-up (Week 26)|Death|0|||
163118889|NCT00624780|589142710|FG004|Follow-up (Week 26)|Death|0|||
163118890|NCT00624780|589142711|FG005|Follow-up (Week 26)|Death|0|||
163118891|NCT00624780|589142706|FG000|Follow-up (Week 26)|Adverse Event|0|||
163118892|NCT00624780|589142707|FG001|Follow-up (Week 26)|Adverse Event|0|||
163118893|NCT00624780|589142708|FG002|Follow-up (Week 26)|Adverse Event|0|||
163118894|NCT00624780|589142709|FG003|Follow-up (Week 26)|Adverse Event|0|||
163118895|NCT00624780|589142710|FG004|Follow-up (Week 26)|Adverse Event|1|||
163118896|NCT00624780|589142711|FG005|Follow-up (Week 26)|Adverse Event|0|||
163118897|NCT00624780|589142706|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
163118898|NCT00624780|589142707|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
163118899|NCT00624780|589142708|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
163118900|NCT00624780|589142709|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
163118901|NCT00624780|589142710|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
163118902|NCT00624780|589142711|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
163118903|NCT00624780|589142706|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
163118904|NCT00624780|589142707|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118905|NCT00624780|589142708|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
162654711|NCT04649151|587451653|FG000|Overall Study|Withdrawal by Subject|370|||
162654712|NCT04649151|587451654|FG001|Overall Study|Withdrawal by Subject|113|||
162654713|NCT04649151|587451655|FG002|Overall Study|Withdrawal by Subject|2|||
162654714|NCT04649151|587451656|FG003|Overall Study|Withdrawal by Subject|7|||
163118906|NCT00624780|589142709|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118907|NCT00624780|589142710|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118908|NCT00624780|589142711|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
163118909|NCT00624780|589142706|FG000|Follow-up (Week 26)|Other|1|||
163118910|NCT00624780|589142707|FG001|Follow-up (Week 26)|Other|1|||
163118911|NCT00624780|589142708|FG002|Follow-up (Week 26)|Other|0|||
163118912|NCT00624780|589142709|FG003|Follow-up (Week 26)|Other|0|||
163118913|NCT00624780|589142710|FG004|Follow-up (Week 26)|Other|0|||
163118914|NCT00624780|589142711|FG005|Follow-up (Week 26)|Other|0|||
163118915|NCT04068519|589142713|FG000|Dose Verification|Death|15|||
163118916|NCT04068519|589142713|FG000|Dose Verification|Withdrawal by Subject|1|||
163118917|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Death|35|||
163118918|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
163118919|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
163118920|NCT04068519|589142713|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
163118921|NCT04068519|589142713|FG000|Indication Expansion|Death|152|||
163118922|NCT04068519|589142713|FG000|Indication Expansion|Withdrawal by Subject|10|||
163118923|NCT04068519|589142713|FG000|Indication Expansion|Lost to Follow-up|7|||
163118924|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118925|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118926|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118927|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118928|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118929|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118930|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118931|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118932|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118933|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163118934|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118935|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
163118936|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118937|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118938|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
163118939|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118940|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118941|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118942|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118943|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118944|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118945|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118946|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118947|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163118948|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118949|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118950|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
163118951|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118952|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118953|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118954|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118955|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118956|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118957|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118958|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118959|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
163118960|NCT00969761|589142714|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118961|NCT00969761|589142715|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118962|NCT00969761|589142716|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118963|NCT00969761|589142717|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118964|NCT00969761|589142718|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118965|NCT00969761|589142719|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118966|NCT00969761|589142720|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118967|NCT00969761|589142721|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118968|NCT00969761|589142722|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
163118969|NCT00969761|589142723|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118970|NCT00969761|589142724|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
162719468|NCT05147233|587680480|FG001|Overall Study|Withdrawal by Subject|1|||
162654715|NCT04649151|587451657|FG004|Overall Study|Withdrawal by Subject|15|||
162654716|NCT04649151|587451653|FG000|Overall Study|Adverse Event|1|||
162654717|NCT04649151|587451654|FG001|Overall Study|Adverse Event|0|||
162654718|NCT04649151|587451655|FG002|Overall Study|Adverse Event|0|||
162654719|NCT04649151|587451656|FG003|Overall Study|Adverse Event|0|||
162654720|NCT04649151|587451657|FG004|Overall Study|Adverse Event|0|||
162654721|NCT04649151|587451653|FG000|Overall Study|Lost to Follow-up|256|||
162654722|NCT04649151|587451654|FG001|Overall Study|Lost to Follow-up|29|||
162654723|NCT04649151|587451655|FG002|Overall Study|Lost to Follow-up|10|||
162654724|NCT04649151|587451656|FG003|Overall Study|Lost to Follow-up|3|||
162654725|NCT04649151|587451657|FG004|Overall Study|Lost to Follow-up|6|||
162654726|NCT04649151|587451653|FG000|Overall Study|Other than specified|59|||
162654727|NCT04649151|587451654|FG001|Overall Study|Other than specified|294|||
162654728|NCT04649151|587451655|FG002|Overall Study|Other than specified|0|||
162654729|NCT04649151|587451656|FG003|Overall Study|Other than specified|0|||
162654730|NCT04649151|587451657|FG004|Overall Study|Other than specified|4|||
162654731|NCT04649151|587451653|FG000|Overall Study|Death|0|||
162654732|NCT04649151|587451654|FG001|Overall Study|Death|0|||
162654733|NCT04649151|587451655|FG002|Overall Study|Death|0|||
162654734|NCT04649151|587451656|FG003|Overall Study|Death|0|||
162654735|NCT04649151|587451657|FG004|Overall Study|Death|1|||
163118971|NCT00969761|589142725|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
163118972|NCT00969761|589142714|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118973|NCT00969761|589142715|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118974|NCT00969761|589142716|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
163118975|NCT00969761|589142717|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118976|NCT00969761|589142718|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118977|NCT00969761|589142719|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118978|NCT00969761|589142720|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118979|NCT00969761|589142721|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
163118980|NCT00969761|589142722|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
163118981|NCT00969761|589142723|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
163118982|NCT00969761|589142724|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118983|NCT00969761|589142725|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
163118984|NCT00969761|589142714|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118985|NCT00969761|589142715|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118986|NCT00969761|589142716|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118987|NCT00969761|589142717|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
163118988|NCT00969761|589142718|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
163118989|NCT00969761|589142719|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118990|NCT00969761|589142720|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118991|NCT00969761|589142721|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118992|NCT00969761|589142722|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
163118993|NCT00969761|589142723|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118994|NCT00969761|589142724|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118995|NCT00969761|589142725|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
163118996|NCT03081858|589144675|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
163118997|NCT03081858|589144676|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163118998|NCT03081858|589144677|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163118999|NCT03081858|589144678|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163119000|NCT02936284|589144685|FG000|Overall Study|Withdrawal by Subject|3|||
163119001|NCT02936284|589144686|FG001|Overall Study|Withdrawal by Subject|1|||
163119002|NCT02936284|589144685|FG000|Overall Study|Lost to Follow-up|7|||
163119003|NCT02936284|589144686|FG001|Overall Study|Lost to Follow-up|8|||
163119004|NCT01610596|589144687|FG000|Overall Study|Lost to Follow-up|0|||
163119005|NCT01610596|589144688|FG001|Overall Study|Lost to Follow-up|1|||
163119006|NCT00799591|589144691|FG000|Overall Study|De-escalation of doses|20|||
163119007|NCT00799591|589144691|FG000|Overall Study|Death|14|||
163119008|NCT00799591|589144691|FG000|Overall Study|Technical failure|12|||
163119009|NCT00799591|589144691|FG000|Overall Study|Resistant germ|11|||
163119010|NCT00799591|589144691|FG000|Overall Study|New infection|4|||
163119011|NCT00799591|589144691|FG000|Overall Study|Resistance germ and technical failure|2|||
163119012|NCT00799591|589144691|FG000|Overall Study|Persistance of fever undetermined origin|1|||
163119013|NCT00799591|589144691|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
163119014|NCT00799591|589144691|FG000|Overall Study|Infectious origin not probable|1|||
163119015|NCT02098369|589144692|FG000|Overall Study|Withdrawal by Subject|1|||
162654736|NCT03752619|587451658|FG000|Overall Study|Lost to Follow-up|2|||
162654737|NCT03752619|587451659|FG001|Overall Study|Lost to Follow-up|1|||
162654738|NCT03752619|587451658|FG000|Overall Study|Withdrawal by Subject|1|||
162654739|NCT03752619|587451659|FG001|Overall Study|Withdrawal by Subject|1|||
162654740|NCT03752619|587451658|FG000|Overall Study|Adverse Event|0|||
163119016|NCT02098369|589144693|FG001|Overall Study|Withdrawal by Subject|5|||
163119017|NCT02098369|589144694|FG002|Overall Study|Withdrawal by Subject|0|||
163119018|NCT02098369|589144692|FG000|Overall Study|Lost to Follow-up|5|||
163119019|NCT02098369|589144693|FG001|Overall Study|Lost to Follow-up|1|||
163119020|NCT02098369|589144694|FG002|Overall Study|Lost to Follow-up|3|||
163119021|NCT02098369|589144692|FG000|Overall Study|Death|1|||
163119022|NCT02098369|589144693|FG001|Overall Study|Death|1|||
163119023|NCT02098369|589144694|FG002|Overall Study|Death|1|||
163119024|NCT02098369|589144692|FG000|Overall Study|Other|0|||
163119025|NCT02098369|589144693|FG001|Overall Study|Other|2|||
163119026|NCT02098369|589144694|FG002|Overall Study|Other|1|||
163119027|NCT00413920|589144704|FG000|Overall Study|Adverse Event|9|||
163119028|NCT00413920|589144705|FG001|Overall Study|Adverse Event|11|||
163119029|NCT00413920|589144704|FG000|Overall Study|Lack of Efficacy|11|||
163119030|NCT00413920|589144705|FG001|Overall Study|Lack of Efficacy|9|||
162654741|NCT03752619|587451659|FG001|Overall Study|Adverse Event|1|||
162654742|NCT04476017|587451660|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
162654743|NCT04476017|587451661|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
162654744|NCT03362502|587451662|FG000|Overall Study|Death|0|||
162654745|NCT03362502|587451663|FG001|Overall Study|Death|0|||
162654746|NCT03362502|587451664|FG002|Overall Study|Death|1|||
162654747|NCT02018458|587451667|FG000|Overall Study|Death|4|||
163119031|NCT00413920|589144704|FG000|Overall Study|Death|3|||
163119032|NCT00413920|589144705|FG001|Overall Study|Death|5|||
163119033|NCT00413920|589144704|FG000|Overall Study|Graft Loss|5|||
163119034|NCT00413920|589144705|FG001|Overall Study|Graft Loss|3|||
163119035|NCT01765426|589144707|FG000|Overall Study|Lost to Follow-up|0|||
163119036|NCT01765426|589144708|FG001|Overall Study|Lost to Follow-up|1|||
163119037|NCT01765426|589144709|FG002|Overall Study|Lost to Follow-up|0|||
163119038|NCT01765426|589144710|FG003|Overall Study|Lost to Follow-up|0|||
163119039|NCT00545532|589144711|FG000|Overall Study|Withdrawal by Subject|1|||
163119040|NCT00545532|589144712|FG001|Overall Study|Withdrawal by Subject|3|||
163119041|NCT00545532|589144711|FG000|Overall Study|Lost to Follow-up|5|||
163119042|NCT00545532|589144712|FG001|Overall Study|Lost to Follow-up|6|||
163119043|NCT00545532|589144711|FG000|Overall Study|Death|0|||
163119044|NCT00545532|589144712|FG001|Overall Study|Death|1|||
163119045|NCT01479595|589144713|FG000|Overall Study|Protocol deviation|0|||
163119046|NCT01479595|589144714|FG001|Overall Study|Protocol deviation|1|||
163119047|NCT01479595|589144713|FG000|Overall Study|Adverse Event|2|||
163119048|NCT01479595|589144714|FG001|Overall Study|Adverse Event|1|||
163119049|NCT02120365|589144715|FG000|Overall Study|Withdrawal by Subject|0|||
163119050|NCT02120365|589144716|FG001|Overall Study|Withdrawal by Subject|0|||
163119051|NCT02120365|589144717|FG002|Overall Study|Withdrawal by Subject|2|||
163119052|NCT02120365|589144718|FG003|Overall Study|Withdrawal by Subject|4|||
163119053|NCT02120365|589144719|FG004|Overall Study|Withdrawal by Subject|0|||
163119054|NCT02120365|589144720|FG005|Overall Study|Withdrawal by Subject|2|||
163119055|NCT01344629|589144723|FG000|Crossover Period 2|Withdrawal by Subject|0|||
163119056|NCT01344629|589144724|FG001|Crossover Period 2|Withdrawal by Subject|1|||
163119057|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
163119058|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
163119059|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
163119060|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
163119061|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
163119062|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
163119063|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
163119064|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
163119065|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
163119066|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
163119067|NCT00900146|589144725|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
163119068|NCT00900146|589144726|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119069|NCT00900146|589144727|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119070|NCT00900146|589144728|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119071|NCT00900146|589144729|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
163119072|NCT00900146|589144725|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
163119073|NCT00900146|589144726|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
163119074|NCT00900146|589144727|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
163119075|NCT00900146|589144728|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
163119076|NCT00900146|589144729|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
163119077|NCT00900146|589144725|FG000|Intermediate: Period III|Lost to Follow-up|2|||
163119078|NCT00900146|589144726|FG001|Intermediate: Period III|Lost to Follow-up|0|||
163119079|NCT00900146|589144727|FG002|Intermediate: Period III|Lost to Follow-up|0|||
163119080|NCT00900146|589144728|FG003|Intermediate: Period III|Lost to Follow-up|0|||
162654748|NCT00727714|587451673|FG000|Overall Study|Lost to Follow-up|2|||
162654749|NCT00325234|587451676|FG000|Overall Study|Adverse Event|10|||
163119081|NCT00900146|589144729|FG004|Intermediate: Period III|Lost to Follow-up|1|||
163119082|NCT00900146|589144725|FG000|Intermediate: Period III|Administrative problems|85|||
163119083|NCT00900146|589144726|FG001|Intermediate: Period III|Administrative problems|92|||
163119084|NCT00900146|589144727|FG002|Intermediate: Period III|Administrative problems|84|||
163119085|NCT00900146|589144728|FG003|Intermediate: Period III|Administrative problems|90|||
163119086|NCT00900146|589144729|FG004|Intermediate: Period III|Administrative problems|163|||
163119087|NCT02305849|589144730|FG000|Overall Study|Adverse Event|10|||
163119088|NCT02305849|589144731|FG001|Overall Study|Adverse Event|12|||
163119089|NCT02305849|589144732|FG002|Overall Study|Adverse Event|7|||
163119090|NCT02305849|589144733|FG003|Overall Study|Adverse Event|3|||
163119091|NCT02305849|589144730|FG000|Overall Study|Lack of Efficacy|10|||
163119092|NCT02305849|589144731|FG001|Overall Study|Lack of Efficacy|6|||
163119093|NCT02305849|589144732|FG002|Overall Study|Lack of Efficacy|3|||
163119094|NCT02305849|589144733|FG003|Overall Study|Lack of Efficacy|9|||
163119095|NCT02305849|589144730|FG000|Overall Study|Withdrawal by Subject|2|||
163119096|NCT02305849|589144731|FG001|Overall Study|Withdrawal by Subject|2|||
163119097|NCT02305849|589144732|FG002|Overall Study|Withdrawal by Subject|1|||
163119098|NCT02305849|589144733|FG003|Overall Study|Withdrawal by Subject|4|||
163119099|NCT02305849|589144730|FG000|Overall Study|Lost to Follow-up|0|||
163119100|NCT02305849|589144731|FG001|Overall Study|Lost to Follow-up|2|||
163119101|NCT02305849|589144732|FG002|Overall Study|Lost to Follow-up|0|||
163119102|NCT02305849|589144733|FG003|Overall Study|Lost to Follow-up|0|||
163119103|NCT02305849|589144730|FG000|Overall Study|Protocol Violation|3|||
163119104|NCT02305849|589144731|FG001|Overall Study|Protocol Violation|2|||
163119105|NCT02305849|589144732|FG002|Overall Study|Protocol Violation|1|||
163119106|NCT02305849|589144733|FG003|Overall Study|Protocol Violation|1|||
163119107|NCT02305849|589144730|FG000|Overall Study|Lab data met discontinuation criteria|0|||
163119108|NCT02305849|589144731|FG001|Overall Study|Lab data met discontinuation criteria|1|||
163119109|NCT02305849|589144732|FG002|Overall Study|Lab data met discontinuation criteria|2|||
163119110|NCT02305849|589144733|FG003|Overall Study|Lab data met discontinuation criteria|1|||
163119111|NCT02305849|589144730|FG000|Overall Study|Miscellaneous|1|||
163119112|NCT02305849|589144731|FG001|Overall Study|Miscellaneous|2|||
163119113|NCT02305849|589144732|FG002|Overall Study|Miscellaneous|4|||
163119114|NCT02305849|589144733|FG003|Overall Study|Miscellaneous|1|||
163119115|NCT02305849|589144730|FG000|Overall Study|Not fulfill eligibility criteria|1|||
163119116|NCT02305849|589144731|FG001|Overall Study|Not fulfill eligibility criteria|1|||
163119117|NCT02305849|589144732|FG002|Overall Study|Not fulfill eligibility criteria|0|||
163119118|NCT02305849|589144733|FG003|Overall Study|Not fulfill eligibility criteria|0|||
163119119|NCT00355342|589144734|FG000|Overall Study|Adverse Event|13|||
163119120|NCT00355342|589144735|FG001|Overall Study|Adverse Event|15|||
163119121|NCT00355342|589144734|FG000|Overall Study|Lost to Follow-up|4|||
163119122|NCT00355342|589144735|FG001|Overall Study|Lost to Follow-up|2|||
163119123|NCT00355342|589144734|FG000|Overall Study|Withdrawal by Subject|14|||
163119124|NCT00355342|589144735|FG001|Overall Study|Withdrawal by Subject|11|||
163119125|NCT00355342|589144734|FG000|Overall Study|Sponsor terminated study|2|||
163119126|NCT00355342|589144735|FG001|Overall Study|Sponsor terminated study|2|||
163119127|NCT00355342|589144734|FG000|Overall Study|Overcompliant-PI discretion|1|||
163119128|NCT00355342|589144735|FG001|Overall Study|Overcompliant-PI discretion|0|||
163119129|NCT00355342|589144734|FG000|Overall Study|Use of prohibited medication|1|||
163119130|NCT00355342|589144735|FG001|Overall Study|Use of prohibited medication|0|||
163119131|NCT00355342|589144734|FG000|Overall Study|COPD exacerbation|1|||
163119132|NCT00355342|589144735|FG001|Overall Study|COPD exacerbation|1|||
163119133|NCT00355342|589144734|FG000|Overall Study|Dispensed wrong study drug kit|1|||
163119134|NCT00355342|589144735|FG001|Overall Study|Dispensed wrong study drug kit|0|||
163119135|NCT00355342|589144734|FG000|Overall Study|Non-compliance with Dexa scans|1|||
163119136|NCT00355342|589144735|FG001|Overall Study|Non-compliance with Dexa scans|0|||
163119137|NCT00355342|589144734|FG000|Overall Study|Withdrawal by participant and physician|1|||
163119138|NCT00355342|589144735|FG001|Overall Study|Withdrawal by participant and physician|0|||
163119139|NCT00355342|589144734|FG000|Overall Study|Participant relocated|0|||
163119140|NCT00355342|589144735|FG001|Overall Study|Participant relocated|1|||
163119141|NCT00355342|589144734|FG000|Overall Study|Participant discontinued study drug|0|||
163119142|NCT00355342|589144735|FG001|Overall Study|Participant discontinued study drug|1|||
163119143|NCT00355342|589144734|FG000|Overall Study|Study management|0|||
163119144|NCT00355342|589144735|FG001|Overall Study|Study management|1|||
163119145|NCT00355342|589144734|FG000|Overall Study|Protocol Violation|0|||
163119146|NCT00355342|589144735|FG001|Overall Study|Protocol Violation|1|||
163119147|NCT00355342|589144734|FG000|Overall Study|Use of protocol excluded medication|0|||
163119148|NCT00355342|589144735|FG001|Overall Study|Use of protocol excluded medication|1|||
163119149|NCT00495521|589144737|FG000|Overall Study|Physician Decision|0|||
163119150|NCT00495521|589144738|FG001|Overall Study|Physician Decision|1|||
163119151|NCT02782325|589144739|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
163119152|NCT02782325|589144740|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
163119153|NCT02782325|589144741|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
162654750|NCT00325234|587451677|FG001|Overall Study|Adverse Event|7|||
162654751|NCT00325234|587451676|FG000|Overall Study|Death due to Study Disease|1|||
162654752|NCT00325234|587451677|FG001|Overall Study|Death due to Study Disease|0|||
162654753|NCT00325234|587451676|FG000|Overall Study|Entry Criteria Not Met|1|||
162654754|NCT00325234|587451677|FG001|Overall Study|Entry Criteria Not Met|2|||
162654755|NCT00325234|587451676|FG000|Overall Study|Subject Decision|6|||
162654756|NCT00325234|587451677|FG001|Overall Study|Subject Decision|8|||
162654757|NCT00325234|587451676|FG000|Overall Study|Physician Decision|17|||
162654758|NCT00325234|587451677|FG001|Overall Study|Physician Decision|12|||
163119154|NCT02782325|589144739|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
163119155|NCT02782325|589144740|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
163119156|NCT02782325|589144741|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
163119157|NCT01527383|589144744|FG000|Overall Study|Adverse Event|5|||
163119158|NCT01527383|589144745|FG001|Overall Study|Adverse Event|0|||
163119159|NCT01527383|589144744|FG000|Overall Study|Lost to Follow-up|3|||
163119160|NCT01527383|589144745|FG001|Overall Study|Lost to Follow-up|0|||
163119161|NCT01527383|589144744|FG000|Overall Study|Physician Decision|2|||
163119162|NCT01527383|589144745|FG001|Overall Study|Physician Decision|0|||
163119163|NCT01527383|589144744|FG000|Overall Study|Pregnancy|1|||
163119164|NCT01527383|589144745|FG001|Overall Study|Pregnancy|0|||
163119165|NCT01527383|589144744|FG000|Overall Study|Protocol Violation|1|||
163119166|NCT01527383|589144745|FG001|Overall Study|Protocol Violation|0|||
163119167|NCT01527383|589144744|FG000|Overall Study|Screen failure|1|||
163119168|NCT01527383|589144745|FG001|Overall Study|Screen failure|0|||
163119169|NCT01527383|589144744|FG000|Overall Study|Participant moved|0|||
163119170|NCT01527383|589144745|FG001|Overall Study|Participant moved|1|||
163119171|NCT01527383|589144744|FG000|Overall Study|Withdrawal by Subject|2|||
163119172|NCT01527383|589144745|FG001|Overall Study|Withdrawal by Subject|3|||
163119173|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
163119174|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
163119175|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
163119176|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
163119177|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
163119178|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
163119179|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163119180|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163119181|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
163119182|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
163119183|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
163119184|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
163119185|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
163119186|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
163119187|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
163119188|NCT00554099|589144749|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163119189|NCT00554099|589144750|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163119190|NCT00554099|589144751|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
163119191|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
163119192|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
163119193|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
163119194|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
163119195|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
163119196|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
163119197|NCT00554099|589144749|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
163119198|NCT00554099|589144750|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
163119199|NCT00554099|589144751|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
163119200|NCT04957758|589144756|FG000|Overall Study|Adverse Event|1|||
163119201|NCT04957758|589144757|FG001|Overall Study|Adverse Event|0|||
163119202|NCT04957758|589144756|FG000|Overall Study|Lost to Follow-up|0|||
163119203|NCT04957758|589144757|FG001|Overall Study|Lost to Follow-up|2|||
163119204|NCT04957758|589144756|FG000|Overall Study|Withdrawal by Subject|4|||
163119205|NCT04957758|589144757|FG001|Overall Study|Withdrawal by Subject|2|||
163119206|NCT04957758|589144756|FG000|Overall Study|Protocol Violation|0|||
163119207|NCT04957758|589144757|FG001|Overall Study|Protocol Violation|1|||
163119208|NCT03353922|589144758|FG000|Overall Study|Withdrawal by Subject|1|||
163119209|NCT03353922|589144759|FG001|Overall Study|Withdrawal by Subject|0|||
163119210|NCT03353922|589144760|FG002|Overall Study|Withdrawal by Subject|1|||
163119211|NCT03353922|589144761|FG003|Overall Study|Withdrawal by Subject|1|||
163119212|NCT03353922|589144762|FG004|Overall Study|Withdrawal by Subject|0|||
163119213|NCT03353922|589144763|FG005|Overall Study|Withdrawal by Subject|0|||
163119214|NCT03353922|589144758|FG000|Overall Study|Adverse Event|0|||
163119215|NCT03353922|589144759|FG001|Overall Study|Adverse Event|1|||
163119216|NCT03353922|589144760|FG002|Overall Study|Adverse Event|0|||
163119217|NCT03353922|589144761|FG003|Overall Study|Adverse Event|0|||
163119218|NCT03353922|589144762|FG004|Overall Study|Adverse Event|0|||
163119219|NCT03353922|589144763|FG005|Overall Study|Adverse Event|0|||
163119220|NCT03688555|589144764|FG000|Treatment Period|Adverse Event|0|||
163119221|NCT03688555|589144765|FG001|Treatment Period|Adverse Event|0|||
163119222|NCT03688555|589144766|FG002|Treatment Period|Adverse Event|1|||
163119223|NCT00886119|589144767|FG000|Period 1|Did not meet inclusion criteria|1|||
163119224|NCT00886119|589144768|FG001|Period 1|Did not meet inclusion criteria|0|||
163119225|NCT00394901|589144769|FG000|Baseline Phase|Protocol Violation|0|||
162654759|NCT00325234|587451676|FG000|Overall Study|Progressive Disease|34|||
163119226|NCT00394901|589144770|FG001|Baseline Phase|Protocol Violation|0|||
163119227|NCT00394901|589144771|FG002|Baseline Phase|Protocol Violation|1|||
163119228|NCT00394901|589144772|FG003|Baseline Phase|Protocol Violation|0|||
163119229|NCT00394901|589144769|FG000|Double-blind Phase|Adverse Event|5|||
163119230|NCT00394901|589144770|FG001|Double-blind Phase|Adverse Event|7|||
163119231|NCT00394901|589144771|FG002|Double-blind Phase|Adverse Event|16|||
163119232|NCT00394901|589144772|FG003|Double-blind Phase|Adverse Event|20|||
163119233|NCT00394901|589144769|FG000|Double-blind Phase|Lack of Efficacy|6|||
163119234|NCT00394901|589144770|FG001|Double-blind Phase|Lack of Efficacy|4|||
163119235|NCT00394901|589144771|FG002|Double-blind Phase|Lack of Efficacy|1|||
163119236|NCT00394901|589144772|FG003|Double-blind Phase|Lack of Efficacy|3|||
163119237|NCT00394901|589144769|FG000|Double-blind Phase|Withdrawal by Subject|2|||
163119238|NCT00394901|589144770|FG001|Double-blind Phase|Withdrawal by Subject|0|||
163119239|NCT00394901|589144771|FG002|Double-blind Phase|Withdrawal by Subject|0|||
163119240|NCT00394901|589144772|FG003|Double-blind Phase|Withdrawal by Subject|0|||
163119241|NCT00394901|589144769|FG000|Double-blind Phase|Lost to Follow-up|0|||
163119242|NCT00394901|589144770|FG001|Double-blind Phase|Lost to Follow-up|0|||
163119243|NCT00394901|589144771|FG002|Double-blind Phase|Lost to Follow-up|0|||
163119244|NCT00394901|589144772|FG003|Double-blind Phase|Lost to Follow-up|1|||
163119245|NCT00394901|589144769|FG000|Double-blind Phase|Protocol Violation|0|||
163119246|NCT00394901|589144770|FG001|Double-blind Phase|Protocol Violation|0|||
163119247|NCT00394901|589144771|FG002|Double-blind Phase|Protocol Violation|0|||
163119248|NCT00394901|589144772|FG003|Double-blind Phase|Protocol Violation|1|||
163119249|NCT00394901|589144769|FG000|Double-blind Phase|Death|1|||
163119250|NCT00394901|589144770|FG001|Double-blind Phase|Death|0|||
163119251|NCT00394901|589144771|FG002|Double-blind Phase|Death|0|||
163119252|NCT00394901|589144772|FG003|Double-blind Phase|Death|0|||
163119253|NCT00394901|589144769|FG000|Double-blind Phase|Subject's Personal Reason|1|||
163119254|NCT00394901|589144770|FG001|Double-blind Phase|Subject's Personal Reason|0|||
163119255|NCT00394901|589144771|FG002|Double-blind Phase|Subject's Personal Reason|0|||
163119256|NCT00394901|589144772|FG003|Double-blind Phase|Subject's Personal Reason|1|||
163119257|NCT00394901|589144769|FG000|Double-blind Phase|Lack of Compliance|0|||
163119258|NCT00394901|589144770|FG001|Double-blind Phase|Lack of Compliance|3|||
163119259|NCT00394901|589144771|FG002|Double-blind Phase|Lack of Compliance|0|||
163119260|NCT00394901|589144772|FG003|Double-blind Phase|Lack of Compliance|0|||
163119261|NCT00394901|589144769|FG000|Double-blind Phase|Entry into another study was found|0|||
163119262|NCT00394901|589144770|FG001|Double-blind Phase|Entry into another study was found|0|||
163119263|NCT00394901|589144771|FG002|Double-blind Phase|Entry into another study was found|1|||
163119264|NCT00394901|589144772|FG003|Double-blind Phase|Entry into another study was found|0|||
163119265|NCT00394901|589144769|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
163119266|NCT00394901|589144770|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
163119267|NCT00394901|589144771|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
163119268|NCT00394901|589144772|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
163119269|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
163119270|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
163119271|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
163119272|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
163119273|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
163119274|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
163119275|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
163119276|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
163119277|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
163119278|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
163119279|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
163119280|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
163119281|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
163119282|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
163119283|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
163119284|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
163119285|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
163119286|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
163119287|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
163119288|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
163119289|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
163119290|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
163119291|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
163119292|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
163119293|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
163119294|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
163119295|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
163119296|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
163119297|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
163119298|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
163119299|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
163119300|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
163119301|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
163119302|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
163119303|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
163119304|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
163119305|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
163119306|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
163119307|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
163119308|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
163119309|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
163119310|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
163119311|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
163119312|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
163119313|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
163119314|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
163119315|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
163119316|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
163119317|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
163119318|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
163119319|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
163119320|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
163119321|NCT02008357|589144776|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
163119322|NCT02008357|589144777|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
163119323|NCT02008357|589144776|FG000|Open-label Extension Period|Adverse Event|8|||
163119324|NCT02008357|589144777|FG001|Open-label Extension Period|Adverse Event|7|||
163119325|NCT02008357|589144776|FG000|Open-label Extension Period|Death|7|||
163119326|NCT02008357|589144777|FG001|Open-label Extension Period|Death|4|||
162654760|NCT00325234|587451677|FG001|Overall Study|Progressive Disease|37|||
162654761|NCT01234467|587451678|FG000|Overall Study|Adverse Event|3|||
162654762|NCT01234467|587451678|FG000|Overall Study|Death|2|||
162654763|NCT01234467|587451678|FG000|Overall Study|Withdrawal by Subject|2|||
162654764|NCT01234467|587451678|FG000|Overall Study|Disease Progression|2|||
162654765|NCT01234467|587451678|FG000|Overall Study|Clinical deterioration|1|||
162654766|NCT01234467|587451678|FG000|Overall Study|Physician Decision|1|||
163119327|NCT02008357|589144776|FG000|Open-label Extension Period|Lack of Efficacy|9|||
163119328|NCT02008357|589144777|FG001|Open-label Extension Period|Lack of Efficacy|5|||
163119329|NCT02008357|589144776|FG000|Open-label Extension Period|Lost to Follow-up|2|||
163119330|NCT02008357|589144777|FG001|Open-label Extension Period|Lost to Follow-up|2|||
163119331|NCT02008357|589144776|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
163119332|NCT02008357|589144777|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
163119333|NCT02008357|589144776|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
163119334|NCT02008357|589144777|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
163119335|NCT02008357|589144776|FG000|Open-label Extension Period|Safety Risk|2|||
163119336|NCT02008357|589144777|FG001|Open-label Extension Period|Safety Risk|1|||
163119337|NCT02008357|589144776|FG000|Open-label Extension Period|Non-Compliance|0|||
163119338|NCT02008357|589144777|FG001|Open-label Extension Period|Non-Compliance|1|||
163119339|NCT02008357|589144776|FG000|Open-label Extension Period|Investigator Recommendation|0|||
163119340|NCT02008357|589144777|FG001|Open-label Extension Period|Investigator Recommendation|1|||
163119341|NCT02008357|589144776|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
163119342|NCT02008357|589144777|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
163119343|NCT02008357|589144776|FG000|Open-label Extension Period|Coordinating Center Request|2|||
163119344|NCT02008357|589144777|FG001|Open-label Extension Period|Coordinating Center Request|4|||
163119345|NCT02008357|589144776|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
163119346|NCT02008357|589144777|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
163119347|NCT02008357|589144776|FG000|Open-label Extension Period|Study Ended|20|||
163119348|NCT02008357|589144777|FG001|Open-label Extension Period|Study Ended|25|||
163119349|NCT02008357|589144776|FG000|Open-label Extension Period|Personal Reasons|0|||
163119350|NCT02008357|589144777|FG001|Open-label Extension Period|Personal Reasons|1|||
163119351|NCT02008357|589144776|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
163119352|NCT02008357|589144777|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
163119353|NCT02008357|589144776|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
163119354|NCT02008357|589144777|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
163119355|NCT02008357|589144776|FG000|Open-label Extension Period|Other|2|||
163119356|NCT02008357|589144777|FG001|Open-label Extension Period|Other|0|||
163119357|NCT04941807|589144779|FG000|Overall Study|Lost to Follow-up|1|||
163119358|NCT04941807|589144780|FG001|Overall Study|Lost to Follow-up|1|||
163119359|NCT03553498|589144781|FG000|Overall Study|Missing primary outcome|1|||
163119360|NCT03553498|589144782|FG001|Overall Study|Missing primary outcome|2|||
163119361|NCT01498185|589144783|FG000|Overall Study|Adverse Event|0|||
163119362|NCT01498185|589144784|FG001|Overall Study|Adverse Event|0|||
163119363|NCT01498185|589144785|FG002|Overall Study|Adverse Event|0|||
163119364|NCT01498185|589144786|FG003|Overall Study|Adverse Event|1|||
163119365|NCT01498185|589144787|FG004|Overall Study|Adverse Event|0|||
163119366|NCT01498185|589144783|FG000|Overall Study|Withdrawal by Subject|1|||
163119367|NCT01498185|589144784|FG001|Overall Study|Withdrawal by Subject|1|||
163119368|NCT01498185|589144785|FG002|Overall Study|Withdrawal by Subject|0|||
163119369|NCT01498185|589144786|FG003|Overall Study|Withdrawal by Subject|2|||
163119370|NCT01498185|589144787|FG004|Overall Study|Withdrawal by Subject|1|||
163119371|NCT01498185|589144783|FG000|Overall Study|No longer met criteria, etc|0|||
163119372|NCT01498185|589144784|FG001|Overall Study|No longer met criteria, etc|0|||
163119373|NCT01498185|589144785|FG002|Overall Study|No longer met criteria, etc|0|||
163119374|NCT01498185|589144786|FG003|Overall Study|No longer met criteria, etc|0|||
163119375|NCT01498185|589144787|FG004|Overall Study|No longer met criteria, etc|2|||
163119376|NCT01453946|589144789|FG000|Overall Study|Did not receive drug for the taper phase|1|||
163119377|NCT01453946|589144789|FG000|Overall Study|Protocol Violation|2|||
163119378|NCT01453946|589144789|FG000|Overall Study|Lack of Efficacy|3|||
163119379|NCT01453946|589144789|FG000|Overall Study|Adverse Event|3|||
163119380|NCT00846040|589144790|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
163119381|NCT00846040|589144791|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
163119382|NCT00846040|589144792|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
163119383|NCT00846040|589144790|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
163119384|NCT00846040|589144791|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
163119385|NCT00846040|589144792|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
163119386|NCT03352453|589144794|FG000|Overall Study|Miscellaneous Reasons|1|||
163119387|NCT03352453|589144795|FG001|Overall Study|Miscellaneous Reasons|2|||
163119388|NCT03352453|589144794|FG000|Overall Study|Lack of Efficacy|1|||
163119389|NCT03352453|589144795|FG001|Overall Study|Lack of Efficacy|0|||
163119390|NCT03352453|589144794|FG000|Overall Study|Withdrawal by Subject|8|||
163119391|NCT03352453|589144795|FG001|Overall Study|Withdrawal by Subject|14|||
163119392|NCT03352453|589144794|FG000|Overall Study|Study Terminated by Sponsor|2|||
163119393|NCT03352453|589144795|FG001|Overall Study|Study Terminated by Sponsor|1|||
163119394|NCT03352453|589144794|FG000|Overall Study|Protocol Deviation|1|||
162654767|NCT01234467|587451678|FG000|Overall Study|Other complicating disease (stroke)|1|||
162654768|NCT01120210|587451681|FG000|MAIN INFUSION|Adverse Event|1|||
162654769|NCT01120210|587451682|FG001|MAIN INFUSION|Adverse Event|0|||
162654770|NCT01120210|587451681|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
162654771|NCT01120210|587451682|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
162654772|NCT04049760|587451690|FG000|Overall Study|Withdrawal by Subject|1|||
163119395|NCT03352453|589144795|FG001|Overall Study|Protocol Deviation|0|||
163119396|NCT03352453|589144794|FG000|Overall Study|Lost to Follow-up|7|||
163119397|NCT03352453|589144795|FG001|Overall Study|Lost to Follow-up|6|||
163119398|NCT03352453|589144794|FG000|Overall Study|Adverse Event|2|||
163119399|NCT03352453|589144795|FG001|Overall Study|Adverse Event|9|||
163119400|NCT02827500|589144800|FG000|Overall Study|Death|7|||
163119401|NCT02827500|589144801|FG001|Overall Study|Death|3|||
163119402|NCT02827500|589144800|FG000|Overall Study|Lost to Follow-up|1|||
163119403|NCT02827500|589144801|FG001|Overall Study|Lost to Follow-up|1|||
163119404|NCT02827500|589144800|FG000|Overall Study|Withdrawal by Subject|3|||
163119405|NCT02827500|589144801|FG001|Overall Study|Withdrawal by Subject|1|||
163119406|NCT02827500|589144800|FG000|Overall Study|Missing primary endpoint data|3|||
163119407|NCT02827500|589144801|FG001|Overall Study|Missing primary endpoint data|1|||
163119408|NCT02827500|589144800|FG000|Overall Study|Other|5|||
163119409|NCT02827500|589144801|FG001|Overall Study|Other|1|||
163119410|NCT03158272|589144804|FG000|Overall Study|Disease progression|3|||
163119411|NCT03158272|589144805|FG001|Overall Study|Disease progression|3|||
163119412|NCT03158272|589144806|FG002|Overall Study|Disease progression|4|||
163119413|NCT03158272|589144807|FG003|Overall Study|Disease progression|6|||
163119414|NCT03158272|589144804|FG000|Overall Study|Death|0|||
163119415|NCT03158272|589144805|FG001|Overall Study|Death|0|||
163119416|NCT03158272|589144806|FG002|Overall Study|Death|1|||
163119417|NCT03158272|589144807|FG003|Overall Study|Death|0|||
163119418|NCT03158272|589144804|FG000|Overall Study|Other reasons|0|||
163119419|NCT03158272|589144805|FG001|Overall Study|Other reasons|0|||
163119420|NCT03158272|589144806|FG002|Overall Study|Other reasons|1|||
163119421|NCT03158272|589144807|FG003|Overall Study|Other reasons|0|||
163119422|NCT03158272|589144804|FG000|Overall Study|Adverse event unrelated to the drug|0|||
163119423|NCT03158272|589144805|FG001|Overall Study|Adverse event unrelated to the drug|1|||
163119424|NCT03158272|589144806|FG002|Overall Study|Adverse event unrelated to the drug|0|||
163119425|NCT03158272|589144807|FG003|Overall Study|Adverse event unrelated to the drug|0|||
163119426|NCT00514020|589144808|FG000|Overall Study|Adverse Event|6|||
163119427|NCT00514020|589144808|FG000|Overall Study|Withdrawal by Subject|3|||
163119428|NCT00514020|589144808|FG000|Overall Study|Physician Decision|1|||
163119429|NCT00514020|589144808|FG000|Overall Study|disease progression|9|||
163119430|NCT00514020|589144808|FG000|Overall Study|other complicating disease|2|||
163119431|NCT00514020|589144808|FG000|Overall Study|patient went to radiation treatment|1|||
163119432|NCT00514020|589144808|FG000|Overall Study|"patients moved to the no tx group"|6|||
163119433|NCT01688921|589144809|FG000|Overall Study|Lost to Follow-up|7|||
163119434|NCT01688921|589144810|FG001|Overall Study|Lost to Follow-up|13|||
163119435|NCT01688921|589144809|FG000|Overall Study|Physician Decision|6|||
163119436|NCT01688921|589144810|FG001|Overall Study|Physician Decision|1|||
163119437|NCT01688921|589144809|FG000|Overall Study|Protocol Violation|0|||
163119438|NCT01688921|589144810|FG001|Overall Study|Protocol Violation|1|||
163119439|NCT01688921|589144809|FG000|Overall Study|informed consent|3|||
163119440|NCT01688921|589144810|FG001|Overall Study|informed consent|0|||
163119441|NCT03697993|589144816|FG000|Overall Study|Became Ineligible after Enrollment|1|||
163119442|NCT03697993|589144817|FG001|Overall Study|Became Ineligible after Enrollment|3|||
163119443|NCT03697993|589144816|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
163119444|NCT03697993|589144817|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
163119445|NCT03697993|589144816|FG000|Overall Study|Lost to Follow-up|3|||
163119446|NCT03697993|589144817|FG001|Overall Study|Lost to Follow-up|0|||
163119447|NCT03697993|589144816|FG000|Overall Study|Physician Decision|4|||
163119448|NCT03697993|589144817|FG001|Overall Study|Physician Decision|0|||
162654773|NCT03995953|587451693|FG000|Overall Study|Death|3|||
162654774|NCT03995953|587451694|FG001|Overall Study|Death|0|||
162654775|NCT03995953|587451695|FG002|Overall Study|Death|3|||
162654776|NCT03995953|587451696|FG003|Overall Study|Death|0|||
162654777|NCT03995953|587451697|FG004|Overall Study|Death|3|||
162654778|NCT03995953|587451698|FG005|Overall Study|Death|0|||
163119449|NCT03697993|589144816|FG000|Overall Study|Initial Urine Culture Negative|0|||
163119450|NCT03697993|589144817|FG001|Overall Study|Initial Urine Culture Negative|1|||
163119451|NCT04384107|589144818|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
163119452|NCT04384107|589144819|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
163119453|NCT04384107|589144818|FG000|Overall Study|Lost to Follow-up|1|||
163119454|NCT04384107|589144819|FG001|Overall Study|Lost to Follow-up|0|||
163119455|NCT01048866|589144824|FG000|Overall Study|Adverse Event|1|||
163119456|NCT01048866|589144825|FG001|Overall Study|Adverse Event|0|||
163119457|NCT01048866|589144824|FG000|Overall Study|Protocol Violation|1|||
163119458|NCT01048866|589144825|FG001|Overall Study|Protocol Violation|0|||
163119459|NCT01048866|589144824|FG000|Overall Study|Physician Decision|1|||
163119460|NCT01048866|589144825|FG001|Overall Study|Physician Decision|0|||
163119461|NCT01048866|589144824|FG000|Overall Study|Withdrawal by Subject|0|||
163119462|NCT01048866|589144825|FG001|Overall Study|Withdrawal by Subject|2|||
163119463|NCT01048866|589144824|FG000|Overall Study|Lost to Follow-up|0|||
163119464|NCT01048866|589144825|FG001|Overall Study|Lost to Follow-up|2|||
163119465|NCT01048866|589144824|FG000|Overall Study|Other|1|||
163119466|NCT01048866|589144825|FG001|Overall Study|Other|1|||
163119467|NCT03582813|589144826|FG000|Overall Study|Lost to Follow-up|18|||
163119468|NCT03582813|589144827|FG001|Overall Study|Lost to Follow-up|21|||
163119469|NCT03582813|589144826|FG000|Overall Study|Withdrawal by Subject|1|||
163119470|NCT03582813|589144827|FG001|Overall Study|Withdrawal by Subject|0|||
163119471|NCT02525094|589144832|FG000|Overall Study|Lost to Follow-up|2|||
163119472|NCT02525094|589144833|FG001|Overall Study|Lost to Follow-up|1|||
163119473|NCT02525094|589144832|FG000|Overall Study|Withdrawal by Subject|5|||
163119474|NCT02525094|589144833|FG001|Overall Study|Withdrawal by Subject|6|||
163119475|NCT02525094|589144832|FG000|Overall Study|Not Treated|1|||
163119476|NCT02525094|589144833|FG001|Overall Study|Not Treated|1|||
163119477|NCT01591863|589144834|FG000|Overall Study|Adverse Event|3|||
163119478|NCT01591863|589144834|FG000|Overall Study|Withdrawal by Subject|1|||
163119479|NCT01591863|589144834|FG000|Overall Study|recurrence|9|||
163119480|NCT01591863|589144834|FG000|Overall Study|Lack of Efficacy|1|||
163119481|NCT01751776|589144837|FG000|Overall Study|Adverse Event|0|||
163119482|NCT01751776|589144838|FG001|Overall Study|Adverse Event|0|||
163119483|NCT01751776|589144839|FG002|Overall Study|Adverse Event|0|||
163119484|NCT01751776|589144840|FG003|Overall Study|Adverse Event|0|||
163119485|NCT01751776|589144841|FG004|Overall Study|Adverse Event|0|||
163119486|NCT01751776|589144842|FG005|Overall Study|Adverse Event|0|||
163119487|NCT01751776|589144843|FG006|Overall Study|Adverse Event|4|||
163119488|NCT01751776|589144844|FG007|Overall Study|Adverse Event|2|||
163119489|NCT01751776|589144837|FG000|Overall Study|Consent withdrawn|0|||
163119490|NCT01751776|589144838|FG001|Overall Study|Consent withdrawn|0|||
163119491|NCT01751776|589144839|FG002|Overall Study|Consent withdrawn|0|||
163119492|NCT01751776|589144840|FG003|Overall Study|Consent withdrawn|0|||
163119493|NCT01751776|589144841|FG004|Overall Study|Consent withdrawn|0|||
163119494|NCT01751776|589144842|FG005|Overall Study|Consent withdrawn|0|||
163119495|NCT01751776|589144843|FG006|Overall Study|Consent withdrawn|0|||
163119496|NCT01751776|589144844|FG007|Overall Study|Consent withdrawn|1|||
163119497|NCT01751776|589144837|FG000|Overall Study|Other reason not specified above|0|||
163119498|NCT01751776|589144838|FG001|Overall Study|Other reason not specified above|0|||
163119499|NCT01751776|589144839|FG002|Overall Study|Other reason not specified above|0|||
163119500|NCT01751776|589144840|FG003|Overall Study|Other reason not specified above|0|||
163119501|NCT01751776|589144841|FG004|Overall Study|Other reason not specified above|0|||
163119502|NCT01751776|589144842|FG005|Overall Study|Other reason not specified above|0|||
163119503|NCT01751776|589144843|FG006|Overall Study|Other reason not specified above|0|||
163119504|NCT01751776|589144844|FG007|Overall Study|Other reason not specified above|1|||
163119505|NCT00160654|589144845|FG000|Overall Study|Adverse Event|14|||
163119506|NCT00160654|589144845|FG000|Overall Study|Lack of Efficacy|4|||
163119507|NCT00160654|589144845|FG000|Overall Study|Lost to Follow-up|2|||
163119508|NCT00160654|589144845|FG000|Overall Study|Intake of expired drug|7|||
163119509|NCT00160654|589144845|FG000|Overall Study|Psychological trauma|1|||
163119510|NCT00160654|589144845|FG000|Overall Study|Sponsor decision|1|||
163119511|NCT00160654|589144845|FG000|Overall Study|Patient met exclusion criteria|1|||
163119512|NCT00160654|589144845|FG000|Overall Study|Patient decision|1|||
163119513|NCT00160654|589144845|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
163119514|NCT00160654|589144845|FG000|Overall Study|Met exclusion criteria|1|||
163119515|NCT00831701|589144846|FG000|Overall Study|Withdrawal by Subject|2|||
163119516|NCT00831701|589144847|FG001|Overall Study|Withdrawal by Subject|0|||
163119517|NCT00831701|589144846|FG000|Overall Study|Stone expulsion before first medication|2|||
163119518|NCT00831701|589144847|FG001|Overall Study|Stone expulsion before first medication|2|||
163119519|NCT00831701|589144846|FG000|Overall Study|Lost to Follow-up|1|||
163119520|NCT00831701|589144847|FG001|Overall Study|Lost to Follow-up|3|||
163119521|NCT02366767|589144848|FG000|Overall Study|left for home after 1 day at camp|1|||
163119522|NCT02366767|589144849|FG001|Overall Study|left for home after 1 day at camp|0|||
163119523|NCT00664326|589146375|FG000|Overall Study|Adverse Event|14|||
163119524|NCT00664326|589146375|FG000|Overall Study|Noncompliance with study medication|3|||
163119525|NCT00664326|589146375|FG000|Overall Study|Withdrawal by Subject|1|||
163119526|NCT00664326|589146375|FG000|Overall Study|Physician Decision|1|||
163119527|NCT00664326|589146375|FG000|Overall Study|Other Reasons|3|||
163119528|NCT00664326|589146375|FG000|Overall Study|Death|2|||
163119529|NCT00664326|589146375|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
163119530|NCT01161537|589146377|FG000|Part B|Withdrawal by Subject|2|||
163119531|NCT00004445|589146378|FG000|Overall Study|Physician Decision|2|||
163119532|NCT00004445|589146378|FG000|Overall Study|Withdrawal by Subject|1|||
163119533|NCT00076336|589146379|FG000|Overall Study|Death|13|||
163119534|NCT00076336|589146380|FG001|Overall Study|Death|17|||
163119535|NCT00076336|589146379|FG000|Overall Study|Adverse Event|4|||
163119536|NCT00076336|589146380|FG001|Overall Study|Adverse Event|4|||
163119537|NCT00076336|589146379|FG000|Overall Study|Lost to Follow-up|4|||
163119538|NCT00076336|589146380|FG001|Overall Study|Lost to Follow-up|4|||
163119539|NCT00076336|589146379|FG000|Overall Study|Non-Compliance|2|||
163119540|NCT00076336|589146380|FG001|Overall Study|Non-Compliance|0|||
163119541|NCT00076336|589146379|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
163119542|NCT00076336|589146380|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
163119543|NCT00076336|589146379|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
163119544|NCT00076336|589146380|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
163119545|NCT00076336|589146379|FG000|Overall Study|Liver Transplantation|3|||
163119546|NCT00076336|589146380|FG001|Overall Study|Liver Transplantation|3|||
163119547|NCT00076336|589146379|FG000|Overall Study|Virologic Breakthrough|14|||
163119548|NCT00076336|589146380|FG001|Overall Study|Virologic Breakthrough|16|||
163119549|NCT00076336|589146379|FG000|Overall Study|Treatment failure|4|||
163119550|NCT00076336|589146380|FG001|Overall Study|Treatment failure|5|||
163119551|NCT01519674|589146382|FG000|Overall Study|Adverse Event|3|||
163119552|NCT01519674|589146383|FG001|Overall Study|Adverse Event|3|||
163119553|NCT01519674|589146384|FG002|Overall Study|Adverse Event|0|||
163119554|NCT01519674|589146382|FG000|Overall Study|Lack of Efficacy|1|||
163119555|NCT01519674|589146383|FG001|Overall Study|Lack of Efficacy|1|||
163119556|NCT01519674|589146384|FG002|Overall Study|Lack of Efficacy|1|||
163119557|NCT01519674|589146382|FG000|Overall Study|Protocol Violation|0|||
163119558|NCT01519674|589146383|FG001|Overall Study|Protocol Violation|3|||
163119559|NCT01519674|589146384|FG002|Overall Study|Protocol Violation|1|||
163119560|NCT01519674|589146382|FG000|Overall Study|Withdrawal Criteria|7|||
163119561|NCT01519674|589146383|FG001|Overall Study|Withdrawal Criteria|2|||
163119562|NCT01519674|589146384|FG002|Overall Study|Withdrawal Criteria|7|||
163119563|NCT01519674|589146382|FG000|Overall Study|Unsclassified|10|||
163119564|NCT01519674|589146383|FG001|Overall Study|Unsclassified|4|||
163119565|NCT01519674|589146384|FG002|Overall Study|Unsclassified|3|||
163119566|NCT02046174|589146388|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
163119567|NCT02046174|589146389|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
163119568|NCT00186537|589146391|FG000|Overall Study|Withdrawal by Subject|4|||
163119569|NCT00186537|589146392|FG001|Overall Study|Withdrawal by Subject|0|||
163119570|NCT00186537|589146393|FG002|Overall Study|Withdrawal by Subject|3|||
163119571|NCT00186537|589146391|FG000|Overall Study|ALT > 1.5 x ULN|3|||
163119572|NCT00186537|589146392|FG001|Overall Study|ALT > 1.5 x ULN|0|||
163119573|NCT00186537|589146393|FG002|Overall Study|ALT > 1.5 x ULN|0|||
163119574|NCT01146288|589146397|FG000|First Intervention(1 Day)|Adverse Event|0|||
163119575|NCT01146288|589146398|FG001|First Intervention(1 Day)|Adverse Event|1|||
163119576|NCT03630302|589146399|FG000|Surgery|hardware issue prevented LFP recordings|1|||
163119577|NCT03630302|589146399|FG000|3 Month Visit|Adverse Event|2|||
163119578|NCT03630302|589146399|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
163119579|NCT01135914|589146400|FG000|Overall Study|Withdrawal by Subject|1|||
163119580|NCT01135914|589146401|FG001|Overall Study|Withdrawal by Subject|3|||
163119581|NCT01135914|589146402|FG002|Overall Study|Withdrawal by Subject|6|||
163119582|NCT01135914|589146400|FG000|Overall Study|Lost to Follow-up|1|||
163119583|NCT01135914|589146401|FG001|Overall Study|Lost to Follow-up|0|||
163119584|NCT01135914|589146402|FG002|Overall Study|Lost to Follow-up|1|||
163119585|NCT01135914|589146400|FG000|Overall Study|Protocol Violation|0|||
163119586|NCT01135914|589146401|FG001|Overall Study|Protocol Violation|0|||
163119587|NCT01135914|589146402|FG002|Overall Study|Protocol Violation|3|||
163119588|NCT01135914|589146400|FG000|Overall Study|Lack of Efficacy|2|||
163119589|NCT01135914|589146401|FG001|Overall Study|Lack of Efficacy|1|||
163119590|NCT01135914|589146402|FG002|Overall Study|Lack of Efficacy|10|||
163119591|NCT01135914|589146400|FG000|Overall Study|Adverse Event|0|||
163119592|NCT01135914|589146401|FG001|Overall Study|Adverse Event|1|||
163119593|NCT01135914|589146402|FG002|Overall Study|Adverse Event|2|||
163119594|NCT00931801|589146405|FG000|Overall Study|Adverse Event|0|||
163119595|NCT00931801|589146406|FG001|Overall Study|Adverse Event|0|||
163119596|NCT00931801|589146407|FG002|Overall Study|Adverse Event|1|||
163119597|NCT00931801|589146405|FG000|Overall Study|Lost to Follow-up|0|||
163119598|NCT00931801|589146406|FG001|Overall Study|Lost to Follow-up|1|||
163119599|NCT00931801|589146407|FG002|Overall Study|Lost to Follow-up|0|||
163119600|NCT00931801|589146405|FG000|Overall Study|Withdrawal by Subject|1|||
163119601|NCT00931801|589146406|FG001|Overall Study|Withdrawal by Subject|0|||
163119602|NCT00931801|589146407|FG002|Overall Study|Withdrawal by Subject|0|||
163119603|NCT00931801|589146405|FG000|Overall Study|Confirmed Virologic Failure|0|||
163119604|NCT00931801|589146406|FG001|Overall Study|Confirmed Virologic Failure|0|||
163119605|NCT00931801|589146407|FG002|Overall Study|Confirmed Virologic Failure|3|||
163119606|NCT00746733|589146408|FG000|Second Intervention|Adverse Event|1|||
163119607|NCT00746733|589146409|FG001|Second Intervention|Adverse Event|0|||
163119608|NCT00746733|589146408|FG000|Third Intervention|Withdrawal by Subject|1|||
163119609|NCT00746733|589146409|FG001|Third Intervention|Withdrawal by Subject|1|||
163119610|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163119611|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163119612|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
163119613|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
163119614|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119615|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119616|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
163119617|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
163119618|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119619|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119620|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
163119621|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
163119622|NCT00610441|589146410|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119623|NCT00610441|589146411|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
163119624|NCT00610441|589146412|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119625|NCT00610441|589146413|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
163119626|NCT00610441|589146410|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119627|NCT00610441|589146411|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119628|NCT00610441|589146412|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
163119629|NCT00610441|589146413|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
163119630|NCT00610441|589146410|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119631|NCT00610441|589146411|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
163119632|NCT00610441|589146412|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119633|NCT00610441|589146413|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163119634|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
163119635|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
163119636|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
163119637|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
163119638|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119639|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119640|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
163119641|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
163119642|NCT00610441|589146410|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
163119643|NCT00610441|589146411|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119644|NCT00610441|589146412|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119645|NCT00610441|589146413|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
163119646|NCT00334282|589146414|FG000|Overall Study|Lost to Follow-up|11|||
163119647|NCT00334282|589146415|FG001|Overall Study|Lost to Follow-up|5|||
163119648|NCT00334282|589146414|FG000|Overall Study|Withdrawal by Subject|17|||
163119649|NCT00334282|589146415|FG001|Overall Study|Withdrawal by Subject|3|||
163119650|NCT00334282|589146414|FG000|Overall Study|Death|194|||
163119651|NCT00334282|589146415|FG001|Overall Study|Death|100|||
163119652|NCT00837876|589146420|FG000|Overall Study|Death|2|||
163119653|NCT00837876|589146420|FG000|Overall Study|Adverse Event|7|||
163119654|NCT00837876|589146420|FG000|Overall Study|Physician Decision|1|||
163119655|NCT00837876|589146420|FG000|Overall Study|Withdrawal by Subject|3|||
163119656|NCT00837876|589146420|FG000|Overall Study|disease progression|24|||
163119657|NCT00276094|589146422|FG000|Overall Study|Adverse Event|15|||
163119658|NCT00276094|589146423|FG001|Overall Study|Adverse Event|13|||
163119659|NCT00276094|589146424|FG002|Overall Study|Adverse Event|11|||
163119660|NCT00276094|589146422|FG000|Overall Study|Withdrawal by Subject|14|||
163119661|NCT00276094|589146423|FG001|Overall Study|Withdrawal by Subject|14|||
163119662|NCT00276094|589146424|FG002|Overall Study|Withdrawal by Subject|12|||
163119663|NCT00276094|589146422|FG000|Overall Study|Protocol Violation|16|||
163119664|NCT00276094|589146423|FG001|Overall Study|Protocol Violation|7|||
163119665|NCT00276094|589146424|FG002|Overall Study|Protocol Violation|10|||
163119666|NCT00276094|589146422|FG000|Overall Study|Lost to Follow-up|8|||
163119667|NCT00276094|589146423|FG001|Overall Study|Lost to Follow-up|6|||
163119668|NCT00276094|589146424|FG002|Overall Study|Lost to Follow-up|4|||
163119669|NCT00276094|589146422|FG000|Overall Study|Other-Subject moved out of country|1|||
163119670|NCT00276094|589146423|FG001|Overall Study|Other-Subject moved out of country|0|||
163119671|NCT00276094|589146424|FG002|Overall Study|Other-Subject moved out of country|0|||
163119672|NCT00276094|589146422|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
163119673|NCT00276094|589146423|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
163119674|NCT00276094|589146424|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
163119675|NCT00276094|589146422|FG000|Overall Study|Other-Lack of efficacy|1|||
163119676|NCT00276094|589146423|FG001|Overall Study|Other-Lack of efficacy|0|||
163119677|NCT00276094|589146424|FG002|Overall Study|Other-Lack of efficacy|0|||
163119678|NCT00276094|589146422|FG000|Overall Study|Other-Refused follow-up visit|1|||
163119679|NCT00276094|589146423|FG001|Overall Study|Other-Refused follow-up visit|0|||
163119680|NCT00276094|589146424|FG002|Overall Study|Other-Refused follow-up visit|0|||
163119681|NCT00276094|589146422|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
163119682|NCT00276094|589146423|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
163119683|NCT00276094|589146424|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
162654779|NCT03995953|587451699|FG006|Overall Study|Death|0|||
162654780|NCT03995953|587451700|FG007|Overall Study|Death|0|||
162654781|NCT03995953|587451701|FG008|Overall Study|Death|1|||
162654782|NCT03995953|587451702|FG009|Overall Study|Death|0|||
162719469|NCT04513522|587680481|FG000|Overall Study|Other reasons|1|||
162719470|NCT04513522|587680481|FG000|Overall Study|Adverse event unrelated to study drug|9|||
162719471|NCT04513522|587680481|FG000|Overall Study|Study drug toxicity|14|||
163119684|NCT00276094|589146422|FG000|Overall Study|Other-Relocation|0|||
163119685|NCT00276094|589146423|FG001|Overall Study|Other-Relocation|1|||
163119686|NCT00276094|589146424|FG002|Overall Study|Other-Relocation|0|||
163119687|NCT00276094|589146422|FG000|Overall Study|Other-Study medication lost|0|||
163119688|NCT00276094|589146423|FG001|Overall Study|Other-Study medication lost|0|||
163119689|NCT00276094|589146424|FG002|Overall Study|Other-Study medication lost|1|||
163119690|NCT00787137|589146425|FG000|Overall Study|Study Termination|0|||
163119691|NCT00787137|589146426|FG001|Overall Study|Study Termination|0|||
163119692|NCT00787137|589146427|FG002|Overall Study|Study Termination|1|||
163119693|NCT02075632|589146431|FG000|Overall Study|Adverse Event|1|||
163119694|NCT02075632|589146432|FG001|Overall Study|Adverse Event|1|||
163119695|NCT02075632|589146431|FG000|Overall Study|Lost to Follow-up|0|||
163119696|NCT02075632|589146432|FG001|Overall Study|Lost to Follow-up|3|||
163119697|NCT02075632|589146431|FG000|Overall Study|Withdrawal by Subject|0|||
163119698|NCT02075632|589146432|FG001|Overall Study|Withdrawal by Subject|1|||
163119699|NCT03464422|589146433|FG000|Overall Study|Lost to Follow-up|2|||
163119700|NCT03464422|589146433|FG000|Overall Study|Withdrawal by Subject|2|||
163119701|NCT01628367|589146437|FG000|Overall Study|Adverse Event|1|||
163119702|NCT01628367|589146438|FG001|Overall Study|Adverse Event|0|||
163119703|NCT00740714|589146439|FG000|Overall Study|Withdrawal by Subject|17|||
163119704|NCT00740714|589146440|FG001|Overall Study|Withdrawal by Subject|19|||
163119705|NCT00740714|589146441|FG002|Overall Study|Withdrawal by Subject|29|||
163119706|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
163119707|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
163119708|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
163119709|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
163119710|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
163119711|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
163119712|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
163119713|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
163119714|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
163119715|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
163119716|NCT01352741|589146452|FG000|Open-label Tapentadol Titration Period|Other|4|||
163119717|NCT01352741|589146453|FG001|Open-label Tapentadol Titration Period|Other|0|||
163119718|NCT01352741|589146452|FG000|Double-blind Comparative Period|Protocol Violation|2|||
163119719|NCT01352741|589146453|FG001|Double-blind Comparative Period|Protocol Violation|0|||
163119720|NCT01352741|589146452|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
163119721|NCT01352741|589146453|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
163119722|NCT01352741|589146452|FG000|Double-blind Comparative Period|Adverse Event|16|||
163119723|NCT01352741|589146453|FG001|Double-blind Comparative Period|Adverse Event|17|||
163119724|NCT01352741|589146452|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
163119725|NCT01352741|589146453|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
163119726|NCT01352741|589146452|FG000|Double-blind Comparative Period|Death|0|||
163119727|NCT01352741|589146453|FG001|Double-blind Comparative Period|Death|1|||
163119728|NCT01352741|589146452|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
163119729|NCT01352741|589146453|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
163119730|NCT01352741|589146452|FG000|Double-blind Comparative Period|Other|1|||
163119731|NCT01352741|589146453|FG001|Double-blind Comparative Period|Other|2|||
163119732|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
163119733|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
163119734|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
163119735|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
163119736|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
163119737|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
163119738|NCT01352741|589146452|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
163119739|NCT01352741|589146453|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
163119740|NCT04070326|589146455|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
163119741|NCT04070326|589146456|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
163119742|NCT00645528|589146457|FG000|Overall Study|Did not show up for Visit 2|7|||
163119743|NCT01367704|589146460|FG000|Overall Study|Lost to Follow-up|47|||
163119744|NCT01367704|589146461|FG001|Overall Study|Lost to Follow-up|161|||
163119745|NCT03461406|589146463|FG000|Overall Study|Death|1|||
163119746|NCT03461406|589146464|FG001|Overall Study|Death|2|||
163119747|NCT03461406|589146463|FG000|Overall Study|Consent Withdrawn by Participant|0|||
163119748|NCT03461406|589146464|FG001|Overall Study|Consent Withdrawn by Participant|1|||
163119749|NCT03461406|589146463|FG000|Overall Study|Screen Failure|3|||
163119750|NCT03461406|589146464|FG001|Overall Study|Screen Failure|1|||
163119751|NCT03461406|589146463|FG000|Overall Study|Reason not Specified|1|||
163119752|NCT03461406|589146464|FG001|Overall Study|Reason not Specified|3|||
163119753|NCT03461406|589146463|FG000|Overall Study|Lost to Follow-up|3|||
163119754|NCT03461406|589146464|FG001|Overall Study|Lost to Follow-up|0|||
163119755|NCT01886690|589146465|FG000|Overall Study|Protocol Violation|0|||
163119756|NCT01886690|589146466|FG001|Overall Study|Protocol Violation|1|||
163119757|NCT01886690|589146465|FG000|Overall Study|Personal Reasons|0|||
163119758|NCT01886690|589146466|FG001|Overall Study|Personal Reasons|1|||
163119759|NCT03077698|589146467|FG000|Progestin Monotherapy|Stable Disease|8|||
163119760|NCT03077698|589146468|FG001|Progestin Monotherapy|Stable Disease|0|||
163119761|NCT03077698|589146467|FG000|Progestin Monotherapy|Adverse Event|1|||
163119762|NCT03077698|589146468|FG001|Progestin Monotherapy|Adverse Event|0|||
163119763|NCT03077698|589146467|FG000|Progestin Monotherapy|Death|1|||
163119764|NCT03077698|589146468|FG001|Progestin Monotherapy|Death|0|||
163119765|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
163119766|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
163119767|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
163119768|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
162654783|NCT03995953|587451703|FG010|Overall Study|Death|0|||
162654784|NCT03995953|587451704|FG011|Overall Study|Death|0|||
163119769|NCT03077698|589146467|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
163119770|NCT03077698|589146468|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
163119771|NCT03077698|589146467|FG000|Safety Follow Up|Withdrawal by Subject|2|||
163119772|NCT03077698|589146468|FG001|Safety Follow Up|Withdrawal by Subject|1|||
163119773|NCT03077698|589146467|FG000|Safety Follow Up|Transfer of care to hospice|1|||
163119774|NCT03077698|589146468|FG001|Safety Follow Up|Transfer of care to hospice|0|||
163119775|NCT01439074|589146469|FG000|Overall Study|Lost to Follow-up|3|||
163119776|NCT01439074|589146470|FG001|Overall Study|Lost to Follow-up|4|||
163119777|NCT01439074|589146469|FG000|Overall Study|Subject shedding|1|||
163119778|NCT01439074|589146470|FG001|Overall Study|Subject shedding|0|||
163119779|NCT01439074|589146469|FG000|Overall Study|Withdrawal by Subject|1|||
163119780|NCT01439074|589146470|FG001|Overall Study|Withdrawal by Subject|5|||
163119781|NCT01439074|589146469|FG000|Overall Study|Other|4|||
163119782|NCT01439074|589146470|FG001|Overall Study|Other|4|||
163119783|NCT01140568|589146471|FG000|Overall Study|disease progression|31|||
163119784|NCT01140568|589146471|FG000|Overall Study|Withdrawal by Subject|1|||
163119785|NCT01140568|589146471|FG000|Overall Study|Screen Fail|4|||
163119786|NCT03618628|589146472|FG000|Overall Study|Death|1|||
163119787|NCT03618628|589146472|FG000|Overall Study|Lost to Follow-up|1|||
163119788|NCT01969500|589146473|FG000|Overall Study|Death|0|||
163119789|NCT01969500|589146474|FG001|Overall Study|Death|1|||
163119790|NCT01969500|589146473|FG000|Overall Study|extended hospitalization|1|||
163119791|NCT01969500|589146474|FG001|Overall Study|extended hospitalization|1|||
163119792|NCT02193087|589146475|FG000|Overall Study|Adverse Event|2|||
163119793|NCT02193087|589146476|FG001|Overall Study|Adverse Event|0|||
163119794|NCT02193087|589146477|FG002|Overall Study|Adverse Event|0|||
163119795|NCT02193087|589146478|FG003|Overall Study|Adverse Event|11|||
163119796|NCT02193087|589146475|FG000|Overall Study|Lost to Follow-up|14|||
163119797|NCT02193087|589146476|FG001|Overall Study|Lost to Follow-up|6|||
163119798|NCT02193087|589146477|FG002|Overall Study|Lost to Follow-up|4|||
163119799|NCT02193087|589146478|FG003|Overall Study|Lost to Follow-up|37|||
163119800|NCT02193087|589146475|FG000|Overall Study|Protocol Violation|2|||
163119801|NCT02193087|589146476|FG001|Overall Study|Protocol Violation|0|||
163119802|NCT02193087|589146477|FG002|Overall Study|Protocol Violation|1|||
163119803|NCT02193087|589146478|FG003|Overall Study|Protocol Violation|2|||
163119804|NCT02193087|589146475|FG000|Overall Study|Withdrawal by Subject|10|||
163119805|NCT02193087|589146476|FG001|Overall Study|Withdrawal by Subject|3|||
163119806|NCT02193087|589146477|FG002|Overall Study|Withdrawal by Subject|1|||
163119807|NCT02193087|589146478|FG003|Overall Study|Withdrawal by Subject|19|||
163119808|NCT02193087|589146475|FG000|Overall Study|Other Reason Not Specified|7|||
163119809|NCT02193087|589146476|FG001|Overall Study|Other Reason Not Specified|2|||
163119810|NCT02193087|589146477|FG002|Overall Study|Other Reason Not Specified|1|||
163119811|NCT02193087|589146478|FG003|Overall Study|Other Reason Not Specified|9|||
163119812|NCT02193087|589146475|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
163119813|NCT02193087|589146476|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
163119814|NCT02193087|589146477|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
163119815|NCT02193087|589146478|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
163119816|NCT04096820|589146479|FG000|Overall Study|Did not return for intervention|2|||
163119817|NCT04096820|589146479|FG000|Overall Study|Death|1|||
163119818|NCT02463032|589146480|FG000|Overall Study|Lack of Efficacy|61|||
162654785|NCT03995953|587451693|FG000|Overall Study|Lost to Follow-up|6|||
162654786|NCT03995953|587451694|FG001|Overall Study|Lost to Follow-up|54|||
162654787|NCT03995953|587451695|FG002|Overall Study|Lost to Follow-up|3|||
163119819|NCT02463032|589146481|FG001|Overall Study|Lack of Efficacy|50|||
163119820|NCT02463032|589146480|FG000|Overall Study|Death|8|||
163119821|NCT02463032|589146481|FG001|Overall Study|Death|8|||
163119822|NCT02463032|589146480|FG000|Overall Study|Adverse Event|2|||
163119823|NCT02463032|589146481|FG001|Overall Study|Adverse Event|6|||
163119824|NCT00612508|589146482|FG000|Overall Study|Withdrawal by Subject|3|||
163119825|NCT00612508|589146483|FG001|Overall Study|Withdrawal by Subject|4|||
163119826|NCT02312219|589146484|FG000|Overall Study|Withdrawal by Subject|1|||
163119827|NCT02312219|589146485|FG001|Overall Study|Withdrawal by Subject|2|||
163119828|NCT02312219|589146484|FG000|Overall Study|could not schedule imaging in time|0|||
163119829|NCT02312219|589146485|FG001|Overall Study|could not schedule imaging in time|2|||
163119830|NCT02312219|589146484|FG000|Overall Study|Other|0|||
162654788|NCT03995953|587451696|FG003|Overall Study|Lost to Follow-up|32|||
162654789|NCT03995953|587451697|FG004|Overall Study|Lost to Follow-up|5|||
162654790|NCT03995953|587451698|FG005|Overall Study|Lost to Follow-up|44|||
162654791|NCT03995953|587451699|FG006|Overall Study|Lost to Follow-up|0|||
162654792|NCT03995953|587451700|FG007|Overall Study|Lost to Follow-up|31|||
162654793|NCT03995953|587451701|FG008|Overall Study|Lost to Follow-up|8|||
163119831|NCT02312219|589146485|FG001|Overall Study|Other|1|||
163119832|NCT02312219|589146484|FG000|Overall Study|Not randomized. Ineligible|0|||
162654794|NCT03995953|587451702|FG009|Overall Study|Lost to Follow-up|36|||
162654795|NCT03995953|587451703|FG010|Overall Study|Lost to Follow-up|5|||
163119833|NCT02312219|589146485|FG001|Overall Study|Not randomized. Ineligible|1|||
163119834|NCT01100567|589146486|FG000|Overall Study|Withdrawal by Subject|5|||
163119835|NCT01100567|589146487|FG001|Overall Study|Withdrawal by Subject|8|||
163119836|NCT01100567|589146486|FG000|Overall Study|Early Hospital Discharge|6|||
163119837|NCT01100567|589146487|FG001|Overall Study|Early Hospital Discharge|4|||
163119838|NCT01100567|589146486|FG000|Overall Study|Lost to Follow-up|1|||
163119839|NCT01100567|589146487|FG001|Overall Study|Lost to Follow-up|2|||
163119840|NCT01100567|589146486|FG000|Overall Study|Physician Decision|0|||
163119841|NCT01100567|589146487|FG001|Overall Study|Physician Decision|1|||
163119842|NCT01100567|589146486|FG000|Overall Study|Deemed ineligible after consent|0|||
163119843|NCT01100567|589146487|FG001|Overall Study|Deemed ineligible after consent|1|||
163119844|NCT02741570|589146488|FG000|Pre-Treatment Period|Other reasons|0|||
163119845|NCT02741570|589146489|FG001|Pre-Treatment Period|Other reasons|3|||
163119846|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
163119847|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
163119848|NCT02741570|589146488|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
163119849|NCT02741570|589146489|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
163119850|NCT02741570|589146488|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
163119851|NCT02741570|589146489|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
163119852|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
163119853|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
163119854|NCT02741570|589146488|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163119855|NCT02741570|589146489|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
163119856|NCT02741570|589146488|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
163119857|NCT02741570|589146489|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
163119858|NCT02741570|589146488|FG000|Pre-Treatment Period|Death|0|||
163119859|NCT02741570|589146489|FG001|Pre-Treatment Period|Death|1|||
163119860|NCT02741570|589146488|FG000|Pre-Treatment Period|Disease progression|0|||
163119861|NCT02741570|589146489|FG001|Pre-Treatment Period|Disease progression|1|||
163119862|NCT02741570|589146488|FG000|Treatment Period|Other reasons|47|||
163119863|NCT02741570|589146489|FG001|Treatment Period|Other reasons|12|||
163119864|NCT02741570|589146488|FG000|Treatment Period|Poor/non-compliance|0|||
163119865|NCT02741570|589146489|FG001|Treatment Period|Poor/non-compliance|2|||
163119866|NCT02741570|589146488|FG000|Treatment Period|Maximum clinical benefit|4|||
163119867|NCT02741570|589146489|FG001|Treatment Period|Maximum clinical benefit|6|||
163119868|NCT02741570|589146488|FG000|Treatment Period|Lost to Follow-up|1|||
163119869|NCT02741570|589146489|FG001|Treatment Period|Lost to Follow-up|3|||
163119870|NCT02741570|589146488|FG000|Treatment Period|Participant withdrew consent|9|||
163119871|NCT02741570|589146489|FG001|Treatment Period|Participant withdrew consent|13|||
163119872|NCT02741570|589146488|FG000|Treatment Period|Participant request to discontinue treatment|8|||
163119873|NCT02741570|589146489|FG001|Treatment Period|Participant request to discontinue treatment|23|||
163119874|NCT02741570|589146488|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
163119875|NCT02741570|589146489|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
163119876|NCT02741570|589146488|FG000|Treatment Period|Death|9|||
163119877|NCT02741570|589146489|FG001|Treatment Period|Death|7|||
163119878|NCT02741570|589146488|FG000|Treatment Period|Study drug toxicity|55|||
163119879|NCT02741570|589146489|FG001|Treatment Period|Study drug toxicity|47|||
163119880|NCT02741570|589146488|FG000|Treatment Period|Disease progression|294|||
163119881|NCT02741570|589146489|FG001|Treatment Period|Disease progression|301|||
163119882|NCT02741570|589146488|FG000|Treatment Period|Administrative reason by sponsor|0|||
162654796|NCT03995953|587451704|FG011|Overall Study|Lost to Follow-up|41|||
162654797|NCT03995953|587451693|FG000|Overall Study|Withdrawal by Subject|4|||
162654798|NCT03995953|587451694|FG001|Overall Study|Withdrawal by Subject|0|||
162654799|NCT03995953|587451695|FG002|Overall Study|Withdrawal by Subject|1|||
162654800|NCT03995953|587451696|FG003|Overall Study|Withdrawal by Subject|0|||
162654801|NCT03995953|587451697|FG004|Overall Study|Withdrawal by Subject|1|||
162654802|NCT03995953|587451698|FG005|Overall Study|Withdrawal by Subject|0|||
163119883|NCT02741570|589146489|FG001|Treatment Period|Administrative reason by sponsor|1|||
163119884|NCT00946322|589146492|FG000|Pre-treatment|participant failure to follow up|1|||
163119885|NCT00946322|589146492|FG000|Post-treatment|participant failure to follow up|2|||
163119886|NCT01241760|589146494|FG000|Overall Study|Adverse Event|1|||
162654803|NCT03995953|587451699|FG006|Overall Study|Withdrawal by Subject|1|||
162654804|NCT03995953|587451700|FG007|Overall Study|Withdrawal by Subject|0|||
162654805|NCT03995953|587451701|FG008|Overall Study|Withdrawal by Subject|3|||
162719472|NCT04513522|587680481|FG000|Overall Study|Disease progression|39|||
162719473|NCT04513522|587680481|FG000|Overall Study|Participants withdrew consent|2|||
163119887|NCT01241760|589146495|FG001|Overall Study|Adverse Event|0|||
163119888|NCT01241760|589146494|FG000|Overall Study|Lost to Follow-up|18|||
163119889|NCT01241760|589146495|FG001|Overall Study|Lost to Follow-up|22|||
163119890|NCT01241760|589146494|FG000|Overall Study|Withdrawal by Subject|13|||
163119891|NCT01241760|589146495|FG001|Overall Study|Withdrawal by Subject|13|||
163119892|NCT01241760|589146494|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
163119893|NCT01241760|589146495|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
163119894|NCT01241760|589146494|FG000|Overall Study|Other|1|||
163119895|NCT01241760|589146495|FG001|Overall Study|Other|1|||
163119896|NCT01636713|589146497|FG000|Overall Study|Adverse Event|16|||
163119897|NCT01636713|589146498|FG001|Overall Study|Adverse Event|16|||
163119898|NCT01636713|589146499|FG002|Overall Study|Adverse Event|7|||
163119899|NCT01636713|589146497|FG000|Overall Study|Lack of Efficacy|6|||
163119900|NCT01636713|589146498|FG001|Overall Study|Lack of Efficacy|6|||
163119901|NCT01636713|589146499|FG002|Overall Study|Lack of Efficacy|2|||
163119902|NCT01636713|589146497|FG000|Overall Study|Protocol Violation|3|||
163119903|NCT01636713|589146498|FG001|Overall Study|Protocol Violation|0|||
163119904|NCT01636713|589146499|FG002|Overall Study|Protocol Violation|1|||
163119905|NCT01636713|589146497|FG000|Overall Study|Lost to Follow-up|0|||
163119906|NCT01636713|589146498|FG001|Overall Study|Lost to Follow-up|0|||
163119907|NCT01636713|589146499|FG002|Overall Study|Lost to Follow-up|1|||
163119908|NCT01636713|589146497|FG000|Overall Study|Withdrawal by Subject|5|||
163119909|NCT01636713|589146498|FG001|Overall Study|Withdrawal by Subject|4|||
163119910|NCT01636713|589146499|FG002|Overall Study|Withdrawal by Subject|8|||
163119911|NCT01636713|589146497|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163119912|NCT01636713|589146498|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163119913|NCT01636713|589146499|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
162719474|NCT04517864|587680484|FG000|Placebo-Controlled Phase|Adverse Event|1|||
163119914|NCT00276614|589146502|FG000|Overall Study|Progression of disease under study|3|||
163119915|NCT02117349|589146505|FG000|Overall Study|Withdrawal by Subject|1|||
163119916|NCT02117349|589146506|FG001|Overall Study|Withdrawal by Subject|0|||
163119917|NCT02117349|589146505|FG000|Overall Study|Lost to Follow-up|1|||
163119918|NCT02117349|589146506|FG001|Overall Study|Lost to Follow-up|1|||
163119919|NCT02117349|589146505|FG000|Overall Study|Death|1|||
163119920|NCT02117349|589146506|FG001|Overall Study|Death|0|||
162654806|NCT03995953|587451702|FG009|Overall Study|Withdrawal by Subject|0|||
162654807|NCT03995953|587451703|FG010|Overall Study|Withdrawal by Subject|3|||
162654808|NCT03995953|587451704|FG011|Overall Study|Withdrawal by Subject|0|||
162654809|NCT03995953|587451693|FG000|Overall Study|Health Issues|0|||
162654810|NCT03995953|587451694|FG001|Overall Study|Health Issues|0|||
162654811|NCT03995953|587451695|FG002|Overall Study|Health Issues|0|||
162654812|NCT03995953|587451696|FG003|Overall Study|Health Issues|0|||
162654813|NCT03995953|587451697|FG004|Overall Study|Health Issues|1|||
162654814|NCT03995953|587451698|FG005|Overall Study|Health Issues|0|||
162654815|NCT03995953|587451699|FG006|Overall Study|Health Issues|0|||
162654816|NCT03995953|587451700|FG007|Overall Study|Health Issues|0|||
162654817|NCT03995953|587451701|FG008|Overall Study|Health Issues|4|||
162654818|NCT03995953|587451702|FG009|Overall Study|Health Issues|0|||
162654819|NCT03995953|587451703|FG010|Overall Study|Health Issues|0|||
162654820|NCT03995953|587451704|FG011|Overall Study|Health Issues|0|||
162654821|NCT03995953|587451693|FG000|Overall Study|Relocated|11|||
162654822|NCT03995953|587451694|FG001|Overall Study|Relocated|0|||
162654823|NCT03995953|587451695|FG002|Overall Study|Relocated|16|||
162654824|NCT03995953|587451696|FG003|Overall Study|Relocated|0|||
162654825|NCT03995953|587451697|FG004|Overall Study|Relocated|14|||
162654826|NCT03995953|587451698|FG005|Overall Study|Relocated|0|||
162654827|NCT03995953|587451699|FG006|Overall Study|Relocated|16|||
162654828|NCT03995953|587451700|FG007|Overall Study|Relocated|0|||
162654829|NCT03995953|587451701|FG008|Overall Study|Relocated|14|||
162654830|NCT03995953|587451702|FG009|Overall Study|Relocated|0|||
162654831|NCT03995953|587451703|FG010|Overall Study|Relocated|15|||
162654832|NCT03995953|587451704|FG011|Overall Study|Relocated|0|||
162654833|NCT02388997|587451705|FG000|Overall Study|Adverse Event|1|||
162654834|NCT02388997|587451706|FG001|Overall Study|Adverse Event|2|||
162654835|NCT02388997|587451705|FG000|Overall Study|Withdrawal by Subject|2|||
162654836|NCT02388997|587451706|FG001|Overall Study|Withdrawal by Subject|1|||
162654837|NCT02388997|587451705|FG000|Overall Study|Lung function exclusion criteria|0|||
162654838|NCT02388997|587451706|FG001|Overall Study|Lung function exclusion criteria|2|||
162654839|NCT02388997|587451705|FG000|Overall Study|Tested positive for virus during run-in|0|||
162654840|NCT02388997|587451706|FG001|Overall Study|Tested positive for virus during run-in|1|||
162654841|NCT02130765|587451707|FG000|Overall Study|Did not receive treatment|4|||
162654842|NCT02130765|587451708|FG001|Overall Study|Did not receive treatment|0|||
162654843|NCT02130765|587451709|FG002|Overall Study|Did not receive treatment|0|||
162654844|NCT02130765|587451710|FG003|Overall Study|Did not receive treatment|0|||
162654845|NCT00006184|587451713|FG000|Overall Study|Death|1|||
162654846|NCT00006184|587451714|FG001|Overall Study|Death|0|||
162654847|NCT01256710|587451715|FG000|Overall Study|Death|449|||
163119921|NCT02242981|589146509|FG000|Overall Study|Withdrawal by Subject|1|||
163119922|NCT03474081|589146512|FG000|Overall Study|Adverse Event|6|||
163119923|NCT03474081|589146513|FG001|Overall Study|Adverse Event|3|||
163119924|NCT03474081|589146512|FG000|Overall Study|Lost to Follow-up|2|||
163119925|NCT03474081|589146513|FG001|Overall Study|Lost to Follow-up|1|||
163119926|NCT03474081|589146512|FG000|Overall Study|Physician Decision|3|||
163119927|NCT03474081|589146513|FG001|Overall Study|Physician Decision|2|||
163119928|NCT03474081|589146512|FG000|Overall Study|Withdrawal by Subject|5|||
163119929|NCT03474081|589146513|FG001|Overall Study|Withdrawal by Subject|7|||
163119930|NCT03474081|589146512|FG000|Overall Study|Investigator site closed|1|||
163119931|NCT03474081|589146513|FG001|Overall Study|Investigator site closed|0|||
162654848|NCT01256710|587451715|FG000|Overall Study|System Explant|67|||
162654849|NCT01256710|587451715|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
162654850|NCT01256710|587451715|FG000|Overall Study|Lost to Follow-up|67|||
162654851|NCT01256710|587451715|FG000|Overall Study|Withdrawal by Subject|29|||
162654852|NCT01256710|587451715|FG000|Overall Study|Physician Decision|9|||
163119932|NCT01977690|589146514|FG000|Overall Study|Withdrawal by Subject|0|||
162654853|NCT01256710|587451715|FG000|Overall Study|Subject Noncompliance|2|||
162654854|NCT01256710|587451715|FG000|Overall Study|Study Terminated by Sponsor|273|||
162654855|NCT01838642|587451716|FG000|Overall Study|Died on study|1|||
162654856|NCT04019041|587451719|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
162654857|NCT04019041|587451720|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
162654858|NCT04019041|587451721|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162654859|NCT04019041|587451722|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162654860|NCT04019041|587451723|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162654861|NCT04019041|587451724|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162654862|NCT04019041|587451719|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162654863|NCT04019041|587451720|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
163119933|NCT01977690|589146515|FG001|Overall Study|Withdrawal by Subject|4|||
163119934|NCT01711866|589146521|FG000|Overall Study|Noncompliant|3|||
163119935|NCT01711866|589146521|FG000|Overall Study|Withdrawal by Subject|3|||
162654864|NCT04019041|587451721|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
162654865|NCT04019041|587451722|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162654866|NCT04019041|587451723|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162654867|NCT04019041|587451724|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162654868|NCT04019041|587451719|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
162654869|NCT04019041|587451720|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
162654870|NCT04019041|587451721|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
162654871|NCT04019041|587451722|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162654872|NCT04019041|587451723|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162654873|NCT04019041|587451724|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162654874|NCT04019041|587451719|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162654875|NCT04019041|587451720|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162654876|NCT04019041|587451721|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
162654877|NCT04019041|587451722|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162654878|NCT04019041|587451723|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162654879|NCT04019041|587451724|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162654880|NCT04019041|587451719|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162654881|NCT04019041|587451720|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
163119936|NCT01711866|589146521|FG000|Overall Study|Adverse Event|2|||
163119937|NCT00459537|589146522|FG000|Overall Study|Adverse Event|1|||
163119938|NCT00459537|589146523|FG001|Overall Study|Adverse Event|6|||
163119939|NCT00459537|589146522|FG000|Overall Study|Lack of Efficacy|10|||
163119940|NCT00459537|589146523|FG001|Overall Study|Lack of Efficacy|11|||
163119941|NCT00459537|589146522|FG000|Overall Study|Withdrawal by Subject|20|||
163119942|NCT00459537|589146523|FG001|Overall Study|Withdrawal by Subject|26|||
163119943|NCT00459537|589146522|FG000|Overall Study|Lost to Follow-up|27|||
163119944|NCT00459537|589146523|FG001|Overall Study|Lost to Follow-up|30|||
163119945|NCT00459537|589146522|FG000|Overall Study|Administrative problems|3|||
163119946|NCT00459537|589146523|FG001|Overall Study|Administrative problems|0|||
163119947|NCT00459537|589146522|FG000|Overall Study|Protocol Violation|4|||
163119948|NCT00459537|589146523|FG001|Overall Study|Protocol Violation|3|||
163119949|NCT00459537|589146522|FG000|Overall Study|Missing|1|||
163119950|NCT00459537|589146523|FG001|Overall Study|Missing|0|||
163119951|NCT00546260|589146524|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
163119952|NCT00546260|589146525|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
163119953|NCT03172130|589148279|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
163119954|NCT03172130|589148280|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
163119955|NCT00262847|589148291|FG000|Overall Study|Disease Progression|309|||
163119956|NCT00262847|589148292|FG001|Overall Study|Disease Progression|274|||
163119957|NCT00262847|589148293|FG002|Overall Study|Disease Progression|195|||
163119958|NCT00262847|589148291|FG000|Overall Study|Patient Refusal|41|||
163119959|NCT00262847|589148292|FG001|Overall Study|Patient Refusal|52|||
163119960|NCT00262847|589148293|FG002|Overall Study|Patient Refusal|47|||
163119961|NCT00262847|589148291|FG000|Overall Study|Adverse Event|74|||
163119962|NCT00262847|589148292|FG001|Overall Study|Adverse Event|88|||
163119963|NCT00262847|589148293|FG002|Overall Study|Adverse Event|108|||
163119964|NCT00262847|589148291|FG000|Overall Study|Death|8|||
163119965|NCT00262847|589148292|FG001|Overall Study|Death|8|||
163119966|NCT00262847|589148293|FG002|Overall Study|Death|11|||
163119967|NCT00262847|589148291|FG000|Overall Study|Concomitant disease|3|||
163119968|NCT00262847|589148292|FG001|Overall Study|Concomitant disease|2|||
163119969|NCT00262847|589148293|FG002|Overall Study|Concomitant disease|4|||
163119970|NCT00262847|589148291|FG000|Overall Study|Other Reasons|79|||
163119971|NCT00262847|589148292|FG001|Overall Study|Other Reasons|88|||
163119972|NCT00262847|589148293|FG002|Overall Study|Other Reasons|27|||
163119973|NCT00262847|589148291|FG000|Overall Study|Did not receive study treatment|4|||
163119974|NCT00262847|589148292|FG001|Overall Study|Did not receive study treatment|1|||
163119975|NCT00262847|589148293|FG002|Overall Study|Did not receive study treatment|4|||
163119976|NCT00387647|589148294|FG000|Overall Study|Death|18|||
163119977|NCT01825941|589148295|FG000|Overall Study|Lost to Follow-up|4|||
163119978|NCT01825941|589148296|FG001|Overall Study|Lost to Follow-up|1|||
163119979|NCT00528996|589148297|FG000|Overall Study|Other reasons than listing|6|||
163119980|NCT00528996|589148298|FG001|Overall Study|Other reasons than listing|7|||
163119981|NCT00528996|589148299|FG002|Overall Study|Other reasons than listing|14|||
163119982|NCT00528996|589148300|FG003|Overall Study|Other reasons than listing|11|||
163119983|NCT00528996|589148301|FG004|Overall Study|Other reasons than listing|5|||
163119984|NCT00528996|589148297|FG000|Overall Study|Refused continue medication|16|||
163119985|NCT00528996|589148298|FG001|Overall Study|Refused continue medication|0|||
163119986|NCT00528996|589148299|FG002|Overall Study|Refused continue medication|3|||
163119987|NCT00528996|589148300|FG003|Overall Study|Refused continue medication|3|||
163119988|NCT00528996|589148301|FG004|Overall Study|Refused continue medication|6|||
163119989|NCT00528996|589148297|FG000|Overall Study|Lost to Follow-up|2|||
163119990|NCT00528996|589148298|FG001|Overall Study|Lost to Follow-up|0|||
163119991|NCT00528996|589148299|FG002|Overall Study|Lost to Follow-up|4|||
163119992|NCT00528996|589148300|FG003|Overall Study|Lost to Follow-up|1|||
163119993|NCT00528996|589148301|FG004|Overall Study|Lost to Follow-up|3|||
163119994|NCT00528996|589148297|FG000|Overall Study|Protocol Violation|1|||
163119995|NCT00528996|589148298|FG001|Overall Study|Protocol Violation|2|||
163119996|NCT00528996|589148299|FG002|Overall Study|Protocol Violation|3|||
163119997|NCT00528996|589148300|FG003|Overall Study|Protocol Violation|3|||
163119998|NCT00528996|589148301|FG004|Overall Study|Protocol Violation|2|||
163119999|NCT00528996|589148297|FG000|Overall Study|Lack of Efficacy|7|||
163120000|NCT00528996|589148298|FG001|Overall Study|Lack of Efficacy|2|||
163120001|NCT00528996|589148299|FG002|Overall Study|Lack of Efficacy|1|||
163120002|NCT00528996|589148300|FG003|Overall Study|Lack of Efficacy|3|||
163120003|NCT00528996|589148301|FG004|Overall Study|Lack of Efficacy|3|||
163120004|NCT00528996|589148297|FG000|Overall Study|Adverse Event|32|||
163120005|NCT00528996|589148298|FG001|Overall Study|Adverse Event|13|||
163120006|NCT00528996|589148299|FG002|Overall Study|Adverse Event|18|||
163120007|NCT00528996|589148300|FG003|Overall Study|Adverse Event|29|||
163120008|NCT00528996|589148301|FG004|Overall Study|Adverse Event|18|||
163120009|NCT02831933|589148302|FG000|Overall Study|Physician Decision|11|||
163120010|NCT03495102|589148303|FG000|Overall Study|Adverse Event|5|||
163120011|NCT03495102|589148304|FG001|Overall Study|Adverse Event|7|||
163120012|NCT03495102|589148305|FG002|Overall Study|Adverse Event|10|||
163120013|NCT03495102|589148303|FG000|Overall Study|Death|3|||
163120014|NCT03495102|589148304|FG001|Overall Study|Death|4|||
163120015|NCT03495102|589148305|FG002|Overall Study|Death|4|||
163120016|NCT03495102|589148303|FG000|Overall Study|Lost to Follow-up|15|||
163120017|NCT03495102|589148304|FG001|Overall Study|Lost to Follow-up|16|||
163120018|NCT03495102|589148305|FG002|Overall Study|Lost to Follow-up|17|||
163120019|NCT03495102|589148303|FG000|Overall Study|Physician Decision|2|||
163120020|NCT03495102|589148304|FG001|Overall Study|Physician Decision|0|||
163120021|NCT03495102|589148305|FG002|Overall Study|Physician Decision|2|||
163120022|NCT03495102|589148303|FG000|Overall Study|Withdrawal by Subject|25|||
163120023|NCT03495102|589148304|FG001|Overall Study|Withdrawal by Subject|36|||
163120024|NCT03495102|589148305|FG002|Overall Study|Withdrawal by Subject|18|||
163120025|NCT03495102|589148303|FG000|Overall Study|Protocol Violation|1|||
163120026|NCT03495102|589148304|FG001|Overall Study|Protocol Violation|1|||
163120027|NCT03495102|589148305|FG002|Overall Study|Protocol Violation|0|||
163120028|NCT03495102|589148303|FG000|Overall Study|Site Closure|3|||
163120029|NCT03495102|589148304|FG001|Overall Study|Site Closure|1|||
163120030|NCT03495102|589148305|FG002|Overall Study|Site Closure|2|||
163120031|NCT03495102|589148303|FG000|Overall Study|Non-compliance|1|||
163120032|NCT03495102|589148304|FG001|Overall Study|Non-compliance|0|||
163120033|NCT03495102|589148305|FG002|Overall Study|Non-compliance|0|||
163120034|NCT03495102|589148303|FG000|Overall Study|Participant Duplicated at Another Site|0|||
163120035|NCT03495102|589148304|FG001|Overall Study|Participant Duplicated at Another Site|0|||
163120036|NCT03495102|589148305|FG002|Overall Study|Participant Duplicated at Another Site|1|||
163120037|NCT03495102|589148303|FG000|Overall Study|Primary Care Physician Recommendation|0|||
163120038|NCT03495102|589148304|FG001|Overall Study|Primary Care Physician Recommendation|1|||
163120039|NCT03495102|589148305|FG002|Overall Study|Primary Care Physician Recommendation|0|||
163120040|NCT03495102|589148303|FG000|Overall Study|Relocated to Another Country|0|||
163120041|NCT03495102|589148304|FG001|Overall Study|Relocated to Another Country|1|||
163120042|NCT03495102|589148305|FG002|Overall Study|Relocated to Another Country|0|||
163120043|NCT03495102|589148303|FG000|Overall Study|Participant was in Rehabilitation|1|||
163120044|NCT03495102|589148304|FG001|Overall Study|Participant was in Rehabilitation|0|||
163120045|NCT03495102|589148305|FG002|Overall Study|Participant was in Rehabilitation|0|||
163120046|NCT00358436|589148312|FG000|Overall Study|Adverse Event|29|||
163120047|NCT00358436|589148313|FG001|Overall Study|Adverse Event|13|||
163120048|NCT00358436|589148312|FG000|Overall Study|Lack of Efficacy|34|||
163120049|NCT00358436|589148313|FG001|Overall Study|Lack of Efficacy|36|||
163120050|NCT00358436|589148312|FG000|Overall Study|Lost to Follow-up|11|||
163120051|NCT00358436|589148313|FG001|Overall Study|Lost to Follow-up|6|||
163120052|NCT00358436|589148312|FG000|Overall Study|Protocol Violation|8|||
163120053|NCT00358436|589148313|FG001|Overall Study|Protocol Violation|3|||
163120054|NCT00358436|589148312|FG000|Overall Study|Withdrawal by Subject|40|||
163120055|NCT00358436|589148313|FG001|Overall Study|Withdrawal by Subject|17|||
163120056|NCT00358436|589148312|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
163120057|NCT00358436|589148313|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
163120058|NCT00358436|589148312|FG000|Overall Study|COPD exacerbation|22|||
163120059|NCT00358436|589148313|FG001|Overall Study|COPD exacerbation|10|||
163120060|NCT00358436|589148312|FG000|Overall Study|Other|6|||
163120061|NCT00358436|589148313|FG001|Overall Study|Other|1|||
163120062|NCT05065190|589148315|FG000|Overall Study|Other than listed|2|||
163120063|NCT05065190|589148316|FG001|Overall Study|Other than listed|12|||
163120064|NCT05065190|589148315|FG000|Overall Study|Lack of Efficacy|4|||
163120065|NCT05065190|589148316|FG001|Overall Study|Lack of Efficacy|0|||
163120066|NCT05065190|589148315|FG000|Overall Study|Adverse Event|1|||
163120067|NCT05065190|589148316|FG001|Overall Study|Adverse Event|10|||
163120068|NCT03938324|589148324|FG000|Overall Study|Lost to Follow-up|42|||
163120069|NCT03938324|589148325|FG001|Overall Study|Lost to Follow-up|21|||
163120070|NCT03938324|589148324|FG000|Overall Study|Withdrawal by Subject|6|||
163120071|NCT03938324|589148325|FG001|Overall Study|Withdrawal by Subject|1|||
163120072|NCT02769962|589148326|FG000|Overall Study|Physician Decision|0|||
163120073|NCT02769962|589148327|FG001|Overall Study|Physician Decision|0|||
163120074|NCT02769962|589148328|FG002|Overall Study|Physician Decision|0|||
163120075|NCT02769962|589148329|FG003|Overall Study|Physician Decision|0|||
163120076|NCT02769962|589148330|FG004|Overall Study|Physician Decision|0|||
163120077|NCT02769962|589148331|FG005|Overall Study|Physician Decision|1|||
163120078|NCT02769962|589148332|FG006|Overall Study|Physician Decision|0|||
163120079|NCT02769962|589148333|FG007|Overall Study|Physician Decision|1|||
163120080|NCT02769962|589148326|FG000|Overall Study|Refused further treatment|0|||
163120081|NCT02769962|589148327|FG001|Overall Study|Refused further treatment|0|||
163120082|NCT02769962|589148328|FG002|Overall Study|Refused further treatment|0|||
163120083|NCT02769962|589148329|FG003|Overall Study|Refused further treatment|0|||
163120084|NCT02769962|589148330|FG004|Overall Study|Refused further treatment|0|||
163120085|NCT02769962|589148331|FG005|Overall Study|Refused further treatment|1|||
163120086|NCT02769962|589148332|FG006|Overall Study|Refused further treatment|1|||
163120087|NCT02769962|589148333|FG007|Overall Study|Refused further treatment|0|||
163120088|NCT05565937|589148334|FG000|Overall Study|Adverse Event|0|||
163120089|NCT05565937|589148335|FG001|Overall Study|Adverse Event|1|||
163120090|NCT05565937|589148334|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
163120091|NCT05565937|589148335|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
163120092|NCT05565937|589148334|FG000|Overall Study|Lost to Follow-up|2|||
163120093|NCT05565937|589148335|FG001|Overall Study|Lost to Follow-up|0|||
163120094|NCT05565937|589148334|FG000|Overall Study|Pregnancy|0|||
163120095|NCT05565937|589148335|FG001|Overall Study|Pregnancy|2|||
163120096|NCT05565937|589148334|FG000|Overall Study|Anisometropia|0|||
163120097|NCT05565937|589148335|FG001|Overall Study|Anisometropia|1|||
163120098|NCT04544683|589148336|FG000|Overall Study|Lost to Follow-up|2|||
163120099|NCT04544683|589148336|FG000|Overall Study|Underwent cervical spine surgery|6|||
163120100|NCT00151372|589148337|FG000|Overall Study|Death|12|||
163120101|NCT00151372|589148338|FG001|Overall Study|Death|11|||
163120102|NCT00151372|589148337|FG000|Overall Study|Lost to Follow-up|5|||
163120103|NCT00151372|589148338|FG001|Overall Study|Lost to Follow-up|5|||
163120104|NCT00151372|589148337|FG000|Overall Study|Too sick medically to continue|5|||
163120105|NCT00151372|589148338|FG001|Overall Study|Too sick medically to continue|6|||
163120106|NCT00151372|589148337|FG000|Overall Study|Withdrawal by Subject|7|||
163120107|NCT00151372|589148338|FG001|Overall Study|Withdrawal by Subject|7|||
163120108|NCT05160766|589148339|FG000|Overall Study|Adverse Event|0|||
163120109|NCT05160766|589148340|FG001|Overall Study|Adverse Event|1|||
163120110|NCT05160766|589148341|FG002|Overall Study|Adverse Event|0|||
163120111|NCT05160766|589148342|FG003|Overall Study|Adverse Event|0|||
163120112|NCT05160766|589148339|FG000|Overall Study|COVID-19 infection|0|||
163120113|NCT05160766|589148340|FG001|Overall Study|COVID-19 infection|1|||
163120114|NCT05160766|589148341|FG002|Overall Study|COVID-19 infection|0|||
163120115|NCT05160766|589148342|FG003|Overall Study|COVID-19 infection|0|||
163120116|NCT05160766|589148339|FG000|Overall Study|travel time|1|||
163120117|NCT05160766|589148340|FG001|Overall Study|travel time|0|||
163120118|NCT05160766|589148341|FG002|Overall Study|travel time|0|||
163120119|NCT05160766|589148342|FG003|Overall Study|travel time|1|||
163120120|NCT05160766|589148339|FG000|Overall Study|Withdrawal by Subject|3|||
163120121|NCT05160766|589148340|FG001|Overall Study|Withdrawal by Subject|5|||
163120122|NCT05160766|589148341|FG002|Overall Study|Withdrawal by Subject|4|||
163120123|NCT05160766|589148342|FG003|Overall Study|Withdrawal by Subject|2|||
163120124|NCT05160766|589148339|FG000|Overall Study|Death|0|||
163120125|NCT05160766|589148340|FG001|Overall Study|Death|0|||
163120126|NCT05160766|589148341|FG002|Overall Study|Death|2|||
163120127|NCT05160766|589148342|FG003|Overall Study|Death|5|||
163120128|NCT05160766|589148339|FG000|Overall Study|Lost to Follow-up|0|||
163120129|NCT05160766|589148340|FG001|Overall Study|Lost to Follow-up|0|||
163120130|NCT05160766|589148341|FG002|Overall Study|Lost to Follow-up|1|||
163120131|NCT05160766|589148342|FG003|Overall Study|Lost to Follow-up|2|||
163120132|NCT05160766|589148339|FG000|Overall Study|No show|0|||
163120133|NCT05160766|589148340|FG001|Overall Study|No show|0|||
163120134|NCT05160766|589148341|FG002|Overall Study|No show|1|||
163120135|NCT05160766|589148342|FG003|Overall Study|No show|1|||
163120136|NCT05160766|589148339|FG000|Overall Study|Physician Decision|0|||
163120137|NCT05160766|589148340|FG001|Overall Study|Physician Decision|0|||
163120138|NCT05160766|589148341|FG002|Overall Study|Physician Decision|0|||
163120139|NCT05160766|589148342|FG003|Overall Study|Physician Decision|1|||
163120140|NCT05160766|589148339|FG000|Overall Study|Protocol Violation|0|||
163120141|NCT05160766|589148340|FG001|Overall Study|Protocol Violation|0|||
163120142|NCT05160766|589148341|FG002|Overall Study|Protocol Violation|1|||
163120143|NCT05160766|589148342|FG003|Overall Study|Protocol Violation|0|||
163120144|NCT01282294|589148343|FG000|Overall Study|Lost to Follow-up|14|||
162654882|NCT04019041|587451721|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162654883|NCT04019041|587451722|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
162654884|NCT04019041|587451723|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
162654885|NCT04019041|587451724|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
162654886|NCT04019041|587451719|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162654887|NCT04019041|587451720|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162654888|NCT04019041|587451721|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162654889|NCT04019041|587451722|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
162654890|NCT04019041|587451723|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162654891|NCT04019041|587451724|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162654892|NCT04019041|587451719|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163120145|NCT01282294|589148343|FG000|Overall Study|Screening failure|1|||
163120146|NCT01282294|589148343|FG000|Overall Study|Adverse Event|1|||
163120147|NCT01282294|589148343|FG000|Overall Study|Patient non-compliance|2|||
163120148|NCT01282294|589148343|FG000|Overall Study|Physician Decision|1|||
163120149|NCT02408523|589148344|FG000|Overall Study|Adverse Event|4|||
163120150|NCT02408523|589148345|FG001|Overall Study|Adverse Event|10|||
163120151|NCT02408523|589148344|FG000|Overall Study|Lack of Efficacy|0|||
163120152|NCT02408523|589148345|FG001|Overall Study|Lack of Efficacy|1|||
163120153|NCT02408523|589148344|FG000|Overall Study|Protocol Violation|1|||
162654893|NCT04019041|587451720|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162654894|NCT04019041|587451721|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163120154|NCT02408523|589148345|FG001|Overall Study|Protocol Violation|2|||
163120155|NCT02408523|589148344|FG000|Overall Study|Lost to Follow-up|2|||
163120156|NCT02408523|589148345|FG001|Overall Study|Lost to Follow-up|3|||
163120157|NCT02408523|589148344|FG000|Overall Study|Withdrawal by Subject|3|||
163120158|NCT02408523|589148345|FG001|Overall Study|Withdrawal by Subject|1|||
163120159|NCT02408523|589148344|FG000|Overall Study|Sponsor request|1|||
163120160|NCT02408523|589148345|FG001|Overall Study|Sponsor request|0|||
163120161|NCT02408523|589148344|FG000|Overall Study|Did not satisfy extension conditions|0|||
163120162|NCT02408523|589148345|FG001|Overall Study|Did not satisfy extension conditions|1|||
163120163|NCT02943915|589148346|FG000|Overall Study|Withdrawal by Subject|2|||
163120164|NCT02943915|589148347|FG001|Overall Study|Withdrawal by Subject|1|||
163120165|NCT02943915|589148348|FG002|Overall Study|Withdrawal by Subject|0|||
163120166|NCT02943915|589148349|FG003|Overall Study|Withdrawal by Subject|0|||
163120167|NCT02943915|589148346|FG000|Overall Study|Lost to Follow-up|3|||
163120168|NCT02943915|589148347|FG001|Overall Study|Lost to Follow-up|1|||
163120169|NCT02943915|589148348|FG002|Overall Study|Lost to Follow-up|0|||
163120170|NCT02943915|589148349|FG003|Overall Study|Lost to Follow-up|0|||
163120171|NCT02943915|589148346|FG000|Overall Study|excluded|0|||
163120172|NCT02943915|589148347|FG001|Overall Study|excluded|1|||
163120173|NCT02943915|589148348|FG002|Overall Study|excluded|0|||
163120174|NCT02943915|589148349|FG003|Overall Study|excluded|0|||
163120175|NCT03769311|589148351|FG000|Overall Study|Withdrawal by Subject|1|||
163120176|NCT00996801|589148352|FG000|Overall Study|Adverse Event|6|||
163120177|NCT00996801|589148353|FG001|Overall Study|Adverse Event|4|||
163120178|NCT00996801|589148354|FG002|Overall Study|Adverse Event|12|||
163120179|NCT00996801|589148355|FG003|Overall Study|Adverse Event|17|||
163120180|NCT00996801|589148356|FG004|Overall Study|Adverse Event|31|||
163120181|NCT00996801|589148357|FG005|Overall Study|Adverse Event|3|||
163120182|NCT00996801|589148352|FG000|Overall Study|Lack of Efficacy|3|||
163120183|NCT00996801|589148353|FG001|Overall Study|Lack of Efficacy|0|||
163120184|NCT00996801|589148354|FG002|Overall Study|Lack of Efficacy|1|||
163120185|NCT00996801|589148355|FG003|Overall Study|Lack of Efficacy|3|||
163120186|NCT00996801|589148356|FG004|Overall Study|Lack of Efficacy|0|||
162719475|NCT04517864|587680485|FG001|Placebo-Controlled Phase|Adverse Event|0|||
162719476|NCT04517864|587680486|FG002|Placebo-Controlled Phase|Adverse Event|0|||
163120187|NCT00996801|589148357|FG005|Overall Study|Lack of Efficacy|1|||
163120188|NCT00996801|589148352|FG000|Overall Study|Lost to Follow-up|0|||
163120189|NCT00996801|589148353|FG001|Overall Study|Lost to Follow-up|0|||
163120190|NCT00996801|589148354|FG002|Overall Study|Lost to Follow-up|0|||
163120191|NCT00996801|589148355|FG003|Overall Study|Lost to Follow-up|3|||
163120192|NCT00996801|589148356|FG004|Overall Study|Lost to Follow-up|3|||
163120193|NCT00996801|589148357|FG005|Overall Study|Lost to Follow-up|2|||
163120194|NCT00996801|589148352|FG000|Overall Study|Physician Decision|0|||
163120195|NCT00996801|589148353|FG001|Overall Study|Physician Decision|0|||
163120196|NCT00996801|589148354|FG002|Overall Study|Physician Decision|0|||
163120197|NCT00996801|589148355|FG003|Overall Study|Physician Decision|1|||
163120198|NCT00996801|589148356|FG004|Overall Study|Physician Decision|0|||
163120199|NCT00996801|589148357|FG005|Overall Study|Physician Decision|0|||
163120200|NCT00996801|589148352|FG000|Overall Study|Progressive Disease|0|||
163120201|NCT00996801|589148353|FG001|Overall Study|Progressive Disease|1|||
163120202|NCT00996801|589148354|FG002|Overall Study|Progressive Disease|0|||
163120203|NCT00996801|589148355|FG003|Overall Study|Progressive Disease|0|||
163120204|NCT00996801|589148356|FG004|Overall Study|Progressive Disease|0|||
162654895|NCT04019041|587451722|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
163120205|NCT00996801|589148357|FG005|Overall Study|Progressive Disease|0|||
162719477|NCT04517864|587680484|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
162719478|NCT04517864|587680485|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
162719479|NCT04517864|587680486|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
162719480|NCT04517864|587680484|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
162719481|NCT04517864|587680485|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
162719482|NCT04517864|587680486|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
162719483|NCT04517864|587680484|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
162719484|NCT04517864|587680485|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
162719485|NCT04517864|587680486|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
162719486|NCT04517864|587680484|FG000|Active Therapy Extension Phase|Adverse Event|1|||
162719487|NCT04517864|587680485|FG001|Active Therapy Extension Phase|Adverse Event|0|||
162719488|NCT04517864|587680486|FG002|Active Therapy Extension Phase|Adverse Event|0|||
162719489|NCT04517864|587680484|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
162719490|NCT04517864|587680485|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
162719491|NCT04517864|587680486|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
162719492|NCT04517864|587680484|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
162719493|NCT04517864|587680485|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
162719494|NCT04517864|587680486|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
162719495|NCT04517864|587680484|FG000|Active Therapy Extension Phase|Physician Decision|1|||
162719496|NCT04517864|587680485|FG001|Active Therapy Extension Phase|Physician Decision|0|||
162719497|NCT04517864|587680486|FG002|Active Therapy Extension Phase|Physician Decision|0|||
162719498|NCT04517864|587680484|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
162719499|NCT04517864|587680485|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
162719500|NCT04517864|587680486|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
162719501|NCT04517864|587680484|FG000|Extension Phase|Adverse Event|0|||
162719502|NCT04517864|587680485|FG001|Extension Phase|Adverse Event|0|||
163120206|NCT00996801|589148352|FG000|Overall Study|Protocol Violation|3|||
163120207|NCT00996801|589148353|FG001|Overall Study|Protocol Violation|4|||
163120208|NCT00996801|589148354|FG002|Overall Study|Protocol Violation|1|||
163120209|NCT00996801|589148355|FG003|Overall Study|Protocol Violation|2|||
163120210|NCT00996801|589148356|FG004|Overall Study|Protocol Violation|3|||
163120211|NCT00996801|589148357|FG005|Overall Study|Protocol Violation|4|||
163120212|NCT00996801|589148352|FG000|Overall Study|Study Terminated by Sponsor|0|||
163120213|NCT00996801|589148353|FG001|Overall Study|Study Terminated by Sponsor|1|||
163120214|NCT00996801|589148354|FG002|Overall Study|Study Terminated by Sponsor|0|||
163120215|NCT00996801|589148355|FG003|Overall Study|Study Terminated by Sponsor|0|||
163120216|NCT00996801|589148356|FG004|Overall Study|Study Terminated by Sponsor|46|||
163120217|NCT00996801|589148357|FG005|Overall Study|Study Terminated by Sponsor|0|||
163120218|NCT00996801|589148352|FG000|Overall Study|Withdrawal by Subject|8|||
163120219|NCT00996801|589148353|FG001|Overall Study|Withdrawal by Subject|6|||
163120220|NCT00996801|589148354|FG002|Overall Study|Withdrawal by Subject|9|||
163120221|NCT00996801|589148355|FG003|Overall Study|Withdrawal by Subject|5|||
163120222|NCT00996801|589148356|FG004|Overall Study|Withdrawal by Subject|5|||
163120223|NCT00996801|589148357|FG005|Overall Study|Withdrawal by Subject|9|||
163120224|NCT00289198|589148358|FG000|Overall Study|Adverse Event|0|||
163120225|NCT00289198|589148359|FG001|Overall Study|Adverse Event|2|||
163120226|NCT00289198|589148358|FG000|Overall Study|Protocol Violation|2|||
163120227|NCT00289198|589148359|FG001|Overall Study|Protocol Violation|1|||
163120228|NCT00289198|589148358|FG000|Overall Study|Withdrawal by Subject|4|||
163120229|NCT00289198|589148359|FG001|Overall Study|Withdrawal by Subject|1|||
163120230|NCT00289198|589148358|FG000|Overall Study|Lack of Efficacy|2|||
162719503|NCT04517864|587680486|FG002|Extension Phase|Adverse Event|1|||
162719504|NCT04517864|587680484|FG000|Extension Phase|Lack of Efficacy|0|||
162719505|NCT04517864|587680485|FG001|Extension Phase|Lack of Efficacy|0|||
162719506|NCT04517864|587680486|FG002|Extension Phase|Lack of Efficacy|2|||
162719507|NCT04517864|587680484|FG000|Extension Phase|Study Terminated By Sponsor|0|||
162719508|NCT04517864|587680485|FG001|Extension Phase|Study Terminated By Sponsor|0|||
163120231|NCT00289198|589148359|FG001|Overall Study|Lack of Efficacy|0|||
163120232|NCT00289198|589148358|FG000|Overall Study|Other: Low compliance|0|||
163120233|NCT00289198|589148359|FG001|Overall Study|Other: Low compliance|1|||
162654896|NCT04019041|587451723|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
162654897|NCT04019041|587451724|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162654898|NCT04019041|587451719|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162654899|NCT04019041|587451720|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162654900|NCT04019041|587451721|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162654901|NCT04019041|587451722|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
162654902|NCT04019041|587451723|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
162654903|NCT04019041|587451724|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162654904|NCT04019041|587451719|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162654905|NCT04019041|587451720|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162654906|NCT04019041|587451721|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162654907|NCT04019041|587451722|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162654908|NCT04019041|587451723|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
162654909|NCT04019041|587451724|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
162654910|NCT03925727|587451725|FG000|Overall Study|Adverse Event|4|||
163120234|NCT00289198|589148358|FG000|Overall Study|Other: Physician's decision|0|||
163120235|NCT00289198|589148359|FG001|Overall Study|Other: Physician's decision|1|||
163120236|NCT00289198|589148358|FG000|Overall Study|Other: Unable to attend on schedule|2|||
163120237|NCT00289198|589148359|FG001|Overall Study|Other: Unable to attend on schedule|1|||
163120238|NCT00289198|589148358|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
163120239|NCT00289198|589148359|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
163120240|NCT00289198|589148358|FG000|Overall Study|Other: Impossible to come on visit|0|||
163120241|NCT00289198|589148359|FG001|Overall Study|Other: Impossible to come on visit|1|||
163120242|NCT02559414|589148367|FG000|Overall Study|Lost to Follow-up|0|||
163120243|NCT02559414|589148368|FG001|Overall Study|Lost to Follow-up|1|||
163120244|NCT02559414|589148369|FG002|Overall Study|Lost to Follow-up|0|||
163120245|NCT02559414|589148367|FG000|Overall Study|Withdrawal by Subject|1|||
163120246|NCT02559414|589148368|FG001|Overall Study|Withdrawal by Subject|0|||
163120247|NCT02559414|589148369|FG002|Overall Study|Withdrawal by Subject|1|||
163120248|NCT02559414|589148367|FG000|Overall Study|Other|0|||
163120249|NCT02559414|589148368|FG001|Overall Study|Other|1|||
163120250|NCT02559414|589148369|FG002|Overall Study|Other|1|||
163120251|NCT03369431|589148370|FG000|Overall Study|Lost to Follow-up|1|||
163120252|NCT03369431|589148371|FG001|Overall Study|Lost to Follow-up|3|||
163120253|NCT03369431|589148370|FG000|Overall Study|Withdrawal by Subject|2|||
163120254|NCT03369431|589148371|FG001|Overall Study|Withdrawal by Subject|3|||
163120255|NCT03369431|589148370|FG000|Overall Study|Protocol Violation|1|||
163120256|NCT03369431|589148371|FG001|Overall Study|Protocol Violation|1|||
163120257|NCT01062061|589148372|FG000|Overall Study|Enrolled more than once|2|||
163120258|NCT01062061|589148372|FG000|Overall Study|Investigated before study start|13|||
163120259|NCT01062061|589148372|FG000|Overall Study|Outside chief indications|10|||
163120260|NCT01062061|589148372|FG000|Overall Study|Failed to meet inclusion criteria|2|||
163120261|NCT00524589|589148373|FG000|Overall Study|Withdrawal by Subject|2|||
163120262|NCT00524589|589148373|FG000|Overall Study|Disease Progression|16|||
163120263|NCT01266317|589148376|FG000|Overall Study|Withdrawal by Subject|2|||
163120264|NCT02753127|589148379|FG000|Overall Study|Lost to Follow-up|13|||
163120265|NCT02753127|589148380|FG001|Overall Study|Lost to Follow-up|11|||
163120266|NCT02753127|589148379|FG000|Overall Study|Withdrawal by Subject|37|||
163120267|NCT02753127|589148380|FG001|Overall Study|Withdrawal by Subject|47|||
163120268|NCT02753127|589148379|FG000|Overall Study|Other|3|||
163120269|NCT02753127|589148380|FG001|Overall Study|Other|8|||
163120270|NCT02753127|589148379|FG000|Overall Study|Hospice|0|||
163120271|NCT02753127|589148380|FG001|Overall Study|Hospice|2|||
163120272|NCT00098722|589148381|FG000|Double Blind Phase|Adverse Event|7|||
163120273|NCT00098722|589148382|FG001|Double Blind Phase|Adverse Event|7|||
163120274|NCT00098722|589148383|FG002|Double Blind Phase|Adverse Event|3|||
163120275|NCT00098722|589148384|FG003|Double Blind Phase|Adverse Event|0|||
163120276|NCT00098722|589148385|FG004|Double Blind Phase|Adverse Event|0|||
163120277|NCT00098722|589148386|FG005|Double Blind Phase|Adverse Event|0|||
162654911|NCT03925727|587451726|FG001|Overall Study|Adverse Event|0|||
162654912|NCT03925727|587451727|FG002|Overall Study|Adverse Event|3|||
162654913|NCT03925727|587451725|FG000|Overall Study|Protocol Violation|1|||
162654914|NCT03925727|587451726|FG001|Overall Study|Protocol Violation|2|||
162654915|NCT03925727|587451727|FG002|Overall Study|Protocol Violation|2|||
162654916|NCT03925727|587451725|FG000|Overall Study|Withdrawal by Subject|3|||
163120278|NCT00098722|589148387|FG006|Double Blind Phase|Adverse Event|0|||
163120279|NCT00098722|589148381|FG000|Double Blind Phase|Death|2|||
163120280|NCT00098722|589148382|FG001|Double Blind Phase|Death|5|||
163120281|NCT00098722|589148383|FG002|Double Blind Phase|Death|0|||
163120282|NCT00098722|589148384|FG003|Double Blind Phase|Death|0|||
163120283|NCT00098722|589148385|FG004|Double Blind Phase|Death|0|||
163120284|NCT00098722|589148386|FG005|Double Blind Phase|Death|0|||
163120285|NCT00098722|589148387|FG006|Double Blind Phase|Death|0|||
163120286|NCT00098722|589148381|FG000|Double Blind Phase|Lack of Efficacy|21|||
163120287|NCT00098722|589148382|FG001|Double Blind Phase|Lack of Efficacy|23|||
163120288|NCT00098722|589148383|FG002|Double Blind Phase|Lack of Efficacy|15|||
163120289|NCT00098722|589148384|FG003|Double Blind Phase|Lack of Efficacy|0|||
163120290|NCT00098722|589148385|FG004|Double Blind Phase|Lack of Efficacy|0|||
163120291|NCT00098722|589148386|FG005|Double Blind Phase|Lack of Efficacy|0|||
163120292|NCT00098722|589148387|FG006|Double Blind Phase|Lack of Efficacy|0|||
163120293|NCT00098722|589148381|FG000|Double Blind Phase|Participant defaulted|16|||
163120294|NCT00098722|589148382|FG001|Double Blind Phase|Participant defaulted|11|||
163120295|NCT00098722|589148383|FG002|Double Blind Phase|Participant defaulted|9|||
163120296|NCT00098722|589148384|FG003|Double Blind Phase|Participant defaulted|0|||
163120297|NCT00098722|589148385|FG004|Double Blind Phase|Participant defaulted|0|||
163120298|NCT00098722|589148386|FG005|Double Blind Phase|Participant defaulted|0|||
163120299|NCT00098722|589148387|FG006|Double Blind Phase|Participant defaulted|0|||
163120300|NCT00098722|589148381|FG000|Double Blind Phase|Pregnancy|1|||
163120301|NCT00098722|589148382|FG001|Double Blind Phase|Pregnancy|0|||
163120302|NCT00098722|589148383|FG002|Double Blind Phase|Pregnancy|0|||
163120303|NCT00098722|589148384|FG003|Double Blind Phase|Pregnancy|0|||
163120304|NCT00098722|589148385|FG004|Double Blind Phase|Pregnancy|0|||
163120305|NCT00098722|589148386|FG005|Double Blind Phase|Pregnancy|0|||
163120306|NCT00098722|589148387|FG006|Double Blind Phase|Pregnancy|0|||
163120307|NCT00098722|589148381|FG000|Double Blind Phase|Randomized, not treated|4|||
163120308|NCT00098722|589148382|FG001|Double Blind Phase|Randomized, not treated|3|||
163120309|NCT00098722|589148383|FG002|Double Blind Phase|Randomized, not treated|3|||
163120310|NCT00098722|589148384|FG003|Double Blind Phase|Randomized, not treated|0|||
163120311|NCT00098722|589148385|FG004|Double Blind Phase|Randomized, not treated|0|||
163120312|NCT00098722|589148386|FG005|Double Blind Phase|Randomized, not treated|0|||
163120313|NCT00098722|589148387|FG006|Double Blind Phase|Randomized, not treated|0|||
163120314|NCT00098722|589148381|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
163120315|NCT00098722|589148382|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
163120316|NCT00098722|589148383|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
163120317|NCT00098722|589148384|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
163120318|NCT00098722|589148385|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
163120319|NCT00098722|589148386|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
163120320|NCT00098722|589148387|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
163120321|NCT00098722|589148381|FG000|Double Blind Phase|Other|7|||
163120322|NCT00098722|589148382|FG001|Double Blind Phase|Other|8|||
163120323|NCT00098722|589148383|FG002|Double Blind Phase|Other|7|||
163120324|NCT00098722|589148384|FG003|Double Blind Phase|Other|0|||
163120325|NCT00098722|589148385|FG004|Double Blind Phase|Other|0|||
163120326|NCT00098722|589148386|FG005|Double Blind Phase|Other|0|||
163120327|NCT00098722|589148387|FG006|Double Blind Phase|Other|0|||
163120328|NCT00098722|589148381|FG000|Open Label Phase|Adverse Event|0|||
163120329|NCT00098722|589148382|FG001|Open Label Phase|Adverse Event|0|||
163120330|NCT00098722|589148383|FG002|Open Label Phase|Adverse Event|0|||
163120331|NCT00098722|589148384|FG003|Open Label Phase|Adverse Event|5|||
163120332|NCT00098722|589148385|FG004|Open Label Phase|Adverse Event|0|||
163120333|NCT00098722|589148386|FG005|Open Label Phase|Adverse Event|0|||
163120334|NCT00098722|589148387|FG006|Open Label Phase|Adverse Event|0|||
163120335|NCT00098722|589148381|FG000|Open Label Phase|Death|0|||
163120336|NCT00098722|589148382|FG001|Open Label Phase|Death|0|||
162654917|NCT03925727|587451726|FG001|Overall Study|Withdrawal by Subject|2|||
163120337|NCT00098722|589148383|FG002|Open Label Phase|Death|0|||
163120338|NCT00098722|589148384|FG003|Open Label Phase|Death|2|||
163120339|NCT00098722|589148385|FG004|Open Label Phase|Death|0|||
163120340|NCT00098722|589148386|FG005|Open Label Phase|Death|0|||
163120341|NCT00098722|589148387|FG006|Open Label Phase|Death|0|||
163120342|NCT00098722|589148381|FG000|Open Label Phase|Lack of Efficacy|0|||
163120343|NCT00098722|589148382|FG001|Open Label Phase|Lack of Efficacy|0|||
163120344|NCT00098722|589148383|FG002|Open Label Phase|Lack of Efficacy|0|||
163120345|NCT00098722|589148384|FG003|Open Label Phase|Lack of Efficacy|8|||
163120346|NCT00098722|589148385|FG004|Open Label Phase|Lack of Efficacy|0|||
163120347|NCT00098722|589148386|FG005|Open Label Phase|Lack of Efficacy|0|||
163120348|NCT00098722|589148387|FG006|Open Label Phase|Lack of Efficacy|0|||
163120349|NCT00098722|589148381|FG000|Open Label Phase|Pregnancy|0|||
163120350|NCT00098722|589148382|FG001|Open Label Phase|Pregnancy|0|||
163120351|NCT00098722|589148383|FG002|Open Label Phase|Pregnancy|0|||
163120352|NCT00098722|589148384|FG003|Open Label Phase|Pregnancy|1|||
163120353|NCT00098722|589148385|FG004|Open Label Phase|Pregnancy|0|||
163120354|NCT00098722|589148386|FG005|Open Label Phase|Pregnancy|0|||
163120355|NCT00098722|589148387|FG006|Open Label Phase|Pregnancy|0|||
163120356|NCT00098722|589148381|FG000|Open Label Phase|Participant defaulted|0|||
163120357|NCT00098722|589148382|FG001|Open Label Phase|Participant defaulted|0|||
163120358|NCT00098722|589148383|FG002|Open Label Phase|Participant defaulted|0|||
163120359|NCT00098722|589148384|FG003|Open Label Phase|Participant defaulted|18|||
163120360|NCT00098722|589148385|FG004|Open Label Phase|Participant defaulted|0|||
163120361|NCT00098722|589148386|FG005|Open Label Phase|Participant defaulted|0|||
163120362|NCT00098722|589148387|FG006|Open Label Phase|Participant defaulted|0|||
163120363|NCT00098722|589148381|FG000|Open Label Phase|Ongoing at cut-off date|0|||
163120364|NCT00098722|589148382|FG001|Open Label Phase|Ongoing at cut-off date|0|||
162654918|NCT03925727|587451727|FG002|Overall Study|Withdrawal by Subject|4|||
163120365|NCT00098722|589148383|FG002|Open Label Phase|Ongoing at cut-off date|0|||
163120366|NCT00098722|589148384|FG003|Open Label Phase|Ongoing at cut-off date|220|||
163120367|NCT00098722|589148385|FG004|Open Label Phase|Ongoing at cut-off date|50|||
163120368|NCT00098722|589148386|FG005|Open Label Phase|Ongoing at cut-off date|0|||
163120369|NCT00098722|589148387|FG006|Open Label Phase|Ongoing at cut-off date|0|||
163120370|NCT00098722|589148381|FG000|Open Label Phase|Other|0|||
163120371|NCT00098722|589148382|FG001|Open Label Phase|Other|0|||
163120372|NCT00098722|589148383|FG002|Open Label Phase|Other|0|||
163120373|NCT00098722|589148384|FG003|Open Label Phase|Other|18|||
163120374|NCT00098722|589148385|FG004|Open Label Phase|Other|0|||
163120375|NCT00098722|589148386|FG005|Open Label Phase|Other|0|||
163120376|NCT00098722|589148387|FG006|Open Label Phase|Other|0|||
163120377|NCT00098722|589148381|FG000|Observation Phase|Death|0|||
163120378|NCT00098722|589148382|FG001|Observation Phase|Death|0|||
163120379|NCT00098722|589148383|FG002|Observation Phase|Death|0|||
163120380|NCT00098722|589148384|FG003|Observation Phase|Death|0|||
163120381|NCT00098722|589148385|FG004|Observation Phase|Death|0|||
163120382|NCT00098722|589148386|FG005|Observation Phase|Death|5|||
163120383|NCT00098722|589148387|FG006|Observation Phase|Death|3|||
163120384|NCT00098722|589148381|FG000|Observation Phase|Lack of Efficacy|0|||
163120385|NCT00098722|589148382|FG001|Observation Phase|Lack of Efficacy|0|||
163120386|NCT00098722|589148383|FG002|Observation Phase|Lack of Efficacy|0|||
163120387|NCT00098722|589148384|FG003|Observation Phase|Lack of Efficacy|0|||
163120388|NCT00098722|589148385|FG004|Observation Phase|Lack of Efficacy|0|||
163120389|NCT00098722|589148386|FG005|Observation Phase|Lack of Efficacy|2|||
163120390|NCT00098722|589148387|FG006|Observation Phase|Lack of Efficacy|0|||
163120391|NCT00098722|589148381|FG000|Observation Phase|Participant defaulted|0|||
163120392|NCT00098722|589148382|FG001|Observation Phase|Participant defaulted|0|||
163120393|NCT00098722|589148383|FG002|Observation Phase|Participant defaulted|0|||
163120394|NCT00098722|589148384|FG003|Observation Phase|Participant defaulted|0|||
163120395|NCT00098722|589148385|FG004|Observation Phase|Participant defaulted|0|||
163120396|NCT00098722|589148386|FG005|Observation Phase|Participant defaulted|17|||
163120397|NCT00098722|589148387|FG006|Observation Phase|Participant defaulted|4|||
163120398|NCT00098722|589148381|FG000|Observation Phase|Other|0|||
163120399|NCT00098722|589148382|FG001|Observation Phase|Other|0|||
163120400|NCT00098722|589148383|FG002|Observation Phase|Other|0|||
163120401|NCT00098722|589148384|FG003|Observation Phase|Other|0|||
163120402|NCT00098722|589148385|FG004|Observation Phase|Other|0|||
163120403|NCT00098722|589148386|FG005|Observation Phase|Other|21|||
163120404|NCT00098722|589148387|FG006|Observation Phase|Other|10|||
163120405|NCT02046070|589148396|FG000|Overall Study|Progressive Disease|18|||
163120406|NCT02046070|589148397|FG001|Overall Study|Progressive Disease|11|||
163120407|NCT02046070|589148398|FG002|Overall Study|Progressive Disease|40|||
163120408|NCT02046070|589148396|FG000|Overall Study|Adverse Event|8|||
163120409|NCT02046070|589148397|FG001|Overall Study|Adverse Event|10|||
163120410|NCT02046070|589148398|FG002|Overall Study|Adverse Event|17|||
163120411|NCT02046070|589148396|FG000|Overall Study|Withdrawal by Subject|1|||
163120412|NCT02046070|589148397|FG001|Overall Study|Withdrawal by Subject|2|||
163120413|NCT02046070|589148398|FG002|Overall Study|Withdrawal by Subject|6|||
163120414|NCT02046070|589148396|FG000|Overall Study|Study Terminated by Sponsor|1|||
163120415|NCT02046070|589148397|FG001|Overall Study|Study Terminated by Sponsor|1|||
163120416|NCT02046070|589148398|FG002|Overall Study|Study Terminated by Sponsor|1|||
163120417|NCT02046070|589148396|FG000|Overall Study|Reason not Specified|4|||
163120418|NCT02046070|589148397|FG001|Overall Study|Reason not Specified|4|||
163120419|NCT02046070|589148398|FG002|Overall Study|Reason not Specified|6|||
163120420|NCT04619004|589148401|FG000|Overall Study|Death|114|||
163120421|NCT04619004|589148402|FG001|Overall Study|Death|28|||
163120422|NCT04619004|589148401|FG000|Overall Study|Lost to Follow-up|1|||
163120423|NCT04619004|589148402|FG001|Overall Study|Lost to Follow-up|1|||
163120424|NCT04619004|589148401|FG000|Overall Study|Withdrawal by Subject|24|||
163120425|NCT04619004|589148402|FG001|Overall Study|Withdrawal by Subject|7|||
163120426|NCT04619004|589148401|FG000|Overall Study|Other - Not specified|0|||
163120427|NCT04619004|589148402|FG001|Overall Study|Other - Not specified|1|||
163120428|NCT05601102|589148406|FG000|Overall Study|Death|1|||
163120429|NCT05601102|589148407|FG001|Overall Study|Death|2|||
163120430|NCT05601102|589148406|FG000|Overall Study|Withdrawal by Subject|1|||
163120431|NCT05601102|589148407|FG001|Overall Study|Withdrawal by Subject|1|||
163120432|NCT05601102|589148406|FG000|Overall Study|Lost to Follow-up|0|||
163120433|NCT05601102|589148407|FG001|Overall Study|Lost to Follow-up|2|||
163120434|NCT04284813|589148412|FG000|Overall Study|Withdrawal by Subject|1|||
163120435|NCT01145053|589148418|FG000|Overall Study|Adverse Event|22|||
163120436|NCT01145053|589148418|FG000|Overall Study|Lost to Follow-up|28|||
163120437|NCT01145053|589148418|FG000|Overall Study|Withdrawal by Subject|25|||
163120438|NCT01145053|589148418|FG000|Overall Study|Other|18|||
163120439|NCT00293709|589148419|FG000|Overall Study|Other|47|||
163120440|NCT02785458|589148420|FG000|1 Month|Withdrawal by Subject|2|||
163120441|NCT02785458|589148421|FG001|1 Month|Withdrawal by Subject|1|||
163120442|NCT02785458|589148420|FG000|1 Month|Lost to Follow-up|38|||
163120443|NCT02785458|589148421|FG001|1 Month|Lost to Follow-up|31|||
163120444|NCT02785458|589148420|FG000|1 Month|Deemed Ineligible|1|||
163120445|NCT02785458|589148421|FG001|1 Month|Deemed Ineligible|0|||
163120446|NCT02785458|589148420|FG000|1 Month|Completed Evaluation by Baseline|42|||
163120447|NCT02785458|589148421|FG001|1 Month|Completed Evaluation by Baseline|39|||
163120448|NCT02785458|589148420|FG000|1 Month|Partial Interview|0|||
163120449|NCT02785458|589148421|FG001|1 Month|Partial Interview|4|||
163120450|NCT02785458|589148420|FG000|3 Months|Withdrawal by Subject|3|||
163120451|NCT02785458|589148421|FG001|3 Months|Withdrawal by Subject|1|||
163120452|NCT02785458|589148420|FG000|3 Months|Lost to Follow-up|25|||
163120453|NCT02785458|589148421|FG001|3 Months|Lost to Follow-up|21|||
163120454|NCT02785458|589148420|FG000|3 Months|Completed Evaluation at 1 Month|100|||
163120455|NCT02785458|589148421|FG001|3 Months|Completed Evaluation at 1 Month|89|||
163120456|NCT01146652|589148422|FG000|Overall Study|Adverse Event|506|||
163120457|NCT01146652|589148423|FG001|Overall Study|Adverse Event|15|||
163120458|NCT01146652|589148422|FG000|Overall Study|Lack of Efficacy|91|||
163120459|NCT01146652|589148423|FG001|Overall Study|Lack of Efficacy|7|||
163120460|NCT01146652|589148422|FG000|Overall Study|Poor compliance to protocol|38|||
163120461|NCT01146652|589148423|FG001|Overall Study|Poor compliance to protocol|1|||
163120462|NCT01146652|589148422|FG000|Overall Study|Other unspecified reasons|314|||
163120463|NCT01146652|589148423|FG001|Overall Study|Other unspecified reasons|22|||
163120464|NCT01146652|589148422|FG000|Overall Study|Enrolled but not treated|2|||
163120465|NCT01146652|589148423|FG001|Overall Study|Enrolled but not treated|0|||
162719509|NCT04517864|587680486|FG002|Extension Phase|Study Terminated By Sponsor|32|||
163120466|NCT02590562|589148431|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
163120467|NCT01457950|589148432|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
163120468|NCT01457950|589148433|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120469|NCT01457950|589148434|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120470|NCT01457950|589148435|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
163120471|NCT01457950|589148432|FG000|Double-Blind Phase|Protocol Violation|2|||
163120472|NCT01457950|589148433|FG001|Double-Blind Phase|Protocol Violation|1|||
163120473|NCT01457950|589148434|FG002|Double-Blind Phase|Protocol Violation|0|||
163120474|NCT01457950|589148435|FG003|Double-Blind Phase|Protocol Violation|0|||
163120475|NCT01457950|589148432|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
163120476|NCT01457950|589148433|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
163120477|NCT01457950|589148434|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
162654919|NCT03925727|587451725|FG000|Overall Study|Administrative Reasons|3|||
162654920|NCT03925727|587451726|FG001|Overall Study|Administrative Reasons|1|||
162654921|NCT03925727|587451727|FG002|Overall Study|Administrative Reasons|2|||
162654922|NCT03925727|587451725|FG000|Overall Study|Randomized in error or Disqualified|8|||
162654923|NCT03925727|587451726|FG001|Overall Study|Randomized in error or Disqualified|1|||
162654924|NCT03925727|587451727|FG002|Overall Study|Randomized in error or Disqualified|7|||
162654925|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
163120478|NCT01457950|589148435|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163120479|NCT01457950|589148432|FG000|Open-Label Phase|Adverse Event|0|||
163120480|NCT01457950|589148433|FG001|Open-Label Phase|Adverse Event|0|||
163120481|NCT01457950|589148434|FG002|Open-Label Phase|Adverse Event|0|||
163120482|NCT01457950|589148435|FG003|Open-Label Phase|Adverse Event|1|||
163120483|NCT01457950|589148432|FG000|Open-Label Phase|Protocol Violation|0|||
163120484|NCT01457950|589148433|FG001|Open-Label Phase|Protocol Violation|0|||
163120485|NCT01457950|589148434|FG002|Open-Label Phase|Protocol Violation|0|||
163120486|NCT01457950|589148435|FG003|Open-Label Phase|Protocol Violation|1|||
163120487|NCT01457950|589148432|FG000|Open-Label Phase|Withdrawal by Subject|0|||
163120488|NCT01457950|589148433|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163120489|NCT01457950|589148434|FG002|Open-Label Phase|Withdrawal by Subject|2|||
163120490|NCT01457950|589148435|FG003|Open-Label Phase|Withdrawal by Subject|0|||
163120491|NCT03351114|589148438|FG000|Overall Study|Withdrawal by Subject|1|||
163120492|NCT00989235|589148442|FG000|Overall Study|Death|0|||
163120493|NCT00989235|589148443|FG001|Overall Study|Death|1|||
163120494|NCT00989235|589148442|FG000|Overall Study|Adverse Event|0|||
163120495|NCT00989235|589148443|FG001|Overall Study|Adverse Event|1|||
163120496|NCT00989235|589148442|FG000|Overall Study|Lack of Efficacy|1|||
163120497|NCT00989235|589148443|FG001|Overall Study|Lack of Efficacy|0|||
163120498|NCT00989235|589148442|FG000|Overall Study|Withdrawal of Consent|1|||
163120499|NCT00989235|589148443|FG001|Overall Study|Withdrawal of Consent|1|||
163120500|NCT00989235|589148442|FG000|Overall Study|Desire to Become Pregnant|1|||
163120501|NCT00989235|589148443|FG001|Overall Study|Desire to Become Pregnant|0|||
163120502|NCT00989235|589148442|FG000|Overall Study|Randomized by Mistake|0|||
163120503|NCT00989235|589148443|FG001|Overall Study|Randomized by Mistake|2|||
163120504|NCT00989235|589148442|FG000|Overall Study|Lost to Follow-up|0|||
163120505|NCT00989235|589148443|FG001|Overall Study|Lost to Follow-up|1|||
163120506|NCT03249935|589148444|FG000|Overall Study|Discharged from facility early|36|||
163120507|NCT03249935|589148444|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
163120508|NCT03249935|589148444|FG000|Overall Study|Protocol Violation|5|||
163120509|NCT03780959|589148450|FG000|Part 1|Adverse Event|1|||
163120510|NCT03780959|589148451|FG001|Part 1|Adverse Event|0|||
163120511|NCT03780959|589148452|FG002|Part 1|Adverse Event|0|||
163120512|NCT03780959|589148450|FG000|Part 1|Withdrawal by Subject|1|||
163120513|NCT03780959|589148451|FG001|Part 1|Withdrawal by Subject|0|||
163120514|NCT03780959|589148452|FG002|Part 1|Withdrawal by Subject|0|||
163120515|NCT03780959|589148450|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
163120516|NCT03780959|589148451|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
163120517|NCT03780959|589148452|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
163120518|NCT03780959|589148450|FG000|Part 1|Response Status|2|||
163120519|NCT03780959|589148451|FG001|Part 1|Response Status|0|||
163120520|NCT03780959|589148452|FG002|Part 1|Response Status|0|||
163120521|NCT03780959|589148450|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
163120522|NCT03780959|589148451|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
163120523|NCT03780959|589148452|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
163120524|NCT03780959|589148450|FG000|Part 2|Response Status|0|||
162654926|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
162654927|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
163120525|NCT03780959|589148451|FG001|Part 2|Response Status|18|||
163120526|NCT03780959|589148452|FG002|Part 2|Response Status|6|||
163120527|NCT04732949|589150270|FG000|Overall Study|Withdrawal by Subject|23|||
163120528|NCT04732949|589150271|FG001|Overall Study|Withdrawal by Subject|27|||
163120529|NCT04732949|589150270|FG000|Overall Study|Protocol Violation|0|||
163120530|NCT04732949|589150271|FG001|Overall Study|Protocol Violation|1|||
163120531|NCT04732949|589150270|FG000|Overall Study|Non-compliance|0|||
163120532|NCT04732949|589150271|FG001|Overall Study|Non-compliance|2|||
163120533|NCT04732949|589150270|FG000|Overall Study|Physician Decision|2|||
163120534|NCT04732949|589150271|FG001|Overall Study|Physician Decision|1|||
163120535|NCT04732949|589150270|FG000|Overall Study|Serious adverse event (Fatal)|16|||
162654928|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
162654929|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
163120536|NCT04732949|589150271|FG001|Overall Study|Serious adverse event (Fatal)|18|||
163120537|NCT04732949|589150270|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
163120538|NCT04732949|589150271|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
162654930|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
162654931|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
162654932|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
162654933|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
163120539|NCT04732949|589150270|FG000|Overall Study|Non-serious adverse event|1|||
163120540|NCT04732949|589150271|FG001|Overall Study|Non-serious adverse event|3|||
163120541|NCT04732949|589150270|FG000|Overall Study|Lost to Follow-up|26|||
163120542|NCT04732949|589150271|FG001|Overall Study|Lost to Follow-up|27|||
163120543|NCT04732949|589150270|FG000|Overall Study|Other|6|||
163120544|NCT04732949|589150271|FG001|Overall Study|Other|3|||
163120545|NCT01023672|589150272|FG000|Overall Study|Worsening disease|2|||
163120546|NCT01023672|589150272|FG000|Overall Study|Death|1|||
163120547|NCT01286077|589150273|FG000|Overall Study|Adverse Event|2|||
163120548|NCT01286077|589150274|FG001|Overall Study|Adverse Event|0|||
163120549|NCT01286077|589150273|FG000|Overall Study|Death|1|||
163120550|NCT01286077|589150274|FG001|Overall Study|Death|0|||
163120551|NCT01286077|589150273|FG000|Overall Study|Protocol Violation|1|||
163120552|NCT01286077|589150274|FG001|Overall Study|Protocol Violation|1|||
163120553|NCT01286077|589150273|FG000|Overall Study|Withdrawal by Subject|0|||
163120554|NCT01286077|589150274|FG001|Overall Study|Withdrawal by Subject|2|||
163120555|NCT01286077|589150273|FG000|Overall Study|Intercurrent illness|1|||
163120556|NCT01286077|589150274|FG001|Overall Study|Intercurrent illness|0|||
163120557|NCT01286077|589150273|FG000|Overall Study|Non-compliance|1|||
163120558|NCT01286077|589150274|FG001|Overall Study|Non-compliance|0|||
163120559|NCT01286077|589150273|FG000|Overall Study|The subject starts with alternative MMY|0|||
163120560|NCT01286077|589150274|FG001|Overall Study|The subject starts with alternative MMY|3|||
163120561|NCT01286077|589150273|FG000|Overall Study|Patient's decision to stop treatment|3|||
163120562|NCT01286077|589150274|FG001|Overall Study|Patient's decision to stop treatment|0|||
163120563|NCT01286077|589150273|FG000|Overall Study|Progression of disease|0|||
163120564|NCT01286077|589150274|FG001|Overall Study|Progression of disease|1|||
163120565|NCT01286077|589150273|FG000|Overall Study|refill medication not received in time|1|||
163120566|NCT01286077|589150274|FG001|Overall Study|refill medication not received in time|0|||
163120567|NCT02654236|589150275|FG000|Overall Study|Withdrawal by Subject|0|||
163120568|NCT02654236|589150276|FG001|Overall Study|Withdrawal by Subject|0|||
163120569|NCT02654236|589150277|FG002|Overall Study|Withdrawal by Subject|2|||
163120570|NCT01549873|589150278|FG000|Overall Study|Physician Decision|0|||
163120571|NCT01549873|589150279|FG001|Overall Study|Physician Decision|1|||
163120572|NCT02905006|589150280|FG000|Overall Study|Adverse Event|1|||
163120573|NCT02905006|589150281|FG001|Overall Study|Adverse Event|1|||
163120574|NCT02905006|589150282|FG002|Overall Study|Adverse Event|1|||
163120575|NCT02905006|589150283|FG003|Overall Study|Adverse Event|1|||
163120576|NCT02905006|589150284|FG004|Overall Study|Adverse Event|0|||
163120577|NCT02905006|589150285|FG005|Overall Study|Adverse Event|1|||
163120578|NCT02905006|589150280|FG000|Overall Study|Lack of Efficacy|1|||
163120579|NCT02905006|589150281|FG001|Overall Study|Lack of Efficacy|0|||
163120580|NCT02905006|589150282|FG002|Overall Study|Lack of Efficacy|0|||
163120581|NCT02905006|589150283|FG003|Overall Study|Lack of Efficacy|0|||
163120582|NCT02905006|589150284|FG004|Overall Study|Lack of Efficacy|0|||
163120583|NCT02905006|589150285|FG005|Overall Study|Lack of Efficacy|0|||
163120584|NCT02905006|589150280|FG000|Overall Study|Protocol Violation|2|||
163120585|NCT02905006|589150281|FG001|Overall Study|Protocol Violation|0|||
163120586|NCT02905006|589150282|FG002|Overall Study|Protocol Violation|0|||
163120587|NCT02905006|589150283|FG003|Overall Study|Protocol Violation|0|||
163120588|NCT02905006|589150284|FG004|Overall Study|Protocol Violation|0|||
163120589|NCT02905006|589150285|FG005|Overall Study|Protocol Violation|0|||
163120590|NCT02905006|589150280|FG000|Overall Study|Lost to Follow-up|0|||
163120591|NCT02905006|589150281|FG001|Overall Study|Lost to Follow-up|0|||
163120592|NCT02905006|589150282|FG002|Overall Study|Lost to Follow-up|0|||
163120593|NCT02905006|589150283|FG003|Overall Study|Lost to Follow-up|1|||
163120594|NCT02905006|589150284|FG004|Overall Study|Lost to Follow-up|1|||
163120595|NCT02905006|589150285|FG005|Overall Study|Lost to Follow-up|0|||
163120596|NCT02905006|589150280|FG000|Overall Study|Withdrawal by Subject|0|||
163120597|NCT02905006|589150281|FG001|Overall Study|Withdrawal by Subject|0|||
163120598|NCT02905006|589150282|FG002|Overall Study|Withdrawal by Subject|1|||
163120599|NCT02905006|589150283|FG003|Overall Study|Withdrawal by Subject|1|||
163120600|NCT02905006|589150284|FG004|Overall Study|Withdrawal by Subject|0|||
163120601|NCT02905006|589150285|FG005|Overall Study|Withdrawal by Subject|1|||
163120602|NCT02905006|589150280|FG000|Overall Study|Screening exclusion criteria met|1|||
163120603|NCT02905006|589150281|FG001|Overall Study|Screening exclusion criteria met|0|||
163120604|NCT02905006|589150282|FG002|Overall Study|Screening exclusion criteria met|0|||
163120605|NCT02905006|589150283|FG003|Overall Study|Screening exclusion criteria met|0|||
163120606|NCT02905006|589150284|FG004|Overall Study|Screening exclusion criteria met|0|||
163120607|NCT02905006|589150285|FG005|Overall Study|Screening exclusion criteria met|0|||
163120608|NCT02905006|589150280|FG000|Overall Study|Lab withdrawal criterion met|0|||
163120609|NCT02905006|589150281|FG001|Overall Study|Lab withdrawal criterion met|1|||
163120610|NCT02905006|589150282|FG002|Overall Study|Lab withdrawal criterion met|2|||
163120611|NCT02905006|589150283|FG003|Overall Study|Lab withdrawal criterion met|2|||
163120612|NCT02905006|589150284|FG004|Overall Study|Lab withdrawal criterion met|2|||
163120613|NCT02905006|589150285|FG005|Overall Study|Lab withdrawal criterion met|1|||
163120614|NCT02905006|589150280|FG000|Overall Study|Positive for Tuberculosis|0|||
163120615|NCT02905006|589150281|FG001|Overall Study|Positive for Tuberculosis|1|||
163120616|NCT02905006|589150282|FG002|Overall Study|Positive for Tuberculosis|0|||
163120617|NCT02905006|589150283|FG003|Overall Study|Positive for Tuberculosis|0|||
163120618|NCT02905006|589150284|FG004|Overall Study|Positive for Tuberculosis|0|||
163120619|NCT02905006|589150285|FG005|Overall Study|Positive for Tuberculosis|0|||
163120620|NCT02905006|589150280|FG000|Overall Study|Subject positive for Hep B|0|||
163120621|NCT02905006|589150281|FG001|Overall Study|Subject positive for Hep B|0|||
163120622|NCT02905006|589150282|FG002|Overall Study|Subject positive for Hep B|1|||
163120623|NCT02905006|589150283|FG003|Overall Study|Subject positive for Hep B|0|||
163120624|NCT02905006|589150284|FG004|Overall Study|Subject positive for Hep B|0|||
163120625|NCT02905006|589150285|FG005|Overall Study|Subject positive for Hep B|0|||
163120626|NCT02905006|589150280|FG000|Overall Study|Patient moved abroad|0|||
163120627|NCT02905006|589150281|FG001|Overall Study|Patient moved abroad|0|||
163120628|NCT02905006|589150282|FG002|Overall Study|Patient moved abroad|0|||
163120629|NCT02905006|589150283|FG003|Overall Study|Patient moved abroad|1|||
163120630|NCT02905006|589150284|FG004|Overall Study|Patient moved abroad|0|||
163120631|NCT02905006|589150285|FG005|Overall Study|Patient moved abroad|0|||
163120632|NCT02905006|589150280|FG000|Overall Study|Patient randomized by mistake|0|||
163120633|NCT02905006|589150281|FG001|Overall Study|Patient randomized by mistake|0|||
163120634|NCT02905006|589150282|FG002|Overall Study|Patient randomized by mistake|0|||
163120635|NCT02905006|589150283|FG003|Overall Study|Patient randomized by mistake|0|||
163120636|NCT02905006|589150284|FG004|Overall Study|Patient randomized by mistake|0|||
163120637|NCT02905006|589150285|FG005|Overall Study|Patient randomized by mistake|1|||
163120638|NCT03627065|589150288|FG000|Overall Study|Study Terminated by sponsor|1|||
163120639|NCT03627065|589150288|FG000|Overall Study|Withdrawal by Subject|2|||
163120640|NCT02797184|589150289|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
163120641|NCT02797184|589150290|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
163120642|NCT06250738|589150291|FG000|Overall Study|Lost to Follow-up|1|||
163120643|NCT04912895|589150292|FG000|Overall Study|Unable to provide specimen|2|||
163120644|NCT04912895|589150293|FG001|Overall Study|Unable to provide specimen|0|||
163120645|NCT04912895|589150294|FG002|Overall Study|Unable to provide specimen|0|||
163120646|NCT03294135|589150295|FG000|Overall Study|Serious Adverse Event|1|||
163120647|NCT03294135|589150296|FG001|Overall Study|Serious Adverse Event|0|||
163120648|NCT03294135|589150297|FG002|Overall Study|Serious Adverse Event|0|||
163120649|NCT03294135|589150295|FG000|Overall Study|Lost to Follow-up|1|||
163120650|NCT03294135|589150296|FG001|Overall Study|Lost to Follow-up|0|||
163120651|NCT03294135|589150297|FG002|Overall Study|Lost to Follow-up|1|||
163120652|NCT03294135|589150295|FG000|Overall Study|Withdrawal by Subject|0|||
163120653|NCT03294135|589150296|FG001|Overall Study|Withdrawal by Subject|0|||
163120654|NCT03294135|589150297|FG002|Overall Study|Withdrawal by Subject|1|||
163120655|NCT03294135|589150295|FG000|Overall Study|Other|2|||
163120656|NCT03294135|589150296|FG001|Overall Study|Other|0|||
163120657|NCT03294135|589150297|FG002|Overall Study|Other|0|||
163120658|NCT02763254|589150298|FG000|Overall Study|Adverse Event|1|||
163120659|NCT03684304|589150299|FG000|Overall Study|Lost to Follow-up|19|||
163120660|NCT03684304|589150300|FG001|Overall Study|Lost to Follow-up|17|||
163120661|NCT00824005|589150301|FG000|Overall Study|Death|0|||
163120662|NCT00824005|589150302|FG001|Overall Study|Death|1|||
163120663|NCT00824005|589150301|FG000|Overall Study|Lost to Follow-up|0|||
163120664|NCT00824005|589150302|FG001|Overall Study|Lost to Follow-up|1|||
163120665|NCT01510184|589150303|FG000|Overall Study|Sponsor discretion|28|||
163120666|NCT01510184|589150304|FG001|Overall Study|Sponsor discretion|28|||
163120667|NCT01510184|589150303|FG000|Overall Study|Death|1|||
163120668|NCT01510184|589150304|FG001|Overall Study|Death|2|||
163120669|NCT01510184|589150303|FG000|Overall Study|Withdrawal by Subject|1|||
163120670|NCT01510184|589150304|FG001|Overall Study|Withdrawal by Subject|4|||
163120671|NCT01510184|589150303|FG000|Overall Study|Other|0|||
163120672|NCT01510184|589150304|FG001|Overall Study|Other|1|||
163120673|NCT01143051|589150305|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
163120674|NCT01143051|589150306|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
163120675|NCT01143051|589150307|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
163120676|NCT01143051|589150308|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
163120677|NCT01143051|589150309|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
163120678|NCT01143051|589150310|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
163120679|NCT01143051|589150305|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
163120680|NCT01143051|589150306|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
163120681|NCT01143051|589150307|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
163120682|NCT01143051|589150308|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
163120683|NCT01143051|589150309|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
163120684|NCT01143051|589150310|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
163120685|NCT03458702|589150311|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
163120686|NCT03458702|589150312|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
163120687|NCT03458702|589150311|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
163120688|NCT03458702|589150312|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
163120689|NCT01390779|589150313|FG000|Overall Study|Physician Decision|1|||
163120690|NCT01697462|589150314|FG000|Overall Study|Disease Progression|1|||
163120691|NCT01697462|589150314|FG000|Overall Study|Adverse Event|6|||
163120692|NCT01697462|589150314|FG000|Overall Study|Lost to Follow-up|21|||
163120693|NCT01697462|589150314|FG000|Overall Study|Withdrawal by Subject|12|||
163120694|NCT01697462|589150314|FG000|Overall Study|Investigator Decision|21|||
163120695|NCT01697462|589150314|FG000|Overall Study|Death|1|||
163120696|NCT01697462|589150314|FG000|Overall Study|Other|10|||
163120697|NCT01697462|589150314|FG000|Overall Study|Missing|5|||
163120698|NCT02255565|589150321|FG000|Overall Study|Withdrawal by Subject|0|||
163120699|NCT02255565|589150322|FG001|Overall Study|Withdrawal by Subject|1|||
163120700|NCT02255565|589150323|FG002|Overall Study|Withdrawal by Subject|0|||
163120701|NCT01635764|589150324|FG000|Overall Study|Adverse Event|46|||
163120702|NCT01635764|589150324|FG000|Overall Study|Lack of Efficacy|76|||
163120703|NCT01635764|589150324|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
163120704|NCT01635764|589150324|FG000|Overall Study|Protocol Deviation|1|||
163120705|NCT01635764|589150324|FG000|Overall Study|Withdrew Consent|67|||
163120706|NCT01635764|589150324|FG000|Overall Study|Lost to Follow-up|53|||
163120707|NCT01635764|589150324|FG000|Overall Study|Other|28|||
163120708|NCT01816906|589150328|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
163120709|NCT01816906|589150329|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
163120710|NCT01816906|589150328|FG000|Six Months|Lost to Follow-up|14|||
163120711|NCT01816906|589150329|FG001|Six Months|Lost to Follow-up|16|||
163120712|NCT01816906|589150328|FG000|12 Months|Adverse Event|2|||
163120713|NCT01816906|589150329|FG001|12 Months|Adverse Event|2|||
163120714|NCT01816906|589150328|FG000|12 Months|Death|0|||
163120715|NCT01816906|589150329|FG001|12 Months|Death|2|||
163120716|NCT01816906|589150328|FG000|12 Months|Lost to Follow-up|2|||
163120717|NCT01816906|589150329|FG001|12 Months|Lost to Follow-up|1|||
163120718|NCT04375397|589150330|FG000|Overall Study|Death|1|||
163120719|NCT04375397|589150331|FG001|Overall Study|Death|1|||
163120720|NCT04375397|589150330|FG000|Overall Study|Withdrew consent|2|||
163120721|NCT04375397|589150331|FG001|Overall Study|Withdrew consent|0|||
163120722|NCT04375397|589150330|FG000|Overall Study|Lost to Follow-up|6|||
163120723|NCT04375397|589150331|FG001|Overall Study|Lost to Follow-up|4|||
163120724|NCT04375397|589150330|FG000|Overall Study|Other, not specified|0|||
163120725|NCT04375397|589150331|FG001|Overall Study|Other, not specified|1|||
163120726|NCT00086502|589150332|FG000|Overall Study|Adverse Event|11|||
163120727|NCT00086502|589150333|FG001|Overall Study|Adverse Event|2|||
163120728|NCT00086502|589150332|FG000|Overall Study|Lack of Efficacy|0|||
163120729|NCT00086502|589150333|FG001|Overall Study|Lack of Efficacy|2|||
163120730|NCT00086502|589150332|FG000|Overall Study|Lost to Follow-up|3|||
163120731|NCT00086502|589150333|FG001|Overall Study|Lost to Follow-up|1|||
163120732|NCT00086502|589150332|FG000|Overall Study|Physician Decision|1|||
163120733|NCT00086502|589150333|FG001|Overall Study|Physician Decision|1|||
163120734|NCT00086502|589150332|FG000|Overall Study|Pregnancy|0|||
163120735|NCT00086502|589150333|FG001|Overall Study|Pregnancy|1|||
163120736|NCT00086502|589150332|FG000|Overall Study|Protocol Violation|3|||
163120737|NCT00086502|589150333|FG001|Overall Study|Protocol Violation|3|||
163120738|NCT00086502|589150332|FG000|Overall Study|Withdrawal by Subject|5|||
163120739|NCT00086502|589150333|FG001|Overall Study|Withdrawal by Subject|6|||
163120740|NCT00086502|589150332|FG000|Overall Study|Patient Moved|1|||
163120741|NCT00086502|589150333|FG001|Overall Study|Patient Moved|1|||
163120742|NCT00086502|589150332|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
163120743|NCT00086502|589150333|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
163120744|NCT00086502|589150332|FG000|Overall Study|Patient Accidentally Unblinded|1|||
163120745|NCT00086502|589150333|FG001|Overall Study|Patient Accidentally Unblinded|0|||
163120746|NCT01304329|589150334|FG000|Third Intervention (3 Days)|Adverse Event|0|||
163120747|NCT01304329|589150335|FG001|Third Intervention (3 Days)|Adverse Event|1|||
163120748|NCT01304329|589150336|FG002|Third Intervention (3 Days)|Adverse Event|0|||
163120749|NCT01304329|589150337|FG003|Third Intervention (3 Days)|Adverse Event|0|||
163120750|NCT01304329|589150338|FG004|Third Intervention (3 Days)|Adverse Event|0|||
163120751|NCT01304329|589150339|FG005|Third Intervention (3 Days)|Adverse Event|0|||
163120752|NCT05545644|589150341|FG000|Overall Study|Lost to Follow-up|4|||
163120753|NCT05545644|589150342|FG001|Overall Study|Lost to Follow-up|3|||
163120754|NCT01945775|589150349|FG000|Overall Study|Death|214|||
163120755|NCT01945775|589150350|FG001|Overall Study|Death|98|||
163120756|NCT01945775|589150349|FG000|Overall Study|Lost to Follow-up|12|||
163120757|NCT01945775|589150350|FG001|Overall Study|Lost to Follow-up|7|||
163120758|NCT01945775|589150349|FG000|Overall Study|Withdrawal by Subject|11|||
163120759|NCT01945775|589150350|FG001|Overall Study|Withdrawal by Subject|21|||
163120760|NCT01945775|589150349|FG000|Overall Study|Other|50|||
163120761|NCT01945775|589150350|FG001|Overall Study|Other|18|||
163120762|NCT02876328|589150351|FG000|Overall Study|Death|2|||
163120763|NCT02876328|589150352|FG001|Overall Study|Death|1|||
163120764|NCT02876328|589150353|FG002|Overall Study|Death|3|||
162654934|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
163120765|NCT02876328|589150354|FG003|Overall Study|Death|0|||
163120766|NCT02876328|589150355|FG004|Overall Study|Death|0|||
163120767|NCT02876328|589150356|FG005|Overall Study|Death|0|||
163120768|NCT02876328|589150357|FG006|Overall Study|Death|1|||
163120769|NCT02876328|589150358|FG007|Overall Study|Death|3|||
163120770|NCT02876328|589150359|FG008|Overall Study|Death|0|||
163120771|NCT02876328|589150360|FG009|Overall Study|Death|1|||
163120772|NCT02876328|589150361|FG010|Overall Study|Death|1|||
163120773|NCT02876328|589150362|FG011|Overall Study|Death|0|||
163120774|NCT02876328|589150363|FG012|Overall Study|Death|0|||
163120775|NCT02876328|589150364|FG013|Overall Study|Death|0|||
163120776|NCT02876328|589150365|FG014|Overall Study|Death|0|||
163120777|NCT02876328|589150366|FG015|Overall Study|Death|0|||
163120778|NCT02876328|589150367|FG016|Overall Study|Death|1|||
163120779|NCT02876328|589150368|FG017|Overall Study|Death|1|||
163120780|NCT02876328|589150369|FG018|Overall Study|Death|0|||
163120781|NCT02876328|589150370|FG019|Overall Study|Death|0|||
163120782|NCT02876328|589150371|FG020|Overall Study|Death|0|||
163120783|NCT02876328|589150372|FG021|Overall Study|Death|1|||
162719510|NCT04517864|587680484|FG000|Extension Phase|Withdrawal by Subject|0|||
163120784|NCT02876328|589150373|FG022|Overall Study|Death|0|||
163120785|NCT02876328|589150374|FG023|Overall Study|Death|0|||
163120786|NCT02876328|589150351|FG000|Overall Study|Withdrawal by Subject|0|||
163120787|NCT02876328|589150352|FG001|Overall Study|Withdrawal by Subject|2|||
163120788|NCT02876328|589150353|FG002|Overall Study|Withdrawal by Subject|3|||
163120789|NCT02876328|589150354|FG003|Overall Study|Withdrawal by Subject|3|||
163120790|NCT02876328|589150355|FG004|Overall Study|Withdrawal by Subject|0|||
163120791|NCT02876328|589150356|FG005|Overall Study|Withdrawal by Subject|1|||
163120792|NCT02876328|589150357|FG006|Overall Study|Withdrawal by Subject|0|||
163120793|NCT02876328|589150358|FG007|Overall Study|Withdrawal by Subject|1|||
163120794|NCT02876328|589150359|FG008|Overall Study|Withdrawal by Subject|1|||
163120795|NCT02876328|589150360|FG009|Overall Study|Withdrawal by Subject|2|||
163120796|NCT02876328|589150361|FG010|Overall Study|Withdrawal by Subject|0|||
163120797|NCT02876328|589150362|FG011|Overall Study|Withdrawal by Subject|0|||
163120798|NCT02876328|589150363|FG012|Overall Study|Withdrawal by Subject|0|||
163120799|NCT02876328|589150364|FG013|Overall Study|Withdrawal by Subject|0|||
163120800|NCT02876328|589150365|FG014|Overall Study|Withdrawal by Subject|0|||
163120801|NCT02876328|589150366|FG015|Overall Study|Withdrawal by Subject|0|||
163120802|NCT02876328|589150367|FG016|Overall Study|Withdrawal by Subject|1|||
163120803|NCT02876328|589150368|FG017|Overall Study|Withdrawal by Subject|3|||
163120804|NCT02876328|589150369|FG018|Overall Study|Withdrawal by Subject|0|||
163120805|NCT02876328|589150370|FG019|Overall Study|Withdrawal by Subject|0|||
163120806|NCT02876328|589150371|FG020|Overall Study|Withdrawal by Subject|1|||
163120807|NCT02876328|589150372|FG021|Overall Study|Withdrawal by Subject|0|||
163120808|NCT02876328|589150373|FG022|Overall Study|Withdrawal by Subject|0|||
163120809|NCT02876328|589150374|FG023|Overall Study|Withdrawal by Subject|0|||
163120810|NCT02876328|589150351|FG000|Overall Study|Missed 12 Month Visit|15|||
163120811|NCT02876328|589150352|FG001|Overall Study|Missed 12 Month Visit|10|||
163120812|NCT02876328|589150353|FG002|Overall Study|Missed 12 Month Visit|11|||
163120813|NCT02876328|589150354|FG003|Overall Study|Missed 12 Month Visit|6|||
163120814|NCT02876328|589150355|FG004|Overall Study|Missed 12 Month Visit|10|||
163120815|NCT02876328|589150356|FG005|Overall Study|Missed 12 Month Visit|14|||
163120816|NCT02876328|589150357|FG006|Overall Study|Missed 12 Month Visit|3|||
163120817|NCT02876328|589150358|FG007|Overall Study|Missed 12 Month Visit|8|||
163120818|NCT02876328|589150359|FG008|Overall Study|Missed 12 Month Visit|9|||
163120819|NCT02876328|589150360|FG009|Overall Study|Missed 12 Month Visit|5|||
163120820|NCT02876328|589150361|FG010|Overall Study|Missed 12 Month Visit|4|||
162719511|NCT04517864|587680485|FG001|Extension Phase|Withdrawal by Subject|0|||
163120821|NCT02876328|589150362|FG011|Overall Study|Missed 12 Month Visit|1|||
163120822|NCT02876328|589150363|FG012|Overall Study|Missed 12 Month Visit|5|||
163120823|NCT02876328|589150364|FG013|Overall Study|Missed 12 Month Visit|4|||
163120824|NCT02876328|589150365|FG014|Overall Study|Missed 12 Month Visit|4|||
163120825|NCT02876328|589150366|FG015|Overall Study|Missed 12 Month Visit|4|||
163120826|NCT02876328|589150367|FG016|Overall Study|Missed 12 Month Visit|3|||
163120827|NCT02876328|589150368|FG017|Overall Study|Missed 12 Month Visit|6|||
163120828|NCT02876328|589150369|FG018|Overall Study|Missed 12 Month Visit|2|||
163120829|NCT02876328|589150370|FG019|Overall Study|Missed 12 Month Visit|2|||
163120830|NCT02876328|589150371|FG020|Overall Study|Missed 12 Month Visit|11|||
163120831|NCT02876328|589150372|FG021|Overall Study|Missed 12 Month Visit|7|||
163120832|NCT02876328|589150373|FG022|Overall Study|Missed 12 Month Visit|1|||
163120833|NCT02876328|589150374|FG023|Overall Study|Missed 12 Month Visit|0|||
163120834|NCT01995552|589150375|FG000|Overall Study|Protocol Violation|1|||
163120835|NCT01995552|589150375|FG000|Overall Study|Lack of Efficacy|15|||
163120836|NCT01995552|589150375|FG000|Overall Study|Death|1|||
163120837|NCT02068118|589150377|FG000|18-month Comparative Study Period|Death|90|||
163120838|NCT02068118|589150378|FG001|18-month Comparative Study Period|Death|97|||
163120839|NCT02068118|589150377|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
163120840|NCT02068118|589150378|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
163120841|NCT02068118|589150377|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
163120842|NCT02068118|589150378|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
163120843|NCT02068118|589150377|FG000|18-month Comparative Study Period|Heart transplant|9|||
163120844|NCT02068118|589150378|FG001|18-month Comparative Study Period|Heart transplant|15|||
163120845|NCT02068118|589150377|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
163120846|NCT02068118|589150378|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
163120847|NCT02068118|589150377|FG000|18-month Comparative Study Period|Hemiplegia|0|||
163120848|NCT02068118|589150378|FG001|18-month Comparative Study Period|Hemiplegia|1|||
163120849|NCT02068118|589150377|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
163120850|NCT02068118|589150378|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
163120851|NCT02068118|589150377|FG000|18-month Comparative Study Period|Move|0|||
163120852|NCT02068118|589150378|FG001|18-month Comparative Study Period|Move|1|||
163120853|NCT02068118|589150377|FG000|18-month Comparative Study Period|Hearing loss|0|||
163120854|NCT02068118|589150378|FG001|18-month Comparative Study Period|Hearing loss|1|||
163120855|NCT02068118|589150377|FG000|Extension Period|Death|0|||
163120856|NCT02068118|589150378|FG001|Extension Period|Death|2|||
163120857|NCT02068118|589150377|FG000|Extension Period|Withdrawal by Subject|1|||
163120858|NCT02068118|589150378|FG001|Extension Period|Withdrawal by Subject|0|||
163120859|NCT02068118|589150377|FG000|Extension Period|Heart transplant|1|||
163120860|NCT02068118|589150378|FG001|Extension Period|Heart transplant|0|||
163120861|NCT02068118|589150377|FG000|Extension Period|Wrong device use|0|||
163120862|NCT02068118|589150378|FG001|Extension Period|Wrong device use|1|||
163120863|NCT00353873|589150381|FG000|Overall Study|Protocol Violation|1|||
163120864|NCT00353873|589150382|FG001|Overall Study|Protocol Violation|2|||
163120865|NCT00353873|589150381|FG000|Overall Study|Exacerbation|1|||
163120866|NCT00353873|589150382|FG001|Overall Study|Exacerbation|0|||
163120867|NCT00353873|589150381|FG000|Overall Study|Adverse Event|1|||
163120868|NCT00353873|589150382|FG001|Overall Study|Adverse Event|0|||
163120869|NCT00353873|589150381|FG000|Overall Study|Physician Decision|2|||
163120870|NCT00353873|589150382|FG001|Overall Study|Physician Decision|0|||
163120871|NCT00353873|589150381|FG000|Overall Study|Withdrawal by Subject|1|||
163120872|NCT00353873|589150382|FG001|Overall Study|Withdrawal by Subject|1|||
163120873|NCT01420627|589150383|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
163120874|NCT00453973|589150384|FG000|Overall Study|Adverse Event|4|||
163120875|NCT00453973|589150385|FG001|Overall Study|Adverse Event|9|||
163120876|NCT00453973|589150384|FG000|Overall Study|Withdrawal by Subject|7|||
163120877|NCT00453973|589150385|FG001|Overall Study|Withdrawal by Subject|6|||
163120878|NCT00453973|589150384|FG000|Overall Study|PI Decision|0|||
163120879|NCT00453973|589150385|FG001|Overall Study|PI Decision|2|||
163120880|NCT00453973|589150384|FG000|Overall Study|Relocation|1|||
163120881|NCT00453973|589150385|FG001|Overall Study|Relocation|0|||
163120882|NCT00453973|589150384|FG000|Overall Study|Renal transplant|1|||
163120883|NCT00453973|589150385|FG001|Overall Study|Renal transplant|1|||
163120884|NCT00453973|589150384|FG000|Overall Study|Site closed by sponsor|3|||
163120885|NCT00453973|589150385|FG001|Overall Study|Site closed by sponsor|0|||
163120886|NCT00453973|589150384|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
163120887|NCT00453973|589150385|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
163120888|NCT03743064|589150386|FG000|Overall Study|Adverse Event|7|||
163120889|NCT03743064|589150387|FG001|Overall Study|Adverse Event|9|||
163120890|NCT03743064|589150386|FG000|Overall Study|Death|25|||
163120891|NCT03743064|589150387|FG001|Overall Study|Death|28|||
163120892|NCT03743064|589150386|FG000|Overall Study|Lost to Follow-up|3|||
163120893|NCT03743064|589150387|FG001|Overall Study|Lost to Follow-up|6|||
163120894|NCT03743064|589150386|FG000|Overall Study|Withdrawal by Subject|28|||
163120895|NCT03743064|589150387|FG001|Overall Study|Withdrawal by Subject|25|||
163120896|NCT03743064|589150386|FG000|Overall Study|Physician Decision|2|||
163120897|NCT03743064|589150387|FG001|Overall Study|Physician Decision|4|||
163120898|NCT03743064|589150386|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
163120899|NCT03743064|589150387|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
163120900|NCT02759315|589150392|FG000|Overall Study|Adverse Event|0|||
163120901|NCT02759315|589150393|FG001|Overall Study|Adverse Event|0|||
163120902|NCT02759315|589150394|FG002|Overall Study|Adverse Event|0|||
163120903|NCT02759315|589150395|FG003|Overall Study|Adverse Event|1|||
163120904|NCT02759315|589150396|FG004|Overall Study|Adverse Event|0|||
163120905|NCT02759315|589150392|FG000|Overall Study|Death|0|||
163120906|NCT02759315|589150393|FG001|Overall Study|Death|0|||
163120907|NCT02759315|589150394|FG002|Overall Study|Death|1|||
163120908|NCT02759315|589150395|FG003|Overall Study|Death|0|||
163120909|NCT02759315|589150396|FG004|Overall Study|Death|0|||
163120910|NCT02759315|589150392|FG000|Overall Study|Lost to Follow-up|2|||
163120911|NCT02759315|589150393|FG001|Overall Study|Lost to Follow-up|0|||
163120912|NCT02759315|589150394|FG002|Overall Study|Lost to Follow-up|4|||
162654935|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
163120913|NCT02759315|589150395|FG003|Overall Study|Lost to Follow-up|0|||
163120914|NCT02759315|589150396|FG004|Overall Study|Lost to Follow-up|0|||
163120915|NCT02759315|589150392|FG000|Overall Study|Protocol Violation|0|||
163120916|NCT02759315|589150393|FG001|Overall Study|Protocol Violation|1|||
163120917|NCT02759315|589150394|FG002|Overall Study|Protocol Violation|0|||
163120918|NCT02759315|589150395|FG003|Overall Study|Protocol Violation|0|||
163120919|NCT02759315|589150396|FG004|Overall Study|Protocol Violation|0|||
163120920|NCT02759315|589150392|FG000|Overall Study|Study terminated prior to completion|2|||
163120921|NCT02759315|589150393|FG001|Overall Study|Study terminated prior to completion|0|||
163120922|NCT02759315|589150394|FG002|Overall Study|Study terminated prior to completion|5|||
163120923|NCT02759315|589150395|FG003|Overall Study|Study terminated prior to completion|0|||
163120924|NCT02759315|589150396|FG004|Overall Study|Study terminated prior to completion|1|||
163120925|NCT00870194|589150397|FG000|Overall Study|Adverse Event|10|||
163120926|NCT00870194|589150398|FG001|Overall Study|Adverse Event|5|||
163120927|NCT00870194|589150397|FG000|Overall Study|Lack of Efficacy|0|||
163120928|NCT00870194|589150398|FG001|Overall Study|Lack of Efficacy|1|||
163120929|NCT00870194|589150397|FG000|Overall Study|Lost to Follow-up|2|||
163120930|NCT00870194|589150398|FG001|Overall Study|Lost to Follow-up|0|||
163120931|NCT00870194|589150397|FG000|Overall Study|Physician Decision|3|||
163120932|NCT00870194|589150398|FG001|Overall Study|Physician Decision|1|||
163120933|NCT00870194|589150397|FG000|Overall Study|Protocol Violation|3|||
163120934|NCT00870194|589150398|FG001|Overall Study|Protocol Violation|3|||
163120935|NCT00870194|589150397|FG000|Overall Study|Entry Criteria Not Met|1|||
163120936|NCT00870194|589150398|FG001|Overall Study|Entry Criteria Not Met|2|||
163120937|NCT00870194|589150397|FG000|Overall Study|Subject Decision|7|||
163120938|NCT00870194|589150398|FG001|Overall Study|Subject Decision|2|||
163120939|NCT00582738|589150400|FG000|Overall Study|Administrative Problems|7|||
163120940|NCT00582738|589150401|FG001|Overall Study|Administrative Problems|8|||
163120941|NCT00582738|589150400|FG000|Overall Study|Adverse Event|0|||
163120942|NCT00582738|589150401|FG001|Overall Study|Adverse Event|5|||
163120943|NCT00582738|589150400|FG000|Overall Study|Graft Lost|0|||
163120944|NCT00582738|589150401|FG001|Overall Study|Graft Lost|1|||
163120945|NCT00582738|589150400|FG000|Overall Study|Other|1|||
163120946|NCT00582738|589150401|FG001|Overall Study|Other|0|||
163120947|NCT00582738|589150400|FG000|Overall Study|Protocol Violation|1|||
163120948|NCT00582738|589150401|FG001|Overall Study|Protocol Violation|1|||
163120949|NCT00582738|589150400|FG000|Overall Study|Withdrawal by Subject|0|||
163120950|NCT00582738|589150401|FG001|Overall Study|Withdrawal by Subject|3|||
163120951|NCT01490294|589150403|FG000|Overall Study|Prematurely discontinuation|4|||
163120952|NCT01490294|589150404|FG001|Overall Study|Prematurely discontinuation|0|||
163120953|NCT01490294|589150405|FG002|Overall Study|Prematurely discontinuation|1|||
163120954|NCT01490294|589150406|FG003|Overall Study|Prematurely discontinuation|1|||
162654936|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
163120955|NCT01490294|589150403|FG000|Overall Study|Adverse Event|1|||
163120956|NCT01490294|589150404|FG001|Overall Study|Adverse Event|0|||
163120957|NCT01490294|589150405|FG002|Overall Study|Adverse Event|0|||
163120958|NCT01490294|589150406|FG003|Overall Study|Adverse Event|0|||
163120959|NCT02210091|589150412|FG000|Overall Study|Physician Decision|0|||
163120960|NCT02210091|589150413|FG001|Overall Study|Physician Decision|1|||
163120961|NCT02210091|589150412|FG000|Overall Study|Withdrawal by Sponsor|0|||
163120962|NCT02210091|589150413|FG001|Overall Study|Withdrawal by Sponsor|1|||
163120963|NCT01831817|589150414|FG000|Overall Study|Lost to Follow-up|1|||
163120964|NCT01831817|589150415|FG001|Overall Study|Lost to Follow-up|0|||
163120965|NCT01831817|589150416|FG002|Overall Study|Lost to Follow-up|0|||
163120966|NCT01831817|589150417|FG003|Overall Study|Lost to Follow-up|0|||
163120967|NCT01831817|589150414|FG000|Overall Study|Withdrawl of Consent|3|||
163120968|NCT01831817|589150415|FG001|Overall Study|Withdrawl of Consent|0|||
163120969|NCT01831817|589150416|FG002|Overall Study|Withdrawl of Consent|0|||
163120970|NCT01831817|589150417|FG003|Overall Study|Withdrawl of Consent|0|||
163120971|NCT00958217|589150418|FG000|Overall Study|Death|2|||
162654937|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
163120972|NCT00958217|589150419|FG001|Overall Study|Death|1|||
163120973|NCT00958217|589150418|FG000|Overall Study|Withdrawal by Subject|4|||
163120974|NCT00958217|589150419|FG001|Overall Study|Withdrawal by Subject|3|||
163120975|NCT00958217|589150418|FG000|Overall Study|Lost to Follow-up|17|||
163120976|NCT00958217|589150419|FG001|Overall Study|Lost to Follow-up|19|||
163120977|NCT00958217|589150418|FG000|Overall Study|Moved out of area|1|||
163120978|NCT00958217|589150419|FG001|Overall Study|Moved out of area|1|||
163120979|NCT00958217|589150418|FG000|Overall Study|Inpatient hospitalization|0|||
163120980|NCT00958217|589150419|FG001|Overall Study|Inpatient hospitalization|1|||
163120981|NCT00456599|589150421|FG000|Overall Study|Non-compliance|1|||
163120982|NCT00456599|589150421|FG000|Overall Study|Withdrawal by Subject|2|||
163120983|NCT00260065|589150422|FG000|Overall Study|Progressive Disease|22|||
163120984|NCT00260065|589150422|FG000|Overall Study|Adverse Event|17|||
163120985|NCT00260065|589150422|FG000|Overall Study|Death|13|||
163120986|NCT00260065|589150422|FG000|Overall Study|Withdrawal by Subject|13|||
163120987|NCT00260065|589150422|FG000|Overall Study|Physician Decision|19|||
163120988|NCT00260065|589150422|FG000|Overall Study|Not otherwise specified|8|||
163120989|NCT00260065|589150422|FG000|Overall Study|Medication Noncompliance|1|||
163120990|NCT02198235|589150423|FG000|Overall Study|Lost to Follow-up|3|||
163120991|NCT02198235|589150424|FG001|Overall Study|Lost to Follow-up|2|||
163120992|NCT02198235|589150425|FG002|Overall Study|Lost to Follow-up|2|||
163120993|NCT02440789|589150428|FG000|Overall Study|Withdrawal by Subject|3|||
163120994|NCT02440789|589150428|FG000|Overall Study|Not willing to adhere to reqs|1|||
163120995|NCT01999218|589150430|FG000|Overall Study|Hyperglycemia|18|||
163120996|NCT01999218|589150431|FG001|Overall Study|Hyperglycemia|17|||
163120997|NCT01999218|589150432|FG002|Overall Study|Hyperglycemia|17|||
163120998|NCT01999218|589150430|FG000|Overall Study|Lack of Efficacy|1|||
163120999|NCT01999218|589150431|FG001|Overall Study|Lack of Efficacy|0|||
163121000|NCT01999218|589150432|FG002|Overall Study|Lack of Efficacy|1|||
163121001|NCT01999218|589150430|FG000|Overall Study|Lost to Follow-up|22|||
163121002|NCT01999218|589150431|FG001|Overall Study|Lost to Follow-up|17|||
163121003|NCT01999218|589150432|FG002|Overall Study|Lost to Follow-up|18|||
163121004|NCT01999218|589150430|FG000|Overall Study|Non-Compliance With Study Drug|6|||
163121005|NCT01999218|589150431|FG001|Overall Study|Non-Compliance With Study Drug|4|||
163121006|NCT01999218|589150432|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163121007|NCT01999218|589150430|FG000|Overall Study|Physician Decision|1|||
163121008|NCT01999218|589150431|FG001|Overall Study|Physician Decision|4|||
163121009|NCT01999218|589150432|FG002|Overall Study|Physician Decision|6|||
163121010|NCT01999218|589150430|FG000|Overall Study|Protocol Violation|4|||
163121011|NCT01999218|589150431|FG001|Overall Study|Protocol Violation|5|||
163121012|NCT01999218|589150432|FG002|Overall Study|Protocol Violation|4|||
163121013|NCT01999218|589150430|FG000|Overall Study|Screen failure|0|||
163121014|NCT01999218|589150431|FG001|Overall Study|Screen failure|1|||
163121015|NCT01999218|589150432|FG002|Overall Study|Screen failure|0|||
163121016|NCT01999218|589150430|FG000|Overall Study|Study Terminated By Sponsor|7|||
163121017|NCT01999218|589150431|FG001|Overall Study|Study Terminated By Sponsor|5|||
163121018|NCT01999218|589150432|FG002|Overall Study|Study Terminated By Sponsor|12|||
163121019|NCT01999218|589150430|FG000|Overall Study|Participant moves|2|||
163121020|NCT01999218|589150431|FG001|Overall Study|Participant moves|5|||
163121021|NCT01999218|589150432|FG002|Overall Study|Participant moves|3|||
163121022|NCT01999218|589150430|FG000|Overall Study|Withdrawal by Subject|28|||
162654938|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
162654939|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
162654940|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
162654941|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
162654942|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
162654943|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
162654944|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
162654945|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Other|3|||
162654946|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Other|0|||
162654947|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Other|2|||
163121023|NCT01999218|589150431|FG001|Overall Study|Withdrawal by Subject|29|||
163121024|NCT01999218|589150432|FG002|Overall Study|Withdrawal by Subject|34|||
163121025|NCT01999218|589150430|FG000|Overall Study|Creatinine/eGFR|0|||
163121026|NCT01999218|589150431|FG001|Overall Study|Creatinine/eGFR|0|||
163121027|NCT01999218|589150432|FG002|Overall Study|Creatinine/eGFR|1|||
163121028|NCT01999218|589150430|FG000|Overall Study|Death|7|||
163121029|NCT01999218|589150431|FG001|Overall Study|Death|1|||
163121030|NCT01999218|589150432|FG002|Overall Study|Death|2|||
163121031|NCT01999218|589150430|FG000|Overall Study|Excluded Medication|1|||
163121032|NCT01999218|589150431|FG001|Overall Study|Excluded Medication|1|||
163121033|NCT01999218|589150432|FG002|Overall Study|Excluded Medication|2|||
163121034|NCT01999218|589150430|FG000|Overall Study|Adverse Event|9|||
163121035|NCT01999218|589150431|FG001|Overall Study|Adverse Event|7|||
163121036|NCT01999218|589150432|FG002|Overall Study|Adverse Event|7|||
163121037|NCT01999218|589150430|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
163121038|NCT01999218|589150431|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
162654948|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Other|2|||
162654949|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Other|7|||
162654950|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
163121039|NCT01999218|589150432|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
163121040|NCT01073930|589152476|FG000|Overall Study|Withdrawal by Subject|3|||
163121041|NCT01073930|589152477|FG001|Overall Study|Withdrawal by Subject|2|||
163121042|NCT01073930|589152476|FG000|Overall Study|Lost to Follow-up|0|||
163121043|NCT01073930|589152477|FG001|Overall Study|Lost to Follow-up|1|||
163121044|NCT01073930|589152476|FG000|Overall Study|Adverse Event|0|||
163121045|NCT01073930|589152477|FG001|Overall Study|Adverse Event|1|||
163121046|NCT01073930|589152476|FG000|Overall Study|Noncompliance with study drug|0|||
163121047|NCT01073930|589152477|FG001|Overall Study|Noncompliance with study drug|1|||
163121048|NCT01073930|589152476|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
163121049|NCT01073930|589152477|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
163121050|NCT00541346|589152478|FG000|Follow-up|Adverse Event|1|||
163121051|NCT02008773|589152479|FG000|Overall Study|Adverse Event|3|||
163121052|NCT02008773|589152480|FG001|Overall Study|Adverse Event|3|||
163121053|NCT02008773|589152481|FG002|Overall Study|Adverse Event|1|||
163121054|NCT02008773|589152482|FG003|Overall Study|Adverse Event|2|||
163121055|NCT02008773|589152479|FG000|Overall Study|Medication Non-compliance|2|||
163121056|NCT02008773|589152480|FG001|Overall Study|Medication Non-compliance|1|||
163121057|NCT02008773|589152481|FG002|Overall Study|Medication Non-compliance|3|||
163121058|NCT02008773|589152482|FG003|Overall Study|Medication Non-compliance|2|||
163121059|NCT02008773|589152479|FG000|Overall Study|Withdrawal by Subject|8|||
163121060|NCT02008773|589152480|FG001|Overall Study|Withdrawal by Subject|4|||
163121061|NCT02008773|589152481|FG002|Overall Study|Withdrawal by Subject|7|||
163121062|NCT02008773|589152482|FG003|Overall Study|Withdrawal by Subject|6|||
163121063|NCT02008773|589152479|FG000|Overall Study|Lost to Follow-up|0|||
163121064|NCT02008773|589152480|FG001|Overall Study|Lost to Follow-up|1|||
163121065|NCT02008773|589152481|FG002|Overall Study|Lost to Follow-up|3|||
163121066|NCT02008773|589152482|FG003|Overall Study|Lost to Follow-up|2|||
163121067|NCT04435600|589152485|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121068|NCT04435600|589152486|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121069|NCT04435600|589152487|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
163121070|NCT04435600|589152488|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121071|NCT04435600|589152489|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121072|NCT04435600|589152490|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121073|NCT04435600|589152491|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121074|NCT04435600|589152492|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121075|NCT04435600|589152493|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121076|NCT04435600|589152494|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
163121077|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121078|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121079|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121080|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121081|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121082|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121083|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121084|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121085|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
163121086|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
163121087|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121088|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121089|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121090|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121091|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121092|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121093|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121094|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121095|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
163121096|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
163121097|NCT04435600|589152485|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121098|NCT04435600|589152486|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121099|NCT04435600|589152487|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121100|NCT04435600|589152488|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121101|NCT04435600|589152489|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121102|NCT04435600|589152490|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121103|NCT04435600|589152491|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121104|NCT04435600|589152492|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121105|NCT04435600|589152493|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
163121106|NCT04435600|589152494|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
163121107|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
163121108|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
163121109|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
163121110|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
163121111|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
163121112|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
163121113|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
163121114|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
163121115|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
163121116|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121117|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121118|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
163121119|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
163121120|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
163121121|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
163121122|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
163121123|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
163121124|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121125|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121126|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
163121127|NCT05149313|589152500|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
163121128|NCT05149313|589152501|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
163121129|NCT05149313|589152502|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
163121130|NCT05149313|589152503|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
163121131|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
162654951|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654952|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654953|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
163121132|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
163121133|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
163121134|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
163121135|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163121136|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163121137|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
163121138|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
163121139|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163121140|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163121141|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
163121142|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
163121143|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121144|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121145|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
163121146|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163121147|NCT05149313|589152500|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121148|NCT05149313|589152501|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121149|NCT05149313|589152502|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
163121150|NCT05149313|589152503|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
163121151|NCT03826342|589152513|FG000|Overall Study|Withdrawal by Subject|8|||
163121152|NCT03826342|589152514|FG001|Overall Study|Withdrawal by Subject|1|||
163121153|NCT03826342|589152513|FG000|Overall Study|Lost to Follow-up|7|||
163121154|NCT03826342|589152514|FG001|Overall Study|Lost to Follow-up|7|||
163121155|NCT03826342|589152513|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
163121156|NCT03826342|589152514|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
163121157|NCT02212678|589152517|FG000|Overall Study|Adverse Event|1|||
163121158|NCT04030962|589152519|FG000|Stage 2|Adverse Event|0|||
163121159|NCT04030962|589152520|FG001|Stage 2|Adverse Event|0|||
163121160|NCT04030962|589152521|FG002|Stage 2|Adverse Event|0|||
163121161|NCT04030962|589152522|FG003|Stage 2|Adverse Event|0|||
163121162|NCT04030962|589152523|FG004|Stage 2|Adverse Event|0|||
163121163|NCT04030962|589152524|FG005|Stage 2|Adverse Event|0|||
163121164|NCT04030962|589152525|FG006|Stage 2|Adverse Event|0|||
163121165|NCT04030962|589152526|FG007|Stage 2|Adverse Event|0|||
163121166|NCT04030962|589152527|FG008|Stage 2|Adverse Event|1|||
163121167|NCT04030962|589152528|FG009|Stage 2|Adverse Event|0|||
163121168|NCT04030962|589152529|FG010|Stage 2|Adverse Event|1|||
163121169|NCT04030962|589152530|FG011|Stage 2|Adverse Event|1|||
163121170|NCT04030962|589152531|FG012|Stage 2|Adverse Event|1|||
163121171|NCT04030962|589152519|FG000|Stage 2|Withdrawal by Subject|0|||
163121172|NCT04030962|589152520|FG001|Stage 2|Withdrawal by Subject|0|||
163121173|NCT04030962|589152521|FG002|Stage 2|Withdrawal by Subject|0|||
163121174|NCT04030962|589152522|FG003|Stage 2|Withdrawal by Subject|0|||
163121175|NCT04030962|589152523|FG004|Stage 2|Withdrawal by Subject|0|||
163121176|NCT04030962|589152524|FG005|Stage 2|Withdrawal by Subject|0|||
163121177|NCT04030962|589152525|FG006|Stage 2|Withdrawal by Subject|0|||
163121178|NCT04030962|589152526|FG007|Stage 2|Withdrawal by Subject|0|||
163121179|NCT04030962|589152527|FG008|Stage 2|Withdrawal by Subject|1|||
163121180|NCT04030962|589152528|FG009|Stage 2|Withdrawal by Subject|0|||
163121181|NCT04030962|589152529|FG010|Stage 2|Withdrawal by Subject|0|||
163121182|NCT04030962|589152530|FG011|Stage 2|Withdrawal by Subject|2|||
163121183|NCT04030962|589152531|FG012|Stage 2|Withdrawal by Subject|1|||
163121184|NCT04030962|589152519|FG000|Stage 2|Lost to Follow-up|0|||
163121185|NCT04030962|589152520|FG001|Stage 2|Lost to Follow-up|0|||
163121186|NCT04030962|589152521|FG002|Stage 2|Lost to Follow-up|0|||
163121187|NCT04030962|589152522|FG003|Stage 2|Lost to Follow-up|0|||
163121188|NCT04030962|589152523|FG004|Stage 2|Lost to Follow-up|0|||
163121189|NCT04030962|589152524|FG005|Stage 2|Lost to Follow-up|0|||
163121190|NCT04030962|589152525|FG006|Stage 2|Lost to Follow-up|0|||
163121191|NCT04030962|589152526|FG007|Stage 2|Lost to Follow-up|0|||
163121192|NCT04030962|589152527|FG008|Stage 2|Lost to Follow-up|1|||
163121193|NCT04030962|589152528|FG009|Stage 2|Lost to Follow-up|0|||
163121194|NCT04030962|589152529|FG010|Stage 2|Lost to Follow-up|0|||
163121195|NCT04030962|589152530|FG011|Stage 2|Lost to Follow-up|0|||
163121196|NCT04030962|589152531|FG012|Stage 2|Lost to Follow-up|0|||
163121197|NCT04030962|589152519|FG000|Stage 2|Technical Problems|0|||
163121198|NCT04030962|589152520|FG001|Stage 2|Technical Problems|0|||
163121199|NCT04030962|589152521|FG002|Stage 2|Technical Problems|0|||
163121200|NCT04030962|589152522|FG003|Stage 2|Technical Problems|0|||
163121201|NCT04030962|589152523|FG004|Stage 2|Technical Problems|0|||
163121202|NCT04030962|589152524|FG005|Stage 2|Technical Problems|0|||
163121203|NCT04030962|589152525|FG006|Stage 2|Technical Problems|0|||
163121204|NCT04030962|589152526|FG007|Stage 2|Technical Problems|0|||
163121205|NCT04030962|589152527|FG008|Stage 2|Technical Problems|0|||
163121206|NCT04030962|589152528|FG009|Stage 2|Technical Problems|0|||
163121207|NCT04030962|589152529|FG010|Stage 2|Technical Problems|0|||
163121208|NCT04030962|589152530|FG011|Stage 2|Technical Problems|1|||
163121209|NCT04030962|589152531|FG012|Stage 2|Technical Problems|0|||
163121210|NCT05288166|589152534|FG000|Overall Study|Adverse Event|1|||
163121211|NCT05288166|589152535|FG001|Overall Study|Adverse Event|0|||
163121212|NCT05288166|589152534|FG000|Overall Study|Lost to Follow-up|2|||
163121213|NCT05288166|589152535|FG001|Overall Study|Lost to Follow-up|0|||
163121214|NCT05288166|589152534|FG000|Overall Study|Physician Decision|0|||
163121215|NCT05288166|589152535|FG001|Overall Study|Physician Decision|2|||
163121216|NCT05288166|589152534|FG000|Overall Study|Screen Failure|1|||
163121217|NCT05288166|589152535|FG001|Overall Study|Screen Failure|1|||
163121218|NCT05288166|589152534|FG000|Overall Study|Withdrawal by Subject|4|||
163121219|NCT05288166|589152535|FG001|Overall Study|Withdrawal by Subject|2|||
163121220|NCT05288166|589152534|FG000|Overall Study|On Study Treatment|408|||
163121221|NCT05288166|589152535|FG001|Overall Study|On Study Treatment|418|||
163121222|NCT01114360|589152536|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
163121223|NCT01114360|589152537|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
163121224|NCT03007745|589152538|FG000|Overall Study|Sleep test negative for OSA|53|||
163121225|NCT03007745|589152539|FG001|Overall Study|Sleep test negative for OSA|49|||
163121226|NCT03007745|589152538|FG000|Overall Study|Physician Decision|6|||
163121227|NCT03007745|589152539|FG001|Overall Study|Physician Decision|9|||
163121228|NCT03007745|589152538|FG000|Overall Study|Withdrawal by Subject|38|||
163121229|NCT03007745|589152539|FG001|Overall Study|Withdrawal by Subject|16|||
163121230|NCT03007745|589152538|FG000|Overall Study|Lost to Follow-up|19|||
163121231|NCT03007745|589152539|FG001|Overall Study|Lost to Follow-up|25|||
163121232|NCT03007745|589152538|FG000|Overall Study|Unable to login to website|17|||
163121233|NCT03007745|589152539|FG001|Overall Study|Unable to login to website|4|||
163121234|NCT02981524|589152542|FG000|Overall Study|Progressive Disease|14|||
163121235|NCT02981524|589152542|FG000|Overall Study|Death (unrelated)|1|||
163121236|NCT02981524|589152542|FG000|Overall Study|Treatment Related Toxicity|1|||
163121237|NCT02981524|589152542|FG000|Overall Study|Withdrawal by Subject|1|||
163121238|NCT00431951|589152544|FG000|Overall Study|Inability to follow study procedures|1|||
163121239|NCT00431951|589152545|FG001|Overall Study|Inability to follow study procedures|0|||
163121240|NCT00431951|589152546|FG002|Overall Study|Inability to follow study procedures|1|||
163121241|NCT00431951|589152547|FG003|Overall Study|Inability to follow study procedures|2|||
163121242|NCT00431951|589152544|FG000|Overall Study|Lost to Follow-up|0|||
163121243|NCT00431951|589152545|FG001|Overall Study|Lost to Follow-up|1|||
163121244|NCT00431951|589152546|FG002|Overall Study|Lost to Follow-up|0|||
163121245|NCT00431951|589152547|FG003|Overall Study|Lost to Follow-up|0|||
163121246|NCT00431951|589152544|FG000|Overall Study|Withdrawal by Subject|0|||
163121247|NCT00431951|589152545|FG001|Overall Study|Withdrawal by Subject|1|||
163121248|NCT00431951|589152546|FG002|Overall Study|Withdrawal by Subject|0|||
163121249|NCT00431951|589152547|FG003|Overall Study|Withdrawal by Subject|0|||
163121250|NCT00431951|589152544|FG000|Overall Study|Adverse Event|0|||
163121251|NCT00431951|589152545|FG001|Overall Study|Adverse Event|0|||
163121252|NCT00431951|589152546|FG002|Overall Study|Adverse Event|1|||
163121253|NCT00431951|589152547|FG003|Overall Study|Adverse Event|0|||
163121254|NCT02677844|589152548|FG000|Period 3|Withdrawal by Subject|0|||
163121255|NCT02677844|589152549|FG001|Period 3|Withdrawal by Subject|0|||
163121256|NCT02677844|589152550|FG002|Period 3|Withdrawal by Subject|0|||
163121257|NCT02677844|589152551|FG003|Period 3|Withdrawal by Subject|1|||
163121258|NCT02677844|589152552|FG004|Period 3|Withdrawal by Subject|0|||
163121259|NCT02677844|589152553|FG005|Period 3|Withdrawal by Subject|0|||
163121260|NCT02677844|589152554|FG006|Period 3|Withdrawal by Subject|0|||
163121261|NCT00765882|589152555|FG000|Overall Study|Adverse Event|10|||
163121262|NCT00765882|589152556|FG001|Overall Study|Adverse Event|21|||
163121263|NCT00765882|589152557|FG002|Overall Study|Adverse Event|20|||
163121264|NCT00765882|589152555|FG000|Overall Study|Lack of Efficacy|4|||
163121265|NCT00765882|589152556|FG001|Overall Study|Lack of Efficacy|0|||
163121266|NCT00765882|589152557|FG002|Overall Study|Lack of Efficacy|1|||
163121267|NCT00765882|589152555|FG000|Overall Study|Protocol Violation|4|||
163121268|NCT00765882|589152556|FG001|Overall Study|Protocol Violation|3|||
163121269|NCT00765882|589152557|FG002|Overall Study|Protocol Violation|1|||
163121270|NCT00765882|589152555|FG000|Overall Study|Withdrawal by Subject|2|||
163121271|NCT00765882|589152556|FG001|Overall Study|Withdrawal by Subject|6|||
163121272|NCT00765882|589152557|FG002|Overall Study|Withdrawal by Subject|6|||
163121273|NCT00765882|589152555|FG000|Overall Study|Lost to Follow-up|1|||
163121274|NCT00765882|589152556|FG001|Overall Study|Lost to Follow-up|9|||
163121275|NCT00765882|589152557|FG002|Overall Study|Lost to Follow-up|6|||
163121276|NCT00765882|589152555|FG000|Overall Study|Other Reason|3|||
163121277|NCT00765882|589152556|FG001|Overall Study|Other Reason|1|||
163121278|NCT00765882|589152557|FG002|Overall Study|Other Reason|2|||
163121279|NCT02231762|589152560|FG000|Combination Phase|Adverse Event|10|||
163121280|NCT02231762|589152561|FG001|Combination Phase|Adverse Event|0|||
163121281|NCT02231762|589152562|FG002|Combination Phase|Adverse Event|0|||
163121282|NCT02231762|589152563|FG003|Combination Phase|Adverse Event|0|||
163121283|NCT02231762|589152560|FG000|Combination Phase|Withdrawal by Subject|2|||
163121284|NCT02231762|589152561|FG001|Combination Phase|Withdrawal by Subject|0|||
163121285|NCT02231762|589152562|FG002|Combination Phase|Withdrawal by Subject|0|||
163121286|NCT02231762|589152563|FG003|Combination Phase|Withdrawal by Subject|0|||
162654954|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654955|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654956|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163121287|NCT02231762|589152560|FG000|Combination Phase|Disease Progression|6|||
163121288|NCT02231762|589152561|FG001|Combination Phase|Disease Progression|0|||
163121289|NCT02231762|589152562|FG002|Combination Phase|Disease Progression|0|||
163121290|NCT02231762|589152563|FG003|Combination Phase|Disease Progression|0|||
163121291|NCT02231762|589152560|FG000|Combination Phase|Did not meet inclusion criteria|1|||
163121292|NCT02231762|589152561|FG001|Combination Phase|Did not meet inclusion criteria|0|||
163121293|NCT02231762|589152562|FG002|Combination Phase|Did not meet inclusion criteria|0|||
163121294|NCT02231762|589152563|FG003|Combination Phase|Did not meet inclusion criteria|0|||
163121295|NCT02231762|589152560|FG000|Combination Phase|Protocol Violation|1|||
163121296|NCT02231762|589152561|FG001|Combination Phase|Protocol Violation|0|||
163121297|NCT02231762|589152562|FG002|Combination Phase|Protocol Violation|0|||
163121298|NCT02231762|589152563|FG003|Combination Phase|Protocol Violation|0|||
163121299|NCT02231762|589152560|FG000|Maintenance Phase|Disease progression|0|||
163121300|NCT02231762|589152561|FG001|Maintenance Phase|Disease progression|3|||
163121301|NCT02231762|589152562|FG002|Maintenance Phase|Disease progression|4|||
163121302|NCT02231762|589152563|FG003|Maintenance Phase|Disease progression|3|||
163121303|NCT02231762|589152560|FG000|Maintenance Phase|Adverse Event|0|||
163121304|NCT02231762|589152561|FG001|Maintenance Phase|Adverse Event|0|||
163121305|NCT02231762|589152562|FG002|Maintenance Phase|Adverse Event|1|||
163121306|NCT02231762|589152563|FG003|Maintenance Phase|Adverse Event|2|||
163121307|NCT03455829|589152564|FG000|Overall Study|Death|2|||
163121308|NCT03455829|589152565|FG001|Overall Study|Death|3|||
163121309|NCT03455829|589152566|FG002|Overall Study|Death|2|||
163121310|NCT03455829|589152567|FG003|Overall Study|Death|4|||
163121311|NCT03455829|589152568|FG004|Overall Study|Death|2|||
163121312|NCT03455829|589152564|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
163121313|NCT03455829|589152565|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
163121314|NCT03455829|589152566|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
163121315|NCT03455829|589152567|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
163121316|NCT03455829|589152568|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
163121317|NCT03455829|589152564|FG000|Overall Study|Disease progression|0|||
163121318|NCT03455829|589152565|FG001|Overall Study|Disease progression|0|||
163121319|NCT03455829|589152566|FG002|Overall Study|Disease progression|0|||
163121320|NCT03455829|589152567|FG003|Overall Study|Disease progression|1|||
163121321|NCT03455829|589152568|FG004|Overall Study|Disease progression|1|||
163121322|NCT00168103|589152573|FG000|Overall Study|Withdrawal by Subject|1|||
163121323|NCT00168103|589152574|FG001|Overall Study|Withdrawal by Subject|2|||
163121324|NCT00168103|589152575|FG002|Overall Study|Withdrawal by Subject|1|||
163121325|NCT00168103|589152576|FG003|Overall Study|Withdrawal by Subject|0|||
163121326|NCT00168103|589152573|FG000|Overall Study|Lost to Follow-up|1|||
163121327|NCT00168103|589152574|FG001|Overall Study|Lost to Follow-up|3|||
163121328|NCT00168103|589152575|FG002|Overall Study|Lost to Follow-up|0|||
163121329|NCT00168103|589152576|FG003|Overall Study|Lost to Follow-up|0|||
163121330|NCT03532932|589152579|FG000|Overall Study|Protocol Deviation|33|||
163121331|NCT03532932|589152580|FG001|Overall Study|Protocol Deviation|31|||
163121332|NCT03532932|589152579|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
163121333|NCT03532932|589152580|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
163121334|NCT03532932|589152579|FG000|Overall Study|Withdrawal by Subject|2|||
163121335|NCT03532932|589152580|FG001|Overall Study|Withdrawal by Subject|0|||
163121336|NCT03532932|589152579|FG000|Overall Study|Lost to Follow-up|15|||
163121337|NCT03532932|589152580|FG001|Overall Study|Lost to Follow-up|9|||
163121338|NCT03532932|589152579|FG000|Overall Study|Adverse Event|4|||
163121339|NCT03532932|589152580|FG001|Overall Study|Adverse Event|3|||
163121340|NCT03532932|589152579|FG000|Overall Study|Death|0|||
163121341|NCT03532932|589152580|FG001|Overall Study|Death|2|||
163121342|NCT03532932|589152579|FG000|Overall Study|Other|11|||
163121343|NCT03532932|589152580|FG001|Overall Study|Other|16|||
163121344|NCT02699450|589152582|FG000|Overall Study|Death|2|||
163121345|NCT02699450|589152583|FG001|Overall Study|Death|1|||
163121346|NCT02699450|589152584|FG002|Overall Study|Death|2|||
163121347|NCT02699450|589152582|FG000|Overall Study|Met Criteria for Study Exit|0|||
163121348|NCT02699450|589152583|FG001|Overall Study|Met Criteria for Study Exit|0|||
163121349|NCT02699450|589152584|FG002|Overall Study|Met Criteria for Study Exit|1|||
163121350|NCT02699450|589152582|FG000|Overall Study|Protocol Violation|4|||
163121351|NCT02699450|589152583|FG001|Overall Study|Protocol Violation|3|||
163121352|NCT02699450|589152584|FG002|Overall Study|Protocol Violation|5|||
162654957|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
163121353|NCT02699450|589152582|FG000|Overall Study|Lost to Follow-up|3|||
163121354|NCT02699450|589152583|FG001|Overall Study|Lost to Follow-up|0|||
163121355|NCT02699450|589152584|FG002|Overall Study|Lost to Follow-up|5|||
163121356|NCT02699450|589152582|FG000|Overall Study|Physician Decision|2|||
163121357|NCT02699450|589152583|FG001|Overall Study|Physician Decision|0|||
162654958|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654959|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
163121358|NCT02699450|589152584|FG002|Overall Study|Physician Decision|0|||
163121359|NCT02699450|589152582|FG000|Overall Study|Withdrawal by Subject|3|||
163121360|NCT02699450|589152583|FG001|Overall Study|Withdrawal by Subject|1|||
163121361|NCT02699450|589152584|FG002|Overall Study|Withdrawal by Subject|2|||
163121362|NCT02699450|589152582|FG000|Overall Study|Adverse Event|1|||
163121363|NCT02699450|589152583|FG001|Overall Study|Adverse Event|0|||
163121364|NCT02699450|589152584|FG002|Overall Study|Adverse Event|0|||
163121365|NCT00810901|589152585|FG000|Overall Study|Lost to Follow-up|88|||
163121366|NCT00810901|589152586|FG001|Overall Study|Lost to Follow-up|58|||
163121367|NCT03689712|589152587|FG000|Overall Study|Adverse Event|1|||
163121368|NCT03689712|589152588|FG001|Overall Study|Adverse Event|0|||
163121369|NCT03689712|589152587|FG000|Overall Study|Death|20|||
163121370|NCT03689712|589152588|FG001|Overall Study|Death|10|||
163121371|NCT03689712|589152587|FG000|Overall Study|Lost to Follow-up|6|||
163121372|NCT03689712|589152588|FG001|Overall Study|Lost to Follow-up|6|||
163121373|NCT03689712|589152587|FG000|Overall Study|Other|1|||
163121374|NCT03689712|589152588|FG001|Overall Study|Other|0|||
163121375|NCT03689712|589152587|FG000|Overall Study|Patient Non-Compliance|0|||
163121376|NCT03689712|589152588|FG001|Overall Study|Patient Non-Compliance|1|||
163121377|NCT03689712|589152587|FG000|Overall Study|Withdrawal by Subject|20|||
163121378|NCT03689712|589152588|FG001|Overall Study|Withdrawal by Subject|4|||
163121379|NCT03689712|589152587|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
163121380|NCT03689712|589152588|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
163121381|NCT03689712|589152587|FG000|Overall Study|Randomized but not Treated|13|||
163121382|NCT03689712|589152588|FG001|Overall Study|Randomized but not Treated|7|||
163121383|NCT03689712|589152587|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
163121384|NCT03689712|589152588|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
163121385|NCT00689793|589152589|FG000|Overall Study|Lost to Follow-up|4|||
163121386|NCT00689793|589152590|FG001|Overall Study|Lost to Follow-up|5|||
163121387|NCT01133275|589152600|FG000|Overall Study|Withdrawal by Subject|1|||
163121388|NCT01133275|589152600|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
163121389|NCT02266875|589152605|FG000|Overall Study|Withdrawal by Subject|9|||
163121390|NCT02266875|589152606|FG001|Overall Study|Withdrawal by Subject|0|||
163121391|NCT02266875|589152605|FG000|Overall Study|Lost to Follow-up|2|||
163121392|NCT02266875|589152606|FG001|Overall Study|Lost to Follow-up|0|||
163121393|NCT02956850|589152607|FG000|Overall Study|Withdrawal by Subject|0|||
163121394|NCT02956850|589152608|FG001|Overall Study|Withdrawal by Subject|0|||
163121395|NCT02956850|589152609|FG002|Overall Study|Withdrawal by Subject|0|||
163121396|NCT02956850|589152610|FG003|Overall Study|Withdrawal by Subject|0|||
163121397|NCT02956850|589152611|FG004|Overall Study|Withdrawal by Subject|0|||
163121398|NCT02956850|589152612|FG005|Overall Study|Withdrawal by Subject|0|||
163121399|NCT02956850|589152613|FG006|Overall Study|Withdrawal by Subject|0|||
163121400|NCT02956850|589152614|FG007|Overall Study|Withdrawal by Subject|0|||
163121401|NCT02956850|589152615|FG008|Overall Study|Withdrawal by Subject|0|||
163121402|NCT02956850|589152616|FG009|Overall Study|Withdrawal by Subject|0|||
163121403|NCT02956850|589152617|FG010|Overall Study|Withdrawal by Subject|0|||
163121404|NCT02956850|589152618|FG011|Overall Study|Withdrawal by Subject|0|||
163121405|NCT02956850|589152619|FG012|Overall Study|Withdrawal by Subject|0|||
163121406|NCT02956850|589152620|FG013|Overall Study|Withdrawal by Subject|0|||
163121407|NCT02956850|589152621|FG014|Overall Study|Withdrawal by Subject|0|||
163121408|NCT02956850|589152622|FG015|Overall Study|Withdrawal by Subject|0|||
163121409|NCT02956850|589152623|FG016|Overall Study|Withdrawal by Subject|0|||
163121410|NCT02956850|589152624|FG017|Overall Study|Withdrawal by Subject|1|||
163121411|NCT01920152|589152625|FG000|Overall Study|Withdrawal by Subject|1|||
163121412|NCT01920152|589152626|FG001|Overall Study|Withdrawal by Subject|2|||
163121413|NCT00708734|589152627|FG000|Overall Study|scheduling conflict|2|||
163121414|NCT00708734|589152627|FG000|Overall Study|moved|1|||
163121415|NCT00708734|589152627|FG000|Overall Study|leg injury|1|||
163121416|NCT00708734|589152627|FG000|Overall Study|knee replacement|1|||
162654960|NCT00213148|587451728|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
162654961|NCT00213148|587451729|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
162654962|NCT00213148|587451730|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
162654963|NCT00213148|587451731|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
162654964|NCT00213148|587451732|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
163121417|NCT00708734|589152627|FG000|Overall Study|vertigo|1|||
163121418|NCT00708734|589152627|FG000|Overall Study|leg fracture|1|||
163121419|NCT03412604|589152629|FG000|Overall Study|Withdrawal by Subject|1|||
163121420|NCT02634606|589152630|FG000|Overall Study|unable to obtain the drug at start|13|||
163121421|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Adverse Event|0|||
163121422|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Adverse Event|1|||
163121423|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Adverse Event|0|||
163121424|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Adverse Event|0|||
163121425|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Adverse Event|0|||
163121426|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Adverse Event|0|||
163121427|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
162654965|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
162654966|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
163121428|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121429|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121430|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121431|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121432|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
163121433|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
163121434|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
163121435|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
163121436|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
163121437|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
163121438|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
163121439|NCT00993499|589152640|FG000|Run-in Period (8 Days)|Progressive disease|0|||
163121440|NCT00993499|589152641|FG001|Run-in Period (8 Days)|Progressive disease|1|||
163121441|NCT00993499|589152642|FG002|Run-in Period (8 Days)|Progressive disease|1|||
163121442|NCT00993499|589152643|FG003|Run-in Period (8 Days)|Progressive disease|0|||
163121443|NCT00993499|589152644|FG004|Run-in Period (8 Days)|Progressive disease|0|||
163121444|NCT00993499|589152645|FG005|Run-in Period (8 Days)|Progressive disease|0|||
163121445|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
163121446|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
163121447|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121448|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121449|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121450|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
163121451|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
163121452|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
163121453|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121454|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121455|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121456|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
163121457|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121458|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121459|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
163121460|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
163121461|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121462|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
163121463|NCT00993499|589152640|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121464|NCT00993499|589152641|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121465|NCT00993499|589152642|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
163121466|NCT00993499|589152643|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121467|NCT00993499|589152644|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121468|NCT00993499|589152645|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
163121469|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121470|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
163121471|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121472|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121473|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121474|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
163121475|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
163121476|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
163121477|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
163121478|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
162654967|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
162654968|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
162654969|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
163121479|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
163121480|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
163121481|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|DLT|1|||
163121482|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|DLT|0|||
162654970|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
162654971|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
162654972|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
163121483|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|DLT|2|||
163121484|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|DLT|1|||
163121485|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|DLT|0|||
162654973|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
162654974|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
162654975|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Other|2|||
162654976|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Other|1|||
162654977|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Other|2|||
162654978|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Other|8|||
162654979|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Other|7|||
162654980|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654981|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
162654982|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654983|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654984|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162654985|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
162654986|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654987|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654988|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654989|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162654990|NCT00213148|587451728|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
162654991|NCT00213148|587451729|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
162654992|NCT00213148|587451730|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
162654993|NCT00213148|587451731|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
162654994|NCT00213148|587451732|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
162654995|NCT00213148|587451728|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162654996|NCT00213148|587451729|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
162654997|NCT00213148|587451730|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162654998|NCT00213148|587451731|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162654999|NCT00213148|587451732|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
162655000|NCT00213148|587451728|FG000|Cycle 3 (1 Month)|Other|0|||
162655001|NCT00213148|587451729|FG001|Cycle 3 (1 Month)|Other|0|||
162655002|NCT00213148|587451730|FG002|Cycle 3 (1 Month)|Other|1|||
162655003|NCT00213148|587451731|FG003|Cycle 3 (1 Month)|Other|1|||
162655004|NCT00213148|587451732|FG004|Cycle 3 (1 Month)|Other|0|||
162655005|NCT02321462|587451735|FG000|Overall Study|Withdrawal by Subject|5|||
162655006|NCT02321462|587451736|FG001|Overall Study|Withdrawal by Subject|2|||
162655007|NCT02321462|587451735|FG000|Overall Study|Subject withdrawn before any treatment|1|||
162655008|NCT02321462|587451736|FG001|Overall Study|Subject withdrawn before any treatment|1|||
162655009|NCT03044197|587451740|FG000|Overall Study|Withdrawal by Subject|3|||
162655010|NCT03044197|587451741|FG001|Overall Study|Withdrawal by Subject|1|||
162655011|NCT01574352|587451743|FG000|Overall Study|Withdrawal by Subject|6|||
162655012|NCT01574352|587451744|FG001|Overall Study|Withdrawal by Subject|13|||
162655013|NCT01574352|587451743|FG000|Overall Study|Injury in non-camp related sport|1|||
162655014|NCT01574352|587451744|FG001|Overall Study|Injury in non-camp related sport|0|||
162655015|NCT00660348|587451745|FG000|Overall Study|Withdrawal by Subject|1|||
162655016|NCT00660348|587451746|FG001|Overall Study|Withdrawal by Subject|0|||
162655017|NCT02741115|587451747|FG000|Overall Study|Adverse Event|1|||
162655018|NCT02741115|587451748|FG001|Overall Study|Adverse Event|0|||
162655019|NCT02741115|587451747|FG000|Overall Study|Lost to Follow-up|7|||
162655020|NCT02741115|587451748|FG001|Overall Study|Lost to Follow-up|4|||
162655021|NCT02741115|587451747|FG000|Overall Study|Withdrawal by Subject|4|||
162655022|NCT02741115|587451748|FG001|Overall Study|Withdrawal by Subject|2|||
162655023|NCT03945981|587451749|FG000|Overall Study|Lost to Follow-up|12|||
162655024|NCT03945981|587451749|FG000|Overall Study|Physician Decision|4|||
162655025|NCT03945981|587451749|FG000|Overall Study|Withdrawal by Subject|6|||
162655026|NCT03945981|587451749|FG000|Overall Study|Protocol Violation|1|||
162655027|NCT00256698|587451752|FG000|Overall Study|Withdrawal by Subject|7|||
162655028|NCT00256698|587451753|FG001|Overall Study|Withdrawal by Subject|7|||
162655029|NCT00256698|587451752|FG000|Overall Study|Adverse Event|13|||
162655030|NCT00256698|587451753|FG001|Overall Study|Adverse Event|6|||
162655031|NCT00256698|587451752|FG000|Overall Study|Protocol Violation|6|||
162655032|NCT00256698|587451753|FG001|Overall Study|Protocol Violation|5|||
162655033|NCT00256698|587451752|FG000|Overall Study|Lost to Follow-up|1|||
162655034|NCT00256698|587451753|FG001|Overall Study|Lost to Follow-up|3|||
162655035|NCT00256698|587451752|FG000|Overall Study|disease progression|97|||
162719512|NCT04517864|587680486|FG002|Extension Phase|Withdrawal by Subject|3|||
162719513|NCT04517864|587680484|FG000|Extension Phase|Approved Drug Available for Indication|0|||
162719514|NCT04517864|587680485|FG001|Extension Phase|Approved Drug Available for Indication|0|||
162655036|NCT00256698|587451753|FG001|Overall Study|disease progression|105|||
162655037|NCT00256698|587451752|FG000|Overall Study|still ongoing at data cut-off|41|||
162655038|NCT00256698|587451753|FG001|Overall Study|still ongoing at data cut-off|46|||
162655039|NCT00256698|587451752|FG000|Overall Study|withdrawn due to osteoporosis|1|||
162655040|NCT00256698|587451753|FG001|Overall Study|withdrawn due to osteoporosis|0|||
162655041|NCT00256698|587451752|FG000|Overall Study|Prematurely Discontinued|1|||
162655042|NCT00256698|587451753|FG001|Overall Study|Prematurely Discontinued|0|||
163121486|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|DLT|0|||
163121487|NCT00993499|589152640|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
162655043|NCT03548584|587453426|FG000|Overall Study|Lost to Follow-up|0|||
162655044|NCT03548584|587453427|FG001|Overall Study|Lost to Follow-up|0|||
162655045|NCT03548584|587453428|FG002|Overall Study|Lost to Follow-up|1|||
162655046|NCT03548584|587453426|FG000|Overall Study|Adverse Event|1|||
162655047|NCT03548584|587453427|FG001|Overall Study|Adverse Event|11|||
162655048|NCT03548584|587453428|FG002|Overall Study|Adverse Event|5|||
162655049|NCT03548584|587453426|FG000|Overall Study|Site Terminated by Sponsor|1|||
162655050|NCT03548584|587453427|FG001|Overall Study|Site Terminated by Sponsor|3|||
162655051|NCT03548584|587453428|FG002|Overall Study|Site Terminated by Sponsor|2|||
162655052|NCT03548584|587453426|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
162655053|NCT03548584|587453427|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
162655054|NCT03548584|587453428|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
162655055|NCT03548584|587453426|FG000|Overall Study|Lack of Efficacy|0|||
162655056|NCT03548584|587453427|FG001|Overall Study|Lack of Efficacy|1|||
162655057|NCT03548584|587453428|FG002|Overall Study|Lack of Efficacy|0|||
162655058|NCT03548584|587453426|FG000|Overall Study|Non-compliance with Study Drug|0|||
162655059|NCT03548584|587453427|FG001|Overall Study|Non-compliance with Study Drug|1|||
162655060|NCT03548584|587453428|FG002|Overall Study|Non-compliance with Study Drug|0|||
162655061|NCT03548584|587453426|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
162655062|NCT03548584|587453427|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
162655063|NCT03548584|587453428|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
162655064|NCT04346615|587453429|FG000|Overall Study|Lost to Follow-up|0|||
162655065|NCT04346615|587453430|FG001|Overall Study|Lost to Follow-up|2|||
162655066|NCT04346615|587453429|FG000|Overall Study|Withdrawal by Subject|1|||
162655067|NCT04346615|587453430|FG001|Overall Study|Withdrawal by Subject|0|||
162655068|NCT04346615|587453429|FG000|Overall Study|Death|5|||
162655069|NCT04346615|587453430|FG001|Overall Study|Death|1|||
162655070|NCT04346615|587453429|FG000|Overall Study|Other|0|||
162655071|NCT04346615|587453430|FG001|Overall Study|Other|2|||
162655072|NCT04346615|587453429|FG000|Overall Study|Randomized not treated|1|||
162655073|NCT04346615|587453430|FG001|Overall Study|Randomized not treated|0|||
162655074|NCT02096835|587453436|FG000|Overall Study|Withdrawal by Subject|1|||
162655075|NCT02096835|587453437|FG001|Overall Study|Withdrawal by Subject|0|||
162655076|NCT02096835|587453438|FG002|Overall Study|Withdrawal by Subject|0|||
162655077|NCT02096835|587453436|FG000|Overall Study|converted to open procedures|1|||
162655078|NCT02096835|587453437|FG001|Overall Study|converted to open procedures|0|||
162655079|NCT02096835|587453438|FG002|Overall Study|converted to open procedures|0|||
162655080|NCT02096835|587453436|FG000|Overall Study|Lost to Follow-up|1|||
162655081|NCT02096835|587453437|FG001|Overall Study|Lost to Follow-up|0|||
162655082|NCT02096835|587453438|FG002|Overall Study|Lost to Follow-up|1|||
162655083|NCT01677195|587453439|FG000|Overall Study|Lost to Follow-up|14|||
162655084|NCT01677195|587453440|FG001|Overall Study|Lost to Follow-up|22|||
162655085|NCT01677195|587453441|FG002|Overall Study|Lost to Follow-up|22|||
162655086|NCT01677195|587453439|FG000|Overall Study|Withdrawal by Subject|1|||
162655087|NCT01677195|587453440|FG001|Overall Study|Withdrawal by Subject|0|||
162655088|NCT01677195|587453441|FG002|Overall Study|Withdrawal by Subject|1|||
162655089|NCT01677195|587453439|FG000|Overall Study|Adverse Event|6|||
162655090|NCT01677195|587453440|FG001|Overall Study|Adverse Event|4|||
162655091|NCT01677195|587453441|FG002|Overall Study|Adverse Event|1|||
162655092|NCT01677195|587453439|FG000|Overall Study|Physician Decision|1|||
162655093|NCT01677195|587453440|FG001|Overall Study|Physician Decision|2|||
162655094|NCT01677195|587453441|FG002|Overall Study|Physician Decision|2|||
162655095|NCT01677195|587453439|FG000|Overall Study|Pregnancy|0|||
162655096|NCT01677195|587453440|FG001|Overall Study|Pregnancy|1|||
162655097|NCT01677195|587453441|FG002|Overall Study|Pregnancy|0|||
162655098|NCT01677195|587453439|FG000|Overall Study|Protocol Violation|7|||
162655099|NCT01677195|587453440|FG001|Overall Study|Protocol Violation|3|||
163121488|NCT00993499|589152641|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
163121489|NCT00993499|589152642|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
163121490|NCT00993499|589152643|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
163121491|NCT00993499|589152644|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
163121492|NCT00993499|589152645|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
163121493|NCT01287195|589152646|FG000|Overall Study|Withdrawal by Subject|2|||
163121494|NCT00283868|589152653|FG000|Overall Study|Lost to Follow-up|7|||
163121495|NCT00283868|589152654|FG001|Overall Study|Lost to Follow-up|8|||
163121496|NCT01515475|589152655|FG000|Overall Study|Lost to Follow-up|20|||
162655100|NCT01677195|587453441|FG002|Overall Study|Protocol Violation|4|||
162655101|NCT04368429|587453442|FG000|Overall Study|Adverse Event|1|||
162655102|NCT04368429|587453443|FG001|Overall Study|Adverse Event|0|||
162655103|NCT03633396|587453446|FG000|Overall Study|Withdrawal by Subject|4|||
162655104|NCT03633396|587453447|FG001|Overall Study|Withdrawal by Subject|4|||
162655105|NCT03633396|587453446|FG000|Overall Study|Adverse Event|1|||
162655106|NCT03633396|587453447|FG001|Overall Study|Adverse Event|1|||
162655107|NCT03633396|587453446|FG000|Overall Study|Lack of Efficacy|1|||
162655108|NCT03633396|587453447|FG001|Overall Study|Lack of Efficacy|0|||
162655109|NCT03633396|587453446|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
162655110|NCT03633396|587453447|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
162655111|NCT00023673|587453448|FG000|Overall Study|Ineligible / no protocol treatment|0|||
162655112|NCT00023673|587453449|FG001|Overall Study|Ineligible / no protocol treatment|0|||
162655113|NCT00023673|587453450|FG002|Overall Study|Ineligible / no protocol treatment|0|||
162655114|NCT00023673|587453451|FG003|Overall Study|Ineligible / no protocol treatment|1|||
162655115|NCT00023673|587453448|FG000|Overall Study|Patient withdrew consent|0|||
162655116|NCT00023673|587453449|FG001|Overall Study|Patient withdrew consent|0|||
162655117|NCT00023673|587453450|FG002|Overall Study|Patient withdrew consent|0|||
162655118|NCT00023673|587453451|FG003|Overall Study|Patient withdrew consent|1|||
162655119|NCT00110266|587453452|FG000|Overall Study|Adverse Event|27|||
162655120|NCT00110266|587453452|FG000|Overall Study|Abnormal laboratory value|15|||
162655121|NCT00110266|587453452|FG000|Overall Study|Withdrawal by Subject|16|||
162655122|NCT00110266|587453452|FG000|Overall Study|Death|17|||
162655123|NCT00110266|587453452|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162655124|NCT00110266|587453452|FG000|Overall Study|Participant condition no longer requires study drug|1|||
162655125|NCT00667342|587453457|FG000|Overall Study|Protocol Violation|1|||
162655126|NCT00667342|587453458|FG001|Overall Study|Protocol Violation|0|||
162655127|NCT00667342|587453459|FG002|Overall Study|Protocol Violation|0|||
162655128|NCT00667342|587453457|FG000|Overall Study|Withdrawal by Subject|1|||
162655129|NCT00667342|587453458|FG001|Overall Study|Withdrawal by Subject|0|||
162655130|NCT00667342|587453459|FG002|Overall Study|Withdrawal by Subject|0|||
162655131|NCT00667342|587453457|FG000|Overall Study|Physician Decision|3|||
162655132|NCT00667342|587453458|FG001|Overall Study|Physician Decision|0|||
162655133|NCT00667342|587453459|FG002|Overall Study|Physician Decision|0|||
162655134|NCT00667342|587453457|FG000|Overall Study|Relapse or tumor progression|9|||
162655135|NCT00667342|587453458|FG001|Overall Study|Relapse or tumor progression|0|||
162655136|NCT00667342|587453459|FG002|Overall Study|Relapse or tumor progression|7|||
162655137|NCT00667342|587453457|FG000|Overall Study|Adverse Event|0|||
162655138|NCT00667342|587453458|FG001|Overall Study|Adverse Event|0|||
162655139|NCT00667342|587453459|FG002|Overall Study|Adverse Event|1|||
162655140|NCT00667342|587453457|FG000|Overall Study|Ineligible|0|||
162655141|NCT00667342|587453458|FG001|Overall Study|Ineligible|0|||
162655142|NCT00667342|587453459|FG002|Overall Study|Ineligible|1|||
162655143|NCT01433263|587453460|FG000|Overall Study|Adverse Event|3|||
162655144|NCT01433263|587453461|FG001|Overall Study|Adverse Event|1|||
162655145|NCT01433263|587453460|FG000|Overall Study|Death|5|||
162655146|NCT01433263|587453461|FG001|Overall Study|Death|3|||
162655147|NCT01433263|587453460|FG000|Overall Study|Lost to Follow-up|0|||
162655148|NCT01433263|587453461|FG001|Overall Study|Lost to Follow-up|1|||
162655149|NCT01433263|587453460|FG000|Overall Study|Protocol Deviation|1|||
162655150|NCT01433263|587453461|FG001|Overall Study|Protocol Deviation|0|||
162655151|NCT01433263|587453460|FG000|Overall Study|Withdrawal by Subject|10|||
162655152|NCT01433263|587453461|FG001|Overall Study|Withdrawal by Subject|7|||
162655153|NCT00293384|587453462|FG000|Overall Study|Non-compliance|2|||
162655154|NCT00293384|587453462|FG000|Overall Study|Missed dosage/study drug|1|||
162655155|NCT00293384|587453462|FG000|Overall Study|Ineligible|2|||
162655156|NCT04709237|587453464|FG000|Overall Study|Lost to Follow-up|1|||
162655157|NCT04709237|587453465|FG001|Overall Study|Lost to Follow-up|0|||
162655158|NCT04709237|587453466|FG002|Overall Study|Lost to Follow-up|0|||
162655159|NCT02610192|587453467|FG000|Overall Study|Received other treatment|8|||
162655160|NCT02610192|587453467|FG000|Overall Study|Physician Decision|1|||
162655161|NCT01359592|587453469|FG000|Initial Registration|Adverse Event|1|||
162655162|NCT01359592|587453470|FG001|Initial Registration|Adverse Event|0|||
162655163|NCT01359592|587453471|FG002|Initial Registration|Adverse Event|0|||
162655164|NCT01359592|587453472|FG003|Initial Registration|Adverse Event|0|||
162655165|NCT01359592|587453469|FG000|Initial Registration|Death|1|||
162655166|NCT01359592|587453470|FG001|Initial Registration|Death|0|||
162655167|NCT01359592|587453471|FG002|Initial Registration|Death|0|||
162655168|NCT01359592|587453472|FG003|Initial Registration|Death|0|||
162655169|NCT01359592|587453469|FG000|Initial Registration|Other reason not protocol specified|1|||
162655170|NCT01359592|587453470|FG001|Initial Registration|Other reason not protocol specified|0|||
162655171|NCT01359592|587453471|FG002|Initial Registration|Other reason not protocol specified|0|||
162655172|NCT01359592|587453472|FG003|Initial Registration|Other reason not protocol specified|0|||
162655173|NCT01359592|587453469|FG000|Initial Registration|Ineligible|26|||
162655174|NCT01359592|587453470|FG001|Initial Registration|Ineligible|0|||
162655175|NCT01359592|587453471|FG002|Initial Registration|Ineligible|0|||
162655176|NCT01359592|587453472|FG003|Initial Registration|Ineligible|0|||
162655177|NCT01359592|587453469|FG000|PET-Directed Therapy|Adverse Event|0|||
162655178|NCT01359592|587453470|FG001|PET-Directed Therapy|Adverse Event|0|||
162655179|NCT01359592|587453471|FG002|PET-Directed Therapy|Adverse Event|1|||
162655180|NCT01359592|587453472|FG003|PET-Directed Therapy|Adverse Event|0|||
162719515|NCT04517864|587680486|FG002|Extension Phase|Approved Drug Available for Indication|7|||
162655181|NCT01359592|587453469|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162655182|NCT01359592|587453470|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162655183|NCT01359592|587453471|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
162655184|NCT01359592|587453472|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162655185|NCT01359592|587453469|FG000|PET-Directed Therapy|Ineligible|0|||
162655186|NCT01359592|587453470|FG001|PET-Directed Therapy|Ineligible|0|||
162655187|NCT01359592|587453471|FG002|PET-Directed Therapy|Ineligible|24|||
162655188|NCT01359592|587453472|FG003|PET-Directed Therapy|Ineligible|0|||
162655189|NCT00326612|587453475|FG000|Overall Study|They did not have a seizure requiring tx|129|||
162655190|NCT00326612|587453476|FG001|Overall Study|They did not have a seizure requiring tx|137|||
162655191|NCT00419562|587453477|FG000|Overall Study|Lost to Follow-up|12|||
162655192|NCT00419562|587453478|FG001|Overall Study|Lost to Follow-up|13|||
162655193|NCT00419562|587453477|FG000|Overall Study|Withdrawal by Subject|20|||
162655194|NCT00419562|587453478|FG001|Overall Study|Withdrawal by Subject|18|||
162655195|NCT00419562|587453477|FG000|Overall Study|Participant Institutionalized|1|||
162655196|NCT00419562|587453478|FG001|Overall Study|Participant Institutionalized|0|||
162655197|NCT00355238|587453479|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162655198|NCT00355238|587453480|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162655199|NCT00355238|587453481|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162655200|NCT00355238|587453482|FG003|Overall Study|Adverse event unrelated to study drug|1|||
162655201|NCT00355238|587453479|FG000|Overall Study|Death|1|||
162655202|NCT00355238|587453480|FG001|Overall Study|Death|0|||
162655203|NCT00355238|587453481|FG002|Overall Study|Death|0|||
162655204|NCT00355238|587453482|FG003|Overall Study|Death|0|||
162655205|NCT00355238|587453479|FG000|Overall Study|Disease progression|37|||
162655206|NCT00355238|587453480|FG001|Overall Study|Disease progression|36|||
162655207|NCT00355238|587453481|FG002|Overall Study|Disease progression|16|||
162655208|NCT00355238|587453482|FG003|Overall Study|Disease progression|11|||
162655209|NCT00355238|587453479|FG000|Overall Study|Study drug toxicity|11|||
162655210|NCT00355238|587453480|FG001|Overall Study|Study drug toxicity|7|||
162655211|NCT00355238|587453481|FG002|Overall Study|Study drug toxicity|5|||
162655212|NCT00355238|587453482|FG003|Overall Study|Study drug toxicity|2|||
162655213|NCT00355238|587453479|FG000|Overall Study|Participant withdrew consent|3|||
162655214|NCT00355238|587453480|FG001|Overall Study|Participant withdrew consent|1|||
162655215|NCT00355238|587453481|FG002|Overall Study|Participant withdrew consent|0|||
162655216|NCT00355238|587453482|FG003|Overall Study|Participant withdrew consent|0|||
162655217|NCT00355238|587453479|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162655218|NCT00355238|587453480|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162655219|NCT00355238|587453481|FG002|Overall Study|Participant request to discontinue study treatment|1|||
162655220|NCT00355238|587453482|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162655221|NCT01454934|587453483|FG000|Overall Study|Clinical progression|28|||
162655222|NCT01454934|587453484|FG001|Overall Study|Clinical progression|25|||
162655223|NCT01454934|587453483|FG000|Overall Study|Other|6|||
162655224|NCT01454934|587453484|FG001|Overall Study|Other|17|||
162655225|NCT01454934|587453483|FG000|Overall Study|Adverse Event|28|||
162655226|NCT01454934|587453484|FG001|Overall Study|Adverse Event|24|||
162655227|NCT01454934|587453483|FG000|Overall Study|Withdrawn consent|2|||
162655228|NCT01454934|587453484|FG001|Overall Study|Withdrawn consent|5|||
162655229|NCT01454934|587453483|FG000|Overall Study|Withdrawal by Subject|11|||
162655230|NCT01454934|587453484|FG001|Overall Study|Withdrawal by Subject|15|||
162655231|NCT01454934|587453483|FG000|Overall Study|Disease progression|194|||
162655232|NCT01454934|587453484|FG001|Overall Study|Disease progression|181|||
162655233|NCT01454934|587453483|FG000|Overall Study|Lost to Follow-up|0|||
162655234|NCT01454934|587453484|FG001|Overall Study|Lost to Follow-up|1|||
162655235|NCT01454934|587453483|FG000|Overall Study|Not treated|1|||
162655236|NCT01454934|587453484|FG001|Overall Study|Not treated|2|||
162655237|NCT00480636|587453485|FG000|Overall Study|Death|12|||
162655238|NCT00480636|587453485|FG000|Overall Study|Lost to Follow-up|4|||
162655239|NCT00480636|587453485|FG000|Overall Study|Other|2|||
162655240|NCT00480636|587453485|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
162655241|NCT00546715|587453486|FG000|Overall Study|Withdrawal by Subject|0|||
162655242|NCT00546715|587453487|FG001|Overall Study|Withdrawal by Subject|1|||
162655243|NCT00546715|587453488|FG002|Overall Study|Withdrawal by Subject|0|||
162655244|NCT00546715|587453489|FG003|Overall Study|Withdrawal by Subject|0|||
162655245|NCT01018264|587453490|FG000|Overall Study|Withdrawal by Subject|1|||
162655246|NCT01018264|587453491|FG001|Overall Study|Withdrawal by Subject|0|||
162655247|NCT01018264|587453490|FG000|Overall Study|Lost to Follow-up|0|||
162655248|NCT01018264|587453491|FG001|Overall Study|Lost to Follow-up|1|||
162655249|NCT03746522|587453493|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
162655250|NCT03746522|587453494|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
162655251|NCT03746522|587453495|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
162655252|NCT03746522|587453493|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
162655253|NCT03746522|587453494|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
162655254|NCT03746522|587453495|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
163121497|NCT01515475|589152656|FG001|Overall Study|Lost to Follow-up|15|||
163121498|NCT01515475|589152657|FG002|Overall Study|Lost to Follow-up|12|||
163121499|NCT01515475|589152658|FG003|Overall Study|Lost to Follow-up|12|||
163121500|NCT01996592|589152661|FG000|Overall Study|no response to text/no diary entry|32|||
163121501|NCT01996592|589152661|FG000|Overall Study|change in surgical date|4|||
163121502|NCT01996592|589152661|FG000|Overall Study|Withdrawal by Subject|5|||
163121503|NCT01996592|589152661|FG000|Overall Study|change in mode of delivery|4|||
163121504|NCT01406015|589152662|FG000|Overall Study|Withdrawal by Subject|3|||
163121505|NCT01406015|589152663|FG001|Overall Study|Withdrawal by Subject|3|||
163121506|NCT00707746|589152664|FG000|Treatment Period|Adverse Event|2|||
163121507|NCT00707746|589152665|FG001|Treatment Period|Adverse Event|4|||
163121508|NCT00707746|589152664|FG000|Treatment Period|Ineligibility|0|||
163121509|NCT00707746|589152665|FG001|Treatment Period|Ineligibility|1|||
163121510|NCT02573246|589152670|FG000|Overall Study|Lost to Follow-up|2|||
162655255|NCT03746522|587453493|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
162655256|NCT03746522|587453494|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
162655257|NCT03746522|587453495|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
162655258|NCT03746522|587453493|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
162655259|NCT03746522|587453494|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
162655260|NCT03746522|587453495|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
162655261|NCT03746522|587453493|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
162655262|NCT03746522|587453494|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
162655263|NCT03746522|587453495|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
162655264|NCT03323099|587453496|FG000|Overall Study|Withdrawal by Subject|6|||
162655265|NCT03323099|587453497|FG001|Overall Study|Withdrawal by Subject|12|||
162655266|NCT03323099|587453496|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
162655267|NCT03323099|587453497|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
162655268|NCT00767676|587453498|FG000|Overall Study|Investigator error|54|||
162655269|NCT05132127|587453504|FG000|Overall Study|Adverse Event|1|||
162655270|NCT05220397|587453505|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162655271|NCT05220397|587453506|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162655272|NCT05220397|587453507|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
162655273|NCT05220397|587453508|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162655274|NCT05220397|587453509|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162655275|NCT02659020|587453510|FG000|Overall Study|Adverse Event|0|||
162719516|NCT04722003|587680489|FG000|Overall Study|Lost to Follow-up|2|||
162719517|NCT04722003|587680490|FG001|Overall Study|Lost to Follow-up|0|||
162719518|NCT04722003|587680489|FG000|Overall Study|Physician Decision|1|||
162719519|NCT04722003|587680490|FG001|Overall Study|Physician Decision|0|||
162719520|NCT03351075|587680491|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
162719521|NCT03351075|587680492|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
162719522|NCT03351075|587680491|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
162719523|NCT03351075|587680492|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
162719524|NCT03351075|587680491|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
162719525|NCT03351075|587680492|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
162719526|NCT03351075|587680491|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
162719527|NCT03351075|587680492|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
162719528|NCT05219253|587680493|FG000|Overall Study|Withdrawal by Subject|1|||
162719529|NCT05219253|587680494|FG001|Overall Study|Withdrawal by Subject|2|||
162719530|NCT03086369|587680495|FG000|Overall Study|Lost to Follow-up|1|||
162719531|NCT03086369|587680496|FG001|Overall Study|Lost to Follow-up|0|||
162719532|NCT03086369|587680497|FG002|Overall Study|Lost to Follow-up|0|||
162719533|NCT03086369|587680498|FG003|Overall Study|Lost to Follow-up|2|||
162719534|NCT03086369|587680499|FG004|Overall Study|Lost to Follow-up|1|||
162719535|NCT03086369|587680495|FG000|Overall Study|Physician Decision|0|||
162719536|NCT03086369|587680496|FG001|Overall Study|Physician Decision|0|||
162719537|NCT03086369|587680497|FG002|Overall Study|Physician Decision|0|||
162719538|NCT03086369|587680498|FG003|Overall Study|Physician Decision|1|||
163121511|NCT02573246|589152671|FG001|Overall Study|Lost to Follow-up|0|||
163121512|NCT02573246|589152672|FG002|Overall Study|Lost to Follow-up|0|||
163121513|NCT02573246|589152673|FG003|Overall Study|Lost to Follow-up|0|||
163121514|NCT02573246|589152674|FG004|Overall Study|Lost to Follow-up|1|||
163121515|NCT02573246|589152670|FG000|Overall Study|Withdrawal by Subject|0|||
163121516|NCT02573246|589152671|FG001|Overall Study|Withdrawal by Subject|0|||
163121517|NCT02573246|589152672|FG002|Overall Study|Withdrawal by Subject|0|||
163121518|NCT02573246|589152673|FG003|Overall Study|Withdrawal by Subject|0|||
163121519|NCT02573246|589152674|FG004|Overall Study|Withdrawal by Subject|1|||
163121520|NCT02573246|589152670|FG000|Overall Study|Physician Decision|1|||
163121521|NCT02573246|589152671|FG001|Overall Study|Physician Decision|1|||
163121522|NCT02573246|589152672|FG002|Overall Study|Physician Decision|3|||
163121523|NCT02573246|589152673|FG003|Overall Study|Physician Decision|2|||
163121524|NCT02573246|589152674|FG004|Overall Study|Physician Decision|2|||
163121525|NCT01219933|589152675|FG000|Overall Study|Adverse Event|8|||
163121526|NCT01219933|589152675|FG000|Overall Study|No LDA reached|5|||
163121527|NCT01219933|589152675|FG000|Overall Study|No LDA maintained|7|||
163121528|NCT01219933|589152675|FG000|Overall Study|Lost to Follow-up|3|||
163121529|NCT01219933|589152675|FG000|Overall Study|GC free|1|||
163121530|NCT01219933|589152675|FG000|Overall Study|Withdrawal by Subject|5|||
163121531|NCT01219933|589152675|FG000|Overall Study|Protocol Violation|8|||
163121532|NCT01219933|589152675|FG000|Overall Study|Lack of Efficacy|1|||
163121533|NCT01902888|589152676|FG000|Overall Study|Study Terminated|3|||
163121534|NCT02256267|589152677|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
163121535|NCT02256267|589152677|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
163121536|NCT01685983|589152678|FG000|Overall Study|Adverse Event|7|||
163121537|NCT01685983|589152678|FG000|Overall Study|Death|1|||
163121538|NCT01685983|589152678|FG000|Overall Study|Withdrawal by Subject|19|||
163121539|NCT01685983|589152678|FG000|Overall Study|Protocol Violation|2|||
163121540|NCT01685983|589152678|FG000|Overall Study|Physician Decision|13|||
163121541|NCT01685983|589152678|FG000|Overall Study|Other|7|||
163121542|NCT01685983|589152678|FG000|Overall Study|Progressive Disease|32|||
163121543|NCT01685983|589152678|FG000|Overall Study|Noncompliance with Study Drug|1|||
163121544|NCT03149003|589152679|FG000|Overall Study|Randomized but not treated|0|||
163121545|NCT03149003|589152680|FG001|Overall Study|Randomized but not treated|1|||
163121546|NCT03149003|589152681|FG002|Overall Study|Randomized but not treated|18|||
163121547|NCT01443130|589152682|FG000|Overall Study|Lost to Follow-up|44|||
163121548|NCT01443130|589152683|FG001|Overall Study|Lost to Follow-up|42|||
163121549|NCT01443130|589152684|FG002|Overall Study|Lost to Follow-up|50|||
163121550|NCT01443130|589152685|FG003|Overall Study|Lost to Follow-up|23|||
163121551|NCT01443130|589152686|FG004|Overall Study|Lost to Follow-up|25|||
163121552|NCT01443130|589152687|FG005|Overall Study|Lost to Follow-up|21|||
163121553|NCT01443130|589152682|FG000|Overall Study|Death|0|||
163121554|NCT01443130|589152683|FG001|Overall Study|Death|1|||
162719539|NCT03086369|587680499|FG004|Overall Study|Physician Decision|2|||
162719540|NCT03086369|587680495|FG000|Overall Study|Withdrawal by Subject|0|||
162719541|NCT03086369|587680496|FG001|Overall Study|Withdrawal by Subject|0|||
162719542|NCT03086369|587680497|FG002|Overall Study|Withdrawal by Subject|0|||
163121555|NCT01443130|589152684|FG002|Overall Study|Death|0|||
163121556|NCT01443130|589152685|FG003|Overall Study|Death|7|||
163121557|NCT01443130|589152686|FG004|Overall Study|Death|10|||
163121558|NCT01443130|589152687|FG005|Overall Study|Death|8|||
163121559|NCT01443130|589152682|FG000|Overall Study|Adverse Event|2|||
163121560|NCT01443130|589152683|FG001|Overall Study|Adverse Event|1|||
163121561|NCT01443130|589152684|FG002|Overall Study|Adverse Event|1|||
162655276|NCT02659020|587453511|FG001|Overall Study|Adverse Event|0|||
162655277|NCT02659020|587453512|FG002|Overall Study|Adverse Event|0|||
163121562|NCT01443130|589152685|FG003|Overall Study|Adverse Event|0|||
163121563|NCT01443130|589152686|FG004|Overall Study|Adverse Event|0|||
163121564|NCT01443130|589152687|FG005|Overall Study|Adverse Event|0|||
163121565|NCT01443130|589152682|FG000|Overall Study|Protocol Violation|2|||
163121566|NCT01443130|589152683|FG001|Overall Study|Protocol Violation|1|||
163121567|NCT01443130|589152684|FG002|Overall Study|Protocol Violation|3|||
163121568|NCT01443130|589152685|FG003|Overall Study|Protocol Violation|2|||
163121569|NCT01443130|589152686|FG004|Overall Study|Protocol Violation|2|||
163121570|NCT01443130|589152687|FG005|Overall Study|Protocol Violation|3|||
163121571|NCT01443130|589152682|FG000|Overall Study|Withdrawal by Subject|15|||
163121572|NCT01443130|589152683|FG001|Overall Study|Withdrawal by Subject|14|||
163121573|NCT01443130|589152684|FG002|Overall Study|Withdrawal by Subject|12|||
163121574|NCT01443130|589152685|FG003|Overall Study|Withdrawal by Subject|7|||
163121575|NCT01443130|589152686|FG004|Overall Study|Withdrawal by Subject|7|||
163121576|NCT01443130|589152687|FG005|Overall Study|Withdrawal by Subject|2|||
163121577|NCT01443130|589152682|FG000|Overall Study|Death of Subject's Infant|5|||
163121578|NCT01443130|589152683|FG001|Overall Study|Death of Subject's Infant|10|||
163121579|NCT01443130|589152684|FG002|Overall Study|Death of Subject's Infant|11|||
163121580|NCT01443130|589152685|FG003|Overall Study|Death of Subject's Infant|0|||
163121581|NCT01443130|589152686|FG004|Overall Study|Death of Subject's Infant|0|||
163121582|NCT01443130|589152687|FG005|Overall Study|Death of Subject's Infant|0|||
163121583|NCT01266590|589153743|FG000|Overall Study|Adverse Event|3|||
163121584|NCT01266590|589153743|FG000|Overall Study|Lost to Follow-up|1|||
163121585|NCT01266590|589153743|FG000|Overall Study|Withdrawal by Subject|1|||
163121586|NCT01266590|589153743|FG000|Overall Study|Physician Decision|1|||
163121587|NCT01806064|589153746|FG000|Overall Study|Randomized Not Enrolled|0|||
163121588|NCT01806064|589153747|FG001|Overall Study|Randomized Not Enrolled|0|||
163121589|NCT01806064|589153748|FG002|Overall Study|Randomized Not Enrolled|0|||
163121590|NCT01806064|589153749|FG003|Overall Study|Randomized Not Enrolled|1|||
163121591|NCT01806064|589153750|FG004|Overall Study|Randomized Not Enrolled|2|||
163121592|NCT02804750|589153754|FG000|Period 1|Adverse Event|0|||
163121593|NCT02804750|589153755|FG001|Period 1|Adverse Event|2|||
163121594|NCT02804750|589153754|FG000|Period 1|Withdrawal by Subject|0|||
163121595|NCT02804750|589153755|FG001|Period 1|Withdrawal by Subject|1|||
163121596|NCT02804750|589153754|FG000|Period 2|Adverse Event|1|||
163121597|NCT02804750|589153755|FG001|Period 2|Adverse Event|0|||
162655278|NCT02659020|587453513|FG003|Overall Study|Adverse Event|2|||
162655279|NCT02659020|587453514|FG004|Overall Study|Adverse Event|0|||
162655280|NCT02659020|587453515|FG005|Overall Study|Adverse Event|0|||
162655281|NCT02659020|587453516|FG006|Overall Study|Adverse Event|2|||
162655282|NCT02659020|587453510|FG000|Overall Study|Lost to Follow-up|1|||
163121598|NCT02804750|589153754|FG000|Period 3|Adverse Event|0|||
163121599|NCT02804750|589153755|FG001|Period 3|Adverse Event|2|||
163121600|NCT02804750|589153754|FG000|Period 4|Adverse Event|0|||
163121601|NCT02804750|589153755|FG001|Period 4|Adverse Event|5|||
163121602|NCT02337634|589153763|FG000|Overall Study|Protocol Violation|3|||
163121603|NCT02337634|589153764|FG001|Overall Study|Protocol Violation|1|||
163121604|NCT02337634|589153763|FG000|Overall Study|Lost to Follow-up|1|||
163121605|NCT02337634|589153764|FG001|Overall Study|Lost to Follow-up|0|||
163121606|NCT02428205|589153766|FG000|Overall Study|Lack of Efficacy|1|||
163121607|NCT02428205|589153767|FG001|Overall Study|Lack of Efficacy|0|||
163121608|NCT02428205|589153766|FG000|Overall Study|Lost to Follow-up|1|||
163121609|NCT02428205|589153767|FG001|Overall Study|Lost to Follow-up|1|||
163121610|NCT02428205|589153766|FG000|Overall Study|Worse behavior|0|||
163121611|NCT02428205|589153767|FG001|Overall Study|Worse behavior|1|||
163121612|NCT02888743|589153768|FG000|Overall Study|Withdrawal by Subject|1|||
163121613|NCT02888743|589153769|FG001|Overall Study|Withdrawal by Subject|2|||
163121614|NCT02888743|589153770|FG002|Overall Study|Withdrawal by Subject|2|||
163121615|NCT02888743|589153771|FG003|Overall Study|Withdrawal by Subject|0|||
163121616|NCT02888743|589153772|FG004|Overall Study|Withdrawal by Subject|1|||
163121617|NCT02888743|589153768|FG000|Overall Study|Disease progression before treatment|2|||
163121618|NCT02888743|589153769|FG001|Overall Study|Disease progression before treatment|0|||
163121619|NCT02888743|589153770|FG002|Overall Study|Disease progression before treatment|2|||
163121620|NCT02888743|589153771|FG003|Overall Study|Disease progression before treatment|0|||
163121621|NCT02888743|589153772|FG004|Overall Study|Disease progression before treatment|0|||
163121622|NCT02888743|589153768|FG000|Overall Study|Patient ineligible|1|||
163121623|NCT02888743|589153769|FG001|Overall Study|Patient ineligible|2|||
163121624|NCT02888743|589153770|FG002|Overall Study|Patient ineligible|0|||
163121625|NCT02888743|589153771|FG003|Overall Study|Patient ineligible|0|||
163121626|NCT02888743|589153772|FG004|Overall Study|Patient ineligible|0|||
163121627|NCT00527319|589153773|FG000|Overall Study|Withdrawal by Subject|5|||
163121628|NCT00527319|589153774|FG001|Overall Study|Withdrawal by Subject|0|||
163121629|NCT00527319|589153775|FG002|Overall Study|Withdrawal by Subject|1|||
163121630|NCT00527319|589153773|FG000|Overall Study|Lost to Follow-up|1|||
163121631|NCT00527319|589153774|FG001|Overall Study|Lost to Follow-up|0|||
163121632|NCT00527319|589153775|FG002|Overall Study|Lost to Follow-up|0|||
163121633|NCT00527319|589153773|FG000|Overall Study|Death|0|||
163121634|NCT00527319|589153774|FG001|Overall Study|Death|3|||
163121635|NCT00527319|589153775|FG002|Overall Study|Death|1|||
163121636|NCT00527319|589153773|FG000|Overall Study|Intercurrent Medical Illness|0|||
163121637|NCT00527319|589153774|FG001|Overall Study|Intercurrent Medical Illness|1|||
163121638|NCT00527319|589153775|FG002|Overall Study|Intercurrent Medical Illness|3|||
163121639|NCT00527319|589153773|FG000|Overall Study|Adverse Event|0|||
163121640|NCT00527319|589153774|FG001|Overall Study|Adverse Event|0|||
163121641|NCT00527319|589153775|FG002|Overall Study|Adverse Event|1|||
163121642|NCT03344172|589153778|FG000|Overall Study|Received <1 dose of treatment|1|||
163121643|NCT03344172|589153779|FG001|Overall Study|Received <1 dose of treatment|0|||
162655283|NCT02659020|587453511|FG001|Overall Study|Lost to Follow-up|2|||
162655284|NCT02659020|587453512|FG002|Overall Study|Lost to Follow-up|1|||
162655285|NCT02659020|587453513|FG003|Overall Study|Lost to Follow-up|6|||
162655286|NCT02659020|587453514|FG004|Overall Study|Lost to Follow-up|1|||
162655287|NCT02659020|587453515|FG005|Overall Study|Lost to Follow-up|5|||
162655288|NCT02659020|587453516|FG006|Overall Study|Lost to Follow-up|0|||
163121644|NCT03106415|589153780|FG000|Phase 1|Withdrawal by Subject|1|||
163121645|NCT03106415|589153781|FG001|Phase 1|Withdrawal by Subject|0|||
163121646|NCT03106415|589153782|FG002|Phase 1|Withdrawal by Subject|0|||
163121647|NCT03106415|589153780|FG000|Phase 1|Adverse Event|1|||
163121648|NCT03106415|589153781|FG001|Phase 1|Adverse Event|1|||
163121649|NCT03106415|589153782|FG002|Phase 1|Adverse Event|0|||
163121650|NCT03106415|589153780|FG000|Phase 1|Protocol Violation|0|||
163121651|NCT03106415|589153781|FG001|Phase 1|Protocol Violation|1|||
163121652|NCT03106415|589153782|FG002|Phase 1|Protocol Violation|0|||
163121653|NCT01804582|589153783|FG000|Overall Study|Lost to Follow-up|47|||
163121654|NCT01804582|589153784|FG001|Overall Study|Lost to Follow-up|56|||
163121655|NCT01804582|589153783|FG000|Overall Study|Physician Decision|2|||
163121656|NCT01804582|589153784|FG001|Overall Study|Physician Decision|0|||
163121657|NCT00520013|589153787|FG000|Overall Study|Withdrawal by Subject|0|||
163121658|NCT00520013|589153788|FG001|Overall Study|Withdrawal by Subject|0|||
163121659|NCT00520013|589153789|FG002|Overall Study|Withdrawal by Subject|1|||
163121660|NCT00520013|589153787|FG000|Overall Study|Adverse Event|2|||
163121661|NCT00520013|589153788|FG001|Overall Study|Adverse Event|10|||
162655289|NCT02659020|587453510|FG000|Overall Study|Physician Decision|0|||
162655290|NCT02659020|587453511|FG001|Overall Study|Physician Decision|0|||
162655291|NCT02659020|587453512|FG002|Overall Study|Physician Decision|0|||
163121662|NCT00520013|589153789|FG002|Overall Study|Adverse Event|7|||
163121663|NCT00520013|589153787|FG000|Overall Study|Progressive Disease|7|||
162655292|NCT02659020|587453513|FG003|Overall Study|Physician Decision|1|||
162655293|NCT02659020|587453514|FG004|Overall Study|Physician Decision|1|||
162655294|NCT02659020|587453515|FG005|Overall Study|Physician Decision|0|||
163121664|NCT00520013|589153788|FG001|Overall Study|Progressive Disease|3|||
163121665|NCT00520013|589153789|FG002|Overall Study|Progressive Disease|0|||
163121666|NCT00520013|589153787|FG000|Overall Study|Clinical Progression|3|||
163121667|NCT00520013|589153788|FG001|Overall Study|Clinical Progression|1|||
163121668|NCT00520013|589153789|FG002|Overall Study|Clinical Progression|0|||
163121669|NCT00520013|589153787|FG000|Overall Study|Death|0|||
163121670|NCT00520013|589153788|FG001|Overall Study|Death|1|||
163121671|NCT00520013|589153789|FG002|Overall Study|Death|0|||
163121672|NCT00520013|589153787|FG000|Overall Study|Physician Decision|0|||
163121673|NCT00520013|589153788|FG001|Overall Study|Physician Decision|0|||
163121674|NCT00520013|589153789|FG002|Overall Study|Physician Decision|3|||
163121675|NCT00159913|589153790|FG000|Overall Study|Adverse Event|1|||
163121676|NCT00159913|589153791|FG001|Overall Study|Adverse Event|0|||
163121677|NCT00159913|589153792|FG002|Overall Study|Adverse Event|1|||
163121678|NCT00159913|589153793|FG003|Overall Study|Adverse Event|0|||
163121679|NCT00159913|589153790|FG000|Overall Study|Withdrawal by Subject|0|||
163121680|NCT00159913|589153791|FG001|Overall Study|Withdrawal by Subject|0|||
163121681|NCT00159913|589153792|FG002|Overall Study|Withdrawal by Subject|0|||
163121682|NCT00159913|589153793|FG003|Overall Study|Withdrawal by Subject|1|||
163121683|NCT00159913|589153790|FG000|Overall Study|Lost to Follow-up|0|||
163121684|NCT00159913|589153791|FG001|Overall Study|Lost to Follow-up|0|||
163121685|NCT00159913|589153792|FG002|Overall Study|Lost to Follow-up|0|||
163121686|NCT00159913|589153793|FG003|Overall Study|Lost to Follow-up|1|||
163121687|NCT00159913|589153790|FG000|Overall Study|Protocol Violation|1|||
163121688|NCT00159913|589153791|FG001|Overall Study|Protocol Violation|0|||
163121689|NCT00159913|589153792|FG002|Overall Study|Protocol Violation|1|||
163121690|NCT00159913|589153793|FG003|Overall Study|Protocol Violation|0|||
163121691|NCT00385723|589153794|FG000|Overall Study|Lost to Follow-up|1|||
163121692|NCT00385723|589153795|FG001|Overall Study|Lost to Follow-up|1|||
163121693|NCT00385723|589153796|FG002|Overall Study|Lost to Follow-up|0|||
163121694|NCT00385723|589153794|FG000|Overall Study|Withdrawal by Subject|1|||
163121695|NCT00385723|589153795|FG001|Overall Study|Withdrawal by Subject|0|||
163121696|NCT00385723|589153796|FG002|Overall Study|Withdrawal by Subject|2|||
163121697|NCT00413010|589153798|FG000|Overall Study|Adverse Event|8|||
163121698|NCT00413010|589153799|FG001|Overall Study|Adverse Event|4|||
163121699|NCT00413010|589153798|FG000|Overall Study|Laboratory abnormality|0|||
163121700|NCT00413010|589153799|FG001|Overall Study|Laboratory abnormality|2|||
163121701|NCT00413010|589153798|FG000|Overall Study|Lack of Efficacy|0|||
163121702|NCT00413010|589153799|FG001|Overall Study|Lack of Efficacy|3|||
163121703|NCT00413010|589153798|FG000|Overall Study|Lost to Follow-up|3|||
163121704|NCT00413010|589153799|FG001|Overall Study|Lost to Follow-up|0|||
163121705|NCT00413010|589153798|FG000|Overall Study|Withdrawal by Subject|7|||
163121706|NCT00413010|589153799|FG001|Overall Study|Withdrawal by Subject|2|||
163121707|NCT00413010|589153798|FG000|Overall Study|Due to termination of the study|54|||
163121708|NCT00413010|589153799|FG001|Overall Study|Due to termination of the study|52|||
163121709|NCT05432167|589153802|FG000|Overall Study|Adverse Event|0|||
163121710|NCT05432167|589153803|FG001|Overall Study|Adverse Event|2|||
163121711|NCT05432167|589153804|FG002|Overall Study|Adverse Event|1|||
163121712|NCT05432167|589153802|FG000|Overall Study|Lost to Follow-up|3|||
163121713|NCT05432167|589153803|FG001|Overall Study|Lost to Follow-up|3|||
163121714|NCT05432167|589153804|FG002|Overall Study|Lost to Follow-up|2|||
163121715|NCT05432167|589153802|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
163121716|NCT05432167|589153803|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
163121717|NCT05432167|589153804|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
163121718|NCT05432167|589153802|FG000|Overall Study|Physician Decision|1|||
163121719|NCT05432167|589153803|FG001|Overall Study|Physician Decision|0|||
163121720|NCT05432167|589153804|FG002|Overall Study|Physician Decision|0|||
163121721|NCT05432167|589153802|FG000|Overall Study|Withdrawal by Subject|7|||
163121722|NCT05432167|589153803|FG001|Overall Study|Withdrawal by Subject|4|||
163121723|NCT05432167|589153804|FG002|Overall Study|Withdrawal by Subject|11|||
163121724|NCT05432167|589153802|FG000|Overall Study|Other|0|||
163121725|NCT05432167|589153803|FG001|Overall Study|Other|0|||
163121726|NCT05432167|589153804|FG002|Overall Study|Other|1|||
163121727|NCT02758301|589153813|FG000|Overall Study|Death|12|||
163121728|NCT02758301|589153814|FG001|Overall Study|Death|0|||
163121729|NCT02758301|589153813|FG000|Overall Study|Physician Decision|10|||
162655295|NCT02659020|587453516|FG006|Overall Study|Physician Decision|1|||
163121730|NCT02758301|589153814|FG001|Overall Study|Physician Decision|1|||
163121731|NCT02758301|589153813|FG000|Overall Study|Withdrawal by Subject|5|||
163121732|NCT02758301|589153814|FG001|Overall Study|Withdrawal by Subject|6|||
163121733|NCT02758301|589153813|FG000|Overall Study|Lost to Follow-up|7|||
162655296|NCT02659020|587453510|FG000|Overall Study|Withdrawal by Subject|2|||
162655297|NCT02659020|587453511|FG001|Overall Study|Withdrawal by Subject|1|||
163121734|NCT02758301|589153814|FG001|Overall Study|Lost to Follow-up|0|||
163121735|NCT02758301|589153813|FG000|Overall Study|Protocol Violation|0|||
163121736|NCT02758301|589153814|FG001|Overall Study|Protocol Violation|1|||
163121737|NCT00364533|589153815|FG000|Overall Study|Adverse Event|8|||
163121738|NCT00364533|589153816|FG001|Overall Study|Adverse Event|7|||
163121739|NCT00364533|589153817|FG002|Overall Study|Adverse Event|15|||
163121740|NCT00364533|589153818|FG003|Overall Study|Adverse Event|5|||
163121741|NCT00364533|589153819|FG004|Overall Study|Adverse Event|2|||
163121742|NCT00364533|589153815|FG000|Overall Study|Withdrawal by Subject|4|||
163121743|NCT00364533|589153816|FG001|Overall Study|Withdrawal by Subject|8|||
163121744|NCT00364533|589153817|FG002|Overall Study|Withdrawal by Subject|6|||
163121745|NCT00364533|589153818|FG003|Overall Study|Withdrawal by Subject|6|||
163121746|NCT00364533|589153819|FG004|Overall Study|Withdrawal by Subject|6|||
163121747|NCT00364533|589153815|FG000|Overall Study|Lack of Efficacy|22|||
163121748|NCT00364533|589153816|FG001|Overall Study|Lack of Efficacy|22|||
163121749|NCT00364533|589153817|FG002|Overall Study|Lack of Efficacy|21|||
163121750|NCT00364533|589153818|FG003|Overall Study|Lack of Efficacy|17|||
163121751|NCT00364533|589153819|FG004|Overall Study|Lack of Efficacy|42|||
163121752|NCT00364533|589153815|FG000|Overall Study|Subject discharged from hospital|4|||
163121753|NCT00364533|589153816|FG001|Overall Study|Subject discharged from hospital|1|||
163121754|NCT00364533|589153817|FG002|Overall Study|Subject discharged from hospital|2|||
163121755|NCT00364533|589153818|FG003|Overall Study|Subject discharged from hospital|3|||
163121756|NCT00364533|589153819|FG004|Overall Study|Subject discharged from hospital|1|||
163121757|NCT00364533|589153815|FG000|Overall Study|Variations in drug compliance|2|||
163121758|NCT00364533|589153816|FG001|Overall Study|Variations in drug compliance|1|||
163121759|NCT00364533|589153817|FG002|Overall Study|Variations in drug compliance|1|||
163121760|NCT00364533|589153818|FG003|Overall Study|Variations in drug compliance|0|||
163121761|NCT00364533|589153819|FG004|Overall Study|Variations in drug compliance|0|||
163121762|NCT00364533|589153815|FG000|Overall Study|Non-compliance|1|||
163121763|NCT00364533|589153816|FG001|Overall Study|Non-compliance|0|||
163121764|NCT00364533|589153817|FG002|Overall Study|Non-compliance|0|||
163121765|NCT00364533|589153818|FG003|Overall Study|Non-compliance|0|||
163121766|NCT00364533|589153819|FG004|Overall Study|Non-compliance|0|||
163121767|NCT00364533|589153815|FG000|Overall Study|Protocol Violation|1|||
163121768|NCT00364533|589153816|FG001|Overall Study|Protocol Violation|1|||
163121769|NCT00364533|589153817|FG002|Overall Study|Protocol Violation|0|||
163121770|NCT00364533|589153818|FG003|Overall Study|Protocol Violation|0|||
163121771|NCT00364533|589153819|FG004|Overall Study|Protocol Violation|0|||
163121772|NCT01167907|589153821|FG000|Overall Study|Protocol Violation|1|||
163121773|NCT01167907|589153822|FG001|Overall Study|Protocol Violation|0|||
163121774|NCT01167907|589153821|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
163121775|NCT01167907|589153822|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
163121776|NCT01814670|589153829|FG000|Overall Study|Protocol Violation|12|||
163121777|NCT00973102|589153830|FG000|Overall Study|Protocol Violation|1|||
163121778|NCT00973102|589153831|FG001|Overall Study|Protocol Violation|0|||
163121779|NCT00973102|589153830|FG000|Overall Study|Prisoner|0|||
163121780|NCT00973102|589153831|FG001|Overall Study|Prisoner|1|||
163121781|NCT01066780|589153832|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
163121782|NCT01066780|589153833|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
163121783|NCT02360293|589153834|FG000|Overall Study|Lost to Follow-up|73|||
163121784|NCT02360293|589153835|FG001|Overall Study|Lost to Follow-up|95|||
163121785|NCT02360293|589153834|FG000|Overall Study|Withdrawal by Subject|2|||
163121786|NCT02360293|589153835|FG001|Overall Study|Withdrawal by Subject|1|||
163121787|NCT02360293|589153834|FG000|Overall Study|Excluded|1|||
163121788|NCT02360293|589153835|FG001|Overall Study|Excluded|0|||
163121789|NCT02226549|589153836|FG000|Overall Study|Randomized but Never Treated|1|||
163121790|NCT02226549|589153837|FG001|Overall Study|Randomized but Never Treated|0|||
163121791|NCT02226549|589153836|FG000|Overall Study|Lost to Follow-up|0|||
163121792|NCT02226549|589153837|FG001|Overall Study|Lost to Follow-up|1|||
163121793|NCT03099148|589153838|FG000|Wash-out|scheduling conflict|0|||
163121794|NCT03099148|589153839|FG001|Wash-out|scheduling conflict|1|||
163121795|NCT03099148|589153840|FG002|Wash-out|scheduling conflict|0|||
163121796|NCT03099148|589153841|FG003|Wash-out|scheduling conflict|0|||
163121797|NCT03099148|589153838|FG000|Wash-out|Adverse Event|0|||
163121798|NCT03099148|589153839|FG001|Wash-out|Adverse Event|1|||
163121799|NCT03099148|589153840|FG002|Wash-out|Adverse Event|0|||
163121800|NCT03099148|589153841|FG003|Wash-out|Adverse Event|0|||
163121801|NCT01269385|589153842|FG000|Overall Study|Adverse Event|1|||
163121802|NCT01269385|589153843|FG001|Overall Study|Adverse Event|1|||
163121803|NCT01269385|589153844|FG002|Overall Study|Adverse Event|0|||
163121804|NCT01269385|589153845|FG003|Overall Study|Adverse Event|0|||
163121805|NCT00687609|589153850|FG000|Overall Study|Physician Decision|1|||
163121806|NCT00687609|589153850|FG000|Overall Study|Withdrawal by Subject|2|||
163121807|NCT02713529|589153851|FG000|Overall Study|Withdrawal by Subject|3|||
163121808|NCT02713529|589153852|FG001|Overall Study|Withdrawal by Subject|1|||
163121809|NCT02713529|589153853|FG002|Overall Study|Withdrawal by Subject|4|||
163121810|NCT02713529|589153854|FG003|Overall Study|Withdrawal by Subject|2|||
163121811|NCT02713529|589153855|FG004|Overall Study|Withdrawal by Subject|0|||
163121812|NCT02713529|589153856|FG005|Overall Study|Withdrawal by Subject|1|||
163121813|NCT02713529|589153857|FG006|Overall Study|Withdrawal by Subject|1|||
163121814|NCT02713529|589153851|FG000|Overall Study|Lost to Follow-up|1|||
163121815|NCT02713529|589153852|FG001|Overall Study|Lost to Follow-up|0|||
163121816|NCT02713529|589153853|FG002|Overall Study|Lost to Follow-up|1|||
163121817|NCT02713529|589153854|FG003|Overall Study|Lost to Follow-up|0|||
163121818|NCT02713529|589153855|FG004|Overall Study|Lost to Follow-up|0|||
163121819|NCT02713529|589153856|FG005|Overall Study|Lost to Follow-up|0|||
163121820|NCT02713529|589153857|FG006|Overall Study|Lost to Follow-up|0|||
163121821|NCT02713529|589153851|FG000|Overall Study|Death|3|||
163121822|NCT02713529|589153852|FG001|Overall Study|Death|3|||
163121823|NCT02713529|589153853|FG002|Overall Study|Death|26|||
163121824|NCT02713529|589153854|FG003|Overall Study|Death|27|||
163121825|NCT02713529|589153855|FG004|Overall Study|Death|3|||
163121826|NCT02713529|589153856|FG005|Overall Study|Death|13|||
163121827|NCT02713529|589153857|FG006|Overall Study|Death|3|||
163121828|NCT01739803|589153859|FG000|Overall Study|Lost to Follow-up|9|||
163121829|NCT01739803|589153860|FG001|Overall Study|Lost to Follow-up|6|||
163121830|NCT03759041|589153865|FG000|Overall Study|Withdrawal by Subject|4|||
163121831|NCT03759041|589153866|FG001|Overall Study|Withdrawal by Subject|10|||
163121832|NCT03759041|589153867|FG002|Overall Study|Withdrawal by Subject|10|||
163121833|NCT03759041|589153865|FG000|Overall Study|Adverse Event|1|||
163121834|NCT03759041|589153866|FG001|Overall Study|Adverse Event|3|||
163121835|NCT03759041|589153867|FG002|Overall Study|Adverse Event|4|||
163121836|NCT03759041|589153865|FG000|Overall Study|Lack of Efficacy|0|||
163121837|NCT03759041|589153866|FG001|Overall Study|Lack of Efficacy|0|||
163121838|NCT03759041|589153867|FG002|Overall Study|Lack of Efficacy|1|||
163121839|NCT03759041|589153865|FG000|Overall Study|Study Terminated by Sponsor|15|||
163121840|NCT03759041|589153866|FG001|Overall Study|Study Terminated by Sponsor|16|||
163121841|NCT03759041|589153867|FG002|Overall Study|Study Terminated by Sponsor|10|||
163121842|NCT03759041|589153865|FG000|Overall Study|Other reason for discontinuation|0|||
163121843|NCT03759041|589153866|FG001|Overall Study|Other reason for discontinuation|2|||
163121844|NCT03759041|589153867|FG002|Overall Study|Other reason for discontinuation|1|||
163121845|NCT03759041|589153865|FG000|Overall Study|Lost to Follow-up|7|||
163121846|NCT03759041|589153866|FG001|Overall Study|Lost to Follow-up|2|||
163121847|NCT03759041|589153867|FG002|Overall Study|Lost to Follow-up|2|||
163121848|NCT03759041|589153865|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
163121849|NCT03759041|589153866|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
163121850|NCT03759041|589153867|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
163121851|NCT02449018|589153868|FG000|Overall Study|Abnormal laboratory value|0|||
163121852|NCT02449018|589153869|FG001|Overall Study|Abnormal laboratory value|1|||
163121853|NCT02449018|589153868|FG000|Overall Study|Administrative problems|1|||
163121854|NCT02449018|589153869|FG001|Overall Study|Administrative problems|0|||
163121855|NCT02449018|589153868|FG000|Overall Study|Adverse Event|5|||
163121856|NCT02449018|589153869|FG001|Overall Study|Adverse Event|1|||
163121857|NCT02449018|589153868|FG000|Overall Study|Protocol deviation|4|||
163121858|NCT02449018|589153869|FG001|Overall Study|Protocol deviation|0|||
163121859|NCT02449018|589153868|FG000|Overall Study|Patient decision|2|||
163121860|NCT02449018|589153869|FG001|Overall Study|Patient decision|0|||
162719543|NCT03086369|587680498|FG003|Overall Study|Withdrawal by Subject|5|||
162719544|NCT03086369|587680499|FG004|Overall Study|Withdrawal by Subject|3|||
162719545|NCT03086369|587680495|FG000|Overall Study|Progressive Disease|0|||
163121861|NCT00525824|589153875|FG000|Overall Study|Adverse Event|7|||
163121862|NCT00525824|589153876|FG001|Overall Study|Adverse Event|11|||
163121863|NCT00525824|589153877|FG002|Overall Study|Adverse Event|6|||
163121864|NCT00525824|589153878|FG003|Overall Study|Adverse Event|7|||
163121865|NCT00525824|589153875|FG000|Overall Study|Withdrawal by Subject|5|||
163121866|NCT00525824|589153876|FG001|Overall Study|Withdrawal by Subject|9|||
163121867|NCT00525824|589153877|FG002|Overall Study|Withdrawal by Subject|3|||
163121868|NCT00525824|589153878|FG003|Overall Study|Withdrawal by Subject|4|||
163121869|NCT00525824|589153875|FG000|Overall Study|Lost to Follow-up|4|||
162719546|NCT03086369|587680496|FG001|Overall Study|Progressive Disease|0|||
162655298|NCT02659020|587453512|FG002|Overall Study|Withdrawal by Subject|0|||
162655299|NCT02659020|587453513|FG003|Overall Study|Withdrawal by Subject|3|||
162655300|NCT02659020|587453514|FG004|Overall Study|Withdrawal by Subject|3|||
163121870|NCT00525824|589153876|FG001|Overall Study|Lost to Follow-up|2|||
162655301|NCT02659020|587453515|FG005|Overall Study|Withdrawal by Subject|6|||
162655302|NCT02659020|587453516|FG006|Overall Study|Withdrawal by Subject|3|||
162655303|NCT02659020|587453510|FG000|Overall Study|Progressive Disease|0|||
162655304|NCT02659020|587453511|FG001|Overall Study|Progressive Disease|0|||
162655305|NCT02659020|587453512|FG002|Overall Study|Progressive Disease|0|||
162655306|NCT02659020|587453513|FG003|Overall Study|Progressive Disease|4|||
162655307|NCT02659020|587453514|FG004|Overall Study|Progressive Disease|1|||
162655308|NCT02659020|587453515|FG005|Overall Study|Progressive Disease|0|||
162655309|NCT02659020|587453516|FG006|Overall Study|Progressive Disease|2|||
162655310|NCT02052739|587453517|FG000|Overall Study|Withdrew due to Adverse Event|3|||
162655311|NCT02052739|587453518|FG001|Overall Study|Withdrew due to Adverse Event|0|||
162655312|NCT02052739|587453517|FG000|Overall Study|Participant Died|2|||
162655313|NCT02052739|587453518|FG001|Overall Study|Participant Died|1|||
162655314|NCT02043015|587453519|FG000|Overall Study|Lost to Follow-up|4|||
162655315|NCT02043015|587453519|FG000|Overall Study|Withdrawal by Subject|4|||
162655316|NCT02043015|587453519|FG000|Overall Study|Removed once target enrollment reached|15|||
162655317|NCT02043015|587453519|FG000|Overall Study|Participant moved away from study city|4|||
162655318|NCT02043015|587453519|FG000|Overall Study|Incarceration|1|||
162655319|NCT00393939|587453523|FG000|Overall Study|Protocol Violation|1|||
162655320|NCT00393939|587453524|FG001|Overall Study|Protocol Violation|1|||
162655321|NCT00393939|587453523|FG000|Overall Study|Lost to Follow-up|2|||
162655322|NCT00393939|587453524|FG001|Overall Study|Lost to Follow-up|4|||
162655323|NCT00393939|587453523|FG000|Overall Study|Death|10|||
162655324|NCT00393939|587453524|FG001|Overall Study|Death|4|||
162655325|NCT00393939|587453523|FG000|Overall Study|Sponsor|5|||
162655326|NCT00393939|587453524|FG001|Overall Study|Sponsor|13|||
162655327|NCT00393939|587453523|FG000|Overall Study|Objective progression or relapse|239|||
162655328|NCT00393939|587453524|FG001|Overall Study|Objective progression or relapse|223|||
162655329|NCT00393939|587453523|FG000|Overall Study|Withdrawal by Subject|2|||
162655330|NCT00393939|587453524|FG001|Overall Study|Withdrawal by Subject|7|||
162655331|NCT00393939|587453523|FG000|Overall Study|Other|37|||
162655332|NCT00393939|587453524|FG001|Overall Study|Other|45|||
162655333|NCT01494610|587453525|FG000|Period 1|Withdrawal by Subject|1|||
162655334|NCT01494610|587453526|FG001|Period 1|Withdrawal by Subject|1|||
162655335|NCT01494610|587453525|FG000|Period 3|Adverse Event|1|||
163121871|NCT00525824|589153877|FG002|Overall Study|Lost to Follow-up|4|||
163121872|NCT00525824|589153878|FG003|Overall Study|Lost to Follow-up|0|||
163121873|NCT00525824|589153875|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
163121874|NCT00525824|589153876|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
163121875|NCT00525824|589153877|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
163121876|NCT00525824|589153878|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
163121877|NCT00525824|589153875|FG000|Overall Study|Severe non-compliance|0|||
163121878|NCT00525824|589153876|FG001|Overall Study|Severe non-compliance|1|||
163121879|NCT00525824|589153877|FG002|Overall Study|Severe non-compliance|1|||
163121880|NCT00525824|589153878|FG003|Overall Study|Severe non-compliance|1|||
163121881|NCT00525824|589153875|FG000|Overall Study|Safety reasons|1|||
163121882|NCT00525824|589153876|FG001|Overall Study|Safety reasons|0|||
163121883|NCT00525824|589153877|FG002|Overall Study|Safety reasons|1|||
163121884|NCT00525824|589153878|FG003|Overall Study|Safety reasons|0|||
163121885|NCT00525824|589153875|FG000|Overall Study|Other|1|||
162655336|NCT01494610|587453526|FG001|Period 3|Adverse Event|0|||
162655337|NCT01494610|587453525|FG000|Period 3|Withdrawal by Subject|1|||
162655338|NCT01494610|587453526|FG001|Period 3|Withdrawal by Subject|0|||
162655339|NCT01494610|587453525|FG000|Period 4|Protocol Violation|1|||
162655340|NCT01494610|587453526|FG001|Period 4|Protocol Violation|0|||
162655341|NCT02385799|587453527|FG000|Overall Study|Lost to Follow-up|1|||
162655342|NCT02385799|587453528|FG001|Overall Study|Lost to Follow-up|2|||
162655343|NCT02385799|587453527|FG000|Overall Study|Adverse Event|4|||
162655344|NCT02385799|587453528|FG001|Overall Study|Adverse Event|2|||
162655345|NCT02385799|587453527|FG000|Overall Study|Withdrawal by Subject|0|||
162719547|NCT03086369|587680497|FG002|Overall Study|Progressive Disease|0|||
162719548|NCT03086369|587680498|FG003|Overall Study|Progressive Disease|1|||
163121886|NCT00525824|589153876|FG001|Overall Study|Other|3|||
163121887|NCT00525824|589153877|FG002|Overall Study|Other|3|||
162655346|NCT02385799|587453528|FG001|Overall Study|Withdrawal by Subject|4|||
162655347|NCT04958109|587453529|FG000|Overall Study|Withdrawal by Subject|0|||
162655348|NCT04958109|587453530|FG001|Overall Study|Withdrawal by Subject|1|||
162655349|NCT04958109|587453529|FG000|Overall Study|Lost to Follow-up|0|||
162655350|NCT04958109|587453530|FG001|Overall Study|Lost to Follow-up|1|||
162655351|NCT00715793|587453531|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
162655352|NCT00715793|587453532|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
162655353|NCT00715793|587453531|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
162655354|NCT00715793|587453532|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
163121888|NCT00525824|589153878|FG003|Overall Study|Other|1|||
163121889|NCT05011513|589155563|FG000|Overall Study|Death|0|||
163121890|NCT05011513|589155564|FG001|Overall Study|Death|1|||
163121891|NCT05011513|589155563|FG000|Overall Study|Lost to Follow-up|4|||
163121892|NCT05011513|589155564|FG001|Overall Study|Lost to Follow-up|0|||
163121893|NCT05011513|589155563|FG000|Overall Study|Withdrawal by Subject|18|||
163121894|NCT05011513|589155564|FG001|Overall Study|Withdrawal by Subject|17|||
163121895|NCT05011513|589155563|FG000|Overall Study|Other|4|||
163121896|NCT05011513|589155564|FG001|Overall Study|Other|2|||
163121897|NCT03667690|589155565|FG000|Overall Study|Adverse Event|0|||
163121898|NCT03667690|589155566|FG001|Overall Study|Adverse Event|3|||
163121899|NCT03667690|589155565|FG000|Overall Study|Death|22|||
163121900|NCT03667690|589155566|FG001|Overall Study|Death|21|||
163121901|NCT03667690|589155565|FG000|Overall Study|Lost to Follow-up|4|||
163121902|NCT03667690|589155566|FG001|Overall Study|Lost to Follow-up|5|||
163121903|NCT03667690|589155565|FG000|Overall Study|Withdrawal by Subject|7|||
163121904|NCT03667690|589155566|FG001|Overall Study|Withdrawal by Subject|8|||
163121905|NCT03667690|589155565|FG000|Overall Study|Subject could not return for additional investigational product|1|||
163121906|NCT03667690|589155566|FG001|Overall Study|Subject could not return for additional investigational product|0|||
163121907|NCT03667690|589155565|FG000|Overall Study|Subject discharged to hospice care|2|||
163121908|NCT03667690|589155566|FG001|Overall Study|Subject discharged to hospice care|0|||
163121909|NCT03667690|589155565|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
163121910|NCT03667690|589155566|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
163121911|NCT03667690|589155565|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
163121912|NCT03667690|589155566|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
163121913|NCT03667690|589155565|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
163121914|NCT03667690|589155566|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
163121915|NCT03667690|589155565|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
163121916|NCT03667690|589155566|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
163121917|NCT03667690|589155565|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
163121918|NCT03667690|589155566|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
163121919|NCT01192568|589155575|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
163121920|NCT01192568|589155576|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
163121921|NCT01192568|589155577|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
163121922|NCT01192568|589155578|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
163121923|NCT01192568|589155575|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
163121924|NCT01192568|589155576|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
163121925|NCT01192568|589155577|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
162655355|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163121926|NCT01192568|589155578|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
163121927|NCT02593825|589155579|FG000|Intervention|Lost to Follow-up|10|||
163121928|NCT02593825|589155580|FG001|Intervention|Lost to Follow-up|12|||
163121929|NCT06359080|589155581|FG000|Overall Study|Withdrawal by Subject|3|||
163121930|NCT00511134|589155584|FG000|Overall Study|Withdrawal by Subject|0|||
163121931|NCT00511134|589155585|FG001|Overall Study|Withdrawal by Subject|2|||
163121932|NCT01949090|589155588|FG000|Overall Study|Serious Adverse Event|0|||
163121933|NCT01949090|589155589|FG001|Overall Study|Serious Adverse Event|1|||
163121934|NCT01949090|589155590|FG002|Overall Study|Serious Adverse Event|2|||
163121935|NCT01949090|589155591|FG003|Overall Study|Serious Adverse Event|0|||
163121936|NCT01949090|589155592|FG004|Overall Study|Serious Adverse Event|1|||
163121937|NCT01949090|589155588|FG000|Overall Study|Withdrawal by Subject|2|||
163121938|NCT01949090|589155589|FG001|Overall Study|Withdrawal by Subject|0|||
163121939|NCT01949090|589155590|FG002|Overall Study|Withdrawal by Subject|0|||
163121940|NCT01949090|589155591|FG003|Overall Study|Withdrawal by Subject|0|||
163121941|NCT01949090|589155592|FG004|Overall Study|Withdrawal by Subject|1|||
163121942|NCT01949090|589155588|FG000|Overall Study|Protocol non-compliance|0|||
163121943|NCT01949090|589155589|FG001|Overall Study|Protocol non-compliance|0|||
163121944|NCT01949090|589155590|FG002|Overall Study|Protocol non-compliance|0|||
163121945|NCT01949090|589155591|FG003|Overall Study|Protocol non-compliance|0|||
163121946|NCT01949090|589155592|FG004|Overall Study|Protocol non-compliance|1|||
163121947|NCT01949090|589155588|FG000|Overall Study|Lost to Follow-up|2|||
163121948|NCT01949090|589155589|FG001|Overall Study|Lost to Follow-up|1|||
163121949|NCT01949090|589155590|FG002|Overall Study|Lost to Follow-up|0|||
163121950|NCT01949090|589155591|FG003|Overall Study|Lost to Follow-up|1|||
163121951|NCT01949090|589155592|FG004|Overall Study|Lost to Follow-up|1|||
163121952|NCT02783170|589155593|FG000|Overall Study|Randomized but not Vaccinated|1|||
163121953|NCT02783170|589155594|FG001|Overall Study|Randomized but not Vaccinated|0|||
163121954|NCT03323736|589155595|FG000|Overall Study|Screen Failure|14|||
163121955|NCT03323736|589155596|FG001|Overall Study|Screen Failure|9|||
163121956|NCT03323736|589155597|FG002|Overall Study|Screen Failure|1|||
163121957|NCT03323736|589155595|FG000|Overall Study|Withdrawal Before Treatment|3|||
163121958|NCT03323736|589155596|FG001|Overall Study|Withdrawal Before Treatment|1|||
163121959|NCT03323736|589155597|FG002|Overall Study|Withdrawal Before Treatment|1|||
163121960|NCT03323736|589155595|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
163121961|NCT03323736|589155596|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
163121962|NCT03323736|589155597|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
163121963|NCT00701805|589155604|FG000|Overall Study|Withdrawal by Subject|3|||
163121964|NCT00701805|589155605|FG001|Overall Study|Withdrawal by Subject|1|||
163121965|NCT00701805|589155606|FG002|Overall Study|Withdrawal by Subject|4|||
163121966|NCT00701805|589155607|FG003|Overall Study|Withdrawal by Subject|3|||
163121967|NCT00701805|589155604|FG000|Overall Study|Adverse Event|0|||
163121968|NCT00701805|589155605|FG001|Overall Study|Adverse Event|1|||
163121969|NCT00701805|589155606|FG002|Overall Study|Adverse Event|1|||
163121970|NCT00701805|589155607|FG003|Overall Study|Adverse Event|0|||
163121971|NCT00701805|589155604|FG000|Overall Study|Missed 7 consecutive doses|0|||
163121972|NCT00701805|589155605|FG001|Overall Study|Missed 7 consecutive doses|1|||
162655356|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
162655357|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
162655358|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
162655359|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655360|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655361|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655362|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655363|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655364|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655365|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655366|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655367|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655368|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655369|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655370|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163121973|NCT00701805|589155606|FG002|Overall Study|Missed 7 consecutive doses|0|||
162655371|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163121974|NCT00701805|589155607|FG003|Overall Study|Missed 7 consecutive doses|0|||
163121975|NCT00701805|589155604|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
163121976|NCT00701805|589155605|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
163121977|NCT00701805|589155606|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
163121978|NCT00701805|589155607|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
163121979|NCT00701805|589155604|FG000|Overall Study|Physician decision, change of therapy|0|||
163121980|NCT00701805|589155605|FG001|Overall Study|Physician decision, change of therapy|0|||
163121981|NCT00701805|589155606|FG002|Overall Study|Physician decision, change of therapy|0|||
162655372|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163121982|NCT00701805|589155607|FG003|Overall Study|Physician decision, change of therapy|1|||
163121983|NCT00701805|589155604|FG000|Overall Study|Difficult to travel to dialysis site|0|||
163121984|NCT00701805|589155605|FG001|Overall Study|Difficult to travel to dialysis site|0|||
163121985|NCT00701805|589155606|FG002|Overall Study|Difficult to travel to dialysis site|1|||
163121986|NCT00701805|589155607|FG003|Overall Study|Difficult to travel to dialysis site|0|||
163121987|NCT00701805|589155604|FG000|Overall Study|Resumption criteria were not met|0|||
163121988|NCT00701805|589155605|FG001|Overall Study|Resumption criteria were not met|1|||
163121989|NCT00701805|589155606|FG002|Overall Study|Resumption criteria were not met|0|||
163121990|NCT00701805|589155607|FG003|Overall Study|Resumption criteria were not met|0|||
163121991|NCT05063539|589155608|FG000|Overall Study|Adverse Event|1|||
163121992|NCT05063539|589155609|FG001|Overall Study|Adverse Event|2|||
163121993|NCT05063539|589155610|FG002|Overall Study|Adverse Event|1|||
163121994|NCT05063539|589155608|FG000|Overall Study|Death|0|||
163121995|NCT05063539|589155609|FG001|Overall Study|Death|1|||
163121996|NCT05063539|589155610|FG002|Overall Study|Death|1|||
163121997|NCT05063539|589155608|FG000|Overall Study|Lost to Follow-up|0|||
163121998|NCT05063539|589155609|FG001|Overall Study|Lost to Follow-up|1|||
163121999|NCT05063539|589155610|FG002|Overall Study|Lost to Follow-up|0|||
163122000|NCT05063539|589155608|FG000|Overall Study|Physician Decision|4|||
163122001|NCT05063539|589155609|FG001|Overall Study|Physician Decision|3|||
163122002|NCT05063539|589155610|FG002|Overall Study|Physician Decision|1|||
163122003|NCT05063539|589155608|FG000|Overall Study|Progressive Disease|0|||
163122004|NCT05063539|589155609|FG001|Overall Study|Progressive Disease|2|||
163122005|NCT05063539|589155610|FG002|Overall Study|Progressive Disease|0|||
163122006|NCT05063539|589155608|FG000|Overall Study|Withdrawal by Subject|17|||
163122007|NCT05063539|589155609|FG001|Overall Study|Withdrawal by Subject|26|||
163122008|NCT05063539|589155610|FG002|Overall Study|Withdrawal by Subject|14|||
163122009|NCT05063539|589155608|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
163122010|NCT05063539|589155609|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
163122011|NCT05063539|589155610|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
163122012|NCT05063539|589155608|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
163122013|NCT05063539|589155609|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
163122014|NCT05063539|589155610|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
163122015|NCT05063539|589155608|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
163122016|NCT05063539|589155609|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
163122017|NCT05063539|589155610|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
163122018|NCT05063539|589155608|FG000|Overall Study|Discontinued due to Common Close Design|0|||
163122019|NCT05063539|589155609|FG001|Overall Study|Discontinued due to Common Close Design|1|||
163122020|NCT05063539|589155610|FG002|Overall Study|Discontinued due to Common Close Design|0|||
163122021|NCT05063539|589155608|FG000|Overall Study|Participant not co-operative|0|||
163122022|NCT05063539|589155609|FG001|Overall Study|Participant not co-operative|1|||
163122023|NCT05063539|589155610|FG002|Overall Study|Participant not co-operative|0|||
163122024|NCT05063539|589155608|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
163122025|NCT05063539|589155609|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
163122026|NCT05063539|589155610|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
163122027|NCT05063539|589155608|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
163122028|NCT05063539|589155609|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
163122029|NCT05063539|589155610|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
163122030|NCT04256512|589155611|FG000|Overall Study|Withdrawal by Subject|1|||
163122031|NCT04692077|589155614|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
163122032|NCT01751139|589155615|FG000|Overall Study|Other|135|||
163122033|NCT01751139|589155615|FG000|Overall Study|Sponsor study termination|1609|||
163122034|NCT01751139|589155615|FG000|Overall Study|Lost to Follow-up|240|||
163122035|NCT01751139|589155615|FG000|Overall Study|Withdrawal by Subject|251|||
163122036|NCT01751139|589155615|FG000|Overall Study|Adverse Event|1|||
163122037|NCT01751139|589155615|FG000|Overall Study|Death|31|||
163122038|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Death|1|||
163122039|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Death|0|||
163122040|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Death|0|||
163122041|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Death|0|||
163122042|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
163122043|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
163122044|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
163122045|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
163122046|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
162655373|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655374|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163122047|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
162655375|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655376|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655377|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162655378|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
163122048|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
163122049|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
163122050|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
163122051|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
163122052|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
163122053|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
163122054|NCT04271475|589155618|FG000|DB Period: Day 1 up to EODBT|Other|8|||
163122055|NCT04271475|589155619|FG001|DB Period: Day 1 up to EODBT|Other|5|||
163122056|NCT04271475|589155620|FG002|DB Period: Day 1 up to EODBT|Other|0|||
163122057|NCT04271475|589155621|FG003|DB Period: Day 1 up to EODBT|Other|0|||
163122058|NCT04271475|589155618|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
163122059|NCT04271475|589155619|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
163122060|NCT04271475|589155620|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
163122061|NCT04271475|589155621|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
163122062|NCT04271475|589155618|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122063|NCT04271475|589155619|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122064|NCT04271475|589155620|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
163122065|NCT04271475|589155621|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
163122066|NCT01818284|589155624|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
163122067|NCT01818284|589155625|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
163122068|NCT01818284|589155624|FG000|Overall Study|Death|0|||
163122069|NCT01818284|589155625|FG001|Overall Study|Death|2|||
163122070|NCT01300351|589155627|FG000|Overall Study|Did not receive treatment|2|||
163122071|NCT01300351|589155628|FG001|Overall Study|Did not receive treatment|0|||
163122072|NCT01300351|589155627|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
163122073|NCT01300351|589155628|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
163122074|NCT01300351|589155627|FG000|Overall Study|Lost to Follow-up|0|||
163122075|NCT01300351|589155628|FG001|Overall Study|Lost to Follow-up|1|||
163122076|NCT01300351|589155627|FG000|Overall Study|Adverse Event|0|||
163122077|NCT01300351|589155628|FG001|Overall Study|Adverse Event|4|||
163122078|NCT01300351|589155627|FG000|Overall Study|Withdrawal by Subject|7|||
163122079|NCT01300351|589155628|FG001|Overall Study|Withdrawal by Subject|10|||
163122080|NCT05824936|589155633|FG000|Overall Study|Lost to Follow-up|1|||
163122081|NCT00673881|589155634|FG000|Overall Study|Withdrawal by Subject|1|||
163122082|NCT00096018|589155635|FG000|Overall Study|Became Ineligible (not treated)|0|||
163122083|NCT00096018|589155636|FG001|Overall Study|Became Ineligible (not treated)|3|||
163122084|NCT00096018|589155635|FG000|Overall Study|Miscellaneous (not treated)|0|||
163122085|NCT00096018|589155636|FG001|Overall Study|Miscellaneous (not treated)|2|||
163122086|NCT00096018|589155635|FG000|Overall Study|Adverse Event|0|||
163122087|NCT00096018|589155636|FG001|Overall Study|Adverse Event|5|||
163122088|NCT00096018|589155635|FG000|Overall Study|Death|0|||
163122089|NCT00096018|589155636|FG001|Overall Study|Death|1|||
163122090|NCT00096018|589155635|FG000|Overall Study|Withdrawal by Subject|0|||
163122091|NCT00096018|589155636|FG001|Overall Study|Withdrawal by Subject|2|||
163122092|NCT00096018|589155635|FG000|Overall Study|Miscellaneous|2|||
163122093|NCT00096018|589155636|FG001|Overall Study|Miscellaneous|1|||
162655379|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655380|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
162655381|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655382|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655383|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655384|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655385|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655386|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655387|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655388|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655389|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655390|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655391|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655392|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163122094|NCT00483041|589155637|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
163122095|NCT00483041|589155638|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
163122096|NCT02258529|589155639|FG000|Overall Study|Study Terminated by Sponsor|9|||
162655393|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655394|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655395|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655396|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655397|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655398|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655399|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655400|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655401|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
163122097|NCT02258529|589155639|FG000|Overall Study|Adverse Event|1|||
163122098|NCT00875056|589155642|FG000|Overall Study|Adverse Event|6|||
163122099|NCT00875056|589155643|FG001|Overall Study|Adverse Event|1|||
163122100|NCT00875056|589155644|FG002|Overall Study|Adverse Event|2|||
163122101|NCT00875056|589155642|FG000|Overall Study|Progressive Disease|14|||
163122102|NCT00875056|589155643|FG001|Overall Study|Progressive Disease|8|||
163122103|NCT00875056|589155644|FG002|Overall Study|Progressive Disease|3|||
163122104|NCT00875056|589155642|FG000|Overall Study|Withdrawal by Subject|3|||
163122105|NCT00875056|589155643|FG001|Overall Study|Withdrawal by Subject|0|||
163122106|NCT00875056|589155644|FG002|Overall Study|Withdrawal by Subject|1|||
163122107|NCT01842581|589155652|FG000|Overall Study|Adverse Event|6|||
163122108|NCT01842581|589155653|FG001|Overall Study|Adverse Event|4|||
163122109|NCT01842581|589155652|FG000|Overall Study|HE breakthrough|26|||
163122110|NCT01842581|589155653|FG001|Overall Study|HE breakthrough|13|||
163122111|NCT01842581|589155652|FG000|Overall Study|Liver transplant|2|||
163122112|NCT01842581|589155653|FG001|Overall Study|Liver transplant|0|||
163122113|NCT01842581|589155652|FG000|Overall Study|Lost to Follow-up|2|||
163122114|NCT01842581|589155653|FG001|Overall Study|Lost to Follow-up|5|||
163122115|NCT01842581|589155652|FG000|Overall Study|Withdrawal by Subject|5|||
163122116|NCT01842581|589155653|FG001|Overall Study|Withdrawal by Subject|7|||
163122117|NCT01842581|589155652|FG000|Overall Study|Other than specified|3|||
163122118|NCT01842581|589155653|FG001|Overall Study|Other than specified|1|||
163122119|NCT00286221|589155654|FG000|Overall Study|Protocol Violation|2|||
163122120|NCT00286221|589155655|FG001|Overall Study|Protocol Violation|1|||
163122121|NCT00286221|589155656|FG002|Overall Study|Protocol Violation|6|||
163122122|NCT00286221|589155657|FG003|Overall Study|Protocol Violation|4|||
163122123|NCT00286221|589155654|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
163122124|NCT00286221|589155655|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
163122125|NCT00286221|589155656|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
163122126|NCT00286221|589155657|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
163122127|NCT00286221|589155654|FG000|Overall Study|Inability to trigger PCA|2|||
163122128|NCT00286221|589155655|FG001|Overall Study|Inability to trigger PCA|0|||
163122129|NCT00286221|589155656|FG002|Overall Study|Inability to trigger PCA|0|||
163122130|NCT00286221|589155657|FG003|Overall Study|Inability to trigger PCA|0|||
163122131|NCT00286221|589155654|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
163122132|NCT00286221|589155655|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
163122133|NCT00286221|589155656|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
163122134|NCT00286221|589155657|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
163122135|NCT02553538|589155660|FG000|Overall Study|Could Not Reach by Telephone|133|||
163122136|NCT02553538|589155661|FG001|Overall Study|Could Not Reach by Telephone|0|||
163122137|NCT02553538|589155660|FG000|Overall Study|Died or Left Network|54|||
163122138|NCT02553538|589155661|FG001|Overall Study|Died or Left Network|56|||
163122139|NCT02648217|589155662|FG000|Overall Study|Adverse Event|0|||
162655402|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162655403|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655404|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
162655405|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655406|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655407|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655408|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122140|NCT02648217|589155663|FG001|Overall Study|Adverse Event|1|||
163122141|NCT02648217|589155662|FG000|Overall Study|Lost to Follow-up|1|||
163122142|NCT02648217|589155663|FG001|Overall Study|Lost to Follow-up|1|||
163122143|NCT02648217|589155662|FG000|Overall Study|Withdrawal by Subject|4|||
163122144|NCT02648217|589155663|FG001|Overall Study|Withdrawal by Subject|3|||
163122145|NCT02648217|589155662|FG000|Overall Study|Unclassified|5|||
163122146|NCT02648217|589155663|FG001|Overall Study|Unclassified|0|||
163122147|NCT00357656|589155664|FG000|Overall Study|Other, No surgery performed|0|||
163122148|NCT00357656|589155665|FG001|Overall Study|Other, No surgery performed|3|||
163122149|NCT00815191|589155671|FG000|Overall Study|Protocol Violation|1|||
163122150|NCT00815191|589155672|FG001|Overall Study|Protocol Violation|1|||
163122151|NCT02900170|589155673|FG000|Overall Study|Lost to Follow-up|8|||
163122152|NCT01873729|589155674|FG000|Overall Study|Withdrawal by Subject|1|||
163122153|NCT01741532|589155675|FG000|Overall Study|Adverse Event|4|||
163122154|NCT01741532|589155676|FG001|Overall Study|Adverse Event|0|||
163122155|NCT01741532|589155675|FG000|Overall Study|Withdrawal by Subject|1|||
162655409|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122156|NCT01741532|589155676|FG001|Overall Study|Withdrawal by Subject|1|||
163122157|NCT01741532|589155675|FG000|Overall Study|Protocol Violation|0|||
163122158|NCT01741532|589155676|FG001|Overall Study|Protocol Violation|1|||
163122159|NCT01741532|589155675|FG000|Overall Study|Worsening of the disease|3|||
163122160|NCT01741532|589155676|FG001|Overall Study|Worsening of the disease|1|||
163122161|NCT01741532|589155675|FG000|Overall Study|Sponsor decision|1|||
163122162|NCT01741532|589155676|FG001|Overall Study|Sponsor decision|0|||
163122163|NCT01741532|589155675|FG000|Overall Study|Medical event|1|||
163122164|NCT01741532|589155676|FG001|Overall Study|Medical event|0|||
163122165|NCT00613080|589155677|FG000|Overall Study|Ineligible / no protocol treatment|11|||
163122166|NCT02012686|589155679|FG000|Overall Study|muscle contraction|0|||
163122167|NCT02012686|589155680|FG001|Overall Study|muscle contraction|1|||
163122168|NCT02012686|589155679|FG000|Overall Study|electrocardiography monitoring noise|0|||
163122169|NCT02012686|589155680|FG001|Overall Study|electrocardiography monitoring noise|1|||
163122170|NCT01703065|589155681|FG000|Overall Study|Lack of Efficacy|1|||
163122171|NCT01703065|589155682|FG001|Overall Study|Lack of Efficacy|0|||
163122172|NCT02124772|589155683|FG000|Overall Study|Lack of Efficacy|2|||
163122173|NCT02124772|589155684|FG001|Overall Study|Lack of Efficacy|0|||
163122174|NCT02124772|589155685|FG002|Overall Study|Lack of Efficacy|0|||
163122175|NCT02124772|589155686|FG003|Overall Study|Lack of Efficacy|1|||
163122176|NCT02124772|589155687|FG004|Overall Study|Lack of Efficacy|2|||
163122177|NCT02124772|589155688|FG005|Overall Study|Lack of Efficacy|3|||
163122178|NCT02124772|589155689|FG006|Overall Study|Lack of Efficacy|0|||
163122179|NCT02124772|589155690|FG007|Overall Study|Lack of Efficacy|2|||
163122180|NCT02124772|589155691|FG008|Overall Study|Lack of Efficacy|0|||
163122181|NCT02124772|589155692|FG009|Overall Study|Lack of Efficacy|1|||
163122182|NCT02124772|589155693|FG010|Overall Study|Lack of Efficacy|0|||
163122183|NCT02124772|589155694|FG011|Overall Study|Lack of Efficacy|0|||
163122184|NCT02124772|589155695|FG012|Overall Study|Lack of Efficacy|1|||
163122185|NCT02124772|589155683|FG000|Overall Study|Adverse Event|1|||
163122186|NCT02124772|589155684|FG001|Overall Study|Adverse Event|4|||
163122187|NCT02124772|589155685|FG002|Overall Study|Adverse Event|1|||
163122188|NCT02124772|589155686|FG003|Overall Study|Adverse Event|5|||
163122189|NCT02124772|589155687|FG004|Overall Study|Adverse Event|2|||
163122190|NCT02124772|589155688|FG005|Overall Study|Adverse Event|1|||
163122191|NCT02124772|589155689|FG006|Overall Study|Adverse Event|1|||
163122192|NCT02124772|589155690|FG007|Overall Study|Adverse Event|5|||
163122193|NCT02124772|589155691|FG008|Overall Study|Adverse Event|0|||
163122194|NCT02124772|589155692|FG009|Overall Study|Adverse Event|3|||
163122195|NCT02124772|589155693|FG010|Overall Study|Adverse Event|1|||
163122196|NCT02124772|589155694|FG011|Overall Study|Adverse Event|3|||
163122197|NCT02124772|589155695|FG012|Overall Study|Adverse Event|1|||
163122198|NCT02124772|589155683|FG000|Overall Study|Withdrawal consent|0|||
163122199|NCT02124772|589155684|FG001|Overall Study|Withdrawal consent|1|||
163122200|NCT02124772|589155685|FG002|Overall Study|Withdrawal consent|1|||
163122201|NCT02124772|589155686|FG003|Overall Study|Withdrawal consent|1|||
163122202|NCT02124772|589155687|FG004|Overall Study|Withdrawal consent|0|||
163122203|NCT02124772|589155688|FG005|Overall Study|Withdrawal consent|1|||
163122204|NCT02124772|589155689|FG006|Overall Study|Withdrawal consent|1|||
163122205|NCT02124772|589155690|FG007|Overall Study|Withdrawal consent|0|||
163122206|NCT02124772|589155691|FG008|Overall Study|Withdrawal consent|0|||
163122207|NCT02124772|589155692|FG009|Overall Study|Withdrawal consent|1|||
163122208|NCT02124772|589155693|FG010|Overall Study|Withdrawal consent|0|||
162655410|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655411|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655412|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655413|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655414|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655415|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162719549|NCT03086369|587680499|FG004|Overall Study|Progressive Disease|1|||
163122209|NCT02124772|589155694|FG011|Overall Study|Withdrawal consent|1|||
163122210|NCT02124772|589155695|FG012|Overall Study|Withdrawal consent|0|||
163122211|NCT02124772|589155683|FG000|Overall Study|Investigator discretion|0|||
163122212|NCT02124772|589155684|FG001|Overall Study|Investigator discretion|2|||
163122213|NCT02124772|589155685|FG002|Overall Study|Investigator discretion|2|||
163122214|NCT02124772|589155686|FG003|Overall Study|Investigator discretion|1|||
163122215|NCT02124772|589155687|FG004|Overall Study|Investigator discretion|1|||
163122216|NCT02124772|589155688|FG005|Overall Study|Investigator discretion|0|||
163122217|NCT02124772|589155689|FG006|Overall Study|Investigator discretion|1|||
163122218|NCT02124772|589155690|FG007|Overall Study|Investigator discretion|0|||
163122219|NCT02124772|589155691|FG008|Overall Study|Investigator discretion|0|||
163122220|NCT02124772|589155692|FG009|Overall Study|Investigator discretion|1|||
163122221|NCT02124772|589155693|FG010|Overall Study|Investigator discretion|0|||
163122222|NCT02124772|589155694|FG011|Overall Study|Investigator discretion|1|||
163122223|NCT02124772|589155695|FG012|Overall Study|Investigator discretion|0|||
163122224|NCT02124772|589155683|FG000|Overall Study|Progressive disease|0|||
163122225|NCT02124772|589155684|FG001|Overall Study|Progressive disease|0|||
163122226|NCT02124772|589155685|FG002|Overall Study|Progressive disease|0|||
163122227|NCT02124772|589155686|FG003|Overall Study|Progressive disease|0|||
163122228|NCT02124772|589155687|FG004|Overall Study|Progressive disease|0|||
163122229|NCT02124772|589155688|FG005|Overall Study|Progressive disease|0|||
163122230|NCT02124772|589155689|FG006|Overall Study|Progressive disease|1|||
163122231|NCT02124772|589155690|FG007|Overall Study|Progressive disease|1|||
163122232|NCT02124772|589155691|FG008|Overall Study|Progressive disease|0|||
163122233|NCT02124772|589155692|FG009|Overall Study|Progressive disease|0|||
163122234|NCT02124772|589155693|FG010|Overall Study|Progressive disease|0|||
163122235|NCT02124772|589155694|FG011|Overall Study|Progressive disease|0|||
163122236|NCT02124772|589155695|FG012|Overall Study|Progressive disease|0|||
163122237|NCT02124772|589155683|FG000|Overall Study|Other|0|||
163122238|NCT02124772|589155684|FG001|Overall Study|Other|7|||
163122239|NCT02124772|589155685|FG002|Overall Study|Other|2|||
163122240|NCT02124772|589155686|FG003|Overall Study|Other|5|||
163122241|NCT02124772|589155687|FG004|Overall Study|Other|4|||
163122242|NCT02124772|589155688|FG005|Overall Study|Other|3|||
163122243|NCT02124772|589155689|FG006|Overall Study|Other|4|||
163122244|NCT02124772|589155690|FG007|Overall Study|Other|1|||
163122245|NCT02124772|589155691|FG008|Overall Study|Other|1|||
163122246|NCT02124772|589155692|FG009|Overall Study|Other|1|||
163122247|NCT02124772|589155693|FG010|Overall Study|Other|1|||
163122248|NCT02124772|589155694|FG011|Overall Study|Other|1|||
163122249|NCT02124772|589155695|FG012|Overall Study|Other|0|||
163122250|NCT01827332|589155696|FG000|Overall Study|Lost to Follow-up|2|||
163122251|NCT01827332|589155697|FG001|Overall Study|Lost to Follow-up|1|||
163122252|NCT01522404|589155698|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
163122253|NCT01522404|589155699|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
163122254|NCT01522404|589155698|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
163122255|NCT01522404|589155699|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
163122256|NCT01522404|589155698|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
163122257|NCT01522404|589155699|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
163122258|NCT02698371|589155700|FG000|All Participants Flow|Lost to Follow-up|3|||
163122259|NCT02698371|589155700|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
163122260|NCT02698371|589155700|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
163122261|NCT02698371|589155700|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
163122262|NCT02698371|589155700|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
163122263|NCT02698371|589155700|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
163122264|NCT02698371|589155700|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
163122265|NCT01440881|589155701|FG000|Overall Study|Death|0|||
163122266|NCT01440881|589155702|FG001|Overall Study|Death|1|||
163122267|NCT02644356|589155704|FG000|Overall Study|Withdrawal by Subject|2|||
163122268|NCT02290938|589155705|FG000|Overall Study|Lost to Follow-up|14|||
163122269|NCT02290938|589155706|FG001|Overall Study|Lost to Follow-up|43|||
163122270|NCT00897390|589155707|FG000|Overall Study|Adverse Event|2|||
163122271|NCT00897390|589155707|FG000|Overall Study|No Longer Met Study Criteria|1|||
163122272|NCT00897390|589155707|FG000|Overall Study|Personal Reasons|1|||
163122273|NCT00897390|589155707|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
163122274|NCT04500769|589156658|FG000|Overall Study|Withdrawal by Subject|5|||
163122275|NCT01511562|589156659|FG000|Induction|Adverse Event|2|||
163122276|NCT01511562|589156660|FG001|Induction|Adverse Event|0|||
163122277|NCT01511562|589156659|FG000|Induction|Disease Progression|3|||
163122278|NCT01511562|589156660|FG001|Induction|Disease Progression|7|||
163122279|NCT01511562|589156659|FG000|Induction|Death|1|||
163122280|NCT01511562|589156660|FG001|Induction|Death|3|||
163122281|NCT01511562|589156659|FG000|Induction|Withdrawal by Subject|0|||
163122282|NCT01511562|589156660|FG001|Induction|Withdrawal by Subject|4|||
163122283|NCT01511562|589156659|FG000|Induction|Other|3|||
163122284|NCT01511562|589156660|FG001|Induction|Other|0|||
163122285|NCT01511562|589156659|FG000|Consolidation|Withdrawal by Subject|1|||
163122286|NCT01511562|589156660|FG001|Consolidation|Withdrawal by Subject|0|||
163122287|NCT01511562|589156659|FG000|Consolidation|Other|1|||
163122288|NCT01511562|589156660|FG001|Consolidation|Other|0|||
163122289|NCT04736199|589156661|FG000|Overall Study|Adverse Event|28|||
163122290|NCT04736199|589156662|FG001|Overall Study|Adverse Event|22|||
163122291|NCT04736199|589156661|FG000|Overall Study|Death|9|||
163122292|NCT04736199|589156662|FG001|Overall Study|Death|3|||
163122293|NCT04736199|589156661|FG000|Overall Study|Lost to Follow-up|4|||
163122294|NCT04736199|589156662|FG001|Overall Study|Lost to Follow-up|1|||
163122295|NCT04736199|589156661|FG000|Overall Study|Physician Decision|5|||
163122296|NCT04736199|589156662|FG001|Overall Study|Physician Decision|9|||
163122297|NCT04736199|589156661|FG000|Overall Study|Withdrawal by Subject|21|||
163122298|NCT04736199|589156662|FG001|Overall Study|Withdrawal by Subject|9|||
163122299|NCT04736199|589156661|FG000|Overall Study|Progressive disease|120|||
163122300|NCT04736199|589156662|FG001|Overall Study|Progressive disease|101|||
163122301|NCT04736199|589156661|FG000|Overall Study|Subject decision|13|||
163122302|NCT04736199|589156662|FG001|Overall Study|Subject decision|13|||
163122303|NCT04736199|589156661|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
163122304|NCT04736199|589156662|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
162719550|NCT03544515|587680500|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
163122305|NCT04736199|589156661|FG000|Overall Study|Additional primary malignancy|1|||
163122306|NCT04736199|589156662|FG001|Overall Study|Additional primary malignancy|0|||
163122307|NCT04736199|589156661|FG000|Overall Study|Non-compliance with study drug|0|||
163122308|NCT04736199|589156662|FG001|Overall Study|Non-compliance with study drug|1|||
163122309|NCT04736199|589156661|FG000|Overall Study|Other reason|0|||
163122310|NCT04736199|589156662|FG001|Overall Study|Other reason|1|||
163122311|NCT04736199|589156661|FG000|Overall Study|Ongoing with study drug|240|||
163122312|NCT04736199|589156662|FG001|Overall Study|Ongoing with study drug|63|||
163122313|NCT04736199|589156661|FG000|Overall Study|Study drug never administered|3|||
163122314|NCT04736199|589156662|FG001|Overall Study|Study drug never administered|0|||
163122315|NCT04744831|589156663|FG000|Overall Study|Adverse Event|6|||
163122316|NCT04744831|589156664|FG001|Overall Study|Adverse Event|4|||
163122317|NCT04744831|589156663|FG000|Overall Study|Clinical Progression|5|||
163122318|NCT04744831|589156664|FG001|Overall Study|Clinical Progression|5|||
162655416|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655417|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655418|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655419|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122319|NCT04744831|589156663|FG000|Overall Study|Death|2|||
163122320|NCT04744831|589156664|FG001|Overall Study|Death|1|||
163122321|NCT04744831|589156663|FG000|Overall Study|Other|5|||
163122322|NCT04744831|589156664|FG001|Overall Study|Other|1|||
163122323|NCT04744831|589156663|FG000|Overall Study|Progressive Disease|63|||
163122324|NCT04744831|589156664|FG001|Overall Study|Progressive Disease|29|||
163122325|NCT04744831|589156663|FG000|Overall Study|Withdrawal by Subject|1|||
163122326|NCT04744831|589156664|FG001|Overall Study|Withdrawal by Subject|0|||
163122327|NCT02805725|589156665|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
163122328|NCT02805725|589156666|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
163122329|NCT02805725|589156667|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
163122330|NCT02805725|589156668|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
163122331|NCT02805725|589156669|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
163122332|NCT02805725|589156665|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
163122333|NCT02805725|589156666|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
163122334|NCT02805725|589156667|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
163122335|NCT02805725|589156668|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
163122336|NCT02805725|589156669|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
163122337|NCT02805725|589156665|FG000|Phase II|Protocol Violation|0|||
163122338|NCT02805725|589156666|FG001|Phase II|Protocol Violation|0|||
163122339|NCT02805725|589156667|FG002|Phase II|Protocol Violation|0|||
163122340|NCT02805725|589156668|FG003|Phase II|Protocol Violation|0|||
163122341|NCT02805725|589156669|FG004|Phase II|Protocol Violation|6|||
163122342|NCT06024096|589156675|FG000|Overall Study|Lost to Follow-up|2|||
163122343|NCT06024096|589156676|FG001|Overall Study|Lost to Follow-up|5|||
163122344|NCT06024096|589156675|FG000|Overall Study|Physician Decision|0|||
163122345|NCT06024096|589156676|FG001|Overall Study|Physician Decision|1|||
163122346|NCT06024096|589156675|FG000|Overall Study|Withdrawal by Subject|2|||
163122347|NCT06024096|589156676|FG001|Overall Study|Withdrawal by Subject|3|||
163122348|NCT05818137|589156677|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163122349|NCT05818137|589156677|FG000|Extension Treatment Period|Ongoing participants|44|||
163122350|NCT04938037|589156678|FG000|Overall Study|Lost to Follow-up|4|||
163122351|NCT04938037|589156679|FG001|Overall Study|Lost to Follow-up|3|||
163122352|NCT05925374|589156680|FG000|Overall Study|Lost to Follow-up|13|||
163122353|NCT03320330|589156683|FG000|Overall Study|Lack of Efficacy|5|||
163122354|NCT03320330|589156684|FG001|Overall Study|Lack of Efficacy|5|||
163122355|NCT03320330|589156685|FG002|Overall Study|Lack of Efficacy|14|||
163122356|NCT03320330|589156683|FG000|Overall Study|Physician Decision|1|||
163122357|NCT03320330|589156684|FG001|Overall Study|Physician Decision|0|||
163122358|NCT03320330|589156685|FG002|Overall Study|Physician Decision|0|||
163122359|NCT05206370|589156686|FG000|Overall Study|Adverse Event|3|||
163122360|NCT05206370|589156687|FG001|Overall Study|Adverse Event|4|||
163122361|NCT05206370|589156688|FG002|Overall Study|Adverse Event|5|||
163122362|NCT05206370|589156686|FG000|Overall Study|Withdrawal by Subject|27|||
163122363|NCT05206370|589156687|FG001|Overall Study|Withdrawal by Subject|30|||
163122364|NCT05206370|589156688|FG002|Overall Study|Withdrawal by Subject|24|||
163122365|NCT05206370|589156686|FG000|Overall Study|Physician Decision|1|||
163122366|NCT05206370|589156687|FG001|Overall Study|Physician Decision|3|||
163122367|NCT05206370|589156688|FG002|Overall Study|Physician Decision|2|||
163122368|NCT05206370|589156686|FG000|Overall Study|Death|0|||
163122369|NCT05206370|589156687|FG001|Overall Study|Death|1|||
163122370|NCT05206370|589156688|FG002|Overall Study|Death|3|||
163122371|NCT05206370|589156686|FG000|Overall Study|Lost to Follow-up|23|||
163122372|NCT05206370|589156687|FG001|Overall Study|Lost to Follow-up|16|||
163122373|NCT05206370|589156688|FG002|Overall Study|Lost to Follow-up|14|||
163122374|NCT05206370|589156686|FG000|Overall Study|Other, Nor Specified|2|||
163122375|NCT05206370|589156687|FG001|Overall Study|Other, Nor Specified|2|||
163122376|NCT05206370|589156688|FG002|Overall Study|Other, Nor Specified|4|||
163122377|NCT04998851|589156689|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
163122378|NCT04998851|589156690|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
162655420|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655421|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122379|NCT04998851|589156689|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
163122380|NCT04998851|589156690|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
163122381|NCT06038123|589156695|FG000|Overall Study|Withdrawal by Subject|1|||
163122382|NCT06038123|589156695|FG000|Overall Study|not return due to femur fracture|1|||
163122383|NCT05218499|589156696|FG000|Overall Study|Not treated|1|||
163122384|NCT05218499|589156697|FG001|Overall Study|Not treated|1|||
163122385|NCT05218499|589156698|FG002|Overall Study|Not treated|8|||
163122386|NCT05218499|589156696|FG000|Overall Study|Death|2|||
163122387|NCT05218499|589156697|FG001|Overall Study|Death|0|||
163122388|NCT05218499|589156698|FG002|Overall Study|Death|0|||
163122389|NCT05218499|589156696|FG000|Overall Study|Other than listed|3|||
163122390|NCT05218499|589156697|FG001|Overall Study|Other than listed|7|||
163122391|NCT05218499|589156698|FG002|Overall Study|Other than listed|10|||
163122392|NCT05218499|589156696|FG000|Overall Study|Protocol deviation|5|||
163122393|NCT05218499|589156697|FG001|Overall Study|Protocol deviation|6|||
163122394|NCT05218499|589156698|FG002|Overall Study|Protocol deviation|4|||
163122395|NCT05218499|589156696|FG000|Overall Study|Technical problems|0|||
163122396|NCT05218499|589156697|FG001|Overall Study|Technical problems|1|||
163122397|NCT05218499|589156698|FG002|Overall Study|Technical problems|0|||
163122398|NCT05218499|589156696|FG000|Overall Study|Burden of trial procedures|0|||
163122399|NCT05218499|589156697|FG001|Overall Study|Burden of trial procedures|1|||
163122400|NCT05218499|589156698|FG002|Overall Study|Burden of trial procedures|2|||
163122401|NCT05218499|589156696|FG000|Overall Study|Clinical disease progression|6|||
163122402|NCT05218499|589156697|FG001|Overall Study|Clinical disease progression|6|||
163122403|NCT05218499|589156698|FG002|Overall Study|Clinical disease progression|11|||
163122404|NCT05218499|589156696|FG000|Overall Study|Objective disease progression|44|||
163122405|NCT05218499|589156697|FG001|Overall Study|Objective disease progression|61|||
163122406|NCT05218499|589156698|FG002|Overall Study|Objective disease progression|42|||
163122407|NCT05218499|589156696|FG000|Overall Study|Adverse Event|11|||
163122408|NCT05218499|589156697|FG001|Overall Study|Adverse Event|36|||
163122409|NCT05218499|589156698|FG002|Overall Study|Adverse Event|9|||
163122410|NCT05218499|589156696|FG000|Overall Study|On treatment at time of snapshot|18|||
163122411|NCT05218499|589156697|FG001|Overall Study|On treatment at time of snapshot|29|||
163122412|NCT05218499|589156698|FG002|Overall Study|On treatment at time of snapshot|0|||
163122413|NCT03199469|589156699|FG000|Overall Study|Randomized, not treated|0|||
163122414|NCT03199469|589156700|FG001|Overall Study|Randomized, not treated|3|||
163122415|NCT03199469|589156699|FG000|Overall Study|Withdrawal by Subject|1|||
163122416|NCT03199469|589156700|FG001|Overall Study|Withdrawal by Subject|0|||
163122417|NCT03199469|589156699|FG000|Overall Study|Death|1|||
163122418|NCT03199469|589156700|FG001|Overall Study|Death|3|||
163122419|NCT03199469|589156699|FG000|Overall Study|Ongoing|5|||
163122420|NCT03199469|589156700|FG001|Overall Study|Ongoing|14|||
163122421|NCT05431387|589156710|FG000|Overall Study|Adverse Event|1|||
163122422|NCT05431387|589156711|FG001|Overall Study|Adverse Event|0|||
163122423|NCT05431387|589156710|FG000|Overall Study|Withdrawal by Subject|4|||
163122424|NCT05431387|589156711|FG001|Overall Study|Withdrawal by Subject|4|||
163122425|NCT05431387|589156710|FG000|Overall Study|Physician Decision|0|||
163122426|NCT05431387|589156711|FG001|Overall Study|Physician Decision|1|||
163122427|NCT05431387|589156710|FG000|Overall Study|Lost to Follow-up|5|||
163122428|NCT05431387|589156711|FG001|Overall Study|Lost to Follow-up|9|||
163122429|NCT05431387|589156710|FG000|Overall Study|Other, Not Specified|1|||
163122430|NCT05431387|589156711|FG001|Overall Study|Other, Not Specified|4|||
163122431|NCT03199391|589156712|FG000|Overall Study|Death|1|||
163122432|NCT03199391|589156712|FG000|Overall Study|Lost to Follow-up|3|||
163122433|NCT03199391|589156712|FG000|Overall Study|Adverse Event|2|||
163122434|NCT03199391|589156712|FG000|Overall Study|Withdrawal by Subject|10|||
163122435|NCT01867086|589156713|FG000|Overall Study|Disease Progression|1|||
163122436|NCT04257929|589156714|FG000|Overall Study|Adverse Event|1|||
163122437|NCT04257929|589156715|FG001|Overall Study|Adverse Event|0|||
163122438|NCT04257929|589156716|FG002|Overall Study|Adverse Event|1|||
163122439|NCT04257929|589156714|FG000|Overall Study|Withdrawal by Subject|1|||
163122440|NCT04257929|589156715|FG001|Overall Study|Withdrawal by Subject|0|||
163122441|NCT04257929|589156716|FG002|Overall Study|Withdrawal by Subject|0|||
163122442|NCT04257929|589156714|FG000|Overall Study|COVID-19|0|||
163122443|NCT04257929|589156715|FG001|Overall Study|COVID-19|1|||
163122444|NCT04257929|589156716|FG002|Overall Study|COVID-19|1|||
163122445|NCT04257929|589156714|FG000|Overall Study|Lost to Follow-up|0|||
163122446|NCT04257929|589156715|FG001|Overall Study|Lost to Follow-up|0|||
163122447|NCT04257929|589156716|FG002|Overall Study|Lost to Follow-up|1|||
163122448|NCT06036914|589156717|FG000|Overall Study|Withdrawal by Subject|1|||
163122449|NCT06036914|589156718|FG001|Overall Study|Withdrawal by Subject|0|||
162719551|NCT03544515|587680501|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
162719552|NCT03544515|587680500|FG000|Overall Study|Lost to Follow-up|2|||
162719553|NCT03544515|587680501|FG001|Overall Study|Lost to Follow-up|0|||
163122450|NCT04697381|589156719|FG000|Extension Period|Adverse Event|0|||
163122451|NCT04697381|589156720|FG001|Extension Period|Adverse Event|0|||
163122452|NCT04697381|589156721|FG002|Extension Period|Adverse Event|3|||
163122453|NCT04697381|589156719|FG000|Extension Period|Physician Decision|0|||
163122454|NCT04697381|589156720|FG001|Extension Period|Physician Decision|0|||
163122455|NCT04697381|589156721|FG002|Extension Period|Physician Decision|2|||
163122456|NCT04697381|589156719|FG000|Extension Period|Other|0|||
163122457|NCT04697381|589156720|FG001|Extension Period|Other|0|||
163122458|NCT04697381|589156721|FG002|Extension Period|Other|1|||
163122459|NCT04088331|589156724|FG000|Overall Study|Lost to Follow-up|3|||
163122460|NCT04088331|589156724|FG000|Overall Study|Withdrawal by Subject|7|||
163122461|NCT04088331|589156724|FG000|Overall Study|Adverse Event|4|||
163122462|NCT03500172|589156728|FG000|Period 1: Baseline Randomization|Death|0|||
163122463|NCT03500172|589156729|FG001|Period 1: Baseline Randomization|Death|0|||
163122464|NCT03500172|589156730|FG002|Period 1: Baseline Randomization|Death|0|||
163122465|NCT03500172|589156731|FG003|Period 1: Baseline Randomization|Death|0|||
163122466|NCT03500172|589156732|FG004|Period 1: Baseline Randomization|Death|0|||
163122467|NCT03500172|589156733|FG005|Period 1: Baseline Randomization|Death|0|||
163122468|NCT03500172|589156734|FG006|Period 1: Baseline Randomization|Death|0|||
163122469|NCT03500172|589156735|FG007|Period 1: Baseline Randomization|Death|0|||
163122470|NCT03500172|589156736|FG008|Period 1: Baseline Randomization|Death|0|||
163122471|NCT03500172|589156737|FG009|Period 1: Baseline Randomization|Death|2|||
163122472|NCT03500172|589156738|FG010|Period 1: Baseline Randomization|Death|0|||
163122473|NCT03500172|589156728|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
163122474|NCT03500172|589156729|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
163122475|NCT03500172|589156730|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
163122476|NCT03500172|589156731|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
163122477|NCT03500172|589156732|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
163122478|NCT03500172|589156733|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
163122479|NCT03500172|589156734|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
163122480|NCT03500172|589156735|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
163122481|NCT03500172|589156736|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
163122482|NCT03500172|589156737|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
163122483|NCT03500172|589156738|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
163122484|NCT03500172|589156728|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
163122485|NCT03500172|589156729|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
163122486|NCT03500172|589156730|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
163122487|NCT03500172|589156731|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
163122488|NCT03500172|589156732|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
163122489|NCT03500172|589156733|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
163122490|NCT03500172|589156734|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
163122491|NCT03500172|589156735|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
163122492|NCT03500172|589156736|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122493|NCT03500172|589156737|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122494|NCT03500172|589156738|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
163122495|NCT03500172|589156728|FG000|Period 2: Re-Randomization|Death|0|||
163122496|NCT03500172|589156729|FG001|Period 2: Re-Randomization|Death|0|||
163122497|NCT03500172|589156730|FG002|Period 2: Re-Randomization|Death|0|||
163122498|NCT03500172|589156731|FG003|Period 2: Re-Randomization|Death|4|||
163122499|NCT03500172|589156732|FG004|Period 2: Re-Randomization|Death|2|||
163122500|NCT03500172|589156733|FG005|Period 2: Re-Randomization|Death|0|||
163122501|NCT03500172|589156734|FG006|Period 2: Re-Randomization|Death|5|||
163122502|NCT03500172|589156735|FG007|Period 2: Re-Randomization|Death|2|||
163122503|NCT03500172|589156736|FG008|Period 2: Re-Randomization|Death|0|||
163122504|NCT03500172|589156737|FG009|Period 2: Re-Randomization|Death|0|||
163122505|NCT03500172|589156738|FG010|Period 2: Re-Randomization|Death|0|||
163122506|NCT03298451|589156745|FG000|Overall Study|Death|275|||
163122507|NCT03298451|589156746|FG001|Overall Study|Death|260|||
163122508|NCT03298451|589156747|FG002|Overall Study|Death|122|||
163122509|NCT03298451|589156748|FG003|Overall Study|Death|280|||
163122510|NCT03298451|589156745|FG000|Overall Study|Lost to Follow-up|1|||
163122511|NCT03298451|589156746|FG001|Overall Study|Lost to Follow-up|1|||
163122512|NCT03298451|589156747|FG002|Overall Study|Lost to Follow-up|0|||
163122513|NCT03298451|589156748|FG003|Overall Study|Lost to Follow-up|7|||
163122514|NCT03298451|589156745|FG000|Overall Study|Withdrawal by Subject|9|||
163122515|NCT03298451|589156746|FG001|Overall Study|Withdrawal by Subject|7|||
163122516|NCT03298451|589156747|FG002|Overall Study|Withdrawal by Subject|1|||
163122517|NCT03298451|589156748|FG003|Overall Study|Withdrawal by Subject|20|||
163122518|NCT01299571|589156756|FG000|Overall Study|Protocol Violation|107|||
163122519|NCT02486718|589157292|FG000|Enrollment Phase|Death|19|||
163122520|NCT02486718|589157293|FG001|Enrollment Phase|Death|0|||
163122521|NCT02486718|589157294|FG002|Enrollment Phase|Death|0|||
163122522|NCT02486718|589157292|FG000|Enrollment Phase|Symptomatic deterioration|1|||
163122523|NCT02486718|589157293|FG001|Enrollment Phase|Symptomatic deterioration|0|||
163122524|NCT02486718|589157294|FG002|Enrollment Phase|Symptomatic deterioration|0|||
163122525|NCT02486718|589157292|FG000|Enrollment Phase|Withdrawal by Subject|86|||
163122526|NCT02486718|589157293|FG001|Enrollment Phase|Withdrawal by Subject|0|||
163122527|NCT02486718|589157294|FG002|Enrollment Phase|Withdrawal by Subject|0|||
163122528|NCT02486718|589157292|FG000|Enrollment Phase|Protocol Violation|18|||
163122529|NCT02486718|589157293|FG001|Enrollment Phase|Protocol Violation|0|||
163122530|NCT02486718|589157294|FG002|Enrollment Phase|Protocol Violation|0|||
163122531|NCT02486718|589157292|FG000|Enrollment Phase|Physician Decision|18|||
163122532|NCT02486718|589157293|FG001|Enrollment Phase|Physician Decision|0|||
163122533|NCT02486718|589157294|FG002|Enrollment Phase|Physician Decision|0|||
163122534|NCT02486718|589157292|FG000|Enrollment Phase|Reason not provided|41|||
163122535|NCT02486718|589157293|FG001|Enrollment Phase|Reason not provided|0|||
163122536|NCT02486718|589157294|FG002|Enrollment Phase|Reason not provided|0|||
163122537|NCT02486718|589157292|FG000|Enrollment Phase|Disease relapse|54|||
163122538|NCT02486718|589157293|FG001|Enrollment Phase|Disease relapse|0|||
163122539|NCT02486718|589157294|FG002|Enrollment Phase|Disease relapse|0|||
163122540|NCT02486718|589157292|FG000|Enrollment Phase|Lost to Follow-up|4|||
163122541|NCT02486718|589157293|FG001|Enrollment Phase|Lost to Follow-up|0|||
163122542|NCT02486718|589157294|FG002|Enrollment Phase|Lost to Follow-up|0|||
163122543|NCT02486718|589157292|FG000|Enrollment Phase|Adverse Event|34|||
163122544|NCT02486718|589157293|FG001|Enrollment Phase|Adverse Event|0|||
163122545|NCT02486718|589157294|FG002|Enrollment Phase|Adverse Event|0|||
163122546|NCT02486718|589157292|FG000|Randomized Phase|Withdrawal by Subject|0|||
163122547|NCT02486718|589157293|FG001|Randomized Phase|Withdrawal by Subject|44|||
163122548|NCT02486718|589157294|FG002|Randomized Phase|Withdrawal by Subject|47|||
163122549|NCT02486718|589157292|FG000|Randomized Phase|Protocol Violation|0|||
163122550|NCT02486718|589157293|FG001|Randomized Phase|Protocol Violation|2|||
163122551|NCT02486718|589157294|FG002|Randomized Phase|Protocol Violation|0|||
163122552|NCT02486718|589157292|FG000|Randomized Phase|Physician Decision|0|||
163122553|NCT02486718|589157293|FG001|Randomized Phase|Physician Decision|0|||
163122554|NCT02486718|589157294|FG002|Randomized Phase|Physician Decision|3|||
163122555|NCT02486718|589157292|FG000|Randomized Phase|Lost to Follow-up|0|||
163122556|NCT02486718|589157293|FG001|Randomized Phase|Lost to Follow-up|5|||
163122557|NCT02486718|589157294|FG002|Randomized Phase|Lost to Follow-up|11|||
163122558|NCT02486718|589157292|FG000|Randomized Phase|Disease Relapse|0|||
163122559|NCT02486718|589157293|FG001|Randomized Phase|Disease Relapse|1|||
163122560|NCT02486718|589157294|FG002|Randomized Phase|Disease Relapse|0|||
163122561|NCT02486718|589157292|FG000|Randomized Phase|Death|0|||
163122562|NCT02486718|589157293|FG001|Randomized Phase|Death|154|||
163122563|NCT02486718|589157294|FG002|Randomized Phase|Death|155|||
163122564|NCT02486718|589157292|FG000|Randomized Phase|Ongoing|0|||
163122565|NCT02486718|589157293|FG001|Randomized Phase|Ongoing|301|||
163122566|NCT02486718|589157294|FG002|Randomized Phase|Ongoing|282|||
163122567|NCT05702918|589157295|FG000|Overall Study|Withdrawal by Subject|0|||
163122568|NCT05702918|589157296|FG001|Overall Study|Withdrawal by Subject|2|||
163122569|NCT05702918|589157295|FG000|Overall Study|Lost to Follow-up|0|||
163122570|NCT05702918|589157296|FG001|Overall Study|Lost to Follow-up|2|||
163122571|NCT05702918|589157295|FG000|Overall Study|Unrelated injury|2|||
163122572|NCT05702918|589157296|FG001|Overall Study|Unrelated injury|0|||
163122573|NCT03171545|589157303|FG000|Baseline|Withdrawal by Subject|0|||
163122574|NCT03171545|589157304|FG001|Baseline|Withdrawal by Subject|0|||
163122575|NCT03171545|589157305|FG002|Baseline|Withdrawal by Subject|1|||
163122576|NCT03171545|589157306|FG003|Baseline|Withdrawal by Subject|2|||
163122577|NCT03171545|589157303|FG000|Baseline|Transferred out of clinic|4|||
163122578|NCT03171545|589157304|FG001|Baseline|Transferred out of clinic|0|||
163122579|NCT03171545|589157305|FG002|Baseline|Transferred out of clinic|2|||
163122580|NCT03171545|589157306|FG003|Baseline|Transferred out of clinic|0|||
163122581|NCT03171545|589157303|FG000|Baseline|Death|1|||
163122582|NCT03171545|589157304|FG001|Baseline|Death|2|||
163122583|NCT03171545|589157305|FG002|Baseline|Death|1|||
163122584|NCT03171545|589157306|FG003|Baseline|Death|5|||
163122585|NCT03171545|589157303|FG000|Baseline|Recovered renal function|0|||
163122586|NCT03171545|589157304|FG001|Baseline|Recovered renal function|0|||
163122587|NCT03171545|589157305|FG002|Baseline|Recovered renal function|1|||
163122588|NCT03171545|589157306|FG003|Baseline|Recovered renal function|0|||
163122589|NCT03171545|589157303|FG000|Baseline|Received transplant|0|||
163122590|NCT03171545|589157304|FG001|Baseline|Received transplant|0|||
163122591|NCT03171545|589157305|FG002|Baseline|Received transplant|1|||
163122592|NCT03171545|589157306|FG003|Baseline|Received transplant|0|||
163122593|NCT03171545|589157303|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
163122594|NCT03171545|589157304|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
163122595|NCT03171545|589157305|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
163122596|NCT03171545|589157306|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
163122597|NCT03171545|589157303|FG000|Intervention|Withdrawal by Subject|2|||
163122598|NCT03171545|589157304|FG001|Intervention|Withdrawal by Subject|0|||
163122599|NCT03171545|589157305|FG002|Intervention|Withdrawal by Subject|0|||
163122600|NCT03171545|589157306|FG003|Intervention|Withdrawal by Subject|4|||
162719554|NCT00393848|587680504|FG000|Overall Study|Surgical schedule|0|||
163122601|NCT03171545|589157303|FG000|Intervention|Transferred out of clinic|12|||
163122602|NCT03171545|589157304|FG001|Intervention|Transferred out of clinic|9|||
163122603|NCT03171545|589157305|FG002|Intervention|Transferred out of clinic|17|||
163122604|NCT03171545|589157306|FG003|Intervention|Transferred out of clinic|9|||
163122605|NCT03171545|589157303|FG000|Intervention|Death|26|||
163122606|NCT03171545|589157304|FG001|Intervention|Death|16|||
163122607|NCT03171545|589157305|FG002|Intervention|Death|29|||
163122608|NCT03171545|589157306|FG003|Intervention|Death|14|||
163122609|NCT03171545|589157303|FG000|Intervention|Received transplant|7|||
163122610|NCT03171545|589157304|FG001|Intervention|Received transplant|5|||
163122611|NCT03171545|589157305|FG002|Intervention|Received transplant|3|||
163122612|NCT03171545|589157306|FG003|Intervention|Received transplant|6|||
163122613|NCT03171545|589157303|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
163122614|NCT03171545|589157304|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
163122615|NCT03171545|589157305|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
163122616|NCT03171545|589157306|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
163122617|NCT03171545|589157303|FG000|Intervention|Lost to Follow-up|0|||
163122618|NCT03171545|589157304|FG001|Intervention|Lost to Follow-up|1|||
163122619|NCT03171545|589157305|FG002|Intervention|Lost to Follow-up|0|||
163122620|NCT03171545|589157306|FG003|Intervention|Lost to Follow-up|0|||
163122621|NCT03171545|589157303|FG000|Follow up|Withdrawal by Subject|1|||
163122622|NCT03171545|589157304|FG001|Follow up|Withdrawal by Subject|1|||
163122623|NCT03171545|589157305|FG002|Follow up|Withdrawal by Subject|0|||
163122624|NCT03171545|589157306|FG003|Follow up|Withdrawal by Subject|0|||
163122625|NCT03171545|589157303|FG000|Follow up|Transferred out of clinic|4|||
163122626|NCT03171545|589157304|FG001|Follow up|Transferred out of clinic|4|||
163122627|NCT03171545|589157305|FG002|Follow up|Transferred out of clinic|12|||
163122628|NCT03171545|589157306|FG003|Follow up|Transferred out of clinic|7|||
163122629|NCT03171545|589157303|FG000|Follow up|Death|18|||
163122630|NCT03171545|589157304|FG001|Follow up|Death|12|||
163122631|NCT03171545|589157305|FG002|Follow up|Death|5|||
163122632|NCT03171545|589157306|FG003|Follow up|Death|8|||
163122633|NCT03171545|589157303|FG000|Follow up|Received transplant|4|||
163122634|NCT03171545|589157304|FG001|Follow up|Received transplant|1|||
163122635|NCT03171545|589157305|FG002|Follow up|Received transplant|0|||
163122636|NCT03171545|589157306|FG003|Follow up|Received transplant|1|||
163122637|NCT03171545|589157303|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
163122638|NCT03171545|589157304|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
163122639|NCT03171545|589157305|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
163122640|NCT03171545|589157306|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
163122641|NCT03171545|589157303|FG000|Follow up|Lost to Follow-up|1|||
163122642|NCT03171545|589157304|FG001|Follow up|Lost to Follow-up|2|||
163122643|NCT03171545|589157305|FG002|Follow up|Lost to Follow-up|3|||
163122644|NCT03171545|589157306|FG003|Follow up|Lost to Follow-up|1|||
163122645|NCT04409457|589157307|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
163122646|NCT04409457|589157308|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
163122647|NCT04409457|589157309|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122648|NCT04409457|589157310|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122649|NCT04409457|589157311|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122650|NCT04409457|589157312|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
163122651|NCT04409457|589157307|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
163122652|NCT04409457|589157308|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
163122653|NCT04409457|589157309|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122654|NCT04409457|589157310|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122655|NCT04409457|589157311|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122656|NCT04409457|589157312|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
163122657|NCT04409457|589157307|FG000|Randomization|Withdrawal by Subject|0|||
163122658|NCT04409457|589157308|FG001|Randomization|Withdrawal by Subject|0|||
163122659|NCT04409457|589157309|FG002|Randomization|Withdrawal by Subject|0|||
163122660|NCT04409457|589157310|FG003|Randomization|Withdrawal by Subject|0|||
163122661|NCT04409457|589157311|FG004|Randomization|Withdrawal by Subject|1|||
163122662|NCT04409457|589157312|FG005|Randomization|Withdrawal by Subject|0|||
163122663|NCT04409457|589157307|FG000|Randomization|Incidental MRI finding at scan 1|0|||
163122664|NCT04409457|589157308|FG001|Randomization|Incidental MRI finding at scan 1|0|||
163122665|NCT04409457|589157309|FG002|Randomization|Incidental MRI finding at scan 1|0|||
163122666|NCT04409457|589157310|FG003|Randomization|Incidental MRI finding at scan 1|1|||
163122667|NCT04409457|589157311|FG004|Randomization|Incidental MRI finding at scan 1|0|||
163122668|NCT04409457|589157312|FG005|Randomization|Incidental MRI finding at scan 1|1|||
163122669|NCT04409457|589157307|FG000|Randomization|Technical/equipment error at scan 1|0|||
163122670|NCT04409457|589157308|FG001|Randomization|Technical/equipment error at scan 1|0|||
163122671|NCT04409457|589157309|FG002|Randomization|Technical/equipment error at scan 1|0|||
162655422|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655423|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122672|NCT04409457|589157310|FG003|Randomization|Technical/equipment error at scan 1|0|||
163122673|NCT04409457|589157311|FG004|Randomization|Technical/equipment error at scan 1|0|||
163122674|NCT04409457|589157312|FG005|Randomization|Technical/equipment error at scan 1|1|||
163122675|NCT04865770|589157313|FG000|Overall Study|Withdrawal by Subject|3|||
163122676|NCT04865770|589157314|FG001|Overall Study|Withdrawal by Subject|0|||
163122677|NCT04865770|589157313|FG000|Overall Study|Physician Decision|9|||
163122678|NCT04865770|589157314|FG001|Overall Study|Physician Decision|0|||
163122679|NCT04865770|589157313|FG000|Overall Study|Death|1|||
163122680|NCT04865770|589157314|FG001|Overall Study|Death|1|||
163122681|NCT04522973|589157318|FG000|Overall Study|Lost to Follow-up|4|||
163122682|NCT04522973|589157318|FG000|Overall Study|Could not adhere to study schedule|1|||
163122683|NCT04007796|589157319|FG000|Overall Study|Exclusion criterion met during the trial|1|||
163122684|NCT04007796|589157320|FG001|Overall Study|Exclusion criterion met during the trial|1|||
163122685|NCT04007796|589157319|FG000|Overall Study|Withdrawal by Subject|1|||
163122686|NCT04007796|589157320|FG001|Overall Study|Withdrawal by Subject|0|||
163122687|NCT03573401|589157321|FG000|Overall Study|Withdrawal by Subject|2|||
163122688|NCT03573401|589157322|FG001|Overall Study|Withdrawal by Subject|0|||
163122689|NCT03573401|589157321|FG000|Overall Study|Subject non-compliance with study schedule|1|||
163122690|NCT03573401|589157322|FG001|Overall Study|Subject non-compliance with study schedule|0|||
163122691|NCT03573401|589157321|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
163122692|NCT03573401|589157322|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
163122693|NCT03573401|589157321|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
163122694|NCT03573401|589157322|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
163122695|NCT05579249|589157323|FG000|Overall Study|Withdrawal by Subject|1|||
163122696|NCT05579249|589157324|FG001|Overall Study|Withdrawal by Subject|3|||
163122697|NCT05579249|589157323|FG000|Overall Study|Lost to Follow-up|33|||
163122698|NCT05579249|589157324|FG001|Overall Study|Lost to Follow-up|52|||
163122699|NCT05579249|589157323|FG000|Overall Study|Physician Decision|2|||
163122700|NCT05579249|589157324|FG001|Overall Study|Physician Decision|2|||
163122701|NCT05579249|589157323|FG000|Overall Study|Death|0|||
163122702|NCT05579249|589157324|FG001|Overall Study|Death|2|||
163122703|NCT05028517|589157325|FG000|Overall Study|Lost to Follow-up|13|||
163122704|NCT05028517|589157326|FG001|Overall Study|Lost to Follow-up|20|||
163122705|NCT05028517|589157327|FG002|Overall Study|Lost to Follow-up|12|||
163122706|NCT05028517|589157325|FG000|Overall Study|Withdrawal by Subject|0|||
163122707|NCT05028517|589157326|FG001|Overall Study|Withdrawal by Subject|0|||
163122708|NCT05028517|589157327|FG002|Overall Study|Withdrawal by Subject|1|||
163122709|NCT04514341|589157328|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
163122710|NCT04514341|589157329|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
163122711|NCT04514341|589157328|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
163122712|NCT04514341|589157329|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
163122713|NCT01216683|589158226|FG000|Induction|Never started treatment|0|||
163122714|NCT01216683|589158227|FG001|Induction|Never started treatment|6|||
163122715|NCT01216683|589158228|FG002|Induction|Never started treatment|3|||
163122716|NCT01216683|589158226|FG000|Induction|Lack of Efficacy|4|||
163122717|NCT01216683|589158227|FG001|Induction|Lack of Efficacy|3|||
163122718|NCT01216683|589158228|FG002|Induction|Lack of Efficacy|7|||
163122719|NCT01216683|589158226|FG000|Induction|Adverse Event|0|||
163122720|NCT01216683|589158227|FG001|Induction|Adverse Event|5|||
163122721|NCT01216683|589158228|FG002|Induction|Adverse Event|5|||
163122722|NCT01216683|589158226|FG000|Induction|Death|0|||
163122723|NCT01216683|589158227|FG001|Induction|Death|0|||
163122724|NCT01216683|589158228|FG002|Induction|Death|2|||
163122725|NCT01216683|589158226|FG000|Induction|Withdrawal by Subject|0|||
163122726|NCT01216683|589158227|FG001|Induction|Withdrawal by Subject|4|||
163122727|NCT01216683|589158228|FG002|Induction|Withdrawal by Subject|2|||
163122728|NCT01216683|589158226|FG000|Induction|Other disease|0|||
163122729|NCT01216683|589158227|FG001|Induction|Other disease|1|||
163122730|NCT01216683|589158228|FG002|Induction|Other disease|2|||
163122731|NCT01216683|589158226|FG000|Continuation|Lack of Efficacy|3|||
163122732|NCT01216683|589158227|FG001|Continuation|Lack of Efficacy|2|||
163122733|NCT01216683|589158228|FG002|Continuation|Lack of Efficacy|7|||
163122734|NCT01216683|589158226|FG000|Continuation|Adverse Event|5|||
163122735|NCT01216683|589158227|FG001|Continuation|Adverse Event|3|||
163122736|NCT01216683|589158228|FG002|Continuation|Adverse Event|16|||
163122737|NCT01216683|589158226|FG000|Continuation|Death|1|||
163122738|NCT01216683|589158227|FG001|Continuation|Death|0|||
163122739|NCT01216683|589158228|FG002|Continuation|Death|2|||
163122740|NCT01216683|589158226|FG000|Continuation|Withdrawal by Subject|4|||
163122741|NCT01216683|589158227|FG001|Continuation|Withdrawal by Subject|5|||
163122742|NCT01216683|589158228|FG002|Continuation|Withdrawal by Subject|9|||
163122743|NCT01216683|589158226|FG000|Continuation|Other diseases|0|||
163122744|NCT01216683|589158227|FG001|Continuation|Other diseases|2|||
163122745|NCT01216683|589158228|FG002|Continuation|Other diseases|1|||
163122746|NCT01216683|589158226|FG000|Continuation|Physician Decision|1|||
163122747|NCT01216683|589158227|FG001|Continuation|Physician Decision|0|||
163122748|NCT01216683|589158228|FG002|Continuation|Physician Decision|1|||
163122749|NCT01216683|589158226|FG000|Continuation|Non-compliance|1|||
163122750|NCT01216683|589158227|FG001|Continuation|Non-compliance|0|||
163122751|NCT01216683|589158228|FG002|Continuation|Non-compliance|1|||
163122752|NCT01216683|589158226|FG000|Continuation|Insurance change|0|||
163122753|NCT01216683|589158227|FG001|Continuation|Insurance change|1|||
163122754|NCT01216683|589158228|FG002|Continuation|Insurance change|0|||
163122755|NCT01216683|589158226|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
163122756|NCT01216683|589158227|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
163122757|NCT01216683|589158228|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
163122758|NCT01216683|589158226|FG000|Continuation|Not reported|0|||
163122759|NCT01216683|589158227|FG001|Continuation|Not reported|0|||
163122760|NCT01216683|589158228|FG002|Continuation|Not reported|1|||
163122761|NCT01216683|589158226|FG000|Continuation|Never started treatment|0|||
163122762|NCT01216683|589158227|FG001|Continuation|Never started treatment|1|||
163122763|NCT01216683|589158228|FG002|Continuation|Never started treatment|5|||
163122764|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
163122765|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
163122766|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
163122767|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
163122768|NCT01350115|589158229|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
163122769|NCT01350115|589158230|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
163122770|NCT04327024|589158231|FG000|Overall Study|Death|1|||
163122771|NCT04327024|589158232|FG001|Overall Study|Death|2|||
163122772|NCT04327024|589158233|FG002|Overall Study|Death|1|||
163122773|NCT04327024|589158231|FG000|Overall Study|Non-compliance with study drug|0|||
163122774|NCT04327024|589158232|FG001|Overall Study|Non-compliance with study drug|1|||
163122775|NCT04327024|589158233|FG002|Overall Study|Non-compliance with study drug|0|||
163122776|NCT04327024|589158231|FG000|Overall Study|Withdrawal by Subject|1|||
163122777|NCT04327024|589158232|FG001|Overall Study|Withdrawal by Subject|1|||
163122778|NCT04327024|589158233|FG002|Overall Study|Withdrawal by Subject|2|||
163122779|NCT03968159|589158235|FG000|Overall Study|Adverse Event|4|||
163122780|NCT03968159|589158236|FG001|Overall Study|Adverse Event|4|||
163122781|NCT03968159|589158235|FG000|Overall Study|Lost to Follow-up|1|||
163122782|NCT03968159|589158236|FG001|Overall Study|Lost to Follow-up|1|||
163122783|NCT03968159|589158235|FG000|Overall Study|Use of prohibited medication|0|||
163122784|NCT03968159|589158236|FG001|Overall Study|Use of prohibited medication|1|||
163122785|NCT03968159|589158235|FG000|Overall Study|Protocol Violation|2|||
163122786|NCT03968159|589158236|FG001|Overall Study|Protocol Violation|2|||
163122787|NCT03968159|589158235|FG000|Overall Study|Withdrawal by Subject|4|||
163122788|NCT03968159|589158236|FG001|Overall Study|Withdrawal by Subject|6|||
163122789|NCT03968159|589158235|FG000|Overall Study|Lack of Efficacy|0|||
163122790|NCT03968159|589158236|FG001|Overall Study|Lack of Efficacy|1|||
163122791|NCT03968159|589158235|FG000|Overall Study|Not further specified|2|||
163122792|NCT03968159|589158236|FG001|Overall Study|Not further specified|0|||
163122793|NCT00864851|589158237|FG000|Overall Study|Withdrawal by Subject|0|||
163122794|NCT00864851|589158238|FG001|Overall Study|Withdrawal by Subject|1|||
163122795|NCT00864851|589158239|FG002|Overall Study|Withdrawal by Subject|0|||
163122796|NCT00864851|589158237|FG000|Overall Study|Physician Decision|1|||
163122797|NCT00864851|589158238|FG001|Overall Study|Physician Decision|0|||
163122798|NCT00864851|589158239|FG002|Overall Study|Physician Decision|0|||
163122799|NCT00864851|589158237|FG000|Overall Study|Death|1|||
163122800|NCT00864851|589158238|FG001|Overall Study|Death|0|||
163122801|NCT00864851|589158239|FG002|Overall Study|Death|0|||
163122802|NCT00864851|589158237|FG000|Overall Study|Patient uncooperative|1|||
163122803|NCT00864851|589158238|FG001|Overall Study|Patient uncooperative|0|||
163122804|NCT00864851|589158239|FG002|Overall Study|Patient uncooperative|0|||
163122805|NCT00443781|589158240|FG000|Overall Study|Lost to Follow-up|10|||
163122806|NCT00443781|589158240|FG000|Overall Study|Physician Decision|2|||
163122807|NCT00443781|589158240|FG000|Overall Study|Protocol Violation|1|||
163122808|NCT00443781|589158240|FG000|Overall Study|Withdrawal by Subject|6|||
163122809|NCT00443781|589158240|FG000|Overall Study|Unable to comply with study follow up|2|||
163122810|NCT00443781|589158240|FG000|Overall Study|Investigator terminated participation|1|||
163122811|NCT00443781|589158240|FG000|Overall Study|Insurance not covered|2|||
163122812|NCT00443781|589158240|FG000|Overall Study|PD/FAD not done|1|||
163122813|NCT00430937|589158241|FG000|Overall Study|Adverse Event|3|||
163122814|NCT00430937|589158242|FG001|Overall Study|Adverse Event|8|||
163122815|NCT00430937|589158241|FG000|Overall Study|Death|0|||
163122816|NCT00430937|589158242|FG001|Overall Study|Death|1|||
163122817|NCT00430937|589158241|FG000|Overall Study|Lost to Follow-up|6|||
163122818|NCT00430937|589158242|FG001|Overall Study|Lost to Follow-up|6|||
163122819|NCT00430937|589158241|FG000|Overall Study|Withdrawal by Subject|5|||
163122820|NCT00430937|589158242|FG001|Overall Study|Withdrawal by Subject|2|||
163122821|NCT00430937|589158241|FG000|Overall Study|Protocol Violation|3|||
163122822|NCT00430937|589158242|FG001|Overall Study|Protocol Violation|2|||
163122823|NCT00430937|589158241|FG000|Overall Study|Lack of Efficacy|6|||
163122824|NCT00430937|589158242|FG001|Overall Study|Lack of Efficacy|5|||
163122825|NCT00430937|589158241|FG000|Overall Study|Inappropriate enrollment|2|||
163122826|NCT00430937|589158242|FG001|Overall Study|Inappropriate enrollment|1|||
163122827|NCT00430937|589158241|FG000|Overall Study|Administrative reasons|1|||
163122828|NCT00430937|589158242|FG001|Overall Study|Administrative reasons|0|||
163122829|NCT00430937|589158241|FG000|Overall Study|Protocol discontinuation criteria met|1|||
163122830|NCT00430937|589158242|FG001|Overall Study|Protocol discontinuation criteria met|2|||
163122831|NCT00430937|589158241|FG000|Overall Study|Unable to classify|0|||
163122832|NCT00430937|589158242|FG001|Overall Study|Unable to classify|1|||
163122833|NCT01533922|589158243|FG000|Overall Study|Adverse Event|5|||
163122834|NCT01533922|589158244|FG001|Overall Study|Adverse Event|8|||
163122835|NCT01533922|589158245|FG002|Overall Study|Adverse Event|6|||
163122836|NCT01533922|589158246|FG003|Overall Study|Adverse Event|3|||
163122837|NCT01533922|589158247|FG004|Overall Study|Adverse Event|4|||
163122838|NCT01533922|589158243|FG000|Overall Study|Lack of Efficacy|0|||
163122839|NCT01533922|589158244|FG001|Overall Study|Lack of Efficacy|0|||
163122840|NCT01533922|589158245|FG002|Overall Study|Lack of Efficacy|1|||
163122841|NCT01533922|589158246|FG003|Overall Study|Lack of Efficacy|0|||
163122842|NCT01533922|589158247|FG004|Overall Study|Lack of Efficacy|0|||
163122843|NCT01533922|589158243|FG000|Overall Study|Protocol Violation|0|||
163122844|NCT01533922|589158244|FG001|Overall Study|Protocol Violation|3|||
163122845|NCT01533922|589158245|FG002|Overall Study|Protocol Violation|0|||
163122846|NCT01533922|589158246|FG003|Overall Study|Protocol Violation|0|||
163122847|NCT01533922|589158247|FG004|Overall Study|Protocol Violation|1|||
163122848|NCT01533922|589158243|FG000|Overall Study|Withdrawal by Subject|3|||
163122849|NCT01533922|589158244|FG001|Overall Study|Withdrawal by Subject|1|||
163122850|NCT01533922|589158245|FG002|Overall Study|Withdrawal by Subject|2|||
163122851|NCT01533922|589158246|FG003|Overall Study|Withdrawal by Subject|2|||
163122852|NCT01533922|589158247|FG004|Overall Study|Withdrawal by Subject|1|||
163122853|NCT01533922|589158243|FG000|Overall Study|Other reason not defined above|2|||
163122854|NCT01533922|589158244|FG001|Overall Study|Other reason not defined above|0|||
163122855|NCT01533922|589158245|FG002|Overall Study|Other reason not defined above|1|||
163122856|NCT01533922|589158246|FG003|Overall Study|Other reason not defined above|0|||
163122857|NCT01533922|589158247|FG004|Overall Study|Other reason not defined above|0|||
163122858|NCT00895661|589158250|FG000|Overall Study|Death|1|||
163122859|NCT00895661|589158250|FG000|Overall Study|reason unknown|2|||
163122860|NCT02006069|589158251|FG000|Overall Study|MPP other programming|239|||
163122861|NCT02006069|589158252|FG001|Overall Study|MPP other programming|0|||
163122862|NCT02006069|589158251|FG000|Overall Study|RV only pacing|0|||
163122863|NCT02006069|589158252|FG001|Overall Study|RV only pacing|3|||
163122864|NCT02989805|589158255|FG000|Overall Study|invalid consent|6|||
163122865|NCT02989805|589158256|FG001|Overall Study|invalid consent|4|||
163122866|NCT02776033|589158257|FG000|Overall Study|Withdrawal by Subject|0|||
163122867|NCT02776033|589158258|FG001|Overall Study|Withdrawal by Subject|0|||
163122868|NCT02776033|589158259|FG002|Overall Study|Withdrawal by Subject|2|||
163122869|NCT02776033|589158257|FG000|Overall Study|Physician Decision|2|||
163122870|NCT02776033|589158258|FG001|Overall Study|Physician Decision|0|||
163122871|NCT02776033|589158259|FG002|Overall Study|Physician Decision|0|||
163122872|NCT02776033|589158257|FG000|Overall Study|Lost to Follow-up|1|||
163122873|NCT02776033|589158258|FG001|Overall Study|Lost to Follow-up|0|||
163122874|NCT02776033|589158259|FG002|Overall Study|Lost to Follow-up|0|||
163122875|NCT02776033|589158257|FG000|Overall Study|Adverse Event|1|||
163122876|NCT02776033|589158258|FG001|Overall Study|Adverse Event|2|||
163122877|NCT02776033|589158259|FG002|Overall Study|Adverse Event|0|||
163122878|NCT00685373|589158260|FG000|Overall Study|Adverse Event|3|||
163122879|NCT00685373|589158260|FG000|Overall Study|Withdrawal by Subject|5|||
163122880|NCT00685373|589158260|FG000|Overall Study|Lack of Efficacy|3|||
163122881|NCT00685373|589158260|FG000|Overall Study|Condition no longer requires study drug|1|||
163122882|NCT00685373|589158260|FG000|Overall Study|Lost to Follow-up|2|||
163122883|NCT00685373|589158260|FG000|Overall Study|Protocol Violation|1|||
163122884|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
163122885|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
163122886|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
163122887|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
163122888|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
163122889|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
163122890|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
163122891|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
163122892|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
163122893|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
163122894|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
163122895|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
163122896|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
163122897|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
163122898|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
163122899|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
163122900|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
163122901|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
163122902|NCT01302054|589158261|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
163122903|NCT01302054|589158262|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
163122904|NCT01302054|589158263|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
163122905|NCT01302054|589158261|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
163122906|NCT01302054|589158262|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
163122907|NCT01302054|589158263|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
163122908|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
163122909|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
163122910|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
163122911|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
163122912|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
163122913|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
163122914|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163122915|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
163122916|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
163122917|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
163122918|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
163122919|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
163122920|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
163122921|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
163122922|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
163122923|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
163122924|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
163122925|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
163122926|NCT01302054|589158261|FG000|Double-Blind Treatment Phase|Other|0|||
163122927|NCT01302054|589158262|FG001|Double-Blind Treatment Phase|Other|4|||
163122928|NCT01302054|589158263|FG002|Double-Blind Treatment Phase|Other|9|||
163122929|NCT02639338|589158264|FG000|Overall Study|Lost to Follow-up|2|||
163122930|NCT02639338|589158265|FG001|Overall Study|Lost to Follow-up|2|||
163122931|NCT02639338|589158264|FG000|Overall Study|Withdrew Consent|1|||
163122932|NCT02639338|589158265|FG001|Overall Study|Withdrew Consent|2|||
163122933|NCT02639338|589158264|FG000|Overall Study|Death|1|||
163122934|NCT02639338|589158265|FG001|Overall Study|Death|0|||
163122935|NCT02639338|589158264|FG000|Overall Study|Randomized but Not Treated|0|||
163122936|NCT02639338|589158265|FG001|Overall Study|Randomized but Not Treated|1|||
163122937|NCT02725593|589158271|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
163122938|NCT02725593|589158272|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
163122939|NCT02725593|589158271|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
163122940|NCT02725593|589158272|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
163122941|NCT02725593|589158271|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
163122942|NCT02725593|589158272|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
163122943|NCT02725593|589158271|FG000|Long Term Extension|Withdrawal by Subject|1|||
163122944|NCT02725593|589158272|FG001|Long Term Extension|Withdrawal by Subject|3|||
163122945|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
163122946|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
163122947|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
163122948|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
163122949|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
163122950|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
163122951|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
163122952|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
163122953|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
163122954|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
163122955|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
163122956|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
163122957|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
163122958|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122959|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122960|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
163122961|NCT03689244|589158273|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
163122962|NCT03689244|589158274|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
163122963|NCT03689244|589158275|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
163122964|NCT03689244|589158276|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
163122965|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122966|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122967|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
163122968|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
163122969|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122970|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122971|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
163122972|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
163122973|NCT03689244|589158273|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
163122974|NCT03689244|589158274|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
163122975|NCT03689244|589158275|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
163122976|NCT03689244|589158276|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
162655424|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122977|NCT00444067|589158281|FG000|Overall Study|Lost to Follow-up|0|||
162655425|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
163122978|NCT00444067|589158282|FG001|Overall Study|Lost to Follow-up|1|||
163122979|NCT00267150|589158285|FG000|Overall Study|Adverse Event|1|||
163122980|NCT00969436|589158290|FG000|Overall Study|Protocol Violation|1|||
163122981|NCT00969436|589158291|FG001|Overall Study|Protocol Violation|3|||
163122982|NCT00969436|589158292|FG002|Overall Study|Protocol Violation|0|||
163122983|NCT00969436|589158290|FG000|Overall Study|Migrated/moved from study area|12|||
163122984|NCT00969436|589158291|FG001|Overall Study|Migrated/moved from study area|10|||
163122985|NCT00969436|589158292|FG002|Overall Study|Migrated/moved from study area|2|||
163122986|NCT00969436|589158290|FG000|Overall Study|Father - serious health problem|0|||
163122987|NCT00969436|589158291|FG001|Overall Study|Father - serious health problem|0|||
163122988|NCT00969436|589158292|FG002|Overall Study|Father - serious health problem|1|||
163122989|NCT00969436|589158290|FG000|Overall Study|Parents personal problem|0|||
163122990|NCT00969436|589158291|FG001|Overall Study|Parents personal problem|0|||
163122991|NCT00969436|589158292|FG002|Overall Study|Parents personal problem|1|||
163122992|NCT00969436|589158290|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
163122993|NCT00969436|589158291|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
163122994|NCT00969436|589158292|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
163122995|NCT00969436|589158290|FG000|Overall Study|Withdrawal by Subject|3|||
163122996|NCT00969436|589158291|FG001|Overall Study|Withdrawal by Subject|0|||
163122997|NCT00969436|589158292|FG002|Overall Study|Withdrawal by Subject|2|||
163122998|NCT00969436|589158290|FG000|Overall Study|Lost to Follow-up|8|||
163122999|NCT00969436|589158291|FG001|Overall Study|Lost to Follow-up|8|||
163123000|NCT00969436|589158292|FG002|Overall Study|Lost to Follow-up|5|||
163123001|NCT00351273|589158293|FG000|Overall Study|Lost to Follow-up|1|||
163123002|NCT00351273|589158294|FG001|Overall Study|Lost to Follow-up|2|||
163123003|NCT00351273|589158295|FG002|Overall Study|Lost to Follow-up|5|||
163123004|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
163123005|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
163123006|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
163123007|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
163123008|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
163123009|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
163123010|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
163123011|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
163123012|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
163123013|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123014|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123015|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
163123016|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
163123017|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
163123018|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
163123019|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
163123020|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
163123021|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
163123022|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
163123023|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
163123024|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
163123025|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
163123026|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
163123027|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
163123028|NCT01672866|589158296|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
163123029|NCT01672866|589158297|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
163123030|NCT01672866|589158298|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
163123031|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
163123032|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
163123033|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
163123034|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
163123035|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
163123036|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
163123037|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
163123038|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
163123039|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
163123040|NCT01672866|589158296|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
163123041|NCT01672866|589158297|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
163123042|NCT01672866|589158298|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
163123043|NCT02544373|589158305|FG000|Overall Study|Lost to Follow-up|5|||
163123044|NCT02544373|589158306|FG001|Overall Study|Lost to Follow-up|3|||
163123045|NCT02544373|589158305|FG000|Overall Study|Withdrawal by Subject|8|||
163123046|NCT02544373|589158306|FG001|Overall Study|Withdrawal by Subject|2|||
163123047|NCT04208087|589158308|FG000|Overall Study|Adverse Event|1|||
163123048|NCT04208087|589158309|FG001|Overall Study|Adverse Event|0|||
163123049|NCT04208087|589158310|FG002|Overall Study|Adverse Event|0|||
163123050|NCT04208087|589158311|FG003|Overall Study|Adverse Event|0|||
163123051|NCT04208087|589158312|FG004|Overall Study|Adverse Event|0|||
163123052|NCT04208087|589158308|FG000|Overall Study|Withdrawal by Subject|0|||
163123053|NCT04208087|589158309|FG001|Overall Study|Withdrawal by Subject|0|||
163123054|NCT04208087|589158310|FG002|Overall Study|Withdrawal by Subject|1|||
163123055|NCT04208087|589158311|FG003|Overall Study|Withdrawal by Subject|0|||
163123056|NCT04208087|589158312|FG004|Overall Study|Withdrawal by Subject|0|||
163123057|NCT04208087|589158308|FG000|Overall Study|Other|0|||
163123058|NCT04208087|589158309|FG001|Overall Study|Other|0|||
163123059|NCT04208087|589158310|FG002|Overall Study|Other|0|||
163123060|NCT04208087|589158311|FG003|Overall Study|Other|0|||
163123061|NCT04208087|589158312|FG004|Overall Study|Other|1|||
163123062|NCT01198509|589158313|FG000|Overall Study|Withdrawal by Subject|1|||
163123063|NCT01198509|589158314|FG001|Overall Study|Withdrawal by Subject|0|||
163123064|NCT01198509|589158315|FG002|Overall Study|Withdrawal by Subject|0|||
163123065|NCT01198509|589158316|FG003|Overall Study|Withdrawal by Subject|0|||
163123066|NCT01198509|589158317|FG004|Overall Study|Withdrawal by Subject|0|||
163123067|NCT01198509|589158318|FG005|Overall Study|Withdrawal by Subject|0|||
163123068|NCT02621073|589158328|FG000|Overall Study|Lost to Follow-up|0|||
163123069|NCT02621073|589158329|FG001|Overall Study|Lost to Follow-up|1|||
163123070|NCT02621073|589158328|FG000|Overall Study|Physician Decision|3|||
163123071|NCT02621073|589158329|FG001|Overall Study|Physician Decision|2|||
163123072|NCT01595581|589158330|FG000|Overall Study|Withdrawal by Subject|1|||
163123073|NCT01595581|589158331|FG001|Overall Study|Withdrawal by Subject|0|||
163123074|NCT01969721|589158332|FG000|Overall Study|Adverse Event|3|||
163123075|NCT01969721|589158333|FG001|Overall Study|Adverse Event|8|||
163123076|NCT01969721|589158334|FG002|Overall Study|Adverse Event|3|||
163123077|NCT01969721|589158335|FG003|Overall Study|Adverse Event|2|||
163123078|NCT01969721|589158332|FG000|Overall Study|Lack of Efficacy|0|||
163123079|NCT01969721|589158333|FG001|Overall Study|Lack of Efficacy|0|||
163123080|NCT01969721|589158334|FG002|Overall Study|Lack of Efficacy|1|||
163123081|NCT01969721|589158335|FG003|Overall Study|Lack of Efficacy|0|||
163123082|NCT01969721|589158332|FG000|Overall Study|Non compliant with protocol|1|||
163123083|NCT01969721|589158333|FG001|Overall Study|Non compliant with protocol|1|||
163123084|NCT01969721|589158334|FG002|Overall Study|Non compliant with protocol|0|||
163123085|NCT01969721|589158335|FG003|Overall Study|Non compliant with protocol|2|||
163123086|NCT01969721|589158332|FG000|Overall Study|Other not defined above|0|||
163123087|NCT01969721|589158333|FG001|Overall Study|Other not defined above|2|||
163123088|NCT01969721|589158334|FG002|Overall Study|Other not defined above|0|||
163123089|NCT01969721|589158335|FG003|Overall Study|Other not defined above|0|||
163123090|NCT01969721|589158332|FG000|Overall Study|Discontinued during washout periods.|0|||
163123091|NCT01969721|589158333|FG001|Overall Study|Discontinued during washout periods.|1|||
163123092|NCT01969721|589158334|FG002|Overall Study|Discontinued during washout periods.|1|||
163123093|NCT01969721|589158335|FG003|Overall Study|Discontinued during washout periods.|2|||
163123094|NCT02920957|589158339|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
163123095|NCT02920957|589158340|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
163123096|NCT02920957|589158339|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
163123097|NCT02920957|589158340|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
163123098|NCT02920957|589158339|FG000|First Intervention : 1 Month|Adverse Event|1|||
163123099|NCT02920957|589158340|FG001|First Intervention : 1 Month|Adverse Event|0|||
163123100|NCT02920957|589158339|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
163123101|NCT02920957|589158340|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
163123102|NCT01789606|589158341|FG000|Overall Study|Participant not Purchased the Product|0|||
163123103|NCT01789606|589158342|FG001|Overall Study|Participant not Purchased the Product|20|||
163123104|NCT01789606|589158341|FG000|Overall Study|Withdrawal by Subject|0|||
163123105|NCT01789606|589158342|FG001|Overall Study|Withdrawal by Subject|1|||
163123106|NCT01789606|589158341|FG000|Overall Study|Ineligible|6|||
162655426|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162655427|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
163123107|NCT01789606|589158342|FG001|Overall Study|Ineligible|2|||
163123108|NCT01789606|589158341|FG000|Overall Study|Administrative Reasons|17|||
163123109|NCT01789606|589158342|FG001|Overall Study|Administrative Reasons|6|||
163123110|NCT01789606|589158341|FG000|Overall Study|No Study Medication Taken|0|||
163123111|NCT01789606|589158342|FG001|Overall Study|No Study Medication Taken|1|||
163123112|NCT01789606|589158341|FG000|Overall Study|Protocol Violation|0|||
163123113|NCT01789606|589158342|FG001|Overall Study|Protocol Violation|55|||
163123114|NCT01789606|589158341|FG000|Overall Study|Adverse Event|0|||
163123115|NCT01789606|589158342|FG001|Overall Study|Adverse Event|3|||
162655428|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
162719555|NCT00393848|587680505|FG001|Overall Study|Surgical schedule|0|||
163123116|NCT01789606|589158341|FG000|Overall Study|Lost to Follow-up|0|||
163123117|NCT01789606|589158342|FG001|Overall Study|Lost to Follow-up|14|||
163123118|NCT01789606|589158341|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
163123119|NCT01789606|589158342|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
163123120|NCT03180307|589158345|FG000|Overall Study|Lost to Follow-up|2|||
163123121|NCT03180307|589158346|FG001|Overall Study|Lost to Follow-up|0|||
163123122|NCT03180307|589158345|FG000|Overall Study|Death|1|||
163123123|NCT03180307|589158346|FG001|Overall Study|Death|0|||
163123124|NCT03180307|589158345|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
163123125|NCT03180307|589158346|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
163123126|NCT03159104|589158347|FG000|Overall Study|Violation of inclusion criteria|1|||
163123127|NCT03159104|589158348|FG001|Overall Study|Violation of inclusion criteria|2|||
163123128|NCT01563172|589158352|FG000|Overall Study|Adverse Event|5|||
163123129|NCT01563172|589158352|FG000|Overall Study|Lost to Follow-up|2|||
163123130|NCT01563172|589158352|FG000|Overall Study|Other (Protocol deviation)|5|||
163123131|NCT01563172|589158352|FG000|Overall Study|Other (Not specified)|1|||
163123132|NCT00837759|589160236|FG000|Overall Study|Protocol Violation|3|||
163123133|NCT00837759|589160236|FG000|Overall Study|Lost to Follow-up|1|||
163123134|NCT01597635|589160237|FG000|Part A|Adverse Event|3|||
163123135|NCT01597635|589160238|FG001|Part A|Adverse Event|0|||
163123136|NCT01597635|589160239|FG002|Part A|Adverse Event|0|||
163123137|NCT01597635|589160237|FG000|Part B|Adverse Event|0|||
163123138|NCT01597635|589160238|FG001|Part B|Adverse Event|0|||
163123139|NCT01597635|589160239|FG002|Part B|Adverse Event|1|||
163123140|NCT01597635|589160237|FG000|Part B|Protocol Violation|0|||
163123141|NCT01597635|589160238|FG001|Part B|Protocol Violation|1|||
163123142|NCT01597635|589160239|FG002|Part B|Protocol Violation|0|||
163123143|NCT01597635|589160237|FG000|Part B|Protocol-defined stopping criteria|0|||
163123144|NCT01597635|589160238|FG001|Part B|Protocol-defined stopping criteria|4|||
163123145|NCT01597635|589160239|FG002|Part B|Protocol-defined stopping criteria|3|||
163123146|NCT01597635|589160237|FG000|Part B|Withdrawal by Subject|0|||
163123147|NCT01597635|589160238|FG001|Part B|Withdrawal by Subject|1|||
163123148|NCT01597635|589160239|FG002|Part B|Withdrawal by Subject|0|||
163123149|NCT01267175|589160241|FG000|Overall Study|Withdrawal by Subject|1|||
163123150|NCT01267175|589160241|FG000|Overall Study|Lost to Follow-up|1|||
163123151|NCT02066129|589160242|FG000|Overall Study|Lost to Follow-up|13|||
163123152|NCT02066129|589160243|FG001|Overall Study|Lost to Follow-up|12|||
163123153|NCT02066129|589160242|FG000|Overall Study|Withdrawal by Subject|7|||
163123154|NCT02066129|589160243|FG001|Overall Study|Withdrawal by Subject|10|||
163123155|NCT02066129|589160242|FG000|Overall Study|Lack of Efficacy|8|||
163123156|NCT02066129|589160243|FG001|Overall Study|Lack of Efficacy|10|||
163123157|NCT02066129|589160242|FG000|Overall Study|Physician Decision|1|||
163123158|NCT02066129|589160243|FG001|Overall Study|Physician Decision|1|||
163123159|NCT02616393|589160244|FG000|Overall Study|Death|5|||
163123160|NCT02616393|589160245|FG001|Overall Study|Death|12|||
163123161|NCT02616393|589160246|FG002|Overall Study|Death|1|||
163123162|NCT02616393|589160244|FG000|Overall Study|Termination by Sponsor|4|||
163123163|NCT02616393|589160245|FG001|Overall Study|Termination by Sponsor|5|||
163123164|NCT02616393|589160246|FG002|Overall Study|Termination by Sponsor|2|||
163123165|NCT02616393|589160244|FG000|Overall Study|Other|3|||
163123166|NCT02616393|589160245|FG001|Overall Study|Other|0|||
163123167|NCT02616393|589160246|FG002|Overall Study|Other|0|||
163123168|NCT02616393|589160244|FG000|Overall Study|Withdrawal by Subject|1|||
163123169|NCT02616393|589160245|FG001|Overall Study|Withdrawal by Subject|1|||
163123170|NCT02616393|589160246|FG002|Overall Study|Withdrawal by Subject|0|||
162655429|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
163123171|NCT02616393|589160244|FG000|Overall Study|Lost to Follow-up|0|||
163123172|NCT02616393|589160245|FG001|Overall Study|Lost to Follow-up|2|||
163123173|NCT02616393|589160246|FG002|Overall Study|Lost to Follow-up|0|||
163123174|NCT02642965|589160247|FG000|Overall Study|Lack of Efficacy|4|||
163123175|NCT02642965|589160247|FG000|Overall Study|Physician Decision|9|||
163123176|NCT02713867|589160254|FG000|Randomization|Other Reason|2|||
163123177|NCT02713867|589160255|FG001|Randomization|Other Reason|1|||
163123178|NCT02713867|589160254|FG000|Randomization|Participant Withdrew consent|0|||
162655430|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
163123179|NCT02713867|589160255|FG001|Randomization|Participant Withdrew consent|2|||
163123180|NCT02713867|589160254|FG000|Treatment Period|Other Reasons|22|||
163123181|NCT02713867|589160255|FG001|Treatment Period|Other Reasons|28|||
163123182|NCT02713867|589160254|FG000|Treatment Period|Administrative reason by sponsor|21|||
163123183|NCT02713867|589160255|FG001|Treatment Period|Administrative reason by sponsor|16|||
163123184|NCT02713867|589160254|FG000|Treatment Period|No longer meets study criteria|2|||
163123185|NCT02713867|589160255|FG001|Treatment Period|No longer meets study criteria|1|||
163123186|NCT02713867|589160254|FG000|Treatment Period|Poor/Non Compliance|1|||
163123187|NCT02713867|589160255|FG001|Treatment Period|Poor/Non Compliance|0|||
163123188|NCT02713867|589160254|FG000|Treatment Period|Maximum Clinical Benefit|5|||
163123189|NCT02713867|589160255|FG001|Treatment Period|Maximum Clinical Benefit|6|||
163123190|NCT02713867|589160254|FG000|Treatment Period|Withdrew consent|3|||
163123191|NCT02713867|589160255|FG001|Treatment Period|Withdrew consent|6|||
163123192|NCT02713867|589160254|FG000|Treatment Period|Requested to Discontinue|8|||
163123193|NCT02713867|589160255|FG001|Treatment Period|Requested to Discontinue|8|||
163123194|NCT02713867|589160254|FG000|Treatment Period|AE unrelated to Study Drug|11|||
163123195|NCT02713867|589160255|FG001|Treatment Period|AE unrelated to Study Drug|10|||
163123196|NCT02713867|589160254|FG000|Treatment Period|Death|7|||
163123197|NCT02713867|589160255|FG001|Treatment Period|Death|3|||
163123198|NCT02713867|589160254|FG000|Treatment Period|Study Drug Toxicity|16|||
163123199|NCT02713867|589160255|FG001|Treatment Period|Study Drug Toxicity|19|||
163123200|NCT02713867|589160254|FG000|Treatment Period|Disease Progression|82|||
163123201|NCT02713867|589160255|FG001|Treatment Period|Disease Progression|83|||
163123202|NCT00857948|589160256|FG000|Overall Study|Withdrawal by Subject|2|||
163123203|NCT00857948|589160257|FG001|Overall Study|Withdrawal by Subject|0|||
163123204|NCT00857948|589160258|FG002|Overall Study|Withdrawal by Subject|0|||
163123205|NCT00857948|589160259|FG003|Overall Study|Withdrawal by Subject|0|||
163123206|NCT00857948|589160256|FG000|Overall Study|Protocol Violation|1|||
163123207|NCT00857948|589160257|FG001|Overall Study|Protocol Violation|0|||
163123208|NCT00857948|589160258|FG002|Overall Study|Protocol Violation|1|||
163123209|NCT00857948|589160259|FG003|Overall Study|Protocol Violation|0|||
163123210|NCT04135859|589160265|FG000|Overall Study|Withdrawal by Subject|1|||
163123211|NCT04135859|589160266|FG001|Overall Study|Withdrawal by Subject|0|||
163123212|NCT04135859|589160265|FG000|Overall Study|Withdrawal due to screening failure|1|||
163123213|NCT04135859|589160266|FG001|Overall Study|Withdrawal due to screening failure|2|||
163123214|NCT04135859|589160265|FG000|Overall Study|Did not complete stress test|3|||
163123215|NCT04135859|589160266|FG001|Overall Study|Did not complete stress test|3|||
163123216|NCT04135859|589160265|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
163123217|NCT04135859|589160266|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
163123218|NCT00493636|589160267|FG000|Overall Study|Withdrawal by Subject|1|||
163123219|NCT00493636|589160268|FG001|Overall Study|Withdrawal by Subject|0|||
163123220|NCT00493636|589160267|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
163123221|NCT00493636|589160268|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
163123222|NCT00493636|589160267|FG000|Overall Study|Mis-randomization|1|||
163123223|NCT00493636|589160268|FG001|Overall Study|Mis-randomization|1|||
163123224|NCT01600053|589160271|FG000|Overall Study|Adverse Event|2|||
163123225|NCT01600053|589160271|FG000|Overall Study|trial will not meet the interim endpoint|9|||
163123226|NCT03230292|589160274|FG000|Overall Study|Adverse Event|1|||
163123227|NCT03230292|589160274|FG000|Overall Study|Protocol Violation|1|||
163123228|NCT03230292|589160274|FG000|Overall Study|Lost to Follow-up|1|||
163123229|NCT03230292|589160274|FG000|Overall Study|Withdrawal by Subject|3|||
163123230|NCT04047420|589160277|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
163123231|NCT04047420|589160277|FG000|Washout Period|Refused Participation|2|||
163123232|NCT02855944|589160278|FG000|Period 1: Treatment|Ongoing|14|||
163123233|NCT02855944|589160279|FG001|Period 1: Treatment|Ongoing|0|||
163123234|NCT02855944|589160278|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
163123235|NCT02855944|589160279|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
163123236|NCT02855944|589160278|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
163123237|NCT02855944|589160279|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
163123238|NCT03757130|589160280|FG000|Overall Study|Lost to Follow-up|0|||
163123239|NCT03757130|589160281|FG001|Overall Study|Lost to Follow-up|0|||
163123240|NCT03757130|589160282|FG002|Overall Study|Lost to Follow-up|0|||
163123241|NCT03757130|589160283|FG003|Overall Study|Lost to Follow-up|1|||
163123242|NCT03757130|589160284|FG004|Overall Study|Lost to Follow-up|0|||
163123243|NCT03757130|589160285|FG005|Overall Study|Lost to Follow-up|0|||
163123244|NCT03757130|589160286|FG006|Overall Study|Lost to Follow-up|0|||
163123245|NCT03757130|589160287|FG007|Overall Study|Lost to Follow-up|1|||
163123246|NCT03757130|589160280|FG000|Overall Study|Withdrawal by Subject|0|||
163123247|NCT03757130|589160281|FG001|Overall Study|Withdrawal by Subject|0|||
163123248|NCT03757130|589160282|FG002|Overall Study|Withdrawal by Subject|0|||
163123249|NCT03757130|589160283|FG003|Overall Study|Withdrawal by Subject|0|||
163123250|NCT03757130|589160284|FG004|Overall Study|Withdrawal by Subject|0|||
163123251|NCT03757130|589160285|FG005|Overall Study|Withdrawal by Subject|0|||
163123252|NCT03757130|589160286|FG006|Overall Study|Withdrawal by Subject|1|||
163123253|NCT03757130|589160287|FG007|Overall Study|Withdrawal by Subject|0|||
163123254|NCT01639755|589160288|FG000|Overall Study|Study Ongoing|15|||
163123255|NCT01639755|589160288|FG000|Overall Study|Patient had device explantation|4|||
163123256|NCT00966719|589160289|FG000|Overall Study|Lost to Follow-up|6|||
163123257|NCT00966719|589160290|FG001|Overall Study|Lost to Follow-up|11|||
163123258|NCT01439126|589160291|FG000|Overall Study|Adverse Event|2|||
163123259|NCT01439126|589160292|FG001|Overall Study|Adverse Event|0|||
163123260|NCT01439126|589160291|FG000|Overall Study|Withdrawal by Subject|5|||
163123261|NCT01439126|589160292|FG001|Overall Study|Withdrawal by Subject|21|||
163123262|NCT01439126|589160291|FG000|Overall Study|Protocol Violation|6|||
163123263|NCT01439126|589160292|FG001|Overall Study|Protocol Violation|4|||
163123264|NCT01439126|589160291|FG000|Overall Study|Lost to Follow-up|6|||
163123265|NCT01439126|589160292|FG001|Overall Study|Lost to Follow-up|3|||
163123266|NCT01439126|589160291|FG000|Overall Study|Other-Use of prohibited treatment|0|||
163123267|NCT01439126|589160292|FG001|Overall Study|Other-Use of prohibited treatment|2|||
163123268|NCT01439126|589160291|FG000|Overall Study|Other-Miscellaneous|12|||
163123269|NCT01439126|589160292|FG001|Overall Study|Other-Miscellaneous|12|||
163123270|NCT03242018|589160294|FG000|Overall Study|Adverse Event|7|||
163123271|NCT03242018|589160295|FG001|Overall Study|Adverse Event|7|||
163123272|NCT03242018|589160296|FG002|Overall Study|Adverse Event|6|||
163123273|NCT03242018|589160294|FG000|Overall Study|Lost to Follow-up|2|||
163123274|NCT03242018|589160295|FG001|Overall Study|Lost to Follow-up|2|||
163123275|NCT03242018|589160296|FG002|Overall Study|Lost to Follow-up|2|||
163123276|NCT03242018|589160294|FG000|Overall Study|At the Participant's Own Request|5|||
163123277|NCT03242018|589160295|FG001|Overall Study|At the Participant's Own Request|1|||
163123278|NCT03242018|589160296|FG002|Overall Study|At the Participant's Own Request|4|||
163123279|NCT03242018|589160294|FG000|Overall Study|Reason Not Specified|3|||
163123280|NCT03242018|589160295|FG001|Overall Study|Reason Not Specified|4|||
163123281|NCT03242018|589160296|FG002|Overall Study|Reason Not Specified|1|||
163123282|NCT03242018|589160294|FG000|Overall Study|Study Terminated by Sponsor|1|||
163123283|NCT03242018|589160295|FG001|Overall Study|Study Terminated by Sponsor|0|||
163123284|NCT03242018|589160296|FG002|Overall Study|Study Terminated by Sponsor|1|||
163123285|NCT00160199|589160299|FG000|Overall Study|Adverse Event|5|||
163123286|NCT00160199|589160300|FG001|Overall Study|Adverse Event|14|||
163123287|NCT00160199|589160299|FG000|Overall Study|Lack of Efficacy|0|||
163123288|NCT00160199|589160300|FG001|Overall Study|Lack of Efficacy|1|||
163123289|NCT00160199|589160299|FG000|Overall Study|Lost to Follow-up|7|||
163123290|NCT00160199|589160300|FG001|Overall Study|Lost to Follow-up|7|||
163123291|NCT00160199|589160299|FG000|Overall Study|Withdrawal by Subject|4|||
163123292|NCT00160199|589160300|FG001|Overall Study|Withdrawal by Subject|6|||
163123293|NCT00160199|589160299|FG000|Overall Study|Administrative|0|||
163123294|NCT00160199|589160300|FG001|Overall Study|Administrative|1|||
163123295|NCT00160199|589160299|FG000|Overall Study|Protocol Violation|8|||
163123296|NCT00160199|589160300|FG001|Overall Study|Protocol Violation|8|||
163123297|NCT02365285|589160301|FG000|Overall Study|Physician Decision|0|||
163123298|NCT02365285|589160302|FG001|Overall Study|Physician Decision|1|||
163123299|NCT02365285|589160303|FG002|Overall Study|Physician Decision|1|||
163123300|NCT02365285|589160304|FG003|Overall Study|Physician Decision|0|||
163123301|NCT02365285|589160301|FG000|Overall Study|Adverse Event|0|||
163123302|NCT02365285|589160302|FG001|Overall Study|Adverse Event|0|||
163123303|NCT02365285|589160303|FG002|Overall Study|Adverse Event|0|||
163123304|NCT02365285|589160304|FG003|Overall Study|Adverse Event|2|||
163123305|NCT03262116|589160305|FG000|Overall Study|Physician Decision|0|||
163123306|NCT03262116|589160306|FG001|Overall Study|Physician Decision|2|||
163123307|NCT03262116|589160307|FG002|Overall Study|Physician Decision|1|||
163123308|NCT03262116|589160308|FG003|Overall Study|Physician Decision|1|||
163123309|NCT03262116|589160309|FG004|Overall Study|Physician Decision|1|||
163123310|NCT03262116|589160310|FG005|Overall Study|Physician Decision|2|||
163123311|NCT02635347|589160313|FG000|Overall Study|Failed screening|20|||
163123312|NCT02635347|589160314|FG001|Overall Study|Failed screening|7|||
163123313|NCT00635089|589160319|FG000|Overall Study|Adverse Event|7|||
163123314|NCT00635089|589160319|FG000|Overall Study|Lack of Efficacy|28|||
163123315|NCT00635089|589160319|FG000|Overall Study|Protocol Deviation|4|||
163123316|NCT00635089|589160319|FG000|Overall Study|Lost to Follow-up|8|||
163123317|NCT00635089|589160319|FG000|Overall Study|Other|31|||
163123318|NCT01617447|589160320|FG000|Overall Study|Adverse Event|0|||
163123319|NCT01617447|589160321|FG001|Overall Study|Adverse Event|1|||
163123320|NCT01617447|589160320|FG000|Overall Study|Physician Decision|0|||
163123321|NCT01617447|589160321|FG001|Overall Study|Physician Decision|2|||
163123322|NCT01283542|589160323|FG000|Main Phase|Acute or progressive vision loss|1|||
163123323|NCT01283542|589160323|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
163123324|NCT01283542|589160323|FG000|Main Phase|abnormal laboratory values|5|||
163123325|NCT01283542|589160323|FG000|Extension Phase|Physician Decision|1|||
163123326|NCT01283542|589160323|FG000|Extension Phase|Adverse Event|1|||
163123327|NCT01283542|589160323|FG000|Extension Phase|Administrative problems|1|||
163123328|NCT05059977|589160324|FG000|Overall Study|Withdrawal by Subject|0|||
163123329|NCT05059977|589160325|FG001|Overall Study|Withdrawal by Subject|0|||
163123330|NCT05059977|589160326|FG002|Overall Study|Withdrawal by Subject|1|||
163123331|NCT00576472|589160327|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123332|NCT00576472|589160328|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123333|NCT00576472|589160329|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123334|NCT00576472|589160330|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
163123335|NCT00576472|589160331|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123336|NCT00576472|589160332|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123337|NCT00576472|589160333|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123338|NCT00576472|589160334|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123339|NCT00576472|589160335|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123340|NCT00576472|589160336|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123341|NCT00576472|589160337|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123342|NCT00576472|589160338|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123343|NCT00576472|589160339|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123344|NCT00576472|589160340|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123345|NCT00576472|589160341|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
163123346|NCT00576472|589160327|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
163123347|NCT00576472|589160328|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
163123348|NCT00576472|589160329|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
163123349|NCT00576472|589160330|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
163123350|NCT00576472|589160331|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
163123351|NCT00576472|589160332|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
163123352|NCT00576472|589160333|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
163123353|NCT00576472|589160334|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
163123354|NCT00576472|589160335|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
163123355|NCT00576472|589160336|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
163123356|NCT00576472|589160337|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
163123357|NCT00576472|589160338|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
163123358|NCT00576472|589160339|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
163123359|NCT00576472|589160340|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
163123360|NCT00576472|589160341|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
163123361|NCT00576472|589160327|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123362|NCT00576472|589160328|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123363|NCT00576472|589160329|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123364|NCT00576472|589160330|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
163123365|NCT00576472|589160331|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123366|NCT00576472|589160332|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123367|NCT00576472|589160333|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123368|NCT00576472|589160334|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123369|NCT00576472|589160335|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123370|NCT00576472|589160336|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123371|NCT00576472|589160337|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123372|NCT00576472|589160338|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123373|NCT00576472|589160339|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123374|NCT00576472|589160340|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123375|NCT00576472|589160341|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
163123376|NCT00576472|589160327|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
163123377|NCT00576472|589160328|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
163123378|NCT00576472|589160329|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
163123379|NCT00576472|589160330|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
163123380|NCT00576472|589160331|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
163123381|NCT00576472|589160332|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
163123382|NCT00576472|589160333|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
163123383|NCT00576472|589160334|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
163123384|NCT00576472|589160335|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
163123385|NCT00576472|589160336|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
163123386|NCT00576472|589160337|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
163123387|NCT00576472|589160338|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
163123388|NCT00576472|589160339|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
163123389|NCT00576472|589160340|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
163123390|NCT00576472|589160341|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
163123391|NCT00576472|589160327|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123392|NCT00576472|589160328|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123393|NCT00576472|589160329|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123394|NCT00576472|589160330|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
163123395|NCT00576472|589160331|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123396|NCT00576472|589160332|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123397|NCT00576472|589160333|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123398|NCT00576472|589160334|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123399|NCT00576472|589160335|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123400|NCT00576472|589160336|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123401|NCT00576472|589160337|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123402|NCT00576472|589160338|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123403|NCT00576472|589160339|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123404|NCT00576472|589160340|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123405|NCT00576472|589160341|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
163123406|NCT00576472|589160327|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123407|NCT00576472|589160328|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123408|NCT00576472|589160329|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123409|NCT00576472|589160330|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123410|NCT00576472|589160331|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123411|NCT00576472|589160332|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123412|NCT00576472|589160333|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
163123413|NCT00576472|589160334|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123414|NCT00576472|589160335|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123415|NCT00576472|589160336|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123416|NCT00576472|589160337|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123417|NCT00576472|589160338|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123418|NCT00576472|589160339|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123419|NCT00576472|589160340|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123420|NCT00576472|589160341|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
163123421|NCT00576472|589160327|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
163123422|NCT00576472|589160328|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
163123423|NCT00576472|589160329|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
163123424|NCT00576472|589160330|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
163123425|NCT00576472|589160331|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
163123426|NCT00576472|589160332|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
163123427|NCT00576472|589160333|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
163123428|NCT00576472|589160334|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
163123429|NCT00576472|589160335|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
163123430|NCT00576472|589160336|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
163123431|NCT00576472|589160337|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
163123432|NCT00576472|589160338|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
163123433|NCT00576472|589160339|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
163123434|NCT00576472|589160340|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
163123435|NCT00576472|589160341|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
163123436|NCT00576472|589160327|FG000|MPH Cross Over Phase|Physician Decision|0|||
163123437|NCT00576472|589160328|FG001|MPH Cross Over Phase|Physician Decision|0|||
163123438|NCT00576472|589160329|FG002|MPH Cross Over Phase|Physician Decision|0|||
163123439|NCT00576472|589160330|FG003|MPH Cross Over Phase|Physician Decision|0|||
163123440|NCT00576472|589160331|FG004|MPH Cross Over Phase|Physician Decision|0|||
163123441|NCT00576472|589160332|FG005|MPH Cross Over Phase|Physician Decision|0|||
163123442|NCT00576472|589160333|FG006|MPH Cross Over Phase|Physician Decision|4|||
163123443|NCT00576472|589160334|FG007|MPH Cross Over Phase|Physician Decision|0|||
163123444|NCT00576472|589160335|FG008|MPH Cross Over Phase|Physician Decision|0|||
163123445|NCT00576472|589160336|FG009|MPH Cross Over Phase|Physician Decision|0|||
163123446|NCT00576472|589160337|FG010|MPH Cross Over Phase|Physician Decision|0|||
163123447|NCT00576472|589160338|FG011|MPH Cross Over Phase|Physician Decision|0|||
163123448|NCT00576472|589160339|FG012|MPH Cross Over Phase|Physician Decision|0|||
163123449|NCT00576472|589160340|FG013|MPH Cross Over Phase|Physician Decision|0|||
163123450|NCT00576472|589160341|FG014|MPH Cross Over Phase|Physician Decision|0|||
163123451|NCT00576472|589160327|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123452|NCT00576472|589160328|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123453|NCT00576472|589160329|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123454|NCT00576472|589160330|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123455|NCT00576472|589160331|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123456|NCT00576472|589160332|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123457|NCT00576472|589160333|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123458|NCT00576472|589160334|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123459|NCT00576472|589160335|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
163123460|NCT00576472|589160336|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123461|NCT00576472|589160337|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
163123462|NCT00576472|589160338|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
163123463|NCT00576472|589160339|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123464|NCT00576472|589160340|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123465|NCT00576472|589160341|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
163123466|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123467|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123468|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123469|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123470|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123471|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123472|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123473|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123474|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123475|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123476|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123477|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123478|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123479|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
163123480|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163123481|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
163123482|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
163123483|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
163123484|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
163123485|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
163123486|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
163123487|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
163123488|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
163123489|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
163123490|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
163123491|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
163123492|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
163123493|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
163123494|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
163123495|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
163123496|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
163123497|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
163123498|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
163123499|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
163123500|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
163123501|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
163123502|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
163123503|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
163123504|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
163123505|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
163123506|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
163123507|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
163123508|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
163123509|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
163123510|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
163123511|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Side effects|0|||
163123512|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Side effects|0|||
163123513|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Side effects|0|||
163123514|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Side effects|0|||
163123515|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Side effects|0|||
163123516|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Side effects|0|||
163123517|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Side effects|0|||
163123518|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Side effects|0|||
163123519|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Side effects|0|||
163123520|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Side effects|0|||
163123521|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Side effects|0|||
163123522|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Side effects|0|||
163123523|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Side effects|0|||
163123524|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Side effects|0|||
163123525|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Side effects|8|||
163123526|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123527|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123528|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123529|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123530|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123531|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123532|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123533|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123534|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123535|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123536|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123537|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123538|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123539|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
163123540|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
163123541|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
163123542|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
163123543|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
163123544|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
163123545|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
163123546|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
163123547|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
163123548|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
163123549|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
163123550|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
163123551|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
163123552|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
163123553|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
163123554|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
163123555|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
163123556|NCT00576472|589160327|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123557|NCT00576472|589160328|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123558|NCT00576472|589160329|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123559|NCT00576472|589160330|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123560|NCT00576472|589160331|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123561|NCT00576472|589160332|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123562|NCT00576472|589160333|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123563|NCT00576472|589160334|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123564|NCT00576472|589160335|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123565|NCT00576472|589160336|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
162655431|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655432|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655433|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655434|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655435|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655436|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655437|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655438|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655439|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655440|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655441|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655442|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655443|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655444|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655445|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655446|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655447|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655448|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162655449|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162719556|NCT00393848|587680506|FG002|Overall Study|Surgical schedule|0|||
162719557|NCT00393848|587680507|FG003|Overall Study|Surgical schedule|1|||
163123566|NCT00576472|589160337|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123567|NCT00576472|589160338|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123568|NCT00576472|589160339|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123569|NCT00576472|589160340|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163123570|NCT00576472|589160341|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
163123571|NCT04405245|589160342|FG000|Overall Study|Adverse Event|0|||
163123572|NCT04405245|589160343|FG001|Overall Study|Adverse Event|1|||
163123573|NCT04405245|589160344|FG002|Overall Study|Adverse Event|0|||
163123574|NCT03443427|589160346|FG000|Overall Study|Adverse Event|2|||
162655450|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162719558|NCT00393848|587680504|FG000|Overall Study|Personal reasons|0|||
162719559|NCT00393848|587680505|FG001|Overall Study|Personal reasons|0|||
162719560|NCT00393848|587680506|FG002|Overall Study|Personal reasons|2|||
162719561|NCT00393848|587680507|FG003|Overall Study|Personal reasons|0|||
163123575|NCT03443427|589160347|FG001|Overall Study|Adverse Event|3|||
163123576|NCT03443427|589160346|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
163123577|NCT03443427|589160347|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163123578|NCT03443427|589160346|FG000|Overall Study|Other|4|||
163123579|NCT03443427|589160347|FG001|Overall Study|Other|6|||
162655451|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
162655452|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
162655453|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
162719562|NCT01376089|587680508|FG000|Overall Study|Patient received no contrast media|3|||
163123580|NCT02576860|589160350|FG000|Overall Study|Adverse Event|6|||
163123581|NCT02576860|589160351|FG001|Overall Study|Adverse Event|6|||
163123582|NCT02576860|589160350|FG000|Overall Study|Lost to Follow-up|5|||
163123583|NCT02576860|589160351|FG001|Overall Study|Lost to Follow-up|7|||
163123584|NCT02576860|589160350|FG000|Overall Study|Physician Decision|0|||
163123585|NCT02576860|589160351|FG001|Overall Study|Physician Decision|1|||
163123586|NCT02576860|589160350|FG000|Overall Study|Protocol Violation|0|||
163123587|NCT02576860|589160351|FG001|Overall Study|Protocol Violation|2|||
163123588|NCT02576860|589160350|FG000|Overall Study|Withdrawal by Subject|13|||
163123589|NCT02576860|589160351|FG001|Overall Study|Withdrawal by Subject|8|||
163123590|NCT02576860|589160350|FG000|Overall Study|Disallowed medication|1|||
163123591|NCT02576860|589160351|FG001|Overall Study|Disallowed medication|0|||
163123592|NCT00780273|589160352|FG000|Overall Study|Death|1|||
163123593|NCT00780273|589160352|FG000|Overall Study|Lost to Follow-up|1|||
163123594|NCT02391961|589160353|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
163123595|NCT02391961|589160354|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
163123596|NCT02391961|589160353|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163123597|NCT02391961|589160354|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
163123598|NCT02391961|589160353|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163123599|NCT02391961|589160354|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
163123600|NCT00477269|589160355|FG000|Core Study|Adverse Event|6|||
163123601|NCT00477269|589160356|FG001|Core Study|Adverse Event|4|||
163123602|NCT00477269|589160357|FG002|Core Study|Adverse Event|0|||
163123603|NCT00477269|589160355|FG000|Core Study|Death|3|||
163123604|NCT00477269|589160356|FG001|Core Study|Death|3|||
163123605|NCT00477269|589160357|FG002|Core Study|Death|0|||
163123606|NCT00477269|589160355|FG000|Core Study|Withdrawn Consent|0|||
163123607|NCT00477269|589160356|FG001|Core Study|Withdrawn Consent|1|||
163123608|NCT00477269|589160357|FG002|Core Study|Withdrawn Consent|0|||
163123609|NCT00477269|589160355|FG000|Open Label Extension|Adverse Event|0|||
163123610|NCT00477269|589160356|FG001|Open Label Extension|Adverse Event|0|||
163123611|NCT00477269|589160357|FG002|Open Label Extension|Adverse Event|4|||
163123612|NCT00477269|589160355|FG000|Open Label Extension|Abnormal laboratory values|0|||
162655454|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
162655455|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655456|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655457|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655458|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655459|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655460|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655461|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655462|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655463|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655464|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655465|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655466|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655467|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655468|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655469|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655470|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655471|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655472|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655473|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655474|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162655475|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655476|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
162655477|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655478|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
162655479|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655480|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655481|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655482|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655483|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655484|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655485|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163123613|NCT00477269|589160356|FG001|Open Label Extension|Abnormal laboratory values|0|||
163123614|NCT00477269|589160357|FG002|Open Label Extension|Abnormal laboratory values|1|||
163123615|NCT00477269|589160355|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
163123616|NCT00477269|589160356|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
163123617|NCT00477269|589160357|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
163123618|NCT00477269|589160355|FG000|Open Label Extension|Adminiatrative problems|0|||
163123619|NCT00477269|589160356|FG001|Open Label Extension|Adminiatrative problems|0|||
163123620|NCT00477269|589160357|FG002|Open Label Extension|Adminiatrative problems|2|||
163123621|NCT00477269|589160355|FG000|Open Label Extension|Death|0|||
163123622|NCT00477269|589160356|FG001|Open Label Extension|Death|0|||
163123623|NCT00477269|589160357|FG002|Open Label Extension|Death|4|||
163123624|NCT01565564|589160370|FG000|Overall Study|Lost to Follow-up|5|||
163123625|NCT01565564|589160371|FG001|Overall Study|Lost to Follow-up|1|||
163123626|NCT00249613|589160372|FG000|12 Month Follow-up|Death|1|||
163123627|NCT00249613|589160373|FG001|12 Month Follow-up|Death|1|||
163123628|NCT00249613|589160372|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
163123629|NCT00249613|589160373|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
163123630|NCT00249613|589160372|FG000|12 Month Follow-up|Lost to Follow-up|10|||
163123631|NCT00249613|589160373|FG001|12 Month Follow-up|Lost to Follow-up|8|||
163123632|NCT00806442|589160396|FG000|Overall Study|Lost to Follow-up|3|||
163123633|NCT00806442|589160397|FG001|Overall Study|Lost to Follow-up|2|||
163123634|NCT00806442|589160396|FG000|Overall Study|Withdrawal by Subject|1|||
163123635|NCT00806442|589160397|FG001|Overall Study|Withdrawal by Subject|5|||
163123636|NCT00654004|589160401|FG000|Overall Study|Lost to Follow-up|1|||
163123637|NCT00654004|589160402|FG001|Overall Study|Lost to Follow-up|0|||
163123638|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123639|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
163123640|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123641|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123642|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123643|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123644|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123645|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123646|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123647|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123648|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123649|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123650|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123651|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123652|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123653|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123654|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123655|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123656|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
163123657|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123658|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123659|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123660|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
163123661|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123662|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
163123663|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123664|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
163123665|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123666|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123667|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123668|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123669|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123670|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123671|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123672|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123673|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
162655486|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655487|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655488|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655489|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
163123674|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123675|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
163123676|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123677|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123678|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
163123679|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123680|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
163123681|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123682|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
163123683|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
163123684|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123685|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123686|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123687|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123688|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123689|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123690|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123691|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123692|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123693|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123694|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
163123695|NCT02528357|589160411|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123696|NCT02528357|589160412|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123697|NCT02528357|589160413|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123698|NCT02528357|589160414|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123699|NCT02528357|589160415|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123700|NCT02528357|589160416|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123701|NCT02528357|589160417|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123702|NCT02528357|589160418|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123703|NCT02528357|589160419|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123704|NCT02528357|589160420|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123705|NCT02528357|589160421|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123706|NCT02528357|589160422|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123707|NCT02528357|589160423|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123708|NCT02528357|589160424|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123709|NCT02528357|589160425|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123710|NCT02528357|589160426|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123711|NCT02528357|589160427|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123712|NCT02528357|589160428|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123713|NCT02528357|589160429|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123714|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123715|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123716|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123717|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123718|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123719|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123720|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123721|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123722|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123723|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123724|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123725|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123726|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123727|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
163123728|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
163123729|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123730|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123731|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123732|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163123733|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123734|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123735|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123736|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123737|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123738|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123739|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123740|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123741|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123742|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123743|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123744|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123745|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123746|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
163123747|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123748|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123749|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123750|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123751|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
163123752|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123753|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123754|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123755|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123756|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123757|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123758|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123759|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123760|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123761|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123762|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
163123763|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123764|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
163123765|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
163123766|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
163123767|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123768|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123769|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123770|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
163123771|NCT02528357|589160411|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123772|NCT02528357|589160412|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123773|NCT02528357|589160413|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123774|NCT02528357|589160414|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123775|NCT02528357|589160415|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123776|NCT02528357|589160416|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123777|NCT02528357|589160417|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123778|NCT02528357|589160418|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123779|NCT02528357|589160419|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123780|NCT02528357|589160420|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123781|NCT02528357|589160421|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123782|NCT02528357|589160422|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
163123783|NCT02528357|589160423|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
163123784|NCT02528357|589160424|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123785|NCT02528357|589160425|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123786|NCT02528357|589160426|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123787|NCT02528357|589160427|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123788|NCT02528357|589160428|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123789|NCT02528357|589160429|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123790|NCT02528357|589160411|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123791|NCT02528357|589160412|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123792|NCT02528357|589160413|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123793|NCT02528357|589160414|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123794|NCT02528357|589160415|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123795|NCT02528357|589160416|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123796|NCT02528357|589160417|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123797|NCT02528357|589160418|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123798|NCT02528357|589160419|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123799|NCT02528357|589160420|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123800|NCT02528357|589160421|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123801|NCT02528357|589160422|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123802|NCT02528357|589160423|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123803|NCT02528357|589160424|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123804|NCT02528357|589160425|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123805|NCT02528357|589160426|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123806|NCT02528357|589160427|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
163123807|NCT02528357|589160428|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123808|NCT02528357|589160429|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
163123809|NCT02528357|589160411|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123810|NCT02528357|589160412|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123811|NCT02528357|589160413|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123812|NCT02528357|589160414|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123813|NCT02528357|589160415|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123814|NCT02528357|589160416|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123815|NCT02528357|589160417|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123816|NCT02528357|589160418|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123817|NCT02528357|589160419|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123818|NCT02528357|589160420|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123819|NCT02528357|589160421|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123820|NCT02528357|589160422|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123821|NCT02528357|589160423|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123822|NCT02528357|589160424|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123823|NCT02528357|589160425|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123824|NCT02528357|589160426|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163123825|NCT02528357|589160427|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
163123826|NCT02528357|589160428|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
163123827|NCT02528357|589160429|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
163123828|NCT01455220|589160431|FG000|Overall Study|screen fail|30|||
163123829|NCT00495755|589160432|FG000|Overall Study|Adverse Event|3|||
163123830|NCT00720343|589162039|FG000|Overall Study|Lost to Follow-up|1|||
163123831|NCT00720343|589162040|FG001|Overall Study|Lost to Follow-up|0|||
163123832|NCT00720343|589162039|FG000|Overall Study|Protocol Violation|0|||
163123833|NCT00720343|589162040|FG001|Overall Study|Protocol Violation|2|||
163123834|NCT03459365|589162043|FG000|Overall Study|Withdrawal by Subject|6|||
163123835|NCT03459365|589162043|FG000|Overall Study|Protocol Violation|8|||
163123836|NCT00344500|589162045|FG000|Overall Study|Adverse Event|6|||
163123837|NCT00344500|589162046|FG001|Overall Study|Adverse Event|2|||
163123838|NCT00344500|589162047|FG002|Overall Study|Adverse Event|0|||
163123839|NCT00344500|589162045|FG000|Overall Study|Lost to Follow-up|5|||
163123840|NCT00344500|589162046|FG001|Overall Study|Lost to Follow-up|13|||
163123841|NCT00344500|589162047|FG002|Overall Study|Lost to Follow-up|1|||
163123842|NCT00344500|589162045|FG000|Overall Study|Withdrawal by Subject|7|||
163123843|NCT00344500|589162046|FG001|Overall Study|Withdrawal by Subject|10|||
163123844|NCT00344500|589162047|FG002|Overall Study|Withdrawal by Subject|0|||
162655490|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655491|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655492|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655493|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655494|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655495|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655496|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655497|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655498|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162655499|NCT02346240|587453533|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655500|NCT02346240|587453534|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655501|NCT02346240|587453535|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
162655502|NCT02346240|587453536|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655503|NCT02346240|587453537|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655504|NCT02346240|587453538|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655505|NCT02346240|587453539|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655506|NCT02346240|587453540|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655507|NCT02346240|587453541|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655508|NCT02346240|587453542|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655509|NCT02346240|587453543|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655510|NCT02346240|587453544|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655511|NCT02346240|587453545|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655512|NCT02346240|587453546|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655513|NCT02346240|587453547|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163123845|NCT00344500|589162045|FG000|Overall Study|Protocol Violation|4|||
163123846|NCT00344500|589162046|FG001|Overall Study|Protocol Violation|7|||
163123847|NCT00344500|589162047|FG002|Overall Study|Protocol Violation|1|||
163123848|NCT00344500|589162045|FG000|Overall Study|Not Noted|1|||
163123849|NCT00344500|589162046|FG001|Overall Study|Not Noted|3|||
163123850|NCT00344500|589162047|FG002|Overall Study|Not Noted|0|||
163123851|NCT00599755|589162048|FG000|Overall Study|Adverse Event|11|||
163123852|NCT00599755|589162048|FG000|Overall Study|Withdrawal by Subject|2|||
163123853|NCT00599755|589162048|FG000|Overall Study|Progression of Disease|3|||
163123854|NCT00599755|589162048|FG000|Overall Study|Other Reason|2|||
163123855|NCT00599755|589162048|FG000|Overall Study|No data available|1|||
163123856|NCT04037254|589162049|FG000|Overall Study|Protocol Violation|1|||
163123857|NCT04037254|589162050|FG001|Overall Study|Protocol Violation|0|||
163123858|NCT04037254|589162051|FG002|Overall Study|Protocol Violation|0|||
163123859|NCT04037254|589162052|FG003|Overall Study|Protocol Violation|0|||
163123860|NCT04037254|589162053|FG004|Overall Study|Protocol Violation|0|||
163123861|NCT04037254|589162049|FG000|Overall Study|Withdrawal by Subject|0|||
163123862|NCT04037254|589162050|FG001|Overall Study|Withdrawal by Subject|0|||
163123863|NCT04037254|589162051|FG002|Overall Study|Withdrawal by Subject|1|||
163123864|NCT04037254|589162052|FG003|Overall Study|Withdrawal by Subject|0|||
163123865|NCT04037254|589162053|FG004|Overall Study|Withdrawal by Subject|0|||
163123866|NCT04037254|589162049|FG000|Overall Study|Delayed or incomplete treatment|0|||
163123867|NCT04037254|589162050|FG001|Overall Study|Delayed or incomplete treatment|2|||
163123868|NCT04037254|589162051|FG002|Overall Study|Delayed or incomplete treatment|1|||
163123869|NCT04037254|589162052|FG003|Overall Study|Delayed or incomplete treatment|0|||
163123870|NCT04037254|589162053|FG004|Overall Study|Delayed or incomplete treatment|0|||
163123871|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
163123872|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123873|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123874|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
163123875|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
163123876|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123877|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123878|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
163123879|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
163123880|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
162655514|NCT02346240|587453548|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655515|NCT02346240|587453549|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655516|NCT02346240|587453550|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163123881|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
163123882|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
163123883|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
163123884|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
163123885|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
163123886|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
162655517|NCT02346240|587453551|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655518|NCT02346240|587453552|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655519|NCT02346240|587453553|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655520|NCT02346240|587453554|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655521|NCT02346240|587453555|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
163123887|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
163123888|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
163123889|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
163123890|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
163123891|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
163123892|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123893|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123894|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
163123895|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
163123896|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123897|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123898|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
163123899|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
163123900|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123901|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123902|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163123903|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
163123904|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123905|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123906|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
163123907|NCT02198794|589162054|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
163123908|NCT02198794|589162055|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123909|NCT02198794|589162056|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123910|NCT02198794|589162057|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
163123911|NCT02198794|589162054|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
163123912|NCT02198794|589162055|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
163123913|NCT02198794|589162056|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
163123914|NCT02198794|589162057|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
163123915|NCT02198794|589162054|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
163123916|NCT02198794|589162055|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
163123917|NCT02198794|589162056|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
163123918|NCT02198794|589162057|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
163123919|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123920|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123921|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
163123922|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
163123923|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123924|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123925|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
163123926|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
163123927|NCT02198794|589162054|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123928|NCT02198794|589162055|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123929|NCT02198794|589162056|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
163123930|NCT02198794|589162057|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
163123931|NCT01306656|589162058|FG000|Overall Study|Lost to Follow-up|1|||
163123932|NCT01306656|589162059|FG001|Overall Study|Lost to Follow-up|0|||
163123933|NCT01918332|589162063|FG000|Overall Study|Adverse Event|0|||
163123934|NCT01918332|589162064|FG001|Overall Study|Adverse Event|0|||
163123935|NCT01918332|589162065|FG002|Overall Study|Adverse Event|0|||
163123936|NCT01918332|589162066|FG003|Overall Study|Adverse Event|1|||
163123937|NCT01918332|589162063|FG000|Overall Study|Withdrawal by Subject|2|||
163123938|NCT01918332|589162064|FG001|Overall Study|Withdrawal by Subject|3|||
163123939|NCT01918332|589162065|FG002|Overall Study|Withdrawal by Subject|2|||
163123940|NCT01918332|589162066|FG003|Overall Study|Withdrawal by Subject|3|||
163123941|NCT01918332|589162063|FG000|Overall Study|Protocol Violation|6|||
163123942|NCT01918332|589162064|FG001|Overall Study|Protocol Violation|2|||
163123943|NCT01918332|589162065|FG002|Overall Study|Protocol Violation|6|||
163123944|NCT01918332|589162066|FG003|Overall Study|Protocol Violation|3|||
163123945|NCT01918332|589162063|FG000|Overall Study|lipid result by central lab did not meet|0|||
163123946|NCT01918332|589162064|FG001|Overall Study|lipid result by central lab did not meet|0|||
163123947|NCT01918332|589162065|FG002|Overall Study|lipid result by central lab did not meet|1|||
162655522|NCT02346240|587453556|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162655523|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163123948|NCT01918332|589162066|FG003|Overall Study|lipid result by central lab did not meet|0|||
163123949|NCT02252965|589162069|FG000|Overall Study|Adverse Event|9|||
163123950|NCT02252965|589162070|FG001|Overall Study|Adverse Event|14|||
163123951|NCT02252965|589162069|FG000|Overall Study|Lost to Follow-up|16|||
162655524|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
163123952|NCT02252965|589162070|FG001|Overall Study|Lost to Follow-up|8|||
163123953|NCT02252965|589162069|FG000|Overall Study|Protocol Violation|4|||
163123954|NCT02252965|589162070|FG001|Overall Study|Protocol Violation|5|||
163123955|NCT02252965|589162069|FG000|Overall Study|Lack of Efficacy|0|||
163123956|NCT02252965|589162070|FG001|Overall Study|Lack of Efficacy|2|||
163123957|NCT02252965|589162069|FG000|Overall Study|Withdrawal by Subject|7|||
163123958|NCT02252965|589162070|FG001|Overall Study|Withdrawal by Subject|9|||
163123959|NCT02252965|589162069|FG000|Overall Study|Other|4|||
163123960|NCT02252965|589162070|FG001|Overall Study|Other|5|||
163123961|NCT04736628|589162075|FG000|Overall Study|Not treated|0|||
163123962|NCT04736628|589162076|FG001|Overall Study|Not treated|0|||
163123963|NCT04736628|589162077|FG002|Overall Study|Not treated|0|||
163123964|NCT04736628|589162078|FG003|Overall Study|Not treated|2|||
163123965|NCT04736628|589162075|FG000|Overall Study|Other reason than listed|1|||
163123966|NCT04736628|589162076|FG001|Overall Study|Other reason than listed|2|||
163123967|NCT04736628|589162077|FG002|Overall Study|Other reason than listed|2|||
163123968|NCT04736628|589162078|FG003|Overall Study|Other reason than listed|3|||
163123969|NCT04736628|589162075|FG000|Overall Study|Protocol deviation|0|||
163123970|NCT04736628|589162076|FG001|Overall Study|Protocol deviation|0|||
163123971|NCT04736628|589162077|FG002|Overall Study|Protocol deviation|0|||
163123972|NCT04736628|589162078|FG003|Overall Study|Protocol deviation|1|||
163123973|NCT04736628|589162075|FG000|Overall Study|Burden of study procedures|1|||
163123974|NCT04736628|589162076|FG001|Overall Study|Burden of study procedures|0|||
163123975|NCT04736628|589162077|FG002|Overall Study|Burden of study procedures|0|||
163123976|NCT04736628|589162078|FG003|Overall Study|Burden of study procedures|1|||
163123977|NCT04736628|589162075|FG000|Overall Study|Change of residence|0|||
163123978|NCT04736628|589162076|FG001|Overall Study|Change of residence|1|||
163123979|NCT04736628|589162077|FG002|Overall Study|Change of residence|0|||
163123980|NCT04736628|589162078|FG003|Overall Study|Change of residence|0|||
163123981|NCT04736628|589162075|FG000|Overall Study|Perceived lack of efficacy|1|||
163123982|NCT04736628|589162076|FG001|Overall Study|Perceived lack of efficacy|0|||
163123983|NCT04736628|589162077|FG002|Overall Study|Perceived lack of efficacy|0|||
163123984|NCT04736628|589162078|FG003|Overall Study|Perceived lack of efficacy|1|||
163123985|NCT04736628|589162075|FG000|Overall Study|Adverse Event|3|||
163123986|NCT04736628|589162076|FG001|Overall Study|Adverse Event|2|||
163123987|NCT04736628|589162077|FG002|Overall Study|Adverse Event|4|||
163123988|NCT04736628|589162078|FG003|Overall Study|Adverse Event|3|||
163123989|NCT04279613|589162079|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123990|NCT04279613|589162080|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123991|NCT04279613|589162081|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123992|NCT04279613|589162082|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
163123993|NCT04279613|589162083|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
163123994|NCT04279613|589162079|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123995|NCT04279613|589162080|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
163123996|NCT04279613|589162081|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123997|NCT04279613|589162082|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123998|NCT04279613|589162083|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
163123999|NCT04279613|589162079|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124000|NCT04279613|589162080|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124001|NCT04279613|589162081|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
163124002|NCT04279613|589162082|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124003|NCT04279613|589162083|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
163124004|NCT04279613|589162079|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124005|NCT04279613|589162080|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124006|NCT04279613|589162081|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124007|NCT04279613|589162082|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
163124008|NCT04279613|589162083|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
163124009|NCT04279613|589162079|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124010|NCT04279613|589162080|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
162655525|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655526|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655527|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655528|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655529|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655530|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162655531|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
162655532|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655533|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655534|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655535|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655536|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162655537|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
162655538|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162655539|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
162655540|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655541|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655542|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655543|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655544|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655545|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655546|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162655547|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655548|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655549|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655550|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655551|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655552|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655553|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655554|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655555|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655556|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655557|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655558|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655559|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655560|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
162655561|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655562|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
162655563|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655564|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655565|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655566|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655567|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655568|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162655569|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163124011|NCT04279613|589162081|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124012|NCT04279613|589162082|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
163124013|NCT04279613|589162083|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
163124014|NCT02478164|589162084|FG000|Overall Study|Lack of Efficacy|13|||
163124015|NCT02478164|589162084|FG000|Overall Study|Adverse Event|1|||
163124016|NCT02478164|589162084|FG000|Overall Study|Withdrawal by Subject|1|||
163124017|NCT04051827|589162085|FG000|Overall Study|Death|1|||
163124018|NCT04051827|589162085|FG000|Overall Study|Withdrawal by Subject|4|||
163124019|NCT04051827|589162085|FG000|Overall Study|Progressive disease|16|||
163124020|NCT04051827|589162085|FG000|Overall Study|Physician Decision|1|||
163124021|NCT04051827|589162085|FG000|Overall Study|Other|4|||
163124022|NCT05779007|589162086|FG000|Overall Study|not meeting eligibility criteria|3517|||
163124023|NCT05779007|589162087|FG001|Overall Study|not meeting eligibility criteria|2009|||
163124024|NCT01424566|589162088|FG000|Single-blind Treatment|Adverse Event|71|||
163124025|NCT01424566|589162089|FG001|Single-blind Treatment|Adverse Event|0|||
162655570|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
163124026|NCT01424566|589162090|FG002|Single-blind Treatment|Adverse Event|0|||
163124027|NCT01424566|589162088|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
163124028|NCT01424566|589162089|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
163124029|NCT01424566|589162090|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
162655571|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655572|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655573|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655574|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124030|NCT01424566|589162088|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
163124031|NCT01424566|589162089|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
163124032|NCT01424566|589162090|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
163124033|NCT01424566|589162088|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
163124034|NCT01424566|589162089|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
163124035|NCT01424566|589162090|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
163124036|NCT01424566|589162088|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
163124037|NCT01424566|589162089|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
163124038|NCT01424566|589162090|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
163124039|NCT01424566|589162088|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
163124040|NCT01424566|589162089|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
163124041|NCT01424566|589162090|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
163124042|NCT01424566|589162088|FG000|Double-blind Treatment|Adverse Event|0|||
163124043|NCT01424566|589162089|FG001|Double-blind Treatment|Adverse Event|21|||
163124044|NCT01424566|589162090|FG002|Double-blind Treatment|Adverse Event|13|||
163124045|NCT01424566|589162088|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
163124046|NCT01424566|589162089|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
163124047|NCT01424566|589162090|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
163124048|NCT01424566|589162088|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
163124049|NCT01424566|589162089|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
163124050|NCT01424566|589162090|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
163124051|NCT01424566|589162088|FG000|Double-blind Treatment|Lack of Efficacy|0|||
163124052|NCT01424566|589162089|FG001|Double-blind Treatment|Lack of Efficacy|1|||
163124053|NCT01424566|589162090|FG002|Double-blind Treatment|Lack of Efficacy|1|||
163124054|NCT00680368|589162093|FG000|Overall Study|not supervised, not eligible|15|||
163124055|NCT03779503|589162094|FG000|First Intervention|Adverse Event|0|||
163124056|NCT03779503|589162095|FG001|First Intervention|Adverse Event|1|||
163124057|NCT03779503|589162094|FG000|First Intervention|Withdrawal by Subject|1|||
163124058|NCT03779503|589162095|FG001|First Intervention|Withdrawal by Subject|0|||
163124059|NCT02771626|589162099|FG000|Overall Study|Adverse Event|1|||
163124060|NCT02771626|589162100|FG001|Overall Study|Adverse Event|5|||
163124061|NCT02771626|589162101|FG002|Overall Study|Adverse Event|3|||
163124062|NCT02771626|589162102|FG003|Overall Study|Adverse Event|0|||
163124063|NCT02771626|589162103|FG004|Overall Study|Adverse Event|1|||
163124064|NCT02771626|589162104|FG005|Overall Study|Adverse Event|1|||
163124065|NCT02771626|589162099|FG000|Overall Study|Radiologic Disease Progression|6|||
163124066|NCT02771626|589162100|FG001|Overall Study|Radiologic Disease Progression|13|||
163124067|NCT02771626|589162101|FG002|Overall Study|Radiologic Disease Progression|10|||
163124068|NCT02771626|589162102|FG003|Overall Study|Radiologic Disease Progression|7|||
163124069|NCT02771626|589162103|FG004|Overall Study|Radiologic Disease Progression|28|||
163124070|NCT02771626|589162104|FG005|Overall Study|Radiologic Disease Progression|15|||
163124071|NCT02771626|589162099|FG000|Overall Study|Symptomatic Deterioration|0|||
163124072|NCT02771626|589162100|FG001|Overall Study|Symptomatic Deterioration|4|||
163124073|NCT02771626|589162101|FG002|Overall Study|Symptomatic Deterioration|2|||
163124074|NCT02771626|589162102|FG003|Overall Study|Symptomatic Deterioration|0|||
163124075|NCT02771626|589162103|FG004|Overall Study|Symptomatic Deterioration|5|||
163124076|NCT02771626|589162104|FG005|Overall Study|Symptomatic Deterioration|2|||
163124077|NCT02771626|589162099|FG000|Overall Study|Participant Request|0|||
163124078|NCT02771626|589162100|FG001|Overall Study|Participant Request|1|||
163124079|NCT02771626|589162101|FG002|Overall Study|Participant Request|0|||
163124080|NCT02771626|589162102|FG003|Overall Study|Participant Request|2|||
163124081|NCT02771626|589162103|FG004|Overall Study|Participant Request|0|||
163124082|NCT02771626|589162104|FG005|Overall Study|Participant Request|1|||
163124083|NCT02771626|589162099|FG000|Overall Study|Investigator Decision|0|||
163124084|NCT02771626|589162100|FG001|Overall Study|Investigator Decision|1|||
163124085|NCT02771626|589162101|FG002|Overall Study|Investigator Decision|0|||
162655575|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655576|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124086|NCT02771626|589162102|FG003|Overall Study|Investigator Decision|0|||
163124087|NCT02771626|589162103|FG004|Overall Study|Investigator Decision|1|||
163124088|NCT02771626|589162104|FG005|Overall Study|Investigator Decision|0|||
163124089|NCT02771626|589162099|FG000|Overall Study|Study Termination by Sponsor|0|||
163124090|NCT02771626|589162100|FG001|Overall Study|Study Termination by Sponsor|2|||
163124091|NCT02771626|589162101|FG002|Overall Study|Study Termination by Sponsor|1|||
163124092|NCT02771626|589162102|FG003|Overall Study|Study Termination by Sponsor|0|||
163124093|NCT02771626|589162103|FG004|Overall Study|Study Termination by Sponsor|1|||
163124094|NCT02771626|589162104|FG005|Overall Study|Study Termination by Sponsor|0|||
163124095|NCT02771626|589162099|FG000|Overall Study|Informed Consent Withdrawn|0|||
163124096|NCT02771626|589162100|FG001|Overall Study|Informed Consent Withdrawn|0|||
163124097|NCT02771626|589162101|FG002|Overall Study|Informed Consent Withdrawn|1|||
163124098|NCT02771626|589162102|FG003|Overall Study|Informed Consent Withdrawn|0|||
163124099|NCT02771626|589162103|FG004|Overall Study|Informed Consent Withdrawn|1|||
163124100|NCT02771626|589162104|FG005|Overall Study|Informed Consent Withdrawn|1|||
163124101|NCT02771626|589162099|FG000|Overall Study|Other, Not Specified|1|||
163124102|NCT02771626|589162100|FG001|Overall Study|Other, Not Specified|0|||
163124103|NCT02771626|589162101|FG002|Overall Study|Other, Not Specified|0|||
163124104|NCT02771626|589162102|FG003|Overall Study|Other, Not Specified|0|||
163124105|NCT02771626|589162103|FG004|Overall Study|Other, Not Specified|0|||
163124106|NCT02771626|589162104|FG005|Overall Study|Other, Not Specified|1|||
163124107|NCT02690649|589162105|FG000|Overall Study|Withdrawal by Subject|1|||
163124108|NCT02690649|589162106|FG001|Overall Study|Withdrawal by Subject|1|||
163124109|NCT02690649|589162105|FG000|Overall Study|Protocol Violation|0|||
163124110|NCT02690649|589162106|FG001|Overall Study|Protocol Violation|3|||
163124111|NCT02392403|589162107|FG000|Overall Study|Adverse Event|1|||
163124112|NCT02392403|589162107|FG000|Overall Study|Death|1|||
163124113|NCT02392403|589162107|FG000|Overall Study|Withdrawal by Subject|1|||
163124114|NCT00316888|589162113|FG000|Overall Study|Adverse Event|4|||
163124115|NCT00316888|589162114|FG001|Overall Study|Adverse Event|5|||
163124116|NCT00316888|589162113|FG000|Overall Study|Withdrawal by Subject|2|||
163124117|NCT00316888|589162114|FG001|Overall Study|Withdrawal by Subject|2|||
163124118|NCT00316888|589162113|FG000|Overall Study|Not start protocol therapy|0|||
163124119|NCT00316888|589162114|FG001|Overall Study|Not start protocol therapy|1|||
163124120|NCT00657371|589162115|FG000|Overall Study|Poor bowel preparation|15|||
163124121|NCT00657371|589162115|FG000|Overall Study|Unable to intubate the cecum|5|||
163124122|NCT00657371|589162115|FG000|Overall Study|Protocol Violation|2|||
163124123|NCT00657371|589162115|FG000|Overall Study|Device- related reasons|13|||
163124124|NCT00657371|589162115|FG000|Overall Study|Pre-existing medical condition|4|||
163124125|NCT00652899|589162116|FG000|Overall Study|Death|1|||
163124126|NCT00652899|589162116|FG000|Overall Study|Treating physician decision|1|||
163124127|NCT02715726|589162117|FG000|Overall Study|Adverse Event|2|||
163124128|NCT02715726|589162118|FG001|Overall Study|Adverse Event|6|||
163124129|NCT02715726|589162117|FG000|Overall Study|Protocol Violation|1|||
163124130|NCT02715726|589162118|FG001|Overall Study|Protocol Violation|0|||
163124131|NCT02715726|589162117|FG000|Overall Study|Death|2|||
163124132|NCT02715726|589162118|FG001|Overall Study|Death|1|||
163124133|NCT02715726|589162117|FG000|Overall Study|Participant moved|1|||
163124134|NCT02715726|589162118|FG001|Overall Study|Participant moved|3|||
163124135|NCT02715726|589162117|FG000|Overall Study|Other than specified above|11|||
163124136|NCT02715726|589162118|FG001|Overall Study|Other than specified above|15|||
163124137|NCT02715726|589162117|FG000|Overall Study|Randomized but not treated|1|||
163124138|NCT02715726|589162118|FG001|Overall Study|Randomized but not treated|2|||
163124139|NCT02445573|589162119|FG000|Overall Study|Withdrawal by Subject|1|||
163124140|NCT02445573|589162120|FG001|Overall Study|Withdrawal by Subject|1|||
163124141|NCT02445573|589162119|FG000|Overall Study|Lost to Follow-up|0|||
163124142|NCT02445573|589162120|FG001|Overall Study|Lost to Follow-up|1|||
163124143|NCT01565941|589162121|FG000|Overall Study|Withdrawn by parent/guardian|3|||
163124144|NCT01565941|589162122|FG001|Overall Study|Withdrawn by parent/guardian|2|||
163124145|NCT01565941|589162121|FG000|Overall Study|Randomized; did not receive intevention|8|||
163124146|NCT01565941|589162122|FG001|Overall Study|Randomized; did not receive intevention|2|||
163124147|NCT03629912|589162130|FG000|Overall Study|Lost to Follow-up|19|||
163124148|NCT03629912|589162131|FG001|Overall Study|Lost to Follow-up|7|||
163124149|NCT03629912|589162132|FG002|Overall Study|Lost to Follow-up|5|||
163124150|NCT03629912|589162133|FG003|Overall Study|Lost to Follow-up|1|||
163124151|NCT03629912|589162130|FG000|Overall Study|Withdrawal by Subject|6|||
163124152|NCT03629912|589162131|FG001|Overall Study|Withdrawal by Subject|0|||
163124153|NCT03629912|589162132|FG002|Overall Study|Withdrawal by Subject|1|||
163124154|NCT03629912|589162133|FG003|Overall Study|Withdrawal by Subject|2|||
163124155|NCT03629912|589162130|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
163124156|NCT03629912|589162131|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
163124157|NCT03629912|589162132|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
163124158|NCT03629912|589162133|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
163124159|NCT03629912|589162130|FG000|Overall Study|Death|1|||
163124160|NCT03629912|589162131|FG001|Overall Study|Death|0|||
163124161|NCT03629912|589162132|FG002|Overall Study|Death|0|||
163124162|NCT03629912|589162133|FG003|Overall Study|Death|0|||
163124163|NCT02608450|589162134|FG000|Overall Study|Lost to Follow-up|39|||
163124164|NCT02608450|589162135|FG001|Overall Study|Lost to Follow-up|32|||
163124165|NCT02608450|589162134|FG000|Overall Study|Withdrawal by Subject|21|||
163124166|NCT02608450|589162135|FG001|Overall Study|Withdrawal by Subject|15|||
163124167|NCT02608450|589162134|FG000|Overall Study|Adverse Event|3|||
163124168|NCT02608450|589162135|FG001|Overall Study|Adverse Event|6|||
163124169|NCT02608450|589162134|FG000|Overall Study|Withdrawal by parent|2|||
162655577|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124170|NCT02608450|589162135|FG001|Overall Study|Withdrawal by parent|3|||
163124171|NCT02608450|589162134|FG000|Overall Study|Lack of Efficacy|0|||
163124172|NCT02608450|589162135|FG001|Overall Study|Lack of Efficacy|3|||
163124173|NCT02608450|589162134|FG000|Overall Study|Noncompliance with study drug|0|||
163124174|NCT02608450|589162135|FG001|Overall Study|Noncompliance with study drug|2|||
163124175|NCT02608450|589162134|FG000|Overall Study|Physician Decision|0|||
163124176|NCT02608450|589162135|FG001|Overall Study|Physician Decision|1|||
163124177|NCT02608450|589162134|FG000|Overall Study|Pregnancy|0|||
163124178|NCT02608450|589162135|FG001|Overall Study|Pregnancy|1|||
163124179|NCT02608450|589162134|FG000|Overall Study|Progressive disease|1|||
163124180|NCT02608450|589162135|FG001|Overall Study|Progressive disease|0|||
163124181|NCT02608450|589162134|FG000|Overall Study|Multiple reasons|0|||
163124182|NCT02608450|589162135|FG001|Overall Study|Multiple reasons|2|||
163124183|NCT02565810|589162136|FG000|Overall Study|Withdrawal by Subject|1|||
163124184|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
163124185|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
163124186|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
163124187|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
163124188|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
163124189|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
163124190|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
163124191|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
163124192|NCT02636946|589162139|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
163124193|NCT02636946|589162140|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
163124194|NCT02636946|589162139|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
163124195|NCT02636946|589162140|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
163124196|NCT03089944|589162141|FG000|Overall Study|Lost to Follow-up|8|||
163124197|NCT03089944|589162141|FG000|Overall Study|Withdrew Consent|2|||
163124198|NCT03089944|589162141|FG000|Overall Study|Adverse Event|1|||
163124199|NCT03089944|589162141|FG000|Overall Study|Other|1|||
163124200|NCT02308488|589162142|FG000|Overall Study|Withdrawal by Subject|2|||
163124201|NCT01541917|589162143|FG000|Overall Study|Lost to Follow-up|2|||
163124202|NCT01541917|589162144|FG001|Overall Study|Lost to Follow-up|2|||
163124203|NCT01541917|589162143|FG000|Overall Study|Withdrawal by Subject|13|||
163124204|NCT01541917|589162144|FG001|Overall Study|Withdrawal by Subject|7|||
163124205|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
163124206|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
163124207|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
163124208|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
163124209|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
163124210|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
163124211|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
163124212|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
163124213|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
163124214|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
163124215|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
163124216|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
163124217|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
163124218|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
163124219|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
163124220|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
163124221|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
163124222|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
163124223|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
163124224|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
163124225|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
163124226|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
163124227|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
163124228|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
162655578|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655579|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655580|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655581|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124229|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
163124230|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124231|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124232|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
163124233|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
162655582|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655583|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655584|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124234|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
163124235|NCT00121641|589162149|FG000|24-week Short-term Treatment Period|Other Reason|1|||
163124236|NCT00121641|589162150|FG001|24-week Short-term Treatment Period|Other Reason|0|||
163124237|NCT00121641|589162151|FG002|24-week Short-term Treatment Period|Other Reason|0|||
163124238|NCT00121641|589162152|FG003|24-week Short-term Treatment Period|Other Reason|0|||
163124239|NCT00121641|589162153|FG004|24-week Short-term Treatment Period|Other Reason|0|||
163124240|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
163124241|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
163124242|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
163124243|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
163124244|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
163124245|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
163124246|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
163124247|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
163124248|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
163124249|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
163124250|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
163124251|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
163124252|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
163124253|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
163124254|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
163124255|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
163124256|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
163124257|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
163124258|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
163124259|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
163124260|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
163124261|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
163124262|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
163124263|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
163124264|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
163124265|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
163124266|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
163124267|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
163124268|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
163124269|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
163124270|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
163124271|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
163124272|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
163124273|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
163124274|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
163124275|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
163124276|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
163124277|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
163124278|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
163124279|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
163124280|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Death|0|||
163124281|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Death|0|||
163124282|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Death|0|||
163124283|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Death|1|||
163124284|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Death|0|||
163124285|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Missing|0|||
163124286|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Missing|0|||
163124287|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Missing|1|||
163124288|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Missing|0|||
163124289|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Missing|0|||
163124290|NCT00121641|589162149|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
163124291|NCT00121641|589162150|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
163124292|NCT00121641|589162151|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
163124293|NCT00121641|589162152|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
163124294|NCT00121641|589162153|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
163124295|NCT01792518|589162154|FG000|Overall Study|Adverse Event|3|||
163124296|NCT01792518|589162155|FG001|Overall Study|Adverse Event|4|||
163124297|NCT01792518|589162154|FG000|Overall Study|Protocol Violation|0|||
163124298|NCT01792518|589162155|FG001|Overall Study|Protocol Violation|1|||
163124299|NCT01792518|589162154|FG000|Overall Study|Lost to Follow-up|3|||
163124300|NCT01792518|589162155|FG001|Overall Study|Lost to Follow-up|1|||
163124301|NCT01792518|589162154|FG000|Overall Study|Withdrawal by Subject|2|||
163124302|NCT01792518|589162155|FG001|Overall Study|Withdrawal by Subject|0|||
163124303|NCT01792518|589162154|FG000|Overall Study|Other Reason|0|||
163124304|NCT01792518|589162155|FG001|Overall Study|Other Reason|1|||
163124305|NCT03263780|589162156|FG000|Overall Study|Withdrawal by Subject|3|||
163124306|NCT03263780|589162156|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
163124307|NCT01504204|589162157|FG000|Overall Study|Lost to Follow-up|1|||
163124308|NCT01504204|589162158|FG001|Overall Study|Lost to Follow-up|1|||
163124309|NCT02241187|589162161|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
163124310|NCT02966015|589162162|FG000|Inclusion Visit|did not answer questionnaire|8|||
163124311|NCT02966015|589162163|FG001|Inclusion Visit|did not answer questionnaire|3|||
163124312|NCT02356887|589162164|FG000|Overall Study|poor compliance|2|||
163124313|NCT00558272|589162169|FG000|Overall Study|Adverse Event|10|||
163124314|NCT00558272|589162170|FG001|Overall Study|Adverse Event|0|||
163124315|NCT00558272|589162169|FG000|Overall Study|Death|1|||
163124316|NCT00558272|589162170|FG001|Overall Study|Death|0|||
163124317|NCT00558272|589162169|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
163124318|NCT00558272|589162170|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
163124319|NCT00558272|589162169|FG000|Overall Study|AZ study team decision|0|||
163124320|NCT00558272|589162170|FG001|Overall Study|AZ study team decision|1|||
163124321|NCT00558272|589162169|FG000|Overall Study|Incorrectly enrolled|1|||
163124322|NCT00558272|589162170|FG001|Overall Study|Incorrectly enrolled|0|||
163124323|NCT00558272|589162169|FG000|Overall Study|Withdrawal by Subject|0|||
163124324|NCT00558272|589162170|FG001|Overall Study|Withdrawal by Subject|1|||
163124325|NCT03442296|589162175|FG000|3 Month Follow-up|Death|3|||
163124326|NCT03442296|589162176|FG001|3 Month Follow-up|Death|1|||
163124327|NCT03442296|589162175|FG000|3 Month Follow-up|Lost to Follow-up|1|||
163124328|NCT03442296|589162176|FG001|3 Month Follow-up|Lost to Follow-up|1|||
163124329|NCT03442296|589162175|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
163124330|NCT03442296|589162176|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
163124331|NCT03442296|589162175|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
163124332|NCT03442296|589162176|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
163124333|NCT03442296|589162175|FG000|12 Month Follow-up|Incomplete measurement|1|||
163124334|NCT03442296|589162176|FG001|12 Month Follow-up|Incomplete measurement|1|||
163124335|NCT00447122|589162177|FG000|Overall Study|worsening medical condition -came off|0|||
163124336|NCT00447122|589162178|FG001|Overall Study|worsening medical condition -came off|1|||
163124337|NCT00447122|589162179|FG002|Overall Study|worsening medical condition -came off|0|||
163124338|NCT00447122|589162180|FG003|Overall Study|worsening medical condition -came off|0|||
163124339|NCT02409342|589162181|FG000|Overall Study|Death|211|||
163124340|NCT02409342|589162182|FG001|Overall Study|Death|201|||
163124341|NCT02409342|589162181|FG000|Overall Study|Withdrawal by Subject|24|||
163124342|NCT02409342|589162182|FG001|Overall Study|Withdrawal by Subject|17|||
163124343|NCT02409342|589162181|FG000|Overall Study|Study Terminated By Sponsor|48|||
163124344|NCT02409342|589162182|FG001|Overall Study|Study Terminated By Sponsor|59|||
163124345|NCT02409342|589162181|FG000|Overall Study|Lost to Follow-up|3|||
162655585|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
162655586|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655587|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655588|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
163124346|NCT02409342|589162182|FG001|Overall Study|Lost to Follow-up|5|||
163124347|NCT02409342|589162181|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
163124348|NCT02409342|589162182|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
163124349|NCT02409342|589162181|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
163124350|NCT02409342|589162182|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
163124351|NCT02409342|589162181|FG000|Overall Study|Sponsor Decision|1|||
163124352|NCT02409342|589162182|FG001|Overall Study|Sponsor Decision|0|||
163124353|NCT00279812|589162183|FG000|Overall Study|Protocol Violation|1|||
163124354|NCT00279812|589162184|FG001|Overall Study|Protocol Violation|1|||
163124355|NCT00279812|589162185|FG002|Overall Study|Protocol Violation|0|||
163124356|NCT00279812|589162186|FG003|Overall Study|Protocol Violation|0|||
163124357|NCT00279812|589162187|FG004|Overall Study|Protocol Violation|1|||
163124358|NCT00279812|589162188|FG005|Overall Study|Protocol Violation|0|||
163124359|NCT00279812|589162183|FG000|Overall Study|Withdrawal by Subject|0|||
163124360|NCT00279812|589162184|FG001|Overall Study|Withdrawal by Subject|4|||
163124361|NCT00279812|589162185|FG002|Overall Study|Withdrawal by Subject|2|||
163124362|NCT00279812|589162186|FG003|Overall Study|Withdrawal by Subject|0|||
163124363|NCT00279812|589162187|FG004|Overall Study|Withdrawal by Subject|0|||
163124364|NCT00279812|589162188|FG005|Overall Study|Withdrawal by Subject|0|||
163124365|NCT00279812|589162183|FG000|Overall Study|Adverse Event|0|||
162655589|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655590|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655591|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655592|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655593|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655594|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162655595|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655596|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
163124366|NCT00279812|589162184|FG001|Overall Study|Adverse Event|1|||
163124367|NCT00279812|589162185|FG002|Overall Study|Adverse Event|1|||
163124368|NCT00279812|589162186|FG003|Overall Study|Adverse Event|0|||
163124369|NCT00279812|589162187|FG004|Overall Study|Adverse Event|2|||
163124370|NCT00279812|589162188|FG005|Overall Study|Adverse Event|1|||
163124371|NCT04046250|589162196|FG000|Overall Study|Death|0|||
163124372|NCT04046250|589162197|FG001|Overall Study|Death|1|||
163124373|NCT04046250|589162196|FG000|Overall Study|Withdrawal by Subject|3|||
163124374|NCT04046250|589162197|FG001|Overall Study|Withdrawal by Subject|3|||
163124375|NCT03834220|589162202|FG000|Overall Study|Adverse Event|1|||
163124376|NCT03834220|589162203|FG001|Overall Study|Adverse Event|0|||
163124377|NCT03834220|589162204|FG002|Overall Study|Adverse Event|0|||
163124378|NCT03834220|589162202|FG000|Overall Study|Death|8|||
163124379|NCT03834220|589162203|FG001|Overall Study|Death|1|||
163124380|NCT03834220|589162204|FG002|Overall Study|Death|17|||
163124381|NCT03834220|589162202|FG000|Overall Study|Reason not Specified|9|||
163124382|NCT03834220|589162203|FG001|Overall Study|Reason not Specified|0|||
163124383|NCT03834220|589162204|FG002|Overall Study|Reason not Specified|6|||
163124384|NCT03834220|589162202|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
163124385|NCT03834220|589162203|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
163124386|NCT03834220|589162204|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
163124387|NCT03834220|589162202|FG000|Overall Study|Withdrawal of Consent|2|||
163124388|NCT03834220|589162203|FG001|Overall Study|Withdrawal of Consent|2|||
163124389|NCT03834220|589162204|FG002|Overall Study|Withdrawal of Consent|2|||
163124390|NCT00527332|589162206|FG000|Overall Study|Protocol Violation|4|||
163124391|NCT00527332|589162207|FG001|Overall Study|Protocol Violation|8|||
163124392|NCT00527332|589162206|FG000|Overall Study|Withdrew consent|5|||
163124393|NCT00527332|589162207|FG001|Overall Study|Withdrew consent|1|||
163124394|NCT03684694|589162210|FG000|Phase 1|Withdrawal by Subject|1|||
163124395|NCT03684694|589162211|FG001|Phase 1|Withdrawal by Subject|0|||
163124396|NCT03684694|589162212|FG002|Phase 1|Withdrawal by Subject|0|||
163124397|NCT03684694|589162213|FG003|Phase 1|Withdrawal by Subject|0|||
163124398|NCT03684694|589162214|FG004|Phase 1|Withdrawal by Subject|0|||
163124399|NCT03684694|589162215|FG005|Phase 1|Withdrawal by Subject|0|||
163124400|NCT03684694|589162210|FG000|Phase 1|Investigator/Sponsor Decision|12|||
163124401|NCT03684694|589162211|FG001|Phase 1|Investigator/Sponsor Decision|2|||
163124402|NCT03684694|589162212|FG002|Phase 1|Investigator/Sponsor Decision|1|||
163124403|NCT03684694|589162213|FG003|Phase 1|Investigator/Sponsor Decision|0|||
163124404|NCT03684694|589162214|FG004|Phase 1|Investigator/Sponsor Decision|0|||
163124405|NCT03684694|589162215|FG005|Phase 1|Investigator/Sponsor Decision|0|||
163124406|NCT03684694|589162210|FG000|Phase 1|Death|24|||
163124407|NCT03684694|589162211|FG001|Phase 1|Death|0|||
163124408|NCT03684694|589162212|FG002|Phase 1|Death|3|||
163124409|NCT03684694|589162213|FG003|Phase 1|Death|0|||
163124410|NCT03684694|589162214|FG004|Phase 1|Death|0|||
163124411|NCT03684694|589162215|FG005|Phase 1|Death|0|||
163124412|NCT03684694|589162210|FG000|Phase 1|Lost to Follow-up|0|||
163124413|NCT03684694|589162211|FG001|Phase 1|Lost to Follow-up|0|||
163124414|NCT03684694|589162212|FG002|Phase 1|Lost to Follow-up|1|||
163124415|NCT03684694|589162213|FG003|Phase 1|Lost to Follow-up|0|||
163124416|NCT03684694|589162214|FG004|Phase 1|Lost to Follow-up|0|||
163124417|NCT03684694|589162215|FG005|Phase 1|Lost to Follow-up|0|||
163124418|NCT03684694|589162210|FG000|Phase 1|Miscellaneous|0|||
163124419|NCT03684694|589162211|FG001|Phase 1|Miscellaneous|1|||
163124420|NCT03684694|589162212|FG002|Phase 1|Miscellaneous|0|||
163124421|NCT03684694|589162213|FG003|Phase 1|Miscellaneous|0|||
163124422|NCT03684694|589162214|FG004|Phase 1|Miscellaneous|0|||
163124423|NCT03684694|589162215|FG005|Phase 1|Miscellaneous|0|||
163124424|NCT03684694|589162210|FG000|Phase 2|Withdrawal by Subject|0|||
163124425|NCT03684694|589162211|FG001|Phase 2|Withdrawal by Subject|0|||
163124426|NCT03684694|589162212|FG002|Phase 2|Withdrawal by Subject|0|||
163124427|NCT03684694|589162213|FG003|Phase 2|Withdrawal by Subject|0|||
163124428|NCT03684694|589162214|FG004|Phase 2|Withdrawal by Subject|0|||
163124429|NCT03684694|589162215|FG005|Phase 2|Withdrawal by Subject|1|||
163124430|NCT03684694|589162210|FG000|Phase 2|Investigator/Sponsor Decision|0|||
163124431|NCT03684694|589162211|FG001|Phase 2|Investigator/Sponsor Decision|0|||
163124432|NCT03684694|589162212|FG002|Phase 2|Investigator/Sponsor Decision|0|||
163124433|NCT03684694|589162213|FG003|Phase 2|Investigator/Sponsor Decision|17|||
163124434|NCT03684694|589162214|FG004|Phase 2|Investigator/Sponsor Decision|16|||
163124435|NCT03684694|589162215|FG005|Phase 2|Investigator/Sponsor Decision|6|||
163124436|NCT03684694|589162210|FG000|Phase 2|Death|0|||
163124437|NCT03684694|589162211|FG001|Phase 2|Death|0|||
163124438|NCT03684694|589162212|FG002|Phase 2|Death|0|||
163124439|NCT03684694|589162213|FG003|Phase 2|Death|28|||
163124440|NCT03684694|589162214|FG004|Phase 2|Death|14|||
163124441|NCT03684694|589162215|FG005|Phase 2|Death|3|||
163124442|NCT03684694|589162210|FG000|Phase 2|Lost to Follow-up|0|||
163124443|NCT03684694|589162211|FG001|Phase 2|Lost to Follow-up|0|||
163124444|NCT03684694|589162212|FG002|Phase 2|Lost to Follow-up|0|||
163124445|NCT03684694|589162213|FG003|Phase 2|Lost to Follow-up|1|||
163124446|NCT03684694|589162214|FG004|Phase 2|Lost to Follow-up|0|||
163124447|NCT03684694|589162215|FG005|Phase 2|Lost to Follow-up|0|||
163124448|NCT03684694|589162210|FG000|Phase 2|Miscellaneous|0|||
163124449|NCT03684694|589162211|FG001|Phase 2|Miscellaneous|0|||
163124450|NCT03684694|589162212|FG002|Phase 2|Miscellaneous|0|||
163124451|NCT03684694|589162213|FG003|Phase 2|Miscellaneous|3|||
163124452|NCT03684694|589162214|FG004|Phase 2|Miscellaneous|0|||
163124453|NCT03684694|589162215|FG005|Phase 2|Miscellaneous|0|||
163124454|NCT02720692|589163932|FG000|Overall Study|Withdrawal by Subject|3|||
163124455|NCT02720692|589163933|FG001|Overall Study|Withdrawal by Subject|0|||
163124456|NCT02720692|589163932|FG000|Overall Study|Physician Decision|1|||
163124457|NCT02720692|589163933|FG001|Overall Study|Physician Decision|0|||
163124458|NCT02720692|589163932|FG000|Overall Study|Lost to Follow-up|8|||
163124459|NCT02720692|589163933|FG001|Overall Study|Lost to Follow-up|3|||
163124460|NCT02720692|589163932|FG000|Overall Study|Subject unable to return for visit|1|||
163124461|NCT02720692|589163933|FG001|Overall Study|Subject unable to return for visit|0|||
163124462|NCT01206582|589163934|FG000|Overall Study|Withdrew prior to study|1|||
163124463|NCT01206582|589163935|FG001|Overall Study|Withdrew prior to study|0|||
163124464|NCT01206582|589163934|FG000|Overall Study|Discontinued intervention before week 8|1|||
163124465|NCT01206582|589163935|FG001|Overall Study|Discontinued intervention before week 8|2|||
163124466|NCT00528801|589163936|FG000|Overall Study|Withdrawal by Subject|1|||
163124467|NCT00528801|589163937|FG001|Overall Study|Withdrawal by Subject|1|||
163124468|NCT00528801|589163936|FG000|Overall Study|Protocol Violation|11|||
163124469|NCT00528801|589163937|FG001|Overall Study|Protocol Violation|5|||
163124470|NCT00528801|589163936|FG000|Overall Study|Lost to Follow-up|15|||
163124471|NCT00528801|589163937|FG001|Overall Study|Lost to Follow-up|4|||
163124472|NCT00528801|589163936|FG000|Overall Study|Administrative Reasons|0|||
163124473|NCT00528801|589163937|FG001|Overall Study|Administrative Reasons|1|||
163124474|NCT02207491|589163938|FG000|Overall Study|Adverse Event|20|||
163124475|NCT02207491|589163939|FG001|Overall Study|Adverse Event|4|||
163124476|NCT02207491|589163938|FG000|Overall Study|Withdrawal by Subject|3|||
163124477|NCT02207491|589163939|FG001|Overall Study|Withdrawal by Subject|2|||
163124478|NCT02207491|589163938|FG000|Overall Study|Non-compliant|0|||
163124479|NCT02207491|589163939|FG001|Overall Study|Non-compliant|1|||
163124480|NCT02207491|589163938|FG000|Overall Study|Lost to Follow-up|0|||
163124481|NCT02207491|589163939|FG001|Overall Study|Lost to Follow-up|1|||
163124482|NCT02207491|589163938|FG000|Overall Study|Lack of Efficacy|3|||
163124483|NCT02207491|589163939|FG001|Overall Study|Lack of Efficacy|0|||
163124484|NCT02207491|589163938|FG000|Overall Study|Physician Decision|2|||
163124485|NCT02207491|589163939|FG001|Overall Study|Physician Decision|0|||
163124486|NCT02207491|589163938|FG000|Overall Study|Protocol Violation|3|||
163124487|NCT02207491|589163939|FG001|Overall Study|Protocol Violation|5|||
163124488|NCT00477152|589163942|FG000|Overall Study|Parent withdrew consent|2|||
163124489|NCT00477152|589163942|FG000|Overall Study|Adverse Event|1|||
163124490|NCT03221842|589163943|FG000|Period 1 (Open-label)|Adverse Event|4|||
163124491|NCT03221842|589163944|FG001|Period 1 (Open-label)|Adverse Event|0|||
163124492|NCT03221842|589163943|FG000|Period 1 (Open-label)|Physician Decision|2|||
163124493|NCT03221842|589163944|FG001|Period 1 (Open-label)|Physician Decision|0|||
163124494|NCT03221842|589163943|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
163124495|NCT03221842|589163944|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
163124496|NCT03221842|589163943|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
163124497|NCT03221842|589163944|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
163124498|NCT03221842|589163943|FG000|Period 1 (Open-label)|Other|2|||
162719563|NCT01376089|587680509|FG001|Overall Study|Patient received no contrast media|4|||
163124499|NCT03221842|589163944|FG001|Period 1 (Open-label)|Other|0|||
163124500|NCT03221842|589163943|FG000|Period 2 (Randomized, Blinded)|Death|0|||
163124501|NCT03221842|589163944|FG001|Period 2 (Randomized, Blinded)|Death|1|||
163124502|NCT03221842|589163943|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
163124503|NCT03221842|589163944|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
163124504|NCT02504580|589163945|FG000|Overall Study|Other|1|||
163124505|NCT02504580|589163946|FG001|Overall Study|Other|0|||
163124506|NCT02504580|589163947|FG002|Overall Study|Other|0|||
163124507|NCT02504580|589163948|FG003|Overall Study|Other|2|||
163124508|NCT02504580|589163949|FG004|Overall Study|Other|1|||
163124509|NCT02504580|589163950|FG005|Overall Study|Other|1|||
163124510|NCT02504580|589163951|FG006|Overall Study|Other|1|||
163124511|NCT02504580|589163952|FG007|Overall Study|Other|2|||
163124512|NCT02504580|589163953|FG008|Overall Study|Other|0|||
162655597|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655598|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655599|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655600|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655601|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655602|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655603|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655604|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655605|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655606|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162655607|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655608|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162655609|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
162655610|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162655611|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162655612|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655613|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655614|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655615|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655616|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655617|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655618|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162655619|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655620|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655621|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655622|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655623|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655624|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655625|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163124513|NCT02504580|589163954|FG009|Overall Study|Other|0|||
163124514|NCT02504580|589163955|FG010|Overall Study|Other|0|||
163124515|NCT02504580|589163956|FG011|Overall Study|Other|2|||
163124516|NCT02504580|589163945|FG000|Overall Study|Subject refusal to continue|0|||
163124517|NCT02504580|589163946|FG001|Overall Study|Subject refusal to continue|1|||
163124518|NCT02504580|589163947|FG002|Overall Study|Subject refusal to continue|0|||
163124519|NCT02504580|589163948|FG003|Overall Study|Subject refusal to continue|0|||
163124520|NCT02504580|589163949|FG004|Overall Study|Subject refusal to continue|0|||
163124521|NCT02504580|589163950|FG005|Overall Study|Subject refusal to continue|0|||
163124522|NCT02504580|589163951|FG006|Overall Study|Subject refusal to continue|0|||
163124523|NCT02504580|589163952|FG007|Overall Study|Subject refusal to continue|0|||
163124524|NCT02504580|589163953|FG008|Overall Study|Subject refusal to continue|0|||
163124525|NCT02504580|589163954|FG009|Overall Study|Subject refusal to continue|0|||
163124526|NCT02504580|589163955|FG010|Overall Study|Subject refusal to continue|0|||
163124527|NCT02504580|589163956|FG011|Overall Study|Subject refusal to continue|0|||
163124528|NCT01939366|589163957|FG000|Overall Study|Adverse Event|8|||
163124529|NCT01939366|589163958|FG001|Overall Study|Adverse Event|17|||
163124530|NCT01939366|589163959|FG002|Overall Study|Adverse Event|30|||
163124531|NCT01939366|589163960|FG003|Overall Study|Adverse Event|8|||
163124532|NCT01939366|589163961|FG004|Overall Study|Adverse Event|5|||
163124533|NCT01939366|589163957|FG000|Overall Study|Lack of Efficacy|2|||
163124534|NCT01939366|589163958|FG001|Overall Study|Lack of Efficacy|1|||
163124535|NCT01939366|589163959|FG002|Overall Study|Lack of Efficacy|1|||
163124536|NCT01939366|589163960|FG003|Overall Study|Lack of Efficacy|1|||
163124537|NCT01939366|589163961|FG004|Overall Study|Lack of Efficacy|3|||
163124538|NCT01939366|589163957|FG000|Overall Study|Lost to Follow-up|1|||
163124539|NCT01939366|589163958|FG001|Overall Study|Lost to Follow-up|1|||
163124540|NCT01939366|589163959|FG002|Overall Study|Lost to Follow-up|0|||
163124541|NCT01939366|589163960|FG003|Overall Study|Lost to Follow-up|0|||
163124542|NCT01939366|589163961|FG004|Overall Study|Lost to Follow-up|0|||
163124543|NCT01939366|589163957|FG000|Overall Study|Withdrawal by Subject|1|||
163124544|NCT01939366|589163958|FG001|Overall Study|Withdrawal by Subject|0|||
163124545|NCT01939366|589163959|FG002|Overall Study|Withdrawal by Subject|2|||
163124546|NCT01939366|589163960|FG003|Overall Study|Withdrawal by Subject|2|||
163124547|NCT01939366|589163961|FG004|Overall Study|Withdrawal by Subject|3|||
163124548|NCT01939366|589163957|FG000|Overall Study|Inclusion criteria not met|0|||
163124549|NCT01939366|589163958|FG001|Overall Study|Inclusion criteria not met|1|||
163124550|NCT01939366|589163959|FG002|Overall Study|Inclusion criteria not met|1|||
163124551|NCT01939366|589163960|FG003|Overall Study|Inclusion criteria not met|0|||
163124552|NCT01939366|589163961|FG004|Overall Study|Inclusion criteria not met|1|||
163124553|NCT01939366|589163957|FG000|Overall Study|Other|0|||
163124554|NCT01939366|589163958|FG001|Overall Study|Other|0|||
163124555|NCT01939366|589163959|FG002|Overall Study|Other|2|||
163124556|NCT01939366|589163960|FG003|Overall Study|Other|2|||
163124557|NCT01939366|589163961|FG004|Overall Study|Other|1|||
163124558|NCT01939366|589163957|FG000|Overall Study|Protocol Violation|0|||
163124559|NCT01939366|589163958|FG001|Overall Study|Protocol Violation|0|||
163124560|NCT01939366|589163959|FG002|Overall Study|Protocol Violation|0|||
163124561|NCT01939366|589163960|FG003|Overall Study|Protocol Violation|1|||
163124562|NCT01939366|589163961|FG004|Overall Study|Protocol Violation|0|||
163124563|NCT01939366|589163957|FG000|Overall Study|Sponsor decision|0|||
163124564|NCT01939366|589163958|FG001|Overall Study|Sponsor decision|0|||
163124565|NCT01939366|589163959|FG002|Overall Study|Sponsor decision|0|||
163124566|NCT01939366|589163960|FG003|Overall Study|Sponsor decision|0|||
163124567|NCT01939366|589163961|FG004|Overall Study|Sponsor decision|2|||
163124568|NCT01939366|589163957|FG000|Overall Study|GCP non-compliance at site|2|||
163124569|NCT01939366|589163958|FG001|Overall Study|GCP non-compliance at site|3|||
163124570|NCT01939366|589163959|FG002|Overall Study|GCP non-compliance at site|2|||
163124571|NCT01939366|589163960|FG003|Overall Study|GCP non-compliance at site|3|||
163124572|NCT01939366|589163961|FG004|Overall Study|GCP non-compliance at site|3|||
163124573|NCT00231413|589163964|FG000|Overall Study|Non-serious AE|0|||
163124574|NCT00231413|589163965|FG001|Overall Study|Non-serious AE|0|||
163124575|NCT00231413|589163966|FG002|Overall Study|Non-serious AE|1|||
163124576|NCT00231413|589163967|FG003|Overall Study|Non-serious AE|0|||
163124577|NCT00231413|589163968|FG004|Overall Study|Non-serious AE|0|||
163124578|NCT00231413|589163969|FG005|Overall Study|Non-serious AE|0|||
163124579|NCT00231413|589163970|FG006|Overall Study|Non-serious AE|1|||
163124580|NCT00231413|589163964|FG000|Overall Study|Withdrawal by Subject|3|||
163124581|NCT00231413|589163965|FG001|Overall Study|Withdrawal by Subject|1|||
163124582|NCT00231413|589163966|FG002|Overall Study|Withdrawal by Subject|4|||
163124583|NCT00231413|589163967|FG003|Overall Study|Withdrawal by Subject|2|||
163124584|NCT00231413|589163968|FG004|Overall Study|Withdrawal by Subject|2|||
163124585|NCT00231413|589163969|FG005|Overall Study|Withdrawal by Subject|0|||
163124586|NCT00231413|589163970|FG006|Overall Study|Withdrawal by Subject|3|||
163124587|NCT00231413|589163964|FG000|Overall Study|Migrated/moved from study area|0|||
163124588|NCT00231413|589163965|FG001|Overall Study|Migrated/moved from study area|0|||
162655626|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655627|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655628|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163124589|NCT00231413|589163966|FG002|Overall Study|Migrated/moved from study area|1|||
163124590|NCT00231413|589163967|FG003|Overall Study|Migrated/moved from study area|0|||
163124591|NCT00231413|589163968|FG004|Overall Study|Migrated/moved from study area|0|||
163124592|NCT00231413|589163969|FG005|Overall Study|Migrated/moved from study area|1|||
163124593|NCT00231413|589163970|FG006|Overall Study|Migrated/moved from study area|0|||
163124594|NCT00231413|589163964|FG000|Overall Study|Lost to Follow-up|4|||
163124595|NCT00231413|589163965|FG001|Overall Study|Lost to Follow-up|4|||
163124596|NCT00231413|589163966|FG002|Overall Study|Lost to Follow-up|1|||
163124597|NCT00231413|589163967|FG003|Overall Study|Lost to Follow-up|1|||
162655629|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655630|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655631|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655632|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
162655633|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
162655634|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
162655635|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
162655636|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655637|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655638|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655639|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655640|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655641|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162655642|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
163124598|NCT00231413|589163968|FG004|Overall Study|Lost to Follow-up|1|||
163124599|NCT00231413|589163969|FG005|Overall Study|Lost to Follow-up|4|||
163124600|NCT00231413|589163970|FG006|Overall Study|Lost to Follow-up|0|||
163124601|NCT00231413|589163964|FG000|Overall Study|Pregnancy|1|||
163124602|NCT00231413|589163965|FG001|Overall Study|Pregnancy|0|||
163124603|NCT00231413|589163966|FG002|Overall Study|Pregnancy|0|||
163124604|NCT00231413|589163967|FG003|Overall Study|Pregnancy|0|||
163124605|NCT00231413|589163968|FG004|Overall Study|Pregnancy|0|||
163124606|NCT00231413|589163969|FG005|Overall Study|Pregnancy|0|||
163124607|NCT00231413|589163970|FG006|Overall Study|Pregnancy|0|||
163124608|NCT03242252|589163975|FG000|Overall Study|At the Participant's own Request|18|||
163124609|NCT03242252|589163976|FG001|Overall Study|At the Participant's own Request|10|||
163124610|NCT03242252|589163977|FG002|Overall Study|At the Participant's own Request|15|||
163124611|NCT03242252|589163975|FG000|Overall Study|Adverse Event|8|||
163124612|NCT03242252|589163976|FG001|Overall Study|Adverse Event|6|||
163124613|NCT03242252|589163977|FG002|Overall Study|Adverse Event|9|||
163124614|NCT03242252|589163975|FG000|Overall Study|Poor Compliance to Protocol|0|||
163124615|NCT03242252|589163976|FG001|Overall Study|Poor Compliance to Protocol|2|||
163124616|NCT03242252|589163977|FG002|Overall Study|Poor Compliance to Protocol|3|||
163124617|NCT03242252|589163975|FG000|Overall Study|Study Terminated by Sponsor|1|||
163124618|NCT03242252|589163976|FG001|Overall Study|Study Terminated by Sponsor|0|||
163124619|NCT03242252|589163977|FG002|Overall Study|Study Terminated by Sponsor|0|||
163124620|NCT03242252|589163975|FG000|Overall Study|Reason not Specified|4|||
163124621|NCT03242252|589163976|FG001|Overall Study|Reason not Specified|4|||
163124622|NCT03242252|589163977|FG002|Overall Study|Reason not Specified|1|||
163124623|NCT03242252|589163975|FG000|Overall Study|Lost to Follow-up|5|||
163124624|NCT03242252|589163976|FG001|Overall Study|Lost to Follow-up|1|||
163124625|NCT03242252|589163977|FG002|Overall Study|Lost to Follow-up|4|||
163124626|NCT01659255|589163978|FG000|Overall Study|Adverse Event|0|||
163124627|NCT01659255|589163979|FG001|Overall Study|Adverse Event|0|||
163124628|NCT01659255|589163980|FG002|Overall Study|Adverse Event|0|||
163124629|NCT01659255|589163981|FG003|Overall Study|Adverse Event|0|||
163124630|NCT01659255|589163982|FG004|Overall Study|Adverse Event|0|||
163124631|NCT01659255|589163983|FG005|Overall Study|Adverse Event|1|||
163124632|NCT01659255|589163984|FG006|Overall Study|Adverse Event|1|||
163124633|NCT01659255|589163985|FG007|Overall Study|Adverse Event|0|||
163124634|NCT01659255|589163986|FG008|Overall Study|Adverse Event|0|||
163124635|NCT01659255|589163987|FG009|Overall Study|Adverse Event|1|||
163124636|NCT01659255|589163988|FG010|Overall Study|Adverse Event|0|||
163124637|NCT01659255|589163989|FG011|Overall Study|Adverse Event|1|||
163124638|NCT01659255|589163990|FG012|Overall Study|Adverse Event|0|||
163124639|NCT01659255|589163991|FG013|Overall Study|Adverse Event|2|||
163124640|NCT01659255|589163992|FG014|Overall Study|Adverse Event|0|||
163124641|NCT01659255|589163993|FG015|Overall Study|Adverse Event|1|||
163124642|NCT01659255|589163994|FG016|Overall Study|Adverse Event|0|||
162655643|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
163124643|NCT01659255|589163978|FG000|Overall Study|Death|0|||
163124644|NCT01659255|589163979|FG001|Overall Study|Death|1|||
163124645|NCT01659255|589163980|FG002|Overall Study|Death|0|||
163124646|NCT01659255|589163981|FG003|Overall Study|Death|0|||
163124647|NCT01659255|589163982|FG004|Overall Study|Death|0|||
163124648|NCT01659255|589163983|FG005|Overall Study|Death|0|||
163124649|NCT01659255|589163984|FG006|Overall Study|Death|0|||
163124650|NCT01659255|589163985|FG007|Overall Study|Death|1|||
163124651|NCT01659255|589163986|FG008|Overall Study|Death|1|||
163124652|NCT01659255|589163987|FG009|Overall Study|Death|0|||
163124653|NCT01659255|589163988|FG010|Overall Study|Death|0|||
163124654|NCT01659255|589163989|FG011|Overall Study|Death|0|||
163124655|NCT01659255|589163990|FG012|Overall Study|Death|1|||
163124656|NCT01659255|589163991|FG013|Overall Study|Death|1|||
163124657|NCT01659255|589163992|FG014|Overall Study|Death|2|||
162655644|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655645|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655646|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655647|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655648|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655649|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
162655650|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655651|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655652|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655653|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655654|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655655|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655656|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655657|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655658|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655659|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655660|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655661|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655662|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655663|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655664|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655665|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655666|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162655667|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655668|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655669|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655670|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655671|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655672|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655673|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655674|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655675|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162655676|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655677|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655678|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162655679|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655680|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162655681|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162655682|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655683|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
163124658|NCT01659255|589163993|FG015|Overall Study|Death|1|||
163124659|NCT01659255|589163994|FG016|Overall Study|Death|0|||
163124660|NCT01659255|589163978|FG000|Overall Study|Progressive Disease|2|||
163124661|NCT01659255|589163979|FG001|Overall Study|Progressive Disease|0|||
163124662|NCT01659255|589163980|FG002|Overall Study|Progressive Disease|0|||
163124663|NCT01659255|589163981|FG003|Overall Study|Progressive Disease|0|||
163124664|NCT01659255|589163982|FG004|Overall Study|Progressive Disease|0|||
163124665|NCT01659255|589163983|FG005|Overall Study|Progressive Disease|0|||
163124666|NCT01659255|589163984|FG006|Overall Study|Progressive Disease|0|||
163124667|NCT01659255|589163985|FG007|Overall Study|Progressive Disease|1|||
163124668|NCT01659255|589163986|FG008|Overall Study|Progressive Disease|0|||
163124669|NCT01659255|589163987|FG009|Overall Study|Progressive Disease|2|||
163124670|NCT01659255|589163988|FG010|Overall Study|Progressive Disease|2|||
163124671|NCT01659255|589163989|FG011|Overall Study|Progressive Disease|3|||
163124672|NCT01659255|589163990|FG012|Overall Study|Progressive Disease|5|||
163124673|NCT01659255|589163991|FG013|Overall Study|Progressive Disease|13|||
163124674|NCT01659255|589163992|FG014|Overall Study|Progressive Disease|6|||
163124675|NCT01659255|589163993|FG015|Overall Study|Progressive Disease|2|||
163124676|NCT01659255|589163994|FG016|Overall Study|Progressive Disease|3|||
163124677|NCT01659255|589163978|FG000|Overall Study|Withdrew Consent|0|||
163124678|NCT01659255|589163979|FG001|Overall Study|Withdrew Consent|0|||
163124679|NCT01659255|589163980|FG002|Overall Study|Withdrew Consent|0|||
163124680|NCT01659255|589163981|FG003|Overall Study|Withdrew Consent|0|||
163124681|NCT01659255|589163982|FG004|Overall Study|Withdrew Consent|0|||
163124682|NCT01659255|589163983|FG005|Overall Study|Withdrew Consent|0|||
163124683|NCT01659255|589163984|FG006|Overall Study|Withdrew Consent|0|||
163124684|NCT01659255|589163985|FG007|Overall Study|Withdrew Consent|0|||
163124685|NCT01659255|589163986|FG008|Overall Study|Withdrew Consent|0|||
163124686|NCT01659255|589163987|FG009|Overall Study|Withdrew Consent|0|||
163124687|NCT01659255|589163988|FG010|Overall Study|Withdrew Consent|1|||
163124688|NCT01659255|589163989|FG011|Overall Study|Withdrew Consent|0|||
163124689|NCT01659255|589163990|FG012|Overall Study|Withdrew Consent|0|||
163124690|NCT01659255|589163991|FG013|Overall Study|Withdrew Consent|1|||
163124691|NCT01659255|589163992|FG014|Overall Study|Withdrew Consent|0|||
163124692|NCT01659255|589163993|FG015|Overall Study|Withdrew Consent|0|||
163124693|NCT01659255|589163994|FG016|Overall Study|Withdrew Consent|0|||
163124694|NCT01659255|589163978|FG000|Overall Study|Investigator Decision|0|||
163124695|NCT01659255|589163979|FG001|Overall Study|Investigator Decision|0|||
163124696|NCT01659255|589163980|FG002|Overall Study|Investigator Decision|0|||
162655684|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655685|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655686|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655687|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655688|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655689|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655690|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162655691|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655692|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655693|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655694|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655695|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655696|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655697|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655698|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655699|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655700|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
162655701|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655702|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655703|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655704|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655705|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655706|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655707|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655708|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655709|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655710|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655711|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655712|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655713|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162655714|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
163124697|NCT01659255|589163981|FG003|Overall Study|Investigator Decision|0|||
163124698|NCT01659255|589163982|FG004|Overall Study|Investigator Decision|0|||
163124699|NCT01659255|589163983|FG005|Overall Study|Investigator Decision|0|||
163124700|NCT01659255|589163984|FG006|Overall Study|Investigator Decision|0|||
163124701|NCT01659255|589163985|FG007|Overall Study|Investigator Decision|0|||
163124702|NCT01659255|589163986|FG008|Overall Study|Investigator Decision|0|||
163124703|NCT01659255|589163987|FG009|Overall Study|Investigator Decision|0|||
163124704|NCT01659255|589163988|FG010|Overall Study|Investigator Decision|0|||
163124705|NCT01659255|589163989|FG011|Overall Study|Investigator Decision|0|||
163124706|NCT01659255|589163990|FG012|Overall Study|Investigator Decision|1|||
163124707|NCT01659255|589163991|FG013|Overall Study|Investigator Decision|1|||
163124708|NCT01659255|589163992|FG014|Overall Study|Investigator Decision|0|||
163124709|NCT01659255|589163993|FG015|Overall Study|Investigator Decision|0|||
163124710|NCT01659255|589163994|FG016|Overall Study|Investigator Decision|0|||
163124711|NCT01659255|589163978|FG000|Overall Study|Sponsor's Decision|0|||
163124712|NCT01659255|589163979|FG001|Overall Study|Sponsor's Decision|0|||
163124713|NCT01659255|589163980|FG002|Overall Study|Sponsor's Decision|0|||
163124714|NCT01659255|589163981|FG003|Overall Study|Sponsor's Decision|0|||
163124715|NCT01659255|589163982|FG004|Overall Study|Sponsor's Decision|0|||
163124716|NCT01659255|589163983|FG005|Overall Study|Sponsor's Decision|0|||
163124717|NCT01659255|589163984|FG006|Overall Study|Sponsor's Decision|1|||
163124718|NCT01659255|589163985|FG007|Overall Study|Sponsor's Decision|0|||
163124719|NCT01659255|589163986|FG008|Overall Study|Sponsor's Decision|0|||
163124720|NCT01659255|589163987|FG009|Overall Study|Sponsor's Decision|0|||
163124721|NCT01659255|589163988|FG010|Overall Study|Sponsor's Decision|0|||
163124722|NCT01659255|589163989|FG011|Overall Study|Sponsor's Decision|0|||
163124723|NCT01659255|589163990|FG012|Overall Study|Sponsor's Decision|0|||
163124724|NCT01659255|589163991|FG013|Overall Study|Sponsor's Decision|0|||
163124725|NCT01659255|589163992|FG014|Overall Study|Sponsor's Decision|0|||
163124726|NCT01659255|589163993|FG015|Overall Study|Sponsor's Decision|0|||
163124727|NCT01659255|589163994|FG016|Overall Study|Sponsor's Decision|0|||
163124728|NCT01659255|589163978|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124729|NCT01659255|589163979|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124730|NCT01659255|589163980|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124731|NCT01659255|589163981|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124732|NCT01659255|589163982|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124733|NCT01659255|589163983|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124734|NCT01659255|589163984|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124735|NCT01659255|589163985|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124736|NCT01659255|589163986|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124737|NCT01659255|589163987|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124738|NCT01659255|589163988|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124739|NCT01659255|589163989|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124740|NCT01659255|589163990|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124741|NCT01659255|589163991|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124742|NCT01659255|589163992|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124743|NCT01659255|589163993|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
163124744|NCT01659255|589163994|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163124745|NCT01659255|589163978|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
163124746|NCT01659255|589163979|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
163124747|NCT01659255|589163980|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
163124748|NCT01659255|589163981|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
163124749|NCT01659255|589163982|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
163124750|NCT01659255|589163983|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
163124751|NCT01659255|589163984|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
163124752|NCT01659255|589163985|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
163124753|NCT01659255|589163986|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
163124754|NCT01659255|589163987|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
163124755|NCT01659255|589163988|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
163124756|NCT01659255|589163989|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
163124757|NCT01659255|589163990|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
163124758|NCT01659255|589163991|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
163124759|NCT01659255|589163992|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
163124760|NCT01659255|589163993|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
163124761|NCT01659255|589163994|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
163124762|NCT04094584|589163997|FG000|Overall Study|No interest in study|88|||
163124763|NCT04094584|589163997|FG000|Overall Study|Unwilling to undergo screening tests|36|||
163124764|NCT04094584|589163997|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
163124765|NCT04094584|589163997|FG000|Overall Study|Opioid use|7|||
163124766|NCT04094584|589163997|FG000|Overall Study|Need for major surgery in study period|4|||
163124767|NCT04094584|589163997|FG000|Overall Study|eligible but declined enrollment|4|||
163124768|NCT04094584|589163997|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
163124769|NCT04094584|589163997|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
163124770|NCT04094584|589163997|FG000|Overall Study|Lost to Follow-up|3|||
163124771|NCT04094584|589163997|FG000|Overall Study|Withdrawal by Subject|2|||
163124772|NCT02276547|589163998|FG000|Overall Study|Death|2|||
163124773|NCT02276547|589163998|FG000|Overall Study|Explant|2|||
163124774|NCT00106691|589163999|FG000|Overall Study|Adverse Event|60|||
163124775|NCT00106691|589164000|FG001|Overall Study|Adverse Event|64|||
163124776|NCT00106691|589163999|FG000|Overall Study|Lost to Follow-up|23|||
163124777|NCT00106691|589164000|FG001|Overall Study|Lost to Follow-up|18|||
162655715|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655716|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163124778|NCT00106691|589163999|FG000|Overall Study|Physician Decision|18|||
163124779|NCT00106691|589164000|FG001|Overall Study|Physician Decision|21|||
163124780|NCT00106691|589163999|FG000|Overall Study|Protocol Violation|13|||
163124781|NCT00106691|589164000|FG001|Overall Study|Protocol Violation|18|||
163124782|NCT00106691|589163999|FG000|Overall Study|Withdrawal by Subject|75|||
163124783|NCT00106691|589164000|FG001|Overall Study|Withdrawal by Subject|70|||
163124784|NCT00106691|589163999|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
163124785|NCT00106691|589164000|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
163124786|NCT00106691|589163999|FG000|Overall Study|QTc>480|3|||
163124787|NCT00106691|589164000|FG001|Overall Study|QTc>480|1|||
163124788|NCT00106691|589163999|FG000|Overall Study|mililtary deployment|2|||
163124789|NCT00106691|589164000|FG001|Overall Study|mililtary deployment|0|||
163124790|NCT00106691|589163999|FG000|Overall Study|Study Site Closing/PI Moved|1|||
163124791|NCT00106691|589164000|FG001|Overall Study|Study Site Closing/PI Moved|2|||
163124792|NCT00106691|589163999|FG000|Overall Study|Cardiologist recommendation|1|||
163124793|NCT00106691|589164000|FG001|Overall Study|Cardiologist recommendation|0|||
163124794|NCT00106691|589163999|FG000|Overall Study|Pt. moved to another state|1|||
163124795|NCT00106691|589164000|FG001|Overall Study|Pt. moved to another state|0|||
163124796|NCT00106691|589163999|FG000|Overall Study|Taking exclusionary avodart|1|||
163124797|NCT00106691|589164000|FG001|Overall Study|Taking exclusionary avodart|0|||
163124798|NCT00106691|589163999|FG000|Overall Study|Not able to discontinue plavix|0|||
163124799|NCT00106691|589164000|FG001|Overall Study|Not able to discontinue plavix|1|||
163124800|NCT00530920|589164001|FG000|Overall Study|Randomized but not treated|0|||
163124801|NCT00530920|589164002|FG001|Overall Study|Randomized but not treated|2|||
163124802|NCT00530920|589164003|FG002|Overall Study|Randomized but not treated|0|||
163124803|NCT00530920|589164001|FG000|Overall Study|Adverse Event|0|||
163124804|NCT00530920|589164002|FG001|Overall Study|Adverse Event|0|||
163124805|NCT00530920|589164003|FG002|Overall Study|Adverse Event|3|||
163124806|NCT00530920|589164001|FG000|Overall Study|Withdrawal by Subject|0|||
163124807|NCT00530920|589164002|FG001|Overall Study|Withdrawal by Subject|0|||
163124808|NCT00530920|589164003|FG002|Overall Study|Withdrawal by Subject|1|||
163124809|NCT00907296|589164004|FG000|Overall Study|Ineligibility Determined|1|||
163124810|NCT00907296|589164005|FG001|Overall Study|Ineligibility Determined|0|||
163124811|NCT00907296|589164006|FG002|Overall Study|Ineligibility Determined|0|||
163124812|NCT00907296|589164007|FG003|Overall Study|Ineligibility Determined|1|||
163124813|NCT00907296|589164008|FG004|Overall Study|Ineligibility Determined|0|||
163124814|NCT00907296|589164009|FG005|Overall Study|Ineligibility Determined|0|||
163124815|NCT00907296|589164010|FG006|Overall Study|Ineligibility Determined|0|||
163124816|NCT00907296|589164011|FG007|Overall Study|Ineligibility Determined|1|||
163124817|NCT00907296|589164012|FG008|Overall Study|Ineligibility Determined|0|||
163124818|NCT00907296|589164013|FG009|Overall Study|Ineligibility Determined|0|||
163124819|NCT00907296|589164004|FG000|Overall Study|Protocol Deviation|0|||
163124820|NCT00907296|589164005|FG001|Overall Study|Protocol Deviation|1|||
163124821|NCT00907296|589164006|FG002|Overall Study|Protocol Deviation|0|||
163124822|NCT00907296|589164007|FG003|Overall Study|Protocol Deviation|0|||
163124823|NCT00907296|589164008|FG004|Overall Study|Protocol Deviation|0|||
163124824|NCT00907296|589164009|FG005|Overall Study|Protocol Deviation|0|||
163124825|NCT00907296|589164010|FG006|Overall Study|Protocol Deviation|0|||
163124826|NCT00907296|589164011|FG007|Overall Study|Protocol Deviation|0|||
163124827|NCT00907296|589164012|FG008|Overall Study|Protocol Deviation|0|||
163124828|NCT00907296|589164013|FG009|Overall Study|Protocol Deviation|0|||
163124829|NCT00907296|589164004|FG000|Overall Study|Noncompliance|1|||
163124830|NCT00907296|589164005|FG001|Overall Study|Noncompliance|1|||
163124831|NCT00907296|589164006|FG002|Overall Study|Noncompliance|1|||
163124832|NCT00907296|589164007|FG003|Overall Study|Noncompliance|0|||
163124833|NCT00907296|589164008|FG004|Overall Study|Noncompliance|0|||
163124834|NCT00907296|589164009|FG005|Overall Study|Noncompliance|1|||
163124835|NCT00907296|589164010|FG006|Overall Study|Noncompliance|0|||
163124836|NCT00907296|589164011|FG007|Overall Study|Noncompliance|2|||
163124837|NCT00907296|589164012|FG008|Overall Study|Noncompliance|0|||
163124838|NCT00907296|589164013|FG009|Overall Study|Noncompliance|0|||
163124839|NCT00907296|589164004|FG000|Overall Study|Adverse Event|2|||
163124840|NCT00907296|589164005|FG001|Overall Study|Adverse Event|0|||
163124841|NCT00907296|589164006|FG002|Overall Study|Adverse Event|0|||
163124842|NCT00907296|589164007|FG003|Overall Study|Adverse Event|0|||
163124843|NCT00907296|589164008|FG004|Overall Study|Adverse Event|0|||
163124844|NCT00907296|589164009|FG005|Overall Study|Adverse Event|0|||
163124845|NCT00907296|589164010|FG006|Overall Study|Adverse Event|1|||
163124846|NCT00907296|589164011|FG007|Overall Study|Adverse Event|0|||
163124847|NCT00907296|589164012|FG008|Overall Study|Adverse Event|0|||
163124848|NCT00907296|589164013|FG009|Overall Study|Adverse Event|1|||
163124849|NCT00907296|589164004|FG000|Overall Study|Withdrawal by Subject|7|||
163124850|NCT00907296|589164005|FG001|Overall Study|Withdrawal by Subject|2|||
163124851|NCT00907296|589164006|FG002|Overall Study|Withdrawal by Subject|1|||
162655717|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655718|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655719|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655720|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655721|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163124852|NCT00907296|589164007|FG003|Overall Study|Withdrawal by Subject|1|||
163124853|NCT00907296|589164008|FG004|Overall Study|Withdrawal by Subject|1|||
163124854|NCT00907296|589164009|FG005|Overall Study|Withdrawal by Subject|5|||
163124855|NCT00907296|589164010|FG006|Overall Study|Withdrawal by Subject|3|||
163124856|NCT00907296|589164011|FG007|Overall Study|Withdrawal by Subject|2|||
163124857|NCT00907296|589164012|FG008|Overall Study|Withdrawal by Subject|4|||
163124858|NCT00907296|589164013|FG009|Overall Study|Withdrawal by Subject|2|||
163124859|NCT00907296|589164004|FG000|Overall Study|Lost to Follow-up|9|||
163124860|NCT00907296|589164005|FG001|Overall Study|Lost to Follow-up|1|||
163124861|NCT00907296|589164006|FG002|Overall Study|Lost to Follow-up|0|||
163124862|NCT00907296|589164007|FG003|Overall Study|Lost to Follow-up|2|||
163124863|NCT00907296|589164008|FG004|Overall Study|Lost to Follow-up|0|||
163124864|NCT00907296|589164009|FG005|Overall Study|Lost to Follow-up|3|||
163124865|NCT00907296|589164010|FG006|Overall Study|Lost to Follow-up|2|||
163124866|NCT00907296|589164011|FG007|Overall Study|Lost to Follow-up|2|||
163124867|NCT00907296|589164012|FG008|Overall Study|Lost to Follow-up|0|||
163124868|NCT00907296|589164013|FG009|Overall Study|Lost to Follow-up|4|||
163124869|NCT01177969|589164023|FG000|Overall Study|Protocol Violation|2|||
163124870|NCT01177969|589164024|FG001|Overall Study|Protocol Violation|1|||
163124871|NCT01177969|589164023|FG000|Overall Study|Withdrawal by Subject|1|||
163124872|NCT01177969|589164024|FG001|Overall Study|Withdrawal by Subject|2|||
163124873|NCT01353911|589164031|FG000|Overall Study|Lost to Follow-up|2|||
163124874|NCT01353911|589164032|FG001|Overall Study|Lost to Follow-up|6|||
163124875|NCT01353911|589164033|FG002|Overall Study|Lost to Follow-up|4|||
163124876|NCT01353911|589164034|FG003|Overall Study|Lost to Follow-up|0|||
163124877|NCT01353911|589164035|FG004|Overall Study|Lost to Follow-up|4|||
163124878|NCT01353911|589164036|FG005|Overall Study|Lost to Follow-up|4|||
163124879|NCT01353911|589164037|FG006|Overall Study|Lost to Follow-up|3|||
163124880|NCT01353911|589164038|FG007|Overall Study|Lost to Follow-up|6|||
163124881|NCT01353911|589164031|FG000|Overall Study|Withdrawal by Subject|2|||
163124882|NCT01353911|589164032|FG001|Overall Study|Withdrawal by Subject|3|||
163124883|NCT01353911|589164033|FG002|Overall Study|Withdrawal by Subject|4|||
163124884|NCT01353911|589164034|FG003|Overall Study|Withdrawal by Subject|2|||
163124885|NCT01353911|589164035|FG004|Overall Study|Withdrawal by Subject|2|||
163124886|NCT01353911|589164036|FG005|Overall Study|Withdrawal by Subject|3|||
163124887|NCT01353911|589164037|FG006|Overall Study|Withdrawal by Subject|3|||
163124888|NCT01353911|589164038|FG007|Overall Study|Withdrawal by Subject|9|||
163124889|NCT01353911|589164031|FG000|Overall Study|Status Not Recorded|4|||
163124890|NCT01353911|589164032|FG001|Overall Study|Status Not Recorded|0|||
163124891|NCT01353911|589164033|FG002|Overall Study|Status Not Recorded|1|||
163124892|NCT01353911|589164034|FG003|Overall Study|Status Not Recorded|0|||
163124893|NCT01353911|589164035|FG004|Overall Study|Status Not Recorded|0|||
163124894|NCT01353911|589164036|FG005|Overall Study|Status Not Recorded|0|||
163124895|NCT01353911|589164037|FG006|Overall Study|Status Not Recorded|0|||
163124896|NCT01353911|589164038|FG007|Overall Study|Status Not Recorded|0|||
163124897|NCT02049138|589164043|FG000|Overall Study|Adverse Event|46|||
163124898|NCT02049138|589164044|FG001|Overall Study|Adverse Event|25|||
163124899|NCT02049138|589164045|FG002|Overall Study|Adverse Event|1|||
163124900|NCT02049138|589164043|FG000|Overall Study|Withdrawal by Subject|57|||
163124901|NCT02049138|589164044|FG001|Overall Study|Withdrawal by Subject|21|||
163124902|NCT02049138|589164045|FG002|Overall Study|Withdrawal by Subject|5|||
162655722|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655723|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655724|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163124903|NCT02049138|589164043|FG000|Overall Study|Lost to Follow-up|18|||
163124904|NCT02049138|589164044|FG001|Overall Study|Lost to Follow-up|5|||
163124905|NCT02049138|589164045|FG002|Overall Study|Lost to Follow-up|1|||
163124906|NCT02049138|589164043|FG000|Overall Study|Lack of Efficacy|10|||
163124907|NCT02049138|589164044|FG001|Overall Study|Lack of Efficacy|26|||
163124908|NCT02049138|589164045|FG002|Overall Study|Lack of Efficacy|1|||
163124909|NCT02049138|589164043|FG000|Overall Study|Non-Compliance|15|||
163124910|NCT02049138|589164044|FG001|Overall Study|Non-Compliance|6|||
163124911|NCT02049138|589164045|FG002|Overall Study|Non-Compliance|0|||
163124912|NCT02049138|589164043|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
163124913|NCT02049138|589164044|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
163124914|NCT02049138|589164045|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
163124915|NCT02049138|589164043|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
162719564|NCT01458210|587680510|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
162719565|NCT01458210|587680510|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
163124916|NCT02049138|589164044|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163124917|NCT02049138|589164045|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
163124918|NCT02049138|589164043|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163124919|NCT02049138|589164044|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
163124920|NCT02049138|589164045|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163124921|NCT02049138|589164043|FG000|Overall Study|Other|15|||
163124922|NCT02049138|589164044|FG001|Overall Study|Other|13|||
163124923|NCT02049138|589164045|FG002|Overall Study|Other|0|||
163124924|NCT02049138|589164043|FG000|Overall Study|Missing|0|||
163124925|NCT02049138|589164044|FG001|Overall Study|Missing|1|||
163124926|NCT02049138|589164045|FG002|Overall Study|Missing|0|||
163124927|NCT03995355|589164046|FG000|Overall Study|Adverse Event|1|||
163124928|NCT03995355|589164047|FG001|Overall Study|Adverse Event|0|||
163124929|NCT03995355|589164046|FG000|Overall Study|Withdrawal by Subject|1|||
163124930|NCT03995355|589164047|FG001|Overall Study|Withdrawal by Subject|0|||
163124931|NCT03995355|589164046|FG000|Overall Study|Scheduling Issues|0|||
163124932|NCT03995355|589164047|FG001|Overall Study|Scheduling Issues|1|||
163124933|NCT00094107|589164048|FG000|Overall Study|Lack of Efficacy|23|||
163124934|NCT00094107|589164048|FG000|Overall Study|Death|5|||
163124935|NCT00094107|589164048|FG000|Overall Study|Adverse Event|3|||
163124936|NCT00094107|589164048|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
163124937|NCT00587847|589164050|FG000|Overall Study|Lack of Efficacy|5|||
163124938|NCT00587847|589164050|FG000|Overall Study|Adverse Event|2|||
163124939|NCT00343382|589164051|FG000|Overall Study|Adverse Event|2|||
163124940|NCT00343382|589164052|FG001|Overall Study|Adverse Event|10|||
163124941|NCT00343382|589164053|FG002|Overall Study|Adverse Event|7|||
163124942|NCT00343382|589164051|FG000|Overall Study|Withdrawal by Subject|1|||
163124943|NCT00343382|589164052|FG001|Overall Study|Withdrawal by Subject|2|||
163124944|NCT00343382|589164053|FG002|Overall Study|Withdrawal by Subject|6|||
163124945|NCT00343382|589164051|FG000|Overall Study|Other Reason Not Specified|1|||
163124946|NCT00343382|589164052|FG001|Overall Study|Other Reason Not Specified|2|||
163124947|NCT00343382|589164053|FG002|Overall Study|Other Reason Not Specified|4|||
163124948|NCT00199888|589164060|FG000|Overall Study|Lost to Follow-up|1|||
163124949|NCT05219669|589164065|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124950|NCT05219669|589164066|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124951|NCT05219669|589164067|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
163124952|NCT05219669|589164068|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124953|NCT05219669|589164069|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124954|NCT05219669|589164070|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
163124955|NCT02177838|589164072|FG000|Overall Study|Withdrawal by Subject|1|||
163124956|NCT02177838|589164072|FG000|Overall Study|Physician Decision|1|||
163124957|NCT02177838|589164072|FG000|Overall Study|Death|1|||
163124958|NCT02404649|589164074|FG000|Overall Study|Adverse Event|1|||
163124959|NCT02404649|589164075|FG001|Overall Study|Adverse Event|2|||
163124960|NCT02299076|589164079|FG000|Overall Study|Fraudulent Entries|20|||
163124961|NCT02299076|589164080|FG001|Overall Study|Fraudulent Entries|14|||
163124962|NCT00162266|589164081|FG000|Double-Blind Period|Adverse Event|5|||
163124963|NCT00162266|589164082|FG001|Double-Blind Period|Adverse Event|9|||
163124964|NCT00162266|589164083|FG002|Double-Blind Period|Adverse Event|11|||
163124965|NCT00162266|589164084|FG003|Double-Blind Period|Adverse Event|0|||
163124966|NCT00162266|589164081|FG000|Double-Blind Period|Death|0|||
163124967|NCT00162266|589164082|FG001|Double-Blind Period|Death|1|||
163124968|NCT00162266|589164083|FG002|Double-Blind Period|Death|0|||
163124969|NCT00162266|589164084|FG003|Double-Blind Period|Death|0|||
163124970|NCT00162266|589164081|FG000|Double-Blind Period|Lost to Follow-up|1|||
163124971|NCT00162266|589164082|FG001|Double-Blind Period|Lost to Follow-up|2|||
163124972|NCT00162266|589164083|FG002|Double-Blind Period|Lost to Follow-up|0|||
163124973|NCT00162266|589164084|FG003|Double-Blind Period|Lost to Follow-up|0|||
163124974|NCT00162266|589164081|FG000|Double-Blind Period|Other Reason|1|||
163124975|NCT00162266|589164082|FG001|Double-Blind Period|Other Reason|0|||
163124976|NCT00162266|589164083|FG002|Double-Blind Period|Other Reason|1|||
163124977|NCT00162266|589164084|FG003|Double-Blind Period|Other Reason|0|||
163124978|NCT00162266|589164081|FG000|Double-Blind Period|Lack of Efficacy|13|||
163124979|NCT00162266|589164082|FG001|Double-Blind Period|Lack of Efficacy|17|||
163124980|NCT00162266|589164083|FG002|Double-Blind Period|Lack of Efficacy|30|||
163124981|NCT00162266|589164084|FG003|Double-Blind Period|Lack of Efficacy|0|||
163124982|NCT00162266|589164081|FG000|Double-Blind Period|Withdrawal by Subject|5|||
163124983|NCT00162266|589164082|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163124984|NCT00162266|589164083|FG002|Double-Blind Period|Withdrawal by Subject|6|||
163124985|NCT00162266|589164084|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163124986|NCT00162266|589164081|FG000|Open-Label Period|Death|0|||
163124987|NCT00162266|589164082|FG001|Open-Label Period|Death|0|||
163124988|NCT00162266|589164083|FG002|Open-Label Period|Death|0|||
163124989|NCT00162266|589164084|FG003|Open-Label Period|Death|7|||
163124990|NCT00162266|589164081|FG000|Open-Label Period|Adverse Event|0|||
163124991|NCT00162266|589164082|FG001|Open-Label Period|Adverse Event|0|||
163124992|NCT00162266|589164083|FG002|Open-Label Period|Adverse Event|0|||
163124993|NCT00162266|589164084|FG003|Open-Label Period|Adverse Event|46|||
163124994|NCT00162266|589164081|FG000|Open-Label Period|Lack of Efficacy|0|||
163124995|NCT00162266|589164082|FG001|Open-Label Period|Lack of Efficacy|0|||
163124996|NCT00162266|589164083|FG002|Open-Label Period|Lack of Efficacy|0|||
163124997|NCT00162266|589164084|FG003|Open-Label Period|Lack of Efficacy|26|||
163124998|NCT00162266|589164081|FG000|Open-Label Period|Lost to Follow-up|0|||
163124999|NCT00162266|589164082|FG001|Open-Label Period|Lost to Follow-up|0|||
163125000|NCT00162266|589164083|FG002|Open-Label Period|Lost to Follow-up|0|||
163125001|NCT00162266|589164084|FG003|Open-Label Period|Lost to Follow-up|3|||
163125002|NCT00162266|589164081|FG000|Open-Label Period|Withdrawal by Subject|0|||
163125003|NCT00162266|589164082|FG001|Open-Label Period|Withdrawal by Subject|0|||
163125004|NCT00162266|589164083|FG002|Open-Label Period|Withdrawal by Subject|0|||
163125005|NCT00162266|589164084|FG003|Open-Label Period|Withdrawal by Subject|31|||
163125006|NCT00162266|589164081|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
163125007|NCT00162266|589164082|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
163125008|NCT00162266|589164083|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
163125009|NCT00162266|589164084|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
163125010|NCT00162266|589164081|FG000|Open-Label Period|Other Reasons|0|||
163125011|NCT00162266|589164082|FG001|Open-Label Period|Other Reasons|0|||
163125012|NCT00162266|589164083|FG002|Open-Label Period|Other Reasons|0|||
163125013|NCT00162266|589164084|FG003|Open-Label Period|Other Reasons|15|||
163125014|NCT00330668|589164085|FG000|BID Dosing Period|Adverse Event|1|||
163125015|NCT00330668|589164085|FG000|BID Dosing Period|Lost to Follow-up|7|||
163125016|NCT00330668|589164085|FG000|BID Dosing Period|Non-Compliance|5|||
163125017|NCT00330668|589164085|FG000|BID Dosing Period|Withdrawal by Subject|19|||
163125018|NCT00330668|589164085|FG000|BID Dosing Period|Sponsor's decision|1|||
163125019|NCT00330668|589164085|FG000|BID Dosing Period|Other|3|||
163125020|NCT00330668|589164085|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
163125021|NCT00330668|589164085|FG000|QD Dosing Period|Other|1|||
163125022|NCT00330668|589164085|FG000|QD Dosing Period|Withdrawal by Subject|1|||
163125023|NCT00330668|589164085|FG000|QD Dosing Period|Lost to Follow-up|2|||
163125024|NCT01839656|589164086|FG000|Overall Study|Withdrawal by Subject|1|||
163125025|NCT01839656|589164087|FG001|Overall Study|Withdrawal by Subject|1|||
163125026|NCT01839656|589164086|FG000|Overall Study|Adverse event, serious fatal|1|||
163125027|NCT01839656|589164087|FG001|Overall Study|Adverse event, serious fatal|4|||
163125028|NCT01839656|589164086|FG000|Overall Study|Early study closure|0|||
163125029|NCT01839656|589164087|FG001|Overall Study|Early study closure|11|||
163125030|NCT01839656|589164086|FG000|Overall Study|Adverse Event|1|||
163125031|NCT01839656|589164087|FG001|Overall Study|Adverse Event|0|||
163125032|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
163125033|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
163125034|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
163125035|NCT00499746|589164093|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
163125036|NCT01012323|589164094|FG000|Overall Study|Investigator Judgment|1|||
163125037|NCT02273960|589164095|FG000|Short Term Period|Lost to Follow-up|1|||
163125038|NCT02273960|589164096|FG001|Short Term Period|Lost to Follow-up|0|||
163125039|NCT02273960|589164097|FG002|Short Term Period|Lost to Follow-up|0|||
162655725|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
162655726|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655727|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655728|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655729|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655730|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655731|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655732|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655733|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655734|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655735|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163125040|NCT02273960|589164098|FG003|Short Term Period|Lost to Follow-up|0|||
163125041|NCT02273960|589164095|FG000|Short Term Period|Lack of Efficacy|0|||
163125042|NCT02273960|589164096|FG001|Short Term Period|Lack of Efficacy|0|||
163125043|NCT02273960|589164097|FG002|Short Term Period|Lack of Efficacy|0|||
163125044|NCT02273960|589164098|FG003|Short Term Period|Lack of Efficacy|1|||
163125045|NCT02273960|589164095|FG000|Short Term Period|ST complete, not entering LTE|4|||
163125046|NCT02273960|589164096|FG001|Short Term Period|ST complete, not entering LTE|6|||
163125047|NCT02273960|589164097|FG002|Short Term Period|ST complete, not entering LTE|4|||
163125048|NCT02273960|589164098|FG003|Short Term Period|ST complete, not entering LTE|5|||
163125049|NCT02273960|589164095|FG000|Long Term Extension|Death|0|||
163125050|NCT02273960|589164096|FG001|Long Term Extension|Death|0|||
163125051|NCT02273960|589164097|FG002|Long Term Extension|Death|0|||
163125052|NCT02273960|589164098|FG003|Long Term Extension|Death|1|||
163125053|NCT00737633|589164105|FG000|Overall Study|Study terminated by sponsor|44|||
163125054|NCT00737633|589164106|FG001|Overall Study|Study terminated by sponsor|55|||
163125055|NCT00737633|589164105|FG000|Overall Study|Lost to Follow-up|0|||
163125056|NCT00737633|589164106|FG001|Overall Study|Lost to Follow-up|1|||
163125057|NCT00737633|589164105|FG000|Overall Study|protocol non-compliance|0|||
163125058|NCT00737633|589164106|FG001|Overall Study|protocol non-compliance|1|||
163125059|NCT01105377|589164112|FG000|Overall Study|Withdrawal by Subject|0|||
163125060|NCT01105377|589164113|FG001|Overall Study|Withdrawal by Subject|1|||
163125061|NCT02100475|589166368|FG000|Overall Study|Unclassified|1|||
163125062|NCT02100475|589166369|FG001|Overall Study|Unclassified|2|||
163125063|NCT02100475|589166368|FG000|Overall Study|Withdrawal criteria|1|||
163125064|NCT02100475|589166369|FG001|Overall Study|Withdrawal criteria|0|||
163125065|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125066|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125067|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125068|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
163125069|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125070|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125071|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163125072|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125073|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125074|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125075|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
163125076|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125077|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125078|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
163125079|NCT03268941|589166370|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
163125080|NCT03268941|589166371|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125081|NCT03268941|589166372|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125082|NCT03268941|589166373|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125083|NCT03268941|589166374|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125084|NCT03268941|589166375|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125085|NCT03268941|589166376|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
163125086|NCT03268941|589166370|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
163125087|NCT03268941|589166371|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
163125088|NCT03268941|589166372|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
163125089|NCT03268941|589166373|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
163125090|NCT03268941|589166374|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
163125091|NCT03268941|589166375|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
162655736|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
163125092|NCT03268941|589166376|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
163125093|NCT03268941|589166370|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125094|NCT03268941|589166371|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125095|NCT03268941|589166372|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125096|NCT03268941|589166373|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125097|NCT03268941|589166374|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125098|NCT03268941|589166375|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
163125099|NCT03268941|589166376|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
163125100|NCT03878758|589166381|FG000|Overall Study|Withdrawal by Subject|1|||
163125101|NCT03878758|589166381|FG000|Overall Study|Protocol defined|2|||
163125102|NCT03878758|589166381|FG000|Overall Study|Improper consent documentation|1|||
163125103|NCT01769196|589166382|FG000|Overall Study|Adverse Event|24|||
163125104|NCT01769196|589166383|FG001|Overall Study|Adverse Event|20|||
163125105|NCT01769196|589166382|FG000|Overall Study|Death|21|||
163125106|NCT01769196|589166383|FG001|Overall Study|Death|26|||
163125107|NCT01769196|589166382|FG000|Overall Study|Investigator Discretion|7|||
163125108|NCT01769196|589166383|FG001|Overall Study|Investigator Discretion|3|||
163125109|NCT01769196|589166382|FG000|Overall Study|Lack of Efficacy|3|||
163125110|NCT01769196|589166383|FG001|Overall Study|Lack of Efficacy|2|||
163125111|NCT01769196|589166382|FG000|Overall Study|Progressive disease|11|||
163125112|NCT01769196|589166383|FG001|Overall Study|Progressive disease|6|||
163125113|NCT01769196|589166382|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
163125114|NCT01769196|589166383|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
163125115|NCT01769196|589166382|FG000|Overall Study|Protocol Violation|0|||
163125116|NCT01769196|589166383|FG001|Overall Study|Protocol Violation|3|||
163125117|NCT01769196|589166382|FG000|Overall Study|Study terminated by sponsor|160|||
163125118|NCT01769196|589166383|FG001|Overall Study|Study terminated by sponsor|161|||
163125119|NCT01769196|589166382|FG000|Overall Study|Participant never dosed with study drug|1|||
163125120|NCT01769196|589166383|FG001|Overall Study|Participant never dosed with study drug|0|||
163125121|NCT01769196|589166382|FG000|Overall Study|Withdrew consent|36|||
163125122|NCT01769196|589166383|FG001|Overall Study|Withdrew consent|40|||
163125123|NCT00765063|589166384|FG000|Overall Study|Lack of Efficacy|5|||
163125124|NCT00765063|589166384|FG000|Overall Study|Withdrawal by Subject|1|||
163125125|NCT00765063|589166384|FG000|Overall Study|Other|16|||
163125126|NCT00765063|589166384|FG000|Overall Study|Protocol Violation|6|||
163125127|NCT00765063|589166384|FG000|Overall Study|Adverse Event|4|||
163125128|NCT03614325|589166385|FG000|Overall Study|Withdrawal by Subject|0|||
163125129|NCT03614325|589166386|FG001|Overall Study|Withdrawal by Subject|2|||
163125130|NCT03614325|589166385|FG000|Overall Study|Surgery Cancelled|2|||
163125131|NCT03614325|589166386|FG001|Overall Study|Surgery Cancelled|1|||
163125132|NCT03614325|589166385|FG000|Overall Study|Lost to Follow-up|2|||
163125133|NCT03614325|589166386|FG001|Overall Study|Lost to Follow-up|1|||
163125134|NCT03614325|589166385|FG000|Overall Study|Surgery never scheduled|1|||
163125135|NCT03614325|589166386|FG001|Overall Study|Surgery never scheduled|0|||
163125136|NCT00321464|589166387|FG000|Overall Study|Death|169|||
163125137|NCT00321464|589166388|FG001|Overall Study|Death|174|||
163125138|NCT00321464|589166387|FG000|Overall Study|Disease progression|124|||
163125139|NCT00321464|589166388|FG001|Overall Study|Disease progression|124|||
163125140|NCT00321464|589166387|FG000|Overall Study|Withdrawal by Subject|117|||
163125141|NCT00321464|589166388|FG001|Overall Study|Withdrawal by Subject|118|||
163125142|NCT00321464|589166387|FG000|Overall Study|Participant request|57|||
163125143|NCT00321464|589166388|FG001|Overall Study|Participant request|61|||
163125144|NCT00321464|589166387|FG000|Overall Study|Adverse Event|43|||
163125145|NCT00321464|589166388|FG001|Overall Study|Adverse Event|28|||
163125146|NCT00321464|589166387|FG000|Overall Study|Physician Decision|15|||
163125147|NCT00321464|589166388|FG001|Overall Study|Physician Decision|14|||
163125148|NCT00321464|589166387|FG000|Overall Study|Noncompliance|4|||
163125149|NCT00321464|589166388|FG001|Overall Study|Noncompliance|10|||
163125150|NCT00321464|589166387|FG000|Overall Study|Lost to Follow-up|7|||
163125151|NCT00321464|589166388|FG001|Overall Study|Lost to Follow-up|8|||
163125152|NCT00321464|589166387|FG000|Overall Study|Protocol deviation|0|||
163125153|NCT00321464|589166388|FG001|Overall Study|Protocol deviation|2|||
163125154|NCT00321464|589166387|FG000|Overall Study|Ineligibility determined|2|||
163125155|NCT00321464|589166388|FG001|Overall Study|Ineligibility determined|1|||
163125156|NCT00321464|589166387|FG000|Overall Study|Other|21|||
163125157|NCT00321464|589166388|FG001|Overall Study|Other|18|||
163125158|NCT01673620|589166394|FG000|Overall Study|Adverse Event|1|||
163125159|NCT01673620|589166395|FG001|Overall Study|Adverse Event|0|||
163125160|NCT00652951|589166396|FG000|Booster Phase|Adverse event, non-fatal|0|||
163125161|NCT00652951|589166397|FG001|Booster Phase|Adverse event, non-fatal|1|||
163125162|NCT00652951|589166398|FG002|Booster Phase|Adverse event, non-fatal|0|||
162719566|NCT01458210|587680510|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
163125163|NCT00652951|589166396|FG000|Booster Phase|Other|1|||
163125164|NCT00652951|589166397|FG001|Booster Phase|Other|0|||
163125165|NCT00652951|589166398|FG002|Booster Phase|Other|0|||
163125166|NCT01022424|589166399|FG000|Overall Study|Adverse Event|1|||
163125167|NCT01022424|589166399|FG000|Overall Study|Physician Decision|1|||
163125168|NCT01022424|589166399|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
163125169|NCT02100969|589166400|FG000|Overall Study|Did not pass screening phase|1|||
163125170|NCT00372697|589166401|FG000|Overall Study|Protocol Violation|1|||
163125171|NCT00372697|589166402|FG001|Overall Study|Protocol Violation|1|||
163125172|NCT00527982|589166404|FG000|Overall Study|Physician Decision|1|||
163125173|NCT00527982|589166405|FG001|Overall Study|Physician Decision|0|||
163125174|NCT00007020|589166408|FG000|Overall Study|Death|16|||
163125175|NCT00007020|589166408|FG000|Overall Study|Lost to Follow-up|13|||
162655737|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655738|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162655739|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
163125176|NCT00007020|589166408|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
163125177|NCT00007020|589166408|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
163125178|NCT00007020|589166408|FG000|Overall Study|Pt cared for by outside physician|4|||
163125179|NCT00007020|589166408|FG000|Overall Study|No evidence of treatment|6|||
163125180|NCT02708485|589166409|FG000|Overall Study|Withdrawal by Subject|3|||
163125181|NCT02708485|589166410|FG001|Overall Study|Withdrawal by Subject|2|||
163125182|NCT01100528|589166411|FG000|Overall Study|Death|1|||
163125183|NCT01100528|589166411|FG000|Overall Study|Withdrawal by Subject|2|||
163125184|NCT02066415|589166412|FG000|Overall Study|Decision by Sponsor|5|||
163125185|NCT02066415|589166413|FG001|Overall Study|Decision by Sponsor|4|||
163125186|NCT02066415|589166414|FG002|Overall Study|Decision by Sponsor|2|||
163125187|NCT02066415|589166412|FG000|Overall Study|Withdrawal by Subject|9|||
163125188|NCT02066415|589166413|FG001|Overall Study|Withdrawal by Subject|1|||
163125189|NCT02066415|589166414|FG002|Overall Study|Withdrawal by Subject|4|||
163125190|NCT02066415|589166412|FG000|Overall Study|Lost to Follow-up|7|||
163125191|NCT02066415|589166413|FG001|Overall Study|Lost to Follow-up|2|||
163125192|NCT02066415|589166414|FG002|Overall Study|Lost to Follow-up|2|||
163125193|NCT01116427|589166415|FG000|Core Phase|Adverse Event|0|||
163125194|NCT01116427|589166416|FG001|Core Phase|Adverse Event|1|||
163125195|NCT01116427|589166415|FG000|Core Phase|Lost to Follow-up|1|||
163125196|NCT01116427|589166416|FG001|Core Phase|Lost to Follow-up|0|||
163125197|NCT01116427|589166415|FG000|Core Phase|Withdrawal by Subject|3|||
163125198|NCT01116427|589166416|FG001|Core Phase|Withdrawal by Subject|0|||
163125199|NCT01116427|589166415|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
163125200|NCT01116427|589166416|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
163125201|NCT01116427|589166415|FG000|Extension Phase|Adverse Event|1|||
163125202|NCT01116427|589166416|FG001|Extension Phase|Adverse Event|1|||
163125203|NCT01116427|589166415|FG000|Extension Phase|Lost to Follow-up|2|||
163125204|NCT01116427|589166416|FG001|Extension Phase|Lost to Follow-up|0|||
163125205|NCT01116427|589166415|FG000|Extension Phase|Withdrawal by Subject|5|||
163125206|NCT01116427|589166416|FG001|Extension Phase|Withdrawal by Subject|1|||
163125207|NCT01116427|589166415|FG000|Extension Phase|Not using appropriate birth control|1|||
163125208|NCT01116427|589166416|FG001|Extension Phase|Not using appropriate birth control|0|||
163125209|NCT02211313|589166417|FG000|Overall Study|Treatment Failure|5|||
163125210|NCT02211313|589166418|FG001|Overall Study|Treatment Failure|2|||
163125211|NCT02211313|589166417|FG000|Overall Study|No Follow up Questionnaires|1|||
163125212|NCT02211313|589166418|FG001|Overall Study|No Follow up Questionnaires|1|||
163125213|NCT01423916|589166419|FG000|Overall Study|Adverse Event|5|||
163125214|NCT01423916|589166420|FG001|Overall Study|Adverse Event|9|||
163125215|NCT01423916|589166421|FG002|Overall Study|Adverse Event|2|||
163125216|NCT01423916|589166419|FG000|Overall Study|Met Withdrawal Criteria|1|||
163125217|NCT01423916|589166420|FG001|Overall Study|Met Withdrawal Criteria|1|||
163125218|NCT01423916|589166421|FG002|Overall Study|Met Withdrawal Criteria|1|||
163125219|NCT01423916|589166419|FG000|Overall Study|Physician Decision|1|||
163125220|NCT01423916|589166420|FG001|Overall Study|Physician Decision|0|||
163125221|NCT01423916|589166421|FG002|Overall Study|Physician Decision|1|||
163125222|NCT01423916|589166419|FG000|Overall Study|Withdrawal by Subject|3|||
163125223|NCT01423916|589166420|FG001|Overall Study|Withdrawal by Subject|10|||
163125224|NCT01423916|589166421|FG002|Overall Study|Withdrawal by Subject|3|||
163125225|NCT01423916|589166419|FG000|Overall Study|Protocol Deviation|1|||
163125226|NCT01423916|589166420|FG001|Overall Study|Protocol Deviation|0|||
163125227|NCT01423916|589166421|FG002|Overall Study|Protocol Deviation|0|||
163125228|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
163125229|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
163125230|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
163125231|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
163125232|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
163125233|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
163125234|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
163125235|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
163125236|NCT03316950|589166422|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
163125237|NCT03316950|589166423|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
163125238|NCT03316950|589166424|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
163125239|NCT03316950|589166425|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
163125240|NCT01754194|589166426|FG000|Overall Study|Lost to Follow-up|39|||
163125241|NCT01754194|589166427|FG001|Overall Study|Lost to Follow-up|14|||
163125242|NCT01754194|589166426|FG000|Overall Study|Withdrawal by Subject|4|||
163125243|NCT01754194|589166427|FG001|Overall Study|Withdrawal by Subject|5|||
163125244|NCT01754194|589166426|FG000|Overall Study|Other|9|||
163125245|NCT01754194|589166427|FG001|Overall Study|Other|8|||
163125246|NCT00791557|589166428|FG000|Overall Study|Adverse Event|1|||
163125247|NCT01079936|589166429|FG000|Phase I: MTD|First Remission Status|2|||
163125248|NCT01079936|589166430|FG001|Phase I: MTD|First Remission Status|0|||
163125249|NCT01079936|589166431|FG002|Phase I: MTD|First Remission Status|0|||
163125250|NCT01079936|589166432|FG003|Phase I: MTD|First Remission Status|0|||
163125251|NCT01079936|589166433|FG004|Phase I: MTD|First Remission Status|0|||
163125252|NCT01079936|589166429|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
163125253|NCT01079936|589166430|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
163125254|NCT01079936|589166431|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
163125255|NCT01079936|589166432|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
163125256|NCT01079936|589166433|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
163125257|NCT01079936|589166429|FG000|Phase II|Adverse Event|0|||
163125258|NCT01079936|589166430|FG001|Phase II|Adverse Event|0|||
163125259|NCT01079936|589166431|FG002|Phase II|Adverse Event|1|||
163125260|NCT01079936|589166432|FG003|Phase II|Adverse Event|0|||
163125261|NCT01079936|589166433|FG004|Phase II|Adverse Event|0|||
163125262|NCT01079936|589166429|FG000|Phase II|Insurance Issue|0|||
163125263|NCT01079936|589166430|FG001|Phase II|Insurance Issue|0|||
163125264|NCT01079936|589166431|FG002|Phase II|Insurance Issue|0|||
163125265|NCT01079936|589166432|FG003|Phase II|Insurance Issue|0|||
163125266|NCT01079936|589166433|FG004|Phase II|Insurance Issue|1|||
163125267|NCT02322190|589166434|FG000|Overall Study|Death on study|1|||
163125268|NCT02322190|589166435|FG001|Overall Study|Death on study|0|||
163125269|NCT03344640|589166436|FG000|Overall Study|Adverse Event|1|||
163125270|NCT03344640|589166437|FG001|Overall Study|Adverse Event|0|||
163125271|NCT03344640|589166436|FG000|Overall Study|Physician Decision|1|||
163125272|NCT03344640|589166437|FG001|Overall Study|Physician Decision|1|||
163125273|NCT03344640|589166436|FG000|Overall Study|Withdrawal by Subject|1|||
163125274|NCT03344640|589166437|FG001|Overall Study|Withdrawal by Subject|2|||
163125275|NCT03344640|589166436|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
163125276|NCT03344640|589166437|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
163125277|NCT02809053|589166438|FG000|Overall Study|Death|0|||
163125278|NCT02809053|589166439|FG001|Overall Study|Death|1|||
163125279|NCT02809053|589166438|FG000|Overall Study|Lost to Follow-up|3|||
163125280|NCT02809053|589166439|FG001|Overall Study|Lost to Follow-up|1|||
163125281|NCT02809053|589166438|FG000|Overall Study|Withdrawal by Subject|2|||
163125282|NCT02809053|589166439|FG001|Overall Study|Withdrawal by Subject|3|||
163125283|NCT02809053|589166438|FG000|Overall Study|Disease Progression|2|||
163125284|NCT02809053|589166439|FG001|Overall Study|Disease Progression|1|||
163125285|NCT01147900|589166440|FG000|At Year 10|Lost to Follow-up|0|||
163125286|NCT01147900|589166441|FG001|At Year 10|Lost to Follow-up|1|||
163125287|NCT01147900|589166442|FG002|At Year 10|Lost to Follow-up|0|||
163125288|NCT00025155|589166443|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
163125289|NCT00025155|589166443|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
163125290|NCT05086510|589166444|FG000|Overall Study|Lost to Follow-up|0|||
163125291|NCT05086510|589166445|FG001|Overall Study|Lost to Follow-up|2|||
163125292|NCT05086510|589166444|FG000|Overall Study|Death|0|||
163125293|NCT05086510|589166445|FG001|Overall Study|Death|2|||
163125294|NCT03022981|589166446|FG000|Overall Study|Adverse Event|0|||
163125295|NCT03022981|589166447|FG001|Overall Study|Adverse Event|1|||
163125296|NCT03022981|589166448|FG002|Overall Study|Adverse Event|0|||
163125297|NCT03022981|589166446|FG000|Overall Study|Investigator's Discretion|0|||
163125298|NCT03022981|589166447|FG001|Overall Study|Investigator's Discretion|1|||
163125299|NCT03022981|589166448|FG002|Overall Study|Investigator's Discretion|2|||
163125300|NCT03022981|589166446|FG000|Overall Study|Lost to Follow-up|6|||
163125301|NCT03022981|589166447|FG001|Overall Study|Lost to Follow-up|2|||
163125302|NCT03022981|589166448|FG002|Overall Study|Lost to Follow-up|1|||
163125303|NCT03022981|589166446|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163125304|NCT03022981|589166447|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163125305|NCT03022981|589166448|FG002|Overall Study|Non-Compliance With Study Drug|2|||
163125306|NCT03022981|589166446|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
163125307|NCT03022981|589166447|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
163125308|NCT03022981|589166448|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
163125309|NCT00884832|589166450|FG000|Overall Study|Withdrawal by Subject|0|||
163125310|NCT00884832|589166451|FG001|Overall Study|Withdrawal by Subject|1|||
163125311|NCT02337725|589166452|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
163125312|NCT02337725|589166453|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
163125313|NCT02337725|589166452|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
163125314|NCT02337725|589166453|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
163125315|NCT02337725|589166452|FG000|Overall Study|Major Protocol Deviation|0|||
163125316|NCT02337725|589166453|FG001|Overall Study|Major Protocol Deviation|1|||
163125317|NCT02337725|589166452|FG000|Overall Study|Voluntary Withdrawal|14|||
163125318|NCT02337725|589166453|FG001|Overall Study|Voluntary Withdrawal|3|||
163125319|NCT02337725|589166452|FG000|Overall Study|Lack of Efficacy|4|||
163125320|NCT02337725|589166453|FG001|Overall Study|Lack of Efficacy|0|||
163125321|NCT00500760|589166455|FG000|Overall Study|Death|32|||
163125322|NCT00500760|589166456|FG001|Overall Study|Death|15|||
163125323|NCT00500760|589166455|FG000|Overall Study|Withdrawal by Subject|5|||
163125324|NCT00500760|589166456|FG001|Overall Study|Withdrawal by Subject|7|||
163125325|NCT00500760|589166455|FG000|Overall Study|Administrative decision|2|||
163125326|NCT00500760|589166456|FG001|Overall Study|Administrative decision|0|||
163125327|NCT00500760|589166455|FG000|Overall Study|Lost to Follow-up|3|||
163125328|NCT00500760|589166456|FG001|Overall Study|Lost to Follow-up|0|||
163125329|NCT00500760|589166455|FG000|Overall Study|Other|1|||
163125330|NCT00500760|589166456|FG001|Overall Study|Other|2|||
163125331|NCT01264770|589166457|FG000|Overall Study|Not reported|0|||
163125332|NCT01264770|589166458|FG001|Overall Study|Not reported|0|||
163125333|NCT01264770|589166459|FG002|Overall Study|Not reported|1|||
163125334|NCT01264770|589166460|FG003|Overall Study|Not reported|0|||
163125335|NCT01264770|589166461|FG004|Overall Study|Not reported|0|||
163125336|NCT01264770|589166462|FG005|Overall Study|Not reported|0|||
163125337|NCT01264770|589166457|FG000|Overall Study|e.g., change in circumstances|8|||
163125338|NCT01264770|589166458|FG001|Overall Study|e.g., change in circumstances|3|||
163125339|NCT01264770|589166459|FG002|Overall Study|e.g., change in circumstances|3|||
163125340|NCT01264770|589166460|FG003|Overall Study|e.g., change in circumstances|3|||
163125341|NCT01264770|589166461|FG004|Overall Study|e.g., change in circumstances|4|||
163125342|NCT01264770|589166462|FG005|Overall Study|e.g., change in circumstances|4|||
163125343|NCT01264770|589166457|FG000|Overall Study|Severe non-compliance to protocol|0|||
163125344|NCT01264770|589166458|FG001|Overall Study|Severe non-compliance to protocol|0|||
163125345|NCT01264770|589166459|FG002|Overall Study|Severe non-compliance to protocol|1|||
163125346|NCT01264770|589166460|FG003|Overall Study|Severe non-compliance to protocol|1|||
163125347|NCT01264770|589166461|FG004|Overall Study|Severe non-compliance to protocol|0|||
163125348|NCT01264770|589166462|FG005|Overall Study|Severe non-compliance to protocol|0|||
163125349|NCT01264770|589166457|FG000|Overall Study|Lack of therapeutic response|1|||
163125350|NCT01264770|589166458|FG001|Overall Study|Lack of therapeutic response|0|||
163125351|NCT01264770|589166459|FG002|Overall Study|Lack of therapeutic response|2|||
163125352|NCT01264770|589166460|FG003|Overall Study|Lack of therapeutic response|1|||
163125353|NCT01264770|589166461|FG004|Overall Study|Lack of therapeutic response|1|||
163125354|NCT01264770|589166462|FG005|Overall Study|Lack of therapeutic response|0|||
163125355|NCT01264770|589166457|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
163125356|NCT01264770|589166458|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
163125357|NCT01264770|589166459|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
163125358|NCT01264770|589166460|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
163125359|NCT01264770|589166461|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
163125360|NCT01264770|589166462|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
163125361|NCT01264770|589166457|FG000|Overall Study|Lost to Follow-up|0|||
163125362|NCT01264770|589166458|FG001|Overall Study|Lost to Follow-up|0|||
163125363|NCT01264770|589166459|FG002|Overall Study|Lost to Follow-up|1|||
163125364|NCT01264770|589166460|FG003|Overall Study|Lost to Follow-up|1|||
163125365|NCT01264770|589166461|FG004|Overall Study|Lost to Follow-up|0|||
163125366|NCT01264770|589166462|FG005|Overall Study|Lost to Follow-up|0|||
163125367|NCT01264770|589166457|FG000|Overall Study|Adverse Event|7|||
163125368|NCT01264770|589166458|FG001|Overall Study|Adverse Event|7|||
163125369|NCT01264770|589166459|FG002|Overall Study|Adverse Event|8|||
163125370|NCT01264770|589166460|FG003|Overall Study|Adverse Event|0|||
163125371|NCT01264770|589166461|FG004|Overall Study|Adverse Event|2|||
163125372|NCT01264770|589166462|FG005|Overall Study|Adverse Event|1|||
163125373|NCT00129961|589166463|FG000|Overall Study|Adverse Event|1|||
163125374|NCT00129961|589166464|FG001|Overall Study|Adverse Event|0|||
163125375|NCT00129961|589166463|FG000|Overall Study|Death|1|||
163125376|NCT00129961|589166464|FG001|Overall Study|Death|1|||
163125377|NCT00129961|589166463|FG000|Overall Study|Withdrawal by Sponsor|14|||
163125378|NCT00129961|589166464|FG001|Overall Study|Withdrawal by Sponsor|20|||
163125379|NCT00129961|589166463|FG000|Overall Study|Physician Decision|1|||
163125380|NCT00129961|589166464|FG001|Overall Study|Physician Decision|0|||
163125381|NCT00129961|589166463|FG000|Overall Study|Withdrawal by Subject|2|||
163125382|NCT00129961|589166464|FG001|Overall Study|Withdrawal by Subject|1|||
163125383|NCT00129961|589166463|FG000|Overall Study|Missing Record|0|||
163125384|NCT00129961|589166464|FG001|Overall Study|Missing Record|1|||
163125385|NCT00084487|589166465|FG000|Overall Study|Death|1|||
163125386|NCT03691779|589166468|FG000|Part B (24 Weeks)|Adverse Event|0|||
163125387|NCT03691779|589166469|FG001|Part B (24 Weeks)|Adverse Event|1|||
163125388|NCT03691779|589166468|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
163125389|NCT03691779|589166469|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
163125390|NCT04881747|589166470|FG000|Period 2 Washout|Adverse Event|1|||
163125391|NCT04881747|589166471|FG001|Period 2 Washout|Adverse Event|0|||
163125392|NCT04881747|589166472|FG002|Period 2 Washout|Adverse Event|0|||
163125393|NCT04881747|589166473|FG003|Period 2 Washout|Adverse Event|0|||
163125394|NCT04881747|589166474|FG004|Period 2 Washout|Adverse Event|1|||
163125395|NCT04881747|589166475|FG005|Period 2 Washout|Adverse Event|0|||
163125396|NCT04881747|589166470|FG000|Period 2 Washout|Withdrawal by Subject|1|||
163125397|NCT04881747|589166471|FG001|Period 2 Washout|Withdrawal by Subject|0|||
163125398|NCT04881747|589166472|FG002|Period 2 Washout|Withdrawal by Subject|0|||
163125399|NCT04881747|589166473|FG003|Period 2 Washout|Withdrawal by Subject|1|||
163125400|NCT04881747|589166474|FG004|Period 2 Washout|Withdrawal by Subject|0|||
163125401|NCT04881747|589166475|FG005|Period 2 Washout|Withdrawal by Subject|0|||
163125402|NCT03869333|589166481|FG000|Overall Study|Lost to Follow-up|1|||
163125403|NCT03869333|589166482|FG001|Overall Study|Lost to Follow-up|0|||
163125404|NCT03869333|589166483|FG002|Overall Study|Lost to Follow-up|0|||
163125405|NCT03869333|589166484|FG003|Overall Study|Lost to Follow-up|0|||
163125406|NCT03869333|589166481|FG000|Overall Study|Pregnancy|1|||
163125407|NCT03869333|589166482|FG001|Overall Study|Pregnancy|0|||
163125408|NCT03869333|589166483|FG002|Overall Study|Pregnancy|0|||
163125409|NCT03869333|589166484|FG003|Overall Study|Pregnancy|0|||
163125410|NCT03869333|589166481|FG000|Overall Study|Physician Decision|0|||
163125411|NCT03869333|589166482|FG001|Overall Study|Physician Decision|1|||
163125412|NCT03869333|589166483|FG002|Overall Study|Physician Decision|0|||
163125413|NCT03869333|589166484|FG003|Overall Study|Physician Decision|0|||
163125414|NCT01927055|589166485|FG000|Open-label|Adverse Event|6|||
163125415|NCT01927055|589166486|FG001|Open-label|Adverse Event|0|||
163125416|NCT01927055|589166487|FG002|Open-label|Adverse Event|0|||
163125417|NCT01927055|589166485|FG000|Open-label|Withdrawal by Subject|1|||
163125418|NCT01927055|589166486|FG001|Open-label|Withdrawal by Subject|0|||
163125419|NCT01927055|589166487|FG002|Open-label|Withdrawal by Subject|0|||
163125420|NCT01927055|589166485|FG000|Open-label|Study Stopped|4|||
163125421|NCT01927055|589166486|FG001|Open-label|Study Stopped|0|||
163125422|NCT01927055|589166487|FG002|Open-label|Study Stopped|0|||
163125423|NCT01927055|589166485|FG000|Open-label|Supine Hypertension|4|||
163125424|NCT01927055|589166486|FG001|Open-label|Supine Hypertension|0|||
163125425|NCT01927055|589166487|FG002|Open-label|Supine Hypertension|0|||
163125426|NCT01927055|589166485|FG000|Open-label|Difficulty attending study visits|1|||
163125427|NCT01927055|589166486|FG001|Open-label|Difficulty attending study visits|0|||
162655740|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655741|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655742|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655743|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655744|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655745|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162719567|NCT01458210|587680510|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
162719568|NCT01867216|587680511|FG000|Overall Study|Withdrawal by Subject|2|||
162719569|NCT01867216|587680512|FG001|Overall Study|Withdrawal by Subject|0|||
163125428|NCT01927055|589166487|FG002|Open-label|Difficulty attending study visits|0|||
163125429|NCT01927055|589166485|FG000|Double-Blind|Adverse Event|0|||
163125430|NCT01927055|589166486|FG001|Double-Blind|Adverse Event|1|||
163125431|NCT01927055|589166487|FG002|Double-Blind|Adverse Event|1|||
163125432|NCT01927055|589166485|FG000|Double-Blind|Protocol Violation|0|||
163125433|NCT01927055|589166486|FG001|Double-Blind|Protocol Violation|0|||
163125434|NCT01927055|589166487|FG002|Double-Blind|Protocol Violation|1|||
163125435|NCT01927055|589166485|FG000|Double-Blind|Withdrawal by Subject|0|||
163125436|NCT01927055|589166486|FG001|Double-Blind|Withdrawal by Subject|2|||
163125437|NCT01927055|589166487|FG002|Double-Blind|Withdrawal by Subject|3|||
163125438|NCT01927055|589166485|FG000|Double-Blind|Study Stopped|0|||
163125439|NCT01927055|589166486|FG001|Double-Blind|Study Stopped|7|||
163125440|NCT01927055|589166487|FG002|Double-Blind|Study Stopped|7|||
163125441|NCT01927055|589166485|FG000|Double-Blind|Supine Hypertension|0|||
163125442|NCT01927055|589166486|FG001|Double-Blind|Supine Hypertension|0|||
163125443|NCT01927055|589166487|FG002|Double-Blind|Supine Hypertension|1|||
163125444|NCT01927055|589166485|FG000|Double-Blind|Extended Vacation|0|||
163125445|NCT01927055|589166486|FG001|Double-Blind|Extended Vacation|1|||
163125446|NCT01927055|589166487|FG002|Double-Blind|Extended Vacation|0|||
163125447|NCT02598128|589166488|FG000|Period A: Days -7 to -1|Adverse Event|1|||
163125448|NCT02598128|589166489|FG001|Period A: Days -7 to -1|Adverse Event|0|||
163125449|NCT02598128|589166490|FG002|Period A: Days -7 to -1|Adverse Event|0|||
163125450|NCT02598128|589166491|FG003|Period A: Days -7 to -1|Adverse Event|0|||
163125451|NCT01378429|589166492|FG000|Overall Study|Noncompliance with study drug|1|||
163125452|NCT01378429|589166493|FG001|Overall Study|Noncompliance with study drug|0|||
163125453|NCT01064687|589166494|FG000|Overall Study|Adverse Event|9|||
163125454|NCT01064687|589166495|FG001|Overall Study|Adverse Event|4|||
163125455|NCT01064687|589166496|FG002|Overall Study|Adverse Event|10|||
163125456|NCT01064687|589166497|FG003|Overall Study|Adverse Event|3|||
163125457|NCT01064687|589166494|FG000|Overall Study|Death|1|||
163125458|NCT01064687|589166495|FG001|Overall Study|Death|1|||
163125459|NCT01064687|589166496|FG002|Overall Study|Death|0|||
163125460|NCT01064687|589166497|FG003|Overall Study|Death|0|||
163125461|NCT01064687|589166494|FG000|Overall Study|Entry Criteria Not Met|3|||
163125462|NCT01064687|589166495|FG001|Overall Study|Entry Criteria Not Met|0|||
163125463|NCT01064687|589166496|FG002|Overall Study|Entry Criteria Not Met|0|||
163125464|NCT01064687|589166497|FG003|Overall Study|Entry Criteria Not Met|0|||
163125465|NCT01064687|589166494|FG000|Overall Study|Lack of Efficacy|1|||
163125466|NCT01064687|589166495|FG001|Overall Study|Lack of Efficacy|0|||
163125467|NCT01064687|589166496|FG002|Overall Study|Lack of Efficacy|2|||
163125468|NCT01064687|589166497|FG003|Overall Study|Lack of Efficacy|3|||
163125469|NCT01064687|589166494|FG000|Overall Study|Lost to Follow-up|7|||
163125470|NCT01064687|589166495|FG001|Overall Study|Lost to Follow-up|10|||
163125471|NCT01064687|589166496|FG002|Overall Study|Lost to Follow-up|13|||
163125472|NCT01064687|589166497|FG003|Overall Study|Lost to Follow-up|5|||
163125473|NCT01064687|589166494|FG000|Overall Study|Physician Decision|2|||
163125474|NCT01064687|589166495|FG001|Overall Study|Physician Decision|2|||
163125475|NCT01064687|589166496|FG002|Overall Study|Physician Decision|0|||
163125476|NCT01064687|589166497|FG003|Overall Study|Physician Decision|0|||
163125477|NCT01064687|589166494|FG000|Overall Study|Protocol Violation|1|||
163125478|NCT01064687|589166495|FG001|Overall Study|Protocol Violation|1|||
163125479|NCT01064687|589166496|FG002|Overall Study|Protocol Violation|0|||
163125480|NCT01064687|589166497|FG003|Overall Study|Protocol Violation|1|||
163125481|NCT01064687|589166494|FG000|Overall Study|Sponsor Decision|0|||
162719570|NCT01867216|587680513|FG002|Overall Study|Withdrawal by Subject|0|||
163125482|NCT01064687|589166495|FG001|Overall Study|Sponsor Decision|0|||
163125483|NCT01064687|589166496|FG002|Overall Study|Sponsor Decision|3|||
163125484|NCT01064687|589166497|FG003|Overall Study|Sponsor Decision|0|||
163125485|NCT01064687|589166494|FG000|Overall Study|Withdrawal by Subject|9|||
163125486|NCT01064687|589166495|FG001|Overall Study|Withdrawal by Subject|7|||
163125487|NCT01064687|589166496|FG002|Overall Study|Withdrawal by Subject|12|||
163125488|NCT01064687|589166497|FG003|Overall Study|Withdrawal by Subject|5|||
163125489|NCT01064687|589166494|FG000|Overall Study|Treatment Noncompliance|1|||
163125490|NCT01064687|589166495|FG001|Overall Study|Treatment Noncompliance|1|||
163125491|NCT01064687|589166496|FG002|Overall Study|Treatment Noncompliance|1|||
163125492|NCT01064687|589166497|FG003|Overall Study|Treatment Noncompliance|0|||
162655746|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655747|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655748|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655749|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655750|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655751|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655752|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162719571|NCT01867216|587680514|FG003|Overall Study|Withdrawal by Subject|0|||
162655753|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
162655754|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655755|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655756|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655757|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655758|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655759|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655760|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655761|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162719572|NCT01867216|587680515|FG004|Overall Study|Withdrawal by Subject|1|||
163125493|NCT00619489|589166498|FG000|Overall Study|Adverse Event|0|||
163125494|NCT00619489|589166499|FG001|Overall Study|Adverse Event|7|||
163125495|NCT00619489|589166498|FG000|Overall Study|Withdrawal by Subject|1|||
163125496|NCT00619489|589166499|FG001|Overall Study|Withdrawal by Subject|1|||
163125497|NCT00619489|589166498|FG000|Overall Study|Lack of Efficacy|0|||
163125498|NCT00619489|589166499|FG001|Overall Study|Lack of Efficacy|11|||
163125499|NCT00619489|589166498|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
163125500|NCT00619489|589166499|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
163125501|NCT03134183|589166500|FG000|Overall Study|Withdrawal by Subject|1|||
163125502|NCT03134183|589166501|FG001|Overall Study|Withdrawal by Subject|1|||
163125503|NCT02265796|589166504|FG000|Overall Study|Death|1|||
163125504|NCT02265796|589166505|FG001|Overall Study|Death|0|||
163125505|NCT02265796|589166504|FG000|Overall Study|started on excluded medication|1|||
163125506|NCT02265796|589166505|FG001|Overall Study|started on excluded medication|0|||
163125507|NCT02265796|589166504|FG000|Overall Study|Withdrawal by Subject|1|||
163125508|NCT02265796|589166505|FG001|Overall Study|Withdrawal by Subject|1|||
163125509|NCT02477553|589166506|FG000|Overall Study|Screening up-to-date|12|||
163125510|NCT02477553|589166507|FG001|Overall Study|Screening up-to-date|13|||
163125511|NCT02477553|589166506|FG000|Overall Study|No MD visit|1|||
163125512|NCT02477553|589166507|FG001|Overall Study|No MD visit|1|||
163125513|NCT02477553|589166506|FG000|Overall Study|Workup consistent w/CRC|1|||
163125514|NCT02477553|589166507|FG001|Overall Study|Workup consistent w/CRC|1|||
163125515|NCT02477553|589166506|FG000|Overall Study|Technical issues with intervention|2|||
163125516|NCT02477553|589166507|FG001|Overall Study|Technical issues with intervention|0|||
163125517|NCT02477553|589166506|FG000|Overall Study|Elevated risk for CRC|2|||
163125518|NCT02477553|589166507|FG001|Overall Study|Elevated risk for CRC|2|||
163125519|NCT02477553|589166506|FG000|Overall Study|MD advised against screening|1|||
163125520|NCT02477553|589166507|FG001|Overall Study|MD advised against screening|3|||
163125521|NCT02477553|589166506|FG000|Overall Study|patient deceased|1|||
163125522|NCT02477553|589166507|FG001|Overall Study|patient deceased|0|||
163125523|NCT04311463|589166508|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
163125524|NCT04311463|589166509|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
163125525|NCT04311463|589166508|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
163125526|NCT04311463|589166509|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
163125527|NCT04311463|589166508|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
163125528|NCT04311463|589166509|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
163125529|NCT04023682|589166510|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
163125530|NCT00454649|589166511|FG000|Overall Study|Lack of Efficacy|2|||
163125531|NCT00454649|589166512|FG001|Overall Study|Lack of Efficacy|2|||
163125532|NCT00454649|589166513|FG002|Overall Study|Lack of Efficacy|10|||
163125533|NCT00454649|589166514|FG003|Overall Study|Lack of Efficacy|3|||
163125534|NCT00454649|589166515|FG004|Overall Study|Lack of Efficacy|0|||
163125535|NCT00454649|589166516|FG005|Overall Study|Lack of Efficacy|4|||
163125536|NCT00454649|589166517|FG006|Overall Study|Lack of Efficacy|5|||
163125537|NCT00454649|589166518|FG007|Overall Study|Lack of Efficacy|13|||
163125538|NCT00454649|589166519|FG008|Overall Study|Lack of Efficacy|10|||
163125539|NCT00454649|589166520|FG009|Overall Study|Lack of Efficacy|2|||
163125540|NCT00454649|589166511|FG000|Overall Study|Adverse Event|0|||
163125541|NCT00454649|589166512|FG001|Overall Study|Adverse Event|1|||
163125542|NCT00454649|589166513|FG002|Overall Study|Adverse Event|3|||
163125543|NCT00454649|589166514|FG003|Overall Study|Adverse Event|0|||
163125544|NCT00454649|589166515|FG004|Overall Study|Adverse Event|1|||
163125545|NCT00454649|589166516|FG005|Overall Study|Adverse Event|2|||
163125546|NCT00454649|589166517|FG006|Overall Study|Adverse Event|3|||
163125547|NCT00454649|589166518|FG007|Overall Study|Adverse Event|4|||
163125548|NCT00454649|589166519|FG008|Overall Study|Adverse Event|6|||
163125549|NCT00454649|589166520|FG009|Overall Study|Adverse Event|2|||
163125550|NCT00454649|589166511|FG000|Overall Study|Lost to Follow-up|0|||
163125551|NCT00454649|589166512|FG001|Overall Study|Lost to Follow-up|0|||
163125552|NCT00454649|589166513|FG002|Overall Study|Lost to Follow-up|1|||
163125553|NCT00454649|589166514|FG003|Overall Study|Lost to Follow-up|0|||
163125554|NCT00454649|589166515|FG004|Overall Study|Lost to Follow-up|0|||
163125555|NCT00454649|589166516|FG005|Overall Study|Lost to Follow-up|0|||
163125556|NCT00454649|589166517|FG006|Overall Study|Lost to Follow-up|1|||
163125557|NCT00454649|589166518|FG007|Overall Study|Lost to Follow-up|0|||
163125558|NCT00454649|589166519|FG008|Overall Study|Lost to Follow-up|0|||
163125559|NCT00454649|589166520|FG009|Overall Study|Lost to Follow-up|0|||
163125560|NCT00454649|589166511|FG000|Overall Study|Other|1|||
163125561|NCT00454649|589166512|FG001|Overall Study|Other|1|||
163125562|NCT00454649|589166513|FG002|Overall Study|Other|5|||
163125563|NCT00454649|589166514|FG003|Overall Study|Other|3|||
163125564|NCT00454649|589166515|FG004|Overall Study|Other|0|||
163125565|NCT00454649|589166516|FG005|Overall Study|Other|0|||
163125566|NCT00454649|589166517|FG006|Overall Study|Other|0|||
163125567|NCT00454649|589166518|FG007|Overall Study|Other|0|||
163125568|NCT00454649|589166519|FG008|Overall Study|Other|3|||
163125569|NCT00454649|589166520|FG009|Overall Study|Other|1|||
162719573|NCT01867216|587680516|FG005|Overall Study|Withdrawal by Subject|0|||
162719574|NCT01867216|587680517|FG006|Overall Study|Withdrawal by Subject|1|||
162719575|NCT01867216|587680511|FG000|Overall Study|Physician Decision|1|||
162719576|NCT01867216|587680512|FG001|Overall Study|Physician Decision|0|||
162655762|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162655763|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655764|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655765|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655766|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655767|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655768|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
163125570|NCT00454649|589166511|FG000|Overall Study|Withdrawal by Subject|0|||
163125571|NCT00454649|589166512|FG001|Overall Study|Withdrawal by Subject|0|||
163125572|NCT00454649|589166513|FG002|Overall Study|Withdrawal by Subject|0|||
163125573|NCT00454649|589166514|FG003|Overall Study|Withdrawal by Subject|0|||
163125574|NCT00454649|589166515|FG004|Overall Study|Withdrawal by Subject|0|||
163125575|NCT00454649|589166516|FG005|Overall Study|Withdrawal by Subject|1|||
163125576|NCT00454649|589166517|FG006|Overall Study|Withdrawal by Subject|0|||
163125577|NCT00454649|589166518|FG007|Overall Study|Withdrawal by Subject|2|||
163125578|NCT00454649|589166519|FG008|Overall Study|Withdrawal by Subject|1|||
163125579|NCT00454649|589166520|FG009|Overall Study|Withdrawal by Subject|0|||
163125580|NCT02745535|589166522|FG000|Overall Study|Death|1|||
163125581|NCT02745535|589166522|FG000|Overall Study|Adverse Event|3|||
163125582|NCT02745535|589166522|FG000|Overall Study|Lost to Follow-up|2|||
163125583|NCT00377364|589166527|FG000|Overall Study|Lost to Follow-up|1|||
163125584|NCT00377364|589166528|FG001|Overall Study|Lost to Follow-up|0|||
163125585|NCT00377364|589166527|FG000|Overall Study|Withdrawal by Subject|1|||
163125586|NCT00377364|589166528|FG001|Overall Study|Withdrawal by Subject|0|||
163125587|NCT01291277|589166529|FG000|Overall Study|Death|2|||
163125588|NCT01291277|589166530|FG001|Overall Study|Death|2|||
163125589|NCT01291277|589166529|FG000|Overall Study|Lost to Follow-up|3|||
163125590|NCT01291277|589166530|FG001|Overall Study|Lost to Follow-up|1|||
163125591|NCT03480009|589166534|FG000|Overall Study|Lost to Follow-up|4|||
163125592|NCT03480009|589166535|FG001|Overall Study|Lost to Follow-up|5|||
163125593|NCT03480009|589166536|FG002|Overall Study|Lost to Follow-up|4|||
163125594|NCT03480009|589166537|FG003|Overall Study|Lost to Follow-up|0|||
163125595|NCT01638559|589166538|FG000|Overall Study|Lost to Follow-up|1|||
163125596|NCT01638559|589166538|FG000|Overall Study|Withdrawal by Subject|1|||
163125597|NCT01638559|589166538|FG000|Overall Study|Subject declined to travel for biopsy|1|||
163125598|NCT00483002|589166539|FG000|Overall Study|Adverse Event|68|||
163125599|NCT00483002|589166539|FG000|Overall Study|Lack of Efficacy|555|||
163125600|NCT00483002|589166539|FG000|Overall Study|Lost to Follow-up|962|||
163125601|NCT00483002|589166539|FG000|Overall Study|Other|2|||
163125602|NCT00483002|589166539|FG000|Overall Study|Other|967|||
163125603|NCT02014584|589166540|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125604|NCT02014584|589166541|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
163125605|NCT02014584|589166542|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125606|NCT02014584|589166543|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125607|NCT02014584|589166544|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125608|NCT02014584|589166545|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163125609|NCT02014584|589166540|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
163125610|NCT02014584|589166541|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
163125611|NCT02014584|589166542|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125612|NCT02014584|589166543|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125613|NCT02014584|589166544|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125614|NCT02014584|589166545|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163125615|NCT02014584|589166540|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125616|NCT02014584|589166541|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125617|NCT02014584|589166542|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
163125618|NCT02014584|589166543|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125619|NCT02014584|589166544|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125620|NCT02014584|589166545|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
163125621|NCT02014584|589166540|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125622|NCT02014584|589166541|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125623|NCT02014584|589166542|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
163125624|NCT02014584|589166543|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
163125625|NCT02014584|589166544|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125626|NCT02014584|589166545|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
163125627|NCT02014584|589166540|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125628|NCT02014584|589166541|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125629|NCT02014584|589166542|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125630|NCT02014584|589166543|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125631|NCT02014584|589166544|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
163125632|NCT02014584|589166545|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
163125633|NCT02651220|589166549|FG000|Overall Study|Adverse Event|1|||
163125634|NCT02651220|589166550|FG001|Overall Study|Adverse Event|5|||
163125635|NCT02651220|589166551|FG002|Overall Study|Adverse Event|1|||
163125636|NCT02651220|589166549|FG000|Overall Study|Lost to Follow-up|8|||
162655769|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162719577|NCT01867216|587680513|FG002|Overall Study|Physician Decision|0|||
162719578|NCT01867216|587680514|FG003|Overall Study|Physician Decision|0|||
162719579|NCT01867216|587680515|FG004|Overall Study|Physician Decision|0|||
162719580|NCT01867216|587680516|FG005|Overall Study|Physician Decision|0|||
162719581|NCT01867216|587680517|FG006|Overall Study|Physician Decision|0|||
162655770|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655771|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655772|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655773|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655774|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655775|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655776|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655777|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
162655778|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655779|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655780|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655781|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655782|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655783|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655784|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655785|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655786|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162655787|NCT02346240|587453533|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655788|NCT02346240|587453534|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655789|NCT02346240|587453535|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655790|NCT02346240|587453536|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655791|NCT02346240|587453537|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655792|NCT02346240|587453538|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655793|NCT02346240|587453539|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655794|NCT02346240|587453540|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655795|NCT02346240|587453541|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655796|NCT02346240|587453542|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655797|NCT02346240|587453543|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655798|NCT02346240|587453544|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655799|NCT02346240|587453545|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163125637|NCT02651220|589166550|FG001|Overall Study|Lost to Follow-up|14|||
163125638|NCT02651220|589166551|FG002|Overall Study|Lost to Follow-up|14|||
163125639|NCT02651220|589166549|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163125640|NCT02651220|589166550|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163125641|NCT02651220|589166551|FG002|Overall Study|Non-Compliance with Study Drug|1|||
163125642|NCT02651220|589166549|FG000|Overall Study|Pregnancy|1|||
163125643|NCT02651220|589166550|FG001|Overall Study|Pregnancy|0|||
163125644|NCT02651220|589166551|FG002|Overall Study|Pregnancy|1|||
163125645|NCT02651220|589166549|FG000|Overall Study|Protocol Violation|0|||
163125646|NCT02651220|589166550|FG001|Overall Study|Protocol Violation|0|||
163125647|NCT02651220|589166551|FG002|Overall Study|Protocol Violation|1|||
163125648|NCT02651220|589166549|FG000|Overall Study|Withdrawal by Subject|5|||
163125649|NCT02651220|589166550|FG001|Overall Study|Withdrawal by Subject|6|||
163125650|NCT02651220|589166551|FG002|Overall Study|Withdrawal by Subject|8|||
163125651|NCT02651220|589166549|FG000|Overall Study|Miscellaneous|4|||
163125652|NCT02651220|589166550|FG001|Overall Study|Miscellaneous|1|||
163125653|NCT02651220|589166551|FG002|Overall Study|Miscellaneous|2|||
163125654|NCT02651220|589166549|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163125655|NCT02651220|589166550|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163125656|NCT02651220|589166551|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
163125657|NCT01274429|589166553|FG000|Overall Study|Study closed do to lack of funding|5|||
163125658|NCT01439373|589166554|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
163125659|NCT01439373|589166555|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
163125660|NCT01439373|589166554|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
163125661|NCT01439373|589166555|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
163125662|NCT04576897|589166558|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
163125663|NCT02593318|589166561|FG000|Overall Study|Withdrawal by Subject|1|||
163125664|NCT02593318|589166562|FG001|Overall Study|Withdrawal by Subject|1|||
163125665|NCT02806960|589168232|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125666|NCT02806960|589168233|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125667|NCT02806960|589168234|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125668|NCT02806960|589168235|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
163125669|NCT02522325|589168237|FG000|Overall Study|Adverse Event|0|||
163125670|NCT02522325|589168238|FG001|Overall Study|Adverse Event|1|||
163125671|NCT01209078|589168239|FG000|Overall Study|Adverse Event|5|||
162655800|NCT02346240|587453546|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655801|NCT02346240|587453547|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
162655802|NCT02346240|587453548|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655803|NCT02346240|587453549|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
163125672|NCT01209078|589168240|FG001|Overall Study|Adverse Event|0|||
163125673|NCT01209078|589168239|FG000|Overall Study|Lost to Follow-up|4|||
163125674|NCT01209078|589168240|FG001|Overall Study|Lost to Follow-up|0|||
163125675|NCT01209078|589168239|FG000|Overall Study|Physician Decision|5|||
163125676|NCT01209078|589168240|FG001|Overall Study|Physician Decision|2|||
163125677|NCT01209078|589168239|FG000|Overall Study|Withdrawal by Subject|2|||
163125678|NCT01209078|589168240|FG001|Overall Study|Withdrawal by Subject|1|||
163125679|NCT01629953|589168241|FG000|Overall Study|Death|3|||
163125680|NCT01629953|589168242|FG001|Overall Study|Death|1|||
163125681|NCT01629953|589168241|FG000|Overall Study|Lost to Follow-up|10|||
163125682|NCT01629953|589168242|FG001|Overall Study|Lost to Follow-up|14|||
163125683|NCT00448747|589168245|FG000|Overall Study|collapsed veins|1|||
163125684|NCT00448747|589168246|FG001|Overall Study|collapsed veins|0|||
163125685|NCT00387725|589168247|FG000|Overall Study|Adverse Event|0|||
163125686|NCT00387725|589168248|FG001|Overall Study|Adverse Event|0|||
163125687|NCT00387725|589168249|FG002|Overall Study|Adverse Event|0|||
163125688|NCT00387725|589168250|FG003|Overall Study|Adverse Event|1|||
163125689|NCT00387725|589168247|FG000|Overall Study|Protocol Violation|0|||
163125690|NCT00387725|589168248|FG001|Overall Study|Protocol Violation|1|||
163125691|NCT00387725|589168249|FG002|Overall Study|Protocol Violation|0|||
163125692|NCT00387725|589168250|FG003|Overall Study|Protocol Violation|0|||
163125693|NCT00387725|589168247|FG000|Overall Study|Withdrawal by Subject|1|||
163125694|NCT00387725|589168248|FG001|Overall Study|Withdrawal by Subject|0|||
163125695|NCT00387725|589168249|FG002|Overall Study|Withdrawal by Subject|1|||
163125696|NCT00387725|589168250|FG003|Overall Study|Withdrawal by Subject|0|||
163125697|NCT00387725|589168247|FG000|Overall Study|Parent/legal guardian request|0|||
163125698|NCT00387725|589168248|FG001|Overall Study|Parent/legal guardian request|0|||
163125699|NCT00387725|589168249|FG002|Overall Study|Parent/legal guardian request|1|||
163125700|NCT00387725|589168250|FG003|Overall Study|Parent/legal guardian request|1|||
163125701|NCT00568126|589168251|FG000|Overall Study|Adverse Event|3|||
163125702|NCT00568126|589168252|FG001|Overall Study|Adverse Event|0|||
163125703|NCT00568126|589168251|FG000|Overall Study|Withdrawal by Subject|2|||
163125704|NCT00568126|589168252|FG001|Overall Study|Withdrawal by Subject|3|||
163125705|NCT00568126|589168251|FG000|Overall Study|Lost to Follow-up|4|||
163125706|NCT00568126|589168252|FG001|Overall Study|Lost to Follow-up|3|||
163125707|NCT00568126|589168251|FG000|Overall Study|Lack of Efficacy|0|||
163125708|NCT00568126|589168252|FG001|Overall Study|Lack of Efficacy|1|||
163125709|NCT00568126|589168251|FG000|Overall Study|Physician Decision|2|||
163125710|NCT00568126|589168252|FG001|Overall Study|Physician Decision|2|||
163125711|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
163125712|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
163125713|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
163125714|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
163125715|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
163125716|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
163125717|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
163125718|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
163125719|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
163125720|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
163125721|NCT02429791|589168256|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
163125722|NCT02429791|589168257|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
163125723|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
163125724|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
163125725|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
163125726|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
163125727|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
163125728|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
163125729|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
163125730|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
163125731|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163125732|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
163125733|NCT02429791|589168256|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
163125734|NCT02429791|589168257|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
163125735|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
163125736|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
162655804|NCT02346240|587453550|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655805|NCT02346240|587453551|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162719582|NCT01867216|587680511|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
162655806|NCT02346240|587453552|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655807|NCT02346240|587453553|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655808|NCT02346240|587453554|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655809|NCT02346240|587453555|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655810|NCT02346240|587453556|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162655811|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655812|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655813|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655814|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655815|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655816|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655817|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163125737|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
163125738|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
162655818|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
163125739|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
163125740|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
163125741|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
163125742|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
163125743|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
163125744|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
163125745|NCT02429791|589168256|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
163125746|NCT02429791|589168257|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
163125747|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
163125748|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
163125749|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
163125750|NCT02615691|589168258|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
163125751|NCT04201093|589168259|FG000|Overall Study|Adverse Event|6|||
163125752|NCT04201093|589168260|FG001|Overall Study|Adverse Event|29|||
163125753|NCT04201093|589168261|FG002|Overall Study|Adverse Event|35|||
163125754|NCT04201093|589168259|FG000|Overall Study|Death|2|||
163125755|NCT04201093|589168260|FG001|Overall Study|Death|1|||
163125756|NCT04201093|589168261|FG002|Overall Study|Death|0|||
163125757|NCT04201093|589168259|FG000|Overall Study|Lack of Efficacy|5|||
163125758|NCT04201093|589168260|FG001|Overall Study|Lack of Efficacy|1|||
163125759|NCT04201093|589168261|FG002|Overall Study|Lack of Efficacy|2|||
163125760|NCT04201093|589168259|FG000|Overall Study|Lost to Follow-up|0|||
163125761|NCT04201093|589168260|FG001|Overall Study|Lost to Follow-up|0|||
163125762|NCT04201093|589168261|FG002|Overall Study|Lost to Follow-up|1|||
163125763|NCT04201093|589168259|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163125764|NCT04201093|589168260|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163125765|NCT04201093|589168261|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
163125766|NCT04201093|589168259|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163125767|NCT04201093|589168260|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
163125768|NCT04201093|589168261|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
163125769|NCT04201093|589168259|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
163125770|NCT04201093|589168260|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
163125771|NCT04201093|589168261|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
163125772|NCT04201093|589168259|FG000|Overall Study|Physician Decision|1|||
163125773|NCT04201093|589168260|FG001|Overall Study|Physician Decision|0|||
162655819|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655820|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655821|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655822|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655823|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655824|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655825|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655826|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655827|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162655828|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
162655829|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
162655830|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
162655831|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162655832|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
162655833|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162655834|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162655835|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655836|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655837|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655838|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655839|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655840|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655841|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655842|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655843|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655844|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655845|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655846|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655847|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655848|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
163125774|NCT04201093|589168261|FG002|Overall Study|Physician Decision|0|||
163125775|NCT04201093|589168259|FG000|Overall Study|Protocol Deviation|1|||
163125776|NCT04201093|589168260|FG001|Overall Study|Protocol Deviation|0|||
163125777|NCT04201093|589168261|FG002|Overall Study|Protocol Deviation|0|||
163125778|NCT04201093|589168259|FG000|Overall Study|Site Terminated by Sponsor|5|||
163125779|NCT04201093|589168260|FG001|Overall Study|Site Terminated by Sponsor|3|||
163125780|NCT04201093|589168261|FG002|Overall Study|Site Terminated by Sponsor|1|||
163125781|NCT04201093|589168259|FG000|Overall Study|Withdrawal by Subject|7|||
163125782|NCT04201093|589168260|FG001|Overall Study|Withdrawal by Subject|8|||
163125783|NCT04201093|589168261|FG002|Overall Study|Withdrawal by Subject|15|||
163125784|NCT04201093|589168259|FG000|Overall Study|Other|0|||
163125785|NCT04201093|589168260|FG001|Overall Study|Other|1|||
163125786|NCT04201093|589168261|FG002|Overall Study|Other|2|||
163125787|NCT00881504|589168262|FG000|Overall Study|Withdrawal by Subject|1|||
163125788|NCT01276223|589168263|FG000|Overall Study|Adverse Event|7|||
163125789|NCT01276223|589168264|FG001|Overall Study|Adverse Event|4|||
163125790|NCT01276223|589168265|FG002|Overall Study|Adverse Event|1|||
163125791|NCT01276223|589168263|FG000|Overall Study|Lost to Follow-up|0|||
162655849|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655850|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655851|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
163125792|NCT01276223|589168264|FG001|Overall Study|Lost to Follow-up|0|||
163125793|NCT01276223|589168265|FG002|Overall Study|Lost to Follow-up|1|||
163125794|NCT01276223|589168263|FG000|Overall Study|Other|0|||
163125795|NCT01276223|589168264|FG001|Overall Study|Other|0|||
162655852|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655853|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
162655854|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
162655855|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655856|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
162655857|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655858|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
162655859|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655860|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655861|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655862|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163125796|NCT01276223|589168265|FG002|Overall Study|Other|1|||
163125797|NCT01276223|589168263|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
163125798|NCT01276223|589168264|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
163125799|NCT01276223|589168265|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
163125800|NCT01276223|589168263|FG000|Overall Study|Protocol Violation|1|||
163125801|NCT01276223|589168264|FG001|Overall Study|Protocol Violation|0|||
163125802|NCT01276223|589168265|FG002|Overall Study|Protocol Violation|0|||
163125803|NCT02017522|589168266|FG000|Overall Study|Withdrawal by Subject|1|||
163125804|NCT02596230|589168267|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
163125805|NCT02596230|589168268|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
163125806|NCT02596230|589168269|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
163125807|NCT02596230|589168270|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
162719583|NCT01867216|587680512|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163125808|NCT02596230|589168271|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
163125809|NCT02596230|589168267|FG000|Objective 2, One Year|Lost to Follow-up|0|||
163125810|NCT02596230|589168268|FG001|Objective 2, One Year|Lost to Follow-up|41|||
163125811|NCT02596230|589168269|FG002|Objective 2, One Year|Lost to Follow-up|41|||
163125812|NCT02596230|589168270|FG003|Objective 2, One Year|Lost to Follow-up|32|||
163125813|NCT02596230|589168271|FG004|Objective 2, One Year|Lost to Follow-up|46|||
163125814|NCT02596230|589168267|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
163125815|NCT02596230|589168268|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
163125816|NCT02596230|589168269|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
163125817|NCT02596230|589168270|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
163125818|NCT02596230|589168271|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
163125819|NCT02596230|589168267|FG000|Objective 2, One Year|Adverse drug reaction|0|||
163125820|NCT02596230|589168268|FG001|Objective 2, One Year|Adverse drug reaction|1|||
163125821|NCT02596230|589168269|FG002|Objective 2, One Year|Adverse drug reaction|0|||
163125822|NCT02596230|589168270|FG003|Objective 2, One Year|Adverse drug reaction|0|||
163125823|NCT02596230|589168271|FG004|Objective 2, One Year|Adverse drug reaction|0|||
163125824|NCT02596230|589168267|FG000|Objective 2, One Year|Death|0|||
163125825|NCT02596230|589168268|FG001|Objective 2, One Year|Death|12|||
163125826|NCT02596230|589168269|FG002|Objective 2, One Year|Death|41|||
163125827|NCT02596230|589168270|FG003|Objective 2, One Year|Death|21|||
163125828|NCT02596230|589168271|FG004|Objective 2, One Year|Death|30|||
163125829|NCT02596230|589168267|FG000|Objective 2, One Year|Other|0|||
163125830|NCT02596230|589168268|FG001|Objective 2, One Year|Other|3|||
163125831|NCT02596230|589168269|FG002|Objective 2, One Year|Other|2|||
163125832|NCT02596230|589168270|FG003|Objective 2, One Year|Other|0|||
163125833|NCT02596230|589168271|FG004|Objective 2, One Year|Other|0|||
163125834|NCT00771615|589168272|FG000|Overall Study|Withdrawal by Subject|0|||
163125835|NCT00771615|589168273|FG001|Overall Study|Withdrawal by Subject|1|||
163125836|NCT00771615|589168274|FG002|Overall Study|Withdrawal by Subject|0|||
163125837|NCT00771615|589168275|FG003|Overall Study|Withdrawal by Subject|0|||
163125838|NCT00771615|589168276|FG004|Overall Study|Withdrawal by Subject|0|||
163125839|NCT00771615|589168277|FG005|Overall Study|Withdrawal by Subject|0|||
163125840|NCT00771615|589168278|FG006|Overall Study|Withdrawal by Subject|0|||
163125841|NCT00771615|589168279|FG007|Overall Study|Withdrawal by Subject|1|||
162719584|NCT01867216|587680513|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162719585|NCT01867216|587680514|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162719586|NCT01867216|587680515|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163125842|NCT00771615|589168280|FG008|Overall Study|Withdrawal by Subject|0|||
163125843|NCT00771615|589168272|FG000|Overall Study|Lost to Follow-up|1|||
163125844|NCT00771615|589168273|FG001|Overall Study|Lost to Follow-up|1|||
163125845|NCT00771615|589168274|FG002|Overall Study|Lost to Follow-up|1|||
162719587|NCT01867216|587680516|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163125846|NCT00771615|589168275|FG003|Overall Study|Lost to Follow-up|1|||
163125847|NCT00771615|589168276|FG004|Overall Study|Lost to Follow-up|0|||
163125848|NCT00771615|589168277|FG005|Overall Study|Lost to Follow-up|1|||
162655863|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162719588|NCT01867216|587680517|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162719589|NCT03020745|587680518|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
163125849|NCT00771615|589168278|FG006|Overall Study|Lost to Follow-up|1|||
163125850|NCT00771615|589168279|FG007|Overall Study|Lost to Follow-up|0|||
162655864|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655865|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655866|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655867|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655868|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655869|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655870|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655871|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655872|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655873|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655874|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655875|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655876|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655877|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
162655878|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655879|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655880|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
162655881|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655882|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162655883|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655884|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655885|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655886|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655887|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655888|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655889|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655890|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655891|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655892|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655893|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655894|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655895|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655896|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655897|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655898|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655899|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655900|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655901|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655902|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655903|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655904|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
162655905|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655906|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162655907|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655908|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655909|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655910|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655911|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655912|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655913|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655914|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
163125851|NCT00771615|589168280|FG008|Overall Study|Lost to Follow-up|0|||
163125852|NCT02704689|589168282|FG000|Overall Study|Physician Decision|1|||
163125853|NCT02704689|589168282|FG000|Overall Study|Study device not implanted|2|||
163125854|NCT00802893|589168283|FG000|Overall Study|study terminated|3|||
163125855|NCT00320424|589168284|FG000|Overall Study|Adverse Event|3|||
163125856|NCT00320424|589168284|FG000|Overall Study|Other|3|||
163125857|NCT03270891|589168286|FG000|Overall Study|Lost to Follow-up|3|||
163125858|NCT03270891|589168287|FG001|Overall Study|Lost to Follow-up|6|||
163125859|NCT03270891|589168288|FG002|Overall Study|Lost to Follow-up|0|||
163125860|NCT03270891|589168286|FG000|Overall Study|Withdrawal by Subject|1|||
163125861|NCT03270891|589168287|FG001|Overall Study|Withdrawal by Subject|0|||
163125862|NCT03270891|589168288|FG002|Overall Study|Withdrawal by Subject|0|||
163125863|NCT03270891|589168286|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
162655915|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655916|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655917|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655918|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655919|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655920|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655921|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655922|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655923|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655924|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
162655925|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
162655926|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
162655927|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162655928|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
162655929|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
162655930|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
163125864|NCT03270891|589168287|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
163125865|NCT03270891|589168288|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
163125866|NCT02540668|589168289|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
163125867|NCT02540668|589168290|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
163125868|NCT00849108|589168291|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
163125869|NCT00849108|589168292|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
163125870|NCT00849108|589168291|FG000|Cohort 2 Efficacy|Adverse Event|0|||
163125871|NCT00849108|589168292|FG001|Cohort 2 Efficacy|Adverse Event|1|||
163125872|NCT00849108|589168291|FG000|Cohort 2 Efficacy|Other|0|||
163125873|NCT00849108|589168292|FG001|Cohort 2 Efficacy|Other|9|||
163125874|NCT02294734|589168295|FG000|Overall Study|Adverse Event|5|||
163125875|NCT02294734|589168296|FG001|Overall Study|Adverse Event|5|||
163125876|NCT02294734|589168295|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
163125877|NCT02294734|589168296|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
163125878|NCT02294734|589168295|FG000|Overall Study|Lost to Follow-up|2|||
163125879|NCT02294734|589168296|FG001|Overall Study|Lost to Follow-up|0|||
163125880|NCT02294734|589168295|FG000|Overall Study|Physician Decision|2|||
163125881|NCT02294734|589168296|FG001|Overall Study|Physician Decision|1|||
163125882|NCT02294734|589168295|FG000|Overall Study|Withdrawal by Subject|4|||
163125883|NCT02294734|589168296|FG001|Overall Study|Withdrawal by Subject|2|||
163125884|NCT03157583|589168297|FG000|Overall Study|Other (did not meet study criteria)|1|||
163125885|NCT01943552|589168298|FG000|Overall Study|Adverse Event|3|||
163125886|NCT01943552|589168299|FG001|Overall Study|Adverse Event|2|||
163125887|NCT01943552|589168298|FG000|Overall Study|Withdrawal by Subject|6|||
163125888|NCT01943552|589168299|FG001|Overall Study|Withdrawal by Subject|6|||
163125889|NCT01943552|589168298|FG000|Overall Study|Other Reasons|16|||
163125890|NCT01943552|589168299|FG001|Overall Study|Other Reasons|17|||
163125891|NCT01475162|589168300|FG000|Overall Study|Physician Decision|1|||
163125892|NCT01475162|589168300|FG000|Overall Study|Death|10|||
163125893|NCT01475162|589168300|FG000|Overall Study|Study closed for safety|3|||
163125894|NCT00545103|589168301|FG000|Overall Study|Lack of Efficacy|48|||
163125895|NCT00545103|589168302|FG001|Overall Study|Lack of Efficacy|45|||
163125896|NCT00545103|589168303|FG002|Overall Study|Lack of Efficacy|31|||
163125897|NCT00545103|589168304|FG003|Overall Study|Lack of Efficacy|27|||
163125898|NCT00545103|589168301|FG000|Overall Study|Withdrawal by Subject|6|||
163125899|NCT00545103|589168302|FG001|Overall Study|Withdrawal by Subject|10|||
163125900|NCT00545103|589168303|FG002|Overall Study|Withdrawal by Subject|18|||
163125901|NCT00545103|589168304|FG003|Overall Study|Withdrawal by Subject|22|||
163125902|NCT00545103|589168301|FG000|Overall Study|Adverse Event|11|||
163125903|NCT00545103|589168302|FG001|Overall Study|Adverse Event|12|||
163125904|NCT00545103|589168303|FG002|Overall Study|Adverse Event|17|||
163125905|NCT00545103|589168304|FG003|Overall Study|Adverse Event|10|||
163125906|NCT00545103|589168301|FG000|Overall Study|Lost to Follow-up|4|||
163125907|NCT00545103|589168302|FG001|Overall Study|Lost to Follow-up|6|||
163125908|NCT00545103|589168303|FG002|Overall Study|Lost to Follow-up|3|||
163125909|NCT00545103|589168304|FG003|Overall Study|Lost to Follow-up|4|||
163125910|NCT00545103|589168301|FG000|Overall Study|Protocol Violation|1|||
163125911|NCT00545103|589168302|FG001|Overall Study|Protocol Violation|2|||
163125912|NCT00545103|589168303|FG002|Overall Study|Protocol Violation|3|||
163125913|NCT00545103|589168304|FG003|Overall Study|Protocol Violation|0|||
163125914|NCT00545103|589168301|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
163125915|NCT00545103|589168302|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
163125916|NCT00545103|589168303|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
163125917|NCT00545103|589168304|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
163125918|NCT00545103|589168301|FG000|Overall Study|Difficult to open package|0|||
163125919|NCT00545103|589168302|FG001|Overall Study|Difficult to open package|0|||
162655931|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655932|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163125920|NCT00545103|589168303|FG002|Overall Study|Difficult to open package|0|||
163125921|NCT00545103|589168304|FG003|Overall Study|Difficult to open package|1|||
163125922|NCT00545103|589168301|FG000|Overall Study|Investigational product not taken|1|||
163125923|NCT00545103|589168302|FG001|Overall Study|Investigational product not taken|0|||
163125924|NCT00545103|589168303|FG002|Overall Study|Investigational product not taken|0|||
163125925|NCT00545103|589168304|FG003|Overall Study|Investigational product not taken|1|||
163125926|NCT00545103|589168301|FG000|Overall Study|Wish to start a family|0|||
162655933|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655934|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655935|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655936|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655937|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655938|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655939|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655940|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162719590|NCT03020745|587680519|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719591|NCT03020745|587680520|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719592|NCT03020745|587680521|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
163125927|NCT00545103|589168302|FG001|Overall Study|Wish to start a family|0|||
163125928|NCT00545103|589168303|FG002|Overall Study|Wish to start a family|0|||
163125929|NCT00545103|589168304|FG003|Overall Study|Wish to start a family|1|||
163125930|NCT00545103|589168301|FG000|Overall Study|Diverticulitis crisis|0|||
163125931|NCT00545103|589168302|FG001|Overall Study|Diverticulitis crisis|0|||
163125932|NCT00545103|589168303|FG002|Overall Study|Diverticulitis crisis|0|||
163125933|NCT00545103|589168304|FG003|Overall Study|Diverticulitis crisis|1|||
163125934|NCT00545103|589168301|FG000|Overall Study|Personal reasons|1|||
163125935|NCT00545103|589168302|FG001|Overall Study|Personal reasons|0|||
163125936|NCT00545103|589168303|FG002|Overall Study|Personal reasons|0|||
163125937|NCT00545103|589168304|FG003|Overall Study|Personal reasons|0|||
163125938|NCT00545103|589168301|FG000|Overall Study|Subject's decision|1|||
163125939|NCT00545103|589168302|FG001|Overall Study|Subject's decision|0|||
163125940|NCT00545103|589168303|FG002|Overall Study|Subject's decision|0|||
163125941|NCT00545103|589168304|FG003|Overall Study|Subject's decision|0|||
163125942|NCT00545103|589168301|FG000|Overall Study|Noncompliance|0|||
163125943|NCT00545103|589168302|FG001|Overall Study|Noncompliance|1|||
163125944|NCT00545103|589168303|FG002|Overall Study|Noncompliance|0|||
163125945|NCT00545103|589168304|FG003|Overall Study|Noncompliance|0|||
163125946|NCT00545103|589168301|FG000|Overall Study|Investigator decision|0|||
163125947|NCT00545103|589168302|FG001|Overall Study|Investigator decision|0|||
163125948|NCT00545103|589168303|FG002|Overall Study|Investigator decision|1|||
163125949|NCT00545103|589168304|FG003|Overall Study|Investigator decision|0|||
163125950|NCT00545103|589168301|FG000|Overall Study|Subject moved|0|||
163125951|NCT00545103|589168302|FG001|Overall Study|Subject moved|1|||
163125952|NCT00545103|589168303|FG002|Overall Study|Subject moved|0|||
163125953|NCT00545103|589168304|FG003|Overall Study|Subject moved|0|||
163125954|NCT00545103|589168301|FG000|Overall Study|Use of prohibited medication|0|||
163125955|NCT00545103|589168302|FG001|Overall Study|Use of prohibited medication|0|||
163125956|NCT00545103|589168303|FG002|Overall Study|Use of prohibited medication|1|||
163125957|NCT00545103|589168304|FG003|Overall Study|Use of prohibited medication|0|||
163125958|NCT00545103|589168301|FG000|Overall Study|Does not want to take study drug anymore|1|||
163125959|NCT00545103|589168302|FG001|Overall Study|Does not want to take study drug anymore|0|||
163125960|NCT00545103|589168303|FG002|Overall Study|Does not want to take study drug anymore|1|||
163125961|NCT00545103|589168304|FG003|Overall Study|Does not want to take study drug anymore|0|||
163125962|NCT00545103|589168301|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125963|NCT00545103|589168302|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125964|NCT00545103|589168303|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
163125965|NCT00545103|589168304|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
163125966|NCT00545103|589168301|FG000|Overall Study|Death|0|||
163125967|NCT00545103|589168302|FG001|Overall Study|Death|1|||
163125968|NCT00545103|589168303|FG002|Overall Study|Death|0|||
163125969|NCT00545103|589168304|FG003|Overall Study|Death|0|||
163125970|NCT05026853|589168305|FG000|Overall Study|Cancelled appointment|1|||
163125971|NCT05026853|589168306|FG001|Overall Study|Cancelled appointment|0|||
163125972|NCT05026853|589168305|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
163125973|NCT05026853|589168306|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
163125974|NCT05026853|589168305|FG000|Overall Study|Did not complete 12-week survey|16|||
163125975|NCT05026853|589168306|FG001|Overall Study|Did not complete 12-week survey|16|||
163125976|NCT02358044|589168307|FG000|Overall Study|Adverse Event|0|||
163125977|NCT02358044|589168308|FG001|Overall Study|Adverse Event|1|||
163125978|NCT02358044|589168307|FG000|Overall Study|Lost to Follow-up|2|||
163125979|NCT02358044|589168308|FG001|Overall Study|Lost to Follow-up|1|||
163125980|NCT02358044|589168307|FG000|Overall Study|Physician Decision|0|||
163125981|NCT02358044|589168308|FG001|Overall Study|Physician Decision|1|||
163125982|NCT02358044|589168307|FG000|Overall Study|Withdrawal by Subject|0|||
163125983|NCT02358044|589168308|FG001|Overall Study|Withdrawal by Subject|4|||
163125984|NCT01732913|589168309|FG000|Overall Study|Study Terminated by Sponsor|105|||
163125985|NCT01732913|589168310|FG001|Overall Study|Study Terminated by Sponsor|55|||
163125986|NCT01732913|589168309|FG000|Overall Study|Withdrawal by Subject|27|||
163125987|NCT01732913|589168310|FG001|Overall Study|Withdrawal by Subject|4|||
163125988|NCT01732913|589168309|FG000|Overall Study|Physician Decision|14|||
162655941|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655942|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655943|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655944|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655945|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655946|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655947|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163125989|NCT01732913|589168310|FG001|Overall Study|Physician Decision|7|||
163125990|NCT01732913|589168309|FG000|Overall Study|Other|7|||
163125991|NCT01732913|589168310|FG001|Overall Study|Other|1|||
163125992|NCT01732913|589168309|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
163125993|NCT01732913|589168310|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
163125994|NCT00903331|589168311|FG000|Overall Study|Death|4|||
163125995|NCT00903331|589168312|FG001|Overall Study|Death|8|||
163125996|NCT00903331|589168311|FG000|Overall Study|Withdrawal of consent|1|||
163125997|NCT00903331|589168312|FG001|Overall Study|Withdrawal of consent|8|||
163125998|NCT00903331|589168311|FG000|Overall Study|Lung transplant|0|||
163125999|NCT00903331|589168312|FG001|Overall Study|Lung transplant|2|||
163126000|NCT02723175|589168313|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
163126001|NCT02723175|589168314|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
163126002|NCT02723175|589168313|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
163126003|NCT02723175|589168314|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
163126004|NCT03233438|589168315|FG000|Overall Study|Lost to Follow-up|4|||
163126005|NCT03233438|589168316|FG001|Overall Study|Lost to Follow-up|9|||
163126006|NCT03233438|589168315|FG000|Overall Study|Withdrawal by Subject|2|||
163126007|NCT03233438|589168316|FG001|Overall Study|Withdrawal by Subject|1|||
163126008|NCT03233438|589168315|FG000|Overall Study|No recording of dalbavancin|0|||
163126009|NCT03233438|589168316|FG001|Overall Study|No recording of dalbavancin|1|||
163126010|NCT04109976|589168321|FG000|Overall Study|Withdrawal by Subject|1|||
163126011|NCT04109976|589168322|FG001|Overall Study|Withdrawal by Subject|0|||
163126012|NCT00257660|589168323|FG000|Overall Study|Lack of Efficacy|5|||
163126013|NCT00257660|589168324|FG001|Overall Study|Lack of Efficacy|23|||
163126014|NCT00257660|589168323|FG000|Overall Study|Withdrawal by Subject|2|||
163126015|NCT00257660|589168324|FG001|Overall Study|Withdrawal by Subject|0|||
163126016|NCT00257660|589168323|FG000|Overall Study|Lost to Follow-up|1|||
163126017|NCT00257660|589168324|FG001|Overall Study|Lost to Follow-up|0|||
163126018|NCT00257660|589168323|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
163126019|NCT00257660|589168324|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
163126020|NCT00257660|589168323|FG000|Overall Study|No longer wanted to do blood draws|1|||
163126021|NCT00257660|589168324|FG001|Overall Study|No longer wanted to do blood draws|0|||
163126022|NCT00491608|589168325|FG000|Overall Study|Death|2|||
163126023|NCT00491608|589168325|FG000|Overall Study|Withdrawal by Subject|1|||
163126024|NCT00413374|589168330|FG000|Overall Study|Ineligible due to screening criteria.|3|||
163126025|NCT00413374|589168331|FG001|Overall Study|Ineligible due to screening criteria.|0|||
163126026|NCT00413374|589168330|FG000|Overall Study|Adverse Event|1|||
163126027|NCT00413374|589168331|FG001|Overall Study|Adverse Event|0|||
163126028|NCT00413374|589168330|FG000|Overall Study|Lost to Follow-up|1|||
163126029|NCT00413374|589168331|FG001|Overall Study|Lost to Follow-up|0|||
163126030|NCT00413374|589168330|FG000|Overall Study|Surgery|1|||
163126031|NCT00413374|589168331|FG001|Overall Study|Surgery|0|||
163126032|NCT00552760|589168334|FG000|Overall Study|Adverse Event|3|||
163126033|NCT00552760|589168335|FG001|Overall Study|Adverse Event|5|||
163126034|NCT00552760|589168334|FG000|Overall Study|Relapsed- Depressed Event|10|||
163126035|NCT00552760|589168335|FG001|Overall Study|Relapsed- Depressed Event|16|||
163126036|NCT00552760|589168334|FG000|Overall Study|Relapse- Manic Event|3|||
163126037|NCT00552760|589168335|FG001|Overall Study|Relapse- Manic Event|3|||
163126038|NCT00552760|589168334|FG000|Overall Study|Relapsed- Mixed Event|3|||
163126039|NCT00552760|589168335|FG001|Overall Study|Relapsed- Mixed Event|5|||
163126040|NCT00552760|589168334|FG000|Overall Study|Protocol Violation|0|||
163126041|NCT00552760|589168335|FG001|Overall Study|Protocol Violation|1|||
163126042|NCT00552760|589168334|FG000|Overall Study|Lost to Follow-up|1|||
163126043|NCT00552760|589168335|FG001|Overall Study|Lost to Follow-up|1|||
163126044|NCT00552760|589168334|FG000|Overall Study|Non-compliance|1|||
163126045|NCT00552760|589168335|FG001|Overall Study|Non-compliance|1|||
163126046|NCT00552760|589168334|FG000|Overall Study|Medical Condition|1|||
163126047|NCT00552760|589168335|FG001|Overall Study|Medical Condition|1|||
163126048|NCT00552760|589168334|FG000|Overall Study|Withdrawal by Subject|3|||
163126049|NCT00552760|589168335|FG001|Overall Study|Withdrawal by Subject|0|||
163126050|NCT00552760|589168334|FG000|Overall Study|Medication Change|1|||
163126051|NCT00552760|589168335|FG001|Overall Study|Medication Change|0|||
163126052|NCT00494507|589168337|FG000|Double-Blind Phase|Adverse Event|2|||
163126053|NCT00494507|589168338|FG001|Double-Blind Phase|Adverse Event|0|||
163126054|NCT00494507|589168339|FG002|Double-Blind Phase|Adverse Event|1|||
163126055|NCT00494507|589168340|FG003|Double-Blind Phase|Adverse Event|0|||
163126056|NCT00494507|589168337|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
163126057|NCT00494507|589168338|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
162655948|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655949|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
162655950|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162655951|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162655952|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
162655953|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162655954|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162655955|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655956|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655957|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655958|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655959|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655960|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655961|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655962|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655963|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655964|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655965|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655966|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655967|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655968|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655969|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655970|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655971|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655972|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655973|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
162655974|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655975|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162655976|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
162655977|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
162655978|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
162655979|NCT02346240|587453533|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655980|NCT02346240|587453534|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655981|NCT02346240|587453535|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163126058|NCT00494507|589168339|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163126059|NCT00494507|589168340|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163126060|NCT00494507|589168337|FG000|Double-Blind Phase|Subject Non-compliance|0|||
163126061|NCT00494507|589168338|FG001|Double-Blind Phase|Subject Non-compliance|0|||
163126062|NCT00494507|589168339|FG002|Double-Blind Phase|Subject Non-compliance|1|||
163126063|NCT00494507|589168340|FG003|Double-Blind Phase|Subject Non-compliance|0|||
163126064|NCT00494507|589168337|FG000|Double-Blind Phase|Negative DNA test|0|||
163126065|NCT00494507|589168338|FG001|Double-Blind Phase|Negative DNA test|0|||
163126066|NCT00494507|589168339|FG002|Double-Blind Phase|Negative DNA test|0|||
163126067|NCT00494507|589168340|FG003|Double-Blind Phase|Negative DNA test|1|||
163126068|NCT00494507|589168337|FG000|Open-Label Phase|Adverse Event|0|||
163126069|NCT00494507|589168338|FG001|Open-Label Phase|Adverse Event|1|||
163126070|NCT00494507|589168339|FG002|Open-Label Phase|Adverse Event|5|||
163126071|NCT00494507|589168340|FG003|Open-Label Phase|Adverse Event|3|||
163126072|NCT00494507|589168337|FG000|Open-Label Phase|Worsening Disease|0|||
163126073|NCT00494507|589168338|FG001|Open-Label Phase|Worsening Disease|0|||
163126074|NCT00494507|589168339|FG002|Open-Label Phase|Worsening Disease|0|||
163126075|NCT00494507|589168340|FG003|Open-Label Phase|Worsening Disease|2|||
163126076|NCT03615066|589168341|FG000|Main Study|Withdrew Consent|0|||
163126077|NCT03615066|589168342|FG001|Main Study|Withdrew Consent|1|||
163126078|NCT03615066|589168343|FG002|Main Study|Withdrew Consent|1|||
163126079|NCT03615066|589168341|FG000|Main Study|Lost to Follow-up|0|||
163126080|NCT03615066|589168342|FG001|Main Study|Lost to Follow-up|0|||
163126081|NCT03615066|589168343|FG002|Main Study|Lost to Follow-up|1|||
163126082|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
163126083|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
163126084|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
163126085|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
163126086|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
163126087|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
163126088|NCT03615066|589168341|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
162655982|NCT02346240|587453536|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655983|NCT02346240|587453537|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655984|NCT02346240|587453538|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655985|NCT02346240|587453539|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655986|NCT02346240|587453540|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655987|NCT02346240|587453541|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163126089|NCT03615066|589168342|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
163126090|NCT03615066|589168343|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
163126091|NCT00924404|589168346|FG000|Overall Study|Lost to Follow-up|6|||
163126092|NCT00924404|589168347|FG001|Overall Study|Lost to Follow-up|4|||
163126093|NCT03831945|589168350|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
163126094|NCT03831945|589168351|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
163126095|NCT03831945|589168350|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
163126096|NCT03831945|589168351|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
163126097|NCT03831945|589168350|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
163126098|NCT03831945|589168351|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
163126099|NCT03426631|589168352|FG000|Overall Study|Lost to Follow-up|0|||
163126100|NCT03426631|589168353|FG001|Overall Study|Lost to Follow-up|1|||
163126101|NCT00454181|589168354|FG000|Overall Study|Adverse Event|1|||
163126102|NCT00454181|589168355|FG001|Overall Study|Adverse Event|1|||
163126103|NCT00454181|589168354|FG000|Overall Study|Lost to Follow-up|11|||
163126104|NCT00454181|589168355|FG001|Overall Study|Lost to Follow-up|1|||
162655988|NCT02346240|587453542|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655989|NCT02346240|587453543|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655990|NCT02346240|587453544|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655991|NCT02346240|587453545|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
163126105|NCT00454181|589168354|FG000|Overall Study|Protocol Violation|1|||
163126106|NCT00454181|589168355|FG001|Overall Study|Protocol Violation|1|||
163126107|NCT00454181|589168354|FG000|Overall Study|Withdrawal by Subject|2|||
163126108|NCT00454181|589168355|FG001|Overall Study|Withdrawal by Subject|0|||
163126109|NCT04032080|589168356|FG000|Overall Study|Death|6|||
163126110|NCT02096263|589168357|FG000|Overall Study|Adverse Event|1|||
163126111|NCT02096263|589168358|FG001|Overall Study|Adverse Event|0|||
163126112|NCT02096263|589168359|FG002|Overall Study|Adverse Event|1|||
163126113|NCT02096263|589168357|FG000|Overall Study|Lost to Follow-up|14|||
163126114|NCT02096263|589168358|FG001|Overall Study|Lost to Follow-up|18|||
163126115|NCT02096263|589168359|FG002|Overall Study|Lost to Follow-up|15|||
163126116|NCT02096263|589168357|FG000|Overall Study|Other|7|||
163126117|NCT02096263|589168358|FG001|Overall Study|Other|9|||
163126118|NCT02096263|589168359|FG002|Overall Study|Other|6|||
163126119|NCT02096263|589168357|FG000|Overall Study|Sponsor study termination|0|||
163126120|NCT02096263|589168358|FG001|Overall Study|Sponsor study termination|0|||
163126121|NCT02096263|589168359|FG002|Overall Study|Sponsor study termination|1|||
163126122|NCT02096263|589168357|FG000|Overall Study|Protocol Violation|7|||
163126123|NCT02096263|589168358|FG001|Overall Study|Protocol Violation|2|||
163126124|NCT02096263|589168359|FG002|Overall Study|Protocol Violation|8|||
163126125|NCT02096263|589168357|FG000|Overall Study|Withdrawal by Subject|5|||
163126126|NCT02096263|589168358|FG001|Overall Study|Withdrawal by Subject|7|||
163126127|NCT02096263|589168359|FG002|Overall Study|Withdrawal by Subject|8|||
163126128|NCT01571453|589168360|FG000|Overall Study|Adverse Event|14|||
163126129|NCT01571453|589168361|FG001|Overall Study|Adverse Event|32|||
163126130|NCT01571453|589168360|FG000|Overall Study|Lack of Efficacy|8|||
163126131|NCT01571453|589168361|FG001|Overall Study|Lack of Efficacy|3|||
163126132|NCT01571453|589168360|FG000|Overall Study|Non-compliance|2|||
163126133|NCT01571453|589168361|FG001|Overall Study|Non-compliance|4|||
163126134|NCT01571453|589168360|FG000|Overall Study|Protocol Violation|1|||
163126135|NCT01571453|589168361|FG001|Overall Study|Protocol Violation|5|||
163126136|NCT01571453|589168360|FG000|Overall Study|Withdrawal of consent|5|||
163126137|NCT01571453|589168361|FG001|Overall Study|Withdrawal of consent|13|||
163126138|NCT01571453|589168360|FG000|Overall Study|Lost to Follow-up|4|||
163126139|NCT01571453|589168361|FG001|Overall Study|Lost to Follow-up|2|||
163126140|NCT01571453|589168360|FG000|Overall Study|Administrative or other reason(s)|4|||
163126141|NCT01571453|589168361|FG001|Overall Study|Administrative or other reason(s)|3|||
163126142|NCT00521222|589168366|FG000|Overall Study|Lost to Follow-up|0|||
163126143|NCT00521222|589168367|FG001|Overall Study|Lost to Follow-up|0|||
163126144|NCT00521222|589168368|FG002|Overall Study|Lost to Follow-up|1|||
163126145|NCT00521222|589168369|FG003|Overall Study|Lost to Follow-up|1|||
163126146|NCT00521222|589168366|FG000|Overall Study|Withdrawal by Subject|0|||
163126147|NCT00521222|589168367|FG001|Overall Study|Withdrawal by Subject|0|||
163126148|NCT00521222|589168368|FG002|Overall Study|Withdrawal by Subject|2|||
163126149|NCT00521222|589168369|FG003|Overall Study|Withdrawal by Subject|0|||
163126150|NCT00521222|589168366|FG000|Overall Study|Physician Decision|0|||
163126151|NCT00521222|589168367|FG001|Overall Study|Physician Decision|1|||
163126152|NCT00521222|589168368|FG002|Overall Study|Physician Decision|0|||
163126153|NCT00521222|589168369|FG003|Overall Study|Physician Decision|1|||
163126154|NCT03109184|589169811|FG000|Overall Study|Lost to Follow-up|6|||
163126155|NCT03109184|589169812|FG001|Overall Study|Lost to Follow-up|6|||
163126156|NCT03109184|589169811|FG000|Overall Study|Withdrawal by Subject|1|||
163126157|NCT03109184|589169812|FG001|Overall Study|Withdrawal by Subject|1|||
163126158|NCT00602420|589169813|FG000|Overall Study|Death|1|||
163126159|NCT00602420|589169814|FG001|Overall Study|Death|4|||
163126160|NCT00602420|589169813|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
163126161|NCT00602420|589169814|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
163126162|NCT00602420|589169813|FG000|Overall Study|Withdrawal by Subject|18|||
163126163|NCT00602420|589169814|FG001|Overall Study|Withdrawal by Subject|17|||
163126164|NCT00602420|589169813|FG000|Overall Study|Adverse Event|1|||
163126165|NCT00602420|589169814|FG001|Overall Study|Adverse Event|0|||
163126166|NCT00649428|589169825|FG000|Overall Study|Adverse Event|2|||
163126167|NCT00649428|589169826|FG001|Overall Study|Adverse Event|2|||
163126168|NCT00649428|589169825|FG000|Overall Study|Withdrawal by Subject|6|||
163126169|NCT00649428|589169826|FG001|Overall Study|Withdrawal by Subject|6|||
163126170|NCT00649428|589169825|FG000|Overall Study|Lost to Follow-up|1|||
163126171|NCT00649428|589169826|FG001|Overall Study|Lost to Follow-up|3|||
163126172|NCT00649428|589169825|FG000|Overall Study|Insufficient manufacturing yield|5|||
163126173|NCT00649428|589169826|FG001|Overall Study|Insufficient manufacturing yield|1|||
163126174|NCT00649428|589169825|FG000|Overall Study|Protocol Violation|6|||
163126175|NCT00649428|589169826|FG001|Overall Study|Protocol Violation|2|||
162719593|NCT03020745|587680522|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
163126176|NCT00649428|589169825|FG000|Overall Study|Physician Decision|0|||
163126177|NCT00649428|589169826|FG001|Overall Study|Physician Decision|1|||
163126178|NCT02503501|589169828|FG000|Overall Study|Physician Decision|1|||
163126179|NCT02503501|589169829|FG001|Overall Study|Physician Decision|0|||
163126180|NCT02503501|589169828|FG000|Overall Study|Protocol Violation|0|||
163126181|NCT02503501|589169829|FG001|Overall Study|Protocol Violation|1|||
163126182|NCT02503501|589169828|FG000|Overall Study|Withdrawal by Subject|0|||
163126183|NCT02503501|589169829|FG001|Overall Study|Withdrawal by Subject|2|||
163126184|NCT01740401|589169830|FG000|Overall Study|Progression of disease|6|||
163126185|NCT01740401|589169830|FG000|Overall Study|Adverse Event|2|||
163126186|NCT01740401|589169830|FG000|Overall Study|Did not reach primary endpoint|2|||
163126187|NCT02315560|589169831|FG000|Overall Study|noncompliance by subjects|3|||
163126188|NCT02008227|589169832|FG000|Overall Study|Lost to Follow-up|7|||
163126189|NCT02008227|589169833|FG001|Overall Study|Lost to Follow-up|9|||
163126190|NCT02008227|589169832|FG000|Overall Study|Death|494|||
163126191|NCT02008227|589169833|FG001|Overall Study|Death|485|||
163126192|NCT02008227|589169832|FG000|Overall Study|Withdrawal by Subject|67|||
163126193|NCT02008227|589169833|FG001|Overall Study|Withdrawal by Subject|36|||
163126194|NCT02008227|589169832|FG000|Overall Study|Study Terminated By Sponsor|44|||
163126195|NCT02008227|589169833|FG001|Overall Study|Study Terminated By Sponsor|83|||
163126196|NCT04599465|589169834|FG000|Overall Study|Physician Decision|1|||
163126197|NCT04599465|589169834|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
163126198|NCT04566601|589169835|FG000|Overall Study|Other than listed|13|||
163126199|NCT04566601|589169836|FG001|Overall Study|Other than listed|4|||
163126200|NCT04566601|589169837|FG002|Overall Study|Other than listed|2|||
163126201|NCT04566601|589169838|FG003|Overall Study|Other than listed|1|||
163126202|NCT04566601|589169839|FG004|Overall Study|Other than listed|4|||
163126203|NCT04566601|589169835|FG000|Overall Study|Protocol deviation|3|||
163126204|NCT04566601|589169836|FG001|Overall Study|Protocol deviation|0|||
163126205|NCT04566601|589169837|FG002|Overall Study|Protocol deviation|1|||
163126206|NCT04566601|589169838|FG003|Overall Study|Protocol deviation|1|||
163126207|NCT04566601|589169839|FG004|Overall Study|Protocol deviation|1|||
163126208|NCT04566601|589169835|FG000|Overall Study|Technical problems|0|||
163126209|NCT04566601|589169836|FG001|Overall Study|Technical problems|0|||
163126210|NCT04566601|589169837|FG002|Overall Study|Technical problems|1|||
163126211|NCT04566601|589169838|FG003|Overall Study|Technical problems|0|||
163126212|NCT04566601|589169839|FG004|Overall Study|Technical problems|0|||
163126213|NCT04566601|589169835|FG000|Overall Study|No reason available|3|||
163126214|NCT04566601|589169836|FG001|Overall Study|No reason available|2|||
163126215|NCT04566601|589169837|FG002|Overall Study|No reason available|7|||
163126216|NCT04566601|589169838|FG003|Overall Study|No reason available|1|||
163126217|NCT04566601|589169839|FG004|Overall Study|No reason available|5|||
163126218|NCT04566601|589169835|FG000|Overall Study|Burden of study procedures|3|||
163126219|NCT04566601|589169836|FG001|Overall Study|Burden of study procedures|0|||
163126220|NCT04566601|589169837|FG002|Overall Study|Burden of study procedures|0|||
163126221|NCT04566601|589169838|FG003|Overall Study|Burden of study procedures|3|||
163126222|NCT04566601|589169839|FG004|Overall Study|Burden of study procedures|1|||
163126223|NCT04566601|589169835|FG000|Overall Study|Change of residence|2|||
163126224|NCT04566601|589169836|FG001|Overall Study|Change of residence|2|||
163126225|NCT04566601|589169837|FG002|Overall Study|Change of residence|0|||
163126226|NCT04566601|589169838|FG003|Overall Study|Change of residence|1|||
163126227|NCT04566601|589169839|FG004|Overall Study|Change of residence|2|||
163126228|NCT04566601|589169835|FG000|Overall Study|Perceived lack of efficacy|2|||
163126229|NCT04566601|589169836|FG001|Overall Study|Perceived lack of efficacy|0|||
163126230|NCT04566601|589169837|FG002|Overall Study|Perceived lack of efficacy|1|||
163126231|NCT04566601|589169838|FG003|Overall Study|Perceived lack of efficacy|1|||
163126232|NCT04566601|589169839|FG004|Overall Study|Perceived lack of efficacy|2|||
163126233|NCT04566601|589169835|FG000|Overall Study|Adverse Event|7|||
163126234|NCT04566601|589169836|FG001|Overall Study|Adverse Event|4|||
163126235|NCT04566601|589169837|FG002|Overall Study|Adverse Event|6|||
163126236|NCT04566601|589169838|FG003|Overall Study|Adverse Event|5|||
163126237|NCT04566601|589169839|FG004|Overall Study|Adverse Event|12|||
163126238|NCT00306527|589169844|FG000|Overall Study|Lost to Follow-up|3|||
163126239|NCT00306527|589169845|FG001|Overall Study|Lost to Follow-up|4|||
163126240|NCT00306527|589169846|FG002|Overall Study|Lost to Follow-up|3|||
163126241|NCT00306527|589169847|FG003|Overall Study|Lost to Follow-up|0|||
163126242|NCT00306527|589169844|FG000|Overall Study|Withdrawal by Subject|2|||
163126243|NCT00306527|589169845|FG001|Overall Study|Withdrawal by Subject|3|||
163126244|NCT00306527|589169846|FG002|Overall Study|Withdrawal by Subject|0|||
163126245|NCT00306527|589169847|FG003|Overall Study|Withdrawal by Subject|3|||
163126246|NCT00306527|589169844|FG000|Overall Study|Adverse Event|0|||
163126247|NCT00306527|589169845|FG001|Overall Study|Adverse Event|0|||
163126248|NCT00306527|589169846|FG002|Overall Study|Adverse Event|1|||
163126249|NCT00306527|589169847|FG003|Overall Study|Adverse Event|1|||
163126250|NCT00306527|589169844|FG000|Overall Study|Death|1|||
163126251|NCT00306527|589169845|FG001|Overall Study|Death|0|||
163126252|NCT00306527|589169846|FG002|Overall Study|Death|1|||
163126253|NCT00306527|589169847|FG003|Overall Study|Death|2|||
163126254|NCT02702180|589169848|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163126255|NCT02702180|589169849|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163126256|NCT02702180|589169850|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163126257|NCT02702180|589169848|FG000|Double-blind Treatment Period|Adverse Event|0|||
163126258|NCT02702180|589169849|FG001|Double-blind Treatment Period|Adverse Event|0|||
163126259|NCT02702180|589169850|FG002|Double-blind Treatment Period|Adverse Event|1|||
163126260|NCT02702180|589169848|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163126261|NCT02702180|589169849|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163126262|NCT02702180|589169850|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163126263|NCT02702180|589169848|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163126264|NCT02702180|589169849|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163126265|NCT02702180|589169850|FG002|Double-blind Treatment Period|Protocol Violation|2|||
163126266|NCT02702180|589169848|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
162719594|NCT03020745|587680523|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719595|NCT03020745|587680524|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719596|NCT03020745|587680525|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719597|NCT03020745|587680526|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
162719598|NCT03020745|587680527|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
162719599|NCT03020745|587680518|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719600|NCT03020745|587680519|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719601|NCT03020745|587680520|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719602|NCT03020745|587680521|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719603|NCT03020745|587680522|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719604|NCT03020745|587680523|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719605|NCT03020745|587680524|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719606|NCT03020745|587680525|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
162719607|NCT03020745|587680526|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719608|NCT03020745|587680527|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162719609|NCT03020745|587680518|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719610|NCT03020745|587680519|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719611|NCT03020745|587680520|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719612|NCT03020745|587680521|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719613|NCT03020745|587680522|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719614|NCT03020745|587680523|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
162719615|NCT03020745|587680524|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719616|NCT03020745|587680525|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719617|NCT03020745|587680526|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
163126267|NCT02702180|589169849|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
163126268|NCT02702180|589169850|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
163126269|NCT02702180|589169848|FG000|Open-label Treatment Period|Withdrawn in error|0|||
163126270|NCT02702180|589169849|FG001|Open-label Treatment Period|Withdrawn in error|0|||
163126271|NCT02702180|589169850|FG002|Open-label Treatment Period|Withdrawn in error|1|||
163126272|NCT00785980|589169851|FG000|7 Day Washout Period|Protocol Violation|3|||
163126273|NCT02241343|589169864|FG000|Overall Study|Adverse Event|1|||
163126274|NCT04680975|589169865|FG000|Overall Study|Adverse Event|3|||
163126275|NCT04680975|589169865|FG000|Overall Study|Death|1|||
163126276|NCT04680975|589169865|FG000|Overall Study|Progressive Disease|1|||
163126277|NCT04680975|589169865|FG000|Overall Study|Withdrawal by Subject|1|||
163126278|NCT00753454|589169866|FG000|Overall Study|Adverse Event|4|||
163126279|NCT00753454|589169866|FG000|Overall Study|Lack of Efficacy|1|||
163126280|NCT00753454|589169866|FG000|Overall Study|Lost to Follow-up|3|||
163126281|NCT00753454|589169866|FG000|Overall Study|Withdrawal by Subject|5|||
163126282|NCT00753454|589169866|FG000|Overall Study|Investigator Decision|1|||
163126283|NCT05856227|589169869|FG000|Overall Study|Adverse Event|0|||
163126284|NCT05856227|589169870|FG001|Overall Study|Adverse Event|1|||
163126285|NCT05856227|589169869|FG000|Overall Study|Due to Investigator absence|1|||
163126286|NCT05856227|589169870|FG001|Overall Study|Due to Investigator absence|0|||
163126287|NCT05856227|589169869|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
163126288|NCT05856227|589169870|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
163126289|NCT01571232|589169871|FG000|Overall Study|Lost to Follow-up|0|||
163126290|NCT01571232|589169872|FG001|Overall Study|Lost to Follow-up|1|||
163126291|NCT01571232|589169871|FG000|Overall Study|Withdrawal by Subject|1|||
163126292|NCT01571232|589169872|FG001|Overall Study|Withdrawal by Subject|0|||
163126293|NCT01272869|589169873|FG000|Period 2 (14 Days)|Adverse Event|1|||
163126294|NCT01272869|589169874|FG001|Period 2 (14 Days)|Adverse Event|0|||
163126295|NCT02271945|589169875|FG000|Overall Study|Death|3|||
163126296|NCT02271945|589169876|FG001|Overall Study|Death|3|||
163126297|NCT02271945|589169875|FG000|Overall Study|Withdrawal by Subject|1|||
163126298|NCT02271945|589169876|FG001|Overall Study|Withdrawal by Subject|1|||
163126299|NCT02271945|589169875|FG000|Overall Study|Other|1|||
163126300|NCT02271945|589169876|FG001|Overall Study|Other|1|||
163126301|NCT00548717|589169877|FG000|Overall Study|Death|5|||
163126302|NCT00548717|589169878|FG001|Overall Study|Death|2|||
163126303|NCT00548717|589169877|FG000|Overall Study|Relapse|3|||
163126304|NCT00548717|589169878|FG001|Overall Study|Relapse|0|||
163126305|NCT00548717|589169877|FG000|Overall Study|Alternative treatment for GVHD|1|||
163126306|NCT00548717|589169878|FG001|Overall Study|Alternative treatment for GVHD|0|||
163126307|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126308|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126309|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126310|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126311|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
163126312|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126313|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
163126314|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126315|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
162655992|NCT02346240|587453546|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655993|NCT02346240|587453547|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655994|NCT02346240|587453548|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655995|NCT02346240|587453549|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655996|NCT02346240|587453550|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655997|NCT02346240|587453551|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
162655998|NCT02346240|587453552|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162655999|NCT02346240|587453553|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162656000|NCT02346240|587453554|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162656001|NCT02346240|587453555|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162656002|NCT02346240|587453556|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162656003|NCT02681302|587453557|FG000|Overall Study|Withdrawal by Subject|1|||
162656004|NCT02681302|587453558|FG001|Overall Study|Withdrawal by Subject|1|||
162656005|NCT02681302|587453559|FG002|Overall Study|Withdrawal by Subject|0|||
162656006|NCT02681302|587453560|FG003|Overall Study|Withdrawal by Subject|0|||
162656007|NCT02681302|587453561|FG004|Overall Study|Withdrawal by Subject|1|||
162656008|NCT02681302|587453562|FG005|Overall Study|Withdrawal by Subject|0|||
162656009|NCT02681302|587453557|FG000|Overall Study|Screen Failure|2|||
162656010|NCT02681302|587453558|FG001|Overall Study|Screen Failure|4|||
162656011|NCT02681302|587453559|FG002|Overall Study|Screen Failure|2|||
162656012|NCT02681302|587453560|FG003|Overall Study|Screen Failure|0|||
162656013|NCT02681302|587453561|FG004|Overall Study|Screen Failure|1|||
162656014|NCT02681302|587453562|FG005|Overall Study|Screen Failure|1|||
162656015|NCT02681302|587453557|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162656016|NCT02681302|587453558|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162656017|NCT02681302|587453559|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162656018|NCT02681302|587453560|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162656019|NCT02681302|587453561|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162656020|NCT02681302|587453562|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
162656021|NCT02942017|587453563|FG000|Overall Study|Adverse Event|0|||
162656022|NCT02942017|587453564|FG001|Overall Study|Adverse Event|1|||
162656023|NCT02942017|587453563|FG000|Overall Study|Withdrawal by Subject|0|||
163126316|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126317|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126318|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
163126319|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126320|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126321|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126322|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126323|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
163126324|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126325|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126326|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126327|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
163126328|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126329|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126330|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
163126331|NCT00908037|589169886|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126332|NCT00908037|589169887|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126333|NCT00908037|589169888|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126334|NCT00908037|589169889|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
163126335|NCT00908037|589169890|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126336|NCT00908037|589169891|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126337|NCT00908037|589169892|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
163126338|NCT00908037|589169893|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126339|NCT00908037|589169894|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126340|NCT00908037|589169895|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126341|NCT00908037|589169896|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126342|NCT00908037|589169897|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
163126343|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126344|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126345|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126346|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126347|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126348|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126349|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126350|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126351|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126352|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126353|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
163126354|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
163126355|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126356|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126357|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126358|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126359|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126360|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126361|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126362|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126363|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126364|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
163126365|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
163126366|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
163126367|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126368|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126369|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126370|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126371|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126372|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126373|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126374|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
162656024|NCT02942017|587453564|FG001|Overall Study|Withdrawal by Subject|1|||
162656025|NCT02942017|587453563|FG000|Overall Study|Lost to Follow-up|1|||
162656026|NCT02942017|587453564|FG001|Overall Study|Lost to Follow-up|1|||
162656027|NCT02942017|587453563|FG000|Overall Study|Randomized but not dosed|1|||
162656028|NCT02942017|587453564|FG001|Overall Study|Randomized but not dosed|3|||
162656029|NCT00477672|587453565|FG000|Overall Study|Adverse Event|3|||
162656030|NCT00477672|587453566|FG001|Overall Study|Adverse Event|5|||
162656031|NCT00477672|587453567|FG002|Overall Study|Adverse Event|6|||
162656032|NCT00477672|587453565|FG000|Overall Study|Death|0|||
162656033|NCT00477672|587453566|FG001|Overall Study|Death|1|||
162656034|NCT00477672|587453567|FG002|Overall Study|Death|0|||
162656035|NCT00477672|587453565|FG000|Overall Study|Disease progression|0|||
162656036|NCT00477672|587453566|FG001|Overall Study|Disease progression|1|||
162656037|NCT00477672|587453567|FG002|Overall Study|Disease progression|0|||
162656038|NCT00477672|587453565|FG000|Overall Study|Physician Decision|1|||
162656039|NCT00477672|587453566|FG001|Overall Study|Physician Decision|0|||
162656040|NCT00477672|587453567|FG002|Overall Study|Physician Decision|0|||
162656041|NCT00477672|587453565|FG000|Overall Study|Protocol noncompliance|0|||
162656042|NCT00477672|587453566|FG001|Overall Study|Protocol noncompliance|2|||
162656043|NCT00477672|587453567|FG002|Overall Study|Protocol noncompliance|0|||
162656044|NCT00477672|587453565|FG000|Overall Study|Consent withdrawn|2|||
162656045|NCT00477672|587453566|FG001|Overall Study|Consent withdrawn|5|||
162656046|NCT00477672|587453567|FG002|Overall Study|Consent withdrawn|10|||
162656047|NCT00477672|587453565|FG000|Overall Study|Discretion of Sponsor|1|||
162656048|NCT00477672|587453566|FG001|Overall Study|Discretion of Sponsor|2|||
162656049|NCT00477672|587453567|FG002|Overall Study|Discretion of Sponsor|0|||
162656050|NCT00838565|587453568|FG000|Overall Study|Withdrawal by Subject|0|||
162656051|NCT00838565|587453569|FG001|Overall Study|Withdrawal by Subject|0|||
162656052|NCT00838565|587453570|FG002|Overall Study|Withdrawal by Subject|1|||
162656053|NCT00838565|587453571|FG003|Overall Study|Withdrawal by Subject|0|||
162656054|NCT00838565|587453572|FG004|Overall Study|Withdrawal by Subject|0|||
162656055|NCT00838565|587453573|FG005|Overall Study|Withdrawal by Subject|2|||
162656056|NCT00838565|587453568|FG000|Overall Study|Other|0|||
162656057|NCT00838565|587453569|FG001|Overall Study|Other|2|||
162656058|NCT00838565|587453570|FG002|Overall Study|Other|0|||
162656059|NCT00838565|587453571|FG003|Overall Study|Other|0|||
162656060|NCT00838565|587453572|FG004|Overall Study|Other|0|||
162656061|NCT00838565|587453573|FG005|Overall Study|Other|0|||
162656062|NCT00838565|587453568|FG000|Overall Study|Randomized but not Treated|0|||
162656063|NCT00838565|587453569|FG001|Overall Study|Randomized but not Treated|1|||
162656064|NCT00838565|587453570|FG002|Overall Study|Randomized but not Treated|0|||
162656065|NCT00838565|587453571|FG003|Overall Study|Randomized but not Treated|0|||
162656066|NCT00838565|587453572|FG004|Overall Study|Randomized but not Treated|0|||
162656067|NCT00838565|587453573|FG005|Overall Study|Randomized but not Treated|0|||
162656068|NCT00458484|587453574|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
162656069|NCT00458484|587453575|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
162656070|NCT00458484|587453576|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
162656071|NCT00458484|587453577|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
162656072|NCT00458484|587453578|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
162656073|NCT00458484|587453579|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
162656074|NCT00458484|587453580|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
162656075|NCT04907032|587453581|FG000|Overall Study|Withdrawal by Subject|7|||
162656076|NCT04907032|587453582|FG001|Overall Study|Withdrawal by Subject|1|||
162656077|NCT02253810|587453583|FG000|Overall Study|Withdrawal by Subject|2|||
162656078|NCT02253810|587453584|FG001|Overall Study|Withdrawal by Subject|1|||
162656079|NCT02253810|587453583|FG000|Overall Study|Unknown concomitant procedure|3|||
162656080|NCT02253810|587453584|FG001|Overall Study|Unknown concomitant procedure|2|||
162656081|NCT00291668|587453586|FG000|Overall Study|Lack of Efficacy|1|||
162656082|NCT00291668|587453587|FG001|Overall Study|Lack of Efficacy|0|||
162656083|NCT00291668|587453588|FG002|Overall Study|Lack of Efficacy|0|||
162656084|NCT00291668|587453586|FG000|Overall Study|SAE, non-fatal|1|||
162656085|NCT00291668|587453587|FG001|Overall Study|SAE, non-fatal|1|||
163126375|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126376|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
163126377|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126378|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
163126379|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
162656086|NCT00291668|587453588|FG002|Overall Study|SAE, non-fatal|1|||
162656087|NCT00291668|587453586|FG000|Overall Study|AE, non-serious non-fatal|1|||
162656088|NCT00291668|587453587|FG001|Overall Study|AE, non-serious non-fatal|0|||
162656089|NCT00291668|587453588|FG002|Overall Study|AE, non-serious non-fatal|0|||
162656090|NCT00291668|587453586|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162656091|NCT00291668|587453587|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162656092|NCT00291668|587453588|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162656093|NCT01557400|587453589|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
162656094|NCT01557400|587453589|FG000|Overall Study|Adverse Event|3|||
162656095|NCT01557400|587453589|FG000|Overall Study|Lost to Follow-up|5|||
162656096|NCT01557400|587453589|FG000|Overall Study|Withdrawal by Subject|9|||
162656097|NCT00245765|587453605|FG000|Overall Study|Adverse Event|1|||
162656098|NCT00245765|587453606|FG001|Overall Study|Adverse Event|1|||
162656099|NCT00245765|587453607|FG002|Overall Study|Adverse Event|0|||
162656100|NCT00245765|587453605|FG000|Overall Study|Lack of Efficacy|14|||
162656101|NCT00245765|587453606|FG001|Overall Study|Lack of Efficacy|7|||
162656102|NCT00245765|587453607|FG002|Overall Study|Lack of Efficacy|0|||
162656103|NCT00245765|587453605|FG000|Overall Study|Lost to Follow-up|1|||
162656104|NCT00245765|587453606|FG001|Overall Study|Lost to Follow-up|2|||
162656105|NCT00245765|587453607|FG002|Overall Study|Lost to Follow-up|0|||
162656106|NCT00245765|587453605|FG000|Overall Study|Withdrawal by Subject|1|||
162656107|NCT00245765|587453606|FG001|Overall Study|Withdrawal by Subject|0|||
162656108|NCT00245765|587453607|FG002|Overall Study|Withdrawal by Subject|3|||
162656109|NCT00245765|587453605|FG000|Overall Study|Other reason|2|||
162656110|NCT00245765|587453606|FG001|Overall Study|Other reason|0|||
162656111|NCT00245765|587453607|FG002|Overall Study|Other reason|1|||
162656112|NCT00245765|587453605|FG000|Overall Study|Other|13|||
163126380|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126381|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126382|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126383|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126384|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126385|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126386|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126387|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126388|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
162656113|NCT00245765|587453606|FG001|Overall Study|Other|4|||
162656114|NCT00245765|587453607|FG002|Overall Study|Other|4|||
162656115|NCT06425458|587453608|FG000|Overall Study|Removed by study team|2|||
162656116|NCT06425458|587453608|FG000|Overall Study|Lost to Follow-up|5|||
162656117|NCT03962543|587453612|FG000|Treatment Phase|Death|0|||
163126389|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
163126390|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
163126391|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126392|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126393|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126394|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126395|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126396|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126397|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126398|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126399|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126400|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
163126401|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126402|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
163126403|NCT00908037|589169886|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
162656118|NCT03962543|587453613|FG001|Treatment Phase|Death|1|||
162656119|NCT03962543|587453612|FG000|Treatment Phase|Withdrawal by Subject|3|||
162656120|NCT03962543|587453613|FG001|Treatment Phase|Withdrawal by Subject|0|||
162656121|NCT03962543|587453612|FG000|Treatment Phase|Adverse Event|3|||
163126404|NCT00908037|589169887|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126405|NCT00908037|589169888|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126406|NCT00908037|589169889|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126407|NCT00908037|589169890|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126408|NCT00908037|589169891|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126409|NCT00908037|589169892|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
162656122|NCT03962543|587453613|FG001|Treatment Phase|Adverse Event|12|||
163126410|NCT00908037|589169893|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126411|NCT00908037|589169894|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126412|NCT00908037|589169895|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
162656123|NCT03962543|587453612|FG000|Treatment Phase|Lost to Follow-up|1|||
162656124|NCT03962543|587453613|FG001|Treatment Phase|Lost to Follow-up|2|||
162656125|NCT03962543|587453612|FG000|Treatment Phase|Radiographic PD|9|||
162656126|NCT03962543|587453613|FG001|Treatment Phase|Radiographic PD|3|||
162656127|NCT03962543|587453612|FG000|Treatment Phase|Participant Decision|3|||
162656128|NCT03962543|587453613|FG001|Treatment Phase|Participant Decision|8|||
163126413|NCT00908037|589169896|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
163126414|NCT00908037|589169897|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
163126415|NCT02613169|589169898|FG000|Overall Study|Withdrawal by Subject|4|||
163126416|NCT02613169|589169899|FG001|Overall Study|Withdrawal by Subject|1|||
163126417|NCT02613169|589169898|FG000|Overall Study|Lost to Follow-up|0|||
163126418|NCT02613169|589169899|FG001|Overall Study|Lost to Follow-up|5|||
163126419|NCT02613169|589169898|FG000|Overall Study|HIV|0|||
163126420|NCT02613169|589169899|FG001|Overall Study|HIV|2|||
163126421|NCT02613169|589169898|FG000|Overall Study|No TB infection endpoint|14|||
163126422|NCT02613169|589169899|FG001|Overall Study|No TB infection endpoint|9|||
163126423|NCT03729245|589169900|FG000|Overall Study|Lost to Follow-up|5|||
163126424|NCT03729245|589169901|FG001|Overall Study|Lost to Follow-up|6|||
163126425|NCT03729245|589169900|FG000|Overall Study|Withdrawal by Subject|16|||
163126426|NCT03729245|589169901|FG001|Overall Study|Withdrawal by Subject|19|||
163126427|NCT03729245|589169900|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
163126428|NCT03729245|589169901|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
163126429|NCT00079677|589169913|FG000|Overall Study|Adverse Event|5|||
163126430|NCT00079677|589169914|FG001|Overall Study|Adverse Event|6|||
163126431|NCT00079677|589169913|FG000|Overall Study|Lack of Efficacy|1|||
163126432|NCT00079677|589169914|FG001|Overall Study|Lack of Efficacy|0|||
163126433|NCT00079677|589169913|FG000|Overall Study|Lost to Follow-up|2|||
163126434|NCT00079677|589169914|FG001|Overall Study|Lost to Follow-up|2|||
163126435|NCT00079677|589169913|FG000|Overall Study|Physician Decision|3|||
163126436|NCT00079677|589169914|FG001|Overall Study|Physician Decision|0|||
163126437|NCT00079677|589169913|FG000|Overall Study|Protocol Violation|2|||
163126438|NCT00079677|589169914|FG001|Overall Study|Protocol Violation|3|||
163126439|NCT00079677|589169913|FG000|Overall Study|Withdrawal by Subject|5|||
163126440|NCT00079677|589169914|FG001|Overall Study|Withdrawal by Subject|3|||
163126441|NCT00079677|589169913|FG000|Overall Study|Miscellaneous|2|||
163126442|NCT00079677|589169914|FG001|Overall Study|Miscellaneous|0|||
163126443|NCT01985360|589169915|FG000|Overall Study|Withdrawal by Subject|4|||
163126444|NCT01985360|589169916|FG001|Overall Study|Withdrawal by Subject|0|||
163126445|NCT01985360|589169915|FG000|Overall Study|Lost to Follow-up|5|||
163126446|NCT01985360|589169916|FG001|Overall Study|Lost to Follow-up|3|||
163126447|NCT04598269|589169917|FG000|Overall Study|Adverse Event|0|||
163126448|NCT04598269|589169918|FG001|Overall Study|Adverse Event|3|||
163126449|NCT04598269|589169917|FG000|Overall Study|Withdrawal by Subject|1|||
163126450|NCT04598269|589169918|FG001|Overall Study|Withdrawal by Subject|4|||
163126451|NCT04598269|589169917|FG000|Overall Study|Lost to Follow-up|1|||
163126452|NCT04598269|589169918|FG001|Overall Study|Lost to Follow-up|0|||
163126453|NCT04598269|589169917|FG000|Overall Study|Not Treated|2|||
163126454|NCT04598269|589169918|FG001|Overall Study|Not Treated|0|||
163126455|NCT00424190|589169919|FG000|Overall Study|Withdrew consent|3|||
163126456|NCT00424190|589169920|FG001|Overall Study|Withdrew consent|4|||
163126457|NCT00424190|589169919|FG000|Overall Study|Death|3|||
163126458|NCT00424190|589169920|FG001|Overall Study|Death|0|||
163126459|NCT00424190|589169919|FG000|Overall Study|Noncompliance|1|||
163126460|NCT00424190|589169920|FG001|Overall Study|Noncompliance|2|||
163126461|NCT00424190|589169919|FG000|Overall Study|Request of sponsor or investigator|0|||
163126462|NCT00424190|589169920|FG001|Overall Study|Request of sponsor or investigator|2|||
163126463|NCT00424190|589169919|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
163126464|NCT00424190|589169920|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
163126465|NCT00424190|589169919|FG000|Overall Study|Other|15|||
163126466|NCT00424190|589169920|FG001|Overall Study|Other|21|||
163126467|NCT00845065|589169922|FG000|Overall Study|Adverse Event|3|||
163126468|NCT00845065|589169923|FG001|Overall Study|Adverse Event|23|||
163126469|NCT00845065|589169922|FG000|Overall Study|Lack of Efficacy|43|||
163126470|NCT00845065|589169923|FG001|Overall Study|Lack of Efficacy|21|||
163126471|NCT00845065|589169922|FG000|Overall Study|Non-Medical Reasons|1|||
163126472|NCT00845065|589169923|FG001|Overall Study|Non-Medical Reasons|11|||
163126473|NCT02383433|589169924|FG000|Overall Study|Disease progression|2|||
163126474|NCT00952614|589169927|FG000|Overall Study|Death|3|||
163126475|NCT00952614|589169927|FG000|Overall Study|Lost to Follow-up|3|||
163126476|NCT00952614|589169927|FG000|Overall Study|other reason|1|||
163126477|NCT02963701|589169929|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
163126478|NCT02963701|589169930|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
163126479|NCT01345682|589169931|FG000|Overall Study|Progressive disease per RECIST|226|||
163126480|NCT01345682|589169932|FG001|Overall Study|Progressive disease per RECIST|93|||
163126481|NCT01345682|589169931|FG000|Overall Study|Worsening of underlying cancer disease|23|||
163126482|NCT01345682|589169932|FG001|Overall Study|Worsening of underlying cancer disease|12|||
163126483|NCT01345682|589169931|FG000|Overall Study|Adverse Event|51|||
163126484|NCT01345682|589169932|FG001|Overall Study|Adverse Event|41|||
163126485|NCT01345682|589169931|FG000|Overall Study|Non-compliance with protocol|0|||
163126486|NCT01345682|589169932|FG001|Overall Study|Non-compliance with protocol|1|||
163126487|NCT01345682|589169931|FG000|Overall Study|Lost to Follow-up|0|||
163126488|NCT01345682|589169932|FG001|Overall Study|Lost to Follow-up|1|||
163126489|NCT01345682|589169931|FG000|Overall Study|Refused to continue trial medication|16|||
163126490|NCT01345682|589169932|FG001|Overall Study|Refused to continue trial medication|9|||
163126491|NCT01345682|589169931|FG000|Overall Study|Not treated|2|||
163126492|NCT01345682|589169932|FG001|Overall Study|Not treated|1|||
163126493|NCT01345682|589169931|FG000|Overall Study|Reason other than those specified above|4|||
163126494|NCT01345682|589169932|FG001|Overall Study|Reason other than those specified above|3|||
163126495|NCT00896649|589169933|FG000|Overall Study|Physician Decision|1|||
163126496|NCT00896649|589169933|FG000|Overall Study|Pregnancy|1|||
163126497|NCT00896649|589169933|FG000|Overall Study|missing documentation|1|||
163126498|NCT00896649|589169933|FG000|Overall Study|technical difficulties|2|||
163126499|NCT01075984|589169935|FG000|Treatment Phase|Adverse Event|0|||
163126500|NCT01075984|589169936|FG001|Treatment Phase|Adverse Event|1|||
163126501|NCT01075984|589169937|FG002|Treatment Phase|Adverse Event|3|||
163126502|NCT01075984|589169938|FG003|Treatment Phase|Adverse Event|7|||
163126503|NCT01075984|589169939|FG004|Treatment Phase|Adverse Event|35|||
163126504|NCT01075984|589169935|FG000|Treatment Phase|Protocol Violation|0|||
163126505|NCT01075984|589169936|FG001|Treatment Phase|Protocol Violation|0|||
163126506|NCT01075984|589169937|FG002|Treatment Phase|Protocol Violation|1|||
163126507|NCT01075984|589169938|FG003|Treatment Phase|Protocol Violation|0|||
163126508|NCT01075984|589169939|FG004|Treatment Phase|Protocol Violation|3|||
163126509|NCT01075984|589169935|FG000|Treatment Phase|Withdrawal by Subject|0|||
163126510|NCT01075984|589169936|FG001|Treatment Phase|Withdrawal by Subject|0|||
163126511|NCT01075984|589169937|FG002|Treatment Phase|Withdrawal by Subject|2|||
163126512|NCT01075984|589169938|FG003|Treatment Phase|Withdrawal by Subject|0|||
163126513|NCT01075984|589169939|FG004|Treatment Phase|Withdrawal by Subject|15|||
163126514|NCT01075984|589169935|FG000|Treatment Phase|Treatment Failure|0|||
163126515|NCT01075984|589169936|FG001|Treatment Phase|Treatment Failure|0|||
163126516|NCT01075984|589169937|FG002|Treatment Phase|Treatment Failure|1|||
163126517|NCT01075984|589169938|FG003|Treatment Phase|Treatment Failure|0|||
163126518|NCT01075984|589169939|FG004|Treatment Phase|Treatment Failure|5|||
163126519|NCT01075984|589169935|FG000|Treatment Phase|Progression of disease|0|||
163126520|NCT01075984|589169936|FG001|Treatment Phase|Progression of disease|0|||
163126521|NCT01075984|589169937|FG002|Treatment Phase|Progression of disease|0|||
163126522|NCT01075984|589169938|FG003|Treatment Phase|Progression of disease|0|||
163126523|NCT01075984|589169939|FG004|Treatment Phase|Progression of disease|2|||
163126524|NCT01075984|589169935|FG000|Follow-up Phase|Protocol Violation|0|||
163126525|NCT01075984|589169936|FG001|Follow-up Phase|Protocol Violation|0|||
163126526|NCT01075984|589169937|FG002|Follow-up Phase|Protocol Violation|1|||
163126527|NCT01075984|589169938|FG003|Follow-up Phase|Protocol Violation|0|||
163126528|NCT01075984|589169939|FG004|Follow-up Phase|Protocol Violation|3|||
163126529|NCT01075984|589169935|FG000|Follow-up Phase|Adverse Event|0|||
163126530|NCT01075984|589169936|FG001|Follow-up Phase|Adverse Event|0|||
163126531|NCT01075984|589169937|FG002|Follow-up Phase|Adverse Event|0|||
163126532|NCT01075984|589169938|FG003|Follow-up Phase|Adverse Event|2|||
163126533|NCT01075984|589169939|FG004|Follow-up Phase|Adverse Event|27|||
163126534|NCT01075984|589169935|FG000|Follow-up Phase|Administrative|0|||
163126535|NCT01075984|589169936|FG001|Follow-up Phase|Administrative|0|||
163126536|NCT01075984|589169937|FG002|Follow-up Phase|Administrative|0|||
163126537|NCT01075984|589169938|FG003|Follow-up Phase|Administrative|0|||
163126538|NCT01075984|589169939|FG004|Follow-up Phase|Administrative|1|||
163126539|NCT01075984|589169935|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163126540|NCT01075984|589169936|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163126541|NCT01075984|589169937|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163126542|NCT01075984|589169938|FG003|Follow-up Phase|Withdrawal by Subject|0|||
163126543|NCT01075984|589169939|FG004|Follow-up Phase|Withdrawal by Subject|10|||
163126544|NCT01075984|589169935|FG000|Follow-up Phase|Progression of disease|0|||
163126545|NCT01075984|589169936|FG001|Follow-up Phase|Progression of disease|0|||
163126546|NCT01075984|589169937|FG002|Follow-up Phase|Progression of disease|0|||
163126547|NCT01075984|589169938|FG003|Follow-up Phase|Progression of disease|0|||
163126548|NCT01075984|589169939|FG004|Follow-up Phase|Progression of disease|2|||
163126549|NCT01075984|589169935|FG000|Follow-up Phase|Treatment failure|0|||
163126550|NCT01075984|589169936|FG001|Follow-up Phase|Treatment failure|0|||
163126551|NCT01075984|589169937|FG002|Follow-up Phase|Treatment failure|0|||
163126552|NCT01075984|589169938|FG003|Follow-up Phase|Treatment failure|0|||
163126553|NCT01075984|589169939|FG004|Follow-up Phase|Treatment failure|4|||
163126554|NCT03101085|589169940|FG000|Overall Study|Lost to Follow-up|0|||
163126555|NCT03101085|589169941|FG001|Overall Study|Lost to Follow-up|1|||
163126556|NCT02986854|589169943|FG000|Overall Study|Withdrawal by Subject|0|||
163126557|NCT02986854|589169944|FG001|Overall Study|Withdrawal by Subject|1|||
163126558|NCT02986854|589169945|FG002|Overall Study|Withdrawal by Subject|1|||
163126559|NCT02986854|589169943|FG000|Overall Study|Lost to Follow-up|3|||
163126560|NCT02986854|589169944|FG001|Overall Study|Lost to Follow-up|11|||
163126561|NCT02986854|589169945|FG002|Overall Study|Lost to Follow-up|2|||
163126562|NCT02039856|589169948|FG000|Overall Study|Death|5|||
163126563|NCT02039856|589169949|FG001|Overall Study|Death|3|||
163126564|NCT02039856|589169948|FG000|Overall Study|Partial survey completion|61|||
163126565|NCT02039856|589169949|FG001|Overall Study|Partial survey completion|26|||
163126566|NCT02039856|589169948|FG000|Overall Study|Lost to Follow-up|388|||
163126567|NCT02039856|589169949|FG001|Overall Study|Lost to Follow-up|206|||
163126568|NCT02039856|589169948|FG000|Overall Study|Withdrawal by Subject|1573|||
163126569|NCT02039856|589169949|FG001|Overall Study|Withdrawal by Subject|618|||
163126570|NCT00626405|589169961|FG000|Overall Study|Deemed Ineligible|1|||
163126571|NCT00626405|589169962|FG001|Overall Study|Deemed Ineligible|0|||
163126572|NCT00626405|589169961|FG000|Overall Study|Withdrawal by Subject|0|||
163126573|NCT00626405|589169962|FG001|Overall Study|Withdrawal by Subject|1|||
163126574|NCT01174173|589169963|FG000|Overall Study|drug-drug interaction|1|||
163154840|NCT00911170|589281449|FG001|Treatment Period|Disease progression|2|||
163154841|NCT00911170|589281448|FG000|Treatment Period|Physician Decision|5|||
163154842|NCT00911170|589281449|FG001|Treatment Period|Physician Decision|5|||
163154843|NCT00911170|589281448|FG000|Treatment Period|Lost to Follow-up|0|||
163154844|NCT00911170|589281449|FG001|Treatment Period|Lost to Follow-up|1|||
163154845|NCT00911170|589281448|FG000|Treatment Period|Death|6|||
163154846|NCT00911170|589281449|FG001|Treatment Period|Death|9|||
163154847|NCT00911170|589281448|FG000|Long Term Follow-Up|Continuing in study|274|||
163154848|NCT00911170|589281449|FG001|Long Term Follow-Up|Continuing in study|269|||
163154849|NCT00911170|589281448|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
163154850|NCT00911170|589281449|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
163154851|NCT00911170|589281448|FG000|Long Term Follow-Up|Physician Decision|5|||
163154852|NCT00911170|589281449|FG001|Long Term Follow-Up|Physician Decision|4|||
163154853|NCT00911170|589281448|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
163154854|NCT00911170|589281449|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
163154855|NCT00911170|589281448|FG000|Long Term Follow-Up|Death|116|||
163154856|NCT00911170|589281449|FG001|Long Term Follow-Up|Death|121|||
163154857|NCT02681523|589281450|FG000|Overall Study|Adverse Event|1|||
163154858|NCT02681523|589281450|FG000|Overall Study|Patient Non-compliance|1|||
162656129|NCT03962543|587453612|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
162656130|NCT03962543|587453613|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
162656131|NCT03962543|587453612|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
162656132|NCT03962543|587453613|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
162656133|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
162656134|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
162656135|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
162656136|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
162656137|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
163126575|NCT03775512|589172514|FG000|Overall Study|Death|1|||
163126576|NCT03775512|589172515|FG001|Overall Study|Death|1|||
163126577|NCT03775512|589172514|FG000|Overall Study|Withdrawal by Subject|7|||
163126578|NCT03775512|589172515|FG001|Overall Study|Withdrawal by Subject|4|||
163126579|NCT03775512|589172514|FG000|Overall Study|Lost to Follow-up|5|||
163126580|NCT03775512|589172515|FG001|Overall Study|Lost to Follow-up|5|||
163126581|NCT03775512|589172514|FG000|Overall Study|Excluded before Catheter insertion|14|||
163126582|NCT03775512|589172515|FG001|Overall Study|Excluded before Catheter insertion|5|||
163126583|NCT03775512|589172514|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
163126584|NCT03775512|589172515|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
163126585|NCT03775512|589172514|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
163126586|NCT03775512|589172515|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
163126587|NCT02629822|589172516|FG000|Base Study|Lost to Follow-up|2|||
163126588|NCT02629822|589172516|FG000|Base Study|Non-Compliance With Study Drug|1|||
163126589|NCT02629822|589172516|FG000|Extension Study|Adverse Event|1|||
163126590|NCT02629822|589172516|FG000|Extension Study|Lost to Follow-up|1|||
163126591|NCT01610336|589172517|FG000|Overall Study|Progressive Disease|4|||
163126592|NCT01610336|589172518|FG001|Overall Study|Progressive Disease|6|||
163126593|NCT01610336|589172519|FG002|Overall Study|Progressive Disease|6|||
163126594|NCT01610336|589172520|FG003|Overall Study|Progressive Disease|5|||
163126595|NCT01610336|589172521|FG004|Overall Study|Progressive Disease|3|||
163126596|NCT01610336|589172522|FG005|Overall Study|Progressive Disease|10|||
163126597|NCT01610336|589172523|FG006|Overall Study|Progressive Disease|1|||
163126598|NCT01610336|589172524|FG007|Overall Study|Progressive Disease|6|||
163126599|NCT01610336|589172525|FG008|Overall Study|Progressive Disease|6|||
163126600|NCT01610336|589172526|FG009|Overall Study|Progressive Disease|40|||
163126601|NCT01610336|589172527|FG010|Overall Study|Progressive Disease|36|||
163126602|NCT01610336|589172517|FG000|Overall Study|Adverse Event|0|||
163126603|NCT01610336|589172518|FG001|Overall Study|Adverse Event|0|||
163126604|NCT01610336|589172519|FG002|Overall Study|Adverse Event|0|||
163126605|NCT01610336|589172520|FG003|Overall Study|Adverse Event|1|||
163126606|NCT01610336|589172521|FG004|Overall Study|Adverse Event|1|||
163126607|NCT01610336|589172522|FG005|Overall Study|Adverse Event|1|||
163126608|NCT01610336|589172523|FG006|Overall Study|Adverse Event|0|||
163126609|NCT01610336|589172524|FG007|Overall Study|Adverse Event|0|||
163126610|NCT01610336|589172525|FG008|Overall Study|Adverse Event|2|||
163126611|NCT01610336|589172526|FG009|Overall Study|Adverse Event|8|||
163126612|NCT01610336|589172527|FG010|Overall Study|Adverse Event|6|||
163126613|NCT01610336|589172517|FG000|Overall Study|Subject/Guardian decision|1|||
163126614|NCT01610336|589172518|FG001|Overall Study|Subject/Guardian decision|1|||
163126615|NCT01610336|589172519|FG002|Overall Study|Subject/Guardian decision|0|||
163126616|NCT01610336|589172520|FG003|Overall Study|Subject/Guardian decision|1|||
163126617|NCT01610336|589172521|FG004|Overall Study|Subject/Guardian decision|0|||
163126618|NCT01610336|589172522|FG005|Overall Study|Subject/Guardian decision|0|||
163126619|NCT01610336|589172523|FG006|Overall Study|Subject/Guardian decision|0|||
163126620|NCT01610336|589172524|FG007|Overall Study|Subject/Guardian decision|1|||
163126621|NCT01610336|589172525|FG008|Overall Study|Subject/Guardian decision|0|||
163126622|NCT01610336|589172526|FG009|Overall Study|Subject/Guardian decision|2|||
163126623|NCT01610336|589172527|FG010|Overall Study|Subject/Guardian decision|2|||
163126624|NCT01610336|589172517|FG000|Overall Study|Death|0|||
163126625|NCT01610336|589172518|FG001|Overall Study|Death|0|||
163126626|NCT01610336|589172519|FG002|Overall Study|Death|0|||
163126627|NCT01610336|589172520|FG003|Overall Study|Death|0|||
163126628|NCT01610336|589172521|FG004|Overall Study|Death|0|||
163126629|NCT01610336|589172522|FG005|Overall Study|Death|1|||
163126630|NCT01610336|589172523|FG006|Overall Study|Death|3|||
163126631|NCT01610336|589172524|FG007|Overall Study|Death|0|||
163126632|NCT01610336|589172525|FG008|Overall Study|Death|0|||
163126633|NCT01610336|589172526|FG009|Overall Study|Death|1|||
163126634|NCT01610336|589172527|FG010|Overall Study|Death|2|||
163126635|NCT01610336|589172517|FG000|Overall Study|Non-Compliance with study treatment|0|||
162656138|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
162656139|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
163126636|NCT01610336|589172518|FG001|Overall Study|Non-Compliance with study treatment|0|||
163126637|NCT01610336|589172519|FG002|Overall Study|Non-Compliance with study treatment|0|||
163126638|NCT01610336|589172520|FG003|Overall Study|Non-Compliance with study treatment|0|||
163126639|NCT01610336|589172521|FG004|Overall Study|Non-Compliance with study treatment|0|||
163126640|NCT01610336|589172522|FG005|Overall Study|Non-Compliance with study treatment|0|||
163126641|NCT01610336|589172523|FG006|Overall Study|Non-Compliance with study treatment|0|||
163126642|NCT01610336|589172524|FG007|Overall Study|Non-Compliance with study treatment|0|||
163126643|NCT01610336|589172525|FG008|Overall Study|Non-Compliance with study treatment|0|||
163126644|NCT01610336|589172526|FG009|Overall Study|Non-Compliance with study treatment|1|||
163126645|NCT01610336|589172527|FG010|Overall Study|Non-Compliance with study treatment|0|||
163126646|NCT01610336|589172517|FG000|Overall Study|Physician Decision|0|||
163126647|NCT01610336|589172518|FG001|Overall Study|Physician Decision|0|||
163126648|NCT01610336|589172519|FG002|Overall Study|Physician Decision|0|||
163126649|NCT01610336|589172520|FG003|Overall Study|Physician Decision|0|||
163126650|NCT01610336|589172521|FG004|Overall Study|Physician Decision|0|||
162656140|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
162656141|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
162656142|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
162656143|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
162656144|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
162656145|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
162656146|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
162656147|NCT03962543|587453612|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
162656148|NCT03962543|587453613|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
162656149|NCT02777125|587453614|FG000|Overall Study|Consent form violation|14|||
162656150|NCT02777125|587453615|FG001|Overall Study|Consent form violation|12|||
162656151|NCT02777125|587453614|FG000|Overall Study|Assent form violation|21|||
162656152|NCT02777125|587453615|FG001|Overall Study|Assent form violation|23|||
162656153|NCT02777125|587453614|FG000|Overall Study|Protocol Violation|8|||
162656154|NCT02777125|587453615|FG001|Overall Study|Protocol Violation|12|||
162656155|NCT02917031|587453616|FG000|Overall Study|Reason not specified|7|||
162656156|NCT02917031|587453617|FG001|Overall Study|Reason not specified|5|||
162656157|NCT02917031|587453618|FG002|Overall Study|Reason not specified|6|||
162656158|NCT02917031|587453616|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
162656159|NCT02917031|587453617|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
162656160|NCT02917031|587453618|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
163126651|NCT01610336|589172522|FG005|Overall Study|Physician Decision|0|||
163126652|NCT01610336|589172523|FG006|Overall Study|Physician Decision|1|||
163126653|NCT01610336|589172524|FG007|Overall Study|Physician Decision|0|||
163126654|NCT01610336|589172525|FG008|Overall Study|Physician Decision|0|||
163126655|NCT01610336|589172526|FG009|Overall Study|Physician Decision|0|||
163126656|NCT01610336|589172527|FG010|Overall Study|Physician Decision|0|||
163126657|NCT01610336|589172517|FG000|Overall Study|Protocol Deviation|0|||
163126658|NCT01610336|589172518|FG001|Overall Study|Protocol Deviation|0|||
163126659|NCT01610336|589172519|FG002|Overall Study|Protocol Deviation|0|||
163126660|NCT01610336|589172520|FG003|Overall Study|Protocol Deviation|0|||
163126661|NCT01610336|589172521|FG004|Overall Study|Protocol Deviation|0|||
163126662|NCT01610336|589172522|FG005|Overall Study|Protocol Deviation|0|||
163126663|NCT01610336|589172523|FG006|Overall Study|Protocol Deviation|0|||
163126664|NCT01610336|589172524|FG007|Overall Study|Protocol Deviation|0|||
163126665|NCT01610336|589172525|FG008|Overall Study|Protocol Deviation|0|||
163126666|NCT01610336|589172526|FG009|Overall Study|Protocol Deviation|1|||
163126667|NCT01610336|589172527|FG010|Overall Study|Protocol Deviation|0|||
163126668|NCT01610336|589172517|FG000|Overall Study|Transfer to another trial|0|||
163126669|NCT01610336|589172518|FG001|Overall Study|Transfer to another trial|0|||
163126670|NCT01610336|589172519|FG002|Overall Study|Transfer to another trial|0|||
163126671|NCT01610336|589172520|FG003|Overall Study|Transfer to another trial|0|||
163126672|NCT01610336|589172521|FG004|Overall Study|Transfer to another trial|0|||
163126673|NCT01610336|589172522|FG005|Overall Study|Transfer to another trial|0|||
163126674|NCT01610336|589172523|FG006|Overall Study|Transfer to another trial|0|||
163126675|NCT01610336|589172524|FG007|Overall Study|Transfer to another trial|0|||
163126676|NCT01610336|589172525|FG008|Overall Study|Transfer to another trial|0|||
163126677|NCT01610336|589172526|FG009|Overall Study|Transfer to another trial|0|||
163126678|NCT01610336|589172527|FG010|Overall Study|Transfer to another trial|1|||
163126679|NCT00082407|589172528|FG000|Overall Study|Adverse Event|20|||
163126680|NCT00082407|589172529|FG001|Overall Study|Adverse Event|0|||
163126681|NCT00082407|589172528|FG000|Overall Study|Protocol Violation|14|||
163126682|NCT00082407|589172529|FG001|Overall Study|Protocol Violation|12|||
163126683|NCT00082407|589172528|FG000|Overall Study|Patient Decision|13|||
163126684|NCT00082407|589172529|FG001|Overall Study|Patient Decision|6|||
163126685|NCT00082407|589172528|FG000|Overall Study|Physician Decision|5|||
163126686|NCT00082407|589172529|FG001|Overall Study|Physician Decision|3|||
163126687|NCT00082407|589172528|FG000|Overall Study|Loss of Glucose Control|2|||
162656161|NCT02917031|587453616|FG000|Overall Study|Withdrawal by Subject|3|||
162656162|NCT02917031|587453617|FG001|Overall Study|Withdrawal by Subject|3|||
163126688|NCT00082407|589172529|FG001|Overall Study|Loss of Glucose Control|2|||
163126689|NCT00082407|589172528|FG000|Overall Study|Death|2|||
163126690|NCT00082407|589172529|FG001|Overall Study|Death|1|||
163126691|NCT00082407|589172528|FG000|Overall Study|Lost to Follow-up|0|||
163126692|NCT00082407|589172529|FG001|Overall Study|Lost to Follow-up|3|||
163126693|NCT03464019|589172530|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
163126694|NCT03464019|589172531|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
162656163|NCT02917031|587453618|FG002|Overall Study|Withdrawal by Subject|0|||
162656164|NCT02917031|587453616|FG000|Overall Study|Physician Decision|1|||
162656165|NCT02917031|587453617|FG001|Overall Study|Physician Decision|0|||
163126695|NCT03464019|589172532|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
163126696|NCT03464019|589172530|FG000|NODE-301 Part 1|Ablation|0|||
163126697|NCT03464019|589172531|FG001|NODE-301 Part 1|Ablation|0|||
163126698|NCT03464019|589172532|FG002|NODE-301 Part 1|Ablation|16|||
163126699|NCT03464019|589172530|FG000|NODE-301 Part 1|Test Dose Failure|0|||
163126700|NCT03464019|589172531|FG001|NODE-301 Part 1|Test Dose Failure|0|||
163126701|NCT03464019|589172532|FG002|NODE-301 Part 1|Test Dose Failure|8|||
163126702|NCT03464019|589172530|FG000|NODE-301 Part 1|Adverse Event|0|||
163126703|NCT03464019|589172531|FG001|NODE-301 Part 1|Adverse Event|0|||
163126704|NCT03464019|589172532|FG002|NODE-301 Part 1|Adverse Event|5|||
163126705|NCT03464019|589172530|FG000|NODE-301 Part 1|Physician Decision|0|||
163126706|NCT03464019|589172531|FG001|NODE-301 Part 1|Physician Decision|0|||
163126707|NCT03464019|589172532|FG002|NODE-301 Part 1|Physician Decision|4|||
163126708|NCT03464019|589172530|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
163126709|NCT03464019|589172531|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
163126710|NCT03464019|589172532|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
163126711|NCT03464019|589172530|FG000|NODE-301 Part 1|Protocol Violation|0|||
163126712|NCT03464019|589172531|FG001|NODE-301 Part 1|Protocol Violation|0|||
163126713|NCT03464019|589172532|FG002|NODE-301 Part 1|Protocol Violation|2|||
163126714|NCT03464019|589172530|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
163126715|NCT03464019|589172531|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
163126716|NCT03464019|589172532|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
163126717|NCT03464019|589172530|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
163126718|NCT03464019|589172531|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
163126719|NCT03464019|589172532|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
163126720|NCT03464019|589172530|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
163126721|NCT03464019|589172531|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
163126722|NCT03464019|589172532|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
163126723|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
163126724|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
163126725|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
163126726|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
163126727|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
163126728|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
163126729|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
163126730|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
163126731|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
163126732|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
163126733|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
163126734|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
163126735|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
163126736|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
163126737|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
163126738|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
163126739|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
163126740|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
163126741|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
163126742|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
163126743|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
163126744|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
163126745|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
163126746|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
163126747|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
163126748|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
163126749|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
163126750|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
163126751|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
163126752|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
163126753|NCT03464019|589172530|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
163126754|NCT03464019|589172531|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
163126755|NCT03464019|589172532|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
163126756|NCT00767806|589172533|FG000|Overall Study|Adverse Event|30|||
163126757|NCT00767806|589172534|FG001|Overall Study|Adverse Event|11|||
163126758|NCT00767806|589172533|FG000|Overall Study|Withdrawal by Subject|8|||
163126759|NCT00767806|589172534|FG001|Overall Study|Withdrawal by Subject|13|||
163126760|NCT00767806|589172533|FG000|Overall Study|Protocol Violation|6|||
163126761|NCT00767806|589172534|FG001|Overall Study|Protocol Violation|5|||
163126762|NCT00767806|589172533|FG000|Overall Study|Lack of Efficacy|1|||
163126763|NCT00767806|589172534|FG001|Overall Study|Lack of Efficacy|9|||
163126764|NCT00767806|589172533|FG000|Overall Study|Physician Decision|4|||
163126765|NCT00767806|589172534|FG001|Overall Study|Physician Decision|3|||
163126766|NCT00767806|589172533|FG000|Overall Study|Lost to Follow-up|1|||
163126767|NCT00767806|589172534|FG001|Overall Study|Lost to Follow-up|4|||
163126768|NCT00767806|589172533|FG000|Overall Study|Entry Criteria Not Met|1|||
163126769|NCT00767806|589172534|FG001|Overall Study|Entry Criteria Not Met|1|||
163126770|NCT00767806|589172533|FG000|Overall Study|Sponsor Decision|0|||
163126771|NCT00767806|589172534|FG001|Overall Study|Sponsor Decision|1|||
163126772|NCT02489942|589172535|FG000|Overall Study|Request by patient|602|||
163126773|NCT02489942|589172535|FG000|Overall Study|Improvement/remission|157|||
163126774|NCT02489942|589172535|FG000|Overall Study|No change/Progressive disease|263|||
163126775|NCT02489942|589172535|FG000|Overall Study|Adverse Event|522|||
163126776|NCT02489942|589172535|FG000|Overall Study|Other personal reasons|1218|||
163126777|NCT02489942|589172535|FG000|Overall Study|Lost to Follow-up|456|||
163126778|NCT02489942|589172535|FG000|Overall Study|Not continuously investigated|7|||
163126779|NCT02489942|589172535|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
163126780|NCT02489942|589172535|FG000|Overall Study|Multiple registration|1|||
163126781|NCT02489942|589172535|FG000|Overall Study|No patient visit after entry|100|||
163126782|NCT02489942|589172535|FG000|Overall Study|No treatment with Jardiance|2|||
163126783|NCT02489942|589172535|FG000|Overall Study|Patient received Jardiance before registration|1|||
163126784|NCT02489942|589172535|FG000|Overall Study|No CRF collected|86|||
163126785|NCT00858208|589172536|FG000|Overall Study|Adverse Event|3|||
163126786|NCT00858208|589172536|FG000|Overall Study|Lost to Follow-up|26|||
163126787|NCT00858208|589172536|FG000|Overall Study|Participant refused|40|||
163126788|NCT00858208|589172536|FG000|Overall Study|Other|10|||
163126789|NCT01272635|589172537|FG000|Overall Study|Lost to Follow-up|31|||
163126790|NCT01272635|589172538|FG001|Overall Study|Lost to Follow-up|20|||
163126791|NCT01272635|589172539|FG002|Overall Study|Lost to Follow-up|31|||
163126792|NCT01272635|589172540|FG003|Overall Study|Lost to Follow-up|23|||
163126793|NCT01543776|589172541|FG000|Overall Study|Withdrawal by Subject|2|||
163126794|NCT01543776|589172542|FG001|Overall Study|Withdrawal by Subject|2|||
163126795|NCT00567359|589172543|FG000|Overall Study|Withdrawal by Subject|1|||
163126796|NCT02352753|589172544|FG000|6-Month Dosing Period|Decision by sponsor|2|||
163126797|NCT02352753|589172544|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
163126798|NCT02352753|589172544|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
163126799|NCT02352753|589172544|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
163126800|NCT02352753|589172544|FG000|3-Month Dosing Period|Decision by sponsor|14|||
163126801|NCT02352753|589172544|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
163126802|NCT00539305|589172545|FG000|Overall Study|Adverse Event|1|||
163126803|NCT00539305|589172546|FG001|Overall Study|Adverse Event|0|||
163126804|NCT00539305|589172545|FG000|Overall Study|Substance Use|0|||
163126805|NCT00539305|589172546|FG001|Overall Study|Substance Use|1|||
163126806|NCT00539305|589172545|FG000|Overall Study|Withdrawal by Subject|0|||
163126807|NCT00539305|589172546|FG001|Overall Study|Withdrawal by Subject|1|||
163126808|NCT00126776|589172548|FG000|Overall Study|follow up complete on all patients|0|||
163126809|NCT00126776|589172549|FG001|Overall Study|follow up complete on all patients|0|||
163126810|NCT00679172|589172553|FG000|Overall Study|Non-compliance|1|||
163126811|NCT00679172|589172554|FG001|Overall Study|Non-compliance|1|||
163126812|NCT00679172|589172555|FG002|Overall Study|Non-compliance|0|||
163126813|NCT00679172|589172556|FG003|Overall Study|Non-compliance|1|||
163126814|NCT00679172|589172557|FG004|Overall Study|Non-compliance|0|||
163126815|NCT00679172|589172553|FG000|Overall Study|Other not specified|0|||
163126816|NCT00679172|589172554|FG001|Overall Study|Other not specified|0|||
163126817|NCT00679172|589172555|FG002|Overall Study|Other not specified|1|||
163126818|NCT00679172|589172556|FG003|Overall Study|Other not specified|0|||
163126819|NCT00679172|589172557|FG004|Overall Study|Other not specified|0|||
163126820|NCT00417963|589172558|FG000|Overall Study|Lost to Follow-up|3|||
163126821|NCT00417963|589172558|FG000|Overall Study|Withdrawal by Subject|18|||
163126822|NCT00417963|589172558|FG000|Overall Study|Death|17|||
163126823|NCT00417963|589172558|FG000|Overall Study|Study device could not be deployed|3|||
163126824|NCT01815840|589172559|FG000|Overall Study|Missing|1|||
163126825|NCT01815840|589172560|FG001|Overall Study|Missing|0|||
163126826|NCT01815840|589172559|FG000|Overall Study|Withdrew Consent|31|||
163126827|NCT01815840|589172560|FG001|Overall Study|Withdrew Consent|30|||
163126828|NCT01815840|589172559|FG000|Overall Study|Administrative/Other|1|||
163126829|NCT01815840|589172560|FG001|Overall Study|Administrative/Other|3|||
163126830|NCT01815840|589172559|FG000|Overall Study|Adverse Event|10|||
162656166|NCT02917031|587453618|FG002|Overall Study|Physician Decision|0|||
162656167|NCT02917031|587453616|FG000|Overall Study|Adverse Event|4|||
162656168|NCT02917031|587453617|FG001|Overall Study|Adverse Event|1|||
162656169|NCT02917031|587453618|FG002|Overall Study|Adverse Event|5|||
162656170|NCT02917031|587453616|FG000|Overall Study|Death|2|||
162656171|NCT02917031|587453617|FG001|Overall Study|Death|3|||
163126831|NCT01815840|589172560|FG001|Overall Study|Adverse Event|16|||
163126832|NCT01815840|589172559|FG000|Overall Study|Death|2|||
163126833|NCT01815840|589172560|FG001|Overall Study|Death|2|||
163126834|NCT01815840|589172559|FG000|Overall Study|Disease progression|3|||
163126835|NCT01815840|589172560|FG001|Overall Study|Disease progression|2|||
162656172|NCT02917031|587453618|FG002|Overall Study|Death|4|||
163126836|NCT01815840|589172559|FG000|Overall Study|Investigators Decision|2|||
163126837|NCT01815840|589172560|FG001|Overall Study|Investigators Decision|3|||
163126838|NCT01815840|589172559|FG000|Overall Study|Lost to Follow-up|3|||
163126839|NCT01815840|589172560|FG001|Overall Study|Lost to Follow-up|6|||
162656173|NCT00640510|587455127|FG000|Overall Study|Lack of Efficacy|0|||
162656174|NCT00640510|587455128|FG001|Overall Study|Lack of Efficacy|1|||
162656175|NCT00640510|587455127|FG000|Overall Study|Protocol Violation|1|||
162656176|NCT00640510|587455128|FG001|Overall Study|Protocol Violation|0|||
162656177|NCT00640510|587455127|FG000|Overall Study|Physician Decision|0|||
162656178|NCT00640510|587455128|FG001|Overall Study|Physician Decision|1|||
162656179|NCT01440322|587455129|FG000|Overall Study|Discomfort|2|||
162656180|NCT01440322|587455130|FG001|Overall Study|Discomfort|0|||
162656181|NCT01440322|587455129|FG000|Overall Study|Biomicroscopy|1|||
162656182|NCT01440322|587455130|FG001|Overall Study|Biomicroscopy|0|||
162656183|NCT01440322|587455129|FG000|Overall Study|Symptoms and Problems|1|||
162656184|NCT01440322|587455130|FG001|Overall Study|Symptoms and Problems|0|||
162656185|NCT01440322|587455129|FG000|Overall Study|Unacceptable Subjective Vision|1|||
162656186|NCT01440322|587455130|FG001|Overall Study|Unacceptable Subjective Vision|0|||
162656187|NCT01440322|587455129|FG000|Overall Study|Other Product Related|1|||
162656188|NCT01440322|587455130|FG001|Overall Study|Other Product Related|0|||
162656189|NCT01440322|587455129|FG000|Overall Study|Unrelated Medical Problem|0|||
162656190|NCT01440322|587455130|FG001|Overall Study|Unrelated Medical Problem|1|||
162656191|NCT01440322|587455129|FG000|Overall Study|Other Non-Product Related|1|||
162656192|NCT01440322|587455130|FG001|Overall Study|Other Non-Product Related|0|||
162656193|NCT04300296|587455134|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
162656194|NCT04300296|587455135|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162656195|NCT04300296|587455136|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162656196|NCT04300296|587455137|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162656197|NCT04300296|587455138|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162656198|NCT04300296|587455139|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162656199|NCT04300296|587455134|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162656200|NCT04300296|587455135|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162656201|NCT04300296|587455136|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162656202|NCT04300296|587455137|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162656203|NCT04300296|587455138|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
162656204|NCT04300296|587455139|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162656205|NCT04300296|587455134|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
162656206|NCT04300296|587455135|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
162656207|NCT04300296|587455136|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162656208|NCT04300296|587455137|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162656209|NCT04300296|587455138|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162656210|NCT04300296|587455139|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
162656211|NCT04300296|587455134|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
162656212|NCT04300296|587455135|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162656213|NCT04300296|587455136|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
162656214|NCT04300296|587455137|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162656215|NCT04300296|587455138|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
162656216|NCT04300296|587455139|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162656217|NCT04300296|587455134|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
162656218|NCT04300296|587455135|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162656219|NCT04300296|587455136|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
162656220|NCT04300296|587455137|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162656221|NCT04300296|587455138|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
162656222|NCT04300296|587455139|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162656223|NCT04300296|587455134|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162656224|NCT04300296|587455135|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
162656225|NCT04300296|587455136|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162656226|NCT04300296|587455137|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162656227|NCT04300296|587455138|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
163126840|NCT01815840|589172559|FG000|Overall Study|Refused Treatment|5|||
163126841|NCT01815840|589172560|FG001|Overall Study|Refused Treatment|1|||
163126842|NCT01815840|589172559|FG000|Overall Study|Sponsor Termination Treatment|1|||
163126843|NCT01815840|589172560|FG001|Overall Study|Sponsor Termination Treatment|0|||
162656228|NCT04300296|587455139|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162656229|NCT04300296|587455134|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
162656230|NCT04300296|587455135|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
162656231|NCT04300296|587455136|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
162656232|NCT04300296|587455137|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
162656233|NCT04300296|587455138|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
163126844|NCT00434642|589172561|FG000|Blinded Treatment Phase|Adverse Event|12|||
163126845|NCT00434642|589172562|FG001|Blinded Treatment Phase|Adverse Event|58|||
163126846|NCT00434642|589172561|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
163126847|NCT00434642|589172562|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
163126848|NCT00434642|589172561|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
163126849|NCT00434642|589172562|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
163126850|NCT00434642|589172561|FG000|Blinded Treatment Phase|Physician Decision|19|||
163126851|NCT00434642|589172562|FG001|Blinded Treatment Phase|Physician Decision|27|||
163126852|NCT00434642|589172561|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
163126853|NCT00434642|589172562|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
163126854|NCT00434642|589172561|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
163126855|NCT00434642|589172562|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
163126856|NCT00434642|589172561|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
163126857|NCT00434642|589172562|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
163126858|NCT00434642|589172561|FG000|Open-label Treatment Phase|Adverse Event|0|||
163126859|NCT00434642|589172562|FG001|Open-label Treatment Phase|Adverse Event|5|||
163126860|NCT00434642|589172561|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
163126861|NCT00434642|589172562|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
163126862|NCT05011058|589172565|FG000|Overall Study|Sponsor Decision|2|||
163126863|NCT05011058|589172566|FG001|Overall Study|Sponsor Decision|0|||
163126864|NCT05011058|589172567|FG002|Overall Study|Sponsor Decision|14|||
163126865|NCT05011058|589172568|FG003|Overall Study|Sponsor Decision|0|||
163126866|NCT05011058|589172569|FG004|Overall Study|Sponsor Decision|0|||
163126867|NCT05011058|589172570|FG005|Overall Study|Sponsor Decision|1|||
163126868|NCT05011058|589172571|FG006|Overall Study|Sponsor Decision|0|||
163126869|NCT05011058|589172572|FG007|Overall Study|Sponsor Decision|5|||
163126870|NCT02455076|589172573|FG000|Inpatient|Withdrawal by Subject|1|||
163126871|NCT02455076|589172574|FG001|Inpatient|Withdrawal by Subject|0|||
163126872|NCT02455076|589172575|FG002|Inpatient|Withdrawal by Subject|0|||
163126873|NCT02455076|589172576|FG003|Inpatient|Withdrawal by Subject|0|||
163126874|NCT02455076|589172577|FG004|Inpatient|Withdrawal by Subject|0|||
163126875|NCT02455076|589172573|FG000|Inpatient|Discharged <24 h after admission|0|||
163126876|NCT02455076|589172574|FG001|Inpatient|Discharged <24 h after admission|1|||
163126877|NCT02455076|589172575|FG002|Inpatient|Discharged <24 h after admission|0|||
163126878|NCT02455076|589172576|FG003|Inpatient|Discharged <24 h after admission|0|||
163126879|NCT02455076|589172577|FG004|Inpatient|Discharged <24 h after admission|0|||
163126880|NCT02455076|589172573|FG000|Inpatient|Adverse Event|3|||
163126881|NCT02455076|589172574|FG001|Inpatient|Adverse Event|0|||
163126882|NCT02455076|589172575|FG002|Inpatient|Adverse Event|0|||
163126883|NCT02455076|589172576|FG003|Inpatient|Adverse Event|0|||
163126884|NCT02455076|589172577|FG004|Inpatient|Adverse Event|0|||
163126885|NCT02455076|589172573|FG000|Outpatient|Adverse Event|0|||
163126886|NCT02455076|589172574|FG001|Outpatient|Adverse Event|0|||
163126887|NCT02455076|589172575|FG002|Outpatient|Adverse Event|0|||
163126888|NCT02455076|589172576|FG003|Outpatient|Adverse Event|5|||
163126889|NCT02455076|589172577|FG004|Outpatient|Adverse Event|0|||
163126890|NCT02455076|589172573|FG000|Outpatient|Lost to Follow-up|0|||
163126891|NCT02455076|589172574|FG001|Outpatient|Lost to Follow-up|0|||
163126892|NCT02455076|589172575|FG002|Outpatient|Lost to Follow-up|0|||
163126893|NCT02455076|589172576|FG003|Outpatient|Lost to Follow-up|1|||
163126894|NCT02455076|589172577|FG004|Outpatient|Lost to Follow-up|12|||
163126895|NCT03908476|589172579|FG000|Overall Study|Death|3|||
163126896|NCT03908476|589172580|FG001|Overall Study|Death|0|||
163126897|NCT03908476|589172579|FG000|Overall Study|Lost to Follow-up|3|||
163126898|NCT03908476|589172580|FG001|Overall Study|Lost to Follow-up|1|||
163126899|NCT03908476|589172579|FG000|Overall Study|Withdrawal by Subject|7|||
163126900|NCT03908476|589172580|FG001|Overall Study|Withdrawal by Subject|1|||
163126901|NCT03908476|589172579|FG000|Overall Study|Physician Decision|2|||
163126902|NCT03908476|589172580|FG001|Overall Study|Physician Decision|0|||
163126903|NCT03908476|589172579|FG000|Overall Study|System Explanted and not Replaced|4|||
163126904|NCT03908476|589172580|FG001|Overall Study|System Explanted and not Replaced|0|||
163126905|NCT03908476|589172579|FG000|Overall Study|Intrathecal Pump|1|||
163126906|NCT03908476|589172580|FG001|Overall Study|Intrathecal Pump|0|||
163126907|NCT03908476|589172579|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
163126908|NCT03908476|589172580|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
163126909|NCT05194267|589172581|FG000|Overall Study|Withdrawal by Subject|2|||
163126910|NCT02868229|589172582|FG000|Overall Study|Adverse Event|1|||
163126911|NCT02868229|589172583|FG001|Overall Study|Adverse Event|0|||
163126912|NCT02868229|589172584|FG002|Overall Study|Adverse Event|0|||
163126913|NCT02868229|589172585|FG003|Overall Study|Adverse Event|1|||
163126914|NCT02868229|589172582|FG000|Overall Study|Death|0|||
163126915|NCT02868229|589172583|FG001|Overall Study|Death|0|||
163126916|NCT02868229|589172584|FG002|Overall Study|Death|1|||
163126917|NCT02868229|589172585|FG003|Overall Study|Death|1|||
163126918|NCT02868229|589172582|FG000|Overall Study|Missed dose|0|||
163126919|NCT02868229|589172583|FG001|Overall Study|Missed dose|0|||
163126920|NCT02868229|589172584|FG002|Overall Study|Missed dose|0|||
163126921|NCT02868229|589172585|FG003|Overall Study|Missed dose|3|||
163126922|NCT06151288|589172586|FG000|Overall Study|Lost to Follow-up|4|||
163126923|NCT06151288|589172587|FG001|Overall Study|Lost to Follow-up|2|||
163126924|NCT06151288|589172588|FG002|Overall Study|Lost to Follow-up|4|||
162656234|NCT04300296|587455139|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
162656235|NCT05044234|587455140|FG000|Overall Study|Lost to Follow-up|2|||
162656236|NCT05044234|587455141|FG001|Overall Study|Lost to Follow-up|1|||
162656237|NCT05044234|587455142|FG002|Overall Study|Lost to Follow-up|1|||
162656238|NCT05044234|587455143|FG003|Overall Study|Lost to Follow-up|2|||
162656239|NCT05044234|587455140|FG000|Overall Study|Withdrawal by Subject|6|||
162656240|NCT05044234|587455141|FG001|Overall Study|Withdrawal by Subject|4|||
163126925|NCT06151288|589172589|FG003|Overall Study|Lost to Follow-up|3|||
163126926|NCT06151288|589172586|FG000|Overall Study|Withdrawal by Subject|4|||
163126927|NCT06151288|589172587|FG001|Overall Study|Withdrawal by Subject|5|||
163126928|NCT06151288|589172588|FG002|Overall Study|Withdrawal by Subject|1|||
163126929|NCT06151288|589172589|FG003|Overall Study|Withdrawal by Subject|1|||
163126930|NCT00719680|589172593|FG000|Overall Study|Adverse Event|1|||
163126931|NCT00719680|589172593|FG000|Overall Study|Lost to Follow-up|1|||
163126932|NCT00719680|589172593|FG000|Overall Study|Withdrawal by Subject|3|||
163126933|NCT01646203|589172607|FG000|Overall Study|Adverse Event|2|||
163126934|NCT01646203|589172608|FG001|Overall Study|Adverse Event|0|||
163126935|NCT01646203|589172609|FG002|Overall Study|Adverse Event|1|||
162656241|NCT05044234|587455142|FG002|Overall Study|Withdrawal by Subject|5|||
162656242|NCT05044234|587455143|FG003|Overall Study|Withdrawal by Subject|8|||
163126936|NCT01646203|589172607|FG000|Overall Study|Withdrawal by Subject|0|||
163126937|NCT01646203|589172608|FG001|Overall Study|Withdrawal by Subject|1|||
163126938|NCT01646203|589172609|FG002|Overall Study|Withdrawal by Subject|0|||
163126939|NCT01646203|589172607|FG000|Overall Study|Physician's Decision|0|||
163126940|NCT01646203|589172608|FG001|Overall Study|Physician's Decision|1|||
163126941|NCT01646203|589172609|FG002|Overall Study|Physician's Decision|0|||
163126942|NCT04676867|589172610|FG000|Overall Study|Screen failure|0|||
163126943|NCT04676867|589172611|FG001|Overall Study|Screen failure|0|||
163126944|NCT04676867|589172612|FG002|Overall Study|Screen failure|6|||
163126945|NCT04676867|589172613|FG003|Overall Study|Screen failure|2|||
163126946|NCT04676867|589172610|FG000|Overall Study|Death|0|||
163126947|NCT04676867|589172611|FG001|Overall Study|Death|0|||
163126948|NCT04676867|589172612|FG002|Overall Study|Death|1|||
163126949|NCT04676867|589172613|FG003|Overall Study|Death|0|||
163126950|NCT04676867|589172610|FG000|Overall Study|Withdrawal by Subject|2|||
163126951|NCT04676867|589172611|FG001|Overall Study|Withdrawal by Subject|2|||
163126952|NCT04676867|589172612|FG002|Overall Study|Withdrawal by Subject|4|||
163126953|NCT04676867|589172613|FG003|Overall Study|Withdrawal by Subject|4|||
163126954|NCT04676867|589172610|FG000|Overall Study|Lost to Follow-up|1|||
163126955|NCT04676867|589172611|FG001|Overall Study|Lost to Follow-up|0|||
163126956|NCT04676867|589172612|FG002|Overall Study|Lost to Follow-up|0|||
163126957|NCT04676867|589172613|FG003|Overall Study|Lost to Follow-up|0|||
163126958|NCT00551291|589172617|FG000|Overall Study|Physician Decision|1|||
163126959|NCT04268173|589172618|FG000|Overall Study|Lost to Follow-up|75|||
163126960|NCT04268173|589172619|FG001|Overall Study|Lost to Follow-up|108|||
163126961|NCT01375608|589172620|FG000|Overall Study|Withdrawal by Subject|2|||
163126962|NCT01953913|589172621|FG000|Overall Study|Disease Progression|349|||
163126963|NCT01953913|589172621|FG000|Overall Study|Worsening of underlying cancer|22|||
163126964|NCT01953913|589172621|FG000|Overall Study|Adverse Event|20|||
163126965|NCT01953913|589172621|FG000|Overall Study|Protocol Violation|6|||
163126966|NCT01953913|589172621|FG000|Overall Study|Lost to Follow-up|4|||
163126967|NCT01953913|589172621|FG000|Overall Study|Withdrawal by Subject|32|||
163126968|NCT01953913|589172621|FG000|Overall Study|Other than listed|108|||
163126969|NCT01953913|589172621|FG000|Overall Study|Not Treated|1|||
163126970|NCT02925741|589172622|FG000|Overall Study|Withdrawal by Subject|11|||
163126971|NCT02925741|589172623|FG001|Overall Study|Withdrawal by Subject|0|||
163126972|NCT02437084|589172624|FG000|Overall Study|Withdrawal by Subject|2|||
163126973|NCT02437084|589172624|FG000|Overall Study|Physician Decision|1|||
163126974|NCT00710385|589172627|FG000|Overall Study|Did not qualify|1|||
163126975|NCT00710385|589172627|FG000|Overall Study|Withdrawal by Subject|1|||
163126976|NCT00710385|589172627|FG000|Overall Study|Undisclosed back pain|1|||
163126977|NCT00710385|589172627|FG000|Overall Study|Physician Decision|1|||
162656243|NCT05044234|587455140|FG000|Overall Study|Study terminated by Sponsor|21|||
162656244|NCT05044234|587455141|FG001|Overall Study|Study terminated by Sponsor|21|||
163126978|NCT00710385|589172627|FG000|Overall Study|Undisclosed excessive methadone use|1|||
163126979|NCT02976103|589172628|FG000|Overall Study|Withdrawal by Subject|1|||
163126980|NCT02976103|589172629|FG001|Overall Study|Withdrawal by Subject|0|||
163126981|NCT02976103|589172628|FG000|Overall Study|Lost to Follow-up|12|||
162656245|NCT05044234|587455142|FG002|Overall Study|Study terminated by Sponsor|20|||
163126982|NCT02976103|589172629|FG001|Overall Study|Lost to Follow-up|8|||
163126983|NCT00694304|589172630|FG000|Overall Study|Adverse Event|42|||
162656246|NCT05044234|587455143|FG003|Overall Study|Study terminated by Sponsor|14|||
162656247|NCT05044234|587455140|FG000|Overall Study|Other, not specified|0|||
163126984|NCT00694304|589172630|FG000|Overall Study|Lack of Efficacy|35|||
163126985|NCT00694304|589172630|FG000|Overall Study|Non-compliance With Study Product|16|||
163126986|NCT00694304|589172630|FG000|Overall Study|Protocol Violation|6|||
163126987|NCT00694304|589172630|FG000|Overall Study|Withdrawal of Consent|61|||
163126988|NCT00694304|589172630|FG000|Overall Study|Lost to Follow-up|15|||
163126989|NCT00694304|589172630|FG000|Overall Study|Administrative or Other Reasons|32|||
163126990|NCT03040986|589172633|FG000|Overall Study|Hospice|1|||
163126991|NCT03040986|589172634|FG001|Overall Study|Hospice|0|||
163126992|NCT03040986|589172633|FG000|Overall Study|Adverse Event|2|||
163126993|NCT03040986|589172634|FG001|Overall Study|Adverse Event|1|||
163126994|NCT03040986|589172633|FG000|Overall Study|Disease progression on study|3|||
163126995|NCT03040986|589172634|FG001|Overall Study|Disease progression on study|1|||
163126996|NCT02228096|589172638|FG000|Overall Study|Study terminated by Sponsor|24|||
163126997|NCT02228096|589172638|FG000|Overall Study|Lack of Efficacy|18|||
163126998|NCT02228096|589172638|FG000|Overall Study|Death|12|||
163126999|NCT02228096|589172638|FG000|Overall Study|Physician Decision|3|||
163127000|NCT02228096|589172638|FG000|Overall Study|Subject/guardian decision|2|||
163127001|NCT02228096|589172638|FG000|Overall Study|New therapy for study indication|1|||
163127002|NCT02228096|589172638|FG000|Overall Study|Enrolled, not infused|11|||
163127003|NCT02925728|589172639|FG000|Overall Study|Death|3|||
163127004|NCT02925728|589172640|FG001|Overall Study|Death|5|||
163127005|NCT02925728|589172639|FG000|Overall Study|Physician Decision|1|||
163127006|NCT02925728|589172640|FG001|Overall Study|Physician Decision|0|||
163127007|NCT02925728|589172639|FG000|Overall Study|Withdrawal by Subject|1|||
163127008|NCT02925728|589172640|FG001|Overall Study|Withdrawal by Subject|0|||
163127009|NCT02102399|589172643|FG000|Overall Study|Withdrawal by Subject|6|||
163127010|NCT02102399|589172644|FG001|Overall Study|Withdrawal by Subject|4|||
163127011|NCT03652675|589172645|FG000|Overall Study|Lost to Follow-up|4|||
163127012|NCT03652675|589172646|FG001|Overall Study|Lost to Follow-up|4|||
163127013|NCT00086411|589172653|FG000|Overall Study|Lost to Follow-up|11|||
163127014|NCT00086411|589172654|FG001|Overall Study|Lost to Follow-up|11|||
163127015|NCT00086411|589172655|FG002|Overall Study|Lost to Follow-up|13|||
163127016|NCT00086411|589172656|FG003|Overall Study|Lost to Follow-up|12|||
163127017|NCT00695864|589172659|FG000|Placebo|Withdrawal by Subject|1|||
163127018|NCT00695864|589172659|FG000|Placebo|Physician Decision|4|||
163127019|NCT01624090|589172665|FG000|Overall Study|DLT, taken off therapy|0|||
163127020|NCT01624090|589172666|FG001|Overall Study|DLT, taken off therapy|1|||
163127021|NCT01624090|589172667|FG002|Overall Study|DLT, taken off therapy|0|||
163127022|NCT01624090|589172668|FG003|Overall Study|DLT, taken off therapy|0|||
163127023|NCT01624090|589172665|FG000|Overall Study|Withdrew prior to treatment|0|||
163127024|NCT01624090|589172666|FG001|Overall Study|Withdrew prior to treatment|1|||
163127025|NCT01624090|589172667|FG002|Overall Study|Withdrew prior to treatment|0|||
163127026|NCT01624090|589172668|FG003|Overall Study|Withdrew prior to treatment|0|||
163127027|NCT01624090|589172665|FG000|Overall Study|Died on study|0|||
163127028|NCT01624090|589172666|FG001|Overall Study|Died on study|0|||
163127029|NCT01624090|589172667|FG002|Overall Study|Died on study|2|||
163127030|NCT01624090|589172668|FG003|Overall Study|Died on study|0|||
163127031|NCT01624090|589172665|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
163127032|NCT01624090|589172666|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
163127033|NCT01624090|589172667|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
163127034|NCT01624090|589172668|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
163127035|NCT01624090|589172665|FG000|Overall Study|Dose escalated|0|||
163127036|NCT01624090|589172666|FG001|Overall Study|Dose escalated|0|||
163127037|NCT01624090|589172667|FG002|Overall Study|Dose escalated|3|||
163127038|NCT01624090|589172668|FG003|Overall Study|Dose escalated|0|||
163127039|NCT00752726|589172669|FG000|Overall Study|Lost to Follow-up|2|||
163127040|NCT00752726|589172670|FG001|Overall Study|Lost to Follow-up|1|||
163127041|NCT00752726|589172669|FG000|Overall Study|Adverse Event|3|||
163127042|NCT00752726|589172670|FG001|Overall Study|Adverse Event|0|||
163127043|NCT00752726|589172669|FG000|Overall Study|Withdrawal by Subject|5|||
163127044|NCT00752726|589172670|FG001|Overall Study|Withdrawal by Subject|10|||
163127045|NCT00752726|589172669|FG000|Overall Study|Other Reason|1|||
163127046|NCT00752726|589172670|FG001|Overall Study|Other Reason|2|||
163127047|NCT01403116|589172671|FG000|Overall Study|Adverse Event|7|||
163127048|NCT01403116|589172672|FG001|Overall Study|Adverse Event|4|||
163127049|NCT01403116|589172671|FG000|Overall Study|Lost to Follow-up|7|||
163127050|NCT01403116|589172672|FG001|Overall Study|Lost to Follow-up|5|||
162656248|NCT05044234|587455141|FG001|Overall Study|Other, not specified|0|||
163127051|NCT01403116|589172671|FG000|Overall Study|Withdrawal by Subject|12|||
163127052|NCT01403116|589172672|FG001|Overall Study|Withdrawal by Subject|15|||
163127053|NCT01403116|589172671|FG000|Overall Study|Non-compliance of study drug|3|||
163127054|NCT01403116|589172672|FG001|Overall Study|Non-compliance of study drug|0|||
163127055|NCT01403116|589172671|FG000|Overall Study|Protocol Violation|0|||
162656249|NCT05044234|587455142|FG002|Overall Study|Other, not specified|1|||
162656250|NCT05044234|587455143|FG003|Overall Study|Other, not specified|2|||
162656251|NCT05044234|587455140|FG000|Overall Study|Delayed data entry|0|||
163127056|NCT01403116|589172672|FG001|Overall Study|Protocol Violation|1|||
163127057|NCT01403116|589172671|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
163127058|NCT01403116|589172672|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
163127059|NCT01403116|589172671|FG000|Overall Study|Hct >54%|2|||
163127060|NCT01403116|589172672|FG001|Overall Study|Hct >54%|0|||
163127061|NCT01403116|589172671|FG000|Overall Study|unable to keep appointments|0|||
163127062|NCT01403116|589172672|FG001|Overall Study|unable to keep appointments|2|||
163127063|NCT01895309|589172673|FG000|Overall Study|Adverse Event|13|||
163127064|NCT01895309|589172674|FG001|Overall Study|Adverse Event|17|||
163127065|NCT01895309|589172673|FG000|Overall Study|Protocol Violation|1|||
163127066|NCT01895309|589172674|FG001|Overall Study|Protocol Violation|0|||
163127067|NCT01895309|589172673|FG000|Overall Study|Lack of Efficacy|1|||
163127068|NCT01895309|589172674|FG001|Overall Study|Lack of Efficacy|3|||
163127069|NCT01895309|589172673|FG000|Overall Study|Lost to Follow-up|1|||
163127070|NCT01895309|589172674|FG001|Overall Study|Lost to Follow-up|3|||
163127071|NCT01895309|589172673|FG000|Overall Study|Physician Decision|15|||
163127072|NCT01895309|589172674|FG001|Overall Study|Physician Decision|10|||
163127073|NCT01895309|589172673|FG000|Overall Study|Withdrawal by Subject|9|||
163127074|NCT01895309|589172674|FG001|Overall Study|Withdrawal by Subject|18|||
163127075|NCT00042666|589172675|FG000|Overall Study|Adverse Event|2|||
163127076|NCT00042666|589172675|FG000|Overall Study|Death|4|||
163127077|NCT00042666|589172675|FG000|Overall Study|Protocol Violation|1|||
163127078|NCT00042666|589172675|FG000|Overall Study|Participant/Physician Perception|1|||
163127079|NCT00042666|589172675|FG000|Overall Study|Progressive Disease|41|||
163127080|NCT00042666|589172675|FG000|Overall Study|Other|1|||
163127081|NCT00042666|589172675|FG000|Overall Study|Other|4|||
163127082|NCT04232215|589172676|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163127083|NCT04232215|589172677|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
163127084|NCT01555125|589172678|FG000|Induction Period|Lost to Follow-up|0|||
163127085|NCT01555125|589172679|FG001|Induction Period|Lost to Follow-up|2|||
163127086|NCT01555125|589172680|FG002|Induction Period|Lost to Follow-up|0|||
163127087|NCT01555125|589172681|FG003|Induction Period|Lost to Follow-up|0|||
163127088|NCT01555125|589172682|FG004|Induction Period|Lost to Follow-up|0|||
163127089|NCT01555125|589172678|FG000|Induction Period|Adverse Event|0|||
163127090|NCT01555125|589172679|FG001|Induction Period|Adverse Event|1|||
163127091|NCT01555125|589172680|FG002|Induction Period|Adverse Event|0|||
163127092|NCT01555125|589172681|FG003|Induction Period|Adverse Event|0|||
163127093|NCT01555125|589172682|FG004|Induction Period|Adverse Event|1|||
163127094|NCT01555125|589172678|FG000|Induction Period|Subject / guardian decision|0|||
163127095|NCT01555125|589172679|FG001|Induction Period|Subject / guardian decision|0|||
163127096|NCT01555125|589172680|FG002|Induction Period|Subject / guardian decision|0|||
163127097|NCT01555125|589172681|FG003|Induction Period|Subject / guardian decision|0|||
163127098|NCT01555125|589172682|FG004|Induction Period|Subject / guardian decision|2|||
163127099|NCT01555125|589172678|FG000|Induction Period|Death|1|||
163127100|NCT01555125|589172679|FG001|Induction Period|Death|0|||
163127101|NCT01555125|589172680|FG002|Induction Period|Death|0|||
163127102|NCT01555125|589172681|FG003|Induction Period|Death|0|||
163127103|NCT01555125|589172682|FG004|Induction Period|Death|0|||
163127104|NCT01555125|589172678|FG000|Maintenance Period|Adverse Event|1|||
163127105|NCT01555125|589172679|FG001|Maintenance Period|Adverse Event|1|||
163127106|NCT01555125|589172680|FG002|Maintenance Period|Adverse Event|0|||
163127107|NCT01555125|589172681|FG003|Maintenance Period|Adverse Event|0|||
163127108|NCT01555125|589172682|FG004|Maintenance Period|Adverse Event|0|||
163127109|NCT01555125|589172678|FG000|Maintenance Period|Subject / guardian decision|1|||
163127110|NCT01555125|589172679|FG001|Maintenance Period|Subject / guardian decision|2|||
163127111|NCT01555125|589172680|FG002|Maintenance Period|Subject / guardian decision|0|||
163127112|NCT01555125|589172681|FG003|Maintenance Period|Subject / guardian decision|0|||
163127113|NCT01555125|589172682|FG004|Maintenance Period|Subject / guardian decision|0|||
163127114|NCT01555125|589172678|FG000|Maintenance Period|Lost to Follow-up|2|||
163127115|NCT01555125|589172679|FG001|Maintenance Period|Lost to Follow-up|0|||
163127116|NCT01555125|589172680|FG002|Maintenance Period|Lost to Follow-up|0|||
163127117|NCT01555125|589172681|FG003|Maintenance Period|Lost to Follow-up|1|||
163127118|NCT01555125|589172682|FG004|Maintenance Period|Lost to Follow-up|0|||
163127119|NCT01555125|589172678|FG000|Maintenance Period|Lack of Efficacy|6|||
163127120|NCT01555125|589172679|FG001|Maintenance Period|Lack of Efficacy|1|||
163127121|NCT01555125|589172680|FG002|Maintenance Period|Lack of Efficacy|3|||
163127122|NCT01555125|589172681|FG003|Maintenance Period|Lack of Efficacy|0|||
163127123|NCT01555125|589172682|FG004|Maintenance Period|Lack of Efficacy|0|||
163127124|NCT01555125|589172678|FG000|Maintenance Period|Physician Decision|0|||
163127125|NCT01555125|589172679|FG001|Maintenance Period|Physician Decision|0|||
163127126|NCT01555125|589172680|FG002|Maintenance Period|Physician Decision|1|||
163127127|NCT01555125|589172681|FG003|Maintenance Period|Physician Decision|0|||
163127128|NCT01555125|589172682|FG004|Maintenance Period|Physician Decision|0|||
163127129|NCT01555125|589172678|FG000|Maintenance Period|Death|0|||
163127130|NCT01555125|589172679|FG001|Maintenance Period|Death|0|||
163127131|NCT01555125|589172680|FG002|Maintenance Period|Death|0|||
163127132|NCT01555125|589172681|FG003|Maintenance Period|Death|1|||
163127133|NCT01555125|589172682|FG004|Maintenance Period|Death|0|||
163127134|NCT01555125|589172678|FG000|Extension|Adverse Event|1|||
163127135|NCT01555125|589172679|FG001|Extension|Adverse Event|2|||
162719618|NCT03020745|587680527|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162719619|NCT03020745|587680518|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163127136|NCT01555125|589172680|FG002|Extension|Adverse Event|1|||
163127137|NCT01555125|589172681|FG003|Extension|Adverse Event|1|||
163127138|NCT01555125|589172682|FG004|Extension|Adverse Event|0|||
162656252|NCT05044234|587455141|FG001|Overall Study|Delayed data entry|0|||
162656253|NCT05044234|587455142|FG002|Overall Study|Delayed data entry|0|||
162656254|NCT05044234|587455143|FG003|Overall Study|Delayed data entry|1|||
162656255|NCT00279708|587455149|FG000|Overall Study|Withdrawal by Subject|2|||
162656256|NCT00279708|587455150|FG001|Overall Study|Withdrawal by Subject|3|||
162656257|NCT00279708|587455149|FG000|Overall Study|Adverse Event|1|||
162656258|NCT00279708|587455150|FG001|Overall Study|Adverse Event|1|||
162656259|NCT02624284|587455151|FG000|Overall Study|Withdrawal by Subject|3|||
162656260|NCT02624284|587455152|FG001|Overall Study|Withdrawal by Subject|6|||
163127139|NCT01555125|589172678|FG000|Extension|Protocol deviation|1|||
163127140|NCT01555125|589172679|FG001|Extension|Protocol deviation|0|||
163127141|NCT01555125|589172680|FG002|Extension|Protocol deviation|0|||
163127142|NCT01555125|589172681|FG003|Extension|Protocol deviation|0|||
163127143|NCT01555125|589172682|FG004|Extension|Protocol deviation|0|||
163127144|NCT01555125|589172678|FG000|Extension|Lack of Efficacy|7|||
163127145|NCT01555125|589172679|FG001|Extension|Lack of Efficacy|6|||
163127146|NCT01555125|589172680|FG002|Extension|Lack of Efficacy|3|||
163127147|NCT01555125|589172681|FG003|Extension|Lack of Efficacy|0|||
163127148|NCT01555125|589172682|FG004|Extension|Lack of Efficacy|0|||
163127149|NCT01555125|589172678|FG000|Extension|Lost to Follow-up|2|||
163127150|NCT01555125|589172679|FG001|Extension|Lost to Follow-up|1|||
163127151|NCT01555125|589172680|FG002|Extension|Lost to Follow-up|2|||
163127152|NCT01555125|589172681|FG003|Extension|Lost to Follow-up|0|||
163127153|NCT01555125|589172682|FG004|Extension|Lost to Follow-up|0|||
163127154|NCT01555125|589172678|FG000|Extension|Study terminated by sponsor|32|||
163127155|NCT01555125|589172679|FG001|Extension|Study terminated by sponsor|33|||
163127156|NCT01555125|589172680|FG002|Extension|Study terminated by sponsor|16|||
163127157|NCT01555125|589172681|FG003|Extension|Study terminated by sponsor|20|||
163127158|NCT01555125|589172682|FG004|Extension|Study terminated by sponsor|0|||
163127159|NCT01555125|589172678|FG000|Extension|Subject/guardian decision|1|||
163127160|NCT01555125|589172679|FG001|Extension|Subject/guardian decision|9|||
163127161|NCT01555125|589172680|FG002|Extension|Subject/guardian decision|1|||
163127162|NCT01555125|589172681|FG003|Extension|Subject/guardian decision|0|||
163127163|NCT01555125|589172682|FG004|Extension|Subject/guardian decision|0|||
163127164|NCT01555125|589172678|FG000|Extension|Technical Problems|1|||
163127165|NCT01555125|589172679|FG001|Extension|Technical Problems|0|||
163127166|NCT01555125|589172680|FG002|Extension|Technical Problems|0|||
163127167|NCT01555125|589172681|FG003|Extension|Technical Problems|1|||
163127168|NCT01555125|589172682|FG004|Extension|Technical Problems|0|||
163127169|NCT01555125|589172678|FG000|Follow-Up Period|Lost to Follow-up|1|||
163127170|NCT01555125|589172679|FG001|Follow-Up Period|Lost to Follow-up|0|||
163127171|NCT01555125|589172680|FG002|Follow-Up Period|Lost to Follow-up|0|||
163127172|NCT01555125|589172681|FG003|Follow-Up Period|Lost to Follow-up|0|||
163127173|NCT01555125|589172682|FG004|Follow-Up Period|Lost to Follow-up|0|||
163127174|NCT01555125|589172678|FG000|Follow-Up Period|Subject / guardian decision|3|||
163127175|NCT01555125|589172679|FG001|Follow-Up Period|Subject / guardian decision|1|||
163127176|NCT01555125|589172680|FG002|Follow-Up Period|Subject / guardian decision|1|||
163127177|NCT01555125|589172681|FG003|Follow-Up Period|Subject / guardian decision|1|||
163127178|NCT01555125|589172682|FG004|Follow-Up Period|Subject / guardian decision|0|||
163127179|NCT04268745|589172685|FG000|Overall Study|Lost to Follow-up|2|||
163127180|NCT04268745|589172686|FG001|Overall Study|Lost to Follow-up|3|||
163127181|NCT04268745|589172685|FG000|Overall Study|Withdrawal by Subject|4|||
163127182|NCT04268745|589172686|FG001|Overall Study|Withdrawal by Subject|2|||
163127183|NCT04268745|589172685|FG000|Overall Study|Death in the family|1|||
163127184|NCT04268745|589172686|FG001|Overall Study|Death in the family|0|||
163127185|NCT01887353|589172688|FG000|Overall Study|Study stopped early|4|||
163127186|NCT01887353|589172689|FG001|Overall Study|Study stopped early|3|||
163127187|NCT05327361|589172692|FG000|Overall Study|Lost to Follow-up|4|||
163127188|NCT01078168|589172696|FG000|Overall Study|Physician Decision|0|||
163127189|NCT01078168|589172697|FG001|Overall Study|Physician Decision|1|||
163127190|NCT02467582|589174132|FG000|Allocation|Withdrawal by Subject|1|||
162656261|NCT02624284|587455153|FG002|Overall Study|Withdrawal by Subject|3|||
163127191|NCT02467582|589174133|FG001|Allocation|Withdrawal by Subject|0|||
163127192|NCT02467582|589174132|FG000|Follow-up|Death|5|||
162656262|NCT02624284|587455151|FG000|Overall Study|Protocol Violation|9|||
162656263|NCT02624284|587455152|FG001|Overall Study|Protocol Violation|10|||
162656264|NCT02624284|587455153|FG002|Overall Study|Protocol Violation|7|||
162656265|NCT02624284|587455151|FG000|Overall Study|Revealed exclusionary condition|2|||
163127193|NCT02467582|589174133|FG001|Follow-up|Death|4|||
163127194|NCT02467582|589174132|FG000|Follow-up|Lost to Follow-up|6|||
163127195|NCT02467582|589174133|FG001|Follow-up|Lost to Follow-up|5|||
163127196|NCT00742417|589174136|FG000|Randomized|Withdrawal by legal representative|0|||
163127197|NCT00742417|589174137|FG001|Randomized|Withdrawal by legal representative|1|||
163127198|NCT00742417|589174136|FG000|Randomized|Withdrawal by Subject|1|||
163127199|NCT00742417|589174137|FG001|Randomized|Withdrawal by Subject|0|||
163127200|NCT00742417|589174136|FG000|Randomized|Physician Decision|1|||
163127201|NCT00742417|589174137|FG001|Randomized|Physician Decision|0|||
163127202|NCT00742417|589174136|FG000|Intensive Period|Withdrawal by Subject|1|||
162656266|NCT02624284|587455152|FG001|Overall Study|Revealed exclusionary condition|2|||
163127203|NCT00742417|589174137|FG001|Intensive Period|Withdrawal by Subject|1|||
163127204|NCT00742417|589174136|FG000|Intensive Period|Adverse Event|2|||
163127205|NCT00742417|589174137|FG001|Intensive Period|Adverse Event|0|||
163127206|NCT00965575|589174142|FG000|Overall Study|subject unwillingness to swallow study c|1|||
163127207|NCT00965575|589174143|FG001|Overall Study|subject unwillingness to swallow study c|0|||
163127208|NCT01041287|589174146|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
163127209|NCT01041287|589174147|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
163127210|NCT01041287|589174146|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
163127211|NCT01041287|589174147|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
163127212|NCT02397057|589174148|FG000|Overall Study|Withdrawal by Subject|6|||
163127213|NCT02397057|589174149|FG001|Overall Study|Withdrawal by Subject|7|||
163127214|NCT02397057|589174148|FG000|Overall Study|Lost to Follow-up|4|||
163127215|NCT02397057|589174149|FG001|Overall Study|Lost to Follow-up|3|||
163127216|NCT02397057|589174148|FG000|Overall Study|Death|1|||
163127217|NCT02397057|589174149|FG001|Overall Study|Death|0|||
163127218|NCT02397057|589174148|FG000|Overall Study|Adverse Event|0|||
163127219|NCT02397057|589174149|FG001|Overall Study|Adverse Event|1|||
163127220|NCT02397057|589174148|FG000|Overall Study|Physician Decision|0|||
163127221|NCT02397057|589174149|FG001|Overall Study|Physician Decision|1|||
163127222|NCT02397057|589174148|FG000|Overall Study|Subject did not receive study drug|0|||
163127223|NCT02397057|589174149|FG001|Overall Study|Subject did not receive study drug|1|||
163127224|NCT00704288|589174151|FG000|Overall Treatment Period|Adverse Event|11|||
163127225|NCT00704288|589174152|FG001|Overall Treatment Period|Adverse Event|8|||
163127226|NCT00704288|589174153|FG002|Overall Treatment Period|Adverse Event|22|||
163127227|NCT00704288|589174151|FG000|Overall Treatment Period|Death|0|||
163127228|NCT00704288|589174152|FG001|Overall Treatment Period|Death|0|||
163127229|NCT00704288|589174153|FG002|Overall Treatment Period|Death|1|||
163127230|NCT00704288|589174151|FG000|Overall Treatment Period|Physician Decision|0|||
163127231|NCT00704288|589174152|FG001|Overall Treatment Period|Physician Decision|2|||
163127232|NCT00704288|589174153|FG002|Overall Treatment Period|Physician Decision|0|||
163127233|NCT00704288|589174151|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
163127234|NCT00704288|589174152|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
163127235|NCT00704288|589174153|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
163127236|NCT00704288|589174151|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
163127237|NCT00704288|589174152|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
163127238|NCT00704288|589174153|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
163127239|NCT00704288|589174151|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
163127240|NCT00704288|589174152|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
163127241|NCT00704288|589174153|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
163127242|NCT00704288|589174151|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
163127243|NCT00704288|589174152|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
163127244|NCT00704288|589174153|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
163127245|NCT00704288|589174151|FG000|Overall Treatment Period|Roll-over to another study|1|||
163127246|NCT00704288|589174152|FG001|Overall Treatment Period|Roll-over to another study|0|||
163127247|NCT00704288|589174153|FG002|Overall Treatment Period|Roll-over to another study|4|||
163127248|NCT00704288|589174151|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
163127249|NCT00704288|589174152|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
163127250|NCT00704288|589174153|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
163127251|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Death|41|||
163127252|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Death|50|||
163127253|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Death|93|||
163127254|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
163127255|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
163127256|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
162656267|NCT02624284|587455153|FG002|Overall Study|Revealed exclusionary condition|0|||
162656268|NCT02624284|587455151|FG000|Overall Study|Adverse Event|0|||
163127257|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
163127258|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
163127259|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
162656269|NCT02624284|587455152|FG001|Overall Study|Adverse Event|0|||
163127260|NCT00704288|589174151|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
163127261|NCT00704288|589174152|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
163127262|NCT00704288|589174153|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
163127263|NCT01055314|589174154|FG000|Overall Study|Adverse Event|7|||
163127264|NCT01055314|589174155|FG001|Overall Study|Adverse Event|4|||
162656270|NCT02624284|587455153|FG002|Overall Study|Adverse Event|1|||
162656271|NCT02940691|587455154|FG000|Overall Study|Lost to Follow-up|5|||
162656272|NCT02940691|587455154|FG000|Overall Study|Incarceration|1|||
162656273|NCT02506816|587455155|FG000|Overall Study|Adverse Event|3|||
162656274|NCT02477020|587455162|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
162656275|NCT02477020|587455163|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
162656276|NCT02477020|587455162|FG000|Overall Study|Voluntary Withdrawal|7|||
162719620|NCT03020745|587680519|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719621|NCT03020745|587680520|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719622|NCT03020745|587680521|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719623|NCT03020745|587680522|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719624|NCT03020745|587680523|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719625|NCT03020745|587680524|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719626|NCT03020745|587680525|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719627|NCT03020745|587680526|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
162719628|NCT03020745|587680527|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162719629|NCT03622580|587680530|FG000|Overall Study|Death|16|||
162719630|NCT03622580|587680531|FG001|Overall Study|Death|21|||
162719631|NCT03622580|587680532|FG002|Overall Study|Death|13|||
162719632|NCT03622580|587680530|FG000|Overall Study|Adverse Event|6|||
162719633|NCT03622580|587680531|FG001|Overall Study|Adverse Event|6|||
162719634|NCT03622580|587680532|FG002|Overall Study|Adverse Event|5|||
162719635|NCT03622580|587680530|FG000|Overall Study|Withdrawal by Subject|12|||
162719636|NCT03622580|587680531|FG001|Overall Study|Withdrawal by Subject|7|||
162719637|NCT03622580|587680532|FG002|Overall Study|Withdrawal by Subject|19|||
162719638|NCT03622580|587680530|FG000|Overall Study|Lost to Follow-up|12|||
162719639|NCT03622580|587680531|FG001|Overall Study|Lost to Follow-up|9|||
162719640|NCT03622580|587680532|FG002|Overall Study|Lost to Follow-up|9|||
162719641|NCT03622580|587680530|FG000|Overall Study|Protocol Violation|1|||
162719642|NCT03622580|587680531|FG001|Overall Study|Protocol Violation|0|||
162719643|NCT03622580|587680532|FG002|Overall Study|Protocol Violation|1|||
162719644|NCT03622580|587680530|FG000|Overall Study|Physician Decision|3|||
162719645|NCT03622580|587680531|FG001|Overall Study|Physician Decision|0|||
162719646|NCT03622580|587680532|FG002|Overall Study|Physician Decision|1|||
162719647|NCT03622580|587680530|FG000|Overall Study|Pregnancy|0|||
162719648|NCT03622580|587680531|FG001|Overall Study|Pregnancy|1|||
162719649|NCT03622580|587680532|FG002|Overall Study|Pregnancy|0|||
162719650|NCT03622580|587680530|FG000|Overall Study|Lack of Efficacy|0|||
162719651|NCT03622580|587680531|FG001|Overall Study|Lack of Efficacy|0|||
162719652|NCT03622580|587680532|FG002|Overall Study|Lack of Efficacy|1|||
162719653|NCT03622580|587680530|FG000|Overall Study|Other|2|||
162719654|NCT03622580|587680531|FG001|Overall Study|Other|0|||
162719655|NCT03622580|587680532|FG002|Overall Study|Other|3|||
162719656|NCT03959241|587680535|FG000|Overall Study|Withdrawal by Subject|7|||
162719657|NCT03959241|587680536|FG001|Overall Study|Withdrawal by Subject|8|||
162719658|NCT03959241|587680535|FG000|Overall Study|Lost to Follow-up|1|||
162719659|NCT03959241|587680536|FG001|Overall Study|Lost to Follow-up|0|||
162719660|NCT03959241|587680535|FG000|Overall Study|Move to Hospice Care|1|||
162719661|NCT03959241|587680536|FG001|Overall Study|Move to Hospice Care|0|||
162719662|NCT03959241|587680535|FG000|Overall Study|Screen Failure|1|||
162719663|NCT03959241|587680536|FG001|Overall Study|Screen Failure|0|||
162719664|NCT03959241|587680535|FG000|Overall Study|Disease Relapse|0|||
162719665|NCT03959241|587680536|FG001|Overall Study|Disease Relapse|1|||
162719666|NCT03959241|587680535|FG000|Overall Study|Off Study|1|||
162719667|NCT03959241|587680536|FG001|Overall Study|Off Study|0|||
162719668|NCT02194933|587680537|FG000|Overall Study|Lost to Follow-up|1|||
162719669|NCT02194933|587680538|FG001|Overall Study|Lost to Follow-up|2|||
162719670|NCT02194933|587680537|FG000|Overall Study|Participant met withdrawal criteria|1|||
162719671|NCT02194933|587680538|FG001|Overall Study|Participant met withdrawal criteria|3|||
162719672|NCT02194933|587680537|FG000|Overall Study|Withdrawal by Subject|0|||
162719673|NCT02194933|587680538|FG001|Overall Study|Withdrawal by Subject|2|||
162719674|NCT02194933|587680537|FG000|Overall Study|Lack of Efficacy|1|||
162719675|NCT02194933|587680538|FG001|Overall Study|Lack of Efficacy|2|||
162719676|NCT00988637|587680539|FG000|Overall Study|Lost to Follow-up|2|||
163127265|NCT01055314|589174154|FG000|Overall Study|Death|2|||
163127266|NCT01055314|589174155|FG001|Overall Study|Death|1|||
162656277|NCT02477020|587455163|FG001|Overall Study|Voluntary Withdrawal|16|||
162656278|NCT02477020|587455162|FG000|Overall Study|Reason not Specified|3|||
162719677|NCT00988637|587680540|FG001|Overall Study|Lost to Follow-up|1|||
162719678|NCT00988637|587680539|FG000|Overall Study|Withdrawal by Subject|1|||
162719679|NCT00988637|587680540|FG001|Overall Study|Withdrawal by Subject|1|||
162719680|NCT00988637|587680539|FG000|Overall Study|non-compliance with study drug|0|||
163127267|NCT01055314|589174154|FG000|Overall Study|Lack of Efficacy|11|||
162656279|NCT02477020|587455163|FG001|Overall Study|Reason not Specified|1|||
162719681|NCT00988637|587680540|FG001|Overall Study|non-compliance with study drug|1|||
162719682|NCT02807493|587680542|FG000|Overall Study|Adverse Event|5|||
162719683|NCT02807493|587680543|FG001|Overall Study|Adverse Event|2|||
162719684|NCT02807493|587680542|FG000|Overall Study|Lost to Follow-up|6|||
163127268|NCT01055314|589174155|FG001|Overall Study|Lack of Efficacy|19|||
163127269|NCT01055314|589174154|FG000|Overall Study|Physician Decision|10|||
163127270|NCT01055314|589174155|FG001|Overall Study|Physician Decision|5|||
163127271|NCT01055314|589174154|FG000|Overall Study|Withdrawal by Subject|1|||
163127272|NCT01055314|589174155|FG001|Overall Study|Withdrawal by Subject|0|||
163127273|NCT01055314|589174154|FG000|Overall Study|Ineligible|3|||
163127274|NCT01055314|589174155|FG001|Overall Study|Ineligible|5|||
163127275|NCT01055314|589174154|FG000|Overall Study|Refusal of further protocol therapy|10|||
163127276|NCT01055314|589174155|FG001|Overall Study|Refusal of further protocol therapy|4|||
163127277|NCT01055314|589174154|FG000|Overall Study|No treatment|1|||
163127278|NCT01055314|589174155|FG001|Overall Study|No treatment|0|||
163127279|NCT04395690|589174156|FG000|Overall Study|Lost to Follow-up|1|||
163127280|NCT04395690|589174157|FG001|Overall Study|Lost to Follow-up|1|||
163127281|NCT03927144|589174158|FG000|Core Phase|Adverse Event|9|||
163127282|NCT03927144|589174159|FG001|Core Phase|Adverse Event|5|||
163127283|NCT03927144|589174158|FG000|Core Phase|Lost to Follow-up|3|||
163127284|NCT03927144|589174159|FG001|Core Phase|Lost to Follow-up|2|||
163127285|NCT03927144|589174158|FG000|Core Phase|New Therapy for Study Indication|0|||
163127286|NCT03927144|589174159|FG001|Core Phase|New Therapy for Study Indication|1|||
163127287|NCT03927144|589174158|FG000|Core Phase|No Longer Clinically Benefiting|4|||
163127288|NCT03927144|589174159|FG001|Core Phase|No Longer Clinically Benefiting|4|||
163127289|NCT03927144|589174158|FG000|Core Phase|Physician Decision|2|||
163127290|NCT03927144|589174159|FG001|Core Phase|Physician Decision|8|||
163127291|NCT03927144|589174158|FG000|Core Phase|Protocol Violation|2|||
163127292|NCT03927144|589174159|FG001|Core Phase|Protocol Violation|2|||
163127293|NCT03927144|589174158|FG000|Core Phase|Withdrawal by Subject|16|||
163127294|NCT03927144|589174159|FG001|Core Phase|Withdrawal by Subject|40|||
163127295|NCT03927144|589174158|FG000|Extension Phase|Adverse Event|2|||
163127296|NCT03927144|589174159|FG001|Extension Phase|Adverse Event|1|||
163127297|NCT03927144|589174158|FG000|Extension Phase|No longer clinically benefiting|4|||
163127298|NCT03927144|589174159|FG001|Extension Phase|No longer clinically benefiting|5|||
163127299|NCT03927144|589174158|FG000|Extension Phase|Pregnancy|1|||
163127300|NCT03927144|589174159|FG001|Extension Phase|Pregnancy|0|||
163127301|NCT03927144|589174158|FG000|Extension Phase|Protocol Violation|0|||
163127302|NCT03927144|589174159|FG001|Extension Phase|Protocol Violation|1|||
163127303|NCT03927144|589174158|FG000|Extension Phase|Withdrawal by Subject|8|||
163127304|NCT03927144|589174159|FG001|Extension Phase|Withdrawal by Subject|3|||
163127305|NCT03909152|589174160|FG000|Overall Study|Adverse Event|14|||
163127306|NCT03909152|589174161|FG001|Overall Study|Adverse Event|5|||
163127307|NCT03909152|589174162|FG002|Overall Study|Adverse Event|1|||
163127308|NCT03909152|589174163|FG003|Overall Study|Adverse Event|14|||
163127309|NCT00615030|589174166|FG000|Period I|Administrative problem|0|||
163127310|NCT00615030|589174167|FG001|Period I|Administrative problem|0|||
163127311|NCT00615030|589174168|FG002|Period I|Administrative problem|0|||
163127312|NCT00615030|589174169|FG003|Period I|Administrative problem|0|||
163127313|NCT00615030|589174170|FG004|Period I|Administrative problem|1|||
163127314|NCT00615030|589174171|FG005|Period I|Administrative problem|0|||
163127315|NCT00615030|589174172|FG006|Period I|Administrative problem|0|||
163127316|NCT00615030|589174173|FG007|Period I|Administrative problem|0|||
163127317|NCT00615030|589174174|FG008|Period I|Administrative problem|0|||
163127318|NCT00615030|589174175|FG009|Period I|Administrative problem|0|||
163127319|NCT00615030|589174176|FG010|Period I|Administrative problem|0|||
163127320|NCT00615030|589174177|FG011|Period I|Administrative problem|0|||
163127321|NCT00615030|589174166|FG000|Period I|Protocol deviation|1|||
163127322|NCT00615030|589174167|FG001|Period I|Protocol deviation|0|||
163127323|NCT00615030|589174168|FG002|Period I|Protocol deviation|0|||
163127324|NCT00615030|589174169|FG003|Period I|Protocol deviation|0|||
163127325|NCT00615030|589174170|FG004|Period I|Protocol deviation|0|||
163127326|NCT00615030|589174171|FG005|Period I|Protocol deviation|0|||
163127327|NCT00615030|589174172|FG006|Period I|Protocol deviation|0|||
163127328|NCT00615030|589174173|FG007|Period I|Protocol deviation|0|||
163127329|NCT00615030|589174174|FG008|Period I|Protocol deviation|0|||
163127330|NCT00615030|589174175|FG009|Period I|Protocol deviation|0|||
163127331|NCT00615030|589174176|FG010|Period I|Protocol deviation|0|||
163127332|NCT00615030|589174177|FG011|Period I|Protocol deviation|0|||
163127333|NCT00615030|589174166|FG000|Period I|Subject withdrew consent|0|||
163127334|NCT00615030|589174167|FG001|Period I|Subject withdrew consent|0|||
163127335|NCT00615030|589174168|FG002|Period I|Subject withdrew consent|0|||
163127336|NCT00615030|589174169|FG003|Period I|Subject withdrew consent|0|||
163127337|NCT00615030|589174170|FG004|Period I|Subject withdrew consent|0|||
163127338|NCT00615030|589174171|FG005|Period I|Subject withdrew consent|0|||
163127339|NCT00615030|589174172|FG006|Period I|Subject withdrew consent|0|||
163127340|NCT00615030|589174173|FG007|Period I|Subject withdrew consent|0|||
163127341|NCT00615030|589174174|FG008|Period I|Subject withdrew consent|1|||
163127342|NCT00615030|589174175|FG009|Period I|Subject withdrew consent|0|||
163127343|NCT00615030|589174176|FG010|Period I|Subject withdrew consent|1|||
163127344|NCT00615030|589174177|FG011|Period I|Subject withdrew consent|1|||
163127345|NCT00615030|589174166|FG000|Period I|Abnormal laboratory value(s)|0|||
163127346|NCT00615030|589174167|FG001|Period I|Abnormal laboratory value(s)|0|||
163127347|NCT00615030|589174168|FG002|Period I|Abnormal laboratory value(s)|0|||
162656280|NCT02477020|587455162|FG000|Overall Study|Lack of Efficacy|14|||
162656281|NCT02477020|587455163|FG001|Overall Study|Lack of Efficacy|5|||
162656282|NCT03852316|587455164|FG000|Overall Study|Protocol Violation|1|||
162656283|NCT03852316|587455164|FG000|Overall Study|Withdrawal by Subject|2|||
162656284|NCT03852316|587455164|FG000|Overall Study|Enrolled but Device not Utilized|1|||
162656285|NCT01049919|587455165|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
162656286|NCT01049919|587455166|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
162656287|NCT01049919|587455165|FG000|Overall Study|Withdrawal by Subject|5|||
162656288|NCT01049919|587455166|FG001|Overall Study|Withdrawal by Subject|0|||
162656289|NCT01049919|587455165|FG000|Overall Study|Lost to Follow-up|6|||
162656290|NCT01049919|587455166|FG001|Overall Study|Lost to Follow-up|1|||
162656291|NCT01049919|587455165|FG000|Overall Study|Physician Decision|2|||
162656292|NCT01049919|587455166|FG001|Overall Study|Physician Decision|0|||
162656293|NCT01049919|587455165|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
162656294|NCT01049919|587455166|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
162656295|NCT01049919|587455165|FG000|Overall Study|Early study termination by sponsor.|2|||
162656296|NCT01049919|587455166|FG001|Overall Study|Early study termination by sponsor.|0|||
162656297|NCT04354831|587455167|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
162656298|NCT04354831|587455168|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
162656299|NCT00812929|587455169|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
162656300|NCT00812929|587455170|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
162656301|NCT00812929|587455171|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
162656302|NCT00812929|587455172|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
162656303|NCT00812929|587455173|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
162656304|NCT00812929|587455174|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
162656305|NCT00812929|587455175|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
162656306|NCT00812929|587455176|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
162656307|NCT00812929|587455177|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
162656308|NCT00812929|587455178|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
162656309|NCT00812929|587455169|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
162656310|NCT00812929|587455170|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
162656311|NCT00812929|587455171|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
162656312|NCT00812929|587455172|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
162656313|NCT00812929|587455173|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
162656314|NCT00812929|587455174|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
162656315|NCT00812929|587455175|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
162656316|NCT00812929|587455176|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
162656317|NCT00812929|587455177|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
162656318|NCT00812929|587455178|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
162656319|NCT00812929|587455169|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
162656320|NCT00812929|587455170|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
162656321|NCT00812929|587455171|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
162656322|NCT00812929|587455172|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
162656323|NCT00812929|587455173|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
162656324|NCT00812929|587455174|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
162656325|NCT00812929|587455175|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
162656326|NCT00812929|587455176|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
162656327|NCT00812929|587455177|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
162656328|NCT00812929|587455178|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
162656329|NCT02975934|587455179|FG000|Treatment Phase|Never initiated study drug|0|||
162656330|NCT02975934|587455180|FG001|Treatment Phase|Never initiated study drug|5|||
162656331|NCT02975934|587455181|FG002|Treatment Phase|Never initiated study drug|0|||
162656332|NCT02075840|587455183|FG000|Overall Study|Withdrawal by Subject|13|||
162656333|NCT02075840|587455184|FG001|Overall Study|Withdrawal by Subject|22|||
162656334|NCT02075840|587455183|FG000|Overall Study|Reason not specified|1|||
162656335|NCT02075840|587455184|FG001|Overall Study|Reason not specified|0|||
162656336|NCT02075840|587455183|FG000|Overall Study|Adverse Event|0|||
163127348|NCT00615030|589174169|FG003|Period I|Abnormal laboratory value(s)|0|||
163127349|NCT00615030|589174170|FG004|Period I|Abnormal laboratory value(s)|0|||
162656337|NCT02075840|587455184|FG001|Overall Study|Adverse Event|2|||
162656338|NCT02075840|587455183|FG000|Overall Study|Death|35|||
162656339|NCT02075840|587455184|FG001|Overall Study|Death|40|||
162656340|NCT02075840|587455183|FG000|Overall Study|Lost to Follow-up|3|||
162656341|NCT02075840|587455184|FG001|Overall Study|Lost to Follow-up|2|||
162656342|NCT02075840|587455183|FG000|Overall Study|Physician Decision|1|||
162656343|NCT02075840|587455184|FG001|Overall Study|Physician Decision|3|||
162656344|NCT02075840|587455183|FG000|Overall Study|Ongoing at CCOD|99|||
162656345|NCT02075840|587455184|FG001|Overall Study|Ongoing at CCOD|82|||
162656346|NCT03491150|587455187|FG000|Overall Study|Adverse Event|1|||
162656347|NCT03491150|587455188|FG001|Overall Study|Adverse Event|0|||
162656348|NCT03491150|587455187|FG000|Overall Study|Study Terminated by Sponsor|74|||
162656349|NCT03491150|587455188|FG001|Overall Study|Study Terminated by Sponsor|70|||
162656350|NCT03491150|587455187|FG000|Overall Study|Other|0|||
162656351|NCT03491150|587455188|FG001|Overall Study|Other|1|||
162656352|NCT03491150|587455187|FG000|Overall Study|Withdrawal by Subject|1|||
162656353|NCT03491150|587455188|FG001|Overall Study|Withdrawal by Subject|2|||
162656354|NCT02644967|587455191|FG000|Overall Study|Death|26|||
162656355|NCT02644967|587455191|FG000|Overall Study|Physician Decision|1|||
162656356|NCT02644967|587455191|FG000|Overall Study|Withdrawal by Subject|2|||
162656357|NCT02644967|587455191|FG000|Overall Study|Protocol Violation|1|||
162656358|NCT02644967|587455191|FG000|Overall Study|Progressive Disease|1|||
162656359|NCT02644967|587455191|FG000|Overall Study|Study Terminated by Sponsor|4|||
162656360|NCT02287896|587455192|FG000|Second Injection Visit|Withdrawal by Subject|0|||
162656361|NCT02287896|587455193|FG001|Second Injection Visit|Withdrawal by Subject|1|||
162656362|NCT05179421|587455194|FG000|First Infusion Day|Adverse Event|1|||
162656363|NCT05179421|587455195|FG001|First Infusion Day|Adverse Event|0|||
162656364|NCT01077960|587455196|FG000|Overall Study|Adverse Event|6|||
162656365|NCT01077960|587455196|FG000|Overall Study|Protocol Violation|3|||
162656366|NCT01077960|587455196|FG000|Overall Study|Lost to Follow-up|5|||
163127350|NCT00615030|589174171|FG005|Period I|Abnormal laboratory value(s)|1|||
163127351|NCT00615030|589174172|FG006|Period I|Abnormal laboratory value(s)|0|||
163127352|NCT00615030|589174173|FG007|Period I|Abnormal laboratory value(s)|0|||
163127353|NCT00615030|589174174|FG008|Period I|Abnormal laboratory value(s)|0|||
163127354|NCT00615030|589174175|FG009|Period I|Abnormal laboratory value(s)|0|||
163127355|NCT00615030|589174176|FG010|Period I|Abnormal laboratory value(s)|0|||
163127356|NCT00615030|589174177|FG011|Period I|Abnormal laboratory value(s)|0|||
163127357|NCT00615030|589174166|FG000|Period II|Adverse Event|0|||
163127358|NCT00615030|589174167|FG001|Period II|Adverse Event|0|||
163127359|NCT00615030|589174168|FG002|Period II|Adverse Event|1|||
163127360|NCT00615030|589174169|FG003|Period II|Adverse Event|0|||
163127361|NCT00615030|589174170|FG004|Period II|Adverse Event|0|||
163127362|NCT00615030|589174171|FG005|Period II|Adverse Event|0|||
163127363|NCT00615030|589174172|FG006|Period II|Adverse Event|0|||
163127364|NCT00615030|589174173|FG007|Period II|Adverse Event|0|||
163127365|NCT00615030|589174174|FG008|Period II|Adverse Event|1|||
163127366|NCT00615030|589174175|FG009|Period II|Adverse Event|0|||
163127367|NCT00615030|589174176|FG010|Period II|Adverse Event|0|||
163127368|NCT00615030|589174177|FG011|Period II|Adverse Event|0|||
163127369|NCT00615030|589174166|FG000|Period II|Subject withdrew consent|0|||
163127370|NCT00615030|589174167|FG001|Period II|Subject withdrew consent|0|||
163127371|NCT00615030|589174168|FG002|Period II|Subject withdrew consent|0|||
163127372|NCT00615030|589174169|FG003|Period II|Subject withdrew consent|1|||
163127373|NCT00615030|589174170|FG004|Period II|Subject withdrew consent|0|||
163127374|NCT00615030|589174171|FG005|Period II|Subject withdrew consent|0|||
163127375|NCT00615030|589174172|FG006|Period II|Subject withdrew consent|1|||
163127376|NCT00615030|589174173|FG007|Period II|Subject withdrew consent|0|||
163127377|NCT00615030|589174174|FG008|Period II|Subject withdrew consent|0|||
163127378|NCT00615030|589174175|FG009|Period II|Subject withdrew consent|0|||
163127379|NCT00615030|589174176|FG010|Period II|Subject withdrew consent|0|||
163127380|NCT00615030|589174177|FG011|Period II|Subject withdrew consent|0|||
163127381|NCT00615030|589174166|FG000|Period III|Administrative problems|1|||
163127382|NCT00615030|589174167|FG001|Period III|Administrative problems|0|||
163127383|NCT00615030|589174168|FG002|Period III|Administrative problems|0|||
163127384|NCT00615030|589174169|FG003|Period III|Administrative problems|1|||
163127385|NCT00615030|589174170|FG004|Period III|Administrative problems|0|||
163127386|NCT00615030|589174171|FG005|Period III|Administrative problems|0|||
163127387|NCT00615030|589174172|FG006|Period III|Administrative problems|0|||
163127388|NCT00615030|589174173|FG007|Period III|Administrative problems|0|||
163127389|NCT00615030|589174174|FG008|Period III|Administrative problems|0|||
163127390|NCT00615030|589174175|FG009|Period III|Administrative problems|0|||
163127391|NCT00615030|589174176|FG010|Period III|Administrative problems|0|||
163127392|NCT00615030|589174177|FG011|Period III|Administrative problems|0|||
163127393|NCT03002311|589174190|FG000|Overall Study|Lost to Follow-up|13|||
163127394|NCT03002311|589174191|FG001|Overall Study|Lost to Follow-up|26|||
162656367|NCT01077960|587455196|FG000|Overall Study|Subject decision|1|||
162656368|NCT01077960|587455196|FG000|Overall Study|Reason unspecified|1|||
162656369|NCT03837899|587455200|FG000|Overall Study|Death|6|||
162656370|NCT03837899|587455201|FG001|Overall Study|Death|8|||
162656371|NCT03837899|587455202|FG002|Overall Study|Death|3|||
162656372|NCT03837899|587455203|FG003|Overall Study|Death|7|||
162656373|NCT03837899|587455204|FG004|Overall Study|Death|8|||
162656374|NCT03837899|587455205|FG005|Overall Study|Death|7|||
163127395|NCT03002311|589174190|FG000|Overall Study|Referral provider called to schedule app|3|||
163127396|NCT03002311|589174191|FG001|Overall Study|Referral provider called to schedule app|3|||
163127397|NCT03002311|589174190|FG000|Overall Study|Physician Decision|3|||
163127398|NCT03002311|589174191|FG001|Overall Study|Physician Decision|1|||
163127399|NCT00308074|589174192|FG000|Overall Study|Withdrawal by Subject|1|||
163127400|NCT01329939|589174196|FG000|Overall Study|Lost to Follow-up|3|||
163127401|NCT01329939|589174197|FG001|Overall Study|Lost to Follow-up|0|||
162656375|NCT03837899|587455200|FG000|Overall Study|Moved to post-trial access program|0|||
162656376|NCT03837899|587455201|FG001|Overall Study|Moved to post-trial access program|1|||
163127402|NCT01329939|589174198|FG002|Overall Study|Lost to Follow-up|1|||
162656377|NCT03837899|587455202|FG002|Overall Study|Moved to post-trial access program|0|||
162656378|NCT03837899|587455203|FG003|Overall Study|Moved to post-trial access program|0|||
162656379|NCT03837899|587455204|FG004|Overall Study|Moved to post-trial access program|0|||
162656380|NCT03837899|587455205|FG005|Overall Study|Moved to post-trial access program|0|||
162656381|NCT03837899|587455200|FG000|Overall Study|Other|0|||
162656382|NCT03837899|587455201|FG001|Overall Study|Other|0|||
162656383|NCT03837899|587455202|FG002|Overall Study|Other|0|||
162656384|NCT03837899|587455203|FG003|Overall Study|Other|0|||
162656385|NCT03837899|587455204|FG004|Overall Study|Other|0|||
162656386|NCT03837899|587455205|FG005|Overall Study|Other|2|||
162656387|NCT03837899|587455200|FG000|Overall Study|Lost to Follow-up|0|||
162656388|NCT03837899|587455201|FG001|Overall Study|Lost to Follow-up|1|||
162656389|NCT03837899|587455202|FG002|Overall Study|Lost to Follow-up|0|||
163127403|NCT01329939|589174199|FG003|Overall Study|Lost to Follow-up|2|||
163127404|NCT01329939|589174196|FG000|Overall Study|Withdrawal by Subject|0|||
163127405|NCT01329939|589174197|FG001|Overall Study|Withdrawal by Subject|1|||
163127406|NCT01329939|589174198|FG002|Overall Study|Withdrawal by Subject|0|||
163127407|NCT01329939|589174199|FG003|Overall Study|Withdrawal by Subject|0|||
163127408|NCT01329939|589174196|FG000|Overall Study|Adverse Event|0|||
163127409|NCT01329939|589174197|FG001|Overall Study|Adverse Event|0|||
163127410|NCT01329939|589174198|FG002|Overall Study|Adverse Event|0|||
163127411|NCT01329939|589174199|FG003|Overall Study|Adverse Event|3|||
163127412|NCT03722524|589174200|FG000|Overall Study|Protocol Violation|86|||
163127413|NCT03722524|589174200|FG000|Overall Study|Adverse Event|7|||
163127414|NCT03722524|589174200|FG000|Overall Study|Lost to Follow-up|1|||
163127415|NCT03722524|589174200|FG000|Overall Study|Reason is not stated|1|||
163127416|NCT03722524|589174200|FG000|Overall Study|Physician Decision|1|||
163127417|NCT03722524|589174200|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
163127418|NCT04369950|589174202|FG000|Overall Study|Protocol Violation|2|||
163127419|NCT04369950|589174203|FG001|Overall Study|Protocol Violation|2|||
163127420|NCT00989963|589174204|FG000|Overall Study|Adverse Event|1|||
163127421|NCT00989963|589174205|FG001|Overall Study|Adverse Event|1|||
163127422|NCT00989963|589174206|FG002|Overall Study|Adverse Event|1|||
163127423|NCT01240200|589174214|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
163127424|NCT01240200|589174215|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
163127425|NCT04071158|589174219|FG000|Overall Study|Lost to Follow-up|1|||
163127426|NCT04071158|589174220|FG001|Overall Study|Lost to Follow-up|2|||
163127427|NCT04071158|589174221|FG002|Overall Study|Lost to Follow-up|3|||
163127428|NCT04071158|589174222|FG003|Overall Study|Lost to Follow-up|3|||
163127429|NCT04071158|589174223|FG004|Overall Study|Lost to Follow-up|5|||
163127430|NCT04071158|589174219|FG000|Overall Study|Randomized but not treated|2|||
163127431|NCT04071158|589174220|FG001|Overall Study|Randomized but not treated|2|||
163127432|NCT04071158|589174221|FG002|Overall Study|Randomized but not treated|0|||
163127433|NCT04071158|589174222|FG003|Overall Study|Randomized but not treated|0|||
163127434|NCT04071158|589174223|FG004|Overall Study|Randomized but not treated|0|||
163127435|NCT01178099|589174224|FG000|Overall Study|Physician Decision|0|||
163127436|NCT01178099|589174225|FG001|Overall Study|Physician Decision|1|||
163127437|NCT02473367|589174226|FG000|Wait 1|Withdrawal by Subject|1|||
163127438|NCT02473367|589174226|FG000|Period 4|Lost to Follow-up|1|||
163127439|NCT04816721|589174227|FG000|Overall Study|Withdrawal by Subject|0|||
163127440|NCT04816721|589174228|FG001|Overall Study|Withdrawal by Subject|2|||
163127441|NCT04816721|589174229|FG002|Overall Study|Withdrawal by Subject|0|||
163127442|NCT04816721|589174230|FG003|Overall Study|Withdrawal by Subject|1|||
163127443|NCT04816721|589174231|FG004|Overall Study|Withdrawal by Subject|1|||
163127444|NCT04816721|589174232|FG005|Overall Study|Withdrawal by Subject|0|||
163127445|NCT04816721|589174233|FG006|Overall Study|Withdrawal by Subject|0|||
163127446|NCT04816721|589174234|FG007|Overall Study|Withdrawal by Subject|0|||
163127447|NCT04816721|589174227|FG000|Overall Study|Miscellaneous|0|||
163127448|NCT04816721|589174228|FG001|Overall Study|Miscellaneous|0|||
163127449|NCT04816721|589174229|FG002|Overall Study|Miscellaneous|0|||
163127450|NCT04816721|589174230|FG003|Overall Study|Miscellaneous|0|||
163127451|NCT04816721|589174231|FG004|Overall Study|Miscellaneous|0|||
163127452|NCT04816721|589174232|FG005|Overall Study|Miscellaneous|1|||
163127453|NCT04816721|589174233|FG006|Overall Study|Miscellaneous|0|||
162656390|NCT03837899|587455203|FG003|Overall Study|Lost to Follow-up|0|||
162656391|NCT03837899|587455204|FG004|Overall Study|Lost to Follow-up|0|||
162656392|NCT03837899|587455205|FG005|Overall Study|Lost to Follow-up|0|||
162656393|NCT03837899|587455200|FG000|Overall Study|Withdrawal by Subject|0|||
163127454|NCT04816721|589174234|FG007|Overall Study|Miscellaneous|0|||
163127455|NCT04816721|589174227|FG000|Overall Study|Lost to Follow-up|0|||
163127456|NCT04816721|589174228|FG001|Overall Study|Lost to Follow-up|0|||
163127457|NCT04816721|589174229|FG002|Overall Study|Lost to Follow-up|0|||
163127458|NCT04816721|589174230|FG003|Overall Study|Lost to Follow-up|1|||
162656394|NCT03837899|587455201|FG001|Overall Study|Withdrawal by Subject|0|||
162656395|NCT03837899|587455202|FG002|Overall Study|Withdrawal by Subject|0|||
162656396|NCT03837899|587455203|FG003|Overall Study|Withdrawal by Subject|1|||
163127459|NCT04816721|589174231|FG004|Overall Study|Lost to Follow-up|0|||
163127460|NCT04816721|589174232|FG005|Overall Study|Lost to Follow-up|0|||
162656397|NCT03837899|587455204|FG004|Overall Study|Withdrawal by Subject|0|||
162656398|NCT03837899|587455205|FG005|Overall Study|Withdrawal by Subject|0|||
162656399|NCT03837899|587455200|FG000|Overall Study|Study specific discontinuation criteria|0|||
162656400|NCT03837899|587455201|FG001|Overall Study|Study specific discontinuation criteria|1|||
162656401|NCT03837899|587455202|FG002|Overall Study|Study specific discontinuation criteria|0|||
162656402|NCT03837899|587455203|FG003|Overall Study|Study specific discontinuation criteria|0|||
162656403|NCT03837899|587455204|FG004|Overall Study|Study specific discontinuation criteria|3|||
162656404|NCT03837899|587455205|FG005|Overall Study|Study specific discontinuation criteria|1|||
162656405|NCT01403974|587455206|FG000|Overall Study|Progressive disease according to RECIST|3|||
162656406|NCT01403974|587455207|FG001|Overall Study|Progressive disease according to RECIST|3|||
162656407|NCT01403974|587455208|FG002|Overall Study|Progressive disease according to RECIST|2|||
162656408|NCT01403974|587455209|FG003|Overall Study|Progressive disease according to RECIST|3|||
162656409|NCT01403974|587455210|FG004|Overall Study|Progressive disease according to RECIST|3|||
162656410|NCT01403974|587455211|FG005|Overall Study|Progressive disease according to RECIST|2|||
162656411|NCT01403974|587455212|FG006|Overall Study|Progressive disease according to RECIST|3|||
162656412|NCT01403974|587455213|FG007|Overall Study|Progressive disease according to RECIST|2|||
162656413|NCT01403974|587455214|FG008|Overall Study|Progressive disease according to RECIST|6|||
162656414|NCT01403974|587455215|FG009|Overall Study|Progressive disease according to RECIST|2|||
162656415|NCT01403974|587455216|FG010|Overall Study|Progressive disease according to RECIST|3|||
162656416|NCT01403974|587455217|FG011|Overall Study|Progressive disease according to RECIST|2|||
162656417|NCT01403974|587455218|FG012|Overall Study|Progressive disease according to RECIST|2|||
162656418|NCT01403974|587455219|FG013|Overall Study|Progressive disease according to RECIST|3|||
162656419|NCT01403974|587455220|FG014|Overall Study|Progressive disease according to RECIST|1|||
162656420|NCT01403974|587455221|FG015|Overall Study|Progressive disease according to RECIST|8|||
162656421|NCT01403974|587455206|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
162656422|NCT01403974|587455207|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
162656423|NCT01403974|587455208|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
162656424|NCT01403974|587455209|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
162656425|NCT01403974|587455210|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
162656426|NCT01403974|587455211|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
162656427|NCT01403974|587455212|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
162656428|NCT01403974|587455213|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
162656429|NCT01403974|587455214|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
162656430|NCT01403974|587455215|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
162656431|NCT01403974|587455216|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
162656432|NCT01403974|587455217|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
162656433|NCT01403974|587455218|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
162656434|NCT01403974|587455219|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
162656435|NCT01403974|587455220|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
162656436|NCT01403974|587455221|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
162656437|NCT01403974|587455206|FG000|Overall Study|Refused to continue study medication|0|||
162656438|NCT01403974|587455207|FG001|Overall Study|Refused to continue study medication|0|||
162656439|NCT01403974|587455208|FG002|Overall Study|Refused to continue study medication|0|||
162656440|NCT01403974|587455209|FG003|Overall Study|Refused to continue study medication|0|||
162656441|NCT01403974|587455210|FG004|Overall Study|Refused to continue study medication|0|||
162656442|NCT01403974|587455211|FG005|Overall Study|Refused to continue study medication|1|||
162656443|NCT01403974|587455212|FG006|Overall Study|Refused to continue study medication|0|||
162656444|NCT01403974|587455213|FG007|Overall Study|Refused to continue study medication|0|||
163127461|NCT04816721|589174233|FG006|Overall Study|Lost to Follow-up|0|||
163127462|NCT04816721|589174234|FG007|Overall Study|Lost to Follow-up|0|||
163127463|NCT03194438|589174237|FG000|Overall Study|Withdrawal by Subject|2|||
163127464|NCT01286740|589174238|FG000|Overall Study|Enrolled but not treated|1|||
163127465|NCT01286740|589174238|FG000|Overall Study|Protocol Violation|1|||
163127466|NCT02717130|589174244|FG000|Overall Study|Withdrawal by Subject|1|||
163127467|NCT02717130|589174244|FG000|Overall Study|Adverse Event|1|||
163127468|NCT02717130|589174244|FG000|Overall Study|Physician Decision|1|||
163127469|NCT02717130|589174244|FG000|Overall Study|Study Closure|4|||
162656445|NCT01403974|587455214|FG008|Overall Study|Refused to continue study medication|1|||
162656446|NCT01403974|587455215|FG009|Overall Study|Refused to continue study medication|0|||
162656447|NCT01403974|587455216|FG010|Overall Study|Refused to continue study medication|1|||
162656448|NCT01403974|587455217|FG011|Overall Study|Refused to continue study medication|0|||
162656449|NCT01403974|587455218|FG012|Overall Study|Refused to continue study medication|0|||
162656450|NCT01403974|587455219|FG013|Overall Study|Refused to continue study medication|0|||
162656451|NCT01403974|587455220|FG014|Overall Study|Refused to continue study medication|0|||
162656452|NCT01403974|587455221|FG015|Overall Study|Refused to continue study medication|4|||
162656453|NCT01403974|587455206|FG000|Overall Study|Adverse Event|0|||
162656454|NCT01403974|587455207|FG001|Overall Study|Adverse Event|0|||
163127470|NCT02335424|589174245|FG000|Overall Study|Withdrawal by Subject|19|||
163127471|NCT02335424|589174245|FG000|Overall Study|Adverse Event|25|||
162656455|NCT01403974|587455208|FG002|Overall Study|Adverse Event|1|||
162656456|NCT01403974|587455209|FG003|Overall Study|Adverse Event|0|||
162656457|NCT01403974|587455210|FG004|Overall Study|Adverse Event|0|||
162656458|NCT01403974|587455211|FG005|Overall Study|Adverse Event|0|||
162656459|NCT01403974|587455212|FG006|Overall Study|Adverse Event|0|||
162656460|NCT01403974|587455213|FG007|Overall Study|Adverse Event|1|||
162656461|NCT01403974|587455214|FG008|Overall Study|Adverse Event|0|||
162656462|NCT01403974|587455215|FG009|Overall Study|Adverse Event|0|||
162656463|NCT01403974|587455216|FG010|Overall Study|Adverse Event|0|||
162656464|NCT01403974|587455217|FG011|Overall Study|Adverse Event|0|||
163127472|NCT02335424|589174245|FG000|Overall Study|Death|273|||
163127473|NCT02335424|589174245|FG000|Overall Study|Lost to Follow-up|3|||
163127474|NCT02335424|589174245|FG000|Overall Study|Physician Decision|13|||
163127475|NCT02335424|589174245|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
163127476|NCT02335424|589174245|FG000|Overall Study|Protocol Violation|1|||
163127477|NCT02335424|589174245|FG000|Overall Study|Screen failure|1|||
163127478|NCT01141478|589174246|FG000|Overall Study|Withdrawal by Subject|1|||
163127479|NCT01141478|589174247|FG001|Overall Study|Withdrawal by Subject|1|||
163127480|NCT01581619|589174250|FG000|Overall Study|Withdrawal by Subject|1|||
163127481|NCT01581619|589174250|FG000|Overall Study|Lost to Follow-up|1|||
163127482|NCT00290498|589174251|FG000|Overall Study|Death|2|||
163127483|NCT00290498|589174252|FG001|Overall Study|Death|0|||
163127484|NCT00290498|589174251|FG000|Overall Study|Physician Decision|1|||
163127485|NCT00290498|589174252|FG001|Overall Study|Physician Decision|0|||
163127486|NCT00290498|589174251|FG000|Overall Study|Withdrawal by Subject|1|||
163127487|NCT00290498|589174252|FG001|Overall Study|Withdrawal by Subject|0|||
163127488|NCT00290498|589174251|FG000|Overall Study|Ineligible|3|||
163127489|NCT00290498|589174252|FG001|Overall Study|Ineligible|0|||
163127490|NCT00290498|589174251|FG000|Overall Study|Non-Compliance|1|||
163127491|NCT00290498|589174252|FG001|Overall Study|Non-Compliance|0|||
163127492|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
163127493|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
163127494|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
163127495|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
163127496|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
163127497|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
163127498|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
163127499|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
163127500|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
163127501|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
163127502|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
163127503|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
163127504|NCT00599638|589174253|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
163127505|NCT00599638|589174254|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
163127506|NCT00599638|589174255|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
163127507|NCT00599638|589174256|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
163127508|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
163127509|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
163127510|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
163127511|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
163127512|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
163127513|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
163127514|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
163127515|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
163127516|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127517|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127518|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
163127519|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
163127520|NCT00599638|589174253|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
163127521|NCT00599638|589174254|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
163127522|NCT00599638|589174255|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
163127523|NCT00599638|589174256|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
163127524|NCT00599638|589174253|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
163127525|NCT00599638|589174254|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127526|NCT00599638|589174255|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127527|NCT00599638|589174256|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
163127528|NCT03006887|589174260|FG000|Overall Study|Adverse Event|1|||
163127529|NCT03836677|589174261|FG000|Period 1|Adverse Event|0|||
163127530|NCT03836677|589174262|FG001|Period 1|Adverse Event|1|||
163127531|NCT03836677|589174261|FG000|Period 2|Severe non-compliance to protocol|1|||
162656465|NCT01403974|587455218|FG012|Overall Study|Adverse Event|1|||
162656466|NCT01403974|587455219|FG013|Overall Study|Adverse Event|0|||
162656467|NCT01403974|587455220|FG014|Overall Study|Adverse Event|0|||
162656468|NCT01403974|587455221|FG015|Overall Study|Adverse Event|0|||
162656469|NCT01403974|587455206|FG000|Overall Study|Other than specified|0|||
162656470|NCT01403974|587455207|FG001|Overall Study|Other than specified|0|||
162656471|NCT01403974|587455208|FG002|Overall Study|Other than specified|0|||
162656472|NCT01403974|587455209|FG003|Overall Study|Other than specified|0|||
162656473|NCT01403974|587455210|FG004|Overall Study|Other than specified|0|||
162656474|NCT01403974|587455211|FG005|Overall Study|Other than specified|0|||
162656475|NCT01403974|587455212|FG006|Overall Study|Other than specified|0|||
162656476|NCT01403974|587455213|FG007|Overall Study|Other than specified|0|||
162656477|NCT01403974|587455214|FG008|Overall Study|Other than specified|0|||
162656478|NCT01403974|587455215|FG009|Overall Study|Other than specified|1|||
162656479|NCT01403974|587455216|FG010|Overall Study|Other than specified|0|||
162656480|NCT01403974|587455217|FG011|Overall Study|Other than specified|1|||
162656481|NCT01403974|587455218|FG012|Overall Study|Other than specified|0|||
162656482|NCT01403974|587455219|FG013|Overall Study|Other than specified|0|||
162656483|NCT01403974|587455220|FG014|Overall Study|Other than specified|0|||
162656484|NCT01403974|587455221|FG015|Overall Study|Other than specified|0|||
162656485|NCT01526889|587455222|FG000|Treatment Period|Adverse Event|2|||
163127532|NCT03836677|589174262|FG001|Period 2|Severe non-compliance to protocol|0|||
163127533|NCT02895945|589174263|FG000|Overall Study|Physician Decision|2|||
163127534|NCT02895945|589174264|FG001|Overall Study|Physician Decision|1|||
163127535|NCT00462748|589174265|FG000|Overall Study|Adverse Event|7|||
163127536|NCT00462748|589174266|FG001|Overall Study|Adverse Event|5|||
163127537|NCT00462748|589174267|FG002|Overall Study|Adverse Event|9|||
163127538|NCT00462748|589174265|FG000|Overall Study|Protocol Violation|0|||
163127539|NCT00462748|589174266|FG001|Overall Study|Protocol Violation|2|||
163127540|NCT00462748|589174267|FG002|Overall Study|Protocol Violation|1|||
163127541|NCT00462748|589174265|FG000|Overall Study|Withdrew consent|3|||
163127542|NCT00462748|589174266|FG001|Overall Study|Withdrew consent|3|||
163127543|NCT00462748|589174267|FG002|Overall Study|Withdrew consent|0|||
163127544|NCT00462748|589174265|FG000|Overall Study|Lost to Follow-up|1|||
163127545|NCT00462748|589174266|FG001|Overall Study|Lost to Follow-up|1|||
163127546|NCT00462748|589174267|FG002|Overall Study|Lost to Follow-up|1|||
163127547|NCT00462748|589174265|FG000|Overall Study|Discontinued after 41 days Rx|1|||
163127548|NCT00462748|589174266|FG001|Overall Study|Discontinued after 41 days Rx|0|||
163127549|NCT00462748|589174267|FG002|Overall Study|Discontinued after 41 days Rx|0|||
163127550|NCT03429543|589174268|FG000|Overall Study|Adverse Event|1|||
163127551|NCT03429543|589174269|FG001|Overall Study|Adverse Event|1|||
163127552|NCT03429543|589174270|FG002|Overall Study|Adverse Event|0|||
163127553|NCT03429543|589174271|FG003|Overall Study|Adverse Event|0|||
163127554|NCT03429543|589174272|FG004|Overall Study|Adverse Event|0|||
163127555|NCT03429543|589174273|FG005|Overall Study|Adverse Event|2|||
163127556|NCT03429543|589174274|FG006|Overall Study|Adverse Event|0|||
163127557|NCT03429543|589174268|FG000|Overall Study|Lost to Follow-up|1|||
163127558|NCT03429543|589174269|FG001|Overall Study|Lost to Follow-up|0|||
163127559|NCT03429543|589174270|FG002|Overall Study|Lost to Follow-up|0|||
163127560|NCT03429543|589174271|FG003|Overall Study|Lost to Follow-up|0|||
163127561|NCT03429543|589174272|FG004|Overall Study|Lost to Follow-up|1|||
163127562|NCT03429543|589174273|FG005|Overall Study|Lost to Follow-up|0|||
163127563|NCT03429543|589174274|FG006|Overall Study|Lost to Follow-up|0|||
163127564|NCT03429543|589174268|FG000|Overall Study|Withdrawal by Subject|5|||
163127565|NCT03429543|589174269|FG001|Overall Study|Withdrawal by Subject|0|||
163127566|NCT03429543|589174270|FG002|Overall Study|Withdrawal by Subject|1|||
163127567|NCT03429543|589174271|FG003|Overall Study|Withdrawal by Subject|2|||
163127568|NCT03429543|589174272|FG004|Overall Study|Withdrawal by Subject|6|||
163127569|NCT03429543|589174273|FG005|Overall Study|Withdrawal by Subject|3|||
163127570|NCT03429543|589174274|FG006|Overall Study|Withdrawal by Subject|1|||
163127571|NCT03429543|589174268|FG000|Overall Study|Other reason than listed|0|||
163127572|NCT03429543|589174269|FG001|Overall Study|Other reason than listed|1|||
163127573|NCT03429543|589174270|FG002|Overall Study|Other reason than listed|0|||
163127574|NCT03429543|589174271|FG003|Overall Study|Other reason than listed|0|||
163127575|NCT03429543|589174272|FG004|Overall Study|Other reason than listed|4|||
162656486|NCT01526889|587455223|FG001|Treatment Period|Adverse Event|0|||
162656487|NCT01526889|587455222|FG000|Treatment Extension Period|Administrative problems|1|||
163127576|NCT03429543|589174273|FG005|Overall Study|Other reason than listed|4|||
163127577|NCT03429543|589174274|FG006|Overall Study|Other reason than listed|0|||
163127578|NCT03429543|589174268|FG000|Overall Study|Not treated|0|||
163127579|NCT03429543|589174269|FG001|Overall Study|Not treated|0|||
163127580|NCT03429543|589174270|FG002|Overall Study|Not treated|0|||
163127581|NCT03429543|589174271|FG003|Overall Study|Not treated|0|||
162656488|NCT01526889|587455223|FG001|Treatment Extension Period|Administrative problems|0|||
163127582|NCT03429543|589174272|FG004|Overall Study|Not treated|1|||
163127583|NCT03429543|589174273|FG005|Overall Study|Not treated|0|||
163127584|NCT03429543|589174274|FG006|Overall Study|Not treated|0|||
163127585|NCT01600092|589174275|FG000|Overall Study|Adverse Event|2|||
162656489|NCT03571516|587455226|FG000|Overall Study|Severe diarrhea|1|||
162656490|NCT03571516|587455227|FG001|Overall Study|Severe diarrhea|0|||
162656491|NCT03571516|587455226|FG000|Overall Study|Withdrawal by Subject|0|||
163127586|NCT01600092|589174276|FG001|Overall Study|Adverse Event|0|||
163127587|NCT01600092|589174275|FG000|Overall Study|Lost to Follow-up|4|||
163127588|NCT01600092|589174276|FG001|Overall Study|Lost to Follow-up|6|||
163127589|NCT01600092|589174275|FG000|Overall Study|Withdrawal by parent/guardian|8|||
163127590|NCT01600092|589174276|FG001|Overall Study|Withdrawal by parent/guardian|6|||
163127591|NCT01600092|589174275|FG000|Overall Study|Physician Decision|1|||
163127592|NCT01600092|589174276|FG001|Overall Study|Physician Decision|1|||
163127593|NCT01600092|589174275|FG000|Overall Study|Randomized but not vaccinated|3|||
163127594|NCT01600092|589174276|FG001|Overall Study|Randomized but not vaccinated|3|||
163127595|NCT01561963|589174277|FG000|Overall Study|Adverse Event|1|||
163127596|NCT00637572|589174285|FG000|Overall Study|Adverse Event|1|||
163127597|NCT00637572|589174286|FG001|Overall Study|Adverse Event|2|||
163127598|NCT00637572|589174285|FG000|Overall Study|Death|0|||
163127599|NCT00637572|589174286|FG001|Overall Study|Death|1|||
163127600|NCT00637572|589174285|FG000|Overall Study|Lost to Follow-up|0|||
163127601|NCT00637572|589174286|FG001|Overall Study|Lost to Follow-up|1|||
163127602|NCT00637572|589174285|FG000|Overall Study|Physician Decision|1|||
163127603|NCT00637572|589174286|FG001|Overall Study|Physician Decision|1|||
163127604|NCT00637572|589174285|FG000|Overall Study|Withdrawal by Subject|0|||
163127605|NCT00637572|589174286|FG001|Overall Study|Withdrawal by Subject|2|||
163127606|NCT00637572|589174285|FG000|Overall Study|Illicit Drug Use|1|||
163127607|NCT00637572|589174286|FG001|Overall Study|Illicit Drug Use|0|||
163127608|NCT04667104|589174288|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
163127609|NCT04667104|589174289|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
163127610|NCT04667104|589174290|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
163127611|NCT05066165|589176454|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
163127612|NCT05066165|589176455|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
163127613|NCT05066165|589176454|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
163127614|NCT05066165|589176455|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
163127615|NCT03210961|589176456|FG000|Overall Study|Adverse Event|0|||
163127616|NCT03210961|589176457|FG001|Overall Study|Adverse Event|0|||
163127617|NCT03210961|589176458|FG002|Overall Study|Adverse Event|0|||
163127618|NCT03210961|589176459|FG003|Overall Study|Adverse Event|0|||
163127619|NCT03210961|589176460|FG004|Overall Study|Adverse Event|0|||
163127620|NCT03210961|589176461|FG005|Overall Study|Adverse Event|0|||
163127621|NCT03210961|589176462|FG006|Overall Study|Adverse Event|0|||
163127622|NCT03210961|589176463|FG007|Overall Study|Adverse Event|0|||
163127623|NCT03210961|589176464|FG008|Overall Study|Adverse Event|0|||
163127624|NCT03210961|589176465|FG009|Overall Study|Adverse Event|0|||
163127625|NCT03210961|589176466|FG010|Overall Study|Adverse Event|0|||
163127626|NCT03210961|589176467|FG011|Overall Study|Adverse Event|0|||
163127627|NCT03210961|589176468|FG012|Overall Study|Adverse Event|0|||
163127628|NCT03210961|589176469|FG013|Overall Study|Adverse Event|1|||
163127629|NCT03210961|589176470|FG014|Overall Study|Adverse Event|0|||
163127630|NCT03210961|589176456|FG000|Overall Study|Lost to Follow-up|0|||
163127631|NCT03210961|589176457|FG001|Overall Study|Lost to Follow-up|0|||
163127632|NCT03210961|589176458|FG002|Overall Study|Lost to Follow-up|0|||
163127633|NCT03210961|589176459|FG003|Overall Study|Lost to Follow-up|0|||
163127634|NCT03210961|589176460|FG004|Overall Study|Lost to Follow-up|0|||
163127635|NCT03210961|589176461|FG005|Overall Study|Lost to Follow-up|0|||
163127636|NCT03210961|589176462|FG006|Overall Study|Lost to Follow-up|0|||
163127637|NCT03210961|589176463|FG007|Overall Study|Lost to Follow-up|0|||
163127638|NCT03210961|589176464|FG008|Overall Study|Lost to Follow-up|0|||
163127639|NCT03210961|589176465|FG009|Overall Study|Lost to Follow-up|0|||
163127640|NCT03210961|589176466|FG010|Overall Study|Lost to Follow-up|0|||
163127641|NCT03210961|589176467|FG011|Overall Study|Lost to Follow-up|0|||
163127642|NCT03210961|589176468|FG012|Overall Study|Lost to Follow-up|0|||
163127643|NCT03210961|589176469|FG013|Overall Study|Lost to Follow-up|0|||
163127644|NCT03210961|589176470|FG014|Overall Study|Lost to Follow-up|1|||
163127645|NCT03210961|589176456|FG000|Overall Study|Withdrawal by Subject|0|||
163127646|NCT03210961|589176457|FG001|Overall Study|Withdrawal by Subject|0|||
163127647|NCT03210961|589176458|FG002|Overall Study|Withdrawal by Subject|0|||
163127648|NCT03210961|589176459|FG003|Overall Study|Withdrawal by Subject|0|||
163127649|NCT03210961|589176460|FG004|Overall Study|Withdrawal by Subject|0|||
163127650|NCT03210961|589176461|FG005|Overall Study|Withdrawal by Subject|0|||
163127651|NCT03210961|589176462|FG006|Overall Study|Withdrawal by Subject|0|||
163127652|NCT03210961|589176463|FG007|Overall Study|Withdrawal by Subject|0|||
162656492|NCT03571516|587455227|FG001|Overall Study|Withdrawal by Subject|1|||
163127653|NCT03210961|589176464|FG008|Overall Study|Withdrawal by Subject|0|||
163127654|NCT03210961|589176465|FG009|Overall Study|Withdrawal by Subject|0|||
163127655|NCT03210961|589176466|FG010|Overall Study|Withdrawal by Subject|0|||
163127656|NCT03210961|589176467|FG011|Overall Study|Withdrawal by Subject|0|||
163127657|NCT03210961|589176468|FG012|Overall Study|Withdrawal by Subject|0|||
163127658|NCT03210961|589176469|FG013|Overall Study|Withdrawal by Subject|0|||
163127659|NCT03210961|589176470|FG014|Overall Study|Withdrawal by Subject|1|||
163127660|NCT03210961|589176456|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162656493|NCT00613509|587455231|FG000|Cycle 1|Adverse Event|2|||
163127661|NCT03210961|589176457|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162656494|NCT00613509|587455232|FG001|Cycle 1|Adverse Event|1|||
162656495|NCT00613509|587455231|FG000|Cycle 1|Disease Progression|2|||
162656496|NCT00613509|587455232|FG001|Cycle 1|Disease Progression|6|||
162656497|NCT00613509|587455231|FG000|Cycle 1|Unacceptable Toxicity|1|||
162656498|NCT00613509|587455232|FG001|Cycle 1|Unacceptable Toxicity|0|||
162656499|NCT00613509|587455231|FG000|Cycle 1|Other administrative reason|0|||
163127662|NCT03210961|589176458|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127663|NCT03210961|589176459|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127664|NCT03210961|589176460|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127665|NCT03210961|589176461|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127666|NCT03210961|589176462|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127667|NCT03210961|589176463|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127668|NCT03210961|589176464|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
162656500|NCT00613509|587455232|FG001|Cycle 1|Other administrative reason|1|||
162656501|NCT03465878|587455233|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162656502|NCT03465878|587455234|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
162656503|NCT03465878|587455235|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162656504|NCT03465878|587455236|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162656505|NCT03465878|587455233|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162656506|NCT03465878|587455234|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162656507|NCT03465878|587455235|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162656508|NCT03465878|587455236|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
162719685|NCT02807493|587680543|FG001|Overall Study|Lost to Follow-up|0|||
163127669|NCT03210961|589176465|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127670|NCT03210961|589176466|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127671|NCT03210961|589176467|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127672|NCT03210961|589176468|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127673|NCT03210961|589176469|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
163127674|NCT03210961|589176470|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
163127675|NCT03210961|589176456|FG000|Overall Study|Other|0|||
163127676|NCT03210961|589176457|FG001|Overall Study|Other|0|||
163127677|NCT03210961|589176458|FG002|Overall Study|Other|0|||
163127678|NCT03210961|589176459|FG003|Overall Study|Other|1|||
163127679|NCT03210961|589176460|FG004|Overall Study|Other|0|||
163127680|NCT03210961|589176461|FG005|Overall Study|Other|0|||
163127681|NCT03210961|589176462|FG006|Overall Study|Other|1|||
163127682|NCT03210961|589176463|FG007|Overall Study|Other|0|||
163127683|NCT03210961|589176464|FG008|Overall Study|Other|0|||
163127684|NCT03210961|589176465|FG009|Overall Study|Other|0|||
163127685|NCT03210961|589176466|FG010|Overall Study|Other|1|||
163127686|NCT03210961|589176467|FG011|Overall Study|Other|0|||
163127687|NCT03210961|589176468|FG012|Overall Study|Other|2|||
163127688|NCT03210961|589176469|FG013|Overall Study|Other|2|||
163127689|NCT03210961|589176470|FG014|Overall Study|Other|0|||
163127690|NCT03343626|589176471|FG000|Overall Study|Lost to Follow-up|4|||
163127691|NCT03343626|589176472|FG001|Overall Study|Lost to Follow-up|3|||
163127692|NCT03343626|589176473|FG002|Overall Study|Lost to Follow-up|2|||
163127693|NCT03343626|589176474|FG003|Overall Study|Lost to Follow-up|5|||
163127694|NCT03343626|589176475|FG004|Overall Study|Lost to Follow-up|4|||
163127695|NCT03343626|589176476|FG005|Overall Study|Lost to Follow-up|4|||
163127696|NCT03343626|589176477|FG006|Overall Study|Lost to Follow-up|4|||
163127697|NCT03343626|589176478|FG007|Overall Study|Lost to Follow-up|7|||
163127698|NCT03343626|589176471|FG000|Overall Study|Withdrawal of Consent|2|||
163127699|NCT03343626|589176472|FG001|Overall Study|Withdrawal of Consent|1|||
163127700|NCT03343626|589176473|FG002|Overall Study|Withdrawal of Consent|0|||
163127701|NCT03343626|589176474|FG003|Overall Study|Withdrawal of Consent|3|||
163127702|NCT03343626|589176475|FG004|Overall Study|Withdrawal of Consent|3|||
163127703|NCT03343626|589176476|FG005|Overall Study|Withdrawal of Consent|1|||
163127704|NCT03343626|589176477|FG006|Overall Study|Withdrawal of Consent|1|||
163127705|NCT03343626|589176478|FG007|Overall Study|Withdrawal of Consent|2|||
163127706|NCT03343626|589176471|FG000|Overall Study|Reason not Specified|0|||
163127707|NCT03343626|589176472|FG001|Overall Study|Reason not Specified|1|||
163127708|NCT03343626|589176473|FG002|Overall Study|Reason not Specified|0|||
163127709|NCT03343626|589176474|FG003|Overall Study|Reason not Specified|0|||
163127710|NCT03343626|589176475|FG004|Overall Study|Reason not Specified|0|||
163127711|NCT03343626|589176476|FG005|Overall Study|Reason not Specified|0|||
163127712|NCT03343626|589176477|FG006|Overall Study|Reason not Specified|0|||
162656509|NCT03465878|587455233|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162719686|NCT02807493|587680542|FG000|Overall Study|Physician Decision|4|||
162719687|NCT02807493|587680543|FG001|Overall Study|Physician Decision|1|||
163127713|NCT03343626|589176478|FG007|Overall Study|Reason not Specified|1|||
163127714|NCT03343626|589176471|FG000|Overall Study|Data Entry Error|0|||
162656510|NCT03465878|587455234|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162656511|NCT03465878|587455235|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162656512|NCT03465878|587455236|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
163127715|NCT03343626|589176472|FG001|Overall Study|Data Entry Error|0|||
163127716|NCT03343626|589176473|FG002|Overall Study|Data Entry Error|0|||
163127717|NCT03343626|589176474|FG003|Overall Study|Data Entry Error|0|||
163127718|NCT03343626|589176475|FG004|Overall Study|Data Entry Error|0|||
163127719|NCT03343626|589176476|FG005|Overall Study|Data Entry Error|0|||
163127720|NCT03343626|589176477|FG006|Overall Study|Data Entry Error|0|||
163127721|NCT03343626|589176478|FG007|Overall Study|Data Entry Error|1|||
163127722|NCT03592368|589176482|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127723|NCT03592368|589176483|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
163127724|NCT03592368|589176484|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127725|NCT03592368|589176485|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
163127726|NCT03592368|589176482|FG000|Overall Study|Adverse Event|0|||
163127727|NCT03592368|589176483|FG001|Overall Study|Adverse Event|0|||
163127728|NCT03592368|589176484|FG002|Overall Study|Adverse Event|0|||
163127729|NCT03592368|589176485|FG003|Overall Study|Adverse Event|1|||
163127730|NCT03592368|589176482|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
163127731|NCT03592368|589176483|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
163127732|NCT03592368|589176484|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
163127733|NCT03592368|589176485|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
163127734|NCT03047031|589176488|FG000|Overall Study|Other than listed|1|||
163127735|NCT03047031|589176489|FG001|Overall Study|Other than listed|0|||
163127736|NCT03047031|589176490|FG002|Overall Study|Other than listed|0|||
163127737|NCT03047031|589176488|FG000|Overall Study|Lost to Follow-up|4|||
163127738|NCT03047031|589176489|FG001|Overall Study|Lost to Follow-up|0|||
163127739|NCT03047031|589176490|FG002|Overall Study|Lost to Follow-up|0|||
163127740|NCT03047031|589176488|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
163127741|NCT03047031|589176489|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
163127742|NCT03047031|589176490|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
163127743|NCT03047031|589176488|FG000|Overall Study|Adverse Event|1|||
163127744|NCT03047031|589176489|FG001|Overall Study|Adverse Event|0|||
163127745|NCT03047031|589176490|FG002|Overall Study|Adverse Event|0|||
163127746|NCT03047031|589176488|FG000|Overall Study|Withdrawal by Subject|2|||
163127747|NCT03047031|589176489|FG001|Overall Study|Withdrawal by Subject|0|||
163127748|NCT03047031|589176490|FG002|Overall Study|Withdrawal by Subject|0|||
163127749|NCT03047031|589176488|FG000|Overall Study|Change to other medication|2|||
163127750|NCT03047031|589176489|FG001|Overall Study|Change to other medication|0|||
163127751|NCT03047031|589176490|FG002|Overall Study|Change to other medication|0|||
163127752|NCT03047031|589176488|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
163127753|NCT03047031|589176489|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
163127754|NCT03047031|589176490|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
163127755|NCT02814175|589176491|FG000|Part 1|Adverse Event|2|||
163127756|NCT02814175|589176492|FG001|Part 1|Adverse Event|3|||
163127757|NCT02814175|589176493|FG002|Part 1|Adverse Event|0|||
163127758|NCT02814175|589176494|FG003|Part 1|Adverse Event|0|||
163127759|NCT02814175|589176495|FG004|Part 1|Adverse Event|0|||
163127760|NCT02814175|589176496|FG005|Part 1|Adverse Event|0|||
163127761|NCT02814175|589176491|FG000|Part 1|Withdrawal Consent|8|||
163127762|NCT02814175|589176492|FG001|Part 1|Withdrawal Consent|1|||
163127763|NCT02814175|589176493|FG002|Part 1|Withdrawal Consent|0|||
163127764|NCT02814175|589176494|FG003|Part 1|Withdrawal Consent|0|||
163127765|NCT02814175|589176495|FG004|Part 1|Withdrawal Consent|0|||
163127766|NCT02814175|589176496|FG005|Part 1|Withdrawal Consent|0|||
163127767|NCT02814175|589176491|FG000|Part 1|Lost to Follow-up|1|||
163127768|NCT02814175|589176492|FG001|Part 1|Lost to Follow-up|0|||
163127769|NCT02814175|589176493|FG002|Part 1|Lost to Follow-up|0|||
163127770|NCT02814175|589176494|FG003|Part 1|Lost to Follow-up|0|||
163127771|NCT02814175|589176495|FG004|Part 1|Lost to Follow-up|0|||
163127772|NCT02814175|589176496|FG005|Part 1|Lost to Follow-up|0|||
163127773|NCT02814175|589176491|FG000|Part 1|Lack of Efficacy|1|||
163127774|NCT02814175|589176492|FG001|Part 1|Lack of Efficacy|2|||
162656513|NCT02540954|587455237|FG000|Overall Study|Physician Decision|3|||
162656514|NCT02540954|587455238|FG001|Overall Study|Physician Decision|1|||
162656515|NCT02540954|587455237|FG000|Overall Study|Withdrawal by Subject|6|||
162656516|NCT02540954|587455238|FG001|Overall Study|Withdrawal by Subject|5|||
162656517|NCT02540954|587455237|FG000|Overall Study|Lost to Follow-up|1|||
163127775|NCT02814175|589176493|FG002|Part 1|Lack of Efficacy|0|||
163127776|NCT02814175|589176494|FG003|Part 1|Lack of Efficacy|0|||
163127777|NCT02814175|589176495|FG004|Part 1|Lack of Efficacy|0|||
163127778|NCT02814175|589176496|FG005|Part 1|Lack of Efficacy|0|||
163127779|NCT02814175|589176491|FG000|Part 2|Adverse Event|0|||
163127780|NCT02814175|589176492|FG001|Part 2|Adverse Event|0|||
163127781|NCT02814175|589176493|FG002|Part 2|Adverse Event|0|||
162656518|NCT02540954|587455238|FG001|Overall Study|Lost to Follow-up|1|||
162656519|NCT02540954|587455237|FG000|Overall Study|Adverse Event|4|||
163127782|NCT02814175|589176494|FG003|Part 2|Adverse Event|1|||
163127783|NCT02814175|589176495|FG004|Part 2|Adverse Event|1|||
162656520|NCT02540954|587455238|FG001|Overall Study|Adverse Event|2|||
162656521|NCT02540954|587455237|FG000|Overall Study|Death|0|||
162656522|NCT02540954|587455238|FG001|Overall Study|Death|3|||
162656523|NCT02540954|587455237|FG000|Overall Study|Treatment failure|1|||
162656524|NCT02540954|587455238|FG001|Overall Study|Treatment failure|0|||
162656525|NCT02540954|587455237|FG000|Overall Study|Other reason|4|||
162656526|NCT02540954|587455238|FG001|Overall Study|Other reason|2|||
162656527|NCT01806896|587455242|FG000|Overall Study|Adverse Event|2|||
162656528|NCT01806896|587455243|FG001|Overall Study|Adverse Event|0|||
162656529|NCT01806896|587455242|FG000|Overall Study|Other|1|||
162656530|NCT01806896|587455243|FG001|Overall Study|Other|0|||
162656531|NCT02448875|587455244|FG000|Overall Study|Adverse Event|2|||
162656532|NCT02448875|587455245|FG001|Overall Study|Adverse Event|1|||
162719688|NCT02807493|587680542|FG000|Overall Study|Protocol Violation|7|||
162719689|NCT02807493|587680543|FG001|Overall Study|Protocol Violation|0|||
162719690|NCT02807493|587680542|FG000|Overall Study|Withdrawal by Subject|17|||
162719691|NCT02807493|587680543|FG001|Overall Study|Withdrawal by Subject|10|||
162719692|NCT02807493|587680542|FG000|Overall Study|Other withdrawal|17|||
162719693|NCT02807493|587680543|FG001|Overall Study|Other withdrawal|0|||
162719694|NCT02807493|587680542|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
162719695|NCT02807493|587680543|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
162719696|NCT05190419|587680544|FG000|Overall Study|Lack of Efficacy|8|||
162719697|NCT05190419|587680545|FG001|Overall Study|Lack of Efficacy|0|||
162719698|NCT05190419|587680546|FG002|Overall Study|Lack of Efficacy|1|||
162719699|NCT05190419|587680547|FG003|Overall Study|Lack of Efficacy|0|||
162719700|NCT05190419|587680544|FG000|Overall Study|Withdrawal by Subject|7|||
162719701|NCT05190419|587680545|FG001|Overall Study|Withdrawal by Subject|1|||
162719702|NCT05190419|587680546|FG002|Overall Study|Withdrawal by Subject|2|||
162719703|NCT05190419|587680547|FG003|Overall Study|Withdrawal by Subject|2|||
162719704|NCT05190419|587680544|FG000|Overall Study|Adverse Event|2|||
162719705|NCT05190419|587680545|FG001|Overall Study|Adverse Event|10|||
162719706|NCT05190419|587680546|FG002|Overall Study|Adverse Event|11|||
162719707|NCT05190419|587680547|FG003|Overall Study|Adverse Event|21|||
163127784|NCT02814175|589176496|FG005|Part 2|Adverse Event|2|||
163127785|NCT02814175|589176491|FG000|Part 2|Withdrawal Consent|0|||
163127786|NCT02814175|589176492|FG001|Part 2|Withdrawal Consent|0|||
163127787|NCT02814175|589176493|FG002|Part 2|Withdrawal Consent|0|||
163127788|NCT02814175|589176494|FG003|Part 2|Withdrawal Consent|2|||
163127789|NCT02814175|589176495|FG004|Part 2|Withdrawal Consent|1|||
163127790|NCT02814175|589176496|FG005|Part 2|Withdrawal Consent|1|||
163127791|NCT02814175|589176491|FG000|Part 2|Lost to Follow-up|0|||
163127792|NCT02814175|589176492|FG001|Part 2|Lost to Follow-up|0|||
163127793|NCT02814175|589176493|FG002|Part 2|Lost to Follow-up|0|||
163127794|NCT02814175|589176494|FG003|Part 2|Lost to Follow-up|1|||
163127795|NCT02814175|589176495|FG004|Part 2|Lost to Follow-up|0|||
163127796|NCT02814175|589176496|FG005|Part 2|Lost to Follow-up|0|||
163127797|NCT02814175|589176491|FG000|Part 2|Lack of Efficacy|0|||
163127798|NCT02814175|589176492|FG001|Part 2|Lack of Efficacy|0|||
163127799|NCT02814175|589176493|FG002|Part 2|Lack of Efficacy|0|||
163127800|NCT02814175|589176494|FG003|Part 2|Lack of Efficacy|0|||
163127801|NCT02814175|589176495|FG004|Part 2|Lack of Efficacy|0|||
163127802|NCT02814175|589176496|FG005|Part 2|Lack of Efficacy|3|||
163127803|NCT04207749|589176509|FG000|Overall Study|Lost to Follow-up|0|||
163127804|NCT04207749|589176510|FG001|Overall Study|Lost to Follow-up|2|||
163127805|NCT04207749|589176509|FG000|Overall Study|Protocol Violation|0|||
162656533|NCT02448875|587455246|FG002|Overall Study|Adverse Event|0|||
162656534|NCT02448875|587455244|FG000|Overall Study|Lost to Follow-up|1|||
162656535|NCT02448875|587455245|FG001|Overall Study|Lost to Follow-up|0|||
162656536|NCT02448875|587455246|FG002|Overall Study|Lost to Follow-up|0|||
162719708|NCT05190419|587680544|FG000|Overall Study|Lost to Follow-up|1|||
162719709|NCT05190419|587680545|FG001|Overall Study|Lost to Follow-up|2|||
162719710|NCT05190419|587680546|FG002|Overall Study|Lost to Follow-up|3|||
162719711|NCT05190419|587680547|FG003|Overall Study|Lost to Follow-up|1|||
162719712|NCT05190419|587680544|FG000|Overall Study|Other|1|||
163127806|NCT04207749|589176510|FG001|Overall Study|Protocol Violation|1|||
163127807|NCT04207749|589176509|FG000|Overall Study|Withdrawal by Subject|3|||
163127808|NCT04207749|589176510|FG001|Overall Study|Withdrawal by Subject|0|||
163127809|NCT04207749|589176509|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
162656537|NCT02448875|587455244|FG000|Overall Study|Investigator Decision|3|||
162656538|NCT02448875|587455245|FG001|Overall Study|Investigator Decision|0|||
162656539|NCT02448875|587455246|FG002|Overall Study|Investigator Decision|1|||
162656540|NCT02448875|587455244|FG000|Overall Study|Withdrawal by Subject|1|||
162656541|NCT02448875|587455245|FG001|Overall Study|Withdrawal by Subject|0|||
162719713|NCT05190419|587680545|FG001|Overall Study|Other|1|||
163127810|NCT04207749|589176510|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
163127811|NCT01971008|589176511|FG000|Overall Study|Protocol Violation|2|||
162656542|NCT02448875|587455246|FG002|Overall Study|Withdrawal by Subject|0|||
162719714|NCT05190419|587680546|FG002|Overall Study|Other|0|||
163127812|NCT01971008|589176512|FG001|Overall Study|Protocol Violation|1|||
163127813|NCT03416127|589176513|FG000|Overall Study|Withdrawal by Subject|0|||
163127814|NCT03416127|589176514|FG001|Overall Study|Withdrawal by Subject|1|||
163127815|NCT03416127|589176515|FG002|Overall Study|Withdrawal by Subject|1|||
163127816|NCT00924508|589176516|FG000|Overall Study|Withdrawal by Subject|3|||
163127817|NCT00495625|589176517|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
163127818|NCT01912339|589176518|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
163127819|NCT01912339|589176519|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
163127820|NCT01912339|589176520|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
163127821|NCT01912339|589176518|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
163127822|NCT01912339|589176519|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
163127823|NCT01912339|589176520|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
163127824|NCT01912339|589176518|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
163127825|NCT01912339|589176519|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
163127826|NCT01912339|589176520|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
163127827|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
163127828|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
163127829|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
163127830|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
163127831|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
163127832|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
163127833|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
163127834|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
163127835|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
163127836|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
163127837|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
163127838|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
163127839|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
163127840|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
163127841|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
163127842|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
163127843|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
163127844|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
163127845|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
163127846|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
163127847|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
163127848|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
163127849|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
163127850|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
163127851|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
163127852|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
163127853|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
163127854|NCT01912339|589176518|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
163127855|NCT01912339|589176519|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
163127856|NCT01912339|589176520|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
163127857|NCT03679624|589176521|FG000|Overall Study|Adverse Event|1|||
163127858|NCT03679624|589176522|FG001|Overall Study|Adverse Event|0|||
163127859|NCT00741013|589176523|FG000|Overall Study|Adverse Event|1|||
163127860|NCT00741013|589176524|FG001|Overall Study|Adverse Event|0|||
163127861|NCT00741013|589176525|FG002|Overall Study|Adverse Event|0|||
163127862|NCT00741013|589176523|FG000|Overall Study|Withdrawal by Subject|0|||
163127863|NCT00741013|589176524|FG001|Overall Study|Withdrawal by Subject|0|||
163127864|NCT00741013|589176525|FG002|Overall Study|Withdrawal by Subject|1|||
163127865|NCT00741013|589176523|FG000|Overall Study|Discovered failed screen after enrolled|0|||
163127866|NCT00741013|589176524|FG001|Overall Study|Discovered failed screen after enrolled|2|||
163127867|NCT00741013|589176525|FG002|Overall Study|Discovered failed screen after enrolled|0|||
163127868|NCT01754493|589176527|FG000|Overall Study|Adverse Event|1|||
163127869|NCT01754493|589176527|FG000|Overall Study|Lost to Follow-up|3|||
163127870|NCT01754493|589176527|FG000|Overall Study|Withdrawal by Subject|1|||
163127871|NCT01754493|589176527|FG000|Overall Study|Moved out of town|1|||
163127872|NCT01754493|589176527|FG000|Overall Study|Scheduling conflict|1|||
163127873|NCT02702414|589176530|FG000|Overall Study|Death|96|||
163127874|NCT02702414|589176531|FG001|Overall Study|Death|42|||
163127875|NCT02702414|589176530|FG000|Overall Study|Lost to Follow-up|0|||
163127876|NCT02702414|589176531|FG001|Overall Study|Lost to Follow-up|1|||
162656543|NCT02434770|587455247|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
162656544|NCT02434770|587455248|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
162656545|NCT02434770|587455249|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
162656546|NCT02434770|587455247|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
162656547|NCT02434770|587455248|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
162656548|NCT02434770|587455249|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
162656549|NCT02434770|587455247|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
162656550|NCT02434770|587455248|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
162656551|NCT02434770|587455249|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
162656552|NCT02434770|587455247|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
162656553|NCT02434770|587455248|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
162656554|NCT02434770|587455249|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
162656555|NCT02434770|587455247|FG000|Week 1 to Week 18|Death|1|||
162656556|NCT02434770|587455248|FG001|Week 1 to Week 18|Death|0|||
162656557|NCT02434770|587455249|FG002|Week 1 to Week 18|Death|0|||
162656558|NCT02434770|587455247|FG000|Week 18 to Week|Lost to Follow-up|2|||
162656559|NCT02434770|587455248|FG001|Week 18 to Week|Lost to Follow-up|2|||
162656560|NCT02434770|587455249|FG002|Week 18 to Week|Lost to Follow-up|1|||
162656561|NCT02434770|587455247|FG000|Week 18 to Week|Withdrawal by Subject|0|||
162656562|NCT02434770|587455248|FG001|Week 18 to Week|Withdrawal by Subject|0|||
162656563|NCT02434770|587455249|FG002|Week 18 to Week|Withdrawal by Subject|2|||
162656564|NCT02434770|587455247|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
163127877|NCT02702414|589176530|FG000|Overall Study|Withdrawal by Subject|0|||
163127878|NCT02702414|589176531|FG001|Overall Study|Withdrawal by Subject|1|||
163127879|NCT02702414|589176530|FG000|Overall Study|Protocol Violation|1|||
163127880|NCT02702414|589176531|FG001|Overall Study|Protocol Violation|0|||
163127881|NCT02702414|589176530|FG000|Overall Study|Sponsor Decision|8|||
163127882|NCT02702414|589176531|FG001|Overall Study|Sponsor Decision|7|||
163127883|NCT04541628|589176532|FG000|Overall Study|Study Terminated|1|||
163127884|NCT04541628|589176533|FG001|Overall Study|Study Terminated|1|||
163127885|NCT04541628|589176534|FG002|Overall Study|Study Terminated|1|||
163127886|NCT01452919|589176538|FG000|Open-Label Treatment|Adverse Event|5|||
163127887|NCT01452919|589176539|FG001|Open-Label Treatment|Adverse Event|0|||
163127888|NCT01452919|589176540|FG002|Open-Label Treatment|Adverse Event|0|||
163127889|NCT01452919|589176538|FG000|Open-Label Treatment|Lost to Follow-up|4|||
163127890|NCT01452919|589176539|FG001|Open-Label Treatment|Lost to Follow-up|0|||
163127891|NCT01452919|589176540|FG002|Open-Label Treatment|Lost to Follow-up|0|||
163127892|NCT01452919|589176538|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
163127893|NCT01452919|589176539|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
163127894|NCT01452919|589176540|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
163127895|NCT01452919|589176538|FG000|Open-Label Treatment|Protocol Violation|4|||
163127896|NCT01452919|589176539|FG001|Open-Label Treatment|Protocol Violation|0|||
163127897|NCT01452919|589176540|FG002|Open-Label Treatment|Protocol Violation|0|||
163127898|NCT01452919|589176538|FG000|Open-Label Treatment|Sponsor Decision|1|||
163127899|NCT01452919|589176539|FG001|Open-Label Treatment|Sponsor Decision|0|||
163127900|NCT01452919|589176540|FG002|Open-Label Treatment|Sponsor Decision|0|||
163127901|NCT01452919|589176538|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
163127902|NCT01452919|589176539|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163127903|NCT01452919|589176540|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
163127904|NCT01452919|589176538|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
163127905|NCT01452919|589176539|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
163127906|NCT01452919|589176540|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
163127907|NCT01452919|589176538|FG000|Randomization Treatment|Adverse Event|0|||
163127908|NCT01452919|589176539|FG001|Randomization Treatment|Adverse Event|0|||
163127909|NCT01452919|589176540|FG002|Randomization Treatment|Adverse Event|2|||
163127910|NCT01452919|589176538|FG000|Randomization Treatment|Sponsor Decision|0|||
163127911|NCT01452919|589176539|FG001|Randomization Treatment|Sponsor Decision|1|||
163127912|NCT01452919|589176540|FG002|Randomization Treatment|Sponsor Decision|0|||
163127913|NCT01452919|589176538|FG000|Randomization Treatment|Withdrawal by Subject|0|||
163127914|NCT01452919|589176539|FG001|Randomization Treatment|Withdrawal by Subject|1|||
163127915|NCT01452919|589176540|FG002|Randomization Treatment|Withdrawal by Subject|0|||
163127916|NCT01452919|589176538|FG000|Randomization Treatment|Subject is moving or has moved|0|||
163127917|NCT01452919|589176539|FG001|Randomization Treatment|Subject is moving or has moved|1|||
163127918|NCT01452919|589176540|FG002|Randomization Treatment|Subject is moving or has moved|0|||
163127919|NCT00859937|589176541|FG000|Overall Study|Protocol Violation|1|||
162656565|NCT02434770|587455248|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
162656566|NCT02434770|587455249|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
163127920|NCT00859937|589176542|FG001|Overall Study|Protocol Violation|0|||
163127921|NCT00151476|589176543|FG000|FAP Identified Subjects|Protocol Violation|0|||
163127922|NCT00151476|589176544|FG001|FAP Identified Subjects|Protocol Violation|1|||
162656567|NCT01282424|587455253|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
162656568|NCT01282424|587455253|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
163127923|NCT00151476|589176543|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
162656569|NCT01282424|587455253|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
162656570|NCT01282424|587455253|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
162656571|NCT01282424|587455253|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
163127924|NCT00151476|589176544|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
163127925|NCT00151476|589176543|FG000|FAP Analyzed Subjects|Other study participation|0|||
163127926|NCT00151476|589176544|FG001|FAP Analyzed Subjects|Other study participation|1|||
163127927|NCT03446456|589176545|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
163127928|NCT03446456|589176546|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
163127929|NCT03446456|589176545|FG000|Overall Study|Lost to Follow-up|1|||
163127930|NCT03446456|589176546|FG001|Overall Study|Lost to Follow-up|3|||
163127931|NCT03446456|589176545|FG000|Overall Study|Participant failed the toxicology test|1|||
163127932|NCT03446456|589176546|FG001|Overall Study|Participant failed the toxicology test|0|||
163127933|NCT03446456|589176545|FG000|Overall Study|Break down of the experimental equipment|1|||
163127934|NCT03446456|589176546|FG001|Overall Study|Break down of the experimental equipment|0|||
163127935|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
163127936|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
163127937|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
163127938|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
163127939|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
163127940|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
163127941|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Death|1|||
163127942|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Death|4|||
163127943|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
163127944|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
163127945|NCT00658814|589176549|FG000|Remission Induction Chemotherapy|Not eligible|1|||
163127946|NCT00658814|589176550|FG001|Remission Induction Chemotherapy|Not eligible|2|||
163127947|NCT00658814|589176549|FG000|Consolidation Therapy|Not protocol specified|0|||
163127948|NCT00658814|589176550|FG001|Consolidation Therapy|Not protocol specified|1|||
163127949|NCT00658814|589176549|FG000|Consolidation Therapy|Not eligible|2|||
163127950|NCT00658814|589176550|FG001|Consolidation Therapy|Not eligible|2|||
163127951|NCT00658814|589176549|FG000|Maintenance Therapy|Adverse Event|1|||
163127952|NCT00658814|589176550|FG001|Maintenance Therapy|Adverse Event|1|||
163127953|NCT00658814|589176549|FG000|Maintenance Therapy|Not protocol specified|1|||
163127954|NCT00658814|589176550|FG001|Maintenance Therapy|Not protocol specified|0|||
163127955|NCT00658814|589176549|FG000|Maintenance Therapy|Not eligible|1|||
163127956|NCT00658814|589176550|FG001|Maintenance Therapy|Not eligible|0|||
163127957|NCT00455143|589176553|FG000|Overall Study|Physician Decision|1|||
163127958|NCT00455143|589176553|FG000|Overall Study|Withdrawal by Subject|1|||
163127959|NCT00455143|589176553|FG000|Overall Study|Staff was not avail to follow patient|2|||
163127960|NCT00455143|589176553|FG000|Overall Study|No longer met Inclusion Criteria|1|||
163127961|NCT00455143|589176553|FG000|Overall Study|Surgical time, staff not available|1|||
163127962|NCT00549770|589176556|FG000|Overall Study|Protocol deviation|1|||
163127963|NCT00549770|589176557|FG001|Overall Study|Protocol deviation|1|||
163127964|NCT00549770|589176558|FG002|Overall Study|Protocol deviation|1|||
163127965|NCT00549770|589176559|FG003|Overall Study|Protocol deviation|2|||
163127966|NCT00549770|589176560|FG004|Overall Study|Protocol deviation|2|||
163127967|NCT00549770|589176561|FG005|Overall Study|Protocol deviation|2|||
163127968|NCT00549770|589176562|FG006|Overall Study|Protocol deviation|1|||
163127969|NCT00549770|589176563|FG007|Overall Study|Protocol deviation|2|||
163127970|NCT00549770|589176556|FG000|Overall Study|Administrative problems|0|||
163127971|NCT00549770|589176557|FG001|Overall Study|Administrative problems|1|||
163127972|NCT00549770|589176558|FG002|Overall Study|Administrative problems|0|||
163127973|NCT00549770|589176559|FG003|Overall Study|Administrative problems|0|||
163127974|NCT00549770|589176560|FG004|Overall Study|Administrative problems|0|||
163127975|NCT00549770|589176561|FG005|Overall Study|Administrative problems|0|||
163127976|NCT00549770|589176562|FG006|Overall Study|Administrative problems|0|||
163127977|NCT00549770|589176563|FG007|Overall Study|Administrative problems|1|||
163127978|NCT00549770|589176556|FG000|Overall Study|Lost to Follow-up|0|||
163127979|NCT00549770|589176557|FG001|Overall Study|Lost to Follow-up|0|||
163127980|NCT00549770|589176558|FG002|Overall Study|Lost to Follow-up|2|||
163127981|NCT00549770|589176559|FG003|Overall Study|Lost to Follow-up|2|||
163127982|NCT00549770|589176560|FG004|Overall Study|Lost to Follow-up|3|||
163127983|NCT00549770|589176561|FG005|Overall Study|Lost to Follow-up|2|||
163127984|NCT00549770|589176562|FG006|Overall Study|Lost to Follow-up|0|||
163127985|NCT00549770|589176563|FG007|Overall Study|Lost to Follow-up|0|||
162656572|NCT01282424|587455253|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
162656573|NCT01282424|587455253|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
162656574|NCT01282424|587455253|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
162656575|NCT03316872|587455254|FG000|Overall Study|Death|1|||
162656576|NCT04074317|587455255|FG000|Third Period|Withdrawal by Subject|0|||
162656577|NCT04074317|587455256|FG001|Third Period|Withdrawal by Subject|0|||
162656578|NCT04074317|587455257|FG002|Third Period|Withdrawal by Subject|0|||
162656579|NCT04074317|587455258|FG003|Third Period|Withdrawal by Subject|1|||
162656580|NCT04074317|587455259|FG004|Third Period|Withdrawal by Subject|0|||
163127986|NCT00549770|589176556|FG000|Overall Study|Withdrawal by Subject|4|||
163127987|NCT00549770|589176557|FG001|Overall Study|Withdrawal by Subject|6|||
162656581|NCT04074317|587455260|FG005|Third Period|Withdrawal by Subject|0|||
162656582|NCT02283788|587455263|FG000|Overall Study|Adverse Event|1|||
162656583|NCT02283788|587455264|FG001|Overall Study|Adverse Event|3|||
162656584|NCT02283788|587455265|FG002|Overall Study|Adverse Event|5|||
162656585|NCT02283788|587455266|FG003|Overall Study|Adverse Event|1|||
162656586|NCT02283788|587455263|FG000|Overall Study|Withdrawal by Subject|0|||
163127988|NCT00549770|589176558|FG002|Overall Study|Withdrawal by Subject|4|||
163127989|NCT00549770|589176559|FG003|Overall Study|Withdrawal by Subject|5|||
163127990|NCT00549770|589176560|FG004|Overall Study|Withdrawal by Subject|6|||
163127991|NCT00549770|589176561|FG005|Overall Study|Withdrawal by Subject|6|||
163127992|NCT00549770|589176562|FG006|Overall Study|Withdrawal by Subject|4|||
163127993|NCT00549770|589176563|FG007|Overall Study|Withdrawal by Subject|9|||
163127994|NCT00549770|589176556|FG000|Overall Study|Lack of Efficacy|1|||
163127995|NCT00549770|589176557|FG001|Overall Study|Lack of Efficacy|0|||
163127996|NCT00549770|589176558|FG002|Overall Study|Lack of Efficacy|2|||
163127997|NCT00549770|589176559|FG003|Overall Study|Lack of Efficacy|3|||
163127998|NCT00549770|589176560|FG004|Overall Study|Lack of Efficacy|5|||
163127999|NCT00549770|589176561|FG005|Overall Study|Lack of Efficacy|1|||
163128000|NCT00549770|589176562|FG006|Overall Study|Lack of Efficacy|3|||
163128001|NCT00549770|589176563|FG007|Overall Study|Lack of Efficacy|8|||
163128002|NCT00549770|589176556|FG000|Overall Study|Abnormal test procedure results|0|||
163128003|NCT00549770|589176557|FG001|Overall Study|Abnormal test procedure results|0|||
163128004|NCT00549770|589176558|FG002|Overall Study|Abnormal test procedure results|0|||
163128005|NCT00549770|589176559|FG003|Overall Study|Abnormal test procedure results|2|||
163128006|NCT00549770|589176560|FG004|Overall Study|Abnormal test procedure results|0|||
163128007|NCT00549770|589176561|FG005|Overall Study|Abnormal test procedure results|1|||
163128008|NCT00549770|589176562|FG006|Overall Study|Abnormal test procedure results|1|||
163128009|NCT00549770|589176563|FG007|Overall Study|Abnormal test procedure results|1|||
163128010|NCT00549770|589176556|FG000|Overall Study|Abnormal laboratory values|0|||
163128011|NCT00549770|589176557|FG001|Overall Study|Abnormal laboratory values|0|||
163128012|NCT00549770|589176558|FG002|Overall Study|Abnormal laboratory values|0|||
163128013|NCT00549770|589176559|FG003|Overall Study|Abnormal laboratory values|0|||
163128014|NCT00549770|589176560|FG004|Overall Study|Abnormal laboratory values|0|||
163128015|NCT00549770|589176561|FG005|Overall Study|Abnormal laboratory values|1|||
163128016|NCT00549770|589176562|FG006|Overall Study|Abnormal laboratory values|0|||
163128017|NCT00549770|589176563|FG007|Overall Study|Abnormal laboratory values|0|||
163128018|NCT00549770|589176556|FG000|Overall Study|Adverse Event|1|||
163128019|NCT00549770|589176557|FG001|Overall Study|Adverse Event|3|||
163128020|NCT00549770|589176558|FG002|Overall Study|Adverse Event|1|||
163128021|NCT00549770|589176559|FG003|Overall Study|Adverse Event|2|||
163128022|NCT00549770|589176560|FG004|Overall Study|Adverse Event|1|||
163128023|NCT00549770|589176561|FG005|Overall Study|Adverse Event|0|||
163128024|NCT00549770|589176562|FG006|Overall Study|Adverse Event|5|||
163128025|NCT00549770|589176563|FG007|Overall Study|Adverse Event|4|||
163128026|NCT04856904|589176566|FG000|Overall Study|Physician Decision|1|||
163128027|NCT04856904|589176567|FG001|Overall Study|Physician Decision|1|||
163128028|NCT04856904|589176566|FG000|Overall Study|Withdrawal by Subject|13|||
163128029|NCT04856904|589176567|FG001|Overall Study|Withdrawal by Subject|13|||
163128030|NCT04856904|589176566|FG000|Overall Study|Adverse Event|1|||
163128031|NCT04856904|589176567|FG001|Overall Study|Adverse Event|1|||
163128032|NCT04856904|589176566|FG000|Overall Study|Non-compliance with study drug|1|||
163128033|NCT04856904|589176567|FG001|Overall Study|Non-compliance with study drug|1|||
163128034|NCT04856904|589176566|FG000|Overall Study|Lost to Follow-up|4|||
163128035|NCT04856904|589176567|FG001|Overall Study|Lost to Follow-up|4|||
163128036|NCT04856904|589176566|FG000|Overall Study|Withdrawal by Subject|1|||
163128037|NCT04856904|589176567|FG001|Overall Study|Withdrawal by Subject|1|||
163128038|NCT04856904|589176566|FG000|Overall Study|Protocol Violation|1|||
163128039|NCT04856904|589176567|FG001|Overall Study|Protocol Violation|1|||
163128040|NCT02712424|589176568|FG000|Overall Study|Lost to Follow-up|34|||
163128041|NCT02712424|589176569|FG001|Overall Study|Lost to Follow-up|32|||
163128042|NCT00847015|589176570|FG000|Overall Study|Withdrawal by Subject|1|||
163128043|NCT00847015|589176570|FG000|Overall Study|declined any surgery|1|||
163128044|NCT00847015|589176570|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
162656587|NCT02283788|587455264|FG001|Overall Study|Withdrawal by Subject|1|||
162656588|NCT02283788|587455265|FG002|Overall Study|Withdrawal by Subject|0|||
163128045|NCT01641822|589176573|FG000|Run-in Phase|Noncompliance with study drug|1|||
163128046|NCT01641822|589176574|FG001|Run-in Phase|Noncompliance with study drug|0|||
163128047|NCT01641822|589176575|FG002|Run-in Phase|Noncompliance with study drug|0|||
163128048|NCT01641822|589176573|FG000|Run-in Phase|Adverse Event|3|||
163128049|NCT01641822|589176574|FG001|Run-in Phase|Adverse Event|0|||
163128050|NCT01641822|589176575|FG002|Run-in Phase|Adverse Event|0|||
162656589|NCT02283788|587455266|FG003|Overall Study|Withdrawal by Subject|1|||
163128051|NCT01641822|589176573|FG000|Run-in Phase|Withdrew consent|1|||
163128052|NCT01641822|589176574|FG001|Run-in Phase|Withdrew consent|0|||
163128053|NCT01641822|589176575|FG002|Run-in Phase|Withdrew consent|0|||
163128054|NCT01641822|589176573|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
163128055|NCT01641822|589176574|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
163128056|NCT01641822|589176575|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
163128057|NCT01641822|589176573|FG000|Comparative Phase|Noncompliance with study drug|0|||
163128058|NCT01641822|589176574|FG001|Comparative Phase|Noncompliance with study drug|1|||
163128059|NCT01641822|589176575|FG002|Comparative Phase|Noncompliance with study drug|0|||
163128060|NCT01641822|589176573|FG000|Comparative Phase|Investigator's discretion|0|||
163128061|NCT01641822|589176574|FG001|Comparative Phase|Investigator's discretion|0|||
163128062|NCT01641822|589176575|FG002|Comparative Phase|Investigator's discretion|1|||
163128063|NCT01641822|589176573|FG000|Comparative Phase|Pregnancy|0|||
163128064|NCT01641822|589176574|FG001|Comparative Phase|Pregnancy|0|||
163128065|NCT01641822|589176575|FG002|Comparative Phase|Pregnancy|1|||
163128066|NCT01641822|589176573|FG000|Comparative Phase|Adverse event, serious fatal|0|||
163128067|NCT01641822|589176574|FG001|Comparative Phase|Adverse event, serious fatal|1|||
163128068|NCT01641822|589176575|FG002|Comparative Phase|Adverse event, serious fatal|0|||
162656590|NCT02742103|587456881|FG000|Overall Study|Protocol Violation|1|||
163128069|NCT01641822|589176573|FG000|Comparative Phase|Withdrew consent|0|||
163128070|NCT01641822|589176574|FG001|Comparative Phase|Withdrew consent|3|||
163128071|NCT01641822|589176575|FG002|Comparative Phase|Withdrew consent|7|||
163128072|NCT01641822|589176573|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
163128073|NCT01641822|589176574|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
163128074|NCT01641822|589176575|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
163128075|NCT02760810|589176576|FG000|Overall Study|Protocol Violation|1|||
163128076|NCT02421601|589176577|FG000|Overall Study|Adverse Event|4|||
163128077|NCT02421601|589176577|FG000|Overall Study|Lack of Efficacy|5|||
163128078|NCT02421601|589176577|FG000|Overall Study|Physician Decision|1|||
163128079|NCT02421601|589176577|FG000|Overall Study|Withdrawal by Subject|31|||
163128080|NCT02421601|589176577|FG000|Overall Study|Others|41|||
163128081|NCT03847909|589176582|FG000|Overall Study|Withdrawal by Subject|1|||
163128082|NCT03847909|589176583|FG001|Overall Study|Withdrawal by Subject|1|||
162656591|NCT02742103|587456882|FG001|Overall Study|Protocol Violation|0|||
162656592|NCT02742103|587456881|FG000|Overall Study|Death|2|||
162656593|NCT02742103|587456882|FG001|Overall Study|Death|2|||
162656594|NCT02742103|587456881|FG000|Overall Study|Adverse Event|1|||
162656595|NCT02742103|587456882|FG001|Overall Study|Adverse Event|0|||
162656596|NCT02742103|587456881|FG000|Overall Study|Moved to another town|0|||
162656597|NCT02742103|587456882|FG001|Overall Study|Moved to another town|1|||
162656598|NCT02742103|587456881|FG000|Overall Study|Withdrawal by Subject|5|||
162656599|NCT02742103|587456882|FG001|Overall Study|Withdrawal by Subject|2|||
162656600|NCT00533949|587456885|FG000|Overall Study|Protocol Violation|12|||
162656601|NCT00533949|587456886|FG001|Overall Study|Protocol Violation|12|||
162656602|NCT00533949|587456887|FG002|Overall Study|Protocol Violation|9|||
162656603|NCT00533949|587456888|FG003|Overall Study|Protocol Violation|9|||
162656604|NCT00533949|587456885|FG000|Overall Study|Withdrawal by Subject|3|||
162656605|NCT00533949|587456886|FG001|Overall Study|Withdrawal by Subject|2|||
162656606|NCT00533949|587456887|FG002|Overall Study|Withdrawal by Subject|1|||
162656607|NCT00533949|587456888|FG003|Overall Study|Withdrawal by Subject|1|||
162656608|NCT00727194|587456889|FG000|Screening Period|Low QMG scores|0|||
162656609|NCT00727194|587456890|FG001|Screening Period|Low QMG scores|0|||
162656610|NCT00727194|587456891|FG002|Screening Period|Low QMG scores|6|||
162656611|NCT00727194|587456889|FG000|Screening Period|Lacked AChR antibodies|0|||
162656612|NCT00727194|587456890|FG001|Screening Period|Lacked AChR antibodies|0|||
162656613|NCT00727194|587456891|FG002|Screening Period|Lacked AChR antibodies|5|||
162656614|NCT00727194|587456889|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
162656615|NCT00727194|587456890|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
162656616|NCT00727194|587456891|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
162656617|NCT00727194|587456889|FG000|Screening Period|Severe infections|0|||
163128083|NCT00869401|589176584|FG000|Overall Study|Withdrawal by Subject|0|||
163128084|NCT00869401|589176585|FG001|Overall Study|Withdrawal by Subject|0|||
163128085|NCT00869401|589176586|FG002|Overall Study|Withdrawal by Subject|0|||
162656618|NCT00727194|587456890|FG001|Screening Period|Severe infections|0|||
162656619|NCT00727194|587456891|FG002|Screening Period|Severe infections|2|||
163128086|NCT00869401|589176587|FG003|Overall Study|Withdrawal by Subject|5|||
163128087|NCT00869401|589176588|FG004|Overall Study|Withdrawal by Subject|3|||
163128088|NCT00581360|589176589|FG000|Overall Study|Withdrawal by Subject|1|||
162656620|NCT00727194|587456889|FG000|Screening Period|History of thymoma|0|||
162656621|NCT00727194|587456890|FG001|Screening Period|History of thymoma|0|||
162656622|NCT00727194|587456891|FG002|Screening Period|History of thymoma|1|||
163128089|NCT00082381|589176590|FG000|Overall Study|Adverse Event|27|||
163128090|NCT00082381|589176591|FG001|Overall Study|Adverse Event|2|||
163128091|NCT00082381|589176590|FG000|Overall Study|Lost to Follow-up|5|||
162656623|NCT00727194|587456889|FG000|Treatment Period 2|Lack of Efficacy|0|||
162656624|NCT00727194|587456890|FG001|Treatment Period 2|Lack of Efficacy|1|||
162656625|NCT00727194|587456891|FG002|Treatment Period 2|Lack of Efficacy|0|||
162656626|NCT04269161|587456898|FG000|Overall Study|Change of modality and no longer eligible|3|||
163128092|NCT00082381|589176591|FG001|Overall Study|Lost to Follow-up|7|||
163128093|NCT00082381|589176590|FG000|Overall Study|Patient Decision|8|||
163128094|NCT00082381|589176591|FG001|Overall Study|Patient Decision|4|||
163128095|NCT00082381|589176590|FG000|Overall Study|Physician Decision|1|||
163128096|NCT00082381|589176591|FG001|Overall Study|Physician Decision|2|||
163128097|NCT00082381|589176590|FG000|Overall Study|Protocol Violation|10|||
163128098|NCT00082381|589176591|FG001|Overall Study|Protocol Violation|11|||
163128099|NCT00082381|589176590|FG000|Overall Study|Loss of Glucose Control|4|||
163128100|NCT00082381|589176591|FG001|Overall Study|Loss of Glucose Control|0|||
163128101|NCT02345330|589176595|FG000|Overall Study|Death|1|||
163128102|NCT02345330|589176595|FG000|Overall Study|Progressive Disease|2|||
163128103|NCT00109577|589176596|FG000|Overall Study|Withdrawal by Subject|3|||
163128104|NCT00109577|589176597|FG001|Overall Study|Withdrawal by Subject|3|||
163128105|NCT03322423|589176598|FG000|Period 1|Subject no longer eligible|0|||
163128106|NCT03322423|589176599|FG001|Period 1|Subject no longer eligible|1|||
163128107|NCT03322423|589176598|FG000|Period 1|Withdrawal by Subject|0|||
163128108|NCT03322423|589176599|FG001|Period 1|Withdrawal by Subject|1|||
163128109|NCT03322423|589176598|FG000|Period 1|Incorrect Lens Dispensed|1|||
163128110|NCT03322423|589176599|FG001|Period 1|Incorrect Lens Dispensed|0|||
163128111|NCT03322423|589176598|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
163128112|NCT03322423|589176599|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
163128113|NCT03322423|589176598|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
163128114|NCT03322423|589176599|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
163128115|NCT03322423|589176598|FG000|Period 2|Protocol Violation|1|||
163128116|NCT03322423|589176599|FG001|Period 2|Protocol Violation|0|||
163128117|NCT03322423|589176598|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
163128118|NCT03322423|589176599|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
163128119|NCT04891107|589176600|FG000|Overall Study|Physician Decision|1|||
163128120|NCT04891107|589176600|FG000|Overall Study|Withdrawal by Subject|1|||
163128121|NCT04891107|589176600|FG000|Overall Study|Screen failure after consent|1|||
163128122|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
163128123|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
163128124|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
163128125|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
163128126|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
163128127|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
163128128|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
163128129|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128130|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128131|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128132|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128133|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163128134|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
163128135|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
163128136|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128137|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128138|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128139|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163128140|NCT02453555|589176601|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
163128141|NCT02453555|589176602|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
163128142|NCT02453555|589176603|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
163128143|NCT02453555|589176604|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
163128144|NCT02453555|589176605|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
163128145|NCT02453555|589176606|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
163128146|NCT02453555|589176601|FG000|Extension Period|Adverse Event|0|||
163128147|NCT02453555|589176602|FG001|Extension Period|Adverse Event|0|||
163128148|NCT02453555|589176603|FG002|Extension Period|Adverse Event|1|||
163128149|NCT02453555|589176604|FG003|Extension Period|Adverse Event|2|||
163128150|NCT02453555|589176605|FG004|Extension Period|Adverse Event|1|||
163128151|NCT02453555|589176606|FG005|Extension Period|Adverse Event|1|||
163128152|NCT02453555|589176601|FG000|Extension Period|Protocol Violation|0|||
163128153|NCT02453555|589176602|FG001|Extension Period|Protocol Violation|0|||
163128154|NCT02453555|589176603|FG002|Extension Period|Protocol Violation|1|||
163128155|NCT02453555|589176604|FG003|Extension Period|Protocol Violation|0|||
163128156|NCT02453555|589176605|FG004|Extension Period|Protocol Violation|0|||
163128157|NCT02453555|589176606|FG005|Extension Period|Protocol Violation|0|||
163128158|NCT02453555|589176601|FG000|Extension Period|Withdrawal by Subject|0|||
163128159|NCT02453555|589176602|FG001|Extension Period|Withdrawal by Subject|0|||
163128160|NCT02453555|589176603|FG002|Extension Period|Withdrawal by Subject|1|||
163128161|NCT02453555|589176604|FG003|Extension Period|Withdrawal by Subject|0|||
163128162|NCT02453555|589176605|FG004|Extension Period|Withdrawal by Subject|0|||
163128163|NCT02453555|589176606|FG005|Extension Period|Withdrawal by Subject|0|||
163128164|NCT03689855|589176611|FG000|Overall Study|Adverse Event|3|||
162656627|NCT04269161|587456899|FG001|Overall Study|Change of modality and no longer eligible|3|||
162656628|NCT04269161|587456898|FG000|Overall Study|Required procedure outside of NICU|1|||
162656629|NCT04269161|587456899|FG001|Overall Study|Required procedure outside of NICU|0|||
162656630|NCT04269161|587456898|FG000|Overall Study|Equipment issue|1|||
162656631|NCT04269161|587456899|FG001|Overall Study|Equipment issue|1|||
162656632|NCT02472756|587456900|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
162656633|NCT02472756|587456900|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
162656634|NCT02472756|587456900|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
162656635|NCT02472756|587456900|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
162656636|NCT02472756|587456900|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
162656637|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Adverse Event|9|||
162656638|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Adverse Event|2|||
162656639|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
162656640|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
162656641|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
162656642|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
162656643|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Physician Decision|1|||
162656644|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Physician Decision|1|||
162656645|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Pregnancy|2|||
162656646|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Pregnancy|0|||
162656647|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
162656648|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
162656649|NCT02896127|587456903|FG000|COMPLETED WEEK 52|Technical problems|1|||
162656650|NCT02896127|587456904|FG001|COMPLETED WEEK 52|Technical problems|0|||
162656651|NCT02896127|587456903|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
162656652|NCT02896127|587456904|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
162656653|NCT02896127|587456903|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
162656654|NCT02896127|587456904|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
162656655|NCT02896127|587456903|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
162656656|NCT02896127|587456904|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
163128165|NCT03689855|589176611|FG000|Overall Study|Withdrawal by Subject|1|||
163128166|NCT03178669|589176612|FG000|Overall Study|Adverse Event|4|||
162656657|NCT02896127|587456903|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
162656658|NCT02896127|587456904|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
162656659|NCT02896127|587456903|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
162656660|NCT02896127|587456904|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
162656661|NCT01782313|587456905|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
162656662|NCT01782313|587456905|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
162656663|NCT01782313|587456905|FG000|Treated Cycle 3|Progressive Disease|21|||
162656664|NCT01782313|587456905|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
162656665|NCT01782313|587456905|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
162656666|NCT01782313|587456905|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
162656667|NCT01782313|587456905|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
162656668|NCT01782313|587456905|FG000|Survival Follow up|Lost to Follow-up|1|||
162656669|NCT00958776|587456906|FG000|Overall Study|Adverse Event|0|||
162656670|NCT00958776|587456907|FG001|Overall Study|Adverse Event|1|||
162656671|NCT00958776|587456906|FG000|Overall Study|Physician Decision|1|||
162656672|NCT00958776|587456907|FG001|Overall Study|Physician Decision|0|||
162656673|NCT00958776|587456906|FG000|Overall Study|Lost to Follow-up|2|||
162656674|NCT00958776|587456907|FG001|Overall Study|Lost to Follow-up|6|||
162656675|NCT00958776|587456906|FG000|Overall Study|Withdrawal by Subject|7|||
162656676|NCT00958776|587456907|FG001|Overall Study|Withdrawal by Subject|16|||
162656677|NCT00958776|587456906|FG000|Overall Study|Protocol Violation|1|||
163128167|NCT03178669|589176613|FG001|Overall Study|Adverse Event|1|||
163128168|NCT03178669|589176614|FG002|Overall Study|Adverse Event|4|||
163128169|NCT03178669|589176615|FG003|Overall Study|Adverse Event|2|||
163128170|NCT03178669|589176616|FG004|Overall Study|Adverse Event|2|||
163128171|NCT03178669|589176612|FG000|Overall Study|Lack of Efficacy|0|||
163128172|NCT03178669|589176613|FG001|Overall Study|Lack of Efficacy|0|||
163128173|NCT03178669|589176614|FG002|Overall Study|Lack of Efficacy|2|||
163128174|NCT03178669|589176615|FG003|Overall Study|Lack of Efficacy|0|||
163128175|NCT03178669|589176616|FG004|Overall Study|Lack of Efficacy|1|||
162656678|NCT00958776|587456907|FG001|Overall Study|Protocol Violation|1|||
162656679|NCT00958776|587456906|FG000|Overall Study|Death|2|||
162656680|NCT00958776|587456907|FG001|Overall Study|Death|1|||
162656681|NCT00958776|587456906|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
162656682|NCT00958776|587456907|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
162656683|NCT00958776|587456906|FG000|Overall Study|Missing|1|||
162656684|NCT00958776|587456907|FG001|Overall Study|Missing|1|||
163128176|NCT03178669|589176612|FG000|Overall Study|Physician Decision|0|||
163128177|NCT03178669|589176613|FG001|Overall Study|Physician Decision|0|||
163128178|NCT03178669|589176614|FG002|Overall Study|Physician Decision|0|||
163128179|NCT03178669|589176615|FG003|Overall Study|Physician Decision|0|||
163128180|NCT03178669|589176616|FG004|Overall Study|Physician Decision|1|||
162656685|NCT00326911|587456908|FG000|Overall Study|Hospitalization prior to treatment|0|||
162656686|NCT00326911|587456909|FG001|Overall Study|Hospitalization prior to treatment|1|||
162656687|NCT00326911|587456908|FG000|Overall Study|Physician decision prior to treatment|1|||
162656688|NCT00326911|587456909|FG001|Overall Study|Physician decision prior to treatment|0|||
162656689|NCT00326911|587456908|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
162656690|NCT00326911|587456909|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
162656691|NCT00418691|587456918|FG000|Overall Study|Lost to Follow-up|1|||
162656692|NCT00418691|587456919|FG001|Overall Study|Lost to Follow-up|2|||
162656693|NCT00418691|587456920|FG002|Overall Study|Lost to Follow-up|3|||
162656694|NCT00418691|587456918|FG000|Overall Study|Started new medication voiding entry|0|||
162656695|NCT00418691|587456919|FG001|Overall Study|Started new medication voiding entry|0|||
162656696|NCT00418691|587456920|FG002|Overall Study|Started new medication voiding entry|1|||
162656697|NCT00418691|587456918|FG000|Overall Study|Progressive Disease|1|||
162656698|NCT00418691|587456919|FG001|Overall Study|Progressive Disease|0|||
162656699|NCT00418691|587456920|FG002|Overall Study|Progressive Disease|1|||
162656700|NCT00501540|587456921|FG000|Overall Study|Death|5|||
162656701|NCT02331446|587456922|FG000|Overall Study|Lost to Follow-up|2|||
162656702|NCT02331446|587456923|FG001|Overall Study|Lost to Follow-up|1|||
162656703|NCT02331446|587456924|FG002|Overall Study|Lost to Follow-up|0|||
162656704|NCT02331446|587456925|FG003|Overall Study|Lost to Follow-up|1|||
162656705|NCT02331446|587456922|FG000|Overall Study|Personal Problem|2|||
162656706|NCT02331446|587456923|FG001|Overall Study|Personal Problem|0|||
162656707|NCT02331446|587456924|FG002|Overall Study|Personal Problem|0|||
162656708|NCT02331446|587456925|FG003|Overall Study|Personal Problem|0|||
162656709|NCT02331446|587456922|FG000|Overall Study|Disease|0|||
162656710|NCT02331446|587456923|FG001|Overall Study|Disease|2|||
162656711|NCT02331446|587456924|FG002|Overall Study|Disease|2|||
162656712|NCT02331446|587456925|FG003|Overall Study|Disease|1|||
162656713|NCT02331446|587456922|FG000|Overall Study|Physician Decision|0|||
162656714|NCT02331446|587456923|FG001|Overall Study|Physician Decision|1|||
162656715|NCT02331446|587456924|FG002|Overall Study|Physician Decision|0|||
162656716|NCT02331446|587456925|FG003|Overall Study|Physician Decision|1|||
162656717|NCT02331446|587456922|FG000|Overall Study|Lost before baseline analysis|0|||
162656718|NCT02331446|587456923|FG001|Overall Study|Lost before baseline analysis|1|||
162656719|NCT02331446|587456924|FG002|Overall Study|Lost before baseline analysis|1|||
162656720|NCT02331446|587456925|FG003|Overall Study|Lost before baseline analysis|0|||
162656721|NCT02984995|587456926|FG000|Overall Study|Required stem cell transplant|13|||
162656722|NCT02984995|587456927|FG001|Overall Study|Required stem cell transplant|2|||
162656723|NCT02984995|587456926|FG000|Overall Study|Progressive disease|11|||
162656724|NCT02984995|587456927|FG001|Overall Study|Progressive disease|1|||
162656725|NCT02984995|587456926|FG000|Overall Study|Adverse Event|1|||
162656726|NCT02984995|587456927|FG001|Overall Study|Adverse Event|0|||
162656727|NCT04182100|587456928|FG000|Overall Study|Adverse Event|1|||
162656728|NCT04182100|587456928|FG000|Overall Study|Withdrawal by Subject|1|||
162656729|NCT02504372|587456931|FG000|Overall Study|Death|136|||
162656730|NCT02504372|587456932|FG001|Overall Study|Death|154|||
162656731|NCT02504372|587456931|FG000|Overall Study|Lost to Follow-up|0|||
163128181|NCT03178669|589176612|FG000|Overall Study|Withdrawal by Subject|1|||
163128182|NCT03178669|589176613|FG001|Overall Study|Withdrawal by Subject|0|||
163128183|NCT03178669|589176614|FG002|Overall Study|Withdrawal by Subject|1|||
163128184|NCT03178669|589176615|FG003|Overall Study|Withdrawal by Subject|1|||
163128185|NCT03178669|589176616|FG004|Overall Study|Withdrawal by Subject|0|||
163128186|NCT03178669|589176612|FG000|Overall Study|Lost to Follow-up|0|||
163128187|NCT03178669|589176613|FG001|Overall Study|Lost to Follow-up|0|||
163128188|NCT03178669|589176614|FG002|Overall Study|Lost to Follow-up|0|||
163128189|NCT03178669|589176615|FG003|Overall Study|Lost to Follow-up|1|||
163128190|NCT03178669|589176616|FG004|Overall Study|Lost to Follow-up|0|||
162656732|NCT02504372|587456932|FG001|Overall Study|Lost to Follow-up|2|||
163128191|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
163128192|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
163128193|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
162656733|NCT02504372|587456931|FG000|Overall Study|Withdrawal of consent|25|||
162656734|NCT02504372|587456932|FG001|Overall Study|Withdrawal of consent|16|||
162656735|NCT02504372|587456931|FG000|Overall Study|Participants ongoing|429|||
162719715|NCT05190419|587680547|FG003|Overall Study|Other|3|||
163128194|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
162656736|NCT02504372|587456932|FG001|Overall Study|Participants ongoing|415|||
162656737|NCT00433654|587456933|FG000|Overall Study|Death|4|||
162656738|NCT00433654|587456934|FG001|Overall Study|Death|0|||
162656739|NCT00433654|587456933|FG000|Overall Study|Missed visit|6|||
162656740|NCT00433654|587456934|FG001|Overall Study|Missed visit|3|||
162656741|NCT00433654|587456933|FG000|Overall Study|Subject not yet due for visit|4|||
163128195|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
162656742|NCT00433654|587456934|FG001|Overall Study|Subject not yet due for visit|0|||
162656743|NCT00433654|587456933|FG000|Overall Study|Withdrawal by Subject|1|||
162656744|NCT00433654|587456934|FG001|Overall Study|Withdrawal by Subject|2|||
163128196|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
163128197|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128198|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128199|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128200|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128201|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
163128202|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
163128203|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
163128204|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
163128205|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128206|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
163128207|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
163128208|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128209|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128210|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128211|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128212|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
163128213|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128214|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
163128215|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128216|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128217|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
163128218|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
163128219|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128220|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128221|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128222|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128223|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
163128224|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
163128225|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
163128226|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
163128227|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128228|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
163128229|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
163128230|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128231|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128232|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128233|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128234|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
163128235|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128236|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128237|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
163128238|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128239|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128240|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
163128241|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128242|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128243|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128244|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128245|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
163128246|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
163128247|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128248|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128249|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128250|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128251|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128252|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128253|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128254|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128255|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163128256|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
162656745|NCT00499603|587456958|FG000|Overall Study|Adverse Event|0|||
163128257|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128258|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128259|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
162656746|NCT00499603|587456959|FG001|Overall Study|Adverse Event|1|||
162656747|NCT00937547|587456960|FG000|Overall Study|misdiagnosis|1|||
162656748|NCT00937547|587456961|FG001|Overall Study|misdiagnosis|6|||
162656749|NCT00937547|587456962|FG002|Overall Study|misdiagnosis|7|||
162656750|NCT04439240|587456963|FG000|Overall Study|Ineligible|2|||
162656751|NCT04439240|587456963|FG000|Overall Study|Never started treatment|2|||
162656752|NCT04439240|587456963|FG000|Overall Study|Adverse Event|12|||
162656753|NCT04439240|587456963|FG000|Overall Study|Death|2|||
162656754|NCT04439240|587456963|FG000|Overall Study|Disease progression|25|||
162656755|NCT04439240|587456963|FG000|Overall Study|Other diseases|2|||
162656756|NCT04439240|587456963|FG000|Overall Study|Withdrawal by Subject|3|||
162656757|NCT04439240|587456963|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
162656758|NCT04439240|587456963|FG000|Overall Study|Symptomatic decline|1|||
162656759|NCT04439240|587456963|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
162656760|NCT04439240|587456963|FG000|Overall Study|Clinical progression|1|||
162656761|NCT00813124|587456965|FG000|Overall Study|Death|2|||
162656762|NCT00813124|587456965|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
162656763|NCT00813124|587456965|FG000|Overall Study|Withdrawal by Subject|1|||
162656764|NCT00079274|587456966|FG000|Overall Study|Withdrawal by Subject|111|||
162656765|NCT00079274|587456967|FG001|Overall Study|Withdrawal by Subject|10|||
162656766|NCT00079274|587456968|FG002|Overall Study|Withdrawal by Subject|12|||
162656767|NCT00079274|587456969|FG003|Overall Study|Withdrawal by Subject|163|||
162656768|NCT00079274|587456970|FG004|Overall Study|Withdrawal by Subject|7|||
162656769|NCT00079274|587456971|FG005|Overall Study|Withdrawal by Subject|8|||
162656770|NCT00079274|587456972|FG006|Overall Study|Withdrawal by Subject|0|||
162656771|NCT00079274|587456966|FG000|Overall Study|Adverse Event|130|||
162656772|NCT00079274|587456967|FG001|Overall Study|Adverse Event|8|||
162656773|NCT00079274|587456968|FG002|Overall Study|Adverse Event|8|||
162656774|NCT00079274|587456969|FG003|Overall Study|Adverse Event|184|||
162656775|NCT00079274|587456970|FG004|Overall Study|Adverse Event|7|||
162656776|NCT00079274|587456971|FG005|Overall Study|Adverse Event|8|||
162656777|NCT00079274|587456972|FG006|Overall Study|Adverse Event|0|||
162656778|NCT00079274|587456966|FG000|Overall Study|Recurrence|21|||
162656779|NCT00079274|587456967|FG001|Overall Study|Recurrence|0|||
162656780|NCT00079274|587456968|FG002|Overall Study|Recurrence|1|||
162656781|NCT00079274|587456969|FG003|Overall Study|Recurrence|15|||
162656782|NCT00079274|587456970|FG004|Overall Study|Recurrence|0|||
162656783|NCT00079274|587456971|FG005|Overall Study|Recurrence|2|||
162656784|NCT00079274|587456972|FG006|Overall Study|Recurrence|0|||
162656785|NCT00079274|587456966|FG000|Overall Study|Alternate Treatment|6|||
162656786|NCT00079274|587456967|FG001|Overall Study|Alternate Treatment|1|||
162656787|NCT00079274|587456968|FG002|Overall Study|Alternate Treatment|0|||
162656788|NCT00079274|587456969|FG003|Overall Study|Alternate Treatment|3|||
162656789|NCT00079274|587456970|FG004|Overall Study|Alternate Treatment|0|||
162656790|NCT00079274|587456971|FG005|Overall Study|Alternate Treatment|0|||
162656791|NCT00079274|587456972|FG006|Overall Study|Alternate Treatment|0|||
162656792|NCT00079274|587456966|FG000|Overall Study|Other Medical Problems|6|||
162656793|NCT00079274|587456967|FG001|Overall Study|Other Medical Problems|1|||
162656794|NCT00079274|587456968|FG002|Overall Study|Other Medical Problems|0|||
162656795|NCT00079274|587456969|FG003|Overall Study|Other Medical Problems|7|||
162656796|NCT00079274|587456970|FG004|Overall Study|Other Medical Problems|0|||
162656797|NCT00079274|587456971|FG005|Overall Study|Other Medical Problems|0|||
162656798|NCT00079274|587456972|FG006|Overall Study|Other Medical Problems|0|||
162656799|NCT00079274|587456966|FG000|Overall Study|Death|4|||
162656800|NCT00079274|587456967|FG001|Overall Study|Death|0|||
162656801|NCT00079274|587456968|FG002|Overall Study|Death|1|||
162656802|NCT00079274|587456969|FG003|Overall Study|Death|15|||
162656803|NCT00079274|587456970|FG004|Overall Study|Death|0|||
162656804|NCT00079274|587456971|FG005|Overall Study|Death|0|||
162656805|NCT00079274|587456972|FG006|Overall Study|Death|0|||
162656806|NCT00079274|587456966|FG000|Overall Study|Cytogenetic resistance|0|||
162656807|NCT00079274|587456967|FG001|Overall Study|Cytogenetic resistance|0|||
162656808|NCT00079274|587456968|FG002|Overall Study|Cytogenetic resistance|0|||
162656809|NCT00079274|587456969|FG003|Overall Study|Cytogenetic resistance|2|||
162656810|NCT00079274|587456970|FG004|Overall Study|Cytogenetic resistance|0|||
162656811|NCT00079274|587456971|FG005|Overall Study|Cytogenetic resistance|0|||
162656812|NCT00079274|587456972|FG006|Overall Study|Cytogenetic resistance|0|||
162656813|NCT00079274|587456966|FG000|Overall Study|Other|43|||
162656814|NCT00079274|587456967|FG001|Overall Study|Other|7|||
162656815|NCT00079274|587456968|FG002|Overall Study|Other|5|||
162719716|NCT02020616|587680548|FG000|Overall Study|Adverse Event|0|||
162656816|NCT00079274|587456969|FG003|Overall Study|Other|55|||
162656817|NCT00079274|587456970|FG004|Overall Study|Other|1|||
162656818|NCT00079274|587456971|FG005|Overall Study|Other|2|||
162656819|NCT00079274|587456972|FG006|Overall Study|Other|0|||
162656820|NCT01147653|587456977|FG000|Year 2|Withdrawal by Subject|2|||
162656821|NCT01147653|587456978|FG001|Year 2|Withdrawal by Subject|3|||
162656822|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
162656823|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
162656824|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
162656825|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
162656826|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
163128260|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128261|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
162656827|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
162656828|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
162656829|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
162656830|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
162656831|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
162656832|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
162656833|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
162656834|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
162656835|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
162656836|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
162656837|NCT00280566|587456979|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
162656838|NCT00280566|587456980|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
162656839|NCT00280566|587456981|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
162656840|NCT00280566|587456979|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
162656841|NCT00280566|587456980|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
162656842|NCT00280566|587456981|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
162656843|NCT00280566|587456979|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
162656844|NCT00280566|587456980|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
162656845|NCT00280566|587456981|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
162656846|NCT00280566|587456979|FG000|Period 2 Double Blind|Adverse Event|0|||
162656847|NCT00280566|587456980|FG001|Period 2 Double Blind|Adverse Event|11|||
162656848|NCT00280566|587456981|FG002|Period 2 Double Blind|Adverse Event|15|||
162656849|NCT00280566|587456979|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
162656850|NCT00280566|587456980|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
162656851|NCT00280566|587456981|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
162656852|NCT00280566|587456979|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
162656853|NCT00280566|587456980|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
162656854|NCT00280566|587456981|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
162656855|NCT00280566|587456979|FG000|Period 2 Double Blind|miscellaneous|0|||
162656856|NCT00280566|587456980|FG001|Period 2 Double Blind|miscellaneous|10|||
162656857|NCT00280566|587456981|FG002|Period 2 Double Blind|miscellaneous|5|||
162656858|NCT01302392|587456984|FG000|Overall Study|Lost to Follow-up|1|||
162656859|NCT01302392|587456985|FG001|Overall Study|Lost to Follow-up|0|||
162656860|NCT01302392|587456984|FG000|Overall Study|Withdrawal by Subject|6|||
162656861|NCT01302392|587456985|FG001|Overall Study|Withdrawal by Subject|1|||
162656862|NCT00670228|587456986|FG000|Overall Study|Adverse Event|1|||
162656863|NCT00670228|587456987|FG001|Overall Study|Adverse Event|0|||
162656864|NCT00670228|587456986|FG000|Overall Study|Death or MACE|0|||
162656865|NCT00670228|587456987|FG001|Overall Study|Death or MACE|1|||
162656866|NCT00670228|587456986|FG000|Overall Study|Not treated|2|||
162656867|NCT00670228|587456987|FG001|Overall Study|Not treated|2|||
162656868|NCT00670228|587456986|FG000|Overall Study|Not meeting the selection criteria|2|||
162656869|NCT00670228|587456987|FG001|Overall Study|Not meeting the selection criteria|0|||
162656870|NCT03604692|587456988|FG000|Overall Study|Investigator's Decision|0|||
162656871|NCT03604692|587456989|FG001|Overall Study|Investigator's Decision|0|||
162656872|NCT03604692|587456990|FG002|Overall Study|Investigator's Decision|0|||
162656873|NCT03604692|587456991|FG003|Overall Study|Investigator's Decision|1|||
162656874|NCT03604692|587456992|FG004|Overall Study|Investigator's Decision|0|||
162656875|NCT03604692|587456993|FG005|Overall Study|Investigator's Decision|7|||
162656876|NCT03604692|587456988|FG000|Overall Study|Withdrawal by Subject|0|||
162656877|NCT03604692|587456989|FG001|Overall Study|Withdrawal by Subject|0|||
162656878|NCT03604692|587456990|FG002|Overall Study|Withdrawal by Subject|0|||
162656879|NCT03604692|587456991|FG003|Overall Study|Withdrawal by Subject|0|||
162656880|NCT03604692|587456992|FG004|Overall Study|Withdrawal by Subject|0|||
162656881|NCT03604692|587456993|FG005|Overall Study|Withdrawal by Subject|2|||
162656882|NCT03604692|587456988|FG000|Overall Study|Progressive Disease|1|||
162656883|NCT03604692|587456989|FG001|Overall Study|Progressive Disease|0|||
162719717|NCT02020616|587680549|FG001|Overall Study|Adverse Event|0|||
162656884|NCT03604692|587456990|FG002|Overall Study|Progressive Disease|1|||
162656885|NCT03604692|587456991|FG003|Overall Study|Progressive Disease|0|||
162656886|NCT03604692|587456992|FG004|Overall Study|Progressive Disease|3|||
162656887|NCT03604692|587456993|FG005|Overall Study|Progressive Disease|4|||
162656888|NCT03604692|587456988|FG000|Overall Study|Difficulty Coming into Site|0|||
162656889|NCT03604692|587456989|FG001|Overall Study|Difficulty Coming into Site|0|||
162656890|NCT03604692|587456990|FG002|Overall Study|Difficulty Coming into Site|0|||
162656891|NCT03604692|587456991|FG003|Overall Study|Difficulty Coming into Site|0|||
162656892|NCT03604692|587456992|FG004|Overall Study|Difficulty Coming into Site|0|||
162656893|NCT03604692|587456993|FG005|Overall Study|Difficulty Coming into Site|1|||
162656894|NCT03604692|587456988|FG000|Overall Study|Death|0|||
162656895|NCT03604692|587456989|FG001|Overall Study|Death|0|||
162656896|NCT03604692|587456990|FG002|Overall Study|Death|1|||
162656897|NCT03604692|587456991|FG003|Overall Study|Death|0|||
162656898|NCT03604692|587456992|FG004|Overall Study|Death|0|||
162656899|NCT03604692|587456993|FG005|Overall Study|Death|0|||
162656900|NCT03604692|587456988|FG000|Overall Study|Drug Intolerance|0|||
162656901|NCT03604692|587456989|FG001|Overall Study|Drug Intolerance|0|||
162656902|NCT03604692|587456990|FG002|Overall Study|Drug Intolerance|0|||
162656903|NCT03604692|587456991|FG003|Overall Study|Drug Intolerance|1|||
162656904|NCT03604692|587456992|FG004|Overall Study|Drug Intolerance|0|||
162656905|NCT03604692|587456993|FG005|Overall Study|Drug Intolerance|0|||
162656906|NCT03604692|587456988|FG000|Overall Study|Noncompliance with follow-up visit|0|||
162656907|NCT03604692|587456989|FG001|Overall Study|Noncompliance with follow-up visit|0|||
162656908|NCT03604692|587456990|FG002|Overall Study|Noncompliance with follow-up visit|0|||
162656909|NCT03604692|587456991|FG003|Overall Study|Noncompliance with follow-up visit|1|||
162656910|NCT03604692|587456992|FG004|Overall Study|Noncompliance with follow-up visit|0|||
162656911|NCT03604692|587456993|FG005|Overall Study|Noncompliance with follow-up visit|0|||
162656912|NCT03604692|587456988|FG000|Overall Study|Not Treated|0|||
162656913|NCT03604692|587456989|FG001|Overall Study|Not Treated|0|||
162656914|NCT03604692|587456990|FG002|Overall Study|Not Treated|0|||
162656915|NCT03604692|587456991|FG003|Overall Study|Not Treated|0|||
163128262|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128263|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128264|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
162656916|NCT03604692|587456992|FG004|Overall Study|Not Treated|1|||
163128265|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128266|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128267|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
163128268|NCT02914561|589176617|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
163128269|NCT02914561|589176618|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128270|NCT02914561|589176619|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128271|NCT02914561|589176620|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128272|NCT02914561|589176621|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128273|NCT02914561|589176622|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
163128274|NCT02914561|589176623|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128275|NCT02914561|589176624|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128276|NCT02914561|589176625|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128277|NCT02914561|589176626|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128278|NCT02914561|589176627|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
163128279|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128280|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128281|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128282|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128283|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128284|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
163128285|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
163128286|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
163128287|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
163128288|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
163128289|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
163128290|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128291|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128292|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128293|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128294|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128295|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
163128296|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
163128297|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
163128298|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
163128299|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
163128300|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
163128301|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
162656917|NCT03604692|587456993|FG005|Overall Study|Not Treated|0|||
162656918|NCT00637195|587456994|FG000|Overall Study|Lost to Follow-up|1|||
162656919|NCT00637195|587456995|FG001|Overall Study|Lost to Follow-up|0|||
162656920|NCT00637195|587456994|FG000|Overall Study|Other|2|||
162656921|NCT00637195|587456995|FG001|Overall Study|Other|0|||
162656922|NCT00637195|587456994|FG000|Overall Study|Withdrawal by Subject|0|||
162656923|NCT00637195|587456995|FG001|Overall Study|Withdrawal by Subject|1|||
162656924|NCT00547703|587456998|FG000|Overall Study|Lost to Follow-up|1|||
162656925|NCT00547703|587456999|FG001|Overall Study|Lost to Follow-up|0|||
163128302|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128303|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128304|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128305|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128306|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
163128307|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
163128308|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
163128309|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
163128310|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
163128311|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
163128312|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128313|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128314|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128315|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128316|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128317|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128318|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
163128319|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128320|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
163128321|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
163128322|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
163128323|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128324|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128325|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128326|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128327|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128328|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128329|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
163128330|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
163128331|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
163128332|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
163128333|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
163128334|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128335|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128336|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128337|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128338|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128339|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128340|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
163128341|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128342|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
163128343|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128344|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
163128345|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128346|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128347|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128348|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128349|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128350|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128351|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128352|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128353|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
163128354|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128355|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
163128356|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128357|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128358|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128359|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128360|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128361|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128362|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
163128363|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128364|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128365|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128366|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
163128367|NCT02914561|589176617|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128368|NCT02914561|589176618|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128369|NCT02914561|589176619|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128370|NCT02914561|589176620|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128371|NCT02914561|589176621|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128372|NCT02914561|589176622|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128373|NCT02914561|589176623|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128374|NCT02914561|589176624|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
163128375|NCT02914561|589176625|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128376|NCT02914561|589176626|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128377|NCT02914561|589176627|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
163128378|NCT01300455|589176628|FG000|Washout|Withdrawal by Subject|1|||
163128379|NCT01300455|589176629|FG001|Washout|Withdrawal by Subject|0|||
163128380|NCT00778895|589176642|FG000|Active Phase|Adverse Event|3|||
163128381|NCT00778895|589176643|FG001|Active Phase|Adverse Event|1|||
163128382|NCT00778895|589176644|FG002|Active Phase|Adverse Event|0|||
163128383|NCT00778895|589176642|FG000|Active Phase|Withdrawal by Subject|1|||
163128384|NCT00778895|589176643|FG001|Active Phase|Withdrawal by Subject|4|||
163128385|NCT00778895|589176644|FG002|Active Phase|Withdrawal by Subject|0|||
163128386|NCT00778895|589176642|FG000|Active Phase|Lost to Follow-up|1|||
163128387|NCT00778895|589176643|FG001|Active Phase|Lost to Follow-up|1|||
163128388|NCT00778895|589176644|FG002|Active Phase|Lost to Follow-up|0|||
163128389|NCT00778895|589176642|FG000|Active Phase|Other|2|||
163128390|NCT00778895|589176643|FG001|Active Phase|Other|0|||
163128391|NCT00778895|589176644|FG002|Active Phase|Other|0|||
163128392|NCT00778895|589176642|FG000|ESFU Phase|Adverse Event|2|||
163128393|NCT00778895|589176643|FG001|ESFU Phase|Adverse Event|1|||
163128394|NCT00778895|589176644|FG002|ESFU Phase|Adverse Event|0|||
163128395|NCT00778895|589176642|FG000|ESFU Phase|Withdrawal by Subject|1|||
163128396|NCT00778895|589176643|FG001|ESFU Phase|Withdrawal by Subject|4|||
163128397|NCT00778895|589176644|FG002|ESFU Phase|Withdrawal by Subject|0|||
163128398|NCT00778895|589176642|FG000|ESFU Phase|Lost to Follow-up|6|||
163128399|NCT00778895|589176643|FG001|ESFU Phase|Lost to Follow-up|7|||
163128400|NCT00778895|589176644|FG002|ESFU Phase|Lost to Follow-up|2|||
162656926|NCT01193556|587457005|FG000|Overall Study|Study termination|26|||
162656927|NCT01193556|587457006|FG001|Overall Study|Study termination|25|||
162656928|NCT01696032|587457007|FG000|Overall Study|Withdrawal by Subject|0|||
162656929|NCT01696032|587457008|FG001|Overall Study|Withdrawal by Subject|0|||
162656930|NCT01696032|587457009|FG002|Overall Study|Withdrawal by Subject|1|||
162656931|NCT01696032|587457010|FG003|Overall Study|Withdrawal by Subject|2|||
162656932|NCT01696032|587457007|FG000|Overall Study|Death|14|||
162656933|NCT01696032|587457008|FG001|Overall Study|Death|4|||
162656934|NCT01696032|587457009|FG002|Overall Study|Death|43|||
163128401|NCT00778895|589176642|FG000|ESFU Phase|Other|2|||
163128402|NCT00778895|589176643|FG001|ESFU Phase|Other|0|||
163128403|NCT00778895|589176644|FG002|ESFU Phase|Other|0|||
163128404|NCT03332160|589176645|FG000|Overall Study|Withdrawal by Subject|1|||
163128405|NCT03332160|589176646|FG001|Overall Study|Withdrawal by Subject|1|||
163128406|NCT03332160|589176645|FG000|Overall Study|Adverse Event|0|||
163128407|NCT03332160|589176646|FG001|Overall Study|Adverse Event|1|||
163128408|NCT03332160|589176645|FG000|Overall Study|Developed Exclusion Criteria|0|||
163128409|NCT03332160|589176646|FG001|Overall Study|Developed Exclusion Criteria|1|||
163128410|NCT03332160|589176645|FG000|Overall Study|Non-adherence to treatment|0|||
163128411|NCT03332160|589176646|FG001|Overall Study|Non-adherence to treatment|2|||
163128412|NCT00576576|589176650|FG000|Overall Study|Lost to Follow-up|6|||
163128413|NCT00576576|589176650|FG000|Overall Study|Protocol Violation|1|||
163128414|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128415|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128416|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128417|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128418|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128419|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128420|NCT00718770|589176657|FG000|Overall Study|Lack of Efficacy|1|||
163128421|NCT00718770|589176657|FG000|Overall Study|Adverse Event|1|||
163128422|NCT00772109|589176658|FG000|Overall Study|Serious adverse event|1|||
163128423|NCT00772109|589176659|FG001|Overall Study|Serious adverse event|0|||
162656935|NCT01696032|587457010|FG003|Overall Study|Death|18|||
162656936|NCT01696032|587457007|FG000|Overall Study|Lost to Follow-up|0|||
162656937|NCT01696032|587457008|FG001|Overall Study|Lost to Follow-up|1|||
162656938|NCT01696032|587457009|FG002|Overall Study|Lost to Follow-up|0|||
162719718|NCT02020616|587680550|FG002|Overall Study|Adverse Event|0|||
163128424|NCT00772109|589176660|FG002|Overall Study|Serious adverse event|1|||
163128425|NCT00772109|589176661|FG003|Overall Study|Serious adverse event|0|||
163128426|NCT00772109|589176658|FG000|Overall Study|Protocol Violation|5|||
163128427|NCT00772109|589176659|FG001|Overall Study|Protocol Violation|8|||
163128428|NCT00772109|589176660|FG002|Overall Study|Protocol Violation|7|||
163128429|NCT00772109|589176661|FG003|Overall Study|Protocol Violation|6|||
163128430|NCT00772109|589176658|FG000|Overall Study|Lost to Follow-up|7|||
163128431|NCT00772109|589176659|FG001|Overall Study|Lost to Follow-up|3|||
163128432|NCT00772109|589176660|FG002|Overall Study|Lost to Follow-up|5|||
163128433|NCT00772109|589176661|FG003|Overall Study|Lost to Follow-up|9|||
163128434|NCT00772109|589176658|FG000|Overall Study|Withdrawal by Subject|8|||
163128435|NCT00772109|589176659|FG001|Overall Study|Withdrawal by Subject|8|||
163128436|NCT00772109|589176660|FG002|Overall Study|Withdrawal by Subject|6|||
163128437|NCT00772109|589176661|FG003|Overall Study|Withdrawal by Subject|16|||
163128438|NCT00410605|589176662|FG000|Overall Study|Adverse Event|12|||
163128439|NCT00410605|589176662|FG000|Overall Study|Physician Decision|3|||
163128440|NCT00410605|589176662|FG000|Overall Study|Withdrawal by Subject|5|||
163128441|NCT00410605|589176662|FG000|Overall Study|Started Non-Protocol Therapy|3|||
163128442|NCT00410605|589176662|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
163128443|NCT00410605|589176662|FG000|Overall Study|Transferred to another Institution|1|||
163128444|NCT04583956|589176663|FG000|Overall Study|Death|9|||
163128445|NCT04583956|589176664|FG001|Overall Study|Death|11|||
163128446|NCT04583956|589176663|FG000|Overall Study|Lost to Follow-up|7|||
163128447|NCT04583956|589176664|FG001|Overall Study|Lost to Follow-up|9|||
163128448|NCT04583956|589176663|FG000|Overall Study|Protocol Violation|2|||
163128449|NCT04583956|589176664|FG001|Overall Study|Protocol Violation|0|||
163128450|NCT04583956|589176663|FG000|Overall Study|Withdrawal by Subject|0|||
163128451|NCT04583956|589176664|FG001|Overall Study|Withdrawal by Subject|2|||
163128452|NCT04583956|589176663|FG000|Overall Study|Randomized but not dosed|2|||
163128453|NCT04583956|589176664|FG001|Overall Study|Randomized but not dosed|3|||
163128454|NCT04583956|589176663|FG000|Overall Study|Withdrawal of consent before product administration|1|||
163128455|NCT04583956|589176664|FG001|Overall Study|Withdrawal of consent before product administration|0|||
163128456|NCT01370265|589178011|FG000|First Intervention|Adverse Event|1|||
163128457|NCT01370265|589178012|FG001|First Intervention|Adverse Event|1|||
163128458|NCT00703924|589178013|FG000|Overall Study|Withdrawal by Subject|1|||
163128459|NCT00703924|589178014|FG001|Overall Study|Withdrawal by Subject|1|||
163128460|NCT01900054|589178026|FG000|Overall Study|Physician Decision|1|||
163128461|NCT01900054|589178026|FG000|Overall Study|Withdrawal by Subject|1|||
163128462|NCT01959841|589178029|FG000|Overall Study|Adverse Event|1|||
163128463|NCT01959841|589178030|FG001|Overall Study|Adverse Event|3|||
162656939|NCT01696032|587457010|FG003|Overall Study|Lost to Follow-up|0|||
162656940|NCT01696032|587457007|FG000|Overall Study|Database lock|0|||
162656941|NCT01696032|587457008|FG001|Overall Study|Database lock|1|||
162656942|NCT01696032|587457009|FG002|Overall Study|Database lock|7|||
162656943|NCT01696032|587457010|FG003|Overall Study|Database lock|2|||
162656944|NCT00376168|587457013|FG000|Overall Study|Adverse Event|1|||
162656945|NCT00376168|587457014|FG001|Overall Study|Adverse Event|1|||
162656946|NCT00376168|587457013|FG000|Overall Study|Pregnancy|1|||
162656947|NCT00376168|587457014|FG001|Overall Study|Pregnancy|0|||
162656948|NCT01020019|587457015|FG000|Overall Study|Lost to Follow-up|21|||
162656949|NCT01020019|587457016|FG001|Overall Study|Lost to Follow-up|18|||
162656950|NCT01020019|587457015|FG000|Overall Study|Adverse Event|1|||
162656951|NCT01020019|587457016|FG001|Overall Study|Adverse Event|5|||
162656952|NCT01020019|587457015|FG000|Overall Study|not interested in treatment|4|||
162656953|NCT01020019|587457016|FG001|Overall Study|not interested in treatment|4|||
162656954|NCT01020019|587457015|FG000|Overall Study|moving|0|||
162656955|NCT01020019|587457016|FG001|Overall Study|moving|2|||
162656956|NCT05091528|587457017|FG000|Overall Study|Study Termination by Sponsor|0|||
162656957|NCT05091528|587457018|FG001|Overall Study|Study Termination by Sponsor|1|||
163128464|NCT01959841|589178031|FG002|Overall Study|Adverse Event|2|||
163128465|NCT01959841|589178029|FG000|Overall Study|Lack of Efficacy|5|||
163128466|NCT01959841|589178030|FG001|Overall Study|Lack of Efficacy|0|||
163128467|NCT01959841|589178031|FG002|Overall Study|Lack of Efficacy|0|||
163128468|NCT01959841|589178029|FG000|Overall Study|Lost to Follow-up|1|||
163128469|NCT01959841|589178030|FG001|Overall Study|Lost to Follow-up|1|||
163128470|NCT01959841|589178031|FG002|Overall Study|Lost to Follow-up|0|||
162656958|NCT05091528|587457019|FG002|Overall Study|Study Termination by Sponsor|0|||
162719719|NCT02020616|587680551|FG003|Overall Study|Adverse Event|0|||
163128471|NCT01959841|589178029|FG000|Overall Study|Physician Decision|0|||
162656959|NCT05091528|587457020|FG003|Overall Study|Study Termination by Sponsor|1|||
162656960|NCT02214121|587457023|FG000|Part A|Patient decision|2|||
162656961|NCT02214121|587457024|FG001|Part A|Patient decision|0|||
162656962|NCT02214121|587457025|FG002|Part A|Patient decision|0|||
162656963|NCT02214121|587457023|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
162656964|NCT02214121|587457024|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
162656965|NCT02214121|587457025|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
162719720|NCT02020616|587680552|FG004|Overall Study|Adverse Event|0|||
162719721|NCT02020616|587680553|FG005|Overall Study|Adverse Event|1|||
163128472|NCT01959841|589178030|FG001|Overall Study|Physician Decision|2|||
163128473|NCT01959841|589178031|FG002|Overall Study|Physician Decision|3|||
163128474|NCT01959841|589178029|FG000|Overall Study|Protocol Violation|16|||
163128475|NCT01959841|589178030|FG001|Overall Study|Protocol Violation|23|||
162656966|NCT02214121|587457023|FG000|Part A|Other|1|||
163128476|NCT01959841|589178031|FG002|Overall Study|Protocol Violation|16|||
163128477|NCT01959841|589178029|FG000|Overall Study|Withdrawal by Subject|7|||
163128478|NCT01959841|589178030|FG001|Overall Study|Withdrawal by Subject|7|||
163128479|NCT01959841|589178031|FG002|Overall Study|Withdrawal by Subject|5|||
163128480|NCT01959841|589178029|FG000|Overall Study|Clinical laboratory value|2|||
163128481|NCT01959841|589178030|FG001|Overall Study|Clinical laboratory value|6|||
163128482|NCT01959841|589178031|FG002|Overall Study|Clinical laboratory value|6|||
163128483|NCT01959841|589178029|FG000|Overall Study|Platelet count below on day1 or 4|11|||
163128484|NCT01959841|589178030|FG001|Overall Study|Platelet count below on day1 or 4|15|||
163128485|NCT01959841|589178031|FG002|Overall Study|Platelet count below on day1 or 4|11|||
163128486|NCT01450098|589178033|FG000|Period 3|Protocol Violation|0|||
163128487|NCT01450098|589178034|FG001|Period 3|Protocol Violation|1|||
163128488|NCT01450098|589178033|FG000|Period 3|Withdrawal by Subject|0|||
163128489|NCT01450098|589178034|FG001|Period 3|Withdrawal by Subject|2|||
163128490|NCT00655629|589178043|FG000|Overall Study|Adverse Event|4|||
163128491|NCT00655629|589178044|FG001|Overall Study|Adverse Event|1|||
163128492|NCT00655629|589178043|FG000|Overall Study|Lack of Efficacy|2|||
163128493|NCT00655629|589178044|FG001|Overall Study|Lack of Efficacy|12|||
163128494|NCT00655629|589178043|FG000|Overall Study|Lost to Follow-up|4|||
163128495|NCT00655629|589178044|FG001|Overall Study|Lost to Follow-up|3|||
163128496|NCT00655629|589178043|FG000|Overall Study|Protocol Violation|5|||
163128497|NCT00655629|589178044|FG001|Overall Study|Protocol Violation|3|||
163128498|NCT00655629|589178043|FG000|Overall Study|consent withdrawn|6|||
163128499|NCT00655629|589178044|FG001|Overall Study|consent withdrawn|4|||
163128500|NCT01835223|589178047|FG000|Overall Study|Adverse Event|1|||
163128501|NCT01835223|589178048|FG001|Overall Study|Adverse Event|0|||
163128502|NCT01835223|589178047|FG000|Overall Study|Withdrawal by Subject|2|||
163128503|NCT01835223|589178048|FG001|Overall Study|Withdrawal by Subject|0|||
163128504|NCT01835223|589178047|FG000|Overall Study|Disease progression|2|||
163128505|NCT01835223|589178048|FG001|Overall Study|Disease progression|1|||
163128506|NCT01835223|589178047|FG000|Overall Study|Became Inelligible|4|||
163128507|NCT01835223|589178048|FG001|Overall Study|Became Inelligible|0|||
163128508|NCT04097379|589178052|FG000|Overall Study|Adverse Event|1|||
163128509|NCT04097379|589178053|FG001|Overall Study|Adverse Event|0|||
163128510|NCT04097379|589178054|FG002|Overall Study|Adverse Event|0|||
163128511|NCT04097379|589178055|FG003|Overall Study|Adverse Event|0|||
163128512|NCT04097379|589178052|FG000|Overall Study|Physician Decision|0|||
163128513|NCT04097379|589178053|FG001|Overall Study|Physician Decision|1|||
163128514|NCT04097379|589178054|FG002|Overall Study|Physician Decision|0|||
163128515|NCT04097379|589178055|FG003|Overall Study|Physician Decision|0|||
163128516|NCT03387020|589178056|FG000|Overall Study|Adverse Event|0|||
163128517|NCT03387020|589178057|FG001|Overall Study|Adverse Event|2|||
163128518|NCT03387020|589178058|FG002|Overall Study|Adverse Event|0|||
163128519|NCT03387020|589178056|FG000|Overall Study|Withdrawal by Subject|2|||
163128520|NCT03387020|589178057|FG001|Overall Study|Withdrawal by Subject|0|||
163128521|NCT03387020|589178058|FG002|Overall Study|Withdrawal by Subject|0|||
163128522|NCT01425632|589178059|FG000|Overall Study|Adverse Event|0|||
163128523|NCT01425632|589178060|FG001|Overall Study|Adverse Event|1|||
163128524|NCT01425632|589178061|FG002|Overall Study|Adverse Event|1|||
163128525|NCT01425632|589178059|FG000|Overall Study|Physician Decision|1|||
163128526|NCT01425632|589178060|FG001|Overall Study|Physician Decision|0|||
163128527|NCT01425632|589178061|FG002|Overall Study|Physician Decision|0|||
163128528|NCT01425632|589178059|FG000|Overall Study|Protocol Violation|0|||
163128529|NCT01425632|589178060|FG001|Overall Study|Protocol Violation|0|||
163128530|NCT01425632|589178061|FG002|Overall Study|Protocol Violation|2|||
163128531|NCT01425632|589178059|FG000|Overall Study|Withdrawal by Subject|0|||
163128532|NCT01425632|589178060|FG001|Overall Study|Withdrawal by Subject|0|||
163128533|NCT01425632|589178061|FG002|Overall Study|Withdrawal by Subject|1|||
163128534|NCT03461146|589178062|FG000|Overall Study|Adverse Event|2|||
163128535|NCT03461146|589178062|FG000|Overall Study|Physician Decision|1|||
163128536|NCT02140047|589178063|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163128537|NCT02140047|589178064|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163128538|NCT02140047|589178065|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163128539|NCT04617496|589178066|FG000|Overall Study|Death|2|||
162656967|NCT02214121|587457024|FG001|Part A|Other|0|||
162656968|NCT02214121|587457025|FG002|Part A|Other|0|||
163128540|NCT04617496|589178067|FG001|Overall Study|Death|1|||
162656969|NCT02214121|587457023|FG000|Part B|Patient decision|0|||
162656970|NCT02214121|587457024|FG001|Part B|Patient decision|1|||
162656971|NCT02214121|587457025|FG002|Part B|Patient decision|0|||
163128541|NCT04617496|589178066|FG000|Overall Study|Lost to Follow-up|3|||
163128542|NCT04617496|589178067|FG001|Overall Study|Lost to Follow-up|3|||
163128543|NCT00200356|589178072|FG000|Overall Study|Lack of Efficacy|3|||
163128544|NCT00200356|589178073|FG001|Overall Study|Lack of Efficacy|3|||
163128545|NCT00200356|589178072|FG000|Overall Study|Protocol Violation|4|||
163128546|NCT00200356|589178073|FG001|Overall Study|Protocol Violation|4|||
163128547|NCT00200356|589178072|FG000|Overall Study|Nontreatment|1|||
163128548|NCT00200356|589178073|FG001|Overall Study|Nontreatment|0|||
163128549|NCT04530552|589178076|FG000|Overall Study|Physician Decision|0|||
162656972|NCT02214121|587457023|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
163128550|NCT04530552|589178077|FG001|Overall Study|Physician Decision|1|||
163128551|NCT04530552|589178076|FG000|Overall Study|Withdrawal by Subject|0|||
163128552|NCT04530552|589178077|FG001|Overall Study|Withdrawal by Subject|1|||
163128553|NCT04530552|589178076|FG000|Overall Study|Adverse Event|0|||
163128554|NCT04530552|589178077|FG001|Overall Study|Adverse Event|1|||
163128555|NCT04530552|589178076|FG000|Overall Study|No surgery|0|||
163128556|NCT04530552|589178077|FG001|Overall Study|No surgery|1|||
163128557|NCT00454584|589178084|FG000|Controlled Period|Adverse Event|5|||
163128558|NCT00454584|589178085|FG001|Controlled Period|Adverse Event|2|||
163128559|NCT00454584|589178086|FG002|Controlled Period|Adverse Event|1|||
163128560|NCT00454584|589178087|FG003|Controlled Period|Adverse Event|0|||
163128561|NCT00454584|589178088|FG004|Controlled Period|Adverse Event|0|||
163128562|NCT00454584|589178089|FG005|Controlled Period|Adverse Event|0|||
163128563|NCT00454584|589178084|FG000|Controlled Period|Lost to Follow-up|1|||
162656973|NCT02214121|587457024|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
163128564|NCT00454584|589178085|FG001|Controlled Period|Lost to Follow-up|2|||
163128565|NCT00454584|589178086|FG002|Controlled Period|Lost to Follow-up|2|||
163128566|NCT00454584|589178087|FG003|Controlled Period|Lost to Follow-up|0|||
163128567|NCT00454584|589178088|FG004|Controlled Period|Lost to Follow-up|0|||
163128568|NCT00454584|589178089|FG005|Controlled Period|Lost to Follow-up|0|||
163128569|NCT00454584|589178084|FG000|Controlled Period|Other|5|||
163128570|NCT00454584|589178085|FG001|Controlled Period|Other|4|||
163128571|NCT00454584|589178086|FG002|Controlled Period|Other|2|||
163128572|NCT00454584|589178087|FG003|Controlled Period|Other|0|||
163128573|NCT00454584|589178088|FG004|Controlled Period|Other|0|||
163128574|NCT00454584|589178089|FG005|Controlled Period|Other|0|||
163128575|NCT00454584|589178084|FG000|After Controlled Period|Adverse Event|0|||
163128576|NCT00454584|589178085|FG001|After Controlled Period|Adverse Event|0|||
163128577|NCT00454584|589178086|FG002|After Controlled Period|Adverse Event|0|||
163128578|NCT00454584|589178087|FG003|After Controlled Period|Adverse Event|9|||
163128579|NCT00454584|589178088|FG004|After Controlled Period|Adverse Event|3|||
163128580|NCT00454584|589178089|FG005|After Controlled Period|Adverse Event|9|||
163128581|NCT00454584|589178084|FG000|After Controlled Period|Lack of Efficacy|0|||
163128582|NCT00454584|589178085|FG001|After Controlled Period|Lack of Efficacy|0|||
163128583|NCT00454584|589178086|FG002|After Controlled Period|Lack of Efficacy|0|||
163128584|NCT00454584|589178087|FG003|After Controlled Period|Lack of Efficacy|1|||
163128585|NCT00454584|589178088|FG004|After Controlled Period|Lack of Efficacy|0|||
163128586|NCT00454584|589178089|FG005|After Controlled Period|Lack of Efficacy|0|||
163128587|NCT00454584|589178084|FG000|After Controlled Period|Lost to Follow-up|0|||
163128588|NCT00454584|589178085|FG001|After Controlled Period|Lost to Follow-up|0|||
163128589|NCT00454584|589178086|FG002|After Controlled Period|Lost to Follow-up|0|||
163128590|NCT00454584|589178087|FG003|After Controlled Period|Lost to Follow-up|2|||
163128591|NCT00454584|589178088|FG004|After Controlled Period|Lost to Follow-up|4|||
163128592|NCT00454584|589178089|FG005|After Controlled Period|Lost to Follow-up|6|||
163128593|NCT00454584|589178084|FG000|After Controlled Period|Other|0|||
163128594|NCT00454584|589178085|FG001|After Controlled Period|Other|0|||
163128595|NCT00454584|589178086|FG002|After Controlled Period|Other|0|||
163128596|NCT00454584|589178087|FG003|After Controlled Period|Other|1|||
163128597|NCT00454584|589178088|FG004|After Controlled Period|Other|0|||
163128598|NCT00454584|589178089|FG005|After Controlled Period|Other|0|||
163128599|NCT00454584|589178084|FG000|After Controlled Period|Other|0|||
163128600|NCT00454584|589178085|FG001|After Controlled Period|Other|0|||
163128601|NCT00454584|589178086|FG002|After Controlled Period|Other|0|||
163128602|NCT00454584|589178087|FG003|After Controlled Period|Other|13|||
163128603|NCT00454584|589178088|FG004|After Controlled Period|Other|5|||
163128604|NCT00454584|589178089|FG005|After Controlled Period|Other|17|||
163128605|NCT02250664|589178090|FG000|Overall Study|Lost to Follow-up|18|||
163128606|NCT02250664|589178091|FG001|Overall Study|Lost to Follow-up|28|||
163128607|NCT02250664|589178092|FG002|Overall Study|Lost to Follow-up|33|||
163128608|NCT02250664|589178090|FG000|Overall Study|Personal Reasons|7|||
163128609|NCT02250664|589178091|FG001|Overall Study|Personal Reasons|8|||
163128610|NCT02250664|589178092|FG002|Overall Study|Personal Reasons|14|||
163128611|NCT02250664|589178090|FG000|Overall Study|Adverse Event|6|||
163128612|NCT02250664|589178091|FG001|Overall Study|Adverse Event|3|||
163128613|NCT02250664|589178092|FG002|Overall Study|Adverse Event|8|||
163128614|NCT02250664|589178090|FG000|Overall Study|Incarcerated|2|||
163128615|NCT02250664|589178091|FG001|Overall Study|Incarcerated|1|||
163128616|NCT02250664|589178092|FG002|Overall Study|Incarcerated|2|||
163128617|NCT02250664|589178090|FG000|Overall Study|Withdrawal by Subject|0|||
163128618|NCT02250664|589178091|FG001|Overall Study|Withdrawal by Subject|1|||
163128619|NCT02250664|589178092|FG002|Overall Study|Withdrawal by Subject|2|||
163128620|NCT02250664|589178090|FG000|Overall Study|Death|0|||
163128621|NCT02250664|589178091|FG001|Overall Study|Death|1|||
162656974|NCT02214121|587457025|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
163128622|NCT02250664|589178092|FG002|Overall Study|Death|1|||
163128623|NCT02250664|589178090|FG000|Overall Study|Physician Decision|1|||
163128624|NCT02250664|589178091|FG001|Overall Study|Physician Decision|3|||
163128625|NCT02250664|589178092|FG002|Overall Study|Physician Decision|1|||
163128626|NCT02250664|589178090|FG000|Overall Study|Protocol Violation|1|||
163128627|NCT02250664|589178091|FG001|Overall Study|Protocol Violation|0|||
163128628|NCT02250664|589178092|FG002|Overall Study|Protocol Violation|1|||
163128629|NCT02250664|589178090|FG000|Overall Study|Reason unknown|1|||
163128630|NCT02250664|589178091|FG001|Overall Study|Reason unknown|0|||
163128631|NCT02250664|589178092|FG002|Overall Study|Reason unknown|0|||
163128632|NCT00490022|589178094|FG000|Overall Study|Adverse Event|0|||
163128633|NCT00490022|589178095|FG001|Overall Study|Adverse Event|2|||
163128634|NCT00490022|589178094|FG000|Overall Study|Withdrawal by Subject|1|||
163128635|NCT00490022|589178095|FG001|Overall Study|Withdrawal by Subject|0|||
163128636|NCT00490022|589178094|FG000|Overall Study|Subject failed to disclose concommitant|0|||
163128637|NCT00490022|589178095|FG001|Overall Study|Subject failed to disclose concommitant|1|||
163128638|NCT00975143|589178098|FG000|Overall Study|Adverse Event|19|||
163128639|NCT00975143|589178099|FG001|Overall Study|Adverse Event|15|||
163128640|NCT00975143|589178098|FG000|Overall Study|Withdrawal by Subject|15|||
163128641|NCT00975143|589178099|FG001|Overall Study|Withdrawal by Subject|15|||
163128642|NCT00975143|589178098|FG000|Overall Study|Lost to Follow-up|20|||
163128643|NCT00975143|589178099|FG001|Overall Study|Lost to Follow-up|16|||
163128644|NCT00975143|589178098|FG000|Overall Study|Non-compliance|5|||
163128645|NCT00975143|589178099|FG001|Overall Study|Non-compliance|8|||
163128646|NCT00975143|589178098|FG000|Overall Study|Physician Decision|1|||
163128647|NCT00975143|589178099|FG001|Overall Study|Physician Decision|2|||
163128648|NCT00975143|589178098|FG000|Overall Study|Details not available|10|||
163128649|NCT00975143|589178099|FG001|Overall Study|Details not available|4|||
163128650|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128651|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
163128652|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128653|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
163128654|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
163128655|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
163128656|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163128657|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163128658|NCT01753401|589178100|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128659|NCT01753401|589178101|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
163128660|NCT01753401|589178102|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128661|NCT01753401|589178103|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
163128662|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
163128663|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
163128664|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
163128665|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
163128666|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128667|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128668|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
163128669|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
163128670|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
163128671|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
163128672|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
163128673|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
163128674|NCT01753401|589178100|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
163128675|NCT01753401|589178101|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
163128676|NCT01753401|589178102|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
163128677|NCT01753401|589178103|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
163128678|NCT03129360|589178104|FG000|Overall Study|Did not meet entry criteria|0|||
163128679|NCT03129360|589178105|FG001|Overall Study|Did not meet entry criteria|2|||
163128680|NCT03129360|589178106|FG002|Overall Study|Did not meet entry criteria|1|||
163128681|NCT03129360|589178104|FG000|Overall Study|Excluded due to motion in scanner|1|||
163128682|NCT03129360|589178105|FG001|Overall Study|Excluded due to motion in scanner|0|||
163128683|NCT03129360|589178106|FG002|Overall Study|Excluded due to motion in scanner|0|||
163128684|NCT01729208|589178109|FG000|Baseline|Physician Decision|5|||
163128685|NCT01729208|589178110|FG001|Baseline|Physician Decision|4|||
163128686|NCT01729208|589178109|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
163128687|NCT01729208|589178110|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
162656975|NCT02214121|587457023|FG000|Part B|Lost to Follow-up|0|||
162656976|NCT02214121|587457024|FG001|Part B|Lost to Follow-up|0|||
162656977|NCT02214121|587457025|FG002|Part B|Lost to Follow-up|1|||
163128688|NCT01729208|589178109|FG000|12 Months Follow-up|Lost to Follow-up|3|||
163128689|NCT01729208|589178110|FG001|12 Months Follow-up|Lost to Follow-up|3|||
163128690|NCT01729208|589178109|FG000|24 Months Follow-up|Lost to Follow-up|3|||
162656978|NCT02375672|587457026|FG000|Overall Study|remain on follow up|20|||
162656979|NCT02203591|587457027|FG000|Overall Study|Did not meet treatment day baseline|147|||
162656980|NCT02203591|587457028|FG001|Overall Study|Did not meet treatment day baseline|141|||
163128691|NCT01729208|589178110|FG001|24 Months Follow-up|Lost to Follow-up|0|||
163128692|NCT01729208|589178109|FG000|36 Months Follow-up|Physician Decision|1|||
163128693|NCT01729208|589178110|FG001|36 Months Follow-up|Physician Decision|0|||
163128694|NCT01729208|589178109|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
163128695|NCT01729208|589178110|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
163128696|NCT02428413|589178111|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
163128697|NCT02428413|589178112|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
163128698|NCT02428413|589178111|FG000|Overall Study|Protocol Violation|1|||
163128699|NCT02428413|589178112|FG001|Overall Study|Protocol Violation|2|||
162656981|NCT02203591|587457029|FG002|Overall Study|Did not meet treatment day baseline|150|||
162656982|NCT02203591|587457030|FG003|Overall Study|Did not meet treatment day baseline|45|||
162656983|NCT02203591|587457031|FG004|Overall Study|Did not meet treatment day baseline|33|||
162656984|NCT02203591|587457032|FG005|Overall Study|Did not meet treatment day baseline|35|||
162656985|NCT02203591|587457033|FG006|Overall Study|Did not meet treatment day baseline|29|||
162656986|NCT02203591|587457034|FG007|Overall Study|Did not meet treatment day baseline|12|||
162656987|NCT02203591|587457027|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
162656988|NCT02203591|587457028|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
162656989|NCT02203591|587457029|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
162656990|NCT02203591|587457030|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
162656991|NCT02203591|587457031|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
162656992|NCT02203591|587457032|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
162656993|NCT02203591|587457033|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
162656994|NCT02203591|587457034|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
162656995|NCT04115358|587457035|FG000|Overall Study|exfoliation|0|||
162656996|NCT04115358|587457036|FG001|Overall Study|exfoliation|0|||
162719722|NCT02020616|587680554|FG006|Overall Study|Adverse Event|1|||
162719723|NCT02020616|587680548|FG000|Overall Study|Physician Decision|0|||
163128700|NCT02428413|589178111|FG000|Overall Study|Case Cancelled|2|||
163128701|NCT02428413|589178112|FG001|Overall Study|Case Cancelled|0|||
163128702|NCT02428413|589178111|FG000|Overall Study|Missed Cases|1|||
163128703|NCT02428413|589178112|FG001|Overall Study|Missed Cases|2|||
163128704|NCT02428413|589178111|FG000|Overall Study|Nurse Refusal|1|||
163128705|NCT02428413|589178112|FG001|Overall Study|Nurse Refusal|0|||
163128706|NCT00295932|589178113|FG000|Overall Study|Not Treated|0|||
163128707|NCT00295932|589178114|FG001|Overall Study|Not Treated|0|||
163128708|NCT00295932|589178115|FG002|Overall Study|Not Treated|0|||
163128709|NCT00295932|589178116|FG003|Overall Study|Not Treated|0|||
163128710|NCT00295932|589178117|FG004|Overall Study|Not Treated|0|||
163128711|NCT00295932|589178118|FG005|Overall Study|Not Treated|0|||
163128712|NCT00295932|589178119|FG006|Overall Study|Not Treated|0|||
163128713|NCT00295932|589178120|FG007|Overall Study|Not Treated|0|||
163128714|NCT00295932|589178121|FG008|Overall Study|Not Treated|0|||
163128715|NCT00295932|589178122|FG009|Overall Study|Not Treated|0|||
163128716|NCT00295932|589178123|FG010|Overall Study|Not Treated|1|||
163128717|NCT02409719|589178126|FG000|Overall Study|Lost to Follow-up|3|||
163128718|NCT02409719|589178127|FG001|Overall Study|Lost to Follow-up|3|||
163128719|NCT00565136|589178132|FG000|Overall Study|Lost to Follow-up|1|||
163128720|NCT00565136|589178132|FG000|Overall Study|Withdrawal by Subject|1|||
163128721|NCT00565136|589178132|FG000|Overall Study|Protocol Violation|1|||
163128722|NCT01026220|589178133|FG000|Induction|Death|1|||
163128723|NCT01026220|589178134|FG001|Induction|Death|0|||
163128724|NCT01026220|589178135|FG002|Induction|Death|0|||
163128725|NCT01026220|589178133|FG000|Induction|Lack of Efficacy|2|||
163128726|NCT01026220|589178134|FG001|Induction|Lack of Efficacy|0|||
163128727|NCT01026220|589178135|FG002|Induction|Lack of Efficacy|0|||
163128728|NCT01026220|589178133|FG000|Induction|Physician Decision|12|||
163128729|NCT01026220|589178134|FG001|Induction|Physician Decision|0|||
163128730|NCT01026220|589178135|FG002|Induction|Physician Decision|0|||
163128731|NCT01026220|589178133|FG000|Induction|Withdrawal by Subject|9|||
163128732|NCT01026220|589178134|FG001|Induction|Withdrawal by Subject|0|||
163128733|NCT01026220|589178135|FG002|Induction|Withdrawal by Subject|0|||
163128734|NCT01026220|589178133|FG000|Induction|Ineligible|1|||
163128735|NCT01026220|589178134|FG001|Induction|Ineligible|0|||
163128736|NCT01026220|589178135|FG002|Induction|Ineligible|0|||
163128737|NCT01026220|589178133|FG000|Consolidation Maintenance|Death|0|||
163128738|NCT01026220|589178134|FG001|Consolidation Maintenance|Death|1|||
163128739|NCT01026220|589178135|FG002|Consolidation Maintenance|Death|0|||
162656997|NCT04115358|587457037|FG002|Overall Study|exfoliation|1|||
162656998|NCT01573624|587457040|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163128740|NCT01026220|589178133|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
163128741|NCT01026220|589178134|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
163128742|NCT01026220|589178135|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
163128743|NCT01026220|589178133|FG000|Consolidation Maintenance|Physician Decision|0|||
163128744|NCT01026220|589178134|FG001|Consolidation Maintenance|Physician Decision|2|||
163128745|NCT01026220|589178135|FG002|Consolidation Maintenance|Physician Decision|7|||
163128746|NCT01026220|589178133|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
163128747|NCT01026220|589178134|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
163128748|NCT01026220|589178135|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
163128749|NCT01459913|589178136|FG000|Overall Study|Adverse Event|0|||
163128750|NCT01459913|589178137|FG001|Overall Study|Adverse Event|0|||
163128751|NCT01459913|589178138|FG002|Overall Study|Adverse Event|0|||
163128752|NCT01459913|589178139|FG003|Overall Study|Adverse Event|3|||
163128753|NCT01459913|589178136|FG000|Overall Study|Withdrawal by Subject|4|||
163128754|NCT01459913|589178137|FG001|Overall Study|Withdrawal by Subject|0|||
163128755|NCT01459913|589178138|FG002|Overall Study|Withdrawal by Subject|0|||
163128756|NCT01459913|589178139|FG003|Overall Study|Withdrawal by Subject|5|||
163128757|NCT01459913|589178136|FG000|Overall Study|Lost to Follow-up|7|||
163128758|NCT01459913|589178137|FG001|Overall Study|Lost to Follow-up|4|||
163128759|NCT01459913|589178138|FG002|Overall Study|Lost to Follow-up|1|||
163128760|NCT01459913|589178139|FG003|Overall Study|Lost to Follow-up|8|||
163128761|NCT01459913|589178136|FG000|Overall Study|Death|0|||
163128762|NCT01459913|589178137|FG001|Overall Study|Death|0|||
163128763|NCT01459913|589178138|FG002|Overall Study|Death|0|||
163128764|NCT01459913|589178139|FG003|Overall Study|Death|1|||
163128765|NCT01459913|589178136|FG000|Overall Study|Non- Compliance|0|||
163128766|NCT01459913|589178137|FG001|Overall Study|Non- Compliance|0|||
163128767|NCT01459913|589178138|FG002|Overall Study|Non- Compliance|0|||
163128768|NCT01459913|589178139|FG003|Overall Study|Non- Compliance|3|||
163128769|NCT01459913|589178136|FG000|Overall Study|Physician Decision|0|||
163128770|NCT01459913|589178137|FG001|Overall Study|Physician Decision|1|||
163128771|NCT01459913|589178138|FG002|Overall Study|Physician Decision|0|||
163128772|NCT01459913|589178139|FG003|Overall Study|Physician Decision|0|||
163128773|NCT01459913|589178136|FG000|Overall Study|Study Terminated by Sponsor|30|||
163128774|NCT01459913|589178137|FG001|Overall Study|Study Terminated by Sponsor|15|||
163128775|NCT01459913|589178138|FG002|Overall Study|Study Terminated by Sponsor|9|||
163128776|NCT01459913|589178139|FG003|Overall Study|Study Terminated by Sponsor|11|||
163128777|NCT01459913|589178136|FG000|Overall Study|Other|0|||
163128778|NCT01459913|589178137|FG001|Overall Study|Other|0|||
163128779|NCT01459913|589178138|FG002|Overall Study|Other|3|||
163128780|NCT01459913|589178139|FG003|Overall Study|Other|1|||
163128781|NCT01459913|589178136|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128782|NCT01459913|589178137|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128783|NCT01459913|589178138|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
163128784|NCT01459913|589178139|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
163128785|NCT05096312|589178142|FG000|Overall Study|Lost to Follow-up|2|||
163128786|NCT05096312|589178143|FG001|Overall Study|Lost to Follow-up|4|||
163128787|NCT05096312|589178142|FG000|Overall Study|Adverse Event|1|||
163128788|NCT05096312|589178143|FG001|Overall Study|Adverse Event|0|||
163128789|NCT03135210|589178144|FG000|Overall Study|Death|0|||
163128790|NCT03135210|589178145|FG001|Overall Study|Death|1|||
163128791|NCT03517566|589178146|FG000|Overall Study|Adverse Event|5|||
163128792|NCT03517566|589178147|FG001|Overall Study|Adverse Event|2|||
163128793|NCT03517566|589178148|FG002|Overall Study|Adverse Event|2|||
163128794|NCT03517566|589178149|FG003|Overall Study|Adverse Event|8|||
163128795|NCT03517566|589178150|FG004|Overall Study|Adverse Event|7|||
163128796|NCT03517566|589178146|FG000|Overall Study|Lack of Efficacy|3|||
163128797|NCT03517566|589178147|FG001|Overall Study|Lack of Efficacy|2|||
163128798|NCT03517566|589178148|FG002|Overall Study|Lack of Efficacy|1|||
163128799|NCT03517566|589178149|FG003|Overall Study|Lack of Efficacy|1|||
163128800|NCT03517566|589178150|FG004|Overall Study|Lack of Efficacy|4|||
163128801|NCT03517566|589178146|FG000|Overall Study|Lost to Follow-up|3|||
163128802|NCT03517566|589178147|FG001|Overall Study|Lost to Follow-up|1|||
163128803|NCT03517566|589178148|FG002|Overall Study|Lost to Follow-up|1|||
163128804|NCT03517566|589178149|FG003|Overall Study|Lost to Follow-up|1|||
163128805|NCT03517566|589178150|FG004|Overall Study|Lost to Follow-up|0|||
163128806|NCT03517566|589178146|FG000|Overall Study|Physician Decision|1|||
163128807|NCT03517566|589178147|FG001|Overall Study|Physician Decision|1|||
163128808|NCT03517566|589178148|FG002|Overall Study|Physician Decision|0|||
163128809|NCT03517566|589178149|FG003|Overall Study|Physician Decision|1|||
163128810|NCT03517566|589178150|FG004|Overall Study|Physician Decision|0|||
163128811|NCT03517566|589178146|FG000|Overall Study|Pregnancy|0|||
163128812|NCT03517566|589178147|FG001|Overall Study|Pregnancy|1|||
162656999|NCT01573624|587457041|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
163128813|NCT03517566|589178148|FG002|Overall Study|Pregnancy|0|||
162657000|NCT01573624|587457042|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
162657001|NCT01573624|587457043|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162657002|NCT01573624|587457044|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162657003|NCT01573624|587457045|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
163128814|NCT03517566|589178149|FG003|Overall Study|Pregnancy|0|||
163128815|NCT03517566|589178150|FG004|Overall Study|Pregnancy|0|||
163128816|NCT03517566|589178146|FG000|Overall Study|Protocol Deviation|0|||
163128817|NCT03517566|589178147|FG001|Overall Study|Protocol Deviation|1|||
163128818|NCT03517566|589178148|FG002|Overall Study|Protocol Deviation|0|||
163128819|NCT03517566|589178149|FG003|Overall Study|Protocol Deviation|1|||
163128820|NCT03517566|589178150|FG004|Overall Study|Protocol Deviation|1|||
163128821|NCT03517566|589178146|FG000|Overall Study|Study terminated by Sponsor|11|||
163128822|NCT03517566|589178147|FG001|Overall Study|Study terminated by Sponsor|5|||
163128823|NCT03517566|589178148|FG002|Overall Study|Study terminated by Sponsor|6|||
163128824|NCT03517566|589178149|FG003|Overall Study|Study terminated by Sponsor|14|||
163128825|NCT03517566|589178150|FG004|Overall Study|Study terminated by Sponsor|12|||
163128826|NCT03517566|589178146|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
163128827|NCT03517566|589178147|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
163128828|NCT03517566|589178148|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
163128829|NCT03517566|589178149|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
163128830|NCT03517566|589178150|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
163128831|NCT00671437|589178151|FG000|Overall Study|Progressive disease before C1 week 8|8|||
163128832|NCT00671437|589178151|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
163128833|NCT00671437|589178151|FG000|Overall Study|Adverse Event|3|||
163128834|NCT00671437|589178151|FG000|Overall Study|Ineligible post-hoc|1|||
163128835|NCT04349033|589178152|FG000|Overall Study|Lost to Follow-up|3|||
163128836|NCT04349033|589178153|FG001|Overall Study|Lost to Follow-up|1|||
163128837|NCT04349033|589178154|FG002|Overall Study|Lost to Follow-up|1|||
163128838|NCT01704456|589178158|FG000|Overall Study|Lost to Follow-up|8|||
163128839|NCT01704456|589178159|FG001|Overall Study|Lost to Follow-up|14|||
163128840|NCT00915551|589178165|FG000|Overall Study|Withdrawal by Subject|0|||
163128841|NCT00915551|589178166|FG001|Overall Study|Withdrawal by Subject|1|||
163128842|NCT04390841|589178167|FG000|Overall Study|Withdrawal by Subject|2|||
163128843|NCT02540291|589178168|FG000|Overall Study|Death|7|||
163128844|NCT02540291|589178169|FG001|Overall Study|Death|7|||
163128845|NCT02540291|589178170|FG002|Overall Study|Death|5|||
163128846|NCT02540291|589178171|FG003|Overall Study|Death|7|||
163128847|NCT02540291|589178168|FG000|Overall Study|Lost to Follow-up|0|||
163128848|NCT02540291|589178169|FG001|Overall Study|Lost to Follow-up|0|||
163128849|NCT02540291|589178170|FG002|Overall Study|Lost to Follow-up|1|||
163128850|NCT02540291|589178171|FG003|Overall Study|Lost to Follow-up|0|||
163128851|NCT02540291|589178168|FG000|Overall Study|Withdrawal Of Consent|0|||
163128852|NCT02540291|589178169|FG001|Overall Study|Withdrawal Of Consent|1|||
163128853|NCT02540291|589178170|FG002|Overall Study|Withdrawal Of Consent|0|||
163128854|NCT02540291|589178171|FG003|Overall Study|Withdrawal Of Consent|0|||
163128855|NCT02540291|589178168|FG000|Overall Study|Study Terminated By Sponsor|1|||
163128856|NCT02540291|589178169|FG001|Overall Study|Study Terminated By Sponsor|0|||
163128857|NCT02540291|589178170|FG002|Overall Study|Study Terminated By Sponsor|0|||
163128858|NCT02540291|589178171|FG003|Overall Study|Study Terminated By Sponsor|0|||
163128859|NCT02540291|589178168|FG000|Overall Study|Other|0|||
163128860|NCT02540291|589178169|FG001|Overall Study|Other|0|||
163128861|NCT02540291|589178170|FG002|Overall Study|Other|1|||
163128862|NCT02540291|589178171|FG003|Overall Study|Other|0|||
163128863|NCT01031979|589179763|FG000|Overall Study|Lost to Follow-up|5|||
163128864|NCT01031979|589179764|FG001|Overall Study|Lost to Follow-up|4|||
163128865|NCT03831100|589179765|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
163128866|NCT03831100|589179766|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
163128867|NCT02454478|589179769|FG000|Overall Study|Incomplete DLT Evaluation|1|||
163128868|NCT01732770|589179770|FG000|Overall Study|Lost to Follow-up|2|||
163128869|NCT01732770|589179771|FG001|Overall Study|Lost to Follow-up|3|||
163128870|NCT01732770|589179770|FG000|Overall Study|Withdrawal by Subject|5|||
163128871|NCT01732770|589179771|FG001|Overall Study|Withdrawal by Subject|3|||
163128872|NCT01732770|589179770|FG000|Overall Study|Decision by Sponsor|2|||
163128873|NCT01732770|589179771|FG001|Overall Study|Decision by Sponsor|2|||
163128874|NCT01732770|589179770|FG000|Overall Study|Death|1|||
163128875|NCT01732770|589179771|FG001|Overall Study|Death|0|||
163128876|NCT03229109|589179772|FG000|Overall Study|Withdrawal by Subject|0|||
163128877|NCT03229109|589179773|FG001|Overall Study|Withdrawal by Subject|0|||
163128878|NCT03229109|589179774|FG002|Overall Study|Withdrawal by Subject|0|||
163128879|NCT03229109|589179775|FG003|Overall Study|Withdrawal by Subject|1|||
163128880|NCT03329196|589179778|FG000|Overall Study|Adverse Event|10|||
163128881|NCT03329196|589179779|FG001|Overall Study|Adverse Event|5|||
163128882|NCT03329196|589179778|FG000|Overall Study|Physician Decision|2|||
163128883|NCT03329196|589179779|FG001|Overall Study|Physician Decision|2|||
163128884|NCT03329196|589179778|FG000|Overall Study|Withdrawal by Subject|11|||
163128885|NCT03329196|589179779|FG001|Overall Study|Withdrawal by Subject|3|||
163128886|NCT03329196|589179778|FG000|Overall Study|Hepatic function abnormalities|0|||
163128887|NCT03329196|589179779|FG001|Overall Study|Hepatic function abnormalities|1|||
163128888|NCT03329196|589179778|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
163128889|NCT03329196|589179779|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
163128890|NCT03329196|589179778|FG000|Overall Study|Difficult to control Hb|2|||
163128891|NCT03329196|589179779|FG001|Overall Study|Difficult to control Hb|3|||
163128892|NCT03329196|589179778|FG000|Overall Study|Dialysis or renal transplant|13|||
163128893|NCT03329196|589179779|FG001|Overall Study|Dialysis or renal transplant|15|||
163128894|NCT04481750|589179783|FG000|Period 1 (Fasted)|Adverse Event|0|||
162657004|NCT01573624|587457046|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162657005|NCT01573624|587457040|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
163128895|NCT04481750|589179784|FG001|Period 1 (Fasted)|Adverse Event|0|||
163128896|NCT04481750|589179785|FG002|Period 1 (Fasted)|Adverse Event|1|||
163128897|NCT04481750|589179786|FG003|Period 1 (Fasted)|Adverse Event|0|||
163128898|NCT04481750|589179787|FG004|Period 1 (Fasted)|Adverse Event|0|||
163128899|NCT04481750|589179788|FG005|Period 1 (Fasted)|Adverse Event|0|||
163128900|NCT04481750|589179789|FG006|Period 1 (Fasted)|Adverse Event|0|||
163128901|NCT04481750|589179790|FG007|Period 1 (Fasted)|Adverse Event|0|||
163128902|NCT04481750|589179791|FG008|Period 1 (Fasted)|Adverse Event|0|||
163128903|NCT04481750|589179792|FG009|Period 1 (Fasted)|Adverse Event|0|||
163128904|NCT04481750|589179793|FG010|Period 1 (Fasted)|Adverse Event|0|||
163128905|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
163128906|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
163128907|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
163128908|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
163128909|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
163128910|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128911|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
163128912|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128913|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128914|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
163128915|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
163128916|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
163128917|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
163128918|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
163128919|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
163128920|NCT03176771|589179794|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128921|NCT03176771|589179795|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128922|NCT03176771|589179796|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
163128923|NCT03176771|589179797|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128924|NCT03176771|589179798|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
163128925|NCT03176771|589179794|FG000|Double-Blind Extension Period|Adverse Event|0|||
163128926|NCT03176771|589179795|FG001|Double-Blind Extension Period|Adverse Event|0|||
163128927|NCT03176771|589179796|FG002|Double-Blind Extension Period|Adverse Event|0|||
163128928|NCT03176771|589179797|FG003|Double-Blind Extension Period|Adverse Event|15|||
163128929|NCT03176771|589179798|FG004|Double-Blind Extension Period|Adverse Event|18|||
163128930|NCT03176771|589179794|FG000|Double-Blind Extension Period|Death|0|||
163128931|NCT03176771|589179795|FG001|Double-Blind Extension Period|Death|0|||
163128932|NCT03176771|589179796|FG002|Double-Blind Extension Period|Death|0|||
163128933|NCT03176771|589179797|FG003|Double-Blind Extension Period|Death|3|||
163128934|NCT03176771|589179798|FG004|Double-Blind Extension Period|Death|4|||
163128935|NCT03176771|589179794|FG000|Double-Blind Extension Period|Physician Decision|0|||
163128936|NCT03176771|589179795|FG001|Double-Blind Extension Period|Physician Decision|0|||
163128937|NCT03176771|589179796|FG002|Double-Blind Extension Period|Physician Decision|0|||
163128938|NCT03176771|589179797|FG003|Double-Blind Extension Period|Physician Decision|3|||
163128939|NCT03176771|589179798|FG004|Double-Blind Extension Period|Physician Decision|1|||
163128940|NCT03176771|589179794|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128941|NCT03176771|589179795|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128942|NCT03176771|589179796|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
163128943|NCT03176771|589179797|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
163128944|NCT03176771|589179798|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
163128945|NCT03439137|589179799|FG000|Overall Study|Adverse Event|16|||
163128946|NCT03439137|589179800|FG001|Overall Study|Adverse Event|12|||
163128947|NCT03439137|589179799|FG000|Overall Study|Physician Decision|0|||
163128948|NCT03439137|589179800|FG001|Overall Study|Physician Decision|5|||
163128949|NCT03439137|589179799|FG000|Overall Study|Withdrawal by Subject|14|||
163128950|NCT03439137|589179800|FG001|Overall Study|Withdrawal by Subject|4|||
163128951|NCT03439137|589179799|FG000|Overall Study|Conducting rescue therapy|2|||
163128952|NCT03439137|589179800|FG001|Overall Study|Conducting rescue therapy|1|||
163128953|NCT03439137|589179799|FG000|Overall Study|Difficult to control Hb|10|||
163128954|NCT03439137|589179800|FG001|Overall Study|Difficult to control Hb|2|||
163128955|NCT03439137|589179799|FG000|Overall Study|Initiation of a renal transplant|0|||
163128956|NCT03439137|589179800|FG001|Overall Study|Initiation of a renal transplant|2|||
163128957|NCT00691028|589179801|FG000|Open-label Period|Adverse Event|0|||
163128958|NCT00691028|589179802|FG001|Open-label Period|Adverse Event|0|||
163128959|NCT00691028|589179803|FG002|Open-label Period|Adverse Event|0|||
163128960|NCT00691028|589179804|FG003|Open-label Period|Adverse Event|16|||
163128961|NCT00691028|589179801|FG000|Open-label Period|Withdrawal by Subject|0|||
163128962|NCT00691028|589179802|FG001|Open-label Period|Withdrawal by Subject|0|||
163128963|NCT00691028|589179803|FG002|Open-label Period|Withdrawal by Subject|0|||
163128964|NCT00691028|589179804|FG003|Open-label Period|Withdrawal by Subject|3|||
163128965|NCT00691028|589179801|FG000|Open-label Period|not come to a hospital|0|||
163128966|NCT00691028|589179802|FG001|Open-label Period|not come to a hospital|0|||
163128967|NCT00691028|589179803|FG002|Open-label Period|not come to a hospital|0|||
163128968|NCT00691028|589179804|FG003|Open-label Period|not come to a hospital|1|||
163128969|NCT00691028|589179801|FG000|Double-blind Period|Adverse Event|8|||
163128970|NCT00691028|589179802|FG001|Double-blind Period|Adverse Event|9|||
163128971|NCT00691028|589179803|FG002|Double-blind Period|Adverse Event|6|||
163128972|NCT00691028|589179804|FG003|Double-blind Period|Adverse Event|0|||
163128973|NCT00691028|589179801|FG000|Double-blind Period|Lack of Efficacy|4|||
163128974|NCT00691028|589179802|FG001|Double-blind Period|Lack of Efficacy|3|||
163128975|NCT00691028|589179803|FG002|Double-blind Period|Lack of Efficacy|2|||
163128976|NCT00691028|589179804|FG003|Double-blind Period|Lack of Efficacy|0|||
163128977|NCT00691028|589179801|FG000|Double-blind Period|Withdrawal by Subject|1|||
163128978|NCT00691028|589179802|FG001|Double-blind Period|Withdrawal by Subject|0|||
163128979|NCT00691028|589179803|FG002|Double-blind Period|Withdrawal by Subject|1|||
163128980|NCT00691028|589179804|FG003|Double-blind Period|Withdrawal by Subject|0|||
163128981|NCT00691028|589179801|FG000|Double-blind Period|not come to a hospital.|0|||
163128982|NCT00691028|589179802|FG001|Double-blind Period|not come to a hospital.|1|||
163128983|NCT00691028|589179803|FG002|Double-blind Period|not come to a hospital.|0|||
163128984|NCT00691028|589179804|FG003|Double-blind Period|not come to a hospital.|0|||
163128985|NCT04512976|589179809|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128986|NCT04512976|589179810|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128987|NCT04512976|589179811|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128988|NCT04512976|589179812|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128989|NCT04512976|589179813|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
163128990|NCT04512976|589179814|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
163128991|NCT05249569|589179818|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
163128992|NCT03703856|589179819|FG000|Enrolled in study|Withdrawal by Subject|23|||
163128993|NCT03703856|589179819|FG000|Titrated to full dose|Withdrawal by Subject|5|||
163128994|NCT03703856|589179819|FG000|16 week assessment|Withdrawal by Subject|1|||
163128995|NCT03703856|589179819|FG000|24 week assessment|Withdrawal by Subject|1|||
163128996|NCT01596335|589179820|FG000|Overall Study|exacerbation of primary disease|5|||
163128997|NCT01596335|589179821|FG001|Overall Study|exacerbation of primary disease|9|||
163128998|NCT03402386|589179822|FG000|Overall Study|Adverse Event|3|||
163128999|NCT03402386|589179822|FG000|Overall Study|Physician Decision|1|||
163129000|NCT03402386|589179822|FG000|Overall Study|Difficult to control Hb|2|||
163129001|NCT01585155|589179826|FG000|Overall Study|Adverse Event|1|||
163129002|NCT01585155|589179826|FG000|Overall Study|Lack of Efficacy|2|||
163129003|NCT01585155|589179826|FG000|Overall Study|Worsening ulcerative colitis|2|||
163129004|NCT01192412|589179828|FG000|Overall Study|Lost to Follow-up|2|||
163129005|NCT01192412|589179829|FG001|Overall Study|Lost to Follow-up|1|||
163129006|NCT01192412|589179828|FG000|Overall Study|Withdrawal by Subject|2|||
163129007|NCT01192412|589179829|FG001|Overall Study|Withdrawal by Subject|1|||
163129008|NCT02421588|589179830|FG000|Overall Study|Non-treatment-related AE|8|||
163129009|NCT02421588|589179831|FG001|Overall Study|Non-treatment-related AE|8|||
163129010|NCT02421588|589179830|FG000|Overall Study|Progressive disease|152|||
163129011|NCT02421588|589179831|FG001|Overall Study|Progressive disease|135|||
163129012|NCT02421588|589179830|FG000|Overall Study|Death|11|||
163129013|NCT02421588|589179831|FG001|Overall Study|Death|3|||
163129014|NCT02421588|589179830|FG000|Overall Study|Physician Decision|8|||
162657006|NCT01573624|587457041|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
162657007|NCT01573624|587457042|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
162657008|NCT01573624|587457043|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163129015|NCT02421588|589179831|FG001|Overall Study|Physician Decision|17|||
163129016|NCT02421588|589179830|FG000|Overall Study|Other reason not specified|3|||
163129017|NCT02421588|589179831|FG001|Overall Study|Other reason not specified|1|||
163129018|NCT02421588|589179830|FG000|Overall Study|Symptomatic deterioration|13|||
163129019|NCT02421588|589179831|FG001|Overall Study|Symptomatic deterioration|19|||
163129020|NCT02421588|589179830|FG000|Overall Study|Treatment-related AE|10|||
163129021|NCT02421588|589179831|FG001|Overall Study|Treatment-related AE|14|||
163129022|NCT02421588|589179830|FG000|Overall Study|Withdrawal by Subject|14|||
163129023|NCT02421588|589179831|FG001|Overall Study|Withdrawal by Subject|16|||
163129024|NCT02421588|589179830|FG000|Overall Study|Not treated|2|||
163129025|NCT02421588|589179831|FG001|Overall Study|Not treated|8|||
163129026|NCT04254913|589179834|FG000|Overall Study|Adverse Event|1|||
163129027|NCT01004952|589179835|FG000|Overall Study|Lost to Follow-up|0|||
163129028|NCT01004952|589179836|FG001|Overall Study|Lost to Follow-up|11|||
162657009|NCT01573624|587457044|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
162657010|NCT01573624|587457045|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
162657011|NCT01573624|587457046|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
163129029|NCT01004952|589179835|FG000|Overall Study|Withdrawal by Subject|0|||
163129030|NCT01004952|589179836|FG001|Overall Study|Withdrawal by Subject|5|||
163129031|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
163129032|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
163129033|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
163129034|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
163129035|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
163129036|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
162657012|NCT01573624|587457040|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
163129037|NCT01359943|589179837|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
163129038|NCT01359943|589179838|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
163129039|NCT01359943|589179839|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
163129040|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
163129041|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
163129042|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
163129043|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
163129044|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
163129045|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
163129046|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
163129047|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
163129048|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
163129049|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129050|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129051|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
163129052|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
162657013|NCT01573624|587457041|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657014|NCT01573624|587457042|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657015|NCT01573624|587457043|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657016|NCT01573624|587457044|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657017|NCT01573624|587457045|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657018|NCT01573624|587457046|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162657019|NCT01573624|587457040|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162657020|NCT01573624|587457041|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162657021|NCT01573624|587457042|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162657022|NCT01573624|587457043|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162657023|NCT01573624|587457044|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162657024|NCT01573624|587457045|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
162657025|NCT01573624|587457046|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162657026|NCT01573624|587457040|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162657027|NCT01573624|587457041|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162657028|NCT01573624|587457042|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162657029|NCT01573624|587457043|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162657030|NCT01573624|587457044|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162657031|NCT01573624|587457045|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162657032|NCT01573624|587457046|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162657033|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657034|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657035|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657036|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657037|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657038|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
162657039|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162657040|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162657041|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162657042|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162657043|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162657044|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162657045|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162657046|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162657047|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162657048|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162657049|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
162657050|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162657051|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162657052|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162657053|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162657054|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162657055|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162657056|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162657057|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162719724|NCT02020616|587680549|FG001|Overall Study|Physician Decision|0|||
162657058|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162657059|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
162657060|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162657061|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162657062|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162657063|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163129053|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
163129054|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
163129055|NCT01359943|589179837|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
163129056|NCT01359943|589179838|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
163129057|NCT01359943|589179839|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
163129058|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
163129059|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
163129060|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
163129061|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
163129062|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
163129063|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
163129064|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
163129065|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
163129066|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
163129067|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129068|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129069|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
163129070|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
163129071|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
163129072|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
163129073|NCT01359943|589179837|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
163129074|NCT01359943|589179838|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
163129075|NCT01359943|589179839|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
163129076|NCT01529034|589179840|FG000|Overall Study|Discontinued prior to study treatment|14|||
163129077|NCT01529034|589179840|FG000|Overall Study|Site closure|62|||
163129078|NCT01529034|589179840|FG000|Overall Study|Study termination|29|||
163129079|NCT01529034|589179840|FG000|Overall Study|Withdrawal by Subject|25|||
163129080|NCT01529034|589179840|FG000|Overall Study|No treated SCs within protocol window|13|||
163129081|NCT01529034|589179840|FG000|Overall Study|Noncompliance|8|||
163129082|NCT01529034|589179840|FG000|Overall Study|Caregiver no longer available|7|||
163129083|NCT01529034|589179840|FG000|Overall Study|Adverse Event|4|||
163129084|NCT01529034|589179840|FG000|Overall Study|Protocol Violation|4|||
163129085|NCT01529034|589179840|FG000|Overall Study|Lack of Efficacy|4|||
163129086|NCT01529034|589179840|FG000|Overall Study|Investigator no longer available|2|||
163129087|NCT01529034|589179840|FG000|Overall Study|Study drug not available|2|||
163129088|NCT02911142|589179843|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
163129089|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
163129090|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
163129091|NCT02911142|589179843|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
163129092|NCT03436693|589179844|FG000|Overall Study|Adverse Event|22|||
163129093|NCT03436693|589179845|FG001|Overall Study|Adverse Event|10|||
163129094|NCT03436693|589179844|FG000|Overall Study|Physician Decision|3|||
163129095|NCT03436693|589179845|FG001|Overall Study|Physician Decision|3|||
163129096|NCT03436693|589179844|FG000|Overall Study|Withdrawal by Subject|4|||
163129097|NCT03436693|589179845|FG001|Overall Study|Withdrawal by Subject|13|||
163129098|NCT03436693|589179844|FG000|Overall Study|Progressive Disease|1|||
163129099|NCT03436693|589179845|FG001|Overall Study|Progressive Disease|1|||
163129100|NCT04481789|589179846|FG000|Period 1|Withdrawal by Subject|1|||
163129101|NCT04481789|589179847|FG001|Period 1|Withdrawal by Subject|0|||
163129102|NCT04481789|589179848|FG002|Period 1|Withdrawal by Subject|0|||
163129103|NCT04481789|589179849|FG003|Period 1|Withdrawal by Subject|0|||
163129104|NCT04481789|589179850|FG004|Period 1|Withdrawal by Subject|0|||
163129105|NCT04481789|589179851|FG005|Period 1|Withdrawal by Subject|0|||
163129106|NCT05216224|589179852|FG000|Overall Study|Adverse Event|6|||
163129107|NCT05216224|589179853|FG001|Overall Study|Adverse Event|3|||
163129108|NCT05216224|589179852|FG000|Overall Study|Lack of Efficacy|1|||
163129109|NCT05216224|589179853|FG001|Overall Study|Lack of Efficacy|0|||
162657064|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
162657065|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162657066|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
163129110|NCT05216224|589179852|FG000|Overall Study|Lost to Follow-up|8|||
163129111|NCT05216224|589179853|FG001|Overall Study|Lost to Follow-up|6|||
163129112|NCT05216224|589179852|FG000|Overall Study|Protocol Violation|1|||
163129113|NCT05216224|589179853|FG001|Overall Study|Protocol Violation|1|||
163129114|NCT05216224|589179852|FG000|Overall Study|Withdrawal by Subject|6|||
162657067|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162657068|NCT01573624|587457040|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657069|NCT01573624|587457041|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657070|NCT01573624|587457042|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657071|NCT01573624|587457043|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657072|NCT01573624|587457044|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657073|NCT01573624|587457045|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657074|NCT01573624|587457046|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657075|NCT01573624|587457040|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
162657076|NCT01573624|587457041|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
162657077|NCT01573624|587457042|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
162657078|NCT01573624|587457043|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
162657079|NCT01573624|587457044|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
162657080|NCT01573624|587457045|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
162657081|NCT01573624|587457046|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
162657082|NCT01573624|587457040|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163129115|NCT05216224|589179853|FG001|Overall Study|Withdrawal by Subject|5|||
163129116|NCT05216224|589179852|FG000|Overall Study|Other than specified|1|||
163129117|NCT05216224|589179853|FG001|Overall Study|Other than specified|0|||
163129118|NCT03245008|589179854|FG000|Overall Study|Adverse Event|15|||
163129119|NCT03245008|589179855|FG001|Overall Study|Adverse Event|18|||
163129120|NCT03245008|589179856|FG002|Overall Study|Adverse Event|15|||
163129121|NCT03245008|589179857|FG003|Overall Study|Adverse Event|0|||
163129122|NCT03245008|589179858|FG004|Overall Study|Adverse Event|1|||
163129123|NCT03245008|589179854|FG000|Overall Study|Lack of Efficacy|0|||
163129124|NCT03245008|589179855|FG001|Overall Study|Lack of Efficacy|1|||
163129125|NCT03245008|589179856|FG002|Overall Study|Lack of Efficacy|0|||
163129126|NCT03245008|589179857|FG003|Overall Study|Lack of Efficacy|0|||
163129127|NCT03245008|589179858|FG004|Overall Study|Lack of Efficacy|0|||
163129128|NCT03245008|589179854|FG000|Overall Study|Lost to Follow-up|4|||
163129129|NCT03245008|589179855|FG001|Overall Study|Lost to Follow-up|1|||
163129130|NCT03245008|589179856|FG002|Overall Study|Lost to Follow-up|0|||
163129131|NCT03245008|589179857|FG003|Overall Study|Lost to Follow-up|0|||
163129132|NCT03245008|589179858|FG004|Overall Study|Lost to Follow-up|1|||
163129133|NCT03245008|589179854|FG000|Overall Study|Physician Decision|1|||
163129134|NCT03245008|589179855|FG001|Overall Study|Physician Decision|3|||
163129135|NCT03245008|589179856|FG002|Overall Study|Physician Decision|4|||
163129136|NCT03245008|589179857|FG003|Overall Study|Physician Decision|0|||
163129137|NCT03245008|589179858|FG004|Overall Study|Physician Decision|0|||
163129138|NCT03245008|589179854|FG000|Overall Study|Protocol Violation|0|||
163129139|NCT03245008|589179855|FG001|Overall Study|Protocol Violation|1|||
163129140|NCT03245008|589179856|FG002|Overall Study|Protocol Violation|0|||
163129141|NCT03245008|589179857|FG003|Overall Study|Protocol Violation|0|||
163129142|NCT03245008|589179858|FG004|Overall Study|Protocol Violation|0|||
163129143|NCT03245008|589179854|FG000|Overall Study|Withdrawal by Subject|20|||
163129144|NCT03245008|589179855|FG001|Overall Study|Withdrawal by Subject|19|||
163129145|NCT03245008|589179856|FG002|Overall Study|Withdrawal by Subject|11|||
163129146|NCT03245008|589179857|FG003|Overall Study|Withdrawal by Subject|0|||
163129147|NCT03245008|589179858|FG004|Overall Study|Withdrawal by Subject|0|||
163129148|NCT03245008|589179854|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129149|NCT03245008|589179855|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129150|NCT03245008|589179856|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
163129151|NCT03245008|589179857|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
163129152|NCT03245008|589179858|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
163129153|NCT03245008|589179854|FG000|Overall Study|Failure to meet randomization criteria|0|||
163129154|NCT03245008|589179855|FG001|Overall Study|Failure to meet randomization criteria|1|||
163129155|NCT03245008|589179856|FG002|Overall Study|Failure to meet randomization criteria|0|||
163129156|NCT03245008|589179857|FG003|Overall Study|Failure to meet randomization criteria|1|||
163129157|NCT03245008|589179858|FG004|Overall Study|Failure to meet randomization criteria|0|||
163129158|NCT04655144|589179864|FG000|Overall Study|Consumed THC|1|||
163129159|NCT04655144|589179865|FG001|Overall Study|Consumed THC|0|||
163129160|NCT04655144|589179864|FG000|Overall Study|Unilateral embolization|0|||
163129161|NCT04655144|589179865|FG001|Overall Study|Unilateral embolization|1|||
162657083|NCT01573624|587457041|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
162719725|NCT02020616|587680550|FG002|Overall Study|Physician Decision|0|||
163129162|NCT04317742|589179866|FG000|Overall Study|Lost to Follow-up|57|||
163129163|NCT04317742|589179867|FG001|Overall Study|Lost to Follow-up|59|||
163129164|NCT04317742|589179866|FG000|Overall Study|Pregnancy|1|||
163129165|NCT04317742|589179867|FG001|Overall Study|Pregnancy|1|||
163129166|NCT04317742|589179866|FG000|Overall Study|Withdrawal by Subject|46|||
163129167|NCT04317742|589179867|FG001|Overall Study|Withdrawal by Subject|24|||
163129168|NCT01580670|589179868|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
163129169|NCT01580670|589179868|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
163129170|NCT02678923|589179869|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
163129171|NCT02678923|589179870|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
163129172|NCT02678923|589179869|FG000|Overall Study|Withdrawal by Subject|3|||
163129173|NCT02678923|589179870|FG001|Overall Study|Withdrawal by Subject|2|||
163129174|NCT02678923|589179869|FG000|Overall Study|Lost to Follow-up|1|||
163129175|NCT02678923|589179870|FG001|Overall Study|Lost to Follow-up|0|||
163129176|NCT02678923|589179869|FG000|Overall Study|Did Not Return for Study Visits|1|||
163129177|NCT02678923|589179870|FG001|Overall Study|Did Not Return for Study Visits|0|||
163129178|NCT03266172|589179871|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
163129179|NCT03266172|589179872|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
163129180|NCT03266172|589179873|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
163129181|NCT03266172|589179871|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
163129182|NCT03266172|589179872|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
163129183|NCT03266172|589179873|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
163129184|NCT03266172|589179871|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
163129185|NCT03266172|589179872|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
163129186|NCT03266172|589179873|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
163129187|NCT03266172|589179871|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
163129188|NCT03266172|589179872|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
163129189|NCT03266172|589179873|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
163129190|NCT03266172|589179871|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129191|NCT03266172|589179872|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129192|NCT03266172|589179873|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
163129193|NCT03266172|589179871|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129194|NCT03266172|589179872|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
163129195|NCT03266172|589179873|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
163129196|NCT01554514|589179874|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
163129197|NCT01554514|589179874|FG000|Overall Study|Physician Decision|1|||
163129198|NCT01422824|589179875|FG000|Overall Study|Case record form not evaluated|1|||
163129199|NCT01422824|589179875|FG000|Overall Study|Lost to Follow-up|37|||
163129200|NCT00470418|589179876|FG000|Overall Study|Withdrawal by Subject|1|||
163129201|NCT00470418|589179877|FG001|Overall Study|Withdrawal by Subject|0|||
163129202|NCT02879578|589179880|FG000|Overall Study|Adverse Event|1|||
163129203|NCT02879578|589179881|FG001|Overall Study|Adverse Event|2|||
163129204|NCT02879578|589179882|FG002|Overall Study|Adverse Event|14|||
163129205|NCT02879578|589179880|FG000|Overall Study|Protocol Violation|0|||
163129206|NCT02879578|589179881|FG001|Overall Study|Protocol Violation|1|||
163129207|NCT02879578|589179882|FG002|Overall Study|Protocol Violation|1|||
163129208|NCT02879578|589179880|FG000|Overall Study|Withdrawal by Subject|8|||
163129209|NCT02879578|589179881|FG001|Overall Study|Withdrawal by Subject|6|||
163129210|NCT02879578|589179882|FG002|Overall Study|Withdrawal by Subject|9|||
163129211|NCT02879578|589179880|FG000|Overall Study|Lost to Follow-up|1|||
163129212|NCT02879578|589179881|FG001|Overall Study|Lost to Follow-up|0|||
163129213|NCT02879578|589179882|FG002|Overall Study|Lost to Follow-up|4|||
163129214|NCT02879578|589179880|FG000|Overall Study|Physician Decision|0|||
163129215|NCT02879578|589179881|FG001|Overall Study|Physician Decision|0|||
163129216|NCT02879578|589179882|FG002|Overall Study|Physician Decision|4|||
163129217|NCT01879072|589179884|FG000|Overall Study|Withdrawal by Subject|121|||
163129218|NCT01879072|589179884|FG000|Overall Study|Not Transplanted|30|||
163129219|NCT02666105|589179891|FG000|Overall Study|Death|1|||
163129220|NCT00411632|589179892|FG000|Overall Study|Death|1|||
163129221|NCT01264419|589179893|FG000|Overall Study|Lost to Follow-up|3|||
163129222|NCT00659230|589179894|FG000|Overall Study|Lost to Follow-up|2|||
163129223|NCT00659230|589179895|FG001|Overall Study|Lost to Follow-up|5|||
163129224|NCT00659230|589179894|FG000|Overall Study|Lost source documentation|5|||
163129225|NCT00659230|589179895|FG001|Overall Study|Lost source documentation|4|||
163129226|NCT00659230|589179894|FG000|Overall Study|Did not return post-randomization|2|||
162657084|NCT01573624|587457042|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162657085|NCT01573624|587457043|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162657086|NCT01573624|587457044|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
163129227|NCT00659230|589179895|FG001|Overall Study|Did not return post-randomization|3|||
163129228|NCT05138419|589180856|FG000|Overall Study|Study terminated before participant completed.|0|||
163129229|NCT05138419|589180857|FG001|Overall Study|Study terminated before participant completed.|0|||
162657087|NCT01573624|587457045|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
163129230|NCT05138419|589180858|FG002|Overall Study|Study terminated before participant completed.|1|||
163129231|NCT01048853|589180859|FG000|Overall Study|Death|1|||
163129232|NCT01048853|589180860|FG001|Overall Study|Death|0|||
163129233|NCT01048853|589180861|FG002|Overall Study|Death|0|||
163129234|NCT01048853|589180859|FG000|Overall Study|Lost to Follow-up|1|||
163129235|NCT01048853|589180860|FG001|Overall Study|Lost to Follow-up|4|||
163129236|NCT01048853|589180861|FG002|Overall Study|Lost to Follow-up|0|||
162657088|NCT01573624|587457046|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162657089|NCT01573624|587457040|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
162719726|NCT02020616|587680551|FG003|Overall Study|Physician Decision|0|||
163129237|NCT01532570|589180866|FG000|Overall Study|Lack of Efficacy|1|||
163129238|NCT01532570|589180867|FG001|Overall Study|Lack of Efficacy|0|||
163129239|NCT01532570|589180868|FG002|Overall Study|Lack of Efficacy|0|||
163129240|NCT01532570|589180869|FG003|Overall Study|Lack of Efficacy|0|||
163129241|NCT01532570|589180866|FG000|Overall Study|Withdrawal by Subject|0|||
163129242|NCT01532570|589180867|FG001|Overall Study|Withdrawal by Subject|1|||
163129243|NCT01532570|589180868|FG002|Overall Study|Withdrawal by Subject|0|||
163129244|NCT01532570|589180869|FG003|Overall Study|Withdrawal by Subject|0|||
163129245|NCT00805766|589180870|FG000|Screening Period|Adverse Event|1|||
163129246|NCT00805766|589180870|FG000|Screening Period|Lack of Efficacy|2|||
163129247|NCT00805766|589180870|FG000|Screening Period|Pregnancy|1|||
163129248|NCT00805766|589180870|FG000|Screening Period|Responder|2|||
163129249|NCT00805766|589180870|FG000|Increased Dose Period|Adverse Event|4|||
163129250|NCT00805766|589180870|FG000|Increased Dose Period|Lack of Efficacy|7|||
163129251|NCT00805766|589180870|FG000|Increased Dose Period|Pregnancy|1|||
163129252|NCT00805766|589180870|FG000|Increased Dose Period|Withdrawal by Subject|1|||
163129253|NCT02354222|589180871|FG000|Overall Study|Adverse Event|0|||
163129254|NCT02354222|589180872|FG001|Overall Study|Adverse Event|3|||
163129255|NCT02354222|589180871|FG000|Overall Study|Physician Decision|1|||
163129256|NCT02354222|589180872|FG001|Overall Study|Physician Decision|1|||
163129257|NCT02354222|589180871|FG000|Overall Study|Pregnancy|1|||
163129258|NCT02354222|589180872|FG001|Overall Study|Pregnancy|0|||
163129259|NCT02354222|589180871|FG000|Overall Study|Withdrawal by Subject|2|||
163129260|NCT02354222|589180872|FG001|Overall Study|Withdrawal by Subject|3|||
163129261|NCT02354222|589180871|FG000|Overall Study|Conflict with the stopping criteria|0|||
163129262|NCT02354222|589180872|FG001|Overall Study|Conflict with the stopping criteria|4|||
163129263|NCT04300218|589180873|FG000|Overall Study|Lost to Follow-up|6|||
163129264|NCT04300218|589180874|FG001|Overall Study|Lost to Follow-up|8|||
163129265|NCT05451940|589180875|FG000|Treatment Period|Physician Decision|1|||
163129266|NCT03645863|589180876|FG000|Overall Study|Withdrawal by Subject|1|||
163129267|NCT03645863|589180877|FG001|Overall Study|Withdrawal by Subject|0|||
163129268|NCT03645863|589180878|FG002|Overall Study|Withdrawal by Subject|0|||
163129269|NCT02220907|589180879|FG000|Overall Study|Adverse Event|7|||
163129270|NCT02220907|589180879|FG000|Overall Study|Physician Decision|1|||
163129271|NCT02220907|589180879|FG000|Overall Study|Withdrawal by Subject|2|||
163129272|NCT02220907|589180879|FG000|Overall Study|Conflict with the stopping criteria|1|||
163129273|NCT00542815|589180880|FG000|Overall Study|Adverse Event|19|||
163129274|NCT00542815|589180881|FG001|Overall Study|Adverse Event|6|||
163129275|NCT00542815|589180882|FG002|Overall Study|Adverse Event|9|||
163129276|NCT00542815|589180880|FG000|Overall Study|Death|10|||
163129277|NCT00542815|589180881|FG001|Overall Study|Death|7|||
163129278|NCT00542815|589180882|FG002|Overall Study|Death|3|||
163129279|NCT00542815|589180880|FG000|Overall Study|Lack of Efficacy|9|||
163129280|NCT00542815|589180881|FG001|Overall Study|Lack of Efficacy|2|||
163129281|NCT00542815|589180882|FG002|Overall Study|Lack of Efficacy|0|||
163129282|NCT00542815|589180880|FG000|Overall Study|Physician Decision|2|||
163129283|NCT00542815|589180881|FG001|Overall Study|Physician Decision|1|||
163129284|NCT00542815|589180882|FG002|Overall Study|Physician Decision|0|||
163129285|NCT00542815|589180880|FG000|Overall Study|Protocol Violation|1|||
163129286|NCT00542815|589180881|FG001|Overall Study|Protocol Violation|1|||
163129287|NCT00542815|589180882|FG002|Overall Study|Protocol Violation|2|||
163129288|NCT00542815|589180880|FG000|Overall Study|Withdrawal by Subject|41|||
163129289|NCT00542815|589180881|FG001|Overall Study|Withdrawal by Subject|5|||
163129290|NCT00542815|589180882|FG002|Overall Study|Withdrawal by Subject|8|||
163129291|NCT00542815|589180880|FG000|Overall Study|Other reasons|24|||
163129292|NCT00542815|589180881|FG001|Overall Study|Other reasons|10|||
163129293|NCT00542815|589180882|FG002|Overall Study|Other reasons|10|||
163129294|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129295|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129296|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129297|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
163129298|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129299|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
163129300|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
163129301|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129302|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129303|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129304|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129305|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
163129306|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129307|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
163129308|NCT01966445|589180891|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129309|NCT01966445|589180892|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
163129310|NCT01966445|589180893|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
163129311|NCT01966445|589180894|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129312|NCT01966445|589180895|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
163129313|NCT01966445|589180896|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129314|NCT01966445|589180897|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
163129315|NCT01966445|589180891|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129316|NCT01966445|589180892|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129317|NCT01966445|589180893|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129318|NCT01966445|589180894|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129319|NCT01966445|589180895|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129320|NCT01966445|589180896|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
163129321|NCT01966445|589180897|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
163129322|NCT01966445|589180891|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129323|NCT01966445|589180892|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129324|NCT01966445|589180893|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129325|NCT01966445|589180894|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129326|NCT01966445|589180895|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129327|NCT01966445|589180896|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
163129328|NCT01966445|589180897|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
163129329|NCT01374178|589180898|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
163129330|NCT01374178|589180899|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
163129331|NCT01374178|589180898|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
163129332|NCT01374178|589180899|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
163129333|NCT01716104|589180900|FG000|Overall Study|Do not meet inclusion criteria|6|||
163129334|NCT01716104|589180901|FG001|Overall Study|Do not meet inclusion criteria|7|||
163129335|NCT00117793|589180902|FG000|Overall Study|Withdrawal by Subject|12|||
163129336|NCT01818492|589180907|FG000|Overall Study|Adverse Event|2|||
163129337|NCT01818492|589180907|FG000|Overall Study|Death|3|||
163129338|NCT01818492|589180907|FG000|Overall Study|Withdrawal by Subject|1|||
163129339|NCT01818492|589180907|FG000|Overall Study|Additional therapy when not allowed PP|4|||
163129340|NCT00885482|589180908|FG000|Overall Study|Pregnancy|1|||
163129341|NCT00885482|589180908|FG000|Overall Study|Lack of Efficacy|1|||
163129342|NCT00885482|589180908|FG000|Overall Study|Death|1|||
163129343|NCT00885482|589180908|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
163129344|NCT02772978|589180909|FG000|Overall Study|Withdrawal by Subject|1|||
163129345|NCT02772978|589180910|FG001|Overall Study|Withdrawal by Subject|1|||
163129346|NCT02438813|589180911|FG000|Overall Study|Patient Decision|59|||
163129347|NCT02438813|589180911|FG000|Overall Study|Patient Lost to Follow-Up|137|||
163129348|NCT02438813|589180911|FG000|Overall Study|Study Ended by Sponsor|80|||
163129349|NCT02438813|589180911|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
163129350|NCT00409344|589180913|FG000|Overall Study|no enrollment|0|||
163129351|NCT00409344|589180914|FG001|Overall Study|no enrollment|0|||
163129352|NCT01069705|589180922|FG000|Overall Study|Adverse Event|1|||
163129353|NCT01069705|589180922|FG000|Overall Study|Withdrawal by Subject|2|||
163129354|NCT03624127|589180923|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
163129355|NCT03624127|589180924|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
163129356|NCT03624127|589180925|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
163129357|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
163129358|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
163129359|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
163129360|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Death|0|||
163129361|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Death|1|||
163129362|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Death|0|||
163129363|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
163129364|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
163129365|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
163129366|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
163129367|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
163129368|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
163129369|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
163129370|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
163129371|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
163129372|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
163129373|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
163129374|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
163129375|NCT03624127|589180923|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
163129376|NCT03624127|589180924|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
163129377|NCT03624127|589180925|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
163129378|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
163129379|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
163129380|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
163129381|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
163129382|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
162657090|NCT01573624|587457041|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657091|NCT01573624|587457042|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657092|NCT01573624|587457043|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657093|NCT01573624|587457044|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657094|NCT01573624|587457045|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657095|NCT01573624|587457046|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162657096|NCT01573624|587457040|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162657097|NCT01573624|587457041|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162657098|NCT01573624|587457042|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162657099|NCT01573624|587457043|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162657100|NCT01573624|587457044|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162657101|NCT01573624|587457045|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162657102|NCT01573624|587457046|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162657103|NCT01573624|587457040|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
162657104|NCT01573624|587457041|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657105|NCT01573624|587457042|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657106|NCT01573624|587457043|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657107|NCT01573624|587457044|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657108|NCT01573624|587457045|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657109|NCT01573624|587457046|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162657110|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
162657111|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162657112|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162657113|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162657114|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162657115|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163129383|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
163129384|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
163129385|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
163129386|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
163129387|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
163129388|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
163129389|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
163129390|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
163129391|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
163129392|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
163129393|NCT03624127|589180923|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
163129394|NCT03624127|589180924|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
163129395|NCT03624127|589180925|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
163129396|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
163129397|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
163129398|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
163129399|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
163129400|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163129401|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163129402|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
163129403|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
163129404|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
163129405|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
163129406|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
163129407|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
163129408|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
163129409|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
163129410|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
163129411|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
163129412|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
163129413|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
163129414|NCT03624127|589180923|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
163129415|NCT03624127|589180924|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
163129416|NCT03624127|589180925|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
163129417|NCT00666224|589182256|FG000|Double-Blind|Adverse Event|15|||
163129418|NCT00666224|589182257|FG001|Double-Blind|Adverse Event|5|||
162657116|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
162657117|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
162657118|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162657119|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162657120|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162657121|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162657122|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
162657123|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162657124|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657125|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
162657126|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657127|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657128|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657129|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657130|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162657131|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657132|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
162657133|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657134|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657135|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657136|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657137|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162657138|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162657139|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162657140|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162657141|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162657142|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162657143|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162657144|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162657145|NCT01573624|587457040|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657146|NCT01573624|587457041|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657147|NCT01573624|587457042|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657148|NCT01573624|587457043|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657149|NCT01573624|587457044|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657150|NCT01573624|587457045|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162657151|NCT01573624|587457046|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162657152|NCT01573624|587457040|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
162657153|NCT01573624|587457041|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162657154|NCT01573624|587457042|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162657155|NCT01573624|587457043|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162657156|NCT01573624|587457044|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
162657157|NCT01573624|587457045|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
162657158|NCT01573624|587457046|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
162657159|NCT01573624|587457040|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162657160|NCT01573624|587457041|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
162657161|NCT01573624|587457042|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162657162|NCT01573624|587457043|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162657163|NCT01573624|587457044|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162657164|NCT01573624|587457045|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
163129419|NCT00666224|589182256|FG000|Double-Blind|Lost to Follow-up|2|||
163129420|NCT00666224|589182257|FG001|Double-Blind|Lost to Follow-up|2|||
163129421|NCT00666224|589182256|FG000|Double-Blind|Withdrawal by Subject|18|||
163129422|NCT00666224|589182257|FG001|Double-Blind|Withdrawal by Subject|14|||
163129423|NCT00666224|589182256|FG000|Double-Blind|Physician Decision|0|||
163129424|NCT00666224|589182257|FG001|Double-Blind|Physician Decision|3|||
163129425|NCT00666224|589182256|FG000|Double-Blind|Sponsor decision|1|||
163129426|NCT00666224|589182257|FG001|Double-Blind|Sponsor decision|0|||
163129427|NCT00666224|589182256|FG000|Double-Blind|Pregnancy|3|||
163129428|NCT00666224|589182257|FG001|Double-Blind|Pregnancy|2|||
163129429|NCT00666224|589182256|FG000|Double-Blind|Noncompliance|1|||
162657165|NCT01573624|587457046|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162657166|NCT01573624|587457040|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
162657167|NCT01573624|587457041|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163129430|NCT00666224|589182257|FG001|Double-Blind|Noncompliance|0|||
163129431|NCT00666224|589182256|FG000|Double-Blind|Death|1|||
163129432|NCT00666224|589182257|FG001|Double-Blind|Death|0|||
163129433|NCT00666224|589182256|FG000|Double-Blind|Undefined/Unknown|4|||
163129434|NCT00666224|589182257|FG001|Double-Blind|Undefined/Unknown|1|||
163129435|NCT00666224|589182256|FG000|Open-Label|Adverse Event|8|||
163129436|NCT00666224|589182257|FG001|Open-Label|Adverse Event|43|||
163129437|NCT00666224|589182256|FG000|Open-Label|Lost to Follow-up|4|||
163129438|NCT00666224|589182257|FG001|Open-Label|Lost to Follow-up|5|||
163129439|NCT00666224|589182256|FG000|Open-Label|Withdrawal by Subject|12|||
163129440|NCT00666224|589182257|FG001|Open-Label|Withdrawal by Subject|25|||
163129441|NCT00666224|589182256|FG000|Open-Label|Physician Decision|7|||
163129442|NCT00666224|589182257|FG001|Open-Label|Physician Decision|5|||
163129443|NCT00666224|589182256|FG000|Open-Label|Pregnancy|1|||
163129444|NCT00666224|589182257|FG001|Open-Label|Pregnancy|5|||
163129445|NCT00666224|589182256|FG000|Open-Label|Noncompliance|2|||
163129446|NCT00666224|589182257|FG001|Open-Label|Noncompliance|1|||
163129447|NCT00666224|589182256|FG000|Open-Label|Undefined/Unknown|1|||
163129448|NCT00666224|589182257|FG001|Open-Label|Undefined/Unknown|1|||
163129449|NCT03521141|589182258|FG000|Overall Study|Death|1|||
163129450|NCT03521141|589182259|FG001|Overall Study|Death|0|||
163129451|NCT03521141|589182260|FG002|Overall Study|Death|1|||
163129452|NCT03828617|589182262|FG000|Overall Study|Lost to Follow-up|22|||
163129453|NCT03828617|589182263|FG001|Overall Study|Lost to Follow-up|12|||
163129454|NCT03828617|589182264|FG002|Overall Study|Lost to Follow-up|23|||
163129455|NCT03828617|589182265|FG003|Overall Study|Lost to Follow-up|7|||
163129456|NCT03828617|589182262|FG000|Overall Study|No longer met eligibility criteria|0|||
163129457|NCT03828617|589182263|FG001|Overall Study|No longer met eligibility criteria|1|||
163129458|NCT03828617|589182264|FG002|Overall Study|No longer met eligibility criteria|1|||
163129459|NCT03828617|589182265|FG003|Overall Study|No longer met eligibility criteria|3|||
163129460|NCT03828617|589182262|FG000|Overall Study|Protocol Violation|0|||
163129461|NCT03828617|589182263|FG001|Overall Study|Protocol Violation|2|||
163129462|NCT03828617|589182264|FG002|Overall Study|Protocol Violation|0|||
163129463|NCT03828617|589182265|FG003|Overall Study|Protocol Violation|0|||
163129464|NCT03828617|589182262|FG000|Overall Study|Withdrawal by Subject|2|||
163129465|NCT03828617|589182263|FG001|Overall Study|Withdrawal by Subject|0|||
163129466|NCT03828617|589182264|FG002|Overall Study|Withdrawal by Subject|2|||
163129467|NCT03828617|589182265|FG003|Overall Study|Withdrawal by Subject|0|||
163129468|NCT03354273|589182266|FG000|Overall Study|Adverse Event|5|||
163129469|NCT03354273|589182266|FG000|Overall Study|Screen Failure|21|||
163129470|NCT03354273|589182266|FG000|Overall Study|Withdrawal by Subject|34|||
163129471|NCT03354273|589182266|FG000|Overall Study|Technical Problems|30|||
163129472|NCT03354273|589182266|FG000|Overall Study|Lost to Follow-up|4|||
163129473|NCT03354273|589182266|FG000|Overall Study|Investigator Decision|3|||
163129474|NCT03354273|589182266|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
163129475|NCT03354273|589182266|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
163129476|NCT03354273|589182266|FG000|Overall Study|COVID-19 Restrictions|9|||
163129477|NCT03354273|589182266|FG000|Overall Study|Other|5|||
163129478|NCT00303485|589182267|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
163129479|NCT00303485|589182268|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
163129480|NCT00303485|589182267|FG000|Overall Study|Failure to return|0|||
163129481|NCT00303485|589182268|FG001|Overall Study|Failure to return|1|||
163129482|NCT00303485|589182267|FG000|Overall Study|Withdrawal by Subject|1|||
163129483|NCT00303485|589182268|FG001|Overall Study|Withdrawal by Subject|0|||
163129484|NCT00971243|589182269|FG000|Double Blind Period|Adverse Event|2|||
163129485|NCT00971243|589182270|FG001|Double Blind Period|Adverse Event|3|||
163129486|NCT00971243|589182271|FG002|Double Blind Period|Adverse Event|2|||
163129487|NCT00971243|589182272|FG003|Double Blind Period|Adverse Event|2|||
163129488|NCT00971243|589182273|FG004|Double Blind Period|Adverse Event|3|||
163129489|NCT00971243|589182269|FG000|Double Blind Period|Lost to Follow-up|0|||
163129490|NCT00971243|589182270|FG001|Double Blind Period|Lost to Follow-up|1|||
163129491|NCT00971243|589182271|FG002|Double Blind Period|Lost to Follow-up|1|||
162657168|NCT01573624|587457042|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162657169|NCT01573624|587457043|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162657170|NCT01573624|587457044|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162657171|NCT01573624|587457045|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
163129492|NCT00971243|589182272|FG003|Double Blind Period|Lost to Follow-up|0|||
163129493|NCT00971243|589182273|FG004|Double Blind Period|Lost to Follow-up|1|||
163129494|NCT00971243|589182269|FG000|Double Blind Period|Physician Decision|10|||
163129495|NCT00971243|589182270|FG001|Double Blind Period|Physician Decision|6|||
163129496|NCT00971243|589182271|FG002|Double Blind Period|Physician Decision|7|||
163129497|NCT00971243|589182272|FG003|Double Blind Period|Physician Decision|6|||
163129498|NCT00971243|589182273|FG004|Double Blind Period|Physician Decision|7|||
163129499|NCT00971243|589182269|FG000|Double Blind Period|Protocol Violation|2|||
163129500|NCT00971243|589182270|FG001|Double Blind Period|Protocol Violation|0|||
163129501|NCT00971243|589182271|FG002|Double Blind Period|Protocol Violation|3|||
163129502|NCT00971243|589182272|FG003|Double Blind Period|Protocol Violation|2|||
163129503|NCT00971243|589182273|FG004|Double Blind Period|Protocol Violation|2|||
163129504|NCT00971243|589182269|FG000|Double Blind Period|Withdrawal by Subject|4|||
163129505|NCT00971243|589182270|FG001|Double Blind Period|Withdrawal by Subject|1|||
163129506|NCT00971243|589182271|FG002|Double Blind Period|Withdrawal by Subject|4|||
163129507|NCT00971243|589182272|FG003|Double Blind Period|Withdrawal by Subject|4|||
163129508|NCT00971243|589182273|FG004|Double Blind Period|Withdrawal by Subject|4|||
163129509|NCT00971243|589182269|FG000|Double Blind Period|Other reasons|1|||
163129510|NCT00971243|589182270|FG001|Double Blind Period|Other reasons|0|||
163129511|NCT00971243|589182271|FG002|Double Blind Period|Other reasons|2|||
163129512|NCT00971243|589182272|FG003|Double Blind Period|Other reasons|0|||
163129513|NCT00971243|589182273|FG004|Double Blind Period|Other reasons|1|||
163129514|NCT00971243|589182269|FG000|Open-label Period|Adverse Event|1|||
163129515|NCT00971243|589182270|FG001|Open-label Period|Adverse Event|0|||
163129516|NCT00971243|589182271|FG002|Open-label Period|Adverse Event|1|||
163129517|NCT00971243|589182272|FG003|Open-label Period|Adverse Event|1|||
163129518|NCT00971243|589182273|FG004|Open-label Period|Adverse Event|0|||
163129519|NCT00971243|589182269|FG000|Open-label Period|Physician Decision|5|||
163129520|NCT00971243|589182270|FG001|Open-label Period|Physician Decision|9|||
163129521|NCT00971243|589182271|FG002|Open-label Period|Physician Decision|3|||
163129522|NCT00971243|589182272|FG003|Open-label Period|Physician Decision|7|||
163129523|NCT00971243|589182273|FG004|Open-label Period|Physician Decision|2|||
163129524|NCT00971243|589182269|FG000|Open-label Period|Protocol Violation|1|||
163129525|NCT00971243|589182270|FG001|Open-label Period|Protocol Violation|1|||
163129526|NCT00971243|589182271|FG002|Open-label Period|Protocol Violation|1|||
163129527|NCT00971243|589182272|FG003|Open-label Period|Protocol Violation|0|||
162657172|NCT01573624|587457046|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162657173|NCT01573624|587457040|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
163129528|NCT00971243|589182273|FG004|Open-label Period|Protocol Violation|1|||
163129529|NCT00971243|589182269|FG000|Open-label Period|Withdrawal by Subject|1|||
163129530|NCT00971243|589182270|FG001|Open-label Period|Withdrawal by Subject|0|||
163129531|NCT00971243|589182271|FG002|Open-label Period|Withdrawal by Subject|0|||
163129532|NCT00971243|589182272|FG003|Open-label Period|Withdrawal by Subject|2|||
163129533|NCT00971243|589182273|FG004|Open-label Period|Withdrawal by Subject|1|||
163129534|NCT00971243|589182269|FG000|Open-label Period|Other reason|0|||
163129535|NCT00971243|589182270|FG001|Open-label Period|Other reason|0|||
163129536|NCT00971243|589182271|FG002|Open-label Period|Other reason|0|||
163129537|NCT00971243|589182272|FG003|Open-label Period|Other reason|0|||
163129538|NCT00971243|589182273|FG004|Open-label Period|Other reason|2|||
163129539|NCT04099511|589182277|FG000|Overall Study|Lost to Follow-up|2|||
163129540|NCT04099511|589182278|FG001|Overall Study|Lost to Follow-up|2|||
163129541|NCT04099511|589182277|FG000|Overall Study|Withdrawal by Subject|8|||
163129542|NCT04099511|589182278|FG001|Overall Study|Withdrawal by Subject|4|||
163129543|NCT06581094|589182281|FG000|Overall Study|Lost to Follow-up|1|||
163129544|NCT06581094|589182282|FG001|Overall Study|Lost to Follow-up|1|||
163129545|NCT05740618|589182283|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
163129546|NCT05740618|589182283|FG000|Overall Study|Physician Decision|1|||
163129547|NCT04588389|589182284|FG000|Overall Study|Issues with anesthesia during surgery|2|||
163129548|NCT04588389|589182285|FG001|Overall Study|Issues with anesthesia during surgery|0|||
163129549|NCT04588389|589182286|FG002|Overall Study|Issues with anesthesia during surgery|0|||
163129550|NCT02354235|589182290|FG000|Overall Study|Adverse Event|2|||
163129551|NCT02354235|589182291|FG001|Overall Study|Adverse Event|2|||
163129552|NCT02354235|589182290|FG000|Overall Study|Physician Decision|0|||
163129553|NCT02354235|589182291|FG001|Overall Study|Physician Decision|1|||
163129554|NCT02354235|589182290|FG000|Overall Study|Withdrawal by Subject|1|||
163129555|NCT02354235|589182291|FG001|Overall Study|Withdrawal by Subject|3|||
163129556|NCT02354235|589182290|FG000|Overall Study|Conflict with the stopping criteria|0|||
163129557|NCT02354235|589182291|FG001|Overall Study|Conflict with the stopping criteria|1|||
163129558|NCT06045507|589182292|FG000|Overall Study|Death|0|||
163129559|NCT06045507|589182293|FG001|Overall Study|Death|0|||
163129560|NCT06045507|589182294|FG002|Overall Study|Death|1|||
163129561|NCT06045507|589182295|FG003|Overall Study|Death|0|||
163129562|NCT06045507|589182292|FG000|Overall Study|Lost to Follow-up|3|||
163129563|NCT06045507|589182293|FG001|Overall Study|Lost to Follow-up|3|||
163129564|NCT06045507|589182294|FG002|Overall Study|Lost to Follow-up|0|||
163129565|NCT06045507|589182295|FG003|Overall Study|Lost to Follow-up|0|||
163129566|NCT06045507|589182292|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
163129567|NCT06045507|589182293|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
163129568|NCT06045507|589182294|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
163129569|NCT06045507|589182295|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
163129570|NCT06045507|589182292|FG000|Overall Study|Withdrawal by Subject|4|||
163129571|NCT06045507|589182293|FG001|Overall Study|Withdrawal by Subject|1|||
163129572|NCT06045507|589182294|FG002|Overall Study|Withdrawal by Subject|0|||
163129573|NCT06045507|589182295|FG003|Overall Study|Withdrawal by Subject|2|||
163129574|NCT06045507|589182292|FG000|Overall Study|Miscellaneous|2|||
163129575|NCT06045507|589182293|FG001|Overall Study|Miscellaneous|0|||
163129576|NCT06045507|589182294|FG002|Overall Study|Miscellaneous|0|||
162719727|NCT02020616|587680552|FG004|Overall Study|Physician Decision|0|||
163129577|NCT06045507|589182295|FG003|Overall Study|Miscellaneous|1|||
162657174|NCT01573624|587457041|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162657175|NCT01573624|587457042|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162657176|NCT01573624|587457043|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162657177|NCT01573624|587457044|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
162657178|NCT01573624|587457045|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
162657179|NCT01573624|587457046|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162657180|NCT01573624|587457040|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
162657181|NCT01573624|587457041|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657182|NCT01573624|587457042|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657183|NCT01573624|587457043|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657184|NCT01573624|587457044|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657185|NCT01573624|587457045|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657186|NCT01573624|587457046|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162657187|NCT04399161|587457047|FG000|Overall Study|Withdrawal by Subject|1|||
162657188|NCT04399161|587457048|FG001|Overall Study|Withdrawal by Subject|0|||
162657189|NCT04399161|587457049|FG002|Overall Study|Withdrawal by Subject|2|||
162657190|NCT04399161|587457047|FG000|Overall Study|Protocol Violation|1|||
162657191|NCT04399161|587457048|FG001|Overall Study|Protocol Violation|2|||
162657192|NCT04399161|587457049|FG002|Overall Study|Protocol Violation|0|||
163129578|NCT03688100|589182297|FG000|Overall Study|Lost to Follow-up|21|||
163129579|NCT03688100|589182298|FG001|Overall Study|Lost to Follow-up|15|||
163129580|NCT03688100|589182299|FG002|Overall Study|Lost to Follow-up|15|||
163129581|NCT03688100|589182300|FG003|Overall Study|Lost to Follow-up|18|||
163129582|NCT03688100|589182297|FG000|Overall Study|Withdrawal by Subject|19|||
163129583|NCT03688100|589182298|FG001|Overall Study|Withdrawal by Subject|16|||
163129584|NCT03688100|589182299|FG002|Overall Study|Withdrawal by Subject|0|||
163129585|NCT03688100|589182300|FG003|Overall Study|Withdrawal by Subject|0|||
163129586|NCT03688100|589182297|FG000|Overall Study|Death|36|||
163129587|NCT03688100|589182298|FG001|Overall Study|Death|27|||
163129588|NCT03688100|589182299|FG002|Overall Study|Death|0|||
163129589|NCT03688100|589182300|FG003|Overall Study|Death|0|||
163129590|NCT02479139|589182306|FG000|Overall Study|Lost to Follow-up|2|||
163129591|NCT02479139|589182307|FG001|Overall Study|Lost to Follow-up|4|||
163129592|NCT02479139|589182308|FG002|Overall Study|Lost to Follow-up|4|||
163129593|NCT02479139|589182309|FG003|Overall Study|Lost to Follow-up|2|||
163129594|NCT02479139|589182310|FG004|Overall Study|Lost to Follow-up|3|||
163129595|NCT02479139|589182311|FG005|Overall Study|Lost to Follow-up|5|||
163129596|NCT02479139|589182306|FG000|Overall Study|Withdrew Consent|5|||
163129597|NCT02479139|589182307|FG001|Overall Study|Withdrew Consent|6|||
163129598|NCT02479139|589182308|FG002|Overall Study|Withdrew Consent|1|||
163129599|NCT02479139|589182309|FG003|Overall Study|Withdrew Consent|4|||
163129600|NCT02479139|589182310|FG004|Overall Study|Withdrew Consent|1|||
163129601|NCT02479139|589182311|FG005|Overall Study|Withdrew Consent|1|||
163129602|NCT02479139|589182306|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129603|NCT02479139|589182307|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129604|NCT02479139|589182308|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
163129605|NCT02479139|589182309|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129606|NCT02479139|589182310|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129607|NCT02479139|589182311|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
163129608|NCT02479139|589182306|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163129609|NCT02479139|589182307|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163129610|NCT02479139|589182308|FG002|Overall Study|Other Miscellaneous Reasons|1|||
163129611|NCT02479139|589182309|FG003|Overall Study|Other Miscellaneous Reasons|1|||
163129612|NCT02479139|589182310|FG004|Overall Study|Other Miscellaneous Reasons|1|||
163129613|NCT02479139|589182311|FG005|Overall Study|Other Miscellaneous Reasons|0|||
163129614|NCT00084656|589182312|FG000|Overall Study|Other reasons|0|||
163129615|NCT00084656|589182313|FG001|Overall Study|Other reasons|12|||
163129616|NCT00084656|589182314|FG002|Overall Study|Other reasons|11|||
163129617|NCT00084656|589182312|FG000|Overall Study|Withdrawal by Subject|15|||
163129618|NCT00084656|589182313|FG001|Overall Study|Withdrawal by Subject|4|||
163129619|NCT00084656|589182314|FG002|Overall Study|Withdrawal by Subject|4|||
163129620|NCT00084656|589182312|FG000|Overall Study|Disease relapse|0|||
163129621|NCT00084656|589182313|FG001|Overall Study|Disease relapse|9|||
162657193|NCT03417141|587457050|FG000|Overall Study|Withdrawal by Subject|1|||
162719728|NCT02020616|587680553|FG005|Overall Study|Physician Decision|1|||
162719729|NCT02020616|587680554|FG006|Overall Study|Physician Decision|2|||
163129622|NCT00084656|589182314|FG002|Overall Study|Disease relapse|10|||
163129623|NCT00084656|589182312|FG000|Overall Study|Disease progression|9|||
163129624|NCT00084656|589182313|FG001|Overall Study|Disease progression|0|||
163129625|NCT00084656|589182314|FG002|Overall Study|Disease progression|0|||
163129626|NCT00084656|589182312|FG000|Overall Study|Lost to Follow-up|1|||
162657194|NCT03417141|587457050|FG000|Overall Study|Protocol Violation|3|||
162657195|NCT01723228|587457051|FG000|Overall Study|Adverse Event|2|||
162719730|NCT02020616|587680548|FG000|Overall Study|Withdrawal by Subject|0|||
163129627|NCT00084656|589182313|FG001|Overall Study|Lost to Follow-up|0|||
163129628|NCT00084656|589182314|FG002|Overall Study|Lost to Follow-up|1|||
163129629|NCT04033068|589182318|FG000|Overall Study|Withdrawal by Subject|0|||
163129630|NCT04033068|589182319|FG001|Overall Study|Withdrawal by Subject|0|||
163129631|NCT04033068|589182320|FG002|Overall Study|Withdrawal by Subject|1|||
163129632|NCT04033068|589182321|FG003|Overall Study|Withdrawal by Subject|0|||
163129633|NCT04033068|589182318|FG000|Overall Study|Lost to Follow-up|0|||
163129634|NCT04033068|589182319|FG001|Overall Study|Lost to Follow-up|1|||
163129635|NCT04033068|589182320|FG002|Overall Study|Lost to Follow-up|0|||
163129636|NCT04033068|589182321|FG003|Overall Study|Lost to Follow-up|0|||
163129637|NCT04033068|589182318|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129638|NCT04033068|589182319|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129639|NCT04033068|589182320|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
163129640|NCT04033068|589182321|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
163129641|NCT01817959|589182322|FG000|Overall Study|Graft loss|1|||
163129642|NCT01817959|589182323|FG001|Overall Study|Graft loss|1|||
163129643|NCT01817959|589182322|FG000|Overall Study|forbidden medication|1|||
163129644|NCT01817959|589182323|FG001|Overall Study|forbidden medication|1|||
163129645|NCT01817959|589182322|FG000|Overall Study|Adverse Event|1|||
163129646|NCT01817959|589182323|FG001|Overall Study|Adverse Event|0|||
163129647|NCT01817959|589182322|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
163129648|NCT01817959|589182323|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
163129649|NCT03235089|589182324|FG000|Overall Study|Lost to Follow-up|1|||
163129650|NCT03235089|589182325|FG001|Overall Study|Lost to Follow-up|1|||
163129651|NCT03235089|589182324|FG000|Overall Study|Physician Decision|2|||
163129652|NCT03235089|589182325|FG001|Overall Study|Physician Decision|2|||
163129653|NCT03238924|589182330|FG000|Overall Study|Withdrawal by Subject|2|||
163129654|NCT03238924|589182331|FG001|Overall Study|Withdrawal by Subject|2|||
163129655|NCT03576716|589182332|FG000|Overall Study|Withdrawal by Subject|0|||
163129656|NCT03576716|589182333|FG001|Overall Study|Withdrawal by Subject|1|||
163129657|NCT00559988|589182334|FG000|Overall Study|Death|147|||
163129658|NCT00559988|589182335|FG001|Overall Study|Death|140|||
163129659|NCT00559988|589182334|FG000|Overall Study|Withdrawal by Subject|152|||
163129660|NCT00559988|589182335|FG001|Overall Study|Withdrawal by Subject|139|||
163129661|NCT00559988|589182334|FG000|Overall Study|Lost to Follow-up|42|||
163129662|NCT00559988|589182335|FG001|Overall Study|Lost to Follow-up|56|||
163129663|NCT00559988|589182334|FG000|Overall Study|ICD device explanted|10|||
163129664|NCT00559988|589182335|FG001|Overall Study|ICD device explanted|17|||
163129665|NCT02891382|589182336|FG000|Overall Study|Lost to Follow-up|3|||
163129666|NCT02891382|589182337|FG001|Overall Study|Lost to Follow-up|4|||
163129667|NCT02891382|589182338|FG002|Overall Study|Lost to Follow-up|5|||
163129668|NCT02891382|589182339|FG003|Overall Study|Lost to Follow-up|3|||
163129669|NCT02891382|589182340|FG004|Overall Study|Lost to Follow-up|4|||
163129670|NCT02516228|589182341|FG000|Overall Study|Lost to Follow-up|1|||
163129671|NCT02516228|589182341|FG000|Overall Study|Withdrawal by Subject|1|||
163129672|NCT02516228|589182341|FG000|Overall Study|Physician Decision|1|||
163129673|NCT03916484|589182342|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129674|NCT03916484|589182343|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
163129675|NCT03916484|589182344|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129676|NCT03916484|589182345|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
163129677|NCT03916484|589182342|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
163129678|NCT03916484|589182343|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
163129679|NCT03916484|589182344|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
163129680|NCT03916484|589182345|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
163129681|NCT01123707|589182347|FG000|Overall Study|Lost to Follow-up|3|||
163129682|NCT01123707|589182348|FG001|Overall Study|Lost to Follow-up|1|||
163129683|NCT01123707|589182349|FG002|Overall Study|Lost to Follow-up|3|||
163129684|NCT01123707|589182350|FG003|Overall Study|Lost to Follow-up|2|||
163129685|NCT01123707|589182347|FG000|Overall Study|Adverse Event|5|||
163129686|NCT01123707|589182348|FG001|Overall Study|Adverse Event|7|||
163129687|NCT01123707|589182349|FG002|Overall Study|Adverse Event|5|||
163129688|NCT01123707|589182350|FG003|Overall Study|Adverse Event|3|||
163129689|NCT01123707|589182347|FG000|Overall Study|Sponsor Discontinued Study|30|||
163129690|NCT01123707|589182348|FG001|Overall Study|Sponsor Discontinued Study|24|||
163129691|NCT01123707|589182349|FG002|Overall Study|Sponsor Discontinued Study|25|||
163129692|NCT01123707|589182350|FG003|Overall Study|Sponsor Discontinued Study|40|||
163129693|NCT01123707|589182347|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
163129694|NCT01123707|589182348|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163129695|NCT01123707|589182349|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
163129696|NCT01123707|589182350|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
163129697|NCT01123707|589182347|FG000|Overall Study|Investigator Withdrew Participant|0|||
163129698|NCT01123707|589182348|FG001|Overall Study|Investigator Withdrew Participant|1|||
163129699|NCT01123707|589182349|FG002|Overall Study|Investigator Withdrew Participant|1|||
163129700|NCT01123707|589182350|FG003|Overall Study|Investigator Withdrew Participant|1|||
163129701|NCT01123707|589182347|FG000|Overall Study|Subject Withdrew Consent|4|||
163129702|NCT01123707|589182348|FG001|Overall Study|Subject Withdrew Consent|5|||
162657196|NCT01723228|587457052|FG001|Overall Study|Adverse Event|6|||
162657197|NCT01723228|587457051|FG000|Overall Study|Withdrawal by Subject|2|||
162657198|NCT01723228|587457052|FG001|Overall Study|Withdrawal by Subject|1|||
162657199|NCT01723228|587457051|FG000|Overall Study|Protocol Violation|0|||
162657200|NCT01723228|587457052|FG001|Overall Study|Protocol Violation|2|||
162657201|NCT01723228|587457051|FG000|Overall Study|Lost to Follow-up|2|||
162657202|NCT01723228|587457052|FG001|Overall Study|Lost to Follow-up|1|||
162657203|NCT01723228|587457051|FG000|Overall Study|Other|2|||
162657204|NCT01723228|587457052|FG001|Overall Study|Other|1|||
162657205|NCT01864291|587457053|FG000|Overall Study|need for revision surgery|2|||
162719731|NCT02020616|587680549|FG001|Overall Study|Withdrawal by Subject|0|||
162719732|NCT02020616|587680550|FG002|Overall Study|Withdrawal by Subject|1|||
162719733|NCT02020616|587680551|FG003|Overall Study|Withdrawal by Subject|0|||
162719734|NCT02020616|587680552|FG004|Overall Study|Withdrawal by Subject|0|||
162719735|NCT02020616|587680553|FG005|Overall Study|Withdrawal by Subject|1|||
162719736|NCT02020616|587680554|FG006|Overall Study|Withdrawal by Subject|1|||
162719737|NCT02020616|587680548|FG000|Overall Study|Lost to Follow-up|0|||
162719738|NCT02020616|587680549|FG001|Overall Study|Lost to Follow-up|1|||
162719739|NCT02020616|587680550|FG002|Overall Study|Lost to Follow-up|0|||
162719740|NCT02020616|587680551|FG003|Overall Study|Lost to Follow-up|1|||
162719741|NCT02020616|587680552|FG004|Overall Study|Lost to Follow-up|1|||
162719742|NCT02020616|587680553|FG005|Overall Study|Lost to Follow-up|1|||
162719743|NCT02020616|587680554|FG006|Overall Study|Lost to Follow-up|0|||
162719744|NCT02020616|587680548|FG000|Overall Study|Early Termination Criteria Met|0|||
162719745|NCT02020616|587680549|FG001|Overall Study|Early Termination Criteria Met|0|||
162719746|NCT02020616|587680550|FG002|Overall Study|Early Termination Criteria Met|1|||
162719747|NCT02020616|587680551|FG003|Overall Study|Early Termination Criteria Met|0|||
162719748|NCT02020616|587680552|FG004|Overall Study|Early Termination Criteria Met|0|||
162719749|NCT02020616|587680553|FG005|Overall Study|Early Termination Criteria Met|1|||
162719750|NCT02020616|587680554|FG006|Overall Study|Early Termination Criteria Met|0|||
162719751|NCT02020616|587680548|FG000|Overall Study|Randomized in Error|0|||
162719752|NCT02020616|587680549|FG001|Overall Study|Randomized in Error|0|||
162719753|NCT02020616|587680550|FG002|Overall Study|Randomized in Error|0|||
162719754|NCT02020616|587680551|FG003|Overall Study|Randomized in Error|1|||
162719755|NCT02020616|587680552|FG004|Overall Study|Randomized in Error|0|||
162719756|NCT02020616|587680553|FG005|Overall Study|Randomized in Error|0|||
162719757|NCT02020616|587680554|FG006|Overall Study|Randomized in Error|0|||
162719758|NCT02020616|587680548|FG000|Overall Study|Lack of Efficacy|0|||
162719759|NCT02020616|587680549|FG001|Overall Study|Lack of Efficacy|0|||
162719760|NCT02020616|587680550|FG002|Overall Study|Lack of Efficacy|0|||
162719761|NCT02020616|587680551|FG003|Overall Study|Lack of Efficacy|0|||
162719762|NCT02020616|587680552|FG004|Overall Study|Lack of Efficacy|1|||
162719763|NCT02020616|587680553|FG005|Overall Study|Lack of Efficacy|0|||
162719764|NCT02020616|587680554|FG006|Overall Study|Lack of Efficacy|0|||
162719765|NCT05019729|587680557|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162719766|NCT05019729|587680558|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162719767|NCT05019729|587680559|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162719768|NCT05019729|587680560|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162719769|NCT05019729|587680561|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
162719770|NCT05019729|587680562|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162719771|NCT03008915|587680567|FG000|Treatment 1|Withdrawal by Subject|0|||
162719772|NCT03008915|587680568|FG001|Treatment 1|Withdrawal by Subject|1|||
162719773|NCT00712166|587680571|FG000|Overall Study|Noncompliance|0|||
162719774|NCT00712166|587680572|FG001|Overall Study|Noncompliance|1|||
162719775|NCT01773122|587680573|FG000|Overall Study|Due to amended age eligibility criteria|3|||
162719776|NCT01773122|587680574|FG001|Overall Study|Due to amended age eligibility criteria|1|||
162719777|NCT01773122|587680575|FG002|Overall Study|Due to amended age eligibility criteria|0|||
162719778|NCT01773122|587680576|FG003|Overall Study|Due to amended age eligibility criteria|1|||
162719779|NCT02289560|587680579|FG000|Overall Study|Lost to Follow-up|6|||
162719780|NCT02289560|587680579|FG000|Overall Study|Alternative Treatment|4|||
163129703|NCT01123707|589182349|FG002|Overall Study|Subject Withdrew Consent|1|||
163129704|NCT01123707|589182350|FG003|Overall Study|Subject Withdrew Consent|2|||
163129705|NCT01123707|589182347|FG000|Overall Study|Lack of Efficacy|1|||
163129706|NCT01123707|589182348|FG001|Overall Study|Lack of Efficacy|2|||
163129707|NCT01123707|589182349|FG002|Overall Study|Lack of Efficacy|1|||
163129708|NCT01123707|589182350|FG003|Overall Study|Lack of Efficacy|0|||
163129709|NCT01123707|589182347|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
162719781|NCT02289560|587680579|FG000|Overall Study|Inadequate Treatment|2|||
162719782|NCT02289560|587680579|FG000|Overall Study|Withdrawal by Subject|23|||
162719783|NCT02540213|587680580|FG000|Overall Study|Death/adverse event|18|||
163129710|NCT01123707|589182348|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
162657206|NCT01282216|587457054|FG000|Overall Study|Graft failure|0|||
162657207|NCT01282216|587457055|FG001|Overall Study|Graft failure|0|||
162657208|NCT01282216|587457056|FG002|Overall Study|Graft failure|3|||
162657209|NCT01282216|587457057|FG003|Overall Study|Graft failure|2|||
162657210|NCT01282216|587457054|FG000|Overall Study|Physician Decision|0|||
162657211|NCT01282216|587457055|FG001|Overall Study|Physician Decision|0|||
162657212|NCT01282216|587457056|FG002|Overall Study|Physician Decision|11|||
162657213|NCT01282216|587457057|FG003|Overall Study|Physician Decision|0|||
162657214|NCT01282216|587457054|FG000|Overall Study|Relapse|0|||
162657215|NCT01282216|587457055|FG001|Overall Study|Relapse|0|||
162657216|NCT01282216|587457056|FG002|Overall Study|Relapse|17|||
163129711|NCT01123707|589182349|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
163129712|NCT01123707|589182350|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
163129713|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
163129714|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
163129715|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
163129716|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
163129717|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
163129718|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
163129719|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
163129720|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
163129721|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Death|0|||
163129722|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Death|1|||
163129723|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
163129724|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
163129725|NCT03281304|589182353|FG000|Treatment Phase (up to 42 Months)|Other|0|||
163129726|NCT03281304|589182354|FG001|Treatment Phase (up to 42 Months)|Other|2|||
163129727|NCT03281304|589182353|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
163129728|NCT03281304|589182354|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
163129729|NCT00858637|589182355|FG000|Active Comparison Phase|Adverse Event|14|||
163129730|NCT00858637|589182356|FG001|Active Comparison Phase|Adverse Event|0|||
163129731|NCT00858637|589182357|FG002|Active Comparison Phase|Adverse Event|0|||
163129732|NCT00858637|589182358|FG003|Active Comparison Phase|Adverse Event|9|||
163129733|NCT00858637|589182359|FG004|Active Comparison Phase|Adverse Event|0|||
163129734|NCT00858637|589182360|FG005|Active Comparison Phase|Adverse Event|0|||
163129735|NCT00858637|589182355|FG000|Active Comparison Phase|Death|1|||
163129736|NCT00858637|589182356|FG001|Active Comparison Phase|Death|0|||
163129737|NCT00858637|589182357|FG002|Active Comparison Phase|Death|0|||
163129738|NCT00858637|589182358|FG003|Active Comparison Phase|Death|1|||
163129739|NCT00858637|589182359|FG004|Active Comparison Phase|Death|0|||
163129740|NCT00858637|589182360|FG005|Active Comparison Phase|Death|0|||
163129741|NCT00858637|589182355|FG000|Active Comparison Phase|Physician Decision|1|||
163129742|NCT00858637|589182356|FG001|Active Comparison Phase|Physician Decision|0|||
163129743|NCT00858637|589182357|FG002|Active Comparison Phase|Physician Decision|0|||
163129744|NCT00858637|589182358|FG003|Active Comparison Phase|Physician Decision|1|||
163129745|NCT00858637|589182359|FG004|Active Comparison Phase|Physician Decision|0|||
163129746|NCT00858637|589182360|FG005|Active Comparison Phase|Physician Decision|0|||
163129747|NCT00858637|589182355|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
163129748|NCT00858637|589182356|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
163129749|NCT00858637|589182357|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
163129750|NCT00858637|589182358|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
163129751|NCT00858637|589182359|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
163129752|NCT00858637|589182360|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
163129753|NCT00858637|589182355|FG000|Active Comparison Phase|Other Reasons|1|||
163129754|NCT00858637|589182356|FG001|Active Comparison Phase|Other Reasons|0|||
163129755|NCT00858637|589182357|FG002|Active Comparison Phase|Other Reasons|0|||
163129756|NCT00858637|589182358|FG003|Active Comparison Phase|Other Reasons|1|||
163129757|NCT00858637|589182359|FG004|Active Comparison Phase|Other Reasons|0|||
163129758|NCT00858637|589182360|FG005|Active Comparison Phase|Other Reasons|0|||
163129759|NCT00858637|589182355|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
163129760|NCT00858637|589182356|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
163129761|NCT00858637|589182357|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
163129762|NCT00858637|589182358|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
163129763|NCT00858637|589182359|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
163129764|NCT00858637|589182360|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
163129765|NCT00858637|589182355|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129766|NCT00858637|589182356|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
162657217|NCT01282216|587457057|FG003|Overall Study|Relapse|6|||
163129767|NCT00858637|589182357|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129768|NCT00858637|589182358|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
163129769|NCT00858637|589182359|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
162657218|NCT01282216|587457054|FG000|Overall Study|Death|0|||
163129770|NCT00858637|589182360|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
163129771|NCT02292706|589182361|FG000|Overall Study|Lost to Follow-up|20|||
163129772|NCT02292706|589182362|FG001|Overall Study|Lost to Follow-up|44|||
162657219|NCT01282216|587457055|FG001|Overall Study|Death|0|||
162657220|NCT01282216|587457056|FG002|Overall Study|Death|2|||
162657221|NCT01282216|587457057|FG003|Overall Study|Death|0|||
162657222|NCT02239536|587457062|FG000|Overall Study|Non-neoplastic polyp|23|||
163129773|NCT02292706|589182363|FG002|Overall Study|Lost to Follow-up|24|||
163129774|NCT02292706|589182364|FG003|Overall Study|Lost to Follow-up|61|||
163129775|NCT02292706|589182365|FG004|Overall Study|Lost to Follow-up|21|||
163129776|NCT02292706|589182366|FG005|Overall Study|Lost to Follow-up|52|||
163129777|NCT02292706|589182367|FG006|Overall Study|Lost to Follow-up|25|||
163129778|NCT02292706|589182368|FG007|Overall Study|Lost to Follow-up|0|||
163129779|NCT02292706|589182361|FG000|Overall Study|Withdrew consent|15|||
163129780|NCT02292706|589182362|FG001|Overall Study|Withdrew consent|56|||
163129781|NCT02292706|589182363|FG002|Overall Study|Withdrew consent|43|||
163129782|NCT02292706|589182364|FG003|Overall Study|Withdrew consent|36|||
163129783|NCT02292706|589182365|FG004|Overall Study|Withdrew consent|13|||
163129784|NCT02292706|589182366|FG005|Overall Study|Withdrew consent|51|||
163129785|NCT02292706|589182367|FG006|Overall Study|Withdrew consent|20|||
163129786|NCT02292706|589182368|FG007|Overall Study|Withdrew consent|0|||
163129787|NCT02292706|589182361|FG000|Overall Study|Death|3|||
163129788|NCT02292706|589182362|FG001|Overall Study|Death|11|||
163129789|NCT02292706|589182363|FG002|Overall Study|Death|16|||
163129790|NCT02292706|589182364|FG003|Overall Study|Death|22|||
163129791|NCT02292706|589182365|FG004|Overall Study|Death|8|||
163129792|NCT02292706|589182366|FG005|Overall Study|Death|17|||
163129793|NCT02292706|589182367|FG006|Overall Study|Death|3|||
163129794|NCT02292706|589182368|FG007|Overall Study|Death|0|||
163129795|NCT02292706|589182361|FG000|Overall Study|Study terminated by sponsor|0|||
163129796|NCT02292706|589182362|FG001|Overall Study|Study terminated by sponsor|9|||
163129797|NCT02292706|589182363|FG002|Overall Study|Study terminated by sponsor|4|||
163129798|NCT02292706|589182364|FG003|Overall Study|Study terminated by sponsor|21|||
163129799|NCT02292706|589182365|FG004|Overall Study|Study terminated by sponsor|11|||
163129800|NCT02292706|589182366|FG005|Overall Study|Study terminated by sponsor|13|||
163129801|NCT02292706|589182367|FG006|Overall Study|Study terminated by sponsor|3|||
163129802|NCT02292706|589182368|FG007|Overall Study|Study terminated by sponsor|0|||
163129803|NCT02292706|589182361|FG000|Overall Study|Investigator's discretion|4|||
163129804|NCT02292706|589182362|FG001|Overall Study|Investigator's discretion|9|||
163129805|NCT02292706|589182363|FG002|Overall Study|Investigator's discretion|7|||
163129806|NCT02292706|589182364|FG003|Overall Study|Investigator's discretion|11|||
163129807|NCT02292706|589182365|FG004|Overall Study|Investigator's discretion|4|||
163129808|NCT02292706|589182366|FG005|Overall Study|Investigator's discretion|10|||
163129809|NCT02292706|589182367|FG006|Overall Study|Investigator's discretion|1|||
163129810|NCT02292706|589182368|FG007|Overall Study|Investigator's discretion|0|||
163129811|NCT02292706|589182361|FG000|Overall Study|Liver transplant|1|||
163129812|NCT02292706|589182362|FG001|Overall Study|Liver transplant|1|||
163129813|NCT02292706|589182363|FG002|Overall Study|Liver transplant|11|||
163129814|NCT02292706|589182364|FG003|Overall Study|Liver transplant|16|||
163129815|NCT02292706|589182365|FG004|Overall Study|Liver transplant|5|||
163129816|NCT02292706|589182366|FG005|Overall Study|Liver transplant|6|||
163129817|NCT02292706|589182367|FG006|Overall Study|Liver transplant|5|||
163129818|NCT02292706|589182368|FG007|Overall Study|Liver transplant|0|||
163129819|NCT02292706|589182361|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
163129820|NCT02292706|589182362|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
163129821|NCT02292706|589182363|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
163129822|NCT02292706|589182364|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
163129823|NCT02292706|589182365|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
163129824|NCT02292706|589182366|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
163129825|NCT02292706|589182367|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
163129826|NCT02292706|589182368|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
163129827|NCT02292706|589182361|FG000|Overall Study|Subject terminated by sponsor|1|||
162657223|NCT02239536|587457063|FG001|Overall Study|Non-neoplastic polyp|17|||
162657224|NCT01038778|587457064|FG000|Overall Study|Withdrawal by Subject|0|||
163129828|NCT02292706|589182362|FG001|Overall Study|Subject terminated by sponsor|0|||
163129829|NCT02292706|589182363|FG002|Overall Study|Subject terminated by sponsor|0|||
163129830|NCT02292706|589182364|FG003|Overall Study|Subject terminated by sponsor|2|||
163129831|NCT02292706|589182365|FG004|Overall Study|Subject terminated by sponsor|1|||
163129832|NCT02292706|589182366|FG005|Overall Study|Subject terminated by sponsor|0|||
163129833|NCT02292706|589182367|FG006|Overall Study|Subject terminated by sponsor|0|||
163129834|NCT02292706|589182368|FG007|Overall Study|Subject terminated by sponsor|0|||
163129835|NCT02292706|589182361|FG000|Overall Study|Missing|0|||
163129836|NCT02292706|589182362|FG001|Overall Study|Missing|0|||
163129837|NCT02292706|589182363|FG002|Overall Study|Missing|1|||
163129838|NCT02292706|589182364|FG003|Overall Study|Missing|1|||
163129839|NCT02292706|589182365|FG004|Overall Study|Missing|0|||
163129840|NCT02292706|589182366|FG005|Overall Study|Missing|1|||
163129841|NCT02292706|589182367|FG006|Overall Study|Missing|0|||
163129842|NCT02292706|589182368|FG007|Overall Study|Missing|0|||
163129843|NCT02292706|589182361|FG000|Overall Study|Virologic relapse or reinfection|1|||
163129844|NCT02292706|589182362|FG001|Overall Study|Virologic relapse or reinfection|0|||
163129845|NCT02292706|589182363|FG002|Overall Study|Virologic relapse or reinfection|0|||
163129846|NCT02292706|589182364|FG003|Overall Study|Virologic relapse or reinfection|1|||
163129847|NCT02292706|589182365|FG004|Overall Study|Virologic relapse or reinfection|0|||
163129848|NCT02292706|589182366|FG005|Overall Study|Virologic relapse or reinfection|1|||
163129849|NCT02292706|589182367|FG006|Overall Study|Virologic relapse or reinfection|0|||
163129850|NCT02292706|589182368|FG007|Overall Study|Virologic relapse or reinfection|0|||
163129851|NCT02725866|589182373|FG000|Overall Study|Failure to return|6|||
163129852|NCT02725866|589182373|FG000|Overall Study|Withdrew consent|3|||
163129853|NCT02725866|589182373|FG000|Overall Study|Insufficient virological response|1|||
163129854|NCT02725866|589182373|FG000|Overall Study|Other, not specified|4|||
163129855|NCT01990612|589182374|FG000|Overall Study|Lost to Follow-up|2|||
163129856|NCT01990612|589182375|FG001|Overall Study|Lost to Follow-up|1|||
163129857|NCT01990612|589182374|FG000|Overall Study|Withdrawal by Subject|5|||
163129858|NCT01990612|589182375|FG001|Overall Study|Withdrawal by Subject|2|||
163129859|NCT02188849|589182378|FG000|Overall Study|Lost to Follow-up|3|||
163129860|NCT02188849|589182379|FG001|Overall Study|Lost to Follow-up|8|||
163129861|NCT02980133|589182381|FG000|Overall Study|Other than specified|1|||
163129862|NCT02980133|589182382|FG001|Overall Study|Other than specified|1|||
163129863|NCT02980133|589182383|FG002|Overall Study|Other than specified|2|||
163129864|NCT02980133|589182384|FG003|Overall Study|Other than specified|2|||
163129865|NCT02980133|589182381|FG000|Overall Study|Lost to Follow-up|0|||
163129866|NCT02980133|589182382|FG001|Overall Study|Lost to Follow-up|0|||
163129867|NCT02980133|589182383|FG002|Overall Study|Lost to Follow-up|1|||
163129868|NCT02980133|589182384|FG003|Overall Study|Lost to Follow-up|3|||
163129869|NCT02980133|589182381|FG000|Overall Study|Protocol Violation|0|||
163129870|NCT02980133|589182382|FG001|Overall Study|Protocol Violation|1|||
163129871|NCT02980133|589182383|FG002|Overall Study|Protocol Violation|0|||
163129872|NCT02980133|589182384|FG003|Overall Study|Protocol Violation|0|||
163129873|NCT02980133|589182381|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163129874|NCT02980133|589182382|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163129875|NCT02980133|589182383|FG002|Overall Study|Withdrawal by parent/guardian|3|||
163129876|NCT02980133|589182384|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163129877|NCT02980133|589182381|FG000|Overall Study|Withdrawal by Subject|0|||
163129878|NCT02980133|589182382|FG001|Overall Study|Withdrawal by Subject|0|||
163129879|NCT02980133|589182383|FG002|Overall Study|Withdrawal by Subject|1|||
163129880|NCT02980133|589182384|FG003|Overall Study|Withdrawal by Subject|0|||
163129881|NCT03208088|589182391|FG000|Period 2|Withdrawal by Subject|0|||
163129882|NCT03208088|589182392|FG001|Period 2|Withdrawal by Subject|0|||
163129883|NCT03208088|589182393|FG002|Period 2|Withdrawal by Subject|0|||
163129884|NCT03208088|589182394|FG003|Period 2|Withdrawal by Subject|0|||
163129885|NCT03208088|589182395|FG004|Period 2|Withdrawal by Subject|0|||
163129886|NCT03208088|589182396|FG005|Period 2|Withdrawal by Subject|0|||
163129887|NCT03208088|589182397|FG006|Period 2|Withdrawal by Subject|0|||
163129888|NCT03208088|589182398|FG007|Period 2|Withdrawal by Subject|0|||
163129889|NCT03208088|589182399|FG008|Period 2|Withdrawal by Subject|1|||
163129890|NCT03208088|589182400|FG009|Period 2|Withdrawal by Subject|0|||
163129891|NCT03208088|589182391|FG000|Period 3|Unsatisfactory Test Article|0|||
163129892|NCT03208088|589182392|FG001|Period 3|Unsatisfactory Test Article|0|||
163129893|NCT03208088|589182393|FG002|Period 3|Unsatisfactory Test Article|0|||
163129894|NCT03208088|589182394|FG003|Period 3|Unsatisfactory Test Article|1|||
163129895|NCT03208088|589182395|FG004|Period 3|Unsatisfactory Test Article|0|||
163129896|NCT03208088|589182396|FG005|Period 3|Unsatisfactory Test Article|0|||
163129897|NCT03208088|589182397|FG006|Period 3|Unsatisfactory Test Article|0|||
163129898|NCT03208088|589182398|FG007|Period 3|Unsatisfactory Test Article|0|||
163129899|NCT03208088|589182399|FG008|Period 3|Unsatisfactory Test Article|0|||
163129900|NCT03208088|589182400|FG009|Period 3|Unsatisfactory Test Article|0|||
163129901|NCT03208088|589182391|FG000|Period 4|Unsatisfactory Test Article|0|||
163129902|NCT03208088|589182392|FG001|Period 4|Unsatisfactory Test Article|0|||
163129903|NCT03208088|589182393|FG002|Period 4|Unsatisfactory Test Article|0|||
163129904|NCT03208088|589182394|FG003|Period 4|Unsatisfactory Test Article|1|||
163129905|NCT03208088|589182395|FG004|Period 4|Unsatisfactory Test Article|0|||
163129906|NCT03208088|589182396|FG005|Period 4|Unsatisfactory Test Article|0|||
163129907|NCT03208088|589182397|FG006|Period 4|Unsatisfactory Test Article|0|||
163129908|NCT03208088|589182398|FG007|Period 4|Unsatisfactory Test Article|0|||
163129909|NCT03208088|589182399|FG008|Period 4|Unsatisfactory Test Article|0|||
163129910|NCT03208088|589182400|FG009|Period 4|Unsatisfactory Test Article|0|||
163129911|NCT00605345|589182406|FG000|Overall Study|Withdrawal by Subject|1|||
163129912|NCT00605345|589182407|FG001|Overall Study|Withdrawal by Subject|0|||
163129913|NCT00605345|589182406|FG000|Overall Study|Adverse Event|0|||
163129914|NCT00605345|589182407|FG001|Overall Study|Adverse Event|1|||
163129915|NCT00605345|589182406|FG000|Overall Study|Protocol Violation|0|||
163129916|NCT00605345|589182407|FG001|Overall Study|Protocol Violation|2|||
163129917|NCT02577016|589182408|FG000|Overall Study|Adverse Event|2|||
163129918|NCT02577016|589182409|FG001|Overall Study|Adverse Event|1|||
163129919|NCT02577016|589182408|FG000|Overall Study|Physician Decision|0|||
163129920|NCT02577016|589182409|FG001|Overall Study|Physician Decision|1|||
163129921|NCT02942485|589184078|FG000|Overall Study|Lost to Follow-up|1|||
163129922|NCT02942485|589184079|FG001|Overall Study|Lost to Follow-up|0|||
163129923|NCT00902174|589184083|FG000|Overall Study|Adverse Event|27|||
163129924|NCT00902174|589184084|FG001|Overall Study|Adverse Event|7|||
163129925|NCT00902174|589184083|FG000|Overall Study|Lack of Efficacy|1|||
163129926|NCT00902174|589184084|FG001|Overall Study|Lack of Efficacy|5|||
163129927|NCT00902174|589184083|FG000|Overall Study|Death|2|||
163129928|NCT00902174|589184084|FG001|Overall Study|Death|2|||
163129929|NCT00902174|589184083|FG000|Overall Study|Withdrawal by Subject|2|||
163129930|NCT00902174|589184084|FG001|Overall Study|Withdrawal by Subject|1|||
163129931|NCT00902174|589184083|FG000|Overall Study|Abnormal labs|1|||
163129932|NCT00902174|589184084|FG001|Overall Study|Abnormal labs|1|||
163129933|NCT00902174|589184083|FG000|Overall Study|Protocol Violation|1|||
163129934|NCT00902174|589184084|FG001|Overall Study|Protocol Violation|1|||
163129935|NCT00902174|589184083|FG000|Overall Study|Administration problem|0|||
163129936|NCT00902174|589184084|FG001|Overall Study|Administration problem|1|||
163129937|NCT00989781|589184087|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
163129938|NCT00989781|589184088|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
163129939|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
163129940|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
163129941|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
163129942|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
163129943|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
163129944|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
163129945|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
163129946|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
163129947|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
163129948|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
163129949|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
163129950|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
163129951|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
163129952|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
163129953|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
163129954|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
163129955|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
163129956|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
163129957|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
163129958|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
163129959|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
163129960|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
163129961|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
163129962|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
163129963|NCT01532869|589184089|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
163129964|NCT01532869|589184090|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
163129965|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
163129966|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
163129967|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
163129968|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
163129969|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
163129970|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
163129971|NCT01532869|589184089|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
163129972|NCT01532869|589184090|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
163129973|NCT01331291|589184091|FG000|Overall Study|Lack of Efficacy|2|||
163129974|NCT01331291|589184092|FG001|Overall Study|Lack of Efficacy|8|||
163129975|NCT01331291|589184091|FG000|Overall Study|Death|0|||
163129976|NCT01331291|589184092|FG001|Overall Study|Death|1|||
163129977|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
163129978|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
163129979|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
163129980|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
163129981|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
163129982|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
163129983|NCT01389323|589184098|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
163129984|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
163129985|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
163129986|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
163129987|NCT01389323|589184098|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
163129988|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
163129989|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
163129990|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
163129991|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
163129992|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
163129993|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
163129994|NCT01805037|589184100|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
163129995|NCT01805037|589184101|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
163129996|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
163129997|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
163129998|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
163129999|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
163130000|NCT01805037|589184100|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
163130001|NCT01805037|589184101|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
163130002|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Death|0|||
163130003|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Death|2|||
163130004|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
163130005|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
163130006|NCT01805037|589184100|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
163130007|NCT01805037|589184101|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
163130008|NCT01270256|589184102|FG000|Overall Study|Withdrawal by Subject|1|||
163130009|NCT01270256|589184103|FG001|Overall Study|Withdrawal by Subject|0|||
163130010|NCT04566692|589184108|FG000|Overall Study|Adverse Event|2|||
163130011|NCT04566692|589184109|FG001|Overall Study|Adverse Event|0|||
163130012|NCT04566692|589184108|FG000|Overall Study|Withdrawal by Subject|1|||
163130013|NCT04566692|589184109|FG001|Overall Study|Withdrawal by Subject|1|||
163130014|NCT01183468|589184110|FG000|Overall Study|Lost to Follow-up|2|||
163130015|NCT01183468|589184111|FG001|Overall Study|Lost to Follow-up|1|||
163130016|NCT01183468|589184112|FG002|Overall Study|Lost to Follow-up|0|||
163130017|NCT01183468|589184113|FG003|Overall Study|Lost to Follow-up|0|||
163130018|NCT01183468|589184110|FG000|Overall Study|Physician Decision|1|||
163130019|NCT01183468|589184111|FG001|Overall Study|Physician Decision|0|||
163130020|NCT01183468|589184112|FG002|Overall Study|Physician Decision|0|||
163130021|NCT01183468|589184113|FG003|Overall Study|Physician Decision|0|||
163130022|NCT01183468|589184110|FG000|Overall Study|Withdrawal by Subject|0|||
163130023|NCT01183468|589184111|FG001|Overall Study|Withdrawal by Subject|1|||
163130024|NCT01183468|589184112|FG002|Overall Study|Withdrawal by Subject|0|||
163130025|NCT01183468|589184113|FG003|Overall Study|Withdrawal by Subject|0|||
163130026|NCT00590577|589184114|FG000|Overall Study|Lack of Efficacy|31|||
163130027|NCT00590577|589184115|FG001|Overall Study|Lack of Efficacy|28|||
163130028|NCT00590577|589184116|FG002|Overall Study|Lack of Efficacy|23|||
163130029|NCT00590577|589184117|FG003|Overall Study|Lack of Efficacy|45|||
163130030|NCT00590577|589184114|FG000|Overall Study|Withdrawal by Subject|23|||
163130031|NCT00590577|589184115|FG001|Overall Study|Withdrawal by Subject|28|||
163130032|NCT00590577|589184116|FG002|Overall Study|Withdrawal by Subject|30|||
163130033|NCT00590577|589184117|FG003|Overall Study|Withdrawal by Subject|26|||
163130034|NCT00590577|589184114|FG000|Overall Study|Adverse Event|10|||
163130035|NCT00590577|589184115|FG001|Overall Study|Adverse Event|10|||
163130036|NCT00590577|589184116|FG002|Overall Study|Adverse Event|13|||
163130037|NCT00590577|589184117|FG003|Overall Study|Adverse Event|11|||
163130038|NCT00590577|589184114|FG000|Overall Study|Lost to Follow-up|12|||
163130039|NCT00590577|589184115|FG001|Overall Study|Lost to Follow-up|6|||
163130040|NCT00590577|589184116|FG002|Overall Study|Lost to Follow-up|6|||
163130041|NCT00590577|589184117|FG003|Overall Study|Lost to Follow-up|9|||
163130042|NCT00590577|589184114|FG000|Overall Study|Pregnancy|0|||
163130043|NCT00590577|589184115|FG001|Overall Study|Pregnancy|1|||
163130044|NCT00590577|589184116|FG002|Overall Study|Pregnancy|0|||
163130045|NCT00590577|589184117|FG003|Overall Study|Pregnancy|0|||
163130046|NCT00590577|589184114|FG000|Overall Study|Various reasons|1|||
163130047|NCT00590577|589184115|FG001|Overall Study|Various reasons|3|||
163130048|NCT00590577|589184116|FG002|Overall Study|Various reasons|1|||
163130049|NCT00590577|589184117|FG003|Overall Study|Various reasons|2|||
163130050|NCT03927404|589184119|FG000|Overall Study|Withdrawal by Subject|1|||
163130051|NCT01229449|589184120|FG000|Overall Study|Withdrawal by Subject|0|||
163130052|NCT01229449|589184121|FG001|Overall Study|Withdrawal by Subject|3|||
162719784|NCT02540213|587680580|FG000|Overall Study|Administrative reasons|3|||
163130053|NCT01229449|589184122|FG002|Overall Study|Withdrawal by Subject|0|||
163130054|NCT01229449|589184123|FG003|Overall Study|Withdrawal by Subject|1|||
163130055|NCT01229449|589184124|FG004|Overall Study|Withdrawal by Subject|1|||
163130056|NCT01229449|589184120|FG000|Overall Study|Lost to Follow-up|1|||
163130057|NCT01229449|589184121|FG001|Overall Study|Lost to Follow-up|1|||
163130058|NCT01229449|589184122|FG002|Overall Study|Lost to Follow-up|1|||
163130059|NCT01229449|589184123|FG003|Overall Study|Lost to Follow-up|0|||
163130060|NCT01229449|589184124|FG004|Overall Study|Lost to Follow-up|0|||
163130061|NCT01229449|589184120|FG000|Overall Study|Physician Decision|0|||
163130062|NCT01229449|589184121|FG001|Overall Study|Physician Decision|0|||
163130063|NCT01229449|589184122|FG002|Overall Study|Physician Decision|1|||
163130064|NCT01229449|589184123|FG003|Overall Study|Physician Decision|0|||
163130065|NCT01229449|589184124|FG004|Overall Study|Physician Decision|0|||
163130066|NCT03203291|589184127|FG000|Overall Study|Withdrawal by Subject|1|||
163130067|NCT01300260|589184129|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
163130068|NCT01300260|589184130|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
163130069|NCT01300260|589184129|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
163130070|NCT01300260|589184130|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
163130071|NCT01300260|589184129|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
163130072|NCT01300260|589184130|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
163130073|NCT05098509|589184133|FG000|Overall Study|Withdrawal by Subject|0|||
163130074|NCT05098509|589184134|FG001|Overall Study|Withdrawal by Subject|0|||
163130075|NCT05098509|589184135|FG002|Overall Study|Withdrawal by Subject|1|||
163130076|NCT05098509|589184136|FG003|Overall Study|Withdrawal by Subject|0|||
163130077|NCT05098509|589184133|FG000|Overall Study|Early study termination|1|||
163130078|NCT05098509|589184134|FG001|Overall Study|Early study termination|1|||
163130079|NCT05098509|589184135|FG002|Overall Study|Early study termination|1|||
163130080|NCT05098509|589184136|FG003|Overall Study|Early study termination|0|||
163130081|NCT01147848|589184137|FG000|Run-in Period|Screen Failure|623|||
163130082|NCT01147848|589184138|FG001|Run-in Period|Screen Failure|0|||
163130083|NCT01147848|589184139|FG002|Run-in Period|Screen Failure|0|||
163130084|NCT01147848|589184137|FG000|Run-in Period|Run-in Failure|135|||
163130085|NCT01147848|589184138|FG001|Run-in Period|Run-in Failure|0|||
163130086|NCT01147848|589184139|FG002|Run-in Period|Run-in Failure|0|||
163130087|NCT01147848|589184137|FG000|Randomized Phase|Adverse Event|0|||
163130088|NCT01147848|589184138|FG001|Randomized Phase|Adverse Event|6|||
163130089|NCT01147848|589184139|FG002|Randomized Phase|Adverse Event|8|||
163130090|NCT01147848|589184137|FG000|Randomized Phase|Lack of Efficacy|0|||
163130091|NCT01147848|589184138|FG001|Randomized Phase|Lack of Efficacy|20|||
163130092|NCT01147848|589184139|FG002|Randomized Phase|Lack of Efficacy|11|||
163130093|NCT01147848|589184137|FG000|Randomized Phase|Protocol Violation|0|||
163130094|NCT01147848|589184138|FG001|Randomized Phase|Protocol Violation|7|||
163130095|NCT01147848|589184139|FG002|Randomized Phase|Protocol Violation|10|||
163130096|NCT01147848|589184137|FG000|Randomized Phase|Lost to Follow-up|0|||
163130097|NCT01147848|589184138|FG001|Randomized Phase|Lost to Follow-up|5|||
163130098|NCT01147848|589184139|FG002|Randomized Phase|Lost to Follow-up|7|||
163130099|NCT01147848|589184137|FG000|Randomized Phase|Physician Decision|0|||
163130100|NCT01147848|589184138|FG001|Randomized Phase|Physician Decision|0|||
163130101|NCT01147848|589184139|FG002|Randomized Phase|Physician Decision|1|||
163130102|NCT01147848|589184137|FG000|Randomized Phase|Withdrawal by Subject|0|||
163130103|NCT01147848|589184138|FG001|Randomized Phase|Withdrawal by Subject|7|||
163130104|NCT01147848|589184139|FG002|Randomized Phase|Withdrawal by Subject|9|||
163130105|NCT02540265|589184140|FG000|Overall Study|Lost to Follow-up|0|||
163130106|NCT02540265|589184141|FG001|Overall Study|Lost to Follow-up|0|||
163130107|NCT02540265|589184142|FG002|Overall Study|Lost to Follow-up|1|||
163130108|NCT03157037|589184145|FG000|Overall Study|Death|1|||
163130109|NCT00324233|589184146|FG000|First Period|unable to insert catheter|1|||
163130110|NCT00324233|589184147|FG001|First Period|unable to insert catheter|0|||
163130111|NCT00324233|589184146|FG000|Second Period|unable to insert catheter|1|||
163130112|NCT00324233|589184147|FG001|Second Period|unable to insert catheter|1|||
163130113|NCT00324233|589184146|FG000|Second Period|Protocol Violation|4|||
163130114|NCT00324233|589184147|FG001|Second Period|Protocol Violation|6|||
163130115|NCT01972789|589184148|FG000|Overall Study|Adverse Event|11|||
163130116|NCT01972789|589184149|FG001|Overall Study|Adverse Event|4|||
163130117|NCT01972789|589184148|FG000|Overall Study|Subject withdrew consent|14|||
162719785|NCT02540213|587680580|FG000|Overall Study|Kidney transplant|3|||
163130118|NCT01972789|589184149|FG001|Overall Study|Subject withdrew consent|12|||
162719786|NCT02540213|587680580|FG000|Overall Study|Lack of Efficacy|6|||
163130119|NCT01972789|589184148|FG000|Overall Study|Lost to Follow-up|4|||
163130120|NCT01972789|589184149|FG001|Overall Study|Lost to Follow-up|7|||
163130121|NCT01972789|589184148|FG000|Overall Study|Death|7|||
163130122|NCT01972789|589184149|FG001|Overall Study|Death|5|||
163130123|NCT01972789|589184148|FG000|Overall Study|Protocol deviation|1|||
163130124|NCT01972789|589184149|FG001|Overall Study|Protocol deviation|0|||
163130125|NCT01972789|589184148|FG000|Overall Study|Physician Decision|3|||
163130126|NCT01972789|589184149|FG001|Overall Study|Physician Decision|2|||
163130127|NCT00666965|589184152|FG000|Overall Study|Adverse Event|0|||
163130128|NCT00666965|589184153|FG001|Overall Study|Adverse Event|2|||
163130129|NCT00666965|589184154|FG002|Overall Study|Adverse Event|1|||
163130130|NCT00666965|589184155|FG003|Overall Study|Adverse Event|9|||
163130131|NCT00666965|589184152|FG000|Overall Study|Lack of Efficacy|1|||
163130132|NCT00666965|589184153|FG001|Overall Study|Lack of Efficacy|1|||
163130133|NCT00666965|589184154|FG002|Overall Study|Lack of Efficacy|0|||
163130134|NCT00666965|589184155|FG003|Overall Study|Lack of Efficacy|0|||
163130135|NCT00666965|589184152|FG000|Overall Study|Protocol Violation|0|||
163130136|NCT00666965|589184153|FG001|Overall Study|Protocol Violation|0|||
163130137|NCT00666965|589184154|FG002|Overall Study|Protocol Violation|0|||
163130138|NCT00666965|589184155|FG003|Overall Study|Protocol Violation|2|||
163130139|NCT00666965|589184152|FG000|Overall Study|Discontinuation criteria|2|||
163130140|NCT00666965|589184153|FG001|Overall Study|Discontinuation criteria|1|||
163130141|NCT00666965|589184154|FG002|Overall Study|Discontinuation criteria|1|||
163130142|NCT00666965|589184155|FG003|Overall Study|Discontinuation criteria|2|||
163130143|NCT00666965|589184152|FG000|Overall Study|Withdrawal by Subject|0|||
163130144|NCT00666965|589184153|FG001|Overall Study|Withdrawal by Subject|0|||
163130145|NCT00666965|589184154|FG002|Overall Study|Withdrawal by Subject|0|||
163130146|NCT00666965|589184155|FG003|Overall Study|Withdrawal by Subject|2|||
163130147|NCT03596450|589184161|FG000|Overall Study|Death|9|||
163130148|NCT03596450|589184162|FG001|Overall Study|Death|9|||
163130149|NCT03596450|589184161|FG000|Overall Study|Protocol Violation|18|||
163130150|NCT03596450|589184162|FG001|Overall Study|Protocol Violation|26|||
163130151|NCT03596450|589184161|FG000|Overall Study|Lost to Follow-up|50|||
163130152|NCT03596450|589184162|FG001|Overall Study|Lost to Follow-up|56|||
163130153|NCT03596450|589184161|FG000|Overall Study|Adverse Event|14|||
163130154|NCT03596450|589184162|FG001|Overall Study|Adverse Event|7|||
163130155|NCT03596450|589184161|FG000|Overall Study|Withdrawal by Subject|38|||
163130156|NCT03596450|589184162|FG001|Overall Study|Withdrawal by Subject|36|||
163130157|NCT03596450|589184161|FG000|Overall Study|Accidentally Randomized|2|||
163130158|NCT03596450|589184162|FG001|Overall Study|Accidentally Randomized|0|||
163130159|NCT03596450|589184161|FG000|Overall Study|Other reasons|48|||
163130160|NCT03596450|589184162|FG001|Overall Study|Other reasons|53|||
163130161|NCT03596450|589184161|FG000|Overall Study|Pregnancy|2|||
163130162|NCT03596450|589184162|FG001|Overall Study|Pregnancy|0|||
163130163|NCT00498355|589184163|FG000|Overall Study|Lost to Follow-up|1|||
163130164|NCT03262441|589184174|FG000|Overall Study|Withdrawal by Subject|1|||
163130165|NCT02607228|589184175|FG000|Overall Study|Progressive Disease|4|||
163130166|NCT02607228|589184176|FG001|Overall Study|Progressive Disease|3|||
163130167|NCT02607228|589184177|FG002|Overall Study|Progressive Disease|1|||
163130168|NCT02607228|589184178|FG003|Overall Study|Progressive Disease|5|||
163130169|NCT02607228|589184179|FG004|Overall Study|Progressive Disease|4|||
163130170|NCT02607228|589184180|FG005|Overall Study|Progressive Disease|3|||
163130171|NCT02607228|589184181|FG006|Overall Study|Progressive Disease|1|||
163130172|NCT02607228|589184175|FG000|Overall Study|Adverse Event|1|||
163130173|NCT02607228|589184176|FG001|Overall Study|Adverse Event|0|||
163130174|NCT02607228|589184177|FG002|Overall Study|Adverse Event|1|||
163130175|NCT02607228|589184178|FG003|Overall Study|Adverse Event|0|||
163130176|NCT02607228|589184179|FG004|Overall Study|Adverse Event|1|||
163130177|NCT02607228|589184180|FG005|Overall Study|Adverse Event|1|||
163130178|NCT02607228|589184181|FG006|Overall Study|Adverse Event|1|||
163130179|NCT02607228|589184175|FG000|Overall Study|Investigator's Discretion|0|||
163130180|NCT02607228|589184176|FG001|Overall Study|Investigator's Discretion|0|||
162657225|NCT01038778|587457065|FG001|Overall Study|Withdrawal by Subject|2|||
162657226|NCT01038778|587457066|FG002|Overall Study|Withdrawal by Subject|3|||
162657227|NCT02349711|587458328|FG000|Overall Study|Withdrawal by Subject|2|||
162657228|NCT02349711|587458329|FG001|Overall Study|Withdrawal by Subject|1|||
162657229|NCT02349711|587458328|FG000|Overall Study|Lost to Follow-up|1|||
162657230|NCT02349711|587458329|FG001|Overall Study|Lost to Follow-up|1|||
162657231|NCT01610700|587458333|FG000|Overall Study|Adverse Event|3|||
162657232|NCT01610700|587458334|FG001|Overall Study|Adverse Event|1|||
162657233|NCT01610700|587458333|FG000|Overall Study|Withdrawal by Subject|0|||
162657234|NCT01610700|587458334|FG001|Overall Study|Withdrawal by Subject|1|||
162657235|NCT01610700|587458333|FG000|Overall Study|subject took one dose of street cannabis|0|||
162657236|NCT01610700|587458334|FG001|Overall Study|subject took one dose of street cannabis|1|||
162657237|NCT02143414|587458336|FG000|Induction|Adverse Event|1|||
162657238|NCT02143414|587458337|FG001|Induction|Adverse Event|2|||
162657239|NCT02143414|587458336|FG000|Induction|Death|1|||
162657240|NCT02143414|587458337|FG001|Induction|Death|2|||
162657241|NCT02143414|587458336|FG000|Induction|Patient refusal|1|||
162657242|NCT02143414|587458337|FG001|Induction|Patient refusal|1|||
162657243|NCT02143414|587458336|FG000|Induction|Refractory|1|||
162657244|NCT02143414|587458337|FG001|Induction|Refractory|0|||
162657245|NCT02143414|587458336|FG000|Induction|Began alternative treatment|1|||
162657246|NCT02143414|587458337|FG001|Induction|Began alternative treatment|0|||
162657247|NCT02143414|587458336|FG000|Induction|Ineligible for postremission|5|||
162657248|NCT02143414|587458337|FG001|Induction|Ineligible for postremission|1|||
162657249|NCT02143414|587458336|FG000|Post-remission|Adverse Event|0|||
162657250|NCT02143414|587458337|FG001|Post-remission|Adverse Event|2|||
163130181|NCT02607228|589184177|FG002|Overall Study|Investigator's Discretion|1|||
163130182|NCT02607228|589184178|FG003|Overall Study|Investigator's Discretion|0|||
163130183|NCT02607228|589184179|FG004|Overall Study|Investigator's Discretion|0|||
163130184|NCT02607228|589184180|FG005|Overall Study|Investigator's Discretion|1|||
163130185|NCT02607228|589184181|FG006|Overall Study|Investigator's Discretion|0|||
163130186|NCT02607228|589184175|FG000|Overall Study|Withdrew Consent|0|||
163130187|NCT02607228|589184176|FG001|Overall Study|Withdrew Consent|1|||
163130188|NCT02607228|589184177|FG002|Overall Study|Withdrew Consent|0|||
163130189|NCT02607228|589184178|FG003|Overall Study|Withdrew Consent|0|||
163130190|NCT02607228|589184179|FG004|Overall Study|Withdrew Consent|0|||
163130191|NCT02607228|589184180|FG005|Overall Study|Withdrew Consent|1|||
163130192|NCT02607228|589184181|FG006|Overall Study|Withdrew Consent|0|||
163130193|NCT02607228|589184175|FG000|Overall Study|Study Terminated by Sponsor|0|||
163130194|NCT02607228|589184176|FG001|Overall Study|Study Terminated by Sponsor|0|||
163130195|NCT02607228|589184177|FG002|Overall Study|Study Terminated by Sponsor|0|||
163130196|NCT02607228|589184178|FG003|Overall Study|Study Terminated by Sponsor|1|||
163130197|NCT02607228|589184179|FG004|Overall Study|Study Terminated by Sponsor|0|||
163130198|NCT02607228|589184180|FG005|Overall Study|Study Terminated by Sponsor|0|||
163130199|NCT02607228|589184181|FG006|Overall Study|Study Terminated by Sponsor|0|||
163130200|NCT01455194|589184189|FG000|Overall Study|Screen Failure|20|||
163130201|NCT01455194|589184190|FG001|Overall Study|Screen Failure|0|||
163130202|NCT01455194|589184191|FG002|Overall Study|Screen Failure|0|||
163130203|NCT01455194|589184192|FG003|Overall Study|Screen Failure|0|||
163130204|NCT01455194|589184189|FG000|Overall Study|Randomisation Failure|90|||
163130205|NCT01455194|589184190|FG001|Overall Study|Randomisation Failure|0|||
163130206|NCT01455194|589184191|FG002|Overall Study|Randomisation Failure|0|||
163130207|NCT01455194|589184192|FG003|Overall Study|Randomisation Failure|0|||
163130208|NCT01455194|589184189|FG000|Overall Study|Deterioration in asthma|12|||
163130209|NCT01455194|589184190|FG001|Overall Study|Deterioration in asthma|6|||
163130210|NCT01455194|589184191|FG002|Overall Study|Deterioration in asthma|14|||
163130211|NCT01455194|589184192|FG003|Overall Study|Deterioration in asthma|9|||
163130212|NCT01455194|589184189|FG000|Overall Study|Adverse Event|1|||
163130213|NCT01455194|589184190|FG001|Overall Study|Adverse Event|1|||
163130214|NCT01455194|589184191|FG002|Overall Study|Adverse Event|1|||
163130215|NCT01455194|589184192|FG003|Overall Study|Adverse Event|3|||
163130216|NCT01455194|589184189|FG000|Overall Study|Withdrawal by Subject|21|||
163130217|NCT01455194|589184190|FG001|Overall Study|Withdrawal by Subject|16|||
163130218|NCT01455194|589184191|FG002|Overall Study|Withdrawal by Subject|12|||
163130219|NCT01455194|589184192|FG003|Overall Study|Withdrawal by Subject|9|||
163130220|NCT01455194|589184189|FG000|Overall Study|Lost to Follow-up|2|||
163130221|NCT01455194|589184190|FG001|Overall Study|Lost to Follow-up|0|||
163130222|NCT01455194|589184191|FG002|Overall Study|Lost to Follow-up|1|||
163130223|NCT01455194|589184192|FG003|Overall Study|Lost to Follow-up|1|||
163130224|NCT01455194|589184189|FG000|Overall Study|Pregnancy|0|||
163130225|NCT01455194|589184190|FG001|Overall Study|Pregnancy|1|||
163130226|NCT01455194|589184191|FG002|Overall Study|Pregnancy|1|||
163130227|NCT01455194|589184192|FG003|Overall Study|Pregnancy|0|||
163130228|NCT01455194|589184189|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
163130229|NCT01455194|589184190|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
163130230|NCT01455194|589184191|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
163130231|NCT01455194|589184192|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
163130232|NCT01455194|589184189|FG000|Overall Study|Miscellaneous|4|||
163130233|NCT01455194|589184190|FG001|Overall Study|Miscellaneous|5|||
163130234|NCT01455194|589184191|FG002|Overall Study|Miscellaneous|1|||
163130235|NCT01455194|589184192|FG003|Overall Study|Miscellaneous|4|||
163130236|NCT05090852|589184193|FG000|Overall Study|Physician Decision|5|||
163130237|NCT00504894|589184194|FG000|Overall Study|fMRI technical problems|1|||
163130238|NCT00504894|589184195|FG001|Overall Study|fMRI technical problems|1|||
163130239|NCT00504894|589184196|FG002|Overall Study|fMRI technical problems|0|||
163130240|NCT00504894|589184194|FG000|Overall Study|Withdrawal by Subject|0|||
163130241|NCT00504894|589184195|FG001|Overall Study|Withdrawal by Subject|1|||
163130242|NCT00504894|589184196|FG002|Overall Study|Withdrawal by Subject|0|||
163130243|NCT00504894|589184194|FG000|Overall Study|Infusion technical problems|0|||
163130244|NCT00504894|589184195|FG001|Overall Study|Infusion technical problems|1|||
163130245|NCT00504894|589184196|FG002|Overall Study|Infusion technical problems|0|||
163130246|NCT00504894|589184194|FG000|Overall Study|poor subject data|2|||
163130247|NCT00504894|589184195|FG001|Overall Study|poor subject data|0|||
163130248|NCT00504894|589184196|FG002|Overall Study|poor subject data|0|||
163130249|NCT01196416|589184197|FG000|Overall Study|Withdrawal by Subject|2|||
163130250|NCT00148941|589184198|FG000|Overall Study|Lost to Follow-up|17|||
163130251|NCT00148941|589184199|FG001|Overall Study|Lost to Follow-up|24|||
163130252|NCT00148941|589184200|FG002|Overall Study|Lost to Follow-up|18|||
163130253|NCT00148941|589184201|FG003|Overall Study|Lost to Follow-up|22|||
163130254|NCT00148941|589184198|FG000|Overall Study|Withdrawal by Subject|1|||
163130255|NCT00148941|589184199|FG001|Overall Study|Withdrawal by Subject|0|||
163130256|NCT00148941|589184200|FG002|Overall Study|Withdrawal by Subject|1|||
162657251|NCT02143414|587458336|FG000|Post-remission|Disease progression/relapse|5|||
162719787|NCT02540213|587680580|FG000|Overall Study|Consent withdrawn|7|||
162719788|NCT02540213|587680580|FG000|Overall Study|Enrolled but not treated|2|||
162719789|NCT01264718|587680581|FG000|Overall Study|Lost to Follow-up|3|||
162719790|NCT01264718|587680582|FG001|Overall Study|Lost to Follow-up|2|||
162719791|NCT01264718|587680581|FG000|Overall Study|Withdrawal by Subject|9|||
162719792|NCT01264718|587680582|FG001|Overall Study|Withdrawal by Subject|15|||
162657252|NCT02143414|587458337|FG001|Post-remission|Disease progression/relapse|0|||
162657253|NCT02143414|587458336|FG000|Maintenance|Adverse Event|4|||
162657254|NCT02143414|587458337|FG001|Maintenance|Adverse Event|6|||
162657255|NCT02143414|587458336|FG000|Maintenance|Disease progression/relapse|3|||
162657256|NCT02143414|587458337|FG001|Maintenance|Disease progression/relapse|2|||
162657257|NCT02143414|587458336|FG000|Maintenance|Patient refusal|2|||
162657258|NCT02143414|587458337|FG001|Maintenance|Patient refusal|1|||
162657259|NCT02143414|587458336|FG000|Maintenance|Physician Decision|1|||
162657260|NCT02143414|587458337|FG001|Maintenance|Physician Decision|0|||
162657261|NCT02143414|587458336|FG000|Maintenance|Death|0|||
162657262|NCT02143414|587458337|FG001|Maintenance|Death|1|||
162657263|NCT02143414|587458336|FG000|Maintenance|On protocol treatment|0|||
162657264|NCT02143414|587458337|FG001|Maintenance|On protocol treatment|6|||
162657265|NCT00978731|587458341|FG000|Overall Study|Death|4|||
162657266|NCT00978731|587458342|FG001|Overall Study|Death|1|||
162657267|NCT00978731|587458343|FG002|Overall Study|Death|1|||
162657268|NCT00978731|587458344|FG003|Overall Study|Death|0|||
162657269|NCT00978731|587458341|FG000|Overall Study|Lost to Follow-up|0|||
162657270|NCT00978731|587458342|FG001|Overall Study|Lost to Follow-up|0|||
162657271|NCT00978731|587458343|FG002|Overall Study|Lost to Follow-up|0|||
162657272|NCT00978731|587458344|FG003|Overall Study|Lost to Follow-up|1|||
162657273|NCT00978731|587458341|FG000|Overall Study|Adverse Event|5|||
162657274|NCT00978731|587458342|FG001|Overall Study|Adverse Event|2|||
162657275|NCT00978731|587458343|FG002|Overall Study|Adverse Event|0|||
162657276|NCT00978731|587458344|FG003|Overall Study|Adverse Event|0|||
162657277|NCT00978731|587458341|FG000|Overall Study|Participant's request|1|||
162657278|NCT00978731|587458342|FG001|Overall Study|Participant's request|0|||
163130257|NCT00148941|589184201|FG003|Overall Study|Withdrawal by Subject|0|||
163130258|NCT00148941|589184198|FG000|Overall Study|Other|0|||
163130259|NCT00148941|589184199|FG001|Overall Study|Other|0|||
163130260|NCT00148941|589184200|FG002|Overall Study|Other|1|||
163130261|NCT00148941|589184201|FG003|Overall Study|Other|2|||
163130262|NCT02673684|589184202|FG000|Overall Study|Study not completed d/t loss of funding|9|||
163130263|NCT02673684|589184203|FG001|Overall Study|Study not completed d/t loss of funding|8|||
163130264|NCT01092663|589184206|FG000|Overall Study|Withdrawal by Subject|3|||
163130265|NCT01092663|589184207|FG001|Overall Study|Withdrawal by Subject|2|||
163130266|NCT01092663|589184206|FG000|Overall Study|Glucose >300mg/dL|1|||
163130267|NCT01092663|589184207|FG001|Overall Study|Glucose >300mg/dL|0|||
163130268|NCT01092663|589184206|FG000|Overall Study|High fasting triglyceride|2|||
163130269|NCT01092663|589184207|FG001|Overall Study|High fasting triglyceride|0|||
163130270|NCT01092663|589184206|FG000|Overall Study|Adverse Event|1|||
163130271|NCT01092663|589184207|FG001|Overall Study|Adverse Event|1|||
163130272|NCT01092663|589184206|FG000|Overall Study|Protocol Violation|0|||
163130273|NCT01092663|589184207|FG001|Overall Study|Protocol Violation|1|||
163130274|NCT00788710|589184208|FG000|Overall Study|Adverse Event|1|||
163130275|NCT00788710|589184209|FG001|Overall Study|Adverse Event|3|||
163130276|NCT00788710|589184210|FG002|Overall Study|Adverse Event|4|||
163130277|NCT00788710|589184208|FG000|Overall Study|Lack of Efficacy|0|||
163130278|NCT00788710|589184209|FG001|Overall Study|Lack of Efficacy|0|||
163130279|NCT00788710|589184210|FG002|Overall Study|Lack of Efficacy|1|||
163130280|NCT00788710|589184208|FG000|Overall Study|Lost to Follow-up|0|||
163130281|NCT00788710|589184209|FG001|Overall Study|Lost to Follow-up|1|||
163130282|NCT00788710|589184210|FG002|Overall Study|Lost to Follow-up|0|||
163130283|NCT00788710|589184208|FG000|Overall Study|Physician Decision|2|||
163130284|NCT00788710|589184209|FG001|Overall Study|Physician Decision|1|||
163130285|NCT00788710|589184210|FG002|Overall Study|Physician Decision|0|||
163130286|NCT00788710|589184208|FG000|Overall Study|Protocol Violation|0|||
163130287|NCT00788710|589184209|FG001|Overall Study|Protocol Violation|1|||
163130288|NCT00788710|589184210|FG002|Overall Study|Protocol Violation|1|||
163130289|NCT00788710|589184208|FG000|Overall Study|Withdrawal by Subject|2|||
163130290|NCT00788710|589184209|FG001|Overall Study|Withdrawal by Subject|2|||
163130291|NCT00788710|589184210|FG002|Overall Study|Withdrawal by Subject|0|||
163130292|NCT01008904|589184211|FG000|Overall Study|Lost to Follow-up|1|||
163130293|NCT01008904|589184211|FG000|Overall Study|Adverse Event|2|||
163130294|NCT01008904|589184211|FG000|Overall Study|unexpected unrelated surgery|1|||
163130295|NCT03908970|589184212|FG000|Overall Study|Adverse Event|7|||
163130296|NCT03908970|589184213|FG001|Overall Study|Adverse Event|21|||
163130297|NCT03908970|589184212|FG000|Overall Study|Physician Decision|1|||
163130298|NCT03908970|589184213|FG001|Overall Study|Physician Decision|4|||
163130299|NCT03908970|589184212|FG000|Overall Study|Withdrawal by Subject|9|||
163130300|NCT03908970|589184213|FG001|Overall Study|Withdrawal by Subject|22|||
163130301|NCT04407234|589184214|FG000|Overall Study|Adverse Event|3|||
163130302|NCT04407234|589184215|FG001|Overall Study|Adverse Event|3|||
163130303|NCT00727558|589184221|FG000|Overall Study|Lens issue|0|||
163130304|NCT00727558|589184222|FG001|Overall Study|Lens issue|1|||
163130305|NCT00727558|589184221|FG000|Overall Study|Adverse Event|0|||
163130306|NCT00727558|589184222|FG001|Overall Study|Adverse Event|1|||
163130307|NCT00727558|589184221|FG000|Overall Study|Subject unable to return for follow-up|1|||
163130308|NCT00727558|589184222|FG001|Overall Study|Subject unable to return for follow-up|1|||
163130309|NCT00727558|589184221|FG000|Overall Study|Lost to Follow-up|1|||
163130310|NCT00727558|589184222|FG001|Overall Study|Lost to Follow-up|0|||
163130311|NCT02262754|589184225|FG000|Overall Study|Adverse Event|3|||
163130312|NCT02262754|589184226|FG001|Overall Study|Adverse Event|4|||
163130313|NCT02262754|589184227|FG002|Overall Study|Adverse Event|0|||
163130314|NCT02262754|589184225|FG000|Overall Study|Lack of Efficacy|2|||
163130315|NCT02262754|589184226|FG001|Overall Study|Lack of Efficacy|0|||
163130316|NCT02262754|589184227|FG002|Overall Study|Lack of Efficacy|1|||
163130317|NCT02262754|589184225|FG000|Overall Study|Lost to Follow-up|0|||
163130318|NCT02262754|589184226|FG001|Overall Study|Lost to Follow-up|0|||
163130319|NCT02262754|589184227|FG002|Overall Study|Lost to Follow-up|1|||
163130320|NCT02262754|589184225|FG000|Overall Study|No longer meets eligibility criteria|0|||
163130321|NCT02262754|589184226|FG001|Overall Study|No longer meets eligibility criteria|1|||
163130322|NCT02262754|589184227|FG002|Overall Study|No longer meets eligibility criteria|0|||
163130323|NCT02262754|589184225|FG000|Overall Study|Study terminated by sponsor|5|||
163130324|NCT02262754|589184226|FG001|Overall Study|Study terminated by sponsor|4|||
163130325|NCT02262754|589184227|FG002|Overall Study|Study terminated by sponsor|4|||
163130326|NCT02262754|589184225|FG000|Overall Study|Protocol Violation|1|||
163130327|NCT02262754|589184226|FG001|Overall Study|Protocol Violation|0|||
163130328|NCT02262754|589184227|FG002|Overall Study|Protocol Violation|0|||
163130329|NCT02262754|589184225|FG000|Overall Study|Withdrawal by Subject|1|||
163130330|NCT02262754|589184226|FG001|Overall Study|Withdrawal by Subject|0|||
163130331|NCT02262754|589184227|FG002|Overall Study|Withdrawal by Subject|1|||
162657279|NCT00978731|587458343|FG002|Overall Study|Participant's request|0|||
162657280|NCT00978731|587458344|FG003|Overall Study|Participant's request|0|||
162657281|NCT00978731|587458341|FG000|Overall Study|Administrative reason|3|||
162657282|NCT00978731|587458342|FG001|Overall Study|Administrative reason|3|||
162657283|NCT00978731|587458343|FG002|Overall Study|Administrative reason|1|||
162657284|NCT00978731|587458344|FG003|Overall Study|Administrative reason|0|||
162657285|NCT00978731|587458341|FG000|Overall Study|Deterioration without progression|0|||
162657286|NCT00978731|587458342|FG001|Overall Study|Deterioration without progression|1|||
162657287|NCT00978731|587458343|FG002|Overall Study|Deterioration without progression|0|||
162657288|NCT00978731|587458344|FG003|Overall Study|Deterioration without progression|0|||
162657289|NCT00978731|587458341|FG000|Overall Study|Disease progression/relapse|5|||
162657290|NCT00978731|587458342|FG001|Overall Study|Disease progression/relapse|4|||
162657291|NCT00978731|587458343|FG002|Overall Study|Disease progression/relapse|2|||
162657292|NCT00978731|587458344|FG003|Overall Study|Disease progression/relapse|2|||
162657293|NCT00978731|587458341|FG000|Overall Study|Study closure|3|||
162657294|NCT00978731|587458342|FG001|Overall Study|Study closure|4|||
162657295|NCT00978731|587458343|FG002|Overall Study|Study closure|1|||
162657296|NCT00978731|587458344|FG003|Overall Study|Study closure|1|||
162657297|NCT00978731|587458341|FG000|Overall Study|No response|1|||
162657298|NCT00978731|587458342|FG001|Overall Study|No response|0|||
162657299|NCT00978731|587458343|FG002|Overall Study|No response|0|||
162657300|NCT00978731|587458344|FG003|Overall Study|No response|0|||
162657301|NCT02649972|587458351|FG000|Overall Study|Not treated|1|||
162657302|NCT01428193|587458352|FG000|Overall Study|Physician Decision|1|||
162657303|NCT01428193|587458352|FG000|Overall Study|Elevated screening liver enzymes|1|||
162657304|NCT00357370|587458359|FG000|Cohort 2|Lack of Efficacy|0|||
162657305|NCT00357370|587458360|FG001|Cohort 2|Lack of Efficacy|2|||
162657306|NCT00357370|587458361|FG002|Cohort 2|Lack of Efficacy|1|||
162657307|NCT00357370|587458359|FG000|Cohort 2|Adverse Event|1|||
162657308|NCT00357370|587458360|FG001|Cohort 2|Adverse Event|1|||
162657309|NCT00357370|587458361|FG002|Cohort 2|Adverse Event|1|||
162657310|NCT00357370|587458359|FG000|Cohort 2|Lost to Follow-up|0|||
162657311|NCT00357370|587458360|FG001|Cohort 2|Lost to Follow-up|1|||
162657312|NCT00357370|587458361|FG002|Cohort 2|Lost to Follow-up|0|||
162657313|NCT00357370|587458359|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
162657314|NCT00357370|587458360|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
162657315|NCT00357370|587458361|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
162657316|NCT00357370|587458359|FG000|Cohort 2|Withdrawal by Subject|0|||
162657317|NCT00357370|587458360|FG001|Cohort 2|Withdrawal by Subject|2|||
162657318|NCT00357370|587458361|FG002|Cohort 2|Withdrawal by Subject|0|||
162657319|NCT01632800|587458363|FG000|Overall Study|Subject did not fit in apparatus|1|||
162657320|NCT01502644|587458366|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
162657321|NCT01502644|587458367|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162657322|NCT01502644|587458368|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162657323|NCT01502644|587458369|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162657324|NCT01502644|587458366|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
162657325|NCT01502644|587458367|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162657326|NCT01502644|587458368|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162657327|NCT01502644|587458369|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162657328|NCT01502644|587458366|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
162657329|NCT01502644|587458367|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162657330|NCT01502644|587458368|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162657331|NCT01502644|587458369|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162657332|NCT01502644|587458366|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
162657333|NCT01502644|587458367|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
162657334|NCT01502644|587458368|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
162719793|NCT01264718|587680581|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
162719794|NCT01264718|587680582|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
162719795|NCT02908464|587680583|FG000|Overall Study|Withdrawal by Subject|2|||
163130332|NCT02262754|589184225|FG000|Overall Study|Other|4|||
163130333|NCT02262754|589184226|FG001|Overall Study|Other|0|||
163130334|NCT02262754|589184227|FG002|Overall Study|Other|2|||
163130335|NCT04079114|589184231|FG000|Overall Study|Study prematuely terminated.|166|||
163130336|NCT00629798|589184236|FG000|Overall Study|Not Treated|4|||
163130337|NCT02126839|589184237|FG000|Overall Study|Adverse Event|0|||
163130338|NCT02126839|589184238|FG001|Overall Study|Adverse Event|1|||
162657335|NCT01502644|587458369|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
162657336|NCT01502644|587458366|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
162657337|NCT01502644|587458367|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
162657338|NCT01502644|587458368|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
162657339|NCT01502644|587458369|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
162657340|NCT03306264|587458372|FG000|Overall Study|Death|33|||
163130339|NCT02126839|589184237|FG000|Overall Study|Withdrawal by Subject|1|||
162657341|NCT03306264|587458373|FG001|Overall Study|Death|25|||
162657342|NCT03306264|587458374|FG002|Overall Study|Death|34|||
162657343|NCT03306264|587458375|FG003|Overall Study|Death|34|||
162657344|NCT03306264|587458372|FG000|Overall Study|Complete Consent Withdrawal|4|||
162657345|NCT03306264|587458373|FG001|Overall Study|Complete Consent Withdrawal|4|||
162657346|NCT03306264|587458374|FG002|Overall Study|Complete Consent Withdrawal|1|||
162657347|NCT03306264|587458375|FG003|Overall Study|Complete Consent Withdrawal|8|||
162657348|NCT03306264|587458372|FG000|Overall Study|Lost to Follow-up|1|||
162657349|NCT03306264|587458373|FG001|Overall Study|Lost to Follow-up|0|||
162657350|NCT03306264|587458374|FG002|Overall Study|Lost to Follow-up|1|||
162657351|NCT03306264|587458375|FG003|Overall Study|Lost to Follow-up|0|||
162657352|NCT03306264|587458372|FG000|Overall Study|Rollover to ASTX727-06|10|||
162657353|NCT03306264|587458373|FG001|Overall Study|Rollover to ASTX727-06|18|||
162657354|NCT03306264|587458374|FG002|Overall Study|Rollover to ASTX727-06|4|||
162657355|NCT03306264|587458375|FG003|Overall Study|Rollover to ASTX727-06|2|||
162657356|NCT03306264|587458372|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
162657357|NCT03306264|587458373|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
162657358|NCT03306264|587458374|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
162657359|NCT03306264|587458375|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
162657360|NCT02722928|587458379|FG000|Overall Study|Standard CT was not as required per prot|5|||
162657361|NCT02722928|587458380|FG001|Overall Study|Standard CT was not as required per prot|13|||
162657362|NCT02722928|587458379|FG000|Overall Study|Required Intraoperative MRI|5|||
162657363|NCT02722928|587458380|FG001|Overall Study|Required Intraoperative MRI|7|||
162657364|NCT00094653|587458381|FG000|Overall Study|Death|306|||
162657365|NCT00094653|587458382|FG001|Overall Study|Death|100|||
162657366|NCT00094653|587458383|FG002|Overall Study|Death|119|||
162657367|NCT00094653|587458381|FG000|Overall Study|Subject Withdrew Consent|10|||
162657368|NCT00094653|587458382|FG001|Overall Study|Subject Withdrew Consent|2|||
162657369|NCT00094653|587458383|FG002|Overall Study|Subject Withdrew Consent|3|||
162657370|NCT00094653|587458381|FG000|Overall Study|Other|2|||
162657371|NCT00094653|587458382|FG001|Overall Study|Other|2|||
162657372|NCT00094653|587458383|FG002|Overall Study|Other|2|||
162657373|NCT00094653|587458381|FG000|Overall Study|Lost to Follow-up|3|||
162657374|NCT00094653|587458382|FG001|Overall Study|Lost to Follow-up|2|||
162657375|NCT00094653|587458383|FG002|Overall Study|Lost to Follow-up|1|||
162657376|NCT00094653|587458381|FG000|Overall Study|Protocol Violation|0|||
162657377|NCT00094653|587458382|FG001|Overall Study|Protocol Violation|0|||
162657378|NCT00094653|587458383|FG002|Overall Study|Protocol Violation|1|||
162657379|NCT05059600|587458386|FG000|Overall Study|Enrolled but not Treated|10|||
162719796|NCT02908464|587680584|FG001|Overall Study|Withdrawal by Subject|1|||
162657380|NCT02152995|587458387|FG000|Overall Study|Withdrawal by Subject|1|||
162657381|NCT02152995|587458388|FG001|Overall Study|Withdrawal by Subject|0|||
162657382|NCT01565291|587458389|FG000|Overall Study|Withdrawal by Subject|1|||
162657383|NCT01565291|587458390|FG001|Overall Study|Withdrawal by Subject|0|||
162657384|NCT04552587|587458396|FG000|Overall Study|Lost to Follow-up|4|||
162657385|NCT01822132|587458397|FG000|Overall Study|Lost to Follow-up|4|||
162657386|NCT01822132|587458398|FG001|Overall Study|Lost to Follow-up|2|||
162657387|NCT00313612|587458399|FG000|Overall Study|Patient never received treatment|0|||
162657388|NCT00313612|587458400|FG001|Overall Study|Patient never received treatment|1|||
162657389|NCT00677807|587458403|FG000|Overall Study|Adverse Event|4|||
162657390|NCT00677807|587458404|FG001|Overall Study|Adverse Event|1|||
162657391|NCT00677807|587458405|FG002|Overall Study|Adverse Event|6|||
162657392|NCT00677807|587458403|FG000|Overall Study|Lack of Efficacy|0|||
162657393|NCT00677807|587458404|FG001|Overall Study|Lack of Efficacy|0|||
162657394|NCT00677807|587458405|FG002|Overall Study|Lack of Efficacy|2|||
162657395|NCT00677807|587458403|FG000|Overall Study|Participant no longer needs study drug|0|||
162657396|NCT00677807|587458404|FG001|Overall Study|Participant no longer needs study drug|0|||
162657397|NCT00677807|587458405|FG002|Overall Study|Participant no longer needs study drug|1|||
162657398|NCT00677807|587458403|FG000|Overall Study|Withdrawal by Subject|10|||
162657399|NCT00677807|587458404|FG001|Overall Study|Withdrawal by Subject|3|||
162657400|NCT00677807|587458405|FG002|Overall Study|Withdrawal by Subject|6|||
163130340|NCT02126839|589184238|FG001|Overall Study|Withdrawal by Subject|0|||
163130341|NCT02126839|589184237|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163130342|NCT02126839|589184238|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163130343|NCT02126839|589184237|FG000|Overall Study|Protocol Violation|2|||
163130344|NCT02126839|589184238|FG001|Overall Study|Protocol Violation|3|||
163130345|NCT02126839|589184237|FG000|Overall Study|Sponsor request|0|||
163130346|NCT02126839|589184238|FG001|Overall Study|Sponsor request|1|||
163130347|NCT02126839|589184237|FG000|Overall Study|Lost to Follow-up|1|||
163130348|NCT02126839|589184238|FG001|Overall Study|Lost to Follow-up|4|||
163130349|NCT02126839|589184237|FG000|Overall Study|Other|5|||
163130350|NCT02126839|589184238|FG001|Overall Study|Other|5|||
163130351|NCT01108523|589184239|FG000|Overall Study|Protocol Violation|4|||
163130352|NCT00687531|589184240|FG000|Overall Study|Did not meet protocol eligibility|104|||
163130353|NCT00687531|589184240|FG000|Overall Study|Adverse Event|5|||
163130354|NCT00687531|589184240|FG000|Overall Study|Lost to Follow-up|26|||
163130355|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Adverse Event|1|||
163130356|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Adverse Event|0|||
163130357|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
163130358|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
163130359|NCT00547521|589184243|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
163130360|NCT00547521|589184244|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
163130361|NCT00547521|589184243|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
163130362|NCT00547521|589184244|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
163130363|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
163130364|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
163130365|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
163130366|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
163130367|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
163130368|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
163130369|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
163130370|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
163130371|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Other|0|||
163130372|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Other|2|||
163130373|NCT00547521|589184243|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
163130374|NCT00547521|589184244|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
163130375|NCT03077919|589186251|FG000|Overall Study|Lost to Follow-up|4|||
163130376|NCT03077919|589186252|FG001|Overall Study|Lost to Follow-up|1|||
163130377|NCT00826618|589186253|FG000|Overall Study|Withdrawal by Subject|1|||
163130378|NCT01487265|589186256|FG000|Overall Study|Adverse Event|8|||
163130379|NCT01487265|589186256|FG000|Overall Study|Withdrawal by Subject|5|||
163130380|NCT01487265|589186256|FG000|Overall Study|Disease Progression|21|||
163130381|NCT01487265|589186256|FG000|Overall Study|Death|2|||
163130382|NCT01487265|589186256|FG000|Overall Study|Still on Treatment|1|||
163130383|NCT01496469|589186266|FG000|Overall Study|Adverse Event|1|||
163130384|NCT01496469|589186267|FG001|Overall Study|Adverse Event|0|||
163130385|NCT01496469|589186266|FG000|Overall Study|Protocol Violation|2|||
163130386|NCT01496469|589186267|FG001|Overall Study|Protocol Violation|0|||
163130387|NCT01496469|589186266|FG000|Overall Study|Lost to Follow-up|1|||
163130388|NCT01496469|589186267|FG001|Overall Study|Lost to Follow-up|1|||
163130389|NCT01496469|589186266|FG000|Overall Study|Withdrawal by Subject|4|||
163130390|NCT01496469|589186267|FG001|Overall Study|Withdrawal by Subject|4|||
163130391|NCT01496469|589186266|FG000|Overall Study|BP exceeds protocol limits|1|||
163130392|NCT01496469|589186267|FG001|Overall Study|BP exceeds protocol limits|2|||
163130393|NCT01496469|589186266|FG000|Overall Study|Other|1|||
163130394|NCT01496469|589186267|FG001|Overall Study|Other|1|||
162657401|NCT00677807|587458403|FG000|Overall Study|Lost to Follow-up|2|||
163130395|NCT00193180|589186269|FG000|Overall Study|Lack of Efficacy|1|||
163130396|NCT00193180|589186269|FG000|Overall Study|Adverse Event|8|||
163130397|NCT00193180|589186269|FG000|Overall Study|Protocol Violation|1|||
163130398|NCT02219334|589186270|FG000|Overall Study|Withdrawal by Subject|1|||
162657402|NCT00677807|587458404|FG001|Overall Study|Lost to Follow-up|2|||
163130399|NCT02219334|589186271|FG001|Overall Study|Withdrawal by Subject|0|||
163130400|NCT02219334|589186270|FG000|Overall Study|Protocol Violation|7|||
163130401|NCT02219334|589186271|FG001|Overall Study|Protocol Violation|3|||
163130402|NCT02688985|589186279|FG000|Overall Study|Adverse Event|1|||
163130403|NCT02688985|589186280|FG001|Overall Study|Adverse Event|2|||
163130404|NCT02688985|589186281|FG002|Overall Study|Adverse Event|2|||
163130405|NCT02688985|589186282|FG003|Overall Study|Adverse Event|0|||
163130406|NCT02688985|589186283|FG004|Overall Study|Adverse Event|0|||
162657403|NCT00677807|587458405|FG002|Overall Study|Lost to Follow-up|2|||
162657404|NCT00677807|587458403|FG000|Overall Study|Administrative problems|1|||
162657405|NCT00677807|587458404|FG001|Overall Study|Administrative problems|1|||
162657406|NCT00677807|587458405|FG002|Overall Study|Administrative problems|2|||
162657407|NCT00677807|587458403|FG000|Overall Study|Death|0|||
162657408|NCT00677807|587458404|FG001|Overall Study|Death|1|||
162657409|NCT00677807|587458405|FG002|Overall Study|Death|1|||
162657410|NCT00677807|587458403|FG000|Overall Study|Protocol Deviation|1|||
162657411|NCT00677807|587458404|FG001|Overall Study|Protocol Deviation|3|||
162657412|NCT00677807|587458405|FG002|Overall Study|Protocol Deviation|0|||
162657413|NCT01393743|587458406|FG000|Core Study|Adverse Event|5|||
162657414|NCT01393743|587458407|FG001|Core Study|Adverse Event|9|||
162657415|NCT01393743|587458408|FG002|Core Study|Adverse Event|0|||
162657416|NCT01393743|587458406|FG000|Core Study|Lost to Follow-up|1|||
162657417|NCT01393743|587458407|FG001|Core Study|Lost to Follow-up|1|||
162657418|NCT01393743|587458408|FG002|Core Study|Lost to Follow-up|0|||
162657419|NCT01393743|587458406|FG000|Core Study|Participant's Choice|2|||
162657420|NCT01393743|587458407|FG001|Core Study|Participant's Choice|3|||
162657421|NCT01393743|587458408|FG002|Core Study|Participant's Choice|0|||
162657422|NCT01393743|587458406|FG000|Core Study|Inadequate therapeutic effect|2|||
162657423|NCT01393743|587458407|FG001|Core Study|Inadequate therapeutic effect|0|||
162657424|NCT01393743|587458408|FG002|Core Study|Inadequate therapeutic effect|0|||
162657425|NCT01393743|587458406|FG000|Extension Phase|Adverse Event|0|||
162657426|NCT01393743|587458407|FG001|Extension Phase|Adverse Event|0|||
162657427|NCT01393743|587458408|FG002|Extension Phase|Adverse Event|12|||
162657428|NCT01393743|587458406|FG000|Extension Phase|Lost to Follow-up|0|||
162657429|NCT01393743|587458407|FG001|Extension Phase|Lost to Follow-up|0|||
162657430|NCT01393743|587458408|FG002|Extension Phase|Lost to Follow-up|2|||
162657431|NCT01393743|587458406|FG000|Extension Phase|Participant choice|0|||
162657432|NCT01393743|587458407|FG001|Extension Phase|Participant choice|0|||
162657433|NCT01393743|587458408|FG002|Extension Phase|Participant choice|16|||
162657434|NCT01393743|587458406|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162657435|NCT01393743|587458407|FG001|Extension Phase|Inadequate therapeutic effect|0|||
162657436|NCT01393743|587458408|FG002|Extension Phase|Inadequate therapeutic effect|7|||
162657437|NCT01393743|587458406|FG000|Extension Phase|Withdrawal by Subject|0|||
162657438|NCT01393743|587458407|FG001|Extension Phase|Withdrawal by Subject|0|||
162657439|NCT01393743|587458408|FG002|Extension Phase|Withdrawal by Subject|8|||
162657440|NCT01393743|587458406|FG000|Extension Phase|Pregnancy|0|||
162657441|NCT01393743|587458407|FG001|Extension Phase|Pregnancy|0|||
162657442|NCT01393743|587458408|FG002|Extension Phase|Pregnancy|1|||
162657443|NCT01393743|587458406|FG000|Extension Phase|Other|0|||
162657444|NCT01393743|587458407|FG001|Extension Phase|Other|0|||
162657445|NCT01393743|587458408|FG002|Extension Phase|Other|14|||
162657446|NCT00989833|587458413|FG000|Overall Study|Lost to Follow-up|0|||
162657447|NCT00989833|587458414|FG001|Overall Study|Lost to Follow-up|1|||
162657448|NCT00989833|587458415|FG002|Overall Study|Lost to Follow-up|0|||
162657449|NCT00989833|587458413|FG000|Overall Study|Protocol Violation|1|||
162657450|NCT00989833|587458414|FG001|Overall Study|Protocol Violation|2|||
162657451|NCT00989833|587458415|FG002|Overall Study|Protocol Violation|1|||
162657452|NCT00989833|587458413|FG000|Overall Study|Withdrawal by Subject|0|||
162657453|NCT00989833|587458414|FG001|Overall Study|Withdrawal by Subject|0|||
162657454|NCT00989833|587458415|FG002|Overall Study|Withdrawal by Subject|1|||
162657455|NCT00989833|587458413|FG000|Overall Study|Incorrectly randomized|1|||
162657456|NCT00989833|587458414|FG001|Overall Study|Incorrectly randomized|0|||
162657457|NCT00989833|587458415|FG002|Overall Study|Incorrectly randomized|0|||
162657458|NCT01420081|587458417|FG000|Overall Study|Death|1|||
162657459|NCT01420081|587458418|FG001|Overall Study|Death|0|||
162657460|NCT01420081|587458419|FG002|Overall Study|Death|8|||
162657461|NCT01420081|587458420|FG003|Overall Study|Death|0|||
162657462|NCT01420081|587458421|FG004|Overall Study|Death|7|||
162657463|NCT01420081|587458422|FG005|Overall Study|Death|12|||
163130407|NCT02688985|589186279|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
163130408|NCT02688985|589186280|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
163130409|NCT02688985|589186281|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
162657464|NCT01420081|587458423|FG006|Overall Study|Death|0|||
162657465|NCT01420081|587458424|FG007|Overall Study|Death|1|||
162657466|NCT01420081|587458425|FG008|Overall Study|Death|1|||
162657467|NCT01420081|587458417|FG000|Overall Study|Lost to Follow-up|0|||
162657468|NCT01420081|587458418|FG001|Overall Study|Lost to Follow-up|0|||
162657469|NCT01420081|587458419|FG002|Overall Study|Lost to Follow-up|0|||
162657470|NCT01420081|587458420|FG003|Overall Study|Lost to Follow-up|0|||
162657471|NCT01420081|587458421|FG004|Overall Study|Lost to Follow-up|1|||
162657472|NCT01420081|587458422|FG005|Overall Study|Lost to Follow-up|1|||
162657473|NCT01420081|587458423|FG006|Overall Study|Lost to Follow-up|0|||
162657474|NCT01420081|587458424|FG007|Overall Study|Lost to Follow-up|0|||
162657475|NCT01420081|587458425|FG008|Overall Study|Lost to Follow-up|0|||
162657476|NCT01420081|587458417|FG000|Overall Study|Study Terminated by Sponsor|2|||
162657477|NCT01420081|587458418|FG001|Overall Study|Study Terminated by Sponsor|1|||
162657478|NCT01420081|587458419|FG002|Overall Study|Study Terminated by Sponsor|1|||
162657479|NCT01420081|587458420|FG003|Overall Study|Study Terminated by Sponsor|3|||
163130410|NCT02688985|589186282|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
163130411|NCT02688985|589186283|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
163130412|NCT02688985|589186279|FG000|Overall Study|Death|0|||
163130413|NCT02688985|589186280|FG001|Overall Study|Death|0|||
163130414|NCT02688985|589186281|FG002|Overall Study|Death|0|||
163130415|NCT02688985|589186282|FG003|Overall Study|Death|0|||
163130416|NCT02688985|589186283|FG004|Overall Study|Death|1|||
163130417|NCT02688985|589186279|FG000|Overall Study|Lack of Efficacy|0|||
163130418|NCT02688985|589186280|FG001|Overall Study|Lack of Efficacy|0|||
163130419|NCT02688985|589186281|FG002|Overall Study|Lack of Efficacy|0|||
163130420|NCT02688985|589186282|FG003|Overall Study|Lack of Efficacy|0|||
162657480|NCT01420081|587458421|FG004|Overall Study|Study Terminated by Sponsor|11|||
162657481|NCT01420081|587458422|FG005|Overall Study|Study Terminated by Sponsor|7|||
162657482|NCT01420081|587458423|FG006|Overall Study|Study Terminated by Sponsor|3|||
162657483|NCT01420081|587458424|FG007|Overall Study|Study Terminated by Sponsor|2|||
162657484|NCT01420081|587458425|FG008|Overall Study|Study Terminated by Sponsor|2|||
162657485|NCT01420081|587458417|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
162657486|NCT01420081|587458418|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
162657487|NCT01420081|587458419|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
162657488|NCT01420081|587458420|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
162657489|NCT01420081|587458421|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
162657490|NCT01420081|587458422|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
162657491|NCT01420081|587458423|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
162657492|NCT01420081|587458424|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
162657493|NCT01420081|587458425|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
162657494|NCT01420081|587458417|FG000|Overall Study|Other Reasons|0|||
162657495|NCT01420081|587458418|FG001|Overall Study|Other Reasons|0|||
162657496|NCT01420081|587458419|FG002|Overall Study|Other Reasons|1|||
162657497|NCT01420081|587458420|FG003|Overall Study|Other Reasons|0|||
162657498|NCT01420081|587458421|FG004|Overall Study|Other Reasons|0|||
162657499|NCT01420081|587458422|FG005|Overall Study|Other Reasons|0|||
162657500|NCT01420081|587458423|FG006|Overall Study|Other Reasons|0|||
162657501|NCT01420081|587458424|FG007|Overall Study|Other Reasons|0|||
162657502|NCT01420081|587458425|FG008|Overall Study|Other Reasons|0|||
162657503|NCT00678561|587458427|FG000|Overall Study|Adverse Event|0|||
162657504|NCT00678561|587458428|FG001|Overall Study|Adverse Event|1|||
162657505|NCT00678561|587458429|FG002|Overall Study|Adverse Event|1|||
162657506|NCT00678561|587458430|FG003|Overall Study|Adverse Event|0|||
162657507|NCT00678561|587458431|FG004|Overall Study|Adverse Event|1|||
162657508|NCT00678561|587458432|FG005|Overall Study|Adverse Event|0|||
162657509|NCT00678561|587458433|FG006|Overall Study|Adverse Event|0|||
162657510|NCT00678561|587458434|FG007|Overall Study|Adverse Event|0|||
162657511|NCT00678561|587458427|FG000|Overall Study|Protocol Violation|0|||
162657512|NCT00678561|587458428|FG001|Overall Study|Protocol Violation|0|||
162657513|NCT00678561|587458429|FG002|Overall Study|Protocol Violation|0|||
162657514|NCT00678561|587458430|FG003|Overall Study|Protocol Violation|0|||
162657515|NCT00678561|587458431|FG004|Overall Study|Protocol Violation|1|||
162657516|NCT00678561|587458432|FG005|Overall Study|Protocol Violation|1|||
162657517|NCT00678561|587458433|FG006|Overall Study|Protocol Violation|0|||
162657518|NCT00678561|587458434|FG007|Overall Study|Protocol Violation|0|||
162657519|NCT00678561|587458427|FG000|Overall Study|Withdrawal by Subject|0|||
162657520|NCT00678561|587458428|FG001|Overall Study|Withdrawal by Subject|0|||
162657521|NCT00678561|587458429|FG002|Overall Study|Withdrawal by Subject|0|||
162657522|NCT00678561|587458430|FG003|Overall Study|Withdrawal by Subject|0|||
162657523|NCT00678561|587458431|FG004|Overall Study|Withdrawal by Subject|0|||
162657524|NCT00678561|587458432|FG005|Overall Study|Withdrawal by Subject|0|||
162657525|NCT00678561|587458433|FG006|Overall Study|Withdrawal by Subject|0|||
162657526|NCT00678561|587458434|FG007|Overall Study|Withdrawal by Subject|1|||
162657527|NCT03080961|587458435|FG000|Overall Study|Withdrawal by Subject|3|||
162657528|NCT03508219|587458438|FG000|Overall Study|Death|2|||
162657529|NCT03508219|587458438|FG000|Overall Study|Withdrawal by Subject|1|||
162657530|NCT03508219|587458438|FG000|Overall Study|Lost to Follow-up|4|||
162657531|NCT03508219|587458438|FG000|Overall Study|Missed visit|2|||
163130421|NCT02688985|589186283|FG004|Overall Study|Lack of Efficacy|1|||
163130422|NCT02688985|589186279|FG000|Overall Study|Lost to Follow-up|2|||
163130423|NCT02688985|589186280|FG001|Overall Study|Lost to Follow-up|0|||
163130424|NCT02688985|589186281|FG002|Overall Study|Lost to Follow-up|1|||
163130425|NCT02688985|589186282|FG003|Overall Study|Lost to Follow-up|1|||
162657532|NCT04466891|587458439|FG000|Overall Study|Death|60|||
162657533|NCT04466891|587458440|FG001|Overall Study|Death|6|||
162657534|NCT04466891|587458439|FG000|Overall Study|Withdrawal by Subject|8|||
163130426|NCT02688985|589186283|FG004|Overall Study|Lost to Follow-up|1|||
163130427|NCT02688985|589186279|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163130428|NCT02688985|589186280|FG001|Overall Study|Non-Compliance With Study Drug|3|||
163130429|NCT02688985|589186281|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162657535|NCT04466891|587458440|FG001|Overall Study|Withdrawal by Subject|1|||
162657536|NCT04466891|587458439|FG000|Overall Study|Study terminated by sponsor|5|||
162657537|NCT04466891|587458440|FG001|Overall Study|Study terminated by sponsor|0|||
163130430|NCT02688985|589186282|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163130431|NCT02688985|589186283|FG004|Overall Study|Non-Compliance With Study Drug|1|||
163130432|NCT02688985|589186279|FG000|Overall Study|Other|3|||
163130433|NCT02688985|589186280|FG001|Overall Study|Other|4|||
163130434|NCT02688985|589186281|FG002|Overall Study|Other|1|||
163130435|NCT02688985|589186282|FG003|Overall Study|Other|0|||
163130436|NCT02688985|589186283|FG004|Overall Study|Other|0|||
163130437|NCT02688985|589186279|FG000|Overall Study|Physician Decision|2|||
163130438|NCT02688985|589186280|FG001|Overall Study|Physician Decision|2|||
163130439|NCT02688985|589186281|FG002|Overall Study|Physician Decision|0|||
163130440|NCT02688985|589186282|FG003|Overall Study|Physician Decision|0|||
163130441|NCT02688985|589186283|FG004|Overall Study|Physician Decision|1|||
163130442|NCT02688985|589186279|FG000|Overall Study|Pregnancy|0|||
163130443|NCT02688985|589186280|FG001|Overall Study|Pregnancy|0|||
163130444|NCT02688985|589186281|FG002|Overall Study|Pregnancy|2|||
163130445|NCT02688985|589186282|FG003|Overall Study|Pregnancy|1|||
163130446|NCT02688985|589186283|FG004|Overall Study|Pregnancy|0|||
163130447|NCT02688985|589186279|FG000|Overall Study|Study Terminated By Sponsor|0|||
163130448|NCT02688985|589186280|FG001|Overall Study|Study Terminated By Sponsor|0|||
163130449|NCT02688985|589186281|FG002|Overall Study|Study Terminated By Sponsor|0|||
163130450|NCT02688985|589186282|FG003|Overall Study|Study Terminated By Sponsor|1|||
163130451|NCT02688985|589186283|FG004|Overall Study|Study Terminated By Sponsor|0|||
163130452|NCT02688985|589186279|FG000|Overall Study|Withdrawal by Subject|2|||
163130453|NCT02688985|589186280|FG001|Overall Study|Withdrawal by Subject|8|||
163130454|NCT02688985|589186281|FG002|Overall Study|Withdrawal by Subject|7|||
163130455|NCT02688985|589186282|FG003|Overall Study|Withdrawal by Subject|1|||
163130456|NCT02688985|589186283|FG004|Overall Study|Withdrawal by Subject|4|||
163130457|NCT01964963|589186286|FG000|Overall Study|Case Report Forms Uncollected|888|||
163130458|NCT01964963|589186286|FG000|Overall Study|Protocol Deviation|50|||
163130459|NCT01964963|589186286|FG000|Overall Study|Data Reliability was not Assured|5|||
163130460|NCT00930553|589186287|FG000|Overall Study|Adverse Event|1|||
163130461|NCT00930553|589186287|FG000|Overall Study|Lack of Efficacy|7|||
163130462|NCT00930553|589186287|FG000|Overall Study|Physician Decision|39|||
163130463|NCT00930553|589186287|FG000|Overall Study|Protocol Violation|1|||
163130464|NCT00930553|589186287|FG000|Overall Study|Pregnancy|1|||
163130465|NCT00930553|589186287|FG000|Overall Study|Withdrawal by Subject|88|||
163130466|NCT00930553|589186287|FG000|Overall Study|Lost to Follow-up|25|||
163130467|NCT00930553|589186287|FG000|Overall Study|Death|9|||
163130468|NCT00930553|589186287|FG000|Overall Study|Study terminated by sponsor|24|||
163130469|NCT00930553|589186287|FG000|Overall Study|Other than specified above|28|||
163130470|NCT01726582|589186288|FG000|Overall Study|Physician Decision|99|||
163130471|NCT01726582|589186288|FG000|Overall Study|Death|85|||
163130472|NCT01235234|589186289|FG000|Overall Study|Adverse Event|2|||
163130473|NCT01235234|589186290|FG001|Overall Study|Adverse Event|2|||
163130474|NCT01235234|589186291|FG002|Overall Study|Adverse Event|1|||
163130475|NCT02630472|589186292|FG000|Overall Study|Physician Decision|10|||
163130476|NCT02630472|589186293|FG001|Overall Study|Physician Decision|0|||
163130477|NCT01832155|589186298|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
163130478|NCT01832155|589186299|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
163130479|NCT01832155|589186298|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
163130480|NCT01832155|589186299|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
163130481|NCT00787189|589186300|FG000|Overall Study|Lost to Follow-up|2|||
163130482|NCT00787189|589186301|FG001|Overall Study|Lost to Follow-up|2|||
163130483|NCT01279616|589186302|FG000|Overall Study|donor could not be located|5|||
163130484|NCT01279616|589186302|FG000|Overall Study|no signs of sickle cell disease|2|||
163130485|NCT00842543|589186305|FG000|Overall Study|Withdrawal by Subject|2|||
163130486|NCT00842543|589186306|FG001|Overall Study|Withdrawal by Subject|0|||
163130487|NCT00842543|589186307|FG002|Overall Study|Withdrawal by Subject|3|||
163130488|NCT00842543|589186308|FG003|Overall Study|Withdrawal by Subject|4|||
163130489|NCT01483183|589186313|FG000|Overall Study|Physician Decision|0|||
163130490|NCT01483183|589186314|FG001|Overall Study|Physician Decision|0|||
163130491|NCT01483183|589186315|FG002|Overall Study|Physician Decision|0|||
163130492|NCT01483183|589186316|FG003|Overall Study|Physician Decision|0|||
163130493|NCT01483183|589186317|FG004|Overall Study|Physician Decision|0|||
163130494|NCT01483183|589186318|FG005|Overall Study|Physician Decision|0|||
163130495|NCT01483183|589186319|FG006|Overall Study|Physician Decision|2|||
163130496|NCT01483183|589186320|FG007|Overall Study|Physician Decision|0|||
163130497|NCT01483183|589186321|FG008|Overall Study|Physician Decision|0|||
163130498|NCT01483183|589186322|FG009|Overall Study|Physician Decision|0|||
163130499|NCT01483183|589186313|FG000|Overall Study|Withdrawal by Subject|0|||
163130500|NCT01483183|589186314|FG001|Overall Study|Withdrawal by Subject|0|||
163130501|NCT01483183|589186315|FG002|Overall Study|Withdrawal by Subject|0|||
163130502|NCT01483183|589186316|FG003|Overall Study|Withdrawal by Subject|0|||
163130503|NCT01483183|589186317|FG004|Overall Study|Withdrawal by Subject|0|||
163130504|NCT01483183|589186318|FG005|Overall Study|Withdrawal by Subject|0|||
163130505|NCT01483183|589186319|FG006|Overall Study|Withdrawal by Subject|0|||
163130506|NCT01483183|589186320|FG007|Overall Study|Withdrawal by Subject|0|||
163130507|NCT01483183|589186321|FG008|Overall Study|Withdrawal by Subject|0|||
163130508|NCT01483183|589186322|FG009|Overall Study|Withdrawal by Subject|1|||
163130509|NCT00239928|589186323|FG000|Overall Study|Lack of Efficacy|1|||
163130510|NCT00239928|589186323|FG000|Overall Study|Adverse Event|4|||
163130511|NCT00239928|589186323|FG000|Overall Study|Not need to continue study|3|||
163130512|NCT00239928|589186323|FG000|Overall Study|Withdrawal by Subject|2|||
163130513|NCT04302545|589186333|FG000|Overall Study|Lost to Follow-up|3|||
163130514|NCT04302545|589186334|FG001|Overall Study|Lost to Follow-up|4|||
163130515|NCT02516592|589186335|FG000|Overall Study|Patient withdrew consent|5|||
163130516|NCT02516592|589186336|FG001|Overall Study|Patient withdrew consent|2|||
163130517|NCT02516592|589186335|FG000|Overall Study|Protocol deviation|4|||
163130518|NCT02516592|589186336|FG001|Overall Study|Protocol deviation|4|||
163130519|NCT02516592|589186335|FG000|Overall Study|Lost to Follow-up|2|||
163130520|NCT02516592|589186336|FG001|Overall Study|Lost to Follow-up|3|||
163130521|NCT02516592|589186335|FG000|Overall Study|Patient/guardian decision|2|||
163130522|NCT02516592|589186336|FG001|Overall Study|Patient/guardian decision|1|||
163130523|NCT02516592|589186335|FG000|Overall Study|Adverse Event|1|||
163130524|NCT02516592|589186336|FG001|Overall Study|Adverse Event|2|||
163130525|NCT02516592|589186335|FG000|Overall Study|Abnormal test procedure result|1|||
163130526|NCT02516592|589186336|FG001|Overall Study|Abnormal test procedure result|0|||
163130527|NCT02516592|589186335|FG000|Overall Study|Death|1|||
163130528|NCT02516592|589186336|FG001|Overall Study|Death|1|||
163130529|NCT00300365|589186338|FG000|Overall Study|Lost to Follow-up|1|||
163130530|NCT00300365|589186339|FG001|Overall Study|Lost to Follow-up|0|||
163130531|NCT00300365|589186338|FG000|Overall Study|Physician Decision|2|||
163130532|NCT00300365|589186339|FG001|Overall Study|Physician Decision|0|||
163130533|NCT00300365|589186338|FG000|Overall Study|Withdrawal by Subject|1|||
163130534|NCT00300365|589186339|FG001|Overall Study|Withdrawal by Subject|0|||
163130535|NCT00300365|589186338|FG000|Overall Study|Adverse Event|0|||
163130536|NCT00300365|589186339|FG001|Overall Study|Adverse Event|2|||
163130537|NCT00764673|589186341|FG000|Overall Study|Death|1|||
163130538|NCT00764673|589186341|FG000|Overall Study|Lost to Follow-up|3|||
163130539|NCT00764673|589186341|FG000|Overall Study|Withdrawal by Subject|6|||
163130540|NCT00764673|589186341|FG000|Overall Study|Revision of Device|2|||
163130541|NCT01438177|589186342|FG000|Overall Study|Withdrawal by Subject|1|||
163130542|NCT01438177|589186342|FG000|Overall Study|Initiation of new therapy|1|||
163130543|NCT01727336|589186343|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130544|NCT01727336|589186344|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
163130545|NCT01727336|589186345|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
163130546|NCT01727336|589186346|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130547|NCT01727336|589186347|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130548|NCT01727336|589186348|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
163130549|NCT01727336|589186343|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
163130550|NCT01727336|589186344|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
163130551|NCT01727336|589186345|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
163130552|NCT01727336|589186346|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130553|NCT01727336|589186347|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130554|NCT01727336|589186348|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
163130555|NCT01727336|589186343|FG000|Part 2 Blinded|Death|0|||
163130556|NCT01727336|589186344|FG001|Part 2 Blinded|Death|0|||
163130557|NCT01727336|589186345|FG002|Part 2 Blinded|Death|0|||
163130558|NCT01727336|589186346|FG003|Part 2 Blinded|Death|0|||
163130559|NCT01727336|589186347|FG004|Part 2 Blinded|Death|20|||
163130560|NCT01727336|589186348|FG005|Part 2 Blinded|Death|16|||
163130561|NCT01727336|589186343|FG000|Part 2 Blinded|Lack of Efficacy|0|||
163130562|NCT01727336|589186344|FG001|Part 2 Blinded|Lack of Efficacy|0|||
163130563|NCT01727336|589186345|FG002|Part 2 Blinded|Lack of Efficacy|0|||
163130564|NCT01727336|589186346|FG003|Part 2 Blinded|Lack of Efficacy|0|||
163130565|NCT01727336|589186347|FG004|Part 2 Blinded|Lack of Efficacy|42|||
163130566|NCT01727336|589186348|FG005|Part 2 Blinded|Lack of Efficacy|44|||
163130567|NCT01727336|589186343|FG000|Part 2 Blinded|Lost to Follow-up|0|||
163130568|NCT01727336|589186344|FG001|Part 2 Blinded|Lost to Follow-up|0|||
163130569|NCT01727336|589186345|FG002|Part 2 Blinded|Lost to Follow-up|0|||
162657538|NCT04466891|587458439|FG000|Overall Study|Lost to Follow-up|2|||
162657539|NCT04466891|587458440|FG001|Overall Study|Lost to Follow-up|0|||
163130570|NCT01727336|589186346|FG003|Part 2 Blinded|Lost to Follow-up|0|||
163130571|NCT01727336|589186347|FG004|Part 2 Blinded|Lost to Follow-up|0|||
163130572|NCT01727336|589186348|FG005|Part 2 Blinded|Lost to Follow-up|1|||
163130573|NCT01727336|589186343|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
163130574|NCT01727336|589186344|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
163130575|NCT01727336|589186345|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
163130576|NCT01727336|589186346|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
163130577|NCT01727336|589186347|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
163130578|NCT01727336|589186348|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
163130579|NCT01727336|589186343|FG000|Part 2 Blinded|use of prohibited medications|0|||
163130580|NCT01727336|589186344|FG001|Part 2 Blinded|use of prohibited medications|0|||
163130581|NCT01727336|589186345|FG002|Part 2 Blinded|use of prohibited medications|0|||
163130582|NCT01727336|589186346|FG003|Part 2 Blinded|use of prohibited medications|0|||
163130583|NCT01727336|589186347|FG004|Part 2 Blinded|use of prohibited medications|1|||
163130584|NCT01727336|589186348|FG005|Part 2 Blinded|use of prohibited medications|3|||
163130585|NCT00619099|589186349|FG000|Overall Study|Progressive Disease|7|||
163130586|NCT00619099|589186350|FG001|Overall Study|Progressive Disease|5|||
163130587|NCT00619099|589186349|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
163130588|NCT00619099|589186350|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
163130589|NCT00619099|589186349|FG000|Overall Study|Adverse Event|4|||
163130590|NCT00619099|589186350|FG001|Overall Study|Adverse Event|3|||
163130591|NCT00619099|589186349|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
163130592|NCT00619099|589186350|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
163130593|NCT00619099|589186349|FG000|Overall Study|Withdrawal by Subject|10|||
163130594|NCT00619099|589186350|FG001|Overall Study|Withdrawal by Subject|2|||
163130595|NCT00619099|589186349|FG000|Overall Study|Physician Decision|9|||
163130596|NCT00619099|589186350|FG001|Overall Study|Physician Decision|6|||
163130597|NCT04058886|589186353|FG000|Overall Study|Withdrawal by Subject|4|||
163130598|NCT04058886|589186353|FG000|Overall Study|Inadequate deafness interpreter service|1|||
163130599|NCT00699335|589186356|FG000|Overall Study|Combination of multiple reasons|176|||
163130600|NCT00699335|589186356|FG000|Overall Study|Missing data|52|||
163130601|NCT01717326|589186365|FG000|Overall Study|Death|0|||
163130602|NCT01717326|589186366|FG001|Overall Study|Death|0|||
163130603|NCT01717326|589186367|FG002|Overall Study|Death|0|||
163130604|NCT01717326|589186368|FG003|Overall Study|Death|0|||
163130605|NCT01717326|589186369|FG004|Overall Study|Death|0|||
163130606|NCT01717326|589186370|FG005|Overall Study|Death|0|||
163130607|NCT01717326|589186371|FG006|Overall Study|Death|0|||
163130608|NCT01717326|589186372|FG007|Overall Study|Death|0|||
163130609|NCT01717326|589186373|FG008|Overall Study|Death|0|||
163130610|NCT01717326|589186374|FG009|Overall Study|Death|0|||
163130611|NCT01717326|589186375|FG010|Overall Study|Death|1|||
163130612|NCT01717326|589186376|FG011|Overall Study|Death|0|||
163130613|NCT01717326|589186377|FG012|Overall Study|Death|0|||
163130614|NCT01717326|589186378|FG013|Overall Study|Death|0|||
163130615|NCT01717326|589186379|FG014|Overall Study|Death|0|||
163130616|NCT01717326|589186380|FG015|Overall Study|Death|0|||
163130617|NCT01717326|589186381|FG016|Overall Study|Death|0|||
163130618|NCT01717326|589186382|FG017|Overall Study|Death|0|||
163130619|NCT01717326|589186383|FG018|Overall Study|Death|0|||
163130620|NCT01717326|589186384|FG019|Overall Study|Death|0|||
163130621|NCT01717326|589186365|FG000|Overall Study|Lost to Follow-up|3|||
163130622|NCT01717326|589186366|FG001|Overall Study|Lost to Follow-up|0|||
163130623|NCT01717326|589186367|FG002|Overall Study|Lost to Follow-up|0|||
163130624|NCT01717326|589186368|FG003|Overall Study|Lost to Follow-up|2|||
163130625|NCT01717326|589186369|FG004|Overall Study|Lost to Follow-up|1|||
163130626|NCT01717326|589186370|FG005|Overall Study|Lost to Follow-up|0|||
163130627|NCT01717326|589186371|FG006|Overall Study|Lost to Follow-up|1|||
163130628|NCT01717326|589186372|FG007|Overall Study|Lost to Follow-up|0|||
163130629|NCT01717326|589186373|FG008|Overall Study|Lost to Follow-up|0|||
163130630|NCT01717326|589186374|FG009|Overall Study|Lost to Follow-up|0|||
163130631|NCT01717326|589186375|FG010|Overall Study|Lost to Follow-up|1|||
163130632|NCT01717326|589186376|FG011|Overall Study|Lost to Follow-up|0|||
163130633|NCT01717326|589186377|FG012|Overall Study|Lost to Follow-up|0|||
163130634|NCT01717326|589186378|FG013|Overall Study|Lost to Follow-up|0|||
163130635|NCT01717326|589186379|FG014|Overall Study|Lost to Follow-up|0|||
163130636|NCT01717326|589186380|FG015|Overall Study|Lost to Follow-up|2|||
163130637|NCT01717326|589186381|FG016|Overall Study|Lost to Follow-up|1|||
163130638|NCT01717326|589186382|FG017|Overall Study|Lost to Follow-up|0|||
163130639|NCT01717326|589186383|FG018|Overall Study|Lost to Follow-up|2|||
163130640|NCT01717326|589186384|FG019|Overall Study|Lost to Follow-up|3|||
163130641|NCT01717326|589186365|FG000|Overall Study|Physician Decision|0|||
163130642|NCT01717326|589186366|FG001|Overall Study|Physician Decision|0|||
163130643|NCT01717326|589186367|FG002|Overall Study|Physician Decision|0|||
163130644|NCT01717326|589186368|FG003|Overall Study|Physician Decision|0|||
163130645|NCT01717326|589186369|FG004|Overall Study|Physician Decision|0|||
163130646|NCT01717326|589186370|FG005|Overall Study|Physician Decision|0|||
162719797|NCT02908464|587680583|FG000|Overall Study|Found ineligible after randomization|0|||
163130647|NCT01717326|589186371|FG006|Overall Study|Physician Decision|0|||
163130648|NCT01717326|589186372|FG007|Overall Study|Physician Decision|0|||
163130649|NCT01717326|589186373|FG008|Overall Study|Physician Decision|0|||
163130650|NCT01717326|589186374|FG009|Overall Study|Physician Decision|1|||
163130651|NCT01717326|589186375|FG010|Overall Study|Physician Decision|0|||
163130652|NCT01717326|589186376|FG011|Overall Study|Physician Decision|0|||
163130653|NCT01717326|589186377|FG012|Overall Study|Physician Decision|0|||
163130654|NCT01717326|589186378|FG013|Overall Study|Physician Decision|0|||
163130655|NCT01717326|589186379|FG014|Overall Study|Physician Decision|0|||
163130656|NCT01717326|589186380|FG015|Overall Study|Physician Decision|0|||
163130657|NCT01717326|589186381|FG016|Overall Study|Physician Decision|0|||
163130658|NCT01717326|589186382|FG017|Overall Study|Physician Decision|0|||
163130659|NCT01717326|589186383|FG018|Overall Study|Physician Decision|0|||
163130660|NCT01717326|589186384|FG019|Overall Study|Physician Decision|0|||
163130661|NCT01717326|589186365|FG000|Overall Study|Protocol Violation|0|||
163130662|NCT01717326|589186366|FG001|Overall Study|Protocol Violation|0|||
162657540|NCT04466891|587458439|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
162657541|NCT04466891|587458440|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
162657542|NCT00445328|587458441|FG000|Overall Study|Death|0|||
162657543|NCT00445328|587458442|FG001|Overall Study|Death|1|||
162657544|NCT00445328|587458441|FG000|Overall Study|Adverse Event|0|||
162657545|NCT00445328|587458442|FG001|Overall Study|Adverse Event|3|||
162657546|NCT00445328|587458441|FG000|Overall Study|Other|0|||
162657547|NCT00445328|587458442|FG001|Overall Study|Other|2|||
162657548|NCT00445328|587458441|FG000|Overall Study|Withdrawal by Subject|2|||
162657549|NCT00445328|587458442|FG001|Overall Study|Withdrawal by Subject|0|||
162657550|NCT00445328|587458441|FG000|Overall Study|Protocol Violation|1|||
162657551|NCT00445328|587458442|FG001|Overall Study|Protocol Violation|0|||
162657552|NCT03107988|587459655|FG000|Overall Study|Adverse Event|0|||
162657553|NCT03107988|587459656|FG001|Overall Study|Adverse Event|0|||
162657554|NCT03107988|587459657|FG002|Overall Study|Adverse Event|0|||
162657555|NCT03107988|587459658|FG003|Overall Study|Adverse Event|1|||
163130663|NCT01717326|589186367|FG002|Overall Study|Protocol Violation|0|||
163130664|NCT01717326|589186368|FG003|Overall Study|Protocol Violation|0|||
163130665|NCT01717326|589186369|FG004|Overall Study|Protocol Violation|1|||
163130666|NCT01717326|589186370|FG005|Overall Study|Protocol Violation|0|||
163130667|NCT01717326|589186371|FG006|Overall Study|Protocol Violation|0|||
163130668|NCT01717326|589186372|FG007|Overall Study|Protocol Violation|0|||
163130669|NCT01717326|589186373|FG008|Overall Study|Protocol Violation|0|||
163130670|NCT01717326|589186374|FG009|Overall Study|Protocol Violation|0|||
163130671|NCT01717326|589186375|FG010|Overall Study|Protocol Violation|0|||
163130672|NCT01717326|589186376|FG011|Overall Study|Protocol Violation|0|||
163130673|NCT01717326|589186377|FG012|Overall Study|Protocol Violation|0|||
163130674|NCT01717326|589186378|FG013|Overall Study|Protocol Violation|0|||
163130675|NCT01717326|589186379|FG014|Overall Study|Protocol Violation|0|||
163130676|NCT01717326|589186380|FG015|Overall Study|Protocol Violation|0|||
163130677|NCT01717326|589186381|FG016|Overall Study|Protocol Violation|0|||
163130678|NCT01717326|589186382|FG017|Overall Study|Protocol Violation|0|||
163130679|NCT01717326|589186383|FG018|Overall Study|Protocol Violation|0|||
163130680|NCT01717326|589186384|FG019|Overall Study|Protocol Violation|0|||
163130681|NCT01717326|589186365|FG000|Overall Study|Withdrawal by Subject|0|||
163130682|NCT01717326|589186366|FG001|Overall Study|Withdrawal by Subject|1|||
163130683|NCT01717326|589186367|FG002|Overall Study|Withdrawal by Subject|0|||
163130684|NCT01717326|589186368|FG003|Overall Study|Withdrawal by Subject|0|||
163130685|NCT01717326|589186369|FG004|Overall Study|Withdrawal by Subject|0|||
163130686|NCT01717326|589186370|FG005|Overall Study|Withdrawal by Subject|0|||
163130687|NCT01717326|589186371|FG006|Overall Study|Withdrawal by Subject|0|||
163130688|NCT01717326|589186372|FG007|Overall Study|Withdrawal by Subject|0|||
163130689|NCT01717326|589186373|FG008|Overall Study|Withdrawal by Subject|0|||
163130690|NCT01717326|589186374|FG009|Overall Study|Withdrawal by Subject|1|||
163130691|NCT01717326|589186375|FG010|Overall Study|Withdrawal by Subject|0|||
163130692|NCT01717326|589186376|FG011|Overall Study|Withdrawal by Subject|0|||
163130693|NCT01717326|589186377|FG012|Overall Study|Withdrawal by Subject|1|||
163130694|NCT01717326|589186378|FG013|Overall Study|Withdrawal by Subject|0|||
163130695|NCT01717326|589186379|FG014|Overall Study|Withdrawal by Subject|0|||
163130696|NCT01717326|589186380|FG015|Overall Study|Withdrawal by Subject|1|||
163130697|NCT01717326|589186381|FG016|Overall Study|Withdrawal by Subject|0|||
163130698|NCT01717326|589186382|FG017|Overall Study|Withdrawal by Subject|0|||
163130699|NCT01717326|589186383|FG018|Overall Study|Withdrawal by Subject|2|||
163130700|NCT01717326|589186384|FG019|Overall Study|Withdrawal by Subject|3|||
163130701|NCT01299116|589186385|FG000|Overall Study|Lost to Follow-up|65|||
163130702|NCT01299116|589186386|FG001|Overall Study|Lost to Follow-up|9|||
163130703|NCT01299116|589186387|FG002|Overall Study|Lost to Follow-up|11|||
163130704|NCT00488826|589186392|FG000|Overall Study|Withdrawal by Subject|40|||
163130705|NCT00488826|589186393|FG001|Overall Study|Withdrawal by Subject|35|||
163130706|NCT00488826|589186394|FG002|Overall Study|Withdrawal by Subject|19|||
163130707|NCT00488826|589186392|FG000|Overall Study|Protocol Violation|0|||
163130708|NCT00488826|589186393|FG001|Overall Study|Protocol Violation|0|||
163130709|NCT00488826|589186394|FG002|Overall Study|Protocol Violation|2|||
163130710|NCT00488826|589186392|FG000|Overall Study|Adverse Event|9|||
163130711|NCT00488826|589186393|FG001|Overall Study|Adverse Event|15|||
163130712|NCT00488826|589186394|FG002|Overall Study|Adverse Event|4|||
163130713|NCT00488826|589186392|FG000|Overall Study|Lost to Follow-up|5|||
163130714|NCT00488826|589186393|FG001|Overall Study|Lost to Follow-up|1|||
163130715|NCT00488826|589186394|FG002|Overall Study|Lost to Follow-up|0|||
163130716|NCT00488826|589186392|FG000|Overall Study|Protocol Deviations|2|||
163130717|NCT00488826|589186393|FG001|Overall Study|Protocol Deviations|1|||
163130718|NCT00488826|589186394|FG002|Overall Study|Protocol Deviations|1|||
163130719|NCT02974842|589186397|FG000|Overall Study|Withdrawal by Subject|4|||
163130720|NCT02974842|589186397|FG000|Overall Study|Screen failures|4|||
163130721|NCT01959243|589186398|FG000|Overall Study|Investigator Decision|3|||
163130722|NCT01959243|589186399|FG001|Overall Study|Investigator Decision|0|||
163130723|NCT01959243|589186398|FG000|Overall Study|Adverse Event|5|||
163130724|NCT01959243|589186399|FG001|Overall Study|Adverse Event|2|||
163130725|NCT01959243|589186398|FG000|Overall Study|Administrative reasons|2|||
163130726|NCT01959243|589186399|FG001|Overall Study|Administrative reasons|1|||
163130727|NCT01959243|589186398|FG000|Overall Study|Lost to Follow-up|3|||
163130728|NCT01959243|589186399|FG001|Overall Study|Lost to Follow-up|1|||
163130729|NCT00812565|589186402|FG000|Overall Study|Did Not Receive Study Medication|1|||
163130730|NCT00812565|589186403|FG001|Overall Study|Did Not Receive Study Medication|1|||
163130731|NCT00812565|589186404|FG002|Overall Study|Did Not Receive Study Medication|0|||
163130732|NCT00812565|589186405|FG003|Overall Study|Did Not Receive Study Medication|0|||
163130733|NCT00812565|589186406|FG004|Overall Study|Did Not Receive Study Medication|0|||
163130734|NCT00812565|589186407|FG005|Overall Study|Did Not Receive Study Medication|0|||
162657556|NCT03107988|587459659|FG004|Overall Study|Adverse Event|0|||
162657557|NCT03107988|587459660|FG005|Overall Study|Adverse Event|1|||
163130735|NCT00812565|589186408|FG006|Overall Study|Did Not Receive Study Medication|0|||
163130736|NCT00812565|589186409|FG007|Overall Study|Did Not Receive Study Medication|0|||
163130737|NCT00812565|589186402|FG000|Overall Study|Adverse Event|0|||
163130738|NCT00812565|589186403|FG001|Overall Study|Adverse Event|0|||
163130739|NCT00812565|589186404|FG002|Overall Study|Adverse Event|0|||
163130740|NCT00812565|589186405|FG003|Overall Study|Adverse Event|2|||
163130741|NCT00812565|589186406|FG004|Overall Study|Adverse Event|0|||
163130742|NCT00812565|589186407|FG005|Overall Study|Adverse Event|0|||
163130743|NCT00812565|589186408|FG006|Overall Study|Adverse Event|0|||
163130744|NCT00812565|589186409|FG007|Overall Study|Adverse Event|1|||
163130745|NCT00812565|589186402|FG000|Overall Study|Did Not Come to Study Visit|1|||
163130746|NCT00812565|589186403|FG001|Overall Study|Did Not Come to Study Visit|0|||
163130747|NCT00812565|589186404|FG002|Overall Study|Did Not Come to Study Visit|0|||
163130748|NCT00812565|589186405|FG003|Overall Study|Did Not Come to Study Visit|0|||
163130749|NCT00812565|589186406|FG004|Overall Study|Did Not Come to Study Visit|0|||
163130750|NCT00812565|589186407|FG005|Overall Study|Did Not Come to Study Visit|0|||
163130751|NCT00812565|589186408|FG006|Overall Study|Did Not Come to Study Visit|0|||
163130752|NCT00812565|589186409|FG007|Overall Study|Did Not Come to Study Visit|0|||
163130753|NCT00812565|589186402|FG000|Overall Study|Withdrawal of Consent|1|||
163130754|NCT00812565|589186403|FG001|Overall Study|Withdrawal of Consent|0|||
163130755|NCT00812565|589186404|FG002|Overall Study|Withdrawal of Consent|0|||
163130756|NCT00812565|589186405|FG003|Overall Study|Withdrawal of Consent|0|||
163130757|NCT00812565|589186406|FG004|Overall Study|Withdrawal of Consent|1|||
163130758|NCT00812565|589186407|FG005|Overall Study|Withdrawal of Consent|0|||
163130759|NCT00812565|589186408|FG006|Overall Study|Withdrawal of Consent|0|||
163130760|NCT00812565|589186409|FG007|Overall Study|Withdrawal of Consent|0|||
163130761|NCT00812565|589186402|FG000|Overall Study|Reason Not Specified|0|||
163130762|NCT00812565|589186403|FG001|Overall Study|Reason Not Specified|0|||
163130763|NCT00812565|589186404|FG002|Overall Study|Reason Not Specified|0|||
163130764|NCT00812565|589186405|FG003|Overall Study|Reason Not Specified|0|||
163130765|NCT00812565|589186406|FG004|Overall Study|Reason Not Specified|0|||
163130766|NCT00812565|589186407|FG005|Overall Study|Reason Not Specified|1|||
163130767|NCT00812565|589186408|FG006|Overall Study|Reason Not Specified|0|||
163130768|NCT00812565|589186409|FG007|Overall Study|Reason Not Specified|0|||
163130769|NCT02596945|589186410|FG000|Overall Study|No documentation of study drug dosing|3|||
163130770|NCT02596945|589186410|FG000|Overall Study|Other|32|||
163130771|NCT02596945|589186410|FG000|Overall Study|Change to hemodialysis|15|||
163130772|NCT02596945|589186410|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
163130773|NCT02596945|589186410|FG000|Overall Study|Withdrawal by Subject|1|||
163130774|NCT02596945|589186410|FG000|Overall Study|Missing|1|||
163130775|NCT00422383|589186411|FG000|Overall Study|Adverse Event|5|||
163130776|NCT00422383|589186412|FG001|Overall Study|Adverse Event|3|||
163130777|NCT00422383|589186413|FG002|Overall Study|Adverse Event|1|||
163130778|NCT00422383|589186414|FG003|Overall Study|Adverse Event|1|||
163130779|NCT00422383|589186415|FG004|Overall Study|Adverse Event|0|||
163130780|NCT00422383|589186411|FG000|Overall Study|Lack of Efficacy|4|||
163130781|NCT00422383|589186412|FG001|Overall Study|Lack of Efficacy|4|||
163130782|NCT00422383|589186413|FG002|Overall Study|Lack of Efficacy|2|||
163130783|NCT00422383|589186414|FG003|Overall Study|Lack of Efficacy|1|||
163130784|NCT00422383|589186415|FG004|Overall Study|Lack of Efficacy|1|||
163130785|NCT00422383|589186411|FG000|Overall Study|Lost to Follow-up|0|||
163130786|NCT00422383|589186412|FG001|Overall Study|Lost to Follow-up|1|||
163130787|NCT00422383|589186413|FG002|Overall Study|Lost to Follow-up|0|||
163130788|NCT00422383|589186414|FG003|Overall Study|Lost to Follow-up|0|||
163130789|NCT00422383|589186415|FG004|Overall Study|Lost to Follow-up|1|||
163130790|NCT00422383|589186411|FG000|Overall Study|Protocol Violation|1|||
163130791|NCT00422383|589186412|FG001|Overall Study|Protocol Violation|1|||
163130792|NCT00422383|589186413|FG002|Overall Study|Protocol Violation|1|||
163130793|NCT00422383|589186414|FG003|Overall Study|Protocol Violation|0|||
163130794|NCT00422383|589186415|FG004|Overall Study|Protocol Violation|0|||
163130795|NCT00422383|589186411|FG000|Overall Study|Withdrawal by Subject|5|||
163130796|NCT00422383|589186412|FG001|Overall Study|Withdrawal by Subject|5|||
163130797|NCT00422383|589186413|FG002|Overall Study|Withdrawal by Subject|0|||
163130798|NCT00422383|589186414|FG003|Overall Study|Withdrawal by Subject|0|||
163130799|NCT00422383|589186415|FG004|Overall Study|Withdrawal by Subject|1|||
162719798|NCT02908464|587680584|FG001|Overall Study|Found ineligible after randomization|2|||
163130800|NCT00566254|589186416|FG000|Overall Study|Adverse Event|3|||
163130801|NCT00566254|589186417|FG001|Overall Study|Adverse Event|1|||
163130802|NCT00566254|589186416|FG000|Overall Study|Protocol Violation|1|||
163130803|NCT00566254|589186417|FG001|Overall Study|Protocol Violation|3|||
163130804|NCT00566254|589186416|FG000|Overall Study|Withdrawal by Subject|1|||
163130805|NCT00566254|589186417|FG001|Overall Study|Withdrawal by Subject|2|||
163130806|NCT00566254|589186416|FG000|Overall Study|Lack of Efficacy|5|||
163130807|NCT00566254|589186417|FG001|Overall Study|Lack of Efficacy|6|||
163130808|NCT00566254|589186416|FG000|Overall Study|Other|0|||
163130809|NCT00566254|589186417|FG001|Overall Study|Other|2|||
163130810|NCT00238238|589186418|FG000|Overall Study|Withdrawal by Subject|0|||
163130811|NCT00238238|589186419|FG001|Overall Study|Withdrawal by Subject|3|||
163130812|NCT00238238|589186420|FG002|Overall Study|Withdrawal by Subject|0|||
163130813|NCT01007838|589186421|FG000|Overall Study|Withdrawal by Subject|1|||
163130814|NCT01007838|589186422|FG001|Overall Study|Withdrawal by Subject|0|||
163130815|NCT01007838|589186423|FG002|Overall Study|Withdrawal by Subject|0|||
163130816|NCT01007838|589186424|FG003|Overall Study|Withdrawal by Subject|0|||
163130817|NCT01007838|589186421|FG000|Overall Study|Physician Decision|1|||
163130818|NCT01007838|589186422|FG001|Overall Study|Physician Decision|0|||
163130819|NCT01007838|589186423|FG002|Overall Study|Physician Decision|0|||
163130820|NCT01007838|589186424|FG003|Overall Study|Physician Decision|0|||
163130821|NCT01007838|589186421|FG000|Overall Study|Started home haemodialysis|1|||
163130822|NCT01007838|589186422|FG001|Overall Study|Started home haemodialysis|0|||
163130823|NCT01007838|589186423|FG002|Overall Study|Started home haemodialysis|0|||
163130824|NCT01007838|589186424|FG003|Overall Study|Started home haemodialysis|0|||
163130825|NCT02277119|589186428|FG000|Overall Study|Lack of Efficacy|1|||
163130826|NCT02277119|589186429|FG001|Overall Study|Lack of Efficacy|1|||
163130827|NCT02277119|589186430|FG002|Overall Study|Lack of Efficacy|1|||
163130828|NCT02277119|589186428|FG000|Overall Study|Protocol Violation|2|||
163130829|NCT02277119|589186429|FG001|Overall Study|Protocol Violation|3|||
163130830|NCT02277119|589186430|FG002|Overall Study|Protocol Violation|7|||
163130831|NCT01345669|589186431|FG000|Overall Study|Primary tumour recurrence|53|||
163130832|NCT01345669|589186432|FG001|Overall Study|Primary tumour recurrence|32|||
163130833|NCT01345669|589186431|FG000|Overall Study|Second primary tumour|4|||
163130834|NCT01345669|589186432|FG001|Overall Study|Second primary tumour|3|||
163130835|NCT01345669|589186431|FG000|Overall Study|Adverse Event|63|||
163130836|NCT01345669|589186432|FG001|Overall Study|Adverse Event|9|||
163130837|NCT01345669|589186431|FG000|Overall Study|Protocol Violation|3|||
163130838|NCT01345669|589186432|FG001|Overall Study|Protocol Violation|1|||
163130839|NCT01345669|589186431|FG000|Overall Study|Lost to Follow-up|1|||
163130840|NCT01345669|589186432|FG001|Overall Study|Lost to Follow-up|1|||
163130841|NCT01345669|589186431|FG000|Overall Study|Withdrawal by Subject|52|||
163130842|NCT01345669|589186432|FG001|Overall Study|Withdrawal by Subject|13|||
163130843|NCT01345669|589186431|FG000|Overall Study|Other Reasons|111|||
163130844|NCT01345669|589186432|FG001|Overall Study|Other Reasons|60|||
163130845|NCT04699461|589186433|FG000|Overall Study|Withdrawal by Subject|1|||
163130846|NCT04699461|589186434|FG001|Overall Study|Withdrawal by Subject|0|||
163130847|NCT04699461|589186433|FG000|Overall Study|Study termination by sponsor|2|||
163130848|NCT04699461|589186434|FG001|Overall Study|Study termination by sponsor|1|||
163130849|NCT04699461|589186433|FG000|Overall Study|Death|1|||
163130850|NCT04699461|589186434|FG001|Overall Study|Death|0|||
163130851|NCT04699461|589186433|FG000|Overall Study|Radiographic progression|0|||
163130852|NCT04699461|589186434|FG001|Overall Study|Radiographic progression|1|||
163130853|NCT01793883|589186435|FG000|Overall Study|Withdrawal by Subject|3|||
163130854|NCT01793883|589186436|FG001|Overall Study|Withdrawal by Subject|7|||
163130855|NCT01793883|589186437|FG002|Overall Study|Withdrawal by Subject|3|||
163130856|NCT01793883|589186435|FG000|Overall Study|Subject noncompliance|0|||
163130857|NCT01793883|589186436|FG001|Overall Study|Subject noncompliance|1|||
163130858|NCT01793883|589186437|FG002|Overall Study|Subject noncompliance|1|||
163130859|NCT01793883|589186435|FG000|Overall Study|Lost to Follow-up|5|||
163130860|NCT01793883|589186436|FG001|Overall Study|Lost to Follow-up|1|||
163130861|NCT01793883|589186437|FG002|Overall Study|Lost to Follow-up|3|||
163130862|NCT01793883|589186435|FG000|Overall Study|Randomized in error|1|||
163130863|NCT01793883|589186436|FG001|Overall Study|Randomized in error|0|||
163130864|NCT01793883|589186437|FG002|Overall Study|Randomized in error|0|||
163130865|NCT01793883|589186435|FG000|Overall Study|Unable to complete spriometry|1|||
163130866|NCT01793883|589186436|FG001|Overall Study|Unable to complete spriometry|0|||
163130867|NCT01793883|589186437|FG002|Overall Study|Unable to complete spriometry|0|||
163130868|NCT01793883|589186435|FG000|Overall Study|Unable to complete measurements|1|||
163130869|NCT01793883|589186436|FG001|Overall Study|Unable to complete measurements|0|||
163130870|NCT01793883|589186437|FG002|Overall Study|Unable to complete measurements|0|||
163130871|NCT01793883|589186435|FG000|Overall Study|Met exclusion criteria|1|||
163130872|NCT01793883|589186436|FG001|Overall Study|Met exclusion criteria|0|||
163130873|NCT01793883|589186437|FG002|Overall Study|Met exclusion criteria|0|||
163130874|NCT01793883|589186435|FG000|Overall Study|Dosing error|0|||
163130875|NCT01793883|589186436|FG001|Overall Study|Dosing error|1|||
163130876|NCT01793883|589186437|FG002|Overall Study|Dosing error|0|||
163130877|NCT01793883|589186435|FG000|Overall Study|Respiratory distress during spirometry|0|||
163130878|NCT01793883|589186436|FG001|Overall Study|Respiratory distress during spirometry|0|||
163130879|NCT01793883|589186437|FG002|Overall Study|Respiratory distress during spirometry|1|||
163130880|NCT00761527|589186440|FG000|Overall Study|Adverse Event|3|||
163130881|NCT00761527|589186440|FG000|Overall Study|Poor Compliance|8|||
163130882|NCT00761527|589186440|FG000|Overall Study|Lost to Follow-up|9|||
163130883|NCT00761527|589186440|FG000|Overall Study|Unknown reason|2|||
163130884|NCT02301624|589186443|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
163130885|NCT02301624|589186444|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
163130886|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
162719799|NCT01769391|587680587|FG000|Overall Study|Death|10|||
163130887|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
163130888|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Adverse Event|2|||
163130889|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Adverse Event|5|||
163130890|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Physician Decision|3|||
163130891|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Physician Decision|3|||
163130892|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Death|2|||
163130893|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Death|1|||
163130894|NCT02301624|589186443|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
163130895|NCT02301624|589186444|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
163130896|NCT00895310|589186445|FG000|Overall Study|Withdrawal by Subject|1|||
163130897|NCT03738618|589188150|FG000|Overall Study|Protocol deviation|23|||
163130898|NCT03738618|589188151|FG001|Overall Study|Protocol deviation|0|||
163130899|NCT03738618|589188150|FG000|Overall Study|Adverse Event|4|||
163130900|NCT03738618|589188151|FG001|Overall Study|Adverse Event|0|||
163130901|NCT03738618|589188150|FG000|Overall Study|Lost to Follow-up|2|||
163130902|NCT03738618|589188151|FG001|Overall Study|Lost to Follow-up|0|||
163130903|NCT03738618|589188150|FG000|Overall Study|Randomization failure|1|||
163130904|NCT03738618|589188151|FG001|Overall Study|Randomization failure|0|||
163130905|NCT03738618|589188150|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
163130906|NCT03738618|589188151|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
163130907|NCT03738618|589188150|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
163130908|NCT03738618|589188151|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
163130909|NCT01271725|589188156|FG000|Part A|Progressive disease according to RECIST|8|||
163130910|NCT01271725|589188157|FG001|Part A|Progressive disease according to RECIST|0|||
163130911|NCT01271725|589188156|FG000|Part A|Clinical signs/symptoms of progression|2|||
163130912|NCT01271725|589188157|FG001|Part A|Clinical signs/symptoms of progression|0|||
163130913|NCT01271725|589188156|FG000|Part A|Other Adverse Event|8|||
163130914|NCT01271725|589188157|FG001|Part A|Other Adverse Event|0|||
163130915|NCT01271725|589188156|FG000|Part A|Lost to Follow-up|1|||
163130916|NCT01271725|589188157|FG001|Part A|Lost to Follow-up|0|||
163130917|NCT01271725|589188156|FG000|Part A|Withdrawal by Subject|12|||
163130918|NCT01271725|589188157|FG001|Part A|Withdrawal by Subject|0|||
163130919|NCT01271725|589188156|FG000|Part A|Other than specified|3|||
163130920|NCT01271725|589188157|FG001|Part A|Other than specified|0|||
163130921|NCT01271725|589188156|FG000|Part A|Protocol Violation|1|||
163130922|NCT01271725|589188157|FG001|Part A|Protocol Violation|0|||
163130923|NCT01271725|589188156|FG000|Part B|Other than specified|0|||
163130924|NCT01271725|589188157|FG001|Part B|Other than specified|2|||
163130925|NCT01271725|589188156|FG000|Part B|Clinical signs/symptoms of progression|0|||
163130926|NCT01271725|589188157|FG001|Part B|Clinical signs/symptoms of progression|2|||
163130927|NCT01271725|589188156|FG000|Part B|Other Adverse Event|0|||
163130928|NCT01271725|589188157|FG001|Part B|Other Adverse Event|1|||
163130929|NCT01271725|589188156|FG000|Part B|Protocol Violation|0|||
163130930|NCT01271725|589188157|FG001|Part B|Protocol Violation|1|||
163130931|NCT01271725|589188156|FG000|Part B|Withdrawal by Subject|0|||
163130932|NCT01271725|589188157|FG001|Part B|Withdrawal by Subject|6|||
163130933|NCT00801229|589188158|FG000|Signed Consent|Withdrawal by Subject|2|||
163130934|NCT00801229|589188159|FG001|Signed Consent|Withdrawal by Subject|2|||
163130935|NCT00801229|589188158|FG000|Signed Consent|Found Ineligible|1|||
163130936|NCT00801229|589188159|FG001|Signed Consent|Found Ineligible|1|||
163130937|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
163130938|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
163130939|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
163130940|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
163130941|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
163130942|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
163130943|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
163130944|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
163130945|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
163130946|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
163130947|NCT00801229|589188158|FG000|Received Study Drug/Placebo|Adverse Event|1|||
163130948|NCT00801229|589188159|FG001|Received Study Drug/Placebo|Adverse Event|1|||
163130949|NCT03826186|589188160|FG000|Overall Study|Protocol Violation|2|||
163130950|NCT03826186|589188161|FG001|Overall Study|Protocol Violation|0|||
163130951|NCT03826186|589188160|FG000|Overall Study|Withdrawal by Subject|1|||
163130952|NCT03826186|589188161|FG001|Overall Study|Withdrawal by Subject|0|||
163130953|NCT02950480|589188164|FG000|Overall Study|Withdrawal by Subject|1|||
162719800|NCT01769391|587680588|FG001|Overall Study|Death|1|||
163130954|NCT02950480|589188165|FG001|Overall Study|Withdrawal by Subject|0|||
163130955|NCT01363661|589188166|FG000|Overall Study|Adverse Event|9|||
163130956|NCT01363661|589188167|FG001|Overall Study|Adverse Event|2|||
163130957|NCT01363661|589188166|FG000|Overall Study|Withdrawal by Subject|1|||
163130958|NCT01363661|589188167|FG001|Overall Study|Withdrawal by Subject|1|||
163130959|NCT01363661|589188166|FG000|Overall Study|Protocol Violation|1|||
163130960|NCT01363661|589188167|FG001|Overall Study|Protocol Violation|0|||
162657558|NCT03107988|587459661|FG006|Overall Study|Adverse Event|0|||
162657559|NCT03107988|587459662|FG007|Overall Study|Adverse Event|1|||
162657560|NCT03107988|587459663|FG008|Overall Study|Adverse Event|0|||
162657561|NCT03107988|587459664|FG009|Overall Study|Adverse Event|0|||
162657562|NCT03107988|587459665|FG010|Overall Study|Adverse Event|0|||
162657563|NCT03107988|587459666|FG011|Overall Study|Adverse Event|0|||
162657564|NCT03107988|587459667|FG012|Overall Study|Adverse Event|0|||
162657565|NCT03107988|587459655|FG000|Overall Study|Disease Progression or Relapse|1|||
163130961|NCT01363661|589188166|FG000|Overall Study|Lost to Follow-up|3|||
163130962|NCT01363661|589188167|FG001|Overall Study|Lost to Follow-up|1|||
163130963|NCT00705367|589188174|FG000|Long-term Extension Period|Adverse Event|2|||
163130964|NCT00705367|589188175|FG001|Long-term Extension Period|Adverse Event|0|||
163130965|NCT00705367|589188174|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
163130966|NCT00705367|589188175|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
163130967|NCT00705367|589188174|FG000|Long-term Extension Period|Lack of Efficacy|1|||
163130968|NCT00705367|589188175|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163130969|NCT00705367|589188174|FG000|Long-term Extension Period|No longer met study criteria|1|||
163130970|NCT00705367|589188175|FG001|Long-term Extension Period|No longer met study criteria|0|||
163130971|NCT00705367|589188174|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
163130972|NCT00705367|589188175|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
163130973|NCT01959139|589188176|FG000|Phase II|Disease progression|0|||
163130974|NCT01959139|589188177|FG001|Phase II|Disease progression|0|||
163130975|NCT01959139|589188178|FG002|Phase II|Disease progression|26|||
163130976|NCT01959139|589188179|FG003|Phase II|Disease progression|34|||
163130977|NCT01959139|589188176|FG000|Phase II|Adverse Event|0|||
163130978|NCT01959139|589188177|FG001|Phase II|Adverse Event|0|||
163130979|NCT01959139|589188178|FG002|Phase II|Adverse Event|10|||
163130980|NCT01959139|589188179|FG003|Phase II|Adverse Event|11|||
163130981|NCT01959139|589188176|FG000|Phase II|Patient Refusal|0|||
163130982|NCT01959139|589188177|FG001|Phase II|Patient Refusal|0|||
163130983|NCT01959139|589188178|FG002|Phase II|Patient Refusal|5|||
163130984|NCT01959139|589188179|FG003|Phase II|Patient Refusal|4|||
163130985|NCT01959139|589188176|FG000|Phase II|Death|0|||
163130986|NCT01959139|589188177|FG001|Phase II|Death|0|||
163130987|NCT01959139|589188178|FG002|Phase II|Death|3|||
163130988|NCT01959139|589188179|FG003|Phase II|Death|1|||
163130989|NCT01959139|589188176|FG000|Phase II|Other/Unknown|0|||
163130990|NCT01959139|589188177|FG001|Phase II|Other/Unknown|0|||
163130991|NCT01959139|589188178|FG002|Phase II|Other/Unknown|8|||
163130992|NCT01959139|589188179|FG003|Phase II|Other/Unknown|5|||
163130993|NCT01959139|589188176|FG000|Phase II|On treatment|0|||
163130994|NCT01959139|589188177|FG001|Phase II|On treatment|0|||
163130995|NCT01959139|589188178|FG002|Phase II|On treatment|4|||
163130996|NCT01959139|589188179|FG003|Phase II|On treatment|0|||
163130997|NCT01378325|589188182|FG000|Overall Study|Protocol Violation|0|||
163130998|NCT01378325|589188183|FG001|Overall Study|Protocol Violation|1|||
163130999|NCT02255461|589188184|FG000|Overall Study|Adverse Event|0|||
163131000|NCT02255461|589188185|FG001|Overall Study|Adverse Event|1|||
163131001|NCT02255461|589188186|FG002|Overall Study|Adverse Event|0|||
163131002|NCT02255461|589188187|FG003|Overall Study|Adverse Event|0|||
163131003|NCT02255461|589188188|FG004|Overall Study|Adverse Event|1|||
163131004|NCT02255461|589188184|FG000|Overall Study|Withdrawal by Subject|0|||
163131005|NCT02255461|589188185|FG001|Overall Study|Withdrawal by Subject|0|||
163131006|NCT02255461|589188186|FG002|Overall Study|Withdrawal by Subject|1|||
163131007|NCT02255461|589188187|FG003|Overall Study|Withdrawal by Subject|0|||
163131008|NCT02255461|589188188|FG004|Overall Study|Withdrawal by Subject|1|||
163131009|NCT02255461|589188184|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
163131010|NCT02255461|589188185|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
163131011|NCT02255461|589188186|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
163131012|NCT02255461|589188187|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
163131013|NCT02255461|589188188|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
163131014|NCT01559675|589188189|FG000|Overall Study|Protocol Violation|1|||
163131015|NCT01559675|589188190|FG001|Overall Study|Protocol Violation|2|||
163131016|NCT01559675|589188189|FG000|Overall Study|2nd operation on same patient excluded|14|||
163131017|NCT01559675|589188190|FG001|Overall Study|2nd operation on same patient excluded|12|||
163131018|NCT01357551|589188193|FG000|Overall Study|Withdrawal by Subject|6|||
163131019|NCT01357551|589188194|FG001|Overall Study|Withdrawal by Subject|4|||
163131020|NCT01357551|589188193|FG000|Overall Study|Death|0|||
163131021|NCT01357551|589188194|FG001|Overall Study|Death|1|||
163131022|NCT01357551|589188193|FG000|Overall Study|Lost to Follow-up|16|||
163131023|NCT01357551|589188194|FG001|Overall Study|Lost to Follow-up|6|||
163131024|NCT00891228|589188198|FG000|Overall Study|Adverse Event|0|||
163131025|NCT00891228|589188199|FG001|Overall Study|Adverse Event|2|||
163131026|NCT00891228|589188200|FG002|Overall Study|Adverse Event|3|||
162657566|NCT03107988|587459656|FG001|Overall Study|Disease Progression or Relapse|2|||
162657567|NCT03107988|587459657|FG002|Overall Study|Disease Progression or Relapse|2|||
162657568|NCT03107988|587459658|FG003|Overall Study|Disease Progression or Relapse|5|||
162657569|NCT03107988|587459659|FG004|Overall Study|Disease Progression or Relapse|1|||
162657570|NCT03107988|587459660|FG005|Overall Study|Disease Progression or Relapse|1|||
162657571|NCT03107988|587459661|FG006|Overall Study|Disease Progression or Relapse|0|||
162657572|NCT03107988|587459662|FG007|Overall Study|Disease Progression or Relapse|0|||
162657573|NCT03107988|587459663|FG008|Overall Study|Disease Progression or Relapse|0|||
162657574|NCT03107988|587459664|FG009|Overall Study|Disease Progression or Relapse|1|||
162657575|NCT03107988|587459665|FG010|Overall Study|Disease Progression or Relapse|4|||
162657576|NCT03107988|587459666|FG011|Overall Study|Disease Progression or Relapse|0|||
162657577|NCT03107988|587459667|FG012|Overall Study|Disease Progression or Relapse|0|||
162657578|NCT03107988|587459655|FG000|Overall Study|Ineligible|0|||
162657579|NCT03107988|587459656|FG001|Overall Study|Ineligible|0|||
162657580|NCT03107988|587459657|FG002|Overall Study|Ineligible|0|||
162657581|NCT03107988|587459658|FG003|Overall Study|Ineligible|0|||
162657582|NCT03107988|587459659|FG004|Overall Study|Ineligible|0|||
162657583|NCT03107988|587459660|FG005|Overall Study|Ineligible|0|||
162657584|NCT03107988|587459661|FG006|Overall Study|Ineligible|0|||
162657585|NCT03107988|587459662|FG007|Overall Study|Ineligible|0|||
162657586|NCT03107988|587459663|FG008|Overall Study|Ineligible|1|||
162657587|NCT03107988|587459664|FG009|Overall Study|Ineligible|0|||
162657588|NCT03107988|587459665|FG010|Overall Study|Ineligible|0|||
162657589|NCT03107988|587459666|FG011|Overall Study|Ineligible|0|||
162657590|NCT03107988|587459667|FG012|Overall Study|Ineligible|0|||
162657591|NCT01344057|587459668|FG000|Overall Study|Premature Withdrawal|1|||
162657592|NCT00529386|587459669|FG000|Overall Study|Lost to Follow-up|1|||
162657593|NCT04027686|587459670|FG000|Overall Study|Lost to Follow-up|2|||
162657594|NCT04027686|587459671|FG001|Overall Study|Lost to Follow-up|0|||
162657595|NCT04027686|587459670|FG000|Overall Study|Withdrawal by Subject|0|||
162657596|NCT04027686|587459671|FG001|Overall Study|Withdrawal by Subject|1|||
162657597|NCT02939404|587459672|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
162657598|NCT02939404|587459673|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
162657599|NCT02939404|587459672|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
162657600|NCT02939404|587459673|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
162657601|NCT02075437|587459675|FG000|Overall Study|Withdrawal by Subject|5|||
162657602|NCT02075437|587459675|FG000|Overall Study|Lost to Follow-up|1|||
162657603|NCT03921411|587459680|FG000|Overall Study|Withdrawal by Subject|1|||
162657604|NCT03921411|587459680|FG000|Overall Study|Protocol Deviation|2|||
162657605|NCT03921411|587459680|FG000|Overall Study|Enrolled, but never treated|2|||
162657606|NCT02114879|587459681|FG000|Overall Study|Withdrawal by Subject|9|||
162657607|NCT02114879|587459682|FG001|Overall Study|Withdrawal by Subject|5|||
162657608|NCT02114879|587459681|FG000|Overall Study|Death|6|||
162657609|NCT02114879|587459682|FG001|Overall Study|Death|11|||
162657610|NCT02114879|587459681|FG000|Overall Study|Lost to Follow-up|4|||
162657611|NCT02114879|587459682|FG001|Overall Study|Lost to Follow-up|6|||
162657612|NCT02114879|587459681|FG000|Overall Study|Physician Decision|0|||
162657613|NCT02114879|587459682|FG001|Overall Study|Physician Decision|2|||
162657614|NCT03120013|587459684|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162657615|NCT03120013|587459685|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162657616|NCT02098109|587459686|FG000|Overall Study|Protocol Violation|3|||
162657617|NCT02098109|587459687|FG001|Overall Study|Protocol Violation|0|||
162657618|NCT01541826|587459689|FG000|Overall Study|Lost to Follow-up|2|||
162657619|NCT01541826|587459690|FG001|Overall Study|Lost to Follow-up|3|||
162657620|NCT01541826|587459691|FG002|Overall Study|Lost to Follow-up|0|||
162657621|NCT01541826|587459689|FG000|Overall Study|Withdrawal by Subject|2|||
162657622|NCT01541826|587459690|FG001|Overall Study|Withdrawal by Subject|0|||
162657623|NCT01541826|587459691|FG002|Overall Study|Withdrawal by Subject|0|||
162657624|NCT00480779|587459694|FG000|Overall Study|Other|2|||
162657625|NCT00480779|587459695|FG001|Overall Study|Other|0|||
162657626|NCT00480779|587459694|FG000|Overall Study|Job and Health-related|0|||
162657627|NCT00480779|587459695|FG001|Overall Study|Job and Health-related|3|||
162657628|NCT01365273|587459696|FG000|Overall Study|Lost to Follow-up|1|||
162657629|NCT01365273|587459697|FG001|Overall Study|Lost to Follow-up|0|||
162657630|NCT01365273|587459696|FG000|Overall Study|Protocol Violation|0|||
162657631|NCT01365273|587459697|FG001|Overall Study|Protocol Violation|1|||
162657632|NCT01365273|587459696|FG000|Overall Study|Physician Decision|1|||
162657633|NCT01365273|587459697|FG001|Overall Study|Physician Decision|0|||
162657634|NCT00854581|587459702|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
162657635|NCT00854581|587459702|FG000|Induction (Up to Day 21)|Death|1|||
162657636|NCT00854581|587459702|FG000|Induction (Up to Day 21)|Physician Decision|1|||
162657637|NCT00854581|587459702|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
162657638|NCT04847674|587459703|FG000|Overall Study|Withdrawal by Subject|0|||
162657639|NCT04847674|587459704|FG001|Overall Study|Withdrawal by Subject|1|||
162657640|NCT04847674|587459705|FG002|Overall Study|Withdrawal by Subject|0|||
162719801|NCT01769391|587680587|FG000|Overall Study|Adverse Event|0|||
162657641|NCT04847674|587459703|FG000|Overall Study|Lost to Follow-up|0|||
162657642|NCT04847674|587459704|FG001|Overall Study|Lost to Follow-up|0|||
162657643|NCT04847674|587459705|FG002|Overall Study|Lost to Follow-up|2|||
162657644|NCT04847674|587459703|FG000|Overall Study|Other than specified|21|||
163131027|NCT00891228|589188198|FG000|Overall Study|Withdrawal by Subject|2|||
163131028|NCT00891228|589188199|FG001|Overall Study|Withdrawal by Subject|4|||
163131029|NCT00891228|589188200|FG002|Overall Study|Withdrawal by Subject|5|||
163131030|NCT00891228|589188198|FG000|Overall Study|Protocol Violation|3|||
163131031|NCT00891228|589188199|FG001|Overall Study|Protocol Violation|1|||
163131032|NCT00891228|589188200|FG002|Overall Study|Protocol Violation|2|||
163131033|NCT00891228|589188198|FG000|Overall Study|Physician Decision|2|||
163131034|NCT00891228|589188199|FG001|Overall Study|Physician Decision|1|||
163131035|NCT00891228|589188200|FG002|Overall Study|Physician Decision|0|||
163131036|NCT00891228|589188198|FG000|Overall Study|Lost to Follow-up|4|||
163131037|NCT00891228|589188199|FG001|Overall Study|Lost to Follow-up|4|||
163131038|NCT00891228|589188200|FG002|Overall Study|Lost to Follow-up|5|||
163131039|NCT00891228|589188198|FG000|Overall Study|Pregnancy|0|||
163131040|NCT00891228|589188199|FG001|Overall Study|Pregnancy|1|||
163131041|NCT00891228|589188200|FG002|Overall Study|Pregnancy|0|||
163131042|NCT03704688|589188211|FG000|Overall Study|Adverse Event|0|||
163131043|NCT03704688|589188212|FG001|Overall Study|Adverse Event|0|||
163131044|NCT03704688|589188213|FG002|Overall Study|Adverse Event|0|||
163131045|NCT03704688|589188214|FG003|Overall Study|Adverse Event|4|||
163131046|NCT03704688|589188215|FG004|Overall Study|Adverse Event|1|||
163131047|NCT03704688|589188216|FG005|Overall Study|Adverse Event|0|||
163131048|NCT03704688|589188211|FG000|Overall Study|Disease Progression|0|||
163131049|NCT03704688|589188212|FG001|Overall Study|Disease Progression|0|||
163131050|NCT03704688|589188213|FG002|Overall Study|Disease Progression|0|||
163131051|NCT03704688|589188214|FG003|Overall Study|Disease Progression|3|||
163131052|NCT03704688|589188215|FG004|Overall Study|Disease Progression|1|||
163131053|NCT03704688|589188216|FG005|Overall Study|Disease Progression|0|||
163131054|NCT03704688|589188211|FG000|Overall Study|Death|0|||
163131055|NCT03704688|589188212|FG001|Overall Study|Death|0|||
163131056|NCT03704688|589188213|FG002|Overall Study|Death|0|||
163131057|NCT03704688|589188214|FG003|Overall Study|Death|0|||
163131058|NCT03704688|589188215|FG004|Overall Study|Death|3|||
163131059|NCT03704688|589188216|FG005|Overall Study|Death|0|||
163131060|NCT00847886|589188218|FG000|Overall Study|Adverse Event|0|||
163131061|NCT00847886|589188219|FG001|Overall Study|Adverse Event|1|||
163131062|NCT00413036|589188220|FG000|Overall Study|Adverse Event|44|||
163131063|NCT00413036|589188220|FG000|Overall Study|Lack of Efficacy|129|||
163131064|NCT00413036|589188220|FG000|Overall Study|Withdrawal by Subject|7|||
163131065|NCT00413036|589188220|FG000|Overall Study|Death|9|||
163131066|NCT00413036|589188220|FG000|Overall Study|Other|26|||
163131067|NCT00413036|589188220|FG000|Overall Study|Missing|2|||
163131068|NCT00183625|589188221|FG000|Overall Study|Withdrawal by Subject|18|||
163131069|NCT00183625|589188222|FG001|Overall Study|Withdrawal by Subject|18|||
163131070|NCT00183625|589188223|FG002|Overall Study|Withdrawal by Subject|19|||
163131071|NCT00183625|589188224|FG003|Overall Study|Withdrawal by Subject|14|||
163131072|NCT01369641|589188225|FG000|Overall Study|Withdrawal by Subject|1|||
163131073|NCT02524158|589188226|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
163131074|NCT02524158|589188227|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
163131075|NCT02524158|589188226|FG000|12-weeks Assessment|Lost to Follow-up|18|||
163131076|NCT02524158|589188227|FG001|12-weeks Assessment|Lost to Follow-up|12|||
163131077|NCT02524158|589188226|FG000|6-month Assessment|Withdrawal by Subject|1|||
163131078|NCT02524158|589188227|FG001|6-month Assessment|Withdrawal by Subject|1|||
163131079|NCT02524158|589188226|FG000|6-month Assessment|Lost to Follow-up|21|||
163131080|NCT02524158|589188227|FG001|6-month Assessment|Lost to Follow-up|20|||
163131081|NCT01835158|589188228|FG000|Overall Study|Withdrawal by Subject|1|||
163131082|NCT01835158|589188229|FG001|Overall Study|Withdrawal by Subject|6|||
163131083|NCT00596830|589188230|FG000|Overall Study|Death|258|||
163131084|NCT00596830|589188231|FG001|Overall Study|Death|247|||
163131085|NCT00596830|589188230|FG000|Overall Study|Lost to Follow-up|7|||
163131086|NCT00596830|589188231|FG001|Overall Study|Lost to Follow-up|11|||
163131087|NCT00596830|589188230|FG000|Overall Study|Withdrawal by Subject|22|||
163131088|NCT00596830|589188231|FG001|Overall Study|Withdrawal by Subject|12|||
163131089|NCT00596830|589188230|FG000|Overall Study|Study terminated by sponsor|51|||
162657645|NCT04847674|587459704|FG001|Overall Study|Other than specified|20|||
162657646|NCT04847674|587459705|FG002|Overall Study|Other than specified|20|||
162657647|NCT02705820|587459708|FG000|Overall Study|Death|2|||
162657648|NCT02705820|587459708|FG000|Overall Study|Disease Progression|34|||
162657649|NCT02705820|587459708|FG000|Overall Study|Clinical Deterioration|3|||
162657650|NCT02702401|587459710|FG000|Overall Study|Death|242|||
163131090|NCT00596830|589188231|FG001|Overall Study|Study terminated by sponsor|62|||
162657651|NCT02702401|587459711|FG001|Overall Study|Death|125|||
163131091|NCT00596830|589188230|FG000|Overall Study|Follow-up was discontinued|1|||
163131092|NCT00596830|589188231|FG001|Overall Study|Follow-up was discontinued|0|||
163131093|NCT00596830|589188230|FG000|Overall Study|Randomized but not treated|3|||
163131094|NCT00596830|589188231|FG001|Overall Study|Randomized but not treated|7|||
162657652|NCT02702401|587459710|FG000|Overall Study|Withdrawal by Subject|15|||
162657653|NCT02702401|587459711|FG001|Overall Study|Withdrawal by Subject|5|||
163131095|NCT00887926|589188232|FG000|Overall Study|Withdrawal by Subject|0|||
163131096|NCT00887926|589188233|FG001|Overall Study|Withdrawal by Subject|1|||
163131097|NCT00887926|589188234|FG002|Overall Study|Withdrawal by Subject|0|||
163131098|NCT00887926|589188235|FG003|Overall Study|Withdrawal by Subject|0|||
163131099|NCT04427072|589188238|FG000|Randomized Treatment Phase|Progressive disease|9|||
163131100|NCT04427072|589188239|FG001|Randomized Treatment Phase|Progressive disease|4|||
163131101|NCT04427072|589188238|FG000|Randomized Treatment Phase|Adverse Event|3|||
163131102|NCT04427072|589188239|FG001|Randomized Treatment Phase|Adverse Event|1|||
163131103|NCT04427072|589188238|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
163131104|NCT04427072|589188239|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
163131105|NCT04427072|589188238|FG000|Randomized Treatment Phase|Death|0|||
163131106|NCT04427072|589188239|FG001|Randomized Treatment Phase|Death|1|||
163131107|NCT04427072|589188238|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
163131108|NCT04427072|589188239|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
163131109|NCT04427072|589188238|FG000|Extension Treatment Phase|Progressive disease|0|||
163131110|NCT04427072|589188239|FG001|Extension Treatment Phase|Progressive disease|5|||
163131111|NCT01110382|589188244|FG000|Overall Study|Withdrawal by Subject|0|||
163131112|NCT01110382|589188245|FG001|Overall Study|Withdrawal by Subject|1|||
163131113|NCT01110382|589188244|FG000|Overall Study|Protocol Violation|0|||
163131114|NCT01110382|589188245|FG001|Overall Study|Protocol Violation|1|||
163131115|NCT00098306|589188246|FG000|Double Blind|Randomized, not treated|9|||
163131116|NCT00098306|589188247|FG001|Double Blind|Randomized, not treated|5|||
163131117|NCT00098306|589188248|FG002|Double Blind|Randomized, not treated|2|||
163131118|NCT00098306|589188249|FG003|Double Blind|Randomized, not treated|0|||
163131119|NCT00098306|589188250|FG004|Double Blind|Randomized, not treated|0|||
163131120|NCT00098306|589188251|FG005|Double Blind|Randomized, not treated|0|||
163131121|NCT00098306|589188252|FG006|Double Blind|Randomized, not treated|0|||
163131122|NCT00098306|589188246|FG000|Double Blind|Ongoing at cut-off date|151|||
163131123|NCT00098306|589188247|FG001|Double Blind|Ongoing at cut-off date|166|||
163131124|NCT00098306|589188248|FG002|Double Blind|Ongoing at cut-off date|72|||
163131125|NCT00098306|589188249|FG003|Double Blind|Ongoing at cut-off date|0|||
163131126|NCT00098306|589188250|FG004|Double Blind|Ongoing at cut-off date|0|||
163131127|NCT00098306|589188251|FG005|Double Blind|Ongoing at cut-off date|0|||
163131128|NCT00098306|589188252|FG006|Double Blind|Ongoing at cut-off date|0|||
163131129|NCT00098306|589188246|FG000|Double Blind|Adverse Event|11|||
163131130|NCT00098306|589188247|FG001|Double Blind|Adverse Event|10|||
163131131|NCT00098306|589188248|FG002|Double Blind|Adverse Event|6|||
163131132|NCT00098306|589188249|FG003|Double Blind|Adverse Event|0|||
163131133|NCT00098306|589188250|FG004|Double Blind|Adverse Event|0|||
163131134|NCT00098306|589188251|FG005|Double Blind|Adverse Event|0|||
163131135|NCT00098306|589188252|FG006|Double Blind|Adverse Event|0|||
163131136|NCT00098306|589188246|FG000|Double Blind|Lack of Efficacy|43|||
163131137|NCT00098306|589188247|FG001|Double Blind|Lack of Efficacy|34|||
163131138|NCT00098306|589188248|FG002|Double Blind|Lack of Efficacy|17|||
163131139|NCT00098306|589188249|FG003|Double Blind|Lack of Efficacy|0|||
163131140|NCT00098306|589188250|FG004|Double Blind|Lack of Efficacy|0|||
163131141|NCT00098306|589188251|FG005|Double Blind|Lack of Efficacy|0|||
163131142|NCT00098306|589188252|FG006|Double Blind|Lack of Efficacy|0|||
163131143|NCT00098306|589188246|FG000|Double Blind|Death|1|||
163131144|NCT00098306|589188247|FG001|Double Blind|Death|4|||
163131145|NCT00098306|589188248|FG002|Double Blind|Death|1|||
163131146|NCT00098306|589188249|FG003|Double Blind|Death|0|||
163131147|NCT00098306|589188250|FG004|Double Blind|Death|0|||
163131148|NCT00098306|589188251|FG005|Double Blind|Death|0|||
163131149|NCT00098306|589188252|FG006|Double Blind|Death|0|||
163131150|NCT00098306|589188246|FG000|Double Blind|Participant defaulted|19|||
163131151|NCT00098306|589188247|FG001|Double Blind|Participant defaulted|18|||
163131152|NCT00098306|589188248|FG002|Double Blind|Participant defaulted|11|||
163131153|NCT00098306|589188249|FG003|Double Blind|Participant defaulted|0|||
163131154|NCT00098306|589188250|FG004|Double Blind|Participant defaulted|0|||
162719802|NCT01769391|587680588|FG001|Overall Study|Adverse Event|3|||
162719803|NCT01769391|587680587|FG000|Overall Study|Progressive Disease|1|||
162719804|NCT01769391|587680588|FG001|Overall Study|Progressive Disease|2|||
162719805|NCT01769391|587680587|FG000|Overall Study|Withdrawal by Subject|4|||
163131155|NCT00098306|589188251|FG005|Double Blind|Participant defaulted|0|||
163131156|NCT00098306|589188252|FG006|Double Blind|Participant defaulted|0|||
163131157|NCT00098306|589188246|FG000|Double Blind|Un-specified|7|||
163131158|NCT00098306|589188247|FG001|Double Blind|Un-specified|3|||
163131159|NCT00098306|589188248|FG002|Double Blind|Un-specified|11|||
162719806|NCT01769391|587680588|FG001|Overall Study|Withdrawal by Subject|3|||
163131160|NCT00098306|589188249|FG003|Double Blind|Un-specified|0|||
163131161|NCT00098306|589188250|FG004|Double Blind|Un-specified|0|||
163131162|NCT00098306|589188251|FG005|Double Blind|Un-specified|0|||
163131163|NCT00098306|589188252|FG006|Double Blind|Un-specified|0|||
163131164|NCT00098306|589188246|FG000|Open Label|Lack of Efficacy|0|||
162657654|NCT02702401|587459710|FG000|Overall Study|Sponsor Decision|19|||
162657655|NCT02702401|587459711|FG001|Overall Study|Sponsor Decision|3|||
162657656|NCT02702401|587459710|FG000|Overall Study|Physician Decision|1|||
162657657|NCT02702401|587459711|FG001|Overall Study|Physician Decision|2|||
162657658|NCT02702401|587459710|FG000|Overall Study|Lost to Follow-up|1|||
162657659|NCT02702401|587459711|FG001|Overall Study|Lost to Follow-up|0|||
162657660|NCT01524770|587459719|FG000|First Intervention|Withdrawal by Subject|1|||
162657661|NCT01524770|587459720|FG001|First Intervention|Withdrawal by Subject|0|||
162657662|NCT01524770|587459719|FG000|First Intervention|Adverse Event|1|||
162657663|NCT01524770|587459720|FG001|First Intervention|Adverse Event|1|||
162657664|NCT01524770|587459719|FG000|First Intervention|Protocol Violation|1|||
162657665|NCT01524770|587459720|FG001|First Intervention|Protocol Violation|0|||
162657666|NCT00689481|587459721|FG000|Overall Study|Adverse Event|7|||
162657667|NCT00689481|587459722|FG001|Overall Study|Adverse Event|1|||
162657668|NCT00689481|587459721|FG000|Overall Study|Lost to Follow-up|4|||
162657669|NCT00689481|587459722|FG001|Overall Study|Lost to Follow-up|3|||
162657670|NCT00689481|587459721|FG000|Overall Study|Lack of Efficacy|4|||
162657671|NCT00689481|587459722|FG001|Overall Study|Lack of Efficacy|3|||
162657672|NCT00689481|587459721|FG000|Overall Study|Non-compliance with study treatment|1|||
162657673|NCT00689481|587459722|FG001|Overall Study|Non-compliance with study treatment|1|||
162657674|NCT00689481|587459721|FG000|Overall Study|Withdrawal by Subject|8|||
162657675|NCT00689481|587459722|FG001|Overall Study|Withdrawal by Subject|4|||
162657676|NCT00689481|587459721|FG000|Overall Study|Excluded medication started during study|0|||
162657677|NCT00689481|587459722|FG001|Overall Study|Excluded medication started during study|1|||
162657678|NCT00689481|587459721|FG000|Overall Study|Subject early term, left on vacation|0|||
162657679|NCT00689481|587459722|FG001|Overall Study|Subject early term, left on vacation|1|||
162657680|NCT03337724|587459723|FG000|Overall Study|Reason not Specified|12|||
162719807|NCT01769391|587680587|FG000|Overall Study|Investigator Decision|2|||
162719808|NCT01769391|587680588|FG001|Overall Study|Investigator Decision|0|||
162657681|NCT03337724|587459724|FG001|Overall Study|Reason not Specified|21|||
162657682|NCT03337724|587459725|FG002|Overall Study|Reason not Specified|9|||
162657683|NCT03337724|587459726|FG003|Overall Study|Reason not Specified|9|||
162657684|NCT03337724|587459727|FG004|Overall Study|Reason not Specified|29|||
162657685|NCT03337724|587459723|FG000|Overall Study|Withdrawal by Subject|13|||
162657686|NCT03337724|587459724|FG001|Overall Study|Withdrawal by Subject|15|||
162657687|NCT03337724|587459725|FG002|Overall Study|Withdrawal by Subject|4|||
162657688|NCT03337724|587459726|FG003|Overall Study|Withdrawal by Subject|15|||
162657689|NCT03337724|587459727|FG004|Overall Study|Withdrawal by Subject|6|||
162657690|NCT03337724|587459723|FG000|Overall Study|Protocol Deviation|0|||
162657691|NCT03337724|587459724|FG001|Overall Study|Protocol Deviation|1|||
162657692|NCT03337724|587459725|FG002|Overall Study|Protocol Deviation|1|||
162657693|NCT03337724|587459726|FG003|Overall Study|Protocol Deviation|1|||
162657694|NCT03337724|587459727|FG004|Overall Study|Protocol Deviation|0|||
162657695|NCT03337724|587459723|FG000|Overall Study|Adverse Event|1|||
162657696|NCT03337724|587459724|FG001|Overall Study|Adverse Event|1|||
162657697|NCT03337724|587459725|FG002|Overall Study|Adverse Event|0|||
162657698|NCT03337724|587459726|FG003|Overall Study|Adverse Event|1|||
162657699|NCT03337724|587459727|FG004|Overall Study|Adverse Event|0|||
162657700|NCT03337724|587459723|FG000|Overall Study|Death|40|||
162657701|NCT03337724|587459724|FG001|Overall Study|Death|89|||
162657702|NCT03337724|587459725|FG002|Overall Study|Death|43|||
162657703|NCT03337724|587459726|FG003|Overall Study|Death|76|||
162657704|NCT03337724|587459727|FG004|Overall Study|Death|50|||
162657705|NCT03337724|587459723|FG000|Overall Study|Lost to Follow-up|5|||
162657706|NCT03337724|587459724|FG001|Overall Study|Lost to Follow-up|5|||
162657707|NCT03337724|587459725|FG002|Overall Study|Lost to Follow-up|4|||
162657708|NCT03337724|587459726|FG003|Overall Study|Lost to Follow-up|7|||
162719809|NCT03386929|587680589|FG000|Overall Study|Death|0|||
162719810|NCT03386929|587680590|FG001|Overall Study|Death|0|||
162719811|NCT03386929|587680591|FG002|Overall Study|Death|1|||
162719812|NCT03386929|587680589|FG000|Overall Study|Withdrawal by Subject|0|||
163131165|NCT00098306|589188247|FG001|Open Label|Lack of Efficacy|0|||
162719813|NCT03386929|587680590|FG001|Overall Study|Withdrawal by Subject|1|||
162657709|NCT03337724|587459727|FG004|Overall Study|Lost to Follow-up|4|||
162657710|NCT03337724|587459723|FG000|Overall Study|Physician Decision|16|||
162657711|NCT03337724|587459724|FG001|Overall Study|Physician Decision|34|||
162657712|NCT03337724|587459725|FG002|Overall Study|Physician Decision|14|||
162657713|NCT03337724|587459726|FG003|Overall Study|Physician Decision|34|||
162657714|NCT03337724|587459727|FG004|Overall Study|Physician Decision|13|||
162657715|NCT03337724|587459723|FG000|Overall Study|Progressive Disease|0|||
162657716|NCT03337724|587459724|FG001|Overall Study|Progressive Disease|2|||
162657717|NCT03337724|587459725|FG002|Overall Study|Progressive Disease|1|||
162657718|NCT03337724|587459726|FG003|Overall Study|Progressive Disease|2|||
162657719|NCT03337724|587459727|FG004|Overall Study|Progressive Disease|0|||
162657720|NCT03337724|587459723|FG000|Overall Study|Symptomatic Deterioration|0|||
162657721|NCT03337724|587459724|FG001|Overall Study|Symptomatic Deterioration|0|||
162657722|NCT03337724|587459725|FG002|Overall Study|Symptomatic Deterioration|0|||
162657723|NCT03337724|587459726|FG003|Overall Study|Symptomatic Deterioration|1|||
162719814|NCT03386929|587680591|FG002|Overall Study|Withdrawal by Subject|0|||
163131166|NCT00098306|589188248|FG002|Open Label|Lack of Efficacy|0|||
163131167|NCT00098306|589188249|FG003|Open Label|Lack of Efficacy|13|||
163131168|NCT00098306|589188250|FG004|Open Label|Lack of Efficacy|0|||
163131169|NCT00098306|589188251|FG005|Open Label|Lack of Efficacy|0|||
163131170|NCT00098306|589188252|FG006|Open Label|Lack of Efficacy|0|||
163131171|NCT00098306|589188246|FG000|Open Label|Adverse Event|0|||
163131172|NCT00098306|589188247|FG001|Open Label|Adverse Event|0|||
163131173|NCT00098306|589188248|FG002|Open Label|Adverse Event|0|||
163131174|NCT00098306|589188249|FG003|Open Label|Adverse Event|2|||
163131175|NCT00098306|589188250|FG004|Open Label|Adverse Event|0|||
163131176|NCT00098306|589188251|FG005|Open Label|Adverse Event|0|||
163131177|NCT00098306|589188252|FG006|Open Label|Adverse Event|0|||
163131178|NCT00098306|589188246|FG000|Open Label|Death|0|||
163131179|NCT00098306|589188247|FG001|Open Label|Death|0|||
163131180|NCT00098306|589188248|FG002|Open Label|Death|0|||
163131181|NCT00098306|589188249|FG003|Open Label|Death|4|||
163131182|NCT00098306|589188250|FG004|Open Label|Death|0|||
163131183|NCT00098306|589188251|FG005|Open Label|Death|0|||
163131184|NCT00098306|589188252|FG006|Open Label|Death|0|||
163131185|NCT00098306|589188246|FG000|Open Label|Participant defaulted|0|||
163131186|NCT00098306|589188247|FG001|Open Label|Participant defaulted|0|||
163131187|NCT00098306|589188248|FG002|Open Label|Participant defaulted|0|||
163131188|NCT00098306|589188249|FG003|Open Label|Participant defaulted|24|||
163131189|NCT00098306|589188250|FG004|Open Label|Participant defaulted|0|||
163131190|NCT00098306|589188251|FG005|Open Label|Participant defaulted|0|||
163131191|NCT00098306|589188252|FG006|Open Label|Participant defaulted|0|||
163131192|NCT00098306|589188246|FG000|Open Label|Un-specified|0|||
163131193|NCT00098306|589188247|FG001|Open Label|Un-specified|0|||
162657724|NCT03337724|587459727|FG004|Overall Study|Symptomatic Deterioration|0|||
162657725|NCT00528528|587459728|FG000|Overall Study|Lost to Follow-up|0|||
162657726|NCT00528528|587459729|FG001|Overall Study|Lost to Follow-up|0|||
162657727|NCT00528528|587459730|FG002|Overall Study|Lost to Follow-up|1|||
162657728|NCT00528528|587459731|FG003|Overall Study|Lost to Follow-up|1|||
162657729|NCT00528528|587459728|FG000|Overall Study|Ineligible to continue the trial|0|||
162657730|NCT00528528|587459729|FG001|Overall Study|Ineligible to continue the trial|0|||
162657731|NCT00528528|587459730|FG002|Overall Study|Ineligible to continue the trial|0|||
162657732|NCT00528528|587459731|FG003|Overall Study|Ineligible to continue the trial|1|||
162657733|NCT00528528|587459728|FG000|Overall Study|Other|0|||
162657734|NCT00528528|587459729|FG001|Overall Study|Other|1|||
162657735|NCT00528528|587459730|FG002|Overall Study|Other|0|||
162657736|NCT00528528|587459731|FG003|Overall Study|Other|0|||
162657737|NCT00528528|587459728|FG000|Overall Study|Withdrawal by Subject|3|||
163131194|NCT00098306|589188248|FG002|Open Label|Un-specified|0|||
163131195|NCT00098306|589188249|FG003|Open Label|Un-specified|15|||
163131196|NCT00098306|589188250|FG004|Open Label|Un-specified|0|||
163131197|NCT00098306|589188251|FG005|Open Label|Un-specified|0|||
163131198|NCT00098306|589188252|FG006|Open Label|Un-specified|0|||
163131199|NCT00098306|589188246|FG000|Open Label|Ongoing at cut-off date|0|||
163131200|NCT00098306|589188247|FG001|Open Label|Ongoing at cut-off date|0|||
163131201|NCT00098306|589188248|FG002|Open Label|Ongoing at cut-off date|0|||
163131202|NCT00098306|589188249|FG003|Open Label|Ongoing at cut-off date|269|||
163131203|NCT00098306|589188250|FG004|Open Label|Ongoing at cut-off date|62|||
163131204|NCT00098306|589188251|FG005|Open Label|Ongoing at cut-off date|0|||
163131205|NCT00098306|589188252|FG006|Open Label|Ongoing at cut-off date|0|||
163131206|NCT00098306|589188246|FG000|Observational Phase|Death|0|||
163131207|NCT00098306|589188247|FG001|Observational Phase|Death|0|||
163131208|NCT00098306|589188248|FG002|Observational Phase|Death|0|||
163131209|NCT00098306|589188249|FG003|Observational Phase|Death|0|||
163131210|NCT00098306|589188250|FG004|Observational Phase|Death|0|||
163131211|NCT00098306|589188251|FG005|Observational Phase|Death|5|||
163131212|NCT00098306|589188252|FG006|Observational Phase|Death|4|||
163131213|NCT00098306|589188246|FG000|Observational Phase|Participant defaulted|0|||
163131214|NCT00098306|589188247|FG001|Observational Phase|Participant defaulted|0|||
163131215|NCT00098306|589188248|FG002|Observational Phase|Participant defaulted|0|||
163131216|NCT00098306|589188249|FG003|Observational Phase|Participant defaulted|0|||
163131217|NCT00098306|589188250|FG004|Observational Phase|Participant defaulted|0|||
162657738|NCT00528528|587459729|FG001|Overall Study|Withdrawal by Subject|2|||
162657739|NCT00528528|587459730|FG002|Overall Study|Withdrawal by Subject|1|||
162657740|NCT00528528|587459731|FG003|Overall Study|Withdrawal by Subject|1|||
163131218|NCT00098306|589188251|FG005|Observational Phase|Participant defaulted|34|||
163131219|NCT00098306|589188252|FG006|Observational Phase|Participant defaulted|18|||
163131220|NCT00098306|589188246|FG000|Observational Phase|Un-specified|0|||
163131221|NCT00098306|589188247|FG001|Observational Phase|Un-specified|0|||
163131222|NCT00098306|589188248|FG002|Observational Phase|Un-specified|0|||
163131223|NCT00098306|589188249|FG003|Observational Phase|Un-specified|0|||
162657741|NCT00528528|587459728|FG000|Overall Study|Ongoing participant|0|||
163131224|NCT00098306|589188250|FG004|Observational Phase|Un-specified|0|||
163131225|NCT00098306|589188251|FG005|Observational Phase|Un-specified|7|||
163131226|NCT00098306|589188252|FG006|Observational Phase|Un-specified|4|||
163131227|NCT00077649|589188253|FG000|Overall Study|Adverse Event|5|||
163131228|NCT00077649|589188254|FG001|Overall Study|Adverse Event|1|||
163131229|NCT00077649|589188255|FG002|Overall Study|Adverse Event|7|||
163131230|NCT00077649|589188256|FG003|Overall Study|Adverse Event|9|||
163131231|NCT00077649|589188253|FG000|Overall Study|Lack of Efficacy|5|||
163131232|NCT00077649|589188254|FG001|Overall Study|Lack of Efficacy|3|||
163131233|NCT00077649|589188255|FG002|Overall Study|Lack of Efficacy|3|||
163131234|NCT00077649|589188256|FG003|Overall Study|Lack of Efficacy|2|||
163131235|NCT00077649|589188253|FG000|Overall Study|Withdrawal by Subject|0|||
163131236|NCT00077649|589188254|FG001|Overall Study|Withdrawal by Subject|1|||
163131237|NCT00077649|589188255|FG002|Overall Study|Withdrawal by Subject|1|||
163131238|NCT00077649|589188256|FG003|Overall Study|Withdrawal by Subject|2|||
163131239|NCT00077649|589188253|FG000|Overall Study|Lost to Follow-up|2|||
163131240|NCT00077649|589188254|FG001|Overall Study|Lost to Follow-up|2|||
163131241|NCT00077649|589188255|FG002|Overall Study|Lost to Follow-up|3|||
163131242|NCT00077649|589188256|FG003|Overall Study|Lost to Follow-up|2|||
163131243|NCT00077649|589188253|FG000|Overall Study|Abnormality of Laboratory Test|1|||
163131244|NCT00077649|589188254|FG001|Overall Study|Abnormality of Laboratory Test|2|||
163131245|NCT00077649|589188255|FG002|Overall Study|Abnormality of Laboratory Test|1|||
163131246|NCT00077649|589188256|FG003|Overall Study|Abnormality of Laboratory Test|2|||
163131247|NCT00077649|589188253|FG000|Overall Study|Randomized but never dosed|1|||
163131248|NCT00077649|589188254|FG001|Overall Study|Randomized but never dosed|0|||
163131249|NCT00077649|589188255|FG002|Overall Study|Randomized but never dosed|0|||
163131250|NCT00077649|589188256|FG003|Overall Study|Randomized but never dosed|0|||
163131251|NCT03550404|589188259|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
163131252|NCT03550404|589188260|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
163131253|NCT03550404|589188261|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
162657742|NCT00528528|587459729|FG001|Overall Study|Ongoing participant|0|||
162657743|NCT00528528|587459730|FG002|Overall Study|Ongoing participant|1|||
162657744|NCT00528528|587459731|FG003|Overall Study|Ongoing participant|0|||
163131254|NCT03550404|589188259|FG000|Phase 2|Vacated position|1|||
163131255|NCT03550404|589188260|FG001|Phase 2|Vacated position|0|||
163131256|NCT03550404|589188261|FG002|Phase 2|Vacated position|0|||
163131257|NCT00820222|589188263|FG000|Overall Study|Lost to Follow-up|10|||
162657745|NCT00773097|587459732|FG000|Overall Study|Withdrawal by Subject|1|||
162657746|NCT00773097|587459732|FG000|Overall Study|Physician Decision|6|||
162657747|NCT04602624|587459740|FG000|Overall Study|Protocol Deviation|1|||
162657748|NCT04602624|587459740|FG000|Overall Study|Withdrawal by Participant|1|||
162657749|NCT04084769|587459741|FG000|Overall Study|Protocol Violation|1|||
162657750|NCT04084769|587459742|FG001|Overall Study|Protocol Violation|3|||
162657751|NCT04084769|587459743|FG002|Overall Study|Protocol Violation|0|||
162657752|NCT04084769|587459744|FG003|Overall Study|Protocol Violation|1|||
162657753|NCT04084769|587459741|FG000|Overall Study|Withdrawal by Subject|0|||
162657754|NCT04084769|587459742|FG001|Overall Study|Withdrawal by Subject|1|||
162657755|NCT04084769|587459743|FG002|Overall Study|Withdrawal by Subject|0|||
162657756|NCT04084769|587459744|FG003|Overall Study|Withdrawal by Subject|0|||
162657757|NCT04084769|587459741|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162657758|NCT04084769|587459742|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162657759|NCT04084769|587459743|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162657760|NCT04084769|587459744|FG003|Overall Study|Withdrawal by parent/guardian|1|||
162657761|NCT04084769|587459741|FG000|Overall Study|Lost to Follow-up|2|||
162657762|NCT04084769|587459742|FG001|Overall Study|Lost to Follow-up|0|||
162657763|NCT04084769|587459743|FG002|Overall Study|Lost to Follow-up|0|||
162657764|NCT04084769|587459744|FG003|Overall Study|Lost to Follow-up|0|||
162657765|NCT00316199|587459745|FG000|Overall Study|Adverse Event|2|||
162657766|NCT00316199|587459745|FG000|Overall Study|Death|8|||
162657767|NCT00316199|587459745|FG000|Overall Study|Lost to Follow-up|2|||
162657768|NCT00590954|587459746|FG000|Overall Study|Inevaluable|2|||
162657769|NCT04477304|587459747|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
162657770|NCT04477304|587459748|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
162657771|NCT02782949|587459750|FG000|Overall Study|Protocol Violation|1|||
162657772|NCT02782949|587459751|FG001|Overall Study|Protocol Violation|0|||
162657773|NCT02782949|587459750|FG000|Overall Study|Withdrawal by Subject|0|||
162657774|NCT02782949|587459751|FG001|Overall Study|Withdrawal by Subject|1|||
162657775|NCT03238911|587459754|FG000|Overall Study|Withdrawal by Subject|1|||
162657776|NCT03238911|587459755|FG001|Overall Study|Withdrawal by Subject|2|||
162657777|NCT03238911|587459754|FG000|Overall Study|Lost to Follow-up|2|||
162657778|NCT03238911|587459755|FG001|Overall Study|Lost to Follow-up|1|||
162657779|NCT03091192|587459759|FG000|Overall Study|Study terminated by sponsor|21|||
162657780|NCT03091192|587459760|FG001|Overall Study|Study terminated by sponsor|14|||
162657781|NCT03091192|587459759|FG000|Overall Study|Death|9|||
162657782|NCT03091192|587459760|FG001|Overall Study|Death|13|||
162657783|NCT03091192|587459759|FG000|Overall Study|Withdrawal by Subject|2|||
162657784|NCT03091192|587459760|FG001|Overall Study|Withdrawal by Subject|0|||
162657785|NCT03091192|587459759|FG000|Overall Study|Lost to Follow-up|1|||
162657786|NCT03091192|587459760|FG001|Overall Study|Lost to Follow-up|0|||
162657787|NCT05645432|587459761|FG000|Overall Study|Withdrawal by Subject|1|||
162657788|NCT03195478|587459762|FG000|Overall Study|Disease Progression|5|||
162657789|NCT03195478|587459763|FG001|Overall Study|Disease Progression|4|||
162657790|NCT03195478|587459764|FG002|Overall Study|Disease Progression|6|||
162657791|NCT03195478|587459765|FG003|Overall Study|Disease Progression|1|||
162657792|NCT03195478|587459762|FG000|Overall Study|Study Drug Toxicity|2|||
162657793|NCT03195478|587459763|FG001|Overall Study|Study Drug Toxicity|0|||
162657794|NCT03195478|587459764|FG002|Overall Study|Study Drug Toxicity|0|||
162657795|NCT03195478|587459765|FG003|Overall Study|Study Drug Toxicity|1|||
162657796|NCT03195478|587459762|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162657797|NCT03195478|587459763|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
162657798|NCT03195478|587459764|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162657799|NCT03195478|587459765|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
162657800|NCT03195478|587459762|FG000|Overall Study|Participant Withdrew Consent|1|||
162657801|NCT03195478|587459763|FG001|Overall Study|Participant Withdrew Consent|0|||
162657802|NCT03195478|587459764|FG002|Overall Study|Participant Withdrew Consent|0|||
162657803|NCT03195478|587459765|FG003|Overall Study|Participant Withdrew Consent|0|||
162657804|NCT03195478|587459762|FG000|Overall Study|Maximum Clinical benefit|0|||
162657805|NCT03195478|587459763|FG001|Overall Study|Maximum Clinical benefit|0|||
162657806|NCT03195478|587459764|FG002|Overall Study|Maximum Clinical benefit|1|||
162657807|NCT03195478|587459765|FG003|Overall Study|Maximum Clinical benefit|0|||
162657808|NCT03195478|587459762|FG000|Overall Study|Other Reasons|0|||
162657809|NCT03195478|587459763|FG001|Overall Study|Other Reasons|0|||
162657810|NCT03195478|587459764|FG002|Overall Study|Other Reasons|1|||
162657811|NCT03195478|587459765|FG003|Overall Study|Other Reasons|0|||
162657812|NCT03370341|587461145|FG000|Overall Study|Lost to Follow-up|0|||
162657813|NCT03370341|587461146|FG001|Overall Study|Lost to Follow-up|1|||
162657814|NCT01707004|587461149|FG000|Overall Study|Physician Decision|3|||
162657815|NCT02573324|587461153|FG000|Overall Study|Withdrawal by Subject|26|||
162657816|NCT02573324|587461154|FG001|Overall Study|Withdrawal by Subject|23|||
162657817|NCT02573324|587461155|FG002|Overall Study|Withdrawal by Subject|3|||
162657818|NCT02573324|587461153|FG000|Overall Study|Lost to Follow-up|4|||
162657819|NCT02573324|587461154|FG001|Overall Study|Lost to Follow-up|5|||
162657820|NCT02573324|587461155|FG002|Overall Study|Lost to Follow-up|0|||
162657821|NCT02573324|587461153|FG000|Overall Study|Study Terminated by Sponsor|107|||
162657822|NCT02573324|587461154|FG001|Overall Study|Study Terminated by Sponsor|89|||
162657823|NCT02573324|587461155|FG002|Overall Study|Study Terminated by Sponsor|2|||
162657824|NCT02573324|587461153|FG000|Overall Study|Death|182|||
162657825|NCT02573324|587461154|FG001|Overall Study|Death|200|||
162657826|NCT02573324|587461155|FG002|Overall Study|Death|1|||
162657827|NCT02573324|587461153|FG000|Overall Study|Other, Not Specified|20|||
162657828|NCT02573324|587461154|FG001|Overall Study|Other, Not Specified|27|||
162657829|NCT02573324|587461155|FG002|Overall Study|Other, Not Specified|0|||
162657830|NCT02573324|587461153|FG000|Overall Study|Unknown Reason|2|||
162657831|NCT02573324|587461154|FG001|Overall Study|Unknown Reason|0|||
162657832|NCT02573324|587461155|FG002|Overall Study|Unknown Reason|0|||
162657833|NCT00194012|587461156|FG000|Randomized Phase|Lack of Efficacy|8|||
162719815|NCT03386929|587680589|FG000|Overall Study|Physician Decision|0|||
162719816|NCT03386929|587680590|FG001|Overall Study|Physician Decision|0|||
163131258|NCT00820222|589188264|FG001|Overall Study|Lost to Follow-up|9|||
163131259|NCT00820222|589188263|FG000|Overall Study|Withdrawal by Subject|19|||
163131260|NCT00820222|589188264|FG001|Overall Study|Withdrawal by Subject|21|||
163131261|NCT00820222|589188263|FG000|Overall Study|Physician Decision|93|||
163131262|NCT00820222|589188264|FG001|Overall Study|Physician Decision|88|||
163131263|NCT00820222|589188263|FG000|Overall Study|Sponsor Terminated Study|43|||
163131264|NCT00820222|589188264|FG001|Overall Study|Sponsor Terminated Study|65|||
163131265|NCT00820222|589188263|FG000|Overall Study|Unkown|11|||
163131266|NCT00820222|589188264|FG001|Overall Study|Unkown|7|||
163131267|NCT02690714|589188265|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
163131268|NCT02690714|589188265|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
163131269|NCT00293020|589188266|FG000|Overall Study|Withdrawal by Subject|34|||
163131270|NCT00293020|589188266|FG000|Overall Study|Adverse Event|30|||
163131271|NCT00293020|589188266|FG000|Overall Study|Death|32|||
163131272|NCT00293020|589188266|FG000|Overall Study|Lack of Efficacy|12|||
163131273|NCT00293020|589188266|FG000|Overall Study|Lost to Follow-up|4|||
163131274|NCT00293020|589188266|FG000|Overall Study|Protocol Violation|6|||
163131275|NCT00293020|589188266|FG000|Overall Study|Physician Decision|21|||
163131276|NCT00293020|589188266|FG000|Overall Study|Other Reason|22|||
163131277|NCT00293020|589188266|FG000|Overall Study|No dose taken|1|||
163131278|NCT01336023|589188267|FG000|Week 0 to Week 26|Adverse Event|8|||
163131279|NCT01336023|589188268|FG001|Week 0 to Week 26|Adverse Event|10|||
163131280|NCT01336023|589188269|FG002|Week 0 to Week 26|Adverse Event|24|||
163131281|NCT01336023|589188267|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
163131282|NCT01336023|589188268|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
163131283|NCT01336023|589188269|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
163131284|NCT01336023|589188267|FG000|Week 0 to Week 26|Protocol Violation|1|||
163131285|NCT01336023|589188268|FG001|Week 0 to Week 26|Protocol Violation|2|||
163131286|NCT01336023|589188269|FG002|Week 0 to Week 26|Protocol Violation|0|||
163131287|NCT01336023|589188267|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
163131288|NCT01336023|589188268|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
163131289|NCT01336023|589188269|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
163131290|NCT01336023|589188267|FG000|Week 0 to Week 26|Unclassified|5|||
163131291|NCT01336023|589188268|FG001|Week 0 to Week 26|Unclassified|16|||
163131292|NCT01336023|589188269|FG002|Week 0 to Week 26|Unclassified|9|||
163131293|NCT01336023|589188267|FG000|Week 27 to 52|Adverse Event|1|||
163131294|NCT01336023|589188268|FG001|Week 27 to 52|Adverse Event|5|||
163131295|NCT01336023|589188269|FG002|Week 27 to 52|Adverse Event|2|||
163131296|NCT01336023|589188267|FG000|Week 27 to 52|Protocol Violation|0|||
163131297|NCT01336023|589188268|FG001|Week 27 to 52|Protocol Violation|2|||
163131298|NCT01336023|589188269|FG002|Week 27 to 52|Protocol Violation|1|||
163131299|NCT01336023|589188267|FG000|Week 27 to 52|Withdrawal Criteria|14|||
163131300|NCT01336023|589188268|FG001|Week 27 to 52|Withdrawal Criteria|19|||
163131301|NCT01336023|589188269|FG002|Week 27 to 52|Withdrawal Criteria|16|||
163131302|NCT01336023|589188267|FG000|Week 27 to 52|Unclassified|13|||
163131303|NCT01336023|589188268|FG001|Week 27 to 52|Unclassified|18|||
163131304|NCT01336023|589188269|FG002|Week 27 to 52|Unclassified|9|||
163131305|NCT01894022|589188272|FG000|Overall Study|Death|1|||
163131306|NCT01894022|589188273|FG001|Overall Study|Death|0|||
162657834|NCT00194012|587461157|FG001|Randomized Phase|Lack of Efficacy|18|||
163131307|NCT01894022|589188272|FG000|Overall Study|Adverse Event, non-fatal|1|||
163131308|NCT01894022|589188273|FG001|Overall Study|Adverse Event, non-fatal|0|||
163131309|NCT01894022|589188272|FG000|Overall Study|Study Closed/terminated|7|||
163131310|NCT01894022|589188273|FG001|Overall Study|Study Closed/terminated|10|||
163131311|NCT04496453|589188274|FG000|Overall Study|Lost to Follow-up|6|||
163131312|NCT00767819|589188275|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
163131313|NCT00767819|589188276|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
162657835|NCT00194012|587461156|FG000|Randomized Phase|Study nonadherence|2|||
163131314|NCT00767819|589188277|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162657836|NCT00194012|587461157|FG001|Randomized Phase|Study nonadherence|1|||
162719817|NCT03386929|587680591|FG002|Overall Study|Physician Decision|1|||
163131315|NCT00767819|589188275|FG000|Overall Study|Withdrawal by Subject|1|||
163131316|NCT00767819|589188276|FG001|Overall Study|Withdrawal by Subject|1|||
162657837|NCT00194012|587461156|FG000|Randomized Phase|Withdrawal by Subject|3|||
162657838|NCT00194012|587461157|FG001|Randomized Phase|Withdrawal by Subject|3|||
162657839|NCT00194012|587461156|FG000|Randomized Phase|Adverse Event|2|||
162657840|NCT00194012|587461157|FG001|Randomized Phase|Adverse Event|1|||
162657841|NCT00194012|587461156|FG000|Randomized Phase|Participant reported having a rash|1|||
163131317|NCT00767819|589188277|FG002|Overall Study|Withdrawal by Subject|0|||
163131318|NCT00767819|589188275|FG000|Overall Study|Administrative problems|0|||
163131319|NCT00767819|589188276|FG001|Overall Study|Administrative problems|1|||
163131320|NCT00767819|589188277|FG002|Overall Study|Administrative problems|0|||
163131321|NCT00767819|589188275|FG000|Overall Study|Death|2|||
163131322|NCT00767819|589188276|FG001|Overall Study|Death|3|||
163131323|NCT00767819|589188277|FG002|Overall Study|Death|0|||
163131324|NCT00767819|589188275|FG000|Overall Study|Adverse Event|2|||
163131325|NCT00767819|589188276|FG001|Overall Study|Adverse Event|0|||
163131326|NCT00767819|589188277|FG002|Overall Study|Adverse Event|0|||
163131327|NCT00767819|589188275|FG000|Overall Study|Abnormal lab values|1|||
163131328|NCT00767819|589188276|FG001|Overall Study|Abnormal lab values|0|||
163131329|NCT00767819|589188277|FG002|Overall Study|Abnormal lab values|0|||
163131330|NCT00767819|589188275|FG000|Overall Study|Lost to Follow-up|1|||
163131331|NCT00767819|589188276|FG001|Overall Study|Lost to Follow-up|0|||
163131332|NCT00767819|589188277|FG002|Overall Study|Lost to Follow-up|0|||
163131333|NCT03916081|589188278|FG000|Overall Study|Adverse Event|1|||
163131334|NCT03916081|589188279|FG001|Overall Study|Adverse Event|0|||
163131335|NCT03916081|589188280|FG002|Overall Study|Adverse Event|0|||
163131336|NCT03916081|589188278|FG000|Overall Study|Physician Decision|0|||
163131337|NCT03916081|589188279|FG001|Overall Study|Physician Decision|0|||
163131338|NCT03916081|589188280|FG002|Overall Study|Physician Decision|1|||
163131339|NCT03916081|589188278|FG000|Overall Study|Lost to Follow-up|0|||
163131340|NCT03916081|589188279|FG001|Overall Study|Lost to Follow-up|1|||
163131341|NCT03916081|589188280|FG002|Overall Study|Lost to Follow-up|0|||
163131342|NCT03916081|589188278|FG000|Overall Study|Withdrawal by Subject|3|||
163131343|NCT03916081|589188279|FG001|Overall Study|Withdrawal by Subject|0|||
163131344|NCT03916081|589188280|FG002|Overall Study|Withdrawal by Subject|1|||
163131345|NCT03916081|589188278|FG000|Overall Study|Worsening of AD|0|||
163131346|NCT03916081|589188279|FG001|Overall Study|Worsening of AD|0|||
163131347|NCT03916081|589188280|FG002|Overall Study|Worsening of AD|1|||
163131348|NCT00235716|589188281|FG000|Overall Study|Death|26|||
163131349|NCT00235716|589188282|FG001|Overall Study|Death|39|||
163131350|NCT00235716|589188283|FG002|Overall Study|Death|32|||
163131351|NCT00235716|589188284|FG003|Overall Study|Death|31|||
163131352|NCT00235716|589188281|FG000|Overall Study|Withdrawal by Subject|23|||
163131353|NCT00235716|589188282|FG001|Overall Study|Withdrawal by Subject|19|||
163131354|NCT00235716|589188283|FG002|Overall Study|Withdrawal by Subject|17|||
163131355|NCT00235716|589188284|FG003|Overall Study|Withdrawal by Subject|18|||
163131356|NCT00235716|589188281|FG000|Overall Study|Lost to Follow-up|12|||
163131357|NCT00235716|589188282|FG001|Overall Study|Lost to Follow-up|7|||
163131358|NCT00235716|589188283|FG002|Overall Study|Lost to Follow-up|14|||
163131359|NCT00235716|589188284|FG003|Overall Study|Lost to Follow-up|10|||
163131360|NCT00235716|589188281|FG000|Overall Study|Adverse Event|1|||
163131361|NCT00235716|589188282|FG001|Overall Study|Adverse Event|1|||
163131362|NCT00235716|589188283|FG002|Overall Study|Adverse Event|1|||
163131363|NCT00235716|589188284|FG003|Overall Study|Adverse Event|0|||
163131364|NCT00235716|589188281|FG000|Overall Study|Physician Decision|0|||
163131365|NCT00235716|589188282|FG001|Overall Study|Physician Decision|1|||
163131366|NCT00235716|589188283|FG002|Overall Study|Physician Decision|1|||
163131367|NCT00235716|589188284|FG003|Overall Study|Physician Decision|3|||
163131368|NCT01545050|589188285|FG000|Overall Study|Lack of Efficacy|0|||
163131369|NCT01545050|589188286|FG001|Overall Study|Lack of Efficacy|0|||
163131370|NCT01545050|589188287|FG002|Overall Study|Lack of Efficacy|0|||
163131371|NCT01545050|589188288|FG003|Overall Study|Lack of Efficacy|3|||
163131372|NCT01545050|589188289|FG004|Overall Study|Lack of Efficacy|2|||
163131373|NCT01545050|589188285|FG000|Overall Study|Adverse Event|1|||
163131374|NCT01545050|589188286|FG001|Overall Study|Adverse Event|1|||
163131375|NCT01545050|589188287|FG002|Overall Study|Adverse Event|2|||
163131376|NCT01545050|589188288|FG003|Overall Study|Adverse Event|2|||
163131377|NCT01545050|589188289|FG004|Overall Study|Adverse Event|0|||
163131378|NCT01545050|589188285|FG000|Overall Study|Discontinued study treatment|1|||
163131379|NCT01545050|589188286|FG001|Overall Study|Discontinued study treatment|0|||
163131380|NCT01545050|589188287|FG002|Overall Study|Discontinued study treatment|0|||
163131381|NCT01545050|589188288|FG003|Overall Study|Discontinued study treatment|0|||
163131382|NCT01545050|589188289|FG004|Overall Study|Discontinued study treatment|0|||
163131383|NCT01545050|589188285|FG000|Overall Study|Withdrawal by Subject|1|||
163131384|NCT01545050|589188286|FG001|Overall Study|Withdrawal by Subject|0|||
163131385|NCT01545050|589188287|FG002|Overall Study|Withdrawal by Subject|0|||
163131386|NCT01545050|589188288|FG003|Overall Study|Withdrawal by Subject|2|||
163131387|NCT01545050|589188289|FG004|Overall Study|Withdrawal by Subject|1|||
163131388|NCT01545050|589188285|FG000|Overall Study|Participant no longer meets study criteria|0|||
163131389|NCT01545050|589188286|FG001|Overall Study|Participant no longer meets study criteria|2|||
163131390|NCT01545050|589188287|FG002|Overall Study|Participant no longer meets study criteria|0|||
163131391|NCT01545050|589188288|FG003|Overall Study|Participant no longer meets study criteria|0|||
162719818|NCT03386929|587680589|FG000|Overall Study|Progression|4|||
163131392|NCT01545050|589188289|FG004|Overall Study|Participant no longer meets study criteria|1|||
163131393|NCT01545050|589188285|FG000|Overall Study|Administrative reason by sponsor|4|||
162657842|NCT00194012|587461157|FG001|Randomized Phase|Participant reported having a rash|0|||
162657843|NCT00194012|587461156|FG000|Randomized Phase|Emesis and enuresis|0|||
162657844|NCT00194012|587461157|FG001|Randomized Phase|Emesis and enuresis|1|||
162657845|NCT00194012|587461156|FG000|Randomized Phase|Oral/nasal twitching|0|||
162657846|NCT00194012|587461157|FG001|Randomized Phase|Oral/nasal twitching|1|||
162657847|NCT00194012|587461156|FG000|Open Label Extension (OLE)|Weight Gain|1|||
162657848|NCT00194012|587461157|FG001|Open Label Extension (OLE)|Weight Gain|0|||
163131394|NCT01545050|589188286|FG001|Overall Study|Administrative reason by sponsor|2|||
163131395|NCT01545050|589188287|FG002|Overall Study|Administrative reason by sponsor|3|||
163131396|NCT01545050|589188288|FG003|Overall Study|Administrative reason by sponsor|5|||
163131397|NCT01545050|589188289|FG004|Overall Study|Administrative reason by sponsor|5|||
163131398|NCT02249182|589188290|FG000|Treatment Phase|Lost to Follow-up|4|||
163131399|NCT02249182|589188291|FG001|Treatment Phase|Lost to Follow-up|0|||
163131400|NCT02249182|589188292|FG002|Treatment Phase|Lost to Follow-up|0|||
163131401|NCT02249182|589188293|FG003|Treatment Phase|Lost to Follow-up|0|||
163131402|NCT02249182|589188294|FG004|Treatment Phase|Lost to Follow-up|0|||
163131403|NCT03244826|589188301|FG000|Overall Study|Withdrawal by Subject|2|||
163131404|NCT03244826|589188302|FG001|Overall Study|Withdrawal by Subject|0|||
163131405|NCT03244826|589188301|FG000|Overall Study|Transplant delayed or withdrawn|12|||
163131406|NCT03244826|589188302|FG001|Overall Study|Transplant delayed or withdrawn|10|||
163131407|NCT04356040|589188303|FG000|Overall Study|Death|2|||
163131408|NCT04356040|589188304|FG001|Overall Study|Death|0|||
163131409|NCT04356040|589188303|FG000|Overall Study|Lost to Follow-up|1|||
163131410|NCT04356040|589188304|FG001|Overall Study|Lost to Follow-up|0|||
163131411|NCT04356040|589188303|FG000|Overall Study|Physician Decision|0|||
163131412|NCT04356040|589188304|FG001|Overall Study|Physician Decision|1|||
163131413|NCT04356040|589188303|FG000|Overall Study|Withdrawal by Subject|13|||
163131414|NCT04356040|589188304|FG001|Overall Study|Withdrawal by Subject|1|||
163131415|NCT04356040|589188303|FG000|Overall Study|Enrollment Pause|10|||
163131416|NCT04356040|589188304|FG001|Overall Study|Enrollment Pause|0|||
163131417|NCT04356040|589188303|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
163131418|NCT04356040|589188304|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
163131419|NCT04356040|589188303|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
163131420|NCT04356040|589188304|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
163131421|NCT04356040|589188303|FG000|Overall Study|PI left institution|3|||
163131422|NCT04356040|589188304|FG001|Overall Study|PI left institution|0|||
163131423|NCT00416455|589188305|FG000|Overall Study|PET / CT not done|3|||
163131424|NCT00416455|589188306|FG001|Overall Study|PET / CT not done|5|||
163131425|NCT00416455|589188305|FG000|Overall Study|PET / CT poor quality|2|||
163131426|NCT00416455|589188306|FG001|Overall Study|PET / CT poor quality|1|||
163131427|NCT00416455|589188305|FG000|Overall Study|Inadequate pathology|11|||
163131428|NCT00416455|589188306|FG001|Overall Study|Inadequate pathology|2|||
163131429|NCT00360568|589188307|FG000|Overall Study|Adverse Event|1|||
163131430|NCT00360568|589188308|FG001|Overall Study|Adverse Event|2|||
163131431|NCT00360568|589188307|FG000|Overall Study|Lack of Efficacy|1|||
163131432|NCT00360568|589188308|FG001|Overall Study|Lack of Efficacy|0|||
163131433|NCT00360568|589188307|FG000|Overall Study|Withdrawal by Subject|0|||
163131434|NCT00360568|589188308|FG001|Overall Study|Withdrawal by Subject|3|||
163131435|NCT01008449|589188309|FG000|Overall Study|Lost to Follow-up|29|||
163131436|NCT01008449|589188310|FG001|Overall Study|Lost to Follow-up|19|||
163131437|NCT01114438|589188311|FG000|Overall Study|Adverse Event|10|||
163131438|NCT01114438|589188311|FG000|Overall Study|concomitant medication|1|||
163131439|NCT01114438|589188311|FG000|Overall Study|Physician Decision|1|||
163131440|NCT01114438|589188311|FG000|Overall Study|Withdrawal by Subject|2|||
163131441|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Adverse Event|2|||
163131442|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Adverse Event|4|||
163131443|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Adverse Event|4|||
163131444|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
163131445|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
163131446|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
163131447|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
162657849|NCT00194012|587461156|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
163131448|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
163131449|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
163131450|NCT00428844|589188314|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
163131451|NCT00428844|589188315|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
163131452|NCT00428844|589188316|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
162657850|NCT00194012|587461157|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
162657851|NCT00194012|587461156|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
163131453|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
163131454|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
163131455|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
162657852|NCT00194012|587461157|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
163131456|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
163131457|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
163131458|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
163131459|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
163131460|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
163131461|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
163131462|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
163131463|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
163131464|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
163131465|NCT00428844|589188314|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
163131466|NCT00428844|589188315|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
163131467|NCT00428844|589188316|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
163131468|NCT03043651|589188319|FG000|Overall Study|Death|1|||
163131469|NCT03043651|589188319|FG000|Overall Study|Progressive Disease|2|||
163131470|NCT03043651|589188319|FG000|Overall Study|Adverse Event|2|||
163131471|NCT03043651|589188319|FG000|Overall Study|Withdrawal by Subject|4|||
163131472|NCT03043651|589188319|FG000|Overall Study|Study Terminated by Sponsor|39|||
163131473|NCT02353728|589188320|FG000|Overall Study|Subject non-compliance|1|||
163131474|NCT02611817|589190936|FG000|Open-label Induction Phase|Reason not Specified|9|||
163131475|NCT02611817|589190937|FG001|Open-label Induction Phase|Reason not Specified|0|||
163131476|NCT02611817|589190938|FG002|Open-label Induction Phase|Reason not Specified|0|||
163131477|NCT02611817|589190936|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
163131478|NCT02611817|589190937|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
163131479|NCT02611817|589190938|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
163131480|NCT02611817|589190936|FG000|Open-label Induction Phase|Pregnancy|1|||
163131481|NCT02611817|589190937|FG001|Open-label Induction Phase|Pregnancy|0|||
163131482|NCT02611817|589190938|FG002|Open-label Induction Phase|Pregnancy|0|||
163131483|NCT02611817|589190936|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
163131484|NCT02611817|589190937|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
163131485|NCT02611817|589190938|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
163131486|NCT02611817|589190936|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
163131487|NCT02611817|589190937|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
163131488|NCT02611817|589190938|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
163131489|NCT02611817|589190936|FG000|Open-label Induction Phase|Protocol Violation|5|||
163131490|NCT02611817|589190937|FG001|Open-label Induction Phase|Protocol Violation|0|||
163131491|NCT02611817|589190938|FG002|Open-label Induction Phase|Protocol Violation|0|||
163131492|NCT02611817|589190936|FG000|Open-label Induction Phase|Adverse Event|16|||
163131493|NCT02611817|589190937|FG001|Open-label Induction Phase|Adverse Event|0|||
163131494|NCT02611817|589190938|FG002|Open-label Induction Phase|Adverse Event|0|||
163131495|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
163131496|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
163131497|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
163131498|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
163131499|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
163131500|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
163131501|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
163131502|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
163131503|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
163131504|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
163131505|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
163131506|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
163131507|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
163131508|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
163131509|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
163131510|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
163131511|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
163131512|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
163131513|NCT02611817|589190936|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
163131514|NCT02611817|589190937|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
163131515|NCT02611817|589190938|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
163131516|NCT00265317|589190939|FG000|Lead-In|Objective progression or relapse|6|||
163131517|NCT00265317|589190940|FG001|Lead-In|Objective progression or relapse|11|||
163131518|NCT00265317|589190941|FG002|Lead-In|Objective progression or relapse|0|||
163131519|NCT00265317|589190942|FG003|Lead-In|Objective progression or relapse|0|||
163131520|NCT00265317|589190939|FG000|Lead-In|Adverse Event|2|||
163131521|NCT00265317|589190940|FG001|Lead-In|Adverse Event|1|||
163131522|NCT00265317|589190941|FG002|Lead-In|Adverse Event|0|||
163131523|NCT00265317|589190942|FG003|Lead-In|Adverse Event|0|||
163131524|NCT00265317|589190939|FG000|Lead-In|Death|3|||
163131525|NCT00265317|589190940|FG001|Lead-In|Death|5|||
163131526|NCT00265317|589190941|FG002|Lead-In|Death|0|||
163131527|NCT00265317|589190942|FG003|Lead-In|Death|0|||
163131528|NCT00265317|589190939|FG000|Lead-In|Withdrawal/other than adverse event|1|||
163131529|NCT00265317|589190940|FG001|Lead-In|Withdrawal/other than adverse event|0|||
163131530|NCT00265317|589190941|FG002|Lead-In|Withdrawal/other than adverse event|0|||
163131531|NCT00265317|589190942|FG003|Lead-In|Withdrawal/other than adverse event|0|||
163131532|NCT00265317|589190939|FG000|Phase 2|Objective progression or relapse|0|||
163131533|NCT00265317|589190940|FG001|Phase 2|Objective progression or relapse|0|||
163131534|NCT00265317|589190941|FG002|Phase 2|Objective progression or relapse|37|||
163131535|NCT00265317|589190942|FG003|Phase 2|Objective progression or relapse|38|||
163131536|NCT00265317|589190939|FG000|Phase 2|Global deterioration of health status|0|||
163131537|NCT00265317|589190940|FG001|Phase 2|Global deterioration of health status|0|||
163131538|NCT00265317|589190941|FG002|Phase 2|Global deterioration of health status|3|||
163131539|NCT00265317|589190942|FG003|Phase 2|Global deterioration of health status|0|||
163131540|NCT00265317|589190939|FG000|Phase 2|Adverse Event|0|||
163131541|NCT00265317|589190940|FG001|Phase 2|Adverse Event|0|||
163131542|NCT00265317|589190941|FG002|Phase 2|Adverse Event|7|||
163131543|NCT00265317|589190942|FG003|Phase 2|Adverse Event|5|||
163131544|NCT00265317|589190939|FG000|Phase 2|Death|0|||
162657853|NCT00194012|587461156|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
162657854|NCT00194012|587461157|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
162657855|NCT03892889|587461158|FG000|Overall Study|Adverse Event|17|||
162657856|NCT03892889|587461158|FG000|Overall Study|Lack of Efficacy|1|||
162657857|NCT03892889|587461158|FG000|Overall Study|Lost to Follow-up|46|||
162657858|NCT03892889|587461158|FG000|Overall Study|Non-compliance with study drug|22|||
162657859|NCT03892889|587461158|FG000|Overall Study|Pregnancy|1|||
162657860|NCT03892889|587461158|FG000|Overall Study|Protocol Deviation|3|||
162657861|NCT03892889|587461158|FG000|Overall Study|Withdrawal by Subject|50|||
162657862|NCT03892889|587461158|FG000|Overall Study|Withdrawal by Caregiver|1|||
162657863|NCT03892889|587461158|FG000|Overall Study|Study Terminated by Sponsor|50|||
162657864|NCT03892889|587461158|FG000|Overall Study|Physician Decision|8|||
162657865|NCT03892889|587461158|FG000|Overall Study|Reason not Specified|5|||
162657866|NCT01639001|587461164|FG000|Overall Study|Refused further follow-up|9|||
162657867|NCT01639001|587461165|FG001|Overall Study|Refused further follow-up|12|||
162657868|NCT01639001|587461164|FG000|Overall Study|Lost to Follow-up|3|||
162657869|NCT01639001|587461165|FG001|Overall Study|Lost to Follow-up|0|||
162657870|NCT01639001|587461164|FG000|Overall Study|Death|62|||
162657871|NCT01639001|587461165|FG001|Overall Study|Death|61|||
162657872|NCT01639001|587461164|FG000|Overall Study|Randomized but not treated|0|||
162657873|NCT01639001|587461165|FG001|Overall Study|Randomized but not treated|2|||
162657874|NCT01639001|587461164|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
162657875|NCT01639001|587461165|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
162657876|NCT02097134|587461166|FG000|Overall Study|Physician Decision|4|||
162657877|NCT02097134|587461166|FG000|Overall Study|Non-Protocol Therapy|1|||
162657878|NCT02097134|587461166|FG000|Overall Study|Progressive Disease|3|||
162657879|NCT02097134|587461166|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
162657880|NCT00679341|587461168|FG000|Overall Study|Disease progression|42|||
162657881|NCT00679341|587461169|FG001|Overall Study|Disease progression|36|||
162657882|NCT00679341|587461168|FG000|Overall Study|Adverse Event|5|||
162657883|NCT00679341|587461169|FG001|Overall Study|Adverse Event|6|||
162657884|NCT00679341|587461168|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
162657885|NCT00679341|587461169|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
162657886|NCT00679341|587461168|FG000|Overall Study|Death|1|||
162657887|NCT00679341|587461169|FG001|Overall Study|Death|1|||
162657888|NCT00679341|587461168|FG000|Overall Study|Other|1|||
162657889|NCT00679341|587461169|FG001|Overall Study|Other|0|||
162657890|NCT00679341|587461168|FG000|Overall Study|Physician Decision|1|||
162657891|NCT00679341|587461169|FG001|Overall Study|Physician Decision|0|||
162657892|NCT00679341|587461168|FG000|Overall Study|Not treated|0|||
162657893|NCT00679341|587461169|FG001|Overall Study|Not treated|2|||
162657894|NCT00679341|587461168|FG000|Overall Study|Physician/patient decision to withdraw|0|||
162657895|NCT00679341|587461169|FG001|Overall Study|Physician/patient decision to withdraw|6|||
162657896|NCT00298896|587461173|FG000|Overall Study|Death|3|||
162657897|NCT00298896|587461173|FG000|Overall Study|Physician Decision|2|||
162657898|NCT00298896|587461173|FG000|Overall Study|Intercurrent Illness|1|||
162657899|NCT00298896|587461173|FG000|Overall Study|Disease Progression|41|||
162657900|NCT00298896|587461173|FG000|Overall Study|Withdrawal by Subject|2|||
163131545|NCT00265317|589190940|FG001|Phase 2|Death|0|||
163131546|NCT00265317|589190941|FG002|Phase 2|Death|12|||
163131547|NCT00265317|589190942|FG003|Phase 2|Death|15|||
163131548|NCT00265317|589190939|FG000|Phase 2|Protocol Violation|0|||
163131549|NCT00265317|589190940|FG001|Phase 2|Protocol Violation|0|||
162657901|NCT00298896|587461173|FG000|Overall Study|Assigned to treatment in error|1|||
162657902|NCT02880371|587461174|FG000|Phase 1b|Lost to Follow-up|1|||
162657903|NCT02880371|587461175|FG001|Phase 1b|Lost to Follow-up|0|||
162657904|NCT02880371|587461176|FG002|Phase 1b|Lost to Follow-up|0|||
162657905|NCT02880371|587461177|FG003|Phase 1b|Lost to Follow-up|0|||
162657906|NCT02880371|587461178|FG004|Phase 1b|Lost to Follow-up|0|||
162657907|NCT02880371|587461179|FG005|Phase 1b|Lost to Follow-up|0|||
162657908|NCT02880371|587461180|FG006|Phase 1b|Lost to Follow-up|0|||
162657909|NCT02880371|587461181|FG007|Phase 1b|Lost to Follow-up|0|||
162657910|NCT02880371|587461174|FG000|Phase 1b|Participants terminated by Sponsor|1|||
162657911|NCT02880371|587461175|FG001|Phase 1b|Participants terminated by Sponsor|0|||
162657912|NCT02880371|587461176|FG002|Phase 1b|Participants terminated by Sponsor|0|||
162657913|NCT02880371|587461177|FG003|Phase 1b|Participants terminated by Sponsor|0|||
162657914|NCT02880371|587461178|FG004|Phase 1b|Participants terminated by Sponsor|0|||
162657915|NCT02880371|587461179|FG005|Phase 1b|Participants terminated by Sponsor|0|||
162657916|NCT02880371|587461180|FG006|Phase 1b|Participants terminated by Sponsor|0|||
162657917|NCT02880371|587461181|FG007|Phase 1b|Participants terminated by Sponsor|0|||
162657918|NCT02880371|587461174|FG000|Phase 1b|Withdrawal by Subject|0|||
162657919|NCT02880371|587461175|FG001|Phase 1b|Withdrawal by Subject|0|||
162657920|NCT02880371|587461176|FG002|Phase 1b|Withdrawal by Subject|1|||
162657921|NCT02880371|587461177|FG003|Phase 1b|Withdrawal by Subject|0|||
162657922|NCT02880371|587461178|FG004|Phase 1b|Withdrawal by Subject|0|||
162657923|NCT02880371|587461179|FG005|Phase 1b|Withdrawal by Subject|0|||
162657924|NCT02880371|587461180|FG006|Phase 1b|Withdrawal by Subject|0|||
162657925|NCT02880371|587461181|FG007|Phase 1b|Withdrawal by Subject|0|||
162657926|NCT02880371|587461174|FG000|Phase 1b|Death|4|||
162657927|NCT02880371|587461175|FG001|Phase 1b|Death|6|||
162657928|NCT02880371|587461176|FG002|Phase 1b|Death|5|||
162657929|NCT02880371|587461177|FG003|Phase 1b|Death|1|||
162657930|NCT02880371|587461178|FG004|Phase 1b|Death|0|||
163131550|NCT00265317|589190941|FG002|Phase 2|Protocol Violation|1|||
162657931|NCT02880371|587461179|FG005|Phase 1b|Death|0|||
162657932|NCT02880371|587461180|FG006|Phase 1b|Death|0|||
162657933|NCT02880371|587461181|FG007|Phase 1b|Death|0|||
162657934|NCT02880371|587461174|FG000|Phase 1b|Enrolled but not Treated|0|||
163131551|NCT00265317|589190942|FG003|Phase 2|Protocol Violation|4|||
163131552|NCT00265317|589190939|FG000|Phase 2|Lost to Follow-up|0|||
163131553|NCT00265317|589190940|FG001|Phase 2|Lost to Follow-up|0|||
163131554|NCT00265317|589190941|FG002|Phase 2|Lost to Follow-up|0|||
163131555|NCT00265317|589190942|FG003|Phase 2|Lost to Follow-up|1|||
163131556|NCT00265317|589190939|FG000|Phase 2|Withdrawal/other than adverse event|0|||
163131557|NCT00265317|589190940|FG001|Phase 2|Withdrawal/other than adverse event|0|||
163131558|NCT00265317|589190941|FG002|Phase 2|Withdrawal/other than adverse event|2|||
163131559|NCT00265317|589190942|FG003|Phase 2|Withdrawal/other than adverse event|1|||
163131560|NCT00265317|589190939|FG000|Phase 2|Study terminated by sponsor|0|||
163131561|NCT00265317|589190940|FG001|Phase 2|Study terminated by sponsor|0|||
163131562|NCT00265317|589190941|FG002|Phase 2|Study terminated by sponsor|1|||
163131563|NCT00265317|589190942|FG003|Phase 2|Study terminated by sponsor|0|||
163131564|NCT00265317|589190939|FG000|Phase 2|Other|0|||
163131565|NCT00265317|589190940|FG001|Phase 2|Other|0|||
163131566|NCT00265317|589190941|FG002|Phase 2|Other|1|||
163131567|NCT00265317|589190942|FG003|Phase 2|Other|1|||
163131568|NCT00732875|589190945|FG000|Overall Study|Adverse Event|16|||
163131569|NCT00732875|589190945|FG000|Overall Study|Withdrawal by Subject|6|||
163131570|NCT00732875|589190945|FG000|Overall Study|Lack of Efficacy|13|||
163131571|NCT02300259|589190946|FG000|Period 1|Adverse Event|0|||
163131572|NCT02300259|589190947|FG001|Period 1|Adverse Event|0|||
163131573|NCT02300259|589190948|FG002|Period 1|Adverse Event|1|||
163131574|NCT02300259|589190946|FG000|Period 1|Withdrawal by Subject|0|||
163131575|NCT02300259|589190947|FG001|Period 1|Withdrawal by Subject|0|||
163131576|NCT02300259|589190948|FG002|Period 1|Withdrawal by Subject|1|||
163131577|NCT02300259|589190946|FG000|Period 2|Adverse Event|1|||
163131578|NCT02300259|589190947|FG001|Period 2|Adverse Event|0|||
163131579|NCT02300259|589190948|FG002|Period 2|Adverse Event|0|||
163131580|NCT02300259|589190946|FG000|Period 2|Withdrawal by Subject|0|||
163131581|NCT02300259|589190947|FG001|Period 2|Withdrawal by Subject|0|||
163131582|NCT02300259|589190948|FG002|Period 2|Withdrawal by Subject|1|||
162719819|NCT03386929|587680590|FG001|Overall Study|Progression|4|||
163131583|NCT02737475|589190949|FG000|Overall Study|Other reasons|0|||
163131584|NCT02737475|589190950|FG001|Overall Study|Other reasons|0|||
162657935|NCT02880371|587461175|FG001|Phase 1b|Enrolled but not Treated|1|||
162657936|NCT02880371|587461176|FG002|Phase 1b|Enrolled but not Treated|0|||
162657937|NCT02880371|587461177|FG003|Phase 1b|Enrolled but not Treated|0|||
162657938|NCT02880371|587461178|FG004|Phase 1b|Enrolled but not Treated|0|||
162719820|NCT03386929|587680591|FG002|Overall Study|Progression|0|||
163131585|NCT02737475|589190951|FG002|Overall Study|Other reasons|0|||
163131586|NCT02737475|589190952|FG003|Overall Study|Other reasons|0|||
163131587|NCT02737475|589190953|FG004|Overall Study|Other reasons|1|||
163131588|NCT02737475|589190954|FG005|Overall Study|Other reasons|1|||
163131589|NCT02737475|589190955|FG006|Overall Study|Other reasons|0|||
163131590|NCT02737475|589190956|FG007|Overall Study|Other reasons|0|||
163131591|NCT02737475|589190957|FG008|Overall Study|Other reasons|1|||
163131592|NCT02737475|589190958|FG009|Overall Study|Other reasons|0|||
162657939|NCT02880371|587461179|FG005|Phase 1b|Enrolled but not Treated|0|||
162657940|NCT02880371|587461180|FG006|Phase 1b|Enrolled but not Treated|0|||
162657941|NCT02880371|587461181|FG007|Phase 1b|Enrolled but not Treated|0|||
162657942|NCT02880371|587461174|FG000|Phase 2|Enrolled but not Treated|0|||
162657943|NCT02880371|587461175|FG001|Phase 2|Enrolled but not Treated|0|||
162657944|NCT02880371|587461176|FG002|Phase 2|Enrolled but not Treated|0|||
162657945|NCT02880371|587461177|FG003|Phase 2|Enrolled but not Treated|0|||
162657946|NCT02880371|587461178|FG004|Phase 2|Enrolled but not Treated|0|||
162657947|NCT02880371|587461179|FG005|Phase 2|Enrolled but not Treated|1|||
163131593|NCT02737475|589190959|FG010|Overall Study|Other reasons|1|||
163131594|NCT02737475|589190960|FG011|Overall Study|Other reasons|0|||
163131595|NCT02737475|589190961|FG012|Overall Study|Other reasons|0|||
163131596|NCT02737475|589190962|FG013|Overall Study|Other reasons|0|||
163131597|NCT02737475|589190963|FG014|Overall Study|Other reasons|0|||
163131598|NCT02737475|589190964|FG015|Overall Study|Other reasons|0|||
163131599|NCT02737475|589190965|FG016|Overall Study|Other reasons|0|||
163131600|NCT02737475|589190966|FG017|Overall Study|Other reasons|0|||
163131601|NCT02737475|589190967|FG018|Overall Study|Other reasons|0|||
163131602|NCT02737475|589190968|FG019|Overall Study|Other reasons|0|||
163131603|NCT02737475|589190969|FG020|Overall Study|Other reasons|0|||
163131604|NCT02737475|589190970|FG021|Overall Study|Other reasons|1|||
163131605|NCT02737475|589190971|FG022|Overall Study|Other reasons|0|||
163131606|NCT02737475|589190972|FG023|Overall Study|Other reasons|1|||
163131607|NCT02737475|589190973|FG024|Overall Study|Other reasons|1|||
163131608|NCT02737475|589190974|FG025|Overall Study|Other reasons|1|||
163131609|NCT02737475|589190975|FG026|Overall Study|Other reasons|0|||
163131610|NCT02737475|589190949|FG000|Overall Study|Death|1|||
163131611|NCT02737475|589190950|FG001|Overall Study|Death|0|||
163131612|NCT02737475|589190951|FG002|Overall Study|Death|0|||
163131613|NCT02737475|589190952|FG003|Overall Study|Death|1|||
163131614|NCT02737475|589190953|FG004|Overall Study|Death|0|||
163131615|NCT02737475|589190954|FG005|Overall Study|Death|0|||
163131616|NCT02737475|589190955|FG006|Overall Study|Death|0|||
163131617|NCT02737475|589190956|FG007|Overall Study|Death|2|||
163131618|NCT02737475|589190957|FG008|Overall Study|Death|0|||
163131619|NCT02737475|589190958|FG009|Overall Study|Death|0|||
163131620|NCT02737475|589190959|FG010|Overall Study|Death|0|||
163131621|NCT02737475|589190960|FG011|Overall Study|Death|4|||
163131622|NCT02737475|589190961|FG012|Overall Study|Death|2|||
163131623|NCT02737475|589190962|FG013|Overall Study|Death|2|||
163131624|NCT02737475|589190963|FG014|Overall Study|Death|0|||
163131625|NCT02737475|589190964|FG015|Overall Study|Death|2|||
163131626|NCT02737475|589190965|FG016|Overall Study|Death|2|||
163131627|NCT02737475|589190966|FG017|Overall Study|Death|2|||
163131628|NCT02737475|589190967|FG018|Overall Study|Death|1|||
163131629|NCT02737475|589190968|FG019|Overall Study|Death|0|||
163131630|NCT02737475|589190969|FG020|Overall Study|Death|0|||
163131631|NCT02737475|589190970|FG021|Overall Study|Death|0|||
163131632|NCT02737475|589190971|FG022|Overall Study|Death|0|||
163131633|NCT02737475|589190972|FG023|Overall Study|Death|0|||
163131634|NCT02737475|589190973|FG024|Overall Study|Death|0|||
163131635|NCT02737475|589190974|FG025|Overall Study|Death|0|||
163131636|NCT02737475|589190975|FG026|Overall Study|Death|0|||
163131637|NCT02737475|589190949|FG000|Overall Study|Participant withdrew consent|0|||
163131638|NCT02737475|589190950|FG001|Overall Study|Participant withdrew consent|0|||
163131639|NCT02737475|589190951|FG002|Overall Study|Participant withdrew consent|0|||
163131640|NCT02737475|589190952|FG003|Overall Study|Participant withdrew consent|0|||
163131641|NCT02737475|589190953|FG004|Overall Study|Participant withdrew consent|0|||
163131642|NCT02737475|589190954|FG005|Overall Study|Participant withdrew consent|2|||
163131643|NCT02737475|589190955|FG006|Overall Study|Participant withdrew consent|0|||
163131644|NCT02737475|589190956|FG007|Overall Study|Participant withdrew consent|0|||
163131645|NCT02737475|589190957|FG008|Overall Study|Participant withdrew consent|0|||
163131646|NCT02737475|589190958|FG009|Overall Study|Participant withdrew consent|0|||
163131647|NCT02737475|589190959|FG010|Overall Study|Participant withdrew consent|0|||
162657948|NCT02880371|587461180|FG006|Phase 2|Enrolled but not Treated|1|||
163131648|NCT02737475|589190960|FG011|Overall Study|Participant withdrew consent|0|||
163131649|NCT02737475|589190961|FG012|Overall Study|Participant withdrew consent|0|||
162657949|NCT02880371|587461181|FG007|Phase 2|Enrolled but not Treated|0|||
162657950|NCT02880371|587461174|FG000|Phase 2|Other|0|||
162657951|NCT02880371|587461175|FG001|Phase 2|Other|0|||
162657952|NCT02880371|587461176|FG002|Phase 2|Other|0|||
163131650|NCT02737475|589190962|FG013|Overall Study|Participant withdrew consent|0|||
163131651|NCT02737475|589190963|FG014|Overall Study|Participant withdrew consent|1|||
163131652|NCT02737475|589190964|FG015|Overall Study|Participant withdrew consent|0|||
163131653|NCT02737475|589190965|FG016|Overall Study|Participant withdrew consent|0|||
163131654|NCT02737475|589190966|FG017|Overall Study|Participant withdrew consent|2|||
163131655|NCT02737475|589190967|FG018|Overall Study|Participant withdrew consent|1|||
163131656|NCT02737475|589190968|FG019|Overall Study|Participant withdrew consent|0|||
163131657|NCT02737475|589190969|FG020|Overall Study|Participant withdrew consent|2|||
163131658|NCT02737475|589190970|FG021|Overall Study|Participant withdrew consent|0|||
162657953|NCT02880371|587461177|FG003|Phase 2|Other|0|||
162657954|NCT02880371|587461178|FG004|Phase 2|Other|0|||
162657955|NCT02880371|587461179|FG005|Phase 2|Other|1|||
162657956|NCT02880371|587461180|FG006|Phase 2|Other|2|||
162657957|NCT02880371|587461181|FG007|Phase 2|Other|1|||
162657958|NCT02880371|587461174|FG000|Phase 2|Participants terminated by Sponsor|0|||
162657959|NCT02880371|587461175|FG001|Phase 2|Participants terminated by Sponsor|0|||
162657960|NCT02880371|587461176|FG002|Phase 2|Participants terminated by Sponsor|0|||
162657961|NCT02880371|587461177|FG003|Phase 2|Participants terminated by Sponsor|0|||
162657962|NCT02880371|587461178|FG004|Phase 2|Participants terminated by Sponsor|1|||
162657963|NCT02880371|587461179|FG005|Phase 2|Participants terminated by Sponsor|6|||
162657964|NCT02880371|587461180|FG006|Phase 2|Participants terminated by Sponsor|1|||
162657965|NCT02880371|587461181|FG007|Phase 2|Participants terminated by Sponsor|5|||
162657966|NCT02880371|587461174|FG000|Phase 2|Death|0|||
162657967|NCT02880371|587461175|FG001|Phase 2|Death|0|||
162657968|NCT02880371|587461176|FG002|Phase 2|Death|0|||
163131659|NCT02737475|589190971|FG022|Overall Study|Participant withdrew consent|0|||
163131660|NCT02737475|589190972|FG023|Overall Study|Participant withdrew consent|0|||
163131661|NCT02737475|589190973|FG024|Overall Study|Participant withdrew consent|0|||
163131662|NCT02737475|589190974|FG025|Overall Study|Participant withdrew consent|0|||
163131663|NCT02737475|589190975|FG026|Overall Study|Participant withdrew consent|0|||
163131664|NCT02737475|589190949|FG000|Overall Study|Lost to Follow-up|0|||
163131665|NCT02737475|589190950|FG001|Overall Study|Lost to Follow-up|0|||
163131666|NCT02737475|589190951|FG002|Overall Study|Lost to Follow-up|0|||
163131667|NCT02737475|589190952|FG003|Overall Study|Lost to Follow-up|0|||
163131668|NCT02737475|589190953|FG004|Overall Study|Lost to Follow-up|0|||
163131669|NCT02737475|589190954|FG005|Overall Study|Lost to Follow-up|0|||
163131670|NCT02737475|589190955|FG006|Overall Study|Lost to Follow-up|0|||
163131671|NCT02737475|589190956|FG007|Overall Study|Lost to Follow-up|0|||
163131672|NCT02737475|589190957|FG008|Overall Study|Lost to Follow-up|0|||
163131673|NCT02737475|589190958|FG009|Overall Study|Lost to Follow-up|0|||
163131674|NCT02737475|589190959|FG010|Overall Study|Lost to Follow-up|0|||
163131675|NCT02737475|589190960|FG011|Overall Study|Lost to Follow-up|0|||
163131676|NCT02737475|589190961|FG012|Overall Study|Lost to Follow-up|0|||
163131677|NCT02737475|589190962|FG013|Overall Study|Lost to Follow-up|0|||
163131678|NCT02737475|589190963|FG014|Overall Study|Lost to Follow-up|0|||
163131679|NCT02737475|589190964|FG015|Overall Study|Lost to Follow-up|1|||
163131680|NCT02737475|589190965|FG016|Overall Study|Lost to Follow-up|0|||
163131681|NCT02737475|589190966|FG017|Overall Study|Lost to Follow-up|0|||
163131682|NCT02737475|589190967|FG018|Overall Study|Lost to Follow-up|0|||
163131683|NCT02737475|589190968|FG019|Overall Study|Lost to Follow-up|0|||
163131684|NCT02737475|589190969|FG020|Overall Study|Lost to Follow-up|0|||
163131685|NCT02737475|589190970|FG021|Overall Study|Lost to Follow-up|0|||
163131686|NCT02737475|589190971|FG022|Overall Study|Lost to Follow-up|0|||
163131687|NCT02737475|589190972|FG023|Overall Study|Lost to Follow-up|0|||
163131688|NCT02737475|589190973|FG024|Overall Study|Lost to Follow-up|0|||
163131689|NCT02737475|589190974|FG025|Overall Study|Lost to Follow-up|0|||
163131690|NCT02737475|589190975|FG026|Overall Study|Lost to Follow-up|0|||
163131691|NCT02737475|589190949|FG000|Overall Study|Disease Progression|0|||
163131692|NCT02737475|589190950|FG001|Overall Study|Disease Progression|0|||
163131693|NCT02737475|589190951|FG002|Overall Study|Disease Progression|0|||
163131694|NCT02737475|589190952|FG003|Overall Study|Disease Progression|0|||
163131695|NCT02737475|589190953|FG004|Overall Study|Disease Progression|0|||
163131696|NCT02737475|589190954|FG005|Overall Study|Disease Progression|0|||
163131697|NCT02737475|589190955|FG006|Overall Study|Disease Progression|0|||
163131698|NCT02737475|589190956|FG007|Overall Study|Disease Progression|0|||
163131699|NCT02737475|589190957|FG008|Overall Study|Disease Progression|0|||
163131700|NCT02737475|589190958|FG009|Overall Study|Disease Progression|0|||
163131701|NCT02737475|589190959|FG010|Overall Study|Disease Progression|0|||
163131702|NCT02737475|589190960|FG011|Overall Study|Disease Progression|0|||
163131703|NCT02737475|589190961|FG012|Overall Study|Disease Progression|0|||
163131704|NCT02737475|589190962|FG013|Overall Study|Disease Progression|0|||
163131705|NCT02737475|589190963|FG014|Overall Study|Disease Progression|0|||
163131706|NCT02737475|589190964|FG015|Overall Study|Disease Progression|0|||
163131707|NCT02737475|589190965|FG016|Overall Study|Disease Progression|0|||
163131708|NCT02737475|589190966|FG017|Overall Study|Disease Progression|0|||
163131709|NCT02737475|589190967|FG018|Overall Study|Disease Progression|0|||
163131710|NCT02737475|589190968|FG019|Overall Study|Disease Progression|0|||
163131711|NCT02737475|589190969|FG020|Overall Study|Disease Progression|0|||
163131712|NCT02737475|589190970|FG021|Overall Study|Disease Progression|0|||
163131713|NCT02737475|589190971|FG022|Overall Study|Disease Progression|0|||
163131714|NCT02737475|589190972|FG023|Overall Study|Disease Progression|0|||
163131715|NCT02737475|589190973|FG024|Overall Study|Disease Progression|0|||
163131716|NCT02737475|589190974|FG025|Overall Study|Disease Progression|0|||
163131717|NCT02737475|589190975|FG026|Overall Study|Disease Progression|1|||
163131718|NCT02510001|589190976|FG000|Overall Study|Early disease progression|0|||
163131719|NCT02510001|589190977|FG001|Overall Study|Early disease progression|0|||
163131720|NCT02510001|589190978|FG002|Overall Study|Early disease progression|0|||
163131721|NCT02510001|589190979|FG003|Overall Study|Early disease progression|1|||
162657969|NCT02880371|587461177|FG003|Phase 2|Death|0|||
162657970|NCT02880371|587461178|FG004|Phase 2|Death|1|||
162657971|NCT02880371|587461179|FG005|Phase 2|Death|10|||
162657972|NCT02880371|587461180|FG006|Phase 2|Death|20|||
162657973|NCT02880371|587461181|FG007|Phase 2|Death|5|||
162657974|NCT02880371|587461174|FG000|Phase 2|Lost to Follow-up|0|||
162657975|NCT02880371|587461175|FG001|Phase 2|Lost to Follow-up|0|||
162657976|NCT02880371|587461176|FG002|Phase 2|Lost to Follow-up|0|||
162657977|NCT02880371|587461177|FG003|Phase 2|Lost to Follow-up|0|||
162657978|NCT02880371|587461178|FG004|Phase 2|Lost to Follow-up|0|||
163131722|NCT02510001|589190980|FG004|Overall Study|Early disease progression|1|||
163131723|NCT02510001|589190981|FG005|Overall Study|Early disease progression|1|||
163131724|NCT02510001|589190982|FG006|Overall Study|Early disease progression|0|||
163131725|NCT02510001|589190983|FG007|Overall Study|Early disease progression|0|||
163131726|NCT02510001|589190976|FG000|Overall Study|Adverse Event|0|||
163131727|NCT02510001|589190977|FG001|Overall Study|Adverse Event|0|||
163131728|NCT02510001|589190978|FG002|Overall Study|Adverse Event|0|||
163131729|NCT02510001|589190979|FG003|Overall Study|Adverse Event|1|||
163131730|NCT02510001|589190980|FG004|Overall Study|Adverse Event|2|||
163131731|NCT02510001|589190981|FG005|Overall Study|Adverse Event|1|||
163131732|NCT02510001|589190982|FG006|Overall Study|Adverse Event|2|||
163131733|NCT02510001|589190983|FG007|Overall Study|Adverse Event|5|||
163131734|NCT02510001|589190976|FG000|Overall Study|Physician Decision|0|||
163131735|NCT02510001|589190977|FG001|Overall Study|Physician Decision|0|||
163131736|NCT02510001|589190978|FG002|Overall Study|Physician Decision|0|||
163131737|NCT02510001|589190979|FG003|Overall Study|Physician Decision|0|||
163131738|NCT02510001|589190980|FG004|Overall Study|Physician Decision|1|||
163131739|NCT02510001|589190981|FG005|Overall Study|Physician Decision|0|||
163131740|NCT02510001|589190982|FG006|Overall Study|Physician Decision|0|||
163131741|NCT02510001|589190983|FG007|Overall Study|Physician Decision|0|||
163131742|NCT02510001|589190976|FG000|Overall Study|Withdrawal by Subject|0|||
163131743|NCT02510001|589190977|FG001|Overall Study|Withdrawal by Subject|0|||
163131744|NCT02510001|589190978|FG002|Overall Study|Withdrawal by Subject|0|||
163131745|NCT02510001|589190979|FG003|Overall Study|Withdrawal by Subject|0|||
163131746|NCT02510001|589190980|FG004|Overall Study|Withdrawal by Subject|0|||
163131747|NCT02510001|589190981|FG005|Overall Study|Withdrawal by Subject|0|||
163131748|NCT02510001|589190982|FG006|Overall Study|Withdrawal by Subject|0|||
163131749|NCT02510001|589190983|FG007|Overall Study|Withdrawal by Subject|2|||
163131750|NCT00711971|589190995|FG000|Overall Study|Lost to Follow-up|3|||
163131751|NCT00711971|589190996|FG001|Overall Study|Lost to Follow-up|4|||
163131752|NCT00711971|589190997|FG002|Overall Study|Lost to Follow-up|1|||
163131753|NCT00887549|589191000|FG000|Induction Therapy|Adverse Event|8|||
163131754|NCT00887549|589191000|FG000|Induction Therapy|Physician Decision|1|||
163131755|NCT00887549|589191000|FG000|Induction Therapy|Progressive Disease|13|||
163131756|NCT00887549|589191000|FG000|Induction Therapy|Death due to Study Disease|4|||
163131757|NCT00887549|589191000|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
163131758|NCT00887549|589191000|FG000|Maintenance Therapy|Adverse Event|16|||
163131759|NCT00887549|589191000|FG000|Maintenance Therapy|Physician Decision|1|||
163131760|NCT00887549|589191000|FG000|Maintenance Therapy|Progressive Disease|25|||
163131761|NCT00887549|589191000|FG000|Maintenance Therapy|Death due to adverse event|1|||
163131762|NCT01858740|589191002|FG000|Overall Study|Death|4|||
163131763|NCT02097030|589191009|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
163131764|NCT02097030|589191010|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
163131765|NCT02097030|589191009|FG000|First Intervention (3 Days)|Visual Acuity|0|||
163131766|NCT02097030|589191010|FG001|First Intervention (3 Days)|Visual Acuity|1|||
163131767|NCT01919801|589191011|FG000|Overall Study|Withdrawal by Subject|1|||
163131768|NCT01919801|589191012|FG001|Overall Study|Withdrawal by Subject|0|||
163131769|NCT01919801|589191011|FG000|Overall Study|Physician Decision|0|||
163131770|NCT01919801|589191012|FG001|Overall Study|Physician Decision|1|||
163131771|NCT01919801|589191011|FG000|Overall Study|Lost to Follow-up|0|||
163131772|NCT01919801|589191012|FG001|Overall Study|Lost to Follow-up|1|||
163131773|NCT01919801|589191011|FG000|Overall Study|Other|0|||
163131774|NCT01919801|589191012|FG001|Overall Study|Other|1|||
163131775|NCT01677858|589191017|FG000|Overall Study|Adverse Event|0|||
163131776|NCT01677858|589191018|FG001|Overall Study|Adverse Event|0|||
163131777|NCT01677858|589191019|FG002|Overall Study|Adverse Event|2|||
163131778|NCT01677858|589191020|FG003|Overall Study|Adverse Event|3|||
163131779|NCT01677858|589191021|FG004|Overall Study|Adverse Event|13|||
163131780|NCT01677858|589191017|FG000|Overall Study|Death|0|||
163131781|NCT01677858|589191018|FG001|Overall Study|Death|0|||
163131782|NCT01677858|589191019|FG002|Overall Study|Death|0|||
163131783|NCT01677858|589191020|FG003|Overall Study|Death|0|||
163131784|NCT01677858|589191021|FG004|Overall Study|Death|1|||
163131785|NCT01677858|589191017|FG000|Overall Study|Physician Decision|1|||
163131786|NCT01677858|589191018|FG001|Overall Study|Physician Decision|0|||
163131787|NCT01677858|589191019|FG002|Overall Study|Physician Decision|2|||
163131788|NCT01677858|589191020|FG003|Overall Study|Physician Decision|0|||
163131789|NCT01677858|589191021|FG004|Overall Study|Physician Decision|12|||
163131790|NCT01677858|589191017|FG000|Overall Study|Progressive Disease|2|||
163131791|NCT01677858|589191018|FG001|Overall Study|Progressive Disease|1|||
163131792|NCT01677858|589191019|FG002|Overall Study|Progressive Disease|9|||
163131793|NCT01677858|589191020|FG003|Overall Study|Progressive Disease|3|||
163131794|NCT01677858|589191021|FG004|Overall Study|Progressive Disease|43|||
162657979|NCT02880371|587461179|FG005|Phase 2|Lost to Follow-up|0|||
163131795|NCT01677858|589191017|FG000|Overall Study|Withdrawal by Subject|0|||
163131796|NCT01677858|589191018|FG001|Overall Study|Withdrawal by Subject|1|||
163131797|NCT01677858|589191019|FG002|Overall Study|Withdrawal by Subject|1|||
163131798|NCT01677858|589191020|FG003|Overall Study|Withdrawal by Subject|0|||
163131799|NCT01677858|589191021|FG004|Overall Study|Withdrawal by Subject|15|||
163131800|NCT01677858|589191017|FG000|Overall Study|Lost to Follow-up|0|||
163131801|NCT01677858|589191018|FG001|Overall Study|Lost to Follow-up|0|||
163131802|NCT01677858|589191019|FG002|Overall Study|Lost to Follow-up|0|||
163131803|NCT01677858|589191020|FG003|Overall Study|Lost to Follow-up|0|||
163131804|NCT01677858|589191021|FG004|Overall Study|Lost to Follow-up|1|||
163131805|NCT00988091|589191022|FG000|Double-blind Period|Withdrawal by Subject|15|||
163131806|NCT00988091|589191023|FG001|Double-blind Period|Withdrawal by Subject|13|||
163131807|NCT00988091|589191022|FG000|Double-blind Period|Lost to Follow-up|12|||
163131808|NCT00988091|589191023|FG001|Double-blind Period|Lost to Follow-up|14|||
163131809|NCT00988091|589191022|FG000|Double-blind Period|Other|8|||
163131810|NCT00988091|589191023|FG001|Double-blind Period|Other|8|||
163131811|NCT00988091|589191022|FG000|Double-blind Period|Adverse Event|6|||
163131812|NCT00988091|589191023|FG001|Double-blind Period|Adverse Event|9|||
163131813|NCT00988091|589191022|FG000|Double-blind Period|Use of exclusionary medication|2|||
163131814|NCT00988091|589191023|FG001|Double-blind Period|Use of exclusionary medication|3|||
163131815|NCT00988091|589191022|FG000|Open-label Period|Adverse Event|4|||
163131816|NCT00988091|589191023|FG001|Open-label Period|Adverse Event|7|||
163131817|NCT00988091|589191022|FG000|Open-label Period|Use of exclusionary medication|1|||
163131818|NCT00988091|589191023|FG001|Open-label Period|Use of exclusionary medication|1|||
163131819|NCT00988091|589191022|FG000|Open-label Period|Protocol Violation|1|||
163131820|NCT00988091|589191023|FG001|Open-label Period|Protocol Violation|1|||
163131821|NCT00988091|589191022|FG000|Open-label Period|Withdrawal by Subject|10|||
163131822|NCT00988091|589191023|FG001|Open-label Period|Withdrawal by Subject|16|||
163131823|NCT00988091|589191022|FG000|Open-label Period|Lost to Follow-up|3|||
163131824|NCT00988091|589191023|FG001|Open-label Period|Lost to Follow-up|5|||
163131825|NCT00988091|589191022|FG000|Open-label Period|Other|2|||
163131826|NCT00988091|589191023|FG001|Open-label Period|Other|3|||
163131827|NCT03078855|589191027|FG000|Overall Study|Lack of Efficacy|62|||
163131828|NCT03078855|589191028|FG001|Overall Study|Lack of Efficacy|31|||
163131829|NCT03078855|589191027|FG000|Overall Study|Death|1|||
163131830|NCT03078855|589191028|FG001|Overall Study|Death|0|||
163131831|NCT03078855|589191027|FG000|Overall Study|Withdrawal by Subject|12|||
163131832|NCT03078855|589191028|FG001|Overall Study|Withdrawal by Subject|6|||
163131833|NCT03078855|589191027|FG000|Overall Study|Physician Decision|3|||
163131834|NCT03078855|589191028|FG001|Overall Study|Physician Decision|2|||
163131835|NCT03078855|589191027|FG000|Overall Study|Second Malignancy|4|||
163131836|NCT03078855|589191028|FG001|Overall Study|Second Malignancy|0|||
163131837|NCT03078855|589191027|FG000|Overall Study|Ineligible|2|||
163131838|NCT03078855|589191028|FG001|Overall Study|Ineligible|0|||
163131839|NCT03078855|589191027|FG000|Overall Study|Withdrew before day 1 treatment|2|||
163131840|NCT03078855|589191028|FG001|Overall Study|Withdrew before day 1 treatment|1|||
163131841|NCT00391027|589191029|FG000|Overall Study|Adverse Event|8|||
163131842|NCT00391027|589191030|FG001|Overall Study|Adverse Event|8|||
163131843|NCT00391027|589191029|FG000|Overall Study|Lack of Efficacy|3|||
163131844|NCT00391027|589191030|FG001|Overall Study|Lack of Efficacy|0|||
163131845|NCT00391027|589191029|FG000|Overall Study|Withdrawal by Subject|10|||
163131846|NCT00391027|589191030|FG001|Overall Study|Withdrawal by Subject|1|||
163131847|NCT00391027|589191029|FG000|Overall Study|Other|4|||
163131848|NCT00391027|589191030|FG001|Overall Study|Other|3|||
163131849|NCT03194646|589191031|FG000|Overall Study|Adverse Event|24|||
163131850|NCT03194646|589191032|FG001|Overall Study|Adverse Event|25|||
163131851|NCT03194646|589191033|FG002|Overall Study|Adverse Event|14|||
163131852|NCT03194646|589191034|FG003|Overall Study|Adverse Event|17|||
163131853|NCT03194646|589191031|FG000|Overall Study|Lack of Efficacy|4|||
163131854|NCT03194646|589191032|FG001|Overall Study|Lack of Efficacy|2|||
163131855|NCT03194646|589191033|FG002|Overall Study|Lack of Efficacy|2|||
163131856|NCT03194646|589191034|FG003|Overall Study|Lack of Efficacy|12|||
163131857|NCT03194646|589191031|FG000|Overall Study|Lost to Follow-up|30|||
163131858|NCT03194646|589191032|FG001|Overall Study|Lost to Follow-up|22|||
163131859|NCT03194646|589191033|FG002|Overall Study|Lost to Follow-up|12|||
163131860|NCT03194646|589191034|FG003|Overall Study|Lost to Follow-up|35|||
163131861|NCT03194646|589191031|FG000|Overall Study|Non-compliance with study drug|4|||
163131862|NCT03194646|589191032|FG001|Overall Study|Non-compliance with study drug|0|||
163131863|NCT03194646|589191033|FG002|Overall Study|Non-compliance with study drug|1|||
163131864|NCT03194646|589191034|FG003|Overall Study|Non-compliance with study drug|1|||
163131865|NCT03194646|589191031|FG000|Overall Study|Other|89|||
163131866|NCT03194646|589191032|FG001|Overall Study|Other|68|||
163131867|NCT03194646|589191033|FG002|Overall Study|Other|34|||
163131868|NCT03194646|589191034|FG003|Overall Study|Other|31|||
163131869|NCT03194646|589191031|FG000|Overall Study|Physician Decision|7|||
163131870|NCT03194646|589191032|FG001|Overall Study|Physician Decision|9|||
163131871|NCT03194646|589191033|FG002|Overall Study|Physician Decision|5|||
162657980|NCT02880371|587461180|FG006|Phase 2|Lost to Follow-up|3|||
163131872|NCT03194646|589191034|FG003|Overall Study|Physician Decision|4|||
163131873|NCT03194646|589191031|FG000|Overall Study|Pregnancy|4|||
163131874|NCT03194646|589191032|FG001|Overall Study|Pregnancy|5|||
163131875|NCT03194646|589191033|FG002|Overall Study|Pregnancy|1|||
163131876|NCT03194646|589191034|FG003|Overall Study|Pregnancy|2|||
163131877|NCT03194646|589191031|FG000|Overall Study|Protocol Violation|4|||
163131878|NCT03194646|589191032|FG001|Overall Study|Protocol Violation|2|||
163131879|NCT03194646|589191033|FG002|Overall Study|Protocol Violation|1|||
163131880|NCT03194646|589191034|FG003|Overall Study|Protocol Violation|1|||
163131881|NCT03194646|589191031|FG000|Overall Study|Site terminated by sponsor|0|||
163131882|NCT03194646|589191032|FG001|Overall Study|Site terminated by sponsor|0|||
163131883|NCT03194646|589191033|FG002|Overall Study|Site terminated by sponsor|2|||
163131884|NCT03194646|589191034|FG003|Overall Study|Site terminated by sponsor|0|||
163131885|NCT03194646|589191031|FG000|Overall Study|Study terminated by sponsor|62|||
163131886|NCT03194646|589191032|FG001|Overall Study|Study terminated by sponsor|61|||
163131887|NCT03194646|589191033|FG002|Overall Study|Study terminated by sponsor|30|||
163131888|NCT03194646|589191034|FG003|Overall Study|Study terminated by sponsor|34|||
163131889|NCT03194646|589191031|FG000|Overall Study|Withdrawal by Subject|75|||
163131890|NCT03194646|589191032|FG001|Overall Study|Withdrawal by Subject|74|||
163131891|NCT03194646|589191033|FG002|Overall Study|Withdrawal by Subject|36|||
163131892|NCT03194646|589191034|FG003|Overall Study|Withdrawal by Subject|131|||
163131893|NCT03194646|589191031|FG000|Overall Study|Missing|1|||
163131894|NCT03194646|589191032|FG001|Overall Study|Missing|0|||
163131895|NCT03194646|589191033|FG002|Overall Study|Missing|1|||
163131896|NCT03194646|589191034|FG003|Overall Study|Missing|12|||
163131897|NCT04869358|589191035|FG000|Overall Study|Wish to have children.|1|||
163131898|NCT04869358|589191036|FG001|Overall Study|Wish to have children.|0|||
163131899|NCT04869358|589191037|FG002|Overall Study|Wish to have children.|0|||
163131900|NCT04869358|589191038|FG003|Overall Study|Wish to have children.|0|||
163131901|NCT05232864|589191039|FG000|Overall Study|Adverse Event|0|||
163131902|NCT05232864|589191040|FG001|Overall Study|Adverse Event|1|||
163131903|NCT05232864|589191039|FG000|Overall Study|Study terminated by sponsor|16|||
163131904|NCT05232864|589191040|FG001|Overall Study|Study terminated by sponsor|14|||
163131905|NCT04765202|589191044|FG000|Overall Study|Lost to Follow-up|1|||
163131906|NCT04765202|589191045|FG001|Overall Study|Lost to Follow-up|1|||
163131907|NCT04765202|589191046|FG002|Overall Study|Lost to Follow-up|2|||
163131908|NCT04765202|589191047|FG003|Overall Study|Lost to Follow-up|2|||
163131909|NCT04765202|589191044|FG000|Overall Study|Physician Decision|0|||
163131910|NCT04765202|589191045|FG001|Overall Study|Physician Decision|0|||
163131911|NCT04765202|589191046|FG002|Overall Study|Physician Decision|1|||
163131912|NCT04765202|589191047|FG003|Overall Study|Physician Decision|1|||
163131913|NCT04929249|589191048|FG000|Overall Study|Adverse Event|2|||
163131914|NCT04929249|589191049|FG001|Overall Study|Adverse Event|1|||
163131915|NCT04929249|589191048|FG000|Overall Study|Death|2|||
163131916|NCT04929249|589191049|FG001|Overall Study|Death|1|||
163131917|NCT04929249|589191048|FG000|Overall Study|Lost to Follow-up|3|||
163131918|NCT04929249|589191049|FG001|Overall Study|Lost to Follow-up|11|||
163131919|NCT04929249|589191048|FG000|Overall Study|Technical problems|0|||
163131920|NCT04929249|589191049|FG001|Overall Study|Technical problems|1|||
163131921|NCT04929249|589191048|FG000|Overall Study|Subject decision|6|||
163131922|NCT04929249|589191049|FG001|Overall Study|Subject decision|8|||
163131923|NCT04929249|589191048|FG000|Overall Study|Withdrew consent|0|||
163131924|NCT04929249|589191049|FG001|Overall Study|Withdrew consent|8|||
163131925|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
163131926|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
163131927|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
163131928|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
163131929|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Death|2|||
163131930|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Death|2|||
163131931|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Death|0|||
162657981|NCT02880371|587461181|FG007|Phase 2|Lost to Follow-up|0|||
162657982|NCT02880371|587461174|FG000|Phase 2|Withdrawal by Subject|0|||
163131932|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Death|0|||
163131933|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
163131934|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
163131935|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
163131936|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
163131937|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
163131938|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131939|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131940|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
163131941|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
163131942|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
163131943|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
163131944|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
163131945|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
162657983|NCT02880371|587461175|FG001|Phase 2|Withdrawal by Subject|0|||
162657984|NCT02880371|587461176|FG002|Phase 2|Withdrawal by Subject|0|||
162657985|NCT02880371|587461177|FG003|Phase 2|Withdrawal by Subject|0|||
162657986|NCT02880371|587461178|FG004|Phase 2|Withdrawal by Subject|0|||
162657987|NCT02880371|587461179|FG005|Phase 2|Withdrawal by Subject|1|||
162657988|NCT02880371|587461180|FG006|Phase 2|Withdrawal by Subject|1|||
162657989|NCT02880371|587461181|FG007|Phase 2|Withdrawal by Subject|0|||
162657990|NCT02880371|587461174|FG000|Phase 2|End of Study page not completed by error|0|||
162657991|NCT02880371|587461175|FG001|Phase 2|End of Study page not completed by error|0|||
162657992|NCT02880371|587461176|FG002|Phase 2|End of Study page not completed by error|0|||
162657993|NCT02880371|587461177|FG003|Phase 2|End of Study page not completed by error|0|||
162657994|NCT02880371|587461178|FG004|Phase 2|End of Study page not completed by error|0|||
162657995|NCT02880371|587461179|FG005|Phase 2|End of Study page not completed by error|1|||
162657996|NCT02880371|587461180|FG006|Phase 2|End of Study page not completed by error|0|||
162657997|NCT02880371|587461181|FG007|Phase 2|End of Study page not completed by error|0|||
162657998|NCT03285646|587461186|FG000|Overall Study|Adverse Event|1|||
162657999|NCT03285646|587461187|FG001|Overall Study|Adverse Event|0|||
162658000|NCT03285646|587461186|FG000|Overall Study|Withdrawal by Subject|10|||
162658001|NCT03285646|587461187|FG001|Overall Study|Withdrawal by Subject|2|||
162658002|NCT03285646|587461186|FG000|Overall Study|Lost to Follow-up|2|||
162658003|NCT03285646|587461187|FG001|Overall Study|Lost to Follow-up|1|||
162658004|NCT03285646|587461186|FG000|Overall Study|Investigator/Sponsor Decision|0|||
162658005|NCT03285646|587461187|FG001|Overall Study|Investigator/Sponsor Decision|1|||
162658006|NCT02660359|587461188|FG000|Overall Study|Protocol Deviation|0|||
162658007|NCT02660359|587461189|FG001|Overall Study|Protocol Deviation|0|||
163131946|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131947|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131948|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
163131949|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131950|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
163131951|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131952|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
163131953|NCT03068754|589191050|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
163131954|NCT03068754|589191051|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
163131955|NCT03068754|589191052|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
163131956|NCT03068754|589191053|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
163131957|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
163131958|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
163131959|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
163131960|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
163131961|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Death|0|||
163131962|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Death|0|||
163131963|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Death|0|||
163131964|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Death|1|||
163131965|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
163131966|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
163131967|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
163131968|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
163131969|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131970|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131971|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
163131972|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
163131973|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131974|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131975|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
163131976|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
163131977|NCT03068754|589191050|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
163131978|NCT03068754|589191051|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
163131979|NCT03068754|589191052|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
163131980|NCT03068754|589191053|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
163131981|NCT00129467|589191054|FG000|Received Intervention|Death|1|||
163131982|NCT00129467|589191055|FG001|Received Intervention|Death|1|||
163131983|NCT00129467|589191054|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
163131984|NCT00129467|589191055|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
163131985|NCT00129467|589191054|FG000|Received Intervention|Delirium|2|||
163131986|NCT00129467|589191055|FG001|Received Intervention|Delirium|0|||
163131987|NCT00129467|589191054|FG000|Received Intervention|Withdrawal by Subject|1|||
163131988|NCT00129467|589191055|FG001|Received Intervention|Withdrawal by Subject|0|||
163131989|NCT00129467|589191054|FG000|Received Intervention|Nausea|1|||
163131990|NCT00129467|589191055|FG001|Received Intervention|Nausea|0|||
163131991|NCT00129467|589191054|FG000|Received Intervention|Intolerance to citalopram|0|||
163131992|NCT00129467|589191055|FG001|Received Intervention|Intolerance to citalopram|1|||
163131993|NCT00129467|589191054|FG000|Received Intervention|Dizzyness, fatigue|0|||
163131994|NCT00129467|589191055|FG001|Received Intervention|Dizzyness, fatigue|1|||
163131995|NCT00129467|589191054|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
163131996|NCT00129467|589191055|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
163131997|NCT00129467|589191054|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
162658008|NCT02660359|587461190|FG002|Overall Study|Protocol Deviation|1|||
162658009|NCT02660359|587461188|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
162658010|NCT02660359|587461189|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
163131998|NCT00129467|589191055|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
163131999|NCT01009086|589191056|FG000|Overall Study|Lack of Efficacy|16|||
163132000|NCT01009086|589191057|FG001|Overall Study|Lack of Efficacy|15|||
163132001|NCT01009086|589191058|FG002|Overall Study|Lack of Efficacy|9|||
163132002|NCT01009086|589191056|FG000|Overall Study|Lost to Follow-up|4|||
163132003|NCT01009086|589191057|FG001|Overall Study|Lost to Follow-up|5|||
163132004|NCT01009086|589191058|FG002|Overall Study|Lost to Follow-up|3|||
163132005|NCT01009086|589191056|FG000|Overall Study|Adverse Event|12|||
163132006|NCT01009086|589191057|FG001|Overall Study|Adverse Event|11|||
163132007|NCT01009086|589191058|FG002|Overall Study|Adverse Event|8|||
163132008|NCT01009086|589191056|FG000|Overall Study|Withdrawal by Subject|9|||
163132009|NCT01009086|589191057|FG001|Overall Study|Withdrawal by Subject|11|||
162658011|NCT02660359|587461190|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
162658012|NCT02660359|587461188|FG000|Overall Study|Lack of Efficacy|1|||
162658013|NCT02660359|587461189|FG001|Overall Study|Lack of Efficacy|1|||
162658014|NCT02660359|587461190|FG002|Overall Study|Lack of Efficacy|1|||
162658015|NCT02660359|587461188|FG000|Overall Study|Adverse Event|0|||
162658016|NCT02660359|587461189|FG001|Overall Study|Adverse Event|1|||
162658017|NCT02660359|587461190|FG002|Overall Study|Adverse Event|0|||
162658018|NCT02660359|587461188|FG000|Overall Study|Other|2|||
162658019|NCT02660359|587461189|FG001|Overall Study|Other|1|||
162658020|NCT02660359|587461190|FG002|Overall Study|Other|3|||
162658021|NCT02660359|587461188|FG000|Overall Study|Withdrawal by Subject|7|||
162658022|NCT02660359|587461189|FG001|Overall Study|Withdrawal by Subject|5|||
162658023|NCT02660359|587461190|FG002|Overall Study|Withdrawal by Subject|8|||
162658024|NCT02660359|587461188|FG000|Overall Study|Lost to Follow-up|3|||
163132010|NCT01009086|589191058|FG002|Overall Study|Withdrawal by Subject|13|||
162658025|NCT02660359|587461189|FG001|Overall Study|Lost to Follow-up|3|||
162658026|NCT02660359|587461190|FG002|Overall Study|Lost to Follow-up|0|||
162658027|NCT04101526|587461193|FG000|Overall Study|Did not complete all sleep diary entries|0|||
162658028|NCT04101526|587461194|FG001|Overall Study|Did not complete all sleep diary entries|1|||
162658029|NCT02944578|587461195|FG000|Overall Study|Physician Decision|1|||
162658030|NCT02944578|587461196|FG001|Overall Study|Physician Decision|0|||
162658031|NCT00548808|587461199|FG000|Overall Study|Lost to Follow-up|9|||
162658032|NCT00548808|587461200|FG001|Overall Study|Lost to Follow-up|3|||
162658033|NCT00548808|587461199|FG000|Overall Study|Protocol Violation|8|||
162658034|NCT00548808|587461200|FG001|Overall Study|Protocol Violation|8|||
162658035|NCT00548808|587461199|FG000|Overall Study|Withdrawal by Subject|8|||
162658036|NCT00548808|587461200|FG001|Overall Study|Withdrawal by Subject|4|||
162658037|NCT00548808|587461199|FG000|Overall Study|Physician Decision|6|||
163132011|NCT01009086|589191056|FG000|Overall Study|Other|3|||
163132012|NCT01009086|589191057|FG001|Overall Study|Other|5|||
163132013|NCT01009086|589191058|FG002|Overall Study|Other|1|||
163132014|NCT02202538|589191071|FG000|Overall Study|Withdrawal by Subject|5|||
163132015|NCT02202538|589191071|FG000|Overall Study|Did not meet all inclusion criteria|2|||
163132016|NCT02202538|589191071|FG000|Overall Study|Investigator Decision|1|||
163132017|NCT01853878|589191072|FG000|Overall Study|Recurrence|2|||
163132018|NCT01853878|589191073|FG001|Overall Study|Recurrence|0|||
163132019|NCT01853878|589191072|FG000|Overall Study|Adverse Event|2|||
163132020|NCT01853878|589191073|FG001|Overall Study|Adverse Event|0|||
163132021|NCT01853878|589191072|FG000|Overall Study|Withdrawal by Subject|3|||
163132022|NCT01853878|589191073|FG001|Overall Study|Withdrawal by Subject|1|||
163132023|NCT01853878|589191072|FG000|Overall Study|Migrated/moved from the study area|1|||
163132024|NCT01853878|589191073|FG001|Overall Study|Migrated/moved from the study area|0|||
163132025|NCT01853878|589191072|FG000|Overall Study|Other|55|||
163132026|NCT01853878|589191073|FG001|Overall Study|Other|43|||
163132027|NCT01846741|589191074|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
163132028|NCT01361178|589191075|FG000|Overall Study|Death|13|||
163132029|NCT01361178|589191076|FG001|Overall Study|Death|0|||
163132030|NCT04294147|589191079|FG000|Overall Study|Protocol Violation|2|||
163132031|NCT04294147|589191080|FG001|Overall Study|Protocol Violation|0|||
163132032|NCT01371305|589191088|FG000|Overall Study|Adverse Event|0|||
163132033|NCT01371305|589191089|FG001|Overall Study|Adverse Event|0|||
163132034|NCT01371305|589191090|FG002|Overall Study|Adverse Event|0|||
163132035|NCT01371305|589191091|FG003|Overall Study|Adverse Event|2|||
163132036|NCT01371305|589191092|FG004|Overall Study|Adverse Event|1|||
163132037|NCT01371305|589191093|FG005|Overall Study|Adverse Event|0|||
163132038|NCT01371305|589191088|FG000|Overall Study|Study terminated by sponsor|0|||
163132039|NCT01371305|589191089|FG001|Overall Study|Study terminated by sponsor|0|||
163132040|NCT01371305|589191090|FG002|Overall Study|Study terminated by sponsor|0|||
163132041|NCT01371305|589191091|FG003|Overall Study|Study terminated by sponsor|0|||
163132042|NCT01371305|589191092|FG004|Overall Study|Study terminated by sponsor|3|||
163132043|NCT01371305|589191093|FG005|Overall Study|Study terminated by sponsor|1|||
163132044|NCT01371305|589191088|FG000|Overall Study|Subject request|0|||
163132045|NCT01371305|589191089|FG001|Overall Study|Subject request|0|||
163132046|NCT01371305|589191090|FG002|Overall Study|Subject request|0|||
163132047|NCT01371305|589191091|FG003|Overall Study|Subject request|0|||
163132048|NCT01371305|589191092|FG004|Overall Study|Subject request|0|||
163132049|NCT01371305|589191093|FG005|Overall Study|Subject request|1|||
163132050|NCT04038567|589191094|FG000|Overall Study|Lost to Follow-up|6|||
163132051|NCT04038567|589191095|FG001|Overall Study|Lost to Follow-up|4|||
163132052|NCT04038567|589191096|FG002|Overall Study|Lost to Follow-up|5|||
163132053|NCT04038567|589191097|FG003|Overall Study|Lost to Follow-up|4|||
163132054|NCT04038567|589191098|FG004|Overall Study|Lost to Follow-up|6|||
163132055|NCT04038567|589191099|FG005|Overall Study|Lost to Follow-up|4|||
163132056|NCT04038567|589191100|FG006|Overall Study|Lost to Follow-up|4|||
163132057|NCT04038567|589191101|FG007|Overall Study|Lost to Follow-up|1|||
163132058|NCT04038567|589191094|FG000|Overall Study|Withdrawal by Subject|2|||
163132059|NCT04038567|589191095|FG001|Overall Study|Withdrawal by Subject|1|||
162658038|NCT00548808|587461200|FG001|Overall Study|Physician Decision|3|||
162658039|NCT00548808|587461199|FG000|Overall Study|Adverse Event|4|||
162658040|NCT00548808|587461200|FG001|Overall Study|Adverse Event|5|||
163132060|NCT04038567|589191096|FG002|Overall Study|Withdrawal by Subject|1|||
163132061|NCT04038567|589191097|FG003|Overall Study|Withdrawal by Subject|1|||
163132062|NCT04038567|589191098|FG004|Overall Study|Withdrawal by Subject|4|||
163132063|NCT04038567|589191099|FG005|Overall Study|Withdrawal by Subject|1|||
163132064|NCT04038567|589191100|FG006|Overall Study|Withdrawal by Subject|1|||
162658041|NCT00548808|587461199|FG000|Overall Study|Death|2|||
162658042|NCT00548808|587461200|FG001|Overall Study|Death|0|||
162658043|NCT00548808|587461199|FG000|Overall Study|Entry Criteria Not Met|2|||
162658044|NCT00548808|587461200|FG001|Overall Study|Entry Criteria Not Met|2|||
162658045|NCT00548808|587461199|FG000|Overall Study|Lack of Efficacy|2|||
162658046|NCT00548808|587461200|FG001|Overall Study|Lack of Efficacy|0|||
162658047|NCT00548808|587461199|FG000|Overall Study|Sponsor Decision|1|||
162658048|NCT00548808|587461200|FG001|Overall Study|Sponsor Decision|1|||
162658049|NCT00424372|587461202|FG000|Overall Study|Death|1|||
162658050|NCT00424372|587461202|FG000|Overall Study|Adverse Event|18|||
162658051|NCT00424372|587461202|FG000|Overall Study|Lack of Efficacy|6|||
162658052|NCT00424372|587461202|FG000|Overall Study|Withdrawal by Subject|4|||
162658053|NCT00424372|587461202|FG000|Overall Study|Protocol Violation|1|||
162658054|NCT00424372|587461202|FG000|Overall Study|Health deterioration|1|||
162658055|NCT04879745|587461204|FG000|Overall Study|Lost to Follow-up|4|||
162658056|NCT04879745|587461205|FG001|Overall Study|Lost to Follow-up|1|||
162658057|NCT00120042|587461206|FG000|Overall Study|all completed protocl|0|||
162658058|NCT00120042|587461207|FG001|Overall Study|all completed protocl|0|||
162658059|NCT00120042|587461208|FG002|Overall Study|all completed protocl|0|||
162658060|NCT04532112|587461211|FG000|Overall Study|Adverse Event|3|||
162658061|NCT04532112|587461212|FG001|Overall Study|Adverse Event|0|||
162658062|NCT03592641|587461213|FG000|Overall Study|Withdrawal by Subject|1|||
162658063|NCT01126541|587461215|FG000|Overall Study|Adverse Event|0|||
162658064|NCT01126541|587461216|FG001|Overall Study|Adverse Event|2|||
162658065|NCT01126541|587461217|FG002|Overall Study|Adverse Event|4|||
162658066|NCT01126541|587461215|FG000|Overall Study|Death|0|||
162658067|NCT01126541|587461216|FG001|Overall Study|Death|1|||
162658068|NCT01126541|587461217|FG002|Overall Study|Death|0|||
162658069|NCT01126541|587461215|FG000|Overall Study|Lack of Efficacy|6|||
162658070|NCT01126541|587461216|FG001|Overall Study|Lack of Efficacy|1|||
162658071|NCT01126541|587461217|FG002|Overall Study|Lack of Efficacy|11|||
162658072|NCT01126541|587461215|FG000|Overall Study|Lost to Follow-up|1|||
162658073|NCT01126541|587461216|FG001|Overall Study|Lost to Follow-up|2|||
162658074|NCT01126541|587461217|FG002|Overall Study|Lost to Follow-up|2|||
162658075|NCT01126541|587461215|FG000|Overall Study|Withdrawal by Subject|2|||
162658076|NCT01126541|587461216|FG001|Overall Study|Withdrawal by Subject|5|||
162658077|NCT01126541|587461217|FG002|Overall Study|Withdrawal by Subject|6|||
162658078|NCT01126541|587461215|FG000|Overall Study|Protocol Violation|0|||
162658079|NCT01126541|587461216|FG001|Overall Study|Protocol Violation|0|||
162658080|NCT01126541|587461217|FG002|Overall Study|Protocol Violation|1|||
162658081|NCT01126541|587461215|FG000|Overall Study|Administrative reason or other|1|||
162658082|NCT01126541|587461216|FG001|Overall Study|Administrative reason or other|1|||
162658083|NCT01126541|587461217|FG002|Overall Study|Administrative reason or other|2|||
162658084|NCT02664038|587461221|FG000|13 Week|Lost to Follow-up|7|||
163132065|NCT04038567|589191101|FG007|Overall Study|Withdrawal by Subject|1|||
163132066|NCT04038567|589191094|FG000|Overall Study|missed survey window|1|||
163132067|NCT04038567|589191095|FG001|Overall Study|missed survey window|2|||
163132068|NCT04038567|589191096|FG002|Overall Study|missed survey window|0|||
163132069|NCT04038567|589191097|FG003|Overall Study|missed survey window|0|||
163132070|NCT04038567|589191098|FG004|Overall Study|missed survey window|1|||
163132071|NCT04038567|589191099|FG005|Overall Study|missed survey window|1|||
163132072|NCT04038567|589191100|FG006|Overall Study|missed survey window|2|||
163132073|NCT04038567|589191101|FG007|Overall Study|missed survey window|2|||
163132074|NCT04038567|589191094|FG000|Overall Study|technical issues|0|||
163132075|NCT04038567|589191095|FG001|Overall Study|technical issues|0|||
163132076|NCT04038567|589191096|FG002|Overall Study|technical issues|0|||
163132077|NCT04038567|589191097|FG003|Overall Study|technical issues|0|||
163132078|NCT04038567|589191098|FG004|Overall Study|technical issues|0|||
163132079|NCT04038567|589191099|FG005|Overall Study|technical issues|0|||
163132080|NCT04038567|589191100|FG006|Overall Study|technical issues|1|||
163132081|NCT04038567|589191101|FG007|Overall Study|technical issues|0|||
163132082|NCT04038567|589191094|FG000|Overall Study|Medical issues (i.e., illness)|0|||
163132083|NCT04038567|589191095|FG001|Overall Study|Medical issues (i.e., illness)|1|||
163132084|NCT04038567|589191096|FG002|Overall Study|Medical issues (i.e., illness)|2|||
163132085|NCT04038567|589191097|FG003|Overall Study|Medical issues (i.e., illness)|1|||
163132086|NCT04038567|589191098|FG004|Overall Study|Medical issues (i.e., illness)|1|||
163132087|NCT04038567|589191099|FG005|Overall Study|Medical issues (i.e., illness)|1|||
163132088|NCT04038567|589191100|FG006|Overall Study|Medical issues (i.e., illness)|0|||
162658085|NCT02664038|587461222|FG001|13 Week|Lost to Follow-up|14|||
162658086|NCT02664038|587461221|FG000|13 Week|Withdrawal by Subject|1|||
162658087|NCT02664038|587461222|FG001|13 Week|Withdrawal by Subject|0|||
162658088|NCT02664038|587461221|FG000|26 Week|Lost to Follow-up|5|||
162658089|NCT02664038|587461222|FG001|26 Week|Lost to Follow-up|4|||
162658090|NCT06640829|587461229|FG000|Overall Study|Withdrawal by Subject|1|||
162658091|NCT06640829|587461229|FG000|Overall Study|Lost to Follow-up|1|||
162658092|NCT04456699|587461230|FG000|Overall Study|Death|48|||
162658093|NCT04456699|587461231|FG001|Overall Study|Death|50|||
163132089|NCT04038567|589191101|FG007|Overall Study|Medical issues (i.e., illness)|0|||
162658094|NCT04456699|587461232|FG002|Overall Study|Death|52|||
162658095|NCT04456699|587461230|FG000|Overall Study|Physician Decision|0|||
162658096|NCT04456699|587461231|FG001|Overall Study|Physician Decision|0|||
162658097|NCT04456699|587461232|FG002|Overall Study|Physician Decision|2|||
162658098|NCT04456699|587461230|FG000|Overall Study|Sponsor Decision|55|||
162658099|NCT04456699|587461231|FG001|Overall Study|Sponsor Decision|61|||
162658100|NCT04456699|587461232|FG002|Overall Study|Sponsor Decision|50|||
162658101|NCT04456699|587461230|FG000|Overall Study|Withdrawal by Subject|8|||
162658102|NCT04456699|587461231|FG001|Overall Study|Withdrawal by Subject|4|||
162658103|NCT04456699|587461232|FG002|Overall Study|Withdrawal by Subject|5|||
162658104|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Adverse Event|41|||
162658105|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Adverse Event|24|||
162658106|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
162658107|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
162658108|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
162658109|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
162658110|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Physician Decision|0|||
162658111|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Physician Decision|6|||
162658112|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
162658113|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
162658114|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
162658115|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
162658116|NCT00673452|587461237|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
162658117|NCT00673452|587461238|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
162658118|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
162658119|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
162658120|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
162658121|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
162658122|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
162658123|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
162658124|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
162658125|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
162658126|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
162658127|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
162658128|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
162658129|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
162658130|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
162658131|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
162658132|NCT00673452|587461237|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
162658133|NCT00673452|587461238|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
162658134|NCT03025828|587461239|FG000|Overall Study|Lost to Follow-up|1|||
162658135|NCT02519712|587461242|FG000|Overall Study|Disease Relapse|1|||
162658136|NCT02519712|587461242|FG000|Overall Study|Disease Progression|1|||
162658137|NCT02519712|587461242|FG000|Overall Study|Accruals are donors|2|||
162658138|NCT02908529|587461253|FG000|Overall Study|Lost to Follow-up|0|||
162658139|NCT02908529|587461254|FG001|Overall Study|Lost to Follow-up|2|||
162658140|NCT04497987|587461255|FG000|Overall Study|Adverse Event|1|||
162658141|NCT04497987|587461256|FG001|Overall Study|Adverse Event|0|||
162658142|NCT04497987|587461255|FG000|Overall Study|Death|21|||
162658143|NCT04497987|587461256|FG001|Overall Study|Death|13|||
163132090|NCT04038567|589191094|FG000|Overall Study|Death|0|||
163132091|NCT04038567|589191095|FG001|Overall Study|Death|0|||
163132092|NCT04038567|589191096|FG002|Overall Study|Death|0|||
163132093|NCT04038567|589191097|FG003|Overall Study|Death|1|||
163132094|NCT04038567|589191098|FG004|Overall Study|Death|1|||
163132095|NCT04038567|589191099|FG005|Overall Study|Death|0|||
163132096|NCT04038567|589191100|FG006|Overall Study|Death|0|||
163132097|NCT04038567|589191101|FG007|Overall Study|Death|1|||
163132098|NCT02726022|589191102|FG000|Overall Study|Adverse Event|14|||
163132099|NCT02726022|589191102|FG000|Overall Study|Treatment Failure|8|||
163132100|NCT02726022|589191102|FG000|Overall Study|Poor Compliance|13|||
163132101|NCT02726022|589191102|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
163132102|NCT02999633|589191103|FG000|Overall Study|Adverse Event|2|||
163132103|NCT02999633|589191103|FG000|Overall Study|Progressive disease|12|||
163132104|NCT02456857|589191108|FG000|Overall Study|Disease Progression|4|||
163132105|NCT00781859|589191109|FG000|Overall Study|Adverse Event|2|||
163132106|NCT00781859|589191110|FG001|Overall Study|Adverse Event|2|||
163132107|NCT00781859|589191109|FG000|Overall Study|Withdrawal by Subject|8|||
163132108|NCT00781859|589191110|FG001|Overall Study|Withdrawal by Subject|4|||
163132109|NCT00781859|589191109|FG000|Overall Study|Lost to Follow-up|6|||
163132110|NCT00781859|589191110|FG001|Overall Study|Lost to Follow-up|3|||
163132111|NCT00781859|589191109|FG000|Overall Study|Death|3|||
163132112|NCT00781859|589191110|FG001|Overall Study|Death|0|||
163132113|NCT01138501|589191111|FG000|Overall Study|Protocol Violation|2|||
163132114|NCT01138501|589191111|FG000|Overall Study|Withdrawal by Subject|3|||
163132115|NCT01220180|589191113|FG000|Overall Study|Lost to Follow-up|76|||
163132116|NCT01220180|589191113|FG000|Overall Study|Other|72|||
163132117|NCT01220180|589191113|FG000|Overall Study|Adverse Event|35|||
163132118|NCT01220180|589191113|FG000|Overall Study|Lack of Efficacy|22|||
163132119|NCT01220180|589191113|FG000|Overall Study|Death|1|||
163132120|NCT01220180|589191113|FG000|Overall Study|Randomized but not treated|1|||
163132121|NCT01990859|589191114|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
163132122|NCT01990859|589191114|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
163132123|NCT00348309|589191115|FG000|Overall Study|Adverse Event|56|||
163132124|NCT00348309|589191116|FG001|Overall Study|Adverse Event|28|||
163132125|NCT00348309|589191117|FG002|Overall Study|Adverse Event|63|||
163132126|NCT00348309|589191115|FG000|Overall Study|Lost to Follow-up|6|||
163132127|NCT00348309|589191116|FG001|Overall Study|Lost to Follow-up|7|||
163132128|NCT00348309|589191117|FG002|Overall Study|Lost to Follow-up|4|||
163132129|NCT00348309|589191115|FG000|Overall Study|Protocol Violation|7|||
163132130|NCT00348309|589191116|FG001|Overall Study|Protocol Violation|12|||
163132131|NCT00348309|589191117|FG002|Overall Study|Protocol Violation|7|||
163132132|NCT00348309|589191115|FG000|Overall Study|Withdrawal by Subject|33|||
163132133|NCT00348309|589191116|FG001|Overall Study|Withdrawal by Subject|37|||
163132134|NCT00348309|589191117|FG002|Overall Study|Withdrawal by Subject|40|||
163132135|NCT00348309|589191115|FG000|Overall Study|Non-compliance|8|||
163132136|NCT00348309|589191116|FG001|Overall Study|Non-compliance|6|||
163132137|NCT00348309|589191117|FG002|Overall Study|Non-compliance|8|||
163132138|NCT00348309|589191115|FG000|Overall Study|Death of caregiver|1|||
163132139|NCT00348309|589191116|FG001|Overall Study|Death of caregiver|0|||
163132140|NCT00348309|589191117|FG002|Overall Study|Death of caregiver|1|||
163132141|NCT00348309|589191115|FG000|Overall Study|Lack of insight, dementia|1|||
163132142|NCT00348309|589191116|FG001|Overall Study|Lack of insight, dementia|0|||
163132143|NCT00348309|589191117|FG002|Overall Study|Lack of insight, dementia|0|||
163132144|NCT00348309|589191115|FG000|Overall Study|Wrong bottle allocated|1|||
163132145|NCT00348309|589191116|FG001|Overall Study|Wrong bottle allocated|0|||
163132146|NCT00348309|589191117|FG002|Overall Study|Wrong bottle allocated|0|||
163132147|NCT00348309|589191115|FG000|Overall Study|Caregiver sick|1|||
163132148|NCT00348309|589191116|FG001|Overall Study|Caregiver sick|0|||
163132149|NCT00348309|589191117|FG002|Overall Study|Caregiver sick|0|||
163132150|NCT00348309|589191115|FG000|Overall Study|Use of prohibited medication|5|||
163132151|NCT00348309|589191116|FG001|Overall Study|Use of prohibited medication|2|||
163132152|NCT00348309|589191117|FG002|Overall Study|Use of prohibited medication|2|||
163132153|NCT00348309|589191115|FG000|Overall Study|Caregiver withdrawal|3|||
163132154|NCT00348309|589191116|FG001|Overall Study|Caregiver withdrawal|0|||
163132155|NCT00348309|589191117|FG002|Overall Study|Caregiver withdrawal|7|||
163132156|NCT00348309|589191115|FG000|Overall Study|Unable to complete ET visit|1|||
163132157|NCT00348309|589191116|FG001|Overall Study|Unable to complete ET visit|0|||
163132158|NCT00348309|589191117|FG002|Overall Study|Unable to complete ET visit|0|||
162658144|NCT04497987|587461255|FG000|Overall Study|Lost to Follow-up|19|||
162658145|NCT04497987|587461256|FG001|Overall Study|Lost to Follow-up|17|||
162658146|NCT04497987|587461255|FG000|Overall Study|Other - as reported by the investigator|22|||
162658147|NCT04497987|587461256|FG001|Overall Study|Other - as reported by the investigator|16|||
163132159|NCT00348309|589191115|FG000|Overall Study|PI closing medical practice|1|||
163132160|NCT00348309|589191116|FG001|Overall Study|PI closing medical practice|0|||
163132161|NCT00348309|589191117|FG002|Overall Study|PI closing medical practice|0|||
162658148|NCT04497987|587461255|FG000|Overall Study|Physician Decision|1|||
163132162|NCT00348309|589191115|FG000|Overall Study|Principal investigator's decision|1|||
163132163|NCT00348309|589191116|FG001|Overall Study|Principal investigator's decision|0|||
163132164|NCT00348309|589191117|FG002|Overall Study|Principal investigator's decision|0|||
163132165|NCT00348309|589191115|FG000|Overall Study|No disponibility of medication|1|||
163132166|NCT00348309|589191116|FG001|Overall Study|No disponibility of medication|0|||
163132167|NCT00348309|589191117|FG002|Overall Study|No disponibility of medication|0|||
163132168|NCT00348309|589191115|FG000|Overall Study|Worsened neurodegenerative disease|1|||
163132169|NCT00348309|589191116|FG001|Overall Study|Worsened neurodegenerative disease|0|||
162658149|NCT04497987|587461256|FG001|Overall Study|Physician Decision|0|||
162658150|NCT04497987|587461255|FG000|Overall Study|Withdrawal by Subject|35|||
162658151|NCT04497987|587461256|FG001|Overall Study|Withdrawal by Subject|21|||
162658152|NCT04579679|587461264|FG000|Overall Study|New Antitumor Therapy|6|||
162658153|NCT04579679|587461265|FG001|Overall Study|New Antitumor Therapy|4|||
162658154|NCT04579679|587461266|FG002|Overall Study|New Antitumor Therapy|7|||
162658155|NCT04579679|587461267|FG003|Overall Study|New Antitumor Therapy|0|||
162658156|NCT04579679|587461264|FG000|Overall Study|Withdrawal of Consent|1|||
162658157|NCT04579679|587461265|FG001|Overall Study|Withdrawal of Consent|1|||
162658158|NCT04579679|587461266|FG002|Overall Study|Withdrawal of Consent|2|||
162658159|NCT04579679|587461267|FG003|Overall Study|Withdrawal of Consent|4|||
162658160|NCT04579679|587461264|FG000|Overall Study|Death|2|||
162658161|NCT04579679|587461265|FG001|Overall Study|Death|2|||
162658162|NCT04579679|587461266|FG002|Overall Study|Death|2|||
162658163|NCT04579679|587461267|FG003|Overall Study|Death|0|||
162658164|NCT04579679|587461264|FG000|Overall Study|Adverse Event|0|||
162658165|NCT04579679|587461265|FG001|Overall Study|Adverse Event|4|||
162658166|NCT04579679|587461266|FG002|Overall Study|Adverse Event|0|||
162658167|NCT04579679|587461267|FG003|Overall Study|Adverse Event|0|||
162658168|NCT04579679|587461264|FG000|Overall Study|Disease Progression|9|||
162658169|NCT04579679|587461265|FG001|Overall Study|Disease Progression|13|||
162658170|NCT04579679|587461266|FG002|Overall Study|Disease Progression|7|||
162658171|NCT04579679|587461267|FG003|Overall Study|Disease Progression|0|||
162658172|NCT04579679|587461264|FG000|Overall Study|Physician Decision|0|||
162658173|NCT04579679|587461265|FG001|Overall Study|Physician Decision|0|||
162658174|NCT04579679|587461266|FG002|Overall Study|Physician Decision|1|||
162658175|NCT04579679|587461267|FG003|Overall Study|Physician Decision|0|||
162658176|NCT04579679|587461264|FG000|Overall Study|Study Terminated by Sponsor|2|||
162658177|NCT04579679|587461265|FG001|Overall Study|Study Terminated by Sponsor|7|||
162658178|NCT04579679|587461266|FG002|Overall Study|Study Terminated by Sponsor|1|||
162658179|NCT04579679|587461267|FG003|Overall Study|Study Terminated by Sponsor|0|||
162658180|NCT06023394|587461271|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
162658181|NCT06023394|587461272|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
162658182|NCT06023394|587461271|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
162658183|NCT06023394|587461272|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
162658184|NCT06023394|587461271|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
162658185|NCT06023394|587461272|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
162658186|NCT06023394|587461271|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
162658187|NCT06023394|587461272|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
162658188|NCT01607905|587463546|FG000|Overall Study|Withdrawal by participant|7|||
162658189|NCT01607905|587463547|FG001|Overall Study|Withdrawal by participant|2|||
162658190|NCT01607905|587463548|FG002|Overall Study|Withdrawal by participant|4|||
162658191|NCT01607905|587463549|FG003|Overall Study|Withdrawal by participant|6|||
162658192|NCT01607905|587463550|FG004|Overall Study|Withdrawal by participant|0|||
162658193|NCT01607905|587463551|FG005|Overall Study|Withdrawal by participant|4|||
162658194|NCT01607905|587463552|FG006|Overall Study|Withdrawal by participant|12|||
162658195|NCT01607905|587463546|FG000|Overall Study|Incidence or severity of AEs|5|||
162658196|NCT01607905|587463547|FG001|Overall Study|Incidence or severity of AEs|1|||
162658197|NCT01607905|587463548|FG002|Overall Study|Incidence or severity of AEs|1|||
162658198|NCT01607905|587463549|FG003|Overall Study|Incidence or severity of AEs|3|||
162658199|NCT01607905|587463550|FG004|Overall Study|Incidence or severity of AEs|0|||
162658200|NCT01607905|587463551|FG005|Overall Study|Incidence or severity of AEs|2|||
162658201|NCT01607905|587463552|FG006|Overall Study|Incidence or severity of AEs|8|||
162658202|NCT01607905|587463546|FG000|Overall Study|Disease progression|44|||
162658203|NCT01607905|587463547|FG001|Overall Study|Disease progression|16|||
162658204|NCT01607905|587463548|FG002|Overall Study|Disease progression|15|||
162658205|NCT01607905|587463549|FG003|Overall Study|Disease progression|11|||
162658206|NCT01607905|587463550|FG004|Overall Study|Disease progression|6|||
162658207|NCT01607905|587463551|FG005|Overall Study|Disease progression|7|||
162658208|NCT01607905|587463552|FG006|Overall Study|Disease progression|21|||
162658209|NCT01607905|587463546|FG000|Overall Study|Non-compliance with study procedures|0|||
162658210|NCT01607905|587463547|FG001|Overall Study|Non-compliance with study procedures|0|||
162658211|NCT01607905|587463548|FG002|Overall Study|Non-compliance with study procedures|0|||
162658212|NCT01607905|587463549|FG003|Overall Study|Non-compliance with study procedures|0|||
162658213|NCT01607905|587463550|FG004|Overall Study|Non-compliance with study procedures|0|||
162658214|NCT01607905|587463551|FG005|Overall Study|Non-compliance with study procedures|0|||
162658215|NCT01607905|587463552|FG006|Overall Study|Non-compliance with study procedures|1|||
162658216|NCT01607905|587463546|FG000|Overall Study|Death|1|||
162658217|NCT01607905|587463547|FG001|Overall Study|Death|1|||
162658218|NCT01607905|587463548|FG002|Overall Study|Death|1|||
162658219|NCT01607905|587463549|FG003|Overall Study|Death|1|||
162658220|NCT01607905|587463550|FG004|Overall Study|Death|0|||
162658221|NCT01607905|587463551|FG005|Overall Study|Death|0|||
162658222|NCT01607905|587463552|FG006|Overall Study|Death|3|||
162658223|NCT01607905|587463546|FG000|Overall Study|Other treatments become available|1|||
162658224|NCT01607905|587463547|FG001|Overall Study|Other treatments become available|0|||
162658225|NCT01607905|587463548|FG002|Overall Study|Other treatments become available|0|||
162658226|NCT01607905|587463549|FG003|Overall Study|Other treatments become available|0|||
162658227|NCT01607905|587463550|FG004|Overall Study|Other treatments become available|0|||
162658228|NCT01607905|587463551|FG005|Overall Study|Other treatments become available|0|||
162658229|NCT01607905|587463552|FG006|Overall Study|Other treatments become available|1|||
162658230|NCT01607905|587463546|FG000|Overall Study|Investigator discretion|0|||
162658231|NCT01607905|587463547|FG001|Overall Study|Investigator discretion|0|||
162658232|NCT01607905|587463548|FG002|Overall Study|Investigator discretion|0|||
162658233|NCT01607905|587463549|FG003|Overall Study|Investigator discretion|0|||
162658234|NCT01607905|587463550|FG004|Overall Study|Investigator discretion|0|||
162658235|NCT01607905|587463551|FG005|Overall Study|Investigator discretion|1|||
162658236|NCT01607905|587463552|FG006|Overall Study|Investigator discretion|0|||
162658237|NCT01607905|587463546|FG000|Overall Study|Other|1|||
162658238|NCT01607905|587463547|FG001|Overall Study|Other|0|||
162658239|NCT01607905|587463548|FG002|Overall Study|Other|0|||
162658240|NCT01607905|587463549|FG003|Overall Study|Other|0|||
162658241|NCT01607905|587463550|FG004|Overall Study|Other|0|||
162658242|NCT01607905|587463551|FG005|Overall Study|Other|0|||
162658243|NCT01607905|587463552|FG006|Overall Study|Other|1|||
162658244|NCT01607905|587463546|FG000|Overall Study|Randomized but not treated|1|||
162658245|NCT01607905|587463547|FG001|Overall Study|Randomized but not treated|0|||
162658246|NCT01607905|587463548|FG002|Overall Study|Randomized but not treated|0|||
162658247|NCT01607905|587463549|FG003|Overall Study|Randomized but not treated|0|||
162658248|NCT01607905|587463550|FG004|Overall Study|Randomized but not treated|1|||
162658249|NCT01607905|587463551|FG005|Overall Study|Randomized but not treated|1|||
162658250|NCT01607905|587463552|FG006|Overall Study|Randomized but not treated|0|||
162658251|NCT00941733|587463553|FG000|Overall Study|Death|24|||
162658252|NCT00941733|587463554|FG001|Overall Study|Death|10|||
162658253|NCT00941733|587463553|FG000|Overall Study|Withdrawal by Subject|14|||
162658254|NCT00941733|587463554|FG001|Overall Study|Withdrawal by Subject|6|||
162658255|NCT00941733|587463553|FG000|Overall Study|Adverse Event|20|||
162658256|NCT00941733|587463554|FG001|Overall Study|Adverse Event|4|||
162658257|NCT00941733|587463553|FG000|Overall Study|Lost to Follow-up|1|||
162658258|NCT00941733|587463554|FG001|Overall Study|Lost to Follow-up|2|||
162658259|NCT00941733|587463553|FG000|Overall Study|Protocol Violation|15|||
162658260|NCT00941733|587463554|FG001|Overall Study|Protocol Violation|6|||
162658261|NCT01105533|587463555|FG000|Overall Study|Death|0|||
162658262|NCT01105533|587463556|FG001|Overall Study|Death|0|||
162658263|NCT01105533|587463557|FG002|Overall Study|Death|0|||
162658264|NCT01105533|587463558|FG003|Overall Study|Death|0|||
162658265|NCT01105533|587463559|FG004|Overall Study|Death|1|||
162658266|NCT01105533|587463560|FG005|Overall Study|Death|0|||
162658267|NCT01105533|587463561|FG006|Overall Study|Death|0|||
162658268|NCT01105533|587463562|FG007|Overall Study|Death|0|||
162658269|NCT01105533|587463563|FG008|Overall Study|Death|0|||
162658270|NCT01105533|587463555|FG000|Overall Study|Lack of Efficacy|1|||
162658271|NCT01105533|587463556|FG001|Overall Study|Lack of Efficacy|1|||
162658272|NCT01105533|587463557|FG002|Overall Study|Lack of Efficacy|3|||
162658273|NCT01105533|587463558|FG003|Overall Study|Lack of Efficacy|3|||
162658274|NCT01105533|587463559|FG004|Overall Study|Lack of Efficacy|4|||
162658275|NCT01105533|587463560|FG005|Overall Study|Lack of Efficacy|5|||
162658276|NCT01105533|587463561|FG006|Overall Study|Lack of Efficacy|3|||
162658277|NCT01105533|587463562|FG007|Overall Study|Lack of Efficacy|2|||
162658278|NCT01105533|587463563|FG008|Overall Study|Lack of Efficacy|9|||
162658279|NCT01105533|587463555|FG000|Overall Study|Adverse Event|0|||
162658280|NCT01105533|587463556|FG001|Overall Study|Adverse Event|0|||
162658281|NCT01105533|587463557|FG002|Overall Study|Adverse Event|0|||
162658282|NCT01105533|587463558|FG003|Overall Study|Adverse Event|0|||
162658283|NCT01105533|587463559|FG004|Overall Study|Adverse Event|1|||
162658284|NCT01105533|587463560|FG005|Overall Study|Adverse Event|2|||
162658285|NCT01105533|587463561|FG006|Overall Study|Adverse Event|2|||
162658286|NCT01105533|587463562|FG007|Overall Study|Adverse Event|0|||
162658287|NCT01105533|587463563|FG008|Overall Study|Adverse Event|1|||
162658288|NCT01105533|587463555|FG000|Overall Study|Other|0|||
162719821|NCT03386929|587680589|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
162658289|NCT01105533|587463556|FG001|Overall Study|Other|0|||
162658290|NCT01105533|587463557|FG002|Overall Study|Other|0|||
162658291|NCT01105533|587463558|FG003|Overall Study|Other|0|||
162658292|NCT01105533|587463559|FG004|Overall Study|Other|1|||
162658293|NCT01105533|587463560|FG005|Overall Study|Other|0|||
162658294|NCT01105533|587463561|FG006|Overall Study|Other|3|||
162658295|NCT01105533|587463562|FG007|Overall Study|Other|1|||
162658296|NCT01105533|587463563|FG008|Overall Study|Other|2|||
162658297|NCT01105533|587463555|FG000|Overall Study|Physician Decision|0|||
162658298|NCT01105533|587463556|FG001|Overall Study|Physician Decision|0|||
162658299|NCT01105533|587463557|FG002|Overall Study|Physician Decision|0|||
162658300|NCT01105533|587463558|FG003|Overall Study|Physician Decision|0|||
162658301|NCT01105533|587463559|FG004|Overall Study|Physician Decision|0|||
162658302|NCT01105533|587463560|FG005|Overall Study|Physician Decision|0|||
162658303|NCT01105533|587463561|FG006|Overall Study|Physician Decision|0|||
162658304|NCT01105533|587463562|FG007|Overall Study|Physician Decision|1|||
162658305|NCT01105533|587463563|FG008|Overall Study|Physician Decision|0|||
162658306|NCT02453594|587463567|FG000|Overall Study|Protocol Violation|0|||
162658307|NCT02453594|587463568|FG001|Overall Study|Protocol Violation|0|||
162658308|NCT02453594|587463569|FG002|Overall Study|Protocol Violation|1|||
162658309|NCT02453594|587463567|FG000|Overall Study|Cohort Was Closed|17|||
162658310|NCT02453594|587463568|FG001|Overall Study|Cohort Was Closed|21|||
162658311|NCT02453594|587463569|FG002|Overall Study|Cohort Was Closed|14|||
162658312|NCT02453594|587463567|FG000|Overall Study|Death|20|||
162658313|NCT02453594|587463568|FG001|Overall Study|Death|24|||
162658314|NCT02453594|587463569|FG002|Overall Study|Death|16|||
162658315|NCT02453594|587463567|FG000|Overall Study|Lost to Follow-up|6|||
162658316|NCT02453594|587463568|FG001|Overall Study|Lost to Follow-up|14|||
162658317|NCT02453594|587463569|FG002|Overall Study|Lost to Follow-up|2|||
162658318|NCT02453594|587463567|FG000|Overall Study|Physician Decision|2|||
162658319|NCT02453594|587463568|FG001|Overall Study|Physician Decision|4|||
162658320|NCT02453594|587463569|FG002|Overall Study|Physician Decision|0|||
162658321|NCT02453594|587463567|FG000|Overall Study|Site Terminated by Sponsor|1|||
162658322|NCT02453594|587463568|FG001|Overall Study|Site Terminated by Sponsor|0|||
162658323|NCT02453594|587463569|FG002|Overall Study|Site Terminated by Sponsor|1|||
162658324|NCT02453594|587463567|FG000|Overall Study|Transitioned to Extension Study|16|||
162658325|NCT02453594|587463568|FG001|Overall Study|Transitioned to Extension Study|9|||
162658326|NCT02453594|587463569|FG002|Overall Study|Transitioned to Extension Study|16|||
162658327|NCT02453594|587463567|FG000|Overall Study|Withdrawal by Subject|7|||
162658328|NCT02453594|587463568|FG001|Overall Study|Withdrawal by Subject|9|||
162658329|NCT02453594|587463569|FG002|Overall Study|Withdrawal by Subject|11|||
162658330|NCT01694706|587463578|FG000|Overall Study|Adverse Event|0|||
162658331|NCT01694706|587463579|FG001|Overall Study|Adverse Event|1|||
162658332|NCT01694706|587463580|FG002|Overall Study|Adverse Event|0|||
162658333|NCT01694706|587463578|FG000|Overall Study|other reason not defined above|1|||
162658334|NCT01694706|587463579|FG001|Overall Study|other reason not defined above|0|||
162658335|NCT01694706|587463580|FG002|Overall Study|other reason not defined above|0|||
162658336|NCT00451282|587463581|FG000|Overall Study|Lost to Follow-up|6|||
162658337|NCT00451282|587463582|FG001|Overall Study|Lost to Follow-up|5|||
162658338|NCT01797536|587463583|FG000|Overall Study|Adverse Event|0|||
162658339|NCT01797536|587463584|FG001|Overall Study|Adverse Event|1|||
162658340|NCT01797536|587463585|FG002|Overall Study|Adverse Event|0|||
162658341|NCT01797536|587463586|FG003|Overall Study|Adverse Event|0|||
162658342|NCT00098839|587463587|FG000|Overall Study|Adverse Event|5|||
162658343|NCT00098839|587463588|FG001|Overall Study|Adverse Event|2|||
162658344|NCT00098839|587463587|FG000|Overall Study|Death|1|||
162658345|NCT00098839|587463588|FG001|Overall Study|Death|2|||
162658346|NCT00098839|587463587|FG000|Overall Study|Physician Decision|4|||
162658347|NCT00098839|587463588|FG001|Overall Study|Physician Decision|14|||
162658348|NCT00098839|587463587|FG000|Overall Study|Withdrawal by Subject|1|||
162658349|NCT00098839|587463588|FG001|Overall Study|Withdrawal by Subject|0|||
162658350|NCT00098839|587463587|FG000|Overall Study|Refusal of further protocol therapy|3|||
162658351|NCT00098839|587463588|FG001|Overall Study|Refusal of further protocol therapy|1|||
162658352|NCT00098839|587463587|FG000|Overall Study|Relapse|6|||
162658353|NCT00098839|587463588|FG001|Overall Study|Relapse|3|||
162658354|NCT00098839|587463587|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
162658355|NCT00098839|587463588|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
162658356|NCT00098839|587463587|FG000|Overall Study|Ineligible|2|||
162658357|NCT00098839|587463588|FG001|Overall Study|Ineligible|0|||
162658358|NCT00456092|587463589|FG000|Extension Phase|Grade 2 or Greater AE|2|||
162658359|NCT00456092|587463590|FG001|Extension Phase|Grade 2 or Greater AE|2|||
163132170|NCT00348309|589191117|FG002|Overall Study|Worsened neurodegenerative disease|0|||
163132171|NCT00348309|589191115|FG000|Overall Study|Cognitive and behaviour worsening|2|||
162658360|NCT00456092|587463591|FG002|Extension Phase|Grade 2 or Greater AE|0|||
162658361|NCT00456092|587463592|FG003|Extension Phase|Grade 2 or Greater AE|0|||
162658362|NCT00456092|587463593|FG004|Extension Phase|Grade 2 or Greater AE|2|||
162658363|NCT00456092|587463589|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
162658364|NCT00456092|587463590|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
162658365|NCT00456092|587463591|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
162658366|NCT00456092|587463592|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
162658367|NCT00456092|587463593|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
162658368|NCT00456092|587463589|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
162658369|NCT00456092|587463590|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
162658370|NCT00456092|587463591|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
162658371|NCT00456092|587463592|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
162658372|NCT00456092|587463593|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
162658373|NCT00456092|587463589|FG000|Extension Phase|Withdrew Consent|2|||
162658374|NCT00456092|587463590|FG001|Extension Phase|Withdrew Consent|0|||
162658375|NCT00456092|587463591|FG002|Extension Phase|Withdrew Consent|0|||
162658376|NCT00456092|587463592|FG003|Extension Phase|Withdrew Consent|0|||
162658377|NCT00456092|587463593|FG004|Extension Phase|Withdrew Consent|0|||
162658378|NCT00456092|587463589|FG000|Extension Phase|Lost to Follow-up|1|||
162658379|NCT00456092|587463590|FG001|Extension Phase|Lost to Follow-up|1|||
162658380|NCT00456092|587463591|FG002|Extension Phase|Lost to Follow-up|0|||
162658381|NCT00456092|587463592|FG003|Extension Phase|Lost to Follow-up|0|||
162658382|NCT00456092|587463593|FG004|Extension Phase|Lost to Follow-up|1|||
162658383|NCT00456092|587463589|FG000|Extension Phase|Other|2|||
163132172|NCT00348309|589191116|FG001|Overall Study|Cognitive and behaviour worsening|0|||
163132173|NCT00348309|589191117|FG002|Overall Study|Cognitive and behaviour worsening|0|||
163132174|NCT00348309|589191115|FG000|Overall Study|Worsening of alzheimer|1|||
163132175|NCT00348309|589191116|FG001|Overall Study|Worsening of alzheimer|0|||
163132176|NCT00348309|589191117|FG002|Overall Study|Worsening of alzheimer|1|||
163132177|NCT00348309|589191115|FG000|Overall Study|Did not appear in time for Visit 3|1|||
163132178|NCT00348309|589191116|FG001|Overall Study|Did not appear in time for Visit 3|0|||
163132179|NCT00348309|589191117|FG002|Overall Study|Did not appear in time for Visit 3|0|||
163132180|NCT00348309|589191115|FG000|Overall Study|Participant died|2|||
163132181|NCT00348309|589191116|FG001|Overall Study|Participant died|1|||
163132182|NCT00348309|589191117|FG002|Overall Study|Participant died|1|||
163132183|NCT00348309|589191115|FG000|Overall Study|Decision of sponsor|1|||
163132184|NCT00348309|589191116|FG001|Overall Study|Decision of sponsor|0|||
163132185|NCT00348309|589191117|FG002|Overall Study|Decision of sponsor|0|||
163132186|NCT00348309|589191115|FG000|Overall Study|Ineffectiveness of treatment|0|||
163132187|NCT00348309|589191116|FG001|Overall Study|Ineffectiveness of treatment|1|||
163132188|NCT00348309|589191117|FG002|Overall Study|Ineffectiveness of treatment|0|||
163132189|NCT00348309|589191115|FG000|Overall Study|A foul of exclusion criteria|0|||
163132190|NCT00348309|589191116|FG001|Overall Study|A foul of exclusion criteria|1|||
163132191|NCT00348309|589191117|FG002|Overall Study|A foul of exclusion criteria|0|||
163132192|NCT00348309|589191115|FG000|Overall Study|Participant was hospitalized|0|||
163132193|NCT00348309|589191116|FG001|Overall Study|Participant was hospitalized|1|||
163132194|NCT00348309|589191117|FG002|Overall Study|Participant was hospitalized|0|||
163132195|NCT00348309|589191115|FG000|Overall Study|Sponsor refuseal|0|||
163132196|NCT00348309|589191116|FG001|Overall Study|Sponsor refuseal|1|||
163132197|NCT00348309|589191117|FG002|Overall Study|Sponsor refuseal|1|||
163132198|NCT00348309|589191115|FG000|Overall Study|Forgot often medication|0|||
163132199|NCT00348309|589191116|FG001|Overall Study|Forgot often medication|1|||
163132200|NCT00348309|589191117|FG002|Overall Study|Forgot often medication|0|||
163132201|NCT00348309|589191115|FG000|Overall Study|Medical Monitor decision|0|||
163132202|NCT00348309|589191116|FG001|Overall Study|Medical Monitor decision|0|||
163132203|NCT00348309|589191117|FG002|Overall Study|Medical Monitor decision|1|||
163132204|NCT00348309|589191115|FG000|Overall Study|Increased dose of Aricept|0|||
163132205|NCT00348309|589191116|FG001|Overall Study|Increased dose of Aricept|0|||
163132206|NCT00348309|589191117|FG002|Overall Study|Increased dose of Aricept|1|||
163132207|NCT00348309|589191115|FG000|Overall Study|Site closure|0|||
163132208|NCT00348309|589191116|FG001|Overall Study|Site closure|0|||
163132209|NCT00348309|589191117|FG002|Overall Study|Site closure|1|||
163132210|NCT00348309|589191115|FG000|Overall Study|Adverse event not attended|0|||
163132211|NCT00348309|589191116|FG001|Overall Study|Adverse event not attended|0|||
163132212|NCT00348309|589191117|FG002|Overall Study|Adverse event not attended|1|||
163132213|NCT00348309|589191115|FG000|Overall Study|ECG abnormal|0|||
163132214|NCT00348309|589191116|FG001|Overall Study|ECG abnormal|0|||
163132215|NCT00348309|589191117|FG002|Overall Study|ECG abnormal|2|||
163132216|NCT00348309|589191115|FG000|Overall Study|Cardiologist recommendations|0|||
163132217|NCT00348309|589191116|FG001|Overall Study|Cardiologist recommendations|0|||
163132218|NCT00348309|589191117|FG002|Overall Study|Cardiologist recommendations|1|||
163132219|NCT00348309|589191115|FG000|Overall Study|HCV career|0|||
163132220|NCT00348309|589191116|FG001|Overall Study|HCV career|0|||
163132221|NCT00348309|589191117|FG002|Overall Study|HCV career|1|||
163132222|NCT00622388|589191118|FG000|Overall Study|Disease Progression|47|||
163132223|NCT00622388|589191118|FG000|Overall Study|Adverse Event|6|||
163132224|NCT00622388|589191118|FG000|Overall Study|Protocol Violation|3|||
163132225|NCT00622388|589191118|FG000|Overall Study|Participant Refusal|1|||
163132226|NCT00622388|589191118|FG000|Overall Study|Death|3|||
163132227|NCT00622388|589191118|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
163132228|NCT00622388|589191118|FG000|Overall Study|Took Prohibited Medication|2|||
163132229|NCT00622388|589191118|FG000|Overall Study|Withdrew Consent|1|||
163132230|NCT00622388|589191118|FG000|Overall Study|Insurance Expired|1|||
163132231|NCT01364389|589191121|FG000|Overall Study|Withdrawal by Subject|0|||
163132232|NCT01364389|589191122|FG001|Overall Study|Withdrawal by Subject|1|||
163132233|NCT01364389|589191123|FG002|Overall Study|Withdrawal by Subject|0|||
163132234|NCT01364389|589191121|FG000|Overall Study|Protocol deviation|0|||
162658384|NCT00456092|587463590|FG001|Extension Phase|Other|0|||
162658385|NCT00456092|587463591|FG002|Extension Phase|Other|0|||
163132235|NCT01364389|589191122|FG001|Overall Study|Protocol deviation|0|||
163132236|NCT01364389|589191123|FG002|Overall Study|Protocol deviation|1|||
163132237|NCT01364389|589191121|FG000|Overall Study|Administrative problems|1|||
163132238|NCT01364389|589191122|FG001|Overall Study|Administrative problems|0|||
163132239|NCT01364389|589191123|FG002|Overall Study|Administrative problems|0|||
163132240|NCT01364389|589191121|FG000|Overall Study|Adverse Event|1|||
163132241|NCT01364389|589191122|FG001|Overall Study|Adverse Event|0|||
163132242|NCT01364389|589191123|FG002|Overall Study|Adverse Event|0|||
163132243|NCT01534195|589191124|FG000|Overall Study|Withdrawal by Subject|1|||
163132244|NCT01534195|589191125|FG001|Overall Study|Withdrawal by Subject|1|||
163132245|NCT02554981|589191126|FG000|Overall Study|Adverse Event|1|||
163132246|NCT02554981|589191126|FG000|Overall Study|Administrative Reasons|1|||
163132247|NCT02554981|589191126|FG000|Overall Study|Other Miscellaneous Reasons|3|||
163132248|NCT03068767|589191133|FG000|Overall Study|Lost to Follow-up|7|||
163132249|NCT03068767|589191134|FG001|Overall Study|Lost to Follow-up|3|||
163132250|NCT03068767|589191133|FG000|Overall Study|Protocol Violation|3|||
163132251|NCT03068767|589191134|FG001|Overall Study|Protocol Violation|0|||
163132252|NCT00061633|589191135|FG000|Overall Study|Adverse Event|1|||
162658386|NCT00456092|587463592|FG003|Extension Phase|Other|1|||
162658387|NCT00456092|587463593|FG004|Extension Phase|Other|1|||
162658388|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
162658389|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
162658390|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
162658391|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
162658392|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
162658393|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
162658394|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
162658395|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162658396|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162658397|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162658398|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
162658399|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162658400|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162658401|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162658402|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162658403|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162658404|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
162658405|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
162658406|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162658407|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162658408|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162658409|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
162658410|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
162658411|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162658412|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162658413|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162658414|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
162658415|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
162658416|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162658417|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162658418|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162658419|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
162658420|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
162658421|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162658422|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162658423|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162658424|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
162658425|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
162658426|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162658427|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162658428|NCT00456092|587463589|FG000|Treatment Phase (12 Weeks)|Other|1|||
162658429|NCT00456092|587463590|FG001|Treatment Phase (12 Weeks)|Other|0|||
162658430|NCT00456092|587463591|FG002|Treatment Phase (12 Weeks)|Other|1|||
162658431|NCT00456092|587463592|FG003|Treatment Phase (12 Weeks)|Other|0|||
162658432|NCT00456092|587463593|FG004|Treatment Phase (12 Weeks)|Other|0|||
162658433|NCT01252290|587463598|FG000|Overall Study|Withdrawal by Subject|1|||
162658434|NCT02247349|587463599|FG000|Overall Study|Disease Progression|7|||
162658435|NCT02247349|587463600|FG001|Overall Study|Disease Progression|4|||
162658436|NCT02247349|587463601|FG002|Overall Study|Disease Progression|26|||
162658437|NCT02247349|587463602|FG003|Overall Study|Disease Progression|31|||
162658438|NCT02247349|587463603|FG004|Overall Study|Disease Progression|16|||
162658439|NCT02247349|587463604|FG005|Overall Study|Disease Progression|6|||
162658440|NCT02247349|587463599|FG000|Overall Study|Study drug toxicity|0|||
162658441|NCT02247349|587463600|FG001|Overall Study|Study drug toxicity|1|||
162658442|NCT02247349|587463601|FG002|Overall Study|Study drug toxicity|1|||
162658443|NCT02247349|587463602|FG003|Overall Study|Study drug toxicity|1|||
162658444|NCT02247349|587463603|FG004|Overall Study|Study drug toxicity|2|||
162658445|NCT02247349|587463604|FG005|Overall Study|Study drug toxicity|2|||
163132253|NCT00061633|589191136|FG001|Overall Study|Adverse Event|2|||
163132254|NCT00061633|589191135|FG000|Overall Study|Withdrawal by Subject|2|||
163132255|NCT00061633|589191136|FG001|Overall Study|Withdrawal by Subject|2|||
163132256|NCT00061633|589191135|FG000|Overall Study|Lost to Follow-up|1|||
163132257|NCT00061633|589191136|FG001|Overall Study|Lost to Follow-up|4|||
163132258|NCT00061633|589191135|FG000|Overall Study|Other|1|||
162658446|NCT02247349|587463599|FG000|Overall Study|Death|0|||
162658447|NCT02247349|587463600|FG001|Overall Study|Death|0|||
162658448|NCT02247349|587463601|FG002|Overall Study|Death|0|||
163132259|NCT00061633|589191136|FG001|Overall Study|Other|1|||
163132260|NCT00061633|589191135|FG000|Overall Study|Never received study treatment|0|||
163132261|NCT00061633|589191136|FG001|Overall Study|Never received study treatment|2|||
163132262|NCT01431963|589191137|FG000|Overall Study|Adverse Event|18|||
163132263|NCT01431963|589191137|FG000|Overall Study|Lack of Efficacy|7|||
163132264|NCT01431963|589191137|FG000|Overall Study|Protocol Violation|1|||
163132265|NCT01431963|589191137|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
163132266|NCT01431963|589191137|FG000|Overall Study|Physician Decision|4|||
163132267|NCT01431963|589191137|FG000|Overall Study|Withdrawal by Subject|3|||
163132268|NCT02475278|589194188|FG000|Overall Study|Lost to Follow-up|1|||
163132269|NCT02475278|589194188|FG000|Overall Study|Reason Not Specified|1|||
163132270|NCT01946152|589194189|FG000|Overall Study|Adverse Event|1|||
163132271|NCT01946152|589194190|FG001|Overall Study|Adverse Event|0|||
163132272|NCT01946152|589194191|FG002|Overall Study|Adverse Event|0|||
163132273|NCT01946152|589194192|FG003|Overall Study|Adverse Event|0|||
163132274|NCT01946152|589194189|FG000|Overall Study|Withdrawal by Subject|0|||
163132275|NCT01946152|589194190|FG001|Overall Study|Withdrawal by Subject|2|||
163132276|NCT01946152|589194191|FG002|Overall Study|Withdrawal by Subject|0|||
163132277|NCT01946152|589194192|FG003|Overall Study|Withdrawal by Subject|0|||
163132278|NCT01946152|589194189|FG000|Overall Study|Progression|0|||
163132279|NCT01946152|589194190|FG001|Overall Study|Progression|1|||
163132280|NCT01946152|589194191|FG002|Overall Study|Progression|4|||
163132281|NCT01946152|589194192|FG003|Overall Study|Progression|7|||
163132282|NCT01946152|589194189|FG000|Overall Study|Physician Decision|0|||
163132283|NCT01946152|589194190|FG001|Overall Study|Physician Decision|0|||
163132284|NCT01946152|589194191|FG002|Overall Study|Physician Decision|1|||
163132285|NCT01946152|589194192|FG003|Overall Study|Physician Decision|0|||
163132286|NCT01946152|589194189|FG000|Overall Study|Second malignancy|0|||
163132287|NCT01946152|589194190|FG001|Overall Study|Second malignancy|0|||
163132288|NCT01946152|589194191|FG002|Overall Study|Second malignancy|1|||
163132289|NCT01946152|589194192|FG003|Overall Study|Second malignancy|0|||
163132290|NCT01946152|589194189|FG000|Overall Study|Adverse Event|0|||
163132291|NCT01946152|589194190|FG001|Overall Study|Adverse Event|0|||
163132292|NCT01946152|589194191|FG002|Overall Study|Adverse Event|0|||
163132293|NCT01946152|589194192|FG003|Overall Study|Adverse Event|1|||
163132294|NCT03712787|589194193|FG000|Overall Study|Adverse Event|2|||
163132295|NCT03712787|589194194|FG001|Overall Study|Adverse Event|3|||
163132296|NCT03712787|589194195|FG002|Overall Study|Adverse Event|0|||
163132297|NCT03712787|589194196|FG003|Overall Study|Adverse Event|4|||
163132298|NCT03712787|589194193|FG000|Overall Study|Withdrawal by Subject|4|||
163132299|NCT03712787|589194194|FG001|Overall Study|Withdrawal by Subject|14|||
163132300|NCT03712787|589194195|FG002|Overall Study|Withdrawal by Subject|12|||
163132301|NCT03712787|589194196|FG003|Overall Study|Withdrawal by Subject|8|||
163132302|NCT03712787|589194193|FG000|Overall Study|Lost to Follow-up|1|||
163132303|NCT03712787|589194194|FG001|Overall Study|Lost to Follow-up|1|||
163132304|NCT03712787|589194195|FG002|Overall Study|Lost to Follow-up|2|||
163132305|NCT03712787|589194196|FG003|Overall Study|Lost to Follow-up|1|||
163132306|NCT03712787|589194193|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163132307|NCT03712787|589194194|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163132308|NCT03712787|589194195|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
163132309|NCT03712787|589194196|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
163132310|NCT03712787|589194193|FG000|Overall Study|COVID-19 Infection|0|||
163132311|NCT03712787|589194194|FG001|Overall Study|COVID-19 Infection|1|||
163132312|NCT03712787|589194195|FG002|Overall Study|COVID-19 Infection|0|||
163132313|NCT03712787|589194196|FG003|Overall Study|COVID-19 Infection|0|||
163132314|NCT03712787|589194193|FG000|Overall Study|Other, Not Specified|79|||
163132315|NCT03712787|589194194|FG001|Overall Study|Other, Not Specified|77|||
163132316|NCT03712787|589194195|FG002|Overall Study|Other, Not Specified|74|||
163132317|NCT03712787|589194196|FG003|Overall Study|Other, Not Specified|78|||
163132318|NCT01865448|589194197|FG000|Overall Study|Adverse Event|1|||
162658449|NCT02247349|587463602|FG003|Overall Study|Death|1|||
162658450|NCT02247349|587463603|FG004|Overall Study|Death|0|||
162658451|NCT02247349|587463604|FG005|Overall Study|Death|0|||
162658452|NCT02247349|587463599|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
163132319|NCT01865448|589194198|FG001|Overall Study|Adverse Event|1|||
163132320|NCT01865448|589194197|FG000|Overall Study|Pregnancy|0|||
163132321|NCT01865448|589194198|FG001|Overall Study|Pregnancy|1|||
163132322|NCT01865448|589194197|FG000|Overall Study|dropout unrelated to study|1|||
163132323|NCT01865448|589194198|FG001|Overall Study|dropout unrelated to study|1|||
163132324|NCT03499314|589194199|FG000|Overall Study|Time Commitment|1|||
163132325|NCT03499314|589194200|FG001|Overall Study|Time Commitment|2|||
163132326|NCT03499314|589194199|FG000|Overall Study|Medical issue unrelated to research study|1|||
163132327|NCT03499314|589194200|FG001|Overall Study|Medical issue unrelated to research study|1|||
163132328|NCT01618695|589194201|FG000|Core Phase|Adverse Event|4|||
163132329|NCT01618695|589194202|FG001|Core Phase|Adverse Event|5|||
163132330|NCT01618695|589194203|FG002|Core Phase|Adverse Event|15|||
163132331|NCT01618695|589194204|FG003|Core Phase|Adverse Event|20|||
163132332|NCT01618695|589194201|FG000|Core Phase|Lost to Follow-up|0|||
163132333|NCT01618695|589194202|FG001|Core Phase|Lost to Follow-up|0|||
163132334|NCT01618695|589194203|FG002|Core Phase|Lost to Follow-up|1|||
163132335|NCT01618695|589194204|FG003|Core Phase|Lost to Follow-up|0|||
162719822|NCT03386929|587680590|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
162658453|NCT02247349|587463600|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162658454|NCT02247349|587463601|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162658455|NCT02247349|587463602|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
162658456|NCT02247349|587463603|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
162658457|NCT02247349|587463604|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
162658458|NCT02247349|587463599|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162658459|NCT02247349|587463600|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162658460|NCT02247349|587463601|FG002|Overall Study|Participant request to discontinue study treatment|1|||
162658461|NCT02247349|587463602|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162658462|NCT02247349|587463603|FG004|Overall Study|Participant request to discontinue study treatment|1|||
162658463|NCT02247349|587463604|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162658464|NCT02247349|587463599|FG000|Overall Study|Withdrawal by Subject|0|||
162658465|NCT02247349|587463600|FG001|Overall Study|Withdrawal by Subject|1|||
162658466|NCT02247349|587463601|FG002|Overall Study|Withdrawal by Subject|0|||
162658467|NCT02247349|587463602|FG003|Overall Study|Withdrawal by Subject|0|||
162658468|NCT02247349|587463603|FG004|Overall Study|Withdrawal by Subject|0|||
162658469|NCT02247349|587463604|FG005|Overall Study|Withdrawal by Subject|0|||
162658470|NCT02247349|587463599|FG000|Overall Study|Administrative reason by sponsor|0|||
162658471|NCT02247349|587463600|FG001|Overall Study|Administrative reason by sponsor|0|||
162658472|NCT02247349|587463601|FG002|Overall Study|Administrative reason by sponsor|0|||
162658473|NCT02247349|587463602|FG003|Overall Study|Administrative reason by sponsor|0|||
162658474|NCT02247349|587463603|FG004|Overall Study|Administrative reason by sponsor|1|||
162658475|NCT02247349|587463604|FG005|Overall Study|Administrative reason by sponsor|0|||
162658476|NCT02247349|587463599|FG000|Overall Study|Other reasons|0|||
162658477|NCT02247349|587463600|FG001|Overall Study|Other reasons|0|||
162658478|NCT02247349|587463601|FG002|Overall Study|Other reasons|1|||
162658479|NCT02247349|587463602|FG003|Overall Study|Other reasons|0|||
162658480|NCT02247349|587463603|FG004|Overall Study|Other reasons|0|||
162658481|NCT02247349|587463604|FG005|Overall Study|Other reasons|0|||
162658482|NCT00617240|587463606|FG000|Overall Study|Lack of Efficacy|1|||
162658483|NCT00617240|587463607|FG001|Overall Study|Lack of Efficacy|0|||
162658484|NCT01611259|587463608|FG000|Overall Study|Physician Decision|1|||
162658485|NCT01611259|587463608|FG000|Overall Study|Lack of Efficacy|2|||
162658486|NCT01611259|587463608|FG000|Overall Study|Adverse Event|4|||
162658487|NCT01611259|587463608|FG000|Overall Study|Withdrawal by Subject|7|||
162658488|NCT04936685|587463609|FG000|Overall Study|Protocol Violation|1|||
162658489|NCT04936685|587463610|FG001|Overall Study|Protocol Violation|0|||
162658490|NCT00382733|587463612|FG000|Overall Study|Withdrawal by Subject|0|||
162658491|NCT00382733|587463613|FG001|Overall Study|Withdrawal by Subject|1|||
162658492|NCT00382733|587463614|FG002|Overall Study|Withdrawal by Subject|0|||
162658493|NCT00382733|587463615|FG003|Overall Study|Withdrawal by Subject|0|||
162658494|NCT00382733|587463616|FG004|Overall Study|Withdrawal by Subject|0|||
162658495|NCT03049813|587463617|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162658496|NCT03049813|587463618|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
162658497|NCT03049813|587463619|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162658498|NCT03049813|587463620|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162658499|NCT03049813|587463617|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
162658500|NCT03049813|587463618|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
162658501|NCT03049813|587463619|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
162658502|NCT03049813|587463620|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
162658503|NCT03049813|587463617|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162658504|NCT03049813|587463618|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
162658505|NCT03049813|587463619|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162658506|NCT03049813|587463620|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162658507|NCT03049813|587463617|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
162658508|NCT03049813|587463618|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
162658509|NCT03049813|587463619|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
162658510|NCT03049813|587463620|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
162658511|NCT00179413|587463621|FG000|Overall Study|Adverse Event|38|||
162658512|NCT00179413|587463622|FG001|Overall Study|Adverse Event|20|||
162658513|NCT00179413|587463621|FG000|Overall Study|Withdrawal by Subject|87|||
162658514|NCT00179413|587463622|FG001|Overall Study|Withdrawal by Subject|95|||
162658515|NCT03075644|587463625|FG000|Overall Study|Withdrawal by Subject|1|||
162719823|NCT03386929|587680591|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
162719824|NCT03386929|587680589|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
162658516|NCT03075644|587463626|FG001|Overall Study|Withdrawal by Subject|1|||
162719825|NCT03386929|587680590|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
162719826|NCT03386929|587680591|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
162719827|NCT03538054|587680594|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
163132336|NCT01618695|589194201|FG000|Core Phase|Withdrawal by Subject|16|||
163132337|NCT01618695|589194202|FG001|Core Phase|Withdrawal by Subject|11|||
163132338|NCT01618695|589194203|FG002|Core Phase|Withdrawal by Subject|9|||
163132339|NCT01618695|589194204|FG003|Core Phase|Withdrawal by Subject|13|||
163132340|NCT01618695|589194201|FG000|Core Phase|Pregnancy|2|||
163132341|NCT01618695|589194202|FG001|Core Phase|Pregnancy|0|||
163132342|NCT01618695|589194203|FG002|Core Phase|Pregnancy|0|||
163132343|NCT01618695|589194204|FG003|Core Phase|Pregnancy|0|||
163132344|NCT01618695|589194201|FG000|Core Phase|Lack of Efficacy|1|||
163132345|NCT01618695|589194202|FG001|Core Phase|Lack of Efficacy|2|||
163132346|NCT01618695|589194203|FG002|Core Phase|Lack of Efficacy|1|||
163132347|NCT01618695|589194204|FG003|Core Phase|Lack of Efficacy|1|||
163132348|NCT01618695|589194201|FG000|Core Phase|Other than specified|1|||
163132349|NCT01618695|589194202|FG001|Core Phase|Other than specified|2|||
163132350|NCT01618695|589194203|FG002|Core Phase|Other than specified|2|||
163132351|NCT01618695|589194204|FG003|Core Phase|Other than specified|2|||
163132352|NCT01618695|589194201|FG000|Core Phase|Not treated|1|||
163132353|NCT01618695|589194202|FG001|Core Phase|Not treated|0|||
163132354|NCT01618695|589194203|FG002|Core Phase|Not treated|2|||
163132355|NCT01618695|589194204|FG003|Core Phase|Not treated|0|||
163132356|NCT01618695|589194201|FG000|Extension Phase|Lack of Efficacy|17|||
163132357|NCT01618695|589194202|FG001|Extension Phase|Lack of Efficacy|33|||
163132358|NCT01618695|589194203|FG002|Extension Phase|Lack of Efficacy|26|||
163132359|NCT01618695|589194204|FG003|Extension Phase|Lack of Efficacy|24|||
163132360|NCT01618695|589194201|FG000|Extension Phase|Pregnancy|2|||
163132361|NCT01618695|589194202|FG001|Extension Phase|Pregnancy|0|||
163132362|NCT01618695|589194203|FG002|Extension Phase|Pregnancy|1|||
163132363|NCT01618695|589194204|FG003|Extension Phase|Pregnancy|1|||
163132364|NCT01618695|589194201|FG000|Extension Phase|Withdrawal by Subject|43|||
163132365|NCT01618695|589194202|FG001|Extension Phase|Withdrawal by Subject|48|||
163132366|NCT01618695|589194203|FG002|Extension Phase|Withdrawal by Subject|42|||
163132367|NCT01618695|589194204|FG003|Extension Phase|Withdrawal by Subject|33|||
163132368|NCT01618695|589194201|FG000|Extension Phase|Adverse Event|18|||
163132369|NCT01618695|589194202|FG001|Extension Phase|Adverse Event|16|||
163132370|NCT01618695|589194203|FG002|Extension Phase|Adverse Event|9|||
163132371|NCT01618695|589194204|FG003|Extension Phase|Adverse Event|20|||
163132372|NCT01618695|589194201|FG000|Extension Phase|Lost to Follow-up|2|||
163132373|NCT01618695|589194202|FG001|Extension Phase|Lost to Follow-up|1|||
163132374|NCT01618695|589194203|FG002|Extension Phase|Lost to Follow-up|1|||
163132375|NCT01618695|589194204|FG003|Extension Phase|Lost to Follow-up|1|||
163132376|NCT01618695|589194201|FG000|Extension Phase|Other than specified|13|||
163132377|NCT01618695|589194202|FG001|Extension Phase|Other than specified|18|||
163132378|NCT01618695|589194203|FG002|Extension Phase|Other than specified|13|||
163132379|NCT01618695|589194204|FG003|Extension Phase|Other than specified|18|||
163132380|NCT02291419|589194206|FG000|Overall Study|Early study termination|1|||
163132381|NCT02291419|589194207|FG001|Overall Study|Early study termination|5|||
163132382|NCT00931606|589194210|FG000|Overall Study|Death|1|||
163132383|NCT00931606|589194211|FG001|Overall Study|Death|3|||
163132384|NCT00931606|589194212|FG002|Overall Study|Death|2|||
163132385|NCT00931606|589194213|FG003|Overall Study|Death|0|||
163132386|NCT00931606|589194210|FG000|Overall Study|Lost to Follow-up|0|||
163132387|NCT00931606|589194211|FG001|Overall Study|Lost to Follow-up|1|||
163132388|NCT00931606|589194212|FG002|Overall Study|Lost to Follow-up|0|||
163132389|NCT00931606|589194213|FG003|Overall Study|Lost to Follow-up|0|||
163132390|NCT00931606|589194210|FG000|Overall Study|Physician Decision|0|||
163132391|NCT00931606|589194211|FG001|Overall Study|Physician Decision|0|||
163132392|NCT00931606|589194212|FG002|Overall Study|Physician Decision|3|||
163132393|NCT00931606|589194213|FG003|Overall Study|Physician Decision|0|||
163132394|NCT00931606|589194210|FG000|Overall Study|Sponsor Decision|1|||
163132395|NCT00931606|589194211|FG001|Overall Study|Sponsor Decision|4|||
163132396|NCT00931606|589194212|FG002|Overall Study|Sponsor Decision|0|||
163132397|NCT00931606|589194213|FG003|Overall Study|Sponsor Decision|2|||
163132398|NCT00931606|589194210|FG000|Overall Study|Withdrawal by Subject|3|||
163132399|NCT00931606|589194211|FG001|Overall Study|Withdrawal by Subject|1|||
163132400|NCT00931606|589194212|FG002|Overall Study|Withdrawal by Subject|1|||
163132401|NCT00931606|589194213|FG003|Overall Study|Withdrawal by Subject|1|||
163132402|NCT00871338|589194214|FG000|Prior to Booster|Withdrawal by Subject|1|||
163132403|NCT00871338|589194215|FG001|Prior to Booster|Withdrawal by Subject|3|||
163132404|NCT00871338|589194214|FG000|Prior to Booster|Lost to Follow-up|1|||
163132405|NCT00871338|589194215|FG001|Prior to Booster|Lost to Follow-up|0|||
163132406|NCT02391363|589194216|FG000|Overall Study|Lost to Follow-up|5|||
163132407|NCT02391363|589194217|FG001|Overall Study|Lost to Follow-up|5|||
163132408|NCT02391363|589194216|FG000|Overall Study|Withdrawal by Subject|6|||
163132409|NCT02391363|589194217|FG001|Overall Study|Withdrawal by Subject|3|||
163132410|NCT00799266|589194218|FG000|Overall Study|Adverse Event|0|||
163132411|NCT00799266|589194219|FG001|Overall Study|Adverse Event|1|||
163132412|NCT00799266|589194218|FG000|Overall Study|Subject withdrew consent|3|||
163132413|NCT00799266|589194219|FG001|Overall Study|Subject withdrew consent|0|||
163132414|NCT01016600|589194220|FG000|Overall Study|Did not start treatment|1|||
163132415|NCT01016600|589194221|FG001|Overall Study|Did not start treatment|0|||
162658517|NCT01813019|587463627|FG000|Overall Study|Adverse Event|0|||
162658518|NCT01813019|587463628|FG001|Overall Study|Adverse Event|3|||
162658519|NCT01813019|587463627|FG000|Overall Study|Withdrawal by Subject|3|||
162658520|NCT01813019|587463628|FG001|Overall Study|Withdrawal by Subject|2|||
162658521|NCT01813019|587463627|FG000|Overall Study|administrative problems|2|||
162658522|NCT01813019|587463628|FG001|Overall Study|administrative problems|0|||
162658523|NCT01813019|587463627|FG000|Overall Study|Protocol Deviation|2|||
162658524|NCT01813019|587463628|FG001|Overall Study|Protocol Deviation|1|||
162658525|NCT00439140|587463629|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
162658526|NCT00439140|587463630|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
162658527|NCT00439140|587463631|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
162658528|NCT00439140|587463629|FG000|Treatment Cycle 1|Personal reasons|0|||
162658529|NCT00439140|587463630|FG001|Treatment Cycle 1|Personal reasons|2|||
162658530|NCT00439140|587463631|FG002|Treatment Cycle 1|Personal reasons|0|||
162658531|NCT00439140|587463629|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
162658532|NCT00439140|587463630|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
162658533|NCT00439140|587463631|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
162658534|NCT00439140|587463629|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
162658535|NCT00439140|587463630|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
162658536|NCT00439140|587463631|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
162658537|NCT00439140|587463629|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
162719828|NCT03538054|587680594|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
163132416|NCT01016600|589194222|FG002|Overall Study|Did not start treatment|0|||
163132417|NCT01016600|589194223|FG003|Overall Study|Did not start treatment|0|||
163132418|NCT00872599|589194224|FG000|Second Washout Period|Adverse Event|1|||
163132419|NCT00872599|589194225|FG001|Second Washout Period|Adverse Event|1|||
163132420|NCT04794270|589194226|FG000|Period 1|Non Compliance|1|||
163132421|NCT04794270|589194227|FG001|Period 1|Non Compliance|0|||
163132422|NCT04794270|589194226|FG000|Period 1|Adverse Event|1|||
163132423|NCT04794270|589194227|FG001|Period 1|Adverse Event|0|||
163132424|NCT04794270|589194226|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
163132425|NCT04794270|589194227|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
162658538|NCT00439140|587463630|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
162719829|NCT03538054|587680594|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
162719830|NCT02351180|587680597|FG000|Overall Study|Withdrawal by Subject|1|||
163132426|NCT01504841|589194241|FG000|Overall Study|Withdrawal by Subject|1|||
163132427|NCT01504841|589194242|FG001|Overall Study|Withdrawal by Subject|1|||
163132428|NCT01504841|589194243|FG002|Overall Study|Withdrawal by Subject|0|||
163132429|NCT03149055|589194250|FG000|Overall Study|Not treated|4|||
163132430|NCT04440813|589194251|FG000|Overall Study|Lost to Follow-up|5|||
163132431|NCT04440813|589194252|FG001|Overall Study|Lost to Follow-up|5|||
163132432|NCT00660179|589194253|FG000|Overall Study|Death|44|||
163132433|NCT00660179|589194254|FG001|Overall Study|Death|47|||
163132434|NCT00660179|589194255|FG002|Overall Study|Death|34|||
163132435|NCT00660179|589194253|FG000|Overall Study|Withdrawal of consent|4|||
163132436|NCT00660179|589194254|FG001|Overall Study|Withdrawal of consent|6|||
163132437|NCT00660179|589194255|FG002|Overall Study|Withdrawal of consent|4|||
163132438|NCT00660179|589194253|FG000|Overall Study|Lost to Follow-up|7|||
163132439|NCT00660179|589194254|FG001|Overall Study|Lost to Follow-up|5|||
163132440|NCT00660179|589194255|FG002|Overall Study|Lost to Follow-up|2|||
163132441|NCT00660179|589194253|FG000|Overall Study|Administrative reason|0|||
163132442|NCT00660179|589194254|FG001|Overall Study|Administrative reason|0|||
163132443|NCT00660179|589194255|FG002|Overall Study|Administrative reason|1|||
163132444|NCT00660179|589194253|FG000|Overall Study|Incorrect randomization|1|||
163132445|NCT00660179|589194254|FG001|Overall Study|Incorrect randomization|0|||
163132446|NCT00660179|589194255|FG002|Overall Study|Incorrect randomization|0|||
163132447|NCT00291018|589194262|FG000|Overall Study|Not Consented or Declined PAS|12|||
163132448|NCT00291018|589194263|FG001|Overall Study|Not Consented or Declined PAS|15|||
163132449|NCT00291018|589194264|FG002|Overall Study|Not Consented or Declined PAS|15|||
163132450|NCT00291018|589194262|FG000|Overall Study|Death|3|||
163132451|NCT00291018|589194263|FG001|Overall Study|Death|3|||
163132452|NCT00291018|589194264|FG002|Overall Study|Death|4|||
163132453|NCT00291018|589194262|FG000|Overall Study|Withdrawal by Subject|2|||
163132454|NCT00291018|589194263|FG001|Overall Study|Withdrawal by Subject|8|||
163132455|NCT00291018|589194264|FG002|Overall Study|Withdrawal by Subject|1|||
163132456|NCT00291018|589194262|FG000|Overall Study|Failures|5|||
163132457|NCT00291018|589194263|FG001|Overall Study|Failures|12|||
163132458|NCT00291018|589194264|FG002|Overall Study|Failures|5|||
163132459|NCT00291018|589194262|FG000|Overall Study|Lost to Follow-up|3|||
163132460|NCT00291018|589194263|FG001|Overall Study|Lost to Follow-up|4|||
163132461|NCT00291018|589194264|FG002|Overall Study|Lost to Follow-up|18|||
163132462|NCT01504412|589194265|FG000|Overall Study|Adverse Event|1|||
163132463|NCT01504412|589194266|FG001|Overall Study|Adverse Event|8|||
163132464|NCT01504412|589194267|FG002|Overall Study|Adverse Event|1|||
163132465|NCT01504412|589194268|FG003|Overall Study|Adverse Event|7|||
163132466|NCT01504412|589194269|FG004|Overall Study|Adverse Event|10|||
163132467|NCT01504412|589194265|FG000|Overall Study|Withdrawal by Subject|2|||
163132468|NCT01504412|589194266|FG001|Overall Study|Withdrawal by Subject|1|||
163132469|NCT01504412|589194267|FG002|Overall Study|Withdrawal by Subject|1|||
163132470|NCT01504412|589194268|FG003|Overall Study|Withdrawal by Subject|5|||
163132471|NCT01504412|589194269|FG004|Overall Study|Withdrawal by Subject|1|||
163132472|NCT01504412|589194265|FG000|Overall Study|Other|2|||
163132473|NCT01504412|589194266|FG001|Overall Study|Other|1|||
163132474|NCT01504412|589194267|FG002|Overall Study|Other|1|||
163132475|NCT01504412|589194268|FG003|Overall Study|Other|6|||
163132476|NCT01504412|589194269|FG004|Overall Study|Other|1|||
163132477|NCT01504412|589194265|FG000|Overall Study|Lost to Follow-up|0|||
163132478|NCT01504412|589194266|FG001|Overall Study|Lost to Follow-up|2|||
163132479|NCT01504412|589194267|FG002|Overall Study|Lost to Follow-up|0|||
163132480|NCT01504412|589194268|FG003|Overall Study|Lost to Follow-up|0|||
163132481|NCT01504412|589194269|FG004|Overall Study|Lost to Follow-up|0|||
163132482|NCT01504412|589194265|FG000|Overall Study|Lack of Efficacy|0|||
163132483|NCT01504412|589194266|FG001|Overall Study|Lack of Efficacy|0|||
163132484|NCT01504412|589194267|FG002|Overall Study|Lack of Efficacy|1|||
163132485|NCT01504412|589194268|FG003|Overall Study|Lack of Efficacy|0|||
163132486|NCT01504412|589194269|FG004|Overall Study|Lack of Efficacy|1|||
163132487|NCT01504412|589194265|FG000|Overall Study|Death|0|||
163132488|NCT01504412|589194266|FG001|Overall Study|Death|0|||
163132489|NCT01504412|589194267|FG002|Overall Study|Death|0|||
163132490|NCT01504412|589194268|FG003|Overall Study|Death|1|||
163132491|NCT01504412|589194269|FG004|Overall Study|Death|0|||
163132492|NCT00630344|589194270|FG000|Overall Study|Adverse Event|5|||
162658539|NCT00439140|587463631|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
163132493|NCT00630344|589194270|FG000|Overall Study|Progressive Disease|19|||
163132494|NCT00630344|589194270|FG000|Overall Study|Physician Decision|9|||
163132495|NCT00630344|589194270|FG000|Overall Study|Withdrawal by Subject|1|||
162658540|NCT01458171|587463637|FG000|Overall Study|Adverse Event|1|||
163132496|NCT00630344|589194270|FG000|Overall Study|Intercurrent Illness|1|||
163132497|NCT00630344|589194270|FG000|Overall Study|Other|1|||
163132498|NCT05362058|589194272|FG000|Treatment Period|Adverse Event|3|||
162658541|NCT00578565|587463642|FG000|Overall Study|Adverse Event|3|||
163132499|NCT05362058|589194273|FG001|Treatment Period|Adverse Event|3|||
163132500|NCT05362058|589194272|FG000|Treatment Period|Assigned treatment by mistake|3|||
163132501|NCT05362058|589194273|FG001|Treatment Period|Assigned treatment by mistake|4|||
163132502|NCT05362058|589194272|FG000|Treatment Period|Death|1|||
163132503|NCT05362058|589194273|FG001|Treatment Period|Death|1|||
163132504|NCT05362058|589194272|FG000|Treatment Period|Lost to Follow-up|6|||
163132505|NCT05362058|589194273|FG001|Treatment Period|Lost to Follow-up|3|||
163132506|NCT05362058|589194272|FG000|Treatment Period|Non-compliance with study drug|0|||
163132507|NCT05362058|589194273|FG001|Treatment Period|Non-compliance with study drug|1|||
163132508|NCT05362058|589194272|FG000|Treatment Period|Physician Decision|1|||
163132509|NCT05362058|589194273|FG001|Treatment Period|Physician Decision|0|||
163132510|NCT05362058|589194272|FG000|Treatment Period|Protocol deviation|1|||
163132511|NCT05362058|589194273|FG001|Treatment Period|Protocol deviation|0|||
163132512|NCT05362058|589194272|FG000|Treatment Period|Withdrawal by Subject|10|||
163132513|NCT05362058|589194273|FG001|Treatment Period|Withdrawal by Subject|11|||
163132514|NCT05362058|589194272|FG000|Follow-Up Period|Death|1|||
163132515|NCT05362058|589194273|FG001|Follow-Up Period|Death|0|||
163132516|NCT05362058|589194272|FG000|Follow-Up Period|Lost to Follow-up|2|||
163132517|NCT05362058|589194273|FG001|Follow-Up Period|Lost to Follow-up|1|||
163132518|NCT05362058|589194272|FG000|Follow-Up Period|Protocol deviation|1|||
163132519|NCT05362058|589194273|FG001|Follow-Up Period|Protocol deviation|1|||
163132520|NCT05362058|589194272|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163132521|NCT05362058|589194273|FG001|Follow-Up Period|Withdrawal by Subject|3|||
163132522|NCT04774926|589194274|FG000|Overall Study|Adverse Event|15|||
163132523|NCT04774926|589194274|FG000|Overall Study|Lost to Follow-up|3|||
163132524|NCT04774926|589194274|FG000|Overall Study|Physician Decision|6|||
163132525|NCT04774926|589194274|FG000|Overall Study|Withdrawal by Subject|3|||
163132526|NCT04774926|589194274|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
163132527|NCT01393639|589194275|FG000|Overall Study|Protocol Violation|0|||
163132528|NCT01393639|589194276|FG001|Overall Study|Protocol Violation|0|||
163132529|NCT01393639|589194277|FG002|Overall Study|Protocol Violation|0|||
163132530|NCT01393639|589194278|FG003|Overall Study|Protocol Violation|1|||
163132531|NCT01393639|589194279|FG004|Overall Study|Protocol Violation|0|||
163132532|NCT01393639|589194280|FG005|Overall Study|Protocol Violation|0|||
163132533|NCT01393639|589194281|FG006|Overall Study|Protocol Violation|0|||
163132534|NCT01393639|589194275|FG000|Overall Study|Other|0|||
163132535|NCT01393639|589194276|FG001|Overall Study|Other|2|||
163132536|NCT01393639|589194277|FG002|Overall Study|Other|0|||
163132537|NCT01393639|589194278|FG003|Overall Study|Other|2|||
163132538|NCT01393639|589194279|FG004|Overall Study|Other|1|||
163132539|NCT01393639|589194280|FG005|Overall Study|Other|0|||
163132540|NCT01393639|589194281|FG006|Overall Study|Other|1|||
163132541|NCT01393639|589194275|FG000|Overall Study|Withdrawal by Subject|1|||
163132542|NCT01393639|589194276|FG001|Overall Study|Withdrawal by Subject|1|||
163132543|NCT01393639|589194277|FG002|Overall Study|Withdrawal by Subject|0|||
163132544|NCT01393639|589194278|FG003|Overall Study|Withdrawal by Subject|0|||
163132545|NCT01393639|589194279|FG004|Overall Study|Withdrawal by Subject|0|||
163132546|NCT01393639|589194280|FG005|Overall Study|Withdrawal by Subject|0|||
163132547|NCT01393639|589194281|FG006|Overall Study|Withdrawal by Subject|1|||
163132548|NCT01393639|589194275|FG000|Overall Study|Medication error without associated AE|0|||
163132549|NCT01393639|589194276|FG001|Overall Study|Medication error without associated AE|0|||
163132550|NCT01393639|589194277|FG002|Overall Study|Medication error without associated AE|0|||
163132551|NCT01393639|589194278|FG003|Overall Study|Medication error without associated AE|0|||
163132552|NCT01393639|589194279|FG004|Overall Study|Medication error without associated AE|0|||
163132553|NCT01393639|589194280|FG005|Overall Study|Medication error without associated AE|0|||
163132554|NCT01393639|589194281|FG006|Overall Study|Medication error without associated AE|1|||
163132555|NCT01393639|589194275|FG000|Overall Study|Lost to Follow-up|0|||
163132556|NCT01393639|589194276|FG001|Overall Study|Lost to Follow-up|1|||
163132557|NCT01393639|589194277|FG002|Overall Study|Lost to Follow-up|0|||
163132558|NCT01393639|589194278|FG003|Overall Study|Lost to Follow-up|0|||
163132559|NCT01393639|589194279|FG004|Overall Study|Lost to Follow-up|0|||
163132560|NCT01393639|589194280|FG005|Overall Study|Lost to Follow-up|0|||
163132561|NCT01393639|589194281|FG006|Overall Study|Lost to Follow-up|1|||
163132562|NCT01393639|589194275|FG000|Overall Study|Lack of Efficacy|0|||
163132563|NCT01393639|589194276|FG001|Overall Study|Lack of Efficacy|0|||
163132564|NCT01393639|589194277|FG002|Overall Study|Lack of Efficacy|0|||
163132565|NCT01393639|589194278|FG003|Overall Study|Lack of Efficacy|0|||
163132566|NCT01393639|589194279|FG004|Overall Study|Lack of Efficacy|0|||
162658542|NCT01192152|587463643|FG000|Period 1|left prematurely (while on treatment B)|0|||
162658543|NCT01192152|587463644|FG001|Period 1|left prematurely (while on treatment B)|1|||
162658544|NCT01192152|587463643|FG000|Period 3|family emergency|1|||
162658545|NCT01192152|587463644|FG001|Period 3|family emergency|0|||
162658546|NCT02143843|587463646|FG000|Overall Study|Adverse Event|8|||
162658547|NCT02143843|587463646|FG000|Overall Study|Lack of Efficacy|2|||
163132567|NCT01393639|589194280|FG005|Overall Study|Lack of Efficacy|0|||
163132568|NCT01393639|589194281|FG006|Overall Study|Lack of Efficacy|1|||
163132569|NCT01393639|589194275|FG000|Overall Study|Adverse Event|2|||
163132570|NCT01393639|589194276|FG001|Overall Study|Adverse Event|3|||
163132571|NCT01393639|589194277|FG002|Overall Study|Adverse Event|1|||
163132572|NCT01393639|589194278|FG003|Overall Study|Adverse Event|2|||
163132573|NCT01393639|589194279|FG004|Overall Study|Adverse Event|0|||
163132574|NCT01393639|589194280|FG005|Overall Study|Adverse Event|2|||
162658548|NCT02143843|587463646|FG000|Overall Study|Withdrawal by Subject|2|||
163132575|NCT01393639|589194281|FG006|Overall Study|Adverse Event|3|||
163132576|NCT03626545|589194282|FG000|Overall Study|Progressive disease|3|||
163132577|NCT03626545|589194283|FG001|Overall Study|Progressive disease|82|||
163132578|NCT03626545|589194284|FG002|Overall Study|Progressive disease|85|||
163132579|NCT03626545|589194282|FG000|Overall Study|Adverse Event|3|||
163132580|NCT03626545|589194283|FG001|Overall Study|Adverse Event|13|||
163132581|NCT03626545|589194284|FG002|Overall Study|Adverse Event|10|||
163132582|NCT03626545|589194282|FG000|Overall Study|Physician Decision|1|||
163132583|NCT03626545|589194283|FG001|Overall Study|Physician Decision|18|||
163132584|NCT03626545|589194284|FG002|Overall Study|Physician Decision|14|||
163132585|NCT03626545|589194282|FG000|Overall Study|Subject Decision|0|||
163132586|NCT03626545|589194283|FG001|Overall Study|Subject Decision|5|||
163132587|NCT03626545|589194284|FG002|Overall Study|Subject Decision|5|||
163132588|NCT03626545|589194282|FG000|Overall Study|Death|1|||
163132589|NCT03626545|589194283|FG001|Overall Study|Death|1|||
163132590|NCT03626545|589194284|FG002|Overall Study|Death|1|||
163132591|NCT03626545|589194282|FG000|Overall Study|Protocol Deviation|0|||
163132592|NCT03626545|589194283|FG001|Overall Study|Protocol Deviation|1|||
163132593|NCT03626545|589194284|FG002|Overall Study|Protocol Deviation|1|||
163132594|NCT03626545|589194282|FG000|Overall Study|Guardian Decision|0|||
163132595|NCT03626545|589194283|FG001|Overall Study|Guardian Decision|0|||
163132596|NCT03626545|589194284|FG002|Overall Study|Guardian Decision|1|||
163132597|NCT01440816|589194286|FG000|Overall Study|Disease Progression|0|||
163132598|NCT01440816|589194287|FG001|Overall Study|Disease Progression|9|||
163132599|NCT01440816|589194286|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
163132600|NCT01440816|589194287|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
163132601|NCT02462720|589194291|FG000|Part 2|Withdrawal by Subject|1|||
163132602|NCT02462720|589194292|FG001|Part 2|Withdrawal by Subject|0|||
163132603|NCT02462720|589194291|FG000|Part 2|Protocol Violation|0|||
163132604|NCT02462720|589194292|FG001|Part 2|Protocol Violation|1|||
163132605|NCT05173012|589194297|FG000|Overall Study|Adverse Event|2|||
163132606|NCT05173012|589194298|FG001|Overall Study|Adverse Event|3|||
163132607|NCT05173012|589194299|FG002|Overall Study|Adverse Event|4|||
163132608|NCT05173012|589194300|FG003|Overall Study|Adverse Event|13|||
163132609|NCT05173012|589194301|FG004|Overall Study|Adverse Event|0|||
163132610|NCT05173012|589194302|FG005|Overall Study|Adverse Event|0|||
163132611|NCT05173012|589194303|FG006|Overall Study|Adverse Event|2|||
163132612|NCT05173012|589194304|FG007|Overall Study|Adverse Event|4|||
163132613|NCT05173012|589194297|FG000|Overall Study|Lost to Follow-up|0|||
163132614|NCT05173012|589194298|FG001|Overall Study|Lost to Follow-up|0|||
163132615|NCT05173012|589194299|FG002|Overall Study|Lost to Follow-up|0|||
163132616|NCT05173012|589194300|FG003|Overall Study|Lost to Follow-up|1|||
163132617|NCT05173012|589194301|FG004|Overall Study|Lost to Follow-up|0|||
163132618|NCT05173012|589194302|FG005|Overall Study|Lost to Follow-up|0|||
163132619|NCT05173012|589194303|FG006|Overall Study|Lost to Follow-up|0|||
163132620|NCT05173012|589194304|FG007|Overall Study|Lost to Follow-up|0|||
163132621|NCT05173012|589194297|FG000|Overall Study|Withdrawal by Subject|1|||
163132622|NCT05173012|589194298|FG001|Overall Study|Withdrawal by Subject|0|||
163132623|NCT05173012|589194299|FG002|Overall Study|Withdrawal by Subject|1|||
163132624|NCT05173012|589194300|FG003|Overall Study|Withdrawal by Subject|3|||
163132625|NCT05173012|589194301|FG004|Overall Study|Withdrawal by Subject|1|||
163132626|NCT05173012|589194302|FG005|Overall Study|Withdrawal by Subject|0|||
163132627|NCT05173012|589194303|FG006|Overall Study|Withdrawal by Subject|1|||
162719831|NCT02351180|587680598|FG001|Overall Study|Withdrawal by Subject|0|||
162719832|NCT00208767|587680599|FG000|Overall Study|Adverse Event|9|||
162719833|NCT00208767|587680600|FG001|Overall Study|Adverse Event|1|||
162719834|NCT00208767|587680599|FG000|Overall Study|Withdrawal by Subject|14|||
162719835|NCT00208767|587680600|FG001|Overall Study|Withdrawal by Subject|3|||
162719836|NCT00208767|587680599|FG000|Overall Study|Death|1|||
162719837|NCT00208767|587680600|FG001|Overall Study|Death|0|||
162719838|NCT00208767|587680599|FG000|Overall Study|Lost to Follow-up|3|||
162719839|NCT00208767|587680600|FG001|Overall Study|Lost to Follow-up|3|||
162719840|NCT02317016|587680601|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
162719841|NCT02317016|587680601|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
162719842|NCT02317016|587680601|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
162719843|NCT02317016|587680601|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
162719844|NCT02317016|587680601|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
162719845|NCT02317016|587680601|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
162719846|NCT02317016|587680601|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
162719847|NCT00536380|587680602|FG000|Overall Study|Adverse Event|0|||
162719848|NCT00536380|587680603|FG001|Overall Study|Adverse Event|2|||
162719849|NCT00536380|587680604|FG002|Overall Study|Adverse Event|2|||
162719850|NCT00536380|587680602|FG000|Overall Study|Lost to Follow-up|0|||
162719851|NCT00536380|587680603|FG001|Overall Study|Lost to Follow-up|0|||
162719852|NCT00536380|587680604|FG002|Overall Study|Lost to Follow-up|1|||
162719853|NCT00536380|587680602|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
163132628|NCT05173012|589194304|FG007|Overall Study|Withdrawal by Subject|0|||
163132629|NCT05173012|589194297|FG000|Overall Study|Protocol Deviation|0|||
163132630|NCT05173012|589194298|FG001|Overall Study|Protocol Deviation|0|||
163132631|NCT05173012|589194299|FG002|Overall Study|Protocol Deviation|0|||
163132632|NCT05173012|589194300|FG003|Overall Study|Protocol Deviation|1|||
163132633|NCT05173012|589194301|FG004|Overall Study|Protocol Deviation|0|||
163132634|NCT05173012|589194302|FG005|Overall Study|Protocol Deviation|0|||
163132635|NCT05173012|589194303|FG006|Overall Study|Protocol Deviation|0|||
163132636|NCT05173012|589194304|FG007|Overall Study|Protocol Deviation|0|||
163132637|NCT05173012|589194297|FG000|Overall Study|Other|0|||
163132638|NCT05173012|589194298|FG001|Overall Study|Other|0|||
163132639|NCT05173012|589194299|FG002|Overall Study|Other|0|||
163132640|NCT05173012|589194300|FG003|Overall Study|Other|2|||
163132641|NCT05173012|589194301|FG004|Overall Study|Other|0|||
163132642|NCT05173012|589194302|FG005|Overall Study|Other|0|||
163132643|NCT05173012|589194303|FG006|Overall Study|Other|0|||
163132644|NCT05173012|589194304|FG007|Overall Study|Other|0|||
163132645|NCT03668613|589194305|FG000|Overall Study|Adverse Event|1|||
163132646|NCT03668613|589194306|FG001|Overall Study|Adverse Event|2|||
163132647|NCT03668613|589194305|FG000|Overall Study|Lack of Efficacy|5|||
163132648|NCT03668613|589194306|FG001|Overall Study|Lack of Efficacy|1|||
163132649|NCT03668613|589194305|FG000|Overall Study|Pregnancy|0|||
163132650|NCT03668613|589194306|FG001|Overall Study|Pregnancy|2|||
163132651|NCT03668613|589194305|FG000|Overall Study|Protocol Violation|1|||
163132652|NCT03668613|589194306|FG001|Overall Study|Protocol Violation|0|||
163132653|NCT03668613|589194305|FG000|Overall Study|Physician Decision|1|||
163132654|NCT03668613|589194306|FG001|Overall Study|Physician Decision|0|||
163132655|NCT03668613|589194305|FG000|Overall Study|Withdrawal by Subject|2|||
163132656|NCT03668613|589194306|FG001|Overall Study|Withdrawal by Subject|1|||
163132657|NCT03668613|589194305|FG000|Overall Study|Guardian decision|1|||
163132658|NCT03668613|589194306|FG001|Overall Study|Guardian decision|0|||
163132659|NCT00286494|589194309|FG000|Overall Study|Hyperglycemic rescue|12|||
163132660|NCT00286494|589194310|FG001|Overall Study|Hyperglycemic rescue|19|||
163132661|NCT00286494|589194311|FG002|Overall Study|Hyperglycemic rescue|18|||
163132662|NCT00286494|589194309|FG000|Overall Study|Withdrawal by Subject|2|||
163132663|NCT00286494|589194310|FG001|Overall Study|Withdrawal by Subject|10|||
163132664|NCT00286494|589194311|FG002|Overall Study|Withdrawal by Subject|9|||
163132665|NCT00286494|589194309|FG000|Overall Study|Adverse Event|3|||
163132666|NCT00286494|589194310|FG001|Overall Study|Adverse Event|8|||
163132667|NCT00286494|589194311|FG002|Overall Study|Adverse Event|6|||
163132668|NCT00286494|589194309|FG000|Overall Study|Physician Decision|5|||
163132669|NCT00286494|589194310|FG001|Overall Study|Physician Decision|5|||
163132670|NCT00286494|589194311|FG002|Overall Study|Physician Decision|1|||
163132671|NCT00286494|589194309|FG000|Overall Study|Lost to Follow-up|3|||
163132672|NCT00286494|589194310|FG001|Overall Study|Lost to Follow-up|1|||
163132673|NCT00286494|589194311|FG002|Overall Study|Lost to Follow-up|3|||
163132674|NCT00286494|589194309|FG000|Overall Study|Protocol Violation|1|||
162719854|NCT00536380|587680603|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
163132675|NCT00286494|589194310|FG001|Overall Study|Protocol Violation|1|||
163132676|NCT00286494|589194311|FG002|Overall Study|Protocol Violation|2|||
163132677|NCT04776317|589194312|FG000|Overall Study|Physician Decision|0|||
163132678|NCT04776317|589194313|FG001|Overall Study|Physician Decision|1|||
163132679|NCT04776317|589194314|FG002|Overall Study|Physician Decision|0|||
162658549|NCT01339390|587463647|FG000|Overall Study|Death|32|||
162658550|NCT01339390|587463648|FG001|Overall Study|Death|29|||
162658551|NCT01339390|587463647|FG000|Overall Study|Lost to Follow-up|125|||
162658552|NCT01339390|587463648|FG001|Overall Study|Lost to Follow-up|127|||
162658553|NCT00378703|587463649|FG000|Overall Study|Disease progression|59|||
162658554|NCT00378703|587463650|FG001|Overall Study|Disease progression|43|||
162658555|NCT00378703|587463651|FG002|Overall Study|Disease progression|48|||
162658556|NCT00378703|587463652|FG003|Overall Study|Disease progression|49|||
162658557|NCT00378703|587463649|FG000|Overall Study|Adverse Event|11|||
162658558|NCT00378703|587463650|FG001|Overall Study|Adverse Event|17|||
162658559|NCT00378703|587463651|FG002|Overall Study|Adverse Event|20|||
162658560|NCT00378703|587463652|FG003|Overall Study|Adverse Event|18|||
162658561|NCT00378703|587463649|FG000|Overall Study|Death|2|||
162658562|NCT00378703|587463650|FG001|Overall Study|Death|2|||
162658563|NCT00378703|587463651|FG002|Overall Study|Death|4|||
162658564|NCT00378703|587463652|FG003|Overall Study|Death|3|||
162658565|NCT00378703|587463649|FG000|Overall Study|Withdrawal by Subject|4|||
162658566|NCT00378703|587463650|FG001|Overall Study|Withdrawal by Subject|8|||
162658567|NCT00378703|587463651|FG002|Overall Study|Withdrawal by Subject|5|||
162658568|NCT00378703|587463652|FG003|Overall Study|Withdrawal by Subject|7|||
162658569|NCT00378703|587463649|FG000|Overall Study|Physician Decision|1|||
162658570|NCT00378703|587463650|FG001|Overall Study|Physician Decision|4|||
162658571|NCT00378703|587463651|FG002|Overall Study|Physician Decision|1|||
162658572|NCT00378703|587463652|FG003|Overall Study|Physician Decision|0|||
162658573|NCT00378703|587463649|FG000|Overall Study|Alternative therapy|4|||
162658574|NCT00378703|587463650|FG001|Overall Study|Alternative therapy|2|||
162658575|NCT00378703|587463651|FG002|Overall Study|Alternative therapy|0|||
162658576|NCT00378703|587463652|FG003|Overall Study|Alternative therapy|0|||
162658577|NCT00378703|587463649|FG000|Overall Study|Other complicated disease|0|||
162658578|NCT00378703|587463650|FG001|Overall Study|Other complicated disease|2|||
162658579|NCT00378703|587463651|FG002|Overall Study|Other complicated disease|2|||
162658580|NCT00378703|587463652|FG003|Overall Study|Other complicated disease|0|||
162658581|NCT00378703|587463649|FG000|Overall Study|Symptomatic deterioration|0|||
162658582|NCT00378703|587463650|FG001|Overall Study|Symptomatic deterioration|1|||
162658583|NCT00378703|587463651|FG002|Overall Study|Symptomatic deterioration|0|||
162658584|NCT00378703|587463652|FG003|Overall Study|Symptomatic deterioration|2|||
162658585|NCT00378703|587463649|FG000|Overall Study|Surgery|1|||
162658586|NCT00378703|587463650|FG001|Overall Study|Surgery|0|||
162658587|NCT00378703|587463651|FG002|Overall Study|Surgery|0|||
162658588|NCT00378703|587463652|FG003|Overall Study|Surgery|1|||
162658589|NCT00378703|587463649|FG000|Overall Study|Joint decision of physician and patient|1|||
162658590|NCT00378703|587463650|FG001|Overall Study|Joint decision of physician and patient|0|||
162658591|NCT00378703|587463651|FG002|Overall Study|Joint decision of physician and patient|0|||
162658592|NCT00378703|587463652|FG003|Overall Study|Joint decision of physician and patient|0|||
162658593|NCT00378703|587463649|FG000|Overall Study|Adverse events and progressive disease|0|||
162658594|NCT00378703|587463650|FG001|Overall Study|Adverse events and progressive disease|0|||
162658595|NCT00378703|587463651|FG002|Overall Study|Adverse events and progressive disease|0|||
162719855|NCT00536380|587680604|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
162658596|NCT00378703|587463652|FG003|Overall Study|Adverse events and progressive disease|1|||
162658597|NCT00378703|587463649|FG000|Overall Study|Relocation|0|||
162658598|NCT00378703|587463650|FG001|Overall Study|Relocation|0|||
162658599|NCT00378703|587463651|FG002|Overall Study|Relocation|1|||
162658600|NCT00378703|587463652|FG003|Overall Study|Relocation|0|||
162658601|NCT00378703|587463649|FG000|Overall Study|Ineligible|4|||
162658602|NCT00378703|587463650|FG001|Overall Study|Ineligible|7|||
162658603|NCT00378703|587463651|FG002|Overall Study|Ineligible|7|||
162658604|NCT00378703|587463652|FG003|Overall Study|Ineligible|7|||
162719856|NCT00536380|587680602|FG000|Overall Study|Withdrawal related to study drug|7|||
162719857|NCT00536380|587680603|FG001|Overall Study|Withdrawal related to study drug|5|||
163132680|NCT04776317|589194315|FG003|Overall Study|Physician Decision|0|||
163132681|NCT04776317|589194316|FG004|Overall Study|Physician Decision|0|||
163132682|NCT04776317|589194317|FG005|Overall Study|Physician Decision|0|||
163132683|NCT04776317|589194318|FG006|Overall Study|Physician Decision|0|||
163132684|NCT04776317|589194319|FG007|Overall Study|Physician Decision|0|||
163132685|NCT04776317|589194320|FG008|Overall Study|Physician Decision|0|||
163132686|NCT04776317|589194321|FG009|Overall Study|Physician Decision|0|||
163132687|NCT04776317|589194322|FG010|Overall Study|Physician Decision|0|||
163132688|NCT04776317|589194323|FG011|Overall Study|Physician Decision|0|||
163132689|NCT04776317|589194324|FG012|Overall Study|Physician Decision|0|||
163132690|NCT04776317|589194325|FG013|Overall Study|Physician Decision|0|||
163132691|NCT04776317|589194326|FG014|Overall Study|Physician Decision|0|||
163132692|NCT04776317|589194312|FG000|Overall Study|Protocol Violation|0|||
163132693|NCT04776317|589194313|FG001|Overall Study|Protocol Violation|0|||
163132694|NCT04776317|589194314|FG002|Overall Study|Protocol Violation|1|||
163132695|NCT04776317|589194315|FG003|Overall Study|Protocol Violation|0|||
163132696|NCT04776317|589194316|FG004|Overall Study|Protocol Violation|0|||
163132697|NCT04776317|589194317|FG005|Overall Study|Protocol Violation|0|||
163132698|NCT04776317|589194318|FG006|Overall Study|Protocol Violation|0|||
163132699|NCT04776317|589194319|FG007|Overall Study|Protocol Violation|0|||
163132700|NCT04776317|589194320|FG008|Overall Study|Protocol Violation|0|||
163132701|NCT04776317|589194321|FG009|Overall Study|Protocol Violation|0|||
163132702|NCT04776317|589194322|FG010|Overall Study|Protocol Violation|0|||
163132703|NCT04776317|589194323|FG011|Overall Study|Protocol Violation|0|||
163132704|NCT04776317|589194324|FG012|Overall Study|Protocol Violation|0|||
163132705|NCT04776317|589194325|FG013|Overall Study|Protocol Violation|0|||
163132706|NCT04776317|589194326|FG014|Overall Study|Protocol Violation|0|||
163132707|NCT04776317|589194312|FG000|Overall Study|Withdrawal by Subject|0|||
163132708|NCT04776317|589194313|FG001|Overall Study|Withdrawal by Subject|0|||
163132709|NCT04776317|589194314|FG002|Overall Study|Withdrawal by Subject|0|||
163132710|NCT04776317|589194315|FG003|Overall Study|Withdrawal by Subject|0|||
163132711|NCT04776317|589194316|FG004|Overall Study|Withdrawal by Subject|1|||
163132712|NCT04776317|589194317|FG005|Overall Study|Withdrawal by Subject|0|||
163132713|NCT04776317|589194318|FG006|Overall Study|Withdrawal by Subject|0|||
163132714|NCT04776317|589194319|FG007|Overall Study|Withdrawal by Subject|0|||
163132715|NCT04776317|589194320|FG008|Overall Study|Withdrawal by Subject|0|||
163132716|NCT04776317|589194321|FG009|Overall Study|Withdrawal by Subject|0|||
163132717|NCT04776317|589194322|FG010|Overall Study|Withdrawal by Subject|0|||
163132718|NCT04776317|589194323|FG011|Overall Study|Withdrawal by Subject|0|||
163132719|NCT04776317|589194324|FG012|Overall Study|Withdrawal by Subject|0|||
163132720|NCT04776317|589194325|FG013|Overall Study|Withdrawal by Subject|0|||
163132721|NCT04776317|589194326|FG014|Overall Study|Withdrawal by Subject|0|||
163132722|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132723|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132724|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
163132725|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
163132726|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
163132727|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132728|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
163132729|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
163132730|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
163132731|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132732|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132733|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132734|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
163132735|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
163132736|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132737|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
163132738|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132739|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132740|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132741|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
163132742|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
163132743|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
163132744|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132745|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132746|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
163132747|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
162658605|NCT00378703|587463649|FG000|Overall Study|Never started treatment|1|||
162658606|NCT00378703|587463650|FG001|Overall Study|Never started treatment|4|||
162658607|NCT00378703|587463651|FG002|Overall Study|Never started treatment|0|||
162658608|NCT00378703|587463652|FG003|Overall Study|Never started treatment|0|||
162658609|NCT00378703|587463649|FG000|Overall Study|Other|1|||
162658610|NCT00378703|587463650|FG001|Overall Study|Other|1|||
162658611|NCT00378703|587463651|FG002|Overall Study|Other|2|||
162658612|NCT00378703|587463652|FG003|Overall Study|Other|3|||
162658613|NCT03181542|587463655|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
162658614|NCT03181542|587463656|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
162658615|NCT01462357|587463663|FG000|Overall Study|Death|0|||
162658616|NCT01462357|587463664|FG001|Overall Study|Death|0|||
162658617|NCT01462357|587463665|FG002|Overall Study|Death|1|||
162658618|NCT01462357|587463663|FG000|Overall Study|Withdrawal by Subject|3|||
162658619|NCT01462357|587463664|FG001|Overall Study|Withdrawal by Subject|11|||
162719858|NCT00536380|587680604|FG002|Overall Study|Withdrawal related to study drug|2|||
163132748|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132749|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132750|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132751|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132752|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132753|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132754|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
163132755|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132756|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132757|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132758|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132759|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132760|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
163132761|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132762|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132763|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132764|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
162658620|NCT01462357|587463665|FG002|Overall Study|Withdrawal by Subject|3|||
162658621|NCT01462357|587463663|FG000|Overall Study|Migrated/moved from study area|2|||
162658622|NCT01462357|587463664|FG001|Overall Study|Migrated/moved from study area|3|||
162658623|NCT01462357|587463665|FG002|Overall Study|Migrated/moved from study area|1|||
162658624|NCT01462357|587463663|FG000|Overall Study|Lost to Follow-up|3|||
162658625|NCT01462357|587463664|FG001|Overall Study|Lost to Follow-up|5|||
162658626|NCT01462357|587463665|FG002|Overall Study|Lost to Follow-up|7|||
162658627|NCT04292730|587463674|FG000|Overall Study|Lost to Follow-up|8|||
162658628|NCT04292730|587463675|FG001|Overall Study|Lost to Follow-up|12|||
162658629|NCT04292730|587463676|FG002|Overall Study|Lost to Follow-up|12|||
162658630|NCT04292730|587463677|FG003|Overall Study|Lost to Follow-up|48|||
162658631|NCT04292730|587463674|FG000|Overall Study|Death|2|||
162658632|NCT04292730|587463675|FG001|Overall Study|Death|2|||
162658633|NCT04292730|587463676|FG002|Overall Study|Death|4|||
162658634|NCT04292730|587463677|FG003|Overall Study|Death|12|||
162658635|NCT04292730|587463674|FG000|Overall Study|Withdrew Consent|2|||
162658636|NCT04292730|587463675|FG001|Overall Study|Withdrew Consent|2|||
162658637|NCT04292730|587463676|FG002|Overall Study|Withdrew Consent|5|||
162658638|NCT04292730|587463677|FG003|Overall Study|Withdrew Consent|6|||
162658639|NCT04292730|587463674|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162658640|NCT04292730|587463675|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162658641|NCT04292730|587463676|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162658642|NCT04292730|587463677|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162658643|NCT04292730|587463674|FG000|Overall Study|Protocol Violation|0|||
162719859|NCT00536380|587680602|FG000|Overall Study|Noncompliance with protocol|3|||
162719860|NCT00536380|587680603|FG001|Overall Study|Noncompliance with protocol|2|||
163132765|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132766|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132767|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132768|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132769|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
163132770|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132771|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132772|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132773|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
163132774|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132775|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132776|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132777|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
163132778|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132779|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132780|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132781|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
163132782|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132783|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132784|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132785|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132786|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
163132787|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132788|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132789|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132790|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
163132791|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132792|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132793|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
163132794|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132795|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132796|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132797|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132798|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132799|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
163132800|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132801|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
163132802|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132803|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132804|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132805|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132806|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132807|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132808|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
162658644|NCT04292730|587463675|FG001|Overall Study|Protocol Violation|0|||
162658645|NCT04292730|587463676|FG002|Overall Study|Protocol Violation|1|||
162658646|NCT04292730|587463677|FG003|Overall Study|Protocol Violation|0|||
162658647|NCT04292730|587463674|FG000|Overall Study|Randomized but not Treated|8|||
163132809|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132810|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132811|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132812|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
163132813|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
163132814|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132815|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132816|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132817|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132818|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132819|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132820|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132821|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132822|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132823|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132824|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132825|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
163132826|NCT03100058|589194328|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132827|NCT03100058|589194329|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
162658648|NCT04292730|587463675|FG001|Overall Study|Randomized but not Treated|4|||
162658649|NCT04292730|587463676|FG002|Overall Study|Randomized but not Treated|0|||
162658650|NCT04292730|587463677|FG003|Overall Study|Randomized but not Treated|14|||
162658651|NCT01527292|587463678|FG000|Overall Study|Physician Decision|0|||
162658652|NCT01527292|587463679|FG001|Overall Study|Physician Decision|3|||
162658653|NCT01482767|587463682|FG000|Overall Study|Death|1|||
162658654|NCT01482767|587463683|FG001|Overall Study|Death|1|||
162658655|NCT01482767|587463682|FG000|Overall Study|Withdrawal by Subject|7|||
162658656|NCT01482767|587463683|FG001|Overall Study|Withdrawal by Subject|5|||
162658657|NCT01482767|587463682|FG000|Overall Study|Lost to Follow-up|12|||
162658658|NCT01482767|587463683|FG001|Overall Study|Lost to Follow-up|6|||
162658659|NCT01482767|587463682|FG000|Overall Study|Adverse Event|0|||
162658660|NCT01482767|587463683|FG001|Overall Study|Adverse Event|3|||
162658661|NCT01482767|587463682|FG000|Overall Study|Site closure|22|||
162658662|NCT01482767|587463683|FG001|Overall Study|Site closure|14|||
162658663|NCT01482767|587463682|FG000|Overall Study|Non-adherence to study requirements|4|||
162658664|NCT01482767|587463683|FG001|Overall Study|Non-adherence to study requirements|7|||
162658665|NCT01482767|587463682|FG000|Overall Study|Alternate HCV treatment|7|||
162658666|NCT01482767|587463683|FG001|Overall Study|Alternate HCV treatment|8|||
162658667|NCT01482767|587463682|FG000|Overall Study|Ineligible|0|||
162658668|NCT01482767|587463683|FG001|Overall Study|Ineligible|5|||
162658669|NCT01482767|587463682|FG000|Overall Study|Nurse error|1|||
162658670|NCT01482767|587463683|FG001|Overall Study|Nurse error|0|||
162658671|NCT00314366|587463684|FG000|Overall Study|not treated due to patient medical condi|1|||
162658672|NCT00314366|587463685|FG001|Overall Study|not treated due to patient medical condi|0|||
162658673|NCT03400033|587463695|FG000|Overall Study|Withdrawal by Subject|1|||
162658674|NCT03400033|587463696|FG001|Overall Study|Withdrawal by Subject|2|||
162658675|NCT01247090|587463699|FG000|Overall Study|Physician Decision|1|||
162658676|NCT01247090|587463700|FG001|Overall Study|Physician Decision|0|||
162658677|NCT01247090|587463701|FG002|Overall Study|Physician Decision|0|||
162658678|NCT01247090|587463699|FG000|Overall Study|Withdrawal by Subject|0|||
162658679|NCT01247090|587463700|FG001|Overall Study|Withdrawal by Subject|1|||
162658680|NCT01247090|587463701|FG002|Overall Study|Withdrawal by Subject|0|||
162658681|NCT00006916|587463703|FG000|Overall Study|Device not inserted|4|||
162658682|NCT00006916|587463703|FG000|Overall Study|Complication of device insertion|1|||
162658683|NCT02457325|587463708|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
162658684|NCT02457325|587463709|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
162658685|NCT01541930|587463714|FG000|Overall Study|Withdrawal by Subject|1|||
162658686|NCT03385239|587463715|FG000|Overall Study|Voluntary Withdrawal|2|||
162658687|NCT03385239|587463716|FG001|Overall Study|Voluntary Withdrawal|3|||
162658688|NCT03385239|587463717|FG002|Overall Study|Voluntary Withdrawal|2|||
162658689|NCT03385239|587463718|FG003|Overall Study|Voluntary Withdrawal|3|||
162658690|NCT03385239|587463719|FG004|Overall Study|Voluntary Withdrawal|0|||
162658691|NCT03385239|587463715|FG000|Overall Study|Adverse Event|0|||
162658692|NCT03385239|587463716|FG001|Overall Study|Adverse Event|0|||
162658693|NCT03385239|587463717|FG002|Overall Study|Adverse Event|1|||
162658694|NCT03385239|587463718|FG003|Overall Study|Adverse Event|0|||
162658695|NCT03385239|587463719|FG004|Overall Study|Adverse Event|0|||
162658696|NCT03385239|587463715|FG000|Overall Study|Other|0|||
162658697|NCT03385239|587463716|FG001|Overall Study|Other|0|||
162658698|NCT03385239|587463717|FG002|Overall Study|Other|0|||
162658699|NCT03385239|587463718|FG003|Overall Study|Other|1|||
162658700|NCT03385239|587463719|FG004|Overall Study|Other|0|||
162658701|NCT01574703|587463720|FG000|Overall Study|Adverse Event|0|||
162658702|NCT01574703|587463721|FG001|Overall Study|Adverse Event|2|||
162658703|NCT01574703|587463722|FG002|Overall Study|Adverse Event|1|||
162658704|NCT01574703|587463723|FG003|Overall Study|Adverse Event|1|||
162658705|NCT01574703|587463720|FG000|Overall Study|Protocol Violation|0|||
162658706|NCT01574703|587463721|FG001|Overall Study|Protocol Violation|0|||
162658707|NCT01574703|587463722|FG002|Overall Study|Protocol Violation|0|||
162658708|NCT01574703|587463723|FG003|Overall Study|Protocol Violation|1|||
162658709|NCT01574703|587463720|FG000|Overall Study|Unspecified Reason|27|||
162658710|NCT01574703|587463721|FG001|Overall Study|Unspecified Reason|15|||
162658711|NCT01574703|587463722|FG002|Overall Study|Unspecified Reason|20|||
162658712|NCT01574703|587463723|FG003|Overall Study|Unspecified Reason|16|||
162658713|NCT01574703|587463720|FG000|Overall Study|Withdrawal by Subject|53|||
162658714|NCT01574703|587463721|FG001|Overall Study|Withdrawal by Subject|52|||
162658715|NCT01574703|587463722|FG002|Overall Study|Withdrawal by Subject|36|||
162658716|NCT01574703|587463723|FG003|Overall Study|Withdrawal by Subject|61|||
162658717|NCT01574703|587463720|FG000|Overall Study|Met Withdrawal Criteria|0|||
162658718|NCT01574703|587463721|FG001|Overall Study|Met Withdrawal Criteria|1|||
162658719|NCT01574703|587463722|FG002|Overall Study|Met Withdrawal Criteria|1|||
162658720|NCT01574703|587463723|FG003|Overall Study|Met Withdrawal Criteria|0|||
162658721|NCT01574703|587463720|FG000|Overall Study|Lost to Follow-up|43|||
162658722|NCT01574703|587463721|FG001|Overall Study|Lost to Follow-up|41|||
162658723|NCT01574703|587463722|FG002|Overall Study|Lost to Follow-up|46|||
162658724|NCT01574703|587463723|FG003|Overall Study|Lost to Follow-up|35|||
162658725|NCT01574703|587463720|FG000|Overall Study|Death|2|||
162658726|NCT01574703|587463721|FG001|Overall Study|Death|1|||
162658727|NCT01574703|587463722|FG002|Overall Study|Death|1|||
162658728|NCT01574703|587463723|FG003|Overall Study|Death|0|||
162658729|NCT02553421|587463728|FG000|Overall Study|Lost to Follow-up|21|||
162658730|NCT02553421|587463729|FG001|Overall Study|Lost to Follow-up|1|||
162658731|NCT02553421|587463728|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
162658732|NCT02553421|587463729|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
163132828|NCT03100058|589194330|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132829|NCT03100058|589194331|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132830|NCT03100058|589194332|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132831|NCT03100058|589194333|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132832|NCT03100058|589194334|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
163132833|NCT03100058|589194335|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132834|NCT03100058|589194336|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132835|NCT03100058|589194337|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132836|NCT03100058|589194338|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132837|NCT03100058|589194339|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132838|NCT03100058|589194340|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
163132839|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132840|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132841|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132842|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132843|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132844|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132845|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132846|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132847|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132848|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
163132849|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
163132850|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
163132851|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
163132852|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132853|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132854|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132855|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132856|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132857|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132858|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132859|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132860|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132861|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132862|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
163132863|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
163132864|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
163132865|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132866|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132867|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
162658733|NCT02553421|587463728|FG000|Overall Study|Improper Device Placement|3|||
162658734|NCT02553421|587463729|FG001|Overall Study|Improper Device Placement|0|||
162658735|NCT03890367|587463738|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162658736|NCT03890367|587463739|FG001|Overall Study|Withdrawal by parent/guardian|3|||
162658737|NCT03890367|587463740|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162658738|NCT03890367|587463738|FG000|Overall Study|Protocol deviation|2|||
162658739|NCT03890367|587463739|FG001|Overall Study|Protocol deviation|2|||
162658740|NCT03890367|587463740|FG002|Overall Study|Protocol deviation|1|||
162658741|NCT03890367|587463738|FG000|Overall Study|Lost to Follow-up|1|||
162658742|NCT03890367|587463739|FG001|Overall Study|Lost to Follow-up|1|||
162658743|NCT03890367|587463740|FG002|Overall Study|Lost to Follow-up|0|||
162658744|NCT02556710|587465775|FG000|Overall Study|Surgical treatment|3|||
162658745|NCT02556710|587465776|FG001|Overall Study|Surgical treatment|0|||
162658746|NCT02556710|587465775|FG000|Overall Study|Required proscribed pain medication|2|||
162658747|NCT02556710|587465776|FG001|Overall Study|Required proscribed pain medication|1|||
162658748|NCT02556710|587465775|FG000|Overall Study|Lack of Efficacy|1|||
162658749|NCT02556710|587465776|FG001|Overall Study|Lack of Efficacy|0|||
162658750|NCT02556710|587465775|FG000|Overall Study|Worsening osteoarthritis|1|||
162658751|NCT02556710|587465776|FG001|Overall Study|Worsening osteoarthritis|0|||
162658752|NCT02556710|587465775|FG000|Overall Study|Moved out of state|1|||
162658753|NCT02556710|587465776|FG001|Overall Study|Moved out of state|0|||
162658754|NCT02556710|587465775|FG000|Overall Study|Missing reason|3|||
162658755|NCT02556710|587465776|FG001|Overall Study|Missing reason|1|||
162658756|NCT02556710|587465775|FG000|Overall Study|Pain as lack of efficacy|0|||
162658757|NCT02556710|587465776|FG001|Overall Study|Pain as lack of efficacy|4|||
162658758|NCT04524403|587465779|FG000|Overall Study|Withdrawal by Subject|10|||
162658759|NCT04524403|587465780|FG001|Overall Study|Withdrawal by Subject|3|||
163132868|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132869|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132870|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132871|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132872|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132873|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132874|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
163132875|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
163132876|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
163132877|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
163132878|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132879|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132880|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132881|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132882|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132883|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132884|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132885|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132886|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132887|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
162658760|NCT04524403|587465781|FG002|Overall Study|Withdrawal by Subject|8|||
162658761|NCT04524403|587465779|FG000|Overall Study|Lost to Follow-up|3|||
162658762|NCT04524403|587465780|FG001|Overall Study|Lost to Follow-up|4|||
162658763|NCT04524403|587465781|FG002|Overall Study|Lost to Follow-up|3|||
162658764|NCT04524403|587465779|FG000|Overall Study|Adverse Event|3|||
163132888|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
163132889|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132890|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
163132891|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132892|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132893|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132894|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132895|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132896|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132897|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132898|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132899|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132900|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132901|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132902|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163132903|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
163132904|NCT03100058|589194328|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132905|NCT03100058|589194329|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132906|NCT03100058|589194330|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132907|NCT03100058|589194331|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132908|NCT03100058|589194332|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132909|NCT03100058|589194333|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132910|NCT03100058|589194334|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132911|NCT03100058|589194335|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132912|NCT03100058|589194336|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132913|NCT03100058|589194337|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
163132914|NCT03100058|589194338|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132915|NCT03100058|589194339|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132916|NCT03100058|589194340|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
163132917|NCT03671304|589194343|FG000|Overall Study|study terminated|7|||
163132918|NCT01067144|589194344|FG000|Treatment|Did not receive allocated intervention|4|||
163132919|NCT01067144|589194345|FG001|Treatment|Did not receive allocated intervention|7|||
163132920|NCT01067144|589194344|FG000|Follow-up|Lost to Follow-up|22|||
163132921|NCT01067144|589194345|FG001|Follow-up|Lost to Follow-up|12|||
163132922|NCT01067144|589194344|FG000|Follow-up|Censored owing to second surgery|19|||
163132923|NCT01067144|589194345|FG001|Follow-up|Censored owing to second surgery|28|||
163132924|NCT01067144|589194344|FG000|Follow-up|Withdrawal by Subject|18|||
163132925|NCT01067144|589194345|FG001|Follow-up|Withdrawal by Subject|14|||
163132926|NCT01067144|589194344|FG000|Follow-up|Surgery cancelled|0|||
163132927|NCT01067144|589194345|FG001|Follow-up|Surgery cancelled|1|||
163132928|NCT01067144|589194344|FG000|Follow-up|Death|0|||
163132929|NCT01067144|589194345|FG001|Follow-up|Death|1|||
163132930|NCT02718716|589194347|FG000|Overall Study|Lack of Efficacy|1|||
163132931|NCT02718716|589194348|FG001|Overall Study|Lack of Efficacy|0|||
163132932|NCT02718716|589194349|FG002|Overall Study|Lack of Efficacy|0|||
163132933|NCT02718716|589194350|FG003|Overall Study|Lack of Efficacy|0|||
163132934|NCT02718716|589194351|FG004|Overall Study|Lack of Efficacy|0|||
163132935|NCT00532298|589194352|FG000|Overall Study|Adverse Event|1|||
163132936|NCT00532298|589194353|FG001|Overall Study|Adverse Event|0|||
163132937|NCT00532298|589194354|FG002|Overall Study|Adverse Event|0|||
163132938|NCT00532298|589194355|FG003|Overall Study|Adverse Event|0|||
163132939|NCT00532298|589194356|FG004|Overall Study|Adverse Event|1|||
163132940|NCT00532298|589194357|FG005|Overall Study|Adverse Event|1|||
163132941|NCT00532298|589194352|FG000|Overall Study|Lost to Follow-up|1|||
163132942|NCT00532298|589194353|FG001|Overall Study|Lost to Follow-up|1|||
163132943|NCT00532298|589194354|FG002|Overall Study|Lost to Follow-up|1|||
163132944|NCT00532298|589194355|FG003|Overall Study|Lost to Follow-up|0|||
163132945|NCT00532298|589194356|FG004|Overall Study|Lost to Follow-up|0|||
163132946|NCT00532298|589194357|FG005|Overall Study|Lost to Follow-up|1|||
163132947|NCT00479856|589194358|FG000|Overall Study|Adverse Event|1|||
163132948|NCT00479856|589194358|FG000|Overall Study|Withdrawal by Subject|1|||
163132949|NCT00479856|589194358|FG000|Overall Study|Physician Decision|1|||
163132950|NCT02141360|589194363|FG000|Overall Study|Withdrawal by Subject|6|||
163132951|NCT02141360|589194364|FG001|Overall Study|Withdrawal by Subject|0|||
163132952|NCT02141360|589194365|FG002|Overall Study|Withdrawal by Subject|0|||
163132953|NCT02141360|589194363|FG000|Overall Study|Study Terminated before Visit|1|||
162658765|NCT04524403|587465780|FG001|Overall Study|Adverse Event|1|||
162658766|NCT04524403|587465781|FG002|Overall Study|Adverse Event|4|||
162658767|NCT04524403|587465779|FG000|Overall Study|Non-compliant with study drug|1|||
163132954|NCT02141360|589194364|FG001|Overall Study|Study Terminated before Visit|0|||
163132955|NCT02141360|589194365|FG002|Overall Study|Study Terminated before Visit|0|||
163132956|NCT00646399|589194366|FG000|Overall Study|Death|63|||
163132957|NCT00646399|589194367|FG001|Overall Study|Death|53|||
163132958|NCT00646399|589194366|FG000|Overall Study|Withdrawal by Subject|9|||
163132959|NCT00646399|589194367|FG001|Overall Study|Withdrawal by Subject|10|||
163132960|NCT00646399|589194366|FG000|Overall Study|Other Reason|11|||
163132961|NCT00646399|589194367|FG001|Overall Study|Other Reason|11|||
163132962|NCT00661622|589194368|FG000|Overall Study|Protocol Violation|1|||
163132963|NCT00661622|589194369|FG001|Overall Study|Protocol Violation|0|||
163132964|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
163132965|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
163132966|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
163132967|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
163132968|NCT02332291|589194374|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
163132969|NCT02332291|589194375|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
163132970|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
163132971|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
163132972|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
163132973|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
163132974|NCT02332291|589194374|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
163132975|NCT02332291|589194375|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
163132976|NCT01424228|589194378|FG000|Overall Study|Withdrawal by Subject|27|||
163132977|NCT01424228|589194379|FG001|Overall Study|Withdrawal by Subject|11|||
163132978|NCT01424228|589194378|FG000|Overall Study|Adverse Event|10|||
163132979|NCT01424228|589194379|FG001|Overall Study|Adverse Event|14|||
163132980|NCT01424228|589194378|FG000|Overall Study|Sponsor's decision|9|||
163132981|NCT01424228|589194379|FG001|Overall Study|Sponsor's decision|12|||
163132982|NCT01424228|589194378|FG000|Overall Study|Lack of Efficacy|5|||
163132983|NCT01424228|589194379|FG001|Overall Study|Lack of Efficacy|7|||
163132984|NCT01424228|589194378|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
163132985|NCT01424228|589194379|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
163132986|NCT01424228|589194378|FG000|Overall Study|Non-compliance|2|||
163132987|NCT01424228|589194379|FG001|Overall Study|Non-compliance|0|||
163132988|NCT01424228|589194378|FG000|Overall Study|Worsening of symptoms|1|||
163132989|NCT01424228|589194379|FG001|Overall Study|Worsening of symptoms|0|||
163132990|NCT01424228|589194378|FG000|Overall Study|Unplanned journey|0|||
163132991|NCT01424228|589194379|FG001|Overall Study|Unplanned journey|1|||
163132992|NCT00844558|589194380|FG000|Overall Study|Withdrawal by Subject|9|||
163132993|NCT00844558|589194381|FG001|Overall Study|Withdrawal by Subject|2|||
163132994|NCT00844558|589194380|FG000|Overall Study|Death|1|||
163132995|NCT00844558|589194381|FG001|Overall Study|Death|0|||
163132996|NCT00844558|589194380|FG000|Overall Study|Protocol Violation|1|||
163132997|NCT00844558|589194381|FG001|Overall Study|Protocol Violation|1|||
163132998|NCT00844558|589194380|FG000|Overall Study|Lost to Follow-up|0|||
162658768|NCT04524403|587465780|FG001|Overall Study|Non-compliant with study drug|2|||
162658769|NCT04524403|587465781|FG002|Overall Study|Non-compliant with study drug|3|||
162658770|NCT04524403|587465779|FG000|Overall Study|Moved|0|||
162658771|NCT04524403|587465780|FG001|Overall Study|Moved|1|||
162658772|NCT04524403|587465781|FG002|Overall Study|Moved|0|||
162658773|NCT00991302|587465782|FG000|Overall Study|Death|0|||
162658774|NCT00991302|587465783|FG001|Overall Study|Death|1|||
162658775|NCT00991302|587465782|FG000|Overall Study|Lost to Follow-up|14|||
162658776|NCT00991302|587465783|FG001|Overall Study|Lost to Follow-up|12|||
162658777|NCT01709318|587465784|FG000|Overall Study|Adverse Event|3|||
162658778|NCT01709318|587465785|FG001|Overall Study|Adverse Event|4|||
162658779|NCT01709318|587465786|FG002|Overall Study|Adverse Event|2|||
162658780|NCT01709318|587465787|FG003|Overall Study|Adverse Event|2|||
162658781|NCT01709318|587465788|FG004|Overall Study|Adverse Event|0|||
162658782|NCT01709318|587465789|FG005|Overall Study|Adverse Event|1|||
162658783|NCT01709318|587465790|FG006|Overall Study|Adverse Event|2|||
162658784|NCT01709318|587465784|FG000|Overall Study|Lost to Follow-up|2|||
162658785|NCT01709318|587465785|FG001|Overall Study|Lost to Follow-up|0|||
162658786|NCT01709318|587465786|FG002|Overall Study|Lost to Follow-up|0|||
162658787|NCT01709318|587465787|FG003|Overall Study|Lost to Follow-up|0|||
162658788|NCT01709318|587465788|FG004|Overall Study|Lost to Follow-up|1|||
162658789|NCT01709318|587465789|FG005|Overall Study|Lost to Follow-up|1|||
163132999|NCT00844558|589194381|FG001|Overall Study|Lost to Follow-up|1|||
162658790|NCT01709318|587465790|FG006|Overall Study|Lost to Follow-up|1|||
162658791|NCT01709318|587465784|FG000|Overall Study|Non-compliance with Study Drug|0|||
162658792|NCT01709318|587465785|FG001|Overall Study|Non-compliance with Study Drug|2|||
162658793|NCT01709318|587465786|FG002|Overall Study|Non-compliance with Study Drug|1|||
162658794|NCT01709318|587465787|FG003|Overall Study|Non-compliance with Study Drug|1|||
162658795|NCT01709318|587465788|FG004|Overall Study|Non-compliance with Study Drug|0|||
162658796|NCT01709318|587465789|FG005|Overall Study|Non-compliance with Study Drug|0|||
162658797|NCT01709318|587465790|FG006|Overall Study|Non-compliance with Study Drug|2|||
163133000|NCT00844558|589194380|FG000|Overall Study|Physician Decision|1|||
163133001|NCT00844558|589194381|FG001|Overall Study|Physician Decision|0|||
163133002|NCT01068158|589194386|FG000|Overall Study|Withdrawal by Subject|1|||
163133003|NCT01068158|589194387|FG001|Overall Study|Withdrawal by Subject|2|||
163133004|NCT01068158|589194386|FG000|Overall Study|Lost to Follow-up|7|||
163133005|NCT01068158|589194387|FG001|Overall Study|Lost to Follow-up|0|||
163133006|NCT01068158|589194386|FG000|Overall Study|Protocol Violation|0|||
163133007|NCT01068158|589194387|FG001|Overall Study|Protocol Violation|2|||
163133008|NCT02478255|589194388|FG000|Overall Study|Physician Decision|6|||
163133009|NCT02478255|589194389|FG001|Overall Study|Physician Decision|0|||
163133010|NCT02478255|589194388|FG000|Overall Study|Withdrawal by Subject|2|||
163133011|NCT02478255|589194389|FG001|Overall Study|Withdrawal by Subject|0|||
163133012|NCT02813889|589195680|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
163133013|NCT02813889|589195681|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
163133014|NCT02974257|589195685|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
163133015|NCT02974257|589195686|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
163133016|NCT02974257|589195685|FG000|Overall Study|Clinical indication for thiamine|1|||
163133017|NCT02974257|589195686|FG001|Overall Study|Clinical indication for thiamine|0|||
163133018|NCT02974257|589195685|FG000|Overall Study|Already on thiamine|1|||
163133019|NCT02974257|589195686|FG001|Overall Study|Already on thiamine|0|||
163133020|NCT02974257|589195685|FG000|Overall Study|Extubated prior to study drug|0|||
163133021|NCT02974257|589195686|FG001|Overall Study|Extubated prior to study drug|1|||
163133022|NCT02974257|589195685|FG000|Overall Study|Death|0|||
163133023|NCT02974257|589195686|FG001|Overall Study|Death|1|||
163133024|NCT00398567|589195687|FG000|Overall Study|Disease Progression|3|||
163133025|NCT00398567|589195688|FG001|Overall Study|Disease Progression|4|||
163133026|NCT00398567|589195689|FG002|Overall Study|Disease Progression|27|||
163133027|NCT00398567|589195687|FG000|Overall Study|Withdrawal by Subject|1|||
163133028|NCT00398567|589195688|FG001|Overall Study|Withdrawal by Subject|0|||
163133029|NCT00398567|589195689|FG002|Overall Study|Withdrawal by Subject|4|||
163133030|NCT00398567|589195687|FG000|Overall Study|Adverse Event|0|||
163133031|NCT00398567|589195688|FG001|Overall Study|Adverse Event|0|||
163133032|NCT00398567|589195689|FG002|Overall Study|Adverse Event|2|||
163133033|NCT00398567|589195687|FG000|Overall Study|Protocol Violation|0|||
163133034|NCT00398567|589195688|FG001|Overall Study|Protocol Violation|0|||
163133035|NCT00398567|589195689|FG002|Overall Study|Protocol Violation|1|||
163133036|NCT00793325|589195690|FG000|Overall Study|Protocol Violation|18|||
163133037|NCT00793325|589195690|FG000|Overall Study|Lost to Follow-up|1|||
163133038|NCT03250182|589195696|FG000|Overall Study|Withdrawal by Subject|1|||
163133039|NCT03472950|589195699|FG000|Overall Study|Lost to Follow-up|0|||
163133040|NCT03472950|589195700|FG001|Overall Study|Lost to Follow-up|1|||
163133041|NCT03472950|589195699|FG000|Overall Study|Adverse Event|0|||
163133042|NCT03472950|589195700|FG001|Overall Study|Adverse Event|3|||
163133043|NCT03386487|589195703|FG000|Overall Study|Lost to Follow-up|5|||
163133044|NCT03386487|589195704|FG001|Overall Study|Lost to Follow-up|6|||
163133045|NCT03386487|589195703|FG000|Overall Study|Withdrawal by Subject|11|||
163133046|NCT03386487|589195704|FG001|Overall Study|Withdrawal by Subject|7|||
163133047|NCT03386487|589195703|FG000|Overall Study|Physician Decision|11|||
163133048|NCT03386487|589195704|FG001|Overall Study|Physician Decision|8|||
163133049|NCT01068769|589195705|FG000|Overall Study|Ineligible|1|||
163133050|NCT00517361|589195708|FG000|Overall Study|Death|6|||
163133051|NCT00517361|589195708|FG000|Overall Study|The study was terminated|5|||
163133052|NCT01858766|589195709|FG000|Overall Study|Randomized but Never Treated|0|||
163133053|NCT01858766|589195710|FG001|Overall Study|Randomized but Never Treated|0|||
163133054|NCT01858766|589195711|FG002|Overall Study|Randomized but Never Treated|0|||
163133055|NCT01858766|589195712|FG003|Overall Study|Randomized but Never Treated|0|||
163133056|NCT01858766|589195713|FG004|Overall Study|Randomized but Never Treated|0|||
163133057|NCT01858766|589195714|FG005|Overall Study|Randomized but Never Treated|1|||
163133058|NCT01858766|589195715|FG006|Overall Study|Randomized but Never Treated|0|||
163133059|NCT01858766|589195716|FG007|Overall Study|Randomized but Never Treated|0|||
163133060|NCT01858766|589195717|FG008|Overall Study|Randomized but Never Treated|0|||
163133061|NCT01858766|589195718|FG009|Overall Study|Randomized but Never Treated|0|||
163133062|NCT01858766|589195719|FG010|Overall Study|Randomized but Never Treated|0|||
163133063|NCT01858766|589195720|FG011|Overall Study|Randomized but Never Treated|0|||
163133064|NCT01858766|589195721|FG012|Overall Study|Randomized but Never Treated|0|||
163133065|NCT01858766|589195722|FG013|Overall Study|Randomized but Never Treated|0|||
163133066|NCT01858766|589195723|FG014|Overall Study|Randomized but Never Treated|0|||
162658798|NCT01709318|587465784|FG000|Overall Study|Physician Decision|0|||
162658799|NCT01709318|587465785|FG001|Overall Study|Physician Decision|0|||
163133067|NCT01858766|589195724|FG015|Overall Study|Randomized but Never Treated|0|||
163133068|NCT01858766|589195725|FG016|Overall Study|Randomized but Never Treated|0|||
163133069|NCT01858766|589195726|FG017|Overall Study|Randomized but Never Treated|1|||
163133070|NCT01858766|589195727|FG018|Overall Study|Randomized but Never Treated|0|||
162658800|NCT01709318|587465786|FG002|Overall Study|Physician Decision|0|||
162658801|NCT01709318|587465787|FG003|Overall Study|Physician Decision|0|||
162658802|NCT01709318|587465788|FG004|Overall Study|Physician Decision|0|||
162658803|NCT01709318|587465789|FG005|Overall Study|Physician Decision|0|||
162658804|NCT01709318|587465790|FG006|Overall Study|Physician Decision|1|||
162658805|NCT01709318|587465784|FG000|Overall Study|Pregnancy|0|||
162658806|NCT01709318|587465785|FG001|Overall Study|Pregnancy|0|||
162658807|NCT01709318|587465786|FG002|Overall Study|Pregnancy|0|||
162658808|NCT01709318|587465787|FG003|Overall Study|Pregnancy|0|||
162658809|NCT01709318|587465788|FG004|Overall Study|Pregnancy|1|||
162658810|NCT01709318|587465789|FG005|Overall Study|Pregnancy|0|||
162658811|NCT01709318|587465790|FG006|Overall Study|Pregnancy|0|||
162658812|NCT01709318|587465784|FG000|Overall Study|Protocol Violation|0|||
162658813|NCT01709318|587465785|FG001|Overall Study|Protocol Violation|0|||
162658814|NCT01709318|587465786|FG002|Overall Study|Protocol Violation|0|||
162658815|NCT01709318|587465787|FG003|Overall Study|Protocol Violation|0|||
162658816|NCT01709318|587465788|FG004|Overall Study|Protocol Violation|2|||
162658817|NCT01709318|587465789|FG005|Overall Study|Protocol Violation|0|||
162658818|NCT01709318|587465790|FG006|Overall Study|Protocol Violation|1|||
162658819|NCT01709318|587465784|FG000|Overall Study|Technical Problems|1|||
162658820|NCT01709318|587465785|FG001|Overall Study|Technical Problems|0|||
162658821|NCT01709318|587465786|FG002|Overall Study|Technical Problems|0|||
162658822|NCT01709318|587465787|FG003|Overall Study|Technical Problems|0|||
162658823|NCT01709318|587465788|FG004|Overall Study|Technical Problems|0|||
162658824|NCT01709318|587465789|FG005|Overall Study|Technical Problems|0|||
162658825|NCT01709318|587465790|FG006|Overall Study|Technical Problems|0|||
162658826|NCT01709318|587465784|FG000|Overall Study|Withdrawal by Subject|3|||
162658827|NCT01709318|587465785|FG001|Overall Study|Withdrawal by Subject|0|||
162658828|NCT01709318|587465786|FG002|Overall Study|Withdrawal by Subject|3|||
162658829|NCT01709318|587465787|FG003|Overall Study|Withdrawal by Subject|3|||
162658830|NCT01709318|587465788|FG004|Overall Study|Withdrawal by Subject|0|||
162658831|NCT01709318|587465789|FG005|Overall Study|Withdrawal by Subject|2|||
162658832|NCT01709318|587465790|FG006|Overall Study|Withdrawal by Subject|4|||
162658833|NCT01709318|587465784|FG000|Overall Study|Other Protocol Specified Criteria|0|||
162658834|NCT01709318|587465785|FG001|Overall Study|Other Protocol Specified Criteria|1|||
162658835|NCT01709318|587465786|FG002|Overall Study|Other Protocol Specified Criteria|0|||
162658836|NCT01709318|587465787|FG003|Overall Study|Other Protocol Specified Criteria|0|||
162658837|NCT01709318|587465788|FG004|Overall Study|Other Protocol Specified Criteria|0|||
162658838|NCT01709318|587465789|FG005|Overall Study|Other Protocol Specified Criteria|0|||
162658839|NCT01709318|587465790|FG006|Overall Study|Other Protocol Specified Criteria|0|||
162658840|NCT00646958|587465795|FG000|Overall Study|Lack of Efficacy|1|||
162658841|NCT00646958|587465796|FG001|Overall Study|Lack of Efficacy|0|||
162658842|NCT00646958|587465797|FG002|Overall Study|Lack of Efficacy|0|||
162658843|NCT00646958|587465795|FG000|Overall Study|Adverse Event|4|||
162658844|NCT00646958|587465796|FG001|Overall Study|Adverse Event|0|||
162658845|NCT00646958|587465797|FG002|Overall Study|Adverse Event|0|||
162658846|NCT00646958|587465795|FG000|Overall Study|Lost to Follow-up|1|||
162658847|NCT00646958|587465796|FG001|Overall Study|Lost to Follow-up|5|||
162658848|NCT00646958|587465797|FG002|Overall Study|Lost to Follow-up|7|||
162658849|NCT00646958|587465795|FG000|Overall Study|Protocol Violation|1|||
162658850|NCT00646958|587465796|FG001|Overall Study|Protocol Violation|1|||
162658851|NCT00646958|587465797|FG002|Overall Study|Protocol Violation|0|||
162658852|NCT00646958|587465795|FG000|Overall Study|Abnormal screening lab tests|1|||
162658853|NCT00646958|587465796|FG001|Overall Study|Abnormal screening lab tests|1|||
162658854|NCT00646958|587465797|FG002|Overall Study|Abnormal screening lab tests|0|||
162658855|NCT00646958|587465795|FG000|Overall Study|Withdrawal by Subject|1|||
162658856|NCT00646958|587465796|FG001|Overall Study|Withdrawal by Subject|2|||
162719861|NCT00536380|587680604|FG002|Overall Study|Noncompliance with protocol|2|||
162658857|NCT00646958|587465797|FG002|Overall Study|Withdrawal by Subject|0|||
162658858|NCT00646958|587465795|FG000|Overall Study|Did not receive study drug|2|||
162658859|NCT00646958|587465796|FG001|Overall Study|Did not receive study drug|0|||
162658860|NCT00646958|587465797|FG002|Overall Study|Did not receive study drug|2|||
162658861|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
163133071|NCT01858766|589195709|FG000|Overall Study|Death|0|||
163133072|NCT01858766|589195710|FG001|Overall Study|Death|0|||
163133073|NCT01858766|589195711|FG002|Overall Study|Death|1|||
163133074|NCT01858766|589195712|FG003|Overall Study|Death|0|||
163133075|NCT01858766|589195713|FG004|Overall Study|Death|0|||
163133076|NCT01858766|589195714|FG005|Overall Study|Death|0|||
163133077|NCT01858766|589195715|FG006|Overall Study|Death|0|||
163133078|NCT01858766|589195716|FG007|Overall Study|Death|0|||
163133079|NCT01858766|589195717|FG008|Overall Study|Death|0|||
163133080|NCT01858766|589195718|FG009|Overall Study|Death|0|||
163133081|NCT01858766|589195719|FG010|Overall Study|Death|0|||
163133082|NCT01858766|589195720|FG011|Overall Study|Death|0|||
163133083|NCT01858766|589195721|FG012|Overall Study|Death|0|||
163133084|NCT01858766|589195722|FG013|Overall Study|Death|0|||
163133085|NCT01858766|589195723|FG014|Overall Study|Death|0|||
163133086|NCT01858766|589195724|FG015|Overall Study|Death|0|||
163133087|NCT01858766|589195725|FG016|Overall Study|Death|0|||
163133088|NCT01858766|589195726|FG017|Overall Study|Death|0|||
163133089|NCT01858766|589195727|FG018|Overall Study|Death|0|||
163133090|NCT01858766|589195709|FG000|Overall Study|Lack of Efficacy|1|||
163133091|NCT01858766|589195710|FG001|Overall Study|Lack of Efficacy|0|||
163133092|NCT01858766|589195711|FG002|Overall Study|Lack of Efficacy|0|||
163133093|NCT01858766|589195712|FG003|Overall Study|Lack of Efficacy|0|||
163133094|NCT01858766|589195713|FG004|Overall Study|Lack of Efficacy|1|||
163133095|NCT01858766|589195714|FG005|Overall Study|Lack of Efficacy|2|||
163133096|NCT01858766|589195715|FG006|Overall Study|Lack of Efficacy|0|||
163133097|NCT01858766|589195716|FG007|Overall Study|Lack of Efficacy|0|||
163133098|NCT01858766|589195717|FG008|Overall Study|Lack of Efficacy|0|||
163133099|NCT01858766|589195718|FG009|Overall Study|Lack of Efficacy|0|||
162658862|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162658863|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162658864|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162658865|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162658866|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162658867|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
162658868|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162658869|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162658870|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162658871|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162658872|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162719862|NCT00536380|587680602|FG000|Overall Study|Did not meet protocol eligibility|0|||
162719863|NCT00536380|587680603|FG001|Overall Study|Did not meet protocol eligibility|0|||
163133100|NCT01858766|589195719|FG010|Overall Study|Lack of Efficacy|0|||
163133101|NCT01858766|589195720|FG011|Overall Study|Lack of Efficacy|3|||
163133102|NCT01858766|589195721|FG012|Overall Study|Lack of Efficacy|5|||
163133103|NCT01858766|589195722|FG013|Overall Study|Lack of Efficacy|3|||
163133104|NCT01858766|589195723|FG014|Overall Study|Lack of Efficacy|5|||
163133105|NCT01858766|589195724|FG015|Overall Study|Lack of Efficacy|5|||
163133106|NCT01858766|589195725|FG016|Overall Study|Lack of Efficacy|2|||
163133107|NCT01858766|589195726|FG017|Overall Study|Lack of Efficacy|3|||
163133108|NCT01858766|589195727|FG018|Overall Study|Lack of Efficacy|3|||
163133109|NCT01858766|589195709|FG000|Overall Study|Lost to Follow-up|0|||
163133110|NCT01858766|589195710|FG001|Overall Study|Lost to Follow-up|0|||
163133111|NCT01858766|589195711|FG002|Overall Study|Lost to Follow-up|0|||
163133112|NCT01858766|589195712|FG003|Overall Study|Lost to Follow-up|0|||
163133113|NCT01858766|589195713|FG004|Overall Study|Lost to Follow-up|0|||
163133114|NCT01858766|589195714|FG005|Overall Study|Lost to Follow-up|1|||
163133115|NCT01858766|589195715|FG006|Overall Study|Lost to Follow-up|0|||
163133116|NCT01858766|589195716|FG007|Overall Study|Lost to Follow-up|2|||
163133117|NCT01858766|589195717|FG008|Overall Study|Lost to Follow-up|0|||
163133118|NCT01858766|589195718|FG009|Overall Study|Lost to Follow-up|0|||
163133119|NCT01858766|589195719|FG010|Overall Study|Lost to Follow-up|0|||
163133120|NCT01858766|589195720|FG011|Overall Study|Lost to Follow-up|1|||
163133121|NCT01858766|589195721|FG012|Overall Study|Lost to Follow-up|0|||
163133122|NCT01858766|589195722|FG013|Overall Study|Lost to Follow-up|0|||
163133123|NCT01858766|589195723|FG014|Overall Study|Lost to Follow-up|3|||
162719864|NCT00536380|587680604|FG002|Overall Study|Did not meet protocol eligibility|1|||
163133124|NCT01858766|589195724|FG015|Overall Study|Lost to Follow-up|1|||
163133125|NCT01858766|589195725|FG016|Overall Study|Lost to Follow-up|1|||
163133126|NCT01858766|589195726|FG017|Overall Study|Lost to Follow-up|0|||
163133127|NCT01858766|589195727|FG018|Overall Study|Lost to Follow-up|1|||
163133128|NCT01858766|589195709|FG000|Overall Study|Withdrew Consent|0|||
163133129|NCT01858766|589195710|FG001|Overall Study|Withdrew Consent|0|||
163133130|NCT01858766|589195711|FG002|Overall Study|Withdrew Consent|0|||
162658873|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
162658874|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163133131|NCT01858766|589195712|FG003|Overall Study|Withdrew Consent|0|||
163133132|NCT01858766|589195713|FG004|Overall Study|Withdrew Consent|0|||
163133133|NCT01858766|589195714|FG005|Overall Study|Withdrew Consent|0|||
163133134|NCT01858766|589195715|FG006|Overall Study|Withdrew Consent|0|||
163133135|NCT01858766|589195716|FG007|Overall Study|Withdrew Consent|0|||
163133136|NCT01858766|589195717|FG008|Overall Study|Withdrew Consent|0|||
163133137|NCT01858766|589195718|FG009|Overall Study|Withdrew Consent|0|||
163133138|NCT01858766|589195719|FG010|Overall Study|Withdrew Consent|0|||
163133139|NCT01858766|589195720|FG011|Overall Study|Withdrew Consent|1|||
163133140|NCT01858766|589195721|FG012|Overall Study|Withdrew Consent|0|||
163133141|NCT01858766|589195722|FG013|Overall Study|Withdrew Consent|0|||
163133142|NCT01858766|589195723|FG014|Overall Study|Withdrew Consent|0|||
163133143|NCT01858766|589195724|FG015|Overall Study|Withdrew Consent|0|||
163133144|NCT01858766|589195725|FG016|Overall Study|Withdrew Consent|0|||
163133145|NCT01858766|589195726|FG017|Overall Study|Withdrew Consent|0|||
163133146|NCT01858766|589195727|FG018|Overall Study|Withdrew Consent|0|||
163133147|NCT00894361|589195738|FG000|Overall Study|deaths and less than 2 years followup|24|||
163133148|NCT00894361|589195739|FG001|Overall Study|deaths and less than 2 years followup|64|||
163133149|NCT04207060|589195744|FG000|Overall Study|Lost to Follow-up|2|||
163133150|NCT04207060|589195745|FG001|Overall Study|Lost to Follow-up|0|||
163133151|NCT05438576|589195746|FG000|Overall Study|Death|1|||
163133152|NCT05438576|589195747|FG001|Overall Study|Death|1|||
163133153|NCT05438576|589195746|FG000|Overall Study|Withdrawal by Subject|4|||
163133154|NCT05438576|589195747|FG001|Overall Study|Withdrawal by Subject|2|||
163133155|NCT05438576|589195746|FG000|Overall Study|Not Eligible|2|||
163133156|NCT05438576|589195747|FG001|Overall Study|Not Eligible|1|||
163133157|NCT05438576|589195746|FG000|Overall Study|Did not complete baseline testing|22|||
163133158|NCT05438576|589195747|FG001|Overall Study|Did not complete baseline testing|4|||
163133159|NCT02881762|589195750|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
163133160|NCT02881762|589195751|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
163133161|NCT00245037|589195752|FG000|Overall Study|Death|17|||
163133162|NCT00296140|589195754|FG000|Overall Study|Lost to Follow-up|1|||
163133163|NCT00296140|589195755|FG001|Overall Study|Lost to Follow-up|0|||
163133164|NCT00296140|589195754|FG000|Overall Study|Withdrawal by Subject|1|||
163133165|NCT00296140|589195755|FG001|Overall Study|Withdrawal by Subject|0|||
163133166|NCT00296140|589195754|FG000|Overall Study|Discharge to Nursing Home|1|||
163133167|NCT00296140|589195755|FG001|Overall Study|Discharge to Nursing Home|0|||
163133168|NCT00774800|589195756|FG000|Intervention 4|Withdrawal by Subject|1|||
163133169|NCT01843062|589195757|FG000|Overall Study|Protocol Violation|1|||
163133170|NCT01843062|589195758|FG001|Overall Study|Protocol Violation|0|||
163133171|NCT01843062|589195757|FG000|Overall Study|New treatment following progression|2|||
163133172|NCT01843062|589195758|FG001|Overall Study|New treatment following progression|0|||
163133173|NCT01843062|589195757|FG000|Overall Study|Pregnancy|1|||
163133174|NCT01843062|589195758|FG001|Overall Study|Pregnancy|0|||
163133175|NCT01843062|589195757|FG000|Overall Study|Adverse Event|2|||
163133176|NCT01843062|589195758|FG001|Overall Study|Adverse Event|0|||
163133177|NCT01843062|589195757|FG000|Overall Study|Incorrect randomisation|1|||
163133178|NCT01843062|589195758|FG001|Overall Study|Incorrect randomisation|0|||
163133179|NCT01843062|589195757|FG000|Overall Study|Withdrawal by Subject|12|||
163133180|NCT01843062|589195758|FG001|Overall Study|Withdrawal by Subject|3|||
163133181|NCT01843062|589195757|FG000|Overall Study|Death|1|||
163133182|NCT01843062|589195758|FG001|Overall Study|Death|2|||
163133183|NCT01843062|589195757|FG000|Overall Study|Lost to Follow-up|2|||
163133184|NCT01843062|589195758|FG001|Overall Study|Lost to Follow-up|4|||
163133185|NCT00994422|589195759|FG000|Overall Study|Lost to Follow-up|7|||
163133186|NCT00994422|589195760|FG001|Overall Study|Lost to Follow-up|1|||
163133187|NCT02669212|589195761|FG000|Overall Study|Lost to Follow-up|1|||
163133188|NCT02669212|589195762|FG001|Overall Study|Lost to Follow-up|0|||
163133189|NCT02669212|589195761|FG000|Overall Study|Medical Condition|3|||
163133190|NCT02669212|589195762|FG001|Overall Study|Medical Condition|4|||
163133191|NCT02669212|589195761|FG000|Overall Study|Withdrawal by Subject|0|||
163133192|NCT02669212|589195762|FG001|Overall Study|Withdrawal by Subject|2|||
163133193|NCT02669212|589195761|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
163133194|NCT02669212|589195762|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
163133195|NCT03549104|589195765|FG000|Overall Study|Withdrawal by Subject|5|||
163133196|NCT03549104|589195766|FG001|Overall Study|Withdrawal by Subject|2|||
163133197|NCT03549104|589195765|FG000|Overall Study|Covid shelter in place|1|||
163133198|NCT03549104|589195766|FG001|Overall Study|Covid shelter in place|2|||
163133199|NCT04124705|589195767|FG000|Titration Period|Adverse Event|9|||
163133200|NCT04124705|589195768|FG001|Titration Period|Adverse Event|5|||
163133201|NCT04124705|589195767|FG000|Titration Period|Withdrawal by Subject|6|||
163133202|NCT04124705|589195768|FG001|Titration Period|Withdrawal by Subject|3|||
163133203|NCT04124705|589195767|FG000|Titration Period|Lost to Follow-up|0|||
163133204|NCT04124705|589195768|FG001|Titration Period|Lost to Follow-up|1|||
163133205|NCT04124705|589195767|FG000|Titration Period|Death|1|||
163133206|NCT04124705|589195768|FG001|Titration Period|Death|1|||
163133207|NCT04124705|589195767|FG000|Titration Period|Lack of Efficacy|2|||
163133208|NCT04124705|589195768|FG001|Titration Period|Lack of Efficacy|0|||
163133209|NCT04124705|589195767|FG000|Titration Period|Physician Decision|2|||
163133210|NCT04124705|589195768|FG001|Titration Period|Physician Decision|0|||
163133211|NCT04124705|589195767|FG000|Titration Period|Non-compliance with Study Drug|2|||
163133212|NCT04124705|589195768|FG001|Titration Period|Non-compliance with Study Drug|0|||
163133213|NCT04124705|589195767|FG000|Titration Period|Other|4|||
163133214|NCT04124705|589195768|FG001|Titration Period|Other|9|||
163133215|NCT04124705|589195767|FG000|Stabilization Period|Adverse Event|4|||
163133216|NCT04124705|589195768|FG001|Stabilization Period|Adverse Event|2|||
163133217|NCT04124705|589195767|FG000|Stabilization Period|Withdrawal by Subject|1|||
163133218|NCT04124705|589195768|FG001|Stabilization Period|Withdrawal by Subject|1|||
163133219|NCT04124705|589195767|FG000|Stabilization Period|Lost to Follow-up|0|||
163133220|NCT04124705|589195768|FG001|Stabilization Period|Lost to Follow-up|1|||
163133221|NCT04124705|589195767|FG000|Stabilization Period|Lack of Efficacy|4|||
163133222|NCT04124705|589195768|FG001|Stabilization Period|Lack of Efficacy|2|||
163133223|NCT04124705|589195767|FG000|Stabilization Period|Protocol Deviation|0|||
163133224|NCT04124705|589195768|FG001|Stabilization Period|Protocol Deviation|2|||
163133225|NCT04124705|589195767|FG000|Stabilization Period|Other|2|||
163133226|NCT04124705|589195768|FG001|Stabilization Period|Other|2|||
163133227|NCT04164732|589195769|FG000|Treatment run-in Period|Adverse Event|4|||
163133228|NCT04164732|589195770|FG001|Treatment run-in Period|Adverse Event|0|||
163133229|NCT04164732|589195771|FG002|Treatment run-in Period|Adverse Event|0|||
163133230|NCT04164732|589195769|FG000|Treatment run-in Period|Physician Decision|1|||
163133231|NCT04164732|589195770|FG001|Treatment run-in Period|Physician Decision|0|||
163133232|NCT04164732|589195771|FG002|Treatment run-in Period|Physician Decision|0|||
163133233|NCT04164732|589195769|FG000|Treatment run-in Period|Screen Failure|1|||
163133234|NCT04164732|589195770|FG001|Treatment run-in Period|Screen Failure|0|||
163133235|NCT04164732|589195771|FG002|Treatment run-in Period|Screen Failure|0|||
163133236|NCT04164732|589195769|FG000|Randomized Treatment Period|Adverse Event|0|||
163133237|NCT04164732|589195770|FG001|Randomized Treatment Period|Adverse Event|1|||
163133238|NCT04164732|589195771|FG002|Randomized Treatment Period|Adverse Event|0|||
162719865|NCT00536380|587680602|FG000|Overall Study|Administrative|0|||
162658875|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
163133239|NCT04164732|589195769|FG000|Randomized Treatment Period|Protocol Deviation|0|||
163133240|NCT04164732|589195770|FG001|Randomized Treatment Period|Protocol Deviation|1|||
163133241|NCT04164732|589195771|FG002|Randomized Treatment Period|Protocol Deviation|1|||
163133242|NCT04164732|589195769|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
163133243|NCT04164732|589195770|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
163133244|NCT04164732|589195771|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
163133245|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
163133246|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133247|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133248|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
163133249|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
163133250|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133251|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133252|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163133253|NCT00395850|589195778|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
163133254|NCT00395850|589195779|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
163133255|NCT00395850|589195780|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
162658876|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162658877|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162658878|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162658879|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
162658880|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162658881|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162658882|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
163133256|NCT00395850|589195781|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
163133257|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
163133258|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
163133259|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
163133260|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
163133261|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
163133262|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133263|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133264|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
163133265|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
163133266|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133267|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133268|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
163133269|NCT00395850|589195778|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
163133270|NCT00395850|589195779|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133271|NCT00395850|589195780|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133272|NCT00395850|589195781|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
163133273|NCT02540993|589195786|FG000|Overall Study|Lost to Follow-up|5|||
163133274|NCT02540993|589195787|FG001|Overall Study|Lost to Follow-up|3|||
163133275|NCT02540993|589195786|FG000|Overall Study|Withdrawal by Subject|4|||
163133276|NCT02540993|589195787|FG001|Overall Study|Withdrawal by Subject|6|||
163133277|NCT02540993|589195786|FG000|Overall Study|GCP violations|33|||
163133278|NCT02540993|589195787|FG001|Overall Study|GCP violations|27|||
163133279|NCT00932165|589195788|FG000|Overall Study|Lost to Follow-up|1|||
163133280|NCT00588094|589195789|FG000|Overall Study|Adverse Event|3|||
163133281|NCT00588094|589195789|FG000|Overall Study|Progression of Disease|2|||
163133282|NCT02951429|589195792|FG000|Overall Study|Adverse Event|3|||
163133283|NCT02951429|589195793|FG001|Overall Study|Adverse Event|7|||
163133284|NCT02951429|589195792|FG000|Overall Study|Death|28|||
163133285|NCT02951429|589195793|FG001|Overall Study|Death|36|||
163133286|NCT02951429|589195792|FG000|Overall Study|Lack of Efficacy|0|||
163133287|NCT02951429|589195793|FG001|Overall Study|Lack of Efficacy|1|||
163133288|NCT02951429|589195792|FG000|Overall Study|Lost to Follow-up|0|||
163133289|NCT02951429|589195793|FG001|Overall Study|Lost to Follow-up|1|||
163133290|NCT02951429|589195792|FG000|Overall Study|Lung Transplantation|9|||
163133291|NCT02951429|589195793|FG001|Overall Study|Lung Transplantation|6|||
163133292|NCT02951429|589195792|FG000|Overall Study|Other|1|||
163133293|NCT02951429|589195793|FG001|Overall Study|Other|3|||
163133294|NCT02951429|589195792|FG000|Overall Study|Progressive Disease|1|||
163133295|NCT02951429|589195793|FG001|Overall Study|Progressive Disease|1|||
163133296|NCT02951429|589195792|FG000|Overall Study|Withdrawal by Subject|7|||
163133297|NCT02951429|589195793|FG001|Overall Study|Withdrawal by Subject|11|||
163133298|NCT02951429|589195792|FG000|Overall Study|Participant ongoing in the study|23|||
163133299|NCT02951429|589195793|FG001|Overall Study|Participant ongoing in the study|17|||
163133300|NCT03997825|589195796|FG000|Overall Study|Death|3|||
163133301|NCT03997825|589195796|FG000|Overall Study|Lost to Follow-up|10|||
163133302|NCT03997825|589195796|FG000|Overall Study|Withdrawal by Subject|3|||
163133303|NCT03997825|589195796|FG000|Overall Study|Refused participation|1|||
163133304|NCT00465647|589195798|FG000|Overall Study|Administrative|2|||
163133305|NCT00465647|589195799|FG001|Overall Study|Administrative|2|||
163133306|NCT00465647|589195800|FG002|Overall Study|Administrative|3|||
163133307|NCT00465647|589195801|FG003|Overall Study|Administrative|2|||
163133308|NCT00465647|589195798|FG000|Overall Study|Adverse Event|2|||
163133309|NCT00465647|589195799|FG001|Overall Study|Adverse Event|0|||
163133310|NCT00465647|589195800|FG002|Overall Study|Adverse Event|3|||
163133311|NCT00465647|589195801|FG003|Overall Study|Adverse Event|2|||
163133312|NCT00465647|589195798|FG000|Overall Study|Withdrawal by Subject|1|||
163133313|NCT00465647|589195799|FG001|Overall Study|Withdrawal by Subject|2|||
163133314|NCT00465647|589195800|FG002|Overall Study|Withdrawal by Subject|2|||
163133315|NCT00465647|589195801|FG003|Overall Study|Withdrawal by Subject|7|||
163133316|NCT00465647|589195798|FG000|Overall Study|"The other reasons included loss of IV"|8|||
163133317|NCT00465647|589195799|FG001|Overall Study|"The other reasons included loss of IV"|4|||
163133318|NCT00465647|589195800|FG002|Overall Study|"The other reasons included loss of IV"|3|||
163133319|NCT00465647|589195801|FG003|Overall Study|"The other reasons included loss of IV"|2|||
163133320|NCT01628965|589195802|FG000|Overall Study|Adverse Event|30|||
163133321|NCT01628965|589195802|FG000|Overall Study|Lack of Efficacy|7|||
163133322|NCT01628965|589195802|FG000|Overall Study|Withdrawal by Subject|3|||
163133323|NCT01628965|589195802|FG000|Overall Study|Lost to Follow-up|1|||
163133324|NCT01628965|589195802|FG000|Overall Study|Discontinuation criteria|8|||
163133325|NCT04356352|589195807|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
163133326|NCT04356352|589195808|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
163133327|NCT04356352|589195809|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
163133328|NCT04356352|589195807|FG000|Overall Study|Protocol Violation|0|||
163133329|NCT04356352|589195808|FG001|Overall Study|Protocol Violation|3|||
163133330|NCT04356352|589195809|FG002|Overall Study|Protocol Violation|1|||
163133331|NCT01983774|589195815|FG000|Overall Study|Lung Transplant|0|||
163133332|NCT01983774|589195816|FG001|Overall Study|Lung Transplant|1|||
163133333|NCT01983774|589195815|FG000|Overall Study|Lost to Follow-up|1|||
163133334|NCT01983774|589195816|FG001|Overall Study|Lost to Follow-up|0|||
163133335|NCT01339897|589195817|FG000|Overall Study|Adverse Event|1|||
163133336|NCT01339897|589195818|FG001|Overall Study|Adverse Event|0|||
163133337|NCT01339897|589195819|FG002|Overall Study|Adverse Event|0|||
163133338|NCT01339897|589195820|FG003|Overall Study|Adverse Event|1|||
163133339|NCT00847197|589195821|FG000|Overall Study|Adverse Event|21|||
163133340|NCT00847197|589195822|FG001|Overall Study|Adverse Event|3|||
163133341|NCT00847197|589195821|FG000|Overall Study|Protocol Violation|0|||
163133342|NCT00847197|589195822|FG001|Overall Study|Protocol Violation|1|||
163133343|NCT00847197|589195821|FG000|Overall Study|Withdrawal by Subject|3|||
163133344|NCT00847197|589195822|FG001|Overall Study|Withdrawal by Subject|1|||
163133345|NCT00830180|589195825|FG000|Overall Study|Adverse Event|6|||
163133346|NCT00830180|589195825|FG000|Overall Study|Death|11|||
163133347|NCT00830180|589195825|FG000|Overall Study|Insufficient clinical response|1|||
163133348|NCT00830180|589195825|FG000|Overall Study|Withdrawal by Subject|5|||
163133349|NCT00830180|589195825|FG000|Overall Study|Progressive disease|2|||
163133350|NCT00830180|589195825|FG000|Overall Study|Other - Unspecified|1|||
163133351|NCT01832532|589195826|FG000|Overall Study|Withdrawal by Subject|5|||
163133352|NCT01832532|589195827|FG001|Overall Study|Withdrawal by Subject|2|||
163133353|NCT01630889|589195828|FG000|Overall Study|Death|2|||
163133354|NCT01630889|589195828|FG000|Overall Study|Withdrawal by Subject|1|||
163133355|NCT01630889|589195828|FG000|Overall Study|Other than Specified|2|||
163133356|NCT01630889|589195828|FG000|Overall Study|Lost to Follow-up|4|||
163133357|NCT01630889|589195828|FG000|Overall Study|Other|1|||
163133358|NCT03824587|589195835|FG000|Run-in Period|Screen Failure|0|||
163133359|NCT03824587|589195836|FG001|Run-in Period|Screen Failure|275|||
163133360|NCT03824587|589195835|FG000|Treatment Period|Adverse Event|4|||
163133361|NCT03824587|589195836|FG001|Treatment Period|Adverse Event|1|||
163133362|NCT03824587|589195835|FG000|Treatment Period|Withdrawal by Subject|0|||
163133363|NCT03824587|589195836|FG001|Treatment Period|Withdrawal by Subject|1|||
163133364|NCT03824587|589195835|FG000|Treatment Period|Kidney Transplant|1|||
163133365|NCT03824587|589195836|FG001|Treatment Period|Kidney Transplant|1|||
163133366|NCT01300572|589195837|FG000|Overall Study|HAMA + post dosimetry|1|||
163133367|NCT01368081|589195838|FG000|Overall Study|Adverse Event|4|||
163133368|NCT01368081|589195839|FG001|Overall Study|Adverse Event|4|||
163133369|NCT01368081|589195840|FG002|Overall Study|Adverse Event|3|||
163133370|NCT01368081|589195841|FG003|Overall Study|Adverse Event|2|||
163133371|NCT01368081|589195842|FG004|Overall Study|Adverse Event|2|||
163133372|NCT01368081|589195843|FG005|Overall Study|Adverse Event|5|||
163133373|NCT01368081|589195844|FG006|Overall Study|Adverse Event|6|||
163133374|NCT01368081|589195845|FG007|Overall Study|Adverse Event|2|||
163133375|NCT01368081|589195846|FG008|Overall Study|Adverse Event|3|||
163133376|NCT01368081|589195847|FG009|Overall Study|Adverse Event|5|||
163133377|NCT01368081|589195848|FG010|Overall Study|Adverse Event|6|||
163133378|NCT01368081|589195849|FG011|Overall Study|Adverse Event|1|||
163133379|NCT01368081|589195850|FG012|Overall Study|Adverse Event|3|||
163133380|NCT01368081|589195838|FG000|Overall Study|Lack of Efficacy|0|||
163133381|NCT01368081|589195839|FG001|Overall Study|Lack of Efficacy|1|||
163133382|NCT01368081|589195840|FG002|Overall Study|Lack of Efficacy|0|||
163133383|NCT01368081|589195841|FG003|Overall Study|Lack of Efficacy|1|||
163133384|NCT01368081|589195842|FG004|Overall Study|Lack of Efficacy|0|||
163133385|NCT01368081|589195843|FG005|Overall Study|Lack of Efficacy|0|||
163133386|NCT01368081|589195844|FG006|Overall Study|Lack of Efficacy|0|||
163133387|NCT01368081|589195845|FG007|Overall Study|Lack of Efficacy|2|||
163133388|NCT01368081|589195846|FG008|Overall Study|Lack of Efficacy|0|||
163133389|NCT01368081|589195847|FG009|Overall Study|Lack of Efficacy|0|||
163133390|NCT01368081|589195848|FG010|Overall Study|Lack of Efficacy|0|||
163133391|NCT01368081|589195849|FG011|Overall Study|Lack of Efficacy|0|||
163133392|NCT01368081|589195850|FG012|Overall Study|Lack of Efficacy|0|||
163133393|NCT01368081|589195838|FG000|Overall Study|Protocol Violation|0|||
163133394|NCT01368081|589195839|FG001|Overall Study|Protocol Violation|0|||
163133395|NCT01368081|589195840|FG002|Overall Study|Protocol Violation|0|||
163133396|NCT01368081|589195841|FG003|Overall Study|Protocol Violation|0|||
163133397|NCT01368081|589195842|FG004|Overall Study|Protocol Violation|0|||
163133398|NCT01368081|589195843|FG005|Overall Study|Protocol Violation|1|||
163133399|NCT01368081|589195844|FG006|Overall Study|Protocol Violation|0|||
163133400|NCT01368081|589195845|FG007|Overall Study|Protocol Violation|1|||
163133401|NCT01368081|589195846|FG008|Overall Study|Protocol Violation|0|||
163133402|NCT01368081|589195847|FG009|Overall Study|Protocol Violation|0|||
163133403|NCT01368081|589195848|FG010|Overall Study|Protocol Violation|0|||
163133404|NCT01368081|589195849|FG011|Overall Study|Protocol Violation|0|||
163133405|NCT01368081|589195850|FG012|Overall Study|Protocol Violation|0|||
163133406|NCT01368081|589195838|FG000|Overall Study|Lost to Follow-up|0|||
163133407|NCT01368081|589195839|FG001|Overall Study|Lost to Follow-up|0|||
162658883|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162658884|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162658885|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
162658886|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162658887|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162658888|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162658889|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162658890|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162658891|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
162658892|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
162658893|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
162658894|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
162658895|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
162658896|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
162658897|NCT02139644|587465798|FG000|Run-In Period (Pre-assignment)|Other|6|||
162658898|NCT02139644|587465799|FG001|Run-In Period (Pre-assignment)|Other|0|||
162658899|NCT02139644|587465800|FG002|Run-In Period (Pre-assignment)|Other|0|||
162658900|NCT02139644|587465801|FG003|Run-In Period (Pre-assignment)|Other|0|||
162658901|NCT02139644|587465802|FG004|Run-In Period (Pre-assignment)|Other|0|||
162658902|NCT02139644|587465803|FG005|Run-In Period (Pre-assignment)|Other|0|||
162658903|NCT02139644|587465798|FG000|Treatment Period|Adverse Event|0|||
162658904|NCT02139644|587465799|FG001|Treatment Period|Adverse Event|0|||
162658905|NCT02139644|587465800|FG002|Treatment Period|Adverse Event|3|||
162658906|NCT02139644|587465801|FG003|Treatment Period|Adverse Event|2|||
162658907|NCT02139644|587465802|FG004|Treatment Period|Adverse Event|1|||
162658908|NCT02139644|587465803|FG005|Treatment Period|Adverse Event|6|||
162658909|NCT02139644|587465798|FG000|Treatment Period|Withdrawal by Subject|0|||
162658910|NCT02139644|587465799|FG001|Treatment Period|Withdrawal by Subject|0|||
162658911|NCT02139644|587465800|FG002|Treatment Period|Withdrawal by Subject|2|||
162658912|NCT02139644|587465801|FG003|Treatment Period|Withdrawal by Subject|2|||
162658913|NCT02139644|587465802|FG004|Treatment Period|Withdrawal by Subject|3|||
162658914|NCT02139644|587465803|FG005|Treatment Period|Withdrawal by Subject|2|||
162658915|NCT02139644|587465798|FG000|Treatment Period|Non-compliance|0|||
162658916|NCT02139644|587465799|FG001|Treatment Period|Non-compliance|0|||
162658917|NCT02139644|587465800|FG002|Treatment Period|Non-compliance|0|||
162658918|NCT02139644|587465801|FG003|Treatment Period|Non-compliance|1|||
162658919|NCT02139644|587465802|FG004|Treatment Period|Non-compliance|0|||
162658920|NCT02139644|587465803|FG005|Treatment Period|Non-compliance|0|||
162658921|NCT02139644|587465798|FG000|Treatment Period|Protocol Violation|0|||
162658922|NCT02139644|587465799|FG001|Treatment Period|Protocol Violation|0|||
162658923|NCT02139644|587465800|FG002|Treatment Period|Protocol Violation|0|||
163133408|NCT01368081|589195840|FG002|Overall Study|Lost to Follow-up|0|||
163133409|NCT01368081|589195841|FG003|Overall Study|Lost to Follow-up|0|||
163133410|NCT01368081|589195842|FG004|Overall Study|Lost to Follow-up|0|||
163133411|NCT01368081|589195843|FG005|Overall Study|Lost to Follow-up|0|||
163133412|NCT01368081|589195844|FG006|Overall Study|Lost to Follow-up|0|||
163133413|NCT01368081|589195845|FG007|Overall Study|Lost to Follow-up|0|||
163133414|NCT01368081|589195846|FG008|Overall Study|Lost to Follow-up|0|||
163133415|NCT01368081|589195847|FG009|Overall Study|Lost to Follow-up|0|||
163133416|NCT01368081|589195848|FG010|Overall Study|Lost to Follow-up|0|||
163133417|NCT01368081|589195849|FG011|Overall Study|Lost to Follow-up|0|||
163133418|NCT01368081|589195850|FG012|Overall Study|Lost to Follow-up|1|||
163133419|NCT01368081|589195838|FG000|Overall Study|Withdrawal by Subject|4|||
163133420|NCT01368081|589195839|FG001|Overall Study|Withdrawal by Subject|4|||
163133421|NCT01368081|589195840|FG002|Overall Study|Withdrawal by Subject|1|||
163133422|NCT01368081|589195841|FG003|Overall Study|Withdrawal by Subject|1|||
163133423|NCT01368081|589195842|FG004|Overall Study|Withdrawal by Subject|0|||
163133424|NCT01368081|589195843|FG005|Overall Study|Withdrawal by Subject|3|||
162658924|NCT02139644|587465801|FG003|Treatment Period|Protocol Violation|1|||
162658925|NCT02139644|587465802|FG004|Treatment Period|Protocol Violation|1|||
162658926|NCT02139644|587465803|FG005|Treatment Period|Protocol Violation|1|||
162658927|NCT02139644|587465798|FG000|Treatment Period|Disease progression|0|||
162658928|NCT02139644|587465799|FG001|Treatment Period|Disease progression|0|||
162658929|NCT02139644|587465800|FG002|Treatment Period|Disease progression|0|||
162658930|NCT02139644|587465801|FG003|Treatment Period|Disease progression|1|||
162658931|NCT02139644|587465802|FG004|Treatment Period|Disease progression|1|||
162658932|NCT02139644|587465803|FG005|Treatment Period|Disease progression|2|||
162658933|NCT02139644|587465798|FG000|Treatment Period|Lost to Follow-up|0|||
162658934|NCT02139644|587465799|FG001|Treatment Period|Lost to Follow-up|0|||
162658935|NCT02139644|587465800|FG002|Treatment Period|Lost to Follow-up|1|||
162658936|NCT02139644|587465801|FG003|Treatment Period|Lost to Follow-up|1|||
162658937|NCT02139644|587465802|FG004|Treatment Period|Lost to Follow-up|1|||
162658938|NCT02139644|587465803|FG005|Treatment Period|Lost to Follow-up|1|||
162658939|NCT02139644|587465798|FG000|Treatment Period|Lack of Efficacy|0|||
163133425|NCT01368081|589195844|FG006|Overall Study|Withdrawal by Subject|4|||
163133426|NCT01368081|589195845|FG007|Overall Study|Withdrawal by Subject|2|||
163133427|NCT01368081|589195846|FG008|Overall Study|Withdrawal by Subject|5|||
163133428|NCT01368081|589195847|FG009|Overall Study|Withdrawal by Subject|4|||
163133429|NCT01368081|589195848|FG010|Overall Study|Withdrawal by Subject|3|||
163133430|NCT01368081|589195849|FG011|Overall Study|Withdrawal by Subject|2|||
163133431|NCT01368081|589195850|FG012|Overall Study|Withdrawal by Subject|0|||
163133432|NCT01368081|589195838|FG000|Overall Study|Other reason not defined above|2|||
163133433|NCT01368081|589195839|FG001|Overall Study|Other reason not defined above|0|||
163133434|NCT01368081|589195840|FG002|Overall Study|Other reason not defined above|0|||
163133435|NCT01368081|589195841|FG003|Overall Study|Other reason not defined above|1|||
163133436|NCT01368081|589195842|FG004|Overall Study|Other reason not defined above|0|||
163133437|NCT01368081|589195843|FG005|Overall Study|Other reason not defined above|1|||
163133438|NCT01368081|589195844|FG006|Overall Study|Other reason not defined above|2|||
163133439|NCT01368081|589195845|FG007|Overall Study|Other reason not defined above|0|||
163133440|NCT01368081|589195846|FG008|Overall Study|Other reason not defined above|0|||
163133441|NCT01368081|589195847|FG009|Overall Study|Other reason not defined above|1|||
163133442|NCT01368081|589195848|FG010|Overall Study|Other reason not defined above|0|||
163133443|NCT01368081|589195849|FG011|Overall Study|Other reason not defined above|0|||
163133444|NCT01368081|589195850|FG012|Overall Study|Other reason not defined above|3|||
163133445|NCT02461745|589195852|FG000|Overall Study|Lack of Efficacy|9|||
163133446|NCT02461745|589195853|FG001|Overall Study|Lack of Efficacy|1|||
163133447|NCT02461745|589195852|FG000|Overall Study|Lost to Follow-up|2|||
163133448|NCT02461745|589195853|FG001|Overall Study|Lost to Follow-up|2|||
163133449|NCT02461745|589195852|FG000|Overall Study|Withdrawal by Subject|3|||
163133450|NCT02461745|589195853|FG001|Overall Study|Withdrawal by Subject|1|||
163133451|NCT02921087|589195854|FG000|Overall Study|Withdrawal by Subject|0|||
163133452|NCT02921087|589195855|FG001|Overall Study|Withdrawal by Subject|1|||
163133453|NCT05128578|589197472|FG000|Overall Study|Withdrawal by Subject|9|||
163133454|NCT05128578|589197472|FG000|Overall Study|Lost to Follow-up|5|||
163133455|NCT01128244|589197473|FG000|Overall Study|Adverse Event|1|||
163133456|NCT01128244|589197473|FG000|Overall Study|Scheduling conflict|2|||
163133457|NCT02837029|589197474|FG000|Screening|Failed to meet screening requirements.|7|||
163133458|NCT02837029|589197475|FG001|Screening|Failed to meet screening requirements.|3|||
163133459|NCT02837029|589197476|FG002|Screening|Failed to meet screening requirements.|0|||
163133460|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
163133461|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
163133462|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
163133463|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
163133464|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
163133465|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
163133466|NCT02837029|589197474|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
163133467|NCT02837029|589197475|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
163133468|NCT02837029|589197476|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
163133469|NCT02837029|589197474|FG000|Cycle 2 and Beyond|Adverse Event|1|||
163133470|NCT02837029|589197475|FG001|Cycle 2 and Beyond|Adverse Event|0|||
163133471|NCT02837029|589197476|FG002|Cycle 2 and Beyond|Adverse Event|0|||
163133472|NCT02837029|589197474|FG000|2 Year Follow-up|Death|6|||
163133473|NCT02837029|589197475|FG001|2 Year Follow-up|Death|7|||
163133474|NCT02837029|589197476|FG002|2 Year Follow-up|Death|0|||
163133475|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
163133476|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
163133477|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
163133478|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
163133479|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
163133480|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
163133481|NCT01363908|589197477|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
163133482|NCT01363908|589197478|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
163133483|NCT05258149|589197479|FG000|Period 1|Protocol Deviation|1|||
163133484|NCT05258149|589197480|FG001|Period 1|Protocol Deviation|0|||
163133485|NCT05258149|589197479|FG000|Period 1|Adverse Event|0|||
163133486|NCT05258149|589197480|FG001|Period 1|Adverse Event|1|||
163133487|NCT05258149|589197479|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
163133488|NCT05258149|589197480|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163133489|NCT05258149|589197479|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
163133490|NCT05258149|589197480|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
163133491|NCT05258149|589197479|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
163133492|NCT05258149|589197480|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
163133493|NCT03437577|589197483|FG000|Pre-Randomization|Withdrawal by Subject|0|||
163133494|NCT03437577|589197484|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163133495|NCT03437577|589197485|FG002|Pre-Randomization|Withdrawal by Subject|10|||
163133496|NCT03437577|589197483|FG000|Post-Randomization|Physician Decision|0|||
163133497|NCT03437577|589197484|FG001|Post-Randomization|Physician Decision|2|||
163133498|NCT03437577|589197485|FG002|Post-Randomization|Physician Decision|0|||
163133499|NCT04273893|589197493|FG000|Overall Study|Withdrawal by Subject|0|||
163133500|NCT04273893|589197494|FG001|Overall Study|Withdrawal by Subject|2|||
163133501|NCT04273893|589197493|FG000|Overall Study|Treatment of Disease Progression|0|||
163133502|NCT04273893|589197494|FG001|Overall Study|Treatment of Disease Progression|2|||
163133503|NCT04273893|589197493|FG000|Overall Study|Death|1|||
163133504|NCT04273893|589197494|FG001|Overall Study|Death|2|||
163133505|NCT04273893|589197493|FG000|Overall Study|Lost to Follow-up|0|||
163133506|NCT04273893|589197494|FG001|Overall Study|Lost to Follow-up|2|||
163133507|NCT04273893|589197493|FG000|Overall Study|Physician Decision|1|||
163133508|NCT04273893|589197494|FG001|Overall Study|Physician Decision|0|||
163133509|NCT00100789|589197499|FG000|Overall Study|Adverse Event|10|||
163133510|NCT00100789|589197499|FG000|Overall Study|Withdrawal by Subject|1|||
163133511|NCT00100789|589197499|FG000|Overall Study|Progression/relapse|42|||
163133512|NCT00100789|589197499|FG000|Overall Study|Death|2|||
163133513|NCT00100789|589197499|FG000|Overall Study|Not protocol specified|5|||
163133514|NCT00100789|589197499|FG000|Overall Study|Ineligible|3|||
163133515|NCT00100789|589197499|FG000|Overall Study|Never received treatment|1|||
163133516|NCT02936843|589197500|FG000|Overall Study|Lost to Follow-up|3|||
163133517|NCT02936843|589197501|FG001|Overall Study|Lost to Follow-up|1|||
163133518|NCT02936843|589197500|FG000|Overall Study|Withdrawal by Subject|1|||
163133519|NCT02936843|589197501|FG001|Overall Study|Withdrawal by Subject|1|||
163133520|NCT01393821|589197502|FG000|Overall Study|Cancel|1|||
163133521|NCT01393821|589197503|FG001|Overall Study|Cancel|1|||
163133522|NCT01393821|589197502|FG000|Overall Study|not evaluable for primary endpoint|4|||
163133523|NCT01393821|589197503|FG001|Overall Study|not evaluable for primary endpoint|2|||
163133524|NCT01948063|589197515|FG000|Overall Study|Boston MCI halted research protocol|0|||
163133525|NCT01948063|589197516|FG001|Overall Study|Boston MCI halted research protocol|1|||
163133526|NCT01948063|589197515|FG000|Overall Study|Discovered an enrollment in other study|0|||
163133527|NCT01948063|589197516|FG001|Overall Study|Discovered an enrollment in other study|1|||
163133528|NCT01948063|589197515|FG000|Overall Study|Blood samples were accidentally thawed|1|||
163133529|NCT01948063|589197516|FG001|Overall Study|Blood samples were accidentally thawed|0|||
163133530|NCT00880191|589197524|FG000|Overall Study|Refused further treatment|4|||
163133531|NCT00880191|589197525|FG001|Overall Study|Refused further treatment|1|||
163133532|NCT00880191|589197524|FG000|Overall Study|Adverse Event|8|||
163133533|NCT00880191|589197525|FG001|Overall Study|Adverse Event|6|||
163133534|NCT00880191|589197524|FG000|Overall Study|Hospitalization/efficacy|1|||
163133535|NCT00880191|589197525|FG001|Overall Study|Hospitalization/efficacy|1|||
163133536|NCT00773747|589197530|FG000|Overall Study|Lack of Efficacy|112|||
163133537|NCT00773747|589197531|FG001|Overall Study|Lack of Efficacy|144|||
163133538|NCT00773747|589197530|FG000|Overall Study|Physician Decision|26|||
163133539|NCT00773747|589197531|FG001|Overall Study|Physician Decision|18|||
163133540|NCT00773747|589197530|FG000|Overall Study|Lost to Follow-up|0|||
163133541|NCT00773747|589197531|FG001|Overall Study|Lost to Follow-up|1|||
163133542|NCT00773747|589197530|FG000|Overall Study|Protocol Violation|2|||
163133543|NCT00773747|589197531|FG001|Overall Study|Protocol Violation|2|||
163133544|NCT00773747|589197530|FG000|Overall Study|Withdrawal by Subject|89|||
163133545|NCT00773747|589197531|FG001|Overall Study|Withdrawal by Subject|61|||
163133546|NCT00773747|589197530|FG000|Overall Study|Adverse Event|61|||
163133547|NCT00773747|589197531|FG001|Overall Study|Adverse Event|62|||
163133548|NCT00773747|589197530|FG000|Overall Study|Death|5|||
163133549|NCT00773747|589197531|FG001|Overall Study|Death|8|||
163133550|NCT00773747|589197530|FG000|Overall Study|Not Treated|2|||
163133551|NCT00773747|589197531|FG001|Overall Study|Not Treated|0|||
163133552|NCT00836186|589197532|FG000|Overall Study|Blood could not be drawn|1|||
163133553|NCT04079816|589197533|FG000|Overall Study|Request of Subject|2|||
163133554|NCT04079816|589197533|FG000|Overall Study|Unable to draw samples|1|||
163133555|NCT03422536|589197534|FG000|Randomized|Physician Decision|1|||
163133556|NCT03422536|589197535|FG001|Randomized|Physician Decision|1|||
163133557|NCT03422536|589197534|FG000|Allocation - Received Intervention|Disease progression|19|||
163133558|NCT03422536|589197535|FG001|Allocation - Received Intervention|Disease progression|25|||
163133559|NCT03422536|589197534|FG000|Allocation - Received Intervention|Death|1|||
163133560|NCT03422536|589197535|FG001|Allocation - Received Intervention|Death|3|||
162658940|NCT02139644|587465799|FG001|Treatment Period|Lack of Efficacy|0|||
162658941|NCT02139644|587465800|FG002|Treatment Period|Lack of Efficacy|1|||
163133561|NCT03422536|589197534|FG000|Allocation - Received Intervention|Adverse Event|1|||
163133562|NCT03422536|589197535|FG001|Allocation - Received Intervention|Adverse Event|0|||
163133563|NCT03422536|589197534|FG000|Allocation - Received Intervention|Physician Decision|1|||
163133564|NCT03422536|589197535|FG001|Allocation - Received Intervention|Physician Decision|1|||
163133565|NCT03422536|589197534|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
163133566|NCT03422536|589197535|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
163133567|NCT03422536|589197534|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
163133568|NCT03422536|589197535|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
163133569|NCT01973998|589197536|FG000|Overall Study|Death|2|||
163133570|NCT01973998|589197537|FG001|Overall Study|Death|2|||
163133571|NCT01636986|589197540|FG000|Overall Study|Withdrawal by Subject|0|||
163133572|NCT01636986|589197541|FG001|Overall Study|Withdrawal by Subject|1|||
162658942|NCT02139644|587465801|FG003|Treatment Period|Lack of Efficacy|0|||
162658943|NCT02139644|587465802|FG004|Treatment Period|Lack of Efficacy|1|||
162719866|NCT00536380|587680603|FG001|Overall Study|Administrative|0|||
162719867|NCT00536380|587680604|FG002|Overall Study|Administrative|1|||
162658944|NCT02139644|587465803|FG005|Treatment Period|Lack of Efficacy|4|||
162658945|NCT02139644|587465798|FG000|Treatment Period|Other|0|||
162658946|NCT02139644|587465799|FG001|Treatment Period|Other|3|||
162658947|NCT02139644|587465800|FG002|Treatment Period|Other|1|||
162658948|NCT02139644|587465801|FG003|Treatment Period|Other|1|||
162658949|NCT02139644|587465802|FG004|Treatment Period|Other|0|||
162658950|NCT02139644|587465803|FG005|Treatment Period|Other|1|||
162658951|NCT00630877|587465806|FG000|Overall Study|Adverse Event|11|||
162658952|NCT00630877|587465807|FG001|Overall Study|Adverse Event|8|||
162658953|NCT00630877|587465808|FG002|Overall Study|Adverse Event|7|||
162658954|NCT00630877|587465806|FG000|Overall Study|Withdrawal by Subject|3|||
162658955|NCT00630877|587465807|FG001|Overall Study|Withdrawal by Subject|4|||
162658956|NCT00630877|587465808|FG002|Overall Study|Withdrawal by Subject|0|||
162658957|NCT00630877|587465806|FG000|Overall Study|Lost to Follow-up|2|||
162658958|NCT00630877|587465807|FG001|Overall Study|Lost to Follow-up|0|||
162658959|NCT00630877|587465808|FG002|Overall Study|Lost to Follow-up|0|||
162658960|NCT00630877|587465806|FG000|Overall Study|Noncompliance|2|||
162658961|NCT00630877|587465807|FG001|Overall Study|Noncompliance|3|||
162658962|NCT00630877|587465808|FG002|Overall Study|Noncompliance|1|||
163133573|NCT01636986|589197540|FG000|Overall Study|Corneal Staining|0|||
163133574|NCT01636986|589197541|FG001|Overall Study|Corneal Staining|1|||
163133575|NCT02160145|589197544|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
163133576|NCT02160145|589197545|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
163133577|NCT02160145|589197546|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
163133578|NCT02160145|589197544|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
163133579|NCT02160145|589197545|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
163133580|NCT02160145|589197546|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
163133581|NCT02160145|589197544|FG000|Randomized Double-blind Period|Subject decision|0|||
163133582|NCT02160145|589197545|FG001|Randomized Double-blind Period|Subject decision|21|||
163133583|NCT02160145|589197546|FG002|Randomized Double-blind Period|Subject decision|20|||
163133584|NCT02160145|589197544|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
163133585|NCT02160145|589197545|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
163133586|NCT02160145|589197546|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
163133587|NCT02160145|589197544|FG000|Randomized Double-blind Period|Physician Decision|0|||
163133588|NCT02160145|589197545|FG001|Randomized Double-blind Period|Physician Decision|7|||
163133589|NCT02160145|589197546|FG002|Randomized Double-blind Period|Physician Decision|5|||
163133590|NCT00705146|589197550|FG000|Overall Study|Lost to Follow-up|1|||
163133591|NCT00705146|589197551|FG001|Overall Study|Lost to Follow-up|1|||
163133592|NCT01620528|589197552|FG000|Treatment Period|Did Not Receive Study Drug|0|||
163133593|NCT01620528|589197553|FG001|Treatment Period|Did Not Receive Study Drug|0|||
163133594|NCT01620528|589197554|FG002|Treatment Period|Did Not Receive Study Drug|1|||
163133595|NCT01620528|589197552|FG000|Treatment Period|Withdrawal by Subject|35|||
163133596|NCT01620528|589197553|FG001|Treatment Period|Withdrawal by Subject|21|||
163133597|NCT01620528|589197554|FG002|Treatment Period|Withdrawal by Subject|16|||
163133598|NCT01620528|589197552|FG000|Treatment Period|Adverse Event|17|||
163133599|NCT01620528|589197553|FG001|Treatment Period|Adverse Event|13|||
163133600|NCT01620528|589197554|FG002|Treatment Period|Adverse Event|21|||
163133601|NCT01620528|589197552|FG000|Treatment Period|Lost to Follow-up|16|||
163133602|NCT01620528|589197553|FG001|Treatment Period|Lost to Follow-up|8|||
163133603|NCT01620528|589197554|FG002|Treatment Period|Lost to Follow-up|14|||
163133604|NCT01620528|589197552|FG000|Treatment Period|Other|9|||
163133605|NCT01620528|589197553|FG001|Treatment Period|Other|5|||
163133606|NCT01620528|589197554|FG002|Treatment Period|Other|7|||
163133607|NCT01620528|589197552|FG000|Treatment Period|Subject Noncompliant|11|||
163133608|NCT01620528|589197553|FG001|Treatment Period|Subject Noncompliant|2|||
163133609|NCT01620528|589197554|FG002|Treatment Period|Subject Noncompliant|2|||
163133610|NCT01620528|589197552|FG000|Treatment Period|Pregnancy|7|||
163133611|NCT01620528|589197553|FG001|Treatment Period|Pregnancy|2|||
163133612|NCT01620528|589197554|FG002|Treatment Period|Pregnancy|2|||
163133613|NCT01620528|589197552|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
163133614|NCT01620528|589197553|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
163133615|NCT01620528|589197554|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
163133616|NCT01620528|589197552|FG000|Treatment Period|Exclusionary Medication Received|0|||
163133617|NCT01620528|589197553|FG001|Treatment Period|Exclusionary Medication Received|1|||
163133618|NCT01620528|589197554|FG002|Treatment Period|Exclusionary Medication Received|0|||
163133619|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
163133620|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
163133621|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
163133622|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
163133623|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163133624|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163133625|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
163133626|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
163133627|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
163133628|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
163133629|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
163133630|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
163133631|NCT01620528|589197552|FG000|Post-Treatment Follow-Up Period|Other|6|||
163133632|NCT01620528|589197553|FG001|Post-Treatment Follow-Up Period|Other|4|||
163133633|NCT01620528|589197554|FG002|Post-Treatment Follow-Up Period|Other|2|||
163133634|NCT01457846|589197561|FG000|Overall Study|Death before treatment|1|||
163133635|NCT01457846|589197562|FG001|Overall Study|Death before treatment|2|||
163133636|NCT01457846|589197561|FG000|Overall Study|Did not receive treatment|0|||
163133637|NCT01457846|589197562|FG001|Overall Study|Did not receive treatment|1|||
163133638|NCT01457846|589197561|FG000|Overall Study|Death|27|||
163133639|NCT01457846|589197562|FG001|Overall Study|Death|16|||
163133640|NCT01457846|589197561|FG000|Overall Study|Unclassified reason for not completed|11|||
163133641|NCT01457846|589197562|FG001|Overall Study|Unclassified reason for not completed|10|||
163133642|NCT01457846|589197561|FG000|Overall Study|Withdrawal by Subject|1|||
163133643|NCT01457846|589197562|FG001|Overall Study|Withdrawal by Subject|1|||
163133644|NCT01457846|589197561|FG000|Overall Study|Lost to Follow-up|1|||
163133645|NCT01457846|589197562|FG001|Overall Study|Lost to Follow-up|0|||
163133646|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
163133647|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
163133648|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
163133649|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
163133650|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
163133651|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
163133652|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
163133653|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
163133654|NCT00383162|589197563|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
163133655|NCT00383162|589197564|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
163133656|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
163133657|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
163133658|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
163133659|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
163133660|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
163133661|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
163133662|NCT00383162|589197563|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
163133663|NCT00383162|589197564|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
163133664|NCT01153698|589197565|FG000|Overall Study|Adverse Event|12|||
163133665|NCT01153698|589197565|FG000|Overall Study|Lost to Follow-up|4|||
163133666|NCT01153698|589197565|FG000|Overall Study|Withdrawal by Subject|2|||
163133667|NCT01153698|589197565|FG000|Overall Study|Switch to other anticoagulants|4|||
163133668|NCT01153698|589197565|FG000|Overall Study|Other|2|||
163133669|NCT01153698|589197565|FG000|Overall Study|Not treated with Pradaxa|5|||
163133670|NCT05392803|589197568|FG000|Overall Study|Lost to Follow-up|0|||
163133671|NCT05392803|589197569|FG001|Overall Study|Lost to Follow-up|2|||
163133672|NCT01240135|589197570|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
163133673|NCT01240135|589197571|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
163133674|NCT01240135|589197570|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
163133675|NCT01240135|589197571|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
163133676|NCT02220712|589197572|FG000|Overall Study|Adverse Event|1|||
163133677|NCT02220712|589197572|FG000|Overall Study|Withdrawal by Subject|2|||
163133678|NCT02220712|589197572|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
163133679|NCT00760838|589197576|FG000|Overall Study|Adverse Event|1|||
163133680|NCT00760838|589197577|FG001|Overall Study|Adverse Event|1|||
163133681|NCT00760838|589197576|FG000|Overall Study|Lack of Efficacy|1|||
163133682|NCT00760838|589197577|FG001|Overall Study|Lack of Efficacy|0|||
163133683|NCT00760838|589197576|FG000|Overall Study|Lost to Follow-up|2|||
163133684|NCT00760838|589197577|FG001|Overall Study|Lost to Follow-up|0|||
163133685|NCT00760838|589197576|FG000|Overall Study|Withdrawal by Subject|1|||
163133686|NCT00760838|589197577|FG001|Overall Study|Withdrawal by Subject|1|||
163133687|NCT00923845|589197578|FG000|Induction Therapy|Poor performance status|0|||
163133688|NCT00923845|589197579|FG001|Induction Therapy|Poor performance status|2|||
163133689|NCT01743040|589197584|FG000|Overall Study|Death|1|||
163133690|NCT01743040|589197584|FG000|Overall Study|Lost to Follow-up|66|||
163133691|NCT01743040|589197584|FG000|Overall Study|Physician Decision|40|||
163133692|NCT01743040|589197584|FG000|Overall Study|Protocol Violation|1|||
163133693|NCT01743040|589197584|FG000|Overall Study|Withdrawal by Subject|121|||
163133694|NCT04378114|589197585|FG000|Overall Study|Withdrawal by Subject|5|||
163133695|NCT00392990|589197587|FG000|Treatment on Study|Adverse Event|3|||
163133696|NCT00392990|589197588|FG001|Treatment on Study|Adverse Event|1|||
163133697|NCT00392990|589197587|FG000|Follow up for 2 Years|Death|4|||
163133698|NCT00392990|589197588|FG001|Follow up for 2 Years|Death|0|||
163133699|NCT00825812|589197592|FG000|Overall Study|Never entered follow up|0|||
163133700|NCT00825812|589197593|FG001|Overall Study|Never entered follow up|0|||
163133701|NCT00825812|589197594|FG002|Overall Study|Never entered follow up|0|||
163133702|NCT00825812|589197595|FG003|Overall Study|Never entered follow up|1|||
163133703|NCT00825812|589197592|FG000|Overall Study|Adverse Event|0|||
163133704|NCT00825812|589197593|FG001|Overall Study|Adverse Event|0|||
163133705|NCT00825812|589197594|FG002|Overall Study|Adverse Event|0|||
163133706|NCT00825812|589197595|FG003|Overall Study|Adverse Event|1|||
163133707|NCT00825812|589197592|FG000|Overall Study|Subject withdrew consent|0|||
163133708|NCT00825812|589197593|FG001|Overall Study|Subject withdrew consent|0|||
163133709|NCT00825812|589197594|FG002|Overall Study|Subject withdrew consent|3|||
163133710|NCT00825812|589197595|FG003|Overall Study|Subject withdrew consent|2|||
163133711|NCT00825812|589197592|FG000|Overall Study|Non-compliance with protocol|0|||
163133712|NCT00825812|589197593|FG001|Overall Study|Non-compliance with protocol|0|||
163133713|NCT00825812|589197594|FG002|Overall Study|Non-compliance with protocol|0|||
163133714|NCT00825812|589197595|FG003|Overall Study|Non-compliance with protocol|1|||
163133715|NCT00825812|589197592|FG000|Overall Study|Administrative|0|||
163133716|NCT00825812|589197593|FG001|Overall Study|Administrative|1|||
163133717|NCT00825812|589197594|FG002|Overall Study|Administrative|3|||
163133718|NCT00825812|589197595|FG003|Overall Study|Administrative|5|||
163133719|NCT00991406|589197597|FG000|Overall Study|One participant did not respond to FES.|1|||
163133720|NCT00986362|589197598|FG000|Overall Study|Death|2|||
163133721|NCT00986362|589197599|FG001|Overall Study|Death|0|||
163133722|NCT00986362|589197598|FG000|Overall Study|Lost to Follow-up|0|||
163133723|NCT00986362|589197599|FG001|Overall Study|Lost to Follow-up|1|||
163133724|NCT03755661|589197604|FG000|Overall Study|Lost to Follow-up|1|||
163133725|NCT03755661|589197605|FG001|Overall Study|Lost to Follow-up|0|||
163133726|NCT02038075|589197606|FG000|Overall Study|Withdrawal by Subject|3|||
163133727|NCT02038075|589197607|FG001|Overall Study|Withdrawal by Subject|0|||
163133728|NCT04000581|589197608|FG000|Overall Study|Withdrawal by Subject|0|||
163133729|NCT04000581|589197609|FG001|Overall Study|Withdrawal by Subject|1|||
163133730|NCT00895453|589197613|FG000|Overall Study|Lost to Follow-up|25|||
163133731|NCT00895453|589197614|FG001|Overall Study|Lost to Follow-up|25|||
163133732|NCT00895453|589197615|FG002|Overall Study|Lost to Follow-up|23|||
163133733|NCT02519595|589197616|FG000|Overall Study|Protocol Violation|8|||
163133734|NCT02519595|589197617|FG001|Overall Study|Protocol Violation|22|||
163133735|NCT02519595|589197618|FG002|Overall Study|Protocol Violation|16|||
163133736|NCT03188510|589197621|FG000|Overall Study|Inappropriate behavior with site staff|0|||
163133737|NCT03188510|589197622|FG001|Overall Study|Inappropriate behavior with site staff|1|||
163133738|NCT03188510|589197623|FG002|Overall Study|Inappropriate behavior with site staff|0|||
163133739|NCT01736618|589197626|FG000|Overall Study|Death|294|||
163133740|NCT01736618|589197626|FG000|Overall Study|Lost to Follow-up|193|||
163133741|NCT01736618|589197626|FG000|Overall Study|Withdrawal by Subject|54|||
163133742|NCT01736618|589197626|FG000|Overall Study|Subject unable to be followed at study location|223|||
163133743|NCT01736618|589197626|FG000|Overall Study|Physician Decision|33|||
163133744|NCT01736618|589197626|FG000|Overall Study|Transplant or removal of target organ|19|||
163133745|NCT01736618|589197626|FG000|Overall Study|Change in indication or condition|78|||
163133746|NCT01736618|589197626|FG000|Overall Study|Study device explant|103|||
163133747|NCT01736618|589197626|FG000|Overall Study|Unable to complete implant|2|||
163133748|NCT04167137|589197628|FG000|Overall Study|Disease progression|1|||
163133749|NCT04167137|589197629|FG001|Overall Study|Disease progression|1|||
163133750|NCT04167137|589197630|FG002|Overall Study|Disease progression|3|||
163133751|NCT04167137|589197631|FG003|Overall Study|Disease progression|3|||
163133752|NCT04167137|589197632|FG004|Overall Study|Disease progression|2|||
163133753|NCT04167137|589197633|FG005|Overall Study|Disease progression|3|||
163133754|NCT04167137|589197634|FG006|Overall Study|Disease progression|2|||
163133755|NCT04167137|589197635|FG007|Overall Study|Disease progression|2|||
163133756|NCT04167137|589197628|FG000|Overall Study|Withdrawal by Subject|1|||
163133757|NCT04167137|589197629|FG001|Overall Study|Withdrawal by Subject|0|||
163133758|NCT04167137|589197630|FG002|Overall Study|Withdrawal by Subject|0|||
163133759|NCT04167137|589197631|FG003|Overall Study|Withdrawal by Subject|1|||
163133760|NCT04167137|589197632|FG004|Overall Study|Withdrawal by Subject|0|||
163133761|NCT04167137|589197633|FG005|Overall Study|Withdrawal by Subject|2|||
163133762|NCT04167137|589197634|FG006|Overall Study|Withdrawal by Subject|1|||
163133763|NCT04167137|589197635|FG007|Overall Study|Withdrawal by Subject|0|||
163133764|NCT04167137|589197628|FG000|Overall Study|Adverse Event|0|||
163133765|NCT04167137|589197629|FG001|Overall Study|Adverse Event|0|||
163133766|NCT04167137|589197630|FG002|Overall Study|Adverse Event|0|||
163133767|NCT04167137|589197631|FG003|Overall Study|Adverse Event|0|||
163133768|NCT04167137|589197632|FG004|Overall Study|Adverse Event|0|||
163133769|NCT04167137|589197633|FG005|Overall Study|Adverse Event|1|||
163133770|NCT04167137|589197634|FG006|Overall Study|Adverse Event|0|||
163133771|NCT04167137|589197635|FG007|Overall Study|Adverse Event|1|||
163133772|NCT04167137|589197628|FG000|Overall Study|Physician Decision|0|||
163133773|NCT04167137|589197629|FG001|Overall Study|Physician Decision|0|||
163133774|NCT04167137|589197630|FG002|Overall Study|Physician Decision|0|||
163133775|NCT04167137|589197631|FG003|Overall Study|Physician Decision|1|||
162658963|NCT00630877|587465806|FG000|Overall Study|Protocol violation|1|||
163133776|NCT04167137|589197632|FG004|Overall Study|Physician Decision|0|||
163133777|NCT04167137|589197633|FG005|Overall Study|Physician Decision|0|||
163133778|NCT04167137|589197634|FG006|Overall Study|Physician Decision|1|||
163133779|NCT04167137|589197635|FG007|Overall Study|Physician Decision|0|||
163133780|NCT04167137|589197628|FG000|Overall Study|Death|0|||
163133781|NCT04167137|589197629|FG001|Overall Study|Death|1|||
162658964|NCT00630877|587465807|FG001|Overall Study|Protocol violation|0|||
163133782|NCT04167137|589197630|FG002|Overall Study|Death|0|||
163133783|NCT04167137|589197631|FG003|Overall Study|Death|0|||
163133784|NCT04167137|589197632|FG004|Overall Study|Death|0|||
163133785|NCT04167137|589197633|FG005|Overall Study|Death|0|||
162658965|NCT00630877|587465808|FG002|Overall Study|Protocol violation|1|||
163133786|NCT04167137|589197634|FG006|Overall Study|Death|0|||
163133787|NCT04167137|589197635|FG007|Overall Study|Death|0|||
163133788|NCT04167137|589197628|FG000|Overall Study|Study terminated by Sponsor|0|||
163133789|NCT04167137|589197629|FG001|Overall Study|Study terminated by Sponsor|0|||
163133790|NCT04167137|589197630|FG002|Overall Study|Study terminated by Sponsor|0|||
163133791|NCT04167137|589197631|FG003|Overall Study|Study terminated by Sponsor|0|||
163133792|NCT04167137|589197632|FG004|Overall Study|Study terminated by Sponsor|0|||
163133793|NCT04167137|589197633|FG005|Overall Study|Study terminated by Sponsor|0|||
163133794|NCT04167137|589197634|FG006|Overall Study|Study terminated by Sponsor|0|||
163133795|NCT04167137|589197635|FG007|Overall Study|Study terminated by Sponsor|1|||
163133796|NCT00211887|589197638|FG000|Overall Study|Adverse Event|8|||
163133797|NCT00211887|589197639|FG001|Overall Study|Adverse Event|4|||
163133798|NCT00211887|589197640|FG002|Overall Study|Adverse Event|6|||
163133799|NCT00211887|589197638|FG000|Overall Study|Death|1|||
163133800|NCT00211887|589197639|FG001|Overall Study|Death|1|||
163133801|NCT00211887|589197640|FG002|Overall Study|Death|1|||
163133802|NCT00211887|589197638|FG000|Overall Study|Lost to Follow-up|28|||
163133803|NCT00211887|589197639|FG001|Overall Study|Lost to Follow-up|13|||
163133804|NCT00211887|589197640|FG002|Overall Study|Lost to Follow-up|9|||
163133805|NCT00211887|589197638|FG000|Overall Study|Non-medical reason|31|||
163133806|NCT00211887|589197639|FG001|Overall Study|Non-medical reason|14|||
163133807|NCT00211887|589197640|FG002|Overall Study|Non-medical reason|8|||
163133808|NCT00211887|589197638|FG000|Overall Study|Other medical reason|15|||
163133809|NCT00211887|589197639|FG001|Overall Study|Other medical reason|11|||
163133810|NCT00211887|589197640|FG002|Overall Study|Other medical reason|7|||
163133811|NCT00211887|589197638|FG000|Overall Study|Side effects|19|||
163133812|NCT00211887|589197639|FG001|Overall Study|Side effects|13|||
163133813|NCT00211887|589197640|FG002|Overall Study|Side effects|5|||
163133814|NCT03058692|589200018|FG000|Overall Study|Lost to Follow-up|2|||
163133815|NCT03058692|589200019|FG001|Overall Study|Lost to Follow-up|1|||
163133816|NCT03058692|589200018|FG000|Overall Study|Withdrawal by Subject|1|||
163133817|NCT03058692|589200019|FG001|Overall Study|Withdrawal by Subject|1|||
163133818|NCT05111249|589200024|FG000|Overall Study|Lost to Follow-up|0|||
163133819|NCT05111249|589200025|FG001|Overall Study|Lost to Follow-up|2|||
163133820|NCT05111249|589200024|FG000|Overall Study|Physician Decision|0|||
163133821|NCT05111249|589200025|FG001|Overall Study|Physician Decision|1|||
163133822|NCT05111249|589200024|FG000|Overall Study|Participant decision|1|||
163133823|NCT05111249|589200025|FG001|Overall Study|Participant decision|5|||
163133824|NCT01702025|589200033|FG000|Overall Study|Equipment failure|1|||
163133825|NCT01702025|589200034|FG001|Overall Study|Equipment failure|0|||
163133826|NCT01702025|589200035|FG002|Overall Study|Equipment failure|0|||
163133827|NCT01702025|589200036|FG003|Overall Study|Equipment failure|0|||
163133828|NCT01702025|589200033|FG000|Overall Study|Adverse Event|1|||
163133829|NCT01702025|589200034|FG001|Overall Study|Adverse Event|1|||
163133830|NCT01702025|589200035|FG002|Overall Study|Adverse Event|1|||
163133831|NCT01702025|589200036|FG003|Overall Study|Adverse Event|0|||
163133832|NCT02679755|589200037|FG000|Overall Study|Death|0|||
163133833|NCT02679755|589200038|FG001|Overall Study|Death|3|||
163133834|NCT02679755|589200037|FG000|Overall Study|Global deterioration of health status|1|||
163133835|NCT02679755|589200038|FG001|Overall Study|Global deterioration of health status|8|||
163133836|NCT02679755|589200037|FG000|Overall Study|Lost to Follow-up|1|||
163133837|NCT02679755|589200038|FG001|Overall Study|Lost to Follow-up|0|||
163133838|NCT02679755|589200037|FG000|Overall Study|Objective progression or relapse|24|||
163133839|NCT02679755|589200038|FG001|Overall Study|Objective progression or relapse|83|||
163133840|NCT02679755|589200037|FG000|Overall Study|Not defined|0|||
163133841|NCT02679755|589200038|FG001|Overall Study|Not defined|2|||
163133842|NCT02679755|589200037|FG000|Overall Study|Withdrawal by participant|6|||
163133843|NCT02679755|589200038|FG001|Overall Study|Withdrawal by participant|3|||
163133844|NCT02679755|589200037|FG000|Overall Study|Adverse Event|1|||
163133845|NCT02679755|589200038|FG001|Overall Study|Adverse Event|4|||
163133846|NCT02679755|589200037|FG000|Overall Study|Adverse events not related to study drug|1|||
163133847|NCT02679755|589200038|FG001|Overall Study|Adverse events not related to study drug|2|||
163133848|NCT01061359|589200039|FG000|Overall Study|Death|32|||
163133849|NCT01061359|589200039|FG000|Overall Study|Lost to Follow-up|1072|||
163133850|NCT01061359|589200039|FG000|Overall Study|Relapse|187|||
162658966|NCT00630877|587465806|FG000|Overall Study|Personal reasons|0|||
162658967|NCT00630877|587465807|FG001|Overall Study|Personal reasons|0|||
162658968|NCT00630877|587465808|FG002|Overall Study|Personal reasons|1|||
163133851|NCT01061359|589200039|FG000|Overall Study|Secondary neoplasm|11|||
163133852|NCT03038126|589200041|FG000|Overall Study|Death|1|||
163133853|NCT03038126|589200042|FG001|Overall Study|Death|1|||
163133854|NCT03038126|589200041|FG000|Overall Study|Withdrawal by Subject|5|||
163133855|NCT03038126|589200042|FG001|Overall Study|Withdrawal by Subject|0|||
163133856|NCT03038126|589200041|FG000|Overall Study|Lost to Follow-up|0|||
163133857|NCT03038126|589200042|FG001|Overall Study|Lost to Follow-up|1|||
163133858|NCT03038126|589200041|FG000|Overall Study|Long Term Hospitalization|2|||
163133859|NCT03038126|589200042|FG001|Overall Study|Long Term Hospitalization|0|||
163133860|NCT03038126|589200041|FG000|Overall Study|Too Ill to Participate|1|||
163133861|NCT03038126|589200042|FG001|Overall Study|Too Ill to Participate|2|||
162658969|NCT01312909|587465809|FG000|Overall Study|Randomized but not treated|1|||
162658970|NCT01312909|587465810|FG001|Overall Study|Randomized but not treated|3|||
163133862|NCT02610777|589200043|FG000|Overall Study|Lost to Follow-up|1|||
163133863|NCT02610777|589200044|FG001|Overall Study|Lost to Follow-up|0|||
163133864|NCT02610777|589200043|FG000|Overall Study|Site Terminated by Sponsor|9|||
163133865|NCT02610777|589200044|FG001|Overall Study|Site Terminated by Sponsor|8|||
162658971|NCT01312909|587465811|FG002|Overall Study|Randomized but not treated|1|||
163133866|NCT02610777|589200043|FG000|Overall Study|Withdrawal by Subject|2|||
163133867|NCT02610777|589200044|FG001|Overall Study|Withdrawal by Subject|2|||
163133868|NCT02610777|589200043|FG000|Overall Study|Reason not Specified|0|||
163133869|NCT02610777|589200044|FG001|Overall Study|Reason not Specified|1|||
163133870|NCT02610777|589200043|FG000|Overall Study|Death|50|||
163133871|NCT02610777|589200044|FG001|Overall Study|Death|47|||
163133872|NCT01724866|589200045|FG000|Overall Study|Adverse Event|0|||
163133873|NCT01724866|589200046|FG001|Overall Study|Adverse Event|0|||
163133874|NCT01724866|589200047|FG002|Overall Study|Adverse Event|1|||
163133875|NCT01724866|589200048|FG003|Overall Study|Adverse Event|1|||
163133876|NCT01724866|589200045|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133877|NCT01724866|589200046|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
163133878|NCT01724866|589200047|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133879|NCT01724866|589200048|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
163133880|NCT01724866|589200045|FG000|Overall Study|Investigator's Discretion|0|||
163133881|NCT01724866|589200046|FG001|Overall Study|Investigator's Discretion|1|||
163133882|NCT01724866|589200047|FG002|Overall Study|Investigator's Discretion|1|||
163133883|NCT01724866|589200048|FG003|Overall Study|Investigator's Discretion|0|||
163133884|NCT01724866|589200045|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
163133885|NCT01724866|589200046|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133886|NCT01724866|589200047|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133887|NCT01724866|589200048|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
163133888|NCT01724866|589200045|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
163133889|NCT01724866|589200046|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
163133890|NCT01724866|589200047|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
163133891|NCT01724866|589200048|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
163133892|NCT00411671|589200053|FG000|Overall Study|Adverse Event|15|||
163133893|NCT00411671|589200053|FG000|Overall Study|Death|2|||
163133894|NCT00411671|589200053|FG000|Overall Study|Lost to Follow-up|3|||
163133895|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
163133896|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133897|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133898|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133899|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163133900|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
163133901|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133902|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133903|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133904|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163133905|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
163133906|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133907|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133908|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133909|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163133910|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
163133911|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133912|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133913|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133914|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163133915|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
163133916|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133917|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133918|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133919|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163133920|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
163133921|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133922|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133923|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133924|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163133925|NCT01173601|589200054|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
163133926|NCT01173601|589200055|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133927|NCT01173601|589200056|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133928|NCT01173601|589200057|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162658972|NCT01312909|587465809|FG000|Overall Study|Adverse Event|1|||
163133929|NCT01173601|589200058|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163133930|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163133931|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
163133932|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
163133933|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
163133934|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
163133935|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163133936|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
163133937|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
163133938|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
163133939|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
163133940|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163133941|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
163133942|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163133943|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
163133944|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
163133945|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163133946|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163133947|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163133948|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163133949|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163133950|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163133951|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
163133952|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163133953|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
163133954|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163133955|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163133956|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163133957|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
163133958|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
163133959|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
163133960|NCT01173601|589200054|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133961|NCT01173601|589200055|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133962|NCT01173601|589200056|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163133963|NCT01173601|589200057|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163133964|NCT01173601|589200058|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
163133965|NCT04737278|589200059|FG000|Overall Study|Lost to Follow-up|1|||
163133966|NCT04737278|589200060|FG001|Overall Study|Lost to Follow-up|1|||
163133967|NCT04737278|589200059|FG000|Overall Study|Withdrawal by Subject|1|||
163133968|NCT04737278|589200060|FG001|Overall Study|Withdrawal by Subject|0|||
163133969|NCT04737278|589200059|FG000|Overall Study|Protocol Violation|1|||
163133970|NCT04737278|589200060|FG001|Overall Study|Protocol Violation|1|||
163133971|NCT04737278|589200059|FG000|Overall Study|failure to complete questionnaire|1|||
162658973|NCT01312909|587465810|FG001|Overall Study|Adverse Event|0|||
162658974|NCT01312909|587465811|FG002|Overall Study|Adverse Event|3|||
163133972|NCT04737278|589200060|FG001|Overall Study|failure to complete questionnaire|1|||
163133973|NCT00546000|589200065|FG000|Overall Study|Adverse Event|1|||
163133974|NCT00546000|589200065|FG000|Overall Study|Lost to Follow-up|1|||
163133975|NCT00546000|589200065|FG000|Overall Study|Baseline HPA Axis Supression|2|||
163133976|NCT03688074|589200070|FG000|Overall Study|Adverse Event|0|||
163133977|NCT03688074|589200071|FG001|Overall Study|Adverse Event|1|||
163133978|NCT03688074|589200070|FG000|Overall Study|Other|1|||
163133979|NCT03688074|589200071|FG001|Overall Study|Other|0|||
163133980|NCT01362608|589200072|FG000|Overall Study|Protocol Violation|0|||
163133981|NCT01362608|589200073|FG001|Overall Study|Protocol Violation|1|||
163133982|NCT01362608|589200072|FG000|Overall Study|Lost to Follow-up|3|||
163133983|NCT01362608|589200073|FG001|Overall Study|Lost to Follow-up|1|||
163133984|NCT01362608|589200072|FG000|Overall Study|Withdrawal by Subject|1|||
163133985|NCT01362608|589200073|FG001|Overall Study|Withdrawal by Subject|2|||
163133986|NCT01362608|589200072|FG000|Overall Study|Lack of Efficacy|0|||
163133987|NCT01362608|589200073|FG001|Overall Study|Lack of Efficacy|2|||
163133988|NCT01362608|589200072|FG000|Overall Study|Adverse Event|0|||
163133989|NCT01362608|589200073|FG001|Overall Study|Adverse Event|2|||
163133990|NCT04171219|589200081|FG000|Overall Study|Adverse Event|1|||
163133991|NCT04171219|589200082|FG001|Overall Study|Adverse Event|0|||
163133992|NCT04171219|589200081|FG000|Overall Study|Death|0|||
163133993|NCT04171219|589200082|FG001|Overall Study|Death|1|||
163133994|NCT04171219|589200081|FG000|Overall Study|Lack of Efficacy|9|||
162658975|NCT01312909|587465809|FG000|Overall Study|Protocol Violation|2|||
162658976|NCT01312909|587465810|FG001|Overall Study|Protocol Violation|0|||
163133995|NCT04171219|589200082|FG001|Overall Study|Lack of Efficacy|13|||
163133996|NCT04171219|589200081|FG000|Overall Study|Withdrawal by Subject|1|||
163133997|NCT04171219|589200082|FG001|Overall Study|Withdrawal by Subject|2|||
163133998|NCT04171219|589200081|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
163133999|NCT04171219|589200082|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
163134000|NCT04171219|589200081|FG000|Overall Study|Clinical PD/Patient choice|1|||
163134001|NCT04171219|589200082|FG001|Overall Study|Clinical PD/Patient choice|0|||
163134002|NCT04171219|589200081|FG000|Overall Study|Toxicity/ Patient choice|1|||
163134003|NCT04171219|589200082|FG001|Overall Study|Toxicity/ Patient choice|0|||
163134004|NCT04809285|589200083|FG000|Phase 1|Lost to Follow-up|6|||
163134005|NCT04809285|589200083|FG000|Phase 1|Protocol Violation|2|||
163134006|NCT04809285|589200083|FG000|Phase 1|Physician Decision|3|||
163134007|NCT04809285|589200083|FG000|Phase 1|Withdrawal by Subject|29|||
163134008|NCT04809285|589200083|FG000|Phase 2|Protocol Violation|3|||
163134009|NCT04809285|589200083|FG000|Phase 2|Withdrawal by Subject|4|||
163134010|NCT03350815|589200084|FG000|Period 1|Adverse Event|10|||
163134011|NCT03350815|589200085|FG001|Period 1|Adverse Event|0|||
163134012|NCT03350815|589200086|FG002|Period 1|Adverse Event|0|||
163134013|NCT03350815|589200087|FG003|Period 1|Adverse Event|0|||
163134014|NCT03350815|589200084|FG000|Period 1|Technical problems|1|||
163134015|NCT03350815|589200085|FG001|Period 1|Technical problems|0|||
163134016|NCT03350815|589200086|FG002|Period 1|Technical problems|0|||
163134017|NCT03350815|589200087|FG003|Period 1|Technical problems|0|||
163134018|NCT03350815|589200084|FG000|Period 1|Lost to Follow-up|3|||
163134019|NCT03350815|589200085|FG001|Period 1|Lost to Follow-up|0|||
163134020|NCT03350815|589200086|FG002|Period 1|Lost to Follow-up|0|||
163134021|NCT03350815|589200087|FG003|Period 1|Lost to Follow-up|0|||
163134022|NCT03350815|589200084|FG000|Period 1|Physician Decision|1|||
163134023|NCT03350815|589200085|FG001|Period 1|Physician Decision|0|||
163134024|NCT03350815|589200086|FG002|Period 1|Physician Decision|0|||
163134025|NCT03350815|589200087|FG003|Period 1|Physician Decision|0|||
163134026|NCT03350815|589200084|FG000|Period 1|Withdrawal by Subject|8|||
163134027|NCT03350815|589200085|FG001|Period 1|Withdrawal by Subject|0|||
163134028|NCT03350815|589200086|FG002|Period 1|Withdrawal by Subject|0|||
163134029|NCT03350815|589200087|FG003|Period 1|Withdrawal by Subject|0|||
163134030|NCT03350815|589200084|FG000|Period 1|Lack of Efficacy|15|||
163134031|NCT03350815|589200085|FG001|Period 1|Lack of Efficacy|0|||
163134032|NCT03350815|589200086|FG002|Period 1|Lack of Efficacy|0|||
163134033|NCT03350815|589200087|FG003|Period 1|Lack of Efficacy|0|||
163134034|NCT03350815|589200084|FG000|Period 1|Non-compliance with study treatment|2|||
163134035|NCT03350815|589200085|FG001|Period 1|Non-compliance with study treatment|0|||
163134036|NCT03350815|589200086|FG002|Period 1|Non-compliance with study treatment|0|||
163134037|NCT03350815|589200087|FG003|Period 1|Non-compliance with study treatment|0|||
163134038|NCT03350815|589200084|FG000|Period 1|Protocol Violation|3|||
163134039|NCT03350815|589200085|FG001|Period 1|Protocol Violation|0|||
163134040|NCT03350815|589200086|FG002|Period 1|Protocol Violation|0|||
163134041|NCT03350815|589200087|FG003|Period 1|Protocol Violation|0|||
163134042|NCT03350815|589200084|FG000|Period 2|Adverse Event|0|||
163134043|NCT03350815|589200085|FG001|Period 2|Adverse Event|3|||
163134044|NCT03350815|589200086|FG002|Period 2|Adverse Event|5|||
163134045|NCT03350815|589200087|FG003|Period 2|Adverse Event|0|||
163134046|NCT03350815|589200084|FG000|Period 2|Technical problem|0|||
163134047|NCT03350815|589200085|FG001|Period 2|Technical problem|1|||
163134048|NCT03350815|589200086|FG002|Period 2|Technical problem|0|||
163134049|NCT03350815|589200087|FG003|Period 2|Technical problem|0|||
163134050|NCT03350815|589200084|FG000|Period 2|Lost to Follow-up|0|||
163134051|NCT03350815|589200085|FG001|Period 2|Lost to Follow-up|3|||
163134052|NCT03350815|589200086|FG002|Period 2|Lost to Follow-up|3|||
163134053|NCT03350815|589200087|FG003|Period 2|Lost to Follow-up|0|||
163134054|NCT03350815|589200084|FG000|Period 2|Physician Decision|0|||
163134055|NCT03350815|589200085|FG001|Period 2|Physician Decision|0|||
163134056|NCT03350815|589200086|FG002|Period 2|Physician Decision|1|||
163134057|NCT03350815|589200087|FG003|Period 2|Physician Decision|0|||
163134058|NCT03350815|589200084|FG000|Period 2|Withdrawal by Subject|0|||
163134059|NCT03350815|589200085|FG001|Period 2|Withdrawal by Subject|3|||
163134060|NCT03350815|589200086|FG002|Period 2|Withdrawal by Subject|4|||
162658977|NCT01312909|587465811|FG002|Overall Study|Protocol Violation|2|||
163134061|NCT03350815|589200087|FG003|Period 2|Withdrawal by Subject|0|||
163134062|NCT03350815|589200084|FG000|Period 2|Lack of Efficacy|0|||
163134063|NCT03350815|589200085|FG001|Period 2|Lack of Efficacy|6|||
163134064|NCT03350815|589200086|FG002|Period 2|Lack of Efficacy|2|||
163134065|NCT03350815|589200087|FG003|Period 2|Lack of Efficacy|0|||
163134066|NCT03350815|589200084|FG000|Period 2|Protocol Violation|0|||
162658978|NCT01312909|587465809|FG000|Overall Study|Other|9|||
162658979|NCT01312909|587465810|FG001|Overall Study|Other|6|||
163134067|NCT03350815|589200085|FG001|Period 2|Protocol Violation|0|||
163134068|NCT03350815|589200086|FG002|Period 2|Protocol Violation|1|||
163134069|NCT03350815|589200087|FG003|Period 2|Protocol Violation|0|||
163134070|NCT03350815|589200084|FG000|Period 2|New therapy for study indication|0|||
163134071|NCT03350815|589200085|FG001|Period 2|New therapy for study indication|0|||
163134072|NCT03350815|589200086|FG002|Period 2|New therapy for study indication|1|||
163134073|NCT03350815|589200087|FG003|Period 2|New therapy for study indication|0|||
163134074|NCT03526146|589200088|FG000|Overall Study|Lost to Follow-up|5|||
163134075|NCT03526146|589200088|FG000|Overall Study|Withdrawal by Subject|6|||
163134076|NCT03526146|589200088|FG000|Overall Study|class canceled due to COVID-19|4|||
162658980|NCT01312909|587465811|FG002|Overall Study|Other|11|||
162658981|NCT01312909|587465809|FG000|Overall Study|Withdrawal by Subject|8|||
162658982|NCT01312909|587465810|FG001|Overall Study|Withdrawal by Subject|10|||
163134077|NCT02828436|589200091|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
163134078|NCT02828436|589200092|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
163134079|NCT02828436|589200091|FG000|Period 1|Lost to Follow-up|0|||
163134080|NCT02828436|589200092|FG001|Period 1|Lost to Follow-up|1|||
163134081|NCT02828436|589200091|FG000|Period 2|Withdrawal by Subject|4|||
163134082|NCT02828436|589200092|FG001|Period 2|Withdrawal by Subject|0|||
163134083|NCT02828436|589200091|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
163134084|NCT02828436|589200092|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
163134085|NCT02828436|589200091|FG000|Period 2|Lost to Follow-up|1|||
163134086|NCT02828436|589200092|FG001|Period 2|Lost to Follow-up|0|||
163134087|NCT02644343|589200093|FG000|Overall Study|Withdrawal by Subject|1|||
163134088|NCT00536471|589200094|FG000|Overall Study|Lost to Follow-up|48|||
163134089|NCT00536471|589200095|FG001|Overall Study|Lost to Follow-up|23|||
163134090|NCT00536471|589200096|FG002|Overall Study|Lost to Follow-up|48|||
163134091|NCT00536471|589200097|FG003|Overall Study|Lost to Follow-up|22|||
163134092|NCT00536471|589200094|FG000|Overall Study|Adverse Event|32|||
163134093|NCT00536471|589200095|FG001|Overall Study|Adverse Event|16|||
163134094|NCT00536471|589200096|FG002|Overall Study|Adverse Event|28|||
163134095|NCT00536471|589200097|FG003|Overall Study|Adverse Event|13|||
163134096|NCT00536471|589200094|FG000|Overall Study|Withdrawal by Subject|40|||
163134097|NCT00536471|589200095|FG001|Overall Study|Withdrawal by Subject|24|||
163134098|NCT00536471|589200096|FG002|Overall Study|Withdrawal by Subject|43|||
163134099|NCT00536471|589200097|FG003|Overall Study|Withdrawal by Subject|21|||
163134100|NCT00536471|589200094|FG000|Overall Study|Lack of Efficacy|17|||
163134101|NCT00536471|589200095|FG001|Overall Study|Lack of Efficacy|18|||
163134102|NCT00536471|589200096|FG002|Overall Study|Lack of Efficacy|11|||
163134103|NCT00536471|589200097|FG003|Overall Study|Lack of Efficacy|9|||
163134104|NCT00536471|589200094|FG000|Overall Study|Protocol Violation|8|||
163134105|NCT00536471|589200095|FG001|Overall Study|Protocol Violation|1|||
163134106|NCT00536471|589200096|FG002|Overall Study|Protocol Violation|2|||
163134107|NCT00536471|589200097|FG003|Overall Study|Protocol Violation|3|||
163134108|NCT00536471|589200094|FG000|Overall Study|Physician Decision|11|||
163134109|NCT00536471|589200095|FG001|Overall Study|Physician Decision|1|||
163134110|NCT00536471|589200096|FG002|Overall Study|Physician Decision|3|||
163134111|NCT00536471|589200097|FG003|Overall Study|Physician Decision|2|||
163134112|NCT00536471|589200094|FG000|Overall Study|Death|0|||
163134113|NCT00536471|589200095|FG001|Overall Study|Death|0|||
163134114|NCT00536471|589200096|FG002|Overall Study|Death|1|||
163134115|NCT00536471|589200097|FG003|Overall Study|Death|2|||
163134116|NCT00536471|589200094|FG000|Overall Study|Sponsor Decision|0|||
163134117|NCT00536471|589200095|FG001|Overall Study|Sponsor Decision|1|||
163134118|NCT00536471|589200096|FG002|Overall Study|Sponsor Decision|3|||
163134119|NCT00536471|589200097|FG003|Overall Study|Sponsor Decision|2|||
163134120|NCT01442714|589200098|FG000|Overall Study|Death|11|||
163134121|NCT01442714|589200098|FG000|Overall Study|Withdrawal by Subject|1|||
163134122|NCT01979952|589200109|FG000|Overall Study|Adverse Event|4|||
163134123|NCT01979952|589200110|FG001|Overall Study|Adverse Event|5|||
163134124|NCT01979952|589200109|FG000|Overall Study|Protocol Violation|1|||
163134125|NCT01979952|589200110|FG001|Overall Study|Protocol Violation|0|||
163134126|NCT01979952|589200109|FG000|Overall Study|Withdrawal by Subject|2|||
163134127|NCT01979952|589200110|FG001|Overall Study|Withdrawal by Subject|1|||
163134128|NCT01979952|589200109|FG000|Overall Study|Other than specified above|1|||
163134129|NCT01979952|589200110|FG001|Overall Study|Other than specified above|0|||
163134130|NCT00203424|589200112|FG000|Treatment Period|Withdrawal by Subject|4|||
163134131|NCT00203424|589200112|FG000|Treatment Period|Adverse Event|5|||
163134132|NCT00203424|589200112|FG000|Treatment Period|progressive disease|2|||
163134133|NCT00203424|589200112|FG000|Follow-up Period|Withdrawal by Subject|1|||
163134134|NCT00203424|589200112|FG000|Follow-up Period|progressive disease|4|||
163134135|NCT00203424|589200112|FG000|Follow-up Period|Lost to Follow-up|1|||
163134136|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
162658983|NCT01312909|587465811|FG002|Overall Study|Withdrawal by Subject|7|||
162658984|NCT01312909|587465809|FG000|Overall Study|Lost to Follow-up|21|||
162658985|NCT01312909|587465810|FG001|Overall Study|Lost to Follow-up|17|||
163134137|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134138|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134139|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134140|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134141|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163134142|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
163134143|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134144|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134145|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134146|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134147|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163134148|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
163134149|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134150|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134151|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134152|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134153|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163134154|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
163134155|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134156|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134157|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134158|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134159|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
163134160|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
163134161|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134162|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134163|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134164|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134165|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
163134166|NCT01053988|589200113|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
163134167|NCT01053988|589200114|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134168|NCT01053988|589200115|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134169|NCT01053988|589200116|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134170|NCT01053988|589200117|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134171|NCT01053988|589200118|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163134172|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
163134173|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
163134174|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
163134175|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
163134176|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
163134177|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
163134178|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163134179|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163134180|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
163134181|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
163134182|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163134183|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163134184|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
163134185|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
163134186|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
163134187|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
163134188|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
163134189|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
163134190|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163134191|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
163134192|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163134193|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163134194|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
163134195|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163134196|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163134197|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
163134198|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
163134199|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
163134200|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
163134201|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
163134202|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163134203|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
163134204|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163134205|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163134206|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163134207|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
163134208|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
163134209|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
163134210|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
163134211|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
163134212|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
162658986|NCT01312909|587465811|FG002|Overall Study|Lost to Follow-up|20|||
162658987|NCT01312909|587465809|FG000|Overall Study|Insufficient clinical response|0|||
162658988|NCT01312909|587465810|FG001|Overall Study|Insufficient clinical response|0|||
162658989|NCT01312909|587465811|FG002|Overall Study|Insufficient clinical response|1|||
162658990|NCT01312909|587465809|FG000|Overall Study|Entrance criteria not met|0|||
162658991|NCT01312909|587465810|FG001|Overall Study|Entrance criteria not met|0|||
162658992|NCT01312909|587465811|FG002|Overall Study|Entrance criteria not met|2|||
162658993|NCT02200042|587465812|FG000|Overall Study|Withdrawal by Subject|0|||
162658994|NCT02200042|587465813|FG001|Overall Study|Withdrawal by Subject|1|||
163134213|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
163134214|NCT01053988|589200113|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163134215|NCT01053988|589200114|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
163134216|NCT01053988|589200115|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163134217|NCT01053988|589200116|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
163134218|NCT01053988|589200117|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
163134219|NCT01053988|589200118|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163134220|NCT01922271|589200120|FG000|WASHOUT Period|Withdrawal by Subject|1|||
163134221|NCT01922271|589200121|FG001|WASHOUT Period|Withdrawal by Subject|0|||
163134222|NCT00719355|589200122|FG000|Overall Study|Death|0|||
163134223|NCT00719355|589200123|FG001|Overall Study|Death|1|||
163134224|NCT00719355|589200122|FG000|Overall Study|Medical|14|||
163134225|NCT00719355|589200123|FG001|Overall Study|Medical|5|||
163134226|NCT00719355|589200122|FG000|Overall Study|Compliance|4|||
163134227|NCT00719355|589200123|FG001|Overall Study|Compliance|6|||
163134228|NCT00719355|589200122|FG000|Overall Study|Moved|0|||
163134229|NCT00719355|589200123|FG001|Overall Study|Moved|1|||
163134230|NCT01856582|589200124|FG000|Overall Study|Died prior to Boost infusion|1|||
163134231|NCT01824355|589200125|FG000|Overall Study|Adverse Event|2|||
163134232|NCT01824355|589200125|FG000|Overall Study|unevaluable reference method results per|1|||
163134233|NCT01331109|589200126|FG000|Overall Study|Adverse Event|6|||
163134234|NCT01331109|589200126|FG000|Overall Study|Lack of Efficacy|2|||
163134235|NCT01331109|589200126|FG000|Overall Study|Protocol Violation|3|||
163134236|NCT01331109|589200126|FG000|Overall Study|Withdrawal by Subject|7|||
163134237|NCT01331109|589200126|FG000|Overall Study|Lost to Follow-up|1|||
163134238|NCT01331109|589200126|FG000|Overall Study|Study Terminated by Sponsor|38|||
163134239|NCT03688620|589200132|FG000|Overall Study|Other|0|||
163134240|NCT03688620|589200133|FG001|Overall Study|Other|0|||
163134241|NCT03688620|589200134|FG002|Overall Study|Other|1|||
163134242|NCT03688620|589200132|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
163134243|NCT03688620|589200133|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
162658995|NCT00306592|587465816|FG000|Overall Study|Adverse Event|8|||
162658996|NCT00306592|587465817|FG001|Overall Study|Adverse Event|15|||
163134244|NCT03688620|589200134|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
163134245|NCT03688620|589200132|FG000|Overall Study|Lost to Follow-up|16|||
163134246|NCT03688620|589200133|FG001|Overall Study|Lost to Follow-up|0|||
163134247|NCT03688620|589200134|FG002|Overall Study|Lost to Follow-up|1|||
163134248|NCT03688620|589200132|FG000|Overall Study|Withdrawal by Subject|0|||
163134249|NCT03688620|589200133|FG001|Overall Study|Withdrawal by Subject|0|||
163134250|NCT03688620|589200134|FG002|Overall Study|Withdrawal by Subject|6|||
163134251|NCT02828020|589200135|FG000|Treatment Period|Adverse Event|3|||
163134252|NCT02828020|589200136|FG001|Treatment Period|Adverse Event|1|||
163134253|NCT02828020|589200137|FG002|Treatment Period|Adverse Event|1|||
163134254|NCT02828020|589200135|FG000|Treatment Period|Withdrawal of Consent|10|||
163134255|NCT02828020|589200136|FG001|Treatment Period|Withdrawal of Consent|14|||
163134256|NCT02828020|589200137|FG002|Treatment Period|Withdrawal of Consent|9|||
163134257|NCT02828020|589200135|FG000|Treatment Period|Lost to Follow-up|21|||
163134258|NCT02828020|589200136|FG001|Treatment Period|Lost to Follow-up|24|||
163134259|NCT02828020|589200137|FG002|Treatment Period|Lost to Follow-up|18|||
163134260|NCT02828020|589200135|FG000|Treatment Period|Lack of Qualifying Event|44|||
163134261|NCT02828020|589200136|FG001|Treatment Period|Lack of Qualifying Event|53|||
163134262|NCT02828020|589200137|FG002|Treatment Period|Lack of Qualifying Event|43|||
163134263|NCT02828020|589200135|FG000|Treatment Period|Pregnancy|0|||
163134264|NCT02828020|589200136|FG001|Treatment Period|Pregnancy|2|||
163134265|NCT02828020|589200137|FG002|Treatment Period|Pregnancy|0|||
163134266|NCT02828020|589200135|FG000|Treatment Period|Protocol Violation|2|||
163134267|NCT02828020|589200136|FG001|Treatment Period|Protocol Violation|4|||
163134268|NCT02828020|589200137|FG002|Treatment Period|Protocol Violation|7|||
163134269|NCT02828020|589200135|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
162658997|NCT00306592|587465816|FG000|Overall Study|Lost to Follow-up|1|||
162658998|NCT00306592|587465817|FG001|Overall Study|Lost to Follow-up|0|||
162658999|NCT00306592|587465816|FG000|Overall Study|Noncompliance|0|||
163134270|NCT02828020|589200136|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
163134271|NCT02828020|589200137|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
163134272|NCT02828020|589200135|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
163134273|NCT02828020|589200136|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
163134274|NCT02828020|589200137|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
163134275|NCT02828020|589200135|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
163134276|NCT02828020|589200136|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
163134277|NCT02828020|589200137|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
163134278|NCT02828020|589200135|FG000|Safety Follow-up Period|Protocol Violation|0|||
163134279|NCT02828020|589200136|FG001|Safety Follow-up Period|Protocol Violation|2|||
163134280|NCT02828020|589200137|FG002|Safety Follow-up Period|Protocol Violation|1|||
163134281|NCT02828020|589200135|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
163134282|NCT02828020|589200136|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163134283|NCT02828020|589200137|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
163134284|NCT01183065|589200139|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
163134285|NCT02578186|589200140|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
163134286|NCT02578186|589200141|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
163134287|NCT02578186|589200140|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
163134288|NCT02578186|589200141|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
163134289|NCT03657095|589200142|FG000|Overall Study|Withdrawal by Subject|1|||
163134290|NCT03657095|589200143|FG001|Overall Study|Withdrawal by Subject|1|||
163134291|NCT03657095|589200142|FG000|Overall Study|Adverse Event|0|||
163134292|NCT03657095|589200143|FG001|Overall Study|Adverse Event|3|||
163134293|NCT03657095|589200142|FG000|Overall Study|Study Terminated by Sponsor|58|||
163134294|NCT03657095|589200143|FG001|Overall Study|Study Terminated by Sponsor|49|||
163134295|NCT01894243|589200144|FG000|Overall Study|Adverse Event|0|||
163134296|NCT01894243|589200145|FG001|Overall Study|Adverse Event|1|||
163134297|NCT01894243|589200146|FG002|Overall Study|Adverse Event|2|||
163134298|NCT01894243|589200144|FG000|Overall Study|Death|0|||
163134299|NCT01894243|589200145|FG001|Overall Study|Death|0|||
163134300|NCT01894243|589200146|FG002|Overall Study|Death|3|||
163134301|NCT01894243|589200144|FG000|Overall Study|Lack of Efficacy|3|||
163134302|NCT01894243|589200145|FG001|Overall Study|Lack of Efficacy|3|||
163134303|NCT01894243|589200146|FG002|Overall Study|Lack of Efficacy|1|||
163134304|NCT01894243|589200144|FG000|Overall Study|Condition under investigation worsened|8|||
163134305|NCT01894243|589200145|FG001|Overall Study|Condition under investigation worsened|6|||
163134306|NCT01894243|589200146|FG002|Overall Study|Condition under investigation worsened|2|||
163134307|NCT01894243|589200144|FG000|Overall Study|Subject decision|1|||
163134308|NCT01894243|589200145|FG001|Overall Study|Subject decision|0|||
163134309|NCT01894243|589200146|FG002|Overall Study|Subject decision|0|||
163134310|NCT01894243|589200144|FG000|Overall Study|Other|1|||
163134311|NCT01894243|589200145|FG001|Overall Study|Other|0|||
163134312|NCT01894243|589200146|FG002|Overall Study|Other|0|||
163134313|NCT00828750|589200149|FG000|Overall Study|Lack of Efficacy|3|||
163134314|NCT00828750|589200149|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
163134315|NCT04006392|589200150|FG000|Overall Study|Lost to Follow-up|0|||
163134316|NCT04006392|589200151|FG001|Overall Study|Lost to Follow-up|1|||
163134317|NCT01067469|589200152|FG000|Overall Study|Withdrawal by Subject|0|||
162659000|NCT00306592|587465817|FG001|Overall Study|Noncompliance|2|||
162659001|NCT00306592|587465816|FG000|Overall Study|Persistent Antibodies|6|||
162659002|NCT00306592|587465817|FG001|Overall Study|Persistent Antibodies|3|||
162659003|NCT00306592|587465816|FG000|Overall Study|Voluntary|10|||
162659004|NCT00306592|587465817|FG001|Overall Study|Voluntary|6|||
162659005|NCT00306592|587465816|FG000|Overall Study|Other|5|||
162659006|NCT00306592|587465817|FG001|Overall Study|Other|10|||
162659007|NCT00306592|587465816|FG000|Overall Study|Other|1|||
162659008|NCT00306592|587465817|FG001|Overall Study|Other|2|||
162659009|NCT00306592|587465816|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
162659010|NCT00306592|587465817|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
162659011|NCT01923181|587465818|FG000|Overall Study|Protocol Violation|2|||
162659012|NCT01923181|587465819|FG001|Overall Study|Protocol Violation|2|||
162659013|NCT01923181|587465820|FG002|Overall Study|Protocol Violation|0|||
162659014|NCT01923181|587465821|FG003|Overall Study|Protocol Violation|2|||
162659015|NCT01923181|587465822|FG004|Overall Study|Protocol Violation|2|||
162659016|NCT01923181|587465823|FG005|Overall Study|Protocol Violation|1|||
162659017|NCT01923181|587465824|FG006|Overall Study|Protocol Violation|1|||
162659018|NCT01923181|587465825|FG007|Overall Study|Protocol Violation|2|||
162659019|NCT01923181|587465826|FG008|Overall Study|Protocol Violation|1|||
162659020|NCT01923181|587465818|FG000|Overall Study|Withdrawal by Subject|0|||
162659021|NCT01923181|587465819|FG001|Overall Study|Withdrawal by Subject|1|||
162659022|NCT01923181|587465820|FG002|Overall Study|Withdrawal by Subject|0|||
162659023|NCT01923181|587465821|FG003|Overall Study|Withdrawal by Subject|1|||
163134318|NCT01067469|589200153|FG001|Overall Study|Withdrawal by Subject|1|||
163134319|NCT01067469|589200152|FG000|Overall Study|Disease Progression|0|||
163134320|NCT01067469|589200153|FG001|Overall Study|Disease Progression|1|||
163134321|NCT01620944|589200154|FG000|Overall Study|Early termination of Study|2|||
162659024|NCT01923181|587465822|FG004|Overall Study|Withdrawal by Subject|4|||
162659025|NCT01923181|587465823|FG005|Overall Study|Withdrawal by Subject|2|||
162659026|NCT01923181|587465824|FG006|Overall Study|Withdrawal by Subject|4|||
162659027|NCT01923181|587465825|FG007|Overall Study|Withdrawal by Subject|3|||
163134322|NCT01620944|589200155|FG001|Overall Study|Early termination of Study|1|||
163134323|NCT03597061|589200156|FG000|Overall Study|Lost to Follow-up|1|||
163134324|NCT03597061|589200157|FG001|Overall Study|Lost to Follow-up|0|||
163134325|NCT03597061|589200156|FG000|Overall Study|Protocol Violation|0|||
163134326|NCT03597061|589200157|FG001|Overall Study|Protocol Violation|1|||
163134327|NCT01748825|589200158|FG000|Dose Escalation|Refused further treatment|2|||
163134328|NCT01748825|589200159|FG001|Dose Escalation|Refused further treatment|2|||
163134329|NCT01748825|589200160|FG002|Dose Escalation|Refused further treatment|0|||
163134330|NCT01748825|589200161|FG003|Dose Escalation|Refused further treatment|0|||
163134331|NCT01748825|589200162|FG004|Dose Escalation|Refused further treatment|1|||
163134332|NCT01748825|589200163|FG005|Dose Escalation|Refused further treatment|2|||
163134333|NCT01748825|589200164|FG006|Dose Escalation|Refused further treatment|0|||
163134334|NCT01748825|589200165|FG007|Dose Escalation|Refused further treatment|0|||
163134335|NCT01748825|589200166|FG008|Dose Escalation|Refused further treatment|0|||
163134336|NCT01748825|589200167|FG009|Dose Escalation|Refused further treatment|0|||
163134337|NCT01748825|589200158|FG000|Dose Escalation|Switched to alternative treatment|0|||
163134338|NCT01748825|589200159|FG001|Dose Escalation|Switched to alternative treatment|0|||
163134339|NCT01748825|589200160|FG002|Dose Escalation|Switched to alternative treatment|0|||
163134340|NCT01748825|589200161|FG003|Dose Escalation|Switched to alternative treatment|1|||
163134341|NCT01748825|589200162|FG004|Dose Escalation|Switched to alternative treatment|0|||
163134342|NCT01748825|589200163|FG005|Dose Escalation|Switched to alternative treatment|0|||
163134343|NCT01748825|589200164|FG006|Dose Escalation|Switched to alternative treatment|0|||
163134344|NCT01748825|589200165|FG007|Dose Escalation|Switched to alternative treatment|0|||
163134345|NCT01748825|589200166|FG008|Dose Escalation|Switched to alternative treatment|0|||
163134346|NCT01748825|589200167|FG009|Dose Escalation|Switched to alternative treatment|0|||
163134347|NCT01748825|589200158|FG000|Dose Escalation|Adverse Event|0|||
163134348|NCT01748825|589200159|FG001|Dose Escalation|Adverse Event|0|||
163134349|NCT01748825|589200160|FG002|Dose Escalation|Adverse Event|0|||
163134350|NCT01748825|589200161|FG003|Dose Escalation|Adverse Event|0|||
163134351|NCT01748825|589200162|FG004|Dose Escalation|Adverse Event|0|||
163134352|NCT01748825|589200163|FG005|Dose Escalation|Adverse Event|0|||
163134353|NCT01748825|589200164|FG006|Dose Escalation|Adverse Event|1|||
163134354|NCT01748825|589200165|FG007|Dose Escalation|Adverse Event|0|||
163134355|NCT01748825|589200166|FG008|Dose Escalation|Adverse Event|0|||
163134356|NCT01748825|589200167|FG009|Dose Escalation|Adverse Event|0|||
162659028|NCT01923181|587465826|FG008|Overall Study|Withdrawal by Subject|1|||
162659029|NCT01923181|587465818|FG000|Overall Study|Other|1|||
162659030|NCT01923181|587465819|FG001|Overall Study|Other|0|||
162659031|NCT01923181|587465820|FG002|Overall Study|Other|0|||
162659032|NCT01923181|587465821|FG003|Overall Study|Other|1|||
162659033|NCT01923181|587465822|FG004|Overall Study|Other|0|||
162659034|NCT01923181|587465823|FG005|Overall Study|Other|0|||
162659035|NCT01923181|587465824|FG006|Overall Study|Other|0|||
162659036|NCT01923181|587465825|FG007|Overall Study|Other|0|||
162659037|NCT01923181|587465826|FG008|Overall Study|Other|0|||
162659038|NCT01923181|587465818|FG000|Overall Study|Lost to Follow-up|0|||
162659039|NCT01923181|587465819|FG001|Overall Study|Lost to Follow-up|3|||
162719868|NCT03545984|587680605|FG000|Overall Study|CSF cases not present during rotation|11|||
163134357|NCT01748825|589200158|FG000|Dose Expansion|Refused further treatment|0|||
163134358|NCT01748825|589200159|FG001|Dose Expansion|Refused further treatment|0|||
163134359|NCT01748825|589200160|FG002|Dose Expansion|Refused further treatment|0|||
163134360|NCT01748825|589200161|FG003|Dose Expansion|Refused further treatment|0|||
163134361|NCT01748825|589200162|FG004|Dose Expansion|Refused further treatment|0|||
163134362|NCT01748825|589200163|FG005|Dose Expansion|Refused further treatment|0|||
163134363|NCT01748825|589200164|FG006|Dose Expansion|Refused further treatment|0|||
163134364|NCT01748825|589200165|FG007|Dose Expansion|Refused further treatment|0|||
163134365|NCT01748825|589200166|FG008|Dose Expansion|Refused further treatment|1|||
163134366|NCT01748825|589200167|FG009|Dose Expansion|Refused further treatment|1|||
163134367|NCT01748825|589200158|FG000|Dose Expansion|Switched to alternative treatment|0|||
163134368|NCT01748825|589200159|FG001|Dose Expansion|Switched to alternative treatment|0|||
163134369|NCT01748825|589200160|FG002|Dose Expansion|Switched to alternative treatment|0|||
163134370|NCT01748825|589200161|FG003|Dose Expansion|Switched to alternative treatment|0|||
163134371|NCT01748825|589200162|FG004|Dose Expansion|Switched to alternative treatment|0|||
163134372|NCT01748825|589200163|FG005|Dose Expansion|Switched to alternative treatment|0|||
163134373|NCT01748825|589200164|FG006|Dose Expansion|Switched to alternative treatment|0|||
162659040|NCT01923181|587465820|FG002|Overall Study|Lost to Follow-up|2|||
162659041|NCT01923181|587465821|FG003|Overall Study|Lost to Follow-up|1|||
163134374|NCT01748825|589200165|FG007|Dose Expansion|Switched to alternative treatment|0|||
163134375|NCT01748825|589200166|FG008|Dose Expansion|Switched to alternative treatment|0|||
162659042|NCT01923181|587465822|FG004|Overall Study|Lost to Follow-up|2|||
163134376|NCT01748825|589200167|FG009|Dose Expansion|Switched to alternative treatment|1|||
163134377|NCT01748825|589200158|FG000|Dose Expansion|Adverse Event|0|||
162659043|NCT01923181|587465823|FG005|Overall Study|Lost to Follow-up|1|||
162659044|NCT01923181|587465824|FG006|Overall Study|Lost to Follow-up|3|||
162659045|NCT01923181|587465825|FG007|Overall Study|Lost to Follow-up|3|||
162659046|NCT01923181|587465826|FG008|Overall Study|Lost to Follow-up|1|||
163134378|NCT01748825|589200159|FG001|Dose Expansion|Adverse Event|0|||
163134379|NCT01748825|589200160|FG002|Dose Expansion|Adverse Event|0|||
162659047|NCT00654628|587465828|FG000|6-week Active Treatment Period|Adverse Event|9|||
162659048|NCT00654628|587465828|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
162659049|NCT00654628|587465828|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
162659050|NCT00654628|587465828|FG000|6-week Active Treatment Period|Out of window period|1|||
162659051|NCT00654628|587465828|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
162659052|NCT00654628|587465828|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
163134380|NCT01748825|589200161|FG003|Dose Expansion|Adverse Event|0|||
163134381|NCT01748825|589200162|FG004|Dose Expansion|Adverse Event|0|||
163134382|NCT01748825|589200163|FG005|Dose Expansion|Adverse Event|0|||
163134383|NCT01748825|589200164|FG006|Dose Expansion|Adverse Event|0|||
163134384|NCT01748825|589200165|FG007|Dose Expansion|Adverse Event|0|||
163134385|NCT01748825|589200166|FG008|Dose Expansion|Adverse Event|0|||
163134386|NCT01748825|589200167|FG009|Dose Expansion|Adverse Event|3|||
163134387|NCT01748825|589200158|FG000|Dose Expansion|Physician Decision|0|||
163134388|NCT01748825|589200159|FG001|Dose Expansion|Physician Decision|0|||
163134389|NCT01748825|589200160|FG002|Dose Expansion|Physician Decision|0|||
162659053|NCT00912405|587465831|FG000|Overall Study|Lost to Follow-up|5|||
162659054|NCT00953329|587465832|FG000|Overall Study|Lack of Efficacy|1|||
162659055|NCT01434823|587465835|FG000|Overall Study|Incomplete data in medical record|4|||
162659056|NCT01434823|587465836|FG001|Overall Study|Incomplete data in medical record|7|||
163134390|NCT01748825|589200161|FG003|Dose Expansion|Physician Decision|0|||
163134391|NCT01748825|589200162|FG004|Dose Expansion|Physician Decision|0|||
162659057|NCT00796861|587465847|FG000|Overall Study|Withdrawal by Subject|2|||
162659058|NCT00796861|587465847|FG000|Overall Study|Death|2|||
162659059|NCT00844545|587465852|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
162659060|NCT00844545|587465852|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
162659061|NCT00844545|587465852|FG000|Extension Treatment Period|Adverse Event|2|||
162659062|NCT00844545|587465852|FG000|Post Treatment Period|Withdrawal by Subject|1|||
162659063|NCT00403455|587465853|FG000|Overall Study|Withdrawal by Subject|1|||
162659064|NCT01358981|587465854|FG000|Period 1|Withdrawal by Subject|0|||
162659065|NCT01358981|587465855|FG001|Period 1|Withdrawal by Subject|0|||
162659066|NCT01358981|587465856|FG002|Period 1|Withdrawal by Subject|0|||
162659067|NCT01358981|587465857|FG003|Period 1|Withdrawal by Subject|1|||
162659068|NCT01358981|587465858|FG004|Period 1|Withdrawal by Subject|0|||
162659069|NCT01358981|587465859|FG005|Period 1|Withdrawal by Subject|0|||
162659070|NCT01358981|587465860|FG006|Period 1|Withdrawal by Subject|0|||
162659071|NCT04574362|587465861|FG000|Overall Study|Other|0|||
162659072|NCT04574362|587465862|FG001|Overall Study|Other|5|||
162659073|NCT04574362|587465861|FG000|Overall Study|COVID-19|0|||
162659074|NCT04574362|587465862|FG001|Overall Study|COVID-19|1|||
162659075|NCT04574362|587465861|FG000|Overall Study|Adverse Event|1|||
162659076|NCT04574362|587465862|FG001|Overall Study|Adverse Event|1|||
162659077|NCT04574362|587465861|FG000|Overall Study|Withdrawal by Subject|2|||
162659078|NCT04574362|587465862|FG001|Overall Study|Withdrawal by Subject|4|||
162659079|NCT04574362|587465861|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
162659080|NCT04574362|587465862|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
162659081|NCT04574362|587465861|FG000|Overall Study|Participant refused to come to the hospital|1|||
162659082|NCT04574362|587465862|FG001|Overall Study|Participant refused to come to the hospital|0|||
163134392|NCT01748825|589200163|FG005|Dose Expansion|Physician Decision|0|||
163134393|NCT01748825|589200164|FG006|Dose Expansion|Physician Decision|0|||
163134394|NCT01748825|589200165|FG007|Dose Expansion|Physician Decision|0|||
163134395|NCT01748825|589200166|FG008|Dose Expansion|Physician Decision|1|||
163134396|NCT01748825|589200167|FG009|Dose Expansion|Physician Decision|0|||
163134397|NCT01730586|589200171|FG000|Overall Study|Progressive Disease|2|||
163134398|NCT01730586|589200171|FG000|Overall Study|Inadequate Trial|8|||
163134399|NCT01730586|589200171|FG000|Overall Study|Adverse Event|2|||
163134400|NCT01730586|589200171|FG000|Overall Study|Hospice|1|||
163134401|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
163134402|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
162659083|NCT04574362|587465861|FG000|Overall Study|Participant refused the visit|1|||
162659084|NCT04574362|587465862|FG001|Overall Study|Participant refused the visit|0|||
162659085|NCT04574362|587465861|FG000|Overall Study|Participant quit early because of business trip|1|||
162659086|NCT04574362|587465862|FG001|Overall Study|Participant quit early because of business trip|0|||
162659087|NCT01785524|587465863|FG000|Overall Study|Withdrawal by Subject|2|||
162659088|NCT01785524|587465864|FG001|Overall Study|Withdrawal by Subject|2|||
162659089|NCT01060384|587465865|FG000|Overall Study|Withdrawal by Subject|0|||
162659090|NCT01060384|587465866|FG001|Overall Study|Withdrawal by Subject|1|||
163134403|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
163134404|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
163134405|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
163134406|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
163134407|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
163134408|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
163134409|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
163134410|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
163134411|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
163134412|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
163134413|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
163134414|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
163134415|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
163134416|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
163134417|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134418|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
163134419|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134420|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
163134421|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
163134422|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
162719869|NCT03545984|587680606|FG001|Overall Study|CSF cases not present during rotation|9|||
162719870|NCT00387465|587680607|FG000|Overall Study|Withdrawal by Subject|0|||
162719871|NCT00387465|587680608|FG001|Overall Study|Withdrawal by Subject|1|||
162719872|NCT00387465|587680609|FG002|Overall Study|Withdrawal by Subject|0|||
162719873|NCT03418324|587680610|FG000|Overall Study|Death|0|||
162719874|NCT03418324|587680611|FG001|Overall Study|Death|1|||
162719875|NCT03418324|587680610|FG000|Overall Study|Physician Decision|1|||
162719876|NCT03418324|587680611|FG001|Overall Study|Physician Decision|1|||
162719877|NCT01768676|587680612|FG000|Overall Study|Adverse Event|3|||
162719878|NCT01768676|587680613|FG001|Overall Study|Adverse Event|3|||
162719879|NCT01768676|587680612|FG000|Overall Study|Lost to Follow-up|13|||
162719880|NCT01768676|587680613|FG001|Overall Study|Lost to Follow-up|16|||
162719881|NCT01768676|587680612|FG000|Overall Study|Protocol Violation|1|||
162719882|NCT01768676|587680613|FG001|Overall Study|Protocol Violation|1|||
162719883|NCT01768676|587680612|FG000|Overall Study|Physician Decision|4|||
162719884|NCT01768676|587680613|FG001|Overall Study|Physician Decision|1|||
162719885|NCT01768676|587680612|FG000|Overall Study|Withdrawal by Subject|3|||
162719886|NCT01768676|587680613|FG001|Overall Study|Withdrawal by Subject|10|||
162719887|NCT00605033|587680614|FG000|Overall Study|Adverse Event|2|||
162719888|NCT00605033|587680615|FG001|Overall Study|Adverse Event|2|||
162719889|NCT00605033|587680614|FG000|Overall Study|Lost to Follow-up|1|||
162719890|NCT00605033|587680615|FG001|Overall Study|Lost to Follow-up|1|||
162719891|NCT00605033|587680614|FG000|Overall Study|Withdrawal by Subject|3|||
162719892|NCT00605033|587680615|FG001|Overall Study|Withdrawal by Subject|4|||
162719893|NCT00605033|587680614|FG000|Overall Study|Protocol Violation|1|||
163134423|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
163134424|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
162719894|NCT00605033|587680615|FG001|Overall Study|Protocol Violation|1|||
162719895|NCT03121950|587680618|FG000|Overall Study|Withdrawal by Subject|11|||
162719896|NCT03121950|587680619|FG001|Overall Study|Withdrawal by Subject|2|||
162719897|NCT02754479|587680623|FG000|Overall Study|Lost to Follow-up|1|||
162719898|NCT03183518|587680624|FG000|Overall Study|Other (Not specified)|2|||
162719899|NCT03183518|587680624|FG000|Overall Study|Other (Withdrawal of consent)|1|||
162719900|NCT02132702|587680625|FG000|Overall Study|Protocol Violation|2|||
162719901|NCT02132702|587680625|FG000|Overall Study|Adverse Event|3|||
162719902|NCT02132702|587680625|FG000|Overall Study|Withdrawal by Subject|3|||
162659091|NCT01060384|587465867|FG002|Overall Study|Withdrawal by Subject|0|||
162659092|NCT01060384|587465868|FG003|Overall Study|Withdrawal by Subject|0|||
162659093|NCT01060384|587465869|FG004|Overall Study|Withdrawal by Subject|0|||
162659094|NCT01060384|587465865|FG000|Overall Study|Death|0|||
162659095|NCT01060384|587465866|FG001|Overall Study|Death|0|||
162659096|NCT01060384|587465867|FG002|Overall Study|Death|0|||
162659097|NCT01060384|587465868|FG003|Overall Study|Death|0|||
162659098|NCT01060384|587465869|FG004|Overall Study|Death|1|||
162659099|NCT01060384|587465865|FG000|Overall Study|Intercurrent illness|0|||
162659100|NCT01060384|587465866|FG001|Overall Study|Intercurrent illness|0|||
162659101|NCT01060384|587465867|FG002|Overall Study|Intercurrent illness|0|||
162659102|NCT01060384|587465868|FG003|Overall Study|Intercurrent illness|0|||
162659103|NCT01060384|587465869|FG004|Overall Study|Intercurrent illness|1|||
162659104|NCT01332305|587465870|FG000|Overall Study|Adverse Event|1|||
162659105|NCT01332305|587465871|FG001|Overall Study|Adverse Event|4|||
163134425|NCT03777059|589201531|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
163134426|NCT03777059|589201532|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
162659106|NCT01332305|587465872|FG002|Overall Study|Adverse Event|6|||
162659107|NCT01332305|587465873|FG003|Overall Study|Adverse Event|3|||
162659108|NCT01332305|587465874|FG004|Overall Study|Adverse Event|5|||
162659109|NCT01332305|587465870|FG000|Overall Study|Withdrawal by Subject|6|||
162659110|NCT01332305|587465871|FG001|Overall Study|Withdrawal by Subject|5|||
162659111|NCT01332305|587465872|FG002|Overall Study|Withdrawal by Subject|4|||
163134427|NCT03777059|589201533|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
163134428|NCT03777059|589201534|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
163134429|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
163134430|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
163134431|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
163134432|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
163134433|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
163134434|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
163134435|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
163134436|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
163134437|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
163134438|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
163134439|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
163134440|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
163134441|NCT03777059|589201531|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
163134442|NCT03777059|589201532|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
163134443|NCT03777059|589201533|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
163134444|NCT03777059|589201534|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
163134445|NCT03056339|589201538|FG000|Overall Study|Failed Requirements|0|||
163134446|NCT03056339|589201539|FG001|Overall Study|Failed Requirements|2|||
163134447|NCT03056339|589201540|FG002|Overall Study|Failed Requirements|7|||
163134448|NCT03056339|589201541|FG003|Overall Study|Failed Requirements|1|||
163134449|NCT04506502|589201545|FG000|Overall Study|Withdrawal by Subject|1|||
163134450|NCT04506502|589201545|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
163134451|NCT01449006|589201546|FG000|Overall Study|Lost to Follow-up|1|||
163134452|NCT01449006|589201547|FG001|Overall Study|Lost to Follow-up|0|||
163134453|NCT01449006|589201546|FG000|Overall Study|Withdrawal by Subject|1|||
163134454|NCT01449006|589201547|FG001|Overall Study|Withdrawal by Subject|0|||
163134455|NCT01449006|589201546|FG000|Overall Study|Protocol Violation|1|||
163134456|NCT01449006|589201547|FG001|Overall Study|Protocol Violation|0|||
163134457|NCT02517541|589201550|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
163134458|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
163134459|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
163134460|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
163134461|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
163134462|NCT02517541|589201550|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
163134463|NCT02034877|589201551|FG000|Overall Study|Lost to Follow-up|0|||
163134464|NCT02034877|589201552|FG001|Overall Study|Lost to Follow-up|3|||
163134465|NCT02034877|589201551|FG000|Overall Study|No Longer Willing to Participate|0|||
163134466|NCT02034877|589201552|FG001|Overall Study|No Longer Willing to Participate|3|||
163134467|NCT03574779|589201556|FG000|Overall Study|Screening failure|13|||
162659112|NCT01332305|587465873|FG003|Overall Study|Withdrawal by Subject|1|||
162659113|NCT01332305|587465874|FG004|Overall Study|Withdrawal by Subject|0|||
162659114|NCT01332305|587465870|FG000|Overall Study|Lost to Follow-up|0|||
162659115|NCT01332305|587465871|FG001|Overall Study|Lost to Follow-up|2|||
162659116|NCT01332305|587465872|FG002|Overall Study|Lost to Follow-up|3|||
162659117|NCT01332305|587465873|FG003|Overall Study|Lost to Follow-up|2|||
163134468|NCT03574779|589201557|FG001|Overall Study|Screening failure|83|||
163134469|NCT02003534|589201566|FG000|Overall Study|Lost to Follow-up|47|||
163134470|NCT04112303|589201567|FG000|Overall Study|Death|1|||
162719903|NCT01244828|587680628|FG000|Overall Study|Adverse Event|37|||
162719904|NCT01244828|587680628|FG000|Overall Study|Withdrawal by Subject|31|||
162659118|NCT01332305|587465874|FG004|Overall Study|Lost to Follow-up|3|||
163134471|NCT01685697|589201568|FG000|Overall Study|Protocol Violation|3|||
163134472|NCT01685697|589201569|FG001|Overall Study|Protocol Violation|3|||
163134473|NCT02703324|589201570|FG000|Period Two|Withdrawal by Subject|0|||
163134474|NCT02703324|589201571|FG001|Period Two|Withdrawal by Subject|0|||
163134475|NCT02703324|589201572|FG002|Period Two|Withdrawal by Subject|1|||
163134476|NCT02703324|589201573|FG003|Period Two|Withdrawal by Subject|0|||
163134477|NCT02703324|589201574|FG004|Period Two|Withdrawal by Subject|0|||
163134478|NCT02703324|589201575|FG005|Period Two|Withdrawal by Subject|0|||
163134479|NCT04303572|589201578|FG000|Overall Study|Study closed due to poor enrollment|1|||
163134480|NCT06312592|589201579|FG000|Overall Study|Lost to Follow-up|29|||
163134481|NCT06312592|589201580|FG001|Overall Study|Lost to Follow-up|13|||
163134482|NCT03517228|589201583|FG000|Overall Study|Withdrawal by Subject|2|||
163134483|NCT03517228|589201583|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
163134484|NCT03517228|589201583|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
163134485|NCT03517228|589201583|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
163134486|NCT03517228|589201583|FG000|Overall Study|Canceled due to device being updated|1|||
163134487|NCT03517228|589201583|FG000|Overall Study|No V Cares in stock|1|||
163134488|NCT03517228|589201583|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
163134489|NCT03781414|589201588|FG000|Overall Study|Study terminated by sponsor|39|||
163134490|NCT03781414|589201589|FG001|Overall Study|Study terminated by sponsor|34|||
163134491|NCT03781414|589201590|FG002|Overall Study|Study terminated by sponsor|25|||
163134492|NCT03781414|589201588|FG000|Overall Study|Adverse Event|3|||
163134493|NCT03781414|589201589|FG001|Overall Study|Adverse Event|6|||
163134494|NCT03781414|589201590|FG002|Overall Study|Adverse Event|3|||
163134495|NCT03781414|589201588|FG000|Overall Study|Physician Decision|2|||
163134496|NCT03781414|589201589|FG001|Overall Study|Physician Decision|0|||
163134497|NCT03781414|589201590|FG002|Overall Study|Physician Decision|1|||
163134498|NCT03781414|589201588|FG000|Overall Study|Withdrawal by Subject|2|||
163134499|NCT03781414|589201589|FG001|Overall Study|Withdrawal by Subject|3|||
163134500|NCT03781414|589201590|FG002|Overall Study|Withdrawal by Subject|3|||
163134501|NCT03781414|589201588|FG000|Overall Study|Death|1|||
163134502|NCT03781414|589201589|FG001|Overall Study|Death|4|||
163134503|NCT03781414|589201590|FG002|Overall Study|Death|0|||
163134504|NCT03781414|589201588|FG000|Overall Study|Lost to Follow-up|1|||
163134505|NCT03781414|589201589|FG001|Overall Study|Lost to Follow-up|1|||
163134506|NCT03781414|589201590|FG002|Overall Study|Lost to Follow-up|0|||
163134507|NCT01620762|589201593|FG000|Overall Study|Protocol Violation|1|||
163134508|NCT01620762|589201594|FG001|Overall Study|Protocol Violation|1|||
163134509|NCT01620762|589201595|FG002|Overall Study|Protocol Violation|1|||
163134510|NCT01620762|589201593|FG000|Overall Study|Adverse Event|9|||
163134511|NCT01620762|589201594|FG001|Overall Study|Adverse Event|5|||
163134512|NCT01620762|589201595|FG002|Overall Study|Adverse Event|2|||
163134513|NCT01620762|589201593|FG000|Overall Study|Withdrawal by Subject|23|||
163134514|NCT01620762|589201594|FG001|Overall Study|Withdrawal by Subject|26|||
163134515|NCT01620762|589201595|FG002|Overall Study|Withdrawal by Subject|27|||
163134516|NCT01620762|589201593|FG000|Overall Study|Lost to Follow-up|11|||
163134517|NCT01620762|589201594|FG001|Overall Study|Lost to Follow-up|17|||
163134518|NCT01620762|589201595|FG002|Overall Study|Lost to Follow-up|10|||
163134519|NCT01620762|589201593|FG000|Overall Study|Protocol deviation|1|||
163134520|NCT01620762|589201594|FG001|Overall Study|Protocol deviation|1|||
163134521|NCT01620762|589201595|FG002|Overall Study|Protocol deviation|6|||
163134522|NCT01620762|589201593|FG000|Overall Study|Subject deterioration|0|||
163134523|NCT01620762|589201594|FG001|Overall Study|Subject deterioration|1|||
163134524|NCT01620762|589201595|FG002|Overall Study|Subject deterioration|1|||
163134525|NCT01620762|589201593|FG000|Overall Study|Non-specified|3|||
163134526|NCT01620762|589201594|FG001|Overall Study|Non-specified|6|||
163134527|NCT01620762|589201595|FG002|Overall Study|Non-specified|5|||
163134528|NCT01620762|589201593|FG000|Overall Study|Use of prohibted therapies|0|||
163134529|NCT01620762|589201594|FG001|Overall Study|Use of prohibted therapies|1|||
163134530|NCT01620762|589201595|FG002|Overall Study|Use of prohibted therapies|1|||
163134531|NCT02161757|589201606|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
163134532|NCT02161757|589201607|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
163134533|NCT02161757|589201608|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
163134534|NCT02161757|589201606|FG000|Treatment Through Study Completion|Adverse Event|1|||
163134535|NCT02161757|589201607|FG001|Treatment Through Study Completion|Adverse Event|1|||
163134536|NCT02161757|589201608|FG002|Treatment Through Study Completion|Adverse Event|0|||
163134537|NCT02161757|589201606|FG000|Treatment Through Study Completion|Protocol Violation|0|||
163134538|NCT02161757|589201607|FG001|Treatment Through Study Completion|Protocol Violation|1|||
163134539|NCT02161757|589201608|FG002|Treatment Through Study Completion|Protocol Violation|2|||
163134540|NCT02161757|589201606|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
163134541|NCT02161757|589201607|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
163134542|NCT02161757|589201608|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
163134543|NCT02161757|589201606|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
163134544|NCT02161757|589201607|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
163134545|NCT02161757|589201608|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
163134546|NCT02161757|589201606|FG000|Treatment Through Study Completion|Other|20|||
163134547|NCT02161757|589201607|FG001|Treatment Through Study Completion|Other|19|||
163134548|NCT02161757|589201608|FG002|Treatment Through Study Completion|Other|12|||
163134549|NCT02161757|589201606|FG000|Treatment Through Study Completion|Death|2|||
163134550|NCT02161757|589201607|FG001|Treatment Through Study Completion|Death|1|||
163134551|NCT02161757|589201608|FG002|Treatment Through Study Completion|Death|1|||
163134552|NCT00391625|589201609|FG000|Month 14|Withdrawal by Subject|1|||
163134553|NCT00391625|589201609|FG000|Month 50|Physician Decision|1|||
163134554|NCT03664765|589201612|FG000|Overall Study|Withdrawal by Subject|4|||
163134555|NCT03664765|589201613|FG001|Overall Study|Withdrawal by Subject|1|||
163134556|NCT03664765|589201612|FG000|Overall Study|Lost to Follow-up|0|||
163134557|NCT03664765|589201613|FG001|Overall Study|Lost to Follow-up|1|||
163134558|NCT02106403|589201618|FG000|Follow-Up Visit 3|Other Reason|0|||
163134559|NCT02106403|589201619|FG001|Follow-Up Visit 3|Other Reason|0|||
163134560|NCT02106403|589201620|FG002|Follow-Up Visit 3|Other Reason|0|||
163134561|NCT02106403|589201621|FG003|Follow-Up Visit 3|Other Reason|0|||
163134562|NCT02106403|589201622|FG004|Follow-Up Visit 3|Other Reason|0|||
163134563|NCT02106403|589201623|FG005|Follow-Up Visit 3|Other Reason|1|||
163134564|NCT01496846|589201624|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
163134565|NCT01496846|589201625|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
163134566|NCT01496846|589201626|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134567|NCT01496846|589201627|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134568|NCT01496846|589201628|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134569|NCT01496846|589201629|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163134570|NCT01772576|589201630|FG000|Overall Study|Death|15|||
163134571|NCT01772576|589201630|FG000|Overall Study|Protocol Violation|1|||
163134572|NCT01772576|589201630|FG000|Overall Study|Lost to Follow-up|3|||
163134573|NCT01772576|589201630|FG000|Overall Study|Study device not used|3|||
163134574|NCT01772576|589201630|FG000|Overall Study|Adverse Event|6|||
163134575|NCT01772576|589201630|FG000|Overall Study|Withdrawal by Subject|6|||
163134576|NCT01128946|589201644|FG000|Period I|Protocol Violation|0|||
163134577|NCT01128946|589201645|FG001|Period I|Protocol Violation|1|||
163134578|NCT01128946|589201646|FG002|Period I|Protocol Violation|0|||
163134579|NCT01128946|589201647|FG003|Period I|Protocol Violation|0|||
163134580|NCT01128946|589201644|FG000|Period I|Withdrawal by Subject|0|||
163134581|NCT01128946|589201645|FG001|Period I|Withdrawal by Subject|0|||
163134582|NCT01128946|589201646|FG002|Period I|Withdrawal by Subject|1|||
163134583|NCT01128946|589201647|FG003|Period I|Withdrawal by Subject|1|||
163134584|NCT01128946|589201644|FG000|Period II|Protocol Violation|0|||
163134585|NCT01128946|589201645|FG001|Period II|Protocol Violation|1|||
163134586|NCT01128946|589201646|FG002|Period II|Protocol Violation|0|||
162659119|NCT01332305|587465870|FG000|Overall Study|Protocol Violation|1|||
163134587|NCT01128946|589201647|FG003|Period II|Protocol Violation|0|||
163134588|NCT01128946|589201644|FG000|Period II|Withdrawal by Subject|0|||
163134589|NCT01128946|589201645|FG001|Period II|Withdrawal by Subject|0|||
163134590|NCT01128946|589201646|FG002|Period II|Withdrawal by Subject|0|||
163134591|NCT01128946|589201647|FG003|Period II|Withdrawal by Subject|1|||
163134592|NCT01128946|589201644|FG000|Period III|Protocol Violation|1|||
163134593|NCT01128946|589201645|FG001|Period III|Protocol Violation|0|||
163134594|NCT01128946|589201646|FG002|Period III|Protocol Violation|0|||
163134595|NCT01128946|589201647|FG003|Period III|Protocol Violation|0|||
163134596|NCT00527904|589201648|FG000|Overall Study|Adverse Event|45|||
163134597|NCT00527904|589201648|FG000|Overall Study|Withdrawal by Subject|21|||
163134598|NCT00527904|589201648|FG000|Overall Study|Lost to Follow-up|8|||
163134599|NCT00527904|589201648|FG000|Overall Study|misc|22|||
163134600|NCT02873338|589201652|FG000|Overall Study|Adverse Event|0|||
163134601|NCT02873338|589201653|FG001|Overall Study|Adverse Event|2|||
163134602|NCT02873338|589201654|FG002|Overall Study|Adverse Event|1|||
163134603|NCT02873338|589201652|FG000|Overall Study|Death|2|||
163134604|NCT02873338|589201653|FG001|Overall Study|Death|1|||
163134605|NCT02873338|589201654|FG002|Overall Study|Death|1|||
163134606|NCT02873338|589201652|FG000|Overall Study|Withdrawal by Subject|2|||
163134607|NCT02873338|589201653|FG001|Overall Study|Withdrawal by Subject|1|||
163134608|NCT02873338|589201654|FG002|Overall Study|Withdrawal by Subject|3|||
163134609|NCT02873338|589201652|FG000|Overall Study|Lack of Efficacy|0|||
163134610|NCT02873338|589201653|FG001|Overall Study|Lack of Efficacy|2|||
163134611|NCT02873338|589201654|FG002|Overall Study|Lack of Efficacy|0|||
163134612|NCT02873338|589201652|FG000|Overall Study|Other or Missing|14|||
163134613|NCT02873338|589201653|FG001|Overall Study|Other or Missing|15|||
163134614|NCT02873338|589201654|FG002|Overall Study|Other or Missing|13|||
163134615|NCT00766051|589201656|FG000|Overall Study|Withdrawal by Subject|2|||
163134616|NCT00766051|589201657|FG001|Overall Study|Withdrawal by Subject|0|||
163134617|NCT01320202|589201658|FG000|Overall Study|Adverse Event|5|||
163134618|NCT01320202|589201659|FG001|Overall Study|Adverse Event|5|||
162659120|NCT01332305|587465871|FG001|Overall Study|Protocol Violation|2|||
163134619|NCT01320202|589201658|FG000|Overall Study|Death|5|||
163134620|NCT01320202|589201659|FG001|Overall Study|Death|3|||
163134621|NCT01320202|589201658|FG000|Overall Study|Lost to Follow-up|1|||
163134622|NCT01320202|589201659|FG001|Overall Study|Lost to Follow-up|0|||
163134623|NCT01320202|589201658|FG000|Overall Study|Physician Decision|3|||
163134624|NCT01320202|589201659|FG001|Overall Study|Physician Decision|1|||
163134625|NCT01320202|589201658|FG000|Overall Study|Protocol Violation|2|||
163134626|NCT01320202|589201659|FG001|Overall Study|Protocol Violation|1|||
163134627|NCT01320202|589201658|FG000|Overall Study|Withdrawal by Subject|10|||
163134628|NCT01320202|589201659|FG001|Overall Study|Withdrawal by Subject|3|||
163134629|NCT01320202|589201658|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
163134630|NCT01320202|589201659|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
163134631|NCT01320202|589201658|FG000|Overall Study|kidney transplant|1|||
163134632|NCT01320202|589201659|FG001|Overall Study|kidney transplant|2|||
163134633|NCT01320202|589201658|FG000|Overall Study|blood transfusion|1|||
163134634|NCT01320202|589201659|FG001|Overall Study|blood transfusion|7|||
163134635|NCT01320202|589201658|FG000|Overall Study|moved/changed dialysis|5|||
163134636|NCT01320202|589201659|FG001|Overall Study|moved/changed dialysis|2|||
163134637|NCT01320202|589201658|FG000|Overall Study|sponsor request|2|||
163134638|NCT01320202|589201659|FG001|Overall Study|sponsor request|0|||
163134639|NCT01320202|589201658|FG000|Overall Study|ineligible|3|||
163134640|NCT01320202|589201659|FG001|Overall Study|ineligible|0|||
163134641|NCT01320202|589201658|FG000|Overall Study|regained renal function|1|||
163134642|NCT01320202|589201659|FG001|Overall Study|regained renal function|0|||
163134643|NCT00635882|589201660|FG000|Overall Study|Protocol Violation|1|||
163134644|NCT00635882|589201661|FG001|Overall Study|Protocol Violation|0|||
163134645|NCT00635882|589201662|FG002|Overall Study|Protocol Violation|0|||
163134646|NCT00635882|589201663|FG003|Overall Study|Protocol Violation|0|||
163134647|NCT00635882|589201664|FG004|Overall Study|Protocol Violation|0|||
163134648|NCT00635882|589201665|FG005|Overall Study|Protocol Violation|0|||
163134649|NCT02006979|589201666|FG000|Overall Study|Withdrawal by Subject|1|||
163134650|NCT02006979|589201667|FG001|Overall Study|Withdrawal by Subject|1|||
163134651|NCT02006979|589201666|FG000|Overall Study|Protocol Violation|0|||
163134652|NCT02006979|589201667|FG001|Overall Study|Protocol Violation|1|||
163134653|NCT03477838|589201672|FG000|Overall Study|Lost to Follow-up|14|||
163134654|NCT00850538|589201674|FG000|Overall Study|unable/unwilling to complete MRI|13|||
163134655|NCT00850538|589201674|FG000|Overall Study|specimen missed due to scheduling error|14|||
163134656|NCT00850538|589201674|FG000|Overall Study|specimen unusable|7|||
163134657|NCT00850538|589201674|FG000|Overall Study|Withdrawal by Subject|3|||
163134658|NCT00850538|589201674|FG000|Overall Study|radiology error|2|||
163134659|NCT00850538|589201674|FG000|Overall Study|Protocol Violation|2|||
163134660|NCT01088399|589201680|FG000|Overall Study|Adverse Event|211|||
163134661|NCT01088399|589201681|FG001|Overall Study|Adverse Event|16|||
163134662|NCT01088399|589201682|FG002|Overall Study|Adverse Event|0|||
163134663|NCT01088399|589201680|FG000|Overall Study|Death|204|||
163134664|NCT01088399|589201681|FG001|Overall Study|Death|45|||
163134665|NCT01088399|589201682|FG002|Overall Study|Death|0|||
163134666|NCT01088399|589201680|FG000|Overall Study|Lack of Efficacy|298|||
163134667|NCT01088399|589201681|FG001|Overall Study|Lack of Efficacy|7|||
163134668|NCT01088399|589201682|FG002|Overall Study|Lack of Efficacy|5|||
163134669|NCT01088399|589201680|FG000|Overall Study|Lost to Follow-up|1070|||
163134670|NCT01088399|589201681|FG001|Overall Study|Lost to Follow-up|278|||
163134671|NCT01088399|589201682|FG002|Overall Study|Lost to Follow-up|58|||
163134672|NCT01088399|589201680|FG000|Overall Study|Physician Decision|531|||
163134673|NCT01088399|589201681|FG001|Overall Study|Physician Decision|88|||
163134674|NCT01088399|589201682|FG002|Overall Study|Physician Decision|16|||
163134675|NCT01088399|589201680|FG000|Overall Study|Withdrawal by Subject|544|||
163134676|NCT01088399|589201681|FG001|Overall Study|Withdrawal by Subject|195|||
163134677|NCT01088399|589201682|FG002|Overall Study|Withdrawal by Subject|33|||
163134678|NCT01088399|589201680|FG000|Overall Study|Change to or start of somatropin therapy|234|||
163134679|NCT01088399|589201681|FG001|Overall Study|Change to or start of somatropin therapy|17|||
163134680|NCT01088399|589201682|FG002|Overall Study|Change to or start of somatropin therapy|12|||
163134681|NCT01088399|589201680|FG000|Overall Study|Sponsor decision|1573|||
163134682|NCT01088399|589201681|FG001|Overall Study|Sponsor decision|298|||
163134683|NCT01088399|589201682|FG002|Overall Study|Sponsor decision|7|||
163134684|NCT01088399|589201680|FG000|Overall Study|Protocol Violation|10|||
163134685|NCT01088399|589201681|FG001|Overall Study|Protocol Violation|1|||
163134686|NCT01088399|589201682|FG002|Overall Study|Protocol Violation|0|||
163134687|NCT01088399|589201680|FG000|Overall Study|Enrollment criteria not met|48|||
163134688|NCT01088399|589201681|FG001|Overall Study|Enrollment criteria not met|119|||
163134689|NCT01088399|589201682|FG002|Overall Study|Enrollment criteria not met|70|||
163134690|NCT01088399|589201680|FG000|Overall Study|Study summary visit not completed|2398|||
163134691|NCT01088399|589201681|FG001|Overall Study|Study summary visit not completed|283|||
163134692|NCT01088399|589201682|FG002|Overall Study|Study summary visit not completed|80|||
163134693|NCT03193736|589201683|FG000|Overall Study|Death|2|||
163134694|NCT03193736|589201683|FG000|Overall Study|Withdrawal by Subject|1|||
163134695|NCT03193736|589201683|FG000|Overall Study|Lost to Follow-up|1|||
163134696|NCT03193736|589201683|FG000|Overall Study|implant not received|1|||
162719905|NCT01244828|587680628|FG000|Overall Study|Lack of Efficacy|7|||
163134697|NCT00852241|589201684|FG000|Overall Study|Physician Decision|18|||
163134698|NCT02697435|589201685|FG000|Overall Study|Withdrawal by Subject|1|||
163134699|NCT02697435|589201686|FG001|Overall Study|Withdrawal by Subject|0|||
163134700|NCT02697435|589201685|FG000|Overall Study|Physician Decision|0|||
163134701|NCT02697435|589201686|FG001|Overall Study|Physician Decision|4|||
163134702|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
163134703|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
163134704|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
163134705|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
163134706|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
163134707|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
163134708|NCT04230213|589201687|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
163134709|NCT04230213|589201688|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
163134710|NCT04230213|589201689|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
163134711|NCT04230213|589201687|FG000|TP2: Week 10 to Week 16|Other|0|||
163134712|NCT04230213|589201688|FG001|TP2: Week 10 to Week 16|Other|2|||
163134713|NCT04230213|589201689|FG002|TP2: Week 10 to Week 16|Other|1|||
163134714|NCT04230213|589201687|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
163134715|NCT04230213|589201688|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
163134716|NCT04230213|589201689|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
163134717|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
163134718|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
163134719|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
163134720|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
163134721|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
163134722|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
163134723|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
163134724|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
163134725|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
163134726|NCT04230213|589201687|FG000|TP3: Week 16 to Week 22|Other|0|||
163134727|NCT04230213|589201688|FG001|TP3: Week 16 to Week 22|Other|1|||
163134728|NCT04230213|589201689|FG002|TP3: Week 16 to Week 22|Other|3|||
163134729|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Other|0|||
163134730|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Other|5|||
163134731|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Other|5|||
163134732|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
163134733|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
163134734|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
163134735|NCT04230213|589201687|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
163134736|NCT04230213|589201688|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
163134737|NCT04230213|589201689|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
163134738|NCT04230213|589201687|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
163134739|NCT04230213|589201688|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
163134740|NCT04230213|589201689|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
163134741|NCT04230213|589201687|FG000|Follow up: Week 32 to Week 36|Other|0|||
163134742|NCT04230213|589201688|FG001|Follow up: Week 32 to Week 36|Other|1|||
163134743|NCT04230213|589201689|FG002|Follow up: Week 32 to Week 36|Other|1|||
163134744|NCT00619307|589201701|FG000|Overall Study|Adverse Event|0|||
163134745|NCT00619307|589201702|FG001|Overall Study|Adverse Event|1|||
163134746|NCT00619307|589201701|FG000|Overall Study|Lost to Follow-up|0|||
163134747|NCT00619307|589201702|FG001|Overall Study|Lost to Follow-up|1|||
163134748|NCT00619307|589201701|FG000|Overall Study|Protocol Violation|3|||
163134749|NCT00619307|589201702|FG001|Overall Study|Protocol Violation|0|||
163134750|NCT00619307|589201701|FG000|Overall Study|Withdrew consent|1|||
163134751|NCT00619307|589201702|FG001|Overall Study|Withdrew consent|0|||
163134752|NCT00619307|589201701|FG000|Overall Study|Severe migraine|0|||
163134753|NCT00619307|589201702|FG001|Overall Study|Severe migraine|1|||
163134754|NCT00619307|589201701|FG000|Overall Study|MS attack plus steroids|0|||
162659121|NCT01332305|587465872|FG002|Overall Study|Protocol Violation|1|||
162659122|NCT01332305|587465873|FG003|Overall Study|Protocol Violation|0|||
162659123|NCT01332305|587465874|FG004|Overall Study|Protocol Violation|3|||
162659124|NCT01332305|587465870|FG000|Overall Study|Withdrawal by Sponsor|1|||
162659125|NCT01332305|587465871|FG001|Overall Study|Withdrawal by Sponsor|0|||
163134755|NCT00619307|589201702|FG001|Overall Study|MS attack plus steroids|1|||
163134756|NCT00861471|589201705|FG000|Overall Study|Withdrawal by Subject|1|||
163134757|NCT00861471|589201705|FG000|Overall Study|Adverse Event|2|||
163134758|NCT00861471|589201705|FG000|Overall Study|Lack of Efficacy|3|||
163134759|NCT00861471|589201705|FG000|Overall Study|treatment for lumbar laminectomy|1|||
163134760|NCT00861471|589201705|FG000|Overall Study|Physician Decision|2|||
163134761|NCT02069392|589201708|FG000|Overall Study|Withdrawal by Subject|4|||
163134762|NCT02069392|589201709|FG001|Overall Study|Withdrawal by Subject|2|||
162659126|NCT01332305|587465872|FG002|Overall Study|Withdrawal by Sponsor|0|||
163134763|NCT00269633|589201710|FG000|Overall Study|Withdrawal by Subject|1|||
163134764|NCT00269633|589201711|FG001|Overall Study|Withdrawal by Subject|0|||
163134765|NCT01574651|589201712|FG000|Overall Study|Lost to Follow-up|2|||
163134766|NCT01574651|589201713|FG001|Overall Study|Lost to Follow-up|4|||
163134767|NCT01574651|589201712|FG000|Overall Study|Administrative problems|0|||
163134768|NCT01574651|589201713|FG001|Overall Study|Administrative problems|1|||
163134769|NCT01574651|589201712|FG000|Overall Study|Death|3|||
163134770|NCT01574651|589201713|FG001|Overall Study|Death|3|||
163134771|NCT01574651|589201712|FG000|Overall Study|Patient's inability to use the device|0|||
163134772|NCT01574651|589201713|FG001|Overall Study|Patient's inability to use the device|1|||
163134773|NCT01574651|589201712|FG000|Overall Study|Adverse Event|36|||
163134774|NCT01574651|589201713|FG001|Overall Study|Adverse Event|27|||
163134775|NCT01574651|589201712|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163134776|NCT01574651|589201713|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163134777|NCT01574651|589201712|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163134778|NCT01574651|589201713|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163134779|NCT01574651|589201712|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163134780|NCT01574651|589201713|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163134781|NCT01574651|589201712|FG000|Overall Study|Protocol Violation|3|||
163134782|NCT01574651|589201713|FG001|Overall Study|Protocol Violation|5|||
163134783|NCT01574651|589201712|FG000|Overall Study|Withdrawal by Subject|9|||
163134784|NCT01574651|589201713|FG001|Overall Study|Withdrawal by Subject|10|||
163134785|NCT04412707|589201714|FG000|Cycle 1|Death|0|||
163134786|NCT04412707|589201715|FG001|Cycle 1|Death|3|||
163134787|NCT04412707|589201714|FG000|Cycle 1|Disease progression|1|||
163134788|NCT04412707|589201715|FG001|Cycle 1|Disease progression|2|||
163134789|NCT04412707|589201714|FG000|Cycle 2|Death|0|||
163134790|NCT04412707|589201715|FG001|Cycle 2|Death|1|||
163134791|NCT04412707|589201714|FG000|Cycle 2|Disease progression|3|||
163134792|NCT04412707|589201715|FG001|Cycle 2|Disease progression|0|||
163134793|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
163134794|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
163134795|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
163134796|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
163134797|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
163134798|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
163134799|NCT04412707|589201714|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
163134800|NCT04412707|589201715|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
163134801|NCT00699608|589203919|FG000|First Intervention|Withdrawal by Subject|0|||
163134802|NCT00699608|589203920|FG001|First Intervention|Withdrawal by Subject|0|||
163134803|NCT00699608|589203921|FG002|First Intervention|Withdrawal by Subject|1|||
163134804|NCT00699608|589203922|FG003|First Intervention|Withdrawal by Subject|0|||
163134805|NCT00699608|589203923|FG004|First Intervention|Withdrawal by Subject|0|||
163134806|NCT00699608|589203924|FG005|First Intervention|Withdrawal by Subject|0|||
163134807|NCT00699608|589203919|FG000|First Intervention|Protocol Violation|0|||
163134808|NCT00699608|589203920|FG001|First Intervention|Protocol Violation|0|||
163134809|NCT00699608|589203921|FG002|First Intervention|Protocol Violation|0|||
163134810|NCT00699608|589203922|FG003|First Intervention|Protocol Violation|0|||
163134811|NCT00699608|589203923|FG004|First Intervention|Protocol Violation|1|||
163134812|NCT00699608|589203924|FG005|First Intervention|Protocol Violation|0|||
163134813|NCT00699608|589203919|FG000|Second Intervention|Adverse Event|0|||
163134814|NCT00699608|589203920|FG001|Second Intervention|Adverse Event|0|||
163134815|NCT00699608|589203921|FG002|Second Intervention|Adverse Event|1|||
163134816|NCT00699608|589203922|FG003|Second Intervention|Adverse Event|0|||
163134817|NCT00699608|589203923|FG004|Second Intervention|Adverse Event|0|||
163134818|NCT00699608|589203924|FG005|Second Intervention|Adverse Event|0|||
163134819|NCT00699608|589203919|FG000|Second Intervention|Withdrawal by Subject|0|||
163134820|NCT00699608|589203920|FG001|Second Intervention|Withdrawal by Subject|0|||
163134821|NCT00699608|589203921|FG002|Second Intervention|Withdrawal by Subject|0|||
163134822|NCT00699608|589203922|FG003|Second Intervention|Withdrawal by Subject|1|||
163134823|NCT00699608|589203923|FG004|Second Intervention|Withdrawal by Subject|0|||
163134824|NCT00699608|589203924|FG005|Second Intervention|Withdrawal by Subject|0|||
163134825|NCT04306510|589203929|FG000|Overall Study|Voluntarily withdrawal|1|||
163134826|NCT04306510|589203929|FG000|Overall Study|Enrolled but Not Treated|1|||
163134827|NCT04720417|589203930|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
163134828|NCT03329092|589203931|FG000|Overall Study|Other|2|||
163134829|NCT03329092|589203932|FG001|Overall Study|Other|2|||
163134830|NCT03329092|589203931|FG000|Overall Study|Withdrawal by Subject|16|||
163134831|NCT03329092|589203932|FG001|Overall Study|Withdrawal by Subject|3|||
163134832|NCT03329092|589203931|FG000|Overall Study|Physician Decision|1|||
163134833|NCT03329092|589203932|FG001|Overall Study|Physician Decision|0|||
163134834|NCT03329092|589203931|FG000|Overall Study|Death|17|||
163134835|NCT03329092|589203932|FG001|Overall Study|Death|11|||
163134836|NCT03329092|589203931|FG000|Overall Study|Adverse Event|3|||
163134837|NCT03329092|589203932|FG001|Overall Study|Adverse Event|1|||
163134838|NCT03329092|589203931|FG000|Overall Study|Lost to Follow-up|1|||
163134839|NCT03329092|589203932|FG001|Overall Study|Lost to Follow-up|1|||
163134840|NCT04878211|589203933|FG000|Overall Study|Lost to Follow-up|0|||
163134841|NCT04878211|589203934|FG001|Overall Study|Lost to Follow-up|0|||
163134842|NCT04878211|589203935|FG002|Overall Study|Lost to Follow-up|0|||
163134843|NCT04878211|589203936|FG003|Overall Study|Lost to Follow-up|1|||
162659127|NCT01332305|587465873|FG003|Overall Study|Withdrawal by Sponsor|1|||
162659128|NCT01332305|587465874|FG004|Overall Study|Withdrawal by Sponsor|1|||
162659129|NCT01332305|587465870|FG000|Overall Study|Treatment Failure|1|||
162659130|NCT01332305|587465871|FG001|Overall Study|Treatment Failure|1|||
162659131|NCT01332305|587465872|FG002|Overall Study|Treatment Failure|0|||
162659132|NCT01332305|587465873|FG003|Overall Study|Treatment Failure|0|||
162659133|NCT01332305|587465874|FG004|Overall Study|Treatment Failure|0|||
162659134|NCT01332305|587465870|FG000|Overall Study|Physician Decision|0|||
162659135|NCT01332305|587465871|FG001|Overall Study|Physician Decision|0|||
162659136|NCT01332305|587465872|FG002|Overall Study|Physician Decision|0|||
162659137|NCT01332305|587465873|FG003|Overall Study|Physician Decision|1|||
162659138|NCT01332305|587465874|FG004|Overall Study|Physician Decision|0|||
162659139|NCT01600040|587465875|FG000|Overall Study|Withdrawal by Subject|1|||
162659140|NCT01401530|587465881|FG000|Overall Study|Disease Progression|1|||
162659141|NCT01401530|587465882|FG001|Overall Study|Disease Progression|2|||
162659142|NCT01401530|587465883|FG002|Overall Study|Disease Progression|1|||
162659143|NCT01401530|587465881|FG000|Overall Study|Adverse Event|1|||
162659144|NCT01401530|587465882|FG001|Overall Study|Adverse Event|1|||
162659145|NCT01401530|587465883|FG002|Overall Study|Adverse Event|1|||
162659146|NCT01401530|587465881|FG000|Overall Study|Participant Choice|1|||
162659147|NCT01401530|587465882|FG001|Overall Study|Participant Choice|2|||
162659148|NCT01401530|587465883|FG002|Overall Study|Participant Choice|1|||
162659149|NCT01401530|587465881|FG000|Overall Study|Physician Decision|0|||
162659150|NCT01401530|587465882|FG001|Overall Study|Physician Decision|1|||
162659151|NCT01401530|587465883|FG002|Overall Study|Physician Decision|0|||
162659152|NCT03670810|587465884|FG000|Main Study|Adverse Event|37|||
162659153|NCT03670810|587465885|FG001|Main Study|Adverse Event|38|||
163134844|NCT04878211|589203937|FG004|Overall Study|Lost to Follow-up|0|||
163134845|NCT04878211|589203938|FG005|Overall Study|Lost to Follow-up|1|||
163134846|NCT04878211|589203933|FG000|Overall Study|Protocol deviation|1|||
163134847|NCT04878211|589203934|FG001|Overall Study|Protocol deviation|0|||
163134848|NCT04878211|589203935|FG002|Overall Study|Protocol deviation|0|||
163134849|NCT04878211|589203936|FG003|Overall Study|Protocol deviation|0|||
163134850|NCT04878211|589203937|FG004|Overall Study|Protocol deviation|0|||
163134851|NCT04878211|589203938|FG005|Overall Study|Protocol deviation|0|||
163134852|NCT04878211|589203933|FG000|Overall Study|Study terminated by sponsor|0|||
163134853|NCT04878211|589203934|FG001|Overall Study|Study terminated by sponsor|0|||
163134854|NCT04878211|589203935|FG002|Overall Study|Study terminated by sponsor|0|||
163134855|NCT04878211|589203936|FG003|Overall Study|Study terminated by sponsor|0|||
163134856|NCT04878211|589203937|FG004|Overall Study|Study terminated by sponsor|9|||
163134857|NCT04878211|589203938|FG005|Overall Study|Study terminated by sponsor|4|||
163134858|NCT04878211|589203933|FG000|Overall Study|Subject decision|0|||
163134859|NCT04878211|589203934|FG001|Overall Study|Subject decision|0|||
163134860|NCT04878211|589203935|FG002|Overall Study|Subject decision|0|||
163134861|NCT04878211|589203936|FG003|Overall Study|Subject decision|0|||
163134862|NCT04878211|589203937|FG004|Overall Study|Subject decision|1|||
163134863|NCT04878211|589203938|FG005|Overall Study|Subject decision|0|||
163134864|NCT01036321|589203941|FG000|Overall Study|Ineligible after randomization|0|||
163134865|NCT01036321|589203942|FG001|Overall Study|Ineligible after randomization|1|||
163134866|NCT01036321|589203941|FG000|Overall Study|Withdrawal by Subject|3|||
163134867|NCT01036321|589203942|FG001|Overall Study|Withdrawal by Subject|2|||
163134868|NCT01036321|589203941|FG000|Overall Study|Adverse Event|2|||
163134869|NCT01036321|589203942|FG001|Overall Study|Adverse Event|1|||
163134870|NCT03755882|589203943|FG000|Period 1|Protocol Violation|1|||
163134871|NCT03755882|589203944|FG001|Period 1|Protocol Violation|0|||
163134872|NCT03755882|589203943|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
163134873|NCT03755882|589203944|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
163134874|NCT00381693|589203945|FG000|Overall Study|Death|1|||
163134875|NCT00381693|589203945|FG000|Overall Study|Adverse Event|4|||
163134876|NCT00381693|589203945|FG000|Overall Study|Patient Choice|1|||
163134877|NCT00381693|589203945|FG000|Overall Study|Progression|2|||
163134878|NCT01687101|589203946|FG000|Overall Study|Lost to Follow-up|7|||
163134879|NCT02598297|589203947|FG000|Overall Study|Study terminated by Sponsor|21|||
163134880|NCT02598297|589203948|FG001|Overall Study|Study terminated by Sponsor|23|||
163134881|NCT02598297|589203947|FG000|Overall Study|Adverse Event|1|||
163134882|NCT02598297|589203948|FG001|Overall Study|Adverse Event|1|||
162659154|NCT03670810|587465886|FG002|Main Study|Adverse Event|3|||
162659155|NCT03670810|587465887|FG003|Main Study|Adverse Event|4|||
163134883|NCT02598297|589203947|FG000|Overall Study|Physician Decision|1|||
163134884|NCT02598297|589203948|FG001|Overall Study|Physician Decision|0|||
163134885|NCT02598297|589203947|FG000|Overall Study|Subject/guardian decision|1|||
163134886|NCT02598297|589203948|FG001|Overall Study|Subject/guardian decision|0|||
162659156|NCT03670810|587465888|FG004|Main Study|Adverse Event|4|||
162659157|NCT03670810|587465889|FG005|Main Study|Adverse Event|5|||
162659158|NCT03670810|587465890|FG006|Main Study|Adverse Event|0|||
162659159|NCT03670810|587465891|FG007|Main Study|Adverse Event|0|||
162659160|NCT03670810|587465892|FG008|Main Study|Adverse Event|0|||
162659161|NCT03670810|587465884|FG000|Main Study|Lack of Efficacy|8|||
163134887|NCT02598297|589203947|FG000|Overall Study|Followed for survival|1|||
162719906|NCT01244828|587680628|FG000|Overall Study|Lost to Follow-up|2|||
163134888|NCT02598297|589203948|FG001|Overall Study|Followed for survival|0|||
163134889|NCT03040674|589203950|FG000|Overall Study|Lost to Follow-up|225|||
163134890|NCT03040674|589203950|FG000|Overall Study|Death|23|||
163134891|NCT02206035|589203952|FG000|Overall Study|Physician Decision|10|||
163134892|NCT02206035|589203953|FG001|Overall Study|Physician Decision|0|||
163134893|NCT02206035|589203954|FG002|Overall Study|Physician Decision|175|||
163134894|NCT01934010|589203955|FG000|Overall Study|Adverse Event|1|||
163134895|NCT01934010|589203956|FG001|Overall Study|Adverse Event|1|||
163134896|NCT01934010|589203957|FG002|Overall Study|Adverse Event|0|||
163134897|NCT01934010|589203955|FG000|Overall Study|Withdrawal by Subject|15|||
163134898|NCT01934010|589203956|FG001|Overall Study|Withdrawal by Subject|6|||
163134899|NCT01934010|589203957|FG002|Overall Study|Withdrawal by Subject|2|||
163134900|NCT01934010|589203955|FG000|Overall Study|Lost to Follow-up|7|||
163134901|NCT01934010|589203956|FG001|Overall Study|Lost to Follow-up|4|||
163134902|NCT01934010|589203957|FG002|Overall Study|Lost to Follow-up|0|||
163134903|NCT00377858|589203959|FG000|Overall Study|Withdrawal by Subject|12|||
163134904|NCT00377858|589203960|FG001|Overall Study|Withdrawal by Subject|11|||
163134905|NCT00377858|589203959|FG000|Overall Study|Lost to Follow-up|6|||
163134906|NCT00377858|589203960|FG001|Overall Study|Lost to Follow-up|1|||
163134907|NCT00377858|589203959|FG000|Overall Study|Physician Decision|5|||
163134908|NCT00377858|589203960|FG001|Overall Study|Physician Decision|5|||
163134909|NCT00377858|589203959|FG000|Overall Study|Protocol Violation|3|||
163134910|NCT00377858|589203960|FG001|Overall Study|Protocol Violation|4|||
163134911|NCT00377858|589203959|FG000|Overall Study|Adverse Event|2|||
163134912|NCT00377858|589203960|FG001|Overall Study|Adverse Event|1|||
163134913|NCT00377858|589203959|FG000|Overall Study|Entry Criteria Not Met|2|||
163134914|NCT00377858|589203960|FG001|Overall Study|Entry Criteria Not Met|0|||
163134915|NCT00377858|589203959|FG000|Overall Study|Sponsor Decision|1|||
163134916|NCT00377858|589203960|FG001|Overall Study|Sponsor Decision|2|||
163134917|NCT00377858|589203959|FG000|Overall Study|Death|0|||
163134918|NCT00377858|589203960|FG001|Overall Study|Death|3|||
163134919|NCT02506192|589203961|FG000|Overall Study|Withdrawal by Subject|1|||
163134920|NCT02506192|589203962|FG001|Overall Study|Withdrawal by Subject|1|||
163134921|NCT04042909|589203963|FG000|Overall Study|Withdrawal by Subject|1|||
163134922|NCT04042909|589203964|FG001|Overall Study|Withdrawal by Subject|0|||
163134923|NCT04042909|589203965|FG002|Overall Study|Withdrawal by Subject|0|||
163134924|NCT04042909|589203963|FG000|Overall Study|duplicate cases|2|||
163134925|NCT04042909|589203964|FG001|Overall Study|duplicate cases|0|||
163134926|NCT04042909|589203965|FG002|Overall Study|duplicate cases|0|||
163134927|NCT04042909|589203963|FG000|Overall Study|technical problem|0|||
163134928|NCT04042909|589203964|FG001|Overall Study|technical problem|1|||
163134929|NCT04042909|589203965|FG002|Overall Study|technical problem|0|||
163134930|NCT03785405|589203966|FG000|Overall Study|Adverse Event|16|||
163134931|NCT03785405|589203967|FG001|Overall Study|Adverse Event|1|||
163134932|NCT03785405|589203966|FG000|Overall Study|Death|6|||
163134933|NCT03785405|589203967|FG001|Overall Study|Death|4|||
163134934|NCT03785405|589203966|FG000|Overall Study|Guardian decision|4|||
163134935|NCT03785405|589203967|FG001|Overall Study|Guardian decision|1|||
163134936|NCT03785405|589203966|FG000|Overall Study|Lost to Follow-up|1|||
163134937|NCT03785405|589203967|FG001|Overall Study|Lost to Follow-up|0|||
163134938|NCT03785405|589203966|FG000|Overall Study|Physician Decision|8|||
163134939|NCT03785405|589203967|FG001|Overall Study|Physician Decision|5|||
163134940|NCT03785405|589203966|FG000|Overall Study|Participant decision|2|||
163134941|NCT03785405|589203967|FG001|Overall Study|Participant decision|0|||
163134942|NCT03785405|589203966|FG000|Overall Study|Other|1|||
163134943|NCT03785405|589203967|FG001|Overall Study|Other|0|||
163134944|NCT03785405|589203966|FG000|Overall Study|No treatment was received|0|||
163134945|NCT03785405|589203967|FG001|Overall Study|No treatment was received|1|||
163134946|NCT03705559|589203968|FG000|Overall Study|COVID Shut down|1|||
163134947|NCT06041919|589203974|FG000|Overall Study|Lost to Follow-up|1|||
163134948|NCT06041919|589203975|FG001|Overall Study|Lost to Follow-up|0|||
163134949|NCT06041919|589203976|FG002|Overall Study|Lost to Follow-up|0|||
163134950|NCT06041919|589203977|FG003|Overall Study|Lost to Follow-up|0|||
163134951|NCT06041919|589203978|FG004|Overall Study|Lost to Follow-up|0|||
163134952|NCT06041919|589203974|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
163134953|NCT06041919|589203975|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
163134954|NCT06041919|589203976|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
162659162|NCT03670810|587465885|FG001|Main Study|Lack of Efficacy|9|||
163134955|NCT06041919|589203977|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
163134956|NCT06041919|589203978|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
163134957|NCT01147055|589203979|FG000|First Intervention Period|Lost to Follow-up|1|||
163134958|NCT01147055|589203980|FG001|First Intervention Period|Lost to Follow-up|0|||
163134959|NCT02576795|589203981|FG000|Overall Study|Lost to Follow-up|0|||
163134960|NCT02576795|589203982|FG001|Overall Study|Lost to Follow-up|0|||
163134961|NCT02576795|589203983|FG002|Overall Study|Lost to Follow-up|1|||
163134962|NCT02576795|589203984|FG003|Overall Study|Lost to Follow-up|0|||
163134963|NCT03724890|589203985|FG000|Overall Study|Death|2|||
163134964|NCT03724890|589203986|FG001|Overall Study|Death|6|||
163134965|NCT03724890|589203987|FG002|Overall Study|Death|3|||
163134966|NCT03724890|589203988|FG003|Overall Study|Death|5|||
163134967|NCT03724890|589203989|FG004|Overall Study|Death|2|||
163134968|NCT03724890|589203990|FG005|Overall Study|Death|0|||
163134969|NCT03724890|589203991|FG006|Overall Study|Death|2|||
163134970|NCT03724890|589203992|FG007|Overall Study|Death|3|||
163134971|NCT03724890|589203993|FG008|Overall Study|Death|4|||
163134972|NCT03724890|589203994|FG009|Overall Study|Death|2|||
163134973|NCT03724890|589203995|FG010|Overall Study|Death|2|||
163134974|NCT03724890|589203985|FG000|Overall Study|Lost to Follow-up|0|||
163134975|NCT03724890|589203986|FG001|Overall Study|Lost to Follow-up|3|||
163134976|NCT03724890|589203987|FG002|Overall Study|Lost to Follow-up|0|||
163134977|NCT03724890|589203988|FG003|Overall Study|Lost to Follow-up|1|||
163134978|NCT03724890|589203989|FG004|Overall Study|Lost to Follow-up|2|||
163134979|NCT03724890|589203990|FG005|Overall Study|Lost to Follow-up|2|||
163134980|NCT03724890|589203991|FG006|Overall Study|Lost to Follow-up|1|||
163134981|NCT03724890|589203992|FG007|Overall Study|Lost to Follow-up|0|||
163134982|NCT03724890|589203993|FG008|Overall Study|Lost to Follow-up|2|||
163134983|NCT03724890|589203994|FG009|Overall Study|Lost to Follow-up|0|||
163134984|NCT03724890|589203995|FG010|Overall Study|Lost to Follow-up|0|||
163134985|NCT03724890|589203985|FG000|Overall Study|Withdrawal by Subject|1|||
163134986|NCT03724890|589203986|FG001|Overall Study|Withdrawal by Subject|2|||
163134987|NCT03724890|589203987|FG002|Overall Study|Withdrawal by Subject|1|||
163134988|NCT03724890|589203988|FG003|Overall Study|Withdrawal by Subject|0|||
163134989|NCT03724890|589203989|FG004|Overall Study|Withdrawal by Subject|0|||
163134990|NCT03724890|589203990|FG005|Overall Study|Withdrawal by Subject|1|||
163134991|NCT03724890|589203991|FG006|Overall Study|Withdrawal by Subject|0|||
163134992|NCT03724890|589203992|FG007|Overall Study|Withdrawal by Subject|0|||
163134993|NCT03724890|589203993|FG008|Overall Study|Withdrawal by Subject|2|||
163134994|NCT03724890|589203994|FG009|Overall Study|Withdrawal by Subject|2|||
163134995|NCT03724890|589203995|FG010|Overall Study|Withdrawal by Subject|1|||
163134996|NCT03724890|589203985|FG000|Overall Study|Other|1|||
163134997|NCT03724890|589203986|FG001|Overall Study|Other|0|||
163134998|NCT03724890|589203987|FG002|Overall Study|Other|0|||
163134999|NCT03724890|589203988|FG003|Overall Study|Other|0|||
163135000|NCT03724890|589203989|FG004|Overall Study|Other|0|||
163135001|NCT03724890|589203990|FG005|Overall Study|Other|0|||
163135002|NCT03724890|589203991|FG006|Overall Study|Other|0|||
163135003|NCT03724890|589203992|FG007|Overall Study|Other|1|||
163135004|NCT03724890|589203993|FG008|Overall Study|Other|1|||
163135005|NCT03724890|589203994|FG009|Overall Study|Other|0|||
163135006|NCT03724890|589203995|FG010|Overall Study|Other|2|||
163135007|NCT02362464|589203997|FG000|Overall Study|Switched to alternative therapy|1|||
163135008|NCT02362464|589203997|FG000|Overall Study|Refused further treatment|1|||
163135009|NCT02362464|589203997|FG000|Overall Study|Physician Decision|4|||
163135010|NCT02123823|589203998|FG000|Overall Study|Lack of Efficacy|0|||
163135011|NCT02123823|589203999|FG001|Overall Study|Lack of Efficacy|2|||
163135012|NCT02123823|589204000|FG002|Overall Study|Lack of Efficacy|8|||
163135013|NCT02123823|589204001|FG003|Overall Study|Lack of Efficacy|10|||
163135014|NCT02123823|589203998|FG000|Overall Study|Progressive disease|3|||
163135015|NCT02123823|589203999|FG001|Overall Study|Progressive disease|19|||
163135016|NCT02123823|589204000|FG002|Overall Study|Progressive disease|52|||
163135017|NCT02123823|589204001|FG003|Overall Study|Progressive disease|53|||
163135018|NCT02123823|589203998|FG000|Overall Study|Withdrawal by Subject|0|||
163135019|NCT02123823|589203999|FG001|Overall Study|Withdrawal by Subject|0|||
163135020|NCT02123823|589204000|FG002|Overall Study|Withdrawal by Subject|7|||
163135021|NCT02123823|589204001|FG003|Overall Study|Withdrawal by Subject|2|||
163135022|NCT02123823|589203998|FG000|Overall Study|Adverse Event|0|||
163135023|NCT02123823|589203999|FG001|Overall Study|Adverse Event|0|||
163135024|NCT02123823|589204000|FG002|Overall Study|Adverse Event|3|||
163135025|NCT02123823|589204001|FG003|Overall Study|Adverse Event|5|||
163135026|NCT01635855|589204036|FG000|Overall Study|Withdrawal by Subject|4|||
163135027|NCT02104947|589204039|FG000|Overall Study|Withdrawal by Subject|10|||
163135028|NCT02104947|589204040|FG001|Overall Study|Withdrawal by Subject|3|||
163135029|NCT02104947|589204039|FG000|Overall Study|Lost to Follow-up|4|||
163135030|NCT02104947|589204040|FG001|Overall Study|Lost to Follow-up|4|||
163135031|NCT02104947|589204039|FG000|Overall Study|Protocol Violation|6|||
163135032|NCT02104947|589204040|FG001|Overall Study|Protocol Violation|8|||
163135033|NCT02104947|589204039|FG000|Overall Study|Adverse Event|57|||
163135034|NCT02104947|589204040|FG001|Overall Study|Adverse Event|38|||
163135035|NCT02104947|589204039|FG000|Overall Study|Other than stated above|2|||
163135036|NCT02104947|589204040|FG001|Overall Study|Other than stated above|3|||
163135037|NCT01844778|589204041|FG000|Overall Study|Protocol deviation|0|||
163135038|NCT01844778|589204042|FG001|Overall Study|Protocol deviation|1|||
163135039|NCT01844778|589204043|FG002|Overall Study|Protocol deviation|2|||
163135040|NCT01844778|589204041|FG000|Overall Study|Withdrawal by Subject|2|||
163135041|NCT01844778|589204042|FG001|Overall Study|Withdrawal by Subject|0|||
163135042|NCT01844778|589204043|FG002|Overall Study|Withdrawal by Subject|0|||
163135043|NCT01844778|589204041|FG000|Overall Study|Adverse Event|0|||
163135044|NCT01844778|589204042|FG001|Overall Study|Adverse Event|2|||
163135045|NCT01844778|589204043|FG002|Overall Study|Adverse Event|2|||
163135046|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
163135047|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135048|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135049|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135050|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135051|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
163135052|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
163135053|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135054|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135055|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135056|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135057|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
163135058|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
163135059|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135060|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135061|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135062|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135063|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163135064|NCT00095173|589204044|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
163135065|NCT00095173|589204045|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
163135066|NCT00095173|589204046|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
163135067|NCT00095173|589204047|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
163135068|NCT00095173|589204048|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
163135069|NCT00095173|589204049|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
163135070|NCT00095173|589204044|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135071|NCT00095173|589204045|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
163135072|NCT00095173|589204046|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
163135073|NCT00095173|589204047|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135074|NCT00095173|589204048|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135075|NCT00095173|589204049|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163135076|NCT00095173|589204044|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135077|NCT00095173|589204045|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
163135078|NCT00095173|589204046|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135079|NCT00095173|589204047|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135080|NCT00095173|589204048|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135081|NCT00095173|589204049|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
163135082|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Death|0|||
163135083|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Death|0|||
163135084|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Death|0|||
163135085|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Death|0|||
163135086|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Death|0|||
163135087|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Death|1|||
163135088|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135089|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135090|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163135091|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
163135092|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
163135093|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
163135094|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135095|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135096|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163135097|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
163135098|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
163135099|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
163135100|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135101|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135102|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
163135103|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
163135104|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
163135105|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
163135106|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135107|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135108|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135109|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
163135110|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
163135111|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
163135112|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135113|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135114|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135115|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163135116|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
163135117|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
163135118|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135119|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135120|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135121|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
163135122|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
163135123|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
163135124|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135125|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135126|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
163135127|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
163135128|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
163135129|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
163135130|NCT00095173|589204044|FG000|Open-Label Extension Phase (Period C)|Other|0|||
163135131|NCT00095173|589204045|FG001|Open-Label Extension Phase (Period C)|Other|0|||
163135132|NCT00095173|589204046|FG002|Open-Label Extension Phase (Period C)|Other|0|||
163135133|NCT00095173|589204047|FG003|Open-Label Extension Phase (Period C)|Other|4|||
163135134|NCT00095173|589204048|FG004|Open-Label Extension Phase (Period C)|Other|6|||
163135135|NCT00095173|589204049|FG005|Open-Label Extension Phase (Period C)|Other|8|||
163135136|NCT02343406|589204050|FG000|Overall Study|Progressive disease|72|||
163135137|NCT02343406|589204051|FG001|Overall Study|Progressive disease|70|||
163135138|NCT02343406|589204052|FG002|Overall Study|Progressive disease|43|||
163135139|NCT02343406|589204053|FG003|Overall Study|Progressive disease|15|||
163135140|NCT02343406|589204054|FG004|Overall Study|Progressive disease|5|||
163135141|NCT02343406|589204050|FG000|Overall Study|Adverse Event|6|||
163135142|NCT02343406|589204051|FG001|Overall Study|Adverse Event|8|||
162659163|NCT03670810|587465886|FG002|Main Study|Lack of Efficacy|3|||
162659164|NCT03670810|587465887|FG003|Main Study|Lack of Efficacy|4|||
163135143|NCT02343406|589204052|FG002|Overall Study|Adverse Event|6|||
163135144|NCT02343406|589204053|FG003|Overall Study|Adverse Event|3|||
163135145|NCT02343406|589204054|FG004|Overall Study|Adverse Event|0|||
163135146|NCT02343406|589204050|FG000|Overall Study|Withdrawal by Subject|6|||
163135147|NCT02343406|589204051|FG001|Overall Study|Withdrawal by Subject|4|||
163135148|NCT02343406|589204052|FG002|Overall Study|Withdrawal by Subject|8|||
163135149|NCT02343406|589204053|FG003|Overall Study|Withdrawal by Subject|3|||
163135150|NCT02343406|589204054|FG004|Overall Study|Withdrawal by Subject|0|||
163135151|NCT02343406|589204050|FG000|Overall Study|Death|2|||
163135152|NCT02343406|589204051|FG001|Overall Study|Death|1|||
163135153|NCT02343406|589204052|FG002|Overall Study|Death|0|||
162659165|NCT03670810|587465888|FG004|Main Study|Lack of Efficacy|0|||
163135154|NCT02343406|589204053|FG003|Overall Study|Death|0|||
163135155|NCT02343406|589204054|FG004|Overall Study|Death|0|||
163135156|NCT02343406|589204050|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
163135157|NCT02343406|589204051|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
163135158|NCT02343406|589204052|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
163135159|NCT02343406|589204053|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
163135160|NCT02343406|589204054|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
163135161|NCT02343406|589204050|FG000|Overall Study|Other primary malignancy|0|||
163135162|NCT02343406|589204051|FG001|Overall Study|Other primary malignancy|1|||
163135163|NCT02343406|589204052|FG002|Overall Study|Other primary malignancy|0|||
163135164|NCT02343406|589204053|FG003|Overall Study|Other primary malignancy|0|||
163135165|NCT02343406|589204054|FG004|Overall Study|Other primary malignancy|0|||
163135166|NCT02343406|589204050|FG000|Overall Study|Other, not specified|2|||
163135167|NCT02343406|589204051|FG001|Overall Study|Other, not specified|1|||
163135168|NCT02343406|589204052|FG002|Overall Study|Other, not specified|1|||
163135169|NCT02343406|589204053|FG003|Overall Study|Other, not specified|4|||
163135170|NCT02343406|589204054|FG004|Overall Study|Other, not specified|0|||
163135171|NCT00548145|589204055|FG000|Overall Study|Death|0|||
163135172|NCT00548145|589204056|FG001|Overall Study|Death|1|||
163135173|NCT00548145|589204055|FG000|Overall Study|Withdrawal by Subject|0|||
163135174|NCT00548145|589204056|FG001|Overall Study|Withdrawal by Subject|2|||
163135175|NCT00548145|589204055|FG000|Overall Study|Physician Decision|1|||
163135176|NCT00548145|589204056|FG001|Overall Study|Physician Decision|1|||
163135177|NCT00874848|589204057|FG000|Overall Study|Adverse Event|13|||
163135178|NCT00874848|589204058|FG001|Overall Study|Adverse Event|2|||
163135179|NCT00874848|589204057|FG000|Overall Study|Progressive neoplastic disease|38|||
163135180|NCT00874848|589204058|FG001|Overall Study|Progressive neoplastic disease|18|||
163135181|NCT00874848|589204057|FG000|Overall Study|Withdrawal by Subject|7|||
163135182|NCT00874848|589204058|FG001|Overall Study|Withdrawal by Subject|4|||
163135183|NCT00874848|589204057|FG000|Overall Study|Noncompliance|1|||
163135184|NCT00874848|589204058|FG001|Overall Study|Noncompliance|1|||
163135185|NCT00874848|589204057|FG000|Overall Study|Failure to comply with protocol|0|||
163135186|NCT00874848|589204058|FG001|Overall Study|Failure to comply with protocol|1|||
163135187|NCT00874848|589204057|FG000|Overall Study|Physician Decision|0|||
163135188|NCT00874848|589204058|FG001|Overall Study|Physician Decision|2|||
163135189|NCT03301350|589204067|FG000|Overall Study|Withdrawal by Subject|4|||
163135190|NCT03301350|589204067|FG000|Overall Study|Adverse Event|1|||
163135191|NCT03301350|589204067|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
163135192|NCT03301350|589204067|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
163135193|NCT03301350|589204067|FG000|Overall Study|no detail provided|1|||
163135194|NCT00379912|589204068|FG000|Overall Study|Lack of Efficacy|1|||
163135195|NCT00379912|589204069|FG001|Overall Study|Lack of Efficacy|0|||
163135196|NCT04698993|589204070|FG000|Overall Study|PCR results not accessible|2|||
163135197|NCT04698993|589204071|FG001|Overall Study|PCR results not accessible|7|||
163135198|NCT04698993|589204070|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
163135199|NCT04698993|589204071|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
163135200|NCT01371734|589204072|FG000|Overall Study|Other|2|||
163135201|NCT01371734|589204073|FG001|Overall Study|Other|1|||
163135202|NCT01371734|589204074|FG002|Overall Study|Other|2|||
163135203|NCT01371734|589204072|FG000|Overall Study|Withdrawal by Subject|3|||
163135204|NCT01371734|589204073|FG001|Overall Study|Withdrawal by Subject|4|||
163135205|NCT01371734|589204074|FG002|Overall Study|Withdrawal by Subject|9|||
163135206|NCT01371734|589204072|FG000|Overall Study|Lost to Follow-up|5|||
163135207|NCT01371734|589204073|FG001|Overall Study|Lost to Follow-up|3|||
163135208|NCT01371734|589204074|FG002|Overall Study|Lost to Follow-up|1|||
162659166|NCT03670810|587465889|FG005|Main Study|Lack of Efficacy|0|||
162659167|NCT03670810|587465890|FG006|Main Study|Lack of Efficacy|0|||
163135209|NCT01371734|589204072|FG000|Overall Study|Protocol Violation|3|||
162659168|NCT03670810|587465891|FG007|Main Study|Lack of Efficacy|0|||
163135210|NCT01371734|589204073|FG001|Overall Study|Protocol Violation|1|||
163135211|NCT01371734|589204074|FG002|Overall Study|Protocol Violation|2|||
163135212|NCT01371734|589204072|FG000|Overall Study|Adverse Event|8|||
163135213|NCT01371734|589204073|FG001|Overall Study|Adverse Event|8|||
163135214|NCT01371734|589204074|FG002|Overall Study|Adverse Event|3|||
163135215|NCT01371734|589204072|FG000|Overall Study|Lack of Efficacy|2|||
163135216|NCT01371734|589204073|FG001|Overall Study|Lack of Efficacy|2|||
163135217|NCT01371734|589204074|FG002|Overall Study|Lack of Efficacy|0|||
163135218|NCT00206440|589204075|FG000|Overall Study|Protocol Violation|1|||
163135219|NCT00206440|589204076|FG001|Overall Study|Protocol Violation|2|||
163135220|NCT00206440|589204075|FG000|Overall Study|Adverse Event|4|||
163135221|NCT00206440|589204076|FG001|Overall Study|Adverse Event|2|||
163135222|NCT00958165|589204077|FG000|Overall Study|Lost to Follow-up|5|||
163135223|NCT00958165|589204077|FG000|Overall Study|Not eligible|9|||
163135224|NCT00145574|589204078|FG000|Double Blind|Adverse Event|0|||
163135225|NCT00145574|589204079|FG001|Double Blind|Adverse Event|3|||
163135226|NCT00145574|589204080|FG002|Double Blind|Adverse Event|1|||
163135227|NCT00145574|589204078|FG000|Double Blind|Withdrawal by Subject|1|||
163135228|NCT00145574|589204079|FG001|Double Blind|Withdrawal by Subject|1|||
163135229|NCT00145574|589204080|FG002|Double Blind|Withdrawal by Subject|1|||
163135230|NCT00145574|589204078|FG000|Double Blind|required restricted medicine|0|||
163135231|NCT00145574|589204079|FG001|Double Blind|required restricted medicine|1|||
163135232|NCT00145574|589204080|FG002|Double Blind|required restricted medicine|0|||
163135233|NCT00145574|589204078|FG000|Open Label Long-term Extension|Adverse Event|0|||
163135234|NCT00145574|589204079|FG001|Open Label Long-term Extension|Adverse Event|0|||
163135235|NCT00145574|589204080|FG002|Open Label Long-term Extension|Adverse Event|5|||
163135236|NCT00145574|589204078|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
163135237|NCT00145574|589204079|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
163135238|NCT00145574|589204080|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
163135239|NCT00145574|589204078|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
163135240|NCT00145574|589204079|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
163135241|NCT00145574|589204080|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
163135242|NCT00145574|589204078|FG000|Open Label Long-term Extension|required restricted medicine|0|||
163135243|NCT00145574|589204079|FG001|Open Label Long-term Extension|required restricted medicine|0|||
163135244|NCT00145574|589204080|FG002|Open Label Long-term Extension|required restricted medicine|1|||
163135245|NCT00621140|589204081|FG000|Overall Study|Adverse Event|4|||
163135246|NCT00621140|589204082|FG001|Overall Study|Adverse Event|5|||
163135247|NCT00621140|589204081|FG000|Overall Study|Lost to Follow-up|1|||
163135248|NCT00621140|589204082|FG001|Overall Study|Lost to Follow-up|2|||
163135249|NCT00621140|589204081|FG000|Overall Study|Withdrawal by Subject|4|||
163135250|NCT00621140|589204082|FG001|Overall Study|Withdrawal by Subject|6|||
163135251|NCT00621140|589204081|FG000|Overall Study|Other incl. lack of efficacy|6|||
163135252|NCT00621140|589204082|FG001|Overall Study|Other incl. lack of efficacy|5|||
163135253|NCT01298765|589204084|FG000|Titration Period|Adverse Event|26|||
163135254|NCT01298765|589204084|FG000|Titration Period|Death|1|||
163135255|NCT01298765|589204084|FG000|Titration Period|Lack of Efficacy|21|||
163135256|NCT01298765|589204084|FG000|Titration Period|Lost to Follow-up|9|||
163135257|NCT01298765|589204084|FG000|Titration Period|Physician Decision|1|||
163135258|NCT01298765|589204084|FG000|Titration Period|Withdrawal by Subject|10|||
163135259|NCT01298765|589204084|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
163135260|NCT01298765|589204084|FG000|Long-Term Treatment Period|Adverse Event|19|||
163135261|NCT01298765|589204084|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
162659169|NCT03670810|587465892|FG008|Main Study|Lack of Efficacy|0|||
162659170|NCT03670810|587465884|FG000|Main Study|Lost to Follow-up|9|||
163135262|NCT01298765|589204084|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
163135263|NCT01298765|589204084|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
163135264|NCT01298765|589204084|FG000|Long-Term Treatment Period|Physician Decision|1|||
163135265|NCT01298765|589204084|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
163135266|NCT03565237|589204085|FG000|Overall Study|Non-compliance of Investigational Product|1|||
163135267|NCT03565237|589204085|FG000|Overall Study|Physician Decision|1|||
163135268|NCT01140061|589204088|FG000|Part I|Adverse Event|1|||
163135269|NCT01140061|589204089|FG001|Part I|Adverse Event|0|||
163135270|NCT01140061|589204090|FG002|Part I|Adverse Event|0|||
163135271|NCT01140061|589204091|FG003|Part I|Adverse Event|0|||
163135272|NCT01140061|589204092|FG004|Part I|Adverse Event|0|||
163135273|NCT01140061|589204093|FG005|Part I|Adverse Event|0|||
163135274|NCT01140061|589204094|FG006|Part I|Adverse Event|0|||
163135275|NCT01140061|589204095|FG007|Part I|Adverse Event|0|||
163135276|NCT01140061|589204096|FG008|Part I|Adverse Event|0|||
163135277|NCT01140061|589204097|FG009|Part I|Adverse Event|0|||
163135278|NCT01140061|589204088|FG000|Extension|Laboratory Adverse Event|0|||
162659171|NCT03670810|587465885|FG001|Main Study|Lost to Follow-up|7|||
162659172|NCT03670810|587465886|FG002|Main Study|Lost to Follow-up|4|||
162659173|NCT03670810|587465887|FG003|Main Study|Lost to Follow-up|6|||
163135279|NCT01140061|589204089|FG001|Extension|Laboratory Adverse Event|0|||
163135280|NCT01140061|589204090|FG002|Extension|Laboratory Adverse Event|0|||
163135281|NCT01140061|589204091|FG003|Extension|Laboratory Adverse Event|0|||
163135282|NCT01140061|589204092|FG004|Extension|Laboratory Adverse Event|0|||
163135283|NCT01140061|589204093|FG005|Extension|Laboratory Adverse Event|0|||
163135284|NCT01140061|589204094|FG006|Extension|Laboratory Adverse Event|0|||
163135285|NCT01140061|589204095|FG007|Extension|Laboratory Adverse Event|0|||
163135286|NCT01140061|589204096|FG008|Extension|Laboratory Adverse Event|0|||
163135287|NCT01140061|589204097|FG009|Extension|Laboratory Adverse Event|1|||
163135288|NCT00428389|589204098|FG000|Core Phase|Adverse Event|6|||
163135289|NCT00428389|589204099|FG001|Core Phase|Adverse Event|4|||
163135290|NCT00428389|589204098|FG000|Core Phase|Lack of Efficacy|2|||
163135291|NCT00428389|589204099|FG001|Core Phase|Lack of Efficacy|0|||
163135292|NCT00428389|589204098|FG000|Core Phase|Abnormal test procedure result(s)|0|||
163135293|NCT00428389|589204099|FG001|Core Phase|Abnormal test procedure result(s)|1|||
163135294|NCT00428389|589204098|FG000|Core Phase|Withdrawal by Subject|3|||
163135295|NCT00428389|589204099|FG001|Core Phase|Withdrawal by Subject|4|||
163135296|NCT00428389|589204098|FG000|Core Phase|Protocol deviation|0|||
163135297|NCT00428389|589204099|FG001|Core Phase|Protocol deviation|2|||
163135298|NCT00428389|589204098|FG000|Extension Phase|Adverse Event|17|||
163135299|NCT00428389|589204099|FG001|Extension Phase|Adverse Event|11|||
163135300|NCT00428389|589204098|FG000|Extension Phase|Lack of Efficacy|4|||
163135301|NCT00428389|589204099|FG001|Extension Phase|Lack of Efficacy|3|||
163135302|NCT00428389|589204098|FG000|Extension Phase|Withdrawal by Subject|6|||
163135303|NCT00428389|589204099|FG001|Extension Phase|Withdrawal by Subject|6|||
163135304|NCT00428389|589204098|FG000|Extension Phase|Lost to Follow-up|0|||
163135305|NCT00428389|589204099|FG001|Extension Phase|Lost to Follow-up|3|||
163135306|NCT00428389|589204098|FG000|Extension Phase|Death|1|||
163135307|NCT00428389|589204099|FG001|Extension Phase|Death|0|||
163135308|NCT00428389|589204098|FG000|Extension Phase|Protocol Violation|3|||
163135309|NCT00428389|589204099|FG001|Extension Phase|Protocol Violation|2|||
163135310|NCT00428389|589204098|FG000|Extension Phase|Administrative problems|1|||
163135311|NCT00428389|589204099|FG001|Extension Phase|Administrative problems|1|||
163135312|NCT02669121|589204100|FG000|Overall Study|Adverse Event|4|||
163135313|NCT02669121|589204101|FG001|Overall Study|Adverse Event|5|||
163135314|NCT02669121|589204100|FG000|Overall Study|Lost to Follow-up|15|||
163135315|NCT02669121|589204101|FG001|Overall Study|Lost to Follow-up|27|||
163135316|NCT02669121|589204100|FG000|Overall Study|Withdrawal by Subject|132|||
163135317|NCT02669121|589204101|FG001|Overall Study|Withdrawal by Subject|140|||
163135318|NCT02669121|589204100|FG000|Overall Study|Pregnancy|0|||
163135319|NCT02669121|589204101|FG001|Overall Study|Pregnancy|1|||
163135320|NCT02669121|589204100|FG000|Overall Study|Discharged from US Military Active Service|117|||
163135321|NCT02669121|589204101|FG001|Overall Study|Discharged from US Military Active Service|91|||
163135322|NCT02669121|589204100|FG000|Overall Study|Reason not Specified|22|||
163135323|NCT02669121|589204101|FG001|Overall Study|Reason not Specified|18|||
163135324|NCT03216746|589204102|FG000|Overall Study|Lost to Follow-up|6|||
163135325|NCT03216746|589204103|FG001|Overall Study|Lost to Follow-up|8|||
163135326|NCT03216746|589204104|FG002|Overall Study|Lost to Follow-up|5|||
163135327|NCT03216746|589204105|FG003|Overall Study|Lost to Follow-up|6|||
163135328|NCT04384523|589204106|FG000|Overall Study|Lost to Follow-up|0|||
163135329|NCT04384523|589204107|FG001|Overall Study|Lost to Follow-up|0|||
163135330|NCT04384523|589204108|FG002|Overall Study|Lost to Follow-up|0|||
163135331|NCT04384523|589204109|FG003|Overall Study|Lost to Follow-up|0|||
163135332|NCT04384523|589204110|FG004|Overall Study|Lost to Follow-up|0|||
163135333|NCT04384523|589204111|FG005|Overall Study|Lost to Follow-up|1|||
163135334|NCT04384523|589204106|FG000|Overall Study|Protocol Violation|0|||
163135335|NCT04384523|589204107|FG001|Overall Study|Protocol Violation|1|||
163135336|NCT04384523|589204108|FG002|Overall Study|Protocol Violation|0|||
163135337|NCT04384523|589204109|FG003|Overall Study|Protocol Violation|0|||
163135338|NCT04384523|589204110|FG004|Overall Study|Protocol Violation|0|||
163135339|NCT04384523|589204111|FG005|Overall Study|Protocol Violation|0|||
163135340|NCT04384523|589204106|FG000|Overall Study|Withdrawal by Subject|1|||
163135341|NCT04384523|589204107|FG001|Overall Study|Withdrawal by Subject|0|||
163135342|NCT04384523|589204108|FG002|Overall Study|Withdrawal by Subject|0|||
163135343|NCT04384523|589204109|FG003|Overall Study|Withdrawal by Subject|0|||
163135344|NCT04384523|589204110|FG004|Overall Study|Withdrawal by Subject|0|||
163135345|NCT04384523|589204111|FG005|Overall Study|Withdrawal by Subject|0|||
163135346|NCT00835341|589204112|FG000|Overall Study|Lost to Follow-up|3|||
163135347|NCT00835341|589204113|FG001|Overall Study|Lost to Follow-up|12|||
163135348|NCT01098305|589204115|FG000|Overall Study|Lost to Follow-up|31|||
163135349|NCT01098305|589204116|FG001|Overall Study|Lost to Follow-up|33|||
163135350|NCT03170193|589204127|FG000|Overall Study|Withdrawal by Subject|0|||
163135351|NCT03170193|589204128|FG001|Overall Study|Withdrawal by Subject|0|||
163135352|NCT03170193|589204129|FG002|Overall Study|Withdrawal by Subject|0|||
163135353|NCT03170193|589204130|FG003|Overall Study|Withdrawal by Subject|1|||
162719907|NCT01244828|587680628|FG000|Overall Study|Other reason (not specified)|1|||
163135354|NCT03170193|589204131|FG004|Overall Study|Withdrawal by Subject|0|||
163135355|NCT03170193|589204132|FG005|Overall Study|Withdrawal by Subject|0|||
163135356|NCT03170193|589204133|FG006|Overall Study|Withdrawal by Subject|0|||
163135357|NCT03170193|589204127|FG000|Overall Study|Lost to Follow-up|1|||
163135358|NCT03170193|589204128|FG001|Overall Study|Lost to Follow-up|1|||
163135359|NCT03170193|589204129|FG002|Overall Study|Lost to Follow-up|0|||
163135360|NCT03170193|589204130|FG003|Overall Study|Lost to Follow-up|0|||
163135361|NCT03170193|589204131|FG004|Overall Study|Lost to Follow-up|0|||
163135362|NCT03170193|589204132|FG005|Overall Study|Lost to Follow-up|0|||
163135363|NCT03170193|589204133|FG006|Overall Study|Lost to Follow-up|0|||
163135364|NCT03848949|589204137|FG000|Overall Study|Lost to Follow-up|5|||
163135365|NCT03848949|589204138|FG001|Overall Study|Lost to Follow-up|7|||
163135366|NCT00118430|589204149|FG000|Overall Study|Withdrawal by Subject|6|||
163135367|NCT00118430|589204150|FG001|Overall Study|Withdrawal by Subject|2|||
163135368|NCT00118430|589204151|FG002|Overall Study|Withdrawal by Subject|0|||
163135369|NCT00118430|589204149|FG000|Overall Study|Lost to Follow-up|15|||
163135370|NCT00118430|589204150|FG001|Overall Study|Lost to Follow-up|22|||
163135371|NCT00118430|589204151|FG002|Overall Study|Lost to Follow-up|28|||
163135372|NCT00534976|589204152|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
163135373|NCT00534976|589204153|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
163135374|NCT00534976|589204152|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
163135375|NCT00534976|589204153|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
163135376|NCT00534976|589204152|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
163135377|NCT00534976|589204153|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
163135378|NCT02147288|589204154|FG000|Overall Study|post-operative hematoma|1|||
163135379|NCT02147288|589204155|FG001|Overall Study|post-operative hematoma|1|||
163135380|NCT02147288|589204156|FG002|Overall Study|post-operative hematoma|0|||
163135381|NCT02147288|589204157|FG003|Overall Study|post-operative hematoma|0|||
163135382|NCT02147288|589204158|FG004|Overall Study|post-operative hematoma|0|||
163135383|NCT02147288|589204159|FG005|Overall Study|post-operative hematoma|0|||
163135384|NCT02147288|589204160|FG006|Overall Study|post-operative hematoma|0|||
163135385|NCT02147288|589204161|FG007|Overall Study|post-operative hematoma|0|||
163135386|NCT02147288|589204162|FG008|Overall Study|post-operative hematoma|0|||
163135387|NCT02147288|589204163|FG009|Overall Study|post-operative hematoma|0|||
163135388|NCT02147288|589204154|FG000|Overall Study|complications from concurrent hernia rep|0|||
163135389|NCT02147288|589204155|FG001|Overall Study|complications from concurrent hernia rep|1|||
163135390|NCT02147288|589204156|FG002|Overall Study|complications from concurrent hernia rep|0|||
163135391|NCT02147288|589204157|FG003|Overall Study|complications from concurrent hernia rep|0|||
163135392|NCT02147288|589204158|FG004|Overall Study|complications from concurrent hernia rep|0|||
163135393|NCT02147288|589204159|FG005|Overall Study|complications from concurrent hernia rep|0|||
163135394|NCT02147288|589204160|FG006|Overall Study|complications from concurrent hernia rep|0|||
163135395|NCT02147288|589204161|FG007|Overall Study|complications from concurrent hernia rep|0|||
163135396|NCT02147288|589204162|FG008|Overall Study|complications from concurrent hernia rep|0|||
163135397|NCT02147288|589204163|FG009|Overall Study|complications from concurrent hernia rep|0|||
163135398|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Adverse Event|33|||
163135399|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
163135400|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
163135401|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
163135402|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Physician Decision|6|||
163135403|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
163135404|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
163135405|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
163135406|NCT00965419|589204164|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
163135407|NCT00965419|589204164|FG000|Follow-up Phase|Adverse Event|9|||
163135408|NCT00965419|589204164|FG000|Follow-up Phase|Protocol Violation|4|||
163135409|NCT00965419|589204164|FG000|Follow-up Phase|Withdrawal by Subject|8|||
163135410|NCT00965419|589204164|FG000|Follow-up Phase|Physician Decision|4|||
163135411|NCT00965419|589204164|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
163135412|NCT00965419|589204164|FG000|Follow-up Phase|Lack of Efficacy|28|||
163135413|NCT00264537|589204165|FG000|Overall Study|Death|0|||
163135414|NCT00264537|589204166|FG001|Overall Study|Death|3|||
163135415|NCT00264537|589204167|FG002|Overall Study|Death|3|||
163135416|NCT00264537|589204168|FG003|Overall Study|Death|2|||
163135417|NCT00264537|589204165|FG000|Overall Study|Lost to Follow-up|3|||
163135418|NCT00264537|589204166|FG001|Overall Study|Lost to Follow-up|4|||
163135419|NCT00264537|589204167|FG002|Overall Study|Lost to Follow-up|7|||
163135420|NCT00264537|589204168|FG003|Overall Study|Lost to Follow-up|6|||
163135421|NCT00264537|589204165|FG000|Overall Study|Adverse Event|21|||
163135422|NCT00264537|589204166|FG001|Overall Study|Adverse Event|32|||
163135423|NCT00264537|589204167|FG002|Overall Study|Adverse Event|24|||
163135424|NCT00264537|589204168|FG003|Overall Study|Adverse Event|34|||
163135425|NCT00264537|589204165|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163135426|NCT00264537|589204166|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163135427|NCT00264537|589204167|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
163135428|NCT00264537|589204168|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
163135429|NCT00264537|589204165|FG000|Overall Study|Other|21|||
163135430|NCT00264537|589204166|FG001|Overall Study|Other|11|||
163135431|NCT00264537|589204167|FG002|Overall Study|Other|10|||
163135432|NCT00264537|589204168|FG003|Overall Study|Other|11|||
163135433|NCT00264537|589204165|FG000|Overall Study|Not treated|0|||
163135434|NCT00264537|589204166|FG001|Overall Study|Not treated|2|||
163135435|NCT00264537|589204167|FG002|Overall Study|Not treated|1|||
163135436|NCT00264537|589204168|FG003|Overall Study|Not treated|0|||
163135437|NCT00615017|589206064|FG000|Overall Study|Adverse Event|0|||
163135438|NCT00615017|589206065|FG001|Overall Study|Adverse Event|1|||
163135439|NCT00615017|589206066|FG002|Overall Study|Adverse Event|2|||
163135440|NCT00615017|589206067|FG003|Overall Study|Adverse Event|0|||
163135441|NCT00615017|589206068|FG004|Overall Study|Adverse Event|0|||
163135442|NCT00615017|589206069|FG005|Overall Study|Adverse Event|1|||
163135443|NCT00615017|589206064|FG000|Overall Study|Death|0|||
163135444|NCT00615017|589206065|FG001|Overall Study|Death|0|||
163135445|NCT00615017|589206066|FG002|Overall Study|Death|2|||
163135446|NCT00615017|589206067|FG003|Overall Study|Death|0|||
163135447|NCT00615017|589206068|FG004|Overall Study|Death|1|||
163135448|NCT00615017|589206069|FG005|Overall Study|Death|1|||
163135449|NCT00615017|589206064|FG000|Overall Study|Sepsis resolved|0|||
163135450|NCT00615017|589206065|FG001|Overall Study|Sepsis resolved|0|||
163135451|NCT00615017|589206066|FG002|Overall Study|Sepsis resolved|1|||
163135452|NCT00615017|589206067|FG003|Overall Study|Sepsis resolved|0|||
163135453|NCT00615017|589206068|FG004|Overall Study|Sepsis resolved|0|||
163135454|NCT00615017|589206069|FG005|Overall Study|Sepsis resolved|0|||
163135455|NCT00615017|589206064|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
163135456|NCT00615017|589206065|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
163135457|NCT00615017|589206066|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
163135458|NCT00615017|589206067|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
163135459|NCT00615017|589206068|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
163135460|NCT00615017|589206069|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
163135461|NCT00615017|589206064|FG000|Overall Study|Physician discontinued drug|0|||
163135462|NCT00615017|589206065|FG001|Overall Study|Physician discontinued drug|0|||
163135463|NCT00615017|589206066|FG002|Overall Study|Physician discontinued drug|0|||
163135464|NCT00615017|589206067|FG003|Overall Study|Physician discontinued drug|0|||
163135465|NCT00615017|589206068|FG004|Overall Study|Physician discontinued drug|0|||
163135466|NCT00615017|589206069|FG005|Overall Study|Physician discontinued drug|1|||
163135467|NCT00806988|589206070|FG000|Overall Study|Death|15|||
163135468|NCT00806988|589206071|FG001|Overall Study|Death|16|||
163135469|NCT00806988|589206070|FG000|Overall Study|Withdrawal by Subject|8|||
163135470|NCT00806988|589206071|FG001|Overall Study|Withdrawal by Subject|8|||
163135471|NCT00806988|589206070|FG000|Overall Study|Lost to Follow-up|4|||
163135472|NCT00806988|589206071|FG001|Overall Study|Lost to Follow-up|19|||
163135473|NCT04775953|589206073|FG000|Overall Study|Lost to Follow-up|6|||
163135474|NCT04775953|589206074|FG001|Overall Study|Lost to Follow-up|11|||
163135475|NCT04775953|589206073|FG000|Overall Study|Death|5|||
163135476|NCT04775953|589206074|FG001|Overall Study|Death|4|||
163135477|NCT04775953|589206073|FG000|Overall Study|Withdrawal by Subject|3|||
163135478|NCT04775953|589206074|FG001|Overall Study|Withdrawal by Subject|3|||
163135479|NCT04775953|589206073|FG000|Overall Study|Protocol Violation|2|||
163135480|NCT04775953|589206074|FG001|Overall Study|Protocol Violation|0|||
163135481|NCT04775953|589206073|FG000|Overall Study|Participant non-compliance|0|||
163135482|NCT04775953|589206074|FG001|Overall Study|Participant non-compliance|1|||
163135483|NCT01698814|589206075|FG000|Overall Study|Adverse Event|0|||
163135484|NCT01698814|589206076|FG001|Overall Study|Adverse Event|2|||
163135485|NCT01698814|589206075|FG000|Overall Study|Lost to Follow-up|0|||
163135486|NCT01698814|589206076|FG001|Overall Study|Lost to Follow-up|1|||
163135487|NCT01698814|589206075|FG000|Overall Study|Pregnancy|1|||
163135488|NCT01698814|589206076|FG001|Overall Study|Pregnancy|0|||
163135489|NCT01698814|589206075|FG000|Overall Study|Randomized in error|1|||
163135490|NCT01698814|589206076|FG001|Overall Study|Randomized in error|0|||
163135491|NCT00855959|589206077|FG000|Overall Study|Adverse Event|2|||
163135492|NCT00855959|589206077|FG000|Overall Study|Lost to Follow-up|2|||
163135493|NCT00855959|589206077|FG000|Overall Study|Withdrawal by Subject|3|||
162659174|NCT03670810|587465888|FG004|Main Study|Lost to Follow-up|1|||
163135494|NCT00855959|589206077|FG000|Overall Study|Pregnancy|1|||
163135495|NCT00855959|589206077|FG000|Overall Study|Incorrect enrolment|1|||
163135496|NCT04014062|589206078|FG000|Period I: Dosing|Medical Grounds|4|||
163135497|NCT04014062|589206079|FG001|Period I: Dosing|Medical Grounds|5|||
163135498|NCT04014062|589206078|FG000|Period I: Dosing|Withdrawal by Subject|3|||
163135499|NCT04014062|589206079|FG001|Period I: Dosing|Withdrawal by Subject|1|||
163135500|NCT01424501|589206080|FG000|Overall Study|Withdrawal by Subject|1|||
163135501|NCT01424501|589206081|FG001|Overall Study|Withdrawal by Subject|0|||
163135502|NCT01424501|589206082|FG002|Overall Study|Withdrawal by Subject|1|||
163135503|NCT01424501|589206083|FG003|Overall Study|Withdrawal by Subject|0|||
163135504|NCT01424501|589206084|FG004|Overall Study|Withdrawal by Subject|0|||
163135505|NCT01424501|589206085|FG005|Overall Study|Withdrawal by Subject|0|||
163135506|NCT01424501|589206080|FG000|Overall Study|Lost to Follow-up|0|||
163135507|NCT01424501|589206081|FG001|Overall Study|Lost to Follow-up|1|||
163135508|NCT01424501|589206082|FG002|Overall Study|Lost to Follow-up|1|||
163135509|NCT01424501|589206083|FG003|Overall Study|Lost to Follow-up|0|||
163135510|NCT01424501|589206084|FG004|Overall Study|Lost to Follow-up|0|||
163135511|NCT01424501|589206085|FG005|Overall Study|Lost to Follow-up|0|||
163135512|NCT01980095|589206086|FG000|Overall Study|Lost to Follow-up|6|||
163135513|NCT01980095|589206087|FG001|Overall Study|Lost to Follow-up|7|||
163135514|NCT01980095|589206086|FG000|Overall Study|Withdrawal by Subject|2|||
163135515|NCT01980095|589206087|FG001|Overall Study|Withdrawal by Subject|3|||
163135516|NCT01980095|589206086|FG000|Overall Study|Poor compliance|5|||
163135517|NCT01980095|589206087|FG001|Overall Study|Poor compliance|0|||
163135518|NCT01980095|589206086|FG000|Overall Study|Safety issue|0|||
163135519|NCT01980095|589206087|FG001|Overall Study|Safety issue|1|||
163135520|NCT01980095|589206086|FG000|Overall Study|Study drug discontinued|1|||
163135521|NCT01980095|589206087|FG001|Overall Study|Study drug discontinued|0|||
163135522|NCT01980095|589206086|FG000|Overall Study|Randomized by mistake|1|||
163135523|NCT01980095|589206087|FG001|Overall Study|Randomized by mistake|0|||
163135524|NCT02783599|589206094|FG000|Overall Study|Progressive disease|23|||
163135525|NCT02783599|589206094|FG000|Overall Study|Surgical Resection|10|||
163135526|NCT02783599|589206094|FG000|Overall Study|Adverse Event|4|||
163135527|NCT02783599|589206094|FG000|Overall Study|Physician Decision|2|||
163135528|NCT02783599|589206094|FG000|Overall Study|Death|1|||
163135529|NCT00856544|589206095|FG000|Overall Study|Randomized but not treated|3|||
163135530|NCT00856544|589206096|FG001|Overall Study|Randomized but not treated|0|||
163135531|NCT00856544|589206097|FG002|Overall Study|Randomized but not treated|0|||
163135532|NCT00856544|589206098|FG003|Overall Study|Randomized but not treated|0|||
163135533|NCT00856544|589206095|FG000|Overall Study|Death|0|||
163135534|NCT00856544|589206096|FG001|Overall Study|Death|2|||
163135535|NCT00856544|589206097|FG002|Overall Study|Death|0|||
163135536|NCT00856544|589206098|FG003|Overall Study|Death|0|||
163135537|NCT00856544|589206095|FG000|Overall Study|Adverse Event|20|||
163135538|NCT00856544|589206096|FG001|Overall Study|Adverse Event|29|||
163135539|NCT00856544|589206097|FG002|Overall Study|Adverse Event|2|||
163135540|NCT00856544|589206098|FG003|Overall Study|Adverse Event|3|||
163135541|NCT00856544|589206095|FG000|Overall Study|Lack of Efficacy|16|||
163135542|NCT00856544|589206096|FG001|Overall Study|Lack of Efficacy|12|||
163135543|NCT00856544|589206097|FG002|Overall Study|Lack of Efficacy|3|||
163135544|NCT00856544|589206098|FG003|Overall Study|Lack of Efficacy|3|||
163135545|NCT00856544|589206095|FG000|Overall Study|Other|9|||
163135546|NCT00856544|589206096|FG001|Overall Study|Other|16|||
163135547|NCT00856544|589206097|FG002|Overall Study|Other|1|||
163135548|NCT00856544|589206098|FG003|Overall Study|Other|6|||
163135549|NCT00856544|589206095|FG000|Overall Study|Lost to Follow-up|1|||
163135550|NCT00856544|589206096|FG001|Overall Study|Lost to Follow-up|2|||
163135551|NCT00856544|589206097|FG002|Overall Study|Lost to Follow-up|2|||
163135552|NCT00856544|589206098|FG003|Overall Study|Lost to Follow-up|0|||
163135553|NCT00856544|589206095|FG000|Overall Study|Withdrawal by Subject|8|||
163135554|NCT00856544|589206096|FG001|Overall Study|Withdrawal by Subject|5|||
163135555|NCT00856544|589206097|FG002|Overall Study|Withdrawal by Subject|0|||
163135556|NCT00856544|589206098|FG003|Overall Study|Withdrawal by Subject|1|||
163135557|NCT01564732|589206099|FG000|Overall Study|Early termination by the study sponsor|6|||
163135558|NCT01564732|589206100|FG001|Overall Study|Early termination by the study sponsor|5|||
163135559|NCT00394706|589206106|FG000|Overall Study|Withdrawal by Subject|2|||
163135560|NCT00394706|589206107|FG001|Overall Study|Withdrawal by Subject|0|||
163135561|NCT00394706|589206108|FG002|Overall Study|Withdrawal by Subject|1|||
163135562|NCT00394706|589206109|FG003|Overall Study|Withdrawal by Subject|0|||
163135563|NCT00394706|589206110|FG004|Overall Study|Withdrawal by Subject|0|||
163135564|NCT00394706|589206111|FG005|Overall Study|Withdrawal by Subject|2|||
163135565|NCT00394706|589206112|FG006|Overall Study|Withdrawal by Subject|1|||
163135566|NCT00394706|589206113|FG007|Overall Study|Withdrawal by Subject|0|||
163135567|NCT00394706|589206106|FG000|Overall Study|Lost to Follow-up|2|||
163135568|NCT00394706|589206107|FG001|Overall Study|Lost to Follow-up|2|||
163135569|NCT00394706|589206108|FG002|Overall Study|Lost to Follow-up|8|||
163135570|NCT00394706|589206109|FG003|Overall Study|Lost to Follow-up|1|||
163135571|NCT00394706|589206110|FG004|Overall Study|Lost to Follow-up|2|||
163135572|NCT00394706|589206111|FG005|Overall Study|Lost to Follow-up|5|||
163135573|NCT00394706|589206112|FG006|Overall Study|Lost to Follow-up|2|||
163135574|NCT00394706|589206113|FG007|Overall Study|Lost to Follow-up|0|||
163135575|NCT03920254|589206114|FG000|Overall Study|Adverse Event|1|||
163135576|NCT03920254|589206115|FG001|Overall Study|Adverse Event|0|||
163135577|NCT03920254|589206116|FG002|Overall Study|Adverse Event|0|||
163135578|NCT03920254|589206114|FG000|Overall Study|Physician Decision|0|||
163135579|NCT03920254|589206115|FG001|Overall Study|Physician Decision|1|||
163135580|NCT03920254|589206116|FG002|Overall Study|Physician Decision|2|||
163135581|NCT03920254|589206114|FG000|Overall Study|Study Terminated By Sponsor|12|||
162659175|NCT03670810|587465889|FG005|Main Study|Lost to Follow-up|0|||
162659176|NCT03670810|587465890|FG006|Main Study|Lost to Follow-up|0|||
162659177|NCT03670810|587465891|FG007|Main Study|Lost to Follow-up|0|||
162659178|NCT03670810|587465892|FG008|Main Study|Lost to Follow-up|0|||
162659179|NCT03670810|587465884|FG000|Main Study|Non-compliance with Study Drug|0|||
163135582|NCT03920254|589206115|FG001|Overall Study|Study Terminated By Sponsor|17|||
162659180|NCT03670810|587465885|FG001|Main Study|Non-compliance with Study Drug|2|||
162659181|NCT03670810|587465886|FG002|Main Study|Non-compliance with Study Drug|3|||
163135583|NCT03920254|589206116|FG002|Overall Study|Study Terminated By Sponsor|12|||
163135584|NCT03920254|589206114|FG000|Overall Study|Withdrawal by Subject|0|||
163135585|NCT03920254|589206115|FG001|Overall Study|Withdrawal by Subject|0|||
163135586|NCT03920254|589206116|FG002|Overall Study|Withdrawal by Subject|1|||
163135587|NCT05274269|589206117|FG000|Overall Study|Adverse Event|0|||
163135588|NCT05274269|589206118|FG001|Overall Study|Adverse Event|3|||
163135589|NCT05274269|589206117|FG000|Overall Study|Death|0|||
163135590|NCT05274269|589206118|FG001|Overall Study|Death|1|||
163135591|NCT05274269|589206117|FG000|Overall Study|Other|0|||
163135592|NCT05274269|589206118|FG001|Overall Study|Other|2|||
163135593|NCT05274269|589206117|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163135594|NCT05274269|589206118|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
163135595|NCT01746368|589206119|FG000|Overall Study|Lost to Follow-up|2|||
163135596|NCT01746368|589206120|FG001|Overall Study|Lost to Follow-up|0|||
163135597|NCT01746368|589206119|FG000|Overall Study|Withdrawal by Subject|0|||
163135598|NCT01746368|589206120|FG001|Overall Study|Withdrawal by Subject|1|||
163135599|NCT05636852|589206121|FG000|Overall Study|Withdrawal by Subject|1|||
163135600|NCT05636852|589206121|FG000|Overall Study|Other than specified|1|||
163135601|NCT03534141|589206122|FG000|Overall Study|Enrolled in other clinical trial|1|||
163135602|NCT03534141|589206123|FG001|Overall Study|Enrolled in other clinical trial|0|||
163135603|NCT03534141|589206122|FG000|Overall Study|Liver transplant aborted after randomization|0|||
163135604|NCT03534141|589206123|FG001|Overall Study|Liver transplant aborted after randomization|2|||
163135605|NCT03534141|589206122|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
163135606|NCT03534141|589206123|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
163135607|NCT00709618|589206124|FG000|Overall Study|Withdrawal by Subject|4|||
163135608|NCT00709618|589206124|FG000|Overall Study|Lost to Follow-up|1|||
163135609|NCT00709618|589206124|FG000|Overall Study|Study Closed/Terminated|25|||
163135610|NCT01415401|589206133|FG000|Overall Study|Adverse Event|5|||
163135611|NCT01415401|589206133|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
163135612|NCT01415401|589206133|FG000|Overall Study|Terminated by Sponsor|1|||
163135613|NCT01746225|589206135|FG000|Overall Study|Death|1|||
163135614|NCT01746225|589206136|FG001|Overall Study|Death|0|||
163135615|NCT01746225|589206137|FG002|Overall Study|Death|1|||
163135616|NCT01746225|589206135|FG000|Overall Study|Withdrawal by Subject|5|||
163135617|NCT01746225|589206136|FG001|Overall Study|Withdrawal by Subject|15|||
163135618|NCT01746225|589206137|FG002|Overall Study|Withdrawal by Subject|19|||
163135619|NCT01746225|589206135|FG000|Overall Study|Physician Decision|14|||
163135620|NCT01746225|589206136|FG001|Overall Study|Physician Decision|11|||
163135621|NCT01746225|589206137|FG002|Overall Study|Physician Decision|3|||
163135622|NCT01746225|589206135|FG000|Overall Study|Adverse Event|15|||
163135623|NCT01746225|589206136|FG001|Overall Study|Adverse Event|12|||
163135624|NCT01746225|589206137|FG002|Overall Study|Adverse Event|17|||
163135625|NCT01746225|589206135|FG000|Overall Study|Continuing Treatment|5|||
163135626|NCT01746225|589206136|FG001|Overall Study|Continuing Treatment|8|||
163135627|NCT01746225|589206137|FG002|Overall Study|Continuing Treatment|3|||
163135628|NCT00595478|589206138|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
163135629|NCT00595478|589206139|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
163135630|NCT00595478|589206138|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
163135631|NCT00595478|589206139|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
163135632|NCT02713828|589206140|FG000|Overall Study|Death|2|||
163135633|NCT02713828|589206141|FG001|Overall Study|Death|0|||
163135634|NCT02713828|589206140|FG000|Overall Study|Withdrawal by Subject|1|||
163135635|NCT02713828|589206141|FG001|Overall Study|Withdrawal by Subject|0|||
163135636|NCT02713828|589206140|FG000|Overall Study|study terminated but patient allowed to|2|||
163135637|NCT02713828|589206141|FG001|Overall Study|study terminated but patient allowed to|0|||
163135638|NCT03302247|589206142|FG000|Overall Study|the study has closed prematurely|2|||
163135639|NCT03302247|589206142|FG000|Overall Study|Death|1|||
163135640|NCT02708355|589206143|FG000|Overall Study|Adverse Event|1|||
162659182|NCT03670810|587465887|FG003|Main Study|Non-compliance with Study Drug|0|||
162659183|NCT03670810|587465888|FG004|Main Study|Non-compliance with Study Drug|0|||
162659184|NCT03670810|587465889|FG005|Main Study|Non-compliance with Study Drug|0|||
163135641|NCT02708355|589206144|FG001|Overall Study|Adverse Event|0|||
163135642|NCT02708355|589206145|FG002|Overall Study|Adverse Event|0|||
163135643|NCT04090242|589206146|FG000|Overall Study|Withdrawal by Subject|1|||
163135644|NCT04090242|589206147|FG001|Overall Study|Withdrawal by Subject|0|||
162719908|NCT00573833|587680629|FG000|Overall Study|Not Treated|2|||
162719909|NCT05052983|587680630|FG000|Overall Study|Lack of Efficacy|3|||
162719910|NCT05052983|587680631|FG001|Overall Study|Lack of Efficacy|12|||
162719911|NCT05052983|587680630|FG000|Overall Study|Adverse Event|1|||
163135645|NCT02687581|589206148|FG000|Overall Study|Withdrawal by Subject|1|||
163135646|NCT02687581|589206149|FG001|Overall Study|Withdrawal by Subject|0|||
163135647|NCT02687581|589206150|FG002|Overall Study|Withdrawal by Subject|0|||
163135648|NCT02687581|589206151|FG003|Overall Study|Withdrawal by Subject|1|||
163135649|NCT02687581|589206148|FG000|Overall Study|Lost to Follow-up|2|||
163135650|NCT02687581|589206149|FG001|Overall Study|Lost to Follow-up|2|||
163135651|NCT02687581|589206150|FG002|Overall Study|Lost to Follow-up|0|||
163135652|NCT02687581|589206151|FG003|Overall Study|Lost to Follow-up|0|||
163135653|NCT02687581|589206148|FG000|Overall Study|the device is too small for the patient.|1|||
163135654|NCT02687581|589206149|FG001|Overall Study|the device is too small for the patient.|0|||
163135655|NCT02687581|589206150|FG002|Overall Study|the device is too small for the patient.|0|||
163135656|NCT02687581|589206151|FG003|Overall Study|the device is too small for the patient.|0|||
163135657|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
163135658|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
163135659|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
163135660|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135661|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135662|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135663|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135664|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135665|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
163135666|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Physician Decision|1|||
163135667|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Physician Decision|2|||
163135668|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Physician Decision|0|||
163135669|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Physician Decision|0|||
163135670|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Physician Decision|0|||
163135671|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Physician Decision|0|||
163135672|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Physician Decision|0|||
163135673|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Physician Decision|0|||
163135674|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Physician Decision|0|||
163135675|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
163135676|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
163135677|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
163135678|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
163135679|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
163135680|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
163135681|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
163135682|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
163135683|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
163135684|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
163135685|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135686|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135687|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135688|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135689|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135690|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135691|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135692|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163135693|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
163135694|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
163135695|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135696|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135697|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135698|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135699|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135700|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135701|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
163135702|NCT04405076|589206152|FG000|Part A (Blinded Phase)|Other than Specified|0|||
163135703|NCT04405076|589206153|FG001|Part A (Blinded Phase)|Other than Specified|0|||
163135704|NCT04405076|589206154|FG002|Part A (Blinded Phase)|Other than Specified|3|||
163135705|NCT04405076|589206155|FG003|Part A (Blinded Phase)|Other than Specified|0|||
163135706|NCT04405076|589206156|FG004|Part A (Blinded Phase)|Other than Specified|0|||
162719912|NCT05052983|587680631|FG001|Overall Study|Adverse Event|0|||
162719913|NCT04493242|587680632|FG000|Overall Study|Death|10|||
162719914|NCT04493242|587680633|FG001|Overall Study|Death|14|||
162719915|NCT04493242|587680634|FG002|Overall Study|Death|16|||
162659185|NCT03670810|587465890|FG006|Main Study|Non-compliance with Study Drug|0|||
163135707|NCT04405076|589206157|FG005|Part A (Blinded Phase)|Other than Specified|0|||
163135708|NCT04405076|589206158|FG006|Part A (Blinded Phase)|Other than Specified|0|||
163135709|NCT04405076|589206159|FG007|Part A (Blinded Phase)|Other than Specified|0|||
163135710|NCT04405076|589206160|FG008|Part A (Blinded Phase)|Other than Specified|0|||
163135711|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135712|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135713|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135714|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
163135715|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
163135716|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
163135717|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135718|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135719|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
163135720|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135721|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135722|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135723|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135724|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
163135725|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135726|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135727|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135728|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
163135729|NCT04405076|589206152|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135730|NCT04405076|589206153|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135731|NCT04405076|589206154|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135732|NCT04405076|589206155|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
163135733|NCT04405076|589206156|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
163135734|NCT04405076|589206157|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
163135735|NCT04405076|589206158|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135736|NCT04405076|589206159|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135737|NCT04405076|589206160|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
163135738|NCT04405076|589206152|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135739|NCT04405076|589206153|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135740|NCT04405076|589206154|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135741|NCT04405076|589206155|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135742|NCT04405076|589206156|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135743|NCT04405076|589206157|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135744|NCT04405076|589206158|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
163135745|NCT04405076|589206159|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
163135746|NCT04405076|589206160|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
163135747|NCT04405076|589206152|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135748|NCT04405076|589206153|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135749|NCT04405076|589206154|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135750|NCT04405076|589206155|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135751|NCT04405076|589206156|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135752|NCT04405076|589206157|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135753|NCT04405076|589206158|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
163135754|NCT04405076|589206159|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135755|NCT04405076|589206160|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
163135756|NCT01019369|589206161|FG000|Overall Study|Lost to Follow-up|10|||
163135757|NCT01019369|589206162|FG001|Overall Study|Lost to Follow-up|6|||
163135758|NCT01019369|589206161|FG000|Overall Study|Withdrawal by Subject|0|||
163135759|NCT01019369|589206162|FG001|Overall Study|Withdrawal by Subject|1|||
163135760|NCT02513472|589206163|FG000|Overall Study|Radiological Disease Progression|45|||
163135761|NCT02513472|589206164|FG001|Overall Study|Radiological Disease Progression|57|||
163135762|NCT02513472|589206163|FG000|Overall Study|Clinical Disease Progression|5|||
163135763|NCT02513472|589206164|FG001|Overall Study|Clinical Disease Progression|13|||
163135764|NCT02513472|589206163|FG000|Overall Study|Adverse Event|8|||
163135765|NCT02513472|589206164|FG001|Overall Study|Adverse Event|11|||
163135766|NCT02513472|589206163|FG000|Overall Study|Withdrawal by Subject|0|||
163135767|NCT02513472|589206164|FG001|Overall Study|Withdrawal by Subject|4|||
163135768|NCT02513472|589206163|FG000|Overall Study|Subject Choice|2|||
162659186|NCT03670810|587465891|FG007|Main Study|Non-compliance with Study Drug|1|||
162719916|NCT04493242|587680632|FG000|Overall Study|Lost to Follow-up|1|||
163135769|NCT02513472|589206164|FG001|Overall Study|Subject Choice|7|||
163135770|NCT02513472|589206163|FG000|Overall Study|Treatment Completed as per Protocol|3|||
163135771|NCT02513472|589206164|FG001|Overall Study|Treatment Completed as per Protocol|3|||
163135772|NCT02513472|589206163|FG000|Overall Study|Other|3|||
163135773|NCT02513472|589206164|FG001|Overall Study|Other|6|||
163135774|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
163135775|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
163135776|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
163135777|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Death|0|||
163135778|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Death|2|||
163135779|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Death|0|||
163135780|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
163135781|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
163135782|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
163135783|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
163135784|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
163135785|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
163135786|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
163135787|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
163135788|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
163135789|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
163135790|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
163135791|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
163135792|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
163135793|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
163135794|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
163135795|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Recovery|1|||
163135796|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Recovery|0|||
163135797|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Recovery|1|||
163135798|NCT00195663|589206165|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
163135799|NCT00195663|589206166|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
163135800|NCT00195663|589206167|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
163135801|NCT00195663|589206165|FG000|Open-Label Extension Period|Adverse Event|21|||
163135802|NCT00195663|589206166|FG001|Open-Label Extension Period|Adverse Event|32|||
163135803|NCT00195663|589206167|FG002|Open-Label Extension Period|Adverse Event|36|||
163135804|NCT00195663|589206165|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
163135805|NCT00195663|589206166|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
163135806|NCT00195663|589206167|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
163135807|NCT00195663|589206165|FG000|Open-Label Extension Period|Recovery|0|||
163135808|NCT00195663|589206166|FG001|Open-Label Extension Period|Recovery|2|||
163135809|NCT00195663|589206167|FG002|Open-Label Extension Period|Recovery|2|||
163135810|NCT00195663|589206165|FG000|Open-Label Extension Period|Protocol Violation|3|||
163135811|NCT00195663|589206166|FG001|Open-Label Extension Period|Protocol Violation|4|||
163135812|NCT00195663|589206167|FG002|Open-Label Extension Period|Protocol Violation|4|||
163135813|NCT00195663|589206165|FG000|Open-Label Extension Period|Death|2|||
163135814|NCT00195663|589206166|FG001|Open-Label Extension Period|Death|2|||
163135815|NCT00195663|589206167|FG002|Open-Label Extension Period|Death|2|||
163135816|NCT00195663|589206165|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
163135817|NCT00195663|589206166|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
163135818|NCT00195663|589206167|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
163135819|NCT00195663|589206165|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
163135820|NCT00195663|589206166|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
163135821|NCT00195663|589206167|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
163135822|NCT00195663|589206165|FG000|Open-Label Extension Period|Administrative reasons|11|||
163135823|NCT00195663|589206166|FG001|Open-Label Extension Period|Administrative reasons|11|||
163135824|NCT00195663|589206167|FG002|Open-Label Extension Period|Administrative reasons|13|||
163135825|NCT01380834|589206168|FG000|Overall Study|Physician Decision|1|||
163135826|NCT01380834|589206169|FG001|Overall Study|Physician Decision|0|||
162659187|NCT03670810|587465892|FG008|Main Study|Non-compliance with Study Drug|0|||
162659188|NCT03670810|587465884|FG000|Main Study|Physician Decision|3|||
162659189|NCT03670810|587465885|FG001|Main Study|Physician Decision|0|||
162659190|NCT03670810|587465886|FG002|Main Study|Physician Decision|1|||
163135827|NCT03214406|589206170|FG000|Overall Study|did not meet enrollment criteria|9|||
163135828|NCT03214406|589206171|FG001|Overall Study|did not meet enrollment criteria|13|||
163135829|NCT03214406|589206170|FG000|Overall Study|Withdrawal by Subject|1|||
163135830|NCT03214406|589206171|FG001|Overall Study|Withdrawal by Subject|0|||
163135831|NCT03214406|589206170|FG000|Overall Study|Lost to Follow-up|0|||
163135832|NCT03214406|589206171|FG001|Overall Study|Lost to Follow-up|2|||
163135833|NCT00604695|589206172|FG000|Overall Study|Did not receive first bolus.|0|||
162659191|NCT03670810|587465887|FG003|Main Study|Physician Decision|0|||
163135834|NCT00604695|589206173|FG001|Overall Study|Did not receive first bolus.|4|||
163135835|NCT04310566|589206179|FG000|Period 1|Study Termination due to COVID-19|15|||
163135836|NCT04310566|589206180|FG001|Period 1|Study Termination due to COVID-19|17|||
163135837|NCT04310566|589206179|FG000|Period 1|Protocol Violation|0|||
163135838|NCT04310566|589206180|FG001|Period 1|Protocol Violation|1|||
163135839|NCT04310566|589206179|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
163135840|NCT04310566|589206180|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
163135841|NCT04310566|589206179|FG000|Period 1|Lost to Follow-up|1|||
163135842|NCT04310566|589206180|FG001|Period 1|Lost to Follow-up|0|||
163135843|NCT04310566|589206179|FG000|Period 1|Withdrawal by Subject|0|||
163135844|NCT04310566|589206180|FG001|Period 1|Withdrawal by Subject|1|||
163135845|NCT04310566|589206179|FG000|Period 2|Study Termination|7|||
163135846|NCT04310566|589206180|FG001|Period 2|Study Termination|5|||
163135847|NCT04677504|589206182|FG000|Overall Study|Death|51|||
163135848|NCT04677504|589206183|FG001|Overall Study|Death|49|||
163135849|NCT04677504|589206182|FG000|Overall Study|Progressive Disease|1|||
163135850|NCT04677504|589206183|FG001|Overall Study|Progressive Disease|0|||
163135851|NCT04677504|589206182|FG000|Overall Study|Symptomatic Deterioration|1|||
163135852|NCT04677504|589206183|FG001|Overall Study|Symptomatic Deterioration|0|||
163135853|NCT04677504|589206182|FG000|Overall Study|Withdrawal by Subject|2|||
163135854|NCT04677504|589206183|FG001|Overall Study|Withdrawal by Subject|5|||
163135855|NCT04677504|589206182|FG000|Overall Study|Study Terminated By Sponsor|28|||
163135856|NCT04677504|589206183|FG001|Overall Study|Study Terminated By Sponsor|24|||
163135857|NCT04677504|589206182|FG000|Overall Study|Adverse Event|0|||
163135858|NCT04677504|589206183|FG001|Overall Study|Adverse Event|1|||
163135859|NCT03182907|589206184|FG000|Overall Study|Death|3|||
163135860|NCT03182907|589206185|FG001|Overall Study|Death|0|||
163135861|NCT03182907|589206184|FG000|Overall Study|Protocol Violation|4|||
162659192|NCT03670810|587465888|FG004|Main Study|Physician Decision|0|||
162659193|NCT03670810|587465889|FG005|Main Study|Physician Decision|0|||
162659194|NCT03670810|587465890|FG006|Main Study|Physician Decision|1|||
162659195|NCT03670810|587465891|FG007|Main Study|Physician Decision|1|||
162659196|NCT03670810|587465892|FG008|Main Study|Physician Decision|0|||
163135862|NCT03182907|589206185|FG001|Overall Study|Protocol Violation|0|||
163135863|NCT03182907|589206184|FG000|Overall Study|Lost to Follow-up|1|||
163135864|NCT03182907|589206185|FG001|Overall Study|Lost to Follow-up|0|||
163135865|NCT03182907|589206184|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163135866|NCT03182907|589206185|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163135867|NCT01711645|589206188|FG000|Overall Study|Withdrawal by Subject|8|||
162659197|NCT03670810|587465884|FG000|Main Study|Pregnancy|1|||
162659198|NCT03670810|587465885|FG001|Main Study|Pregnancy|2|||
162659199|NCT03670810|587465886|FG002|Main Study|Pregnancy|0|||
162659200|NCT03670810|587465887|FG003|Main Study|Pregnancy|0|||
163135868|NCT01711645|589206188|FG000|Overall Study|Lost to Follow-up|6|||
163135869|NCT01711645|589206188|FG000|Overall Study|Physician Decision|5|||
163135870|NCT00172042|589206194|FG000|Overall Study|Adverse Event|27|||
163135871|NCT00172042|589206195|FG001|Overall Study|Adverse Event|13|||
163135872|NCT00172042|589206194|FG000|Overall Study|Abnormal laboratory value(s)|5|||
163135873|NCT00172042|589206195|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163135874|NCT00172042|589206194|FG000|Overall Study|Abnormal test procedure(s)|0|||
163135875|NCT00172042|589206195|FG001|Overall Study|Abnormal test procedure(s)|3|||
163135876|NCT00172042|589206194|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
163135877|NCT00172042|589206195|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
162659201|NCT03670810|587465888|FG004|Main Study|Pregnancy|0|||
163135878|NCT00172042|589206194|FG000|Overall Study|Patient no longer requires study drug|10|||
163135879|NCT00172042|589206195|FG001|Overall Study|Patient no longer requires study drug|8|||
163135880|NCT00172042|589206194|FG000|Overall Study|Protocol Violation|8|||
163135881|NCT00172042|589206195|FG001|Overall Study|Protocol Violation|7|||
163135882|NCT00172042|589206194|FG000|Overall Study|Withdrawal by Subject|37|||
163135883|NCT00172042|589206195|FG001|Overall Study|Withdrawal by Subject|25|||
163135884|NCT00172042|589206194|FG000|Overall Study|Lost to Follow-up|3|||
163135885|NCT00172042|589206195|FG001|Overall Study|Lost to Follow-up|5|||
163135886|NCT00172042|589206194|FG000|Overall Study|Administrative problems|13|||
163135887|NCT00172042|589206195|FG001|Overall Study|Administrative problems|10|||
163135888|NCT00172042|589206194|FG000|Overall Study|Death|42|||
163135889|NCT00172042|589206195|FG001|Overall Study|Death|42|||
163135890|NCT00384332|589206196|FG000|Overall Study|Lost to Follow-up|4|||
163135891|NCT00384332|589206197|FG001|Overall Study|Lost to Follow-up|0|||
163135892|NCT00375518|589206198|FG000|Overall Study|Withdrawal by Subject|2|||
163135893|NCT00375518|589206199|FG001|Overall Study|Withdrawal by Subject|10|||
163135894|NCT00375518|589206198|FG000|Overall Study|Patient Not Treated|6|||
163135895|NCT00375518|589206199|FG001|Overall Study|Patient Not Treated|6|||
163135896|NCT00375518|589206198|FG000|Overall Study|Death|0|||
163135897|NCT00375518|589206199|FG001|Overall Study|Death|1|||
163135898|NCT01771250|589206200|FG000|Period 1|Met exclusion criteria|1|||
163135899|NCT01771250|589206201|FG001|Period 1|Met exclusion criteria|0|||
163135900|NCT02058563|589206202|FG000|Overall Study|Lost to Follow-up|26|||
163135901|NCT02058563|589206203|FG001|Overall Study|Lost to Follow-up|22|||
163135902|NCT02058563|589206202|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
163135903|NCT02058563|589206203|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
163135904|NCT02058563|589206202|FG000|Overall Study|Consent Withdrawal|1|||
163135905|NCT02058563|589206203|FG001|Overall Study|Consent Withdrawal|1|||
163135906|NCT02058563|589206202|FG000|Overall Study|Other (patient incarcerated)|0|||
163135907|NCT02058563|589206203|FG001|Overall Study|Other (patient incarcerated)|1|||
163135908|NCT01180296|589206204|FG000|Overall Study|Protocol Violation|1|||
163135909|NCT01180296|589206205|FG001|Overall Study|Protocol Violation|2|||
163135910|NCT00166439|589206206|FG000|Overall Study|Ineligible|5|||
163135911|NCT02560012|589206207|FG000|Overall Study|Study Terminated|2|||
163135912|NCT00483938|589206208|FG000|Overall Study|Protocol Violation|0|||
163135913|NCT00483938|589206209|FG001|Overall Study|Protocol Violation|0|||
163135914|NCT00483938|589206210|FG002|Overall Study|Protocol Violation|0|||
163135915|NCT00483938|589206211|FG003|Overall Study|Protocol Violation|0|||
163135916|NCT00483938|589206212|FG004|Overall Study|Protocol Violation|0|||
163135917|NCT00483938|589206213|FG005|Overall Study|Protocol Violation|0|||
163135918|NCT00483938|589206214|FG006|Overall Study|Protocol Violation|3|||
163135919|NCT00483938|589206208|FG000|Overall Study|Withdrawal by Subject|1|||
163135920|NCT00483938|589206209|FG001|Overall Study|Withdrawal by Subject|6|||
163135921|NCT00483938|589206210|FG002|Overall Study|Withdrawal by Subject|0|||
163135922|NCT00483938|589206211|FG003|Overall Study|Withdrawal by Subject|0|||
163135923|NCT00483938|589206212|FG004|Overall Study|Withdrawal by Subject|1|||
163135924|NCT00483938|589206213|FG005|Overall Study|Withdrawal by Subject|3|||
163135925|NCT00483938|589206214|FG006|Overall Study|Withdrawal by Subject|2|||
163135926|NCT00483938|589206208|FG000|Overall Study|Lost to Follow-up|1|||
163135927|NCT00483938|589206209|FG001|Overall Study|Lost to Follow-up|2|||
163135928|NCT00483938|589206210|FG002|Overall Study|Lost to Follow-up|0|||
163135929|NCT00483938|589206211|FG003|Overall Study|Lost to Follow-up|2|||
163135930|NCT00483938|589206212|FG004|Overall Study|Lost to Follow-up|1|||
163135931|NCT00483938|589206213|FG005|Overall Study|Lost to Follow-up|1|||
163135932|NCT00483938|589206214|FG006|Overall Study|Lost to Follow-up|3|||
163135933|NCT00483938|589206208|FG000|Overall Study|Death|0|||
163135934|NCT00483938|589206209|FG001|Overall Study|Death|2|||
163135935|NCT00483938|589206210|FG002|Overall Study|Death|0|||
163135936|NCT00483938|589206211|FG003|Overall Study|Death|0|||
163135937|NCT00483938|589206212|FG004|Overall Study|Death|0|||
163135938|NCT00483938|589206213|FG005|Overall Study|Death|0|||
163135939|NCT00483938|589206214|FG006|Overall Study|Death|0|||
163135940|NCT00483938|589206208|FG000|Overall Study|Other|3|||
163135941|NCT00483938|589206209|FG001|Overall Study|Other|9|||
163135942|NCT00483938|589206210|FG002|Overall Study|Other|0|||
163135943|NCT00483938|589206211|FG003|Overall Study|Other|4|||
163135944|NCT00483938|589206212|FG004|Overall Study|Other|0|||
163135945|NCT00483938|589206213|FG005|Overall Study|Other|4|||
163135946|NCT00483938|589206214|FG006|Overall Study|Other|32|||
163135947|NCT03052816|589206217|FG000|Overall Study|Withdrawal by Subject|1|||
163135948|NCT03052816|589206218|FG001|Overall Study|Withdrawal by Subject|0|||
162719917|NCT04493242|587680633|FG001|Overall Study|Lost to Follow-up|1|||
163135949|NCT03052816|589206217|FG000|Overall Study|Desired opioids|2|||
163135950|NCT03052816|589206218|FG001|Overall Study|Desired opioids|0|||
163135951|NCT00042991|589206219|FG000|Overall Study|Adverse Event|1|||
163135952|NCT00042991|589206220|FG001|Overall Study|Adverse Event|4|||
163135953|NCT00042991|589206221|FG002|Overall Study|Adverse Event|2|||
163135954|NCT00042991|589206222|FG003|Overall Study|Adverse Event|0|||
163135955|NCT00042991|589206223|FG004|Overall Study|Adverse Event|0|||
163135956|NCT00042991|589206224|FG005|Overall Study|Adverse Event|1|||
163135957|NCT00042991|589206225|FG006|Overall Study|Adverse Event|0|||
163135958|NCT00042991|589206219|FG000|Overall Study|Withdrawal by Subject|0|||
163135959|NCT00042991|589206220|FG001|Overall Study|Withdrawal by Subject|7|||
163135960|NCT00042991|589206221|FG002|Overall Study|Withdrawal by Subject|2|||
163135961|NCT00042991|589206222|FG003|Overall Study|Withdrawal by Subject|0|||
163135962|NCT00042991|589206223|FG004|Overall Study|Withdrawal by Subject|1|||
163135963|NCT00042991|589206224|FG005|Overall Study|Withdrawal by Subject|0|||
163135964|NCT00042991|589206225|FG006|Overall Study|Withdrawal by Subject|0|||
163135965|NCT00042991|589206219|FG000|Overall Study|Disease Progression|5|||
163135966|NCT00042991|589206220|FG001|Overall Study|Disease Progression|29|||
163135967|NCT00042991|589206221|FG002|Overall Study|Disease Progression|2|||
163135968|NCT00042991|589206222|FG003|Overall Study|Disease Progression|2|||
163135969|NCT00042991|589206223|FG004|Overall Study|Disease Progression|1|||
163135970|NCT00042991|589206224|FG005|Overall Study|Disease Progression|4|||
163135971|NCT00042991|589206225|FG006|Overall Study|Disease Progression|2|||
163135972|NCT00042991|589206219|FG000|Overall Study|Alternative Therapy|0|||
163135973|NCT00042991|589206220|FG001|Overall Study|Alternative Therapy|0|||
163135974|NCT00042991|589206221|FG002|Overall Study|Alternative Therapy|0|||
163135975|NCT00042991|589206222|FG003|Overall Study|Alternative Therapy|0|||
163135976|NCT00042991|589206223|FG004|Overall Study|Alternative Therapy|1|||
163135977|NCT00042991|589206224|FG005|Overall Study|Alternative Therapy|0|||
163135978|NCT00042991|589206225|FG006|Overall Study|Alternative Therapy|0|||
163135979|NCT03369236|589206228|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
163135980|NCT03369236|589206229|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
163135981|NCT03369236|589206228|FG000|Open-label Extension Period|Lack of Efficacy|2|||
163135982|NCT03369236|589206229|FG001|Open-label Extension Period|Lack of Efficacy|1|||
163135983|NCT03369236|589206228|FG000|Open-label Extension Period|Adverse Event|0|||
163135984|NCT03369236|589206229|FG001|Open-label Extension Period|Adverse Event|1|||
163135985|NCT03369236|589206228|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
163135986|NCT03369236|589206229|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
163135987|NCT02508428|589206235|FG000|Overall Study|Death|32|||
163135988|NCT02508428|589206236|FG001|Overall Study|Death|33|||
163135989|NCT02508428|589206235|FG000|Overall Study|Liner revised|3|||
163135990|NCT02508428|589206236|FG001|Overall Study|Liner revised|19|||
163135991|NCT02508428|589206235|FG000|Overall Study|Incomplete follow-up|17|||
163135992|NCT02508428|589206236|FG001|Overall Study|Incomplete follow-up|15|||
163135993|NCT00368641|589207762|FG000|Overall Study|Adverse Event|2|||
163135994|NCT00368641|589207763|FG001|Overall Study|Adverse Event|1|||
163135995|NCT00368641|589207762|FG000|Overall Study|Death|1|||
163135996|NCT00368641|589207763|FG001|Overall Study|Death|0|||
163135997|NCT00368641|589207762|FG000|Overall Study|Withdrawal by Subject|1|||
163135998|NCT00368641|589207763|FG001|Overall Study|Withdrawal by Subject|0|||
163135999|NCT00368641|589207762|FG000|Overall Study|Sponsor decision to terminate study|2|||
163136000|NCT00368641|589207763|FG001|Overall Study|Sponsor decision to terminate study|5|||
163136001|NCT04343755|589207764|FG000|Overall Study|Death|11|||
163136002|NCT04343755|589207764|FG000|Overall Study|Screen Failure|1|||
163136003|NCT00108862|589207765|FG000|Overall Study|Death|31|||
163136004|NCT00108862|589207766|FG001|Overall Study|Death|37|||
163136005|NCT00108862|589207765|FG000|Overall Study|Withdrawal by Subject|10|||
163136006|NCT00108862|589207766|FG001|Overall Study|Withdrawal by Subject|6|||
163136007|NCT00108862|589207765|FG000|Overall Study|Lost to Follow-up|27|||
163136008|NCT00108862|589207766|FG001|Overall Study|Lost to Follow-up|19|||
163136009|NCT00687804|589207769|FG000|Core Study|Adverse Event|5|||
163136010|NCT00687804|589207770|FG001|Core Study|Adverse Event|3|||
163136011|NCT00687804|589207771|FG002|Core Study|Adverse Event|3|||
163136012|NCT00687804|589207769|FG000|Core Study|Abnormal laboratory value(s)|1|||
163136013|NCT00687804|589207770|FG001|Core Study|Abnormal laboratory value(s)|0|||
163136014|NCT00687804|589207771|FG002|Core Study|Abnormal laboratory value(s)|0|||
163136015|NCT00687804|589207769|FG000|Core Study|Lack of Efficacy|1|||
163136016|NCT00687804|589207770|FG001|Core Study|Lack of Efficacy|1|||
163136017|NCT00687804|589207771|FG002|Core Study|Lack of Efficacy|1|||
163136018|NCT00687804|589207769|FG000|Core Study|Withdrawal by Subject|4|||
163136019|NCT00687804|589207770|FG001|Core Study|Withdrawal by Subject|7|||
163136020|NCT00687804|589207771|FG002|Core Study|Withdrawal by Subject|7|||
163136021|NCT00687804|589207769|FG000|Core Study|Lost to Follow-up|0|||
163136022|NCT00687804|589207770|FG001|Core Study|Lost to Follow-up|1|||
163136023|NCT00687804|589207771|FG002|Core Study|Lost to Follow-up|0|||
163136024|NCT00687804|589207769|FG000|Core Study|Death|2|||
163136025|NCT00687804|589207770|FG001|Core Study|Death|2|||
163136026|NCT00687804|589207771|FG002|Core Study|Death|2|||
163136027|NCT00687804|589207769|FG000|Core Study|Protocol Violation|1|||
163136028|NCT00687804|589207770|FG001|Core Study|Protocol Violation|1|||
163136029|NCT00687804|589207771|FG002|Core Study|Protocol Violation|0|||
163136030|NCT00687804|589207769|FG000|Open-Label Extension Study|Adverse Event|2|||
163136031|NCT00687804|589207770|FG001|Open-Label Extension Study|Adverse Event|2|||
163136032|NCT00687804|589207771|FG002|Open-Label Extension Study|Adverse Event|2|||
163136033|NCT00687804|589207769|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
163136034|NCT00687804|589207770|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
163136035|NCT00687804|589207771|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
163136036|NCT00687804|589207769|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
163136037|NCT00687804|589207770|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
163136038|NCT00687804|589207771|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
163136039|NCT00687804|589207769|FG000|Open-Label Extension Study|Administrative problems|1|||
163136040|NCT00687804|589207770|FG001|Open-Label Extension Study|Administrative problems|1|||
163136041|NCT00687804|589207771|FG002|Open-Label Extension Study|Administrative problems|0|||
163136042|NCT00687804|589207769|FG000|Open-Label Extension Study|Death|2|||
163136043|NCT00687804|589207770|FG001|Open-Label Extension Study|Death|3|||
163136044|NCT00687804|589207771|FG002|Open-Label Extension Study|Death|3|||
163136045|NCT04390880|589207772|FG000|Overall Study|Withdrawal by Subject|1|||
163136046|NCT02557542|589207773|FG000|Overall Study|Poor recruitment|3|||
163136047|NCT02557542|589207774|FG001|Overall Study|Poor recruitment|0|||
163136048|NCT00195091|589207775|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
163136049|NCT00475709|589207779|FG000|Overall Study|Did not meet eligibility criteria|8|||
163136050|NCT00475709|589207779|FG000|Overall Study|Death|41|||
163136051|NCT00475709|589207779|FG000|Overall Study|Device Explant|6|||
163136052|NCT00475709|589207779|FG000|Overall Study|Lost to Follow-up|21|||
163136053|NCT00555672|589207782|FG000|Overall Study|Death|0|||
163136054|NCT00555672|589207783|FG001|Overall Study|Death|2|||
163136055|NCT00555672|589207782|FG000|Overall Study|Adverse Event|8|||
163136056|NCT00555672|589207783|FG001|Overall Study|Adverse Event|2|||
163136057|NCT00555672|589207782|FG000|Overall Study|Objective progression or relapse|11|||
163136058|NCT00555672|589207783|FG001|Overall Study|Objective progression or relapse|5|||
163136059|NCT00555672|589207782|FG000|Overall Study|Other|3|||
163136060|NCT00555672|589207783|FG001|Overall Study|Other|1|||
163136061|NCT00555672|589207782|FG000|Overall Study|Participant refused|2|||
163136062|NCT00555672|589207783|FG001|Overall Study|Participant refused|0|||
163136063|NCT04526145|589207784|FG000|Overall Study|Withdrawal by Subject|5|||
163136064|NCT02305238|589207791|FG000|Overall Study|Death|2|||
163136065|NCT02305238|589207792|FG001|Overall Study|Death|1|||
163136066|NCT02305238|589207793|FG002|Overall Study|Death|0|||
163136067|NCT02305238|589207791|FG000|Overall Study|Progressive disease|4|||
163136068|NCT02305238|589207792|FG001|Overall Study|Progressive disease|4|||
163136069|NCT02305238|589207793|FG002|Overall Study|Progressive disease|0|||
163136070|NCT02305238|589207791|FG000|Overall Study|Logistical difficulties|1|||
163136071|NCT02305238|589207792|FG001|Overall Study|Logistical difficulties|3|||
163136072|NCT02305238|589207793|FG002|Overall Study|Logistical difficulties|0|||
163136073|NCT02305238|589207791|FG000|Overall Study|Protocol Violation|0|||
163136074|NCT02305238|589207792|FG001|Overall Study|Protocol Violation|3|||
163136075|NCT02305238|589207793|FG002|Overall Study|Protocol Violation|0|||
163136076|NCT02305238|589207791|FG000|Overall Study|Physician Decision|2|||
163136077|NCT02305238|589207792|FG001|Overall Study|Physician Decision|1|||
163136078|NCT02305238|589207793|FG002|Overall Study|Physician Decision|0|||
163136079|NCT02305238|589207791|FG000|Overall Study|Adverse Event|4|||
163136080|NCT02305238|589207792|FG001|Overall Study|Adverse Event|2|||
163136081|NCT02305238|589207793|FG002|Overall Study|Adverse Event|0|||
163136082|NCT02305238|589207791|FG000|Overall Study|Withdrawal by Subject|3|||
163136083|NCT02305238|589207792|FG001|Overall Study|Withdrawal by Subject|4|||
163136084|NCT02305238|589207793|FG002|Overall Study|Withdrawal by Subject|0|||
163136085|NCT02305238|589207791|FG000|Overall Study|Randomized failure|0|||
163136086|NCT02305238|589207792|FG001|Overall Study|Randomized failure|0|||
163136087|NCT02305238|589207793|FG002|Overall Study|Randomized failure|8|||
163136088|NCT02305238|589207791|FG000|Overall Study|Required procedure failed|0|||
163136089|NCT02305238|589207792|FG001|Overall Study|Required procedure failed|1|||
163136090|NCT02305238|589207793|FG002|Overall Study|Required procedure failed|0|||
163136091|NCT01746173|589207794|FG000|Overall Study|Disease Progression|2|||
163136092|NCT02218008|589207797|FG000|Stage 1 (S1)|Adverse Event|6|||
163136093|NCT02218008|589207798|FG001|Stage 1 (S1)|Adverse Event|5|||
163136094|NCT02218008|589207799|FG002|Stage 1 (S1)|Adverse Event|11|||
163136095|NCT02218008|589207800|FG003|Stage 1 (S1)|Adverse Event|0|||
163136096|NCT02218008|589207801|FG004|Stage 1 (S1)|Adverse Event|0|||
163136097|NCT02218008|589207802|FG005|Stage 1 (S1)|Adverse Event|0|||
163136098|NCT02218008|589207797|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
163136099|NCT02218008|589207798|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
163136100|NCT02218008|589207799|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
163136101|NCT02218008|589207800|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
163136102|NCT02218008|589207801|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
163136103|NCT02218008|589207802|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
163136104|NCT02218008|589207797|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
163136105|NCT02218008|589207798|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
163136106|NCT02218008|589207799|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
163136107|NCT02218008|589207800|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
163136108|NCT02218008|589207801|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
163136109|NCT02218008|589207802|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
163136110|NCT02218008|589207797|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
163136111|NCT02218008|589207798|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
163136112|NCT02218008|589207799|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
163136113|NCT02218008|589207800|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
163136114|NCT02218008|589207801|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
163136115|NCT02218008|589207802|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
163136116|NCT02218008|589207797|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
163136117|NCT02218008|589207798|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
163136118|NCT02218008|589207799|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136119|NCT02218008|589207800|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136120|NCT02218008|589207801|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136121|NCT02218008|589207802|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
163136122|NCT02218008|589207797|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
163136123|NCT02218008|589207798|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
163136124|NCT02218008|589207799|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
163136125|NCT02218008|589207800|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
163136126|NCT02218008|589207801|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
163136127|NCT02218008|589207802|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
163136128|NCT02218008|589207797|FG000|Stage 1 (S1)|Pregnancy|0|||
163136129|NCT02218008|589207798|FG001|Stage 1 (S1)|Pregnancy|0|||
163136130|NCT02218008|589207799|FG002|Stage 1 (S1)|Pregnancy|1|||
163136131|NCT02218008|589207800|FG003|Stage 1 (S1)|Pregnancy|0|||
163136132|NCT02218008|589207801|FG004|Stage 1 (S1)|Pregnancy|0|||
163136133|NCT02218008|589207802|FG005|Stage 1 (S1)|Pregnancy|0|||
163136134|NCT02218008|589207797|FG000|Stage 1 (S1)|Protocol Violation|0|||
163136135|NCT02218008|589207798|FG001|Stage 1 (S1)|Protocol Violation|0|||
163136136|NCT02218008|589207799|FG002|Stage 1 (S1)|Protocol Violation|1|||
163136137|NCT02218008|589207800|FG003|Stage 1 (S1)|Protocol Violation|0|||
163136138|NCT02218008|589207801|FG004|Stage 1 (S1)|Protocol Violation|0|||
163136139|NCT02218008|589207802|FG005|Stage 1 (S1)|Protocol Violation|0|||
163136140|NCT02218008|589207797|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
163136141|NCT02218008|589207798|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136142|NCT02218008|589207799|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136143|NCT02218008|589207800|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136144|NCT02218008|589207801|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136145|NCT02218008|589207802|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
163136146|NCT02218008|589207797|FG000|Stage 2 (S2)|Adverse Event|0|||
163136147|NCT02218008|589207798|FG001|Stage 2 (S2)|Adverse Event|0|||
163136148|NCT02218008|589207799|FG002|Stage 2 (S2)|Adverse Event|0|||
163136149|NCT02218008|589207800|FG003|Stage 2 (S2)|Adverse Event|2|||
163136150|NCT02218008|589207801|FG004|Stage 2 (S2)|Adverse Event|3|||
163136151|NCT02218008|589207802|FG005|Stage 2 (S2)|Adverse Event|3|||
163136152|NCT02218008|589207797|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
163136153|NCT02218008|589207798|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
163136154|NCT02218008|589207799|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
163136155|NCT02218008|589207800|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
163136156|NCT02218008|589207801|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
163136157|NCT02218008|589207802|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
163136158|NCT02218008|589207797|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
163136159|NCT02218008|589207798|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
163136160|NCT02218008|589207799|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
163136161|NCT02218008|589207800|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
163136162|NCT02218008|589207801|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
163136163|NCT02218008|589207802|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
163136164|NCT02218008|589207797|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136165|NCT02218008|589207798|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136166|NCT02218008|589207799|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136167|NCT02218008|589207800|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
163136168|NCT02218008|589207801|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136169|NCT02218008|589207802|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163136170|NCT02218008|589207797|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
163136171|NCT02218008|589207798|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
163136172|NCT02218008|589207799|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
163136173|NCT02218008|589207800|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
163136174|NCT02218008|589207801|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
163136175|NCT02218008|589207802|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
163136176|NCT00408434|589207807|FG000|Overall Study|Adverse Event|0|||
163136177|NCT00408434|589207808|FG001|Overall Study|Adverse Event|0|||
163136178|NCT00408434|589207809|FG002|Overall Study|Adverse Event|1|||
163136179|NCT00408434|589207810|FG003|Overall Study|Adverse Event|0|||
163136180|NCT00408434|589207811|FG004|Overall Study|Adverse Event|0|||
163136181|NCT00408434|589207812|FG005|Overall Study|Adverse Event|0|||
163136182|NCT00408434|589207813|FG006|Overall Study|Adverse Event|0|||
163136183|NCT00408434|589207807|FG000|Overall Study|Progressive disease|6|||
163136184|NCT00408434|589207808|FG001|Overall Study|Progressive disease|3|||
163136185|NCT00408434|589207809|FG002|Overall Study|Progressive disease|4|||
162659202|NCT03670810|587465889|FG005|Main Study|Pregnancy|0|||
162659203|NCT03670810|587465890|FG006|Main Study|Pregnancy|0|||
162659204|NCT03670810|587465891|FG007|Main Study|Pregnancy|0|||
163136186|NCT00408434|589207810|FG003|Overall Study|Progressive disease|3|||
163136187|NCT00408434|589207811|FG004|Overall Study|Progressive disease|3|||
163136188|NCT00408434|589207812|FG005|Overall Study|Progressive disease|1|||
163136189|NCT00408434|589207813|FG006|Overall Study|Progressive disease|4|||
163136190|NCT00408434|589207807|FG000|Overall Study|Other|0|||
163136191|NCT00408434|589207808|FG001|Overall Study|Other|0|||
163136192|NCT00408434|589207809|FG002|Overall Study|Other|1|||
163136193|NCT00408434|589207810|FG003|Overall Study|Other|0|||
163136194|NCT00408434|589207811|FG004|Overall Study|Other|2|||
163136195|NCT00408434|589207812|FG005|Overall Study|Other|1|||
163136196|NCT00408434|589207813|FG006|Overall Study|Other|0|||
163136197|NCT00408434|589207807|FG000|Overall Study|Terminated by Investigator|0|||
163136198|NCT00408434|589207808|FG001|Overall Study|Terminated by Investigator|0|||
163136199|NCT00408434|589207809|FG002|Overall Study|Terminated by Investigator|0|||
163136200|NCT00408434|589207810|FG003|Overall Study|Terminated by Investigator|0|||
163136201|NCT00408434|589207811|FG004|Overall Study|Terminated by Investigator|1|||
163136202|NCT00408434|589207812|FG005|Overall Study|Terminated by Investigator|1|||
163136203|NCT00408434|589207813|FG006|Overall Study|Terminated by Investigator|0|||
163136204|NCT00106353|589207814|FG000|Part 1|Disease progression|3|||
163136205|NCT00106353|589207815|FG001|Part 1|Disease progression|4|||
163136206|NCT00106353|589207816|FG002|Part 1|Disease progression|1|||
163136207|NCT00106353|589207817|FG003|Part 1|Disease progression|3|||
163136208|NCT00106353|589207818|FG004|Part 1|Disease progression|0|||
163136209|NCT00106353|589207819|FG005|Part 1|Disease progression|0|||
163136210|NCT00106353|589207820|FG006|Part 1|Disease progression|0|||
163136211|NCT00106353|589207814|FG000|Part 1|Withdrawal by Subject|0|||
163136212|NCT00106353|589207815|FG001|Part 1|Withdrawal by Subject|0|||
163136213|NCT00106353|589207816|FG002|Part 1|Withdrawal by Subject|1|||
163136214|NCT00106353|589207817|FG003|Part 1|Withdrawal by Subject|2|||
163136215|NCT00106353|589207818|FG004|Part 1|Withdrawal by Subject|0|||
163136216|NCT00106353|589207819|FG005|Part 1|Withdrawal by Subject|0|||
163136217|NCT00106353|589207820|FG006|Part 1|Withdrawal by Subject|0|||
163136218|NCT00106353|589207814|FG000|Part 1|Symptomatic deterioration|0|||
163136219|NCT00106353|589207815|FG001|Part 1|Symptomatic deterioration|0|||
163136220|NCT00106353|589207816|FG002|Part 1|Symptomatic deterioration|1|||
163136221|NCT00106353|589207817|FG003|Part 1|Symptomatic deterioration|0|||
163136222|NCT00106353|589207818|FG004|Part 1|Symptomatic deterioration|0|||
163136223|NCT00106353|589207819|FG005|Part 1|Symptomatic deterioration|0|||
163136224|NCT00106353|589207820|FG006|Part 1|Symptomatic deterioration|0|||
163136225|NCT00106353|589207814|FG000|Part 1|Entered follow-up phase|1|||
163136226|NCT00106353|589207815|FG001|Part 1|Entered follow-up phase|1|||
163136227|NCT00106353|589207816|FG002|Part 1|Entered follow-up phase|0|||
163136228|NCT00106353|589207817|FG003|Part 1|Entered follow-up phase|1|||
163136229|NCT00106353|589207818|FG004|Part 1|Entered follow-up phase|0|||
163136230|NCT00106353|589207819|FG005|Part 1|Entered follow-up phase|0|||
163136231|NCT00106353|589207820|FG006|Part 1|Entered follow-up phase|0|||
163136232|NCT00106353|589207814|FG000|Part 1|Adverse Event|0|||
163136233|NCT00106353|589207815|FG001|Part 1|Adverse Event|0|||
163136234|NCT00106353|589207816|FG002|Part 1|Adverse Event|0|||
163136235|NCT00106353|589207817|FG003|Part 1|Adverse Event|1|||
163136236|NCT00106353|589207818|FG004|Part 1|Adverse Event|0|||
163136237|NCT00106353|589207819|FG005|Part 1|Adverse Event|0|||
163136238|NCT00106353|589207820|FG006|Part 1|Adverse Event|0|||
163136239|NCT00106353|589207814|FG000|Part 2|Disease progression|0|||
163136240|NCT00106353|589207815|FG001|Part 2|Disease progression|0|||
163136241|NCT00106353|589207816|FG002|Part 2|Disease progression|0|||
163136242|NCT00106353|589207817|FG003|Part 2|Disease progression|0|||
163136243|NCT00106353|589207818|FG004|Part 2|Disease progression|8|||
163136244|NCT00106353|589207819|FG005|Part 2|Disease progression|14|||
163136245|NCT00106353|589207820|FG006|Part 2|Disease progression|13|||
163136246|NCT00106353|589207814|FG000|Part 2|Death|0|||
163136247|NCT00106353|589207815|FG001|Part 2|Death|0|||
163136248|NCT00106353|589207816|FG002|Part 2|Death|0|||
163136249|NCT00106353|589207817|FG003|Part 2|Death|0|||
163136250|NCT00106353|589207818|FG004|Part 2|Death|3|||
163136251|NCT00106353|589207819|FG005|Part 2|Death|0|||
163136252|NCT00106353|589207820|FG006|Part 2|Death|1|||
163136253|NCT00106353|589207814|FG000|Part 2|Symptomatic deterioration|0|||
162659205|NCT03670810|587465892|FG008|Main Study|Pregnancy|0|||
163136254|NCT00106353|589207815|FG001|Part 2|Symptomatic deterioration|0|||
163136255|NCT00106353|589207816|FG002|Part 2|Symptomatic deterioration|0|||
163136256|NCT00106353|589207817|FG003|Part 2|Symptomatic deterioration|0|||
163136257|NCT00106353|589207818|FG004|Part 2|Symptomatic deterioration|3|||
163136258|NCT00106353|589207819|FG005|Part 2|Symptomatic deterioration|0|||
163136259|NCT00106353|589207820|FG006|Part 2|Symptomatic deterioration|0|||
163136260|NCT00106353|589207814|FG000|Part 2|Adverse Event|0|||
163136261|NCT00106353|589207815|FG001|Part 2|Adverse Event|0|||
163136262|NCT00106353|589207816|FG002|Part 2|Adverse Event|0|||
163136263|NCT00106353|589207817|FG003|Part 2|Adverse Event|0|||
162659206|NCT03670810|587465884|FG000|Main Study|Protocol Deviation|2|||
162659207|NCT03670810|587465885|FG001|Main Study|Protocol Deviation|12|||
162659208|NCT03670810|587465886|FG002|Main Study|Protocol Deviation|8|||
162659209|NCT03670810|587465887|FG003|Main Study|Protocol Deviation|4|||
162659210|NCT03670810|587465888|FG004|Main Study|Protocol Deviation|0|||
162659211|NCT03670810|587465889|FG005|Main Study|Protocol Deviation|0|||
162659212|NCT03670810|587465890|FG006|Main Study|Protocol Deviation|0|||
162659213|NCT03670810|587465891|FG007|Main Study|Protocol Deviation|0|||
162659214|NCT03670810|587465892|FG008|Main Study|Protocol Deviation|0|||
162659215|NCT03670810|587465884|FG000|Main Study|Withdrawal by Subject|21|||
162659216|NCT03670810|587465885|FG001|Main Study|Withdrawal by Subject|21|||
162659217|NCT03670810|587465886|FG002|Main Study|Withdrawal by Subject|8|||
162659218|NCT03670810|587465887|FG003|Main Study|Withdrawal by Subject|9|||
162659219|NCT03670810|587465888|FG004|Main Study|Withdrawal by Subject|5|||
162659220|NCT03670810|587465889|FG005|Main Study|Withdrawal by Subject|2|||
162659221|NCT03670810|587465890|FG006|Main Study|Withdrawal by Subject|1|||
162659222|NCT03670810|587465891|FG007|Main Study|Withdrawal by Subject|1|||
162659223|NCT03670810|587465892|FG008|Main Study|Withdrawal by Subject|0|||
162659224|NCT03670810|587465884|FG000|Main Study|Participant did not want to take the three other treatments|1|||
162659225|NCT03670810|587465885|FG001|Main Study|Participant did not want to take the three other treatments|0|||
162659226|NCT03670810|587465886|FG002|Main Study|Participant did not want to take the three other treatments|0|||
162659227|NCT03670810|587465887|FG003|Main Study|Participant did not want to take the three other treatments|0|||
162659228|NCT03670810|587465888|FG004|Main Study|Participant did not want to take the three other treatments|0|||
162659229|NCT03670810|587465889|FG005|Main Study|Participant did not want to take the three other treatments|0|||
162659230|NCT03670810|587465890|FG006|Main Study|Participant did not want to take the three other treatments|0|||
162659231|NCT03670810|587465891|FG007|Main Study|Participant did not want to take the three other treatments|0|||
162659232|NCT03670810|587465892|FG008|Main Study|Participant did not want to take the three other treatments|0|||
162659233|NCT03670810|587465884|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659234|NCT03670810|587465885|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
162659235|NCT03670810|587465886|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659236|NCT03670810|587465887|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659237|NCT03670810|587465888|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659238|NCT03670810|587465889|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659239|NCT03670810|587465890|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659240|NCT03670810|587465891|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659241|NCT03670810|587465892|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162659242|NCT03670810|587465884|FG000|Main Study|Travel and Coronavirus issues|0|||
162659243|NCT03670810|587465885|FG001|Main Study|Travel and Coronavirus issues|0|||
162659244|NCT03670810|587465886|FG002|Main Study|Travel and Coronavirus issues|0|||
162659245|NCT03670810|587465887|FG003|Main Study|Travel and Coronavirus issues|1|||
162659246|NCT03670810|587465888|FG004|Main Study|Travel and Coronavirus issues|0|||
162659247|NCT03670810|587465889|FG005|Main Study|Travel and Coronavirus issues|0|||
162659248|NCT03670810|587465890|FG006|Main Study|Travel and Coronavirus issues|0|||
162659249|NCT03670810|587465891|FG007|Main Study|Travel and Coronavirus issues|0|||
162659250|NCT03670810|587465892|FG008|Main Study|Travel and Coronavirus issues|0|||
162659251|NCT03670810|587465884|FG000|Open Label Extension|Protocol Deviation|0|||
162659252|NCT03670810|587465885|FG001|Open Label Extension|Protocol Deviation|0|||
162659253|NCT03670810|587465886|FG002|Open Label Extension|Protocol Deviation|0|||
162659254|NCT03670810|587465887|FG003|Open Label Extension|Protocol Deviation|0|||
162659255|NCT03670810|587465888|FG004|Open Label Extension|Protocol Deviation|0|||
162659256|NCT03670810|587465889|FG005|Open Label Extension|Protocol Deviation|0|||
162659257|NCT03670810|587465890|FG006|Open Label Extension|Protocol Deviation|0|||
162659258|NCT03670810|587465891|FG007|Open Label Extension|Protocol Deviation|0|||
162659259|NCT03670810|587465892|FG008|Open Label Extension|Protocol Deviation|5|||
162659260|NCT03670810|587465884|FG000|Open Label Extension|Death|0|||
162659261|NCT03670810|587465885|FG001|Open Label Extension|Death|0|||
162659262|NCT03670810|587465886|FG002|Open Label Extension|Death|0|||
162659263|NCT03670810|587465887|FG003|Open Label Extension|Death|0|||
162659264|NCT03670810|587465888|FG004|Open Label Extension|Death|0|||
162659265|NCT03670810|587465889|FG005|Open Label Extension|Death|0|||
162659266|NCT03670810|587465890|FG006|Open Label Extension|Death|0|||
162659267|NCT03670810|587465891|FG007|Open Label Extension|Death|0|||
162659268|NCT03670810|587465892|FG008|Open Label Extension|Death|1|||
162659269|NCT03670810|587465884|FG000|Open Label Extension|COVID-19|0|||
162659270|NCT03670810|587465885|FG001|Open Label Extension|COVID-19|0|||
162659271|NCT03670810|587465886|FG002|Open Label Extension|COVID-19|0|||
162659272|NCT03670810|587465887|FG003|Open Label Extension|COVID-19|0|||
162659273|NCT03670810|587465888|FG004|Open Label Extension|COVID-19|0|||
162659274|NCT03670810|587465889|FG005|Open Label Extension|COVID-19|0|||
162659275|NCT03670810|587465890|FG006|Open Label Extension|COVID-19|0|||
162659276|NCT03670810|587465891|FG007|Open Label Extension|COVID-19|0|||
162659277|NCT03670810|587465892|FG008|Open Label Extension|COVID-19|1|||
162719918|NCT04493242|587680634|FG002|Overall Study|Lost to Follow-up|0|||
163136264|NCT00106353|589207818|FG004|Part 2|Adverse Event|0|||
162659278|NCT03670810|587465884|FG000|Open Label Extension|Lack of Efficacy|0|||
163136265|NCT00106353|589207819|FG005|Part 2|Adverse Event|2|||
163136266|NCT00106353|589207820|FG006|Part 2|Adverse Event|1|||
163136267|NCT00106353|589207814|FG000|Part 2|Other|0|||
163136268|NCT00106353|589207815|FG001|Part 2|Other|0|||
163136269|NCT00106353|589207816|FG002|Part 2|Other|0|||
163136270|NCT00106353|589207817|FG003|Part 2|Other|0|||
163136271|NCT00106353|589207818|FG004|Part 2|Other|1|||
163136272|NCT00106353|589207819|FG005|Part 2|Other|1|||
163136273|NCT00106353|589207820|FG006|Part 2|Other|1|||
163136274|NCT00106353|589207814|FG000|Part 2|Withdrawal by Subject|0|||
163136275|NCT00106353|589207815|FG001|Part 2|Withdrawal by Subject|0|||
163136276|NCT00106353|589207816|FG002|Part 2|Withdrawal by Subject|0|||
163136277|NCT00106353|589207817|FG003|Part 2|Withdrawal by Subject|0|||
163136278|NCT00106353|589207818|FG004|Part 2|Withdrawal by Subject|1|||
163136279|NCT00106353|589207819|FG005|Part 2|Withdrawal by Subject|0|||
163136280|NCT00106353|589207820|FG006|Part 2|Withdrawal by Subject|0|||
163136281|NCT00106353|589207814|FG000|Part 2|Physician Decision|0|||
163136282|NCT00106353|589207815|FG001|Part 2|Physician Decision|0|||
163136283|NCT00106353|589207816|FG002|Part 2|Physician Decision|0|||
163136284|NCT00106353|589207817|FG003|Part 2|Physician Decision|0|||
163136285|NCT00106353|589207818|FG004|Part 2|Physician Decision|0|||
163136286|NCT00106353|589207819|FG005|Part 2|Physician Decision|1|||
163136287|NCT00106353|589207820|FG006|Part 2|Physician Decision|0|||
163136288|NCT04039217|589207821|FG000|Overall Study|Lost to Follow-up|1|||
163136289|NCT01278797|589207822|FG000|Period 1|Adverse Event|0|||
163136290|NCT01278797|589207823|FG001|Period 1|Adverse Event|1|||
163136291|NCT01278797|589207822|FG000|Period 1|Protocol Violation|1|||
163136292|NCT01278797|589207823|FG001|Period 1|Protocol Violation|0|||
163136293|NCT00588354|589207824|FG000|Baseline to 2 Weeks|Adverse Event|1|||
163136294|NCT00588354|589207825|FG001|Baseline to 2 Weeks|Adverse Event|0|||
163136295|NCT00588354|589207824|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
163136296|NCT00588354|589207825|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
163136297|NCT00588354|589207824|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
163136298|NCT00588354|589207825|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
163136299|NCT03364309|589207826|FG000|Induction Period|Adverse Event|4|||
163136300|NCT03364309|589207827|FG001|Induction Period|Adverse Event|0|||
163136301|NCT03364309|589207828|FG002|Induction Period|Adverse Event|1|||
163136302|NCT03364309|589207829|FG003|Induction Period|Adverse Event|0|||
163136303|NCT03364309|589207830|FG004|Induction Period|Adverse Event|0|||
163136304|NCT03364309|589207831|FG005|Induction Period|Adverse Event|0|||
163136305|NCT03364309|589207832|FG006|Induction Period|Adverse Event|0|||
163136306|NCT03364309|589207833|FG007|Induction Period|Adverse Event|0|||
163136307|NCT03364309|589207834|FG008|Induction Period|Adverse Event|0|||
163136308|NCT03364309|589207835|FG009|Induction Period|Adverse Event|0|||
163136309|NCT03364309|589207836|FG010|Induction Period|Adverse Event|0|||
163136310|NCT03364309|589207837|FG011|Induction Period|Adverse Event|0|||
163136311|NCT03364309|589207838|FG012|Induction Period|Adverse Event|0|||
163136312|NCT03364309|589207839|FG013|Induction Period|Adverse Event|0|||
163136313|NCT03364309|589207840|FG014|Induction Period|Adverse Event|0|||
163136314|NCT03364309|589207841|FG015|Induction Period|Adverse Event|0|||
163136315|NCT03364309|589207842|FG016|Induction Period|Adverse Event|0|||
163136316|NCT03364309|589207843|FG017|Induction Period|Adverse Event|0|||
163136317|NCT03364309|589207844|FG018|Induction Period|Adverse Event|0|||
163136318|NCT03364309|589207826|FG000|Induction Period|Withdrawal by Subject|1|||
163136319|NCT03364309|589207827|FG001|Induction Period|Withdrawal by Subject|3|||
163136320|NCT03364309|589207828|FG002|Induction Period|Withdrawal by Subject|0|||
163136321|NCT03364309|589207829|FG003|Induction Period|Withdrawal by Subject|0|||
163136322|NCT03364309|589207830|FG004|Induction Period|Withdrawal by Subject|0|||
163136323|NCT03364309|589207831|FG005|Induction Period|Withdrawal by Subject|0|||
163136324|NCT03364309|589207832|FG006|Induction Period|Withdrawal by Subject|0|||
163136325|NCT03364309|589207833|FG007|Induction Period|Withdrawal by Subject|0|||
163136326|NCT03364309|589207834|FG008|Induction Period|Withdrawal by Subject|0|||
163136327|NCT03364309|589207835|FG009|Induction Period|Withdrawal by Subject|0|||
163136328|NCT03364309|589207836|FG010|Induction Period|Withdrawal by Subject|0|||
163136329|NCT03364309|589207837|FG011|Induction Period|Withdrawal by Subject|0|||
163136330|NCT03364309|589207838|FG012|Induction Period|Withdrawal by Subject|0|||
162659279|NCT03670810|587465885|FG001|Open Label Extension|Lack of Efficacy|0|||
162659280|NCT03670810|587465886|FG002|Open Label Extension|Lack of Efficacy|0|||
163136331|NCT03364309|589207839|FG013|Induction Period|Withdrawal by Subject|0|||
163136332|NCT03364309|589207840|FG014|Induction Period|Withdrawal by Subject|0|||
163136333|NCT03364309|589207841|FG015|Induction Period|Withdrawal by Subject|0|||
163136334|NCT03364309|589207842|FG016|Induction Period|Withdrawal by Subject|0|||
163136335|NCT03364309|589207843|FG017|Induction Period|Withdrawal by Subject|0|||
163136336|NCT03364309|589207844|FG018|Induction Period|Withdrawal by Subject|0|||
163136337|NCT03364309|589207826|FG000|Induction Period|Lost to Follow-up|1|||
163136338|NCT03364309|589207827|FG001|Induction Period|Lost to Follow-up|0|||
163136339|NCT03364309|589207828|FG002|Induction Period|Lost to Follow-up|0|||
163136340|NCT03364309|589207829|FG003|Induction Period|Lost to Follow-up|0|||
163136341|NCT03364309|589207830|FG004|Induction Period|Lost to Follow-up|0|||
162659281|NCT03670810|587465887|FG003|Open Label Extension|Lack of Efficacy|0|||
162659282|NCT03670810|587465888|FG004|Open Label Extension|Lack of Efficacy|0|||
162659283|NCT03670810|587465889|FG005|Open Label Extension|Lack of Efficacy|0|||
163136342|NCT03364309|589207831|FG005|Induction Period|Lost to Follow-up|0|||
163136343|NCT03364309|589207832|FG006|Induction Period|Lost to Follow-up|0|||
163136344|NCT03364309|589207833|FG007|Induction Period|Lost to Follow-up|0|||
163136345|NCT03364309|589207834|FG008|Induction Period|Lost to Follow-up|0|||
163136346|NCT03364309|589207835|FG009|Induction Period|Lost to Follow-up|0|||
163136347|NCT03364309|589207836|FG010|Induction Period|Lost to Follow-up|0|||
163136348|NCT03364309|589207837|FG011|Induction Period|Lost to Follow-up|0|||
163136349|NCT03364309|589207838|FG012|Induction Period|Lost to Follow-up|0|||
163136350|NCT03364309|589207839|FG013|Induction Period|Lost to Follow-up|0|||
163136351|NCT03364309|589207840|FG014|Induction Period|Lost to Follow-up|0|||
163136352|NCT03364309|589207841|FG015|Induction Period|Lost to Follow-up|0|||
163136353|NCT03364309|589207842|FG016|Induction Period|Lost to Follow-up|0|||
163136354|NCT03364309|589207843|FG017|Induction Period|Lost to Follow-up|0|||
163136355|NCT03364309|589207844|FG018|Induction Period|Lost to Follow-up|0|||
163136356|NCT03364309|589207826|FG000|Induction Period|Physician Decision|0|||
163136357|NCT03364309|589207827|FG001|Induction Period|Physician Decision|1|||
163136358|NCT03364309|589207828|FG002|Induction Period|Physician Decision|0|||
163136359|NCT03364309|589207829|FG003|Induction Period|Physician Decision|0|||
163136360|NCT03364309|589207830|FG004|Induction Period|Physician Decision|0|||
163136361|NCT03364309|589207831|FG005|Induction Period|Physician Decision|0|||
163136362|NCT03364309|589207832|FG006|Induction Period|Physician Decision|0|||
163136363|NCT03364309|589207833|FG007|Induction Period|Physician Decision|0|||
162719919|NCT04493242|587680632|FG000|Overall Study|Withdrawal by Subject|1|||
162719920|NCT04493242|587680633|FG001|Overall Study|Withdrawal by Subject|0|||
162719921|NCT04493242|587680634|FG002|Overall Study|Withdrawal by Subject|0|||
162719922|NCT04493242|587680632|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
162719923|NCT04493242|587680633|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
162719924|NCT04493242|587680634|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
162719925|NCT04493242|587680632|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
162719926|NCT04493242|587680633|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
162719927|NCT04493242|587680634|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
162719928|NCT00849147|587680635|FG000|Overall Study|Withdrawal by Subject|1|||
162719929|NCT00849147|587680635|FG000|Overall Study|Protocol Violation|2|||
162719930|NCT00849147|587680635|FG000|Overall Study|Disease Relapse/Progression|2|||
162719931|NCT03175172|587682365|FG000|Overall Study|Death|3|||
162719932|NCT03175172|587682365|FG000|Overall Study|Withdrawal by Subject|3|||
162719933|NCT03175172|587682365|FG000|Overall Study|Lost to Follow-up|1|||
162719934|NCT03175172|587682365|FG000|Overall Study|Study Terminated by Sponsor|3|||
162719935|NCT00446550|587682370|FG000|Overall Study|Adverse Event|1|||
162719936|NCT00446550|587682371|FG001|Overall Study|Adverse Event|0|||
162719937|NCT02983617|587682372|FG000|Overall Study|Adverse Event|0|||
162719938|NCT02983617|587682373|FG001|Overall Study|Adverse Event|7|||
162719939|NCT02983617|587682372|FG000|Overall Study|Death|0|||
162719940|NCT02983617|587682373|FG001|Overall Study|Death|1|||
162719941|NCT02983617|587682372|FG000|Overall Study|Investigator's Discretion|0|||
162719942|NCT02983617|587682373|FG001|Overall Study|Investigator's Discretion|1|||
162719943|NCT02027558|587682376|FG000|Overall Study|Death|0|||
162719944|NCT02027558|587682377|FG001|Overall Study|Death|1|||
162719945|NCT02027558|587682376|FG000|Overall Study|Withdrawal by Subject|2|||
162719946|NCT02027558|587682377|FG001|Overall Study|Withdrawal by Subject|0|||
162719947|NCT02027558|587682376|FG000|Overall Study|Lost to Follow-up|4|||
162719948|NCT02027558|587682377|FG001|Overall Study|Lost to Follow-up|1|||
162719949|NCT02027558|587682376|FG000|Overall Study|Refused assessment|3|||
162719950|NCT02027558|587682377|FG001|Overall Study|Refused assessment|0|||
162719951|NCT00516386|587682378|FG000|Overall Study|not interested in the study|4|||
162719952|NCT00516386|587682378|FG000|Overall Study|Lost to Follow-up|2|||
162719953|NCT02698891|587682379|FG000|Overall Study|Withdrawal by Subject|2|||
162719954|NCT02698891|587682379|FG000|Overall Study|deemed ineligible|1|||
162719955|NCT02698891|587682379|FG000|Overall Study|Adverse Event|9|||
162719956|NCT04218110|587682380|FG000|Overall Study|Withdrawal by Subject|0|||
162719957|NCT04218110|587682381|FG001|Overall Study|Withdrawal by Subject|0|||
162719958|NCT04218110|587682382|FG002|Overall Study|Withdrawal by Subject|0|||
162719959|NCT04218110|587682383|FG003|Overall Study|Withdrawal by Subject|1|||
162659284|NCT03670810|587465890|FG006|Open Label Extension|Lack of Efficacy|0|||
162659285|NCT03670810|587465891|FG007|Open Label Extension|Lack of Efficacy|0|||
162659286|NCT03670810|587465892|FG008|Open Label Extension|Lack of Efficacy|39|||
162659287|NCT03670810|587465884|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
162659288|NCT03670810|587465885|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
162659289|NCT03670810|587465886|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
162659290|NCT03670810|587465887|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
162659291|NCT03670810|587465888|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
162659292|NCT03670810|587465889|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
162659293|NCT03670810|587465890|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
162659294|NCT03670810|587465891|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
162659295|NCT03670810|587465892|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
162659296|NCT03670810|587465884|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659297|NCT03670810|587465885|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659298|NCT03670810|587465886|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659299|NCT03670810|587465887|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659300|NCT03670810|587465888|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659301|NCT03670810|587465889|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162719960|NCT00002842|587682384|FG000|Overall Study|ineligible for surgical resection|27|||
162719961|NCT02694978|587682387|FG000|Overall Study|Adverse Event|10|||
162719962|NCT02694978|587682388|FG001|Overall Study|Adverse Event|9|||
162719963|NCT02694978|587682387|FG000|Overall Study|Withdrawal by Subject|22|||
162719964|NCT02694978|587682388|FG001|Overall Study|Withdrawal by Subject|19|||
162719965|NCT02694978|587682387|FG000|Overall Study|Lost to Follow-up|14|||
162719966|NCT02694978|587682388|FG001|Overall Study|Lost to Follow-up|17|||
162719967|NCT02694978|587682387|FG000|Overall Study|Death|4|||
162719968|NCT02694978|587682388|FG001|Overall Study|Death|1|||
162719969|NCT02694978|587682387|FG000|Overall Study|Other-Decision of Participant|6|||
162719970|NCT02694978|587682388|FG001|Overall Study|Other-Decision of Participant|1|||
162719971|NCT02694978|587682387|FG000|Overall Study|Other-Investigator's decision|1|||
162659302|NCT03670810|587465890|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
163136364|NCT03364309|589207834|FG008|Induction Period|Physician Decision|0|||
163136365|NCT03364309|589207835|FG009|Induction Period|Physician Decision|0|||
163136366|NCT03364309|589207836|FG010|Induction Period|Physician Decision|0|||
163136367|NCT03364309|589207837|FG011|Induction Period|Physician Decision|0|||
163136368|NCT03364309|589207838|FG012|Induction Period|Physician Decision|0|||
163136369|NCT03364309|589207839|FG013|Induction Period|Physician Decision|0|||
163136370|NCT03364309|589207840|FG014|Induction Period|Physician Decision|0|||
163136371|NCT03364309|589207841|FG015|Induction Period|Physician Decision|0|||
163136372|NCT03364309|589207842|FG016|Induction Period|Physician Decision|0|||
163136373|NCT03364309|589207843|FG017|Induction Period|Physician Decision|0|||
163136374|NCT03364309|589207844|FG018|Induction Period|Physician Decision|0|||
163136375|NCT03364309|589207826|FG000|Maintenance Period|Withdrawal by Subject|0|||
163136376|NCT03364309|589207827|FG001|Maintenance Period|Withdrawal by Subject|0|||
163136377|NCT03364309|589207828|FG002|Maintenance Period|Withdrawal by Subject|0|||
163136378|NCT03364309|589207829|FG003|Maintenance Period|Withdrawal by Subject|1|||
163136379|NCT03364309|589207830|FG004|Maintenance Period|Withdrawal by Subject|3|||
163136380|NCT03364309|589207831|FG005|Maintenance Period|Withdrawal by Subject|1|||
163136381|NCT03364309|589207832|FG006|Maintenance Period|Withdrawal by Subject|3|||
163136382|NCT03364309|589207833|FG007|Maintenance Period|Withdrawal by Subject|0|||
163136383|NCT03364309|589207834|FG008|Maintenance Period|Withdrawal by Subject|1|||
163136384|NCT03364309|589207835|FG009|Maintenance Period|Withdrawal by Subject|1|||
163136385|NCT03364309|589207836|FG010|Maintenance Period|Withdrawal by Subject|2|||
163136386|NCT03364309|589207837|FG011|Maintenance Period|Withdrawal by Subject|0|||
163136387|NCT03364309|589207838|FG012|Maintenance Period|Withdrawal by Subject|0|||
163136388|NCT03364309|589207839|FG013|Maintenance Period|Withdrawal by Subject|0|||
163136389|NCT03364309|589207840|FG014|Maintenance Period|Withdrawal by Subject|0|||
163136390|NCT03364309|589207841|FG015|Maintenance Period|Withdrawal by Subject|0|||
163136391|NCT03364309|589207842|FG016|Maintenance Period|Withdrawal by Subject|0|||
163136392|NCT03364309|589207843|FG017|Maintenance Period|Withdrawal by Subject|0|||
163136393|NCT03364309|589207844|FG018|Maintenance Period|Withdrawal by Subject|0|||
163136394|NCT03364309|589207826|FG000|Maintenance Period|Adverse Event|0|||
163136395|NCT03364309|589207827|FG001|Maintenance Period|Adverse Event|0|||
163136396|NCT03364309|589207828|FG002|Maintenance Period|Adverse Event|0|||
163136397|NCT03364309|589207829|FG003|Maintenance Period|Adverse Event|0|||
163136398|NCT03364309|589207830|FG004|Maintenance Period|Adverse Event|2|||
163136399|NCT03364309|589207831|FG005|Maintenance Period|Adverse Event|0|||
163136400|NCT03364309|589207832|FG006|Maintenance Period|Adverse Event|3|||
163136401|NCT03364309|589207833|FG007|Maintenance Period|Adverse Event|0|||
163136402|NCT03364309|589207834|FG008|Maintenance Period|Adverse Event|1|||
163136403|NCT03364309|589207835|FG009|Maintenance Period|Adverse Event|0|||
163136404|NCT03364309|589207836|FG010|Maintenance Period|Adverse Event|2|||
163136405|NCT03364309|589207837|FG011|Maintenance Period|Adverse Event|0|||
163136406|NCT03364309|589207838|FG012|Maintenance Period|Adverse Event|0|||
163136407|NCT03364309|589207839|FG013|Maintenance Period|Adverse Event|0|||
163136408|NCT03364309|589207840|FG014|Maintenance Period|Adverse Event|0|||
163136409|NCT03364309|589207841|FG015|Maintenance Period|Adverse Event|0|||
163136410|NCT03364309|589207842|FG016|Maintenance Period|Adverse Event|0|||
163136411|NCT03364309|589207843|FG017|Maintenance Period|Adverse Event|0|||
163136412|NCT03364309|589207844|FG018|Maintenance Period|Adverse Event|0|||
163136413|NCT03364309|589207826|FG000|Maintenance Period|Relapsed|0|||
163136414|NCT03364309|589207827|FG001|Maintenance Period|Relapsed|0|||
163136415|NCT03364309|589207828|FG002|Maintenance Period|Relapsed|0|||
163136416|NCT03364309|589207829|FG003|Maintenance Period|Relapsed|43|||
163136417|NCT03364309|589207830|FG004|Maintenance Period|Relapsed|7|||
163136418|NCT03364309|589207831|FG005|Maintenance Period|Relapsed|45|||
163136419|NCT03364309|589207832|FG006|Maintenance Period|Relapsed|10|||
163136420|NCT03364309|589207833|FG007|Maintenance Period|Relapsed|2|||
163136421|NCT03364309|589207834|FG008|Maintenance Period|Relapsed|0|||
163136422|NCT03364309|589207835|FG009|Maintenance Period|Relapsed|0|||
163136423|NCT03364309|589207836|FG010|Maintenance Period|Relapsed|0|||
163136424|NCT03364309|589207837|FG011|Maintenance Period|Relapsed|0|||
163136425|NCT03364309|589207838|FG012|Maintenance Period|Relapsed|0|||
163136426|NCT03364309|589207839|FG013|Maintenance Period|Relapsed|0|||
163136427|NCT03364309|589207840|FG014|Maintenance Period|Relapsed|0|||
163136428|NCT03364309|589207841|FG015|Maintenance Period|Relapsed|0|||
163136429|NCT03364309|589207842|FG016|Maintenance Period|Relapsed|0|||
163136430|NCT03364309|589207843|FG017|Maintenance Period|Relapsed|0|||
163136431|NCT03364309|589207844|FG018|Maintenance Period|Relapsed|0|||
163136432|NCT03364309|589207826|FG000|Maintenance Period|Lack of Efficacy|0|||
163136433|NCT03364309|589207827|FG001|Maintenance Period|Lack of Efficacy|0|||
163136434|NCT03364309|589207828|FG002|Maintenance Period|Lack of Efficacy|0|||
163136435|NCT03364309|589207829|FG003|Maintenance Period|Lack of Efficacy|0|||
163136436|NCT03364309|589207830|FG004|Maintenance Period|Lack of Efficacy|0|||
163136437|NCT03364309|589207831|FG005|Maintenance Period|Lack of Efficacy|0|||
163136438|NCT03364309|589207832|FG006|Maintenance Period|Lack of Efficacy|0|||
163136439|NCT03364309|589207833|FG007|Maintenance Period|Lack of Efficacy|0|||
163136440|NCT03364309|589207834|FG008|Maintenance Period|Lack of Efficacy|1|||
163136441|NCT03364309|589207835|FG009|Maintenance Period|Lack of Efficacy|3|||
163136442|NCT03364309|589207836|FG010|Maintenance Period|Lack of Efficacy|2|||
163136443|NCT03364309|589207837|FG011|Maintenance Period|Lack of Efficacy|0|||
163136444|NCT03364309|589207838|FG012|Maintenance Period|Lack of Efficacy|0|||
163136445|NCT03364309|589207839|FG013|Maintenance Period|Lack of Efficacy|0|||
163136446|NCT03364309|589207840|FG014|Maintenance Period|Lack of Efficacy|0|||
163136447|NCT03364309|589207841|FG015|Maintenance Period|Lack of Efficacy|0|||
163136448|NCT03364309|589207842|FG016|Maintenance Period|Lack of Efficacy|0|||
163136449|NCT03364309|589207843|FG017|Maintenance Period|Lack of Efficacy|0|||
163136450|NCT03364309|589207844|FG018|Maintenance Period|Lack of Efficacy|0|||
163136451|NCT03364309|589207826|FG000|Maintenance Period|Death|0|||
163136452|NCT03364309|589207827|FG001|Maintenance Period|Death|0|||
163136453|NCT03364309|589207828|FG002|Maintenance Period|Death|0|||
163136454|NCT03364309|589207829|FG003|Maintenance Period|Death|0|||
163136455|NCT03364309|589207830|FG004|Maintenance Period|Death|0|||
163136456|NCT03364309|589207831|FG005|Maintenance Period|Death|0|||
163136457|NCT03364309|589207832|FG006|Maintenance Period|Death|0|||
163136458|NCT03364309|589207833|FG007|Maintenance Period|Death|0|||
163136459|NCT03364309|589207834|FG008|Maintenance Period|Death|1|||
163136460|NCT03364309|589207835|FG009|Maintenance Period|Death|0|||
163136461|NCT03364309|589207836|FG010|Maintenance Period|Death|0|||
163136462|NCT03364309|589207837|FG011|Maintenance Period|Death|0|||
163136463|NCT03364309|589207838|FG012|Maintenance Period|Death|0|||
163136464|NCT03364309|589207839|FG013|Maintenance Period|Death|0|||
163136465|NCT03364309|589207840|FG014|Maintenance Period|Death|0|||
163136466|NCT03364309|589207841|FG015|Maintenance Period|Death|0|||
163136467|NCT03364309|589207842|FG016|Maintenance Period|Death|0|||
163136468|NCT03364309|589207843|FG017|Maintenance Period|Death|0|||
163136469|NCT03364309|589207844|FG018|Maintenance Period|Death|0|||
163136470|NCT03364309|589207826|FG000|Maintenance Period|Lost to Follow-up|0|||
163136471|NCT03364309|589207827|FG001|Maintenance Period|Lost to Follow-up|0|||
163136472|NCT03364309|589207828|FG002|Maintenance Period|Lost to Follow-up|0|||
163136473|NCT03364309|589207829|FG003|Maintenance Period|Lost to Follow-up|0|||
163136474|NCT03364309|589207830|FG004|Maintenance Period|Lost to Follow-up|0|||
163136475|NCT03364309|589207831|FG005|Maintenance Period|Lost to Follow-up|0|||
163136476|NCT03364309|589207832|FG006|Maintenance Period|Lost to Follow-up|0|||
163136477|NCT03364309|589207833|FG007|Maintenance Period|Lost to Follow-up|0|||
163136478|NCT03364309|589207834|FG008|Maintenance Period|Lost to Follow-up|1|||
163136479|NCT03364309|589207835|FG009|Maintenance Period|Lost to Follow-up|0|||
163136480|NCT03364309|589207836|FG010|Maintenance Period|Lost to Follow-up|0|||
163136481|NCT03364309|589207837|FG011|Maintenance Period|Lost to Follow-up|0|||
163136482|NCT03364309|589207838|FG012|Maintenance Period|Lost to Follow-up|0|||
163136483|NCT03364309|589207839|FG013|Maintenance Period|Lost to Follow-up|0|||
163136484|NCT03364309|589207840|FG014|Maintenance Period|Lost to Follow-up|0|||
163136485|NCT03364309|589207841|FG015|Maintenance Period|Lost to Follow-up|0|||
163136486|NCT03364309|589207842|FG016|Maintenance Period|Lost to Follow-up|0|||
163136487|NCT03364309|589207843|FG017|Maintenance Period|Lost to Follow-up|0|||
163136488|NCT03364309|589207844|FG018|Maintenance Period|Lost to Follow-up|0|||
163136489|NCT03364309|589207826|FG000|Maintenance Period|Miscellaneous|0|||
163136490|NCT03364309|589207827|FG001|Maintenance Period|Miscellaneous|0|||
163136491|NCT03364309|589207828|FG002|Maintenance Period|Miscellaneous|0|||
163136492|NCT03364309|589207829|FG003|Maintenance Period|Miscellaneous|0|||
163136493|NCT03364309|589207830|FG004|Maintenance Period|Miscellaneous|0|||
163136494|NCT03364309|589207831|FG005|Maintenance Period|Miscellaneous|0|||
163136495|NCT03364309|589207832|FG006|Maintenance Period|Miscellaneous|0|||
163136496|NCT03364309|589207833|FG007|Maintenance Period|Miscellaneous|0|||
163136497|NCT03364309|589207834|FG008|Maintenance Period|Miscellaneous|1|||
163136498|NCT03364309|589207835|FG009|Maintenance Period|Miscellaneous|0|||
163136499|NCT03364309|589207836|FG010|Maintenance Period|Miscellaneous|0|||
163136500|NCT03364309|589207837|FG011|Maintenance Period|Miscellaneous|0|||
163136501|NCT03364309|589207838|FG012|Maintenance Period|Miscellaneous|0|||
163136502|NCT03364309|589207839|FG013|Maintenance Period|Miscellaneous|0|||
163136503|NCT03364309|589207840|FG014|Maintenance Period|Miscellaneous|0|||
163136504|NCT03364309|589207841|FG015|Maintenance Period|Miscellaneous|0|||
163136505|NCT03364309|589207842|FG016|Maintenance Period|Miscellaneous|0|||
163136506|NCT03364309|589207843|FG017|Maintenance Period|Miscellaneous|0|||
163136507|NCT03364309|589207844|FG018|Maintenance Period|Miscellaneous|0|||
163136508|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136509|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136510|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136511|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136512|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136513|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136514|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136515|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136516|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136517|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136518|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136519|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136520|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136521|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
163136522|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
162719972|NCT02694978|587682388|FG001|Overall Study|Other-Investigator's decision|0|||
163136523|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
163136524|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136525|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136526|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163136527|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136528|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136529|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136530|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136531|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136532|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136533|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136534|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136535|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136536|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136537|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136538|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136539|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136540|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136541|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
163136542|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136543|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136544|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136545|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
163136546|NCT03364309|589207826|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
163136547|NCT03364309|589207827|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
163136548|NCT03364309|589207828|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
163136549|NCT03364309|589207829|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
163136550|NCT03364309|589207830|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
163136551|NCT03364309|589207831|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
163136552|NCT03364309|589207832|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
163136553|NCT03364309|589207833|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
163136554|NCT03364309|589207834|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
163136555|NCT03364309|589207835|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
163136556|NCT03364309|589207836|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
163136557|NCT03364309|589207837|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
163136558|NCT03364309|589207838|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
163136559|NCT03364309|589207839|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
163136560|NCT03364309|589207840|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
163136561|NCT03364309|589207841|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
163136562|NCT03364309|589207842|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
163136563|NCT03364309|589207843|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
163136564|NCT03364309|589207844|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
163136565|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136566|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136567|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136568|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136569|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136570|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136571|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136572|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136573|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136574|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136575|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136576|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136577|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136578|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136579|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136580|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
163136581|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
163136582|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
163136583|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
163136584|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Adverse Event|0|||
163136585|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Adverse Event|0|||
163136586|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Adverse Event|0|||
163136587|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Adverse Event|0|||
163136588|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Adverse Event|0|||
163136589|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Adverse Event|0|||
163136590|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Adverse Event|0|||
163136591|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Adverse Event|0|||
163136592|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Adverse Event|0|||
163136593|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Adverse Event|0|||
163136594|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Adverse Event|0|||
163136595|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Adverse Event|0|||
163136596|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Adverse Event|0|||
163136597|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Adverse Event|0|||
163136598|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Adverse Event|0|||
163136599|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Adverse Event|0|||
163136600|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Adverse Event|2|||
162659303|NCT03670810|587465891|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162659304|NCT03670810|587465892|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
162659305|NCT03670810|587465884|FG000|Open Label Extension|Withdrawal by Subject|0|||
162659306|NCT03670810|587465885|FG001|Open Label Extension|Withdrawal by Subject|0|||
162659307|NCT03670810|587465886|FG002|Open Label Extension|Withdrawal by Subject|0|||
162659308|NCT03670810|587465887|FG003|Open Label Extension|Withdrawal by Subject|0|||
163136601|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Adverse Event|6|||
163136602|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Adverse Event|1|||
163136603|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136604|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136605|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136606|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136607|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136608|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136609|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136610|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136611|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136612|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136613|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136614|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136615|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136616|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136617|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136618|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136619|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136620|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
163136621|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
163136622|NCT03364309|589207826|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
163136623|NCT03364309|589207827|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
163136624|NCT03364309|589207828|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
163136625|NCT03364309|589207829|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
163136626|NCT03364309|589207830|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
163136627|NCT03364309|589207831|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
163136628|NCT03364309|589207832|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
163136629|NCT03364309|589207833|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
163136630|NCT03364309|589207834|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
163136631|NCT03364309|589207835|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
163136632|NCT03364309|589207836|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
163136633|NCT03364309|589207837|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
163136634|NCT03364309|589207838|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
163136635|NCT03364309|589207839|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
163136636|NCT03364309|589207840|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
163136637|NCT03364309|589207841|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
163136638|NCT03364309|589207842|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
163136639|NCT03364309|589207843|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
163136640|NCT03364309|589207844|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
163136641|NCT01371552|589207845|FG000|Part 1, First 3 Days|Inconvenience|0|||
163136642|NCT01371552|589207846|FG001|Part 1, First 3 Days|Inconvenience|0|||
163136643|NCT01371552|589207847|FG002|Part 1, First 3 Days|Inconvenience|1|||
163136644|NCT01371552|589207848|FG003|Part 1, First 3 Days|Inconvenience|0|||
163136645|NCT01371552|589207849|FG004|Part 1, First 3 Days|Inconvenience|0|||
163136646|NCT01371552|589207850|FG005|Part 1, First 3 Days|Inconvenience|0|||
163136647|NCT00167310|589207851|FG000|Overall Study|Protocol Violation|5|||
163136648|NCT00167310|589207852|FG001|Overall Study|Protocol Violation|3|||
163136649|NCT00167310|589207851|FG000|Overall Study|Withdrawal by Subject|3|||
163136650|NCT00167310|589207852|FG001|Overall Study|Withdrawal by Subject|7|||
163136651|NCT00615992|589207853|FG000|Overall Study|Protocol Violation|67|||
163136652|NCT04522141|589207855|FG000|Overall Study|Withdrawal by Subject|1|||
163136653|NCT04522141|589207856|FG001|Overall Study|Withdrawal by Subject|0|||
163136654|NCT03052049|589207857|FG000|Overall Study|Withdrawal by Subject|2|||
163136655|NCT03508609|589207858|FG000|Overall Study|Withdrawal by Subject|1|||
163136656|NCT02328027|589207859|FG000|Overall Study|Withdrawal by Subject|0|||
162659309|NCT03670810|587465888|FG004|Open Label Extension|Withdrawal by Subject|0|||
163136657|NCT02328027|589207860|FG001|Overall Study|Withdrawal by Subject|1|||
162659310|NCT03670810|587465889|FG005|Open Label Extension|Withdrawal by Subject|0|||
163136658|NCT03304873|589207861|FG000|Overall Study|Lost to Follow-up|1|||
163136659|NCT03304873|589207862|FG001|Overall Study|Lost to Follow-up|8|||
163136660|NCT03319212|589207863|FG000|Overall Study|Discontinued as moving out of local area|0|||
163136661|NCT03319212|589207864|FG001|Overall Study|Discontinued as moving out of local area|1|||
163136662|NCT03319212|589207863|FG000|Overall Study|Adverse Event|2|||
163136663|NCT03319212|589207864|FG001|Overall Study|Adverse Event|2|||
163136664|NCT03319212|589207863|FG000|Overall Study|Withdrawal by Subject|0|||
163136665|NCT03319212|589207864|FG001|Overall Study|Withdrawal by Subject|1|||
163136666|NCT03319212|589207863|FG000|Overall Study|Lost to Follow-up|0|||
163136667|NCT03319212|589207864|FG001|Overall Study|Lost to Follow-up|1|||
163136668|NCT03319212|589207863|FG000|Overall Study|Physician Decision|1|||
163136669|NCT03319212|589207864|FG001|Overall Study|Physician Decision|0|||
163136670|NCT00400569|589207865|FG000|Overall Study|Death|1|||
163136671|NCT01868477|589207867|FG000|Overall Study|Adverse Event|2|||
163136672|NCT01868477|589207868|FG001|Overall Study|Adverse Event|4|||
163136673|NCT01868477|589207867|FG000|Overall Study|Disease progression|1|||
163136674|NCT01868477|589207868|FG001|Overall Study|Disease progression|1|||
163136675|NCT01868477|589207867|FG000|Overall Study|Withdrawal by Subject|1|||
163136676|NCT01868477|589207868|FG001|Overall Study|Withdrawal by Subject|0|||
163136677|NCT02465203|589207870|FG000|Overall Study|Protocol Violation|1|||
163136678|NCT02465203|589207871|FG001|Overall Study|Protocol Violation|1|||
163136679|NCT02465203|589207872|FG002|Overall Study|Protocol Violation|1|||
163136680|NCT02465203|589207870|FG000|Overall Study|Study terminated by sponsor|50|||
163136681|NCT02465203|589207871|FG001|Overall Study|Study terminated by sponsor|34|||
163136682|NCT02465203|589207872|FG002|Overall Study|Study terminated by sponsor|11|||
163136683|NCT02465203|589207870|FG000|Overall Study|New therapy for study indication|4|||
163136684|NCT02465203|589207871|FG001|Overall Study|New therapy for study indication|0|||
163136685|NCT02465203|589207872|FG002|Overall Study|New therapy for study indication|0|||
163136686|NCT02465203|589207870|FG000|Overall Study|Patient/guardian decision|1|||
163136687|NCT02465203|589207871|FG001|Overall Study|Patient/guardian decision|1|||
163136688|NCT02465203|589207872|FG002|Overall Study|Patient/guardian decision|1|||
163136689|NCT00620113|589207873|FG000|Overall Study|Adverse Event|3|||
163136690|NCT00620113|589207874|FG001|Overall Study|Adverse Event|2|||
163136691|NCT00620113|589207875|FG002|Overall Study|Adverse Event|2|||
163136692|NCT00620113|589207876|FG003|Overall Study|Adverse Event|1|||
163136693|NCT00620113|589207873|FG000|Overall Study|Lack of Efficacy|2|||
163136694|NCT00620113|589207874|FG001|Overall Study|Lack of Efficacy|3|||
163136695|NCT00620113|589207875|FG002|Overall Study|Lack of Efficacy|0|||
163136696|NCT00620113|589207876|FG003|Overall Study|Lack of Efficacy|2|||
163136697|NCT00620113|589207873|FG000|Overall Study|Physician Decision|1|||
163136698|NCT00620113|589207874|FG001|Overall Study|Physician Decision|0|||
163136699|NCT00620113|589207875|FG002|Overall Study|Physician Decision|0|||
163136700|NCT00620113|589207876|FG003|Overall Study|Physician Decision|2|||
163136701|NCT00620113|589207873|FG000|Overall Study|Protocol Violation|2|||
163136702|NCT00620113|589207874|FG001|Overall Study|Protocol Violation|1|||
163136703|NCT00620113|589207875|FG002|Overall Study|Protocol Violation|0|||
163136704|NCT00620113|589207876|FG003|Overall Study|Protocol Violation|0|||
163136705|NCT00620113|589207873|FG000|Overall Study|Withdrawal by Subject|5|||
163136706|NCT00620113|589207874|FG001|Overall Study|Withdrawal by Subject|1|||
163136707|NCT00620113|589207875|FG002|Overall Study|Withdrawal by Subject|3|||
163136708|NCT00620113|589207876|FG003|Overall Study|Withdrawal by Subject|5|||
163136709|NCT04072887|589207883|FG000|Overall Study|Withdrawal by Subject|3|||
163136710|NCT04072887|589207884|FG001|Overall Study|Withdrawal by Subject|8|||
163136711|NCT04072887|589207885|FG002|Overall Study|Withdrawal by Subject|1|||
163136712|NCT04072887|589207886|FG003|Overall Study|Withdrawal by Subject|3|||
163136713|NCT04072887|589207887|FG004|Overall Study|Withdrawal by Subject|3|||
163136714|NCT04072887|589207888|FG005|Overall Study|Withdrawal by Subject|13|||
163136715|NCT04072887|589207883|FG000|Overall Study|Adverse Event|2|||
163136716|NCT04072887|589207884|FG001|Overall Study|Adverse Event|4|||
163136717|NCT04072887|589207885|FG002|Overall Study|Adverse Event|1|||
163136718|NCT04072887|589207886|FG003|Overall Study|Adverse Event|4|||
163136719|NCT04072887|589207887|FG004|Overall Study|Adverse Event|0|||
163136720|NCT04072887|589207888|FG005|Overall Study|Adverse Event|1|||
163136721|NCT04072887|589207883|FG000|Overall Study|Physician Decision|2|||
163136722|NCT04072887|589207884|FG001|Overall Study|Physician Decision|0|||
163136723|NCT04072887|589207885|FG002|Overall Study|Physician Decision|0|||
163136724|NCT04072887|589207886|FG003|Overall Study|Physician Decision|0|||
163136725|NCT04072887|589207887|FG004|Overall Study|Physician Decision|0|||
163136726|NCT04072887|589207888|FG005|Overall Study|Physician Decision|1|||
163136727|NCT04072887|589207883|FG000|Overall Study|Lost to Follow-up|1|||
163136728|NCT04072887|589207884|FG001|Overall Study|Lost to Follow-up|3|||
163136729|NCT04072887|589207885|FG002|Overall Study|Lost to Follow-up|0|||
163136730|NCT04072887|589207886|FG003|Overall Study|Lost to Follow-up|0|||
162659311|NCT03670810|587465890|FG006|Open Label Extension|Withdrawal by Subject|0|||
162659312|NCT03670810|587465891|FG007|Open Label Extension|Withdrawal by Subject|0|||
162659313|NCT03670810|587465892|FG008|Open Label Extension|Withdrawal by Subject|46|||
162659314|NCT03670810|587465884|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162659315|NCT03670810|587465885|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162659316|NCT03670810|587465886|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163136731|NCT04072887|589207887|FG004|Overall Study|Lost to Follow-up|0|||
163136732|NCT04072887|589207888|FG005|Overall Study|Lost to Follow-up|0|||
163136733|NCT04072887|589207883|FG000|Overall Study|Death|0|||
163136734|NCT04072887|589207884|FG001|Overall Study|Death|2|||
163136735|NCT04072887|589207885|FG002|Overall Study|Death|0|||
163136736|NCT04072887|589207886|FG003|Overall Study|Death|2|||
163136737|NCT04072887|589207887|FG004|Overall Study|Death|3|||
163136738|NCT04072887|589207888|FG005|Overall Study|Death|0|||
163136739|NCT00856297|589207889|FG000|Overall Study|Unable to classify|2|||
163136740|NCT00856297|589207890|FG001|Overall Study|Unable to classify|0|||
163136741|NCT00856297|589207891|FG002|Overall Study|Unable to classify|0|||
163136742|NCT00856297|589207892|FG003|Overall Study|Unable to classify|0|||
163136743|NCT00856297|589207893|FG004|Overall Study|Unable to classify|0|||
163136744|NCT00423449|589207896|FG000|Overall Study|Clinical Adverse Event|1|||
163136745|NCT00423449|589207897|FG001|Overall Study|Clinical Adverse Event|0|||
163136746|NCT00423449|589207898|FG002|Overall Study|Clinical Adverse Event|1|||
163136747|NCT00423449|589207899|FG003|Overall Study|Clinical Adverse Event|8|||
163136748|NCT00423449|589207900|FG004|Overall Study|Clinical Adverse Event|2|||
163136749|NCT00423449|589207896|FG000|Overall Study|Death|1|||
163136750|NCT00423449|589207897|FG001|Overall Study|Death|0|||
163136751|NCT00423449|589207898|FG002|Overall Study|Death|2|||
163136752|NCT00423449|589207899|FG003|Overall Study|Death|1|||
163136753|NCT00423449|589207900|FG004|Overall Study|Death|1|||
163136754|NCT00423449|589207896|FG000|Overall Study|Progressive Disease|1|||
163136755|NCT00423449|589207897|FG001|Overall Study|Progressive Disease|3|||
163136756|NCT00423449|589207898|FG002|Overall Study|Progressive Disease|8|||
163136757|NCT00423449|589207899|FG003|Overall Study|Progressive Disease|11|||
163136758|NCT00423449|589207900|FG004|Overall Study|Progressive Disease|4|||
163136759|NCT00423449|589207896|FG000|Overall Study|Laboratory Adverse Event|0|||
163136760|NCT00423449|589207897|FG001|Overall Study|Laboratory Adverse Event|1|||
163136761|NCT00423449|589207898|FG002|Overall Study|Laboratory Adverse Event|2|||
163136762|NCT00423449|589207899|FG003|Overall Study|Laboratory Adverse Event|0|||
163136763|NCT00423449|589207900|FG004|Overall Study|Laboratory Adverse Event|0|||
163136764|NCT00423449|589207896|FG000|Overall Study|Other|0|||
163136765|NCT00423449|589207897|FG001|Overall Study|Other|0|||
163136766|NCT00423449|589207898|FG002|Overall Study|Other|0|||
163136767|NCT00423449|589207899|FG003|Overall Study|Other|1|||
163136768|NCT00423449|589207900|FG004|Overall Study|Other|0|||
163136769|NCT00423449|589207896|FG000|Overall Study|Protocol Violation|0|||
163136770|NCT00423449|589207897|FG001|Overall Study|Protocol Violation|0|||
163136771|NCT00423449|589207898|FG002|Overall Study|Protocol Violation|2|||
163136772|NCT00423449|589207899|FG003|Overall Study|Protocol Violation|1|||
163136773|NCT00423449|589207900|FG004|Overall Study|Protocol Violation|0|||
163136774|NCT01153724|589207901|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163136775|NCT01153724|589207901|FG000|Treatment Period 2|Adverse Event|1|||
163136776|NCT01153724|589207901|FG000|Treatment Period 2|Other reason not defined above|1|||
163136777|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
163136778|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
163136779|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
163136780|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
163136781|NCT04371666|589207906|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
163136782|NCT04371666|589207907|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
163136783|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
163136784|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
163136785|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
163136786|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
163136787|NCT04371666|589207906|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
163136788|NCT04371666|589207907|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
163136789|NCT00445770|589207908|FG000|Overall Study|Adverse Event|9|||
163136790|NCT00445770|589207909|FG001|Overall Study|Adverse Event|15|||
163136791|NCT00445770|589207910|FG002|Overall Study|Adverse Event|19|||
163136792|NCT00445770|589207908|FG000|Overall Study|Lack of Efficacy|38|||
163136793|NCT00445770|589207909|FG001|Overall Study|Lack of Efficacy|13|||
163136794|NCT00445770|589207910|FG002|Overall Study|Lack of Efficacy|6|||
163136795|NCT00445770|589207908|FG000|Overall Study|Lost to Follow-up|0|||
163136796|NCT00445770|589207909|FG001|Overall Study|Lost to Follow-up|2|||
163136797|NCT00445770|589207910|FG002|Overall Study|Lost to Follow-up|0|||
163136798|NCT00445770|589207908|FG000|Overall Study|Other|6|||
163136799|NCT00445770|589207909|FG001|Overall Study|Other|5|||
163136800|NCT00445770|589207910|FG002|Overall Study|Other|6|||
163136801|NCT00947115|589207911|FG000|Overall Study|Missed reporting interval|3|||
163136802|NCT00947115|589207912|FG001|Overall Study|Missed reporting interval|4|||
163136803|NCT00947115|589207913|FG002|Overall Study|Missed reporting interval|2|||
163136804|NCT00947115|589207911|FG000|Overall Study|Physician Decision|0|||
163136805|NCT00947115|589207912|FG001|Overall Study|Physician Decision|2|||
163136806|NCT00947115|589207913|FG002|Overall Study|Physician Decision|0|||
163136807|NCT00947115|589207911|FG000|Overall Study|Death|0|||
163136808|NCT00947115|589207912|FG001|Overall Study|Death|1|||
163136809|NCT00947115|589207913|FG002|Overall Study|Death|1|||
163136810|NCT00947115|589207911|FG000|Overall Study|Migrated from study area|2|||
163136811|NCT00947115|589207912|FG001|Overall Study|Migrated from study area|0|||
163136812|NCT00947115|589207913|FG002|Overall Study|Migrated from study area|0|||
163136813|NCT00947115|589207911|FG000|Overall Study|Withdrawal by Subject|1|||
163136814|NCT00947115|589207912|FG001|Overall Study|Withdrawal by Subject|3|||
163136815|NCT00947115|589207913|FG002|Overall Study|Withdrawal by Subject|4|||
163136816|NCT00947115|589207911|FG000|Overall Study|Lost to Follow-up|11|||
163136817|NCT00947115|589207912|FG001|Overall Study|Lost to Follow-up|12|||
163136818|NCT00947115|589207913|FG002|Overall Study|Lost to Follow-up|8|||
163136819|NCT02092025|589207914|FG000|Overall Study|Case Report Forms Uncollected|44|||
163136820|NCT02092025|589207914|FG000|Overall Study|Protocol Deviation|24|||
163136821|NCT02927938|589207915|FG000|Overall Study|Death|0|||
163136822|NCT02927938|589207916|FG001|Overall Study|Death|1|||
162719973|NCT02694978|587682387|FG000|Overall Study|Other-Unable to be reached|0|||
162719974|NCT02694978|587682388|FG001|Overall Study|Other-Unable to be reached|1|||
162719975|NCT02694978|587682387|FG000|Overall Study|Other-Protocol noncompliant|2|||
162719976|NCT02694978|587682388|FG001|Overall Study|Other-Protocol noncompliant|1|||
162719977|NCT02694978|587682387|FG000|Overall Study|Other-Personal reasons|3|||
163136823|NCT02927938|589207917|FG002|Overall Study|Death|0|||
163136824|NCT02927938|589207918|FG003|Overall Study|Death|4|||
163136825|NCT02927938|589207915|FG000|Overall Study|Early Study Termination|1|||
163136826|NCT02927938|589207916|FG001|Overall Study|Early Study Termination|5|||
163136827|NCT02927938|589207917|FG002|Overall Study|Early Study Termination|4|||
163136828|NCT02927938|589207918|FG003|Overall Study|Early Study Termination|3|||
163136829|NCT03228212|589207921|FG000|Period 1|Adverse Event|1|||
163136830|NCT03228212|589207922|FG001|Period 1|Adverse Event|0|||
163136831|NCT03228212|589207921|FG000|Period 1|no longer meets eligibility criteria|0|||
163136832|NCT03228212|589207922|FG001|Period 1|no longer meets eligibility criteria|1|||
163136833|NCT03228212|589207921|FG000|Period 2|Lost to Follow-up|1|||
163136834|NCT03228212|589207922|FG001|Period 2|Lost to Follow-up|0|||
163136835|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
163136836|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
163136837|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Adverse Event|4|||
163136838|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Adverse Event|1|||
163136839|NCT00934128|589207923|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
163136840|NCT00934128|589207924|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
163136841|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Patient preference|1|||
163136842|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Patient preference|3|||
163136843|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Pain|1|||
163136844|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Pain|0|||
163136845|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Too tired|1|||
163136846|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Too tired|0|||
163136847|NCT00934128|589207923|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
163136848|NCT00934128|589207924|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
163136849|NCT00934128|589207923|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
163136850|NCT00934128|589207924|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
163136851|NCT02834247|589207925|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
163136852|NCT02834247|589207926|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
163136853|NCT02834247|589207927|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
163136854|NCT02834247|589207928|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
163136855|NCT02834247|589207925|FG000|Dose Escalation Phase|Death|5|||
163136856|NCT02834247|589207926|FG001|Dose Escalation Phase|Death|6|||
163136857|NCT02834247|589207927|FG002|Dose Escalation Phase|Death|5|||
163136858|NCT02834247|589207928|FG003|Dose Escalation Phase|Death|0|||
163136859|NCT02834247|589207925|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
163136860|NCT02834247|589207926|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
163136861|NCT02834247|589207927|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
163136862|NCT02834247|589207928|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
163136863|NCT02834247|589207925|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
163136864|NCT02834247|589207926|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
163136865|NCT02834247|589207927|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163136866|NCT02834247|589207928|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163136867|NCT02834247|589207925|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136868|NCT02834247|589207926|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136869|NCT02834247|589207927|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
163136870|NCT02834247|589207928|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
163136871|NCT02834247|589207925|FG000|Dose Expansion Phase|Death|0|||
163136872|NCT02834247|589207926|FG001|Dose Expansion Phase|Death|0|||
163136873|NCT02834247|589207927|FG002|Dose Expansion Phase|Death|0|||
163136874|NCT02834247|589207928|FG003|Dose Expansion Phase|Death|8|||
163136875|NCT02834247|589207925|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
163136876|NCT02834247|589207926|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
163136877|NCT02834247|589207927|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
163136878|NCT02834247|589207928|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
162719978|NCT02694978|587682388|FG001|Overall Study|Other-Personal reasons|3|||
162719979|NCT02694978|587682387|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
163136879|NCT02834247|589207925|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
163136880|NCT02834247|589207926|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
163136881|NCT02834247|589207927|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
163136882|NCT02834247|589207928|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
163136883|NCT01807299|589207935|FG000|Overall Study|Protocol Violation|3|||
163136884|NCT01807299|589207936|FG001|Overall Study|Protocol Violation|1|||
163136885|NCT01807299|589207937|FG002|Overall Study|Protocol Violation|0|||
163136886|NCT01807299|589207938|FG003|Overall Study|Protocol Violation|2|||
163136887|NCT02476006|589207939|FG000|Overall Study|Death|4|||
163136888|NCT02476006|589207939|FG000|Overall Study|Lack of treatment efficacy|2|||
162719980|NCT02694978|587682388|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
163136889|NCT02476006|589207939|FG000|Overall Study|Pregnancy|1|||
163136890|NCT02476006|589207939|FG000|Overall Study|Participant did not wish to continue|39|||
163136891|NCT02476006|589207939|FG000|Overall Study|Adverse Event|41|||
163136892|NCT02476006|589207939|FG000|Overall Study|Poor compliance to study protocol|3|||
163136893|NCT02476006|589207939|FG000|Overall Study|Sponsor decision|6|||
163136894|NCT02476006|589207939|FG000|Overall Study|Lost to Follow-up|5|||
163136895|NCT02476006|589207939|FG000|Overall Study|Physician Decision|5|||
163136896|NCT02476006|589207939|FG000|Overall Study|Study ended treatment not available|4|||
163136897|NCT02476006|589207939|FG000|Overall Study|Switched to commercial drug|4|||
163136898|NCT02476006|589207939|FG000|Overall Study|Excluded from study|1|||
163136899|NCT02476006|589207939|FG000|Overall Study|Protocol Violation|1|||
163136900|NCT02476006|589207939|FG000|Overall Study|Enrolled but not treated|4|||
163136901|NCT00811174|589207940|FG000|Overall Study|Protocol Violation|2|||
163136902|NCT00811174|589207940|FG000|Overall Study|Sponsors Decision|1|||
163136903|NCT00447226|589209471|FG000|12-Week Open-label Phase|Adverse Event|0|||
163136904|NCT00447226|589209472|FG001|12-Week Open-label Phase|Adverse Event|3|||
163136905|NCT00447226|589209471|FG000|12-Week Open-label Phase|Protocol Violation|0|||
163136906|NCT00447226|589209472|FG001|12-Week Open-label Phase|Protocol Violation|1|||
163136907|NCT00447226|589209471|FG000|12-Week Open-label Phase|Disease Progression|0|||
163136908|NCT00447226|589209472|FG001|12-Week Open-label Phase|Disease Progression|20|||
163136909|NCT00447226|589209471|FG000|12-Week Open-label Phase|Physician Decision|0|||
163136910|NCT00447226|589209472|FG001|12-Week Open-label Phase|Physician Decision|1|||
163136911|NCT00447226|589209471|FG000|Double-blind Phase|Disease Progression|4|||
163136912|NCT00447226|589209472|FG001|Double-blind Phase|Disease Progression|3|||
163136913|NCT03449758|589209480|FG000|Overall Study|Major protocol deviation|1|||
163136914|NCT03449758|589209480|FG000|Overall Study|Treatment inefficacy|5|||
163136915|NCT03449758|589209480|FG000|Overall Study|Adverse Event|9|||
163136916|NCT03449758|589209480|FG000|Overall Study|Consent withdrawal|1|||
163136917|NCT03449758|589209480|FG000|Overall Study|Other unspecified reason|3|||
163136918|NCT00584012|589209489|FG000|Overall Study|Withdrawal by Subject|1|||
163136919|NCT02451943|589209492|FG000|Overall Study|Withdrawal by Subject|13|||
163136920|NCT02451943|589209493|FG001|Overall Study|Withdrawal by Subject|16|||
163136921|NCT02451943|589209492|FG000|Overall Study|Lost to Follow-up|3|||
163136922|NCT02451943|589209493|FG001|Overall Study|Lost to Follow-up|4|||
163136923|NCT02451943|589209492|FG000|Overall Study|Sponsor Decision|0|||
163136924|NCT02451943|589209493|FG001|Overall Study|Sponsor Decision|4|||
163136925|NCT03937713|589209494|FG000|Overall Study|Withdrawal by Subject|3|||
163136926|NCT03937713|589209495|FG001|Overall Study|Withdrawal by Subject|6|||
163136927|NCT03937713|589209494|FG000|Overall Study|Lost to Follow-up|1|||
163136928|NCT03937713|589209495|FG001|Overall Study|Lost to Follow-up|0|||
163136929|NCT02871635|589209496|FG000|Overall Study|Primary lack of efficacy|4|||
163136930|NCT02871635|589209497|FG001|Overall Study|Primary lack of efficacy|4|||
163136931|NCT02871635|589209496|FG000|Overall Study|Protocol Violation|3|||
163136932|NCT02871635|589209497|FG001|Overall Study|Protocol Violation|1|||
163136933|NCT02871635|589209496|FG000|Overall Study|Lost to Follow-up|1|||
163136934|NCT02871635|589209497|FG001|Overall Study|Lost to Follow-up|2|||
163136935|NCT02871635|589209496|FG000|Overall Study|Pregnancy|0|||
163136936|NCT02871635|589209497|FG001|Overall Study|Pregnancy|2|||
163136937|NCT02871635|589209496|FG000|Overall Study|Physician Decision|1|||
163136938|NCT02871635|589209497|FG001|Overall Study|Physician Decision|1|||
163136939|NCT02871635|589209496|FG000|Overall Study|Withdrawal by Subject|3|||
163136940|NCT02871635|589209497|FG001|Overall Study|Withdrawal by Subject|4|||
163136941|NCT02871635|589209496|FG000|Overall Study|Adverse Event|4|||
163136942|NCT02871635|589209497|FG001|Overall Study|Adverse Event|4|||
163136943|NCT02871635|589209496|FG000|Overall Study|Secondary lack of efficacy|2|||
163136944|NCT02871635|589209497|FG001|Overall Study|Secondary lack of efficacy|1|||
163136945|NCT02420379|589209498|FG000|Overall Study|Withdrawal by Subject|0|||
163136946|NCT02420379|589209499|FG001|Overall Study|Withdrawal by Subject|3|||
163136947|NCT02420379|589209498|FG000|Overall Study|Unable to complete due to schooling|0|||
163136948|NCT02420379|589209499|FG001|Overall Study|Unable to complete due to schooling|1|||
163136949|NCT02420379|589209498|FG000|Overall Study|Transitioned to commercial drug|1|||
163136950|NCT02420379|589209499|FG001|Overall Study|Transitioned to commercial drug|0|||
163136951|NCT01402817|589209500|FG000|Overall Study|Withdrawal by Subject|3|||
163136952|NCT01402817|589209500|FG000|Overall Study|Study Suspended by FDA|8|||
163136953|NCT00502671|589209501|FG000|Overall Study|Disease Progression|13|||
163136954|NCT00502671|589209501|FG000|Overall Study|Personal Reasons|22|||
163136955|NCT00502671|589209501|FG000|Overall Study|Lost to Follow-up|7|||
163136956|NCT00502671|589209501|FG000|Overall Study|Protocol Violation|16|||
163136957|NCT00502671|589209501|FG000|Overall Study|Adverse Event|19|||
163136958|NCT00681629|589209508|FG000|Overall Study|Study termination|4|||
163136959|NCT00681629|589209509|FG001|Overall Study|Study termination|2|||
163136960|NCT00681629|589209508|FG000|Overall Study|Adverse Event|1|||
163136961|NCT00681629|589209509|FG001|Overall Study|Adverse Event|0|||
163136962|NCT01410890|589209511|FG000|Overall Study|Withdrawal by Subject|0|||
163136963|NCT01410890|589209512|FG001|Overall Study|Withdrawal by Subject|1|||
163136964|NCT00412893|589209513|FG000|Overall Study|Adverse Event|31|||
163136965|NCT00412893|589209514|FG001|Overall Study|Adverse Event|53|||
163136966|NCT00412893|589209513|FG000|Overall Study|Death|17|||
163136967|NCT00412893|589209514|FG001|Overall Study|Death|21|||
163136968|NCT00412893|589209513|FG000|Overall Study|Insufficient Therapeutic Response|39|||
163136969|NCT00412893|589209514|FG001|Overall Study|Insufficient Therapeutic Response|23|||
163136970|NCT00412893|589209513|FG000|Overall Study|Lost to Follow-up|2|||
163136971|NCT00412893|589209514|FG001|Overall Study|Lost to Follow-up|1|||
163136972|NCT00412893|589209513|FG000|Overall Study|Violation of Selection at Entry|17|||
163136973|NCT00412893|589209514|FG001|Overall Study|Violation of Selection at Entry|10|||
163136974|NCT00412893|589209513|FG000|Overall Study|Other Protocol Violation|10|||
163136975|NCT00412893|589209514|FG001|Overall Study|Other Protocol Violation|6|||
163136976|NCT00412893|589209513|FG000|Overall Study|Did Not Cooperate|12|||
163136977|NCT00412893|589209514|FG001|Overall Study|Did Not Cooperate|9|||
163136978|NCT00412893|589209513|FG000|Overall Study|Administrative Reason|12|||
163136979|NCT00412893|589209514|FG001|Overall Study|Administrative Reason|15|||
163136980|NCT00412893|589209513|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
163136981|NCT00412893|589209514|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
163136982|NCT03951077|589209515|FG000|Overall Study|Adverse Event|1|||
163136983|NCT03951077|589209516|FG001|Overall Study|Adverse Event|0|||
163136984|NCT03951077|589209517|FG002|Overall Study|Adverse Event|0|||
163136985|NCT03951077|589209518|FG003|Overall Study|Adverse Event|0|||
163136986|NCT03951077|589209519|FG004|Overall Study|Adverse Event|0|||
163136987|NCT03951077|589209520|FG005|Overall Study|Adverse Event|0|||
163136988|NCT03951077|589209515|FG000|Overall Study|Withdrawal by Subject|3|||
163136989|NCT03951077|589209516|FG001|Overall Study|Withdrawal by Subject|3|||
163136990|NCT03951077|589209517|FG002|Overall Study|Withdrawal by Subject|0|||
163136991|NCT03951077|589209518|FG003|Overall Study|Withdrawal by Subject|3|||
163136992|NCT03951077|589209519|FG004|Overall Study|Withdrawal by Subject|3|||
163136993|NCT03951077|589209520|FG005|Overall Study|Withdrawal by Subject|2|||
163136994|NCT03951077|589209515|FG000|Overall Study|Lost to Follow-up|1|||
163136995|NCT03951077|589209516|FG001|Overall Study|Lost to Follow-up|1|||
163136996|NCT03951077|589209517|FG002|Overall Study|Lost to Follow-up|2|||
163136997|NCT03951077|589209518|FG003|Overall Study|Lost to Follow-up|3|||
163136998|NCT03951077|589209519|FG004|Overall Study|Lost to Follow-up|2|||
163136999|NCT03951077|589209520|FG005|Overall Study|Lost to Follow-up|3|||
163137000|NCT03951077|589209515|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
163137001|NCT03951077|589209516|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
163137002|NCT03951077|589209517|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
163137003|NCT03951077|589209518|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
163137004|NCT03951077|589209519|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
163137005|NCT03951077|589209520|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
163137006|NCT03951077|589209515|FG000|Overall Study|Other, Not Specified|12|||
163137007|NCT03951077|589209516|FG001|Overall Study|Other, Not Specified|10|||
163137008|NCT03951077|589209517|FG002|Overall Study|Other, Not Specified|10|||
163137009|NCT03951077|589209518|FG003|Overall Study|Other, Not Specified|5|||
163137010|NCT03951077|589209519|FG004|Overall Study|Other, Not Specified|9|||
163137011|NCT03951077|589209520|FG005|Overall Study|Other, Not Specified|6|||
163137012|NCT03951077|589209515|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
163137013|NCT03951077|589209516|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
163137014|NCT03951077|589209517|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
163137015|NCT03951077|589209518|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
163137016|NCT03951077|589209519|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
163137017|NCT03951077|589209520|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
163137018|NCT00086047|589209521|FG000|Overall Study|Lost to Follow-up|7|||
163137019|NCT00086047|589209522|FG001|Overall Study|Lost to Follow-up|6|||
163137020|NCT00086047|589209521|FG000|Overall Study|Physician Decision|0|||
163137021|NCT00086047|589209522|FG001|Overall Study|Physician Decision|1|||
163137022|NCT01395901|589209523|FG000|Overall Study|Lost to Follow-up|4|||
163137023|NCT01395901|589209524|FG001|Overall Study|Lost to Follow-up|0|||
163137024|NCT01395901|589209523|FG000|Overall Study|Randomized but not received study drug|5|||
163137025|NCT01395901|589209524|FG001|Overall Study|Randomized but not received study drug|4|||
163137026|NCT01395901|589209523|FG000|Overall Study|Adverse Event|0|||
163137027|NCT01395901|589209524|FG001|Overall Study|Adverse Event|1|||
162659317|NCT03670810|587465887|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163137028|NCT01395901|589209523|FG000|Overall Study|Withdrawal of consent|1|||
163137029|NCT01395901|589209524|FG001|Overall Study|Withdrawal of consent|0|||
163137030|NCT03579940|589209529|FG000|Period 2|Withdrawal by Subject|0|||
163137031|NCT03579940|589209530|FG001|Period 2|Withdrawal by Subject|0|||
163137032|NCT03579940|589209531|FG002|Period 2|Withdrawal by Subject|1|||
163137033|NCT03579940|589209532|FG003|Period 2|Withdrawal by Subject|0|||
163137034|NCT03579940|589209533|FG004|Period 2|Withdrawal by Subject|0|||
163137035|NCT03579940|589209534|FG005|Period 2|Withdrawal by Subject|0|||
163137036|NCT03579940|589209535|FG006|Period 2|Withdrawal by Subject|0|||
163137037|NCT03579940|589209536|FG007|Period 2|Withdrawal by Subject|0|||
163137038|NCT03579940|589209537|FG008|Period 2|Withdrawal by Subject|0|||
163137039|NCT03579940|589209538|FG009|Period 2|Withdrawal by Subject|0|||
163137040|NCT03579940|589209539|FG010|Period 2|Withdrawal by Subject|0|||
163137041|NCT01217944|589209540|FG000|Overall Study|Protocol Violation|1|||
163137042|NCT01217944|589209541|FG001|Overall Study|Protocol Violation|1|||
163137043|NCT01217944|589209542|FG002|Overall Study|Protocol Violation|0|||
163137044|NCT01217944|589209540|FG000|Overall Study|Lost to Follow-up|3|||
163137045|NCT01217944|589209541|FG001|Overall Study|Lost to Follow-up|1|||
163137046|NCT01217944|589209542|FG002|Overall Study|Lost to Follow-up|0|||
163137047|NCT01217944|589209540|FG000|Overall Study|Withdrawal by Subject|1|||
163137048|NCT01217944|589209541|FG001|Overall Study|Withdrawal by Subject|2|||
163137049|NCT01217944|589209542|FG002|Overall Study|Withdrawal by Subject|0|||
163137050|NCT01217944|589209540|FG000|Overall Study|Lack of Efficacy|1|||
163137051|NCT01217944|589209541|FG001|Overall Study|Lack of Efficacy|0|||
163137052|NCT01217944|589209542|FG002|Overall Study|Lack of Efficacy|0|||
163137053|NCT01751984|589209543|FG000|Overall Study|Adverse Event|5|||
163137054|NCT01751984|589209544|FG001|Overall Study|Adverse Event|3|||
163137055|NCT01751984|589209543|FG000|Overall Study|Withdrawal by Subject|0|||
163137056|NCT01751984|589209544|FG001|Overall Study|Withdrawal by Subject|1|||
163137057|NCT01751984|589209543|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
163137058|NCT01751984|589209544|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
163137059|NCT00587158|589209545|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
163137060|NCT00587158|589209546|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
163137061|NCT00587158|589209545|FG000|Overall Study|Physician Decision|0|||
163137062|NCT00587158|589209546|FG001|Overall Study|Physician Decision|1|||
163137063|NCT00587158|589209545|FG000|Overall Study|Lost to Follow-up|1|||
163137064|NCT00587158|589209546|FG001|Overall Study|Lost to Follow-up|2|||
163137065|NCT00587158|589209545|FG000|Overall Study|Death|0|||
163137066|NCT00587158|589209546|FG001|Overall Study|Death|1|||
163137067|NCT00587158|589209545|FG000|Overall Study|Subject did not want to take study med|0|||
163137068|NCT00587158|589209546|FG001|Overall Study|Subject did not want to take study med|1|||
163137069|NCT01136408|589209547|FG000|Overall Study|Adverse Event|4|||
163137070|NCT01136408|589209548|FG001|Overall Study|Adverse Event|8|||
163137071|NCT01136408|589209549|FG002|Overall Study|Adverse Event|4|||
163137072|NCT01136408|589209547|FG000|Overall Study|Protocol Violation|1|||
163137073|NCT01136408|589209548|FG001|Overall Study|Protocol Violation|1|||
163137074|NCT01136408|589209549|FG002|Overall Study|Protocol Violation|1|||
163137075|NCT02274792|589209550|FG000|Overall Study|Withdrawal by Subject|13|||
163137076|NCT02274792|589209550|FG000|Overall Study|Lost to Follow-up|8|||
163137077|NCT02274792|589209550|FG000|Overall Study|Protocol Specified Criteria|2|||
163137078|NCT02274792|589209550|FG000|Overall Study|Sponsor Decision|2|||
163137079|NCT02751580|589209551|FG000|Overall Study|Lost to Follow-up|4|||
163137080|NCT02751580|589209551|FG000|Overall Study|Death|2|||
163137081|NCT04854551|589209562|FG000|Overall Study|Withdrawal by Subject|1|||
163137082|NCT04854551|589209563|FG001|Overall Study|Withdrawal by Subject|1|||
163137083|NCT01076036|589209566|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
163137084|NCT02221674|589209567|FG000|Overall Study|Lost to Follow-up|1|||
163137085|NCT02221674|589209568|FG001|Overall Study|Lost to Follow-up|0|||
163137086|NCT02221674|589209569|FG002|Overall Study|Lost to Follow-up|0|||
163137087|NCT05292131|589209570|FG000|Overall Study|Lost to Follow-up|1|||
163137088|NCT05292131|589209571|FG001|Overall Study|Lost to Follow-up|1|||
163137089|NCT05292131|589209570|FG000|Overall Study|Withdrawal by Subject|0|||
163137090|NCT05292131|589209571|FG001|Overall Study|Withdrawal by Subject|1|||
163137091|NCT01345188|589209572|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
163137092|NCT01345188|589209572|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
163137093|NCT04752358|589209573|FG000|Overall Study|Death|2|||
163137094|NCT04752358|589209574|FG001|Overall Study|Death|1|||
163137095|NCT04607837|589209575|FG000|Overall Study|Adverse Event|8|||
163137096|NCT04607837|589209576|FG001|Overall Study|Adverse Event|2|||
163137097|NCT04607837|589209575|FG000|Overall Study|Withdrawal by Subject|8|||
163137098|NCT04607837|589209576|FG001|Overall Study|Withdrawal by Subject|7|||
163137099|NCT04607837|589209575|FG000|Overall Study|Physician Decision|2|||
163137100|NCT04607837|589209576|FG001|Overall Study|Physician Decision|0|||
163137101|NCT04607837|589209575|FG000|Overall Study|Lack of Efficacy|2|||
163137102|NCT04607837|589209576|FG001|Overall Study|Lack of Efficacy|0|||
163137103|NCT04607837|589209575|FG000|Overall Study|Participant terminated by sponsor|1|||
163137104|NCT04607837|589209576|FG001|Overall Study|Participant terminated by sponsor|0|||
163137105|NCT04607837|589209575|FG000|Overall Study|Disease worsening|36|||
163137106|NCT04607837|589209576|FG001|Overall Study|Disease worsening|36|||
163137107|NCT04607837|589209575|FG000|Overall Study|Other|1|||
162659318|NCT03670810|587465888|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162659319|NCT03670810|587465889|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162659320|NCT03670810|587465890|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162659321|NCT03670810|587465891|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
163137108|NCT04607837|589209576|FG001|Overall Study|Other|0|||
163137109|NCT02023996|589209586|FG000|Overall Study|Protocol Violation|6|||
163137110|NCT00465452|589209587|FG000|Overall Study|Adverse Event|1|||
163137111|NCT05236257|589209591|FG000|Overall Study|Ongoing with study treatment|29|||
163137112|NCT05236257|589209592|FG001|Overall Study|Ongoing with study treatment|1|||
163137113|NCT05236257|589209591|FG000|Overall Study|Discontinued study treatment|22|||
163137114|NCT05236257|589209592|FG001|Overall Study|Discontinued study treatment|41|||
163137115|NCT05870865|589209593|FG000|Randomized|Did not receive study treatment|2|||
163137116|NCT05870865|589209594|FG001|Randomized|Did not receive study treatment|4|||
163137117|NCT05870865|589209595|FG002|Randomized|Did not receive study treatment|4|||
163137118|NCT05870865|589209596|FG003|Randomized|Did not receive study treatment|3|||
163137119|NCT05870865|589209593|FG000|Treatment Period|Adverse Event|1|||
163137120|NCT05870865|589209594|FG001|Treatment Period|Adverse Event|1|||
163137121|NCT05870865|589209595|FG002|Treatment Period|Adverse Event|1|||
163137122|NCT05870865|589209596|FG003|Treatment Period|Adverse Event|1|||
163137123|NCT05870865|589209593|FG000|Treatment Period|Lost to Follow-up|0|||
163137124|NCT05870865|589209594|FG001|Treatment Period|Lost to Follow-up|1|||
163137125|NCT05870865|589209595|FG002|Treatment Period|Lost to Follow-up|2|||
163137126|NCT05870865|589209596|FG003|Treatment Period|Lost to Follow-up|0|||
163137127|NCT05870865|589209593|FG000|Treatment Period|Protocol Violation|0|||
163137128|NCT05870865|589209594|FG001|Treatment Period|Protocol Violation|0|||
163137129|NCT05870865|589209595|FG002|Treatment Period|Protocol Violation|0|||
163137130|NCT05870865|589209596|FG003|Treatment Period|Protocol Violation|1|||
163137131|NCT05870865|589209593|FG000|Treatment Period|Withdrawal by Subject|0|||
163137132|NCT05870865|589209594|FG001|Treatment Period|Withdrawal by Subject|1|||
163137133|NCT05870865|589209595|FG002|Treatment Period|Withdrawal by Subject|1|||
163137134|NCT05870865|589209596|FG003|Treatment Period|Withdrawal by Subject|1|||
163137135|NCT03828019|589209598|FG000|Overall Study|Withdrawal by Subject|3|||
163137136|NCT03828019|589209599|FG001|Overall Study|Withdrawal by Subject|8|||
163137137|NCT03828019|589209598|FG000|Overall Study|Lost to Follow-up|1|||
163137138|NCT03828019|589209599|FG001|Overall Study|Lost to Follow-up|6|||
163137139|NCT03828019|589209598|FG000|Overall Study|Incarcerated|1|||
163137140|NCT03828019|589209599|FG001|Overall Study|Incarcerated|0|||
163137141|NCT03828019|589209598|FG000|Overall Study|Adverse Event|0|||
163137142|NCT03828019|589209599|FG001|Overall Study|Adverse Event|1|||
163137143|NCT05715242|589209600|FG000|Overall Study|Lost to Follow-up|0|||
163137144|NCT05715242|589209601|FG001|Overall Study|Lost to Follow-up|0|||
163137145|NCT05715242|589209602|FG002|Overall Study|Lost to Follow-up|1|||
163137146|NCT05715242|589209603|FG003|Overall Study|Lost to Follow-up|0|||
163137147|NCT05715242|589209604|FG004|Overall Study|Lost to Follow-up|0|||
163137148|NCT05715242|589209605|FG005|Overall Study|Lost to Follow-up|1|||
163137149|NCT05715242|589209606|FG006|Overall Study|Lost to Follow-up|0|||
163137150|NCT05715242|589209607|FG007|Overall Study|Lost to Follow-up|0|||
163137151|NCT05715242|589209608|FG008|Overall Study|Lost to Follow-up|0|||
163137152|NCT05715242|589209609|FG009|Overall Study|Lost to Follow-up|0|||
163137153|NCT05715242|589209610|FG010|Overall Study|Lost to Follow-up|0|||
163137154|NCT05715242|589209611|FG011|Overall Study|Lost to Follow-up|0|||
163137155|NCT05715242|589209612|FG012|Overall Study|Lost to Follow-up|0|||
163137156|NCT05715242|589209613|FG013|Overall Study|Lost to Follow-up|0|||
163137157|NCT05715242|589209614|FG014|Overall Study|Lost to Follow-up|0|||
163137158|NCT05715242|589209615|FG015|Overall Study|Lost to Follow-up|0|||
163137159|NCT03400176|589209616|FG000|Dose Escalation|Progressive disease|1|||
163137160|NCT03400176|589209617|FG001|Dose Escalation|Progressive disease|1|||
163137161|NCT03400176|589209618|FG002|Dose Escalation|Progressive disease|0|||
163137162|NCT03400176|589209619|FG003|Dose Escalation|Progressive disease|0|||
163137163|NCT03400176|589209620|FG004|Dose Escalation|Progressive disease|1|||
163137164|NCT03400176|589209616|FG000|Dose Escalation|Patient decision|0|||
163137165|NCT03400176|589209617|FG001|Dose Escalation|Patient decision|0|||
163137166|NCT03400176|589209618|FG002|Dose Escalation|Patient decision|0|||
163137167|NCT03400176|589209619|FG003|Dose Escalation|Patient decision|0|||
163137168|NCT03400176|589209620|FG004|Dose Escalation|Patient decision|1|||
163137169|NCT03400176|589209616|FG000|Dose Expansion|Patient decision|0|||
163137170|NCT03400176|589209617|FG001|Dose Expansion|Patient decision|0|||
163137171|NCT03400176|589209618|FG002|Dose Expansion|Patient decision|0|||
163137172|NCT03400176|589209619|FG003|Dose Expansion|Patient decision|1|||
163137173|NCT03400176|589209620|FG004|Dose Expansion|Patient decision|0|||
163137174|NCT03400176|589209616|FG000|Dose Expansion|Adverse Event|0|||
163137175|NCT03400176|589209617|FG001|Dose Expansion|Adverse Event|0|||
163137176|NCT03400176|589209618|FG002|Dose Expansion|Adverse Event|0|||
163137177|NCT03400176|589209619|FG003|Dose Expansion|Adverse Event|1|||
163137178|NCT03400176|589209620|FG004|Dose Expansion|Adverse Event|0|||
163137179|NCT03400176|589209616|FG000|Dose Expansion|Physician Decision|0|||
163137180|NCT03400176|589209617|FG001|Dose Expansion|Physician Decision|0|||
163137181|NCT03400176|589209618|FG002|Dose Expansion|Physician Decision|0|||
163137182|NCT03400176|589209619|FG003|Dose Expansion|Physician Decision|1|||
163137183|NCT03400176|589209620|FG004|Dose Expansion|Physician Decision|0|||
163137184|NCT03400176|589209616|FG000|Dose Expansion|Progressive disease|0|||
163137185|NCT03400176|589209617|FG001|Dose Expansion|Progressive disease|0|||
163137186|NCT03400176|589209618|FG002|Dose Expansion|Progressive disease|1|||
163137187|NCT03400176|589209619|FG003|Dose Expansion|Progressive disease|1|||
163137188|NCT03400176|589209620|FG004|Dose Expansion|Progressive disease|0|||
163137189|NCT01090063|589209628|FG000|Screen|Screen Failed|4|||
163137190|NCT01090063|589209628|FG000|Treatment|Withdrawal by Subject|4|||
163137191|NCT00048347|589209629|FG000|Overall Study|Screen failure|2|||
163137192|NCT02863328|589209630|FG000|Overall Study|Lost to Follow-up|4|||
163137193|NCT02863328|589209631|FG001|Overall Study|Lost to Follow-up|10|||
163137194|NCT02863328|589209630|FG000|Overall Study|Withdrawal by Subject|7|||
163137195|NCT02863328|589209631|FG001|Overall Study|Withdrawal by Subject|12|||
163137196|NCT02863328|589209630|FG000|Overall Study|Died|0|||
163137197|NCT02863328|589209631|FG001|Overall Study|Died|1|||
163137198|NCT04565951|589209634|FG000|Overall Study|Lost to Follow-up|66|||
163137199|NCT04565951|589209635|FG001|Overall Study|Lost to Follow-up|38|||
163137200|NCT04565951|589209634|FG000|Overall Study|Withdrawal by Subject|14|||
163137201|NCT04565951|589209635|FG001|Overall Study|Withdrawal by Subject|7|||
163137202|NCT04565951|589209634|FG000|Overall Study|Death|0|||
163137203|NCT04565951|589209635|FG001|Overall Study|Death|1|||
163137204|NCT00429169|589209636|FG000|Overall Study|Lost to Follow-up|0|||
163137205|NCT00429169|589209637|FG001|Overall Study|Lost to Follow-up|1|||
163137206|NCT00429169|589209636|FG000|Overall Study|Ineligibility discovered after entry|2|||
163137207|NCT00429169|589209637|FG001|Overall Study|Ineligibility discovered after entry|1|||
163137208|NCT02936635|589211285|FG000|Overall Study|Adverse Event|43|||
163137209|NCT02936635|589211286|FG001|Overall Study|Adverse Event|25|||
163137210|NCT02936635|589211285|FG000|Overall Study|Progressive Disease|10|||
163137211|NCT02936635|589211286|FG001|Overall Study|Progressive Disease|18|||
163137212|NCT02936635|589211285|FG000|Overall Study|Sponsor Discretion|10|||
163137213|NCT02936635|589211286|FG001|Overall Study|Sponsor Discretion|16|||
163137214|NCT02936635|589211285|FG000|Overall Study|Death|9|||
163137215|NCT02936635|589211286|FG001|Overall Study|Death|15|||
163137216|NCT02936635|589211285|FG000|Overall Study|Withdrawal by Subject|8|||
163137217|NCT02936635|589211286|FG001|Overall Study|Withdrawal by Subject|15|||
163137218|NCT02936635|589211285|FG000|Overall Study|Physician Decision|2|||
163137219|NCT02936635|589211286|FG001|Overall Study|Physician Decision|9|||
163137220|NCT02936635|589211285|FG000|Overall Study|Lost to Follow-up|1|||
163137221|NCT02936635|589211286|FG001|Overall Study|Lost to Follow-up|2|||
163137222|NCT02936635|589211285|FG000|Overall Study|Protocol Violation|1|||
163137223|NCT02936635|589211286|FG001|Overall Study|Protocol Violation|0|||
163137224|NCT02936635|589211285|FG000|Overall Study|Lack of effect/Entry into other study|31|||
163137225|NCT02936635|589211286|FG001|Overall Study|Lack of effect/Entry into other study|65|||
163137226|NCT02407223|589211287|FG000|Overall Study|Adverse Event|1|||
163137227|NCT02407223|589211288|FG001|Overall Study|Adverse Event|0|||
163137228|NCT02407223|589211289|FG002|Overall Study|Adverse Event|1|||
163137229|NCT02407223|589211287|FG000|Overall Study|Lack of Efficacy|6|||
163137230|NCT02407223|589211288|FG001|Overall Study|Lack of Efficacy|6|||
163137231|NCT02407223|589211289|FG002|Overall Study|Lack of Efficacy|4|||
163137232|NCT02407223|589211287|FG000|Overall Study|Lost to Follow-up|1|||
163137233|NCT02407223|589211288|FG001|Overall Study|Lost to Follow-up|0|||
163137234|NCT02407223|589211289|FG002|Overall Study|Lost to Follow-up|2|||
163137235|NCT02407223|589211287|FG000|Overall Study|Withdrawal by Subject|2|||
163137236|NCT02407223|589211288|FG001|Overall Study|Withdrawal by Subject|4|||
163137237|NCT02407223|589211289|FG002|Overall Study|Withdrawal by Subject|4|||
163137238|NCT02407223|589211287|FG000|Overall Study|Study Terminated by Sponsor|77|||
163137239|NCT02407223|589211288|FG001|Overall Study|Study Terminated by Sponsor|80|||
163137240|NCT02407223|589211289|FG002|Overall Study|Study Terminated by Sponsor|86|||
163137241|NCT02407223|589211287|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
163137242|NCT02407223|589211288|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
163137243|NCT02407223|589211289|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
163137244|NCT02407223|589211287|FG000|Overall Study|Other|29|||
163137245|NCT02407223|589211288|FG001|Overall Study|Other|27|||
163137246|NCT02407223|589211289|FG002|Overall Study|Other|25|||
163137247|NCT01478971|589211290|FG000|Standard of Care Period|Adverse Event|1|||
163137248|NCT01478971|589211290|FG000|Standard of Care Period|Withdrawal by Subject|3|||
163137249|NCT01478971|589211290|FG000|Standard of Care Period|Death|8|||
163137250|NCT01478971|589211290|FG000|Standard of Care Period|Lost to Follow-up|9|||
163137251|NCT01478971|589211290|FG000|Standard of Care Period|Other|4|||
163137252|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Adverse Event|1|||
163137253|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
163137254|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Death|4|||
163137255|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
163137256|NCT01478971|589211290|FG000|Peginesatide Treatment Period|Other|4|||
163137257|NCT04404556|589211291|FG000|Intervention|Withdrawal by Subject|15|||
163137258|NCT04404556|589211292|FG001|Intervention|Withdrawal by Subject|3|||
163137259|NCT04404556|589211291|FG000|Intervention|Did not complete all intervention sessions|2|||
163137260|NCT04404556|589211292|FG001|Intervention|Did not complete all intervention sessions|1|||
163137261|NCT04404556|589211291|FG000|Post-Intervention|Missing Data|1|||
162719981|NCT00186186|587682391|FG000|Overall Study|Lack of Efficacy|3|||
163137262|NCT04404556|589211292|FG001|Post-Intervention|Missing Data|2|||
163137263|NCT04404556|589211291|FG000|Follow-up 1|Withdrawal by Subject|5|||
163137264|NCT04404556|589211292|FG001|Follow-up 1|Withdrawal by Subject|1|||
163137265|NCT04404556|589211291|FG000|Follow-up 1|Missing Data|4|||
162659322|NCT03670810|587465892|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
163137266|NCT04404556|589211292|FG001|Follow-up 1|Missing Data|7|||
163137267|NCT04404556|589211291|FG000|Follow-up 2|Withdrawal by Subject|1|||
163137268|NCT04404556|589211292|FG001|Follow-up 2|Withdrawal by Subject|1|||
163137269|NCT04404556|589211291|FG000|Follow-up 2|Missing Data|6|||
163137270|NCT04404556|589211292|FG001|Follow-up 2|Missing Data|5|||
163137271|NCT00763386|589211301|FG000|Overall Study|Adverse Event|43|||
163137272|NCT00763386|589211302|FG001|Overall Study|Adverse Event|33|||
163137273|NCT00763386|589211301|FG000|Overall Study|Death|1|||
163137274|NCT00763386|589211302|FG001|Overall Study|Death|2|||
163137275|NCT00763386|589211301|FG000|Overall Study|Lost to Follow-up|3|||
163137276|NCT00763386|589211302|FG001|Overall Study|Lost to Follow-up|3|||
163137277|NCT00763386|589211301|FG000|Overall Study|Withdrawal by Subject|0|||
163137278|NCT00763386|589211302|FG001|Overall Study|Withdrawal by Subject|1|||
163137279|NCT00763386|589211301|FG000|Overall Study|CRF missing|0|||
163137280|NCT00763386|589211302|FG001|Overall Study|CRF missing|1|||
163137281|NCT00763386|589211301|FG000|Overall Study|Study Prosthesis Removed|1|||
163137282|NCT00763386|589211302|FG001|Overall Study|Study Prosthesis Removed|0|||
163137283|NCT00922623|589211303|FG000|Overall Study|Other|4|||
163137284|NCT00922623|589211303|FG000|Overall Study|Lost to Follow-up|1|||
163137285|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
163137286|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
163137287|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Death|0|||
163137288|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Death|1|||
163137289|NCT02451917|589211304|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
163137290|NCT02451917|589211305|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
163137291|NCT00853151|589211310|FG000|Overall Study|Adverse Event|1|||
163137292|NCT00853151|589211311|FG001|Overall Study|Adverse Event|4|||
163137293|NCT00853151|589211312|FG002|Overall Study|Adverse Event|2|||
163137294|NCT00853151|589211313|FG003|Overall Study|Adverse Event|0|||
163137295|NCT00853151|589211310|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
163137296|NCT00853151|589211311|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137297|NCT00853151|589211312|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137298|NCT00853151|589211313|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163137299|NCT00853151|589211310|FG000|Overall Study|Lost to Follow-up|2|||
163137300|NCT00853151|589211311|FG001|Overall Study|Lost to Follow-up|0|||
163137301|NCT00853151|589211312|FG002|Overall Study|Lost to Follow-up|3|||
163137302|NCT00853151|589211313|FG003|Overall Study|Lost to Follow-up|0|||
163137303|NCT00853151|589211310|FG000|Overall Study|Death|1|||
163137304|NCT00853151|589211311|FG001|Overall Study|Death|0|||
163137305|NCT00853151|589211312|FG002|Overall Study|Death|0|||
163137306|NCT00853151|589211313|FG003|Overall Study|Death|1|||
163137307|NCT00853151|589211310|FG000|Overall Study|Protocol Violation|0|||
163137308|NCT00853151|589211311|FG001|Overall Study|Protocol Violation|0|||
163137309|NCT00853151|589211312|FG002|Overall Study|Protocol Violation|0|||
163137310|NCT00853151|589211313|FG003|Overall Study|Protocol Violation|1|||
163137311|NCT00853151|589211310|FG000|Overall Study|Withdrawal by Subject|5|||
163137312|NCT00853151|589211311|FG001|Overall Study|Withdrawal by Subject|4|||
163137313|NCT00853151|589211312|FG002|Overall Study|Withdrawal by Subject|2|||
163137314|NCT00853151|589211313|FG003|Overall Study|Withdrawal by Subject|1|||
163137315|NCT00853151|589211310|FG000|Overall Study|Physician Decision|0|||
163137316|NCT00853151|589211311|FG001|Overall Study|Physician Decision|2|||
163137317|NCT00853151|589211312|FG002|Overall Study|Physician Decision|1|||
163137318|NCT00853151|589211313|FG003|Overall Study|Physician Decision|0|||
163137319|NCT00853151|589211310|FG000|Overall Study|Sponsor Decision|0|||
163137320|NCT00853151|589211311|FG001|Overall Study|Sponsor Decision|3|||
163137321|NCT00853151|589211312|FG002|Overall Study|Sponsor Decision|0|||
163137322|NCT00853151|589211313|FG003|Overall Study|Sponsor Decision|0|||
163137323|NCT01510158|589211314|FG000|Overall Study|Adverse Event|7|||
163137324|NCT01510158|589211315|FG001|Overall Study|Adverse Event|8|||
163137325|NCT01510158|589211316|FG002|Overall Study|Adverse Event|5|||
163137326|NCT01510158|589211314|FG000|Overall Study|Gout flare|1|||
163137327|NCT01510158|589211315|FG001|Overall Study|Gout flare|0|||
163137328|NCT01510158|589211316|FG002|Overall Study|Gout flare|0|||
163137329|NCT01510158|589211314|FG000|Overall Study|Protocol Violation|17|||
163137330|NCT01510158|589211315|FG001|Overall Study|Protocol Violation|16|||
163137331|NCT01510158|589211316|FG002|Overall Study|Protocol Violation|24|||
163137332|NCT01510158|589211314|FG000|Overall Study|Sponsor terminated study.|2|||
162659323|NCT03670810|587465884|FG000|Open Label Extension|Physician Decision|0|||
163137333|NCT01510158|589211315|FG001|Overall Study|Sponsor terminated study.|0|||
163137334|NCT01510158|589211316|FG002|Overall Study|Sponsor terminated study.|2|||
162659324|NCT03670810|587465885|FG001|Open Label Extension|Physician Decision|0|||
163137335|NCT01510158|589211314|FG000|Overall Study|Lost to Follow-up|13|||
163137336|NCT01510158|589211315|FG001|Overall Study|Lost to Follow-up|16|||
163137337|NCT01510158|589211316|FG002|Overall Study|Lost to Follow-up|9|||
163137338|NCT01510158|589211314|FG000|Overall Study|Withdrawal by Subject|10|||
163137339|NCT01510158|589211315|FG001|Overall Study|Withdrawal by Subject|13|||
163137340|NCT01510158|589211316|FG002|Overall Study|Withdrawal by Subject|10|||
162659325|NCT03670810|587465886|FG002|Open Label Extension|Physician Decision|0|||
162659326|NCT03670810|587465887|FG003|Open Label Extension|Physician Decision|0|||
162659327|NCT03670810|587465888|FG004|Open Label Extension|Physician Decision|0|||
162659328|NCT03670810|587465889|FG005|Open Label Extension|Physician Decision|0|||
162659329|NCT03670810|587465890|FG006|Open Label Extension|Physician Decision|0|||
163137341|NCT01510158|589211314|FG000|Overall Study|Death|1|||
163137342|NCT01510158|589211315|FG001|Overall Study|Death|0|||
163137343|NCT01510158|589211316|FG002|Overall Study|Death|0|||
163137344|NCT03078556|589211317|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137345|NCT03078556|589211318|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
163137346|NCT03078556|589211319|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137347|NCT03078556|589211320|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
163137348|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
163137349|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
163137350|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
163137351|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
163137352|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
163137353|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
163137354|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
163137355|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
163137356|NCT03078556|589211317|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
163137357|NCT03078556|589211318|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
163137358|NCT03078556|589211319|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
163137359|NCT03078556|589211320|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
163137360|NCT00832416|589211327|FG000|Overall Study|Lack of Efficacy|17|||
163137361|NCT00832416|589211328|FG001|Overall Study|Lack of Efficacy|15|||
163137362|NCT00832416|589211329|FG002|Overall Study|Lack of Efficacy|13|||
163137363|NCT00832416|589211330|FG003|Overall Study|Lack of Efficacy|52|||
163137364|NCT00832416|589211327|FG000|Overall Study|Withdrawal by Subject|5|||
163137365|NCT00832416|589211328|FG001|Overall Study|Withdrawal by Subject|7|||
163137366|NCT00832416|589211329|FG002|Overall Study|Withdrawal by Subject|2|||
163137367|NCT00832416|589211330|FG003|Overall Study|Withdrawal by Subject|10|||
163137368|NCT00832416|589211327|FG000|Overall Study|Physician Decision|2|||
163137369|NCT00832416|589211328|FG001|Overall Study|Physician Decision|12|||
163137370|NCT00832416|589211329|FG002|Overall Study|Physician Decision|5|||
163137371|NCT00832416|589211330|FG003|Overall Study|Physician Decision|10|||
163137372|NCT00832416|589211327|FG000|Overall Study|Administrative|0|||
163137373|NCT00832416|589211328|FG001|Overall Study|Administrative|0|||
163137374|NCT00832416|589211329|FG002|Overall Study|Administrative|0|||
163137375|NCT00832416|589211330|FG003|Overall Study|Administrative|1|||
163137376|NCT00832416|589211327|FG000|Overall Study|Adverse Event|21|||
163137377|NCT00832416|589211328|FG001|Overall Study|Adverse Event|19|||
163137378|NCT00832416|589211329|FG002|Overall Study|Adverse Event|41|||
163137379|NCT00832416|589211330|FG003|Overall Study|Adverse Event|10|||
163137380|NCT00832416|589211327|FG000|Overall Study|Death|1|||
163137381|NCT00832416|589211328|FG001|Overall Study|Death|0|||
163137382|NCT00832416|589211329|FG002|Overall Study|Death|0|||
163137383|NCT00832416|589211330|FG003|Overall Study|Death|0|||
163137384|NCT04421482|589211337|FG000|Overall Study|Physician Decision|1|||
163137385|NCT00571038|589211340|FG000|Overall Study|Lost to Follow-up|1|||
163137386|NCT00571038|589211341|FG001|Overall Study|Lost to Follow-up|4|||
163137387|NCT00571038|589211340|FG000|Overall Study|Death|7|||
163137388|NCT00571038|589211341|FG001|Overall Study|Death|5|||
163137389|NCT00571038|589211340|FG000|Overall Study|Withdrawal by Subject|1|||
163137390|NCT00571038|589211341|FG001|Overall Study|Withdrawal by Subject|3|||
163137391|NCT00571038|589211340|FG000|Overall Study|Moved out of state|2|||
163137392|NCT00571038|589211341|FG001|Overall Study|Moved out of state|2|||
163137393|NCT05786508|589211342|FG000|Overall Study|Withdrawal by Subject|2|||
163137394|NCT05786508|589211343|FG001|Overall Study|Withdrawal by Subject|0|||
163137395|NCT04426318|589211344|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
163137396|NCT04426318|589211345|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
162659330|NCT03670810|587465891|FG007|Open Label Extension|Physician Decision|0|||
163137397|NCT02588261|589211348|FG000|Overall Study|Study Terminated by Sponsor|157|||
163137398|NCT02588261|589211349|FG001|Overall Study|Study Terminated by Sponsor|142|||
163137399|NCT02588261|589211348|FG000|Overall Study|Protocol Deviation|1|||
163137400|NCT02588261|589211349|FG001|Overall Study|Protocol Deviation|0|||
163137401|NCT02588261|589211348|FG000|Overall Study|Death|1|||
163137402|NCT02588261|589211349|FG001|Overall Study|Death|2|||
163137403|NCT02588261|589211348|FG000|Overall Study|Withdrawal by Subject|12|||
163137404|NCT02588261|589211349|FG001|Overall Study|Withdrawal by Subject|8|||
162659331|NCT03670810|587465892|FG008|Open Label Extension|Physician Decision|2|||
162659332|NCT03670810|587465884|FG000|Open Label Extension|Non-compliance with study drug|0|||
163137405|NCT02588261|589211348|FG000|Overall Study|Noncompliance with Study Drug|0|||
163137406|NCT02588261|589211349|FG001|Overall Study|Noncompliance with Study Drug|1|||
163137407|NCT02588261|589211348|FG000|Overall Study|Miscellaneous|5|||
163137408|NCT02588261|589211349|FG001|Overall Study|Miscellaneous|4|||
163137409|NCT02588261|589211348|FG000|Overall Study|Progressive Disease|61|||
162719982|NCT00186186|587682391|FG000|Overall Study|Withdrawal by Subject|3|||
162719983|NCT00186186|587682391|FG000|Overall Study|Not reported as to reason|2|||
162719984|NCT00807144|587682394|FG000|Overall Study|Lost to Follow-up|0|||
162719985|NCT00807144|587682395|FG001|Overall Study|Lost to Follow-up|1|||
162719986|NCT02567656|587682397|FG000|Overall Study|Premature discontinuation due to PD|1|||
162719987|NCT02567656|587682398|FG001|Overall Study|Premature discontinuation due to PD|1|||
162719988|NCT02567656|587682399|FG002|Overall Study|Premature discontinuation due to PD|2|||
162719989|NCT02567656|587682400|FG003|Overall Study|Premature discontinuation due to PD|0|||
162719990|NCT02567656|587682401|FG004|Overall Study|Premature discontinuation due to PD|0|||
162719991|NCT02567656|587682402|FG005|Overall Study|Premature discontinuation due to PD|0|||
162719992|NCT01616654|587682403|FG000|Overall Study|Lack of Efficacy|1|||
162719993|NCT01616654|587682404|FG001|Overall Study|Lack of Efficacy|0|||
162719994|NCT01616654|587682405|FG002|Overall Study|Lack of Efficacy|0|||
162719995|NCT01616654|587682406|FG003|Overall Study|Lack of Efficacy|0|||
162719996|NCT01616654|587682407|FG004|Overall Study|Lack of Efficacy|1|||
162719997|NCT01616654|587682403|FG000|Overall Study|Adverse Event|0|||
162719998|NCT01616654|587682404|FG001|Overall Study|Adverse Event|1|||
162719999|NCT01616654|587682405|FG002|Overall Study|Adverse Event|2|||
162720000|NCT01616654|587682406|FG003|Overall Study|Adverse Event|1|||
162720001|NCT01616654|587682407|FG004|Overall Study|Adverse Event|0|||
162720002|NCT01616654|587682403|FG000|Overall Study|Withdrawal by Subject|2|||
162720003|NCT01616654|587682404|FG001|Overall Study|Withdrawal by Subject|2|||
162720004|NCT01616654|587682405|FG002|Overall Study|Withdrawal by Subject|3|||
162720005|NCT01616654|587682406|FG003|Overall Study|Withdrawal by Subject|1|||
162720006|NCT01616654|587682407|FG004|Overall Study|Withdrawal by Subject|5|||
162720007|NCT01616654|587682403|FG000|Overall Study|Protocol Violation|0|||
162720008|NCT01616654|587682404|FG001|Overall Study|Protocol Violation|5|||
162720009|NCT01616654|587682405|FG002|Overall Study|Protocol Violation|2|||
162720010|NCT01616654|587682406|FG003|Overall Study|Protocol Violation|4|||
162720011|NCT01616654|587682407|FG004|Overall Study|Protocol Violation|4|||
162720012|NCT01616654|587682403|FG000|Overall Study|Lost to Follow-up|1|||
162720013|NCT01616654|587682404|FG001|Overall Study|Lost to Follow-up|0|||
162720014|NCT01616654|587682405|FG002|Overall Study|Lost to Follow-up|3|||
162720015|NCT01616654|587682406|FG003|Overall Study|Lost to Follow-up|2|||
162720016|NCT01616654|587682407|FG004|Overall Study|Lost to Follow-up|1|||
162720017|NCT01616654|587682403|FG000|Overall Study|Pregnancy|1|||
162720018|NCT01616654|587682404|FG001|Overall Study|Pregnancy|0|||
162720019|NCT01616654|587682405|FG002|Overall Study|Pregnancy|0|||
162720020|NCT01616654|587682406|FG003|Overall Study|Pregnancy|0|||
162659333|NCT03670810|587465885|FG001|Open Label Extension|Non-compliance with study drug|0|||
162659334|NCT03670810|587465886|FG002|Open Label Extension|Non-compliance with study drug|0|||
162659335|NCT03670810|587465887|FG003|Open Label Extension|Non-compliance with study drug|0|||
162659336|NCT03670810|587465888|FG004|Open Label Extension|Non-compliance with study drug|0|||
162659337|NCT03670810|587465889|FG005|Open Label Extension|Non-compliance with study drug|0|||
162659338|NCT03670810|587465890|FG006|Open Label Extension|Non-compliance with study drug|0|||
162659339|NCT03670810|587465891|FG007|Open Label Extension|Non-compliance with study drug|0|||
162659340|NCT03670810|587465892|FG008|Open Label Extension|Non-compliance with study drug|5|||
162659341|NCT03670810|587465884|FG000|Open Label Extension|Pregnancy|0|||
162659342|NCT03670810|587465885|FG001|Open Label Extension|Pregnancy|0|||
162720021|NCT01616654|587682407|FG004|Overall Study|Pregnancy|1|||
162720022|NCT02057692|587682408|FG000|Overall Study|Adverse Event|1|||
162720023|NCT02057692|587682409|FG001|Overall Study|Adverse Event|0|||
162720024|NCT02057692|587682410|FG002|Overall Study|Adverse Event|0|||
162720025|NCT02057692|587682411|FG003|Overall Study|Adverse Event|0|||
162720026|NCT02057692|587682408|FG000|Overall Study|Lost to Follow-up|0|||
162659343|NCT03670810|587465886|FG002|Open Label Extension|Pregnancy|0|||
162659344|NCT03670810|587465887|FG003|Open Label Extension|Pregnancy|0|||
162720027|NCT02057692|587682409|FG001|Overall Study|Lost to Follow-up|0|||
162720028|NCT02057692|587682410|FG002|Overall Study|Lost to Follow-up|0|||
162720029|NCT02057692|587682411|FG003|Overall Study|Lost to Follow-up|1|||
162720030|NCT03923491|587682412|FG000|Overall Study|Lost to Follow-up|5|||
162720031|NCT03923491|587682413|FG001|Overall Study|Lost to Follow-up|8|||
162720032|NCT03923491|587682412|FG000|Overall Study|Withdrawal by Subject|4|||
162720033|NCT03923491|587682413|FG001|Overall Study|Withdrawal by Subject|6|||
162720034|NCT03823300|587682418|FG000|Overall Study|Withdrawal by Subject|16|||
162720035|NCT03823300|587682419|FG001|Overall Study|Withdrawal by Subject|22|||
162720036|NCT03823300|587682418|FG000|Overall Study|Death|10|||
162720037|NCT03823300|587682419|FG001|Overall Study|Death|14|||
162720038|NCT03823300|587682418|FG000|Overall Study|Adverse Event|3|||
162720039|NCT03823300|587682419|FG001|Overall Study|Adverse Event|5|||
162720040|NCT03823300|587682418|FG000|Overall Study|Physician Decision|1|||
162720041|NCT03823300|587682419|FG001|Overall Study|Physician Decision|7|||
162720042|NCT03823300|587682418|FG000|Overall Study|Lost to Follow-up|1|||
162720043|NCT03823300|587682419|FG001|Overall Study|Lost to Follow-up|3|||
162720044|NCT03823300|587682418|FG000|Overall Study|Protocol Violation|1|||
162720045|NCT03823300|587682419|FG001|Overall Study|Protocol Violation|1|||
162720046|NCT03823300|587682418|FG000|Overall Study|Lack of Efficacy|1|||
162720047|NCT03823300|587682419|FG001|Overall Study|Lack of Efficacy|1|||
163137410|NCT02588261|589211349|FG001|Overall Study|Progressive Disease|82|||
163137411|NCT02588261|589211348|FG000|Overall Study|Adverse Event|29|||
163137412|NCT02588261|589211349|FG001|Overall Study|Adverse Event|24|||
163137413|NCT02588261|589211348|FG000|Overall Study|Lost to Follow-up|1|||
163137414|NCT02588261|589211349|FG001|Overall Study|Lost to Follow-up|0|||
163137415|NCT03781778|589211350|FG000|Overall Study|Withdrawal by Subject|2|||
163137416|NCT03781778|589211351|FG001|Overall Study|Withdrawal by Subject|2|||
163137417|NCT02287467|589211352|FG000|Overall Study|Protocol Violation|12|||
163137418|NCT02287467|589211353|FG001|Overall Study|Protocol Violation|9|||
163137419|NCT01456169|589211356|FG000|Overall Study|Adverse Event|1|||
163137420|NCT01456169|589211357|FG001|Overall Study|Adverse Event|2|||
163137421|NCT01456169|589211358|FG002|Overall Study|Adverse Event|7|||
163137422|NCT01456169|589211356|FG000|Overall Study|Major Protocol Deviation|3|||
163137423|NCT01456169|589211357|FG001|Overall Study|Major Protocol Deviation|2|||
163137424|NCT01456169|589211358|FG002|Overall Study|Major Protocol Deviation|3|||
163137425|NCT01456169|589211356|FG000|Overall Study|Voluntary Withdrawal|3|||
163137426|NCT01456169|589211357|FG001|Overall Study|Voluntary Withdrawal|0|||
163137427|NCT01456169|589211358|FG002|Overall Study|Voluntary Withdrawal|2|||
163137428|NCT01456169|589211356|FG000|Overall Study|Lack of Efficacy|2|||
163137429|NCT01456169|589211357|FG001|Overall Study|Lack of Efficacy|0|||
163137430|NCT01456169|589211358|FG002|Overall Study|Lack of Efficacy|0|||
163137431|NCT01456169|589211356|FG000|Overall Study|Other|1|||
163137432|NCT01456169|589211357|FG001|Overall Study|Other|1|||
163137433|NCT01456169|589211358|FG002|Overall Study|Other|0|||
163137434|NCT02292446|589211359|FG000|Overall Study|Adverse Event|12|||
163137435|NCT02292446|589211359|FG000|Overall Study|Death|1|||
163137436|NCT02292446|589211359|FG000|Overall Study|Disease progression|2|||
163137437|NCT02292446|589211359|FG000|Overall Study|Subject/guardian decision|2|||
163137438|NCT02292446|589211359|FG000|Overall Study|Withdrawal by Subject|3|||
163137439|NCT02652156|589211360|FG000|Overall Study|Physician Decision|1|||
163137440|NCT02652156|589211361|FG001|Overall Study|Physician Decision|0|||
163137441|NCT02652156|589211362|FG002|Overall Study|Physician Decision|0|||
163137442|NCT00496080|589211365|FG000|Overall Study|Lost to Follow-up|9|||
163137443|NCT00496080|589211365|FG000|Overall Study|Surgical re-intervention|7|||
162659345|NCT03670810|587465888|FG004|Open Label Extension|Pregnancy|0|||
162659346|NCT03670810|587465889|FG005|Open Label Extension|Pregnancy|0|||
162659347|NCT03670810|587465890|FG006|Open Label Extension|Pregnancy|0|||
162659348|NCT03670810|587465891|FG007|Open Label Extension|Pregnancy|0|||
162659349|NCT03670810|587465892|FG008|Open Label Extension|Pregnancy|3|||
162659350|NCT03670810|587465884|FG000|Open Label Extension|Adverse Event|0|||
162659351|NCT03670810|587465885|FG001|Open Label Extension|Adverse Event|0|||
162659352|NCT03670810|587465886|FG002|Open Label Extension|Adverse Event|0|||
163137444|NCT00496080|589211365|FG000|Overall Study|Withdrawal by Subject|5|||
163137445|NCT00496080|589211365|FG000|Overall Study|Physician Decision|6|||
163137446|NCT02741596|589211366|FG000|Overall Study|Adverse Event|1|||
163137447|NCT02741596|589211367|FG001|Overall Study|Adverse Event|5|||
163137448|NCT02741596|589211366|FG000|Overall Study|Lost to Follow-up|1|||
163137449|NCT02741596|589211367|FG001|Overall Study|Lost to Follow-up|1|||
163137450|NCT02741596|589211366|FG000|Overall Study|Physician Decision|2|||
163137451|NCT02741596|589211367|FG001|Overall Study|Physician Decision|1|||
163137452|NCT02741596|589211366|FG000|Overall Study|Pregnancy|3|||
163137453|NCT02741596|589211367|FG001|Overall Study|Pregnancy|1|||
163137454|NCT02741596|589211366|FG000|Overall Study|Other (Unspecified)|0|||
163137455|NCT02741596|589211367|FG001|Overall Study|Other (Unspecified)|3|||
163137456|NCT02741596|589211366|FG000|Overall Study|Subject withdrawn-Other|17|||
163137457|NCT02741596|589211367|FG001|Overall Study|Subject withdrawn-Other|4|||
163137458|NCT02741596|589211366|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
163137459|NCT02741596|589211367|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
163137460|NCT03329846|589211368|FG000|Overall Study|Disease progression|4|||
163137461|NCT03329846|589211369|FG001|Overall Study|Disease progression|6|||
163137462|NCT03329846|589211368|FG000|Overall Study|Study drug toxicity|1|||
163137463|NCT03329846|589211369|FG001|Overall Study|Study drug toxicity|0|||
163137464|NCT03329846|589211368|FG000|Overall Study|Participant request to discontinue treatment|0|||
163137465|NCT03329846|589211369|FG001|Overall Study|Participant request to discontinue treatment|1|||
163137466|NCT03329846|589211368|FG000|Overall Study|Participant withdrew consent|1|||
163137467|NCT03329846|589211369|FG001|Overall Study|Participant withdrew consent|0|||
163137468|NCT03329846|589211368|FG000|Overall Study|Other reasons|2|||
163137469|NCT03329846|589211369|FG001|Overall Study|Other reasons|2|||
163137470|NCT00479336|589211370|FG000|Overall Study|Adverse Event|1|||
163137471|NCT00479336|589211371|FG001|Overall Study|Adverse Event|1|||
163137472|NCT00479336|589211372|FG002|Overall Study|Adverse Event|1|||
163137473|NCT00479336|589211373|FG003|Overall Study|Adverse Event|3|||
163137474|NCT00479336|589211370|FG000|Overall Study|Lack of Efficacy|1|||
162659353|NCT03670810|587465887|FG003|Open Label Extension|Adverse Event|0|||
163137475|NCT00479336|589211371|FG001|Overall Study|Lack of Efficacy|0|||
163137476|NCT00479336|589211372|FG002|Overall Study|Lack of Efficacy|0|||
163137477|NCT00479336|589211373|FG003|Overall Study|Lack of Efficacy|0|||
163137478|NCT00479336|589211370|FG000|Overall Study|Protocol Violation|0|||
163137479|NCT00479336|589211371|FG001|Overall Study|Protocol Violation|1|||
162720048|NCT03823300|587682418|FG000|Overall Study|Not Eligible|0|||
162720049|NCT03823300|587682419|FG001|Overall Study|Not Eligible|1|||
162720050|NCT03823300|587682418|FG000|Overall Study|Other|1|||
162720051|NCT03823300|587682419|FG001|Overall Study|Other|0|||
162720052|NCT00831415|587682420|FG000|Overall Study|Adverse Event|14|||
162720053|NCT00831415|587682420|FG000|Overall Study|Failed to return|3|||
162720054|NCT00831415|587682420|FG000|Overall Study|Physician Decision|6|||
162720055|NCT00831415|587682420|FG000|Overall Study|Lost to Follow-up|9|||
162720056|NCT00831415|587682420|FG000|Overall Study|Protocol Violation|3|||
162720057|NCT00831415|587682420|FG000|Overall Study|Withdrawal by Subject|35|||
162720058|NCT00831415|587682420|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
162720059|NCT00831415|587682420|FG000|Overall Study|Death|1|||
162720060|NCT01290224|587682421|FG000|Overall Study|Adverse Event|1|||
162720061|NCT01290224|587682421|FG000|Overall Study|Refused Further Treatment|4|||
162720062|NCT01027286|587682422|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
162720063|NCT01027286|587682423|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
162720064|NCT01027286|587682422|FG000|Overall Study|Lost to Follow-up|0|||
162720065|NCT01027286|587682423|FG001|Overall Study|Lost to Follow-up|1|||
162720066|NCT00813904|587682424|FG000|Overall Study|Death|1|||
162720067|NCT01405924|587682427|FG000|Overall Study|Protocol Violation|8|||
162720068|NCT01405924|587682427|FG000|Overall Study|Missing/Incomplete Data|2|||
162720069|NCT02393716|587682428|FG000|Overall Study|Death|29|||
162720070|NCT02393716|587682428|FG000|Overall Study|Withdrawal by Subject|8|||
162720071|NCT02393716|587682428|FG000|Overall Study|Device Explanted|8|||
162720072|NCT02393716|587682428|FG000|Overall Study|Missed visit|16|||
162720073|NCT01924767|587682429|FG000|Overall Study|Adverse Event|1|||
162720074|NCT01924767|587682430|FG001|Overall Study|Adverse Event|0|||
162720075|NCT01924767|587682431|FG002|Overall Study|Adverse Event|1|||
162720076|NCT01924767|587682432|FG003|Overall Study|Adverse Event|0|||
162720077|NCT01924767|587682433|FG004|Overall Study|Adverse Event|0|||
162720078|NCT01648140|587682434|FG000|Overall Study|Physician Decision|1|||
162720079|NCT01648140|587682435|FG001|Overall Study|Physician Decision|0|||
162720080|NCT01648140|587682436|FG002|Overall Study|Physician Decision|0|||
162720081|NCT01648140|587682437|FG003|Overall Study|Physician Decision|0|||
162720082|NCT01648140|587682434|FG000|Overall Study|Lack of Efficacy|4|||
162720083|NCT01648140|587682435|FG001|Overall Study|Lack of Efficacy|7|||
162720084|NCT01648140|587682436|FG002|Overall Study|Lack of Efficacy|1|||
162720085|NCT01648140|587682437|FG003|Overall Study|Lack of Efficacy|0|||
162720086|NCT01648140|587682434|FG000|Overall Study|Adverse Event|3|||
162720087|NCT01648140|587682435|FG001|Overall Study|Adverse Event|1|||
162720088|NCT01648140|587682436|FG002|Overall Study|Adverse Event|2|||
162720089|NCT01648140|587682437|FG003|Overall Study|Adverse Event|0|||
162720090|NCT01648140|587682434|FG000|Overall Study|Withdrawal by Subject|2|||
162720091|NCT01648140|587682435|FG001|Overall Study|Withdrawal by Subject|3|||
162720092|NCT01648140|587682436|FG002|Overall Study|Withdrawal by Subject|3|||
162720093|NCT01648140|587682437|FG003|Overall Study|Withdrawal by Subject|2|||
162720094|NCT01648140|587682434|FG000|Overall Study|Lost to Follow-up|2|||
162720095|NCT01648140|587682435|FG001|Overall Study|Lost to Follow-up|1|||
162720096|NCT01648140|587682436|FG002|Overall Study|Lost to Follow-up|2|||
162720097|NCT01648140|587682437|FG003|Overall Study|Lost to Follow-up|0|||
162720098|NCT01565928|587682438|FG000|Overall Study|Adverse Event|3|||
162720099|NCT01565928|587682438|FG000|Overall Study|Other|3|||
162720100|NCT01565928|587682438|FG000|Overall Study|Progressive Disease|13|||
162720101|NCT01565928|587682438|FG000|Overall Study|Withdrawal by Subject|1|||
162720102|NCT01565928|587682438|FG000|Overall Study|Death|2|||
162720103|NCT01191788|587682445|FG000|Overall Study|Lost to Follow-up|21|||
162720104|NCT01191788|587682446|FG001|Overall Study|Lost to Follow-up|22|||
162720105|NCT03621761|587682447|FG000|Overall Study|Lost to Follow-up|1|||
162720106|NCT03621761|587682448|FG001|Overall Study|Lost to Follow-up|1|||
162720107|NCT03621761|587682449|FG002|Overall Study|Lost to Follow-up|2|||
162720108|NCT03621761|587682447|FG000|Overall Study|Withdrawal by Subject|2|||
162720109|NCT03621761|587682448|FG001|Overall Study|Withdrawal by Subject|1|||
162720110|NCT03621761|587682449|FG002|Overall Study|Withdrawal by Subject|1|||
162720111|NCT03621761|587682447|FG000|Overall Study|Became Ineligible|0|||
162720112|NCT03621761|587682448|FG001|Overall Study|Became Ineligible|2|||
162720113|NCT03621761|587682449|FG002|Overall Study|Became Ineligible|0|||
162720114|NCT01713530|587682452|FG000|Overall Study|Adverse Event|0|||
162720115|NCT01713530|587682453|FG001|Overall Study|Adverse Event|5|||
162720116|NCT01713530|587682452|FG000|Overall Study|Withdrawal criteria|21|||
162720117|NCT01713530|587682453|FG001|Overall Study|Withdrawal criteria|12|||
162720118|NCT01713530|587682452|FG000|Overall Study|Unclassified|4|||
162720119|NCT01713530|587682453|FG001|Overall Study|Unclassified|2|||
162720120|NCT03939819|587682454|FG000|Overall Study|Death|2|||
162720121|NCT03939819|587682455|FG001|Overall Study|Death|0|||
162720122|NCT03987451|587682456|FG000|Overall Study|Lost to Follow-up|1|||
162720123|NCT03987451|587682457|FG001|Overall Study|Lost to Follow-up|0|||
162720124|NCT03987451|587682456|FG000|Overall Study|Withdrawal by Subject|1|||
162720125|NCT03987451|587682457|FG001|Overall Study|Withdrawal by Subject|1|||
162720126|NCT02441036|587682458|FG000|Overall Study|No tissue resected|0|||
162720127|NCT02441036|587682459|FG001|Overall Study|No tissue resected|1|||
162659354|NCT03670810|587465888|FG004|Open Label Extension|Adverse Event|0|||
162659355|NCT03670810|587465889|FG005|Open Label Extension|Adverse Event|0|||
162659356|NCT03670810|587465890|FG006|Open Label Extension|Adverse Event|0|||
162659357|NCT03670810|587465891|FG007|Open Label Extension|Adverse Event|0|||
162659358|NCT03670810|587465892|FG008|Open Label Extension|Adverse Event|24|||
163137480|NCT00479336|589211372|FG002|Overall Study|Protocol Violation|0|||
163137481|NCT00479336|589211373|FG003|Overall Study|Protocol Violation|0|||
163137482|NCT00479336|589211370|FG000|Overall Study|Withdrawal by Subject|1|||
163137483|NCT00479336|589211371|FG001|Overall Study|Withdrawal by Subject|2|||
163137484|NCT00479336|589211372|FG002|Overall Study|Withdrawal by Subject|0|||
163137485|NCT00479336|589211373|FG003|Overall Study|Withdrawal by Subject|0|||
163137486|NCT00479336|589211370|FG000|Overall Study|Physician Decision|0|||
163137487|NCT00479336|589211371|FG001|Overall Study|Physician Decision|1|||
163137488|NCT00479336|589211372|FG002|Overall Study|Physician Decision|0|||
163137489|NCT00479336|589211373|FG003|Overall Study|Physician Decision|2|||
163137490|NCT00479336|589211370|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
163137491|NCT00479336|589211371|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
163137492|NCT00479336|589211372|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
163137493|NCT00479336|589211373|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
163137494|NCT02021643|589211374|FG000|Overall Study|Enrolled but Never Treated|1|||
163137495|NCT02021643|589211375|FG001|Overall Study|Enrolled but Never Treated|0|||
163137496|NCT02021643|589211376|FG002|Overall Study|Enrolled but Never Treated|0|||
163137497|NCT02021643|589211377|FG003|Overall Study|Enrolled but Never Treated|0|||
163137498|NCT02021643|589211374|FG000|Overall Study|Adverse Event|0|||
163137499|NCT02021643|589211375|FG001|Overall Study|Adverse Event|1|||
163137500|NCT02021643|589211376|FG002|Overall Study|Adverse Event|0|||
163137501|NCT02021643|589211377|FG003|Overall Study|Adverse Event|0|||
163137502|NCT02021643|589211374|FG000|Overall Study|Death|0|||
163137503|NCT02021643|589211375|FG001|Overall Study|Death|1|||
163137504|NCT02021643|589211376|FG002|Overall Study|Death|0|||
163137505|NCT02021643|589211377|FG003|Overall Study|Death|0|||
163137506|NCT02021643|589211374|FG000|Overall Study|Investigator's Discretion|1|||
163137507|NCT02021643|589211375|FG001|Overall Study|Investigator's Discretion|0|||
163137508|NCT02021643|589211376|FG002|Overall Study|Investigator's Discretion|0|||
163137509|NCT02021643|589211377|FG003|Overall Study|Investigator's Discretion|0|||
163137510|NCT02021643|589211374|FG000|Overall Study|Lack of Efficacy|7|||
163137511|NCT02021643|589211375|FG001|Overall Study|Lack of Efficacy|6|||
163137512|NCT02021643|589211376|FG002|Overall Study|Lack of Efficacy|0|||
163137513|NCT02021643|589211377|FG003|Overall Study|Lack of Efficacy|12|||
163137514|NCT02021643|589211374|FG000|Overall Study|Lost to Follow-up|0|||
163137515|NCT02021643|589211375|FG001|Overall Study|Lost to Follow-up|1|||
163137516|NCT02021643|589211376|FG002|Overall Study|Lost to Follow-up|0|||
163137517|NCT02021643|589211377|FG003|Overall Study|Lost to Follow-up|0|||
163137518|NCT02021643|589211374|FG000|Overall Study|Withdrew Consent|0|||
163137519|NCT02021643|589211375|FG001|Overall Study|Withdrew Consent|1|||
163137520|NCT02021643|589211376|FG002|Overall Study|Withdrew Consent|0|||
163137521|NCT02021643|589211377|FG003|Overall Study|Withdrew Consent|0|||
163137522|NCT02631551|589211378|FG000|Overall Study|Adverse Event|1|||
163137523|NCT02631551|589211379|FG001|Overall Study|Adverse Event|2|||
163137524|NCT02631551|589211380|FG002|Overall Study|Adverse Event|4|||
163137525|NCT02631551|589211381|FG003|Overall Study|Adverse Event|0|||
163137526|NCT02631551|589211378|FG000|Overall Study|Lack of Efficacy|0|||
163137527|NCT02631551|589211379|FG001|Overall Study|Lack of Efficacy|0|||
163137528|NCT02631551|589211380|FG002|Overall Study|Lack of Efficacy|1|||
163137529|NCT02631551|589211381|FG003|Overall Study|Lack of Efficacy|0|||
163137530|NCT02631551|589211378|FG000|Overall Study|Lost to Follow-up|1|||
163137531|NCT02631551|589211379|FG001|Overall Study|Lost to Follow-up|2|||
163137532|NCT02631551|589211380|FG002|Overall Study|Lost to Follow-up|0|||
163137533|NCT02631551|589211381|FG003|Overall Study|Lost to Follow-up|3|||
163137534|NCT02631551|589211378|FG000|Overall Study|Withdrawal by Subject|2|||
163137535|NCT02631551|589211379|FG001|Overall Study|Withdrawal by Subject|2|||
163137536|NCT02631551|589211380|FG002|Overall Study|Withdrawal by Subject|0|||
163137537|NCT02631551|589211381|FG003|Overall Study|Withdrawal by Subject|5|||
163137538|NCT02631551|589211378|FG000|Overall Study|Protocol deviation|3|||
163137539|NCT02631551|589211379|FG001|Overall Study|Protocol deviation|6|||
163137540|NCT02631551|589211380|FG002|Overall Study|Protocol deviation|3|||
163137541|NCT02631551|589211381|FG003|Overall Study|Protocol deviation|0|||
163137542|NCT02631551|589211378|FG000|Overall Study|Non-compliance with study procedures|0|||
163137543|NCT02631551|589211379|FG001|Overall Study|Non-compliance with study procedures|0|||
163137544|NCT02631551|589211380|FG002|Overall Study|Non-compliance with study procedures|1|||
162659359|NCT03670810|587465884|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
163137545|NCT02631551|589211381|FG003|Overall Study|Non-compliance with study procedures|1|||
163137546|NCT02631551|589211378|FG000|Overall Study|Non-compliance with study drug|1|||
163137547|NCT02631551|589211379|FG001|Overall Study|Non-compliance with study drug|0|||
162720128|NCT02441036|587682460|FG002|Overall Study|No tissue resected|0|||
163137548|NCT02631551|589211380|FG002|Overall Study|Non-compliance with study drug|0|||
163137549|NCT02631551|589211381|FG003|Overall Study|Non-compliance with study drug|0|||
162659360|NCT03670810|587465885|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
162659361|NCT03670810|587465886|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
162659362|NCT03670810|587465887|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
162659363|NCT03670810|587465888|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
162659364|NCT03670810|587465889|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
162659365|NCT03670810|587465890|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
162659366|NCT03670810|587465891|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
162659367|NCT03670810|587465892|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
162659368|NCT03670810|587465884|FG000|Open Label Extension|Lost to Follow-up|0|||
162659369|NCT03670810|587465885|FG001|Open Label Extension|Lost to Follow-up|0|||
162659370|NCT03670810|587465886|FG002|Open Label Extension|Lost to Follow-up|0|||
162659371|NCT03670810|587465887|FG003|Open Label Extension|Lost to Follow-up|0|||
162659372|NCT03670810|587465888|FG004|Open Label Extension|Lost to Follow-up|0|||
162659373|NCT03670810|587465889|FG005|Open Label Extension|Lost to Follow-up|0|||
162659374|NCT03670810|587465890|FG006|Open Label Extension|Lost to Follow-up|0|||
162659375|NCT03670810|587465891|FG007|Open Label Extension|Lost to Follow-up|0|||
162659376|NCT03670810|587465892|FG008|Open Label Extension|Lost to Follow-up|23|||
162659377|NCT00678691|587465893|FG000|Overall Study|Adverse Event|6|||
162659378|NCT00678691|587465894|FG001|Overall Study|Adverse Event|4|||
162659379|NCT00779766|587465901|FG000|Month 24|Serious Adverse Event|2|||
162659380|NCT00779766|587465902|FG001|Month 24|Serious Adverse Event|3|||
162659381|NCT00779766|587465901|FG000|Month 24|Adverse Event|3|||
162659382|NCT00779766|587465902|FG001|Month 24|Adverse Event|3|||
162659383|NCT00779766|587465901|FG000|Month 24|Protocol Violation|3|||
162659384|NCT00779766|587465902|FG001|Month 24|Protocol Violation|1|||
162659385|NCT00779766|587465901|FG000|Month 24|Withdrawal by Subject|159|||
162659386|NCT00779766|587465902|FG001|Month 24|Withdrawal by Subject|127|||
162659387|NCT00779766|587465901|FG000|Month 24|Migrated/moved from study area|138|||
162659388|NCT00779766|587465902|FG001|Month 24|Migrated/moved from study area|162|||
162659389|NCT00779766|587465901|FG000|Month 24|Lost to Follow-up|9|||
162659390|NCT00779766|587465902|FG001|Month 24|Lost to Follow-up|9|||
162659391|NCT00779766|587465901|FG000|Month 24|Other|18|||
162659392|NCT00779766|587465902|FG001|Month 24|Other|27|||
162659393|NCT00779766|587465901|FG000|Month 48|Withdrawal by Subject|68|||
162659394|NCT00779766|587465902|FG001|Month 48|Withdrawal by Subject|63|||
162659395|NCT00779766|587465901|FG000|Month 48|Migrated/moved from study area|76|||
162659396|NCT00779766|587465902|FG001|Month 48|Migrated/moved from study area|75|||
162659397|NCT00779766|587465901|FG000|Month 48|Lost to Follow-up|29|||
162659398|NCT00779766|587465902|FG001|Month 48|Lost to Follow-up|30|||
162659399|NCT00779766|587465901|FG000|Month 48|Other|1|||
162659400|NCT00779766|587465902|FG001|Month 48|Other|0|||
162659401|NCT00779766|587465901|FG000|Month 72|Withdrawal by Subject|55|||
162659402|NCT00779766|587465902|FG001|Month 72|Withdrawal by Subject|71|||
162659403|NCT00779766|587465901|FG000|Month 72|Migrated/moved from study area|124|||
162659404|NCT00779766|587465902|FG001|Month 72|Migrated/moved from study area|109|||
162659405|NCT00779766|587465901|FG000|Month 72|Lost to Follow-up|6|||
162659406|NCT00779766|587465902|FG001|Month 72|Lost to Follow-up|8|||
162659407|NCT00779766|587465901|FG000|Month 72|Other|0|||
162659408|NCT00779766|587465902|FG001|Month 72|Other|1|||
162659409|NCT01412424|587465903|FG000|Core Treatment Period|Treatment Failure|24|||
162659410|NCT01412424|587465903|FG000|Core Treatment Period|Adverse Event|21|||
162659411|NCT01412424|587465903|FG000|Core Treatment Period|Patient Request|5|||
162659412|NCT01412424|587465903|FG000|Core Treatment Period|Lost to Follow-up|2|||
162659413|NCT01412424|587465903|FG000|Core Treatment Period|Sponsor Request|1|||
162659414|NCT01412424|587465903|FG000|Extension Treatment Period|Adverse Event|2|||
162659415|NCT01412424|587465903|FG000|Extension Treatment Period|Treatment Failure|2|||
162659416|NCT01412424|587465903|FG000|Extension Treatment Period|Patient Request|2|||
162659417|NCT02410811|587465907|FG000|Overall Study|Withdrawal by Subject|0|||
162659418|NCT02410811|587465908|FG001|Overall Study|Withdrawal by Subject|0|||
162659419|NCT02410811|587465909|FG002|Overall Study|Withdrawal by Subject|1|||
162659420|NCT02410811|587465910|FG003|Overall Study|Withdrawal by Subject|0|||
162659421|NCT00353366|587465911|FG000|Overall Study|Adverse Event|8|||
162659422|NCT00353366|587465911|FG000|Overall Study|Protocol Violation|12|||
162659423|NCT00353366|587465911|FG000|Overall Study|Withdrawal by Subject|12|||
162659424|NCT00353366|587465911|FG000|Overall Study|Lost to Follow-up|92|||
162659425|NCT00353366|587465911|FG000|Overall Study|Other|19|||
162659426|NCT00259857|587465912|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
162659427|NCT00259857|587465913|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
162659428|NCT00259857|587465912|FG000|24 Months Treatment|Lost to Follow-up|0|||
162659429|NCT00259857|587465913|FG001|24 Months Treatment|Lost to Follow-up|3|||
162659430|NCT05267054|587465914|FG000|Overall Study|Death|13|||
162659431|NCT05267054|587465915|FG001|Overall Study|Death|14|||
162720129|NCT02441036|587682461|FG003|Overall Study|No tissue resected|1|||
163137550|NCT02631551|589211378|FG000|Overall Study|Other, specific reasons not collected|5|||
163137551|NCT02631551|589211379|FG001|Overall Study|Other, specific reasons not collected|7|||
163137552|NCT02631551|589211380|FG002|Overall Study|Other, specific reasons not collected|2|||
163137553|NCT02631551|589211381|FG003|Overall Study|Other, specific reasons not collected|2|||
163137554|NCT04390243|589211387|FG000|Overall Study|Death|1|||
163137555|NCT04390243|589211387|FG000|Overall Study|Disease Progression|4|||
163137556|NCT04390243|589211387|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
163137557|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
163137558|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
163137559|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
163137560|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
163137561|NCT01521507|589211394|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
163137562|NCT01521507|589211395|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
163137563|NCT01521507|589211394|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
163137564|NCT01521507|589211395|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
163137565|NCT01521507|589211394|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
163137566|NCT01521507|589211395|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
163137567|NCT01521507|589211394|FG000|Stage 2: Observational Design|Physician Decision|1|||
163137568|NCT01521507|589211395|FG001|Stage 2: Observational Design|Physician Decision|0|||
163137569|NCT04034004|589211396|FG000|Overall Study|Withdrawal by Subject|1|||
163137570|NCT04034004|589211397|FG001|Overall Study|Withdrawal by Subject|2|||
163137571|NCT04034004|589211398|FG002|Overall Study|Withdrawal by Subject|2|||
163137572|NCT04034004|589211399|FG003|Overall Study|Withdrawal by Subject|3|||
163137573|NCT04034004|589211396|FG000|Overall Study|could not find vein to administer IV|2|||
163137574|NCT04034004|589211397|FG001|Overall Study|could not find vein to administer IV|1|||
163137575|NCT04034004|589211398|FG002|Overall Study|could not find vein to administer IV|0|||
163137576|NCT04034004|589211399|FG003|Overall Study|could not find vein to administer IV|0|||
163137577|NCT04034004|589211396|FG000|Overall Study|nurse accidentally unblinded subject|0|||
163137578|NCT04034004|589211397|FG001|Overall Study|nurse accidentally unblinded subject|0|||
163137579|NCT04034004|589211398|FG002|Overall Study|nurse accidentally unblinded subject|0|||
163137580|NCT04034004|589211399|FG003|Overall Study|nurse accidentally unblinded subject|1|||
163137581|NCT04317040|589211400|FG000|Overall Study|Lost to Follow-up|2|||
163137582|NCT04317040|589211401|FG001|Overall Study|Lost to Follow-up|0|||
163137583|NCT04317040|589211400|FG000|Overall Study|Death|16|||
163137584|NCT04317040|589211401|FG001|Overall Study|Death|18|||
163137585|NCT04317040|589211400|FG000|Overall Study|Withdrawal by Subject|0|||
163137586|NCT04317040|589211401|FG001|Overall Study|Withdrawal by Subject|1|||
163137587|NCT04317040|589211400|FG000|Overall Study|Incomplete assessments|0|||
163137588|NCT04317040|589211401|FG001|Overall Study|Incomplete assessments|1|||
163137589|NCT03672292|589211402|FG000|Overall Study|Adverse Event|3|||
163137590|NCT03672292|589211403|FG001|Overall Study|Adverse Event|1|||
163137591|NCT03672292|589211402|FG000|Overall Study|Physician Decision|0|||
163137592|NCT03672292|589211403|FG001|Overall Study|Physician Decision|1|||
163137593|NCT03672292|589211402|FG000|Overall Study|Withdrawal by Subject|1|||
163137594|NCT03672292|589211403|FG001|Overall Study|Withdrawal by Subject|2|||
163137595|NCT00799903|589211404|FG000|Overall Study|Investigator Site Closed|25|||
163137596|NCT00799903|589211405|FG001|Overall Study|Investigator Site Closed|23|||
163137597|NCT00799903|589211404|FG000|Overall Study|Withdrawal by Subject|179|||
163137598|NCT00799903|589211405|FG001|Overall Study|Withdrawal by Subject|175|||
163137599|NCT00799903|589211404|FG000|Overall Study|Lost to Follow-up|69|||
163137600|NCT00799903|589211405|FG001|Overall Study|Lost to Follow-up|80|||
163137601|NCT02518971|589211406|FG000|Overall Study|Lost to Follow-up|0|||
163137602|NCT02518971|589211407|FG001|Overall Study|Lost to Follow-up|1|||
163137603|NCT02518971|589211406|FG000|Overall Study|Physician Decision|6|||
163137604|NCT02518971|589211407|FG001|Overall Study|Physician Decision|6|||
163137605|NCT02518971|589211406|FG000|Overall Study|Protocol Violation|6|||
163137606|NCT02518971|589211407|FG001|Overall Study|Protocol Violation|4|||
163137607|NCT02518971|589211406|FG000|Overall Study|Withdrawal by Subject|4|||
163137608|NCT02518971|589211407|FG001|Overall Study|Withdrawal by Subject|5|||
163137609|NCT02518971|589211406|FG000|Overall Study|Side effects|1|||
163137610|NCT02518971|589211407|FG001|Overall Study|Side effects|0|||
163137611|NCT02518971|589211406|FG000|Overall Study|medication lost in mail|0|||
163137612|NCT02518971|589211407|FG001|Overall Study|medication lost in mail|1|||
163137613|NCT02518971|589211406|FG000|Overall Study|eligibility criteria no longer met|6|||
163137614|NCT02518971|589211407|FG001|Overall Study|eligibility criteria no longer met|3|||
163137615|NCT03088917|589211408|FG000|Overall Study|In care/cured elsewhere|15|||
163137616|NCT03088917|589211408|FG000|Overall Study|Refuse re-evaluation|13|||
163137617|NCT03088917|589211408|FG000|Overall Study|Contact not established|13|||
163137618|NCT03088917|589211408|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
163137619|NCT03088917|589211408|FG000|Overall Study|Moved outside study region|50|||
163137620|NCT01514201|589211413|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
163137621|NCT01514201|589211414|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
162659432|NCT05267054|587465914|FG000|Overall Study|Study Ended by Sponsor|9|||
162659433|NCT05267054|587465915|FG001|Overall Study|Study Ended by Sponsor|13|||
162659434|NCT05267054|587465914|FG000|Overall Study|Lost to Follow-up|1|||
162659435|NCT05267054|587465915|FG001|Overall Study|Lost to Follow-up|1|||
162659436|NCT05267054|587465914|FG000|Overall Study|Withdrawal by Subject|1|||
163137622|NCT01514201|589211415|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137623|NCT01514201|589211416|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137624|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137625|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
163137626|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
163137627|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137628|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
163137629|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
163137630|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
163137631|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137632|NCT01514201|589211413|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
163137633|NCT01514201|589211414|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
163137634|NCT01514201|589211415|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137635|NCT01514201|589211416|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137636|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137637|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137638|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
163137639|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
163137640|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137641|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137642|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
163137643|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
163137644|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137645|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137646|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
163137647|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
163137648|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137649|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137650|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
163137651|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
163137652|NCT01514201|589211413|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137653|NCT01514201|589211414|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137654|NCT01514201|589211415|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
163137655|NCT01514201|589211416|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
163137656|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
162659437|NCT05267054|587465915|FG001|Overall Study|Withdrawal by Subject|1|||
162659438|NCT01552226|587465918|FG000|Overall Study|Withdrawal by Subject|4|||
162659439|NCT01552226|587465919|FG001|Overall Study|Withdrawal by Subject|4|||
162659440|NCT01469065|587465923|FG000|Overall Study|Lack of Efficacy|0|||
162659441|NCT01469065|587465924|FG001|Overall Study|Lack of Efficacy|0|||
162659442|NCT01469065|587465925|FG002|Overall Study|Lack of Efficacy|0|||
162659443|NCT01469065|587465926|FG003|Overall Study|Lack of Efficacy|0|||
162659444|NCT01469065|587465927|FG004|Overall Study|Lack of Efficacy|1|||
162659445|NCT01469065|587465923|FG000|Overall Study|Other|0|||
162659446|NCT01469065|587465924|FG001|Overall Study|Other|1|||
162659447|NCT01469065|587465925|FG002|Overall Study|Other|0|||
162659448|NCT01469065|587465926|FG003|Overall Study|Other|0|||
162659449|NCT01469065|587465927|FG004|Overall Study|Other|0|||
162659450|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
162659451|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
162659452|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
162659453|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
162659454|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
162659455|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
162659456|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
162659457|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
162659458|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
162659459|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
162659460|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
162659461|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
162659462|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
162659463|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
162659464|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
162659465|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
162659466|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
162659467|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
162659468|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
163137657|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137658|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
163137659|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
163137660|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137661|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137662|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
163137663|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
163137664|NCT01514201|589211413|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137665|NCT01514201|589211414|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137666|NCT01514201|589211415|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
163137667|NCT01514201|589211416|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
163137668|NCT02735343|589211419|FG000|Overall Study|screen fail|0|||
163137669|NCT02735343|589211420|FG001|Overall Study|screen fail|2|||
163137670|NCT00566852|589211431|FG000|Overall Study|Protocol Violation|22|||
163137671|NCT00566852|589211432|FG001|Overall Study|Protocol Violation|24|||
163137672|NCT00566852|589211431|FG000|Overall Study|Death|95|||
163137673|NCT00566852|589211432|FG001|Overall Study|Death|78|||
163137674|NCT00566852|589211431|FG000|Overall Study|Withdrawal by Subject|30|||
163137675|NCT00566852|589211432|FG001|Overall Study|Withdrawal by Subject|25|||
163137676|NCT00566852|589211431|FG000|Overall Study|Patient refusal|37|||
163137677|NCT00566852|589211432|FG001|Overall Study|Patient refusal|37|||
163137678|NCT00566852|589211431|FG000|Overall Study|Not tested due to disability|6|||
163137679|NCT00566852|589211432|FG001|Overall Study|Not tested due to disability|12|||
163137680|NCT00566852|589211431|FG000|Overall Study|Missing reason not specified|1|||
163137681|NCT00566852|589211432|FG001|Overall Study|Missing reason not specified|2|||
163137682|NCT00566852|589211431|FG000|Overall Study|Missing reason not reported|16|||
163137683|NCT00566852|589211432|FG001|Overall Study|Missing reason not reported|20|||
163137684|NCT04531241|589211435|FG000|Period 1|Withdrawal by Subject|2|||
163137685|NCT04531241|589211436|FG001|Period 1|Withdrawal by Subject|0|||
163137686|NCT04531241|589211435|FG000|Period 1|Dispesed incorrect lens power|1|||
163137687|NCT04531241|589211436|FG001|Period 1|Dispesed incorrect lens power|0|||
163137688|NCT04531241|589211435|FG000|Period 1|Protocol Violation|1|||
163137689|NCT04531241|589211436|FG001|Period 1|Protocol Violation|0|||
163137690|NCT04531241|589211435|FG000|Period 1|No longer eligible|0|||
163137691|NCT04531241|589211436|FG001|Period 1|No longer eligible|1|||
163137692|NCT04531241|589211435|FG000|Period 1|Lens Discomfort|0|||
162659469|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
162659470|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
162659471|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
162720130|NCT02441036|587682462|FG004|Overall Study|No tissue resected|0|||
162659472|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
162659473|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
162659474|NCT04542070|587465928|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
162659475|NCT04542070|587465929|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
162659476|NCT04542070|587465930|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
162720131|NCT01183780|587682463|FG000|Overall Study|Withdrawal by Subject|25|||
162720132|NCT01183780|587682464|FG001|Overall Study|Withdrawal by Subject|14|||
162720133|NCT01183780|587682463|FG000|Overall Study|Lost to Follow-up|6|||
162720134|NCT01183780|587682464|FG001|Overall Study|Lost to Follow-up|11|||
162720135|NCT00079183|587682467|FG000|Overall Study|Withdrawal by Subject|4|||
162720136|NCT00079183|587682467|FG000|Overall Study|Study medication non-compliance|2|||
162720137|NCT00079183|587682467|FG000|Overall Study|Specimen collection non-compliance|1|||
162720138|NCT00762606|587682468|FG000|Overall Study|Lost to Follow-up|18|||
162720139|NCT00762606|587682469|FG001|Overall Study|Lost to Follow-up|13|||
162720140|NCT00949975|587682470|FG000|Overall Study|Voluntary discontinuation|6|||
162720141|NCT00949975|587682471|FG001|Overall Study|Voluntary discontinuation|5|||
162720142|NCT00949975|587682472|FG002|Overall Study|Voluntary discontinuation|3|||
162720143|NCT00949975|587682473|FG003|Overall Study|Voluntary discontinuation|6|||
162720144|NCT00949975|587682470|FG000|Overall Study|Adverse Event|11|||
162720145|NCT00949975|587682471|FG001|Overall Study|Adverse Event|11|||
162720146|NCT00949975|587682472|FG002|Overall Study|Adverse Event|10|||
162720147|NCT00949975|587682473|FG003|Overall Study|Adverse Event|10|||
162720148|NCT00949975|587682470|FG000|Overall Study|Safety reason|0|||
162720149|NCT00949975|587682471|FG001|Overall Study|Safety reason|1|||
162720150|NCT00949975|587682472|FG002|Overall Study|Safety reason|0|||
162720151|NCT00949975|587682473|FG003|Overall Study|Safety reason|0|||
162720152|NCT00949975|587682470|FG000|Overall Study|Study-specific criteria|0|||
162720153|NCT00949975|587682471|FG001|Overall Study|Study-specific criteria|1|||
162720154|NCT00949975|587682472|FG002|Overall Study|Study-specific criteria|1|||
162720155|NCT00949975|587682473|FG003|Overall Study|Study-specific criteria|0|||
162720156|NCT00949975|587682470|FG000|Overall Study|Incorrect enrolment|5|||
162720157|NCT00949975|587682471|FG001|Overall Study|Incorrect enrolment|10|||
162720158|NCT00949975|587682472|FG002|Overall Study|Incorrect enrolment|4|||
162720159|NCT00949975|587682473|FG003|Overall Study|Incorrect enrolment|7|||
162720160|NCT00949975|587682470|FG000|Overall Study|Severe non-compliance|3|||
162720161|NCT00949975|587682471|FG001|Overall Study|Severe non-compliance|1|||
162720162|NCT00949975|587682472|FG002|Overall Study|Severe non-compliance|0|||
162720163|NCT00949975|587682473|FG003|Overall Study|Severe non-compliance|2|||
162720164|NCT00949975|587682470|FG000|Overall Study|Lost to Follow-up|1|||
162720165|NCT00949975|587682471|FG001|Overall Study|Lost to Follow-up|0|||
162720166|NCT00949975|587682472|FG002|Overall Study|Lost to Follow-up|1|||
162720167|NCT00949975|587682473|FG003|Overall Study|Lost to Follow-up|3|||
162720168|NCT00949975|587682470|FG000|Overall Study|Other|1|||
162720169|NCT00949975|587682471|FG001|Overall Study|Other|0|||
162720170|NCT00949975|587682472|FG002|Overall Study|Other|0|||
162720171|NCT00949975|587682473|FG003|Overall Study|Other|0|||
162720172|NCT04246762|587682474|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
162720173|NCT02878330|587682475|FG000|Overall Study|Death|3|||
162720174|NCT02878330|587682476|FG001|Overall Study|Death|2|||
162720175|NCT02878330|587682475|FG000|Overall Study|Lost to Follow-up|11|||
162720176|NCT02878330|587682476|FG001|Overall Study|Lost to Follow-up|26|||
162720177|NCT02878330|587682475|FG000|Overall Study|Withdrawal by Subject|11|||
162720178|NCT02878330|587682476|FG001|Overall Study|Withdrawal by Subject|21|||
162720179|NCT02878330|587682475|FG000|Overall Study|Other|4|||
162720180|NCT02878330|587682476|FG001|Overall Study|Other|7|||
162720181|NCT03615924|587682477|FG000|Overall Study|Withdrawal by Subject|2|||
162720182|NCT03615924|587682478|FG001|Overall Study|Withdrawal by Subject|5|||
162720183|NCT03615924|587682477|FG000|Overall Study|Death|3|||
162720184|NCT03615924|587682478|FG001|Overall Study|Death|1|||
162720185|NCT03615924|587682477|FG000|Overall Study|Lost to Follow-up|1|||
162720186|NCT03615924|587682478|FG001|Overall Study|Lost to Follow-up|0|||
162720187|NCT03615924|587682477|FG000|Overall Study|Randomized in error|1|||
162720188|NCT03615924|587682478|FG001|Overall Study|Randomized in error|0|||
162720189|NCT03615924|587682477|FG000|Overall Study|Study termination by Sponsor|94|||
162720190|NCT03615924|587682478|FG001|Overall Study|Study termination by Sponsor|86|||
162720191|NCT02954848|587682481|FG000|Overall Study|Randomized but Not Treated|0|||
163137693|NCT04531241|589211436|FG001|Period 1|Lens Discomfort|1|||
163137694|NCT04531241|589211435|FG000|Period 2|Covid-19 Related|1|||
163137695|NCT04531241|589211436|FG001|Period 2|Covid-19 Related|1|||
163137696|NCT02715609|589211437|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
163137697|NCT02715609|589211438|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
163137698|NCT02715609|589211439|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
163137699|NCT02715609|589211437|FG000|Overall Study|Withdrawal by Subject|0|||
163137700|NCT02715609|589211438|FG001|Overall Study|Withdrawal by Subject|0|||
162720192|NCT02954848|587682482|FG001|Overall Study|Randomized but Not Treated|1|||
162720193|NCT02954848|587682481|FG000|Overall Study|Adverse Event|2|||
163137701|NCT02715609|589211439|FG002|Overall Study|Withdrawal by Subject|1|||
163137702|NCT03983304|589211440|FG000|Overall Study|Withdrawal by Subject|5|||
163137703|NCT03983304|589211440|FG000|Overall Study|Lost to Follow-up|2|||
162720194|NCT02954848|587682482|FG001|Overall Study|Adverse Event|3|||
162720195|NCT02954848|587682481|FG000|Overall Study|Withdrawal by Participant|0|||
162720196|NCT02954848|587682482|FG001|Overall Study|Withdrawal by Participant|1|||
162720197|NCT01069341|587682483|FG000|Overall Study|Lost to Follow-up|1|||
163137704|NCT01702246|589211441|FG000|Overall Study|Lost to Follow-up|2|||
163137705|NCT01702246|589211441|FG000|Overall Study|Withdrawal by Subject|2|||
163137706|NCT01702246|589211441|FG000|Overall Study|Physician Decision|1|||
163137707|NCT01518374|589211444|FG000|Overall Study|Withdrawal by Subject|2|||
163137708|NCT01518374|589211444|FG000|Overall Study|Protocol Violation|3|||
163137709|NCT01518374|589211444|FG000|Overall Study|Lost to Follow-up|2|||
163137710|NCT04209205|589211447|FG000|Overall Study|Adverse Event|2|||
163137711|NCT04209205|589211448|FG001|Overall Study|Adverse Event|3|||
163137712|NCT04209205|589211447|FG000|Overall Study|Lost to Follow-up|3|||
163137713|NCT04209205|589211448|FG001|Overall Study|Lost to Follow-up|1|||
163137714|NCT04209205|589211447|FG000|Overall Study|Physician Decision|1|||
163137715|NCT04209205|589211448|FG001|Overall Study|Physician Decision|1|||
163137716|NCT04209205|589211447|FG000|Overall Study|Subject decision|10|||
163137717|NCT04209205|589211448|FG001|Overall Study|Subject decision|10|||
163137718|NCT04209205|589211447|FG000|Overall Study|Progressive disease|1|||
163137719|NCT04209205|589211448|FG001|Overall Study|Progressive disease|0|||
163137720|NCT04209205|589211447|FG000|Overall Study|Protocol deviation|0|||
163137721|NCT04209205|589211448|FG001|Overall Study|Protocol deviation|1|||
163137722|NCT04209205|589211447|FG000|Overall Study|New therapy for study indication|1|||
163137723|NCT04209205|589211448|FG001|Overall Study|New therapy for study indication|0|||
163137724|NCT04209205|589211447|FG000|Overall Study|Adverse event - placebo not switched|0|||
163137725|NCT04209205|589211448|FG001|Overall Study|Adverse event - placebo not switched|1|||
163137726|NCT04209205|589211447|FG000|Overall Study|Subject decision - placebo not switched|0|||
163137727|NCT04209205|589211448|FG001|Overall Study|Subject decision - placebo not switched|5|||
163137728|NCT04209205|589211447|FG000|Overall Study|Death - placebo not switched|0|||
163137729|NCT04209205|589211448|FG001|Overall Study|Death - placebo not switched|1|||
163137730|NCT00999544|589213025|FG000|Overall Study|Withdrawal by Subject|1|||
163137731|NCT01392547|589213026|FG000|Overall Study|Adverse Event|2|||
163137732|NCT01392547|589213026|FG000|Overall Study|Non-compliance|2|||
163137733|NCT01392547|589213026|FG000|Overall Study|Withdrawal criteria|3|||
163137734|NCT01392547|589213026|FG000|Overall Study|Unclassified|1|||
163137735|NCT00950846|589213031|FG000|Overall Study|Death|6|||
163137736|NCT00950846|589213031|FG000|Overall Study|Lost to Follow-up|3|||
163137737|NCT00950846|589213031|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
163137738|NCT01799226|589213032|FG000|Overall Study|Withdrawal by Subject|1|||
163137739|NCT01799226|589213033|FG001|Overall Study|Withdrawal by Subject|0|||
163137740|NCT01799226|589213032|FG000|Overall Study|Disqualified at Day 14|1|||
163137741|NCT01799226|589213033|FG001|Overall Study|Disqualified at Day 14|0|||
163137742|NCT02178995|589213034|FG000|Double Blind|Adverse Event|0|||
163137743|NCT02178995|589213035|FG001|Double Blind|Adverse Event|0|||
163137744|NCT02178995|589213036|FG002|Double Blind|Adverse Event|0|||
163137745|NCT02178995|589213037|FG003|Double Blind|Adverse Event|0|||
163137746|NCT02178995|589213038|FG004|Double Blind|Adverse Event|0|||
163137747|NCT02178995|589213039|FG005|Double Blind|Adverse Event|1|||
163137748|NCT02178995|589213040|FG006|Double Blind|Adverse Event|0|||
163137749|NCT02178995|589213041|FG007|Double Blind|Adverse Event|1|||
163137750|NCT02178995|589213042|FG008|Double Blind|Adverse Event|1|||
163137751|NCT02178995|589213034|FG000|Double Blind|Lost to Follow-up|0|||
163137752|NCT02178995|589213035|FG001|Double Blind|Lost to Follow-up|1|||
163137753|NCT02178995|589213036|FG002|Double Blind|Lost to Follow-up|0|||
163137754|NCT02178995|589213037|FG003|Double Blind|Lost to Follow-up|0|||
163137755|NCT02178995|589213038|FG004|Double Blind|Lost to Follow-up|0|||
163137756|NCT02178995|589213039|FG005|Double Blind|Lost to Follow-up|0|||
163137757|NCT02178995|589213040|FG006|Double Blind|Lost to Follow-up|0|||
163137758|NCT02178995|589213041|FG007|Double Blind|Lost to Follow-up|1|||
163137759|NCT02178995|589213042|FG008|Double Blind|Lost to Follow-up|0|||
163137760|NCT02178995|589213034|FG000|Open Label|Adverse Event|2|||
163137761|NCT02178995|589213035|FG001|Open Label|Adverse Event|0|||
163137762|NCT02178995|589213036|FG002|Open Label|Adverse Event|0|||
163137763|NCT02178995|589213037|FG003|Open Label|Adverse Event|0|||
163137764|NCT02178995|589213038|FG004|Open Label|Adverse Event|0|||
162659477|NCT04542070|587465931|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
162659478|NCT04542070|587465928|FG000|Maintenance + Extension Period|Adverse Event|10|||
163137765|NCT02178995|589213039|FG005|Open Label|Adverse Event|0|||
163137766|NCT02178995|589213040|FG006|Open Label|Adverse Event|0|||
163137767|NCT02178995|589213041|FG007|Open Label|Adverse Event|0|||
163137768|NCT02178995|589213042|FG008|Open Label|Adverse Event|0|||
163137769|NCT02114606|589213044|FG000|Overall Study|Unable to swallow Cytosponge|6|||
163137770|NCT00981461|589213045|FG000|Overall Study|Lost to Follow-up|5|||
162659479|NCT04542070|587465929|FG001|Maintenance + Extension Period|Adverse Event|2|||
163137771|NCT00981461|589213046|FG001|Overall Study|Lost to Follow-up|2|||
163137772|NCT01388907|589213047|FG000|Overall Study|Adverse Event|2|||
163137773|NCT01388907|589213048|FG001|Overall Study|Adverse Event|0|||
163137774|NCT03361293|589213049|FG000|Overall Study|Lost to Follow-up|0|||
163137775|NCT03361293|589213050|FG001|Overall Study|Lost to Follow-up|2|||
163137776|NCT03361293|589213049|FG000|Overall Study|Withdrawal by Subject|1|||
162659480|NCT04542070|587465930|FG002|Maintenance + Extension Period|Adverse Event|0|||
162659481|NCT04542070|587465931|FG003|Maintenance + Extension Period|Adverse Event|0|||
162659482|NCT04542070|587465928|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
162659483|NCT04542070|587465929|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
162659484|NCT04542070|587465930|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
163137777|NCT03361293|589213050|FG001|Overall Study|Withdrawal by Subject|3|||
163137778|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
163137779|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
163137780|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
163137781|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
163137782|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
163137783|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
163137784|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
163137785|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
163137786|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
163137787|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
163137788|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
163137789|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
163137790|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
163137791|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
163137792|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
163137793|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
163137794|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
163137795|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
163137796|NCT01910402|589213051|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
163137797|NCT01910402|589213052|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
163137798|NCT01910402|589213053|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
163137799|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
163137800|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
163137801|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
163137802|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
163137803|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
163137804|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
163137805|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
163137806|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
163137807|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
163137808|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
163137809|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
163137810|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
163137811|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
163137812|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
163137813|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
163137814|NCT01910402|589213051|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
163137815|NCT01910402|589213052|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
163137816|NCT01910402|589213053|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
163137817|NCT00483405|589213054|FG000|Overall Study|Adverse Event|8|||
163137818|NCT00483405|589213054|FG000|Overall Study|Lack of Efficacy|14|||
163137819|NCT00483405|589213054|FG000|Overall Study|Death|3|||
163137820|NCT00483405|589213054|FG000|Overall Study|Withdrawal by Subject|2|||
163137821|NCT00483405|589213054|FG000|Overall Study|Other complicating disease|1|||
163137822|NCT03010319|589213055|FG000|Overall Study|Adverse Event|15|||
163137823|NCT03010319|589213056|FG001|Overall Study|Adverse Event|9|||
163137824|NCT03010319|589213055|FG000|Overall Study|Withdrawal by Subject|1|||
163137825|NCT03010319|589213056|FG001|Overall Study|Withdrawal by Subject|6|||
163137826|NCT03010319|589213055|FG000|Overall Study|Physician Decision|2|||
163137827|NCT03010319|589213056|FG001|Overall Study|Physician Decision|4|||
163137828|NCT03010319|589213055|FG000|Overall Study|Sponsor requested withdrawal|2|||
163137829|NCT03010319|589213056|FG001|Overall Study|Sponsor requested withdrawal|2|||
163137830|NCT03010319|589213055|FG000|Overall Study|Death|1|||
163137831|NCT03010319|589213056|FG001|Overall Study|Death|0|||
163137832|NCT03010319|589213055|FG000|Overall Study|Lost to Follow-up|0|||
163137833|NCT03010319|589213056|FG001|Overall Study|Lost to Follow-up|1|||
163137834|NCT03010319|589213055|FG000|Overall Study|Other Reason|5|||
163137835|NCT03010319|589213056|FG001|Overall Study|Other Reason|7|||
163137836|NCT02128724|589213057|FG000|Overall Study|Death|1|||
163137837|NCT02128724|589213058|FG001|Overall Study|Death|0|||
163137838|NCT02128724|589213059|FG002|Overall Study|Death|0|||
163137839|NCT02128724|589213060|FG003|Overall Study|Death|0|||
162659485|NCT04542070|587465931|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
162659486|NCT04542070|587465928|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
163137840|NCT02128724|589213057|FG000|Overall Study|Adverse Event|0|||
163137841|NCT02128724|589213058|FG001|Overall Study|Adverse Event|1|||
163137842|NCT02128724|589213059|FG002|Overall Study|Adverse Event|0|||
163137843|NCT02128724|589213060|FG003|Overall Study|Adverse Event|0|||
162659487|NCT04542070|587465929|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
162659488|NCT04542070|587465930|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
162659489|NCT04542070|587465931|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
162659490|NCT04542070|587465928|FG000|Maintenance + Extension Period|Physician Decision|1|||
162659491|NCT04542070|587465929|FG001|Maintenance + Extension Period|Physician Decision|1|||
162659492|NCT04542070|587465930|FG002|Maintenance + Extension Period|Physician Decision|0|||
162659493|NCT04542070|587465931|FG003|Maintenance + Extension Period|Physician Decision|0|||
162659494|NCT04542070|587465928|FG000|Maintenance + Extension Period|Protocol Violation|2|||
162659495|NCT04542070|587465929|FG001|Maintenance + Extension Period|Protocol Violation|5|||
162659496|NCT04542070|587465930|FG002|Maintenance + Extension Period|Protocol Violation|0|||
162659497|NCT04542070|587465931|FG003|Maintenance + Extension Period|Protocol Violation|0|||
162659498|NCT04542070|587465928|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
162659499|NCT04542070|587465929|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
162659500|NCT04542070|587465930|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
162659501|NCT04542070|587465931|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
162659502|NCT04542070|587465928|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
162659503|NCT04542070|587465929|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
162659504|NCT04542070|587465930|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
162659505|NCT04542070|587465931|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
162659506|NCT04542070|587465928|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162659507|NCT04542070|587465929|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162659508|NCT04542070|587465930|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162659509|NCT04542070|587465931|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
162659510|NCT04542070|587465928|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162659511|NCT04542070|587465929|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162659512|NCT04542070|587465930|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162659513|NCT04542070|587465931|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
162659514|NCT04542070|587465928|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162659515|NCT04542070|587465929|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162659516|NCT04542070|587465930|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162659517|NCT04542070|587465931|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
162659518|NCT04542070|587465928|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162659519|NCT04542070|587465929|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162659520|NCT04542070|587465930|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162659521|NCT04542070|587465931|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
162659522|NCT04542070|587465928|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162659523|NCT04542070|587465929|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162659524|NCT04542070|587465930|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162659525|NCT04542070|587465931|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
162659526|NCT03511560|587465934|FG000|Overall Study|Death|0|||
162659527|NCT03511560|587465935|FG001|Overall Study|Death|1|||
162720198|NCT01802632|587682484|FG000|Overall Study|Death|28|||
162720199|NCT01802632|587682485|FG001|Overall Study|Death|1|||
162720200|NCT01802632|587682486|FG002|Overall Study|Death|38|||
162720201|NCT01802632|587682487|FG003|Overall Study|Death|0|||
163137844|NCT02128724|589213057|FG000|Overall Study|Physician Decision|0|||
163137845|NCT02128724|589213058|FG001|Overall Study|Physician Decision|0|||
163137846|NCT02128724|589213059|FG002|Overall Study|Physician Decision|0|||
163137847|NCT02128724|589213060|FG003|Overall Study|Physician Decision|2|||
163137848|NCT02128724|589213057|FG000|Overall Study|Withdrawal by Subject|0|||
163137849|NCT02128724|589213058|FG001|Overall Study|Withdrawal by Subject|0|||
163137850|NCT02128724|589213059|FG002|Overall Study|Withdrawal by Subject|0|||
163137851|NCT02128724|589213060|FG003|Overall Study|Withdrawal by Subject|1|||
163137852|NCT04829916|589213062|FG000|Overall Study|Withdrawal by Subject|1|||
163137853|NCT04829916|589213063|FG001|Overall Study|Withdrawal by Subject|0|||
163137854|NCT03594773|589213067|FG000|Overall Study|Withdrawal by Subject|3|||
163137855|NCT03594773|589213068|FG001|Overall Study|Withdrawal by Subject|2|||
163137856|NCT03594773|589213067|FG000|Overall Study|Lost to Follow-up|3|||
163137857|NCT03594773|589213068|FG001|Overall Study|Lost to Follow-up|4|||
163137858|NCT04098809|589213071|FG000|Overall Study|Withdrawal by Subject|1|||
163137859|NCT04098809|589213072|FG001|Overall Study|Withdrawal by Subject|3|||
163137860|NCT04098809|589213071|FG000|Overall Study|Physician Decision|2|||
163137861|NCT04098809|589213072|FG001|Overall Study|Physician Decision|1|||
163137862|NCT00193206|589213073|FG000|Preoperative Therapy|Lack of Efficacy|2|||
163137863|NCT00193206|589213073|FG000|Preoperative Therapy|Adverse Event|2|||
163137864|NCT00193206|589213073|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
163137865|NCT00193206|589213073|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
163137866|NCT00193206|589213073|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
163137867|NCT00193206|589213073|FG000|Postoperative Therapy|Physician Decision|3|||
162659528|NCT03511560|587465934|FG000|Overall Study|Adverse Event|0|||
162659529|NCT03511560|587465935|FG001|Overall Study|Adverse Event|2|||
162659530|NCT03511560|587465934|FG000|Overall Study|Transplant cancelled|0|||
162659531|NCT03511560|587465935|FG001|Overall Study|Transplant cancelled|1|||
162659532|NCT03511560|587465934|FG000|Overall Study|Patient switched to another drug|1|||
162659533|NCT03511560|587465935|FG001|Overall Study|Patient switched to another drug|0|||
162659534|NCT02751983|587465942|FG000|Treatment|Stopped ACT, but Remained in study|2|||
162659535|NCT02751983|587465943|FG001|Treatment|Stopped ACT, but Remained in study|0|||
162720202|NCT01802632|587682488|FG004|Overall Study|Death|2|||
163137868|NCT00193206|589213073|FG000|Postoperative Therapy|Intercurrent Illness|2|||
162659536|NCT02751983|587465942|FG000|Treatment|Discharged prior to beginning ACT|2|||
162659537|NCT02751983|587465943|FG001|Treatment|Discharged prior to beginning ACT|0|||
162659538|NCT02751983|587465942|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
162659539|NCT02751983|587465943|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
163137869|NCT00193206|589213073|FG000|Postoperative Therapy|Lack of Efficacy|1|||
163137870|NCT00193206|589213073|FG000|Postoperative Therapy|Protocol Violation|1|||
163137871|NCT01200368|589213078|FG000|Infant Series|Adverse Event|2|||
163137872|NCT01200368|589213079|FG001|Infant Series|Adverse Event|2|||
163137873|NCT01200368|589213080|FG002|Infant Series|Adverse Event|3|||
163137874|NCT01200368|589213078|FG000|Infant Series|Withdrawal by Subject|0|||
163137875|NCT01200368|589213079|FG001|Infant Series|Withdrawal by Subject|2|||
163137876|NCT01200368|589213080|FG002|Infant Series|Withdrawal by Subject|2|||
163137877|NCT01200368|589213078|FG000|Infant Series|Did not meet entrance criteria|0|||
163137878|NCT01200368|589213079|FG001|Infant Series|Did not meet entrance criteria|1|||
162659540|NCT02751983|587465942|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
162659541|NCT02751983|587465943|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
162720203|NCT01802632|587682489|FG005|Overall Study|Death|0|||
162720204|NCT01802632|587682484|FG000|Overall Study|Withdrawal by Subject|4|||
163137879|NCT01200368|589213080|FG002|Infant Series|Did not meet entrance criteria|0|||
162720205|NCT01802632|587682485|FG001|Overall Study|Withdrawal by Subject|2|||
162720206|NCT01802632|587682486|FG002|Overall Study|Withdrawal by Subject|7|||
162720207|NCT01802632|587682487|FG003|Overall Study|Withdrawal by Subject|3|||
162720208|NCT01802632|587682488|FG004|Overall Study|Withdrawal by Subject|0|||
162659542|NCT02751983|587465942|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
163137880|NCT01200368|589213078|FG000|Infant Series|Randomized, not vaccinated|0|||
163137881|NCT01200368|589213079|FG001|Infant Series|Randomized, not vaccinated|1|||
163137882|NCT01200368|589213080|FG002|Infant Series|Randomized, not vaccinated|1|||
163137883|NCT01200368|589213078|FG000|Infant Series|Other|1|||
163137884|NCT01200368|589213079|FG001|Infant Series|Other|0|||
163137885|NCT01200368|589213080|FG002|Infant Series|Other|0|||
163137886|NCT01200368|589213078|FG000|After Infant Series|Adverse Event|6|||
163137887|NCT01200368|589213079|FG001|After Infant Series|Adverse Event|6|||
163137888|NCT01200368|589213080|FG002|After Infant Series|Adverse Event|3|||
163137889|NCT01200368|589213078|FG000|After Infant Series|Withdrawal by Subject|10|||
163137890|NCT01200368|589213079|FG001|After Infant Series|Withdrawal by Subject|8|||
163137891|NCT01200368|589213080|FG002|After Infant Series|Withdrawal by Subject|4|||
163137892|NCT01200368|589213078|FG000|After Infant Series|Lost to Follow-up|1|||
163137893|NCT01200368|589213079|FG001|After Infant Series|Lost to Follow-up|0|||
163137894|NCT01200368|589213080|FG002|After Infant Series|Lost to Follow-up|0|||
163137895|NCT01200368|589213078|FG000|After Infant Series|Other|1|||
163137896|NCT01200368|589213079|FG001|After Infant Series|Other|2|||
163137897|NCT01200368|589213080|FG002|After Infant Series|Other|2|||
163137898|NCT01200368|589213078|FG000|Toddler Dose|Adverse Event|0|||
163137899|NCT01200368|589213079|FG001|Toddler Dose|Adverse Event|3|||
163137900|NCT01200368|589213080|FG002|Toddler Dose|Adverse Event|1|||
163137901|NCT01290757|589213081|FG000|Overall Study|Adverse Event|1|||
163137902|NCT01290757|589213082|FG001|Overall Study|Adverse Event|0|||
163137903|NCT01290757|589213081|FG000|Overall Study|Protocol Violation|1|||
163137904|NCT01290757|589213082|FG001|Overall Study|Protocol Violation|1|||
163137905|NCT01290757|589213081|FG000|Overall Study|Other|0|||
163137906|NCT01290757|589213082|FG001|Overall Study|Other|1|||
163137907|NCT00570310|589213083|FG000|Overall Study|Adverse Event|1|||
163137908|NCT00570310|589213084|FG001|Overall Study|Adverse Event|2|||
163137909|NCT00570310|589213083|FG000|Overall Study|Lack of Efficacy|1|||
163137910|NCT00570310|589213084|FG001|Overall Study|Lack of Efficacy|4|||
163137911|NCT03066193|589213087|FG000|Overall Study|Withdrawal by Subject|1|||
163137912|NCT00181766|589213097|FG000|Overall Study|Lost to Follow-up|6|||
163137913|NCT00181766|589213097|FG000|Overall Study|Adverse Event|4|||
163137914|NCT00181766|589213097|FG000|Overall Study|non-compliance|2|||
163137915|NCT00757237|589213102|FG000|Overall Study|Lost to Follow-up|0|||
163137916|NCT00757237|589213103|FG001|Overall Study|Lost to Follow-up|1|||
163137917|NCT00757237|589213102|FG000|Overall Study|Protocol Violation|0|||
163137918|NCT00757237|589213103|FG001|Overall Study|Protocol Violation|2|||
163137919|NCT00757237|589213102|FG000|Overall Study|Physician Decision|2|||
163137920|NCT00757237|589213103|FG001|Overall Study|Physician Decision|3|||
163137921|NCT00757237|589213102|FG000|Overall Study|Withdrawal by Subject|8|||
163137922|NCT00757237|589213103|FG001|Overall Study|Withdrawal by Subject|12|||
163137923|NCT00757237|589213102|FG000|Overall Study|Safety or Tolerability|3|||
163137924|NCT00757237|589213103|FG001|Overall Study|Safety or Tolerability|5|||
162659543|NCT02751983|587465943|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
162659544|NCT02167256|587465944|FG000|Overall Study|Adverse Event|13|||
162659545|NCT02167256|587465945|FG001|Overall Study|Adverse Event|6|||
162659546|NCT02167256|587465944|FG000|Overall Study|Withdrawal by Subject|4|||
162659547|NCT02167256|587465945|FG001|Overall Study|Withdrawal by Subject|4|||
162659548|NCT02167256|587465944|FG000|Overall Study|non-compliance|3|||
162659549|NCT02167256|587465945|FG001|Overall Study|non-compliance|0|||
162659550|NCT02167256|587465944|FG000|Overall Study|Study partner unable to participate|1|||
162659551|NCT02167256|587465945|FG001|Overall Study|Study partner unable to participate|0|||
162659552|NCT03467425|587465946|FG000|Overall Study|Adverse Event|9|||
162659553|NCT03467425|587465947|FG001|Overall Study|Adverse Event|9|||
162659554|NCT03467425|587465946|FG000|Overall Study|Lack of Efficacy|3|||
162659555|NCT03467425|587465947|FG001|Overall Study|Lack of Efficacy|1|||
162659556|NCT03467425|587465946|FG000|Overall Study|Protocol Violation|0|||
162659557|NCT03467425|587465947|FG001|Overall Study|Protocol Violation|1|||
162659558|NCT03467425|587465946|FG000|Overall Study|Lost to Follow-up|18|||
162659559|NCT03467425|587465947|FG001|Overall Study|Lost to Follow-up|25|||
162659560|NCT03467425|587465946|FG000|Overall Study|Physician Decision|2|||
162659561|NCT03467425|587465947|FG001|Overall Study|Physician Decision|1|||
162659562|NCT03467425|587465946|FG000|Overall Study|Withdrawal by Subject|15|||
162659563|NCT03467425|587465947|FG001|Overall Study|Withdrawal by Subject|17|||
162659564|NCT00025883|587465948|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
162659565|NCT00025883|587465948|FG000|Overall Study|no baseline data|1|||
162659566|NCT00025883|587465948|FG000|Overall Study|Death|1|||
162659567|NCT00025883|587465948|FG000|Overall Study|Adverse Event|1|||
162659568|NCT00025883|587465948|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
162659569|NCT02920983|587465949|FG000|Dispense 1|Unacceptable Lens Fit|0|||
162659570|NCT02920983|587465950|FG001|Dispense 1|Unacceptable Lens Fit|0|||
162659571|NCT02920983|587465951|FG002|Dispense 1|Unacceptable Lens Fit|0|||
162659572|NCT02920983|587465952|FG003|Dispense 1|Unacceptable Lens Fit|0|||
162659573|NCT02920983|587465953|FG004|Dispense 1|Unacceptable Lens Fit|1|||
162659574|NCT02920983|587465954|FG005|Dispense 1|Unacceptable Lens Fit|0|||
162659575|NCT02920983|587465949|FG000|Dispense 2|Unscceptable lens fit|1|||
162659576|NCT02920983|587465950|FG001|Dispense 2|Unscceptable lens fit|0|||
162659577|NCT02920983|587465951|FG002|Dispense 2|Unscceptable lens fit|0|||
162659578|NCT02920983|587465952|FG003|Dispense 2|Unscceptable lens fit|0|||
162659579|NCT02920983|587465953|FG004|Dispense 2|Unscceptable lens fit|1|||
162659580|NCT02920983|587465954|FG005|Dispense 2|Unscceptable lens fit|0|||
162659581|NCT02920983|587465949|FG000|Dispense 3|Unacceptable Lens Fit|1|||
162659582|NCT02920983|587465950|FG001|Dispense 3|Unacceptable Lens Fit|1|||
162659583|NCT02920983|587465951|FG002|Dispense 3|Unacceptable Lens Fit|0|||
162659584|NCT02920983|587465952|FG003|Dispense 3|Unacceptable Lens Fit|0|||
162659585|NCT02920983|587465953|FG004|Dispense 3|Unacceptable Lens Fit|1|||
162659586|NCT02920983|587465954|FG005|Dispense 3|Unacceptable Lens Fit|0|||
162659587|NCT01451424|587465955|FG000|Overall Study|Withdrawal by Subject|1|||
162659588|NCT01451424|587465956|FG001|Overall Study|Withdrawal by Subject|1|||
162659589|NCT01451424|587465957|FG002|Overall Study|Withdrawal by Subject|0|||
162659590|NCT01451424|587465958|FG003|Overall Study|Withdrawal by Subject|2|||
162659591|NCT01451424|587465955|FG000|Overall Study|Lost to Follow-up|0|||
162659592|NCT01451424|587465956|FG001|Overall Study|Lost to Follow-up|1|||
162659593|NCT01451424|587465957|FG002|Overall Study|Lost to Follow-up|0|||
162659594|NCT01451424|587465958|FG003|Overall Study|Lost to Follow-up|1|||
162659595|NCT01451424|587465955|FG000|Overall Study|Physician Decision|0|||
162659596|NCT01451424|587465956|FG001|Overall Study|Physician Decision|0|||
162659597|NCT01451424|587465957|FG002|Overall Study|Physician Decision|1|||
162659598|NCT01451424|587465958|FG003|Overall Study|Physician Decision|1|||
162659599|NCT01451424|587465955|FG000|Overall Study|Adverse Event|0|||
162659600|NCT01451424|587465956|FG001|Overall Study|Adverse Event|0|||
162659601|NCT01451424|587465957|FG002|Overall Study|Adverse Event|0|||
162659602|NCT01451424|587465958|FG003|Overall Study|Adverse Event|1|||
162659603|NCT01387607|587465964|FG000|Overall Study|Adverse Event|23|||
162659604|NCT01387607|587465965|FG001|Overall Study|Adverse Event|11|||
162659605|NCT01387607|587465964|FG000|Overall Study|Lack of Efficacy|8|||
162659606|NCT01387607|587465965|FG001|Overall Study|Lack of Efficacy|6|||
162659607|NCT01387607|587465964|FG000|Overall Study|Lost to Follow-up|2|||
163137925|NCT00757237|589213102|FG000|Overall Study|Other|0|||
163137926|NCT00757237|589213103|FG001|Overall Study|Other|2|||
163137927|NCT01843023|589213104|FG000|Overall Study|Death|1|||
163137928|NCT01843023|589213105|FG001|Overall Study|Death|0|||
163137929|NCT01843023|589213104|FG000|Overall Study|Lost to Follow-up|24|||
163137930|NCT01843023|589213105|FG001|Overall Study|Lost to Follow-up|29|||
163137931|NCT01843023|589213104|FG000|Overall Study|Withdrawal by Subject|8|||
163137932|NCT01843023|589213105|FG001|Overall Study|Withdrawal by Subject|6|||
163137933|NCT01397461|589213107|FG000|Overall Study|Withdrawal by Subject|2|||
162659608|NCT01387607|587465965|FG001|Overall Study|Lost to Follow-up|1|||
162659609|NCT01387607|587465964|FG000|Overall Study|No longer meets eligibility criteria|0|||
162659610|NCT01387607|587465965|FG001|Overall Study|No longer meets eligibility criteria|1|||
162659611|NCT01387607|587465964|FG000|Overall Study|Protocol Violation|1|||
162659612|NCT01387607|587465965|FG001|Overall Study|Protocol Violation|5|||
162659613|NCT01387607|587465964|FG000|Overall Study|Withdrawal by Subject|13|||
163137934|NCT01397461|589213108|FG001|Overall Study|Withdrawal by Subject|1|||
163137935|NCT01397461|589213109|FG002|Overall Study|Withdrawal by Subject|0|||
163137936|NCT01397461|589213107|FG000|Overall Study|Lost to Follow-up|0|||
163137937|NCT01397461|589213108|FG001|Overall Study|Lost to Follow-up|2|||
163137938|NCT01397461|589213109|FG002|Overall Study|Lost to Follow-up|1|||
163137939|NCT01397461|589213107|FG000|Overall Study|Lack of Efficacy|0|||
163137940|NCT01397461|589213108|FG001|Overall Study|Lack of Efficacy|3|||
163137941|NCT01397461|589213109|FG002|Overall Study|Lack of Efficacy|0|||
163137942|NCT01397461|589213107|FG000|Overall Study|Not treated|0|||
162659614|NCT01387607|587465965|FG001|Overall Study|Withdrawal by Subject|14|||
162659615|NCT01387607|587465964|FG000|Overall Study|Other|1|||
162659616|NCT01387607|587465965|FG001|Overall Study|Other|1|||
162659617|NCT01387607|587465964|FG000|Overall Study|Randomized, not treated|3|||
163137943|NCT01397461|589213108|FG001|Overall Study|Not treated|0|||
162659618|NCT01387607|587465965|FG001|Overall Study|Randomized, not treated|6|||
163137944|NCT01397461|589213109|FG002|Overall Study|Not treated|1|||
163137945|NCT04980612|589213126|FG000|Overall Study|Withdrawal by Subject|7|||
162659619|NCT03665038|587465966|FG000|Overall Study|Lost to Follow-up|0|||
162659620|NCT03665038|587465967|FG001|Overall Study|Lost to Follow-up|0|||
163137946|NCT04980612|589213127|FG001|Overall Study|Withdrawal by Subject|5|||
163137947|NCT05730387|589213128|FG000|Overall Study|Stillbirth|0|||
163137948|NCT05730387|589213129|FG001|Overall Study|Stillbirth|262|||
163137949|NCT05730387|589213128|FG000|Overall Study|Died during or after delivery|2|||
163137950|NCT05730387|589213129|FG001|Overall Study|Died during or after delivery|85|||
163137951|NCT05730387|589213128|FG000|Overall Study|Died after being admitted|0|||
163137952|NCT05730387|589213129|FG001|Overall Study|Died after being admitted|44|||
163137953|NCT05730387|589213128|FG000|Overall Study|Lost to Follow-up|69|||
163137954|NCT05730387|589213129|FG001|Overall Study|Lost to Follow-up|77|||
163137955|NCT03364738|589213132|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
163137956|NCT03364738|589213132|FG000|Overall Study|Withdrawal by Subject|1|||
163137957|NCT03364738|589213132|FG000|Overall Study|Adverse Event|1|||
163137958|NCT03245398|589213133|FG000|Overall Study|Travelled to another island|1|||
163137959|NCT03245398|589213134|FG001|Overall Study|Travelled to another island|0|||
163137960|NCT00637416|589213138|FG000|Overall Study|Lost to Follow-up|1|||
163137961|NCT00637416|589213139|FG001|Overall Study|Lost to Follow-up|1|||
163137962|NCT00637416|589213138|FG000|Overall Study|Unable to take study drug|0|||
163137963|NCT00637416|589213139|FG001|Overall Study|Unable to take study drug|1|||
163137964|NCT04137731|589213142|FG000|Overall Study|Surgery Cancellation|1|||
163137965|NCT04137731|589213143|FG001|Overall Study|Surgery Cancellation|2|||
163137966|NCT04137731|589213142|FG000|Overall Study|Withdrawal by Subject|2|||
163137967|NCT04137731|589213143|FG001|Overall Study|Withdrawal by Subject|0|||
163137968|NCT04137731|589213142|FG000|Overall Study|Protocol Violation|0|||
163137969|NCT04137731|589213143|FG001|Overall Study|Protocol Violation|1|||
163137970|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
163137971|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
163137972|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
163137973|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
163137974|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
163137975|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
163137976|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
163137977|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
163137978|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
163137979|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
163137980|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
163137981|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
163137982|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
163137983|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
163137984|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
163137985|NCT02204072|589213148|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137986|NCT02204072|589213149|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137987|NCT02204072|589213150|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
163137988|NCT02204072|589213151|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137989|NCT02204072|589213152|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
163137990|NCT00310817|589213153|FG000|Overall Study|AE or Death|3|||
163137991|NCT00310817|589213154|FG001|Overall Study|AE or Death|1|||
163137992|NCT00310817|589213155|FG002|Overall Study|AE or Death|0|||
163137993|NCT00310817|589213156|FG003|Overall Study|AE or Death|0|||
163137994|NCT00310817|589213153|FG000|Overall Study|Withdrawal by Subject|1|||
163137995|NCT00310817|589213154|FG001|Overall Study|Withdrawal by Subject|4|||
163137996|NCT00310817|589213155|FG002|Overall Study|Withdrawal by Subject|6|||
163137997|NCT00310817|589213156|FG003|Overall Study|Withdrawal by Subject|7|||
163137998|NCT00310817|589213153|FG000|Overall Study|Lost to Follow-up|2|||
163137999|NCT00310817|589213154|FG001|Overall Study|Lost to Follow-up|1|||
163138000|NCT00310817|589213155|FG002|Overall Study|Lost to Follow-up|0|||
163138001|NCT00310817|589213156|FG003|Overall Study|Lost to Follow-up|0|||
163138002|NCT00310817|589213153|FG000|Overall Study|Inappropriate Enrollment|1|||
163138003|NCT00310817|589213154|FG001|Overall Study|Inappropriate Enrollment|0|||
163138004|NCT00310817|589213155|FG002|Overall Study|Inappropriate Enrollment|1|||
163138005|NCT00310817|589213156|FG003|Overall Study|Inappropriate Enrollment|0|||
163138006|NCT00310817|589213153|FG000|Overall Study|Protocol Violation|1|||
163138007|NCT00310817|589213154|FG001|Overall Study|Protocol Violation|1|||
163138008|NCT00310817|589213155|FG002|Overall Study|Protocol Violation|1|||
163138009|NCT00310817|589213156|FG003|Overall Study|Protocol Violation|1|||
163138010|NCT00310817|589213153|FG000|Overall Study|Unable to classify|3|||
163138011|NCT00310817|589213154|FG001|Overall Study|Unable to classify|1|||
163138012|NCT00310817|589213155|FG002|Overall Study|Unable to classify|0|||
163138013|NCT00310817|589213156|FG003|Overall Study|Unable to classify|0|||
163138014|NCT01587040|589213162|FG000|Overall Study|Protocol Violation|0|||
163138015|NCT01587040|589213163|FG001|Overall Study|Protocol Violation|0|||
163138016|NCT01587040|589213164|FG002|Overall Study|Protocol Violation|1|||
163138017|NCT01587040|589213165|FG003|Overall Study|Protocol Violation|0|||
163138018|NCT01587040|589213162|FG000|Overall Study|Adverse Event|0|||
163138019|NCT01587040|589213163|FG001|Overall Study|Adverse Event|1|||
163138020|NCT01587040|589213164|FG002|Overall Study|Adverse Event|10|||
163138021|NCT01587040|589213165|FG003|Overall Study|Adverse Event|0|||
163138022|NCT01587040|589213162|FG000|Overall Study|Disease progression|12|||
163138023|NCT01587040|589213163|FG001|Overall Study|Disease progression|1|||
163138024|NCT01587040|589213164|FG002|Overall Study|Disease progression|15|||
163138025|NCT01587040|589213165|FG003|Overall Study|Disease progression|3|||
163138026|NCT01587040|589213162|FG000|Overall Study|Other than specified|5|||
163138027|NCT01587040|589213163|FG001|Overall Study|Other than specified|1|||
163138028|NCT01587040|589213164|FG002|Overall Study|Other than specified|11|||
163138029|NCT01587040|589213165|FG003|Overall Study|Other than specified|1|||
163138030|NCT00367835|589213169|FG000|Overall Study|Adverse Event|14|||
163138031|NCT00367835|589213170|FG001|Overall Study|Adverse Event|1|||
163138032|NCT00367835|589213169|FG000|Overall Study|Protocol Violation|1|||
163138033|NCT00367835|589213170|FG001|Overall Study|Protocol Violation|7|||
163138034|NCT00367835|589213169|FG000|Overall Study|Withdrawal by Subject|7|||
163138035|NCT00367835|589213170|FG001|Overall Study|Withdrawal by Subject|6|||
163138036|NCT00367835|589213169|FG000|Overall Study|Lost to Follow-up|1|||
163138037|NCT00367835|589213170|FG001|Overall Study|Lost to Follow-up|4|||
163138038|NCT00367835|589213169|FG000|Overall Study|Lack of Efficacy|3|||
163138039|NCT00367835|589213170|FG001|Overall Study|Lack of Efficacy|12|||
163138040|NCT00367835|589213169|FG000|Overall Study|Subject in juvenile detention center|1|||
163138041|NCT00367835|589213170|FG001|Overall Study|Subject in juvenile detention center|0|||
163138042|NCT00367835|589213169|FG000|Overall Study|refused blood collection|1|||
163138043|NCT00367835|589213170|FG001|Overall Study|refused blood collection|0|||
163138044|NCT00367835|589213169|FG000|Overall Study|Did not respond to calls|1|||
163138045|NCT00367835|589213170|FG001|Overall Study|Did not respond to calls|0|||
163138046|NCT00367835|589213169|FG000|Overall Study|History of lead poisoning|0|||
163138047|NCT00367835|589213170|FG001|Overall Study|History of lead poisoning|1|||
163138048|NCT04346654|589213172|FG000|Overall Study|Adverse Event|2|||
163138049|NCT04346654|589213173|FG001|Overall Study|Adverse Event|0|||
163138050|NCT04346654|589213172|FG000|Overall Study|Non-response|1|||
163138051|NCT04346654|589213173|FG001|Overall Study|Non-response|1|||
163138052|NCT04346654|589213172|FG000|Overall Study|Withdrawal by Subject|2|||
163138053|NCT04346654|589213173|FG001|Overall Study|Withdrawal by Subject|0|||
163138054|NCT04346654|589213172|FG000|Overall Study|Lost to Follow-up|0|||
162659621|NCT03665038|587465968|FG002|Overall Study|Lost to Follow-up|1|||
162659622|NCT03013491|587465969|FG000|Main Study|Death|2|||
162659623|NCT03013491|587465970|FG001|Main Study|Death|2|||
162659624|NCT03013491|587465971|FG002|Main Study|Death|5|||
163138055|NCT04346654|589213173|FG001|Overall Study|Lost to Follow-up|1|||
163138056|NCT04346654|589213172|FG000|Overall Study|Pregnancy|0|||
163138057|NCT04346654|589213173|FG001|Overall Study|Pregnancy|1|||
163138058|NCT00999518|589213177|FG000|Overall Study|Adverse Event|1|||
163138059|NCT00999518|589213178|FG001|Overall Study|Adverse Event|6|||
162659625|NCT03013491|587465972|FG003|Main Study|Death|3|||
163138060|NCT00999518|589213179|FG002|Overall Study|Adverse Event|3|||
163138061|NCT00999518|589213180|FG003|Overall Study|Adverse Event|1|||
163138062|NCT00999518|589213181|FG004|Overall Study|Adverse Event|2|||
163138063|NCT00999518|589213177|FG000|Overall Study|Lack of Efficacy|2|||
163138064|NCT00999518|589213178|FG001|Overall Study|Lack of Efficacy|0|||
163138065|NCT00999518|589213179|FG002|Overall Study|Lack of Efficacy|0|||
163138066|NCT00999518|589213180|FG003|Overall Study|Lack of Efficacy|2|||
163138067|NCT00999518|589213181|FG004|Overall Study|Lack of Efficacy|2|||
163138068|NCT00999518|589213177|FG000|Overall Study|Lost to Follow-up|0|||
163138069|NCT00999518|589213178|FG001|Overall Study|Lost to Follow-up|0|||
163138070|NCT00999518|589213179|FG002|Overall Study|Lost to Follow-up|0|||
163138071|NCT00999518|589213180|FG003|Overall Study|Lost to Follow-up|4|||
163138072|NCT00999518|589213181|FG004|Overall Study|Lost to Follow-up|1|||
163138073|NCT00999518|589213177|FG000|Overall Study|Did not meet entrance criteria|0|||
163138074|NCT00999518|589213178|FG001|Overall Study|Did not meet entrance criteria|0|||
163138075|NCT00999518|589213179|FG002|Overall Study|Did not meet entrance criteria|0|||
163138076|NCT00999518|589213180|FG003|Overall Study|Did not meet entrance criteria|0|||
163138077|NCT00999518|589213181|FG004|Overall Study|Did not meet entrance criteria|1|||
163138078|NCT00999518|589213177|FG000|Overall Study|Study terminated by sponsor|10|||
163138079|NCT00999518|589213178|FG001|Overall Study|Study terminated by sponsor|6|||
163138080|NCT00999518|589213179|FG002|Overall Study|Study terminated by sponsor|5|||
163138081|NCT00999518|589213180|FG003|Overall Study|Study terminated by sponsor|5|||
163138082|NCT00999518|589213181|FG004|Overall Study|Study terminated by sponsor|9|||
163138083|NCT00999518|589213177|FG000|Overall Study|Pregnancy|0|||
163138084|NCT00999518|589213178|FG001|Overall Study|Pregnancy|0|||
163138085|NCT00999518|589213179|FG002|Overall Study|Pregnancy|1|||
163138086|NCT00999518|589213180|FG003|Overall Study|Pregnancy|0|||
163138087|NCT00999518|589213181|FG004|Overall Study|Pregnancy|0|||
163138088|NCT00999518|589213177|FG000|Overall Study|Protocol Violation|0|||
163138089|NCT00999518|589213178|FG001|Overall Study|Protocol Violation|1|||
163138090|NCT00999518|589213179|FG002|Overall Study|Protocol Violation|0|||
163138091|NCT00999518|589213180|FG003|Overall Study|Protocol Violation|0|||
163138092|NCT00999518|589213181|FG004|Overall Study|Protocol Violation|2|||
163138093|NCT00999518|589213177|FG000|Overall Study|Withdrawal by Subject|5|||
163138094|NCT00999518|589213178|FG001|Overall Study|Withdrawal by Subject|4|||
163138095|NCT00999518|589213179|FG002|Overall Study|Withdrawal by Subject|10|||
163138096|NCT00999518|589213180|FG003|Overall Study|Withdrawal by Subject|6|||
163138097|NCT00999518|589213181|FG004|Overall Study|Withdrawal by Subject|1|||
163138098|NCT00999518|589213177|FG000|Overall Study|Other|5|||
163138099|NCT00999518|589213178|FG001|Overall Study|Other|7|||
163138100|NCT00999518|589213179|FG002|Overall Study|Other|1|||
163138101|NCT00999518|589213180|FG003|Overall Study|Other|4|||
163138102|NCT00999518|589213181|FG004|Overall Study|Other|5|||
163138103|NCT00999518|589213177|FG000|Overall Study|Randomized but not Treated|1|||
163138104|NCT00999518|589213178|FG001|Overall Study|Randomized but not Treated|1|||
163138105|NCT00999518|589213179|FG002|Overall Study|Randomized but not Treated|2|||
163138106|NCT00999518|589213180|FG003|Overall Study|Randomized but not Treated|0|||
163138107|NCT00999518|589213181|FG004|Overall Study|Randomized but not Treated|1|||
163138108|NCT01811186|589213182|FG000|Overall Study|Adverse Event|54|||
163138109|NCT01811186|589213183|FG001|Overall Study|Adverse Event|38|||
163138110|NCT01811186|589213182|FG000|Overall Study|Protocol Violation|5|||
163138111|NCT01811186|589213183|FG001|Overall Study|Protocol Violation|6|||
163138112|NCT01811186|589213182|FG000|Overall Study|Withdrawal by Subject|5|||
163138113|NCT01811186|589213183|FG001|Overall Study|Withdrawal by Subject|10|||
163138114|NCT01811186|589213182|FG000|Overall Study|Lack of Efficacy|3|||
163138115|NCT01811186|589213183|FG001|Overall Study|Lack of Efficacy|6|||
163138116|NCT01811186|589213182|FG000|Overall Study|Lost to Follow-up|4|||
163138117|NCT01811186|589213183|FG001|Overall Study|Lost to Follow-up|2|||
163138118|NCT01445080|589213188|FG000|Overall Study|Adverse Event|5|||
163138119|NCT01445080|589213189|FG001|Overall Study|Adverse Event|3|||
163138120|NCT01445080|589213190|FG002|Overall Study|Adverse Event|11|||
163138121|NCT01445080|589213191|FG003|Overall Study|Adverse Event|6|||
163138122|NCT01445080|589213192|FG004|Overall Study|Adverse Event|2|||
163138123|NCT01445080|589213193|FG005|Overall Study|Adverse Event|3|||
163138124|NCT01445080|589213194|FG006|Overall Study|Adverse Event|0|||
163138125|NCT01445080|589213195|FG007|Overall Study|Adverse Event|3|||
163138126|NCT01445080|589213196|FG008|Overall Study|Adverse Event|10|||
163138127|NCT01445080|589213188|FG000|Overall Study|Physician Decision|0|||
163138128|NCT01445080|589213189|FG001|Overall Study|Physician Decision|0|||
163138129|NCT01445080|589213190|FG002|Overall Study|Physician Decision|1|||
163138130|NCT01445080|589213191|FG003|Overall Study|Physician Decision|0|||
163138131|NCT01445080|589213192|FG004|Overall Study|Physician Decision|0|||
163138132|NCT01445080|589213193|FG005|Overall Study|Physician Decision|3|||
163138133|NCT01445080|589213194|FG006|Overall Study|Physician Decision|2|||
163138134|NCT01445080|589213195|FG007|Overall Study|Physician Decision|2|||
163138135|NCT01445080|589213196|FG008|Overall Study|Physician Decision|0|||
163138136|NCT01445080|589213188|FG000|Overall Study|Withdrawal by Subject|1|||
163138137|NCT01445080|589213189|FG001|Overall Study|Withdrawal by Subject|0|||
163138138|NCT01445080|589213190|FG002|Overall Study|Withdrawal by Subject|0|||
163138139|NCT01445080|589213191|FG003|Overall Study|Withdrawal by Subject|1|||
163138140|NCT01445080|589213192|FG004|Overall Study|Withdrawal by Subject|0|||
163138141|NCT01445080|589213193|FG005|Overall Study|Withdrawal by Subject|0|||
163138142|NCT01445080|589213194|FG006|Overall Study|Withdrawal by Subject|0|||
163138143|NCT01445080|589213195|FG007|Overall Study|Withdrawal by Subject|0|||
163138144|NCT01445080|589213196|FG008|Overall Study|Withdrawal by Subject|2|||
163138145|NCT01445080|589213188|FG000|Overall Study|Ineligible/Inevaluable|1|||
163138146|NCT01445080|589213189|FG001|Overall Study|Ineligible/Inevaluable|2|||
163138147|NCT01445080|589213190|FG002|Overall Study|Ineligible/Inevaluable|0|||
163138148|NCT01445080|589213191|FG003|Overall Study|Ineligible/Inevaluable|1|||
163138149|NCT01445080|589213192|FG004|Overall Study|Ineligible/Inevaluable|2|||
163138150|NCT01445080|589213193|FG005|Overall Study|Ineligible/Inevaluable|3|||
163138151|NCT01445080|589213194|FG006|Overall Study|Ineligible/Inevaluable|0|||
163138152|NCT01445080|589213195|FG007|Overall Study|Ineligible/Inevaluable|0|||
163138153|NCT01445080|589213196|FG008|Overall Study|Ineligible/Inevaluable|6|||
163138154|NCT03887221|589213197|FG000|Overall Study|Protocol Violation|1|||
163138155|NCT03887221|589213198|FG001|Overall Study|Protocol Violation|0|||
163138156|NCT02123576|589213199|FG000|Overall Study|Adverse Event|1|||
163138157|NCT02123576|589213200|FG001|Overall Study|Adverse Event|0|||
163138158|NCT04864639|589215005|FG000|Overall Study|Death|1|||
163138159|NCT04864639|589215005|FG000|Overall Study|Lost to Follow-up|1|||
163138160|NCT04050618|589215006|FG000|First Intervention|Withdrawal by Subject|2|||
163138161|NCT04050618|589215007|FG001|First Intervention|Withdrawal by Subject|0|||
163138162|NCT04050618|589215006|FG000|Second Intervention|Withdrawal by Subject|1|||
163138163|NCT04050618|589215007|FG001|Second Intervention|Withdrawal by Subject|0|||
163138164|NCT01101035|589215014|FG000|Overall Study|Adverse Event|191|||
163138165|NCT01101035|589215015|FG001|Overall Study|Adverse Event|172|||
163138166|NCT01101035|589215014|FG000|Overall Study|Major Protocol Deviation|52|||
163138167|NCT01101035|589215015|FG001|Overall Study|Major Protocol Deviation|46|||
163138168|NCT01101035|589215014|FG000|Overall Study|Lost to Follow-up|226|||
163138169|NCT01101035|589215015|FG001|Overall Study|Lost to Follow-up|223|||
163138170|NCT01101035|589215014|FG000|Overall Study|Voluntary Withdrawal|595|||
163138171|NCT01101035|589215015|FG001|Overall Study|Voluntary Withdrawal|587|||
163138172|NCT01101035|589215014|FG000|Overall Study|Reason not Specified|333|||
163138173|NCT01101035|589215015|FG001|Overall Study|Reason not Specified|363|||
163138174|NCT00713544|589215024|FG000|Overall Study|Adverse Event|5|||
163138175|NCT00713544|589215025|FG001|Overall Study|Adverse Event|3|||
163138176|NCT00713544|589215026|FG002|Overall Study|Adverse Event|7|||
163138177|NCT00713544|589215027|FG003|Overall Study|Adverse Event|7|||
162659626|NCT03013491|587465973|FG004|Main Study|Death|9|||
162659627|NCT03013491|587465974|FG005|Main Study|Death|12|||
162659628|NCT03013491|587465975|FG006|Main Study|Death|3|||
162659629|NCT03013491|587465976|FG007|Main Study|Death|5|||
162659630|NCT03013491|587465977|FG008|Main Study|Death|1|||
162659631|NCT03013491|587465978|FG009|Main Study|Death|2|||
162659632|NCT03013491|587465979|FG010|Main Study|Death|4|||
162659633|NCT03013491|587465980|FG011|Main Study|Death|1|||
162659634|NCT03013491|587465981|FG012|Main Study|Death|1|||
162659635|NCT03013491|587465982|FG013|Main Study|Death|4|||
162659636|NCT03013491|587465983|FG014|Main Study|Death|0|||
162659637|NCT03013491|587465984|FG015|Main Study|Death|3|||
162659638|NCT03013491|587465985|FG016|Main Study|Death|5|||
162659639|NCT03013491|587465986|FG017|Main Study|Death|1|||
162659640|NCT03013491|587465987|FG018|Main Study|Death|47|||
162659641|NCT03013491|587465969|FG000|Main Study|Lost to Follow-up|0|||
162659642|NCT03013491|587465970|FG001|Main Study|Lost to Follow-up|0|||
162659643|NCT03013491|587465971|FG002|Main Study|Lost to Follow-up|1|||
162659644|NCT03013491|587465972|FG003|Main Study|Lost to Follow-up|0|||
162659645|NCT03013491|587465973|FG004|Main Study|Lost to Follow-up|1|||
162659646|NCT03013491|587465974|FG005|Main Study|Lost to Follow-up|0|||
162659647|NCT03013491|587465975|FG006|Main Study|Lost to Follow-up|0|||
162659648|NCT03013491|587465976|FG007|Main Study|Lost to Follow-up|0|||
162659649|NCT03013491|587465977|FG008|Main Study|Lost to Follow-up|0|||
162659650|NCT03013491|587465978|FG009|Main Study|Lost to Follow-up|0|||
162659651|NCT03013491|587465979|FG010|Main Study|Lost to Follow-up|0|||
162659652|NCT03013491|587465980|FG011|Main Study|Lost to Follow-up|0|||
162659653|NCT03013491|587465981|FG012|Main Study|Lost to Follow-up|0|||
162659654|NCT03013491|587465982|FG013|Main Study|Lost to Follow-up|0|||
162659655|NCT03013491|587465983|FG014|Main Study|Lost to Follow-up|0|||
162720209|NCT01802632|587682489|FG005|Overall Study|Withdrawal by Subject|1|||
162720210|NCT01802632|587682484|FG000|Overall Study|Objective Disease Progression|1|||
162720211|NCT01802632|587682485|FG001|Overall Study|Objective Disease Progression|12|||
162720212|NCT01802632|587682486|FG002|Overall Study|Objective Disease Progression|104|||
162720213|NCT01802632|587682487|FG003|Overall Study|Objective Disease Progression|6|||
162720214|NCT01802632|587682488|FG004|Overall Study|Objective Disease Progression|4|||
162720215|NCT01802632|587682489|FG005|Overall Study|Objective Disease Progression|4|||
162720216|NCT01802632|587682484|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
162720217|NCT01802632|587682485|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
162720218|NCT01802632|587682486|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
162720219|NCT01802632|587682487|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
162720220|NCT01802632|587682488|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
162720221|NCT01802632|587682489|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
162720222|NCT01802632|587682484|FG000|Overall Study|Other (not specified)|0|||
162720223|NCT01802632|587682485|FG001|Overall Study|Other (not specified)|0|||
162720224|NCT01802632|587682486|FG002|Overall Study|Other (not specified)|7|||
162720225|NCT01802632|587682487|FG003|Overall Study|Other (not specified)|1|||
162720226|NCT01802632|587682488|FG004|Overall Study|Other (not specified)|0|||
162720227|NCT01802632|587682489|FG005|Overall Study|Other (not specified)|1|||
162720228|NCT03299816|587682490|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
162720229|NCT03299816|587682491|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
162720230|NCT03299816|587682490|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
162720231|NCT03299816|587682491|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
162720232|NCT03299816|587682490|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
162720233|NCT03299816|587682491|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
162720234|NCT01184508|587682493|FG000|Overall Study|Adverse Event|4|||
162720235|NCT01184508|587682494|FG001|Overall Study|Adverse Event|6|||
162720236|NCT01184508|587682493|FG000|Overall Study|Lack of Efficacy|1|||
162720237|NCT01184508|587682494|FG001|Overall Study|Lack of Efficacy|1|||
162720238|NCT01184508|587682493|FG000|Overall Study|Lost to Follow-up|1|||
162720239|NCT01184508|587682494|FG001|Overall Study|Lost to Follow-up|1|||
162720240|NCT01184508|587682493|FG000|Overall Study|Physician Decision|1|||
162720241|NCT01184508|587682494|FG001|Overall Study|Physician Decision|0|||
162720242|NCT01184508|587682493|FG000|Overall Study|Protocol Violation|3|||
162720243|NCT01184508|587682494|FG001|Overall Study|Protocol Violation|1|||
162720244|NCT01184508|587682493|FG000|Overall Study|Sponsor Decision|5|||
162720245|NCT01184508|587682494|FG001|Overall Study|Sponsor Decision|2|||
162720246|NCT01184508|587682493|FG000|Overall Study|Withdrawal by Subject|1|||
162720247|NCT01184508|587682494|FG001|Overall Study|Withdrawal by Subject|3|||
162720248|NCT01184508|587682493|FG000|Overall Study|Randomized, Not Treated|0|||
162720249|NCT01184508|587682494|FG001|Overall Study|Randomized, Not Treated|1|||
162720250|NCT00790790|587682495|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
162720251|NCT00790790|587682496|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
162720252|NCT00790790|587682497|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
162720253|NCT00790790|587682495|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
163138178|NCT00713544|589215028|FG004|Overall Study|Adverse Event|3|||
163138179|NCT00713544|589215029|FG005|Overall Study|Adverse Event|5|||
163138180|NCT00713544|589215024|FG000|Overall Study|Withdrawal by Subject|2|||
163138181|NCT00713544|589215025|FG001|Overall Study|Withdrawal by Subject|0|||
163138182|NCT00713544|589215026|FG002|Overall Study|Withdrawal by Subject|3|||
163138183|NCT00713544|589215027|FG003|Overall Study|Withdrawal by Subject|2|||
163138184|NCT00713544|589215028|FG004|Overall Study|Withdrawal by Subject|3|||
163138185|NCT00713544|589215029|FG005|Overall Study|Withdrawal by Subject|1|||
163138186|NCT00713544|589215024|FG000|Overall Study|Protocol Violation|0|||
163138187|NCT00713544|589215025|FG001|Overall Study|Protocol Violation|0|||
163138188|NCT00713544|589215026|FG002|Overall Study|Protocol Violation|0|||
163138189|NCT00713544|589215027|FG003|Overall Study|Protocol Violation|0|||
163138190|NCT00713544|589215028|FG004|Overall Study|Protocol Violation|0|||
163138191|NCT00713544|589215029|FG005|Overall Study|Protocol Violation|1|||
163138192|NCT00713544|589215024|FG000|Overall Study|Physician Decision|0|||
163138193|NCT00713544|589215025|FG001|Overall Study|Physician Decision|0|||
163138194|NCT00713544|589215026|FG002|Overall Study|Physician Decision|0|||
163138195|NCT00713544|589215027|FG003|Overall Study|Physician Decision|0|||
163138196|NCT00713544|589215028|FG004|Overall Study|Physician Decision|0|||
163138197|NCT00713544|589215029|FG005|Overall Study|Physician Decision|2|||
163138198|NCT00713544|589215024|FG000|Overall Study|Lack of Efficacy|0|||
162720254|NCT00790790|587682496|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
162720255|NCT00790790|587682497|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
162720256|NCT00790790|587682495|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
162720257|NCT00790790|587682496|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
162720258|NCT00790790|587682497|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
163138199|NCT00713544|589215025|FG001|Overall Study|Lack of Efficacy|1|||
163138200|NCT00713544|589215026|FG002|Overall Study|Lack of Efficacy|0|||
163138201|NCT00713544|589215027|FG003|Overall Study|Lack of Efficacy|1|||
163138202|NCT00713544|589215028|FG004|Overall Study|Lack of Efficacy|1|||
163138203|NCT00713544|589215029|FG005|Overall Study|Lack of Efficacy|0|||
162659656|NCT03013491|587465984|FG015|Main Study|Lost to Follow-up|0|||
162659657|NCT03013491|587465985|FG016|Main Study|Lost to Follow-up|0|||
162659658|NCT03013491|587465986|FG017|Main Study|Lost to Follow-up|0|||
162659659|NCT03013491|587465987|FG018|Main Study|Lost to Follow-up|3|||
162659660|NCT03013491|587465969|FG000|Main Study|Termination of the study by Sponsor|0|||
162659661|NCT03013491|587465970|FG001|Main Study|Termination of the study by Sponsor|0|||
162659662|NCT03013491|587465971|FG002|Main Study|Termination of the study by Sponsor|2|||
162659663|NCT03013491|587465972|FG003|Main Study|Termination of the study by Sponsor|0|||
162659664|NCT03013491|587465973|FG004|Main Study|Termination of the study by Sponsor|1|||
162659665|NCT03013491|587465974|FG005|Main Study|Termination of the study by Sponsor|2|||
162659666|NCT03013491|587465975|FG006|Main Study|Termination of the study by Sponsor|0|||
162659667|NCT03013491|587465976|FG007|Main Study|Termination of the study by Sponsor|0|||
162659668|NCT03013491|587465977|FG008|Main Study|Termination of the study by Sponsor|1|||
162659669|NCT03013491|587465978|FG009|Main Study|Termination of the study by Sponsor|1|||
162659670|NCT03013491|587465979|FG010|Main Study|Termination of the study by Sponsor|1|||
162659671|NCT03013491|587465980|FG011|Main Study|Termination of the study by Sponsor|2|||
162659672|NCT03013491|587465981|FG012|Main Study|Termination of the study by Sponsor|0|||
162659673|NCT03013491|587465982|FG013|Main Study|Termination of the study by Sponsor|0|||
162659674|NCT03013491|587465983|FG014|Main Study|Termination of the study by Sponsor|0|||
162659675|NCT03013491|587465984|FG015|Main Study|Termination of the study by Sponsor|0|||
162659676|NCT03013491|587465985|FG016|Main Study|Termination of the study by Sponsor|0|||
162659677|NCT03013491|587465986|FG017|Main Study|Termination of the study by Sponsor|1|||
162659678|NCT03013491|587465987|FG018|Main Study|Termination of the study by Sponsor|13|||
162659679|NCT03013491|587465969|FG000|Main Study|Withdrawal by Subject|0|||
162659680|NCT03013491|587465970|FG001|Main Study|Withdrawal by Subject|0|||
162659681|NCT03013491|587465971|FG002|Main Study|Withdrawal by Subject|0|||
162659682|NCT03013491|587465972|FG003|Main Study|Withdrawal by Subject|4|||
162659683|NCT03013491|587465973|FG004|Main Study|Withdrawal by Subject|2|||
162659684|NCT03013491|587465974|FG005|Main Study|Withdrawal by Subject|1|||
162659685|NCT03013491|587465975|FG006|Main Study|Withdrawal by Subject|0|||
162659686|NCT03013491|587465976|FG007|Main Study|Withdrawal by Subject|0|||
162659687|NCT03013491|587465977|FG008|Main Study|Withdrawal by Subject|0|||
162659688|NCT03013491|587465978|FG009|Main Study|Withdrawal by Subject|0|||
162659689|NCT03013491|587465979|FG010|Main Study|Withdrawal by Subject|1|||
162659690|NCT03013491|587465980|FG011|Main Study|Withdrawal by Subject|2|||
162659691|NCT03013491|587465981|FG012|Main Study|Withdrawal by Subject|0|||
162659692|NCT03013491|587465982|FG013|Main Study|Withdrawal by Subject|2|||
162659693|NCT03013491|587465983|FG014|Main Study|Withdrawal by Subject|0|||
162659694|NCT03013491|587465984|FG015|Main Study|Withdrawal by Subject|0|||
162659695|NCT03013491|587465985|FG016|Main Study|Withdrawal by Subject|0|||
162659696|NCT03013491|587465986|FG017|Main Study|Withdrawal by Subject|0|||
162659697|NCT03013491|587465987|FG018|Main Study|Withdrawal by Subject|18|||
162659698|NCT03013491|587465969|FG000|Main Study|Disease progression|0|||
162659699|NCT03013491|587465970|FG001|Main Study|Disease progression|0|||
162659700|NCT03013491|587465971|FG002|Main Study|Disease progression|0|||
162659701|NCT03013491|587465972|FG003|Main Study|Disease progression|1|||
162659702|NCT03013491|587465973|FG004|Main Study|Disease progression|0|||
162659703|NCT03013491|587465974|FG005|Main Study|Disease progression|0|||
162659704|NCT03013491|587465975|FG006|Main Study|Disease progression|0|||
162659705|NCT03013491|587465976|FG007|Main Study|Disease progression|0|||
162659706|NCT03013491|587465977|FG008|Main Study|Disease progression|1|||
162659707|NCT03013491|587465978|FG009|Main Study|Disease progression|0|||
162659708|NCT03013491|587465979|FG010|Main Study|Disease progression|1|||
162659709|NCT03013491|587465980|FG011|Main Study|Disease progression|0|||
162659710|NCT03013491|587465981|FG012|Main Study|Disease progression|0|||
162659711|NCT03013491|587465982|FG013|Main Study|Disease progression|0|||
162659712|NCT03013491|587465983|FG014|Main Study|Disease progression|0|||
162659713|NCT03013491|587465984|FG015|Main Study|Disease progression|0|||
162659714|NCT03013491|587465985|FG016|Main Study|Disease progression|0|||
162659715|NCT03013491|587465986|FG017|Main Study|Disease progression|0|||
162659716|NCT03013491|587465987|FG018|Main Study|Disease progression|4|||
162659717|NCT03013491|587465969|FG000|Main Study|Symptomatic deterioration|0|||
162659718|NCT03013491|587465970|FG001|Main Study|Symptomatic deterioration|0|||
162659719|NCT03013491|587465971|FG002|Main Study|Symptomatic deterioration|0|||
162659720|NCT03013491|587465972|FG003|Main Study|Symptomatic deterioration|0|||
162659721|NCT03013491|587465973|FG004|Main Study|Symptomatic deterioration|0|||
162659722|NCT03013491|587465974|FG005|Main Study|Symptomatic deterioration|1|||
162659723|NCT03013491|587465975|FG006|Main Study|Symptomatic deterioration|0|||
162659724|NCT03013491|587465976|FG007|Main Study|Symptomatic deterioration|0|||
162659725|NCT03013491|587465977|FG008|Main Study|Symptomatic deterioration|0|||
162659726|NCT03013491|587465978|FG009|Main Study|Symptomatic deterioration|0|||
162659727|NCT03013491|587465979|FG010|Main Study|Symptomatic deterioration|0|||
162659728|NCT03013491|587465980|FG011|Main Study|Symptomatic deterioration|0|||
162659729|NCT03013491|587465981|FG012|Main Study|Symptomatic deterioration|0|||
162659730|NCT03013491|587465982|FG013|Main Study|Symptomatic deterioration|0|||
162659731|NCT03013491|587465983|FG014|Main Study|Symptomatic deterioration|0|||
162659732|NCT03013491|587465984|FG015|Main Study|Symptomatic deterioration|0|||
162659733|NCT03013491|587465985|FG016|Main Study|Symptomatic deterioration|0|||
162659734|NCT03013491|587465986|FG017|Main Study|Symptomatic deterioration|0|||
162659735|NCT03013491|587465987|FG018|Main Study|Symptomatic deterioration|0|||
162659736|NCT03013491|587465969|FG000|Main Study|Protocol version 8.0 approval|0|||
162659737|NCT03013491|587465970|FG001|Main Study|Protocol version 8.0 approval|0|||
162659738|NCT03013491|587465971|FG002|Main Study|Protocol version 8.0 approval|0|||
162659739|NCT03013491|587465972|FG003|Main Study|Protocol version 8.0 approval|0|||
162659740|NCT03013491|587465973|FG004|Main Study|Protocol version 8.0 approval|0|||
162659741|NCT03013491|587465974|FG005|Main Study|Protocol version 8.0 approval|0|||
162659742|NCT03013491|587465975|FG006|Main Study|Protocol version 8.0 approval|0|||
162659743|NCT03013491|587465976|FG007|Main Study|Protocol version 8.0 approval|0|||
162659744|NCT03013491|587465977|FG008|Main Study|Protocol version 8.0 approval|0|||
162659745|NCT03013491|587465978|FG009|Main Study|Protocol version 8.0 approval|0|||
162659746|NCT03013491|587465979|FG010|Main Study|Protocol version 8.0 approval|1|||
162659747|NCT03013491|587465980|FG011|Main Study|Protocol version 8.0 approval|0|||
162659748|NCT03013491|587465981|FG012|Main Study|Protocol version 8.0 approval|0|||
162659749|NCT03013491|587465982|FG013|Main Study|Protocol version 8.0 approval|0|||
162659750|NCT03013491|587465983|FG014|Main Study|Protocol version 8.0 approval|0|||
162659751|NCT03013491|587465984|FG015|Main Study|Protocol version 8.0 approval|0|||
162659752|NCT03013491|587465985|FG016|Main Study|Protocol version 8.0 approval|0|||
162659753|NCT03013491|587465986|FG017|Main Study|Protocol version 8.0 approval|0|||
162659754|NCT03013491|587465987|FG018|Main Study|Protocol version 8.0 approval|0|||
162659755|NCT03013491|587465969|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
162659756|NCT03013491|587465970|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
162659757|NCT03013491|587465971|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
162659758|NCT03013491|587465972|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
162659759|NCT03013491|587465973|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
162659760|NCT03013491|587465974|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
162659761|NCT03013491|587465975|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
162659762|NCT03013491|587465976|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
162659763|NCT03013491|587465977|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
162659764|NCT03013491|587465978|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
162659765|NCT03013491|587465979|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
162659766|NCT03013491|587465980|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
162659767|NCT03013491|587465981|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
162659768|NCT03013491|587465982|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
162659769|NCT03013491|587465983|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
162659770|NCT03013491|587465984|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
162659771|NCT03013491|587465985|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
162659772|NCT03013491|587465986|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
162659773|NCT03013491|587465987|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
162659774|NCT03013491|587465969|FG000|Main Study|Start of new anticancer therapy|0|||
162659775|NCT03013491|587465970|FG001|Main Study|Start of new anticancer therapy|0|||
162659776|NCT03013491|587465971|FG002|Main Study|Start of new anticancer therapy|0|||
162659777|NCT03013491|587465972|FG003|Main Study|Start of new anticancer therapy|0|||
162659778|NCT03013491|587465973|FG004|Main Study|Start of new anticancer therapy|0|||
162659779|NCT03013491|587465974|FG005|Main Study|Start of new anticancer therapy|0|||
162659780|NCT03013491|587465975|FG006|Main Study|Start of new anticancer therapy|0|||
162659781|NCT03013491|587465976|FG007|Main Study|Start of new anticancer therapy|0|||
163138204|NCT00713544|589215024|FG000|Overall Study|Lost to Follow-up|0|||
163138205|NCT00713544|589215025|FG001|Overall Study|Lost to Follow-up|0|||
163138206|NCT00713544|589215026|FG002|Overall Study|Lost to Follow-up|1|||
163138207|NCT00713544|589215027|FG003|Overall Study|Lost to Follow-up|0|||
163138208|NCT00713544|589215028|FG004|Overall Study|Lost to Follow-up|0|||
163138209|NCT00713544|589215029|FG005|Overall Study|Lost to Follow-up|0|||
163138210|NCT00713544|589215024|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
162659782|NCT03013491|587465977|FG008|Main Study|Start of new anticancer therapy|0|||
162659783|NCT03013491|587465978|FG009|Main Study|Start of new anticancer therapy|0|||
162659784|NCT03013491|587465979|FG010|Main Study|Start of new anticancer therapy|0|||
162659785|NCT03013491|587465980|FG011|Main Study|Start of new anticancer therapy|0|||
162659786|NCT03013491|587465981|FG012|Main Study|Start of new anticancer therapy|0|||
162659787|NCT03013491|587465982|FG013|Main Study|Start of new anticancer therapy|0|||
162659788|NCT03013491|587465983|FG014|Main Study|Start of new anticancer therapy|0|||
162659789|NCT03013491|587465984|FG015|Main Study|Start of new anticancer therapy|0|||
162659790|NCT03013491|587465985|FG016|Main Study|Start of new anticancer therapy|0|||
162659791|NCT03013491|587465986|FG017|Main Study|Start of new anticancer therapy|0|||
162659792|NCT03013491|587465987|FG018|Main Study|Start of new anticancer therapy|2|||
162659793|NCT03013491|587465969|FG000|Long-term Extension|Disease progression|0|||
162659794|NCT03013491|587465970|FG001|Long-term Extension|Disease progression|0|||
162659795|NCT03013491|587465971|FG002|Long-term Extension|Disease progression|0|||
162659796|NCT03013491|587465972|FG003|Long-term Extension|Disease progression|1|||
162659797|NCT03013491|587465973|FG004|Long-term Extension|Disease progression|0|||
162659798|NCT03013491|587465974|FG005|Long-term Extension|Disease progression|0|||
162659799|NCT03013491|587465975|FG006|Long-term Extension|Disease progression|0|||
162659800|NCT03013491|587465976|FG007|Long-term Extension|Disease progression|0|||
162659801|NCT03013491|587465977|FG008|Long-term Extension|Disease progression|0|||
162659802|NCT03013491|587465978|FG009|Long-term Extension|Disease progression|0|||
162659803|NCT03013491|587465979|FG010|Long-term Extension|Disease progression|0|||
162659804|NCT03013491|587465980|FG011|Long-term Extension|Disease progression|0|||
162659805|NCT03013491|587465981|FG012|Long-term Extension|Disease progression|0|||
162659806|NCT03013491|587465982|FG013|Long-term Extension|Disease progression|0|||
162659807|NCT03013491|587465983|FG014|Long-term Extension|Disease progression|0|||
162659808|NCT03013491|587465984|FG015|Long-term Extension|Disease progression|0|||
162659809|NCT03013491|587465985|FG016|Long-term Extension|Disease progression|0|||
162659810|NCT03013491|587465986|FG017|Long-term Extension|Disease progression|0|||
162659811|NCT03013491|587465987|FG018|Long-term Extension|Disease progression|1|||
162659812|NCT03013491|587465969|FG000|Long-term Extension|Withdrawal by Subject|0|||
163138211|NCT00713544|589215025|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
163138212|NCT00713544|589215026|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138213|NCT00713544|589215027|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138214|NCT00713544|589215028|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
163138215|NCT00713544|589215029|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
162659813|NCT03013491|587465970|FG001|Long-term Extension|Withdrawal by Subject|0|||
162659814|NCT03013491|587465971|FG002|Long-term Extension|Withdrawal by Subject|0|||
162659815|NCT03013491|587465972|FG003|Long-term Extension|Withdrawal by Subject|0|||
162659816|NCT03013491|587465973|FG004|Long-term Extension|Withdrawal by Subject|0|||
162659817|NCT03013491|587465974|FG005|Long-term Extension|Withdrawal by Subject|0|||
162659818|NCT03013491|587465975|FG006|Long-term Extension|Withdrawal by Subject|0|||
162659819|NCT03013491|587465976|FG007|Long-term Extension|Withdrawal by Subject|1|||
162659820|NCT03013491|587465977|FG008|Long-term Extension|Withdrawal by Subject|0|||
162659821|NCT03013491|587465978|FG009|Long-term Extension|Withdrawal by Subject|0|||
162659822|NCT03013491|587465979|FG010|Long-term Extension|Withdrawal by Subject|0|||
162659823|NCT03013491|587465980|FG011|Long-term Extension|Withdrawal by Subject|0|||
162659824|NCT03013491|587465981|FG012|Long-term Extension|Withdrawal by Subject|0|||
162659825|NCT03013491|587465982|FG013|Long-term Extension|Withdrawal by Subject|0|||
162659826|NCT03013491|587465983|FG014|Long-term Extension|Withdrawal by Subject|0|||
162659827|NCT03013491|587465984|FG015|Long-term Extension|Withdrawal by Subject|0|||
162659828|NCT03013491|587465985|FG016|Long-term Extension|Withdrawal by Subject|0|||
162659829|NCT03013491|587465986|FG017|Long-term Extension|Withdrawal by Subject|0|||
162659830|NCT03013491|587465987|FG018|Long-term Extension|Withdrawal by Subject|0|||
162659831|NCT03013491|587465969|FG000|Long-term Extension|Adverse Event|0|||
162659832|NCT03013491|587465970|FG001|Long-term Extension|Adverse Event|0|||
162659833|NCT03013491|587465971|FG002|Long-term Extension|Adverse Event|0|||
162659834|NCT03013491|587465972|FG003|Long-term Extension|Adverse Event|0|||
162659835|NCT03013491|587465973|FG004|Long-term Extension|Adverse Event|0|||
162659836|NCT03013491|587465974|FG005|Long-term Extension|Adverse Event|0|||
162659837|NCT03013491|587465975|FG006|Long-term Extension|Adverse Event|0|||
162659838|NCT03013491|587465976|FG007|Long-term Extension|Adverse Event|0|||
162659839|NCT03013491|587465977|FG008|Long-term Extension|Adverse Event|0|||
162659840|NCT03013491|587465978|FG009|Long-term Extension|Adverse Event|0|||
162659841|NCT03013491|587465979|FG010|Long-term Extension|Adverse Event|0|||
162659842|NCT03013491|587465980|FG011|Long-term Extension|Adverse Event|0|||
162659843|NCT03013491|587465981|FG012|Long-term Extension|Adverse Event|0|||
162659844|NCT03013491|587465982|FG013|Long-term Extension|Adverse Event|0|||
162659845|NCT03013491|587465983|FG014|Long-term Extension|Adverse Event|0|||
162659846|NCT03013491|587465984|FG015|Long-term Extension|Adverse Event|0|||
162659847|NCT03013491|587465985|FG016|Long-term Extension|Adverse Event|0|||
162659848|NCT03013491|587465986|FG017|Long-term Extension|Adverse Event|0|||
162659849|NCT03013491|587465987|FG018|Long-term Extension|Adverse Event|1|||
162659850|NCT03013491|587465969|FG000|Long-term Extension|Death|0|||
162659851|NCT03013491|587465970|FG001|Long-term Extension|Death|0|||
162659852|NCT03013491|587465971|FG002|Long-term Extension|Death|0|||
162659853|NCT03013491|587465972|FG003|Long-term Extension|Death|0|||
162659854|NCT03013491|587465973|FG004|Long-term Extension|Death|0|||
162659855|NCT03013491|587465974|FG005|Long-term Extension|Death|0|||
162659856|NCT03013491|587465975|FG006|Long-term Extension|Death|0|||
162659857|NCT03013491|587465976|FG007|Long-term Extension|Death|0|||
162659858|NCT03013491|587465977|FG008|Long-term Extension|Death|0|||
162659859|NCT03013491|587465978|FG009|Long-term Extension|Death|0|||
162659860|NCT03013491|587465979|FG010|Long-term Extension|Death|0|||
162659861|NCT03013491|587465980|FG011|Long-term Extension|Death|0|||
162659862|NCT03013491|587465981|FG012|Long-term Extension|Death|0|||
162659863|NCT03013491|587465982|FG013|Long-term Extension|Death|0|||
162659864|NCT03013491|587465983|FG014|Long-term Extension|Death|0|||
162659865|NCT03013491|587465984|FG015|Long-term Extension|Death|0|||
162659866|NCT03013491|587465985|FG016|Long-term Extension|Death|0|||
162659867|NCT03013491|587465986|FG017|Long-term Extension|Death|0|||
162659868|NCT03013491|587465987|FG018|Long-term Extension|Death|1|||
162659869|NCT02383758|587467854|FG000|Overall Study|Withdrawal by Subject|0|||
162659870|NCT02383758|587467855|FG001|Overall Study|Withdrawal by Subject|2|||
162659871|NCT00827372|587467856|FG000|Overall Study|Adverse Event|5|||
162720259|NCT00790790|587682495|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
162720260|NCT00790790|587682496|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162720261|NCT00790790|587682497|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
162659872|NCT00827372|587467856|FG000|Overall Study|Lack of Efficacy|3|||
162659873|NCT03085927|587467857|FG000|Overall Study|Withdrawal by Subject|1|||
162659874|NCT03085927|587467858|FG001|Overall Study|Withdrawal by Subject|4|||
162659875|NCT03085927|587467857|FG000|Overall Study|Lost to Follow-up|3|||
162659876|NCT03085927|587467858|FG001|Overall Study|Lost to Follow-up|1|||
162659877|NCT03085927|587467857|FG000|Overall Study|Death|1|||
162659878|NCT03085927|587467858|FG001|Overall Study|Death|0|||
162720262|NCT00790790|587682495|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
162659879|NCT03085927|587467857|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
162659880|NCT03085927|587467858|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
162659881|NCT03085927|587467857|FG000|Overall Study|Dyad Became Ineligible|0|||
162659882|NCT03085927|587467858|FG001|Overall Study|Dyad Became Ineligible|1|||
162659883|NCT02564471|587467859|FG000|Overall Study|Adverse Event|1|||
162659884|NCT02564471|587467860|FG001|Overall Study|Adverse Event|0|||
162659885|NCT02564471|587467861|FG002|Overall Study|Adverse Event|0|||
162659886|NCT02564471|587467862|FG003|Overall Study|Adverse Event|0|||
162659887|NCT02564471|587467859|FG000|Overall Study|Withdrawal by Subject|2|||
162659888|NCT02564471|587467860|FG001|Overall Study|Withdrawal by Subject|1|||
162659889|NCT02564471|587467861|FG002|Overall Study|Withdrawal by Subject|3|||
162659890|NCT02564471|587467862|FG003|Overall Study|Withdrawal by Subject|0|||
162659891|NCT02564471|587467859|FG000|Overall Study|Lost to Follow-up|0|||
162659892|NCT02564471|587467860|FG001|Overall Study|Lost to Follow-up|2|||
162659893|NCT02564471|587467861|FG002|Overall Study|Lost to Follow-up|0|||
162659894|NCT02564471|587467862|FG003|Overall Study|Lost to Follow-up|0|||
162659895|NCT02033889|587467866|FG000|Overall Study|Adverse Event|3|||
162659896|NCT02033889|587467867|FG001|Overall Study|Adverse Event|1|||
162659897|NCT02033889|587467868|FG002|Overall Study|Adverse Event|3|||
162659898|NCT02033889|587467866|FG000|Overall Study|Death|3|||
162659899|NCT02033889|587467867|FG001|Overall Study|Death|1|||
162659900|NCT02033889|587467868|FG002|Overall Study|Death|2|||
162659901|NCT02033889|587467866|FG000|Overall Study|Excluded Medication|1|||
162659902|NCT02033889|587467867|FG001|Overall Study|Excluded Medication|1|||
162659903|NCT02033889|587467868|FG002|Overall Study|Excluded Medication|0|||
162659904|NCT02033889|587467866|FG000|Overall Study|Lost to Follow-up|8|||
162659905|NCT02033889|587467867|FG001|Overall Study|Lost to Follow-up|5|||
162659906|NCT02033889|587467868|FG002|Overall Study|Lost to Follow-up|6|||
162659907|NCT02033889|587467866|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162659908|NCT02033889|587467867|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162659909|NCT02033889|587467868|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162659910|NCT02033889|587467866|FG000|Overall Study|Physician Decision|0|||
162659911|NCT02033889|587467867|FG001|Overall Study|Physician Decision|1|||
162720263|NCT00790790|587682496|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
162720264|NCT00790790|587682497|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
162720265|NCT02969863|587682498|FG000|Overall Study|Physician Decision|1|||
163138216|NCT00713544|589215024|FG000|Overall Study|Incorrect enrollment|0|||
163138217|NCT00713544|589215025|FG001|Overall Study|Incorrect enrollment|1|||
163138218|NCT00713544|589215026|FG002|Overall Study|Incorrect enrollment|0|||
163138219|NCT00713544|589215027|FG003|Overall Study|Incorrect enrollment|0|||
163138220|NCT00713544|589215028|FG004|Overall Study|Incorrect enrollment|0|||
163138221|NCT00713544|589215029|FG005|Overall Study|Incorrect enrollment|0|||
163138222|NCT00713544|589215024|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
163138223|NCT00713544|589215025|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
163138224|NCT00713544|589215026|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
163138225|NCT00713544|589215027|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
163138226|NCT00713544|589215028|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
163138227|NCT00713544|589215029|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
163138228|NCT00269919|589215030|FG000|Overall Study|Other|26|||
163138229|NCT00269919|589215030|FG000|Overall Study|Started but not treated|1|||
163138230|NCT01641601|589215033|FG000|Overall Study|Study discontinued.|3|||
163138231|NCT01641601|589215034|FG001|Overall Study|Study discontinued.|5|||
163138232|NCT01957202|589215035|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138233|NCT01957202|589215036|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
163138234|NCT01957202|589215037|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138235|NCT01957202|589215038|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138236|NCT01957202|589215039|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138237|NCT01957202|589215040|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138238|NCT01957202|589215041|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138239|NCT01957202|589215042|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138240|NCT01957202|589215043|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138241|NCT01957202|589215044|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138242|NCT01957202|589215045|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138243|NCT01957202|589215046|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138244|NCT01957202|589215047|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138245|NCT01957202|589215048|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138246|NCT01957202|589215049|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138247|NCT01957202|589215050|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138248|NCT01957202|589215051|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
163138249|NCT01957202|589215052|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163138250|NCT01957202|589215035|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138251|NCT01957202|589215036|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138252|NCT01957202|589215037|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138253|NCT01957202|589215038|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138254|NCT01957202|589215039|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138255|NCT01957202|589215040|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138256|NCT01957202|589215041|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138257|NCT01957202|589215042|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138258|NCT01957202|589215043|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138259|NCT01957202|589215044|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138260|NCT01957202|589215045|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138261|NCT01957202|589215046|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
162659912|NCT02033889|587467868|FG002|Overall Study|Physician Decision|1|||
162720266|NCT02969863|587682499|FG001|Overall Study|Physician Decision|0|||
162720267|NCT02969863|587682500|FG002|Overall Study|Physician Decision|0|||
162720268|NCT02969863|587682501|FG003|Overall Study|Physician Decision|0|||
162720269|NCT02969863|587682502|FG004|Overall Study|Physician Decision|0|||
162659913|NCT02033889|587467866|FG000|Overall Study|Participant moved|0|||
162659914|NCT02033889|587467867|FG001|Overall Study|Participant moved|1|||
162659915|NCT02033889|587467868|FG002|Overall Study|Participant moved|0|||
162659916|NCT02033889|587467866|FG000|Overall Study|Withdrawal by Subject|18|||
162659917|NCT02033889|587467867|FG001|Overall Study|Withdrawal by Subject|10|||
162659918|NCT02033889|587467868|FG002|Overall Study|Withdrawal by Subject|13|||
162659919|NCT00659646|587467869|FG000|Overall Study|Protocol Violation|12|||
162720270|NCT02969863|587682503|FG005|Overall Study|Physician Decision|0|||
162659920|NCT00659646|587467870|FG001|Overall Study|Protocol Violation|8|||
162659921|NCT00659646|587467869|FG000|Overall Study|Adverse Event|1|||
162659922|NCT00659646|587467870|FG001|Overall Study|Adverse Event|0|||
162720271|NCT00756730|587682507|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
162720272|NCT00756730|587682508|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
162659923|NCT00659646|587467869|FG000|Overall Study|Lost to Follow-up|1|||
162659924|NCT00659646|587467870|FG001|Overall Study|Lost to Follow-up|0|||
162659925|NCT00659646|587467869|FG000|Overall Study|protocol noncompliance after randomized|1|||
162659926|NCT00659646|587467870|FG001|Overall Study|protocol noncompliance after randomized|0|||
162659927|NCT01640301|587467871|FG000|Overall Study|Death|0|||
162659928|NCT01640301|587467872|FG001|Overall Study|Death|8|||
162659929|NCT02391948|587467877|FG000|6-month Assessment|Death|0|||
162659930|NCT02391948|587467878|FG001|6-month Assessment|Death|0|||
163138262|NCT01957202|589215047|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138263|NCT01957202|589215048|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138264|NCT01957202|589215049|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138265|NCT01957202|589215050|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138266|NCT01957202|589215051|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
163138267|NCT01957202|589215052|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
163138268|NCT02640547|589215053|FG000|Overall Study|Failure to Return|1|||
163138269|NCT02640547|589215053|FG000|Overall Study|Withdrawal by Subject|1|||
163138270|NCT02640547|589215053|FG000|Overall Study|Death|6|||
163138271|NCT02640547|589215053|FG000|Overall Study|Miscellaneous|3|||
163138272|NCT00080301|589215056|FG000|Overall Study|Randomized but Never Treated|5|||
163138273|NCT00080301|589215057|FG001|Overall Study|Randomized but Never Treated|10|||
163138274|NCT00080301|589215056|FG000|Overall Study|Still on Treatment as of CSR date|0|||
163138275|NCT00080301|589215057|FG001|Overall Study|Still on Treatment as of CSR date|1|||
163138276|NCT00991939|589215058|FG000|Overall Study|Lost to Follow-up|0|||
163138277|NCT00991939|589215059|FG001|Overall Study|Lost to Follow-up|1|||
163138278|NCT00991939|589215058|FG000|Overall Study|Withdrawal by Subject|1|||
163138279|NCT00991939|589215059|FG001|Overall Study|Withdrawal by Subject|0|||
163138280|NCT00991939|589215058|FG000|Overall Study|Entire study terminated|4|||
163138281|NCT00991939|589215059|FG001|Overall Study|Entire study terminated|1|||
163138282|NCT01965704|589215060|FG000|Overall Study|Withdrawal by Subject|2|||
163138283|NCT01965704|589215061|FG001|Overall Study|Withdrawal by Subject|2|||
163138284|NCT01965704|589215062|FG002|Overall Study|Withdrawal by Subject|1|||
163138285|NCT01965704|589215063|FG003|Overall Study|Withdrawal by Subject|1|||
163138286|NCT01965704|589215060|FG000|Overall Study|Delivered at home|1|||
163138287|NCT01965704|589215061|FG001|Overall Study|Delivered at home|1|||
163138288|NCT01965704|589215062|FG002|Overall Study|Delivered at home|0|||
163138289|NCT01965704|589215063|FG003|Overall Study|Delivered at home|0|||
163138290|NCT01965704|589215060|FG000|Overall Study|Experienced complications|0|||
163138291|NCT01965704|589215061|FG001|Overall Study|Experienced complications|0|||
163138292|NCT01965704|589215062|FG002|Overall Study|Experienced complications|2|||
163138293|NCT01965704|589215063|FG003|Overall Study|Experienced complications|2|||
163138294|NCT01965704|589215060|FG000|Overall Study|Adverse Event|0|||
163138295|NCT01965704|589215061|FG001|Overall Study|Adverse Event|0|||
163138296|NCT01965704|589215062|FG002|Overall Study|Adverse Event|1|||
163138297|NCT01965704|589215063|FG003|Overall Study|Adverse Event|1|||
163138298|NCT01965704|589215060|FG000|Overall Study|Did not meet inclusion criteria|0|||
163138299|NCT01965704|589215061|FG001|Overall Study|Did not meet inclusion criteria|0|||
163138300|NCT01965704|589215062|FG002|Overall Study|Did not meet inclusion criteria|1|||
163138301|NCT01965704|589215063|FG003|Overall Study|Did not meet inclusion criteria|1|||
163138302|NCT02524171|589215065|FG000|6-month Follow-up|Lost to Follow-up|53|||
163138303|NCT02524171|589215066|FG001|6-month Follow-up|Lost to Follow-up|45|||
163138304|NCT02524171|589215065|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
163138305|NCT02524171|589215066|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
163138306|NCT02868554|589215071|FG000|Overall Study|Lost to Follow-up|3|||
163138307|NCT02868554|589215072|FG001|Overall Study|Lost to Follow-up|0|||
163138308|NCT02868554|589215073|FG002|Overall Study|Lost to Follow-up|1|||
163138309|NCT05150990|589215074|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
163138310|NCT05150990|589215075|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
163138311|NCT05150990|589215074|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
163138312|NCT05150990|589215075|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
163138313|NCT05150990|589215074|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
163138314|NCT05150990|589215075|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
163138315|NCT05150990|589215074|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
163138316|NCT05150990|589215075|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
163138317|NCT05150990|589215074|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
163138318|NCT05150990|589215075|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
163138319|NCT05150990|589215074|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
163138320|NCT05150990|589215075|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
163138321|NCT05150990|589215074|FG000|Overall Study|Death (unrelated to the intervention)|1|||
163138322|NCT05150990|589215075|FG001|Overall Study|Death (unrelated to the intervention)|2|||
163138323|NCT05447663|589215078|FG000|Overall Study|Study terminated by Sponsor|5|||
162659931|NCT02391948|587467879|FG002|6-month Assessment|Death|0|||
162659932|NCT02391948|587467880|FG003|6-month Assessment|Death|0|||
162659933|NCT02391948|587467881|FG004|6-month Assessment|Death|1|||
163138324|NCT05447663|589215078|FG000|Overall Study|Death|2|||
163138325|NCT05447663|589215078|FG000|Overall Study|Withdrawal by Subject|1|||
163138326|NCT01100320|589215079|FG000|Period 1|Withdrawal by Subject|2|||
163138327|NCT01100320|589215080|FG001|Period 1|Withdrawal by Subject|4|||
163138328|NCT01100320|589215079|FG000|Period 1|Positive Drug Screen|1|||
163138329|NCT01100320|589215080|FG001|Period 1|Positive Drug Screen|1|||
163138330|NCT01100320|589215079|FG000|Period 1|Adverse Event|2|||
163138331|NCT01100320|589215080|FG001|Period 1|Adverse Event|2|||
163138332|NCT01100320|589215079|FG000|Period 2|Withdrawal by Subject|1|||
163138333|NCT01100320|589215080|FG001|Period 2|Withdrawal by Subject|1|||
163138334|NCT04181762|589215081|FG000|Overall Study|Adverse Event|1|||
163138335|NCT04181762|589215082|FG001|Overall Study|Adverse Event|3|||
163138336|NCT04181762|589215081|FG000|Overall Study|Lost to Follow-up|1|||
163138337|NCT04181762|589215082|FG001|Overall Study|Lost to Follow-up|1|||
163138338|NCT04181762|589215081|FG000|Overall Study|Physician Decision|1|||
163138339|NCT04181762|589215082|FG001|Overall Study|Physician Decision|3|||
163138340|NCT04181762|589215081|FG000|Overall Study|Pregnancy|0|||
163138341|NCT04181762|589215082|FG001|Overall Study|Pregnancy|1|||
163138342|NCT04181762|589215081|FG000|Overall Study|Lack of Efficacy|2|||
163138343|NCT04181762|589215082|FG001|Overall Study|Lack of Efficacy|2|||
163138344|NCT04181762|589215081|FG000|Overall Study|Study terminated by sponsor|95|||
163138345|NCT04181762|589215082|FG001|Overall Study|Study terminated by sponsor|97|||
163138346|NCT04181762|589215081|FG000|Overall Study|Subject decision|11|||
163138347|NCT04181762|589215082|FG001|Overall Study|Subject decision|4|||
163138348|NCT04181762|589215081|FG000|Overall Study|Death|1|||
163138349|NCT04181762|589215082|FG001|Overall Study|Death|1|||
163138350|NCT04181762|589215081|FG000|Overall Study|Protocol deviation|1|||
163138351|NCT04181762|589215082|FG001|Overall Study|Protocol deviation|0|||
163138352|NCT04181762|589215081|FG000|Overall Study|Withdrawal of informed consent|1|||
163138353|NCT04181762|589215082|FG001|Overall Study|Withdrawal of informed consent|3|||
163138354|NCT04669301|589215083|FG000|Overall Study|Lost to Follow-up|0|||
163138355|NCT04669301|589215084|FG001|Overall Study|Lost to Follow-up|1|||
163138356|NCT04669301|589215085|FG002|Overall Study|Lost to Follow-up|0|||
163138357|NCT04669301|589215083|FG000|Overall Study|Withdrawal by Subject|3|||
163138358|NCT04669301|589215084|FG001|Overall Study|Withdrawal by Subject|2|||
163138359|NCT04669301|589215085|FG002|Overall Study|Withdrawal by Subject|0|||
163138360|NCT02586727|589215086|FG000|Overall Study|Lost to Follow-up|1|||
163138361|NCT02586727|589215087|FG001|Overall Study|Lost to Follow-up|0|||
163138362|NCT05888181|589215088|FG000|Overall Study|Lost to Follow-up|1|||
163138363|NCT05888181|589215089|FG001|Overall Study|Lost to Follow-up|1|||
163138364|NCT05888181|589215090|FG002|Overall Study|Lost to Follow-up|0|||
163138365|NCT02534909|589215093|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
163138366|NCT00132808|589215096|FG000|Stratum I|Adverse Event|2|||
163138367|NCT00132808|589215097|FG001|Stratum I|Adverse Event|1|||
163138368|NCT00132808|589215098|FG002|Stratum I|Adverse Event|0|||
163138369|NCT00132808|589215096|FG000|Stratum I|Lost to Follow-up|3|||
163138370|NCT00132808|589215097|FG001|Stratum I|Lost to Follow-up|4|||
163138371|NCT00132808|589215098|FG002|Stratum I|Lost to Follow-up|1|||
163138372|NCT00132808|589215096|FG000|Stratum I|Withdrawal by Subject|4|||
163138373|NCT00132808|589215097|FG001|Stratum I|Withdrawal by Subject|7|||
163138374|NCT00132808|589215098|FG002|Stratum I|Withdrawal by Subject|3|||
163138375|NCT00132808|589215096|FG000|Stratum I|Abnormal test procedure result (s)|0|||
163138376|NCT00132808|589215097|FG001|Stratum I|Abnormal test procedure result (s)|0|||
163138377|NCT00132808|589215098|FG002|Stratum I|Abnormal test procedure result (s)|1|||
163138378|NCT00132808|589215096|FG000|Stratum II|Adverse Event|1|||
163138379|NCT00132808|589215097|FG001|Stratum II|Adverse Event|2|||
163138380|NCT00132808|589215098|FG002|Stratum II|Adverse Event|1|||
163138381|NCT00132808|589215096|FG000|Stratum II|Death|1|||
163138382|NCT00132808|589215097|FG001|Stratum II|Death|0|||
163138383|NCT00132808|589215098|FG002|Stratum II|Death|0|||
163138384|NCT00132808|589215096|FG000|Stratum II|Lost to Follow-up|2|||
163138385|NCT00132808|589215097|FG001|Stratum II|Lost to Follow-up|2|||
163138386|NCT00132808|589215098|FG002|Stratum II|Lost to Follow-up|1|||
163138387|NCT00132808|589215096|FG000|Stratum II|Protocol Violation|0|||
163138388|NCT00132808|589215097|FG001|Stratum II|Protocol Violation|2|||
163138389|NCT00132808|589215098|FG002|Stratum II|Protocol Violation|1|||
163138390|NCT00132808|589215096|FG000|Stratum II|Withdrawal by Subject|4|||
163138391|NCT00132808|589215097|FG001|Stratum II|Withdrawal by Subject|9|||
163138392|NCT00132808|589215098|FG002|Stratum II|Withdrawal by Subject|6|||
163138393|NCT00577824|589215102|FG000|Overall Study|Adverse Event|6|||
163138394|NCT00577824|589215103|FG001|Overall Study|Adverse Event|18|||
163138395|NCT00577824|589215104|FG002|Overall Study|Adverse Event|1|||
163138396|NCT00577824|589215102|FG000|Overall Study|Patient decision|0|||
163138397|NCT00577824|589215103|FG001|Overall Study|Patient decision|1|||
163138398|NCT00577824|589215104|FG002|Overall Study|Patient decision|1|||
163138399|NCT00577824|589215102|FG000|Overall Study|Protocol Violation|1|||
163138400|NCT00577824|589215103|FG001|Overall Study|Protocol Violation|1|||
162659934|NCT02391948|587467877|FG000|6-month Assessment|Withdrawal by Subject|0|||
163138401|NCT00577824|589215104|FG002|Overall Study|Protocol Violation|0|||
162720273|NCT00756730|587682507|FG000|Overall Study|persistent low-level viremmia|0|||
162720274|NCT00756730|587682508|FG001|Overall Study|persistent low-level viremmia|1|||
162720275|NCT05382104|587682512|FG000|Period 2 (2 Days)|Adverse Event|0|||
162720276|NCT05382104|587682513|FG001|Period 2 (2 Days)|Adverse Event|1|||
162720277|NCT05382104|587682514|FG002|Period 2 (2 Days)|Adverse Event|0|||
162720278|NCT05382104|587682515|FG003|Period 2 (2 Days)|Adverse Event|0|||
162720279|NCT05382104|587682516|FG004|Period 2 (2 Days)|Adverse Event|0|||
162720280|NCT05382104|587682517|FG005|Period 2 (2 Days)|Adverse Event|0|||
162659935|NCT02391948|587467878|FG001|6-month Assessment|Withdrawal by Subject|0|||
162659936|NCT02391948|587467879|FG002|6-month Assessment|Withdrawal by Subject|1|||
162659937|NCT02391948|587467880|FG003|6-month Assessment|Withdrawal by Subject|2|||
162659938|NCT02391948|587467881|FG004|6-month Assessment|Withdrawal by Subject|0|||
162659939|NCT02391948|587467877|FG000|6-month Assessment|Lost to Follow-up|4|||
162659940|NCT02391948|587467878|FG001|6-month Assessment|Lost to Follow-up|5|||
162659941|NCT02391948|587467879|FG002|6-month Assessment|Lost to Follow-up|2|||
162659942|NCT02391948|587467880|FG003|6-month Assessment|Lost to Follow-up|3|||
162659943|NCT02391948|587467881|FG004|6-month Assessment|Lost to Follow-up|1|||
162659944|NCT02391948|587467877|FG000|6-month Assessment|Medical issue/illness|1|||
162659945|NCT02391948|587467878|FG001|6-month Assessment|Medical issue/illness|1|||
162659946|NCT02391948|587467879|FG002|6-month Assessment|Medical issue/illness|0|||
162659947|NCT02391948|587467880|FG003|6-month Assessment|Medical issue/illness|0|||
162659948|NCT02391948|587467881|FG004|6-month Assessment|Medical issue/illness|0|||
162659949|NCT02391948|587467877|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
162659950|NCT02391948|587467878|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
162659951|NCT02391948|587467879|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
162659952|NCT02391948|587467880|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
162659953|NCT02391948|587467881|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
162659954|NCT02391948|587467877|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
162659955|NCT02391948|587467878|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
162659956|NCT02391948|587467879|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
162659957|NCT02391948|587467880|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
162659958|NCT02391948|587467881|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
162659959|NCT02391948|587467877|FG000|12-month Assessment|Death|0|||
162659960|NCT02391948|587467878|FG001|12-month Assessment|Death|0|||
162659961|NCT02391948|587467879|FG002|12-month Assessment|Death|0|||
162659962|NCT02391948|587467880|FG003|12-month Assessment|Death|1|||
162659963|NCT02391948|587467881|FG004|12-month Assessment|Death|0|||
162659964|NCT02391948|587467877|FG000|12-month Assessment|Withdrawal by Subject|1|||
162659965|NCT02391948|587467878|FG001|12-month Assessment|Withdrawal by Subject|0|||
162659966|NCT02391948|587467879|FG002|12-month Assessment|Withdrawal by Subject|0|||
162659967|NCT02391948|587467880|FG003|12-month Assessment|Withdrawal by Subject|1|||
162659968|NCT02391948|587467881|FG004|12-month Assessment|Withdrawal by Subject|0|||
162659969|NCT02391948|587467877|FG000|12-month Assessment|Lost to Follow-up|5|||
162659970|NCT02391948|587467878|FG001|12-month Assessment|Lost to Follow-up|4|||
162659971|NCT02391948|587467879|FG002|12-month Assessment|Lost to Follow-up|4|||
162659972|NCT02391948|587467880|FG003|12-month Assessment|Lost to Follow-up|4|||
162659973|NCT02391948|587467881|FG004|12-month Assessment|Lost to Follow-up|5|||
162659974|NCT02391948|587467877|FG000|12-month Assessment|Medical issue/illness|0|||
162659975|NCT02391948|587467878|FG001|12-month Assessment|Medical issue/illness|1|||
162659976|NCT02391948|587467879|FG002|12-month Assessment|Medical issue/illness|0|||
162659977|NCT02391948|587467880|FG003|12-month Assessment|Medical issue/illness|1|||
162659978|NCT02391948|587467881|FG004|12-month Assessment|Medical issue/illness|0|||
162659979|NCT02391948|587467877|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
162659980|NCT02391948|587467878|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
162659981|NCT02391948|587467879|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
162659982|NCT02391948|587467880|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
162659983|NCT02391948|587467881|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
162659984|NCT02391948|587467877|FG000|18-month Assessment|Death|0|||
162659985|NCT02391948|587467878|FG001|18-month Assessment|Death|0|||
162659986|NCT02391948|587467879|FG002|18-month Assessment|Death|0|||
162659987|NCT02391948|587467880|FG003|18-month Assessment|Death|1|||
162659988|NCT02391948|587467881|FG004|18-month Assessment|Death|1|||
162659989|NCT02391948|587467877|FG000|18-month Assessment|Withdrawal by Subject|1|||
162659990|NCT02391948|587467878|FG001|18-month Assessment|Withdrawal by Subject|0|||
162659991|NCT02391948|587467879|FG002|18-month Assessment|Withdrawal by Subject|0|||
162659992|NCT02391948|587467880|FG003|18-month Assessment|Withdrawal by Subject|1|||
162659993|NCT02391948|587467881|FG004|18-month Assessment|Withdrawal by Subject|0|||
162659994|NCT02391948|587467877|FG000|18-month Assessment|Lost to Follow-up|2|||
162720281|NCT01493778|587682518|FG000|Overall Study|Withdrawal by Subject|8|||
162720282|NCT01227707|587682519|FG000|Overall Study|Adverse Event|10|||
162659995|NCT02391948|587467878|FG001|18-month Assessment|Lost to Follow-up|6|||
162659996|NCT02391948|587467879|FG002|18-month Assessment|Lost to Follow-up|2|||
162659997|NCT02391948|587467880|FG003|18-month Assessment|Lost to Follow-up|2|||
162659998|NCT02391948|587467881|FG004|18-month Assessment|Lost to Follow-up|3|||
162659999|NCT02391948|587467877|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
162660000|NCT02391948|587467878|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
162660001|NCT02391948|587467879|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
162660002|NCT02391948|587467880|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
162660003|NCT02391948|587467881|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
162660004|NCT02391948|587467877|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
162660005|NCT02391948|587467878|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
162660006|NCT02391948|587467879|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
162660007|NCT02391948|587467880|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
162660008|NCT02391948|587467881|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
162660009|NCT02391948|587467877|FG000|24-month Assessment|Death|0|||
162660010|NCT02391948|587467878|FG001|24-month Assessment|Death|0|||
162660011|NCT02391948|587467879|FG002|24-month Assessment|Death|0|||
162660012|NCT02391948|587467880|FG003|24-month Assessment|Death|0|||
162660013|NCT02391948|587467881|FG004|24-month Assessment|Death|1|||
162660014|NCT02391948|587467877|FG000|24-month Assessment|Withdrawal by Subject|1|||
162660015|NCT02391948|587467878|FG001|24-month Assessment|Withdrawal by Subject|1|||
162660016|NCT02391948|587467879|FG002|24-month Assessment|Withdrawal by Subject|0|||
162660017|NCT02391948|587467880|FG003|24-month Assessment|Withdrawal by Subject|0|||
162660018|NCT02391948|587467881|FG004|24-month Assessment|Withdrawal by Subject|1|||
162660019|NCT02391948|587467877|FG000|24-month Assessment|Lost to Follow-up|5|||
162660020|NCT02391948|587467878|FG001|24-month Assessment|Lost to Follow-up|4|||
162660021|NCT02391948|587467879|FG002|24-month Assessment|Lost to Follow-up|0|||
162660022|NCT02391948|587467880|FG003|24-month Assessment|Lost to Follow-up|0|||
162660023|NCT02391948|587467881|FG004|24-month Assessment|Lost to Follow-up|0|||
162660024|NCT02391948|587467877|FG000|24-month Assessment|Medical issue/illness|0|||
162660025|NCT02391948|587467878|FG001|24-month Assessment|Medical issue/illness|0|||
163138402|NCT00362648|589215105|FG000|Overall Study|Adverse Event|12|||
163138403|NCT00362648|589215106|FG001|Overall Study|Adverse Event|21|||
163138404|NCT00362648|589215107|FG002|Overall Study|Adverse Event|1|||
163138405|NCT00362648|589215108|FG003|Overall Study|Adverse Event|0|||
163138406|NCT00362648|589215105|FG000|Overall Study|Lost to Follow-up|62|||
163138407|NCT00362648|589215106|FG001|Overall Study|Lost to Follow-up|69|||
163138408|NCT00362648|589215107|FG002|Overall Study|Lost to Follow-up|4|||
163138409|NCT00362648|589215108|FG003|Overall Study|Lost to Follow-up|3|||
163138410|NCT00362648|589215105|FG000|Overall Study|Protocol Violation|4|||
163138411|NCT00362648|589215106|FG001|Overall Study|Protocol Violation|2|||
163138412|NCT00362648|589215107|FG002|Overall Study|Protocol Violation|2|||
163138413|NCT00362648|589215108|FG003|Overall Study|Protocol Violation|2|||
163138414|NCT00362648|589215105|FG000|Overall Study|Withdrawal by Subject|48|||
163138415|NCT00362648|589215106|FG001|Overall Study|Withdrawal by Subject|42|||
163138416|NCT00362648|589215107|FG002|Overall Study|Withdrawal by Subject|2|||
163138417|NCT00362648|589215108|FG003|Overall Study|Withdrawal by Subject|6|||
163138418|NCT04752332|589215117|FG000|Overall Study|Adverse Event|3|||
163138419|NCT04752332|589215118|FG001|Overall Study|Adverse Event|1|||
163138420|NCT04752332|589215117|FG000|Overall Study|Disease Relapse|1|||
163138421|NCT04752332|589215118|FG001|Overall Study|Disease Relapse|0|||
163138422|NCT04752332|589215117|FG000|Overall Study|Non-compliance With Study Drug|2|||
163138423|NCT04752332|589215118|FG001|Overall Study|Non-compliance With Study Drug|0|||
163138424|NCT04752332|589215117|FG000|Overall Study|Physician Decision|2|||
163138425|NCT04752332|589215118|FG001|Overall Study|Physician Decision|1|||
163138426|NCT04752332|589215117|FG000|Overall Study|Protocol Violation|1|||
163138427|NCT04752332|589215118|FG001|Overall Study|Protocol Violation|1|||
163138428|NCT04752332|589215117|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
163138429|NCT04752332|589215118|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
163138430|NCT04752332|589215117|FG000|Overall Study|Study Terminated by Sponsor|10|||
163138431|NCT04752332|589215118|FG001|Overall Study|Study Terminated by Sponsor|48|||
163138432|NCT04752332|589215117|FG000|Overall Study|Withdrawal by Subject|11|||
162660026|NCT02391948|587467879|FG002|24-month Assessment|Medical issue/illness|1|||
162660027|NCT02391948|587467880|FG003|24-month Assessment|Medical issue/illness|0|||
162660028|NCT02391948|587467881|FG004|24-month Assessment|Medical issue/illness|0|||
162660029|NCT02391948|587467877|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
163138433|NCT04752332|589215118|FG001|Overall Study|Withdrawal by Subject|3|||
162660030|NCT02391948|587467878|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
162660031|NCT02391948|587467879|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
162660032|NCT02391948|587467880|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
163138434|NCT00924443|589215119|FG000|Overall Study|Physician Decision|2|||
163138435|NCT00924443|589215119|FG000|Overall Study|Protocol Violation|1|||
163138436|NCT00286429|589215120|FG000|Overall Study|Adverse Event|4|||
163138437|NCT00286429|589215121|FG001|Overall Study|Adverse Event|1|||
162720283|NCT01227707|587682519|FG000|Overall Study|Progression of disease|3|||
162720284|NCT01227707|587682519|FG000|Overall Study|Withdrawal by Subject|1|||
162720285|NCT01227707|587682519|FG000|Overall Study|Patient non-compliance|3|||
162720286|NCT01227707|587682519|FG000|Overall Study|Medical decision|6|||
162720287|NCT01227707|587682519|FG000|Overall Study|Death|1|||
162720288|NCT03210402|587682520|FG000|Overall Study|Withdrawal by Subject|0|||
162720289|NCT03210402|587682521|FG001|Overall Study|Withdrawal by Subject|1|||
162720290|NCT00811057|587682522|FG000|Overall Study|Protocol Violation|5|||
162720291|NCT00811057|587682523|FG001|Overall Study|Protocol Violation|10|||
162720292|NCT00811057|587682524|FG002|Overall Study|Protocol Violation|10|||
162720293|NCT03215927|587683694|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
162720294|NCT03215927|587683695|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
162720295|NCT03215927|587683694|FG000|Open Label Extension|Adverse Event|1|||
162660033|NCT02391948|587467881|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
162660034|NCT02348489|587467882|FG000|Overall Study|Death|336|||
162660035|NCT02348489|587467883|FG001|Overall Study|Death|335|||
162660036|NCT02348489|587467882|FG000|Overall Study|Withdrawal by Subject|14|||
162660037|NCT02348489|587467883|FG001|Overall Study|Withdrawal by Subject|27|||
162660038|NCT02348489|587467882|FG000|Overall Study|Lost to Follow-up|3|||
162660039|NCT02348489|587467883|FG001|Overall Study|Lost to Follow-up|5|||
162660040|NCT01969838|587467884|FG000|Double-blind Phase|Adverse Event|10|||
162660041|NCT01969838|587467885|FG001|Double-blind Phase|Adverse Event|4|||
162660042|NCT01969838|587467886|FG002|Double-blind Phase|Adverse Event|0|||
162660043|NCT01969838|587467887|FG003|Double-blind Phase|Adverse Event|0|||
162660044|NCT01969838|587467884|FG000|Double-blind Phase|Death|5|||
162660045|NCT01969838|587467885|FG001|Double-blind Phase|Death|2|||
162660046|NCT01969838|587467886|FG002|Double-blind Phase|Death|0|||
162660047|NCT01969838|587467887|FG003|Double-blind Phase|Death|0|||
162660048|NCT01969838|587467884|FG000|Double-blind Phase|Physician Decision|5|||
162660049|NCT01969838|587467885|FG001|Double-blind Phase|Physician Decision|1|||
162660050|NCT01969838|587467886|FG002|Double-blind Phase|Physician Decision|0|||
162660051|NCT01969838|587467887|FG003|Double-blind Phase|Physician Decision|0|||
162660052|NCT01969838|587467884|FG000|Double-blind Phase|Subject Decision|4|||
162660053|NCT01969838|587467885|FG001|Double-blind Phase|Subject Decision|2|||
162660054|NCT01969838|587467886|FG002|Double-blind Phase|Subject Decision|0|||
162660055|NCT01969838|587467887|FG003|Double-blind Phase|Subject Decision|0|||
162660056|NCT01969838|587467884|FG000|Double-blind Phase|Disease Progression|2|||
162660057|NCT01969838|587467885|FG001|Double-blind Phase|Disease Progression|0|||
162660058|NCT01969838|587467886|FG002|Double-blind Phase|Disease Progression|0|||
162660059|NCT01969838|587467887|FG003|Double-blind Phase|Disease Progression|0|||
162660060|NCT01969838|587467884|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
162660061|NCT01969838|587467885|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
162660062|NCT01969838|587467886|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
162660063|NCT01969838|587467887|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
162660064|NCT01969838|587467884|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
162660065|NCT01969838|587467885|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
162660066|NCT01969838|587467886|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
162660067|NCT01969838|587467887|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
162660068|NCT01969838|587467884|FG000|Open-label Phase|Adverse Event|0|||
162660069|NCT01969838|587467885|FG001|Open-label Phase|Adverse Event|0|||
162660070|NCT01969838|587467886|FG002|Open-label Phase|Adverse Event|37|||
162660071|NCT01969838|587467887|FG003|Open-label Phase|Adverse Event|49|||
162660072|NCT01969838|587467884|FG000|Open-label Phase|Disease Progression|0|||
162660073|NCT01969838|587467885|FG001|Open-label Phase|Disease Progression|0|||
162720296|NCT03215927|587683695|FG001|Open Label Extension|Adverse Event|0|||
162720297|NCT03215927|587683694|FG000|Open Label Extension|Lack of Efficacy|1|||
162720298|NCT03215927|587683695|FG001|Open Label Extension|Lack of Efficacy|0|||
162720299|NCT03215927|587683694|FG000|Open Label Extension|Death|0|||
162720300|NCT03215927|587683695|FG001|Open Label Extension|Death|1|||
163138438|NCT00286429|589215122|FG002|Overall Study|Adverse Event|6|||
163138439|NCT00286429|589215120|FG000|Overall Study|Lack of Efficacy|52|||
163138440|NCT00286429|589215121|FG001|Overall Study|Lack of Efficacy|27|||
162660074|NCT01969838|587467886|FG002|Open-label Phase|Disease Progression|26|||
162720301|NCT03779048|587683696|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
162720302|NCT03779048|587683697|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
162720303|NCT03779048|587683698|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
162720304|NCT03779048|587683696|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
162660075|NCT01969838|587467887|FG003|Open-label Phase|Disease Progression|27|||
162660076|NCT01969838|587467884|FG000|Open-label Phase|Lack of Efficacy|0|||
162660077|NCT01969838|587467885|FG001|Open-label Phase|Lack of Efficacy|0|||
162660078|NCT01969838|587467886|FG002|Open-label Phase|Lack of Efficacy|17|||
162660079|NCT01969838|587467887|FG003|Open-label Phase|Lack of Efficacy|19|||
162660080|NCT01969838|587467884|FG000|Open-label Phase|Subject Decision|0|||
162660081|NCT01969838|587467885|FG001|Open-label Phase|Subject Decision|0|||
162660082|NCT01969838|587467886|FG002|Open-label Phase|Subject Decision|14|||
163138441|NCT00286429|589215122|FG002|Overall Study|Lack of Efficacy|25|||
163138442|NCT00286429|589215120|FG000|Overall Study|Lost to Follow-up|2|||
163138443|NCT00286429|589215121|FG001|Overall Study|Lost to Follow-up|4|||
163138444|NCT00286429|589215122|FG002|Overall Study|Lost to Follow-up|3|||
163138445|NCT00286429|589215120|FG000|Overall Study|Physician Decision|10|||
163138446|NCT00286429|589215121|FG001|Overall Study|Physician Decision|7|||
163138447|NCT00286429|589215122|FG002|Overall Study|Physician Decision|7|||
163138448|NCT00286429|589215120|FG000|Overall Study|Protocol Violation|3|||
163138449|NCT00286429|589215121|FG001|Overall Study|Protocol Violation|5|||
163138450|NCT00286429|589215122|FG002|Overall Study|Protocol Violation|4|||
163138451|NCT00286429|589215120|FG000|Overall Study|Withdrawal by Subject|3|||
163138452|NCT00286429|589215121|FG001|Overall Study|Withdrawal by Subject|2|||
163138453|NCT00286429|589215122|FG002|Overall Study|Withdrawal by Subject|6|||
163138454|NCT00286429|589215120|FG000|Overall Study|Administrative Error|1|||
163138455|NCT00286429|589215121|FG001|Overall Study|Administrative Error|1|||
163138456|NCT00286429|589215122|FG002|Overall Study|Administrative Error|1|||
163138457|NCT00286429|589215120|FG000|Overall Study|Administrative Decision|0|||
163138458|NCT00286429|589215121|FG001|Overall Study|Administrative Decision|1|||
163138459|NCT00286429|589215122|FG002|Overall Study|Administrative Decision|0|||
163138460|NCT03197376|589215126|FG000|Primary and Booster Phase|Adverse Event|0|||
163138461|NCT03197376|589215127|FG001|Primary and Booster Phase|Adverse Event|0|||
163138462|NCT03197376|589215128|FG002|Primary and Booster Phase|Adverse Event|0|||
163138463|NCT03197376|589215129|FG003|Primary and Booster Phase|Adverse Event|1|||
163138464|NCT03197376|589215126|FG000|Primary and Booster Phase|Death|1|||
163138465|NCT03197376|589215127|FG001|Primary and Booster Phase|Death|0|||
163138466|NCT03197376|589215128|FG002|Primary and Booster Phase|Death|0|||
163138467|NCT03197376|589215129|FG003|Primary and Booster Phase|Death|2|||
163138468|NCT03197376|589215126|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
163138469|NCT03197376|589215127|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
163138470|NCT03197376|589215128|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
163138471|NCT03197376|589215129|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
163138472|NCT03197376|589215126|FG000|Primary and Booster Phase|Physician Decision|1|||
163138473|NCT03197376|589215127|FG001|Primary and Booster Phase|Physician Decision|0|||
163138474|NCT03197376|589215128|FG002|Primary and Booster Phase|Physician Decision|1|||
163138475|NCT03197376|589215129|FG003|Primary and Booster Phase|Physician Decision|3|||
163138476|NCT03197376|589215126|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
163138477|NCT03197376|589215127|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
163138478|NCT03197376|589215128|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
163138479|NCT03197376|589215129|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
163138480|NCT03197376|589215126|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
163138481|NCT03197376|589215127|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
163138482|NCT03197376|589215128|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
163138483|NCT03197376|589215129|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
163138484|NCT03197376|589215126|FG000|Primary and Booster Phase|Not vaccine related|1|||
163138485|NCT03197376|589215127|FG001|Primary and Booster Phase|Not vaccine related|2|||
163138486|NCT03197376|589215128|FG002|Primary and Booster Phase|Not vaccine related|0|||
163138487|NCT03197376|589215129|FG003|Primary and Booster Phase|Not vaccine related|6|||
163138488|NCT03197376|589215126|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
163138489|NCT03197376|589215127|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
163138490|NCT03197376|589215128|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
163138491|NCT03197376|589215129|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
163138492|NCT03197376|589215126|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
163138493|NCT03197376|589215127|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
163138494|NCT03197376|589215128|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
163138495|NCT03197376|589215129|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
163138496|NCT03197376|589215126|FG000|Immune Persistence Phase|Not vaccine related|1|||
163138497|NCT03197376|589215127|FG001|Immune Persistence Phase|Not vaccine related|0|||
163138498|NCT03197376|589215128|FG002|Immune Persistence Phase|Not vaccine related|1|||
163138499|NCT03197376|589215129|FG003|Immune Persistence Phase|Not vaccine related|1|||
163138500|NCT02978833|589215133|FG000|Overall Study|Study terminated|1|||
163138501|NCT02978833|589215134|FG001|Overall Study|Study terminated|1|||
163138502|NCT01123395|589215137|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
163138503|NCT01123395|589215138|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
163138504|NCT00186901|589215139|FG000|Overall Study|Pregnancy|6|||
163138505|NCT00186901|589215140|FG001|Overall Study|Pregnancy|3|||
163138506|NCT00186901|589215141|FG002|Overall Study|Pregnancy|0|||
163138507|NCT00186901|589215139|FG000|Overall Study|Lost to Follow-up|6|||
163138508|NCT00186901|589215140|FG001|Overall Study|Lost to Follow-up|3|||
163138509|NCT00186901|589215141|FG002|Overall Study|Lost to Follow-up|0|||
163138510|NCT00186901|589215139|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
163138511|NCT00186901|589215140|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
163138512|NCT00186901|589215141|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
163138513|NCT00186901|589215139|FG000|Overall Study|ALL relapse or second malignancy|1|||
163138514|NCT00186901|589215140|FG001|Overall Study|ALL relapse or second malignancy|2|||
162660083|NCT01969838|587467887|FG003|Open-label Phase|Subject Decision|15|||
162660084|NCT01969838|587467884|FG000|Open-label Phase|Death|0|||
162660085|NCT01969838|587467885|FG001|Open-label Phase|Death|0|||
163138515|NCT00186901|589215141|FG002|Overall Study|ALL relapse or second malignancy|0|||
163138516|NCT00186901|589215139|FG000|Overall Study|Withdrawal by Subject|4|||
163138517|NCT00186901|589215140|FG001|Overall Study|Withdrawal by Subject|5|||
163138518|NCT00186901|589215141|FG002|Overall Study|Withdrawal by Subject|0|||
163138519|NCT00186901|589215139|FG000|Overall Study|Open label|3|||
163138520|NCT00186901|589215140|FG001|Overall Study|Open label|2|||
163138521|NCT00186901|589215141|FG002|Overall Study|Open label|0|||
163138522|NCT00186901|589215139|FG000|Overall Study|Limited adherence to study requirements|20|||
163138523|NCT00186901|589215140|FG001|Overall Study|Limited adherence to study requirements|23|||
163138524|NCT00186901|589215141|FG002|Overall Study|Limited adherence to study requirements|0|||
163138525|NCT00186901|589215139|FG000|Overall Study|Bone Mineral Density > 0|0|||
163138526|NCT00186901|589215140|FG001|Overall Study|Bone Mineral Density > 0|0|||
163138527|NCT00186901|589215141|FG002|Overall Study|Bone Mineral Density > 0|149|||
163138528|NCT00782483|589215147|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
163138529|NCT01052077|589215148|FG000|Phase A|Lost to Follow-up|22|||
163138530|NCT01052077|589215149|FG001|Phase A|Lost to Follow-up|0|||
163138531|NCT01052077|589215150|FG002|Phase A|Lost to Follow-up|0|||
163138532|NCT01052077|589215151|FG003|Phase A|Lost to Follow-up|0|||
163138533|NCT01052077|589215148|FG000|Phase A|Adverse Event|32|||
163138534|NCT01052077|589215149|FG001|Phase A|Adverse Event|0|||
163138535|NCT01052077|589215150|FG002|Phase A|Adverse Event|0|||
163138536|NCT01052077|589215151|FG003|Phase A|Adverse Event|0|||
163138537|NCT01052077|589215148|FG000|Phase A|Met Withdrawal Criteria|26|||
163138538|NCT01052077|589215149|FG001|Phase A|Met Withdrawal Criteria|0|||
163138539|NCT01052077|589215150|FG002|Phase A|Met Withdrawal Criteria|0|||
163138540|NCT01052077|589215151|FG003|Phase A|Met Withdrawal Criteria|0|||
163138541|NCT01052077|589215148|FG000|Phase A|Physician Decision|10|||
163138542|NCT01052077|589215149|FG001|Phase A|Physician Decision|0|||
163138543|NCT01052077|589215150|FG002|Phase A|Physician Decision|0|||
163138544|NCT01052077|589215151|FG003|Phase A|Physician Decision|0|||
163138545|NCT01052077|589215148|FG000|Phase A|Withdrawal by Subject|29|||
163138546|NCT01052077|589215149|FG001|Phase A|Withdrawal by Subject|0|||
163138547|NCT01052077|589215150|FG002|Phase A|Withdrawal by Subject|0|||
163138548|NCT01052077|589215151|FG003|Phase A|Withdrawal by Subject|0|||
163138549|NCT01052077|589215148|FG000|Phase A|Protocol Deviation|27|||
163138550|NCT01052077|589215149|FG001|Phase A|Protocol Deviation|0|||
163138551|NCT01052077|589215150|FG002|Phase A|Protocol Deviation|0|||
163138552|NCT01052077|589215151|FG003|Phase A|Protocol Deviation|0|||
163138553|NCT01052077|589215148|FG000|Phase B|Lost to Follow-up|0|||
163138554|NCT01052077|589215149|FG001|Phase B|Lost to Follow-up|2|||
163138555|NCT01052077|589215150|FG002|Phase B|Lost to Follow-up|3|||
163138556|NCT01052077|589215151|FG003|Phase B|Lost to Follow-up|0|||
163138557|NCT01052077|589215148|FG000|Phase B|Adverse Event|0|||
163138558|NCT01052077|589215149|FG001|Phase B|Adverse Event|9|||
163138559|NCT01052077|589215150|FG002|Phase B|Adverse Event|2|||
163138560|NCT01052077|589215151|FG003|Phase B|Adverse Event|0|||
163138561|NCT01052077|589215148|FG000|Phase B|Met Withdrawal Criteria|0|||
163138562|NCT01052077|589215149|FG001|Phase B|Met Withdrawal Criteria|2|||
163138563|NCT01052077|589215150|FG002|Phase B|Met Withdrawal Criteria|1|||
163138564|NCT01052077|589215151|FG003|Phase B|Met Withdrawal Criteria|0|||
163138565|NCT01052077|589215148|FG000|Phase B|Physician Decision|0|||
163138566|NCT01052077|589215149|FG001|Phase B|Physician Decision|1|||
163138567|NCT01052077|589215150|FG002|Phase B|Physician Decision|1|||
163138568|NCT01052077|589215151|FG003|Phase B|Physician Decision|0|||
163138569|NCT01052077|589215148|FG000|Phase B|Withdrawal by Subject|0|||
163138570|NCT01052077|589215149|FG001|Phase B|Withdrawal by Subject|0|||
163138571|NCT01052077|589215150|FG002|Phase B|Withdrawal by Subject|5|||
163138572|NCT01052077|589215151|FG003|Phase B|Withdrawal by Subject|0|||
163138573|NCT01052077|589215148|FG000|Phase B|Protocol Deviation|0|||
163138574|NCT01052077|589215149|FG001|Phase B|Protocol Deviation|3|||
163138575|NCT01052077|589215150|FG002|Phase B|Protocol Deviation|4|||
163138576|NCT01052077|589215151|FG003|Phase B|Protocol Deviation|0|||
163138577|NCT01052077|589215148|FG000|Phase B|Lack of Efficacy|0|||
163138578|NCT01052077|589215149|FG001|Phase B|Lack of Efficacy|1|||
162660086|NCT01969838|587467886|FG002|Open-label Phase|Death|13|||
162660087|NCT01969838|587467887|FG003|Open-label Phase|Death|11|||
162660088|NCT01969838|587467884|FG000|Open-label Phase|Physician Decision|0|||
163138579|NCT01052077|589215150|FG002|Phase B|Lack of Efficacy|0|||
163138580|NCT01052077|589215151|FG003|Phase B|Lack of Efficacy|0|||
163138581|NCT01052077|589215148|FG000|Phase A+|Lost to Follow-up|0|||
163138582|NCT01052077|589215149|FG001|Phase A+|Lost to Follow-up|0|||
163138583|NCT01052077|589215150|FG002|Phase A+|Lost to Follow-up|0|||
163138584|NCT01052077|589215151|FG003|Phase A+|Lost to Follow-up|8|||
163138585|NCT01052077|589215148|FG000|Phase A+|Adverse Event|0|||
163138586|NCT01052077|589215149|FG001|Phase A+|Adverse Event|0|||
163138587|NCT01052077|589215150|FG002|Phase A+|Adverse Event|0|||
163138588|NCT01052077|589215151|FG003|Phase A+|Adverse Event|4|||
163138589|NCT01052077|589215148|FG000|Phase A+|Met Withdrawal Criteria|0|||
163138590|NCT01052077|589215149|FG001|Phase A+|Met Withdrawal Criteria|0|||
163138591|NCT01052077|589215150|FG002|Phase A+|Met Withdrawal Criteria|0|||
162720305|NCT03779048|587683697|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
162720306|NCT03779048|587683698|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
162720307|NCT03779048|587683696|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
162720308|NCT03779048|587683697|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
162720309|NCT03779048|587683698|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
162720310|NCT05328297|587683699|FG000|Overall Study|Adverse Event|5|||
162720311|NCT05328297|587683700|FG001|Overall Study|Adverse Event|7|||
162720312|NCT05328297|587683699|FG000|Overall Study|Withdrawal by Subject|4|||
162720313|NCT05328297|587683700|FG001|Overall Study|Withdrawal by Subject|3|||
162720314|NCT05328297|587683699|FG000|Overall Study|Lack of Efficacy|1|||
162720315|NCT05328297|587683700|FG001|Overall Study|Lack of Efficacy|0|||
162720316|NCT05328297|587683699|FG000|Overall Study|Lost to Follow-up|1|||
162720317|NCT05328297|587683700|FG001|Overall Study|Lost to Follow-up|0|||
162720318|NCT05328297|587683699|FG000|Overall Study|Protocol Violation|1|||
162720319|NCT05328297|587683700|FG001|Overall Study|Protocol Violation|0|||
162720320|NCT05328297|587683699|FG000|Overall Study|Randomized but not treated|1|||
162720321|NCT05328297|587683700|FG001|Overall Study|Randomized but not treated|1|||
162720322|NCT01286272|587683701|FG000|Overall Study|Ineligible after beginning treatment|1|||
162720323|NCT01286272|587683702|FG001|Overall Study|Ineligible after beginning treatment|3|||
162720324|NCT03979365|587683705|FG000|Overall Study|Death|1|||
162720325|NCT03979365|587683706|FG001|Overall Study|Death|3|||
162720326|NCT03979365|587683705|FG000|Overall Study|Withdrawal by Subject|0|||
162720327|NCT03979365|587683706|FG001|Overall Study|Withdrawal by Subject|1|||
162720328|NCT03979365|587683705|FG000|Overall Study|Drug Conversion|0|||
162720329|NCT03979365|587683706|FG001|Overall Study|Drug Conversion|3|||
162720330|NCT04496960|587683707|FG000|Overall Study|Physician Decision|0|||
162720331|NCT04496960|587683708|FG001|Overall Study|Physician Decision|1|||
162720332|NCT00028769|587683711|FG000|Overall Study|Adverse Event|2|||
162720333|NCT00028769|587683711|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
162720334|NCT00028769|587683711|FG000|Overall Study|Progression or Death|31|||
162720335|NCT00028769|587683711|FG000|Overall Study|Other - Not Protocol Specified|1|||
162720336|NCT00028769|587683711|FG000|Overall Study|Ineligible|5|||
162720337|NCT00028769|587683711|FG000|Overall Study|Not Analyzable|1|||
162720338|NCT02496702|587683714|FG000|Overall Study|Lost to Follow-up|8|||
162720339|NCT02496702|587683715|FG001|Overall Study|Lost to Follow-up|6|||
162720340|NCT02496702|587683714|FG000|Overall Study|Only partially tested|0|||
162720341|NCT02496702|587683715|FG001|Overall Study|Only partially tested|2|||
162720342|NCT00941655|587683716|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
162720343|NCT00941655|587683717|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
162720344|NCT00941655|587683716|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
162720345|NCT00941655|587683717|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
162720346|NCT00941655|587683716|FG000|Overall Study|progressed while on chemo|0|||
162720347|NCT00941655|587683717|FG001|Overall Study|progressed while on chemo|2|||
162720348|NCT00941655|587683716|FG000|Overall Study|refused further treatment|0|||
162720349|NCT00941655|587683717|FG001|Overall Study|refused further treatment|1|||
162720350|NCT00941655|587683716|FG000|Overall Study|withdrew consent|0|||
162720351|NCT00941655|587683717|FG001|Overall Study|withdrew consent|1|||
162720352|NCT00941655|587683716|FG000|Overall Study|non-compliant|0|||
162720353|NCT00941655|587683717|FG001|Overall Study|non-compliant|1|||
162720354|NCT05855655|587683722|FG000|Overall Study|Withdrawal by Subject|0|||
162720355|NCT05855655|587683723|FG001|Overall Study|Withdrawal by Subject|1|||
162720356|NCT05855655|587683722|FG000|Overall Study|Lost to Follow-up|4|||
162720357|NCT05855655|587683723|FG001|Overall Study|Lost to Follow-up|0|||
162720358|NCT01613716|587683726|FG000|Overall Study|screen failures|3|||
162720359|NCT01613716|587683726|FG000|Overall Study|Lost to Follow-up|4|||
162720360|NCT01426269|587683727|FG000|Period 1: 12 Weeks|Adverse Event|5|||
162720361|NCT01426269|587683728|FG001|Period 1: 12 Weeks|Adverse Event|0|||
162720362|NCT01426269|587683729|FG002|Period 1: 12 Weeks|Adverse Event|0|||
162720363|NCT01426269|587683727|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
162720364|NCT01426269|587683728|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
162720365|NCT01426269|587683729|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
162720366|NCT01426269|587683727|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
163138592|NCT01052077|589215151|FG003|Phase A+|Met Withdrawal Criteria|2|||
163138593|NCT01052077|589215148|FG000|Phase A+|Withdrawal by Subject|0|||
163138594|NCT01052077|589215149|FG001|Phase A+|Withdrawal by Subject|0|||
163138595|NCT01052077|589215150|FG002|Phase A+|Withdrawal by Subject|0|||
163138596|NCT01052077|589215151|FG003|Phase A+|Withdrawal by Subject|7|||
163138597|NCT00003199|589215159|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
163138598|NCT00003199|589215159|FG000|Overall Study|Lack of insurance clearance|2|||
163138599|NCT00003199|589215159|FG000|Overall Study|Screen fail|15|||
163138600|NCT02487030|589215160|FG000|Overall Study|Lack of Efficacy|2|||
163138601|NCT02487030|589215161|FG001|Overall Study|Lack of Efficacy|4|||
163138602|NCT02487030|589215162|FG002|Overall Study|Lack of Efficacy|1|||
163138603|NCT02487030|589215163|FG003|Overall Study|Lack of Efficacy|0|||
163138604|NCT02487030|589215164|FG004|Overall Study|Lack of Efficacy|1|||
163138605|NCT02487030|589215165|FG005|Overall Study|Lack of Efficacy|0|||
163138606|NCT02487030|589215166|FG006|Overall Study|Lack of Efficacy|0|||
162660089|NCT01969838|587467885|FG001|Open-label Phase|Physician Decision|0|||
162660090|NCT01969838|587467886|FG002|Open-label Phase|Physician Decision|9|||
162660091|NCT01969838|587467887|FG003|Open-label Phase|Physician Decision|14|||
162660092|NCT01969838|587467884|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
162660093|NCT01969838|587467885|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
162660094|NCT01969838|587467886|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
162660095|NCT01969838|587467887|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
162660096|NCT00408993|587467888|FG000|Overall Study|Adverse Event|15|||
162660097|NCT00408993|587467889|FG001|Overall Study|Adverse Event|4|||
162660098|NCT00408993|587467888|FG000|Overall Study|Protocol Violation|1|||
162660099|NCT00408993|587467889|FG001|Overall Study|Protocol Violation|6|||
162660100|NCT00408993|587467888|FG000|Overall Study|Lack of Efficacy|1|||
162660101|NCT00408993|587467889|FG001|Overall Study|Lack of Efficacy|4|||
162660102|NCT00408993|587467888|FG000|Overall Study|Withdrawal by Subject|2|||
162660103|NCT00408993|587467889|FG001|Overall Study|Withdrawal by Subject|3|||
162660104|NCT04193202|587467890|FG000|Overall Study|Adverse Event|2|||
162720367|NCT01426269|587683728|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
162660105|NCT04193202|587467891|FG001|Overall Study|Adverse Event|1|||
162720368|NCT01426269|587683729|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
162660106|NCT04193202|587467890|FG000|Overall Study|Death|0|||
162660107|NCT04193202|587467891|FG001|Overall Study|Death|1|||
162660108|NCT04193202|587467890|FG000|Overall Study|Physician Decision|1|||
162720369|NCT01426269|587683727|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
162660109|NCT04193202|587467891|FG001|Overall Study|Physician Decision|1|||
162660110|NCT04193202|587467890|FG000|Overall Study|Protocol Violation|2|||
162660111|NCT04193202|587467891|FG001|Overall Study|Protocol Violation|2|||
162660112|NCT04193202|587467890|FG000|Overall Study|Withdrawal by Subject|11|||
162660113|NCT04193202|587467891|FG001|Overall Study|Withdrawal by Subject|5|||
163138607|NCT02487030|589215160|FG000|Overall Study|Lost to Follow-up|0|||
163138608|NCT02487030|589215161|FG001|Overall Study|Lost to Follow-up|0|||
163138609|NCT02487030|589215162|FG002|Overall Study|Lost to Follow-up|1|||
163138610|NCT02487030|589215163|FG003|Overall Study|Lost to Follow-up|1|||
163138611|NCT02487030|589215164|FG004|Overall Study|Lost to Follow-up|0|||
163138612|NCT02487030|589215165|FG005|Overall Study|Lost to Follow-up|1|||
163138613|NCT02487030|589215166|FG006|Overall Study|Lost to Follow-up|0|||
163138614|NCT02487030|589215160|FG000|Overall Study|Adverse Event|0|||
163138615|NCT02487030|589215161|FG001|Overall Study|Adverse Event|0|||
163138616|NCT02487030|589215162|FG002|Overall Study|Adverse Event|0|||
163138617|NCT02487030|589215163|FG003|Overall Study|Adverse Event|1|||
163138618|NCT02487030|589215164|FG004|Overall Study|Adverse Event|0|||
163138619|NCT02487030|589215165|FG005|Overall Study|Adverse Event|0|||
163138620|NCT02487030|589215166|FG006|Overall Study|Adverse Event|0|||
163138621|NCT02487030|589215160|FG000|Overall Study|Death|0|||
163138622|NCT02487030|589215161|FG001|Overall Study|Death|0|||
163138623|NCT02487030|589215162|FG002|Overall Study|Death|0|||
163138624|NCT02487030|589215163|FG003|Overall Study|Death|0|||
163138625|NCT02487030|589215164|FG004|Overall Study|Death|1|||
163138626|NCT02487030|589215165|FG005|Overall Study|Death|0|||
163138627|NCT02487030|589215166|FG006|Overall Study|Death|0|||
163138628|NCT03857542|589215167|FG000|Overall Study|Adverse Event|1|||
163138629|NCT03857542|589215168|FG001|Overall Study|Adverse Event|3|||
163138630|NCT03857542|589215167|FG000|Overall Study|Withdrawal by Subject|2|||
163138631|NCT03857542|589215168|FG001|Overall Study|Withdrawal by Subject|1|||
163138632|NCT03857542|589215167|FG000|Overall Study|Lost to Follow-up|2|||
163138633|NCT03857542|589215168|FG001|Overall Study|Lost to Follow-up|1|||
163138634|NCT03857542|589215167|FG000|Overall Study|Reason not Specified|1|||
163138635|NCT03857542|589215168|FG001|Overall Study|Reason not Specified|0|||
163138636|NCT00900029|589215169|FG000|Overall Study|Lost to Follow-up|0|||
163138637|NCT00900029|589215170|FG001|Overall Study|Lost to Follow-up|2|||
163138638|NCT00900029|589215171|FG002|Overall Study|Lost to Follow-up|1|||
163138639|NCT00900029|589215172|FG003|Overall Study|Lost to Follow-up|4|||
163138640|NCT00900029|589215173|FG004|Overall Study|Lost to Follow-up|4|||
163138641|NCT00900029|589215169|FG000|Overall Study|Withdrawal by Subject|2|||
163138642|NCT00900029|589215170|FG001|Overall Study|Withdrawal by Subject|2|||
163138643|NCT00900029|589215171|FG002|Overall Study|Withdrawal by Subject|1|||
163138644|NCT00900029|589215172|FG003|Overall Study|Withdrawal by Subject|1|||
163138645|NCT00900029|589215173|FG004|Overall Study|Withdrawal by Subject|1|||
163138646|NCT00900029|589215169|FG000|Overall Study|Adverse Event|0|||
163138647|NCT00900029|589215170|FG001|Overall Study|Adverse Event|0|||
163138648|NCT00900029|589215171|FG002|Overall Study|Adverse Event|1|||
163138649|NCT00900029|589215172|FG003|Overall Study|Adverse Event|1|||
163138650|NCT00900029|589215173|FG004|Overall Study|Adverse Event|1|||
163138651|NCT00900029|589215169|FG000|Overall Study|Death|1|||
163138652|NCT00900029|589215170|FG001|Overall Study|Death|0|||
163138653|NCT00900029|589215171|FG002|Overall Study|Death|0|||
163138654|NCT00900029|589215172|FG003|Overall Study|Death|1|||
163138655|NCT00900029|589215173|FG004|Overall Study|Death|0|||
163138656|NCT02709330|589215175|FG000|Overall Study|Death|5|||
163138657|NCT02709330|589215176|FG001|Overall Study|Death|0|||
163138658|NCT02709330|589215175|FG000|Overall Study|Lost to Follow-up|2|||
163138659|NCT02709330|589215176|FG001|Overall Study|Lost to Follow-up|0|||
163138660|NCT02709330|589215175|FG000|Overall Study|Physician Decision|2|||
163138661|NCT02709330|589215176|FG001|Overall Study|Physician Decision|0|||
163138662|NCT02709330|589215175|FG000|Overall Study|Withdrawal by Subject|4|||
163138663|NCT02709330|589215176|FG001|Overall Study|Withdrawal by Subject|0|||
163138664|NCT02587819|589215179|FG000|Overall Study|Adverse Event|1|||
163138665|NCT02587819|589215179|FG000|Overall Study|Lost to Follow-up|1|||
163138666|NCT00859547|589217781|FG000|Overall Study|Lost to Follow-up|1|||
163138667|NCT00859547|589217781|FG000|Overall Study|Parent withdrew consent|1|||
163138668|NCT00786799|589217782|FG000|Overall Study|Lost to Follow-up|1|||
162660114|NCT01777997|587467892|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
163138669|NCT00786799|589217783|FG001|Overall Study|Lost to Follow-up|1|||
163138670|NCT02544503|589217784|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
163138671|NCT02544503|589217785|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
163138672|NCT02544503|589217784|FG000|Overall Study|Lost to Follow-up|9|||
163138673|NCT02544503|589217785|FG001|Overall Study|Lost to Follow-up|0|||
163138674|NCT02544503|589217784|FG000|Overall Study|Withdrawal by Subject|1|||
163138675|NCT02544503|589217785|FG001|Overall Study|Withdrawal by Subject|0|||
163138676|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
163138677|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
162660115|NCT01777997|587467892|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
162660116|NCT01777997|587467892|FG000|Weeks 48 to 72/96 on ART|Death|1|||
162660117|NCT01777997|587467892|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
162660118|NCT02488629|587467894|FG000|Overall Study|Lack of Efficacy|3|||
162660119|NCT02488629|587467895|FG001|Overall Study|Lack of Efficacy|1|||
162660120|NCT02488629|587467896|FG002|Overall Study|Lack of Efficacy|0|||
162660121|NCT02488629|587467897|FG003|Overall Study|Lack of Efficacy|0|||
162660122|NCT02488629|587467894|FG000|Overall Study|Withdrawal by Subject|0|||
162660123|NCT02488629|587467895|FG001|Overall Study|Withdrawal by Subject|1|||
162660124|NCT02488629|587467896|FG002|Overall Study|Withdrawal by Subject|0|||
162660125|NCT02488629|587467897|FG003|Overall Study|Withdrawal by Subject|0|||
162660126|NCT02932891|587467898|FG000|Overall Study|Lost to Follow-up|2|||
162660127|NCT02932891|587467898|FG000|Overall Study|HPA Suppress|2|||
163138678|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138679|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138680|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138681|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138682|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138683|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138684|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138685|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138686|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138687|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138688|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138689|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138690|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
163138691|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138692|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138693|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138694|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138695|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138696|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138697|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138698|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138699|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138700|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138701|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
163138702|NCT04640311|589217786|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138703|NCT04640311|589217787|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
163138704|NCT04640311|589217788|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138705|NCT04640311|589217789|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138706|NCT04640311|589217790|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138707|NCT04640311|589217791|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138708|NCT04640311|589217792|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138709|NCT04640311|589217793|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138710|NCT04640311|589217794|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138711|NCT04640311|589217795|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138712|NCT04640311|589217796|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138713|NCT04640311|589217797|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138714|NCT04640311|589217798|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138715|NCT04640311|589217786|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
163138716|NCT04640311|589217787|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
163138717|NCT04640311|589217788|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
163138718|NCT04640311|589217789|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138719|NCT04640311|589217790|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
162660128|NCT04622254|587467899|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162660129|NCT04622254|587467900|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
162660130|NCT04622254|587467901|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162660131|NCT04622254|587467902|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162660132|NCT04622254|587467903|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162660133|NCT04622254|587467904|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162660134|NCT04622254|587467899|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
162660135|NCT04622254|587467900|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
162660136|NCT04622254|587467901|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
162660137|NCT04622254|587467902|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162660138|NCT04622254|587467903|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162660139|NCT04622254|587467904|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162660140|NCT04622254|587467899|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
162660141|NCT04622254|587467900|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162660142|NCT04622254|587467901|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162720370|NCT01426269|587683728|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
162720371|NCT01426269|587683729|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
162720372|NCT01426269|587683727|FG000|Period 1: 12 Weeks|Pregnancy|1|||
162720373|NCT01426269|587683728|FG001|Period 1: 12 Weeks|Pregnancy|0|||
162720374|NCT01426269|587683729|FG002|Period 1: 12 Weeks|Pregnancy|0|||
162720375|NCT01426269|587683727|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
162720376|NCT01426269|587683728|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
162720377|NCT01426269|587683729|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
162720378|NCT01426269|587683727|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
162720379|NCT01426269|587683728|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
162720380|NCT01426269|587683729|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
162720381|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Adverse Event|0|||
162720382|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Adverse Event|1|||
162720383|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Adverse Event|2|||
162720384|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
162720385|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
162720386|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
162720387|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
162720388|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
162660143|NCT04622254|587467902|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162660144|NCT04622254|587467903|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162660145|NCT04622254|587467904|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162660146|NCT04622254|587467899|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162660147|NCT04622254|587467900|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
162660148|NCT04622254|587467901|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
162660149|NCT04622254|587467902|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162660150|NCT04622254|587467903|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162660151|NCT04622254|587467904|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162660152|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162660153|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162660154|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162660155|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
162660156|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162660157|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162660158|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162660159|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162660160|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162660161|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
162660162|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162660163|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
162660164|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162660165|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162660166|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162660167|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
162660168|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162660169|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162660170|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162660171|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162660172|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162660173|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
162660174|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162660175|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162660176|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162660177|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162660178|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162660179|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
162660180|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
162660181|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
162660182|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162660183|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162660184|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162660185|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
162660186|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
162660187|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
162660188|NCT04622254|587467899|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
162660189|NCT04622254|587467900|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
162660190|NCT04622254|587467901|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
162660191|NCT04622254|587467902|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
162660192|NCT04622254|587467903|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
162660193|NCT04622254|587467904|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
162660194|NCT02652624|587467905|FG000|Randomized Phase|Pregnancy|3|||
162660195|NCT02652624|587467906|FG001|Randomized Phase|Pregnancy|1|||
162660196|NCT02652624|587467905|FG000|Randomized Phase|Investigator's Discretion|0|||
162660197|NCT02652624|587467906|FG001|Randomized Phase|Investigator's Discretion|2|||
162660198|NCT02652624|587467905|FG000|Randomized Phase|Death|0|||
162660199|NCT02652624|587467906|FG001|Randomized Phase|Death|1|||
162660200|NCT02652624|587467905|FG000|Randomized Phase|Lost to Follow-up|0|||
162660201|NCT02652624|587467906|FG001|Randomized Phase|Lost to Follow-up|1|||
162660202|NCT02652624|587467905|FG000|Extension Phase|Lost to Follow-up|3|||
162660203|NCT02652624|587467906|FG001|Extension Phase|Lost to Follow-up|1|||
162660204|NCT02652624|587467905|FG000|Extension Phase|Pregnancy|1|||
162660205|NCT02652624|587467906|FG001|Extension Phase|Pregnancy|1|||
162660206|NCT02652624|587467905|FG000|Extension Phase|Adverse Event|0|||
162660207|NCT02652624|587467906|FG001|Extension Phase|Adverse Event|1|||
162660208|NCT02652624|587467905|FG000|Extension Phase|Withdrew Consent|0|||
162660209|NCT02652624|587467906|FG001|Extension Phase|Withdrew Consent|1|||
162660210|NCT00577122|587467907|FG000|Overall Study|Adverse Event|0|||
162660211|NCT00577122|587467908|FG001|Overall Study|Adverse Event|2|||
162660212|NCT00577122|587467907|FG000|Overall Study|Progression, relapse during active trt|6|||
162660213|NCT00577122|587467908|FG001|Overall Study|Progression, relapse during active trt|8|||
162660214|NCT00577122|587467907|FG000|Overall Study|Prog, refract disease during active trt|8|||
162660215|NCT00577122|587467908|FG001|Overall Study|Prog, refract disease during active trt|5|||
162660216|NCT00577122|587467907|FG000|Overall Study|Alternative Therapy|0|||
162660217|NCT00577122|587467908|FG001|Overall Study|Alternative Therapy|1|||
162660218|NCT03228680|587467910|FG000|Overall Study|Adverse Event|13|||
162660219|NCT03228680|587467911|FG001|Overall Study|Adverse Event|18|||
162660220|NCT03228680|587467910|FG000|Overall Study|Randomization failure|0|||
162660221|NCT03228680|587467911|FG001|Overall Study|Randomization failure|1|||
162660222|NCT03228680|587467910|FG000|Overall Study|Withdrawal by Subject|1|||
162660223|NCT03228680|587467911|FG001|Overall Study|Withdrawal by Subject|0|||
162660224|NCT03228680|587467910|FG000|Overall Study|Other|9|||
162660225|NCT03228680|587467911|FG001|Overall Study|Other|16|||
162660226|NCT02167035|587467912|FG000|Overall Study|Adverse Event|2|||
162660227|NCT02167035|587467913|FG001|Overall Study|Adverse Event|2|||
162660228|NCT02167035|587467912|FG000|Overall Study|Lost to Follow-up|3|||
162660229|NCT02167035|587467913|FG001|Overall Study|Lost to Follow-up|3|||
162660230|NCT02167035|587467912|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
162660231|NCT02167035|587467913|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
162660232|NCT02252081|587467914|FG000|Overall Study|Withdrawal by Subject|2|||
162660233|NCT02252081|587467915|FG001|Overall Study|Withdrawal by Subject|1|||
162660234|NCT02252081|587467914|FG000|Overall Study|Adverse Event|4|||
162660235|NCT02252081|587467915|FG001|Overall Study|Adverse Event|1|||
162660236|NCT02252081|587467914|FG000|Overall Study|non compliance & others|0|||
162660237|NCT02252081|587467915|FG001|Overall Study|non compliance & others|2|||
162660238|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
162660239|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
162660240|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
162660241|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
162660242|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
162660243|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
162660244|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
162660245|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
162660246|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
162660247|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
162660248|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
162660249|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
162660250|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
162660251|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
162660252|NCT03732638|587467922|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
162660253|NCT03732638|587467923|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
162660254|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
162660255|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
162660256|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
162660257|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
162660258|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
162660259|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
162660260|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
162660261|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
162660262|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
163138720|NCT04640311|589217791|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138721|NCT04640311|589217792|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138722|NCT04640311|589217793|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138723|NCT04640311|589217794|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138724|NCT04640311|589217795|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138725|NCT04640311|589217796|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138726|NCT04640311|589217797|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138727|NCT04640311|589217798|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
163138728|NCT04640311|589217786|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138729|NCT04640311|589217787|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138730|NCT04640311|589217788|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
163138731|NCT04640311|589217789|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138732|NCT04640311|589217790|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138733|NCT04640311|589217791|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138734|NCT04640311|589217792|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138735|NCT04640311|589217793|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138736|NCT04640311|589217794|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138737|NCT04640311|589217795|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138738|NCT04640311|589217796|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138739|NCT04640311|589217797|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138740|NCT04640311|589217798|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
163138741|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138742|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138743|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138744|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
163138745|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138746|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138747|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
163138748|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138749|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138750|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
162660263|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
162660264|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
163138751|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138752|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138753|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
163138754|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138755|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138756|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138757|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138758|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138759|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
163138760|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138761|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138762|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
163138763|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138764|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138765|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138766|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
163138767|NCT04640311|589217786|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138768|NCT04640311|589217787|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138769|NCT04640311|589217788|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138770|NCT04640311|589217789|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138771|NCT04640311|589217790|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138772|NCT04640311|589217791|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138773|NCT04640311|589217792|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
163138774|NCT04640311|589217793|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138775|NCT04640311|589217794|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138776|NCT04640311|589217795|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138777|NCT04640311|589217796|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
163138778|NCT04640311|589217797|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138779|NCT04640311|589217798|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
163138780|NCT04640311|589217786|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138781|NCT04640311|589217787|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138782|NCT04640311|589217788|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138783|NCT04640311|589217789|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138784|NCT04640311|589217790|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138785|NCT04640311|589217791|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138786|NCT04640311|589217792|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138787|NCT04640311|589217793|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138788|NCT04640311|589217794|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138789|NCT04640311|589217795|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138790|NCT04640311|589217796|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138791|NCT04640311|589217797|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
163138792|NCT04640311|589217798|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
163138793|NCT03906071|589217799|FG000|Overall Study|Death|180|||
163138794|NCT03906071|589217800|FG001|Overall Study|Death|185|||
163138795|NCT03906071|589217799|FG000|Overall Study|Lost to Follow-up|3|||
163138796|NCT03906071|589217800|FG001|Overall Study|Lost to Follow-up|3|||
163138797|NCT03906071|589217799|FG000|Overall Study|Withdrawal by Subject|15|||
163138798|NCT03906071|589217800|FG001|Overall Study|Withdrawal by Subject|27|||
163138799|NCT03906071|589217799|FG000|Overall Study|Other|2|||
163138800|NCT03906071|589217800|FG001|Overall Study|Other|1|||
163138801|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Technical problems|0|||
163138802|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Technical problems|0|||
163138803|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Technical problems|0|||
163138804|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Technical problems|1|||
163138805|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138806|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
163138807|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138808|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
163138809|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
163138810|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
163138811|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
163138812|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
162720389|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
162720390|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
162720391|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
162720392|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
162720393|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Site closed|0|||
162720394|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Site closed|6|||
162720395|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Site closed|5|||
162720396|NCT01426269|587683727|FG000|Period 2: 40 Weeks|Relapsed|0|||
162720397|NCT01426269|587683728|FG001|Period 2: 40 Weeks|Relapsed|9|||
162720398|NCT01426269|587683729|FG002|Period 2: 40 Weeks|Relapsed|18|||
162720399|NCT00419094|587683731|FG000|Overall Study|Adverse Event|3|||
162720400|NCT00419094|587683732|FG001|Overall Study|Adverse Event|7|||
162720401|NCT00419094|587683731|FG000|Overall Study|Lack of Efficacy|1|||
162720402|NCT00419094|587683732|FG001|Overall Study|Lack of Efficacy|0|||
162720403|NCT00419094|587683731|FG000|Overall Study|Lost to Follow-up|0|||
162720404|NCT00419094|587683732|FG001|Overall Study|Lost to Follow-up|2|||
162720405|NCT00419094|587683731|FG000|Overall Study|Protocol Violation|1|||
162720406|NCT00419094|587683732|FG001|Overall Study|Protocol Violation|14|||
162720407|NCT00419094|587683731|FG000|Overall Study|Withdrawal of consent|1|||
162720408|NCT00419094|587683732|FG001|Overall Study|Withdrawal of consent|5|||
162720409|NCT00419094|587683731|FG000|Overall Study|Other: Error determining exit criteria|1|||
162720410|NCT00419094|587683732|FG001|Overall Study|Other: Error determining exit criteria|0|||
162720411|NCT00419094|587683731|FG000|Overall Study|Other: Patient non-compliant|0|||
162720412|NCT00419094|587683732|FG001|Overall Study|Other: Patient non-compliant|1|||
162720413|NCT00419094|587683731|FG000|Overall Study|Other: No contact for extended period|0|||
162720414|NCT00419094|587683732|FG001|Overall Study|Other: No contact for extended period|1|||
162720415|NCT02296424|587683733|FG000|Part 1|New therapy for study indication|0|||
162720416|NCT02296424|587683734|FG001|Part 1|New therapy for study indication|1|||
162720417|NCT02296424|587683735|FG002|Part 1|New therapy for study indication|0|||
162720418|NCT02296424|587683736|FG003|Part 1|New therapy for study indication|0|||
162720419|NCT02296424|587683733|FG000|Part 1|Protocol Violation|0|||
162720420|NCT02296424|587683734|FG001|Part 1|Protocol Violation|1|||
162720421|NCT02296424|587683735|FG002|Part 1|Protocol Violation|0|||
162720422|NCT02296424|587683736|FG003|Part 1|Protocol Violation|0|||
162720423|NCT02296424|587683733|FG000|Part 1|Withdrawal by Subject|0|||
162720424|NCT02296424|587683734|FG001|Part 1|Withdrawal by Subject|2|||
162720425|NCT02296424|587683735|FG002|Part 1|Withdrawal by Subject|0|||
162720426|NCT02296424|587683736|FG003|Part 1|Withdrawal by Subject|0|||
162720427|NCT02296424|587683733|FG000|Part 1|Study terminated by sponsor|0|||
162720428|NCT02296424|587683734|FG001|Part 1|Study terminated by sponsor|1|||
162720429|NCT02296424|587683735|FG002|Part 1|Study terminated by sponsor|0|||
162720430|NCT02296424|587683736|FG003|Part 1|Study terminated by sponsor|0|||
162720431|NCT02296424|587683733|FG000|Part 1|Adverse Event|2|||
162720432|NCT02296424|587683734|FG001|Part 1|Adverse Event|11|||
162720433|NCT02296424|587683735|FG002|Part 1|Adverse Event|0|||
162720434|NCT02296424|587683736|FG003|Part 1|Adverse Event|0|||
162720435|NCT02296424|587683733|FG000|Part 1|Lack of Efficacy|5|||
162720436|NCT02296424|587683734|FG001|Part 1|Lack of Efficacy|17|||
162720437|NCT02296424|587683735|FG002|Part 1|Lack of Efficacy|0|||
162720438|NCT02296424|587683736|FG003|Part 1|Lack of Efficacy|0|||
162720439|NCT02296424|587683733|FG000|Part 1|16 directly started part II|16|||
162720440|NCT02296424|587683734|FG001|Part 1|16 directly started part II|0|||
162720441|NCT02296424|587683735|FG002|Part 1|16 directly started part II|0|||
162720442|NCT02296424|587683736|FG003|Part 1|16 directly started part II|0|||
162720443|NCT02296424|587683733|FG000|Part 2|Lack of Efficacy|0|||
162720444|NCT02296424|587683734|FG001|Part 2|Lack of Efficacy|0|||
162720445|NCT02296424|587683735|FG002|Part 2|Lack of Efficacy|1|||
162720446|NCT02296424|587683736|FG003|Part 2|Lack of Efficacy|0|||
162720447|NCT02296424|587683733|FG000|Part 2|Adverse Event|0|||
162720448|NCT02296424|587683734|FG001|Part 2|Adverse Event|0|||
162720449|NCT02296424|587683735|FG002|Part 2|Adverse Event|1|||
162720450|NCT02296424|587683736|FG003|Part 2|Adverse Event|0|||
162720451|NCT02296424|587683733|FG000|Part 2|Lost to Follow-up|0|||
162720452|NCT02296424|587683734|FG001|Part 2|Lost to Follow-up|0|||
162720453|NCT02296424|587683735|FG002|Part 2|Lost to Follow-up|1|||
162720454|NCT02296424|587683736|FG003|Part 2|Lost to Follow-up|0|||
162720455|NCT00743444|587683737|FG000|First Intervention|Catheter placement problems|0|||
162720456|NCT00743444|587683738|FG001|First Intervention|Catheter placement problems|1|||
162720457|NCT00743444|587683737|FG000|Washout Period|Adverse Event|0|||
162720458|NCT00743444|587683738|FG001|Washout Period|Adverse Event|1|||
162720459|NCT01337635|587683747|FG000|Overall Study|Lost to Follow-up|0|||
162720460|NCT01337635|587683748|FG001|Overall Study|Lost to Follow-up|1|||
162720461|NCT03287622|587683752|FG000|Overall Study|Withdrawal by Subject|1|||
162720462|NCT03287622|587683753|FG001|Overall Study|Withdrawal by Subject|0|||
162720463|NCT03287622|587683752|FG000|Overall Study|Lost to Follow-up|27|||
162720464|NCT03287622|587683753|FG001|Overall Study|Lost to Follow-up|15|||
162720465|NCT03287622|587683752|FG000|Overall Study|No prescripion after surgery|28|||
162720466|NCT03287622|587683753|FG001|Overall Study|No prescripion after surgery|31|||
162720467|NCT03287622|587683752|FG000|Overall Study|prolonged Length of stay|2|||
162720468|NCT03287622|587683753|FG001|Overall Study|prolonged Length of stay|0|||
162720469|NCT03287622|587683752|FG000|Overall Study|surgery related|0|||
162720470|NCT03287622|587683753|FG001|Overall Study|surgery related|2|||
162720471|NCT00486330|587683762|FG000|Overall Study|Adverse Event|2|||
162720472|NCT03804918|587683763|FG000|Overall Study|Participant did not use the app|1|||
162720473|NCT05694065|587683764|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
162720474|NCT05694065|587683764|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
162720475|NCT05694065|587683764|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
162720476|NCT01087762|587683765|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
162720477|NCT01087762|587683766|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
162720478|NCT01087762|587683767|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
162720479|NCT01087762|587683768|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
162720480|NCT01087762|587683769|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
162720481|NCT01087762|587683765|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
162720482|NCT01087762|587683766|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162720483|NCT01087762|587683767|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
162720484|NCT01087762|587683768|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162720485|NCT01087762|587683769|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162720486|NCT01087762|587683765|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
162720487|NCT01087762|587683766|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
162720488|NCT01087762|587683767|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
162720489|NCT01087762|587683768|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
162660265|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
162660266|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
162660267|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
162660268|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
162660269|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
162660270|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
162660271|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
162660272|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
162660273|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
162660274|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
162660275|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
162660276|NCT03732638|587467922|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
162660277|NCT03732638|587467923|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
162660278|NCT03732638|587467922|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
162660279|NCT03732638|587467923|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
162660280|NCT03732638|587467922|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
162660281|NCT03732638|587467923|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
162660282|NCT03732638|587467922|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
162660283|NCT03732638|587467923|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
162660284|NCT03732638|587467922|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
162660285|NCT03732638|587467923|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
162660286|NCT00642304|587467924|FG000|Overall Study|Adverse Event|1|||
162660287|NCT00642304|587467924|FG000|Overall Study|Death|1|||
162660288|NCT00642304|587467924|FG000|Overall Study|Blood transfusion|2|||
162660289|NCT00642304|587467924|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
162660290|NCT00642304|587467924|FG000|Overall Study|Transplantation|1|||
162660291|NCT03192150|587467925|FG000|Overall Study|Adverse Event|14|||
162660292|NCT03192150|587467926|FG001|Overall Study|Adverse Event|12|||
162660293|NCT03192150|587467925|FG000|Overall Study|Lack of Efficacy|23|||
162660294|NCT03192150|587467926|FG001|Overall Study|Lack of Efficacy|30|||
162660295|NCT03192150|587467925|FG000|Overall Study|Lost to Follow-up|1|||
162660296|NCT03192150|587467926|FG001|Overall Study|Lost to Follow-up|1|||
162660297|NCT03192150|587467925|FG000|Overall Study|Withdrawal by Subject|4|||
162660298|NCT03192150|587467926|FG001|Overall Study|Withdrawal by Subject|2|||
162660299|NCT03192150|587467925|FG000|Overall Study|Protocol Violation|5|||
162660300|NCT03192150|587467926|FG001|Overall Study|Protocol Violation|2|||
162660301|NCT03192150|587467925|FG000|Overall Study|Surgery Canceled|6|||
162660302|NCT03192150|587467926|FG001|Overall Study|Surgery Canceled|2|||
162660303|NCT03192150|587467925|FG000|Overall Study|Other-Various Administrative Reasons|2|||
162660304|NCT03192150|587467926|FG001|Overall Study|Other-Various Administrative Reasons|5|||
162720490|NCT01087762|587683769|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
162720491|NCT01087762|587683765|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
162720492|NCT01087762|587683766|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
162720493|NCT01087762|587683767|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
162720494|NCT01087762|587683768|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
162720495|NCT01087762|587683769|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
162660305|NCT00482391|587467927|FG000|Overall Study|Withdrawal by Subject|1|||
162660306|NCT00482391|587467927|FG000|Overall Study|Adverse Event|1|||
162720496|NCT01087762|587683765|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
162720497|NCT01087762|587683766|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
162720498|NCT01087762|587683767|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
162720499|NCT01087762|587683768|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
162720500|NCT01087762|587683769|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
162720501|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162720502|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162720503|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162720504|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
162720505|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
162720506|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162720507|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162720508|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162720509|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
162720510|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
162720511|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162720512|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162720513|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162720514|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
162720515|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
162720516|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162720517|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162720518|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162720519|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
162720520|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
162720521|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
162720522|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
162720523|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
162720524|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
162720525|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
162720526|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162720527|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162720528|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162720529|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
162720530|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
162720531|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162720532|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162720533|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162720534|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
162720535|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
162720536|NCT01087762|587683765|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162720537|NCT01087762|587683766|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162720538|NCT01087762|587683767|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162720539|NCT01087762|587683768|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
162720540|NCT01087762|587683769|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
162720541|NCT01505881|587683772|FG000|Overall Study|Adverse Event|0|||
162720542|NCT01505881|587683773|FG001|Overall Study|Adverse Event|1|||
163138813|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
163138814|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
163138815|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
163138816|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
163138817|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Death|0|||
163138818|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Death|3|||
163138819|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Death|1|||
163138820|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Death|0|||
163138821|NCT02152761|589217801|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
163138822|NCT02152761|589217802|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
163138823|NCT02152761|589217803|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
163138824|NCT02152761|589217804|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
163138825|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
163138826|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
162720543|NCT01505881|587683772|FG000|Overall Study|Lost to Follow-up|2|||
162720544|NCT01505881|587683773|FG001|Overall Study|Lost to Follow-up|0|||
162720545|NCT01505881|587683772|FG000|Overall Study|Withdrawal by Subject|2|||
163138827|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
163138828|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
163138829|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
163138830|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
162660307|NCT00482391|587467927|FG000|Overall Study|Death|1|||
162660308|NCT01274637|587467932|FG000|Overall Study|Withdrawal by Subject|0|||
162660309|NCT01274637|587467933|FG001|Overall Study|Withdrawal by Subject|1|||
162660310|NCT01274637|587467932|FG000|Overall Study|Lost to Follow-up|0|||
162660311|NCT01274637|587467933|FG001|Overall Study|Lost to Follow-up|1|||
162720546|NCT01505881|587683773|FG001|Overall Study|Withdrawal by Subject|0|||
162720547|NCT01147341|587683774|FG000|Double Blind Period|Lack of Efficacy|1|||
162720548|NCT01147341|587683775|FG001|Double Blind Period|Lack of Efficacy|1|||
162720549|NCT01147341|587683774|FG000|Double Blind Period|Withdrawal by Subject|0|||
162720550|NCT01147341|587683775|FG001|Double Blind Period|Withdrawal by Subject|1|||
162720551|NCT01147341|587683774|FG000|Open Label Period|Lack of Efficacy|3|||
162720552|NCT01147341|587683775|FG001|Open Label Period|Lack of Efficacy|0|||
162720553|NCT01147341|587683774|FG000|Open Label Period|Subject moved|1|||
162720554|NCT01147341|587683775|FG001|Open Label Period|Subject moved|0|||
162720555|NCT01596504|587683776|FG000|Overall Study|Participant's Private Reason|0|||
162720556|NCT01596504|587683777|FG001|Overall Study|Participant's Private Reason|1|||
162720557|NCT01596504|587683778|FG002|Overall Study|Participant's Private Reason|0|||
162720558|NCT01596504|587683776|FG000|Overall Study|Adverse Event|1|||
162720559|NCT01596504|587683777|FG001|Overall Study|Adverse Event|2|||
162720560|NCT01596504|587683778|FG002|Overall Study|Adverse Event|1|||
162720561|NCT01596504|587683776|FG000|Overall Study|Withdrawal by Subject|1|||
162720562|NCT01596504|587683777|FG001|Overall Study|Withdrawal by Subject|0|||
162720563|NCT01596504|587683778|FG002|Overall Study|Withdrawal by Subject|0|||
162720564|NCT04347954|587683782|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
162720565|NCT04347954|587683783|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
162660312|NCT02606136|587467951|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
162660313|NCT02606136|587467951|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
162660314|NCT02606136|587467951|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
162660315|NCT02606136|587467951|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
162660316|NCT03296696|587467952|FG000|Overall Study|Started Other Antitumor Therapy|1|||
162660317|NCT03296696|587467953|FG001|Overall Study|Started Other Antitumor Therapy|2|||
162660318|NCT03296696|587467954|FG002|Overall Study|Started Other Antitumor Therapy|1|||
163138831|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
163138832|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
163138833|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
163138834|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138835|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138836|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
163138837|NCT02152761|589217801|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
163138838|NCT02152761|589217802|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
163138839|NCT02152761|589217803|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
163138840|NCT02152761|589217804|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
163138841|NCT01797263|589217805|FG000|Overall Study|Withdrawal by Subject|21|||
163138842|NCT01797263|589217806|FG001|Overall Study|Withdrawal by Subject|25|||
163138843|NCT01797263|589217805|FG000|Overall Study|Death|1|||
163138844|NCT01797263|589217806|FG001|Overall Study|Death|0|||
163138845|NCT01797263|589217805|FG000|Overall Study|Lost to Follow-up|15|||
163138846|NCT01797263|589217806|FG001|Overall Study|Lost to Follow-up|15|||
163138847|NCT01485094|589217807|FG000|Overall Study|Adverse Event|1|||
163138848|NCT01485094|589217808|FG001|Overall Study|Adverse Event|1|||
163138849|NCT01485094|589217809|FG002|Overall Study|Adverse Event|1|||
163138850|NCT01485094|589217807|FG000|Overall Study|Lost to Follow-up|1|||
163138851|NCT01485094|589217808|FG001|Overall Study|Lost to Follow-up|0|||
163138852|NCT01485094|589217809|FG002|Overall Study|Lost to Follow-up|0|||
163138853|NCT01485094|589217807|FG000|Overall Study|Withdrawal by Subject|1|||
163138854|NCT01485094|589217808|FG001|Overall Study|Withdrawal by Subject|1|||
163138855|NCT01485094|589217809|FG002|Overall Study|Withdrawal by Subject|0|||
163138856|NCT02859246|589217815|FG000|Overall Study|Screen fails|3|||
163138857|NCT02859246|589217815|FG000|Overall Study|Adverse Event|1|||
162720566|NCT04347954|587683784|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
162720567|NCT04347954|587683782|FG000|Overall Study|Lost to Follow-up|0|||
162720568|NCT04347954|587683783|FG001|Overall Study|Lost to Follow-up|1|||
162720569|NCT04347954|587683784|FG002|Overall Study|Lost to Follow-up|0|||
162720570|NCT03257813|587683785|FG000|Overall Study|Protocol Violation|6|||
163138858|NCT02859246|589217815|FG000|Overall Study|Withdrawal by Subject|1|||
163138859|NCT00855816|589217818|FG000|Overall Study|Withdrawal by Subject|22|||
163138860|NCT00855816|589217819|FG001|Overall Study|Withdrawal by Subject|15|||
163138861|NCT00855816|589217818|FG000|Overall Study|Lost to Follow-up|3|||
163138862|NCT00855816|589217819|FG001|Overall Study|Lost to Follow-up|5|||
163138863|NCT00855816|589217818|FG000|Overall Study|Death|1|||
163138864|NCT00855816|589217819|FG001|Overall Study|Death|0|||
163138865|NCT00855816|589217818|FG000|Overall Study|Became ineligible|0|||
163138866|NCT00855816|589217819|FG001|Overall Study|Became ineligible|1|||
163138867|NCT00337207|589217826|FG000|Overall Study|Withdrawal by Subject|3|||
163138868|NCT03188432|589217827|FG000|Overall Study|Death|3|||
162660319|NCT03296696|587467955|FG003|Overall Study|Started Other Antitumor Therapy|2|||
162660320|NCT03296696|587467956|FG004|Overall Study|Started Other Antitumor Therapy|1|||
162660321|NCT03296696|587467957|FG005|Overall Study|Started Other Antitumor Therapy|1|||
163138869|NCT03188432|589217827|FG000|Overall Study|Withdrawal by Subject|15|||
163138870|NCT03188432|589217827|FG000|Overall Study|Did not complete protocol treatment|9|||
162660322|NCT03296696|587467958|FG006|Overall Study|Started Other Antitumor Therapy|2|||
162660323|NCT03296696|587467959|FG007|Overall Study|Started Other Antitumor Therapy|3|||
162660324|NCT03296696|587467960|FG008|Overall Study|Started Other Antitumor Therapy|1|||
162660325|NCT03296696|587467961|FG009|Overall Study|Started Other Antitumor Therapy|0|||
162660326|NCT03296696|587467952|FG000|Overall Study|Death|0|||
162660327|NCT03296696|587467953|FG001|Overall Study|Death|1|||
162660328|NCT03296696|587467954|FG002|Overall Study|Death|1|||
162660329|NCT03296696|587467955|FG003|Overall Study|Death|2|||
162660330|NCT03296696|587467956|FG004|Overall Study|Death|2|||
162660331|NCT03296696|587467957|FG005|Overall Study|Death|3|||
162660332|NCT03296696|587467958|FG006|Overall Study|Death|1|||
162660333|NCT03296696|587467959|FG007|Overall Study|Death|2|||
162660334|NCT03296696|587467960|FG008|Overall Study|Death|0|||
162660335|NCT03296696|587467961|FG009|Overall Study|Death|0|||
162660336|NCT03296696|587467952|FG000|Overall Study|Withdrawal by Subject|0|||
162660337|NCT03296696|587467953|FG001|Overall Study|Withdrawal by Subject|0|||
162660338|NCT03296696|587467954|FG002|Overall Study|Withdrawal by Subject|1|||
162660339|NCT03296696|587467955|FG003|Overall Study|Withdrawal by Subject|0|||
162660340|NCT03296696|587467956|FG004|Overall Study|Withdrawal by Subject|1|||
162660341|NCT03296696|587467957|FG005|Overall Study|Withdrawal by Subject|0|||
162660342|NCT03296696|587467958|FG006|Overall Study|Withdrawal by Subject|0|||
162660343|NCT03296696|587467959|FG007|Overall Study|Withdrawal by Subject|0|||
162660344|NCT03296696|587467960|FG008|Overall Study|Withdrawal by Subject|0|||
162660345|NCT03296696|587467961|FG009|Overall Study|Withdrawal by Subject|1|||
162660346|NCT04694131|587467964|FG000|Overall Study|Withdrawal by Subject|7|||
162660347|NCT04694131|587467964|FG000|Overall Study|Screen Failure|1|||
162660348|NCT04694131|587467964|FG000|Overall Study|High stimulation threshold|3|||
162660349|NCT01350128|587467965|FG000|Overall Study|Withdrawal by Subject|3|||
162660350|NCT01350128|587467965|FG000|Overall Study|Protocol discontinuation criteria|8|||
162660351|NCT01350128|587467965|FG000|Overall Study|Physician Decision|1|||
162660352|NCT01350128|587467965|FG000|Overall Study|Lost to Follow-up|2|||
162660353|NCT02399085|587467969|FG000|Overall Study|Adverse Event|16|||
162660354|NCT02399085|587467969|FG000|Overall Study|Death|2|||
162660355|NCT02399085|587467969|FG000|Overall Study|Withdrawal by Subject|8|||
162660356|NCT02399085|587467969|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
162660357|NCT02399085|587467969|FG000|Overall Study|Physician Decision|5|||
162660358|NCT01859715|587467970|FG000|Overall Study|No 2nd VAS|16|||
162660359|NCT01859715|587467971|FG001|Overall Study|No 2nd VAS|8|||
162660360|NCT01859715|587467972|FG002|Overall Study|No 2nd VAS|23|||
162660361|NCT00086580|587467976|FG000|Treatment Period|Disease progression|9|||
162660362|NCT00086580|587467977|FG001|Treatment Period|Disease progression|8|||
162660363|NCT00086580|587467976|FG000|Treatment Period|Unable to comply with protocol|3|||
162660364|NCT00086580|587467977|FG001|Treatment Period|Unable to comply with protocol|1|||
162660365|NCT00086580|587467976|FG000|Treatment Period|Withdrawal by Subject|7|||
162660366|NCT00086580|587467977|FG001|Treatment Period|Withdrawal by Subject|8|||
162660367|NCT00086580|587467976|FG000|Treatment Period|Physician Decision|13|||
162660368|NCT00086580|587467977|FG001|Treatment Period|Physician Decision|7|||
162660369|NCT00086580|587467976|FG000|Treatment Period|AE - not treatment related|7|||
162660370|NCT00086580|587467977|FG001|Treatment Period|AE - not treatment related|7|||
162660371|NCT00086580|587467976|FG000|Treatment Period|Toxicity - treatment related|15|||
162660372|NCT00086580|587467977|FG001|Treatment Period|Toxicity - treatment related|15|||
162660373|NCT00086580|587467976|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
162660374|NCT00086580|587467977|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
162660375|NCT00086580|587467976|FG000|Treatment Period|Death|5|||
162660376|NCT00086580|587467977|FG001|Treatment Period|Death|7|||
162660377|NCT00086580|587467976|FG000|Treatment Period|Other|5|||
162660378|NCT00086580|587467977|FG001|Treatment Period|Other|3|||
162660379|NCT00086580|587467976|FG000|Follow-up Period|Disease progression|72|||
162660380|NCT00086580|587467977|FG001|Follow-up Period|Disease progression|99|||
162660381|NCT00086580|587467976|FG000|Follow-up Period|Unable to comply with protocol|5|||
162660382|NCT00086580|587467977|FG001|Follow-up Period|Unable to comply with protocol|0|||
162660383|NCT00086580|587467976|FG000|Follow-up Period|Withdrawal by Subject|6|||
162660384|NCT00086580|587467977|FG001|Follow-up Period|Withdrawal by Subject|6|||
162660385|NCT00086580|587467976|FG000|Follow-up Period|Physician Decision|0|||
162660386|NCT00086580|587467977|FG001|Follow-up Period|Physician Decision|1|||
162660387|NCT00086580|587467976|FG000|Follow-up Period|AE - not related|1|||
162660388|NCT00086580|587467977|FG001|Follow-up Period|AE - not related|0|||
162660389|NCT00086580|587467976|FG000|Follow-up Period|Death|13|||
162660390|NCT00086580|587467977|FG001|Follow-up Period|Death|7|||
162660391|NCT00086580|587467976|FG000|Follow-up Period|Other|7|||
162660392|NCT00086580|587467977|FG001|Follow-up Period|Other|6|||
162660393|NCT00086580|587467976|FG000|Observation Period|Unable to comply with protocol|1|||
162660394|NCT00086580|587467977|FG001|Observation Period|Unable to comply with protocol|1|||
162660395|NCT00086580|587467976|FG000|Observation Period|Withdrawal by Subject|4|||
162660396|NCT00086580|587467977|FG001|Observation Period|Withdrawal by Subject|2|||
162660397|NCT00086580|587467976|FG000|Observation Period|Death|33|||
162660398|NCT00086580|587467977|FG001|Observation Period|Death|55|||
162660399|NCT00086580|587467976|FG000|Observation Period|Other|8|||
162660400|NCT00086580|587467977|FG001|Observation Period|Other|7|||
162660401|NCT00806546|587467982|FG000|Overall Study|Enrolled, not treated|35|||
162660402|NCT00806546|587467982|FG000|Overall Study|Lost to Follow-up|32|||
162660403|NCT00806546|587467982|FG000|Overall Study|Adverse Event|74|||
162660404|NCT00806546|587467982|FG000|Overall Study|Withdrawal by Subject|75|||
162660405|NCT00806546|587467982|FG000|Overall Study|Protocol Violation|49|||
162660406|NCT00806546|587467982|FG000|Overall Study|Various|42|||
162660407|NCT00558103|587467985|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
162660408|NCT00558103|587467986|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
162660409|NCT00558103|587467987|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
162660410|NCT00558103|587467988|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
162660411|NCT00558103|587467989|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
162660412|NCT00558103|587467990|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
162660413|NCT00558103|587467985|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
162660414|NCT00558103|587467986|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
162660415|NCT00558103|587467987|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
162660416|NCT00558103|587467988|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
162660417|NCT00558103|587467989|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
162660418|NCT00558103|587467990|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
162720571|NCT03257813|587683786|FG001|Overall Study|Protocol Violation|3|||
162720572|NCT05641311|587683787|FG000|Dosing Period 1|Adverse Event|1|||
162660419|NCT00558103|587467985|FG000|Randomized Treatment Phase|Disease Progression|1|||
162660420|NCT00558103|587467986|FG001|Randomized Treatment Phase|Disease Progression|0|||
162660421|NCT00558103|587467987|FG002|Randomized Treatment Phase|Disease Progression|1|||
162660422|NCT00558103|587467988|FG003|Randomized Treatment Phase|Disease Progression|0|||
162660423|NCT00558103|587467989|FG004|Randomized Treatment Phase|Disease Progression|0|||
162660424|NCT00558103|587467990|FG005|Randomized Treatment Phase|Disease Progression|0|||
162660425|NCT00558103|587467985|FG000|Randomized Treatment Phase|Adverse Event|0|||
162660426|NCT00558103|587467986|FG001|Randomized Treatment Phase|Adverse Event|0|||
162660427|NCT00558103|587467987|FG002|Randomized Treatment Phase|Adverse Event|0|||
162660428|NCT00558103|587467988|FG003|Randomized Treatment Phase|Adverse Event|1|||
162660429|NCT00558103|587467989|FG004|Randomized Treatment Phase|Adverse Event|1|||
162660430|NCT00558103|587467990|FG005|Randomized Treatment Phase|Adverse Event|0|||
162660431|NCT00558103|587467985|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
162660432|NCT00558103|587467986|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
162660433|NCT00558103|587467987|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
162660434|NCT00558103|587467988|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
162660435|NCT00558103|587467989|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
162660436|NCT00558103|587467990|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
162660437|NCT00558103|587467985|FG000|Monotherapy Extension Phase|Disease Progression|0|||
162660438|NCT00558103|587467986|FG001|Monotherapy Extension Phase|Disease Progression|0|||
162660439|NCT00558103|587467987|FG002|Monotherapy Extension Phase|Disease Progression|0|||
162660440|NCT00558103|587467988|FG003|Monotherapy Extension Phase|Disease Progression|0|||
162660441|NCT00558103|587467989|FG004|Monotherapy Extension Phase|Disease Progression|0|||
162660442|NCT00558103|587467990|FG005|Monotherapy Extension Phase|Disease Progression|8|||
162660443|NCT00308711|587467991|FG000|Overall Study|Withdrawal by Subject|1|||
162660444|NCT00308711|587467992|FG001|Overall Study|Withdrawal by Subject|0|||
162660445|NCT00308711|587467993|FG002|Overall Study|Withdrawal by Subject|1|||
162660446|NCT00308711|587467991|FG000|Overall Study|Protocol Violation|0|||
162660447|NCT00308711|587467992|FG001|Overall Study|Protocol Violation|1|||
162660448|NCT00308711|587467993|FG002|Overall Study|Protocol Violation|1|||
162660449|NCT00308711|587467991|FG000|Overall Study|Lost to Follow-up|0|||
162660450|NCT00308711|587467992|FG001|Overall Study|Lost to Follow-up|1|||
162660451|NCT00308711|587467993|FG002|Overall Study|Lost to Follow-up|0|||
162660452|NCT00308711|587467991|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
162660453|NCT00308711|587467992|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
162660454|NCT00308711|587467993|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
162660455|NCT00308711|587467991|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
162660456|NCT00308711|587467992|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
162660457|NCT00308711|587467993|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
162660458|NCT03139916|587467996|FG000|Overall Study|Withdrawal by Subject|2|||
162660459|NCT03139916|587467996|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
162660460|NCT01957475|587467997|FG000|Test Period 1|Withdrawal by Subject|1|||
162660461|NCT01957475|587467998|FG001|Test Period 1|Withdrawal by Subject|0|||
162660462|NCT01957475|587467997|FG000|Test Period 1|Other|1|||
162660463|NCT01957475|587467998|FG001|Test Period 1|Other|0|||
162660464|NCT01957475|587467997|FG000|Test Period 1|Lack of Efficacy|0|||
162660465|NCT01957475|587467998|FG001|Test Period 1|Lack of Efficacy|1|||
162660466|NCT01957475|587467997|FG000|Test Period 2|Adverse Event|1|||
162660467|NCT01957475|587467998|FG001|Test Period 2|Adverse Event|0|||
162660468|NCT02469610|587467999|FG000|Overall Study|Death|1|||
162660469|NCT02469610|587468000|FG001|Overall Study|Death|0|||
162660470|NCT02469610|587467999|FG000|Overall Study|Lost to Follow-up|1|||
162660471|NCT02469610|587468000|FG001|Overall Study|Lost to Follow-up|0|||
162660472|NCT02469610|587467999|FG000|Overall Study|exclusion criteria|2|||
162660473|NCT02469610|587468000|FG001|Overall Study|exclusion criteria|1|||
162660474|NCT00414388|587468003|FG000|Overall Study|Adverse Event|1|||
162660475|NCT02318693|587468004|FG000|Overall Study|Protocol Violation|0|||
162660476|NCT02318693|587468005|FG001|Overall Study|Protocol Violation|1|||
162660477|NCT03591575|587468008|FG000|Overall Study|Adverse Event|2|||
162660478|NCT03591575|587468009|FG001|Overall Study|Adverse Event|0|||
162660479|NCT03591575|587468008|FG000|Overall Study|Withdrawal by Subject|4|||
162660480|NCT03591575|587468009|FG001|Overall Study|Withdrawal by Subject|1|||
162660481|NCT00813358|587468010|FG000|Overall Study|Death|32|||
162660482|NCT00813358|587468010|FG000|Overall Study|Lost to Follow-up|12|||
162660483|NCT00813358|587468010|FG000|Overall Study|other endpoints|5|||
162660484|NCT00813358|587468010|FG000|Overall Study|Withdrawal by Subject|20|||
162660485|NCT00218543|587468011|FG000|Overall Study|Lost to Follow-up|8|||
162660486|NCT00218543|587468011|FG000|Overall Study|relocated|1|||
162660487|NCT00218543|587468011|FG000|Overall Study|Withdrawal by Subject|1|||
162660488|NCT00218543|587468011|FG000|Overall Study|Physician Decision|3|||
162660489|NCT00218543|587468011|FG000|Overall Study|Adverse Event|2|||
162660490|NCT03265119|587468012|FG000|Overall Study|Adverse Event|2|||
162660491|NCT03265119|587468013|FG001|Overall Study|Adverse Event|1|||
162660492|NCT03265119|587468012|FG000|Overall Study|Lack of Efficacy|3|||
162660493|NCT03265119|587468013|FG001|Overall Study|Lack of Efficacy|0|||
162660494|NCT03265119|587468012|FG000|Overall Study|Protocol Violation|1|||
162660495|NCT03265119|587468013|FG001|Overall Study|Protocol Violation|2|||
162660496|NCT03265119|587468012|FG000|Overall Study|Withdrawal by Subject|2|||
162660497|NCT03265119|587468013|FG001|Overall Study|Withdrawal by Subject|4|||
162660498|NCT03265119|587468012|FG000|Overall Study|Lost to Follow-up|1|||
162660499|NCT03265119|587468013|FG001|Overall Study|Lost to Follow-up|0|||
162660500|NCT03265119|587468012|FG000|Overall Study|Lack of Compliance|1|||
162660501|NCT03265119|587468013|FG001|Overall Study|Lack of Compliance|0|||
162660502|NCT04740034|587468014|FG000|Overall Study|Death|0|||
162660503|NCT04740034|587468015|FG001|Overall Study|Death|1|||
162660504|NCT04740034|587468016|FG002|Overall Study|Death|2|||
162660505|NCT04740034|587468017|FG003|Overall Study|Death|3|||
162660506|NCT04740034|587468018|FG004|Overall Study|Death|4|||
162660507|NCT04740034|587468019|FG005|Overall Study|Death|4|||
162660508|NCT04740034|587468020|FG006|Overall Study|Death|2|||
162660509|NCT04740034|587468021|FG007|Overall Study|Death|2|||
162660510|NCT04740034|587468022|FG008|Overall Study|Death|2|||
162660511|NCT04740034|587468023|FG009|Overall Study|Death|4|||
162660512|NCT04740034|587468024|FG010|Overall Study|Death|0|||
162660513|NCT04740034|587468014|FG000|Overall Study|Lost to Follow-up|0|||
162660514|NCT04740034|587468015|FG001|Overall Study|Lost to Follow-up|0|||
162660515|NCT04740034|587468016|FG002|Overall Study|Lost to Follow-up|0|||
162660516|NCT04740034|587468017|FG003|Overall Study|Lost to Follow-up|1|||
162660517|NCT04740034|587468018|FG004|Overall Study|Lost to Follow-up|2|||
162660518|NCT04740034|587468019|FG005|Overall Study|Lost to Follow-up|2|||
162660519|NCT04740034|587468020|FG006|Overall Study|Lost to Follow-up|0|||
162660520|NCT04740034|587468021|FG007|Overall Study|Lost to Follow-up|0|||
162660521|NCT04740034|587468022|FG008|Overall Study|Lost to Follow-up|0|||
162660522|NCT04740034|587468023|FG009|Overall Study|Lost to Follow-up|1|||
162660523|NCT04740034|587468024|FG010|Overall Study|Lost to Follow-up|0|||
162660524|NCT04740034|587468014|FG000|Overall Study|Withdrawal by Subject|1|||
162660525|NCT04740034|587468015|FG001|Overall Study|Withdrawal by Subject|0|||
162660526|NCT04740034|587468016|FG002|Overall Study|Withdrawal by Subject|0|||
162660527|NCT04740034|587468017|FG003|Overall Study|Withdrawal by Subject|0|||
162660528|NCT04740034|587468018|FG004|Overall Study|Withdrawal by Subject|0|||
162660529|NCT04740034|587468019|FG005|Overall Study|Withdrawal by Subject|0|||
162660530|NCT04740034|587468020|FG006|Overall Study|Withdrawal by Subject|0|||
162660531|NCT04740034|587468021|FG007|Overall Study|Withdrawal by Subject|1|||
162660532|NCT04740034|587468022|FG008|Overall Study|Withdrawal by Subject|0|||
162660533|NCT04740034|587468023|FG009|Overall Study|Withdrawal by Subject|1|||
162660534|NCT04740034|587468024|FG010|Overall Study|Withdrawal by Subject|0|||
162660535|NCT04740034|587468014|FG000|Overall Study|Decision by sponsor|0|||
162660536|NCT04740034|587468015|FG001|Overall Study|Decision by sponsor|0|||
162660537|NCT04740034|587468016|FG002|Overall Study|Decision by sponsor|1|||
162660538|NCT04740034|587468017|FG003|Overall Study|Decision by sponsor|0|||
162660539|NCT04740034|587468018|FG004|Overall Study|Decision by sponsor|0|||
162660540|NCT04740034|587468019|FG005|Overall Study|Decision by sponsor|0|||
162660541|NCT04740034|587468020|FG006|Overall Study|Decision by sponsor|1|||
162660542|NCT04740034|587468021|FG007|Overall Study|Decision by sponsor|2|||
162660543|NCT04740034|587468022|FG008|Overall Study|Decision by sponsor|1|||
163138881|NCT02562716|589217830|FG000|Overall Study|Adverse Event|7|||
162660544|NCT04740034|587468023|FG009|Overall Study|Decision by sponsor|1|||
162660545|NCT04740034|587468024|FG010|Overall Study|Decision by sponsor|2|||
162660546|NCT00600821|587469501|FG000|Overall Study|Death|45|||
162660547|NCT00600821|587469502|FG001|Overall Study|Death|46|||
162660548|NCT00600821|587469501|FG000|Overall Study|Lost to Follow-up|2|||
162660549|NCT00600821|587469502|FG001|Overall Study|Lost to Follow-up|2|||
162660550|NCT00600821|587469501|FG000|Overall Study|Withdrawal by Subject|1|||
162660551|NCT00600821|587469502|FG001|Overall Study|Withdrawal by Subject|1|||
162660552|NCT00600821|587469501|FG000|Overall Study|Terminated by sponsor|8|||
162660553|NCT00600821|587469502|FG001|Overall Study|Terminated by sponsor|6|||
162660554|NCT00600821|587469501|FG000|Overall Study|Objective progression or relapse|0|||
162660555|NCT00600821|587469502|FG001|Overall Study|Objective progression or relapse|1|||
162660556|NCT00600821|587469501|FG000|Overall Study|Randomized but not treated|0|||
162660557|NCT00600821|587469502|FG001|Overall Study|Randomized but not treated|1|||
162660558|NCT00600821|587469501|FG000|Overall Study|Other|2|||
162660559|NCT00600821|587469502|FG001|Overall Study|Other|3|||
162660560|NCT02066298|587469505|FG000|Overall Study|Lost to Follow-up|3|||
162660561|NCT02066298|587469506|FG001|Overall Study|Lost to Follow-up|2|||
162660562|NCT02066298|587469507|FG002|Overall Study|Lost to Follow-up|3|||
162660563|NCT02066298|587469508|FG003|Overall Study|Lost to Follow-up|2|||
163138882|NCT02562716|589217831|FG001|Overall Study|Adverse Event|14|||
163138883|NCT02562716|589217830|FG000|Overall Study|Withdrawal unrelated to AE|7|||
163138884|NCT02562716|589217831|FG001|Overall Study|Withdrawal unrelated to AE|1|||
163138885|NCT02562716|589217830|FG000|Overall Study|Progression|8|||
163138886|NCT02562716|589217831|FG001|Overall Study|Progression|10|||
163138887|NCT02562716|589217830|FG000|Overall Study|Death|2|||
163138888|NCT02562716|589217831|FG001|Overall Study|Death|1|||
163138889|NCT02562716|589217830|FG000|Overall Study|Not protocol specified|4|||
163138890|NCT02562716|589217831|FG001|Overall Study|Not protocol specified|2|||
163138891|NCT02753946|589217832|FG000|Overall Study|Adverse Event|7|||
163138892|NCT02753946|589217833|FG001|Overall Study|Adverse Event|6|||
163138893|NCT02753946|589217832|FG000|Overall Study|Withdrawal by Subject|6|||
163138894|NCT02753946|589217833|FG001|Overall Study|Withdrawal by Subject|1|||
163138895|NCT02753946|589217832|FG000|Overall Study|Lack of Efficacy|1|||
163138896|NCT02753946|589217833|FG001|Overall Study|Lack of Efficacy|0|||
163138897|NCT02753946|589217832|FG000|Overall Study|Physician Decision|0|||
163138898|NCT02753946|589217833|FG001|Overall Study|Physician Decision|2|||
163138899|NCT02175017|589217834|FG000|Overall Study|Did not receive the investigational product|1|||
163138900|NCT02175017|589217835|FG001|Overall Study|Did not receive the investigational product|2|||
163138901|NCT02175017|589217834|FG000|Overall Study|Withdrawal by Subject|6|||
163138902|NCT02175017|589217835|FG001|Overall Study|Withdrawal by Subject|3|||
163138903|NCT02175017|589217834|FG000|Overall Study|Met an exclusion criteria|0|||
163138904|NCT02175017|589217835|FG001|Overall Study|Met an exclusion criteria|1|||
163138905|NCT02175017|589217834|FG000|Overall Study|Adverse Event|3|||
163138906|NCT02175017|589217835|FG001|Overall Study|Adverse Event|10|||
163138907|NCT02175017|589217834|FG000|Overall Study|Disease progression|20|||
163138908|NCT02175017|589217835|FG001|Overall Study|Disease progression|27|||
163138909|NCT02175017|589217834|FG000|Overall Study|Other than above reasons|3|||
163138910|NCT02175017|589217835|FG001|Overall Study|Other than above reasons|0|||
163138911|NCT04915729|589217836|FG000|Overall Study|Lost to Follow-up|20|||
163138912|NCT04915729|589217837|FG001|Overall Study|Lost to Follow-up|10|||
163138913|NCT04915729|589217836|FG000|Overall Study|Withdrawal by Subject|12|||
163138914|NCT04915729|589217837|FG001|Overall Study|Withdrawal by Subject|5|||
163138915|NCT04915729|589217836|FG000|Overall Study|Death|34|||
163138916|NCT04915729|589217837|FG001|Overall Study|Death|44|||
163138917|NCT04915729|589217836|FG000|Overall Study|not treated|3|||
163138918|NCT04915729|589217837|FG001|Overall Study|not treated|6|||
163138919|NCT04915729|589217836|FG000|Overall Study|Investigator removed subject|1|||
163138920|NCT04915729|589217837|FG001|Overall Study|Investigator removed subject|2|||
163138921|NCT04915729|589217836|FG000|Overall Study|questionnaire result not evaluated|1|||
163138922|NCT04915729|589217837|FG001|Overall Study|questionnaire result not evaluated|0|||
163138923|NCT04915729|589217836|FG000|Overall Study|refuse of hospital visit|1|||
163138924|NCT04915729|589217837|FG001|Overall Study|refuse of hospital visit|3|||
163138925|NCT04915729|589217836|FG000|Overall Study|Subject withdrew|1|||
163138926|NCT04915729|589217837|FG001|Overall Study|Subject withdrew|0|||
163138927|NCT04961541|589217838|FG000|Overall Study|Adverse Event|0|||
163138928|NCT04961541|589217839|FG001|Overall Study|Adverse Event|0|||
163138929|NCT04961541|589217840|FG002|Overall Study|Adverse Event|0|||
163138930|NCT04961541|589217841|FG003|Overall Study|Adverse Event|0|||
163138931|NCT04961541|589217842|FG004|Overall Study|Adverse Event|0|||
163138932|NCT04961541|589217843|FG005|Overall Study|Adverse Event|1|||
163138933|NCT04961541|589217844|FG006|Overall Study|Adverse Event|0|||
163138934|NCT04961541|589217845|FG007|Overall Study|Adverse Event|0|||
163138935|NCT04961541|589217846|FG008|Overall Study|Adverse Event|0|||
163138936|NCT04961541|589217847|FG009|Overall Study|Adverse Event|0|||
163138937|NCT04961541|589217848|FG010|Overall Study|Adverse Event|0|||
163138938|NCT04961541|589217849|FG011|Overall Study|Adverse Event|0|||
163138939|NCT04961541|589217850|FG012|Overall Study|Adverse Event|0|||
163138940|NCT04961541|589217851|FG013|Overall Study|Adverse Event|0|||
163138941|NCT04961541|589217838|FG000|Overall Study|Lost to Follow-up|0|||
163138942|NCT04961541|589217839|FG001|Overall Study|Lost to Follow-up|0|||
163138943|NCT04961541|589217840|FG002|Overall Study|Lost to Follow-up|3|||
163138944|NCT04961541|589217841|FG003|Overall Study|Lost to Follow-up|0|||
163138945|NCT04961541|589217842|FG004|Overall Study|Lost to Follow-up|0|||
163138946|NCT04961541|589217843|FG005|Overall Study|Lost to Follow-up|0|||
163138947|NCT04961541|589217844|FG006|Overall Study|Lost to Follow-up|1|||
163138948|NCT04961541|589217845|FG007|Overall Study|Lost to Follow-up|1|||
163138949|NCT04961541|589217846|FG008|Overall Study|Lost to Follow-up|0|||
163138950|NCT04961541|589217847|FG009|Overall Study|Lost to Follow-up|1|||
163138951|NCT04961541|589217848|FG010|Overall Study|Lost to Follow-up|0|||
163138952|NCT04961541|589217849|FG011|Overall Study|Lost to Follow-up|0|||
163138953|NCT04961541|589217850|FG012|Overall Study|Lost to Follow-up|1|||
163138954|NCT04961541|589217851|FG013|Overall Study|Lost to Follow-up|0|||
163138955|NCT04961541|589217838|FG000|Overall Study|Withdrawal by Subject|0|||
163138956|NCT04961541|589217839|FG001|Overall Study|Withdrawal by Subject|0|||
163138957|NCT04961541|589217840|FG002|Overall Study|Withdrawal by Subject|1|||
163138958|NCT04961541|589217841|FG003|Overall Study|Withdrawal by Subject|1|||
162660564|NCT02066298|587469509|FG004|Overall Study|Lost to Follow-up|3|||
162660565|NCT02066298|587469510|FG005|Overall Study|Lost to Follow-up|4|||
162660566|NCT02066298|587469505|FG000|Overall Study|Withdrawal by Subject|6|||
163138959|NCT04961541|589217842|FG004|Overall Study|Withdrawal by Subject|0|||
163138960|NCT04961541|589217843|FG005|Overall Study|Withdrawal by Subject|0|||
163138961|NCT04961541|589217844|FG006|Overall Study|Withdrawal by Subject|0|||
163138962|NCT04961541|589217845|FG007|Overall Study|Withdrawal by Subject|0|||
163138963|NCT04961541|589217846|FG008|Overall Study|Withdrawal by Subject|0|||
163138964|NCT04961541|589217847|FG009|Overall Study|Withdrawal by Subject|1|||
163138965|NCT04961541|589217848|FG010|Overall Study|Withdrawal by Subject|0|||
163138966|NCT04961541|589217849|FG011|Overall Study|Withdrawal by Subject|0|||
163138967|NCT04961541|589217850|FG012|Overall Study|Withdrawal by Subject|0|||
163138968|NCT04961541|589217851|FG013|Overall Study|Withdrawal by Subject|0|||
163138969|NCT00466921|589217852|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
163138970|NCT00466921|589217852|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
163138971|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
163138972|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
163138973|NCT00466921|589217852|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
163138974|NCT00466921|589217852|FG000|Follow up for a Minimum of 1 Year|Death|6|||
163138975|NCT03305770|589217853|FG000|Overall Study|Physician Decision - prior to dispense|0|||
163138976|NCT03305770|589217854|FG001|Overall Study|Physician Decision - prior to dispense|1|||
163138977|NCT03305770|589217853|FG000|Overall Study|Subject moved|1|||
163138978|NCT03305770|589217854|FG001|Overall Study|Subject moved|0|||
163138979|NCT03539601|589217855|FG000|Overall Study|Withdraw by parent/guardian|1|||
163138980|NCT03539601|589217856|FG001|Overall Study|Withdraw by parent/guardian|0|||
163138981|NCT03539601|589217857|FG002|Overall Study|Withdraw by parent/guardian|1|||
163138982|NCT03539601|589217858|FG003|Overall Study|Withdraw by parent/guardian|0|||
163138983|NCT03539601|589217855|FG000|Overall Study|Adverse Event|0|||
163138984|NCT03539601|589217856|FG001|Overall Study|Adverse Event|2|||
163138985|NCT03539601|589217857|FG002|Overall Study|Adverse Event|0|||
163138986|NCT03539601|589217858|FG003|Overall Study|Adverse Event|0|||
163138987|NCT03539601|589217855|FG000|Overall Study|Lost to Follow-up|2|||
163138988|NCT03539601|589217856|FG001|Overall Study|Lost to Follow-up|4|||
163138989|NCT03539601|589217857|FG002|Overall Study|Lost to Follow-up|5|||
163138990|NCT03539601|589217858|FG003|Overall Study|Lost to Follow-up|0|||
163138991|NCT03539601|589217855|FG000|Overall Study|Withdrawal by Subject|2|||
163138992|NCT03539601|589217856|FG001|Overall Study|Withdrawal by Subject|0|||
163138993|NCT03539601|589217857|FG002|Overall Study|Withdrawal by Subject|0|||
163138994|NCT03539601|589217858|FG003|Overall Study|Withdrawal by Subject|1|||
163138995|NCT03539601|589217855|FG000|Overall Study|Randomized but not treated|1|||
163138996|NCT03539601|589217856|FG001|Overall Study|Randomized but not treated|1|||
163138997|NCT03539601|589217857|FG002|Overall Study|Randomized but not treated|0|||
163138998|NCT03539601|589217858|FG003|Overall Study|Randomized but not treated|0|||
163138999|NCT03710642|589217859|FG000|Overall Study|Adverse Event|5|||
163139000|NCT03710642|589217860|FG001|Overall Study|Adverse Event|1|||
163139001|NCT03710642|589217859|FG000|Overall Study|non-site physician recommendation|1|||
163139002|NCT03710642|589217860|FG001|Overall Study|non-site physician recommendation|0|||
163139003|NCT03710642|589217859|FG000|Overall Study|Participant unwilling or unable to participate|1|||
163139004|NCT03710642|589217860|FG001|Overall Study|Participant unwilling or unable to participate|1|||
163139005|NCT03710642|589217859|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
163139006|NCT03710642|589217860|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
163139007|NCT03710642|589217859|FG000|Overall Study|NA-no code provided|1|||
163139008|NCT03710642|589217860|FG001|Overall Study|NA-no code provided|0|||
163139009|NCT03710642|589217859|FG000|Overall Study|Withdrawal by Subject|1|||
163139010|NCT03710642|589217860|FG001|Overall Study|Withdrawal by Subject|0|||
163139011|NCT00226811|589217861|FG000|Overall Study|Death|8|||
163139012|NCT00226811|589217861|FG000|Overall Study|Adverse Event|11|||
163139013|NCT00226811|589217861|FG000|Overall Study|Lack of Efficacy|55|||
163139014|NCT00226811|589217861|FG000|Overall Study|Withdrawal by Subject|2|||
163139015|NCT01633541|589217865|FG000|Overall Study|Death|1|||
163139016|NCT01633541|589217866|FG001|Overall Study|Death|0|||
163139017|NCT01010971|589217869|FG000|Overall Study|Adverse Event|2|||
163139018|NCT01010971|589217870|FG001|Overall Study|Adverse Event|4|||
163139019|NCT01010971|589217871|FG002|Overall Study|Adverse Event|3|||
163139020|NCT01010971|589217869|FG000|Overall Study|Withdrawal by Subject|0|||
163139021|NCT01010971|589217870|FG001|Overall Study|Withdrawal by Subject|2|||
163139022|NCT01010971|589217871|FG002|Overall Study|Withdrawal by Subject|5|||
163139023|NCT01010971|589217869|FG000|Overall Study|Lost to Follow-up|0|||
163139024|NCT01010971|589217870|FG001|Overall Study|Lost to Follow-up|2|||
163139025|NCT01010971|589217871|FG002|Overall Study|Lost to Follow-up|3|||
163139026|NCT01010971|589217869|FG000|Overall Study|Other|1|||
163139027|NCT01010971|589217870|FG001|Overall Study|Other|0|||
163139028|NCT01010971|589217871|FG002|Overall Study|Other|2|||
163139029|NCT02330055|589217874|FG000|Overall Study|technical issues|2|||
163139030|NCT02330055|589217875|FG001|Overall Study|technical issues|0|||
163139031|NCT02330055|589217874|FG000|Overall Study|participant forgot to wear device|5|||
162720573|NCT05641311|587683788|FG001|Dosing Period 1|Adverse Event|0|||
162720574|NCT00909363|587683789|FG000|Overall Study|Withdrawal by Subject|1|||
162720575|NCT00909363|587683790|FG001|Overall Study|Withdrawal by Subject|0|||
162720576|NCT00909363|587683791|FG002|Overall Study|Withdrawal by Subject|0|||
162720577|NCT00909363|587683789|FG000|Overall Study|Lack of Efficacy|1|||
162720578|NCT00909363|587683790|FG001|Overall Study|Lack of Efficacy|0|||
162720579|NCT00909363|587683791|FG002|Overall Study|Lack of Efficacy|0|||
162720580|NCT00922207|587683798|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
162720581|NCT00922207|587683799|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
162720582|NCT00922207|587683800|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
162720583|NCT00922207|587683798|FG000|Overall Study|Insufficient Therapeutic Response|0|||
162720584|NCT00922207|587683799|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162720585|NCT00922207|587683800|FG002|Overall Study|Insufficient Therapeutic Response|1|||
162720586|NCT00922207|587683798|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162720587|NCT00922207|587683799|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162720588|NCT00922207|587683800|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
162720589|NCT00922207|587683798|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
162720590|NCT00922207|587683799|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162720591|NCT00922207|587683800|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162720592|NCT00922207|587683798|FG000|Overall Study|Withdrew Consent|2|||
162720593|NCT00922207|587683799|FG001|Overall Study|Withdrew Consent|5|||
162720594|NCT00922207|587683800|FG002|Overall Study|Withdrew Consent|2|||
162720595|NCT00922207|587683798|FG000|Overall Study|Abnormality of Laboratory Test|0|||
162720596|NCT00922207|587683799|FG001|Overall Study|Abnormality of Laboratory Test|1|||
162720597|NCT00922207|587683800|FG002|Overall Study|Abnormality of Laboratory Test|1|||
162720598|NCT00367991|587683805|FG000|Overall Study|Withdrawal by Subject|1|||
162720599|NCT00367991|587683806|FG001|Overall Study|Withdrawal by Subject|1|||
162720600|NCT00367991|587683805|FG000|Overall Study|Adverse Event|1|||
162720601|NCT00367991|587683806|FG001|Overall Study|Adverse Event|1|||
162720602|NCT03515304|587683809|FG000|Overall Study|Lost to Follow-up|0|||
162720603|NCT03515304|587683810|FG001|Overall Study|Lost to Follow-up|3|||
162720604|NCT02705586|587683820|FG000|Overall Study|Health Issues|2|||
162720605|NCT02705586|587683820|FG000|Overall Study|Transportation Difficulties|5|||
162720606|NCT02705586|587683820|FG000|Overall Study|Vacation/Planned Absence|1|||
162720607|NCT02808338|587683821|FG000|Screening|Screen Failure|10|||
162720608|NCT02808338|587683821|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
162720609|NCT02808338|587683821|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
162720610|NCT02045836|587683822|FG000|Overall Study|Adverse Event|4|||
162720611|NCT02045836|587683823|FG001|Overall Study|Adverse Event|4|||
162720612|NCT02045836|587683822|FG000|Overall Study|Withdrawal by Subject|1|||
162720613|NCT02045836|587683823|FG001|Overall Study|Withdrawal by Subject|1|||
162720614|NCT02045836|587683822|FG000|Overall Study|Lost to Follow-up|4|||
162720615|NCT02045836|587683823|FG001|Overall Study|Lost to Follow-up|7|||
162720616|NCT02045836|587683822|FG000|Overall Study|Migrated from study area|0|||
162720617|NCT02045836|587683823|FG001|Overall Study|Migrated from study area|2|||
162720618|NCT05686421|587683824|FG000|Overall Study|Screen failure|22|||
162720619|NCT05686421|587683825|FG001|Overall Study|Screen failure|0|||
162720620|NCT05686421|587683826|FG002|Overall Study|Screen failure|0|||
162720621|NCT05686421|587683827|FG003|Overall Study|Screen failure|0|||
162720622|NCT02974634|587685891|FG000|Overall Study|Advanced disease|12|||
162720623|NCT02974634|587685892|FG001|Overall Study|Advanced disease|3|||
162720624|NCT02974634|587685891|FG000|Overall Study|Noncompliance|3|||
162720625|NCT02974634|587685892|FG001|Overall Study|Noncompliance|7|||
163139032|NCT02330055|589217875|FG001|Overall Study|participant forgot to wear device|5|||
163139033|NCT02330055|589217874|FG000|Overall Study|data for less than 60 minutes|3|||
163139034|NCT02330055|589217875|FG001|Overall Study|data for less than 60 minutes|3|||
163139035|NCT02330055|589217874|FG000|Overall Study|participant did not sleep|0|||
163139036|NCT02330055|589217875|FG001|Overall Study|participant did not sleep|1|||
163139037|NCT05729568|589217877|FG000|Overall Study|Still on Study|52|||
163139038|NCT05729568|589217878|FG001|Overall Study|Still on Study|26|||
163139039|NCT05729568|589217877|FG000|Overall Study|Randomized but Never Treated|3|||
163139040|NCT05729568|589217878|FG001|Overall Study|Randomized but Never Treated|0|||
163139041|NCT05729568|589217877|FG000|Overall Study|Adverse Event|0|||
163139042|NCT05729568|589217878|FG001|Overall Study|Adverse Event|1|||
163139043|NCT05729568|589217877|FG000|Overall Study|Investigator's Discretion|1|||
163139044|NCT05729568|589217878|FG001|Overall Study|Investigator's Discretion|0|||
162720626|NCT02974634|587685891|FG000|Overall Study|intervention technology related issues|5|||
162720627|NCT02974634|587685892|FG001|Overall Study|intervention technology related issues|0|||
162720628|NCT02974634|587685891|FG000|Overall Study|Death|8|||
162720629|NCT02974634|587685892|FG001|Overall Study|Death|11|||
162720630|NCT05011396|587685893|FG000|Overall Study|Lost to Follow-up|3|||
162720631|NCT05011396|587685894|FG001|Overall Study|Lost to Follow-up|1|||
162720632|NCT05011396|587685893|FG000|Overall Study|Withdrawal by Subject|0|||
162720633|NCT05011396|587685894|FG001|Overall Study|Withdrawal by Subject|1|||
163139045|NCT00550953|589217879|FG000|Overall Study|Adverse Event|4|||
163139046|NCT00550953|589217880|FG001|Overall Study|Adverse Event|3|||
163139047|NCT00550953|589217879|FG000|Overall Study|Not able to visit the site|2|||
163139048|NCT00550953|589217880|FG001|Overall Study|Not able to visit the site|3|||
163139049|NCT01502228|589217881|FG000|Overall Study|Death|1|||
163139050|NCT02326597|589217886|FG000|Overall Study|Lost to Follow-up|42|||
162660567|NCT02066298|587469506|FG001|Overall Study|Withdrawal by Subject|6|||
162660568|NCT02066298|587469507|FG002|Overall Study|Withdrawal by Subject|6|||
162660569|NCT02066298|587469508|FG003|Overall Study|Withdrawal by Subject|4|||
162660570|NCT02066298|587469509|FG004|Overall Study|Withdrawal by Subject|5|||
162660571|NCT02066298|587469510|FG005|Overall Study|Withdrawal by Subject|8|||
162660572|NCT02066298|587469505|FG000|Overall Study|Physician Decision|0|||
162660573|NCT02066298|587469506|FG001|Overall Study|Physician Decision|0|||
162660574|NCT02066298|587469507|FG002|Overall Study|Physician Decision|1|||
162660575|NCT02066298|587469508|FG003|Overall Study|Physician Decision|0|||
162660576|NCT02066298|587469509|FG004|Overall Study|Physician Decision|1|||
162660577|NCT02066298|587469510|FG005|Overall Study|Physician Decision|0|||
162660578|NCT01643473|587469511|FG000|Overall Study|Lost to Follow-up|1|||
162660579|NCT01643473|587469512|FG001|Overall Study|Lost to Follow-up|0|||
162660580|NCT01519518|587469513|FG000|Overall Study|Consent not available|7|||
162660581|NCT01519518|587469514|FG001|Overall Study|Consent not available|10|||
162660582|NCT01265953|587469520|FG000|Overall Study|Non compliance|5|||
162660583|NCT01265953|587469521|FG001|Overall Study|Non compliance|3|||
163139051|NCT02326597|589217887|FG001|Overall Study|Lost to Follow-up|32|||
163139052|NCT00428948|589217888|FG000|Overall Study|Lost to Follow-up|15|||
163139053|NCT00428948|589217889|FG001|Overall Study|Lost to Follow-up|8|||
163139054|NCT00428948|589217888|FG000|Overall Study|Adverse Event|148|||
163139055|NCT00428948|589217889|FG001|Overall Study|Adverse Event|24|||
163139056|NCT00428948|589217888|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
163139057|NCT00428948|589217889|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
163139058|NCT00428948|589217888|FG000|Overall Study|Investigator Withdrew Subject|3|||
163139059|NCT00428948|589217889|FG001|Overall Study|Investigator Withdrew Subject|4|||
163139060|NCT00428948|589217888|FG000|Overall Study|Subject Withdrew Consent|50|||
163139061|NCT00428948|589217889|FG001|Overall Study|Subject Withdrew Consent|30|||
163139062|NCT00428948|589217888|FG000|Overall Study|Protocol Deviation|1|||
163139063|NCT00428948|589217889|FG001|Overall Study|Protocol Deviation|1|||
163139064|NCT02119663|589217894|FG000|Overall Study|Disease progression|26|||
163139065|NCT02119663|589217895|FG001|Overall Study|Disease progression|27|||
163139066|NCT02119663|589217894|FG000|Overall Study|Adverse Event|5|||
163139067|NCT02119663|589217895|FG001|Overall Study|Adverse Event|5|||
163139068|NCT02119663|589217894|FG000|Overall Study|Death|3|||
163139069|NCT02119663|589217895|FG001|Overall Study|Death|2|||
163139070|NCT02119663|589217894|FG000|Overall Study|Physician Decision|1|||
163139071|NCT02119663|589217895|FG001|Overall Study|Physician Decision|2|||
163139072|NCT02119663|589217894|FG000|Overall Study|Other unspecified|2|||
163139073|NCT02119663|589217895|FG001|Overall Study|Other unspecified|0|||
162660584|NCT00182689|587469522|FG000|Overall Study|Adverse Event|8|||
162660585|NCT00182689|587469523|FG001|Overall Study|Adverse Event|11|||
162660586|NCT00182689|587469522|FG000|Overall Study|Withdrawal by Subject|2|||
162660587|NCT00182689|587469523|FG001|Overall Study|Withdrawal by Subject|2|||
162660588|NCT00182689|587469522|FG000|Overall Study|Progression|27|||
163139074|NCT02119663|589217894|FG000|Overall Study|Subject decision|0|||
163139075|NCT02119663|589217895|FG001|Overall Study|Subject decision|1|||
163139076|NCT02119663|589217894|FG000|Overall Study|Study Terminated by the Sponsor|3|||
163139077|NCT02119663|589217895|FG001|Overall Study|Study Terminated by the Sponsor|4|||
162720634|NCT05011396|587685893|FG000|Overall Study|Positive Drug Screen|0|||
162720635|NCT05011396|587685894|FG001|Overall Study|Positive Drug Screen|1|||
162720636|NCT04668339|587685895|FG000|Overall Study|Physician Decision|1|||
162720637|NCT04668339|587685896|FG001|Overall Study|Physician Decision|0|||
162720638|NCT04668339|587685897|FG002|Overall Study|Physician Decision|1|||
162660589|NCT00182689|587469523|FG001|Overall Study|Progression|29|||
162660590|NCT00182689|587469522|FG000|Overall Study|Death|1|||
162660591|NCT00182689|587469523|FG001|Overall Study|Death|0|||
162660592|NCT00182689|587469522|FG000|Overall Study|not protocol specified|0|||
162660593|NCT00182689|587469523|FG001|Overall Study|not protocol specified|3|||
162660594|NCT00182689|587469522|FG000|Overall Study|Ineligible|1|||
162660595|NCT00182689|587469523|FG001|Overall Study|Ineligible|4|||
162660596|NCT00182689|587469522|FG000|Overall Study|Never received treatment|1|||
162660597|NCT00182689|587469523|FG001|Overall Study|Never received treatment|0|||
162660598|NCT00201006|587469525|FG000|Overall Study|Withdrawal by Subject|7|||
162660599|NCT00201006|587469526|FG001|Overall Study|Withdrawal by Subject|2|||
162660600|NCT00201006|587469527|FG002|Overall Study|Withdrawal by Subject|3|||
162660601|NCT00201006|587469525|FG000|Overall Study|Adverse Event|1|||
162660602|NCT00201006|587469526|FG001|Overall Study|Adverse Event|0|||
162660603|NCT00201006|587469527|FG002|Overall Study|Adverse Event|1|||
162660604|NCT02148003|587469530|FG000|Overall Study|Failed inclusion criteria|1|||
162660605|NCT02148003|587469531|FG001|Overall Study|Failed inclusion criteria|0|||
162660606|NCT02148003|587469530|FG000|Overall Study|Met exclusion criteria|0|||
162660607|NCT02148003|587469531|FG001|Overall Study|Met exclusion criteria|1|||
162660608|NCT02148003|587469530|FG000|Overall Study|Withdrawal by Subject|0|||
162660609|NCT02148003|587469531|FG001|Overall Study|Withdrawal by Subject|1|||
162660610|NCT02039427|587469532|FG000|Overall Study|Duration of surgery > 3h|1|||
162660611|NCT02039427|587469533|FG001|Overall Study|Duration of surgery > 3h|1|||
162660612|NCT02039427|587469534|FG002|Overall Study|Duration of surgery > 3h|0|||
162660613|NCT02039427|587469535|FG003|Overall Study|Duration of surgery > 3h|0|||
162660614|NCT02039427|587469532|FG000|Overall Study|Withdrawal on concent|0|||
162660615|NCT02039427|587469533|FG001|Overall Study|Withdrawal on concent|0|||
162660616|NCT02039427|587469534|FG002|Overall Study|Withdrawal on concent|0|||
162660617|NCT02039427|587469535|FG003|Overall Study|Withdrawal on concent|1|||
162660618|NCT02039427|587469532|FG000|Overall Study|Cancellation of surgery|0|||
162660619|NCT02039427|587469533|FG001|Overall Study|Cancellation of surgery|0|||
162660620|NCT02039427|587469534|FG002|Overall Study|Cancellation of surgery|1|||
162660621|NCT02039427|587469535|FG003|Overall Study|Cancellation of surgery|0|||
162660622|NCT02039427|587469532|FG000|Overall Study|Loss of follow - up|1|||
162660623|NCT02039427|587469533|FG001|Overall Study|Loss of follow - up|0|||
162660624|NCT02039427|587469534|FG002|Overall Study|Loss of follow - up|2|||
162660625|NCT02039427|587469535|FG003|Overall Study|Loss of follow - up|4|||
162660626|NCT02039427|587469532|FG000|Overall Study|Steroid Use|1|||
162660627|NCT02039427|587469533|FG001|Overall Study|Steroid Use|0|||
162660628|NCT02039427|587469534|FG002|Overall Study|Steroid Use|0|||
162660629|NCT02039427|587469535|FG003|Overall Study|Steroid Use|0|||
162660630|NCT03160703|587469537|FG000|Overall Study|Withdrawal by Subject|0|||
162660631|NCT03160703|587469538|FG001|Overall Study|Withdrawal by Subject|0|||
162660632|NCT03160703|587469539|FG002|Overall Study|Withdrawal by Subject|0|||
162660633|NCT03160703|587469540|FG003|Overall Study|Withdrawal by Subject|1|||
162660634|NCT00087568|587469541|FG000|Overall Study|Adverse Event|4|||
162660635|NCT00087568|587469542|FG001|Overall Study|Adverse Event|0|||
162660636|NCT00087568|587469541|FG000|Overall Study|Withdrawal by Subject|1|||
162660637|NCT00087568|587469542|FG001|Overall Study|Withdrawal by Subject|1|||
162660638|NCT00087568|587469541|FG000|Overall Study|Lost to Follow-up|1|||
162660639|NCT00087568|587469542|FG001|Overall Study|Lost to Follow-up|0|||
162660640|NCT00087568|587469541|FG000|Overall Study|Lack of Efficacy|24|||
162720639|NCT04668339|587685898|FG003|Overall Study|Physician Decision|1|||
162720640|NCT04668339|587685895|FG000|Overall Study|Lost to Follow-up|14|||
162720641|NCT04668339|587685896|FG001|Overall Study|Lost to Follow-up|12|||
162660641|NCT00087568|587469542|FG001|Overall Study|Lack of Efficacy|1|||
162660642|NCT03728582|587469547|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
162660643|NCT03728582|587469548|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
162660644|NCT03728582|587469547|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
162660645|NCT03728582|587469548|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
162660646|NCT02738775|587469549|FG000|Overall Study|Withdrawal by Subject|0|||
162660647|NCT02738775|587469550|FG001|Overall Study|Withdrawal by Subject|1|||
162660648|NCT02738775|587469551|FG002|Overall Study|Withdrawal by Subject|0|||
162660649|NCT02738775|587469552|FG003|Overall Study|Withdrawal by Subject|0|||
162660650|NCT02738775|587469553|FG004|Overall Study|Withdrawal by Subject|0|||
162660651|NCT02738775|587469554|FG005|Overall Study|Withdrawal by Subject|0|||
162660652|NCT02738775|587469549|FG000|Overall Study|Adverse Event|0|||
162660653|NCT02738775|587469550|FG001|Overall Study|Adverse Event|0|||
162660654|NCT02738775|587469551|FG002|Overall Study|Adverse Event|0|||
162660655|NCT02738775|587469552|FG003|Overall Study|Adverse Event|1|||
162660656|NCT02738775|587469553|FG004|Overall Study|Adverse Event|0|||
162660657|NCT02738775|587469554|FG005|Overall Study|Adverse Event|0|||
162660658|NCT02738775|587469549|FG000|Overall Study|Pregnancy|0|||
162660659|NCT02738775|587469550|FG001|Overall Study|Pregnancy|1|||
162660660|NCT02738775|587469551|FG002|Overall Study|Pregnancy|0|||
162660661|NCT02738775|587469552|FG003|Overall Study|Pregnancy|0|||
162660662|NCT02738775|587469553|FG004|Overall Study|Pregnancy|0|||
162660663|NCT02738775|587469554|FG005|Overall Study|Pregnancy|0|||
162660664|NCT02738775|587469549|FG000|Overall Study|Missing|0|||
162660665|NCT02738775|587469550|FG001|Overall Study|Missing|0|||
162660666|NCT02738775|587469551|FG002|Overall Study|Missing|0|||
162660667|NCT02738775|587469552|FG003|Overall Study|Missing|0|||
162660668|NCT02738775|587469553|FG004|Overall Study|Missing|0|||
162660669|NCT02738775|587469554|FG005|Overall Study|Missing|1|||
162660670|NCT02992899|587469555|FG000|Overall Study|Withdrawal by Subject|1|||
162660671|NCT02992899|587469556|FG001|Overall Study|Withdrawal by Subject|0|||
162660672|NCT02992899|587469555|FG000|Overall Study|Lost to Follow-up|1|||
162660673|NCT02992899|587469556|FG001|Overall Study|Lost to Follow-up|3|||
162660674|NCT02370888|587469557|FG000|Overall Study|disease progression|2|||
162660675|NCT02370888|587469557|FG000|Overall Study|did not meet chimerism criteria|6|||
162660676|NCT00047463|587469558|FG000|Overall Study|Withdrawal by Subject|0|||
162660677|NCT00047463|587469559|FG001|Overall Study|Withdrawal by Subject|3|||
162660678|NCT01824303|587469567|FG000|Randomized Study|Withdrawal by Subject|1|||
162660679|NCT01824303|587469568|FG001|Randomized Study|Withdrawal by Subject|1|||
162660680|NCT01824303|587469567|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
162660681|NCT01824303|587469568|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
162660682|NCT03235024|587469569|FG000|Overall Study|Adverse Event|2|||
162660683|NCT03235024|587469570|FG001|Overall Study|Adverse Event|2|||
162660684|NCT03235024|587469569|FG000|Overall Study|Death|1|||
162660685|NCT03235024|587469570|FG001|Overall Study|Death|0|||
162660686|NCT03235024|587469569|FG000|Overall Study|Lost to Follow-up|2|||
162660687|NCT03235024|587469570|FG001|Overall Study|Lost to Follow-up|5|||
162660688|NCT03235024|587469569|FG000|Overall Study|Protocol Violation|1|||
162660689|NCT03235024|587469570|FG001|Overall Study|Protocol Violation|0|||
162660690|NCT03235024|587469569|FG000|Overall Study|Withdrawal by Subject|0|||
162660691|NCT03235024|587469570|FG001|Overall Study|Withdrawal by Subject|3|||
162660692|NCT02357576|587469571|FG000|Treatment Period|Withdrawal by Subject|0|||
162660693|NCT02357576|587469572|FG001|Treatment Period|Withdrawal by Subject|1|||
162660694|NCT02357576|587469571|FG000|Treatment Period|Physician Decision|0|||
162660695|NCT02357576|587469572|FG001|Treatment Period|Physician Decision|1|||
162660696|NCT02357576|587469571|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
162660697|NCT02357576|587469572|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
162660698|NCT02357576|587469571|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
162660699|NCT02357576|587469572|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
162660700|NCT02357576|587469571|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
162660701|NCT02357576|587469572|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
162660702|NCT02357576|587469571|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
162660703|NCT02357576|587469572|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
162660704|NCT00261716|587469573|FG000|Overall Study|Withdrawal by Subject|6|||
162660705|NCT00261716|587469574|FG001|Overall Study|Withdrawal by Subject|8|||
162720642|NCT04668339|587685897|FG002|Overall Study|Lost to Follow-up|8|||
162660706|NCT00261716|587469573|FG000|Overall Study|Lost to Follow-up|0|||
162660707|NCT00261716|587469574|FG001|Overall Study|Lost to Follow-up|2|||
162660708|NCT02047110|587469577|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
162660709|NCT02047110|587469578|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
162660710|NCT02047110|587469579|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
162660711|NCT02047110|587469580|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
162660712|NCT02047110|587469577|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
162660713|NCT02047110|587469578|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162660714|NCT02047110|587469579|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162720643|NCT04668339|587685898|FG003|Overall Study|Lost to Follow-up|5|||
162660715|NCT02047110|587469580|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162660716|NCT02047110|587469577|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
162660717|NCT02047110|587469578|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
162660718|NCT02047110|587469579|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
162660719|NCT02047110|587469580|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
162660720|NCT02047110|587469577|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
162660721|NCT02047110|587469578|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
162660722|NCT02047110|587469579|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
162660723|NCT02047110|587469580|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
162660724|NCT02047110|587469577|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
162660725|NCT02047110|587469578|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
162660726|NCT02047110|587469579|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
162660727|NCT02047110|587469580|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
162720644|NCT04668339|587685895|FG000|Overall Study|Adverse Event|0|||
163139078|NCT01248949|589217896|FG000|Overall Study|Lost to Follow-up|2|||
163139079|NCT01248949|589217897|FG001|Overall Study|Lost to Follow-up|2|||
163139080|NCT01248949|589217898|FG002|Overall Study|Lost to Follow-up|2|||
163139081|NCT01248949|589217899|FG003|Overall Study|Lost to Follow-up|1|||
163139082|NCT01248949|589217900|FG004|Overall Study|Lost to Follow-up|0|||
163139083|NCT01248949|589217896|FG000|Overall Study|Withdrawal by Subject|5|||
163139084|NCT01248949|589217897|FG001|Overall Study|Withdrawal by Subject|3|||
163139085|NCT01248949|589217898|FG002|Overall Study|Withdrawal by Subject|11|||
163139086|NCT01248949|589217899|FG003|Overall Study|Withdrawal by Subject|3|||
163139087|NCT01248949|589217900|FG004|Overall Study|Withdrawal by Subject|1|||
163139088|NCT01248949|589217896|FG000|Overall Study|Death|22|||
163139089|NCT01248949|589217897|FG001|Overall Study|Death|7|||
163139090|NCT01248949|589217898|FG002|Overall Study|Death|21|||
163139091|NCT01248949|589217899|FG003|Overall Study|Death|6|||
163139092|NCT01248949|589217900|FG004|Overall Study|Death|2|||
163139093|NCT01248949|589217896|FG000|Overall Study|Alternative Therapy|1|||
163139094|NCT01248949|589217897|FG001|Overall Study|Alternative Therapy|0|||
163139095|NCT01248949|589217898|FG002|Overall Study|Alternative Therapy|0|||
163139096|NCT01248949|589217899|FG003|Overall Study|Alternative Therapy|0|||
163139097|NCT01248949|589217900|FG004|Overall Study|Alternative Therapy|0|||
163139098|NCT01248949|589217896|FG000|Overall Study|Alternative Therapy.|1|||
163139099|NCT01248949|589217897|FG001|Overall Study|Alternative Therapy.|0|||
163139100|NCT01248949|589217898|FG002|Overall Study|Alternative Therapy.|0|||
163139101|NCT01248949|589217899|FG003|Overall Study|Alternative Therapy.|0|||
163139102|NCT01248949|589217900|FG004|Overall Study|Alternative Therapy.|0|||
163139103|NCT01248949|589217896|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
163139104|NCT01248949|589217897|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139105|NCT01248949|589217898|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139106|NCT01248949|589217899|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139107|NCT01248949|589217900|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
163139108|NCT01248949|589217896|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139109|NCT01248949|589217897|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139110|NCT01248949|589217898|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139111|NCT01248949|589217899|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
163139112|NCT01248949|589217900|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
163139113|NCT01248949|589217896|FG000|Overall Study|Participant Went To Hospice|0|||
163139114|NCT01248949|589217897|FG001|Overall Study|Participant Went To Hospice|0|||
163139115|NCT01248949|589217898|FG002|Overall Study|Participant Went To Hospice|1|||
163139116|NCT01248949|589217899|FG003|Overall Study|Participant Went To Hospice|0|||
163139117|NCT01248949|589217900|FG004|Overall Study|Participant Went To Hospice|0|||
163139118|NCT01248949|589217896|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
163139119|NCT01248949|589217897|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139120|NCT01248949|589217898|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139121|NCT01248949|589217899|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139122|NCT01248949|589217900|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
163139123|NCT01248949|589217896|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
163139124|NCT01248949|589217897|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
163139125|NCT01248949|589217898|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
163139126|NCT01248949|589217899|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
163139127|NCT01248949|589217900|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
163139128|NCT01248949|589217896|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139129|NCT01248949|589217897|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
163139130|NCT01248949|589217898|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139131|NCT01248949|589217899|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139132|NCT01248949|589217900|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
163139133|NCT01248949|589217896|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139134|NCT01248949|589217897|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139135|NCT01248949|589217898|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
163139136|NCT01248949|589217899|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139137|NCT01248949|589217900|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
163139138|NCT03245775|589217903|FG000|Overall Study|Lost to Follow-up|25|||
163139139|NCT03245775|589217904|FG001|Overall Study|Lost to Follow-up|26|||
163139140|NCT03245775|589217905|FG002|Overall Study|Lost to Follow-up|16|||
163139141|NCT03245775|589217906|FG003|Overall Study|Lost to Follow-up|16|||
163139142|NCT01099397|589217908|FG000|Overall Study|Lost to Follow-up|4|||
163139143|NCT01099397|589217908|FG000|Overall Study|Protocol Violation|4|||
163139144|NCT01099397|589217908|FG000|Overall Study|Withdrawal by Subject|5|||
163139145|NCT02363959|589217909|FG000|Overall Study|Medical instability|1|||
163139146|NCT02363959|589217910|FG001|Overall Study|Medical instability|0|||
163139147|NCT00950248|589217913|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
163139148|NCT00950248|589217914|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
163139149|NCT00950248|589217915|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
163139150|NCT00950248|589217913|FG000|Year 1: Baseline|worsening of symptoms|2|||
162720645|NCT04668339|587685896|FG001|Overall Study|Adverse Event|0|||
163139151|NCT00950248|589217914|FG001|Year 1: Baseline|worsening of symptoms|0|||
163139152|NCT00950248|589217915|FG002|Year 1: Baseline|worsening of symptoms|0|||
163139153|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
163139154|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
163139155|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
163139156|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
163139157|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
163139158|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
163139159|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|Death|0|||
163139160|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|Death|0|||
163139161|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|Death|1|||
163139162|NCT00950248|589217913|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
163139163|NCT00950248|589217914|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
163139164|NCT00950248|589217915|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
163139165|NCT00940498|589217919|FG000|Overall Study|Death|2|||
163139166|NCT00940498|589217920|FG001|Overall Study|Death|0|||
163139167|NCT00940498|589217921|FG002|Overall Study|Death|0|||
163139168|NCT00940498|589217922|FG003|Overall Study|Death|1|||
163139169|NCT00940498|589217923|FG004|Overall Study|Death|5|||
163139170|NCT00940498|589217924|FG005|Overall Study|Death|0|||
163139171|NCT00940498|589217925|FG006|Overall Study|Death|1|||
163139172|NCT00940498|589217926|FG007|Overall Study|Death|0|||
163139173|NCT00940498|589217919|FG000|Overall Study|Lost to Follow-up|1|||
163139174|NCT00940498|589217920|FG001|Overall Study|Lost to Follow-up|1|||
163139175|NCT00940498|589217921|FG002|Overall Study|Lost to Follow-up|2|||
163139176|NCT00940498|589217922|FG003|Overall Study|Lost to Follow-up|0|||
163139177|NCT00940498|589217923|FG004|Overall Study|Lost to Follow-up|1|||
163139178|NCT00940498|589217924|FG005|Overall Study|Lost to Follow-up|0|||
163139179|NCT00940498|589217925|FG006|Overall Study|Lost to Follow-up|0|||
163139180|NCT00940498|589217926|FG007|Overall Study|Lost to Follow-up|1|||
163139181|NCT00940498|589217919|FG000|Overall Study|Disease Progression|0|||
163139182|NCT00940498|589217920|FG001|Overall Study|Disease Progression|0|||
163139183|NCT00940498|589217921|FG002|Overall Study|Disease Progression|1|||
163139184|NCT00940498|589217922|FG003|Overall Study|Disease Progression|1|||
163139185|NCT00940498|589217923|FG004|Overall Study|Disease Progression|0|||
163139186|NCT00940498|589217924|FG005|Overall Study|Disease Progression|1|||
163139187|NCT00940498|589217925|FG006|Overall Study|Disease Progression|0|||
163139188|NCT00940498|589217926|FG007|Overall Study|Disease Progression|0|||
163139189|NCT00940498|589217919|FG000|Overall Study|Physician Decision|0|||
163139190|NCT00940498|589217920|FG001|Overall Study|Physician Decision|0|||
163139191|NCT00940498|589217921|FG002|Overall Study|Physician Decision|0|||
163139192|NCT00940498|589217922|FG003|Overall Study|Physician Decision|0|||
163139193|NCT00940498|589217923|FG004|Overall Study|Physician Decision|2|||
163139194|NCT00940498|589217924|FG005|Overall Study|Physician Decision|0|||
163139195|NCT00940498|589217925|FG006|Overall Study|Physician Decision|0|||
163139196|NCT00940498|589217926|FG007|Overall Study|Physician Decision|0|||
163139197|NCT00940498|589217919|FG000|Overall Study|Not treated due to disease related pain|0|||
163139198|NCT00940498|589217920|FG001|Overall Study|Not treated due to disease related pain|0|||
163139199|NCT00940498|589217921|FG002|Overall Study|Not treated due to disease related pain|0|||
163139200|NCT00940498|589217922|FG003|Overall Study|Not treated due to disease related pain|0|||
163139201|NCT00940498|589217923|FG004|Overall Study|Not treated due to disease related pain|1|||
163139202|NCT00940498|589217924|FG005|Overall Study|Not treated due to disease related pain|0|||
163139203|NCT00940498|589217925|FG006|Overall Study|Not treated due to disease related pain|0|||
163139204|NCT00940498|589217926|FG007|Overall Study|Not treated due to disease related pain|0|||
163139205|NCT00650845|589217928|FG000|Overall Study|Withdrawal by Subject|5|||
163139206|NCT00650845|589217929|FG001|Overall Study|Withdrawal by Subject|0|||
163139207|NCT00650845|589217928|FG000|Overall Study|Protocol Violation|0|||
163139208|NCT00650845|589217929|FG001|Overall Study|Protocol Violation|13|||
163139209|NCT01594931|589219777|FG000|Overall Study|Adverse Event|3|||
163139210|NCT01594931|589219778|FG001|Overall Study|Adverse Event|1|||
163139211|NCT01594931|589219779|FG002|Overall Study|Adverse Event|1|||
163139212|NCT01594931|589219777|FG000|Overall Study|Withdrawal by Subject|2|||
163139213|NCT01594931|589219778|FG001|Overall Study|Withdrawal by Subject|1|||
163139214|NCT01594931|589219779|FG002|Overall Study|Withdrawal by Subject|1|||
163139215|NCT01594931|589219777|FG000|Overall Study|Lack of Efficacy|7|||
163139216|NCT01594931|589219778|FG001|Overall Study|Lack of Efficacy|2|||
163139217|NCT01594931|589219779|FG002|Overall Study|Lack of Efficacy|2|||
163139218|NCT01594931|589219777|FG000|Overall Study|Lost to Follow-up|4|||
163139219|NCT01594931|589219778|FG001|Overall Study|Lost to Follow-up|3|||
163139220|NCT01594931|589219779|FG002|Overall Study|Lost to Follow-up|3|||
163139221|NCT01594931|589219777|FG000|Overall Study|Protocol Violation|2|||
163139222|NCT01594931|589219778|FG001|Overall Study|Protocol Violation|1|||
163139223|NCT01594931|589219779|FG002|Overall Study|Protocol Violation|0|||
163139224|NCT01594931|589219777|FG000|Overall Study|No defiined|11|||
163139225|NCT01594931|589219778|FG001|Overall Study|No defiined|4|||
163139226|NCT01594931|589219779|FG002|Overall Study|No defiined|7|||
162660728|NCT02047110|587469577|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162660729|NCT02047110|587469578|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
162660730|NCT02047110|587469579|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162660731|NCT02047110|587469580|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162660732|NCT02047110|587469577|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
162660733|NCT02047110|587469578|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
162660734|NCT02047110|587469579|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
162660735|NCT02047110|587469580|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
162660736|NCT02047110|587469577|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
162660737|NCT02047110|587469578|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
162660738|NCT02047110|587469579|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
162660739|NCT02047110|587469580|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
162660740|NCT02047110|587469577|FG000|Escape Treatment Period|Adverse Event|1|||
162660741|NCT02047110|587469578|FG001|Escape Treatment Period|Adverse Event|2|||
162660742|NCT02047110|587469579|FG002|Escape Treatment Period|Adverse Event|2|||
162660743|NCT02047110|587469580|FG003|Escape Treatment Period|Adverse Event|0|||
162660744|NCT02047110|587469577|FG000|Escape Treatment Period|Other than specified|1|||
162660745|NCT02047110|587469578|FG001|Escape Treatment Period|Other than specified|2|||
162660746|NCT02047110|587469579|FG002|Escape Treatment Period|Other than specified|0|||
162660747|NCT02047110|587469580|FG003|Escape Treatment Period|Other than specified|1|||
162660748|NCT02047110|587469577|FG000|OLE Treatment Period|Other than specified|0|||
162660749|NCT02047110|587469578|FG001|OLE Treatment Period|Other than specified|0|||
162660750|NCT02047110|587469579|FG002|OLE Treatment Period|Other than specified|1|||
162660751|NCT02047110|587469580|FG003|OLE Treatment Period|Other than specified|0|||
162660752|NCT00699699|587469581|FG000|Overall Study|Adverse Event|36|||
162660753|NCT00699699|587469581|FG000|Overall Study|Individual different reasons|21|||
162660754|NCT00705575|587469582|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162660755|NCT00705575|587469583|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162660756|NCT00705575|587469582|FG000|Overall Study|Abnormal test procedure result(s)|2|||
162660757|NCT00705575|587469583|FG001|Overall Study|Abnormal test procedure result(s)|12|||
162660758|NCT00705575|587469582|FG000|Overall Study|Adverse Event|11|||
162660759|NCT00705575|587469583|FG001|Overall Study|Adverse Event|15|||
162660760|NCT00705575|587469582|FG000|Overall Study|Lost to Follow-up|3|||
162660761|NCT00705575|587469583|FG001|Overall Study|Lost to Follow-up|4|||
162660762|NCT00705575|587469582|FG000|Overall Study|Protocol Violation|2|||
162660763|NCT00705575|587469583|FG001|Overall Study|Protocol Violation|2|||
162660764|NCT00705575|587469582|FG000|Overall Study|Withdrawal by Subject|5|||
162660765|NCT00705575|587469583|FG001|Overall Study|Withdrawal by Subject|10|||
162660766|NCT01000051|587469587|FG000|Overall Study|Withdrawal by Subject|1|||
162660767|NCT01000051|587469588|FG001|Overall Study|Withdrawal by Subject|1|||
162660768|NCT01000051|587469587|FG000|Overall Study|Disease Progression|1|||
162660769|NCT01000051|587469588|FG001|Overall Study|Disease Progression|0|||
162660770|NCT01000051|587469587|FG000|Overall Study|Serious noncompliance|1|||
162660771|NCT01000051|587469588|FG001|Overall Study|Serious noncompliance|0|||
162660772|NCT02170727|587469589|FG000|Overall Study|Lost to Follow-up|1|||
162660773|NCT02170727|587469590|FG001|Overall Study|Lost to Follow-up|0|||
162660774|NCT02170727|587469589|FG000|Overall Study|Withdrawal by Subject|2|||
162660775|NCT02170727|587469590|FG001|Overall Study|Withdrawal by Subject|0|||
162660776|NCT01959581|587469593|FG000|Overall Study|Lost to Follow-up|5|||
162660777|NCT03304379|587469604|FG000|Overall Study|Protocol Violation|8|||
162660778|NCT03304379|587469605|FG001|Overall Study|Protocol Violation|10|||
162660779|NCT03304379|587469606|FG002|Overall Study|Protocol Violation|5|||
162660780|NCT03304379|587469607|FG003|Overall Study|Protocol Violation|0|||
162660781|NCT03304379|587469608|FG004|Overall Study|Protocol Violation|2|||
162660782|NCT03304379|587469604|FG000|Overall Study|Adverse Event|4|||
162660783|NCT03304379|587469605|FG001|Overall Study|Adverse Event|20|||
162660784|NCT03304379|587469606|FG002|Overall Study|Adverse Event|17|||
162660785|NCT03304379|587469607|FG003|Overall Study|Adverse Event|1|||
162660786|NCT03304379|587469608|FG004|Overall Study|Adverse Event|0|||
162660787|NCT03304379|587469604|FG000|Overall Study|Lack of Efficacy|17|||
162660788|NCT03304379|587469605|FG001|Overall Study|Lack of Efficacy|16|||
162660789|NCT03304379|587469606|FG002|Overall Study|Lack of Efficacy|20|||
162660790|NCT03304379|587469607|FG003|Overall Study|Lack of Efficacy|0|||
162660791|NCT03304379|587469608|FG004|Overall Study|Lack of Efficacy|0|||
162660792|NCT03304379|587469604|FG000|Overall Study|Physician Decision|6|||
162660793|NCT03304379|587469605|FG001|Overall Study|Physician Decision|10|||
162660794|NCT03304379|587469606|FG002|Overall Study|Physician Decision|6|||
162660795|NCT03304379|587469607|FG003|Overall Study|Physician Decision|9|||
162660796|NCT03304379|587469608|FG004|Overall Study|Physician Decision|10|||
162660797|NCT03304379|587469604|FG000|Overall Study|Withdrawal by Subject|26|||
162660798|NCT03304379|587469605|FG001|Overall Study|Withdrawal by Subject|58|||
162660799|NCT03304379|587469606|FG002|Overall Study|Withdrawal by Subject|66|||
162660800|NCT03304379|587469607|FG003|Overall Study|Withdrawal by Subject|3|||
162660801|NCT03304379|587469608|FG004|Overall Study|Withdrawal by Subject|5|||
162660802|NCT03304379|587469604|FG000|Overall Study|Lost to Follow-up|8|||
162660803|NCT03304379|587469605|FG001|Overall Study|Lost to Follow-up|24|||
162660804|NCT03304379|587469606|FG002|Overall Study|Lost to Follow-up|35|||
162660805|NCT03304379|587469607|FG003|Overall Study|Lost to Follow-up|4|||
162660806|NCT03304379|587469608|FG004|Overall Study|Lost to Follow-up|0|||
162660807|NCT03304379|587469604|FG000|Overall Study|Death|1|||
162660808|NCT03304379|587469605|FG001|Overall Study|Death|2|||
162660809|NCT03304379|587469606|FG002|Overall Study|Death|0|||
162660810|NCT03304379|587469607|FG003|Overall Study|Death|0|||
162660811|NCT03304379|587469608|FG004|Overall Study|Death|0|||
162660812|NCT03304379|587469604|FG000|Overall Study|Other|0|||
162660813|NCT03304379|587469605|FG001|Overall Study|Other|1|||
162660814|NCT03304379|587469606|FG002|Overall Study|Other|0|||
162660815|NCT03304379|587469607|FG003|Overall Study|Other|0|||
162660816|NCT03304379|587469608|FG004|Overall Study|Other|0|||
162660817|NCT02802345|587469616|FG000|Overall Study|Not Treated|0|||
162660818|NCT02802345|587469617|FG001|Overall Study|Not Treated|1|||
162660819|NCT02802345|587469616|FG000|Overall Study|Adverse Event|28|||
162660820|NCT02802345|587469617|FG001|Overall Study|Adverse Event|20|||
162660821|NCT02802345|587469616|FG000|Overall Study|Withdrawal by Subject|3|||
162660822|NCT02802345|587469617|FG001|Overall Study|Withdrawal by Subject|3|||
162660823|NCT02802345|587469616|FG000|Overall Study|Protocol Violation|0|||
162660824|NCT02802345|587469617|FG001|Overall Study|Protocol Violation|1|||
162660825|NCT02802345|587469616|FG000|Overall Study|Other than listed|1|||
162660826|NCT02802345|587469617|FG001|Overall Study|Other than listed|5|||
162660827|NCT03969212|587469618|FG000|Overall Study|Adverse Event|1|||
162660828|NCT03969212|587469619|FG001|Overall Study|Adverse Event|0|||
162660829|NCT03969212|587469620|FG002|Overall Study|Adverse Event|0|||
162660830|NCT03969212|587469621|FG003|Overall Study|Adverse Event|0|||
162660831|NCT03969212|587469618|FG000|Overall Study|Lost to Follow-up|2|||
162660832|NCT03969212|587469619|FG001|Overall Study|Lost to Follow-up|2|||
162660833|NCT03969212|587469620|FG002|Overall Study|Lost to Follow-up|2|||
162660834|NCT03969212|587469621|FG003|Overall Study|Lost to Follow-up|2|||
162660835|NCT03969212|587469618|FG000|Overall Study|Protocol Violation|0|||
162660836|NCT03969212|587469619|FG001|Overall Study|Protocol Violation|0|||
162660837|NCT03969212|587469620|FG002|Overall Study|Protocol Violation|0|||
162660838|NCT03969212|587469621|FG003|Overall Study|Protocol Violation|1|||
162660839|NCT03969212|587469618|FG000|Overall Study|Withdrawal by Subject|7|||
162660840|NCT03969212|587469619|FG001|Overall Study|Withdrawal by Subject|13|||
162660841|NCT03969212|587469620|FG002|Overall Study|Withdrawal by Subject|5|||
162660842|NCT03969212|587469621|FG003|Overall Study|Withdrawal by Subject|11|||
162660843|NCT03969212|587469618|FG000|Overall Study|Physician Decision|0|||
162660844|NCT03969212|587469619|FG001|Overall Study|Physician Decision|0|||
162660845|NCT03969212|587469620|FG002|Overall Study|Physician Decision|1|||
162660846|NCT03969212|587469621|FG003|Overall Study|Physician Decision|0|||
162660847|NCT03969212|587469618|FG000|Overall Study|Reason not Specified|22|||
162660848|NCT03969212|587469619|FG001|Overall Study|Reason not Specified|23|||
162660849|NCT03969212|587469620|FG002|Overall Study|Reason not Specified|28|||
162660850|NCT03969212|587469621|FG003|Overall Study|Reason not Specified|26|||
162660851|NCT02075320|587469622|FG000|Overall Study|Withdrawal by Subject|2|||
162660852|NCT03773757|587469624|FG000|Overall Study|Withdrawal by Subject|2|||
162660853|NCT03773757|587469625|FG001|Overall Study|Withdrawal by Subject|4|||
162660854|NCT00057746|587469626|FG000|Overall Study|Withdrawal by Subject|0|||
162660855|NCT00057746|587469627|FG001|Overall Study|Withdrawal by Subject|0|||
162660856|NCT00057746|587469628|FG002|Overall Study|Withdrawal by Subject|1|||
162660857|NCT02985736|587469633|FG000|Overall Study|Lost to Follow-up|3|||
162660858|NCT00550836|587469634|FG000|Overall Study|Withdrawal by Subject|3|||
162660859|NCT00550836|587469635|FG001|Overall Study|Withdrawal by Subject|9|||
162720646|NCT04668339|587685897|FG002|Overall Study|Adverse Event|1|||
162660860|NCT01856543|587469636|FG000|Overall Study|Treatment discontinued|6|||
162660861|NCT01856543|587469637|FG001|Overall Study|Treatment discontinued|3|||
162660862|NCT01856543|587469636|FG000|Overall Study|Withdrawn before start|7|||
162660863|NCT01856543|587469637|FG001|Overall Study|Withdrawn before start|3|||
162720647|NCT04668339|587685898|FG003|Overall Study|Adverse Event|0|||
162720648|NCT04668339|587685895|FG000|Overall Study|Other than specified|3|||
162720649|NCT04668339|587685896|FG001|Overall Study|Other than specified|0|||
162720650|NCT04668339|587685897|FG002|Overall Study|Other than specified|1|||
162720651|NCT04668339|587685898|FG003|Overall Study|Other than specified|0|||
162720652|NCT04668339|587685895|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
162720653|NCT04668339|587685896|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
162720654|NCT04668339|587685897|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
162720655|NCT04668339|587685898|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
162720656|NCT04668339|587685895|FG000|Overall Study|Vaccine not Administered|0|||
162720657|NCT04668339|587685896|FG001|Overall Study|Vaccine not Administered|0|||
162720658|NCT04668339|587685897|FG002|Overall Study|Vaccine not Administered|1|||
162720659|NCT04668339|587685898|FG003|Overall Study|Vaccine not Administered|0|||
162720660|NCT04668339|587685895|FG000|Overall Study|Protocol Violation|18|||
162720661|NCT04668339|587685896|FG001|Overall Study|Protocol Violation|23|||
162720662|NCT04668339|587685897|FG002|Overall Study|Protocol Violation|12|||
162720663|NCT04668339|587685898|FG003|Overall Study|Protocol Violation|20|||
162720664|NCT04668339|587685895|FG000|Overall Study|Withdrawal by Subject|45|||
162720665|NCT04668339|587685896|FG001|Overall Study|Withdrawal by Subject|46|||
162720666|NCT04668339|587685897|FG002|Overall Study|Withdrawal by Subject|46|||
162720667|NCT04668339|587685898|FG003|Overall Study|Withdrawal by Subject|27|||
162720668|NCT04668339|587685895|FG000|Overall Study|Study Terminated by Sponsor|59|||
162720669|NCT04668339|587685896|FG001|Overall Study|Study Terminated by Sponsor|59|||
162720670|NCT04668339|587685897|FG002|Overall Study|Study Terminated by Sponsor|71|||
162720671|NCT04668339|587685898|FG003|Overall Study|Study Terminated by Sponsor|1|||
162720672|NCT03253848|587685902|FG000|Overall Study|Adverse Event|7|||
163139227|NCT01929226|589219784|FG000|Overall Study|Lost to Follow-up|4|||
163139228|NCT01929226|589219785|FG001|Overall Study|Lost to Follow-up|0|||
163139229|NCT01929226|589219784|FG000|Overall Study|Withdrawal by Subject|1|||
163139230|NCT01929226|589219785|FG001|Overall Study|Withdrawal by Subject|1|||
163139231|NCT01525615|589219786|FG000|Overall Study|Adverse Event|11|||
163139232|NCT01525615|589219787|FG001|Overall Study|Adverse Event|7|||
163139233|NCT01525615|589219788|FG002|Overall Study|Adverse Event|5|||
163139234|NCT01525615|589219786|FG000|Overall Study|Lost to Follow-up|1|||
163139235|NCT01525615|589219787|FG001|Overall Study|Lost to Follow-up|0|||
163139236|NCT01525615|589219788|FG002|Overall Study|Lost to Follow-up|0|||
163139237|NCT01525615|589219786|FG000|Overall Study|Withdrawal by Subject|1|||
163139238|NCT01525615|589219787|FG001|Overall Study|Withdrawal by Subject|0|||
163139239|NCT01525615|589219788|FG002|Overall Study|Withdrawal by Subject|0|||
163139240|NCT01525615|589219786|FG000|Overall Study|Other reason not described above|1|||
163139241|NCT01525615|589219787|FG001|Overall Study|Other reason not described above|0|||
163139242|NCT01525615|589219788|FG002|Overall Study|Other reason not described above|1|||
163139243|NCT00217425|589219789|FG000|Overall Study|Never started treatment|2|||
163139244|NCT00217425|589219789|FG000|Overall Study|Patient ineligible|5|||
163139245|NCT00217425|589219789|FG000|Overall Study|Lack of Efficacy|13|||
163139246|NCT00217425|589219789|FG000|Overall Study|Adverse Event|8|||
163139247|NCT00217425|589219789|FG000|Overall Study|Withdrawal by Subject|4|||
163139248|NCT00217425|589219789|FG000|Overall Study|Other complicating disease|1|||
163139249|NCT00217425|589219789|FG000|Overall Study|Other|4|||
163139250|NCT01473732|589219792|FG000|Overall Study|Adverse Event|1|||
163139251|NCT01473732|589219793|FG001|Overall Study|Adverse Event|0|||
163139252|NCT01473732|589219792|FG000|Overall Study|Death|1|||
163139253|NCT01473732|589219793|FG001|Overall Study|Death|0|||
163139254|NCT00330759|589219797|FG000|Overall Study|Death|316|||
163139255|NCT00330759|589219798|FG001|Overall Study|Death|310|||
163139256|NCT00330759|589219797|FG000|Overall Study|Disease progression|104|||
163139257|NCT00330759|589219798|FG001|Overall Study|Disease progression|126|||
163139258|NCT00330759|589219797|FG000|Overall Study|Withdrawal by Subject|143|||
163139259|NCT00330759|589219798|FG001|Overall Study|Withdrawal by Subject|124|||
163139260|NCT00330759|589219797|FG000|Overall Study|Adverse Event|48|||
163139261|NCT00330759|589219798|FG001|Overall Study|Adverse Event|36|||
163139262|NCT00330759|589219797|FG000|Overall Study|Participant request|31|||
163139263|NCT00330759|589219798|FG001|Overall Study|Participant request|22|||
163139264|NCT00330759|589219797|FG000|Overall Study|Lost to Follow-up|16|||
163139265|NCT00330759|589219798|FG001|Overall Study|Lost to Follow-up|22|||
163139266|NCT00330759|589219797|FG000|Overall Study|Noncompliance|15|||
163139267|NCT00330759|589219798|FG001|Overall Study|Noncompliance|17|||
163139268|NCT00330759|589219797|FG000|Overall Study|Physician Decision|1|||
163139269|NCT00330759|589219798|FG001|Overall Study|Physician Decision|2|||
163139270|NCT00330759|589219797|FG000|Overall Study|Protocol deviation|0|||
163139271|NCT00330759|589219798|FG001|Overall Study|Protocol deviation|2|||
162720673|NCT03253848|587685902|FG000|Overall Study|Death|5|||
162720674|NCT03253848|587685902|FG000|Overall Study|initiation of other treatments|3|||
163139272|NCT00330759|589219797|FG000|Overall Study|Ineligibility determined|2|||
163139273|NCT00330759|589219798|FG001|Overall Study|Ineligibility determined|1|||
163139274|NCT00330759|589219797|FG000|Overall Study|Other|36|||
163139275|NCT00330759|589219798|FG001|Overall Study|Other|44|||
163139276|NCT00671034|589219799|FG000|Overall Study|Adverse Event|5|||
162660864|NCT04545515|587469638|FG000|Overall Study|Adverse Event|1|||
163139277|NCT00671034|589219800|FG001|Overall Study|Adverse Event|7|||
163139278|NCT00671034|589219801|FG002|Overall Study|Adverse Event|1|||
163139279|NCT00671034|589219799|FG000|Overall Study|Death|3|||
163139280|NCT00671034|589219800|FG001|Overall Study|Death|2|||
163139281|NCT00671034|589219801|FG002|Overall Study|Death|1|||
163139282|NCT00671034|589219799|FG000|Overall Study|Physician Decision|12|||
163139283|NCT00671034|589219800|FG001|Overall Study|Physician Decision|4|||
163139284|NCT00671034|589219801|FG002|Overall Study|Physician Decision|5|||
163139285|NCT00671034|589219799|FG000|Overall Study|VHR ALL feature|8|||
163139286|NCT00671034|589219800|FG001|Overall Study|VHR ALL feature|3|||
163139287|NCT00671034|589219801|FG002|Overall Study|VHR ALL feature|5|||
163139288|NCT00671034|589219799|FG000|Overall Study|Refusal|5|||
163139289|NCT00671034|589219800|FG001|Overall Study|Refusal|3|||
163139290|NCT00671034|589219801|FG002|Overall Study|Refusal|5|||
163139291|NCT00671034|589219799|FG000|Overall Study|includes Alternative therapy, etc.|6|||
163139292|NCT00671034|589219800|FG001|Overall Study|includes Alternative therapy, etc.|1|||
163139293|NCT00671034|589219801|FG002|Overall Study|includes Alternative therapy, etc.|7|||
163139294|NCT02380287|589219803|FG000|Overall Study|Adverse Event|0|||
163139295|NCT02380287|589219804|FG001|Overall Study|Adverse Event|0|||
163139296|NCT02380287|589219805|FG002|Overall Study|Adverse Event|1|||
163139297|NCT02380287|589219806|FG003|Overall Study|Adverse Event|0|||
163139298|NCT02380287|589219807|FG004|Overall Study|Adverse Event|0|||
163139299|NCT02380287|589219808|FG005|Overall Study|Adverse Event|0|||
163139300|NCT02380287|589219809|FG006|Overall Study|Adverse Event|0|||
163139301|NCT02380287|589219810|FG007|Overall Study|Adverse Event|0|||
163139302|NCT04473963|589219827|FG000|Overall Study|Withdrawal by Subject|1|||
163139303|NCT04473963|589219828|FG001|Overall Study|Withdrawal by Subject|1|||
163139304|NCT04473963|589219829|FG002|Overall Study|Withdrawal by Subject|0|||
163139305|NCT04473963|589219827|FG000|Overall Study|Not inducible in AF|0|||
163139306|NCT04473963|589219828|FG001|Overall Study|Not inducible in AF|0|||
163139307|NCT04473963|589219829|FG002|Overall Study|Not inducible in AF|2|||
163139308|NCT04685798|589219830|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
163139309|NCT00592904|589219835|FG000|Overall Study|Adverse Event|15|||
163139310|NCT00592904|589219836|FG001|Overall Study|Adverse Event|25|||
163139311|NCT00592904|589219837|FG002|Overall Study|Adverse Event|13|||
163139312|NCT00592904|589219838|FG003|Overall Study|Adverse Event|5|||
163139313|NCT00592904|589219835|FG000|Overall Study|Protocol Violation|1|||
163139314|NCT00592904|589219836|FG001|Overall Study|Protocol Violation|1|||
163139315|NCT00592904|589219837|FG002|Overall Study|Protocol Violation|0|||
163139316|NCT00592904|589219838|FG003|Overall Study|Protocol Violation|1|||
163139317|NCT00592904|589219835|FG000|Overall Study|Withdrawal by Subject|4|||
163139318|NCT00592904|589219836|FG001|Overall Study|Withdrawal by Subject|16|||
163139319|NCT00592904|589219837|FG002|Overall Study|Withdrawal by Subject|1|||
163139320|NCT00592904|589219838|FG003|Overall Study|Withdrawal by Subject|2|||
163139321|NCT00592904|589219835|FG000|Overall Study|Lack of Efficacy|2|||
163139322|NCT00592904|589219836|FG001|Overall Study|Lack of Efficacy|7|||
163139323|NCT00592904|589219837|FG002|Overall Study|Lack of Efficacy|2|||
163139324|NCT00592904|589219838|FG003|Overall Study|Lack of Efficacy|3|||
163139325|NCT00592904|589219835|FG000|Overall Study|Physician Decision|0|||
163139326|NCT00592904|589219836|FG001|Overall Study|Physician Decision|3|||
163139327|NCT00592904|589219837|FG002|Overall Study|Physician Decision|1|||
163139328|NCT00592904|589219838|FG003|Overall Study|Physician Decision|0|||
163139329|NCT00592904|589219835|FG000|Overall Study|Other|3|||
163139330|NCT00592904|589219836|FG001|Overall Study|Other|3|||
163139331|NCT00592904|589219837|FG002|Overall Study|Other|0|||
163139332|NCT00592904|589219838|FG003|Overall Study|Other|0|||
163139333|NCT00824473|589219841|FG000|Overall Study|Adverse Event|4|||
163139334|NCT00824473|589219842|FG001|Overall Study|Adverse Event|5|||
163139335|NCT00824473|589219841|FG000|Overall Study|Lack of Efficacy|2|||
163139336|NCT00824473|589219842|FG001|Overall Study|Lack of Efficacy|2|||
163139337|NCT00824473|589219841|FG000|Overall Study|Protocol Violation|2|||
163139338|NCT00824473|589219842|FG001|Overall Study|Protocol Violation|0|||
163139339|NCT00824473|589219841|FG000|Overall Study|Non-Compliance|4|||
163139340|NCT00824473|589219842|FG001|Overall Study|Non-Compliance|2|||
163139341|NCT00824473|589219841|FG000|Overall Study|Withdrawal by Subject|2|||
163139342|NCT00824473|589219842|FG001|Overall Study|Withdrawal by Subject|3|||
163139343|NCT00824473|589219841|FG000|Overall Study|Other|1|||
163139344|NCT00824473|589219842|FG001|Overall Study|Other|1|||
163139345|NCT01359904|589219843|FG000|Overall Study|Withdrawal by Subject|1|||
163139346|NCT01359904|589219844|FG001|Overall Study|Withdrawal by Subject|0|||
163139347|NCT01550757|589219845|FG000|Overall Study|Lost to Follow-up|21|||
163139348|NCT01550757|589219846|FG001|Overall Study|Lost to Follow-up|14|||
163139349|NCT01550757|589219847|FG002|Overall Study|Lost to Follow-up|42|||
163139350|NCT01550757|589219848|FG003|Overall Study|Lost to Follow-up|53|||
163139351|NCT01550757|589219845|FG000|Overall Study|Withdrawal by Subject|2|||
163139352|NCT01550757|589219846|FG001|Overall Study|Withdrawal by Subject|0|||
162660865|NCT04545515|587469638|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
162660866|NCT04545515|587469638|FG000|Overall Study|Commercial drug is available for participant|7|||
162660867|NCT01552772|587469639|FG000|Overall Study|Lost to Follow-up|2|||
162660868|NCT01552772|587469639|FG000|Overall Study|Adverse Event|1|||
162660869|NCT01552772|587469639|FG000|Overall Study|Protocol Deviation|1|||
162660870|NCT01848990|587469641|FG000|Overall Study|Adverse Event|6|||
162660871|NCT01848990|587469642|FG001|Overall Study|Adverse Event|2|||
162660872|NCT01848990|587469643|FG002|Overall Study|Adverse Event|0|||
162660873|NCT01848990|587469641|FG000|Overall Study|Lost to Follow-up|6|||
162660874|NCT01848990|587469642|FG001|Overall Study|Lost to Follow-up|2|||
162660875|NCT01848990|587469643|FG002|Overall Study|Lost to Follow-up|2|||
162660876|NCT01848990|587469641|FG000|Overall Study|Protocol Violation|1|||
162660877|NCT01848990|587469642|FG001|Overall Study|Protocol Violation|1|||
162660878|NCT01848990|587469643|FG002|Overall Study|Protocol Violation|0|||
162660879|NCT01848990|587469641|FG000|Overall Study|Withdrawal by Subject|29|||
162660880|NCT01848990|587469642|FG001|Overall Study|Withdrawal by Subject|10|||
162660881|NCT01848990|587469643|FG002|Overall Study|Withdrawal by Subject|11|||
162660882|NCT01848990|587469641|FG000|Overall Study|Physician Decision|1|||
162660883|NCT01848990|587469642|FG001|Overall Study|Physician Decision|1|||
162660884|NCT01848990|587469643|FG002|Overall Study|Physician Decision|0|||
162660885|NCT01848990|587469641|FG000|Overall Study|Non Compliance|1|||
162660886|NCT01848990|587469642|FG001|Overall Study|Non Compliance|0|||
162660887|NCT01848990|587469643|FG002|Overall Study|Non Compliance|0|||
162660888|NCT01848990|587469641|FG000|Overall Study|Death|1|||
162660889|NCT01848990|587469642|FG001|Overall Study|Death|0|||
162660890|NCT01848990|587469643|FG002|Overall Study|Death|1|||
162660891|NCT01848990|587469641|FG000|Overall Study|Other|1|||
162660892|NCT01848990|587469642|FG001|Overall Study|Other|4|||
162660893|NCT01848990|587469643|FG002|Overall Study|Other|2|||
162660894|NCT00700011|587469644|FG000|Overall Study|Death|0|||
162660895|NCT00700011|587469645|FG001|Overall Study|Death|1|||
162660896|NCT00004031|587469646|FG000|Overall Study|Adverse Event|5|||
162660897|NCT00004031|587469647|FG001|Overall Study|Adverse Event|0|||
162660898|NCT00004031|587469646|FG000|Overall Study|Refusal unrelated to adverse events|2|||
162660899|NCT00004031|587469647|FG001|Overall Study|Refusal unrelated to adverse events|11|||
162660900|NCT00004031|587469646|FG000|Overall Study|Progression/relapse|9|||
162660901|NCT00004031|587469647|FG001|Overall Study|Progression/relapse|4|||
162660902|NCT00004031|587469646|FG000|Overall Study|Death|3|||
162660903|NCT00004031|587469647|FG001|Overall Study|Death|1|||
162660904|NCT00004031|587469646|FG000|Overall Study|Other- not protocol specified|3|||
162660905|NCT00004031|587469647|FG001|Overall Study|Other- not protocol specified|3|||
162660906|NCT00004031|587469646|FG000|Overall Study|Reason under review|3|||
162660907|NCT00004031|587469647|FG001|Overall Study|Reason under review|2|||
162660908|NCT00512096|587469651|FG000|Overall Study|Adverse Event|2|||
162660909|NCT00512096|587469651|FG000|Overall Study|Withdrawal by Subject|2|||
162660910|NCT00512096|587469651|FG000|Overall Study|Lack of Efficacy|3|||
162660911|NCT00298038|587469658|FG000|Overall Study|Lost to Follow-up|0|||
162660912|NCT00298038|587469659|FG001|Overall Study|Lost to Follow-up|1|||
162660913|NCT00298038|587469658|FG000|Overall Study|Liver Transplant|0|||
162660914|NCT00298038|587469659|FG001|Overall Study|Liver Transplant|1|||
162660915|NCT00298038|587469658|FG000|Overall Study|Protocol Violation|1|||
162660916|NCT00298038|587469659|FG001|Overall Study|Protocol Violation|3|||
162660917|NCT00298038|587469658|FG000|Overall Study|Death|6|||
162660918|NCT00298038|587469659|FG001|Overall Study|Death|3|||
162660919|NCT00298038|587469658|FG000|Overall Study|Withdrawal by Subject|6|||
162660920|NCT00298038|587469659|FG001|Overall Study|Withdrawal by Subject|9|||
162660921|NCT00298038|587469658|FG000|Overall Study|Adverse Event|8|||
162660922|NCT00298038|587469659|FG001|Overall Study|Adverse Event|7|||
162660923|NCT00298038|587469658|FG000|Overall Study|Breakthrough overt HE episode|28|||
162660924|NCT00298038|587469659|FG001|Overall Study|Breakthrough overt HE episode|69|||
162660925|NCT00298038|587469658|FG000|Overall Study|Noncompliance|1|||
162660926|NCT00298038|587469659|FG001|Overall Study|Noncompliance|0|||
162660927|NCT00298038|587469658|FG000|Overall Study|Cocaine Abuse|1|||
162660928|NCT00298038|587469659|FG001|Overall Study|Cocaine Abuse|0|||
162660929|NCT00298038|587469658|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
162660930|NCT00298038|587469659|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
162660931|NCT02696096|587469660|FG000|Overall Study|ruled out at screening|1|||
162660932|NCT02696096|587469660|FG000|Overall Study|did not attend second fMRI|1|||
162660933|NCT01940705|587469661|FG000|Overall Study|Lost to Follow-up|1|||
162660934|NCT01940705|587469662|FG001|Overall Study|Lost to Follow-up|3|||
162720675|NCT03253848|587685902|FG000|Overall Study|Other complicating disease|1|||
162720676|NCT03253848|587685902|FG000|Overall Study|Withdrawal by Subject|1|||
162720677|NCT03253848|587685902|FG000|Overall Study|Declining health|1|||
162720678|NCT05758415|587685904|FG000|Overall Study|Subject Decision|2|||
162720679|NCT05758415|587685905|FG001|Overall Study|Subject Decision|5|||
162720680|NCT05758415|587685904|FG000|Overall Study|Lost to Follow-up|0|||
162660935|NCT01940705|587469663|FG002|Overall Study|Lost to Follow-up|2|||
162660936|NCT01940705|587469664|FG003|Overall Study|Lost to Follow-up|2|||
162660937|NCT01940705|587469661|FG000|Overall Study|Withdrawal by Subject|2|||
162660938|NCT01940705|587469662|FG001|Overall Study|Withdrawal by Subject|2|||
162660939|NCT01940705|587469663|FG002|Overall Study|Withdrawal by Subject|3|||
162660940|NCT01940705|587469664|FG003|Overall Study|Withdrawal by Subject|2|||
162660941|NCT01940705|587469661|FG000|Overall Study|Intervention not given|0|||
162660942|NCT01940705|587469662|FG001|Overall Study|Intervention not given|3|||
162660943|NCT01940705|587469663|FG002|Overall Study|Intervention not given|3|||
162720681|NCT05758415|587685905|FG001|Overall Study|Lost to Follow-up|1|||
162660944|NCT01940705|587469664|FG003|Overall Study|Intervention not given|0|||
163139353|NCT01550757|589219847|FG002|Overall Study|Withdrawal by Subject|3|||
163139354|NCT01550757|589219848|FG003|Overall Study|Withdrawal by Subject|1|||
163139355|NCT02342223|589219849|FG000|Overall Study|Lost to Follow-up|1|||
163139356|NCT03018691|589219850|FG000|Overall Study|Adverse Event|1|||
163139357|NCT03018691|589219851|FG001|Overall Study|Adverse Event|1|||
163139358|NCT03018691|589219852|FG002|Overall Study|Adverse Event|4|||
163139359|NCT03018691|589219850|FG000|Overall Study|Lack of Efficacy|0|||
163139360|NCT03018691|589219851|FG001|Overall Study|Lack of Efficacy|0|||
163139361|NCT03018691|589219852|FG002|Overall Study|Lack of Efficacy|1|||
163139362|NCT03018691|589219850|FG000|Overall Study|Withdrawal by Subject|0|||
163139363|NCT03018691|589219851|FG001|Overall Study|Withdrawal by Subject|0|||
163139364|NCT03018691|589219852|FG002|Overall Study|Withdrawal by Subject|1|||
163139365|NCT03018691|589219850|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163139366|NCT03018691|589219851|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163139367|NCT03018691|589219852|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163139368|NCT03369418|589219853|FG000|Overall Study|Withdrawal by Subject|3|||
163139369|NCT03369418|589219854|FG001|Overall Study|Withdrawal by Subject|3|||
163139370|NCT01426958|589219855|FG000|Overall Study|Adverse Event|2|||
163139371|NCT01172535|589219858|FG000|Overall Study|Death|3|||
163139372|NCT01172535|589219858|FG000|Overall Study|Withdrawal by Subject|2|||
163139373|NCT01172535|589219858|FG000|Overall Study|Lost to Follow-up|1|||
163139374|NCT01172535|589219858|FG000|Overall Study|Ineligible at study entry|1|||
163139375|NCT01172535|589219858|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
163139376|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
163139377|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
163139378|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
163139379|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139380|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139381|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139382|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
163139383|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
163139384|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139385|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139386|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139387|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139388|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139389|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
163139390|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139391|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
163139392|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139393|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139394|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139395|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139396|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
163139397|NCT05280717|589219859|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139398|NCT05280717|589219860|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139399|NCT05280717|589219861|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
163139400|NCT05280717|589219862|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139401|NCT05280717|589219863|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139402|NCT05280717|589219864|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139403|NCT05280717|589219865|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
163139404|NCT05280717|589219859|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139405|NCT05280717|589219860|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139406|NCT05280717|589219861|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139407|NCT05280717|589219862|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139408|NCT05280717|589219863|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139409|NCT05280717|589219864|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
163139410|NCT05280717|589219865|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
163139411|NCT05280717|589219859|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139412|NCT05280717|589219860|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139413|NCT05280717|589219861|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139414|NCT05280717|589219862|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
162660945|NCT01940705|587469661|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
162660946|NCT01940705|587469662|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
162660947|NCT01940705|587469663|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
162660948|NCT01940705|587469664|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
162660949|NCT02447991|587469665|FG000|Overall Study|Withdrawn by subject - no data|0|||
162660950|NCT02447991|587469666|FG001|Overall Study|Withdrawn by subject - no data|2|||
162660951|NCT02447991|587469665|FG000|Overall Study|Withdrawn by Subject - with data|4|||
162660952|NCT02447991|587469666|FG001|Overall Study|Withdrawn by Subject - with data|4|||
162660953|NCT02447991|587469665|FG000|Overall Study|Lost to Follow-up - no data|3|||
162660954|NCT02447991|587469666|FG001|Overall Study|Lost to Follow-up - no data|6|||
162660955|NCT02447991|587469665|FG000|Overall Study|Lost to follow-up - with data|0|||
162660956|NCT02447991|587469666|FG001|Overall Study|Lost to follow-up - with data|3|||
162660957|NCT02447991|587469665|FG000|Overall Study|End of study - no treatment results|3|||
162660958|NCT02447991|587469666|FG001|Overall Study|End of study - no treatment results|6|||
162660959|NCT02447991|587469665|FG000|Overall Study|End of study - partial treatment results|0|||
162660960|NCT02447991|587469666|FG001|Overall Study|End of study - partial treatment results|9|||
162660961|NCT03551210|587469667|FG000|Overall Study|Adverse Event|5|||
162660962|NCT03551210|587469668|FG001|Overall Study|Adverse Event|6|||
162660963|NCT03551210|587469667|FG000|Overall Study|Withdrawal by Subject|1|||
162660964|NCT03551210|587469668|FG001|Overall Study|Withdrawal by Subject|7|||
162660965|NCT03551210|587469667|FG000|Overall Study|Needed in other antibiotic treatment|2|||
162660966|NCT03551210|587469668|FG001|Overall Study|Needed in other antibiotic treatment|5|||
162660967|NCT03551210|587469667|FG000|Overall Study|Lost to Follow-up|1|||
162660968|NCT03551210|587469668|FG001|Overall Study|Lost to Follow-up|1|||
162660969|NCT03551210|587469667|FG000|Overall Study|Absence of visit 4 and 5|1|||
162660970|NCT03551210|587469668|FG001|Overall Study|Absence of visit 4 and 5|0|||
162660971|NCT03551210|587469667|FG000|Overall Study|No drug for dispensing|0|||
162660972|NCT03551210|587469668|FG001|Overall Study|No drug for dispensing|1|||
162660973|NCT02602288|587471606|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
162660974|NCT02602288|587471607|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
162660975|NCT02602288|587471606|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
162660976|NCT02602288|587471607|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
162660977|NCT02602288|587471606|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
162660978|NCT02602288|587471607|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
162660979|NCT02602288|587471606|FG000|12 Month Follow-up|Lost to Follow-up|0|||
162660980|NCT02602288|587471607|FG001|12 Month Follow-up|Lost to Follow-up|4|||
162660981|NCT02602288|587471606|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
162660982|NCT02602288|587471607|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
162660983|NCT01310413|587471608|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
162660984|NCT01310413|587471609|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
162660985|NCT01310413|587471610|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
162660986|NCT01310413|587471611|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
162660987|NCT01310413|587471612|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
162660988|NCT01310413|587471613|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
162660989|NCT01310413|587471614|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
162660990|NCT01310413|587471608|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
162660991|NCT01310413|587471609|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
162660992|NCT01310413|587471610|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
162660993|NCT01310413|587471611|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
162660994|NCT01310413|587471612|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
162660995|NCT01310413|587471613|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
162660996|NCT01310413|587471614|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
162660997|NCT01310413|587471608|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
162660998|NCT01310413|587471609|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
162660999|NCT01310413|587471610|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
162661000|NCT01310413|587471611|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
162661001|NCT01310413|587471612|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
162661002|NCT01310413|587471613|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
162661003|NCT01310413|587471614|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
162661004|NCT01310413|587471608|FG000|Day 0 to Day 385|Other|1|||
162661005|NCT01310413|587471609|FG001|Day 0 to Day 385|Other|0|||
162661006|NCT01310413|587471610|FG002|Day 0 to Day 385|Other|3|||
162661007|NCT01310413|587471611|FG003|Day 0 to Day 385|Other|0|||
162661008|NCT01310413|587471612|FG004|Day 0 to Day 385|Other|0|||
162661009|NCT01310413|587471613|FG005|Day 0 to Day 385|Other|0|||
162661010|NCT01310413|587471614|FG006|Day 0 to Day 385|Other|0|||
162661011|NCT01310413|587471608|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661012|NCT01310413|587471609|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661013|NCT01310413|587471610|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661014|NCT01310413|587471611|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661015|NCT01310413|587471612|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661016|NCT01310413|587471613|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
162661017|NCT01310413|587471614|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
162661018|NCT01310413|587471608|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
162661019|NCT01310413|587471609|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
162661020|NCT01310413|587471610|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
163139415|NCT05280717|589219863|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139416|NCT05280717|589219864|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
163139417|NCT05280717|589219865|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
163139418|NCT00740584|589219866|FG000|Overall Study|Withdrawal by Subject|1|||
163139419|NCT01461707|589219867|FG000|Overall Study|Withdrawal by Subject|1|||
163139420|NCT01461707|589219868|FG001|Overall Study|Withdrawal by Subject|0|||
163139421|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
163139422|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
163139423|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
163139424|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
163139425|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
163139426|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
163139427|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
163139428|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
163139429|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
163139430|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
163139431|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
163139432|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
163139433|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
163139434|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
163139435|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
163139436|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
163139437|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
162661021|NCT01310413|587471611|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
162661022|NCT01310413|587471612|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
163139438|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
163139439|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
163139440|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
163139441|NCT03573323|589219869|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
163139442|NCT03573323|589219870|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
163139443|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
163139444|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
163139445|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
163139446|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
163139447|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
163139448|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
163139449|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
163139450|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
163139451|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
163139452|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
163139453|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
163139454|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
163139455|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
163139456|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
163139457|NCT03573323|589219869|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
163139458|NCT03573323|589219870|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
163139459|NCT01196026|589219876|FG000|Overall Study|Withdrawal by Subject|1|||
163139460|NCT01196026|589219877|FG001|Overall Study|Withdrawal by Subject|4|||
163139461|NCT01196026|589219878|FG002|Overall Study|Withdrawal by Subject|0|||
163139462|NCT01196026|589219879|FG003|Overall Study|Withdrawal by Subject|0|||
163139463|NCT01196026|589219880|FG004|Overall Study|Withdrawal by Subject|0|||
163139464|NCT01196026|589219881|FG005|Overall Study|Withdrawal by Subject|0|||
163139465|NCT01196026|589219876|FG000|Overall Study|Lost to Follow-up|0|||
163139466|NCT01196026|589219877|FG001|Overall Study|Lost to Follow-up|3|||
163139467|NCT01196026|589219878|FG002|Overall Study|Lost to Follow-up|0|||
163139468|NCT01196026|589219879|FG003|Overall Study|Lost to Follow-up|0|||
163139469|NCT01196026|589219880|FG004|Overall Study|Lost to Follow-up|1|||
163139470|NCT01196026|589219881|FG005|Overall Study|Lost to Follow-up|0|||
163139471|NCT01196026|589219876|FG000|Overall Study|Other|0|||
163139472|NCT01196026|589219877|FG001|Overall Study|Other|1|||
163139473|NCT01196026|589219878|FG002|Overall Study|Other|0|||
163139474|NCT01196026|589219879|FG003|Overall Study|Other|0|||
163139475|NCT01196026|589219880|FG004|Overall Study|Other|0|||
163139476|NCT01196026|589219881|FG005|Overall Study|Other|0|||
163139477|NCT02336230|589219891|FG000|Overall Study|Adverse Event|1|||
163139478|NCT02336230|589219891|FG000|Overall Study|Withdrawal of consent|1|||
163139479|NCT02336230|589219891|FG000|Overall Study|Death|9|||
163139480|NCT02336230|589219891|FG000|Overall Study|Dose not received due to shipping delay|1|||
163139481|NCT02336230|589219891|FG000|Overall Study|Discontinuation of MSC infusion|1|||
163139482|NCT01620086|589219898|FG000|Overall Study|Withdrawal by Subject|3|||
163139483|NCT01620086|589219899|FG001|Overall Study|Withdrawal by Subject|3|||
163139484|NCT01620086|589219900|FG002|Overall Study|Withdrawal by Subject|0|||
163139485|NCT01620086|589219898|FG000|Overall Study|failed study criteria|1|||
163139486|NCT01620086|589219899|FG001|Overall Study|failed study criteria|4|||
163139487|NCT01620086|589219900|FG002|Overall Study|failed study criteria|0|||
163139488|NCT01620086|589219898|FG000|Overall Study|Physician Decision|1|||
163139489|NCT01620086|589219899|FG001|Overall Study|Physician Decision|0|||
163139490|NCT01620086|589219900|FG002|Overall Study|Physician Decision|0|||
163139491|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Progressive disease|50|||
163139492|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Progressive disease|110|||
163139493|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Progressive disease|0|||
163139494|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Progressive disease|0|||
163139495|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
163139496|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
163139497|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163139498|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
163139499|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Adverse Event|7|||
163139500|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Adverse Event|7|||
163139501|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Adverse Event|0|||
163139502|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Adverse Event|0|||
163139503|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Other|1|||
163139504|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Other|3|||
163139505|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Other|0|||
163139506|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Other|0|||
163139507|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Physician Decision|6|||
162661023|NCT01310413|587471613|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
162720682|NCT03622593|587685906|FG000|Overall Study|Withdrawal by Subject|11|||
162720683|NCT03622593|587685907|FG001|Overall Study|Withdrawal by Subject|9|||
162720684|NCT03622593|587685908|FG002|Overall Study|Withdrawal by Subject|13|||
162720685|NCT03622593|587685906|FG000|Overall Study|Death|12|||
162720686|NCT03622593|587685907|FG001|Overall Study|Death|9|||
162720687|NCT03622593|587685908|FG002|Overall Study|Death|10|||
162720688|NCT03622593|587685906|FG000|Overall Study|Lost to Follow-up|11|||
162720689|NCT03622593|587685907|FG001|Overall Study|Lost to Follow-up|5|||
162720690|NCT03622593|587685908|FG002|Overall Study|Lost to Follow-up|8|||
162720691|NCT03622593|587685906|FG000|Overall Study|Adverse Event|4|||
162720692|NCT03622593|587685907|FG001|Overall Study|Adverse Event|5|||
162720693|NCT03622593|587685908|FG002|Overall Study|Adverse Event|6|||
162720694|NCT03622593|587685906|FG000|Overall Study|Physician Decision|2|||
162720695|NCT03622593|587685907|FG001|Overall Study|Physician Decision|1|||
162720696|NCT03622593|587685908|FG002|Overall Study|Physician Decision|6|||
162720697|NCT03622593|587685906|FG000|Overall Study|Other|2|||
162661024|NCT01310413|587471614|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
162661025|NCT01076400|587471616|FG000|Overall Study|Adverse Event|2|||
162661026|NCT01076400|587471617|FG001|Overall Study|Adverse Event|0|||
162661027|NCT01076400|587471618|FG002|Overall Study|Adverse Event|0|||
162661028|NCT01076400|587471616|FG000|Overall Study|Progressive Disease|5|||
162661029|NCT01076400|587471617|FG001|Overall Study|Progressive Disease|0|||
162661030|NCT01076400|587471618|FG002|Overall Study|Progressive Disease|0|||
162661031|NCT04260191|587471621|FG000|Overall Study|Decision by Sponsor|0|||
162661032|NCT04260191|587471622|FG001|Overall Study|Decision by Sponsor|1|||
162661033|NCT04260191|587471623|FG002|Overall Study|Decision by Sponsor|0|||
162661034|NCT04260191|587471621|FG000|Overall Study|Withdrawal by Subject|1|||
162720698|NCT03622593|587685907|FG001|Overall Study|Other|2|||
162720699|NCT03622593|587685908|FG002|Overall Study|Other|3|||
162720700|NCT03622593|587685906|FG000|Overall Study|Protocol Violation|0|||
162720701|NCT03622593|587685907|FG001|Overall Study|Protocol Violation|0|||
162720702|NCT03622593|587685908|FG002|Overall Study|Protocol Violation|1|||
162720703|NCT03622593|587685906|FG000|Overall Study|Pregnancy|0|||
162720704|NCT03622593|587685907|FG001|Overall Study|Pregnancy|0|||
162720705|NCT03622593|587685908|FG002|Overall Study|Pregnancy|1|||
162720706|NCT01393119|587685911|FG000|Overall Study|Adverse Event|1|||
162720707|NCT01393119|587685912|FG001|Overall Study|Adverse Event|1|||
162720708|NCT01393119|587685913|FG002|Overall Study|Adverse Event|0|||
162661035|NCT04260191|587471622|FG001|Overall Study|Withdrawal by Subject|0|||
162661036|NCT04260191|587471623|FG002|Overall Study|Withdrawal by Subject|3|||
162661037|NCT04260191|587471621|FG000|Overall Study|Death|4|||
162661038|NCT04260191|587471622|FG001|Overall Study|Death|3|||
162661039|NCT04260191|587471623|FG002|Overall Study|Death|2|||
162661040|NCT02343458|587471624|FG000|Overall Study|Adverse Event|15|||
162661041|NCT02343458|587471625|FG001|Overall Study|Adverse Event|14|||
162661042|NCT02343458|587471626|FG002|Overall Study|Adverse Event|15|||
162661043|NCT02343458|587471627|FG003|Overall Study|Adverse Event|3|||
162661044|NCT02343458|587471624|FG000|Overall Study|Lack of Efficacy|3|||
162661045|NCT02343458|587471625|FG001|Overall Study|Lack of Efficacy|8|||
162661046|NCT02343458|587471626|FG002|Overall Study|Lack of Efficacy|4|||
162661047|NCT02343458|587471627|FG003|Overall Study|Lack of Efficacy|8|||
162661048|NCT02343458|587471624|FG000|Overall Study|Withdrawal by Subject|18|||
162661049|NCT02343458|587471625|FG001|Overall Study|Withdrawal by Subject|17|||
162661050|NCT02343458|587471626|FG002|Overall Study|Withdrawal by Subject|23|||
162661051|NCT02343458|587471627|FG003|Overall Study|Withdrawal by Subject|14|||
162661052|NCT02343458|587471624|FG000|Overall Study|Physician Decision|1|||
162661053|NCT02343458|587471625|FG001|Overall Study|Physician Decision|4|||
162661054|NCT02343458|587471626|FG002|Overall Study|Physician Decision|2|||
162720709|NCT01393119|587685914|FG003|Overall Study|Adverse Event|1|||
162720710|NCT01393119|587685911|FG000|Overall Study|Withdrawal by Subject|0|||
162661055|NCT02343458|587471627|FG003|Overall Study|Physician Decision|2|||
162720711|NCT01393119|587685912|FG001|Overall Study|Withdrawal by Subject|1|||
162720712|NCT01393119|587685913|FG002|Overall Study|Withdrawal by Subject|1|||
162720713|NCT01393119|587685914|FG003|Overall Study|Withdrawal by Subject|0|||
162661056|NCT02343458|587471624|FG000|Overall Study|Lost to Follow-up|5|||
162661057|NCT02343458|587471625|FG001|Overall Study|Lost to Follow-up|5|||
162661058|NCT02343458|587471626|FG002|Overall Study|Lost to Follow-up|3|||
162661059|NCT02343458|587471627|FG003|Overall Study|Lost to Follow-up|1|||
162661060|NCT02343458|587471624|FG000|Overall Study|Protocol Violation|2|||
162661061|NCT02343458|587471625|FG001|Overall Study|Protocol Violation|5|||
162720714|NCT01393119|587685911|FG000|Overall Study|Lack of Efficacy|1|||
162720715|NCT01393119|587685912|FG001|Overall Study|Lack of Efficacy|0|||
162661062|NCT02343458|587471626|FG002|Overall Study|Protocol Violation|2|||
162661063|NCT02343458|587471627|FG003|Overall Study|Protocol Violation|2|||
162661064|NCT02343458|587471624|FG000|Overall Study|Protocol Specified Criteria|17|||
162661065|NCT02343458|587471625|FG001|Overall Study|Protocol Specified Criteria|13|||
162661066|NCT02343458|587471626|FG002|Overall Study|Protocol Specified Criteria|14|||
162661067|NCT02343458|587471627|FG003|Overall Study|Protocol Specified Criteria|8|||
162661068|NCT01913041|587471628|FG000|Overall Study|Protocol Violation|35|||
162661069|NCT01913041|587471628|FG000|Overall Study|Withdrawal by Subject|3|||
162661070|NCT01913041|587471628|FG000|Overall Study|Physician Decision|1|||
162661071|NCT01513317|587471629|FG000|Overall Study|Withdrawal by Subject|15|||
162661072|NCT01513317|587471630|FG001|Overall Study|Withdrawal by Subject|4|||
163139508|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Physician Decision|3|||
163139509|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Physician Decision|0|||
163139510|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Physician Decision|0|||
163139511|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Death|1|||
163139512|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Death|1|||
163139513|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Death|0|||
163139514|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Death|0|||
163139515|NCT01695135|589219901|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139516|NCT01695135|589219902|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
163139517|NCT01695135|589219903|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139518|NCT01695135|589219904|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
163139519|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
163139520|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
163139521|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
163139522|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
163139523|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
163139524|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
163139525|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
163139526|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
163139527|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
163139528|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
163139529|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
163139530|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
163139531|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Other|0|||
163139532|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Other|0|||
163139533|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Other|4|||
163139534|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Other|7|||
163139535|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
163139536|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
163139537|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
163139538|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
163139539|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Death|0|||
163139540|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Death|0|||
163139541|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Death|2|||
163139542|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Death|7|||
163139543|NCT01695135|589219901|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139544|NCT01695135|589219902|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139545|NCT01695135|589219903|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
163139546|NCT01695135|589219904|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
163139547|NCT00580723|589219910|FG000|Overall Study|Did not want to participate in extension|3|||
163139548|NCT00580723|589219910|FG000|Overall Study|Lost to Follow-up|5|||
163139549|NCT00684996|589219911|FG000|Overall Study|Adverse Event|1|||
163139550|NCT00684996|589219911|FG000|Overall Study|Refusal unrelated to adverse event|1|||
163139551|NCT00684996|589219911|FG000|Overall Study|Progression/relapse|2|||
163139552|NCT00684996|589219911|FG000|Overall Study|Other reasons not protocol specified|1|||
163139553|NCT02519439|589219914|FG000|Overall Study|Study Termination|19|||
163139554|NCT02519439|589219914|FG000|Overall Study|Withdrawal by Subject|1|||
163139555|NCT02519439|589219914|FG000|Overall Study|Adverse Event|1|||
163139556|NCT03030417|589219921|FG000|Dose Expansion|Disease progression before treatment|0|||
163139557|NCT03030417|589219922|FG001|Dose Expansion|Disease progression before treatment|0|||
163139558|NCT03030417|589219923|FG002|Dose Expansion|Disease progression before treatment|0|||
163139559|NCT03030417|589219924|FG003|Dose Expansion|Disease progression before treatment|0|||
163139560|NCT03030417|589219925|FG004|Dose Expansion|Disease progression before treatment|0|||
163139561|NCT03030417|589219926|FG005|Dose Expansion|Disease progression before treatment|0|||
163139562|NCT03030417|589219927|FG006|Dose Expansion|Disease progression before treatment|0|||
162661073|NCT01513317|587471629|FG000|Overall Study|Death|1|||
162661074|NCT01513317|587471630|FG001|Overall Study|Death|1|||
162661075|NCT01513317|587471629|FG000|Overall Study|Study terminated by sponsor|18|||
162661076|NCT01513317|587471630|FG001|Overall Study|Study terminated by sponsor|18|||
162661077|NCT01513317|587471629|FG000|Overall Study|Other|0|||
162661078|NCT01513317|587471630|FG001|Overall Study|Other|1|||
162661079|NCT02564198|587471631|FG000|Overall Study|Withdrawal by Subject|2|||
162661080|NCT02564198|587471632|FG001|Overall Study|Withdrawal by Subject|4|||
162661081|NCT02564198|587471633|FG002|Overall Study|Withdrawal by Subject|0|||
162661082|NCT02564198|587471631|FG000|Overall Study|Adverse Event|0|||
162661083|NCT02564198|587471632|FG001|Overall Study|Adverse Event|1|||
162661084|NCT02564198|587471633|FG002|Overall Study|Adverse Event|0|||
162661085|NCT02866682|587471636|FG000|Overall Study|Death|0|||
162661086|NCT02866682|587471637|FG001|Overall Study|Death|1|||
162720716|NCT01393119|587685913|FG002|Overall Study|Lack of Efficacy|2|||
162661087|NCT02866682|587471636|FG000|Overall Study|Lost to Follow-up|0|||
162661088|NCT02866682|587471637|FG001|Overall Study|Lost to Follow-up|4|||
162661089|NCT02866682|587471636|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
162661090|NCT02866682|587471637|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
162661091|NCT02866682|587471636|FG000|Overall Study|Other|0|||
162661092|NCT02866682|587471637|FG001|Overall Study|Other|1|||
162661093|NCT01750268|587471638|FG000|Overall Study|Lost to Follow-up|0|||
162661094|NCT01750268|587471639|FG001|Overall Study|Lost to Follow-up|2|||
162661095|NCT01750268|587471638|FG000|Overall Study|Physician Decision|0|||
163139563|NCT03030417|589219928|FG007|Dose Expansion|Disease progression before treatment|0|||
163139564|NCT03030417|589219929|FG008|Dose Expansion|Disease progression before treatment|0|||
163139565|NCT03030417|589219930|FG009|Dose Expansion|Disease progression before treatment|0|||
163139566|NCT03030417|589219931|FG010|Dose Expansion|Disease progression before treatment|0|||
163139567|NCT03030417|589219932|FG011|Dose Expansion|Disease progression before treatment|0|||
163139568|NCT03030417|589219933|FG012|Dose Expansion|Disease progression before treatment|1|||
163139569|NCT01078441|589219934|FG000|Overall Study|Withdrawal by Subject|1|||
163139570|NCT00216671|589219935|FG000|Overall Study|Adverse Event|4|||
163139571|NCT00216671|589219936|FG001|Overall Study|Adverse Event|9|||
163139572|NCT00216671|589219935|FG000|Overall Study|Pregnancy|0|||
163139573|NCT00216671|589219936|FG001|Overall Study|Pregnancy|1|||
163139574|NCT00216671|589219935|FG000|Overall Study|Withdrawal by Subject|4|||
163139575|NCT00216671|589219936|FG001|Overall Study|Withdrawal by Subject|2|||
163139576|NCT00216671|589219935|FG000|Overall Study|Refused Injections|3|||
163139577|NCT00216671|589219936|FG001|Overall Study|Refused Injections|13|||
163139578|NCT00216671|589219935|FG000|Overall Study|No Need to Continue Medication|1|||
163139579|NCT00216671|589219936|FG001|Overall Study|No Need to Continue Medication|1|||
163139580|NCT00216671|589219935|FG000|Overall Study|Insufficient Response|9|||
163139581|NCT00216671|589219936|FG001|Overall Study|Insufficient Response|4|||
163139582|NCT00216671|589219935|FG000|Overall Study|Lost to Follow-up|3|||
163139583|NCT00216671|589219936|FG001|Overall Study|Lost to Follow-up|5|||
163139584|NCT00216671|589219935|FG000|Overall Study|Non compliant|2|||
163139585|NCT00216671|589219936|FG001|Overall Study|Non compliant|2|||
163139586|NCT00216671|589219935|FG000|Overall Study|Ineligible|0|||
163139587|NCT00216671|589219936|FG001|Overall Study|Ineligible|2|||
163139588|NCT00216671|589219935|FG000|Overall Study|Physician Decision|1|||
163139589|NCT00216671|589219936|FG001|Overall Study|Physician Decision|1|||
163139590|NCT00216671|589219935|FG000|Overall Study|Protocol Violation|3|||
163139591|NCT00216671|589219936|FG001|Overall Study|Protocol Violation|5|||
163139592|NCT00216671|589219935|FG000|Overall Study|Relapse|1|||
163139593|NCT00216671|589219936|FG001|Overall Study|Relapse|0|||
163139594|NCT00216671|589219935|FG000|Overall Study|Investigator Illness|0|||
163139595|NCT00216671|589219936|FG001|Overall Study|Investigator Illness|1|||
163139596|NCT00216671|589219935|FG000|Overall Study|Patient Moved|0|||
163139597|NCT00216671|589219936|FG001|Overall Study|Patient Moved|1|||
163139598|NCT00216671|589219935|FG000|Overall Study|Ineligible, no efficacy data|2|||
163139599|NCT00216671|589219936|FG001|Overall Study|Ineligible, no efficacy data|2|||
163139600|NCT00216671|589219935|FG000|Overall Study|Insufficient Response Adverse Event|2|||
163139601|NCT00216671|589219936|FG001|Overall Study|Insufficient Response Adverse Event|1|||
163139602|NCT02714569|589219937|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
163139603|NCT02714569|589219938|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
163139604|NCT02714569|589219939|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
163139605|NCT02714569|589219940|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
163139606|NCT02714569|589219941|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
163139607|NCT02714569|589219942|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
163139608|NCT02714569|589219943|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
163139609|NCT02714569|589219944|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
163139610|NCT02714569|589219945|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
163139611|NCT02714569|589219946|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
163139612|NCT02714569|589219947|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
163139613|NCT02714569|589219937|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139614|NCT02714569|589219938|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139615|NCT02714569|589219939|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139616|NCT02714569|589219940|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
163139617|NCT02714569|589219941|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139618|NCT02714569|589219942|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139619|NCT02714569|589219943|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139620|NCT02714569|589219944|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139621|NCT02714569|589219945|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139622|NCT02714569|589219946|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139623|NCT02714569|589219947|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
163139624|NCT02714569|589219937|FG000|Part A Third Intervention|Adverse Event|0|||
163139625|NCT02714569|589219938|FG001|Part A Third Intervention|Adverse Event|0|||
163139626|NCT02714569|589219939|FG002|Part A Third Intervention|Adverse Event|1|||
163139627|NCT02714569|589219940|FG003|Part A Third Intervention|Adverse Event|0|||
163139628|NCT02714569|589219941|FG004|Part A Third Intervention|Adverse Event|0|||
163139629|NCT02714569|589219942|FG005|Part A Third Intervention|Adverse Event|0|||
163139630|NCT02714569|589219943|FG006|Part A Third Intervention|Adverse Event|0|||
163139631|NCT02714569|589219944|FG007|Part A Third Intervention|Adverse Event|0|||
163139632|NCT02714569|589219945|FG008|Part A Third Intervention|Adverse Event|0|||
163139633|NCT02714569|589219946|FG009|Part A Third Intervention|Adverse Event|0|||
163139634|NCT02714569|589219947|FG010|Part A Third Intervention|Adverse Event|0|||
163139635|NCT02714569|589219937|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
163139636|NCT02714569|589219938|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139637|NCT02714569|589219939|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139638|NCT02714569|589219940|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139639|NCT02714569|589219941|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139640|NCT02714569|589219942|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
163139641|NCT02714569|589219943|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139642|NCT02714569|589219944|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139643|NCT02714569|589219945|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139644|NCT02714569|589219946|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139645|NCT02714569|589219947|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
163139646|NCT02714569|589219937|FG000|Part B (Overall)|Lost to Follow-up|0|||
163139647|NCT02714569|589219938|FG001|Part B (Overall)|Lost to Follow-up|0|||
163139648|NCT02714569|589219939|FG002|Part B (Overall)|Lost to Follow-up|0|||
163139649|NCT02714569|589219940|FG003|Part B (Overall)|Lost to Follow-up|0|||
163139650|NCT02714569|589219941|FG004|Part B (Overall)|Lost to Follow-up|0|||
163139651|NCT02714569|589219942|FG005|Part B (Overall)|Lost to Follow-up|0|||
163139652|NCT02714569|589219943|FG006|Part B (Overall)|Lost to Follow-up|1|||
163139653|NCT02714569|589219944|FG007|Part B (Overall)|Lost to Follow-up|0|||
163139654|NCT02714569|589219945|FG008|Part B (Overall)|Lost to Follow-up|0|||
163139655|NCT02714569|589219946|FG009|Part B (Overall)|Lost to Follow-up|0|||
163139656|NCT02714569|589219947|FG010|Part B (Overall)|Lost to Follow-up|0|||
163139657|NCT02714569|589219937|FG000|Part B (Overall)|Withdrawal by Subject|0|||
163139658|NCT02714569|589219938|FG001|Part B (Overall)|Withdrawal by Subject|0|||
163139659|NCT02714569|589219939|FG002|Part B (Overall)|Withdrawal by Subject|0|||
163139660|NCT02714569|589219940|FG003|Part B (Overall)|Withdrawal by Subject|0|||
163139661|NCT02714569|589219941|FG004|Part B (Overall)|Withdrawal by Subject|0|||
163139662|NCT02714569|589219942|FG005|Part B (Overall)|Withdrawal by Subject|0|||
163139663|NCT02714569|589219943|FG006|Part B (Overall)|Withdrawal by Subject|0|||
163139664|NCT02714569|589219944|FG007|Part B (Overall)|Withdrawal by Subject|1|||
163139665|NCT02714569|589219945|FG008|Part B (Overall)|Withdrawal by Subject|0|||
163139666|NCT02714569|589219946|FG009|Part B (Overall)|Withdrawal by Subject|1|||
163139667|NCT02714569|589219947|FG010|Part B (Overall)|Withdrawal by Subject|0|||
163139668|NCT02714569|589219937|FG000|Part B (Overall)|Adverse Event|0|||
163139669|NCT02714569|589219938|FG001|Part B (Overall)|Adverse Event|0|||
163139670|NCT02714569|589219939|FG002|Part B (Overall)|Adverse Event|0|||
163139671|NCT02714569|589219940|FG003|Part B (Overall)|Adverse Event|0|||
163139672|NCT02714569|589219941|FG004|Part B (Overall)|Adverse Event|0|||
163139673|NCT02714569|589219942|FG005|Part B (Overall)|Adverse Event|0|||
163139674|NCT02714569|589219943|FG006|Part B (Overall)|Adverse Event|0|||
163139675|NCT02714569|589219944|FG007|Part B (Overall)|Adverse Event|0|||
163139676|NCT02714569|589219945|FG008|Part B (Overall)|Adverse Event|0|||
163139677|NCT02714569|589219946|FG009|Part B (Overall)|Adverse Event|1|||
163139678|NCT02714569|589219947|FG010|Part B (Overall)|Adverse Event|0|||
163139679|NCT01684202|589219948|FG000|Dose-escalation Period|Adverse Event|0|||
163139680|NCT01684202|589219949|FG001|Dose-escalation Period|Adverse Event|1|||
163139681|NCT01684202|589219950|FG002|Dose-escalation Period|Adverse Event|0|||
163139682|NCT01684202|589219951|FG003|Dose-escalation Period|Adverse Event|0|||
163139683|NCT01684202|589219948|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
163139684|NCT01684202|589219949|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
163139685|NCT01684202|589219950|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
163139686|NCT01684202|589219951|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
163139687|NCT01684202|589219948|FG000|Maintenance Period|Adverse Event|1|||
163139688|NCT01684202|589219949|FG001|Maintenance Period|Adverse Event|1|||
163139689|NCT01684202|589219950|FG002|Maintenance Period|Adverse Event|1|||
163139690|NCT01684202|589219951|FG003|Maintenance Period|Adverse Event|1|||
163139691|NCT01684202|589219948|FG000|Maintenance Period|Physician Decision|0|||
163139692|NCT01684202|589219949|FG001|Maintenance Period|Physician Decision|1|||
163139693|NCT01684202|589219950|FG002|Maintenance Period|Physician Decision|0|||
163139694|NCT01684202|589219951|FG003|Maintenance Period|Physician Decision|0|||
163139695|NCT01684202|589219948|FG000|Maintenance Period|Withdrawal by Subject|0|||
163139696|NCT01684202|589219949|FG001|Maintenance Period|Withdrawal by Subject|1|||
163139697|NCT01684202|589219950|FG002|Maintenance Period|Withdrawal by Subject|0|||
163139698|NCT01684202|589219951|FG003|Maintenance Period|Withdrawal by Subject|0|||
163139699|NCT00191308|589219952|FG000|Overall Study|Adverse Event|1|||
163139700|NCT00779025|589219953|FG000|Overall Study|Withdrawal by Subject|1|||
163139701|NCT01970306|589219957|FG000|Overall Study|Not eligible|3|||
163139702|NCT01970306|589219957|FG000|Overall Study|Not able to be treated|9|||
163139703|NCT02741635|589219958|FG000|Overall Study|Withdrawal by Subject|1|||
163139704|NCT01427933|589219959|FG000|Overall Study|Withdrawal by Subject|5|||
163139705|NCT01427933|589219960|FG001|Overall Study|Withdrawal by Subject|8|||
163139706|NCT01427933|589219959|FG000|Overall Study|Lost to Follow-up|1|||
163139707|NCT01427933|589219960|FG001|Overall Study|Lost to Follow-up|5|||
163139708|NCT01427933|589219959|FG000|Overall Study|Other|1|||
162661096|NCT01750268|587471639|FG001|Overall Study|Physician Decision|3|||
162661097|NCT01750268|587471638|FG000|Overall Study|Withdrawal by Subject|2|||
162661098|NCT01750268|587471639|FG001|Overall Study|Withdrawal by Subject|0|||
162661099|NCT02086591|587471642|FG000|Overall Study|Adverse Event|1|||
162661100|NCT02086591|587471642|FG000|Overall Study|Withdrawal by Subject|1|||
162661101|NCT02086591|587471642|FG000|Overall Study|protocol terminated|3|||
162661102|NCT01529645|587471643|FG000|Overall Study|Lost to Follow-up|0|||
162661103|NCT01529645|587471644|FG001|Overall Study|Lost to Follow-up|1|||
162661104|NCT01529645|587471645|FG002|Overall Study|Lost to Follow-up|1|||
162661105|NCT01529645|587471646|FG003|Overall Study|Lost to Follow-up|1|||
162661106|NCT01529645|587471647|FG004|Overall Study|Lost to Follow-up|1|||
162661107|NCT01529645|587471648|FG005|Overall Study|Lost to Follow-up|0|||
162661108|NCT01529645|587471649|FG006|Overall Study|Lost to Follow-up|2|||
162661109|NCT01529645|587471650|FG007|Overall Study|Lost to Follow-up|0|||
162661110|NCT01529645|587471651|FG008|Overall Study|Lost to Follow-up|1|||
162661111|NCT01529645|587471652|FG009|Overall Study|Lost to Follow-up|0|||
162661112|NCT01529645|587471643|FG000|Overall Study|SAE - Premature contractions|0|||
162661113|NCT01529645|587471644|FG001|Overall Study|SAE - Premature contractions|0|||
162661114|NCT01529645|587471645|FG002|Overall Study|SAE - Premature contractions|1|||
162661115|NCT01529645|587471646|FG003|Overall Study|SAE - Premature contractions|0|||
162661116|NCT01529645|587471647|FG004|Overall Study|SAE - Premature contractions|0|||
162661117|NCT01529645|587471648|FG005|Overall Study|SAE - Premature contractions|0|||
162661118|NCT01529645|587471649|FG006|Overall Study|SAE - Premature contractions|0|||
162661119|NCT01529645|587471650|FG007|Overall Study|SAE - Premature contractions|0|||
162661120|NCT01529645|587471651|FG008|Overall Study|SAE - Premature contractions|0|||
162661121|NCT01529645|587471652|FG009|Overall Study|SAE - Premature contractions|0|||
162661122|NCT01529645|587471643|FG000|Overall Study|Withdrawal by Subject|2|||
162661123|NCT01529645|587471644|FG001|Overall Study|Withdrawal by Subject|0|||
162661124|NCT01529645|587471645|FG002|Overall Study|Withdrawal by Subject|0|||
162661125|NCT01529645|587471646|FG003|Overall Study|Withdrawal by Subject|1|||
162661126|NCT01529645|587471647|FG004|Overall Study|Withdrawal by Subject|1|||
162661127|NCT01529645|587471648|FG005|Overall Study|Withdrawal by Subject|1|||
162661128|NCT01529645|587471649|FG006|Overall Study|Withdrawal by Subject|0|||
162661129|NCT01529645|587471650|FG007|Overall Study|Withdrawal by Subject|0|||
162661130|NCT01529645|587471651|FG008|Overall Study|Withdrawal by Subject|0|||
162661131|NCT01529645|587471652|FG009|Overall Study|Withdrawal by Subject|0|||
162661132|NCT00274716|587471657|FG000|Phase A|Other non-reported reason|4|||
162661133|NCT00274716|587471658|FG001|Phase A|Other non-reported reason|2|||
162661134|NCT00274716|587471659|FG002|Phase A|Other non-reported reason|1|||
163139709|NCT01427933|589219960|FG001|Overall Study|Other|0|||
163139710|NCT01427933|589219959|FG000|Overall Study|Investigator's Decision|1|||
163139711|NCT01427933|589219960|FG001|Overall Study|Investigator's Decision|0|||
163139712|NCT03472326|589219961|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
163139713|NCT03472326|589219962|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
163139714|NCT03472326|589219963|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
163139715|NCT03472326|589219964|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
163139716|NCT03472326|589219961|FG000|Part 2: Combination Therapy|Pregnancy|0|||
163139717|NCT03472326|589219962|FG001|Part 2: Combination Therapy|Pregnancy|0|||
163139718|NCT03472326|589219963|FG002|Part 2: Combination Therapy|Pregnancy|0|||
163139719|NCT03472326|589219964|FG003|Part 2: Combination Therapy|Pregnancy|1|||
163139720|NCT00773513|589219965|FG000|Overall Study|Renal Transplant|254|||
163139721|NCT00773513|589219966|FG001|Overall Study|Renal Transplant|263|||
163139722|NCT00773513|589219965|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
163139723|NCT00773513|589219966|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
163139724|NCT00773513|589219965|FG000|Overall Study|Withdrew Consent|68|||
163139725|NCT00773513|589219966|FG001|Overall Study|Withdrew Consent|69|||
163139726|NCT00773513|589219965|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
163139727|NCT00773513|589219966|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
163139728|NCT00773513|589219965|FG000|Overall Study|Failure to Return|22|||
163139729|NCT00773513|589219966|FG001|Overall Study|Failure to Return|8|||
163139730|NCT00773513|589219965|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163139731|NCT00773513|589219966|FG001|Overall Study|Insufficient Therapeutic Response|18|||
163139732|NCT00773513|589219965|FG000|Overall Study|Reason Not Specified|159|||
163139733|NCT00773513|589219966|FG001|Overall Study|Reason Not Specified|126|||
163139734|NCT00773513|589219965|FG000|Overall Study|Death|531|||
163139735|NCT00773513|589219966|FG001|Overall Study|Death|545|||
163139736|NCT01221350|589219967|FG000|Overall Study|Discontinued intervention (GERD)|1|||
163139737|NCT01221350|589219968|FG001|Overall Study|Discontinued intervention (GERD)|0|||
163139738|NCT01221350|589219967|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
163139739|NCT01221350|589219968|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
163139740|NCT01221350|589219967|FG000|Overall Study|Withdrawal by Subject|4|||
163139741|NCT01221350|589219968|FG001|Overall Study|Withdrawal by Subject|2|||
163139742|NCT04739436|589219969|FG000|Overall Study|Lost to Follow-up|21|||
163139743|NCT04739436|589219970|FG001|Overall Study|Lost to Follow-up|23|||
163139744|NCT04739436|589219969|FG000|Overall Study|Withdrawal by Subject|4|||
163139745|NCT04739436|589219970|FG001|Overall Study|Withdrawal by Subject|6|||
163139746|NCT04739436|589219969|FG000|Overall Study|not randomized properly|1|||
163139747|NCT04739436|589219970|FG001|Overall Study|not randomized properly|0|||
163139748|NCT00413218|589221924|FG000|Overall Study|Randomized but didn't receive study drug|2|||
163139749|NCT00413218|589221925|FG001|Overall Study|Randomized but didn't receive study drug|8|||
163139750|NCT00413218|589221924|FG000|Overall Study|Death|57|||
163139751|NCT00413218|589221925|FG001|Overall Study|Death|56|||
163139752|NCT00413218|589221924|FG000|Overall Study|Lost to Follow-up|14|||
163139753|NCT00413218|589221925|FG001|Overall Study|Lost to Follow-up|17|||
163139754|NCT00413218|589221924|FG000|Overall Study|Admin|20|||
163139755|NCT00413218|589221925|FG001|Overall Study|Admin|14|||
163139756|NCT00413218|589221924|FG000|Overall Study|Missing|1|||
163139757|NCT00413218|589221925|FG001|Overall Study|Missing|0|||
163139758|NCT00413218|589221924|FG000|Overall Study|Withdrawal by Subject|9|||
163139759|NCT00413218|589221925|FG001|Overall Study|Withdrawal by Subject|1|||
163139760|NCT00837213|589221926|FG000|Overall Study|Lost to Follow-up|3|||
163139761|NCT00837213|589221927|FG001|Overall Study|Lost to Follow-up|2|||
163139762|NCT00837213|589221926|FG000|Overall Study|Withdrawal by Subject|2|||
163139763|NCT00837213|589221927|FG001|Overall Study|Withdrawal by Subject|2|||
163139764|NCT00837213|589221926|FG000|Overall Study|not stated|1|||
163139765|NCT00837213|589221927|FG001|Overall Study|not stated|1|||
163139766|NCT01479868|589221929|FG000|Overall Study|Adverse Event|1|||
163139767|NCT01479868|589221929|FG000|Overall Study|Lost to Follow-up|4|||
163139768|NCT01479868|589221929|FG000|Overall Study|Protocol Violation|1|||
163139769|NCT01479868|589221929|FG000|Overall Study|Withdrawal by Subject|1|||
163139770|NCT01479868|589221929|FG000|Overall Study|Sponsor's Decision|1|||
163139771|NCT01479868|589221929|FG000|Overall Study|Initiation of new HCV Therapy|1|||
163139772|NCT01618669|589221930|FG000|Overall Study|Lost to Follow-up|1|||
163139773|NCT01618669|589221931|FG001|Overall Study|Lost to Follow-up|1|||
163139774|NCT01618669|589221930|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
163139775|NCT01618669|589221931|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
163139776|NCT01618669|589221930|FG000|Overall Study|Adverse Event|16|||
163139777|NCT01618669|589221931|FG001|Overall Study|Adverse Event|7|||
163139778|NCT01618669|589221930|FG000|Overall Study|Protocol Violation|5|||
163139779|NCT01618669|589221931|FG001|Overall Study|Protocol Violation|3|||
163139780|NCT01618669|589221930|FG000|Overall Study|Withdrawal by Subject|9|||
163139781|NCT01618669|589221931|FG001|Overall Study|Withdrawal by Subject|9|||
163139782|NCT01618669|589221930|FG000|Overall Study|Miscellaneous Reason|0|||
163139783|NCT01618669|589221931|FG001|Overall Study|Miscellaneous Reason|1|||
162661135|NCT00274716|587471660|FG003|Phase A|Other non-reported reason|2|||
162661136|NCT00274716|587471661|FG004|Phase A|Other non-reported reason|0|||
162661137|NCT00274716|587471662|FG005|Phase A|Other non-reported reason|1|||
162661138|NCT00274716|587471657|FG000|Phase A|Participant moved|0|||
162661139|NCT00274716|587471658|FG001|Phase A|Participant moved|0|||
162661140|NCT00274716|587471659|FG002|Phase A|Participant moved|1|||
162661141|NCT00274716|587471660|FG003|Phase A|Participant moved|0|||
162661142|NCT00274716|587471661|FG004|Phase A|Participant moved|0|||
162661143|NCT00274716|587471662|FG005|Phase A|Participant moved|1|||
162661144|NCT00274716|587471657|FG000|Phase A|Site Terminated|0|||
162661145|NCT00274716|587471658|FG001|Phase A|Site Terminated|0|||
162661146|NCT00274716|587471659|FG002|Phase A|Site Terminated|0|||
162661147|NCT00274716|587471660|FG003|Phase A|Site Terminated|1|||
162661148|NCT00274716|587471661|FG004|Phase A|Site Terminated|0|||
162661149|NCT00274716|587471662|FG005|Phase A|Site Terminated|0|||
162661150|NCT00274716|587471657|FG000|Phase A|Protocol Violation|1|||
162661151|NCT00274716|587471658|FG001|Phase A|Protocol Violation|0|||
162661152|NCT00274716|587471659|FG002|Phase A|Protocol Violation|0|||
162661153|NCT00274716|587471660|FG003|Phase A|Protocol Violation|1|||
162661154|NCT00274716|587471661|FG004|Phase A|Protocol Violation|0|||
162661155|NCT00274716|587471662|FG005|Phase A|Protocol Violation|0|||
162661156|NCT00274716|587471657|FG000|Phase A|Met criteria for discontinuation|1|||
162661157|NCT00274716|587471658|FG001|Phase A|Met criteria for discontinuation|1|||
162661158|NCT00274716|587471659|FG002|Phase A|Met criteria for discontinuation|0|||
162661159|NCT00274716|587471660|FG003|Phase A|Met criteria for discontinuation|0|||
162661160|NCT00274716|587471661|FG004|Phase A|Met criteria for discontinuation|0|||
162661161|NCT00274716|587471662|FG005|Phase A|Met criteria for discontinuation|0|||
162661162|NCT00274716|587471657|FG000|Phase A|Withdrawal by Subject|2|||
162661163|NCT00274716|587471658|FG001|Phase A|Withdrawal by Subject|2|||
162661164|NCT00274716|587471659|FG002|Phase A|Withdrawal by Subject|1|||
162661165|NCT00274716|587471660|FG003|Phase A|Withdrawal by Subject|3|||
162661166|NCT00274716|587471661|FG004|Phase A|Withdrawal by Subject|0|||
162661167|NCT00274716|587471662|FG005|Phase A|Withdrawal by Subject|1|||
162661168|NCT00274716|587471657|FG000|Phase A|Adverse Event|2|||
162661169|NCT00274716|587471658|FG001|Phase A|Adverse Event|3|||
162661170|NCT00274716|587471659|FG002|Phase A|Adverse Event|3|||
162661171|NCT00274716|587471660|FG003|Phase A|Adverse Event|0|||
162661172|NCT00274716|587471661|FG004|Phase A|Adverse Event|2|||
162661173|NCT00274716|587471662|FG005|Phase A|Adverse Event|0|||
162661174|NCT00274716|587471657|FG000|Phase A|Completed but did not enter Phase B|1|||
162661175|NCT00274716|587471658|FG001|Phase A|Completed but did not enter Phase B|2|||
162661176|NCT00274716|587471659|FG002|Phase A|Completed but did not enter Phase B|2|||
162661177|NCT00274716|587471660|FG003|Phase A|Completed but did not enter Phase B|2|||
162661178|NCT00274716|587471661|FG004|Phase A|Completed but did not enter Phase B|1|||
162661179|NCT00274716|587471662|FG005|Phase A|Completed but did not enter Phase B|1|||
162661180|NCT00274716|587471657|FG000|Phase B|Adverse Event|0|||
162661181|NCT00274716|587471658|FG001|Phase B|Adverse Event|0|||
162661182|NCT00274716|587471659|FG002|Phase B|Adverse Event|2|||
162661183|NCT00274716|587471660|FG003|Phase B|Adverse Event|0|||
162661184|NCT00274716|587471661|FG004|Phase B|Adverse Event|0|||
162661185|NCT00274716|587471662|FG005|Phase B|Adverse Event|1|||
162661186|NCT00274716|587471657|FG000|Phase B|Protocol Violation|0|||
162661187|NCT00274716|587471658|FG001|Phase B|Protocol Violation|2|||
162661188|NCT00274716|587471659|FG002|Phase B|Protocol Violation|0|||
162661189|NCT00274716|587471660|FG003|Phase B|Protocol Violation|0|||
162661190|NCT00274716|587471661|FG004|Phase B|Protocol Violation|0|||
162661191|NCT00274716|587471662|FG005|Phase B|Protocol Violation|0|||
162661192|NCT00274716|587471657|FG000|Phase B|Withdrawal by Subject|0|||
162661193|NCT00274716|587471658|FG001|Phase B|Withdrawal by Subject|1|||
162661194|NCT00274716|587471659|FG002|Phase B|Withdrawal by Subject|0|||
162661195|NCT00274716|587471660|FG003|Phase B|Withdrawal by Subject|0|||
162661196|NCT00274716|587471661|FG004|Phase B|Withdrawal by Subject|0|||
162661197|NCT00274716|587471662|FG005|Phase B|Withdrawal by Subject|0|||
162661198|NCT00274716|587471657|FG000|Phase B|Participant moved|1|||
162661199|NCT00274716|587471658|FG001|Phase B|Participant moved|0|||
162661200|NCT00274716|587471659|FG002|Phase B|Participant moved|0|||
162661201|NCT00274716|587471660|FG003|Phase B|Participant moved|0|||
162661202|NCT00274716|587471661|FG004|Phase B|Participant moved|0|||
162661203|NCT00274716|587471662|FG005|Phase B|Participant moved|0|||
162661204|NCT00274716|587471657|FG000|Phase B|Other non-reported reason|0|||
162661205|NCT00274716|587471658|FG001|Phase B|Other non-reported reason|0|||
162661206|NCT00274716|587471659|FG002|Phase B|Other non-reported reason|1|||
162661207|NCT00274716|587471660|FG003|Phase B|Other non-reported reason|1|||
162661208|NCT00274716|587471661|FG004|Phase B|Other non-reported reason|0|||
162661209|NCT00274716|587471662|FG005|Phase B|Other non-reported reason|0|||
162661210|NCT00274716|587471657|FG000|Phase B|Lost to Follow-up|0|||
162661211|NCT00274716|587471658|FG001|Phase B|Lost to Follow-up|1|||
162661212|NCT00274716|587471659|FG002|Phase B|Lost to Follow-up|0|||
162661213|NCT00274716|587471660|FG003|Phase B|Lost to Follow-up|0|||
162661214|NCT00274716|587471661|FG004|Phase B|Lost to Follow-up|0|||
162661215|NCT00274716|587471662|FG005|Phase B|Lost to Follow-up|0|||
162661216|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162661217|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
162661218|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
162661219|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
162661220|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
162661221|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
162661222|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162661223|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
162661224|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162661225|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162661226|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
162661227|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162661228|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
162661229|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
162661230|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
162661231|NCT01257204|587471663|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
162661232|NCT01257204|587471664|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
162661233|NCT01257204|587471665|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
162661234|NCT01257204|587471663|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
162661235|NCT01257204|587471664|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
162661236|NCT01257204|587471665|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
162661237|NCT01257204|587471663|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
162661238|NCT01257204|587471664|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
162661239|NCT01257204|587471665|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
162661240|NCT01257204|587471663|FG000|Follow-up Period (up to Week 48)|Other|0|||
162661241|NCT01257204|587471664|FG001|Follow-up Period (up to Week 48)|Other|0|||
162661242|NCT01257204|587471665|FG002|Follow-up Period (up to Week 48)|Other|5|||
162661243|NCT03394391|587471666|FG000|Overall Study|Lost to Follow-up|1|||
162661244|NCT03394391|587471667|FG001|Overall Study|Lost to Follow-up|2|||
162661245|NCT00723801|587471671|FG000|Overall Study|Lost to Follow-up|1|||
162661246|NCT00723801|587471672|FG001|Overall Study|Lost to Follow-up|2|||
162661247|NCT00723801|587471671|FG000|Overall Study|Protocol Violation|2|||
162661248|NCT00723801|587471672|FG001|Overall Study|Protocol Violation|1|||
162661249|NCT02489981|587471678|FG000|Overall Study|Adverse Event|21|||
162661250|NCT02489981|587471678|FG000|Overall Study|Insufficient effectiveness|16|||
162661251|NCT02489981|587471678|FG000|Overall Study|Improved|31|||
162661252|NCT02489981|587471678|FG000|Overall Study|Lost to Follow-up|31|||
162661253|NCT02489981|587471678|FG000|Overall Study|Other than listed|28|||
162661254|NCT01565993|587471686|FG000|Overall Study|Physician Decision|0|||
162661255|NCT01565993|587471687|FG001|Overall Study|Physician Decision|3|||
162661256|NCT04086472|587471690|FG000|Overall Study|Lost to Follow-up|1|||
162661257|NCT04086472|587471691|FG001|Overall Study|Lost to Follow-up|0|||
162661258|NCT04086472|587471692|FG002|Overall Study|Lost to Follow-up|0|||
162661259|NCT04086472|587471693|FG003|Overall Study|Lost to Follow-up|0|||
162661260|NCT04086472|587471694|FG004|Overall Study|Lost to Follow-up|1|||
162661261|NCT04086472|587471690|FG000|Overall Study|Physician Decision|0|||
162661262|NCT04086472|587471691|FG001|Overall Study|Physician Decision|1|||
162661263|NCT04086472|587471692|FG002|Overall Study|Physician Decision|1|||
162661264|NCT04086472|587471693|FG003|Overall Study|Physician Decision|0|||
162661265|NCT04086472|587471694|FG004|Overall Study|Physician Decision|0|||
162661266|NCT04086472|587471690|FG000|Overall Study|Withdrawal by Subject|1|||
162661267|NCT04086472|587471691|FG001|Overall Study|Withdrawal by Subject|1|||
162661268|NCT04086472|587471692|FG002|Overall Study|Withdrawal by Subject|1|||
162661269|NCT04086472|587471693|FG003|Overall Study|Withdrawal by Subject|0|||
162661270|NCT04086472|587471694|FG004|Overall Study|Withdrawal by Subject|0|||
162661271|NCT04086472|587471690|FG000|Overall Study|Various reasons|2|||
162661272|NCT04086472|587471691|FG001|Overall Study|Various reasons|0|||
162661273|NCT04086472|587471692|FG002|Overall Study|Various reasons|0|||
162661274|NCT04086472|587471693|FG003|Overall Study|Various reasons|3|||
162661275|NCT04086472|587471694|FG004|Overall Study|Various reasons|1|||
162661276|NCT03348904|587471695|FG000|Overall Study|Administrative reason by the sponsor|0|||
162661277|NCT03348904|587471696|FG001|Overall Study|Administrative reason by the sponsor|1|||
162661278|NCT03348904|587471697|FG002|Overall Study|Administrative reason by the sponsor|0|||
162661279|NCT00436280|587471703|FG000|Period 1: Induction|Adverse Event|8|||
162661280|NCT00436280|587471703|FG000|Period 1: Induction|Progressive Disease|12|||
162661281|NCT00436280|587471703|FG000|Period 1: Induction|Stable Disease|6|||
162661282|NCT00436280|587471703|FG000|Period 1: Induction|Withdrawal by Subject|1|||
162661283|NCT00436280|587471703|FG000|Period 1: Induction|Death|1|||
162661284|NCT00436280|587471703|FG000|Period 2: Consolidation|Adverse Event|1|||
162661285|NCT00436280|587471703|FG000|Period 2: Consolidation|Progressive Disease|10|||
162661286|NCT00436280|587471703|FG000|Period 2: Consolidation|Stable Disease|1|||
162661287|NCT00436280|587471703|FG000|Period 2: Consolidation|Physician Decision|2|||
162661288|NCT00436280|587471703|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
163139784|NCT01508169|589221932|FG000|Overall Study|Adverse Event|1|||
163139785|NCT01508169|589221933|FG001|Overall Study|Adverse Event|0|||
163139786|NCT01508169|589221932|FG000|Overall Study|Withdrawal by Subject|1|||
163139787|NCT01508169|589221933|FG001|Overall Study|Withdrawal by Subject|0|||
162661289|NCT00436280|587471703|FG000|Period 2: Consolidation|Death|1|||
162661290|NCT00436280|587471703|FG000|Period 3: Maintenance|Adverse Event|6|||
162661291|NCT00436280|587471703|FG000|Period 3: Maintenance|Progressive Disease|12|||
162661292|NCT01532687|587471708|FG000|Overall Study|Death|2|||
163139788|NCT01508169|589221932|FG000|Overall Study|Lost to Follow-up|1|||
162661293|NCT01532687|587471709|FG001|Overall Study|Death|0|||
162661294|NCT01532687|587471708|FG000|Overall Study|Adverse Event|6|||
162661295|NCT01532687|587471709|FG001|Overall Study|Adverse Event|1|||
162661296|NCT01532687|587471708|FG000|Overall Study|Withdrawal by Subject|1|||
162661297|NCT01532687|587471709|FG001|Overall Study|Withdrawal by Subject|0|||
162661298|NCT01532687|587471708|FG000|Overall Study|Physician Decision|2|||
162661299|NCT01532687|587471709|FG001|Overall Study|Physician Decision|1|||
162661300|NCT01532687|587471708|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
162661301|NCT01532687|587471709|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
162661302|NCT04116229|587471710|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
162661303|NCT04116229|587471711|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
162661304|NCT04116229|587471710|FG000|Overall Study|Scheduling not possible.|0|||
162661305|NCT04116229|587471711|FG001|Overall Study|Scheduling not possible.|1|||
162661306|NCT02809976|587471714|FG000|Overall Study|Lost to Follow-up|1|||
162661307|NCT02809976|587471714|FG000|Overall Study|Withdrawal by Subject|1|||
162661308|NCT01513291|587471715|FG000|Treatment Period|Adverse Event|8|||
162661309|NCT01513291|587471716|FG001|Treatment Period|Adverse Event|4|||
162661310|NCT01513291|587471717|FG002|Treatment Period|Adverse Event|0|||
162661311|NCT01513291|587471718|FG003|Treatment Period|Adverse Event|0|||
162661312|NCT01513291|587471719|FG004|Treatment Period|Adverse Event|0|||
162661313|NCT01513291|587471715|FG000|Treatment Period|Lack of Efficacy|3|||
162661314|NCT01513291|587471716|FG001|Treatment Period|Lack of Efficacy|0|||
162661315|NCT01513291|587471717|FG002|Treatment Period|Lack of Efficacy|0|||
162661316|NCT01513291|587471718|FG003|Treatment Period|Lack of Efficacy|0|||
162661317|NCT01513291|587471719|FG004|Treatment Period|Lack of Efficacy|0|||
162661318|NCT01513291|587471715|FG000|Treatment Period|Lost to Follow-up|2|||
162661319|NCT01513291|587471716|FG001|Treatment Period|Lost to Follow-up|3|||
162661320|NCT01513291|587471717|FG002|Treatment Period|Lost to Follow-up|0|||
162661321|NCT01513291|587471718|FG003|Treatment Period|Lost to Follow-up|0|||
162661322|NCT01513291|587471719|FG004|Treatment Period|Lost to Follow-up|0|||
162661323|NCT01513291|587471715|FG000|Treatment Period|Physician Decision|1|||
162661324|NCT01513291|587471716|FG001|Treatment Period|Physician Decision|0|||
162661325|NCT01513291|587471717|FG002|Treatment Period|Physician Decision|0|||
162661326|NCT01513291|587471718|FG003|Treatment Period|Physician Decision|0|||
162661327|NCT01513291|587471719|FG004|Treatment Period|Physician Decision|0|||
162661328|NCT01513291|587471715|FG000|Treatment Period|Protocol Violation|1|||
162661329|NCT01513291|587471716|FG001|Treatment Period|Protocol Violation|2|||
162661330|NCT01513291|587471717|FG002|Treatment Period|Protocol Violation|0|||
162661331|NCT01513291|587471718|FG003|Treatment Period|Protocol Violation|0|||
162661332|NCT01513291|587471719|FG004|Treatment Period|Protocol Violation|0|||
162661333|NCT01513291|587471715|FG000|Treatment Period|Withdrawal by Subject|8|||
162661334|NCT01513291|587471716|FG001|Treatment Period|Withdrawal by Subject|5|||
162661335|NCT01513291|587471717|FG002|Treatment Period|Withdrawal by Subject|0|||
162661336|NCT01513291|587471718|FG003|Treatment Period|Withdrawal by Subject|0|||
162661337|NCT01513291|587471719|FG004|Treatment Period|Withdrawal by Subject|0|||
162661338|NCT01513291|587471715|FG000|Treatment Period|Randomized not treated|0|||
162661339|NCT01513291|587471716|FG001|Treatment Period|Randomized not treated|2|||
162661340|NCT01513291|587471717|FG002|Treatment Period|Randomized not treated|0|||
162661341|NCT01513291|587471718|FG003|Treatment Period|Randomized not treated|0|||
162661342|NCT01513291|587471719|FG004|Treatment Period|Randomized not treated|0|||
162661343|NCT01513291|587471715|FG000|Run-out Period|Lost to Follow-up|0|||
162661344|NCT01513291|587471716|FG001|Run-out Period|Lost to Follow-up|0|||
162661345|NCT01513291|587471717|FG002|Run-out Period|Lost to Follow-up|0|||
162661346|NCT01513291|587471718|FG003|Run-out Period|Lost to Follow-up|1|||
162661347|NCT01513291|587471719|FG004|Run-out Period|Lost to Follow-up|0|||
162661348|NCT01513291|587471715|FG000|Run-out Period|Withdrawal by Subject|0|||
162661349|NCT01513291|587471716|FG001|Run-out Period|Withdrawal by Subject|0|||
162661350|NCT01513291|587471717|FG002|Run-out Period|Withdrawal by Subject|0|||
162661351|NCT01513291|587471718|FG003|Run-out Period|Withdrawal by Subject|1|||
162661352|NCT01513291|587471719|FG004|Run-out Period|Withdrawal by Subject|0|||
162661353|NCT01034397|587471720|FG000|Overall Study|Lack of compliance|0|||
162661354|NCT01034397|587471721|FG001|Overall Study|Lack of compliance|1|||
162661355|NCT01034397|587471720|FG000|Overall Study|Lack of Efficacy|3|||
162661356|NCT01034397|587471721|FG001|Overall Study|Lack of Efficacy|0|||
162661357|NCT01034397|587471720|FG000|Overall Study|Adverse Event|4|||
162661358|NCT01034397|587471721|FG001|Overall Study|Adverse Event|0|||
162661359|NCT01034397|587471720|FG000|Overall Study|Other|0|||
162661360|NCT01034397|587471721|FG001|Overall Study|Other|1|||
162661361|NCT00211081|587471725|FG000|Overall Study|Withdrawal by Subject|2|||
162661362|NCT01931839|587471726|FG000|Overall Study|Death|0|||
162661363|NCT01931839|587471727|FG001|Overall Study|Death|1|||
162661364|NCT01931839|587471728|FG002|Overall Study|Death|2|||
162661365|NCT01931839|587471729|FG003|Overall Study|Death|0|||
162661366|NCT01931839|587471730|FG004|Overall Study|Death|0|||
162661367|NCT01931839|587471731|FG005|Overall Study|Death|0|||
162661368|NCT01931839|587471732|FG006|Overall Study|Death|0|||
162661369|NCT01931839|587471726|FG000|Overall Study|Physician Decision|1|||
162661370|NCT01931839|587471727|FG001|Overall Study|Physician Decision|0|||
162661371|NCT01931839|587471728|FG002|Overall Study|Physician Decision|1|||
162661372|NCT01931839|587471729|FG003|Overall Study|Physician Decision|0|||
162661373|NCT01931839|587471730|FG004|Overall Study|Physician Decision|0|||
162661374|NCT01931839|587471731|FG005|Overall Study|Physician Decision|0|||
162661375|NCT01931839|587471732|FG006|Overall Study|Physician Decision|1|||
162661376|NCT01931839|587471726|FG000|Overall Study|Withdrawal of consent|0|||
162661377|NCT01931839|587471727|FG001|Overall Study|Withdrawal of consent|0|||
162661378|NCT01931839|587471728|FG002|Overall Study|Withdrawal of consent|0|||
162661379|NCT01931839|587471729|FG003|Overall Study|Withdrawal of consent|0|||
162661380|NCT01931839|587471730|FG004|Overall Study|Withdrawal of consent|1|||
162661381|NCT01931839|587471731|FG005|Overall Study|Withdrawal of consent|0|||
162661382|NCT01931839|587471732|FG006|Overall Study|Withdrawal of consent|0|||
162661383|NCT01931839|587471726|FG000|Overall Study|Adverse Event|9|||
162661384|NCT01931839|587471727|FG001|Overall Study|Adverse Event|4|||
162661385|NCT01931839|587471728|FG002|Overall Study|Adverse Event|1|||
162661386|NCT01931839|587471729|FG003|Overall Study|Adverse Event|3|||
162661387|NCT01931839|587471730|FG004|Overall Study|Adverse Event|0|||
162661388|NCT01931839|587471731|FG005|Overall Study|Adverse Event|0|||
162661389|NCT01931839|587471732|FG006|Overall Study|Adverse Event|1|||
162661390|NCT01931839|587471726|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
162661391|NCT01931839|587471727|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
162661392|NCT01931839|587471728|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
162661393|NCT01931839|587471729|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
162661394|NCT01931839|587471730|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
163139789|NCT01508169|589221933|FG001|Overall Study|Lost to Follow-up|2|||
163139790|NCT03600740|589221942|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
163139791|NCT00556998|589221947|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
163139792|NCT00556998|589221947|FG000|Voriconazole Intravenous (IV)|Other|4|||
163139793|NCT00556998|589221947|FG000|Voriconazole Oral|Adverse Event|1|||
163139794|NCT00556998|589221947|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
163139795|NCT02721875|589221948|FG000|Overall Study|Progressive disease/relapse|1|||
163139796|NCT02721875|589221949|FG001|Overall Study|Progressive disease/relapse|0|||
163139797|NCT02888106|589221950|FG000|Overall Study|Withdrawal by Subject|1|||
163139798|NCT02888106|589221951|FG001|Overall Study|Withdrawal by Subject|2|||
163139799|NCT02888106|589221952|FG002|Overall Study|Withdrawal by Subject|0|||
163139800|NCT02888106|589221953|FG003|Overall Study|Withdrawal by Subject|1|||
163139801|NCT02888106|589221954|FG004|Overall Study|Withdrawal by Subject|0|||
163139802|NCT02888106|589221955|FG005|Overall Study|Withdrawal by Subject|0|||
163139803|NCT02888106|589221950|FG000|Overall Study|Lost to Follow-up|1|||
163139804|NCT02888106|589221951|FG001|Overall Study|Lost to Follow-up|0|||
163139805|NCT02888106|589221952|FG002|Overall Study|Lost to Follow-up|0|||
163139806|NCT02888106|589221953|FG003|Overall Study|Lost to Follow-up|1|||
163139807|NCT02888106|589221954|FG004|Overall Study|Lost to Follow-up|0|||
163139808|NCT02888106|589221955|FG005|Overall Study|Lost to Follow-up|1|||
163139809|NCT02888106|589221950|FG000|Overall Study|Adverse Event|2|||
163139810|NCT02888106|589221951|FG001|Overall Study|Adverse Event|0|||
163139811|NCT02888106|589221952|FG002|Overall Study|Adverse Event|0|||
163139812|NCT02888106|589221953|FG003|Overall Study|Adverse Event|0|||
163139813|NCT02888106|589221954|FG004|Overall Study|Adverse Event|0|||
163139814|NCT02888106|589221955|FG005|Overall Study|Adverse Event|0|||
163139815|NCT02888106|589221950|FG000|Overall Study|Withdrawal of consent|0|||
163139816|NCT02888106|589221951|FG001|Overall Study|Withdrawal of consent|0|||
163139817|NCT02888106|589221952|FG002|Overall Study|Withdrawal of consent|0|||
163139818|NCT02888106|589221953|FG003|Overall Study|Withdrawal of consent|0|||
162661395|NCT01931839|587471731|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
162661396|NCT01931839|587471732|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
162661397|NCT01931839|587471726|FG000|Overall Study|Other non-compliance|15|||
162661398|NCT01931839|587471727|FG001|Overall Study|Other non-compliance|9|||
162661399|NCT01931839|587471728|FG002|Overall Study|Other non-compliance|12|||
162661400|NCT01931839|587471729|FG003|Overall Study|Other non-compliance|3|||
162661401|NCT01931839|587471730|FG004|Overall Study|Other non-compliance|0|||
163139819|NCT02888106|589221954|FG004|Overall Study|Withdrawal of consent|1|||
162661402|NCT01931839|587471731|FG005|Overall Study|Other non-compliance|3|||
163139820|NCT02888106|589221955|FG005|Overall Study|Withdrawal of consent|0|||
163139821|NCT02888106|589221950|FG000|Overall Study|Pregnancy|1|||
163139822|NCT02888106|589221951|FG001|Overall Study|Pregnancy|0|||
163139823|NCT02888106|589221952|FG002|Overall Study|Pregnancy|0|||
163139824|NCT02888106|589221953|FG003|Overall Study|Pregnancy|0|||
163139825|NCT02888106|589221954|FG004|Overall Study|Pregnancy|0|||
163139826|NCT02888106|589221955|FG005|Overall Study|Pregnancy|0|||
163139827|NCT01425801|589221961|FG000|Period 1|Withdrawal by Subject|0|||
163139828|NCT01425801|589221962|FG001|Period 1|Withdrawal by Subject|0|||
163139829|NCT01425801|589221963|FG002|Period 1|Withdrawal by Subject|0|||
163139830|NCT01425801|589221964|FG003|Period 1|Withdrawal by Subject|0|||
163139831|NCT01425801|589221965|FG004|Period 1|Withdrawal by Subject|1|||
163139832|NCT01425801|589221966|FG005|Period 1|Withdrawal by Subject|0|||
163139833|NCT01425801|589221961|FG000|Period 2|Withdrawal by Subject|0|||
163139834|NCT01425801|589221962|FG001|Period 2|Withdrawal by Subject|0|||
163139835|NCT01425801|589221963|FG002|Period 2|Withdrawal by Subject|0|||
163139836|NCT01425801|589221964|FG003|Period 2|Withdrawal by Subject|0|||
163139837|NCT01425801|589221965|FG004|Period 2|Withdrawal by Subject|1|||
163139838|NCT01425801|589221966|FG005|Period 2|Withdrawal by Subject|0|||
163139839|NCT01425801|589221961|FG000|Period 3|Stability criteria not fullfilled|0|||
163139840|NCT01425801|589221962|FG001|Period 3|Stability criteria not fullfilled|0|||
163139841|NCT01425801|589221963|FG002|Period 3|Stability criteria not fullfilled|1|||
163139842|NCT01425801|589221964|FG003|Period 3|Stability criteria not fullfilled|0|||
163139843|NCT01425801|589221965|FG004|Period 3|Stability criteria not fullfilled|0|||
163139844|NCT01425801|589221966|FG005|Period 3|Stability criteria not fullfilled|0|||
163139845|NCT01425801|589221961|FG000|Period 4|Not able to maintain visit schedule|0|||
163139846|NCT01425801|589221962|FG001|Period 4|Not able to maintain visit schedule|0|||
163139847|NCT01425801|589221963|FG002|Period 4|Not able to maintain visit schedule|1|||
163139848|NCT01425801|589221964|FG003|Period 4|Not able to maintain visit schedule|0|||
163139849|NCT01425801|589221965|FG004|Period 4|Not able to maintain visit schedule|0|||
163139850|NCT01425801|589221966|FG005|Period 4|Not able to maintain visit schedule|0|||
163139851|NCT03386721|589221967|FG000|Overall Study|Death|12|||
163139852|NCT03386721|589221968|FG001|Overall Study|Death|21|||
163139853|NCT03386721|589221969|FG002|Overall Study|Death|2|||
163139854|NCT03386721|589221970|FG003|Overall Study|Death|5|||
163139855|NCT03386721|589221971|FG004|Overall Study|Death|1|||
163139856|NCT03386721|589221972|FG005|Overall Study|Death|12|||
163139857|NCT03386721|589221973|FG006|Overall Study|Death|1|||
163139858|NCT03386721|589221974|FG007|Overall Study|Death|1|||
163139859|NCT03386721|589221975|FG008|Overall Study|Death|12|||
163139860|NCT03386721|589221976|FG009|Overall Study|Death|20|||
163139861|NCT03386721|589221977|FG010|Overall Study|Death|21|||
163139862|NCT03386721|589221978|FG011|Overall Study|Death|21|||
163139863|NCT03386721|589221979|FG012|Overall Study|Death|14|||
163139864|NCT03386721|589221980|FG013|Overall Study|Death|2|||
163139865|NCT03386721|589221981|FG014|Overall Study|Death|1|||
163139866|NCT03386721|589221967|FG000|Overall Study|Lost to Follow-up|1|||
163139867|NCT03386721|589221968|FG001|Overall Study|Lost to Follow-up|3|||
163139868|NCT03386721|589221969|FG002|Overall Study|Lost to Follow-up|0|||
163139869|NCT03386721|589221970|FG003|Overall Study|Lost to Follow-up|0|||
163139870|NCT03386721|589221971|FG004|Overall Study|Lost to Follow-up|0|||
163139871|NCT03386721|589221972|FG005|Overall Study|Lost to Follow-up|2|||
163139872|NCT03386721|589221973|FG006|Overall Study|Lost to Follow-up|1|||
163139873|NCT03386721|589221974|FG007|Overall Study|Lost to Follow-up|0|||
163139874|NCT03386721|589221975|FG008|Overall Study|Lost to Follow-up|1|||
163139875|NCT03386721|589221976|FG009|Overall Study|Lost to Follow-up|2|||
163139876|NCT03386721|589221977|FG010|Overall Study|Lost to Follow-up|1|||
163139877|NCT03386721|589221978|FG011|Overall Study|Lost to Follow-up|0|||
163139878|NCT03386721|589221979|FG012|Overall Study|Lost to Follow-up|0|||
163139879|NCT03386721|589221980|FG013|Overall Study|Lost to Follow-up|0|||
163139880|NCT03386721|589221981|FG014|Overall Study|Lost to Follow-up|0|||
163139881|NCT03386721|589221967|FG000|Overall Study|Reason not specified|3|||
163139882|NCT03386721|589221968|FG001|Overall Study|Reason not specified|0|||
163139883|NCT03386721|589221969|FG002|Overall Study|Reason not specified|0|||
163139884|NCT03386721|589221970|FG003|Overall Study|Reason not specified|0|||
163139885|NCT03386721|589221971|FG004|Overall Study|Reason not specified|0|||
163139886|NCT03386721|589221972|FG005|Overall Study|Reason not specified|3|||
163139887|NCT03386721|589221973|FG006|Overall Study|Reason not specified|1|||
163139888|NCT03386721|589221974|FG007|Overall Study|Reason not specified|0|||
163139889|NCT03386721|589221975|FG008|Overall Study|Reason not specified|0|||
163139890|NCT03386721|589221976|FG009|Overall Study|Reason not specified|1|||
163139891|NCT03386721|589221977|FG010|Overall Study|Reason not specified|2|||
163139892|NCT03386721|589221978|FG011|Overall Study|Reason not specified|6|||
163139893|NCT03386721|589221979|FG012|Overall Study|Reason not specified|1|||
163139894|NCT03386721|589221980|FG013|Overall Study|Reason not specified|0|||
163139895|NCT03386721|589221981|FG014|Overall Study|Reason not specified|0|||
163139896|NCT03386721|589221967|FG000|Overall Study|Progressive Disease|0|||
163139897|NCT03386721|589221968|FG001|Overall Study|Progressive Disease|0|||
163139898|NCT03386721|589221969|FG002|Overall Study|Progressive Disease|1|||
163139899|NCT03386721|589221970|FG003|Overall Study|Progressive Disease|0|||
162720717|NCT01393119|587685914|FG003|Overall Study|Lack of Efficacy|1|||
163139900|NCT03386721|589221971|FG004|Overall Study|Progressive Disease|0|||
163139901|NCT03386721|589221972|FG005|Overall Study|Progressive Disease|1|||
163139902|NCT03386721|589221973|FG006|Overall Study|Progressive Disease|0|||
163139903|NCT03386721|589221974|FG007|Overall Study|Progressive Disease|0|||
163139904|NCT03386721|589221975|FG008|Overall Study|Progressive Disease|2|||
163139905|NCT03386721|589221976|FG009|Overall Study|Progressive Disease|1|||
163139906|NCT03386721|589221977|FG010|Overall Study|Progressive Disease|1|||
163139907|NCT03386721|589221978|FG011|Overall Study|Progressive Disease|0|||
163139908|NCT03386721|589221979|FG012|Overall Study|Progressive Disease|1|||
163139909|NCT03386721|589221980|FG013|Overall Study|Progressive Disease|0|||
163139910|NCT03386721|589221981|FG014|Overall Study|Progressive Disease|0|||
163139911|NCT03386721|589221967|FG000|Overall Study|Site Terminated by Sponsor|5|||
163139912|NCT03386721|589221968|FG001|Overall Study|Site Terminated by Sponsor|5|||
163139913|NCT03386721|589221969|FG002|Overall Study|Site Terminated by Sponsor|0|||
163139914|NCT03386721|589221970|FG003|Overall Study|Site Terminated by Sponsor|0|||
163139915|NCT03386721|589221971|FG004|Overall Study|Site Terminated by Sponsor|1|||
163139916|NCT03386721|589221972|FG005|Overall Study|Site Terminated by Sponsor|3|||
163139917|NCT03386721|589221973|FG006|Overall Study|Site Terminated by Sponsor|0|||
163139918|NCT03386721|589221974|FG007|Overall Study|Site Terminated by Sponsor|1|||
163139919|NCT03386721|589221975|FG008|Overall Study|Site Terminated by Sponsor|4|||
163139920|NCT03386721|589221976|FG009|Overall Study|Site Terminated by Sponsor|5|||
163139921|NCT03386721|589221977|FG010|Overall Study|Site Terminated by Sponsor|3|||
163139922|NCT03386721|589221978|FG011|Overall Study|Site Terminated by Sponsor|11|||
163139923|NCT03386721|589221979|FG012|Overall Study|Site Terminated by Sponsor|6|||
163139924|NCT03386721|589221980|FG013|Overall Study|Site Terminated by Sponsor|0|||
163139925|NCT03386721|589221981|FG014|Overall Study|Site Terminated by Sponsor|0|||
163139926|NCT03386721|589221967|FG000|Overall Study|Symptomatic Deterioration|0|||
163139927|NCT03386721|589221968|FG001|Overall Study|Symptomatic Deterioration|0|||
163139928|NCT03386721|589221969|FG002|Overall Study|Symptomatic Deterioration|0|||
163139929|NCT03386721|589221970|FG003|Overall Study|Symptomatic Deterioration|0|||
163139930|NCT03386721|589221971|FG004|Overall Study|Symptomatic Deterioration|0|||
163139931|NCT03386721|589221972|FG005|Overall Study|Symptomatic Deterioration|0|||
163139932|NCT03386721|589221973|FG006|Overall Study|Symptomatic Deterioration|0|||
163139933|NCT03386721|589221974|FG007|Overall Study|Symptomatic Deterioration|0|||
163139934|NCT03386721|589221975|FG008|Overall Study|Symptomatic Deterioration|1|||
163139935|NCT03386721|589221976|FG009|Overall Study|Symptomatic Deterioration|0|||
163139936|NCT03386721|589221977|FG010|Overall Study|Symptomatic Deterioration|0|||
163139937|NCT03386721|589221978|FG011|Overall Study|Symptomatic Deterioration|1|||
163139938|NCT03386721|589221979|FG012|Overall Study|Symptomatic Deterioration|0|||
163139939|NCT03386721|589221980|FG013|Overall Study|Symptomatic Deterioration|0|||
163139940|NCT03386721|589221981|FG014|Overall Study|Symptomatic Deterioration|0|||
163139941|NCT03386721|589221967|FG000|Overall Study|Withdrawal by Subject|1|||
163139942|NCT03386721|589221968|FG001|Overall Study|Withdrawal by Subject|2|||
163139943|NCT03386721|589221969|FG002|Overall Study|Withdrawal by Subject|0|||
163139944|NCT03386721|589221970|FG003|Overall Study|Withdrawal by Subject|0|||
163139945|NCT03386721|589221971|FG004|Overall Study|Withdrawal by Subject|0|||
163139946|NCT03386721|589221972|FG005|Overall Study|Withdrawal by Subject|0|||
163139947|NCT03386721|589221973|FG006|Overall Study|Withdrawal by Subject|0|||
163139948|NCT03386721|589221974|FG007|Overall Study|Withdrawal by Subject|0|||
163139949|NCT03386721|589221975|FG008|Overall Study|Withdrawal by Subject|2|||
163139950|NCT03386721|589221976|FG009|Overall Study|Withdrawal by Subject|1|||
163139951|NCT03386721|589221977|FG010|Overall Study|Withdrawal by Subject|3|||
163139952|NCT03386721|589221978|FG011|Overall Study|Withdrawal by Subject|2|||
163139953|NCT03386721|589221979|FG012|Overall Study|Withdrawal by Subject|3|||
163139954|NCT03386721|589221980|FG013|Overall Study|Withdrawal by Subject|0|||
163139955|NCT03386721|589221981|FG014|Overall Study|Withdrawal by Subject|0|||
163139956|NCT03066596|589221982|FG000|Overall Study|Withdrawal by Subject|4|||
163139957|NCT03066596|589221983|FG001|Overall Study|Withdrawal by Subject|2|||
163139958|NCT03066596|589221982|FG000|Overall Study|Lost to Follow-up|14|||
163139959|NCT03066596|589221983|FG001|Overall Study|Lost to Follow-up|10|||
163139960|NCT00700713|589221984|FG000|Overall Study|Protocol Violation|1|||
163139961|NCT00700713|589221985|FG001|Overall Study|Protocol Violation|0|||
163139962|NCT00700713|589221986|FG002|Overall Study|Protocol Violation|1|||
163139963|NCT00700713|589221984|FG000|Overall Study|Withdrawal by Subject|0|||
163139964|NCT00700713|589221985|FG001|Overall Study|Withdrawal by Subject|0|||
163139965|NCT00700713|589221986|FG002|Overall Study|Withdrawal by Subject|1|||
163139966|NCT03797586|589221987|FG000|Overall Study|Lost to Follow-up|3|||
163139967|NCT03797586|589221988|FG001|Overall Study|Lost to Follow-up|6|||
163139968|NCT03797586|589221987|FG000|Overall Study|Death|1|||
163139969|NCT03797586|589221988|FG001|Overall Study|Death|1|||
163139970|NCT03797586|589221987|FG000|Overall Study|Adverse Event|0|||
163139971|NCT03797586|589221988|FG001|Overall Study|Adverse Event|2|||
162661403|NCT01931839|587471732|FG006|Overall Study|Other non-compliance|0|||
162661404|NCT01931839|587471726|FG000|Overall Study|Lost to Follow-up|1|||
162661405|NCT01931839|587471727|FG001|Overall Study|Lost to Follow-up|2|||
162661406|NCT01931839|587471728|FG002|Overall Study|Lost to Follow-up|4|||
163139972|NCT02959437|589221989|FG000|Overall Study|Death|33|||
163139973|NCT02959437|589221990|FG001|Overall Study|Death|3|||
163139974|NCT02959437|589221991|FG002|Overall Study|Death|0|||
163139975|NCT02959437|589221992|FG003|Overall Study|Death|0|||
163139976|NCT02959437|589221989|FG000|Overall Study|Lost to Follow-up|3|||
163139977|NCT02959437|589221990|FG001|Overall Study|Lost to Follow-up|1|||
163139978|NCT02959437|589221991|FG002|Overall Study|Lost to Follow-up|0|||
163139979|NCT02959437|589221992|FG003|Overall Study|Lost to Follow-up|0|||
163139980|NCT02959437|589221989|FG000|Overall Study|Withdrawal by Subject|11|||
163139981|NCT02959437|589221990|FG001|Overall Study|Withdrawal by Subject|3|||
163139982|NCT02959437|589221991|FG002|Overall Study|Withdrawal by Subject|0|||
163139983|NCT02959437|589221992|FG003|Overall Study|Withdrawal by Subject|0|||
163139984|NCT02959437|589221989|FG000|Overall Study|Progressive Disease|9|||
163139985|NCT02959437|589221990|FG001|Overall Study|Progressive Disease|1|||
163139986|NCT02959437|589221991|FG002|Overall Study|Progressive Disease|0|||
163139987|NCT02959437|589221992|FG003|Overall Study|Progressive Disease|0|||
163139988|NCT02959437|589221989|FG000|Overall Study|Study Terminated by Sponsor|4|||
163139989|NCT02959437|589221990|FG001|Overall Study|Study Terminated by Sponsor|0|||
163139990|NCT02959437|589221991|FG002|Overall Study|Study Terminated by Sponsor|0|||
163139991|NCT02959437|589221992|FG003|Overall Study|Study Terminated by Sponsor|0|||
163139992|NCT02959437|589221989|FG000|Overall Study|Other Unspecified|2|||
163139993|NCT02959437|589221990|FG001|Overall Study|Other Unspecified|0|||
163139994|NCT02959437|589221991|FG002|Overall Study|Other Unspecified|0|||
163139995|NCT02959437|589221992|FG003|Overall Study|Other Unspecified|0|||
163139996|NCT02864901|589221993|FG000|Overall Study|Withdrawal by Subject|1|||
163139997|NCT02864901|589221994|FG001|Overall Study|Withdrawal by Subject|0|||
163139998|NCT02728089|589221997|FG000|Overall Study|Physician Decision|2|||
163139999|NCT02728089|589221997|FG000|Overall Study|Withdrawal by Subject|1|||
163140000|NCT01369784|589222002|FG000|Overall Study|Protocol Violation|12|||
163140001|NCT01219985|589222003|FG000|Overall Study|Physician Decision|20|||
163140002|NCT03359174|589222004|FG000|Overall Study|Adverse Event|1|||
163140003|NCT02680665|589222005|FG000|Overall Study|No visit after the first prescription|5|||
163140004|NCT02905266|589222006|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
163140005|NCT02905266|589222007|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
163140006|NCT02905266|589222006|FG000|Treatment Phase Part 1|Disease Progression|6|||
163140007|NCT02905266|589222007|FG001|Treatment Phase Part 1|Disease Progression|7|||
163140008|NCT02905266|589222006|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
163140009|NCT02905266|589222007|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
163140010|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
163140011|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
163140012|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
163140013|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
163140014|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
163140015|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
163140016|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Death|0|||
163140017|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Death|1|||
163140018|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
163140019|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
163140020|NCT02905266|589222006|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
163140021|NCT02905266|589222007|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
163140022|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Disease Progression|9|||
163140023|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Disease Progression|2|||
163140024|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
163140025|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
163140026|NCT02905266|589222006|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
163140027|NCT02905266|589222007|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
163140028|NCT00596752|589222010|FG000|Overall Study|Other Reason|44|||
163140029|NCT00596752|589222011|FG001|Overall Study|Other Reason|49|||
163140030|NCT00596752|589222010|FG000|Overall Study|Adverse Event|34|||
163140031|NCT00596752|589222011|FG001|Overall Study|Adverse Event|34|||
163140032|NCT00596752|589222010|FG000|Overall Study|Lost to Follow-up|22|||
163140033|NCT00596752|589222011|FG001|Overall Study|Lost to Follow-up|38|||
163140034|NCT00596752|589222010|FG000|Overall Study|Withdrawal by Subject|12|||
163140035|NCT00596752|589222011|FG001|Overall Study|Withdrawal by Subject|9|||
163140036|NCT00596752|589222010|FG000|Overall Study|Unsatisfactory Compliance|9|||
163140037|NCT00596752|589222011|FG001|Overall Study|Unsatisfactory Compliance|6|||
163140038|NCT00596752|589222010|FG000|Overall Study|Lack of Efficacy|4|||
163140039|NCT00596752|589222011|FG001|Overall Study|Lack of Efficacy|7|||
163140040|NCT00596752|589222010|FG000|Overall Study|Protocol Violation|1|||
163140041|NCT00596752|589222011|FG001|Overall Study|Protocol Violation|0|||
162661407|NCT01931839|587471729|FG003|Overall Study|Lost to Follow-up|5|||
162661408|NCT01931839|587471730|FG004|Overall Study|Lost to Follow-up|0|||
162661409|NCT01931839|587471731|FG005|Overall Study|Lost to Follow-up|0|||
162661410|NCT01931839|587471732|FG006|Overall Study|Lost to Follow-up|0|||
162661411|NCT01931839|587471726|FG000|Overall Study|Other|4|||
163140042|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
163140043|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
163140044|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
163140045|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
163140046|NCT04445662|589222016|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
163140047|NCT04445662|589222017|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
163140048|NCT04445662|589222016|FG000|Post-treatment (12-24 weeks)|Death|1|||
163140049|NCT04445662|589222017|FG001|Post-treatment (12-24 weeks)|Death|0|||
163140050|NCT04089761|589222018|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
163140051|NCT04089761|589222018|FG000|"Run In Phase"|Lost to Follow-up|1|||
163140052|NCT04089761|589222018|FG000|"Treatment Phase"|No evaluable data|5|||
163140053|NCT04089761|589222018|FG000|"Treatment Phase"|Lost to Follow-up|1|||
163140054|NCT04896593|589222020|FG000|Overall Study|Withdrawal by Subject|2|||
163140055|NCT04896593|589222020|FG000|Overall Study|Lost to Follow-up|1|||
163140056|NCT04896593|589222020|FG000|Overall Study|Did not complete onboarding|2|||
163140057|NCT02915978|589222021|FG000|Overall Study|Adverse Event|2|||
163140058|NCT02915978|589222022|FG001|Overall Study|Adverse Event|1|||
163140059|NCT02915978|589222023|FG002|Overall Study|Adverse Event|0|||
163140060|NCT02451124|589222024|FG000|Overall Study|Withdrawal by Subject|1|||
163140061|NCT00892775|589222025|FG000|Overall Study|Protocol Violation|1|||
163140062|NCT00892775|589222026|FG001|Overall Study|Protocol Violation|0|||
163140063|NCT00892775|589222025|FG000|Overall Study|Subject difficulties with blood drawing|1|||
163140064|NCT00892775|589222026|FG001|Overall Study|Subject difficulties with blood drawing|0|||
163140065|NCT00892775|589222025|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
163140066|NCT00892775|589222026|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
163140067|NCT00892775|589222025|FG000|Overall Study|Migrated/ moved from study area|1|||
163140068|NCT00892775|589222026|FG001|Overall Study|Migrated/ moved from study area|0|||
163140069|NCT00892775|589222025|FG000|Overall Study|Withdrawal by Subject|0|||
163140070|NCT00892775|589222026|FG001|Overall Study|Withdrawal by Subject|1|||
163140071|NCT00892775|589222025|FG000|Overall Study|Lost to Follow-up|1|||
163140072|NCT00892775|589222026|FG001|Overall Study|Lost to Follow-up|0|||
163140073|NCT01870726|589222027|FG000|Overall Study|Withdrawal of informed consent|0|||
163140074|NCT01870726|589222028|FG001|Overall Study|Withdrawal of informed consent|0|||
163140075|NCT01870726|589222029|FG002|Overall Study|Withdrawal of informed consent|0|||
163140076|NCT01870726|589222030|FG003|Overall Study|Withdrawal of informed consent|1|||
163140077|NCT01870726|589222031|FG004|Overall Study|Withdrawal of informed consent|0|||
163140078|NCT01870726|589222032|FG005|Overall Study|Withdrawal of informed consent|0|||
163140079|NCT01870726|589222033|FG006|Overall Study|Withdrawal of informed consent|0|||
163140080|NCT01870726|589222027|FG000|Overall Study|Withdrawal by Subject|0|||
163140081|NCT01870726|589222028|FG001|Overall Study|Withdrawal by Subject|1|||
163140082|NCT01870726|589222029|FG002|Overall Study|Withdrawal by Subject|0|||
163140083|NCT01870726|589222030|FG003|Overall Study|Withdrawal by Subject|0|||
163140084|NCT01870726|589222031|FG004|Overall Study|Withdrawal by Subject|0|||
163140085|NCT01870726|589222032|FG005|Overall Study|Withdrawal by Subject|0|||
163140086|NCT01870726|589222033|FG006|Overall Study|Withdrawal by Subject|0|||
163140087|NCT01870726|589222027|FG000|Overall Study|Adverse Event|0|||
163140088|NCT01870726|589222028|FG001|Overall Study|Adverse Event|0|||
163140089|NCT01870726|589222029|FG002|Overall Study|Adverse Event|0|||
163140090|NCT01870726|589222030|FG003|Overall Study|Adverse Event|0|||
163140091|NCT01870726|589222031|FG004|Overall Study|Adverse Event|1|||
163140092|NCT01870726|589222032|FG005|Overall Study|Adverse Event|1|||
163140093|NCT01870726|589222033|FG006|Overall Study|Adverse Event|0|||
163140094|NCT01870726|589222027|FG000|Overall Study|Progressive disease|5|||
163140095|NCT01870726|589222028|FG001|Overall Study|Progressive disease|5|||
163140096|NCT01870726|589222029|FG002|Overall Study|Progressive disease|4|||
163140097|NCT01870726|589222030|FG003|Overall Study|Progressive disease|5|||
163140098|NCT01870726|589222031|FG004|Overall Study|Progressive disease|6|||
163140099|NCT01870726|589222032|FG005|Overall Study|Progressive disease|4|||
163140100|NCT01870726|589222033|FG006|Overall Study|Progressive disease|10|||
163140101|NCT00103740|589222038|FG000|Period 1 - Core|Adverse Event|1|||
163140102|NCT00103740|589222039|FG001|Period 1 - Core|Adverse Event|0|||
163140103|NCT00103740|589222038|FG000|Period 1 - Core|Protocol Violation|3|||
163140104|NCT00103740|589222039|FG001|Period 1 - Core|Protocol Violation|2|||
163140105|NCT00103740|589222038|FG000|Period 1 - Core|Patient withdrew consent|3|||
163140106|NCT00103740|589222039|FG001|Period 1 - Core|Patient withdrew consent|2|||
163140107|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
163140108|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
162661412|NCT01931839|587471727|FG001|Overall Study|Other|2|||
162661413|NCT01931839|587471728|FG002|Overall Study|Other|6|||
162661414|NCT01931839|587471729|FG003|Overall Study|Other|0|||
163140109|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
162661415|NCT01931839|587471730|FG004|Overall Study|Other|0|||
162661416|NCT01931839|587471731|FG005|Overall Study|Other|0|||
163140110|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
163140111|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
163140112|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
163140113|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Death|6|||
163140114|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Death|2|||
163140115|NCT00103740|589222038|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
163140116|NCT00103740|589222039|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
163140117|NCT03691571|589222040|FG000|Overall Study|Withdrawal by Subject|9|||
163140118|NCT03691571|589222041|FG001|Overall Study|Withdrawal by Subject|2|||
163140119|NCT01463306|589222042|FG000|Overall Study|Adverse Event|6|||
163140120|NCT01463306|589222043|FG001|Overall Study|Adverse Event|9|||
163140121|NCT01463306|589222044|FG002|Overall Study|Adverse Event|3|||
163140122|NCT01463306|589222042|FG000|Overall Study|Death|3|||
163140123|NCT01463306|589222043|FG001|Overall Study|Death|3|||
163140124|NCT01463306|589222044|FG002|Overall Study|Death|0|||
163140125|NCT01463306|589222042|FG000|Overall Study|Lack of Efficacy|22|||
163140126|NCT01463306|589222043|FG001|Overall Study|Lack of Efficacy|16|||
163140127|NCT01463306|589222044|FG002|Overall Study|Lack of Efficacy|1|||
163140128|NCT01463306|589222042|FG000|Overall Study|Lost to Follow-up|5|||
163140129|NCT01463306|589222043|FG001|Overall Study|Lost to Follow-up|2|||
163140130|NCT01463306|589222044|FG002|Overall Study|Lost to Follow-up|0|||
163140131|NCT01463306|589222042|FG000|Overall Study|Protocol Violation|4|||
163140132|NCT01463306|589222043|FG001|Overall Study|Protocol Violation|0|||
163140133|NCT01463306|589222044|FG002|Overall Study|Protocol Violation|0|||
163140134|NCT01463306|589222042|FG000|Overall Study|Withdrawal by Subject|19|||
163140135|NCT01463306|589222043|FG001|Overall Study|Withdrawal by Subject|9|||
163140136|NCT01463306|589222044|FG002|Overall Study|Withdrawal by Subject|1|||
163140137|NCT01463306|589222042|FG000|Overall Study|Other|26|||
163140138|NCT01463306|589222043|FG001|Overall Study|Other|13|||
163140139|NCT01463306|589222044|FG002|Overall Study|Other|0|||
163140140|NCT01463306|589222042|FG000|Overall Study|Approval expiry at site|1|||
163140141|NCT01463306|589222043|FG001|Overall Study|Approval expiry at site|0|||
163140142|NCT01463306|589222044|FG002|Overall Study|Approval expiry at site|0|||
163140143|NCT00250276|589222049|FG000|Overall Study|Serious Adverse Event|0|||
163140144|NCT00250276|589222050|FG001|Overall Study|Serious Adverse Event|0|||
163140145|NCT00250276|589222051|FG002|Overall Study|Serious Adverse Event|1|||
163140146|NCT00250276|589222052|FG003|Overall Study|Serious Adverse Event|0|||
163140147|NCT00250276|589222049|FG000|Overall Study|Non-serious Adverse Event|2|||
163140148|NCT00250276|589222050|FG001|Overall Study|Non-serious Adverse Event|0|||
163140149|NCT00250276|589222051|FG002|Overall Study|Non-serious Adverse Event|0|||
163140150|NCT00250276|589222052|FG003|Overall Study|Non-serious Adverse Event|2|||
163140151|NCT00250276|589222049|FG000|Overall Study|Protocol Violation|0|||
163140152|NCT00250276|589222050|FG001|Overall Study|Protocol Violation|1|||
163140153|NCT00250276|589222051|FG002|Overall Study|Protocol Violation|0|||
163140154|NCT00250276|589222052|FG003|Overall Study|Protocol Violation|0|||
162661417|NCT01931839|587471732|FG006|Overall Study|Other|0|||
162661418|NCT01263873|587471733|FG000|Overall Study|One provider unable to complete numbers|1|||
162661419|NCT01263873|587471734|FG001|Overall Study|One provider unable to complete numbers|1|||
162661420|NCT00113516|587471735|FG000|Part 1|Adverse Event|6|||
162661421|NCT00113516|587471736|FG001|Part 1|Adverse Event|0|||
162661422|NCT00113516|587471735|FG000|Part 1|Death|3|||
162661423|NCT00113516|587471736|FG001|Part 1|Death|0|||
162661424|NCT00113516|587471735|FG000|Part 1|Other|3|||
162661425|NCT00113516|587471736|FG001|Part 1|Other|0|||
162661426|NCT00113516|587471735|FG000|Part 1|Withdrawal by Subject|2|||
162661427|NCT00113516|587471736|FG001|Part 1|Withdrawal by Subject|0|||
162661428|NCT00113516|587471735|FG000|Part 1|Lack of Efficacy|2|||
162661429|NCT00113516|587471736|FG001|Part 1|Lack of Efficacy|0|||
162661430|NCT00113516|587471735|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
162661431|NCT00113516|587471736|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
162661432|NCT00113516|587471735|FG000|Part 1|Laboratory Abnormality|1|||
162661433|NCT00113516|587471736|FG001|Part 1|Laboratory Abnormality|0|||
162661434|NCT00113516|587471735|FG000|Part 1|Ongoing|1|||
162661435|NCT00113516|587471736|FG001|Part 1|Ongoing|0|||
162661436|NCT00113516|587471735|FG000|Part 1|Missing|65|||
162661437|NCT00113516|587471736|FG001|Part 1|Missing|0|||
162661438|NCT00113516|587471735|FG000|Part 2|Adverse Event|0|||
162661439|NCT00113516|587471736|FG001|Part 2|Adverse Event|16|||
162661440|NCT00113516|587471735|FG000|Part 2|Death|0|||
162661441|NCT00113516|587471736|FG001|Part 2|Death|5|||
162661442|NCT00113516|587471735|FG000|Part 2|Lack of Efficacy|0|||
162661443|NCT00113516|587471736|FG001|Part 2|Lack of Efficacy|37|||
162661444|NCT00113516|587471735|FG000|Part 2|Withdrawal by Subject|0|||
162661445|NCT00113516|587471736|FG001|Part 2|Withdrawal by Subject|3|||
162661446|NCT00113516|587471735|FG000|Part 2|Other|0|||
162661447|NCT00113516|587471736|FG001|Part 2|Other|3|||
162661448|NCT00113516|587471735|FG000|Part 2|Laboratory Abnormality|0|||
162661449|NCT00113516|587471736|FG001|Part 2|Laboratory Abnormality|1|||
162661450|NCT00113516|587471735|FG000|Part 2|Ongoing|0|||
162661451|NCT00113516|587471736|FG001|Part 2|Ongoing|1|||
162661452|NCT03217136|587471745|FG000|Overall Study|Lost to Follow-up|2|||
162661453|NCT03217136|587471746|FG001|Overall Study|Lost to Follow-up|1|||
162661454|NCT03217136|587471745|FG000|Overall Study|Site Randomized Participant in Error|0|||
162661455|NCT03217136|587471746|FG001|Overall Study|Site Randomized Participant in Error|1|||
162661456|NCT03217136|587471745|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
162661457|NCT03217136|587471746|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
162661458|NCT03217136|587471745|FG000|Overall Study|Dispensing Error|1|||
162661459|NCT03217136|587471746|FG001|Overall Study|Dispensing Error|0|||
162661460|NCT03217136|587471745|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162661461|NCT03217136|587471746|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162661462|NCT03755765|587471747|FG000|Overall Study|Withdrawal by Subject|2|||
162661463|NCT03755765|587471748|FG001|Overall Study|Withdrawal by Subject|4|||
162661464|NCT03755765|587471749|FG002|Overall Study|Withdrawal by Subject|4|||
162661465|NCT02104557|587471750|FG000|Overall Study|Adverse Event|24|||
162661466|NCT02104557|587471750|FG000|Overall Study|Lost to Follow-up|34|||
162661467|NCT02104557|587471750|FG000|Overall Study|Violated the usage and dosage|14|||
162661468|NCT02104557|587471750|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
162661469|NCT02104557|587471750|FG000|Overall Study|Administered Sayana prior to the contract|1|||
162661470|NCT02104557|587471750|FG000|Overall Study|Other|17|||
162661471|NCT02104557|587471750|FG000|Overall Study|Change to other contraception methods|5|||
162661472|NCT02104557|587471750|FG000|Overall Study|Discontinuation due to no pain|1|||
162661473|NCT02104557|587471750|FG000|Overall Study|Withdrawal consent|2|||
162661474|NCT02104557|587471750|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
162661475|NCT02104557|587471750|FG000|Overall Study|Discontinuation of contraception|9|||
162661476|NCT01158222|587471754|FG000|Overall Study|Not eligible for intermediate phase|17|||
162661477|NCT00111228|587471757|FG000|Overall Study|Withdrawal by Subject|5|||
163140155|NCT00250276|589222049|FG000|Overall Study|Withdrawal by Subject|1|||
163140156|NCT00250276|589222050|FG001|Overall Study|Withdrawal by Subject|2|||
162661478|NCT00111228|587471758|FG001|Overall Study|Withdrawal by Subject|1|||
162661479|NCT00111228|587471759|FG002|Overall Study|Withdrawal by Subject|0|||
162661480|NCT02579616|587471760|FG000|Overall Study|Participants did not receive treatment|3|||
162661481|NCT01430585|587471761|FG000|Overall Study|Death|1|||
162661482|NCT01430585|587471761|FG000|Overall Study|Objective Progression or Relapse|3|||
162661483|NCT01430585|587471761|FG000|Overall Study|Study Terminated by Sponsor|3|||
162661484|NCT01430585|587471761|FG000|Overall Study|Other|7|||
162661485|NCT01448850|587471762|FG000|Overall Study|Death|3|||
162661486|NCT01448850|587471763|FG001|Overall Study|Death|6|||
162661487|NCT01448850|587471762|FG000|Overall Study|Withdrawal by Subject|13|||
162661488|NCT01448850|587471763|FG001|Overall Study|Withdrawal by Subject|21|||
162661489|NCT01448850|587471762|FG000|Overall Study|Lost to Follow-up|3|||
162661490|NCT01448850|587471763|FG001|Overall Study|Lost to Follow-up|1|||
162661491|NCT01448850|587471762|FG000|Overall Study|Other|15|||
162661492|NCT01448850|587471763|FG001|Overall Study|Other|12|||
162661493|NCT01490060|587471766|FG000|Cycle 1|Change of Treatment|0|||
163140157|NCT00250276|589222051|FG002|Overall Study|Withdrawal by Subject|3|||
162661494|NCT01490060|587471767|FG001|Cycle 1|Change of Treatment|1|||
162661495|NCT01490060|587471768|FG002|Cycle 1|Change of Treatment|1|||
162661496|NCT01490060|587471769|FG003|Cycle 1|Change of Treatment|1|||
162661497|NCT01490060|587471766|FG000|Cycle 1|Insurance Denied|0|||
162661498|NCT01490060|587471767|FG001|Cycle 1|Insurance Denied|0|||
162661499|NCT01490060|587471768|FG002|Cycle 1|Insurance Denied|2|||
162661500|NCT01490060|587471769|FG003|Cycle 1|Insurance Denied|0|||
162661501|NCT01490060|587471766|FG000|Cycle 1|Withdrawal by Subject|0|||
162661502|NCT01490060|587471767|FG001|Cycle 1|Withdrawal by Subject|0|||
162661503|NCT01490060|587471768|FG002|Cycle 1|Withdrawal by Subject|0|||
162661504|NCT01490060|587471769|FG003|Cycle 1|Withdrawal by Subject|1|||
162661505|NCT01490060|587471766|FG000|Cycle 1|Treatment at Another Facility|0|||
162661506|NCT01490060|587471767|FG001|Cycle 1|Treatment at Another Facility|0|||
162661507|NCT01490060|587471768|FG002|Cycle 1|Treatment at Another Facility|0|||
162661508|NCT01490060|587471769|FG003|Cycle 1|Treatment at Another Facility|1|||
162661509|NCT01490060|587471766|FG000|Cycle 2|Change of Treatment|1|||
162661510|NCT01490060|587471767|FG001|Cycle 2|Change of Treatment|1|||
162661511|NCT01490060|587471768|FG002|Cycle 2|Change of Treatment|0|||
162661512|NCT01490060|587471769|FG003|Cycle 2|Change of Treatment|0|||
162661513|NCT01490060|587471766|FG000|Cycle 2|Non-Compliance|0|||
162661514|NCT01490060|587471767|FG001|Cycle 2|Non-Compliance|0|||
162661515|NCT01490060|587471768|FG002|Cycle 2|Non-Compliance|1|||
162661516|NCT01490060|587471769|FG003|Cycle 2|Non-Compliance|0|||
162661517|NCT01490060|587471766|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
162661518|NCT01490060|587471767|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162661519|NCT01490060|587471768|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162661520|NCT01490060|587471769|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162661521|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
162661522|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
162661523|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
162661524|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
162661525|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
162661526|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
162661527|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
162661528|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
162661529|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
162661530|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
163140158|NCT00250276|589222052|FG003|Overall Study|Withdrawal by Subject|2|||
163140159|NCT00250276|589222049|FG000|Overall Study|Migrated/moved from study area|3|||
163140160|NCT00250276|589222050|FG001|Overall Study|Migrated/moved from study area|0|||
163140161|NCT00250276|589222051|FG002|Overall Study|Migrated/moved from study area|2|||
163140162|NCT00250276|589222052|FG003|Overall Study|Migrated/moved from study area|7|||
163140163|NCT00250276|589222049|FG000|Overall Study|Lost to Follow-up|11|||
163140164|NCT00250276|589222050|FG001|Overall Study|Lost to Follow-up|18|||
163140165|NCT00250276|589222051|FG002|Overall Study|Lost to Follow-up|13|||
163140166|NCT00250276|589222052|FG003|Overall Study|Lost to Follow-up|8|||
163140167|NCT00555217|589222053|FG000|Overall Study|Withdrawal by Subject|35|||
163140168|NCT00555217|589222054|FG001|Overall Study|Withdrawal by Subject|31|||
163140169|NCT00555217|589222053|FG000|Overall Study|Lost to Follow-up|19|||
163140170|NCT00555217|589222054|FG001|Overall Study|Lost to Follow-up|20|||
163140171|NCT00555217|589222053|FG000|Overall Study|close out sites|21|||
163140172|NCT00555217|589222054|FG001|Overall Study|close out sites|17|||
163140173|NCT01546688|589222055|FG000|Overall Study|Adverse Event|0|||
163140174|NCT01546688|589222056|FG001|Overall Study|Adverse Event|4|||
163140175|NCT01546688|589222055|FG000|Overall Study|Withdrawal by Subject|2|||
163140176|NCT01546688|589222056|FG001|Overall Study|Withdrawal by Subject|1|||
163140177|NCT01546688|589222055|FG000|Overall Study|Lack of Efficacy|1|||
163140178|NCT01546688|589222056|FG001|Overall Study|Lack of Efficacy|0|||
163140179|NCT01657292|589222062|FG000|Overall Study|Adverse Event|6|||
163140180|NCT01657292|589222062|FG000|Overall Study|Withdrawal by Subject|2|||
163140181|NCT01657292|589222062|FG000|Overall Study|Violation of eligibility criteria|1|||
163140182|NCT01657292|589222062|FG000|Overall Study|Change of therapy|1|||
163140183|NCT03566082|589222063|FG000|Overall Study|Death|7|||
163140184|NCT03566082|589222063|FG000|Overall Study|Failures (revision required)|2|||
163140185|NCT03566082|589222063|FG000|Overall Study|Lost to Follow-up|8|||
163140186|NCT00983385|589222064|FG000|Observation Period|Not eligible to be dosed|20|||
163140187|NCT00983385|589222064|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
162661531|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
162661532|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
162661533|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
162661534|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
163140188|NCT02663622|589222065|FG000|Overall Study|Death|3|||
163140189|NCT02663622|589222066|FG001|Overall Study|Death|1|||
163140190|NCT02663622|589222067|FG002|Overall Study|Death|1|||
162661535|NCT02464969|587471770|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
162661536|NCT02464969|587471771|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
162661537|NCT02464969|587471770|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
162661538|NCT02464969|587471771|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
162661539|NCT02464969|587471770|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
162661540|NCT02464969|587471771|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
162661541|NCT02464969|587471770|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
162661542|NCT02464969|587471771|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
162661543|NCT02863354|587471772|FG000|Year 1|Lost to Follow-up|1|||
162661544|NCT02863354|587471773|FG001|Year 1|Lost to Follow-up|1|||
162661545|NCT02863354|587471772|FG000|Year 1|Withdrawal by Subject|3|||
162661546|NCT02863354|587471773|FG001|Year 1|Withdrawal by Subject|0|||
162661547|NCT02863354|587471772|FG000|Year 1|Death|0|||
162661548|NCT02863354|587471773|FG001|Year 1|Death|1|||
162661549|NCT02863354|587471772|FG000|Year 2|Lost to Follow-up|2|||
162661550|NCT02863354|587471773|FG001|Year 2|Lost to Follow-up|2|||
162661551|NCT00720876|587471779|FG000|Overall Study|found to be ineligible after starting tx|2|||
162661552|NCT03495908|587471781|FG000|Overall Study|Withdrawal by Subject|3|||
162661553|NCT03495908|587471782|FG001|Overall Study|Withdrawal by Subject|1|||
162661554|NCT03495908|587471781|FG000|Overall Study|Lost to Follow-up|1|||
162661555|NCT03495908|587471782|FG001|Overall Study|Lost to Follow-up|4|||
162661556|NCT03495908|587471781|FG000|Overall Study|Adverse Event|0|||
162661557|NCT03495908|587471782|FG001|Overall Study|Adverse Event|2|||
162661558|NCT03495908|587471781|FG000|Overall Study|Death|1|||
162661559|NCT03495908|587471782|FG001|Overall Study|Death|0|||
162661560|NCT03495908|587471781|FG000|Overall Study|Physician Decision|5|||
162661561|NCT03495908|587471782|FG001|Overall Study|Physician Decision|4|||
162661562|NCT03495908|587471781|FG000|Overall Study|No documented reason|0|||
162661563|NCT03495908|587471782|FG001|Overall Study|No documented reason|2|||
162661564|NCT01109316|587471783|FG000|Study Period 1|Adverse Event|0|||
163140191|NCT02663622|589222068|FG003|Overall Study|Death|8|||
163140192|NCT02663622|589222065|FG000|Overall Study|Protocol Violation|0|||
163140193|NCT02663622|589222066|FG001|Overall Study|Protocol Violation|0|||
163140194|NCT02663622|589222067|FG002|Overall Study|Protocol Violation|0|||
163140195|NCT02663622|589222068|FG003|Overall Study|Protocol Violation|1|||
163140196|NCT00930930|589222070|FG000|Overall Study|Death|1|||
163140197|NCT00930930|589222071|FG001|Overall Study|Death|0|||
163140198|NCT00930930|589222070|FG000|Overall Study|Physician Decision|1|||
163140199|NCT00930930|589222071|FG001|Overall Study|Physician Decision|0|||
163140200|NCT00930930|589222070|FG000|Overall Study|Adverse Event|13|||
163140201|NCT00930930|589222071|FG001|Overall Study|Adverse Event|3|||
163140202|NCT00930930|589222070|FG000|Overall Study|Withdrawal by Subject|3|||
163140203|NCT00930930|589222071|FG001|Overall Study|Withdrawal by Subject|1|||
163140204|NCT00930930|589222070|FG000|Overall Study|Disease progression|2|||
163140205|NCT00930930|589222071|FG001|Overall Study|Disease progression|3|||
163140206|NCT00930930|589222070|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
163140207|NCT00930930|589222071|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
163140208|NCT00930930|589222070|FG000|Overall Study|patients not compliant|1|||
163140209|NCT00930930|589222071|FG001|Overall Study|patients not compliant|1|||
163140210|NCT00163020|589222072|FG000|Overall Study|Lost to Follow-up|0|||
163140211|NCT00163020|589222073|FG001|Overall Study|Lost to Follow-up|2|||
163140212|NCT03790111|589224199|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
163140213|NCT00985673|589224202|FG000|Overall Study|Lost to Follow-up|6|||
163140214|NCT00985673|589224203|FG001|Overall Study|Lost to Follow-up|7|||
163140215|NCT00985673|589224204|FG002|Overall Study|Lost to Follow-up|6|||
163140216|NCT00985673|589224205|FG003|Overall Study|Lost to Follow-up|10|||
163140217|NCT00985673|589224206|FG004|Overall Study|Lost to Follow-up|5|||
163140218|NCT00985673|589224207|FG005|Overall Study|Lost to Follow-up|3|||
163140219|NCT00985673|589224202|FG000|Overall Study|Withdrawal by Subject|0|||
163140220|NCT00985673|589224203|FG001|Overall Study|Withdrawal by Subject|4|||
163140221|NCT00985673|589224204|FG002|Overall Study|Withdrawal by Subject|5|||
163140222|NCT00985673|589224205|FG003|Overall Study|Withdrawal by Subject|2|||
163140223|NCT00985673|589224206|FG004|Overall Study|Withdrawal by Subject|2|||
163140224|NCT00985673|589224207|FG005|Overall Study|Withdrawal by Subject|3|||
163140225|NCT00985673|589224202|FG000|Overall Study|Other|1|||
163140226|NCT00985673|589224203|FG001|Overall Study|Other|0|||
163140227|NCT00985673|589224204|FG002|Overall Study|Other|1|||
163140228|NCT00985673|589224205|FG003|Overall Study|Other|0|||
163140229|NCT00985673|589224206|FG004|Overall Study|Other|1|||
163140230|NCT00985673|589224207|FG005|Overall Study|Other|0|||
163140231|NCT02252146|589224208|FG000|Overall Study|Lack of Efficacy|4|||
163140232|NCT02252146|589224208|FG000|Overall Study|Entered hospice care|1|||
163140233|NCT02252146|589224208|FG000|Overall Study|Inability to travel to study site|1|||
163140234|NCT00531284|589224209|FG000|Overall Study|Progressive Disease|1|||
162661565|NCT01109316|587471784|FG001|Study Period 1|Adverse Event|0|||
162661566|NCT01109316|587471785|FG002|Study Period 1|Adverse Event|1|||
162661567|NCT01109316|587471786|FG003|Study Period 1|Adverse Event|0|||
163140235|NCT00531284|589224210|FG001|Overall Study|Progressive Disease|3|||
163140236|NCT00531284|589224211|FG002|Overall Study|Progressive Disease|5|||
162661568|NCT01109316|587471787|FG004|Study Period 1|Adverse Event|0|||
162661569|NCT01109316|587471788|FG005|Study Period 1|Adverse Event|0|||
162661570|NCT01109316|587471783|FG000|Study Period 1|Lost to Follow-up|0|||
162661571|NCT01109316|587471784|FG001|Study Period 1|Lost to Follow-up|0|||
162661572|NCT01109316|587471785|FG002|Study Period 1|Lost to Follow-up|1|||
162661573|NCT01109316|587471786|FG003|Study Period 1|Lost to Follow-up|1|||
162661574|NCT01109316|587471787|FG004|Study Period 1|Lost to Follow-up|0|||
162661575|NCT01109316|587471788|FG005|Study Period 1|Lost to Follow-up|0|||
162661576|NCT01109316|587471783|FG000|Study Period 1|Withdrawal by Subject|0|||
162661577|NCT01109316|587471784|FG001|Study Period 1|Withdrawal by Subject|0|||
162661578|NCT01109316|587471785|FG002|Study Period 1|Withdrawal by Subject|1|||
162661579|NCT01109316|587471786|FG003|Study Period 1|Withdrawal by Subject|0|||
162661580|NCT01109316|587471787|FG004|Study Period 1|Withdrawal by Subject|2|||
162661581|NCT01109316|587471788|FG005|Study Period 1|Withdrawal by Subject|0|||
162661582|NCT01109316|587471783|FG000|Study Period 1|Sponsor Decision|0|||
162661583|NCT01109316|587471784|FG001|Study Period 1|Sponsor Decision|0|||
162661584|NCT01109316|587471785|FG002|Study Period 1|Sponsor Decision|0|||
162661585|NCT01109316|587471786|FG003|Study Period 1|Sponsor Decision|0|||
162661586|NCT01109316|587471787|FG004|Study Period 1|Sponsor Decision|0|||
162661587|NCT01109316|587471788|FG005|Study Period 1|Sponsor Decision|2|||
162661588|NCT01109316|587471783|FG000|Study Period 2|Entry Criteria Not Met|0|||
162661589|NCT01109316|587471784|FG001|Study Period 2|Entry Criteria Not Met|1|||
162661590|NCT01109316|587471785|FG002|Study Period 2|Entry Criteria Not Met|0|||
162661591|NCT01109316|587471786|FG003|Study Period 2|Entry Criteria Not Met|0|||
162661592|NCT01109316|587471787|FG004|Study Period 2|Entry Criteria Not Met|0|||
162661593|NCT01109316|587471788|FG005|Study Period 2|Entry Criteria Not Met|0|||
162661594|NCT01109316|587471783|FG000|Study Period 2|Physician Decision|0|||
162661595|NCT01109316|587471784|FG001|Study Period 2|Physician Decision|0|||
162661596|NCT01109316|587471785|FG002|Study Period 2|Physician Decision|0|||
162661597|NCT01109316|587471786|FG003|Study Period 2|Physician Decision|1|||
162661598|NCT01109316|587471787|FG004|Study Period 2|Physician Decision|0|||
162661599|NCT01109316|587471788|FG005|Study Period 2|Physician Decision|0|||
162661600|NCT01109316|587471783|FG000|Study Period 2|Protocol Violation|1|||
162661601|NCT01109316|587471784|FG001|Study Period 2|Protocol Violation|0|||
162661602|NCT01109316|587471785|FG002|Study Period 2|Protocol Violation|0|||
162661603|NCT01109316|587471786|FG003|Study Period 2|Protocol Violation|0|||
162661604|NCT01109316|587471787|FG004|Study Period 2|Protocol Violation|0|||
162661605|NCT01109316|587471788|FG005|Study Period 2|Protocol Violation|0|||
162661606|NCT01109316|587471783|FG000|Study Period 2|Withdrawal by Subject|0|||
162661607|NCT01109316|587471784|FG001|Study Period 2|Withdrawal by Subject|0|||
162661608|NCT01109316|587471785|FG002|Study Period 2|Withdrawal by Subject|1|||
162661609|NCT01109316|587471786|FG003|Study Period 2|Withdrawal by Subject|0|||
162661610|NCT01109316|587471787|FG004|Study Period 2|Withdrawal by Subject|0|||
162661611|NCT01109316|587471788|FG005|Study Period 2|Withdrawal by Subject|1|||
162661612|NCT01109316|587471783|FG000|Study Period 3|Lost to Follow-up|0|||
162661613|NCT01109316|587471784|FG001|Study Period 3|Lost to Follow-up|0|||
162661614|NCT01109316|587471785|FG002|Study Period 3|Lost to Follow-up|0|||
162661615|NCT01109316|587471786|FG003|Study Period 3|Lost to Follow-up|0|||
162661616|NCT01109316|587471787|FG004|Study Period 3|Lost to Follow-up|1|||
162661617|NCT01109316|587471788|FG005|Study Period 3|Lost to Follow-up|0|||
162661618|NCT01109316|587471783|FG000|Study Period 3|Withdrawal by Subject|1|||
162661619|NCT01109316|587471784|FG001|Study Period 3|Withdrawal by Subject|0|||
162661620|NCT01109316|587471785|FG002|Study Period 3|Withdrawal by Subject|0|||
162661621|NCT01109316|587471786|FG003|Study Period 3|Withdrawal by Subject|0|||
162661622|NCT01109316|587471787|FG004|Study Period 3|Withdrawal by Subject|1|||
162661623|NCT01109316|587471788|FG005|Study Period 3|Withdrawal by Subject|0|||
162661624|NCT01559311|587471791|FG000|Overall Study|Protocol Violation|0|||
162661625|NCT01559311|587471792|FG001|Overall Study|Protocol Violation|0|||
162661626|NCT01559311|587471793|FG002|Overall Study|Protocol Violation|2|||
162661627|NCT01559311|587471791|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
162661628|NCT01559311|587471792|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
162661629|NCT01559311|587471793|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
162661630|NCT01559311|587471791|FG000|Overall Study|Withdrawal by Subject|2|||
162661631|NCT01559311|587471792|FG001|Overall Study|Withdrawal by Subject|1|||
162661632|NCT01559311|587471793|FG002|Overall Study|Withdrawal by Subject|0|||
162661633|NCT01559311|587471791|FG000|Overall Study|Death|0|||
162661634|NCT01559311|587471792|FG001|Overall Study|Death|2|||
162661635|NCT01559311|587471793|FG002|Overall Study|Death|3|||
162661636|NCT01559311|587471791|FG000|Overall Study|Lost to Follow-up|0|||
162661637|NCT01559311|587471792|FG001|Overall Study|Lost to Follow-up|3|||
162661638|NCT01559311|587471793|FG002|Overall Study|Lost to Follow-up|2|||
162661639|NCT01559311|587471791|FG000|Overall Study|Adverse Event|0|||
162661640|NCT01559311|587471792|FG001|Overall Study|Adverse Event|0|||
162661641|NCT01559311|587471793|FG002|Overall Study|Adverse Event|1|||
162661642|NCT03027466|587471794|FG000|Overall Study|Opting out of the app|1869|||
162661643|NCT03027466|587471795|FG001|Overall Study|Opting out of the app|1819|||
162661644|NCT03027466|587471796|FG002|Overall Study|Opting out of the app|1743|||
162661645|NCT03027466|587471797|FG003|Overall Study|Opting out of the app|1821|||
162661646|NCT03286140|587471798|FG000|Overall Study|Withdrawal by Subject|10|||
162661647|NCT03286140|587471799|FG001|Overall Study|Withdrawal by Subject|5|||
162661648|NCT03286140|587471798|FG000|Overall Study|Lost to Follow-up|5|||
162661649|NCT03286140|587471799|FG001|Overall Study|Lost to Follow-up|10|||
162661650|NCT03286140|587471798|FG000|Overall Study|Failure to comply|0|||
162661651|NCT03286140|587471799|FG001|Overall Study|Failure to comply|1|||
162661652|NCT01826825|587471800|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
162661653|NCT01826825|587471801|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
162661654|NCT01858194|587471802|FG000|Overall Study|Total Artificial Heart Implant|0|||
162661655|NCT01858194|587471803|FG001|Overall Study|Total Artificial Heart Implant|1|||
162661656|NCT01858194|587471802|FG000|Overall Study|Lost to Follow-up|0|||
162661657|NCT01858194|587471803|FG001|Overall Study|Lost to Follow-up|1|||
162661658|NCT02158039|587471804|FG000|Overall Study|Withdrawal by Subject|1|||
162661659|NCT02158039|587471804|FG000|Overall Study|Screen Failure|9|||
163140237|NCT00531284|589224212|FG003|Overall Study|Progressive Disease|42|||
163140238|NCT00531284|589224213|FG004|Overall Study|Progressive Disease|4|||
163140239|NCT00531284|589224214|FG005|Overall Study|Progressive Disease|4|||
163140240|NCT00531284|589224215|FG006|Overall Study|Progressive Disease|3|||
163140241|NCT00531284|589224216|FG007|Overall Study|Progressive Disease|8|||
163140242|NCT00531284|589224217|FG008|Overall Study|Progressive Disease|6|||
163140243|NCT00531284|589224218|FG009|Overall Study|Progressive Disease|3|||
163140244|NCT00531284|589224219|FG010|Overall Study|Progressive Disease|3|||
163140245|NCT00531284|589224220|FG011|Overall Study|Progressive Disease|14|||
163140246|NCT00531284|589224221|FG012|Overall Study|Progressive Disease|2|||
163140247|NCT00531284|589224222|FG013|Overall Study|Progressive Disease|1|||
163140248|NCT00531284|589224223|FG014|Overall Study|Progressive Disease|2|||
163140249|NCT00531284|589224224|FG015|Overall Study|Progressive Disease|11|||
162661660|NCT02563028|587471806|FG000|Overall Study|Lack of equipment|1|||
162661661|NCT02563028|587471806|FG000|Overall Study|Unable to elicit VEP post induction|1|||
163140250|NCT00531284|589224225|FG016|Overall Study|Progressive Disease|5|||
163140251|NCT00531284|589224209|FG000|Overall Study|Adverse Event|0|||
162661662|NCT00829621|587471807|FG000|Overall Study|Death|1|||
162661663|NCT00829621|587471808|FG001|Overall Study|Death|0|||
163140252|NCT00531284|589224210|FG001|Overall Study|Adverse Event|1|||
162661664|NCT00829621|587471807|FG000|Overall Study|Lost to Follow-up|3|||
162661665|NCT00829621|587471808|FG001|Overall Study|Lost to Follow-up|4|||
162661666|NCT02293005|587473149|FG000|Overall Study|Adverse Event|2|||
162661667|NCT02293005|587473149|FG000|Overall Study|Death|4|||
162661668|NCT02293005|587473149|FG000|Overall Study|Lost to Follow-up|1|||
163140253|NCT00531284|589224211|FG002|Overall Study|Adverse Event|1|||
163140254|NCT00531284|589224212|FG003|Overall Study|Adverse Event|7|||
163140255|NCT00531284|589224213|FG004|Overall Study|Adverse Event|0|||
163140256|NCT00531284|589224214|FG005|Overall Study|Adverse Event|2|||
163140257|NCT00531284|589224215|FG006|Overall Study|Adverse Event|3|||
163140258|NCT00531284|589224216|FG007|Overall Study|Adverse Event|2|||
163140259|NCT00531284|589224217|FG008|Overall Study|Adverse Event|3|||
163140260|NCT00531284|589224218|FG009|Overall Study|Adverse Event|0|||
163140261|NCT00531284|589224219|FG010|Overall Study|Adverse Event|0|||
163140262|NCT00531284|589224220|FG011|Overall Study|Adverse Event|5|||
163140263|NCT00531284|589224221|FG012|Overall Study|Adverse Event|0|||
162661669|NCT02293005|587473149|FG000|Overall Study|Withdrawal by Subject|2|||
162661670|NCT02293005|587473149|FG000|Overall Study|Progression|17|||
162661671|NCT02766608|587473150|FG000|Overall Study|Adverse Event|27|||
162661672|NCT02766608|587473151|FG001|Overall Study|Adverse Event|22|||
162661673|NCT02766608|587473152|FG002|Overall Study|Adverse Event|17|||
162661674|NCT02766608|587473153|FG003|Overall Study|Adverse Event|13|||
162661675|NCT02766608|587473154|FG004|Overall Study|Adverse Event|12|||
162661676|NCT02766608|587473150|FG000|Overall Study|Withdrawal by Subject|21|||
162661677|NCT02766608|587473151|FG001|Overall Study|Withdrawal by Subject|20|||
162661678|NCT02766608|587473152|FG002|Overall Study|Withdrawal by Subject|24|||
162661679|NCT02766608|587473153|FG003|Overall Study|Withdrawal by Subject|13|||
162661680|NCT02766608|587473154|FG004|Overall Study|Withdrawal by Subject|10|||
162661681|NCT02766608|587473150|FG000|Overall Study|Lack of Efficacy|16|||
162661682|NCT02766608|587473151|FG001|Overall Study|Lack of Efficacy|15|||
162661683|NCT02766608|587473152|FG002|Overall Study|Lack of Efficacy|32|||
162661684|NCT02766608|587473153|FG003|Overall Study|Lack of Efficacy|8|||
162661685|NCT02766608|587473154|FG004|Overall Study|Lack of Efficacy|2|||
162661686|NCT02766608|587473150|FG000|Overall Study|Lost to Follow-up|6|||
162661687|NCT02766608|587473151|FG001|Overall Study|Lost to Follow-up|3|||
162661688|NCT02766608|587473152|FG002|Overall Study|Lost to Follow-up|5|||
162661689|NCT02766608|587473153|FG003|Overall Study|Lost to Follow-up|2|||
162661690|NCT02766608|587473154|FG004|Overall Study|Lost to Follow-up|2|||
162661691|NCT02766608|587473150|FG000|Overall Study|Physician Decision|3|||
162661692|NCT02766608|587473151|FG001|Overall Study|Physician Decision|2|||
162661693|NCT02766608|587473152|FG002|Overall Study|Physician Decision|3|||
162661694|NCT02766608|587473153|FG003|Overall Study|Physician Decision|1|||
162661695|NCT02766608|587473154|FG004|Overall Study|Physician Decision|2|||
162661696|NCT02766608|587473150|FG000|Overall Study|Protocol disc criteria|3|||
162661697|NCT02766608|587473151|FG001|Overall Study|Protocol disc criteria|3|||
162661698|NCT02766608|587473152|FG002|Overall Study|Protocol disc criteria|4|||
162661699|NCT02766608|587473153|FG003|Overall Study|Protocol disc criteria|0|||
162661700|NCT02766608|587473154|FG004|Overall Study|Protocol disc criteria|0|||
162661701|NCT02766608|587473150|FG000|Overall Study|Protocol Violation|0|||
162661702|NCT02766608|587473151|FG001|Overall Study|Protocol Violation|4|||
162661703|NCT02766608|587473152|FG002|Overall Study|Protocol Violation|4|||
162661704|NCT02766608|587473153|FG003|Overall Study|Protocol Violation|0|||
162661705|NCT02766608|587473154|FG004|Overall Study|Protocol Violation|1|||
162661706|NCT02766608|587473150|FG000|Overall Study|Administrative Reasons|3|||
162661707|NCT02766608|587473151|FG001|Overall Study|Administrative Reasons|1|||
162661708|NCT02766608|587473152|FG002|Overall Study|Administrative Reasons|1|||
162661709|NCT02766608|587473153|FG003|Overall Study|Administrative Reasons|0|||
162661710|NCT02766608|587473154|FG004|Overall Study|Administrative Reasons|0|||
162661711|NCT02648698|587473157|FG000|Overall Study|Protocol Violation|1|||
162661712|NCT02648698|587473158|FG001|Overall Study|Protocol Violation|5|||
162661713|NCT03143829|587473161|FG000|Overall Study|Withdrawal by Subject|2|||
162661714|NCT03143829|587473162|FG001|Overall Study|Withdrawal by Subject|5|||
162661715|NCT03143829|587473161|FG000|Overall Study|Lost to Follow-up|0|||
162661716|NCT03143829|587473162|FG001|Overall Study|Lost to Follow-up|2|||
162661717|NCT03143829|587473161|FG000|Overall Study|Death|1|||
162661718|NCT03143829|587473162|FG001|Overall Study|Death|1|||
162661719|NCT03143829|587473161|FG000|Overall Study|changed treatment, no longer eligible|2|||
162661720|NCT03143829|587473162|FG001|Overall Study|changed treatment, no longer eligible|2|||
162661721|NCT00672477|587473163|FG000|Overall Study|Adverse Event|10|||
162661722|NCT00672477|587473164|FG001|Overall Study|Adverse Event|7|||
162661723|NCT00672477|587473163|FG000|Overall Study|Death|7|||
162661724|NCT00672477|587473164|FG001|Overall Study|Death|11|||
162661725|NCT00672477|587473163|FG000|Overall Study|Physician Decision|2|||
162661726|NCT00672477|587473164|FG001|Overall Study|Physician Decision|0|||
162661727|NCT00672477|587473163|FG000|Overall Study|Protocol Violation|1|||
162661728|NCT00672477|587473164|FG001|Overall Study|Protocol Violation|1|||
163140264|NCT00531284|589224222|FG013|Overall Study|Adverse Event|1|||
163140265|NCT00531284|589224223|FG014|Overall Study|Adverse Event|1|||
162661729|NCT00672477|587473163|FG000|Overall Study|Withdrawal by Subject|5|||
162661730|NCT00672477|587473164|FG001|Overall Study|Withdrawal by Subject|3|||
162661731|NCT00672477|587473163|FG000|Overall Study|Lack of Efficacy|1|||
162661732|NCT00672477|587473164|FG001|Overall Study|Lack of Efficacy|1|||
162661733|NCT00672477|587473163|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
162661734|NCT00672477|587473164|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
162661735|NCT00938431|587473168|FG000|Overall Study|Adverse Event|5|||
163140266|NCT00531284|589224224|FG015|Overall Study|Adverse Event|0|||
163140267|NCT00531284|589224225|FG016|Overall Study|Adverse Event|2|||
163140268|NCT00531284|589224209|FG000|Overall Study|Withdrawal by Subject|1|||
163140269|NCT00531284|589224210|FG001|Overall Study|Withdrawal by Subject|0|||
163140270|NCT00531284|589224211|FG002|Overall Study|Withdrawal by Subject|0|||
163140271|NCT00531284|589224212|FG003|Overall Study|Withdrawal by Subject|4|||
163140272|NCT00531284|589224213|FG004|Overall Study|Withdrawal by Subject|0|||
163140273|NCT00531284|589224214|FG005|Overall Study|Withdrawal by Subject|0|||
163140274|NCT00531284|589224215|FG006|Overall Study|Withdrawal by Subject|0|||
163140275|NCT00531284|589224216|FG007|Overall Study|Withdrawal by Subject|0|||
163140276|NCT00531284|589224217|FG008|Overall Study|Withdrawal by Subject|0|||
163140277|NCT00531284|589224218|FG009|Overall Study|Withdrawal by Subject|0|||
163140278|NCT00531284|589224219|FG010|Overall Study|Withdrawal by Subject|0|||
163140279|NCT00531284|589224220|FG011|Overall Study|Withdrawal by Subject|3|||
163140280|NCT00531284|589224221|FG012|Overall Study|Withdrawal by Subject|0|||
163140281|NCT00531284|589224222|FG013|Overall Study|Withdrawal by Subject|1|||
163140282|NCT00531284|589224223|FG014|Overall Study|Withdrawal by Subject|0|||
163140283|NCT00531284|589224224|FG015|Overall Study|Withdrawal by Subject|1|||
163140284|NCT00531284|589224225|FG016|Overall Study|Withdrawal by Subject|1|||
162661736|NCT00938431|587473169|FG001|Overall Study|Adverse Event|8|||
162661737|NCT00938431|587473170|FG002|Overall Study|Adverse Event|6|||
162661738|NCT00938431|587473168|FG000|Overall Study|Lack of Efficacy|0|||
162661739|NCT00938431|587473169|FG001|Overall Study|Lack of Efficacy|1|||
162661740|NCT00938431|587473170|FG002|Overall Study|Lack of Efficacy|0|||
162661741|NCT00938431|587473168|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
162661742|NCT00938431|587473169|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
162720718|NCT01393119|587685911|FG000|Overall Study|Protocol Violation|0|||
162720719|NCT01393119|587685912|FG001|Overall Study|Protocol Violation|0|||
162720720|NCT01393119|587685913|FG002|Overall Study|Protocol Violation|1|||
162720721|NCT01393119|587685914|FG003|Overall Study|Protocol Violation|0|||
162720722|NCT01393119|587685911|FG000|Overall Study|Death|0|||
162720723|NCT01393119|587685912|FG001|Overall Study|Death|0|||
162720724|NCT01393119|587685913|FG002|Overall Study|Death|0|||
162720725|NCT01393119|587685914|FG003|Overall Study|Death|1|||
162720726|NCT01393119|587685911|FG000|Overall Study|Randomized but Not treated|1|||
162661743|NCT00938431|587473170|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
162661744|NCT00938431|587473168|FG000|Overall Study|Dosing compliance issue|0|||
162661745|NCT00938431|587473169|FG001|Overall Study|Dosing compliance issue|0|||
162661746|NCT00938431|587473170|FG002|Overall Study|Dosing compliance issue|1|||
162661747|NCT00938431|587473168|FG000|Overall Study|Reached maximum dose early|0|||
162661748|NCT00938431|587473169|FG001|Overall Study|Reached maximum dose early|0|||
162661749|NCT00938431|587473170|FG002|Overall Study|Reached maximum dose early|1|||
162661750|NCT03738865|587473175|FG000|Overall Study|Withdrawal by Subject|3|||
162661751|NCT03738865|587473176|FG001|Overall Study|Withdrawal by Subject|3|||
162661752|NCT03738865|587473175|FG000|Overall Study|Adverse Event|2|||
162661753|NCT03738865|587473176|FG001|Overall Study|Adverse Event|0|||
162661754|NCT03738865|587473175|FG000|Overall Study|Physician Decision|0|||
162661755|NCT03738865|587473176|FG001|Overall Study|Physician Decision|1|||
162661756|NCT03455855|587473177|FG000|Overall Study|Lost to Follow-up|4|||
162661757|NCT03455855|587473178|FG001|Overall Study|Lost to Follow-up|2|||
162661758|NCT00924950|587473179|FG000|Overall Study|Lost to Follow-up|2|||
162661759|NCT01602315|587473180|FG000|Overall Study|Protocol Violation|0|||
162661760|NCT01602315|587473181|FG001|Overall Study|Protocol Violation|0|||
162661761|NCT01602315|587473182|FG002|Overall Study|Protocol Violation|0|||
162661762|NCT01602315|587473183|FG003|Overall Study|Protocol Violation|0|||
162661763|NCT01602315|587473184|FG004|Overall Study|Protocol Violation|0|||
162661764|NCT01602315|587473185|FG005|Overall Study|Protocol Violation|1|||
162661765|NCT01602315|587473186|FG006|Overall Study|Protocol Violation|0|||
162661766|NCT01602315|587473180|FG000|Overall Study|Physician Decision|2|||
162661767|NCT01602315|587473181|FG001|Overall Study|Physician Decision|0|||
162661768|NCT01602315|587473182|FG002|Overall Study|Physician Decision|0|||
162661769|NCT01602315|587473183|FG003|Overall Study|Physician Decision|0|||
162661770|NCT01602315|587473184|FG004|Overall Study|Physician Decision|2|||
162661771|NCT01602315|587473185|FG005|Overall Study|Physician Decision|1|||
162661772|NCT01602315|587473186|FG006|Overall Study|Physician Decision|1|||
162661773|NCT01602315|587473180|FG000|Overall Study|Disease progression|6|||
162661774|NCT01602315|587473181|FG001|Overall Study|Disease progression|3|||
162661775|NCT01602315|587473182|FG002|Overall Study|Disease progression|10|||
162661776|NCT01602315|587473183|FG003|Overall Study|Disease progression|1|||
162720727|NCT01393119|587685912|FG001|Overall Study|Randomized but Not treated|0|||
162720728|NCT01393119|587685913|FG002|Overall Study|Randomized but Not treated|1|||
162720729|NCT01393119|587685914|FG003|Overall Study|Randomized but Not treated|1|||
162720730|NCT01393119|587685911|FG000|Overall Study|Sponsor Termination of Study|11|||
162720731|NCT01393119|587685912|FG001|Overall Study|Sponsor Termination of Study|12|||
162661777|NCT01602315|587473184|FG004|Overall Study|Disease progression|41|||
162661778|NCT01602315|587473185|FG005|Overall Study|Disease progression|12|||
162661779|NCT01602315|587473186|FG006|Overall Study|Disease progression|15|||
162661780|NCT01602315|587473180|FG000|Overall Study|Death|1|||
162661781|NCT01602315|587473181|FG001|Overall Study|Death|1|||
162661782|NCT01602315|587473182|FG002|Overall Study|Death|1|||
162661783|NCT01602315|587473183|FG003|Overall Study|Death|1|||
162661784|NCT01602315|587473184|FG004|Overall Study|Death|7|||
162720732|NCT01393119|587685913|FG002|Overall Study|Sponsor Termination of Study|9|||
162661785|NCT01602315|587473185|FG005|Overall Study|Death|2|||
162661786|NCT01602315|587473186|FG006|Overall Study|Death|2|||
162661787|NCT01602315|587473180|FG000|Overall Study|Withdrawal by Subject|2|||
162661788|NCT01602315|587473181|FG001|Overall Study|Withdrawal by Subject|0|||
162661789|NCT01602315|587473182|FG002|Overall Study|Withdrawal by Subject|2|||
162661790|NCT01602315|587473183|FG003|Overall Study|Withdrawal by Subject|0|||
162661791|NCT01602315|587473184|FG004|Overall Study|Withdrawal by Subject|6|||
162661792|NCT01602315|587473185|FG005|Overall Study|Withdrawal by Subject|0|||
162661793|NCT01602315|587473186|FG006|Overall Study|Withdrawal by Subject|1|||
162661794|NCT01602315|587473180|FG000|Overall Study|Adverse Event|5|||
162661795|NCT01602315|587473181|FG001|Overall Study|Adverse Event|1|||
162720733|NCT01393119|587685914|FG003|Overall Study|Sponsor Termination of Study|12|||
162720734|NCT04860258|587685915|FG000|Overall Study|Withdrawal by Subject|0|||
162720735|NCT04860258|587685916|FG001|Overall Study|Withdrawal by Subject|0|||
162720736|NCT04860258|587685917|FG002|Overall Study|Withdrawal by Subject|4|||
162720737|NCT04860258|587685918|FG003|Overall Study|Withdrawal by Subject|1|||
162720738|NCT04860258|587685919|FG004|Overall Study|Withdrawal by Subject|4|||
162720739|NCT04860258|587685920|FG005|Overall Study|Withdrawal by Subject|1|||
162720740|NCT04860258|587685921|FG006|Overall Study|Withdrawal by Subject|0|||
162720741|NCT01266265|587685922|FG000|Overall Study|Death|95|||
162720742|NCT01266265|587685923|FG001|Overall Study|Death|73|||
162720743|NCT01266265|587685922|FG000|Overall Study|Lost to Follow-up|23|||
162720744|NCT01266265|587685923|FG001|Overall Study|Lost to Follow-up|28|||
162720745|NCT01266265|587685922|FG000|Overall Study|Withdrawal by Subject|13|||
162720746|NCT01266265|587685923|FG001|Overall Study|Withdrawal by Subject|11|||
162720747|NCT01266265|587685922|FG000|Overall Study|Respiratory-related adverse event|2|||
162720748|NCT01266265|587685923|FG001|Overall Study|Respiratory-related adverse event|1|||
162720749|NCT01266265|587685922|FG000|Overall Study|Transferred care to another provider|22|||
162720750|NCT01266265|587685923|FG001|Overall Study|Transferred care to another provider|28|||
162720751|NCT01266265|587685922|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
162720752|NCT01266265|587685923|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
162720753|NCT01266265|587685922|FG000|Overall Study|Enrolled in another clinical study|15|||
162720754|NCT01266265|587685923|FG001|Overall Study|Enrolled in another clinical study|26|||
162720755|NCT01266265|587685922|FG000|Overall Study|Non-compliance|8|||
162720756|NCT01266265|587685923|FG001|Overall Study|Non-compliance|5|||
162720757|NCT01266265|587685922|FG000|Overall Study|Lung transplant|6|||
162720758|NCT01266265|587685923|FG001|Overall Study|Lung transplant|5|||
162720759|NCT01266265|587685922|FG000|Overall Study|Site closed early|4|||
162720760|NCT01266265|587685923|FG001|Overall Study|Site closed early|3|||
162720761|NCT01266265|587685922|FG000|Overall Study|Clinical worsening|1|||
162720762|NCT01266265|587685923|FG001|Overall Study|Clinical worsening|1|||
162720763|NCT01580293|587685924|FG000|Part A_Main Trial|Adverse Event|0|||
162720764|NCT01580293|587685925|FG001|Part A_Main Trial|Adverse Event|2|||
162720765|NCT01580293|587685926|FG002|Part A_Main Trial|Adverse Event|0|||
162720766|NCT01580293|587685924|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
162720767|NCT01580293|587685925|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
162720768|NCT01580293|587685926|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
162720769|NCT01580293|587685924|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
162720770|NCT01580293|587685925|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
162720771|NCT01580293|587685926|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
162720772|NCT01580293|587685924|FG000|Part A_Extension|Adverse Event|0|||
162720773|NCT01580293|587685925|FG001|Part A_Extension|Adverse Event|2|||
162720774|NCT01580293|587685926|FG002|Part A_Extension|Adverse Event|0|||
162661796|NCT01602315|587473182|FG002|Overall Study|Adverse Event|5|||
162661797|NCT01602315|587473183|FG003|Overall Study|Adverse Event|4|||
162661798|NCT01602315|587473184|FG004|Overall Study|Adverse Event|15|||
162661799|NCT01602315|587473185|FG005|Overall Study|Adverse Event|3|||
162661800|NCT01602315|587473186|FG006|Overall Study|Adverse Event|9|||
163140285|NCT00531284|589224209|FG000|Overall Study|Other|1|||
163140286|NCT00531284|589224210|FG001|Overall Study|Other|0|||
163140287|NCT00531284|589224211|FG002|Overall Study|Other|0|||
163140288|NCT00531284|589224212|FG003|Overall Study|Other|10|||
163140289|NCT00531284|589224213|FG004|Overall Study|Other|2|||
163140290|NCT00531284|589224214|FG005|Overall Study|Other|1|||
163140291|NCT00531284|589224215|FG006|Overall Study|Other|0|||
163140292|NCT00531284|589224216|FG007|Overall Study|Other|0|||
163140293|NCT00531284|589224217|FG008|Overall Study|Other|2|||
163140294|NCT00531284|589224218|FG009|Overall Study|Other|1|||
163140295|NCT00531284|589224219|FG010|Overall Study|Other|0|||
163140296|NCT00531284|589224220|FG011|Overall Study|Other|2|||
163140297|NCT00531284|589224221|FG012|Overall Study|Other|0|||
163140298|NCT00531284|589224222|FG013|Overall Study|Other|0|||
163140299|NCT00531284|589224223|FG014|Overall Study|Other|1|||
163140300|NCT00531284|589224224|FG015|Overall Study|Other|0|||
163140301|NCT00531284|589224225|FG016|Overall Study|Other|0|||
163140302|NCT03057496|589224226|FG000|Overall Study|Withdrawal by Subject|8|||
163140303|NCT03057496|589224226|FG000|Overall Study|Lost to Follow-up|5|||
163140304|NCT03057496|589224226|FG000|Overall Study|Did not use device during home trial|3|||
163140305|NCT03057496|589224226|FG000|Overall Study|Device failure|2|||
163140306|NCT00280917|589224227|FG000|Overall Study|Adverse Event|1|||
163140307|NCT00280917|589224228|FG001|Overall Study|Adverse Event|1|||
163140308|NCT00280917|589224229|FG002|Overall Study|Adverse Event|4|||
163140309|NCT00280917|589224230|FG003|Overall Study|Adverse Event|1|||
163140310|NCT00280917|589224227|FG000|Overall Study|Change Therapy|1|||
163140311|NCT00280917|589224228|FG001|Overall Study|Change Therapy|2|||
163140312|NCT00280917|589224229|FG002|Overall Study|Change Therapy|0|||
163140313|NCT00280917|589224230|FG003|Overall Study|Change Therapy|0|||
163140314|NCT00280917|589224227|FG000|Overall Study|Withdrawal by Subject|0|||
163140315|NCT00280917|589224228|FG001|Overall Study|Withdrawal by Subject|2|||
163140316|NCT00280917|589224229|FG002|Overall Study|Withdrawal by Subject|0|||
163140317|NCT00280917|589224230|FG003|Overall Study|Withdrawal by Subject|1|||
163140318|NCT00280917|589224227|FG000|Overall Study|Noncompliance|0|||
163140319|NCT00280917|589224228|FG001|Overall Study|Noncompliance|1|||
163140320|NCT00280917|589224229|FG002|Overall Study|Noncompliance|2|||
163140321|NCT00280917|589224230|FG003|Overall Study|Noncompliance|0|||
163140322|NCT03310723|589224234|FG000|Overall Study|Withdrawal by Subject|0|||
163140323|NCT03310723|589224235|FG001|Overall Study|Withdrawal by Subject|1|||
163140324|NCT03310723|589224234|FG000|Overall Study|Protocol Violation|0|||
163140325|NCT03310723|589224235|FG001|Overall Study|Protocol Violation|2|||
163140326|NCT02098746|589224236|FG000|Overall Study|Changes of Investigator|2|||
163140327|NCT02098746|589224236|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163140328|NCT02098746|589224236|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
163140329|NCT02098746|589224236|FG000|Overall Study|Data Not Available After Treatment|1|||
163140330|NCT00997035|589224237|FG000|3-week Followup Visit|Lost to Follow-up|9|||
163140331|NCT00997035|589224238|FG001|3-week Followup Visit|Lost to Follow-up|6|||
163140332|NCT00997035|589224237|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
163140333|NCT00997035|589224238|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
163140334|NCT01508312|589224239|FG000|Overall Study|Lost to Follow-up|1|||
163140335|NCT01508312|589224240|FG001|Overall Study|Lost to Follow-up|0|||
163140336|NCT01508312|589224241|FG002|Overall Study|Lost to Follow-up|0|||
163140337|NCT01508312|589224242|FG003|Overall Study|Lost to Follow-up|0|||
163140338|NCT01508312|589224239|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140339|NCT01508312|589224240|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
163140340|NCT01508312|589224241|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140341|NCT01508312|589224242|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
163140342|NCT01508312|589224239|FG000|Overall Study|Adverse Event|0|||
162661801|NCT01602315|587473180|FG000|Overall Study|Subject/guardian decision|0|||
162661802|NCT01602315|587473181|FG001|Overall Study|Subject/guardian decision|0|||
162661803|NCT01602315|587473182|FG002|Overall Study|Subject/guardian decision|0|||
163140343|NCT01508312|589224240|FG001|Overall Study|Adverse Event|0|||
163140344|NCT01508312|589224241|FG002|Overall Study|Adverse Event|2|||
163140345|NCT01508312|589224242|FG003|Overall Study|Adverse Event|0|||
163140346|NCT01508312|589224239|FG000|Overall Study|Lack of Efficacy|0|||
163140347|NCT01508312|589224240|FG001|Overall Study|Lack of Efficacy|0|||
163140348|NCT01508312|589224241|FG002|Overall Study|Lack of Efficacy|1|||
162661804|NCT01602315|587473183|FG003|Overall Study|Subject/guardian decision|0|||
163140349|NCT01508312|589224242|FG003|Overall Study|Lack of Efficacy|0|||
163140350|NCT01508312|589224239|FG000|Overall Study|Withdrawal by Subject|0|||
163140351|NCT01508312|589224240|FG001|Overall Study|Withdrawal by Subject|0|||
163140352|NCT01508312|589224241|FG002|Overall Study|Withdrawal by Subject|1|||
163140353|NCT01508312|589224242|FG003|Overall Study|Withdrawal by Subject|0|||
162661805|NCT01602315|587473184|FG004|Overall Study|Subject/guardian decision|0|||
162661806|NCT01602315|587473185|FG005|Overall Study|Subject/guardian decision|0|||
162661807|NCT01602315|587473186|FG006|Overall Study|Subject/guardian decision|1|||
162661808|NCT01602315|587473180|FG000|Overall Study|Cross-over patients to combo treatment|0|||
162661809|NCT01602315|587473181|FG001|Overall Study|Cross-over patients to combo treatment|0|||
162661810|NCT01602315|587473182|FG002|Overall Study|Cross-over patients to combo treatment|0|||
162661811|NCT01602315|587473183|FG003|Overall Study|Cross-over patients to combo treatment|0|||
162661812|NCT01602315|587473184|FG004|Overall Study|Cross-over patients to combo treatment|0|||
162661813|NCT01602315|587473185|FG005|Overall Study|Cross-over patients to combo treatment|16|||
162661814|NCT01602315|587473186|FG006|Overall Study|Cross-over patients to combo treatment|0|||
162661815|NCT02212730|587473189|FG000|Overall Study|Tumor not of the required cell histology|1|||
162661816|NCT02212730|587473190|FG001|Overall Study|Tumor not of the required cell histology|0|||
162661817|NCT02212730|587473189|FG000|Overall Study|Withdrawal by Subject|1|||
162661818|NCT02212730|587473190|FG001|Overall Study|Withdrawal by Subject|0|||
162661819|NCT02212730|587473189|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
162661820|NCT02212730|587473190|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
162661821|NCT00961259|587473191|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
162661822|NCT00961259|587473192|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
162661823|NCT00961259|587473193|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
162661824|NCT02691455|587473196|FG000|Overall Study|Withdrawal by Subject|1|||
162661825|NCT02691455|587473197|FG001|Overall Study|Withdrawal by Subject|2|||
162661826|NCT02691455|587473196|FG000|Overall Study|Lost to Follow-up|15|||
162661827|NCT02691455|587473197|FG001|Overall Study|Lost to Follow-up|15|||
162661828|NCT02057757|587473198|FG000|Overall Study|Withdrawal by Subject|3|||
162661829|NCT02057757|587473199|FG001|Overall Study|Withdrawal by Subject|5|||
162661830|NCT02057757|587473198|FG000|Overall Study|Death|2|||
162661831|NCT02057757|587473199|FG001|Overall Study|Death|0|||
162661832|NCT02057757|587473198|FG000|Overall Study|Lost to Follow-up|8|||
162661833|NCT02057757|587473199|FG001|Overall Study|Lost to Follow-up|3|||
162661834|NCT02057757|587473198|FG000|Overall Study|Non-compliance|1|||
162661835|NCT02057757|587473199|FG001|Overall Study|Non-compliance|0|||
162661836|NCT00440271|587473200|FG000|Overall Study|Protocol Violation|1|||
162661837|NCT00440271|587473201|FG001|Overall Study|Protocol Violation|1|||
162661838|NCT00440271|587473200|FG000|Overall Study|Adverse Event|0|||
162661839|NCT00440271|587473201|FG001|Overall Study|Adverse Event|1|||
162661840|NCT00440271|587473200|FG000|Overall Study|Lost to Follow-up|1|||
162661841|NCT00440271|587473201|FG001|Overall Study|Lost to Follow-up|0|||
162661842|NCT00440271|587473200|FG000|Overall Study|Withdrawal by Subject|0|||
162661843|NCT00440271|587473201|FG001|Overall Study|Withdrawal by Subject|2|||
162661844|NCT00440271|587473200|FG000|Overall Study|Lack of Efficacy|0|||
162661845|NCT00440271|587473201|FG001|Overall Study|Lack of Efficacy|1|||
162661846|NCT00440271|587473200|FG000|Overall Study|Due to closure of trial|8|||
162661847|NCT00440271|587473201|FG001|Overall Study|Due to closure of trial|10|||
162661848|NCT00440271|587473200|FG000|Overall Study|Other|2|||
162661849|NCT00440271|587473201|FG001|Overall Study|Other|0|||
162661850|NCT00048724|587473205|FG000|Overall Study|Adverse Event|53|||
162661851|NCT00048724|587473206|FG001|Overall Study|Adverse Event|12|||
162661852|NCT00048724|587473205|FG000|Overall Study|Withdrawal by Subject|34|||
162661853|NCT00048724|587473206|FG001|Overall Study|Withdrawal by Subject|54|||
162661854|NCT00048724|587473205|FG000|Overall Study|Lost to Follow-up|5|||
162661855|NCT00048724|587473206|FG001|Overall Study|Lost to Follow-up|5|||
162661856|NCT00048724|587473205|FG000|Overall Study|Protocol-defined Clinical Event|17|||
162661857|NCT00048724|587473206|FG001|Overall Study|Protocol-defined Clinical Event|32|||
162661858|NCT00048724|587473205|FG000|Overall Study|Noncompliance With Protocol|4|||
162661859|NCT00048724|587473206|FG001|Overall Study|Noncompliance With Protocol|12|||
162661860|NCT00048724|587473205|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
162661861|NCT00048724|587473206|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
162661862|NCT00048724|587473205|FG000|Overall Study|Administrative|1|||
162661863|NCT00048724|587473206|FG001|Overall Study|Administrative|1|||
162661864|NCT03586869|587473207|FG000|Overall Study|Progressive Disease|3|||
162661865|NCT00226941|587473208|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
162661866|NCT00226941|587473209|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
162661867|NCT00226941|587473210|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
162661868|NCT00226941|587473211|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
162661869|NCT00226941|587473208|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162661870|NCT00226941|587473209|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162661871|NCT00226941|587473210|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162661872|NCT00226941|587473211|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
162661873|NCT02732847|587473212|FG000|Overall Study|some filled early|42|||
162661874|NCT02732847|587473213|FG001|Overall Study|some filled early|42|||
162661875|NCT01163682|587473215|FG000|Overall Study|Lost to Follow-up|6|||
162661876|NCT01163682|587473216|FG001|Overall Study|Lost to Follow-up|9|||
162661877|NCT00724451|587473217|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
162661878|NCT00724451|587473217|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
162661879|NCT00724451|587473217|FG000|Overall Study|Not Eligible for Treatment|431|||
162661880|NCT00724451|587473217|FG000|Overall Study|Participant Refused Treatment|89|||
162661881|NCT00724451|587473217|FG000|Overall Study|Never Started Treatment|89|||
162661882|NCT00724451|587473217|FG000|Overall Study|Unknown; No Data Sources Available|9|||
162661883|NCT00724451|587473217|FG000|Overall Study|Physician Decision|116|||
162661884|NCT00724451|587473217|FG000|Overall Study|Withdrawal by Subject|45|||
162661885|NCT00724451|587473217|FG000|Overall Study|Investigator + Participant Decision|13|||
162661886|NCT00414050|587473219|FG000|Overall Study|Adverse Event|1|||
162661887|NCT00414050|587473220|FG001|Overall Study|Adverse Event|1|||
162661888|NCT00414050|587473221|FG002|Overall Study|Adverse Event|1|||
162661889|NCT00414050|587473222|FG003|Overall Study|Adverse Event|1|||
162661890|NCT00414050|587473219|FG000|Overall Study|Lost to Follow-up|2|||
162661891|NCT00414050|587473220|FG001|Overall Study|Lost to Follow-up|2|||
162661892|NCT00414050|587473221|FG002|Overall Study|Lost to Follow-up|1|||
162661893|NCT00414050|587473222|FG003|Overall Study|Lost to Follow-up|1|||
162661894|NCT00414050|587473219|FG000|Overall Study|Withdrawal by Subject|5|||
162661895|NCT00414050|587473220|FG001|Overall Study|Withdrawal by Subject|3|||
162661896|NCT00414050|587473221|FG002|Overall Study|Withdrawal by Subject|2|||
162661897|NCT00414050|587473222|FG003|Overall Study|Withdrawal by Subject|4|||
162661898|NCT00414050|587473219|FG000|Overall Study|Subject discontinued for other reason|1|||
162661899|NCT00414050|587473220|FG001|Overall Study|Subject discontinued for other reason|2|||
162661900|NCT00414050|587473221|FG002|Overall Study|Subject discontinued for other reason|2|||
162661901|NCT00414050|587473222|FG003|Overall Study|Subject discontinued for other reason|1|||
162661902|NCT00414050|587473219|FG000|Overall Study|Subject Moved|0|||
162661903|NCT00414050|587473220|FG001|Overall Study|Subject Moved|0|||
162661904|NCT00414050|587473221|FG002|Overall Study|Subject Moved|0|||
162661905|NCT00414050|587473222|FG003|Overall Study|Subject Moved|1|||
162661906|NCT00515827|587473229|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
162661907|NCT00515827|587473230|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
162661908|NCT00515827|587473229|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
162661909|NCT00515827|587473230|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
162661910|NCT03254134|587473232|FG000|Overall Study|Not eligible patients|599|||
162661911|NCT03254134|587473233|FG001|Overall Study|Not eligible patients|3630|||
162661912|NCT00205712|587473234|FG000|Overall Study|Lost to Follow-up|0|||
162661913|NCT00205712|587473235|FG001|Overall Study|Lost to Follow-up|1|||
162661914|NCT01009099|587473236|FG000|Overall Study|Lost to Follow-up|1|||
162661915|NCT01009099|587473237|FG001|Overall Study|Lost to Follow-up|0|||
162661916|NCT01009099|587473236|FG000|Overall Study|Physician Decision|3|||
162661917|NCT01009099|587473237|FG001|Overall Study|Physician Decision|2|||
162661918|NCT01009099|587473236|FG000|Overall Study|Withdrawal by Subject|1|||
162661919|NCT01009099|587473237|FG001|Overall Study|Withdrawal by Subject|1|||
162661920|NCT01009099|587473236|FG000|Overall Study|Death|0|||
162661921|NCT01009099|587473237|FG001|Overall Study|Death|1|||
162661922|NCT02188485|587473242|FG000|Overall Study|Withdrawal by Subject|2|||
162661923|NCT02188485|587473243|FG001|Overall Study|Withdrawal by Subject|1|||
162661924|NCT02188485|587473242|FG000|Overall Study|PI withdrew, lack of capacity|0|||
162661925|NCT02188485|587473243|FG001|Overall Study|PI withdrew, lack of capacity|2|||
162661926|NCT00799617|587473244|FG000|Main Testosterone Trial|Randomized in error|1|||
162661927|NCT00799617|587473245|FG001|Main Testosterone Trial|Randomized in error|1|||
162661928|NCT00799617|587473244|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
162661929|NCT00799617|587473245|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
162661930|NCT00799617|587473244|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
162661931|NCT00799617|587473245|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
162661932|NCT00799617|587473244|FG000|Sexual Funtion Trial|No Baseline Data|4|||
162661933|NCT00799617|587473245|FG001|Sexual Funtion Trial|No Baseline Data|7|||
162661934|NCT00799617|587473244|FG000|Physical Function Trial|Lost to Follow-up|6|||
162661935|NCT00799617|587473245|FG001|Physical Function Trial|Lost to Follow-up|11|||
162661936|NCT00799617|587473244|FG000|Vitality Trial|Lost to Follow-up|7|||
162661937|NCT00799617|587473245|FG001|Vitality Trial|Lost to Follow-up|22|||
162661938|NCT00799617|587473244|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
162661939|NCT00799617|587473245|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
162661940|NCT00799617|587473244|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
162661941|NCT00799617|587473245|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
162661942|NCT00799617|587473244|FG000|Bone Trial|Month 12 scan not available|6|||
162661943|NCT00799617|587473245|FG001|Bone Trial|Month 12 scan not available|16|||
162661944|NCT00799617|587473244|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
162661945|NCT00799617|587473245|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
162661946|NCT00799617|587473244|FG000|Anemia Trial|Withdrawal by Subject|3|||
162661947|NCT00799617|587473245|FG001|Anemia Trial|Withdrawal by Subject|3|||
162720775|NCT01580293|587685924|FG000|Part A_Extension|Withdrawal by Subject|0|||
162720776|NCT01580293|587685925|FG001|Part A_Extension|Withdrawal by Subject|3|||
162720777|NCT01580293|587685926|FG002|Part A_Extension|Withdrawal by Subject|0|||
162720778|NCT01580293|587685924|FG000|Part A_Extension|Lost to Follow-up|0|||
162720779|NCT01580293|587685925|FG001|Part A_Extension|Lost to Follow-up|1|||
162720780|NCT01580293|587685926|FG002|Part A_Extension|Lost to Follow-up|0|||
162720781|NCT01580293|587685924|FG000|Part A_Extension|Other Reason|0|||
162720782|NCT01580293|587685925|FG001|Part A_Extension|Other Reason|1|||
162720783|NCT01580293|587685926|FG002|Part A_Extension|Other Reason|0|||
162720784|NCT01580293|587685924|FG000|Part A_Extension|Completed Japan only|0|||
162720785|NCT01580293|587685925|FG001|Part A_Extension|Completed Japan only|5|||
162720786|NCT01580293|587685926|FG002|Part A_Extension|Completed Japan only|0|||
162720787|NCT01580293|587685924|FG000|Part B|Withdrawal by Subject|0|||
162720788|NCT01580293|587685925|FG001|Part B|Withdrawal by Subject|0|||
162720789|NCT01580293|587685926|FG002|Part B|Withdrawal by Subject|1|||
162720790|NCT01580293|587685924|FG000|Part B|Other reason|0|||
162720791|NCT01580293|587685925|FG001|Part B|Other reason|0|||
162720792|NCT01580293|587685926|FG002|Part B|Other reason|1|||
163140354|NCT02222558|589224243|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
163140355|NCT02222558|589224244|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
163140356|NCT02222558|589224245|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
163140357|NCT02222558|589224246|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
163140358|NCT02222558|589224247|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
163140359|NCT02222558|589224248|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
163140360|NCT02222558|589224243|FG000|Period 3|Withdrawal by Subject|0|||
163140361|NCT02222558|589224244|FG001|Period 3|Withdrawal by Subject|0|||
163140362|NCT02222558|589224245|FG002|Period 3|Withdrawal by Subject|0|||
163140363|NCT02222558|589224246|FG003|Period 3|Withdrawal by Subject|0|||
163140364|NCT02222558|589224247|FG004|Period 3|Withdrawal by Subject|0|||
163140365|NCT02222558|589224248|FG005|Period 3|Withdrawal by Subject|1|||
163140366|NCT02322281|589224249|FG000|Overall Study|Progressive Disease|42|||
163140367|NCT02322281|589224250|FG001|Overall Study|Progressive Disease|14|||
163140368|NCT02322281|589224251|FG002|Overall Study|Progressive Disease|49|||
163140369|NCT02322281|589224249|FG000|Overall Study|Adverse Event|3|||
163140370|NCT02322281|589224250|FG001|Overall Study|Adverse Event|4|||
163140371|NCT02322281|589224251|FG002|Overall Study|Adverse Event|6|||
163140372|NCT02322281|589224249|FG000|Overall Study|Death|3|||
163140373|NCT02322281|589224250|FG001|Overall Study|Death|3|||
163140374|NCT02322281|589224251|FG002|Overall Study|Death|3|||
163140375|NCT02322281|589224249|FG000|Overall Study|Withdrawal by Subject|1|||
163140376|NCT02322281|589224250|FG001|Overall Study|Withdrawal by Subject|1|||
163140377|NCT02322281|589224251|FG002|Overall Study|Withdrawal by Subject|6|||
163140378|NCT02322281|589224249|FG000|Overall Study|Physician Decision|2|||
163140379|NCT02322281|589224250|FG001|Overall Study|Physician Decision|0|||
163140380|NCT02322281|589224251|FG002|Overall Study|Physician Decision|5|||
163140381|NCT02322281|589224249|FG000|Overall Study|Study Terminated by Sponsor|2|||
163140382|NCT02322281|589224250|FG001|Overall Study|Study Terminated by Sponsor|0|||
163140383|NCT02322281|589224251|FG002|Overall Study|Study Terminated by Sponsor|0|||
163140384|NCT02322281|589224249|FG000|Overall Study|Missing|0|||
163140385|NCT02322281|589224250|FG001|Overall Study|Missing|0|||
163140386|NCT02322281|589224251|FG002|Overall Study|Missing|1|||
163140387|NCT02322281|589224249|FG000|Overall Study|Miscellaneous|0|||
163140388|NCT02322281|589224250|FG001|Overall Study|Miscellaneous|0|||
163140389|NCT02322281|589224251|FG002|Overall Study|Miscellaneous|4|||
163140390|NCT00936702|589224252|FG000|Overall Study|Disease progression|34|||
163140391|NCT00936702|589224252|FG000|Overall Study|Adverse Event|8|||
163140392|NCT00936702|589224252|FG000|Overall Study|Withdrawal by Subject|2|||
163140393|NCT00936702|589224252|FG000|Overall Study|Alternative Treatment|1|||
163140394|NCT00936702|589224252|FG000|Overall Study|Other|1|||
163140395|NCT00354679|589224253|FG000|Overall Study|Patient Not Treated|1|||
163140396|NCT03456076|589224254|FG000|Overall Study|Withdrawal by Subject|5|||
163140397|NCT03456076|589224255|FG001|Overall Study|Withdrawal by Subject|9|||
163140398|NCT03456076|589224254|FG000|Overall Study|Protocol deviation|0|||
163140399|NCT03456076|589224255|FG001|Overall Study|Protocol deviation|1|||
163140400|NCT03456076|589224254|FG000|Overall Study|Lost to Follow-up|0|||
163140401|NCT03456076|589224255|FG001|Overall Study|Lost to Follow-up|1|||
163140402|NCT03456076|589224254|FG000|Overall Study|Death|2|||
163140403|NCT03456076|589224255|FG001|Overall Study|Death|5|||
163140404|NCT03456076|589224254|FG000|Overall Study|Study ongoing|123|||
163140405|NCT03456076|589224255|FG001|Overall Study|Study ongoing|111|||
163140406|NCT00466440|589224256|FG000|Overall Study|Adverse Event|0|||
162720793|NCT01134562|587685927|FG000|Overall Study|Adverse Event|0|||
162720794|NCT01134562|587685928|FG001|Overall Study|Adverse Event|1|||
163140407|NCT00466440|589224257|FG001|Overall Study|Adverse Event|3|||
163140408|NCT00466440|589224258|FG002|Overall Study|Adverse Event|1|||
163140409|NCT00466440|589224256|FG000|Overall Study|Death|1|||
163140410|NCT00466440|589224257|FG001|Overall Study|Death|1|||
163140411|NCT00466440|589224258|FG002|Overall Study|Death|0|||
163140412|NCT00466440|589224256|FG000|Overall Study|Progressive disease|13|||
163140413|NCT00466440|589224257|FG001|Overall Study|Progressive disease|5|||
163140414|NCT00466440|589224258|FG002|Overall Study|Progressive disease|4|||
163140415|NCT00466440|589224256|FG000|Overall Study|Lost to Follow-up|0|||
163140416|NCT00466440|589224257|FG001|Overall Study|Lost to Follow-up|1|||
163140417|NCT00466440|589224258|FG002|Overall Study|Lost to Follow-up|0|||
163140418|NCT00466440|589224256|FG000|Overall Study|Physician Decision|0|||
163140419|NCT00466440|589224257|FG001|Overall Study|Physician Decision|1|||
163140420|NCT00466440|589224258|FG002|Overall Study|Physician Decision|2|||
163140421|NCT00466440|589224256|FG000|Overall Study|Protocol entry criteria not met|0|||
163140422|NCT00466440|589224257|FG001|Overall Study|Protocol entry criteria not met|0|||
163140423|NCT00466440|589224258|FG002|Overall Study|Protocol entry criteria not met|4|||
163140424|NCT00466440|589224256|FG000|Overall Study|Withdrawal by Subject|0|||
163140425|NCT00466440|589224257|FG001|Overall Study|Withdrawal by Subject|1|||
163140426|NCT00466440|589224258|FG002|Overall Study|Withdrawal by Subject|0|||
163140427|NCT00466440|589224256|FG000|Overall Study|Sponsor decision|0|||
163140428|NCT00466440|589224257|FG001|Overall Study|Sponsor decision|0|||
163140429|NCT00466440|589224258|FG002|Overall Study|Sponsor decision|1|||
163140430|NCT03187132|589224261|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
163140431|NCT03187132|589224262|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
163140432|NCT03187132|589224261|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
163140433|NCT03187132|589224262|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
163140434|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
163140435|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
163140436|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
163140437|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
163140438|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
163140439|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
163140440|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
163140441|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
163140442|NCT03187132|589224261|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
163140443|NCT03187132|589224262|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
163140444|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
163140445|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
163140446|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
163140447|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
163140448|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
163140449|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
163140450|NCT03187132|589224261|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
163140451|NCT03187132|589224262|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
163140452|NCT03191630|589224265|FG000|Overall Study|Lost to Follow-up|7|||
163140453|NCT03191630|589224266|FG001|Overall Study|Lost to Follow-up|7|||
163140454|NCT02525588|589224267|FG000|Overall Study|Death|3|||
163140455|NCT02525588|589224268|FG001|Overall Study|Death|1|||
163140456|NCT02525588|589224267|FG000|Overall Study|Lost to Follow-up|2|||
163140457|NCT02525588|589224268|FG001|Overall Study|Lost to Follow-up|0|||
163140458|NCT02525588|589224267|FG000|Overall Study|Withdrawal by Subject|1|||
163140459|NCT02525588|589224268|FG001|Overall Study|Withdrawal by Subject|1|||
163140460|NCT02525588|589224267|FG000|Overall Study|Adverse Event|0|||
163140461|NCT02525588|589224268|FG001|Overall Study|Adverse Event|1|||
163140462|NCT00714415|589224279|FG000|Overall Study|Lack of Efficacy|1|||
163140463|NCT00714415|589224280|FG001|Overall Study|Lack of Efficacy|0|||
163140464|NCT00714415|589224279|FG000|Overall Study|Death|1|||
163140465|NCT00714415|589224280|FG001|Overall Study|Death|0|||
163140466|NCT02073682|589224295|FG000|Overall Study|Low Creatinine Clearance|1|||
163140467|NCT02073682|589224296|FG001|Overall Study|Low Creatinine Clearance|2|||
163140468|NCT02073682|589224295|FG000|Overall Study|Death|86|||
163140469|NCT02073682|589224296|FG001|Overall Study|Death|100|||
163140470|NCT02073682|589224295|FG000|Overall Study|Cancer Cured|10|||
163140471|NCT02073682|589224296|FG001|Overall Study|Cancer Cured|15|||
163140472|NCT02073682|589224295|FG000|Overall Study|ID: Patient Noncompliance|1|||
163140473|NCT02073682|589224296|FG001|Overall Study|ID: Patient Noncompliance|2|||
163140474|NCT02073682|589224295|FG000|Overall Study|ID: Palliative Treatment Only|10|||
163140475|NCT02073682|589224296|FG001|Overall Study|ID: Palliative Treatment Only|7|||
163140476|NCT02073682|589224295|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
163140477|NCT02073682|589224296|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
163140478|NCT02073682|589224295|FG000|Overall Study|Platelet Count <50,000/mL|1|||
163140479|NCT02073682|589224296|FG001|Overall Study|Platelet Count <50,000/mL|2|||
163140480|NCT02073682|589224295|FG000|Overall Study|Surgery/Medical Procedure|3|||
163140481|NCT02073682|589224296|FG001|Overall Study|Surgery/Medical Procedure|1|||
163140482|NCT02073682|589224295|FG000|Overall Study|Withdrawal by Subject|6|||
163140483|NCT02073682|589224296|FG001|Overall Study|Withdrawal by Subject|8|||
163140484|NCT02073682|589224295|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
163140485|NCT02073682|589224296|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
163140486|NCT02073682|589224295|FG000|Overall Study|Cancer Progression|53|||
163140487|NCT02073682|589224296|FG001|Overall Study|Cancer Progression|33|||
163140488|NCT02073682|589224295|FG000|Overall Study|Protocol Violation|1|||
163140489|NCT02073682|589224296|FG001|Overall Study|Protocol Violation|0|||
163140490|NCT02073682|589224295|FG000|Overall Study|Adverse Event|79|||
163140491|NCT02073682|589224296|FG001|Overall Study|Adverse Event|62|||
163140492|NCT02073682|589224295|FG000|Overall Study|No reason provided|11|||
163140493|NCT02073682|589224296|FG001|Overall Study|No reason provided|9|||
163140494|NCT02073682|589224295|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
163140495|NCT02073682|589224296|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
163140496|NCT02073682|589224295|FG000|Overall Study|Lost to Follow-up|1|||
163140497|NCT02073682|589224296|FG001|Overall Study|Lost to Follow-up|1|||
163140498|NCT02073682|589224295|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
163140499|NCT02073682|589224296|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
163140500|NCT04435366|589224302|FG000|Year 1 (12 Months)|Adverse Event|3|||
163140501|NCT04435366|589224303|FG001|Year 1 (12 Months)|Adverse Event|0|||
163140502|NCT04435366|589224304|FG002|Year 1 (12 Months)|Adverse Event|2|||
163140503|NCT04435366|589224302|FG000|Year 1 (12 Months)|Death|2|||
163140504|NCT04435366|589224303|FG001|Year 1 (12 Months)|Death|0|||
163140505|NCT04435366|589224304|FG002|Year 1 (12 Months)|Death|1|||
163140506|NCT04435366|589224302|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
163140507|NCT04435366|589224303|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
163140508|NCT04435366|589224304|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
163140509|NCT04435366|589224302|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
163140510|NCT04435366|589224303|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
163140511|NCT04435366|589224304|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
163140512|NCT04435366|589224302|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
163140513|NCT04435366|589224303|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
163140514|NCT04435366|589224304|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
163140515|NCT04435366|589224302|FG000|Year 1 (12 Months)|Not treated|0|||
163140516|NCT04435366|589224303|FG001|Year 1 (12 Months)|Not treated|0|||
163140517|NCT04435366|589224304|FG002|Year 1 (12 Months)|Not treated|1|||
163140518|NCT04435366|589224302|FG000|Year 2 (12 Months)|Death|1|||
163140519|NCT04435366|589224303|FG001|Year 2 (12 Months)|Death|4|||
163140520|NCT04435366|589224304|FG002|Year 2 (12 Months)|Death|6|||
163140521|NCT04435366|589224302|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
163140522|NCT04435366|589224303|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
163140523|NCT04435366|589224304|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
163140524|NCT04435366|589224302|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
163140525|NCT04435366|589224303|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
163140526|NCT04435366|589224304|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
163140527|NCT04435366|589224302|FG000|Year 2 (12 Months)|Adverse Event|2|||
163140528|NCT04435366|589224303|FG001|Year 2 (12 Months)|Adverse Event|1|||
163140529|NCT04435366|589224304|FG002|Year 2 (12 Months)|Adverse Event|6|||
163140530|NCT01687296|589224305|FG000|Overall Study|Lack of Efficacy|1|||
163140531|NCT01687296|589224306|FG001|Overall Study|Lack of Efficacy|1|||
163140532|NCT01687296|589224305|FG000|Overall Study|Protocol Violation|0|||
163140533|NCT01687296|589224306|FG001|Overall Study|Protocol Violation|1|||
163140534|NCT01687296|589224305|FG000|Overall Study|Withdrawal by Subject|6|||
163140535|NCT01687296|589224306|FG001|Overall Study|Withdrawal by Subject|3|||
163140536|NCT04497116|589224308|FG000|Overall Study|Lost to Follow-up|1|||
163140537|NCT04497116|589224309|FG001|Overall Study|Lost to Follow-up|0|||
163140538|NCT04497116|589224310|FG002|Overall Study|Lost to Follow-up|0|||
163140539|NCT04497116|589224311|FG003|Overall Study|Lost to Follow-up|0|||
163140540|NCT04497116|589224312|FG004|Overall Study|Lost to Follow-up|0|||
163140541|NCT04497116|589224313|FG005|Overall Study|Lost to Follow-up|0|||
163140542|NCT04497116|589224314|FG006|Overall Study|Lost to Follow-up|0|||
163140543|NCT04497116|589224315|FG007|Overall Study|Lost to Follow-up|3|||
163140544|NCT04497116|589224316|FG008|Overall Study|Lost to Follow-up|3|||
163140545|NCT04497116|589224317|FG009|Overall Study|Lost to Follow-up|0|||
163140546|NCT04497116|589224318|FG010|Overall Study|Lost to Follow-up|0|||
163140547|NCT04497116|589224319|FG011|Overall Study|Lost to Follow-up|0|||
163140548|NCT04497116|589224320|FG012|Overall Study|Lost to Follow-up|0|||
162720795|NCT01134562|587685929|FG002|Overall Study|Adverse Event|0|||
162720796|NCT01134562|587685930|FG003|Overall Study|Adverse Event|0|||
162720797|NCT01134562|587685931|FG004|Overall Study|Adverse Event|0|||
163140549|NCT04497116|589224321|FG013|Overall Study|Lost to Follow-up|0|||
163140550|NCT04497116|589224322|FG014|Overall Study|Lost to Follow-up|0|||
163140551|NCT04497116|589224323|FG015|Overall Study|Lost to Follow-up|0|||
163140552|NCT04497116|589224324|FG016|Overall Study|Lost to Follow-up|0|||
163140553|NCT04497116|589224325|FG017|Overall Study|Lost to Follow-up|0|||
163140554|NCT04497116|589224326|FG018|Overall Study|Lost to Follow-up|0|||
163140555|NCT04497116|589224327|FG019|Overall Study|Lost to Follow-up|0|||
163140556|NCT04497116|589224328|FG020|Overall Study|Lost to Follow-up|0|||
163140557|NCT04497116|589224329|FG021|Overall Study|Lost to Follow-up|0|||
163140558|NCT04497116|589224330|FG022|Overall Study|Lost to Follow-up|1|||
163140559|NCT04497116|589224331|FG023|Overall Study|Lost to Follow-up|0|||
163140560|NCT04497116|589224332|FG024|Overall Study|Lost to Follow-up|0|||
163140561|NCT04497116|589224308|FG000|Overall Study|Sponsor decision to terminate study|0|||
163140562|NCT04497116|589224309|FG001|Overall Study|Sponsor decision to terminate study|0|||
163140563|NCT04497116|589224310|FG002|Overall Study|Sponsor decision to terminate study|0|||
163140564|NCT04497116|589224311|FG003|Overall Study|Sponsor decision to terminate study|0|||
163140565|NCT04497116|589224312|FG004|Overall Study|Sponsor decision to terminate study|0|||
163140566|NCT04497116|589224313|FG005|Overall Study|Sponsor decision to terminate study|0|||
163140567|NCT04497116|589224314|FG006|Overall Study|Sponsor decision to terminate study|1|||
163140568|NCT04497116|589224315|FG007|Overall Study|Sponsor decision to terminate study|0|||
163140569|NCT04497116|589224316|FG008|Overall Study|Sponsor decision to terminate study|0|||
163140570|NCT04497116|589224317|FG009|Overall Study|Sponsor decision to terminate study|1|||
163140571|NCT04497116|589224318|FG010|Overall Study|Sponsor decision to terminate study|0|||
163140572|NCT04497116|589224319|FG011|Overall Study|Sponsor decision to terminate study|0|||
163140573|NCT04497116|589224320|FG012|Overall Study|Sponsor decision to terminate study|0|||
163140574|NCT04497116|589224321|FG013|Overall Study|Sponsor decision to terminate study|0|||
163140575|NCT04497116|589224322|FG014|Overall Study|Sponsor decision to terminate study|0|||
163140576|NCT04497116|589224323|FG015|Overall Study|Sponsor decision to terminate study|0|||
163140577|NCT04497116|589224324|FG016|Overall Study|Sponsor decision to terminate study|0|||
163140578|NCT04497116|589224325|FG017|Overall Study|Sponsor decision to terminate study|0|||
163140579|NCT04497116|589224326|FG018|Overall Study|Sponsor decision to terminate study|0|||
163140580|NCT04497116|589224327|FG019|Overall Study|Sponsor decision to terminate study|1|||
163140581|NCT04497116|589224328|FG020|Overall Study|Sponsor decision to terminate study|0|||
163140582|NCT04497116|589224329|FG021|Overall Study|Sponsor decision to terminate study|0|||
163140583|NCT04497116|589224330|FG022|Overall Study|Sponsor decision to terminate study|0|||
163140584|NCT04497116|589224331|FG023|Overall Study|Sponsor decision to terminate study|0|||
163140585|NCT04497116|589224332|FG024|Overall Study|Sponsor decision to terminate study|0|||
163140586|NCT04497116|589224308|FG000|Overall Study|Death|4|||
163140587|NCT04497116|589224309|FG001|Overall Study|Death|5|||
163140588|NCT04497116|589224310|FG002|Overall Study|Death|2|||
163140589|NCT04497116|589224311|FG003|Overall Study|Death|2|||
163140590|NCT04497116|589224312|FG004|Overall Study|Death|1|||
163140591|NCT04497116|589224313|FG005|Overall Study|Death|1|||
163140592|NCT04497116|589224314|FG006|Overall Study|Death|3|||
163140593|NCT04497116|589224315|FG007|Overall Study|Death|10|||
163140594|NCT04497116|589224316|FG008|Overall Study|Death|37|||
163140595|NCT04497116|589224317|FG009|Overall Study|Death|17|||
163140596|NCT04497116|589224318|FG010|Overall Study|Death|2|||
163140597|NCT04497116|589224319|FG011|Overall Study|Death|1|||
163140598|NCT04497116|589224320|FG012|Overall Study|Death|1|||
163140599|NCT04497116|589224321|FG013|Overall Study|Death|3|||
163140600|NCT04497116|589224322|FG014|Overall Study|Death|18|||
163140601|NCT04497116|589224323|FG015|Overall Study|Death|3|||
163140602|NCT04497116|589224324|FG016|Overall Study|Death|2|||
163140603|NCT04497116|589224325|FG017|Overall Study|Death|1|||
163140604|NCT04497116|589224326|FG018|Overall Study|Death|4|||
163140605|NCT04497116|589224327|FG019|Overall Study|Death|17|||
163140606|NCT04497116|589224328|FG020|Overall Study|Death|1|||
163140607|NCT04497116|589224329|FG021|Overall Study|Death|0|||
163140608|NCT04497116|589224330|FG022|Overall Study|Death|3|||
163140609|NCT04497116|589224331|FG023|Overall Study|Death|5|||
163140610|NCT04497116|589224332|FG024|Overall Study|Death|4|||
163140611|NCT04497116|589224308|FG000|Overall Study|Withdrawal by Subject|1|||
163140612|NCT04497116|589224309|FG001|Overall Study|Withdrawal by Subject|0|||
163140613|NCT04497116|589224310|FG002|Overall Study|Withdrawal by Subject|1|||
163140614|NCT04497116|589224311|FG003|Overall Study|Withdrawal by Subject|0|||
163140615|NCT04497116|589224312|FG004|Overall Study|Withdrawal by Subject|0|||
163140616|NCT04497116|589224313|FG005|Overall Study|Withdrawal by Subject|0|||
163140617|NCT04497116|589224314|FG006|Overall Study|Withdrawal by Subject|0|||
163140618|NCT04497116|589224315|FG007|Overall Study|Withdrawal by Subject|7|||
163140619|NCT04497116|589224316|FG008|Overall Study|Withdrawal by Subject|14|||
163140620|NCT04497116|589224317|FG009|Overall Study|Withdrawal by Subject|3|||
163140621|NCT04497116|589224318|FG010|Overall Study|Withdrawal by Subject|3|||
163140622|NCT04497116|589224319|FG011|Overall Study|Withdrawal by Subject|0|||
163140623|NCT04497116|589224320|FG012|Overall Study|Withdrawal by Subject|1|||
163140624|NCT04497116|589224321|FG013|Overall Study|Withdrawal by Subject|0|||
163140625|NCT04497116|589224322|FG014|Overall Study|Withdrawal by Subject|7|||
163140626|NCT04497116|589224323|FG015|Overall Study|Withdrawal by Subject|1|||
163140627|NCT04497116|589224324|FG016|Overall Study|Withdrawal by Subject|3|||
163140628|NCT04497116|589224325|FG017|Overall Study|Withdrawal by Subject|1|||
163140629|NCT04497116|589224326|FG018|Overall Study|Withdrawal by Subject|1|||
163140630|NCT04497116|589224327|FG019|Overall Study|Withdrawal by Subject|5|||
163140631|NCT04497116|589224328|FG020|Overall Study|Withdrawal by Subject|2|||
163140632|NCT04497116|589224329|FG021|Overall Study|Withdrawal by Subject|2|||
163140633|NCT04497116|589224330|FG022|Overall Study|Withdrawal by Subject|2|||
163140634|NCT04497116|589224331|FG023|Overall Study|Withdrawal by Subject|4|||
163140635|NCT04497116|589224332|FG024|Overall Study|Withdrawal by Subject|3|||
163140636|NCT04497116|589224308|FG000|Overall Study|Physician Decision|0|||
163140637|NCT04497116|589224309|FG001|Overall Study|Physician Decision|0|||
163140638|NCT04497116|589224310|FG002|Overall Study|Physician Decision|0|||
163140639|NCT04497116|589224311|FG003|Overall Study|Physician Decision|0|||
163140640|NCT04497116|589224312|FG004|Overall Study|Physician Decision|0|||
163140641|NCT04497116|589224313|FG005|Overall Study|Physician Decision|0|||
163140642|NCT04497116|589224314|FG006|Overall Study|Physician Decision|0|||
162661948|NCT01712984|587473246|FG000|Overall Study|Adverse Event|0|||
162661949|NCT01712984|587473247|FG001|Overall Study|Adverse Event|0|||
162661950|NCT01712984|587473248|FG002|Overall Study|Adverse Event|1|||
162661951|NCT01712984|587473246|FG000|Overall Study|Protocol Violation|2|||
162661952|NCT01712984|587473247|FG001|Overall Study|Protocol Violation|0|||
162661953|NCT01712984|587473248|FG002|Overall Study|Protocol Violation|1|||
162661954|NCT01712984|587473246|FG000|Overall Study|Lost to Follow-up|8|||
162661955|NCT01712984|587473247|FG001|Overall Study|Lost to Follow-up|10|||
162661956|NCT01712984|587473248|FG002|Overall Study|Lost to Follow-up|1|||
162661957|NCT01712984|587473246|FG000|Overall Study|Withdrawal by Subject|6|||
162661958|NCT01712984|587473247|FG001|Overall Study|Withdrawal by Subject|6|||
162661959|NCT01712984|587473248|FG002|Overall Study|Withdrawal by Subject|7|||
162661960|NCT00096044|587473251|FG000|Overall Study|Withdrawal by Subject|9|||
162661961|NCT00096044|587473251|FG000|Overall Study|Adverse Event|21|||
162661962|NCT00096044|587473251|FG000|Overall Study|Disease Progression|4|||
162661963|NCT03149237|587473252|FG000|Overall Study|Withdrawal by Subject|4|||
162661964|NCT03149237|587473253|FG001|Overall Study|Withdrawal by Subject|5|||
162661965|NCT02442830|587473254|FG000|Overall Study|Technical Failure|0|||
162661966|NCT02442830|587473255|FG001|Overall Study|Technical Failure|1|||
162661967|NCT02052466|587473256|FG000|Overall Study|Withdrawal by Subject|1|||
162661968|NCT02052466|587473256|FG000|Overall Study|Acromial fracture|1|||
162661969|NCT00595582|587473258|FG000|Overall Study|Pilot study that PI terminated|2|||
162661970|NCT00595582|587473258|FG000|Overall Study|Lost to Follow-up|1|||
162661971|NCT00595582|587473258|FG000|Overall Study|Adverse Event|2|||
162661972|NCT00595582|587473258|FG000|Overall Study|Physician Decision|5|||
162661973|NCT03851016|587473259|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162661974|NCT03851016|587473260|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
162661975|NCT03878134|587473261|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
162661976|NCT00586469|587473262|FG000|Overall Study|Adverse Event|0|||
162661977|NCT00586469|587473263|FG001|Overall Study|Adverse Event|1|||
162661978|NCT04055116|587473266|FG000|First Intervention|Physician Decision|2|||
162661979|NCT04055116|587473267|FG001|First Intervention|Physician Decision|7|||
162661980|NCT01660412|587473273|FG000|Overall Study|Protocol Violation|0|||
162661981|NCT01660412|587473274|FG001|Overall Study|Protocol Violation|3|||
162661982|NCT04258839|587474717|FG000|Overall Study|Adverse Event|2|||
162661983|NCT04258839|587474718|FG001|Overall Study|Adverse Event|4|||
162661984|NCT04258839|587474717|FG000|Overall Study|Lack of Efficacy|0|||
162661985|NCT04258839|587474718|FG001|Overall Study|Lack of Efficacy|2|||
162661986|NCT04258839|587474717|FG000|Overall Study|Lost to Follow-up|2|||
162661987|NCT04258839|587474718|FG001|Overall Study|Lost to Follow-up|0|||
162661988|NCT04258839|587474717|FG000|Overall Study|Withdrawal by Subject|1|||
162661989|NCT04258839|587474718|FG001|Overall Study|Withdrawal by Subject|2|||
162661990|NCT04258839|587474717|FG000|Overall Study|Withdrawal by Caregiver|5|||
162661991|NCT04258839|587474718|FG001|Overall Study|Withdrawal by Caregiver|6|||
162661992|NCT04258839|587474717|FG000|Overall Study|Reason not Specified|0|||
162661993|NCT04258839|587474718|FG001|Overall Study|Reason not Specified|1|||
162661994|NCT03328897|587474719|FG000|Randomized-treatment Epoch|Adverse Event|4|||
162661995|NCT03328897|587474720|FG001|Randomized-treatment Epoch|Adverse Event|1|||
162661996|NCT03328897|587474721|FG002|Randomized-treatment Epoch|Adverse Event|1|||
162661997|NCT03328897|587474719|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
162661998|NCT03328897|587474720|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
162661999|NCT03328897|587474721|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
162662000|NCT03328897|587474719|FG000|Randomized-treatment Epoch|Pregnancy|3|||
162662001|NCT03328897|587474720|FG001|Randomized-treatment Epoch|Pregnancy|0|||
162662002|NCT03328897|587474721|FG002|Randomized-treatment Epoch|Pregnancy|0|||
162662003|NCT03328897|587474719|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
162662004|NCT03328897|587474720|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
162662005|NCT03328897|587474721|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
162662006|NCT03328897|587474719|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
162662007|NCT03328897|587474720|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
162662008|NCT03328897|587474721|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
162662009|NCT03328897|587474719|FG000|Follow-up Epoch|Adverse Event|4|||
162662010|NCT03328897|587474720|FG001|Follow-up Epoch|Adverse Event|0|||
162662011|NCT03328897|587474721|FG002|Follow-up Epoch|Adverse Event|1|||
162662012|NCT03328897|587474719|FG000|Follow-up Epoch|Lack of Efficacy|1|||
162662013|NCT03328897|587474720|FG001|Follow-up Epoch|Lack of Efficacy|1|||
162662014|NCT03328897|587474721|FG002|Follow-up Epoch|Lack of Efficacy|1|||
163140643|NCT04497116|589224315|FG007|Overall Study|Physician Decision|0|||
163140644|NCT04497116|589224316|FG008|Overall Study|Physician Decision|0|||
163140645|NCT04497116|589224317|FG009|Overall Study|Physician Decision|0|||
163140646|NCT04497116|589224318|FG010|Overall Study|Physician Decision|0|||
163140647|NCT04497116|589224319|FG011|Overall Study|Physician Decision|0|||
163140648|NCT04497116|589224320|FG012|Overall Study|Physician Decision|0|||
163140649|NCT04497116|589224321|FG013|Overall Study|Physician Decision|0|||
162662015|NCT03328897|587474719|FG000|Follow-up Epoch|Lost to Follow-up|0|||
163140650|NCT04497116|589224322|FG014|Overall Study|Physician Decision|0|||
163140651|NCT04497116|589224323|FG015|Overall Study|Physician Decision|0|||
163140652|NCT04497116|589224324|FG016|Overall Study|Physician Decision|0|||
163140653|NCT04497116|589224325|FG017|Overall Study|Physician Decision|0|||
163140654|NCT04497116|589224326|FG018|Overall Study|Physician Decision|0|||
163140655|NCT04497116|589224327|FG019|Overall Study|Physician Decision|0|||
163140656|NCT04497116|589224328|FG020|Overall Study|Physician Decision|0|||
163140657|NCT04497116|589224329|FG021|Overall Study|Physician Decision|0|||
162662016|NCT03328897|587474720|FG001|Follow-up Epoch|Lost to Follow-up|1|||
163140658|NCT04497116|589224330|FG022|Overall Study|Physician Decision|0|||
163140659|NCT04497116|589224331|FG023|Overall Study|Physician Decision|1|||
163140660|NCT04497116|589224332|FG024|Overall Study|Physician Decision|0|||
163140661|NCT04497116|589224308|FG000|Overall Study|Clinical Progression Related|0|||
163140662|NCT04497116|589224309|FG001|Overall Study|Clinical Progression Related|0|||
163140663|NCT04497116|589224310|FG002|Overall Study|Clinical Progression Related|0|||
163140664|NCT04497116|589224311|FG003|Overall Study|Clinical Progression Related|0|||
163140665|NCT04497116|589224312|FG004|Overall Study|Clinical Progression Related|0|||
163140666|NCT04497116|589224313|FG005|Overall Study|Clinical Progression Related|0|||
163140667|NCT04497116|589224314|FG006|Overall Study|Clinical Progression Related|0|||
163140668|NCT04497116|589224315|FG007|Overall Study|Clinical Progression Related|0|||
162662017|NCT03328897|587474721|FG002|Follow-up Epoch|Lost to Follow-up|0|||
162662018|NCT03328897|587474719|FG000|Follow-up Epoch|Pregnancy|1|||
162662019|NCT03328897|587474720|FG001|Follow-up Epoch|Pregnancy|0|||
162662020|NCT03328897|587474721|FG002|Follow-up Epoch|Pregnancy|0|||
162662021|NCT03328897|587474719|FG000|Follow-up Epoch|Patient/guardian decision|2|||
162662022|NCT03328897|587474720|FG001|Follow-up Epoch|Patient/guardian decision|1|||
163140669|NCT04497116|589224316|FG008|Overall Study|Clinical Progression Related|0|||
163140670|NCT04497116|589224317|FG009|Overall Study|Clinical Progression Related|1|||
163140671|NCT04497116|589224318|FG010|Overall Study|Clinical Progression Related|0|||
163140672|NCT04497116|589224319|FG011|Overall Study|Clinical Progression Related|0|||
163140673|NCT04497116|589224320|FG012|Overall Study|Clinical Progression Related|0|||
163140674|NCT04497116|589224321|FG013|Overall Study|Clinical Progression Related|0|||
163140675|NCT04497116|589224322|FG014|Overall Study|Clinical Progression Related|0|||
163140676|NCT04497116|589224323|FG015|Overall Study|Clinical Progression Related|0|||
163140677|NCT04497116|589224324|FG016|Overall Study|Clinical Progression Related|0|||
163140678|NCT04497116|589224325|FG017|Overall Study|Clinical Progression Related|0|||
163140679|NCT04497116|589224326|FG018|Overall Study|Clinical Progression Related|0|||
163140680|NCT04497116|589224327|FG019|Overall Study|Clinical Progression Related|0|||
163140681|NCT04497116|589224328|FG020|Overall Study|Clinical Progression Related|0|||
163140682|NCT04497116|589224329|FG021|Overall Study|Clinical Progression Related|0|||
163140683|NCT04497116|589224330|FG022|Overall Study|Clinical Progression Related|0|||
163140684|NCT04497116|589224331|FG023|Overall Study|Clinical Progression Related|0|||
163140685|NCT04497116|589224332|FG024|Overall Study|Clinical Progression Related|0|||
163140686|NCT05963022|589224336|FG000|Overall Study|Adverse Event|0|||
163140687|NCT05963022|589224337|FG001|Overall Study|Adverse Event|1|||
163140688|NCT05963022|589224338|FG002|Overall Study|Adverse Event|1|||
163140689|NCT05963022|589224339|FG003|Overall Study|Adverse Event|0|||
163140690|NCT05963022|589224336|FG000|Overall Study|Protocol Violation|0|||
163140691|NCT05963022|589224337|FG001|Overall Study|Protocol Violation|3|||
163140692|NCT05963022|589224338|FG002|Overall Study|Protocol Violation|0|||
163140693|NCT05963022|589224339|FG003|Overall Study|Protocol Violation|0|||
163140694|NCT05963022|589224336|FG000|Overall Study|Pregnancy|0|||
163140695|NCT05963022|589224337|FG001|Overall Study|Pregnancy|1|||
163140696|NCT05963022|589224338|FG002|Overall Study|Pregnancy|1|||
163140697|NCT05963022|589224339|FG003|Overall Study|Pregnancy|1|||
163140698|NCT05963022|589224336|FG000|Overall Study|Withdrawal by Subject|0|||
163140699|NCT05963022|589224337|FG001|Overall Study|Withdrawal by Subject|0|||
163140700|NCT05963022|589224338|FG002|Overall Study|Withdrawal by Subject|2|||
163140701|NCT05963022|589224339|FG003|Overall Study|Withdrawal by Subject|1|||
163140702|NCT05963022|589224336|FG000|Overall Study|Lost to Follow-up|0|||
163140703|NCT05963022|589224337|FG001|Overall Study|Lost to Follow-up|0|||
163140704|NCT05963022|589224338|FG002|Overall Study|Lost to Follow-up|0|||
163140705|NCT05963022|589224339|FG003|Overall Study|Lost to Follow-up|1|||
163140706|NCT05963022|589224336|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
163140707|NCT05963022|589224337|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
162662023|NCT03328897|587474721|FG002|Follow-up Epoch|Patient/guardian decision|0|||
163140708|NCT05963022|589224338|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
163140709|NCT05963022|589224339|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
163140710|NCT02698826|589224342|FG000|Overall Study|Death|13|||
163140711|NCT02698826|589224342|FG000|Overall Study|Adverse Event|1|||
163140712|NCT02915263|589224347|FG000|Overall Study|Covid|3|||
163140713|NCT02915263|589224348|FG001|Overall Study|Covid|2|||
163140714|NCT02478463|589224349|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
163140715|NCT02478463|589224349|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
163140716|NCT02478463|589224349|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
163140717|NCT01358825|589224350|FG000|Overall Study|Blood sample not drawn|0|||
162720798|NCT01499134|587685934|FG000|Overall Study|Withdrawal by Subject|0|||
162720799|NCT01499134|587685935|FG001|Overall Study|Withdrawal by Subject|1|||
162720800|NCT01400776|587685936|FG000|Overall Study|Adverse Event|7|||
162720801|NCT01400776|587685937|FG001|Overall Study|Adverse Event|2|||
162720802|NCT01400776|587685938|FG002|Overall Study|Adverse Event|9|||
162720803|NCT01400776|587685939|FG003|Overall Study|Adverse Event|2|||
162720804|NCT01400776|587685936|FG000|Overall Study|Lost to Follow-up|1|||
162720805|NCT01400776|587685937|FG001|Overall Study|Lost to Follow-up|0|||
162720806|NCT01400776|587685938|FG002|Overall Study|Lost to Follow-up|4|||
162720807|NCT01400776|587685939|FG003|Overall Study|Lost to Follow-up|1|||
162720808|NCT01400776|587685936|FG000|Overall Study|Withdrew Consent|4|||
162720809|NCT01400776|587685937|FG001|Overall Study|Withdrew Consent|2|||
162720810|NCT01400776|587685938|FG002|Overall Study|Withdrew Consent|6|||
162720811|NCT01400776|587685939|FG003|Overall Study|Withdrew Consent|1|||
162720812|NCT01400776|587685936|FG000|Overall Study|Protocol Deviation|6|||
162720813|NCT01400776|587685937|FG001|Overall Study|Protocol Deviation|1|||
162720814|NCT01400776|587685938|FG002|Overall Study|Protocol Deviation|5|||
162720815|NCT01400776|587685939|FG003|Overall Study|Protocol Deviation|2|||
162720816|NCT01400776|587685936|FG000|Overall Study|Reason not Specified|3|||
162720817|NCT01400776|587685937|FG001|Overall Study|Reason not Specified|0|||
162720818|NCT01400776|587685938|FG002|Overall Study|Reason not Specified|4|||
162720819|NCT01400776|587685939|FG003|Overall Study|Reason not Specified|3|||
162720820|NCT03192046|587685942|FG000|Overall Study|Withdrawal by Subject|1|||
162720821|NCT03192046|587685943|FG001|Overall Study|Withdrawal by Subject|1|||
162720822|NCT01194154|587685946|FG000|Overall Study|Adverse Event|12|||
162720823|NCT01194154|587685947|FG001|Overall Study|Adverse Event|7|||
162720824|NCT01194154|587685946|FG000|Overall Study|Lost to Follow-up|2|||
162720825|NCT01194154|587685947|FG001|Overall Study|Lost to Follow-up|3|||
162720826|NCT01194154|587685946|FG000|Overall Study|Protocol Violation|0|||
162720827|NCT01194154|587685947|FG001|Overall Study|Protocol Violation|1|||
162720828|NCT01194154|587685946|FG000|Overall Study|Withdrawal by Subject|5|||
162720829|NCT01194154|587685947|FG001|Overall Study|Withdrawal by Subject|6|||
162720830|NCT01194154|587685946|FG000|Overall Study|Blood pressure increase|5|||
162720831|NCT01194154|587685947|FG001|Overall Study|Blood pressure increase|3|||
162720832|NCT01194154|587685946|FG000|Overall Study|Hemoglobin decrease|0|||
162720833|NCT01194154|587685947|FG001|Overall Study|Hemoglobin decrease|1|||
162720834|NCT01194154|587685946|FG000|Overall Study|Hemoglobin increase|12|||
162720835|NCT01194154|587685947|FG001|Overall Study|Hemoglobin increase|3|||
162720836|NCT01194154|587685946|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
162720837|NCT01194154|587685947|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
162720838|NCT01194154|587685946|FG000|Overall Study|Treatment with prohibited medication|4|||
162720839|NCT01194154|587685947|FG001|Overall Study|Treatment with prohibited medication|5|||
162720840|NCT01194154|587685946|FG000|Overall Study|Other|4|||
162720841|NCT01194154|587685947|FG001|Overall Study|Other|0|||
162720842|NCT01194154|587685946|FG000|Overall Study|Did not receive study medication|2|||
162720843|NCT01194154|587685947|FG001|Overall Study|Did not receive study medication|4|||
162720844|NCT00842257|587685948|FG000|Overall Study|Adverse Event|1|||
162720845|NCT01901276|587685949|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
162720846|NCT01901276|587685950|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
162720847|NCT02314117|587685951|FG000|Overall Study|Lost to Follow-up|9|||
162720848|NCT02314117|587685952|FG001|Overall Study|Lost to Follow-up|14|||
162720849|NCT02314117|587685951|FG000|Overall Study|Withdrawal by Subject|3|||
162720850|NCT02314117|587685952|FG001|Overall Study|Withdrawal by Subject|2|||
162720851|NCT00057837|587685953|FG000|Overall Study|Progression/relapse|12|||
162720852|NCT00057837|587685954|FG001|Overall Study|Progression/relapse|14|||
162720853|NCT00057837|587685953|FG000|Overall Study|Adverse Event|2|||
162720854|NCT00057837|587685954|FG001|Overall Study|Adverse Event|12|||
162720855|NCT00057837|587685953|FG000|Overall Study|Death|5|||
162720856|NCT00057837|587685954|FG001|Overall Study|Death|4|||
162720857|NCT00057837|587685953|FG000|Overall Study|Withdrawal by Subject|5|||
162720858|NCT00057837|587685954|FG001|Overall Study|Withdrawal by Subject|3|||
162720859|NCT00057837|587685953|FG000|Overall Study|Alternative therapy|0|||
162720860|NCT00057837|587685954|FG001|Overall Study|Alternative therapy|1|||
162720861|NCT00057837|587685953|FG000|Overall Study|Other complicating disease|2|||
162720862|NCT00057837|587685954|FG001|Overall Study|Other complicating disease|1|||
162720863|NCT00057837|587685953|FG000|Overall Study|Physician Decision|1|||
162720864|NCT00057837|587685954|FG001|Overall Study|Physician Decision|0|||
162720865|NCT00057837|587685953|FG000|Overall Study|Ineligible|3|||
163140718|NCT01358825|589224351|FG001|Overall Study|Blood sample not drawn|1|||
163140719|NCT01177007|589224352|FG000|Overall Study|Lost to Follow-up|2|||
162720866|NCT00057837|587685954|FG001|Overall Study|Ineligible|3|||
162720867|NCT00057837|587685953|FG000|Overall Study|Never started treatment|1|||
162720868|NCT00057837|587685954|FG001|Overall Study|Never started treatment|1|||
162720869|NCT02000817|587685955|FG000|Overall Study|Withdrawal by Subject|2|||
162720870|NCT02000817|587685956|FG001|Overall Study|Withdrawal by Subject|0|||
162720871|NCT02000817|587685957|FG002|Overall Study|Withdrawal by Subject|0|||
162720872|NCT02000817|587685958|FG003|Overall Study|Withdrawal by Subject|0|||
162720873|NCT02000817|587685955|FG000|Overall Study|Adverse Event|0|||
163140720|NCT01177007|589224352|FG000|Overall Study|Death|4|||
163140721|NCT01177007|589224352|FG000|Overall Study|Entered hospice care|5|||
163140722|NCT01177007|589224352|FG000|Overall Study|Required additional Y90 treatment|6|||
163140723|NCT01177007|589224352|FG000|Overall Study|Change in treatment modality|21|||
163140724|NCT01702558|589224353|FG000|Overall Study|Withdrawal by Subject|0|||
163140725|NCT01702558|589224354|FG001|Overall Study|Withdrawal by Subject|0|||
163140726|NCT01702558|589224355|FG002|Overall Study|Withdrawal by Subject|0|||
162662024|NCT00608829|587474722|FG000|Overall Study|Death|6|||
162662025|NCT00608829|587474722|FG000|Overall Study|Withdrawal by Subject|4|||
162662026|NCT00608829|587474722|FG000|Overall Study|Subject refuses to follow up or return.|5|||
162662027|NCT02080091|587474725|FG000|Overall Study|Study Terminated|22|||
162662028|NCT02080091|587474725|FG000|Overall Study|Death|1|||
162662029|NCT02080091|587474725|FG000|Overall Study|Withdrawal by Subject|1|||
162662030|NCT02080091|587474725|FG000|Overall Study|Other|1|||
162662031|NCT03019536|587474727|FG000|Overall Study|Withdrawal by Subject|1|||
162662032|NCT03019536|587474728|FG001|Overall Study|Withdrawal by Subject|1|||
162662033|NCT03019536|587474729|FG002|Overall Study|Withdrawal by Subject|0|||
163140727|NCT01702558|589224356|FG003|Overall Study|Withdrawal by Subject|12|||
163140728|NCT01702558|589224357|FG004|Overall Study|Withdrawal by Subject|4|||
162662034|NCT03019536|587474727|FG000|Overall Study|Adverse Event|0|||
162662035|NCT03019536|587474728|FG001|Overall Study|Adverse Event|0|||
162662036|NCT03019536|587474729|FG002|Overall Study|Adverse Event|2|||
162662037|NCT00317772|587474735|FG000|Overall Study|Adverse Event|0|||
162662038|NCT00317772|587474736|FG001|Overall Study|Adverse Event|0|||
162662039|NCT00317772|587474737|FG002|Overall Study|Adverse Event|0|||
162662040|NCT00317772|587474738|FG003|Overall Study|Adverse Event|2|||
162662041|NCT00317772|587474735|FG000|Overall Study|Disease Progression|2|||
162662042|NCT00317772|587474736|FG001|Overall Study|Disease Progression|2|||
162662043|NCT00317772|587474737|FG002|Overall Study|Disease Progression|1|||
162662044|NCT00317772|587474738|FG003|Overall Study|Disease Progression|7|||
162662045|NCT00966940|587474739|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
162662046|NCT00966940|587474740|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
162662047|NCT00966940|587474739|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
162662048|NCT00966940|587474740|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
162662049|NCT01040871|587474743|FG000|Overall Study|Adverse Event|6|||
162662050|NCT01040871|587474744|FG001|Overall Study|Adverse Event|2|||
162662051|NCT01040871|587474743|FG000|Overall Study|Withdrawal by Subject|2|||
162662052|NCT01040871|587474744|FG001|Overall Study|Withdrawal by Subject|0|||
162662053|NCT01040871|587474743|FG000|Overall Study|Death|1|||
162662054|NCT01040871|587474744|FG001|Overall Study|Death|3|||
162662055|NCT01040871|587474743|FG000|Overall Study|Lack of Efficacy|1|||
162662056|NCT01040871|587474744|FG001|Overall Study|Lack of Efficacy|1|||
162662057|NCT01040871|587474743|FG000|Overall Study|drug supply issue|1|||
162662058|NCT01040871|587474744|FG001|Overall Study|drug supply issue|0|||
162662059|NCT01040871|587474743|FG000|Overall Study|Randomized and Not Treated|2|||
162662060|NCT01040871|587474744|FG001|Overall Study|Randomized and Not Treated|1|||
162662061|NCT02886572|587474745|FG000|Overall Study|Death|8|||
162662062|NCT03087591|587474746|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
162662063|NCT03087591|587474746|FG000|Overall Study|Withdrawal by Subject|1|||
162662064|NCT02621606|587474747|FG000|Overall Study|Withdrawal by Subject|0|||
162662065|NCT02621606|587474748|FG001|Overall Study|Withdrawal by Subject|1|||
162662066|NCT02621606|587474749|FG002|Overall Study|Withdrawal by Subject|0|||
162662067|NCT01175824|587474750|FG000|Overall Study|Adverse Event|2|||
162662068|NCT01175824|587474751|FG001|Overall Study|Adverse Event|1|||
162662069|NCT01175824|587474750|FG000|Overall Study|Lack of Efficacy|2|||
162662070|NCT01175824|587474751|FG001|Overall Study|Lack of Efficacy|0|||
162662071|NCT01175824|587474750|FG000|Overall Study|Lost to Follow-up|0|||
162662072|NCT01175824|587474751|FG001|Overall Study|Lost to Follow-up|1|||
162662073|NCT01175824|587474750|FG000|Overall Study|Physician Decision|0|||
162662074|NCT01175824|587474751|FG001|Overall Study|Physician Decision|4|||
162662075|NCT01175824|587474750|FG000|Overall Study|Protocol Violation|2|||
162662076|NCT01175824|587474751|FG001|Overall Study|Protocol Violation|5|||
162662077|NCT01175824|587474750|FG000|Overall Study|Withdrawal by Subject|3|||
162662078|NCT01175824|587474751|FG001|Overall Study|Withdrawal by Subject|7|||
162662079|NCT01175824|587474750|FG000|Overall Study|Sponsor Decision|1|||
162662080|NCT01175824|587474751|FG001|Overall Study|Sponsor Decision|0|||
162662081|NCT01175824|587474750|FG000|Overall Study|Entry Criteria Not Met|6|||
162720874|NCT02000817|587685956|FG001|Overall Study|Adverse Event|1|||
162662082|NCT01175824|587474751|FG001|Overall Study|Entry Criteria Not Met|4|||
162662083|NCT01774903|587474752|FG000|Overall Study|Adverse Event|7|||
162662084|NCT01774903|587474752|FG000|Overall Study|Withdrawal by Subject|2|||
162662085|NCT01774903|587474752|FG000|Overall Study|Lack of Efficacy|1|||
162662086|NCT01774903|587474752|FG000|Overall Study|Ineligible to continue the trial|1|||
162720875|NCT02000817|587685957|FG002|Overall Study|Adverse Event|0|||
162662087|NCT00982319|587474753|FG000|Overall Study|Surgery date change|1|||
162662088|NCT00982319|587474754|FG001|Overall Study|Surgery date change|0|||
162662089|NCT00982319|587474753|FG000|Overall Study|Preop values out of acceptable range|1|||
162662090|NCT00982319|587474754|FG001|Overall Study|Preop values out of acceptable range|1|||
163140729|NCT01702558|589224353|FG000|Overall Study|Lost to Follow-up|0|||
163140730|NCT01702558|589224354|FG001|Overall Study|Lost to Follow-up|0|||
163140731|NCT01702558|589224355|FG002|Overall Study|Lost to Follow-up|0|||
163140732|NCT01702558|589224356|FG003|Overall Study|Lost to Follow-up|3|||
163140733|NCT01702558|589224357|FG004|Overall Study|Lost to Follow-up|0|||
163140734|NCT01702558|589224353|FG000|Overall Study|Death|4|||
163140735|NCT01702558|589224354|FG001|Overall Study|Death|3|||
162662091|NCT00982319|587474753|FG000|Overall Study|Pregnancy|0|||
162662092|NCT00982319|587474754|FG001|Overall Study|Pregnancy|1|||
162662093|NCT00767000|587474755|FG000|54-week Study|Adverse Event|4|||
163140736|NCT01702558|589224355|FG002|Overall Study|Death|3|||
163140737|NCT01702558|589224356|FG003|Overall Study|Death|16|||
163140738|NCT01702558|589224357|FG004|Overall Study|Death|20|||
162662094|NCT00767000|587474756|FG001|54-week Study|Adverse Event|6|||
162662095|NCT00767000|587474757|FG002|54-week Study|Adverse Event|6|||
162662096|NCT00767000|587474758|FG003|54-week Study|Adverse Event|8|||
162662097|NCT00767000|587474759|FG004|54-week Study|Adverse Event|4|||
162662098|NCT00767000|587474755|FG000|54-week Study|Creaninine/creatinine clearance|2|||
162662099|NCT00767000|587474756|FG001|54-week Study|Creaninine/creatinine clearance|1|||
162662100|NCT00767000|587474757|FG002|54-week Study|Creaninine/creatinine clearance|2|||
162662101|NCT00767000|587474758|FG003|54-week Study|Creaninine/creatinine clearance|2|||
162662102|NCT00767000|587474759|FG004|54-week Study|Creaninine/creatinine clearance|4|||
162662103|NCT00767000|587474755|FG000|54-week Study|Hyperglycemia|0|||
162662104|NCT00767000|587474756|FG001|54-week Study|Hyperglycemia|0|||
162720876|NCT02000817|587685958|FG003|Overall Study|Adverse Event|0|||
162720877|NCT02000817|587685955|FG000|Overall Study|Lost to Follow-up|0|||
162720878|NCT02000817|587685956|FG001|Overall Study|Lost to Follow-up|0|||
162720879|NCT02000817|587685957|FG002|Overall Study|Lost to Follow-up|1|||
162720880|NCT02000817|587685958|FG003|Overall Study|Lost to Follow-up|0|||
162720881|NCT03383146|587685959|FG000|Overall Study|Screen Failure|1|||
163140739|NCT01702558|589224353|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140740|NCT01702558|589224354|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140741|NCT01702558|589224355|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
163140742|NCT01702558|589224356|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140743|NCT01702558|589224357|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
163140744|NCT01702558|589224353|FG000|Overall Study|Study Terminated by Sponsor|0|||
163140745|NCT01702558|589224354|FG001|Overall Study|Study Terminated by Sponsor|1|||
163140746|NCT01702558|589224355|FG002|Overall Study|Study Terminated by Sponsor|0|||
163140747|NCT01702558|589224356|FG003|Overall Study|Study Terminated by Sponsor|0|||
163140748|NCT01702558|589224357|FG004|Overall Study|Study Terminated by Sponsor|1|||
163140749|NCT01702558|589224353|FG000|Overall Study|Other|0|||
163140750|NCT01702558|589224354|FG001|Overall Study|Other|0|||
163140751|NCT01702558|589224355|FG002|Overall Study|Other|0|||
163140752|NCT01702558|589224356|FG003|Overall Study|Other|16|||
163140753|NCT01702558|589224357|FG004|Overall Study|Other|17|||
163140754|NCT03259087|589224363|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140755|NCT03259087|589224364|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140756|NCT03259087|589224365|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140757|NCT03259087|589224366|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
163140758|NCT03259087|589224367|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
163140759|NCT03259087|589224363|FG000|Period 2 of Part 2|Adverse Event|0|||
163140760|NCT03259087|589224364|FG001|Period 2 of Part 2|Adverse Event|0|||
163140761|NCT03259087|589224365|FG002|Period 2 of Part 2|Adverse Event|0|||
163140762|NCT03259087|589224366|FG003|Period 2 of Part 2|Adverse Event|0|||
163140763|NCT03259087|589224367|FG004|Period 2 of Part 2|Adverse Event|1|||
163140764|NCT04524858|589224368|FG000|Overall Study|Adverse Event|1|||
163140765|NCT03571204|589224369|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
163140766|NCT03571204|589224370|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
163140767|NCT03571204|589224371|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
163140768|NCT03571204|589224369|FG000|Overall Study|Physician Decision|0|||
163140769|NCT03571204|589224370|FG001|Overall Study|Physician Decision|1|||
163140770|NCT03571204|589224371|FG002|Overall Study|Physician Decision|0|||
163140771|NCT02396212|589224372|FG000|Overall Study|Adverse Event|1|||
163140772|NCT02396212|589224372|FG000|Overall Study|Lack of Efficacy|2|||
163140773|NCT01623115|589224373|FG000|Overall Study|Randomized but not treated|0|||
163140774|NCT01623115|589224374|FG001|Overall Study|Randomized but not treated|1|||
163140775|NCT01623115|589224373|FG000|Overall Study|Physician Decision|1|||
163140776|NCT01623115|589224374|FG001|Overall Study|Physician Decision|0|||
163140777|NCT01623115|589224373|FG000|Overall Study|Participants moved|1|||
163140778|NCT01623115|589224374|FG001|Overall Study|Participants moved|5|||
163140779|NCT01623115|589224373|FG000|Overall Study|Adverse Event|10|||
163140780|NCT01623115|589224374|FG001|Overall Study|Adverse Event|13|||
163140781|NCT01623115|589224373|FG000|Overall Study|Poor compliance to protocol|4|||
163140782|NCT01623115|589224374|FG001|Overall Study|Poor compliance to protocol|10|||
163140783|NCT01623115|589224373|FG000|Overall Study|Consent withdrawn by participant|2|||
163140784|NCT01623115|589224374|FG001|Overall Study|Consent withdrawn by participant|6|||
163140785|NCT01623115|589224373|FG000|Overall Study|Related to study drug administration|0|||
163140786|NCT01623115|589224374|FG001|Overall Study|Related to study drug administration|2|||
163140787|NCT01623115|589224373|FG000|Overall Study|Last visit outside protocol visit window|14|||
163140788|NCT01623115|589224374|FG001|Overall Study|Last visit outside protocol visit window|26|||
163140789|NCT01623115|589224373|FG000|Overall Study|Site closure|1|||
163140790|NCT01623115|589224374|FG001|Overall Study|Site closure|7|||
163140791|NCT01623115|589224373|FG000|Overall Study|Death|0|||
163140792|NCT01623115|589224374|FG001|Overall Study|Death|4|||
163140793|NCT01623115|589224373|FG000|Overall Study|Other than specified above|0|||
162662105|NCT00767000|587474757|FG002|54-week Study|Hyperglycemia|1|||
162662106|NCT00767000|587474758|FG003|54-week Study|Hyperglycemia|0|||
163140794|NCT01623115|589224374|FG001|Overall Study|Other than specified above|3|||
162720882|NCT03383146|587685960|FG001|Overall Study|Screen Failure|0|||
162720883|NCT03383146|587685959|FG000|Overall Study|Adverse Event|6|||
162662107|NCT00767000|587474759|FG004|54-week Study|Hyperglycemia|1|||
162662108|NCT00767000|587474755|FG000|54-week Study|Hypoglycemia|0|||
162662109|NCT00767000|587474756|FG001|54-week Study|Hypoglycemia|1|||
162662110|NCT00767000|587474757|FG002|54-week Study|Hypoglycemia|0|||
162662111|NCT00767000|587474758|FG003|54-week Study|Hypoglycemia|0|||
162662112|NCT00767000|587474759|FG004|54-week Study|Hypoglycemia|0|||
162662113|NCT00767000|587474755|FG000|54-week Study|Interruption of study medication|0|||
162662114|NCT00767000|587474756|FG001|54-week Study|Interruption of study medication|0|||
162662115|NCT00767000|587474757|FG002|54-week Study|Interruption of study medication|1|||
162662116|NCT00767000|587474758|FG003|54-week Study|Interruption of study medication|0|||
162662117|NCT00767000|587474759|FG004|54-week Study|Interruption of study medication|0|||
162662118|NCT00767000|587474755|FG000|54-week Study|Lack of Efficacy|2|||
162662119|NCT00767000|587474756|FG001|54-week Study|Lack of Efficacy|0|||
162662120|NCT00767000|587474757|FG002|54-week Study|Lack of Efficacy|1|||
162662121|NCT00767000|587474758|FG003|54-week Study|Lack of Efficacy|0|||
162662122|NCT00767000|587474759|FG004|54-week Study|Lack of Efficacy|5|||
162662123|NCT00767000|587474755|FG000|54-week Study|Lost to Follow-up|4|||
162662124|NCT00767000|587474756|FG001|54-week Study|Lost to Follow-up|0|||
162662125|NCT00767000|587474757|FG002|54-week Study|Lost to Follow-up|1|||
162662126|NCT00767000|587474758|FG003|54-week Study|Lost to Follow-up|4|||
162662127|NCT00767000|587474759|FG004|54-week Study|Lost to Follow-up|2|||
162662128|NCT00767000|587474755|FG000|54-week Study|Physician Decision|4|||
162662129|NCT00767000|587474756|FG001|54-week Study|Physician Decision|0|||
162662130|NCT00767000|587474757|FG002|54-week Study|Physician Decision|1|||
162662131|NCT00767000|587474758|FG003|54-week Study|Physician Decision|1|||
162662132|NCT00767000|587474759|FG004|54-week Study|Physician Decision|1|||
162662133|NCT00767000|587474755|FG000|54-week Study|Progressive disease|0|||
162662134|NCT00767000|587474756|FG001|54-week Study|Progressive disease|0|||
162662135|NCT00767000|587474757|FG002|54-week Study|Progressive disease|1|||
162662136|NCT00767000|587474758|FG003|54-week Study|Progressive disease|0|||
162662137|NCT00767000|587474759|FG004|54-week Study|Progressive disease|0|||
162662138|NCT00767000|587474755|FG000|54-week Study|Protocol Violation|0|||
162662139|NCT00767000|587474756|FG001|54-week Study|Protocol Violation|0|||
162662140|NCT00767000|587474757|FG002|54-week Study|Protocol Violation|1|||
162662141|NCT00767000|587474758|FG003|54-week Study|Protocol Violation|2|||
162662142|NCT00767000|587474759|FG004|54-week Study|Protocol Violation|0|||
162662143|NCT00767000|587474755|FG000|54-week Study|Withdrawal by Subject|2|||
162662144|NCT00767000|587474756|FG001|54-week Study|Withdrawal by Subject|3|||
162662145|NCT00767000|587474757|FG002|54-week Study|Withdrawal by Subject|5|||
162662146|NCT00767000|587474758|FG003|54-week Study|Withdrawal by Subject|11|||
162662147|NCT00767000|587474759|FG004|54-week Study|Withdrawal by Subject|13|||
162720884|NCT03383146|587685960|FG001|Overall Study|Adverse Event|18|||
162662148|NCT00767000|587474755|FG000|54-week Study|Study terminated by sponsor|90|||
162662149|NCT00767000|587474756|FG001|54-week Study|Study terminated by sponsor|102|||
162662150|NCT00767000|587474757|FG002|54-week Study|Study terminated by sponsor|89|||
162662151|NCT00767000|587474758|FG003|54-week Study|Study terminated by sponsor|196|||
163140795|NCT04950465|589224375|FG000|Overall Study|Lost to Follow-up|1|||
163140796|NCT04950465|589224376|FG001|Overall Study|Lost to Follow-up|0|||
163140797|NCT04950465|589224377|FG002|Overall Study|Lost to Follow-up|0|||
163140798|NCT01788566|589224380|FG000|Overall Study|Death|4|||
163140799|NCT01788566|589224380|FG000|Overall Study|Adverse Event|1|||
163140800|NCT01788566|589224380|FG000|Overall Study|Clinical Progressive Disease|3|||
163140801|NCT00857285|589224383|FG000|Overall Study|Adverse Event|4|||
163140802|NCT00857285|589224384|FG001|Overall Study|Adverse Event|2|||
163140803|NCT00857285|589224383|FG000|Overall Study|Lack of Efficacy|0|||
163140804|NCT00857285|589224384|FG001|Overall Study|Lack of Efficacy|2|||
163140805|NCT00857285|589224383|FG000|Overall Study|Protocol Violation|3|||
163140806|NCT00857285|589224384|FG001|Overall Study|Protocol Violation|1|||
163140807|NCT00857285|589224383|FG000|Overall Study|Withdrawal by Subject|4|||
163140808|NCT00857285|589224384|FG001|Overall Study|Withdrawal by Subject|0|||
163140809|NCT00857285|589224383|FG000|Overall Study|Randomization criteria not met|1|||
163140810|NCT00857285|589224384|FG001|Overall Study|Randomization criteria not met|1|||
163140811|NCT04797780|589224385|FG000|Overall Study|Lost to Follow-up|1|||
163140812|NCT04797780|589224386|FG001|Overall Study|Lost to Follow-up|1|||
163140813|NCT04797780|589224385|FG000|Overall Study|Withdrawal by Subject|14|||
163140814|NCT04797780|589224386|FG001|Overall Study|Withdrawal by Subject|9|||
163140815|NCT04797780|589224385|FG000|Overall Study|Death|49|||
163140816|NCT04797780|589224386|FG001|Overall Study|Death|20|||
163140817|NCT02940496|589224387|FG000|Overall Study|Adverse Event|1|||
163140818|NCT02940496|589224388|FG001|Overall Study|Adverse Event|0|||
163140819|NCT02940496|589224387|FG000|Overall Study|Death|2|||
163140820|NCT02940496|589224388|FG001|Overall Study|Death|0|||
163140821|NCT02940496|589224387|FG000|Overall Study|Hospice Care|1|||
163140822|NCT02940496|589224388|FG001|Overall Study|Hospice Care|0|||
163140823|NCT02940496|589224387|FG000|Overall Study|No MRE Done|1|||
163140824|NCT02940496|589224388|FG001|Overall Study|No MRE Done|0|||
163140825|NCT02940496|589224387|FG000|Overall Study|MRE Failure|1|||
163140826|NCT02940496|589224388|FG001|Overall Study|MRE Failure|0|||
163140827|NCT05973006|589224389|FG000|Overall Study|Early termination|3|||
163140828|NCT05973006|589224390|FG001|Overall Study|Early termination|9|||
163140829|NCT05167825|589224391|FG000|Overall Study|Ongoing|3|||
163140830|NCT01807598|589224392|FG000|Overall Study|Withdrawal by Subject|4|||
163140831|NCT01807598|589224392|FG000|Overall Study|Adverse Event|1|||
163140832|NCT01807598|589224392|FG000|Overall Study|Other Physician Decision|1|||
163140833|NCT03622814|589224404|FG000|Overall Study|Lost to Follow-up|8|||
163140834|NCT03622814|589224405|FG001|Overall Study|Lost to Follow-up|14|||
163140835|NCT04417361|589224406|FG000|Overall Study|Withdrawal by Subject|1|||
163140836|NCT04417361|589224407|FG001|Overall Study|Withdrawal by Subject|0|||
163140837|NCT04417361|589224406|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
163140838|NCT04417361|589224407|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
163140839|NCT00165672|589224408|FG000|Overall Study|Adverse Event|0|||
163140840|NCT00165672|589224409|FG001|Overall Study|Adverse Event|1|||
163140841|NCT03868943|589224410|FG000|Overall Study|Adverse Event|1|||
163140842|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
163140843|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
163140844|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
163140845|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
163140846|NCT03543137|589224413|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
163140847|NCT03543137|589224414|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
163140848|NCT01045694|589224415|FG000|Overall Study|Withdrawal by Subject|2|||
163140849|NCT01900652|589224416|FG000|Overall Study|Progressive Disease|1|||
163140850|NCT01900652|589224417|FG001|Overall Study|Progressive Disease|0|||
163140851|NCT01900652|589224416|FG000|Overall Study|Consent withdrawn by subject|1|||
163140852|NCT01900652|589224417|FG001|Overall Study|Consent withdrawn by subject|1|||
163140853|NCT01900652|589224416|FG000|Overall Study|Death|3|||
163140854|NCT01900652|589224417|FG001|Overall Study|Death|0|||
163140855|NCT01900652|589224416|FG000|Overall Study|Adverse Event|2|||
163140856|NCT01900652|589224417|FG001|Overall Study|Adverse Event|1|||
163140857|NCT01900652|589224416|FG000|Overall Study|Physician Decision|1|||
163140858|NCT01900652|589224417|FG001|Overall Study|Physician Decision|1|||
163140859|NCT03761810|589224418|FG000|Overall Study|Adverse Event|12|||
163140860|NCT03761810|589224419|FG001|Overall Study|Adverse Event|0|||
163140861|NCT03761810|589224418|FG000|Overall Study|Lost to Follow-up|15|||
163140862|NCT03761810|589224419|FG001|Overall Study|Lost to Follow-up|7|||
162662152|NCT00767000|587474759|FG004|54-week Study|Study terminated by sponsor|194|||
162662153|NCT00767000|587474755|FG000|54-week Study|Reason not reported|0|||
162662154|NCT00767000|587474756|FG001|54-week Study|Reason not reported|0|||
162662155|NCT00767000|587474757|FG002|54-week Study|Reason not reported|0|||
162662156|NCT00767000|587474758|FG003|54-week Study|Reason not reported|1|||
162662157|NCT00767000|587474759|FG004|54-week Study|Reason not reported|0|||
162662158|NCT00767000|587474755|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
162662159|NCT00767000|587474756|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
162662160|NCT00767000|587474757|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
162662161|NCT00767000|587474758|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
162662162|NCT00767000|587474759|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
162662163|NCT01252251|587474766|FG000|Overall Study|Withdrawal by Subject|1|||
162662164|NCT01324024|587474767|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
162662165|NCT01324024|587474768|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162662166|NCT00097591|587474770|FG000|Overall Study|Withdrawal of consent|342|||
162662167|NCT00097591|587474771|FG001|Overall Study|Withdrawal of consent|323|||
162662168|NCT00097591|587474770|FG000|Overall Study|Less than 6 months on study drug|9|||
162662169|NCT00097591|587474771|FG001|Overall Study|Less than 6 months on study drug|7|||
162662170|NCT00097591|587474770|FG000|Overall Study|Unable to attend termination visit|53|||
162662171|NCT00097591|587474771|FG001|Overall Study|Unable to attend termination visit|51|||
162662172|NCT00097591|587474770|FG000|Overall Study|Lost to follow up|6|||
162662173|NCT00097591|587474771|FG001|Overall Study|Lost to follow up|10|||
162662174|NCT00097591|587474770|FG000|Overall Study|Other|0|||
162662175|NCT00097591|587474771|FG001|Overall Study|Other|3|||
162662176|NCT01743092|587474772|FG000|Overall Study|Lost to Follow-up|14|||
162662177|NCT01743092|587474773|FG001|Overall Study|Lost to Follow-up|15|||
162662178|NCT03603964|587474774|FG000|Overall Study|Death|9|||
162662179|NCT03603964|587474774|FG000|Overall Study|Withdrawal by participant|7|||
162662180|NCT03603964|587474774|FG000|Overall Study|Study terminated by Sponsor|19|||
162662181|NCT00563797|587474775|FG000|Overall Study|Lost to Follow-up|7|||
162662182|NCT00563797|587474776|FG001|Overall Study|Lost to Follow-up|2|||
162662183|NCT00009737|587474779|FG000|Overall Study|Adverse Event|112|||
162662184|NCT00009737|587474780|FG001|Overall Study|Adverse Event|75|||
162662185|NCT00009737|587474779|FG000|Overall Study|Death|4|||
162662186|NCT00009737|587474780|FG001|Overall Study|Death|6|||
162662187|NCT00009737|587474779|FG000|Overall Study|Lack of Efficacy|17|||
162662188|NCT00009737|587474780|FG001|Overall Study|Lack of Efficacy|15|||
162662189|NCT00009737|587474779|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
162662190|NCT00009737|587474780|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
162662191|NCT00009737|587474779|FG000|Overall Study|Other Protocol Violation|1|||
162662192|NCT00009737|587474780|FG001|Overall Study|Other Protocol Violation|0|||
162662193|NCT00009737|587474779|FG000|Overall Study|Refused Treatment|15|||
162662194|NCT00009737|587474780|FG001|Overall Study|Refused Treatment|16|||
162662195|NCT00009737|587474779|FG000|Overall Study|Lost to Follow-up|1|||
162662196|NCT00009737|587474780|FG001|Overall Study|Lost to Follow-up|1|||
162662197|NCT00009737|587474779|FG000|Overall Study|Administrative/Other Reasons|7|||
162662198|NCT00009737|587474780|FG001|Overall Study|Administrative/Other Reasons|1|||
162662199|NCT00530023|587474781|FG000|Overall Study|Withdrawal by Subject|0|||
162662200|NCT00530023|587474782|FG001|Overall Study|Withdrawal by Subject|1|||
162662201|NCT00003498|587474783|FG000|Overall Study|Not evaluable.|4|||
162662202|NCT01416805|587474793|FG000|Overall Study|Lost to Follow-up|4|||
162662203|NCT01416805|587474794|FG001|Overall Study|Lost to Follow-up|4|||
162662204|NCT02604589|587474801|FG000|Overall Study|catheter dislodgement|0|||
162662205|NCT02604589|587474802|FG001|Overall Study|catheter dislodgement|0|||
162662206|NCT02604589|587474803|FG002|Overall Study|catheter dislodgement|1|||
163140863|NCT03761810|589224418|FG000|Overall Study|Pregnancy|1|||
163140864|NCT03761810|589224419|FG001|Overall Study|Pregnancy|0|||
162662207|NCT04632940|587474812|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
162662208|NCT04632940|587474813|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
162662209|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
162662210|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
162662211|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
162662212|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
162662213|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
162662214|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
162662215|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
162662216|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
162662217|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
162662218|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
162662219|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Other than specified|0|||
163140865|NCT03761810|589224418|FG000|Overall Study|Withdrawal by Subject|14|||
163140866|NCT03761810|589224419|FG001|Overall Study|Withdrawal by Subject|5|||
163140867|NCT03761810|589224418|FG000|Overall Study|Physician Decision|1|||
163140868|NCT03761810|589224419|FG001|Overall Study|Physician Decision|0|||
163140869|NCT03761810|589224418|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
163140870|NCT03761810|589224419|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163140871|NCT03761810|589224418|FG000|Overall Study|Other Than Specified|1|||
163140872|NCT03761810|589224419|FG001|Overall Study|Other Than Specified|0|||
163140873|NCT00869518|589224420|FG000|Overall Study|Lost to Follow-up|1|||
163140874|NCT00869518|589224421|FG001|Overall Study|Lost to Follow-up|1|||
163140875|NCT04178720|589224422|FG000|Overall Study|Withdrawal by Subject|2|||
163140876|NCT04178720|589224423|FG001|Overall Study|Withdrawal by Subject|0|||
163140877|NCT04178720|589224422|FG000|Overall Study|Relocation|0|||
163140878|NCT04178720|589224423|FG001|Overall Study|Relocation|1|||
163140879|NCT03922620|589224424|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
163140880|NCT03922620|589224425|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
163140881|NCT00511238|589224426|FG000|Overall Study|Adverse Event|13|||
163140882|NCT00511238|589224427|FG001|Overall Study|Adverse Event|33|||
163140883|NCT00511238|589224426|FG000|Overall Study|Withdrawal by Subject|2|||
163140884|NCT00511238|589224427|FG001|Overall Study|Withdrawal by Subject|22|||
163140885|NCT00511238|589224426|FG000|Overall Study|Progressive Disease|23|||
163140886|NCT00511238|589224427|FG001|Overall Study|Progressive Disease|157|||
163140887|NCT00511238|589224426|FG000|Overall Study|various reasons|4|||
163140888|NCT00511238|589224427|FG001|Overall Study|various reasons|14|||
163140889|NCT01633788|589226126|FG000|Overall Study|Adverse Event|1|||
163140890|NCT01633788|589226127|FG001|Overall Study|Adverse Event|3|||
163140891|NCT01633788|589226128|FG002|Overall Study|Adverse Event|3|||
163140892|NCT01633788|589226129|FG003|Overall Study|Adverse Event|3|||
163140893|NCT01633788|589226126|FG000|Overall Study|Lost to Follow-up|2|||
163140894|NCT01633788|589226127|FG001|Overall Study|Lost to Follow-up|2|||
163140895|NCT01633788|589226128|FG002|Overall Study|Lost to Follow-up|2|||
163140896|NCT01633788|589226129|FG003|Overall Study|Lost to Follow-up|0|||
163140897|NCT01633788|589226126|FG000|Overall Study|Personal Reasons|3|||
163140898|NCT01633788|589226127|FG001|Overall Study|Personal Reasons|1|||
163140899|NCT01633788|589226128|FG002|Overall Study|Personal Reasons|1|||
163140900|NCT01633788|589226129|FG003|Overall Study|Personal Reasons|3|||
163140901|NCT01633788|589226126|FG000|Overall Study|Protocol Violation|1|||
163140902|NCT01633788|589226127|FG001|Overall Study|Protocol Violation|0|||
163140903|NCT01633788|589226128|FG002|Overall Study|Protocol Violation|1|||
163140904|NCT01633788|589226129|FG003|Overall Study|Protocol Violation|0|||
163140905|NCT01633788|589226126|FG000|Overall Study|Other Reasons|0|||
163140906|NCT01633788|589226127|FG001|Overall Study|Other Reasons|2|||
163140907|NCT01633788|589226128|FG002|Overall Study|Other Reasons|3|||
163140908|NCT01633788|589226129|FG003|Overall Study|Other Reasons|7|||
163140909|NCT01389882|589226135|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
163140910|NCT01389882|589226136|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
163140911|NCT01389882|589226135|FG000|Overall Study|Withdrawal by Subject|0|||
163140912|NCT01389882|589226136|FG001|Overall Study|Withdrawal by Subject|1|||
163140913|NCT03811340|589226138|FG000|Overall Study|subjects did not complete the survey.|90|||
163140914|NCT01045967|589226139|FG000|Second Intervention|Protocol Violation|0|||
163140915|NCT01045967|589226140|FG001|Second Intervention|Protocol Violation|1|||
163140916|NCT00404651|589226142|FG000|Overall Study|Serious Adverse Event|0|||
163140917|NCT00404651|589226143|FG001|Overall Study|Serious Adverse Event|0|||
163140918|NCT00404651|589226144|FG002|Overall Study|Serious Adverse Event|2|||
163140919|NCT00404651|589226145|FG003|Overall Study|Serious Adverse Event|0|||
163140920|NCT00404651|589226142|FG000|Overall Study|Protocol Violation|10|||
163140921|NCT00404651|589226143|FG001|Overall Study|Protocol Violation|5|||
163140922|NCT00404651|589226144|FG002|Overall Study|Protocol Violation|14|||
163140923|NCT00404651|589226145|FG003|Overall Study|Protocol Violation|5|||
163140924|NCT00404651|589226142|FG000|Overall Study|Lost to Follow-up|15|||
163140925|NCT00404651|589226143|FG001|Overall Study|Lost to Follow-up|11|||
163140926|NCT00404651|589226144|FG002|Overall Study|Lost to Follow-up|13|||
163140927|NCT00404651|589226145|FG003|Overall Study|Lost to Follow-up|10|||
163140928|NCT00404651|589226142|FG000|Overall Study|Withdrawal by Subject|14|||
163140929|NCT00404651|589226143|FG001|Overall Study|Withdrawal by Subject|12|||
163140930|NCT00404651|589226144|FG002|Overall Study|Withdrawal by Subject|16|||
163140931|NCT00404651|589226145|FG003|Overall Study|Withdrawal by Subject|6|||
163140932|NCT02471014|589226158|FG000|Overall Study|Lost to Follow-up|2|||
163140933|NCT02471014|589226159|FG001|Overall Study|Lost to Follow-up|2|||
163140934|NCT02532465|589226169|FG000|Overall Study|Protocol Violation|1|||
162662220|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Other than specified|1|||
162662221|NCT04632940|587474812|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
163140935|NCT02532465|589226170|FG001|Overall Study|Protocol Violation|0|||
163140936|NCT02532465|589226169|FG000|Overall Study|Lack of Efficacy|0|||
163140937|NCT02532465|589226170|FG001|Overall Study|Lack of Efficacy|1|||
163140938|NCT02045095|589226178|FG000|Overall Study|Other|0|||
163140939|NCT02045095|589226179|FG001|Overall Study|Other|0|||
162720885|NCT03383146|587685959|FG000|Overall Study|Lack of Efficacy|0|||
162662222|NCT04632940|587474813|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
162662223|NCT00179647|587474817|FG000|Overall Study|Adverse Event|294|||
162662224|NCT00179647|587474817|FG000|Overall Study|Lack of Efficacy|478|||
162662225|NCT00179647|587474817|FG000|Overall Study|Withdrawal by Subject|83|||
162662226|NCT00179647|587474817|FG000|Overall Study|Lost to Follow-up|4|||
162662227|NCT00179647|587474817|FG000|Overall Study|Death|94|||
162662228|NCT00179647|587474817|FG000|Overall Study|Other|960|||
162662229|NCT00622635|587474818|FG000|Treatment Period 1|Adverse Event|0|||
163140940|NCT02045095|589226180|FG002|Overall Study|Other|1|||
163140941|NCT02045095|589226181|FG003|Overall Study|Other|0|||
163140942|NCT02045095|589226182|FG004|Overall Study|Other|0|||
163140943|NCT02045095|589226183|FG005|Overall Study|Other|2|||
163140944|NCT02045095|589226184|FG006|Overall Study|Other|0|||
163140945|NCT02045095|589226178|FG000|Overall Study|Progressive Disease|3|||
163140946|NCT02045095|589226179|FG001|Overall Study|Progressive Disease|3|||
163140947|NCT02045095|589226180|FG002|Overall Study|Progressive Disease|2|||
163140948|NCT02045095|589226181|FG003|Overall Study|Progressive Disease|4|||
163140949|NCT02045095|589226182|FG004|Overall Study|Progressive Disease|2|||
163140950|NCT02045095|589226183|FG005|Overall Study|Progressive Disease|4|||
163140951|NCT02045095|589226184|FG006|Overall Study|Progressive Disease|1|||
163140952|NCT02045095|589226178|FG000|Overall Study|Withdrawal by Subject|0|||
163140953|NCT02045095|589226179|FG001|Overall Study|Withdrawal by Subject|0|||
163140954|NCT02045095|589226180|FG002|Overall Study|Withdrawal by Subject|0|||
163140955|NCT02045095|589226181|FG003|Overall Study|Withdrawal by Subject|0|||
163140956|NCT02045095|589226182|FG004|Overall Study|Withdrawal by Subject|3|||
163140957|NCT02045095|589226183|FG005|Overall Study|Withdrawal by Subject|0|||
163140958|NCT02045095|589226184|FG006|Overall Study|Withdrawal by Subject|0|||
163140959|NCT02045095|589226178|FG000|Overall Study|Adverse Event|0|||
163140960|NCT02045095|589226179|FG001|Overall Study|Adverse Event|1|||
163140961|NCT02045095|589226180|FG002|Overall Study|Adverse Event|1|||
163140962|NCT02045095|589226181|FG003|Overall Study|Adverse Event|0|||
163140963|NCT02045095|589226182|FG004|Overall Study|Adverse Event|0|||
163140964|NCT02045095|589226183|FG005|Overall Study|Adverse Event|2|||
163140965|NCT02045095|589226184|FG006|Overall Study|Adverse Event|0|||
163140966|NCT01450761|589226187|FG000|Randomization|Subject no longer meets study criteria|1|||
163140967|NCT01450761|589226188|FG001|Randomization|Subject no longer meets study criteria|2|||
163140968|NCT01450761|589226187|FG000|Randomization|Withdrawal by Subject|2|||
163140969|NCT01450761|589226188|FG001|Randomization|Withdrawal by Subject|0|||
163140970|NCT01450761|589226187|FG000|Randomization|Disease progression|0|||
163140971|NCT01450761|589226188|FG001|Randomization|Disease progression|2|||
163140972|NCT01450761|589226187|FG000|Randomization|Adverse Event unrelated to study drug|1|||
163140973|NCT01450761|589226188|FG001|Randomization|Adverse Event unrelated to study drug|0|||
163140974|NCT01450761|589226187|FG000|Randomization|Other|0|||
163140975|NCT01450761|589226188|FG001|Randomization|Other|1|||
163140976|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Disease progression|33|||
163140977|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Disease progression|32|||
163140978|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
163140979|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
163140980|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
163140981|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
163140982|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
163140983|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
163140984|NCT01450761|589226187|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
163140985|NCT01450761|589226188|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
163140986|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Death|3|||
163140987|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Death|3|||
163140988|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Other|2|||
163140989|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Other|2|||
163140990|NCT01450761|589226187|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
163140991|NCT01450761|589226188|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
163140992|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
163140993|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
163140994|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
163140995|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
163140996|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
163140997|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
162662230|NCT00622635|587474819|FG001|Treatment Period 1|Adverse Event|0|||
163140998|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
162662231|NCT00622635|587474820|FG002|Treatment Period 1|Adverse Event|1|||
163140999|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
163141000|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
163141001|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
163141002|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Death|5|||
163141003|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Death|6|||
163141004|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
163141005|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
163141006|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
163141007|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
163141008|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
163141009|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
163141010|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
163141011|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
163141012|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
163141013|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
163141014|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
163141015|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
163141016|NCT01450761|589226187|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
163141017|NCT01450761|589226188|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
163141018|NCT01818596|589226189|FG000|Overall Study|Enrolled but Not Treated|4|||
163141019|NCT01818596|589226190|FG001|Overall Study|Enrolled but Not Treated|0|||
163141020|NCT01818596|589226189|FG000|Overall Study|Adverse Event|7|||
163141021|NCT01818596|589226190|FG001|Overall Study|Adverse Event|0|||
163141022|NCT01818596|589226189|FG000|Overall Study|Death|3|||
163141023|NCT01818596|589226190|FG001|Overall Study|Death|0|||
163141024|NCT01818596|589226189|FG000|Overall Study|Investigator's Discretion|4|||
163141025|NCT01818596|589226190|FG001|Overall Study|Investigator's Discretion|0|||
163141026|NCT01818596|589226189|FG000|Overall Study|Protocol Violation|1|||
163141027|NCT01818596|589226190|FG001|Overall Study|Protocol Violation|0|||
163141028|NCT01818596|589226189|FG000|Overall Study|Withdrew Consent|5|||
163141029|NCT01818596|589226190|FG001|Overall Study|Withdrew Consent|0|||
163141030|NCT01818596|589226189|FG000|Overall Study|Lost to Follow-up|7|||
163141031|NCT01818596|589226190|FG001|Overall Study|Lost to Follow-up|0|||
163141032|NCT03801174|589226191|FG000|Overall Study|Withdrawal by Subject|14|||
163141033|NCT03801174|589226192|FG001|Overall Study|Withdrawal by Subject|15|||
163141034|NCT03801174|589226191|FG000|Overall Study|Death|1|||
163141035|NCT03801174|589226192|FG001|Overall Study|Death|0|||
163141036|NCT03801174|589226191|FG000|Overall Study|Pregnancy|2|||
163141037|NCT03801174|589226192|FG001|Overall Study|Pregnancy|2|||
163141038|NCT03801174|589226191|FG000|Overall Study|Lost to Follow-up|19|||
163141039|NCT03801174|589226192|FG001|Overall Study|Lost to Follow-up|10|||
163141040|NCT03801174|589226191|FG000|Overall Study|Other|4|||
163141041|NCT03801174|589226192|FG001|Overall Study|Other|3|||
163141042|NCT03801174|589226191|FG000|Overall Study|Lack of Efficacy|4|||
163141043|NCT03801174|589226192|FG001|Overall Study|Lack of Efficacy|0|||
163141044|NCT03801174|589226191|FG000|Overall Study|Unwilling to complete activities|5|||
163141045|NCT03801174|589226192|FG001|Overall Study|Unwilling to complete activities|6|||
163141046|NCT03801174|589226191|FG000|Overall Study|Moved out of area|3|||
163141047|NCT03801174|589226192|FG001|Overall Study|Moved out of area|0|||
163141048|NCT04112810|589226193|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
163141049|NCT01539759|589226195|FG000|Overall Study|Lost to Follow-up|6|||
163141050|NCT01539759|589226196|FG001|Overall Study|Lost to Follow-up|8|||
163141051|NCT01076959|589226197|FG000|Overall Study|Adverse Event|767|||
163141052|NCT01076959|589226197|FG000|Overall Study|Lack of Efficacy|849|||
163141053|NCT01076959|589226197|FG000|Overall Study|Non-compliance|274|||
163141054|NCT01076959|589226197|FG000|Overall Study|Lost to Follow-up|241|||
163141055|NCT01076959|589226197|FG000|Overall Study|Other|119|||
163141056|NCT04170543|589226201|FG000|Overall Study|Death|1|||
163141057|NCT04170543|589226202|FG001|Overall Study|Death|1|||
163141058|NCT04170543|589226203|FG002|Overall Study|Death|1|||
163141059|NCT04170543|589226204|FG003|Overall Study|Death|1|||
163141060|NCT04170543|589226205|FG004|Overall Study|Death|1|||
163141061|NCT04170543|589226201|FG000|Overall Study|Lost to Follow-up|3|||
163141062|NCT04170543|589226202|FG001|Overall Study|Lost to Follow-up|3|||
163141063|NCT04170543|589226203|FG002|Overall Study|Lost to Follow-up|0|||
163141064|NCT04170543|589226204|FG003|Overall Study|Lost to Follow-up|3|||
163141065|NCT04170543|589226205|FG004|Overall Study|Lost to Follow-up|1|||
163141066|NCT04170543|589226201|FG000|Overall Study|Withdrawal by Subject|13|||
163141067|NCT04170543|589226202|FG001|Overall Study|Withdrawal by Subject|6|||
163141068|NCT04170543|589226203|FG002|Overall Study|Withdrawal by Subject|5|||
163141069|NCT04170543|589226204|FG003|Overall Study|Withdrawal by Subject|4|||
163141070|NCT04170543|589226205|FG004|Overall Study|Withdrawal by Subject|9|||
163141071|NCT04170543|589226201|FG000|Overall Study|Not able to transition to phase 2b|8|||
163141072|NCT04170543|589226202|FG001|Overall Study|Not able to transition to phase 2b|0|||
163141073|NCT04170543|589226203|FG002|Overall Study|Not able to transition to phase 2b|10|||
163141074|NCT04170543|589226204|FG003|Overall Study|Not able to transition to phase 2b|0|||
163141075|NCT04170543|589226205|FG004|Overall Study|Not able to transition to phase 2b|6|||
163141076|NCT04170543|589226201|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
163141077|NCT04170543|589226202|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
163141078|NCT04170543|589226203|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
162662232|NCT00622635|587474821|FG003|Treatment Period 1|Adverse Event|0|||
162662233|NCT00622635|587474822|FG004|Treatment Period 1|Adverse Event|0|||
162662234|NCT00622635|587474823|FG005|Treatment Period 1|Adverse Event|0|||
162662235|NCT00622635|587474818|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162662236|NCT00622635|587474819|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162662237|NCT00622635|587474820|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162662238|NCT00622635|587474821|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162662239|NCT00622635|587474822|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162662240|NCT00622635|587474823|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162662241|NCT00622635|587474818|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
162662242|NCT00622635|587474819|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
162662243|NCT00622635|587474820|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
162662244|NCT00622635|587474821|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
162662245|NCT00622635|587474822|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
162662246|NCT00622635|587474823|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
162662247|NCT00622635|587474818|FG000|Treatment Period 2|Adverse Event|1|||
162662248|NCT00622635|587474819|FG001|Treatment Period 2|Adverse Event|0|||
162662249|NCT00622635|587474820|FG002|Treatment Period 2|Adverse Event|0|||
162662250|NCT00622635|587474821|FG003|Treatment Period 2|Adverse Event|0|||
162662251|NCT00622635|587474822|FG004|Treatment Period 2|Adverse Event|0|||
162662252|NCT00622635|587474823|FG005|Treatment Period 2|Adverse Event|0|||
162662253|NCT00622635|587474818|FG000|Treatment Period 3|Adverse Event|0|||
162662254|NCT00622635|587474819|FG001|Treatment Period 3|Adverse Event|0|||
162662255|NCT00622635|587474820|FG002|Treatment Period 3|Adverse Event|0|||
162662256|NCT00622635|587474821|FG003|Treatment Period 3|Adverse Event|2|||
162662257|NCT00622635|587474822|FG004|Treatment Period 3|Adverse Event|0|||
162662258|NCT00622635|587474823|FG005|Treatment Period 3|Adverse Event|0|||
162662259|NCT00622635|587474818|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162662260|NCT00622635|587474819|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162662261|NCT00622635|587474820|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162662262|NCT00622635|587474821|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162662263|NCT00622635|587474822|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162662264|NCT00622635|587474823|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162662265|NCT05013905|587474824|FG000|Overall Study|Adverse Event|1|||
162662266|NCT05013905|587474824|FG000|Overall Study|Lack of Efficacy|1|||
162662267|NCT01849588|587474827|FG000|Overall Study|Lack of Efficacy|3|||
162662268|NCT02550652|587474837|FG000|Overall Study|Death|1|||
162662269|NCT02550652|587474838|FG001|Overall Study|Death|4|||
162662270|NCT02550652|587474837|FG000|Overall Study|Lack of Efficacy|1|||
162662271|NCT02550652|587474838|FG001|Overall Study|Lack of Efficacy|0|||
162662272|NCT02550652|587474837|FG000|Overall Study|Withdrawal by Subject|4|||
162662273|NCT02550652|587474838|FG001|Overall Study|Withdrawal by Subject|7|||
162662274|NCT02550652|587474837|FG000|Overall Study|Post Trial Access|1|||
162662275|NCT02550652|587474838|FG001|Overall Study|Post Trial Access|0|||
162662276|NCT02550652|587474837|FG000|Overall Study|Lost to Follow-up|1|||
162662277|NCT02550652|587474838|FG001|Overall Study|Lost to Follow-up|3|||
162662278|NCT02550652|587474837|FG000|Overall Study|Physician Decision|0|||
162662279|NCT02550652|587474838|FG001|Overall Study|Physician Decision|2|||
162662280|NCT02550652|587474837|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
162662281|NCT02550652|587474838|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
162662282|NCT01706250|587474839|FG000|Overall Study|Lost to Follow-up|2|||
162662283|NCT02486406|587474844|FG000|Overall Study|Withdrew consent|1|||
162662284|NCT02486406|587474845|FG001|Overall Study|Withdrew consent|0|||
162662285|NCT02486406|587474846|FG002|Overall Study|Withdrew consent|0|||
162662286|NCT02486406|587474847|FG003|Overall Study|Withdrew consent|1|||
162662287|NCT02486406|587474844|FG000|Overall Study|Lost to Follow-up|1|||
162662288|NCT02486406|587474845|FG001|Overall Study|Lost to Follow-up|3|||
162662289|NCT02486406|587474846|FG002|Overall Study|Lost to Follow-up|1|||
162662290|NCT02486406|587474847|FG003|Overall Study|Lost to Follow-up|3|||
162662291|NCT02486406|587474844|FG000|Overall Study|Other, not specified|0|||
162662292|NCT02486406|587474845|FG001|Overall Study|Other, not specified|0|||
162662293|NCT02486406|587474846|FG002|Overall Study|Other, not specified|1|||
162662294|NCT02486406|587474847|FG003|Overall Study|Other, not specified|0|||
162662295|NCT03509948|587474870|FG000|Overall Study|Protocol Violation|0|||
162662296|NCT03509948|587474871|FG001|Overall Study|Protocol Violation|1|||
162662297|NCT04587193|587474878|FG000|Overall Study|Screen failure after consent|3|||
162662298|NCT04587193|587474879|FG001|Overall Study|Screen failure after consent|0|||
162662299|NCT04587193|587474878|FG000|Overall Study|Device broke during study|3|||
162662300|NCT04587193|587474879|FG001|Overall Study|Device broke during study|2|||
162662301|NCT00508742|587474880|FG000|Period 1: Infant Series|Adverse Event|5|||
162662302|NCT00508742|587474881|FG001|Period 1: Infant Series|Adverse Event|4|||
162662303|NCT00508742|587474880|FG000|Period 1: Infant Series|Protocol Violation|1|||
162662304|NCT00508742|587474881|FG001|Period 1: Infant Series|Protocol Violation|0|||
162720886|NCT03383146|587685960|FG001|Overall Study|Lack of Efficacy|3|||
162720887|NCT03383146|587685959|FG000|Overall Study|Withdrawal by Subject|20|||
162720888|NCT03383146|587685960|FG001|Overall Study|Withdrawal by Subject|36|||
162720889|NCT03383146|587685959|FG000|Overall Study|Lost to Follow-up|5|||
163141079|NCT04170543|589226204|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
162662305|NCT00508742|587474880|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
162662306|NCT00508742|587474881|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
162662307|NCT00508742|587474880|FG000|Period 1: Infant Series|Physician Decision|1|||
162662308|NCT00508742|587474881|FG001|Period 1: Infant Series|Physician Decision|0|||
162662309|NCT00508742|587474880|FG000|Period 1: Infant Series|Other|4|||
162662310|NCT00508742|587474881|FG001|Period 1: Infant Series|Other|1|||
162662311|NCT00508742|587474880|FG000|Period 2: After Infant Series|Adverse Event|2|||
162662312|NCT00508742|587474881|FG001|Period 2: After Infant Series|Adverse Event|6|||
162662313|NCT00508742|587474880|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
162662314|NCT00508742|587474881|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
162662315|NCT00508742|587474880|FG000|Period 2: After Infant Series|Protocol Violation|1|||
162662316|NCT00508742|587474881|FG001|Period 2: After Infant Series|Protocol Violation|0|||
162662317|NCT00508742|587474880|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
162662318|NCT00508742|587474881|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
162662319|NCT00508742|587474880|FG000|Period 2: After Infant Series|Failed to Return|1|||
162662320|NCT00508742|587474881|FG001|Period 2: After Infant Series|Failed to Return|0|||
162662321|NCT00508742|587474880|FG000|Period 2: After Infant Series|Other|2|||
162662322|NCT00508742|587474881|FG001|Period 2: After Infant Series|Other|1|||
162662323|NCT00508742|587474880|FG000|Period 3: Toddler Dose|Adverse Event|1|||
162662324|NCT00508742|587474881|FG001|Period 3: Toddler Dose|Adverse Event|0|||
162662325|NCT00508742|587474880|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
162662326|NCT00508742|587474881|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
162662327|NCT00508742|587474880|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
162662328|NCT00508742|587474881|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
162662329|NCT00508742|587474880|FG000|Period 3: Toddler Dose|Other|5|||
162662330|NCT00508742|587474881|FG001|Period 3: Toddler Dose|Other|4|||
162662331|NCT02501096|587474882|FG000|Overall Study|Lost to Follow-up|0|||
162662332|NCT02501096|587474883|FG001|Overall Study|Lost to Follow-up|0|||
162662333|NCT02501096|587474884|FG002|Overall Study|Lost to Follow-up|0|||
162662334|NCT02501096|587474885|FG003|Overall Study|Lost to Follow-up|0|||
162662335|NCT02501096|587474886|FG004|Overall Study|Lost to Follow-up|1|||
162662336|NCT02501096|587474887|FG005|Overall Study|Lost to Follow-up|1|||
162662337|NCT02501096|587474888|FG006|Overall Study|Lost to Follow-up|3|||
162662338|NCT02501096|587474889|FG007|Overall Study|Lost to Follow-up|0|||
162662339|NCT02501096|587474890|FG008|Overall Study|Lost to Follow-up|0|||
162662340|NCT02501096|587474882|FG000|Overall Study|Withdrawal by Subject|1|||
162662341|NCT02501096|587474883|FG001|Overall Study|Withdrawal by Subject|0|||
162662342|NCT02501096|587474884|FG002|Overall Study|Withdrawal by Subject|7|||
162720890|NCT03383146|587685960|FG001|Overall Study|Lost to Follow-up|15|||
163141080|NCT04170543|589226205|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
163141081|NCT04170543|589226201|FG000|Overall Study|Not Treated|0|||
163141082|NCT04170543|589226202|FG001|Overall Study|Not Treated|0|||
163141083|NCT04170543|589226203|FG002|Overall Study|Not Treated|0|||
163141084|NCT04170543|589226204|FG003|Overall Study|Not Treated|0|||
163141085|NCT04170543|589226205|FG004|Overall Study|Not Treated|2|||
163141086|NCT04170543|589226201|FG000|Overall Study|(CRF)|16|||
163141087|NCT04170543|589226202|FG001|Overall Study|(CRF)|15|||
163141088|NCT04170543|589226203|FG002|Overall Study|(CRF)|12|||
163141089|NCT04170543|589226204|FG003|Overall Study|(CRF)|17|||
163141090|NCT04170543|589226205|FG004|Overall Study|(CRF)|17|||
163141091|NCT04170543|589226201|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
163141092|NCT04170543|589226202|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
163141093|NCT04170543|589226203|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
163141094|NCT04170543|589226204|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
163141095|NCT04170543|589226205|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
163141096|NCT00770601|589226206|FG000|Overall Study|Withdrawal by Subject|1|||
163141097|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
163141098|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
162662343|NCT02501096|587474885|FG003|Overall Study|Withdrawal by Subject|13|||
162662344|NCT02501096|587474886|FG004|Overall Study|Withdrawal by Subject|2|||
162662345|NCT02501096|587474887|FG005|Overall Study|Withdrawal by Subject|2|||
163141099|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
163141100|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
162662346|NCT02501096|587474888|FG006|Overall Study|Withdrawal by Subject|2|||
162662347|NCT02501096|587474889|FG007|Overall Study|Withdrawal by Subject|3|||
162662348|NCT02501096|587474890|FG008|Overall Study|Withdrawal by Subject|0|||
162662349|NCT02501096|587474882|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
162662350|NCT02501096|587474883|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
162720891|NCT03383146|587685959|FG000|Overall Study|Death|0|||
162720892|NCT03383146|587685960|FG001|Overall Study|Death|2|||
162662351|NCT02501096|587474884|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
162662352|NCT02501096|587474885|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
162662353|NCT02501096|587474886|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
162662354|NCT02501096|587474887|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
162662355|NCT02501096|587474888|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
162662356|NCT02501096|587474889|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
162662357|NCT02501096|587474890|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
162662358|NCT02501096|587474882|FG000|Overall Study|Death|1|||
162662359|NCT02501096|587474883|FG001|Overall Study|Death|1|||
162662360|NCT02501096|587474884|FG002|Overall Study|Death|88|||
163141101|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
163141102|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
163141103|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
163141104|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
163141105|NCT01987102|589226207|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
163141106|NCT01987102|589226208|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
163141107|NCT01987102|589226207|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
163141108|NCT01987102|589226208|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
163141109|NCT04378270|589226211|FG000|Overall Study|Lack of Efficacy|1|||
163141110|NCT04378270|589226211|FG000|Overall Study|Withdrawal by Subject|1|||
163141111|NCT04378270|589226211|FG000|Overall Study|Screen Failure|1|||
163141112|NCT04378270|589226211|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
163141113|NCT01327599|589226212|FG000|Overall Study|Adverse Event|1|||
163141114|NCT01327599|589226212|FG000|Overall Study|Could Not Attend Visit|1|||
163141115|NCT01327599|589226212|FG000|Overall Study|Withdrawal of Consent|1|||
163141116|NCT01236521|589226213|FG000|Overall Study|Withdrawal by Subject|12|||
163141117|NCT01236521|589226214|FG001|Overall Study|Withdrawal by Subject|17|||
163141118|NCT01236521|589226213|FG000|Overall Study|Death|2|||
163141119|NCT01236521|589226214|FG001|Overall Study|Death|1|||
163141120|NCT01236521|589226213|FG000|Overall Study|Lost to Follow-up|9|||
163141121|NCT01236521|589226214|FG001|Overall Study|Lost to Follow-up|7|||
163141122|NCT03201419|589226220|FG000|Overall Study|Adverse Event|3|||
163141123|NCT03201419|589226221|FG001|Overall Study|Adverse Event|1|||
163141124|NCT03201419|589226222|FG002|Overall Study|Adverse Event|0|||
163141125|NCT03201419|589226223|FG003|Overall Study|Adverse Event|0|||
163141126|NCT03201419|589226224|FG004|Overall Study|Adverse Event|1|||
163141127|NCT03201419|589226225|FG005|Overall Study|Adverse Event|1|||
163141128|NCT03201419|589226226|FG006|Overall Study|Adverse Event|5|||
163141129|NCT03201419|589226227|FG007|Overall Study|Adverse Event|0|||
163141130|NCT03201419|589226228|FG008|Overall Study|Adverse Event|0|||
163141131|NCT03201419|589226220|FG000|Overall Study|Lost to Follow-up|1|||
163141132|NCT03201419|589226221|FG001|Overall Study|Lost to Follow-up|0|||
163141133|NCT03201419|589226222|FG002|Overall Study|Lost to Follow-up|0|||
163141134|NCT03201419|589226223|FG003|Overall Study|Lost to Follow-up|0|||
163141135|NCT03201419|589226224|FG004|Overall Study|Lost to Follow-up|0|||
163141136|NCT03201419|589226225|FG005|Overall Study|Lost to Follow-up|0|||
163141137|NCT03201419|589226226|FG006|Overall Study|Lost to Follow-up|0|||
163141138|NCT03201419|589226227|FG007|Overall Study|Lost to Follow-up|0|||
163141139|NCT03201419|589226228|FG008|Overall Study|Lost to Follow-up|0|||
163141140|NCT03201419|589226220|FG000|Overall Study|Protocol Deviation|0|||
163141141|NCT03201419|589226221|FG001|Overall Study|Protocol Deviation|0|||
163141142|NCT03201419|589226222|FG002|Overall Study|Protocol Deviation|0|||
163141143|NCT03201419|589226223|FG003|Overall Study|Protocol Deviation|0|||
163141144|NCT03201419|589226224|FG004|Overall Study|Protocol Deviation|0|||
163141145|NCT03201419|589226225|FG005|Overall Study|Protocol Deviation|0|||
163141146|NCT03201419|589226226|FG006|Overall Study|Protocol Deviation|1|||
163141147|NCT03201419|589226227|FG007|Overall Study|Protocol Deviation|0|||
163141148|NCT03201419|589226228|FG008|Overall Study|Protocol Deviation|0|||
163141149|NCT03201419|589226220|FG000|Overall Study|Withdrawal by Subject|4|||
163141150|NCT03201419|589226221|FG001|Overall Study|Withdrawal by Subject|2|||
163141151|NCT03201419|589226222|FG002|Overall Study|Withdrawal by Subject|1|||
163141152|NCT03201419|589226223|FG003|Overall Study|Withdrawal by Subject|0|||
163141153|NCT03201419|589226224|FG004|Overall Study|Withdrawal by Subject|0|||
163141154|NCT03201419|589226225|FG005|Overall Study|Withdrawal by Subject|0|||
163141155|NCT03201419|589226226|FG006|Overall Study|Withdrawal by Subject|0|||
163141156|NCT03201419|589226227|FG007|Overall Study|Withdrawal by Subject|1|||
162662361|NCT02501096|587474885|FG003|Overall Study|Death|74|||
163141157|NCT03201419|589226228|FG008|Overall Study|Withdrawal by Subject|2|||
163141158|NCT03201419|589226220|FG000|Overall Study|Other|0|||
163141159|NCT03201419|589226221|FG001|Overall Study|Other|0|||
163141160|NCT03201419|589226222|FG002|Overall Study|Other|1|||
163141161|NCT03201419|589226223|FG003|Overall Study|Other|0|||
162662362|NCT02501096|587474886|FG004|Overall Study|Death|15|||
163141162|NCT03201419|589226224|FG004|Overall Study|Other|0|||
163141163|NCT03201419|589226225|FG005|Overall Study|Other|0|||
163141164|NCT03201419|589226226|FG006|Overall Study|Other|0|||
163141165|NCT03201419|589226227|FG007|Overall Study|Other|0|||
162662363|NCT02501096|587474887|FG005|Overall Study|Death|16|||
162662364|NCT02501096|587474888|FG006|Overall Study|Death|15|||
162662365|NCT02501096|587474889|FG007|Overall Study|Death|16|||
162662366|NCT02501096|587474890|FG008|Overall Study|Death|1|||
162662367|NCT00437034|587474891|FG000|Overall Study|Adverse Event|1|||
162662368|NCT00437034|587474891|FG000|Overall Study|Disease progression during treatment|5|||
162720893|NCT03383146|587685959|FG000|Overall Study|Physician Decision|0|||
162720894|NCT03383146|587685960|FG001|Overall Study|Physician Decision|1|||
162720895|NCT03383146|587685959|FG000|Overall Study|Protocol Deviation|1|||
162720896|NCT03383146|587685960|FG001|Overall Study|Protocol Deviation|8|||
162720897|NCT03383146|587685959|FG000|Overall Study|Study Terminated by the Sponsor|48|||
162720898|NCT03383146|587685960|FG001|Overall Study|Study Terminated by the Sponsor|95|||
162720899|NCT03383146|587685959|FG000|Overall Study|Reason not Specified|4|||
162720900|NCT03383146|587685960|FG001|Overall Study|Reason not Specified|6|||
162720901|NCT01317420|587685961|FG000|Overall Study|Progressive disease according to RECIST|2|||
162720902|NCT01317420|587685962|FG001|Overall Study|Progressive disease according to RECIST|3|||
162720903|NCT01317420|587685963|FG002|Overall Study|Progressive disease according to RECIST|3|||
162720904|NCT01317420|587685964|FG003|Overall Study|Progressive disease according to RECIST|3|||
162720905|NCT01317420|587685965|FG004|Overall Study|Progressive disease according to RECIST|3|||
162720906|NCT01317420|587685966|FG005|Overall Study|Progressive disease according to RECIST|3|||
162720907|NCT01317420|587685967|FG006|Overall Study|Progressive disease according to RECIST|3|||
162720908|NCT01317420|587685968|FG007|Overall Study|Progressive disease according to RECIST|3|||
162720909|NCT01317420|587685969|FG008|Overall Study|Progressive disease according to RECIST|3|||
162720910|NCT01317420|587685970|FG009|Overall Study|Progressive disease according to RECIST|2|||
162720911|NCT01317420|587685971|FG010|Overall Study|Progressive disease according to RECIST|3|||
162720912|NCT01317420|587685972|FG011|Overall Study|Progressive disease according to RECIST|11|||
162720913|NCT01317420|587685973|FG012|Overall Study|Progressive disease according to RECIST|16|||
162720914|NCT01317420|587685961|FG000|Overall Study|Other adverse event|1|||
162720915|NCT01317420|587685962|FG001|Overall Study|Other adverse event|0|||
162720916|NCT01317420|587685963|FG002|Overall Study|Other adverse event|0|||
162720917|NCT01317420|587685964|FG003|Overall Study|Other adverse event|0|||
162720918|NCT01317420|587685965|FG004|Overall Study|Other adverse event|0|||
162720919|NCT01317420|587685966|FG005|Overall Study|Other adverse event|0|||
162720920|NCT01317420|587685967|FG006|Overall Study|Other adverse event|0|||
162720921|NCT01317420|587685968|FG007|Overall Study|Other adverse event|0|||
162720922|NCT01317420|587685969|FG008|Overall Study|Other adverse event|0|||
162720923|NCT01317420|587685970|FG009|Overall Study|Other adverse event|0|||
162720924|NCT01317420|587685971|FG010|Overall Study|Other adverse event|0|||
163141166|NCT03201419|589226228|FG008|Overall Study|Other|0|||
163141167|NCT05864586|589226236|FG000|Overall Study|Ineligible|4|||
163141168|NCT05864586|589226237|FG001|Overall Study|Ineligible|12|||
163141169|NCT05864586|589226236|FG000|Overall Study|Pregnancy|0|||
163141170|NCT05864586|589226237|FG001|Overall Study|Pregnancy|1|||
163141171|NCT05864586|589226236|FG000|Overall Study|Withdrawal by Subject|0|||
163141172|NCT05864586|589226237|FG001|Overall Study|Withdrawal by Subject|1|||
163141173|NCT03635424|589226238|FG000|Overall Study|Adverse Event|1|||
163141174|NCT03635424|589226238|FG000|Overall Study|Death|1|||
163141175|NCT03635424|589226238|FG000|Overall Study|Device not implanted|1|||
163141176|NCT02701283|589226239|FG000|Overall Study|Death|25|||
163141177|NCT02701283|589226240|FG001|Overall Study|Death|29|||
163141178|NCT02701283|589226241|FG002|Overall Study|Death|19|||
163141179|NCT02701283|589226239|FG000|Overall Study|Lost to Follow-up|3|||
163141180|NCT02701283|589226240|FG001|Overall Study|Lost to Follow-up|8|||
163141181|NCT02701283|589226241|FG002|Overall Study|Lost to Follow-up|1|||
162662369|NCT01976845|587474892|FG000|Overall Study|Physician Decision|8|||
162662370|NCT01976845|587474893|FG001|Overall Study|Physician Decision|8|||
162662371|NCT01976845|587474894|FG002|Overall Study|Physician Decision|3|||
162662372|NCT01818336|587476313|FG000|Overall Study|Declined retest visit|0|||
162662373|NCT01818336|587476314|FG001|Overall Study|Declined retest visit|11|||
162662374|NCT01818336|587476313|FG000|Overall Study|Lost to Follow-up|0|||
162662375|NCT01818336|587476314|FG001|Overall Study|Lost to Follow-up|1|||
162662376|NCT03042312|587476317|FG000|Overall Study|Administrative Reason|1|||
162662377|NCT03042312|587476318|FG001|Overall Study|Administrative Reason|1|||
162662378|NCT03042312|587476317|FG000|Overall Study|Adverse Event|0|||
162662379|NCT03042312|587476318|FG001|Overall Study|Adverse Event|1|||
162662380|NCT03042312|587476317|FG000|Overall Study|Lost to Follow-up|1|||
162662381|NCT03042312|587476318|FG001|Overall Study|Lost to Follow-up|3|||
162662382|NCT03042312|587476317|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
162662383|NCT03042312|587476318|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
162662384|NCT03042312|587476317|FG000|Overall Study|Withdrawal by Subject|4|||
162662385|NCT03042312|587476318|FG001|Overall Study|Withdrawal by Subject|5|||
162662386|NCT03422003|587476328|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
162720925|NCT01317420|587685972|FG011|Overall Study|Other adverse event|0|||
163141182|NCT02701283|589226239|FG000|Overall Study|Withdrawal by Subject|12|||
163141183|NCT02701283|589226240|FG001|Overall Study|Withdrawal by Subject|41|||
163141184|NCT02701283|589226241|FG002|Overall Study|Withdrawal by Subject|1|||
163141185|NCT02701283|589226239|FG000|Overall Study|Missed 2-year visit|22|||
163141186|NCT02701283|589226240|FG001|Overall Study|Missed 2-year visit|27|||
163141187|NCT02701283|589226241|FG002|Overall Study|Missed 2-year visit|0|||
163141188|NCT02701283|589226239|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
163141189|NCT02701283|589226240|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
163141190|NCT02701283|589226241|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
163141191|NCT04544956|589226242|FG000|Overall Study|Withdrawal by Subject|1|||
163141192|NCT04266795|589226243|FG000|Overall Study|Adverse Event|10|||
163141193|NCT04266795|589226244|FG001|Overall Study|Adverse Event|19|||
163141194|NCT04266795|589226243|FG000|Overall Study|Death|7|||
163141195|NCT04266795|589226244|FG001|Overall Study|Death|8|||
163141196|NCT04266795|589226243|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
163141197|NCT04266795|589226244|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
163141198|NCT04266795|589226243|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163141199|NCT04266795|589226244|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163141200|NCT04266795|589226243|FG000|Overall Study|Progressive Disease|12|||
163141201|NCT04266795|589226244|FG001|Overall Study|Progressive Disease|9|||
163141202|NCT04266795|589226243|FG000|Overall Study|Withdrawal by Patient|5|||
163141203|NCT04266795|589226244|FG001|Overall Study|Withdrawal by Patient|6|||
163141204|NCT04266795|589226243|FG000|Overall Study|Disease Relapse|3|||
163141205|NCT04266795|589226244|FG001|Overall Study|Disease Relapse|6|||
163141206|NCT04266795|589226243|FG000|Overall Study|Reason not Specified|12|||
163141207|NCT04266795|589226244|FG001|Overall Study|Reason not Specified|10|||
163141208|NCT04266795|589226243|FG000|Overall Study|Participants Ongoing on Treatment|25|||
163141209|NCT04266795|589226244|FG001|Overall Study|Participants Ongoing on Treatment|23|||
163141210|NCT00699660|589226247|FG000|Overall Study|Lost to Follow-up|4|||
163141211|NCT00699660|589226248|FG001|Overall Study|Lost to Follow-up|2|||
163141212|NCT00699660|589226247|FG000|Overall Study|missing reports and recording failures|10|||
163141213|NCT00699660|589226248|FG001|Overall Study|missing reports and recording failures|6|||
163141214|NCT03915470|589226249|FG000|Overall Study|Death|3|||
163141215|NCT03915470|589226250|FG001|Overall Study|Death|1|||
163141216|NCT03915470|589226249|FG000|Overall Study|Adverse Event|1|||
163141217|NCT03915470|589226250|FG001|Overall Study|Adverse Event|0|||
163141218|NCT03915470|589226249|FG000|Overall Study|Physician Decision|1|||
163141219|NCT03915470|589226250|FG001|Overall Study|Physician Decision|0|||
163141220|NCT03915470|589226249|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
163141221|NCT03915470|589226250|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
163141222|NCT03160898|589226251|FG000|Overall Study|Adverse Event|4|||
163141223|NCT03160898|589226252|FG001|Overall Study|Adverse Event|8|||
163141224|NCT03160898|589226253|FG002|Overall Study|Adverse Event|7|||
163141225|NCT03160898|589226254|FG003|Overall Study|Adverse Event|10|||
163141226|NCT03160898|589226251|FG000|Overall Study|Death|1|||
163141227|NCT03160898|589226252|FG001|Overall Study|Death|0|||
162662387|NCT03422003|587476329|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
162720926|NCT01317420|587685973|FG012|Overall Study|Other adverse event|2|||
163141228|NCT03160898|589226253|FG002|Overall Study|Death|0|||
163141229|NCT03160898|589226254|FG003|Overall Study|Death|1|||
163141230|NCT03160898|589226251|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
163141231|NCT03160898|589226252|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
163141232|NCT03160898|589226253|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
163141233|NCT03160898|589226254|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
163141234|NCT03160898|589226251|FG000|Overall Study|Lost to Follow-up|1|||
162662388|NCT03422003|587476328|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
162662389|NCT03422003|587476329|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
162662390|NCT00812812|587476336|FG000|Overall Study|Adverse Event|2|||
162662391|NCT00812812|587476337|FG001|Overall Study|Adverse Event|1|||
162662392|NCT00812812|587476336|FG000|Overall Study|Lack of Efficacy|1|||
162662393|NCT00812812|587476337|FG001|Overall Study|Lack of Efficacy|0|||
162662394|NCT00812812|587476336|FG000|Overall Study|Lost to Follow-up|0|||
162662395|NCT00812812|587476337|FG001|Overall Study|Lost to Follow-up|1|||
162662396|NCT00812812|587476336|FG000|Overall Study|Withdrawal by Subject|0|||
162662397|NCT00812812|587476337|FG001|Overall Study|Withdrawal by Subject|2|||
162662398|NCT02114892|587476338|FG000|Overall Study|Lost to Follow-up|1|||
162662399|NCT02114892|587476339|FG001|Overall Study|Lost to Follow-up|2|||
162662400|NCT02178475|587476344|FG000|Overall Study|Withdrawal by Subject|7|||
162662401|NCT02178475|587476344|FG000|Overall Study|Lost to Follow-up|10|||
162662402|NCT02178475|587476344|FG000|Overall Study|Death|13|||
162662403|NCT02178475|587476344|FG000|Overall Study|Protocol-specified Criteria|99|||
162662404|NCT04327934|587476345|FG000|Overall Study|Did not qualify|7|||
162662405|NCT04327934|587476346|FG001|Overall Study|Did not qualify|4|||
162662406|NCT04327934|587476345|FG000|Overall Study|Physician Decision|0|||
162662407|NCT04327934|587476346|FG001|Overall Study|Physician Decision|1|||
162662408|NCT02443298|587476347|FG000|Overall Study|Adverse Event|3|||
162662409|NCT02443298|587476348|FG001|Overall Study|Adverse Event|3|||
162662410|NCT02443298|587476347|FG000|Overall Study|Withdrawal by Subject|1|||
162662411|NCT02443298|587476348|FG001|Overall Study|Withdrawal by Subject|2|||
162662412|NCT03095417|587476349|FG000|Overall Study|missed|1|||
162662413|NCT03095417|587476350|FG001|Overall Study|missed|2|||
162662414|NCT03095417|587476351|FG002|Overall Study|missed|0|||
162662415|NCT03095417|587476352|FG003|Overall Study|missed|1|||
163141235|NCT03160898|589226252|FG001|Overall Study|Lost to Follow-up|1|||
163141236|NCT03160898|589226253|FG002|Overall Study|Lost to Follow-up|1|||
163141237|NCT03160898|589226254|FG003|Overall Study|Lost to Follow-up|2|||
163141238|NCT03160898|589226251|FG000|Overall Study|Physician Decision|1|||
163141239|NCT03160898|589226252|FG001|Overall Study|Physician Decision|0|||
163141240|NCT03160898|589226253|FG002|Overall Study|Physician Decision|0|||
163141241|NCT03160898|589226254|FG003|Overall Study|Physician Decision|1|||
163141242|NCT03160898|589226251|FG000|Overall Study|Progressive Disease|4|||
163141243|NCT03160898|589226252|FG001|Overall Study|Progressive Disease|1|||
163141244|NCT03160898|589226253|FG002|Overall Study|Progressive Disease|2|||
163141245|NCT03160898|589226254|FG003|Overall Study|Progressive Disease|1|||
163141246|NCT03160898|589226251|FG000|Overall Study|Protocol Violation|1|||
163141247|NCT03160898|589226252|FG001|Overall Study|Protocol Violation|0|||
163141248|NCT03160898|589226253|FG002|Overall Study|Protocol Violation|2|||
163141249|NCT03160898|589226254|FG003|Overall Study|Protocol Violation|0|||
163141250|NCT03160898|589226251|FG000|Overall Study|Sponsor Discretion|2|||
163141251|NCT03160898|589226252|FG001|Overall Study|Sponsor Discretion|0|||
163141252|NCT03160898|589226253|FG002|Overall Study|Sponsor Discretion|0|||
163141253|NCT03160898|589226254|FG003|Overall Study|Sponsor Discretion|0|||
163141254|NCT03160898|589226251|FG000|Overall Study|Withdrawal by Subject|1|||
163141255|NCT03160898|589226252|FG001|Overall Study|Withdrawal by Subject|3|||
163141256|NCT03160898|589226253|FG002|Overall Study|Withdrawal by Subject|2|||
163141257|NCT03160898|589226254|FG003|Overall Study|Withdrawal by Subject|1|||
163141258|NCT03160898|589226251|FG000|Overall Study|Other|2|||
163141259|NCT03160898|589226252|FG001|Overall Study|Other|0|||
163141260|NCT03160898|589226253|FG002|Overall Study|Other|2|||
163141261|NCT03160898|589226254|FG003|Overall Study|Other|2|||
163141262|NCT03405818|589226257|FG000|Overall Study|Withdrawal by Subject|4|||
163141263|NCT03405818|589226257|FG000|Overall Study|Lost to Follow-up|4|||
163141264|NCT00434109|589226258|FG000|Overall Study|Physician Decision|9|||
163141265|NCT00434109|589226258|FG000|Overall Study|Adverse Event|5|||
163141266|NCT00434109|589226258|FG000|Overall Study|Protocol Violation|1|||
163141267|NCT00434109|589226258|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
163141268|NCT04186871|589226261|FG000|Overall Study|Lack of Efficacy|0|||
163141269|NCT04186871|589226262|FG001|Overall Study|Lack of Efficacy|1|||
163141270|NCT04186871|589226263|FG002|Overall Study|Lack of Efficacy|0|||
163141271|NCT04186871|589226264|FG003|Overall Study|Lack of Efficacy|0|||
163141272|NCT04186871|589226265|FG004|Overall Study|Lack of Efficacy|1|||
163141273|NCT04186871|589226266|FG005|Overall Study|Lack of Efficacy|1|||
163141274|NCT04186871|589226261|FG000|Overall Study|Adverse Event|1|||
163141275|NCT04186871|589226262|FG001|Overall Study|Adverse Event|1|||
163141276|NCT04186871|589226263|FG002|Overall Study|Adverse Event|0|||
163141277|NCT04186871|589226264|FG003|Overall Study|Adverse Event|0|||
163141278|NCT04186871|589226265|FG004|Overall Study|Adverse Event|0|||
163141279|NCT04186871|589226266|FG005|Overall Study|Adverse Event|2|||
163141280|NCT04186871|589226261|FG000|Overall Study|Study terminated by sponsor|1|||
163141281|NCT04186871|589226262|FG001|Overall Study|Study terminated by sponsor|2|||
163141282|NCT04186871|589226263|FG002|Overall Study|Study terminated by sponsor|0|||
163141283|NCT04186871|589226264|FG003|Overall Study|Study terminated by sponsor|1|||
163141284|NCT04186871|589226265|FG004|Overall Study|Study terminated by sponsor|0|||
163141285|NCT04186871|589226266|FG005|Overall Study|Study terminated by sponsor|0|||
163141286|NCT04186871|589226261|FG000|Overall Study|Other reasons|0|||
163141287|NCT04186871|589226262|FG001|Overall Study|Other reasons|0|||
163141288|NCT04186871|589226263|FG002|Overall Study|Other reasons|0|||
163141289|NCT04186871|589226264|FG003|Overall Study|Other reasons|0|||
163141290|NCT04186871|589226265|FG004|Overall Study|Other reasons|0|||
163141291|NCT04186871|589226266|FG005|Overall Study|Other reasons|1|||
163141292|NCT04186871|589226261|FG000|Overall Study|Withdrawal by Subject|0|||
163141293|NCT04186871|589226262|FG001|Overall Study|Withdrawal by Subject|0|||
163141294|NCT04186871|589226263|FG002|Overall Study|Withdrawal by Subject|0|||
163141295|NCT04186871|589226264|FG003|Overall Study|Withdrawal by Subject|0|||
163141296|NCT04186871|589226265|FG004|Overall Study|Withdrawal by Subject|0|||
163141297|NCT04186871|589226266|FG005|Overall Study|Withdrawal by Subject|1|||
163141298|NCT04186871|589226261|FG000|Overall Study|Lost to Follow-up|0|||
163141299|NCT04186871|589226262|FG001|Overall Study|Lost to Follow-up|0|||
163141300|NCT04186871|589226263|FG002|Overall Study|Lost to Follow-up|0|||
163141301|NCT04186871|589226264|FG003|Overall Study|Lost to Follow-up|0|||
162662416|NCT03095417|587476349|FG000|Overall Study|Lost to Follow-up|2|||
162662417|NCT03095417|587476350|FG001|Overall Study|Lost to Follow-up|2|||
163141302|NCT04186871|589226265|FG004|Overall Study|Lost to Follow-up|0|||
163141303|NCT04186871|589226266|FG005|Overall Study|Lost to Follow-up|1|||
163141304|NCT00549445|589226273|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
163141305|NCT00549445|589226274|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
163141306|NCT03932760|589226275|FG000|Overall Study|Became Ineligible|2|||
162720927|NCT01317420|587685961|FG000|Overall Study|Non-compliant with protocol|0|||
162720928|NCT01317420|587685962|FG001|Overall Study|Non-compliant with protocol|0|||
162720929|NCT01317420|587685963|FG002|Overall Study|Non-compliant with protocol|0|||
162720930|NCT01317420|587685964|FG003|Overall Study|Non-compliant with protocol|0|||
162720931|NCT01317420|587685965|FG004|Overall Study|Non-compliant with protocol|0|||
162720932|NCT01317420|587685966|FG005|Overall Study|Non-compliant with protocol|0|||
163141307|NCT03932760|589226276|FG001|Overall Study|Became Ineligible|5|||
163141308|NCT03932760|589226275|FG000|Overall Study|Withdrawal by Subject|6|||
163141309|NCT03932760|589226276|FG001|Overall Study|Withdrawal by Subject|6|||
163141310|NCT04725500|589226277|FG000|Screening|Screen Failure|26|||
162662418|NCT03095417|587476351|FG002|Overall Study|Lost to Follow-up|1|||
162662419|NCT03095417|587476352|FG003|Overall Study|Lost to Follow-up|0|||
162662420|NCT03095417|587476349|FG000|Overall Study|refusal|0|||
162662421|NCT03095417|587476350|FG001|Overall Study|refusal|1|||
162662422|NCT03095417|587476351|FG002|Overall Study|refusal|0|||
162662423|NCT03095417|587476352|FG003|Overall Study|refusal|1|||
162662424|NCT03095417|587476349|FG000|Overall Study|Withdrawal by Subject|8|||
162662425|NCT03095417|587476350|FG001|Overall Study|Withdrawal by Subject|2|||
163141311|NCT04725500|589226277|FG000|Screening|Withdrawal by Subject|1|||
163141312|NCT04725500|589226277|FG000|2 Week Take Home|Screen Fail|5|||
163141313|NCT01467505|589227858|FG000|Overall Study|Adverse Event|1|||
163141314|NCT01467505|589227859|FG001|Overall Study|Adverse Event|0|||
163141315|NCT01467505|589227858|FG000|Overall Study|Withdrawal by Subject|4|||
163141316|NCT01467505|589227859|FG001|Overall Study|Withdrawal by Subject|0|||
163141317|NCT01467505|589227858|FG000|Overall Study|Study Terminated by Sponsor|28|||
163141318|NCT01467505|589227859|FG001|Overall Study|Study Terminated by Sponsor|3|||
163141319|NCT00227721|589227860|FG000|Overall Study|On study, but never treated.|1|||
163141320|NCT00383786|589227863|FG000|Overall Study|Protocol Violation|2|||
163141321|NCT00383786|589227864|FG001|Overall Study|Protocol Violation|6|||
163141322|NCT00383786|589227863|FG000|Overall Study|Withdrawal by Subject|2|||
163141323|NCT00383786|589227864|FG001|Overall Study|Withdrawal by Subject|5|||
163141324|NCT00383786|589227863|FG000|Overall Study|Physician Decision|0|||
163141325|NCT00383786|589227864|FG001|Overall Study|Physician Decision|1|||
163141326|NCT02219464|589227868|FG000|Overall Study|Withdrawal by Subject|1|||
163141327|NCT02219464|589227869|FG001|Overall Study|Withdrawal by Subject|0|||
163141328|NCT02219464|589227868|FG000|Overall Study|case cancelled|1|||
162662426|NCT03095417|587476351|FG002|Overall Study|Withdrawal by Subject|5|||
162662427|NCT03095417|587476352|FG003|Overall Study|Withdrawal by Subject|4|||
162662428|NCT03095417|587476349|FG000|Overall Study|Physician Decision|1|||
162662429|NCT03095417|587476350|FG001|Overall Study|Physician Decision|2|||
162662430|NCT03095417|587476351|FG002|Overall Study|Physician Decision|2|||
162662431|NCT03095417|587476352|FG003|Overall Study|Physician Decision|2|||
162662432|NCT03095417|587476349|FG000|Overall Study|Death|1|||
162662433|NCT03095417|587476350|FG001|Overall Study|Death|2|||
162662434|NCT03095417|587476351|FG002|Overall Study|Death|1|||
162662435|NCT03095417|587476352|FG003|Overall Study|Death|3|||
162662436|NCT02571452|587476353|FG000|Overall Study Treatment|Protocol Violation|0|||
162662437|NCT02571452|587476354|FG001|Overall Study Treatment|Protocol Violation|1|||
162662438|NCT02571452|587476353|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
162662439|NCT02571452|587476354|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
162662440|NCT02571452|587476353|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
162662441|NCT02571452|587476354|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
162662442|NCT01877421|587476355|FG000|Phase 2|Lost to Follow-up|0|||
162662443|NCT01877421|587476356|FG001|Phase 2|Lost to Follow-up|0|||
162662444|NCT01877421|587476357|FG002|Phase 2|Lost to Follow-up|0|||
162662445|NCT01877421|587476358|FG003|Phase 2|Lost to Follow-up|0|||
162662446|NCT01877421|587476359|FG004|Phase 2|Lost to Follow-up|0|||
162662447|NCT01877421|587476360|FG005|Phase 2|Lost to Follow-up|0|||
162662448|NCT01877421|587476361|FG006|Phase 2|Lost to Follow-up|1|||
162662449|NCT01877421|587476362|FG007|Phase 2|Lost to Follow-up|0|||
162662450|NCT01877421|587476363|FG008|Phase 2|Lost to Follow-up|0|||
162662451|NCT01877421|587476364|FG009|Phase 2|Lost to Follow-up|0|||
162662452|NCT01877421|587476365|FG010|Phase 2|Lost to Follow-up|0|||
163141329|NCT02219464|589227869|FG001|Overall Study|case cancelled|0|||
162662453|NCT01877421|587476366|FG011|Phase 2|Lost to Follow-up|0|||
162662454|NCT01877421|587476367|FG012|Phase 2|Lost to Follow-up|0|||
162662455|NCT01877421|587476368|FG013|Phase 2|Lost to Follow-up|0|||
162662456|NCT01877421|587476369|FG014|Phase 2|Lost to Follow-up|0|||
162662457|NCT01877421|587476370|FG015|Phase 2|Lost to Follow-up|0|||
162662458|NCT01877421|587476371|FG016|Phase 2|Lost to Follow-up|0|||
162662459|NCT01877421|587476372|FG017|Phase 2|Lost to Follow-up|0|||
162662460|NCT01877421|587476355|FG000|Phase 2|Withdrawal by Subject|0|||
162662461|NCT01877421|587476356|FG001|Phase 2|Withdrawal by Subject|0|||
162662462|NCT01877421|587476357|FG002|Phase 2|Withdrawal by Subject|0|||
162662463|NCT01877421|587476358|FG003|Phase 2|Withdrawal by Subject|0|||
162662464|NCT01877421|587476359|FG004|Phase 2|Withdrawal by Subject|0|||
162662465|NCT01877421|587476360|FG005|Phase 2|Withdrawal by Subject|0|||
162662466|NCT01877421|587476361|FG006|Phase 2|Withdrawal by Subject|0|||
162662467|NCT01877421|587476362|FG007|Phase 2|Withdrawal by Subject|0|||
162720933|NCT01317420|587685967|FG006|Overall Study|Non-compliant with protocol|0|||
162662468|NCT01877421|587476363|FG008|Phase 2|Withdrawal by Subject|1|||
162662469|NCT01877421|587476364|FG009|Phase 2|Withdrawal by Subject|0|||
162662470|NCT01877421|587476365|FG010|Phase 2|Withdrawal by Subject|1|||
162662471|NCT01877421|587476366|FG011|Phase 2|Withdrawal by Subject|0|||
162662472|NCT01877421|587476367|FG012|Phase 2|Withdrawal by Subject|1|||
162662473|NCT01877421|587476368|FG013|Phase 2|Withdrawal by Subject|0|||
162662474|NCT01877421|587476369|FG014|Phase 2|Withdrawal by Subject|0|||
162662475|NCT01877421|587476370|FG015|Phase 2|Withdrawal by Subject|1|||
162662476|NCT01877421|587476371|FG016|Phase 2|Withdrawal by Subject|0|||
162662477|NCT01877421|587476372|FG017|Phase 2|Withdrawal by Subject|0|||
162662478|NCT01877421|587476355|FG000|Phase 2|Protocol Violation|0|||
162662479|NCT01877421|587476356|FG001|Phase 2|Protocol Violation|0|||
162662480|NCT01877421|587476357|FG002|Phase 2|Protocol Violation|0|||
162662481|NCT01877421|587476358|FG003|Phase 2|Protocol Violation|0|||
162662482|NCT01877421|587476359|FG004|Phase 2|Protocol Violation|0|||
162662483|NCT01877421|587476360|FG005|Phase 2|Protocol Violation|0|||
162662484|NCT01877421|587476361|FG006|Phase 2|Protocol Violation|0|||
162662485|NCT01877421|587476362|FG007|Phase 2|Protocol Violation|0|||
162662486|NCT01877421|587476363|FG008|Phase 2|Protocol Violation|0|||
162662487|NCT01877421|587476364|FG009|Phase 2|Protocol Violation|0|||
162662488|NCT01877421|587476365|FG010|Phase 2|Protocol Violation|1|||
162662489|NCT01877421|587476366|FG011|Phase 2|Protocol Violation|0|||
162662490|NCT01877421|587476367|FG012|Phase 2|Protocol Violation|0|||
162662491|NCT01877421|587476368|FG013|Phase 2|Protocol Violation|0|||
162662492|NCT01877421|587476369|FG014|Phase 2|Protocol Violation|0|||
162662493|NCT01877421|587476370|FG015|Phase 2|Protocol Violation|0|||
162662494|NCT01877421|587476371|FG016|Phase 2|Protocol Violation|0|||
162662495|NCT01877421|587476372|FG017|Phase 2|Protocol Violation|0|||
162662496|NCT03698773|587476386|FG000|Overall Study|Lost to Follow-up|2|||
162662497|NCT03698773|587476387|FG001|Overall Study|Lost to Follow-up|1|||
162662498|NCT01158924|587476389|FG000|Overall Study|Withdrawal by Subject|1|||
162662499|NCT01158924|587476390|FG001|Overall Study|Withdrawal by Subject|2|||
162662500|NCT01158924|587476389|FG000|Overall Study|Lost to Follow-up|0|||
162662501|NCT01158924|587476390|FG001|Overall Study|Lost to Follow-up|1|||
162662502|NCT01260922|587476394|FG000|First Intervention|Withdrawal by Subject|0|||
162662503|NCT01260922|587476395|FG001|First Intervention|Withdrawal by Subject|1|||
162662504|NCT01260922|587476394|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
162662505|NCT01260922|587476395|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
163141330|NCT02219464|589227868|FG000|Overall Study|catheter malfunction|1|||
163141331|NCT02219464|589227869|FG001|Overall Study|catheter malfunction|0|||
163141332|NCT00984256|589227870|FG000|Overall Study|Withdrawal by Subject|0|||
163141333|NCT00984256|589227871|FG001|Overall Study|Withdrawal by Subject|1|||
163141334|NCT02544321|589227877|FG000|Overall Study|Withdrawal by Subject|1|||
163141335|NCT02544321|589227878|FG001|Overall Study|Withdrawal by Subject|2|||
163141336|NCT02544321|589227877|FG000|Overall Study|Adverse Event|1|||
163141337|NCT02544321|589227878|FG001|Overall Study|Adverse Event|1|||
163141338|NCT02544321|589227877|FG000|Overall Study|Protocol Violation|0|||
163141339|NCT02544321|589227878|FG001|Overall Study|Protocol Violation|1|||
163141340|NCT03529110|589227879|FG000|Overall Study|Progressive Disease|66|||
163141341|NCT03529110|589227880|FG001|Overall Study|Progressive Disease|158|||
163141342|NCT03529110|589227879|FG000|Overall Study|Clinical Progression|4|||
163141343|NCT03529110|589227880|FG001|Overall Study|Clinical Progression|12|||
163141344|NCT03529110|589227879|FG000|Overall Study|Adverse Event|35|||
163141345|NCT03529110|589227880|FG001|Overall Study|Adverse Event|17|||
163141346|NCT03529110|589227879|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
163141347|NCT03529110|589227880|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
163141348|NCT03529110|589227879|FG000|Overall Study|Lack of Efficacy|3|||
163141349|NCT03529110|589227880|FG001|Overall Study|Lack of Efficacy|3|||
163141350|NCT03529110|589227879|FG000|Overall Study|Physician Decision|2|||
163141351|NCT03529110|589227880|FG001|Overall Study|Physician Decision|8|||
163141352|NCT03529110|589227879|FG000|Overall Study|Miscellaneous|2|||
162720934|NCT01317420|587685968|FG007|Overall Study|Non-compliant with protocol|0|||
162662506|NCT01260922|587476394|FG000|Second Intervention|Emesis|0|||
162662507|NCT01260922|587476395|FG001|Second Intervention|Emesis|2|||
162662508|NCT03732248|587476398|FG000|Overall Study|Withdrawal by Subject|1|||
162662509|NCT03732248|587476399|FG001|Overall Study|Withdrawal by Subject|0|||
162662510|NCT01599650|587476400|FG000|Overall Study|Administrative issue|1|||
162662511|NCT01599650|587476401|FG001|Overall Study|Administrative issue|0|||
162662512|NCT01599650|587476402|FG002|Overall Study|Administrative issue|1|||
162662513|NCT01599650|587476400|FG000|Overall Study|Physician Decision|2|||
162662514|NCT01599650|587476401|FG001|Overall Study|Physician Decision|0|||
162662515|NCT01599650|587476402|FG002|Overall Study|Physician Decision|7|||
162662516|NCT01599650|587476400|FG000|Overall Study|Protocol Violation|0|||
162662517|NCT01599650|587476401|FG001|Overall Study|Protocol Violation|3|||
162662518|NCT01599650|587476402|FG002|Overall Study|Protocol Violation|0|||
162662519|NCT01599650|587476400|FG000|Overall Study|Death|2|||
162662520|NCT01599650|587476401|FG001|Overall Study|Death|1|||
162662521|NCT01599650|587476402|FG002|Overall Study|Death|2|||
162662522|NCT01599650|587476400|FG000|Overall Study|Lost to Follow-up|3|||
162662523|NCT01599650|587476401|FG001|Overall Study|Lost to Follow-up|3|||
162662524|NCT01599650|587476402|FG002|Overall Study|Lost to Follow-up|3|||
162662525|NCT01599650|587476400|FG000|Overall Study|Withdrawal by Subject|11|||
162662526|NCT01599650|587476401|FG001|Overall Study|Withdrawal by Subject|11|||
162662527|NCT01599650|587476402|FG002|Overall Study|Withdrawal by Subject|10|||
162662528|NCT01599650|587476400|FG000|Overall Study|Adverse Event|3|||
162662529|NCT01599650|587476401|FG001|Overall Study|Adverse Event|8|||
162662530|NCT01599650|587476402|FG002|Overall Study|Adverse Event|4|||
162662531|NCT01731171|587476403|FG000|Overall Study|Withdrawal by Subject|4|||
162662532|NCT01731171|587476404|FG001|Overall Study|Withdrawal by Subject|1|||
162662533|NCT01731171|587476403|FG000|Overall Study|Lost to Follow-up|3|||
162662534|NCT01731171|587476404|FG001|Overall Study|Lost to Follow-up|2|||
162662535|NCT01731171|587476403|FG000|Overall Study|Moved out of Area|0|||
162662536|NCT01731171|587476404|FG001|Overall Study|Moved out of Area|2|||
162662537|NCT01731171|587476403|FG000|Overall Study|Terminated for Lack of Adherence|0|||
162662538|NCT01731171|587476404|FG001|Overall Study|Terminated for Lack of Adherence|1|||
162662539|NCT01731171|587476403|FG000|Overall Study|Terminated for Safety Reasons|0|||
162662540|NCT01731171|587476404|FG001|Overall Study|Terminated for Safety Reasons|1|||
162662541|NCT01410110|587476405|FG000|Overall Study|Withdrawal by Subject|4|||
162662542|NCT01410110|587476406|FG001|Overall Study|Withdrawal by Subject|2|||
162662543|NCT01700946|587476407|FG000|Overall Study|Lost to Follow-up|1|||
162662544|NCT01700946|587476408|FG001|Overall Study|Lost to Follow-up|0|||
162662545|NCT01700946|587476407|FG000|Overall Study|Physician Decision|7|||
162662546|NCT01700946|587476408|FG001|Overall Study|Physician Decision|12|||
162662547|NCT01700946|587476407|FG000|Overall Study|Withdrawal by Subject|0|||
162662548|NCT01700946|587476408|FG001|Overall Study|Withdrawal by Subject|2|||
163141353|NCT03529110|589227880|FG001|Overall Study|Miscellaneous|5|||
163141354|NCT03493945|589227881|FG000|Phase I Dose Escalation|Ineligible|0|||
163141355|NCT03493945|589227882|FG001|Phase I Dose Escalation|Ineligible|0|||
163141356|NCT03493945|589227883|FG002|Phase I Dose Escalation|Ineligible|1|||
163141357|NCT03493945|589227884|FG003|Phase I Dose Escalation|Ineligible|0|||
163141358|NCT03493945|589227885|FG004|Phase I Dose Escalation|Ineligible|0|||
163141359|NCT03493945|589227886|FG005|Phase I Dose Escalation|Ineligible|0|||
163141360|NCT03493945|589227887|FG006|Phase I Dose Escalation|Ineligible|0|||
163141361|NCT03493945|589227881|FG000|Phase I Dose Escalation|New therapy|0|||
163141362|NCT03493945|589227882|FG001|Phase I Dose Escalation|New therapy|1|||
163141363|NCT03493945|589227883|FG002|Phase I Dose Escalation|New therapy|0|||
163141364|NCT03493945|589227884|FG003|Phase I Dose Escalation|New therapy|0|||
163141365|NCT03493945|589227885|FG004|Phase I Dose Escalation|New therapy|0|||
163141366|NCT03493945|589227886|FG005|Phase I Dose Escalation|New therapy|0|||
163141367|NCT03493945|589227887|FG006|Phase I Dose Escalation|New therapy|0|||
163141368|NCT03493945|589227881|FG000|Phase II Dose Expansion|Refused further treatment|0|||
163141369|NCT03493945|589227882|FG001|Phase II Dose Expansion|Refused further treatment|0|||
163141370|NCT03493945|589227883|FG002|Phase II Dose Expansion|Refused further treatment|0|||
163141371|NCT03493945|589227884|FG003|Phase II Dose Expansion|Refused further treatment|0|||
163141372|NCT03493945|589227885|FG004|Phase II Dose Expansion|Refused further treatment|1|||
162662549|NCT01700946|587476407|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
162662550|NCT01700946|587476408|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
163141373|NCT03493945|589227886|FG005|Phase II Dose Expansion|Refused further treatment|1|||
163141374|NCT03493945|589227887|FG006|Phase II Dose Expansion|Refused further treatment|0|||
163141375|NCT03493945|589227881|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
162662551|NCT01700946|587476407|FG000|Overall Study|Relapse|2|||
162662552|NCT01700946|587476408|FG001|Overall Study|Relapse|1|||
162662553|NCT01700946|587476407|FG000|Overall Study|Unacceptable toxicity|1|||
162662554|NCT01700946|587476408|FG001|Overall Study|Unacceptable toxicity|0|||
162662555|NCT00684424|587476409|FG000|Overall Study|Adverse Event|1|||
162662556|NCT00684424|587476409|FG000|Overall Study|Lost to Follow-up|2|||
162662557|NCT00684424|587476409|FG000|Overall Study|Other|2|||
162662558|NCT01649856|587476412|FG000|Overall Study|Withdrawal by Subject|14|||
163141376|NCT03493945|589227882|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141377|NCT03493945|589227883|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141378|NCT03493945|589227884|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
163141379|NCT03493945|589227885|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141380|NCT03493945|589227886|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141381|NCT03493945|589227887|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
163141382|NCT05104450|589227888|FG000|Overall Study|Death|1|||
163141383|NCT05104450|589227889|FG001|Overall Study|Death|2|||
163141384|NCT05104450|589227888|FG000|Overall Study|Withdrawal by Subject|3|||
163141385|NCT05104450|589227889|FG001|Overall Study|Withdrawal by Subject|1|||
163141386|NCT01584232|589227890|FG000|Overall Study|Adverse Event|3|||
163141387|NCT01584232|589227891|FG001|Overall Study|Adverse Event|1|||
163141388|NCT01584232|589227890|FG000|Overall Study|Withdrawal by Subject|2|||
163141389|NCT01584232|589227891|FG001|Overall Study|Withdrawal by Subject|1|||
163141390|NCT01584232|589227890|FG000|Overall Study|Physician Decision|2|||
163141391|NCT01584232|589227891|FG001|Overall Study|Physician Decision|1|||
163141392|NCT01584232|589227890|FG000|Overall Study|Lost to Follow-up|1|||
163141393|NCT01584232|589227891|FG001|Overall Study|Lost to Follow-up|0|||
163141394|NCT01307319|589227892|FG000|Overall Study|Adverse Event|2|||
163141395|NCT01307319|589227893|FG001|Overall Study|Adverse Event|2|||
163141396|NCT01307319|589227894|FG002|Overall Study|Adverse Event|1|||
163141397|NCT01307319|589227892|FG000|Overall Study|Lost to Follow-up|1|||
163141398|NCT01307319|589227893|FG001|Overall Study|Lost to Follow-up|0|||
163141399|NCT01307319|589227894|FG002|Overall Study|Lost to Follow-up|1|||
163141400|NCT01307319|589227892|FG000|Overall Study|Protocol Violation|1|||
163141401|NCT01307319|589227893|FG001|Overall Study|Protocol Violation|1|||
163141402|NCT01307319|589227894|FG002|Overall Study|Protocol Violation|0|||
163141403|NCT01307319|589227892|FG000|Overall Study|Withdrawal by Subject|0|||
163141404|NCT01307319|589227893|FG001|Overall Study|Withdrawal by Subject|1|||
163141405|NCT01307319|589227894|FG002|Overall Study|Withdrawal by Subject|2|||
163141406|NCT01307319|589227892|FG000|Overall Study|Other|0|||
163141407|NCT01307319|589227893|FG001|Overall Study|Other|4|||
163141408|NCT01307319|589227894|FG002|Overall Study|Other|3|||
163141409|NCT02735239|589227896|FG000|Overall Study|Adverse Event|0|||
163141410|NCT02735239|589227897|FG001|Overall Study|Adverse Event|0|||
163141411|NCT02735239|589227898|FG002|Overall Study|Adverse Event|4|||
163141412|NCT02735239|589227899|FG003|Overall Study|Adverse Event|0|||
163141413|NCT02735239|589227900|FG004|Overall Study|Adverse Event|0|||
163141414|NCT02735239|589227901|FG005|Overall Study|Adverse Event|0|||
163141415|NCT02735239|589227896|FG000|Overall Study|Death|1|||
163141416|NCT02735239|589227897|FG001|Overall Study|Death|1|||
163141417|NCT02735239|589227898|FG002|Overall Study|Death|0|||
163141418|NCT02735239|589227899|FG003|Overall Study|Death|0|||
163141419|NCT02735239|589227900|FG004|Overall Study|Death|0|||
163141420|NCT02735239|589227901|FG005|Overall Study|Death|0|||
163141421|NCT02735239|589227896|FG000|Overall Study|Physician Decision|0|||
163141422|NCT02735239|589227897|FG001|Overall Study|Physician Decision|0|||
163141423|NCT02735239|589227898|FG002|Overall Study|Physician Decision|1|||
163141424|NCT02735239|589227899|FG003|Overall Study|Physician Decision|0|||
163141425|NCT02735239|589227900|FG004|Overall Study|Physician Decision|0|||
163141426|NCT02735239|589227901|FG005|Overall Study|Physician Decision|0|||
163141427|NCT02735239|589227896|FG000|Overall Study|Progressive disease|3|||
163141428|NCT02735239|589227897|FG001|Overall Study|Progressive disease|1|||
163141429|NCT02735239|589227898|FG002|Overall Study|Progressive disease|3|||
163141430|NCT02735239|589227899|FG003|Overall Study|Progressive disease|0|||
163141431|NCT02735239|589227900|FG004|Overall Study|Progressive disease|0|||
163141432|NCT02735239|589227901|FG005|Overall Study|Progressive disease|2|||
163141433|NCT02735239|589227896|FG000|Overall Study|Withdrawal by Subject|0|||
163141434|NCT02735239|589227897|FG001|Overall Study|Withdrawal by Subject|1|||
163141435|NCT02735239|589227898|FG002|Overall Study|Withdrawal by Subject|0|||
163141436|NCT02735239|589227899|FG003|Overall Study|Withdrawal by Subject|0|||
163141437|NCT02735239|589227900|FG004|Overall Study|Withdrawal by Subject|0|||
163141438|NCT02735239|589227901|FG005|Overall Study|Withdrawal by Subject|0|||
163141439|NCT02152631|589227907|FG000|Overall Study|Adverse Event|32|||
163141440|NCT02152631|589227908|FG001|Overall Study|Adverse Event|4|||
163141441|NCT02152631|589227907|FG000|Overall Study|Withdrawal by Subject|13|||
163141442|NCT02152631|589227908|FG001|Overall Study|Withdrawal by Subject|16|||
163141443|NCT02152631|589227907|FG000|Overall Study|Noncompliance with study drug|1|||
163141444|NCT02152631|589227908|FG001|Overall Study|Noncompliance with study drug|0|||
163141445|NCT02152631|589227907|FG000|Overall Study|Physician Decision|1|||
163141446|NCT02152631|589227908|FG001|Overall Study|Physician Decision|2|||
163141447|NCT02152631|589227907|FG000|Overall Study|Lost to Follow-up|0|||
163141448|NCT02152631|589227908|FG001|Overall Study|Lost to Follow-up|1|||
163141449|NCT02152631|589227907|FG000|Overall Study|On Treatment|19|||
163141450|NCT02152631|589227908|FG001|Overall Study|On Treatment|3|||
163141451|NCT00527735|589227913|FG000|Overall Study|Disease progression|47|||
163141452|NCT00527735|589227914|FG001|Overall Study|Disease progression|61|||
163141453|NCT00527735|589227915|FG002|Overall Study|Disease progression|53|||
163141454|NCT00527735|589227913|FG000|Overall Study|Death|23|||
163141455|NCT00527735|589227914|FG001|Overall Study|Death|13|||
163141456|NCT00527735|589227915|FG002|Overall Study|Death|15|||
163141457|NCT00527735|589227913|FG000|Overall Study|Completed treatment in treatment phase|14|||
163141458|NCT00527735|589227914|FG001|Overall Study|Completed treatment in treatment phase|13|||
163141459|NCT00527735|589227915|FG002|Overall Study|Completed treatment in treatment phase|18|||
163141460|NCT00527735|589227913|FG000|Overall Study|Adverse Event|10|||
163141461|NCT00527735|589227914|FG001|Overall Study|Adverse Event|6|||
163141462|NCT00527735|589227915|FG002|Overall Study|Adverse Event|7|||
163141463|NCT00527735|589227913|FG000|Overall Study|Not identified|5|||
163141464|NCT00527735|589227914|FG001|Overall Study|Not identified|5|||
163141465|NCT00527735|589227915|FG002|Overall Study|Not identified|5|||
163141466|NCT00527735|589227913|FG000|Overall Study|Withdrawal by Subject|5|||
163141467|NCT00527735|589227914|FG001|Overall Study|Withdrawal by Subject|4|||
163141468|NCT00527735|589227915|FG002|Overall Study|Withdrawal by Subject|3|||
163141469|NCT00527735|589227913|FG000|Overall Study|No longer met study criteria|2|||
163141470|NCT00527735|589227914|FG001|Overall Study|No longer met study criteria|2|||
163141471|NCT00527735|589227915|FG002|Overall Study|No longer met study criteria|1|||
163141472|NCT00527735|589227913|FG000|Overall Study|Lost to Follow-up|0|||
163141473|NCT00527735|589227914|FG001|Overall Study|Lost to Follow-up|0|||
163141474|NCT00527735|589227915|FG002|Overall Study|Lost to Follow-up|3|||
163141475|NCT00527735|589227913|FG000|Overall Study|Poor compliance or noncompliance|0|||
163141476|NCT00527735|589227914|FG001|Overall Study|Poor compliance or noncompliance|1|||
163141477|NCT00527735|589227915|FG002|Overall Study|Poor compliance or noncompliance|1|||
163141478|NCT00527735|589227913|FG000|Overall Study|Completed treatment during maintenance|2|||
163141479|NCT00527735|589227914|FG001|Overall Study|Completed treatment during maintenance|2|||
163141480|NCT00527735|589227915|FG002|Overall Study|Completed treatment during maintenance|1|||
163141481|NCT01080807|589227920|FG000|Overall Study|Adverse Event|9|||
163141482|NCT01080807|589227921|FG001|Overall Study|Adverse Event|1|||
163141483|NCT01080807|589227920|FG000|Overall Study|Lack of Efficacy|0|||
163141484|NCT01080807|589227921|FG001|Overall Study|Lack of Efficacy|1|||
163141485|NCT01080807|589227920|FG000|Overall Study|Withdrawal by Subject|7|||
163141486|NCT01080807|589227921|FG001|Overall Study|Withdrawal by Subject|2|||
163141487|NCT01080807|589227920|FG000|Overall Study|Protocol Violation|7|||
163141488|NCT01080807|589227921|FG001|Overall Study|Protocol Violation|6|||
163141489|NCT01080807|589227920|FG000|Overall Study|Lost to Follow-up|6|||
163141490|NCT01080807|589227921|FG001|Overall Study|Lost to Follow-up|4|||
163141491|NCT01080807|589227920|FG000|Overall Study|Noncompliance with drug administration|1|||
163141492|NCT01080807|589227921|FG001|Overall Study|Noncompliance with drug administration|1|||
163141493|NCT01080807|589227920|FG000|Overall Study|Noncompliance to study procedures|1|||
163141494|NCT01080807|589227921|FG001|Overall Study|Noncompliance to study procedures|1|||
163141495|NCT01080807|589227920|FG000|Overall Study|Began working day shift|0|||
163141496|NCT01080807|589227921|FG001|Overall Study|Began working day shift|2|||
163141497|NCT01080807|589227920|FG000|Overall Study|Laid off or terminated from job|1|||
163141498|NCT01080807|589227921|FG001|Overall Study|Laid off or terminated from job|2|||
163141499|NCT01080807|589227920|FG000|Overall Study|Stopped working consistent night shifts|0|||
163141500|NCT01080807|589227921|FG001|Overall Study|Stopped working consistent night shifts|1|||
163141501|NCT01080807|589227920|FG000|Overall Study|Work schedule changing|1|||
163141502|NCT01080807|589227921|FG001|Overall Study|Work schedule changing|1|||
163141503|NCT01080807|589227920|FG000|Overall Study|Work schedule and travel|0|||
163141504|NCT01080807|589227921|FG001|Overall Study|Work schedule and travel|1|||
163141505|NCT01080807|589227920|FG000|Overall Study|Switched to first shift|1|||
163141506|NCT01080807|589227921|FG001|Overall Study|Switched to first shift|0|||
163141507|NCT01080807|589227920|FG000|Overall Study|Moved away without notifying center|1|||
163141508|NCT01080807|589227921|FG001|Overall Study|Moved away without notifying center|0|||
163141509|NCT03922581|589227929|FG000|Overall Study|Lost to Follow-up|20|||
163141510|NCT03922581|589227930|FG001|Overall Study|Lost to Follow-up|9|||
163141511|NCT03922581|589227929|FG000|Overall Study|Physician Decision|1|||
163141512|NCT03922581|589227930|FG001|Overall Study|Physician Decision|1|||
163141513|NCT03922581|589227929|FG000|Overall Study|Withdrawal by Subject|1|||
163141514|NCT03922581|589227930|FG001|Overall Study|Withdrawal by Subject|0|||
163141515|NCT00764699|589227933|FG000|Overall Study|PI left and study terminated|3|||
163141516|NCT02223715|589227934|FG000|Overall Study|Death|31|||
163141517|NCT02223715|589227934|FG000|Overall Study|Lost to Follow-up|73|||
163141518|NCT01745367|589227935|FG000|Overall Study|Death|1|||
163141519|NCT01745367|589227936|FG001|Overall Study|Death|0|||
163141520|NCT01745367|589227935|FG000|Overall Study|Withdrawal by Subject|1|||
163141521|NCT01745367|589227936|FG001|Overall Study|Withdrawal by Subject|2|||
162662559|NCT01649856|587476413|FG001|Overall Study|Withdrawal by Subject|14|||
163141522|NCT01745367|589227935|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
163141523|NCT01745367|589227936|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
163141524|NCT01745367|589227935|FG000|Overall Study|Other Reasons Unspecified|0|||
163141525|NCT01745367|589227936|FG001|Overall Study|Other Reasons Unspecified|2|||
163141526|NCT02107703|589227940|FG000|Overall Study|Withdrawal by Subject|46|||
163141527|NCT02107703|589227941|FG001|Overall Study|Withdrawal by Subject|21|||
162662560|NCT01649856|587476412|FG000|Overall Study|Protocol Violation|4|||
162662561|NCT01649856|587476413|FG001|Overall Study|Protocol Violation|4|||
162662562|NCT01649856|587476412|FG000|Overall Study|Treatment Failure|1|||
162662563|NCT01649856|587476413|FG001|Overall Study|Treatment Failure|1|||
162662564|NCT01649856|587476412|FG000|Overall Study|Death|69|||
162662565|NCT01649856|587476413|FG001|Overall Study|Death|34|||
162662566|NCT01649856|587476412|FG000|Overall Study|Stable or Progressed Disease|5|||
162662567|NCT01649856|587476413|FG001|Overall Study|Stable or Progressed Disease|3|||
163141528|NCT02107703|589227940|FG000|Overall Study|Lost to Follow-up|20|||
163141529|NCT02107703|589227941|FG001|Overall Study|Lost to Follow-up|9|||
163141530|NCT02107703|589227940|FG000|Overall Study|On study treatment/follow up|48|||
163141531|NCT02107703|589227941|FG001|Overall Study|On study treatment/follow up|5|||
163141532|NCT02366312|589227942|FG000|Overall Study|Lost to Follow-up|0|||
163141533|NCT02366312|589227943|FG001|Overall Study|Lost to Follow-up|1|||
163141534|NCT00965081|589227944|FG000|Overall Study|Adverse Event|14|||
163141535|NCT00965081|589227945|FG001|Overall Study|Adverse Event|9|||
163141536|NCT00965081|589227944|FG000|Overall Study|Lack of Efficacy|2|||
163141537|NCT00965081|589227945|FG001|Overall Study|Lack of Efficacy|5|||
163141538|NCT00965081|589227944|FG000|Overall Study|Lost to Follow-up|4|||
163141539|NCT00965081|589227945|FG001|Overall Study|Lost to Follow-up|5|||
163141540|NCT00965081|589227944|FG000|Overall Study|Physician Decision|2|||
163141541|NCT00965081|589227945|FG001|Overall Study|Physician Decision|0|||
163141542|NCT00965081|589227944|FG000|Overall Study|Protocol Violation|2|||
163141543|NCT00965081|589227945|FG001|Overall Study|Protocol Violation|5|||
163141544|NCT00965081|589227944|FG000|Overall Study|Sponsor Decision|1|||
163141545|NCT00965081|589227945|FG001|Overall Study|Sponsor Decision|0|||
163141546|NCT00965081|589227944|FG000|Overall Study|Withdrawal by Subject|4|||
163141547|NCT00965081|589227945|FG001|Overall Study|Withdrawal by Subject|7|||
163141548|NCT00965081|589227944|FG000|Overall Study|Switched to Rescue Arm|5|||
163141549|NCT00965081|589227945|FG001|Overall Study|Switched to Rescue Arm|12|||
163141550|NCT01020786|589227950|FG000|Induction Period|Entry Criteria Not Met|2|||
163141551|NCT01020786|589227950|FG000|Induction Period|Adverse Event|10|||
163141552|NCT01020786|589227950|FG000|Induction Period|Progressive Disease|31|||
163141553|NCT01020786|589227950|FG000|Induction Period|Investigator Decision|3|||
163141554|NCT01020786|589227950|FG000|Induction Period|Withdrawal by Subject|3|||
163141555|NCT01020786|589227950|FG000|Maintenance Period|Adverse Event|8|||
163141556|NCT01020786|589227950|FG000|Maintenance Period|Progressive Disease|43|||
163141557|NCT01020786|589227950|FG000|Maintenance Period|Withdrawal by Subject|8|||
163141558|NCT01020786|589227950|FG000|Maintenance Period|Sponsor Decision|1|||
163141559|NCT01338818|589227959|FG000|Overall Study|Adverse Event|8|||
163141560|NCT01338818|589227959|FG000|Overall Study|Lack of Efficacy|5|||
163141561|NCT01338818|589227959|FG000|Overall Study|no longer require study drug|1|||
163141562|NCT01338818|589227959|FG000|Overall Study|Withdrawal by Subject|11|||
163141563|NCT01338818|589227959|FG000|Overall Study|Lost to Follow-up|4|||
163141564|NCT01338818|589227959|FG000|Overall Study|Administrative problems|3|||
163141565|NCT01338818|589227959|FG000|Overall Study|Protocol Deviation|4|||
163141566|NCT05202418|589227960|FG000|Overall Study|Withdrawal by Subject|2|||
163141567|NCT05202418|589227961|FG001|Overall Study|Withdrawal by Subject|1|||
163141568|NCT05202418|589227960|FG000|Overall Study|Lost to Follow-up|1|||
163141569|NCT05202418|589227961|FG001|Overall Study|Lost to Follow-up|1|||
163141570|NCT03901144|589227964|FG000|Overall Study|Lost to Follow-up|1|||
163141571|NCT03901144|589227965|FG001|Overall Study|Lost to Follow-up|1|||
163141572|NCT03901144|589227966|FG002|Overall Study|Lost to Follow-up|1|||
163141573|NCT03901144|589227967|FG003|Overall Study|Lost to Follow-up|1|||
163141574|NCT02491983|589227968|FG000|Overall Study|Physician Decision|1|||
163141575|NCT02491983|589227969|FG001|Overall Study|Physician Decision|0|||
163141576|NCT02491983|589227968|FG000|Overall Study|Not meet selection criteria|1|||
163141577|NCT02491983|589227969|FG001|Overall Study|Not meet selection criteria|0|||
163141578|NCT02491983|589227968|FG000|Overall Study|Withdrawal by Subject|0|||
163141579|NCT02491983|589227969|FG001|Overall Study|Withdrawal by Subject|1|||
163141580|NCT02021565|589227970|FG000|Baseline Through Intervention|Death|0|||
163141581|NCT02021565|589227971|FG001|Baseline Through Intervention|Death|1|||
163141582|NCT02021565|589227970|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
163141583|NCT02021565|589227971|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
163141584|NCT02021565|589227970|FG000|Baseline Through Intervention|Protocol Violation|0|||
163141585|NCT02021565|589227971|FG001|Baseline Through Intervention|Protocol Violation|7|||
163141586|NCT02021565|589227970|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
163141587|NCT02021565|589227971|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
163141588|NCT02021565|589227970|FG000|3-month Follow-up|Death|3|||
162662568|NCT01649856|587476412|FG000|Overall Study|Lost to Follow-up|20|||
163141589|NCT02021565|589227971|FG001|3-month Follow-up|Death|0|||
163141590|NCT02021565|589227970|FG000|3-month Follow-up|Withdrawal by Subject|4|||
162662569|NCT01649856|587476413|FG001|Overall Study|Lost to Follow-up|16|||
162662570|NCT01649856|587476412|FG000|Overall Study|Lack of Compliance|6|||
163141591|NCT02021565|589227971|FG001|3-month Follow-up|Withdrawal by Subject|0|||
162662571|NCT01649856|587476413|FG001|Overall Study|Lack of Compliance|1|||
163141592|NCT02021565|589227970|FG000|3-month Follow-up|Protocol Violation|3|||
163141593|NCT02021565|589227971|FG001|3-month Follow-up|Protocol Violation|2|||
163141594|NCT03575403|589227973|FG000|Overall Study|Adverse Event|1|||
163141595|NCT03575403|589227974|FG001|Overall Study|Adverse Event|0|||
163141596|NCT03575403|589227975|FG002|Overall Study|Adverse Event|0|||
163141597|NCT03575403|589227973|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
163141598|NCT03575403|589227974|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
163141599|NCT03575403|589227975|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
163141600|NCT02292719|589227976|FG000|Overall Study|Withdrawal by Subject|0|||
163141601|NCT02292719|589227977|FG001|Overall Study|Withdrawal by Subject|0|||
163141602|NCT02292719|589227978|FG002|Overall Study|Withdrawal by Subject|0|||
163141603|NCT02292719|589227979|FG003|Overall Study|Withdrawal by Subject|1|||
163141604|NCT02292719|589227980|FG004|Overall Study|Withdrawal by Subject|1|||
163141605|NCT02292719|589227981|FG005|Overall Study|Withdrawal by Subject|0|||
163141606|NCT02292719|589227976|FG000|Overall Study|Subject enrolled in new study.|0|||
163141607|NCT02292719|589227977|FG001|Overall Study|Subject enrolled in new study.|0|||
163141608|NCT02292719|589227978|FG002|Overall Study|Subject enrolled in new study.|1|||
163141609|NCT02292719|589227979|FG003|Overall Study|Subject enrolled in new study.|0|||
163141610|NCT02292719|589227980|FG004|Overall Study|Subject enrolled in new study.|0|||
163141611|NCT02292719|589227981|FG005|Overall Study|Subject enrolled in new study.|0|||
163141612|NCT01332994|589227982|FG000|Overall Study|Adverse Event|34|||
163141613|NCT01332994|589227982|FG000|Overall Study|Death|1|||
163141614|NCT01332994|589227982|FG000|Overall Study|Lack of Efficacy|1|||
163141615|NCT01332994|589227982|FG000|Overall Study|Lost to Follow-up|4|||
163141616|NCT01332994|589227982|FG000|Overall Study|Protocol Violation|6|||
163141617|NCT01332994|589227982|FG000|Overall Study|Withdrawal by Subject|15|||
163141618|NCT01332994|589227982|FG000|Overall Study|Administrative Problem|2|||
163141619|NCT01332994|589227982|FG000|Overall Study|Other|8|||
163141620|NCT00731679|589227984|FG000|Overall Study|Adverse Event|7|||
163141621|NCT00731679|589227985|FG001|Overall Study|Adverse Event|8|||
163141622|NCT00731679|589227984|FG000|Overall Study|Withdrawal by Subject|8|||
163141623|NCT00731679|589227985|FG001|Overall Study|Withdrawal by Subject|8|||
163141624|NCT00731679|589227984|FG000|Overall Study|Lost to Follow-up|7|||
163141625|NCT00731679|589227985|FG001|Overall Study|Lost to Follow-up|8|||
163141626|NCT00731679|589227984|FG000|Overall Study|Noncompliance|0|||
163141627|NCT00731679|589227985|FG001|Overall Study|Noncompliance|1|||
163141628|NCT00731679|589227984|FG000|Overall Study|Pregnancy|0|||
163141629|NCT00731679|589227985|FG001|Overall Study|Pregnancy|1|||
163141630|NCT03089580|589227991|FG000|Overall Study|Lost to Follow-up|2|||
163141631|NCT03087513|589227992|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
163141632|NCT04628780|589227993|FG000|Overall Study|Death|0|||
163141633|NCT04628780|589227994|FG001|Overall Study|Death|1|||
163141634|NCT04628780|589227995|FG002|Overall Study|Death|0|||
163141635|NCT04628780|589227996|FG003|Overall Study|Death|0|||
163141636|NCT04628780|589227997|FG004|Overall Study|Death|1|||
163141637|NCT04628780|589227998|FG005|Overall Study|Death|0|||
163141638|NCT04628780|589227993|FG000|Overall Study|Physician Decision|2|||
163141639|NCT04628780|589227994|FG001|Overall Study|Physician Decision|0|||
163141640|NCT04628780|589227995|FG002|Overall Study|Physician Decision|0|||
163141641|NCT04628780|589227996|FG003|Overall Study|Physician Decision|0|||
163141642|NCT04628780|589227997|FG004|Overall Study|Physician Decision|2|||
163141643|NCT04628780|589227998|FG005|Overall Study|Physician Decision|0|||
163141644|NCT04628780|589227993|FG000|Overall Study|Progressive disease|2|||
163141645|NCT04628780|589227994|FG001|Overall Study|Progressive disease|2|||
163141646|NCT04628780|589227995|FG002|Overall Study|Progressive disease|2|||
163141647|NCT04628780|589227996|FG003|Overall Study|Progressive disease|3|||
163141648|NCT04628780|589227997|FG004|Overall Study|Progressive disease|9|||
163141649|NCT04628780|589227998|FG005|Overall Study|Progressive disease|4|||
163141650|NCT04628780|589227993|FG000|Overall Study|Withdrawal by Subject|0|||
163141651|NCT04628780|589227994|FG001|Overall Study|Withdrawal by Subject|1|||
163141652|NCT04628780|589227995|FG002|Overall Study|Withdrawal by Subject|2|||
163141653|NCT04628780|589227996|FG003|Overall Study|Withdrawal by Subject|0|||
163141654|NCT04628780|589227997|FG004|Overall Study|Withdrawal by Subject|3|||
163141655|NCT04628780|589227998|FG005|Overall Study|Withdrawal by Subject|1|||
163141656|NCT04628780|589227993|FG000|Overall Study|Global deterioration of health status|0|||
163141657|NCT04628780|589227994|FG001|Overall Study|Global deterioration of health status|0|||
163141658|NCT04628780|589227995|FG002|Overall Study|Global deterioration of health status|0|||
163141659|NCT04628780|589227996|FG003|Overall Study|Global deterioration of health status|0|||
163141660|NCT04628780|589227997|FG004|Overall Study|Global deterioration of health status|1|||
163141661|NCT04628780|589227998|FG005|Overall Study|Global deterioration of health status|1|||
163141662|NCT03269994|589228000|FG000|Overall Study|Withdrawal by Subject|4|||
163141663|NCT03269994|589228001|FG001|Overall Study|Withdrawal by Subject|5|||
163141664|NCT03269994|589228000|FG000|Overall Study|Unresectable at surgery|39|||
163141665|NCT03269994|589228001|FG001|Overall Study|Unresectable at surgery|58|||
163141666|NCT03269994|589228000|FG000|Overall Study|Patient canceled surgery|5|||
163141667|NCT03269994|589228001|FG001|Overall Study|Patient canceled surgery|14|||
162662572|NCT01649856|587476412|FG000|Overall Study|Other|20|||
162662573|NCT01649856|587476413|FG001|Overall Study|Other|5|||
162662574|NCT00281840|587476414|FG000|Overall Study|Adverse Event|12|||
162662575|NCT00281840|587476414|FG000|Overall Study|Physician Decision|6|||
162662576|NCT00281840|587476414|FG000|Overall Study|Withdrawal by Subject|3|||
162662577|NCT00281840|587476414|FG000|Overall Study|Disease Progression|2|||
162662578|NCT00281840|587476414|FG000|Overall Study|exceed maximum delay in treatment|1|||
162662579|NCT00281840|587476414|FG000|Overall Study|Complicating Disease|1|||
162662580|NCT00835406|587476415|FG000|Period: First Intervention|Adverse Event|0|||
162662581|NCT00835406|587476416|FG001|Period: First Intervention|Adverse Event|1|||
162662582|NCT00835406|587476415|FG000|Period: First Intervention|Withdrawal by Subject|2|||
162662583|NCT00835406|587476416|FG001|Period: First Intervention|Withdrawal by Subject|0|||
162662584|NCT00835406|587476415|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
162662585|NCT00835406|587476416|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
162662586|NCT01079234|587476419|FG000|Main: Week 0 to 26|Adverse Event|5|||
162662587|NCT01079234|587476420|FG001|Main: Week 0 to 26|Adverse Event|4|||
162662588|NCT01079234|587476421|FG002|Main: Week 0 to 26|Adverse Event|1|||
162662589|NCT01079234|587476422|FG003|Main: Week 0 to 26|Adverse Event|0|||
162662590|NCT01079234|587476419|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
162662591|NCT01079234|587476420|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
162662592|NCT01079234|587476421|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
162662593|NCT01079234|587476422|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
162662594|NCT01079234|587476419|FG000|Main: Week 0 to 26|Protocol Violation|6|||
162662595|NCT01079234|587476420|FG001|Main: Week 0 to 26|Protocol Violation|2|||
162662596|NCT01079234|587476421|FG002|Main: Week 0 to 26|Protocol Violation|4|||
162662597|NCT01079234|587476422|FG003|Main: Week 0 to 26|Protocol Violation|0|||
162662598|NCT01079234|587476419|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
162662599|NCT01079234|587476420|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
162662600|NCT01079234|587476421|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
162662601|NCT01079234|587476422|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
162662602|NCT01079234|587476419|FG000|Main: Week 0 to 26|Unclassified|7|||
162662603|NCT01079234|587476420|FG001|Main: Week 0 to 26|Unclassified|13|||
162662604|NCT01079234|587476421|FG002|Main: Week 0 to 26|Unclassified|4|||
162662605|NCT01079234|587476422|FG003|Main: Week 0 to 26|Unclassified|0|||
162662606|NCT01079234|587476419|FG000|Extension: Week 27 to 52|Adverse Event|0|||
162662607|NCT01079234|587476420|FG001|Extension: Week 27 to 52|Adverse Event|0|||
162662608|NCT01079234|587476421|FG002|Extension: Week 27 to 52|Adverse Event|1|||
162662609|NCT01079234|587476422|FG003|Extension: Week 27 to 52|Adverse Event|0|||
162662610|NCT01079234|587476419|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
162662611|NCT01079234|587476420|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
162662612|NCT01079234|587476421|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
162662613|NCT01079234|587476422|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
162662614|NCT01079234|587476419|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
162662615|NCT01079234|587476420|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
162662616|NCT01079234|587476421|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
162662617|NCT01079234|587476422|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
162662618|NCT01079234|587476419|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
162662619|NCT01079234|587476420|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
162662620|NCT01079234|587476421|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
162662621|NCT01079234|587476422|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
162662622|NCT01079234|587476419|FG000|Extension: Week 27 to 52|Unclassified|0|||
162662623|NCT01079234|587476420|FG001|Extension: Week 27 to 52|Unclassified|0|||
162662624|NCT01079234|587476421|FG002|Extension: Week 27 to 52|Unclassified|4|||
162662625|NCT01079234|587476422|FG003|Extension: Week 27 to 52|Unclassified|7|||
162662626|NCT01071512|587476427|FG000|Overall Study|Adverse Event|1|||
162662627|NCT01071512|587476427|FG000|Overall Study|Development of antibodies to drug|2|||
162662628|NCT01071512|587476427|FG000|Overall Study|positive anti-JC virus antibody test|2|||
162662629|NCT00183872|587476428|FG000|Overall Study|Death|3|||
162662630|NCT00183872|587476428|FG000|Overall Study|Adverse Event|9|||
162662631|NCT00183872|587476428|FG000|Overall Study|Withdrawal by Subject|2|||
162662632|NCT00183872|587476428|FG000|Overall Study|Drug delayed more than 28 days|2|||
162662633|NCT00853658|587476430|FG000|Overall Study|Death|713|||
162662634|NCT00853658|587476431|FG001|Overall Study|Death|768|||
162662635|NCT00853658|587476432|FG002|Overall Study|Death|753|||
162662636|NCT00853658|587476430|FG000|Overall Study|Lost to Follow-up|11|||
162662637|NCT00853658|587476431|FG001|Overall Study|Lost to Follow-up|6|||
162662638|NCT00853658|587476432|FG002|Overall Study|Lost to Follow-up|11|||
162662639|NCT00853658|587476430|FG000|Overall Study|H.A. Request|26|||
162662640|NCT00853658|587476431|FG001|Overall Study|H.A. Request|23|||
162662641|NCT00853658|587476432|FG002|Overall Study|H.A. Request|19|||
162662642|NCT00853658|587476430|FG000|Overall Study|IRB request|0|||
162662643|NCT00853658|587476431|FG001|Overall Study|IRB request|0|||
163141668|NCT03269994|589228000|FG000|Overall Study|Preoperative progression|14|||
163141669|NCT03269994|589228001|FG001|Overall Study|Preoperative progression|9|||
162662644|NCT00853658|587476432|FG002|Overall Study|IRB request|2|||
162720935|NCT01317420|587685969|FG008|Overall Study|Non-compliant with protocol|0|||
162662645|NCT00853658|587476430|FG000|Overall Study|Vital Status known (alive) at study end|2|||
162662646|NCT00853658|587476431|FG001|Overall Study|Vital Status known (alive) at study end|3|||
162662647|NCT00853658|587476432|FG002|Overall Study|Vital Status known (alive) at study end|3|||
162662648|NCT00853658|587476430|FG000|Overall Study|Vital Status unknown at study end|1|||
162662649|NCT00853658|587476431|FG001|Overall Study|Vital Status unknown at study end|1|||
162662650|NCT00853658|587476432|FG002|Overall Study|Vital Status unknown at study end|0|||
162662651|NCT00853658|587476430|FG000|Overall Study|Vital Status at study end N/A|8|||
162662652|NCT00853658|587476431|FG001|Overall Study|Vital Status at study end N/A|10|||
162720936|NCT01317420|587685970|FG009|Overall Study|Non-compliant with protocol|0|||
162662653|NCT00853658|587476432|FG002|Overall Study|Vital Status at study end N/A|10|||
162662654|NCT00853658|587476430|FG000|Overall Study|Patient's request|21|||
162662655|NCT00853658|587476431|FG001|Overall Study|Patient's request|17|||
162662656|NCT00853658|587476432|FG002|Overall Study|Patient's request|11|||
162662657|NCT00853658|587476430|FG000|Overall Study|Missing study completion information|5|||
162662658|NCT00853658|587476431|FG001|Overall Study|Missing study completion information|4|||
162662659|NCT00853658|587476432|FG002|Overall Study|Missing study completion information|6|||
162662660|NCT02797262|587476433|FG000|Overall Study|Withdrawal by Subject|5|||
162662661|NCT02797262|587476434|FG001|Overall Study|Withdrawal by Subject|1|||
162662662|NCT02797262|587476433|FG000|Overall Study|Lost to Follow-up|10|||
162662663|NCT02797262|587476434|FG001|Overall Study|Lost to Follow-up|7|||
162662664|NCT02797262|587476433|FG000|Overall Study|Death|1|||
163141670|NCT03269994|589228000|FG000|Overall Study|Preoperative infection|10|||
163141671|NCT03269994|589228001|FG001|Overall Study|Preoperative infection|4|||
163141672|NCT03269994|589228000|FG000|Overall Study|Kidney insufficiency|1|||
163141673|NCT03269994|589228001|FG001|Overall Study|Kidney insufficiency|0|||
163141674|NCT03269994|589228000|FG000|Overall Study|Drug allergy|0|||
163141675|NCT03269994|589228001|FG001|Overall Study|Drug allergy|2|||
163141676|NCT03269994|589228000|FG000|Overall Study|Operation changed to different resection|9|||
163141677|NCT03269994|589228001|FG001|Overall Study|Operation changed to different resection|0|||
163141678|NCT03269994|589228000|FG000|Overall Study|Preoperative steroid|0|||
163141679|NCT03269994|589228001|FG001|Overall Study|Preoperative steroid|3|||
163141680|NCT03269994|589228000|FG000|Overall Study|Accrual Closed|2|||
163141681|NCT03269994|589228001|FG001|Overall Study|Accrual Closed|0|||
163141682|NCT03269994|589228000|FG000|Overall Study|Operation changed to different resection|0|||
163141683|NCT03269994|589228001|FG001|Overall Study|Operation changed to different resection|10|||
163141684|NCT01288989|589228003|FG000|Overall Study|Death|0|||
163141685|NCT01288989|589228004|FG001|Overall Study|Death|0|||
163141686|NCT01288989|589228005|FG002|Overall Study|Death|0|||
163141687|NCT01288989|589228006|FG003|Overall Study|Death|1|||
163141688|NCT01288989|589228007|FG004|Overall Study|Death|0|||
163141689|NCT01288989|589228003|FG000|Overall Study|Dose limiting toxicity|1|||
163141690|NCT01288989|589228004|FG001|Overall Study|Dose limiting toxicity|0|||
163141691|NCT01288989|589228005|FG002|Overall Study|Dose limiting toxicity|0|||
163141692|NCT01288989|589228006|FG003|Overall Study|Dose limiting toxicity|0|||
163141693|NCT01288989|589228007|FG004|Overall Study|Dose limiting toxicity|0|||
163141694|NCT01288989|589228003|FG000|Overall Study|Adverse Event|0|||
163141695|NCT01288989|589228004|FG001|Overall Study|Adverse Event|0|||
163141696|NCT01288989|589228005|FG002|Overall Study|Adverse Event|0|||
163141697|NCT01288989|589228006|FG003|Overall Study|Adverse Event|0|||
163141698|NCT01288989|589228007|FG004|Overall Study|Adverse Event|2|||
163141699|NCT01288989|589228003|FG000|Overall Study|Physician Decision|0|||
163141700|NCT01288989|589228004|FG001|Overall Study|Physician Decision|0|||
163141701|NCT01288989|589228005|FG002|Overall Study|Physician Decision|0|||
163141702|NCT01288989|589228006|FG003|Overall Study|Physician Decision|0|||
163141703|NCT01288989|589228007|FG004|Overall Study|Physician Decision|1|||
162662665|NCT02797262|587476434|FG001|Overall Study|Death|2|||
162662666|NCT02797262|587476433|FG000|Overall Study|Adverse Event|1|||
162662667|NCT02797262|587476434|FG001|Overall Study|Adverse Event|0|||
162662668|NCT02797262|587476433|FG000|Overall Study|COVID-19|2|||
162662669|NCT02797262|587476434|FG001|Overall Study|COVID-19|1|||
163141704|NCT01288989|589228003|FG000|Overall Study|Withdrawal by Subject|0|||
163141705|NCT01288989|589228004|FG001|Overall Study|Withdrawal by Subject|0|||
163141706|NCT01288989|589228005|FG002|Overall Study|Withdrawal by Subject|0|||
163141707|NCT01288989|589228006|FG003|Overall Study|Withdrawal by Subject|0|||
163141708|NCT01288989|589228007|FG004|Overall Study|Withdrawal by Subject|3|||
163141709|NCT01132313|589228008|FG000|Overall Study|Lack of Efficacy|1|||
163141710|NCT01132313|589228009|FG001|Overall Study|Lack of Efficacy|0|||
163141711|NCT01132313|589228010|FG002|Overall Study|Lack of Efficacy|0|||
163141712|NCT01132313|589228011|FG003|Overall Study|Lack of Efficacy|0|||
163141713|NCT01132313|589228012|FG004|Overall Study|Lack of Efficacy|0|||
163141714|NCT01132313|589228013|FG005|Overall Study|Lack of Efficacy|0|||
163141715|NCT01132313|589228014|FG006|Overall Study|Lack of Efficacy|0|||
163141716|NCT01132313|589228015|FG007|Overall Study|Lack of Efficacy|3|||
163141717|NCT01132313|589228016|FG008|Overall Study|Lack of Efficacy|14|||
163141718|NCT01132313|589228017|FG009|Overall Study|Lack of Efficacy|16|||
163141719|NCT01132313|589228018|FG010|Overall Study|Lack of Efficacy|0|||
163141720|NCT01132313|589228019|FG011|Overall Study|Lack of Efficacy|0|||
163141721|NCT01132313|589228008|FG000|Overall Study|Not treated|2|||
163141722|NCT01132313|589228009|FG001|Overall Study|Not treated|0|||
163141723|NCT01132313|589228010|FG002|Overall Study|Not treated|0|||
163141724|NCT01132313|589228011|FG003|Overall Study|Not treated|0|||
163141725|NCT01132313|589228012|FG004|Overall Study|Not treated|2|||
163141726|NCT01132313|589228013|FG005|Overall Study|Not treated|1|||
163141727|NCT01132313|589228014|FG006|Overall Study|Not treated|3|||
163141728|NCT01132313|589228015|FG007|Overall Study|Not treated|0|||
163141729|NCT01132313|589228016|FG008|Overall Study|Not treated|0|||
163141730|NCT01132313|589228017|FG009|Overall Study|Not treated|0|||
163141731|NCT01132313|589228018|FG010|Overall Study|Not treated|0|||
163141732|NCT01132313|589228019|FG011|Overall Study|Not treated|0|||
163141733|NCT01132313|589228008|FG000|Overall Study|Adverse Event|0|||
163141734|NCT01132313|589228009|FG001|Overall Study|Adverse Event|0|||
163141735|NCT01132313|589228010|FG002|Overall Study|Adverse Event|4|||
163141736|NCT01132313|589228011|FG003|Overall Study|Adverse Event|10|||
163141737|NCT01132313|589228012|FG004|Overall Study|Adverse Event|19|||
163141738|NCT01132313|589228013|FG005|Overall Study|Adverse Event|6|||
163141739|NCT01132313|589228014|FG006|Overall Study|Adverse Event|5|||
163141740|NCT01132313|589228015|FG007|Overall Study|Adverse Event|3|||
163141741|NCT01132313|589228016|FG008|Overall Study|Adverse Event|7|||
163141742|NCT01132313|589228017|FG009|Overall Study|Adverse Event|2|||
163141743|NCT01132313|589228018|FG010|Overall Study|Adverse Event|0|||
163141744|NCT01132313|589228019|FG011|Overall Study|Adverse Event|0|||
163141745|NCT01132313|589228008|FG000|Overall Study|Protocol Violation|0|||
163141746|NCT01132313|589228009|FG001|Overall Study|Protocol Violation|0|||
163141747|NCT01132313|589228010|FG002|Overall Study|Protocol Violation|0|||
163141748|NCT01132313|589228011|FG003|Overall Study|Protocol Violation|1|||
163141749|NCT01132313|589228012|FG004|Overall Study|Protocol Violation|0|||
163141750|NCT01132313|589228013|FG005|Overall Study|Protocol Violation|0|||
163141751|NCT01132313|589228014|FG006|Overall Study|Protocol Violation|0|||
163141752|NCT01132313|589228015|FG007|Overall Study|Protocol Violation|0|||
163141753|NCT01132313|589228016|FG008|Overall Study|Protocol Violation|0|||
163141754|NCT01132313|589228017|FG009|Overall Study|Protocol Violation|0|||
163141755|NCT01132313|589228018|FG010|Overall Study|Protocol Violation|0|||
163141756|NCT01132313|589228019|FG011|Overall Study|Protocol Violation|0|||
162662670|NCT02797262|587476433|FG000|Overall Study|Out-of-country|1|||
162662671|NCT02797262|587476434|FG001|Overall Study|Out-of-country|0|||
163141757|NCT01132313|589228008|FG000|Overall Study|Lost to Follow-up|0|||
163141758|NCT01132313|589228009|FG001|Overall Study|Lost to Follow-up|0|||
163141759|NCT01132313|589228010|FG002|Overall Study|Lost to Follow-up|1|||
163141760|NCT01132313|589228011|FG003|Overall Study|Lost to Follow-up|0|||
163141761|NCT01132313|589228012|FG004|Overall Study|Lost to Follow-up|0|||
163141762|NCT01132313|589228013|FG005|Overall Study|Lost to Follow-up|0|||
162662672|NCT01600586|587476435|FG000|Overall Study|Physician Decision|3|||
162662673|NCT01600586|587476436|FG001|Overall Study|Physician Decision|3|||
163141763|NCT01132313|589228014|FG006|Overall Study|Lost to Follow-up|0|||
163141764|NCT01132313|589228015|FG007|Overall Study|Lost to Follow-up|1|||
163141765|NCT01132313|589228016|FG008|Overall Study|Lost to Follow-up|0|||
163141766|NCT01132313|589228017|FG009|Overall Study|Lost to Follow-up|0|||
163141767|NCT01132313|589228018|FG010|Overall Study|Lost to Follow-up|0|||
163141768|NCT01132313|589228019|FG011|Overall Study|Lost to Follow-up|0|||
163141769|NCT01132313|589228008|FG000|Overall Study|Withdrawal by Subject|0|||
163141770|NCT01132313|589228009|FG001|Overall Study|Withdrawal by Subject|0|||
163141771|NCT01132313|589228010|FG002|Overall Study|Withdrawal by Subject|3|||
163141772|NCT01132313|589228011|FG003|Overall Study|Withdrawal by Subject|3|||
163141773|NCT01132313|589228012|FG004|Overall Study|Withdrawal by Subject|6|||
162662674|NCT01227512|587476438|FG000|Overall Study|Physician Decision|6|||
162662675|NCT01227512|587476439|FG001|Overall Study|Physician Decision|6|||
162662676|NCT01227512|587476438|FG000|Overall Study|Adverse Event|4|||
162662677|NCT01227512|587476439|FG001|Overall Study|Adverse Event|3|||
162662678|NCT01227512|587476438|FG000|Overall Study|Withdrawal by Subject|3|||
162662679|NCT01227512|587476439|FG001|Overall Study|Withdrawal by Subject|0|||
162662680|NCT01227512|587476438|FG000|Overall Study|Participant met withdrawal criteria|0|||
162662681|NCT01227512|587476439|FG001|Overall Study|Participant met withdrawal criteria|1|||
162662682|NCT01978184|587476441|FG000|Overall Study|Progressive disease|5|||
162662683|NCT01978184|587476442|FG001|Overall Study|Progressive disease|5|||
162662684|NCT01978184|587476441|FG000|Overall Study|Other than PDA|2|||
162662685|NCT01978184|587476442|FG001|Overall Study|Other than PDA|2|||
162662686|NCT01978184|587476441|FG000|Overall Study|Physician Decision|0|||
162662687|NCT01978184|587476442|FG001|Overall Study|Physician Decision|3|||
162662688|NCT01978184|587476441|FG000|Overall Study|Noncompliance|1|||
162662689|NCT01978184|587476442|FG001|Overall Study|Noncompliance|2|||
162662690|NCT01978184|587476441|FG000|Overall Study|Death|1|||
162662691|NCT01978184|587476442|FG001|Overall Study|Death|0|||
162662692|NCT01978184|587476441|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
162662693|NCT01978184|587476442|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
162662694|NCT01069289|587476443|FG000|Overall Study|Withdrawal by Subject|15|||
162662695|NCT01069289|587476444|FG001|Overall Study|Withdrawal by Subject|26|||
162662696|NCT01069289|587476443|FG000|Overall Study|Adverse Event|21|||
162662697|NCT01069289|587476444|FG001|Overall Study|Adverse Event|28|||
162662698|NCT01069289|587476443|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162662699|NCT01069289|587476444|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162662700|NCT01069289|587476443|FG000|Overall Study|Severe non-compliance to protocol|3|||
162662701|NCT01069289|587476444|FG001|Overall Study|Severe non-compliance to protocol|2|||
162662702|NCT01069289|587476443|FG000|Overall Study|Due to deteriorating health condition|1|||
162662703|NCT01069289|587476444|FG001|Overall Study|Due to deteriorating health condition|0|||
162662704|NCT02707640|587476445|FG000|Overall Study|Adverse Event|4|||
162662705|NCT02707640|587476446|FG001|Overall Study|Adverse Event|2|||
162662706|NCT02707640|587476445|FG000|Overall Study|Death|1|||
162662707|NCT02707640|587476446|FG001|Overall Study|Death|2|||
162662708|NCT02707640|587476445|FG000|Overall Study|Physician Decision|2|||
162662709|NCT02707640|587476446|FG001|Overall Study|Physician Decision|0|||
162662710|NCT02707640|587476445|FG000|Overall Study|Withdrawal by Subject|0|||
162662711|NCT02707640|587476446|FG001|Overall Study|Withdrawal by Subject|1|||
162662712|NCT02707640|587476445|FG000|Overall Study|Participant's Personal Decision|1|||
162662713|NCT02707640|587476446|FG001|Overall Study|Participant's Personal Decision|2|||
162662714|NCT02707640|587476445|FG000|Overall Study|Sponsor Discretion|1|||
162662715|NCT02707640|587476446|FG001|Overall Study|Sponsor Discretion|0|||
162662716|NCT02517905|587476447|FG000|Overall Study|Lost to Follow-up|4|||
162662717|NCT02517905|587476448|FG001|Overall Study|Lost to Follow-up|0|||
162662718|NCT02517905|587476447|FG000|Overall Study|Withdrawal by Subject|4|||
162662719|NCT02517905|587476448|FG001|Overall Study|Withdrawal by Subject|0|||
163141774|NCT01132313|589228013|FG005|Overall Study|Withdrawal by Subject|0|||
163141775|NCT01132313|589228014|FG006|Overall Study|Withdrawal by Subject|1|||
163141776|NCT01132313|589228015|FG007|Overall Study|Withdrawal by Subject|0|||
163141777|NCT01132313|589228016|FG008|Overall Study|Withdrawal by Subject|0|||
163141778|NCT01132313|589228017|FG009|Overall Study|Withdrawal by Subject|2|||
163141779|NCT01132313|589228018|FG010|Overall Study|Withdrawal by Subject|0|||
163141780|NCT01132313|589228019|FG011|Overall Study|Withdrawal by Subject|0|||
163141781|NCT01132313|589228008|FG000|Overall Study|Lack of antiviral response|0|||
163141782|NCT01132313|589228009|FG001|Overall Study|Lack of antiviral response|0|||
163141783|NCT01132313|589228010|FG002|Overall Study|Lack of antiviral response|12|||
163141784|NCT01132313|589228011|FG003|Overall Study|Lack of antiviral response|18|||
163141785|NCT01132313|589228012|FG004|Overall Study|Lack of antiviral response|18|||
163141786|NCT01132313|589228013|FG005|Overall Study|Lack of antiviral response|18|||
163141787|NCT01132313|589228014|FG006|Overall Study|Lack of antiviral response|21|||
163141788|NCT01132313|589228015|FG007|Overall Study|Lack of antiviral response|0|||
163141789|NCT01132313|589228016|FG008|Overall Study|Lack of antiviral response|0|||
163141790|NCT01132313|589228017|FG009|Overall Study|Lack of antiviral response|0|||
163141791|NCT01132313|589228018|FG010|Overall Study|Lack of antiviral response|1|||
163141792|NCT01132313|589228019|FG011|Overall Study|Lack of antiviral response|0|||
163141793|NCT01132313|589228008|FG000|Overall Study|Other reason not defined above|0|||
163141794|NCT01132313|589228009|FG001|Overall Study|Other reason not defined above|0|||
163141795|NCT01132313|589228010|FG002|Overall Study|Other reason not defined above|0|||
162662720|NCT02517905|587476447|FG000|Overall Study|Screen failure|2|||
162662721|NCT02517905|587476448|FG001|Overall Study|Screen failure|2|||
162662722|NCT00023452|587476449|FG000|Overall Study|Ineligible for Study|163|||
162662723|NCT00023452|587476450|FG001|Overall Study|Ineligible for Study|159|||
162662724|NCT00023452|587476449|FG000|Overall Study|Out of Window|129|||
162662725|NCT00023452|587476450|FG001|Overall Study|Out of Window|69|||
163141796|NCT01132313|589228011|FG003|Overall Study|Other reason not defined above|0|||
163141797|NCT01132313|589228012|FG004|Overall Study|Other reason not defined above|0|||
163141798|NCT01132313|589228013|FG005|Overall Study|Other reason not defined above|0|||
163141799|NCT01132313|589228014|FG006|Overall Study|Other reason not defined above|0|||
163141800|NCT01132313|589228015|FG007|Overall Study|Other reason not defined above|1|||
163141801|NCT01132313|589228016|FG008|Overall Study|Other reason not defined above|0|||
163141802|NCT01132313|589228017|FG009|Overall Study|Other reason not defined above|0|||
163141803|NCT01132313|589228018|FG010|Overall Study|Other reason not defined above|0|||
163141804|NCT01132313|589228019|FG011|Overall Study|Other reason not defined above|0|||
163141805|NCT04661150|589228023|FG000|Overall Study|Ongoing in study|19|||
163141806|NCT04661150|589228024|FG001|Overall Study|Ongoing in study|20|||
163141807|NCT04661150|589228023|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
163141808|NCT04661150|589228024|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
163141809|NCT04661150|589228023|FG000|Overall Study|Death|2|||
163141810|NCT04661150|589228024|FG001|Overall Study|Death|0|||
163141811|NCT04965688|589228025|FG000|Overall Study|Withdrawal by Subject|2|||
163141812|NCT00369577|589228026|FG000|Overall Study|Withdrawal by Subject|0|||
163141813|NCT00369577|589228027|FG001|Overall Study|Withdrawal by Subject|0|||
163141814|NCT00369577|589228028|FG002|Overall Study|Withdrawal by Subject|1|||
163141815|NCT04618744|589228029|FG000|Overall Study|Adverse Event|0|||
163141816|NCT04618744|589228030|FG001|Overall Study|Adverse Event|1|||
163141817|NCT04618744|589228029|FG000|Overall Study|Withdrawal by Subject|0|||
163141818|NCT04618744|589228030|FG001|Overall Study|Withdrawal by Subject|1|||
163141819|NCT03553758|589230272|FG000|Overall Study|Lost to Follow-up|1|||
163141820|NCT02807623|589230273|FG000|Overall Study|Lost to Follow-up|23|||
162662726|NCT00023452|587476449|FG000|Overall Study|Death|2|||
163141821|NCT02807623|589230274|FG001|Overall Study|Lost to Follow-up|18|||
162662727|NCT00023452|587476450|FG001|Overall Study|Death|0|||
163141822|NCT02807623|589230275|FG002|Overall Study|Lost to Follow-up|22|||
163141823|NCT02807623|589230273|FG000|Overall Study|Drug intolerance|0|||
163141824|NCT02807623|589230274|FG001|Overall Study|Drug intolerance|1|||
163141825|NCT02807623|589230275|FG002|Overall Study|Drug intolerance|0|||
163141826|NCT02807623|589230273|FG000|Overall Study|incomplete blood draw|0|||
163141827|NCT02807623|589230274|FG001|Overall Study|incomplete blood draw|2|||
163141828|NCT02807623|589230275|FG002|Overall Study|incomplete blood draw|1|||
163141829|NCT02614729|589230276|FG000|Overall Study|Withdrawal by Subject|1|||
163141830|NCT02614729|589230277|FG001|Overall Study|Withdrawal by Subject|0|||
163141831|NCT04002960|589230280|FG000|Overall Study|Withdrawn prior to Completion|2|||
163141832|NCT01121146|589230286|FG000|Overall Study|Death|17|||
163141833|NCT01121146|589230287|FG001|Overall Study|Death|15|||
163141834|NCT01121146|589230286|FG000|Overall Study|Adverse Event|2|||
163141835|NCT01121146|589230287|FG001|Overall Study|Adverse Event|11|||
163141836|NCT01121146|589230286|FG000|Overall Study|Lost to Follow-up|7|||
163141837|NCT01121146|589230287|FG001|Overall Study|Lost to Follow-up|16|||
163141838|NCT01276639|589230288|FG000|Week 0 to 16|Death|1|||
163141839|NCT01276639|589230289|FG001|Week 0 to 16|Death|0|||
163141840|NCT01276639|589230290|FG002|Week 0 to 16|Death|0|||
163141841|NCT01276639|589230291|FG003|Week 0 to 16|Death|0|||
163141842|NCT01276639|589230292|FG004|Week 0 to 16|Death|0|||
163141843|NCT01276639|589230288|FG000|Week 0 to 16|Adverse Event|11|||
163141844|NCT01276639|589230289|FG001|Week 0 to 16|Adverse Event|8|||
163141845|NCT01276639|589230290|FG002|Week 0 to 16|Adverse Event|11|||
163141846|NCT01276639|589230291|FG003|Week 0 to 16|Adverse Event|0|||
163141847|NCT01276639|589230292|FG004|Week 0 to 16|Adverse Event|0|||
163141848|NCT01276639|589230288|FG000|Week 0 to 16|Lack of Efficacy|20|||
163141849|NCT01276639|589230289|FG001|Week 0 to 16|Lack of Efficacy|15|||
163141850|NCT01276639|589230290|FG002|Week 0 to 16|Lack of Efficacy|25|||
163141851|NCT01276639|589230291|FG003|Week 0 to 16|Lack of Efficacy|0|||
163141852|NCT01276639|589230292|FG004|Week 0 to 16|Lack of Efficacy|0|||
163141853|NCT01276639|589230288|FG000|Week 0 to 16|Lost to Follow-up|3|||
163141854|NCT01276639|589230289|FG001|Week 0 to 16|Lost to Follow-up|5|||
163141855|NCT01276639|589230290|FG002|Week 0 to 16|Lost to Follow-up|3|||
163141856|NCT01276639|589230291|FG003|Week 0 to 16|Lost to Follow-up|0|||
163141857|NCT01276639|589230292|FG004|Week 0 to 16|Lost to Follow-up|0|||
163141858|NCT01276639|589230288|FG000|Week 0 to 16|Withdrawal by Subject|8|||
163141859|NCT01276639|589230289|FG001|Week 0 to 16|Withdrawal by Subject|5|||
163141860|NCT01276639|589230290|FG002|Week 0 to 16|Withdrawal by Subject|4|||
163141861|NCT01276639|589230291|FG003|Week 0 to 16|Withdrawal by Subject|0|||
163141862|NCT01276639|589230292|FG004|Week 0 to 16|Withdrawal by Subject|0|||
163141863|NCT01276639|589230288|FG000|Week 0 to 16|Other|7|||
163141864|NCT01276639|589230289|FG001|Week 0 to 16|Other|7|||
163141865|NCT01276639|589230290|FG002|Week 0 to 16|Other|2|||
163141866|NCT01276639|589230291|FG003|Week 0 to 16|Other|0|||
163141867|NCT01276639|589230292|FG004|Week 0 to 16|Other|0|||
163141868|NCT01276639|589230288|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
163141869|NCT01276639|589230289|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
163141870|NCT01276639|589230290|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
163141871|NCT01276639|589230291|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
163141872|NCT01276639|589230292|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
162720937|NCT01317420|587685971|FG010|Overall Study|Non-compliant with protocol|0|||
163141873|NCT01276639|589230288|FG000|Week 16 to 52|Death|1|||
163141874|NCT01276639|589230289|FG001|Week 16 to 52|Death|0|||
163141875|NCT01276639|589230290|FG002|Week 16 to 52|Death|0|||
163141876|NCT01276639|589230291|FG003|Week 16 to 52|Death|0|||
163141877|NCT01276639|589230292|FG004|Week 16 to 52|Death|0|||
163141878|NCT01276639|589230288|FG000|Week 16 to 52|Adverse Event|10|||
163141879|NCT01276639|589230289|FG001|Week 16 to 52|Adverse Event|13|||
163141880|NCT01276639|589230290|FG002|Week 16 to 52|Adverse Event|0|||
163141881|NCT01276639|589230291|FG003|Week 16 to 52|Adverse Event|1|||
163141882|NCT01276639|589230292|FG004|Week 16 to 52|Adverse Event|3|||
163141883|NCT01276639|589230288|FG000|Week 16 to 52|Lack of Efficacy|99|||
163141884|NCT01276639|589230289|FG001|Week 16 to 52|Lack of Efficacy|71|||
163141885|NCT01276639|589230290|FG002|Week 16 to 52|Lack of Efficacy|0|||
163141886|NCT01276639|589230291|FG003|Week 16 to 52|Lack of Efficacy|14|||
163141887|NCT01276639|589230292|FG004|Week 16 to 52|Lack of Efficacy|13|||
163141888|NCT01276639|589230288|FG000|Week 16 to 52|Lost to Follow-up|3|||
163141889|NCT01276639|589230289|FG001|Week 16 to 52|Lost to Follow-up|1|||
163141890|NCT01276639|589230290|FG002|Week 16 to 52|Lost to Follow-up|0|||
163141891|NCT01276639|589230291|FG003|Week 16 to 52|Lost to Follow-up|0|||
163141892|NCT01276639|589230292|FG004|Week 16 to 52|Lost to Follow-up|1|||
163141893|NCT01276639|589230288|FG000|Week 16 to 52|Withdrawal by Subject|4|||
163141894|NCT01276639|589230289|FG001|Week 16 to 52|Withdrawal by Subject|4|||
163141895|NCT01276639|589230290|FG002|Week 16 to 52|Withdrawal by Subject|0|||
163141896|NCT01276639|589230291|FG003|Week 16 to 52|Withdrawal by Subject|0|||
163141897|NCT01276639|589230292|FG004|Week 16 to 52|Withdrawal by Subject|1|||
163141898|NCT01276639|589230288|FG000|Week 16 to 52|Other|10|||
163141899|NCT01276639|589230289|FG001|Week 16 to 52|Other|12|||
163141900|NCT01276639|589230290|FG002|Week 16 to 52|Other|0|||
163141901|NCT01276639|589230291|FG003|Week 16 to 52|Other|1|||
163141902|NCT01276639|589230292|FG004|Week 16 to 52|Other|3|||
163141903|NCT01132807|589230297|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
163141904|NCT01132807|589230298|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
163141905|NCT01132807|589230299|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
163141906|NCT01132807|589230297|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
163141907|NCT01132807|589230298|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
163141908|NCT01132807|589230299|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
163141909|NCT01380769|589230300|FG000|Overall Study|Withdrawal by Subject|7|||
163141910|NCT01380769|589230301|FG001|Overall Study|Withdrawal by Subject|11|||
163141911|NCT01380769|589230300|FG000|Overall Study|Physician Decision|1|||
163141912|NCT01380769|589230301|FG001|Overall Study|Physician Decision|1|||
163141913|NCT01380769|589230300|FG000|Overall Study|Adverse Event|1|||
163141914|NCT01380769|589230301|FG001|Overall Study|Adverse Event|1|||
163141915|NCT01380769|589230300|FG000|Overall Study|Protocol Violation|0|||
163141916|NCT01380769|589230301|FG001|Overall Study|Protocol Violation|1|||
163141917|NCT03654690|589230303|FG000|Overall Study|Withdrawal by Subject|1|||
163141918|NCT03654690|589230304|FG001|Overall Study|Withdrawal by Subject|0|||
163141919|NCT03654690|589230305|FG002|Overall Study|Withdrawal by Subject|0|||
163141920|NCT01176058|589230318|FG000|Overall Study|Adverse Event|1|||
163141921|NCT01176058|589230319|FG001|Overall Study|Adverse Event|0|||
163141922|NCT01176058|589230318|FG000|Overall Study|Insufficient clinical response|2|||
163141923|NCT01176058|589230319|FG001|Overall Study|Insufficient clinical response|2|||
163141924|NCT01176058|589230318|FG000|Overall Study|Insufficient mycological response|0|||
163141925|NCT01176058|589230319|FG001|Overall Study|Insufficient mycological response|1|||
163141926|NCT01176058|589230318|FG000|Overall Study|Withdrawal by Subject|1|||
163141927|NCT01176058|589230319|FG001|Overall Study|Withdrawal by Subject|0|||
163141928|NCT00256724|589230322|FG000|Overall Study|Physician Decision|2|||
163141929|NCT00256724|589230323|FG001|Overall Study|Physician Decision|5|||
163141930|NCT00256724|589230322|FG000|Overall Study|Protocol Violation|3|||
163141931|NCT00256724|589230323|FG001|Overall Study|Protocol Violation|3|||
163141932|NCT01217463|589230324|FG000|Overall Study|Adverse Event|8|||
163141933|NCT01217463|589230325|FG001|Overall Study|Adverse Event|5|||
163141934|NCT01217463|589230324|FG000|Overall Study|Physician Decision|0|||
163141935|NCT01217463|589230325|FG001|Overall Study|Physician Decision|1|||
163141936|NCT01217463|589230324|FG000|Overall Study|Withdrawal by Subject|3|||
163141937|NCT01217463|589230325|FG001|Overall Study|Withdrawal by Subject|0|||
163141938|NCT01217463|589230324|FG000|Overall Study|Surgery on the Target Limb|0|||
163141939|NCT01217463|589230325|FG001|Overall Study|Surgery on the Target Limb|1|||
163141940|NCT01217463|589230324|FG000|Overall Study|Patient Non-compliant|1|||
163141941|NCT01217463|589230325|FG001|Overall Study|Patient Non-compliant|0|||
163141942|NCT01217463|589230324|FG000|Overall Study|Other|1|||
163141943|NCT01217463|589230325|FG001|Overall Study|Other|1|||
163141944|NCT01569841|589230326|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
163141945|NCT01569841|589230327|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
163141946|NCT01879683|589230332|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
163141947|NCT00782717|589230335|FG000|Overall Study|Adverse Event|2|||
163141948|NCT00782717|589230336|FG001|Overall Study|Adverse Event|5|||
163141949|NCT00782717|589230335|FG000|Overall Study|Patient decision unrelated to AE|6|||
162720938|NCT01317420|587685972|FG011|Overall Study|Non-compliant with protocol|0|||
162720939|NCT01317420|587685973|FG012|Overall Study|Non-compliant with protocol|1|||
162720940|NCT01317420|587685961|FG000|Overall Study|Refused to cont. taking trial medication|0|||
162720941|NCT01317420|587685962|FG001|Overall Study|Refused to cont. taking trial medication|0|||
162720942|NCT01317420|587685963|FG002|Overall Study|Refused to cont. taking trial medication|0|||
162720943|NCT01317420|587685964|FG003|Overall Study|Refused to cont. taking trial medication|0|||
162720944|NCT01317420|587685965|FG004|Overall Study|Refused to cont. taking trial medication|0|||
162720945|NCT01317420|587685966|FG005|Overall Study|Refused to cont. taking trial medication|0|||
162720946|NCT01317420|587685967|FG006|Overall Study|Refused to cont. taking trial medication|0|||
162720947|NCT01317420|587685968|FG007|Overall Study|Refused to cont. taking trial medication|0|||
162720948|NCT01317420|587685969|FG008|Overall Study|Refused to cont. taking trial medication|0|||
162720949|NCT01317420|587685970|FG009|Overall Study|Refused to cont. taking trial medication|0|||
162720950|NCT01317420|587685971|FG010|Overall Study|Refused to cont. taking trial medication|0|||
162720951|NCT01317420|587685972|FG011|Overall Study|Refused to cont. taking trial medication|0|||
162720952|NCT01317420|587685973|FG012|Overall Study|Refused to cont. taking trial medication|1|||
162720953|NCT01317420|587685961|FG000|Overall Study|Reason other than those specified|0|||
162720954|NCT01317420|587685962|FG001|Overall Study|Reason other than those specified|0|||
162720955|NCT01317420|587685963|FG002|Overall Study|Reason other than those specified|0|||
162720956|NCT01317420|587685964|FG003|Overall Study|Reason other than those specified|0|||
162720957|NCT01317420|587685965|FG004|Overall Study|Reason other than those specified|0|||
163141950|NCT00782717|589230336|FG001|Overall Study|Patient decision unrelated to AE|3|||
163141951|NCT00782717|589230335|FG000|Overall Study|Noncompliance|2|||
163141952|NCT00782717|589230336|FG001|Overall Study|Noncompliance|1|||
163141953|NCT00782717|589230335|FG000|Overall Study|Treatment failure|3|||
163141954|NCT00782717|589230336|FG001|Overall Study|Treatment failure|14|||
163141955|NCT00782717|589230335|FG000|Overall Study|Enrollment close prior to surgery|1|||
163141956|NCT00782717|589230336|FG001|Overall Study|Enrollment close prior to surgery|0|||
163141957|NCT00782717|589230335|FG000|Overall Study|Did not meet entrance criteria|1|||
163141958|NCT00782717|589230336|FG001|Overall Study|Did not meet entrance criteria|3|||
163141959|NCT00782717|589230335|FG000|Overall Study|Exited in error|0|||
163141960|NCT00782717|589230336|FG001|Overall Study|Exited in error|2|||
163141961|NCT02446717|589230337|FG000|Overall Study|Adverse Event|0|||
163141962|NCT02446717|589230338|FG001|Overall Study|Adverse Event|0|||
163141963|NCT02446717|589230339|FG002|Overall Study|Adverse Event|1|||
163141964|NCT02446717|589230340|FG003|Overall Study|Adverse Event|0|||
163141965|NCT02446717|589230341|FG004|Overall Study|Adverse Event|0|||
163141966|NCT02446717|589230337|FG000|Overall Study|Lost to Follow-up|0|||
163141967|NCT02446717|589230338|FG001|Overall Study|Lost to Follow-up|1|||
163141968|NCT02446717|589230339|FG002|Overall Study|Lost to Follow-up|1|||
163141969|NCT02446717|589230340|FG003|Overall Study|Lost to Follow-up|0|||
163141970|NCT02446717|589230341|FG004|Overall Study|Lost to Follow-up|1|||
163141971|NCT02446717|589230337|FG000|Overall Study|Withdrew consent|0|||
163141972|NCT02446717|589230338|FG001|Overall Study|Withdrew consent|0|||
163141973|NCT02446717|589230339|FG002|Overall Study|Withdrew consent|0|||
163141974|NCT02446717|589230340|FG003|Overall Study|Withdrew consent|1|||
163141975|NCT02446717|589230341|FG004|Overall Study|Withdrew consent|0|||
163141976|NCT00279916|589230349|FG000|Overall Study|Withdrawal by Subject|4|||
163141977|NCT00279916|589230350|FG001|Overall Study|Withdrawal by Subject|3|||
163141978|NCT00279916|589230349|FG000|Overall Study|Lost to Follow-up|3|||
163141979|NCT00279916|589230350|FG001|Overall Study|Lost to Follow-up|2|||
163141980|NCT02488005|589230355|FG000|Overall Study|Lost to Follow-up|2|||
163141981|NCT00650767|589230360|FG000|Overall Study|Adverse Event|0|||
163141982|NCT00650767|589230361|FG001|Overall Study|Adverse Event|3|||
163141983|NCT00650767|589230362|FG002|Overall Study|Adverse Event|10|||
163141984|NCT00650767|589230363|FG003|Overall Study|Adverse Event|8|||
163141985|NCT00650767|589230360|FG000|Overall Study|Death|1|||
163141986|NCT00650767|589230361|FG001|Overall Study|Death|0|||
163141987|NCT00650767|589230362|FG002|Overall Study|Death|0|||
163141988|NCT00650767|589230363|FG003|Overall Study|Death|0|||
163141989|NCT00650767|589230360|FG000|Overall Study|Withdrawal by Subject|2|||
163141990|NCT00650767|589230361|FG001|Overall Study|Withdrawal by Subject|4|||
163141991|NCT00650767|589230362|FG002|Overall Study|Withdrawal by Subject|3|||
163141992|NCT00650767|589230363|FG003|Overall Study|Withdrawal by Subject|3|||
163141993|NCT00650767|589230360|FG000|Overall Study|Lost to Follow-up|1|||
163141994|NCT00650767|589230361|FG001|Overall Study|Lost to Follow-up|1|||
163141995|NCT00650767|589230362|FG002|Overall Study|Lost to Follow-up|1|||
163141996|NCT00650767|589230363|FG003|Overall Study|Lost to Follow-up|0|||
163141997|NCT00650767|589230360|FG000|Overall Study|Other|1|||
162720958|NCT01317420|587685966|FG005|Overall Study|Reason other than those specified|0|||
163141998|NCT00650767|589230361|FG001|Overall Study|Other|1|||
163141999|NCT00650767|589230362|FG002|Overall Study|Other|0|||
163142000|NCT00650767|589230363|FG003|Overall Study|Other|0|||
163142001|NCT03384940|589230364|FG000|Overall Study|Progressive disease|36|||
163142002|NCT03384940|589230365|FG001|Overall Study|Progressive disease|11|||
163142003|NCT03384940|589230366|FG002|Overall Study|Progressive disease|13|||
163142004|NCT03384940|589230364|FG000|Overall Study|Clinical progression|4|||
162662728|NCT00023452|587476449|FG000|Overall Study|Withdrawal by Subject|66|||
162662729|NCT00023452|587476450|FG001|Overall Study|Withdrawal by Subject|54|||
163142005|NCT03384940|589230365|FG001|Overall Study|Clinical progression|0|||
163142006|NCT03384940|589230366|FG002|Overall Study|Clinical progression|3|||
163142007|NCT03384940|589230364|FG000|Overall Study|Adverse Event|7|||
163142008|NCT03384940|589230365|FG001|Overall Study|Adverse Event|1|||
163142009|NCT03384940|589230366|FG002|Overall Study|Adverse Event|1|||
163142010|NCT03384940|589230364|FG000|Overall Study|Withdrawal by Subject|3|||
163142011|NCT03384940|589230365|FG001|Overall Study|Withdrawal by Subject|1|||
163142012|NCT03384940|589230366|FG002|Overall Study|Withdrawal by Subject|0|||
163142013|NCT03384940|589230364|FG000|Overall Study|Physician Decision|1|||
163142014|NCT03384940|589230365|FG001|Overall Study|Physician Decision|1|||
163142015|NCT03384940|589230366|FG002|Overall Study|Physician Decision|0|||
163142016|NCT03384940|589230364|FG000|Overall Study|Death|2|||
163142017|NCT03384940|589230365|FG001|Overall Study|Death|1|||
163142018|NCT03384940|589230366|FG002|Overall Study|Death|0|||
163142019|NCT03384940|589230364|FG000|Overall Study|Other|0|||
163142020|NCT03384940|589230365|FG001|Overall Study|Other|0|||
163142021|NCT03384940|589230366|FG002|Overall Study|Other|1|||
163142022|NCT03649074|589230369|FG000|Overall Study|Lost to Follow-up|2|||
163142023|NCT03649074|589230370|FG001|Overall Study|Lost to Follow-up|1|||
163142024|NCT03649074|589230369|FG000|Overall Study|Adverse Event|1|||
163142025|NCT03649074|589230370|FG001|Overall Study|Adverse Event|0|||
163142026|NCT03649074|589230369|FG000|Overall Study|Physician Decision|1|||
163142027|NCT03649074|589230370|FG001|Overall Study|Physician Decision|0|||
163142028|NCT03649074|589230369|FG000|Overall Study|Withdrawal by Subject|0|||
163142029|NCT03649074|589230370|FG001|Overall Study|Withdrawal by Subject|2|||
163142030|NCT03649074|589230369|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
163142031|NCT03649074|589230370|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
163142032|NCT03649074|589230369|FG000|Overall Study|Other|1|||
163142033|NCT03649074|589230370|FG001|Overall Study|Other|0|||
163142034|NCT04303559|589230371|FG000|Overall Study|Study closed due to poor enrollment.|1|||
163142035|NCT01156714|589230374|FG000|Overall Study|Withdrawal by Subject|9|||
163142036|NCT01156714|589230375|FG001|Overall Study|Withdrawal by Subject|4|||
163142037|NCT01156714|589230376|FG002|Overall Study|Withdrawal by Subject|3|||
163142038|NCT03775486|589230378|FG000|Initial Therapy Phase|Other reason provided|0|||
163142039|NCT03775486|589230379|FG001|Initial Therapy Phase|Other reason provided|15|||
163142040|NCT03775486|589230378|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
163142041|NCT03775486|589230379|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
163142042|NCT03775486|589230378|FG000|Initial Therapy Phase|Protocol Violation|0|||
163142043|NCT03775486|589230379|FG001|Initial Therapy Phase|Protocol Violation|2|||
163142044|NCT03775486|589230378|FG000|Initial Therapy Phase|Adverse Event|0|||
163142045|NCT03775486|589230379|FG001|Initial Therapy Phase|Adverse Event|34|||
163142046|NCT03775486|589230378|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
163142047|NCT03775486|589230379|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
163142048|NCT03775486|589230378|FG000|Maintenance Phase|Withdrawal by Subject|13|||
163142049|NCT03775486|589230379|FG001|Maintenance Phase|Withdrawal by Subject|12|||
163142050|NCT03775486|589230378|FG000|Maintenance Phase|Death|44|||
163142051|NCT03775486|589230379|FG001|Maintenance Phase|Death|45|||
163142052|NCT00801216|589230380|FG000|Overall Study|Screening Failure|2|||
163142053|NCT05907395|589230381|FG000|Period 1|No longer met eligibility criteria|0|||
163142054|NCT05907395|589230382|FG001|Period 1|No longer met eligibility criteria|1|||
163142055|NCT05907395|589230383|FG002|Period 1|No longer met eligibility criteria|0|||
163142056|NCT05907395|589230384|FG003|Period 1|No longer met eligibility criteria|0|||
163142057|NCT05907395|589230385|FG004|Period 1|No longer met eligibility criteria|0|||
163142058|NCT05907395|589230386|FG005|Period 1|No longer met eligibility criteria|1|||
163142059|NCT05907395|589230387|FG006|Period 1|No longer met eligibility criteria|1|||
163142060|NCT05907395|589230388|FG007|Period 1|No longer met eligibility criteria|0|||
163142061|NCT05907395|589230389|FG008|Period 1|No longer met eligibility criteria|0|||
163142062|NCT05907395|589230390|FG009|Period 1|No longer met eligibility criteria|0|||
163142063|NCT05907395|589230391|FG010|Period 1|No longer met eligibility criteria|0|||
163142064|NCT05907395|589230392|FG011|Period 1|No longer met eligibility criteria|0|||
163142065|NCT05907395|589230381|FG000|Period 2|Adverse Event|0|||
163142066|NCT05907395|589230382|FG001|Period 2|Adverse Event|0|||
163142067|NCT05907395|589230383|FG002|Period 2|Adverse Event|0|||
163142068|NCT05907395|589230384|FG003|Period 2|Adverse Event|1|||
163142069|NCT05907395|589230385|FG004|Period 2|Adverse Event|0|||
163142070|NCT05907395|589230386|FG005|Period 2|Adverse Event|0|||
163142071|NCT05907395|589230387|FG006|Period 2|Adverse Event|0|||
163142072|NCT05907395|589230388|FG007|Period 2|Adverse Event|1|||
163142073|NCT05907395|589230389|FG008|Period 2|Adverse Event|0|||
163142074|NCT05907395|589230390|FG009|Period 2|Adverse Event|0|||
163142075|NCT05907395|589230391|FG010|Period 2|Adverse Event|0|||
163142076|NCT05907395|589230392|FG011|Period 2|Adverse Event|0|||
163142077|NCT05907395|589230381|FG000|Period 2|Personal reason|0|||
163142078|NCT05907395|589230382|FG001|Period 2|Personal reason|0|||
163142079|NCT05907395|589230383|FG002|Period 2|Personal reason|0|||
162662730|NCT00023452|587476449|FG000|Overall Study|Adverse Event|139|||
162662731|NCT00023452|587476450|FG001|Overall Study|Adverse Event|196|||
162662732|NCT00023452|587476449|FG000|Overall Study|Lost to Follow-up|293|||
162662733|NCT00023452|587476450|FG001|Overall Study|Lost to Follow-up|60|||
162662734|NCT00023452|587476449|FG000|Overall Study|Physician Decision|49|||
162662735|NCT00023452|587476450|FG001|Overall Study|Physician Decision|21|||
162662736|NCT00023452|587476449|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
162662737|NCT00023452|587476450|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
162662738|NCT00023452|587476449|FG000|Overall Study|Pregnant|53|||
162662739|NCT00023452|587476450|FG001|Overall Study|Pregnant|20|||
162662740|NCT00023452|587476449|FG000|Overall Study|Other|204|||
162662741|NCT00023452|587476450|FG001|Overall Study|Other|69|||
162662742|NCT05789875|587476451|FG000|Overall Study|Lost to Follow-up|6|||
162662743|NCT01994395|587476452|FG000|Overall Study|Withdrawal by Subject|1|||
162662744|NCT01994395|587476453|FG001|Overall Study|Withdrawal by Subject|2|||
162662745|NCT00459134|587476461|FG000|Overall Study|Physician Decision|1|||
162662746|NCT00459134|587476462|FG001|Overall Study|Physician Decision|1|||
162662747|NCT00459134|587476461|FG000|Overall Study|Withdrawal by Subject|8|||
162662748|NCT00459134|587476462|FG001|Overall Study|Withdrawal by Subject|7|||
162662749|NCT00459134|587476461|FG000|Overall Study|Lost to Follow-up|6|||
162662750|NCT00459134|587476462|FG001|Overall Study|Lost to Follow-up|7|||
162662751|NCT00459134|587476461|FG000|Overall Study|Surgery|1|||
162662752|NCT00459134|587476462|FG001|Overall Study|Surgery|2|||
162662753|NCT00459134|587476461|FG000|Overall Study|Toxicity|4|||
162662754|NCT00459134|587476462|FG001|Overall Study|Toxicity|5|||
162662755|NCT00459134|587476461|FG000|Overall Study|Progression|1|||
162662756|NCT00459134|587476462|FG001|Overall Study|Progression|0|||
162662757|NCT00459134|587476461|FG000|Overall Study|Multiple Reasons|2|||
162662758|NCT00459134|587476462|FG001|Overall Study|Multiple Reasons|3|||
162662759|NCT02770391|587476463|FG000|Overall Study|Lost to Follow-up|2|||
162662760|NCT02770391|587476463|FG000|Overall Study|Withdrawal by Subject|1|||
162662761|NCT02770391|587476463|FG000|Overall Study|Surgery delayed unevaluable|2|||
162662762|NCT02770391|587476463|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
162662763|NCT03333486|587476464|FG000|Overall Study|Withdrawal by Subject|1|||
162662764|NCT03333486|587476464|FG000|Overall Study|Lost to Follow-up|1|||
162662765|NCT01755416|587476470|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
162662766|NCT01755416|587476471|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
162662767|NCT02805257|587478233|FG000|Overall Study|Lost to Follow-up|7|||
162662768|NCT02805257|587478234|FG001|Overall Study|Lost to Follow-up|6|||
162662769|NCT02805257|587478233|FG000|Overall Study|Death|0|||
162662770|NCT02805257|587478234|FG001|Overall Study|Death|1|||
162662771|NCT00612066|587478235|FG000|Overall Study|Adverse Event|1|||
162662772|NCT01043874|587478239|FG000|Overall Study|Adverse Event|3|||
162662773|NCT01043874|587478239|FG000|Overall Study|Withdrawal by Subject|1|||
162662774|NCT01043874|587478239|FG000|Overall Study|Lack of Efficacy|1|||
162662775|NCT01043874|587478239|FG000|Overall Study|Administrative Problems|1|||
162662776|NCT01337089|587478240|FG000|Overall Study|Adverse Event|237|||
162662777|NCT01337089|587478240|FG000|Overall Study|Withdrawal by Subject|129|||
162662778|NCT01337089|587478240|FG000|Overall Study|Withdrawal by Investigator|33|||
162662779|NCT01337089|587478240|FG000|Overall Study|Met Withdrawal Criteria|3|||
162662780|NCT01337089|587478240|FG000|Overall Study|Lost to Follow-up|2|||
162662781|NCT01404312|587478241|FG000|Overall Study|Death|21|||
162662782|NCT01404312|587478242|FG001|Overall Study|Death|27|||
162662783|NCT01404312|587478241|FG000|Overall Study|Withdrawal by Subject|15|||
162662784|NCT01404312|587478242|FG001|Overall Study|Withdrawal by Subject|18|||
162662785|NCT01404312|587478241|FG000|Overall Study|Participant Unable to get to clinic|93|||
162662786|NCT01404312|587478242|FG001|Overall Study|Participant Unable to get to clinic|103|||
162662787|NCT01404312|587478241|FG000|Overall Study|Lost to Follow-up|115|||
162662788|NCT01404312|587478242|FG001|Overall Study|Lost to Follow-up|111|||
162662789|NCT01404312|587478241|FG000|Overall Study|Site closed|22|||
162662790|NCT01404312|587478242|FG001|Overall Study|Site closed|21|||
162662791|NCT01404312|587478241|FG000|Overall Study|Participant not willing to adhere to req|31|||
162662792|NCT01404312|587478242|FG001|Overall Study|Participant not willing to adhere to req|29|||
162662793|NCT01404312|587478241|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162662794|NCT01404312|587478242|FG001|Overall Study|Severe debilitation, unable to continue|2|||
162662795|NCT02627677|587478244|FG000|Overall Study|Adverse event (not progressive disease)|1|||
162662796|NCT02627677|587478245|FG001|Overall Study|Adverse event (not progressive disease)|4|||
162662797|NCT02627677|587478246|FG002|Overall Study|Adverse event (not progressive disease)|1|||
162662798|NCT02627677|587478244|FG000|Overall Study|Progressive disease|1|||
162662799|NCT02627677|587478245|FG001|Overall Study|Progressive disease|3|||
162662800|NCT02627677|587478246|FG002|Overall Study|Progressive disease|0|||
162662801|NCT02627677|587478244|FG000|Overall Study|Lack of Efficacy|1|||
162662802|NCT02627677|587478245|FG001|Overall Study|Lack of Efficacy|2|||
162662803|NCT02627677|587478246|FG002|Overall Study|Lack of Efficacy|0|||
162662804|NCT02627677|587478244|FG000|Overall Study|Lost to Follow-up|0|||
162662805|NCT02627677|587478245|FG001|Overall Study|Lost to Follow-up|0|||
162662806|NCT02627677|587478246|FG002|Overall Study|Lost to Follow-up|1|||
162662807|NCT02627677|587478244|FG000|Overall Study|Pregnancy|0|||
162662808|NCT02627677|587478245|FG001|Overall Study|Pregnancy|1|||
162662809|NCT02627677|587478246|FG002|Overall Study|Pregnancy|0|||
162662810|NCT02627677|587478244|FG000|Overall Study|Study Terminated by Sponsor|5|||
162662811|NCT02627677|587478245|FG001|Overall Study|Study Terminated by Sponsor|10|||
162662812|NCT02627677|587478246|FG002|Overall Study|Study Terminated by Sponsor|6|||
162662813|NCT02627677|587478244|FG000|Overall Study|Physician Decision|0|||
162662814|NCT02627677|587478245|FG001|Overall Study|Physician Decision|0|||
162662815|NCT02627677|587478246|FG002|Overall Study|Physician Decision|2|||
162662816|NCT02627677|587478244|FG000|Overall Study|Withdrawal by Subject|2|||
162662817|NCT02627677|587478245|FG001|Overall Study|Withdrawal by Subject|1|||
162662818|NCT02627677|587478246|FG002|Overall Study|Withdrawal by Subject|1|||
162662819|NCT02627677|587478244|FG000|Overall Study|Reason not Specified|0|||
162662820|NCT02627677|587478245|FG001|Overall Study|Reason not Specified|0|||
162662821|NCT02627677|587478246|FG002|Overall Study|Reason not Specified|1|||
162662822|NCT02627677|587478244|FG000|Overall Study|Randomized but not Treated|1|||
162662823|NCT02627677|587478245|FG001|Overall Study|Randomized but not Treated|0|||
162662824|NCT02627677|587478246|FG002|Overall Study|Randomized but not Treated|0|||
162662825|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Adverse Event|5|||
162662826|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Adverse Event|8|||
162662827|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Adverse Event|4|||
162662828|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Adverse Event|8|||
162662829|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
162662830|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
163142080|NCT05907395|589230384|FG003|Period 2|Personal reason|0|||
163142081|NCT05907395|589230385|FG004|Period 2|Personal reason|0|||
163142082|NCT05907395|589230386|FG005|Period 2|Personal reason|0|||
163142083|NCT05907395|589230387|FG006|Period 2|Personal reason|0|||
163142084|NCT05907395|589230388|FG007|Period 2|Personal reason|0|||
163142085|NCT05907395|589230389|FG008|Period 2|Personal reason|0|||
163142086|NCT05907395|589230390|FG009|Period 2|Personal reason|1|||
163142087|NCT05907395|589230391|FG010|Period 2|Personal reason|0|||
163142088|NCT05907395|589230392|FG011|Period 2|Personal reason|0|||
163142089|NCT05907395|589230381|FG000|Period 3|Adverse Event|0|||
163142090|NCT05907395|589230382|FG001|Period 3|Adverse Event|0|||
163142091|NCT05907395|589230383|FG002|Period 3|Adverse Event|0|||
163142092|NCT05907395|589230384|FG003|Period 3|Adverse Event|0|||
163142093|NCT05907395|589230385|FG004|Period 3|Adverse Event|1|||
163142094|NCT05907395|589230386|FG005|Period 3|Adverse Event|0|||
163142095|NCT05907395|589230387|FG006|Period 3|Adverse Event|0|||
163142096|NCT05907395|589230388|FG007|Period 3|Adverse Event|0|||
163142097|NCT05907395|589230389|FG008|Period 3|Adverse Event|0|||
163142098|NCT05907395|589230390|FG009|Period 3|Adverse Event|0|||
163142099|NCT05907395|589230391|FG010|Period 3|Adverse Event|0|||
163142100|NCT05907395|589230392|FG011|Period 3|Adverse Event|0|||
163142101|NCT05214768|589230393|FG000|Induction Period|Withdrawal by Subject|1|||
163142102|NCT05214768|589230394|FG001|Induction Period|Withdrawal by Subject|0|||
163142103|NCT05214768|589230395|FG002|Induction Period|Withdrawal by Subject|0|||
163142104|NCT05214768|589230396|FG003|Induction Period|Withdrawal by Subject|0|||
163142105|NCT05214768|589230397|FG004|Induction Period|Withdrawal by Subject|0|||
163142106|NCT05214768|589230398|FG005|Induction Period|Withdrawal by Subject|0|||
163142107|NCT05214768|589230393|FG000|Induction Period|Physician Decision|1|||
163142108|NCT05214768|589230394|FG001|Induction Period|Physician Decision|0|||
163142109|NCT05214768|589230395|FG002|Induction Period|Physician Decision|0|||
163142110|NCT05214768|589230396|FG003|Induction Period|Physician Decision|0|||
163142111|NCT05214768|589230397|FG004|Induction Period|Physician Decision|0|||
163142112|NCT05214768|589230398|FG005|Induction Period|Physician Decision|0|||
163142113|NCT05214768|589230393|FG000|Maintenance Period|Other Reasons|0|||
163142114|NCT05214768|589230394|FG001|Maintenance Period|Other Reasons|0|||
163142115|NCT05214768|589230395|FG002|Maintenance Period|Other Reasons|1|||
163142116|NCT05214768|589230396|FG003|Maintenance Period|Other Reasons|1|||
163142117|NCT05214768|589230397|FG004|Maintenance Period|Other Reasons|0|||
163142118|NCT05214768|589230398|FG005|Maintenance Period|Other Reasons|0|||
163142119|NCT05214768|589230393|FG000|Maintenance Period|Withdrawal by Subject|0|||
163142120|NCT05214768|589230394|FG001|Maintenance Period|Withdrawal by Subject|0|||
163142121|NCT05214768|589230395|FG002|Maintenance Period|Withdrawal by Subject|0|||
163142122|NCT05214768|589230396|FG003|Maintenance Period|Withdrawal by Subject|1|||
163142123|NCT05214768|589230397|FG004|Maintenance Period|Withdrawal by Subject|0|||
163142124|NCT05214768|589230398|FG005|Maintenance Period|Withdrawal by Subject|0|||
163142125|NCT05214768|589230393|FG000|Maintenance Period|Lack of Efficacy|0|||
163142126|NCT05214768|589230394|FG001|Maintenance Period|Lack of Efficacy|0|||
163142127|NCT05214768|589230395|FG002|Maintenance Period|Lack of Efficacy|1|||
163142128|NCT05214768|589230396|FG003|Maintenance Period|Lack of Efficacy|0|||
163142129|NCT05214768|589230397|FG004|Maintenance Period|Lack of Efficacy|1|||
163142130|NCT05214768|589230398|FG005|Maintenance Period|Lack of Efficacy|0|||
163142131|NCT05214768|589230393|FG000|Open Label Extension Period|Physician Decision|0|||
163142132|NCT05214768|589230394|FG001|Open Label Extension Period|Physician Decision|0|||
163142133|NCT05214768|589230395|FG002|Open Label Extension Period|Physician Decision|0|||
163142134|NCT05214768|589230396|FG003|Open Label Extension Period|Physician Decision|0|||
163142135|NCT05214768|589230397|FG004|Open Label Extension Period|Physician Decision|0|||
163142136|NCT05214768|589230398|FG005|Open Label Extension Period|Physician Decision|1|||
163142137|NCT05214768|589230393|FG000|Open Label Extension Period|Lack of Efficacy|0|||
163142138|NCT05214768|589230394|FG001|Open Label Extension Period|Lack of Efficacy|0|||
163142139|NCT05214768|589230395|FG002|Open Label Extension Period|Lack of Efficacy|0|||
163142140|NCT05214768|589230396|FG003|Open Label Extension Period|Lack of Efficacy|0|||
163142141|NCT05214768|589230397|FG004|Open Label Extension Period|Lack of Efficacy|0|||
163142142|NCT05214768|589230398|FG005|Open Label Extension Period|Lack of Efficacy|1|||
163142143|NCT05214768|589230393|FG000|Open Label Extension Period|Ongoing Study|0|||
163142144|NCT05214768|589230394|FG001|Open Label Extension Period|Ongoing Study|0|||
163142145|NCT05214768|589230395|FG002|Open Label Extension Period|Ongoing Study|0|||
163142146|NCT05214768|589230396|FG003|Open Label Extension Period|Ongoing Study|0|||
163142147|NCT05214768|589230397|FG004|Open Label Extension Period|Ongoing Study|0|||
163142148|NCT05214768|589230398|FG005|Open Label Extension Period|Ongoing Study|42|||
163142149|NCT05481359|589230399|FG000|Overall Study|Lost to Follow-up|3|||
163142150|NCT05481359|589230399|FG000|Overall Study|Withdrawal by Subject|1|||
163142151|NCT03043872|589230404|FG000|Overall Study|Withdrawal by Subject|6|||
163142152|NCT03043872|589230405|FG001|Overall Study|Withdrawal by Subject|6|||
163142153|NCT03043872|589230406|FG002|Overall Study|Withdrawal by Subject|15|||
163142154|NCT03043872|589230404|FG000|Overall Study|Lost to Follow-up|2|||
163142155|NCT03043872|589230405|FG001|Overall Study|Lost to Follow-up|1|||
163142156|NCT03043872|589230406|FG002|Overall Study|Lost to Follow-up|1|||
163142157|NCT03043872|589230404|FG000|Overall Study|Death|270|||
162662831|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
162662832|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
162662833|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162662834|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
162662835|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162662836|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162662837|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Physician Decision|1|||
163142158|NCT03043872|589230405|FG001|Overall Study|Death|269|||
163142159|NCT03043872|589230406|FG002|Overall Study|Death|296|||
163142160|NCT02777827|589230408|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142161|NCT02777827|589230409|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142162|NCT02777827|589230410|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
163142163|NCT02777827|589230411|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142164|NCT02777827|589230412|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142165|NCT02777827|589230413|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
163142166|NCT04551066|589230414|FG000|Overall Study|Death|5|||
163142167|NCT04551066|589230415|FG001|Overall Study|Death|3|||
163142168|NCT04551066|589230414|FG000|Overall Study|Lost to Follow-up|1|||
163142169|NCT04551066|589230415|FG001|Overall Study|Lost to Follow-up|0|||
163142170|NCT04551066|589230414|FG000|Overall Study|Sponsor Decision|104|||
163142171|NCT04551066|589230415|FG001|Overall Study|Sponsor Decision|117|||
163142172|NCT04551066|589230414|FG000|Overall Study|Withdrawal by Subject|8|||
163142173|NCT04551066|589230415|FG001|Overall Study|Withdrawal by Subject|2|||
163142174|NCT04551066|589230414|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
163142175|NCT04551066|589230415|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
163142176|NCT04551066|589230414|FG000|Overall Study|Adverse Event|2|||
163142177|NCT04551066|589230415|FG001|Overall Study|Adverse Event|0|||
163142178|NCT04551066|589230414|FG000|Overall Study|Physician Decision|2|||
163142179|NCT04551066|589230415|FG001|Overall Study|Physician Decision|0|||
163142180|NCT04551066|589230414|FG000|Overall Study|Protocol Violation|1|||
163142181|NCT04551066|589230415|FG001|Overall Study|Protocol Violation|0|||
163142182|NCT04551066|589230414|FG000|Overall Study|Lack of Efficacy|0|||
163142183|NCT04551066|589230415|FG001|Overall Study|Lack of Efficacy|1|||
163142184|NCT04551066|589230414|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
163142185|NCT04551066|589230415|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
162662838|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Physician Decision|0|||
162720959|NCT01317420|587685967|FG006|Overall Study|Reason other than those specified|0|||
163142186|NCT04491136|589230416|FG000|Overall Study|Patient withdraw informed consent|9|||
163142187|NCT04491136|589230416|FG000|Overall Study|Adverse Event|2|||
163142188|NCT04491136|589230416|FG000|Overall Study|Death|3|||
163142189|NCT04491136|589230416|FG000|Overall Study|Lost to Follow-up|3|||
163142190|NCT04491136|589230416|FG000|Overall Study|Physician Decision|45|||
163142191|NCT04491136|589230416|FG000|Overall Study|sponsor terminated the study early|16|||
163142192|NCT04491136|589230416|FG000|Overall Study|Patient/guardian's decision|1|||
163142193|NCT00319254|589230419|FG000|Overall Study|Withdrawal by Subject|4|||
163142194|NCT00319254|589230419|FG000|Overall Study|Death|46|||
163142195|NCT00319254|589230419|FG000|Overall Study|Lost to Follow-up|2|||
163142196|NCT00319254|589230419|FG000|Overall Study|Enrolled, Not Treated|2|||
163142197|NCT01712204|589230423|FG000|Overall Study|Adverse Event|3|||
163142198|NCT01712204|589230424|FG001|Overall Study|Adverse Event|1|||
163142199|NCT01712204|589230423|FG000|Overall Study|Withdrawal by Subject|3|||
163142200|NCT01712204|589230424|FG001|Overall Study|Withdrawal by Subject|3|||
163142201|NCT01712204|589230423|FG000|Overall Study|Lost to Follow-up|1|||
163142202|NCT01712204|589230424|FG001|Overall Study|Lost to Follow-up|0|||
163142203|NCT01712204|589230423|FG000|Overall Study|Protocol Violation|1|||
163142204|NCT01712204|589230424|FG001|Overall Study|Protocol Violation|1|||
163142205|NCT02452424|589230425|FG000|Overall Study|Death|2|||
163142206|NCT02452424|589230426|FG001|Overall Study|Death|2|||
163142207|NCT02452424|589230427|FG002|Overall Study|Death|2|||
163142208|NCT02452424|589230428|FG003|Overall Study|Death|6|||
163142209|NCT02452424|589230429|FG004|Overall Study|Death|2|||
163142210|NCT02452424|589230430|FG005|Overall Study|Death|0|||
163142211|NCT02452424|589230431|FG006|Overall Study|Death|5|||
163142212|NCT02452424|589230432|FG007|Overall Study|Death|1|||
163142213|NCT02452424|589230433|FG008|Overall Study|Death|3|||
163142214|NCT02452424|589230434|FG009|Overall Study|Death|1|||
163142215|NCT02452424|589230435|FG010|Overall Study|Death|0|||
163142216|NCT02452424|589230425|FG000|Overall Study|Lost to Follow-up|0|||
163142217|NCT02452424|589230426|FG001|Overall Study|Lost to Follow-up|1|||
163142218|NCT02452424|589230427|FG002|Overall Study|Lost to Follow-up|1|||
163142219|NCT02452424|589230428|FG003|Overall Study|Lost to Follow-up|0|||
163142220|NCT02452424|589230429|FG004|Overall Study|Lost to Follow-up|0|||
162662839|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Physician Decision|0|||
162662840|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Physician Decision|0|||
162662841|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
163142221|NCT02452424|589230430|FG005|Overall Study|Lost to Follow-up|0|||
163142222|NCT02452424|589230431|FG006|Overall Study|Lost to Follow-up|0|||
163142223|NCT02452424|589230432|FG007|Overall Study|Lost to Follow-up|0|||
163142224|NCT02452424|589230433|FG008|Overall Study|Lost to Follow-up|0|||
163142225|NCT02452424|589230434|FG009|Overall Study|Lost to Follow-up|0|||
163142226|NCT02452424|589230435|FG010|Overall Study|Lost to Follow-up|0|||
163142227|NCT02452424|589230425|FG000|Overall Study|Withdrawal by Subject|0|||
163142228|NCT02452424|589230426|FG001|Overall Study|Withdrawal by Subject|0|||
163142229|NCT02452424|589230427|FG002|Overall Study|Withdrawal by Subject|3|||
163142230|NCT02452424|589230428|FG003|Overall Study|Withdrawal by Subject|2|||
163142231|NCT02452424|589230429|FG004|Overall Study|Withdrawal by Subject|0|||
163142232|NCT02452424|589230430|FG005|Overall Study|Withdrawal by Subject|0|||
163142233|NCT02452424|589230431|FG006|Overall Study|Withdrawal by Subject|1|||
163142234|NCT02452424|589230432|FG007|Overall Study|Withdrawal by Subject|0|||
163142235|NCT02452424|589230433|FG008|Overall Study|Withdrawal by Subject|1|||
163142236|NCT02452424|589230434|FG009|Overall Study|Withdrawal by Subject|1|||
163142237|NCT02452424|589230435|FG010|Overall Study|Withdrawal by Subject|0|||
163142238|NCT02452424|589230425|FG000|Overall Study|Other|0|||
163142239|NCT02452424|589230426|FG001|Overall Study|Other|0|||
163142240|NCT02452424|589230427|FG002|Overall Study|Other|1|||
162662842|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
163142241|NCT02452424|589230428|FG003|Overall Study|Other|0|||
163142242|NCT02452424|589230429|FG004|Overall Study|Other|0|||
163142243|NCT02452424|589230430|FG005|Overall Study|Other|1|||
163142244|NCT02452424|589230431|FG006|Overall Study|Other|4|||
163142245|NCT02452424|589230432|FG007|Overall Study|Other|3|||
163142246|NCT02452424|589230433|FG008|Overall Study|Other|0|||
163142247|NCT02452424|589230434|FG009|Overall Study|Other|0|||
162662843|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
162662844|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
163142248|NCT02452424|589230435|FG010|Overall Study|Other|1|||
163142249|NCT02452424|589230425|FG000|Overall Study|Progressive disease (per RECIST)|0|||
163142250|NCT02452424|589230426|FG001|Overall Study|Progressive disease (per RECIST)|0|||
163142251|NCT02452424|589230427|FG002|Overall Study|Progressive disease (per RECIST)|0|||
163142252|NCT02452424|589230428|FG003|Overall Study|Progressive disease (per RECIST)|0|||
163142253|NCT02452424|589230429|FG004|Overall Study|Progressive disease (per RECIST)|0|||
163142254|NCT02452424|589230430|FG005|Overall Study|Progressive disease (per RECIST)|0|||
163142255|NCT02452424|589230431|FG006|Overall Study|Progressive disease (per RECIST)|0|||
163142256|NCT02452424|589230432|FG007|Overall Study|Progressive disease (per RECIST)|0|||
163142257|NCT02452424|589230433|FG008|Overall Study|Progressive disease (per RECIST)|2|||
163142258|NCT02452424|589230434|FG009|Overall Study|Progressive disease (per RECIST)|0|||
163142259|NCT02452424|589230435|FG010|Overall Study|Progressive disease (per RECIST)|0|||
163142260|NCT02452424|589230425|FG000|Overall Study|Adverse Event|0|||
163142261|NCT02452424|589230426|FG001|Overall Study|Adverse Event|0|||
163142262|NCT02452424|589230427|FG002|Overall Study|Adverse Event|0|||
163142263|NCT02452424|589230428|FG003|Overall Study|Adverse Event|0|||
163142264|NCT02452424|589230429|FG004|Overall Study|Adverse Event|0|||
163142265|NCT02452424|589230430|FG005|Overall Study|Adverse Event|0|||
163142266|NCT02452424|589230431|FG006|Overall Study|Adverse Event|0|||
163142267|NCT02452424|589230432|FG007|Overall Study|Adverse Event|0|||
163142268|NCT02452424|589230433|FG008|Overall Study|Adverse Event|0|||
163142269|NCT02452424|589230434|FG009|Overall Study|Adverse Event|0|||
163142270|NCT02452424|589230435|FG010|Overall Study|Adverse Event|1|||
163142271|NCT01059318|589230436|FG000|Core Study (26 Week)|Adverse Event|3|||
163142272|NCT01059318|589230436|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
163142273|NCT01059318|589230436|FG000|Extension (36 Week)|Adverse Event|3|||
163142274|NCT03790917|589230437|FG000|Overall Study|Death|1|||
163142275|NCT01223183|589230443|FG000|Imaging Day 1|Physician Decision|0|||
163142276|NCT01223183|589230444|FG001|Imaging Day 1|Physician Decision|1|||
163142277|NCT01223183|589230443|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
163142278|NCT01223183|589230444|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
163142279|NCT01223183|589230443|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
162662845|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Pregnancy|0|||
162662846|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Pregnancy|1|||
162662847|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Pregnancy|0|||
162662848|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Pregnancy|0|||
162662849|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
163142280|NCT01223183|589230444|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
163142281|NCT03772665|589230445|FG000|Overall Study|Protocol Violation|1|||
162662850|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
163142282|NCT03772665|589230446|FG001|Overall Study|Protocol Violation|0|||
163142283|NCT02719171|589231670|FG000|Overall Study|Adverse Event|1|||
163142284|NCT02719171|589231671|FG001|Overall Study|Adverse Event|2|||
163142285|NCT02719171|589231672|FG002|Overall Study|Adverse Event|0|||
163142286|NCT02719171|589231673|FG003|Overall Study|Adverse Event|0|||
163142287|NCT02719171|589231674|FG004|Overall Study|Adverse Event|2|||
163142288|NCT02719171|589231670|FG000|Overall Study|Lost to Follow-up|0|||
163142289|NCT02719171|589231671|FG001|Overall Study|Lost to Follow-up|0|||
163142290|NCT02719171|589231672|FG002|Overall Study|Lost to Follow-up|1|||
163142291|NCT02719171|589231673|FG003|Overall Study|Lost to Follow-up|0|||
163142292|NCT02719171|589231674|FG004|Overall Study|Lost to Follow-up|0|||
163142293|NCT02719171|589231670|FG000|Overall Study|Subject Withdrawal|0|||
163142294|NCT02719171|589231671|FG001|Overall Study|Subject Withdrawal|2|||
163142295|NCT02719171|589231672|FG002|Overall Study|Subject Withdrawal|2|||
163142296|NCT02719171|589231673|FG003|Overall Study|Subject Withdrawal|1|||
163142297|NCT02719171|589231674|FG004|Overall Study|Subject Withdrawal|0|||
163142298|NCT02719171|589231670|FG000|Overall Study|Other|0|||
163142299|NCT02719171|589231671|FG001|Overall Study|Other|0|||
163142300|NCT02719171|589231672|FG002|Overall Study|Other|0|||
163142301|NCT02719171|589231673|FG003|Overall Study|Other|1|||
163142302|NCT02719171|589231674|FG004|Overall Study|Other|0|||
163142303|NCT01232868|589231679|FG000|Overall Study|Lost to Follow-up|2|||
163142304|NCT01232868|589231680|FG001|Overall Study|Lost to Follow-up|4|||
163142305|NCT04481243|589231682|FG000|Overall Study|Withdrawal by Subject|4|||
163142306|NCT02796677|589231687|FG000|Overall Study|Adverse Event|11|||
163142307|NCT02796677|589231688|FG001|Overall Study|Adverse Event|22|||
163142308|NCT02796677|589231689|FG002|Overall Study|Adverse Event|14|||
163142309|NCT02796677|589231690|FG003|Overall Study|Adverse Event|14|||
163142310|NCT02796677|589231687|FG000|Overall Study|Protocol Violation|7|||
163142311|NCT02796677|589231688|FG001|Overall Study|Protocol Violation|5|||
163142312|NCT02796677|589231689|FG002|Overall Study|Protocol Violation|4|||
163142313|NCT02796677|589231690|FG003|Overall Study|Protocol Violation|8|||
163142314|NCT02796677|589231687|FG000|Overall Study|Lost to Follow-up|1|||
163142315|NCT02796677|589231688|FG001|Overall Study|Lost to Follow-up|5|||
163142316|NCT02796677|589231689|FG002|Overall Study|Lost to Follow-up|2|||
163142317|NCT02796677|589231690|FG003|Overall Study|Lost to Follow-up|2|||
163142318|NCT02796677|589231687|FG000|Overall Study|Lack of Efficacy|7|||
163142319|NCT02796677|589231688|FG001|Overall Study|Lack of Efficacy|9|||
163142320|NCT02796677|589231689|FG002|Overall Study|Lack of Efficacy|14|||
163142321|NCT02796677|589231690|FG003|Overall Study|Lack of Efficacy|20|||
163142322|NCT02796677|589231687|FG000|Overall Study|Withdrawal by Subject|4|||
163142323|NCT02796677|589231688|FG001|Overall Study|Withdrawal by Subject|14|||
162662851|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
162662852|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
163142324|NCT02796677|589231689|FG002|Overall Study|Withdrawal by Subject|6|||
163142325|NCT02796677|589231690|FG003|Overall Study|Withdrawal by Subject|7|||
163142326|NCT02796677|589231687|FG000|Overall Study|Progressive disease|6|||
163142327|NCT02796677|589231688|FG001|Overall Study|Progressive disease|15|||
163142328|NCT02796677|589231689|FG002|Overall Study|Progressive disease|13|||
163142329|NCT02796677|589231690|FG003|Overall Study|Progressive disease|18|||
163142330|NCT02796677|589231687|FG000|Overall Study|Reason not mentioned|2|||
163142331|NCT02796677|589231688|FG001|Overall Study|Reason not mentioned|3|||
163142332|NCT02796677|589231689|FG002|Overall Study|Reason not mentioned|0|||
163142333|NCT02796677|589231690|FG003|Overall Study|Reason not mentioned|5|||
163142334|NCT00961181|589231693|FG000|Overall Study|Death|2|||
163142335|NCT00961181|589231693|FG000|Overall Study|Withdrawal by Subject|2|||
163142336|NCT00961181|589231693|FG000|Overall Study|Lost to Follow-up|1|||
163142337|NCT01777308|589231694|FG000|Overall Study|Withdrawal by Subject|5|||
163142338|NCT01777308|589231695|FG001|Overall Study|Withdrawal by Subject|1|||
163142339|NCT01777308|589231694|FG000|Overall Study|Migrated/moved from study area|1|||
163142340|NCT01777308|589231695|FG001|Overall Study|Migrated/moved from study area|0|||
163142341|NCT01777308|589231694|FG000|Overall Study|Lost to Follow-up|7|||
163142342|NCT01777308|589231695|FG001|Overall Study|Lost to Follow-up|2|||
163142343|NCT01777308|589231694|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
163142344|NCT01777308|589231695|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
163142345|NCT03212326|589231697|FG000|Overall Study|Physician Decision|4|||
163142346|NCT01131507|589231711|FG000|Overall Study|Adverse Event|1|||
163142347|NCT01131507|589231711|FG000|Overall Study|Lost to Follow-up|1|||
163142348|NCT01131507|589231711|FG000|Overall Study|Withdrawal by Subject|1|||
163142349|NCT01517750|589231712|FG000|Overall Study|Lost to Follow-up|1|||
163142350|NCT01517750|589231713|FG001|Overall Study|Lost to Follow-up|2|||
163142351|NCT01517750|589231714|FG002|Overall Study|Lost to Follow-up|4|||
163142352|NCT01517750|589231715|FG003|Overall Study|Lost to Follow-up|1|||
163142353|NCT01855412|589231717|FG000|Overall Study|Death|77|||
163142354|NCT01855412|589231718|FG001|Overall Study|Death|123|||
163142355|NCT01855412|589231719|FG002|Overall Study|Death|30|||
163142356|NCT01855412|589231717|FG000|Overall Study|Lost to Follow-up|28|||
163142357|NCT01855412|589231718|FG001|Overall Study|Lost to Follow-up|46|||
163142358|NCT01855412|589231719|FG002|Overall Study|Lost to Follow-up|15|||
163142359|NCT01855412|589231717|FG000|Overall Study|Withdrawal by Subject|77|||
163142360|NCT01855412|589231718|FG001|Overall Study|Withdrawal by Subject|123|||
163142361|NCT01855412|589231719|FG002|Overall Study|Withdrawal by Subject|24|||
163142362|NCT01855412|589231717|FG000|Overall Study|Physician Decision|25|||
163142363|NCT01855412|589231718|FG001|Overall Study|Physician Decision|31|||
163142364|NCT01855412|589231719|FG002|Overall Study|Physician Decision|3|||
163142365|NCT01855412|589231717|FG000|Overall Study|Site Closure|4|||
163142366|NCT01855412|589231718|FG001|Overall Study|Site Closure|18|||
163142367|NCT01855412|589231719|FG002|Overall Study|Site Closure|1|||
163142368|NCT01855412|589231717|FG000|Overall Study|Reason not Specified|1|||
163142369|NCT01855412|589231718|FG001|Overall Study|Reason not Specified|2|||
163142370|NCT01855412|589231719|FG002|Overall Study|Reason not Specified|3|||
163142371|NCT05030350|589231725|FG000|Overall Study|Adverse Event|13|||
163142372|NCT05030350|589231725|FG000|Overall Study|Lack of Efficacy|8|||
163142373|NCT05030350|589231725|FG000|Overall Study|Lost to Follow-up|35|||
163142374|NCT05030350|589231725|FG000|Overall Study|Pregnancy|2|||
163142375|NCT05030350|589231725|FG000|Overall Study|Protocol Violation|2|||
163142376|NCT05030350|589231725|FG000|Overall Study|Withdrawal by Subject|60|||
163142377|NCT05030350|589231725|FG000|Overall Study|Study terminated by sponsor|349|||
163142378|NCT05030350|589231725|FG000|Overall Study|Positive Drug Screen|4|||
163142379|NCT05030350|589231725|FG000|Overall Study|Other|8|||
163142380|NCT00742183|589231726|FG000|Overall Study|Adverse Event|2|||
163142381|NCT00742183|589231727|FG001|Overall Study|Adverse Event|2|||
163142382|NCT00742183|589231726|FG000|Overall Study|Death|1|||
163142383|NCT00742183|589231727|FG001|Overall Study|Death|0|||
163142384|NCT00742183|589231726|FG000|Overall Study|Physician Decision|0|||
163142385|NCT00742183|589231727|FG001|Overall Study|Physician Decision|2|||
163142386|NCT00742183|589231726|FG000|Overall Study|Lost to Follow-up|4|||
163142387|NCT00742183|589231727|FG001|Overall Study|Lost to Follow-up|4|||
163142388|NCT00742183|589231726|FG000|Overall Study|Required skin-graft|1|||
163142389|NCT00742183|589231727|FG001|Overall Study|Required skin-graft|1|||
163142390|NCT00742183|589231726|FG000|Overall Study|Withdrawal by Subject|1|||
163142391|NCT00742183|589231727|FG001|Overall Study|Withdrawal by Subject|0|||
163142392|NCT00742183|589231726|FG000|Overall Study|Lack of Efficacy|0|||
163142393|NCT00742183|589231727|FG001|Overall Study|Lack of Efficacy|3|||
163142394|NCT03985761|589231731|FG000|Overall Study|Withdrawal by Subject|2|||
163142395|NCT03985761|589231732|FG001|Overall Study|Withdrawal by Subject|3|||
163142396|NCT01858363|589231735|FG000|Overall Study|Death|35|||
163142397|NCT01858363|589231736|FG001|Overall Study|Death|9|||
163142398|NCT01858363|589231735|FG000|Overall Study|Withdrawal by Subject|28|||
163142399|NCT01858363|589231736|FG001|Overall Study|Withdrawal by Subject|14|||
163142400|NCT01858363|589231735|FG000|Overall Study|Lost to Follow-up|13|||
162720960|NCT01317420|587685968|FG007|Overall Study|Reason other than those specified|0|||
163142401|NCT01858363|589231736|FG001|Overall Study|Lost to Follow-up|3|||
163142402|NCT01859923|589231737|FG000|Overall Study|Adverse Event|0|||
163142403|NCT01859923|589231738|FG001|Overall Study|Adverse Event|0|||
163142404|NCT01859923|589231739|FG002|Overall Study|Adverse Event|1|||
163142405|NCT01859923|589231740|FG003|Overall Study|Adverse Event|1|||
163142406|NCT00764361|589231746|FG000|Overall Study|Withdrawal by Subject|2|||
163142407|NCT00764361|589231747|FG001|Overall Study|Withdrawal by Subject|3|||
163142408|NCT00764361|589231746|FG000|Overall Study|Adverse Event|0|||
163142409|NCT00764361|589231747|FG001|Overall Study|Adverse Event|1|||
163142410|NCT00687401|589231751|FG000|Overall Study|Protocol Violation|7|||
163142411|NCT00687401|589231751|FG000|Overall Study|Adverse Event|6|||
163142412|NCT00687401|589231751|FG000|Overall Study|Lack of Efficacy|6|||
163142413|NCT00687401|589231751|FG000|Overall Study|Withdrawal by Subject|4|||
163142414|NCT00687401|589231751|FG000|Overall Study|Did not return for visit|3|||
163142415|NCT00687401|589231751|FG000|Overall Study|For reasons different from those above|4|||
163142416|NCT02520726|589231752|FG000|Overall Study|Lost to Follow-up|3|||
163142417|NCT02520726|589231753|FG001|Overall Study|Lost to Follow-up|2|||
163142418|NCT00721396|589231754|FG000|Overall Study|Adverse Event|4|||
163142419|NCT00721396|589231755|FG001|Overall Study|Adverse Event|7|||
163142420|NCT00721396|589231756|FG002|Overall Study|Adverse Event|2|||
163142421|NCT00721396|589231757|FG003|Overall Study|Adverse Event|0|||
163142422|NCT00721396|589231754|FG000|Overall Study|Withdrawal by Subject|12|||
163142423|NCT00721396|589231755|FG001|Overall Study|Withdrawal by Subject|15|||
163142424|NCT00721396|589231756|FG002|Overall Study|Withdrawal by Subject|3|||
163142425|NCT00721396|589231757|FG003|Overall Study|Withdrawal by Subject|7|||
163142426|NCT00721396|589231754|FG000|Overall Study|Lost to Follow-up|7|||
163142427|NCT00721396|589231755|FG001|Overall Study|Lost to Follow-up|9|||
163142428|NCT00721396|589231756|FG002|Overall Study|Lost to Follow-up|3|||
163142429|NCT00721396|589231757|FG003|Overall Study|Lost to Follow-up|3|||
163142430|NCT00721396|589231754|FG000|Overall Study|Protocol Violation|4|||
163142431|NCT00721396|589231755|FG001|Overall Study|Protocol Violation|3|||
163142432|NCT00721396|589231756|FG002|Overall Study|Protocol Violation|1|||
163142433|NCT00721396|589231757|FG003|Overall Study|Protocol Violation|0|||
163142434|NCT00721396|589231754|FG000|Overall Study|Inappropriate enrollment|0|||
163142435|NCT00721396|589231755|FG001|Overall Study|Inappropriate enrollment|2|||
163142436|NCT00721396|589231756|FG002|Overall Study|Inappropriate enrollment|0|||
163142437|NCT00721396|589231757|FG003|Overall Study|Inappropriate enrollment|0|||
163142438|NCT00721396|589231754|FG000|Overall Study|Administrative reason|3|||
163142439|NCT00721396|589231755|FG001|Overall Study|Administrative reason|0|||
163142440|NCT00721396|589231756|FG002|Overall Study|Administrative reason|1|||
163142441|NCT00721396|589231757|FG003|Overall Study|Administrative reason|0|||
163142442|NCT00430716|589231759|FG000|Double Blind Phase|Death|1|||
163142443|NCT00430716|589231760|FG001|Double Blind Phase|Death|0|||
163142444|NCT00430716|589231761|FG002|Double Blind Phase|Death|0|||
163142445|NCT00430716|589231759|FG000|Double Blind Phase|No longer willing to participate|2|||
163142446|NCT00430716|589231760|FG001|Double Blind Phase|No longer willing to participate|1|||
163142447|NCT00430716|589231761|FG002|Double Blind Phase|No longer willing to participate|1|||
163142448|NCT00430716|589231759|FG000|Double Blind Phase|Other|0|||
163142449|NCT00430716|589231760|FG001|Double Blind Phase|Other|2|||
162720961|NCT01317420|587685969|FG008|Overall Study|Reason other than those specified|0|||
163142450|NCT00430716|589231761|FG002|Double Blind Phase|Other|0|||
163142451|NCT00430716|589231759|FG000|Double Blind Phase|Study terminated by sponsor|1|||
163142452|NCT00430716|589231760|FG001|Double Blind Phase|Study terminated by sponsor|1|||
163142453|NCT00430716|589231761|FG002|Double Blind Phase|Study terminated by sponsor|2|||
163142454|NCT00430716|589231759|FG000|Double Blind Phase|Adverse Event|1|||
163142455|NCT00430716|589231760|FG001|Double Blind Phase|Adverse Event|1|||
163142456|NCT00430716|589231761|FG002|Double Blind Phase|Adverse Event|3|||
163142457|NCT00430716|589231759|FG000|Double Blind Phase|Not treated|1|||
163142458|NCT00430716|589231760|FG001|Double Blind Phase|Not treated|0|||
163142459|NCT00430716|589231761|FG002|Double Blind Phase|Not treated|0|||
163142460|NCT00430716|589231759|FG000|Open Label Phase|Lost to Follow-up|1|||
163142461|NCT00430716|589231760|FG001|Open Label Phase|Lost to Follow-up|0|||
163142462|NCT00430716|589231761|FG002|Open Label Phase|Lost to Follow-up|1|||
163142463|NCT00430716|589231759|FG000|Open Label Phase|No longer willing to participate|0|||
163142464|NCT00430716|589231760|FG001|Open Label Phase|No longer willing to participate|1|||
163142465|NCT00430716|589231761|FG002|Open Label Phase|No longer willing to participate|1|||
163142466|NCT00430716|589231759|FG000|Open Label Phase|Other|3|||
163142467|NCT00430716|589231760|FG001|Open Label Phase|Other|1|||
163142468|NCT00430716|589231761|FG002|Open Label Phase|Other|1|||
163142469|NCT00430716|589231759|FG000|Open Label Phase|Protocol Violation|1|||
163142470|NCT00430716|589231760|FG001|Open Label Phase|Protocol Violation|0|||
163142471|NCT00430716|589231761|FG002|Open Label Phase|Protocol Violation|0|||
163142472|NCT00430716|589231759|FG000|Open Label Phase|Study terminated by sponsor|4|||
163142473|NCT00430716|589231760|FG001|Open Label Phase|Study terminated by sponsor|5|||
163142474|NCT00430716|589231761|FG002|Open Label Phase|Study terminated by sponsor|4|||
163142475|NCT05114473|589231764|FG000|Overall Study|Lost to Follow-up|2|||
163142476|NCT05114473|589231765|FG001|Overall Study|Lost to Follow-up|2|||
163142477|NCT05114473|589231766|FG002|Overall Study|Lost to Follow-up|0|||
163142478|NCT00154297|589231769|FG000|Overall Study|Death|5|||
163142479|NCT00154297|589231770|FG001|Overall Study|Death|2|||
163142480|NCT00154297|589231769|FG000|Overall Study|Withdrawal by Subject|0|||
163142481|NCT00154297|589231770|FG001|Overall Study|Withdrawal by Subject|5|||
163142482|NCT00154297|589231769|FG000|Overall Study|Lost to Follow-up|3|||
163142483|NCT00154297|589231770|FG001|Overall Study|Lost to Follow-up|0|||
163142484|NCT03116685|589231773|FG000|Overall Study|Physician Decision|0|||
163142485|NCT03116685|589231774|FG001|Overall Study|Physician Decision|1|||
163142486|NCT00398320|589231776|FG000|Overall Study|Death|1|||
163142487|NCT00398320|589231776|FG000|Overall Study|Adverse Event|4|||
163142488|NCT00398320|589231776|FG000|Overall Study|Physician Decision|1|||
163142489|NCT00064792|589231777|FG000|Overall Study|Withdrawal by Subject|2|||
163142490|NCT00064792|589231778|FG001|Overall Study|Withdrawal by Subject|0|||
163142491|NCT00064792|589231777|FG000|Overall Study|Adverse Event|3|||
163142492|NCT00064792|589231778|FG001|Overall Study|Adverse Event|0|||
163142493|NCT00291486|589231783|FG000|Overall Study|Adverse Event|0|||
163142494|NCT00291486|589231784|FG001|Overall Study|Adverse Event|3|||
163142495|NCT00291486|589231785|FG002|Overall Study|Adverse Event|0|||
163142496|NCT00291486|589231786|FG003|Overall Study|Adverse Event|1|||
163142497|NCT00291486|589231787|FG004|Overall Study|Adverse Event|0|||
163142498|NCT00291486|589231783|FG000|Overall Study|Withdrawal by Subject|0|||
163142499|NCT00291486|589231784|FG001|Overall Study|Withdrawal by Subject|0|||
163142500|NCT00291486|589231785|FG002|Overall Study|Withdrawal by Subject|0|||
163142501|NCT00291486|589231786|FG003|Overall Study|Withdrawal by Subject|0|||
163142502|NCT00291486|589231787|FG004|Overall Study|Withdrawal by Subject|1|||
163142503|NCT00291486|589231783|FG000|Overall Study|Disease progression|1|||
163142504|NCT00291486|589231784|FG001|Overall Study|Disease progression|0|||
163142505|NCT00291486|589231785|FG002|Overall Study|Disease progression|1|||
163142506|NCT00291486|589231786|FG003|Overall Study|Disease progression|0|||
163142507|NCT00291486|589231787|FG004|Overall Study|Disease progression|0|||
163142508|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Death|2|||
163142509|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Death|0|||
163142510|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Death|0|||
163142511|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
163142512|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
163142513|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
163142514|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
163142515|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
163142516|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
163142517|NCT01150097|589231792|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
163142518|NCT01150097|589231793|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
163142519|NCT01150097|589231794|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
163142520|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
163142521|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
163142522|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
163142523|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
163142524|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
163142525|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
163142526|NCT01150097|589231792|FG000|Months 24 to 48 Post-transplantation|Death|2|||
163142527|NCT01150097|589231793|FG001|Months 24 to 48 Post-transplantation|Death|0|||
163142528|NCT01150097|589231794|FG002|Months 24 to 48 Post-transplantation|Death|0|||
163142529|NCT01408459|589231795|FG000|Overall Study|Withdrawal by Subject|1|||
163142530|NCT01408459|589231796|FG001|Overall Study|Withdrawal by Subject|1|||
163142531|NCT00992459|589231797|FG000|Overall Study|Withdrawal by Subject|0|||
163142532|NCT00992459|589231798|FG001|Overall Study|Withdrawal by Subject|1|||
163142533|NCT00992459|589231797|FG000|Overall Study|Adverse Event|1|||
163142534|NCT00992459|589231798|FG001|Overall Study|Adverse Event|0|||
163142535|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Adverse Event|0|||
163142536|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Adverse Event|1|||
163142537|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Adverse Event|0|||
163142538|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Adverse Event|0|||
163142539|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Adverse Event|0|||
163142540|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Adverse Event|0|||
163142541|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Adverse Event|0|||
163142542|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Adverse Event|1|||
163142543|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Adverse Event|1|||
163142544|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Adverse Event|0|||
163142545|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Adverse Event|0|||
163142546|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Physician Decision|0|||
163142547|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Physician Decision|0|||
163142548|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Physician Decision|1|||
163142549|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Physician Decision|0|||
163142550|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Physician Decision|0|||
163142551|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Physician Decision|0|||
163142552|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Physician Decision|0|||
163142553|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Physician Decision|1|||
163142554|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Physician Decision|0|||
163142555|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Physician Decision|0|||
163142556|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Physician Decision|0|||
163142557|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142558|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
163142559|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
163142560|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142561|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142562|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
163142563|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
163142564|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
163142565|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
162662853|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Death|0|||
162662854|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Death|1|||
162662855|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Death|0|||
162662856|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Death|0|||
162662857|NCT00071487|587478252|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
162662858|NCT00071487|587478253|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
163142566|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
163142567|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
163142568|NCT00543387|589231803|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142569|NCT00543387|589231804|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142570|NCT00543387|589231805|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142571|NCT00543387|589231806|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142572|NCT00543387|589231807|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142573|NCT00543387|589231808|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142574|NCT00543387|589231809|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
163142575|NCT00543387|589231810|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142576|NCT00543387|589231811|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142577|NCT00543387|589231812|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142578|NCT00543387|589231813|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
163142579|NCT00543387|589231803|FG000|Crossover Participants|Progressive Disease|0|||
163142580|NCT00543387|589231804|FG001|Crossover Participants|Progressive Disease|0|||
163142581|NCT00543387|589231805|FG002|Crossover Participants|Progressive Disease|0|||
162662859|NCT00071487|587478254|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
162662860|NCT00071487|587478255|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
163142582|NCT00543387|589231806|FG003|Crossover Participants|Progressive Disease|0|||
163142583|NCT00543387|589231807|FG004|Crossover Participants|Progressive Disease|0|||
163142584|NCT00543387|589231808|FG005|Crossover Participants|Progressive Disease|0|||
163142585|NCT00543387|589231809|FG006|Crossover Participants|Progressive Disease|0|||
163142586|NCT00543387|589231810|FG007|Crossover Participants|Progressive Disease|0|||
163142587|NCT00543387|589231811|FG008|Crossover Participants|Progressive Disease|0|||
163142588|NCT00543387|589231812|FG009|Crossover Participants|Progressive Disease|1|||
163142589|NCT00543387|589231813|FG010|Crossover Participants|Progressive Disease|2|||
163142590|NCT00543387|589231803|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
163142591|NCT00543387|589231804|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
163142592|NCT00543387|589231805|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
163142593|NCT00543387|589231806|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
163142594|NCT00543387|589231807|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
163142595|NCT00543387|589231808|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
163142596|NCT00543387|589231809|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
163142597|NCT00543387|589231810|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
163142598|NCT00543387|589231811|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
163142599|NCT00543387|589231812|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
163142600|NCT00543387|589231813|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
163142601|NCT04177212|589231818|FG000|Overall Study|Withdrawal by Subject|9|||
163142602|NCT04177212|589231819|FG001|Overall Study|Withdrawal by Subject|7|||
163142603|NCT04177212|589231818|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
163142604|NCT04177212|589231819|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
163142605|NCT04177212|589231818|FG000|Overall Study|Physician Decision|1|||
163142606|NCT04177212|589231819|FG001|Overall Study|Physician Decision|0|||
163142607|NCT04177212|589231818|FG000|Overall Study|Lost to Follow-up|0|||
163142608|NCT04177212|589231819|FG001|Overall Study|Lost to Follow-up|3|||
163142609|NCT04177212|589231818|FG000|Overall Study|Adverse Event|0|||
163142610|NCT04177212|589231819|FG001|Overall Study|Adverse Event|1|||
163142611|NCT04177212|589231818|FG000|Overall Study|Other|1|||
163142612|NCT04177212|589231819|FG001|Overall Study|Other|2|||
163142613|NCT01792115|589231820|FG000|Overall Study|Lost to Follow-up|0|||
163142614|NCT01792115|589231821|FG001|Overall Study|Lost to Follow-up|1|||
163142615|NCT01792115|589231822|FG002|Overall Study|Lost to Follow-up|0|||
163142616|NCT01279681|589231823|FG000|Overall Study|Disease Progression|9|||
163142617|NCT01279681|589231824|FG001|Overall Study|Disease Progression|6|||
163142618|NCT01279681|589231823|FG000|Overall Study|Withdrawal by Subject|3|||
163142619|NCT01279681|589231824|FG001|Overall Study|Withdrawal by Subject|4|||
163142620|NCT01279681|589231823|FG000|Overall Study|Adverse Event|2|||
163142621|NCT01279681|589231824|FG001|Overall Study|Adverse Event|3|||
163142622|NCT01279681|589231823|FG000|Overall Study|Death|0|||
163142623|NCT01279681|589231824|FG001|Overall Study|Death|1|||
163142624|NCT01279681|589231823|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
163142625|NCT01279681|589231824|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
163142626|NCT01279681|589231823|FG000|Overall Study|Physician Decision|1|||
163142627|NCT01279681|589231824|FG001|Overall Study|Physician Decision|0|||
163142628|NCT01279681|589231823|FG000|Overall Study|Other Reason|0|||
163142629|NCT01279681|589231824|FG001|Overall Study|Other Reason|2|||
163142630|NCT01943591|589231825|FG000|Overall Study|Lost to Follow-up|3|||
163142631|NCT01943591|589231826|FG001|Overall Study|Lost to Follow-up|4|||
163142632|NCT01943591|589231825|FG000|Overall Study|Death|2|||
163142633|NCT01943591|589231826|FG001|Overall Study|Death|7|||
163142634|NCT02539797|589233224|FG000|Overall Study|Lost to Follow-up|0|||
163142635|NCT02539797|589233225|FG001|Overall Study|Lost to Follow-up|1|||
163142636|NCT02539797|589233226|FG002|Overall Study|Lost to Follow-up|0|||
163142637|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142638|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
163142639|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142640|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142641|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
163142642|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
163142643|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
162720962|NCT01317420|587685970|FG009|Overall Study|Reason other than those specified|1|||
162720963|NCT01317420|587685971|FG010|Overall Study|Reason other than those specified|0|||
162720964|NCT01317420|587685972|FG011|Overall Study|Reason other than those specified|0|||
163142644|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
162720965|NCT01317420|587685973|FG012|Overall Study|Reason other than those specified|0|||
162720966|NCT04210180|587685974|FG000|Overall Study|Withdrawal by Subject|2|||
162720967|NCT00367055|587685975|FG000|Overall Study|Adverse Event|6|||
162720968|NCT00367055|587685976|FG001|Overall Study|Adverse Event|3|||
162720969|NCT00367055|587685975|FG000|Overall Study|Patient's Willing|3|||
162720970|NCT00367055|587685976|FG001|Overall Study|Patient's Willing|2|||
163142645|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
163142646|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
163142647|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
163142648|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
163142649|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142650|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142651|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
163142652|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
163142653|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
163142654|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142655|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142656|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
163142657|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
163142658|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
163142659|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142660|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142661|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
163142662|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
163142663|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
163142664|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142665|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142666|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
163142667|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
163142668|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
163142669|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142670|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142671|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
163142672|NCT02831764|589233227|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142673|NCT02831764|589233228|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
163142674|NCT02831764|589233229|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142675|NCT02831764|589233230|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142676|NCT02831764|589233231|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
163142677|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142678|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142679|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
163142680|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
163142681|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163142682|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142683|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142684|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
163142685|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142686|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163142687|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142688|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142689|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
163142690|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
163142691|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163142692|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142693|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142694|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
163142695|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142696|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
163142697|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142698|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142699|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
163142700|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
163142701|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163142702|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142703|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142704|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
163142705|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
163142706|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163142707|NCT02831764|589233227|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142708|NCT02831764|589233228|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142709|NCT02831764|589233229|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
163142710|NCT02831764|589233230|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
163142711|NCT02831764|589233231|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163142712|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142713|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142714|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142715|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163142716|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
163142717|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142718|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142719|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142720|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163142721|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
163142722|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142723|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142724|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142725|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163142726|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
163142727|NCT02831764|589233227|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142728|NCT02831764|589233228|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142729|NCT02831764|589233229|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142730|NCT02831764|589233230|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163142731|NCT02831764|589233231|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
163142732|NCT01790594|589233235|FG000|Overall Study|Death|1|||
163142733|NCT01790594|589233236|FG001|Overall Study|Death|0|||
162662861|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
162720971|NCT00367055|587685975|FG000|Overall Study|Lack of Efficacy|1|||
163142734|NCT01790594|589233237|FG002|Overall Study|Death|0|||
163142735|NCT01790594|589233235|FG000|Overall Study|Physician Decision|2|||
163142736|NCT01790594|589233236|FG001|Overall Study|Physician Decision|1|||
163142737|NCT01790594|589233237|FG002|Overall Study|Physician Decision|0|||
163142738|NCT01790594|589233235|FG000|Overall Study|Withdrawal by Subject|2|||
163142739|NCT01790594|589233236|FG001|Overall Study|Withdrawal by Subject|0|||
163142740|NCT01790594|589233237|FG002|Overall Study|Withdrawal by Subject|0|||
163142741|NCT01790594|589233235|FG000|Overall Study|Transplant was not done|0|||
163142742|NCT01790594|589233236|FG001|Overall Study|Transplant was not done|0|||
163142743|NCT01790594|589233237|FG002|Overall Study|Transplant was not done|3|||
163142744|NCT01790594|589233235|FG000|Overall Study|Terminated prior to week 76|0|||
163142745|NCT01790594|589233236|FG001|Overall Study|Terminated prior to week 76|2|||
163142746|NCT01790594|589233237|FG002|Overall Study|Terminated prior to week 76|0|||
163142747|NCT03347123|589233238|FG000|Overall Study|Death|1|||
163142748|NCT03347123|589233239|FG001|Overall Study|Death|2|||
163142749|NCT03347123|589233240|FG002|Overall Study|Death|0|||
163142750|NCT03347123|589233241|FG003|Overall Study|Death|0|||
163142751|NCT03347123|589233242|FG004|Overall Study|Death|0|||
163142752|NCT03347123|589233243|FG005|Overall Study|Death|0|||
163142753|NCT03347123|589233244|FG006|Overall Study|Death|0|||
163142754|NCT03347123|589233238|FG000|Overall Study|Withdrawal by Subject|1|||
163142755|NCT03347123|589233239|FG001|Overall Study|Withdrawal by Subject|0|||
163142756|NCT03347123|589233240|FG002|Overall Study|Withdrawal by Subject|0|||
163142757|NCT03347123|589233241|FG003|Overall Study|Withdrawal by Subject|0|||
163142758|NCT03347123|589233242|FG004|Overall Study|Withdrawal by Subject|0|||
163142759|NCT03347123|589233243|FG005|Overall Study|Withdrawal by Subject|0|||
163142760|NCT03347123|589233244|FG006|Overall Study|Withdrawal by Subject|0|||
163142761|NCT03347123|589233238|FG000|Overall Study|Reason not Specified|3|||
163142762|NCT03347123|589233239|FG001|Overall Study|Reason not Specified|4|||
163142763|NCT03347123|589233240|FG002|Overall Study|Reason not Specified|0|||
163142764|NCT03347123|589233241|FG003|Overall Study|Reason not Specified|0|||
163142765|NCT03347123|589233242|FG004|Overall Study|Reason not Specified|0|||
163142766|NCT03347123|589233243|FG005|Overall Study|Reason not Specified|0|||
163142767|NCT03347123|589233244|FG006|Overall Study|Reason not Specified|0|||
163142768|NCT00346216|589233249|FG000|Overall Study|Other|181|||
163142769|NCT00346216|589233250|FG001|Overall Study|Other|231|||
163142770|NCT00346216|589233251|FG002|Overall Study|Other|205|||
163142771|NCT00346216|589233249|FG000|Overall Study|No longer willing to participate|600|||
163142772|NCT00346216|589233250|FG001|Overall Study|No longer willing to participate|606|||
163142773|NCT00346216|589233251|FG002|Overall Study|No longer willing to participate|585|||
163142774|NCT00346216|589233249|FG000|Overall Study|Withdrawal by Subject|661|||
163142775|NCT00346216|589233250|FG001|Overall Study|Withdrawal by Subject|692|||
163142776|NCT00346216|589233251|FG002|Overall Study|Withdrawal by Subject|651|||
163142777|NCT00346216|589233249|FG000|Overall Study|Lost to Follow-up|611|||
163142778|NCT00346216|589233250|FG001|Overall Study|Lost to Follow-up|588|||
163142779|NCT00346216|589233251|FG002|Overall Study|Lost to Follow-up|542|||
163142780|NCT00346216|589233249|FG000|Overall Study|Physician Decision|80|||
163142781|NCT00346216|589233250|FG001|Overall Study|Physician Decision|76|||
163142782|NCT00346216|589233251|FG002|Overall Study|Physician Decision|59|||
163142783|NCT00346216|589233249|FG000|Overall Study|Does not meet entrance criteria|13|||
163142784|NCT00346216|589233250|FG001|Overall Study|Does not meet entrance criteria|10|||
163142785|NCT00346216|589233251|FG002|Overall Study|Does not meet entrance criteria|8|||
163142786|NCT00346216|589233249|FG000|Overall Study|Death|189|||
163142787|NCT00346216|589233250|FG001|Overall Study|Death|192|||
163142788|NCT00346216|589233251|FG002|Overall Study|Death|228|||
163142789|NCT00346216|589233249|FG000|Overall Study|Study terminated by sponsor|11|||
163142790|NCT00346216|589233250|FG001|Overall Study|Study terminated by sponsor|4|||
163142791|NCT00346216|589233251|FG002|Overall Study|Study terminated by sponsor|8|||
163142792|NCT00346216|589233249|FG000|Overall Study|Missing Subject Summary Status|62|||
163142793|NCT00346216|589233250|FG001|Overall Study|Missing Subject Summary Status|61|||
163142794|NCT00346216|589233251|FG002|Overall Study|Missing Subject Summary Status|62|||
163142795|NCT03431441|589233252|FG000|Overall Study|Withdrawal by Subject|2|||
163142796|NCT03431441|589233252|FG000|Overall Study|Adverse Event|2|||
163142797|NCT03431441|589233252|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
163142798|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
163142799|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
163142800|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Death|1|||
163142801|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Death|2|||
163142802|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
163142803|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
163142804|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
163142805|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
163142806|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
163142807|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
163142808|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
163142809|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
163142810|NCT01794000|589233258|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
163142811|NCT01794000|589233259|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
163142812|NCT01794000|589233258|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
163142813|NCT01794000|589233259|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
163142814|NCT00796666|589233260|FG000|Overall Study|Death|2|||
163142815|NCT00796666|589233261|FG001|Overall Study|Death|4|||
163142816|NCT00796666|589233260|FG000|Overall Study|Withdrawal by Subject|2|||
163142817|NCT00796666|589233261|FG001|Overall Study|Withdrawal by Subject|0|||
163142818|NCT00796666|589233260|FG000|Overall Study|Adverse Event|7|||
163142819|NCT00796666|589233261|FG001|Overall Study|Adverse Event|5|||
163142820|NCT00796666|589233260|FG000|Overall Study|Protocol Violation|1|||
163142821|NCT00796666|589233261|FG001|Overall Study|Protocol Violation|0|||
163142822|NCT00796666|589233260|FG000|Overall Study|Other|1|||
163142823|NCT00796666|589233261|FG001|Overall Study|Other|0|||
163142824|NCT00796666|589233260|FG000|Overall Study|Terminated by sponsor|53|||
163142825|NCT00796666|589233261|FG001|Overall Study|Terminated by sponsor|55|||
163142826|NCT00796666|589233260|FG000|Overall Study|Randomized and not treated|1|||
163142827|NCT00796666|589233261|FG001|Overall Study|Randomized and not treated|0|||
163142828|NCT01367834|589233262|FG000|Overall Study|Withdrawal by Subject|2|||
163142829|NCT01367834|589233263|FG001|Overall Study|Withdrawal by Subject|2|||
163142830|NCT01367834|589233262|FG000|Overall Study|Study was ended.|0|||
163142831|NCT01367834|589233263|FG001|Overall Study|Study was ended.|1|||
163142832|NCT01156480|589233265|FG000|Overall Study|change in diagnosis|0|||
163142833|NCT01156480|589233266|FG001|Overall Study|change in diagnosis|1|||
163142834|NCT04537793|589233267|FG000|Part B (24 Weeks)|Adverse Event|0|||
163142835|NCT04537793|589233268|FG001|Part B (24 Weeks)|Adverse Event|1|||
163142836|NCT00988598|589233269|FG000|Overall Study|Withdrawal by Subject|2|||
163142837|NCT00988598|589233270|FG001|Overall Study|Withdrawal by Subject|0|||
163142838|NCT03367858|589233271|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
163142839|NCT03367858|589233272|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
163142840|NCT03367858|589233271|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
163142841|NCT03367858|589233272|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
163142842|NCT03367858|589233271|FG000|3 Month Follow Up|Lost to Follow-up|8|||
163142843|NCT03367858|589233272|FG001|3 Month Follow Up|Lost to Follow-up|3|||
163142844|NCT03367858|589233271|FG000|3 Month Follow Up|Moved out of study area|2|||
163142845|NCT03367858|589233272|FG001|3 Month Follow Up|Moved out of study area|6|||
163142846|NCT03367858|589233271|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
163142847|NCT03367858|589233272|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
163142848|NCT03367858|589233271|FG000|3 Month Follow Up|MRI contraindication|2|||
163142849|NCT03367858|589233272|FG001|3 Month Follow Up|MRI contraindication|1|||
163142850|NCT03367858|589233271|FG000|3 Month Follow Up|Incarcerated|0|||
163142851|NCT03367858|589233272|FG001|3 Month Follow Up|Incarcerated|1|||
163142852|NCT03367858|589233271|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
163142853|NCT03367858|589233272|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
163142854|NCT03367858|589233271|FG000|6 Month Follow Up|Lost to Follow-up|5|||
163142855|NCT03367858|589233272|FG001|6 Month Follow Up|Lost to Follow-up|2|||
163142856|NCT03367858|589233271|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
163142857|NCT03367858|589233272|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
163142858|NCT03367858|589233271|FG000|12 Month Follow Up|Lost to Follow-up|3|||
163142859|NCT03367858|589233272|FG001|12 Month Follow Up|Lost to Follow-up|3|||
163142860|NCT03367858|589233271|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
163142861|NCT03367858|589233272|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
163142862|NCT00057863|589233285|FG000|Overall Study|Death|1|||
163142863|NCT00057863|589233285|FG000|Overall Study|Withdrawal by Subject|2|||
163142864|NCT02090426|589233286|FG000|Overall Study|Lost to Follow-up|12|||
163142865|NCT02090426|589233287|FG001|Overall Study|Lost to Follow-up|6|||
163142866|NCT02079038|589233289|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
163142867|NCT02079038|589233290|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
163142868|NCT02079038|589233289|FG000|Modified Intent to Treat Population|Death|1|||
163142869|NCT02079038|589233290|FG001|Modified Intent to Treat Population|Death|0|||
163142870|NCT02079038|589233289|FG000|Completed 6 Months|Lost to Follow-up|2|||
163142871|NCT02079038|589233290|FG001|Completed 6 Months|Lost to Follow-up|1|||
163142872|NCT01141712|589233291|FG000|Overall Study|Disease progression|3|||
163142873|NCT03480152|589233292|FG000|Phase I|Signed consent. Died before treatment.|1|||
163142874|NCT03480152|589233293|FG001|Phase I|Signed consent. Died before treatment.|0|||
163142875|NCT03480152|589233294|FG002|Phase I|Signed consent. Died before treatment.|0|||
163142876|NCT01308736|589233301|FG000|Overall Study|Did not attend a single session|6|||
163142877|NCT01308736|589233302|FG001|Overall Study|Did not attend a single session|5|||
163142878|NCT03634085|589233303|FG000|Overall Study|Adverse Event|1|||
163142879|NCT03634085|589233304|FG001|Overall Study|Adverse Event|0|||
163142880|NCT03634085|589233303|FG000|Overall Study|Withdrawal by Subject|0|||
163142881|NCT03634085|589233304|FG001|Overall Study|Withdrawal by Subject|2|||
163142882|NCT04276233|589233305|FG000|Overall Study|Adverse Event|1|||
163142883|NCT04276233|589233305|FG000|Overall Study|Lost to Follow-up|3|||
163142884|NCT04276233|589233305|FG000|Overall Study|Physician Decision|4|||
163142885|NCT04276233|589233305|FG000|Overall Study|Withdrawal by Subject|2|||
163142886|NCT01946139|589233310|FG000|Overall Study|Withdrawal by Subject|8|||
163142887|NCT01946139|589233310|FG000|Overall Study|ineligible|8|||
163142888|NCT01946139|589233310|FG000|Overall Study|Specimens not available|4|||
163142889|NCT00101686|589233317|FG000|Overall Study|Progressive Disease|37|||
163142890|NCT00101686|589233318|FG001|Overall Study|Progressive Disease|28|||
163142891|NCT00101686|589233319|FG002|Overall Study|Progressive Disease|37|||
163142892|NCT00101686|589233320|FG003|Overall Study|Progressive Disease|38|||
163142893|NCT00101686|589233321|FG004|Overall Study|Progressive Disease|28|||
163142894|NCT00101686|589233322|FG005|Overall Study|Progressive Disease|25|||
163142895|NCT00101686|589233323|FG006|Overall Study|Progressive Disease|5|||
163142896|NCT00101686|589233324|FG007|Overall Study|Progressive Disease|7|||
163142897|NCT00101686|589233325|FG008|Overall Study|Progressive Disease|10|||
163142898|NCT00101686|589233326|FG009|Overall Study|Progressive Disease|8|||
163142899|NCT00101686|589233317|FG000|Overall Study|initiation other anti-cancer treatment|4|||
163142900|NCT00101686|589233318|FG001|Overall Study|initiation other anti-cancer treatment|3|||
163142901|NCT00101686|589233319|FG002|Overall Study|initiation other anti-cancer treatment|4|||
163142902|NCT00101686|589233320|FG003|Overall Study|initiation other anti-cancer treatment|3|||
163142903|NCT00101686|589233321|FG004|Overall Study|initiation other anti-cancer treatment|1|||
163142904|NCT00101686|589233322|FG005|Overall Study|initiation other anti-cancer treatment|1|||
163142905|NCT00101686|589233323|FG006|Overall Study|initiation other anti-cancer treatment|2|||
163142906|NCT00101686|589233324|FG007|Overall Study|initiation other anti-cancer treatment|2|||
163142907|NCT00101686|589233325|FG008|Overall Study|initiation other anti-cancer treatment|3|||
162720972|NCT00367055|587685976|FG001|Overall Study|Lack of Efficacy|2|||
162720973|NCT00367055|587685975|FG000|Overall Study|Lost to Follow-up|1|||
162720974|NCT00367055|587685976|FG001|Overall Study|Lost to Follow-up|1|||
163142908|NCT00101686|589233326|FG009|Overall Study|initiation other anti-cancer treatment|3|||
163142909|NCT00101686|589233317|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
163142910|NCT00101686|589233318|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
163142911|NCT00101686|589233319|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
163142912|NCT00101686|589233320|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
163142913|NCT00101686|589233321|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
163142914|NCT00101686|589233322|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
163142915|NCT00101686|589233323|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
163142916|NCT00101686|589233324|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
163142917|NCT00101686|589233325|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
163142918|NCT00101686|589233326|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
163142919|NCT00101686|589233317|FG000|Overall Study|unacceptable toxicity|3|||
163142920|NCT00101686|589233318|FG001|Overall Study|unacceptable toxicity|9|||
163142921|NCT00101686|589233319|FG002|Overall Study|unacceptable toxicity|10|||
163142922|NCT00101686|589233320|FG003|Overall Study|unacceptable toxicity|6|||
163142923|NCT00101686|589233321|FG004|Overall Study|unacceptable toxicity|16|||
163142924|NCT00101686|589233322|FG005|Overall Study|unacceptable toxicity|10|||
163142925|NCT00101686|589233323|FG006|Overall Study|unacceptable toxicity|4|||
163142926|NCT00101686|589233324|FG007|Overall Study|unacceptable toxicity|2|||
163142927|NCT00101686|589233325|FG008|Overall Study|unacceptable toxicity|1|||
163142928|NCT00101686|589233326|FG009|Overall Study|unacceptable toxicity|4|||
163142929|NCT00101686|589233317|FG000|Overall Study|Randomized but did not receive treament|1|||
163142930|NCT00101686|589233318|FG001|Overall Study|Randomized but did not receive treament|6|||
163142931|NCT00101686|589233319|FG002|Overall Study|Randomized but did not receive treament|2|||
163142932|NCT00101686|589233320|FG003|Overall Study|Randomized but did not receive treament|2|||
163142933|NCT00101686|589233321|FG004|Overall Study|Randomized but did not receive treament|2|||
163142934|NCT00101686|589233322|FG005|Overall Study|Randomized but did not receive treament|2|||
163142935|NCT00101686|589233323|FG006|Overall Study|Randomized but did not receive treament|0|||
163142936|NCT00101686|589233324|FG007|Overall Study|Randomized but did not receive treament|1|||
163142937|NCT00101686|589233325|FG008|Overall Study|Randomized but did not receive treament|0|||
163142938|NCT00101686|589233326|FG009|Overall Study|Randomized but did not receive treament|1|||
163142939|NCT00101686|589233317|FG000|Overall Study|intercurrent non-cancer related illness|0|||
163142940|NCT00101686|589233318|FG001|Overall Study|intercurrent non-cancer related illness|0|||
163142941|NCT00101686|589233319|FG002|Overall Study|intercurrent non-cancer related illness|2|||
163142942|NCT00101686|589233320|FG003|Overall Study|intercurrent non-cancer related illness|0|||
163142943|NCT00101686|589233321|FG004|Overall Study|intercurrent non-cancer related illness|1|||
163142944|NCT00101686|589233322|FG005|Overall Study|intercurrent non-cancer related illness|3|||
163142945|NCT00101686|589233323|FG006|Overall Study|intercurrent non-cancer related illness|1|||
163142946|NCT00101686|589233324|FG007|Overall Study|intercurrent non-cancer related illness|0|||
163142947|NCT00101686|589233325|FG008|Overall Study|intercurrent non-cancer related illness|1|||
163142948|NCT00101686|589233326|FG009|Overall Study|intercurrent non-cancer related illness|1|||
163142949|NCT00101686|589233317|FG000|Overall Study|Physician Decision|10|||
163142950|NCT00101686|589233318|FG001|Overall Study|Physician Decision|13|||
163142951|NCT00101686|589233319|FG002|Overall Study|Physician Decision|6|||
163142952|NCT00101686|589233320|FG003|Overall Study|Physician Decision|7|||
163142953|NCT00101686|589233321|FG004|Overall Study|Physician Decision|8|||
163142954|NCT00101686|589233322|FG005|Overall Study|Physician Decision|9|||
163142955|NCT00101686|589233323|FG006|Overall Study|Physician Decision|5|||
163142956|NCT00101686|589233324|FG007|Overall Study|Physician Decision|5|||
163142957|NCT00101686|589233325|FG008|Overall Study|Physician Decision|1|||
163142958|NCT00101686|589233326|FG009|Overall Study|Physician Decision|1|||
163142959|NCT00101686|589233317|FG000|Overall Study|Other|1|||
163142960|NCT00101686|589233318|FG001|Overall Study|Other|4|||
163142961|NCT00101686|589233319|FG002|Overall Study|Other|1|||
163142962|NCT00101686|589233320|FG003|Overall Study|Other|6|||
163142963|NCT00101686|589233321|FG004|Overall Study|Other|2|||
163142964|NCT00101686|589233322|FG005|Overall Study|Other|12|||
163142965|NCT00101686|589233323|FG006|Overall Study|Other|1|||
163142966|NCT00101686|589233324|FG007|Overall Study|Other|5|||
163142967|NCT00101686|589233325|FG008|Overall Study|Other|3|||
163142968|NCT00101686|589233326|FG009|Overall Study|Other|3|||
163142969|NCT00101686|589233317|FG000|Overall Study|Withdrawal by Subject|9|||
163142970|NCT00101686|589233318|FG001|Overall Study|Withdrawal by Subject|8|||
163142971|NCT00101686|589233319|FG002|Overall Study|Withdrawal by Subject|6|||
163142972|NCT00101686|589233320|FG003|Overall Study|Withdrawal by Subject|8|||
163142973|NCT00101686|589233321|FG004|Overall Study|Withdrawal by Subject|8|||
163142974|NCT00101686|589233322|FG005|Overall Study|Withdrawal by Subject|7|||
163142975|NCT00101686|589233323|FG006|Overall Study|Withdrawal by Subject|7|||
163142976|NCT00101686|589233324|FG007|Overall Study|Withdrawal by Subject|7|||
163142977|NCT00101686|589233325|FG008|Overall Study|Withdrawal by Subject|8|||
163142978|NCT00101686|589233326|FG009|Overall Study|Withdrawal by Subject|9|||
163142979|NCT00296816|589233327|FG000|Overall Study|Disease Progression|37|||
162662862|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
162662863|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
162662864|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
162662865|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162662866|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162662867|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
163142980|NCT00296816|589233327|FG000|Overall Study|Adverse Event|18|||
163142981|NCT00296816|589233327|FG000|Overall Study|Investigator/Participant request|5|||
163142982|NCT00296816|589233327|FG000|Overall Study|Non-compliance|1|||
163142983|NCT00296816|589233327|FG000|Overall Study|Missing for end of treatment|4|||
163142984|NCT00296816|589233327|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
163142985|NCT00296816|589233327|FG000|Overall Study|Poor performance status|1|||
163142986|NCT00296816|589233327|FG000|Overall Study|Relocation to Florida|1|||
163142987|NCT00296816|589233327|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
163142988|NCT00296816|589233327|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
163142989|NCT00296816|589233327|FG000|Overall Study|Neuropathy/patient preference|1|||
163142990|NCT00296816|589233327|FG000|Overall Study|Proteinuria|1|||
163142991|NCT00296816|589233327|FG000|Overall Study|ineligibility due to radiation treatment|1|||
163142992|NCT00985465|589233328|FG000|Overall Study|Withdrawal by Subject|1|||
163142993|NCT00985465|589233329|FG001|Overall Study|Withdrawal by Subject|2|||
163142994|NCT00985465|589233328|FG000|Overall Study|Considered to be part of the other group|0|||
163142995|NCT00985465|589233329|FG001|Overall Study|Considered to be part of the other group|1|||
163142996|NCT01054456|589233332|FG000|Overall Study|Other|1|||
163142997|NCT04701333|589233333|FG000|Overall Study|Lost to Follow-up|3|||
163142998|NCT04701333|589233334|FG001|Overall Study|Lost to Follow-up|7|||
163142999|NCT04701333|589233333|FG000|Overall Study|Withdrawal by Subject|0|||
163143000|NCT04701333|589233334|FG001|Overall Study|Withdrawal by Subject|1|||
163143001|NCT01012258|589233335|FG000|Overall Study|Death|14|||
163143002|NCT01012258|589233335|FG000|Overall Study|Lost to Follow-up|1|||
163143003|NCT01012258|589233335|FG000|Overall Study|Adverse Event|1|||
163143004|NCT01012258|589233335|FG000|Overall Study|Progressive Disease (PD)|18|||
163143005|NCT01012258|589233335|FG000|Overall Study|Symptomatic Deterioration|1|||
163143006|NCT01012258|589233335|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
163143007|NCT01012258|589233335|FG000|Overall Study|Another Tumor Discovered|1|||
163143008|NCT01012258|589233335|FG000|Overall Study|Ongoing|29|||
163143009|NCT01292187|589233336|FG000|Overall Study|Adverse Event|10|||
163143010|NCT01292187|589233337|FG001|Overall Study|Adverse Event|5|||
163143011|NCT01292187|589233336|FG000|Overall Study|Withdrawal by Subject|6|||
163143012|NCT01292187|589233337|FG001|Overall Study|Withdrawal by Subject|5|||
163143013|NCT01292187|589233336|FG000|Overall Study|All other reasons|1|||
163143014|NCT01292187|589233337|FG001|Overall Study|All other reasons|3|||
163143015|NCT01814527|589233339|FG000|Overall Study|RTP greater than 30 days|6|||
163143016|NCT01814527|589233340|FG001|Overall Study|RTP greater than 30 days|1|||
163143017|NCT00113841|589233341|FG000|Overall Study|Disease progression|0|||
163143018|NCT00113841|589233342|FG001|Overall Study|Disease progression|2|||
163143019|NCT00113841|589233341|FG000|Overall Study|Non-compliant|1|||
163143020|NCT00113841|589233342|FG001|Overall Study|Non-compliant|0|||
163143021|NCT00148759|589233343|FG000|Overall Study|Withdrawal by Subject|1|||
163143022|NCT00148759|589233344|FG001|Overall Study|Withdrawal by Subject|1|||
163143023|NCT00148759|589233343|FG000|Overall Study|Lost to Follow-up|1|||
163143024|NCT00148759|589233344|FG001|Overall Study|Lost to Follow-up|0|||
163143025|NCT03948334|589233345|FG000|Overall Study|Adverse Event|1|||
163143026|NCT03948334|589233346|FG001|Overall Study|Adverse Event|4|||
163143027|NCT03948334|589233345|FG000|Overall Study|Lack of Efficacy|2|||
163143028|NCT03948334|589233346|FG001|Overall Study|Lack of Efficacy|0|||
163143029|NCT03948334|589233345|FG000|Overall Study|Lost to Follow-up|1|||
163143030|NCT03948334|589233346|FG001|Overall Study|Lost to Follow-up|0|||
163143031|NCT03948334|589233345|FG000|Overall Study|Physician Decision|1|||
163143032|NCT03948334|589233346|FG001|Overall Study|Physician Decision|0|||
163143033|NCT03948334|589233345|FG000|Overall Study|Pregnancy|0|||
163143034|NCT03948334|589233346|FG001|Overall Study|Pregnancy|1|||
163143035|NCT03948334|589233345|FG000|Overall Study|Protocol Deviation|1|||
163143036|NCT03948334|589233346|FG001|Overall Study|Protocol Deviation|0|||
163143037|NCT03948334|589233345|FG000|Overall Study|Study terminated by Sponsor|50|||
163143038|NCT03948334|589233346|FG001|Overall Study|Study terminated by Sponsor|51|||
163143039|NCT03948334|589233345|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
163143040|NCT03948334|589233346|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
163143041|NCT04332107|589233347|FG000|Day 3|Lost to Follow-up|23|||
163143042|NCT04332107|589233348|FG001|Day 3|Lost to Follow-up|14|||
163143043|NCT04332107|589233347|FG000|Day 3|Missing outcome data|3|||
163143044|NCT04332107|589233348|FG001|Day 3|Missing outcome data|6|||
163143045|NCT04332107|589233347|FG000|Day 14|Lost to Follow-up|13|||
163143046|NCT04332107|589233348|FG001|Day 14|Lost to Follow-up|4|||
163143047|NCT04332107|589233347|FG000|Day 14|Missing outcome data|4|||
163143048|NCT04332107|589233348|FG001|Day 14|Missing outcome data|4|||
163143049|NCT04332107|589233347|FG000|Day 21|Lost to Follow-up|10|||
163143050|NCT04332107|589233348|FG001|Day 21|Lost to Follow-up|2|||
163143051|NCT01670721|589233349|FG000|Overall Study|Participant's decision|15|||
163143052|NCT01670721|589233349|FG000|Overall Study|Other than specified above|38|||
163143053|NCT00141102|589233354|FG000|Overall Study|Adverse Event|233|||
163143054|NCT00141102|589233355|FG001|Overall Study|Adverse Event|305|||
163143055|NCT00141102|589233354|FG000|Overall Study|Laboratory Abnormality|9|||
163143056|NCT00141102|589233355|FG001|Overall Study|Laboratory Abnormality|33|||
163143057|NCT00141102|589233354|FG000|Overall Study|Lack of Efficacy|21|||
163143058|NCT00141102|589233355|FG001|Overall Study|Lack of Efficacy|26|||
163143059|NCT00141102|589233354|FG000|Overall Study|Lost to Follow-up|29|||
163143060|NCT00141102|589233355|FG001|Overall Study|Lost to Follow-up|32|||
163143061|NCT00141102|589233354|FG000|Overall Study|Other|87|||
163143062|NCT00141102|589233355|FG001|Overall Study|Other|76|||
163143063|NCT00141102|589233354|FG000|Overall Study|Withdrawal by Subject|112|||
163143064|NCT00141102|589233355|FG001|Overall Study|Withdrawal by Subject|142|||
163143065|NCT00141102|589233354|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
163143066|NCT00141102|589233355|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
163143067|NCT00141102|589233354|FG000|Overall Study|Death|2|||
163143068|NCT00141102|589233355|FG001|Overall Study|Death|2|||
163143069|NCT05477485|589233356|FG000|Overall Study|Lost to Follow-up|0|||
163143070|NCT05477485|589233357|FG001|Overall Study|Lost to Follow-up|4|||
163143071|NCT03061201|589233358|FG000|Overall Study|Participants Terminated at Month 36|0|||
163143072|NCT03061201|589233359|FG001|Overall Study|Participants Terminated at Month 36|1|||
163143073|NCT03061201|589233360|FG002|Overall Study|Participants Terminated at Month 36|0|||
163143074|NCT03061201|589233361|FG003|Overall Study|Participants Terminated at Month 36|1|||
163143075|NCT03061201|589233358|FG000|Overall Study|Lost to Follow-up|1|||
163143076|NCT03061201|589233359|FG001|Overall Study|Lost to Follow-up|0|||
163143077|NCT03061201|589233360|FG002|Overall Study|Lost to Follow-up|0|||
163143078|NCT03061201|589233361|FG003|Overall Study|Lost to Follow-up|0|||
163143079|NCT01572480|589233362|FG000|Participants Enrolled|Withdrawal by Subject|1|||
163143080|NCT01572480|589233362|FG000|Drug Administration|Discontinued drug/Off Study|1|||
163143081|NCT01572480|589233362|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
163143082|NCT01572480|589233362|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
163143083|NCT05081219|589233363|FG000|Overall Study|Withdrawal by Subject|4|||
163143084|NCT05081219|589233364|FG001|Overall Study|Withdrawal by Subject|0|||
163143085|NCT05081219|589233365|FG002|Overall Study|Withdrawal by Subject|0|||
163143086|NCT05081219|589233366|FG003|Overall Study|Withdrawal by Subject|1|||
163143087|NCT03446313|589233367|FG000|Overall Study|Lost to Follow-up|1|||
162720975|NCT00367055|587685975|FG000|Overall Study|Protocol Violation|0|||
163143088|NCT03446313|589233368|FG001|Overall Study|Lost to Follow-up|2|||
163143089|NCT03446313|589233367|FG000|Overall Study|Failed primary screening|3|||
163143090|NCT03446313|589233368|FG001|Overall Study|Failed primary screening|0|||
163143091|NCT03446313|589233367|FG000|Overall Study|Diagnosed with terminal cancer|1|||
163143092|NCT03446313|589233368|FG001|Overall Study|Diagnosed with terminal cancer|0|||
163143093|NCT03446313|589233367|FG000|Overall Study|Excluded from analysis|1|||
163143094|NCT03446313|589233368|FG001|Overall Study|Excluded from analysis|1|||
163143095|NCT06235905|589233369|FG000|Overall Study|Adverse Event|1|||
163143096|NCT06235905|589233369|FG000|Overall Study|Non-compliant with protocol procedures|1|||
163143097|NCT00866814|589233371|FG000|Overall Study|Lost to Follow-up|12|||
163143098|NCT00866814|589233371|FG000|Overall Study|Adverse Event|2|||
163143099|NCT00866814|589233371|FG000|Overall Study|Physician Decision|1|||
163143100|NCT00866814|589233371|FG000|Overall Study|Death|1|||
163143101|NCT00866814|589233371|FG000|Overall Study|No longer wished to participate|1|||
163143102|NCT00866814|589233371|FG000|Overall Study|Unable to meet follow-up requirements|2|||
163143103|NCT00866814|589233371|FG000|Overall Study|Moved to area without study site|1|||
163143104|NCT02711137|589235088|FG000|Overall Study|Death|1|||
163143105|NCT02711137|589235089|FG001|Overall Study|Death|4|||
163143106|NCT02711137|589235090|FG002|Overall Study|Death|5|||
163143107|NCT02711137|589235091|FG003|Overall Study|Death|5|||
163143108|NCT02711137|589235092|FG004|Overall Study|Death|3|||
163143109|NCT02711137|589235093|FG005|Overall Study|Death|1|||
163143110|NCT02711137|589235094|FG006|Overall Study|Death|61|||
162662868|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
162662869|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162662870|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162662871|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162662872|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
162662873|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
162662874|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
162662875|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
162662876|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
162662877|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
163143111|NCT02711137|589235095|FG007|Overall Study|Death|3|||
163143112|NCT02711137|589235096|FG008|Overall Study|Death|0|||
163143113|NCT02711137|589235097|FG009|Overall Study|Death|1|||
163143114|NCT02711137|589235098|FG010|Overall Study|Death|1|||
163143115|NCT02711137|589235099|FG011|Overall Study|Death|1|||
163143116|NCT02711137|589235100|FG012|Overall Study|Death|0|||
163143117|NCT02711137|589235101|FG013|Overall Study|Death|0|||
163143118|NCT02711137|589235102|FG014|Overall Study|Death|0|||
163143119|NCT02711137|589235088|FG000|Overall Study|Study Terminated by Sponsor|0|||
162662878|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162662879|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162662880|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
162662881|NCT00071487|587478252|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162662882|NCT00071487|587478253|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162662883|NCT00071487|587478254|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162662884|NCT00071487|587478255|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
162662885|NCT02696850|587478258|FG000|Overall Study|Withdrawal by Subject|3|||
162662886|NCT02696850|587478259|FG001|Overall Study|Withdrawal by Subject|3|||
162662887|NCT02696850|587478258|FG000|Overall Study|Lost to Follow-up|8|||
162662888|NCT02696850|587478259|FG001|Overall Study|Lost to Follow-up|5|||
162662889|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
162662890|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
162662891|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
162662892|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
162662893|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Death|235|||
163143120|NCT02711137|589235089|FG001|Overall Study|Study Terminated by Sponsor|0|||
163143121|NCT02711137|589235090|FG002|Overall Study|Study Terminated by Sponsor|1|||
163143122|NCT02711137|589235091|FG003|Overall Study|Study Terminated by Sponsor|0|||
163143123|NCT02711137|589235092|FG004|Overall Study|Study Terminated by Sponsor|0|||
163143124|NCT02711137|589235093|FG005|Overall Study|Study Terminated by Sponsor|0|||
163143125|NCT02711137|589235094|FG006|Overall Study|Study Terminated by Sponsor|1|||
163143126|NCT02711137|589235095|FG007|Overall Study|Study Terminated by Sponsor|0|||
163143127|NCT02711137|589235096|FG008|Overall Study|Study Terminated by Sponsor|0|||
163143128|NCT02711137|589235097|FG009|Overall Study|Study Terminated by Sponsor|0|||
163143129|NCT02711137|589235098|FG010|Overall Study|Study Terminated by Sponsor|0|||
162720976|NCT00367055|587685976|FG001|Overall Study|Protocol Violation|1|||
163143130|NCT02711137|589235099|FG011|Overall Study|Study Terminated by Sponsor|0|||
163143131|NCT02711137|589235100|FG012|Overall Study|Study Terminated by Sponsor|0|||
162662894|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Death|167|||
162662895|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Death|1|||
162662896|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Death|0|||
163143132|NCT02711137|589235101|FG013|Overall Study|Study Terminated by Sponsor|0|||
163143133|NCT02711137|589235102|FG014|Overall Study|Study Terminated by Sponsor|0|||
163143134|NCT02711137|589235088|FG000|Overall Study|Physician Decision|1|||
163143135|NCT02711137|589235089|FG001|Overall Study|Physician Decision|0|||
163143136|NCT02711137|589235090|FG002|Overall Study|Physician Decision|2|||
163143137|NCT02711137|589235091|FG003|Overall Study|Physician Decision|1|||
163143138|NCT02711137|589235092|FG004|Overall Study|Physician Decision|1|||
163143139|NCT02711137|589235093|FG005|Overall Study|Physician Decision|0|||
163143140|NCT02711137|589235094|FG006|Overall Study|Physician Decision|12|||
162662897|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
162662898|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
162662899|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
162662900|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
162662901|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
162662902|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
162662903|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
162662904|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
162662905|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Other|1|||
162662906|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Other|2|||
162662907|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Other|0|||
162662908|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Other|0|||
162662909|NCT00673049|587478262|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
162662910|NCT00673049|587478263|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
162662911|NCT00673049|587478264|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
162662912|NCT00673049|587478265|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
162662913|NCT00673049|587478262|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
162662914|NCT00673049|587478263|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
162662915|NCT00673049|587478264|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
162662916|NCT00673049|587478265|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
162662917|NCT00673049|587478262|FG000|After Progression on Erlotinib|Death|0|||
162662918|NCT00673049|587478263|FG001|After Progression on Erlotinib|Death|0|||
162662919|NCT00673049|587478264|FG002|After Progression on Erlotinib|Death|0|||
162662920|NCT00673049|587478265|FG003|After Progression on Erlotinib|Death|71|||
162662921|NCT00673049|587478262|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
162662922|NCT00673049|587478263|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
162662923|NCT00673049|587478264|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
162662924|NCT00673049|587478265|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
162662925|NCT00673049|587478262|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
162662926|NCT00673049|587478263|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
162662927|NCT00673049|587478264|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
162662928|NCT00673049|587478265|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
162662929|NCT00673049|587478262|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
162662930|NCT00673049|587478263|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
162662931|NCT00673049|587478264|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
162662932|NCT00673049|587478265|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
162662933|NCT01933334|587478269|FG000|Overall Study|Adverse Event|5|||
162662934|NCT01933334|587478270|FG001|Overall Study|Adverse Event|1|||
162662935|NCT01933334|587478269|FG000|Overall Study|Withdrawal by Subject|0|||
162662936|NCT01933334|587478270|FG001|Overall Study|Withdrawal by Subject|1|||
162662937|NCT00975975|587478271|FG000|Overall Study|Death|6|||
162662938|NCT04265755|587478274|FG000|Overall Study|Withdrawal by Subject|39|||
162662939|NCT04265755|587478274|FG000|Overall Study|Decision by sponsor|2|||
162662940|NCT04265755|587478274|FG000|Overall Study|Lost to Follow-up|11|||
162662941|NCT04265755|587478274|FG000|Overall Study|Death|1|||
162662942|NCT01863446|587478277|FG000|Overall Study|Withdrawal by Subject|1|||
162662943|NCT01863446|587478278|FG001|Overall Study|Withdrawal by Subject|0|||
163143141|NCT02711137|589235095|FG007|Overall Study|Physician Decision|2|||
163143142|NCT02711137|589235096|FG008|Overall Study|Physician Decision|1|||
163143143|NCT02711137|589235097|FG009|Overall Study|Physician Decision|1|||
163143144|NCT02711137|589235098|FG010|Overall Study|Physician Decision|3|||
162662944|NCT01863446|587478279|FG002|Overall Study|Withdrawal by Subject|1|||
162662945|NCT01863446|587478280|FG003|Overall Study|Withdrawal by Subject|2|||
162662946|NCT01863446|587478277|FG000|Overall Study|Physician Decision|0|||
162662947|NCT01863446|587478278|FG001|Overall Study|Physician Decision|0|||
162662948|NCT01863446|587478279|FG002|Overall Study|Physician Decision|1|||
162662949|NCT01863446|587478280|FG003|Overall Study|Physician Decision|0|||
162662950|NCT02554773|587478281|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
162662951|NCT02554773|587478282|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
162662952|NCT02554773|587478281|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
162662953|NCT02554773|587478282|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
162662954|NCT02554773|587478281|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
163143145|NCT02711137|589235099|FG011|Overall Study|Physician Decision|2|||
163143146|NCT02711137|589235100|FG012|Overall Study|Physician Decision|1|||
162720977|NCT00367055|587685975|FG000|Overall Study|Stopping Criterion Met|0|||
162720978|NCT00367055|587685976|FG001|Overall Study|Stopping Criterion Met|1|||
162720979|NCT00367055|587685975|FG000|Overall Study|Participant Living too Far from Hospital|0|||
162720980|NCT00367055|587685976|FG001|Overall Study|Participant Living too Far from Hospital|1|||
162720981|NCT03586544|587685989|FG000|First Intervention|Adverse Event|0|||
162720982|NCT03586544|587685990|FG001|First Intervention|Adverse Event|1|||
162720983|NCT03586544|587685989|FG000|Second Intervention|Withdrawal by Subject|0|||
162720984|NCT03586544|587685990|FG001|Second Intervention|Withdrawal by Subject|1|||
162720985|NCT00539292|587685991|FG000|Overall Study|Physician Decision|1|||
162720986|NCT00539292|587685992|FG001|Overall Study|Physician Decision|0|||
162720987|NCT00324038|587686000|FG000|Overall Study|Adverse Event|38|||
162720988|NCT00324038|587686001|FG001|Overall Study|Adverse Event|23|||
162720989|NCT00324038|587686000|FG000|Overall Study|Lack of Efficacy|5|||
162720990|NCT00324038|587686001|FG001|Overall Study|Lack of Efficacy|13|||
162720991|NCT00324038|587686000|FG000|Overall Study|Lost to Follow-up|0|||
162720992|NCT00324038|587686001|FG001|Overall Study|Lost to Follow-up|2|||
162720993|NCT00324038|587686000|FG000|Overall Study|Other|6|||
162720994|NCT00324038|587686001|FG001|Overall Study|Other|13|||
162720995|NCT00361283|587686009|FG000|Overall Study|Lost to Follow-up|27|||
162720996|NCT01123083|587686016|FG000|Overall Study|Investigator recommendation|1|||
162720997|NCT01123083|587686017|FG001|Overall Study|Investigator recommendation|1|||
162720998|NCT01123083|587686016|FG000|Overall Study|Administrative reasons|0|||
162720999|NCT01123083|587686017|FG001|Overall Study|Administrative reasons|4|||
162721000|NCT01123083|587686016|FG000|Overall Study|Lost to Follow-up|2|||
162721001|NCT01123083|587686017|FG001|Overall Study|Lost to Follow-up|6|||
162721002|NCT01123083|587686016|FG000|Overall Study|Adverse Event|1|||
162721003|NCT01123083|587686017|FG001|Overall Study|Adverse Event|0|||
162721004|NCT01123083|587686016|FG000|Overall Study|Withdrew for another reason not covered|0|||
162721005|NCT01123083|587686017|FG001|Overall Study|Withdrew for another reason not covered|1|||
162721006|NCT01123083|587686016|FG000|Overall Study|Participant/legal representative request|7|||
162721007|NCT01123083|587686017|FG001|Overall Study|Participant/legal representative request|3|||
162721008|NCT00961636|587686018|FG000|Overall Study|Adverse Event|35|||
162721009|NCT00961636|587686019|FG001|Overall Study|Adverse Event|54|||
162721010|NCT00961636|587686020|FG002|Overall Study|Adverse Event|13|||
162721011|NCT00961636|587686018|FG000|Overall Study|Flushing Symptoms|29|||
162721012|NCT00961636|587686019|FG001|Overall Study|Flushing Symptoms|46|||
162721013|NCT00961636|587686020|FG002|Overall Study|Flushing Symptoms|3|||
162721014|NCT00961636|587686018|FG000|Overall Study|Lost to Follow-up|2|||
162721015|NCT00961636|587686019|FG001|Overall Study|Lost to Follow-up|3|||
162721016|NCT00961636|587686020|FG002|Overall Study|Lost to Follow-up|1|||
162721017|NCT00961636|587686018|FG000|Overall Study|Physician Decision|3|||
162721018|NCT00961636|587686019|FG001|Overall Study|Physician Decision|1|||
162721019|NCT00961636|587686020|FG002|Overall Study|Physician Decision|1|||
162721020|NCT00961636|587686018|FG000|Overall Study|Protocol Violation|9|||
162721021|NCT00961636|587686019|FG001|Overall Study|Protocol Violation|5|||
162721022|NCT00961636|587686020|FG002|Overall Study|Protocol Violation|1|||
162721023|NCT00961636|587686018|FG000|Overall Study|Withdrawal by Subject|29|||
162721024|NCT00961636|587686019|FG001|Overall Study|Withdrawal by Subject|22|||
162721025|NCT00961636|587686020|FG002|Overall Study|Withdrawal by Subject|13|||
162721026|NCT00290706|587686023|FG000|Overall Study|Withdrawal by Subject|2|||
162721027|NCT00290706|587686024|FG001|Overall Study|Withdrawal by Subject|0|||
162721028|NCT00290706|587686025|FG002|Overall Study|Withdrawal by Subject|0|||
162721029|NCT00290706|587686026|FG003|Overall Study|Withdrawal by Subject|0|||
162721030|NCT00290706|587686023|FG000|Overall Study|Progressive Disease|3|||
162721031|NCT00290706|587686024|FG001|Overall Study|Progressive Disease|5|||
162721032|NCT00290706|587686025|FG002|Overall Study|Progressive Disease|4|||
162721033|NCT00290706|587686026|FG003|Overall Study|Progressive Disease|10|||
162721034|NCT00290706|587686023|FG000|Overall Study|Adverse Event|0|||
162721035|NCT00290706|587686024|FG001|Overall Study|Adverse Event|1|||
162721036|NCT00290706|587686025|FG002|Overall Study|Adverse Event|2|||
163143147|NCT02711137|589235101|FG013|Overall Study|Physician Decision|1|||
162721037|NCT00290706|587686026|FG003|Overall Study|Adverse Event|0|||
162721038|NCT00290706|587686023|FG000|Overall Study|Receive auto transplant or radiation|0|||
162721039|NCT00290706|587686024|FG001|Overall Study|Receive auto transplant or radiation|0|||
162721040|NCT00290706|587686025|FG002|Overall Study|Receive auto transplant or radiation|0|||
162721041|NCT00290706|587686026|FG003|Overall Study|Receive auto transplant or radiation|1|||
162721042|NCT00290706|587686023|FG000|Overall Study|Physician Decision|0|||
162721043|NCT00290706|587686024|FG001|Overall Study|Physician Decision|0|||
162721044|NCT00290706|587686025|FG002|Overall Study|Physician Decision|0|||
162721045|NCT00290706|587686026|FG003|Overall Study|Physician Decision|1|||
162721046|NCT01196429|587686028|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162721047|NCT01196429|587686029|FG001|Overall Study|Ineligible - inadequate pathology|0|||
162721048|NCT01196429|587686028|FG000|Overall Study|Ineligible - wrong cell type|1|||
162721049|NCT01196429|587686029|FG001|Overall Study|Ineligible - wrong cell type|0|||
162721050|NCT01196429|587686028|FG000|Overall Study|Refused - Never Treated|1|||
162721051|NCT01196429|587686029|FG001|Overall Study|Refused - Never Treated|0|||
162721052|NCT00688519|587686030|FG000|Overall Study|Adverse Event|2|||
163143148|NCT02711137|589235102|FG014|Overall Study|Physician Decision|2|||
163143149|NCT02711137|589235088|FG000|Overall Study|Other|0|||
163143150|NCT02711137|589235089|FG001|Overall Study|Other|1|||
163143151|NCT02711137|589235090|FG002|Overall Study|Other|0|||
163143152|NCT02711137|589235091|FG003|Overall Study|Other|0|||
163143153|NCT02711137|589235092|FG004|Overall Study|Other|0|||
163143154|NCT02711137|589235093|FG005|Overall Study|Other|0|||
163143155|NCT02711137|589235094|FG006|Overall Study|Other|3|||
163143156|NCT02711137|589235095|FG007|Overall Study|Other|0|||
163143157|NCT02711137|589235096|FG008|Overall Study|Other|0|||
163143158|NCT02711137|589235097|FG009|Overall Study|Other|0|||
163143159|NCT02711137|589235098|FG010|Overall Study|Other|0|||
163143160|NCT02711137|589235099|FG011|Overall Study|Other|0|||
163143161|NCT02711137|589235100|FG012|Overall Study|Other|0|||
163143162|NCT02711137|589235101|FG013|Overall Study|Other|0|||
163143163|NCT02711137|589235102|FG014|Overall Study|Other|1|||
163143164|NCT02711137|589235088|FG000|Overall Study|Withdrawal by Subject|1|||
163143165|NCT02711137|589235089|FG001|Overall Study|Withdrawal by Subject|0|||
163143166|NCT02711137|589235090|FG002|Overall Study|Withdrawal by Subject|0|||
163143167|NCT02711137|589235091|FG003|Overall Study|Withdrawal by Subject|1|||
163143168|NCT02711137|589235092|FG004|Overall Study|Withdrawal by Subject|1|||
163143169|NCT02711137|589235093|FG005|Overall Study|Withdrawal by Subject|0|||
163143170|NCT02711137|589235094|FG006|Overall Study|Withdrawal by Subject|7|||
163143171|NCT02711137|589235095|FG007|Overall Study|Withdrawal by Subject|0|||
163143172|NCT02711137|589235096|FG008|Overall Study|Withdrawal by Subject|0|||
163143173|NCT02711137|589235097|FG009|Overall Study|Withdrawal by Subject|0|||
163143174|NCT02711137|589235098|FG010|Overall Study|Withdrawal by Subject|0|||
163143175|NCT02711137|589235099|FG011|Overall Study|Withdrawal by Subject|0|||
163143176|NCT02711137|589235100|FG012|Overall Study|Withdrawal by Subject|0|||
163143177|NCT02711137|589235101|FG013|Overall Study|Withdrawal by Subject|1|||
163143178|NCT02711137|589235102|FG014|Overall Study|Withdrawal by Subject|0|||
163143179|NCT02711137|589235088|FG000|Overall Study|Lost to Follow-up|1|||
163143180|NCT02711137|589235089|FG001|Overall Study|Lost to Follow-up|0|||
163143181|NCT02711137|589235090|FG002|Overall Study|Lost to Follow-up|0|||
163143182|NCT02711137|589235091|FG003|Overall Study|Lost to Follow-up|0|||
163143183|NCT02711137|589235092|FG004|Overall Study|Lost to Follow-up|0|||
163143184|NCT02711137|589235093|FG005|Overall Study|Lost to Follow-up|0|||
163143185|NCT02711137|589235094|FG006|Overall Study|Lost to Follow-up|2|||
163143186|NCT02711137|589235095|FG007|Overall Study|Lost to Follow-up|0|||
163143187|NCT02711137|589235096|FG008|Overall Study|Lost to Follow-up|0|||
163143188|NCT02711137|589235097|FG009|Overall Study|Lost to Follow-up|0|||
163143189|NCT02711137|589235098|FG010|Overall Study|Lost to Follow-up|0|||
163143190|NCT02711137|589235099|FG011|Overall Study|Lost to Follow-up|0|||
163143191|NCT02711137|589235100|FG012|Overall Study|Lost to Follow-up|0|||
163143192|NCT02711137|589235101|FG013|Overall Study|Lost to Follow-up|0|||
163143193|NCT02711137|589235102|FG014|Overall Study|Lost to Follow-up|0|||
163143194|NCT03956550|589235103|FG000|Overall Study|Sponsor decision|65|||
163143195|NCT03956550|589235104|FG001|Overall Study|Sponsor decision|66|||
163143196|NCT03956550|589235105|FG002|Overall Study|Sponsor decision|64|||
163143197|NCT03956550|589235103|FG000|Overall Study|Adverse Event|0|||
163143198|NCT03956550|589235104|FG001|Overall Study|Adverse Event|1|||
163143199|NCT03956550|589235105|FG002|Overall Study|Adverse Event|0|||
163143200|NCT03956550|589235103|FG000|Overall Study|Withdrawal by Subject|5|||
163143201|NCT03956550|589235104|FG001|Overall Study|Withdrawal by Subject|5|||
163143202|NCT03956550|589235105|FG002|Overall Study|Withdrawal by Subject|6|||
163143203|NCT03400852|589235106|FG000|Blinded Treatment Period|Physician Decision|0|||
163143204|NCT03400852|589235107|FG001|Blinded Treatment Period|Physician Decision|1|||
163143205|NCT03400852|589235108|FG002|Blinded Treatment Period|Physician Decision|0|||
163143206|NCT03400852|589235106|FG000|Blinded Treatment Period|Adverse Event|1|||
163143207|NCT03400852|589235107|FG001|Blinded Treatment Period|Adverse Event|1|||
163143208|NCT03400852|589235108|FG002|Blinded Treatment Period|Adverse Event|0|||
163143209|NCT03400852|589235106|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
163143210|NCT03400852|589235107|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
163143211|NCT03400852|589235108|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
163143212|NCT03400852|589235106|FG000|Open Label Period|Physician Decision|0|||
163143213|NCT03400852|589235107|FG001|Open Label Period|Physician Decision|0|||
163143214|NCT03400852|589235108|FG002|Open Label Period|Physician Decision|1|||
163143215|NCT03400852|589235106|FG000|Open Label Period|Study terminated by sponsor|0|||
163143216|NCT03400852|589235107|FG001|Open Label Period|Study terminated by sponsor|0|||
163143217|NCT03400852|589235108|FG002|Open Label Period|Study terminated by sponsor|21|||
163143218|NCT00248495|589235109|FG000|Overall Study|Withdrawal by Subject|1|||
163143219|NCT01285401|589235110|FG000|Overall Study|Prematurely withdrawn from the study|17|||
163143220|NCT01285401|589235111|FG001|Overall Study|Prematurely withdrawn from the study|29|||
163143221|NCT03719131|589235115|FG000|Overall Study|Death|1|||
163143222|NCT03719131|589235116|FG001|Overall Study|Death|2|||
163143223|NCT04244253|589235117|FG000|Overall Study|Adverse Event|2|||
163143224|NCT04244253|589235118|FG001|Overall Study|Adverse Event|2|||
163143225|NCT04244253|589235119|FG002|Overall Study|Adverse Event|4|||
163143226|NCT04244253|589235117|FG000|Overall Study|Protocol Violation|1|||
163143227|NCT04244253|589235118|FG001|Overall Study|Protocol Violation|2|||
163143228|NCT04244253|589235119|FG002|Overall Study|Protocol Violation|1|||
163143229|NCT04244253|589235117|FG000|Overall Study|Withdrawal by Subject|0|||
163143230|NCT04244253|589235118|FG001|Overall Study|Withdrawal by Subject|1|||
163143231|NCT04244253|589235119|FG002|Overall Study|Withdrawal by Subject|6|||
163143232|NCT04244253|589235117|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163143233|NCT04244253|589235118|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163143234|NCT04244253|589235119|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163143235|NCT01544920|589235120|FG000|Overall Study|Adverse Event|0|||
163143236|NCT01544920|589235121|FG001|Overall Study|Adverse Event|3|||
163143237|NCT01544920|589235120|FG000|Overall Study|Death|0|||
163143238|NCT01544920|589235121|FG001|Overall Study|Death|1|||
163143239|NCT01544920|589235120|FG000|Overall Study|Lost to Follow-up|11|||
163143240|NCT01544920|589235121|FG001|Overall Study|Lost to Follow-up|12|||
163143241|NCT01544920|589235120|FG000|Overall Study|Protocol Violation|0|||
163143242|NCT01544920|589235121|FG001|Overall Study|Protocol Violation|2|||
163143243|NCT01544920|589235120|FG000|Overall Study|Physician Decision|4|||
163143244|NCT01544920|589235121|FG001|Overall Study|Physician Decision|1|||
163143245|NCT01544920|589235120|FG000|Overall Study|Withdrawal by Subject|4|||
163143246|NCT01544920|589235121|FG001|Overall Study|Withdrawal by Subject|4|||
163143247|NCT03001557|589235125|FG000|Core Phase|Randomized but not treated|0|||
163143248|NCT03001557|589235126|FG001|Core Phase|Randomized but not treated|0|||
163143249|NCT03001557|589235127|FG002|Core Phase|Randomized but not treated|1|||
163143250|NCT03001557|589235128|FG003|Core Phase|Randomized but not treated|0|||
163143251|NCT03001557|589235129|FG004|Core Phase|Randomized but not treated|0|||
163143252|NCT03001557|589235130|FG005|Core Phase|Randomized but not treated|0|||
163143253|NCT03001557|589235131|FG006|Core Phase|Randomized but not treated|0|||
163143254|NCT03001557|589235132|FG007|Core Phase|Randomized but not treated|0|||
163143255|NCT03001557|589235125|FG000|Extension Phase|Adverse Event|0|||
163143256|NCT03001557|589235126|FG001|Extension Phase|Adverse Event|0|||
163143257|NCT03001557|589235127|FG002|Extension Phase|Adverse Event|0|||
163143258|NCT03001557|589235128|FG003|Extension Phase|Adverse Event|0|||
163143259|NCT03001557|589235129|FG004|Extension Phase|Adverse Event|0|||
163143260|NCT03001557|589235130|FG005|Extension Phase|Adverse Event|2|||
163143261|NCT03001557|589235131|FG006|Extension Phase|Adverse Event|0|||
163143262|NCT03001557|589235132|FG007|Extension Phase|Adverse Event|0|||
163143263|NCT03001557|589235125|FG000|Extension Phase|Withdrawal by Subject|0|||
163143264|NCT03001557|589235126|FG001|Extension Phase|Withdrawal by Subject|0|||
163143265|NCT03001557|589235127|FG002|Extension Phase|Withdrawal by Subject|0|||
163143266|NCT03001557|589235128|FG003|Extension Phase|Withdrawal by Subject|0|||
163143267|NCT03001557|589235129|FG004|Extension Phase|Withdrawal by Subject|0|||
163143268|NCT03001557|589235130|FG005|Extension Phase|Withdrawal by Subject|1|||
163143269|NCT03001557|589235131|FG006|Extension Phase|Withdrawal by Subject|5|||
163143270|NCT03001557|589235132|FG007|Extension Phase|Withdrawal by Subject|2|||
163143271|NCT03001557|589235125|FG000|Extension Phase|Lost to Follow-up|0|||
163143272|NCT03001557|589235126|FG001|Extension Phase|Lost to Follow-up|0|||
163143273|NCT03001557|589235127|FG002|Extension Phase|Lost to Follow-up|0|||
163143274|NCT03001557|589235128|FG003|Extension Phase|Lost to Follow-up|0|||
163143275|NCT03001557|589235129|FG004|Extension Phase|Lost to Follow-up|0|||
163143276|NCT03001557|589235130|FG005|Extension Phase|Lost to Follow-up|0|||
163143277|NCT03001557|589235131|FG006|Extension Phase|Lost to Follow-up|2|||
163143278|NCT03001557|589235132|FG007|Extension Phase|Lost to Follow-up|1|||
163143279|NCT03001557|589235125|FG000|Extension Phase|Administrative Reason|0|||
163143280|NCT03001557|589235126|FG001|Extension Phase|Administrative Reason|0|||
163143281|NCT03001557|589235127|FG002|Extension Phase|Administrative Reason|0|||
163143282|NCT03001557|589235128|FG003|Extension Phase|Administrative Reason|0|||
163143283|NCT03001557|589235129|FG004|Extension Phase|Administrative Reason|0|||
163143284|NCT03001557|589235130|FG005|Extension Phase|Administrative Reason|1|||
163143285|NCT03001557|589235131|FG006|Extension Phase|Administrative Reason|3|||
163143286|NCT03001557|589235132|FG007|Extension Phase|Administrative Reason|3|||
163143287|NCT03001557|589235125|FG000|Extension Phase|Loss of caregiver|0|||
163143288|NCT03001557|589235126|FG001|Extension Phase|Loss of caregiver|0|||
163143289|NCT03001557|589235127|FG002|Extension Phase|Loss of caregiver|0|||
163143290|NCT03001557|589235128|FG003|Extension Phase|Loss of caregiver|0|||
163143291|NCT03001557|589235129|FG004|Extension Phase|Loss of caregiver|0|||
163143292|NCT03001557|589235130|FG005|Extension Phase|Loss of caregiver|0|||
163143293|NCT03001557|589235131|FG006|Extension Phase|Loss of caregiver|1|||
163143294|NCT03001557|589235132|FG007|Extension Phase|Loss of caregiver|0|||
163143295|NCT03001557|589235125|FG000|Extension Phase|Others|0|||
163143296|NCT03001557|589235126|FG001|Extension Phase|Others|0|||
163143297|NCT03001557|589235127|FG002|Extension Phase|Others|0|||
163143298|NCT03001557|589235128|FG003|Extension Phase|Others|0|||
163143299|NCT03001557|589235129|FG004|Extension Phase|Others|0|||
163143300|NCT03001557|589235130|FG005|Extension Phase|Others|1|||
162721053|NCT00688519|587686031|FG001|Overall Study|Adverse Event|3|||
163143301|NCT03001557|589235131|FG006|Extension Phase|Others|3|||
163143302|NCT03001557|589235132|FG007|Extension Phase|Others|0|||
163143303|NCT01272232|589235133|FG000|Weeks 0-56|Adverse Event|39|||
163143304|NCT01272232|589235134|FG001|Weeks 0-56|Adverse Event|18|||
163143305|NCT01272232|589235135|FG002|Weeks 0-56|Adverse Event|7|||
163143306|NCT01272232|589235133|FG000|Weeks 0-56|Lack of Efficacy|0|||
163143307|NCT01272232|589235134|FG001|Weeks 0-56|Lack of Efficacy|0|||
163143308|NCT01272232|589235135|FG002|Weeks 0-56|Lack of Efficacy|3|||
163143309|NCT01272232|589235133|FG000|Weeks 0-56|Protocol Violation|12|||
163143310|NCT01272232|589235134|FG001|Weeks 0-56|Protocol Violation|8|||
163143311|NCT01272232|589235135|FG002|Weeks 0-56|Protocol Violation|13|||
163143312|NCT01272232|589235133|FG000|Weeks 0-56|Withdrawal criteria|32|||
163143313|NCT01272232|589235134|FG001|Weeks 0-56|Withdrawal criteria|14|||
163143314|NCT01272232|589235135|FG002|Weeks 0-56|Withdrawal criteria|37|||
163143315|NCT01272232|589235133|FG000|Weeks 0-56|Unclassified|16|||
163143316|NCT01272232|589235134|FG001|Weeks 0-56|Unclassified|7|||
163143317|NCT01272232|589235135|FG002|Weeks 0-56|Unclassified|12|||
163143318|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
163143319|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
163143320|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
163143321|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
163143322|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
163143323|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
163143324|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
163143325|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
163143326|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
163143327|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
163143328|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
163143329|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
163143330|NCT01272232|589235133|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
163143331|NCT01272232|589235134|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
163143332|NCT01272232|589235135|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
163143333|NCT02159066|589235136|FG000|Part I|Adverse Event|7|||
163143334|NCT02159066|589235137|FG001|Part I|Adverse Event|5|||
163143335|NCT02159066|589235138|FG002|Part I|Adverse Event|0|||
163143336|NCT02159066|589235139|FG003|Part I|Adverse Event|0|||
163143337|NCT02159066|589235140|FG004|Part I|Adverse Event|0|||
163143338|NCT02159066|589235141|FG005|Part I|Adverse Event|0|||
163143339|NCT02159066|589235136|FG000|Part I|Death|11|||
163143340|NCT02159066|589235137|FG001|Part I|Death|9|||
163143341|NCT02159066|589235138|FG002|Part I|Death|0|||
163143342|NCT02159066|589235139|FG003|Part I|Death|0|||
163143343|NCT02159066|589235140|FG004|Part I|Death|0|||
163143344|NCT02159066|589235141|FG005|Part I|Death|0|||
163143345|NCT02159066|589235136|FG000|Part I|Progressive Disease|37|||
163143346|NCT02159066|589235137|FG001|Part I|Progressive Disease|46|||
163143347|NCT02159066|589235138|FG002|Part I|Progressive Disease|0|||
163143348|NCT02159066|589235139|FG003|Part I|Progressive Disease|0|||
163143349|NCT02159066|589235140|FG004|Part I|Progressive Disease|0|||
163143350|NCT02159066|589235141|FG005|Part I|Progressive Disease|0|||
163143351|NCT02159066|589235136|FG000|Part I|New Therapy for Study Indication|5|||
163143352|NCT02159066|589235137|FG001|Part I|New Therapy for Study Indication|4|||
163143353|NCT02159066|589235138|FG002|Part I|New Therapy for Study Indication|0|||
163143354|NCT02159066|589235139|FG003|Part I|New Therapy for Study Indication|0|||
163143355|NCT02159066|589235140|FG004|Part I|New Therapy for Study Indication|0|||
163143356|NCT02159066|589235141|FG005|Part I|New Therapy for Study Indication|0|||
163143357|NCT02159066|589235136|FG000|Part I|Termination of participants from the study|3|||
163143358|NCT02159066|589235137|FG001|Part I|Termination of participants from the study|3|||
163143359|NCT02159066|589235138|FG002|Part I|Termination of participants from the study|0|||
163143360|NCT02159066|589235139|FG003|Part I|Termination of participants from the study|0|||
163143361|NCT02159066|589235140|FG004|Part I|Termination of participants from the study|0|||
163143362|NCT02159066|589235141|FG005|Part I|Termination of participants from the study|0|||
163143363|NCT02159066|589235136|FG000|Part I|Physician Decision|2|||
163143364|NCT02159066|589235137|FG001|Part I|Physician Decision|9|||
162662955|NCT02554773|587478282|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
163143365|NCT02159066|589235138|FG002|Part I|Physician Decision|0|||
163143366|NCT02159066|589235139|FG003|Part I|Physician Decision|0|||
163143367|NCT02159066|589235140|FG004|Part I|Physician Decision|0|||
163143368|NCT02159066|589235141|FG005|Part I|Physician Decision|0|||
163143369|NCT02159066|589235136|FG000|Part I|Participant/Guardian Decision|9|||
163143370|NCT02159066|589235137|FG001|Part I|Participant/Guardian Decision|3|||
163143371|NCT02159066|589235138|FG002|Part I|Participant/Guardian Decision|0|||
163143372|NCT02159066|589235139|FG003|Part I|Participant/Guardian Decision|0|||
163143373|NCT02159066|589235140|FG004|Part I|Participant/Guardian Decision|0|||
162662956|NCT02554773|587478281|FG000|Original Dose Regimen (SAS 1)|Death|1|||
162662957|NCT02554773|587478282|FG001|Original Dose Regimen (SAS 1)|Death|0|||
163143374|NCT02159066|589235141|FG005|Part I|Participant/Guardian Decision|0|||
163143375|NCT02159066|589235136|FG000|Part I|Missing Data|1|||
163143376|NCT02159066|589235137|FG001|Part I|Missing Data|0|||
163143377|NCT02159066|589235138|FG002|Part I|Missing Data|0|||
163143378|NCT02159066|589235139|FG003|Part I|Missing Data|0|||
163143379|NCT02159066|589235140|FG004|Part I|Missing Data|0|||
163143380|NCT02159066|589235141|FG005|Part I|Missing Data|0|||
162662958|NCT02554773|587478281|FG000|Original Dose Regimen (SAS 1)|Other|4|||
162662959|NCT02554773|587478282|FG001|Original Dose Regimen (SAS 1)|Other|0|||
162662960|NCT02554773|587478281|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
162662961|NCT02554773|587478282|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
162662962|NCT02554773|587478281|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
163143381|NCT02159066|589235136|FG000|Part II|Adverse Event|0|||
163143382|NCT02159066|589235137|FG001|Part II|Adverse Event|0|||
163143383|NCT02159066|589235138|FG002|Part II|Adverse Event|1|||
163143384|NCT02159066|589235139|FG003|Part II|Adverse Event|0|||
163143385|NCT02159066|589235140|FG004|Part II|Adverse Event|1|||
163143386|NCT02159066|589235141|FG005|Part II|Adverse Event|1|||
163143387|NCT02159066|589235136|FG000|Part II|Death|0|||
163143388|NCT02159066|589235137|FG001|Part II|Death|0|||
163143389|NCT02159066|589235138|FG002|Part II|Death|1|||
163143390|NCT02159066|589235139|FG003|Part II|Death|0|||
163143391|NCT02159066|589235140|FG004|Part II|Death|2|||
163143392|NCT02159066|589235141|FG005|Part II|Death|1|||
163143393|NCT02159066|589235136|FG000|Part II|Progressive Disease|0|||
163143394|NCT02159066|589235137|FG001|Part II|Progressive Disease|0|||
163143395|NCT02159066|589235138|FG002|Part II|Progressive Disease|35|||
163143396|NCT02159066|589235139|FG003|Part II|Progressive Disease|1|||
163143397|NCT02159066|589235140|FG004|Part II|Progressive Disease|7|||
163143398|NCT02159066|589235141|FG005|Part II|Progressive Disease|4|||
163143399|NCT02159066|589235136|FG000|Part II|New Therapy for Study Indication|0|||
162721054|NCT00688519|587686030|FG000|Overall Study|Lost to Follow-up|3|||
163143400|NCT02159066|589235137|FG001|Part II|New Therapy for Study Indication|0|||
163143401|NCT02159066|589235138|FG002|Part II|New Therapy for Study Indication|0|||
163143402|NCT02159066|589235139|FG003|Part II|New Therapy for Study Indication|0|||
163143403|NCT02159066|589235140|FG004|Part II|New Therapy for Study Indication|1|||
163143404|NCT02159066|589235141|FG005|Part II|New Therapy for Study Indication|0|||
163143405|NCT02159066|589235136|FG000|Part II|Physician Decision|0|||
163143406|NCT02159066|589235137|FG001|Part II|Physician Decision|0|||
163143407|NCT02159066|589235138|FG002|Part II|Physician Decision|1|||
163143408|NCT02159066|589235139|FG003|Part II|Physician Decision|0|||
163143409|NCT02159066|589235140|FG004|Part II|Physician Decision|0|||
163143410|NCT02159066|589235141|FG005|Part II|Physician Decision|0|||
163143411|NCT02159066|589235136|FG000|Part II|Participant/Guardian Decision|0|||
163143412|NCT02159066|589235137|FG001|Part II|Participant/Guardian Decision|0|||
163143413|NCT02159066|589235138|FG002|Part II|Participant/Guardian Decision|0|||
163143414|NCT02159066|589235139|FG003|Part II|Participant/Guardian Decision|0|||
163143415|NCT02159066|589235140|FG004|Part II|Participant/Guardian Decision|2|||
163143416|NCT02159066|589235141|FG005|Part II|Participant/Guardian Decision|0|||
163143417|NCT00255190|589235143|FG000|Overall Study|Adverse Event|17|||
163143418|NCT00255190|589235144|FG001|Overall Study|Adverse Event|36|||
162662963|NCT02554773|587478282|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
162662964|NCT02554773|587478281|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
162662965|NCT02554773|587478282|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
162662966|NCT02554773|587478281|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
162662967|NCT02554773|587478282|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
163143419|NCT00255190|589235143|FG000|Overall Study|Protocol Violation|2|||
163143420|NCT00255190|589235144|FG001|Overall Study|Protocol Violation|2|||
163143421|NCT00255190|589235143|FG000|Overall Study|Lost to Follow-up|10|||
162662968|NCT02956629|587478286|FG000|Overall Study|Adverse Event|0|||
162662969|NCT02956629|587478287|FG001|Overall Study|Adverse Event|0|||
162662970|NCT02956629|587478288|FG002|Overall Study|Adverse Event|1|||
163143422|NCT00255190|589235144|FG001|Overall Study|Lost to Follow-up|27|||
163143423|NCT00255190|589235143|FG000|Overall Study|Withdrew Consent|17|||
162662971|NCT02956629|587478289|FG003|Overall Study|Adverse Event|0|||
162662972|NCT02956629|587478290|FG004|Overall Study|Adverse Event|0|||
162662973|NCT02956629|587478291|FG005|Overall Study|Adverse Event|0|||
162662974|NCT02956629|587478286|FG000|Overall Study|Lost to Follow-up|2|||
162662975|NCT02956629|587478287|FG001|Overall Study|Lost to Follow-up|5|||
162662976|NCT02956629|587478288|FG002|Overall Study|Lost to Follow-up|3|||
162662977|NCT02956629|587478289|FG003|Overall Study|Lost to Follow-up|1|||
163143424|NCT00255190|589235144|FG001|Overall Study|Withdrew Consent|48|||
163143425|NCT00255190|589235143|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163143426|NCT00255190|589235144|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163143427|NCT00255190|589235143|FG000|Overall Study|Erosive esophagitis not healed|0|||
163143428|NCT00255190|589235144|FG001|Overall Study|Erosive esophagitis not healed|20|||
163143429|NCT00255190|589235143|FG000|Overall Study|Various|4|||
163143430|NCT00255190|589235144|FG001|Overall Study|Various|23|||
163143431|NCT00628030|589235145|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
163143432|NCT00628030|589235146|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
163143433|NCT00628030|589235145|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
163143434|NCT00628030|589235146|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
162721055|NCT00688519|587686031|FG001|Overall Study|Lost to Follow-up|3|||
162721056|NCT00688519|587686030|FG000|Overall Study|Lack of Efficacy|3|||
162721057|NCT00688519|587686031|FG001|Overall Study|Lack of Efficacy|1|||
162721058|NCT00688519|587686030|FG000|Overall Study|Withdrawal by Subject|7|||
162721059|NCT00688519|587686031|FG001|Overall Study|Withdrawal by Subject|6|||
162721060|NCT00688519|587686030|FG000|Overall Study|Prohibited medication|1|||
162721061|NCT00688519|587686031|FG001|Overall Study|Prohibited medication|0|||
163143435|NCT00628030|589235145|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
163143436|NCT00628030|589235146|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
163143437|NCT01255423|589235147|FG000|Overall Study|Abnormal Laboratory value|3|||
163143438|NCT01255423|589235148|FG001|Overall Study|Abnormal Laboratory value|2|||
163143439|NCT01255423|589235147|FG000|Overall Study|Use of prohibited medications|0|||
162721062|NCT00688519|587686030|FG000|Overall Study|Non-compliance|0|||
163143440|NCT01255423|589235148|FG001|Overall Study|Use of prohibited medications|1|||
163143441|NCT05470387|589235149|FG000|Overall Study|Protocol Violation|0|||
163143442|NCT05470387|589235150|FG001|Overall Study|Protocol Violation|3|||
163143443|NCT02366195|589235153|FG000|Overall Study|Protocol-specified criteria|3|||
163143444|NCT02366195|589235153|FG000|Overall Study|Withdrawal by Subject|9|||
163143445|NCT02366195|589235153|FG000|Overall Study|Lost to Follow-up|1|||
163143446|NCT02366195|589235153|FG000|Overall Study|Death|41|||
163143447|NCT01894607|589235163|FG000|Overall Study|Ineligible|1|||
163143448|NCT01787461|589235170|FG000|Overall Study|Adverse Event|4|||
163143449|NCT01787461|589235171|FG001|Overall Study|Adverse Event|3|||
163143450|NCT01787461|589235170|FG000|Overall Study|Lost to Follow-up|3|||
163143451|NCT01787461|589235171|FG001|Overall Study|Lost to Follow-up|2|||
163143452|NCT01787461|589235170|FG000|Overall Study|No longer met eligibility criteria|1|||
163143453|NCT01787461|589235171|FG001|Overall Study|No longer met eligibility criteria|0|||
163143454|NCT01787461|589235170|FG000|Overall Study|Withdrawal by Subject|3|||
163143455|NCT01787461|589235171|FG001|Overall Study|Withdrawal by Subject|4|||
163143456|NCT01787461|589235170|FG000|Overall Study|Protocol Violation|3|||
163143457|NCT01787461|589235171|FG001|Overall Study|Protocol Violation|0|||
163143458|NCT03259555|589235172|FG000|Overall Study|Adverse Event|6|||
163143459|NCT03259555|589235173|FG001|Overall Study|Adverse Event|4|||
163143460|NCT03259555|589235172|FG000|Overall Study|Lack of Efficacy|6|||
163143461|NCT03259555|589235173|FG001|Overall Study|Lack of Efficacy|4|||
163143462|NCT03259555|589235172|FG000|Overall Study|Lost to Follow-up|0|||
163143463|NCT03259555|589235173|FG001|Overall Study|Lost to Follow-up|2|||
162721063|NCT00688519|587686031|FG001|Overall Study|Non-compliance|1|||
162721064|NCT00688519|587686030|FG000|Overall Study|Subject moved out of state|1|||
163143464|NCT03259555|589235172|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163143465|NCT03259555|589235173|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163143466|NCT03259555|589235172|FG000|Overall Study|Progressive Disease|0|||
163143467|NCT03259555|589235173|FG001|Overall Study|Progressive Disease|2|||
162721065|NCT00688519|587686031|FG001|Overall Study|Subject moved out of state|0|||
162721066|NCT00688519|587686030|FG000|Overall Study|Investigator decision|1|||
163143468|NCT03259555|589235172|FG000|Overall Study|Withdrawal by Subject|19|||
163143469|NCT03259555|589235173|FG001|Overall Study|Withdrawal by Subject|16|||
163143470|NCT03259555|589235172|FG000|Overall Study|Physician Decision|1|||
162662978|NCT02956629|587478290|FG004|Overall Study|Lost to Follow-up|0|||
162662979|NCT02956629|587478291|FG005|Overall Study|Lost to Follow-up|1|||
163143471|NCT03259555|589235173|FG001|Overall Study|Physician Decision|2|||
163143472|NCT03259555|589235172|FG000|Overall Study|Other|1|||
163143473|NCT03259555|589235173|FG001|Overall Study|Other|0|||
163143474|NCT02800863|589235174|FG000|Overall Study|Adverse Event|14|||
163143475|NCT02800863|589235174|FG000|Overall Study|Another Device Implanted|1|||
163143476|NCT02800863|589235174|FG000|Overall Study|Device Explanted|1|||
163143477|NCT02800863|589235174|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
163143478|NCT02800863|589235174|FG000|Overall Study|Health Issues|1|||
163143479|NCT02800863|589235174|FG000|Overall Study|Insurance Denial|8|||
163143480|NCT02800863|589235174|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
163143481|NCT02800863|589235174|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
163143482|NCT02800863|589235174|FG000|Overall Study|Screen Failure|1|||
163143483|NCT02800863|589235174|FG000|Overall Study|Sponsor Request|6|||
163143484|NCT02800863|589235174|FG000|Overall Study|Death|3|||
163143485|NCT02800863|589235174|FG000|Overall Study|Subject Implant at Another Facility|1|||
163143486|NCT02800863|589235174|FG000|Overall Study|Lost to Follow-up|26|||
163143487|NCT02800863|589235174|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
163143488|NCT02800863|589235174|FG000|Overall Study|Subject and/or Family Request|64|||
163143489|NCT02800863|589235174|FG000|Overall Study|Trial Failure|81|||
163143490|NCT02800863|589235174|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
163143491|NCT03957551|589235175|FG000|Overall Study|Adverse Event|2|||
163143492|NCT03957551|589235176|FG001|Overall Study|Adverse Event|2|||
163143493|NCT03957551|589235177|FG002|Overall Study|Adverse Event|6|||
163143494|NCT03957551|589235175|FG000|Overall Study|Physician Decision|1|||
163143495|NCT03957551|589235176|FG001|Overall Study|Physician Decision|0|||
163143496|NCT03957551|589235177|FG002|Overall Study|Physician Decision|2|||
163143497|NCT03957551|589235175|FG000|Overall Study|Withdrawal by Subject|1|||
163143498|NCT03957551|589235176|FG001|Overall Study|Withdrawal by Subject|0|||
163143499|NCT03957551|589235177|FG002|Overall Study|Withdrawal by Subject|2|||
163143500|NCT03957551|589235175|FG000|Overall Study|Disease progression|1|||
163143501|NCT03957551|589235176|FG001|Overall Study|Disease progression|0|||
163143502|NCT03957551|589235177|FG002|Overall Study|Disease progression|8|||
163143503|NCT00607087|589235178|FG000|Overall Study|Withdrawal by Subject|9|||
163143504|NCT00607087|589235179|FG001|Overall Study|Withdrawal by Subject|4|||
163143505|NCT00607087|589235180|FG002|Overall Study|Withdrawal by Subject|4|||
163143506|NCT00607087|589235178|FG000|Overall Study|Adverse Event|3|||
163143507|NCT00607087|589235179|FG001|Overall Study|Adverse Event|2|||
163143508|NCT00607087|589235180|FG002|Overall Study|Adverse Event|3|||
163143509|NCT00607087|589235178|FG000|Overall Study|Other reason|1|||
163143510|NCT00607087|589235179|FG001|Overall Study|Other reason|5|||
163143511|NCT00607087|589235180|FG002|Overall Study|Other reason|2|||
163143512|NCT00607087|589235178|FG000|Overall Study|Poor compliance to protocol|1|||
163143513|NCT00607087|589235179|FG001|Overall Study|Poor compliance to protocol|0|||
163143514|NCT00607087|589235180|FG002|Overall Study|Poor compliance to protocol|1|||
163143515|NCT00607087|589235178|FG000|Overall Study|Lost to Follow-up|1|||
163143516|NCT00607087|589235179|FG001|Overall Study|Lost to Follow-up|0|||
163143517|NCT00607087|589235180|FG002|Overall Study|Lost to Follow-up|0|||
163143518|NCT00607087|589235178|FG000|Period 1|Withdrawal by Subject|7|||
163143519|NCT00607087|589235179|FG001|Period 1|Withdrawal by Subject|2|||
163143520|NCT00607087|589235180|FG002|Period 1|Withdrawal by Subject|3|||
163143521|NCT00607087|589235178|FG000|Period 1|Adverse Event|3|||
163143522|NCT00607087|589235179|FG001|Period 1|Adverse Event|0|||
163143523|NCT00607087|589235180|FG002|Period 1|Adverse Event|0|||
163143524|NCT00607087|589235178|FG000|Period 1|Poor compliance to protocol|1|||
163143525|NCT00607087|589235179|FG001|Period 1|Poor compliance to protocol|0|||
163143526|NCT00607087|589235180|FG002|Period 1|Poor compliance to protocol|0|||
163143527|NCT00607087|589235178|FG000|Period 1|Lost to Follow-up|1|||
163143528|NCT00607087|589235179|FG001|Period 1|Lost to Follow-up|0|||
163143529|NCT00607087|589235180|FG002|Period 1|Lost to Follow-up|0|||
163143530|NCT00607087|589235178|FG000|Period 1|Other reason|0|||
163143531|NCT00607087|589235179|FG001|Period 1|Other reason|4|||
163143532|NCT00607087|589235180|FG002|Period 1|Other reason|2|||
163143533|NCT00607087|589235178|FG000|Period 2|Withdrawal by Subject|0|||
162662980|NCT02956629|587478286|FG000|Overall Study|Withdrawal by Subject|3|||
163143534|NCT00607087|589235179|FG001|Period 2|Withdrawal by Subject|1|||
162662981|NCT02956629|587478287|FG001|Overall Study|Withdrawal by Subject|1|||
162662982|NCT02956629|587478288|FG002|Overall Study|Withdrawal by Subject|0|||
162662983|NCT02956629|587478289|FG003|Overall Study|Withdrawal by Subject|0|||
163143535|NCT00607087|589235180|FG002|Period 2|Withdrawal by Subject|1|||
163143536|NCT00607087|589235178|FG000|Period 2|Other reason|1|||
163143537|NCT00607087|589235179|FG001|Period 2|Other reason|1|||
163143538|NCT00607087|589235180|FG002|Period 2|Other reason|0|||
163143539|NCT00607087|589235178|FG000|Period 2|Adverse Event|0|||
163143540|NCT00607087|589235179|FG001|Period 2|Adverse Event|1|||
163143541|NCT00607087|589235180|FG002|Period 2|Adverse Event|3|||
163143542|NCT00607087|589235178|FG000|Period 2|Poor compliance to protocol|0|||
163143543|NCT00607087|589235179|FG001|Period 2|Poor compliance to protocol|0|||
163143544|NCT00607087|589235180|FG002|Period 2|Poor compliance to protocol|1|||
163143545|NCT00607087|589235178|FG000|Period 3|Withdrawal by Subject|2|||
163143546|NCT00607087|589235179|FG001|Period 3|Withdrawal by Subject|1|||
163143547|NCT00607087|589235180|FG002|Period 3|Withdrawal by Subject|0|||
163143548|NCT00607087|589235178|FG000|Period 3|Adverse Event|0|||
163143549|NCT00607087|589235179|FG001|Period 3|Adverse Event|1|||
163143550|NCT00607087|589235180|FG002|Period 3|Adverse Event|0|||
163143551|NCT02717494|589235183|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
163143552|NCT02717494|589235184|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
163143553|NCT02717494|589235185|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
163143554|NCT02717494|589235183|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
163143555|NCT02717494|589235184|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
163143556|NCT02717494|589235185|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
163143557|NCT02717494|589235183|FG000|First Intervention (Step 1)|Death|0|||
163143558|NCT02717494|589235184|FG001|First Intervention (Step 1)|Death|0|||
163143559|NCT02717494|589235185|FG002|First Intervention (Step 1)|Death|1|||
163143560|NCT02717494|589235183|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
163143561|NCT02717494|589235184|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
163143562|NCT02717494|589235185|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
163143563|NCT01774799|589235191|FG000|Overall Study|Lost to Follow-up|1|||
163143564|NCT01774799|589235192|FG001|Overall Study|Lost to Follow-up|1|||
163143565|NCT01774799|589235193|FG002|Overall Study|Lost to Follow-up|0|||
163143566|NCT01774799|589235194|FG003|Overall Study|Lost to Follow-up|0|||
163143567|NCT01125800|589235196|FG000|Phase I|Protocol Violation|0|||
162662984|NCT02956629|587478290|FG004|Overall Study|Withdrawal by Subject|0|||
162662985|NCT02956629|587478291|FG005|Overall Study|Withdrawal by Subject|0|||
162662986|NCT03224468|587478295|FG000|Overall Study|Did not obtain MM card|53|||
162662987|NCT03224468|587478296|FG001|Overall Study|Did not obtain MM card|0|||
162662988|NCT03224468|587478295|FG000|Overall Study|Lost to Follow-up|4|||
162662989|NCT03224468|587478296|FG001|Overall Study|Lost to Follow-up|11|||
162662990|NCT03224468|587478295|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
162662991|NCT03224468|587478296|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
163143568|NCT01125800|589235197|FG001|Phase I|Protocol Violation|3|||
163143569|NCT01125800|589235198|FG002|Phase I|Protocol Violation|1|||
163143570|NCT01125800|589235199|FG003|Phase I|Protocol Violation|1|||
163143571|NCT01125800|589235200|FG004|Phase I|Protocol Violation|0|||
163143572|NCT01125800|589235196|FG000|Phase I|Adverse Event|2|||
163143573|NCT01125800|589235197|FG001|Phase I|Adverse Event|2|||
163143574|NCT01125800|589235198|FG002|Phase I|Adverse Event|1|||
163143575|NCT01125800|589235199|FG003|Phase I|Adverse Event|7|||
163143576|NCT01125800|589235200|FG004|Phase I|Adverse Event|0|||
163143577|NCT01125800|589235196|FG000|Phase I|Administrative problems|1|||
163143578|NCT01125800|589235197|FG001|Phase I|Administrative problems|0|||
163143579|NCT01125800|589235198|FG002|Phase I|Administrative problems|0|||
163143580|NCT01125800|589235199|FG003|Phase I|Administrative problems|0|||
163143581|NCT01125800|589235200|FG004|Phase I|Administrative problems|0|||
163143582|NCT01125800|589235196|FG000|Phase I|Withdrawal by Subject|0|||
163143583|NCT01125800|589235197|FG001|Phase I|Withdrawal by Subject|0|||
163143584|NCT01125800|589235198|FG002|Phase I|Withdrawal by Subject|1|||
163143585|NCT01125800|589235199|FG003|Phase I|Withdrawal by Subject|0|||
163143586|NCT01125800|589235200|FG004|Phase I|Withdrawal by Subject|0|||
163143587|NCT01125800|589235196|FG000|Phase I|Disease progression|5|||
163143588|NCT01125800|589235197|FG001|Phase I|Disease progression|4|||
163143589|NCT01125800|589235198|FG002|Phase I|Disease progression|1|||
163143590|NCT01125800|589235199|FG003|Phase I|Disease progression|3|||
163143591|NCT01125800|589235200|FG004|Phase I|Disease progression|0|||
163143592|NCT01125800|589235196|FG000|Phase II|Protocol Violation|0|||
163143593|NCT01125800|589235197|FG001|Phase II|Protocol Violation|0|||
163143594|NCT01125800|589235198|FG002|Phase II|Protocol Violation|0|||
163143595|NCT01125800|589235199|FG003|Phase II|Protocol Violation|0|||
163143596|NCT01125800|589235200|FG004|Phase II|Protocol Violation|1|||
163143597|NCT01125800|589235196|FG000|Phase II|Adverse Event|0|||
163143598|NCT01125800|589235197|FG001|Phase II|Adverse Event|0|||
163143599|NCT01125800|589235198|FG002|Phase II|Adverse Event|0|||
163143600|NCT01125800|589235199|FG003|Phase II|Adverse Event|0|||
163143601|NCT01125800|589235200|FG004|Phase II|Adverse Event|2|||
163143602|NCT01125800|589235196|FG000|Phase II|Disease progression|0|||
163143603|NCT01125800|589235197|FG001|Phase II|Disease progression|0|||
163143604|NCT01125800|589235198|FG002|Phase II|Disease progression|0|||
163143605|NCT01125800|589235199|FG003|Phase II|Disease progression|1|||
163143606|NCT01125800|589235200|FG004|Phase II|Disease progression|8|||
163143607|NCT05051579|589235201|FG000|Overall Study|Withdrawal by Subject|3|||
163143608|NCT05051579|589235202|FG001|Overall Study|Withdrawal by Subject|5|||
163143609|NCT05051579|589235203|FG002|Overall Study|Withdrawal by Subject|2|||
163143610|NCT05051579|589235204|FG003|Overall Study|Withdrawal by Subject|1|||
163143611|NCT05051579|589235205|FG004|Overall Study|Withdrawal by Subject|4|||
163143612|NCT05051579|589235206|FG005|Overall Study|Withdrawal by Subject|0|||
163143613|NCT05051579|589235207|FG006|Overall Study|Withdrawal by Subject|4|||
163143614|NCT05051579|589235201|FG000|Overall Study|Lost to Follow-up|1|||
163143615|NCT05051579|589235202|FG001|Overall Study|Lost to Follow-up|0|||
163143616|NCT05051579|589235203|FG002|Overall Study|Lost to Follow-up|0|||
163143617|NCT05051579|589235204|FG003|Overall Study|Lost to Follow-up|0|||
163143618|NCT05051579|589235205|FG004|Overall Study|Lost to Follow-up|1|||
163143619|NCT05051579|589235206|FG005|Overall Study|Lost to Follow-up|0|||
163143620|NCT05051579|589235207|FG006|Overall Study|Lost to Follow-up|1|||
163143621|NCT05051579|589235201|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143622|NCT05051579|589235202|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143623|NCT05051579|589235203|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143624|NCT05051579|589235204|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143625|NCT05051579|589235205|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143626|NCT05051579|589235206|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
163143627|NCT05051579|589235207|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
163143628|NCT05051579|589235201|FG000|Overall Study|Adverse Event|2|||
163143629|NCT05051579|589235202|FG001|Overall Study|Adverse Event|1|||
163143630|NCT05051579|589235203|FG002|Overall Study|Adverse Event|0|||
163143631|NCT05051579|589235204|FG003|Overall Study|Adverse Event|4|||
163143632|NCT05051579|589235205|FG004|Overall Study|Adverse Event|1|||
163143633|NCT05051579|589235206|FG005|Overall Study|Adverse Event|2|||
163143634|NCT05051579|589235207|FG006|Overall Study|Adverse Event|0|||
163143635|NCT05051579|589235201|FG000|Overall Study|Inadvertent Enrollment|0|||
163143636|NCT05051579|589235202|FG001|Overall Study|Inadvertent Enrollment|0|||
163143637|NCT05051579|589235203|FG002|Overall Study|Inadvertent Enrollment|0|||
162662992|NCT04713748|587478297|FG000|Overall Study|Not enough kits allocated|35|||
162662993|NCT01557946|587478298|FG000|Overall Study|Adverse Event|3|||
162662994|NCT01557946|587478299|FG001|Overall Study|Adverse Event|0|||
162662995|NCT00406029|587478300|FG000|Overall Study|Adverse Event|12|||
162662996|NCT00406029|587478301|FG001|Overall Study|Adverse Event|2|||
162662997|NCT00406029|587478302|FG002|Overall Study|Adverse Event|5|||
162662998|NCT00406029|587478303|FG003|Overall Study|Adverse Event|10|||
162662999|NCT00406029|587478304|FG004|Overall Study|Adverse Event|7|||
163143638|NCT05051579|589235204|FG003|Overall Study|Inadvertent Enrollment|0|||
163143639|NCT05051579|589235205|FG004|Overall Study|Inadvertent Enrollment|0|||
163143640|NCT05051579|589235206|FG005|Overall Study|Inadvertent Enrollment|0|||
163143641|NCT05051579|589235207|FG006|Overall Study|Inadvertent Enrollment|1|||
163143642|NCT05051579|589235201|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143643|NCT05051579|589235202|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
163143644|NCT05051579|589235203|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143645|NCT05051579|589235204|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143646|NCT05051579|589235205|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143647|NCT05051579|589235206|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143648|NCT05051579|589235207|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
163143649|NCT05051579|589235201|FG000|Overall Study|Sponsor Decision|0|||
163143650|NCT05051579|589235202|FG001|Overall Study|Sponsor Decision|0|||
163143651|NCT05051579|589235203|FG002|Overall Study|Sponsor Decision|0|||
163143652|NCT05051579|589235204|FG003|Overall Study|Sponsor Decision|0|||
163143653|NCT05051579|589235205|FG004|Overall Study|Sponsor Decision|1|||
163143654|NCT05051579|589235206|FG005|Overall Study|Sponsor Decision|0|||
163143655|NCT05051579|589235207|FG006|Overall Study|Sponsor Decision|0|||
163143656|NCT05051579|589235201|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143657|NCT05051579|589235202|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143658|NCT05051579|589235203|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143659|NCT05051579|589235204|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143660|NCT05051579|589235205|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
163143661|NCT05051579|589235206|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143662|NCT05051579|589235207|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
163143663|NCT01808196|589235210|FG000|Overall Study|Lost to Follow-up|1|||
163143664|NCT00479713|589235211|FG000|Overall Study|Adverse Event|8|||
163143665|NCT00479713|589235212|FG001|Overall Study|Adverse Event|6|||
163143666|NCT00479713|589235211|FG000|Overall Study|Death|1|||
163143667|NCT00479713|589235212|FG001|Overall Study|Death|0|||
163143668|NCT00479713|589235211|FG000|Overall Study|Lost to Follow-up|0|||
163143669|NCT00479713|589235212|FG001|Overall Study|Lost to Follow-up|1|||
163143670|NCT00479713|589235211|FG000|Overall Study|Protocol Violation|0|||
163143671|NCT00479713|589235212|FG001|Overall Study|Protocol Violation|1|||
163143672|NCT00479713|589235211|FG000|Overall Study|Withdrawal by Subject|4|||
163143673|NCT00479713|589235212|FG001|Overall Study|Withdrawal by Subject|1|||
163143674|NCT05274958|589235215|FG000|Overall Study|Only completed 1 set of PROMs|22|||
163143675|NCT05274958|589235216|FG001|Overall Study|Only completed 1 set of PROMs|35|||
163143676|NCT01505374|589235217|FG000|Overall Study|Lost to Follow-up|1|||
163143677|NCT01505374|589235218|FG001|Overall Study|Lost to Follow-up|0|||
163143678|NCT00176462|589235224|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
163143679|NCT00176462|589235225|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
163143680|NCT00176462|589235224|FG000|Induction (4 Weeks)|Death|1|||
163143681|NCT00176462|589235225|FG001|Induction (4 Weeks)|Death|2|||
163143682|NCT00176462|589235224|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
163143683|NCT00176462|589235225|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
163143684|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
163143685|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
163143686|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
163143687|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
163143688|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
163143689|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
163143690|NCT00176462|589235224|FG000|Consolidation (12 Weeks)|Not documented|0|||
163143691|NCT00176462|589235225|FG001|Consolidation (12 Weeks)|Not documented|1|||
163143692|NCT00176462|589235224|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
163143693|NCT00176462|589235225|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
163143694|NCT00176462|589235224|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
163143695|NCT00176462|589235225|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
162663000|NCT00406029|587478300|FG000|Overall Study|Withdrawal by Subject|3|||
162663001|NCT00406029|587478301|FG001|Overall Study|Withdrawal by Subject|4|||
162663002|NCT00406029|587478302|FG002|Overall Study|Withdrawal by Subject|2|||
162721067|NCT00688519|587686031|FG001|Overall Study|Investigator decision|0|||
162721068|NCT00688519|587686030|FG000|Overall Study|Subject moved out of area|1|||
162721069|NCT00688519|587686031|FG001|Overall Study|Subject moved out of area|0|||
162721070|NCT00688519|587686030|FG000|Overall Study|Pregnancy|0|||
163143696|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
163143697|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
163143698|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
163143699|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
162721071|NCT00688519|587686031|FG001|Overall Study|Pregnancy|1|||
162721072|NCT03768206|587686032|FG000|Overall Study|Lost to Follow-up|2|||
162721073|NCT03768206|587686033|FG001|Overall Study|Lost to Follow-up|1|||
162721074|NCT03768206|587686032|FG000|Overall Study|Withdrawal by Subject|0|||
162721075|NCT03768206|587686033|FG001|Overall Study|Withdrawal by Subject|1|||
162721076|NCT02551055|587686036|FG000|Overall Study|Death|2|||
162721077|NCT02551055|587686037|FG001|Overall Study|Death|4|||
162721078|NCT02551055|587686038|FG002|Overall Study|Death|2|||
162721079|NCT02551055|587686039|FG003|Overall Study|Death|2|||
162721080|NCT02551055|587686040|FG004|Overall Study|Death|2|||
163143700|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
163143701|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
163143702|NCT02679287|589235228|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
163143703|NCT02679287|589235229|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
163143704|NCT02679287|589235228|FG000|Period 2|Work/Scheduling Conflict|1|||
163143705|NCT02679287|589235229|FG001|Period 2|Work/Scheduling Conflict|0|||
163143706|NCT02679287|589235228|FG000|Period 2|Disliked Mobile System|2|||
163143707|NCT02679287|589235229|FG001|Period 2|Disliked Mobile System|0|||
163143708|NCT02679287|589235228|FG000|Period 3|Work/Scheduling Conflict|0|||
163143709|NCT02679287|589235229|FG001|Period 3|Work/Scheduling Conflict|1|||
163143710|NCT00320515|589235232|FG000|Overall Study|Death|33|||
163143711|NCT00320515|589235232|FG000|Overall Study|Lost to Follow-up|6|||
163143712|NCT00320515|589235232|FG000|Overall Study|Physician Decision|2|||
163143713|NCT00320515|589235232|FG000|Overall Study|Withdrawal by Subject|8|||
163143714|NCT01114828|589235233|FG000|Overall Study|Adverse Event|1|||
163143715|NCT01114828|589235234|FG001|Overall Study|Adverse Event|1|||
163143716|NCT01114828|589235233|FG000|Overall Study|Lack of Efficacy|0|||
163143717|NCT01114828|589235234|FG001|Overall Study|Lack of Efficacy|2|||
163143718|NCT01114828|589235233|FG000|Overall Study|Protocol Violation|2|||
163143719|NCT01114828|589235234|FG001|Overall Study|Protocol Violation|0|||
163143720|NCT01114828|589235233|FG000|Overall Study|Withdrawal by Subject|0|||
163143721|NCT01114828|589235234|FG001|Overall Study|Withdrawal by Subject|1|||
163143722|NCT00794950|589235235|FG000|BCG Induction|Withdrawal by Subject|2|||
163143723|NCT00794950|589235235|FG000|BCG Induction|ineligible|3|||
163143724|NCT00794950|589235235|FG000|BCG Induction|noncompliant w. BCG|1|||
163143725|NCT00794950|589235235|FG000|BCG Induction|Adverse Event|1|||
163143726|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
163143727|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
163143728|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
163143729|NCT00794950|589235235|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
163143730|NCT02485704|589235236|FG000|Overall Study|Lost to Follow-up|4|||
163143731|NCT02485704|589235237|FG001|Overall Study|Lost to Follow-up|5|||
163143732|NCT02485704|589235236|FG000|Overall Study|Withdrawal by Subject|0|||
163143733|NCT02485704|589235237|FG001|Overall Study|Withdrawal by Subject|3|||
163143734|NCT02485704|589235236|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
163143735|NCT02485704|589235237|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
163143736|NCT00851786|589235240|FG000|Overall Study|Withdrawal by Subject|0|||
163143737|NCT00851786|589235241|FG001|Overall Study|Withdrawal by Subject|1|||
163143738|NCT00851786|589235240|FG000|Overall Study|Protocol Violation|0|||
163143739|NCT00851786|589235241|FG001|Overall Study|Protocol Violation|1|||
163143740|NCT00851786|589235240|FG000|Overall Study|Lost to Follow-up|1|||
163143741|NCT00851786|589235241|FG001|Overall Study|Lost to Follow-up|0|||
162721081|NCT02551055|587686041|FG005|Overall Study|Death|1|||
163143742|NCT00851786|589235240|FG000|Overall Study|Incarceration|1|||
163143743|NCT00851786|589235241|FG001|Overall Study|Incarceration|0|||
163143744|NCT00851786|589235240|FG000|Overall Study|Site Closure|1|||
163143745|NCT00851786|589235241|FG001|Overall Study|Site Closure|0|||
163143746|NCT00851786|589235240|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
163143747|NCT00851786|589235241|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
163143748|NCT03858049|589237124|FG000|Overall Study|Adverse Event|16|||
163143749|NCT03858049|589237125|FG001|Overall Study|Adverse Event|9|||
163143750|NCT03858049|589237124|FG000|Overall Study|Other|1|||
162721082|NCT02551055|587686042|FG006|Overall Study|Death|2|||
162721083|NCT02551055|587686043|FG007|Overall Study|Death|0|||
162721084|NCT02551055|587686036|FG000|Overall Study|Study Terminated by Sponsor|1|||
162721085|NCT02551055|587686037|FG001|Overall Study|Study Terminated by Sponsor|1|||
162721086|NCT02551055|587686038|FG002|Overall Study|Study Terminated by Sponsor|0|||
163143751|NCT03858049|589237125|FG001|Overall Study|Other|1|||
163143752|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
163143753|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
163143754|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
163143755|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
163143756|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
163143757|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
163143758|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
163143759|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
163143760|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
163143761|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
163143762|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
163143763|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
163143764|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
163143765|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
163143766|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
163143767|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
163143768|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
163143769|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
163143770|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
163143771|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
163143772|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
163143773|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
163143774|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
163143775|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
163143776|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
163143777|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
163143778|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143779|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143780|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143781|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143782|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143783|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143784|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143785|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
163143786|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143787|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143788|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143789|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143790|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
163143791|NCT02079740|589237126|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143792|NCT02079740|589237127|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143793|NCT02079740|589237128|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143794|NCT02079740|589237129|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143795|NCT02079740|589237130|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143796|NCT02079740|589237131|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143797|NCT02079740|589237132|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143798|NCT02079740|589237133|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
163143799|NCT02079740|589237134|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143800|NCT02079740|589237135|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143801|NCT02079740|589237136|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143802|NCT02079740|589237137|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143803|NCT02079740|589237138|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
163143804|NCT02079740|589237126|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143805|NCT02079740|589237127|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143806|NCT02079740|589237128|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
162663003|NCT00406029|587478303|FG003|Overall Study|Withdrawal by Subject|2|||
163143807|NCT02079740|589237129|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143808|NCT02079740|589237130|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143809|NCT02079740|589237131|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143810|NCT02079740|589237132|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143811|NCT02079740|589237133|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143812|NCT02079740|589237134|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143813|NCT02079740|589237135|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
163143814|NCT02079740|589237136|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
163143815|NCT02079740|589237137|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
163143816|NCT02079740|589237138|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
163143817|NCT01405768|589237143|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
163143818|NCT01405768|589237144|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
163143819|NCT04388111|589237145|FG000|Overall Study|Lost to Follow-up|5|||
163143820|NCT04388111|589237146|FG001|Overall Study|Lost to Follow-up|3|||
163143821|NCT04388111|589237145|FG000|Overall Study|Adverse Event|1|||
163143822|NCT04388111|589237146|FG001|Overall Study|Adverse Event|1|||
163143823|NCT04388111|589237145|FG000|Overall Study|Protocol Violation|2|||
163143824|NCT04388111|589237146|FG001|Overall Study|Protocol Violation|4|||
163143825|NCT04388111|589237145|FG000|Overall Study|Withdrawal by Subject|1|||
163143826|NCT04388111|589237146|FG001|Overall Study|Withdrawal by Subject|0|||
163143827|NCT01474317|589237151|FG000|Overall Study|Adverse Event|1|||
163143828|NCT01474317|589237151|FG000|Overall Study|Subject ineligible for study|1|||
163143829|NCT00387881|589237154|FG000|Overall Study|Lost to Follow-up|23|||
163143830|NCT00387881|589237155|FG001|Overall Study|Lost to Follow-up|23|||
163143831|NCT00387881|589237154|FG000|Overall Study|Protocol Violation|2|||
163143832|NCT00387881|589237155|FG001|Overall Study|Protocol Violation|12|||
163143833|NCT00387881|589237154|FG000|Overall Study|Withdrawal by Subject|15|||
163143834|NCT00387881|589237155|FG001|Overall Study|Withdrawal by Subject|18|||
163143835|NCT00387881|589237154|FG000|Overall Study|Sponsor terminated Study|0|||
162663004|NCT00406029|587478304|FG004|Overall Study|Withdrawal by Subject|0|||
162663005|NCT00406029|587478300|FG000|Overall Study|Protocol Violation|1|||
162663006|NCT00406029|587478301|FG001|Overall Study|Protocol Violation|2|||
162663007|NCT00406029|587478302|FG002|Overall Study|Protocol Violation|0|||
163143836|NCT00387881|589237155|FG001|Overall Study|Sponsor terminated Study|1|||
163143837|NCT00387881|589237154|FG000|Overall Study|Not eligible|6|||
163143838|NCT00387881|589237155|FG001|Overall Study|Not eligible|7|||
163143839|NCT00387881|589237154|FG000|Overall Study|No opportunity to treat headache|32|||
163143840|NCT00387881|589237155|FG001|Overall Study|No opportunity to treat headache|34|||
163143841|NCT00387881|589237154|FG000|Overall Study|Not otherwise specified|11|||
163143842|NCT00387881|589237155|FG001|Overall Study|Not otherwise specified|7|||
163143843|NCT00453154|589237156|FG000|Double BIind Maintenance|Adverse Event|0|||
163143844|NCT00453154|589237157|FG001|Double BIind Maintenance|Adverse Event|0|||
163143845|NCT00453154|589237158|FG002|Double BIind Maintenance|Adverse Event|3|||
163143846|NCT00453154|589237159|FG003|Double BIind Maintenance|Adverse Event|12|||
163143847|NCT00453154|589237156|FG000|Double BIind Maintenance|Death|0|||
163143848|NCT00453154|589237157|FG001|Double BIind Maintenance|Death|0|||
163143849|NCT00453154|589237158|FG002|Double BIind Maintenance|Death|2|||
163143850|NCT00453154|589237159|FG003|Double BIind Maintenance|Death|1|||
163143851|NCT00453154|589237156|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
163143852|NCT00453154|589237157|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
163143853|NCT00453154|589237158|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
163143854|NCT00453154|589237159|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
163143855|NCT00453154|589237156|FG000|Double BIind Maintenance|Progression|0|||
163143856|NCT00453154|589237157|FG001|Double BIind Maintenance|Progression|0|||
163143857|NCT00453154|589237158|FG002|Double BIind Maintenance|Progression|29|||
163143858|NCT00453154|589237159|FG003|Double BIind Maintenance|Progression|26|||
163143859|NCT00453154|589237156|FG000|Double BIind Maintenance|Medical Issues|0|||
163143860|NCT00453154|589237157|FG001|Double BIind Maintenance|Medical Issues|0|||
162663008|NCT00406029|587478303|FG003|Overall Study|Protocol Violation|2|||
163143861|NCT00453154|589237158|FG002|Double BIind Maintenance|Medical Issues|3|||
163143862|NCT00453154|589237159|FG003|Double BIind Maintenance|Medical Issues|1|||
163143863|NCT00453154|589237156|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
163143864|NCT00453154|589237157|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
163143865|NCT00453154|589237158|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
163143866|NCT00453154|589237159|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
163143867|NCT03629886|589237161|FG000|Overall Study|Migrated / moved from the study area|0|||
163143868|NCT03629886|589237162|FG001|Overall Study|Migrated / moved from the study area|55|||
163143869|NCT03629886|589237161|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
163143870|NCT03629886|589237162|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
163143871|NCT03629886|589237161|FG000|Overall Study|Study vaccine not administrated|0|||
163143872|NCT03629886|589237162|FG001|Overall Study|Study vaccine not administrated|3|||
162663009|NCT00406029|587478304|FG004|Overall Study|Protocol Violation|0|||
162663010|NCT00406029|587478300|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
163143873|NCT03629886|589237161|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
163143874|NCT03629886|589237162|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
163143875|NCT03629886|589237161|FG000|Overall Study|Refused vaccination step of the study|0|||
163143876|NCT03629886|589237162|FG001|Overall Study|Refused vaccination step of the study|44|||
163143877|NCT05473026|589237164|FG000|Overall Study|Lost to Follow-up|5|||
163143878|NCT05473026|589237165|FG001|Overall Study|Lost to Follow-up|2|||
162663011|NCT00406029|587478301|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162663012|NCT00406029|587478302|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
162663013|NCT00406029|587478303|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
162663014|NCT00406029|587478304|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
162663015|NCT00406029|587478300|FG000|Overall Study|Randomized in Error|0|||
162663016|NCT00406029|587478301|FG001|Overall Study|Randomized in Error|0|||
162663017|NCT00406029|587478302|FG002|Overall Study|Randomized in Error|2|||
162663018|NCT00406029|587478303|FG003|Overall Study|Randomized in Error|3|||
163143879|NCT02038153|589237166|FG000|Overall Study|Withdrawal by Subject|1|||
163143880|NCT03683173|589237167|FG000|Completed Follow-up|Unavailable|235|||
163143881|NCT03683173|589237168|FG001|Completed Follow-up|Unavailable|217|||
163143882|NCT03683173|589237167|FG000|Completed Follow-up|Refused|69|||
163143883|NCT03683173|589237168|FG001|Completed Follow-up|Refused|59|||
163143884|NCT03683173|589237167|FG000|Completed Follow-up|Disconnected phone|65|||
163143885|NCT03683173|589237168|FG001|Completed Follow-up|Disconnected phone|95|||
163143886|NCT03683173|589237167|FG000|Completed Follow-up|Health issue/deceased|10|||
163143887|NCT03683173|589237168|FG001|Completed Follow-up|Health issue/deceased|4|||
163143888|NCT03683173|589237167|FG000|Completed Follow-up|Moved away|8|||
163143889|NCT03683173|589237168|FG001|Completed Follow-up|Moved away|1|||
163143890|NCT02647281|589237169|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143891|NCT02647281|589237170|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143892|NCT02647281|589237171|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143893|NCT02647281|589237172|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143894|NCT02647281|589237173|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143895|NCT02647281|589237174|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143896|NCT02647281|589237175|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143897|NCT02647281|589237176|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
163143898|NCT02647281|589237177|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
163143899|NCT01050634|589237178|FG000|Overall Study|Enrolled, but Not Treated|56|||
163143900|NCT01050634|589237178|FG000|Overall Study|Death|2|||
163143901|NCT01050634|589237178|FG000|Overall Study|Adverse Event|42|||
163143902|NCT01050634|589237178|FG000|Overall Study|Lost to Follow-up|2|||
163143903|NCT01050634|589237178|FG000|Overall Study|Other|21|||
163143904|NCT01050634|589237178|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
163143905|NCT00496015|589237179|FG000|Overall Study|Other|1|||
163143906|NCT00496015|589237180|FG001|Overall Study|Other|0|||
163143907|NCT00496015|589237181|FG002|Overall Study|Other|0|||
163143908|NCT00496015|589237182|FG003|Overall Study|Other|1|||
163143909|NCT00496015|589237183|FG004|Overall Study|Other|0|||
163143910|NCT02730728|589237186|FG000|Overall Study|Withdrawal by Subject|0|||
163143911|NCT02730728|589237187|FG001|Overall Study|Withdrawal by Subject|1|||
162663019|NCT00406029|587478304|FG004|Overall Study|Randomized in Error|1|||
162663020|NCT04067141|587478305|FG000|First Intervention|Withdrawal by Subject|0|||
162663021|NCT04067141|587478306|FG001|First Intervention|Withdrawal by Subject|1|||
163143912|NCT02730728|589237188|FG002|Overall Study|Withdrawal by Subject|0|||
163143913|NCT02730728|589237186|FG000|Overall Study|Lack of Efficacy|0|||
163143914|NCT02730728|589237187|FG001|Overall Study|Lack of Efficacy|1|||
163143915|NCT02730728|589237188|FG002|Overall Study|Lack of Efficacy|1|||
163143916|NCT03360682|589237205|FG000|Overall Study|Adverse Event|3|||
163143917|NCT02420093|589237206|FG000|Overall Study|Withdrawal by Subject|1|||
163143918|NCT02420093|589237207|FG001|Overall Study|Withdrawal by Subject|1|||
163143919|NCT03244917|589237209|FG000|Overall Study|Lost to Follow-up|2|||
163143920|NCT03244917|589237210|FG001|Overall Study|Lost to Follow-up|2|||
163143921|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143922|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143923|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143924|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143925|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143926|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143927|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143928|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143929|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143930|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
162663022|NCT04067141|587478305|FG000|Second Intervention|Adverse Event|0|||
162663023|NCT04067141|587478306|FG001|Second Intervention|Adverse Event|2|||
162663024|NCT02013765|587478309|FG000|Overall Study|Trial was terminated by sponsor|1|||
162663025|NCT00718042|587478311|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163143931|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143932|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143933|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
163143934|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
162663026|NCT00718042|587478312|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163143935|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
163143936|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143937|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143938|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143939|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143940|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
163143941|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143942|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
163143943|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
163143944|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143945|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143946|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143947|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143948|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
163143949|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
163143950|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
163143951|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
163143952|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
163143953|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
163143954|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
163143955|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
163143956|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
163143957|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
163143958|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
163143959|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
163143960|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
163143961|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
163143962|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
163143963|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
163143964|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
163143965|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
163143966|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143967|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143968|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143969|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143970|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143971|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143972|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143973|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143974|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143975|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143976|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
163143977|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143978|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143979|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143980|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
163143981|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143982|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143983|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143984|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143985|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143986|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143987|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143988|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143989|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143990|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143991|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143992|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143993|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143994|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
163143995|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
163143996|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163143997|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
162663027|NCT00718042|587478313|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
163143998|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163143999|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
163144000|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144001|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144002|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144003|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144004|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144005|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144006|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
163144007|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144008|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144009|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144010|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
163144011|NCT01147666|589237211|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144012|NCT01147666|589237212|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144013|NCT01147666|589237213|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144014|NCT01147666|589237214|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144015|NCT01147666|589237215|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144016|NCT01147666|589237216|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144017|NCT01147666|589237217|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144018|NCT01147666|589237218|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144019|NCT01147666|589237219|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
162721087|NCT02551055|587686039|FG003|Overall Study|Study Terminated by Sponsor|2|||
163144020|NCT01147666|589237220|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144021|NCT01147666|589237221|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144022|NCT01147666|589237222|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144023|NCT01147666|589237223|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144024|NCT01147666|589237224|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
163144025|NCT01147666|589237225|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
163144026|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
163144027|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
163144028|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
163144029|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
163144030|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
163144031|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
163144032|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
163144033|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
163144034|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
163144035|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
163144036|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
163144037|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
163144038|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
163144039|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
163144040|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
163144041|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144042|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144043|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144044|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144045|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
163144046|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144047|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144048|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144049|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144050|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144051|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144052|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144053|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
163144054|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
163144055|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
163144056|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144057|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144058|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144059|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
163144060|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144061|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
162721088|NCT02551055|587686040|FG004|Overall Study|Study Terminated by Sponsor|2|||
162663028|NCT00718042|587478314|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162663029|NCT00718042|587478315|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
162663030|NCT00718042|587478316|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162663031|NCT00718042|587478311|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
162663032|NCT00718042|587478312|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162663033|NCT00718042|587478313|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162663034|NCT00718042|587478314|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162663035|NCT00718042|587478315|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
162663036|NCT00718042|587478316|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162663037|NCT00718042|587478311|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162663038|NCT00718042|587478312|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
162663039|NCT00718042|587478313|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
162663040|NCT00718042|587478314|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162663041|NCT00718042|587478315|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162663042|NCT00718042|587478316|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162663043|NCT00718042|587478311|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162663044|NCT00718042|587478312|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
162663045|NCT00718042|587478313|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162663046|NCT00718042|587478314|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162663047|NCT00718042|587478315|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162663048|NCT00718042|587478316|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162663049|NCT00718042|587478311|FG000|Donor Follow-up|Lost to Follow-up|13|||
162663050|NCT00718042|587478312|FG001|Donor Follow-up|Lost to Follow-up|0|||
162663051|NCT00718042|587478313|FG002|Donor Follow-up|Lost to Follow-up|0|||
162663052|NCT00718042|587478314|FG003|Donor Follow-up|Lost to Follow-up|0|||
162663053|NCT00718042|587478315|FG004|Donor Follow-up|Lost to Follow-up|19|||
162663054|NCT00718042|587478316|FG005|Donor Follow-up|Lost to Follow-up|0|||
162663055|NCT02822794|587478317|FG000|Overall Study|Withdrew Consent|1|||
162663056|NCT02822794|587478318|FG001|Overall Study|Withdrew Consent|0|||
162663057|NCT04788147|587478319|FG000|Overall Study|Screen Failure|3|||
162663058|NCT04788147|587478320|FG001|Overall Study|Screen Failure|10|||
162663059|NCT04788147|587478319|FG000|Overall Study|Incomplete RMRS image session|2|||
162663060|NCT04788147|587478320|FG001|Overall Study|Incomplete RMRS image session|0|||
162663061|NCT05101252|587478321|FG000|Overall Study|Unsatisfactory Test Article|1|||
162663062|NCT05101252|587478322|FG001|Overall Study|Unsatisfactory Test Article|0|||
162663063|NCT05101252|587478321|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162663064|NCT05101252|587478322|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
162663065|NCT05101252|587478321|FG000|Overall Study|Withdrew Consent during study|0|||
162663066|NCT05101252|587478322|FG001|Overall Study|Withdrew Consent during study|1|||
162721089|NCT02551055|587686041|FG005|Overall Study|Study Terminated by Sponsor|0|||
163144062|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144063|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144064|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144065|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144066|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144067|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144068|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144069|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144070|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
163144071|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144072|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144073|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144074|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144075|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144076|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144077|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144078|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144079|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144080|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144081|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144082|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144083|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144084|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
163144085|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
163144086|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144087|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144088|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144089|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
163144090|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144091|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144092|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144093|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144094|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144095|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144096|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
163144097|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144098|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144099|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144100|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
163144101|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144102|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144103|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144104|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144105|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144106|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144107|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144108|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144109|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144110|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144111|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144112|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144113|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
163144114|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144115|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
163144116|NCT01147666|589237211|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144117|NCT01147666|589237212|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144118|NCT01147666|589237213|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144119|NCT01147666|589237214|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144120|NCT01147666|589237215|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144121|NCT01147666|589237216|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144122|NCT01147666|589237217|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144123|NCT01147666|589237218|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144124|NCT01147666|589237219|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144125|NCT01147666|589237220|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144126|NCT01147666|589237221|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
162663067|NCT05101252|587478321|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
162663068|NCT05101252|587478322|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
162663069|NCT02266381|587478323|FG000|Overall Study|Physician Decision|3|||
162663070|NCT02266381|587478324|FG001|Overall Study|Physician Decision|5|||
162663071|NCT02266381|587478325|FG002|Overall Study|Physician Decision|4|||
162663072|NCT02520531|587478332|FG000|Overall Study|Revision of study device components|2|||
162663073|NCT02520531|587478333|FG001|Overall Study|Revision of study device components|2|||
162663074|NCT02520531|587478332|FG000|Overall Study|Death|1|||
162663075|NCT02520531|587478333|FG001|Overall Study|Death|2|||
162663076|NCT02520531|587478332|FG000|Overall Study|Lost to Follow-up|1|||
162663077|NCT02520531|587478333|FG001|Overall Study|Lost to Follow-up|1|||
162663078|NCT02520531|587478332|FG000|Overall Study|Meet exclusion criterion|0|||
162663079|NCT02520531|587478333|FG001|Overall Study|Meet exclusion criterion|1|||
162721090|NCT02551055|587686042|FG006|Overall Study|Study Terminated by Sponsor|0|||
162721091|NCT02551055|587686043|FG007|Overall Study|Study Terminated by Sponsor|0|||
162721092|NCT02551055|587686036|FG000|Overall Study|Withdrawal by Subject|1|||
162721093|NCT02551055|587686037|FG001|Overall Study|Withdrawal by Subject|1|||
162721094|NCT02551055|587686038|FG002|Overall Study|Withdrawal by Subject|0|||
162721095|NCT02551055|587686039|FG003|Overall Study|Withdrawal by Subject|1|||
162721096|NCT02551055|587686040|FG004|Overall Study|Withdrawal by Subject|2|||
163144127|NCT01147666|589237222|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144128|NCT01147666|589237223|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
163144129|NCT01147666|589237224|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
163144130|NCT01147666|589237225|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
163144131|NCT02748863|589237226|FG000|Treatment Period 1|Adverse Event|0|||
163144132|NCT02748863|589237227|FG001|Treatment Period 1|Adverse Event|1|||
163144133|NCT02748863|589237228|FG002|Treatment Period 1|Adverse Event|0|||
163144134|NCT02748863|589237229|FG003|Treatment Period 1|Adverse Event|0|||
163144135|NCT02748863|589237230|FG004|Treatment Period 1|Adverse Event|0|||
163144136|NCT02748863|589237226|FG000|Treatment Period 1|Lack of Efficacy|0|||
163144137|NCT02748863|589237227|FG001|Treatment Period 1|Lack of Efficacy|0|||
163144138|NCT02748863|589237228|FG002|Treatment Period 1|Lack of Efficacy|1|||
163144139|NCT02748863|589237229|FG003|Treatment Period 1|Lack of Efficacy|0|||
163144140|NCT02748863|589237230|FG004|Treatment Period 1|Lack of Efficacy|0|||
163144141|NCT02748863|589237226|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163144142|NCT02748863|589237227|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163144143|NCT02748863|589237228|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163144144|NCT02748863|589237229|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163144145|NCT02748863|589237230|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163144146|NCT02748863|589237226|FG000|Treatment Period 2|Lost to Follow-up|2|||
163144147|NCT02748863|589237227|FG001|Treatment Period 2|Lost to Follow-up|0|||
163144148|NCT02748863|589237228|FG002|Treatment Period 2|Lost to Follow-up|0|||
163144149|NCT02748863|589237229|FG003|Treatment Period 2|Lost to Follow-up|0|||
163144150|NCT02748863|589237230|FG004|Treatment Period 2|Lost to Follow-up|0|||
163144151|NCT02748863|589237226|FG000|Treatment Period 2|Adverse Event|3|||
163144152|NCT02748863|589237227|FG001|Treatment Period 2|Adverse Event|2|||
163144153|NCT02748863|589237228|FG002|Treatment Period 2|Adverse Event|0|||
163144154|NCT02748863|589237229|FG003|Treatment Period 2|Adverse Event|2|||
163144155|NCT02748863|589237230|FG004|Treatment Period 2|Adverse Event|0|||
163144156|NCT02748863|589237226|FG000|Treatment Period 2|Lack of Efficacy|0|||
163144157|NCT02748863|589237227|FG001|Treatment Period 2|Lack of Efficacy|1|||
163144158|NCT02748863|589237228|FG002|Treatment Period 2|Lack of Efficacy|0|||
163144159|NCT02748863|589237229|FG003|Treatment Period 2|Lack of Efficacy|0|||
163144160|NCT02748863|589237230|FG004|Treatment Period 2|Lack of Efficacy|0|||
163144161|NCT02748863|589237226|FG000|Treatment Period 2|Pregnancy|0|||
163144162|NCT02748863|589237227|FG001|Treatment Period 2|Pregnancy|0|||
163144163|NCT02748863|589237228|FG002|Treatment Period 2|Pregnancy|0|||
163144164|NCT02748863|589237229|FG003|Treatment Period 2|Pregnancy|0|||
163144165|NCT02748863|589237230|FG004|Treatment Period 2|Pregnancy|1|||
163144166|NCT02576639|589237231|FG000|Overall Study|Withdrawal by Subject|1|||
163144167|NCT02576639|589237232|FG001|Overall Study|Withdrawal by Subject|2|||
163144168|NCT02576639|589237233|FG002|Overall Study|Withdrawal by Subject|1|||
163144169|NCT02576639|589237234|FG003|Overall Study|Withdrawal by Subject|0|||
163144170|NCT02576639|589237235|FG004|Overall Study|Withdrawal by Subject|1|||
163144171|NCT02576639|589237231|FG000|Overall Study|Adverse Event|1|||
163144172|NCT02576639|589237232|FG001|Overall Study|Adverse Event|0|||
163144173|NCT02576639|589237233|FG002|Overall Study|Adverse Event|1|||
163144174|NCT02576639|589237234|FG003|Overall Study|Adverse Event|1|||
163144175|NCT02576639|589237235|FG004|Overall Study|Adverse Event|2|||
163144176|NCT02576639|589237231|FG000|Overall Study|Physician Decision|0|||
163144177|NCT02576639|589237232|FG001|Overall Study|Physician Decision|0|||
163144178|NCT02576639|589237233|FG002|Overall Study|Physician Decision|0|||
163144179|NCT02576639|589237234|FG003|Overall Study|Physician Decision|0|||
163144180|NCT02576639|589237235|FG004|Overall Study|Physician Decision|1|||
163144181|NCT01135134|589237236|FG000|Overall Study|Adverse Event|1|||
163144182|NCT01135134|589237237|FG001|Overall Study|Adverse Event|1|||
163144183|NCT01135134|589237236|FG000|Overall Study|Did not meet protocol eligibility|1|||
163144184|NCT01135134|589237237|FG001|Overall Study|Did not meet protocol eligibility|0|||
163144185|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
163144186|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
163144187|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144188|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144189|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
163144190|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
163144191|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
163144192|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
163144193|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
163144194|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
163144195|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
163144196|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
163144197|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
163144198|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
163144199|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
163144200|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144201|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
163144202|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144203|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144204|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
163144205|NCT01329978|589237262|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144206|NCT01329978|589237263|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
163144207|NCT01329978|589237264|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144208|NCT01329978|589237265|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144209|NCT01329978|589237266|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
163144210|NCT01329978|589237262|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144211|NCT01329978|589237263|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144212|NCT01329978|589237264|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
163144213|NCT01329978|589237265|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
163144214|NCT01329978|589237266|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
163144215|NCT01329978|589237262|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
162663080|NCT02520531|587478332|FG000|Overall Study|Withdrawal by Subject|1|||
162663081|NCT02520531|587478333|FG001|Overall Study|Withdrawal by Subject|0|||
162663082|NCT02520531|587478332|FG000|Overall Study|Not study device|1|||
162663083|NCT02520531|587478333|FG001|Overall Study|Not study device|0|||
162663084|NCT02138214|587478337|FG000|Overall Study|Withdrawal by Subject|0|||
162663085|NCT02138214|587478338|FG001|Overall Study|Withdrawal by Subject|1|||
162663086|NCT02138214|587478339|FG002|Overall Study|Withdrawal by Subject|0|||
162663087|NCT02138214|587478337|FG000|Overall Study|Lost to Follow-up|0|||
162663088|NCT02138214|587478338|FG001|Overall Study|Lost to Follow-up|2|||
162663089|NCT02138214|587478339|FG002|Overall Study|Lost to Follow-up|4|||
162663090|NCT02138214|587478337|FG000|Overall Study|Screen Failure|0|||
162663091|NCT02138214|587478338|FG001|Overall Study|Screen Failure|1|||
162663092|NCT02138214|587478339|FG002|Overall Study|Screen Failure|0|||
162663093|NCT02185768|587478340|FG000|Overall Study|Patients were not treated|2|||
162663094|NCT03221257|587478341|FG000|Overall Study|Lost to Follow-up|0|||
162663095|NCT03221257|587478342|FG001|Overall Study|Lost to Follow-up|1|||
162663096|NCT03221257|587478341|FG000|Overall Study|Withdrawal by Subject|1|||
162663097|NCT03221257|587478342|FG001|Overall Study|Withdrawal by Subject|1|||
162663098|NCT01334866|587478343|FG000|Overall Study|Withdrawal by Subject|10|||
162663099|NCT01334866|587478343|FG000|Overall Study|Lost to Follow-up|3|||
162663100|NCT01334866|587478343|FG000|Overall Study|Physician Decision|3|||
162663101|NCT01334866|587478343|FG000|Overall Study|medically necessary prior to procedure|2|||
162663102|NCT01334866|587478343|FG000|Overall Study|medically necessary post-procedure|1|||
162663103|NCT01971346|587478347|FG000|Overall Study|Protocol Violation|3|||
162663104|NCT01971346|587478347|FG000|Overall Study|Lost to Follow-up|2|||
162663105|NCT01971346|587478347|FG000|Overall Study|Withdrawal by Subject|2|||
162663106|NCT01971346|587478347|FG000|Overall Study|Physician Decision|1|||
162663107|NCT04187196|587478350|FG000|Overall Study|Screen Failure|2|||
162663108|NCT04187196|587478351|FG001|Overall Study|Screen Failure|0|||
162663109|NCT01687166|587478352|FG000|Overall Study|Attempt subject|2|||
162663110|NCT01687166|587478353|FG001|Overall Study|Attempt subject|3|||
162663111|NCT01687166|587478354|FG002|Overall Study|Attempt subject|2|||
162663112|NCT01687166|587478355|FG003|Overall Study|Attempt subject|0|||
162663113|NCT01687166|587478352|FG000|Overall Study|Did not meet eligibility criteria|4|||
162663114|NCT01687166|587478353|FG001|Overall Study|Did not meet eligibility criteria|6|||
162663115|NCT01687166|587478354|FG002|Overall Study|Did not meet eligibility criteria|1|||
162663116|NCT01687166|587478355|FG003|Overall Study|Did not meet eligibility criteria|1|||
162663117|NCT01687166|587478352|FG000|Overall Study|Adverse Event|2|||
162663118|NCT01687166|587478353|FG001|Overall Study|Adverse Event|1|||
162663119|NCT01687166|587478354|FG002|Overall Study|Adverse Event|0|||
162663120|NCT01687166|587478355|FG003|Overall Study|Adverse Event|0|||
162663121|NCT01687166|587478352|FG000|Overall Study|Physician Decision|3|||
162663122|NCT01687166|587478353|FG001|Overall Study|Physician Decision|2|||
162663123|NCT01687166|587478354|FG002|Overall Study|Physician Decision|1|||
162663124|NCT01687166|587478355|FG003|Overall Study|Physician Decision|0|||
162663125|NCT01687166|587478352|FG000|Overall Study|Withdrawal by Subject|11|||
162663126|NCT01687166|587478353|FG001|Overall Study|Withdrawal by Subject|4|||
162663127|NCT01687166|587478354|FG002|Overall Study|Withdrawal by Subject|3|||
162663128|NCT01687166|587478355|FG003|Overall Study|Withdrawal by Subject|0|||
162663129|NCT01687166|587478352|FG000|Overall Study|Lost to Follow-up|2|||
162663130|NCT01687166|587478353|FG001|Overall Study|Lost to Follow-up|5|||
162663131|NCT01687166|587478354|FG002|Overall Study|Lost to Follow-up|1|||
162663132|NCT01687166|587478355|FG003|Overall Study|Lost to Follow-up|0|||
162663133|NCT01687166|587478352|FG000|Overall Study|Equipment/Device Availability|0|||
162663134|NCT01687166|587478353|FG001|Overall Study|Equipment/Device Availability|1|||
162663135|NCT01687166|587478354|FG002|Overall Study|Equipment/Device Availability|0|||
162663136|NCT01687166|587478355|FG003|Overall Study|Equipment/Device Availability|0|||
162663137|NCT01687166|587478352|FG000|Overall Study|Death|1|||
162663138|NCT01687166|587478353|FG001|Overall Study|Death|1|||
162663139|NCT01687166|587478354|FG002|Overall Study|Death|0|||
162663140|NCT01687166|587478355|FG003|Overall Study|Death|0|||
162663141|NCT01687166|587478352|FG000|Overall Study|Protocol Violation|1|||
162663142|NCT01687166|587478353|FG001|Overall Study|Protocol Violation|1|||
162663143|NCT01687166|587478354|FG002|Overall Study|Protocol Violation|1|||
162663144|NCT01687166|587478355|FG003|Overall Study|Protocol Violation|0|||
162663145|NCT01687166|587478352|FG000|Overall Study|Subject moved out of state|0|||
163144216|NCT01329978|589237263|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144217|NCT01329978|589237264|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144218|NCT01329978|589237265|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
163144219|NCT01329978|589237266|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
163144220|NCT01188772|589237268|FG000|Overall Study|Randomized but Not Treated|0|||
163144221|NCT01188772|589237269|FG001|Overall Study|Randomized but Not Treated|1|||
163144222|NCT01188772|589237270|FG002|Overall Study|Randomized but Not Treated|0|||
163144223|NCT01188772|589237271|FG003|Overall Study|Randomized but Not Treated|0|||
163144224|NCT01188772|589237268|FG000|Overall Study|Adverse Event|0|||
163144225|NCT01188772|589237269|FG001|Overall Study|Adverse Event|1|||
163144226|NCT01188772|589237270|FG002|Overall Study|Adverse Event|2|||
163144227|NCT01188772|589237271|FG003|Overall Study|Adverse Event|0|||
163144228|NCT01188772|589237268|FG000|Overall Study|Lost to Follow-up|4|||
163144229|NCT01188772|589237269|FG001|Overall Study|Lost to Follow-up|1|||
163144230|NCT01188772|589237270|FG002|Overall Study|Lost to Follow-up|1|||
163144231|NCT01188772|589237271|FG003|Overall Study|Lost to Follow-up|1|||
163144232|NCT01188772|589237268|FG000|Overall Study|Non-responder|0|||
163144233|NCT01188772|589237269|FG001|Overall Study|Non-responder|0|||
163144234|NCT01188772|589237270|FG002|Overall Study|Non-responder|3|||
163144235|NCT01188772|589237271|FG003|Overall Study|Non-responder|0|||
163144236|NCT01188772|589237268|FG000|Overall Study|Physician Decision|0|||
163144237|NCT01188772|589237269|FG001|Overall Study|Physician Decision|0|||
163144238|NCT01188772|589237270|FG002|Overall Study|Physician Decision|1|||
163144239|NCT01188772|589237271|FG003|Overall Study|Physician Decision|0|||
163144240|NCT01188772|589237268|FG000|Overall Study|Terminated by Sponsor|0|||
163144241|NCT01188772|589237269|FG001|Overall Study|Terminated by Sponsor|0|||
163144242|NCT01188772|589237270|FG002|Overall Study|Terminated by Sponsor|1|||
163144243|NCT01188772|589237271|FG003|Overall Study|Terminated by Sponsor|0|||
163144244|NCT01188772|589237268|FG000|Overall Study|Treatment Failure|0|||
163144245|NCT01188772|589237269|FG001|Overall Study|Treatment Failure|0|||
163144246|NCT01188772|589237270|FG002|Overall Study|Treatment Failure|1|||
163144247|NCT01188772|589237271|FG003|Overall Study|Treatment Failure|0|||
163144248|NCT01188772|589237268|FG000|Overall Study|Virologic Failure|1|||
163144249|NCT01188772|589237269|FG001|Overall Study|Virologic Failure|0|||
163144250|NCT01188772|589237270|FG002|Overall Study|Virologic Failure|0|||
163144251|NCT01188772|589237271|FG003|Overall Study|Virologic Failure|0|||
163144252|NCT01188772|589237268|FG000|Overall Study|Withdrawal by Subject|0|||
163144253|NCT01188772|589237269|FG001|Overall Study|Withdrawal by Subject|0|||
163144254|NCT01188772|589237270|FG002|Overall Study|Withdrawal by Subject|2|||
163144255|NCT01188772|589237271|FG003|Overall Study|Withdrawal by Subject|0|||
163144256|NCT03081884|589237275|FG000|Overall Study|deferred prostate cancer treatment|1|||
163144257|NCT03081884|589237275|FG000|Overall Study|metastasis managed with systemic therapy|3|||
163144258|NCT02294058|589237276|FG000|Overall Study|Adverse Event|16|||
163144259|NCT02294058|589237277|FG001|Overall Study|Adverse Event|7|||
163144260|NCT02294058|589237278|FG002|Overall Study|Adverse Event|13|||
163144261|NCT02294058|589237276|FG000|Overall Study|Lack of Efficacy|3|||
163144262|NCT02294058|589237277|FG001|Overall Study|Lack of Efficacy|3|||
163144263|NCT02294058|589237278|FG002|Overall Study|Lack of Efficacy|0|||
163144264|NCT02294058|589237276|FG000|Overall Study|Lost to Follow-up|1|||
163144265|NCT02294058|589237277|FG001|Overall Study|Lost to Follow-up|0|||
163144266|NCT02294058|589237278|FG002|Overall Study|Lost to Follow-up|2|||
163144267|NCT02294058|589237276|FG000|Overall Study|Withdrawal by Subject|10|||
163144268|NCT02294058|589237277|FG001|Overall Study|Withdrawal by Subject|14|||
163144269|NCT02294058|589237278|FG002|Overall Study|Withdrawal by Subject|13|||
163144270|NCT02294058|589237276|FG000|Overall Study|Physician Decision|2|||
163144271|NCT02294058|589237277|FG001|Overall Study|Physician Decision|1|||
163144272|NCT02294058|589237278|FG002|Overall Study|Physician Decision|0|||
163144273|NCT02294058|589237276|FG000|Overall Study|Miscellaneous|4|||
163144274|NCT02294058|589237277|FG001|Overall Study|Miscellaneous|1|||
163144275|NCT02294058|589237278|FG002|Overall Study|Miscellaneous|1|||
163144276|NCT00152503|589237289|FG000|Overall Study|Adverse Event|4|||
163144277|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
163144278|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
163144279|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
163144280|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
163144281|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
163144282|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
163144283|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
163144284|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
162663146|NCT01687166|587478353|FG001|Overall Study|Subject moved out of state|1|||
162663147|NCT01687166|587478354|FG002|Overall Study|Subject moved out of state|0|||
162663148|NCT01687166|587478355|FG003|Overall Study|Subject moved out of state|0|||
162663149|NCT01687166|587478352|FG000|Overall Study|Patient unable to be compliant|1|||
162663150|NCT01687166|587478353|FG001|Overall Study|Patient unable to be compliant|0|||
162663151|NCT01687166|587478354|FG002|Overall Study|Patient unable to be compliant|0|||
162663152|NCT01687166|587478355|FG003|Overall Study|Patient unable to be compliant|0|||
162663153|NCT01687166|587478352|FG000|Overall Study|Physician choice to use different device|1|||
162721097|NCT02551055|587686041|FG005|Overall Study|Withdrawal by Subject|0|||
162721098|NCT02551055|587686042|FG006|Overall Study|Withdrawal by Subject|0|||
162721099|NCT02551055|587686043|FG007|Overall Study|Withdrawal by Subject|0|||
162721100|NCT02551055|587686036|FG000|Overall Study|Reason not specified|0|||
162721101|NCT02551055|587686037|FG001|Overall Study|Reason not specified|0|||
162721102|NCT02551055|587686038|FG002|Overall Study|Reason not specified|0|||
162721103|NCT02551055|587686039|FG003|Overall Study|Reason not specified|0|||
162721104|NCT02551055|587686040|FG004|Overall Study|Reason not specified|1|||
162721105|NCT02551055|587686041|FG005|Overall Study|Reason not specified|0|||
162721106|NCT02551055|587686042|FG006|Overall Study|Reason not specified|1|||
162663154|NCT01687166|587478353|FG001|Overall Study|Physician choice to use different device|2|||
162663155|NCT01687166|587478354|FG002|Overall Study|Physician choice to use different device|4|||
162663156|NCT01687166|587478355|FG003|Overall Study|Physician choice to use different device|0|||
162663157|NCT01687166|587478352|FG000|Overall Study|Insurance|0|||
162663158|NCT01687166|587478353|FG001|Overall Study|Insurance|0|||
162663159|NCT01687166|587478354|FG002|Overall Study|Insurance|1|||
162663160|NCT01687166|587478355|FG003|Overall Study|Insurance|1|||
162663161|NCT02755831|587478356|FG000|Overall Study|Lost to Follow-up|3|||
162663162|NCT02755831|587478357|FG001|Overall Study|Lost to Follow-up|3|||
162663163|NCT02316717|587478358|FG000|Overall Study|Adverse Event|2|||
162663164|NCT02316717|587478359|FG001|Overall Study|Adverse Event|2|||
162663165|NCT02316717|587478360|FG002|Overall Study|Adverse Event|0|||
162663166|NCT02316717|587478358|FG000|Overall Study|Lost to Follow-up|1|||
162663167|NCT02316717|587478359|FG001|Overall Study|Lost to Follow-up|2|||
162663168|NCT02316717|587478360|FG002|Overall Study|Lost to Follow-up|1|||
162663169|NCT02316717|587478358|FG000|Overall Study|Non compliance|3|||
162663170|NCT02316717|587478359|FG001|Overall Study|Non compliance|1|||
162663171|NCT02316717|587478360|FG002|Overall Study|Non compliance|0|||
162663172|NCT02316717|587478358|FG000|Overall Study|Protocol Violation|2|||
162663173|NCT02316717|587478359|FG001|Overall Study|Protocol Violation|0|||
162663174|NCT02316717|587478360|FG002|Overall Study|Protocol Violation|0|||
162663175|NCT02316717|587478358|FG000|Overall Study|Withdrawal by Subject|2|||
162663176|NCT02316717|587478359|FG001|Overall Study|Withdrawal by Subject|1|||
162663177|NCT02316717|587478360|FG002|Overall Study|Withdrawal by Subject|1|||
162663178|NCT02316717|587478358|FG000|Overall Study|Death|0|||
162663179|NCT02316717|587478359|FG001|Overall Study|Death|0|||
162663180|NCT02316717|587478360|FG002|Overall Study|Death|1|||
162663181|NCT02316717|587478358|FG000|Overall Study|Physician Decision|0|||
162663182|NCT02316717|587478359|FG001|Overall Study|Physician Decision|1|||
162663183|NCT02316717|587478360|FG002|Overall Study|Physician Decision|0|||
162663184|NCT02316717|587478358|FG000|Overall Study|TBC|1|||
162663185|NCT02316717|587478359|FG001|Overall Study|TBC|0|||
162663186|NCT02316717|587478360|FG002|Overall Study|TBC|0|||
162663187|NCT02460198|587478363|FG000|Overall Study|Adverse Event|1|||
162663188|NCT02460198|587478364|FG001|Overall Study|Adverse Event|3|||
162663189|NCT02460198|587478363|FG000|Overall Study|Death|36|||
162663190|NCT02460198|587478364|FG001|Overall Study|Death|28|||
162663191|NCT02460198|587478363|FG000|Overall Study|Lost to Follow-up|1|||
162663192|NCT02460198|587478364|FG001|Overall Study|Lost to Follow-up|1|||
162663193|NCT02460198|587478363|FG000|Overall Study|Transferred to Extension Study|15|||
162721107|NCT02551055|587686043|FG007|Overall Study|Reason not specified|0|||
162663194|NCT02460198|587478364|FG001|Overall Study|Transferred to Extension Study|15|||
162663195|NCT02460198|587478363|FG000|Overall Study|Withdrawal by Subject|2|||
162663196|NCT02460198|587478364|FG001|Overall Study|Withdrawal by Subject|4|||
162721108|NCT00430300|587686044|FG000|Overall Study|Adverse Event|0|||
162663197|NCT02460198|587478363|FG000|Overall Study|Site Terminated By Sponsor|0|||
162663198|NCT02460198|587478364|FG001|Overall Study|Site Terminated By Sponsor|1|||
162663199|NCT02460198|587478363|FG000|Overall Study|Did Not Continue on Extension Study|6|||
162663200|NCT02460198|587478364|FG001|Overall Study|Did Not Continue on Extension Study|11|||
162663201|NCT00931307|587478365|FG000|Overall Study|Lack of Efficacy|12|||
162721109|NCT00430300|587686045|FG001|Overall Study|Adverse Event|2|||
162663202|NCT00931307|587478365|FG000|Overall Study|Biomicroscopy|1|||
162663203|NCT00965848|587478368|FG000|Overall Study|Protocol Violation|3|||
162663204|NCT00965848|587478369|FG001|Overall Study|Protocol Violation|0|||
162663205|NCT00965848|587478370|FG002|Overall Study|Protocol Violation|1|||
162663206|NCT00965848|587478368|FG000|Overall Study|Death|11|||
162663207|NCT00965848|587478369|FG001|Overall Study|Death|1|||
162663208|NCT00965848|587478370|FG002|Overall Study|Death|5|||
162663209|NCT00965848|587478368|FG000|Overall Study|Lost to Follow-up|0|||
162663210|NCT00965848|587478369|FG001|Overall Study|Lost to Follow-up|0|||
162663211|NCT00965848|587478370|FG002|Overall Study|Lost to Follow-up|1|||
162663212|NCT00965848|587478368|FG000|Overall Study|Withdrawal by Subject|1|||
162663213|NCT00965848|587478369|FG001|Overall Study|Withdrawal by Subject|0|||
162663214|NCT00965848|587478370|FG002|Overall Study|Withdrawal by Subject|0|||
162663215|NCT00965848|587478368|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
162663216|NCT00965848|587478369|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
162663217|NCT00965848|587478370|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
162663218|NCT00965848|587478368|FG000|Overall Study|Not Clinically Evaluable|7|||
163144285|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
163144286|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
163144287|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
163144288|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
163144289|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
163144290|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
163144291|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
163144292|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
163144293|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
163144294|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
163144295|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
163144296|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
163144297|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
163144298|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
163144299|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
163144300|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
163144301|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
163144302|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
163144303|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
163144304|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
163144305|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
163144306|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
163144307|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
163144308|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
163144309|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
163144310|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
163144311|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
163144312|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
163144313|NCT02586623|589237290|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
163144314|NCT02586623|589237291|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
163144315|NCT02586623|589237292|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
163144316|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
163144317|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
163144318|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
163144319|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
163144320|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
163144321|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
163144322|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
163144323|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
163144324|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
163144325|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
163144326|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
163144327|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
163144328|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
163144329|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
163144330|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
163144331|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
163144332|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
163144333|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
163144334|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
163144335|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
163144336|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
162663219|NCT00965848|587478369|FG001|Overall Study|Not Clinically Evaluable|1|||
162663220|NCT00965848|587478370|FG002|Overall Study|Not Clinically Evaluable|1|||
162663221|NCT00965848|587478368|FG000|Overall Study|Other|5|||
162663222|NCT00965848|587478369|FG001|Overall Study|Other|0|||
162663223|NCT00965848|587478370|FG002|Overall Study|Other|1|||
162663224|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
162663225|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162663226|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162663227|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162663228|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
162663229|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
162663230|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
163144337|NCT02586623|589237290|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
163144338|NCT02586623|589237291|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
163144339|NCT02586623|589237292|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
163144340|NCT04393493|589237295|FG000|First 4 Days of Intervention|Early improvement|5|||
163144341|NCT04393493|589237296|FG001|First 4 Days of Intervention|Early improvement|7|||
163144342|NCT02910466|589237297|FG000|Overall Study|Adverse Event|1|||
163144343|NCT02910466|589237297|FG000|Overall Study|Withdrawal by Subject|3|||
163144344|NCT02910466|589237297|FG000|Overall Study|Lost to Follow-up|5|||
163144345|NCT02910466|589237297|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
163144346|NCT02910466|589237297|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
163144347|NCT00717249|589237301|FG000|Overall Study|Lens Discomfort|4|||
163144348|NCT00717249|589237302|FG001|Overall Study|Lens Discomfort|1|||
163144349|NCT00717249|589237301|FG000|Overall Study|Unsatisfactory visual Response|0|||
163144350|NCT00717249|589237302|FG001|Overall Study|Unsatisfactory visual Response|2|||
163144351|NCT00717249|589237301|FG000|Overall Study|Adverse Event|4|||
163144352|NCT00717249|589237302|FG001|Overall Study|Adverse Event|2|||
163144353|NCT00717249|589237301|FG000|Overall Study|Lost to Follow-up|2|||
163144354|NCT00717249|589237302|FG001|Overall Study|Lost to Follow-up|0|||
163144355|NCT00717249|589237301|FG000|Overall Study|Withdrawal by Subject|1|||
163144356|NCT00717249|589237302|FG001|Overall Study|Withdrawal by Subject|2|||
163144357|NCT00717249|589237301|FG000|Overall Study|Pregnancy|6|||
163144358|NCT00717249|589237302|FG001|Overall Study|Pregnancy|3|||
163144359|NCT00717249|589237301|FG000|Overall Study|Protocol Violation|0|||
163144360|NCT00717249|589237302|FG001|Overall Study|Protocol Violation|2|||
163144361|NCT00717249|589237301|FG000|Overall Study|Subject became Ineligible|1|||
163144362|NCT00717249|589237302|FG001|Overall Study|Subject became Ineligible|1|||
163144363|NCT00717249|589237301|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
163144364|NCT00717249|589237302|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
163144365|NCT00717249|589237301|FG000|Overall Study|Gastric Surgery|0|||
163144366|NCT00717249|589237302|FG001|Overall Study|Gastric Surgery|1|||
163144367|NCT00717249|589237301|FG000|Overall Study|Diagnosed with Diabetes|1|||
163144368|NCT00717249|589237302|FG001|Overall Study|Diagnosed with Diabetes|0|||
163144369|NCT00717249|589237301|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
163144370|NCT00717249|589237302|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
163144371|NCT00717249|589237301|FG000|Overall Study|Subject relocated|1|||
163144372|NCT00717249|589237302|FG001|Overall Study|Subject relocated|0|||
163144373|NCT00717249|589237301|FG000|Overall Study|Headaches|1|||
163144374|NCT00717249|589237302|FG001|Overall Study|Headaches|0|||
163144375|NCT03370718|589237306|FG000|Overall Study|Withdrawal by Subject|1|||
163144376|NCT06172348|589237307|FG000|Treatment Period 2|Adverse Event|0|||
163144377|NCT06172348|589237308|FG001|Treatment Period 2|Adverse Event|0|||
163144378|NCT06172348|589237309|FG002|Treatment Period 2|Adverse Event|1|||
163144379|NCT06172348|589237310|FG003|Treatment Period 2|Adverse Event|0|||
163144380|NCT06172348|589237311|FG004|Treatment Period 2|Adverse Event|0|||
163144381|NCT06172348|589237312|FG005|Treatment Period 2|Adverse Event|0|||
163144382|NCT04539938|589237313|FG000|Overall Study|Death|30|||
163144383|NCT04539938|589237313|FG000|Overall Study|Withdrawal by Subject|4|||
163144384|NCT04037891|589237314|FG000|Open-label Period|Withdrawal by Subject|1|||
163144385|NCT04037891|589237315|FG001|Open-label Period|Withdrawal by Subject|0|||
163144386|NCT04037891|589237316|FG002|Open-label Period|Withdrawal by Subject|0|||
163144387|NCT04037891|589237314|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
163144388|NCT04037891|589237315|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
163144389|NCT04037891|589237316|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
163144390|NCT00990106|589237317|FG000|Overall Study|"too busy to continue"|1|||
163144391|NCT00990106|589237318|FG001|Overall Study|"too busy to continue"|2|||
163144392|NCT00990106|589237317|FG000|Overall Study|Lost to Follow-up|1|||
163144393|NCT00990106|589237318|FG001|Overall Study|Lost to Follow-up|3|||
163144394|NCT00990106|589237317|FG000|Overall Study|Withdrawal by Subject|2|||
163144395|NCT00990106|589237318|FG001|Overall Study|Withdrawal by Subject|1|||
163144396|NCT00990106|589237317|FG000|Overall Study|opted for open label prazosin|1|||
162663231|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
163144397|NCT00990106|589237318|FG001|Overall Study|opted for open label prazosin|1|||
163144398|NCT00990106|589237317|FG000|Overall Study|relocation/deployment|4|||
163144399|NCT00990106|589237318|FG001|Overall Study|relocation/deployment|1|||
162663232|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162663233|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162663234|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162663235|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
162663236|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162663237|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162663238|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
162663239|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162663240|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162663241|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162663242|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
162663243|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162663244|NCT00813761|587478371|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162663245|NCT00813761|587478372|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
162663246|NCT00813761|587478373|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162663247|NCT00813761|587478374|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162663248|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
162663249|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
162663250|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
162663251|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
162663252|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
162663253|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
162663254|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
162663255|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
162663256|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
162663257|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
162663258|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
162663259|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
162663260|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162663261|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162663262|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162663263|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
162663264|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
162663265|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
162663266|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
162663267|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
162663268|NCT00813761|587478371|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
162663269|NCT00813761|587478372|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
162663270|NCT00813761|587478373|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
162721110|NCT00430300|587686046|FG002|Overall Study|Adverse Event|1|||
162663271|NCT00813761|587478374|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
162663272|NCT00691210|587478375|FG000|Overall Study|Progression of Disease|0|||
162663273|NCT00691210|587478376|FG001|Overall Study|Progression of Disease|0|||
163144400|NCT00990106|589237317|FG000|Overall Study|started exclusionary medication|0|||
163144401|NCT00990106|589237318|FG001|Overall Study|started exclusionary medication|1|||
163144402|NCT00990106|589237317|FG000|Overall Study|planned major surgery|0|||
163144403|NCT00990106|589237318|FG001|Overall Study|planned major surgery|1|||
163144404|NCT00990106|589237317|FG000|Overall Study|scheduling conflicts|0|||
163144405|NCT00990106|589237318|FG001|Overall Study|scheduling conflicts|2|||
163144406|NCT04194944|589237319|FG000|Overall Study|Lost to Follow-up|3|||
163144407|NCT04194944|589237320|FG001|Overall Study|Lost to Follow-up|0|||
163144408|NCT04194944|589237319|FG000|Overall Study|Withdrawal by Subject|2|||
163144409|NCT04194944|589237320|FG001|Overall Study|Withdrawal by Subject|2|||
163144410|NCT04194944|589237319|FG000|Overall Study|On Treatment|93|||
163144411|NCT04194944|589237320|FG001|Overall Study|On Treatment|30|||
163144412|NCT00348673|589237323|FG000|Stage 1|Randomized but not Treated|0|||
163144413|NCT00348673|589237324|FG001|Stage 1|Randomized but not Treated|0|||
163144414|NCT00348673|589237325|FG002|Stage 1|Randomized but not Treated|1|||
163144415|NCT00348673|589237326|FG003|Stage 1|Randomized but not Treated|0|||
163144416|NCT00348673|589237327|FG004|Stage 1|Randomized but not Treated|0|||
163144417|NCT00348673|589237328|FG005|Stage 1|Randomized but not Treated|0|||
163144418|NCT00348673|589237329|FG006|Stage 1|Randomized but not Treated|0|||
163144419|NCT00348673|589237330|FG007|Stage 1|Randomized but not Treated|0|||
163144420|NCT00348673|589237331|FG008|Stage 1|Randomized but not Treated|0|||
163144421|NCT03798717|589239387|FG000|Overall Study|Failed Screening|0|||
163144422|NCT03798717|589239388|FG001|Overall Study|Failed Screening|0|||
163144423|NCT03798717|589239389|FG002|Overall Study|Failed Screening|0|||
163144424|NCT03798717|589239390|FG003|Overall Study|Failed Screening|0|||
163144425|NCT03798717|589239391|FG004|Overall Study|Failed Screening|0|||
163144426|NCT03798717|589239392|FG005|Overall Study|Failed Screening|1|||
163144427|NCT03798717|589239387|FG000|Overall Study|Physician Decision|1|||
163144428|NCT03798717|589239388|FG001|Overall Study|Physician Decision|0|||
163144429|NCT03798717|589239389|FG002|Overall Study|Physician Decision|1|||
163144430|NCT03798717|589239390|FG003|Overall Study|Physician Decision|0|||
163144431|NCT03798717|589239391|FG004|Overall Study|Physician Decision|0|||
163144432|NCT03798717|589239392|FG005|Overall Study|Physician Decision|0|||
163144433|NCT03798717|589239387|FG000|Overall Study|Withdrawal by Subject|0|||
163144434|NCT03798717|589239388|FG001|Overall Study|Withdrawal by Subject|0|||
163144435|NCT03798717|589239389|FG002|Overall Study|Withdrawal by Subject|0|||
163144436|NCT03798717|589239390|FG003|Overall Study|Withdrawal by Subject|1|||
163144437|NCT03798717|589239391|FG004|Overall Study|Withdrawal by Subject|0|||
163144438|NCT03798717|589239392|FG005|Overall Study|Withdrawal by Subject|0|||
163144439|NCT03798717|589239387|FG000|Overall Study|Lost to Follow-up|1|||
163144440|NCT03798717|589239388|FG001|Overall Study|Lost to Follow-up|0|||
163144441|NCT03798717|589239389|FG002|Overall Study|Lost to Follow-up|0|||
163144442|NCT03798717|589239390|FG003|Overall Study|Lost to Follow-up|1|||
163144443|NCT03798717|589239391|FG004|Overall Study|Lost to Follow-up|0|||
163144444|NCT03798717|589239392|FG005|Overall Study|Lost to Follow-up|0|||
163144445|NCT03798717|589239387|FG000|Overall Study|Adverse Event|0|||
163144446|NCT03798717|589239388|FG001|Overall Study|Adverse Event|1|||
163144447|NCT03798717|589239389|FG002|Overall Study|Adverse Event|0|||
163144448|NCT03798717|589239390|FG003|Overall Study|Adverse Event|0|||
163144449|NCT03798717|589239391|FG004|Overall Study|Adverse Event|0|||
163144450|NCT03798717|589239392|FG005|Overall Study|Adverse Event|0|||
163144451|NCT03798717|589239387|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144452|NCT03798717|589239388|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144453|NCT03798717|589239389|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144454|NCT03798717|589239390|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144455|NCT03798717|589239391|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
163144456|NCT03798717|589239392|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
163144457|NCT00445549|589239393|FG000|Overall Study|progressive disease|12|||
163144458|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
163144459|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
163144460|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
163144461|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
163144462|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
163144463|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
163144464|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
162663274|NCT00691210|587478377|FG002|Overall Study|Progression of Disease|0|||
162663275|NCT00691210|587478378|FG003|Overall Study|Progression of Disease|2|||
163144465|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
163144466|NCT03096834|589239406|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
163144467|NCT03096834|589239407|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
163144468|NCT03096834|589239408|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
163144469|NCT03096834|589239409|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
162721111|NCT00430300|587686047|FG003|Overall Study|Adverse Event|1|||
162721112|NCT00430300|587686044|FG000|Overall Study|Withdrawal by Subject|1|||
162663276|NCT00691210|587478379|FG004|Overall Study|Progression of Disease|0|||
162663277|NCT00691210|587478380|FG005|Overall Study|Progression of Disease|0|||
162663278|NCT00691210|587478381|FG006|Overall Study|Progression of Disease|0|||
162663279|NCT00691210|587478382|FG007|Overall Study|Progression of Disease|0|||
162663280|NCT00691210|587478375|FG000|Overall Study|Lack of Efficacy|0|||
162663281|NCT00691210|587478376|FG001|Overall Study|Lack of Efficacy|0|||
162663282|NCT00691210|587478377|FG002|Overall Study|Lack of Efficacy|0|||
162663283|NCT00691210|587478378|FG003|Overall Study|Lack of Efficacy|1|||
162663284|NCT00691210|587478379|FG004|Overall Study|Lack of Efficacy|0|||
162663285|NCT00691210|587478380|FG005|Overall Study|Lack of Efficacy|1|||
162663286|NCT00691210|587478381|FG006|Overall Study|Lack of Efficacy|0|||
162663287|NCT00691210|587478382|FG007|Overall Study|Lack of Efficacy|0|||
162663288|NCT02047604|587478385|FG000|Overall Study|Withdrawal by Subject|0|||
162663289|NCT02047604|587478386|FG001|Overall Study|Withdrawal by Subject|0|||
162663290|NCT02047604|587478387|FG002|Overall Study|Withdrawal by Subject|0|||
162663291|NCT02047604|587478388|FG003|Overall Study|Withdrawal by Subject|0|||
162663292|NCT02047604|587478389|FG004|Overall Study|Withdrawal by Subject|1|||
162663293|NCT02047604|587478390|FG005|Overall Study|Withdrawal by Subject|1|||
162663294|NCT00983814|587478391|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
162663295|NCT00983814|587478392|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
162663296|NCT00983814|587478393|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
162663297|NCT00983814|587478391|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
162663298|NCT00983814|587478392|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
162663299|NCT00983814|587478393|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
162663300|NCT00983814|587478391|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
162663301|NCT00983814|587478392|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
162663302|NCT00983814|587478393|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
162663303|NCT00983814|587478391|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
162663304|NCT00983814|587478392|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
162663305|NCT00983814|587478393|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
162663306|NCT00983814|587478391|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
162663307|NCT00983814|587478392|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
162663308|NCT00983814|587478393|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
162663309|NCT01181895|587478394|FG000|Overall Study|Adverse Event|3|||
162663310|NCT01181895|587478395|FG001|Overall Study|Adverse Event|1|||
162663311|NCT01181895|587478396|FG002|Overall Study|Adverse Event|1|||
162663312|NCT01181895|587478394|FG000|Overall Study|Lack of Efficacy|8|||
162663313|NCT01181895|587478395|FG001|Overall Study|Lack of Efficacy|9|||
162663314|NCT01181895|587478396|FG002|Overall Study|Lack of Efficacy|9|||
163144470|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
163144471|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
163144472|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
163144473|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
163144474|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
163144475|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
162663315|NCT01181895|587478394|FG000|Overall Study|Protocol Violation|2|||
162663316|NCT01181895|587478395|FG001|Overall Study|Protocol Violation|1|||
163144476|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
163144477|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
163144478|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
163144479|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
163144480|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
163144481|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
163144482|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
163144483|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
163144484|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
163144485|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
163144486|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
163144487|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
163144488|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
163144489|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
163144490|NCT03096834|589239406|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
163144491|NCT03096834|589239407|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
163144492|NCT03096834|589239408|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
163144493|NCT03096834|589239409|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
163144494|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144495|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144496|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
163144497|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
163144498|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
163144499|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
163144500|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
163144501|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
163144502|NCT03096834|589239406|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144503|NCT03096834|589239407|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144504|NCT03096834|589239408|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
163144505|NCT03096834|589239409|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
163144506|NCT01600326|589239412|FG000|Overall Study|Lost to Follow-up|1|||
163144507|NCT01600326|589239413|FG001|Overall Study|Lost to Follow-up|1|||
163144508|NCT04617782|589239414|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
163144509|NCT04617782|589239414|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
163144510|NCT04617782|589239414|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
163144511|NCT04617782|589239414|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
163144512|NCT04617782|589239414|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
163144513|NCT04617782|589239414|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
163144514|NCT01169103|589239430|FG000|Overall Study|Lost to Follow-up|3|||
163144515|NCT01169103|589239431|FG001|Overall Study|Lost to Follow-up|3|||
163144516|NCT01169103|589239430|FG000|Overall Study|Withdrawal by Subject|3|||
163144517|NCT01169103|589239431|FG001|Overall Study|Withdrawal by Subject|1|||
163144518|NCT02634333|589239436|FG000|Overall Study|Completed out of Window|3|||
163144519|NCT02634333|589239437|FG001|Overall Study|Completed out of Window|2|||
163144520|NCT02634333|589239436|FG000|Overall Study|Missed Visit|5|||
163144521|NCT02634333|589239437|FG001|Overall Study|Missed Visit|2|||
163144522|NCT02634333|589239436|FG000|Overall Study|Lost to Follow-up|12|||
163144523|NCT02634333|589239437|FG001|Overall Study|Lost to Follow-up|7|||
163144524|NCT02634333|589239436|FG000|Overall Study|Withdrawal by Subject|9|||
163144525|NCT02634333|589239437|FG001|Overall Study|Withdrawal by Subject|13|||
163144526|NCT02634333|589239436|FG000|Overall Study|Death|11|||
163144527|NCT02634333|589239437|FG001|Overall Study|Death|8|||
163144528|NCT00657046|589239438|FG000|Overall Study|Adverse Event|1|||
163144529|NCT00657046|589239439|FG001|Overall Study|Adverse Event|1|||
163144530|NCT00657046|589239440|FG002|Overall Study|Adverse Event|0|||
163144531|NCT00657046|589239438|FG000|Overall Study|Protocol Violation|2|||
163144532|NCT00657046|589239439|FG001|Overall Study|Protocol Violation|2|||
162663317|NCT01181895|587478396|FG002|Overall Study|Protocol Violation|0|||
162663318|NCT01181895|587478394|FG000|Overall Study|Lost to Follow-up|0|||
162663319|NCT01181895|587478395|FG001|Overall Study|Lost to Follow-up|1|||
162663320|NCT01181895|587478396|FG002|Overall Study|Lost to Follow-up|2|||
162663321|NCT01181895|587478394|FG000|Overall Study|Investigator Discretion|1|||
162663322|NCT01181895|587478395|FG001|Overall Study|Investigator Discretion|2|||
162663323|NCT01181895|587478396|FG002|Overall Study|Investigator Discretion|1|||
162663324|NCT01181895|587478394|FG000|Overall Study|Withdrawal by Subject|3|||
162663325|NCT01181895|587478395|FG001|Overall Study|Withdrawal by Subject|0|||
163144533|NCT00657046|589239440|FG002|Overall Study|Protocol Violation|0|||
163144534|NCT00657046|589239438|FG000|Overall Study|Withdrawal by Subject|1|||
163144535|NCT00657046|589239439|FG001|Overall Study|Withdrawal by Subject|0|||
163144536|NCT00657046|589239440|FG002|Overall Study|Withdrawal by Subject|0|||
163144537|NCT00657046|589239438|FG000|Overall Study|Death|0|||
163144538|NCT00657046|589239439|FG001|Overall Study|Death|0|||
163144539|NCT00657046|589239440|FG002|Overall Study|Death|1|||
163144540|NCT00657046|589239438|FG000|Overall Study|Surgery|0|||
163144541|NCT00657046|589239439|FG001|Overall Study|Surgery|0|||
163144542|NCT00657046|589239440|FG002|Overall Study|Surgery|1|||
163144543|NCT03827655|589239441|FG000|Overall Study|Death|0|||
163144544|NCT03827655|589239442|FG001|Overall Study|Death|0|||
163144545|NCT03827655|589239443|FG002|Overall Study|Death|0|||
163144546|NCT03827655|589239444|FG003|Overall Study|Death|0|||
163144547|NCT03827655|589239445|FG004|Overall Study|Death|1|||
163144548|NCT03827655|589239441|FG000|Overall Study|Protocol Deviation|1|||
163144549|NCT03827655|589239442|FG001|Overall Study|Protocol Deviation|0|||
163144550|NCT03827655|589239443|FG002|Overall Study|Protocol Deviation|1|||
163144551|NCT03827655|589239444|FG003|Overall Study|Protocol Deviation|1|||
163144552|NCT03827655|589239445|FG004|Overall Study|Protocol Deviation|0|||
163144553|NCT03827655|589239441|FG000|Overall Study|Withdrawal by Subject|3|||
163144554|NCT03827655|589239442|FG001|Overall Study|Withdrawal by Subject|2|||
163144555|NCT03827655|589239443|FG002|Overall Study|Withdrawal by Subject|2|||
163144556|NCT03827655|589239444|FG003|Overall Study|Withdrawal by Subject|0|||
163144557|NCT03827655|589239445|FG004|Overall Study|Withdrawal by Subject|1|||
163144558|NCT03827655|589239441|FG000|Overall Study|Reason not Specified|3|||
163144559|NCT03827655|589239442|FG001|Overall Study|Reason not Specified|1|||
163144560|NCT03827655|589239443|FG002|Overall Study|Reason not Specified|1|||
163144561|NCT03827655|589239444|FG003|Overall Study|Reason not Specified|1|||
163144562|NCT03827655|589239445|FG004|Overall Study|Reason not Specified|1|||
163144563|NCT03935126|589239448|FG000|Overall Study|Study termination by sponsor|3|||
163144564|NCT01092728|589239449|FG000|Overall Study|Withdrawal by Subject|2|||
163144565|NCT01092728|589239450|FG001|Overall Study|Withdrawal by Subject|0|||
163144566|NCT01092728|589239449|FG000|Overall Study|Adverse Event|0|||
163144567|NCT01092728|589239450|FG001|Overall Study|Adverse Event|1|||
163144568|NCT01092728|589239449|FG000|Overall Study|Disease Progression|1|||
163144569|NCT01092728|589239450|FG001|Overall Study|Disease Progression|13|||
163144570|NCT01092728|589239449|FG000|Overall Study|Prohibited Concomitant Medications|1|||
163144571|NCT01092728|589239450|FG001|Overall Study|Prohibited Concomitant Medications|0|||
163144572|NCT01454596|589239452|FG000|Overall Study|Death|0|||
163144573|NCT01454596|589239453|FG001|Overall Study|Death|0|||
163144574|NCT01454596|589239454|FG002|Overall Study|Death|0|||
163144575|NCT01454596|589239455|FG003|Overall Study|Death|0|||
163144576|NCT01454596|589239456|FG004|Overall Study|Death|0|||
163144577|NCT01454596|589239457|FG005|Overall Study|Death|0|||
163144578|NCT01454596|589239458|FG006|Overall Study|Death|0|||
163144579|NCT01454596|589239459|FG007|Overall Study|Death|0|||
163144580|NCT01454596|589239460|FG008|Overall Study|Death|0|||
163144581|NCT01454596|589239461|FG009|Overall Study|Death|1|||
163144582|NCT01454596|589239462|FG010|Overall Study|Death|1|||
163144583|NCT01454596|589239463|FG011|Overall Study|Death|0|||
163144584|NCT03318549|589239473|FG000|Overall Study|Withdrawal by Subject|5|||
163144585|NCT03318549|589239474|FG001|Overall Study|Withdrawal by Subject|19|||
163144586|NCT03318549|589239475|FG002|Overall Study|Withdrawal by Subject|2|||
163144587|NCT03318549|589239476|FG003|Overall Study|Withdrawal by Subject|0|||
163144588|NCT03318549|589239477|FG004|Overall Study|Withdrawal by Subject|0|||
163144589|NCT03318549|589239478|FG005|Overall Study|Withdrawal by Subject|0|||
163144590|NCT03318549|589239479|FG006|Overall Study|Withdrawal by Subject|0|||
163144591|NCT03318549|589239473|FG000|Overall Study|Physician Decision|0|||
163144592|NCT03318549|589239474|FG001|Overall Study|Physician Decision|4|||
163144593|NCT03318549|589239475|FG002|Overall Study|Physician Decision|1|||
163144594|NCT03318549|589239476|FG003|Overall Study|Physician Decision|0|||
162663326|NCT01181895|587478396|FG002|Overall Study|Withdrawal by Subject|5|||
162663327|NCT00555438|587478397|FG000|10 Days Post-operative|Death|4|||
162663328|NCT00555438|587478397|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
162663329|NCT03136068|587480543|FG000|Overall Study|Lost to Follow-up|1|||
163144595|NCT03318549|589239477|FG004|Overall Study|Physician Decision|0|||
163144596|NCT03318549|589239478|FG005|Overall Study|Physician Decision|0|||
163144597|NCT03318549|589239479|FG006|Overall Study|Physician Decision|0|||
163144598|NCT03318549|589239473|FG000|Overall Study|Lost to Follow-up|0|||
163144599|NCT03318549|589239474|FG001|Overall Study|Lost to Follow-up|3|||
163144600|NCT03318549|589239475|FG002|Overall Study|Lost to Follow-up|3|||
162663330|NCT03136068|587480544|FG001|Overall Study|Lost to Follow-up|1|||
163144601|NCT03318549|589239476|FG003|Overall Study|Lost to Follow-up|0|||
163144602|NCT03318549|589239477|FG004|Overall Study|Lost to Follow-up|0|||
163144603|NCT03318549|589239478|FG005|Overall Study|Lost to Follow-up|0|||
163144604|NCT03318549|589239479|FG006|Overall Study|Lost to Follow-up|0|||
163144605|NCT01433172|589239480|FG000|Overall Study|Withdrawal by Subject|0|||
163144606|NCT01433172|589239481|FG001|Overall Study|Withdrawal by Subject|1|||
163144607|NCT01433172|589239482|FG002|Overall Study|Withdrawal by Subject|0|||
163144608|NCT01433172|589239480|FG000|Overall Study|Disease Progression|0|||
163144609|NCT01433172|589239481|FG001|Overall Study|Disease Progression|0|||
163144610|NCT01433172|589239482|FG002|Overall Study|Disease Progression|1|||
163144611|NCT01433172|589239480|FG000|Overall Study|Death|0|||
163144612|NCT01433172|589239481|FG001|Overall Study|Death|2|||
163144613|NCT01433172|589239482|FG002|Overall Study|Death|0|||
163144614|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
163144615|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
163144616|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
163144617|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
162663331|NCT03136068|587480543|FG000|Overall Study|Protocol Violation|1|||
163144618|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
163144619|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
163144620|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Death|7|||
163144621|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Death|5|||
163144622|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Death|6|||
163144623|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
163144624|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
163144625|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
163144626|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
162663332|NCT03136068|587480544|FG001|Overall Study|Protocol Violation|0|||
162663333|NCT00432380|587480545|FG000|Overall Study|Migrated/moved from study area|3|||
163144627|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
163144628|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
162721113|NCT00430300|587686045|FG001|Overall Study|Withdrawal by Subject|0|||
162663334|NCT00432380|587480546|FG001|Overall Study|Migrated/moved from study area|4|||
162663335|NCT00432380|587480547|FG002|Overall Study|Migrated/moved from study area|1|||
162663336|NCT00432380|587480545|FG000|Overall Study|Adverse Event|1|||
162663337|NCT00432380|587480546|FG001|Overall Study|Adverse Event|0|||
162663338|NCT00432380|587480547|FG002|Overall Study|Adverse Event|0|||
163144629|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Other|1|||
163144630|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Other|0|||
163144631|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Other|0|||
163144632|NCT00104650|589239483|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
163144633|NCT00104650|589239484|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
163144634|NCT00104650|589239485|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
163144635|NCT00104650|589239483|FG000|Follow-up Period|Physician Decision|1|||
163144636|NCT00104650|589239484|FG001|Follow-up Period|Physician Decision|1|||
163144637|NCT00104650|589239485|FG002|Follow-up Period|Physician Decision|0|||
163144638|NCT00104650|589239483|FG000|Follow-up Period|Adverse Event|1|||
163144639|NCT00104650|589239484|FG001|Follow-up Period|Adverse Event|0|||
163144640|NCT00104650|589239485|FG002|Follow-up Period|Adverse Event|1|||
163144641|NCT00104650|589239483|FG000|Follow-up Period|Withdrawal by Subject|0|||
163144642|NCT00104650|589239484|FG001|Follow-up Period|Withdrawal by Subject|3|||
163144643|NCT00104650|589239485|FG002|Follow-up Period|Withdrawal by Subject|3|||
163144644|NCT00104650|589239483|FG000|Follow-up Period|Death|6|||
163144645|NCT00104650|589239484|FG001|Follow-up Period|Death|6|||
163144646|NCT00104650|589239485|FG002|Follow-up Period|Death|4|||
163144647|NCT00104650|589239483|FG000|Follow-up Period|Disease progression|3|||
163144648|NCT00104650|589239484|FG001|Follow-up Period|Disease progression|1|||
163144649|NCT00104650|589239485|FG002|Follow-up Period|Disease progression|0|||
163144650|NCT00104650|589239483|FG000|Follow-up Period|Lost to Follow-up|0|||
163144651|NCT00104650|589239484|FG001|Follow-up Period|Lost to Follow-up|1|||
163144652|NCT00104650|589239485|FG002|Follow-up Period|Lost to Follow-up|2|||
163144653|NCT00104650|589239483|FG000|Follow-up Period|Other|0|||
163144654|NCT00104650|589239484|FG001|Follow-up Period|Other|1|||
163144655|NCT00104650|589239485|FG002|Follow-up Period|Other|0|||
163144656|NCT01391663|589239486|FG000|Overall Study|Withdrawal by Subject|0|||
163144657|NCT01391663|589239487|FG001|Overall Study|Withdrawal by Subject|0|||
163144658|NCT01391663|589239488|FG002|Overall Study|Withdrawal by Subject|1|||
163144659|NCT01391663|589239489|FG003|Overall Study|Withdrawal by Subject|0|||
163144660|NCT03515824|589239490|FG000|Overall Study|Death|3|||
163144661|NCT03515824|589239491|FG001|Overall Study|Death|2|||
163144662|NCT03515824|589239492|FG002|Overall Study|Death|6|||
163144663|NCT03515824|589239493|FG003|Overall Study|Death|0|||
163144664|NCT03515824|589239490|FG000|Overall Study|Lost to Follow-up|0|||
163144665|NCT03515824|589239491|FG001|Overall Study|Lost to Follow-up|1|||
163144666|NCT03515824|589239492|FG002|Overall Study|Lost to Follow-up|1|||
163144667|NCT03515824|589239493|FG003|Overall Study|Lost to Follow-up|0|||
163144668|NCT03515824|589239490|FG000|Overall Study|Study terminated by sponsor|0|||
163144669|NCT03515824|589239491|FG001|Overall Study|Study terminated by sponsor|1|||
163144670|NCT03515824|589239492|FG002|Overall Study|Study terminated by sponsor|6|||
163144671|NCT03515824|589239493|FG003|Overall Study|Study terminated by sponsor|0|||
163144672|NCT03515824|589239490|FG000|Overall Study|Status not recorded|0|||
163144673|NCT03515824|589239491|FG001|Overall Study|Status not recorded|0|||
163144674|NCT03515824|589239492|FG002|Overall Study|Status not recorded|2|||
163144675|NCT03515824|589239493|FG003|Overall Study|Status not recorded|0|||
163144676|NCT00510835|589239495|FG000|Overall Study|Withdrawal by Subject|6|||
163144677|NCT00510835|589239496|FG001|Overall Study|Withdrawal by Subject|2|||
163144678|NCT00510835|589239497|FG002|Overall Study|Withdrawal by Subject|2|||
163144679|NCT03084796|589239498|FG000|Overall Study|Adverse Event|4|||
163144680|NCT03084796|589239499|FG001|Overall Study|Adverse Event|5|||
163144681|NCT03084796|589239500|FG002|Overall Study|Adverse Event|6|||
163144682|NCT03084796|589239501|FG003|Overall Study|Adverse Event|2|||
163144683|NCT03084796|589239502|FG004|Overall Study|Adverse Event|3|||
163144684|NCT03084796|589239503|FG005|Overall Study|Adverse Event|5|||
163144685|NCT03084796|589239498|FG000|Overall Study|Withdrawal by Subject|3|||
163144686|NCT03084796|589239499|FG001|Overall Study|Withdrawal by Subject|5|||
163144687|NCT03084796|589239500|FG002|Overall Study|Withdrawal by Subject|2|||
163144688|NCT03084796|589239501|FG003|Overall Study|Withdrawal by Subject|1|||
163144689|NCT03084796|589239502|FG004|Overall Study|Withdrawal by Subject|3|||
163144690|NCT03084796|589239503|FG005|Overall Study|Withdrawal by Subject|0|||
163144691|NCT03084796|589239498|FG000|Overall Study|Protocol Violation|0|||
163144692|NCT03084796|589239499|FG001|Overall Study|Protocol Violation|0|||
163144693|NCT03084796|589239500|FG002|Overall Study|Protocol Violation|1|||
163144694|NCT03084796|589239501|FG003|Overall Study|Protocol Violation|0|||
163144695|NCT03084796|589239502|FG004|Overall Study|Protocol Violation|1|||
163144696|NCT03084796|589239503|FG005|Overall Study|Protocol Violation|1|||
163144697|NCT03084796|589239498|FG000|Overall Study|Lack of Efficacy|0|||
163144698|NCT03084796|589239499|FG001|Overall Study|Lack of Efficacy|0|||
163144699|NCT03084796|589239500|FG002|Overall Study|Lack of Efficacy|1|||
163144700|NCT03084796|589239501|FG003|Overall Study|Lack of Efficacy|0|||
163144701|NCT03084796|589239502|FG004|Overall Study|Lack of Efficacy|1|||
163144702|NCT03084796|589239503|FG005|Overall Study|Lack of Efficacy|0|||
163144703|NCT03084796|589239498|FG000|Overall Study|Lost to Follow-up|0|||
163144704|NCT03084796|589239499|FG001|Overall Study|Lost to Follow-up|0|||
163144705|NCT03084796|589239500|FG002|Overall Study|Lost to Follow-up|1|||
163144706|NCT03084796|589239501|FG003|Overall Study|Lost to Follow-up|1|||
163144707|NCT03084796|589239502|FG004|Overall Study|Lost to Follow-up|3|||
163144708|NCT03084796|589239503|FG005|Overall Study|Lost to Follow-up|1|||
163144709|NCT03084796|589239498|FG000|Overall Study|Randomization error|0|||
163144710|NCT03084796|589239499|FG001|Overall Study|Randomization error|0|||
163144711|NCT03084796|589239500|FG002|Overall Study|Randomization error|1|||
163144712|NCT03084796|589239501|FG003|Overall Study|Randomization error|0|||
163144713|NCT03084796|589239502|FG004|Overall Study|Randomization error|0|||
163144714|NCT03084796|589239503|FG005|Overall Study|Randomization error|0|||
163144715|NCT05470985|589239504|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
163144716|NCT05470985|589239505|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
163144717|NCT05470985|589239504|FG000|Double Blind Treatment Period|Physician Decision|0|||
163144718|NCT05470985|589239505|FG001|Double Blind Treatment Period|Physician Decision|1|||
163144719|NCT05470985|589239504|FG000|Long Term Extension|Adverse Event|0|||
163144720|NCT05470985|589239505|FG001|Long Term Extension|Adverse Event|1|||
163144721|NCT05470985|589239504|FG000|Long Term Extension|Study terminated by sponsor|2|||
163144722|NCT05470985|589239505|FG001|Long Term Extension|Study terminated by sponsor|0|||
163144723|NCT01917747|589239506|FG000|Overall Study|Withdrawal by Subject|1|||
163144724|NCT01917747|589239507|FG001|Overall Study|Withdrawal by Subject|2|||
163144725|NCT01917747|589239506|FG000|Overall Study|Lost to Follow-up|18|||
163144726|NCT01917747|589239507|FG001|Overall Study|Lost to Follow-up|9|||
163144727|NCT02741245|589239516|FG000|Overall Study|Adverse Event|0|||
163144728|NCT02741245|589239517|FG001|Overall Study|Adverse Event|0|||
163144729|NCT02741245|589239518|FG002|Overall Study|Adverse Event|0|||
163144730|NCT02741245|589239519|FG003|Overall Study|Adverse Event|2|||
163144731|NCT02741245|589239520|FG004|Overall Study|Adverse Event|2|||
163144732|NCT02741245|589239516|FG000|Overall Study|Protocol Violation|0|||
163144733|NCT02741245|589239517|FG001|Overall Study|Protocol Violation|1|||
163144734|NCT02741245|589239518|FG002|Overall Study|Protocol Violation|0|||
163144735|NCT02741245|589239519|FG003|Overall Study|Protocol Violation|1|||
163144736|NCT02741245|589239520|FG004|Overall Study|Protocol Violation|0|||
163144737|NCT02741245|589239516|FG000|Overall Study|Withdrawal by Subject|0|||
163144738|NCT02741245|589239517|FG001|Overall Study|Withdrawal by Subject|0|||
163144739|NCT02741245|589239518|FG002|Overall Study|Withdrawal by Subject|0|||
163144740|NCT02741245|589239519|FG003|Overall Study|Withdrawal by Subject|1|||
163144741|NCT02741245|589239520|FG004|Overall Study|Withdrawal by Subject|0|||
163144742|NCT03799341|589239523|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
163144743|NCT03799341|589239524|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
163144744|NCT03799341|589239525|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
163144745|NCT03799341|589239523|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
163144746|NCT03799341|589239524|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
163144747|NCT03799341|589239525|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
163144748|NCT03799341|589239523|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
163144749|NCT03799341|589239524|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
163144750|NCT03799341|589239525|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
163144751|NCT03799341|589239523|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
163144752|NCT03799341|589239524|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
163144753|NCT03799341|589239525|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
163144754|NCT03799341|589239523|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
163144755|NCT03799341|589239524|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
163144756|NCT03799341|589239525|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
163144757|NCT03799341|589239523|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
163144758|NCT03799341|589239524|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
163144759|NCT03799341|589239525|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
163144760|NCT01116648|589239526|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
163144761|NCT01116648|589239527|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
163144762|NCT01116648|589239528|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
163144763|NCT01116648|589239529|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
163144764|NCT01116648|589239530|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
163144765|NCT01116648|589239531|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
163144766|NCT01116648|589239532|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
163144767|NCT01116648|589239533|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
163144768|NCT01116648|589239534|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
163144769|NCT01116648|589239535|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
163144770|NCT01116648|589239536|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
163144771|NCT01116648|589239537|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
163144772|NCT01116648|589239538|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
163144773|NCT01116648|589239539|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
163144774|NCT01116648|589239540|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
163144775|NCT03064490|589239541|FG000|Overall Study|Physician Decision|5|||
163144776|NCT05579977|589239546|FG000|Treatment Phase|Other|0|||
163144777|NCT05579977|589239547|FG001|Treatment Phase|Other|0|||
163144778|NCT05579977|589239548|FG002|Treatment Phase|Other|0|||
163144779|NCT05579977|589239549|FG003|Treatment Phase|Other|2|||
163144780|NCT05579977|589239550|FG004|Treatment Phase|Other|1|||
163144781|NCT05579977|589239551|FG005|Treatment Phase|Other|2|||
163144782|NCT05579977|589239552|FG006|Treatment Phase|Other|1|||
163144783|NCT05579977|589239553|FG007|Treatment Phase|Other|2|||
163144784|NCT05579977|589239554|FG008|Treatment Phase|Other|2|||
163144785|NCT05579977|589239555|FG009|Treatment Phase|Other|1|||
163144786|NCT05579977|589239556|FG010|Treatment Phase|Other|0|||
163144787|NCT05579977|589239557|FG011|Treatment Phase|Other|0|||
163144788|NCT05579977|589239558|FG012|Treatment Phase|Other|3|||
163144789|NCT05579977|589239546|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
163144790|NCT05579977|589239547|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
163144791|NCT05579977|589239548|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
163144792|NCT05579977|589239549|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
163144793|NCT05579977|589239550|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
163144794|NCT05579977|589239551|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
163144795|NCT05579977|589239552|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
163144796|NCT05579977|589239553|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
163144797|NCT05579977|589239554|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
163144798|NCT05579977|589239555|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
163144799|NCT05579977|589239556|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
163144800|NCT05579977|589239557|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
163144801|NCT05579977|589239558|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
163144802|NCT05579977|589239546|FG000|Treatment Phase|Withdrawal by Subject|2|||
163144803|NCT05579977|589239547|FG001|Treatment Phase|Withdrawal by Subject|0|||
163144804|NCT05579977|589239548|FG002|Treatment Phase|Withdrawal by Subject|0|||
163144805|NCT05579977|589239549|FG003|Treatment Phase|Withdrawal by Subject|1|||
163144806|NCT05579977|589239550|FG004|Treatment Phase|Withdrawal by Subject|2|||
163144807|NCT05579977|589239551|FG005|Treatment Phase|Withdrawal by Subject|0|||
163144808|NCT05579977|589239552|FG006|Treatment Phase|Withdrawal by Subject|1|||
163144809|NCT05579977|589239553|FG007|Treatment Phase|Withdrawal by Subject|8|||
163144810|NCT05579977|589239554|FG008|Treatment Phase|Withdrawal by Subject|3|||
163144811|NCT05579977|589239555|FG009|Treatment Phase|Withdrawal by Subject|3|||
163144812|NCT05579977|589239556|FG010|Treatment Phase|Withdrawal by Subject|5|||
163144813|NCT05579977|589239557|FG011|Treatment Phase|Withdrawal by Subject|1|||
163144814|NCT05579977|589239558|FG012|Treatment Phase|Withdrawal by Subject|3|||
163144815|NCT05579977|589239546|FG000|Treatment Phase|Study terminated by sponsor|70|||
163144816|NCT05579977|589239547|FG001|Treatment Phase|Study terminated by sponsor|70|||
163144817|NCT05579977|589239548|FG002|Treatment Phase|Study terminated by sponsor|61|||
163144818|NCT05579977|589239549|FG003|Treatment Phase|Study terminated by sponsor|59|||
163144819|NCT05579977|589239550|FG004|Treatment Phase|Study terminated by sponsor|63|||
163144820|NCT05579977|589239551|FG005|Treatment Phase|Study terminated by sponsor|53|||
163144821|NCT05579977|589239552|FG006|Treatment Phase|Study terminated by sponsor|66|||
163144822|NCT05579977|589239553|FG007|Treatment Phase|Study terminated by sponsor|48|||
163144823|NCT05579977|589239554|FG008|Treatment Phase|Study terminated by sponsor|47|||
163144824|NCT05579977|589239555|FG009|Treatment Phase|Study terminated by sponsor|37|||
163144825|NCT05579977|589239556|FG010|Treatment Phase|Study terminated by sponsor|44|||
163144826|NCT05579977|589239557|FG011|Treatment Phase|Study terminated by sponsor|36|||
163144827|NCT05579977|589239558|FG012|Treatment Phase|Study terminated by sponsor|32|||
163144828|NCT05579977|589239546|FG000|Treatment Phase|Pregnancy|0|||
163144829|NCT05579977|589239547|FG001|Treatment Phase|Pregnancy|0|||
163144830|NCT05579977|589239548|FG002|Treatment Phase|Pregnancy|0|||
163144831|NCT05579977|589239549|FG003|Treatment Phase|Pregnancy|0|||
163144832|NCT05579977|589239550|FG004|Treatment Phase|Pregnancy|0|||
163144833|NCT05579977|589239551|FG005|Treatment Phase|Pregnancy|0|||
163144834|NCT05579977|589239552|FG006|Treatment Phase|Pregnancy|0|||
163144835|NCT05579977|589239553|FG007|Treatment Phase|Pregnancy|0|||
163144836|NCT05579977|589239554|FG008|Treatment Phase|Pregnancy|0|||
163144837|NCT05579977|589239555|FG009|Treatment Phase|Pregnancy|1|||
163144838|NCT05579977|589239556|FG010|Treatment Phase|Pregnancy|0|||
163144839|NCT05579977|589239557|FG011|Treatment Phase|Pregnancy|0|||
163144840|NCT05579977|589239558|FG012|Treatment Phase|Pregnancy|0|||
163144841|NCT05579977|589239546|FG000|Treatment Phase|Physician Decision|0|||
163144842|NCT05579977|589239547|FG001|Treatment Phase|Physician Decision|0|||
163144843|NCT05579977|589239548|FG002|Treatment Phase|Physician Decision|0|||
163144844|NCT05579977|589239549|FG003|Treatment Phase|Physician Decision|0|||
163144845|NCT05579977|589239550|FG004|Treatment Phase|Physician Decision|0|||
163144846|NCT05579977|589239551|FG005|Treatment Phase|Physician Decision|0|||
163144847|NCT05579977|589239552|FG006|Treatment Phase|Physician Decision|0|||
163144848|NCT05579977|589239553|FG007|Treatment Phase|Physician Decision|0|||
163144849|NCT05579977|589239554|FG008|Treatment Phase|Physician Decision|0|||
163144850|NCT05579977|589239555|FG009|Treatment Phase|Physician Decision|0|||
163144851|NCT05579977|589239556|FG010|Treatment Phase|Physician Decision|0|||
163144852|NCT05579977|589239557|FG011|Treatment Phase|Physician Decision|1|||
163144853|NCT05579977|589239558|FG012|Treatment Phase|Physician Decision|0|||
163144854|NCT05579977|589239546|FG000|Treatment Phase|Lost to Follow-up|0|||
162663339|NCT01071395|587480548|FG000|Overall Study|Withdrawal by Subject|2|||
162663340|NCT01071395|587480549|FG001|Overall Study|Withdrawal by Subject|1|||
162663341|NCT01071395|587480548|FG000|Overall Study|Adverse Event|3|||
162663342|NCT01071395|587480549|FG001|Overall Study|Adverse Event|1|||
162663343|NCT04419493|587480550|FG000|Wash-out After Period 1|Adverse Event|1|||
162663344|NCT04419493|587480551|FG001|Wash-out After Period 1|Adverse Event|2|||
162663345|NCT04419493|587480552|FG002|Wash-out After Period 1|Adverse Event|1|||
162663346|NCT04419493|587480553|FG003|Wash-out After Period 1|Adverse Event|0|||
162663347|NCT00524134|587480554|FG000|Overall Study|Withdrawal by Subject|1|||
162663348|NCT00524134|587480554|FG000|Overall Study|Physician Decision|1|||
162663349|NCT03794089|587480555|FG000|Overall Study|Lost to Follow-up|4|||
162663350|NCT03794089|587480556|FG001|Overall Study|Lost to Follow-up|1|||
162663351|NCT03794089|587480555|FG000|Overall Study|Withdrawal by Subject|2|||
162663352|NCT03794089|587480556|FG001|Overall Study|Withdrawal by Subject|0|||
162663353|NCT03985423|587480557|FG000|Overall Study|Adverse Event|1|||
162663354|NCT03985423|587480557|FG000|Overall Study|Death|2|||
162663355|NCT03985423|587480557|FG000|Overall Study|Physician Decision|1|||
162663356|NCT03985423|587480557|FG000|Overall Study|Withdrawal by Subject|2|||
162663357|NCT03985423|587480557|FG000|Overall Study|Lack of insurance and citizenship|1|||
162663358|NCT01045447|587480568|FG000|Overall Study|Adverse Event|0|||
162663359|NCT01045447|587480569|FG001|Overall Study|Adverse Event|1|||
162663360|NCT01045447|587480568|FG000|Overall Study|Lack of Efficacy|3|||
162663361|NCT01045447|587480569|FG001|Overall Study|Lack of Efficacy|1|||
162663362|NCT01045447|587480568|FG000|Overall Study|Protocol Violation|6|||
162663363|NCT01045447|587480569|FG001|Overall Study|Protocol Violation|3|||
162663364|NCT01045447|587480568|FG000|Overall Study|Withdrawal Criteria|10|||
162663365|NCT01045447|587480569|FG001|Overall Study|Withdrawal Criteria|10|||
162663366|NCT01045447|587480568|FG000|Overall Study|Unclassified|17|||
162663367|NCT01045447|587480569|FG001|Overall Study|Unclassified|13|||
162663368|NCT01782131|587480573|FG000|Overall Study|Death|93|||
162663369|NCT01782131|587480574|FG001|Overall Study|Death|96|||
162663370|NCT01782131|587480573|FG000|Overall Study|Lost to Follow-up|1|||
162663371|NCT01782131|587480574|FG001|Overall Study|Lost to Follow-up|3|||
163144855|NCT05579977|589239547|FG001|Treatment Phase|Lost to Follow-up|0|||
163144856|NCT05579977|589239548|FG002|Treatment Phase|Lost to Follow-up|0|||
163144857|NCT05579977|589239549|FG003|Treatment Phase|Lost to Follow-up|1|||
163144858|NCT05579977|589239550|FG004|Treatment Phase|Lost to Follow-up|1|||
163144859|NCT05579977|589239551|FG005|Treatment Phase|Lost to Follow-up|1|||
163144860|NCT05579977|589239552|FG006|Treatment Phase|Lost to Follow-up|0|||
163144861|NCT05579977|589239553|FG007|Treatment Phase|Lost to Follow-up|1|||
163144862|NCT05579977|589239554|FG008|Treatment Phase|Lost to Follow-up|2|||
163144863|NCT05579977|589239555|FG009|Treatment Phase|Lost to Follow-up|2|||
163144864|NCT05579977|589239556|FG010|Treatment Phase|Lost to Follow-up|1|||
163144865|NCT05579977|589239557|FG011|Treatment Phase|Lost to Follow-up|4|||
163144866|NCT05579977|589239558|FG012|Treatment Phase|Lost to Follow-up|3|||
163144867|NCT05579977|589239546|FG000|Treatment Phase|Death|1|||
163144868|NCT05579977|589239547|FG001|Treatment Phase|Death|0|||
163144869|NCT05579977|589239548|FG002|Treatment Phase|Death|0|||
163144870|NCT05579977|589239549|FG003|Treatment Phase|Death|0|||
163144871|NCT05579977|589239550|FG004|Treatment Phase|Death|0|||
163144872|NCT05579977|589239551|FG005|Treatment Phase|Death|0|||
163144873|NCT05579977|589239552|FG006|Treatment Phase|Death|0|||
163144874|NCT05579977|589239553|FG007|Treatment Phase|Death|0|||
163144875|NCT05579977|589239554|FG008|Treatment Phase|Death|0|||
163144876|NCT05579977|589239555|FG009|Treatment Phase|Death|0|||
163144877|NCT05579977|589239556|FG010|Treatment Phase|Death|0|||
163144878|NCT05579977|589239557|FG011|Treatment Phase|Death|0|||
163144879|NCT05579977|589239558|FG012|Treatment Phase|Death|0|||
163144880|NCT05579977|589239546|FG000|Treatment Phase|Adverse Event|0|||
163144881|NCT05579977|589239547|FG001|Treatment Phase|Adverse Event|3|||
163144882|NCT05579977|589239548|FG002|Treatment Phase|Adverse Event|11|||
163144883|NCT05579977|589239549|FG003|Treatment Phase|Adverse Event|10|||
163144884|NCT05579977|589239550|FG004|Treatment Phase|Adverse Event|5|||
163144885|NCT05579977|589239551|FG005|Treatment Phase|Adverse Event|17|||
163144886|NCT05579977|589239552|FG006|Treatment Phase|Adverse Event|5|||
163144887|NCT05579977|589239553|FG007|Treatment Phase|Adverse Event|5|||
163144888|NCT05579977|589239554|FG008|Treatment Phase|Adverse Event|12|||
163144889|NCT05579977|589239555|FG009|Treatment Phase|Adverse Event|20|||
163144890|NCT05579977|589239556|FG010|Treatment Phase|Adverse Event|15|||
163144891|NCT05579977|589239557|FG011|Treatment Phase|Adverse Event|24|||
163144892|NCT05579977|589239558|FG012|Treatment Phase|Adverse Event|23|||
163144893|NCT05579977|589239546|FG000|Treatment Phase|Randomized not treated|0|||
163144894|NCT05579977|589239547|FG001|Treatment Phase|Randomized not treated|0|||
163144895|NCT05579977|589239548|FG002|Treatment Phase|Randomized not treated|0|||
162663372|NCT01782131|587480573|FG000|Overall Study|Withdrawal by Subject|10|||
162663373|NCT01782131|587480574|FG001|Overall Study|Withdrawal by Subject|10|||
162663374|NCT01782131|587480573|FG000|Overall Study|Randomized but not treated|5|||
162663375|NCT01782131|587480574|FG001|Overall Study|Randomized but not treated|5|||
162663376|NCT01782131|587480573|FG000|Overall Study|Reason not provided|0|||
162663377|NCT01782131|587480574|FG001|Overall Study|Reason not provided|1|||
162663378|NCT01627249|587480575|FG000|Overall Study|Death|3|||
162663379|NCT01627249|587480576|FG001|Overall Study|Death|5|||
163144896|NCT05579977|589239549|FG003|Treatment Phase|Randomized not treated|0|||
163144897|NCT05579977|589239550|FG004|Treatment Phase|Randomized not treated|1|||
163144898|NCT05579977|589239551|FG005|Treatment Phase|Randomized not treated|0|||
162663380|NCT01627249|587480577|FG002|Overall Study|Death|3|||
162663381|NCT01627249|587480575|FG000|Overall Study|Withdrawal by Subject|12|||
162663382|NCT01627249|587480576|FG001|Overall Study|Withdrawal by Subject|6|||
162663383|NCT01627249|587480577|FG002|Overall Study|Withdrawal by Subject|9|||
162663384|NCT01627249|587480575|FG000|Overall Study|Missed Visit|1|||
162663385|NCT01627249|587480576|FG001|Overall Study|Missed Visit|1|||
162663386|NCT01627249|587480577|FG002|Overall Study|Missed Visit|0|||
162663387|NCT00796718|587480578|FG000|Overall Study|Adverse Event|2|||
162663388|NCT00796718|587480578|FG000|Overall Study|Exclusion Criteria|1|||
162663389|NCT00796718|587480578|FG000|Overall Study|Lost to Follow-up|5|||
162663390|NCT00796718|587480578|FG000|Overall Study|Withdrawal by Informed Consent|1|||
162663391|NCT03266588|587480579|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
162663392|NCT03266588|587480580|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
162663393|NCT03266588|587480581|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
162663394|NCT03266588|587480579|FG000|Observational Period|Withdrawal by Subject|44|||
162663395|NCT03266588|587480580|FG001|Observational Period|Withdrawal by Subject|22|||
162663396|NCT03266588|587480581|FG002|Observational Period|Withdrawal by Subject|13|||
162663397|NCT03266588|587480579|FG000|Observational Period|Non-compliance|18|||
162663398|NCT03266588|587480580|FG001|Observational Period|Non-compliance|12|||
162663399|NCT03266588|587480581|FG002|Observational Period|Non-compliance|10|||
162663400|NCT03266588|587480579|FG000|Observational Period|Lost to Follow-up|8|||
162663401|NCT03266588|587480580|FG001|Observational Period|Lost to Follow-up|12|||
162663402|NCT03266588|587480581|FG002|Observational Period|Lost to Follow-up|4|||
162721114|NCT00430300|587686046|FG002|Overall Study|Withdrawal by Subject|5|||
162721115|NCT00430300|587686047|FG003|Overall Study|Withdrawal by Subject|0|||
162721116|NCT00430300|587686044|FG000|Overall Study|Laboratory abnormality|1|||
162663403|NCT03266588|587480579|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
162663404|NCT03266588|587480580|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
162663405|NCT03266588|587480581|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
162663406|NCT03266588|587480579|FG000|Observational Period|Protocol Deviation|1|||
162663407|NCT03266588|587480580|FG001|Observational Period|Protocol Deviation|0|||
162721117|NCT00430300|587686045|FG001|Overall Study|Laboratory abnormality|0|||
162721118|NCT00430300|587686046|FG002|Overall Study|Laboratory abnormality|0|||
162721119|NCT00430300|587686047|FG003|Overall Study|Laboratory abnormality|0|||
162663408|NCT03266588|587480581|FG002|Observational Period|Protocol Deviation|0|||
162663409|NCT03266588|587480579|FG000|Observational Period|Other Reasons|3|||
162663410|NCT03266588|587480580|FG001|Observational Period|Other Reasons|0|||
162663411|NCT03266588|587480581|FG002|Observational Period|Other Reasons|1|||
162663412|NCT03266588|587480579|FG000|Long-term Treatment Period|Adverse Event|33|||
162663413|NCT03266588|587480580|FG001|Long-term Treatment Period|Adverse Event|17|||
162663414|NCT03266588|587480581|FG002|Long-term Treatment Period|Adverse Event|8|||
163144899|NCT05579977|589239552|FG006|Treatment Phase|Randomized not treated|0|||
163144900|NCT05579977|589239553|FG007|Treatment Phase|Randomized not treated|0|||
163144901|NCT05579977|589239554|FG008|Treatment Phase|Randomized not treated|0|||
163144902|NCT05579977|589239555|FG009|Treatment Phase|Randomized not treated|0|||
163144903|NCT05579977|589239556|FG010|Treatment Phase|Randomized not treated|0|||
163144904|NCT05579977|589239557|FG011|Treatment Phase|Randomized not treated|0|||
163144905|NCT05579977|589239558|FG012|Treatment Phase|Randomized not treated|0|||
163144906|NCT05579977|589239546|FG000|Follow up|Death|1|||
163144907|NCT05579977|589239547|FG001|Follow up|Death|0|||
163144908|NCT05579977|589239548|FG002|Follow up|Death|0|||
163144909|NCT05579977|589239549|FG003|Follow up|Death|0|||
163144910|NCT05579977|589239550|FG004|Follow up|Death|0|||
163144911|NCT05579977|589239551|FG005|Follow up|Death|0|||
163144912|NCT05579977|589239552|FG006|Follow up|Death|0|||
163144913|NCT05579977|589239553|FG007|Follow up|Death|0|||
163144914|NCT05579977|589239554|FG008|Follow up|Death|0|||
163144915|NCT05579977|589239555|FG009|Follow up|Death|0|||
163144916|NCT05579977|589239556|FG010|Follow up|Death|0|||
163144917|NCT05579977|589239557|FG011|Follow up|Death|0|||
163144918|NCT05579977|589239558|FG012|Follow up|Death|0|||
163144919|NCT05579977|589239546|FG000|Follow up|Lost to Follow-up|0|||
163144920|NCT05579977|589239547|FG001|Follow up|Lost to Follow-up|0|||
163144921|NCT05579977|589239548|FG002|Follow up|Lost to Follow-up|0|||
163144922|NCT05579977|589239549|FG003|Follow up|Lost to Follow-up|1|||
163144923|NCT05579977|589239550|FG004|Follow up|Lost to Follow-up|1|||
163144924|NCT05579977|589239551|FG005|Follow up|Lost to Follow-up|2|||
163144925|NCT05579977|589239552|FG006|Follow up|Lost to Follow-up|1|||
163144926|NCT05579977|589239553|FG007|Follow up|Lost to Follow-up|1|||
163144927|NCT05579977|589239554|FG008|Follow up|Lost to Follow-up|3|||
163144928|NCT05579977|589239555|FG009|Follow up|Lost to Follow-up|2|||
163144929|NCT05579977|589239556|FG010|Follow up|Lost to Follow-up|2|||
163144930|NCT05579977|589239557|FG011|Follow up|Lost to Follow-up|4|||
163144931|NCT05579977|589239558|FG012|Follow up|Lost to Follow-up|4|||
163144932|NCT05579977|589239546|FG000|Follow up|Withdrawal by Subject|2|||
163144933|NCT05579977|589239547|FG001|Follow up|Withdrawal by Subject|0|||
163144934|NCT05579977|589239548|FG002|Follow up|Withdrawal by Subject|0|||
163144935|NCT05579977|589239549|FG003|Follow up|Withdrawal by Subject|0|||
163144936|NCT05579977|589239550|FG004|Follow up|Withdrawal by Subject|1|||
163144937|NCT05579977|589239551|FG005|Follow up|Withdrawal by Subject|0|||
163144938|NCT05579977|589239552|FG006|Follow up|Withdrawal by Subject|1|||
163144939|NCT05579977|589239553|FG007|Follow up|Withdrawal by Subject|4|||
163144940|NCT05579977|589239554|FG008|Follow up|Withdrawal by Subject|2|||
163144941|NCT05579977|589239555|FG009|Follow up|Withdrawal by Subject|3|||
163144942|NCT05579977|589239556|FG010|Follow up|Withdrawal by Subject|3|||
163144943|NCT05579977|589239557|FG011|Follow up|Withdrawal by Subject|1|||
163144944|NCT05579977|589239558|FG012|Follow up|Withdrawal by Subject|3|||
163144945|NCT01777776|589239560|FG000|Overall Study|Adverse Event|2|||
163144946|NCT01777776|589239561|FG001|Overall Study|Adverse Event|4|||
163144947|NCT01777776|589239562|FG002|Overall Study|Adverse Event|0|||
163144948|NCT01777776|589239563|FG003|Overall Study|Adverse Event|0|||
163144949|NCT01777776|589239560|FG000|Overall Study|Disease Progression|4|||
163144950|NCT01777776|589239561|FG001|Overall Study|Disease Progression|8|||
163144951|NCT01777776|589239562|FG002|Overall Study|Disease Progression|6|||
163144952|NCT01777776|589239563|FG003|Overall Study|Disease Progression|3|||
163144953|NCT01777776|589239560|FG000|Overall Study|Withdrawal by Subject|0|||
163144954|NCT01777776|589239561|FG001|Overall Study|Withdrawal by Subject|0|||
163144955|NCT01777776|589239562|FG002|Overall Study|Withdrawal by Subject|0|||
163144956|NCT01777776|589239563|FG003|Overall Study|Withdrawal by Subject|1|||
163144957|NCT01420926|589239566|FG000|Overall Study|Adverse Event|6|||
163144958|NCT01420926|589239567|FG001|Overall Study|Adverse Event|4|||
163144959|NCT01420926|589239566|FG000|Overall Study|Death|18|||
163144960|NCT01420926|589239567|FG001|Overall Study|Death|17|||
163144961|NCT01420926|589239566|FG000|Overall Study|Withdrawal by Subject|11|||
163144962|NCT01420926|589239567|FG001|Overall Study|Withdrawal by Subject|17|||
163144963|NCT01420926|589239566|FG000|Overall Study|Non-protocol treatment|17|||
163144964|NCT01420926|589239567|FG001|Overall Study|Non-protocol treatment|20|||
163144965|NCT01420926|589239566|FG000|Overall Study|Physician Decision|8|||
163144966|NCT01420926|589239567|FG001|Overall Study|Physician Decision|5|||
163144967|NCT04564846|589241545|FG000|Overall Study|Withdrawal by Subject|2|||
163144968|NCT04564846|589241546|FG001|Overall Study|Withdrawal by Subject|1|||
163144969|NCT04564846|589241545|FG000|Overall Study|Physician Decision|0|||
163144970|NCT04564846|589241546|FG001|Overall Study|Physician Decision|1|||
163144971|NCT04564846|589241545|FG000|Overall Study|Lost to Follow-up|0|||
162663415|NCT03266588|587480579|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
162663416|NCT03266588|587480580|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
163144972|NCT04564846|589241546|FG001|Overall Study|Lost to Follow-up|1|||
163144973|NCT04564846|589241545|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
163144974|NCT04564846|589241546|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
163144975|NCT04564846|589241545|FG000|Overall Study|Subject non-compliance|1|||
163144976|NCT04564846|589241546|FG001|Overall Study|Subject non-compliance|0|||
163144977|NCT03737123|589241547|FG000|Study Treatment|Adverse Event|2|||
163144978|NCT03737123|589241548|FG001|Study Treatment|Adverse Event|0|||
163144979|NCT03737123|589241547|FG000|Study Treatment|Disease Progression|2|||
163144980|NCT03737123|589241548|FG001|Study Treatment|Disease Progression|0|||
163144981|NCT03737123|589241547|FG000|Study Treatment|Withdrawal by Subject|2|||
163144982|NCT03737123|589241548|FG001|Study Treatment|Withdrawal by Subject|0|||
163144983|NCT03737123|589241547|FG000|Follow up|Death|1|||
163144984|NCT03737123|589241548|FG001|Follow up|Death|0|||
163144985|NCT03737123|589241547|FG000|Follow up|Withdrawal by Subject|1|||
163144986|NCT03737123|589241548|FG001|Follow up|Withdrawal by Subject|0|||
163144987|NCT03737123|589241547|FG000|Follow up|Termination of study|4|||
163144988|NCT03737123|589241548|FG001|Follow up|Termination of study|0|||
163144989|NCT01519323|589241549|FG000|Overall Study|Death|3|||
163144990|NCT01519323|589241550|FG001|Overall Study|Death|2|||
163144991|NCT01519323|589241549|FG000|Overall Study|Study terminated by sponsor|0|||
163144992|NCT01519323|589241550|FG001|Overall Study|Study terminated by sponsor|1|||
163144993|NCT00762359|589241551|FG000|Overall Study|Adverse Event|20|||
163144994|NCT00762359|589241552|FG001|Overall Study|Adverse Event|23|||
163144995|NCT00762359|589241551|FG000|Overall Study|Protocol Violation|21|||
163144996|NCT00762359|589241552|FG001|Overall Study|Protocol Violation|13|||
163144997|NCT00762359|589241551|FG000|Overall Study|Withdrawal by Subject|13|||
163144998|NCT00762359|589241552|FG001|Overall Study|Withdrawal by Subject|10|||
163144999|NCT00762359|589241551|FG000|Overall Study|Lack of Efficacy|0|||
163145000|NCT00762359|589241552|FG001|Overall Study|Lack of Efficacy|4|||
163145001|NCT00762359|589241551|FG000|Overall Study|Institution closed|2|||
163145002|NCT00762359|589241552|FG001|Overall Study|Institution closed|3|||
163145003|NCT00762359|589241551|FG000|Overall Study|Physician Decision|2|||
163145004|NCT00762359|589241552|FG001|Overall Study|Physician Decision|3|||
163145005|NCT00762359|589241551|FG000|Overall Study|Removal|0|||
163145006|NCT00762359|589241552|FG001|Overall Study|Removal|1|||
163145007|NCT00762359|589241551|FG000|Overall Study|Withdrew consent|1|||
163145008|NCT00762359|589241552|FG001|Overall Study|Withdrew consent|0|||
163145009|NCT01421017|589241557|FG000|Overall Study|Withdrawal by Subject|2|||
163145010|NCT01421017|589241558|FG001|Overall Study|Withdrawal by Subject|0|||
163145011|NCT01421017|589241559|FG002|Overall Study|Withdrawal by Subject|0|||
163145012|NCT01421017|589241557|FG000|Overall Study|POD|0|||
163145013|NCT01421017|589241558|FG001|Overall Study|POD|6|||
163145014|NCT01421017|589241559|FG002|Overall Study|POD|3|||
163145015|NCT02313766|589241560|FG000|Overall Study|surgery cancelled|1|||
163145016|NCT02313766|589241561|FG001|Overall Study|surgery cancelled|0|||
163145017|NCT02313766|589241562|FG002|Overall Study|surgery cancelled|0|||
163145018|NCT02313766|589241560|FG000|Overall Study|Lost to Follow-up|0|||
163145019|NCT02313766|589241561|FG001|Overall Study|Lost to Follow-up|2|||
163145020|NCT02313766|589241562|FG002|Overall Study|Lost to Follow-up|0|||
163145021|NCT02313766|589241560|FG000|Overall Study|Adverse Event|0|||
163145022|NCT02313766|589241561|FG001|Overall Study|Adverse Event|1|||
163145023|NCT02313766|589241562|FG002|Overall Study|Adverse Event|0|||
163145024|NCT00416624|589241565|FG000|Overall Study|Withdrawal by Subject|1|||
163145025|NCT00416624|589241566|FG001|Overall Study|Withdrawal by Subject|6|||
163145026|NCT00416624|589241567|FG002|Overall Study|Withdrawal by Subject|4|||
163145027|NCT00416624|589241568|FG003|Overall Study|Withdrawal by Subject|9|||
163145028|NCT00416624|589241565|FG000|Overall Study|Death|4|||
163145029|NCT00416624|589241566|FG001|Overall Study|Death|7|||
163145030|NCT00416624|589241567|FG002|Overall Study|Death|7|||
163145031|NCT00416624|589241568|FG003|Overall Study|Death|1|||
163145032|NCT00416624|589241565|FG000|Overall Study|Adverse Event|8|||
163145033|NCT00416624|589241566|FG001|Overall Study|Adverse Event|3|||
163145034|NCT00416624|589241567|FG002|Overall Study|Adverse Event|2|||
163145035|NCT00416624|589241568|FG003|Overall Study|Adverse Event|2|||
163145036|NCT00416624|589241565|FG000|Overall Study|Other|8|||
163145037|NCT00416624|589241566|FG001|Overall Study|Other|11|||
163145038|NCT00416624|589241567|FG002|Overall Study|Other|5|||
163145039|NCT00416624|589241568|FG003|Overall Study|Other|5|||
163145040|NCT00416624|589241565|FG000|Overall Study|Cancel|1|||
163145041|NCT00416624|589241566|FG001|Overall Study|Cancel|0|||
163145042|NCT00416624|589241567|FG002|Overall Study|Cancel|0|||
163145043|NCT00416624|589241568|FG003|Overall Study|Cancel|0|||
163145044|NCT01005251|589241569|FG000|Overall Study|Withdrawal by Subject|2|||
163145045|NCT01005251|589241570|FG001|Overall Study|Withdrawal by Subject|5|||
163145046|NCT01005251|589241571|FG002|Overall Study|Withdrawal by Subject|3|||
163145047|NCT01005251|589241572|FG003|Overall Study|Withdrawal by Subject|4|||
163145048|NCT01005251|589241573|FG004|Overall Study|Withdrawal by Subject|9|||
163145049|NCT01005251|589241569|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
163145050|NCT01005251|589241570|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163145051|NCT01005251|589241571|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
163145052|NCT01005251|589241572|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
163145053|NCT01005251|589241573|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
162663417|NCT03266588|587480581|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
162663418|NCT03266588|587480579|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
162663419|NCT03266588|587480580|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
162663420|NCT03266588|587480581|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
162663421|NCT03266588|587480579|FG000|Long-term Treatment Period|Non-Compliance|126|||
162663422|NCT03266588|587480580|FG001|Long-term Treatment Period|Non-Compliance|57|||
162663423|NCT03266588|587480581|FG002|Long-term Treatment Period|Non-Compliance|7|||
162663424|NCT03266588|587480579|FG000|Long-term Treatment Period|Pregnancy|11|||
162663425|NCT03266588|587480580|FG001|Long-term Treatment Period|Pregnancy|5|||
162663426|NCT03266588|587480581|FG002|Long-term Treatment Period|Pregnancy|0|||
162663427|NCT03266588|587480579|FG000|Long-term Treatment Period|Protocol Deviation|17|||
162663428|NCT03266588|587480580|FG001|Long-term Treatment Period|Protocol Deviation|10|||
162663429|NCT03266588|587480581|FG002|Long-term Treatment Period|Protocol Deviation|4|||
162663430|NCT03266588|587480579|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
162663431|NCT03266588|587480580|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
162663432|NCT03266588|587480581|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
162663433|NCT03266588|587480579|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
162663434|NCT03266588|587480580|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
162663435|NCT03266588|587480581|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
162663436|NCT03266588|587480579|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
162663437|NCT03266588|587480580|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
162663438|NCT03266588|587480581|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
162663439|NCT03266588|587480579|FG000|Long-term Treatment Period|Other Reasons|5|||
162663440|NCT03266588|587480580|FG001|Long-term Treatment Period|Other Reasons|0|||
162663441|NCT03266588|587480581|FG002|Long-term Treatment Period|Other Reasons|0|||
162663442|NCT03266588|587480579|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
162663443|NCT03266588|587480580|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
162663444|NCT03266588|587480581|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
162663445|NCT01073618|587480584|FG000|Overall Study|Death|208|||
162663446|NCT01073618|587480584|FG000|Overall Study|Adverse Event|19|||
162663447|NCT01073618|587480584|FG000|Overall Study|Other|80|||
162663448|NCT02044510|587480585|FG000|Overall Study|Adverse Event|1|||
162663449|NCT02044510|587480586|FG001|Overall Study|Adverse Event|2|||
162663450|NCT02039505|587480592|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
162663451|NCT02039505|587480593|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
162663452|NCT02039505|587480594|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
162663453|NCT02039505|587480595|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162663454|NCT02039505|587480596|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162663455|NCT02039505|587480597|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
163145054|NCT01005251|589241569|FG000|Overall Study|Adverse Event|2|||
163145055|NCT01005251|589241570|FG001|Overall Study|Adverse Event|6|||
163145056|NCT01005251|589241571|FG002|Overall Study|Adverse Event|8|||
163145057|NCT01005251|589241572|FG003|Overall Study|Adverse Event|5|||
163145058|NCT01005251|589241573|FG004|Overall Study|Adverse Event|4|||
163145059|NCT01005251|589241569|FG000|Overall Study|Protocol Violation|1|||
163145060|NCT01005251|589241570|FG001|Overall Study|Protocol Violation|0|||
163145061|NCT01005251|589241571|FG002|Overall Study|Protocol Violation|0|||
163145062|NCT01005251|589241572|FG003|Overall Study|Protocol Violation|0|||
163145063|NCT01005251|589241573|FG004|Overall Study|Protocol Violation|2|||
163145064|NCT01005251|589241569|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
163145065|NCT01005251|589241570|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
162663456|NCT02039505|587480598|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162663457|NCT02039505|587480592|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
162663458|NCT02039505|587480593|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
162663459|NCT02039505|587480594|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
162663460|NCT02039505|587480595|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162663461|NCT02039505|587480596|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162663462|NCT02039505|587480597|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162663463|NCT02039505|587480598|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162663464|NCT02039505|587480592|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
162663465|NCT02039505|587480593|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663466|NCT02039505|587480594|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663467|NCT02039505|587480595|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663468|NCT02039505|587480596|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663469|NCT02039505|587480597|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663470|NCT02039505|587480598|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162663471|NCT02039505|587480592|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162663472|NCT02039505|587480593|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162663473|NCT02039505|587480594|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162663474|NCT02039505|587480595|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
162663475|NCT02039505|587480596|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
162663476|NCT02039505|587480597|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
162663477|NCT02039505|587480598|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162663478|NCT02039505|587480592|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162663479|NCT02039505|587480593|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162663480|NCT02039505|587480594|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162663481|NCT02039505|587480595|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
162663482|NCT02039505|587480596|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
162663483|NCT02039505|587480597|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
162663484|NCT02039505|587480598|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162721120|NCT00430300|587686044|FG000|Overall Study|Other|0|||
163145066|NCT01005251|589241571|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
163145067|NCT01005251|589241572|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
162663485|NCT02039505|587480592|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162663486|NCT02039505|587480593|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162663487|NCT02039505|587480594|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162663488|NCT02039505|587480595|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
162663489|NCT02039505|587480596|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
162663490|NCT02039505|587480597|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
162663491|NCT02039505|587480598|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162663492|NCT02039505|587480592|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663493|NCT02039505|587480593|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663494|NCT02039505|587480594|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663495|NCT02039505|587480595|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
162663496|NCT02039505|587480596|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663497|NCT02039505|587480597|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663498|NCT02039505|587480598|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162663499|NCT02039505|587480592|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162663500|NCT02039505|587480593|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162663501|NCT02039505|587480594|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162663502|NCT02039505|587480595|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162663503|NCT02039505|587480596|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162663504|NCT02039505|587480597|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162721121|NCT00430300|587686045|FG001|Overall Study|Other|0|||
162721122|NCT00430300|587686046|FG002|Overall Study|Other|0|||
162721123|NCT00430300|587686047|FG003|Overall Study|Other|1|||
162663505|NCT02039505|587480598|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
162663506|NCT02039505|587480592|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663507|NCT02039505|587480593|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663508|NCT02039505|587480594|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663509|NCT02039505|587480595|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663510|NCT02039505|587480596|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663511|NCT02039505|587480597|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162663512|NCT02039505|587480598|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
162721124|NCT02041104|587686050|FG000|Overall Study|Lost to Follow-up|1|||
163145068|NCT01005251|589241573|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
163145069|NCT01005251|589241569|FG000|Overall Study|Lost to Follow-up|1|||
163145070|NCT01005251|589241570|FG001|Overall Study|Lost to Follow-up|4|||
163145071|NCT01005251|589241571|FG002|Overall Study|Lost to Follow-up|2|||
163145072|NCT01005251|589241572|FG003|Overall Study|Lost to Follow-up|0|||
163145073|NCT01005251|589241573|FG004|Overall Study|Lost to Follow-up|0|||
163145074|NCT01005251|589241569|FG000|Overall Study|Physician Decision|0|||
163145075|NCT01005251|589241570|FG001|Overall Study|Physician Decision|0|||
163145076|NCT01005251|589241571|FG002|Overall Study|Physician Decision|0|||
163145077|NCT01005251|589241572|FG003|Overall Study|Physician Decision|0|||
163145078|NCT01005251|589241573|FG004|Overall Study|Physician Decision|2|||
163145079|NCT01005251|589241569|FG000|Overall Study|Patient moved|1|||
163145080|NCT01005251|589241570|FG001|Overall Study|Patient moved|0|||
163145081|NCT01005251|589241571|FG002|Overall Study|Patient moved|0|||
163145082|NCT01005251|589241572|FG003|Overall Study|Patient moved|0|||
163145083|NCT01005251|589241573|FG004|Overall Study|Patient moved|0|||
163145084|NCT01005251|589241569|FG000|Overall Study|Wrong drug dispensed|0|||
163145085|NCT01005251|589241570|FG001|Overall Study|Wrong drug dispensed|1|||
163145086|NCT01005251|589241571|FG002|Overall Study|Wrong drug dispensed|0|||
163145087|NCT01005251|589241572|FG003|Overall Study|Wrong drug dispensed|0|||
163145088|NCT01005251|589241573|FG004|Overall Study|Wrong drug dispensed|0|||
163145089|NCT01005251|589241569|FG000|Overall Study|Randomized in error|0|||
163145090|NCT01005251|589241570|FG001|Overall Study|Randomized in error|0|||
163145091|NCT01005251|589241571|FG002|Overall Study|Randomized in error|1|||
163145092|NCT01005251|589241572|FG003|Overall Study|Randomized in error|1|||
163145093|NCT01005251|589241573|FG004|Overall Study|Randomized in error|0|||
163145094|NCT01005251|589241569|FG000|Overall Study|Lack of Efficacy|0|||
163145095|NCT01005251|589241570|FG001|Overall Study|Lack of Efficacy|0|||
163145096|NCT01005251|589241571|FG002|Overall Study|Lack of Efficacy|1|||
163145097|NCT01005251|589241572|FG003|Overall Study|Lack of Efficacy|1|||
163145098|NCT01005251|589241573|FG004|Overall Study|Lack of Efficacy|0|||
163145099|NCT01702844|589241574|FG000|Overall Study|Adverse Event|9|||
163145100|NCT01702844|589241574|FG000|Overall Study|Death|1|||
163145101|NCT01702844|589241574|FG000|Overall Study|Withdrawal by Subject|3|||
163145102|NCT01702844|589241574|FG000|Overall Study|Physician Decision|6|||
163145103|NCT02193776|589241575|FG000|Overall Study|Consent withdrawn|1|||
163145104|NCT02193776|589241576|FG001|Overall Study|Consent withdrawn|0|||
163145105|NCT02193776|589241577|FG002|Overall Study|Consent withdrawn|0|||
163145106|NCT02193776|589241578|FG003|Overall Study|Consent withdrawn|0|||
163145107|NCT02193776|589241575|FG000|Overall Study|Failure to comply with protocol|0|||
163145108|NCT02193776|589241576|FG001|Overall Study|Failure to comply with protocol|1|||
163145109|NCT02193776|589241577|FG002|Overall Study|Failure to comply with protocol|0|||
163145110|NCT02193776|589241578|FG003|Overall Study|Failure to comply with protocol|0|||
163145111|NCT02193776|589241575|FG000|Overall Study|Investigator/Sponsor decision|1|||
163145112|NCT02193776|589241576|FG001|Overall Study|Investigator/Sponsor decision|1|||
163145113|NCT02193776|589241577|FG002|Overall Study|Investigator/Sponsor decision|0|||
163145114|NCT02193776|589241578|FG003|Overall Study|Investigator/Sponsor decision|0|||
163145115|NCT02193776|589241575|FG000|Overall Study|Death|1|||
163145116|NCT02193776|589241576|FG001|Overall Study|Death|0|||
163145117|NCT02193776|589241577|FG002|Overall Study|Death|0|||
163145118|NCT02193776|589241578|FG003|Overall Study|Death|0|||
163145119|NCT02193776|589241575|FG000|Overall Study|Adverse event/Specific toxicity|5|||
163145120|NCT02193776|589241576|FG001|Overall Study|Adverse event/Specific toxicity|5|||
163145121|NCT02193776|589241577|FG002|Overall Study|Adverse event/Specific toxicity|2|||
163145122|NCT02193776|589241578|FG003|Overall Study|Adverse event/Specific toxicity|2|||
163145123|NCT02995980|589241579|FG000|Overall Study|Lost to Follow-up|14|||
163145124|NCT01458639|589241581|FG000|Overall Study|Physician Decision|4|||
163145125|NCT01458639|589241581|FG000|Overall Study|Equipment issue|1|||
163145126|NCT01458639|589241581|FG000|Overall Study|Inability to obtain subject blood sample|1|||
163145127|NCT04245111|589241582|FG000|Overall Study|Lost to Follow-up|5|||
163145128|NCT04245111|589241583|FG001|Overall Study|Lost to Follow-up|1|||
163145129|NCT04245111|589241584|FG002|Overall Study|Lost to Follow-up|1|||
163145130|NCT06039579|589241585|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145131|NCT06039579|589241586|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145132|NCT06039579|589241587|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145133|NCT06039579|589241588|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162721125|NCT02041104|587686051|FG001|Overall Study|Lost to Follow-up|4|||
162663513|NCT02039505|587480592|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663514|NCT02039505|587480593|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663515|NCT02039505|587480594|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663516|NCT02039505|587480595|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663517|NCT02039505|587480596|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663518|NCT02039505|587480597|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162663519|NCT02039505|587480598|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
162663520|NCT02039505|587480592|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663521|NCT02039505|587480593|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663522|NCT02039505|587480594|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663523|NCT02039505|587480595|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663524|NCT02039505|587480596|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663525|NCT02039505|587480597|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162663526|NCT02039505|587480598|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
162663527|NCT00353704|587480603|FG000|Overall Study|Protocol Violation|3|||
162663528|NCT00353704|587480604|FG001|Overall Study|Protocol Violation|1|||
162663529|NCT01154166|587480605|FG000|Overall Study|Adverse Event|14|||
162663530|NCT01154166|587480606|FG001|Overall Study|Adverse Event|9|||
162663531|NCT01154166|587480605|FG000|Overall Study|Lost to Follow-up|1|||
162663532|NCT01154166|587480606|FG001|Overall Study|Lost to Follow-up|1|||
162663533|NCT01154166|587480605|FG000|Overall Study|Protocol Violation|4|||
162663534|NCT01154166|587480606|FG001|Overall Study|Protocol Violation|1|||
162663535|NCT01154166|587480605|FG000|Overall Study|Withdrawal by Subject|10|||
162663536|NCT01154166|587480606|FG001|Overall Study|Withdrawal by Subject|1|||
162663537|NCT01154166|587480605|FG000|Overall Study|Lack of Efficacy|3|||
162663538|NCT01154166|587480606|FG001|Overall Study|Lack of Efficacy|0|||
162663539|NCT01154166|587480605|FG000|Overall Study|Disease Progression|1|||
162663540|NCT01154166|587480606|FG001|Overall Study|Disease Progression|0|||
162663541|NCT01154166|587480605|FG000|Overall Study|Poor Compliance|1|||
162663542|NCT01154166|587480606|FG001|Overall Study|Poor Compliance|0|||
162663543|NCT03614793|587480607|FG000|Overall Study|Lost to Follow-up|1|||
162663544|NCT03614793|587480608|FG001|Overall Study|Lost to Follow-up|2|||
162663545|NCT03614793|587480607|FG000|Overall Study|Lack of Efficacy|0|||
162663546|NCT03614793|587480608|FG001|Overall Study|Lack of Efficacy|5|||
162663547|NCT03614793|587480607|FG000|Overall Study|Withdrawal by Subject|0|||
162663548|NCT03614793|587480608|FG001|Overall Study|Withdrawal by Subject|1|||
162663549|NCT03614793|587480607|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
162663550|NCT03614793|587480608|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
162663551|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
162663552|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
162663553|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
162663554|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Death|1|||
162663555|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
162663556|NCT02840877|587480609|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
162721126|NCT02041104|587686050|FG000|Overall Study|discomfort during OGTT|0|||
162721127|NCT02041104|587686051|FG001|Overall Study|discomfort during OGTT|3|||
162721128|NCT01063517|587686052|FG000|Overall Study|Consent withdrawal|1|||
162721129|NCT01063517|587686053|FG001|Overall Study|Consent withdrawal|0|||
162721130|NCT01063517|587686052|FG000|Overall Study|Study reached data cut-off|19|||
162721131|NCT01063517|587686053|FG001|Overall Study|Study reached data cut-off|7|||
162721132|NCT01063517|587686052|FG000|Overall Study|Lost to Follow-up|4|||
162721133|NCT01063517|587686053|FG001|Overall Study|Lost to Follow-up|3|||
162721134|NCT01063517|587686052|FG000|Overall Study|Withdrawal by Subject|1|||
162721135|NCT01063517|587686053|FG001|Overall Study|Withdrawal by Subject|2|||
162721136|NCT01063517|587686052|FG000|Overall Study|Death|33|||
162721137|NCT01063517|587686053|FG001|Overall Study|Death|48|||
162663557|NCT02840877|587480609|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
162721138|NCT02106442|587686055|FG000|Overall Study|Case Report Forms Uncollected|7|||
162721139|NCT02106442|587686055|FG000|Overall Study|Protocol Deviation|30|||
162721140|NCT06269640|587688199|FG000|Overall Study|Death|1|||
162721141|NCT00423098|587688202|FG000|Overall Study|Adverse Event|1|||
162663558|NCT02840877|587480609|FG000|12 Weeks to 6 Months|Treatment failure|1|||
162663559|NCT02840877|587480609|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
162663560|NCT02840877|587480609|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
162663561|NCT02840877|587480609|FG000|12 Weeks to 6 Months|Death|1|||
162663562|NCT02840877|587480609|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
162663563|NCT02840877|587480609|FG000|6 Months to 18 Months|Treatment failure|7|||
162663564|NCT02840877|587480609|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
162663565|NCT02840877|587480609|FG000|6 Months to 18 Months|Moved/transferred out|6|||
162663566|NCT02840877|587480609|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
162663567|NCT02840877|587480609|FG000|6 Months to 18 Months|Death|4|||
162663568|NCT02840877|587480609|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
162663569|NCT02840877|587480609|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
162663570|NCT02840877|587480609|FG000|6 Months to 18 Months|Still in study.|14|||
162663571|NCT04317586|587480610|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
162663572|NCT04317586|587480610|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
162663573|NCT01276327|587480613|FG000|Overall Study|Adverse Event|1|||
162663574|NCT01276327|587480614|FG001|Overall Study|Adverse Event|3|||
162663575|NCT01276327|587480613|FG000|Overall Study|Withdrawal by Subject|1|||
162663576|NCT01276327|587480614|FG001|Overall Study|Withdrawal by Subject|0|||
162663577|NCT00807092|587480615|FG000|Overall Study|Adverse Event|0|||
162721142|NCT00423098|587688203|FG001|Overall Study|Adverse Event|2|||
162721143|NCT00423098|587688202|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162663578|NCT00807092|587480616|FG001|Overall Study|Adverse Event|1|||
162663579|NCT00807092|587480615|FG000|Overall Study|Protocol Violation|0|||
162721144|NCT00423098|587688203|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162721145|NCT00423098|587688202|FG000|Overall Study|Administrative problems|0|||
162663580|NCT00807092|587480616|FG001|Overall Study|Protocol Violation|2|||
162721146|NCT00423098|587688203|FG001|Overall Study|Administrative problems|1|||
162721147|NCT00423098|587688202|FG000|Overall Study|Death|2|||
162721148|NCT00423098|587688203|FG001|Overall Study|Death|0|||
162663581|NCT00807092|587480615|FG000|Overall Study|Withdrawal by Subject|1|||
162663582|NCT00807092|587480616|FG001|Overall Study|Withdrawal by Subject|0|||
162721149|NCT00711958|587688216|FG000|Overall Study|Withdrawal by Subject|6|||
162721150|NCT00711958|587688217|FG001|Overall Study|Withdrawal by Subject|8|||
163145134|NCT06039579|589241589|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145135|NCT06039579|589241590|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145136|NCT06039579|589241591|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
163145137|NCT06039579|589241592|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
163145138|NCT02792231|589241593|FG000|Overall Study|Patient/guardian decision|32|||
163145139|NCT02792231|589241594|FG001|Overall Study|Patient/guardian decision|42|||
163145140|NCT02792231|589241593|FG000|Overall Study|Adverse Event|15|||
163145141|NCT02792231|589241594|FG001|Overall Study|Adverse Event|11|||
163145142|NCT02792231|589241593|FG000|Overall Study|Physician Decision|14|||
163145143|NCT02792231|589241594|FG001|Overall Study|Physician Decision|12|||
163145144|NCT02792231|589241593|FG000|Overall Study|Lack of Efficacy|7|||
163145145|NCT02792231|589241594|FG001|Overall Study|Lack of Efficacy|9|||
163145146|NCT02792231|589241593|FG000|Overall Study|Lost to Follow-up|9|||
163145147|NCT02792231|589241594|FG001|Overall Study|Lost to Follow-up|5|||
163145148|NCT02792231|589241593|FG000|Overall Study|Pregnancy|1|||
162721151|NCT00711958|587688216|FG000|Overall Study|Lack of Efficacy|3|||
162721152|NCT00711958|587688217|FG001|Overall Study|Lack of Efficacy|1|||
162721153|NCT00711958|587688216|FG000|Overall Study|Clinical deterioration|1|||
162721154|NCT00711958|587688217|FG001|Overall Study|Clinical deterioration|0|||
162721155|NCT00711958|587688216|FG000|Overall Study|Adverse Event|9|||
162721156|NCT00711958|587688217|FG001|Overall Study|Adverse Event|7|||
162721157|NCT00711958|587688216|FG000|Overall Study|Protocol Violation|1|||
162721158|NCT00711958|587688217|FG001|Overall Study|Protocol Violation|0|||
162721159|NCT00711958|587688216|FG000|Overall Study|Lost to Follow-up|2|||
162721160|NCT00711958|587688217|FG001|Overall Study|Lost to Follow-up|2|||
162721161|NCT00711958|587688216|FG000|Overall Study|Death|10|||
162721162|NCT00711958|587688217|FG001|Overall Study|Death|5|||
162721163|NCT00711958|587688216|FG000|Overall Study|Progression of disease|1|||
163145149|NCT02792231|589241594|FG001|Overall Study|Pregnancy|3|||
163145150|NCT02792231|589241593|FG000|Overall Study|Non-compliance with study treatment|2|||
163145151|NCT02792231|589241594|FG001|Overall Study|Non-compliance with study treatment|1|||
163145152|NCT02792231|589241593|FG000|Overall Study|Protocol deviation|2|||
163145153|NCT02792231|589241594|FG001|Overall Study|Protocol deviation|0|||
163145154|NCT02792231|589241593|FG000|Overall Study|Technical problems|0|||
163145155|NCT02792231|589241594|FG001|Overall Study|Technical problems|1|||
163145156|NCT03309878|589241595|FG000|Overall Study|Adverse Event|1|||
163145157|NCT03309878|589241596|FG001|Overall Study|Adverse Event|0|||
163145158|NCT03309878|589241597|FG002|Overall Study|Adverse Event|0|||
163145159|NCT03309878|589241598|FG003|Overall Study|Adverse Event|0|||
163145160|NCT03309878|589241595|FG000|Overall Study|Did not maintain eligibility|2|||
163145161|NCT03309878|589241596|FG001|Overall Study|Did not maintain eligibility|1|||
163145162|NCT03309878|589241597|FG002|Overall Study|Did not maintain eligibility|0|||
163145163|NCT03309878|589241598|FG003|Overall Study|Did not maintain eligibility|0|||
163145164|NCT03309878|589241595|FG000|Overall Study|Withdrawal by Subject|0|||
163145165|NCT03309878|589241596|FG001|Overall Study|Withdrawal by Subject|1|||
163145166|NCT03309878|589241597|FG002|Overall Study|Withdrawal by Subject|0|||
163145167|NCT03309878|589241598|FG003|Overall Study|Withdrawal by Subject|0|||
163145168|NCT01884077|589241599|FG000|Overall Study|screen fail|0|||
163145169|NCT01884077|589241600|FG001|Overall Study|screen fail|2|||
163145170|NCT01884077|589241599|FG000|Overall Study|canceled surgery|2|||
163145171|NCT01884077|589241600|FG001|Overall Study|canceled surgery|0|||
163145172|NCT01884077|589241599|FG000|Overall Study|Lost to Follow-up|0|||
163145173|NCT01884077|589241600|FG001|Overall Study|Lost to Follow-up|4|||
163145174|NCT01884077|589241599|FG000|Overall Study|study closed|6|||
163145175|NCT01884077|589241600|FG001|Overall Study|study closed|4|||
163145176|NCT00981149|589241602|FG000|Overall Study|Lost to Follow-up|1|||
163145177|NCT00981149|589241603|FG001|Overall Study|Lost to Follow-up|2|||
163145178|NCT00981149|589241602|FG000|Overall Study|Withdrawal by Subject|1|||
163145179|NCT00981149|589241603|FG001|Overall Study|Withdrawal by Subject|1|||
163145180|NCT01220167|589241607|FG000|Period 3|Urine positive for substance abuse|0|||
163145181|NCT01220167|589241608|FG001|Period 3|Urine positive for substance abuse|1|||
163145182|NCT01220167|589241609|FG002|Period 3|Urine positive for substance abuse|0|||
162721164|NCT00711958|587688217|FG001|Overall Study|Progression of disease|0|||
163145183|NCT01008943|589241610|FG000|Overall Study|Withdrawal by Subject|1|||
163145184|NCT00861705|589241611|FG000|Overall Study|Never Began Treatment|7|||
163145185|NCT00861705|589241612|FG001|Overall Study|Never Began Treatment|3|||
163145186|NCT00861705|589241613|FG002|Overall Study|Never Began Treatment|0|||
163145187|NCT00861705|589241614|FG003|Overall Study|Never Began Treatment|1|||
163145188|NCT06237049|589241623|FG000|Overall Study|Death|0|||
163145189|NCT06237049|589241624|FG001|Overall Study|Death|0|||
163145190|NCT06237049|589241625|FG002|Overall Study|Death|0|||
163145191|NCT06237049|589241626|FG003|Overall Study|Death|1|||
163145192|NCT06237049|589241623|FG000|Overall Study|Lost to Follow-up|11|||
163145193|NCT06237049|589241624|FG001|Overall Study|Lost to Follow-up|5|||
163145194|NCT06237049|589241625|FG002|Overall Study|Lost to Follow-up|8|||
163145195|NCT06237049|589241626|FG003|Overall Study|Lost to Follow-up|8|||
163145196|NCT06237049|589241623|FG000|Overall Study|Protocol Violation|0|||
163145197|NCT06237049|589241624|FG001|Overall Study|Protocol Violation|1|||
163145198|NCT06237049|589241625|FG002|Overall Study|Protocol Violation|0|||
163145199|NCT06237049|589241626|FG003|Overall Study|Protocol Violation|1|||
163145200|NCT06237049|589241623|FG000|Overall Study|Withdrawal by Subject|4|||
163145201|NCT06237049|589241624|FG001|Overall Study|Withdrawal by Subject|2|||
163145202|NCT06237049|589241625|FG002|Overall Study|Withdrawal by Subject|1|||
163145203|NCT06237049|589241626|FG003|Overall Study|Withdrawal by Subject|0|||
163145204|NCT04678115|589241627|FG000|Overall Study|Lost to Follow-up|1|||
163145205|NCT04678115|589241628|FG001|Overall Study|Lost to Follow-up|0|||
163145206|NCT02336607|589241629|FG000|Overall Study|Physician Decision|1|||
163145207|NCT02336607|589241630|FG001|Overall Study|Physician Decision|4|||
163145208|NCT02336607|589241631|FG002|Overall Study|Physician Decision|3|||
163145209|NCT02336607|589241632|FG003|Overall Study|Physician Decision|15|||
163145210|NCT02336607|589241629|FG000|Overall Study|Lack of Efficacy|1|||
163145211|NCT02336607|589241630|FG001|Overall Study|Lack of Efficacy|0|||
163145212|NCT02336607|589241631|FG002|Overall Study|Lack of Efficacy|0|||
163145213|NCT02336607|589241632|FG003|Overall Study|Lack of Efficacy|2|||
163145214|NCT02336607|589241629|FG000|Overall Study|Lost to Follow-up|2|||
163145215|NCT02336607|589241630|FG001|Overall Study|Lost to Follow-up|1|||
163145216|NCT02336607|589241631|FG002|Overall Study|Lost to Follow-up|0|||
163145217|NCT02336607|589241632|FG003|Overall Study|Lost to Follow-up|21|||
163145218|NCT02336607|589241629|FG000|Overall Study|Protocol Violation|0|||
163145219|NCT02336607|589241630|FG001|Overall Study|Protocol Violation|1|||
163145220|NCT02336607|589241631|FG002|Overall Study|Protocol Violation|1|||
163145221|NCT02336607|589241632|FG003|Overall Study|Protocol Violation|3|||
163145222|NCT02336607|589241629|FG000|Overall Study|Adverse Event|0|||
163145223|NCT02336607|589241630|FG001|Overall Study|Adverse Event|2|||
163145224|NCT02336607|589241631|FG002|Overall Study|Adverse Event|2|||
163145225|NCT02336607|589241632|FG003|Overall Study|Adverse Event|26|||
163145226|NCT02336607|589241629|FG000|Overall Study|Withdrawal by Subject|0|||
163145227|NCT02336607|589241630|FG001|Overall Study|Withdrawal by Subject|2|||
163145228|NCT02336607|589241631|FG002|Overall Study|Withdrawal by Subject|0|||
163145229|NCT02336607|589241632|FG003|Overall Study|Withdrawal by Subject|20|||
163145230|NCT02552966|589241633|FG000|Overall Study|Lost to Follow-up|2|||
163145231|NCT02552966|589241633|FG000|Overall Study|Withdrawal by Subject|3|||
163145232|NCT01091675|589241641|FG000|Overall Study|Adverse Event|7|||
163145233|NCT01091675|589241641|FG000|Overall Study|Lack of Efficacy|27|||
163145234|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145235|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145236|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145237|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
163145238|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145239|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145240|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145241|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145242|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145243|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
163145244|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
163145245|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
163145246|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145247|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
163145248|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
163145249|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
163145250|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145251|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145252|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145253|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
163145254|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
163145255|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145256|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145257|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145258|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
162663583|NCT00807092|587480615|FG000|Overall Study|CGMS data collection failed|0|||
162663584|NCT00807092|587480616|FG001|Overall Study|CGMS data collection failed|1|||
162663585|NCT01794949|587480617|FG000|Overall Study|Lost to Follow-up|1|||
162663586|NCT01794949|587480618|FG001|Overall Study|Lost to Follow-up|0|||
162663587|NCT03003676|587480619|FG000|Overall Study|Lack of Efficacy|5|||
162663588|NCT03003676|587480620|FG001|Overall Study|Lack of Efficacy|7|||
163145259|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
163145260|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145261|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145262|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145263|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
163145264|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145265|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145266|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145267|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145268|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145269|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
163145270|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145271|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145272|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145273|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
163145274|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
163145275|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145276|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
163145277|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145278|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
163145279|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145280|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145281|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145282|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145283|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
163145284|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145285|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145286|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145287|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145288|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145289|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
163145290|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145291|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145292|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145293|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
163145294|NCT02365649|589241649|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145295|NCT02365649|589241650|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145296|NCT02365649|589241651|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
163145297|NCT02365649|589241652|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145298|NCT02365649|589241653|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145299|NCT02365649|589241654|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145300|NCT02365649|589241655|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145301|NCT02365649|589241656|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145302|NCT02365649|589241657|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145303|NCT02365649|589241658|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
163145304|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145305|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145306|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145307|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145308|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145309|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145310|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
163145311|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145312|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145313|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
163145314|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145315|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145316|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145317|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162663589|NCT03003676|587480619|FG000|Overall Study|Withdrawal by Subject|0|||
162721165|NCT02383472|587688218|FG000|Overall Study|Withdrawal by Subject|1|||
162663590|NCT03003676|587480620|FG001|Overall Study|Withdrawal by Subject|1|||
162663591|NCT03003676|587480619|FG000|Overall Study|Hepatitis B infection|1|||
162663592|NCT03003676|587480620|FG001|Overall Study|Hepatitis B infection|0|||
162663593|NCT02617589|587480637|FG000|Randomization|Request to Discontinue Study Treatment|1|||
162663594|NCT02617589|587480638|FG001|Randomization|Request to Discontinue Study Treatment|3|||
162663595|NCT02617589|587480637|FG000|Randomization|Participant Withdrew Consent|1|||
163145318|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145319|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145320|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
163145321|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
163145322|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
163145323|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
163145324|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145325|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145326|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145327|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145328|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145329|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
163145330|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
163145331|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
163145332|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
163145333|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
163145334|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145335|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145336|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145337|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145338|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145339|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145340|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
163145341|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
163145342|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
163145343|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
163145344|NCT02365649|589241649|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145345|NCT02365649|589241650|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145346|NCT02365649|589241651|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145347|NCT02365649|589241652|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145348|NCT02365649|589241653|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145349|NCT02365649|589241654|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145350|NCT02365649|589241655|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
163145351|NCT02365649|589241656|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145352|NCT02365649|589241657|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
163145353|NCT02365649|589241658|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
163145354|NCT01506271|589241659|FG000|Overall Study|Progressive disease|0|||
163145355|NCT01506271|589241660|FG001|Overall Study|Progressive disease|1|||
163145356|NCT01506271|589241661|FG002|Overall Study|Progressive disease|0|||
163145357|NCT01506271|589241659|FG000|Overall Study|Protocol Violation|3|||
163145358|NCT01506271|589241660|FG001|Overall Study|Protocol Violation|1|||
163145359|NCT01506271|589241661|FG002|Overall Study|Protocol Violation|0|||
163145360|NCT01506271|589241659|FG000|Overall Study|Death|0|||
163145361|NCT01506271|589241660|FG001|Overall Study|Death|1|||
163145362|NCT01506271|589241661|FG002|Overall Study|Death|0|||
163145363|NCT01506271|589241659|FG000|Overall Study|Adverse Event|0|||
163145364|NCT01506271|589241660|FG001|Overall Study|Adverse Event|2|||
163145365|NCT01506271|589241661|FG002|Overall Study|Adverse Event|0|||
163145366|NCT01506271|589241659|FG000|Overall Study|Insufficient supply of study drug|1|||
163145367|NCT01506271|589241660|FG001|Overall Study|Insufficient supply of study drug|0|||
163145368|NCT01506271|589241661|FG002|Overall Study|Insufficient supply of study drug|0|||
163145369|NCT01506271|589241659|FG000|Overall Study|Withdrawal by Subject|0|||
163145370|NCT01506271|589241660|FG001|Overall Study|Withdrawal by Subject|1|||
163145371|NCT01506271|589241661|FG002|Overall Study|Withdrawal by Subject|1|||
163145372|NCT01506271|589241659|FG000|Overall Study|Lost to Follow-up|0|||
163145373|NCT01506271|589241660|FG001|Overall Study|Lost to Follow-up|1|||
163145374|NCT01506271|589241661|FG002|Overall Study|Lost to Follow-up|2|||
163145375|NCT00689390|589241662|FG000|Overall Study|Adverse Event|19|||
163145376|NCT00689390|589241663|FG001|Overall Study|Adverse Event|0|||
163145377|NCT00689390|589241662|FG000|Overall Study|Lost to Follow-up|179|||
163145378|NCT00689390|589241663|FG001|Overall Study|Lost to Follow-up|7|||
162663596|NCT02617589|587480638|FG001|Randomization|Participant Withdrew Consent|2|||
162663597|NCT02617589|587480637|FG000|Treatment|Other Reasons|3|||
162721166|NCT02383472|587688219|FG001|Overall Study|Withdrawal by Subject|1|||
162721167|NCT02013830|587688220|FG000|Overall Study|Adverse Event|3|||
162721168|NCT02013830|587688220|FG000|Overall Study|Death|1|||
162721169|NCT02013830|587688220|FG000|Overall Study|Insufficient therapeutic response|25|||
162721170|NCT02013830|587688220|FG000|Overall Study|Refused treatment|1|||
162721171|NCT01111526|587688221|FG000|Overall Study|GVHD Disease Progression|0|||
162721172|NCT01111526|587688222|FG001|Overall Study|GVHD Disease Progression|1|||
162721173|NCT01111526|587688223|FG002|Overall Study|GVHD Disease Progression|2|||
162721174|NCT04424641|587688224|FG000|Overall Study|Death|1|||
162721175|NCT04424641|587688225|FG001|Overall Study|Death|2|||
162721176|NCT04424641|587688226|FG002|Overall Study|Death|3|||
162721177|NCT04424641|587688227|FG003|Overall Study|Death|0|||
162721178|NCT04424641|587688228|FG004|Overall Study|Death|3|||
162721179|NCT04424641|587688229|FG005|Overall Study|Death|0|||
162721180|NCT04424641|587688230|FG006|Overall Study|Death|1|||
162721181|NCT04424641|587688231|FG007|Overall Study|Death|2|||
162721182|NCT04424641|587688224|FG000|Overall Study|Sponsor decision|0|||
163145379|NCT00689390|589241662|FG000|Overall Study|Withdrawal by Subject|117|||
163145380|NCT00689390|589241663|FG001|Overall Study|Withdrawal by Subject|3|||
163145381|NCT00689390|589241662|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
163145382|NCT00689390|589241663|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
163145383|NCT00689390|589241662|FG000|Overall Study|Non-Compliance With Protocol|21|||
163145384|NCT00689390|589241663|FG001|Overall Study|Non-Compliance With Protocol|0|||
163145385|NCT00689390|589241662|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163145386|NCT00689390|589241663|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
163145387|NCT00689390|589241662|FG000|Overall Study|Administrative|37|||
163145388|NCT00689390|589241663|FG001|Overall Study|Administrative|0|||
163145389|NCT00920855|589241665|FG000|Overall Study|Adverse Event|1|||
163145390|NCT00920855|589241666|FG001|Overall Study|Adverse Event|1|||
163145391|NCT00920855|589241667|FG002|Overall Study|Adverse Event|4|||
163145392|NCT00920855|589241665|FG000|Overall Study|Withdrawal by Subject|2|||
163145393|NCT00920855|589241666|FG001|Overall Study|Withdrawal by Subject|1|||
163145394|NCT00920855|589241667|FG002|Overall Study|Withdrawal by Subject|6|||
163145395|NCT00920855|589241665|FG000|Overall Study|Disease progression|2|||
163145396|NCT00920855|589241666|FG001|Overall Study|Disease progression|1|||
163145397|NCT00920855|589241667|FG002|Overall Study|Disease progression|10|||
163145398|NCT00920855|589241665|FG000|Overall Study|Noncompliance to study medication|0|||
163145399|NCT00920855|589241666|FG001|Overall Study|Noncompliance to study medication|0|||
163145400|NCT00920855|589241667|FG002|Overall Study|Noncompliance to study medication|1|||
163145401|NCT00920855|589241665|FG000|Overall Study|Response plateau; started maintenance|0|||
163145402|NCT00920855|589241666|FG001|Overall Study|Response plateau; started maintenance|0|||
163145403|NCT00920855|589241667|FG002|Overall Study|Response plateau; started maintenance|1|||
163145404|NCT00539994|589241668|FG000|Overall Study|Lost to Follow-up|2|||
163145405|NCT00539994|589241669|FG001|Overall Study|Lost to Follow-up|1|||
163145406|NCT00539994|589241670|FG002|Overall Study|Lost to Follow-up|0|||
163145407|NCT00539994|589241668|FG000|Overall Study|Withdrawal by Subject|1|||
163145408|NCT00539994|589241669|FG001|Overall Study|Withdrawal by Subject|0|||
163145409|NCT00539994|589241670|FG002|Overall Study|Withdrawal by Subject|1|||
163145410|NCT00539994|589241668|FG000|Overall Study|Physician Decision|0|||
163145411|NCT00539994|589241669|FG001|Overall Study|Physician Decision|0|||
163145412|NCT00539994|589241670|FG002|Overall Study|Physician Decision|1|||
163145413|NCT01611194|589241674|FG000|Overall Study|Lost to Follow-up|0|||
163145414|NCT01611194|589241675|FG001|Overall Study|Lost to Follow-up|1|||
163145415|NCT01611194|589241674|FG000|Overall Study|Withdrawal by Subject|0|||
163145416|NCT01611194|589241675|FG001|Overall Study|Withdrawal by Subject|1|||
163145417|NCT01611194|589241674|FG000|Overall Study|drug use|0|||
163145418|NCT01611194|589241675|FG001|Overall Study|drug use|1|||
163145419|NCT02464410|589241687|FG000|Overall Study|Death|3|||
163145420|NCT02464410|589241688|FG001|Overall Study|Death|4|||
163145421|NCT02464410|589241687|FG000|Overall Study|Lost to Follow-up|7|||
163145422|NCT02464410|589241688|FG001|Overall Study|Lost to Follow-up|9|||
163145423|NCT02464410|589241687|FG000|Overall Study|Withdrawal by Subject|12|||
163145424|NCT02464410|589241688|FG001|Overall Study|Withdrawal by Subject|3|||
163145425|NCT01928927|589241689|FG000|Overall Study|Lost to Follow-up|1|||
163145426|NCT01928927|589241690|FG001|Overall Study|Lost to Follow-up|0|||
163145427|NCT01928927|589241689|FG000|Overall Study|Withdrawal by Subject|1|||
163145428|NCT01928927|589241690|FG001|Overall Study|Withdrawal by Subject|1|||
163145429|NCT01871519|589241695|FG000|Overall Study|Death|26|||
163145430|NCT01871519|589241695|FG000|Overall Study|Lost to Follow-up|15|||
163145431|NCT01871519|589241695|FG000|Overall Study|Withdrawal by Subject|49|||
163145432|NCT00350844|589241696|FG000|Overall Study|Lost to Follow-up|1|||
163145433|NCT02775916|589241697|FG000|Overall Study|Adverse Event|1|||
163145434|NCT02775916|589241698|FG001|Overall Study|Adverse Event|0|||
163145435|NCT02775916|589241697|FG000|Overall Study|Subject/Guardian Decision|2|||
163145436|NCT02775916|589241698|FG001|Overall Study|Subject/Guardian Decision|0|||
163145437|NCT00179621|589243036|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
163145438|NCT00179621|589243037|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
163145439|NCT00179621|589243038|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
162721183|NCT04424641|587688225|FG001|Overall Study|Sponsor decision|2|||
162721184|NCT04424641|587688226|FG002|Overall Study|Sponsor decision|3|||
162721185|NCT04424641|587688227|FG003|Overall Study|Sponsor decision|7|||
162663598|NCT02617589|587480638|FG001|Treatment|Other Reasons|3|||
162663599|NCT02617589|587480637|FG000|Treatment|Poor/Non Compliance|1|||
162663600|NCT02617589|587480638|FG001|Treatment|Poor/Non Compliance|1|||
162663601|NCT02617589|587480637|FG000|Treatment|Maximum Clinical Benefit|0|||
162663602|NCT02617589|587480638|FG001|Treatment|Maximum Clinical Benefit|2|||
162663603|NCT02617589|587480637|FG000|Treatment|Participant Withdrew Consent|2|||
162663604|NCT02617589|587480638|FG001|Treatment|Participant Withdrew Consent|6|||
163145440|NCT00179621|589243039|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
163145441|NCT00179621|589243036|FG000|Double-Blind Period|Adverse Event|2|||
163145442|NCT00179621|589243037|FG001|Double-Blind Period|Adverse Event|7|||
163145443|NCT00179621|589243038|FG002|Double-Blind Period|Adverse Event|4|||
163145444|NCT00179621|589243039|FG003|Double-Blind Period|Adverse Event|0|||
163145445|NCT00179621|589243036|FG000|Double-Blind Period|Withdrawal by Subject|2|||
163145446|NCT00179621|589243037|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163145447|NCT00179621|589243038|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163145448|NCT00179621|589243039|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163145449|NCT00179621|589243036|FG000|Double-Blind Period|Death|0|||
163145450|NCT00179621|589243037|FG001|Double-Blind Period|Death|1|||
163145451|NCT00179621|589243038|FG002|Double-Blind Period|Death|2|||
163145452|NCT00179621|589243039|FG003|Double-Blind Period|Death|0|||
163145453|NCT00179621|589243036|FG000|Double-Blind Period|Protocol Violation|1|||
163145454|NCT00179621|589243037|FG001|Double-Blind Period|Protocol Violation|0|||
163145455|NCT00179621|589243038|FG002|Double-Blind Period|Protocol Violation|0|||
163145456|NCT00179621|589243039|FG003|Double-Blind Period|Protocol Violation|0|||
163145457|NCT00179621|589243036|FG000|Double-Blind Period|Other|0|||
163145458|NCT00179621|589243037|FG001|Double-Blind Period|Other|2|||
163145459|NCT00179621|589243038|FG002|Double-Blind Period|Other|2|||
163145460|NCT00179621|589243039|FG003|Double-Blind Period|Other|0|||
163145461|NCT00179621|589243036|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
163145462|NCT00179621|589243037|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
163145463|NCT00179621|589243038|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
163145464|NCT00179621|589243039|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
163145465|NCT00179621|589243036|FG000|Open-Label Period|Adverse Event|0|||
163145466|NCT00179621|589243037|FG001|Open-Label Period|Adverse Event|6|||
163145467|NCT00179621|589243038|FG002|Open-Label Period|Adverse Event|5|||
163145468|NCT00179621|589243039|FG003|Open-Label Period|Adverse Event|6|||
163145469|NCT00179621|589243036|FG000|Open-Label Period|Withdrawal by Subject|0|||
163145470|NCT00179621|589243037|FG001|Open-Label Period|Withdrawal by Subject|2|||
163145471|NCT00179621|589243038|FG002|Open-Label Period|Withdrawal by Subject|2|||
163145472|NCT00179621|589243039|FG003|Open-Label Period|Withdrawal by Subject|2|||
163145473|NCT00179621|589243036|FG000|Open-Label Period|Death|0|||
163145474|NCT00179621|589243037|FG001|Open-Label Period|Death|0|||
163145475|NCT00179621|589243038|FG002|Open-Label Period|Death|1|||
163145476|NCT00179621|589243039|FG003|Open-Label Period|Death|2|||
163145477|NCT00179621|589243036|FG000|Open-Label Period|Other|0|||
163145478|NCT00179621|589243037|FG001|Open-Label Period|Other|1|||
163145479|NCT00179621|589243038|FG002|Open-Label Period|Other|1|||
163145480|NCT00179621|589243039|FG003|Open-Label Period|Other|2|||
163145481|NCT00865345|589243041|FG000|Overall Study|Withdrawal by Subject|2|||
163145482|NCT00966654|589243046|FG000|Overall Study|Study was terminated,PI left institution|12|||
163145483|NCT00882440|589243049|FG000|Overall Study|Adverse Event|2|||
163145484|NCT00882440|589243050|FG001|Overall Study|Adverse Event|2|||
163145485|NCT00882440|589243051|FG002|Overall Study|Adverse Event|2|||
163145486|NCT00882440|589243052|FG003|Overall Study|Adverse Event|1|||
163145487|NCT00882440|589243053|FG004|Overall Study|Adverse Event|1|||
163145488|NCT00882440|589243054|FG005|Overall Study|Adverse Event|4|||
163145489|NCT00882440|589243055|FG006|Overall Study|Adverse Event|2|||
163145490|NCT00882440|589243049|FG000|Overall Study|Lack of Efficacy|3|||
163145491|NCT00882440|589243050|FG001|Overall Study|Lack of Efficacy|5|||
163145492|NCT00882440|589243051|FG002|Overall Study|Lack of Efficacy|2|||
163145493|NCT00882440|589243052|FG003|Overall Study|Lack of Efficacy|0|||
163145494|NCT00882440|589243053|FG004|Overall Study|Lack of Efficacy|0|||
163145495|NCT00882440|589243054|FG005|Overall Study|Lack of Efficacy|3|||
163145496|NCT00882440|589243055|FG006|Overall Study|Lack of Efficacy|0|||
163145497|NCT00882440|589243049|FG000|Overall Study|Lost to Follow-up|2|||
163145498|NCT00882440|589243050|FG001|Overall Study|Lost to Follow-up|0|||
162721186|NCT04424641|587688228|FG004|Overall Study|Sponsor decision|2|||
162721187|NCT04424641|587688229|FG005|Overall Study|Sponsor decision|2|||
162721188|NCT04424641|587688230|FG006|Overall Study|Sponsor decision|3|||
162721189|NCT04424641|587688231|FG007|Overall Study|Sponsor decision|4|||
162721190|NCT04424641|587688224|FG000|Overall Study|Withdrawal by Subject|0|||
162721191|NCT04424641|587688225|FG001|Overall Study|Withdrawal by Subject|0|||
162721192|NCT04424641|587688226|FG002|Overall Study|Withdrawal by Subject|0|||
162721193|NCT04424641|587688227|FG003|Overall Study|Withdrawal by Subject|0|||
162721194|NCT04424641|587688228|FG004|Overall Study|Withdrawal by Subject|1|||
162721195|NCT04424641|587688229|FG005|Overall Study|Withdrawal by Subject|0|||
162721196|NCT04424641|587688230|FG006|Overall Study|Withdrawal by Subject|0|||
162721197|NCT04424641|587688231|FG007|Overall Study|Withdrawal by Subject|0|||
162721198|NCT04424641|587688224|FG000|Overall Study|Other|0|||
162721199|NCT04424641|587688225|FG001|Overall Study|Other|0|||
162721200|NCT04424641|587688226|FG002|Overall Study|Other|1|||
162721201|NCT04424641|587688227|FG003|Overall Study|Other|0|||
162721202|NCT04424641|587688228|FG004|Overall Study|Other|0|||
162721203|NCT04424641|587688229|FG005|Overall Study|Other|0|||
162721204|NCT04424641|587688230|FG006|Overall Study|Other|0|||
162721205|NCT04424641|587688231|FG007|Overall Study|Other|0|||
162721206|NCT02015546|587688232|FG000|Overall Study|Withdrawal by Subject|1|||
162721207|NCT02015546|587688233|FG001|Overall Study|Withdrawal by Subject|1|||
162721208|NCT02015546|587688234|FG002|Overall Study|Withdrawal by Subject|1|||
162721209|NCT02015546|587688232|FG000|Overall Study|Screem Failure|2|||
162721210|NCT02015546|587688233|FG001|Overall Study|Screem Failure|1|||
162721211|NCT02015546|587688234|FG002|Overall Study|Screem Failure|3|||
162721212|NCT01171625|587688235|FG000|Overall Study|On-Protocol|67|||
162721213|NCT01171625|587688235|FG000|Overall Study|Death|38|||
162721214|NCT01171625|587688235|FG000|Overall Study|Withdrawal by Subject|31|||
162721215|NCT01171625|587688235|FG000|Overall Study|Explanted|10|||
162721216|NCT01171625|587688235|FG000|Overall Study|Lost to Follow-up|5|||
162721217|NCT01171625|587688235|FG000|Overall Study|Patient received valve-in-valve|3|||
162721218|NCT01171625|587688235|FG000|Overall Study|Other|1|||
162721219|NCT01171625|587688235|FG000|Overall Study|Consented but did not receive device|25|||
162721220|NCT00799396|587688238|FG000|Clopidogrel Treatment|Adverse Event|6|||
162721221|NCT00799396|587688238|FG000|Clopidogrel Treatment|Physician Decision|5|||
162721222|NCT00799396|587688238|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
162721223|NCT00799396|587688238|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
162721224|NCT00799396|587688238|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
162721225|NCT01113931|587688239|FG000|Overall Study|Adverse Event|2|||
162721226|NCT01113931|587688240|FG001|Overall Study|Adverse Event|2|||
162721227|NCT01113931|587688239|FG000|Overall Study|Physician Decision|0|||
162721228|NCT01113931|587688240|FG001|Overall Study|Physician Decision|2|||
162721229|NCT01113931|587688239|FG000|Overall Study|Lost to Follow-up|12|||
162721230|NCT01113931|587688240|FG001|Overall Study|Lost to Follow-up|9|||
162721231|NCT01113931|587688239|FG000|Overall Study|Various|2|||
162721232|NCT01113931|587688240|FG001|Overall Study|Various|4|||
162721233|NCT01113931|587688239|FG000|Overall Study|Withdrawal by Subject|3|||
162721234|NCT01113931|587688240|FG001|Overall Study|Withdrawal by Subject|0|||
162721235|NCT01307267|587688241|FG000|Overall Study|Death|4|||
162721236|NCT01307267|587688242|FG001|Overall Study|Death|3|||
162721237|NCT01307267|587688243|FG002|Overall Study|Death|5|||
162721238|NCT01307267|587688244|FG003|Overall Study|Death|3|||
162721239|NCT01307267|587688245|FG004|Overall Study|Death|1|||
162721240|NCT01307267|587688246|FG005|Overall Study|Death|26|||
162721241|NCT01307267|587688247|FG006|Overall Study|Death|2|||
162721242|NCT01307267|587688248|FG007|Overall Study|Death|2|||
162721243|NCT01307267|587688249|FG008|Overall Study|Death|21|||
162721244|NCT01307267|587688250|FG009|Overall Study|Death|2|||
162721245|NCT01307267|587688251|FG010|Overall Study|Death|3|||
162721246|NCT01307267|587688252|FG011|Overall Study|Death|9|||
162721247|NCT01307267|587688253|FG012|Overall Study|Death|0|||
162721248|NCT01307267|587688254|FG013|Overall Study|Death|0|||
162721249|NCT01307267|587688255|FG014|Overall Study|Death|0|||
162721250|NCT01307267|587688256|FG015|Overall Study|Death|0|||
162721251|NCT01307267|587688257|FG016|Overall Study|Death|1|||
162721252|NCT01307267|587688258|FG017|Overall Study|Death|1|||
162721253|NCT01307267|587688259|FG018|Overall Study|Death|2|||
162721254|NCT01307267|587688260|FG019|Overall Study|Death|8|||
162721255|NCT01307267|587688261|FG020|Overall Study|Death|1|||
162721256|NCT01307267|587688262|FG021|Overall Study|Death|2|||
162721257|NCT01307267|587688263|FG022|Overall Study|Death|2|||
162721258|NCT01307267|587688241|FG000|Overall Study|Lost to Follow-up|0|||
162721259|NCT01307267|587688242|FG001|Overall Study|Lost to Follow-up|0|||
162721260|NCT01307267|587688243|FG002|Overall Study|Lost to Follow-up|0|||
162721261|NCT01307267|587688244|FG003|Overall Study|Lost to Follow-up|0|||
162721262|NCT01307267|587688245|FG004|Overall Study|Lost to Follow-up|0|||
162721263|NCT01307267|587688246|FG005|Overall Study|Lost to Follow-up|7|||
162721264|NCT01307267|587688247|FG006|Overall Study|Lost to Follow-up|0|||
162721265|NCT01307267|587688248|FG007|Overall Study|Lost to Follow-up|0|||
162721266|NCT01307267|587688249|FG008|Overall Study|Lost to Follow-up|1|||
162721267|NCT01307267|587688250|FG009|Overall Study|Lost to Follow-up|2|||
162663605|NCT02617589|587480637|FG000|Treatment|Participant Request to Discontinue|12|||
162663606|NCT02617589|587480638|FG001|Treatment|Participant Request to Discontinue|21|||
162663607|NCT02617589|587480637|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
162663608|NCT02617589|587480638|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
162663609|NCT02617589|587480637|FG000|Treatment|Death|1|||
162663610|NCT02617589|587480638|FG001|Treatment|Death|1|||
162663611|NCT02617589|587480637|FG000|Treatment|Study Drug Toxicity|27|||
162663612|NCT02617589|587480638|FG001|Treatment|Study Drug Toxicity|20|||
162663613|NCT02617589|587480637|FG000|Treatment|Disease Progression|216|||
162663614|NCT02617589|587480638|FG001|Treatment|Disease Progression|136|||
162663615|NCT03062891|587480639|FG000|Overall Study|Withdrawal by Subject|2|||
162663616|NCT03062891|587480640|FG001|Overall Study|Withdrawal by Subject|0|||
162663617|NCT03062891|587480639|FG000|Overall Study|Lost to Follow-up|50|||
162663618|NCT03062891|587480640|FG001|Overall Study|Lost to Follow-up|38|||
162663619|NCT00958880|587480650|FG000|Overall Study|Lost to Follow-up|2|||
162663620|NCT00958880|587480651|FG001|Overall Study|Lost to Follow-up|2|||
162663621|NCT00298831|587480652|FG000|Overall Study|Adverse Event|1|||
162663622|NCT00298831|587480652|FG000|Overall Study|Lost to Follow-up|3|||
162663623|NCT00298831|587480652|FG000|Overall Study|Withdrawal by Subject|1|||
162663624|NCT00298831|587480652|FG000|Overall Study|Participants did not receive treatment|27|||
162663625|NCT01516879|587480653|FG000|Overall Study|Withdrawal by Subject|9|||
162663626|NCT01516879|587480654|FG001|Overall Study|Withdrawal by Subject|11|||
162663627|NCT01516879|587480653|FG000|Overall Study|Death|0|||
162663628|NCT01516879|587480654|FG001|Overall Study|Death|2|||
162663629|NCT01516879|587480653|FG000|Overall Study|Lost to Follow-up|2|||
162663630|NCT01516879|587480654|FG001|Overall Study|Lost to Follow-up|11|||
162663631|NCT01516879|587480653|FG000|Overall Study|Other|5|||
162663632|NCT01516879|587480654|FG001|Overall Study|Other|10|||
162663633|NCT04568122|587480655|FG000|Overall Study|Lost to Follow-up|48|||
162663634|NCT04568122|587480656|FG001|Overall Study|Lost to Follow-up|44|||
162663635|NCT04568122|587480657|FG002|Overall Study|Lost to Follow-up|4|||
162663636|NCT04568122|587480658|FG003|Overall Study|Lost to Follow-up|0|||
162663637|NCT04568122|587480659|FG004|Overall Study|Lost to Follow-up|0|||
162663638|NCT02460224|587480665|FG000|Overall Study|Adverse Event|0|||
162663639|NCT02460224|587480666|FG001|Overall Study|Adverse Event|0|||
162663640|NCT02460224|587480667|FG002|Overall Study|Adverse Event|0|||
162663641|NCT02460224|587480668|FG003|Overall Study|Adverse Event|0|||
162663642|NCT02460224|587480669|FG004|Overall Study|Adverse Event|0|||
162663643|NCT02460224|587480670|FG005|Overall Study|Adverse Event|0|||
162663644|NCT02460224|587480671|FG006|Overall Study|Adverse Event|1|||
162663645|NCT02460224|587480672|FG007|Overall Study|Adverse Event|0|||
162663646|NCT02460224|587480673|FG008|Overall Study|Adverse Event|0|||
162663647|NCT02460224|587480674|FG009|Overall Study|Adverse Event|0|||
162663648|NCT02460224|587480675|FG010|Overall Study|Adverse Event|0|||
162663649|NCT02460224|587480676|FG011|Overall Study|Adverse Event|0|||
163145499|NCT00882440|589243051|FG002|Overall Study|Lost to Follow-up|1|||
163145500|NCT00882440|589243052|FG003|Overall Study|Lost to Follow-up|1|||
163145501|NCT00882440|589243053|FG004|Overall Study|Lost to Follow-up|1|||
163145502|NCT00882440|589243054|FG005|Overall Study|Lost to Follow-up|0|||
163145503|NCT00882440|589243055|FG006|Overall Study|Lost to Follow-up|1|||
163145504|NCT00882440|589243049|FG000|Overall Study|Protocol Violation|0|||
163145505|NCT00882440|589243050|FG001|Overall Study|Protocol Violation|0|||
163145506|NCT00882440|589243051|FG002|Overall Study|Protocol Violation|1|||
163145507|NCT00882440|589243052|FG003|Overall Study|Protocol Violation|1|||
163145508|NCT00882440|589243053|FG004|Overall Study|Protocol Violation|1|||
163145509|NCT00882440|589243054|FG005|Overall Study|Protocol Violation|0|||
163145510|NCT00882440|589243055|FG006|Overall Study|Protocol Violation|0|||
163145511|NCT00882440|589243049|FG000|Overall Study|Withdrawal by Subject|2|||
163145512|NCT00882440|589243050|FG001|Overall Study|Withdrawal by Subject|1|||
163145513|NCT00882440|589243051|FG002|Overall Study|Withdrawal by Subject|1|||
163145514|NCT00882440|589243052|FG003|Overall Study|Withdrawal by Subject|0|||
163145515|NCT00882440|589243053|FG004|Overall Study|Withdrawal by Subject|6|||
163145516|NCT00882440|589243054|FG005|Overall Study|Withdrawal by Subject|0|||
163145517|NCT00882440|589243055|FG006|Overall Study|Withdrawal by Subject|1|||
163145518|NCT00882440|589243049|FG000|Overall Study|Patient Uncooperative|2|||
163145519|NCT00882440|589243050|FG001|Overall Study|Patient Uncooperative|0|||
163145520|NCT00882440|589243051|FG002|Overall Study|Patient Uncooperative|0|||
163145521|NCT00882440|589243052|FG003|Overall Study|Patient Uncooperative|0|||
163145522|NCT00882440|589243053|FG004|Overall Study|Patient Uncooperative|1|||
163145523|NCT00882440|589243054|FG005|Overall Study|Patient Uncooperative|0|||
163145524|NCT00882440|589243055|FG006|Overall Study|Patient Uncooperative|0|||
163145525|NCT05482308|589243059|FG000|Overall Study|Withdrawal by Subject|1|||
163145526|NCT05482308|589243060|FG001|Overall Study|Withdrawal by Subject|0|||
163145527|NCT05482308|589243059|FG000|Overall Study|No longer meets eligibility criteria|0|||
163145528|NCT05482308|589243060|FG001|Overall Study|No longer meets eligibility criteria|1|||
163145529|NCT01693029|589243069|FG000|Overall Study|Withdrawal by Subject|15|||
163145530|NCT01693029|589243070|FG001|Overall Study|Withdrawal by Subject|22|||
163145531|NCT01693029|589243069|FG000|Overall Study|Kidney transplantation|7|||
163145532|NCT01693029|589243070|FG001|Overall Study|Kidney transplantation|7|||
163145533|NCT01693029|589243069|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
163145534|NCT01693029|589243070|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
163145535|NCT01693029|589243069|FG000|Overall Study|Protocol Violation|6|||
163145536|NCT01693029|589243070|FG001|Overall Study|Protocol Violation|7|||
163145537|NCT01693029|589243069|FG000|Overall Study|Change in dialysis modality|2|||
163145538|NCT01693029|589243070|FG001|Overall Study|Change in dialysis modality|1|||
163145539|NCT01693029|589243069|FG000|Overall Study|Physician Decision|0|||
163145540|NCT01693029|589243070|FG001|Overall Study|Physician Decision|2|||
163145541|NCT01693029|589243069|FG000|Overall Study|Lost to Follow-up|0|||
163145542|NCT01693029|589243070|FG001|Overall Study|Lost to Follow-up|1|||
163145543|NCT01693029|589243069|FG000|Overall Study|Adverse Event|1|||
163145544|NCT01693029|589243070|FG001|Overall Study|Adverse Event|6|||
163145545|NCT01693029|589243069|FG000|Overall Study|Death|5|||
163145546|NCT01693029|589243070|FG001|Overall Study|Death|8|||
163145547|NCT01693029|589243069|FG000|Overall Study|Non-compliance|2|||
163145548|NCT01693029|589243070|FG001|Overall Study|Non-compliance|1|||
163145549|NCT01535807|589243071|FG000|Overall Study|Withdrawal by Subject|1|||
163145550|NCT01535807|589243072|FG001|Overall Study|Withdrawal by Subject|1|||
163145551|NCT01535807|589243071|FG000|Overall Study|Data collection error|1|||
163145552|NCT01535807|589243072|FG001|Overall Study|Data collection error|1|||
163145553|NCT01329263|589243073|FG000|Overall Study|Lost to Follow-up|4|||
163145554|NCT01329263|589243074|FG001|Overall Study|Lost to Follow-up|21|||
163145555|NCT01329263|589243073|FG000|Overall Study|Withdrawal by Subject|1|||
163145556|NCT01329263|589243074|FG001|Overall Study|Withdrawal by Subject|2|||
163145557|NCT01631435|589243075|FG000|Overall Study|Adverse Event|2|||
163145558|NCT01631435|589243075|FG000|Overall Study|Withdrawal by Subject|2|||
163145559|NCT01631435|589243075|FG000|Overall Study|incomplete study procedure|5|||
163145560|NCT02123134|589243076|FG000|Overall Study|Withdrawal of consent|3|||
163145561|NCT02123134|589243077|FG001|Overall Study|Withdrawal of consent|2|||
163145562|NCT02123134|589243076|FG000|Overall Study|Administrative decision|0|||
162663650|NCT02460224|587480677|FG012|Overall Study|Adverse Event|1|||
162663651|NCT02460224|587480678|FG013|Overall Study|Adverse Event|0|||
162663652|NCT02460224|587480679|FG014|Overall Study|Adverse Event|0|||
162663653|NCT02460224|587480680|FG015|Overall Study|Adverse Event|0|||
162663654|NCT02460224|587480681|FG016|Overall Study|Adverse Event|1|||
163145563|NCT02123134|589243077|FG001|Overall Study|Administrative decision|1|||
163145564|NCT00657540|589243078|FG000|Overall Study|Lost to Follow-up|1|||
163145565|NCT00657540|589243079|FG001|Overall Study|Lost to Follow-up|4|||
163145566|NCT00141453|589243080|FG000|Overall Study|Protocol Violation|6|||
163145567|NCT00141453|589243081|FG001|Overall Study|Protocol Violation|5|||
163145568|NCT02656017|589243084|FG000|Overall Study|Study burden|3|||
163145569|NCT02656017|589243085|FG001|Overall Study|Study burden|3|||
163145570|NCT02656017|589243084|FG000|Overall Study|Adverse Event|2|||
163145571|NCT02656017|589243085|FG001|Overall Study|Adverse Event|1|||
162663655|NCT02460224|587480682|FG017|Overall Study|Adverse Event|0|||
162663656|NCT02460224|587480683|FG018|Overall Study|Adverse Event|1|||
162663657|NCT02460224|587480684|FG019|Overall Study|Adverse Event|0|||
162663658|NCT02460224|587480685|FG020|Overall Study|Adverse Event|1|||
162663659|NCT02460224|587480686|FG021|Overall Study|Adverse Event|1|||
162663660|NCT02460224|587480687|FG022|Overall Study|Adverse Event|1|||
162663661|NCT02460224|587480688|FG023|Overall Study|Adverse Event|0|||
162663662|NCT02460224|587480689|FG024|Overall Study|Adverse Event|0|||
162663663|NCT02460224|587480690|FG025|Overall Study|Adverse Event|0|||
162663664|NCT02460224|587480691|FG026|Overall Study|Adverse Event|11|||
162663665|NCT02460224|587480692|FG027|Overall Study|Adverse Event|1|||
162663666|NCT02460224|587480693|FG028|Overall Study|Adverse Event|6|||
162663667|NCT02460224|587480665|FG000|Overall Study|Death|0|||
162663668|NCT02460224|587480666|FG001|Overall Study|Death|0|||
162663669|NCT02460224|587480667|FG002|Overall Study|Death|0|||
162663670|NCT02460224|587480668|FG003|Overall Study|Death|0|||
162663671|NCT02460224|587480669|FG004|Overall Study|Death|0|||
162663672|NCT02460224|587480670|FG005|Overall Study|Death|2|||
162663673|NCT02460224|587480671|FG006|Overall Study|Death|1|||
162663674|NCT02460224|587480672|FG007|Overall Study|Death|0|||
162663675|NCT02460224|587480673|FG008|Overall Study|Death|0|||
162663676|NCT02460224|587480674|FG009|Overall Study|Death|1|||
162663677|NCT02460224|587480675|FG010|Overall Study|Death|0|||
162663678|NCT02460224|587480676|FG011|Overall Study|Death|0|||
162663679|NCT02460224|587480677|FG012|Overall Study|Death|0|||
162663680|NCT02460224|587480678|FG013|Overall Study|Death|1|||
162663681|NCT02460224|587480679|FG014|Overall Study|Death|0|||
162663682|NCT02460224|587480680|FG015|Overall Study|Death|0|||
162663683|NCT02460224|587480681|FG016|Overall Study|Death|2|||
162663684|NCT02460224|587480682|FG017|Overall Study|Death|1|||
162663685|NCT02460224|587480683|FG018|Overall Study|Death|0|||
162663686|NCT02460224|587480684|FG019|Overall Study|Death|2|||
162663687|NCT02460224|587480685|FG020|Overall Study|Death|0|||
162663688|NCT02460224|587480686|FG021|Overall Study|Death|0|||
163145572|NCT02656017|589243084|FG000|Overall Study|Unable/unwilling to take study medication|2|||
163145573|NCT02656017|589243085|FG001|Overall Study|Unable/unwilling to take study medication|1|||
163145574|NCT02656017|589243084|FG000|Overall Study|Began Tolvaptan|1|||
163145575|NCT02656017|589243085|FG001|Overall Study|Began Tolvaptan|1|||
163145576|NCT02656017|589243084|FG000|Overall Study|Withdrawal by Subject|1|||
163145577|NCT02656017|589243085|FG001|Overall Study|Withdrawal by Subject|0|||
163145578|NCT02611479|589243090|FG000|Baseline Enrollment|Exited study|13|||
163145579|NCT02611479|589243090|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
163145580|NCT02611479|589243090|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
163145581|NCT02611479|589243090|FG000|Data Cleaning|No baseline function or pain metrics|2|||
163145582|NCT00743249|589243091|FG000|Overall Study|Adverse Event|0|||
163145583|NCT00743249|589243092|FG001|Overall Study|Adverse Event|4|||
163145584|NCT00743249|589243091|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
163145585|NCT00743249|589243092|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
163145586|NCT00743249|589243091|FG000|Overall Study|Unsuccessful insertion of stent|2|||
163145587|NCT00743249|589243092|FG001|Overall Study|Unsuccessful insertion of stent|1|||
163145588|NCT02314052|589243093|FG000|Cycle One|Adverse Event|0|||
163145589|NCT02314052|589243094|FG001|Cycle One|Adverse Event|0|||
163145590|NCT02314052|589243095|FG002|Cycle One|Adverse Event|0|||
163145591|NCT02314052|589243096|FG003|Cycle One|Adverse Event|1|||
163145592|NCT02314052|589243097|FG004|Cycle One|Adverse Event|0|||
163145593|NCT02314052|589243098|FG005|Cycle One|Adverse Event|0|||
163145594|NCT00474955|589243099|FG000|Overall Study|Adverse Event|2|||
163145595|NCT00474955|589243099|FG000|Overall Study|Drug unavailability|1|||
163145596|NCT00474955|589243099|FG000|Overall Study|Personal reasons|5|||
163145597|NCT02422498|589243100|FG000|Overall Study|Inevaluable|4|||
163145598|NCT02653326|589243101|FG000|Overall Study|Lost to Follow-up|10|||
163145599|NCT02653326|589243102|FG001|Overall Study|Lost to Follow-up|7|||
163145600|NCT01620060|589243103|FG000|Overall Study|Adverse Event|9|||
163145601|NCT01620060|589243103|FG000|Overall Study|Protocol Violation|1|||
163145602|NCT01620060|589243103|FG000|Overall Study|Withdrawal by Subject|1|||
163145603|NCT01620060|589243103|FG000|Overall Study|Did not comply with Study Produre|1|||
163145604|NCT01620060|589243103|FG000|Overall Study|Family emergency|1|||
163145605|NCT01620060|589243103|FG000|Overall Study|Per Sponsor Decision|2|||
163145606|NCT01960140|589243104|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
163145607|NCT03452540|589243105|FG000|Overall Study|Adverse Event|1|||
163145608|NCT03452540|589243105|FG000|Overall Study|Withdrawal by Subject|1|||
163145609|NCT03452540|589243105|FG000|Overall Study|Other SAE and AE|2|||
163145610|NCT04551989|589243117|FG000|Overall Study|Adverse Event|4|||
162663689|NCT02460224|587480687|FG022|Overall Study|Death|0|||
163145611|NCT04551989|589243117|FG000|Overall Study|Protocol Violation|3|||
163145612|NCT04551989|589243117|FG000|Overall Study|Lost to Follow-up|1|||
163145613|NCT04551989|589243117|FG000|Overall Study|Physician Decision|3|||
163145614|NCT04201431|589243118|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
163145615|NCT04201431|589243119|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
163145616|NCT04201431|589243120|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
163145617|NCT00088530|589243125|FG000|Overall Study|Progressive/Relapsed Disease|28|||
163145618|NCT00088530|589243126|FG001|Overall Study|Progressive/Relapsed Disease|39|||
163145619|NCT00088530|589243125|FG000|Overall Study|Adverse Event|15|||
163145620|NCT00088530|589243126|FG001|Overall Study|Adverse Event|9|||
163145621|NCT00088530|589243125|FG000|Overall Study|Withdrawal by Subject|2|||
163145622|NCT00088530|589243126|FG001|Overall Study|Withdrawal by Subject|5|||
163145623|NCT00088530|589243125|FG000|Overall Study|Lost to Follow-up|2|||
163145624|NCT00088530|589243126|FG001|Overall Study|Lost to Follow-up|0|||
163145625|NCT00088530|589243125|FG000|Overall Study|Physician Decision|2|||
163145626|NCT00088530|589243126|FG001|Overall Study|Physician Decision|0|||
163145627|NCT00088530|589243125|FG000|Overall Study|Sponsor decision|0|||
163145628|NCT00088530|589243126|FG001|Overall Study|Sponsor decision|1|||
163145629|NCT00088530|589243125|FG000|Overall Study|Patient never treated|1|||
163145630|NCT00088530|589243126|FG001|Overall Study|Patient never treated|0|||
163145631|NCT00300755|589243127|FG000|Overall Study|Adverse Event|1|||
163145632|NCT00300755|589243128|FG001|Overall Study|Adverse Event|2|||
163145633|NCT00300755|589243129|FG002|Overall Study|Adverse Event|1|||
163145634|NCT00300755|589243127|FG000|Overall Study|Withdrawal by Subject|0|||
163145635|NCT00300755|589243128|FG001|Overall Study|Withdrawal by Subject|2|||
163145636|NCT00300755|589243129|FG002|Overall Study|Withdrawal by Subject|0|||
163145637|NCT00300755|589243127|FG000|Overall Study|Protocol Violation|0|||
163145638|NCT00300755|589243128|FG001|Overall Study|Protocol Violation|0|||
163145639|NCT00300755|589243129|FG002|Overall Study|Protocol Violation|1|||
163145640|NCT04571944|589243130|FG000|Overall Study|Death|1|||
163145641|NCT04571944|589243131|FG001|Overall Study|Death|0|||
163145642|NCT04571944|589243130|FG000|Overall Study|Withdrawal by Subject|3|||
163145643|NCT04571944|589243131|FG001|Overall Study|Withdrawal by Subject|0|||
163145644|NCT04571944|589243130|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
163145645|NCT04571944|589243131|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
163145646|NCT02694744|589243135|FG000|Overall Study|Adverse Event|2|||
163145647|NCT02694744|589243136|FG001|Overall Study|Adverse Event|1|||
163145648|NCT02694744|589243135|FG000|Overall Study|Withdrawal by Subject|2|||
163145649|NCT02694744|589243136|FG001|Overall Study|Withdrawal by Subject|1|||
163145650|NCT02694744|589243135|FG000|Overall Study|Physician Decision|1|||
163145651|NCT02694744|589243136|FG001|Overall Study|Physician Decision|2|||
163145652|NCT02694744|589243135|FG000|Overall Study|Lost to Follow-up|1|||
163145653|NCT02694744|589243136|FG001|Overall Study|Lost to Follow-up|0|||
163145654|NCT02694744|589243135|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
163145655|NCT02694744|589243136|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
163145656|NCT00686777|589243139|FG000|Overall Study|Adverse Event|2|||
163145657|NCT00686777|589243139|FG000|Overall Study|Pregnancy|1|||
163145658|NCT00686777|589243139|FG000|Overall Study|Withdrawal by Subject|2|||
163145659|NCT00686777|589243139|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
163145660|NCT00686777|589243139|FG000|Overall Study|No Visit|1|||
163145661|NCT00667888|589243140|FG000|Overall Study|Death|1|||
163145662|NCT00667888|589243141|FG001|Overall Study|Death|1|||
163145663|NCT00667888|589243140|FG000|Overall Study|Withdrawal by Subject|6|||
163145664|NCT00667888|589243141|FG001|Overall Study|Withdrawal by Subject|3|||
163145665|NCT00667888|589243140|FG000|Overall Study|Proceed with other treatment|3|||
163145666|NCT00667888|589243141|FG001|Overall Study|Proceed with other treatment|3|||
163145667|NCT00667888|589243140|FG000|Overall Study|Ineligible after SIM|0|||
163145668|NCT00667888|589243141|FG001|Overall Study|Ineligible after SIM|2|||
163145669|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
163145670|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
163145671|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Disease progression|75|||
163145672|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Disease progression|59|||
163145673|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Adverse Event|16|||
163145674|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Adverse Event|16|||
163145675|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Death|2|||
163145676|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Death|3|||
163145677|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
163145678|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
163145679|NCT00883779|589243142|FG000|Primary Study Treatment Phase|Other|3|||
163145680|NCT00883779|589243143|FG001|Primary Study Treatment Phase|Other|0|||
163145681|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Adverse Event|2|||
163145682|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Adverse Event|3|||
163145683|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Death|1|||
163145684|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Death|3|||
162663690|NCT02460224|587480688|FG023|Overall Study|Death|0|||
162663691|NCT02460224|587480689|FG024|Overall Study|Death|1|||
162663692|NCT02460224|587480690|FG025|Overall Study|Death|1|||
162663693|NCT02460224|587480691|FG026|Overall Study|Death|5|||
162663694|NCT02460224|587480692|FG027|Overall Study|Death|0|||
162663695|NCT02460224|587480693|FG028|Overall Study|Death|1|||
162663696|NCT02460224|587480665|FG000|Overall Study|Lost to Follow-up|0|||
162663697|NCT02460224|587480666|FG001|Overall Study|Lost to Follow-up|0|||
162663698|NCT02460224|587480667|FG002|Overall Study|Lost to Follow-up|0|||
162663699|NCT02460224|587480668|FG003|Overall Study|Lost to Follow-up|0|||
162663700|NCT02460224|587480669|FG004|Overall Study|Lost to Follow-up|0|||
162663701|NCT02460224|587480670|FG005|Overall Study|Lost to Follow-up|0|||
162663702|NCT02460224|587480671|FG006|Overall Study|Lost to Follow-up|0|||
162663703|NCT02460224|587480672|FG007|Overall Study|Lost to Follow-up|0|||
162663704|NCT02460224|587480673|FG008|Overall Study|Lost to Follow-up|0|||
162663705|NCT02460224|587480674|FG009|Overall Study|Lost to Follow-up|0|||
162663706|NCT02460224|587480675|FG010|Overall Study|Lost to Follow-up|0|||
162663707|NCT02460224|587480676|FG011|Overall Study|Lost to Follow-up|0|||
162663708|NCT02460224|587480677|FG012|Overall Study|Lost to Follow-up|0|||
162663709|NCT02460224|587480678|FG013|Overall Study|Lost to Follow-up|0|||
162663710|NCT02460224|587480679|FG014|Overall Study|Lost to Follow-up|0|||
162663711|NCT02460224|587480680|FG015|Overall Study|Lost to Follow-up|0|||
162663712|NCT02460224|587480681|FG016|Overall Study|Lost to Follow-up|0|||
162663713|NCT02460224|587480682|FG017|Overall Study|Lost to Follow-up|0|||
162663714|NCT02460224|587480683|FG018|Overall Study|Lost to Follow-up|0|||
162663715|NCT02460224|587480684|FG019|Overall Study|Lost to Follow-up|0|||
162663716|NCT02460224|587480685|FG020|Overall Study|Lost to Follow-up|0|||
162663717|NCT02460224|587480686|FG021|Overall Study|Lost to Follow-up|0|||
162663718|NCT02460224|587480687|FG022|Overall Study|Lost to Follow-up|1|||
162663719|NCT02460224|587480688|FG023|Overall Study|Lost to Follow-up|0|||
162663720|NCT02460224|587480689|FG024|Overall Study|Lost to Follow-up|0|||
162663721|NCT02460224|587480690|FG025|Overall Study|Lost to Follow-up|0|||
162663722|NCT02460224|587480691|FG026|Overall Study|Lost to Follow-up|0|||
162663723|NCT02460224|587480692|FG027|Overall Study|Lost to Follow-up|0|||
162663724|NCT02460224|587480693|FG028|Overall Study|Lost to Follow-up|0|||
162663725|NCT02460224|587480665|FG000|Overall Study|Physician Decision|0|||
162663726|NCT02460224|587480666|FG001|Overall Study|Physician Decision|1|||
162663727|NCT02460224|587480667|FG002|Overall Study|Physician Decision|0|||
162663728|NCT02460224|587480668|FG003|Overall Study|Physician Decision|0|||
162663729|NCT02460224|587480669|FG004|Overall Study|Physician Decision|1|||
162663730|NCT02460224|587480670|FG005|Overall Study|Physician Decision|0|||
162663731|NCT02460224|587480671|FG006|Overall Study|Physician Decision|0|||
162663732|NCT02460224|587480672|FG007|Overall Study|Physician Decision|1|||
162663733|NCT02460224|587480673|FG008|Overall Study|Physician Decision|0|||
162663734|NCT02460224|587480674|FG009|Overall Study|Physician Decision|0|||
162663735|NCT02460224|587480675|FG010|Overall Study|Physician Decision|0|||
162663736|NCT02460224|587480676|FG011|Overall Study|Physician Decision|1|||
162663737|NCT02460224|587480677|FG012|Overall Study|Physician Decision|0|||
162663738|NCT02460224|587480678|FG013|Overall Study|Physician Decision|1|||
162663739|NCT02460224|587480679|FG014|Overall Study|Physician Decision|0|||
162663740|NCT02460224|587480680|FG015|Overall Study|Physician Decision|0|||
162663741|NCT02460224|587480681|FG016|Overall Study|Physician Decision|2|||
162663742|NCT02460224|587480682|FG017|Overall Study|Physician Decision|1|||
162663743|NCT02460224|587480683|FG018|Overall Study|Physician Decision|1|||
162663744|NCT02460224|587480684|FG019|Overall Study|Physician Decision|2|||
162663745|NCT02460224|587480685|FG020|Overall Study|Physician Decision|1|||
162721268|NCT01307267|587688251|FG010|Overall Study|Lost to Follow-up|1|||
162663746|NCT02460224|587480686|FG021|Overall Study|Physician Decision|1|||
162663747|NCT02460224|587480687|FG022|Overall Study|Physician Decision|0|||
162721269|NCT01307267|587688252|FG011|Overall Study|Lost to Follow-up|0|||
162663748|NCT02460224|587480688|FG023|Overall Study|Physician Decision|0|||
162663749|NCT02460224|587480689|FG024|Overall Study|Physician Decision|1|||
162663750|NCT02460224|587480690|FG025|Overall Study|Physician Decision|0|||
162663751|NCT02460224|587480691|FG026|Overall Study|Physician Decision|14|||
162663752|NCT02460224|587480692|FG027|Overall Study|Physician Decision|1|||
162663753|NCT02460224|587480693|FG028|Overall Study|Physician Decision|6|||
163145685|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
163145686|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
163145687|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
163145688|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
163145689|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Disease progression|103|||
163145690|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Disease progression|122|||
163145691|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Other|3|||
163145692|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Other|0|||
163145693|NCT00883779|589243142|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
163145694|NCT00883779|589243143|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
163145695|NCT00883779|589243142|FG000|Off-study Phase|Death|185|||
163145696|NCT00883779|589243143|FG001|Off-study Phase|Death|174|||
163145697|NCT00883779|589243142|FG000|Off-study Phase|Refused treatment|1|||
163145698|NCT00883779|589243143|FG001|Off-study Phase|Refused treatment|1|||
163145699|NCT00883779|589243142|FG000|Off-study Phase|Failure to return|5|||
163145700|NCT00883779|589243143|FG001|Off-study Phase|Failure to return|6|||
163145701|NCT00883779|589243142|FG000|Off-study Phase|Other|18|||
163145702|NCT00883779|589243143|FG001|Off-study Phase|Other|21|||
163145703|NCT00499681|589243144|FG000|Overall Study|toxicity|0|||
163145704|NCT00499681|589243145|FG001|Overall Study|toxicity|1|||
163145705|NCT00499681|589243144|FG000|Overall Study|disease progression|0|||
163145706|NCT00499681|589243145|FG001|Overall Study|disease progression|1|||
163145707|NCT00739401|589243146|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
163145708|NCT00739401|589243146|FG000|Overall Study|Death|3|||
163145709|NCT00739401|589243146|FG000|Overall Study|Withdrawal by Subject|4|||
163145710|NCT04575155|589243147|FG000|2 Month|Withdrawal by Subject|1|||
163145711|NCT04575155|589243148|FG001|2 Month|Withdrawal by Subject|1|||
163145712|NCT04575155|589243147|FG000|2 Month|Lost to Follow-up|5|||
163145713|NCT04575155|589243148|FG001|2 Month|Lost to Follow-up|3|||
163145714|NCT04575155|589243147|FG000|2 Month|Ineligible|1|||
163145715|NCT04575155|589243148|FG001|2 Month|Ineligible|0|||
163145716|NCT01239381|589243150|FG000|Overall Study|Protocol Violation|1|||
163145717|NCT01239381|589243150|FG000|Overall Study|Withdrawal by Subject|1|||
163145718|NCT03748823|589243151|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
163145719|NCT03748823|589243152|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
163145720|NCT03748823|589243151|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
163145721|NCT03748823|589243152|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
163145722|NCT03748823|589243151|FG000|Extension Period|Withdrawal by Subject|9|||
163145723|NCT03748823|589243152|FG001|Extension Period|Withdrawal by Subject|12|||
163145724|NCT03748823|589243151|FG000|Extension Period|Death|2|||
163145725|NCT03748823|589243152|FG001|Extension Period|Death|2|||
163145726|NCT03748823|589243151|FG000|Extension Period|Other than Specified|0|||
163145727|NCT03748823|589243152|FG001|Extension Period|Other than Specified|1|||
163145728|NCT03748823|589243151|FG000|Extension Period|Protocol Violation|1|||
163145729|NCT03748823|589243152|FG001|Extension Period|Protocol Violation|0|||
163145730|NCT03748823|589243151|FG000|Extension Period|Lost to Follow-up|0|||
163145731|NCT03748823|589243152|FG001|Extension Period|Lost to Follow-up|1|||
163145732|NCT03748823|589243151|FG000|Extension Period|Lack of Efficacy|0|||
163145733|NCT03748823|589243152|FG001|Extension Period|Lack of Efficacy|1|||
163145734|NCT03748823|589243151|FG000|Extension Period|Physician Decision|1|||
163145735|NCT03748823|589243152|FG001|Extension Period|Physician Decision|2|||
163145736|NCT00890825|589243153|FG000|Overall Study|Withdrawal by Subject|1|||
163145737|NCT00890825|589243154|FG001|Overall Study|Withdrawal by Subject|0|||
163145738|NCT00890825|589243153|FG000|Overall Study|Alive at data cut off (DCO)|13|||
163145739|NCT00890825|589243154|FG001|Overall Study|Alive at data cut off (DCO)|14|||
163145740|NCT01363700|589243155|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145741|NCT01363700|589243156|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
163145742|NCT01363700|589243157|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145743|NCT01363700|589243158|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145744|NCT01363700|589243159|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
163145745|NCT02920892|589243160|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
163145746|NCT02920892|589243161|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
163145747|NCT02920892|589243162|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
163145748|NCT02920892|589243160|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
163145749|NCT02920892|589243161|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
163145750|NCT02920892|589243162|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
163145751|NCT02920892|589243160|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
163145752|NCT02920892|589243161|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
163145753|NCT02920892|589243162|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
163145754|NCT02920892|589243160|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
163145755|NCT02920892|589243161|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
163145756|NCT02920892|589243162|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
163145757|NCT02920892|589243160|FG000|Placebo-Controlled Period|Physician Decision|0|||
163145758|NCT02920892|589243161|FG001|Placebo-Controlled Period|Physician Decision|0|||
163145759|NCT02920892|589243162|FG002|Placebo-Controlled Period|Physician Decision|1|||
162663754|NCT02460224|587480665|FG000|Overall Study|Progressive disease|15|||
162663755|NCT02460224|587480666|FG001|Overall Study|Progressive disease|11|||
162663756|NCT02460224|587480667|FG002|Overall Study|Progressive disease|5|||
162663757|NCT02460224|587480668|FG003|Overall Study|Progressive disease|6|||
162663758|NCT02460224|587480669|FG004|Overall Study|Progressive disease|3|||
162663759|NCT02460224|587480670|FG005|Overall Study|Progressive disease|26|||
162663760|NCT02460224|587480671|FG006|Overall Study|Progressive disease|28|||
162663761|NCT02460224|587480672|FG007|Overall Study|Progressive disease|4|||
162663762|NCT02460224|587480673|FG008|Overall Study|Progressive disease|5|||
162663763|NCT02460224|587480674|FG009|Overall Study|Progressive disease|9|||
162663764|NCT02460224|587480675|FG010|Overall Study|Progressive disease|5|||
162663765|NCT02460224|587480676|FG011|Overall Study|Progressive disease|4|||
162663766|NCT02460224|587480677|FG012|Overall Study|Progressive disease|5|||
162663767|NCT02460224|587480678|FG013|Overall Study|Progressive disease|4|||
162663768|NCT02460224|587480679|FG014|Overall Study|Progressive disease|5|||
162663769|NCT02460224|587480680|FG015|Overall Study|Progressive disease|5|||
162663770|NCT02460224|587480681|FG016|Overall Study|Progressive disease|15|||
162663771|NCT02460224|587480682|FG017|Overall Study|Progressive disease|3|||
162663772|NCT02460224|587480683|FG018|Overall Study|Progressive disease|8|||
162663773|NCT02460224|587480684|FG019|Overall Study|Progressive disease|3|||
162663774|NCT02460224|587480685|FG020|Overall Study|Progressive disease|4|||
162663775|NCT02460224|587480686|FG021|Overall Study|Progressive disease|9|||
162663776|NCT02460224|587480687|FG022|Overall Study|Progressive disease|4|||
162663777|NCT02460224|587480688|FG023|Overall Study|Progressive disease|11|||
162663778|NCT02460224|587480689|FG024|Overall Study|Progressive disease|4|||
162663779|NCT02460224|587480690|FG025|Overall Study|Progressive disease|5|||
162663780|NCT02460224|587480691|FG026|Overall Study|Progressive disease|85|||
162663781|NCT02460224|587480692|FG027|Overall Study|Progressive disease|17|||
162663782|NCT02460224|587480693|FG028|Overall Study|Progressive disease|77|||
162663783|NCT02460224|587480665|FG000|Overall Study|Subject/guardian decision|2|||
162663784|NCT02460224|587480666|FG001|Overall Study|Subject/guardian decision|0|||
162721270|NCT01307267|587688253|FG012|Overall Study|Lost to Follow-up|0|||
162721271|NCT01307267|587688254|FG013|Overall Study|Lost to Follow-up|0|||
162721272|NCT01307267|587688255|FG014|Overall Study|Lost to Follow-up|0|||
162663785|NCT02460224|587480667|FG002|Overall Study|Subject/guardian decision|1|||
162663786|NCT02460224|587480668|FG003|Overall Study|Subject/guardian decision|0|||
162663787|NCT02460224|587480669|FG004|Overall Study|Subject/guardian decision|2|||
162663788|NCT02460224|587480670|FG005|Overall Study|Subject/guardian decision|2|||
162663789|NCT02460224|587480671|FG006|Overall Study|Subject/guardian decision|0|||
162721273|NCT01307267|587688256|FG015|Overall Study|Lost to Follow-up|0|||
162663790|NCT02460224|587480672|FG007|Overall Study|Subject/guardian decision|0|||
162663791|NCT02460224|587480673|FG008|Overall Study|Subject/guardian decision|1|||
162663792|NCT02460224|587480674|FG009|Overall Study|Subject/guardian decision|1|||
162663793|NCT02460224|587480675|FG010|Overall Study|Subject/guardian decision|0|||
162663794|NCT02460224|587480676|FG011|Overall Study|Subject/guardian decision|1|||
162663795|NCT02460224|587480677|FG012|Overall Study|Subject/guardian decision|0|||
162721274|NCT01307267|587688257|FG016|Overall Study|Lost to Follow-up|0|||
162721275|NCT01307267|587688258|FG017|Overall Study|Lost to Follow-up|0|||
162721276|NCT01307267|587688259|FG018|Overall Study|Lost to Follow-up|0|||
162663796|NCT02460224|587480678|FG013|Overall Study|Subject/guardian decision|0|||
162663797|NCT02460224|587480679|FG014|Overall Study|Subject/guardian decision|0|||
162663798|NCT02460224|587480680|FG015|Overall Study|Subject/guardian decision|1|||
162663799|NCT02460224|587480681|FG016|Overall Study|Subject/guardian decision|0|||
162663800|NCT02460224|587480682|FG017|Overall Study|Subject/guardian decision|1|||
162663801|NCT02460224|587480683|FG018|Overall Study|Subject/guardian decision|2|||
162663802|NCT02460224|587480684|FG019|Overall Study|Subject/guardian decision|0|||
163145760|NCT02920892|589243160|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
163145761|NCT02920892|589243161|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
163145762|NCT02920892|589243162|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
163145763|NCT02920892|589243160|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163145764|NCT02920892|589243161|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
163145765|NCT02920892|589243162|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163145766|NCT02920892|589243160|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
163145767|NCT02920892|589243161|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
163145768|NCT02920892|589243162|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
163145769|NCT03649217|589243163|FG000|Overall Study|subject had severe ataxia not initially found|1|||
163145770|NCT03649217|589243163|FG000|Overall Study|subject had cognitive issues not initially found|1|||
163145771|NCT01721161|589243164|FG000|Overall Study|Adverse Event|2|||
163145772|NCT01721161|589243165|FG001|Overall Study|Adverse Event|3|||
163145773|NCT01721161|589243164|FG000|Overall Study|Lost to Follow-up|1|||
163145774|NCT01721161|589243165|FG001|Overall Study|Lost to Follow-up|2|||
163145775|NCT01721161|589243164|FG000|Overall Study|Withdrawal by Subject|1|||
163145776|NCT01721161|589243165|FG001|Overall Study|Withdrawal by Subject|1|||
163145777|NCT01721161|589243164|FG000|Overall Study|Other|0|||
163145778|NCT01721161|589243165|FG001|Overall Study|Other|1|||
163145779|NCT01216202|589243166|FG000|Overall Study|Withdrawal by Subject|8|||
163145780|NCT01216202|589243167|FG001|Overall Study|Withdrawal by Subject|0|||
163145781|NCT01216202|589243166|FG000|Overall Study|Death|0|||
163145782|NCT01216202|589243167|FG001|Overall Study|Death|2|||
163145783|NCT01216202|589243166|FG000|Overall Study|Lost to Follow-up|14|||
163145784|NCT01216202|589243167|FG001|Overall Study|Lost to Follow-up|0|||
163145785|NCT00614380|589243170|FG000|Overall Study|Adverse Event|14|||
163145786|NCT00614380|589243171|FG001|Overall Study|Adverse Event|4|||
163145787|NCT00614380|589243172|FG002|Overall Study|Adverse Event|0|||
163145788|NCT00614380|589243173|FG003|Overall Study|Adverse Event|0|||
163145789|NCT00614380|589243170|FG000|Overall Study|Lost to Follow-up|6|||
163145790|NCT00614380|589243171|FG001|Overall Study|Lost to Follow-up|1|||
163145791|NCT00614380|589243172|FG002|Overall Study|Lost to Follow-up|0|||
163145792|NCT00614380|589243173|FG003|Overall Study|Lost to Follow-up|0|||
163145793|NCT00614380|589243170|FG000|Overall Study|Non compliant with the protocol|12|||
163145794|NCT00614380|589243171|FG001|Overall Study|Non compliant with the protocol|2|||
163145795|NCT00614380|589243172|FG002|Overall Study|Non compliant with the protocol|1|||
163145796|NCT00614380|589243173|FG003|Overall Study|Non compliant with the protocol|2|||
163145797|NCT00614380|589243170|FG000|Overall Study|Consent withdrawn|3|||
163145798|NCT00614380|589243171|FG001|Overall Study|Consent withdrawn|1|||
163145799|NCT00614380|589243172|FG002|Overall Study|Consent withdrawn|0|||
163145800|NCT00614380|589243173|FG003|Overall Study|Consent withdrawn|0|||
163145801|NCT04908397|589243178|FG000|Overall Study|Withdrawal by Subject|2|||
163145802|NCT00462306|589243179|FG000|Overall Study|insufficient data|0|||
163145803|NCT00462306|589243180|FG001|Overall Study|insufficient data|13|||
163145804|NCT00191334|589243186|FG000|Overall Study|Adverse Event|4|||
163145805|NCT00191334|589243186|FG000|Overall Study|Disease Progression or Relapse|8|||
163145806|NCT00191334|589243186|FG000|Overall Study|Physician Decision|1|||
163145807|NCT00191334|589243186|FG000|Overall Study|Withdrawal by Subject|4|||
163145808|NCT00452790|589243187|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
163145809|NCT00452790|589243188|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
163145810|NCT00452790|589243187|FG000|Infant Series|Parent/legal guardian request|8|||
163145811|NCT00452790|589243188|FG001|Infant Series|Parent/legal guardian request|6|||
163145812|NCT00452790|589243187|FG000|Infant Series|Failed to return|4|||
163145813|NCT00452790|589243188|FG001|Infant Series|Failed to return|1|||
163145814|NCT00452790|589243187|FG000|Infant Series|Protocol Violation|1|||
163145815|NCT00452790|589243188|FG001|Infant Series|Protocol Violation|3|||
163145816|NCT00452790|589243187|FG000|Infant Series|Lost to Follow-up|2|||
163145817|NCT00452790|589243188|FG001|Infant Series|Lost to Follow-up|2|||
163145818|NCT00452790|589243187|FG000|Infant Series|Adverse Event|1|||
163145819|NCT00452790|589243188|FG001|Infant Series|Adverse Event|2|||
163145820|NCT00452790|589243187|FG000|Infant Series|Other reasons|1|||
163145821|NCT00452790|589243188|FG001|Infant Series|Other reasons|2|||
163145822|NCT00452790|589243187|FG000|Infant Series|Investigator request|0|||
163145823|NCT00452790|589243188|FG001|Infant Series|Investigator request|1|||
163145824|NCT00452790|589243187|FG000|Infant Series|Death|0|||
163145825|NCT00452790|589243188|FG001|Infant Series|Death|1|||
163145826|NCT00452790|589243187|FG000|After Infant Series|Investigator request|10|||
163145827|NCT00452790|589243188|FG001|After Infant Series|Investigator request|10|||
163145828|NCT00452790|589243187|FG000|After Infant Series|Adverse Event|4|||
162663803|NCT02460224|587480685|FG020|Overall Study|Subject/guardian decision|0|||
162663804|NCT02460224|587480686|FG021|Overall Study|Subject/guardian decision|1|||
162663805|NCT02460224|587480687|FG022|Overall Study|Subject/guardian decision|0|||
163145829|NCT00452790|589243188|FG001|After Infant Series|Adverse Event|1|||
163145830|NCT00452790|589243187|FG000|After Infant Series|Parent/legal guardian request|1|||
163145831|NCT00452790|589243188|FG001|After Infant Series|Parent/legal guardian request|3|||
163145832|NCT00452790|589243187|FG000|After Infant Series|Lost to Follow-up|4|||
163145833|NCT00452790|589243188|FG001|After Infant Series|Lost to Follow-up|0|||
163145834|NCT00452790|589243187|FG000|After Infant Series|Failed to return|1|||
163145835|NCT00452790|589243188|FG001|After Infant Series|Failed to return|0|||
163145836|NCT00452790|589243187|FG000|After Infant Series|Other reasons|1|||
163145837|NCT00452790|589243188|FG001|After Infant Series|Other reasons|0|||
163145838|NCT00452790|589243187|FG000|Toddler Dose|Failed to return|0|||
163145839|NCT00452790|589243188|FG001|Toddler Dose|Failed to return|1|||
163145840|NCT00452790|589243187|FG000|Toddler Dose|Parent/legal guardian request|0|||
163145841|NCT00452790|589243188|FG001|Toddler Dose|Parent/legal guardian request|1|||
163145842|NCT02926638|589243192|FG000|Overall Study|Progression|2|||
163145843|NCT02926638|589243193|FG001|Overall Study|Progression|5|||
163145844|NCT02926638|589243192|FG000|Overall Study|Ineligible|1|||
163145845|NCT02926638|589243193|FG001|Overall Study|Ineligible|0|||
163145846|NCT02926638|589243192|FG000|Overall Study|Not protocol specified|1|||
163145847|NCT02926638|589243193|FG001|Overall Study|Not protocol specified|0|||
163145848|NCT02360228|589243196|FG000|Overall Study|Withdrawal by Subject|1|||
163145849|NCT02360228|589243197|FG001|Overall Study|Withdrawal by Subject|0|||
163145850|NCT02360228|589243198|FG002|Overall Study|Withdrawal by Subject|0|||
163145851|NCT02360228|589243196|FG000|Overall Study|Self-discontinued medication|0|||
163145852|NCT02360228|589243197|FG001|Overall Study|Self-discontinued medication|1|||
163145853|NCT02360228|589243198|FG002|Overall Study|Self-discontinued medication|0|||
163145854|NCT02360228|589243196|FG000|Overall Study|Unstable symptoms during screening|0|||
163145855|NCT02360228|589243197|FG001|Overall Study|Unstable symptoms during screening|0|||
163145856|NCT02360228|589243198|FG002|Overall Study|Unstable symptoms during screening|1|||
163145857|NCT01063153|589243199|FG000|Overall Study|Found Ineligible During Screening|2|||
163145858|NCT01063153|589243200|FG001|Overall Study|Found Ineligible During Screening|0|||
163145859|NCT01063153|589243199|FG000|Overall Study|Lost to Follow-up|0|||
163145860|NCT01063153|589243200|FG001|Overall Study|Lost to Follow-up|7|||
163145861|NCT01063153|589243199|FG000|Overall Study|Withdrawal by Subject|0|||
163145862|NCT01063153|589243200|FG001|Overall Study|Withdrawal by Subject|1|||
163145863|NCT01063153|589243199|FG000|Overall Study|Physician Decision|0|||
163145864|NCT01063153|589243200|FG001|Overall Study|Physician Decision|4|||
163145865|NCT02426580|589244454|FG000|Overall Study|Death|2|||
163145866|NCT02426580|589244455|FG001|Overall Study|Death|2|||
163145867|NCT02426580|589244454|FG000|Overall Study|Lost to Follow-up|0|||
163145868|NCT02426580|589244455|FG001|Overall Study|Lost to Follow-up|9|||
163145869|NCT02426580|589244454|FG000|Overall Study|transfer to hemodialysis|5|||
163145870|NCT02426580|589244455|FG001|Overall Study|transfer to hemodialysis|5|||
163145871|NCT02426580|589244454|FG000|Overall Study|Kidney transplant|3|||
163145872|NCT02426580|589244455|FG001|Overall Study|Kidney transplant|0|||
163145873|NCT02426580|589244454|FG000|Overall Study|Allergic to egg white|1|||
163145874|NCT02426580|589244455|FG001|Overall Study|Allergic to egg white|0|||
163145875|NCT00383552|589244456|FG000|Overall Study|Adverse Event|7|||
163145876|NCT00383552|589244457|FG001|Overall Study|Adverse Event|6|||
163145877|NCT00383552|589244458|FG002|Overall Study|Adverse Event|9|||
163145878|NCT00383552|589244459|FG003|Overall Study|Adverse Event|6|||
163145879|NCT00383552|589244456|FG000|Overall Study|Lack of Efficacy|4|||
163145880|NCT00383552|589244457|FG001|Overall Study|Lack of Efficacy|13|||
163145881|NCT00383552|589244458|FG002|Overall Study|Lack of Efficacy|29|||
163145882|NCT00383552|589244459|FG003|Overall Study|Lack of Efficacy|42|||
163145883|NCT00383552|589244456|FG000|Overall Study|Lost to Follow-up|0|||
163145884|NCT00383552|589244457|FG001|Overall Study|Lost to Follow-up|1|||
163145885|NCT00383552|589244458|FG002|Overall Study|Lost to Follow-up|5|||
163145886|NCT00383552|589244459|FG003|Overall Study|Lost to Follow-up|1|||
163145887|NCT00383552|589244456|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
163145888|NCT00383552|589244457|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
163145889|NCT00383552|589244458|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
163145890|NCT00383552|589244459|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
163145891|NCT00383552|589244456|FG000|Overall Study|Did not wish to continue (related)|1|||
163145892|NCT00383552|589244457|FG001|Overall Study|Did not wish to continue (related)|0|||
163145893|NCT00383552|589244458|FG002|Overall Study|Did not wish to continue (related)|2|||
163145894|NCT00383552|589244459|FG003|Overall Study|Did not wish to continue (related)|3|||
163145895|NCT00383552|589244456|FG000|Overall Study|Noncompliance with the protocol|11|||
163145896|NCT00383552|589244457|FG001|Overall Study|Noncompliance with the protocol|6|||
163145897|NCT00383552|589244458|FG002|Overall Study|Noncompliance with the protocol|8|||
163145898|NCT00383552|589244459|FG003|Overall Study|Noncompliance with the protocol|10|||
163145899|NCT00383552|589244456|FG000|Overall Study|Did not meet protocol eligibility|8|||
163145900|NCT00383552|589244457|FG001|Overall Study|Did not meet protocol eligibility|6|||
163145901|NCT00383552|589244458|FG002|Overall Study|Did not meet protocol eligibility|2|||
163145902|NCT00383552|589244459|FG003|Overall Study|Did not meet protocol eligibility|3|||
163145903|NCT00383552|589244456|FG000|Overall Study|Administrative|1|||
162663806|NCT02460224|587480688|FG023|Overall Study|Subject/guardian decision|0|||
162663807|NCT02460224|587480689|FG024|Overall Study|Subject/guardian decision|0|||
162663808|NCT02460224|587480690|FG025|Overall Study|Subject/guardian decision|0|||
162663809|NCT02460224|587480691|FG026|Overall Study|Subject/guardian decision|6|||
162663810|NCT02460224|587480692|FG027|Overall Study|Subject/guardian decision|2|||
162663811|NCT02460224|587480693|FG028|Overall Study|Subject/guardian decision|3|||
162663812|NCT01916304|587480694|FG000|Overall Study|Screening failure|17|||
162663813|NCT02774681|587480703|FG000|Treatment on Study|Progressive Disease|7|||
162663814|NCT02774681|587480703|FG000|Follow-Up for 3 Years|Death|11|||
162663815|NCT02774681|587480703|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
162663816|NCT03146650|587480706|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
162663817|NCT03146650|587480706|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
162663818|NCT03146650|587480706|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
162663819|NCT03146650|587480706|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
162663820|NCT03146650|587480706|FG000|2 Year Follow-up|Death|11|||
162663821|NCT03146650|587480706|FG000|2 Year Follow-up|Still in follow-up|7|||
162663822|NCT03146650|587480706|FG000|2 Year Follow-up|Lost to Follow-up|1|||
162663823|NCT04666441|587480707|FG000|Overall Study|Lost to Follow-up|1|||
162663824|NCT04666441|587480708|FG001|Overall Study|Lost to Follow-up|4|||
162663825|NCT04666441|587480709|FG002|Overall Study|Lost to Follow-up|1|||
162663826|NCT04666441|587480710|FG003|Overall Study|Lost to Follow-up|3|||
162663827|NCT04666441|587480711|FG004|Overall Study|Lost to Follow-up|0|||
162663828|NCT04666441|587480712|FG005|Overall Study|Lost to Follow-up|2|||
162663829|NCT04666441|587480713|FG006|Overall Study|Lost to Follow-up|2|||
162663830|NCT04666441|587480714|FG007|Overall Study|Lost to Follow-up|2|||
162663831|NCT04666441|587480707|FG000|Overall Study|Subject Decision|1|||
162663832|NCT04666441|587480708|FG001|Overall Study|Subject Decision|1|||
162663833|NCT04666441|587480709|FG002|Overall Study|Subject Decision|3|||
162663834|NCT04666441|587480710|FG003|Overall Study|Subject Decision|1|||
162663835|NCT04666441|587480711|FG004|Overall Study|Subject Decision|0|||
162663836|NCT04666441|587480712|FG005|Overall Study|Subject Decision|1|||
162663837|NCT04666441|587480713|FG006|Overall Study|Subject Decision|3|||
162663838|NCT04666441|587480714|FG007|Overall Study|Subject Decision|2|||
162663839|NCT00766415|587480725|FG000|Overall Study|Withdrawal by Subject|0|||
162663840|NCT00766415|587480726|FG001|Overall Study|Withdrawal by Subject|1|||
162663841|NCT01114516|587480727|FG000|Overall Study|Lost to Follow-up|2|||
162663842|NCT01114516|587480728|FG001|Overall Study|Lost to Follow-up|1|||
162663843|NCT01431508|587480731|FG000|Overall Study|Lack of Efficacy|1|||
162663844|NCT01431508|587480731|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
162663845|NCT00132769|587480732|FG000|Overall Study|Withdrawal by Subject|1|||
162663846|NCT00132769|587480733|FG001|Overall Study|Withdrawal by Subject|3|||
162663847|NCT00132769|587480732|FG000|Overall Study|Lack of Efficacy|7|||
162663848|NCT00132769|587480733|FG001|Overall Study|Lack of Efficacy|6|||
162663849|NCT00132769|587480732|FG000|Overall Study|Adverse Event|2|||
162663850|NCT00132769|587480733|FG001|Overall Study|Adverse Event|1|||
162663851|NCT00132769|587480732|FG000|Overall Study|Protocol Violation|1|||
162663852|NCT00132769|587480733|FG001|Overall Study|Protocol Violation|1|||
162663853|NCT02758236|587480735|FG000|Overall Study|Investigator discretion|43|||
162663854|NCT00441337|587480738|FG000|Overall Study|Disease Progression|6|||
162663855|NCT00441337|587480739|FG001|Overall Study|Disease Progression|6|||
162663856|NCT00441337|587480740|FG002|Overall Study|Disease Progression|4|||
162663857|NCT00441337|587480741|FG003|Overall Study|Disease Progression|18|||
162721277|NCT01307267|587688260|FG019|Overall Study|Lost to Follow-up|2|||
162663858|NCT00441337|587480738|FG000|Overall Study|Lost to Follow-up|0|||
162663859|NCT00441337|587480739|FG001|Overall Study|Lost to Follow-up|0|||
162663860|NCT00441337|587480740|FG002|Overall Study|Lost to Follow-up|0|||
162663861|NCT00441337|587480741|FG003|Overall Study|Lost to Follow-up|1|||
162663862|NCT00441337|587480738|FG000|Overall Study|Sponsor Decision|0|||
162663863|NCT00441337|587480739|FG001|Overall Study|Sponsor Decision|0|||
162663864|NCT00441337|587480740|FG002|Overall Study|Sponsor Decision|1|||
162663865|NCT00441337|587480741|FG003|Overall Study|Sponsor Decision|2|||
162663866|NCT00441337|587480738|FG000|Overall Study|Did not meet inclusion criteria|0|||
162663867|NCT00441337|587480739|FG001|Overall Study|Did not meet inclusion criteria|0|||
162663868|NCT00441337|587480740|FG002|Overall Study|Did not meet inclusion criteria|1|||
162663869|NCT00441337|587480741|FG003|Overall Study|Did not meet inclusion criteria|0|||
162663870|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
162663871|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
162663872|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
162663873|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Death|1|||
162663874|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Death|0|||
162663875|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Death|0|||
162663876|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
162663877|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
162663878|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
163145904|NCT00383552|589244457|FG001|Overall Study|Administrative|0|||
163145905|NCT00383552|589244458|FG002|Overall Study|Administrative|1|||
163145906|NCT00383552|589244459|FG003|Overall Study|Administrative|1|||
163145907|NCT01381016|589244461|FG000|Overall Study|Lost to Follow-up|1|||
163145908|NCT01381016|589244462|FG001|Overall Study|Lost to Follow-up|1|||
163145909|NCT01381016|589244461|FG000|Overall Study|Screen Failure|2|||
163145910|NCT01381016|589244462|FG001|Overall Study|Screen Failure|2|||
163145911|NCT01381016|589244461|FG000|Overall Study|Withdrawal by Subject|0|||
163145912|NCT01381016|589244462|FG001|Overall Study|Withdrawal by Subject|1|||
163145913|NCT01381016|589244461|FG000|Overall Study|Physician Decision|0|||
163145914|NCT01381016|589244462|FG001|Overall Study|Physician Decision|2|||
163145915|NCT03598036|589244468|FG000|Overall Study|Withdrawal by Subject|1|||
163145916|NCT03598036|589244469|FG001|Overall Study|Withdrawal by Subject|0|||
163145917|NCT05801991|589244473|FG000|Overall Study|Lost to Follow-up|1|||
163145918|NCT05801991|589244474|FG001|Overall Study|Lost to Follow-up|0|||
163145919|NCT01838694|589244475|FG000|Overall Study|Adverse Event|0|||
163145920|NCT01838694|589244476|FG001|Overall Study|Adverse Event|1|||
163145921|NCT04235140|589244477|FG000|Overall Study|Adverse Event|2|||
163145922|NCT04235140|589244477|FG000|Overall Study|Lost to Follow-up|1|||
163145923|NCT04235140|589244477|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
163145924|NCT04235140|589244477|FG000|Overall Study|Commercial drug is available for participants|7|||
163145925|NCT03016312|589244478|FG000|Overall Study|discontinued before the treatment started|0|||
163145926|NCT03016312|589244479|FG001|Overall Study|discontinued before the treatment started|1|||
163145927|NCT03016312|589244478|FG000|Overall Study|Withdrawal by Subject|37|||
163145928|NCT03016312|589244479|FG001|Overall Study|Withdrawal by Subject|44|||
163145929|NCT03016312|589244478|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
163145930|NCT03016312|589244479|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
163145931|NCT03016312|589244478|FG000|Overall Study|Physician Decision|1|||
163145932|NCT03016312|589244479|FG001|Overall Study|Physician Decision|3|||
163145933|NCT03016312|589244478|FG000|Overall Study|Lost to Follow-up|12|||
163145934|NCT03016312|589244479|FG001|Overall Study|Lost to Follow-up|12|||
163145935|NCT03016312|589244478|FG000|Overall Study|Death|210|||
163145936|NCT03016312|589244479|FG001|Overall Study|Death|184|||
163145937|NCT03016312|589244478|FG000|Overall Study|loss to contact|1|||
163145938|NCT03016312|589244479|FG001|Overall Study|loss to contact|0|||
163145939|NCT03016312|589244478|FG000|Overall Study|started a new cancer therapy|1|||
163145940|NCT03016312|589244479|FG001|Overall Study|started a new cancer therapy|0|||
163145941|NCT01451723|589244481|FG000|Overall Study|study halted|6|||
163145942|NCT01451723|589244482|FG001|Overall Study|study halted|5|||
163145943|NCT02210000|589244483|FG000|Overall Study|Study Terminated|11|||
163145944|NCT02210000|589244484|FG001|Overall Study|Study Terminated|12|||
163145945|NCT02210000|589244483|FG000|Overall Study|Withdrawal by Subject|7|||
163145946|NCT02210000|589244484|FG001|Overall Study|Withdrawal by Subject|1|||
163145947|NCT02210000|589244483|FG000|Overall Study|Adverse Event|1|||
163145948|NCT02210000|589244484|FG001|Overall Study|Adverse Event|5|||
163145949|NCT02210000|589244483|FG000|Overall Study|Lost to Follow-up|0|||
163145950|NCT02210000|589244484|FG001|Overall Study|Lost to Follow-up|2|||
163145951|NCT02210000|589244483|FG000|Overall Study|Physician Decision|0|||
163145952|NCT02210000|589244484|FG001|Overall Study|Physician Decision|1|||
163145953|NCT00833040|589244485|FG000|Overall Study|Adverse Event|0|||
163145954|NCT00833040|589244486|FG001|Overall Study|Adverse Event|0|||
163145955|NCT00833040|589244487|FG002|Overall Study|Adverse Event|0|||
163145956|NCT00833040|589244488|FG003|Overall Study|Adverse Event|0|||
163145957|NCT00833040|589244489|FG004|Overall Study|Adverse Event|0|||
163145958|NCT00833040|589244490|FG005|Overall Study|Adverse Event|1|||
163039240|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
163039241|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
163039242|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
163039243|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039244|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039245|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
163039246|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
163039247|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
163039248|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
163039249|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
163039250|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039251|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039252|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039253|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039254|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039255|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163145959|NCT01731912|589244501|FG000|Overall Study|noncompliance|2|||
163145960|NCT02043938|589244502|FG000|Overall Study|Withdrawal by Subject|7|||
163145961|NCT02043938|589244502|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
163145962|NCT02043938|589244502|FG000|Overall Study|No show by subject|1|||
163145963|NCT02043938|589244502|FG000|Overall Study|Investigator decision|1|||
162663879|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
162663880|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
162663881|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
162663882|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
163145964|NCT00443040|589244505|FG000|Overall Study|Withdrawal by Subject|1|||
163145965|NCT00443040|589244506|FG001|Overall Study|Withdrawal by Subject|0|||
163145966|NCT00443040|589244507|FG002|Overall Study|Withdrawal by Subject|0|||
163145967|NCT00443040|589244505|FG000|Overall Study|Converted to an open laparotomy|3|||
163145968|NCT00443040|589244506|FG001|Overall Study|Converted to an open laparotomy|0|||
163145969|NCT00443040|589244507|FG002|Overall Study|Converted to an open laparotomy|1|||
163145970|NCT01755234|589244510|FG000|Overall Study|Lost to Follow-up|11|||
163145971|NCT01755234|589244511|FG001|Overall Study|Lost to Follow-up|6|||
163145972|NCT01755234|589244510|FG000|Overall Study|Change in surgical case|2|||
163145973|NCT01755234|589244511|FG001|Overall Study|Change in surgical case|1|||
163145974|NCT01755234|589244510|FG000|Overall Study|case cancelled|1|||
163145975|NCT01755234|589244511|FG001|Overall Study|case cancelled|0|||
163145976|NCT01755234|589244510|FG000|Overall Study|Withdrawal by Subject|0|||
163145977|NCT01755234|589244511|FG001|Overall Study|Withdrawal by Subject|1|||
163145978|NCT01755234|589244510|FG000|Overall Study|unblinded|1|||
163145979|NCT01755234|589244511|FG001|Overall Study|unblinded|0|||
163145980|NCT02836652|589244512|FG000|Overall Study|Death|3|||
163145981|NCT02836652|589244513|FG001|Overall Study|Death|3|||
163145982|NCT02836652|589244512|FG000|Overall Study|Transplant/Explant|3|||
163145983|NCT02836652|589244513|FG001|Overall Study|Transplant/Explant|4|||
163145984|NCT02836652|589244512|FG000|Overall Study|Withdrawn|9|||
163145985|NCT02836652|589244513|FG001|Overall Study|Withdrawn|9|||
163145986|NCT02836652|589244512|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
163145987|NCT02836652|589244513|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
163145988|NCT03812380|589244514|FG000|Overall Study|Protocol Violation|3|||
163145989|NCT03812380|589244515|FG001|Overall Study|Protocol Violation|3|||
163145990|NCT03812380|589244514|FG000|Overall Study|Withdrawal by Subject|5|||
163145991|NCT03812380|589244515|FG001|Overall Study|Withdrawal by Subject|4|||
163145992|NCT03812380|589244514|FG000|Overall Study|Early termination of study|14|||
163145993|NCT03812380|589244515|FG001|Overall Study|Early termination of study|14|||
163145994|NCT02349633|589244517|FG000|Overall Study|Death|0|||
163145995|NCT02349633|589244518|FG001|Overall Study|Death|1|||
163145996|NCT02349633|589244519|FG002|Overall Study|Death|0|||
163145997|NCT02349633|589244520|FG003|Overall Study|Death|0|||
163145998|NCT02349633|589244521|FG004|Overall Study|Death|0|||
163145999|NCT02349633|589244522|FG005|Overall Study|Death|1|||
163146000|NCT02349633|589244523|FG006|Overall Study|Death|1|||
163146001|NCT02349633|589244524|FG007|Overall Study|Death|1|||
163146002|NCT02349633|589244525|FG008|Overall Study|Death|0|||
163146003|NCT02349633|589244526|FG009|Overall Study|Death|1|||
163146004|NCT02349633|589244527|FG010|Overall Study|Death|0|||
163146005|NCT02349633|589244528|FG011|Overall Study|Death|0|||
163146006|NCT02349633|589244529|FG012|Overall Study|Death|0|||
163146007|NCT02349633|589244530|FG013|Overall Study|Death|0|||
163146008|NCT02349633|589244517|FG000|Overall Study|Withdrawal by Subject|0|||
163146009|NCT02349633|589244518|FG001|Overall Study|Withdrawal by Subject|0|||
163146010|NCT02349633|589244519|FG002|Overall Study|Withdrawal by Subject|0|||
162721278|NCT01307267|587688261|FG020|Overall Study|Lost to Follow-up|0|||
162721279|NCT01307267|587688262|FG021|Overall Study|Lost to Follow-up|0|||
163039256|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
163039257|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039258|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
163039259|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
162721280|NCT01307267|587688263|FG022|Overall Study|Lost to Follow-up|0|||
162721281|NCT01307267|587688241|FG000|Overall Study|Withdrawal by Subject|0|||
162721282|NCT01307267|587688242|FG001|Overall Study|Withdrawal by Subject|0|||
163146011|NCT02349633|589244520|FG003|Overall Study|Withdrawal by Subject|1|||
163146012|NCT02349633|589244521|FG004|Overall Study|Withdrawal by Subject|0|||
163146013|NCT02349633|589244522|FG005|Overall Study|Withdrawal by Subject|0|||
163146014|NCT02349633|589244523|FG006|Overall Study|Withdrawal by Subject|0|||
163146015|NCT02349633|589244524|FG007|Overall Study|Withdrawal by Subject|2|||
163146016|NCT02349633|589244525|FG008|Overall Study|Withdrawal by Subject|2|||
163146017|NCT02349633|589244526|FG009|Overall Study|Withdrawal by Subject|1|||
163146018|NCT02349633|589244527|FG010|Overall Study|Withdrawal by Subject|0|||
163146019|NCT02349633|589244528|FG011|Overall Study|Withdrawal by Subject|0|||
163146020|NCT02349633|589244529|FG012|Overall Study|Withdrawal by Subject|0|||
163146021|NCT02349633|589244530|FG013|Overall Study|Withdrawal by Subject|0|||
163146022|NCT02349633|589244517|FG000|Overall Study|Withdrawal of informed consent|0|||
163146023|NCT02349633|589244518|FG001|Overall Study|Withdrawal of informed consent|0|||
163146024|NCT02349633|589244519|FG002|Overall Study|Withdrawal of informed consent|0|||
163146025|NCT02349633|589244520|FG003|Overall Study|Withdrawal of informed consent|1|||
163146026|NCT02349633|589244521|FG004|Overall Study|Withdrawal of informed consent|1|||
163146027|NCT02349633|589244522|FG005|Overall Study|Withdrawal of informed consent|0|||
163146028|NCT02349633|589244523|FG006|Overall Study|Withdrawal of informed consent|0|||
163146029|NCT02349633|589244524|FG007|Overall Study|Withdrawal of informed consent|3|||
163146030|NCT02349633|589244525|FG008|Overall Study|Withdrawal of informed consent|0|||
163146031|NCT02349633|589244526|FG009|Overall Study|Withdrawal of informed consent|0|||
163146032|NCT02349633|589244527|FG010|Overall Study|Withdrawal of informed consent|0|||
163146033|NCT02349633|589244528|FG011|Overall Study|Withdrawal of informed consent|0|||
163146034|NCT02349633|589244529|FG012|Overall Study|Withdrawal of informed consent|0|||
163146035|NCT02349633|589244530|FG013|Overall Study|Withdrawal of informed consent|0|||
163146036|NCT02349633|589244517|FG000|Overall Study|Transition to compassionate use|0|||
163146037|NCT02349633|589244518|FG001|Overall Study|Transition to compassionate use|0|||
163146038|NCT02349633|589244519|FG002|Overall Study|Transition to compassionate use|0|||
163146039|NCT02349633|589244520|FG003|Overall Study|Transition to compassionate use|0|||
163146040|NCT02349633|589244521|FG004|Overall Study|Transition to compassionate use|1|||
163146041|NCT02349633|589244522|FG005|Overall Study|Transition to compassionate use|0|||
163146042|NCT02349633|589244523|FG006|Overall Study|Transition to compassionate use|0|||
163146043|NCT02349633|589244524|FG007|Overall Study|Transition to compassionate use|3|||
163146044|NCT02349633|589244525|FG008|Overall Study|Transition to compassionate use|0|||
163146045|NCT02349633|589244526|FG009|Overall Study|Transition to compassionate use|1|||
163146046|NCT02349633|589244527|FG010|Overall Study|Transition to compassionate use|0|||
163146047|NCT02349633|589244528|FG011|Overall Study|Transition to compassionate use|0|||
163146048|NCT02349633|589244529|FG012|Overall Study|Transition to compassionate use|0|||
163146049|NCT02349633|589244530|FG013|Overall Study|Transition to compassionate use|0|||
163146050|NCT02349633|589244517|FG000|Overall Study|Early termination of survival follow-up|0|||
163146051|NCT02349633|589244518|FG001|Overall Study|Early termination of survival follow-up|0|||
163146052|NCT02349633|589244519|FG002|Overall Study|Early termination of survival follow-up|0|||
163146053|NCT02349633|589244520|FG003|Overall Study|Early termination of survival follow-up|0|||
163146054|NCT02349633|589244521|FG004|Overall Study|Early termination of survival follow-up|0|||
163146055|NCT02349633|589244522|FG005|Overall Study|Early termination of survival follow-up|0|||
163146056|NCT02349633|589244523|FG006|Overall Study|Early termination of survival follow-up|0|||
163146057|NCT02349633|589244524|FG007|Overall Study|Early termination of survival follow-up|4|||
163146058|NCT02349633|589244525|FG008|Overall Study|Early termination of survival follow-up|0|||
163146059|NCT02349633|589244526|FG009|Overall Study|Early termination of survival follow-up|0|||
163039260|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039261|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
162721283|NCT01307267|587688243|FG002|Overall Study|Withdrawal by Subject|0|||
162663883|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
162663884|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
163146060|NCT02349633|589244527|FG010|Overall Study|Early termination of survival follow-up|0|||
163146061|NCT02349633|589244528|FG011|Overall Study|Early termination of survival follow-up|0|||
163146062|NCT02349633|589244529|FG012|Overall Study|Early termination of survival follow-up|0|||
163146063|NCT02349633|589244530|FG013|Overall Study|Early termination of survival follow-up|0|||
163146064|NCT02349633|589244517|FG000|Overall Study|Termination by sponsor|0|||
163146065|NCT02349633|589244518|FG001|Overall Study|Termination by sponsor|0|||
163146066|NCT02349633|589244519|FG002|Overall Study|Termination by sponsor|0|||
163146067|NCT02349633|589244520|FG003|Overall Study|Termination by sponsor|0|||
163146068|NCT02349633|589244521|FG004|Overall Study|Termination by sponsor|0|||
163146069|NCT02349633|589244522|FG005|Overall Study|Termination by sponsor|0|||
163146070|NCT02349633|589244523|FG006|Overall Study|Termination by sponsor|0|||
163146071|NCT02349633|589244524|FG007|Overall Study|Termination by sponsor|1|||
163146072|NCT02349633|589244525|FG008|Overall Study|Termination by sponsor|0|||
163146073|NCT02349633|589244526|FG009|Overall Study|Termination by sponsor|2|||
163146074|NCT02349633|589244527|FG010|Overall Study|Termination by sponsor|0|||
163146075|NCT02349633|589244528|FG011|Overall Study|Termination by sponsor|0|||
163146076|NCT02349633|589244529|FG012|Overall Study|Termination by sponsor|0|||
163146077|NCT02349633|589244530|FG013|Overall Study|Termination by sponsor|0|||
163146078|NCT02349633|589244517|FG000|Overall Study|Other|0|||
163146079|NCT02349633|589244518|FG001|Overall Study|Other|0|||
163146080|NCT02349633|589244519|FG002|Overall Study|Other|0|||
163146081|NCT02349633|589244520|FG003|Overall Study|Other|0|||
163146082|NCT02349633|589244521|FG004|Overall Study|Other|0|||
163146083|NCT02349633|589244522|FG005|Overall Study|Other|0|||
163146084|NCT02349633|589244523|FG006|Overall Study|Other|0|||
163146085|NCT02349633|589244524|FG007|Overall Study|Other|2|||
163146086|NCT02349633|589244525|FG008|Overall Study|Other|0|||
163146087|NCT02349633|589244526|FG009|Overall Study|Other|0|||
163146088|NCT02349633|589244527|FG010|Overall Study|Other|0|||
163146089|NCT02349633|589244528|FG011|Overall Study|Other|0|||
163146090|NCT02349633|589244529|FG012|Overall Study|Other|0|||
163146091|NCT02349633|589244530|FG013|Overall Study|Other|0|||
163146092|NCT00667628|589244531|FG000|Overall Study|Lost to Follow-up|1|||
163146093|NCT00667628|589244532|FG001|Overall Study|Lost to Follow-up|0|||
163146094|NCT00667628|589244531|FG000|Overall Study|Death|6|||
163146095|NCT00667628|589244532|FG001|Overall Study|Death|6|||
163146096|NCT00667628|589244531|FG000|Overall Study|Investigator Considers in Best Interest|1|||
163146097|NCT00667628|589244532|FG001|Overall Study|Investigator Considers in Best Interest|0|||
163146098|NCT00667628|589244531|FG000|Overall Study|Sponsor Terminated Study|17|||
163146099|NCT00667628|589244532|FG001|Overall Study|Sponsor Terminated Study|21|||
163146100|NCT05789745|589244533|FG000|Overall Study|Withdrawal by Subject|0|||
163146101|NCT05789745|589244534|FG001|Overall Study|Withdrawal by Subject|0|||
163146102|NCT05789745|589244535|FG002|Overall Study|Withdrawal by Subject|0|||
163146103|NCT05789745|589244536|FG003|Overall Study|Withdrawal by Subject|0|||
163146104|NCT05789745|589244537|FG004|Overall Study|Withdrawal by Subject|1|||
163146105|NCT04663321|589244538|FG000|Overall Study|Study terminated by Sponsor|2|||
163146106|NCT04663321|589244539|FG001|Overall Study|Study terminated by Sponsor|1|||
163146107|NCT04663321|589244540|FG002|Overall Study|Study terminated by Sponsor|2|||
163146108|NCT04663321|589244538|FG000|Overall Study|Withdrawal by Subject|10|||
163146109|NCT04663321|589244539|FG001|Overall Study|Withdrawal by Subject|3|||
163146110|NCT04663321|589244540|FG002|Overall Study|Withdrawal by Subject|2|||
163146111|NCT04663321|589244538|FG000|Overall Study|Not provided|0|||
163146112|NCT04663321|589244539|FG001|Overall Study|Not provided|0|||
163146113|NCT04663321|589244540|FG002|Overall Study|Not provided|1|||
163146114|NCT00622505|589244543|FG000|Overall Study|Adverse Event|9|||
163146115|NCT00622505|589244544|FG001|Overall Study|Adverse Event|7|||
163146116|NCT00622505|589244543|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
163146117|NCT00622505|589244544|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
163146118|NCT00622505|589244543|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163146119|NCT00622505|589244544|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163146120|NCT00622505|589244543|FG000|Overall Study|Withdrawal by Subject|12|||
163146121|NCT00622505|589244544|FG001|Overall Study|Withdrawal by Subject|5|||
163146122|NCT00622505|589244543|FG000|Overall Study|Administrative Problems|2|||
163146123|NCT00622505|589244544|FG001|Overall Study|Administrative Problems|4|||
163146124|NCT00622505|589244543|FG000|Overall Study|Death|2|||
163146125|NCT00622505|589244544|FG001|Overall Study|Death|2|||
163146126|NCT00619515|589244545|FG000|Overall Study|Study Termination by IRB|73|||
163146127|NCT03294590|589244548|FG000|Overall Study|Lost to Follow-up|105|||
163146128|NCT03294590|589244549|FG001|Overall Study|Lost to Follow-up|107|||
163146129|NCT01962441|589244552|FG000|Randomized Period|Randomized but Never Treated|4|||
163146130|NCT01962441|589244553|FG001|Randomized Period|Randomized but Never Treated|2|||
163146131|NCT01962441|589244554|FG002|Randomized Period|Randomized but Never Treated|3|||
163146132|NCT01962441|589244552|FG000|Randomized Period|Lost to Follow-up|2|||
163146133|NCT01962441|589244553|FG001|Randomized Period|Lost to Follow-up|4|||
162663885|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
162663886|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
162663887|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
162663888|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
162663889|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
162663890|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
162663891|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
162663892|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
162663893|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
162663894|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
162663895|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
162663896|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
162663897|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
162663898|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
162663899|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
162663900|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
162663901|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
162663902|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
162663903|NCT03655236|587480742|FG000|Subject Disposition in Part 1 Period|Other|0|||
162663904|NCT03655236|587480743|FG001|Subject Disposition in Part 1 Period|Other|2|||
162663905|NCT03655236|587480744|FG002|Subject Disposition in Part 1 Period|Other|2|||
162663906|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
162663907|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
162663908|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
162663909|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
162663910|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
162663911|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
163146134|NCT01962441|589244554|FG002|Randomized Period|Lost to Follow-up|4|||
163146135|NCT01962441|589244552|FG000|Randomized Period|Withdrew Consent|3|||
163146136|NCT01962441|589244553|FG001|Randomized Period|Withdrew Consent|3|||
163146137|NCT01962441|589244554|FG002|Randomized Period|Withdrew Consent|2|||
163146138|NCT01962441|589244552|FG000|Randomized Period|Adverse Event|1|||
163146139|NCT01962441|589244553|FG001|Randomized Period|Adverse Event|1|||
163146140|NCT01962441|589244554|FG002|Randomized Period|Adverse Event|0|||
163146141|NCT01962441|589244552|FG000|Randomized Period|Death|0|||
163146142|NCT01962441|589244553|FG001|Randomized Period|Death|0|||
163146143|NCT01962441|589244554|FG002|Randomized Period|Death|2|||
163146144|NCT01962441|589244552|FG000|Randomized Period|Protocol Violation|0|||
163146145|NCT01962441|589244553|FG001|Randomized Period|Protocol Violation|1|||
163146146|NCT01962441|589244554|FG002|Randomized Period|Protocol Violation|0|||
163146147|NCT01962441|589244552|FG000|Retreatment Substudy|Lack of Efficacy|1|||
163146148|NCT01962441|589244553|FG001|Retreatment Substudy|Lack of Efficacy|0|||
163146149|NCT01962441|589244554|FG002|Retreatment Substudy|Lack of Efficacy|0|||
163146150|NCT01962441|589244552|FG000|Retreatment Substudy|Lost to Follow-up|1|||
163146151|NCT01962441|589244553|FG001|Retreatment Substudy|Lost to Follow-up|0|||
163146152|NCT01962441|589244554|FG002|Retreatment Substudy|Lost to Follow-up|0|||
163146153|NCT04862065|589244555|FG000|Screening|Protocol Violation|54|||
163146154|NCT04862065|589244556|FG001|Screening|Protocol Violation|0|||
163146155|NCT04862065|589244557|FG002|Screening|Protocol Violation|0|||
163146156|NCT04862065|589244555|FG000|Screening|Insufficient Sample|1|||
163146157|NCT04862065|589244556|FG001|Screening|Insufficient Sample|0|||
163146158|NCT04862065|589244557|FG002|Screening|Insufficient Sample|0|||
163146159|NCT04862065|589244555|FG000|Follow-Up|Lost to Follow-up|3|||
163146160|NCT04862065|589244556|FG001|Follow-Up|Lost to Follow-up|0|||
163146161|NCT04862065|589244557|FG002|Follow-Up|Lost to Follow-up|0|||
163146162|NCT01453140|589244558|FG000|Overall Study|Adverse Event|3|||
163146163|NCT00718510|589244559|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163146164|NCT00718510|589244560|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163146165|NCT00718510|589244559|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
163146166|NCT00718510|589244560|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163146167|NCT00423657|589244562|FG000|Overall Study|Withdrew consent|10|||
163146168|NCT00423657|589244563|FG001|Overall Study|Withdrew consent|8|||
163146169|NCT00423657|589244562|FG000|Overall Study|Non-compliance|0|||
163146170|NCT00423657|589244563|FG001|Overall Study|Non-compliance|1|||
163146171|NCT00423657|589244562|FG000|Overall Study|Other|15|||
163146172|NCT00423657|589244563|FG001|Overall Study|Other|16|||
163146173|NCT00423657|589244562|FG000|Overall Study|Request of sponsor/investigator|1|||
163146174|NCT00423657|589244563|FG001|Overall Study|Request of sponsor/investigator|0|||
163146175|NCT02269124|589244565|FG000|Overall Study|Lost to Follow-up|1|||
163146176|NCT02269124|589244566|FG001|Overall Study|Lost to Follow-up|0|||
163146177|NCT02269124|589244565|FG000|Overall Study|Withdrawal by Subject|0|||
163146178|NCT02269124|589244566|FG001|Overall Study|Withdrawal by Subject|2|||
162663912|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
162663913|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
162663914|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
162663915|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
162663916|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
162663917|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
162663918|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
162663919|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
162663920|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
162663921|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
162663922|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
162663923|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
162663924|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
162663925|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
162663926|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
162663927|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
162663928|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
162663929|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
162663930|NCT03655236|587480742|FG000|Subject Disposition in Part 2 Period|Other|1|||
162663931|NCT03655236|587480743|FG001|Subject Disposition in Part 2 Period|Other|0|||
162663932|NCT03655236|587480744|FG002|Subject Disposition in Part 2 Period|Other|0|||
162663933|NCT06748040|587480745|FG000|Overall Study|Death|3|||
162663934|NCT06748040|587480746|FG001|Overall Study|Death|4|||
162663935|NCT06748040|587480745|FG000|Overall Study|Lost to Follow-up|134|||
162663936|NCT06748040|587480746|FG001|Overall Study|Lost to Follow-up|132|||
162663937|NCT06748040|587480745|FG000|Overall Study|Withdrawal by Subject|3|||
162663938|NCT06748040|587480746|FG001|Overall Study|Withdrawal by Subject|5|||
162663939|NCT01722331|587482810|FG000|Part 1|Adverse Event|5|||
162663940|NCT01722331|587482811|FG001|Part 1|Adverse Event|0|||
162663941|NCT01722331|587482812|FG002|Part 1|Adverse Event|0|||
162663942|NCT01722331|587482813|FG003|Part 1|Adverse Event|0|||
163146179|NCT04664153|589244569|FG000|Overall Study|Lack of Efficacy|0|||
163146180|NCT04664153|589244570|FG001|Overall Study|Lack of Efficacy|0|||
163146181|NCT04664153|589244571|FG002|Overall Study|Lack of Efficacy|1|||
163146182|NCT04664153|589244572|FG003|Overall Study|Lack of Efficacy|0|||
163146183|NCT04664153|589244569|FG000|Overall Study|Physician Decision|0|||
163146184|NCT04664153|589244570|FG001|Overall Study|Physician Decision|0|||
163146185|NCT04664153|589244571|FG002|Overall Study|Physician Decision|1|||
163146186|NCT04664153|589244572|FG003|Overall Study|Physician Decision|0|||
163146187|NCT04664153|589244569|FG000|Overall Study|Withdrawal by Subject|3|||
163146188|NCT04664153|589244570|FG001|Overall Study|Withdrawal by Subject|2|||
163146189|NCT04664153|589244571|FG002|Overall Study|Withdrawal by Subject|1|||
163146190|NCT04664153|589244572|FG003|Overall Study|Withdrawal by Subject|2|||
163146191|NCT04664153|589244569|FG000|Overall Study|Other|0|||
163146192|NCT04664153|589244570|FG001|Overall Study|Other|1|||
163146193|NCT04664153|589244571|FG002|Overall Study|Other|0|||
163146194|NCT04664153|589244572|FG003|Overall Study|Other|0|||
163146195|NCT04664153|589244569|FG000|Overall Study|Adverse Event|4|||
163146196|NCT04664153|589244570|FG001|Overall Study|Adverse Event|0|||
163146197|NCT04664153|589244571|FG002|Overall Study|Adverse Event|1|||
163146198|NCT04664153|589244572|FG003|Overall Study|Adverse Event|0|||
163146199|NCT00231777|589244573|FG000|Overall Study|Lost to Follow-up|3|||
163146200|NCT00231777|589244574|FG001|Overall Study|Lost to Follow-up|0|||
163146201|NCT00231777|589244573|FG000|Overall Study|Other|3|||
163146202|NCT00231777|589244574|FG001|Overall Study|Other|2|||
163146203|NCT00524485|589244575|FG000|Overall Study|Withdrawal by Subject|5|||
163146204|NCT01600885|589244576|FG000|First Period|Adverse Event|1|||
163146205|NCT01600885|589244577|FG001|First Period|Adverse Event|1|||
163146206|NCT01600885|589244576|FG000|First Period|moved out of area|1|||
163146207|NCT01600885|589244577|FG001|First Period|moved out of area|0|||
163146208|NCT00642356|589244583|FG000|Overall Study|Adverse Event|1|||
163146209|NCT00642356|589244584|FG001|Overall Study|Adverse Event|0|||
163146210|NCT00642356|589244583|FG000|Overall Study|Protocol Violation|0|||
163146211|NCT00642356|589244584|FG001|Overall Study|Protocol Violation|3|||
163146212|NCT00642356|589244583|FG000|Overall Study|Lack of Efficacy|1|||
163146213|NCT00642356|589244584|FG001|Overall Study|Lack of Efficacy|0|||
163146214|NCT01009060|589244585|FG000|Overall Study|Adverse Event|1|||
163146215|NCT01009060|589244586|FG001|Overall Study|Adverse Event|2|||
163146216|NCT01009060|589244585|FG000|Overall Study|Protocol Violation|0|||
163146217|NCT01009060|589244586|FG001|Overall Study|Protocol Violation|1|||
163146218|NCT01009060|589244585|FG000|Overall Study|Lost to Follow-up|1|||
163146219|NCT01009060|589244586|FG001|Overall Study|Lost to Follow-up|0|||
163146220|NCT01009060|589244585|FG000|Overall Study|Physician Decision|1|||
163146221|NCT01009060|589244586|FG001|Overall Study|Physician Decision|1|||
163146222|NCT01009060|589244585|FG000|Overall Study|Withdrawal by Subject|1|||
162721284|NCT01307267|587688244|FG003|Overall Study|Withdrawal by Subject|0|||
162721285|NCT01307267|587688245|FG004|Overall Study|Withdrawal by Subject|0|||
162721286|NCT01307267|587688246|FG005|Overall Study|Withdrawal by Subject|1|||
162721287|NCT01307267|587688247|FG006|Overall Study|Withdrawal by Subject|0|||
162721288|NCT01307267|587688248|FG007|Overall Study|Withdrawal by Subject|1|||
162721289|NCT01307267|587688249|FG008|Overall Study|Withdrawal by Subject|5|||
162721290|NCT01307267|587688250|FG009|Overall Study|Withdrawal by Subject|1|||
162721291|NCT01307267|587688251|FG010|Overall Study|Withdrawal by Subject|1|||
162721292|NCT01307267|587688252|FG011|Overall Study|Withdrawal by Subject|1|||
162721293|NCT01307267|587688253|FG012|Overall Study|Withdrawal by Subject|0|||
162721294|NCT01307267|587688254|FG013|Overall Study|Withdrawal by Subject|0|||
162721295|NCT01307267|587688255|FG014|Overall Study|Withdrawal by Subject|0|||
162721296|NCT01307267|587688256|FG015|Overall Study|Withdrawal by Subject|0|||
162721297|NCT01307267|587688257|FG016|Overall Study|Withdrawal by Subject|0|||
162721298|NCT01307267|587688258|FG017|Overall Study|Withdrawal by Subject|0|||
162721299|NCT01307267|587688259|FG018|Overall Study|Withdrawal by Subject|0|||
162721300|NCT01307267|587688260|FG019|Overall Study|Withdrawal by Subject|3|||
162721301|NCT01307267|587688261|FG020|Overall Study|Withdrawal by Subject|0|||
162721302|NCT01307267|587688262|FG021|Overall Study|Withdrawal by Subject|0|||
162721303|NCT01307267|587688263|FG022|Overall Study|Withdrawal by Subject|0|||
162721304|NCT01307267|587688241|FG000|Overall Study|Other|0|||
162721305|NCT01307267|587688242|FG001|Overall Study|Other|0|||
162721306|NCT01307267|587688243|FG002|Overall Study|Other|0|||
162721307|NCT01307267|587688244|FG003|Overall Study|Other|0|||
162721308|NCT01307267|587688245|FG004|Overall Study|Other|0|||
163039262|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039263|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
163039264|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
163039265|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039266|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163039267|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
163146223|NCT01009060|589244586|FG001|Overall Study|Withdrawal by Subject|1|||
163146224|NCT00005906|589244587|FG000|Overall Study|Lack of Efficacy|3|||
163146225|NCT01945021|589244588|FG000|Overall Study|Adverse Event|1|||
162721309|NCT01307267|587688246|FG005|Overall Study|Other|7|||
162721310|NCT01307267|587688247|FG006|Overall Study|Other|0|||
162721311|NCT01307267|587688248|FG007|Overall Study|Other|1|||
162721312|NCT01307267|587688249|FG008|Overall Study|Other|3|||
163146226|NCT01945021|589244588|FG000|Overall Study|Withdrawal of consent|12|||
163146227|NCT01945021|589244588|FG000|Overall Study|Lost to Follow-up|5|||
163146228|NCT01945021|589244588|FG000|Overall Study|Death|65|||
163146229|NCT03409796|589246153|FG000|Overall Study|Adverse Event|2|||
163146230|NCT03409796|589246154|FG001|Overall Study|Adverse Event|0|||
163146231|NCT03409796|589246153|FG000|Overall Study|Other|0|||
163146232|NCT03409796|589246154|FG001|Overall Study|Other|1|||
163146233|NCT00740220|589246155|FG000|Overall Study|screen failures (non-COPD patients)|9|||
163146234|NCT00770653|589246159|FG000|Overall Study|Adverse Event|13|||
163146235|NCT00770653|589246160|FG001|Overall Study|Adverse Event|5|||
163146236|NCT00770653|589246159|FG000|Overall Study|Protocol Violation|8|||
163146237|NCT00770653|589246160|FG001|Overall Study|Protocol Violation|6|||
163146238|NCT00770653|589246159|FG000|Overall Study|Withdrawal by Subject|4|||
163146239|NCT00770653|589246160|FG001|Overall Study|Withdrawal by Subject|7|||
163146240|NCT00770653|589246159|FG000|Overall Study|Lack of Compliance|1|||
163146241|NCT00770653|589246160|FG001|Overall Study|Lack of Compliance|4|||
163146242|NCT00770653|589246159|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
163146243|NCT00770653|589246160|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
163146244|NCT00770653|589246159|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
163146245|NCT00770653|589246160|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
163146246|NCT00770653|589246159|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
163146247|NCT00770653|589246160|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
163146248|NCT00770653|589246159|FG000|Overall Study|Lost to Follow-up|1|||
163146249|NCT00770653|589246160|FG001|Overall Study|Lost to Follow-up|2|||
163146250|NCT00770653|589246159|FG000|Overall Study|Physician Decision|1|||
163146251|NCT00770653|589246160|FG001|Overall Study|Physician Decision|0|||
163146252|NCT01908426|589246162|FG000|Overall Study|Adverse Event|98|||
163146253|NCT01908426|589246163|FG001|Overall Study|Adverse Event|11|||
163146254|NCT01908426|589246162|FG000|Overall Study|Clinical Deterioration|72|||
163146255|NCT01908426|589246163|FG001|Overall Study|Clinical Deterioration|38|||
163146256|NCT01908426|589246162|FG000|Overall Study|Lack of Efficacy|3|||
163146257|NCT01908426|589246163|FG001|Overall Study|Lack of Efficacy|0|||
163146258|NCT01908426|589246162|FG000|Overall Study|Lost to Follow-up|0|||
163146259|NCT01908426|589246163|FG001|Overall Study|Lost to Follow-up|1|||
163146260|NCT01908426|589246162|FG000|Overall Study|Physician Decision|3|||
163146261|NCT01908426|589246163|FG001|Overall Study|Physician Decision|3|||
163146262|NCT01908426|589246162|FG000|Overall Study|Withdrawal by Subject|11|||
162721313|NCT01307267|587688250|FG009|Overall Study|Other|0|||
162721314|NCT01307267|587688251|FG010|Overall Study|Other|1|||
163039268|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039269|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039270|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039271|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039272|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039273|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039274|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039275|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
163039276|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
163039277|NCT00528372|588850681|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039278|NCT00528372|588850682|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039279|NCT00528372|588850683|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
163039280|NCT00528372|588850684|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
163039281|NCT00528372|588850685|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
163039282|NCT00528372|588850686|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
163039283|NCT00528372|588850687|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
163039284|NCT00528372|588850688|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
163039285|NCT00528372|588850689|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
163039286|NCT01289574|588850692|FG000|Overall Study|Lack of Efficacy|4|||
163039287|NCT01289574|588850693|FG001|Overall Study|Lack of Efficacy|0|||
163039288|NCT01289574|588850694|FG002|Overall Study|Lack of Efficacy|1|||
163039289|NCT01289574|588850692|FG000|Overall Study|Lost to Follow-up|2|||
163039290|NCT01289574|588850693|FG001|Overall Study|Lost to Follow-up|0|||
163039291|NCT01289574|588850694|FG002|Overall Study|Lost to Follow-up|1|||
163039292|NCT01289574|588850692|FG000|Overall Study|Withdrawal by Subject|1|||
163039293|NCT01289574|588850693|FG001|Overall Study|Withdrawal by Subject|1|||
163039294|NCT01289574|588850694|FG002|Overall Study|Withdrawal by Subject|1|||
163039295|NCT01289574|588850692|FG000|Overall Study|Adverse Event|0|||
163039296|NCT01289574|588850693|FG001|Overall Study|Adverse Event|1|||
163039297|NCT01289574|588850694|FG002|Overall Study|Adverse Event|0|||
163039298|NCT01289574|588850692|FG000|Overall Study|Subject wanted alternate treatment|0|||
163039299|NCT01289574|588850693|FG001|Overall Study|Subject wanted alternate treatment|1|||
163039300|NCT01289574|588850694|FG002|Overall Study|Subject wanted alternate treatment|0|||
163039301|NCT02432144|588850696|FG000|Overall Study|Participant Non-Compliance|1|||
163039302|NCT00262002|588850697|FG000|Overall Study|Adverse Event|2|||
163039303|NCT00262002|588850698|FG001|Overall Study|Adverse Event|1|||
163039304|NCT00262002|588850699|FG002|Overall Study|Adverse Event|0|||
163039305|NCT00262002|588850700|FG003|Overall Study|Adverse Event|0|||
162663943|NCT01722331|587482814|FG004|Part 1|Adverse Event|0|||
162663944|NCT01722331|587482815|FG005|Part 1|Adverse Event|0|||
162663945|NCT01722331|587482816|FG006|Part 1|Adverse Event|0|||
163039306|NCT00262002|588850701|FG004|Overall Study|Adverse Event|0|||
163039307|NCT00262002|588850702|FG005|Overall Study|Adverse Event|1|||
162663946|NCT01722331|587482810|FG000|Part 1|Lack of Efficacy|0|||
162663947|NCT01722331|587482811|FG001|Part 1|Lack of Efficacy|0|||
162663948|NCT01722331|587482812|FG002|Part 1|Lack of Efficacy|1|||
163146263|NCT01908426|589246163|FG001|Overall Study|Withdrawal by Subject|6|||
163146264|NCT01908426|589246162|FG000|Overall Study|Progressive Disease|206|||
163146265|NCT01908426|589246163|FG001|Overall Study|Progressive Disease|152|||
163146266|NCT01908426|589246162|FG000|Overall Study|Protocol Violation|1|||
163146267|NCT01908426|589246163|FG001|Overall Study|Protocol Violation|0|||
163146268|NCT01908426|589246162|FG000|Overall Study|No Study Treatment Given|3|||
163146269|NCT01908426|589246163|FG001|Overall Study|No Study Treatment Given|0|||
163146270|NCT02973100|589246168|FG000|Overall Study|Adverse Event|1|||
163146271|NCT02973100|589246169|FG001|Overall Study|Adverse Event|2|||
163146272|NCT02973100|589246170|FG002|Overall Study|Adverse Event|1|||
163146273|NCT02973100|589246171|FG003|Overall Study|Adverse Event|2|||
163146274|NCT02973100|589246168|FG000|Overall Study|Lost to Follow-up|3|||
163146275|NCT02973100|589246169|FG001|Overall Study|Lost to Follow-up|1|||
163146276|NCT02973100|589246170|FG002|Overall Study|Lost to Follow-up|1|||
163146277|NCT02973100|589246171|FG003|Overall Study|Lost to Follow-up|0|||
163146278|NCT02973100|589246168|FG000|Overall Study|Withdrawal by Subject|3|||
163146279|NCT02973100|589246169|FG001|Overall Study|Withdrawal by Subject|5|||
163146280|NCT02973100|589246170|FG002|Overall Study|Withdrawal by Subject|1|||
163146281|NCT02973100|589246171|FG003|Overall Study|Withdrawal by Subject|4|||
163146282|NCT02973100|589246168|FG000|Overall Study|Notification of change in address|0|||
163146283|NCT02973100|589246169|FG001|Overall Study|Notification of change in address|0|||
163146284|NCT02973100|589246170|FG002|Overall Study|Notification of change in address|0|||
163146285|NCT02973100|589246171|FG003|Overall Study|Notification of change in address|1|||
163146286|NCT02973100|589246168|FG000|Overall Study|Failed to attend Safety followup period|0|||
163146287|NCT02973100|589246169|FG001|Overall Study|Failed to attend Safety followup period|0|||
163146288|NCT02973100|589246170|FG002|Overall Study|Failed to attend Safety followup period|1|||
163146289|NCT02973100|589246171|FG003|Overall Study|Failed to attend Safety followup period|0|||
163146290|NCT01419236|589246178|FG000|Overall Study|Adverse Event|1|||
163146291|NCT01419236|589246179|FG001|Overall Study|Adverse Event|0|||
163146292|NCT01419236|589246178|FG000|Overall Study|Lack of Efficacy|0|||
163146293|NCT01419236|589246179|FG001|Overall Study|Lack of Efficacy|1|||
163146294|NCT01419236|589246178|FG000|Overall Study|Lost to Follow-up|1|||
163146295|NCT01419236|589246179|FG001|Overall Study|Lost to Follow-up|0|||
163146296|NCT01419236|589246178|FG000|Overall Study|Physician Decision|1|||
163146297|NCT01419236|589246179|FG001|Overall Study|Physician Decision|0|||
163146298|NCT01419236|589246178|FG000|Overall Study|Withdrawal by Subject|1|||
163146299|NCT01419236|589246179|FG001|Overall Study|Withdrawal by Subject|4|||
163146300|NCT01419236|589246178|FG000|Overall Study|Entry Criteria Not Met|1|||
163146301|NCT01419236|589246179|FG001|Overall Study|Entry Criteria Not Met|0|||
163146302|NCT04456504|589246180|FG000|Overall Study|Lost to Follow-up|2|||
163146303|NCT01342913|589246183|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
163146304|NCT01342913|589246184|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163146305|NCT01342913|589246185|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163146306|NCT01342913|589246183|FG000|2-week Run-in Period|Physician Decision|6|||
163146307|NCT01342913|589246184|FG001|2-week Run-in Period|Physician Decision|0|||
163146308|NCT01342913|589246185|FG002|2-week Run-in Period|Physician Decision|0|||
163146309|NCT01342913|589246183|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
163146310|NCT01342913|589246184|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163146311|NCT01342913|589246185|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163146312|NCT01342913|589246183|FG000|2-week Run-in Period|Adverse Event|2|||
163146313|NCT01342913|589246184|FG001|2-week Run-in Period|Adverse Event|0|||
163146314|NCT01342913|589246185|FG002|2-week Run-in Period|Adverse Event|0|||
163146315|NCT01342913|589246183|FG000|2-week Run-in Period|Protocol Violation|5|||
163146316|NCT01342913|589246184|FG001|2-week Run-in Period|Protocol Violation|0|||
163146317|NCT01342913|589246185|FG002|2-week Run-in Period|Protocol Violation|0|||
163146318|NCT01342913|589246183|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
163146319|NCT01342913|589246184|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163146320|NCT01342913|589246185|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163146321|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163146322|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Adverse Event|3|||
163146323|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Adverse Event|6|||
163146324|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
163146325|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
163146326|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
163146327|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163146328|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
163146329|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
163146330|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163146331|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163146332|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
163146333|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Physician Decision|0|||
163146334|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Physician Decision|2|||
163146335|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Physician Decision|0|||
162663949|NCT01722331|587482813|FG003|Part 1|Lack of Efficacy|0|||
162663950|NCT01722331|587482814|FG004|Part 1|Lack of Efficacy|2|||
162663951|NCT01722331|587482815|FG005|Part 1|Lack of Efficacy|0|||
162663952|NCT01722331|587482816|FG006|Part 1|Lack of Efficacy|0|||
162663953|NCT01722331|587482810|FG000|Part 1|Lost to Follow-up|1|||
162663954|NCT01722331|587482811|FG001|Part 1|Lost to Follow-up|0|||
162663955|NCT01722331|587482812|FG002|Part 1|Lost to Follow-up|2|||
162663956|NCT01722331|587482813|FG003|Part 1|Lost to Follow-up|0|||
162663957|NCT01722331|587482814|FG004|Part 1|Lost to Follow-up|1|||
162663958|NCT01722331|587482815|FG005|Part 1|Lost to Follow-up|0|||
162663959|NCT01722331|587482816|FG006|Part 1|Lost to Follow-up|0|||
162663960|NCT01722331|587482810|FG000|Part 1|Physician Decision|0|||
162663961|NCT01722331|587482811|FG001|Part 1|Physician Decision|0|||
162663962|NCT01722331|587482812|FG002|Part 1|Physician Decision|3|||
162663963|NCT01722331|587482813|FG003|Part 1|Physician Decision|0|||
162663964|NCT01722331|587482814|FG004|Part 1|Physician Decision|1|||
162663965|NCT01722331|587482815|FG005|Part 1|Physician Decision|0|||
162663966|NCT01722331|587482816|FG006|Part 1|Physician Decision|0|||
162663967|NCT01722331|587482810|FG000|Part 1|Pregnancy|1|||
162663968|NCT01722331|587482811|FG001|Part 1|Pregnancy|0|||
162663969|NCT01722331|587482812|FG002|Part 1|Pregnancy|0|||
162663970|NCT01722331|587482813|FG003|Part 1|Pregnancy|0|||
163039308|NCT00262002|588850703|FG006|Overall Study|Adverse Event|0|||
163039309|NCT00262002|588850697|FG000|Overall Study|Withdrawal by Subject|4|||
163039310|NCT00262002|588850698|FG001|Overall Study|Withdrawal by Subject|2|||
163039311|NCT00262002|588850699|FG002|Overall Study|Withdrawal by Subject|0|||
163039312|NCT00262002|588850700|FG003|Overall Study|Withdrawal by Subject|1|||
163039313|NCT00262002|588850701|FG004|Overall Study|Withdrawal by Subject|2|||
163039314|NCT00262002|588850702|FG005|Overall Study|Withdrawal by Subject|2|||
163039315|NCT00262002|588850703|FG006|Overall Study|Withdrawal by Subject|2|||
162663971|NCT01722331|587482814|FG004|Part 1|Pregnancy|0|||
162663972|NCT01722331|587482815|FG005|Part 1|Pregnancy|0|||
162663973|NCT01722331|587482816|FG006|Part 1|Pregnancy|0|||
162663974|NCT01722331|587482810|FG000|Part 1|Progressive Disease|0|||
162663975|NCT01722331|587482811|FG001|Part 1|Progressive Disease|0|||
162663976|NCT01722331|587482812|FG002|Part 1|Progressive Disease|0|||
162663977|NCT01722331|587482813|FG003|Part 1|Progressive Disease|0|||
162663978|NCT01722331|587482814|FG004|Part 1|Progressive Disease|1|||
163039316|NCT00262002|588850697|FG000|Overall Study|Lost to Follow-up|2|||
163039317|NCT00262002|588850698|FG001|Overall Study|Lost to Follow-up|0|||
163039318|NCT00262002|588850699|FG002|Overall Study|Lost to Follow-up|0|||
162663979|NCT01722331|587482815|FG005|Part 1|Progressive Disease|0|||
162663980|NCT01722331|587482816|FG006|Part 1|Progressive Disease|0|||
162663981|NCT01722331|587482810|FG000|Part 1|Protocol Violation|1|||
162663982|NCT01722331|587482811|FG001|Part 1|Protocol Violation|0|||
162663983|NCT01722331|587482812|FG002|Part 1|Protocol Violation|0|||
163039319|NCT00262002|588850700|FG003|Overall Study|Lost to Follow-up|2|||
163039320|NCT00262002|588850701|FG004|Overall Study|Lost to Follow-up|0|||
162663984|NCT01722331|587482813|FG003|Part 1|Protocol Violation|0|||
162663985|NCT01722331|587482814|FG004|Part 1|Protocol Violation|1|||
162663986|NCT01722331|587482815|FG005|Part 1|Protocol Violation|0|||
162663987|NCT01722331|587482816|FG006|Part 1|Protocol Violation|0|||
162663988|NCT01722331|587482810|FG000|Part 1|Withdrawal by Subject|2|||
162663989|NCT01722331|587482811|FG001|Part 1|Withdrawal by Subject|0|||
163039321|NCT00262002|588850702|FG005|Overall Study|Lost to Follow-up|1|||
163039322|NCT00262002|588850703|FG006|Overall Study|Lost to Follow-up|0|||
163039323|NCT00262002|588850697|FG000|Overall Study|Inapropriate enrollment|0|||
163039324|NCT00262002|588850698|FG001|Overall Study|Inapropriate enrollment|1|||
163039325|NCT00262002|588850699|FG002|Overall Study|Inapropriate enrollment|0|||
163039326|NCT00262002|588850700|FG003|Overall Study|Inapropriate enrollment|0|||
163039327|NCT00262002|588850701|FG004|Overall Study|Inapropriate enrollment|0|||
163039328|NCT00262002|588850702|FG005|Overall Study|Inapropriate enrollment|0|||
163039329|NCT00262002|588850703|FG006|Overall Study|Inapropriate enrollment|0|||
163039330|NCT00262002|588850697|FG000|Overall Study|Protocol Violation|3|||
163039331|NCT00262002|588850698|FG001|Overall Study|Protocol Violation|2|||
163039332|NCT00262002|588850699|FG002|Overall Study|Protocol Violation|0|||
163039333|NCT00262002|588850700|FG003|Overall Study|Protocol Violation|2|||
163039334|NCT00262002|588850701|FG004|Overall Study|Protocol Violation|5|||
163039335|NCT00262002|588850702|FG005|Overall Study|Protocol Violation|3|||
163039336|NCT00262002|588850703|FG006|Overall Study|Protocol Violation|2|||
163039337|NCT00262002|588850697|FG000|Overall Study|Unable to classify|0|||
163039338|NCT00262002|588850698|FG001|Overall Study|Unable to classify|0|||
163039339|NCT00262002|588850699|FG002|Overall Study|Unable to classify|0|||
163039340|NCT00262002|588850700|FG003|Overall Study|Unable to classify|0|||
163039341|NCT00262002|588850701|FG004|Overall Study|Unable to classify|0|||
163039342|NCT00262002|588850702|FG005|Overall Study|Unable to classify|0|||
163039343|NCT00262002|588850703|FG006|Overall Study|Unable to classify|2|||
163039344|NCT00958412|588850706|FG000|Overall Study|Study prematurely terminated|18|||
163039345|NCT02552888|588850709|FG000|Overall Study|Lost to Follow-up|1|||
163039346|NCT02552888|588850710|FG001|Overall Study|Lost to Follow-up|1|||
163039347|NCT00398216|588852710|FG000|Overall Study|Adverse Event|4|||
163039348|NCT00398216|588852711|FG001|Overall Study|Adverse Event|2|||
163039349|NCT00398216|588852712|FG002|Overall Study|Adverse Event|5|||
162663990|NCT01722331|587482812|FG002|Part 1|Withdrawal by Subject|3|||
162663991|NCT01722331|587482813|FG003|Part 1|Withdrawal by Subject|0|||
162663992|NCT01722331|587482814|FG004|Part 1|Withdrawal by Subject|3|||
162663993|NCT01722331|587482815|FG005|Part 1|Withdrawal by Subject|0|||
162663994|NCT01722331|587482816|FG006|Part 1|Withdrawal by Subject|0|||
162663995|NCT01722331|587482810|FG000|Part 2|Adverse Event|3|||
162663996|NCT01722331|587482811|FG001|Part 2|Adverse Event|0|||
162663997|NCT01722331|587482812|FG002|Part 2|Adverse Event|0|||
162663998|NCT01722331|587482813|FG003|Part 2|Adverse Event|0|||
162663999|NCT01722331|587482814|FG004|Part 2|Adverse Event|0|||
162664000|NCT01722331|587482815|FG005|Part 2|Adverse Event|1|||
162664001|NCT01722331|587482816|FG006|Part 2|Adverse Event|0|||
162664002|NCT01722331|587482810|FG000|Part 2|Lack of Efficacy|3|||
162664003|NCT01722331|587482811|FG001|Part 2|Lack of Efficacy|0|||
162664004|NCT01722331|587482812|FG002|Part 2|Lack of Efficacy|11|||
163039350|NCT00398216|588852713|FG003|Overall Study|Adverse Event|7|||
163039351|NCT00398216|588852714|FG004|Overall Study|Adverse Event|2|||
163039352|NCT00398216|588852710|FG000|Overall Study|Protocol Violation|2|||
163039353|NCT00398216|588852711|FG001|Overall Study|Protocol Violation|4|||
163039354|NCT00398216|588852712|FG002|Overall Study|Protocol Violation|5|||
163039355|NCT00398216|588852713|FG003|Overall Study|Protocol Violation|7|||
163039356|NCT00398216|588852714|FG004|Overall Study|Protocol Violation|5|||
163039357|NCT00398216|588852710|FG000|Overall Study|Lost to Follow-up|1|||
163039358|NCT00398216|588852711|FG001|Overall Study|Lost to Follow-up|6|||
163039359|NCT00398216|588852712|FG002|Overall Study|Lost to Follow-up|4|||
163039360|NCT00398216|588852713|FG003|Overall Study|Lost to Follow-up|4|||
163039361|NCT00398216|588852714|FG004|Overall Study|Lost to Follow-up|1|||
163039362|NCT00398216|588852710|FG000|Overall Study|Death|0|||
163039363|NCT00398216|588852711|FG001|Overall Study|Death|3|||
163039364|NCT00398216|588852712|FG002|Overall Study|Death|0|||
163039365|NCT00398216|588852713|FG003|Overall Study|Death|0|||
162664005|NCT01722331|587482813|FG003|Part 2|Lack of Efficacy|0|||
162664006|NCT01722331|587482814|FG004|Part 2|Lack of Efficacy|0|||
162664007|NCT01722331|587482815|FG005|Part 2|Lack of Efficacy|3|||
162664008|NCT01722331|587482816|FG006|Part 2|Lack of Efficacy|3|||
162664009|NCT01722331|587482810|FG000|Part 2|Lost to Follow-up|0|||
162664010|NCT01722331|587482811|FG001|Part 2|Lost to Follow-up|0|||
162664011|NCT01722331|587482812|FG002|Part 2|Lost to Follow-up|3|||
162664012|NCT01722331|587482813|FG003|Part 2|Lost to Follow-up|0|||
162664013|NCT01722331|587482814|FG004|Part 2|Lost to Follow-up|0|||
162664014|NCT01722331|587482815|FG005|Part 2|Lost to Follow-up|1|||
162664015|NCT01722331|587482816|FG006|Part 2|Lost to Follow-up|1|||
162664016|NCT01722331|587482810|FG000|Part 2|Non-Compliance with Study Drug|1|||
162664017|NCT01722331|587482811|FG001|Part 2|Non-Compliance with Study Drug|0|||
163039366|NCT00398216|588852714|FG004|Overall Study|Death|0|||
163039367|NCT00398216|588852710|FG000|Overall Study|Withdrawal by Subject|1|||
163039368|NCT00398216|588852711|FG001|Overall Study|Withdrawal by Subject|0|||
163039369|NCT00398216|588852712|FG002|Overall Study|Withdrawal by Subject|3|||
163039370|NCT00398216|588852713|FG003|Overall Study|Withdrawal by Subject|1|||
163039371|NCT00398216|588852714|FG004|Overall Study|Withdrawal by Subject|2|||
163039372|NCT00398216|588852710|FG000|Overall Study|administrative reasons|3|||
163039373|NCT00398216|588852711|FG001|Overall Study|administrative reasons|4|||
163039374|NCT00398216|588852712|FG002|Overall Study|administrative reasons|4|||
163039375|NCT00398216|588852713|FG003|Overall Study|administrative reasons|3|||
163039376|NCT00398216|588852714|FG004|Overall Study|administrative reasons|3|||
163039377|NCT00398216|588852710|FG000|Overall Study|entrance criteria|0|||
163039378|NCT00398216|588852711|FG001|Overall Study|entrance criteria|0|||
163039379|NCT00398216|588852712|FG002|Overall Study|entrance criteria|0|||
163039380|NCT00398216|588852713|FG003|Overall Study|entrance criteria|0|||
163039381|NCT00398216|588852714|FG004|Overall Study|entrance criteria|2|||
163039382|NCT01048944|588852715|FG000|Overall Study|Protocol Violation|8|||
163039383|NCT01048944|588852716|FG001|Overall Study|Protocol Violation|10|||
163039384|NCT01048944|588852717|FG002|Overall Study|Protocol Violation|10|||
163039385|NCT01048944|588852718|FG003|Overall Study|Protocol Violation|2|||
163039386|NCT01962948|588852719|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
163039387|NCT01962948|588852720|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
163039388|NCT01962948|588852721|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
163039389|NCT01962948|588852722|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
163039390|NCT00376532|588852723|FG000|Overall Study|Lack sufficient blood sample|6|||
163039391|NCT00376532|588852724|FG001|Overall Study|Lack sufficient blood sample|6|||
163039392|NCT01133704|588852725|FG000|Overall Study|Death|44|||
163039393|NCT01133704|588852726|FG001|Overall Study|Death|26|||
163039394|NCT01133704|588852725|FG000|Overall Study|Patient refused to continue|4|||
163039395|NCT01133704|588852726|FG001|Overall Study|Patient refused to continue|0|||
163039396|NCT01133704|588852725|FG000|Overall Study|Study Closure|1|||
163039397|NCT01133704|588852726|FG001|Overall Study|Study Closure|0|||
163039398|NCT02207400|588852727|FG000|Overall Study|Adverse Event|1|||
163039399|NCT02207400|588852728|FG001|Overall Study|Adverse Event|1|||
163039400|NCT02207400|588852727|FG000|Overall Study|Lost to Follow-up|6|||
163039401|NCT02207400|588852728|FG001|Overall Study|Lost to Follow-up|7|||
163039402|NCT02207400|588852727|FG000|Overall Study|Protocol Violation|1|||
163039403|NCT02207400|588852728|FG001|Overall Study|Protocol Violation|1|||
163039404|NCT02207400|588852727|FG000|Overall Study|Withdrawal by Subject|8|||
163039405|NCT02207400|588852728|FG001|Overall Study|Withdrawal by Subject|4|||
163039406|NCT02207400|588852727|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
163039407|NCT02207400|588852728|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
163039408|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
162664018|NCT01722331|587482812|FG002|Part 2|Non-Compliance with Study Drug|1|||
163039409|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
163039410|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
163039411|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
163039412|NCT02849704|588852729|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
163039413|NCT02849704|588852730|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
162664019|NCT01722331|587482813|FG003|Part 2|Non-Compliance with Study Drug|0|||
163039414|NCT00314808|588852738|FG000|Overall Study|Disease Progression without AE|4|||
163039415|NCT00314808|588852738|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
163039416|NCT04304508|588852739|FG000|Overall Study|Subject Decision|29|||
163039417|NCT04304508|588852740|FG001|Overall Study|Subject Decision|39|||
163039418|NCT04304508|588852741|FG002|Overall Study|Subject Decision|37|||
163039419|NCT04304508|588852742|FG003|Overall Study|Subject Decision|48|||
163039420|NCT04304508|588852739|FG000|Overall Study|Death|6|||
163039421|NCT04304508|588852740|FG001|Overall Study|Death|1|||
163039422|NCT04304508|588852741|FG002|Overall Study|Death|8|||
163039423|NCT04304508|588852742|FG003|Overall Study|Death|5|||
163039424|NCT04304508|588852739|FG000|Overall Study|Non-compliance With Study Drug|3|||
163039425|NCT04304508|588852740|FG001|Overall Study|Non-compliance With Study Drug|1|||
163039426|NCT04304508|588852741|FG002|Overall Study|Non-compliance With Study Drug|2|||
163039427|NCT04304508|588852742|FG003|Overall Study|Non-compliance With Study Drug|0|||
163039428|NCT04304508|588852739|FG000|Overall Study|Switching To Other Therapy|1|||
163039429|NCT04304508|588852740|FG001|Overall Study|Switching To Other Therapy|1|||
163039430|NCT04304508|588852741|FG002|Overall Study|Switching To Other Therapy|1|||
163039431|NCT04304508|588852742|FG003|Overall Study|Switching To Other Therapy|2|||
163039432|NCT04304508|588852739|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
163039433|NCT04304508|588852740|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
163039434|NCT04304508|588852741|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
163039435|NCT04304508|588852742|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
163039436|NCT04304508|588852739|FG000|Overall Study|Withdrawal by Subject|7|||
163039437|NCT04304508|588852740|FG001|Overall Study|Withdrawal by Subject|5|||
163039438|NCT04304508|588852741|FG002|Overall Study|Withdrawal by Subject|11|||
163039439|NCT04304508|588852742|FG003|Overall Study|Withdrawal by Subject|6|||
163039440|NCT04304508|588852739|FG000|Overall Study|Logistical Difficulties|2|||
163039441|NCT04304508|588852740|FG001|Overall Study|Logistical Difficulties|2|||
163039442|NCT04304508|588852741|FG002|Overall Study|Logistical Difficulties|3|||
163039443|NCT04304508|588852742|FG003|Overall Study|Logistical Difficulties|2|||
163039444|NCT04304508|588852739|FG000|Overall Study|Missing Information|1|||
163039445|NCT04304508|588852740|FG001|Overall Study|Missing Information|2|||
163039446|NCT04304508|588852741|FG002|Overall Study|Missing Information|1|||
163039447|NCT04304508|588852742|FG003|Overall Study|Missing Information|3|||
163039448|NCT04304508|588852739|FG000|Overall Study|Other|7|||
163039449|NCT04304508|588852740|FG001|Overall Study|Other|6|||
163039450|NCT04304508|588852741|FG002|Overall Study|Other|5|||
163039451|NCT04304508|588852742|FG003|Overall Study|Other|4|||
163039452|NCT04304508|588852739|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
163039453|NCT04304508|588852740|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039454|NCT04304508|588852741|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039455|NCT04304508|588852742|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
163039456|NCT04304508|588852739|FG000|Overall Study|Physician Decision|3|||
163039457|NCT04304508|588852740|FG001|Overall Study|Physician Decision|4|||
163039458|NCT04304508|588852741|FG002|Overall Study|Physician Decision|9|||
163039459|NCT04304508|588852742|FG003|Overall Study|Physician Decision|7|||
163039460|NCT04304508|588852739|FG000|Overall Study|Study drug never administered|10|||
163039461|NCT04304508|588852740|FG001|Overall Study|Study drug never administered|4|||
163039462|NCT04304508|588852741|FG002|Overall Study|Study drug never administered|4|||
163039463|NCT04304508|588852742|FG003|Overall Study|Study drug never administered|4|||
163039464|NCT04304508|588852739|FG000|Overall Study|Adverse Event|49|||
163039465|NCT04304508|588852740|FG001|Overall Study|Adverse Event|50|||
163039466|NCT04304508|588852741|FG002|Overall Study|Adverse Event|51|||
163039467|NCT04304508|588852742|FG003|Overall Study|Adverse Event|56|||
163039468|NCT04304508|588852739|FG000|Overall Study|Lost to Follow-up|1|||
163039469|NCT04304508|588852740|FG001|Overall Study|Lost to Follow-up|5|||
163039470|NCT04304508|588852741|FG002|Overall Study|Lost to Follow-up|2|||
163039471|NCT04304508|588852742|FG003|Overall Study|Lost to Follow-up|3|||
163039472|NCT02113007|588852743|FG000|Overall Study|Progressive disease|2|||
162664020|NCT01722331|587482814|FG004|Part 2|Non-Compliance with Study Drug|0|||
162664021|NCT01722331|587482815|FG005|Part 2|Non-Compliance with Study Drug|0|||
162664022|NCT01722331|587482816|FG006|Part 2|Non-Compliance with Study Drug|0|||
162664023|NCT01722331|587482810|FG000|Part 2|Physician Decision|0|||
162664024|NCT01722331|587482811|FG001|Part 2|Physician Decision|0|||
162664025|NCT01722331|587482812|FG002|Part 2|Physician Decision|2|||
162664026|NCT01722331|587482813|FG003|Part 2|Physician Decision|0|||
163039473|NCT00885378|588852744|FG000|Overall Study|Lack of Efficacy|2|||
163039474|NCT00885378|588852745|FG001|Overall Study|Lack of Efficacy|2|||
163039475|NCT00885378|588852744|FG000|Overall Study|Withdrawal by Subject|1|||
163039476|NCT00885378|588852745|FG001|Overall Study|Withdrawal by Subject|2|||
163039477|NCT00885378|588852744|FG000|Overall Study|Lost to Follow-up|1|||
163039478|NCT00885378|588852745|FG001|Overall Study|Lost to Follow-up|2|||
163039479|NCT00885378|588852744|FG000|Overall Study|Poor/Noncompliance|2|||
163039480|NCT00885378|588852745|FG001|Overall Study|Poor/Noncompliance|2|||
163039481|NCT00885378|588852744|FG000|Overall Study|Protocol Violation|2|||
163039482|NCT00885378|588852745|FG001|Overall Study|Protocol Violation|0|||
163039483|NCT03091738|588852746|FG000|Overall Study|Adverse Event|1|||
163039484|NCT03091738|588852746|FG000|Overall Study|Lost to Follow-up|1|||
163146336|NCT01342913|589246183|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163146337|NCT01342913|589246184|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163146338|NCT01342913|589246185|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163146339|NCT02869633|589246189|FG000|Overall Study|Death|2|||
163146340|NCT02869633|589246190|FG001|Overall Study|Death|1|||
163146341|NCT02869633|589246189|FG000|Overall Study|Patient refused follow-up|1|||
163146342|NCT02869633|589246190|FG001|Overall Study|Patient refused follow-up|0|||
163146343|NCT02869633|589246189|FG000|Overall Study|Provider discretion|1|||
163146344|NCT02869633|589246190|FG001|Overall Study|Provider discretion|0|||
163146345|NCT02869633|589246189|FG000|Overall Study|Investigator decision|1|||
163146346|NCT02869633|589246190|FG001|Overall Study|Investigator decision|0|||
163146347|NCT02869633|589246189|FG000|Overall Study|Lost to Follow-up|0|||
163146348|NCT02869633|589246190|FG001|Overall Study|Lost to Follow-up|1|||
163146349|NCT02869633|589246189|FG000|Overall Study|Not eligible|6|||
163146350|NCT02869633|589246190|FG001|Overall Study|Not eligible|1|||
163146351|NCT02869633|589246189|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
163146352|NCT02869633|589246190|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
163146353|NCT02869633|589246189|FG000|Overall Study|Withdrawal by Subject|0|||
163146354|NCT02869633|589246190|FG001|Overall Study|Withdrawal by Subject|1|||
163146355|NCT03287791|589246191|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163146356|NCT03287791|589246192|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163146357|NCT03287791|589246193|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163146358|NCT03287791|589246191|FG000|Overall Study|Adverse Event|0|||
163146359|NCT03287791|589246192|FG001|Overall Study|Adverse Event|4|||
163146360|NCT03287791|589246193|FG002|Overall Study|Adverse Event|3|||
163146361|NCT03287791|589246191|FG000|Overall Study|Withdrawal by Subject|12|||
163146362|NCT03287791|589246192|FG001|Overall Study|Withdrawal by Subject|12|||
163146363|NCT03287791|589246193|FG002|Overall Study|Withdrawal by Subject|17|||
163146364|NCT03287791|589246191|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
163146365|NCT03287791|589246192|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
163146366|NCT03287791|589246193|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
163146367|NCT03287791|589246191|FG000|Overall Study|Lost to Follow-up|8|||
163146368|NCT03287791|589246192|FG001|Overall Study|Lost to Follow-up|14|||
163146369|NCT03287791|589246193|FG002|Overall Study|Lost to Follow-up|11|||
163146370|NCT03287791|589246191|FG000|Overall Study|Protocol Violation|7|||
163146371|NCT03287791|589246192|FG001|Overall Study|Protocol Violation|2|||
163146372|NCT03287791|589246193|FG002|Overall Study|Protocol Violation|1|||
163146373|NCT03287791|589246191|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
163146374|NCT03287791|589246192|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
163146375|NCT03287791|589246193|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
163146376|NCT03287791|589246191|FG000|Overall Study|Too much time between 2 visits|0|||
163146377|NCT03287791|589246192|FG001|Overall Study|Too much time between 2 visits|1|||
163146378|NCT03287791|589246193|FG002|Overall Study|Too much time between 2 visits|0|||
163146379|NCT03287791|589246191|FG000|Overall Study|Non-compliance|0|||
163146380|NCT03287791|589246192|FG001|Overall Study|Non-compliance|1|||
163146381|NCT03287791|589246193|FG002|Overall Study|Non-compliance|0|||
163146382|NCT03287791|589246191|FG000|Overall Study|Did not meet inclusion criteria|1|||
163146383|NCT03287791|589246192|FG001|Overall Study|Did not meet inclusion criteria|0|||
163146384|NCT03287791|589246193|FG002|Overall Study|Did not meet inclusion criteria|0|||
163146385|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
163146386|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
163146387|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
163146388|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
163146389|NCT02891174|589246195|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
163146390|NCT02891174|589246196|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
163146391|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
163146392|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
163146393|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
163146394|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
163146395|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
163146396|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
163146397|NCT02891174|589246195|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
163146398|NCT02891174|589246196|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
163146399|NCT04319198|589246199|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
162664027|NCT01722331|587482814|FG004|Part 2|Physician Decision|0|||
162664028|NCT01722331|587482815|FG005|Part 2|Physician Decision|0|||
163146400|NCT04319198|589246200|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
163146401|NCT04319198|589246201|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
163146402|NCT04319198|589246199|FG000|Overall Study|Death|0|||
163146403|NCT04319198|589246200|FG001|Overall Study|Death|3|||
163146404|NCT04319198|589246201|FG002|Overall Study|Death|3|||
163146405|NCT04319198|589246199|FG000|Overall Study|Reason Not Specified|0|||
163039485|NCT03746405|588852749|FG000|Overall Study|Withdrawal by Subject|3|||
163039486|NCT03746405|588852750|FG001|Overall Study|Withdrawal by Subject|0|||
163039487|NCT03746405|588852749|FG000|Overall Study|technical difficulties|0|||
163039488|NCT03746405|588852750|FG001|Overall Study|technical difficulties|2|||
163039489|NCT03479008|588852751|FG000|Overall Study|Withdrawal by Subject|3|||
163039490|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
163039491|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
163039492|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
163039493|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
163039494|NCT00412932|588852752|FG000|Olmesartan (Olm) 20 mg|Other|1|||
163039495|NCT00412932|588852752|FG000|Olmesartan 40 mg|Adverse Event|4|||
163039496|NCT00412932|588852752|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
163039497|NCT00412932|588852752|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
163039498|NCT00412932|588852752|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
163039499|NCT00412932|588852752|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
163039500|NCT00412932|588852752|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
163039501|NCT00412932|588852752|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
163039502|NCT02630563|588852753|FG000|Overall Study|Administrative|1|||
163039503|NCT00929994|588852754|FG000|Overall Study|Withdrawal by Subject|1|||
163039504|NCT00929994|588852754|FG000|Overall Study|medical issue unrelated to intervention|4|||
163039505|NCT00929994|588852754|FG000|Overall Study|employment|1|||
163039506|NCT02061813|588852756|FG000|Overall Study|Withdrawal by Subject|1|||
163039507|NCT02061813|588852756|FG000|Overall Study|Protocol Violation|2|||
163039508|NCT01705080|588852757|FG000|Overall Study|Missed visit|10|||
163039509|NCT01705080|588852758|FG001|Overall Study|Missed visit|4|||
163039510|NCT01705080|588852759|FG002|Overall Study|Missed visit|1|||
163039511|NCT01705080|588852757|FG000|Overall Study|Death|4|||
163039512|NCT01705080|588852758|FG001|Overall Study|Death|4|||
163039513|NCT01705080|588852759|FG002|Overall Study|Death|6|||
163039514|NCT01705080|588852757|FG000|Overall Study|Withdrawal by Subject|61|||
163039515|NCT01705080|588852758|FG001|Overall Study|Withdrawal by Subject|44|||
163039516|NCT01705080|588852759|FG002|Overall Study|Withdrawal by Subject|9|||
163039517|NCT00667563|588852761|FG000|Overall Study|Protocol Violation|24|||
163039518|NCT03130959|588852764|FG000|Overall Study|Disease progression|19|||
163039519|NCT03130959|588852765|FG001|Overall Study|Disease progression|7|||
163039520|NCT03130959|588852766|FG002|Overall Study|Disease progression|12|||
163039521|NCT03130959|588852767|FG003|Overall Study|Disease progression|7|||
163039522|NCT03130959|588852768|FG004|Overall Study|Disease progression|12|||
163039523|NCT03130959|588852769|FG005|Overall Study|Disease progression|3|||
163039524|NCT03130959|588852770|FG006|Overall Study|Disease progression|6|||
163039525|NCT03130959|588852771|FG007|Overall Study|Disease progression|3|||
163039526|NCT03130959|588852772|FG008|Overall Study|Disease progression|15|||
163039527|NCT03130959|588852773|FG009|Overall Study|Disease progression|8|||
163039528|NCT03130959|588852764|FG000|Overall Study|Study drug toxicity|2|||
163039529|NCT03130959|588852765|FG001|Overall Study|Study drug toxicity|2|||
163039530|NCT03130959|588852766|FG002|Overall Study|Study drug toxicity|1|||
163039531|NCT03130959|588852767|FG003|Overall Study|Study drug toxicity|2|||
163039532|NCT03130959|588852768|FG004|Overall Study|Study drug toxicity|1|||
162664029|NCT01722331|587482816|FG006|Part 2|Physician Decision|0|||
162664030|NCT01722331|587482810|FG000|Part 2|Pregnancy|0|||
162664031|NCT01722331|587482811|FG001|Part 2|Pregnancy|0|||
162664032|NCT01722331|587482812|FG002|Part 2|Pregnancy|0|||
162664033|NCT01722331|587482813|FG003|Part 2|Pregnancy|0|||
162664034|NCT01722331|587482814|FG004|Part 2|Pregnancy|0|||
162664035|NCT01722331|587482815|FG005|Part 2|Pregnancy|1|||
162664036|NCT01722331|587482816|FG006|Part 2|Pregnancy|0|||
162664037|NCT01722331|587482810|FG000|Part 2|Progressive Disease|0|||
162664038|NCT01722331|587482811|FG001|Part 2|Progressive Disease|0|||
162664039|NCT01722331|587482812|FG002|Part 2|Progressive Disease|1|||
162664040|NCT01722331|587482813|FG003|Part 2|Progressive Disease|0|||
162664041|NCT01722331|587482814|FG004|Part 2|Progressive Disease|0|||
162664042|NCT01722331|587482815|FG005|Part 2|Progressive Disease|0|||
162664043|NCT01722331|587482816|FG006|Part 2|Progressive Disease|0|||
162664044|NCT01722331|587482810|FG000|Part 2|Protocol Violation|1|||
162664045|NCT01722331|587482811|FG001|Part 2|Protocol Violation|0|||
162664046|NCT01722331|587482812|FG002|Part 2|Protocol Violation|0|||
162664047|NCT01722331|587482813|FG003|Part 2|Protocol Violation|0|||
162721315|NCT01307267|587688252|FG011|Overall Study|Other|1|||
162721316|NCT01307267|587688253|FG012|Overall Study|Other|1|||
163039533|NCT03130959|588852769|FG005|Overall Study|Study drug toxicity|1|||
163039534|NCT03130959|588852770|FG006|Overall Study|Study drug toxicity|3|||
163039535|NCT03130959|588852771|FG007|Overall Study|Study drug toxicity|0|||
163039536|NCT03130959|588852772|FG008|Overall Study|Study drug toxicity|3|||
163039537|NCT03130959|588852773|FG009|Overall Study|Study drug toxicity|3|||
163039538|NCT03130959|588852764|FG000|Overall Study|Other reasons|0|||
163039539|NCT03130959|588852765|FG001|Overall Study|Other reasons|0|||
163039540|NCT03130959|588852766|FG002|Overall Study|Other reasons|0|||
163039541|NCT03130959|588852767|FG003|Overall Study|Other reasons|0|||
163039542|NCT03130959|588852768|FG004|Overall Study|Other reasons|0|||
163039543|NCT03130959|588852769|FG005|Overall Study|Other reasons|1|||
163039544|NCT03130959|588852770|FG006|Overall Study|Other reasons|1|||
163039545|NCT03130959|588852771|FG007|Overall Study|Other reasons|0|||
163039546|NCT03130959|588852772|FG008|Overall Study|Other reasons|0|||
163039547|NCT03130959|588852773|FG009|Overall Study|Other reasons|0|||
163039548|NCT03130959|588852764|FG000|Overall Study|Subject request to discontinue therapy|0|||
163039549|NCT03130959|588852765|FG001|Overall Study|Subject request to discontinue therapy|0|||
163039550|NCT03130959|588852766|FG002|Overall Study|Subject request to discontinue therapy|1|||
163039551|NCT03130959|588852767|FG003|Overall Study|Subject request to discontinue therapy|1|||
163039552|NCT03130959|588852768|FG004|Overall Study|Subject request to discontinue therapy|0|||
163039553|NCT03130959|588852769|FG005|Overall Study|Subject request to discontinue therapy|0|||
163039554|NCT03130959|588852770|FG006|Overall Study|Subject request to discontinue therapy|1|||
163039555|NCT03130959|588852771|FG007|Overall Study|Subject request to discontinue therapy|1|||
163039556|NCT03130959|588852772|FG008|Overall Study|Subject request to discontinue therapy|0|||
163039557|NCT03130959|588852773|FG009|Overall Study|Subject request to discontinue therapy|0|||
163039558|NCT03130959|588852764|FG000|Overall Study|Not reported|0|||
163039559|NCT03130959|588852765|FG001|Overall Study|Not reported|0|||
163039560|NCT03130959|588852766|FG002|Overall Study|Not reported|0|||
163039561|NCT03130959|588852767|FG003|Overall Study|Not reported|1|||
163039562|NCT03130959|588852768|FG004|Overall Study|Not reported|0|||
163039563|NCT03130959|588852769|FG005|Overall Study|Not reported|1|||
163039564|NCT03130959|588852770|FG006|Overall Study|Not reported|0|||
163039565|NCT03130959|588852771|FG007|Overall Study|Not reported|0|||
163039566|NCT03130959|588852772|FG008|Overall Study|Not reported|0|||
163039567|NCT03130959|588852773|FG009|Overall Study|Not reported|1|||
163039568|NCT03130959|588852764|FG000|Overall Study|Adverse Event unrelated to drug|0|||
163039569|NCT03130959|588852765|FG001|Overall Study|Adverse Event unrelated to drug|0|||
163039570|NCT03130959|588852766|FG002|Overall Study|Adverse Event unrelated to drug|1|||
163039571|NCT03130959|588852767|FG003|Overall Study|Adverse Event unrelated to drug|1|||
163039572|NCT03130959|588852768|FG004|Overall Study|Adverse Event unrelated to drug|1|||
163039573|NCT03130959|588852769|FG005|Overall Study|Adverse Event unrelated to drug|0|||
163039574|NCT03130959|588852770|FG006|Overall Study|Adverse Event unrelated to drug|1|||
163039575|NCT03130959|588852771|FG007|Overall Study|Adverse Event unrelated to drug|0|||
163039576|NCT03130959|588852772|FG008|Overall Study|Adverse Event unrelated to drug|1|||
163039577|NCT03130959|588852773|FG009|Overall Study|Adverse Event unrelated to drug|1|||
163039578|NCT03130959|588852764|FG000|Overall Study|Participant withdrew consent|0|||
163039579|NCT03130959|588852765|FG001|Overall Study|Participant withdrew consent|1|||
163039580|NCT03130959|588852766|FG002|Overall Study|Participant withdrew consent|0|||
163039581|NCT03130959|588852767|FG003|Overall Study|Participant withdrew consent|2|||
163039582|NCT03130959|588852768|FG004|Overall Study|Participant withdrew consent|1|||
163039583|NCT03130959|588852769|FG005|Overall Study|Participant withdrew consent|0|||
163039584|NCT03130959|588852770|FG006|Overall Study|Participant withdrew consent|0|||
163039585|NCT03130959|588852771|FG007|Overall Study|Participant withdrew consent|0|||
163039586|NCT03130959|588852772|FG008|Overall Study|Participant withdrew consent|0|||
163039587|NCT03130959|588852773|FG009|Overall Study|Participant withdrew consent|2|||
163039588|NCT03130959|588852764|FG000|Overall Study|Administrative reason by sponsor|1|||
163039589|NCT03130959|588852765|FG001|Overall Study|Administrative reason by sponsor|0|||
163039590|NCT03130959|588852766|FG002|Overall Study|Administrative reason by sponsor|1|||
163039591|NCT03130959|588852767|FG003|Overall Study|Administrative reason by sponsor|0|||
163039592|NCT03130959|588852768|FG004|Overall Study|Administrative reason by sponsor|0|||
163039593|NCT03130959|588852769|FG005|Overall Study|Administrative reason by sponsor|0|||
163039594|NCT03130959|588852770|FG006|Overall Study|Administrative reason by sponsor|0|||
163039595|NCT03130959|588852771|FG007|Overall Study|Administrative reason by sponsor|0|||
163039596|NCT03130959|588852772|FG008|Overall Study|Administrative reason by sponsor|0|||
163039597|NCT03130959|588852773|FG009|Overall Study|Administrative reason by sponsor|0|||
163039598|NCT03130959|588852764|FG000|Overall Study|Lost to Follow-up|1|||
163039599|NCT03130959|588852765|FG001|Overall Study|Lost to Follow-up|0|||
163039600|NCT03130959|588852766|FG002|Overall Study|Lost to Follow-up|0|||
163039601|NCT03130959|588852767|FG003|Overall Study|Lost to Follow-up|0|||
163039602|NCT03130959|588852768|FG004|Overall Study|Lost to Follow-up|0|||
163039603|NCT03130959|588852769|FG005|Overall Study|Lost to Follow-up|0|||
163039604|NCT03130959|588852770|FG006|Overall Study|Lost to Follow-up|0|||
163039605|NCT03130959|588852771|FG007|Overall Study|Lost to Follow-up|0|||
163039606|NCT03130959|588852772|FG008|Overall Study|Lost to Follow-up|0|||
163039607|NCT03130959|588852773|FG009|Overall Study|Lost to Follow-up|0|||
163039608|NCT02384538|588852788|FG000|Overall Study|Adverse Event|1|||
163039609|NCT02384538|588852789|FG001|Overall Study|Adverse Event|4|||
163039610|NCT02384538|588852788|FG000|Overall Study|Lack of Efficacy|4|||
163039611|NCT02384538|588852789|FG001|Overall Study|Lack of Efficacy|4|||
163039612|NCT02384538|588852788|FG000|Overall Study|Withdrew Consent|0|||
163039613|NCT02384538|588852789|FG001|Overall Study|Withdrew Consent|4|||
163039614|NCT02384538|588852788|FG000|Overall Study|Other|1|||
163039615|NCT02384538|588852789|FG001|Overall Study|Other|3|||
163039616|NCT03042910|588852792|FG000|Overall Study|Adverse Event|1|||
163039617|NCT03042910|588852792|FG000|Overall Study|Disease Progression|2|||
163039618|NCT03042910|588852792|FG000|Overall Study|Withdrawal by Subject|3|||
163039619|NCT03042910|588852792|FG000|Overall Study|Enrolled but not treated|1|||
163039620|NCT02187861|588852793|FG000|Overall Study|Adverse Event|2|||
163039621|NCT02187861|588852794|FG001|Overall Study|Adverse Event|1|||
163039622|NCT02187861|588852795|FG002|Overall Study|Adverse Event|2|||
163039623|NCT02187861|588852796|FG003|Overall Study|Adverse Event|1|||
163039624|NCT02187861|588852793|FG000|Overall Study|Death|0|||
163039625|NCT02187861|588852794|FG001|Overall Study|Death|3|||
163039626|NCT02187861|588852795|FG002|Overall Study|Death|1|||
163039627|NCT02187861|588852796|FG003|Overall Study|Death|2|||
163039628|NCT02187861|588852793|FG000|Overall Study|Physician Decision|0|||
163039629|NCT02187861|588852794|FG001|Overall Study|Physician Decision|1|||
163039630|NCT02187861|588852795|FG002|Overall Study|Physician Decision|0|||
163039631|NCT02187861|588852796|FG003|Overall Study|Physician Decision|3|||
163039632|NCT02187861|588852793|FG000|Overall Study|Progressive Disease|4|||
163039633|NCT02187861|588852794|FG001|Overall Study|Progressive Disease|42|||
163039634|NCT02187861|588852795|FG002|Overall Study|Progressive Disease|19|||
163039635|NCT02187861|588852796|FG003|Overall Study|Progressive Disease|22|||
163039636|NCT02187861|588852793|FG000|Overall Study|Withdrawal by Subject|0|||
163039637|NCT02187861|588852794|FG001|Overall Study|Withdrawal by Subject|0|||
163039638|NCT02187861|588852795|FG002|Overall Study|Withdrawal by Subject|3|||
163039639|NCT02187861|588852796|FG003|Overall Study|Withdrawal by Subject|3|||
163039640|NCT02187861|588852793|FG000|Overall Study|Other|0|||
163039641|NCT02187861|588852794|FG001|Overall Study|Other|1|||
163039642|NCT02187861|588852795|FG002|Overall Study|Other|7|||
163039643|NCT02187861|588852796|FG003|Overall Study|Other|1|||
163039644|NCT01491841|588852798|FG000|Overall Study|Screen Failure|10|||
163039645|NCT01491841|588852798|FG000|Overall Study|Withdrawal by Subject|1|||
163039646|NCT01301079|588852799|FG000|Overall Study|Lost to Follow-up|2|||
163039647|NCT01301079|588852800|FG001|Overall Study|Lost to Follow-up|2|||
163039648|NCT00313586|588852801|FG000|Overall Study|Disease progression|14|||
163039649|NCT00313586|588852802|FG001|Overall Study|Disease progression|19|||
163039650|NCT00313586|588852803|FG002|Overall Study|Disease progression|10|||
163039651|NCT00313586|588852804|FG003|Overall Study|Disease progression|3|||
163039652|NCT00313586|588852801|FG000|Overall Study|Adverse Event|12|||
163039653|NCT00313586|588852802|FG001|Overall Study|Adverse Event|18|||
163039654|NCT00313586|588852803|FG002|Overall Study|Adverse Event|3|||
163039655|NCT00313586|588852804|FG003|Overall Study|Adverse Event|10|||
163039656|NCT00313586|588852801|FG000|Overall Study|Death|11|||
163039657|NCT00313586|588852802|FG001|Overall Study|Death|8|||
163039658|NCT00313586|588852803|FG002|Overall Study|Death|1|||
163039659|NCT00313586|588852804|FG003|Overall Study|Death|7|||
163039660|NCT00313586|588852801|FG000|Overall Study|Withdrawal by Subject|13|||
163039661|NCT00313586|588852802|FG001|Overall Study|Withdrawal by Subject|6|||
163039662|NCT00313586|588852803|FG002|Overall Study|Withdrawal by Subject|6|||
163039663|NCT00313586|588852804|FG003|Overall Study|Withdrawal by Subject|2|||
163039664|NCT00313586|588852801|FG000|Overall Study|Alternative therapy|3|||
163039665|NCT00313586|588852802|FG001|Overall Study|Alternative therapy|6|||
163039666|NCT00313586|588852803|FG002|Overall Study|Alternative therapy|2|||
163039667|NCT00313586|588852804|FG003|Overall Study|Alternative therapy|0|||
163039668|NCT00313586|588852801|FG000|Overall Study|Other complicating disease|2|||
162664048|NCT01722331|587482814|FG004|Part 2|Protocol Violation|0|||
162664049|NCT01722331|587482815|FG005|Part 2|Protocol Violation|0|||
162664050|NCT01722331|587482816|FG006|Part 2|Protocol Violation|0|||
162664051|NCT01722331|587482810|FG000|Part 2|Withdrawal by Subject|5|||
162664052|NCT01722331|587482811|FG001|Part 2|Withdrawal by Subject|0|||
162664053|NCT01722331|587482812|FG002|Part 2|Withdrawal by Subject|3|||
162664054|NCT01722331|587482813|FG003|Part 2|Withdrawal by Subject|0|||
162664055|NCT01722331|587482814|FG004|Part 2|Withdrawal by Subject|0|||
162664056|NCT01722331|587482815|FG005|Part 2|Withdrawal by Subject|2|||
163039669|NCT00313586|588852802|FG001|Overall Study|Other complicating disease|2|||
163039670|NCT00313586|588852803|FG002|Overall Study|Other complicating disease|0|||
163039671|NCT00313586|588852804|FG003|Overall Study|Other complicating disease|0|||
163039672|NCT00313586|588852801|FG000|Overall Study|Did not achieve HI-major/better response|10|||
163039673|NCT00313586|588852802|FG001|Overall Study|Did not achieve HI-major/better response|7|||
163039674|NCT00313586|588852803|FG002|Overall Study|Did not achieve HI-major/better response|2|||
163039675|NCT00313586|588852804|FG003|Overall Study|Did not achieve HI-major/better response|1|||
163039676|NCT00313586|588852801|FG000|Overall Study|Physician Decision|2|||
163039677|NCT00313586|588852802|FG001|Overall Study|Physician Decision|1|||
163039678|NCT00313586|588852803|FG002|Overall Study|Physician Decision|0|||
163039679|NCT00313586|588852804|FG003|Overall Study|Physician Decision|0|||
163039680|NCT00313586|588852801|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
163039681|NCT00313586|588852802|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
163039682|NCT00313586|588852803|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
163039683|NCT00313586|588852804|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
163039684|NCT00313586|588852801|FG000|Overall Study|Lost insurance|0|||
163039685|NCT00313586|588852802|FG001|Overall Study|Lost insurance|1|||
163039686|NCT00313586|588852803|FG002|Overall Study|Lost insurance|0|||
163039687|NCT00313586|588852804|FG003|Overall Study|Lost insurance|0|||
163039688|NCT00313586|588852801|FG000|Overall Study|Moved|0|||
163039689|NCT00313586|588852802|FG001|Overall Study|Moved|1|||
162664057|NCT01722331|587482816|FG006|Part 2|Withdrawal by Subject|2|||
162664058|NCT01722331|587482810|FG000|Part 2|Other Protocol Specified Criteria|6|||
162664059|NCT01722331|587482811|FG001|Part 2|Other Protocol Specified Criteria|0|||
162664060|NCT01722331|587482812|FG002|Part 2|Other Protocol Specified Criteria|10|||
162664061|NCT01722331|587482813|FG003|Part 2|Other Protocol Specified Criteria|0|||
162664062|NCT01722331|587482814|FG004|Part 2|Other Protocol Specified Criteria|0|||
162664063|NCT01722331|587482815|FG005|Part 2|Other Protocol Specified Criteria|2|||
162664064|NCT01722331|587482816|FG006|Part 2|Other Protocol Specified Criteria|1|||
162664065|NCT01722331|587482810|FG000|Part 3|Adverse Event|2|||
162664066|NCT01722331|587482811|FG001|Part 3|Adverse Event|2|||
162664067|NCT01722331|587482812|FG002|Part 3|Adverse Event|0|||
162664068|NCT01722331|587482813|FG003|Part 3|Adverse Event|1|||
162664069|NCT01722331|587482814|FG004|Part 3|Adverse Event|0|||
162664070|NCT01722331|587482815|FG005|Part 3|Adverse Event|0|||
162664071|NCT01722331|587482816|FG006|Part 3|Adverse Event|0|||
162664072|NCT01722331|587482810|FG000|Part 3|Death|1|||
162664073|NCT01722331|587482811|FG001|Part 3|Death|0|||
162664074|NCT01722331|587482812|FG002|Part 3|Death|0|||
162664075|NCT01722331|587482813|FG003|Part 3|Death|0|||
162664076|NCT01722331|587482814|FG004|Part 3|Death|0|||
162664077|NCT01722331|587482815|FG005|Part 3|Death|0|||
162664078|NCT01722331|587482816|FG006|Part 3|Death|0|||
162664079|NCT01722331|587482810|FG000|Part 3|Lack of Efficacy|1|||
162664080|NCT01722331|587482811|FG001|Part 3|Lack of Efficacy|0|||
162664081|NCT01722331|587482812|FG002|Part 3|Lack of Efficacy|0|||
162664082|NCT01722331|587482813|FG003|Part 3|Lack of Efficacy|0|||
162664083|NCT01722331|587482814|FG004|Part 3|Lack of Efficacy|0|||
162664084|NCT01722331|587482815|FG005|Part 3|Lack of Efficacy|0|||
162664085|NCT01722331|587482816|FG006|Part 3|Lack of Efficacy|0|||
162664086|NCT01722331|587482810|FG000|Part 3|Lost to Follow-up|3|||
162664087|NCT01722331|587482811|FG001|Part 3|Lost to Follow-up|4|||
162664088|NCT01722331|587482812|FG002|Part 3|Lost to Follow-up|0|||
162664089|NCT01722331|587482813|FG003|Part 3|Lost to Follow-up|0|||
162664090|NCT01722331|587482814|FG004|Part 3|Lost to Follow-up|0|||
162664091|NCT01722331|587482815|FG005|Part 3|Lost to Follow-up|1|||
162664092|NCT01722331|587482816|FG006|Part 3|Lost to Follow-up|0|||
162664093|NCT01722331|587482810|FG000|Part 3|Non-Compliance with Study Drug|0|||
162664094|NCT01722331|587482811|FG001|Part 3|Non-Compliance with Study Drug|1|||
162664095|NCT01722331|587482812|FG002|Part 3|Non-Compliance with Study Drug|0|||
162664096|NCT01722331|587482813|FG003|Part 3|Non-Compliance with Study Drug|0|||
162664097|NCT01722331|587482814|FG004|Part 3|Non-Compliance with Study Drug|0|||
162664098|NCT01722331|587482815|FG005|Part 3|Non-Compliance with Study Drug|0|||
162664099|NCT01722331|587482816|FG006|Part 3|Non-Compliance with Study Drug|0|||
162664100|NCT01722331|587482810|FG000|Part 3|Physician Decision|1|||
162664101|NCT01722331|587482811|FG001|Part 3|Physician Decision|1|||
162664102|NCT01722331|587482812|FG002|Part 3|Physician Decision|0|||
162664103|NCT01722331|587482813|FG003|Part 3|Physician Decision|0|||
162664104|NCT01722331|587482814|FG004|Part 3|Physician Decision|0|||
162664105|NCT01722331|587482815|FG005|Part 3|Physician Decision|0|||
162664106|NCT01722331|587482816|FG006|Part 3|Physician Decision|1|||
162664107|NCT01722331|587482810|FG000|Part 3|Protocol Violation|2|||
162664108|NCT01722331|587482811|FG001|Part 3|Protocol Violation|1|||
162664109|NCT01722331|587482812|FG002|Part 3|Protocol Violation|0|||
162664110|NCT01722331|587482813|FG003|Part 3|Protocol Violation|0|||
162664111|NCT01722331|587482814|FG004|Part 3|Protocol Violation|0|||
162664112|NCT01722331|587482815|FG005|Part 3|Protocol Violation|0|||
162664113|NCT01722331|587482816|FG006|Part 3|Protocol Violation|0|||
162664114|NCT01722331|587482810|FG000|Part 3|Withdrawal by Subject|4|||
162664115|NCT01722331|587482811|FG001|Part 3|Withdrawal by Subject|7|||
162664116|NCT01722331|587482812|FG002|Part 3|Withdrawal by Subject|0|||
162664117|NCT01722331|587482813|FG003|Part 3|Withdrawal by Subject|0|||
162664118|NCT01722331|587482814|FG004|Part 3|Withdrawal by Subject|0|||
162664119|NCT01722331|587482815|FG005|Part 3|Withdrawal by Subject|2|||
162721317|NCT01307267|587688254|FG013|Overall Study|Other|0|||
162721318|NCT01307267|587688255|FG014|Overall Study|Other|2|||
163146406|NCT04319198|589246200|FG001|Overall Study|Reason Not Specified|2|||
162664120|NCT01722331|587482816|FG006|Part 3|Withdrawal by Subject|1|||
162664121|NCT01722331|587482810|FG000|Part 3|Other Protocol Specified Criteria|1|||
162664122|NCT01722331|587482811|FG001|Part 3|Other Protocol Specified Criteria|1|||
162664123|NCT01722331|587482812|FG002|Part 3|Other Protocol Specified Criteria|0|||
162664124|NCT01722331|587482813|FG003|Part 3|Other Protocol Specified Criteria|0|||
162664125|NCT01722331|587482814|FG004|Part 3|Other Protocol Specified Criteria|0|||
162664126|NCT01722331|587482815|FG005|Part 3|Other Protocol Specified Criteria|0|||
162664127|NCT01722331|587482816|FG006|Part 3|Other Protocol Specified Criteria|0|||
162664128|NCT02807948|587482821|FG000|Overall Study|Physician Decision|1|||
162664129|NCT02807948|587482822|FG001|Overall Study|Physician Decision|0|||
162664130|NCT03727750|587482823|FG000|Overall Study|Death|45|||
162664131|NCT03727750|587482823|FG000|Overall Study|Withdrawal by Subject|2|||
162664132|NCT03727750|587482823|FG000|Overall Study|Lost to Follow-up|1|||
162664133|NCT03727750|587482823|FG000|Overall Study|Other|1|||
162664134|NCT01375049|587482824|FG000|Overall Study|Adverse Event|2|||
162664135|NCT01375049|587482824|FG000|Overall Study|Lost to Follow-up|1|||
162664136|NCT01375049|587482824|FG000|Overall Study|Withdrawal by Subject|2|||
162664137|NCT01375049|587482824|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
162664138|NCT02082522|587482825|FG000|Overall Study|Sponsor termination|5|||
162664139|NCT02082522|587482826|FG001|Overall Study|Sponsor termination|3|||
162664140|NCT02082522|587482825|FG000|Overall Study|Withdrawal by Subject|2|||
162664141|NCT02082522|587482826|FG001|Overall Study|Withdrawal by Subject|4|||
162664142|NCT02082522|587482825|FG000|Overall Study|Death|1|||
162664143|NCT02082522|587482826|FG001|Overall Study|Death|0|||
162664144|NCT02082522|587482825|FG000|Overall Study|Lost to Follow-up|1|||
162721319|NCT01307267|587688256|FG015|Overall Study|Other|1|||
162721320|NCT01307267|587688257|FG016|Overall Study|Other|0|||
162721321|NCT01307267|587688258|FG017|Overall Study|Other|0|||
162721322|NCT01307267|587688259|FG018|Overall Study|Other|0|||
162721323|NCT01307267|587688260|FG019|Overall Study|Other|19|||
162721324|NCT01307267|587688261|FG020|Overall Study|Other|2|||
162721325|NCT01307267|587688262|FG021|Overall Study|Other|3|||
162721326|NCT01307267|587688263|FG022|Overall Study|Other|2|||
162721327|NCT04956575|587688266|FG000|Overall Study|Death|1|||
162721328|NCT04956575|587688267|FG001|Overall Study|Death|0|||
162721329|NCT04956575|587688268|FG002|Overall Study|Death|0|||
162721330|NCT04956575|587688269|FG003|Overall Study|Death|0|||
162721331|NCT04956575|587688270|FG004|Overall Study|Death|0|||
162721332|NCT04956575|587688271|FG005|Overall Study|Death|0|||
162721333|NCT04956575|587688272|FG006|Overall Study|Death|0|||
162721334|NCT04956575|587688273|FG007|Overall Study|Death|1|||
162721335|NCT04956575|587688274|FG008|Overall Study|Death|0|||
162721336|NCT04956575|587688275|FG009|Overall Study|Death|1|||
162721337|NCT04956575|587688276|FG010|Overall Study|Death|0|||
163039690|NCT00313586|588852803|FG002|Overall Study|Moved|0|||
163039691|NCT00313586|588852804|FG003|Overall Study|Moved|0|||
163039692|NCT00313586|588852801|FG000|Overall Study|Death before starting treatment|1|||
163039693|NCT00313586|588852802|FG001|Overall Study|Death before starting treatment|0|||
163039694|NCT00313586|588852803|FG002|Overall Study|Death before starting treatment|0|||
163039695|NCT00313586|588852804|FG003|Overall Study|Death before starting treatment|0|||
163039696|NCT00264290|588852805|FG000|Intervention (8 Weeks)|Adverse Event|1|||
163039697|NCT00264290|588852806|FG001|Intervention (8 Weeks)|Adverse Event|0|||
163039698|NCT04472494|588852807|FG000|Pre-treatment|Other reasons|2|||
163039699|NCT04472494|588852808|FG001|Pre-treatment|Other reasons|0|||
163039700|NCT04472494|588852807|FG000|Treatment|Death|5|||
163039701|NCT04472494|588852808|FG001|Treatment|Death|2|||
163039702|NCT04472494|588852807|FG000|Treatment|Hospital discharge|1|||
163039703|NCT04472494|588852808|FG001|Treatment|Hospital discharge|1|||
163039704|NCT03519919|588852810|FG000|Overall Study|Withdrawal by Subject|1|||
163039705|NCT03519919|588852810|FG000|Overall Study|Lack of Efficacy|1|||
163039706|NCT03519919|588852810|FG000|Overall Study|Screen Failure|1|||
163039707|NCT03076996|588852811|FG000|Overall Study|Withdrawal by Subject|2|||
163039708|NCT03076996|588852811|FG000|Overall Study|Lost to Follow-up|3|||
163039709|NCT03076996|588852811|FG000|Overall Study|Literacy precluded participation|1|||
163039710|NCT00587795|588852816|FG000|Overall Study|Withdrawal by Subject|1|||
163039711|NCT00587795|588852817|FG001|Overall Study|Withdrawal by Subject|0|||
163039712|NCT02144077|588852818|FG000|Overall Study|Withdrawal by Subject|3|||
163039713|NCT02144077|588852819|FG001|Overall Study|Withdrawal by Subject|3|||
163039714|NCT02144077|588852818|FG000|Overall Study|Adverse Event|2|||
163039715|NCT02144077|588852819|FG001|Overall Study|Adverse Event|3|||
163039716|NCT02144077|588852818|FG000|Overall Study|Lost to Follow-up|2|||
163039717|NCT02144077|588852819|FG001|Overall Study|Lost to Follow-up|2|||
163039718|NCT02144077|588852818|FG000|Overall Study|Protocol Violation|1|||
163039719|NCT02144077|588852819|FG001|Overall Study|Protocol Violation|2|||
163039720|NCT02144077|588852818|FG000|Overall Study|Death|0|||
163039721|NCT02144077|588852819|FG001|Overall Study|Death|1|||
163039722|NCT02144077|588852818|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
163039723|NCT02144077|588852819|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
163039724|NCT00943592|588852820|FG000|Overall Study|Death|3|||
163039725|NCT01909973|588852821|FG000|Overall Study|Lost to Follow-up|1|||
163039726|NCT01909973|588852822|FG001|Overall Study|Lost to Follow-up|0|||
163039727|NCT00460239|588852823|FG000|Overall Study|Physician Decision|0|||
163039728|NCT00460239|588852824|FG001|Overall Study|Physician Decision|1|||
163039729|NCT00460239|588852825|FG002|Overall Study|Physician Decision|0|||
163039730|NCT00460239|588852826|FG003|Overall Study|Physician Decision|0|||
163039731|NCT00460239|588852827|FG004|Overall Study|Physician Decision|0|||
163039732|NCT00460239|588852828|FG005|Overall Study|Physician Decision|2|||
163039733|NCT00460239|588852829|FG006|Overall Study|Physician Decision|0|||
163039734|NCT00460239|588852830|FG007|Overall Study|Physician Decision|0|||
163039735|NCT00460239|588852831|FG008|Overall Study|Physician Decision|0|||
163039736|NCT00460239|588852823|FG000|Overall Study|Withdrawal by Subject|0|||
163039737|NCT00460239|588852824|FG001|Overall Study|Withdrawal by Subject|0|||
163039738|NCT00460239|588852825|FG002|Overall Study|Withdrawal by Subject|0|||
163039739|NCT00460239|588852826|FG003|Overall Study|Withdrawal by Subject|0|||
163039740|NCT00460239|588852827|FG004|Overall Study|Withdrawal by Subject|0|||
163039741|NCT00460239|588852828|FG005|Overall Study|Withdrawal by Subject|1|||
163039742|NCT00460239|588852829|FG006|Overall Study|Withdrawal by Subject|0|||
163039743|NCT00460239|588852830|FG007|Overall Study|Withdrawal by Subject|0|||
162664145|NCT02082522|587482826|FG001|Overall Study|Lost to Follow-up|0|||
162664146|NCT02082522|587482825|FG000|Overall Study|Physician Decision|3|||
162664147|NCT02082522|587482826|FG001|Overall Study|Physician Decision|1|||
162664148|NCT02082522|587482825|FG000|Overall Study|Disease progression|2|||
162664149|NCT02082522|587482826|FG001|Overall Study|Disease progression|2|||
162664150|NCT02082522|587482825|FG000|Overall Study|Chemotherapy change|1|||
162664151|NCT02082522|587482826|FG001|Overall Study|Chemotherapy change|3|||
162664152|NCT00633984|587482827|FG000|Overall Study|Lost to Follow-up|0|||
162664153|NCT00633984|587482828|FG001|Overall Study|Lost to Follow-up|6|||
162664154|NCT00633984|587482827|FG000|Overall Study|Withdrawal by Subject|8|||
162664155|NCT00633984|587482828|FG001|Overall Study|Withdrawal by Subject|7|||
162664156|NCT00633984|587482827|FG000|Overall Study|Hospitalized|1|||
162664157|NCT00633984|587482828|FG001|Overall Study|Hospitalized|0|||
162664158|NCT02496884|587482829|FG000|Overall Study|Counted twice as enrolled|2|||
162664159|NCT02496884|587482830|FG001|Overall Study|Counted twice as enrolled|0|||
162664160|NCT02496884|587482831|FG002|Overall Study|Counted twice as enrolled|0|||
162664161|NCT02496884|587482832|FG003|Overall Study|Counted twice as enrolled|0|||
162664162|NCT02496884|587482829|FG000|Overall Study|Withdrawal by Subject|0|||
162664163|NCT02496884|587482830|FG001|Overall Study|Withdrawal by Subject|3|||
162664164|NCT02496884|587482831|FG002|Overall Study|Withdrawal by Subject|0|||
162664165|NCT02496884|587482832|FG003|Overall Study|Withdrawal by Subject|0|||
162664166|NCT01168999|587482833|FG000|Overall Study|Lost to Follow-up|2|||
162664167|NCT01168999|587482834|FG001|Overall Study|Lost to Follow-up|1|||
162664168|NCT01168999|587482835|FG002|Overall Study|Lost to Follow-up|0|||
162664169|NCT01168999|587482836|FG003|Overall Study|Lost to Follow-up|0|||
162664170|NCT03766646|587482837|FG000|Overall Study|Withdrawal by Subject|1|||
162664171|NCT03766646|587482838|FG001|Overall Study|Withdrawal by Subject|0|||
162664172|NCT03766646|587482837|FG000|Overall Study|Protocol Violation|0|||
162664173|NCT03766646|587482838|FG001|Overall Study|Protocol Violation|3|||
162664174|NCT02530619|587482848|FG000|Registered for Study|Withdrawal by Subject|2|||
162664175|NCT02530619|587482848|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
162664176|NCT02530619|587482848|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
162664177|NCT02530619|587482848|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
162664178|NCT02530619|587482848|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
162664179|NCT02530619|587482848|FG000|Follow-up Period (6 Months)|Death|4|||
162664180|NCT02530619|587482848|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
162664181|NCT02530619|587482848|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
162664182|NCT01854554|587482850|FG000|Overall Study|Denial of Insurance Coverage|12|||
162664183|NCT01854554|587482851|FG001|Overall Study|Denial of Insurance Coverage|0|||
162664184|NCT01854554|587482850|FG000|Overall Study|Decided to get treatment locally|1|||
162664185|NCT01854554|587482851|FG001|Overall Study|Decided to get treatment locally|5|||
162664186|NCT01854554|587482850|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
162664187|NCT01854554|587482851|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
162664188|NCT01854554|587482850|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162664189|NCT01854554|587482851|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
162664190|NCT01854554|587482850|FG000|Overall Study|Progression|0|||
162664191|NCT01854554|587482851|FG001|Overall Study|Progression|1|||
162664192|NCT01854554|587482850|FG000|Overall Study|Lost to Follow-up|0|||
163039744|NCT00460239|588852831|FG008|Overall Study|Withdrawal by Subject|0|||
163039745|NCT02438280|588852837|FG000|Overall Study|Physician Decision|1|||
163039746|NCT02438280|588852838|FG001|Overall Study|Physician Decision|0|||
163039747|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
163039748|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
162664193|NCT01854554|587482851|FG001|Overall Study|Lost to Follow-up|1|||
162664194|NCT00359762|587482854|FG000|Period II|Adverse Event|17|||
162664195|NCT00359762|587482855|FG001|Period II|Adverse Event|0|||
162664196|NCT00359762|587482856|FG002|Period II|Adverse Event|0|||
162664197|NCT00359762|587482857|FG003|Period II|Adverse Event|0|||
162664198|NCT00359762|587482858|FG004|Period II|Adverse Event|49|||
162664199|NCT00359762|587482854|FG000|Period II|Protocol Violation|18|||
162664200|NCT00359762|587482855|FG001|Period II|Protocol Violation|0|||
162664201|NCT00359762|587482856|FG002|Period II|Protocol Violation|0|||
162664202|NCT00359762|587482857|FG003|Period II|Protocol Violation|0|||
162664203|NCT00359762|587482858|FG004|Period II|Protocol Violation|11|||
162664204|NCT00359762|587482854|FG000|Period II|Physician Decision|17|||
162664205|NCT00359762|587482855|FG001|Period II|Physician Decision|0|||
162664206|NCT00359762|587482856|FG002|Period II|Physician Decision|0|||
163039749|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
163039750|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
162664207|NCT00359762|587482857|FG003|Period II|Physician Decision|0|||
163039751|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
163039752|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
162664208|NCT00359762|587482858|FG004|Period II|Physician Decision|23|||
162664209|NCT00359762|587482854|FG000|Period II|Death|2|||
162664210|NCT00359762|587482855|FG001|Period II|Death|0|||
162664211|NCT00359762|587482856|FG002|Period II|Death|0|||
162664212|NCT00359762|587482857|FG003|Period II|Death|0|||
162664213|NCT00359762|587482858|FG004|Period II|Death|4|||
162664214|NCT00359762|587482854|FG000|Period II|Lack of Efficacy|11|||
162664215|NCT00359762|587482855|FG001|Period II|Lack of Efficacy|0|||
162664216|NCT00359762|587482856|FG002|Period II|Lack of Efficacy|0|||
162664217|NCT00359762|587482857|FG003|Period II|Lack of Efficacy|0|||
162664218|NCT00359762|587482858|FG004|Period II|Lack of Efficacy|8|||
162664219|NCT00359762|587482854|FG000|Period II|Lost to follow up|5|||
162664220|NCT00359762|587482855|FG001|Period II|Lost to follow up|0|||
162664221|NCT00359762|587482856|FG002|Period II|Lost to follow up|0|||
162664222|NCT00359762|587482857|FG003|Period II|Lost to follow up|0|||
162664223|NCT00359762|587482858|FG004|Period II|Lost to follow up|5|||
162664224|NCT00359762|587482854|FG000|Period II|Entry Criteria Not Met|8|||
162664225|NCT00359762|587482855|FG001|Period II|Entry Criteria Not Met|0|||
162664226|NCT00359762|587482856|FG002|Period II|Entry Criteria Not Met|0|||
162664227|NCT00359762|587482857|FG003|Period II|Entry Criteria Not Met|0|||
162664228|NCT00359762|587482858|FG004|Period II|Entry Criteria Not Met|4|||
162664229|NCT00359762|587482854|FG000|Period II|Subject Decision|50|||
162664230|NCT00359762|587482855|FG001|Period II|Subject Decision|0|||
162664231|NCT00359762|587482856|FG002|Period II|Subject Decision|0|||
162664232|NCT00359762|587482857|FG003|Period II|Subject Decision|0|||
162664233|NCT00359762|587482858|FG004|Period II|Subject Decision|70|||
162664234|NCT00359762|587482854|FG000|Period III|Protocol Violation|0|||
162664235|NCT00359762|587482855|FG001|Period III|Protocol Violation|5|||
162664236|NCT00359762|587482856|FG002|Period III|Protocol Violation|3|||
162664237|NCT00359762|587482857|FG003|Period III|Protocol Violation|8|||
162664238|NCT00359762|587482858|FG004|Period III|Protocol Violation|0|||
162664239|NCT00359762|587482854|FG000|Period III|Adverse Event|0|||
162664240|NCT00359762|587482855|FG001|Period III|Adverse Event|3|||
162664241|NCT00359762|587482856|FG002|Period III|Adverse Event|4|||
162664242|NCT00359762|587482857|FG003|Period III|Adverse Event|10|||
162664243|NCT00359762|587482858|FG004|Period III|Adverse Event|0|||
162664244|NCT00359762|587482854|FG000|Period III|Physician Decision|0|||
162664245|NCT00359762|587482855|FG001|Period III|Physician Decision|5|||
162664246|NCT00359762|587482856|FG002|Period III|Physician Decision|9|||
162664247|NCT00359762|587482857|FG003|Period III|Physician Decision|15|||
162664248|NCT00359762|587482858|FG004|Period III|Physician Decision|0|||
162664249|NCT00359762|587482854|FG000|Period III|Lack of Efficacy|0|||
162664250|NCT00359762|587482855|FG001|Period III|Lack of Efficacy|7|||
162664251|NCT00359762|587482856|FG002|Period III|Lack of Efficacy|5|||
162664252|NCT00359762|587482857|FG003|Period III|Lack of Efficacy|9|||
163146407|NCT04319198|589246201|FG002|Overall Study|Reason Not Specified|4|||
163146408|NCT04319198|589246199|FG000|Overall Study|Withdrawal of Consent|0|||
162664253|NCT00359762|587482858|FG004|Period III|Lack of Efficacy|0|||
162664254|NCT00359762|587482854|FG000|Period III|Lost to follow up|0|||
162664255|NCT00359762|587482855|FG001|Period III|Lost to follow up|1|||
162664256|NCT00359762|587482856|FG002|Period III|Lost to follow up|1|||
162664257|NCT00359762|587482857|FG003|Period III|Lost to follow up|2|||
162664258|NCT00359762|587482858|FG004|Period III|Lost to follow up|0|||
162664259|NCT00359762|587482854|FG000|Period III|Entry Criteria Not Met|0|||
162664260|NCT00359762|587482855|FG001|Period III|Entry Criteria Not Met|1|||
162664261|NCT00359762|587482856|FG002|Period III|Entry Criteria Not Met|0|||
162664262|NCT00359762|587482857|FG003|Period III|Entry Criteria Not Met|1|||
162664263|NCT00359762|587482858|FG004|Period III|Entry Criteria Not Met|0|||
162664264|NCT00359762|587482854|FG000|Period III|Subject Decision|0|||
162664265|NCT00359762|587482855|FG001|Period III|Subject Decision|7|||
162664266|NCT00359762|587482856|FG002|Period III|Subject Decision|8|||
162664267|NCT00359762|587482857|FG003|Period III|Subject Decision|20|||
162664268|NCT00359762|587482858|FG004|Period III|Subject Decision|0|||
162664269|NCT02819726|587482859|FG000|Part A (All Participants)|Lost to Follow-up|0|||
163146409|NCT04319198|589246200|FG001|Overall Study|Withdrawal of Consent|0|||
163146410|NCT04319198|589246201|FG002|Overall Study|Withdrawal of Consent|5|||
163146411|NCT04319198|589246199|FG000|Overall Study|Site Terminated by Sponsor|0|||
163146412|NCT04319198|589246200|FG001|Overall Study|Site Terminated by Sponsor|1|||
163146413|NCT04319198|589246201|FG002|Overall Study|Site Terminated by Sponsor|0|||
163146414|NCT04607668|589246203|FG000|Overall Study|Death|49|||
163146415|NCT04607668|589246204|FG001|Overall Study|Death|26|||
162664270|NCT02819726|587482860|FG001|Part A (All Participants)|Lost to Follow-up|1|||
162664271|NCT02819726|587482861|FG002|Part A (All Participants)|Lost to Follow-up|0|||
162664272|NCT02819726|587482862|FG003|Part A (All Participants)|Lost to Follow-up|0|||
162664273|NCT02819726|587482859|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
162664274|NCT02819726|587482860|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
162664275|NCT02819726|587482861|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
162664276|NCT02819726|587482862|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
163146416|NCT04607668|589246203|FG000|Overall Study|Lost to Follow-up|3|||
163146417|NCT04607668|589246204|FG001|Overall Study|Lost to Follow-up|4|||
163146418|NCT04607668|589246203|FG000|Overall Study|Study terminated by Sponsor|92|||
163039753|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
163039754|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
163039755|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
163039756|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
163039757|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
163039758|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
163039759|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
163039760|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
163039761|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
163039762|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
163039763|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039764|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
163039765|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039766|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
163039767|NCT02087943|588852839|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039768|NCT02087943|588852840|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
163039769|NCT02087943|588852841|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039770|NCT02087943|588852842|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
163039771|NCT02087943|588852843|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
162664277|NCT02819726|587482859|FG000|Part A (All Participants)|Protocol non-compliance|3|||
162664278|NCT02819726|587482860|FG001|Part A (All Participants)|Protocol non-compliance|4|||
162664279|NCT02819726|587482861|FG002|Part A (All Participants)|Protocol non-compliance|5|||
162664280|NCT02819726|587482862|FG003|Part A (All Participants)|Protocol non-compliance|0|||
162664281|NCT02819726|587482859|FG000|Part B (All Participants)|Lost to Follow-up|1|||
163039772|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
163039773|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
163039774|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
163039775|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
162664282|NCT02819726|587482860|FG001|Part B (All Participants)|Lost to Follow-up|1|||
162664283|NCT02819726|587482861|FG002|Part B (All Participants)|Lost to Follow-up|2|||
162664284|NCT02819726|587482862|FG003|Part B (All Participants)|Lost to Follow-up|2|||
162664285|NCT02819726|587482859|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
162721338|NCT04956575|587688277|FG011|Overall Study|Death|0|||
163039776|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
163039777|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
163039778|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
163039779|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
163039780|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
163039781|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
163039782|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039783|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039784|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
163039785|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039786|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
163039787|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039788|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039789|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039790|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
163039791|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
163039792|NCT02087943|588852839|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039793|NCT02087943|588852840|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039794|NCT02087943|588852841|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
163039795|NCT02087943|588852842|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
163039796|NCT02087943|588852843|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
163039797|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
163039798|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
163039799|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
163039800|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039801|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039802|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
163039803|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
163039804|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039805|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
162664286|NCT02819726|587482860|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
162664287|NCT02819726|587482861|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
162664288|NCT02819726|587482862|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
162664289|NCT02819726|587482859|FG000|Part B (All Participants)|Protocol non-compliance|0|||
162664290|NCT02819726|587482860|FG001|Part B (All Participants)|Protocol non-compliance|0|||
162664291|NCT02819726|587482861|FG002|Part B (All Participants)|Protocol non-compliance|1|||
162664292|NCT02819726|587482862|FG003|Part B (All Participants)|Protocol non-compliance|0|||
162664293|NCT00803023|587482865|FG000|Overall Study|Adverse Event|5|||
162664294|NCT00803023|587482866|FG001|Overall Study|Adverse Event|4|||
162664295|NCT00803023|587482867|FG002|Overall Study|Adverse Event|8|||
162664296|NCT00803023|587482868|FG003|Overall Study|Adverse Event|6|||
162664297|NCT00803023|587482865|FG000|Overall Study|Withdrawal by Subject|0|||
162664298|NCT00803023|587482866|FG001|Overall Study|Withdrawal by Subject|2|||
162664299|NCT00803023|587482867|FG002|Overall Study|Withdrawal by Subject|0|||
162664300|NCT00803023|587482868|FG003|Overall Study|Withdrawal by Subject|0|||
162664301|NCT00803023|587482865|FG000|Overall Study|Lost to Follow-up|0|||
162664302|NCT00803023|587482866|FG001|Overall Study|Lost to Follow-up|1|||
162664303|NCT00803023|587482867|FG002|Overall Study|Lost to Follow-up|2|||
162664304|NCT00803023|587482868|FG003|Overall Study|Lost to Follow-up|1|||
162664305|NCT00803023|587482865|FG000|Overall Study|Lack of Efficacy|0|||
162664306|NCT00803023|587482866|FG001|Overall Study|Lack of Efficacy|1|||
162664307|NCT00803023|587482867|FG002|Overall Study|Lack of Efficacy|1|||
162664308|NCT00803023|587482868|FG003|Overall Study|Lack of Efficacy|1|||
162664309|NCT02647658|587482869|FG000|Overall Study|Consent refusal|15|||
162664310|NCT02647658|587482870|FG001|Overall Study|Consent refusal|24|||
162664311|NCT02461589|587482871|FG000|Overall Study|Withdrawal by Subject|5|||
162664312|NCT02461589|587482872|FG001|Overall Study|Withdrawal by Subject|1|||
162664313|NCT02461589|587482873|FG002|Overall Study|Withdrawal by Subject|3|||
162664314|NCT02461589|587482874|FG003|Overall Study|Withdrawal by Subject|2|||
162664315|NCT02461589|587482875|FG004|Overall Study|Withdrawal by Subject|1|||
162664316|NCT02461589|587482876|FG005|Overall Study|Withdrawal by Subject|2|||
162664317|NCT02461589|587482877|FG006|Overall Study|Withdrawal by Subject|1|||
162664318|NCT02461589|587482878|FG007|Overall Study|Withdrawal by Subject|3|||
162664319|NCT02461589|587482879|FG008|Overall Study|Withdrawal by Subject|3|||
162664320|NCT02461589|587482880|FG009|Overall Study|Withdrawal by Subject|1|||
162664321|NCT02461589|587482871|FG000|Overall Study|Lost to Follow-up|0|||
162664322|NCT02461589|587482872|FG001|Overall Study|Lost to Follow-up|0|||
162664323|NCT02461589|587482873|FG002|Overall Study|Lost to Follow-up|2|||
162664324|NCT02461589|587482874|FG003|Overall Study|Lost to Follow-up|3|||
162664325|NCT02461589|587482875|FG004|Overall Study|Lost to Follow-up|1|||
162664326|NCT02461589|587482876|FG005|Overall Study|Lost to Follow-up|1|||
162664327|NCT02461589|587482877|FG006|Overall Study|Lost to Follow-up|3|||
162664328|NCT02461589|587482878|FG007|Overall Study|Lost to Follow-up|1|||
162664329|NCT02461589|587482879|FG008|Overall Study|Lost to Follow-up|3|||
162664330|NCT02461589|587482880|FG009|Overall Study|Lost to Follow-up|1|||
162664331|NCT02461589|587482871|FG000|Overall Study|Death|0|||
162664332|NCT02461589|587482872|FG001|Overall Study|Death|0|||
162664333|NCT02461589|587482873|FG002|Overall Study|Death|0|||
162664334|NCT02461589|587482874|FG003|Overall Study|Death|0|||
162664335|NCT02461589|587482875|FG004|Overall Study|Death|0|||
162664336|NCT02461589|587482876|FG005|Overall Study|Death|0|||
162664337|NCT02461589|587482877|FG006|Overall Study|Death|0|||
162664338|NCT02461589|587482878|FG007|Overall Study|Death|1|||
162664339|NCT02461589|587482879|FG008|Overall Study|Death|0|||
162664340|NCT02461589|587482880|FG009|Overall Study|Death|0|||
162664341|NCT02461589|587482871|FG000|Overall Study|Unclassified|0|||
162664342|NCT02461589|587482872|FG001|Overall Study|Unclassified|0|||
162664343|NCT02461589|587482873|FG002|Overall Study|Unclassified|0|||
162664344|NCT02461589|587482874|FG003|Overall Study|Unclassified|0|||
162664345|NCT02461589|587482875|FG004|Overall Study|Unclassified|0|||
162664346|NCT02461589|587482876|FG005|Overall Study|Unclassified|0|||
162721339|NCT04956575|587688266|FG000|Overall Study|Lost to Follow-up|3|||
162664347|NCT02461589|587482877|FG006|Overall Study|Unclassified|1|||
162664348|NCT02461589|587482878|FG007|Overall Study|Unclassified|0|||
162664349|NCT02461589|587482879|FG008|Overall Study|Unclassified|0|||
162664350|NCT02461589|587482880|FG009|Overall Study|Unclassified|2|||
162664351|NCT02461589|587482871|FG000|Overall Study|Missing follow-up information|1|||
162664352|NCT02461589|587482872|FG001|Overall Study|Missing follow-up information|1|||
162664353|NCT02461589|587482873|FG002|Overall Study|Missing follow-up information|0|||
162664354|NCT02461589|587482874|FG003|Overall Study|Missing follow-up information|0|||
162664355|NCT02461589|587482875|FG004|Overall Study|Missing follow-up information|0|||
162664356|NCT02461589|587482876|FG005|Overall Study|Missing follow-up information|0|||
162664357|NCT02461589|587482877|FG006|Overall Study|Missing follow-up information|1|||
162664358|NCT02461589|587482878|FG007|Overall Study|Missing follow-up information|0|||
162664359|NCT02461589|587482879|FG008|Overall Study|Missing follow-up information|0|||
162664360|NCT02461589|587482880|FG009|Overall Study|Missing follow-up information|0|||
162664361|NCT02461589|587482871|FG000|Overall Study|Withdrawal from trial before exposure|0|||
162664362|NCT02461589|587482872|FG001|Overall Study|Withdrawal from trial before exposure|0|||
162664363|NCT02461589|587482873|FG002|Overall Study|Withdrawal from trial before exposure|0|||
162664364|NCT02461589|587482874|FG003|Overall Study|Withdrawal from trial before exposure|0|||
162664365|NCT02461589|587482875|FG004|Overall Study|Withdrawal from trial before exposure|0|||
162664366|NCT02461589|587482876|FG005|Overall Study|Withdrawal from trial before exposure|0|||
162664367|NCT02461589|587482877|FG006|Overall Study|Withdrawal from trial before exposure|0|||
162664368|NCT02461589|587482878|FG007|Overall Study|Withdrawal from trial before exposure|0|||
162664369|NCT02461589|587482879|FG008|Overall Study|Withdrawal from trial before exposure|0|||
162664370|NCT02461589|587482880|FG009|Overall Study|Withdrawal from trial before exposure|1|||
162664371|NCT01978119|587482885|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
162664372|NCT01978119|587482886|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
162664373|NCT01978119|587482885|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162664374|NCT01978119|587482886|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162664375|NCT01978119|587482885|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162664376|NCT01978119|587482886|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
162664377|NCT03295201|587482889|FG000|Overall Study|Lost to Follow-up|1|||
162664378|NCT03295201|587482890|FG001|Overall Study|Lost to Follow-up|1|||
162664379|NCT03295201|587482889|FG000|Overall Study|Hospital admission|0|||
162664380|NCT03295201|587482890|FG001|Overall Study|Hospital admission|1|||
162664381|NCT02519504|587482891|FG000|Overall Study|Protocol Violation|6|||
162664382|NCT02519504|587482892|FG001|Overall Study|Protocol Violation|5|||
162664383|NCT02519504|587482891|FG000|Overall Study|Ineligible for direct testing|12|||
162664384|NCT02519504|587482892|FG001|Overall Study|Ineligible for direct testing|12|||
162664385|NCT02519504|587482891|FG000|Overall Study|Did not participate in direct testing|95|||
162664386|NCT02519504|587482892|FG001|Overall Study|Did not participate in direct testing|86|||
162664387|NCT02548962|587482893|FG000|Overall Study|Withdrawal by Subject|1|||
162664388|NCT02548962|587482894|FG001|Overall Study|Withdrawal by Subject|0|||
162664389|NCT01958918|587482895|FG000|Overall Study|Death|1|||
162664390|NCT01958918|587482896|FG001|Overall Study|Death|3|||
162664391|NCT01958918|587482895|FG000|Overall Study|Lost to Follow-up|4|||
162664392|NCT01958918|587482896|FG001|Overall Study|Lost to Follow-up|7|||
162664393|NCT01958918|587482895|FG000|Overall Study|Withdrawal by Subject|13|||
162664394|NCT01958918|587482896|FG001|Overall Study|Withdrawal by Subject|8|||
162664395|NCT01958918|587482895|FG000|Overall Study|Lack of Efficacy|13|||
162664396|NCT01958918|587482896|FG001|Overall Study|Lack of Efficacy|10|||
162664397|NCT01958918|587482895|FG000|Overall Study|Adverse Event|12|||
162721340|NCT04956575|587688267|FG001|Overall Study|Lost to Follow-up|4|||
162721341|NCT04956575|587688268|FG002|Overall Study|Lost to Follow-up|2|||
162721342|NCT04956575|587688269|FG003|Overall Study|Lost to Follow-up|3|||
162721343|NCT04956575|587688270|FG004|Overall Study|Lost to Follow-up|1|||
162721344|NCT04956575|587688271|FG005|Overall Study|Lost to Follow-up|10|||
162721345|NCT04956575|587688272|FG006|Overall Study|Lost to Follow-up|11|||
162721346|NCT04956575|587688273|FG007|Overall Study|Lost to Follow-up|7|||
162721347|NCT04956575|587688274|FG008|Overall Study|Lost to Follow-up|4|||
162721348|NCT04956575|587688275|FG009|Overall Study|Lost to Follow-up|2|||
162721349|NCT04956575|587688276|FG010|Overall Study|Lost to Follow-up|3|||
162721350|NCT04956575|587688277|FG011|Overall Study|Lost to Follow-up|8|||
162721351|NCT04956575|587688266|FG000|Overall Study|Withdrawal by Subject|1|||
162721352|NCT04956575|587688267|FG001|Overall Study|Withdrawal by Subject|2|||
162721353|NCT04956575|587688268|FG002|Overall Study|Withdrawal by Subject|1|||
162721354|NCT04956575|587688269|FG003|Overall Study|Withdrawal by Subject|4|||
162721355|NCT04956575|587688270|FG004|Overall Study|Withdrawal by Subject|2|||
162721356|NCT04956575|587688271|FG005|Overall Study|Withdrawal by Subject|8|||
162721357|NCT04956575|587688272|FG006|Overall Study|Withdrawal by Subject|5|||
162721358|NCT04956575|587688273|FG007|Overall Study|Withdrawal by Subject|1|||
162721359|NCT04956575|587688274|FG008|Overall Study|Withdrawal by Subject|1|||
162721360|NCT04956575|587688275|FG009|Overall Study|Withdrawal by Subject|0|||
162721361|NCT04956575|587688276|FG010|Overall Study|Withdrawal by Subject|3|||
162721362|NCT04956575|587688277|FG011|Overall Study|Withdrawal by Subject|1|||
162721363|NCT00854906|587688280|FG000|Overall Study|One person had no ocular history|1|||
162721364|NCT05526248|587688281|FG000|Overall Study|Lost to Follow-up|1|||
162721365|NCT05526248|587688281|FG000|Overall Study|Adverse Event|2|||
162721366|NCT05526248|587688281|FG000|Overall Study|Withdrawal by Subject|1|||
162721367|NCT01135511|587688289|FG000|Overall Study|Adverse Event|0|||
162721368|NCT01135511|587688290|FG001|Overall Study|Adverse Event|1|||
162721369|NCT01135511|587688291|FG002|Overall Study|Adverse Event|2|||
162721370|NCT01135511|587688292|FG003|Overall Study|Adverse Event|0|||
162721371|NCT01135511|587688293|FG004|Overall Study|Adverse Event|0|||
162721372|NCT01135511|587688294|FG005|Overall Study|Adverse Event|1|||
162721373|NCT01135511|587688295|FG006|Overall Study|Adverse Event|0|||
162721374|NCT01135511|587688296|FG007|Overall Study|Adverse Event|1|||
162721375|NCT01135511|587688297|FG008|Overall Study|Adverse Event|0|||
162721376|NCT01135511|587688289|FG000|Overall Study|Lack of Efficacy|0|||
162721377|NCT01135511|587688290|FG001|Overall Study|Lack of Efficacy|1|||
162721378|NCT01135511|587688291|FG002|Overall Study|Lack of Efficacy|1|||
162721379|NCT01135511|587688292|FG003|Overall Study|Lack of Efficacy|2|||
162664398|NCT01958918|587482896|FG001|Overall Study|Adverse Event|12|||
162664399|NCT01958918|587482895|FG000|Overall Study|administrative problems|0|||
162664400|NCT01958918|587482896|FG001|Overall Study|administrative problems|2|||
162664401|NCT00659269|587482900|FG000|Overall Study|Physician Decision|1|||
162664402|NCT00659269|587482901|FG001|Overall Study|Physician Decision|1|||
162664403|NCT00908960|587482903|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
162664404|NCT00908960|587482904|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
162664405|NCT00908960|587482905|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
162664406|NCT02401672|587482908|FG000|Overall Study|Withdrawal by Subject|1|||
162664407|NCT02401672|587482909|FG001|Overall Study|Withdrawal by Subject|3|||
162664408|NCT03653429|587482912|FG000|Overall Study|Physician Decision|4|||
162664409|NCT03653429|587482913|FG001|Overall Study|Physician Decision|10|||
162664410|NCT00403546|587482914|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
162664411|NCT00403546|587482915|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
162664412|NCT00403546|587482916|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
162664413|NCT00403546|587482914|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
162664414|NCT00403546|587482915|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
162664415|NCT00403546|587482916|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
162664416|NCT00403546|587482914|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
162664417|NCT00403546|587482915|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
162664418|NCT00403546|587482916|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
162664419|NCT00403546|587482914|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
162664420|NCT00403546|587482915|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
162664421|NCT00403546|587482916|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
162664422|NCT00403546|587482914|FG000|Screening Phase|Screening Failure|22|||
162664423|NCT00403546|587482915|FG001|Screening Phase|Screening Failure|0|||
162664424|NCT00403546|587482916|FG002|Screening Phase|Screening Failure|0|||
162664425|NCT00403546|587482914|FG000|Screening Phase|Adverse Event|1|||
162664426|NCT00403546|587482915|FG001|Screening Phase|Adverse Event|0|||
162664427|NCT00403546|587482916|FG002|Screening Phase|Adverse Event|0|||
162664428|NCT00403546|587482914|FG000|Screening Phase|Terminated Prior to Randomization|5|||
162664429|NCT00403546|587482915|FG001|Screening Phase|Terminated Prior to Randomization|0|||
162664430|NCT00403546|587482916|FG002|Screening Phase|Terminated Prior to Randomization|0|||
162664431|NCT00403546|587482914|FG000|Randomized Trial|Early Terminations|0|||
162664432|NCT00403546|587482915|FG001|Randomized Trial|Early Terminations|17|||
162664433|NCT00403546|587482916|FG002|Randomized Trial|Early Terminations|16|||
162664434|NCT00793910|587482920|FG000|Overall Study|discarded study pills|0|||
162664435|NCT00793910|587482921|FG001|Overall Study|discarded study pills|1|||
162664436|NCT00793910|587482920|FG000|Overall Study|did not pick up medications|1|||
162664437|NCT00793910|587482921|FG001|Overall Study|did not pick up medications|1|||
162664438|NCT00793910|587482920|FG000|Overall Study|ineligible based on entry criteria|2|||
162664439|NCT00793910|587482921|FG001|Overall Study|ineligible based on entry criteria|3|||
162664440|NCT00793910|587482920|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
162664441|NCT00793910|587482921|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
162664442|NCT00793910|587482920|FG000|Overall Study|Withdrawal by Subject|0|||
162664443|NCT00793910|587482921|FG001|Overall Study|Withdrawal by Subject|1|||
162664444|NCT03634579|587482926|FG000|Overall Study|study termination|9|||
162664445|NCT05061446|587482927|FG000|Overall Study|Adverse Event|2|||
162664446|NCT05061446|587482928|FG001|Overall Study|Adverse Event|0|||
162664447|NCT05061446|587482929|FG002|Overall Study|Adverse Event|0|||
162664448|NCT05061446|587482927|FG000|Overall Study|Participant no longer available due to personal reason|0|||
162664449|NCT05061446|587482928|FG001|Overall Study|Participant no longer available due to personal reason|1|||
162664450|NCT05061446|587482929|FG002|Overall Study|Participant no longer available due to personal reason|0|||
162664451|NCT04111497|587482930|FG000|Overall Study|relapse of primary disease|1|||
162664452|NCT04111497|587482930|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
162664453|NCT01993719|587482933|FG000|First Drug Administration|Not treated|1|||
162664454|NCT01993719|587482934|FG001|First Drug Administration|Not treated|0|||
162664455|NCT01993719|587482935|FG002|First Drug Administration|Not treated|0|||
162664456|NCT01993719|587482936|FG003|First Drug Administration|Not treated|0|||
162664457|NCT01993719|587482937|FG004|First Drug Administration|Not treated|0|||
162664458|NCT05857527|587482938|FG000|Overall Study|Withdrawal by Subject|0|||
162664459|NCT05857527|587482939|FG001|Overall Study|Withdrawal by Subject|1|||
162664460|NCT02799082|587482940|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
162664461|NCT02799082|587482941|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
162664462|NCT02799082|587482940|FG000|Overall Study|Protocol Violation|0|||
162664463|NCT02799082|587482941|FG001|Overall Study|Protocol Violation|1|||
162664464|NCT01592708|587482943|FG000|Overall Study|Protocol Violation|3|||
162664465|NCT01592708|587482944|FG001|Overall Study|Protocol Violation|0|||
162664466|NCT01723904|587482948|FG000|Overall Study|Noncompliant|3|||
162664467|NCT01723904|587482948|FG000|Overall Study|Adverse Event|5|||
162664468|NCT01723904|587482948|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
162664469|NCT02610140|587482959|FG000|Randomization and Treatment Period|Radiological progression|23|||
163039806|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039807|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039808|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
163039809|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
163039810|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
163039811|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039812|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039813|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039814|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
163039815|NCT01690299|588852844|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
163039816|NCT01690299|588852845|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
163039817|NCT01690299|588852846|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
163039818|NCT01690299|588852847|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039819|NCT01690299|588852848|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039820|NCT01690299|588852849|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
163039821|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039822|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039823|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
163039824|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
163039825|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
163039826|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
163039827|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039828|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039829|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
163039830|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
163039831|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
163039832|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
163039833|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039834|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039835|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039836|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
163039837|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
163039838|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
163039839|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039840|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039841|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
163039842|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
163039843|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
163039844|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
163039845|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039846|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039847|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
163039848|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
163039849|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
163039850|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
163039851|NCT01690299|588852844|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039852|NCT01690299|588852845|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039853|NCT01690299|588852846|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039854|NCT01690299|588852847|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039855|NCT01690299|588852848|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
163039856|NCT01690299|588852849|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
163039857|NCT01882803|588852854|FG000|Overall Study|Disease Progression|1|||
163039858|NCT01882803|588852854|FG000|Overall Study|Withdrawal by Subject|9|||
163039859|NCT01882803|588852854|FG000|Overall Study|Death|68|||
163039860|NCT01882803|588852854|FG000|Overall Study|Physician Decision|3|||
163039861|NCT01882803|588852854|FG000|Overall Study|Lost to Follow-up|3|||
163039862|NCT01882803|588852854|FG000|Overall Study|Follow-up Completed|39|||
163039863|NCT01882803|588852854|FG000|Overall Study|Study Terminated by the Sponsor|6|||
163039864|NCT02869893|588852855|FG000|Overall Study|participant aversion to IV|5|||
163039865|NCT02869893|588852855|FG000|Overall Study|participant fear of MRI scanner|2|||
163039866|NCT01563913|588852856|FG000|Overall Study|Physician Decision|1|||
163039867|NCT01563913|588852857|FG001|Overall Study|Physician Decision|0|||
163039868|NCT01563913|588852856|FG000|Overall Study|Spouse Passed Away|1|||
163039869|NCT01563913|588852857|FG001|Overall Study|Spouse Passed Away|0|||
163039870|NCT03066778|588852858|FG000|Overall Study|Death|195|||
163039871|NCT03066778|588852859|FG001|Overall Study|Death|205|||
163039872|NCT03066778|588852858|FG000|Overall Study|Withdrawal by Subject|5|||
163039873|NCT03066778|588852859|FG001|Overall Study|Withdrawal by Subject|7|||
163039874|NCT00551525|588852860|FG000|Overall Study|Protocol Violation|5|||
163039875|NCT02912455|588852862|FG000|Overall Study|Withdrawal by Subject|0|||
163039876|NCT02912455|588852863|FG001|Overall Study|Withdrawal by Subject|1|||
163039877|NCT02912455|588852862|FG000|Overall Study|Lack of Efficacy|0|||
163039878|NCT02912455|588852863|FG001|Overall Study|Lack of Efficacy|1|||
163039879|NCT02912455|588852862|FG000|Overall Study|Lost to Follow-up|2|||
163039880|NCT02912455|588852863|FG001|Overall Study|Lost to Follow-up|1|||
163039881|NCT00073008|588852864|FG000|Overall Study|Missing|6|||
163039882|NCT00073008|588852865|FG001|Overall Study|Missing|6|||
163039883|NCT00073008|588852864|FG000|Overall Study|Withdrawal by Subject|2|||
163039884|NCT00073008|588852865|FG001|Overall Study|Withdrawal by Subject|2|||
163039885|NCT00073008|588852864|FG000|Overall Study|Lost to Follow-up|1|||
163039886|NCT00073008|588852865|FG001|Overall Study|Lost to Follow-up|3|||
163039887|NCT00073008|588852864|FG000|Overall Study|Death|46|||
163039888|NCT00073008|588852865|FG001|Overall Study|Death|47|||
163039889|NCT00073008|588852864|FG000|Overall Study|"Other selected on Case Report Form"|7|||
163039890|NCT00073008|588852865|FG001|Overall Study|"Other selected on Case Report Form"|5|||
163039891|NCT01778751|588852875|FG000|Overall Study|Lost to Follow-up|1|||
163039892|NCT01778751|588852876|FG001|Overall Study|Lost to Follow-up|0|||
163039893|NCT01778751|588852875|FG000|Overall Study|Withdrawal by Subject|0|||
163039894|NCT01778751|588852876|FG001|Overall Study|Withdrawal by Subject|2|||
163039895|NCT01778751|588852875|FG000|Overall Study|Transfered care|1|||
163039896|NCT01778751|588852876|FG001|Overall Study|Transfered care|0|||
163039897|NCT03337048|588852877|FG000|Overall Study|Withdrawal by Subject|2|||
163039898|NCT03337048|588852878|FG001|Overall Study|Withdrawal by Subject|0|||
163039899|NCT03337048|588852879|FG002|Overall Study|Withdrawal by Subject|0|||
163039900|NCT02669667|588852880|FG000|Overall Study|Lost to Follow-up|0|||
162664470|NCT02610140|587482960|FG001|Randomization and Treatment Period|Radiological progression|15|||
162664471|NCT02610140|587482959|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
162664472|NCT02610140|587482960|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
163146419|NCT04607668|589246204|FG001|Overall Study|Study terminated by Sponsor|114|||
163146420|NCT04607668|589246203|FG000|Overall Study|Withdrawal by Subject|12|||
163146421|NCT04607668|589246204|FG001|Overall Study|Withdrawal by Subject|11|||
163146422|NCT04607668|589246203|FG000|Overall Study|Other, unspecified|8|||
163146423|NCT04607668|589246204|FG001|Overall Study|Other, unspecified|7|||
163146424|NCT02250326|589246205|FG000|Treatment|Death|1|||
163146425|NCT02250326|589246206|FG001|Treatment|Death|13|||
163146426|NCT02250326|589246207|FG002|Treatment|Death|2|||
163146427|NCT02250326|589246205|FG000|Treatment|Adverse Event|8|||
163146428|NCT02250326|589246206|FG001|Treatment|Adverse Event|8|||
163146429|NCT02250326|589246207|FG002|Treatment|Adverse Event|9|||
163146430|NCT02250326|589246205|FG000|Treatment|Progressive Disease|42|||
163039901|NCT02669667|588852881|FG001|Overall Study|Lost to Follow-up|0|||
163039902|NCT02669667|588852882|FG002|Overall Study|Lost to Follow-up|0|||
163039903|NCT02669667|588852883|FG003|Overall Study|Lost to Follow-up|0|||
163039904|NCT02669667|588852884|FG004|Overall Study|Lost to Follow-up|0|||
163039905|NCT02669667|588852885|FG005|Overall Study|Lost to Follow-up|1|||
163039906|NCT02669667|588852886|FG006|Overall Study|Lost to Follow-up|0|||
163146431|NCT02250326|589246206|FG001|Treatment|Progressive Disease|40|||
163146432|NCT02250326|589246207|FG002|Treatment|Progressive Disease|47|||
163146433|NCT02250326|589246205|FG000|Treatment|Symptomatic Deterioration|9|||
163146434|NCT02250326|589246206|FG001|Treatment|Symptomatic Deterioration|4|||
162664473|NCT02610140|587482959|FG000|Randomization and Treatment Period|Protocol Violation|1|||
162664474|NCT02610140|587482960|FG001|Randomization and Treatment Period|Protocol Violation|0|||
162664475|NCT02610140|587482959|FG000|Randomization and Treatment Period|Physician Decision|0|||
163146435|NCT02250326|589246207|FG002|Treatment|Symptomatic Deterioration|10|||
163146436|NCT02250326|589246205|FG000|Treatment|Withdrawal by Subject|11|||
163146437|NCT02250326|589246206|FG001|Treatment|Withdrawal by Subject|6|||
163146438|NCT02250326|589246207|FG002|Treatment|Withdrawal by Subject|4|||
163146439|NCT02250326|589246205|FG000|Treatment|Other reasons|8|||
163146440|NCT02250326|589246206|FG001|Treatment|Other reasons|7|||
163146441|NCT02250326|589246207|FG002|Treatment|Other reasons|7|||
163146442|NCT02250326|589246205|FG000|Extension Period|Progressive Disease|0|||
162664476|NCT02610140|587482960|FG001|Randomization and Treatment Period|Physician Decision|1|||
162664477|NCT02610140|587482959|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
162664478|NCT02610140|587482960|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
162664479|NCT02610140|587482959|FG000|Randomization and Treatment Period|Death|7|||
162664480|NCT02610140|587482960|FG001|Randomization and Treatment Period|Death|1|||
162664481|NCT02610140|587482959|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
162664482|NCT02610140|587482960|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
163039907|NCT00636961|588852894|FG000|Period 1|Administrative problems|1|||
163039908|NCT00636961|588852895|FG001|Period 1|Administrative problems|1|||
163039909|NCT00636961|588852894|FG000|Period 2|Adverse Event|1|||
163039910|NCT00636961|588852895|FG001|Period 2|Adverse Event|0|||
163146443|NCT02250326|589246206|FG001|Extension Period|Progressive Disease|2|||
163146444|NCT02250326|589246207|FG002|Extension Period|Progressive Disease|0|||
163146445|NCT02250326|589246205|FG000|Extension Period|Withdrawal by Subject|0|||
163146446|NCT02250326|589246206|FG001|Extension Period|Withdrawal by Subject|1|||
163146447|NCT02250326|589246207|FG002|Extension Period|Withdrawal by Subject|0|||
163146448|NCT02250326|589246205|FG000|Extension Period|Withdrawal by investigator|0|||
163039911|NCT01428115|588852899|FG000|Overall Study|Lack of Efficacy|3|||
163039912|NCT01428115|588852899|FG000|Overall Study|Lost to Follow-up|10|||
163039913|NCT01428115|588852899|FG000|Overall Study|Pregnancy|1|||
163039914|NCT01428115|588852899|FG000|Overall Study|Protocol Violation|3|||
163039915|NCT01428115|588852899|FG000|Overall Study|Withdrawal by Subject|4|||
163039916|NCT03755518|588852900|FG000|Overall Study|Lack of Efficacy|10|||
163039917|NCT03755518|588852900|FG000|Overall Study|Adverse Event|7|||
163039918|NCT03755518|588852900|FG000|Overall Study|Study Terminated by Sponsor|5|||
163039919|NCT03755518|588852900|FG000|Overall Study|Death|1|||
163039920|NCT03755518|588852900|FG000|Overall Study|Withdrawal by Subject|3|||
163039921|NCT03755518|588852900|FG000|Overall Study|Progressive Disease|4|||
163039922|NCT03755518|588852900|FG000|Overall Study|Bone Marrow Transplant|4|||
163039923|NCT03755518|588852900|FG000|Overall Study|Physicians Decision|1|||
163039924|NCT03755518|588852900|FG000|Overall Study|Relapse|1|||
163039925|NCT03755518|588852900|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
163039926|NCT03755518|588852900|FG000|Overall Study|Withdrawal by PI|1|||
163039927|NCT01714609|588852901|FG000|Overall Study|Protocol Violation|1|||
163039928|NCT01714609|588852902|FG001|Overall Study|Protocol Violation|0|||
163039929|NCT03403621|588852903|FG000|Overall Study|Withdrawal by Subject|2|||
163039930|NCT03403621|588852904|FG001|Overall Study|Withdrawal by Subject|2|||
163039931|NCT00395642|588852905|FG000|Overall Study|Death|4|||
163039932|NCT00395642|588852905|FG000|Overall Study|Lost to Follow-up|1|||
163039933|NCT00395642|588852905|FG000|Overall Study|Physician Decision|7|||
163039934|NCT00395642|588852905|FG000|Overall Study|Withdrawal by Subject|1|||
163039935|NCT00659776|588852910|FG000|Overall Study|Withdrawal by Subject|12|||
163039936|NCT00659776|588852911|FG001|Overall Study|Withdrawal by Subject|2|||
163039937|NCT00659776|588852912|FG002|Overall Study|Withdrawal by Subject|0|||
163039938|NCT01738191|588852915|FG000|Overall Study|Withdrawal by Subject|4|||
163039939|NCT01738191|588852916|FG001|Overall Study|Withdrawal by Subject|1|||
163039940|NCT02483572|588852917|FG000|Overall Study|Withdrawal by Subject|1|||
163039941|NCT02483572|588852918|FG001|Overall Study|Withdrawal by Subject|0|||
163039942|NCT02483572|588852917|FG000|Overall Study|Lost to Follow-up|1|||
163039943|NCT02483572|588852918|FG001|Overall Study|Lost to Follow-up|0|||
163039944|NCT02483572|588852917|FG000|Overall Study|Physician Decision|0|||
163039945|NCT02483572|588852918|FG001|Overall Study|Physician Decision|1|||
163039946|NCT01451554|588852919|FG000|Overall Study|Withdrawal by Subject|14|||
163039947|NCT01451554|588852920|FG001|Overall Study|Withdrawal by Subject|9|||
162664483|NCT02610140|587482959|FG000|Randomization and Treatment Period|Adverse Event|44|||
162664484|NCT02610140|587482960|FG001|Randomization and Treatment Period|Adverse Event|13|||
162664485|NCT02610140|587482959|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
162664486|NCT02610140|587482960|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
162664487|NCT02610140|587482959|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
162664488|NCT02610140|587482960|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
162664489|NCT02610140|587482959|FG000|Randomization and Treatment Period|Not treated|3|||
162664490|NCT02610140|587482960|FG001|Randomization and Treatment Period|Not treated|10|||
162664491|NCT02610140|587482959|FG000|Safety Follow-up|Other|0|||
162664492|NCT02610140|587482960|FG001|Safety Follow-up|Other|2|||
162664493|NCT02610140|587482959|FG000|Safety Follow-up|Lost to Follow-up|1|||
162664494|NCT02610140|587482960|FG001|Safety Follow-up|Lost to Follow-up|0|||
162664495|NCT02610140|587482959|FG000|Safety Follow-up|No follow-up|5|||
162664496|NCT02610140|587482960|FG001|Safety Follow-up|No follow-up|3|||
162664497|NCT02610140|587482959|FG000|Safety Follow-up|Death|12|||
162664498|NCT02610140|587482960|FG001|Safety Follow-up|Death|2|||
162664499|NCT02610140|587482959|FG000|Safety Follow-up|Deterioration of general conditions|15|||
162664500|NCT02610140|587482960|FG001|Safety Follow-up|Deterioration of general conditions|5|||
162664501|NCT02610140|587482959|FG000|Safety Follow-up|Withdrawal by Subject|12|||
162664502|NCT02610140|587482960|FG001|Safety Follow-up|Withdrawal by Subject|12|||
162664503|NCT02610140|587482959|FG000|Active Follow-up|Progressive disease - radiological|30|||
162664504|NCT02610140|587482960|FG001|Active Follow-up|Progressive disease - radiological|22|||
162664505|NCT02610140|587482959|FG000|Active Follow-up|Death|8|||
162664506|NCT02610140|587482960|FG001|Active Follow-up|Death|1|||
162664507|NCT02610140|587482959|FG000|Active Follow-up|Withdrawal by Subject|4|||
162664508|NCT02610140|587482960|FG001|Active Follow-up|Withdrawal by Subject|0|||
162664509|NCT02610140|587482959|FG000|Active Follow-up|Progressive disease - clinical|1|||
162664510|NCT02610140|587482960|FG001|Active Follow-up|Progressive disease - clinical|2|||
162664511|NCT02610140|587482959|FG000|Active Follow-up|Deterioration of general conditions|1|||
162664512|NCT02610140|587482960|FG001|Active Follow-up|Deterioration of general conditions|0|||
162664513|NCT02610140|587482959|FG000|Active Follow-up|Ongoing but not completed|4|||
162664514|NCT02610140|587482960|FG001|Active Follow-up|Ongoing but not completed|1|||
162664515|NCT02610140|587482959|FG000|Long-term Follow-up|Death|86|||
162664516|NCT02610140|587482960|FG001|Long-term Follow-up|Death|44|||
162664517|NCT02610140|587482959|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
162664518|NCT02610140|587482960|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
162664519|NCT02610140|587482959|FG000|Long-term Follow-up|Lost to Follow-up|1|||
162664520|NCT02610140|587482960|FG001|Long-term Follow-up|Lost to Follow-up|2|||
162664521|NCT02610140|587482959|FG000|Long-term Follow-up|Ongoing but not completed|30|||
162664522|NCT02610140|587482960|FG001|Long-term Follow-up|Ongoing but not completed|17|||
162664523|NCT00887341|587482961|FG000|Overall Study|Refused treatment|1|||
162664524|NCT00887341|587482962|FG001|Overall Study|Refused treatment|0|||
162664525|NCT00887341|587482961|FG000|Overall Study|Withdrawal by Subject|1|||
162664526|NCT00887341|587482962|FG001|Overall Study|Withdrawal by Subject|1|||
162664527|NCT00887341|587482961|FG000|Overall Study|Adverse Event|0|||
162664528|NCT00887341|587482962|FG001|Overall Study|Adverse Event|1|||
162664529|NCT00887341|587482961|FG000|Overall Study|Lost to Follow-up|0|||
162664530|NCT00887341|587482962|FG001|Overall Study|Lost to Follow-up|1|||
162664531|NCT01752933|587482965|FG000|Treatment|Disease Progression|3|||
162664532|NCT01752933|587482966|FG001|Treatment|Disease Progression|29|||
162664533|NCT01752933|587482965|FG000|Treatment|Withdrawal by Subject|0|||
162664534|NCT01752933|587482966|FG001|Treatment|Withdrawal by Subject|5|||
162664535|NCT01752933|587482965|FG000|Treatment|Adverse Event|1|||
162664536|NCT01752933|587482966|FG001|Treatment|Adverse Event|4|||
162664537|NCT01752933|587482965|FG000|Treatment|Physician Decision|0|||
162664538|NCT01752933|587482966|FG001|Treatment|Physician Decision|3|||
162664539|NCT01752933|587482965|FG000|Treatment|Death|0|||
162664540|NCT01752933|587482966|FG001|Treatment|Death|2|||
162664541|NCT01752933|587482965|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
162664542|NCT01752933|587482966|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
162664543|NCT01752933|587482965|FG000|Treatment|Patient noncompliant|0|||
162664544|NCT01752933|587482966|FG001|Treatment|Patient noncompliant|1|||
162664545|NCT01752933|587482965|FG000|Treatment|Patient unable to travel to appointments|0|||
162664546|NCT01752933|587482966|FG001|Treatment|Patient unable to travel to appointments|1|||
162664547|NCT01752933|587482965|FG000|Overall Study and Follow-up|Death|4|||
162664548|NCT01752933|587482966|FG001|Overall Study and Follow-up|Death|34|||
162664549|NCT01752933|587482965|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
162664550|NCT01752933|587482966|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
162664551|NCT01752933|587482965|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
162664552|NCT01752933|587482966|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
162664553|NCT01752933|587482965|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
162664554|NCT01752933|587482966|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
162664555|NCT01591681|587482967|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
162664556|NCT01591681|587482967|FG000|Overall Study|Failed to use system during run-in|1|||
162664557|NCT05402995|587482969|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
162664558|NCT05402995|587482970|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162664559|NCT05402995|587482971|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162664560|NCT05402995|587482972|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162664561|NCT01337297|587482975|FG000|Overall Study|They entered to single anodal tDCS|4|||
162664562|NCT01337297|587482976|FG001|Overall Study|They entered to single anodal tDCS|3|||
162664563|NCT01337297|587482975|FG000|Overall Study|Lost to Follow-up|1|||
162664564|NCT01337297|587482976|FG001|Overall Study|Lost to Follow-up|3|||
162664565|NCT01800903|587482977|FG000|Second Test Period|unable to catheterise|1|||
162664566|NCT01800903|587482978|FG001|Second Test Period|unable to catheterise|0|||
162664567|NCT01800903|587482979|FG002|Second Test Period|unable to catheterise|0|||
162664568|NCT01800903|587482980|FG003|Second Test Period|unable to catheterise|0|||
162664569|NCT01800903|587482981|FG004|Second Test Period|unable to catheterise|0|||
162664570|NCT01800903|587482982|FG005|Second Test Period|unable to catheterise|0|||
162664571|NCT01306617|587482983|FG000|Overall Study|Adverse Event|1|||
162664572|NCT01306617|587482984|FG001|Overall Study|Adverse Event|0|||
162664573|NCT01306617|587482985|FG002|Overall Study|Adverse Event|0|||
162664574|NCT01306617|587482983|FG000|Overall Study|Virologic Failure|0|||
162664575|NCT01306617|587482984|FG001|Overall Study|Virologic Failure|0|||
162664576|NCT01306617|587482985|FG002|Overall Study|Virologic Failure|5|||
162664577|NCT01306617|587482983|FG000|Overall Study|Non-compliance|0|||
162664578|NCT01306617|587482984|FG001|Overall Study|Non-compliance|1|||
162664579|NCT01306617|587482985|FG002|Overall Study|Non-compliance|0|||
162664580|NCT01208233|587482986|FG000|Overall Study|Adverse Event|0|||
162664581|NCT01208233|587482987|FG001|Overall Study|Adverse Event|1|||
162664582|NCT01208233|587482988|FG002|Overall Study|Adverse Event|2|||
162664583|NCT01208233|587482989|FG003|Overall Study|Adverse Event|0|||
162664584|NCT01208233|587482990|FG004|Overall Study|Adverse Event|3|||
162664585|NCT01208233|587482991|FG005|Overall Study|Adverse Event|5|||
162664586|NCT01208233|587482986|FG000|Overall Study|Death|0|||
162664587|NCT01208233|587482987|FG001|Overall Study|Death|0|||
162664588|NCT01208233|587482988|FG002|Overall Study|Death|0|||
162664589|NCT01208233|587482989|FG003|Overall Study|Death|0|||
162664590|NCT01208233|587482990|FG004|Overall Study|Death|3|||
162664591|NCT01208233|587482991|FG005|Overall Study|Death|5|||
162664592|NCT01208233|587482986|FG000|Overall Study|Did not meet entrance criteria|2|||
162664593|NCT01208233|587482987|FG001|Overall Study|Did not meet entrance criteria|1|||
162664594|NCT01208233|587482988|FG002|Overall Study|Did not meet entrance criteria|1|||
162664595|NCT01208233|587482989|FG003|Overall Study|Did not meet entrance criteria|0|||
162664596|NCT01208233|587482990|FG004|Overall Study|Did not meet entrance criteria|1|||
162664597|NCT01208233|587482991|FG005|Overall Study|Did not meet entrance criteria|0|||
162664598|NCT01208233|587482986|FG000|Overall Study|Medication error without adverse event|0|||
162664599|NCT01208233|587482987|FG001|Overall Study|Medication error without adverse event|0|||
162664600|NCT01208233|587482988|FG002|Overall Study|Medication error without adverse event|0|||
162664601|NCT01208233|587482989|FG003|Overall Study|Medication error without adverse event|0|||
162664602|NCT01208233|587482990|FG004|Overall Study|Medication error without adverse event|0|||
162664603|NCT01208233|587482991|FG005|Overall Study|Medication error without adverse event|1|||
162664604|NCT01208233|587482986|FG000|Overall Study|Study terminated by sponsor|0|||
162664605|NCT01208233|587482987|FG001|Overall Study|Study terminated by sponsor|0|||
162664606|NCT01208233|587482988|FG002|Overall Study|Study terminated by sponsor|0|||
162664607|NCT01208233|587482989|FG003|Overall Study|Study terminated by sponsor|0|||
162664608|NCT01208233|587482990|FG004|Overall Study|Study terminated by sponsor|10|||
162664609|NCT01208233|587482991|FG005|Overall Study|Study terminated by sponsor|7|||
162664610|NCT01208233|587482986|FG000|Overall Study|Protocol Violation|0|||
162664611|NCT01208233|587482987|FG001|Overall Study|Protocol Violation|0|||
162664612|NCT01208233|587482988|FG002|Overall Study|Protocol Violation|0|||
162664613|NCT01208233|587482989|FG003|Overall Study|Protocol Violation|0|||
162664614|NCT01208233|587482990|FG004|Overall Study|Protocol Violation|3|||
162664615|NCT01208233|587482991|FG005|Overall Study|Protocol Violation|0|||
162664616|NCT01208233|587482986|FG000|Overall Study|Other|2|||
162664617|NCT01208233|587482987|FG001|Overall Study|Other|1|||
162664618|NCT01208233|587482988|FG002|Overall Study|Other|0|||
162664619|NCT01208233|587482989|FG003|Overall Study|Other|0|||
162664620|NCT01208233|587482990|FG004|Overall Study|Other|0|||
162664621|NCT01208233|587482991|FG005|Overall Study|Other|1|||
162664622|NCT01208233|587482986|FG000|Overall Study|Withdrawal by Subject|1|||
162664623|NCT01208233|587482987|FG001|Overall Study|Withdrawal by Subject|0|||
162664624|NCT01208233|587482988|FG002|Overall Study|Withdrawal by Subject|1|||
162664625|NCT01208233|587482989|FG003|Overall Study|Withdrawal by Subject|1|||
162664626|NCT01208233|587482990|FG004|Overall Study|Withdrawal by Subject|4|||
162664627|NCT01208233|587482991|FG005|Overall Study|Withdrawal by Subject|2|||
162664628|NCT04028388|587482996|FG000|Overall Study|Evaluations missing|3|||
162664629|NCT04028388|587482997|FG001|Overall Study|Evaluations missing|6|||
162664630|NCT04028388|587482996|FG000|Overall Study|Not started|2|||
162664631|NCT04028388|587482997|FG001|Overall Study|Not started|0|||
162664632|NCT00129259|587483004|FG000|Overall Study|Lost to Follow-up|1|||
162664633|NCT00129259|587483005|FG001|Overall Study|Lost to Follow-up|1|||
163146449|NCT02250326|589246206|FG001|Extension Period|Withdrawal by investigator|1|||
163146450|NCT02250326|589246207|FG002|Extension Period|Withdrawal by investigator|0|||
163146451|NCT00962208|589246208|FG000|Overall Study|Could not achieve good vision|9|||
163146452|NCT00962208|589246209|FG001|Overall Study|Could not achieve good vision|0|||
163146453|NCT00962208|589246208|FG000|Overall Study|Contraindicated to continue study|5|||
163146454|NCT00962208|589246209|FG001|Overall Study|Contraindicated to continue study|1|||
163146455|NCT00962208|589246208|FG000|Overall Study|Lost to Follow-up|0|||
163146456|NCT00962208|589246209|FG001|Overall Study|Lost to Follow-up|9|||
163146457|NCT03010527|589246211|FG000|Overall Study|Death|0|||
163146458|NCT03010527|589246212|FG001|Overall Study|Death|0|||
163146459|NCT03010527|589246213|FG002|Overall Study|Death|1|||
163146460|NCT03010527|589246211|FG000|Overall Study|Adverse Event|0|||
163146461|NCT03010527|589246212|FG001|Overall Study|Adverse Event|4|||
163146462|NCT03010527|589246213|FG002|Overall Study|Adverse Event|2|||
163146463|NCT03010527|589246211|FG000|Overall Study|Protocol Violation|0|||
163146464|NCT03010527|589246212|FG001|Overall Study|Protocol Violation|1|||
163146465|NCT03010527|589246213|FG002|Overall Study|Protocol Violation|0|||
163146466|NCT03010527|589246211|FG000|Overall Study|Lost to Follow-up|0|||
163146467|NCT03010527|589246212|FG001|Overall Study|Lost to Follow-up|2|||
163146468|NCT03010527|589246213|FG002|Overall Study|Lost to Follow-up|1|||
163146469|NCT03010527|589246211|FG000|Overall Study|Withdrawal by Subject|0|||
163146470|NCT03010527|589246212|FG001|Overall Study|Withdrawal by Subject|3|||
163146471|NCT03010527|589246213|FG002|Overall Study|Withdrawal by Subject|4|||
163146472|NCT03010527|589246211|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
163146473|NCT03010527|589246212|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
163146474|NCT03010527|589246213|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
163146475|NCT03010527|589246211|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
163146476|NCT03010527|589246212|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
163146477|NCT03010527|589246213|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
163146478|NCT03010527|589246211|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
163146479|NCT03010527|589246212|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
163146480|NCT03010527|589246213|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
163146481|NCT02469623|589246214|FG000|Overall Study|Not consented for long-term follow-up|4|||
163146482|NCT02469623|589246214|FG000|Overall Study|Lost to Follow-up|4|||
163146483|NCT02469623|589246214|FG000|Overall Study|Withdrawal by Subject|2|||
163146484|NCT02469623|589246214|FG000|Overall Study|Death|3|||
163146485|NCT04073186|589246215|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
163146486|NCT04073186|589246215|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
163146487|NCT04073186|589246215|FG000|First Wearing Cycle|Protocol Violation|1|||
163146488|NCT04073186|589246215|FG000|First Wearing Cycle|Lens Discomfort|2|||
163146489|NCT04073186|589246215|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
163146490|NCT04073186|589246215|FG000|Second Wearing Cycle|Adverse Event|1|||
163146491|NCT01096316|589246216|FG000|Overall Study|Lost to Follow-up|15|||
163146492|NCT01096316|589246217|FG001|Overall Study|Lost to Follow-up|9|||
163146493|NCT00473434|589246218|FG000|Overall Study|Physician Decision|3|||
163146494|NCT00473434|589246218|FG000|Overall Study|Withdrawal by Subject|9|||
163146495|NCT00473434|589246218|FG000|Overall Study|Compliance|3|||
163146496|NCT00473434|589246218|FG000|Overall Study|Lack of Efficacy|3|||
163146497|NCT00473434|589246218|FG000|Overall Study|Adverse Event|3|||
163146498|NCT00473434|589246218|FG000|Overall Study|Patient was selling medication to others|1|||
163146499|NCT00473434|589246218|FG000|Overall Study|Safety evaluation|1|||
163146500|NCT00473434|589246218|FG000|Overall Study|Reason not specified|6|||
163146501|NCT00473434|589246218|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
162664634|NCT00129259|587483004|FG000|Overall Study|Withdrawal by Subject|2|||
162664635|NCT00129259|587483005|FG001|Overall Study|Withdrawal by Subject|1|||
162664636|NCT00129259|587483004|FG000|Overall Study|Only available minimal phone assessments|0|||
162664637|NCT00129259|587483005|FG001|Overall Study|Only available minimal phone assessments|1|||
162664638|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664639|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664640|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664641|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664642|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
163146502|NCT00473434|589246218|FG000|Overall Study|Switching to trial medication|1|||
163146503|NCT00473434|589246218|FG000|Overall Study|No longer required|1|||
163146504|NCT06418152|589246220|FG000|Overall Study|Frequent DBS setting changes|1|||
163146505|NCT06418152|589246220|FG000|Overall Study|Withdrawal by Subject|2|||
163146506|NCT02529852|589246223|FG000|Overall Study|Withdrawal by Subject|2|||
163146507|NCT02055898|589246224|FG000|First Intervention (5 Days)|Physician Decision|2|||
163146508|NCT02055898|589246225|FG001|First Intervention (5 Days)|Physician Decision|0|||
163146509|NCT02055898|589246224|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
163146510|NCT02055898|589246225|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
163146511|NCT02201524|589246227|FG000|Overall Study|Adverse Event|0|||
163146512|NCT02201524|589246228|FG001|Overall Study|Adverse Event|2|||
163146513|NCT02201524|589246229|FG002|Overall Study|Adverse Event|1|||
162664643|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664644|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664645|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162664646|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162664647|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664648|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162664649|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162664650|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664651|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664652|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664653|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162664654|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162664655|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162664656|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162664657|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162664658|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
162664659|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
162664660|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
162664661|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
162664662|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162664663|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162664664|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
162664665|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162664666|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162664667|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162664668|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162664669|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162664670|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664671|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664672|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664673|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664674|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664675|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162664676|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162664677|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664678|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664679|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
162664680|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
162664681|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162664682|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664683|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664684|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664685|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162664686|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664687|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664688|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664689|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664690|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664691|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
162664692|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664693|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664694|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664695|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664696|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664697|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
162664698|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664699|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664700|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664701|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162664702|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664703|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664704|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664705|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664706|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664707|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
162664708|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664709|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664710|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664711|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664712|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664713|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664714|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664715|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664716|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664717|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162664718|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664719|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664720|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664721|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664722|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664723|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664724|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664725|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664726|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
162664727|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664728|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664729|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664730|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664731|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664732|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664733|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162664734|NCT01609556|587483006|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
162664735|NCT01609556|587483007|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664736|NCT01609556|587483008|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664737|NCT01609556|587483009|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664738|NCT01609556|587483010|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664739|NCT01609556|587483011|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
162664740|NCT01609556|587483012|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664741|NCT01609556|587483013|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664742|NCT01609556|587483014|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664743|NCT01609556|587483015|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664744|NCT01609556|587483016|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
162664745|NCT01609556|587483017|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664746|NCT01609556|587483018|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664747|NCT01609556|587483019|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664748|NCT01609556|587483020|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664749|NCT01609556|587483021|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162664750|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664751|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664752|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664753|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664754|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664755|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664756|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664757|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664758|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664759|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664760|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664761|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162664762|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
162664763|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162664764|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162664765|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162664766|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664767|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664768|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664769|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664770|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664771|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664772|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664773|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664774|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664775|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664776|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664777|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162664778|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
162664779|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
162664780|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
162664781|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
162664782|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664783|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664784|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664785|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664786|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664787|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664788|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664789|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664790|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664791|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664792|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162664793|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162721380|NCT01135511|587688293|FG004|Overall Study|Lack of Efficacy|0|||
162721381|NCT01135511|587688294|FG005|Overall Study|Lack of Efficacy|0|||
162721382|NCT01135511|587688295|FG006|Overall Study|Lack of Efficacy|0|||
162721383|NCT01135511|587688296|FG007|Overall Study|Lack of Efficacy|0|||
162721384|NCT01135511|587688297|FG008|Overall Study|Lack of Efficacy|0|||
162721385|NCT01135511|587688289|FG000|Overall Study|Protocol Violation|0|||
162721386|NCT01135511|587688290|FG001|Overall Study|Protocol Violation|0|||
162721387|NCT01135511|587688291|FG002|Overall Study|Protocol Violation|3|||
162721388|NCT01135511|587688292|FG003|Overall Study|Protocol Violation|0|||
162721389|NCT01135511|587688293|FG004|Overall Study|Protocol Violation|0|||
162721390|NCT01135511|587688294|FG005|Overall Study|Protocol Violation|0|||
162721391|NCT01135511|587688295|FG006|Overall Study|Protocol Violation|0|||
162721392|NCT01135511|587688296|FG007|Overall Study|Protocol Violation|0|||
162721393|NCT01135511|587688297|FG008|Overall Study|Protocol Violation|0|||
162721394|NCT01135511|587688289|FG000|Overall Study|Pregnancy|0|||
162721395|NCT01135511|587688290|FG001|Overall Study|Pregnancy|0|||
162721396|NCT01135511|587688291|FG002|Overall Study|Pregnancy|0|||
162721397|NCT01135511|587688292|FG003|Overall Study|Pregnancy|1|||
162721398|NCT01135511|587688293|FG004|Overall Study|Pregnancy|0|||
162721399|NCT01135511|587688294|FG005|Overall Study|Pregnancy|0|||
162721400|NCT01135511|587688295|FG006|Overall Study|Pregnancy|0|||
162721401|NCT01135511|587688296|FG007|Overall Study|Pregnancy|0|||
162721402|NCT01135511|587688297|FG008|Overall Study|Pregnancy|0|||
162721403|NCT01135511|587688289|FG000|Overall Study|could not visit the clinic|0|||
162721404|NCT01135511|587688290|FG001|Overall Study|could not visit the clinic|1|||
162721405|NCT01135511|587688291|FG002|Overall Study|could not visit the clinic|2|||
162721406|NCT01135511|587688292|FG003|Overall Study|could not visit the clinic|0|||
162721407|NCT01135511|587688293|FG004|Overall Study|could not visit the clinic|0|||
162721408|NCT01135511|587688294|FG005|Overall Study|could not visit the clinic|0|||
162721409|NCT01135511|587688295|FG006|Overall Study|could not visit the clinic|0|||
162721410|NCT01135511|587688296|FG007|Overall Study|could not visit the clinic|0|||
162721411|NCT01135511|587688297|FG008|Overall Study|could not visit the clinic|0|||
162721412|NCT01135511|587688289|FG000|Overall Study|noncompliance with study drug taken|0|||
162721413|NCT01135511|587688290|FG001|Overall Study|noncompliance with study drug taken|0|||
162721414|NCT01135511|587688291|FG002|Overall Study|noncompliance with study drug taken|0|||
162721415|NCT01135511|587688292|FG003|Overall Study|noncompliance with study drug taken|0|||
162721416|NCT01135511|587688293|FG004|Overall Study|noncompliance with study drug taken|1|||
162721417|NCT01135511|587688294|FG005|Overall Study|noncompliance with study drug taken|0|||
162721418|NCT01135511|587688295|FG006|Overall Study|noncompliance with study drug taken|0|||
162721419|NCT01135511|587688296|FG007|Overall Study|noncompliance with study drug taken|0|||
162721420|NCT01135511|587688297|FG008|Overall Study|noncompliance with study drug taken|0|||
162721421|NCT01135511|587688289|FG000|Overall Study|Withdrawal by Subject|0|||
162721422|NCT01135511|587688290|FG001|Overall Study|Withdrawal by Subject|0|||
162721423|NCT01135511|587688291|FG002|Overall Study|Withdrawal by Subject|0|||
162721424|NCT01135511|587688292|FG003|Overall Study|Withdrawal by Subject|0|||
162721425|NCT01135511|587688293|FG004|Overall Study|Withdrawal by Subject|0|||
162664794|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162664795|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162664796|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162664797|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
162721426|NCT01135511|587688294|FG005|Overall Study|Withdrawal by Subject|0|||
162721427|NCT01135511|587688295|FG006|Overall Study|Withdrawal by Subject|1|||
162664798|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664799|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664800|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664801|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664802|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162721428|NCT01135511|587688296|FG007|Overall Study|Withdrawal by Subject|0|||
162721429|NCT01135511|587688297|FG008|Overall Study|Withdrawal by Subject|1|||
162721430|NCT02425111|587688303|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
162721431|NCT02425111|587688303|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
162721432|NCT02425111|587688303|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
162721433|NCT02425111|587688303|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
162721434|NCT02425111|587688303|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
162721435|NCT02425111|587688303|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
162721436|NCT03482011|587688307|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
162721437|NCT03482011|587688308|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
162721438|NCT03482011|587688309|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
162721439|NCT03482011|587688310|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
162721440|NCT03482011|587688311|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
162721441|NCT03482011|587688312|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
162721442|NCT03482011|587688313|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
162721443|NCT03482011|587688314|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
162721444|NCT03482011|587688307|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
162721445|NCT03482011|587688308|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
162721446|NCT03482011|587688309|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721447|NCT03482011|587688310|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721448|NCT03482011|587688311|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721449|NCT03482011|587688312|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721450|NCT03482011|587688313|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721451|NCT03482011|587688314|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162721452|NCT03482011|587688307|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721453|NCT03482011|587688308|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
162721454|NCT03482011|587688309|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721455|NCT03482011|587688310|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721456|NCT03482011|587688311|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721457|NCT03482011|587688312|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721458|NCT03482011|587688313|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162721459|NCT03482011|587688314|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162664803|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664804|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664805|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664806|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664807|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664808|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664809|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664810|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
162664811|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664812|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664813|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162664814|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664815|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664816|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664817|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664818|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664819|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664820|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664821|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664822|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664823|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664824|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664825|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162664826|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
162664827|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
162664828|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
162664829|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
162664830|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664831|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664832|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163146514|NCT02201524|589246230|FG003|Overall Study|Adverse Event|0|||
163146515|NCT02201524|589246227|FG000|Overall Study|Insufficient clinical response|1|||
163146516|NCT02201524|589246228|FG001|Overall Study|Insufficient clinical response|0|||
163146517|NCT02201524|589246229|FG002|Overall Study|Insufficient clinical response|0|||
163146518|NCT02201524|589246230|FG003|Overall Study|Insufficient clinical response|0|||
163146519|NCT02201524|589246227|FG000|Overall Study|Lost to Follow-up|0|||
163146520|NCT02201524|589246228|FG001|Overall Study|Lost to Follow-up|0|||
163146521|NCT02201524|589246229|FG002|Overall Study|Lost to Follow-up|2|||
163146522|NCT02201524|589246230|FG003|Overall Study|Lost to Follow-up|0|||
163146523|NCT02201524|589246227|FG000|Overall Study|No longer meets eligibility criteria|0|||
163146524|NCT02201524|589246228|FG001|Overall Study|No longer meets eligibility criteria|0|||
163146525|NCT02201524|589246229|FG002|Overall Study|No longer meets eligibility criteria|0|||
163146526|NCT02201524|589246230|FG003|Overall Study|No longer meets eligibility criteria|2|||
163146527|NCT02201524|589246227|FG000|Overall Study|Protocol Violation|0|||
163146528|NCT02201524|589246228|FG001|Overall Study|Protocol Violation|0|||
163146529|NCT02201524|589246229|FG002|Overall Study|Protocol Violation|0|||
163146530|NCT02201524|589246230|FG003|Overall Study|Protocol Violation|1|||
163146531|NCT02201524|589246227|FG000|Overall Study|Withdrawal by Subject|0|||
163146532|NCT02201524|589246228|FG001|Overall Study|Withdrawal by Subject|0|||
163146533|NCT02201524|589246229|FG002|Overall Study|Withdrawal by Subject|1|||
163146534|NCT02201524|589246230|FG003|Overall Study|Withdrawal by Subject|1|||
163146535|NCT02201524|589246227|FG000|Overall Study|Other|1|||
163146536|NCT02201524|589246228|FG001|Overall Study|Other|1|||
163146537|NCT02201524|589246229|FG002|Overall Study|Other|0|||
163146538|NCT02201524|589246230|FG003|Overall Study|Other|0|||
163146539|NCT03206216|589246235|FG000|Overall Study|Withdrawal by Subject|0|||
163146540|NCT03206216|589246236|FG001|Overall Study|Withdrawal by Subject|1|||
163146541|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
163146542|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
163146543|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
163146544|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
163146545|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
163146546|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
163146547|NCT00097500|589246239|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
163146548|NCT00097500|589246240|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
163146549|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
163146550|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
163146551|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
163146552|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
163146553|NCT00097500|589246239|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
163146554|NCT00097500|589246240|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
163146555|NCT01553084|589246245|FG000|Overall Study|Withdrawal by Subject|15|||
163146556|NCT01553084|589246246|FG001|Overall Study|Withdrawal by Subject|13|||
163146557|NCT01553084|589246247|FG002|Overall Study|Withdrawal by Subject|35|||
163146558|NCT03119259|589246249|FG000|Overall Study|Withdrawn as no longer eligible|1|||
163146559|NCT03119259|589246250|FG001|Overall Study|Withdrawn as no longer eligible|0|||
163146560|NCT03119259|589246249|FG000|Overall Study|Withdrawal by Subject|4|||
163146561|NCT03119259|589246250|FG001|Overall Study|Withdrawal by Subject|2|||
163146562|NCT03119259|589246249|FG000|Overall Study|Lost to Follow-up|0|||
163146563|NCT03119259|589246250|FG001|Overall Study|Lost to Follow-up|1|||
163146564|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146565|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146566|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146567|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
163146568|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
163146569|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
163146570|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
163146571|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
163146572|NCT00647296|589246257|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163146573|NCT00647296|589246258|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
163146574|NCT00647296|589246259|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163146575|NCT00647296|589246260|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
163146576|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
162664833|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664834|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664835|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664836|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664837|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664838|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664839|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664840|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664841|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664842|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664843|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664844|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162664845|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
162664846|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664847|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664848|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664849|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664850|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664851|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664852|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664853|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664854|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664855|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664856|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664857|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664858|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
162664859|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
162664860|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
162664861|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
162664862|NCT01609556|587483006|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664863|NCT01609556|587483007|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664864|NCT01609556|587483008|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664865|NCT01609556|587483009|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664866|NCT01609556|587483010|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664867|NCT01609556|587483011|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664868|NCT01609556|587483012|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664869|NCT01609556|587483013|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664870|NCT01609556|587483014|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664871|NCT01609556|587483015|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664872|NCT01609556|587483016|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664873|NCT01609556|587483017|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664874|NCT01609556|587483018|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
162664875|NCT01609556|587483019|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664876|NCT01609556|587483020|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664877|NCT01609556|587483021|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162664878|NCT01632579|587483024|FG000|Washout Period|Adverse Event|1|||
162664879|NCT01632579|587483025|FG001|Washout Period|Adverse Event|0|||
162664880|NCT01632579|587483026|FG002|Washout Period|Adverse Event|0|||
162664881|NCT01632579|587483027|FG003|Washout Period|Adverse Event|0|||
162664882|NCT01632579|587483028|FG004|Washout Period|Adverse Event|0|||
162664883|NCT01632579|587483029|FG005|Washout Period|Adverse Event|0|||
162664884|NCT01632579|587483030|FG006|Washout Period|Adverse Event|0|||
162664885|NCT01632579|587483031|FG007|Washout Period|Adverse Event|0|||
162664886|NCT01632579|587483032|FG008|Washout Period|Adverse Event|0|||
162664887|NCT01632579|587483024|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
162664888|NCT01632579|587483025|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
162664889|NCT01632579|587483026|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
162664890|NCT01632579|587483027|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
162664891|NCT01632579|587483028|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
162664892|NCT01632579|587483029|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
162664893|NCT01632579|587483030|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
162664894|NCT01632579|587483031|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
162664895|NCT01632579|587483032|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
162664896|NCT01539291|587485048|FG000|Study GS-US-312-0116|Adverse Event|9|||
162664897|NCT01539291|587485049|FG001|Study GS-US-312-0116|Adverse Event|0|||
162664898|NCT01539291|587485050|FG002|Study GS-US-312-0116|Adverse Event|0|||
162664899|NCT01539291|587485051|FG003|Study GS-US-312-0116|Adverse Event|0|||
162664900|NCT01539291|587485048|FG000|Study GS-US-312-0116|Physician Decision|1|||
162664901|NCT01539291|587485049|FG001|Study GS-US-312-0116|Physician Decision|0|||
162664902|NCT01539291|587485050|FG002|Study GS-US-312-0116|Physician Decision|0|||
162664903|NCT01539291|587485051|FG003|Study GS-US-312-0116|Physician Decision|0|||
162664904|NCT01539291|587485048|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
162664905|NCT01539291|587485049|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
162664906|NCT01539291|587485050|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
162664907|NCT01539291|587485051|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
162664908|NCT01539291|587485048|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
162664909|NCT01539291|587485049|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162664910|NCT01539291|587485050|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162664911|NCT01539291|587485051|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162664912|NCT01539291|587485048|FG000|Study GS-US-312-0116|Other|1|||
162664913|NCT01539291|587485049|FG001|Study GS-US-312-0116|Other|0|||
162664914|NCT01539291|587485050|FG002|Study GS-US-312-0116|Other|0|||
162664915|NCT01539291|587485051|FG003|Study GS-US-312-0116|Other|0|||
162664916|NCT01539291|587485048|FG000|Study GS-US-312-0117|Adverse Event|22|||
162664917|NCT01539291|587485049|FG001|Study GS-US-312-0117|Adverse Event|1|||
162664918|NCT01539291|587485050|FG002|Study GS-US-312-0117|Adverse Event|9|||
162664919|NCT01539291|587485051|FG003|Study GS-US-312-0117|Adverse Event|12|||
162664920|NCT01539291|587485048|FG000|Study GS-US-312-0117|Physician Decision|9|||
162664921|NCT01539291|587485049|FG001|Study GS-US-312-0117|Physician Decision|0|||
162664922|NCT01539291|587485050|FG002|Study GS-US-312-0117|Physician Decision|6|||
162664923|NCT01539291|587485051|FG003|Study GS-US-312-0117|Physician Decision|4|||
162664924|NCT01539291|587485048|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
162664925|NCT01539291|587485049|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
162664926|NCT01539291|587485050|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
162664927|NCT01539291|587485051|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
162664928|NCT01539291|587485048|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
162664929|NCT01539291|587485049|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
162664930|NCT01539291|587485050|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
162664931|NCT01539291|587485051|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
162664932|NCT01539291|587485048|FG000|Study GS-US-312-0117|Other|2|||
162664933|NCT01539291|587485049|FG001|Study GS-US-312-0117|Other|1|||
162664934|NCT01539291|587485050|FG002|Study GS-US-312-0117|Other|1|||
162664935|NCT01539291|587485051|FG003|Study GS-US-312-0117|Other|1|||
162664936|NCT00129987|587485056|FG000|1st Educational Session|Withdrawal by Subject|141|||
162664937|NCT00129987|587485057|FG001|1st Educational Session|Withdrawal by Subject|109|||
162664938|NCT00129987|587485056|FG000|1 Year|Withdrawal by Subject|32|||
162664939|NCT00129987|587485057|FG001|1 Year|Withdrawal by Subject|21|||
162664940|NCT00116805|587485058|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
162664941|NCT00116805|587485059|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
162664942|NCT00116805|587485058|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
162664943|NCT00116805|587485059|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
162664944|NCT00116805|587485058|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
162664945|NCT00116805|587485059|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
162664946|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
162664947|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
162664948|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
162664949|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
162664950|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
162664951|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
162664952|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
162664953|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
162664954|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
162664955|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
162664956|NCT00116805|587485058|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
162664957|NCT00116805|587485059|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
162664958|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
162664959|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
162664960|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
162664961|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
162664962|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
162664963|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
162664964|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
162721460|NCT03482011|587688307|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
162721461|NCT03482011|587688308|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
162664965|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
162664966|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
162664967|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
162664968|NCT00116805|587485058|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
162664969|NCT00116805|587485059|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
162664970|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
162664971|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
163146577|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146578|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146579|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
163146580|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
163146581|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146582|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146583|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
163146584|NCT00647296|589246257|FG000|Part 2: 4-week Placebo Washout|Death|3|||
163146585|NCT00647296|589246258|FG001|Part 2: 4-week Placebo Washout|Death|0|||
163146586|NCT00647296|589246259|FG002|Part 2: 4-week Placebo Washout|Death|0|||
163146587|NCT00647296|589246260|FG003|Part 2: 4-week Placebo Washout|Death|0|||
163146588|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146589|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
163146590|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
163146591|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
163146592|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
163146593|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
163146594|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
163146595|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
163146596|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146597|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
163146598|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146599|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
163146600|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
163146601|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
163146602|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
163146603|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
162664972|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
163146604|NCT00647296|589246257|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
163146605|NCT00647296|589246258|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
163146606|NCT00647296|589246259|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
163146607|NCT00647296|589246260|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
163146608|NCT01300234|589246261|FG000|Overall Study|Adverse Event|1|||
163146609|NCT01300234|589246262|FG001|Overall Study|Adverse Event|1|||
163146610|NCT01300234|589246261|FG000|Overall Study|Protocol Violation|2|||
163146611|NCT01300234|589246262|FG001|Overall Study|Protocol Violation|3|||
163146612|NCT01300234|589246261|FG000|Overall Study|Withdrawal by Subject|5|||
163146613|NCT01300234|589246262|FG001|Overall Study|Withdrawal by Subject|9|||
163146614|NCT01300234|589246261|FG000|Overall Study|Lost to Follow-up|14|||
163146615|NCT01300234|589246262|FG001|Overall Study|Lost to Follow-up|12|||
163146616|NCT01300234|589246261|FG000|Overall Study|Pregnancy|2|||
163146617|NCT01300234|589246262|FG001|Overall Study|Pregnancy|1|||
163146618|NCT01300234|589246261|FG000|Overall Study|Participant reached stopping critera|2|||
163146619|NCT01300234|589246262|FG001|Overall Study|Participant reached stopping critera|0|||
163146620|NCT01300234|589246261|FG000|Overall Study|Participant stopped medication|1|||
163146621|NCT01300234|589246262|FG001|Overall Study|Participant stopped medication|1|||
163146622|NCT01300234|589246261|FG000|Overall Study|Participant refused return to hospital|1|||
163146623|NCT01300234|589246262|FG001|Overall Study|Participant refused return to hospital|0|||
163146624|NCT03253679|589246263|FG000|Overall Study|Screen Failure|1|||
163146625|NCT04816214|589246264|FG000|Overall Study|Progressive Disease|4|||
163146626|NCT04816214|589246265|FG001|Overall Study|Progressive Disease|0|||
163146627|NCT04816214|589246266|FG002|Overall Study|Progressive Disease|0|||
163146628|NCT04816214|589246264|FG000|Overall Study|Death|1|||
163146629|NCT04816214|589246265|FG001|Overall Study|Death|0|||
163146630|NCT04816214|589246266|FG002|Overall Study|Death|0|||
163146631|NCT04816214|589246264|FG000|Overall Study|Study Terminated by Sponsor|1|||
163146632|NCT04816214|589246265|FG001|Overall Study|Study Terminated by Sponsor|0|||
163146633|NCT04816214|589246266|FG002|Overall Study|Study Terminated by Sponsor|0|||
163146634|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146635|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146636|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
162664973|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
162664974|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
163146637|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
163146638|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
162664975|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
162664976|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
163146639|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163146640|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
163146641|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163146642|NCT04879628|589246267|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146643|NCT04879628|589246268|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146644|NCT04879628|589246269|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
163146645|NCT04879628|589246270|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
163146646|NCT04879628|589246267|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
163146647|NCT04879628|589246268|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
163146648|NCT04879628|589246269|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
163146649|NCT04879628|589246270|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
163146650|NCT00360412|589246276|FG000|Overall Study|Adverse Event|37|||
163146651|NCT00360412|589246277|FG001|Overall Study|Adverse Event|65|||
163146652|NCT00360412|589246276|FG000|Overall Study|Protocol Violation|2|||
163146653|NCT00360412|589246277|FG001|Overall Study|Protocol Violation|5|||
163146654|NCT00360412|589246276|FG000|Overall Study|Patient withdrew consent|27|||
163146655|NCT00360412|589246277|FG001|Overall Study|Patient withdrew consent|52|||
163146656|NCT00360412|589246276|FG000|Overall Study|Lack of therapeutic efficacy|46|||
163146657|NCT00360412|589246277|FG001|Overall Study|Lack of therapeutic efficacy|61|||
163146658|NCT00360412|589246276|FG000|Overall Study|Physician Decision|2|||
163146659|NCT00360412|589246277|FG001|Overall Study|Physician Decision|4|||
163146660|NCT00360412|589246276|FG000|Overall Study|Other|5|||
163146661|NCT00360412|589246277|FG001|Overall Study|Other|6|||
163146662|NCT00360412|589246276|FG000|Overall Study|Study termination by Sponsor|214|||
163146663|NCT00360412|589246277|FG001|Overall Study|Study termination by Sponsor|469|||
163146664|NCT00871871|589246278|FG000|Part I|Adverse Event|0|||
163146665|NCT00871871|589246279|FG001|Part I|Adverse Event|2|||
163146666|NCT00871871|589246280|FG002|Part I|Adverse Event|0|||
163146667|NCT00871871|589246281|FG003|Part I|Adverse Event|0|||
163146668|NCT00871871|589246278|FG000|Part I|Withdrawal by Subject|3|||
163146669|NCT00871871|589246279|FG001|Part I|Withdrawal by Subject|0|||
163146670|NCT00871871|589246280|FG002|Part I|Withdrawal by Subject|0|||
163146671|NCT00871871|589246281|FG003|Part I|Withdrawal by Subject|0|||
163146672|NCT00871871|589246278|FG000|Part I|Laboratory abnormality|0|||
163146673|NCT00871871|589246279|FG001|Part I|Laboratory abnormality|1|||
163146674|NCT00871871|589246280|FG002|Part I|Laboratory abnormality|0|||
163146675|NCT00871871|589246281|FG003|Part I|Laboratory abnormality|0|||
163146676|NCT00871871|589246278|FG000|Part II|Lack of Efficacy|0|||
163146677|NCT00871871|589246279|FG001|Part II|Lack of Efficacy|0|||
163146678|NCT00871871|589246280|FG002|Part II|Lack of Efficacy|1|||
163146679|NCT00871871|589246281|FG003|Part II|Lack of Efficacy|0|||
163146680|NCT00871871|589246278|FG000|Part II|Withdrawal by Subject|0|||
163146681|NCT00871871|589246279|FG001|Part II|Withdrawal by Subject|0|||
163146682|NCT00871871|589246280|FG002|Part II|Withdrawal by Subject|2|||
163146683|NCT00871871|589246281|FG003|Part II|Withdrawal by Subject|1|||
163146684|NCT00871871|589246278|FG000|Part II|Adverse Event|0|||
163146685|NCT00871871|589246279|FG001|Part II|Adverse Event|0|||
163146686|NCT00871871|589246280|FG002|Part II|Adverse Event|1|||
163146687|NCT00871871|589246281|FG003|Part II|Adverse Event|2|||
163146688|NCT00871871|589246278|FG000|Part II|Protocol Violation|0|||
163146689|NCT00871871|589246279|FG001|Part II|Protocol Violation|0|||
163146690|NCT00871871|589246280|FG002|Part II|Protocol Violation|0|||
163146691|NCT00871871|589246281|FG003|Part II|Protocol Violation|1|||
163146692|NCT04612725|589246282|FG000|Overall Study|Adverse Event|1|||
163146693|NCT04612725|589246283|FG001|Overall Study|Adverse Event|3|||
163146694|NCT04612725|589246284|FG002|Overall Study|Adverse Event|1|||
163146695|NCT04612725|589246285|FG003|Overall Study|Adverse Event|0|||
163146696|NCT04612725|589246286|FG004|Overall Study|Adverse Event|1|||
163146697|NCT04612725|589246282|FG000|Overall Study|Lost to Follow-up|0|||
163146698|NCT04612725|589246283|FG001|Overall Study|Lost to Follow-up|1|||
163146699|NCT04612725|589246284|FG002|Overall Study|Lost to Follow-up|0|||
163146700|NCT04612725|589246285|FG003|Overall Study|Lost to Follow-up|0|||
163146701|NCT04612725|589246286|FG004|Overall Study|Lost to Follow-up|0|||
163146702|NCT04612725|589246282|FG000|Overall Study|Physician Decision|2|||
163146703|NCT04612725|589246283|FG001|Overall Study|Physician Decision|0|||
163146704|NCT04612725|589246284|FG002|Overall Study|Physician Decision|0|||
163146705|NCT04612725|589246285|FG003|Overall Study|Physician Decision|0|||
163146706|NCT04612725|589246286|FG004|Overall Study|Physician Decision|0|||
163146707|NCT04612725|589246282|FG000|Overall Study|Study terminated by sponsor|3|||
163146708|NCT04612725|589246283|FG001|Overall Study|Study terminated by sponsor|1|||
163146709|NCT04612725|589246284|FG002|Overall Study|Study terminated by sponsor|2|||
163146710|NCT04612725|589246285|FG003|Overall Study|Study terminated by sponsor|4|||
163146711|NCT04612725|589246286|FG004|Overall Study|Study terminated by sponsor|5|||
163146712|NCT04612725|589246282|FG000|Overall Study|Withdrawal by Subject|8|||
163146713|NCT04612725|589246283|FG001|Overall Study|Withdrawal by Subject|3|||
163146714|NCT04612725|589246284|FG002|Overall Study|Withdrawal by Subject|5|||
163146715|NCT04612725|589246285|FG003|Overall Study|Withdrawal by Subject|1|||
163146716|NCT04612725|589246286|FG004|Overall Study|Withdrawal by Subject|9|||
162664977|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
162664978|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
162664979|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
162664980|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
162664981|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
162664982|NCT00116805|587485058|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
162664983|NCT00116805|587485059|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
162664984|NCT00116805|587485058|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
162664985|NCT00116805|587485059|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
162664986|NCT00116805|587485058|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
162664987|NCT00116805|587485059|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
162664988|NCT00116805|587485058|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
162664989|NCT00116805|587485059|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
162664990|NCT00116805|587485058|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162664991|NCT00116805|587485059|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162664992|NCT00116805|587485058|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
162664993|NCT00116805|587485059|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
162664994|NCT00116805|587485058|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
162664995|NCT00116805|587485059|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
162664996|NCT00116805|587485058|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
162664997|NCT00116805|587485059|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
162664998|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
162664999|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
162665000|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
162665001|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
162665002|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
162665003|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
162665004|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
162665005|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
162665006|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
162665007|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
162665008|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
162665009|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
162665010|NCT00116805|587485058|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
162665011|NCT00116805|587485059|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
162665012|NCT00116805|587485058|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
162665013|NCT00116805|587485059|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
162665014|NCT00116805|587485058|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
162665015|NCT00116805|587485059|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
162665016|NCT00116805|587485058|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
162665017|NCT00116805|587485059|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
162665018|NCT00116805|587485058|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
162665019|NCT00116805|587485059|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
162665020|NCT00116805|587485058|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
162665021|NCT00116805|587485059|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
162665022|NCT00116805|587485058|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
162665023|NCT00116805|587485059|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
162665024|NCT00116805|587485058|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
162665025|NCT00116805|587485059|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
162665026|NCT00116805|587485058|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
162665027|NCT00116805|587485059|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
162665028|NCT00116805|587485058|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
162665029|NCT00116805|587485059|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
163146717|NCT04612725|589246282|FG000|Overall Study|Other|0|||
163146718|NCT04612725|589246283|FG001|Overall Study|Other|0|||
163146719|NCT04612725|589246284|FG002|Overall Study|Other|0|||
163146720|NCT04612725|589246285|FG003|Overall Study|Other|0|||
163146721|NCT04612725|589246286|FG004|Overall Study|Other|1|||
163146722|NCT03863509|589246287|FG000|Overall Study|COVID-19 shutdown period|0|||
162665030|NCT01159938|587485060|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162665031|NCT01159938|587485061|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162665032|NCT01159938|587485062|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
162665033|NCT01159938|587485063|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
163146723|NCT03863509|589246288|FG001|Overall Study|COVID-19 shutdown period|4|||
163146724|NCT03863509|589246289|FG002|Overall Study|COVID-19 shutdown period|0|||
163146725|NCT03863509|589246287|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
163146726|NCT03863509|589246288|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
163146727|NCT03863509|589246289|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
163146728|NCT03863509|589246287|FG000|Overall Study|Lost to Follow-up|8|||
163146729|NCT03863509|589246288|FG001|Overall Study|Lost to Follow-up|0|||
163146730|NCT03863509|589246289|FG002|Overall Study|Lost to Follow-up|2|||
163146731|NCT03863509|589246287|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
163146732|NCT03863509|589246288|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
163146733|NCT03863509|589246289|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
163146734|NCT03863509|589246287|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
163146735|NCT03863509|589246288|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
163146736|NCT03863509|589246289|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
163146737|NCT03861273|589246290|FG000|Screening Phase (3 Weeks)|Other|1|||
163146738|NCT03861273|589246290|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
163146739|NCT03861273|589246290|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
163146740|NCT03861273|589246290|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
163146741|NCT03861273|589246290|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
163146742|NCT00948064|589248428|FG000|Phase I|No treatment received|1|||
163146743|NCT00948064|589248429|FG001|Phase I|No treatment received|0|||
163146744|NCT00948064|589248430|FG002|Phase I|No treatment received|0|||
163146745|NCT00948064|589248428|FG000|Phase II|Physician Decision|0|||
163146746|NCT00948064|589248429|FG001|Phase II|Physician Decision|0|||
163146747|NCT00948064|589248430|FG002|Phase II|Physician Decision|1|||
163146748|NCT00948064|589248428|FG000|Phase II|Withdrawal by Subject|0|||
163146749|NCT00948064|589248429|FG001|Phase II|Withdrawal by Subject|1|||
163146750|NCT00948064|589248430|FG002|Phase II|Withdrawal by Subject|0|||
163146751|NCT04416204|589248440|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146752|NCT04416204|589248441|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
163146753|NCT04416204|589248442|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146754|NCT04416204|589248443|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
163146755|NCT01959503|589248444|FG000|Overall Study|Death|2|||
163146756|NCT01959503|589248445|FG001|Overall Study|Death|1|||
163146757|NCT01959503|589248444|FG000|Overall Study|Randomized but not treated|1|||
163146758|NCT01959503|589248445|FG001|Overall Study|Randomized but not treated|1|||
163146759|NCT01393158|589248447|FG000|Overall Study|Adverse Event|1|||
163146760|NCT01393158|589248448|FG001|Overall Study|Adverse Event|0|||
163146761|NCT04233801|589248450|FG000|Overall Study|Other than listed|0|||
163146762|NCT04233801|589248451|FG001|Overall Study|Other than listed|0|||
163146763|NCT04233801|589248452|FG002|Overall Study|Other than listed|1|||
163146764|NCT04233801|589248450|FG000|Overall Study|Withdrawal by Subject|0|||
163146765|NCT04233801|589248451|FG001|Overall Study|Withdrawal by Subject|2|||
163146766|NCT04233801|589248452|FG002|Overall Study|Withdrawal by Subject|3|||
163146767|NCT02173769|589248453|FG000|Overall Study|Protocol Violation|4|||
163146768|NCT00683878|589248464|FG000|Overall Study|Lack of Efficacy|3|||
163146769|NCT00683878|589248465|FG001|Overall Study|Lack of Efficacy|0|||
163146770|NCT00683878|589248466|FG002|Overall Study|Lack of Efficacy|1|||
163146771|NCT00683878|589248464|FG000|Overall Study|Adverse Event|4|||
163146772|NCT00683878|589248465|FG001|Overall Study|Adverse Event|3|||
163146773|NCT00683878|589248466|FG002|Overall Study|Adverse Event|3|||
163146774|NCT00683878|589248464|FG000|Overall Study|Withdrawal by Subject|9|||
163146775|NCT00683878|589248465|FG001|Overall Study|Withdrawal by Subject|8|||
163146776|NCT00683878|589248466|FG002|Overall Study|Withdrawal by Subject|6|||
163146777|NCT00683878|589248464|FG000|Overall Study|Death|0|||
163146778|NCT00683878|589248465|FG001|Overall Study|Death|1|||
163146779|NCT00683878|589248466|FG002|Overall Study|Death|0|||
163146780|NCT00683878|589248464|FG000|Overall Study|Lost to Follow-up|4|||
163146781|NCT00683878|589248465|FG001|Overall Study|Lost to Follow-up|2|||
163146782|NCT00683878|589248466|FG002|Overall Study|Lost to Follow-up|4|||
163146783|NCT00683878|589248464|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
163146784|NCT00683878|589248465|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
163146785|NCT00683878|589248466|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
163146786|NCT04024891|589248467|FG000|Overall Study|Pregnancy|0|||
163146787|NCT04024891|589248468|FG001|Overall Study|Pregnancy|1|||
163146788|NCT03095651|589248476|FG000|Overall Study|Lost to Follow-up|1|||
163146789|NCT03095651|589248477|FG001|Overall Study|Lost to Follow-up|1|||
163146790|NCT03095651|589248478|FG002|Overall Study|Lost to Follow-up|0|||
163146791|NCT03095651|589248479|FG003|Overall Study|Lost to Follow-up|1|||
163146792|NCT03095651|589248480|FG004|Overall Study|Lost to Follow-up|0|||
163146793|NCT03095651|589248481|FG005|Overall Study|Lost to Follow-up|0|||
163146794|NCT03095651|589248482|FG006|Overall Study|Lost to Follow-up|0|||
163146795|NCT03095651|589248483|FG007|Overall Study|Lost to Follow-up|0|||
163146796|NCT03095651|589248476|FG000|Overall Study|Withdrawal by Subject|0|||
163146797|NCT03095651|589248477|FG001|Overall Study|Withdrawal by Subject|0|||
163146798|NCT03095651|589248478|FG002|Overall Study|Withdrawal by Subject|0|||
163146799|NCT03095651|589248479|FG003|Overall Study|Withdrawal by Subject|0|||
163146800|NCT03095651|589248480|FG004|Overall Study|Withdrawal by Subject|0|||
163146801|NCT03095651|589248481|FG005|Overall Study|Withdrawal by Subject|1|||
163146802|NCT03095651|589248482|FG006|Overall Study|Withdrawal by Subject|0|||
163146803|NCT03095651|589248483|FG007|Overall Study|Withdrawal by Subject|0|||
163146804|NCT04124939|589248489|FG000|Overall Study|Lost to Follow-up|1|||
163146805|NCT04124939|589248490|FG001|Overall Study|Lost to Follow-up|3|||
162665034|NCT01159938|587485064|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162665035|NCT02105116|587485066|FG000|Overall Study|not eligible for step 2 of trial|5|||
162665036|NCT02105116|587485066|FG000|Overall Study|Death|1|||
162665037|NCT02318329|587485068|FG000|Overall Study|Progressive Disease|2|||
162665038|NCT02318329|587485069|FG001|Overall Study|Progressive Disease|3|||
162665039|NCT02318329|587485070|FG002|Overall Study|Progressive Disease|2|||
162665040|NCT02318329|587485071|FG003|Overall Study|Progressive Disease|3|||
162665041|NCT02318329|587485072|FG004|Overall Study|Progressive Disease|3|||
162665042|NCT02318329|587485073|FG005|Overall Study|Progressive Disease|3|||
162665043|NCT02318329|587485074|FG006|Overall Study|Progressive Disease|1|||
162665044|NCT02318329|587485075|FG007|Overall Study|Progressive Disease|1|||
162665045|NCT02318329|587485076|FG008|Overall Study|Progressive Disease|5|||
162665046|NCT02318329|587485077|FG009|Overall Study|Progressive Disease|39|||
162665047|NCT02318329|587485068|FG000|Overall Study|Death|0|||
162665048|NCT02318329|587485069|FG001|Overall Study|Death|0|||
162665049|NCT02318329|587485070|FG002|Overall Study|Death|0|||
162665050|NCT02318329|587485071|FG003|Overall Study|Death|0|||
162665051|NCT02318329|587485072|FG004|Overall Study|Death|0|||
162665052|NCT02318329|587485073|FG005|Overall Study|Death|0|||
162665053|NCT02318329|587485074|FG006|Overall Study|Death|0|||
162665054|NCT02318329|587485075|FG007|Overall Study|Death|0|||
162665055|NCT02318329|587485076|FG008|Overall Study|Death|0|||
162665056|NCT02318329|587485077|FG009|Overall Study|Death|5|||
162665057|NCT02318329|587485068|FG000|Overall Study|Lost to Follow-up|0|||
162665058|NCT02318329|587485069|FG001|Overall Study|Lost to Follow-up|0|||
162665059|NCT02318329|587485070|FG002|Overall Study|Lost to Follow-up|0|||
162665060|NCT02318329|587485071|FG003|Overall Study|Lost to Follow-up|0|||
162665061|NCT02318329|587485072|FG004|Overall Study|Lost to Follow-up|0|||
162665062|NCT02318329|587485073|FG005|Overall Study|Lost to Follow-up|0|||
162665063|NCT02318329|587485074|FG006|Overall Study|Lost to Follow-up|0|||
162665064|NCT02318329|587485075|FG007|Overall Study|Lost to Follow-up|0|||
162665065|NCT02318329|587485076|FG008|Overall Study|Lost to Follow-up|0|||
162665066|NCT02318329|587485077|FG009|Overall Study|Lost to Follow-up|1|||
162665067|NCT02318329|587485068|FG000|Overall Study|Withdrawal by Subject|0|||
162665068|NCT02318329|587485069|FG001|Overall Study|Withdrawal by Subject|0|||
162665069|NCT02318329|587485070|FG002|Overall Study|Withdrawal by Subject|0|||
162665070|NCT02318329|587485071|FG003|Overall Study|Withdrawal by Subject|0|||
162665071|NCT02318329|587485072|FG004|Overall Study|Withdrawal by Subject|0|||
162665072|NCT02318329|587485073|FG005|Overall Study|Withdrawal by Subject|0|||
162665073|NCT02318329|587485074|FG006|Overall Study|Withdrawal by Subject|0|||
162665074|NCT02318329|587485075|FG007|Overall Study|Withdrawal by Subject|0|||
162665075|NCT02318329|587485076|FG008|Overall Study|Withdrawal by Subject|0|||
162665076|NCT02318329|587485077|FG009|Overall Study|Withdrawal by Subject|6|||
162665077|NCT02318329|587485068|FG000|Overall Study|Other|1|||
162665078|NCT02318329|587485069|FG001|Overall Study|Other|1|||
162665079|NCT02318329|587485070|FG002|Overall Study|Other|1|||
162665080|NCT02318329|587485071|FG003|Overall Study|Other|0|||
162665081|NCT02318329|587485072|FG004|Overall Study|Other|0|||
162665082|NCT02318329|587485073|FG005|Overall Study|Other|0|||
162665083|NCT02318329|587485074|FG006|Overall Study|Other|0|||
162665084|NCT02318329|587485075|FG007|Overall Study|Other|0|||
162665085|NCT02318329|587485076|FG008|Overall Study|Other|1|||
162665086|NCT02318329|587485077|FG009|Overall Study|Other|1|||
162665087|NCT04837482|587485078|FG000|Period 2|Withdrawal by Subject|0|||
162665088|NCT04837482|587485079|FG001|Period 2|Withdrawal by Subject|1|||
162665089|NCT00581945|587485080|FG000|Overall Study|Adverse Event|4|||
162665090|NCT00581945|587485081|FG001|Overall Study|Adverse Event|4|||
162665091|NCT00581945|587485080|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162665092|NCT00581945|587485081|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162665093|NCT00581945|587485080|FG000|Overall Study|Withdrawal by Subject|2|||
162665094|NCT00581945|587485081|FG001|Overall Study|Withdrawal by Subject|6|||
162665095|NCT00581945|587485080|FG000|Overall Study|Death|1|||
162665096|NCT00581945|587485081|FG001|Overall Study|Death|0|||
162665097|NCT02979535|587485082|FG000|Overall Study|Non compliance with the protocol|78|||
162665098|NCT02979535|587485083|FG001|Overall Study|Non compliance with the protocol|82|||
162665099|NCT02979535|587485082|FG000|Overall Study|Consent withdrawn by participant|11|||
162665100|NCT02979535|587485083|FG001|Overall Study|Consent withdrawn by participant|18|||
162665101|NCT02979535|587485082|FG000|Overall Study|Lost to Follow-up|6|||
162665102|NCT02979535|587485083|FG001|Overall Study|Lost to Follow-up|1|||
162665103|NCT04820673|587485084|FG000|Overall Study|Adverse Event|6|||
162665104|NCT04820673|587485084|FG000|Overall Study|Due to Lack of Effectiveness|1|||
162665105|NCT04820673|587485084|FG000|Overall Study|Pregnancy|1|||
162665106|NCT04820673|587485084|FG000|Overall Study|Voluntary Withdrawal|20|||
163146806|NCT00308139|589248493|FG000|Overall Study|Adverse Event|20|||
163146807|NCT00308139|589248494|FG001|Overall Study|Adverse Event|14|||
163146808|NCT00308139|589248493|FG000|Overall Study|Lost to Follow-up|13|||
163146809|NCT00308139|589248494|FG001|Overall Study|Lost to Follow-up|8|||
163146810|NCT00308139|589248493|FG000|Overall Study|Protocol Violation|3|||
163146811|NCT00308139|589248494|FG001|Overall Study|Protocol Violation|2|||
163146812|NCT00308139|589248493|FG000|Overall Study|Withdrawal of Consent|40|||
163146813|NCT00308139|589248494|FG001|Overall Study|Withdrawal of Consent|42|||
163146814|NCT00308139|589248493|FG000|Overall Study|Investigator Decision|11|||
163146815|NCT00308139|589248494|FG001|Overall Study|Investigator Decision|10|||
163146816|NCT00308139|589248493|FG000|Overall Study|Loss of Glucose Control|5|||
163146817|NCT00308139|589248494|FG001|Overall Study|Loss of Glucose Control|7|||
163146818|NCT00308139|589248493|FG000|Overall Study|Administrative|1|||
163146819|NCT00308139|589248494|FG001|Overall Study|Administrative|4|||
163146820|NCT00308139|589248493|FG000|Overall Study|Other|1|||
163146821|NCT00308139|589248494|FG001|Overall Study|Other|0|||
163146822|NCT00791388|589248499|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146823|NCT00791388|589248500|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
163146824|NCT00791388|589248501|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146825|NCT00791388|589248502|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146826|NCT00791388|589248503|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
163146827|NCT00791388|589248499|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
163146828|NCT00791388|589248500|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146829|NCT00791388|589248501|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146830|NCT00791388|589248502|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146831|NCT00791388|589248503|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
163146832|NCT00791388|589248499|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146833|NCT00791388|589248500|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146834|NCT00791388|589248501|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146835|NCT00791388|589248502|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
163146836|NCT00791388|589248503|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
163146837|NCT00435409|589248512|FG000|Overall Study|Protocol Violation|1|||
163146838|NCT00435409|589248513|FG001|Overall Study|Protocol Violation|2|||
163146839|NCT00435409|589248514|FG002|Overall Study|Protocol Violation|0|||
163146840|NCT00435409|589248512|FG000|Overall Study|Lost to Follow-up|1|||
163146841|NCT00435409|589248513|FG001|Overall Study|Lost to Follow-up|2|||
163146842|NCT00435409|589248514|FG002|Overall Study|Lost to Follow-up|0|||
163146843|NCT00435409|589248512|FG000|Overall Study|Death|8|||
163146844|NCT00435409|589248513|FG001|Overall Study|Death|6|||
163146845|NCT00435409|589248514|FG002|Overall Study|Death|6|||
163146846|NCT00435409|589248512|FG000|Overall Study|Objective progression or relapse|158|||
163146847|NCT00435409|589248513|FG001|Overall Study|Objective progression or relapse|93|||
163146848|NCT00435409|589248514|FG002|Overall Study|Objective progression or relapse|58|||
163146849|NCT00435409|589248512|FG000|Overall Study|Global deterioration of health status|0|||
163146850|NCT00435409|589248513|FG001|Overall Study|Global deterioration of health status|0|||
163146851|NCT00435409|589248514|FG002|Overall Study|Global deterioration of health status|4|||
163146852|NCT00435409|589248512|FG000|Overall Study|Withdrawal by Subject|8|||
163146853|NCT00435409|589248513|FG001|Overall Study|Withdrawal by Subject|7|||
163146854|NCT00435409|589248514|FG002|Overall Study|Withdrawal by Subject|1|||
163146855|NCT00435409|589248512|FG000|Overall Study|Other|45|||
163146856|NCT00435409|589248513|FG001|Overall Study|Other|30|||
163146857|NCT00435409|589248514|FG002|Overall Study|Other|1|||
163146858|NCT00435409|589248512|FG000|Overall Study|Adverse Event|0|||
163146859|NCT00435409|589248513|FG001|Overall Study|Adverse Event|0|||
163146860|NCT00435409|589248514|FG002|Overall Study|Adverse Event|8|||
163146861|NCT00435409|589248512|FG000|Overall Study|Sponsor decision|0|||
163146862|NCT00435409|589248513|FG001|Overall Study|Sponsor decision|3|||
163146863|NCT00435409|589248514|FG002|Overall Study|Sponsor decision|0|||
163146864|NCT04750824|589248515|FG000|Overall Study|Toxicity/intolerability|3|||
163146865|NCT04750824|589248516|FG001|Overall Study|Toxicity/intolerability|1|||
162665107|NCT04820673|587485084|FG000|Overall Study|Lost to Follow-up|10|||
162665108|NCT00587587|587485087|FG000|Overall Study|Lost to Follow-up|6|||
162665109|NCT00587587|587485088|FG001|Overall Study|Lost to Follow-up|1|||
162665110|NCT02032901|587485091|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
162665111|NCT02032901|587485092|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
163146866|NCT04750824|589248515|FG000|Overall Study|Death|1|||
163146867|NCT04750824|589248516|FG001|Overall Study|Death|3|||
163146868|NCT04750824|589248515|FG000|Overall Study|Scheduled duration of therapy complete|1|||
163146869|NCT04750824|589248516|FG001|Overall Study|Scheduled duration of therapy complete|9|||
163146870|NCT04750824|589248515|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
163146871|NCT04750824|589248516|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
163146872|NCT05196828|589248517|FG000|Overall Study|Withdrawal by Subject|2|||
163146873|NCT05196828|589248518|FG001|Overall Study|Withdrawal by Subject|0|||
163146874|NCT05196828|589248517|FG000|Overall Study|Lost to Follow-up|0|||
162665112|NCT02032901|587485091|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
163146875|NCT05196828|589248518|FG001|Overall Study|Lost to Follow-up|4|||
163146876|NCT05196828|589248517|FG000|Overall Study|Adverse Event|1|||
163146877|NCT05196828|589248518|FG001|Overall Study|Adverse Event|0|||
163146878|NCT02763644|589248519|FG000|Overall Study|Patient/guardian decision|1|||
163146879|NCT02763644|589248520|FG001|Overall Study|Patient/guardian decision|0|||
163146880|NCT02763644|589248519|FG000|Overall Study|Death|1|||
163146881|NCT02763644|589248520|FG001|Overall Study|Death|1|||
163146882|NCT02763644|589248519|FG000|Overall Study|Adverse Event|1|||
163146883|NCT02763644|589248520|FG001|Overall Study|Adverse Event|1|||
163146884|NCT02356159|589248521|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146885|NCT02356159|589248522|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146886|NCT02356159|589248523|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146887|NCT02356159|589248524|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146888|NCT02356159|589248525|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163146889|NCT02356159|589248526|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
163146890|NCT03192176|589248527|FG000|Overall Study|Adverse Event|1|||
163146891|NCT03192176|589248528|FG001|Overall Study|Adverse Event|0|||
163146892|NCT03192176|589248529|FG002|Overall Study|Adverse Event|4|||
163146893|NCT03192176|589248530|FG003|Overall Study|Adverse Event|5|||
163146894|NCT03192176|589248531|FG004|Overall Study|Adverse Event|3|||
163146895|NCT03192176|589248532|FG005|Overall Study|Adverse Event|2|||
163146896|NCT03192176|589248533|FG006|Overall Study|Adverse Event|3|||
163146897|NCT03192176|589248534|FG007|Overall Study|Adverse Event|3|||
163146898|NCT03192176|589248527|FG000|Overall Study|Lost to Follow-up|0|||
163146899|NCT03192176|589248528|FG001|Overall Study|Lost to Follow-up|0|||
163146900|NCT03192176|589248529|FG002|Overall Study|Lost to Follow-up|1|||
163146901|NCT03192176|589248530|FG003|Overall Study|Lost to Follow-up|2|||
163146902|NCT03192176|589248531|FG004|Overall Study|Lost to Follow-up|3|||
163146903|NCT03192176|589248532|FG005|Overall Study|Lost to Follow-up|1|||
163146904|NCT03192176|589248533|FG006|Overall Study|Lost to Follow-up|1|||
163146905|NCT03192176|589248534|FG007|Overall Study|Lost to Follow-up|1|||
163146906|NCT03192176|589248527|FG000|Overall Study|Physician Decision|1|||
163146907|NCT03192176|589248528|FG001|Overall Study|Physician Decision|0|||
163146908|NCT03192176|589248529|FG002|Overall Study|Physician Decision|0|||
163146909|NCT03192176|589248530|FG003|Overall Study|Physician Decision|0|||
163146910|NCT03192176|589248531|FG004|Overall Study|Physician Decision|0|||
163146911|NCT03192176|589248532|FG005|Overall Study|Physician Decision|2|||
163146912|NCT03192176|589248533|FG006|Overall Study|Physician Decision|1|||
163146913|NCT03192176|589248534|FG007|Overall Study|Physician Decision|0|||
163146914|NCT03192176|589248527|FG000|Overall Study|Protocol Deviation|1|||
163146915|NCT03192176|589248528|FG001|Overall Study|Protocol Deviation|1|||
163146916|NCT03192176|589248529|FG002|Overall Study|Protocol Deviation|0|||
163146917|NCT03192176|589248530|FG003|Overall Study|Protocol Deviation|0|||
163146918|NCT03192176|589248531|FG004|Overall Study|Protocol Deviation|2|||
163146919|NCT03192176|589248532|FG005|Overall Study|Protocol Deviation|0|||
163146920|NCT03192176|589248533|FG006|Overall Study|Protocol Deviation|0|||
163146921|NCT03192176|589248534|FG007|Overall Study|Protocol Deviation|0|||
163146922|NCT03192176|589248527|FG000|Overall Study|Withdrawal by Subject|3|||
163146923|NCT03192176|589248528|FG001|Overall Study|Withdrawal by Subject|4|||
163146924|NCT03192176|589248529|FG002|Overall Study|Withdrawal by Subject|0|||
163146925|NCT03192176|589248530|FG003|Overall Study|Withdrawal by Subject|4|||
163146926|NCT03192176|589248531|FG004|Overall Study|Withdrawal by Subject|3|||
163146927|NCT03192176|589248532|FG005|Overall Study|Withdrawal by Subject|4|||
163146928|NCT03192176|589248533|FG006|Overall Study|Withdrawal by Subject|4|||
163146929|NCT03192176|589248534|FG007|Overall Study|Withdrawal by Subject|2|||
163146930|NCT03192176|589248527|FG000|Overall Study|Miscellaneous|1|||
163146931|NCT03192176|589248528|FG001|Overall Study|Miscellaneous|0|||
163146932|NCT03192176|589248529|FG002|Overall Study|Miscellaneous|1|||
163146933|NCT03192176|589248530|FG003|Overall Study|Miscellaneous|1|||
163146934|NCT03192176|589248531|FG004|Overall Study|Miscellaneous|1|||
163146935|NCT03192176|589248532|FG005|Overall Study|Miscellaneous|2|||
163146936|NCT03192176|589248533|FG006|Overall Study|Miscellaneous|0|||
163146937|NCT03192176|589248534|FG007|Overall Study|Miscellaneous|1|||
163146938|NCT00836589|589248539|FG000|Overall Study|Lost to Follow-up|246|||
163146939|NCT00836589|589248539|FG000|Overall Study|Death|429|||
163146940|NCT00836589|589248539|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
163146941|NCT00117637|589248540|FG000|First Intervention (Period 1)|Adverse Event|11|||
163146942|NCT00117637|589248541|FG001|First Intervention (Period 1)|Adverse Event|16|||
163146943|NCT00117637|589248540|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
163146944|NCT00117637|589248541|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
163146945|NCT00117637|589248540|FG000|First Intervention (Period 1)|Protocol Violation|1|||
163146946|NCT00117637|589248541|FG001|First Intervention (Period 1)|Protocol Violation|0|||
163146947|NCT00117637|589248540|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
163146948|NCT00117637|589248541|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
163146949|NCT00117637|589248540|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
163146950|NCT00117637|589248541|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
163146951|NCT00117637|589248540|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
163146952|NCT00117637|589248541|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
163146953|NCT00117637|589248540|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
163146954|NCT00117637|589248541|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
163146955|NCT00117637|589248540|FG000|First Intervention (Period 1)|reason not reported|0|||
163146956|NCT00117637|589248541|FG001|First Intervention (Period 1)|reason not reported|1|||
163146957|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Adverse Event|0|||
163146958|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Adverse Event|9|||
163146959|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
163146960|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
163146961|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
163146962|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
163146963|NCT00117637|589248540|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
163146964|NCT00117637|589248541|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
163146965|NCT00117637|589248540|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
163146966|NCT00117637|589248541|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
163146967|NCT00117637|589248540|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
163146968|NCT00117637|589248541|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
163146969|NCT00117637|589248540|FG000|Second Intervention (Period 2)|reason not reported|1|||
163146970|NCT00117637|589248541|FG001|Second Intervention (Period 2)|reason not reported|0|||
163146971|NCT02914639|589248544|FG000|Overall Study|Withdrawal by Subject|0|||
163146972|NCT02914639|589248545|FG001|Overall Study|Withdrawal by Subject|2|||
163146973|NCT01582061|589248546|FG000|Overall Study|Lack of Efficacy|3|||
163146974|NCT01582061|589248547|FG001|Overall Study|Lack of Efficacy|23|||
163146975|NCT01582061|589248546|FG000|Overall Study|Adverse Event|12|||
163146976|NCT01582061|589248547|FG001|Overall Study|Adverse Event|8|||
163146977|NCT01582061|589248546|FG000|Overall Study|Withdrawal by Subject|10|||
163146978|NCT01582061|589248547|FG001|Overall Study|Withdrawal by Subject|4|||
163146979|NCT01582061|589248546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163146980|NCT01582061|589248547|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163146981|NCT01582061|589248546|FG000|Overall Study|Death|0|||
163146982|NCT01582061|589248547|FG001|Overall Study|Death|1|||
163146983|NCT01582061|589248546|FG000|Overall Study|condition no longer requires study drug|1|||
163146984|NCT01582061|589248547|FG001|Overall Study|condition no longer requires study drug|0|||
163146985|NCT01582061|589248546|FG000|Overall Study|Lost to Follow-up|1|||
163146986|NCT01582061|589248547|FG001|Overall Study|Lost to Follow-up|0|||
163146987|NCT01045460|589248551|FG000|Overall Study|Physician Decision|3|||
163146988|NCT01045460|589248552|FG001|Overall Study|Physician Decision|2|||
163146989|NCT01045460|589248551|FG000|Overall Study|Lost to Follow-up|0|||
163146990|NCT01045460|589248552|FG001|Overall Study|Lost to Follow-up|1|||
163146991|NCT01045460|589248551|FG000|Overall Study|Lack of Efficacy|3|||
163146992|NCT01045460|589248552|FG001|Overall Study|Lack of Efficacy|0|||
163146993|NCT00436332|589248555|FG000|Overall Study|Adverse Event|9|||
163146994|NCT00436332|589248555|FG000|Overall Study|Withdrawal by Subject|2|||
163146995|NCT00436332|589248555|FG000|Overall Study|Progression|59|||
163146996|NCT00436332|589248555|FG000|Overall Study|Death|2|||
163146997|NCT00436332|589248555|FG000|Overall Study|Not Protocol Specified|6|||
163146998|NCT00436332|589248555|FG000|Overall Study|Ineligible|2|||
163146999|NCT00436332|589248555|FG000|Overall Study|Never Received Treatment|3|||
163147000|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
163147001|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
163147002|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
163147003|NCT00062439|589248556|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
163147004|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Death|1|||
163147005|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Disease progression|2|||
163147006|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
163147007|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
163147008|NCT00062439|589248556|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
162721462|NCT03482011|587688309|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
162721463|NCT03482011|587688310|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
163147009|NCT00062439|589248556|FG000|Surgery|Physician Decision|4|||
163147010|NCT00062439|589248556|FG000|Surgery|Death|1|||
163147011|NCT00062439|589248556|FG000|Surgery|Adverse Event|2|||
163147012|NCT00062439|589248556|FG000|Consolidation Chemotherapy|Adverse Event|2|||
163147013|NCT01924845|589248557|FG000|Overall Study|Adverse Event|3|||
162665113|NCT02032901|587485092|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
162665114|NCT00466193|587485093|FG000|Overall Study|Adverse Event|0|||
162665115|NCT00466193|587485094|FG001|Overall Study|Adverse Event|1|||
162665116|NCT00466193|587485093|FG000|Overall Study|Lost to Follow-up|2|||
162665117|NCT00466193|587485094|FG001|Overall Study|Lost to Follow-up|4|||
162665118|NCT00466193|587485093|FG000|Overall Study|Physician Decision|1|||
162665119|NCT00466193|587485094|FG001|Overall Study|Physician Decision|0|||
162665120|NCT00466193|587485093|FG000|Overall Study|Protocol Violation|1|||
162665121|NCT00466193|587485094|FG001|Overall Study|Protocol Violation|1|||
162665122|NCT00466193|587485093|FG000|Overall Study|Withdrawal by Subject|7|||
162665123|NCT00466193|587485094|FG001|Overall Study|Withdrawal by Subject|2|||
162665124|NCT00466193|587485093|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
162665125|NCT00466193|587485094|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
162665126|NCT00086346|587485101|FG000|Randomization|Did not receive test article|4|||
162665127|NCT00086346|587485102|FG001|Randomization|Did not receive test article|4|||
162665128|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Adverse Event|94|||
162665129|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Adverse Event|11|||
162665130|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
162665131|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
162665132|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
162665133|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
162665134|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
162665135|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
162665136|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
162665137|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
162665138|NCT00086346|587485101|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
162665139|NCT00086346|587485102|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
162665140|NCT04495374|587485103|FG000|Overall Study|Protocol Violation|2|||
162665141|NCT04495374|587485104|FG001|Overall Study|Protocol Violation|1|||
162665142|NCT02473614|587485105|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
162665143|NCT02473614|587485106|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
162665144|NCT02525133|587485107|FG000|Overall Study|Adverse Event|0|||
163147014|NCT01924845|589248557|FG000|Overall Study|Withdrawal by Subject|2|||
163147015|NCT01924845|589248557|FG000|Overall Study|Protocol Violation|1|||
163147016|NCT03780452|589248558|FG000|Overall Study|Screening failure|2|||
163147017|NCT02388269|589248559|FG000|Overall Study|Adverse Event|2|||
163147018|NCT02388269|589248560|FG001|Overall Study|Adverse Event|0|||
163147019|NCT02388269|589248561|FG002|Overall Study|Adverse Event|0|||
163147020|NCT02388269|589248559|FG000|Overall Study|Withdrawal by Subject|1|||
163147021|NCT02388269|589248560|FG001|Overall Study|Withdrawal by Subject|2|||
163147022|NCT02388269|589248561|FG002|Overall Study|Withdrawal by Subject|0|||
163147023|NCT02388269|589248559|FG000|Overall Study|less than 50% stimulations|1|||
163147024|NCT02388269|589248560|FG001|Overall Study|less than 50% stimulations|0|||
163147025|NCT02388269|589248561|FG002|Overall Study|less than 50% stimulations|0|||
163147026|NCT02388269|589248559|FG000|Overall Study|no diary data|3|||
163147027|NCT02388269|589248560|FG001|Overall Study|no diary data|0|||
163147028|NCT02388269|589248561|FG002|Overall Study|no diary data|0|||
163147029|NCT02388269|589248559|FG000|Overall Study|Protocol Violation|2|||
163147030|NCT02388269|589248560|FG001|Overall Study|Protocol Violation|0|||
163147031|NCT02388269|589248561|FG002|Overall Study|Protocol Violation|0|||
163147032|NCT02388269|589248559|FG000|Overall Study|Screen Failure|0|||
163147033|NCT02388269|589248560|FG001|Overall Study|Screen Failure|0|||
163147034|NCT02388269|589248561|FG002|Overall Study|Screen Failure|10|||
163147035|NCT00265564|589248564|FG000|Overall Study|Lost to Follow-up|5|||
163147036|NCT00265564|589248565|FG001|Overall Study|Lost to Follow-up|7|||
163147037|NCT00265564|589248564|FG000|Overall Study|met exclusion criteria|5|||
163147038|NCT00265564|589248565|FG001|Overall Study|met exclusion criteria|2|||
163147039|NCT04698343|589248566|FG000|Overall Study|Withdrawal by Subject|6|||
163147040|NCT04698343|589248566|FG000|Overall Study|Physician Decision|2|||
163147041|NCT04698343|589248566|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
163147042|NCT04698343|589248566|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
163147043|NCT04698343|589248566|FG000|Overall Study|Personal reasons|3|||
163147044|NCT04698343|589248566|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
162665145|NCT02525133|587485108|FG001|Overall Study|Adverse Event|1|||
162665146|NCT02525133|587485107|FG000|Overall Study|Death|0|||
162665147|NCT02525133|587485108|FG001|Overall Study|Death|1|||
163147045|NCT02163902|589248569|FG000|Overall Study|Subject's Request|3|||
162665148|NCT02525133|587485107|FG000|Overall Study|did not meet randomization criteria|1|||
162665149|NCT02525133|587485108|FG001|Overall Study|did not meet randomization criteria|0|||
162665150|NCT02525133|587485107|FG000|Overall Study|Lost to Follow-up|5|||
163147046|NCT02163902|589248570|FG001|Overall Study|Subject's Request|4|||
163147047|NCT02163902|589248569|FG000|Overall Study|Lost to Follow-up|6|||
163147048|NCT02163902|589248570|FG001|Overall Study|Lost to Follow-up|7|||
163147049|NCT02163902|589248569|FG000|Overall Study|Administrative Decision|2|||
163147050|NCT02163902|589248570|FG001|Overall Study|Administrative Decision|2|||
163147051|NCT00325897|589248573|FG000|Overall Study|Lost to Follow-up|12|||
163147052|NCT00325897|589248574|FG001|Overall Study|Lost to Follow-up|13|||
163147053|NCT00467740|589248575|FG000|Overall Study|Adverse Event|0|||
163147054|NCT00467740|589248576|FG001|Overall Study|Adverse Event|0|||
163147055|NCT00467740|589248577|FG002|Overall Study|Adverse Event|1|||
163147056|NCT00467740|589248578|FG003|Overall Study|Adverse Event|0|||
163147057|NCT00467740|589248579|FG004|Overall Study|Adverse Event|0|||
163147058|NCT00467740|589248575|FG000|Overall Study|Protocol Violation|0|||
163147059|NCT00467740|589248576|FG001|Overall Study|Protocol Violation|0|||
163147060|NCT00467740|589248577|FG002|Overall Study|Protocol Violation|1|||
163147061|NCT00467740|589248578|FG003|Overall Study|Protocol Violation|0|||
163147062|NCT00467740|589248579|FG004|Overall Study|Protocol Violation|0|||
163147063|NCT00467740|589248575|FG000|Overall Study|Lost to Follow-up|0|||
163147064|NCT00467740|589248576|FG001|Overall Study|Lost to Follow-up|1|||
163147065|NCT00467740|589248577|FG002|Overall Study|Lost to Follow-up|0|||
163147066|NCT00467740|589248578|FG003|Overall Study|Lost to Follow-up|0|||
163147067|NCT00467740|589248579|FG004|Overall Study|Lost to Follow-up|0|||
163147068|NCT00467740|589248575|FG000|Overall Study|Withdrawal by Subject|1|||
163147069|NCT00467740|589248576|FG001|Overall Study|Withdrawal by Subject|1|||
163147070|NCT00467740|589248577|FG002|Overall Study|Withdrawal by Subject|0|||
163147071|NCT00467740|589248578|FG003|Overall Study|Withdrawal by Subject|1|||
163147072|NCT00467740|589248579|FG004|Overall Study|Withdrawal by Subject|0|||
163147073|NCT00467740|589248575|FG000|Overall Study|Lack of Efficacy|0|||
163147074|NCT00467740|589248576|FG001|Overall Study|Lack of Efficacy|1|||
163147075|NCT00467740|589248577|FG002|Overall Study|Lack of Efficacy|0|||
163147076|NCT00467740|589248578|FG003|Overall Study|Lack of Efficacy|0|||
162665151|NCT02525133|587485108|FG001|Overall Study|Lost to Follow-up|1|||
162665152|NCT02525133|587485107|FG000|Overall Study|randomized not enrolled|3|||
162665153|NCT02525133|587485108|FG001|Overall Study|randomized not enrolled|0|||
162665154|NCT02525133|587485107|FG000|Overall Study|Withdrawal by Subject|1|||
162665155|NCT02525133|587485108|FG001|Overall Study|Withdrawal by Subject|0|||
162665156|NCT01343082|587485109|FG000|The run-in Period|Not meeting criteria|3|||
162665157|NCT01343082|587485110|FG001|The run-in Period|Not meeting criteria|4|||
162665158|NCT01343082|587485111|FG002|The run-in Period|Not meeting criteria|5|||
162665159|NCT01343082|587485109|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
162665160|NCT01343082|587485110|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
162665161|NCT01343082|587485111|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
162665162|NCT01343082|587485109|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
162665163|NCT01343082|587485110|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
162665164|NCT01343082|587485111|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
162665165|NCT01343082|587485109|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
162665166|NCT01343082|587485110|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
162665167|NCT01343082|587485111|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
162665168|NCT01343082|587485109|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
162665169|NCT01343082|587485110|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
162665170|NCT01343082|587485111|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
162665171|NCT01075074|587485112|FG000|Overall Study|Surgeon changed to open incisional case|1|||
162665172|NCT01075074|587485113|FG001|Overall Study|Surgeon changed to open incisional case|2|||
162665173|NCT01075074|587485114|FG002|Overall Study|Surgeon changed to open incisional case|2|||
162665174|NCT01575561|587485116|FG000|Overall Study|Adverse Event|9|||
162665175|NCT01575561|587485116|FG000|Overall Study|Lack of Efficacy|8|||
162665176|NCT01575561|587485116|FG000|Overall Study|Lost to Follow-up|6|||
162665177|NCT01575561|587485116|FG000|Overall Study|Protocol Violation|4|||
162665178|NCT01575561|587485116|FG000|Overall Study|Withdrawal by Subject|11|||
162665179|NCT01575561|587485116|FG000|Overall Study|administration|1|||
162665180|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
162665181|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
162665182|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
162665183|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665184|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665185|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665186|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665187|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665188|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162665189|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
162665190|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
162665191|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
162665192|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163147077|NCT00467740|589248579|FG004|Overall Study|Lack of Efficacy|0|||
163147078|NCT02903160|589248580|FG000|Overall Study|Adverse Event|2|||
163147079|NCT02903160|589248580|FG000|Overall Study|Death|1|||
163147080|NCT02903160|589248580|FG000|Overall Study|Lost to Follow-up|2|||
163147081|NCT02903160|589248580|FG000|Overall Study|Withdrawal by Subject|1|||
163147082|NCT02903160|589248580|FG000|Overall Study|Medical Insurance Barriers|1|||
163147083|NCT01664910|589248583|FG000|Overall Study|Adverse Event|0|||
163147084|NCT01664910|589248584|FG001|Overall Study|Adverse Event|0|||
163147085|NCT01664910|589248585|FG002|Overall Study|Adverse Event|1|||
163147086|NCT02240485|589248586|FG000|3 Months Post-admission|Lost to Follow-up|1|||
163147087|NCT02240485|589248587|FG001|3 Months Post-admission|Lost to Follow-up|5|||
163147088|NCT02240485|589248586|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
163147089|NCT02240485|589248587|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
163147090|NCT02240485|589248586|FG000|9 Months Post-admission|Lost to Follow-up|3|||
163147091|NCT02240485|589248587|FG001|9 Months Post-admission|Lost to Follow-up|1|||
163147092|NCT02240485|589248586|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
163147093|NCT02240485|589248587|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
163147094|NCT02240485|589248586|FG000|18 Months Post-admission|Lost to Follow-up|1|||
163147095|NCT02240485|589248587|FG001|18 Months Post-admission|Lost to Follow-up|1|||
163147096|NCT02240485|589248586|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
163147097|NCT02240485|589248587|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
163147098|NCT02525471|589248588|FG000|Overall Study|Screen Failure|6|||
163147099|NCT02525471|589248588|FG000|Overall Study|Withdrawal by Subject|4|||
163147100|NCT02525471|589248588|FG000|Overall Study|Death|1|||
163147101|NCT00844376|589248592|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
163147102|NCT00844376|589248593|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
163147103|NCT00539981|589248596|FG000|Overall Study|Adverse events (AE)|3|||
163147104|NCT00539981|589248597|FG001|Overall Study|Adverse events (AE)|3|||
163147105|NCT00539981|589248596|FG000|Overall Study|Lost to Follow-up|260|||
163147106|NCT00539981|589248597|FG001|Overall Study|Lost to Follow-up|251|||
163147107|NCT00539981|589248596|FG000|Overall Study|Withdrew consent|22|||
163147108|NCT00539981|589248597|FG001|Overall Study|Withdrew consent|14|||
163147109|NCT00539981|589248596|FG000|Overall Study|Death|1|||
163147110|NCT00539981|589248597|FG001|Overall Study|Death|1|||
163147111|NCT00539981|589248596|FG000|Overall Study|Other reason-unspecified|9|||
163147112|NCT00539981|589248597|FG001|Overall Study|Other reason-unspecified|13|||
163147113|NCT01759420|589248598|FG000|Overall Study|Screen failure|5|||
163147114|NCT01759420|589248598|FG000|Overall Study|Inaccurate EKG machine readings|1|||
163147115|NCT01129622|589248599|FG000|Overall Study|Withdrawal by Subject|2|||
163147116|NCT03069352|589248603|FG000|Overall Study|Ongoing|12|||
163147117|NCT03069352|589248604|FG001|Overall Study|Ongoing|40|||
163147118|NCT02621424|589248605|FG000|Overall Study|Withdrawal by Subject|1|||
163147119|NCT02621424|589248606|FG001|Overall Study|Withdrawal by Subject|2|||
163147120|NCT00633477|589251150|FG000|Overall Study|Death|1|||
163147121|NCT00633477|589251151|FG001|Overall Study|Death|0|||
163147122|NCT00633477|589251150|FG000|Overall Study|Randomized but not treated|1|||
163147123|NCT00633477|589251151|FG001|Overall Study|Randomized but not treated|0|||
163147124|NCT04906499|589251153|FG000|Overall Study|Lack of time|1|||
163147125|NCT03346434|589251154|FG000|Overall Study|Randomized in Error|0|||
163147126|NCT03346434|589251155|FG001|Overall Study|Randomized in Error|0|||
163147127|NCT03346434|589251156|FG002|Overall Study|Randomized in Error|0|||
163147128|NCT03346434|589251157|FG003|Overall Study|Randomized in Error|0|||
163147129|NCT03346434|589251158|FG004|Overall Study|Randomized in Error|1|||
163147130|NCT03346434|589251159|FG005|Overall Study|Randomized in Error|0|||
163147131|NCT03346434|589251154|FG000|Overall Study|Withdrawal by Subject|0|||
163147132|NCT03346434|589251155|FG001|Overall Study|Withdrawal by Subject|0|||
163147133|NCT03346434|589251156|FG002|Overall Study|Withdrawal by Subject|1|||
163147134|NCT03346434|589251157|FG003|Overall Study|Withdrawal by Subject|0|||
163147135|NCT03346434|589251158|FG004|Overall Study|Withdrawal by Subject|1|||
163147136|NCT03346434|589251159|FG005|Overall Study|Withdrawal by Subject|0|||
163147137|NCT03346434|589251154|FG000|Overall Study|Lost to Follow-up|0|||
163147138|NCT03346434|589251155|FG001|Overall Study|Lost to Follow-up|0|||
163147139|NCT03346434|589251156|FG002|Overall Study|Lost to Follow-up|0|||
163147140|NCT03346434|589251157|FG003|Overall Study|Lost to Follow-up|0|||
163147141|NCT03346434|589251158|FG004|Overall Study|Lost to Follow-up|1|||
163147142|NCT03346434|589251159|FG005|Overall Study|Lost to Follow-up|1|||
163147143|NCT03346434|589251154|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147144|NCT03346434|589251155|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147145|NCT03346434|589251156|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147146|NCT03346434|589251157|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
163147147|NCT03346434|589251158|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
163147148|NCT03346434|589251159|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
163147149|NCT02081677|589251160|FG000|Overall Study|Adverse Event|0|||
163147150|NCT02081677|589251161|FG001|Overall Study|Adverse Event|0|||
163147151|NCT02081677|589251162|FG002|Overall Study|Adverse Event|1|||
163147152|NCT02081677|589251163|FG003|Overall Study|Adverse Event|0|||
163147153|NCT02081677|589251160|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147154|NCT02081677|589251161|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147155|NCT02081677|589251162|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
163147156|NCT02081677|589251163|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
163147157|NCT02081677|589251160|FG000|Overall Study|Not comfortable with lens care system|1|||
163147158|NCT02081677|589251161|FG001|Overall Study|Not comfortable with lens care system|0|||
163147159|NCT02081677|589251162|FG002|Overall Study|Not comfortable with lens care system|0|||
163147160|NCT02081677|589251163|FG003|Overall Study|Not comfortable with lens care system|0|||
163147161|NCT02081677|589251160|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163147162|NCT02081677|589251161|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163147163|NCT02081677|589251162|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
163147164|NCT02081677|589251163|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
163147165|NCT01751061|589251174|FG000|Overall Study|Death|1|||
163147166|NCT01751061|589251175|FG001|Overall Study|Death|0|||
163147167|NCT01751061|589251174|FG000|Overall Study|patient death|5|||
163147168|NCT01751061|589251175|FG001|Overall Study|patient death|0|||
163147169|NCT01751061|589251174|FG000|Overall Study|Lost to Follow-up|40|||
163147170|NCT01751061|589251175|FG001|Overall Study|Lost to Follow-up|25|||
163147171|NCT01751061|589251174|FG000|Overall Study|patient regained decisional capacity|4|||
163147172|NCT01751061|589251175|FG001|Overall Study|patient regained decisional capacity|8|||
163147173|NCT01751061|589251174|FG000|Overall Study|Withdrawal by Subject|4|||
163147174|NCT01751061|589251175|FG001|Overall Study|Withdrawal by Subject|1|||
163147175|NCT01751061|589251174|FG000|Overall Study|Physician Decision|2|||
163147176|NCT01751061|589251175|FG001|Overall Study|Physician Decision|0|||
163147177|NCT02412306|589251176|FG000|Overall Study|Lost to Follow-up|0|||
163147178|NCT02412306|589251177|FG001|Overall Study|Lost to Follow-up|1|||
163147179|NCT02412306|589251178|FG002|Overall Study|Lost to Follow-up|0|||
163147180|NCT02412306|589251179|FG003|Overall Study|Lost to Follow-up|0|||
163147181|NCT02412306|589251180|FG004|Overall Study|Lost to Follow-up|0|||
163147182|NCT02412306|589251176|FG000|Overall Study|Withdrawal by Subject|0|||
163147183|NCT02412306|589251177|FG001|Overall Study|Withdrawal by Subject|0|||
163147184|NCT02412306|589251178|FG002|Overall Study|Withdrawal by Subject|1|||
163147185|NCT02412306|589251179|FG003|Overall Study|Withdrawal by Subject|0|||
163147186|NCT02412306|589251180|FG004|Overall Study|Withdrawal by Subject|0|||
163147187|NCT02412306|589251176|FG000|Overall Study|Death|5|||
163147188|NCT02412306|589251177|FG001|Overall Study|Death|7|||
163147189|NCT02412306|589251178|FG002|Overall Study|Death|15|||
163147190|NCT02412306|589251179|FG003|Overall Study|Death|0|||
163147191|NCT02412306|589251180|FG004|Overall Study|Death|2|||
163147192|NCT05635461|589251181|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147193|NCT05635461|589251182|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147194|NCT05635461|589251183|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147195|NCT05635461|589251184|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147196|NCT05635461|589251185|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
163147197|NCT05635461|589251186|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
163147198|NCT05635461|589251181|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147199|NCT05635461|589251182|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
163147200|NCT05635461|589251183|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147201|NCT05635461|589251184|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147202|NCT05635461|589251185|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147203|NCT05635461|589251186|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
163147204|NCT05635461|589251181|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147205|NCT05635461|589251182|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147206|NCT05635461|589251183|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147207|NCT05635461|589251184|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
163147208|NCT05635461|589251185|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147209|NCT05635461|589251186|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
163147210|NCT00614575|589251187|FG000|Overall Study|Adverse Event|106|||
163147211|NCT00614575|589251187|FG000|Overall Study|Lost to Follow-up|55|||
163147212|NCT00614575|589251187|FG000|Overall Study|Lack of Efficacy|14|||
163147213|NCT00614575|589251187|FG000|Overall Study|Withdrawal by Subject|6|||
163147214|NCT00614575|589251187|FG000|Overall Study|Death|3|||
163147215|NCT00614575|589251187|FG000|Overall Study|Physician Decision|2|||
163147216|NCT00614575|589251187|FG000|Overall Study|No data were collected.|18|||
163147217|NCT00614575|589251187|FG000|Overall Study|Irregularly enrolled patients|23|||
162721464|NCT03482011|587688311|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
162721465|NCT03482011|587688312|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
163147218|NCT00614575|589251187|FG000|Overall Study|No treatment|1|||
163147219|NCT00189540|589251188|FG000|Overall Study|Withdrawal by Subject|3|||
163147220|NCT00189540|589251189|FG001|Overall Study|Withdrawal by Subject|0|||
163147221|NCT00189540|589251188|FG000|Overall Study|Death|4|||
163147222|NCT00189540|589251189|FG001|Overall Study|Death|1|||
163147223|NCT00472108|589251190|FG000|Overall Study|Lost to Follow-up|0|||
163147224|NCT00472108|589251191|FG001|Overall Study|Lost to Follow-up|1|||
163147225|NCT03882021|589251192|FG000|Enrollment|Procedure aborted/cancelled|2|||
163147226|NCT03882021|589251192|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
163147227|NCT03882021|589251192|FG000|Enrollment to 3-Month|Death|1|||
163147228|NCT03882021|589251192|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
163147229|NCT03882021|589251192|FG000|Enrollment to 3-Month|Missed Visit|4|||
163147230|NCT03882021|589251192|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
163147231|NCT03882021|589251192|FG000|6-Month to 12-Month Visit|Death|1|||
163147232|NCT03882021|589251192|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
163147233|NCT00286442|589251193|FG000|Overall Study|Hyperglycemic Rescue|19|||
163147234|NCT00286442|589251194|FG001|Overall Study|Hyperglycemic Rescue|17|||
163147235|NCT00286442|589251195|FG002|Overall Study|Hyperglycemic Rescue|25|||
163147236|NCT00286442|589251193|FG000|Overall Study|Adverse Event|7|||
163147237|NCT00286442|589251194|FG001|Overall Study|Adverse Event|6|||
163147238|NCT00286442|589251195|FG002|Overall Study|Adverse Event|1|||
163147239|NCT00286442|589251193|FG000|Overall Study|Protocol Violation|2|||
163147240|NCT00286442|589251194|FG001|Overall Study|Protocol Violation|4|||
163147241|NCT00286442|589251195|FG002|Overall Study|Protocol Violation|2|||
163147242|NCT00286442|589251193|FG000|Overall Study|Lost to Follow-up|5|||
163147243|NCT00286442|589251194|FG001|Overall Study|Lost to Follow-up|2|||
163147244|NCT00286442|589251195|FG002|Overall Study|Lost to Follow-up|1|||
163147245|NCT00286442|589251193|FG000|Overall Study|Physician Decision|1|||
163147246|NCT00286442|589251194|FG001|Overall Study|Physician Decision|1|||
163147247|NCT00286442|589251195|FG002|Overall Study|Physician Decision|1|||
163147248|NCT00286442|589251193|FG000|Overall Study|Administrative Error|1|||
163147249|NCT00286442|589251194|FG001|Overall Study|Administrative Error|1|||
163147250|NCT00286442|589251195|FG002|Overall Study|Administrative Error|0|||
163147251|NCT00286442|589251193|FG000|Overall Study|Withdrawal by Subject|2|||
163147252|NCT00286442|589251194|FG001|Overall Study|Withdrawal by Subject|14|||
163147253|NCT00286442|589251195|FG002|Overall Study|Withdrawal by Subject|2|||
163147254|NCT03582215|589251198|FG000|Overall Study|Adverse Event|1|||
163147255|NCT03582215|589251199|FG001|Overall Study|Adverse Event|0|||
163147256|NCT03582215|589251200|FG002|Overall Study|Adverse Event|0|||
163147257|NCT03582215|589251201|FG003|Overall Study|Adverse Event|0|||
163147258|NCT03582215|589251202|FG004|Overall Study|Adverse Event|0|||
163147259|NCT03582215|589251203|FG005|Overall Study|Adverse Event|0|||
163147260|NCT03582215|589251204|FG006|Overall Study|Adverse Event|2|||
163147261|NCT03582215|589251205|FG007|Overall Study|Adverse Event|2|||
163147262|NCT02174731|589251206|FG000|Overall Study|Participant decision|67|||
163147263|NCT02174731|589251207|FG001|Overall Study|Participant decision|64|||
163147264|NCT02174731|589251206|FG000|Overall Study|Incorrect enrolment before randomization|0|||
163147265|NCT02174731|589251207|FG001|Overall Study|Incorrect enrolment before randomization|1|||
163147266|NCT02174731|589251206|FG000|Overall Study|Missing|2|||
163147267|NCT02174731|589251207|FG001|Overall Study|Missing|0|||
163147268|NCT00079040|589251208|FG000|Overall Study|Withdrew before treatment|1|||
163147269|NCT00079040|589251208|FG000|Overall Study|Ineligible|1|||
163147270|NCT03915717|589251213|FG000|Overall Study|EchoMark Not Implanted|6|||
163147271|NCT04079296|589251216|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147272|NCT04079296|589251217|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147273|NCT04079296|589251218|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
163147274|NCT04079296|589251219|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
163147275|NCT04079296|589251220|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
163147276|NCT04079296|589251216|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147277|NCT04079296|589251217|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147278|NCT04079296|589251218|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
163147279|NCT04079296|589251219|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
163147280|NCT04079296|589251220|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
163147281|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147282|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147283|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163147284|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
162665193|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162665194|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162665195|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162665196|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162665197|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162665198|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162665199|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
162665200|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
162665201|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162665202|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163147285|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
163147286|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147287|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147288|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147289|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
163147290|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
163147291|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147292|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147293|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147294|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
163147295|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
163147296|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147297|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147298|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
163147299|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
163147300|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
163147301|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147302|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147303|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
163147304|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
163147305|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
163147306|NCT04079296|589251216|FG000|Dose Expansion Phase (168 Days)|Death|0|||
163147307|NCT04079296|589251217|FG001|Dose Expansion Phase (168 Days)|Death|0|||
163147308|NCT04079296|589251218|FG002|Dose Expansion Phase (168 Days)|Death|0|||
163147309|NCT04079296|589251219|FG003|Dose Expansion Phase (168 Days)|Death|1|||
163147310|NCT04079296|589251220|FG004|Dose Expansion Phase (168 Days)|Death|0|||
163147311|NCT00867165|589251233|FG000|Overall Study|Adverse Event|3|||
163147312|NCT00867165|589251234|FG001|Overall Study|Adverse Event|0|||
163147313|NCT00867165|589251233|FG000|Overall Study|Withdrawal by Subject|1|||
163147314|NCT00867165|589251234|FG001|Overall Study|Withdrawal by Subject|0|||
163147315|NCT03275740|589251235|FG000|Overall Study|Adverse Event|0|||
163147316|NCT03275740|589251236|FG001|Overall Study|Adverse Event|0|||
163147317|NCT03275740|589251237|FG002|Overall Study|Adverse Event|0|||
163147318|NCT03275740|589251238|FG003|Overall Study|Adverse Event|0|||
163147319|NCT03275740|589251239|FG004|Overall Study|Adverse Event|1|||
163147320|NCT03275740|589251240|FG005|Overall Study|Adverse Event|0|||
163147321|NCT03275740|589251241|FG006|Overall Study|Adverse Event|0|||
163147322|NCT03275740|589251242|FG007|Overall Study|Adverse Event|0|||
163147323|NCT03275740|589251243|FG008|Overall Study|Adverse Event|0|||
163147324|NCT03275740|589251244|FG009|Overall Study|Adverse Event|0|||
163147325|NCT03275740|589251245|FG010|Overall Study|Adverse Event|0|||
163147326|NCT03275740|589251246|FG011|Overall Study|Adverse Event|0|||
163147327|NCT03275740|589251235|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147328|NCT03275740|589251236|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147329|NCT03275740|589251237|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147330|NCT03275740|589251238|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147331|NCT03275740|589251239|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147332|NCT03275740|589251240|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
163147333|NCT03275740|589251241|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147334|NCT03275740|589251242|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147335|NCT03275740|589251243|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147336|NCT03275740|589251244|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147337|NCT03275740|589251245|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147338|NCT03275740|589251246|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
163147339|NCT03275740|589251235|FG000|Overall Study|Withdrawal by Subject|0|||
163147340|NCT03275740|589251236|FG001|Overall Study|Withdrawal by Subject|0|||
163147341|NCT03275740|589251237|FG002|Overall Study|Withdrawal by Subject|0|||
163147342|NCT03275740|589251238|FG003|Overall Study|Withdrawal by Subject|0|||
163147343|NCT03275740|589251239|FG004|Overall Study|Withdrawal by Subject|0|||
163147344|NCT03275740|589251240|FG005|Overall Study|Withdrawal by Subject|0|||
163147345|NCT03275740|589251241|FG006|Overall Study|Withdrawal by Subject|0|||
163147346|NCT03275740|589251242|FG007|Overall Study|Withdrawal by Subject|0|||
163147347|NCT03275740|589251243|FG008|Overall Study|Withdrawal by Subject|1|||
163147348|NCT03275740|589251244|FG009|Overall Study|Withdrawal by Subject|1|||
163147349|NCT03275740|589251245|FG010|Overall Study|Withdrawal by Subject|0|||
163147350|NCT03275740|589251246|FG011|Overall Study|Withdrawal by Subject|0|||
163147351|NCT00988884|589251248|FG000|Overall Study|Adverse Event|0|||
163147352|NCT00988884|589251249|FG001|Overall Study|Adverse Event|1|||
163147353|NCT00988884|589251248|FG000|Overall Study|Lost to Follow-up|20|||
163147354|NCT00988884|589251249|FG001|Overall Study|Lost to Follow-up|16|||
163147355|NCT00988884|589251248|FG000|Overall Study|Protocol Violation|0|||
163147356|NCT00988884|589251249|FG001|Overall Study|Protocol Violation|1|||
163147357|NCT00988884|589251248|FG000|Overall Study|Withdrawal by Subject|15|||
163147358|NCT00988884|589251249|FG001|Overall Study|Withdrawal by Subject|18|||
163147359|NCT04621448|589251251|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
163147360|NCT04621448|589251252|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
163147361|NCT04621448|589251253|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
163147362|NCT04621448|589251254|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
163147363|NCT04621448|589251251|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
163147364|NCT04621448|589251252|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
163147365|NCT04621448|589251253|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
163147366|NCT04621448|589251254|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
163147367|NCT04621448|589251251|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
163147368|NCT04621448|589251252|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
163147369|NCT04621448|589251253|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
163147370|NCT04621448|589251254|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
163147371|NCT04621448|589251251|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
163147372|NCT04621448|589251252|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
163147373|NCT04621448|589251253|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
162721466|NCT03482011|587688313|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
162721467|NCT03482011|587688314|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
163147374|NCT04621448|589251254|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
162721468|NCT03482011|587688307|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
162721469|NCT03482011|587688308|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
163147375|NCT00549640|589251255|FG000|Overall Study|Withdrawal by Subject|6|||
163147376|NCT00549640|589251256|FG001|Overall Study|Withdrawal by Subject|12|||
163147377|NCT00549640|589251255|FG000|Overall Study|Adverse Event|5|||
162665203|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162665204|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163147378|NCT00549640|589251256|FG001|Overall Study|Adverse Event|0|||
163147379|NCT00549640|589251255|FG000|Overall Study|Lost to Follow-up|7|||
163147380|NCT00549640|589251256|FG001|Overall Study|Lost to Follow-up|4|||
163147381|NCT03550378|589251257|FG000|Overall Study|Death|0|||
163147382|NCT03550378|589251258|FG001|Overall Study|Death|1|||
163147383|NCT04486235|589251259|FG000|Overall Study|Pregnancy|1|||
163147384|NCT04486235|589251260|FG001|Overall Study|Pregnancy|0|||
163147385|NCT04486235|589251259|FG000|Overall Study|Lost to Follow-up|1|||
163147386|NCT04486235|589251260|FG001|Overall Study|Lost to Follow-up|0|||
163147387|NCT00626275|589251261|FG000|Part A - Treatment Period 1|Adverse Event|1|||
163147388|NCT00626275|589251262|FG001|Part A - Treatment Period 1|Adverse Event|0|||
163147389|NCT00626275|589251263|FG002|Part A - Treatment Period 1|Adverse Event|0|||
163147390|NCT00626275|589251264|FG003|Part A - Treatment Period 1|Adverse Event|0|||
163147391|NCT00626275|589251265|FG004|Part A - Treatment Period 1|Adverse Event|0|||
163147392|NCT00626275|589251266|FG005|Part A - Treatment Period 1|Adverse Event|0|||
163147393|NCT00626275|589251267|FG006|Part A - Treatment Period 1|Adverse Event|0|||
163147394|NCT00626275|589251268|FG007|Part A - Treatment Period 1|Adverse Event|0|||
163147395|NCT00626275|589251261|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147396|NCT00626275|589251262|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147397|NCT00626275|589251263|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
163147398|NCT00626275|589251264|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147399|NCT00626275|589251265|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147400|NCT00626275|589251266|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147401|NCT00626275|589251267|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147402|NCT00626275|589251268|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
163147403|NCT00626275|589251261|FG000|Part B|Lost to Follow-up|0|||
163147404|NCT00626275|589251262|FG001|Part B|Lost to Follow-up|0|||
163147405|NCT00626275|589251263|FG002|Part B|Lost to Follow-up|0|||
163147406|NCT00626275|589251264|FG003|Part B|Lost to Follow-up|0|||
163147407|NCT00626275|589251265|FG004|Part B|Lost to Follow-up|0|||
163147408|NCT00626275|589251266|FG005|Part B|Lost to Follow-up|0|||
163147409|NCT00626275|589251267|FG006|Part B|Lost to Follow-up|1|||
163147410|NCT00626275|589251268|FG007|Part B|Lost to Follow-up|0|||
163147411|NCT00626275|589251261|FG000|Part B|Withdrawal by Subject|0|||
163147412|NCT00626275|589251262|FG001|Part B|Withdrawal by Subject|0|||
163147413|NCT00626275|589251263|FG002|Part B|Withdrawal by Subject|0|||
163147414|NCT00626275|589251264|FG003|Part B|Withdrawal by Subject|0|||
163147415|NCT00626275|589251265|FG004|Part B|Withdrawal by Subject|0|||
163147416|NCT00626275|589251266|FG005|Part B|Withdrawal by Subject|0|||
163147417|NCT00626275|589251267|FG006|Part B|Withdrawal by Subject|0|||
163147418|NCT00626275|589251268|FG007|Part B|Withdrawal by Subject|1|||
163147419|NCT04999839|589251269|FG000|Overall Study|Adverse Event|1|||
163147420|NCT04999839|589251270|FG001|Overall Study|Adverse Event|1|||
163147421|NCT04999839|589251271|FG002|Overall Study|Adverse Event|1|||
163147422|NCT04999839|589251272|FG003|Overall Study|Adverse Event|1|||
163147423|NCT04999839|589251273|FG004|Overall Study|Adverse Event|1|||
163147424|NCT04999839|589251269|FG000|Overall Study|Lost to Follow-up|2|||
163147425|NCT04999839|589251270|FG001|Overall Study|Lost to Follow-up|0|||
163147426|NCT04999839|589251271|FG002|Overall Study|Lost to Follow-up|2|||
163147427|NCT04999839|589251272|FG003|Overall Study|Lost to Follow-up|4|||
163147428|NCT04999839|589251273|FG004|Overall Study|Lost to Follow-up|1|||
163147429|NCT04999839|589251269|FG000|Overall Study|Withdrawal by Subject|6|||
163147430|NCT04999839|589251270|FG001|Overall Study|Withdrawal by Subject|5|||
163147431|NCT04999839|589251271|FG002|Overall Study|Withdrawal by Subject|3|||
163147432|NCT04999839|589251272|FG003|Overall Study|Withdrawal by Subject|2|||
163147433|NCT04999839|589251273|FG004|Overall Study|Withdrawal by Subject|2|||
163147434|NCT04999839|589251269|FG000|Overall Study|Lack of Efficacy|0|||
163147435|NCT04999839|589251270|FG001|Overall Study|Lack of Efficacy|1|||
163147436|NCT04999839|589251271|FG002|Overall Study|Lack of Efficacy|0|||
163147437|NCT04999839|589251272|FG003|Overall Study|Lack of Efficacy|0|||
163147438|NCT04999839|589251273|FG004|Overall Study|Lack of Efficacy|0|||
163147439|NCT04999839|589251269|FG000|Overall Study|Physician Decision|0|||
163147440|NCT04999839|589251270|FG001|Overall Study|Physician Decision|0|||
163147441|NCT04999839|589251271|FG002|Overall Study|Physician Decision|0|||
163147442|NCT04999839|589251272|FG003|Overall Study|Physician Decision|0|||
163147443|NCT04999839|589251273|FG004|Overall Study|Physician Decision|1|||
162665205|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162665206|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162665207|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
162665208|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
163147444|NCT04999839|589251269|FG000|Overall Study|Sponsor request|0|||
163147445|NCT04999839|589251270|FG001|Overall Study|Sponsor request|1|||
163147446|NCT04999839|589251271|FG002|Overall Study|Sponsor request|0|||
163147447|NCT04999839|589251272|FG003|Overall Study|Sponsor request|0|||
163147448|NCT04999839|589251273|FG004|Overall Study|Sponsor request|0|||
163147449|NCT04999839|589251269|FG000|Overall Study|Other|0|||
163147450|NCT04999839|589251270|FG001|Overall Study|Other|0|||
163147451|NCT04999839|589251271|FG002|Overall Study|Other|1|||
163147452|NCT04999839|589251272|FG003|Overall Study|Other|0|||
163147453|NCT04999839|589251273|FG004|Overall Study|Other|0|||
163147454|NCT01362348|589251274|FG000|Overall Study|Protocol-defined stopping criteria|9|||
163147455|NCT01362348|589251274|FG000|Overall Study|Study closed/terminated|5|||
163147456|NCT00399516|589251275|FG000|Overall Study|Lost to Follow-up|2|||
163147457|NCT01046565|589251276|FG000|Overall Study|Adverse Event|2|||
163147458|NCT01046565|589251276|FG000|Overall Study|Withdrawal by Subject|7|||
163147459|NCT03546621|589251277|FG000|Overall Study|Withdrawal by Subject|0|||
163147460|NCT03546621|589251278|FG001|Overall Study|Withdrawal by Subject|1|||
163147461|NCT03546621|589251279|FG002|Overall Study|Withdrawal by Subject|2|||
163147462|NCT03546621|589251280|FG003|Overall Study|Withdrawal by Subject|1|||
163147463|NCT03546621|589251277|FG000|Overall Study|Lost to Follow-up|0|||
163147464|NCT03546621|589251278|FG001|Overall Study|Lost to Follow-up|1|||
163147465|NCT03546621|589251279|FG002|Overall Study|Lost to Follow-up|0|||
163147466|NCT03546621|589251280|FG003|Overall Study|Lost to Follow-up|0|||
163147467|NCT03546621|589251277|FG000|Overall Study|Adverse Event|0|||
163147468|NCT03546621|589251278|FG001|Overall Study|Adverse Event|1|||
163147469|NCT03546621|589251279|FG002|Overall Study|Adverse Event|0|||
163147470|NCT03546621|589251280|FG003|Overall Study|Adverse Event|1|||
163147471|NCT03546621|589251277|FG000|Overall Study|Progressive disease|0|||
163147472|NCT03546621|589251278|FG001|Overall Study|Progressive disease|0|||
163147473|NCT03546621|589251279|FG002|Overall Study|Progressive disease|0|||
163147474|NCT03546621|589251280|FG003|Overall Study|Progressive disease|1|||
163147475|NCT00660192|589251281|FG000|Overall Study|Lost to Follow-up|2|||
163147476|NCT00660192|589251282|FG001|Overall Study|Lost to Follow-up|3|||
163147477|NCT00377520|589251283|FG000|Overall Study|Ineligible (Prior radiation)|1|||
163147478|NCT00982735|589251284|FG000|Overall Study|Lost to Follow-up|6|||
163147479|NCT00982735|589251284|FG000|Overall Study|Patient ineligible for trial|224|||
163147480|NCT03740048|589251285|FG000|Overall Study|Withdrawal by Subject|1|||
163147481|NCT03740048|589251286|FG001|Overall Study|Withdrawal by Subject|1|||
163147482|NCT03740048|589251285|FG000|Overall Study|Death|1|||
163147483|NCT03740048|589251286|FG001|Overall Study|Death|6|||
163147484|NCT03740048|589251285|FG000|Overall Study|Switched to thrice-weekly HD|2|||
163147485|NCT03740048|589251286|FG001|Overall Study|Switched to thrice-weekly HD|0|||
163147486|NCT03740048|589251285|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
163147487|NCT03740048|589251286|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
163147488|NCT03740048|589251285|FG000|Overall Study|Lost to Follow-up|0|||
163147489|NCT03740048|589251286|FG001|Overall Study|Lost to Follow-up|1|||
163147490|NCT03740048|589251285|FG000|Overall Study|Non-compliance with HD|0|||
163147491|NCT03740048|589251286|FG001|Overall Study|Non-compliance with HD|1|||
163147492|NCT03261336|589251287|FG000|Overall Study|Adverse Event|1|||
163147493|NCT01069484|589251288|FG000|Overall Study|Death-in-near-family|1|||
163147494|NCT01069484|589251289|FG001|Overall Study|Death-in-near-family|0|||
163147495|NCT01069484|589251288|FG000|Overall Study|No specific reason|8|||
163147496|NCT01069484|589251289|FG001|Overall Study|No specific reason|2|||
163147497|NCT01069484|589251288|FG000|Overall Study|Illness mother or child|3|||
163147498|NCT01069484|589251289|FG001|Overall Study|Illness mother or child|1|||
163147499|NCT00292942|589251290|FG000|Overall Study|Withdrawal by Subject|0|||
163147500|NCT00292942|589251291|FG001|Overall Study|Withdrawal by Subject|0|||
163147501|NCT00292942|589251292|FG002|Overall Study|Withdrawal by Subject|1|||
163147502|NCT00292942|589251293|FG003|Overall Study|Withdrawal by Subject|0|||
163147503|NCT00292942|589251290|FG000|Overall Study|Adverse Event|0|||
163147504|NCT00292942|589251291|FG001|Overall Study|Adverse Event|0|||
163147505|NCT00292942|589251292|FG002|Overall Study|Adverse Event|0|||
163147506|NCT00292942|589251293|FG003|Overall Study|Adverse Event|1|||
163147507|NCT00644358|589251294|FG000|Overall Study|Adverse Event|124|||
163147508|NCT00644358|589251294|FG000|Overall Study|Lost to Follow-up|105|||
163147509|NCT00644358|589251294|FG000|Overall Study|Consent Withdrawal|64|||
163147510|NCT00644358|589251294|FG000|Overall Study|Lack of Effectiveness|39|||
163147511|NCT00644358|589251294|FG000|Overall Study|Protocol Violation|5|||
163147512|NCT00644358|589251294|FG000|Overall Study|Noncompliance|14|||
163147513|NCT00644358|589251294|FG000|Overall Study|Other Unspecified|11|||
163147514|NCT00651924|589251299|FG000|Overall Study|Withdrawal by PI|0|||
163147515|NCT00651924|589251300|FG001|Overall Study|Withdrawal by PI|2|||
163147516|NCT00651924|589251299|FG000|Overall Study|Withdrawal by Subject|0|||
163147517|NCT00651924|589251300|FG001|Overall Study|Withdrawal by Subject|5|||
163147518|NCT00758771|589251301|FG000|Overall Study|Withdrawal by Subject|1|||
163147519|NCT00758771|589251302|FG001|Overall Study|Withdrawal by Subject|1|||
163147520|NCT00758771|589251301|FG000|Overall Study|Did not meet eligibility criteria|2|||
162665209|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
162665210|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163147521|NCT00758771|589251302|FG001|Overall Study|Did not meet eligibility criteria|4|||
163147522|NCT00960063|589251303|FG000|Overall Study|Adverse Event|1|||
163147523|NCT00960063|589251304|FG001|Overall Study|Adverse Event|0|||
163147524|NCT00960063|589251305|FG002|Overall Study|Adverse Event|0|||
163147525|NCT00960063|589251303|FG000|Overall Study|Progression of Disease|0|||
163147526|NCT00960063|589251304|FG001|Overall Study|Progression of Disease|0|||
163147527|NCT00960063|589251305|FG002|Overall Study|Progression of Disease|3|||
163147528|NCT02051764|589251310|FG000|Overall Study|Study terminated by sponsor|0|||
163147529|NCT02051764|589251311|FG001|Overall Study|Study terminated by sponsor|7|||
163147530|NCT00591006|589251312|FG000|Overall Study|Withdrawal by Subject|0|||
163147531|NCT00591006|589251313|FG001|Overall Study|Withdrawal by Subject|0|||
163147532|NCT00591006|589251314|FG002|Overall Study|Withdrawal by Subject|0|||
163147533|NCT00591006|589251315|FG003|Overall Study|Withdrawal by Subject|0|||
163147534|NCT00591006|589251316|FG004|Overall Study|Withdrawal by Subject|0|||
163147535|NCT00591006|589251317|FG005|Overall Study|Withdrawal by Subject|0|||
163147536|NCT00591006|589251318|FG006|Overall Study|Withdrawal by Subject|0|||
163147537|NCT00591006|589251319|FG007|Overall Study|Withdrawal by Subject|0|||
163147538|NCT00591006|589251320|FG008|Overall Study|Withdrawal by Subject|0|||
163147539|NCT00591006|589251321|FG009|Overall Study|Withdrawal by Subject|0|||
163147540|NCT00591006|589251322|FG010|Overall Study|Withdrawal by Subject|0|||
163147541|NCT00591006|589251323|FG011|Overall Study|Withdrawal by Subject|0|||
163147542|NCT00591006|589251324|FG012|Overall Study|Withdrawal by Subject|0|||
163147543|NCT00591006|589251325|FG013|Overall Study|Withdrawal by Subject|0|||
163147544|NCT00591006|589251326|FG014|Overall Study|Withdrawal by Subject|0|||
163147545|NCT00591006|589251327|FG015|Overall Study|Withdrawal by Subject|1|||
163147546|NCT00591006|589251328|FG016|Overall Study|Withdrawal by Subject|0|||
163147547|NCT00591006|589251329|FG017|Overall Study|Withdrawal by Subject|0|||
163147548|NCT00591006|589251330|FG018|Overall Study|Withdrawal by Subject|0|||
163147549|NCT00591006|589251331|FG019|Overall Study|Withdrawal by Subject|0|||
163147550|NCT00591006|589251332|FG020|Overall Study|Withdrawal by Subject|0|||
163147551|NCT00591006|589251333|FG021|Overall Study|Withdrawal by Subject|0|||
163147552|NCT00591006|589251334|FG022|Overall Study|Withdrawal by Subject|0|||
163147553|NCT00591006|589251335|FG023|Overall Study|Withdrawal by Subject|1|||
163147554|NCT00591006|589251312|FG000|Overall Study|Adverse Event|0|||
163147555|NCT00591006|589251313|FG001|Overall Study|Adverse Event|0|||
163147556|NCT00591006|589251314|FG002|Overall Study|Adverse Event|0|||
163147557|NCT00591006|589251315|FG003|Overall Study|Adverse Event|0|||
163147558|NCT00591006|589251316|FG004|Overall Study|Adverse Event|0|||
163147559|NCT00591006|589251317|FG005|Overall Study|Adverse Event|0|||
163147560|NCT00591006|589251318|FG006|Overall Study|Adverse Event|0|||
163147561|NCT00591006|589251319|FG007|Overall Study|Adverse Event|0|||
163147562|NCT00591006|589251320|FG008|Overall Study|Adverse Event|0|||
163147563|NCT00591006|589251321|FG009|Overall Study|Adverse Event|0|||
163147564|NCT00591006|589251322|FG010|Overall Study|Adverse Event|0|||
163147565|NCT00591006|589251323|FG011|Overall Study|Adverse Event|0|||
163147566|NCT00591006|589251324|FG012|Overall Study|Adverse Event|0|||
163147567|NCT00591006|589251325|FG013|Overall Study|Adverse Event|0|||
163147568|NCT00591006|589251326|FG014|Overall Study|Adverse Event|0|||
163147569|NCT00591006|589251327|FG015|Overall Study|Adverse Event|0|||
163147570|NCT00591006|589251328|FG016|Overall Study|Adverse Event|0|||
163147571|NCT00591006|589251329|FG017|Overall Study|Adverse Event|0|||
163147572|NCT00591006|589251330|FG018|Overall Study|Adverse Event|0|||
163147573|NCT00591006|589251331|FG019|Overall Study|Adverse Event|0|||
163147574|NCT00591006|589251332|FG020|Overall Study|Adverse Event|0|||
163147575|NCT00591006|589251333|FG021|Overall Study|Adverse Event|0|||
163147576|NCT00591006|589251334|FG022|Overall Study|Adverse Event|1|||
163147577|NCT00591006|589251335|FG023|Overall Study|Adverse Event|0|||
163147578|NCT02898454|589251336|FG000|Overall Study|Adverse Event|4|||
163147579|NCT02898454|589251337|FG001|Overall Study|Adverse Event|1|||
163147580|NCT02898454|589251338|FG002|Overall Study|Adverse Event|2|||
163147581|NCT02898454|589251336|FG000|Overall Study|Protocol Violation|1|||
163147582|NCT02898454|589251337|FG001|Overall Study|Protocol Violation|0|||
163147583|NCT02898454|589251338|FG002|Overall Study|Protocol Violation|1|||
163147584|NCT02898454|589251336|FG000|Overall Study|Lack of Efficacy|4|||
163147585|NCT02898454|589251337|FG001|Overall Study|Lack of Efficacy|1|||
163147586|NCT02898454|589251338|FG002|Overall Study|Lack of Efficacy|0|||
163147587|NCT02898454|589251336|FG000|Overall Study|Withdrawal by Subject|6|||
163147588|NCT02898454|589251337|FG001|Overall Study|Withdrawal by Subject|3|||
163147589|NCT02898454|589251338|FG002|Overall Study|Withdrawal by Subject|3|||
163147590|NCT02898454|589251336|FG000|Overall Study|Lost to Follow-up|1|||
162665211|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163147591|NCT02898454|589251337|FG001|Overall Study|Lost to Follow-up|0|||
163147592|NCT02898454|589251338|FG002|Overall Study|Lost to Follow-up|0|||
163147593|NCT02898454|589251336|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
163147594|NCT02898454|589251337|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
163147595|NCT02898454|589251338|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
163147596|NCT03040141|589251339|FG000|Overall Study|Death|1|||
163147597|NCT03040141|589251340|FG001|Overall Study|Death|2|||
163147598|NCT03040141|589251341|FG002|Overall Study|Death|3|||
163147599|NCT03040141|589251339|FG000|Overall Study|Withdrawal by Subject|3|||
163147600|NCT03040141|589251340|FG001|Overall Study|Withdrawal by Subject|1|||
163147601|NCT03040141|589251341|FG002|Overall Study|Withdrawal by Subject|1|||
163147602|NCT03040141|589251339|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
163147603|NCT03040141|589251340|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
163147604|NCT03040141|589251341|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
163147605|NCT03040141|589251339|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
163147606|NCT03040141|589251340|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
163147607|NCT03040141|589251341|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
163147608|NCT01384734|589251343|FG000|Overall Study|Adverse Event|0|||
163147609|NCT01384734|589251344|FG001|Overall Study|Adverse Event|3|||
163147610|NCT01384734|589251345|FG002|Overall Study|Adverse Event|0|||
163147611|NCT01384734|589251346|FG003|Overall Study|Adverse Event|2|||
163147612|NCT01384734|589251347|FG004|Overall Study|Adverse Event|7|||
163147613|NCT01384734|589251343|FG000|Overall Study|Death|1|||
163147614|NCT01384734|589251344|FG001|Overall Study|Death|0|||
163147615|NCT01384734|589251345|FG002|Overall Study|Death|1|||
163147616|NCT01384734|589251346|FG003|Overall Study|Death|0|||
163147617|NCT01384734|589251347|FG004|Overall Study|Death|0|||
163147618|NCT01384734|589251343|FG000|Overall Study|Continuation criteria not met|0|||
163147619|NCT01384734|589251344|FG001|Overall Study|Continuation criteria not met|0|||
163147620|NCT01384734|589251345|FG002|Overall Study|Continuation criteria not met|1|||
163147621|NCT01384734|589251346|FG003|Overall Study|Continuation criteria not met|1|||
163147622|NCT01384734|589251347|FG004|Overall Study|Continuation criteria not met|0|||
163147623|NCT01384734|589251343|FG000|Overall Study|Lack of Efficacy|3|||
163147624|NCT01384734|589251344|FG001|Overall Study|Lack of Efficacy|7|||
163147625|NCT01384734|589251345|FG002|Overall Study|Lack of Efficacy|4|||
163147626|NCT01384734|589251346|FG003|Overall Study|Lack of Efficacy|4|||
163147627|NCT01384734|589251347|FG004|Overall Study|Lack of Efficacy|2|||
163147628|NCT01384734|589251343|FG000|Overall Study|Lost to Follow-up|5|||
163147629|NCT01384734|589251344|FG001|Overall Study|Lost to Follow-up|3|||
163147630|NCT01384734|589251345|FG002|Overall Study|Lost to Follow-up|3|||
163147631|NCT01384734|589251346|FG003|Overall Study|Lost to Follow-up|8|||
163147632|NCT01384734|589251347|FG004|Overall Study|Lost to Follow-up|5|||
163147633|NCT01384734|589251343|FG000|Overall Study|Non-compliance with study drug|1|||
163147634|NCT01384734|589251344|FG001|Overall Study|Non-compliance with study drug|2|||
163147635|NCT01384734|589251345|FG002|Overall Study|Non-compliance with study drug|6|||
163147636|NCT01384734|589251346|FG003|Overall Study|Non-compliance with study drug|0|||
162721470|NCT03482011|587688309|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162721471|NCT03482011|587688310|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162721472|NCT03482011|587688311|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162665212|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162721473|NCT03482011|587688312|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162721474|NCT03482011|587688313|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162721475|NCT03482011|587688314|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162721476|NCT03482011|587688307|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
163147637|NCT01384734|589251347|FG004|Overall Study|Non-compliance with study drug|2|||
163147638|NCT01384734|589251343|FG000|Overall Study|Pregnancy|0|||
163147639|NCT01384734|589251344|FG001|Overall Study|Pregnancy|1|||
163147640|NCT01384734|589251345|FG002|Overall Study|Pregnancy|0|||
163147641|NCT01384734|589251346|FG003|Overall Study|Pregnancy|0|||
163147642|NCT01384734|589251347|FG004|Overall Study|Pregnancy|1|||
163147643|NCT01384734|589251343|FG000|Overall Study|Sponsor terminated|0|||
163147644|NCT01384734|589251344|FG001|Overall Study|Sponsor terminated|0|||
163147645|NCT01384734|589251345|FG002|Overall Study|Sponsor terminated|0|||
163147646|NCT01384734|589251346|FG003|Overall Study|Sponsor terminated|0|||
163147647|NCT01384734|589251347|FG004|Overall Study|Sponsor terminated|1|||
163147648|NCT01384734|589251343|FG000|Overall Study|Withdrawal by Subject|5|||
163147649|NCT01384734|589251344|FG001|Overall Study|Withdrawal by Subject|5|||
163147650|NCT01384734|589251345|FG002|Overall Study|Withdrawal by Subject|6|||
163147651|NCT01384734|589251346|FG003|Overall Study|Withdrawal by Subject|7|||
163147652|NCT01384734|589251347|FG004|Overall Study|Withdrawal by Subject|9|||
163147653|NCT01384734|589251343|FG000|Overall Study|Investigator relocating|0|||
163147654|NCT01384734|589251344|FG001|Overall Study|Investigator relocating|2|||
163147655|NCT01384734|589251345|FG002|Overall Study|Investigator relocating|0|||
163147656|NCT01384734|589251346|FG003|Overall Study|Investigator relocating|3|||
163147657|NCT01384734|589251347|FG004|Overall Study|Investigator relocating|1|||
163147658|NCT01384734|589251343|FG000|Overall Study|Unable to come back for visit|1|||
163147659|NCT01384734|589251344|FG001|Overall Study|Unable to come back for visit|0|||
163147660|NCT01384734|589251345|FG002|Overall Study|Unable to come back for visit|1|||
163147661|NCT01384734|589251346|FG003|Overall Study|Unable to come back for visit|1|||
163147662|NCT01384734|589251347|FG004|Overall Study|Unable to come back for visit|0|||
163147663|NCT01384734|589251343|FG000|Overall Study|Prison|0|||
163147664|NCT01384734|589251344|FG001|Overall Study|Prison|0|||
163147665|NCT01384734|589251345|FG002|Overall Study|Prison|1|||
163147666|NCT01384734|589251346|FG003|Overall Study|Prison|0|||
163147667|NCT01384734|589251347|FG004|Overall Study|Prison|0|||
163147668|NCT01384734|589251343|FG000|Overall Study|As per Exclusion criteria|0|||
163147669|NCT01384734|589251344|FG001|Overall Study|As per Exclusion criteria|1|||
163147670|NCT01384734|589251345|FG002|Overall Study|As per Exclusion criteria|0|||
163147671|NCT01384734|589251346|FG003|Overall Study|As per Exclusion criteria|0|||
163147672|NCT01384734|589251347|FG004|Overall Study|As per Exclusion criteria|0|||
163147673|NCT01384734|589251343|FG000|Overall Study|Missed End of treatment visit|0|||
163147674|NCT01384734|589251344|FG001|Overall Study|Missed End of treatment visit|0|||
163147675|NCT01384734|589251345|FG002|Overall Study|Missed End of treatment visit|0|||
163147676|NCT01384734|589251346|FG003|Overall Study|Missed End of treatment visit|1|||
163147677|NCT01384734|589251347|FG004|Overall Study|Missed End of treatment visit|0|||
163147678|NCT01384734|589251343|FG000|Overall Study|Adhesion problem|0|||
163147679|NCT01384734|589251344|FG001|Overall Study|Adhesion problem|0|||
163147680|NCT01384734|589251345|FG002|Overall Study|Adhesion problem|0|||
163147681|NCT01384734|589251346|FG003|Overall Study|Adhesion problem|1|||
163147682|NCT01384734|589251347|FG004|Overall Study|Adhesion problem|0|||
163147683|NCT01384734|589251343|FG000|Overall Study|Early termination|0|||
163147684|NCT01384734|589251344|FG001|Overall Study|Early termination|0|||
163147685|NCT01384734|589251345|FG002|Overall Study|Early termination|0|||
163147686|NCT01384734|589251346|FG003|Overall Study|Early termination|0|||
163147687|NCT01384734|589251347|FG004|Overall Study|Early termination|1|||
163147688|NCT01384734|589251343|FG000|Overall Study|Physician Decision|1|||
163147689|NCT01384734|589251344|FG001|Overall Study|Physician Decision|0|||
163147690|NCT01384734|589251345|FG002|Overall Study|Physician Decision|0|||
163147691|NCT01384734|589251346|FG003|Overall Study|Physician Decision|0|||
163147692|NCT01384734|589251347|FG004|Overall Study|Physician Decision|0|||
163147693|NCT01290523|589251348|FG000|Overall Study|Death|3|||
163147694|NCT03071263|589251349|FG000|Overall Study|Adverse Event|1|||
163147695|NCT03071263|589251350|FG001|Overall Study|Adverse Event|3|||
163147696|NCT03071263|589251349|FG000|Overall Study|Withdrawal by Subject|1|||
163147697|NCT03071263|589251350|FG001|Overall Study|Withdrawal by Subject|3|||
163147698|NCT03071263|589251349|FG000|Overall Study|Physician Decision|1|||
163147699|NCT03071263|589251350|FG001|Overall Study|Physician Decision|0|||
163147700|NCT03071263|589251349|FG000|Overall Study|Participant moved to another city|0|||
163147701|NCT03071263|589251350|FG001|Overall Study|Participant moved to another city|1|||
163147702|NCT02922725|589251352|FG000|Overall Study|Withdrawal by Subject|1|||
163147703|NCT02922725|589251353|FG001|Overall Study|Withdrawal by Subject|0|||
163147704|NCT02922725|589251354|FG002|Overall Study|Withdrawal by Subject|0|||
163147705|NCT05148234|589251358|FG000|Phase I|Ineligible|0|||
163147706|NCT05148234|589251359|FG001|Phase I|Ineligible|0|||
163147707|NCT05148234|589251360|FG002|Phase I|Ineligible|0|||
163147708|NCT05148234|589251361|FG003|Phase I|Ineligible|0|||
163147709|NCT05148234|589251362|FG004|Phase I|Ineligible|0|||
163147710|NCT05148234|589251363|FG005|Phase I|Ineligible|0|||
163147711|NCT05148234|589251364|FG006|Phase I|Ineligible|0|||
163147712|NCT05148234|589251365|FG007|Phase I|Ineligible|1|||
163147713|NCT05148234|589251358|FG000|Phase I|Company closed the trial.|0|||
163147714|NCT05148234|589251359|FG001|Phase I|Company closed the trial.|1|||
163147715|NCT05148234|589251360|FG002|Phase I|Company closed the trial.|0|||
162665213|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163147716|NCT05148234|589251361|FG003|Phase I|Company closed the trial.|0|||
163147717|NCT05148234|589251362|FG004|Phase I|Company closed the trial.|0|||
163147718|NCT05148234|589251363|FG005|Phase I|Company closed the trial.|0|||
163147719|NCT05148234|589251364|FG006|Phase I|Company closed the trial.|0|||
163147720|NCT05148234|589251365|FG007|Phase I|Company closed the trial.|0|||
163147721|NCT01400698|589251366|FG000|Overall Study|Lost to Follow-up|2|||
163147722|NCT01400698|589251367|FG001|Overall Study|Lost to Follow-up|5|||
163147723|NCT01400698|589251368|FG002|Overall Study|Lost to Follow-up|2|||
163147724|NCT01400698|589251369|FG003|Overall Study|Lost to Follow-up|1|||
163147725|NCT01400698|589251370|FG004|Overall Study|Lost to Follow-up|4|||
163147726|NCT01400698|589251371|FG005|Overall Study|Lost to Follow-up|3|||
163147727|NCT01400698|589251366|FG000|Overall Study|Withdrawal by Subject|8|||
163147728|NCT01400698|589251367|FG001|Overall Study|Withdrawal by Subject|2|||
163147729|NCT01400698|589251368|FG002|Overall Study|Withdrawal by Subject|0|||
163147730|NCT01400698|589251369|FG003|Overall Study|Withdrawal by Subject|4|||
163147731|NCT01400698|589251370|FG004|Overall Study|Withdrawal by Subject|1|||
163147732|NCT01400698|589251371|FG005|Overall Study|Withdrawal by Subject|3|||
163147733|NCT01400698|589251366|FG000|Overall Study|Protocol Violation|0|||
163147734|NCT01400698|589251367|FG001|Overall Study|Protocol Violation|1|||
163147735|NCT01400698|589251368|FG002|Overall Study|Protocol Violation|0|||
163147736|NCT01400698|589251369|FG003|Overall Study|Protocol Violation|0|||
163147737|NCT01400698|589251370|FG004|Overall Study|Protocol Violation|1|||
163147738|NCT01400698|589251371|FG005|Overall Study|Protocol Violation|0|||
163147739|NCT01400698|589251366|FG000|Overall Study|Non-compliance|0|||
163147740|NCT01400698|589251367|FG001|Overall Study|Non-compliance|1|||
163147741|NCT01400698|589251368|FG002|Overall Study|Non-compliance|0|||
163147742|NCT01400698|589251369|FG003|Overall Study|Non-compliance|1|||
163147743|NCT01400698|589251370|FG004|Overall Study|Non-compliance|0|||
163147744|NCT01400698|589251371|FG005|Overall Study|Non-compliance|0|||
163147745|NCT01400698|589251366|FG000|Overall Study|Adverse Event|1|||
163147746|NCT01400698|589251367|FG001|Overall Study|Adverse Event|0|||
163147747|NCT01400698|589251368|FG002|Overall Study|Adverse Event|0|||
163147748|NCT01400698|589251369|FG003|Overall Study|Adverse Event|0|||
163147749|NCT01400698|589251370|FG004|Overall Study|Adverse Event|0|||
163147750|NCT01400698|589251371|FG005|Overall Study|Adverse Event|0|||
163147751|NCT01400698|589251366|FG000|Overall Study|Other|4|||
163147752|NCT01400698|589251367|FG001|Overall Study|Other|2|||
163147753|NCT01400698|589251368|FG002|Overall Study|Other|0|||
163147754|NCT01400698|589251369|FG003|Overall Study|Other|2|||
163147755|NCT01400698|589251370|FG004|Overall Study|Other|1|||
163147756|NCT01400698|589251371|FG005|Overall Study|Other|0|||
163147757|NCT04750642|589251372|FG000|Overall Study|Adverse Event|1|||
163147758|NCT04750642|589251373|FG001|Overall Study|Adverse Event|0|||
163147759|NCT04750642|589251372|FG000|Overall Study|Withdrawal by Subject|0|||
163147760|NCT04750642|589251373|FG001|Overall Study|Withdrawal by Subject|1|||
163147761|NCT04750642|589251372|FG000|Overall Study|Protocol Violation|0|||
163147762|NCT04750642|589251373|FG001|Overall Study|Protocol Violation|1|||
163147763|NCT01650194|589251374|FG000|Overall Study|Progressive Disease (PD)|35|||
163147764|NCT01650194|589251374|FG000|Overall Study|Withdrawal by Subject|2|||
163147765|NCT01650194|589251374|FG000|Overall Study|Miscellaneous|10|||
163147766|NCT01602224|589252932|FG000|Overall Study|Adverse Event|0|||
163147767|NCT01602224|589252933|FG001|Overall Study|Adverse Event|1|||
163147768|NCT01602224|589252934|FG002|Overall Study|Adverse Event|0|||
163147769|NCT01602224|589252932|FG000|Overall Study|Investigator Decison|1|||
163147770|NCT01602224|589252933|FG001|Overall Study|Investigator Decison|0|||
163147771|NCT01602224|589252934|FG002|Overall Study|Investigator Decison|0|||
163147772|NCT01602224|589252932|FG000|Overall Study|Lost to Follow-up|0|||
163147773|NCT01602224|589252933|FG001|Overall Study|Lost to Follow-up|0|||
163147774|NCT01602224|589252934|FG002|Overall Study|Lost to Follow-up|1|||
163147775|NCT01602224|589252932|FG000|Overall Study|Protocol Violation|0|||
163147776|NCT01602224|589252933|FG001|Overall Study|Protocol Violation|1|||
163147777|NCT01602224|589252934|FG002|Overall Study|Protocol Violation|0|||
163147778|NCT01602224|589252932|FG000|Overall Study|Sponsor Decision|2|||
163147779|NCT01602224|589252933|FG001|Overall Study|Sponsor Decision|3|||
163147780|NCT01602224|589252934|FG002|Overall Study|Sponsor Decision|2|||
163147781|NCT01602224|589252932|FG000|Overall Study|Withdrawal by Subject|5|||
163147782|NCT01602224|589252933|FG001|Overall Study|Withdrawal by Subject|3|||
163147783|NCT01602224|589252934|FG002|Overall Study|Withdrawal by Subject|3|||
163147784|NCT01352117|589252935|FG000|Overall Study|Death|15|||
163147785|NCT01352117|589252936|FG001|Overall Study|Death|16|||
163147786|NCT01352117|589252935|FG000|Overall Study|Withdrawal by Subject|1|||
163147787|NCT01352117|589252936|FG001|Overall Study|Withdrawal by Subject|0|||
163147788|NCT01352117|589252935|FG000|Overall Study|Lost to Follow-up|2|||
163147789|NCT01352117|589252936|FG001|Overall Study|Lost to Follow-up|7|||
163147790|NCT01352117|589252935|FG000|Overall Study|Non-adherent to study requirements|1|||
163147791|NCT01352117|589252936|FG001|Overall Study|Non-adherent to study requirements|1|||
163147792|NCT01352117|589252935|FG000|Overall Study|Did not initiate study treatment|1|||
163147793|NCT01352117|589252936|FG001|Overall Study|Did not initiate study treatment|0|||
163147794|NCT01352117|589252935|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
163147795|NCT01352117|589252936|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
163147796|NCT00644423|589252937|FG000|Overall Study|Lost to Follow-up|1|||
163147797|NCT00644423|589252938|FG001|Overall Study|Lost to Follow-up|1|||
163147798|NCT03525444|589252939|FG000|Overall Study|Adverse Event|0|||
163147799|NCT03525444|589252940|FG001|Overall Study|Adverse Event|1|||
163147800|NCT03525444|589252939|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
163147801|NCT03525444|589252940|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
163147802|NCT03525444|589252939|FG000|Overall Study|Other|0|||
163147803|NCT03525444|589252940|FG001|Overall Study|Other|1|||
163147804|NCT00262860|589252942|FG000|Overall Study|Adverse Event|2|||
163147805|NCT02741128|589252943|FG000|Overall Study|Protocol Violation|4|||
163147806|NCT02741128|589252944|FG001|Overall Study|Protocol Violation|1|||
163147807|NCT02741128|589252943|FG000|Overall Study|Withdrawal by Subject|2|||
163147808|NCT02741128|589252944|FG001|Overall Study|Withdrawal by Subject|0|||
163147809|NCT02741128|589252943|FG000|Overall Study|Lost to Follow-up|1|||
163147810|NCT02741128|589252944|FG001|Overall Study|Lost to Follow-up|0|||
163147811|NCT01419769|589252945|FG000|Overall Study|Did not receive the AXIOS stent|3|||
163147812|NCT01419769|589252945|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
163147813|NCT00878501|589252946|FG000|Overall Study|Adverse Event|11|||
163147814|NCT00878501|589252947|FG001|Overall Study|Adverse Event|3|||
163147815|NCT00878501|589252948|FG002|Overall Study|Adverse Event|3|||
163147816|NCT00878501|589252946|FG000|Overall Study|Lack of Efficacy|2|||
163147817|NCT00878501|589252947|FG001|Overall Study|Lack of Efficacy|1|||
163147818|NCT00878501|589252948|FG002|Overall Study|Lack of Efficacy|0|||
163147819|NCT00878501|589252946|FG000|Overall Study|Withdrawal by Subject|2|||
163147820|NCT00878501|589252947|FG001|Overall Study|Withdrawal by Subject|1|||
163147821|NCT00878501|589252948|FG002|Overall Study|Withdrawal by Subject|2|||
163147822|NCT00878501|589252946|FG000|Overall Study|Protocol Violation|0|||
163147823|NCT00878501|589252947|FG001|Overall Study|Protocol Violation|0|||
163147824|NCT00878501|589252948|FG002|Overall Study|Protocol Violation|1|||
163147825|NCT00878501|589252946|FG000|Overall Study|Incorrect enrolment|1|||
163147826|NCT00878501|589252947|FG001|Overall Study|Incorrect enrolment|2|||
163147827|NCT00878501|589252948|FG002|Overall Study|Incorrect enrolment|0|||
163147828|NCT00878501|589252946|FG000|Overall Study|Intake of prohibited concom. medication|0|||
163147829|NCT00878501|589252947|FG001|Overall Study|Intake of prohibited concom. medication|0|||
163147830|NCT00878501|589252948|FG002|Overall Study|Intake of prohibited concom. medication|1|||
163147831|NCT00878501|589252946|FG000|Overall Study|Mis-randomisation of patient|1|||
162665214|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162665215|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162665216|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665217|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
162665218|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665219|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665220|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665221|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665222|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665223|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665224|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
162665225|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
162665226|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665227|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665228|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665229|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665230|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665231|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665232|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665233|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162665234|NCT01172938|587485118|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665235|NCT01172938|587485119|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
162665236|NCT01172938|587485120|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
162665237|NCT01172938|587485121|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665238|NCT01172938|587485122|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665239|NCT01172938|587485123|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665240|NCT01172938|587485124|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665241|NCT01172938|587485125|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665242|NCT01172938|587485126|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
162665243|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162665244|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
162665245|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
162665246|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
162665247|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
162665248|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
162665249|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162721477|NCT03482011|587688308|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
162665250|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162665251|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162721478|NCT03482011|587688309|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
162721479|NCT03482011|587688310|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
163147832|NCT00878501|589252947|FG001|Overall Study|Mis-randomisation of patient|0|||
163147833|NCT00878501|589252948|FG002|Overall Study|Mis-randomisation of patient|0|||
163147834|NCT00878501|589252946|FG000|Overall Study|Administrative|0|||
163147835|NCT00878501|589252947|FG001|Overall Study|Administrative|0|||
163147836|NCT00878501|589252948|FG002|Overall Study|Administrative|1|||
163147837|NCT01690052|589252955|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
163147838|NCT01690052|589252956|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
163147839|NCT01194830|589252960|FG000|Overall Study|Adverse Event|3|||
163147840|NCT01194830|589252961|FG001|Overall Study|Adverse Event|2|||
163147841|NCT01194830|589252960|FG000|Overall Study|Protocol Violation|5|||
163147842|NCT01194830|589252961|FG001|Overall Study|Protocol Violation|4|||
163147843|NCT01194830|589252960|FG000|Overall Study|Lost to Follow-up|9|||
163147844|NCT01194830|589252961|FG001|Overall Study|Lost to Follow-up|7|||
163147845|NCT01194830|589252960|FG000|Overall Study|Withdrawal by Subject|2|||
163147846|NCT01194830|589252961|FG001|Overall Study|Withdrawal by Subject|1|||
163147847|NCT01194830|589252960|FG000|Overall Study|Lack of Efficacy|1|||
163147848|NCT01194830|589252961|FG001|Overall Study|Lack of Efficacy|1|||
163147849|NCT01194830|589252960|FG000|Overall Study|Non-compliance issues|4|||
163147850|NCT01194830|589252961|FG001|Overall Study|Non-compliance issues|4|||
163147851|NCT01194830|589252960|FG000|Overall Study|Other Reason|12|||
163147852|NCT01194830|589252961|FG001|Overall Study|Other Reason|8|||
163147853|NCT01317472|589252964|FG000|Overall Study|Withdrawal by Subject|1|||
163147854|NCT01317472|589252965|FG001|Overall Study|Withdrawal by Subject|0|||
163147855|NCT01317472|589252964|FG000|Overall Study|Unrelated hospitalization|1|||
163147856|NCT01317472|589252965|FG001|Overall Study|Unrelated hospitalization|0|||
163147857|NCT01815918|589252966|FG000|Overall Study|Patient samples not analyzable|3|||
163147858|NCT01815918|589252967|FG001|Overall Study|Patient samples not analyzable|4|||
163147859|NCT01815918|589252966|FG000|Overall Study|Lack of Efficacy|15|||
163147860|NCT01815918|589252967|FG001|Overall Study|Lack of Efficacy|15|||
163147861|NCT00866177|589252970|FG000|Overall Study|Withdrawal by Subject|1|||
163147862|NCT00866177|589252970|FG000|Overall Study|Not Treated|151|||
163147863|NCT00807911|589252979|FG000|Overall Study|Withdrawal by Subject|12|||
163147864|NCT00807911|589252980|FG001|Overall Study|Withdrawal by Subject|10|||
163147865|NCT00807911|589252979|FG000|Overall Study|Ineligible|0|||
163147866|NCT00807911|589252980|FG001|Overall Study|Ineligible|4|||
163147867|NCT02648204|589252985|FG000|Overall Study|Withdrawal by Subject|12|||
163147868|NCT02648204|589252986|FG001|Overall Study|Withdrawal by Subject|8|||
163147869|NCT02648204|589252987|FG002|Overall Study|Withdrawal by Subject|2|||
163147870|NCT02648204|589252988|FG003|Overall Study|Withdrawal by Subject|6|||
163147871|NCT02648204|589252985|FG000|Overall Study|Lost to Follow-up|5|||
163147872|NCT02648204|589252986|FG001|Overall Study|Lost to Follow-up|8|||
163147873|NCT02648204|589252987|FG002|Overall Study|Lost to Follow-up|4|||
163147874|NCT02648204|589252988|FG003|Overall Study|Lost to Follow-up|6|||
163147875|NCT02648204|589252985|FG000|Overall Study|Missing follow-up information|4|||
163147876|NCT02648204|589252986|FG001|Overall Study|Missing follow-up information|4|||
163147877|NCT02648204|589252987|FG002|Overall Study|Missing follow-up information|4|||
163147878|NCT02648204|589252988|FG003|Overall Study|Missing follow-up information|2|||
163147879|NCT02648204|589252985|FG000|Overall Study|Death|1|||
163147880|NCT02648204|589252986|FG001|Overall Study|Death|1|||
163147881|NCT02648204|589252987|FG002|Overall Study|Death|2|||
163147882|NCT02648204|589252988|FG003|Overall Study|Death|2|||
163147883|NCT02648204|589252985|FG000|Overall Study|Adverse Event|0|||
163147884|NCT02648204|589252986|FG001|Overall Study|Adverse Event|0|||
163147885|NCT02648204|589252987|FG002|Overall Study|Adverse Event|1|||
163147886|NCT02648204|589252988|FG003|Overall Study|Adverse Event|0|||
163147887|NCT04349891|589252989|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
163147888|NCT04349891|589252990|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
163147889|NCT04349891|589252989|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
163147890|NCT04349891|589252990|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
163147891|NCT04349891|589252989|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
163147892|NCT04349891|589252990|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
163147893|NCT04349891|589252989|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
163147894|NCT04349891|589252990|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
162721480|NCT03482011|587688311|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
162721481|NCT03482011|587688312|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
163147895|NCT03532542|589252993|FG000|Overall Study|Death|1|||
163147896|NCT03532542|589252994|FG001|Overall Study|Death|0|||
163147897|NCT03532542|589252993|FG000|Overall Study|Study Terminated by Sponsor|41|||
163147898|NCT03532542|589252994|FG001|Overall Study|Study Terminated by Sponsor|65|||
163147899|NCT03532542|589252993|FG000|Overall Study|Withdrawal by Subject|6|||
163147900|NCT03532542|589252994|FG001|Overall Study|Withdrawal by Subject|5|||
163147901|NCT01018030|589252995|FG000|Overall Study|Adverse Event|10|||
163147902|NCT01018030|589252996|FG001|Overall Study|Adverse Event|5|||
163147903|NCT01018030|589252997|FG002|Overall Study|Adverse Event|5|||
163147904|NCT01018030|589252995|FG000|Overall Study|Withdrawal by Subject|2|||
162665252|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163147905|NCT01018030|589252996|FG001|Overall Study|Withdrawal by Subject|2|||
163147906|NCT01018030|589252997|FG002|Overall Study|Withdrawal by Subject|4|||
163147907|NCT01018030|589252995|FG000|Overall Study|Lost to Follow-up|2|||
163147908|NCT01018030|589252996|FG001|Overall Study|Lost to Follow-up|0|||
163147909|NCT01018030|589252997|FG002|Overall Study|Lost to Follow-up|3|||
163147910|NCT01018030|589252995|FG000|Overall Study|Protocol Violation|2|||
163147911|NCT01018030|589252996|FG001|Overall Study|Protocol Violation|1|||
163147912|NCT01018030|589252997|FG002|Overall Study|Protocol Violation|0|||
163147913|NCT01018030|589252995|FG000|Overall Study|Physician Decision|1|||
163147914|NCT01018030|589252996|FG001|Overall Study|Physician Decision|0|||
163147915|NCT01018030|589252997|FG002|Overall Study|Physician Decision|1|||
163147916|NCT01018030|589252995|FG000|Overall Study|Lack of Efficacy|1|||
163147917|NCT01018030|589252996|FG001|Overall Study|Lack of Efficacy|0|||
163147918|NCT01018030|589252997|FG002|Overall Study|Lack of Efficacy|0|||
163147919|NCT01018030|589252995|FG000|Overall Study|Did Not Receive Study Drug|1|||
163147920|NCT01018030|589252996|FG001|Overall Study|Did Not Receive Study Drug|3|||
163147921|NCT01018030|589252997|FG002|Overall Study|Did Not Receive Study Drug|0|||
163147922|NCT04590014|589253013|FG000|Overall Study|Withdrawal by Subject|1|||
163147923|NCT04590014|589253014|FG001|Overall Study|Withdrawal by Subject|0|||
163147924|NCT00468299|589253015|FG000|Overall Study|Withdrawal by Subject|0|||
163147925|NCT00468299|589253016|FG001|Overall Study|Withdrawal by Subject|1|||
163147926|NCT00625131|589253017|FG000|Overall Study|Lost to Follow-up|3|||
163147927|NCT00625131|589253018|FG001|Overall Study|Lost to Follow-up|2|||
163147928|NCT00625131|589253019|FG002|Overall Study|Lost to Follow-up|0|||
163147929|NCT00625131|589253017|FG000|Overall Study|Withdrawal by Subject|1|||
163147930|NCT00625131|589253018|FG001|Overall Study|Withdrawal by Subject|0|||
163147931|NCT00625131|589253019|FG002|Overall Study|Withdrawal by Subject|5|||
163147932|NCT05083351|589253025|FG000|Overall Study|Adverse Event|3|||
163147933|NCT05083351|589253025|FG000|Overall Study|Did not meet data inclusion criteria|8|||
163147934|NCT05083351|589253025|FG000|Overall Study|Did not meet eligibility criteria|19|||
163147935|NCT05083351|589253025|FG000|Overall Study|Study Staff Decision|19|||
163147936|NCT02343263|589253032|FG000|Overall Study|Physician Decision|5|||
163147937|NCT02343263|589253033|FG001|Overall Study|Physician Decision|3|||
163147938|NCT02343263|589253034|FG002|Overall Study|Physician Decision|1|||
163147939|NCT00849940|589253037|FG000|Overall Study|Physician Decision|4|||
163147940|NCT03353675|589253041|FG000|Overall Study|Adverse Event|4|||
163147941|NCT00402168|589253042|FG000|Randomized|Lost to Follow-up|1|||
163147942|NCT00402168|589253043|FG001|Randomized|Lost to Follow-up|0|||
163147943|NCT00402168|589253042|FG000|Randomized|Withdrawal by Subject|0|||
163147944|NCT00402168|589253043|FG001|Randomized|Withdrawal by Subject|1|||
163147945|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|Death|0|||
163147946|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|Death|1|||
163147947|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
163147948|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
163147949|NCT00402168|589253042|FG000|Treatment (up to 12 Months)|non-specified|0|||
163147950|NCT00402168|589253043|FG001|Treatment (up to 12 Months)|non-specified|1|||
163147951|NCT00402168|589253042|FG000|Long Term (LT)|Adverse Event|1|||
163147952|NCT00402168|589253043|FG001|Long Term (LT)|Adverse Event|5|||
163147953|NCT00402168|589253042|FG000|Long Term (LT)|Withdrawal by Subject|4|||
163147954|NCT00402168|589253043|FG001|Long Term (LT)|Withdrawal by Subject|7|||
163147955|NCT00402168|589253042|FG000|Long Term (LT)|Pregnancy|0|||
163147956|NCT00402168|589253043|FG001|Long Term (LT)|Pregnancy|1|||
163147957|NCT00402168|589253042|FG000|Long Term (LT)|Lost to Follow-up|1|||
163147958|NCT00402168|589253043|FG001|Long Term (LT)|Lost to Follow-up|0|||
163147959|NCT00402168|589253042|FG000|Long Term (LT)|Death|4|||
163147960|NCT00402168|589253043|FG001|Long Term (LT)|Death|0|||
163147961|NCT00402168|589253042|FG000|Long Term (LT)|Lack of Efficacy|0|||
163147962|NCT00402168|589253043|FG001|Long Term (LT)|Lack of Efficacy|2|||
163147963|NCT00402168|589253042|FG000|Long Term (LT)|non-specified|1|||
163147964|NCT00402168|589253043|FG001|Long Term (LT)|non-specified|2|||
163147965|NCT00402168|589253042|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
163147966|NCT00402168|589253043|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
163147967|NCT00402168|589253042|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
163147968|NCT00402168|589253043|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
163147969|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
163147970|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
163147971|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
163147972|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
163147973|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
163147974|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
162665253|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
163147975|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
162665254|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
162665255|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
162665256|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
162665257|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
162665258|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162665259|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
163147976|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
163147977|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
163147978|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
163147979|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
163147980|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
163147981|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
163147982|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
163147983|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
163147984|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
163147985|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
163147986|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
163147987|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
163147988|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
163147989|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
163147990|NCT00550407|589253046|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
163147991|NCT00550407|589253047|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
163147992|NCT00550407|589253048|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
163147993|NCT00550407|589253046|FG000|26-Week Randomized Phase|Adverse Event|0|||
162721482|NCT03482011|587688313|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
162721483|NCT03482011|587688314|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
162721484|NCT03482011|587688307|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163147994|NCT00550407|589253047|FG001|26-Week Randomized Phase|Adverse Event|5|||
163147995|NCT00550407|589253048|FG002|26-Week Randomized Phase|Adverse Event|2|||
163147996|NCT00550407|589253046|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
163147997|NCT00550407|589253047|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
163147998|NCT00550407|589253048|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
163147999|NCT00550407|589253046|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
163148000|NCT00550407|589253047|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
163148001|NCT00550407|589253048|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
163148002|NCT00550407|589253046|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
163148003|NCT00550407|589253047|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
163148004|NCT00550407|589253048|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
163148005|NCT00584415|589253049|FG000|Overall Study|Adverse Event|7|||
163148006|NCT02370420|589253050|FG000|Overall Study|Physician Decision|3|||
163148007|NCT02370420|589253051|FG001|Overall Study|Physician Decision|3|||
163148008|NCT02370420|589253050|FG000|Overall Study|Lost to Follow-up|11|||
163148009|NCT02370420|589253051|FG001|Overall Study|Lost to Follow-up|9|||
163148010|NCT00556894|589253052|FG000|Overall Study|Adverse Event|2|||
163148011|NCT00556894|589253053|FG001|Overall Study|Adverse Event|3|||
163148012|NCT00556894|589253054|FG002|Overall Study|Adverse Event|3|||
163148013|NCT00556894|589253052|FG000|Overall Study|Death|1|||
163148014|NCT00556894|589253053|FG001|Overall Study|Death|0|||
163148015|NCT00556894|589253054|FG002|Overall Study|Death|0|||
163148016|NCT00556894|589253052|FG000|Overall Study|regulatory decision in Bulgaria|10|||
163148017|NCT00556894|589253053|FG001|Overall Study|regulatory decision in Bulgaria|14|||
163148018|NCT00556894|589253054|FG002|Overall Study|regulatory decision in Bulgaria|13|||
163148019|NCT00556894|589253052|FG000|Overall Study|Change in therapy|2|||
163148020|NCT00556894|589253053|FG001|Overall Study|Change in therapy|1|||
163148021|NCT00556894|589253054|FG002|Overall Study|Change in therapy|2|||
163148022|NCT00556894|589253052|FG000|Overall Study|Withdrawal by Subject|1|||
163148023|NCT00556894|589253053|FG001|Overall Study|Withdrawal by Subject|1|||
163148024|NCT00556894|589253054|FG002|Overall Study|Withdrawal by Subject|1|||
163148025|NCT03883581|589253055|FG000|Overall Study|Withdrawal by Subject|4|||
163148026|NCT03224130|589255347|FG000|Overall Study|consent issue|0|||
163148027|NCT03224130|589255348|FG001|Overall Study|consent issue|1|||
163148028|NCT01453049|589255349|FG000|Overall Study|Protocol Violation|2|||
163148029|NCT01453049|589255350|FG001|Overall Study|Protocol Violation|5|||
163148030|NCT01453049|589255349|FG000|Overall Study|Lost to Follow-up|2|||
163148031|NCT01453049|589255350|FG001|Overall Study|Lost to Follow-up|1|||
163148032|NCT01453049|589255349|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
163148033|NCT01453049|589255350|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
163148034|NCT01453049|589255349|FG000|Overall Study|Withdrawal by Subject|1|||
163148035|NCT01453049|589255350|FG001|Overall Study|Withdrawal by Subject|0|||
163148036|NCT01453049|589255349|FG000|Overall Study|Randomized in Error|1|||
163148037|NCT01453049|589255350|FG001|Overall Study|Randomized in Error|0|||
163148038|NCT00768989|589255353|FG000|Prior to Week 24|Withdrawal by Subject|1|||
163148039|NCT00768989|589255354|FG001|Prior to Week 24|Withdrawal by Subject|0|||
163148040|NCT00768989|589255353|FG000|Prior to Week 24|Adverse Event|3|||
163148041|NCT00768989|589255354|FG001|Prior to Week 24|Adverse Event|0|||
163148042|NCT00768989|589255353|FG000|Prior to Week 24|Lost to Follow-up|0|||
163148043|NCT00768989|589255354|FG001|Prior to Week 24|Lost to Follow-up|1|||
163148044|NCT00768989|589255353|FG000|Prior to Week 24|Protocol Violation|0|||
163148045|NCT00768989|589255354|FG001|Prior to Week 24|Protocol Violation|2|||
163148046|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
163148047|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
163148048|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
163148049|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
163148050|NCT00768989|589255353|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
163148051|NCT00768989|589255354|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
163148052|NCT00768989|589255353|FG000|On or After Week 36|Lack of Efficacy|1|||
163148053|NCT00768989|589255354|FG001|On or After Week 36|Lack of Efficacy|0|||
163148054|NCT00768989|589255353|FG000|On or After Week 36|Adverse Event|0|||
163148055|NCT00768989|589255354|FG001|On or After Week 36|Adverse Event|1|||
163148056|NCT00768989|589255353|FG000|On or After Week 36|Lost to Follow-up|1|||
163148057|NCT00768989|589255354|FG001|On or After Week 36|Lost to Follow-up|0|||
163148058|NCT00768989|589255353|FG000|On or After Week 36|Poor Compliance|1|||
163148059|NCT00768989|589255354|FG001|On or After Week 36|Poor Compliance|0|||
163148060|NCT00768989|589255353|FG000|On or After Week 36|Protocol Violation|1|||
163148061|NCT00768989|589255354|FG001|On or After Week 36|Protocol Violation|0|||
163148062|NCT00768989|589255353|FG000|On or After Week 36|Did not attend termination visit|2|||
163148063|NCT00768989|589255354|FG001|On or After Week 36|Did not attend termination visit|0|||
163148064|NCT00768989|589255353|FG000|On or After Week 36|Sponsor Termination|45|||
163148065|NCT00768989|589255354|FG001|On or After Week 36|Sponsor Termination|26|||
163148066|NCT02153086|589255355|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
163148067|NCT02153086|589255355|FG000|Overall Study|Other|2|||
163148068|NCT03115359|589255356|FG000|Overall Study|Withdrawal by Subject|29|||
163148069|NCT03115359|589255357|FG001|Overall Study|Withdrawal by Subject|39|||
163148070|NCT03115359|589255356|FG000|Overall Study|Scheduling conflict|25|||
163148071|NCT03115359|589255357|FG001|Overall Study|Scheduling conflict|23|||
162665260|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162665261|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665262|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665263|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
162665264|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665265|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665266|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665267|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665268|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665269|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162665270|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162721485|NCT03482011|587688308|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
162721486|NCT03482011|587688309|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162665271|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
162665272|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
162665273|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
162721487|NCT03482011|587688310|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
163148072|NCT03115359|589255356|FG000|Overall Study|Personal reasons including health|12|||
163148073|NCT03115359|589255357|FG001|Overall Study|Personal reasons including health|9|||
163148074|NCT03115359|589255356|FG000|Overall Study|Transportation barriers|3|||
163148075|NCT03115359|589255357|FG001|Overall Study|Transportation barriers|0|||
163148076|NCT03115359|589255356|FG000|Overall Study|No longer interested|5|||
163148077|NCT03115359|589255357|FG001|Overall Study|No longer interested|4|||
163148078|NCT03115359|589255356|FG000|Overall Study|No reason provided|45|||
163148079|NCT03115359|589255357|FG001|Overall Study|No reason provided|47|||
163148080|NCT05546476|589255361|FG000|Period 1: Part A|Adverse Event|2|||
163148081|NCT05546476|589255362|FG001|Period 1: Part A|Adverse Event|0|||
163148082|NCT05546476|589255363|FG002|Period 1: Part A|Adverse Event|0|||
163148083|NCT05546476|589255364|FG003|Period 1: Part A|Adverse Event|1|||
163148084|NCT05546476|589255361|FG000|Period 1: Part A|Death|4|||
163148085|NCT05546476|589255362|FG001|Period 1: Part A|Death|4|||
163148086|NCT05546476|589255363|FG002|Period 1: Part A|Death|5|||
163148087|NCT05546476|589255364|FG003|Period 1: Part A|Death|6|||
163148088|NCT05546476|589255361|FG000|Period 1: Part A|Lack of Efficacy|0|||
163148089|NCT05546476|589255362|FG001|Period 1: Part A|Lack of Efficacy|0|||
163148090|NCT05546476|589255363|FG002|Period 1: Part A|Lack of Efficacy|0|||
163148091|NCT05546476|589255364|FG003|Period 1: Part A|Lack of Efficacy|1|||
163148092|NCT05546476|589255361|FG000|Period 1: Part A|Lost to Follow-up|0|||
163148093|NCT05546476|589255362|FG001|Period 1: Part A|Lost to Follow-up|0|||
163148094|NCT05546476|589255363|FG002|Period 1: Part A|Lost to Follow-up|0|||
163148095|NCT05546476|589255364|FG003|Period 1: Part A|Lost to Follow-up|1|||
163148096|NCT05546476|589255361|FG000|Period 1: Part A|Physician Decision|1|||
163148097|NCT05546476|589255362|FG001|Period 1: Part A|Physician Decision|0|||
163148098|NCT05546476|589255363|FG002|Period 1: Part A|Physician Decision|0|||
163148099|NCT05546476|589255364|FG003|Period 1: Part A|Physician Decision|0|||
163148100|NCT05546476|589255361|FG000|Period 1: Part A|Progressive disease|3|||
163148101|NCT05546476|589255362|FG001|Period 1: Part A|Progressive disease|5|||
163148102|NCT05546476|589255363|FG002|Period 1: Part A|Progressive disease|0|||
163148103|NCT05546476|589255364|FG003|Period 1: Part A|Progressive disease|1|||
163148104|NCT05546476|589255361|FG000|Period 1: Part A|Withdrawal by Subject|1|||
163148105|NCT05546476|589255362|FG001|Period 1: Part A|Withdrawal by Subject|1|||
163148106|NCT05546476|589255363|FG002|Period 1: Part A|Withdrawal by Subject|1|||
163148107|NCT05546476|589255364|FG003|Period 1: Part A|Withdrawal by Subject|2|||
163148108|NCT05546476|589255361|FG000|Period 1: Part A|Global deterioration of health status|2|||
163148109|NCT05546476|589255362|FG001|Period 1: Part A|Global deterioration of health status|2|||
163148110|NCT05546476|589255363|FG002|Period 1: Part A|Global deterioration of health status|1|||
163148111|NCT05546476|589255364|FG003|Period 1: Part A|Global deterioration of health status|4|||
163148112|NCT05546476|589255361|FG000|Period 1: Part A|Other: Unspecified|0|||
163148113|NCT05546476|589255362|FG001|Period 1: Part A|Other: Unspecified|2|||
163148114|NCT05546476|589255363|FG002|Period 1: Part A|Other: Unspecified|0|||
163148115|NCT05546476|589255364|FG003|Period 1: Part A|Other: Unspecified|0|||
163148116|NCT05546476|589255361|FG000|Period 2: Part B|Ongoing|26|||
163148117|NCT05546476|589255362|FG001|Period 2: Part B|Ongoing|27|||
163148118|NCT05546476|589255363|FG002|Period 2: Part B|Ongoing|35|||
163148119|NCT05546476|589255364|FG003|Period 2: Part B|Ongoing|29|||
163148120|NCT03585660|589255373|FG000|Overall Study|operator error|1|||
163148121|NCT03585660|589255373|FG000|Overall Study|technical error|2|||
163148122|NCT03585660|589255373|FG000|Overall Study|hip prosthesis|2|||
163148123|NCT03585660|589255373|FG000|Overall Study|did not undergo biopsy|8|||
163148124|NCT03585660|589255373|FG000|Overall Study|scanner problem|2|||
163148125|NCT03661723|589255380|FG000|Overall Study|Disease Progression|4|||
163148126|NCT03661723|589255381|FG001|Overall Study|Disease Progression|24|||
163148127|NCT03661723|589255382|FG002|Overall Study|Disease Progression|4|||
163148128|NCT03661723|589255383|FG003|Overall Study|Disease Progression|19|||
163148129|NCT03661723|589255380|FG000|Overall Study|Withdrawal by Subject|1|||
163148130|NCT03661723|589255381|FG001|Overall Study|Withdrawal by Subject|0|||
163148131|NCT03661723|589255382|FG002|Overall Study|Withdrawal by Subject|2|||
163148132|NCT03661723|589255383|FG003|Overall Study|Withdrawal by Subject|4|||
163148133|NCT03661723|589255380|FG000|Overall Study|Physician Decision|1|||
163148134|NCT03661723|589255381|FG001|Overall Study|Physician Decision|0|||
163148135|NCT03661723|589255382|FG002|Overall Study|Physician Decision|0|||
163148136|NCT03661723|589255383|FG003|Overall Study|Physician Decision|0|||
163148137|NCT03661723|589255380|FG000|Overall Study|Clinical Deterioration|0|||
163148138|NCT03661723|589255381|FG001|Overall Study|Clinical Deterioration|0|||
163148139|NCT03661723|589255382|FG002|Overall Study|Clinical Deterioration|0|||
163148140|NCT03661723|589255383|FG003|Overall Study|Clinical Deterioration|1|||
163148141|NCT03760029|589255384|FG000|Overall Study|Death|1|||
163148142|NCT03760029|589255385|FG001|Overall Study|Death|0|||
163148143|NCT03760029|589255386|FG002|Overall Study|Death|0|||
163148144|NCT03760029|589255384|FG000|Overall Study|Lost to Follow-up|0|||
163148145|NCT03760029|589255385|FG001|Overall Study|Lost to Follow-up|2|||
163148146|NCT03760029|589255386|FG002|Overall Study|Lost to Follow-up|1|||
163148147|NCT03760029|589255384|FG000|Overall Study|Withdrawal by Subject|1|||
163148148|NCT03760029|589255385|FG001|Overall Study|Withdrawal by Subject|4|||
163148149|NCT03760029|589255386|FG002|Overall Study|Withdrawal by Subject|1|||
163148150|NCT03760029|589255384|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163148151|NCT03760029|589255385|FG001|Overall Study|Withdrawal by parent/guardian|4|||
163148152|NCT03760029|589255386|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163148153|NCT03760029|589255384|FG000|Overall Study|Other|2|||
163148154|NCT03760029|589255385|FG001|Overall Study|Other|1|||
163148155|NCT03760029|589255386|FG002|Overall Study|Other|0|||
163148156|NCT04890652|589255392|FG000|Overall Study|Withdrawal by Subject|2|||
163148157|NCT02399215|589255401|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
163148158|NCT02399215|589255401|FG000|Overall Study|Withdrawal by Subject|1|||
163148159|NCT00772538|589255402|FG000|Overall Study|Adverse Event|6|||
163148160|NCT00772538|589255403|FG001|Overall Study|Adverse Event|6|||
163148161|NCT00772538|589255402|FG000|Overall Study|Protocol Violation|3|||
163148162|NCT00772538|589255403|FG001|Overall Study|Protocol Violation|3|||
163148163|NCT00772538|589255402|FG000|Overall Study|Lost to Follow-up|1|||
163148164|NCT00772538|589255403|FG001|Overall Study|Lost to Follow-up|1|||
163148165|NCT00772538|589255402|FG000|Overall Study|Withdrawal by Subject|3|||
163148166|NCT00772538|589255403|FG001|Overall Study|Withdrawal by Subject|8|||
163148167|NCT00772538|589255402|FG000|Overall Study|Lack of Efficacy|0|||
163148168|NCT00772538|589255403|FG001|Overall Study|Lack of Efficacy|1|||
163148169|NCT00772538|589255402|FG000|Overall Study|Other|7|||
163148170|NCT00772538|589255403|FG001|Overall Study|Other|7|||
163148171|NCT01089504|589255406|FG000|Overall Study|Lost to Follow-up|1|||
163148172|NCT01089504|589255407|FG001|Overall Study|Lost to Follow-up|1|||
163148173|NCT01089504|589255406|FG000|Overall Study|Withdrawal by Subject|2|||
163148174|NCT01089504|589255407|FG001|Overall Study|Withdrawal by Subject|0|||
163148175|NCT00001832|589255408|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
163148176|NCT00001832|589255409|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
163148177|NCT00001832|589255410|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
163148178|NCT00001832|589255411|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
163148179|NCT00001832|589255412|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
163148180|NCT00001832|589255413|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
163148181|NCT00001832|589255414|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
163148182|NCT00001832|589255415|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
163148183|NCT00001832|589255416|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
163148184|NCT00001832|589255417|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
163148185|NCT00001832|589255418|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
163148186|NCT00001832|589255419|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
163148187|NCT00001832|589255420|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
163148188|NCT00001832|589255421|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
163148189|NCT00001832|589255422|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
163148190|NCT00001832|589255408|FG000|Treatment Period|Death during treatment|0|||
163148191|NCT00001832|589255409|FG001|Treatment Period|Death during treatment|0|||
163148192|NCT00001832|589255410|FG002|Treatment Period|Death during treatment|0|||
163148193|NCT00001832|589255411|FG003|Treatment Period|Death during treatment|0|||
163148194|NCT00001832|589255412|FG004|Treatment Period|Death during treatment|0|||
163148195|NCT00001832|589255413|FG005|Treatment Period|Death during treatment|1|||
163148196|NCT00001832|589255414|FG006|Treatment Period|Death during treatment|0|||
163148197|NCT00001832|589255415|FG007|Treatment Period|Death during treatment|0|||
163148198|NCT00001832|589255416|FG008|Treatment Period|Death during treatment|0|||
163148199|NCT00001832|589255417|FG009|Treatment Period|Death during treatment|0|||
163148200|NCT00001832|589255418|FG010|Treatment Period|Death during treatment|0|||
163148201|NCT00001832|589255419|FG011|Treatment Period|Death during treatment|0|||
163148202|NCT00001832|589255420|FG012|Treatment Period|Death during treatment|0|||
163148203|NCT00001832|589255421|FG013|Treatment Period|Death during treatment|0|||
163148204|NCT00001832|589255422|FG014|Treatment Period|Death during treatment|0|||
163148205|NCT00001832|589255408|FG000|Treatment Period|Not treated|0|||
163148206|NCT00001832|589255409|FG001|Treatment Period|Not treated|0|||
163148207|NCT00001832|589255410|FG002|Treatment Period|Not treated|0|||
163148208|NCT00001832|589255411|FG003|Treatment Period|Not treated|0|||
163148209|NCT00001832|589255412|FG004|Treatment Period|Not treated|0|||
163148210|NCT00001832|589255413|FG005|Treatment Period|Not treated|0|||
163148211|NCT00001832|589255414|FG006|Treatment Period|Not treated|0|||
163148212|NCT00001832|589255415|FG007|Treatment Period|Not treated|1|||
163148213|NCT00001832|589255416|FG008|Treatment Period|Not treated|0|||
162665274|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
162665275|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
162665276|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
162665277|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162665278|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162665279|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162665280|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162665281|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162665282|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162665283|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163148214|NCT00001832|589255417|FG009|Treatment Period|Not treated|0|||
163148215|NCT00001832|589255418|FG010|Treatment Period|Not treated|0|||
163148216|NCT00001832|589255419|FG011|Treatment Period|Not treated|0|||
163148217|NCT00001832|589255420|FG012|Treatment Period|Not treated|0|||
163148218|NCT00001832|589255421|FG013|Treatment Period|Not treated|0|||
163148219|NCT00001832|589255422|FG014|Treatment Period|Not treated|0|||
163148220|NCT00713609|589255423|FG000|Overall Study|Adverse Event|2|||
163148221|NCT00713609|589255424|FG001|Overall Study|Adverse Event|0|||
163148222|NCT00713609|589255425|FG002|Overall Study|Adverse Event|2|||
163148223|NCT00713609|589255426|FG003|Overall Study|Adverse Event|2|||
163148224|NCT00713609|589255427|FG004|Overall Study|Adverse Event|3|||
163148225|NCT00713609|589255428|FG005|Overall Study|Adverse Event|1|||
163148226|NCT00713609|589255423|FG000|Overall Study|Lost to Follow-up|5|||
163148227|NCT00713609|589255424|FG001|Overall Study|Lost to Follow-up|7|||
163148228|NCT00713609|589255425|FG002|Overall Study|Lost to Follow-up|5|||
162665284|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
163148229|NCT00713609|589255426|FG003|Overall Study|Lost to Follow-up|5|||
163148230|NCT00713609|589255427|FG004|Overall Study|Lost to Follow-up|7|||
163148231|NCT00713609|589255428|FG005|Overall Study|Lost to Follow-up|0|||
162665285|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162665286|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162665287|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162665288|NCT01172938|587485118|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665289|NCT01172938|587485119|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665290|NCT01172938|587485120|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665291|NCT01172938|587485121|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665292|NCT01172938|587485122|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665293|NCT01172938|587485123|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
162665294|NCT01172938|587485124|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
162665295|NCT01172938|587485125|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665296|NCT01172938|587485126|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
162665297|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162665298|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
162665299|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
162665300|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162665301|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162665302|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162665303|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162665304|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
162721488|NCT03482011|587688311|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162721489|NCT03482011|587688312|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162721490|NCT03482011|587688313|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
162721491|NCT03482011|587688314|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
162721492|NCT03482011|587688307|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162721493|NCT03482011|587688308|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162721494|NCT03482011|587688309|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162721495|NCT03482011|587688310|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162721496|NCT03482011|587688311|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
163148232|NCT00713609|589255423|FG000|Overall Study|Lack of Efficacy|1|||
163148233|NCT00713609|589255424|FG001|Overall Study|Lack of Efficacy|3|||
163148234|NCT00713609|589255425|FG002|Overall Study|Lack of Efficacy|0|||
163148235|NCT00713609|589255426|FG003|Overall Study|Lack of Efficacy|0|||
163148236|NCT00713609|589255427|FG004|Overall Study|Lack of Efficacy|1|||
163148237|NCT00713609|589255428|FG005|Overall Study|Lack of Efficacy|0|||
163148238|NCT00713609|589255423|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
163148239|NCT00713609|589255424|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
163148240|NCT00713609|589255425|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
163148241|NCT00713609|589255426|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
163148242|NCT00713609|589255427|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
163148243|NCT00713609|589255428|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
163148244|NCT00713609|589255423|FG000|Overall Study|Withdrawal by Subject|6|||
163148245|NCT00713609|589255424|FG001|Overall Study|Withdrawal by Subject|1|||
163148246|NCT00713609|589255425|FG002|Overall Study|Withdrawal by Subject|5|||
163148247|NCT00713609|589255426|FG003|Overall Study|Withdrawal by Subject|1|||
163148248|NCT00713609|589255427|FG004|Overall Study|Withdrawal by Subject|5|||
163148249|NCT00713609|589255428|FG005|Overall Study|Withdrawal by Subject|7|||
163148250|NCT00713609|589255423|FG000|Overall Study|Protocol Violation|6|||
163148251|NCT00713609|589255424|FG001|Overall Study|Protocol Violation|3|||
163148252|NCT00713609|589255425|FG002|Overall Study|Protocol Violation|1|||
163148253|NCT00713609|589255426|FG003|Overall Study|Protocol Violation|1|||
163148254|NCT00713609|589255427|FG004|Overall Study|Protocol Violation|2|||
163148255|NCT00713609|589255428|FG005|Overall Study|Protocol Violation|0|||
163148256|NCT01903356|589255429|FG000|Overall Study|Lost to Follow-up|7|||
163148257|NCT01903356|589255429|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
163148258|NCT01903356|589255429|FG000|Overall Study|Violated the dosage and administration|3|||
163148259|NCT04529083|589255430|FG000|Overall Study|Withdrawal by Subject|3|||
163148260|NCT03305666|589255435|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
163148261|NCT03305666|589255436|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
163148262|NCT04196686|589255437|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
163148263|NCT04196686|589255438|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
163148264|NCT00914849|589255444|FG000|Overall Study|Withdrawal by Subject|1|||
163148265|NCT00914849|589255445|FG001|Overall Study|Withdrawal by Subject|0|||
162721497|NCT03482011|587688312|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162665305|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
162665306|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162665307|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
162665308|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
162665309|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162665310|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162665311|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163148266|NCT00914849|589255444|FG000|Overall Study|Not eligible|0|||
163148267|NCT00914849|589255445|FG001|Overall Study|Not eligible|1|||
163148268|NCT01001221|589255446|FG000|Overall Study|Adverse Event|1|||
163148269|NCT01001221|589255447|FG001|Overall Study|Adverse Event|2|||
163148270|NCT01001221|589255448|FG002|Overall Study|Adverse Event|0|||
163148271|NCT01001221|589255449|FG003|Overall Study|Adverse Event|2|||
163148272|NCT01001221|589255450|FG004|Overall Study|Adverse Event|0|||
163148273|NCT01001221|589255446|FG000|Overall Study|Disease progression|3|||
163148274|NCT01001221|589255447|FG001|Overall Study|Disease progression|2|||
163148275|NCT01001221|589255448|FG002|Overall Study|Disease progression|2|||
163148276|NCT01001221|589255449|FG003|Overall Study|Disease progression|4|||
163148277|NCT01001221|589255450|FG004|Overall Study|Disease progression|0|||
163148278|NCT01001221|589255446|FG000|Overall Study|Other|1|||
163148279|NCT01001221|589255447|FG001|Overall Study|Other|1|||
163148280|NCT01001221|589255448|FG002|Overall Study|Other|0|||
163148281|NCT01001221|589255449|FG003|Overall Study|Other|0|||
163148282|NCT01001221|589255450|FG004|Overall Study|Other|0|||
163148283|NCT01001221|589255446|FG000|Overall Study|Not treated; protocol exclusion|0|||
163148284|NCT01001221|589255447|FG001|Overall Study|Not treated; protocol exclusion|0|||
163148285|NCT01001221|589255448|FG002|Overall Study|Not treated; protocol exclusion|1|||
163148286|NCT01001221|589255449|FG003|Overall Study|Not treated; protocol exclusion|0|||
163148287|NCT01001221|589255450|FG004|Overall Study|Not treated; protocol exclusion|0|||
163148288|NCT05106959|589255451|FG000|Overall Study|Lost to Follow-up|1|||
163148289|NCT03448406|589255452|FG000|Overall Study|Noncompliance of scheduled visits|1|||
163148290|NCT03448406|589255453|FG001|Overall Study|Noncompliance of scheduled visits|2|||
163148291|NCT03448406|589255452|FG000|Overall Study|Withdrawal by Subject|1|||
163148292|NCT03448406|589255453|FG001|Overall Study|Withdrawal by Subject|2|||
163148293|NCT03448406|589255452|FG000|Overall Study|Protocol Violation|1|||
163148294|NCT03448406|589255453|FG001|Overall Study|Protocol Violation|0|||
163148295|NCT03448406|589255452|FG000|Overall Study|Adverse Event|8|||
163148296|NCT03448406|589255453|FG001|Overall Study|Adverse Event|9|||
163148297|NCT01292486|589255454|FG000|Overall Study|Protocol Violation|2|||
163148298|NCT01292486|589255454|FG000|Overall Study|Did not meet screening criteria|2|||
163148299|NCT01292486|589255454|FG000|Overall Study|Adverse Event|1|||
163148300|NCT01292486|589255454|FG000|Overall Study|Physician Decision|1|||
163148301|NCT00087152|589255455|FG000|Overall Study|Ineligible|6|||
163148302|NCT04602390|589255462|FG000|Overall Study|Withdrawal by Subject|0|||
163148303|NCT04602390|589255463|FG001|Overall Study|Withdrawal by Subject|0|||
163148304|NCT04602390|589255464|FG002|Overall Study|Withdrawal by Subject|0|||
163148305|NCT04602390|589255465|FG003|Overall Study|Withdrawal by Subject|0|||
163148306|NCT04602390|589255466|FG004|Overall Study|Withdrawal by Subject|1|||
163148307|NCT04602390|589255467|FG005|Overall Study|Withdrawal by Subject|0|||
163148308|NCT04602390|589255462|FG000|Overall Study|Adverse Event|0|||
163148309|NCT04602390|589255463|FG001|Overall Study|Adverse Event|0|||
163148310|NCT04602390|589255464|FG002|Overall Study|Adverse Event|0|||
163148311|NCT04602390|589255465|FG003|Overall Study|Adverse Event|0|||
163148312|NCT04602390|589255466|FG004|Overall Study|Adverse Event|0|||
163148313|NCT04602390|589255467|FG005|Overall Study|Adverse Event|1|||
163148314|NCT01277744|589255472|FG000|Overall Study|Physician Decision|2|||
163148315|NCT01791244|589255473|FG000|Overall Study|Adverse Event|5|||
163148316|NCT01791244|589255474|FG001|Overall Study|Adverse Event|7|||
163148317|NCT01791244|589255473|FG000|Overall Study|Insufficient clinical response|10|||
163148318|NCT01791244|589255474|FG001|Overall Study|Insufficient clinical response|10|||
163148319|NCT01791244|589255473|FG000|Overall Study|Laboratory Abnormality|0|||
163148320|NCT01791244|589255474|FG001|Overall Study|Laboratory Abnormality|1|||
163148321|NCT02358473|589255476|FG000|Overall Study|Disease Progession|6|||
163148322|NCT02358473|589255476|FG000|Overall Study|Adverse Event|3|||
163148323|NCT02358473|589255476|FG000|Overall Study|Withdrawal by Subject|2|||
163148324|NCT02358473|589255476|FG000|Overall Study|Physician Decision|2|||
163148325|NCT00703014|589255479|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
163148326|NCT00703014|589255480|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
163148327|NCT00703014|589255481|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148328|NCT00703014|589255482|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148329|NCT00703014|589255479|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148330|NCT00703014|589255480|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
163148331|NCT00703014|589255481|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
163148332|NCT00703014|589255482|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
163148333|NCT04949191|589255483|FG000|Overall Study|Non-compliance with Study Drug|1|||
163148334|NCT04949191|589255484|FG001|Overall Study|Non-compliance with Study Drug|0|||
163148335|NCT04949191|589255485|FG002|Overall Study|Non-compliance with Study Drug|0|||
163148336|NCT04949191|589255486|FG003|Overall Study|Non-compliance with Study Drug|0|||
163148337|NCT04949191|589255483|FG000|Overall Study|Progressive Disease|0|||
163148338|NCT04949191|589255484|FG001|Overall Study|Progressive Disease|1|||
163148339|NCT04949191|589255485|FG002|Overall Study|Progressive Disease|0|||
163148340|NCT04949191|589255486|FG003|Overall Study|Progressive Disease|0|||
163148341|NCT04949191|589255483|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148342|NCT04949191|589255484|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
163148343|NCT04949191|589255485|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148344|NCT04949191|589255486|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
163148345|NCT04949191|589255483|FG000|Overall Study|Sponsor Terminated Study|0|||
163148346|NCT04949191|589255484|FG001|Overall Study|Sponsor Terminated Study|0|||
163148347|NCT04949191|589255485|FG002|Overall Study|Sponsor Terminated Study|1|||
163148348|NCT04949191|589255486|FG003|Overall Study|Sponsor Terminated Study|1|||
163148349|NCT00730158|589255487|FG000|Overall Study|Withdrawal by Subject|1|||
163148350|NCT00730158|589255488|FG001|Overall Study|Withdrawal by Subject|1|||
163148351|NCT03535974|589255490|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
163148352|NCT03535974|589255491|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
163148353|NCT03535974|589255492|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
163148354|NCT03535974|589255490|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
163148355|NCT03535974|589255491|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
163148356|NCT03535974|589255492|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
163148357|NCT04059549|589255493|FG000|Overall Study|Withdrawal by Subject|2|||
163148358|NCT04059549|589255494|FG001|Overall Study|Withdrawal by Subject|0|||
163148359|NCT02678351|589255495|FG000|Overall Study|Withdrawal by Subject|1|||
163148360|NCT03259230|589255496|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
163148361|NCT03259230|589255497|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
163148362|NCT02913482|589255498|FG000|Overall Study|Death|0|||
163148363|NCT02913482|589255499|FG001|Overall Study|Death|2|||
163148364|NCT02913482|589255500|FG002|Overall Study|Death|2|||
163148365|NCT02913482|589255498|FG000|Overall Study|Progressive Disease|1|||
163148366|NCT02913482|589255499|FG001|Overall Study|Progressive Disease|1|||
163148367|NCT02913482|589255500|FG002|Overall Study|Progressive Disease|1|||
163148368|NCT02913482|589255498|FG000|Overall Study|Reason not specified|0|||
163148369|NCT02913482|589255499|FG001|Overall Study|Reason not specified|0|||
163148370|NCT02913482|589255500|FG002|Overall Study|Reason not specified|1|||
163148371|NCT02913482|589255498|FG000|Overall Study|Withdrawal by Subject|0|||
163148372|NCT02913482|589255499|FG001|Overall Study|Withdrawal by Subject|1|||
163148373|NCT02913482|589255500|FG002|Overall Study|Withdrawal by Subject|1|||
163148374|NCT01919229|589255501|FG000|Overall Study|Subject/guardian decision|0|||
163148375|NCT01919229|589255502|FG001|Overall Study|Subject/guardian decision|0|||
163148376|NCT01919229|589255503|FG002|Overall Study|Subject/guardian decision|1|||
163148377|NCT01011673|589255504|FG000|Randomized|Secondary headache|2|||
163148378|NCT01011673|589255505|FG001|Randomized|Secondary headache|1|||
163148379|NCT01011673|589255504|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
163148380|NCT01011673|589255505|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
163148381|NCT05468814|589255506|FG000|Overall Study|Lost to Follow-up|5|||
163148382|NCT05468814|589255507|FG001|Overall Study|Lost to Follow-up|6|||
163148383|NCT04716426|589255512|FG000|Overall Study|Vaccination|1|||
163148384|NCT04716426|589255513|FG001|Overall Study|Vaccination|1|||
163148385|NCT04716426|589255512|FG000|Overall Study|Contamination|1|||
163148386|NCT04716426|589255513|FG001|Overall Study|Contamination|0|||
163148387|NCT01650558|589255516|FG000|Overall Study|Migration out of study area|61|||
163148388|NCT01650558|589255517|FG001|Overall Study|Migration out of study area|71|||
163148389|NCT01650558|589255518|FG002|Overall Study|Migration out of study area|56|||
163148390|NCT01650558|589255516|FG000|Overall Study|Lost to Follow-up|10|||
163148391|NCT01650558|589255517|FG001|Overall Study|Lost to Follow-up|13|||
163148392|NCT01650558|589255518|FG002|Overall Study|Lost to Follow-up|6|||
163148393|NCT01650558|589255516|FG000|Overall Study|Death|10|||
163148394|NCT01650558|589255517|FG001|Overall Study|Death|6|||
163148395|NCT01650558|589255518|FG002|Overall Study|Death|8|||
163148396|NCT01650558|589255516|FG000|Overall Study|Withdrawal by Subject|1|||
163148397|NCT01650558|589255517|FG001|Overall Study|Withdrawal by Subject|1|||
163148398|NCT01650558|589255518|FG002|Overall Study|Withdrawal by Subject|3|||
163148399|NCT01650558|589255516|FG000|Overall Study|Non-compliant participant|1|||
163148400|NCT01650558|589255517|FG001|Overall Study|Non-compliant participant|0|||
163148401|NCT01650558|589255518|FG002|Overall Study|Non-compliant participant|2|||
163148402|NCT01650558|589255516|FG000|Overall Study|Physician Decision|0|||
163148403|NCT01650558|589255517|FG001|Overall Study|Physician Decision|1|||
163148404|NCT01650558|589255518|FG002|Overall Study|Physician Decision|0|||
162721498|NCT03482011|587688313|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163148405|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
163148406|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
163148407|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
163148408|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
163148409|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
163148410|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
163148411|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
163148412|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
163148413|NCT02960217|589255519|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
163148414|NCT02960217|589255520|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
163148415|NCT02960217|589255519|FG000|Open-Label Extension Phase|Adverse Event|1|||
163148416|NCT02960217|589255520|FG001|Open-Label Extension Phase|Adverse Event|0|||
163148417|NCT02960217|589255519|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
163148418|NCT02960217|589255520|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
163148419|NCT02960217|589255519|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
163148420|NCT02960217|589255520|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
163148421|NCT02960217|589255519|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
163148422|NCT02960217|589255520|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
163148423|NCT02734693|589255521|FG000|Overall Study|Adverse Event|1|||
163148424|NCT02734693|589255522|FG001|Overall Study|Adverse Event|3|||
163148425|NCT02734693|589255523|FG002|Overall Study|Adverse Event|3|||
163148426|NCT02734693|589255521|FG000|Overall Study|Lack of Efficacy|1|||
163148427|NCT02734693|589255522|FG001|Overall Study|Lack of Efficacy|0|||
163148428|NCT02734693|589255523|FG002|Overall Study|Lack of Efficacy|0|||
163148429|NCT02734693|589255521|FG000|Overall Study|Lost to Follow-up|2|||
163148430|NCT02734693|589255522|FG001|Overall Study|Lost to Follow-up|0|||
163148431|NCT02734693|589255523|FG002|Overall Study|Lost to Follow-up|0|||
163148432|NCT02734693|589255521|FG000|Overall Study|Protocol Violation|1|||
163148433|NCT02734693|589255522|FG001|Overall Study|Protocol Violation|0|||
163148434|NCT02734693|589255523|FG002|Overall Study|Protocol Violation|0|||
163148435|NCT02734693|589255521|FG000|Overall Study|Withdrawal by Subject|1|||
163148436|NCT02734693|589255522|FG001|Overall Study|Withdrawal by Subject|0|||
163148437|NCT02734693|589255523|FG002|Overall Study|Withdrawal by Subject|0|||
163148438|NCT04158583|589255527|FG000|Overall Study|Withdrawal by Subject|1|||
163148439|NCT04158583|589255528|FG001|Overall Study|Withdrawal by Subject|1|||
163148440|NCT04158583|589255529|FG002|Overall Study|Withdrawal by Subject|0|||
163148441|NCT04158583|589255530|FG003|Overall Study|Withdrawal by Subject|0|||
163148442|NCT04158583|589255531|FG004|Overall Study|Withdrawal by Subject|1|||
163148443|NCT04158583|589255532|FG005|Overall Study|Withdrawal by Subject|0|||
163148444|NCT04158583|589255533|FG006|Overall Study|Withdrawal by Subject|0|||
163148445|NCT04158583|589255534|FG007|Overall Study|Withdrawal by Subject|0|||
163148446|NCT04158583|589255535|FG008|Overall Study|Withdrawal by Subject|2|||
163148447|NCT04158583|589255536|FG009|Overall Study|Withdrawal by Subject|0|||
163148448|NCT04158583|589255527|FG000|Overall Study|Study Terminated by Sponsor|0|||
163148449|NCT04158583|589255528|FG001|Overall Study|Study Terminated by Sponsor|0|||
163148450|NCT04158583|589255529|FG002|Overall Study|Study Terminated by Sponsor|0|||
163148451|NCT04158583|589255530|FG003|Overall Study|Study Terminated by Sponsor|1|||
163148452|NCT04158583|589255531|FG004|Overall Study|Study Terminated by Sponsor|0|||
163148453|NCT04158583|589255532|FG005|Overall Study|Study Terminated by Sponsor|0|||
163148454|NCT04158583|589255533|FG006|Overall Study|Study Terminated by Sponsor|0|||
163148455|NCT04158583|589255534|FG007|Overall Study|Study Terminated by Sponsor|0|||
163148456|NCT04158583|589255535|FG008|Overall Study|Study Terminated by Sponsor|0|||
163148457|NCT04158583|589255536|FG009|Overall Study|Study Terminated by Sponsor|0|||
163148458|NCT04158583|589255527|FG000|Overall Study|Progressive Disease|1|||
163148459|NCT04158583|589255528|FG001|Overall Study|Progressive Disease|0|||
163148460|NCT04158583|589255529|FG002|Overall Study|Progressive Disease|3|||
163148461|NCT04158583|589255530|FG003|Overall Study|Progressive Disease|5|||
163148462|NCT04158583|589255531|FG004|Overall Study|Progressive Disease|0|||
163148463|NCT04158583|589255532|FG005|Overall Study|Progressive Disease|1|||
163148464|NCT04158583|589255533|FG006|Overall Study|Progressive Disease|6|||
163148465|NCT04158583|589255534|FG007|Overall Study|Progressive Disease|2|||
163148466|NCT04158583|589255535|FG008|Overall Study|Progressive Disease|1|||
163148467|NCT04158583|589255536|FG009|Overall Study|Progressive Disease|2|||
163148468|NCT04158583|589255527|FG000|Overall Study|Lost to Follow-up|0|||
163148469|NCT04158583|589255528|FG001|Overall Study|Lost to Follow-up|0|||
163148470|NCT04158583|589255529|FG002|Overall Study|Lost to Follow-up|1|||
163148471|NCT04158583|589255530|FG003|Overall Study|Lost to Follow-up|1|||
163148472|NCT04158583|589255531|FG004|Overall Study|Lost to Follow-up|1|||
163148473|NCT04158583|589255532|FG005|Overall Study|Lost to Follow-up|0|||
163148474|NCT04158583|589255533|FG006|Overall Study|Lost to Follow-up|0|||
163148475|NCT04158583|589255534|FG007|Overall Study|Lost to Follow-up|0|||
163148476|NCT04158583|589255535|FG008|Overall Study|Lost to Follow-up|0|||
163148477|NCT04158583|589255536|FG009|Overall Study|Lost to Follow-up|0|||
162665312|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162665313|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
162665314|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
163148478|NCT04158583|589255527|FG000|Overall Study|Due To Patient Status|0|||
163148479|NCT04158583|589255528|FG001|Overall Study|Due To Patient Status|0|||
163148480|NCT04158583|589255529|FG002|Overall Study|Due To Patient Status|0|||
163148481|NCT04158583|589255530|FG003|Overall Study|Due To Patient Status|0|||
163148482|NCT04158583|589255531|FG004|Overall Study|Due To Patient Status|0|||
163148483|NCT04158583|589255532|FG005|Overall Study|Due To Patient Status|0|||
163148484|NCT04158583|589255533|FG006|Overall Study|Due To Patient Status|0|||
163148485|NCT04158583|589255534|FG007|Overall Study|Due To Patient Status|0|||
163148486|NCT04158583|589255535|FG008|Overall Study|Due To Patient Status|1|||
163148487|NCT04158583|589255536|FG009|Overall Study|Due To Patient Status|0|||
163148488|NCT04158583|589255527|FG000|Overall Study|Death|3|||
163148489|NCT04158583|589255528|FG001|Overall Study|Death|4|||
163148490|NCT04158583|589255529|FG002|Overall Study|Death|2|||
163148491|NCT04158583|589255530|FG003|Overall Study|Death|2|||
163148492|NCT04158583|589255531|FG004|Overall Study|Death|4|||
163148493|NCT04158583|589255532|FG005|Overall Study|Death|3|||
163148494|NCT04158583|589255533|FG006|Overall Study|Death|5|||
163148495|NCT04158583|589255534|FG007|Overall Study|Death|2|||
163148496|NCT04158583|589255535|FG008|Overall Study|Death|0|||
163148497|NCT04158583|589255536|FG009|Overall Study|Death|1|||
163148498|NCT04158583|589255527|FG000|Overall Study|Clinical Progression Disease|0|||
163148499|NCT04158583|589255528|FG001|Overall Study|Clinical Progression Disease|0|||
163148500|NCT04158583|589255529|FG002|Overall Study|Clinical Progression Disease|0|||
163148501|NCT04158583|589255530|FG003|Overall Study|Clinical Progression Disease|1|||
163148502|NCT04158583|589255531|FG004|Overall Study|Clinical Progression Disease|0|||
163148503|NCT04158583|589255532|FG005|Overall Study|Clinical Progression Disease|0|||
163148504|NCT04158583|589255533|FG006|Overall Study|Clinical Progression Disease|0|||
163148505|NCT04158583|589255534|FG007|Overall Study|Clinical Progression Disease|0|||
163148506|NCT04158583|589255535|FG008|Overall Study|Clinical Progression Disease|0|||
163148507|NCT04158583|589255536|FG009|Overall Study|Clinical Progression Disease|0|||
163148508|NCT04158583|589255527|FG000|Overall Study|Clinical Progression|0|||
163148509|NCT04158583|589255528|FG001|Overall Study|Clinical Progression|0|||
163148510|NCT04158583|589255529|FG002|Overall Study|Clinical Progression|0|||
163148511|NCT04158583|589255530|FG003|Overall Study|Clinical Progression|0|||
163148512|NCT04158583|589255531|FG004|Overall Study|Clinical Progression|1|||
163148513|NCT04158583|589255532|FG005|Overall Study|Clinical Progression|0|||
163148514|NCT04158583|589255533|FG006|Overall Study|Clinical Progression|2|||
163148515|NCT04158583|589255534|FG007|Overall Study|Clinical Progression|0|||
163148516|NCT04158583|589255535|FG008|Overall Study|Clinical Progression|0|||
163148517|NCT04158583|589255536|FG009|Overall Study|Clinical Progression|0|||
163148518|NCT04158583|589255527|FG000|Overall Study|Clinical Deterioration|0|||
163148519|NCT04158583|589255528|FG001|Overall Study|Clinical Deterioration|0|||
163148520|NCT04158583|589255529|FG002|Overall Study|Clinical Deterioration|0|||
163148521|NCT04158583|589255530|FG003|Overall Study|Clinical Deterioration|1|||
163148522|NCT04158583|589255531|FG004|Overall Study|Clinical Deterioration|0|||
163148523|NCT04158583|589255532|FG005|Overall Study|Clinical Deterioration|0|||
163148524|NCT04158583|589255533|FG006|Overall Study|Clinical Deterioration|0|||
163148525|NCT04158583|589255534|FG007|Overall Study|Clinical Deterioration|0|||
163148526|NCT04158583|589255535|FG008|Overall Study|Clinical Deterioration|0|||
163148527|NCT04158583|589255536|FG009|Overall Study|Clinical Deterioration|1|||
163148528|NCT01766050|589257277|FG000|Overall Study|Adverse Event|1|||
163148529|NCT01766050|589257277|FG000|Overall Study|Lost to Follow-up|1|||
163148530|NCT01766050|589257277|FG000|Overall Study|Withdrawal by Subject|2|||
163148531|NCT01097668|589257278|FG000|Overall Study|Withdrawal by Subject|1|||
163148532|NCT01097668|589257279|FG001|Overall Study|Withdrawal by Subject|2|||
163148533|NCT01097668|589257278|FG000|Overall Study|Lost to Follow-up|1|||
163148534|NCT01097668|589257279|FG001|Overall Study|Lost to Follow-up|0|||
163148535|NCT00812708|589257280|FG000|Overall Study|Device could not be implanted|2|||
163148536|NCT00812708|589257280|FG000|Overall Study|Lack of medical insurance|1|||
163148537|NCT00812708|589257280|FG000|Overall Study|Switched to another study|1|||
163148538|NCT00812708|589257280|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
163148539|NCT00812708|589257280|FG000|Overall Study|Signed consent but later withdrew|3|||
163148540|NCT02421172|589257281|FG000|Period 1|Adverse Event|1|||
163148541|NCT02421172|589257282|FG001|Period 1|Adverse Event|0|||
163148542|NCT02421172|589257283|FG002|Period 1|Adverse Event|0|||
163148543|NCT02421172|589257284|FG003|Period 1|Adverse Event|0|||
163148544|NCT02421172|589257285|FG004|Period 1|Adverse Event|0|||
163148545|NCT02421172|589257281|FG000|Period 1|Lost to Follow-up|3|||
163148546|NCT02421172|589257282|FG001|Period 1|Lost to Follow-up|1|||
163148547|NCT02421172|589257283|FG002|Period 1|Lost to Follow-up|0|||
163148548|NCT02421172|589257284|FG003|Period 1|Lost to Follow-up|0|||
163148549|NCT02421172|589257285|FG004|Period 1|Lost to Follow-up|0|||
163148550|NCT02421172|589257281|FG000|Period 1|Patient/guardian decision|0|||
163148551|NCT02421172|589257282|FG001|Period 1|Patient/guardian decision|1|||
163148552|NCT02421172|589257283|FG002|Period 1|Patient/guardian decision|0|||
163148553|NCT02421172|589257284|FG003|Period 1|Patient/guardian decision|0|||
163148554|NCT02421172|589257285|FG004|Period 1|Patient/guardian decision|0|||
162665315|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665316|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665317|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
162665318|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665319|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665320|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665321|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665322|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665323|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162665324|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163148555|NCT02421172|589257281|FG000|Period 2|Adverse Event|0|||
163148556|NCT02421172|589257282|FG001|Period 2|Adverse Event|0|||
163148557|NCT02421172|589257283|FG002|Period 2|Adverse Event|4|||
163148558|NCT02421172|589257284|FG003|Period 2|Adverse Event|0|||
163148559|NCT02421172|589257285|FG004|Period 2|Adverse Event|0|||
163148560|NCT02421172|589257281|FG000|Period 2|Lost to Follow-up|0|||
163148561|NCT02421172|589257282|FG001|Period 2|Lost to Follow-up|0|||
163148562|NCT02421172|589257283|FG002|Period 2|Lost to Follow-up|0|||
163148563|NCT02421172|589257284|FG003|Period 2|Lost to Follow-up|1|||
163148564|NCT02421172|589257285|FG004|Period 2|Lost to Follow-up|0|||
163148565|NCT02421172|589257281|FG000|Period 2|Patient/guardian decision|0|||
163148566|NCT02421172|589257282|FG001|Period 2|Patient/guardian decision|0|||
163148567|NCT02421172|589257283|FG002|Period 2|Patient/guardian decision|3|||
163148568|NCT02421172|589257284|FG003|Period 2|Patient/guardian decision|2|||
163148569|NCT02421172|589257285|FG004|Period 2|Patient/guardian decision|1|||
163148570|NCT00928486|589257286|FG000|Overall Study|Adverse Event|2|||
163148571|NCT00928486|589257286|FG000|Overall Study|Disease Progression|7|||
163148572|NCT00928486|589257286|FG000|Overall Study|Withdrawal by Subject|1|||
163148573|NCT01021020|589257287|FG000|Period I|Protocol Violation|1|||
163148574|NCT01021020|589257287|FG000|Period I|Withdrawal by Subject|1|||
163148575|NCT01021020|589257287|FG000|14 Day Washout Period A|Physician Decision|1|||
163148576|NCT00755183|589257288|FG000|Overall Study|Adverse Event|5|||
163148577|NCT00755183|589257289|FG001|Overall Study|Adverse Event|2|||
163148578|NCT00755183|589257288|FG000|Overall Study|Protocol Violation|0|||
163148579|NCT00755183|589257289|FG001|Overall Study|Protocol Violation|1|||
163148580|NCT00755183|589257288|FG000|Overall Study|Withdrawal by Subject|0|||
163148581|NCT00755183|589257289|FG001|Overall Study|Withdrawal by Subject|2|||
163148582|NCT00755183|589257288|FG000|Overall Study|Administrative|2|||
163148583|NCT00755183|589257289|FG001|Overall Study|Administrative|1|||
163148584|NCT02587520|589257292|FG000|Overall Study|Protocol Violation|2|||
163148585|NCT02587520|589257293|FG001|Overall Study|Protocol Violation|0|||
163148586|NCT02587520|589257294|FG002|Overall Study|Protocol Violation|0|||
163148587|NCT02587520|589257295|FG003|Overall Study|Protocol Violation|2|||
163148588|NCT02587520|589257296|FG004|Overall Study|Protocol Violation|0|||
163148589|NCT02587520|589257297|FG005|Overall Study|Protocol Violation|1|||
163148590|NCT02587520|589257298|FG006|Overall Study|Protocol Violation|1|||
163148591|NCT02587520|589257299|FG007|Overall Study|Protocol Violation|1|||
163148592|NCT02587520|589257300|FG008|Overall Study|Protocol Violation|3|||
163148593|NCT02587520|589257301|FG009|Overall Study|Protocol Violation|3|||
163148594|NCT02587520|589257302|FG010|Overall Study|Protocol Violation|1|||
163148595|NCT02587520|589257303|FG011|Overall Study|Protocol Violation|2|||
162721499|NCT03482011|587688314|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
162721500|NCT03482011|587688307|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
162721501|NCT03482011|587688308|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
162721502|NCT03482011|587688309|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
162721503|NCT03482011|587688310|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
162721504|NCT03482011|587688311|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
162721505|NCT03482011|587688312|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
162721506|NCT03482011|587688313|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
162721507|NCT03482011|587688314|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
162721508|NCT03482011|587688307|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162721509|NCT03482011|587688308|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162721510|NCT03482011|587688309|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162721511|NCT03482011|587688310|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
162721512|NCT03482011|587688311|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162721513|NCT03482011|587688312|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
162721514|NCT03482011|587688313|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162665325|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
162665326|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
162665327|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162665328|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162665329|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162665330|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162665331|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
162665332|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
162665333|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665334|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665335|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
162665336|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665337|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665338|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665339|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665340|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665341|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162665342|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665343|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
162665344|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
162665345|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665346|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665347|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665348|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665349|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
162665350|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162665351|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665352|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
162665353|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665354|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665355|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665356|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665357|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665358|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162665359|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
162665360|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665361|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
162665362|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665363|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665364|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665365|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665366|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665367|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665368|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162665369|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665370|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665371|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665372|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665373|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162721515|NCT03482011|587688314|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162721516|NCT03482011|587688307|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162665374|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665375|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665376|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162665377|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
162665378|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162665379|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
162665380|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162665381|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162665382|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162665383|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162665384|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162665385|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162665386|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162665387|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162665388|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
162665389|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
162665390|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162665391|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162665392|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162665393|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162665394|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
162665395|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
162665396|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665397|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665398|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665399|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665400|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665401|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665402|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665403|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
162665404|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
162665405|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665406|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
162665407|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665408|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665409|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665410|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665411|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665412|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665413|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162665414|NCT01172938|587485118|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665415|NCT01172938|587485119|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665416|NCT01172938|587485120|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
162665417|NCT01172938|587485121|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665418|NCT01172938|587485122|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665419|NCT01172938|587485123|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665420|NCT01172938|587485124|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665421|NCT01172938|587485125|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665422|NCT01172938|587485126|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162665423|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665424|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
162665425|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
162665426|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665427|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665428|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665429|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665430|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
162665431|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162665432|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163148596|NCT02587520|589257304|FG012|Overall Study|Protocol Violation|0|||
163148597|NCT02587520|589257305|FG013|Overall Study|Protocol Violation|0|||
163148598|NCT02587520|589257306|FG014|Overall Study|Protocol Violation|0|||
162665433|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
162665434|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
162665435|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
163148599|NCT02587520|589257307|FG015|Overall Study|Protocol Violation|0|||
162665436|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162665437|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162665438|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162665439|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
162665440|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
162665441|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162665442|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
162665443|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
162665444|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162665445|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162665446|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162665447|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162665448|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
162665449|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
162665450|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665451|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665452|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
162665453|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665454|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665455|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665456|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665457|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162665458|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
162665459|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665460|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665461|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665462|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665463|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665464|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665465|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665466|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
162665467|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162665468|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162665469|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162665470|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162665471|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162665472|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162665473|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163148600|NCT02587520|589257308|FG016|Overall Study|Protocol Violation|0|||
163148601|NCT02587520|589257309|FG017|Overall Study|Protocol Violation|0|||
163148602|NCT02587520|589257292|FG000|Overall Study|Adverse Event|0|||
163148603|NCT02587520|589257293|FG001|Overall Study|Adverse Event|0|||
163148604|NCT02587520|589257294|FG002|Overall Study|Adverse Event|0|||
163148605|NCT02587520|589257295|FG003|Overall Study|Adverse Event|0|||
163148606|NCT02587520|589257296|FG004|Overall Study|Adverse Event|0|||
163148607|NCT02587520|589257297|FG005|Overall Study|Adverse Event|0|||
163148608|NCT02587520|589257298|FG006|Overall Study|Adverse Event|0|||
163148609|NCT02587520|589257299|FG007|Overall Study|Adverse Event|0|||
163148610|NCT02587520|589257300|FG008|Overall Study|Adverse Event|0|||
163148611|NCT02587520|589257301|FG009|Overall Study|Adverse Event|0|||
163148612|NCT02587520|589257302|FG010|Overall Study|Adverse Event|0|||
163148613|NCT02587520|589257303|FG011|Overall Study|Adverse Event|1|||
163148614|NCT02587520|589257304|FG012|Overall Study|Adverse Event|0|||
163148615|NCT02587520|589257305|FG013|Overall Study|Adverse Event|0|||
163148616|NCT02587520|589257306|FG014|Overall Study|Adverse Event|0|||
163148617|NCT02587520|589257307|FG015|Overall Study|Adverse Event|0|||
163148618|NCT02587520|589257308|FG016|Overall Study|Adverse Event|0|||
163148619|NCT02587520|589257309|FG017|Overall Study|Adverse Event|0|||
163148620|NCT02587520|589257292|FG000|Overall Study|Withdrawal by Subject|0|||
163148621|NCT02587520|589257293|FG001|Overall Study|Withdrawal by Subject|0|||
163148622|NCT02587520|589257294|FG002|Overall Study|Withdrawal by Subject|1|||
163148623|NCT02587520|589257295|FG003|Overall Study|Withdrawal by Subject|1|||
163148624|NCT02587520|589257296|FG004|Overall Study|Withdrawal by Subject|0|||
163148625|NCT02587520|589257297|FG005|Overall Study|Withdrawal by Subject|1|||
163148626|NCT02587520|589257298|FG006|Overall Study|Withdrawal by Subject|1|||
163148627|NCT02587520|589257299|FG007|Overall Study|Withdrawal by Subject|0|||
163148628|NCT02587520|589257300|FG008|Overall Study|Withdrawal by Subject|0|||
163148629|NCT02587520|589257301|FG009|Overall Study|Withdrawal by Subject|0|||
163148630|NCT02587520|589257302|FG010|Overall Study|Withdrawal by Subject|0|||
162721517|NCT03482011|587688308|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162721518|NCT03482011|587688309|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162721519|NCT03482011|587688310|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
162721520|NCT03482011|587688311|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162721521|NCT03482011|587688312|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
162721522|NCT03482011|587688313|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
162721523|NCT03482011|587688314|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
162721524|NCT03482011|587688307|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
162721525|NCT03482011|587688308|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
163148631|NCT02587520|589257303|FG011|Overall Study|Withdrawal by Subject|0|||
163148632|NCT02587520|589257304|FG012|Overall Study|Withdrawal by Subject|0|||
163148633|NCT02587520|589257305|FG013|Overall Study|Withdrawal by Subject|1|||
163148634|NCT02587520|589257306|FG014|Overall Study|Withdrawal by Subject|0|||
163148635|NCT02587520|589257307|FG015|Overall Study|Withdrawal by Subject|0|||
163148636|NCT02587520|589257308|FG016|Overall Study|Withdrawal by Subject|0|||
163148637|NCT02587520|589257309|FG017|Overall Study|Withdrawal by Subject|0|||
163148638|NCT02587520|589257292|FG000|Overall Study|Lost to Follow-up|0|||
163148639|NCT02587520|589257293|FG001|Overall Study|Lost to Follow-up|2|||
163148640|NCT02587520|589257294|FG002|Overall Study|Lost to Follow-up|0|||
163148641|NCT02587520|589257295|FG003|Overall Study|Lost to Follow-up|2|||
163148642|NCT02587520|589257296|FG004|Overall Study|Lost to Follow-up|0|||
163148643|NCT02587520|589257297|FG005|Overall Study|Lost to Follow-up|1|||
163148644|NCT02587520|589257298|FG006|Overall Study|Lost to Follow-up|1|||
163148645|NCT02587520|589257299|FG007|Overall Study|Lost to Follow-up|1|||
163148646|NCT02587520|589257300|FG008|Overall Study|Lost to Follow-up|0|||
163148647|NCT02587520|589257301|FG009|Overall Study|Lost to Follow-up|2|||
163148648|NCT02587520|589257302|FG010|Overall Study|Lost to Follow-up|2|||
163148649|NCT02587520|589257303|FG011|Overall Study|Lost to Follow-up|1|||
163148650|NCT02587520|589257304|FG012|Overall Study|Lost to Follow-up|0|||
163148651|NCT02587520|589257305|FG013|Overall Study|Lost to Follow-up|0|||
163148652|NCT02587520|589257306|FG014|Overall Study|Lost to Follow-up|0|||
163148653|NCT02587520|589257307|FG015|Overall Study|Lost to Follow-up|0|||
163148654|NCT02587520|589257308|FG016|Overall Study|Lost to Follow-up|0|||
163148655|NCT02587520|589257309|FG017|Overall Study|Lost to Follow-up|0|||
163148656|NCT00672555|589257310|FG000|Overall Study|Lost to Follow-up|4|||
163148657|NCT00672555|589257310|FG000|Overall Study|Did not want to answer questionnaire|2|||
163148658|NCT04516746|589257313|FG000|Overall Study|Randomized but not Treated|51|||
163148659|NCT04516746|589257314|FG001|Overall Study|Randomized but not Treated|19|||
163148660|NCT04516746|589257313|FG000|Overall Study|Adverse Event|0|||
163148661|NCT04516746|589257314|FG001|Overall Study|Adverse Event|1|||
163148662|NCT04516746|589257313|FG000|Overall Study|Death|62|||
163148663|NCT04516746|589257314|FG001|Overall Study|Death|32|||
163148664|NCT04516746|589257313|FG000|Overall Study|Lost to Follow-up|3431|||
162721526|NCT03482011|587688309|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
162721527|NCT03482011|587688310|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
162721528|NCT03482011|587688311|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
162721529|NCT03482011|587688312|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
162721530|NCT03482011|587688313|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
162721531|NCT03482011|587688314|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
163148665|NCT04516746|589257314|FG001|Overall Study|Lost to Follow-up|1831|||
163148666|NCT04516746|589257313|FG000|Overall Study|Withdrawal by Subject|1946|||
163148667|NCT04516746|589257314|FG001|Overall Study|Withdrawal by Subject|1696|||
163148668|NCT04516746|589257313|FG000|Overall Study|Physician Decision|10|||
163148669|NCT04516746|589257314|FG001|Overall Study|Physician Decision|8|||
163148670|NCT04516746|589257313|FG000|Overall Study|Other|35|||
163148671|NCT04516746|589257314|FG001|Overall Study|Other|16|||
163148672|NCT03489863|589257315|FG000|Overall Study|Withdrawal by Subject|0|||
163148673|NCT03489863|589257316|FG001|Overall Study|Withdrawal by Subject|1|||
163148674|NCT00446849|589257318|FG000|Acute Phase|Lack of Efficacy|64|||
163148675|NCT00446849|589257318|FG000|Acute Phase|Protocol Violation|10|||
163148676|NCT00446849|589257318|FG000|Acute Phase|Consent withdrawn|4|||
163148677|NCT00446849|589257318|FG000|Acute Phase|Lost to Follow-up|2|||
163148678|NCT00446849|589257318|FG000|Acute Phase|Physician Decision|1|||
163148679|NCT00446849|589257318|FG000|Acute Phase|noncompliance|1|||
163148680|NCT00446849|589257318|FG000|Maintenance Phase|Lack of Efficacy|40|||
163148681|NCT00446849|589257318|FG000|Maintenance Phase|Protocol Violation|7|||
163148682|NCT00446849|589257318|FG000|Maintenance Phase|Adverse Event|6|||
163148683|NCT00446849|589257318|FG000|Maintenance Phase|Consent withdrawn|5|||
163148684|NCT00446849|589257318|FG000|Maintenance Phase|Lost to Follow-up|3|||
163148685|NCT00446849|589257318|FG000|Maintenance Phase|Pregnancy|1|||
163148686|NCT00446849|589257318|FG000|Maintenance Phase|noncompliance|2|||
163148687|NCT00446849|589257318|FG000|Maintenance Phase|prohibited medication use|2|||
163148688|NCT00446849|589257318|FG000|Maintenance Phase|antibiotic use|1|||
162721532|NCT03482011|587688307|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162721533|NCT03482011|587688308|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162721534|NCT03482011|587688309|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
162721535|NCT03482011|587688310|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
162721536|NCT03482011|587688311|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162721537|NCT03482011|587688312|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162721538|NCT03482011|587688313|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162721539|NCT03482011|587688314|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
162721540|NCT03482011|587688307|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721541|NCT03482011|587688308|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721542|NCT03482011|587688309|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721543|NCT03482011|587688310|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721544|NCT03482011|587688311|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721545|NCT03482011|587688312|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721546|NCT03482011|587688313|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
162721547|NCT03482011|587688314|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
162665474|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162665475|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162665476|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162665477|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665478|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665479|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
162665480|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665481|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665482|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665483|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665484|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665485|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162665486|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665487|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
162665488|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162721548|NCT03482011|587688307|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721549|NCT03482011|587688308|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721550|NCT03482011|587688309|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721551|NCT03482011|587688310|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721552|NCT03482011|587688311|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721553|NCT03482011|587688312|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721554|NCT03482011|587688313|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162721555|NCT03482011|587688314|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
162721556|NCT00468052|587688315|FG000|Overall Study|Protocol Violation|7|||
162721557|NCT00468052|587688316|FG001|Overall Study|Protocol Violation|8|||
162721558|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
162721559|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
163148689|NCT00446849|589257318|FG000|Maintenance Phase|study closure|1|||
163148690|NCT00446849|589257318|FG000|Maintenance Phase|hydrocodone use|1|||
163148691|NCT00446849|589257318|FG000|Maintenance Phase|concomitant medication use|1|||
163148692|NCT01706458|589257319|FG000|Overall Study|Physician Decision|3|||
163148693|NCT01706458|589257320|FG001|Overall Study|Physician Decision|4|||
163148694|NCT03547518|589257321|FG000|Overall Study|Lost to Follow-up|2|||
163148695|NCT03547518|589257322|FG001|Overall Study|Lost to Follow-up|0|||
163148696|NCT03035032|589257326|FG000|Overall Study|Adverse Event|2|||
163148697|NCT03035032|589257326|FG000|Overall Study|Death|9|||
163148698|NCT03035032|589257326|FG000|Overall Study|Lost to Follow-up|1|||
163148699|NCT03035032|589257326|FG000|Overall Study|Progressive Disease|22|||
163148700|NCT03035032|589257326|FG000|Overall Study|Protocol Violation|2|||
163148701|NCT03035032|589257326|FG000|Overall Study|Withdrawal by Subject|2|||
163148702|NCT03035032|589257326|FG000|Overall Study|Physician Decision|5|||
163148703|NCT01546857|589257330|FG000|Overall Study|Withdrawal by Subject|2|||
163148704|NCT01546857|589257331|FG001|Overall Study|Withdrawal by Subject|3|||
163148705|NCT02542865|589257332|FG000|Overall Study|Identified as screen failure|1|||
163148706|NCT02542865|589257333|FG001|Overall Study|Identified as screen failure|0|||
163148707|NCT02542865|589257332|FG000|Overall Study|Withdrawal by Subject|16|||
163148708|NCT02542865|589257333|FG001|Overall Study|Withdrawal by Subject|0|||
163148709|NCT01339689|589257334|FG000|Overall Study|Adverse Event|1|||
163148710|NCT01339689|589257335|FG001|Overall Study|Adverse Event|2|||
163148711|NCT01339689|589257334|FG000|Overall Study|Lost to Follow-up|9|||
163148712|NCT01339689|589257335|FG001|Overall Study|Lost to Follow-up|3|||
163148713|NCT01339689|589257334|FG000|Overall Study|Withdrawal by Subject|3|||
163148714|NCT01339689|589257335|FG001|Overall Study|Withdrawal by Subject|0|||
163148715|NCT01339689|589257334|FG000|Overall Study|Noncompliance|1|||
163148716|NCT01339689|589257335|FG001|Overall Study|Noncompliance|0|||
162665489|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665490|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665491|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665492|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665493|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
162665494|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162665495|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665496|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
162665497|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
162665498|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665499|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665500|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665501|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665502|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
162665503|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162665504|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665505|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665506|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
162665507|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665508|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665509|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665510|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665511|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162665512|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162721560|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
162721561|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
162721562|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
162721563|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
162721564|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
162721565|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
162721566|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
162721567|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162721568|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162721569|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162721570|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162721571|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
162721572|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
162721573|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721574|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721575|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
162721576|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721577|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721578|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721579|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721580|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721581|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721582|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721583|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162721584|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
162721585|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
162721586|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
162721587|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
162721588|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
162721589|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162721590|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
162721591|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162721592|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162721593|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162721594|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162721595|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163148717|NCT01339689|589257334|FG000|Overall Study|Relocated out of area|0|||
162665513|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665514|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665515|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
162665516|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665517|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665518|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665519|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665520|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665521|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162665522|NCT01172938|587485118|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665523|NCT01172938|587485119|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665524|NCT01172938|587485120|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665525|NCT01172938|587485121|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665526|NCT01172938|587485122|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665527|NCT01172938|587485123|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665528|NCT01172938|587485124|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665529|NCT01172938|587485125|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162665530|NCT01172938|587485126|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
162665531|NCT01033747|587485127|FG000|Overall Study|Adverse Event|9|||
162665532|NCT01033747|587485128|FG001|Overall Study|Adverse Event|4|||
162665533|NCT01033747|587485127|FG000|Overall Study|Abnormal Laboratory Value|1|||
162665534|NCT01033747|587485128|FG001|Overall Study|Abnormal Laboratory Value|0|||
162665535|NCT01033747|587485127|FG000|Overall Study|Abnormal test procedure|0|||
162665536|NCT01033747|587485128|FG001|Overall Study|Abnormal test procedure|1|||
162665537|NCT01033747|587485127|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
162665538|NCT01033747|587485128|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162665539|NCT01033747|587485127|FG000|Overall Study|Protocol Violation|1|||
162665540|NCT01033747|587485128|FG001|Overall Study|Protocol Violation|0|||
162665541|NCT01033747|587485127|FG000|Overall Study|Withdrawal by Subject|9|||
162665542|NCT01033747|587485128|FG001|Overall Study|Withdrawal by Subject|6|||
162665543|NCT01033747|587485127|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
162665544|NCT01033747|587485128|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
162665545|NCT01033747|587485127|FG000|Overall Study|Stopped at end of Extension 1|2|||
162665546|NCT01033747|587485128|FG001|Overall Study|Stopped at end of Extension 1|0|||
162665547|NCT02613481|587485129|FG000|Overall Study|Lost to Follow-up|7|||
162665548|NCT02613481|587485129|FG000|Overall Study|Withdrawal by Subject|2|||
162665549|NCT00844194|587485130|FG000|Overall Study|Adverse Event|17|||
162665550|NCT00844194|587485131|FG001|Overall Study|Adverse Event|5|||
162665551|NCT00844194|587485130|FG000|Overall Study|Protocol Violation|1|||
162665552|NCT00844194|587485131|FG001|Overall Study|Protocol Violation|1|||
162665553|NCT00844194|587485130|FG000|Overall Study|Lost to Follow-up|1|||
162665554|NCT00844194|587485131|FG001|Overall Study|Lost to Follow-up|1|||
162665555|NCT00844194|587485130|FG000|Overall Study|Withdrawal by Subject|2|||
162665556|NCT00844194|587485131|FG001|Overall Study|Withdrawal by Subject|1|||
162665557|NCT00844194|587485130|FG000|Overall Study|Lack of Efficacy|3|||
162665558|NCT00844194|587485131|FG001|Overall Study|Lack of Efficacy|0|||
162665559|NCT00844194|587485130|FG000|Overall Study|Other reason (not specified)|1|||
162665560|NCT00844194|587485131|FG001|Overall Study|Other reason (not specified)|0|||
162665561|NCT01542528|587485136|FG000|Overall Study|Lost to Follow-up|2|||
162665562|NCT01542528|587485137|FG001|Overall Study|Lost to Follow-up|1|||
162665563|NCT01542528|587485136|FG000|Overall Study|Physician Decision|1|||
162665564|NCT01542528|587485137|FG001|Overall Study|Physician Decision|0|||
162665565|NCT01542528|587485136|FG000|Overall Study|Withdrawal by Subject|9|||
162665566|NCT01542528|587485137|FG001|Overall Study|Withdrawal by Subject|6|||
162665567|NCT05282004|587485138|FG000|Overall Study|Adverse Event|2|||
162665568|NCT04808609|587485139|FG000|Overall Study|Lost to Follow-up|0|||
162665569|NCT04808609|587485140|FG001|Overall Study|Lost to Follow-up|2|||
162665570|NCT04808609|587485139|FG000|Overall Study|Administrative Withdrawal|0|||
162665571|NCT04808609|587485140|FG001|Overall Study|Administrative Withdrawal|1|||
162665572|NCT00562159|587485142|FG000|Overall Study|Adverse Event|11|||
162665573|NCT00562159|587485143|FG001|Overall Study|Adverse Event|8|||
162665574|NCT00562159|587485142|FG000|Overall Study|Lost to Follow-up|5|||
162665575|NCT00562159|587485143|FG001|Overall Study|Lost to Follow-up|4|||
162665576|NCT00562159|587485142|FG000|Overall Study|Withdrawal by Subject|9|||
162665577|NCT00562159|587485143|FG001|Overall Study|Withdrawal by Subject|8|||
162665578|NCT00562159|587485142|FG000|Overall Study|Protocol Violation|12|||
162665579|NCT00562159|587485143|FG001|Overall Study|Protocol Violation|12|||
162665580|NCT00562159|587485142|FG000|Overall Study|Did not meet protocol eligibility|1|||
162665581|NCT00562159|587485143|FG001|Overall Study|Did not meet protocol eligibility|1|||
162665582|NCT04382326|587485146|FG000|Overall Study|Adverse Event, not serious|1|||
162665583|NCT04382326|587485147|FG001|Overall Study|Adverse Event, not serious|2|||
162665584|NCT04382326|587485146|FG000|Overall Study|Other|1|||
162665585|NCT04382326|587485147|FG001|Overall Study|Other|0|||
162665586|NCT04382326|587485146|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
162665587|NCT04382326|587485147|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
162665588|NCT04382326|587485146|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
162665589|NCT04382326|587485147|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
162665590|NCT04382326|587485146|FG000|Overall Study|Protocol Violation|29|||
162665591|NCT04382326|587485147|FG001|Overall Study|Protocol Violation|23|||
162665592|NCT04382326|587485146|FG000|Overall Study|Physician Decision|0|||
162665593|NCT04382326|587485147|FG001|Overall Study|Physician Decision|1|||
162665594|NCT04382326|587485146|FG000|Overall Study|Lost to Follow-up|48|||
162665595|NCT04382326|587485147|FG001|Overall Study|Lost to Follow-up|63|||
162665596|NCT04382326|587485146|FG000|Overall Study|Adverse Event, non-fatal|1|||
162665597|NCT04382326|587485147|FG001|Overall Study|Adverse Event, non-fatal|1|||
162665598|NCT01181921|587485150|FG000|Overall Study|Lost to Follow-up|1|||
162665599|NCT01038921|587485156|FG000|Overall Study|Withdrawal by Subject|1|||
162665600|NCT01038921|587485157|FG001|Overall Study|Withdrawal by Subject|0|||
163148718|NCT01339689|589257335|FG001|Overall Study|Relocated out of area|1|||
163148719|NCT01339689|589257334|FG000|Overall Study|Other|2|||
163148720|NCT01339689|589257335|FG001|Overall Study|Other|2|||
162665601|NCT01038921|587485156|FG000|Overall Study|Physician Decision|1|||
162665602|NCT01038921|587485157|FG001|Overall Study|Physician Decision|0|||
162665603|NCT00572572|587485158|FG000|Overall Study|Withdrawal by Subject|3|||
162665604|NCT00572572|587485159|FG001|Overall Study|Withdrawal by Subject|6|||
162665605|NCT02480621|587485172|FG000|Randomization|Withdrawal by Subject|1|||
162665606|NCT02480621|587485173|FG001|Randomization|Withdrawal by Subject|0|||
162665607|NCT02480621|587485172|FG000|Randomization|Surgeon did not give intervention|0|||
162665608|NCT02480621|587485173|FG001|Randomization|Surgeon did not give intervention|1|||
162665609|NCT02480621|587485172|FG000|Follow Up|Lost to Follow-up|4|||
162665610|NCT02480621|587485173|FG001|Follow Up|Lost to Follow-up|2|||
162665611|NCT01748994|587485174|FG000|Overall Study|Lost to Follow-up|8|||
162665612|NCT01748994|587485175|FG001|Overall Study|Lost to Follow-up|6|||
162665613|NCT03105362|587485176|FG000|Overall Study|Withdrawal by Subject|1|||
162665614|NCT03105362|587485176|FG000|Overall Study|Lost to Follow-up|1|||
162665615|NCT00861341|587485178|FG000|Overall Study|Withdrawal by Subject|2|||
162665616|NCT01440946|587485179|FG000|Overall Study|Lost to Follow-up|1|||
162665617|NCT01440946|587485180|FG001|Overall Study|Lost to Follow-up|1|||
162665618|NCT01440946|587485179|FG000|Overall Study|Physician Decision|1|||
162665619|NCT01440946|587485180|FG001|Overall Study|Physician Decision|0|||
162665620|NCT01975389|587485181|FG000|Overall Study|Adverse Event|10|||
162665621|NCT01975389|587485182|FG001|Overall Study|Adverse Event|6|||
162665622|NCT01975389|587485181|FG000|Overall Study|Death|61|||
162665623|NCT01975389|587485182|FG001|Overall Study|Death|54|||
162665624|NCT01975389|587485181|FG000|Overall Study|Lost to Follow-up|81|||
162665625|NCT01975389|587485182|FG001|Overall Study|Lost to Follow-up|86|||
162665626|NCT01975389|587485181|FG000|Overall Study|Withdrawal by Subject|90|||
162665627|NCT01975389|587485182|FG001|Overall Study|Withdrawal by Subject|76|||
162665628|NCT01975389|587485181|FG000|Overall Study|Other|6|||
162665629|NCT01975389|587485182|FG001|Overall Study|Other|9|||
162665630|NCT01975389|587485181|FG000|Overall Study|Randomized, not treated|4|||
162665631|NCT01975389|587485182|FG001|Overall Study|Randomized, not treated|5|||
162665632|NCT01312961|587485183|FG000|Overall Study|Adverse Event|3|||
162665633|NCT01312961|587485184|FG001|Overall Study|Adverse Event|3|||
162665634|NCT01312961|587485183|FG000|Overall Study|Lack of Efficacy|11|||
162665635|NCT01312961|587485184|FG001|Overall Study|Lack of Efficacy|1|||
162665636|NCT01312961|587485183|FG000|Overall Study|Poor compliance to protocol|1|||
162665637|NCT01312961|587485184|FG001|Overall Study|Poor compliance to protocol|0|||
162665638|NCT01312961|587485183|FG000|Overall Study|Other than specified above|2|||
162665639|NCT01312961|587485184|FG001|Overall Study|Other than specified above|3|||
162665640|NCT02296112|587485191|FG000|Overall Study|Disease progression|7|||
162665641|NCT02296112|587485191|FG000|Overall Study|Toxicity|1|||
162665642|NCT02296112|587485191|FG000|Overall Study|Began an alternate therapy|1|||
162665643|NCT02778204|587485192|FG000|Overall Study|Adverse Event|1|||
162665644|NCT02778204|587485193|FG001|Overall Study|Adverse Event|0|||
162665645|NCT02778204|587485194|FG002|Overall Study|Adverse Event|0|||
162665646|NCT02778204|587485195|FG003|Overall Study|Adverse Event|0|||
162665647|NCT02778204|587485192|FG000|Overall Study|Withdrawal by Subject|0|||
162665648|NCT02778204|587485193|FG001|Overall Study|Withdrawal by Subject|0|||
162665649|NCT02778204|587485194|FG002|Overall Study|Withdrawal by Subject|1|||
162665650|NCT02778204|587485195|FG003|Overall Study|Withdrawal by Subject|2|||
162665651|NCT02778204|587485192|FG000|Overall Study|Lost to Follow-up|1|||
162665652|NCT02778204|587485193|FG001|Overall Study|Lost to Follow-up|0|||
162665653|NCT02778204|587485194|FG002|Overall Study|Lost to Follow-up|2|||
162665654|NCT02778204|587485195|FG003|Overall Study|Lost to Follow-up|1|||
162665655|NCT02778204|587485192|FG000|Overall Study|Protocol Violation|0|||
162665656|NCT02778204|587485193|FG001|Overall Study|Protocol Violation|0|||
162665657|NCT02778204|587485194|FG002|Overall Study|Protocol Violation|1|||
162665658|NCT02778204|587485195|FG003|Overall Study|Protocol Violation|0|||
162665659|NCT02778204|587485192|FG000|Overall Study|Eligibility Violation|0|||
162665660|NCT02778204|587485193|FG001|Overall Study|Eligibility Violation|0|||
162665661|NCT02778204|587485194|FG002|Overall Study|Eligibility Violation|0|||
162665662|NCT02778204|587485195|FG003|Overall Study|Eligibility Violation|1|||
162665663|NCT01720069|587485196|FG000|Overall Study|Could not use e-diary correctly|0|||
162665664|NCT01720069|587485197|FG001|Overall Study|Could not use e-diary correctly|1|||
162665665|NCT01720069|587485198|FG002|Overall Study|Could not use e-diary correctly|1|||
163148721|NCT01339689|589257334|FG000|Overall Study|multiple reasons|1|||
162665666|NCT01720069|587485196|FG000|Overall Study|Randomised without baseline values|0|||
162665667|NCT01720069|587485197|FG001|Overall Study|Randomised without baseline values|0|||
162665668|NCT01720069|587485198|FG002|Overall Study|Randomised without baseline values|1|||
162665669|NCT01720069|587485196|FG000|Overall Study|Adverse Event|0|||
162665670|NCT01720069|587485197|FG001|Overall Study|Adverse Event|0|||
162665671|NCT01720069|587485198|FG002|Overall Study|Adverse Event|1|||
162665672|NCT01720069|587485196|FG000|Overall Study|Lack of Efficacy|0|||
162665673|NCT01720069|587485197|FG001|Overall Study|Lack of Efficacy|4|||
162665674|NCT01720069|587485198|FG002|Overall Study|Lack of Efficacy|0|||
162665675|NCT01720069|587485196|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
162665676|NCT01720069|587485197|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
162665677|NCT01720069|587485198|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
162665678|NCT01720069|587485196|FG000|Overall Study|Withdrawal by Subject|0|||
162665679|NCT01720069|587485197|FG001|Overall Study|Withdrawal by Subject|2|||
162665680|NCT01720069|587485198|FG002|Overall Study|Withdrawal by Subject|1|||
162665681|NCT01720069|587485196|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
162665682|NCT01720069|587485197|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
162665683|NCT01720069|587485198|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
162665684|NCT01720069|587485196|FG000|Overall Study|Non-compliance on using e-diary|0|||
162665685|NCT01720069|587485197|FG001|Overall Study|Non-compliance on using e-diary|0|||
162665686|NCT01720069|587485198|FG002|Overall Study|Non-compliance on using e-diary|1|||
162665687|NCT01720069|587485196|FG000|Overall Study|Lost to Follow-up|0|||
162665688|NCT01720069|587485197|FG001|Overall Study|Lost to Follow-up|0|||
162665689|NCT01720069|587485198|FG002|Overall Study|Lost to Follow-up|1|||
162665690|NCT00360334|587485199|FG000|Overall Study|Adverse Event|7|||
162665691|NCT00360334|587485200|FG001|Overall Study|Adverse Event|4|||
162665692|NCT00360334|587485199|FG000|Overall Study|Protocol Violation|1|||
162665693|NCT00360334|587485200|FG001|Overall Study|Protocol Violation|1|||
162665694|NCT00360334|587485199|FG000|Overall Study|Physician Decision|2|||
162665695|NCT00360334|587485200|FG001|Overall Study|Physician Decision|3|||
162665696|NCT00360334|587485199|FG000|Overall Study|Lack of Efficacy|0|||
162665697|NCT00360334|587485200|FG001|Overall Study|Lack of Efficacy|1|||
162665698|NCT00360334|587485199|FG000|Overall Study|Entry criterion not met|1|||
162665699|NCT00360334|587485200|FG001|Overall Study|Entry criterion not met|2|||
162665700|NCT00360334|587485199|FG000|Overall Study|Subject decision|8|||
162665701|NCT00360334|587485200|FG001|Overall Study|Subject decision|2|||
162665702|NCT01898793|587485202|FG000|Overall Study|Death|2|||
162665703|NCT01898793|587485203|FG001|Overall Study|Death|1|||
162665704|NCT01898793|587485204|FG002|Overall Study|Death|4|||
162665705|NCT01898793|587485205|FG003|Overall Study|Death|0|||
162665706|NCT01898793|587485206|FG004|Overall Study|Death|0|||
162665707|NCT01898793|587485207|FG005|Overall Study|Death|0|||
162665708|NCT01898793|587485208|FG006|Overall Study|Death|0|||
162665709|NCT00162136|587485212|FG000|Overall Study|Adverse Event|1|||
162665710|NCT00162136|587485212|FG000|Overall Study|Death|1|||
162665711|NCT00162136|587485212|FG000|Overall Study|Disease Progression/Relapse|23|||
162665712|NCT00162136|587485212|FG000|Overall Study|Investigator Request|5|||
162665713|NCT00162136|587485212|FG000|Overall Study|Study Drug Toxicity|4|||
162665714|NCT00162136|587485212|FG000|Overall Study|Withdrawal by Subject|1|||
162665715|NCT04450264|587486795|FG000|Overall Study|Incomplete survey|13|||
162665716|NCT04450264|587486796|FG001|Overall Study|Incomplete survey|19|||
162665717|NCT01992536|587486802|FG000|Overall Study|Administrative Reason|0|||
162665718|NCT01992536|587486803|FG001|Overall Study|Administrative Reason|0|||
162665719|NCT01992536|587486804|FG002|Overall Study|Administrative Reason|0|||
162665720|NCT01992536|587486805|FG003|Overall Study|Administrative Reason|0|||
162665721|NCT01992536|587486806|FG004|Overall Study|Administrative Reason|0|||
162665722|NCT01992536|587486807|FG005|Overall Study|Administrative Reason|0|||
162665723|NCT01992536|587486808|FG006|Overall Study|Administrative Reason|7|||
162665724|NCT01992536|587486809|FG007|Overall Study|Administrative Reason|0|||
162665725|NCT01992536|587486810|FG008|Overall Study|Administrative Reason|0|||
162665726|NCT01992536|587486811|FG009|Overall Study|Administrative Reason|0|||
162665727|NCT01992536|587486802|FG000|Overall Study|Lost to Follow-up|4|||
162665728|NCT01992536|587486803|FG001|Overall Study|Lost to Follow-up|2|||
162665729|NCT01992536|587486804|FG002|Overall Study|Lost to Follow-up|1|||
162665730|NCT01992536|587486805|FG003|Overall Study|Lost to Follow-up|0|||
162665731|NCT01992536|587486806|FG004|Overall Study|Lost to Follow-up|0|||
162665732|NCT01992536|587486807|FG005|Overall Study|Lost to Follow-up|1|||
162665733|NCT01992536|587486808|FG006|Overall Study|Lost to Follow-up|0|||
162665734|NCT01992536|587486809|FG007|Overall Study|Lost to Follow-up|0|||
162665735|NCT01992536|587486810|FG008|Overall Study|Lost to Follow-up|1|||
162665736|NCT01992536|587486811|FG009|Overall Study|Lost to Follow-up|1|||
162665737|NCT01992536|587486802|FG000|Overall Study|Withdrawal by Subject|0|||
162665738|NCT01992536|587486803|FG001|Overall Study|Withdrawal by Subject|1|||
162665739|NCT01992536|587486804|FG002|Overall Study|Withdrawal by Subject|0|||
162665740|NCT01992536|587486805|FG003|Overall Study|Withdrawal by Subject|2|||
162665741|NCT01992536|587486806|FG004|Overall Study|Withdrawal by Subject|0|||
162665742|NCT01992536|587486807|FG005|Overall Study|Withdrawal by Subject|0|||
162665743|NCT01992536|587486808|FG006|Overall Study|Withdrawal by Subject|0|||
162665744|NCT01992536|587486809|FG007|Overall Study|Withdrawal by Subject|0|||
162665745|NCT01992536|587486810|FG008|Overall Study|Withdrawal by Subject|0|||
162665746|NCT01992536|587486811|FG009|Overall Study|Withdrawal by Subject|0|||
162665747|NCT02162810|587486814|FG000|Overall Study|Protocol Violation|1|||
162665748|NCT02162810|587486815|FG001|Overall Study|Protocol Violation|0|||
162665749|NCT02162810|587486814|FG000|Overall Study|patients did not report compliance|4|||
163148722|NCT01339689|589257335|FG001|Overall Study|multiple reasons|1|||
162665750|NCT02162810|587486815|FG001|Overall Study|patients did not report compliance|1|||
162665751|NCT00389324|587486816|FG000|Run-In Phase|Adverse Event|1|||
162665752|NCT00389324|587486816|FG000|Run-In Phase|Lost to Follow-up|1|||
162665753|NCT00389324|587486816|FG000|Run-In Phase|Withdrawal by Subject|1|||
162665754|NCT00389324|587486816|FG000|Subcutaneous Phase|Adverse Event|2|||
162665755|NCT00389324|587486816|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
162665756|NCT00389324|587486816|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
162721596|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162721597|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721598|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
162721599|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
162721600|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721601|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
162721602|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721603|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721604|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721605|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721606|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721607|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721608|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721609|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162721610|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162721611|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
162721612|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162721613|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162721614|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
162721615|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162721616|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163148723|NCT01469221|589257336|FG000|Double Blind Phase|Protocol Violation|1|||
162665757|NCT00389324|587486816|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
162665758|NCT01831089|587486817|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
162665759|NCT01831089|587486818|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
162665760|NCT01831089|587486819|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
162665761|NCT01831089|587486820|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
162665762|NCT01831089|587486821|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
162665763|NCT01831089|587486822|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
162665764|NCT01831089|587486817|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
162665765|NCT01831089|587486818|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
162665766|NCT01831089|587486819|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
162665767|NCT01831089|587486820|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
162665768|NCT01831089|587486821|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
162665769|NCT01831089|587486822|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
162721617|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162721618|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163148724|NCT01469221|589257337|FG001|Double Blind Phase|Protocol Violation|0|||
163148725|NCT01469221|589257338|FG002|Double Blind Phase|Protocol Violation|0|||
163148726|NCT01469221|589257336|FG000|Double Blind Phase|Physician Decision|1|||
163148727|NCT01469221|589257337|FG001|Double Blind Phase|Physician Decision|1|||
163148728|NCT01469221|589257338|FG002|Double Blind Phase|Physician Decision|0|||
163148729|NCT01469221|589257336|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
163148730|NCT01469221|589257337|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
163148731|NCT01469221|589257338|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
163148732|NCT05121766|589257346|FG000|Overall Study|Covid reinfection|3|||
163148733|NCT05121766|589257347|FG001|Overall Study|Covid reinfection|0|||
163148734|NCT05121766|589257346|FG000|Overall Study|Withdrawal by Subject|3|||
163148735|NCT05121766|589257347|FG001|Overall Study|Withdrawal by Subject|1|||
163148736|NCT05121766|589257346|FG000|Overall Study|Adverse Event|2|||
163148737|NCT05121766|589257347|FG001|Overall Study|Adverse Event|4|||
163148738|NCT05121766|589257346|FG000|Overall Study|Lost to Follow-up|0|||
163148739|NCT05121766|589257347|FG001|Overall Study|Lost to Follow-up|1|||
163148740|NCT01632020|589257348|FG000|Overall Study|Withdrawal by Subject|1|||
163148741|NCT01632020|589257349|FG001|Overall Study|Withdrawal by Subject|0|||
163148742|NCT01632020|589257348|FG000|Overall Study|Adverse Event|1|||
163148743|NCT01632020|589257349|FG001|Overall Study|Adverse Event|0|||
163148744|NCT00528957|589257350|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
163148745|NCT00528957|589257351|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
163148746|NCT00528957|589257350|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
163148747|NCT00528957|589257351|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
163148748|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
163148749|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
163148750|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
163148751|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
163148752|NCT00528957|589257350|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
162721619|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162721620|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163148753|NCT00528957|589257351|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
162665770|NCT01831089|587486817|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162665771|NCT01831089|587486818|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
162665772|NCT01831089|587486819|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162665773|NCT01831089|587486820|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162665774|NCT01831089|587486821|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162665775|NCT01831089|587486822|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162665776|NCT01831089|587486817|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
162665777|NCT01831089|587486818|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
162665778|NCT01831089|587486819|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
162665779|NCT01831089|587486820|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
162665780|NCT01831089|587486821|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
162665781|NCT01831089|587486822|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
162665782|NCT01831089|587486817|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162665783|NCT01831089|587486818|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162665784|NCT01831089|587486819|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
162665785|NCT01831089|587486820|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162665786|NCT01831089|587486821|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162665787|NCT01831089|587486822|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162665788|NCT01831089|587486817|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
162665789|NCT01831089|587486818|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
162665790|NCT01831089|587486819|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
162665791|NCT01831089|587486820|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
162665792|NCT01831089|587486821|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
162665793|NCT01831089|587486822|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
162665794|NCT01831089|587486817|FG000|Cohort III: Dose Level 3|Global end of study|0|||
162665795|NCT01831089|587486818|FG001|Cohort III: Dose Level 3|Global end of study|0|||
162665796|NCT01831089|587486819|FG002|Cohort III: Dose Level 3|Global end of study|1|||
162665797|NCT01831089|587486820|FG003|Cohort III: Dose Level 3|Global end of study|0|||
162665798|NCT01831089|587486821|FG004|Cohort III: Dose Level 3|Global end of study|0|||
162665799|NCT01831089|587486822|FG005|Cohort III: Dose Level 3|Global end of study|0|||
162665800|NCT01831089|587486817|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
162665801|NCT01831089|587486818|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
162665802|NCT01831089|587486819|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
162665803|NCT01831089|587486820|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
162665804|NCT01831089|587486821|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
162665805|NCT01831089|587486822|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
162665806|NCT01831089|587486817|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
162665807|NCT01831089|587486818|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
162665808|NCT01831089|587486819|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
162665809|NCT01831089|587486820|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
162665810|NCT01831089|587486821|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
162665811|NCT01831089|587486822|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
162665812|NCT01831089|587486817|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162665813|NCT01831089|587486818|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162665814|NCT01831089|587486819|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162665815|NCT01831089|587486820|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162665816|NCT01831089|587486821|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
162665817|NCT01831089|587486822|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162665818|NCT01831089|587486817|FG000|Cohort V: Dose Level 5|Death|0|||
162665819|NCT01831089|587486818|FG001|Cohort V: Dose Level 5|Death|0|||
162665820|NCT01831089|587486819|FG002|Cohort V: Dose Level 5|Death|0|||
162665821|NCT01831089|587486820|FG003|Cohort V: Dose Level 5|Death|0|||
162665822|NCT01831089|587486821|FG004|Cohort V: Dose Level 5|Death|1|||
162665823|NCT01831089|587486822|FG005|Cohort V: Dose Level 5|Death|0|||
162665824|NCT01831089|587486817|FG000|Cohort V: Dose Level 5|Global end of study|0|||
162665825|NCT01831089|587486818|FG001|Cohort V: Dose Level 5|Global end of study|0|||
162665826|NCT01831089|587486819|FG002|Cohort V: Dose Level 5|Global end of study|0|||
162665827|NCT01831089|587486820|FG003|Cohort V: Dose Level 5|Global end of study|0|||
162665828|NCT01831089|587486821|FG004|Cohort V: Dose Level 5|Global end of study|2|||
162665829|NCT01831089|587486822|FG005|Cohort V: Dose Level 5|Global end of study|0|||
162665830|NCT01831089|587486817|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162665831|NCT01831089|587486818|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162665832|NCT01831089|587486819|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162665833|NCT01831089|587486820|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162665834|NCT01831089|587486821|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
162665835|NCT01831089|587486822|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162665836|NCT01831089|587486817|FG000|Cohort B: Arm B|Progressive disease|0|||
162665837|NCT01831089|587486818|FG001|Cohort B: Arm B|Progressive disease|0|||
162665838|NCT01831089|587486819|FG002|Cohort B: Arm B|Progressive disease|0|||
162665839|NCT01831089|587486820|FG003|Cohort B: Arm B|Progressive disease|0|||
162665840|NCT01831089|587486821|FG004|Cohort B: Arm B|Progressive disease|0|||
162665841|NCT01831089|587486822|FG005|Cohort B: Arm B|Progressive disease|8|||
162665842|NCT01831089|587486817|FG000|Cohort B: Arm B|Physician Decision|0|||
162665843|NCT01831089|587486818|FG001|Cohort B: Arm B|Physician Decision|0|||
162665844|NCT01831089|587486819|FG002|Cohort B: Arm B|Physician Decision|0|||
162665845|NCT01831089|587486820|FG003|Cohort B: Arm B|Physician Decision|0|||
162721621|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162721622|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163148754|NCT00528957|589257350|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
162665846|NCT01831089|587486821|FG004|Cohort B: Arm B|Physician Decision|0|||
162665847|NCT01831089|587486822|FG005|Cohort B: Arm B|Physician Decision|2|||
162665848|NCT01831089|587486817|FG000|Cohort B: Arm B|Never treated|0|||
162665849|NCT01831089|587486818|FG001|Cohort B: Arm B|Never treated|0|||
162665850|NCT01831089|587486819|FG002|Cohort B: Arm B|Never treated|0|||
162665851|NCT01831089|587486820|FG003|Cohort B: Arm B|Never treated|0|||
162721623|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162665852|NCT01831089|587486821|FG004|Cohort B: Arm B|Never treated|0|||
162665853|NCT01831089|587486822|FG005|Cohort B: Arm B|Never treated|2|||
162665854|NCT01831089|587486817|FG000|Cohort B: Arm B|Adverse Event|0|||
162665855|NCT01831089|587486818|FG001|Cohort B: Arm B|Adverse Event|0|||
162665856|NCT01831089|587486819|FG002|Cohort B: Arm B|Adverse Event|0|||
162665857|NCT01831089|587486820|FG003|Cohort B: Arm B|Adverse Event|0|||
162665858|NCT01831089|587486821|FG004|Cohort B: Arm B|Adverse Event|0|||
162665859|NCT01831089|587486822|FG005|Cohort B: Arm B|Adverse Event|1|||
162665860|NCT01831089|587486817|FG000|Cohort B: Arm B|Global end of study|0|||
162665861|NCT01831089|587486818|FG001|Cohort B: Arm B|Global end of study|0|||
162665862|NCT01831089|587486819|FG002|Cohort B: Arm B|Global end of study|0|||
162665863|NCT01831089|587486820|FG003|Cohort B: Arm B|Global end of study|0|||
162665864|NCT01831089|587486821|FG004|Cohort B: Arm B|Global end of study|0|||
162665865|NCT01831089|587486822|FG005|Cohort B: Arm B|Global end of study|1|||
162665866|NCT00889421|587486823|FG000|Overall Study|Lack of Efficacy|3|||
162665867|NCT03936244|587486827|FG000|Overall Study|Lost to Follow-up|5|||
162665868|NCT03936244|587486828|FG001|Overall Study|Lost to Follow-up|1|||
162665869|NCT03936244|587486827|FG000|Overall Study|Physician Decision|7|||
162665870|NCT03936244|587486828|FG001|Overall Study|Physician Decision|3|||
162665871|NCT03551938|587486831|FG000|3-Month Follow Up|Lost to Follow-up|39|||
162665872|NCT03551938|587486832|FG001|3-Month Follow Up|Lost to Follow-up|38|||
162665873|NCT03551938|587486831|FG000|6-Month Follow Up|Lost to Follow-up|46|||
162665874|NCT03551938|587486832|FG001|6-Month Follow Up|Lost to Follow-up|42|||
162665875|NCT03551938|587486831|FG000|9-Month Follow Up|Lost to Follow-up|44|||
162665876|NCT03551938|587486832|FG001|9-Month Follow Up|Lost to Follow-up|43|||
162665877|NCT01925183|587486833|FG000|Overall Study|Adverse Event|1|||
162665878|NCT01925183|587486834|FG001|Overall Study|Adverse Event|0|||
162665879|NCT01114646|587486835|FG000|Overall Study|Withdrawal by Subject|3|||
162665880|NCT01114646|587486836|FG001|Overall Study|Withdrawal by Subject|2|||
162665881|NCT01046110|587486837|FG000|Overall Study|Adverse Event|9|||
162665882|NCT01046110|587486838|FG001|Overall Study|Adverse Event|2|||
162665883|NCT01046110|587486837|FG000|Overall Study|Lack of Efficacy|0|||
162665884|NCT01046110|587486838|FG001|Overall Study|Lack of Efficacy|1|||
162665885|NCT01046110|587486837|FG000|Overall Study|Protocol Violation|7|||
162665886|NCT01046110|587486838|FG001|Overall Study|Protocol Violation|12|||
162665887|NCT01046110|587486837|FG000|Overall Study|Withdrawal Criteria|3|||
162665888|NCT01046110|587486838|FG001|Overall Study|Withdrawal Criteria|5|||
162665889|NCT01046110|587486837|FG000|Overall Study|Unclassified|36|||
162665890|NCT01046110|587486838|FG001|Overall Study|Unclassified|35|||
162665891|NCT02667912|587486848|FG000|Overall Study|Death|3|||
162665892|NCT02667912|587486849|FG001|Overall Study|Death|1|||
162665893|NCT02667912|587486848|FG000|Overall Study|Withdrawal by Subject|1|||
162665894|NCT02667912|587486849|FG001|Overall Study|Withdrawal by Subject|2|||
162665895|NCT02667912|587486848|FG000|Overall Study|Withdrawal by Subject|1|||
162665896|NCT02667912|587486849|FG001|Overall Study|Withdrawal by Subject|0|||
162665897|NCT04443218|587486850|FG000|Overall Study|Exited study for other reasons|9|||
162665898|NCT04443218|587486850|FG000|Overall Study|Withdrawal by Subject|1|||
162665899|NCT04443218|587486850|FG000|Overall Study|Lost to Follow-up|4|||
162665900|NCT04443218|587486850|FG000|Overall Study|Death|19|||
162665901|NCT01047683|587486851|FG000|Overall Study|Adverse Event|3|||
162665902|NCT01047683|587486852|FG001|Overall Study|Adverse Event|1|||
162665903|NCT01047683|587486853|FG002|Overall Study|Adverse Event|0|||
162665904|NCT01047683|587486851|FG000|Overall Study|Withdrew Consent|1|||
162665905|NCT01047683|587486852|FG001|Overall Study|Withdrew Consent|4|||
162665906|NCT01047683|587486853|FG002|Overall Study|Withdrew Consent|2|||
162665907|NCT01047683|587486851|FG000|Overall Study|Lost to Follow-up|0|||
162665908|NCT01047683|587486852|FG001|Overall Study|Lost to Follow-up|1|||
162665909|NCT01047683|587486853|FG002|Overall Study|Lost to Follow-up|0|||
162665910|NCT01047683|587486851|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
162665911|NCT01047683|587486852|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
162665912|NCT01047683|587486853|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
162665913|NCT03447769|587486854|FG000|Overall Study|Progressive disease|138|||
162665914|NCT03447769|587486855|FG001|Overall Study|Progressive disease|148|||
162665915|NCT03447769|587486854|FG000|Overall Study|Study terminated by Sponsor|60|||
162665916|NCT03447769|587486855|FG001|Overall Study|Study terminated by Sponsor|44|||
162665917|NCT03447769|587486854|FG000|Overall Study|Adverse Event|34|||
162665918|NCT03447769|587486855|FG001|Overall Study|Adverse Event|31|||
162665919|NCT03447769|587486854|FG000|Overall Study|Patient decision|27|||
162665920|NCT03447769|587486855|FG001|Overall Study|Patient decision|27|||
162665921|NCT03447769|587486854|FG000|Overall Study|Protocol deviation|4|||
162665922|NCT03447769|587486855|FG001|Overall Study|Protocol deviation|6|||
162665923|NCT03447769|587486854|FG000|Overall Study|Death|2|||
162665924|NCT03447769|587486855|FG001|Overall Study|Death|7|||
163148755|NCT00528957|589257351|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
163148756|NCT00528957|589257350|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
163148757|NCT00528957|589257351|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
163148758|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
163148759|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
163148760|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
163148761|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
163148762|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
163148763|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
163148764|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
163148765|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
163148766|NCT00528957|589257350|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
163148767|NCT00528957|589257351|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
163148768|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
163148769|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
163148770|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
163148771|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
163148772|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
163148773|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
163148774|NCT00528957|589257350|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
163148775|NCT00528957|589257351|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
163148776|NCT02675907|589257356|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
163148777|NCT02675907|589257357|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
163148778|NCT02675907|589257356|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
163148779|NCT02675907|589257357|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
163148780|NCT02675907|589257356|FG000|Study Overall|Lack of Efficacy|1|||
163148781|NCT02675907|589257357|FG001|Study Overall|Lack of Efficacy|0|||
163148782|NCT02675907|589257356|FG000|Study Overall|Withdrawal by Subject|2|||
163148783|NCT02675907|589257357|FG001|Study Overall|Withdrawal by Subject|2|||
163148784|NCT02675907|589257356|FG000|Study Overall|Lost to Follow-up|0|||
163148785|NCT02675907|589257357|FG001|Study Overall|Lost to Follow-up|2|||
162665925|NCT03447769|587486854|FG000|Overall Study|Technical problems|1|||
162665926|NCT03447769|587486855|FG001|Overall Study|Technical problems|0|||
162665927|NCT03447769|587486854|FG000|Overall Study|Lost to Follow-up|0|||
162665928|NCT03447769|587486855|FG001|Overall Study|Lost to Follow-up|1|||
162665929|NCT03447769|587486854|FG000|Overall Study|Physician Decision|13|||
163148786|NCT01611792|589257358|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
163148787|NCT01611792|589257359|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
163148788|NCT01611792|589257358|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
163148789|NCT01611792|589257359|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
163148790|NCT03416868|589257360|FG000|Overall Study|Withdrawal by Subject|2|||
163148791|NCT03416868|589257360|FG000|Overall Study|Lost to Follow-up|1|||
163148792|NCT00960375|589257363|FG000|Overall Study|Lost to Follow-up|20|||
163148793|NCT00960375|589257364|FG001|Overall Study|Lost to Follow-up|22|||
163148794|NCT00083889|589257365|FG000|Overall Study|Adverse Event|76|||
163148795|NCT00083889|589257366|FG001|Overall Study|Adverse Event|86|||
163148796|NCT00083889|589257365|FG000|Overall Study|Protocol Violation|2|||
163148797|NCT00083889|589257366|FG001|Overall Study|Protocol Violation|2|||
163148798|NCT00083889|589257365|FG000|Overall Study|Withdrawal by Subject|22|||
163148799|NCT00083889|589257366|FG001|Overall Study|Withdrawal by Subject|24|||
163148800|NCT00083889|589257365|FG000|Overall Study|Lack of Efficacy|240|||
163148801|NCT00083889|589257366|FG001|Overall Study|Lack of Efficacy|219|||
163148802|NCT00083889|589257365|FG000|Overall Study|Decision of sponsor|32|||
163148803|NCT00083889|589257366|FG001|Overall Study|Decision of sponsor|4|||
163148804|NCT00083889|589257365|FG000|Overall Study|Randomized: did not take study drug|0|||
163148805|NCT00083889|589257366|FG001|Overall Study|Randomized: did not take study drug|15|||
163148806|NCT00083889|589257365|FG000|Overall Study|Completed on marketed sunitinub|3|||
163148807|NCT00083889|589257366|FG001|Overall Study|Completed on marketed sunitinub|0|||
163148808|NCT00083889|589257365|FG000|Overall Study|Crossover to SU011248|0|||
163148809|NCT00083889|589257366|FG001|Overall Study|Crossover to SU011248|25|||
163148810|NCT03624881|589257367|FG000|Overall Study|Screen Failure|14|||
163148811|NCT03624881|589257368|FG001|Overall Study|Screen Failure|0|||
163148812|NCT03624881|589257367|FG000|Overall Study|No Catheter Inserted|6|||
163148813|NCT03624881|589257368|FG001|Overall Study|No Catheter Inserted|1|||
163148814|NCT03624881|589257367|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
163148815|NCT03624881|589257368|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
163148816|NCT03624881|589257367|FG000|Overall Study|Death|2|||
163148817|NCT03624881|589257368|FG001|Overall Study|Death|0|||
163148818|NCT03624881|589257367|FG000|Overall Study|Lost to Follow-up|10|||
163148819|NCT03624881|589257368|FG001|Overall Study|Lost to Follow-up|4|||
163148820|NCT03624881|589257367|FG000|Overall Study|Withdrawal by Subject|12|||
163148821|NCT03624881|589257368|FG001|Overall Study|Withdrawal by Subject|1|||
163148822|NCT00168844|589257369|FG000|Overall Study|Adverse Event|31|||
163148823|NCT00168844|589257370|FG001|Overall Study|Adverse Event|32|||
163148824|NCT00168844|589257371|FG002|Overall Study|Adverse Event|48|||
163148825|NCT00168844|589257369|FG000|Overall Study|Lost to Follow-up|4|||
163148826|NCT00168844|589257370|FG001|Overall Study|Lost to Follow-up|5|||
163148827|NCT00168844|589257371|FG002|Overall Study|Lost to Follow-up|11|||
163148828|NCT00168844|589257369|FG000|Overall Study|Withdrawal by Subject|12|||
163148829|NCT00168844|589257370|FG001|Overall Study|Withdrawal by Subject|9|||
163148830|NCT00168844|589257371|FG002|Overall Study|Withdrawal by Subject|19|||
163148831|NCT00168844|589257369|FG000|Overall Study|Protocol Violation|2|||
163148832|NCT00168844|589257370|FG001|Overall Study|Protocol Violation|2|||
163148833|NCT00168844|589257371|FG002|Overall Study|Protocol Violation|4|||
163148834|NCT00168844|589257369|FG000|Overall Study|Other|6|||
163148835|NCT00168844|589257370|FG001|Overall Study|Other|7|||
163148836|NCT00168844|589257371|FG002|Overall Study|Other|9|||
163148837|NCT03473236|589257373|FG000|Overall Study|Withdrawal by Subject|0|||
163148838|NCT03473236|589257374|FG001|Overall Study|Withdrawal by Subject|0|||
163148839|NCT03473236|589257375|FG002|Overall Study|Withdrawal by Subject|0|||
163148840|NCT03473236|589257376|FG003|Overall Study|Withdrawal by Subject|0|||
163148841|NCT03473236|589257377|FG004|Overall Study|Withdrawal by Subject|0|||
163148842|NCT03473236|589257378|FG005|Overall Study|Withdrawal by Subject|1|||
163148843|NCT03473236|589257379|FG006|Overall Study|Withdrawal by Subject|0|||
163148844|NCT03473236|589257380|FG007|Overall Study|Withdrawal by Subject|0|||
163148845|NCT03473236|589257381|FG008|Overall Study|Withdrawal by Subject|1|||
163148846|NCT03473236|589257382|FG009|Overall Study|Withdrawal by Subject|0|||
163148847|NCT04264442|589257383|FG000|Overall Study|Lack of Efficacy|6|||
163148848|NCT04264442|589257383|FG000|Overall Study|Lost to Follow-up|2|||
163148849|NCT04264442|589257383|FG000|Overall Study|Sponsor Decision|23|||
163148850|NCT04264442|589257383|FG000|Overall Study|Withdrawal by Subject|11|||
162665930|NCT03447769|587486855|FG001|Overall Study|Physician Decision|5|||
163148851|NCT04264442|589257383|FG000|Overall Study|Study Termination|5|||
163148852|NCT03309020|589257386|FG000|Overall Study|Death|1|||
163148853|NCT03309020|589257387|FG001|Overall Study|Death|0|||
163148854|NCT03309020|589257386|FG000|Overall Study|Did not undergo surgery|2|||
163148855|NCT03309020|589257387|FG001|Overall Study|Did not undergo surgery|1|||
163148856|NCT02362724|589257394|FG000|Overall Study|Withdrawal by Subject|3|||
163148857|NCT02362724|589257395|FG001|Overall Study|Withdrawal by Subject|1|||
163148858|NCT02362724|589257394|FG000|Overall Study|Adverse Event|3|||
163148859|NCT02362724|589257395|FG001|Overall Study|Adverse Event|0|||
163148860|NCT05190120|589257401|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162665931|NCT00781326|587486858|FG000|Phase I|Adverse Event|1|||
162665932|NCT00781326|587486858|FG000|Phase I|Withdrawal by Subject|1|||
162665933|NCT00781326|587486858|FG000|Phase I|Physician Decision|2|||
162665934|NCT00096941|587486859|FG000|Overall Study|disease progression|3|||
162665935|NCT01525082|587486869|FG000|Overall Study|Death|1|||
162665936|NCT00022516|587486879|FG000|Overall Study|Adverse Event|0|||
162665937|NCT00022516|587486880|FG001|Overall Study|Adverse Event|59|||
162665938|NCT00022516|587486879|FG000|Overall Study|Lack of Efficacy|0|||
162665939|NCT00022516|587486880|FG001|Overall Study|Lack of Efficacy|27|||
162665940|NCT00022516|587486879|FG000|Overall Study|Physician Decision|0|||
162665941|NCT00022516|587486880|FG001|Overall Study|Physician Decision|1|||
162665942|NCT00022516|587486879|FG000|Overall Study|Protocol Violation|1|||
162665943|NCT00022516|587486880|FG001|Overall Study|Protocol Violation|3|||
162665944|NCT00022516|587486879|FG000|Overall Study|Withdrawal by Subject|2|||
162665945|NCT00022516|587486880|FG001|Overall Study|Withdrawal by Subject|113|||
162665946|NCT00022516|587486879|FG000|Overall Study|Incomplete documentation|0|||
162665947|NCT00022516|587486880|FG001|Overall Study|Incomplete documentation|27|||
162665948|NCT01568047|587486883|FG000|Overall Study|Ineligibility|1|||
162665949|NCT01568047|587486884|FG001|Overall Study|Ineligibility|0|||
162665950|NCT01568047|587486885|FG002|Overall Study|Ineligibility|0|||
162665951|NCT01568047|587486886|FG003|Overall Study|Ineligibility|0|||
162665952|NCT01568047|587486883|FG000|Overall Study|Withdrawal by Subject|0|||
162665953|NCT01568047|587486884|FG001|Overall Study|Withdrawal by Subject|1|||
162665954|NCT01568047|587486885|FG002|Overall Study|Withdrawal by Subject|0|||
162665955|NCT01568047|587486886|FG003|Overall Study|Withdrawal by Subject|0|||
162665956|NCT01568047|587486883|FG000|Overall Study|Adverse Event|0|||
162665957|NCT01568047|587486884|FG001|Overall Study|Adverse Event|0|||
162665958|NCT01568047|587486885|FG002|Overall Study|Adverse Event|1|||
162665959|NCT01568047|587486886|FG003|Overall Study|Adverse Event|1|||
162665960|NCT03783923|587486887|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
162665961|NCT03783923|587486888|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
162665962|NCT03783923|587486887|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
162665963|NCT03783923|587486888|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
162665964|NCT03783923|587486887|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
162665965|NCT03783923|587486888|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
162665966|NCT03783923|587486887|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
162665967|NCT03783923|587486888|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
162665968|NCT03783923|587486887|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
162665969|NCT03783923|587486888|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
162665970|NCT02328326|587486893|FG000|Overall Study|Withdrawal by Subject|10|||
162665971|NCT02328326|587486894|FG001|Overall Study|Withdrawal by Subject|3|||
162665972|NCT02328326|587486893|FG000|Overall Study|Death|2|||
162665973|NCT02328326|587486894|FG001|Overall Study|Death|1|||
162665974|NCT02328326|587486893|FG000|Overall Study|Lost to Follow-up|10|||
162665975|NCT02328326|587486894|FG001|Overall Study|Lost to Follow-up|4|||
162665976|NCT02543346|587486895|FG000|Second Priming Visit|Withdrawal by Subject|0|||
162665977|NCT02543346|587486896|FG001|Second Priming Visit|Withdrawal by Subject|2|||
162665978|NCT02543346|587486897|FG002|Second Priming Visit|Withdrawal by Subject|2|||
162665979|NCT02543346|587486898|FG003|Second Priming Visit|Withdrawal by Subject|2|||
162665980|NCT02543346|587486895|FG000|Second Priming Visit|Adverse Event|1|||
162665981|NCT02543346|587486896|FG001|Second Priming Visit|Adverse Event|0|||
162665982|NCT02543346|587486897|FG002|Second Priming Visit|Adverse Event|0|||
162665983|NCT02543346|587486898|FG003|Second Priming Visit|Adverse Event|0|||
162665984|NCT02209324|587486901|FG000|Overall Study|Adverse Event|2|||
162665985|NCT02209324|587486901|FG000|Overall Study|Lack of Efficacy|1|||
162665986|NCT02209324|587486901|FG000|Overall Study|Lost to Follow-up|1|||
162665987|NCT02209324|587486901|FG000|Overall Study|Physician Decision|3|||
162665988|NCT02209324|587486901|FG000|Overall Study|Protocol Violation|14|||
162665989|NCT02209324|587486901|FG000|Overall Study|Withdrawal by Subject|8|||
162665990|NCT02209324|587486901|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
162665991|NCT02209324|587486901|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
162665992|NCT02209324|587486901|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
162665993|NCT01985126|587486902|FG000|Overall Study|Death|15|||
162665994|NCT01985126|587486903|FG001|Overall Study|Death|69|||
162665995|NCT01985126|587486902|FG000|Overall Study|Lost to Follow-up|0|||
162665996|NCT01985126|587486903|FG001|Overall Study|Lost to Follow-up|8|||
162665997|NCT01985126|587486902|FG000|Overall Study|Study Terminated By Sponsor|1|||
162665998|NCT01985126|587486903|FG001|Overall Study|Study Terminated By Sponsor|22|||
162665999|NCT01985126|587486902|FG000|Overall Study|Withdrawal by Subject|2|||
162666000|NCT01985126|587486903|FG001|Overall Study|Withdrawal by Subject|7|||
162666001|NCT03433456|587486906|FG000|Overall Study|Death|1|||
162666002|NCT03433456|587486907|FG001|Overall Study|Death|1|||
162666003|NCT03433456|587486906|FG000|Overall Study|Lost to Follow-up|14|||
162666004|NCT03433456|587486907|FG001|Overall Study|Lost to Follow-up|11|||
162666005|NCT03433456|587486906|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
162666006|NCT03433456|587486907|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
162666007|NCT01198600|587486912|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
162666008|NCT01198600|587486913|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162666009|NCT01198600|587486914|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162666010|NCT01198600|587486915|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162666011|NCT01198600|587486912|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
162666012|NCT01198600|587486913|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162666013|NCT01198600|587486914|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162666014|NCT01198600|587486915|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162666015|NCT01198600|587486912|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162666016|NCT01198600|587486913|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
162666017|NCT01198600|587486914|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162721624|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721625|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721626|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721627|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721628|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162721629|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
162721630|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162721631|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721632|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721633|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721634|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721635|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162721636|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
162721637|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
162721638|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
162721639|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
162721640|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
162721641|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162721642|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
162721643|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162721644|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162721645|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162721646|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162721647|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162721648|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162721649|NCT04707313|587688318|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721650|NCT04707313|587688319|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721651|NCT04707313|587688320|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
162721652|NCT04707313|587688321|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721653|NCT04707313|587688322|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721654|NCT04707313|587688323|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721655|NCT04707313|587688324|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163148861|NCT05190120|589257402|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162666018|NCT01198600|587486915|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162721656|NCT04707313|587688325|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
162721657|NCT04707313|587688326|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721658|NCT04707313|587688327|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721659|NCT04707313|587688328|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162666019|NCT01198600|587486912|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162666020|NCT01198600|587486913|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
162666021|NCT01198600|587486914|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162666022|NCT01198600|587486915|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162666023|NCT01198600|587486912|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
162666024|NCT01198600|587486913|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
162666025|NCT01198600|587486914|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
162666026|NCT01198600|587486915|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
162666027|NCT01198600|587486912|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
162666028|NCT01198600|587486913|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
162666029|NCT01198600|587486914|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
162666030|NCT01198600|587486915|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
162666031|NCT01198600|587486912|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162666032|NCT01198600|587486913|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162666033|NCT01198600|587486914|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
162666034|NCT01198600|587486915|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162666035|NCT01785602|587486916|FG000|Overall Study|Withdrawal by Subject|2|||
162666036|NCT01785602|587486917|FG001|Overall Study|Withdrawal by Subject|0|||
162666037|NCT01785602|587486916|FG000|Overall Study|Lost to Follow-up|1|||
162666038|NCT01785602|587486917|FG001|Overall Study|Lost to Follow-up|1|||
162666039|NCT01785602|587486916|FG000|Overall Study|Adverse Event|3|||
162666040|NCT01785602|587486917|FG001|Overall Study|Adverse Event|5|||
162666041|NCT01785602|587486916|FG000|Overall Study|Administrative problems|7|||
162666042|NCT01785602|587486917|FG001|Overall Study|Administrative problems|3|||
162666043|NCT02141516|587486920|FG000|Overall Study|Adverse Event|0|||
162666044|NCT02141516|587486921|FG001|Overall Study|Adverse Event|1|||
162666045|NCT02141516|587486922|FG002|Overall Study|Adverse Event|0|||
162666046|NCT02141516|587486920|FG000|Overall Study|Lost to Follow-up|0|||
162666047|NCT02141516|587486921|FG001|Overall Study|Lost to Follow-up|1|||
162666048|NCT02141516|587486922|FG002|Overall Study|Lost to Follow-up|0|||
162666049|NCT02141516|587486920|FG000|Overall Study|Other|0|||
162666050|NCT02141516|587486921|FG001|Overall Study|Other|3|||
162666051|NCT02141516|587486922|FG002|Overall Study|Other|0|||
162666052|NCT03251924|587486924|FG000|Overall Study|Disease Progression|6|||
162666053|NCT03251924|587486925|FG001|Overall Study|Disease Progression|6|||
162666054|NCT03251924|587486926|FG002|Overall Study|Disease Progression|7|||
162666055|NCT03251924|587486927|FG003|Overall Study|Disease Progression|8|||
162666056|NCT03251924|587486928|FG004|Overall Study|Disease Progression|8|||
162666057|NCT03251924|587486929|FG005|Overall Study|Disease Progression|7|||
162666058|NCT03251924|587486930|FG006|Overall Study|Disease Progression|6|||
162666059|NCT03251924|587486931|FG007|Overall Study|Disease Progression|10|||
162666060|NCT03251924|587486932|FG008|Overall Study|Disease Progression|6|||
162666061|NCT03251924|587486924|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
162666062|NCT03251924|587486925|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162666063|NCT03251924|587486926|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162666064|NCT03251924|587486927|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
162666065|NCT03251924|587486928|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
162666066|NCT03251924|587486929|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
162666067|NCT03251924|587486930|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
162666068|NCT03251924|587486931|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
162666069|NCT03251924|587486932|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
162666070|NCT03251924|587486924|FG000|Overall Study|Death|0|||
162666071|NCT03251924|587486925|FG001|Overall Study|Death|1|||
162666072|NCT03251924|587486926|FG002|Overall Study|Death|0|||
162666073|NCT03251924|587486927|FG003|Overall Study|Death|1|||
162666074|NCT03251924|587486928|FG004|Overall Study|Death|1|||
162666075|NCT03251924|587486929|FG005|Overall Study|Death|1|||
162666076|NCT03251924|587486930|FG006|Overall Study|Death|0|||
162666077|NCT03251924|587486931|FG007|Overall Study|Death|0|||
162666078|NCT03251924|587486932|FG008|Overall Study|Death|0|||
162666079|NCT03251924|587486924|FG000|Overall Study|Study Drug Toxicity|0|||
162666080|NCT03251924|587486925|FG001|Overall Study|Study Drug Toxicity|0|||
162666081|NCT03251924|587486926|FG002|Overall Study|Study Drug Toxicity|0|||
162666082|NCT03251924|587486927|FG003|Overall Study|Study Drug Toxicity|1|||
162666083|NCT03251924|587486928|FG004|Overall Study|Study Drug Toxicity|0|||
162666084|NCT03251924|587486929|FG005|Overall Study|Study Drug Toxicity|0|||
162666085|NCT03251924|587486930|FG006|Overall Study|Study Drug Toxicity|0|||
162666086|NCT03251924|587486931|FG007|Overall Study|Study Drug Toxicity|0|||
162666087|NCT03251924|587486932|FG008|Overall Study|Study Drug Toxicity|1|||
162666088|NCT03251924|587486924|FG000|Overall Study|Other Reasons|0|||
162666089|NCT03251924|587486925|FG001|Overall Study|Other Reasons|0|||
162666090|NCT03251924|587486926|FG002|Overall Study|Other Reasons|0|||
162666091|NCT03251924|587486927|FG003|Overall Study|Other Reasons|0|||
162666092|NCT03251924|587486928|FG004|Overall Study|Other Reasons|0|||
162666093|NCT03251924|587486929|FG005|Overall Study|Other Reasons|0|||
162666094|NCT03251924|587486930|FG006|Overall Study|Other Reasons|0|||
162666095|NCT03251924|587486931|FG007|Overall Study|Other Reasons|0|||
162666096|NCT03251924|587486932|FG008|Overall Study|Other Reasons|1|||
162666097|NCT03251924|587486924|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162666098|NCT03251924|587486925|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162666099|NCT03251924|587486926|FG002|Overall Study|Participant request to discontinue study treatment|0|||
162666100|NCT03251924|587486927|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162666101|NCT03251924|587486928|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162666102|NCT03251924|587486929|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162666103|NCT03251924|587486930|FG006|Overall Study|Participant request to discontinue study treatment|0|||
162666104|NCT03251924|587486931|FG007|Overall Study|Participant request to discontinue study treatment|1|||
162666105|NCT03251924|587486932|FG008|Overall Study|Participant request to discontinue study treatment|0|||
162666106|NCT02127307|587486935|FG000|Overall Study|Protocol Violation|36|||
162666107|NCT02127307|587486935|FG000|Overall Study|Lost to Follow-up|2|||
162666108|NCT02127307|587486935|FG000|Overall Study|Death|101|||
162666109|NCT02127307|587486935|FG000|Overall Study|Other than specified above|169|||
162666110|NCT00235989|587486936|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
162666111|NCT00235989|587486937|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
162666112|NCT00235989|587486938|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
162666113|NCT00235989|587486939|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
162666114|NCT00235989|587486940|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
162666115|NCT00235989|587486941|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
162666116|NCT00235989|587486936|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
162666117|NCT00235989|587486937|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
162666118|NCT00235989|587486938|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
162666119|NCT00235989|587486939|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
162666120|NCT00235989|587486940|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
162666121|NCT00235989|587486941|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
162666122|NCT00235989|587486936|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
162666123|NCT00235989|587486937|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162666124|NCT00235989|587486938|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
162666125|NCT00235989|587486939|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162666126|NCT00235989|587486940|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162666127|NCT00235989|587486941|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162666128|NCT00235989|587486936|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162666129|NCT00235989|587486937|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162666130|NCT00235989|587486938|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162666131|NCT00235989|587486939|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
162666132|NCT00235989|587486940|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
163148862|NCT05190120|589257403|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162666133|NCT00235989|587486941|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
162666134|NCT00235989|587486936|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
162666135|NCT00235989|587486937|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
162666136|NCT00235989|587486938|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
162666137|NCT00235989|587486939|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
162666138|NCT00235989|587486940|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
162666139|NCT00235989|587486941|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
162666140|NCT00983580|587486943|FG000|Overall Study|Cancel Prior to treatment|1|||
162666141|NCT00983580|587486944|FG001|Overall Study|Cancel Prior to treatment|3|||
162666142|NCT00983580|587486943|FG000|Overall Study|Protocol Violation|1|||
162721660|NCT04707313|587688329|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162666143|NCT00983580|587486944|FG001|Overall Study|Protocol Violation|1|||
162666144|NCT00983580|587486943|FG000|Overall Study|Ineligible|3|||
162666145|NCT00983580|587486944|FG001|Overall Study|Ineligible|0|||
162666146|NCT00836875|587486946|FG000|Overall Study|Death|3|||
162666147|NCT00836875|587486947|FG001|Overall Study|Death|2|||
162666148|NCT00836875|587486946|FG000|Overall Study|Withdrawal by Subject|0|||
162666149|NCT00836875|587486947|FG001|Overall Study|Withdrawal by Subject|1|||
162666150|NCT03964454|587486957|FG000|Overall Study|Lost to Follow-up|13|||
162666151|NCT03964454|587486958|FG001|Overall Study|Lost to Follow-up|7|||
162666152|NCT03964454|587486957|FG000|Overall Study|Withdrawal by Subject|4|||
162666153|NCT03964454|587486958|FG001|Overall Study|Withdrawal by Subject|11|||
162666154|NCT00074282|587488790|FG000|Step 1|Adverse Event|32|||
162666155|NCT00074282|587488791|FG001|Step 1|Adverse Event|0|||
162666156|NCT00074282|587488792|FG002|Step 1|Adverse Event|0|||
162666157|NCT00074282|587488790|FG000|Step 1|Death|6|||
162666158|NCT00074282|587488791|FG001|Step 1|Death|0|||
162666159|NCT00074282|587488792|FG002|Step 1|Death|0|||
162666160|NCT00074282|587488790|FG000|Step 1|Withdrawal by Subject|7|||
162666161|NCT00074282|587488791|FG001|Step 1|Withdrawal by Subject|0|||
162666162|NCT00074282|587488792|FG002|Step 1|Withdrawal by Subject|0|||
162666163|NCT00074282|587488790|FG000|Step 1|Disease progression|2|||
162666164|NCT00074282|587488791|FG001|Step 1|Disease progression|0|||
162666165|NCT00074282|587488792|FG002|Step 1|Disease progression|0|||
162666166|NCT00074282|587488790|FG000|Step 1|Alternative therapy|2|||
162666167|NCT00074282|587488791|FG001|Step 1|Alternative therapy|0|||
162666168|NCT00074282|587488792|FG002|Step 1|Alternative therapy|0|||
162666169|NCT00074282|587488790|FG000|Step 1|Other complicating disease|2|||
162666170|NCT00074282|587488791|FG001|Step 1|Other complicating disease|0|||
162666171|NCT00074282|587488792|FG002|Step 1|Other complicating disease|0|||
162666172|NCT00074282|587488790|FG000|Step 1|Physician Decision|1|||
162666173|NCT00074282|587488791|FG001|Step 1|Physician Decision|0|||
162666174|NCT00074282|587488792|FG002|Step 1|Physician Decision|0|||
162666175|NCT00074282|587488790|FG000|Step 1|Ineligible|4|||
162666176|NCT00074282|587488791|FG001|Step 1|Ineligible|0|||
162666177|NCT00074282|587488792|FG002|Step 1|Ineligible|0|||
162666178|NCT00074282|587488790|FG000|Step 1|Never started treatment|2|||
162666179|NCT00074282|587488791|FG001|Step 1|Never started treatment|0|||
162666180|NCT00074282|587488792|FG002|Step 1|Never started treatment|0|||
162666181|NCT00074282|587488790|FG000|Step 2|Adverse Event|0|||
162666182|NCT00074282|587488791|FG001|Step 2|Adverse Event|2|||
162666183|NCT00074282|587488792|FG002|Step 2|Adverse Event|12|||
162666184|NCT00074282|587488790|FG000|Step 2|Disease progression|0|||
162666185|NCT00074282|587488791|FG001|Step 2|Disease progression|0|||
162666186|NCT00074282|587488792|FG002|Step 2|Disease progression|5|||
162666187|NCT00074282|587488790|FG000|Step 2|Death|0|||
162666188|NCT00074282|587488791|FG001|Step 2|Death|0|||
162666189|NCT00074282|587488792|FG002|Step 2|Death|3|||
162666190|NCT00074282|587488790|FG000|Step 2|Withdrawal by Subject|0|||
162666191|NCT00074282|587488791|FG001|Step 2|Withdrawal by Subject|0|||
162666192|NCT00074282|587488792|FG002|Step 2|Withdrawal by Subject|2|||
162666193|NCT00074282|587488790|FG000|Step 2|Physician Decision|0|||
162666194|NCT00074282|587488791|FG001|Step 2|Physician Decision|0|||
162666195|NCT00074282|587488792|FG002|Step 2|Physician Decision|1|||
162666196|NCT00074282|587488790|FG000|Step 2|Ineligible|0|||
162666197|NCT00074282|587488791|FG001|Step 2|Ineligible|0|||
162666198|NCT00074282|587488792|FG002|Step 2|Ineligible|1|||
162666199|NCT00464542|587488793|FG000|Pre-treatment|Withdrawal by Subject|2|||
162666200|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
162666201|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
162666202|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
162666203|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
162666204|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Adverse Event|5|||
162666205|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Adverse Event|3|||
162666206|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Adverse Event|4|||
162666207|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Adverse Event|10|||
162666208|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
162666209|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
162666210|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
162666211|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
162666212|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162666213|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162666214|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162666215|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
162666216|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Pregnancy|5|||
162666217|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Pregnancy|0|||
162666218|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Pregnancy|3|||
162666219|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Pregnancy|2|||
162666220|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Non-compliance|1|||
162666221|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Non-compliance|4|||
162666222|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Non-compliance|0|||
162666223|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Non-compliance|3|||
162666224|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Other|0|||
162666225|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Other|3|||
162666226|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Other|3|||
162666227|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Other|1|||
162666228|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
162666229|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
162666230|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
162666231|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
162666232|NCT01760954|587488795|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
162666233|NCT01760954|587488796|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
162666234|NCT01760954|587488797|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
162721661|NCT04707313|587688330|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162721662|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162666235|NCT01760954|587488798|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
162666236|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162666237|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162666238|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
162666239|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
162666240|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
162666241|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
162666242|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
162666243|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
162666244|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
162666245|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
162666246|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
162666247|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
162666248|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
162666249|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
162666250|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
162666251|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
162666252|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162666253|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162666254|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
162666255|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162666256|NCT01760954|587488795|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
162666257|NCT01760954|587488796|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
162666258|NCT01760954|587488797|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
162666259|NCT01760954|587488798|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
162666260|NCT00982020|587488799|FG000|Overall Study|Adverse Event|19|||
162666261|NCT00982020|587488800|FG001|Overall Study|Adverse Event|15|||
162666262|NCT00982020|587488799|FG000|Overall Study|Withdrawal by Subject|11|||
162666263|NCT00982020|587488800|FG001|Overall Study|Withdrawal by Subject|14|||
162666264|NCT00982020|587488799|FG000|Overall Study|Lost to Follow-up|5|||
162666265|NCT00982020|587488800|FG001|Overall Study|Lost to Follow-up|11|||
162666266|NCT00982020|587488799|FG000|Overall Study|Lack of Efficacy|10|||
162666267|NCT00982020|587488800|FG001|Overall Study|Lack of Efficacy|4|||
162666268|NCT00982020|587488799|FG000|Overall Study|Parent/Caregiver Decision|5|||
162666269|NCT00982020|587488800|FG001|Overall Study|Parent/Caregiver Decision|5|||
162666270|NCT00982020|587488799|FG000|Overall Study|Treatment Non-compliance|3|||
162666271|NCT00982020|587488800|FG001|Overall Study|Treatment Non-compliance|6|||
162666272|NCT00982020|587488799|FG000|Overall Study|Physician Decision|2|||
162666273|NCT00982020|587488800|FG001|Overall Study|Physician Decision|5|||
162666274|NCT00982020|587488799|FG000|Overall Study|Entry Criteria Not Met|2|||
162666275|NCT00982020|587488800|FG001|Overall Study|Entry Criteria Not Met|1|||
162666276|NCT00982020|587488799|FG000|Overall Study|Protocol Violation|0|||
162666277|NCT00982020|587488800|FG001|Overall Study|Protocol Violation|2|||
162666278|NCT00982020|587488799|FG000|Overall Study|Clinical Relapse|0|||
162666279|NCT00982020|587488800|FG001|Overall Study|Clinical Relapse|1|||
162666280|NCT01762761|587488801|FG000|Overall Study|Adverse Event|15|||
162666281|NCT01762761|587488802|FG001|Overall Study|Adverse Event|17|||
162666282|NCT01762761|587488801|FG000|Overall Study|Lack of Efficacy|9|||
162666283|NCT01762761|587488802|FG001|Overall Study|Lack of Efficacy|25|||
162666284|NCT01762761|587488801|FG000|Overall Study|Protocol Violation|1|||
162666285|NCT01762761|587488802|FG001|Overall Study|Protocol Violation|1|||
162666286|NCT01762761|587488801|FG000|Overall Study|Study closed/terminated|0|||
162666287|NCT01762761|587488802|FG001|Overall Study|Study closed/terminated|2|||
162666288|NCT01762761|587488801|FG000|Overall Study|Lost to Follow-up|3|||
162666289|NCT01762761|587488802|FG001|Overall Study|Lost to Follow-up|6|||
162666290|NCT01762761|587488801|FG000|Overall Study|Physician Decision|4|||
162666291|NCT01762761|587488802|FG001|Overall Study|Physician Decision|6|||
162666292|NCT01762761|587488801|FG000|Overall Study|Withdrawal by Subject|7|||
162666293|NCT01762761|587488802|FG001|Overall Study|Withdrawal by Subject|8|||
162666294|NCT02352493|587488803|FG000|Overall Study|Pregnancy|0|||
162666295|NCT02352493|587488804|FG001|Overall Study|Pregnancy|0|||
163148863|NCT05190120|589257404|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
163148864|NCT05190120|589257401|FG000|Overall Study|Lost to Follow-up|5|||
163148865|NCT05190120|589257402|FG001|Overall Study|Lost to Follow-up|0|||
163148866|NCT05190120|589257403|FG002|Overall Study|Lost to Follow-up|2|||
163148867|NCT05190120|589257404|FG003|Overall Study|Lost to Follow-up|3|||
162666296|NCT02352493|587488805|FG002|Overall Study|Pregnancy|0|||
162666297|NCT02352493|587488806|FG003|Overall Study|Pregnancy|0|||
162666298|NCT02352493|587488807|FG004|Overall Study|Pregnancy|0|||
162666299|NCT02352493|587488808|FG005|Overall Study|Pregnancy|0|||
162721663|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163148868|NCT03062358|589257405|FG000|Overall Study|Death|269|||
162666300|NCT02352493|587488809|FG006|Overall Study|Pregnancy|1|||
162666301|NCT02352493|587488810|FG007|Overall Study|Pregnancy|0|||
162666302|NCT02352493|587488811|FG008|Overall Study|Pregnancy|1|||
163148869|NCT03062358|589257406|FG001|Overall Study|Death|145|||
163148870|NCT03062358|589257405|FG000|Overall Study|Withdrawal by Subject|2|||
163148871|NCT03062358|589257406|FG001|Overall Study|Withdrawal by Subject|1|||
163148872|NCT03062358|589257405|FG000|Overall Study|Sponsor Decision|29|||
163148873|NCT03062358|589257406|FG001|Overall Study|Sponsor Decision|7|||
163148874|NCT05893862|589257407|FG000|Overall Study|Physician Decision|0|||
163148875|NCT05893862|589257408|FG001|Overall Study|Physician Decision|1|||
163148876|NCT05893862|589257409|FG002|Overall Study|Physician Decision|0|||
163148877|NCT05893862|589257410|FG003|Overall Study|Physician Decision|0|||
163148878|NCT05893862|589257411|FG004|Overall Study|Physician Decision|1|||
163148879|NCT05893862|589257412|FG005|Overall Study|Physician Decision|0|||
163148880|NCT05893862|589257407|FG000|Overall Study|Withdrawal by Subject|1|||
163148881|NCT05893862|589257408|FG001|Overall Study|Withdrawal by Subject|7|||
163148882|NCT05893862|589257409|FG002|Overall Study|Withdrawal by Subject|1|||
163148883|NCT05893862|589257410|FG003|Overall Study|Withdrawal by Subject|3|||
163148884|NCT05893862|589257411|FG004|Overall Study|Withdrawal by Subject|3|||
163148885|NCT05893862|589257412|FG005|Overall Study|Withdrawal by Subject|2|||
163148886|NCT05893862|589257407|FG000|Overall Study|Adverse Event|1|||
163148887|NCT05893862|589257408|FG001|Overall Study|Adverse Event|4|||
163148888|NCT05893862|589257409|FG002|Overall Study|Adverse Event|2|||
163148889|NCT05893862|589257410|FG003|Overall Study|Adverse Event|2|||
163148890|NCT05893862|589257411|FG004|Overall Study|Adverse Event|1|||
163148891|NCT05893862|589257412|FG005|Overall Study|Adverse Event|0|||
163148892|NCT00410956|589257413|FG000|Overall Study|Adverse Event|1|||
163148893|NCT00410956|589257413|FG000|Overall Study|Death|2|||
163148894|NCT00410956|589257413|FG000|Overall Study|Lack of Efficacy|10|||
163148895|NCT00410956|589257413|FG000|Overall Study|Physician Decision|6|||
163148896|NCT00880698|589257414|FG000|Overall Study|Death|0|||
163148897|NCT00880698|589257415|FG001|Overall Study|Death|0|||
163148898|NCT00880698|589257416|FG002|Overall Study|Death|1|||
163148899|NCT00880698|589257417|FG003|Overall Study|Death|2|||
163148900|NCT00880698|589257414|FG000|Overall Study|Lost to Follow-up|1|||
163148901|NCT00880698|589257415|FG001|Overall Study|Lost to Follow-up|3|||
163148902|NCT00880698|589257416|FG002|Overall Study|Lost to Follow-up|0|||
163148903|NCT00880698|589257417|FG003|Overall Study|Lost to Follow-up|1|||
163148904|NCT00089297|589259348|FG000|Overall Study|Adverse Event|9|||
163148905|NCT00089297|589259348|FG000|Overall Study|Death|1|||
163148906|NCT00089297|589259348|FG000|Overall Study|Withdrawal by Subject|12|||
163148907|NCT00089297|589259348|FG000|Overall Study|Disease progression|2|||
163148908|NCT00089297|589259348|FG000|Overall Study|Ineligible|11|||
163148909|NCT00089297|589259348|FG000|Overall Study|Secondary malignancy|1|||
163148910|NCT00089297|589259348|FG000|Overall Study|IRB approval not ready|1|||
163148911|NCT00089297|589259348|FG000|Overall Study|Non-compliance|1|||
163148912|NCT04199351|589259351|FG000|Overall Study|Decision by sponsor|0|||
163148913|NCT04199351|589259352|FG001|Overall Study|Decision by sponsor|0|||
163148914|NCT04199351|589259353|FG002|Overall Study|Decision by sponsor|0|||
163148915|NCT04199351|589259354|FG003|Overall Study|Decision by sponsor|2|||
163148916|NCT04199351|589259355|FG004|Overall Study|Decision by sponsor|0|||
163148917|NCT04199351|589259356|FG005|Overall Study|Decision by sponsor|0|||
163148918|NCT04199351|589259357|FG006|Overall Study|Decision by sponsor|0|||
163148919|NCT04199351|589259358|FG007|Overall Study|Decision by sponsor|0|||
162666303|NCT02352493|587488812|FG009|Overall Study|Pregnancy|0|||
162666304|NCT02352493|587488813|FG010|Overall Study|Pregnancy|0|||
163148920|NCT04199351|589259359|FG008|Overall Study|Decision by sponsor|0|||
163148921|NCT04199351|589259360|FG009|Overall Study|Decision by sponsor|6|||
163148922|NCT04199351|589259351|FG000|Overall Study|Lost to Follow-up|0|||
163148923|NCT04199351|589259352|FG001|Overall Study|Lost to Follow-up|0|||
163148924|NCT04199351|589259353|FG002|Overall Study|Lost to Follow-up|1|||
163148925|NCT04199351|589259354|FG003|Overall Study|Lost to Follow-up|0|||
163148926|NCT04199351|589259355|FG004|Overall Study|Lost to Follow-up|0|||
163148927|NCT04199351|589259356|FG005|Overall Study|Lost to Follow-up|1|||
163148928|NCT04199351|589259357|FG006|Overall Study|Lost to Follow-up|0|||
163148929|NCT04199351|589259358|FG007|Overall Study|Lost to Follow-up|0|||
163148930|NCT04199351|589259359|FG008|Overall Study|Lost to Follow-up|0|||
163148931|NCT04199351|589259360|FG009|Overall Study|Lost to Follow-up|0|||
163148932|NCT04199351|589259351|FG000|Overall Study|Withdrawal by Subject|0|||
163148933|NCT04199351|589259352|FG001|Overall Study|Withdrawal by Subject|1|||
163148934|NCT04199351|589259353|FG002|Overall Study|Withdrawal by Subject|0|||
163148935|NCT04199351|589259354|FG003|Overall Study|Withdrawal by Subject|0|||
163148936|NCT04199351|589259355|FG004|Overall Study|Withdrawal by Subject|1|||
163148937|NCT04199351|589259356|FG005|Overall Study|Withdrawal by Subject|4|||
163148938|NCT04199351|589259357|FG006|Overall Study|Withdrawal by Subject|2|||
163148939|NCT04199351|589259358|FG007|Overall Study|Withdrawal by Subject|0|||
162666305|NCT02352493|587488814|FG011|Overall Study|Pregnancy|0|||
163148940|NCT04199351|589259359|FG008|Overall Study|Withdrawal by Subject|3|||
163148941|NCT04199351|589259360|FG009|Overall Study|Withdrawal by Subject|0|||
163148942|NCT00979901|589259361|FG000|Overall Study|Adverse Event|1|||
163148943|NCT00979901|589259362|FG001|Overall Study|Adverse Event|3|||
162666306|NCT02352493|587488815|FG012|Overall Study|Pregnancy|0|||
163148944|NCT00979901|589259363|FG002|Overall Study|Adverse Event|9|||
163148945|NCT00979901|589259364|FG003|Overall Study|Adverse Event|2|||
163148946|NCT00979901|589259361|FG000|Overall Study|Lack of Efficacy|8|||
163148947|NCT00979901|589259362|FG001|Overall Study|Lack of Efficacy|4|||
163148948|NCT00979901|589259363|FG002|Overall Study|Lack of Efficacy|9|||
163148949|NCT00979901|589259364|FG003|Overall Study|Lack of Efficacy|0|||
163148950|NCT00979901|589259361|FG000|Overall Study|Lost to Follow-up|1|||
163148951|NCT00979901|589259362|FG001|Overall Study|Lost to Follow-up|1|||
163148952|NCT00979901|589259363|FG002|Overall Study|Lost to Follow-up|2|||
163148953|NCT00979901|589259364|FG003|Overall Study|Lost to Follow-up|0|||
163148954|NCT00979901|589259361|FG000|Overall Study|Protocol Violation|2|||
163148955|NCT00979901|589259362|FG001|Overall Study|Protocol Violation|2|||
163148956|NCT00979901|589259363|FG002|Overall Study|Protocol Violation|7|||
163148957|NCT00979901|589259364|FG003|Overall Study|Protocol Violation|1|||
163148958|NCT00979901|589259361|FG000|Overall Study|Withdrawal by Subject|2|||
163148959|NCT00979901|589259362|FG001|Overall Study|Withdrawal by Subject|1|||
163148960|NCT00979901|589259363|FG002|Overall Study|Withdrawal by Subject|1|||
163148961|NCT00979901|589259364|FG003|Overall Study|Withdrawal by Subject|1|||
163148962|NCT00979901|589259361|FG000|Overall Study|Noncompliance|1|||
163148963|NCT00979901|589259362|FG001|Overall Study|Noncompliance|0|||
163148964|NCT00979901|589259363|FG002|Overall Study|Noncompliance|0|||
163148965|NCT00979901|589259364|FG003|Overall Study|Noncompliance|0|||
163148966|NCT00979901|589259361|FG000|Overall Study|out-of-state|1|||
163148967|NCT00979901|589259362|FG001|Overall Study|out-of-state|0|||
163148968|NCT00979901|589259363|FG002|Overall Study|out-of-state|0|||
163148969|NCT00979901|589259364|FG003|Overall Study|out-of-state|0|||
163148970|NCT00979901|589259361|FG000|Overall Study|vacation|1|||
163148971|NCT00979901|589259362|FG001|Overall Study|vacation|0|||
163148972|NCT00979901|589259363|FG002|Overall Study|vacation|0|||
163148973|NCT00979901|589259364|FG003|Overall Study|vacation|0|||
163148974|NCT00979901|589259361|FG000|Overall Study|elevated lab values pre-randomization|1|||
163148975|NCT00979901|589259362|FG001|Overall Study|elevated lab values pre-randomization|0|||
163148976|NCT00979901|589259363|FG002|Overall Study|elevated lab values pre-randomization|0|||
163148977|NCT00979901|589259364|FG003|Overall Study|elevated lab values pre-randomization|0|||
163148978|NCT00979901|589259361|FG000|Overall Study|Discontinued in Error|0|||
163148979|NCT00979901|589259362|FG001|Overall Study|Discontinued in Error|1|||
163148980|NCT00979901|589259363|FG002|Overall Study|Discontinued in Error|0|||
163148981|NCT00979901|589259364|FG003|Overall Study|Discontinued in Error|0|||
163148982|NCT00979901|589259361|FG000|Overall Study|Left Country|0|||
163148983|NCT00979901|589259362|FG001|Overall Study|Left Country|0|||
163148984|NCT00979901|589259363|FG002|Overall Study|Left Country|1|||
163148985|NCT00979901|589259364|FG003|Overall Study|Left Country|0|||
163148986|NCT00979901|589259361|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148987|NCT00979901|589259362|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148988|NCT00979901|589259363|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
163148989|NCT00979901|589259364|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
163148990|NCT02814916|589259368|FG000|Overall Study|Withdrawal of consent|0|||
163148991|NCT02814916|589259369|FG001|Overall Study|Withdrawal of consent|2|||
163148992|NCT02814916|589259370|FG002|Overall Study|Withdrawal of consent|0|||
163148993|NCT02814916|589259368|FG000|Overall Study|Lost to Follow-up|0|||
163148994|NCT02814916|589259369|FG001|Overall Study|Lost to Follow-up|1|||
163148995|NCT02814916|589259370|FG002|Overall Study|Lost to Follow-up|0|||
163148996|NCT02814916|589259368|FG000|Overall Study|Other, not specified|0|||
163148997|NCT02814916|589259369|FG001|Overall Study|Other, not specified|1|||
163148998|NCT02814916|589259370|FG002|Overall Study|Other, not specified|0|||
163148999|NCT05316597|589259375|FG000|First Session|Withdrawal by Subject|0|||
163149000|NCT05316597|589259376|FG001|First Session|Withdrawal by Subject|1|||
163149001|NCT05316597|589259375|FG000|Washout Period|Lost to Follow-up|1|||
163149002|NCT05316597|589259376|FG001|Washout Period|Lost to Follow-up|2|||
162666307|NCT02352493|587488816|FG013|Overall Study|Pregnancy|0|||
163149003|NCT05316597|589259375|FG000|Washout Period|Physician Decision|1|||
163149004|NCT05316597|589259376|FG001|Washout Period|Physician Decision|1|||
163149005|NCT05316597|589259375|FG000|Washout Period|Excluded before second session|1|||
163149006|NCT05316597|589259376|FG001|Washout Period|Excluded before second session|1|||
163149007|NCT05316597|589259375|FG000|Washout Period|Withdrawal by Subject|0|||
163149008|NCT05316597|589259376|FG001|Washout Period|Withdrawal by Subject|4|||
163149009|NCT02766023|589259381|FG000|Overall Study|Lost to Follow-up|23|||
163149010|NCT02766023|589259382|FG001|Overall Study|Lost to Follow-up|11|||
163149011|NCT02766023|589259381|FG000|Overall Study|Pregnancy|1|||
163149012|NCT02766023|589259382|FG001|Overall Study|Pregnancy|0|||
163149013|NCT02766023|589259381|FG000|Overall Study|Adverse Event|1|||
163149014|NCT02766023|589259382|FG001|Overall Study|Adverse Event|0|||
163149015|NCT02766023|589259381|FG000|Overall Study|Withdrawal by Subject|4|||
163149016|NCT02766023|589259382|FG001|Overall Study|Withdrawal by Subject|5|||
163149017|NCT02766023|589259381|FG000|Overall Study|Physician Decision|1|||
163149018|NCT02766023|589259382|FG001|Overall Study|Physician Decision|0|||
163149019|NCT02766023|589259381|FG000|Overall Study|Not Eligible at Enrollment|0|||
162666308|NCT02352493|587488817|FG014|Overall Study|Pregnancy|0|||
162666309|NCT02352493|587488818|FG015|Overall Study|Pregnancy|0|||
162666310|NCT02352493|587488819|FG016|Overall Study|Pregnancy|0|||
162666311|NCT02352493|587488820|FG017|Overall Study|Pregnancy|0|||
162666312|NCT02352493|587488803|FG000|Overall Study|Withdrawal by Subject|0|||
162666313|NCT02352493|587488804|FG001|Overall Study|Withdrawal by Subject|0|||
162666314|NCT02352493|587488805|FG002|Overall Study|Withdrawal by Subject|0|||
162666315|NCT02352493|587488806|FG003|Overall Study|Withdrawal by Subject|0|||
162666316|NCT02352493|587488807|FG004|Overall Study|Withdrawal by Subject|0|||
162666317|NCT02352493|587488808|FG005|Overall Study|Withdrawal by Subject|0|||
162666318|NCT02352493|587488809|FG006|Overall Study|Withdrawal by Subject|0|||
162666319|NCT02352493|587488810|FG007|Overall Study|Withdrawal by Subject|0|||
162666320|NCT02352493|587488811|FG008|Overall Study|Withdrawal by Subject|1|||
162721664|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163149020|NCT02766023|589259382|FG001|Overall Study|Not Eligible at Enrollment|1|||
163149021|NCT00286468|589259383|FG000|Overall Study|Hyperglycemic Rescue|28|||
163149022|NCT00286468|589259384|FG001|Overall Study|Hyperglycemic Rescue|30|||
163149023|NCT00286468|589259385|FG002|Overall Study|Hyperglycemic Rescue|31|||
163149024|NCT00286468|589259383|FG000|Overall Study|Adverse Event|2|||
163149025|NCT00286468|589259384|FG001|Overall Study|Adverse Event|6|||
163149026|NCT00286468|589259385|FG002|Overall Study|Adverse Event|4|||
163149027|NCT00286468|589259383|FG000|Overall Study|Protocol Violation|0|||
163149028|NCT00286468|589259384|FG001|Overall Study|Protocol Violation|3|||
163149029|NCT00286468|589259385|FG002|Overall Study|Protocol Violation|1|||
163149030|NCT00286468|589259383|FG000|Overall Study|Lost to Follow-up|1|||
163149031|NCT00286468|589259384|FG001|Overall Study|Lost to Follow-up|1|||
163149032|NCT00286468|589259385|FG002|Overall Study|Lost to Follow-up|2|||
163149033|NCT00286468|589259383|FG000|Overall Study|Withdrawal by Subject|3|||
163149034|NCT00286468|589259384|FG001|Overall Study|Withdrawal by Subject|8|||
163149035|NCT00286468|589259385|FG002|Overall Study|Withdrawal by Subject|11|||
163149036|NCT00286468|589259383|FG000|Overall Study|Physician Decision|3|||
163149037|NCT00286468|589259384|FG001|Overall Study|Physician Decision|2|||
162666321|NCT02352493|587488812|FG009|Overall Study|Withdrawal by Subject|0|||
162666322|NCT02352493|587488813|FG010|Overall Study|Withdrawal by Subject|0|||
162666323|NCT02352493|587488814|FG011|Overall Study|Withdrawal by Subject|0|||
162666324|NCT02352493|587488815|FG012|Overall Study|Withdrawal by Subject|0|||
162666325|NCT02352493|587488816|FG013|Overall Study|Withdrawal by Subject|0|||
162666326|NCT02352493|587488817|FG014|Overall Study|Withdrawal by Subject|1|||
162666327|NCT02352493|587488818|FG015|Overall Study|Withdrawal by Subject|0|||
162666328|NCT02352493|587488819|FG016|Overall Study|Withdrawal by Subject|0|||
162666329|NCT02352493|587488820|FG017|Overall Study|Withdrawal by Subject|0|||
162666330|NCT02352493|587488803|FG000|Overall Study|Lost to Follow-up|0|||
162666331|NCT02352493|587488804|FG001|Overall Study|Lost to Follow-up|0|||
162666332|NCT02352493|587488805|FG002|Overall Study|Lost to Follow-up|0|||
162666333|NCT02352493|587488806|FG003|Overall Study|Lost to Follow-up|0|||
162666334|NCT02352493|587488807|FG004|Overall Study|Lost to Follow-up|0|||
162666335|NCT02352493|587488808|FG005|Overall Study|Lost to Follow-up|0|||
162666336|NCT02352493|587488809|FG006|Overall Study|Lost to Follow-up|0|||
162666337|NCT02352493|587488810|FG007|Overall Study|Lost to Follow-up|0|||
162666338|NCT02352493|587488811|FG008|Overall Study|Lost to Follow-up|0|||
162666339|NCT02352493|587488812|FG009|Overall Study|Lost to Follow-up|1|||
162666340|NCT02352493|587488813|FG010|Overall Study|Lost to Follow-up|0|||
162666341|NCT02352493|587488814|FG011|Overall Study|Lost to Follow-up|0|||
162666342|NCT02352493|587488815|FG012|Overall Study|Lost to Follow-up|1|||
162666343|NCT02352493|587488816|FG013|Overall Study|Lost to Follow-up|2|||
162666344|NCT02352493|587488817|FG014|Overall Study|Lost to Follow-up|0|||
162666345|NCT02352493|587488818|FG015|Overall Study|Lost to Follow-up|0|||
162666346|NCT02352493|587488819|FG016|Overall Study|Lost to Follow-up|0|||
162666347|NCT02352493|587488820|FG017|Overall Study|Lost to Follow-up|0|||
162666348|NCT02317575|587488821|FG000|Period 1|Difficulty with venous cannulation|0|||
162666349|NCT02317575|587488822|FG001|Period 1|Difficulty with venous cannulation|1|||
162666350|NCT02317575|587488823|FG002|Period 1|Difficulty with venous cannulation|0|||
162666351|NCT02317575|587488824|FG003|Period 1|Difficulty with venous cannulation|0|||
162666352|NCT02317575|587488825|FG004|Period 1|Difficulty with venous cannulation|0|||
162666353|NCT02317575|587488821|FG000|Period 1|Withdrawal by Subject|1|||
162666354|NCT02317575|587488822|FG001|Period 1|Withdrawal by Subject|0|||
162666355|NCT02317575|587488823|FG002|Period 1|Withdrawal by Subject|0|||
162666356|NCT02317575|587488824|FG003|Period 1|Withdrawal by Subject|0|||
162666357|NCT02317575|587488825|FG004|Period 1|Withdrawal by Subject|0|||
162666358|NCT01465334|587488826|FG000|Overall Study|Disease Progression|1|||
162666359|NCT01465334|587488827|FG001|Overall Study|Disease Progression|0|||
162666360|NCT01465334|587488826|FG000|Overall Study|Adverse Event|1|||
162666361|NCT01465334|587488827|FG001|Overall Study|Adverse Event|0|||
162666362|NCT01465334|587488826|FG000|Overall Study|Richter's transformation|0|||
162721665|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163149038|NCT00286468|589259385|FG002|Overall Study|Physician Decision|1|||
163149039|NCT03103542|589259386|FG000|Overall Study|Physician Decision|2|||
163149040|NCT03103542|589259386|FG000|Overall Study|Adverse Event|2|||
163149041|NCT03103542|589259386|FG000|Overall Study|Other|2|||
163149042|NCT03103542|589259386|FG000|Overall Study|Withdrawal by Subject|1|||
163149043|NCT02953652|589259387|FG000|Overall Study|Adverse Event|18|||
163149044|NCT02953652|589259387|FG000|Overall Study|Withdrawal by Subject|6|||
163149045|NCT02953652|589259387|FG000|Overall Study|Protocol Violation|1|||
163149046|NCT02953652|589259387|FG000|Overall Study|Disease Progression|27|||
163149047|NCT02384551|589259390|FG000|Overall Study|Lost to Follow-up|13|||
163149048|NCT02384551|589259391|FG001|Overall Study|Lost to Follow-up|14|||
163149049|NCT02384551|589259392|FG002|Overall Study|Lost to Follow-up|14|||
163149050|NCT02384551|589259393|FG003|Overall Study|Lost to Follow-up|14|||
163149051|NCT02927301|589259397|FG000|Overall Study|Death|39|||
163149052|NCT02927301|589259397|FG000|Overall Study|Lost to Follow-up|8|||
163149053|NCT02927301|589259397|FG000|Overall Study|Physician Decision|2|||
163149054|NCT02927301|589259397|FG000|Overall Study|Withdrawal by Subject|12|||
163149055|NCT02927301|589259397|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
163149056|NCT04742556|589259398|FG000|Overall Study|Withdrawal by Subject|0|||
163149057|NCT04742556|589259399|FG001|Overall Study|Withdrawal by Subject|1|||
163149058|NCT04742556|589259400|FG002|Overall Study|Withdrawal by Subject|0|||
163149059|NCT04742556|589259398|FG000|Overall Study|Adverse Event|0|||
163149060|NCT04742556|589259399|FG001|Overall Study|Adverse Event|0|||
163149061|NCT04742556|589259400|FG002|Overall Study|Adverse Event|2|||
163149062|NCT04742556|589259398|FG000|Overall Study|Clinical disease progression|0|||
163149063|NCT04742556|589259399|FG001|Overall Study|Clinical disease progression|1|||
163149064|NCT04742556|589259400|FG002|Overall Study|Clinical disease progression|2|||
163149065|NCT04742556|589259398|FG000|Overall Study|Objective disease progression|3|||
163149066|NCT04742556|589259399|FG001|Overall Study|Objective disease progression|2|||
162666363|NCT01465334|587488827|FG001|Overall Study|Richter's transformation|3|||
162666364|NCT01465334|587488826|FG000|Overall Study|Refractory Disease|0|||
162666365|NCT01465334|587488827|FG001|Overall Study|Refractory Disease|3|||
162666366|NCT02159482|587488828|FG000|Overall Study|Withdrawal by Subject|2|||
162666367|NCT02159482|587488828|FG000|Overall Study|Physician Decision|3|||
162721666|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162666368|NCT04479618|587488829|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
162666369|NCT04479618|587488830|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
162666370|NCT04479618|587488831|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
162666371|NCT04479618|587488829|FG000|Overall Study|Lack of Efficacy|1|||
162666372|NCT04479618|587488830|FG001|Overall Study|Lack of Efficacy|0|||
162666373|NCT04479618|587488831|FG002|Overall Study|Lack of Efficacy|0|||
162666374|NCT04479618|587488829|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
162666375|NCT04479618|587488830|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
162666376|NCT04479618|587488831|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
162666377|NCT04479618|587488829|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
162666378|NCT04479618|587488830|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
162666379|NCT04479618|587488831|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
162666380|NCT04479618|587488829|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
162666381|NCT04479618|587488830|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
162721667|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163149067|NCT04742556|589259400|FG002|Overall Study|Objective disease progression|4|||
163149068|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
163149069|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149070|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149071|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149072|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149073|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
163149074|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
163149075|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149076|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
163149077|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149078|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149079|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
162666382|NCT04479618|587488831|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
162666383|NCT04479618|587488829|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
162666384|NCT04479618|587488830|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
162666385|NCT04479618|587488831|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
162666386|NCT01430130|587488832|FG000|Overall Study|Lost to Follow-up|1|||
162666387|NCT01430130|587488832|FG000|Overall Study|Infection on Control Side of Incision|1|||
162666388|NCT00797667|587488833|FG000|Overall Study|Lack of Efficacy|0|||
162666389|NCT00797667|587488834|FG001|Overall Study|Lack of Efficacy|1|||
162666390|NCT00797667|587488835|FG002|Overall Study|Lack of Efficacy|0|||
162666391|NCT00797667|587488833|FG000|Overall Study|Lost to Follow-up|8|||
162666392|NCT00797667|587488834|FG001|Overall Study|Lost to Follow-up|12|||
162666393|NCT00797667|587488835|FG002|Overall Study|Lost to Follow-up|2|||
162666394|NCT00797667|587488833|FG000|Overall Study|Physician Decision|3|||
162666395|NCT00797667|587488834|FG001|Overall Study|Physician Decision|1|||
162666396|NCT00797667|587488835|FG002|Overall Study|Physician Decision|0|||
162666397|NCT00797667|587488833|FG000|Overall Study|Pregnancy|2|||
162666398|NCT00797667|587488834|FG001|Overall Study|Pregnancy|0|||
162666399|NCT00797667|587488835|FG002|Overall Study|Pregnancy|0|||
162666400|NCT00797667|587488833|FG000|Overall Study|Protocol Violation|2|||
162666401|NCT00797667|587488834|FG001|Overall Study|Protocol Violation|7|||
162666402|NCT00797667|587488835|FG002|Overall Study|Protocol Violation|0|||
162666403|NCT00797667|587488833|FG000|Overall Study|Study Terminated by Sponsor|217|||
162666404|NCT00797667|587488834|FG001|Overall Study|Study Terminated by Sponsor|216|||
162666405|NCT00797667|587488835|FG002|Overall Study|Study Terminated by Sponsor|115|||
162666406|NCT00797667|587488833|FG000|Overall Study|Withdrawal by Subject|9|||
162666407|NCT00797667|587488834|FG001|Overall Study|Withdrawal by Subject|14|||
162666408|NCT00797667|587488835|FG002|Overall Study|Withdrawal by Subject|2|||
162666409|NCT00797667|587488833|FG000|Overall Study|Adverse Event|19|||
162666410|NCT00797667|587488834|FG001|Overall Study|Adverse Event|8|||
162666411|NCT00797667|587488835|FG002|Overall Study|Adverse Event|8|||
162666412|NCT01485861|587488836|FG000|Phase Ib|Death|1|||
162666413|NCT01485861|587488837|FG001|Phase Ib|Death|0|||
162666414|NCT01485861|587488838|FG002|Phase Ib|Death|0|||
162666415|NCT01485861|587488839|FG003|Phase Ib|Death|0|||
162666416|NCT01485861|587488840|FG004|Phase Ib|Death|0|||
162666417|NCT01485861|587488841|FG005|Phase Ib|Death|0|||
162666418|NCT01485861|587488836|FG000|Phase Ib|Physician Decision|1|||
162666419|NCT01485861|587488837|FG001|Phase Ib|Physician Decision|1|||
162666420|NCT01485861|587488838|FG002|Phase Ib|Physician Decision|0|||
162666421|NCT01485861|587488839|FG003|Phase Ib|Physician Decision|0|||
162666422|NCT01485861|587488840|FG004|Phase Ib|Physician Decision|0|||
162666423|NCT01485861|587488841|FG005|Phase Ib|Physician Decision|0|||
162666424|NCT01485861|587488836|FG000|Phase Ib|Adverse Event|0|||
162666425|NCT01485861|587488837|FG001|Phase Ib|Adverse Event|4|||
162666426|NCT01485861|587488838|FG002|Phase Ib|Adverse Event|0|||
162666427|NCT01485861|587488839|FG003|Phase Ib|Adverse Event|0|||
162666428|NCT01485861|587488840|FG004|Phase Ib|Adverse Event|0|||
162666429|NCT01485861|587488841|FG005|Phase Ib|Adverse Event|0|||
162666430|NCT01485861|587488836|FG000|Phase Ib|Progression of disease|5|||
162666431|NCT01485861|587488837|FG001|Phase Ib|Progression of disease|0|||
162666432|NCT01485861|587488838|FG002|Phase Ib|Progression of disease|0|||
162666433|NCT01485861|587488839|FG003|Phase Ib|Progression of disease|0|||
162666434|NCT01485861|587488840|FG004|Phase Ib|Progression of disease|0|||
162666435|NCT01485861|587488841|FG005|Phase Ib|Progression of disease|0|||
162666436|NCT01485861|587488836|FG000|Phase Ib|Other|3|||
162666437|NCT01485861|587488837|FG001|Phase Ib|Other|0|||
162666438|NCT01485861|587488838|FG002|Phase Ib|Other|0|||
162666439|NCT01485861|587488839|FG003|Phase Ib|Other|0|||
162666440|NCT01485861|587488840|FG004|Phase Ib|Other|0|||
162666441|NCT01485861|587488841|FG005|Phase Ib|Other|0|||
162666442|NCT01485861|587488836|FG000|Phase Ib|Withdrawal by Subject|4|||
162666443|NCT01485861|587488837|FG001|Phase Ib|Withdrawal by Subject|1|||
162666444|NCT01485861|587488838|FG002|Phase Ib|Withdrawal by Subject|0|||
162666445|NCT01485861|587488839|FG003|Phase Ib|Withdrawal by Subject|0|||
162666446|NCT01485861|587488840|FG004|Phase Ib|Withdrawal by Subject|0|||
162666447|NCT01485861|587488841|FG005|Phase Ib|Withdrawal by Subject|0|||
162666448|NCT01485861|587488836|FG000|Phase II|Death|0|||
162666449|NCT01485861|587488837|FG001|Phase II|Death|0|||
162666450|NCT01485861|587488838|FG002|Phase II|Death|67|||
162666451|NCT01485861|587488839|FG003|Phase II|Death|71|||
162666452|NCT01485861|587488840|FG004|Phase II|Death|68|||
162666453|NCT01485861|587488841|FG005|Phase II|Death|0|||
162666454|NCT01485861|587488836|FG000|Phase II|Progression of Disease|0|||
162666455|NCT01485861|587488837|FG001|Phase II|Progression of Disease|0|||
162666456|NCT01485861|587488838|FG002|Phase II|Progression of Disease|1|||
162666457|NCT01485861|587488839|FG003|Phase II|Progression of Disease|0|||
162666458|NCT01485861|587488840|FG004|Phase II|Progression of Disease|0|||
162666459|NCT01485861|587488841|FG005|Phase II|Progression of Disease|0|||
162666460|NCT01485861|587488836|FG000|Phase II|Other|0|||
162666461|NCT01485861|587488837|FG001|Phase II|Other|0|||
162666462|NCT01485861|587488838|FG002|Phase II|Other|0|||
162666463|NCT01485861|587488839|FG003|Phase II|Other|1|||
162666464|NCT01485861|587488840|FG004|Phase II|Other|0|||
162666465|NCT01485861|587488841|FG005|Phase II|Other|0|||
162666466|NCT01485861|587488836|FG000|Phase II|Withdrawal by Subject|0|||
162666467|NCT01485861|587488837|FG001|Phase II|Withdrawal by Subject|0|||
162666468|NCT01485861|587488838|FG002|Phase II|Withdrawal by Subject|6|||
162666469|NCT01485861|587488839|FG003|Phase II|Withdrawal by Subject|3|||
162666470|NCT01485861|587488840|FG004|Phase II|Withdrawal by Subject|4|||
162666471|NCT01485861|587488841|FG005|Phase II|Withdrawal by Subject|0|||
162666472|NCT01485861|587488836|FG000|Phase II|Lost to Follow-up|0|||
162666473|NCT01485861|587488837|FG001|Phase II|Lost to Follow-up|0|||
162666474|NCT01485861|587488838|FG002|Phase II|Lost to Follow-up|2|||
162666475|NCT01485861|587488839|FG003|Phase II|Lost to Follow-up|3|||
162666476|NCT01485861|587488840|FG004|Phase II|Lost to Follow-up|5|||
162666477|NCT01485861|587488841|FG005|Phase II|Lost to Follow-up|0|||
162666478|NCT01485861|587488836|FG000|Phase II|Study Ended|0|||
162666479|NCT01485861|587488837|FG001|Phase II|Study Ended|0|||
162666480|NCT01485861|587488838|FG002|Phase II|Study Ended|7|||
162666481|NCT01485861|587488839|FG003|Phase II|Study Ended|8|||
162666482|NCT01485861|587488840|FG004|Phase II|Study Ended|6|||
162666483|NCT01485861|587488841|FG005|Phase II|Study Ended|0|||
162666484|NCT01485861|587488836|FG000|Safety Phase|Death|0|||
162666485|NCT01485861|587488837|FG001|Safety Phase|Death|0|||
162666486|NCT01485861|587488838|FG002|Safety Phase|Death|0|||
162666487|NCT01485861|587488839|FG003|Safety Phase|Death|0|||
162666488|NCT01485861|587488840|FG004|Safety Phase|Death|0|||
162666489|NCT01485861|587488841|FG005|Safety Phase|Death|2|||
162666490|NCT01485861|587488836|FG000|Safety Phase|Adverse Event|0|||
162666491|NCT01485861|587488837|FG001|Safety Phase|Adverse Event|0|||
162666492|NCT01485861|587488838|FG002|Safety Phase|Adverse Event|0|||
162666493|NCT01485861|587488839|FG003|Safety Phase|Adverse Event|0|||
162666494|NCT01485861|587488840|FG004|Safety Phase|Adverse Event|0|||
162666495|NCT01485861|587488841|FG005|Safety Phase|Adverse Event|1|||
162666496|NCT01485861|587488836|FG000|Safety Phase|Other|0|||
162666497|NCT01485861|587488837|FG001|Safety Phase|Other|0|||
162666498|NCT01485861|587488838|FG002|Safety Phase|Other|0|||
162666499|NCT01485861|587488839|FG003|Safety Phase|Other|0|||
162666500|NCT01485861|587488840|FG004|Safety Phase|Other|0|||
162666501|NCT01485861|587488841|FG005|Safety Phase|Other|5|||
162666502|NCT01485861|587488836|FG000|Safety Phase|Progression of Disease|0|||
162666503|NCT01485861|587488837|FG001|Safety Phase|Progression of Disease|0|||
162666504|NCT01485861|587488838|FG002|Safety Phase|Progression of Disease|0|||
162666505|NCT01485861|587488839|FG003|Safety Phase|Progression of Disease|0|||
162666506|NCT01485861|587488840|FG004|Safety Phase|Progression of Disease|0|||
162666507|NCT01485861|587488841|FG005|Safety Phase|Progression of Disease|9|||
162666508|NCT01485861|587488836|FG000|Safety Phase|Withdrawal by Subject|0|||
162666509|NCT01485861|587488837|FG001|Safety Phase|Withdrawal by Subject|0|||
162666510|NCT01485861|587488838|FG002|Safety Phase|Withdrawal by Subject|0|||
162666511|NCT01485861|587488839|FG003|Safety Phase|Withdrawal by Subject|0|||
162666512|NCT01485861|587488840|FG004|Safety Phase|Withdrawal by Subject|0|||
162666513|NCT01485861|587488841|FG005|Safety Phase|Withdrawal by Subject|6|||
162666514|NCT01485861|587488836|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
162666515|NCT01485861|587488837|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
162666516|NCT01485861|587488838|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
162666517|NCT01485861|587488839|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
162666518|NCT01485861|587488840|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
162666519|NCT01485861|587488841|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
162666520|NCT01986829|587488846|FG000|Overall Study|Death|1|||
162666521|NCT03795922|587488847|FG000|Overall Study|Adverse Event|2|||
162666522|NCT03795922|587488848|FG001|Overall Study|Adverse Event|1|||
162666523|NCT03795922|587488847|FG000|Overall Study|Withdrawal by Subject|5|||
163149080|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
162666524|NCT03795922|587488848|FG001|Overall Study|Withdrawal by Subject|13|||
162666525|NCT03795922|587488847|FG000|Overall Study|Lost to Follow-up|2|||
162666526|NCT03795922|587488848|FG001|Overall Study|Lost to Follow-up|3|||
162666527|NCT03795922|587488847|FG000|Overall Study|Pregnancy|0|||
162666528|NCT03795922|587488848|FG001|Overall Study|Pregnancy|1|||
162666529|NCT03795922|587488847|FG000|Overall Study|Physician Decision|1|||
162666530|NCT03795922|587488848|FG001|Overall Study|Physician Decision|2|||
162666531|NCT03795922|587488847|FG000|Overall Study|Protocol Violation|0|||
162666532|NCT03795922|587488848|FG001|Overall Study|Protocol Violation|1|||
162666533|NCT03795922|587488847|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
162666534|NCT03795922|587488848|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
162666535|NCT00701051|587488851|FG000|Screening|Failed Screening|40|||
162666536|NCT00701051|587488852|FG001|Screening|Failed Screening|0|||
162666537|NCT00701051|587488853|FG002|Screening|Failed Screening|0|||
162666538|NCT00701051|587488851|FG000|Screening|Time conflicts|19|||
162666539|NCT00701051|587488852|FG001|Screening|Time conflicts|0|||
162666540|NCT00701051|587488853|FG002|Screening|Time conflicts|0|||
162666541|NCT00701051|587488851|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
162666542|NCT00701051|587488852|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
162666543|NCT00701051|587488853|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
162666544|NCT01243944|587488854|FG000|Overall Study|Adverse Event|15|||
162666545|NCT01243944|587488855|FG001|Overall Study|Adverse Event|13|||
162666546|NCT01243944|587488854|FG000|Overall Study|Lost to Follow-up|2|||
162666547|NCT01243944|587488855|FG001|Overall Study|Lost to Follow-up|1|||
162666548|NCT01243944|587488854|FG000|Overall Study|Physician Decision|2|||
162666549|NCT01243944|587488855|FG001|Overall Study|Physician Decision|7|||
162666550|NCT01243944|587488854|FG000|Overall Study|Disease progression|12|||
163149081|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
163149082|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149083|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149084|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
163149085|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149086|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149087|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
163149088|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
163149089|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149090|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149091|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149092|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149093|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
163149094|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149095|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
163149096|NCT02903771|589259401|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149097|NCT02903771|589259402|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149098|NCT02903771|589259403|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149099|NCT02903771|589259404|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149100|NCT02903771|589259405|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149101|NCT02903771|589259406|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
163149102|NCT02903771|589259407|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
163149103|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149104|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149105|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149106|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149107|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
163149108|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149109|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
163149110|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149111|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149112|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149113|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149114|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
163149115|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149116|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
163149117|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149118|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149119|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149120|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149121|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
163149122|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149123|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
163149124|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149125|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149126|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149127|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149128|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
163149129|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149130|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
163149131|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149132|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149133|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149134|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149135|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
163149136|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149137|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
163149138|NCT02903771|589259401|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162666551|NCT01243944|587488855|FG001|Overall Study|Disease progression|11|||
162666552|NCT01243944|587488854|FG000|Overall Study|Protocol deviation|1|||
162666553|NCT01243944|587488855|FG001|Overall Study|Protocol deviation|1|||
162666554|NCT01243944|587488854|FG000|Overall Study|Participant decision|10|||
162666555|NCT01243944|587488855|FG001|Overall Study|Participant decision|15|||
162666556|NCT01243944|587488854|FG000|Overall Study|Death|2|||
162666557|NCT01243944|587488855|FG001|Overall Study|Death|3|||
162666558|NCT01243944|587488854|FG000|Overall Study|Non-compliance with study treatment|1|||
162666559|NCT01243944|587488855|FG001|Overall Study|Non-compliance with study treatment|0|||
162666560|NCT03029208|587488858|FG000|Overall Study|Withdrawal by Subject|2|||
162666561|NCT03029208|587488859|FG001|Overall Study|Withdrawal by Subject|3|||
162666562|NCT03029208|587488858|FG000|Overall Study|Lost to Follow-up|0|||
162666563|NCT03029208|587488859|FG001|Overall Study|Lost to Follow-up|1|||
162666564|NCT02673697|587488864|FG000|Overall Study|Adverse Event|2|||
162666565|NCT02673697|587488865|FG001|Overall Study|Adverse Event|0|||
162666566|NCT02673697|587488864|FG000|Overall Study|Death|32|||
162666567|NCT02673697|587488865|FG001|Overall Study|Death|24|||
162666568|NCT02673697|587488864|FG000|Overall Study|Lost to Follow-up|5|||
162666569|NCT02673697|587488865|FG001|Overall Study|Lost to Follow-up|2|||
162666570|NCT02673697|587488864|FG000|Overall Study|Physician Decision|2|||
162666571|NCT02673697|587488865|FG001|Overall Study|Physician Decision|1|||
162666572|NCT02673697|587488864|FG000|Overall Study|Withdrawal by Subject|10|||
162666573|NCT02673697|587488865|FG001|Overall Study|Withdrawal by Subject|7|||
162666574|NCT02673697|587488864|FG000|Overall Study|Change subj medical status|1|||
162666575|NCT02673697|587488865|FG001|Overall Study|Change subj medical status|2|||
162666576|NCT02673697|587488864|FG000|Overall Study|Explant|10|||
162666577|NCT02673697|587488865|FG001|Overall Study|Explant|5|||
162666578|NCT02673697|587488864|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
162666579|NCT02673697|587488865|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
162666580|NCT00437489|587488866|FG000|Overall Study|Study terminated by sponsor|23|||
162666581|NCT00437489|587488867|FG001|Overall Study|Study terminated by sponsor|21|||
162666582|NCT00437489|587488866|FG000|Overall Study|Lost to Follow-up|0|||
162666583|NCT00437489|587488867|FG001|Overall Study|Lost to Follow-up|1|||
162666584|NCT03893448|587488870|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
162666585|NCT03893448|587488871|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
162666586|NCT03893448|587488870|FG000|Overall Study|Physician Decision|8|||
162666587|NCT03893448|587488871|FG001|Overall Study|Physician Decision|14|||
162666588|NCT03893448|587488870|FG000|Overall Study|Lost to Follow-up|34|||
162666589|NCT03893448|587488871|FG001|Overall Study|Lost to Follow-up|27|||
162666590|NCT03893448|587488870|FG000|Overall Study|Death|1|||
162666591|NCT03893448|587488871|FG001|Overall Study|Death|0|||
162666592|NCT03321981|587488873|FG000|Overall Study|Progressive Disease (PD)|15|||
162666593|NCT03321981|587488874|FG001|Overall Study|Progressive Disease (PD)|30|||
162666594|NCT03321981|587488875|FG002|Overall Study|Progressive Disease (PD)|47|||
162666595|NCT03321981|587488873|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
162666596|NCT03321981|587488874|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
162666597|NCT03321981|587488875|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
162666598|NCT03321981|587488873|FG000|Overall Study|Adverse Event|0|||
162666599|NCT03321981|587488874|FG001|Overall Study|Adverse Event|0|||
162666600|NCT03321981|587488875|FG002|Overall Study|Adverse Event|2|||
162666601|NCT03321981|587488873|FG000|Overall Study|symptomatic deterioration|0|||
162666602|NCT03321981|587488874|FG001|Overall Study|symptomatic deterioration|1|||
162666603|NCT03321981|587488875|FG002|Overall Study|symptomatic deterioration|1|||
162666604|NCT03321981|587488873|FG000|Overall Study|Lack of compliance|0|||
162666605|NCT03321981|587488874|FG001|Overall Study|Lack of compliance|1|||
162666606|NCT03321981|587488875|FG002|Overall Study|Lack of compliance|0|||
162666607|NCT03321981|587488873|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
162666608|NCT03321981|587488874|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
162666609|NCT03321981|587488875|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
162666610|NCT03321981|587488873|FG000|Overall Study|Death|0|||
162666611|NCT03321981|587488874|FG001|Overall Study|Death|1|||
162721668|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162721669|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162666612|NCT03321981|587488875|FG002|Overall Study|Death|0|||
162666613|NCT03321981|587488873|FG000|Overall Study|Subject withdrawal of investigational product|0|||
162666614|NCT03321981|587488874|FG001|Overall Study|Subject withdrawal of investigational product|1|||
162721670|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162721671|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162721672|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
162666615|NCT03321981|587488875|FG002|Overall Study|Subject withdrawal of investigational product|0|||
162666616|NCT03321981|587488873|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
162666617|NCT03321981|587488874|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
162666618|NCT03321981|587488875|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
162666619|NCT03321981|587488873|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
162666620|NCT03321981|587488874|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
162666621|NCT03321981|587488875|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
162666622|NCT03321019|587488877|FG000|Overall Study|Withdrawal by Subject|0|||
162666623|NCT03321019|587488878|FG001|Overall Study|Withdrawal by Subject|6|||
162666624|NCT03321019|587488877|FG000|Overall Study|Lost to Follow-up|0|||
162666625|NCT03321019|587488878|FG001|Overall Study|Lost to Follow-up|22|||
162666626|NCT03880578|587488879|FG000|Overall Study|Withdrawal by Subject|0|||
162666627|NCT03880578|587488880|FG001|Overall Study|Withdrawal by Subject|3|||
162666628|NCT03880578|587488881|FG002|Overall Study|Withdrawal by Subject|1|||
162666629|NCT03880578|587488879|FG000|Overall Study|Death|0|||
162666630|NCT03880578|587488880|FG001|Overall Study|Death|1|||
162666631|NCT03880578|587488881|FG002|Overall Study|Death|0|||
162666632|NCT04934670|587488882|FG000|Overall Study|Death|4|||
162666633|NCT04934670|587488883|FG001|Overall Study|Death|0|||
162666634|NCT04934670|587488882|FG000|Overall Study|Lost to Follow-up|1|||
162666635|NCT04934670|587488883|FG001|Overall Study|Lost to Follow-up|4|||
162666636|NCT03056690|587488885|FG000|Overall Study|Adverse Event|3|||
162666637|NCT03056690|587488886|FG001|Overall Study|Adverse Event|2|||
162666638|NCT03056690|587488885|FG000|Overall Study|Lack of Efficacy|1|||
162666639|NCT03056690|587488886|FG001|Overall Study|Lack of Efficacy|2|||
162666640|NCT03056690|587488885|FG000|Overall Study|Lost to Follow-up|3|||
162666641|NCT03056690|587488886|FG001|Overall Study|Lost to Follow-up|2|||
162666642|NCT03056690|587488885|FG000|Overall Study|Protocol Violation|2|||
162666643|NCT03056690|587488886|FG001|Overall Study|Protocol Violation|2|||
162666644|NCT03056690|587488885|FG000|Overall Study|Withdrawal by Subject|3|||
162666645|NCT03056690|587488886|FG001|Overall Study|Withdrawal by Subject|6|||
162666646|NCT03056690|587488885|FG000|Overall Study|Non-compliance with Study Drug|1|||
162666647|NCT03056690|587488886|FG001|Overall Study|Non-compliance with Study Drug|0|||
162666648|NCT03056690|587488885|FG000|Overall Study|Miscellaneous|1|||
162666649|NCT03056690|587488886|FG001|Overall Study|Miscellaneous|2|||
162666650|NCT01944046|587488890|FG000|Randomized to DB|Adverse Event|5|||
162666651|NCT01944046|587488891|FG001|Randomized to DB|Adverse Event|2|||
162666652|NCT01944046|587488890|FG000|Randomized to DB|Clinical Worsening|3|||
162666653|NCT01944046|587488891|FG001|Randomized to DB|Clinical Worsening|2|||
162666654|NCT01944046|587488890|FG000|Randomized to DB|Lost to Follow-up|3|||
162666655|NCT01944046|587488891|FG001|Randomized to DB|Lost to Follow-up|3|||
162666656|NCT01944046|587488890|FG000|Randomized to DB|Withdrawal by Subject|2|||
162666657|NCT01944046|587488891|FG001|Randomized to DB|Withdrawal by Subject|4|||
162666658|NCT01944046|587488890|FG000|Randomized to DB|Physician Decision|1|||
162666659|NCT01944046|587488891|FG001|Randomized to DB|Physician Decision|2|||
162666660|NCT01944046|587488890|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
162666661|NCT01944046|587488891|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
162666662|NCT01944046|587488890|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
162666663|NCT01944046|587488891|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
162666664|NCT01944046|587488890|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
162666665|NCT01944046|587488891|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
162666666|NCT01944046|587488890|FG000|Open Label Eligible and Consented|Adverse Event|6|||
162666667|NCT01944046|587488891|FG001|Open Label Eligible and Consented|Adverse Event|1|||
162666668|NCT01944046|587488890|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
162666669|NCT01944046|587488891|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
162666670|NCT01944046|587488890|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
162666671|NCT01944046|587488891|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
162666672|NCT04496258|587488897|FG000|Overall Study|Withdrawal by Subject|2|||
162666673|NCT04496258|587488898|FG001|Overall Study|Withdrawal by Subject|1|||
162666674|NCT02041429|587488899|FG000|Overall Study|Progressive Disease|2|||
162666675|NCT02041429|587488900|FG001|Overall Study|Progressive Disease|2|||
162666676|NCT02041429|587488901|FG002|Overall Study|Progressive Disease|3|||
162666677|NCT02041429|587488902|FG003|Overall Study|Progressive Disease|2|||
162666678|NCT02041429|587488899|FG000|Overall Study|Toxicity|0|||
162666679|NCT02041429|587488900|FG001|Overall Study|Toxicity|1|||
162666680|NCT02041429|587488901|FG002|Overall Study|Toxicity|4|||
162666681|NCT02041429|587488902|FG003|Overall Study|Toxicity|2|||
162666682|NCT02041429|587488899|FG000|Overall Study|Withdrawal by Subject|0|||
162666683|NCT02041429|587488900|FG001|Overall Study|Withdrawal by Subject|1|||
162666684|NCT02041429|587488901|FG002|Overall Study|Withdrawal by Subject|0|||
162666685|NCT02041429|587488902|FG003|Overall Study|Withdrawal by Subject|0|||
162666686|NCT02041429|587488899|FG000|Overall Study|On Maintenance Therapy|1|||
162666687|NCT02041429|587488900|FG001|Overall Study|On Maintenance Therapy|0|||
162666688|NCT02041429|587488901|FG002|Overall Study|On Maintenance Therapy|0|||
162666689|NCT02041429|587488902|FG003|Overall Study|On Maintenance Therapy|2|||
162666690|NCT01427712|587488903|FG000|Overall Study|Transfer to a different hospital|2|||
162666691|NCT01427712|587488903|FG000|Overall Study|Lost to Follow-up|1|||
162666692|NCT01427712|587488903|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
162666693|NCT01427712|587488903|FG000|Overall Study|Failure to visit|1|||
162666694|NCT00153101|587488904|FG000|Overall Study|Lost to Follow-up|14|||
162666695|NCT00153101|587488905|FG001|Overall Study|Lost to Follow-up|14|||
162666696|NCT00153101|587488906|FG002|Overall Study|Lost to Follow-up|12|||
162666697|NCT00153101|587488907|FG003|Overall Study|Lost to Follow-up|5|||
162666698|NCT00153101|587488908|FG004|Overall Study|Lost to Follow-up|5|||
162666699|NCT00153101|587488904|FG000|Overall Study|Withdrawal by Subject|3|||
162666700|NCT00153101|587488905|FG001|Overall Study|Withdrawal by Subject|4|||
162666701|NCT00153101|587488906|FG002|Overall Study|Withdrawal by Subject|3|||
162666702|NCT00153101|587488907|FG003|Overall Study|Withdrawal by Subject|3|||
162666703|NCT00153101|587488908|FG004|Overall Study|Withdrawal by Subject|5|||
162666704|NCT03169153|587488909|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
162666705|NCT03169153|587488910|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
162666706|NCT03169153|587488909|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
162666707|NCT03169153|587488910|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
162666708|NCT03169153|587488909|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
162666709|NCT03169153|587488910|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
162666710|NCT03169153|587488909|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
162666711|NCT03169153|587488910|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
162666712|NCT00439777|587488911|FG000|Treatment Period|Death|29|||
162666713|NCT00439777|587488912|FG001|Treatment Period|Death|21|||
162666714|NCT00439777|587488911|FG000|Treatment Period|Study terminated by sponsor|125|||
162666715|NCT00439777|587488912|FG001|Treatment Period|Study terminated by sponsor|132|||
162666716|NCT00439777|587488911|FG000|Treatment Period|Site closed by investigator|0|||
162666717|NCT00439777|587488912|FG001|Treatment Period|Site closed by investigator|1|||
162666718|NCT00439777|587488911|FG000|Treatment Period|Did not take study treatment|7|||
162666719|NCT00439777|587488912|FG001|Treatment Period|Did not take study treatment|8|||
162666720|NCT00439777|587488911|FG000|Treatment Period|Adverse Event|111|||
162666721|NCT00439777|587488912|FG001|Treatment Period|Adverse Event|92|||
162666722|NCT00439777|587488911|FG000|Treatment Period|Protocol Violation|23|||
162666723|NCT00439777|587488912|FG001|Treatment Period|Protocol Violation|30|||
162666724|NCT00439777|587488911|FG000|Treatment Period|Withdrawal by Subject|66|||
162666725|NCT00439777|587488912|FG001|Treatment Period|Withdrawal by Subject|118|||
162666726|NCT00439777|587488911|FG000|Treatment Period|Lack of Efficacy|1|||
162666727|NCT00439777|587488912|FG001|Treatment Period|Lack of Efficacy|4|||
162666728|NCT00439777|587488911|FG000|Treatment Period|Lost to Follow-up|8|||
162666729|NCT00439777|587488912|FG001|Treatment Period|Lost to Follow-up|10|||
162666730|NCT00439777|587488911|FG000|Treatment Period|Protocol driven decision point|1|||
162666731|NCT00439777|587488912|FG001|Treatment Period|Protocol driven decision point|3|||
162666732|NCT00439777|587488911|FG000|Treatment Period|Physician Decision|7|||
162666733|NCT00439777|587488912|FG001|Treatment Period|Physician Decision|18|||
162666734|NCT00439777|587488911|FG000|Treatment Period|Clinical endpoint reached|26|||
162666735|NCT00439777|587488912|FG001|Treatment Period|Clinical endpoint reached|13|||
162666736|NCT00439777|587488911|FG000|Treatment Period|Technical problems|3|||
162666737|NCT00439777|587488912|FG001|Treatment Period|Technical problems|1|||
162666738|NCT00439777|587488911|FG000|Treatment Period|Participant convenience|12|||
162666739|NCT00439777|587488912|FG001|Treatment Period|Participant convenience|8|||
162666740|NCT00439777|587488911|FG000|Observational Period|Protocol Violation|0|||
162666741|NCT00439777|587488912|FG001|Observational Period|Protocol Violation|2|||
162666742|NCT00439777|587488911|FG000|Observational Period|Withdrawal by Subject|9|||
162666743|NCT00439777|587488912|FG001|Observational Period|Withdrawal by Subject|5|||
162666744|NCT00439777|587488911|FG000|Observational Period|Lost to Follow-up|1|||
162666745|NCT00439777|587488912|FG001|Observational Period|Lost to Follow-up|11|||
162666746|NCT00439777|587488911|FG000|Observational Period|Death|27|||
162666747|NCT00439777|587488912|FG001|Observational Period|Death|20|||
162666748|NCT00439777|587488911|FG000|Observational Period|Study terminated by sponsor|3|||
162666749|NCT00439777|587488912|FG001|Observational Period|Study terminated by sponsor|1|||
162666750|NCT00439777|587488911|FG000|Observational Period|Protocol driven decision point|0|||
162666751|NCT00439777|587488912|FG001|Observational Period|Protocol driven decision point|1|||
162666752|NCT00439777|587488911|FG000|Observational Period|Lack of Efficacy|1|||
162666753|NCT00439777|587488912|FG001|Observational Period|Lack of Efficacy|0|||
162666754|NCT00439777|587488911|FG000|Observational Period|Technical problems|0|||
162666755|NCT00439777|587488912|FG001|Observational Period|Technical problems|1|||
162666756|NCT00661492|587488913|FG000|Overall Study|Adverse Event|16|||
162666757|NCT00661492|587488914|FG001|Overall Study|Adverse Event|13|||
162666758|NCT00661492|587488913|FG000|Overall Study|Disease Progression|44|||
162666759|NCT00661492|587488914|FG001|Overall Study|Disease Progression|14|||
162666760|NCT00661492|587488913|FG000|Overall Study|Patient Request|6|||
162666761|NCT00661492|587488914|FG001|Overall Study|Patient Request|1|||
162666762|NCT00661492|587488913|FG000|Overall Study|Investigator Request|1|||
162666763|NCT00661492|587488914|FG001|Overall Study|Investigator Request|0|||
162666764|NCT00661492|587488913|FG000|Overall Study|Lost to Follow-up|0|||
162666765|NCT00661492|587488914|FG001|Overall Study|Lost to Follow-up|1|||
162666766|NCT00661492|587488913|FG000|Overall Study|Other|1|||
162666767|NCT00661492|587488914|FG001|Overall Study|Other|0|||
162666768|NCT00784043|587488915|FG000|Overall Study|Withdrawal by Subject|8|||
162666769|NCT00784043|587488916|FG001|Overall Study|Withdrawal by Subject|5|||
162666770|NCT00784043|587488915|FG000|Overall Study|Protocol Terminated|23|||
162666771|NCT00784043|587488916|FG001|Overall Study|Protocol Terminated|1|||
162666772|NCT00803634|587488917|FG000|Overall Study|Withdrew Consent|1|||
162666773|NCT00803634|587488918|FG001|Overall Study|Withdrew Consent|0|||
162666774|NCT00803634|587488917|FG000|Overall Study|Lost to Follow-up|2|||
162666775|NCT00803634|587488918|FG001|Overall Study|Lost to Follow-up|3|||
162666776|NCT00803634|587488917|FG000|Overall Study|Death|3|||
162666777|NCT00803634|587488918|FG001|Overall Study|Death|2|||
162666778|NCT03791398|587488925|FG000|Overall Study|Progression of Disease Under Study|2|||
162666779|NCT03791398|587488926|FG001|Overall Study|Progression of Disease Under Study|0|||
162666780|NCT03791398|587488927|FG002|Overall Study|Progression of Disease Under Study|0|||
162666781|NCT00766376|587488928|FG000|Overall Study|Withdrawal by Subject|27|||
162666782|NCT01072201|587488933|FG000|Overall Study|Lost to Follow-up|0|||
162666783|NCT01072201|587488934|FG001|Overall Study|Lost to Follow-up|1|||
162666784|NCT04382612|587488935|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
162666785|NCT01328002|587488937|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
162666786|NCT01328002|587488938|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
162666787|NCT01328002|587488937|FG000|Open-Label Period|Adverse Event|8|||
162666788|NCT01328002|587488938|FG001|Open-Label Period|Adverse Event|0|||
162666789|NCT01328002|587488937|FG000|Open-Label Period|Lack of Efficacy|3|||
162666790|NCT01328002|587488938|FG001|Open-Label Period|Lack of Efficacy|0|||
162666791|NCT01328002|587488937|FG000|Open-Label Period|Protocol Violation|2|||
162666792|NCT01328002|587488938|FG001|Open-Label Period|Protocol Violation|0|||
162666793|NCT01328002|587488937|FG000|Open-Label Period|Withdrawal by Subject|9|||
162666794|NCT01328002|587488938|FG001|Open-Label Period|Withdrawal by Subject|0|||
162666795|NCT01328002|587488937|FG000|Open-Label Period|Lost to Follow-up|6|||
162666796|NCT01328002|587488938|FG001|Open-Label Period|Lost to Follow-up|0|||
162666797|NCT01328002|587488937|FG000|Open-Label Period|Other Reason|2|||
162666798|NCT01328002|587488938|FG001|Open-Label Period|Other Reason|0|||
162666799|NCT01328002|587488937|FG000|Double-Blind Period|Adverse Event|1|||
162666800|NCT01328002|587488938|FG001|Double-Blind Period|Adverse Event|0|||
162666801|NCT01328002|587488937|FG000|Double-Blind Period|Lack of Efficacy|1|||
162666802|NCT01328002|587488938|FG001|Double-Blind Period|Lack of Efficacy|0|||
162666803|NCT01578551|587488939|FG000|Overall Study|Adverse Event|1|||
162666804|NCT01578551|587488940|FG001|Overall Study|Adverse Event|0|||
162666805|NCT02752048|587488942|FG000|Overall Study|Withdrawal by Subject|0|||
162666806|NCT02752048|587488943|FG001|Overall Study|Withdrawal by Subject|0|||
162666807|NCT02752048|587488944|FG002|Overall Study|Withdrawal by Subject|3|||
162666808|NCT00061048|587488945|FG000|Overall Study|Adverse Event|2|||
162666809|NCT00061048|587488945|FG000|Overall Study|disease progression|20|||
162666810|NCT00818441|587488949|FG000|Overall Study|Death|69|||
162666811|NCT00818441|587488950|FG001|Overall Study|Death|26|||
162666812|NCT00818441|587488949|FG000|Overall Study|Other|5|||
162666813|NCT00818441|587488950|FG001|Overall Study|Other|0|||
162666814|NCT00818441|587488949|FG000|Overall Study|Lost to Follow-up|2|||
162666815|NCT00818441|587488950|FG001|Overall Study|Lost to Follow-up|1|||
162666816|NCT00818441|587488949|FG000|Overall Study|Withdrawal by Subject|2|||
162666817|NCT00818441|587488950|FG001|Overall Study|Withdrawal by Subject|0|||
162666818|NCT00818441|587488949|FG000|Overall Study|Adverse Event|0|||
162666819|NCT00818441|587488950|FG001|Overall Study|Adverse Event|1|||
162666820|NCT00818441|587488949|FG000|Overall Study|Study terminated by sponsor|11|||
162666821|NCT00818441|587488950|FG001|Overall Study|Study terminated by sponsor|2|||
162666822|NCT00898677|587488953|FG000|Overall Study|Adverse Event|0|||
162666823|NCT00898677|587488954|FG001|Overall Study|Adverse Event|0|||
162666824|NCT00898677|587488955|FG002|Overall Study|Adverse Event|1|||
162666825|NCT00898677|587488956|FG003|Overall Study|Adverse Event|0|||
162666826|NCT00898677|587488953|FG000|Overall Study|Lost to Follow-up|0|||
162666827|NCT00898677|587488954|FG001|Overall Study|Lost to Follow-up|0|||
162666828|NCT00898677|587488955|FG002|Overall Study|Lost to Follow-up|2|||
162666829|NCT00898677|587488956|FG003|Overall Study|Lost to Follow-up|0|||
162666830|NCT00898677|587488953|FG000|Overall Study|Protocol Violation|1|||
162666831|NCT00898677|587488954|FG001|Overall Study|Protocol Violation|1|||
162666832|NCT00898677|587488955|FG002|Overall Study|Protocol Violation|2|||
162666833|NCT00898677|587488956|FG003|Overall Study|Protocol Violation|0|||
162666834|NCT00898677|587488953|FG000|Overall Study|Withdrawal by Subject|0|||
162666835|NCT00898677|587488954|FG001|Overall Study|Withdrawal by Subject|0|||
162666836|NCT00898677|587488955|FG002|Overall Study|Withdrawal by Subject|0|||
162666837|NCT00898677|587488956|FG003|Overall Study|Withdrawal by Subject|1|||
162666838|NCT00898677|587488953|FG000|Overall Study|Not Treated: Adverse Event|0|||
162666839|NCT00898677|587488954|FG001|Overall Study|Not Treated: Adverse Event|2|||
162666840|NCT00898677|587488955|FG002|Overall Study|Not Treated: Adverse Event|1|||
162666841|NCT00898677|587488956|FG003|Overall Study|Not Treated: Adverse Event|0|||
162666842|NCT00898677|587488953|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
162666843|NCT00898677|587488954|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
162666844|NCT00898677|587488955|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
162666845|NCT00898677|587488956|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
162666846|NCT00898677|587488953|FG000|Overall Study|Not Treated: Pregnancy|0|||
162666847|NCT00898677|587488954|FG001|Overall Study|Not Treated: Pregnancy|0|||
162666848|NCT00898677|587488955|FG002|Overall Study|Not Treated: Pregnancy|1|||
162666849|NCT00898677|587488956|FG003|Overall Study|Not Treated: Pregnancy|0|||
162666850|NCT00898677|587488953|FG000|Overall Study|Not Treated: Protocol Violation|2|||
162666851|NCT00898677|587488954|FG001|Overall Study|Not Treated: Protocol Violation|0|||
162666852|NCT00898677|587488955|FG002|Overall Study|Not Treated: Protocol Violation|2|||
162666853|NCT00898677|587488956|FG003|Overall Study|Not Treated: Protocol Violation|0|||
162666854|NCT00898677|587488953|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
162666855|NCT00898677|587488954|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
162666856|NCT00898677|587488955|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
162666857|NCT00898677|587488956|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
162666858|NCT00898677|587488953|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
162666859|NCT00898677|587488954|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
162666860|NCT00898677|587488955|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
162666861|NCT00898677|587488956|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
162666862|NCT00898677|587488953|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162666863|NCT00898677|587488954|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162666864|NCT00898677|587488955|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162666865|NCT00898677|587488956|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
162666866|NCT00898677|587488953|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
162666867|NCT00898677|587488954|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162666868|NCT00898677|587488955|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162666869|NCT00898677|587488956|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162666870|NCT00898677|587488953|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
162666871|NCT00898677|587488954|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
162666872|NCT00898677|587488955|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
162666873|NCT00898677|587488956|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
162666874|NCT00898677|587488953|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
162666875|NCT00898677|587488954|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
162666876|NCT00898677|587488955|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
162666877|NCT00898677|587488956|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
162666878|NCT00898677|587488953|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
162666879|NCT00898677|587488954|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
162666880|NCT00898677|587488955|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
162666881|NCT00898677|587488956|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
162666882|NCT00852397|587488957|FG000|Overall Study|Adverse Event|4|||
162666883|NCT00852397|587488958|FG001|Overall Study|Adverse Event|6|||
162666884|NCT00852397|587488959|FG002|Overall Study|Adverse Event|4|||
162666885|NCT00852397|587488957|FG000|Overall Study|Death|0|||
162666886|NCT00852397|587488958|FG001|Overall Study|Death|0|||
162666887|NCT00852397|587488959|FG002|Overall Study|Death|1|||
162666888|NCT00852397|587488957|FG000|Overall Study|Withdrawal by Subject|4|||
162666889|NCT00852397|587488958|FG001|Overall Study|Withdrawal by Subject|1|||
162666890|NCT00852397|587488959|FG002|Overall Study|Withdrawal by Subject|2|||
162666891|NCT00852397|587488957|FG000|Overall Study|Study terminated by sponsor|2|||
162666892|NCT00852397|587488958|FG001|Overall Study|Study terminated by sponsor|1|||
162666893|NCT00852397|587488959|FG002|Overall Study|Study terminated by sponsor|6|||
162666894|NCT00852397|587488957|FG000|Overall Study|Difficulty in study site visit|1|||
162666895|NCT00852397|587488958|FG001|Overall Study|Difficulty in study site visit|0|||
162666896|NCT00852397|587488959|FG002|Overall Study|Difficulty in study site visit|0|||
162666897|NCT00852397|587488957|FG000|Overall Study|Protocol Violation|0|||
162666898|NCT00852397|587488958|FG001|Overall Study|Protocol Violation|0|||
162721673|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
162666899|NCT00852397|587488959|FG002|Overall Study|Protocol Violation|1|||
162666900|NCT00774995|587488964|FG000|Overall Study|Protocol Violation|0|||
162666901|NCT00774995|587488965|FG001|Overall Study|Protocol Violation|0|||
162666902|NCT00774995|587488966|FG002|Overall Study|Protocol Violation|1|||
162666903|NCT00774995|587488967|FG003|Overall Study|Protocol Violation|0|||
162666904|NCT02055352|587490612|FG000|Overall Study|Adverse Event|0|||
162666905|NCT02055352|587490613|FG001|Overall Study|Adverse Event|1|||
162666906|NCT02055352|587490612|FG000|Overall Study|Non-eligible|0|||
162666907|NCT02055352|587490613|FG001|Overall Study|Non-eligible|1|||
162666908|NCT02055352|587490612|FG000|Overall Study|Poor compliance|1|||
162666909|NCT02055352|587490613|FG001|Overall Study|Poor compliance|1|||
162666910|NCT02055352|587490612|FG000|Overall Study|Death|1|||
162666911|NCT02055352|587490613|FG001|Overall Study|Death|2|||
162666912|NCT02055352|587490612|FG000|Overall Study|Patient decision|1|||
162666913|NCT02055352|587490613|FG001|Overall Study|Patient decision|1|||
162666914|NCT02055352|587490612|FG000|Overall Study|Use of prohibited treatment|0|||
162666915|NCT02055352|587490613|FG001|Overall Study|Use of prohibited treatment|3|||
162666916|NCT02055352|587490612|FG000|Overall Study|AE, study drug would be detrimental|1|||
162666917|NCT02055352|587490613|FG001|Overall Study|AE, study drug would be detrimental|3|||
162666918|NCT02055352|587490612|FG000|Overall Study|Withdrawal of informed consent|1|||
162666919|NCT02055352|587490613|FG001|Overall Study|Withdrawal of informed consent|0|||
162666920|NCT02055352|587490612|FG000|Overall Study|Reason unknown|1|||
162666921|NCT02055352|587490613|FG001|Overall Study|Reason unknown|5|||
162666922|NCT04745169|587490614|FG000|Overall Study|Kidney transplantation|1|||
162666923|NCT04745169|587490614|FG000|Overall Study|Participant health problems|3|||
162666924|NCT04745169|587490614|FG000|Overall Study|Physician Decision|2|||
162666925|NCT00993447|587490615|FG000|Overall Study|Withdrawal by Subject|23|||
162666926|NCT00993447|587490616|FG001|Overall Study|Withdrawal by Subject|8|||
162666927|NCT00993447|587490615|FG000|Overall Study|Protocol Violation|12|||
162666928|NCT00993447|587490616|FG001|Overall Study|Protocol Violation|8|||
162666929|NCT00993447|587490615|FG000|Overall Study|Lost to Follow-up|1|||
162666930|NCT00993447|587490616|FG001|Overall Study|Lost to Follow-up|3|||
162666931|NCT00993447|587490615|FG000|Overall Study|Adverse Event|1|||
162666932|NCT00993447|587490616|FG001|Overall Study|Adverse Event|0|||
162666933|NCT02707055|587490617|FG000|Phase 1|Withdrawal by Subject|1|||
162666934|NCT02707055|587490618|FG001|Phase 1|Withdrawal by Subject|2|||
162666935|NCT02707055|587490617|FG000|Phase 1|Physician Decision|0|||
162666936|NCT02707055|587490618|FG001|Phase 1|Physician Decision|1|||
162666937|NCT02707055|587490617|FG000|Phase 2|Adverse Event|1|||
162666938|NCT02707055|587490618|FG001|Phase 2|Adverse Event|2|||
162666939|NCT01880424|587490619|FG000|Overall Study|Adverse Event|7|||
162666940|NCT01880424|587490620|FG001|Overall Study|Adverse Event|6|||
162666941|NCT01880424|587490619|FG000|Overall Study|Lack of Efficacy|1|||
162666942|NCT01880424|587490620|FG001|Overall Study|Lack of Efficacy|4|||
162666943|NCT01880424|587490619|FG000|Overall Study|Lost to Follow-up|3|||
162666944|NCT01880424|587490620|FG001|Overall Study|Lost to Follow-up|2|||
162666945|NCT01880424|587490619|FG000|Overall Study|Protocol Violation|11|||
162666946|NCT01880424|587490620|FG001|Overall Study|Protocol Violation|13|||
162666947|NCT01880424|587490619|FG000|Overall Study|Withdrawal by Subject|10|||
162666948|NCT01880424|587490620|FG001|Overall Study|Withdrawal by Subject|30|||
162666949|NCT01880424|587490619|FG000|Overall Study|Other|1|||
162666950|NCT01880424|587490620|FG001|Overall Study|Other|0|||
162666951|NCT02280044|587490623|FG000|Overall Study|Planned alternate|0|||
162666952|NCT02280044|587490624|FG001|Overall Study|Planned alternate|2|||
162666953|NCT05706506|587490625|FG000|Overall Study|Adverse Event|1|||
162666954|NCT05706506|587490625|FG000|Overall Study|Withdrawal by Subject|4|||
162666955|NCT05706506|587490625|FG000|Overall Study|Lost to Follow-up|2|||
162666956|NCT05706506|587490625|FG000|Overall Study|Inadvertent Enrolment|12|||
162666957|NCT05706506|587490625|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
162666958|NCT05706506|587490625|FG000|Overall Study|Participant Moved Out of State|1|||
162666959|NCT02246998|587490626|FG000|Overall Study|Adverse Event|0|||
162666960|NCT02246998|587490627|FG001|Overall Study|Adverse Event|1|||
162666961|NCT02246998|587490628|FG002|Overall Study|Adverse Event|1|||
162666962|NCT02246998|587490629|FG003|Overall Study|Adverse Event|0|||
162666963|NCT02246998|587490626|FG000|Overall Study|Lost to Follow-up|1|||
162666964|NCT02246998|587490627|FG001|Overall Study|Lost to Follow-up|0|||
162666965|NCT02246998|587490628|FG002|Overall Study|Lost to Follow-up|0|||
162666966|NCT02246998|587490629|FG003|Overall Study|Lost to Follow-up|1|||
162666967|NCT02246998|587490626|FG000|Overall Study|Randomized but Never Dosed|1|||
162666968|NCT02246998|587490627|FG001|Overall Study|Randomized but Never Dosed|2|||
162666969|NCT02246998|587490628|FG002|Overall Study|Randomized but Never Dosed|2|||
162666970|NCT02246998|587490629|FG003|Overall Study|Randomized but Never Dosed|1|||
162666971|NCT01303627|587490631|FG000|Overall Study|the failure while performing URS|0|||
162666972|NCT01303627|587490632|FG001|Overall Study|the failure while performing URS|1|||
162666973|NCT01709227|587490637|FG000|Overall Study|Physician Decision|1|||
162666974|NCT01709227|587490638|FG001|Overall Study|Physician Decision|0|||
162666975|NCT01709227|587490637|FG000|Overall Study|Pleural Peritoneal communication|0|||
162666976|NCT01709227|587490638|FG001|Overall Study|Pleural Peritoneal communication|9|||
162666977|NCT04831736|587490641|FG000|Overall Study|Withdrawal by Subject|0|||
162666978|NCT04831736|587490642|FG001|Overall Study|Withdrawal by Subject|1|||
162666979|NCT00795600|587490643|FG000|Overall Study|Adverse Event|1|||
162666980|NCT00795600|587490644|FG001|Overall Study|Adverse Event|1|||
162666981|NCT00795600|587490643|FG000|Overall Study|Protocol Violation|1|||
162666982|NCT00795600|587490644|FG001|Overall Study|Protocol Violation|2|||
162666983|NCT00795600|587490643|FG000|Overall Study|Withdrawal by Subject|1|||
162666984|NCT00795600|587490644|FG001|Overall Study|Withdrawal by Subject|0|||
162666985|NCT00795600|587490643|FG000|Overall Study|Unclassified|1|||
162666986|NCT00795600|587490644|FG001|Overall Study|Unclassified|1|||
162666987|NCT01659021|587490645|FG000|Main Study|Adverse Event|2|||
162666988|NCT01659021|587490646|FG001|Main Study|Adverse Event|3|||
162666989|NCT01659021|587490645|FG000|Main Study|Lost to Follow-up|1|||
162666990|NCT01659021|587490646|FG001|Main Study|Lost to Follow-up|0|||
162666991|NCT01659021|587490645|FG000|Main Study|Unknown Reasons|2|||
162666992|NCT01659021|587490646|FG001|Main Study|Unknown Reasons|1|||
162666993|NCT01659021|587490645|FG000|Main Study|Physician Decision|34|||
162666994|NCT01659021|587490646|FG001|Main Study|Physician Decision|16|||
162666995|NCT01659021|587490645|FG000|Main Study|Withdrawal by Subject|19|||
162666996|NCT01659021|587490646|FG001|Main Study|Withdrawal by Subject|16|||
162666997|NCT01659021|587490645|FG000|Main Study|Study Terminated by Sponsor|16|||
162666998|NCT01659021|587490646|FG001|Main Study|Study Terminated by Sponsor|1|||
162666999|NCT01659021|587490645|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
162667000|NCT01659021|587490646|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
162667001|NCT01659021|587490645|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
162667002|NCT01659021|587490646|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
162667003|NCT01233817|587490647|FG000|Overall Study|Lost to Follow-up|1|||
162667004|NCT01233817|587490647|FG000|Overall Study|Withdrawal by Subject|2|||
162667005|NCT01248884|587490648|FG000|Overall Study|Withdrawal by Subject|1|||
162667006|NCT01248884|587490649|FG001|Overall Study|Withdrawal by Subject|3|||
162667007|NCT01248884|587490650|FG002|Overall Study|Withdrawal by Subject|1|||
162667008|NCT01248884|587490648|FG000|Overall Study|Adverse Event|1|||
162667009|NCT01248884|587490649|FG001|Overall Study|Adverse Event|0|||
162667010|NCT01248884|587490650|FG002|Overall Study|Adverse Event|0|||
162667011|NCT00840970|587490653|FG000|Overall Study|Adverse Event|0|||
162667012|NCT00840970|587490654|FG001|Overall Study|Adverse Event|0|||
162667013|NCT00840970|587490655|FG002|Overall Study|Adverse Event|1|||
162667014|NCT03465540|587490656|FG000|Overall Study|Withdrawal by Subject|0|||
162667015|NCT03465540|587490657|FG001|Overall Study|Withdrawal by Subject|0|||
162667016|NCT03465540|587490658|FG002|Overall Study|Withdrawal by Subject|1|||
162667017|NCT03465540|587490659|FG003|Overall Study|Withdrawal by Subject|1|||
162667018|NCT03465540|587490660|FG004|Overall Study|Withdrawal by Subject|1|||
162667019|NCT03465540|587490661|FG005|Overall Study|Withdrawal by Subject|0|||
162667020|NCT03465540|587490656|FG000|Overall Study|Lost to Follow-up|0|||
162667021|NCT03465540|587490657|FG001|Overall Study|Lost to Follow-up|1|||
162667022|NCT03465540|587490658|FG002|Overall Study|Lost to Follow-up|0|||
162667023|NCT03465540|587490659|FG003|Overall Study|Lost to Follow-up|0|||
162667024|NCT03465540|587490660|FG004|Overall Study|Lost to Follow-up|1|||
162667025|NCT03465540|587490661|FG005|Overall Study|Lost to Follow-up|0|||
162667026|NCT03465540|587490656|FG000|Overall Study|Death|1|||
162667027|NCT03465540|587490657|FG001|Overall Study|Death|1|||
162667028|NCT03465540|587490658|FG002|Overall Study|Death|0|||
162667029|NCT03465540|587490659|FG003|Overall Study|Death|2|||
162667030|NCT03465540|587490660|FG004|Overall Study|Death|0|||
162667031|NCT03465540|587490661|FG005|Overall Study|Death|2|||
162667032|NCT03465540|587490656|FG000|Overall Study|Protocol specified criteria|0|||
162667033|NCT03465540|587490657|FG001|Overall Study|Protocol specified criteria|2|||
162667034|NCT03465540|587490658|FG002|Overall Study|Protocol specified criteria|2|||
162667035|NCT03465540|587490659|FG003|Overall Study|Protocol specified criteria|0|||
162667036|NCT03465540|587490660|FG004|Overall Study|Protocol specified criteria|2|||
163149139|NCT02903771|589259402|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149140|NCT02903771|589259403|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149141|NCT02903771|589259404|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149142|NCT02903771|589259405|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
163149143|NCT02903771|589259406|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
163149144|NCT02903771|589259407|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162667037|NCT03465540|587490661|FG005|Overall Study|Protocol specified criteria|0|||
162667038|NCT00504829|587490662|FG000|Overall Study|Protocol Violation|6|||
162667039|NCT00504829|587490663|FG001|Overall Study|Protocol Violation|4|||
162721674|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
162667040|NCT00504829|587490664|FG002|Overall Study|Protocol Violation|10|||
162667041|NCT01854827|587490665|FG000|Overall Study|Death|1|||
162667042|NCT00736996|587490666|FG000|Overall Study|Lost to Follow-up|1|||
162667043|NCT00736996|587490667|FG001|Overall Study|Lost to Follow-up|9|||
162667044|NCT00736996|587490668|FG002|Overall Study|Lost to Follow-up|2|||
162667045|NCT00462384|587490669|FG000|Overall Study|Adverse Event|2|||
162667046|NCT00462384|587490669|FG000|Overall Study|Death|2|||
162667047|NCT00462384|587490669|FG000|Overall Study|Withdrawal by Subject|1|||
162721675|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721676|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162667048|NCT00462384|587490669|FG000|Overall Study|Other|4|||
162667049|NCT04000165|587490670|FG000|Overall Study|Physician Decision|1|||
162667050|NCT04000165|587490670|FG000|Overall Study|Withdrawal by Subject|1|||
162667051|NCT01751568|587490675|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
162667052|NCT01751568|587490676|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
162667053|NCT01751568|587490677|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
162667054|NCT02660944|587490686|FG000|Overall Study|Adverse Event|3|||
162667055|NCT02660944|587490687|FG001|Overall Study|Adverse Event|4|||
162667056|NCT02660944|587490686|FG000|Overall Study|Physician Decision|3|||
162667057|NCT02660944|587490687|FG001|Overall Study|Physician Decision|1|||
162667058|NCT02660944|587490686|FG000|Overall Study|Withdrawal by Subject|5|||
162667059|NCT02660944|587490687|FG001|Overall Study|Withdrawal by Subject|3|||
162667060|NCT02660944|587490686|FG000|Overall Study|Lost to Follow-up|4|||
162667061|NCT02660944|587490687|FG001|Overall Study|Lost to Follow-up|1|||
162667062|NCT02660944|587490686|FG000|Overall Study|Subject schedule|0|||
162667063|NCT02660944|587490687|FG001|Overall Study|Subject schedule|1|||
162667064|NCT02660944|587490686|FG000|Overall Study|Exclusion criteria met|2|||
162667065|NCT02660944|587490687|FG001|Overall Study|Exclusion criteria met|0|||
163149145|NCT04247347|589259408|FG000|Overall Study|Withdrawal by Subject|2|||
163149146|NCT04247347|589259409|FG001|Overall Study|Withdrawal by Subject|3|||
162667066|NCT02843568|587490688|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
162667067|NCT02843568|587490689|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
162667068|NCT02843568|587490688|FG000|Overall Study|Death|3|||
162667069|NCT02843568|587490689|FG001|Overall Study|Death|3|||
162667070|NCT02843568|587490688|FG000|Overall Study|Withdrawal by Subject|1|||
162667071|NCT02843568|587490689|FG001|Overall Study|Withdrawal by Subject|1|||
162667072|NCT02843568|587490688|FG000|Overall Study|Lost to Follow-up|2|||
162667073|NCT02843568|587490689|FG001|Overall Study|Lost to Follow-up|0|||
162667074|NCT03586999|587490690|FG000|Overall Study|Lack of Efficacy|2|||
162667075|NCT04096560|587490691|FG000|Overall Study|Reason not Specified|1|||
162667076|NCT04096560|587490692|FG001|Overall Study|Reason not Specified|0|||
162667077|NCT04096560|587490693|FG002|Overall Study|Reason not Specified|0|||
162667078|NCT04096560|587490694|FG003|Overall Study|Reason not Specified|0|||
162667079|NCT04096560|587490695|FG004|Overall Study|Reason not Specified|1|||
162667080|NCT04096560|587490696|FG005|Overall Study|Reason not Specified|1|||
162667081|NCT04096560|587490697|FG006|Overall Study|Reason not Specified|1|||
162667082|NCT04096560|587490698|FG007|Overall Study|Reason not Specified|0|||
162667083|NCT04096560|587490691|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667084|NCT04096560|587490692|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667085|NCT04096560|587490693|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667086|NCT04096560|587490694|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667087|NCT04096560|587490695|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667088|NCT04096560|587490696|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
162667089|NCT04096560|587490697|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
162667090|NCT04096560|587490698|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162667091|NCT04096560|587490691|FG000|Overall Study|Study Terminated by Sponsor|0|||
162667092|NCT04096560|587490692|FG001|Overall Study|Study Terminated by Sponsor|0|||
162667093|NCT04096560|587490693|FG002|Overall Study|Study Terminated by Sponsor|0|||
162667094|NCT04096560|587490694|FG003|Overall Study|Study Terminated by Sponsor|5|||
162667095|NCT04096560|587490695|FG004|Overall Study|Study Terminated by Sponsor|6|||
162667096|NCT04096560|587490696|FG005|Overall Study|Study Terminated by Sponsor|4|||
162667097|NCT04096560|587490697|FG006|Overall Study|Study Terminated by Sponsor|6|||
162667098|NCT04096560|587490698|FG007|Overall Study|Study Terminated by Sponsor|1|||
162667099|NCT04096560|587490691|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667100|NCT04096560|587490692|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667101|NCT04096560|587490693|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
163149147|NCT04247347|589259410|FG002|Overall Study|Withdrawal by Subject|3|||
163149148|NCT04247347|589259408|FG000|Overall Study|Lost to Follow-up|1|||
163149149|NCT04247347|589259409|FG001|Overall Study|Lost to Follow-up|1|||
163149150|NCT04247347|589259410|FG002|Overall Study|Lost to Follow-up|1|||
163149151|NCT03562195|589259411|FG000|Overall Study|Adverse Event|0|||
163149152|NCT03562195|589259412|FG001|Overall Study|Adverse Event|6|||
163149153|NCT03562195|589259411|FG000|Overall Study|Lack of Efficacy|0|||
163149154|NCT03562195|589259412|FG001|Overall Study|Lack of Efficacy|5|||
163149155|NCT03562195|589259411|FG000|Overall Study|Protocol Violation|0|||
163149156|NCT03562195|589259412|FG001|Overall Study|Protocol Violation|1|||
163149157|NCT03562195|589259411|FG000|Overall Study|Lost to Follow-up|0|||
163149158|NCT03562195|589259412|FG001|Overall Study|Lost to Follow-up|1|||
163149159|NCT03562195|589259411|FG000|Overall Study|Physician Decision|1|||
163149160|NCT03562195|589259412|FG001|Overall Study|Physician Decision|0|||
163149161|NCT03562195|589259411|FG000|Overall Study|Withdrawal by Subject|3|||
163149162|NCT03562195|589259412|FG001|Overall Study|Withdrawal by Subject|0|||
163149163|NCT02218372|589259413|FG000|Overall Study|Adverse Event|1|||
163149164|NCT02218372|589259414|FG001|Overall Study|Adverse Event|1|||
163149165|NCT02218372|589259413|FG000|Overall Study|Miscellaneous|2|||
162667102|NCT04096560|587490694|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667103|NCT04096560|587490695|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667104|NCT04096560|587490696|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667105|NCT04096560|587490697|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162667106|NCT04096560|587490698|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
162667107|NCT00534352|587490701|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
162667108|NCT00534352|587490701|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
162667109|NCT00534352|587490701|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
162667110|NCT00534352|587490701|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
162667111|NCT00534352|587490701|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
162667112|NCT00534352|587490701|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
163149166|NCT02218372|589259414|FG001|Overall Study|Miscellaneous|1|||
163149167|NCT02218372|589259413|FG000|Overall Study|Randomized but did not receive treatment|2|||
163149168|NCT02218372|589259414|FG001|Overall Study|Randomized but did not receive treatment|3|||
162721677|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721678|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721679|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721680|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721681|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721682|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162721683|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163149169|NCT02218372|589259413|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163149170|NCT02218372|589259414|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163149171|NCT02923726|589259415|FG000|Overall Study|Death|196|||
163149172|NCT02923726|589259416|FG001|Overall Study|Death|175|||
163149173|NCT02923726|589259415|FG000|Overall Study|Withdrawal by Subject|337|||
163149174|NCT02923726|589259416|FG001|Overall Study|Withdrawal by Subject|307|||
163149175|NCT03406780|589259421|FG000|Overall Study|Withdrawal by Subject|1|||
163149176|NCT03406780|589259422|FG001|Overall Study|Withdrawal by Subject|1|||
163149177|NCT03406780|589259421|FG000|Overall Study|Other|0|||
163149178|NCT03406780|589259422|FG001|Overall Study|Other|2|||
163149179|NCT02546609|589259434|FG000|Overall Study|Withdrawal by Subject|0|||
163149180|NCT02546609|589259435|FG001|Overall Study|Withdrawal by Subject|1|||
163149181|NCT02546609|589259436|FG002|Overall Study|Withdrawal by Subject|2|||
163149182|NCT02546609|589259434|FG000|Overall Study|Adverse Event|0|||
163149183|NCT02546609|589259435|FG001|Overall Study|Adverse Event|6|||
163149184|NCT02546609|589259436|FG002|Overall Study|Adverse Event|1|||
163149185|NCT02546609|589259434|FG000|Overall Study|Protocol Violation|0|||
163149186|NCT02546609|589259435|FG001|Overall Study|Protocol Violation|1|||
163149187|NCT02546609|589259436|FG002|Overall Study|Protocol Violation|1|||
163149188|NCT02546609|589259434|FG000|Overall Study|Lost to Follow-up|2|||
163149189|NCT02546609|589259435|FG001|Overall Study|Lost to Follow-up|3|||
163149190|NCT02546609|589259436|FG002|Overall Study|Lost to Follow-up|1|||
163149191|NCT02546609|589259434|FG000|Overall Study|travel or work schedule restriction|0|||
163149192|NCT02546609|589259435|FG001|Overall Study|travel or work schedule restriction|0|||
163149193|NCT02546609|589259436|FG002|Overall Study|travel or work schedule restriction|2|||
163149194|NCT02756338|589259438|FG000|Overall Study|Withdrawn by Investigator|1|||
163149195|NCT02756338|589259438|FG000|Overall Study|Device Replaced with Pacemaker|4|||
163149196|NCT01176032|589259439|FG000|Overall Study|Adverse Event|1|||
163149197|NCT01176032|589259440|FG001|Overall Study|Adverse Event|0|||
163149198|NCT01176032|589259439|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163149199|NCT01176032|589259440|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163149200|NCT01176032|589259439|FG000|Overall Study|Protocol Violation|1|||
163149201|NCT01176032|589259440|FG001|Overall Study|Protocol Violation|0|||
163149202|NCT01176032|589259439|FG000|Overall Study|Informed consent withdrawn|3|||
163149203|NCT01176032|589259440|FG001|Overall Study|Informed consent withdrawn|0|||
163149204|NCT01176032|589259439|FG000|Overall Study|Other|1|||
163149205|NCT01176032|589259440|FG001|Overall Study|Other|0|||
163149206|NCT00659061|589259441|FG000|Overall Study|Migration due to political unrest|21|||
163149207|NCT00659061|589259442|FG001|Overall Study|Migration due to political unrest|15|||
163149208|NCT04038359|589259445|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
163149209|NCT04038359|589259446|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
163149210|NCT04038359|589259445|FG000|Overall Study|Death|8|||
163149211|NCT04038359|589259446|FG001|Overall Study|Death|7|||
163149212|NCT04038359|589259445|FG000|Overall Study|Lost to Follow-up|3|||
163149213|NCT04038359|589259446|FG001|Overall Study|Lost to Follow-up|0|||
163149214|NCT04038359|589259445|FG000|Overall Study|Participant Moved|1|||
163149215|NCT04038359|589259446|FG001|Overall Study|Participant Moved|0|||
163149216|NCT04038359|589259445|FG000|Overall Study|Withdrawal by Subject|4|||
163149217|NCT04038359|589259446|FG001|Overall Study|Withdrawal by Subject|3|||
163149218|NCT04038359|589259445|FG000|Overall Study|Physician Decision|3|||
163149219|NCT04038359|589259446|FG001|Overall Study|Physician Decision|2|||
163149220|NCT04038359|589259445|FG000|Overall Study|Adverse Event|0|||
163149221|NCT04038359|589259446|FG001|Overall Study|Adverse Event|2|||
163149222|NCT04038359|589259445|FG000|Overall Study|Progressive Disease|0|||
163149223|NCT04038359|589259446|FG001|Overall Study|Progressive Disease|1|||
163149224|NCT00475670|589259447|FG000|Overall Study|Death|0|||
163149225|NCT00475670|589259448|FG001|Overall Study|Death|1|||
163149226|NCT00475670|589259447|FG000|Overall Study|Lack of Efficacy|3|||
163149227|NCT00475670|589259448|FG001|Overall Study|Lack of Efficacy|34|||
163149228|NCT00475670|589259447|FG000|Overall Study|Refused treatment|0|||
163149229|NCT00475670|589259448|FG001|Overall Study|Refused treatment|2|||
163149230|NCT00475670|589259447|FG000|Overall Study|Failure to Return|0|||
163149231|NCT00475670|589259448|FG001|Overall Study|Failure to Return|1|||
163149232|NCT00475670|589259447|FG000|Overall Study|Other|0|||
163149233|NCT00475670|589259448|FG001|Overall Study|Other|3|||
163149234|NCT02004236|589259451|FG000|Overall Study|Lack of Efficacy|0|||
163149235|NCT02004236|589259452|FG001|Overall Study|Lack of Efficacy|0|||
163149236|NCT02004236|589259453|FG002|Overall Study|Lack of Efficacy|16|||
163149237|NCT01168349|589259455|FG000|Overall Study|Death|157|||
162667113|NCT03264989|587490704|FG000|Overall Study|Lost to Follow-up|1|||
162667114|NCT03264989|587490705|FG001|Overall Study|Lost to Follow-up|0|||
162667115|NCT03264989|587490704|FG000|Overall Study|New Therapy for study Indication|1|||
162667116|NCT03264989|587490705|FG001|Overall Study|New Therapy for study Indication|0|||
162667117|NCT03264989|587490704|FG000|Overall Study|Protocol Violation|0|||
162667118|NCT03264989|587490705|FG001|Overall Study|Protocol Violation|1|||
162667119|NCT03264989|587490704|FG000|Overall Study|Patient decision|13|||
162667120|NCT03264989|587490705|FG001|Overall Study|Patient decision|0|||
162667121|NCT03264989|587490704|FG000|Overall Study|Physician Decision|6|||
162667122|NCT03264989|587490705|FG001|Overall Study|Physician Decision|4|||
162667123|NCT03264989|587490704|FG000|Overall Study|Adverse Event|2|||
162667124|NCT03264989|587490705|FG001|Overall Study|Adverse Event|1|||
162667125|NCT03264989|587490704|FG000|Overall Study|Death|1|||
162667126|NCT03264989|587490705|FG001|Overall Study|Death|1|||
162667127|NCT03264989|587490704|FG000|Overall Study|Pregnancy|2|||
162667128|NCT03264989|587490705|FG001|Overall Study|Pregnancy|0|||
162667129|NCT03264989|587490704|FG000|Overall Study|End of Study|19|||
162667130|NCT03264989|587490705|FG001|Overall Study|End of Study|5|||
162667131|NCT00833924|587490711|FG000|Overall Study|Death|21|||
162667132|NCT00833924|587490711|FG000|Overall Study|Conversion|2|||
162667133|NCT00833924|587490711|FG000|Overall Study|Lost to Follow-up|2|||
162667134|NCT00833924|587490711|FG000|Overall Study|Withdrawal by Subject|13|||
162667135|NCT00833924|587490711|FG000|Overall Study|In study follow-up|71|||
162667136|NCT02504866|587490712|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
162667137|NCT02504866|587490713|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
162667138|NCT02504866|587490714|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
162667139|NCT01229436|587490715|FG000|Overall Study|Withdrawal by Subject|2|||
162667140|NCT01229436|587490715|FG000|Overall Study|Lost to Follow-up|3|||
162667141|NCT04796610|587490718|FG000|Overall Study|Withdrawal by Subject|1|||
162667142|NCT04796610|587490719|FG001|Overall Study|Withdrawal by Subject|0|||
162667143|NCT04796610|587490720|FG002|Overall Study|Withdrawal by Subject|0|||
162667144|NCT04796610|587490721|FG003|Overall Study|Withdrawal by Subject|0|||
162667145|NCT04796610|587490718|FG000|Overall Study|Lost to Follow-up|2|||
162667146|NCT04796610|587490719|FG001|Overall Study|Lost to Follow-up|0|||
162667147|NCT04796610|587490720|FG002|Overall Study|Lost to Follow-up|1|||
162667148|NCT04796610|587490721|FG003|Overall Study|Lost to Follow-up|1|||
162667149|NCT01775137|587490722|FG000|Overall Study|Death|1|||
162667150|NCT01775137|587490722|FG000|Overall Study|Protocol deviation|2|||
162667151|NCT01775137|587490722|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162667152|NCT01775137|587490722|FG000|Overall Study|Adverse Event|1|||
162667153|NCT01775137|587490722|FG000|Overall Study|Withdrawal by participants|5|||
162667154|NCT00733824|587490723|FG000|Phase I|Withdrawal by Subject|1|||
162667155|NCT00733824|587490724|FG001|Phase I|Withdrawal by Subject|0|||
162667156|NCT00733824|587490725|FG002|Phase I|Withdrawal by Subject|0|||
162667157|NCT00733824|587490726|FG003|Phase I|Withdrawal by Subject|0|||
162667158|NCT00733824|587490727|FG004|Phase I|Withdrawal by Subject|0|||
162667159|NCT01459796|587490728|FG000|Overall Study|Non compliance with protocol|2|||
162667160|NCT01459796|587490729|FG001|Overall Study|Non compliance with protocol|4|||
162667161|NCT01459796|587490728|FG000|Overall Study|Adverse Event|5|||
162667162|NCT01459796|587490729|FG001|Overall Study|Adverse Event|5|||
162667163|NCT01459796|587490728|FG000|Overall Study|Withdrawal by Subject|6|||
162667164|NCT01459796|587490729|FG001|Overall Study|Withdrawal by Subject|3|||
162667165|NCT01459796|587490728|FG000|Overall Study|Lost to Follow-up|5|||
162667166|NCT01459796|587490729|FG001|Overall Study|Lost to Follow-up|4|||
162667167|NCT01459796|587490728|FG000|Overall Study|Reason unspecified|1|||
162667168|NCT01459796|587490729|FG001|Overall Study|Reason unspecified|2|||
162667169|NCT01459796|587490728|FG000|Overall Study|Decision by the sponsor|75|||
162667170|NCT01459796|587490729|FG001|Overall Study|Decision by the sponsor|108|||
162667171|NCT01343056|587490730|FG000|Overall Study|Lost to Follow-up|7|||
162667172|NCT01343056|587490731|FG001|Overall Study|Lost to Follow-up|5|||
162667173|NCT01343056|587490732|FG002|Overall Study|Lost to Follow-up|3|||
162667174|NCT01343056|587490733|FG003|Overall Study|Lost to Follow-up|9|||
162667175|NCT02059148|587490734|FG000|Treatment 1|Protocol Violation|0|||
162667176|NCT02059148|587490735|FG001|Treatment 1|Protocol Violation|0|||
162667177|NCT02059148|587490736|FG002|Treatment 1|Protocol Violation|0|||
162667178|NCT02059148|587490737|FG003|Treatment 1|Protocol Violation|0|||
162667179|NCT02059148|587490738|FG004|Treatment 1|Protocol Violation|0|||
162667180|NCT02059148|587490739|FG005|Treatment 1|Protocol Violation|1|||
162667181|NCT03231371|587490741|FG000|Overall Study|Withdrawal by Subject|1|||
162667182|NCT03231371|587490741|FG000|Overall Study|chose or were ineligible to have MRI|12|||
162667183|NCT03067441|587490745|FG000|Overall Study|Withdrawal by Subject|16|||
162667184|NCT03067441|587490746|FG001|Overall Study|Withdrawal by Subject|34|||
162667185|NCT03067441|587490745|FG000|Overall Study|Lost to Follow-up|7|||
162667186|NCT03067441|587490746|FG001|Overall Study|Lost to Follow-up|5|||
162667187|NCT03067441|587490745|FG000|Overall Study|Adverse Event|7|||
162667188|NCT03067441|587490746|FG001|Overall Study|Adverse Event|14|||
162667189|NCT03067441|587490745|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
162667190|NCT03067441|587490746|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
162667191|NCT03067441|587490745|FG000|Overall Study|Physician Decision|1|||
162667192|NCT03067441|587490746|FG001|Overall Study|Physician Decision|3|||
162667193|NCT03067441|587490745|FG000|Overall Study|Other|1|||
162667194|NCT03067441|587490746|FG001|Overall Study|Other|1|||
162667195|NCT00856583|587490747|FG000|Overall Study|Lack of Efficacy|389|||
162667196|NCT00856583|587490748|FG001|Overall Study|Lack of Efficacy|377|||
162667197|NCT00856583|587490747|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
162667198|NCT00856583|587490748|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
162667199|NCT00856583|587490747|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
162667200|NCT00856583|587490748|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
162667201|NCT00856583|587490747|FG000|Overall Study|Non-compliance|305|||
162667202|NCT00856583|587490748|FG001|Overall Study|Non-compliance|262|||
162667203|NCT00856583|587490747|FG000|Overall Study|Withdrawal by Subject|1092|||
162667204|NCT00856583|587490748|FG001|Overall Study|Withdrawal by Subject|919|||
162667205|NCT00856583|587490747|FG000|Overall Study|Physician Decision|59|||
162667206|NCT00856583|587490748|FG001|Overall Study|Physician Decision|82|||
162667207|NCT00856583|587490747|FG000|Overall Study|Pregnancy|14|||
162667208|NCT00856583|587490748|FG001|Overall Study|Pregnancy|5|||
162667209|NCT00856583|587490747|FG000|Overall Study|Other|92|||
162667210|NCT00856583|587490748|FG001|Overall Study|Other|104|||
162667211|NCT00856583|587490747|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
162667212|NCT00856583|587490748|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
162667213|NCT02056301|587490752|FG000|Overall Study|Protocol Violation|1|||
162667214|NCT02056301|587490753|FG001|Overall Study|Protocol Violation|2|||
162667215|NCT02056301|587490752|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
162667216|NCT02056301|587490753|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
162667217|NCT02056301|587490752|FG000|Overall Study|Withdrawal by Subject|0|||
162667218|NCT02056301|587490753|FG001|Overall Study|Withdrawal by Subject|1|||
162667219|NCT02056301|587490752|FG000|Overall Study|Issues with epidural|0|||
162667220|NCT02056301|587490753|FG001|Overall Study|Issues with epidural|3|||
162667221|NCT00499889|587490759|FG000|Overall Study|Infection prior to treatment|1|||
162667222|NCT03299192|587490760|FG000|Overall Study|Fell before classes started|1|||
162667223|NCT03299192|587490761|FG001|Overall Study|Fell before classes started|0|||
162667224|NCT03299192|587490762|FG002|Overall Study|Fell before classes started|0|||
162667225|NCT03299192|587490760|FG000|Overall Study|Other|0|||
162667226|NCT03299192|587490761|FG001|Overall Study|Other|2|||
162667227|NCT03299192|587490762|FG002|Overall Study|Other|1|||
162667228|NCT01418209|587490768|FG000|Overall Study|Withdrawal by Subject|1|||
162667229|NCT01418209|587490769|FG001|Overall Study|Withdrawal by Subject|0|||
162667230|NCT01418209|587490770|FG002|Overall Study|Withdrawal by Subject|1|||
162667231|NCT01418209|587490768|FG000|Overall Study|Did not provide hot flash diary data|1|||
162667232|NCT01418209|587490769|FG001|Overall Study|Did not provide hot flash diary data|3|||
162667233|NCT01418209|587490770|FG002|Overall Study|Did not provide hot flash diary data|3|||
162667234|NCT03779841|587490771|FG000|Randomized Population|Did Not Receive Treatment|3|||
162667235|NCT03779841|587490772|FG001|Randomized Population|Did Not Receive Treatment|1|||
162667236|NCT03779841|587490773|FG002|Randomized Population|Did Not Receive Treatment|0|||
162667237|NCT03779841|587490771|FG000|Treated (Safety) Population|Adverse Event|1|||
162667238|NCT03779841|587490772|FG001|Treated (Safety) Population|Adverse Event|1|||
162667239|NCT03779841|587490773|FG002|Treated (Safety) Population|Adverse Event|0|||
162667240|NCT03779841|587490771|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
162667241|NCT03779841|587490772|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
162667242|NCT03779841|587490773|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
162667243|NCT03779841|587490771|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
162667244|NCT03779841|587490772|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
162667245|NCT03779841|587490773|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
162667246|NCT03779841|587490771|FG000|Treated (Safety) Population|Death|1|||
162667247|NCT03779841|587490772|FG001|Treated (Safety) Population|Death|0|||
162667248|NCT03779841|587490773|FG002|Treated (Safety) Population|Death|2|||
162667249|NCT02788175|587490774|FG000|Overall Study|Protocol Violation|3|||
162667250|NCT02788175|587490774|FG000|Overall Study|Withdrawal by Subject|4|||
162667251|NCT02788175|587490774|FG000|Overall Study|Ineligible prior to study agent|6|||
162667252|NCT02239510|587493521|FG000|Overall Study|Lost to Follow-up|2|||
162667253|NCT02239510|587493522|FG001|Overall Study|Lost to Follow-up|1|||
162667254|NCT05349617|587493526|FG000|Overall Study|Death|1|||
162667255|NCT05349617|587493527|FG001|Overall Study|Death|1|||
162667256|NCT05349617|587493526|FG000|Overall Study|Lost to Follow-up|3|||
162667257|NCT05349617|587493527|FG001|Overall Study|Lost to Follow-up|8|||
162667258|NCT05349617|587493526|FG000|Overall Study|Withdrawal by Subject|2|||
162667259|NCT05349617|587493527|FG001|Overall Study|Withdrawal by Subject|10|||
162667260|NCT04401579|587493532|FG000|Overall Study|Death|23|||
162667261|NCT04401579|587493533|FG001|Overall Study|Death|36|||
162667262|NCT04401579|587493532|FG000|Overall Study|Lost to Follow-up|40|||
162667263|NCT04401579|587493533|FG001|Overall Study|Lost to Follow-up|41|||
162667264|NCT04401579|587493532|FG000|Overall Study|Withdrawal by Subject|8|||
162667265|NCT04401579|587493533|FG001|Overall Study|Withdrawal by Subject|16|||
162667266|NCT04401579|587493532|FG000|Overall Study|Physician Decision|1|||
162667267|NCT04401579|587493533|FG001|Overall Study|Physician Decision|2|||
162667268|NCT04401579|587493532|FG000|Overall Study|Became ineligible after enrollment|1|||
162667269|NCT04401579|587493533|FG001|Overall Study|Became ineligible after enrollment|1|||
162667270|NCT04401579|587493532|FG000|Overall Study|Enrolled but treatment not administered|7|||
162667271|NCT04401579|587493533|FG001|Overall Study|Enrolled but treatment not administered|9|||
162667272|NCT04401579|587493532|FG000|Overall Study|Adverse Event|2|||
162667273|NCT04401579|587493533|FG001|Overall Study|Adverse Event|1|||
162667274|NCT04401579|587493532|FG000|Overall Study|Scheduling error|1|||
162667275|NCT04401579|587493533|FG001|Overall Study|Scheduling error|2|||
162667276|NCT04401579|587493532|FG000|Overall Study|Transferred to another hospital|1|||
162667277|NCT04401579|587493533|FG001|Overall Study|Transferred to another hospital|2|||
162667278|NCT00489970|587493534|FG000|Persistence Year 9|Lost to Follow-up|2|||
162667279|NCT00489970|587493535|FG001|Persistence Year 9|Lost to Follow-up|2|||
162667280|NCT00489970|587493536|FG002|Persistence Year 9|Lost to Follow-up|3|||
162667281|NCT00489970|587493534|FG000|Persistence Year 9|Other|1|||
162667282|NCT00489970|587493535|FG001|Persistence Year 9|Other|0|||
162667283|NCT00489970|587493536|FG002|Persistence Year 9|Other|2|||
162667284|NCT01075321|587493542|FG000|Overall Study|Withdrawal by Subject|0|||
162667285|NCT01075321|587493543|FG001|Overall Study|Withdrawal by Subject|0|||
162667286|NCT01075321|587493544|FG002|Overall Study|Withdrawal by Subject|1|||
162667287|NCT01075321|587493545|FG003|Overall Study|Withdrawal by Subject|1|||
162667288|NCT01075321|587493542|FG000|Overall Study|Protocol Violation|0|||
162667289|NCT01075321|587493543|FG001|Overall Study|Protocol Violation|0|||
162667290|NCT01075321|587493544|FG002|Overall Study|Protocol Violation|1|||
162667291|NCT01075321|587493545|FG003|Overall Study|Protocol Violation|0|||
162721684|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
162667292|NCT01075321|587493542|FG000|Overall Study|Treatment Incomplete due to progression|1|||
162667293|NCT01075321|587493543|FG001|Overall Study|Treatment Incomplete due to progression|0|||
162667294|NCT01075321|587493544|FG002|Overall Study|Treatment Incomplete due to progression|0|||
162667295|NCT01075321|587493545|FG003|Overall Study|Treatment Incomplete due to progression|0|||
162667296|NCT01075321|587493542|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
162667297|NCT01075321|587493543|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
162667298|NCT01075321|587493544|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
162667299|NCT01075321|587493545|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
162667300|NCT02646423|587493546|FG000|Overall Study|Adverse Event|5|||
162667301|NCT02646423|587493547|FG001|Overall Study|Adverse Event|7|||
162667302|NCT02646423|587493546|FG000|Overall Study|Ineligible|2|||
162667303|NCT02646423|587493547|FG001|Overall Study|Ineligible|1|||
162721685|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
162721686|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
162667304|NCT00003457|587493548|FG000|Overall Study|Not evaluable|9|||
162667305|NCT01054729|587493552|FG000|Overall Study|Randomized but Not Treated|0|||
162667306|NCT01054729|587493553|FG001|Overall Study|Randomized but Not Treated|1|||
162667307|NCT01054729|587493554|FG002|Overall Study|Randomized but Not Treated|0|||
162667308|NCT01054729|587493555|FG003|Overall Study|Randomized but Not Treated|0|||
162667309|NCT01054729|587493552|FG000|Overall Study|Adverse Event|1|||
162667310|NCT01054729|587493553|FG001|Overall Study|Adverse Event|1|||
162667311|NCT01054729|587493554|FG002|Overall Study|Adverse Event|2|||
162667312|NCT01054729|587493555|FG003|Overall Study|Adverse Event|1|||
162667313|NCT01054729|587493552|FG000|Overall Study|Withdrawal by Subject|1|||
162667314|NCT01054729|587493553|FG001|Overall Study|Withdrawal by Subject|0|||
162667315|NCT01054729|587493554|FG002|Overall Study|Withdrawal by Subject|1|||
162667316|NCT01054729|587493555|FG003|Overall Study|Withdrawal by Subject|0|||
162667317|NCT01054729|587493552|FG000|Overall Study|Lost to Follow-up|0|||
162667318|NCT01054729|587493553|FG001|Overall Study|Lost to Follow-up|1|||
162667319|NCT01054729|587493554|FG002|Overall Study|Lost to Follow-up|0|||
162667320|NCT01054729|587493555|FG003|Overall Study|Lost to Follow-up|0|||
162667321|NCT01054729|587493552|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162667322|NCT01054729|587493553|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
162667323|NCT01054729|587493554|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162667324|NCT01054729|587493555|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162667325|NCT01054729|587493552|FG000|Overall Study|Non-responder|1|||
162667326|NCT01054729|587493553|FG001|Overall Study|Non-responder|0|||
162667327|NCT01054729|587493554|FG002|Overall Study|Non-responder|1|||
162667328|NCT01054729|587493555|FG003|Overall Study|Non-responder|1|||
162667329|NCT01054729|587493552|FG000|Overall Study|PEG/RBV Non-responder|1|||
162667330|NCT01054729|587493553|FG001|Overall Study|PEG/RBV Non-responder|0|||
162667331|NCT01054729|587493554|FG002|Overall Study|PEG/RBV Non-responder|1|||
162667332|NCT01054729|587493555|FG003|Overall Study|PEG/RBV Non-responder|0|||
162667333|NCT01054729|587493552|FG000|Overall Study|Personal/Obligations|0|||
162667334|NCT01054729|587493553|FG001|Overall Study|Personal/Obligations|1|||
162667335|NCT01054729|587493554|FG002|Overall Study|Personal/Obligations|0|||
162667336|NCT01054729|587493555|FG003|Overall Study|Personal/Obligations|0|||
162667337|NCT01054729|587493552|FG000|Overall Study|Subject moved|0|||
162667338|NCT01054729|587493553|FG001|Overall Study|Subject moved|0|||
162667339|NCT01054729|587493554|FG002|Overall Study|Subject moved|1|||
162667340|NCT01054729|587493555|FG003|Overall Study|Subject moved|0|||
162667341|NCT01054729|587493552|FG000|Overall Study|Lack of Efficacy|0|||
162667342|NCT01054729|587493553|FG001|Overall Study|Lack of Efficacy|0|||
162667343|NCT01054729|587493554|FG002|Overall Study|Lack of Efficacy|0|||
162667344|NCT01054729|587493555|FG003|Overall Study|Lack of Efficacy|1|||
162667345|NCT00321919|587493556|FG000|Overall Study|Adverse Event|17|||
162667346|NCT00321919|587493557|FG001|Overall Study|Adverse Event|10|||
162667347|NCT00321919|587493556|FG000|Overall Study|Death|21|||
162667348|NCT00321919|587493557|FG001|Overall Study|Death|17|||
162667349|NCT00321919|587493556|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162667350|NCT00321919|587493557|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162667351|NCT00321919|587493556|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162667352|NCT00321919|587493557|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162667353|NCT00321919|587493556|FG000|Overall Study|Refused Treatment|23|||
162667354|NCT00321919|587493557|FG001|Overall Study|Refused Treatment|14|||
162667355|NCT00321919|587493556|FG000|Overall Study|Other Protocol Violation|2|||
162667356|NCT00321919|587493557|FG001|Overall Study|Other Protocol Violation|3|||
162667357|NCT00321919|587493556|FG000|Overall Study|Failure to Return|3|||
162667358|NCT00321919|587493557|FG001|Overall Study|Failure to Return|1|||
162667359|NCT00321919|587493556|FG000|Overall Study|Other withdrawal reason|7|||
162667360|NCT00321919|587493557|FG001|Overall Study|Other withdrawal reason|6|||
162667361|NCT02624804|587493558|FG000|Overall Study|Screen Failure|5|||
162667362|NCT02590354|587493559|FG000|Phase 1|Active hepatitis B or C infection|1|||
162667363|NCT02590354|587493559|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
162667364|NCT02590354|587493559|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
162667365|NCT02590354|587493559|FG000|Phase 1|Subject does not want to participate|20|||
162667366|NCT02590354|587493559|FG000|Phase 1|Lost to Follow-up|1|||
162667367|NCT02590354|587493559|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
162667368|NCT00996996|587493560|FG000|Overall Study|Progressive Disease|10|||
162667369|NCT00996996|587493560|FG000|Overall Study|Non-compliance|8|||
162667370|NCT00996996|587493560|FG000|Overall Study|Lost to Follow-up|9|||
162667371|NCT00996996|587493560|FG000|Overall Study|Death|5|||
162667372|NCT00996996|587493560|FG000|Overall Study|Did Not Receive Study Medications|1|||
162667373|NCT01227889|587493561|FG000|Randomized Phase (RP)|Adverse Event|13|||
162667374|NCT01227889|587493562|FG001|Randomized Phase (RP)|Adverse Event|0|||
162667375|NCT01227889|587493561|FG000|Randomized Phase (RP)|Physician Decision|13|||
162667376|NCT01227889|587493562|FG001|Randomized Phase (RP)|Physician Decision|5|||
162667377|NCT01227889|587493561|FG000|Randomized Phase (RP)|Progressive Disease|135|||
162667378|NCT01227889|587493562|FG001|Randomized Phase (RP)|Progressive Disease|52|||
162667379|NCT01227889|587493561|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
163149238|NCT01168349|589259455|FG000|Overall Study|Lost to Follow-up|34|||
162667380|NCT01227889|587493562|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
162667381|NCT01227889|587493561|FG000|Randomized Phase (RP)|Missing|1|||
162667382|NCT01227889|587493562|FG001|Randomized Phase (RP)|Missing|3|||
162667383|NCT01227889|587493561|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
162667384|NCT01227889|587493562|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
162667385|NCT01227889|587493561|FG000|Crossover Phase|Adverse Event|0|||
162667386|NCT01227889|587493562|FG001|Crossover Phase|Adverse Event|1|||
162667387|NCT01227889|587493561|FG000|Crossover Phase|Physician Decision|0|||
162667388|NCT01227889|587493562|FG001|Crossover Phase|Physician Decision|3|||
162667389|NCT01227889|587493561|FG000|Crossover Phase|Progressive Disease|0|||
162667390|NCT01227889|587493562|FG001|Crossover Phase|Progressive Disease|31|||
162667391|NCT01227889|587493561|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
162667392|NCT01227889|587493562|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
162667393|NCT01227889|587493561|FG000|Crossover Phase|Withdrawal by Subject|0|||
162667394|NCT01227889|587493562|FG001|Crossover Phase|Withdrawal by Subject|1|||
162667395|NCT01148810|587493565|FG000|Overall Study|Adverse Event|0|||
162667396|NCT01148810|587493566|FG001|Overall Study|Adverse Event|2|||
162667397|NCT01148810|587493565|FG000|Overall Study|Lack of Efficacy|0|||
162667398|NCT01148810|587493566|FG001|Overall Study|Lack of Efficacy|1|||
162667399|NCT01148810|587493565|FG000|Overall Study|Withdrawal by Subject|0|||
162667400|NCT01148810|587493566|FG001|Overall Study|Withdrawal by Subject|2|||
162667401|NCT01148810|587493565|FG000|Overall Study|Protocol Violation|1|||
162667402|NCT01148810|587493566|FG001|Overall Study|Protocol Violation|0|||
162667403|NCT02731131|587493573|FG000|Overall Study|Psychiatric Disorder|0|||
162667404|NCT02731131|587493574|FG001|Overall Study|Psychiatric Disorder|1|||
162667405|NCT02731131|587493573|FG000|Overall Study|Refused Therapy|0|||
162667406|NCT02731131|587493574|FG001|Overall Study|Refused Therapy|1|||
162667407|NCT02348216|587493580|FG000|Overall Study|Death|5|||
162667408|NCT02348216|587493581|FG001|Overall Study|Death|53|||
162667409|NCT02348216|587493582|FG002|Overall Study|Death|11|||
162667410|NCT02348216|587493583|FG003|Overall Study|Death|20|||
162667411|NCT02348216|587493584|FG004|Overall Study|Death|16|||
162667412|NCT02348216|587493585|FG005|Overall Study|Death|32|||
162667413|NCT02348216|587493586|FG006|Overall Study|Death|17|||
162667414|NCT02348216|587493580|FG000|Overall Study|Full consent withdrawal|0|||
162667415|NCT02348216|587493581|FG001|Overall Study|Full consent withdrawal|0|||
162667416|NCT02348216|587493582|FG002|Overall Study|Full consent withdrawal|0|||
162667417|NCT02348216|587493583|FG003|Overall Study|Full consent withdrawal|1|||
162667418|NCT02348216|587493584|FG004|Overall Study|Full consent withdrawal|3|||
162667419|NCT02348216|587493585|FG005|Overall Study|Full consent withdrawal|0|||
162667420|NCT02348216|587493586|FG006|Overall Study|Full consent withdrawal|3|||
162667421|NCT02348216|587493580|FG000|Overall Study|Lost to Follow-up|0|||
162667422|NCT02348216|587493581|FG001|Overall Study|Lost to Follow-up|5|||
162667423|NCT02348216|587493582|FG002|Overall Study|Lost to Follow-up|2|||
162667424|NCT02348216|587493583|FG003|Overall Study|Lost to Follow-up|0|||
162667425|NCT02348216|587493584|FG004|Overall Study|Lost to Follow-up|1|||
162667426|NCT02348216|587493585|FG005|Overall Study|Lost to Follow-up|1|||
162667427|NCT02348216|587493586|FG006|Overall Study|Lost to Follow-up|1|||
162667428|NCT02348216|587493580|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
162667429|NCT02348216|587493581|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
162667430|NCT02348216|587493582|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
162667431|NCT02348216|587493583|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
162667432|NCT02348216|587493584|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
162667433|NCT02348216|587493585|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
162667434|NCT02348216|587493586|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
162667435|NCT02348216|587493580|FG000|Overall Study|Reason not specified|2|||
162667436|NCT02348216|587493581|FG001|Overall Study|Reason not specified|19|||
162667437|NCT02348216|587493582|FG002|Overall Study|Reason not specified|11|||
162667438|NCT02348216|587493583|FG003|Overall Study|Reason not specified|17|||
162667439|NCT02348216|587493584|FG004|Overall Study|Reason not specified|21|||
162721687|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163149239|NCT01168349|589259455|FG000|Overall Study|Withdrawal by Subject|9|||
163149240|NCT01168349|589259455|FG000|Overall Study|Kidney transplantation|3|||
163149241|NCT01168349|589259455|FG000|Overall Study|Other|22|||
163149242|NCT01168349|589259455|FG000|Overall Study|Protocol Violation|76|||
163149243|NCT01033240|589259456|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
163149244|NCT01033240|589259457|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
163149245|NCT01033240|589259458|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
163149246|NCT01033240|589259456|FG000|Overall Study|Death|2|||
163149247|NCT01033240|589259457|FG001|Overall Study|Death|0|||
163149248|NCT01033240|589259458|FG002|Overall Study|Death|0|||
163149249|NCT01033240|589259456|FG000|Overall Study|Withdrew Consent|2|||
163149250|NCT01033240|589259457|FG001|Overall Study|Withdrew Consent|9|||
163149251|NCT01033240|589259458|FG002|Overall Study|Withdrew Consent|2|||
163149252|NCT01033240|589259456|FG000|Overall Study|Disease Progression|35|||
163149253|NCT01033240|589259457|FG001|Overall Study|Disease Progression|32|||
163149254|NCT01033240|589259458|FG002|Overall Study|Disease Progression|41|||
163149255|NCT01033240|589259456|FG000|Overall Study|Investigator Discretion|0|||
163149256|NCT01033240|589259457|FG001|Overall Study|Investigator Discretion|0|||
163149257|NCT01033240|589259458|FG002|Overall Study|Investigator Discretion|2|||
163149258|NCT01033240|589259456|FG000|Overall Study|Other|0|||
163149259|NCT01033240|589259457|FG001|Overall Study|Other|1|||
163149260|NCT01033240|589259458|FG002|Overall Study|Other|2|||
163149261|NCT00918385|589259462|FG000|Monotherapy|Adverse Event|1|||
163149262|NCT00918385|589259463|FG001|Monotherapy|Adverse Event|6|||
163149263|NCT00918385|589259462|FG000|Monotherapy|Complicating illness|1|||
163149264|NCT00918385|589259463|FG001|Monotherapy|Complicating illness|0|||
163149265|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
163149266|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
163149267|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
163149268|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
163149269|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
163149270|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
163149271|NCT00918385|589259462|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
163149272|NCT00918385|589259463|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
163149273|NCT01476722|589259466|FG000|Overall Study|Adverse Event|1|||
163149274|NCT00918281|589259471|FG000|Overall Study|Physician Decision|29|||
163149275|NCT02978417|589259472|FG000|Overall Study|Lost to Follow-up|2|||
163149276|NCT02978417|589259473|FG001|Overall Study|Lost to Follow-up|2|||
163149277|NCT01323582|589259474|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
163149278|NCT01323582|589259475|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
163149279|NCT01323582|589259474|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
163149280|NCT01323582|589259475|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
163149281|NCT01323582|589259474|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
163149282|NCT01323582|589259475|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
163149283|NCT03557970|589259480|FG000|Overall Study|Study closure|1|||
163149284|NCT03557970|589259481|FG001|Overall Study|Study closure|0|||
163149285|NCT03557970|589259480|FG000|Overall Study|Physician Decision|0|||
163149286|NCT03557970|589259481|FG001|Overall Study|Physician Decision|1|||
163149287|NCT03557970|589259480|FG000|Overall Study|Death|0|||
163149288|NCT03557970|589259481|FG001|Overall Study|Death|1|||
163149289|NCT00525512|589259487|FG000|Double-Blind Phase|Adverse Event|48|||
163149290|NCT00525512|589259488|FG001|Double-Blind Phase|Adverse Event|28|||
163149291|NCT00525512|589259489|FG002|Double-Blind Phase|Adverse Event|0|||
163149292|NCT00525512|589259490|FG003|Double-Blind Phase|Adverse Event|0|||
163149293|NCT00525512|589259487|FG000|Double-Blind Phase|Protocol Violation|3|||
163149294|NCT00525512|589259488|FG001|Double-Blind Phase|Protocol Violation|1|||
163149295|NCT00525512|589259489|FG002|Double-Blind Phase|Protocol Violation|0|||
163149296|NCT00525512|589259490|FG003|Double-Blind Phase|Protocol Violation|0|||
163149297|NCT00525512|589259487|FG000|Double-Blind Phase|Lost to Follow-up|3|||
163149298|NCT00525512|589259488|FG001|Double-Blind Phase|Lost to Follow-up|7|||
163149299|NCT00525512|589259489|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162667440|NCT02348216|587493585|FG005|Overall Study|Reason not specified|17|||
162667441|NCT02348216|587493586|FG006|Overall Study|Reason not specified|19|||
162667442|NCT01055639|587493587|FG000|Overall Study|Adverse Event|0|||
162667443|NCT01055639|587493588|FG001|Overall Study|Adverse Event|1|||
162667444|NCT01055639|587493587|FG000|Overall Study|Lack of Efficacy|0|||
162667445|NCT01055639|587493588|FG001|Overall Study|Lack of Efficacy|1|||
162667446|NCT01055639|587493587|FG000|Overall Study|Lost to Follow-up|8|||
162667447|NCT01055639|587493588|FG001|Overall Study|Lost to Follow-up|11|||
162667448|NCT01055639|587493587|FG000|Overall Study|Protocol Violation|5|||
162667449|NCT01055639|587493588|FG001|Overall Study|Protocol Violation|5|||
162667450|NCT01055639|587493587|FG000|Overall Study|Withdrawal by Subject|8|||
162667451|NCT01055639|587493588|FG001|Overall Study|Withdrawal by Subject|11|||
162667452|NCT01202773|587493590|FG000|Overall Study|Adverse Event|4|||
162667453|NCT01202773|587493591|FG001|Overall Study|Adverse Event|5|||
162667454|NCT01202773|587493592|FG002|Overall Study|Adverse Event|5|||
162667455|NCT01202773|587493590|FG000|Overall Study|Lack of Efficacy|5|||
162667456|NCT01202773|587493591|FG001|Overall Study|Lack of Efficacy|4|||
162667457|NCT01202773|587493592|FG002|Overall Study|Lack of Efficacy|9|||
162667458|NCT01202773|587493590|FG000|Overall Study|Entry Criteria Not Met|2|||
162667459|NCT01202773|587493591|FG001|Overall Study|Entry Criteria Not Met|0|||
162667460|NCT01202773|587493592|FG002|Overall Study|Entry Criteria Not Met|1|||
162667461|NCT01202773|587493590|FG000|Overall Study|Lost to Follow-up|1|||
162667462|NCT01202773|587493591|FG001|Overall Study|Lost to Follow-up|2|||
162667463|NCT01202773|587493592|FG002|Overall Study|Lost to Follow-up|2|||
162667464|NCT01202773|587493590|FG000|Overall Study|Withdrawal by Subject|13|||
162667465|NCT01202773|587493591|FG001|Overall Study|Withdrawal by Subject|6|||
162667466|NCT01202773|587493592|FG002|Overall Study|Withdrawal by Subject|5|||
162667467|NCT01202773|587493590|FG000|Overall Study|Physician Decision|2|||
162667468|NCT01202773|587493591|FG001|Overall Study|Physician Decision|0|||
162667469|NCT01202773|587493592|FG002|Overall Study|Physician Decision|0|||
162667470|NCT01202773|587493590|FG000|Overall Study|Protocol Violation|11|||
162667471|NCT01202773|587493591|FG001|Overall Study|Protocol Violation|6|||
162667472|NCT01202773|587493592|FG002|Overall Study|Protocol Violation|10|||
162667473|NCT01202773|587493590|FG000|Overall Study|Sponsor Decision|19|||
162667474|NCT01202773|587493591|FG001|Overall Study|Sponsor Decision|20|||
162667475|NCT01202773|587493592|FG002|Overall Study|Sponsor Decision|23|||
162667476|NCT03058679|587493593|FG000|Baseline to Week 6|Lost to Follow-up|3|||
162667477|NCT03058679|587493594|FG001|Baseline to Week 6|Lost to Follow-up|2|||
162667478|NCT03058679|587493593|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
162667479|NCT03058679|587493594|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
162667480|NCT03058679|587493593|FG000|Baseline to Week 6|Adverse Event|6|||
162667481|NCT03058679|587493594|FG001|Baseline to Week 6|Adverse Event|6|||
162667482|NCT03058679|587493593|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
162667483|NCT03058679|587493594|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
162667484|NCT03058679|587493593|FG000|Baseline to Week 6|Difficulty following the diet|0|||
162667485|NCT03058679|587493594|FG001|Baseline to Week 6|Difficulty following the diet|2|||
162667486|NCT03058679|587493593|FG000|Baseline to Week 6|Physician Decision|1|||
162667487|NCT03058679|587493594|FG001|Baseline to Week 6|Physician Decision|0|||
162667488|NCT03058679|587493593|FG000|Week 6 to Week 12|Change in medication|5|||
162667489|NCT03058679|587493594|FG001|Week 6 to Week 12|Change in medication|7|||
162667490|NCT03058679|587493593|FG000|Week 6 to Week 12|Adverse Event|4|||
162667491|NCT03058679|587493594|FG001|Week 6 to Week 12|Adverse Event|3|||
162667492|NCT03058679|587493593|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
162667493|NCT03058679|587493594|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
162667494|NCT03058679|587493593|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
162667495|NCT03058679|587493594|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
162667496|NCT04137380|587493599|FG000|Overall Study|Physician Decision|0|||
162667497|NCT04137380|587493600|FG001|Overall Study|Physician Decision|0|||
162667498|NCT04137380|587493601|FG002|Overall Study|Physician Decision|0|||
162667499|NCT04137380|587493602|FG003|Overall Study|Physician Decision|1|||
162667500|NCT04137380|587493603|FG004|Overall Study|Physician Decision|0|||
162667501|NCT04137380|587493604|FG005|Overall Study|Physician Decision|0|||
162667502|NCT04137380|587493605|FG006|Overall Study|Physician Decision|0|||
162667503|NCT00575588|587493611|FG000|Overall Study|Adverse Event|11|||
162667504|NCT00575588|587493612|FG001|Overall Study|Adverse Event|13|||
162667505|NCT00575588|587493611|FG000|Overall Study|Withdrawal by Subject|27|||
162667506|NCT00575588|587493612|FG001|Overall Study|Withdrawal by Subject|31|||
162667507|NCT00575588|587493611|FG000|Overall Study|Lost to Follow-up|1|||
162667508|NCT00575588|587493612|FG001|Overall Study|Lost to Follow-up|3|||
162667509|NCT00575588|587493611|FG000|Overall Study|Death|4|||
162667510|NCT00575588|587493612|FG001|Overall Study|Death|2|||
162667511|NCT00575588|587493611|FG000|Overall Study|Incorrect enrollment|8|||
162667512|NCT00575588|587493612|FG001|Overall Study|Incorrect enrollment|4|||
162667513|NCT00575588|587493611|FG000|Overall Study|Study specific discontinuation criteria|203|||
162667514|NCT00575588|587493612|FG001|Overall Study|Study specific discontinuation criteria|218|||
162667515|NCT00575588|587493611|FG000|Overall Study|Severe non-compliance to protocol|5|||
162667516|NCT00575588|587493612|FG001|Overall Study|Severe non-compliance to protocol|7|||
162667517|NCT00575588|587493611|FG000|Overall Study|Safety reasons|2|||
162667518|NCT00575588|587493612|FG001|Overall Study|Safety reasons|1|||
162667519|NCT00575588|587493611|FG000|Overall Study|Elevated triglyceride|1|||
162667520|NCT00575588|587493612|FG001|Overall Study|Elevated triglyceride|0|||
162667521|NCT00575588|587493611|FG000|Overall Study|Patient moved|1|||
163149300|NCT00525512|589259490|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163149301|NCT00525512|589259487|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
163149302|NCT00525512|589259488|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
163149303|NCT00525512|589259489|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
163149304|NCT00525512|589259490|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163149305|NCT00525512|589259487|FG000|Double-Blind Phase|Lack of Efficacy|13|||
163149306|NCT00525512|589259488|FG001|Double-Blind Phase|Lack of Efficacy|5|||
163149307|NCT00525512|589259489|FG002|Double-Blind Phase|Lack of Efficacy|0|||
163149308|NCT00525512|589259490|FG003|Double-Blind Phase|Lack of Efficacy|0|||
163149309|NCT00525512|589259487|FG000|Double-Blind Phase|Other reason (not specified)|12|||
163149310|NCT00525512|589259488|FG001|Double-Blind Phase|Other reason (not specified)|13|||
163149311|NCT00525512|589259489|FG002|Double-Blind Phase|Other reason (not specified)|0|||
163149312|NCT00525512|589259490|FG003|Double-Blind Phase|Other reason (not specified)|0|||
163149313|NCT00525512|589259487|FG000|Open-Label Phase|Adverse Event|0|||
163149314|NCT00525512|589259488|FG001|Open-Label Phase|Adverse Event|0|||
163149315|NCT00525512|589259489|FG002|Open-Label Phase|Adverse Event|1|||
163149316|NCT00525512|589259490|FG003|Open-Label Phase|Adverse Event|0|||
163149317|NCT00525512|589259487|FG000|Open-Label Phase|Lost to Follow-up|0|||
163149318|NCT00525512|589259488|FG001|Open-Label Phase|Lost to Follow-up|0|||
163149319|NCT00525512|589259489|FG002|Open-Label Phase|Lost to Follow-up|1|||
163149320|NCT00525512|589259490|FG003|Open-Label Phase|Lost to Follow-up|0|||
163149321|NCT00525512|589259487|FG000|Open-Label Phase|Other reason (not specified)|0|||
163149322|NCT00525512|589259488|FG001|Open-Label Phase|Other reason (not specified)|0|||
163149323|NCT00525512|589259489|FG002|Open-Label Phase|Other reason (not specified)|4|||
163149324|NCT00525512|589259490|FG003|Open-Label Phase|Other reason (not specified)|5|||
163149325|NCT01601535|589259495|FG000|Phase 1|Adverse Event|1|||
163149326|NCT01601535|589259496|FG001|Phase 1|Adverse Event|0|||
163149327|NCT01601535|589259497|FG002|Phase 1|Adverse Event|2|||
163149328|NCT01601535|589259498|FG003|Phase 1|Adverse Event|1|||
163149329|NCT01601535|589259499|FG004|Phase 1|Adverse Event|0|||
163149330|NCT01601535|589259500|FG005|Phase 1|Adverse Event|0|||
163149331|NCT01601535|589259495|FG000|Phase 1|Withdrawal by Subject|2|||
163149332|NCT01601535|589259496|FG001|Phase 1|Withdrawal by Subject|1|||
163149333|NCT01601535|589259497|FG002|Phase 1|Withdrawal by Subject|1|||
163149334|NCT01601535|589259498|FG003|Phase 1|Withdrawal by Subject|2|||
163149335|NCT01601535|589259499|FG004|Phase 1|Withdrawal by Subject|0|||
163149336|NCT01601535|589259500|FG005|Phase 1|Withdrawal by Subject|0|||
163149337|NCT01601535|589259495|FG000|Phase 1|Progressive Disease|2|||
163149338|NCT01601535|589259496|FG001|Phase 1|Progressive Disease|3|||
163149339|NCT01601535|589259497|FG002|Phase 1|Progressive Disease|2|||
163149340|NCT01601535|589259498|FG003|Phase 1|Progressive Disease|1|||
163149341|NCT01601535|589259499|FG004|Phase 1|Progressive Disease|0|||
163149342|NCT01601535|589259500|FG005|Phase 1|Progressive Disease|0|||
163149343|NCT01601535|589259495|FG000|Phase 1|Started Another Treatment|1|||
163149344|NCT01601535|589259496|FG001|Phase 1|Started Another Treatment|2|||
163149345|NCT01601535|589259497|FG002|Phase 1|Started Another Treatment|0|||
163149346|NCT01601535|589259498|FG003|Phase 1|Started Another Treatment|0|||
163149347|NCT01601535|589259499|FG004|Phase 1|Started Another Treatment|0|||
163149348|NCT01601535|589259500|FG005|Phase 1|Started Another Treatment|0|||
163149349|NCT01601535|589259495|FG000|Phase 2|Adverse Event|0|||
163149350|NCT01601535|589259496|FG001|Phase 2|Adverse Event|0|||
163149351|NCT01601535|589259497|FG002|Phase 2|Adverse Event|0|||
163149352|NCT01601535|589259498|FG003|Phase 2|Adverse Event|0|||
163149353|NCT01601535|589259499|FG004|Phase 2|Adverse Event|5|||
163149354|NCT01601535|589259500|FG005|Phase 2|Adverse Event|1|||
163149355|NCT01601535|589259495|FG000|Phase 2|Withdrawal by Subject|0|||
163149356|NCT01601535|589259496|FG001|Phase 2|Withdrawal by Subject|0|||
163149357|NCT01601535|589259497|FG002|Phase 2|Withdrawal by Subject|0|||
163149358|NCT01601535|589259498|FG003|Phase 2|Withdrawal by Subject|0|||
163149359|NCT01601535|589259499|FG004|Phase 2|Withdrawal by Subject|8|||
163149360|NCT01601535|589259500|FG005|Phase 2|Withdrawal by Subject|2|||
163149361|NCT01601535|589259495|FG000|Phase 2|Progressive Disease|0|||
163149362|NCT01601535|589259496|FG001|Phase 2|Progressive Disease|0|||
163149363|NCT01601535|589259497|FG002|Phase 2|Progressive Disease|0|||
163149364|NCT01601535|589259498|FG003|Phase 2|Progressive Disease|0|||
163149365|NCT01601535|589259499|FG004|Phase 2|Progressive Disease|5|||
163149366|NCT01601535|589259500|FG005|Phase 2|Progressive Disease|7|||
163149367|NCT01601535|589259495|FG000|Phase 2|Started Another Treatment|0|||
163149368|NCT01601535|589259496|FG001|Phase 2|Started Another Treatment|0|||
163149369|NCT01601535|589259497|FG002|Phase 2|Started Another Treatment|0|||
163149370|NCT01601535|589259498|FG003|Phase 2|Started Another Treatment|0|||
163149371|NCT01601535|589259499|FG004|Phase 2|Started Another Treatment|1|||
163149372|NCT01601535|589259500|FG005|Phase 2|Started Another Treatment|2|||
163149373|NCT03600909|589259503|FG000|Overall Study|Not treated|0|||
163149374|NCT03600909|589259504|FG001|Overall Study|Not treated|3|||
163149375|NCT03600909|589259505|FG002|Overall Study|Not treated|0|||
163149376|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
163149377|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
163149378|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
163149379|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
163149380|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
163149381|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
163149382|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
163149383|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
163149384|NCT04576988|589259506|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
163149385|NCT04576988|589259507|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
163149386|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
163149387|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
163149388|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
163149389|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
163149390|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
163149391|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
163149392|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Death|2|||
163149393|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Death|1|||
163149394|NCT04576988|589259506|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
163149395|NCT04576988|589259507|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
163149396|NCT02919761|589259515|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
163149397|NCT02919761|589259516|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
163149398|NCT02919761|589259517|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
163149399|NCT02919761|589259515|FG000|Part 1: Open Label|Adverse Event|1|||
163149400|NCT02919761|589259516|FG001|Part 1: Open Label|Adverse Event|0|||
163149401|NCT02919761|589259517|FG002|Part 1: Open Label|Adverse Event|0|||
163149402|NCT02919761|589259515|FG000|Part 1: Open Label|Lost to Follow-up|1|||
163149403|NCT02919761|589259516|FG001|Part 1: Open Label|Lost to Follow-up|0|||
163149404|NCT02919761|589259517|FG002|Part 1: Open Label|Lost to Follow-up|0|||
163149405|NCT02919761|589259515|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
163149406|NCT02919761|589259516|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
163149407|NCT02919761|589259517|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
163149408|NCT02919761|589259515|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
163149409|NCT02919761|589259516|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
163149410|NCT02919761|589259517|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
163149411|NCT02919761|589259515|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
163149412|NCT02919761|589259516|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
163149413|NCT02919761|589259517|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
163149414|NCT02919761|589259515|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
163149415|NCT02919761|589259516|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
163149416|NCT02919761|589259517|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
163149417|NCT02919761|589259515|FG000|Part 1: Open Label|Termination by Sponsor|1|||
163149418|NCT02919761|589259516|FG001|Part 1: Open Label|Termination by Sponsor|0|||
163149419|NCT02919761|589259517|FG002|Part 1: Open Label|Termination by Sponsor|0|||
163149420|NCT02919761|589259515|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
163149421|NCT02919761|589259516|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
163149422|NCT02919761|589259517|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
163149423|NCT02919761|589259515|FG000|Part 2: Double-blind|Adverse Event|0|||
163149424|NCT02919761|589259516|FG001|Part 2: Double-blind|Adverse Event|1|||
163149425|NCT02919761|589259517|FG002|Part 2: Double-blind|Adverse Event|0|||
163149426|NCT02919761|589259515|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
163149427|NCT02919761|589259516|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
163149428|NCT02919761|589259517|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
163149429|NCT02919761|589259515|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
163149430|NCT02919761|589259516|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
163149431|NCT02919761|589259517|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
163149432|NCT02919761|589259515|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
162667522|NCT00575588|587493612|FG001|Overall Study|Patient moved|3|||
162667523|NCT00575588|587493611|FG000|Overall Study|Impossible to determine HbA1c|0|||
162667524|NCT00575588|587493612|FG001|Overall Study|Impossible to determine HbA1c|1|||
162667525|NCT02265705|587493613|FG000|Treatment Period Week 0-24|Adverse Event|3|||
162667526|NCT02265705|587493614|FG001|Treatment Period Week 0-24|Adverse Event|2|||
162667527|NCT02265705|587493615|FG002|Treatment Period Week 0-24|Adverse Event|0|||
162667528|NCT02265705|587493616|FG003|Treatment Period Week 0-24|Adverse Event|0|||
162721688|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721689|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721690|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721691|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721692|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721693|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163149433|NCT02919761|589259516|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
163149434|NCT02919761|589259517|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
163149435|NCT02919761|589259515|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
163149436|NCT02919761|589259516|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
163149437|NCT02919761|589259517|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
163149438|NCT02919761|589259515|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
163149439|NCT02919761|589259516|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
163149440|NCT02919761|589259517|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
163149441|NCT02919761|589259515|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
163149442|NCT02919761|589259516|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
163149443|NCT02919761|589259517|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
163149444|NCT03724942|589259518|FG000|Overall Study|Adverse Event|20|||
163149445|NCT03724942|589259519|FG001|Overall Study|Adverse Event|14|||
163149446|NCT03724942|589259518|FG000|Overall Study|Lack of Efficacy|0|||
163149447|NCT03724942|589259519|FG001|Overall Study|Lack of Efficacy|1|||
163149448|NCT03724942|589259518|FG000|Overall Study|Physician Decision|5|||
163149449|NCT03724942|589259519|FG001|Overall Study|Physician Decision|2|||
163149450|NCT03724942|589259518|FG000|Overall Study|Protocol Violation|1|||
163149451|NCT03724942|589259519|FG001|Overall Study|Protocol Violation|0|||
163149452|NCT03724942|589259518|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
163149453|NCT03724942|589259519|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
163149454|NCT03724942|589259518|FG000|Overall Study|Withdrawal by Legal Representative|3|||
163149455|NCT03724942|589259519|FG001|Overall Study|Withdrawal by Legal Representative|0|||
163149456|NCT02994108|589261414|FG000|Intervention Messages|Withdrawal by Subject|2|||
163149457|NCT02994108|589261415|FG001|Intervention Messages|Withdrawal by Subject|0|||
163149458|NCT02994108|589261414|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
163149459|NCT02994108|589261415|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
163149460|NCT02994108|589261414|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
163149461|NCT02994108|589261415|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
163149462|NCT02994108|589261414|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
163149463|NCT02994108|589261415|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
163149464|NCT00904969|589261416|FG000|Overall Study|Lost to Follow-up|4|||
163149465|NCT00904969|589261416|FG000|Overall Study|Withdrawal by Subject|3|||
163149466|NCT00904969|589261416|FG000|Overall Study|Additional Treatments|11|||
163149467|NCT00904969|589261416|FG000|Overall Study|Case Aborted; Subject Exited|1|||
162667529|NCT02265705|587493617|FG004|Treatment Period Week 0-24|Adverse Event|0|||
162667530|NCT02265705|587493618|FG005|Treatment Period Week 0-24|Adverse Event|0|||
162667531|NCT02265705|587493619|FG006|Treatment Period Week 0-24|Adverse Event|0|||
162667532|NCT02265705|587493613|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
162667533|NCT02265705|587493614|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
162667534|NCT02265705|587493615|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162667535|NCT02265705|587493616|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162667536|NCT02265705|587493617|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162667537|NCT02265705|587493618|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162667538|NCT02265705|587493619|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162667539|NCT02265705|587493613|FG000|Treatment Period Week 0-24|Physician Decision|1|||
162667540|NCT02265705|587493614|FG001|Treatment Period Week 0-24|Physician Decision|0|||
162667541|NCT02265705|587493615|FG002|Treatment Period Week 0-24|Physician Decision|0|||
162667542|NCT02265705|587493616|FG003|Treatment Period Week 0-24|Physician Decision|0|||
162667543|NCT02265705|587493617|FG004|Treatment Period Week 0-24|Physician Decision|0|||
162667544|NCT02265705|587493618|FG005|Treatment Period Week 0-24|Physician Decision|0|||
162667545|NCT02265705|587493619|FG006|Treatment Period Week 0-24|Physician Decision|0|||
162667546|NCT02265705|587493613|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
162667547|NCT02265705|587493614|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
162667548|NCT02265705|587493615|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162667549|NCT02265705|587493616|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162667550|NCT02265705|587493617|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162667551|NCT02265705|587493618|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162667552|NCT02265705|587493619|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162667553|NCT02265705|587493613|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667554|NCT02265705|587493614|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
162667555|NCT02265705|587493615|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667556|NCT02265705|587493616|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667557|NCT02265705|587493617|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667558|NCT02265705|587493618|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667559|NCT02265705|587493619|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
162667560|NCT02265705|587493613|FG000|Rescue Period|Withdrawal by Subject|0|||
162667561|NCT02265705|587493614|FG001|Rescue Period|Withdrawal by Subject|0|||
162667562|NCT02265705|587493615|FG002|Rescue Period|Withdrawal by Subject|1|||
162667563|NCT02265705|587493616|FG003|Rescue Period|Withdrawal by Subject|0|||
162667564|NCT02265705|587493617|FG004|Rescue Period|Withdrawal by Subject|0|||
162667565|NCT02265705|587493618|FG005|Rescue Period|Withdrawal by Subject|0|||
162667566|NCT02265705|587493619|FG006|Rescue Period|Withdrawal by Subject|0|||
162667567|NCT02265705|587493613|FG000|Rescue Period|Death|0|||
162667568|NCT02265705|587493614|FG001|Rescue Period|Death|0|||
162667569|NCT02265705|587493615|FG002|Rescue Period|Death|1|||
162667570|NCT02265705|587493616|FG003|Rescue Period|Death|0|||
162667571|NCT02265705|587493617|FG004|Rescue Period|Death|0|||
162667572|NCT02265705|587493618|FG005|Rescue Period|Death|0|||
162667573|NCT02265705|587493619|FG006|Rescue Period|Death|0|||
162667574|NCT02265705|587493613|FG000|Rescue Period|Lack of Efficacy|0|||
162667575|NCT02265705|587493614|FG001|Rescue Period|Lack of Efficacy|0|||
162667576|NCT02265705|587493615|FG002|Rescue Period|Lack of Efficacy|1|||
162667577|NCT02265705|587493616|FG003|Rescue Period|Lack of Efficacy|0|||
162667578|NCT02265705|587493617|FG004|Rescue Period|Lack of Efficacy|0|||
162667579|NCT02265705|587493618|FG005|Rescue Period|Lack of Efficacy|0|||
162667580|NCT02265705|587493619|FG006|Rescue Period|Lack of Efficacy|0|||
162667581|NCT02265705|587493613|FG000|Open Label Period|Adverse Event|0|||
162667582|NCT02265705|587493614|FG001|Open Label Period|Adverse Event|0|||
162667583|NCT02265705|587493615|FG002|Open Label Period|Adverse Event|0|||
162667584|NCT02265705|587493616|FG003|Open Label Period|Adverse Event|2|||
162667585|NCT02265705|587493617|FG004|Open Label Period|Adverse Event|2|||
162667586|NCT02265705|587493618|FG005|Open Label Period|Adverse Event|0|||
162667587|NCT02265705|587493619|FG006|Open Label Period|Adverse Event|0|||
162721694|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721695|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721696|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162721697|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
162721698|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
162667588|NCT02265705|587493613|FG000|Open Label Period|Physician Decision|0|||
162667589|NCT02265705|587493614|FG001|Open Label Period|Physician Decision|0|||
162667590|NCT02265705|587493615|FG002|Open Label Period|Physician Decision|0|||
162667591|NCT02265705|587493616|FG003|Open Label Period|Physician Decision|0|||
162667592|NCT02265705|587493617|FG004|Open Label Period|Physician Decision|1|||
162667593|NCT02265705|587493618|FG005|Open Label Period|Physician Decision|0|||
162667594|NCT02265705|587493619|FG006|Open Label Period|Physician Decision|0|||
162667595|NCT02265705|587493613|FG000|Open Label Period|Withdrawal by Subject|0|||
162667596|NCT02265705|587493614|FG001|Open Label Period|Withdrawal by Subject|0|||
162667597|NCT02265705|587493615|FG002|Open Label Period|Withdrawal by Subject|0|||
162721699|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
162667598|NCT02265705|587493616|FG003|Open Label Period|Withdrawal by Subject|0|||
162667599|NCT02265705|587493617|FG004|Open Label Period|Withdrawal by Subject|2|||
162667600|NCT02265705|587493618|FG005|Open Label Period|Withdrawal by Subject|0|||
162667601|NCT02265705|587493619|FG006|Open Label Period|Withdrawal by Subject|0|||
162667602|NCT02265705|587493613|FG000|Follow-up Period|Sponsor Decision|0|||
162667603|NCT02265705|587493614|FG001|Follow-up Period|Sponsor Decision|0|||
162667604|NCT02265705|587493615|FG002|Follow-up Period|Sponsor Decision|0|||
162667605|NCT02265705|587493616|FG003|Follow-up Period|Sponsor Decision|0|||
162667606|NCT02265705|587493617|FG004|Follow-up Period|Sponsor Decision|0|||
162667607|NCT02265705|587493618|FG005|Follow-up Period|Sponsor Decision|1|||
162667608|NCT02265705|587493619|FG006|Follow-up Period|Sponsor Decision|6|||
162667609|NCT02265705|587493613|FG000|Follow-up Period|Adverse Event|0|||
162667610|NCT02265705|587493614|FG001|Follow-up Period|Adverse Event|0|||
162667611|NCT02265705|587493615|FG002|Follow-up Period|Adverse Event|0|||
162667612|NCT02265705|587493616|FG003|Follow-up Period|Adverse Event|0|||
162667613|NCT02265705|587493617|FG004|Follow-up Period|Adverse Event|0|||
162667614|NCT02265705|587493618|FG005|Follow-up Period|Adverse Event|0|||
162667615|NCT02265705|587493619|FG006|Follow-up Period|Adverse Event|3|||
162667616|NCT02265705|587493613|FG000|Follow-up Period|Physician Decision|0|||
162667617|NCT02265705|587493614|FG001|Follow-up Period|Physician Decision|0|||
162667618|NCT02265705|587493615|FG002|Follow-up Period|Physician Decision|0|||
162667619|NCT02265705|587493616|FG003|Follow-up Period|Physician Decision|0|||
162667620|NCT02265705|587493617|FG004|Follow-up Period|Physician Decision|0|||
162667621|NCT02265705|587493618|FG005|Follow-up Period|Physician Decision|0|||
162667622|NCT02265705|587493619|FG006|Follow-up Period|Physician Decision|1|||
162667623|NCT02265705|587493613|FG000|Follow-up Period|Withdrawal by Subject|0|||
162667624|NCT02265705|587493614|FG001|Follow-up Period|Withdrawal by Subject|0|||
162667625|NCT02265705|587493615|FG002|Follow-up Period|Withdrawal by Subject|0|||
162667626|NCT02265705|587493616|FG003|Follow-up Period|Withdrawal by Subject|0|||
162667627|NCT02265705|587493617|FG004|Follow-up Period|Withdrawal by Subject|0|||
162667628|NCT02265705|587493618|FG005|Follow-up Period|Withdrawal by Subject|0|||
162667629|NCT02265705|587493619|FG006|Follow-up Period|Withdrawal by Subject|1|||
162667630|NCT02828111|587493624|FG000|Overall Study|Withdrawal by Subject|0|||
162667631|NCT02828111|587493625|FG001|Overall Study|Withdrawal by Subject|0|||
162667632|NCT02828111|587493626|FG002|Overall Study|Withdrawal by Subject|2|||
162667633|NCT02828111|587493627|FG003|Overall Study|Withdrawal by Subject|0|||
162667634|NCT02828111|587493628|FG004|Overall Study|Withdrawal by Subject|0|||
162667635|NCT02828111|587493624|FG000|Overall Study|Lost to Follow-up|0|||
162667636|NCT02828111|587493625|FG001|Overall Study|Lost to Follow-up|0|||
162667637|NCT02828111|587493626|FG002|Overall Study|Lost to Follow-up|0|||
162667638|NCT02828111|587493627|FG003|Overall Study|Lost to Follow-up|1|||
162667639|NCT02828111|587493628|FG004|Overall Study|Lost to Follow-up|1|||
162667640|NCT00614939|587493629|FG000|Overall Study|Withdrawal by Subject|10|||
162667641|NCT00614939|587493630|FG001|Overall Study|Withdrawal by Subject|17|||
162667642|NCT00614939|587493629|FG000|Overall Study|Study specific discontinuation criteris|13|||
162667643|NCT00614939|587493630|FG001|Overall Study|Study specific discontinuation criteris|16|||
162667644|NCT00614939|587493629|FG000|Overall Study|Adverse Event|2|||
162667645|NCT00614939|587493630|FG001|Overall Study|Adverse Event|5|||
162667646|NCT00614939|587493629|FG000|Overall Study|Incorrect enrollment|1|||
162667647|NCT00614939|587493630|FG001|Overall Study|Incorrect enrollment|2|||
162667648|NCT00614939|587493629|FG000|Overall Study|Death|4|||
162667649|NCT00614939|587493630|FG001|Overall Study|Death|3|||
162667650|NCT00614939|587493629|FG000|Overall Study|Poor/non-compliance|4|||
162667651|NCT00614939|587493630|FG001|Overall Study|Poor/non-compliance|0|||
162667652|NCT00614939|587493629|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
162667653|NCT00614939|587493630|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
162667654|NCT02079805|587493634|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162667655|NCT02079805|587493635|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162667656|NCT02079805|587493634|FG000|Overall Study|Voluntary Withdrawal|0|||
162667657|NCT02079805|587493635|FG001|Overall Study|Voluntary Withdrawal|1|||
162667658|NCT01753193|587493636|FG000|Overall Study|Withdrawal by Subject|23|||
162667659|NCT01753193|587493636|FG000|Overall Study|Lost to Follow-up|6|||
162667660|NCT01753193|587493636|FG000|Overall Study|Death|1|||
162667661|NCT01753193|587493636|FG000|Overall Study|Other|16|||
162667662|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
162667663|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
162667664|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
162667665|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
162667666|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
162667667|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162667668|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
162667669|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162667670|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
162667671|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
162667672|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
162667673|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
162667674|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
162667675|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162667676|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162667677|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
162667678|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
162667679|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
162667680|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
162667681|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
162667682|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
162667683|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
162667684|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
162667685|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
162667686|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
162667687|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
162667688|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
162667689|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
162667690|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
162667691|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
162667692|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
162667693|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
162667694|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
162667695|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162667696|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
162667697|NCT00383435|587493637|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
162667698|NCT00383435|587493638|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
162667699|NCT00383435|587493639|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
162667700|NCT00383435|587493640|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
162667701|NCT00383435|587493641|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
162667702|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
162667703|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
162667704|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
162667705|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
162667706|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
162667707|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162667708|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162667709|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
163149468|NCT01295814|589261423|FG000|Overall Study|Lack of Efficacy|0|||
163149469|NCT01295814|589261424|FG001|Overall Study|Lack of Efficacy|2|||
163149470|NCT01295814|589261423|FG000|Overall Study|Withdrawal by Subject|2|||
163149471|NCT01295814|589261424|FG001|Overall Study|Withdrawal by Subject|0|||
163149472|NCT03414983|589261425|FG000|Pre-Treatment|Other reasons|1|||
163149473|NCT03414983|589261426|FG001|Pre-Treatment|Other reasons|0|||
163149474|NCT03414983|589261425|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163149475|NCT03414983|589261426|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
163149476|NCT03414983|589261425|FG000|Pre-Treatment|Participant withdrew consent|1|||
163149477|NCT03414983|589261426|FG001|Pre-Treatment|Participant withdrew consent|3|||
163149478|NCT03414983|589261425|FG000|Treatment|Participant withdrew consent|4|||
163149479|NCT03414983|589261426|FG001|Treatment|Participant withdrew consent|3|||
163149480|NCT03414983|589261425|FG000|Treatment|Participant request to discontinue study treatment|8|||
163149481|NCT03414983|589261426|FG001|Treatment|Participant request to discontinue study treatment|10|||
163149482|NCT03414983|589261425|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
163149483|NCT03414983|589261426|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
163149484|NCT03414983|589261425|FG000|Treatment|Death|0|||
163149485|NCT03414983|589261426|FG001|Treatment|Death|1|||
163149486|NCT03414983|589261425|FG000|Treatment|Study Drug Toxicity|10|||
163149487|NCT03414983|589261426|FG001|Treatment|Study Drug Toxicity|5|||
163149488|NCT03414983|589261425|FG000|Treatment|Disease Progression|75|||
163149489|NCT03414983|589261426|FG001|Treatment|Disease Progression|29|||
163149490|NCT03414983|589261425|FG000|Treatment|Not reported|1|||
163149491|NCT03414983|589261426|FG001|Treatment|Not reported|0|||
163149492|NCT03414983|589261425|FG000|Treatment|Other reasons|3|||
163149493|NCT03414983|589261426|FG001|Treatment|Other reasons|2|||
163149494|NCT03414983|589261425|FG000|Treatment|Poor/non-compliance|2|||
163149495|NCT03414983|589261426|FG001|Treatment|Poor/non-compliance|0|||
163149496|NCT03414983|589261425|FG000|Treatment|Maximum clinical benefit|5|||
163149497|NCT03414983|589261426|FG001|Treatment|Maximum clinical benefit|9|||
163149498|NCT03414983|589261425|FG000|Treatment|Lost to Follow-up|0|||
162667710|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162667711|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
162667712|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162667713|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
162667714|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162667715|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162667716|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162667717|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
162667718|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
162667719|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
162667720|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
162667721|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
162667722|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162667723|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
162667724|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
162667725|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
162667726|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162667727|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
162667728|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162667729|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162667730|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162667731|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
162667732|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162667733|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162667734|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162667735|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162667736|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162667737|NCT00383435|587493637|FG000|26-Week Treatment Safety Extension|Administrative|1|||
162667738|NCT00383435|587493638|FG001|26-Week Treatment Safety Extension|Administrative|1|||
162667739|NCT00383435|587493639|FG002|26-Week Treatment Safety Extension|Administrative|0|||
162667740|NCT00383435|587493640|FG003|26-Week Treatment Safety Extension|Administrative|1|||
162667741|NCT00383435|587493641|FG004|26-Week Treatment Safety Extension|Administrative|0|||
162667742|NCT00583557|587493642|FG000|Overall Study|Withdrawal by Subject|18|||
162667743|NCT00583557|587493642|FG000|Overall Study|Adverse Event|9|||
162667744|NCT00583557|587493642|FG000|Overall Study|Lack of Efficacy|31|||
162667745|NCT00583557|587493642|FG000|Overall Study|Lack of Compliance|5|||
162667746|NCT00583557|587493642|FG000|Overall Study|Other|5|||
162667747|NCT00583557|587493642|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
162667748|NCT02347761|587493643|FG000|All Collected|Death|1|||
162667749|NCT02347761|587493644|FG001|All Collected|Death|0|||
162667750|NCT02347761|587493645|FG002|All Collected|Death|0|||
162667751|NCT02347761|587493643|FG000|All Collected|Lost to Follow-up|3|||
162667752|NCT02347761|587493644|FG001|All Collected|Lost to Follow-up|2|||
162667753|NCT02347761|587493645|FG002|All Collected|Lost to Follow-up|3|||
162667754|NCT02347761|587493643|FG000|All Collected|Withdrawal by Subject|11|||
162667755|NCT02347761|587493644|FG001|All Collected|Withdrawal by Subject|11|||
162667756|NCT02347761|587493645|FG002|All Collected|Withdrawal by Subject|22|||
162667757|NCT02347761|587493643|FG000|All Collected|invetigator disretion|2|||
162667758|NCT02347761|587493644|FG001|All Collected|invetigator disretion|0|||
162667759|NCT02347761|587493645|FG002|All Collected|invetigator disretion|0|||
162667760|NCT02347761|587493643|FG000|All Collected|instillation site pain|0|||
162667761|NCT02347761|587493644|FG001|All Collected|instillation site pain|0|||
162667762|NCT02347761|587493645|FG002|All Collected|instillation site pain|1|||
162667763|NCT02347761|587493643|FG000|All Collected|exacerbation of COPD|0|||
162667764|NCT02347761|587493644|FG001|All Collected|exacerbation of COPD|0|||
162667765|NCT02347761|587493645|FG002|All Collected|exacerbation of COPD|1|||
162667766|NCT02347761|587493643|FG000|All Collected|moved/travel|0|||
162667767|NCT02347761|587493644|FG001|All Collected|moved/travel|1|||
162667768|NCT02347761|587493645|FG002|All Collected|moved/travel|0|||
162667769|NCT02347761|587493643|FG000|On Study Treatment|Lack of Efficacy|2|||
162667770|NCT02347761|587493644|FG001|On Study Treatment|Lack of Efficacy|3|||
162667771|NCT02347761|587493645|FG002|On Study Treatment|Lack of Efficacy|4|||
162667772|NCT02347761|587493643|FG000|On Study Treatment|non-compliance with study medication|0|||
162667773|NCT02347761|587493644|FG001|On Study Treatment|non-compliance with study medication|0|||
162667774|NCT02347761|587493645|FG002|On Study Treatment|non-compliance with study medication|2|||
162667775|NCT02347761|587493643|FG000|On Study Treatment|Withdrawal by Subject|7|||
162667776|NCT02347761|587493644|FG001|On Study Treatment|Withdrawal by Subject|3|||
162667777|NCT02347761|587493645|FG002|On Study Treatment|Withdrawal by Subject|5|||
162667778|NCT02347761|587493643|FG000|On Study Treatment|move/travel|2|||
162667779|NCT02347761|587493644|FG001|On Study Treatment|move/travel|6|||
162667780|NCT02347761|587493645|FG002|On Study Treatment|move/travel|5|||
162667781|NCT02347761|587493643|FG000|On Study Treatment|dissastisfaction with device|2|||
162667782|NCT02347761|587493644|FG001|On Study Treatment|dissastisfaction with device|1|||
162667783|NCT02347761|587493645|FG002|On Study Treatment|dissastisfaction with device|4|||
162667784|NCT02347761|587493643|FG000|On Study Treatment|Lost to Follow-up|2|||
162667785|NCT02347761|587493644|FG001|On Study Treatment|Lost to Follow-up|1|||
162667786|NCT02347761|587493645|FG002|On Study Treatment|Lost to Follow-up|1|||
162667787|NCT02347761|587493643|FG000|On Study Treatment|investigator discretion|2|||
162667788|NCT02347761|587493644|FG001|On Study Treatment|investigator discretion|0|||
162667789|NCT02347761|587493645|FG002|On Study Treatment|investigator discretion|0|||
162667790|NCT02347761|587493643|FG000|On Study Treatment|durg not working|0|||
162667791|NCT02347761|587493644|FG001|On Study Treatment|durg not working|1|||
162667792|NCT02347761|587493645|FG002|On Study Treatment|durg not working|1|||
162667793|NCT02347761|587493643|FG000|On Study Treatment|Adverse Event|10|||
162667794|NCT02347761|587493644|FG001|On Study Treatment|Adverse Event|8|||
162667795|NCT02347761|587493645|FG002|On Study Treatment|Adverse Event|20|||
162667796|NCT01131312|587493646|FG000|Overall Study|Lost to Follow-up|425|||
162667797|NCT01131312|587493647|FG001|Overall Study|Lost to Follow-up|229|||
162667798|NCT01131312|587493648|FG002|Overall Study|Lost to Follow-up|351|||
162667799|NCT02682264|587493649|FG000|Overall Study|Withdrawal by Subject|56|||
162721700|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
162667800|NCT02682264|587493650|FG001|Overall Study|Withdrawal by Subject|45|||
162667801|NCT02682264|587493649|FG000|Overall Study|Lost to Follow-up|49|||
162667802|NCT02682264|587493650|FG001|Overall Study|Lost to Follow-up|41|||
162667803|NCT02682264|587493649|FG000|Overall Study|Lack of Efficacy|14|||
162667804|NCT02682264|587493650|FG001|Overall Study|Lack of Efficacy|16|||
162667805|NCT02682264|587493649|FG000|Overall Study|Withdrawal by Parent|6|||
162667806|NCT02682264|587493650|FG001|Overall Study|Withdrawal by Parent|7|||
162667807|NCT02682264|587493649|FG000|Overall Study|Adverse Event|9|||
162667808|NCT02682264|587493650|FG001|Overall Study|Adverse Event|0|||
162667809|NCT02682264|587493649|FG000|Overall Study|Noncompliance with study drug|1|||
162667810|NCT02682264|587493650|FG001|Overall Study|Noncompliance with study drug|4|||
162667811|NCT02682264|587493649|FG000|Overall Study|Pregnancy|1|||
162667812|NCT02682264|587493650|FG001|Overall Study|Pregnancy|2|||
162667813|NCT02682264|587493649|FG000|Overall Study|Recovery|1|||
162667814|NCT02682264|587493650|FG001|Overall Study|Recovery|2|||
162667815|NCT02682264|587493649|FG000|Overall Study|Progressive Disease|1|||
162667816|NCT02682264|587493650|FG001|Overall Study|Progressive Disease|0|||
162667817|NCT02682264|587493649|FG000|Overall Study|Technical Problems|0|||
162667818|NCT02682264|587493650|FG001|Overall Study|Technical Problems|1|||
162667819|NCT02682264|587493649|FG000|Overall Study|Moved abroad and unable to continue|0|||
162667820|NCT02682264|587493650|FG001|Overall Study|Moved abroad and unable to continue|3|||
162667821|NCT02682264|587493649|FG000|Overall Study|Stopped test article application|0|||
162667822|NCT02682264|587493650|FG001|Overall Study|Stopped test article application|1|||
162667823|NCT01255358|587493651|FG000|Overall Study|Adverse Event|2|||
162667824|NCT01255358|587493651|FG000|Overall Study|Protocol Violation|2|||
162667825|NCT04079933|587493654|FG000|Overall Study|Withdrawal by Subject|3|||
162667826|NCT04079933|587493655|FG001|Overall Study|Withdrawal by Subject|4|||
162667827|NCT04079933|587493654|FG000|Overall Study|Lost to Follow-up|0|||
162667828|NCT04079933|587493655|FG001|Overall Study|Lost to Follow-up|1|||
162667829|NCT03207750|587493656|FG000|Overall Study|Adverse Event|3|||
162667830|NCT03207750|587493657|FG001|Overall Study|Adverse Event|2|||
162667831|NCT03207750|587493656|FG000|Overall Study|Lost to Follow-up|21|||
162667832|NCT03207750|587493657|FG001|Overall Study|Lost to Follow-up|29|||
162667833|NCT03207750|587493656|FG000|Overall Study|Protocol Violation|0|||
162667834|NCT03207750|587493657|FG001|Overall Study|Protocol Violation|1|||
162667835|NCT03207750|587493656|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
162667836|NCT03207750|587493657|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
162667837|NCT03207750|587493656|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
162667838|NCT03207750|587493657|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
162667839|NCT03207750|587493656|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
162667840|NCT03207750|587493657|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
162667841|NCT03207750|587493656|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
162667842|NCT03207750|587493657|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
162667843|NCT03207750|587493656|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
162667844|NCT03207750|587493657|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
162667845|NCT02493361|587493658|FG000|Overall Study|Withdrawal by Subject|3|||
162667846|NCT02937545|587493662|FG000|Overall Study|Withdrawal by Subject|1|||
162667847|NCT02937545|587493663|FG001|Overall Study|Withdrawal by Subject|2|||
162721701|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721702|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
162667848|NCT02937545|587493664|FG002|Overall Study|Withdrawal by Subject|6|||
162667849|NCT02937545|587493665|FG003|Overall Study|Withdrawal by Subject|7|||
162667850|NCT02937545|587493662|FG000|Overall Study|Lost to Follow-up|1|||
162667851|NCT02937545|587493663|FG001|Overall Study|Lost to Follow-up|0|||
162667852|NCT02937545|587493664|FG002|Overall Study|Lost to Follow-up|0|||
162667853|NCT02937545|587493665|FG003|Overall Study|Lost to Follow-up|0|||
162667854|NCT02504294|587493668|FG000|Overall Study|Adverse Event|15|||
162667855|NCT02504294|587493669|FG001|Overall Study|Adverse Event|12|||
162667856|NCT02504294|587493668|FG000|Overall Study|Withdrawal by Subject|7|||
163149499|NCT03414983|589261426|FG001|Treatment|Lost to Follow-up|1|||
163149500|NCT03414983|589261425|FG000|Treatment|Administrative reasons by sponsor|1|||
163149501|NCT03414983|589261426|FG001|Treatment|Administrative reasons by sponsor|0|||
163149502|NCT04515771|589261431|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
163149503|NCT04515771|589261432|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
163149504|NCT04515771|589261431|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
163149505|NCT04515771|589261432|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
163149506|NCT04515771|589261431|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
163149507|NCT04515771|589261432|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
163149508|NCT00948246|589261436|FG000|Overall Study|Lost to Follow-up|11|||
163149509|NCT00948246|589261436|FG000|Overall Study|Adverse Event|11|||
163149510|NCT00948246|589261436|FG000|Overall Study|Death|1|||
163149511|NCT00948246|589261436|FG000|Overall Study|Withdrawal by Subject|1|||
163149512|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
163149513|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
162667857|NCT02504294|587493669|FG001|Overall Study|Withdrawal by Subject|1|||
162667858|NCT02504294|587493668|FG000|Overall Study|Protocol Violation|27|||
162667859|NCT02504294|587493669|FG001|Overall Study|Protocol Violation|26|||
162667860|NCT02504294|587493668|FG000|Overall Study|Physician Decision|1|||
162667861|NCT02504294|587493669|FG001|Overall Study|Physician Decision|2|||
162667862|NCT02504294|587493668|FG000|Overall Study|Lost to Follow-up|6|||
162667863|NCT02504294|587493669|FG001|Overall Study|Lost to Follow-up|7|||
162667864|NCT02252211|587493670|FG000|Overall Study|Adverse Event|0|||
162667865|NCT02252211|587493671|FG001|Overall Study|Adverse Event|1|||
162667866|NCT02252211|587493672|FG002|Overall Study|Adverse Event|0|||
162667867|NCT02252211|587493670|FG000|Overall Study|Progressive disease|3|||
162667868|NCT02252211|587493671|FG001|Overall Study|Progressive disease|2|||
162667869|NCT02252211|587493672|FG002|Overall Study|Progressive disease|0|||
162667870|NCT02252211|587493670|FG000|Overall Study|Withdrawal by Subject|1|||
162667871|NCT02252211|587493671|FG001|Overall Study|Withdrawal by Subject|0|||
162667872|NCT02252211|587493672|FG002|Overall Study|Withdrawal by Subject|0|||
162667873|NCT02252211|587493670|FG000|Overall Study|Serious Adverse Event During Screening|1|||
162667874|NCT02252211|587493671|FG001|Overall Study|Serious Adverse Event During Screening|0|||
162667875|NCT02252211|587493672|FG002|Overall Study|Serious Adverse Event During Screening|1|||
162667876|NCT05799495|587493679|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
162667877|NCT05799495|587493680|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
162667878|NCT05799495|587493681|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
162667879|NCT05799495|587493682|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
162667880|NCT05799495|587493679|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162667881|NCT05799495|587493680|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162667882|NCT05799495|587493681|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162667883|NCT05799495|587493682|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
162667884|NCT05799495|587493679|FG000|Treatment (Up to 5 Days)|Other|0|||
162667885|NCT05799495|587493680|FG001|Treatment (Up to 5 Days)|Other|1|||
162667886|NCT05799495|587493681|FG002|Treatment (Up to 5 Days)|Other|0|||
162667887|NCT05799495|587493682|FG003|Treatment (Up to 5 Days)|Other|0|||
162667888|NCT05799495|587493679|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162667889|NCT05799495|587493680|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162667890|NCT05799495|587493681|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162667891|NCT05799495|587493682|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
162667892|NCT05799495|587493679|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
162667893|NCT05799495|587493680|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
162667894|NCT05799495|587493681|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
162667895|NCT05799495|587493682|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
162667896|NCT05799495|587493679|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162667897|NCT05799495|587493680|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162667898|NCT05799495|587493681|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
162667899|NCT05799495|587493682|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162667900|NCT03694548|587493686|FG000|Part A Survey|Protocol Violation|3|||
162667901|NCT03694548|587493687|FG001|Part A Survey|Protocol Violation|3|||
162667902|NCT03694548|587493688|FG002|Part A Survey|Protocol Violation|0|||
162667903|NCT03694548|587493686|FG000|Part B Yoga Program|Protocol Violation|0|||
162667904|NCT03694548|587493687|FG001|Part B Yoga Program|Protocol Violation|0|||
162667905|NCT03694548|587493688|FG002|Part B Yoga Program|Protocol Violation|3|||
162667906|NCT03694548|587493686|FG000|Part B Yoga Program|Did not attend intervention|0|||
162667907|NCT03694548|587493687|FG001|Part B Yoga Program|Did not attend intervention|0|||
162667908|NCT03694548|587493688|FG002|Part B Yoga Program|Did not attend intervention|8|||
162667909|NCT04177108|587493689|FG000|Overall Study|Withdrawal by Subject|4|||
162667910|NCT04177108|587493690|FG001|Overall Study|Withdrawal by Subject|8|||
162667911|NCT04177108|587493691|FG002|Overall Study|Withdrawal by Subject|9|||
162667912|NCT04177108|587493692|FG003|Overall Study|Withdrawal by Subject|11|||
162667913|NCT04177108|587493693|FG004|Overall Study|Withdrawal by Subject|13|||
162667914|NCT04177108|587493689|FG000|Overall Study|Physician Decision|23|||
162667915|NCT04177108|587493690|FG001|Overall Study|Physician Decision|15|||
162667916|NCT04177108|587493691|FG002|Overall Study|Physician Decision|18|||
162667917|NCT04177108|587493692|FG003|Overall Study|Physician Decision|29|||
162667918|NCT04177108|587493693|FG004|Overall Study|Physician Decision|23|||
162667919|NCT04177108|587493689|FG000|Overall Study|Reason Not Specified|0|||
162667920|NCT04177108|587493690|FG001|Overall Study|Reason Not Specified|1|||
162667921|NCT04177108|587493691|FG002|Overall Study|Reason Not Specified|0|||
162667922|NCT04177108|587493692|FG003|Overall Study|Reason Not Specified|0|||
163149514|NCT00148317|589261437|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
163149515|NCT03623243|589261442|FG000|Overall Study|Adverse Event|15|||
163149516|NCT03623243|589261442|FG000|Overall Study|Guardian Decision|1|||
162667923|NCT04177108|587493693|FG004|Overall Study|Reason Not Specified|2|||
162667924|NCT04177108|587493689|FG000|Overall Study|Lost to Follow-up|0|||
162667925|NCT04177108|587493690|FG001|Overall Study|Lost to Follow-up|0|||
162667926|NCT04177108|587493691|FG002|Overall Study|Lost to Follow-up|1|||
162667927|NCT04177108|587493692|FG003|Overall Study|Lost to Follow-up|1|||
162667928|NCT04177108|587493693|FG004|Overall Study|Lost to Follow-up|1|||
162667929|NCT04177108|587493689|FG000|Overall Study|Death|16|||
162667930|NCT04177108|587493690|FG001|Overall Study|Death|19|||
162667931|NCT04177108|587493691|FG002|Overall Study|Death|13|||
162667932|NCT04177108|587493692|FG003|Overall Study|Death|17|||
162667933|NCT04177108|587493693|FG004|Overall Study|Death|18|||
162667934|NCT00101101|587493694|FG000|Overall Study|never received vaccine|20|||
162667935|NCT01603875|587493695|FG000|Overall Study|Preexisting rabies antibody|3|||
162667936|NCT01603875|587493696|FG001|Overall Study|Preexisting rabies antibody|4|||
162667937|NCT01603875|587493697|FG002|Overall Study|Preexisting rabies antibody|3|||
162667938|NCT01603875|587493695|FG000|Overall Study|Lost to Follow-up|4|||
162667939|NCT01603875|587493696|FG001|Overall Study|Lost to Follow-up|3|||
162667940|NCT01603875|587493697|FG002|Overall Study|Lost to Follow-up|6|||
162667941|NCT01603875|587493695|FG000|Overall Study|Protocol Violation|0|||
162667942|NCT01603875|587493696|FG001|Overall Study|Protocol Violation|1|||
162667943|NCT01603875|587493697|FG002|Overall Study|Protocol Violation|0|||
162667944|NCT01652716|587493701|FG000|Overall Study|Loss of glucose control|1|||
162667945|NCT01652716|587493702|FG001|Overall Study|Loss of glucose control|0|||
162667946|NCT01652716|587493701|FG000|Overall Study|Administrative|0|||
162667947|NCT01652716|587493702|FG001|Overall Study|Administrative|2|||
162667948|NCT01652716|587493701|FG000|Overall Study|Investigator decision|1|||
162667949|NCT01652716|587493702|FG001|Overall Study|Investigator decision|4|||
162667950|NCT01652716|587493701|FG000|Overall Study|Lost to Follow-up|12|||
162667951|NCT01652716|587493702|FG001|Overall Study|Lost to Follow-up|11|||
162667952|NCT01652716|587493701|FG000|Overall Study|Protocol Violation|2|||
162667953|NCT01652716|587493702|FG001|Overall Study|Protocol Violation|1|||
162667954|NCT01652716|587493701|FG000|Overall Study|Adverse Event|7|||
162667955|NCT01652716|587493702|FG001|Overall Study|Adverse Event|10|||
162667956|NCT01652716|587493701|FG000|Overall Study|Withdrawal by Subject|33|||
162667957|NCT01652716|587493702|FG001|Overall Study|Withdrawal by Subject|18|||
162667958|NCT04122443|587493705|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
162667959|NCT04122443|587493706|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
162667960|NCT04122443|587493707|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
162667961|NCT04122443|587493705|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
162667962|NCT04122443|587493706|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
162667963|NCT04122443|587493707|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
162667964|NCT05204134|587493708|FG000|Overall Study|Withdrawal by Subject|3|||
162667965|NCT05204134|587493708|FG000|Overall Study|Physician Decision|1|||
162667966|NCT01312467|587493712|FG000|Overall Study|Adverse Event|4|||
162667967|NCT01312467|587493712|FG000|Overall Study|Lost to Follow-up|1|||
162667968|NCT01312467|587493712|FG000|Overall Study|Withdrawal by Subject|2|||
162667969|NCT01312467|587493712|FG000|Overall Study|Deported to country of origin|1|||
162667970|NCT01312467|587493712|FG000|Overall Study|Another medical condition|1|||
162667971|NCT01312467|587493712|FG000|Overall Study|Ineligible|4|||
162667972|NCT01059617|587493713|FG000|Overall Study|Other|7|||
162667973|NCT01059617|587493714|FG001|Overall Study|Other|1|||
162667974|NCT01059617|587493715|FG002|Overall Study|Other|8|||
162667975|NCT01059617|587493716|FG003|Overall Study|Other|6|||
162667976|NCT01968434|587493719|FG000|Overall Study|Lost to Follow-up|3|||
162667977|NCT01968434|587493720|FG001|Overall Study|Lost to Follow-up|6|||
162667978|NCT02199691|587493721|FG000|Overall Study|Protocol Violation|3|||
162667979|NCT02199691|587493722|FG001|Overall Study|Protocol Violation|3|||
162667980|NCT02199691|587493723|FG002|Overall Study|Protocol Violation|6|||
162667981|NCT02199691|587493724|FG003|Overall Study|Protocol Violation|7|||
162667982|NCT02199691|587493721|FG000|Overall Study|Withdrawal by Subject|5|||
162667983|NCT02199691|587493722|FG001|Overall Study|Withdrawal by Subject|3|||
162667984|NCT02199691|587493723|FG002|Overall Study|Withdrawal by Subject|12|||
162667985|NCT02199691|587493724|FG003|Overall Study|Withdrawal by Subject|13|||
162667986|NCT02199691|587493721|FG000|Overall Study|Lost to Follow-up|2|||
162667987|NCT02199691|587493722|FG001|Overall Study|Lost to Follow-up|1|||
162667988|NCT02199691|587493723|FG002|Overall Study|Lost to Follow-up|9|||
162667989|NCT02199691|587493724|FG003|Overall Study|Lost to Follow-up|10|||
162667990|NCT00612313|587493727|FG000|Overall Study|Withdrawal by Subject|6|||
162667991|NCT00612313|587493728|FG001|Overall Study|Withdrawal by Subject|9|||
162667992|NCT00612313|587493727|FG000|Overall Study|Lost to Follow-up|11|||
162667993|NCT00612313|587493728|FG001|Overall Study|Lost to Follow-up|4|||
162667994|NCT00136955|587495664|FG000|Overall Study|Adverse Event|8|||
162667995|NCT00136955|587495664|FG000|Overall Study|Lost to Follow-up|1|||
162667996|NCT00136955|587495664|FG000|Overall Study|Withdrawal by Subject|2|||
162667997|NCT00136955|587495664|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
163149517|NCT03623243|589261442|FG000|Overall Study|New Therapy for Study Indication|1|||
163149518|NCT03623243|589261442|FG000|Overall Study|Protocol Deviation|3|||
163149519|NCT03623243|589261442|FG000|Overall Study|Physician Decision|4|||
163149520|NCT03623243|589261442|FG000|Overall Study|Patient Decision|15|||
162667998|NCT01773226|587495665|FG000|Overall Study|Withdrawal by Subject|1|||
162667999|NCT00724282|587495668|FG000|Overall Study|Withdrawal by Subject|3|||
163149521|NCT03007966|589261443|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
163149522|NCT03007966|589261444|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
162668000|NCT00724282|587495668|FG000|Overall Study|Physician Decision|1|||
162668001|NCT00970502|587495669|FG000|Overall Study|Withdrawal by Subject|1|||
162668002|NCT01438411|587495670|FG000|Overall Study|Adverse Event|8|||
162668003|NCT01438411|587495670|FG000|Overall Study|Lost to Follow-up|1|||
162668004|NCT01438411|587495670|FG000|Overall Study|Lack of Efficacy|1|||
162668005|NCT01438411|587495670|FG000|Overall Study|Withdrawal by Subject|3|||
162668006|NCT01863680|587495671|FG000|Overall Study|Adverse Event|17|||
162668007|NCT01863680|587495671|FG000|Overall Study|Risk of OHSS|17|||
162668008|NCT01863680|587495671|FG000|Overall Study|Spontaneous pregnancy|2|||
162668009|NCT01863680|587495671|FG000|Overall Study|Withdrawal by Subject|1|||
162668010|NCT01863680|587495671|FG000|Overall Study|Did not undergo IVF/ET|14|||
162668011|NCT01863680|587495671|FG000|Overall Study|Other|6|||
162668012|NCT00618514|587495672|FG000|Overall Study|Lost to Follow-up|11|||
162668013|NCT00618514|587495673|FG001|Overall Study|Lost to Follow-up|12|||
162668014|NCT00618514|587495674|FG002|Overall Study|Lost to Follow-up|4|||
162668015|NCT00566228|587495681|FG000|Overall Study|Withdrawal by Subject|1|||
162668016|NCT00566228|587495682|FG001|Overall Study|Withdrawal by Subject|0|||
162668017|NCT00566228|587495681|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
162668018|NCT00566228|587495682|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
162668019|NCT00566228|587495681|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
162668020|NCT00566228|587495682|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
162668021|NCT00566228|587495681|FG000|Overall Study|progressed before infusion could occur|0|||
162668022|NCT00566228|587495682|FG001|Overall Study|progressed before infusion could occur|1|||
162721703|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
162668023|NCT03320070|587495685|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
162668024|NCT03320070|587495686|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
162668025|NCT03320070|587495685|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
162668026|NCT03320070|587495686|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
162668027|NCT03320070|587495685|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
162721704|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721705|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721706|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721707|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
162668028|NCT03320070|587495686|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
162668029|NCT03320070|587495685|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
162668030|NCT03320070|587495686|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
162668031|NCT03320070|587495685|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
162668032|NCT03320070|587495686|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
162668033|NCT03320070|587495685|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
162668034|NCT03320070|587495686|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
162668035|NCT03586648|587495687|FG000|Period 1|Withdrawal by Subject|0|||
162668036|NCT03586648|587495688|FG001|Period 1|Withdrawal by Subject|1|||
162668037|NCT03586648|587495687|FG000|Period 1|Lost to Follow-up|1|||
162668038|NCT03586648|587495688|FG001|Period 1|Lost to Follow-up|1|||
162668039|NCT03586648|587495687|FG000|Period 1|Adverse Event|1|||
162668040|NCT03586648|587495688|FG001|Period 1|Adverse Event|0|||
162668041|NCT03586648|587495687|FG000|Period 1|Study related symptoms or complaints|2|||
162668042|NCT03586648|587495688|FG001|Period 1|Study related symptoms or complaints|1|||
162668043|NCT03586648|587495687|FG000|Period 1|Physician Decision|0|||
162668044|NCT03586648|587495688|FG001|Period 1|Physician Decision|1|||
162668045|NCT03586648|587495687|FG000|Period 2|Adverse Event|1|||
162668046|NCT03586648|587495688|FG001|Period 2|Adverse Event|0|||
162668047|NCT02041195|587495689|FG000|Overall Study|Adverse Event|1|||
162668048|NCT02041195|587495690|FG001|Overall Study|Adverse Event|2|||
162668049|NCT02041195|587495691|FG002|Overall Study|Adverse Event|0|||
162668050|NCT02041195|587495692|FG003|Overall Study|Adverse Event|0|||
162668051|NCT02041195|587495693|FG004|Overall Study|Adverse Event|0|||
162668052|NCT02041195|587495694|FG005|Overall Study|Adverse Event|0|||
162668053|NCT02041195|587495695|FG006|Overall Study|Adverse Event|3|||
162668054|NCT02041195|587495696|FG007|Overall Study|Adverse Event|0|||
162668055|NCT02041195|587495689|FG000|Overall Study|Withdrawal by Subject|1|||
162668056|NCT02041195|587495690|FG001|Overall Study|Withdrawal by Subject|0|||
162668057|NCT02041195|587495691|FG002|Overall Study|Withdrawal by Subject|0|||
162668058|NCT02041195|587495692|FG003|Overall Study|Withdrawal by Subject|0|||
162668059|NCT02041195|587495693|FG004|Overall Study|Withdrawal by Subject|0|||
162668060|NCT02041195|587495694|FG005|Overall Study|Withdrawal by Subject|0|||
162668061|NCT02041195|587495695|FG006|Overall Study|Withdrawal by Subject|4|||
162668062|NCT02041195|587495696|FG007|Overall Study|Withdrawal by Subject|3|||
162668063|NCT02041195|587495689|FG000|Overall Study|Unable to comply with study visits|0|||
162668064|NCT02041195|587495690|FG001|Overall Study|Unable to comply with study visits|1|||
162668065|NCT02041195|587495691|FG002|Overall Study|Unable to comply with study visits|0|||
162668066|NCT02041195|587495692|FG003|Overall Study|Unable to comply with study visits|0|||
162668067|NCT02041195|587495693|FG004|Overall Study|Unable to comply with study visits|1|||
162668068|NCT02041195|587495694|FG005|Overall Study|Unable to comply with study visits|0|||
162668069|NCT02041195|587495695|FG006|Overall Study|Unable to comply with study visits|0|||
162668070|NCT02041195|587495696|FG007|Overall Study|Unable to comply with study visits|0|||
162668071|NCT02367911|587495699|FG000|Overall Study|Withdrawal by Subject|3|||
162668072|NCT02367911|587495700|FG001|Overall Study|Withdrawal by Subject|2|||
162668073|NCT02367911|587495699|FG000|Overall Study|Lost to Follow-up|2|||
162668074|NCT02367911|587495700|FG001|Overall Study|Lost to Follow-up|2|||
162668075|NCT00263666|587495701|FG000|Overall Study|Adverse Event|6|||
162668076|NCT00263666|587495702|FG001|Overall Study|Adverse Event|8|||
162668077|NCT00263666|587495701|FG000|Overall Study|Lost to Follow-up|1|||
162668078|NCT00263666|587495702|FG001|Overall Study|Lost to Follow-up|2|||
162668079|NCT00263666|587495701|FG000|Overall Study|Withdrawal by Subject|0|||
162668080|NCT00263666|587495702|FG001|Overall Study|Withdrawal by Subject|1|||
162668081|NCT00896168|587495703|FG000|Overall Study|Adverse Event|4|||
162668082|NCT00896168|587495704|FG001|Overall Study|Adverse Event|7|||
162668083|NCT00896168|587495703|FG000|Overall Study|Treatment failure|8|||
162668084|NCT00896168|587495704|FG001|Overall Study|Treatment failure|10|||
162668085|NCT00896168|587495703|FG000|Overall Study|Lost to Follow-up|1|||
162668086|NCT00896168|587495704|FG001|Overall Study|Lost to Follow-up|1|||
162668087|NCT00896168|587495703|FG000|Overall Study|Other|1|||
162668088|NCT00896168|587495704|FG001|Overall Study|Other|1|||
162668089|NCT00902304|587495705|FG000|Overall Study|Adverse Event|4|||
162668090|NCT00902304|587495706|FG001|Overall Study|Adverse Event|10|||
162668091|NCT00902304|587495707|FG002|Overall Study|Adverse Event|25|||
162668092|NCT00902304|587495705|FG000|Overall Study|Investigator discretion|3|||
162668093|NCT00902304|587495706|FG001|Overall Study|Investigator discretion|5|||
162668094|NCT00902304|587495707|FG002|Overall Study|Investigator discretion|13|||
162668095|NCT00902304|587495705|FG000|Overall Study|Lost to Follow-up|7|||
162668096|NCT00902304|587495706|FG001|Overall Study|Lost to Follow-up|7|||
162668097|NCT00902304|587495707|FG002|Overall Study|Lost to Follow-up|7|||
162668098|NCT00902304|587495705|FG000|Overall Study|Protocol Violation|9|||
162668099|NCT00902304|587495706|FG001|Overall Study|Protocol Violation|18|||
162668100|NCT00902304|587495707|FG002|Overall Study|Protocol Violation|20|||
162668101|NCT00902304|587495705|FG000|Overall Study|Withdrawal by Subject|32|||
162668102|NCT00902304|587495706|FG001|Overall Study|Withdrawal by Subject|22|||
162668103|NCT00902304|587495707|FG002|Overall Study|Withdrawal by Subject|43|||
162668104|NCT00902304|587495705|FG000|Overall Study|includes pregnancy|3|||
162668105|NCT00902304|587495706|FG001|Overall Study|includes pregnancy|9|||
162668106|NCT00902304|587495707|FG002|Overall Study|includes pregnancy|2|||
162668107|NCT02492100|587495708|FG000|Overall Study|Death|1|||
162668108|NCT03832010|587495709|FG000|Overall Study|Withdrawal by Subject|2|||
162668109|NCT03832010|587495710|FG001|Overall Study|Withdrawal by Subject|1|||
162668110|NCT03832010|587495711|FG002|Overall Study|Withdrawal by Subject|0|||
162668111|NCT03832010|587495709|FG000|Overall Study|Lost to Follow-up|2|||
162668112|NCT03832010|587495710|FG001|Overall Study|Lost to Follow-up|1|||
162668113|NCT03832010|587495711|FG002|Overall Study|Lost to Follow-up|1|||
162721708|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721709|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721710|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
162668114|NCT04969783|587495712|FG000|Overall Study|Lost to Follow-up|2|||
162668115|NCT04969783|587495713|FG001|Overall Study|Lost to Follow-up|0|||
162668116|NCT04969783|587495712|FG000|Overall Study|Withdrawal by Subject|4|||
162668117|NCT04969783|587495713|FG001|Overall Study|Withdrawal by Subject|0|||
162668118|NCT04969783|587495712|FG000|Overall Study|Physician Decision|6|||
162668119|NCT04969783|587495713|FG001|Overall Study|Physician Decision|0|||
162668120|NCT02489500|587495714|FG000|Overall Study|Death|1|||
162668121|NCT02489500|587495715|FG001|Overall Study|Death|1|||
162668122|NCT00987467|587495720|FG000|Overall Study|Lost to Follow-up|2|||
162668123|NCT00512135|587495721|FG000|Overall Study|Not Treated|5|||
162668124|NCT00512135|587495721|FG000|Overall Study|Lack of Efficacy|2|||
162668125|NCT00512135|587495721|FG000|Overall Study|Adverse Event|6|||
162668126|NCT00512135|587495721|FG000|Overall Study|Withdrawal by Subject|22|||
162668127|NCT00512135|587495721|FG000|Overall Study|Lost to Follow-up|27|||
162668128|NCT00512135|587495721|FG000|Overall Study|Other|22|||
162668129|NCT00262834|587495722|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
162668130|NCT00262834|587495723|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
162668131|NCT03422250|587495724|FG000|Intervention|Adverse Event|0|||
162668132|NCT03422250|587495725|FG001|Intervention|Adverse Event|1|||
162668133|NCT03422250|587495726|FG002|Intervention|Adverse Event|0|||
162668134|NCT03422250|587495727|FG003|Intervention|Adverse Event|1|||
162668135|NCT03422250|587495724|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
162668136|NCT03422250|587495725|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
162668137|NCT03422250|587495726|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
162668138|NCT03422250|587495727|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
162668139|NCT03422250|587495724|FG000|Follow-up|Withdrawal by Subject|0|||
162668140|NCT03422250|587495725|FG001|Follow-up|Withdrawal by Subject|0|||
162668141|NCT03422250|587495726|FG002|Follow-up|Withdrawal by Subject|0|||
162668142|NCT03422250|587495727|FG003|Follow-up|Withdrawal by Subject|1|||
162668143|NCT03422250|587495724|FG000|Follow-up|Adverse Event|0|||
162668144|NCT03422250|587495725|FG001|Follow-up|Adverse Event|0|||
162668145|NCT03422250|587495726|FG002|Follow-up|Adverse Event|0|||
162668146|NCT03422250|587495727|FG003|Follow-up|Adverse Event|1|||
162668147|NCT00377819|587495730|FG000|Overall Study|Adverse Event|2|||
162668148|NCT00377819|587495731|FG001|Overall Study|Adverse Event|3|||
162668149|NCT00377819|587495730|FG000|Overall Study|Withdrawal by Subject|10|||
162668150|NCT00377819|587495731|FG001|Overall Study|Withdrawal by Subject|4|||
162668151|NCT00377819|587495730|FG000|Overall Study|Death|0|||
162668152|NCT00377819|587495731|FG001|Overall Study|Death|1|||
162668153|NCT00377819|587495730|FG000|Overall Study|Lost to Follow-up|0|||
162668154|NCT00377819|587495731|FG001|Overall Study|Lost to Follow-up|1|||
162668155|NCT00377819|587495730|FG000|Overall Study|Protocol Violation|1|||
162668156|NCT00377819|587495731|FG001|Overall Study|Protocol Violation|1|||
162668157|NCT02416791|587495732|FG000|6 Months|Lost to Follow-up|0|||
162668158|NCT02416791|587495733|FG001|6 Months|Lost to Follow-up|0|||
162668159|NCT02416791|587495734|FG002|6 Months|Lost to Follow-up|1|||
162668160|NCT01054820|587495735|FG000|Overall Study|Withdrawal by Subject|2|||
162668161|NCT00467870|587495742|FG000|Overall Study|Adverse Event|13|||
162668162|NCT00467870|587495743|FG001|Overall Study|Adverse Event|9|||
162668163|NCT00467870|587495744|FG002|Overall Study|Adverse Event|1|||
162668164|NCT00467870|587495745|FG003|Overall Study|Adverse Event|15|||
162668165|NCT00467870|587495746|FG004|Overall Study|Adverse Event|15|||
162668166|NCT00467870|587495747|FG005|Overall Study|Adverse Event|1|||
162668167|NCT00467870|587495742|FG000|Overall Study|Protocol Violation|2|||
162668168|NCT00467870|587495743|FG001|Overall Study|Protocol Violation|1|||
162668169|NCT00467870|587495744|FG002|Overall Study|Protocol Violation|1|||
162668170|NCT00467870|587495745|FG003|Overall Study|Protocol Violation|2|||
162668171|NCT00467870|587495746|FG004|Overall Study|Protocol Violation|0|||
162668172|NCT00467870|587495747|FG005|Overall Study|Protocol Violation|0|||
162668173|NCT00467870|587495742|FG000|Overall Study|Withdrawal by Subject|14|||
162668174|NCT00467870|587495743|FG001|Overall Study|Withdrawal by Subject|21|||
162668175|NCT00467870|587495744|FG002|Overall Study|Withdrawal by Subject|0|||
162668176|NCT00467870|587495745|FG003|Overall Study|Withdrawal by Subject|9|||
162668177|NCT00467870|587495746|FG004|Overall Study|Withdrawal by Subject|10|||
162668178|NCT00467870|587495747|FG005|Overall Study|Withdrawal by Subject|1|||
162668179|NCT00467870|587495742|FG000|Overall Study|Lost to Follow-up|5|||
162668180|NCT00467870|587495743|FG001|Overall Study|Lost to Follow-up|3|||
162668181|NCT00467870|587495744|FG002|Overall Study|Lost to Follow-up|1|||
162668182|NCT00467870|587495745|FG003|Overall Study|Lost to Follow-up|1|||
162668183|NCT00467870|587495746|FG004|Overall Study|Lost to Follow-up|3|||
162668184|NCT00467870|587495747|FG005|Overall Study|Lost to Follow-up|0|||
162668185|NCT00467870|587495742|FG000|Overall Study|Subject Non-compliance|3|||
162668186|NCT00467870|587495743|FG001|Overall Study|Subject Non-compliance|4|||
162668187|NCT00467870|587495744|FG002|Overall Study|Subject Non-compliance|0|||
162668188|NCT00467870|587495745|FG003|Overall Study|Subject Non-compliance|1|||
162668189|NCT00467870|587495746|FG004|Overall Study|Subject Non-compliance|5|||
162668190|NCT00467870|587495747|FG005|Overall Study|Subject Non-compliance|0|||
162668191|NCT00467870|587495742|FG000|Overall Study|Other/Unknown|8|||
162668192|NCT00467870|587495743|FG001|Overall Study|Other/Unknown|5|||
162668193|NCT00467870|587495744|FG002|Overall Study|Other/Unknown|1|||
162668194|NCT00467870|587495745|FG003|Overall Study|Other/Unknown|5|||
162668195|NCT00467870|587495746|FG004|Overall Study|Other/Unknown|4|||
162668196|NCT00467870|587495747|FG005|Overall Study|Other/Unknown|0|||
162668197|NCT03489304|587495748|FG000|Overall Study|Lost to Follow-up|4|||
162668198|NCT02239679|587495749|FG000|Overall Study|Lost to Follow-up|1|||
162668199|NCT02239679|587495750|FG001|Overall Study|Lost to Follow-up|0|||
162668200|NCT02239679|587495751|FG002|Overall Study|Lost to Follow-up|0|||
162668201|NCT02239679|587495749|FG000|Overall Study|Withdrawal by Subject|2|||
162668202|NCT02239679|587495750|FG001|Overall Study|Withdrawal by Subject|3|||
162668203|NCT02239679|587495751|FG002|Overall Study|Withdrawal by Subject|1|||
162668204|NCT01917526|587495752|FG000|Overall Study|Protocol Violation|1|||
162668205|NCT01917526|587495753|FG001|Overall Study|Protocol Violation|1|||
162668206|NCT00760929|587495757|FG000|Overall Study|Adverse Event|2|||
162668207|NCT00760929|587495758|FG001|Overall Study|Adverse Event|0|||
162668208|NCT00760929|587495759|FG002|Overall Study|Adverse Event|6|||
162668209|NCT00760929|587495760|FG003|Overall Study|Adverse Event|10|||
162668210|NCT00760929|587495757|FG000|Overall Study|Lack of Efficacy|0|||
162668211|NCT00760929|587495758|FG001|Overall Study|Lack of Efficacy|2|||
162668212|NCT00760929|587495759|FG002|Overall Study|Lack of Efficacy|1|||
162668213|NCT00760929|587495760|FG003|Overall Study|Lack of Efficacy|0|||
162668214|NCT00760929|587495757|FG000|Overall Study|Withdrawal by Subject|1|||
162668215|NCT00760929|587495758|FG001|Overall Study|Withdrawal by Subject|0|||
162668216|NCT00760929|587495759|FG002|Overall Study|Withdrawal by Subject|9|||
162668217|NCT00760929|587495760|FG003|Overall Study|Withdrawal by Subject|1|||
162668218|NCT00760929|587495757|FG000|Overall Study|Lost to Follow-up|0|||
162668219|NCT00760929|587495758|FG001|Overall Study|Lost to Follow-up|0|||
162668220|NCT00760929|587495759|FG002|Overall Study|Lost to Follow-up|1|||
162668221|NCT00760929|587495760|FG003|Overall Study|Lost to Follow-up|0|||
162668222|NCT00760929|587495757|FG000|Overall Study|Progression of Disease|21|||
162668223|NCT00760929|587495758|FG001|Overall Study|Progression of Disease|26|||
162668224|NCT00760929|587495759|FG002|Overall Study|Progression of Disease|38|||
162668225|NCT00760929|587495760|FG003|Overall Study|Progression of Disease|42|||
162668226|NCT00760929|587495757|FG000|Overall Study|Other|2|||
162668227|NCT00760929|587495758|FG001|Overall Study|Other|0|||
162668228|NCT00760929|587495759|FG002|Overall Study|Other|2|||
162668229|NCT00760929|587495760|FG003|Overall Study|Other|1|||
162668230|NCT00760929|587495757|FG000|Overall Study|Death|0|||
162668231|NCT00760929|587495758|FG001|Overall Study|Death|0|||
162668232|NCT00760929|587495759|FG002|Overall Study|Death|1|||
162668233|NCT00760929|587495760|FG003|Overall Study|Death|0|||
162668234|NCT00760929|587495757|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162668235|NCT00760929|587495758|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
162668236|NCT00760929|587495759|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
162668237|NCT00760929|587495760|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
162668238|NCT04408469|587495767|FG000|Overall Study|Lost to Follow-up|6|||
162668239|NCT04408469|587495768|FG001|Overall Study|Lost to Follow-up|9|||
162668240|NCT04408469|587495767|FG000|Overall Study|Withdrawal by Subject|6|||
162668241|NCT04408469|587495768|FG001|Overall Study|Withdrawal by Subject|1|||
162668242|NCT04408469|587495767|FG000|Overall Study|Dismissal due to ineligibility|0|||
162668243|NCT04408469|587495768|FG001|Overall Study|Dismissal due to ineligibility|1|||
162668244|NCT04321460|587495769|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
162668245|NCT04321460|587495770|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
162668246|NCT03669081|587495773|FG000|Overall Study|Data could not be validated|1|||
162668247|NCT03669081|587495774|FG001|Overall Study|Data could not be validated|1|||
162668248|NCT01308749|587495779|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
162668249|NCT01308749|587495780|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
162668250|NCT01308749|587495779|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
162668251|NCT01308749|587495780|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
162668252|NCT01308749|587495779|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
162668253|NCT01308749|587495780|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
162668254|NCT02546544|587495781|FG000|Overall Study|Disease Progression|14|||
162668255|NCT02546544|587495781|FG000|Overall Study|Adverse Event|1|||
162668256|NCT02546544|587495781|FG000|Overall Study|Withdrawal by Subject|1|||
162668257|NCT02223390|587495782|FG000|Overall Study|Lost to Follow-up|9|||
162668258|NCT02223390|587495783|FG001|Overall Study|Lost to Follow-up|4|||
162668259|NCT01197950|587495787|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
162668260|NCT01197950|587495788|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
162668261|NCT01197950|587495789|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
162668262|NCT02553330|587495790|FG000|Overall Study|Study Terminated by Sponsor|2|||
162668263|NCT02553330|587495791|FG001|Overall Study|Study Terminated by Sponsor|13|||
162668264|NCT02553330|587495792|FG002|Overall Study|Study Terminated by Sponsor|12|||
162668265|NCT02553330|587495790|FG000|Overall Study|Withdrawal by Subject|3|||
162668266|NCT02553330|587495791|FG001|Overall Study|Withdrawal by Subject|19|||
162668267|NCT02553330|587495792|FG002|Overall Study|Withdrawal by Subject|21|||
162668268|NCT02553330|587495790|FG000|Overall Study|Other|0|||
162668269|NCT02553330|587495791|FG001|Overall Study|Other|1|||
162668270|NCT02553330|587495792|FG002|Overall Study|Other|0|||
162668271|NCT02553330|587495790|FG000|Overall Study|Non compliance to study treatment|0|||
162668272|NCT02553330|587495791|FG001|Overall Study|Non compliance to study treatment|1|||
162668273|NCT02553330|587495792|FG002|Overall Study|Non compliance to study treatment|0|||
162668274|NCT02553330|587495790|FG000|Overall Study|Adverse Event|0|||
162668275|NCT02553330|587495791|FG001|Overall Study|Adverse Event|1|||
162668276|NCT02553330|587495792|FG002|Overall Study|Adverse Event|0|||
162668277|NCT02553330|587495790|FG000|Overall Study|Lost to Follow-up|0|||
162668278|NCT02553330|587495791|FG001|Overall Study|Lost to Follow-up|4|||
162668279|NCT02553330|587495792|FG002|Overall Study|Lost to Follow-up|4|||
162668280|NCT01666002|587495793|FG000|Overall Study|Lost to Follow-up|5|||
162668281|NCT01666002|587495794|FG001|Overall Study|Lost to Follow-up|0|||
162668282|NCT02511431|587495795|FG000|Treatment|Lost to Follow-up|0|||
162668283|NCT02511431|587495796|FG001|Treatment|Lost to Follow-up|0|||
162668284|NCT02511431|587495797|FG002|Treatment|Lost to Follow-up|1|||
162668285|NCT02511431|587495798|FG003|Treatment|Lost to Follow-up|0|||
162668286|NCT02511431|587495799|FG004|Treatment|Lost to Follow-up|0|||
162668287|NCT02511431|587495800|FG005|Treatment|Lost to Follow-up|1|||
162668288|NCT00346034|587495817|FG000|Overall Study|Adverse Event|34|||
162668289|NCT00346034|587495817|FG000|Overall Study|Lack of Efficacy|8|||
162668290|NCT00346034|587495817|FG000|Overall Study|Withdrawal by Subject|13|||
162668291|NCT00346034|587495817|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
162668292|NCT00346034|587495817|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
162668293|NCT00099983|587495819|FG000|Overall Study|Lost to Follow-up|2|||
162668294|NCT00099983|587495820|FG001|Overall Study|Lost to Follow-up|3|||
162668295|NCT00099983|587495819|FG000|Overall Study|Missing Source Documents|14|||
162668296|NCT00099983|587495820|FG001|Overall Study|Missing Source Documents|15|||
162668297|NCT00099983|587495819|FG000|Overall Study|Withdrawal by Subject|3|||
162668298|NCT00099983|587495820|FG001|Overall Study|Withdrawal by Subject|2|||
162668299|NCT00099983|587495819|FG000|Overall Study|Adverse Event|1|||
162668300|NCT00099983|587495820|FG001|Overall Study|Adverse Event|1|||
162668301|NCT00099983|587495819|FG000|Overall Study|Lack of Efficacy|0|||
162668302|NCT00099983|587495820|FG001|Overall Study|Lack of Efficacy|1|||
162668303|NCT00099983|587495819|FG000|Overall Study|Unable to return for appointments|1|||
162668304|NCT00099983|587495820|FG001|Overall Study|Unable to return for appointments|1|||
162668305|NCT00099983|587495819|FG000|Overall Study|Moved|1|||
162668306|NCT00099983|587495820|FG001|Overall Study|Moved|0|||
162668307|NCT00099983|587495819|FG000|Overall Study|Other psychiatric problem|1|||
162668308|NCT00099983|587495820|FG001|Overall Study|Other psychiatric problem|0|||
162668309|NCT00099983|587495819|FG000|Overall Study|Incarcerated|0|||
162668310|NCT00099983|587495820|FG001|Overall Study|Incarcerated|1|||
162668311|NCT00099983|587495819|FG000|Overall Study|Intolerant of burden of visits|0|||
162668312|NCT00099983|587495820|FG001|Overall Study|Intolerant of burden of visits|1|||
162668313|NCT00099983|587495819|FG000|Overall Study|Other issue|1|||
162668314|NCT00099983|587495820|FG001|Overall Study|Other issue|0|||
162668315|NCT02641080|587495821|FG000|Overall Study|Physician Decision|2|||
162668316|NCT02641080|587495822|FG001|Overall Study|Physician Decision|0|||
162668317|NCT02641080|587495821|FG000|Overall Study|Withdrawal by Subject|0|||
162668318|NCT02641080|587495822|FG001|Overall Study|Withdrawal by Subject|1|||
162668319|NCT02641080|587495821|FG000|Overall Study|Rehab Center denied use of pumps|0|||
162668320|NCT02641080|587495822|FG001|Overall Study|Rehab Center denied use of pumps|3|||
162668321|NCT02641080|587495821|FG000|Overall Study|Lost to Follow-up|0|||
162668322|NCT02641080|587495822|FG001|Overall Study|Lost to Follow-up|3|||
162668323|NCT06281548|587495823|FG000|Overall Study|Lost to Follow-up|3|||
162668324|NCT03835533|587495824|FG000|Overall Study|Death|5|||
162668325|NCT03835533|587495825|FG001|Overall Study|Death|10|||
162668326|NCT03835533|587495826|FG002|Overall Study|Death|9|||
162668327|NCT03835533|587495824|FG000|Overall Study|Withdrawal by Subject|2|||
162668328|NCT03835533|587495825|FG001|Overall Study|Withdrawal by Subject|2|||
162668329|NCT03835533|587495826|FG002|Overall Study|Withdrawal by Subject|2|||
162668330|NCT03835533|587495824|FG000|Overall Study|Lost to Follow-up|1|||
162668331|NCT03835533|587495825|FG001|Overall Study|Lost to Follow-up|0|||
162668332|NCT03835533|587495826|FG002|Overall Study|Lost to Follow-up|0|||
162668333|NCT01866709|587495830|FG000|Overall Study|Adverse Event|1|||
162668334|NCT01866709|587495831|FG001|Overall Study|Adverse Event|0|||
162668335|NCT02207829|587495833|FG000|Overall Study|Adverse Event|10|||
162668336|NCT02207829|587495834|FG001|Overall Study|Adverse Event|9|||
162668337|NCT02207829|587495833|FG000|Overall Study|Lack of Efficacy|7|||
162668338|NCT02207829|587495834|FG001|Overall Study|Lack of Efficacy|5|||
162668339|NCT02207829|587495833|FG000|Overall Study|Lost to Follow-up|2|||
162668340|NCT02207829|587495834|FG001|Overall Study|Lost to Follow-up|2|||
162668341|NCT02207829|587495833|FG000|Overall Study|Protocol deviation|5|||
162668342|NCT02207829|587495834|FG001|Overall Study|Protocol deviation|4|||
162668343|NCT02207829|587495833|FG000|Overall Study|Withdrew consent|18|||
162668344|NCT02207829|587495834|FG001|Overall Study|Withdrew consent|14|||
162668345|NCT03285477|587495836|FG000|Treatment and Response Assessment Period|Death|1|||
162668346|NCT03285477|587495837|FG001|Treatment and Response Assessment Period|Death|0|||
162668347|NCT03285477|587495836|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
162668348|NCT03285477|587495837|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
162668349|NCT03285477|587495836|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
162668350|NCT03285477|587495837|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
162668351|NCT03285477|587495836|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
162668352|NCT03285477|587495837|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
162668353|NCT03285477|587495836|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
162668354|NCT03285477|587495837|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
162668355|NCT00560833|587495850|FG000|Overall Study|Adverse Event|16|||
162668356|NCT00560833|587495851|FG001|Overall Study|Adverse Event|10|||
162668357|NCT00560833|587495852|FG002|Overall Study|Adverse Event|25|||
162668358|NCT00560833|587495853|FG003|Overall Study|Adverse Event|23|||
162668359|NCT00560833|587495854|FG004|Overall Study|Adverse Event|35|||
162668360|NCT00560833|587495850|FG000|Overall Study|Lost to Follow-up|0|||
162668361|NCT00560833|587495851|FG001|Overall Study|Lost to Follow-up|0|||
162668362|NCT00560833|587495852|FG002|Overall Study|Lost to Follow-up|1|||
162668363|NCT00560833|587495853|FG003|Overall Study|Lost to Follow-up|0|||
162668364|NCT00560833|587495854|FG004|Overall Study|Lost to Follow-up|0|||
162668365|NCT00560833|587495850|FG000|Overall Study|Lack of Efficacy|22|||
162668366|NCT00560833|587495851|FG001|Overall Study|Lack of Efficacy|9|||
162668367|NCT00560833|587495852|FG002|Overall Study|Lack of Efficacy|6|||
162668368|NCT00560833|587495853|FG003|Overall Study|Lack of Efficacy|4|||
162668369|NCT00560833|587495854|FG004|Overall Study|Lack of Efficacy|4|||
162668370|NCT00560833|587495850|FG000|Overall Study|Participant uncooperative|5|||
162668371|NCT00560833|587495851|FG001|Overall Study|Participant uncooperative|5|||
162668372|NCT00560833|587495852|FG002|Overall Study|Participant uncooperative|4|||
162668373|NCT00560833|587495853|FG003|Overall Study|Participant uncooperative|4|||
162668374|NCT00560833|587495854|FG004|Overall Study|Participant uncooperative|2|||
163149523|NCT00474487|589261448|FG000|Overall Study|Withdrawal by Subject|6|||
163149524|NCT00474487|589261449|FG001|Overall Study|Withdrawal by Subject|0|||
163149525|NCT00474487|589261450|FG002|Overall Study|Withdrawal by Subject|0|||
163149526|NCT00474487|589261451|FG003|Overall Study|Withdrawal by Subject|0|||
163149527|NCT00474487|589261448|FG000|Overall Study|Lost to Follow-up|20|||
163149528|NCT00474487|589261449|FG001|Overall Study|Lost to Follow-up|1|||
163149529|NCT00474487|589261450|FG002|Overall Study|Lost to Follow-up|7|||
163149530|NCT00474487|589261451|FG003|Overall Study|Lost to Follow-up|0|||
163149531|NCT00474487|589261448|FG000|Overall Study|Inappropriate enrollment|4|||
163149532|NCT00474487|589261449|FG001|Overall Study|Inappropriate enrollment|0|||
163149533|NCT00474487|589261450|FG002|Overall Study|Inappropriate enrollment|7|||
163149534|NCT00474487|589261451|FG003|Overall Study|Inappropriate enrollment|0|||
163149535|NCT00474487|589261448|FG000|Overall Study|Death|0|||
163149536|NCT00474487|589261449|FG001|Overall Study|Death|1|||
163149537|NCT00474487|589261450|FG002|Overall Study|Death|0|||
163149538|NCT00474487|589261451|FG003|Overall Study|Death|0|||
163149539|NCT03924622|589261452|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
163149540|NCT03924622|589261453|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149541|NCT03924622|589261454|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149542|NCT03924622|589261455|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
163149543|NCT03924622|589261456|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149544|NCT03924622|589261457|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
163149545|NCT00248625|589261458|FG000|Overall Study|Withdrawal by Subject|0|||
163149546|NCT00248625|589261459|FG001|Overall Study|Withdrawal by Subject|2|||
163149547|NCT03085095|589261462|FG000|Overall Study|Adverse Event|23|||
163149548|NCT03085095|589261463|FG001|Overall Study|Adverse Event|8|||
163149549|NCT03085095|589261462|FG000|Overall Study|Protocol Violation|0|||
163149550|NCT03085095|589261463|FG001|Overall Study|Protocol Violation|1|||
163149551|NCT03085095|589261462|FG000|Overall Study|Lost to Follow-up|2|||
163149552|NCT03085095|589261463|FG001|Overall Study|Lost to Follow-up|1|||
163149553|NCT03085095|589261462|FG000|Overall Study|Withdrawal by Subject|17|||
163149554|NCT03085095|589261463|FG001|Overall Study|Withdrawal by Subject|6|||
163149555|NCT03085095|589261462|FG000|Overall Study|Physician Decision|9|||
163149556|NCT03085095|589261463|FG001|Overall Study|Physician Decision|3|||
163149557|NCT03085095|589261462|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
163149558|NCT03085095|589261463|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
163149559|NCT03085095|589261462|FG000|Overall Study|Did not Receive Study Drug|2|||
163149560|NCT03085095|589261463|FG001|Overall Study|Did not Receive Study Drug|2|||
163149561|NCT03085095|589261462|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
163149562|NCT03085095|589261463|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
163149563|NCT03284710|589261464|FG000|Overall Study|Withdrawal by Subject|1|||
163149564|NCT03284710|589261465|FG001|Overall Study|Withdrawal by Subject|0|||
163149565|NCT03284710|589261466|FG002|Overall Study|Withdrawal by Subject|1|||
163149566|NCT03284710|589261467|FG003|Overall Study|Withdrawal by Subject|6|||
163149567|NCT03284710|589261464|FG000|Overall Study|Lost to Follow-up|3|||
163149568|NCT03284710|589261465|FG001|Overall Study|Lost to Follow-up|3|||
163149569|NCT03284710|589261466|FG002|Overall Study|Lost to Follow-up|1|||
163149570|NCT03284710|589261467|FG003|Overall Study|Lost to Follow-up|0|||
163149571|NCT03284710|589261464|FG000|Overall Study|Physician Decision|1|||
163149572|NCT03284710|589261465|FG001|Overall Study|Physician Decision|0|||
163149573|NCT03284710|589261466|FG002|Overall Study|Physician Decision|0|||
163149574|NCT03284710|589261467|FG003|Overall Study|Physician Decision|0|||
163149575|NCT03284710|589261464|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163149576|NCT03284710|589261465|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163149577|NCT03284710|589261466|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163149578|NCT03284710|589261467|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163149579|NCT03284710|589261464|FG000|Overall Study|HIV Infection|0|||
163149580|NCT03284710|589261465|FG001|Overall Study|HIV Infection|2|||
162668375|NCT00560833|587495850|FG000|Overall Study|Other|1|||
163149581|NCT03284710|589261466|FG002|Overall Study|HIV Infection|2|||
163149582|NCT03284710|589261467|FG003|Overall Study|HIV Infection|1|||
163149583|NCT05176314|589261470|FG000|Overall Study|Lost to Follow-up|2|||
163149584|NCT05176314|589261470|FG000|Overall Study|Physician Decision|1|||
163149585|NCT05176314|589261470|FG000|Overall Study|Adverse Event|1|||
163149586|NCT05543265|589261472|FG000|Overall Study|Lost to Follow-up|3|||
163149587|NCT05543265|589261473|FG001|Overall Study|Lost to Follow-up|3|||
163149588|NCT05543265|589261472|FG000|Overall Study|Withdrawal by Subject|0|||
163149589|NCT05543265|589261473|FG001|Overall Study|Withdrawal by Subject|1|||
163149590|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
163149591|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
163149592|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
163149593|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Death|9|||
163149594|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Death|0|||
163149595|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Death|0|||
162668376|NCT00560833|587495851|FG001|Overall Study|Other|1|||
162668377|NCT00560833|587495852|FG002|Overall Study|Other|3|||
162668378|NCT00560833|587495853|FG003|Overall Study|Other|0|||
162668379|NCT00560833|587495854|FG004|Overall Study|Other|0|||
162668380|NCT00560833|587495850|FG000|Overall Study|Never received drug|0|||
162668381|NCT00560833|587495851|FG001|Overall Study|Never received drug|1|||
162668382|NCT00560833|587495852|FG002|Overall Study|Never received drug|0|||
162668383|NCT00560833|587495853|FG003|Overall Study|Never received drug|0|||
162668384|NCT00560833|587495854|FG004|Overall Study|Never received drug|1|||
162668385|NCT03283670|587495855|FG000|Placebo Gas|Withdrawal by Subject|2|||
162668386|NCT03283670|587495855|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
162668387|NCT03283670|587495855|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
162668388|NCT01307501|587495858|FG000|Overall Study|Treatment Failure|1|||
162668389|NCT01307501|587495858|FG000|Overall Study|Death|20|||
162668390|NCT01307501|587495858|FG000|Overall Study|Lost to Follow-up|1|||
162668391|NCT01307501|587495858|FG000|Overall Study|Starting Hospice|1|||
162668392|NCT01209624|587495862|FG000|Overall Study|Death|2|||
162668393|NCT01209624|587495862|FG000|Overall Study|Adverse Event|13|||
162668394|NCT01209624|587495862|FG000|Overall Study|Lack of Efficacy|17|||
162668395|NCT01209624|587495862|FG000|Overall Study|Lost to Follow-up|290|||
162668396|NCT01209624|587495862|FG000|Overall Study|Other|4|||
162668397|NCT03564496|587495863|FG000|Overall Study|Withdrawal by Subject|1|||
162668398|NCT03564496|587495864|FG001|Overall Study|Withdrawal by Subject|1|||
162668399|NCT03564496|587495865|FG002|Overall Study|Withdrawal by Subject|0|||
162668400|NCT03564496|587495863|FG000|Overall Study|Screen failure|0|||
162668401|NCT03564496|587495864|FG001|Overall Study|Screen failure|3|||
162668402|NCT03564496|587495865|FG002|Overall Study|Screen failure|0|||
162668403|NCT00428610|587495866|FG000|Overall Study|Death Due to Adverse Event|3|||
162668404|NCT00428610|587495867|FG001|Overall Study|Death Due to Adverse Event|0|||
162668405|NCT00428610|587495868|FG002|Overall Study|Death Due to Adverse Event|5|||
162668406|NCT00428610|587495866|FG000|Overall Study|Death Due to Progressive Disease|0|||
162668407|NCT00428610|587495867|FG001|Overall Study|Death Due to Progressive Disease|0|||
162668408|NCT00428610|587495868|FG002|Overall Study|Death Due to Progressive Disease|2|||
162668409|NCT00428610|587495866|FG000|Overall Study|Adverse Event|2|||
162668410|NCT00428610|587495867|FG001|Overall Study|Adverse Event|3|||
162668411|NCT00428610|587495868|FG002|Overall Study|Adverse Event|2|||
162668412|NCT00428610|587495866|FG000|Overall Study|Investigator Decision|2|||
162668413|NCT00428610|587495867|FG001|Overall Study|Investigator Decision|1|||
162668414|NCT00428610|587495868|FG002|Overall Study|Investigator Decision|1|||
162668415|NCT00428610|587495866|FG000|Overall Study|Progressive Disease|42|||
162668416|NCT00428610|587495867|FG001|Overall Study|Progressive Disease|14|||
162668417|NCT00428610|587495868|FG002|Overall Study|Progressive Disease|22|||
162668418|NCT00428610|587495866|FG000|Overall Study|Withdrawal by Subject|4|||
162668419|NCT00428610|587495867|FG001|Overall Study|Withdrawal by Subject|0|||
162668420|NCT00428610|587495868|FG002|Overall Study|Withdrawal by Subject|0|||
162721711|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
162721712|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
162721713|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
162721714|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721715|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721716|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721717|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721718|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721719|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721720|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721721|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721722|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721723|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
162721724|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
162721725|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721726|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162721727|NCT04707313|587688318|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721728|NCT04707313|587688319|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721729|NCT04707313|587688320|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721730|NCT04707313|587688321|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721731|NCT04707313|587688322|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721732|NCT04707313|587688323|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721733|NCT04707313|587688324|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721734|NCT04707313|587688325|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721735|NCT04707313|587688326|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162721736|NCT04707313|587688327|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
162721737|NCT04707313|587688328|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
162721738|NCT04707313|587688329|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
162721739|NCT04707313|587688330|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
162721740|NCT02459899|587688331|FG000|Overall Study|Adverse Event|1|||
162668421|NCT04827576|587497864|FG000|Overall Study|Death|5|||
162668422|NCT04827576|587497865|FG001|Overall Study|Death|17|||
162668423|NCT04827576|587497866|FG002|Overall Study|Death|17|||
162668424|NCT04827576|587497867|FG003|Overall Study|Death|32|||
162668425|NCT04827576|587497864|FG000|Overall Study|Study Terminated by Sponsor|2|||
162668426|NCT04827576|587497865|FG001|Overall Study|Study Terminated by Sponsor|9|||
162668427|NCT04827576|587497866|FG002|Overall Study|Study Terminated by Sponsor|7|||
162668428|NCT04827576|587497867|FG003|Overall Study|Study Terminated by Sponsor|5|||
162668429|NCT04827576|587497864|FG000|Overall Study|Investigator's Discretion|1|||
162668430|NCT04827576|587497865|FG001|Overall Study|Investigator's Discretion|0|||
162668431|NCT04827576|587497866|FG002|Overall Study|Investigator's Discretion|2|||
162668432|NCT04827576|587497867|FG003|Overall Study|Investigator's Discretion|5|||
162668433|NCT04827576|587497864|FG000|Overall Study|Withdrew Consent|0|||
162668434|NCT04827576|587497865|FG001|Overall Study|Withdrew Consent|3|||
162668435|NCT04827576|587497866|FG002|Overall Study|Withdrew Consent|0|||
162668436|NCT04827576|587497867|FG003|Overall Study|Withdrew Consent|0|||
162668437|NCT04827576|587497864|FG000|Overall Study|Lost to Follow-up|1|||
162668438|NCT04827576|587497865|FG001|Overall Study|Lost to Follow-up|0|||
162668439|NCT04827576|587497866|FG002|Overall Study|Lost to Follow-up|0|||
162668440|NCT04827576|587497867|FG003|Overall Study|Lost to Follow-up|0|||
162668441|NCT00791765|587497868|FG000|Weeks 1 to 12|Adverse Event|0|||
162668442|NCT00791765|587497869|FG001|Weeks 1 to 12|Adverse Event|1|||
162668443|NCT00791765|587497868|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
162721741|NCT02459899|587688332|FG001|Overall Study|Adverse Event|1|||
162721742|NCT02459899|587688333|FG002|Overall Study|Adverse Event|0|||
162721743|NCT02459899|587688334|FG003|Overall Study|Adverse Event|0|||
162721744|NCT02459899|587688331|FG000|Overall Study|Lost to Follow-up|1|||
162721745|NCT02459899|587688332|FG001|Overall Study|Lost to Follow-up|2|||
162668444|NCT00791765|587497869|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
162668445|NCT00791765|587497868|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
162668446|NCT00791765|587497869|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
162668447|NCT00791765|587497868|FG000|Weeks 1 to 12|Physician Decision|1|||
162668448|NCT00791765|587497869|FG001|Weeks 1 to 12|Physician Decision|0|||
162668449|NCT00791765|587497868|FG000|Weeks 1 to 12|Disease progression|3|||
162668450|NCT00791765|587497869|FG001|Weeks 1 to 12|Disease progression|0|||
162668451|NCT00791765|587497868|FG000|Weeks 1 to 12|Ineligibility determined|0|||
162668452|NCT00791765|587497869|FG001|Weeks 1 to 12|Ineligibility determined|3|||
162668453|NCT00791765|587497868|FG000|Weeks 13 to 24|Protocol deviation|2|||
162668454|NCT00791765|587497869|FG001|Weeks 13 to 24|Protocol deviation|0|||
162668455|NCT00791765|587497868|FG000|Weeks 13 to 24|Adverse Event|0|||
162668456|NCT00791765|587497869|FG001|Weeks 13 to 24|Adverse Event|3|||
162668457|NCT00791765|587497868|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
162668458|NCT00791765|587497869|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
162721746|NCT02459899|587688333|FG002|Overall Study|Lost to Follow-up|0|||
163149596|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
163149597|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163149598|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163149599|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
163149600|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
163149601|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
163149602|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Other|135|||
163149603|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Other|0|||
163149604|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Other|0|||
163149605|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
163149606|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
163149607|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
163149608|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
163149609|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
163149610|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
163149611|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
163149612|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
163149613|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
163149614|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Other|3|||
163149615|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Other|0|||
163149616|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Other|0|||
163149617|NCT02118584|589261474|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
163149618|NCT02118584|589261475|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162668459|NCT00791765|587497868|FG000|Weeks 13 to 24|Disease progression|0|||
162668460|NCT00791765|587497869|FG001|Weeks 13 to 24|Disease progression|1|||
162668461|NCT00791765|587497868|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
162668462|NCT00791765|587497869|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
162668463|NCT00791765|587497868|FG000|Weeks 13 to 24|Other|0|||
162668464|NCT00791765|587497869|FG001|Weeks 13 to 24|Other|1|||
162721747|NCT02459899|587688334|FG003|Overall Study|Lost to Follow-up|1|||
162721748|NCT02459899|587688331|FG000|Overall Study|Non-compliance with the treatment|0|||
162668465|NCT04295564|587497870|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
162668466|NCT04295564|587497871|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
162668467|NCT04537923|587497872|FG000|Overall Study|Adverse Event|2|||
162668468|NCT04537923|587497873|FG001|Overall Study|Adverse Event|1|||
162668469|NCT04537923|587497874|FG002|Overall Study|Adverse Event|2|||
162668470|NCT04537923|587497875|FG003|Overall Study|Adverse Event|4|||
162668471|NCT04537923|587497872|FG000|Overall Study|Death|3|||
162668472|NCT04537923|587497873|FG001|Overall Study|Death|3|||
162668473|NCT04537923|587497874|FG002|Overall Study|Death|1|||
162668474|NCT04537923|587497875|FG003|Overall Study|Death|11|||
162668475|NCT04537923|587497872|FG000|Overall Study|Lost to Follow-up|1|||
162668476|NCT04537923|587497873|FG001|Overall Study|Lost to Follow-up|2|||
162668477|NCT04537923|587497874|FG002|Overall Study|Lost to Follow-up|1|||
162668478|NCT04537923|587497875|FG003|Overall Study|Lost to Follow-up|6|||
162668479|NCT04537923|587497872|FG000|Overall Study|Physician Decision|1|||
162668480|NCT04537923|587497873|FG001|Overall Study|Physician Decision|0|||
162668481|NCT04537923|587497874|FG002|Overall Study|Physician Decision|2|||
162668482|NCT04537923|587497875|FG003|Overall Study|Physician Decision|5|||
162668483|NCT04537923|587497872|FG000|Overall Study|Pregnancy|1|||
162668484|NCT04537923|587497873|FG001|Overall Study|Pregnancy|0|||
162668485|NCT04537923|587497874|FG002|Overall Study|Pregnancy|0|||
162668486|NCT04537923|587497875|FG003|Overall Study|Pregnancy|0|||
162668487|NCT04537923|587497872|FG000|Overall Study|Withdrawal by Subject|4|||
162668488|NCT04537923|587497873|FG001|Overall Study|Withdrawal by Subject|4|||
162668489|NCT04537923|587497874|FG002|Overall Study|Withdrawal by Subject|4|||
162668490|NCT04537923|587497875|FG003|Overall Study|Withdrawal by Subject|58|||
162668491|NCT04537923|587497872|FG000|Overall Study|Missed study visits|2|||
162668492|NCT04537923|587497873|FG001|Overall Study|Missed study visits|0|||
162668493|NCT04537923|587497874|FG002|Overall Study|Missed study visits|0|||
162668494|NCT04537923|587497875|FG003|Overall Study|Missed study visits|3|||
162668495|NCT04537923|587497872|FG000|Overall Study|Sponsor's decision|0|||
162668496|NCT04537923|587497873|FG001|Overall Study|Sponsor's decision|0|||
162668497|NCT04537923|587497874|FG002|Overall Study|Sponsor's decision|1|||
162668498|NCT04537923|587497875|FG003|Overall Study|Sponsor's decision|1|||
162668499|NCT04537923|587497872|FG000|Overall Study|Safety reasons|1|||
162668500|NCT04537923|587497873|FG001|Overall Study|Safety reasons|0|||
162668501|NCT04537923|587497874|FG002|Overall Study|Safety reasons|0|||
162668502|NCT04537923|587497875|FG003|Overall Study|Safety reasons|0|||
162668503|NCT01261611|587497876|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
162668504|NCT01261611|587497877|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
162668505|NCT01261611|587497878|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
162668506|NCT01261611|587497876|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
162668507|NCT01261611|587497877|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
162668508|NCT01261611|587497878|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
162668509|NCT01261611|587497876|FG000|Treatment Cycle 1|Adverse Event|0|||
162668510|NCT01261611|587497877|FG001|Treatment Cycle 1|Adverse Event|1|||
162668511|NCT01261611|587497878|FG002|Treatment Cycle 1|Adverse Event|0|||
162668512|NCT01261611|587497876|FG000|Treatment Cycle 1|Protocol Violation|0|||
162668513|NCT01261611|587497877|FG001|Treatment Cycle 1|Protocol Violation|0|||
162668514|NCT01261611|587497878|FG002|Treatment Cycle 1|Protocol Violation|2|||
162668515|NCT01261611|587497876|FG000|Treatment Cycle 2|Completed study|4|||
162668516|NCT01261611|587497877|FG001|Treatment Cycle 2|Completed study|0|||
162668517|NCT01261611|587497878|FG002|Treatment Cycle 2|Completed study|0|||
162668518|NCT01261611|587497876|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
162668519|NCT01261611|587497877|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
162668520|NCT01261611|587497878|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
162668521|NCT01261611|587497876|FG000|Treatment Cycle 2|Adverse Event|1|||
162668522|NCT01261611|587497877|FG001|Treatment Cycle 2|Adverse Event|0|||
162668523|NCT01261611|587497878|FG002|Treatment Cycle 2|Adverse Event|0|||
162668524|NCT01261611|587497876|FG000|Treatment Cycle 2|Protocol Violation|2|||
162668525|NCT01261611|587497877|FG001|Treatment Cycle 2|Protocol Violation|0|||
162668526|NCT01261611|587497878|FG002|Treatment Cycle 2|Protocol Violation|0|||
162668527|NCT01261611|587497876|FG000|Treatment Cycle 2|Not otherwise specified|2|||
162668528|NCT01261611|587497877|FG001|Treatment Cycle 2|Not otherwise specified|0|||
162668529|NCT01261611|587497878|FG002|Treatment Cycle 2|Not otherwise specified|0|||
162668530|NCT01261611|587497876|FG000|Treatment Cycle 3|Completed study|24|||
162668531|NCT01261611|587497877|FG001|Treatment Cycle 3|Completed study|0|||
162668532|NCT01261611|587497878|FG002|Treatment Cycle 3|Completed study|0|||
162668533|NCT01261611|587497876|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
162668534|NCT01261611|587497877|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
162668535|NCT01261611|587497878|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
162668536|NCT01261611|587497876|FG000|Treatment Cycle 3|Adverse Event|1|||
162668537|NCT01261611|587497877|FG001|Treatment Cycle 3|Adverse Event|0|||
162668538|NCT01261611|587497878|FG002|Treatment Cycle 3|Adverse Event|0|||
162668539|NCT01261611|587497876|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
162668540|NCT01261611|587497877|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
162668541|NCT01261611|587497878|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
162668542|NCT01261611|587497876|FG000|Treatment Cycle 4|Completed study|87|||
162668543|NCT01261611|587497877|FG001|Treatment Cycle 4|Completed study|0|||
162668544|NCT01261611|587497878|FG002|Treatment Cycle 4|Completed study|0|||
162668545|NCT01261611|587497876|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
162668546|NCT01261611|587497877|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
162668547|NCT01261611|587497878|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
162668548|NCT01261611|587497876|FG000|Treatment Cycle 4|Adverse Event|1|||
162668549|NCT01261611|587497877|FG001|Treatment Cycle 4|Adverse Event|0|||
162668550|NCT01261611|587497878|FG002|Treatment Cycle 4|Adverse Event|0|||
162668551|NCT01261611|587497876|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
162668552|NCT01261611|587497877|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
162668553|NCT01261611|587497878|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
162668554|NCT01261611|587497876|FG000|Treatment Cycle 4|Not otherwise specified|3|||
162668555|NCT01261611|587497877|FG001|Treatment Cycle 4|Not otherwise specified|0|||
162668556|NCT01261611|587497878|FG002|Treatment Cycle 4|Not otherwise specified|0|||
162668557|NCT01261611|587497876|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
162668558|NCT01261611|587497877|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
163149619|NCT02118584|589261476|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162668559|NCT01261611|587497878|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
162668560|NCT01261611|587497876|FG000|Treatment Cycle 5|Adverse Event|1|||
162668561|NCT01261611|587497877|FG001|Treatment Cycle 5|Adverse Event|0|||
162668562|NCT01261611|587497878|FG002|Treatment Cycle 5|Adverse Event|0|||
162668563|NCT01261611|587497876|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
162668564|NCT01261611|587497877|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
162668565|NCT01261611|587497878|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
162668566|NCT02527798|587497879|FG000|Overall Study|Physician Decision|1|||
162668567|NCT02527798|587497880|FG001|Overall Study|Physician Decision|0|||
162668568|NCT02527798|587497881|FG002|Overall Study|Physician Decision|1|||
162668569|NCT02527798|587497882|FG003|Overall Study|Physician Decision|1|||
162668570|NCT02527798|587497883|FG004|Overall Study|Physician Decision|0|||
162668571|NCT02527798|587497884|FG005|Overall Study|Physician Decision|0|||
162668572|NCT02527798|587497879|FG000|Overall Study|Death|0|||
162668573|NCT02527798|587497880|FG001|Overall Study|Death|0|||
162668574|NCT02527798|587497881|FG002|Overall Study|Death|1|||
162668575|NCT02527798|587497882|FG003|Overall Study|Death|0|||
162668576|NCT02527798|587497883|FG004|Overall Study|Death|0|||
162668577|NCT02527798|587497884|FG005|Overall Study|Death|0|||
162668578|NCT02527798|587497879|FG000|Overall Study|Withdrawal by Subject|0|||
162668579|NCT02527798|587497880|FG001|Overall Study|Withdrawal by Subject|1|||
162668580|NCT02527798|587497881|FG002|Overall Study|Withdrawal by Subject|2|||
162668581|NCT02527798|587497882|FG003|Overall Study|Withdrawal by Subject|0|||
162668582|NCT02527798|587497883|FG004|Overall Study|Withdrawal by Subject|0|||
162668583|NCT02527798|587497884|FG005|Overall Study|Withdrawal by Subject|0|||
162668584|NCT02527798|587497879|FG000|Overall Study|Reason undisclosed|1|||
162668585|NCT02527798|587497880|FG001|Overall Study|Reason undisclosed|0|||
162668586|NCT02527798|587497881|FG002|Overall Study|Reason undisclosed|1|||
162668587|NCT02527798|587497882|FG003|Overall Study|Reason undisclosed|0|||
162668588|NCT02527798|587497883|FG004|Overall Study|Reason undisclosed|0|||
162668589|NCT02527798|587497884|FG005|Overall Study|Reason undisclosed|0|||
162668590|NCT02527798|587497879|FG000|Overall Study|Did not receive intervention|1|||
162668591|NCT02527798|587497880|FG001|Overall Study|Did not receive intervention|1|||
162668592|NCT02527798|587497881|FG002|Overall Study|Did not receive intervention|0|||
162668593|NCT02527798|587497882|FG003|Overall Study|Did not receive intervention|0|||
162668594|NCT02527798|587497883|FG004|Overall Study|Did not receive intervention|0|||
162668595|NCT02527798|587497884|FG005|Overall Study|Did not receive intervention|0|||
162668596|NCT03859323|587497886|FG000|Overall Study|Lost to Follow-up|0|||
162668597|NCT03859323|587497887|FG001|Overall Study|Lost to Follow-up|0|||
162668598|NCT03859323|587497888|FG002|Overall Study|Lost to Follow-up|0|||
162668599|NCT03859323|587497889|FG003|Overall Study|Lost to Follow-up|0|||
162668600|NCT03859323|587497890|FG004|Overall Study|Lost to Follow-up|0|||
162668601|NCT03859323|587497891|FG005|Overall Study|Lost to Follow-up|0|||
162668602|NCT03859323|587497892|FG006|Overall Study|Lost to Follow-up|1|||
162668603|NCT03859323|587497893|FG007|Overall Study|Lost to Follow-up|0|||
162668604|NCT03859323|587497894|FG008|Overall Study|Lost to Follow-up|0|||
162668605|NCT03859323|587497895|FG009|Overall Study|Lost to Follow-up|0|||
162668606|NCT03859323|587497896|FG010|Overall Study|Lost to Follow-up|0|||
162668607|NCT03859323|587497897|FG011|Overall Study|Lost to Follow-up|0|||
162668608|NCT03859323|587497898|FG012|Overall Study|Lost to Follow-up|0|||
162668609|NCT03859323|587497886|FG000|Overall Study|Withdrawal by Subject|0|||
162668610|NCT03859323|587497887|FG001|Overall Study|Withdrawal by Subject|0|||
162668611|NCT03859323|587497888|FG002|Overall Study|Withdrawal by Subject|1|||
162668612|NCT03859323|587497889|FG003|Overall Study|Withdrawal by Subject|0|||
162668613|NCT03859323|587497890|FG004|Overall Study|Withdrawal by Subject|0|||
162668614|NCT03859323|587497891|FG005|Overall Study|Withdrawal by Subject|1|||
162668615|NCT03859323|587497892|FG006|Overall Study|Withdrawal by Subject|0|||
162668616|NCT03859323|587497893|FG007|Overall Study|Withdrawal by Subject|0|||
162668617|NCT03859323|587497894|FG008|Overall Study|Withdrawal by Subject|0|||
162668618|NCT03859323|587497895|FG009|Overall Study|Withdrawal by Subject|1|||
162668619|NCT03859323|587497896|FG010|Overall Study|Withdrawal by Subject|1|||
162668620|NCT03859323|587497897|FG011|Overall Study|Withdrawal by Subject|2|||
162668621|NCT03859323|587497898|FG012|Overall Study|Withdrawal by Subject|1|||
162668622|NCT03859323|587497886|FG000|Overall Study|Pregnancy|0|||
162668623|NCT03859323|587497887|FG001|Overall Study|Pregnancy|0|||
162668624|NCT03859323|587497888|FG002|Overall Study|Pregnancy|0|||
162668625|NCT03859323|587497889|FG003|Overall Study|Pregnancy|0|||
162668626|NCT03859323|587497890|FG004|Overall Study|Pregnancy|0|||
162668627|NCT03859323|587497891|FG005|Overall Study|Pregnancy|0|||
162668628|NCT03859323|587497892|FG006|Overall Study|Pregnancy|0|||
162668629|NCT03859323|587497893|FG007|Overall Study|Pregnancy|0|||
162668630|NCT03859323|587497894|FG008|Overall Study|Pregnancy|0|||
162668631|NCT03859323|587497895|FG009|Overall Study|Pregnancy|1|||
162668632|NCT03859323|587497896|FG010|Overall Study|Pregnancy|0|||
162668633|NCT03859323|587497897|FG011|Overall Study|Pregnancy|0|||
162668634|NCT03859323|587497898|FG012|Overall Study|Pregnancy|0|||
162668635|NCT01682460|587497900|FG000|Overall Study|Withdrawal by Subject|2|||
162668636|NCT01682460|587497900|FG000|Overall Study|Did not meet inclusion criteria|2|||
162668637|NCT01808690|587497904|FG000|Overall Study|Withdrawal by Subject|1|||
162668638|NCT01808690|587497905|FG001|Overall Study|Withdrawal by Subject|2|||
162668639|NCT03811912|587497906|FG000|Overall Study|Withdrew Consent|4|||
162668640|NCT03811912|587497907|FG001|Overall Study|Withdrew Consent|2|||
162668641|NCT02891187|587497908|FG000|Overall Study|Lost to Follow-up|1|||
162668642|NCT02891187|587497909|FG001|Overall Study|Lost to Follow-up|2|||
162668643|NCT00674986|587497910|FG000|Overall Study|Adverse Event|2|||
162668644|NCT00674986|587497911|FG001|Overall Study|Adverse Event|1|||
162668645|NCT00674986|587497910|FG000|Overall Study|Subject withdrew consent|12|||
162668646|NCT00674986|587497911|FG001|Overall Study|Subject withdrew consent|19|||
162668647|NCT00674986|587497910|FG000|Overall Study|Lost to Follow-up|25|||
162668648|NCT00674986|587497911|FG001|Overall Study|Lost to Follow-up|53|||
162668649|NCT00674986|587497910|FG000|Overall Study|Other reasons|4|||
162668650|NCT00674986|587497911|FG001|Overall Study|Other reasons|8|||
162668651|NCT00377234|587497912|FG000|Overall Study|Adverse Event|14|||
162668652|NCT00377234|587497913|FG001|Overall Study|Adverse Event|17|||
162668653|NCT00377234|587497912|FG000|Overall Study|Withdrawal by Subject|11|||
162668654|NCT00377234|587497913|FG001|Overall Study|Withdrawal by Subject|9|||
162668655|NCT00377234|587497912|FG000|Overall Study|Lost to Follow-up|4|||
162668656|NCT00377234|587497913|FG001|Overall Study|Lost to Follow-up|2|||
162668657|NCT00377234|587497912|FG000|Overall Study|Administrative|2|||
162668658|NCT00377234|587497913|FG001|Overall Study|Administrative|1|||
162668659|NCT00377234|587497912|FG000|Overall Study|Not assigned|3|||
162668660|NCT00377234|587497913|FG001|Overall Study|Not assigned|2|||
162668661|NCT02053350|587497920|FG000|Overall Study|Withdrawal by Subject|1|||
162668662|NCT02053350|587497920|FG000|Overall Study|Adverse Event|4|||
162668663|NCT01275625|587497921|FG000|Overall Study|Death|1|||
162668664|NCT01275625|587497921|FG000|Overall Study|Lack of Efficacy|2|||
162668665|NCT01275625|587497921|FG000|Overall Study|Lost to Follow-up|1|||
162668666|NCT01275625|587497921|FG000|Overall Study|Withdrawal by Subject|3|||
162668667|NCT01275625|587497921|FG000|Overall Study|Protocol Violation|1|||
162668668|NCT01275625|587497921|FG000|Overall Study|Adverse Event|4|||
162668669|NCT01275625|587497921|FG000|Overall Study|Other|1|||
162668670|NCT01585103|587497923|FG000|Overall Study|Unable to swallow Cytosponge|6|||
162668671|NCT03521635|587497924|FG000|Overall Study|Adverse Event|1|||
162668672|NCT03521635|587497925|FG001|Overall Study|Adverse Event|1|||
162668673|NCT03521635|587497924|FG000|Overall Study|Refused to complete study visit|1|||
162668674|NCT03521635|587497925|FG001|Overall Study|Refused to complete study visit|0|||
162668675|NCT03521635|587497924|FG000|Overall Study|Refused to continue trial medication|2|||
162668676|NCT03521635|587497925|FG001|Overall Study|Refused to continue trial medication|2|||
162668677|NCT03521635|587497924|FG000|Overall Study|Lost to Follow-up|0|||
162668678|NCT03521635|587497925|FG001|Overall Study|Lost to Follow-up|1|||
162668679|NCT03521635|587497924|FG000|Overall Study|Meet exclusion criteria|0|||
162668680|NCT03521635|587497925|FG001|Overall Study|Meet exclusion criteria|1|||
162668681|NCT03521635|587497924|FG000|Overall Study|Patient not taken study medicine|0|||
162668682|NCT03521635|587497925|FG001|Overall Study|Patient not taken study medicine|1|||
162668683|NCT02244944|587497926|FG000|Overall Study|Withdrawal by Subject|1|||
162668684|NCT02244944|587497926|FG000|Overall Study|Study Terminated|1|||
162668685|NCT01747772|587497927|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
162668686|NCT00626522|587497930|FG000|Overall Study|Protocol Violation|0|||
162668687|NCT00626522|587497931|FG001|Overall Study|Protocol Violation|0|||
162668688|NCT00626522|587497932|FG002|Overall Study|Protocol Violation|0|||
162668689|NCT00626522|587497933|FG003|Overall Study|Protocol Violation|0|||
162668690|NCT00626522|587497934|FG004|Overall Study|Protocol Violation|1|||
162668691|NCT00626522|587497935|FG005|Overall Study|Protocol Violation|0|||
162668692|NCT00626522|587497930|FG000|Overall Study|Adverse Event|2|||
162668693|NCT00626522|587497931|FG001|Overall Study|Adverse Event|1|||
162668694|NCT00626522|587497932|FG002|Overall Study|Adverse Event|2|||
162668695|NCT00626522|587497933|FG003|Overall Study|Adverse Event|0|||
162668696|NCT00626522|587497934|FG004|Overall Study|Adverse Event|1|||
162668697|NCT00626522|587497935|FG005|Overall Study|Adverse Event|1|||
162668698|NCT00626522|587497930|FG000|Overall Study|Withdrawal by Subject|2|||
162668699|NCT00626522|587497931|FG001|Overall Study|Withdrawal by Subject|5|||
162668700|NCT00626522|587497932|FG002|Overall Study|Withdrawal by Subject|5|||
162668701|NCT00626522|587497933|FG003|Overall Study|Withdrawal by Subject|0|||
162668702|NCT00626522|587497934|FG004|Overall Study|Withdrawal by Subject|4|||
162668703|NCT00626522|587497935|FG005|Overall Study|Withdrawal by Subject|1|||
162668704|NCT00626522|587497930|FG000|Overall Study|COPD exacerbation|0|||
162668705|NCT00626522|587497931|FG001|Overall Study|COPD exacerbation|0|||
162668706|NCT00626522|587497932|FG002|Overall Study|COPD exacerbation|0|||
162668707|NCT00626522|587497933|FG003|Overall Study|COPD exacerbation|1|||
162668708|NCT00626522|587497934|FG004|Overall Study|COPD exacerbation|1|||
162668709|NCT00626522|587497935|FG005|Overall Study|COPD exacerbation|0|||
162668710|NCT00626522|587497930|FG000|Overall Study|Lost to Follow-up|0|||
162668711|NCT00626522|587497931|FG001|Overall Study|Lost to Follow-up|1|||
162668712|NCT00626522|587497932|FG002|Overall Study|Lost to Follow-up|0|||
162668713|NCT00626522|587497933|FG003|Overall Study|Lost to Follow-up|0|||
162668714|NCT00626522|587497934|FG004|Overall Study|Lost to Follow-up|0|||
162668715|NCT00626522|587497935|FG005|Overall Study|Lost to Follow-up|0|||
162668716|NCT00626522|587497930|FG000|Overall Study|Inconsistent reason reported|1|||
162668717|NCT00626522|587497931|FG001|Overall Study|Inconsistent reason reported|0|||
162668718|NCT00626522|587497932|FG002|Overall Study|Inconsistent reason reported|0|||
162668719|NCT00626522|587497933|FG003|Overall Study|Inconsistent reason reported|0|||
162668720|NCT00626522|587497934|FG004|Overall Study|Inconsistent reason reported|0|||
162668721|NCT00626522|587497935|FG005|Overall Study|Inconsistent reason reported|0|||
162668722|NCT00626522|587497930|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162668723|NCT00626522|587497931|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162668724|NCT00626522|587497932|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162668725|NCT00626522|587497933|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162668726|NCT00626522|587497934|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162668727|NCT00626522|587497935|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162668728|NCT01928719|587497936|FG000|Overall Study|Lost to Follow-up|26|||
162668729|NCT01928719|587497937|FG001|Overall Study|Lost to Follow-up|11|||
162668730|NCT01928719|587497936|FG000|Overall Study|Withdrawal by Subject|22|||
162668731|NCT01928719|587497937|FG001|Overall Study|Withdrawal by Subject|7|||
162668732|NCT01928719|587497936|FG000|Overall Study|Protocol Violation|3|||
162668733|NCT01928719|587497937|FG001|Overall Study|Protocol Violation|1|||
162668734|NCT01928719|587497936|FG000|Overall Study|Adverse Event|1|||
162668735|NCT01928719|587497937|FG001|Overall Study|Adverse Event|0|||
162668736|NCT03725982|587497938|FG000|First Intervention|Withdrawal by Subject|0|||
162668737|NCT03725982|587497939|FG001|First Intervention|Withdrawal by Subject|1|||
162668738|NCT03725982|587497938|FG000|First Intervention|Physician Decision|1|||
162668739|NCT03725982|587497939|FG001|First Intervention|Physician Decision|1|||
162668740|NCT01003899|587497940|FG000|Overall Study|Other Adverse Event|8|||
162668741|NCT01003899|587497940|FG000|Overall Study|Not entered|4|||
162668742|NCT01003899|587497940|FG000|Overall Study|Not treated|1|||
162668743|NCT01003899|587497940|FG000|Overall Study|Progressive disease|34|||
162668744|NCT02099838|587497943|FG000|Overall Study|Death|1|||
162668745|NCT02099838|587497944|FG001|Overall Study|Death|0|||
162668746|NCT02099838|587497943|FG000|Overall Study|Lost to Follow-up|3|||
162668747|NCT02099838|587497944|FG001|Overall Study|Lost to Follow-up|1|||
162668748|NCT02099838|587497943|FG000|Overall Study|Withdrawal by Subject|0|||
162668749|NCT02099838|587497944|FG001|Overall Study|Withdrawal by Subject|1|||
162668750|NCT04121962|587497947|FG000|Overall Study|Lost to Follow-up|42|||
162668751|NCT04121962|587497948|FG001|Overall Study|Lost to Follow-up|39|||
162668752|NCT01175382|587497949|FG000|Overall Study|Lost to Follow-up|4|||
162668753|NCT01175382|587497950|FG001|Overall Study|Lost to Follow-up|3|||
162668754|NCT01175382|587497951|FG002|Overall Study|Lost to Follow-up|1|||
162668755|NCT01175382|587497949|FG000|Overall Study|Physician Decision|0|||
163149620|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163149621|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
163149622|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163149623|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
163149624|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
162721749|NCT02459899|587688332|FG001|Overall Study|Non-compliance with the treatment|0|||
162721750|NCT02459899|587688333|FG002|Overall Study|Non-compliance with the treatment|0|||
162668756|NCT01175382|587497950|FG001|Overall Study|Physician Decision|1|||
162668757|NCT01175382|587497951|FG002|Overall Study|Physician Decision|0|||
162668758|NCT01175382|587497949|FG000|Overall Study|Withdrawal by Subject|0|||
162668759|NCT01175382|587497950|FG001|Overall Study|Withdrawal by Subject|0|||
162668760|NCT01175382|587497951|FG002|Overall Study|Withdrawal by Subject|1|||
162668761|NCT01175382|587497949|FG000|Overall Study|No longer having problem|1|||
162668762|NCT01175382|587497950|FG001|Overall Study|No longer having problem|0|||
162668763|NCT01175382|587497951|FG002|Overall Study|No longer having problem|1|||
162668764|NCT01175382|587497949|FG000|Overall Study|Unable/unwilling to attend visits|3|||
162668765|NCT01175382|587497950|FG001|Overall Study|Unable/unwilling to attend visits|1|||
162668766|NCT01175382|587497951|FG002|Overall Study|Unable/unwilling to attend visits|2|||
162668767|NCT01175382|587497949|FG000|Overall Study|Unwilling to follow protocol|0|||
162668768|NCT01175382|587497950|FG001|Overall Study|Unwilling to follow protocol|1|||
162668769|NCT01175382|587497951|FG002|Overall Study|Unwilling to follow protocol|0|||
162668770|NCT01175382|587497949|FG000|Overall Study|Unable to tolerate study meds|0|||
162668771|NCT01175382|587497950|FG001|Overall Study|Unable to tolerate study meds|1|||
162668772|NCT01175382|587497951|FG002|Overall Study|Unable to tolerate study meds|1|||
162668773|NCT00774787|587497952|FG000|Overall Study|Lost to Follow-up|1|||
162668774|NCT02019719|587497953|FG000|Overall Study|Adverse Event|1|||
162668775|NCT02019719|587497954|FG001|Overall Study|Adverse Event|0|||
162668776|NCT02019719|587497955|FG002|Overall Study|Adverse Event|0|||
162668777|NCT02019719|587497956|FG003|Overall Study|Adverse Event|1|||
162668778|NCT02019719|587497957|FG004|Overall Study|Adverse Event|1|||
162668779|NCT02019719|587497953|FG000|Overall Study|Protocol Violation|1|||
162668780|NCT02019719|587497954|FG001|Overall Study|Protocol Violation|1|||
162668781|NCT02019719|587497955|FG002|Overall Study|Protocol Violation|0|||
162668782|NCT02019719|587497956|FG003|Overall Study|Protocol Violation|0|||
162668783|NCT02019719|587497957|FG004|Overall Study|Protocol Violation|0|||
162668784|NCT02019719|587497953|FG000|Overall Study|Protocol defined stopping criteria|2|||
162668785|NCT02019719|587497954|FG001|Overall Study|Protocol defined stopping criteria|0|||
163149625|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
163149626|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
163149627|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
163149628|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
163149629|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163149630|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163149631|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
163149632|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163149633|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
162668786|NCT02019719|587497955|FG002|Overall Study|Protocol defined stopping criteria|0|||
162668787|NCT02019719|587497956|FG003|Overall Study|Protocol defined stopping criteria|1|||
162668788|NCT02019719|587497957|FG004|Overall Study|Protocol defined stopping criteria|1|||
162668789|NCT02019719|587497953|FG000|Overall Study|Physician Decision|2|||
162668790|NCT02019719|587497954|FG001|Overall Study|Physician Decision|0|||
162668791|NCT02019719|587497955|FG002|Overall Study|Physician Decision|0|||
162668792|NCT02019719|587497956|FG003|Overall Study|Physician Decision|0|||
162668793|NCT02019719|587497957|FG004|Overall Study|Physician Decision|0|||
162668794|NCT04535037|587497958|FG000|Overall Study|Protocol Violation|1|||
162668795|NCT04535037|587497959|FG001|Overall Study|Protocol Violation|0|||
162668796|NCT04535037|587497958|FG000|Overall Study|Withdrawal by Subject|8|||
162668797|NCT04535037|587497959|FG001|Overall Study|Withdrawal by Subject|9|||
162668798|NCT04535037|587497958|FG000|Overall Study|Migrated / moved from the study area|1|||
162668799|NCT04535037|587497959|FG001|Overall Study|Migrated / moved from the study area|4|||
162668800|NCT04535037|587497958|FG000|Overall Study|Other|2|||
162668801|NCT04535037|587497959|FG001|Overall Study|Other|5|||
162668802|NCT02031276|587497960|FG000|Period 1 Double-blind IV|Adverse Event|6|||
162668803|NCT02031276|587497961|FG001|Period 1 Double-blind IV|Adverse Event|5|||
162668804|NCT02031276|587497962|FG002|Period 1 Double-blind IV|Adverse Event|1|||
162668805|NCT02031276|587497960|FG000|Period 1 Double-blind IV|Other|0|||
162668806|NCT02031276|587497961|FG001|Period 1 Double-blind IV|Other|1|||
162668807|NCT02031276|587497962|FG002|Period 1 Double-blind IV|Other|0|||
162668808|NCT02031276|587497960|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
162668809|NCT02031276|587497961|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
162668810|NCT02031276|587497962|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
162668811|NCT02031276|587497960|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
162668812|NCT02031276|587497961|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
162668813|NCT02031276|587497962|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
162668814|NCT02031276|587497960|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
162668815|NCT02031276|587497961|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
162668816|NCT02031276|587497962|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
162668817|NCT02031276|587497960|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
162668818|NCT02031276|587497961|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
162668819|NCT02031276|587497962|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
162668820|NCT02031276|587497960|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
162668821|NCT02031276|587497961|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
162668822|NCT02031276|587497962|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
162668823|NCT02031276|587497960|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162668824|NCT02031276|587497961|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162668825|NCT02031276|587497962|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162668826|NCT02031276|587497960|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
162668827|NCT02031276|587497961|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
162668828|NCT02031276|587497962|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
162668829|NCT00765245|587497963|FG000|Overall Study|disease progression|3|||
162668830|NCT00765245|587497964|FG001|Overall Study|disease progression|2|||
162668831|NCT00765245|587497963|FG000|Overall Study|Withdrawal by Subject|3|||
162668832|NCT00765245|587497964|FG001|Overall Study|Withdrawal by Subject|0|||
162668833|NCT00765245|587497963|FG000|Overall Study|Adverse Event|5|||
162668834|NCT00765245|587497964|FG001|Overall Study|Adverse Event|0|||
162668835|NCT00765245|587497963|FG000|Overall Study|Physician Decision|1|||
162668836|NCT00765245|587497964|FG001|Overall Study|Physician Decision|0|||
162668837|NCT00765245|587497963|FG000|Overall Study|Death|1|||
162668838|NCT00765245|587497964|FG001|Overall Study|Death|0|||
162668839|NCT02417246|587497965|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
162668840|NCT02417246|587497966|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
162668841|NCT02417246|587497965|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
162668842|NCT02417246|587497966|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
162668843|NCT02417246|587497965|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
162668844|NCT02417246|587497966|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
162668845|NCT02417246|587497965|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
162668846|NCT02417246|587497966|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
162668847|NCT01921348|587497971|FG000|Overall Study|Withdrawal by Subject|1|||
162668848|NCT01921348|587497972|FG001|Overall Study|Withdrawal by Subject|0|||
162668849|NCT01921348|587497971|FG000|Overall Study|Lost to Follow-up|0|||
162668850|NCT01921348|587497972|FG001|Overall Study|Lost to Follow-up|2|||
162668851|NCT02896855|587497975|FG000|Overall Study|Death|50|||
162668852|NCT02896855|587497976|FG001|Overall Study|Death|40|||
162668853|NCT02896855|587497975|FG000|Overall Study|Lost to Follow-up|15|||
162668854|NCT02896855|587497976|FG001|Overall Study|Lost to Follow-up|9|||
162668855|NCT02896855|587497975|FG000|Overall Study|Withdrawal by Subject|7|||
162668856|NCT02896855|587497976|FG001|Overall Study|Withdrawal by Subject|4|||
162668857|NCT01205685|587497977|FG000|Overall Study|Disease Progression|10|||
162668858|NCT01205685|587497977|FG000|Overall Study|Withdrawal by Subject|1|||
162668859|NCT02169674|587497978|FG000|Overall Study|Withdrawal by Subject|2|||
162668860|NCT02169674|587497979|FG001|Overall Study|Withdrawal by Subject|1|||
162668861|NCT02169674|587497978|FG000|Overall Study|Seroprotected|30|||
162668862|NCT02169674|587497979|FG001|Overall Study|Seroprotected|76|||
162668863|NCT02169674|587497978|FG000|Overall Study|Lost to Follow-up|0|||
162668864|NCT02169674|587497979|FG001|Overall Study|Lost to Follow-up|1|||
162668865|NCT03525834|587497982|FG000|Overall Study|Progressive disease|1|||
162668866|NCT00941603|587497985|FG000|Overall Study|Adverse Event|10|||
162668867|NCT00941603|587497986|FG001|Overall Study|Adverse Event|15|||
162668868|NCT00941603|587497987|FG002|Overall Study|Adverse Event|5|||
162668869|NCT00941603|587497988|FG003|Overall Study|Adverse Event|1|||
162668870|NCT00941603|587497989|FG004|Overall Study|Adverse Event|4|||
162668871|NCT00941603|587497990|FG005|Overall Study|Adverse Event|0|||
162668872|NCT00941603|587497985|FG000|Overall Study|Lost to Follow-up|0|||
162668873|NCT00941603|587497986|FG001|Overall Study|Lost to Follow-up|0|||
162668874|NCT00941603|587497987|FG002|Overall Study|Lost to Follow-up|0|||
162668875|NCT00941603|587497988|FG003|Overall Study|Lost to Follow-up|1|||
162668876|NCT00941603|587497989|FG004|Overall Study|Lost to Follow-up|0|||
162668877|NCT00941603|587497990|FG005|Overall Study|Lost to Follow-up|2|||
162668878|NCT00941603|587497985|FG000|Overall Study|Withdrawal by Subject|0|||
162668879|NCT00941603|587497986|FG001|Overall Study|Withdrawal by Subject|0|||
162668880|NCT00941603|587497987|FG002|Overall Study|Withdrawal by Subject|0|||
162668881|NCT00941603|587497988|FG003|Overall Study|Withdrawal by Subject|2|||
162668882|NCT00941603|587497989|FG004|Overall Study|Withdrawal by Subject|0|||
162668883|NCT00941603|587497990|FG005|Overall Study|Withdrawal by Subject|1|||
162668884|NCT00941603|587497985|FG000|Overall Study|Protocol Violation|0|||
162668885|NCT00941603|587497986|FG001|Overall Study|Protocol Violation|1|||
162668886|NCT00941603|587497987|FG002|Overall Study|Protocol Violation|0|||
162668887|NCT00941603|587497988|FG003|Overall Study|Protocol Violation|0|||
162668888|NCT00941603|587497989|FG004|Overall Study|Protocol Violation|0|||
162668889|NCT00941603|587497990|FG005|Overall Study|Protocol Violation|0|||
162668890|NCT00941603|587497985|FG000|Overall Study|Did not meet protocol eligibility|1|||
162668891|NCT00941603|587497986|FG001|Overall Study|Did not meet protocol eligibility|0|||
162668892|NCT00941603|587497987|FG002|Overall Study|Did not meet protocol eligibility|0|||
162668893|NCT00941603|587497988|FG003|Overall Study|Did not meet protocol eligibility|0|||
162668894|NCT00941603|587497989|FG004|Overall Study|Did not meet protocol eligibility|0|||
162668895|NCT00941603|587497990|FG005|Overall Study|Did not meet protocol eligibility|0|||
162668896|NCT03879798|587497993|FG000|Overall Study|Adverse Event|0|||
162668897|NCT03879798|587497994|FG001|Overall Study|Adverse Event|0|||
162668898|NCT03879798|587497995|FG002|Overall Study|Adverse Event|0|||
162668899|NCT03879798|587497996|FG003|Overall Study|Adverse Event|0|||
162668900|NCT03879798|587497997|FG004|Overall Study|Adverse Event|0|||
162668901|NCT03879798|587497998|FG005|Overall Study|Adverse Event|1|||
162668902|NCT03879798|587497993|FG000|Overall Study|Lack of Efficacy|0|||
162668903|NCT03879798|587497994|FG001|Overall Study|Lack of Efficacy|0|||
162668904|NCT03879798|587497995|FG002|Overall Study|Lack of Efficacy|0|||
162668905|NCT03879798|587497996|FG003|Overall Study|Lack of Efficacy|0|||
162668906|NCT03879798|587497997|FG004|Overall Study|Lack of Efficacy|0|||
162668907|NCT03879798|587497998|FG005|Overall Study|Lack of Efficacy|1|||
162668908|NCT03879798|587497993|FG000|Overall Study|Withdrawal by Subject|0|||
162668909|NCT03879798|587497994|FG001|Overall Study|Withdrawal by Subject|0|||
162668910|NCT03879798|587497995|FG002|Overall Study|Withdrawal by Subject|0|||
162668911|NCT03879798|587497996|FG003|Overall Study|Withdrawal by Subject|0|||
162668912|NCT03879798|587497997|FG004|Overall Study|Withdrawal by Subject|0|||
162668913|NCT03879798|587497998|FG005|Overall Study|Withdrawal by Subject|1|||
162668914|NCT01343407|587497999|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
162668915|NCT01343407|587498000|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
162668916|NCT01343407|587498001|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
162668917|NCT01343407|587498002|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
162668918|NCT01343407|587498003|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
162668919|NCT01343407|587498004|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
162668920|NCT01343407|587497999|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
162668921|NCT01343407|587498000|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
162668922|NCT01343407|587498001|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
162668923|NCT01343407|587498002|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
162668924|NCT01343407|587498003|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
162668925|NCT01343407|587498004|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
162668926|NCT06027216|587498005|FG000|Overall Study|Did not qualify|8|||
162668927|NCT01732835|587498009|FG000|6-month Primary Endpoint|Did not receive device|19|||
162668928|NCT01732835|587498009|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
162668929|NCT01732835|587498009|FG000|6-month Primary Endpoint|Adverse Event|3|||
162668930|NCT01732835|587498009|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
162668931|NCT01732835|587498009|FG000|2-year Extended Follow-up|Adverse Event|3|||
162668932|NCT01732835|587498009|FG000|2-year Extended Follow-up|Death|1|||
162721751|NCT02459899|587688334|FG003|Overall Study|Non-compliance with the treatment|1|||
162721752|NCT02459899|587688331|FG000|Overall Study|Withdrawal by Subject|1|||
162668933|NCT00874029|587498014|FG000|Overall Study|Withdrawal by Subject|10|||
162668934|NCT00874029|587498014|FG000|Overall Study|Pregnancy|4|||
162668935|NCT00874029|587498014|FG000|Overall Study|Physician Decision|1|||
162668936|NCT00874029|587498014|FG000|Overall Study|Adverse Event|1|||
162668937|NCT00874029|587498014|FG000|Overall Study|Lost to Follow-up|5|||
162668938|NCT01767116|587498015|FG000|Overall Study|Lost to Follow-up|2|||
162668939|NCT01767116|587498016|FG001|Overall Study|Lost to Follow-up|2|||
162668940|NCT00968669|587498017|FG000|Overall Study|Lost to Follow-up|5|||
162668941|NCT00968669|587498018|FG001|Overall Study|Lost to Follow-up|2|||
162668942|NCT00968669|587498019|FG002|Overall Study|Lost to Follow-up|1|||
162668943|NCT00968669|587498020|FG003|Overall Study|Lost to Follow-up|4|||
162668944|NCT00968669|587498017|FG000|Overall Study|Withdrawal by Subject|9|||
162668945|NCT00968669|587498018|FG001|Overall Study|Withdrawal by Subject|7|||
162668946|NCT00968669|587498019|FG002|Overall Study|Withdrawal by Subject|5|||
162668947|NCT00968669|587498020|FG003|Overall Study|Withdrawal by Subject|3|||
162668948|NCT00968669|587498017|FG000|Overall Study|Pregnancy|0|||
162668949|NCT00968669|587498018|FG001|Overall Study|Pregnancy|0|||
162668950|NCT00968669|587498019|FG002|Overall Study|Pregnancy|2|||
162668951|NCT00968669|587498020|FG003|Overall Study|Pregnancy|0|||
162668952|NCT00968669|587498017|FG000|Overall Study|AE|1|||
162668953|NCT00968669|587498018|FG001|Overall Study|AE|0|||
162668954|NCT00968669|587498019|FG002|Overall Study|AE|0|||
162668955|NCT00968669|587498020|FG003|Overall Study|AE|0|||
162668956|NCT00968669|587498017|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162668957|NCT00968669|587498018|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162668958|NCT00968669|587498019|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162668959|NCT00968669|587498020|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
162668960|NCT00968669|587498017|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
162668961|NCT00968669|587498018|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162668962|NCT00968669|587498019|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162668963|NCT00968669|587498020|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162668964|NCT00968669|587498017|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
162668965|NCT00968669|587498018|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162668966|NCT00968669|587498019|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162668967|NCT00968669|587498020|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162668968|NCT00968669|587498017|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162668969|NCT00968669|587498018|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162668970|NCT00968669|587498019|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
162668971|NCT00968669|587498020|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162668972|NCT00968669|587498017|FG000|Overall Study|EARLY WITHDRAWAL|0|||
162668973|NCT00968669|587498018|FG001|Overall Study|EARLY WITHDRAWAL|1|||
162668974|NCT00968669|587498019|FG002|Overall Study|EARLY WITHDRAWAL|0|||
162668975|NCT00968669|587498020|FG003|Overall Study|EARLY WITHDRAWAL|0|||
162668976|NCT00968669|587498017|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162668977|NCT00968669|587498018|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162668978|NCT00968669|587498019|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
162668979|NCT00968669|587498020|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162668980|NCT00968669|587498017|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
162668981|NCT00968669|587498018|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162668982|NCT00968669|587498019|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162668983|NCT00968669|587498020|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162668984|NCT00968669|587498017|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162668985|NCT00968669|587498018|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
162668986|NCT00968669|587498019|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162668987|NCT00968669|587498020|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162668988|NCT00968669|587498017|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162668989|NCT00968669|587498018|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
162668990|NCT00968669|587498019|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162668991|NCT00968669|587498020|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162668992|NCT00968669|587498017|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162668993|NCT00968669|587498018|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
162668994|NCT00968669|587498019|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162668995|NCT00968669|587498020|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162668996|NCT00968669|587498017|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162668997|NCT00968669|587498018|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
162668998|NCT00968669|587498019|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162668999|NCT00968669|587498020|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162669000|NCT00968669|587498017|FG000|Overall Study|SPONSOR DECISION|0|||
162669001|NCT00968669|587498018|FG001|Overall Study|SPONSOR DECISION|1|||
162669002|NCT00968669|587498019|FG002|Overall Study|SPONSOR DECISION|0|||
162669003|NCT00968669|587498020|FG003|Overall Study|SPONSOR DECISION|0|||
162669004|NCT00968669|587498017|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162669005|NCT00968669|587498018|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162669006|NCT00968669|587498019|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
162669007|NCT00968669|587498020|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162669008|NCT00968669|587498017|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162669009|NCT00968669|587498018|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
162669010|NCT00968669|587498019|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162669011|NCT00968669|587498020|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162669012|NCT00968669|587498017|FG000|Overall Study|SUBJECT INCARCERATED|0|||
162669013|NCT00968669|587498018|FG001|Overall Study|SUBJECT INCARCERATED|1|||
162669014|NCT00968669|587498019|FG002|Overall Study|SUBJECT INCARCERATED|0|||
162669015|NCT00968669|587498020|FG003|Overall Study|SUBJECT INCARCERATED|0|||
162669016|NCT00968669|587498017|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162669017|NCT00968669|587498018|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
162669018|NCT00968669|587498019|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162669019|NCT00968669|587498020|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162669020|NCT00968669|587498017|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162669021|NCT00968669|587498018|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162669022|NCT00968669|587498019|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162669023|NCT00968669|587498020|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
162669024|NCT01669343|587498023|FG000|Part A: All Patients|Withdrawal by Subject|7|||
162669025|NCT01669343|587498023|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
162669026|NCT01669343|587498023|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
162669027|NCT01669343|587498023|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
162669028|NCT01669343|587498023|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
162669029|NCT02371369|587498028|FG000|Part 1|Physician Decision|0|||
162669030|NCT02371369|587498029|FG001|Part 1|Physician Decision|3|||
162669031|NCT02371369|587498028|FG000|Part 1|Adverse Event|8|||
162669032|NCT02371369|587498029|FG001|Part 1|Adverse Event|0|||
162669033|NCT02371369|587498028|FG000|Part 1|Withdrawal by Subject|1|||
162669034|NCT02371369|587498029|FG001|Part 1|Withdrawal by Subject|6|||
162669035|NCT02371369|587498028|FG000|Part 1|Disease progression|0|||
162669036|NCT02371369|587498029|FG001|Part 1|Disease progression|1|||
162669037|NCT02371369|587498028|FG000|Part 1|Protocol Violation|0|||
162669038|NCT02371369|587498029|FG001|Part 1|Protocol Violation|1|||
162669039|NCT02371369|587498028|FG000|Part 2|Adverse Event|6|||
162669040|NCT02371369|587498029|FG001|Part 2|Adverse Event|5|||
162669041|NCT02371369|587498028|FG000|Part 2|Withdrawal by Subject|16|||
162669042|NCT02371369|587498029|FG001|Part 2|Withdrawal by Subject|6|||
162669043|NCT02371369|587498028|FG000|Part 2|Investigator decision|1|||
162669044|NCT02371369|587498029|FG001|Part 2|Investigator decision|2|||
162669045|NCT02371369|587498028|FG000|Part 2|Death|0|||
162669046|NCT02371369|587498029|FG001|Part 2|Death|1|||
162669047|NCT02371369|587498028|FG000|Part 2|Disease progression|1|||
162669048|NCT02371369|587498029|FG001|Part 2|Disease progression|0|||
162669049|NCT02371369|587498028|FG000|Part 2|Subject Noncompliance|1|||
162669050|NCT02371369|587498029|FG001|Part 2|Subject Noncompliance|0|||
162669051|NCT02371369|587498028|FG000|Part 2|Lost to Follow-up|1|||
162669052|NCT02371369|587498029|FG001|Part 2|Lost to Follow-up|1|||
162669053|NCT02371369|587498028|FG000|Part 2|Subject transitioned to commercial supply|6|||
162669054|NCT02371369|587498029|FG001|Part 2|Subject transitioned to commercial supply|4|||
162669055|NCT02371369|587498028|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
162669056|NCT02371369|587498029|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
162669057|NCT02371369|587498028|FG000|Part 2|Surgical resection of tumor|1|||
162669058|NCT02371369|587498029|FG001|Part 2|Surgical resection of tumor|1|||
162669059|NCT02371369|587498028|FG000|Part 2|Other|0|||
162669060|NCT02371369|587498029|FG001|Part 2|Other|1|||
163149634|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163149635|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163149636|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
163149637|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
163149638|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163149639|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
163149640|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163149641|NCT02118584|589261474|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
163149642|NCT02118584|589261475|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
163149643|NCT02118584|589261476|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
163149644|NCT02182895|589261477|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
163149645|NCT02182895|589261478|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
163149646|NCT01488045|589261488|FG000|Overall Study|Withdrawal by Subject|6|||
163149647|NCT01488045|589261489|FG001|Overall Study|Withdrawal by Subject|11|||
163149648|NCT01488045|589261488|FG000|Overall Study|Failure to present for colonoscopy|3|||
163149649|NCT01488045|589261489|FG001|Overall Study|Failure to present for colonoscopy|6|||
163149650|NCT01488045|589261488|FG000|Overall Study|Failure to report exclusion criteria|0|||
163149651|NCT01488045|589261489|FG001|Overall Study|Failure to report exclusion criteria|1|||
163149652|NCT00671658|589261491|FG000|Overall Study|Physician Decision|5|||
163149653|NCT03617172|589261494|FG000|Overall Study|Lost to Follow-up|1|||
163149654|NCT03617172|589261495|FG001|Overall Study|Lost to Follow-up|0|||
163149655|NCT01680341|589261496|FG000|Overall Study|Adverse Event|3|||
163149656|NCT01680341|589261497|FG001|Overall Study|Adverse Event|2|||
163149657|NCT01680341|589261496|FG000|Overall Study|Unclassified|18|||
163149658|NCT01680341|589261497|FG001|Overall Study|Unclassified|15|||
163149659|NCT02587221|589261499|FG000|Overall Study|Adverse Event|3|||
163149660|NCT02587221|589261500|FG001|Overall Study|Adverse Event|3|||
163149661|NCT02587221|589261499|FG000|Overall Study|Death|33|||
163149662|NCT02587221|589261500|FG001|Overall Study|Death|34|||
163149663|NCT02587221|589261499|FG000|Overall Study|Withdrawal by Subject|66|||
163149664|NCT02587221|589261500|FG001|Overall Study|Withdrawal by Subject|61|||
163149665|NCT02587221|589261499|FG000|Overall Study|Lost to Follow-up|21|||
163149666|NCT02587221|589261500|FG001|Overall Study|Lost to Follow-up|19|||
163149667|NCT02587221|589261499|FG000|Overall Study|Protocol Violation|6|||
163149668|NCT02587221|589261500|FG001|Overall Study|Protocol Violation|5|||
163149669|NCT02587221|589261499|FG000|Overall Study|Other Reason or Unspecified|2|||
163149670|NCT02587221|589261500|FG001|Overall Study|Other Reason or Unspecified|1|||
163149671|NCT03988400|589261501|FG000|Overall Study|Adverse Event|1|||
163149672|NCT03988400|589261502|FG001|Overall Study|Adverse Event|0|||
163149673|NCT03988400|589261501|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
163149674|NCT03988400|589261502|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
163149675|NCT03988400|589261501|FG000|Overall Study|Lost to Follow-up|0|||
163149676|NCT03988400|589261502|FG001|Overall Study|Lost to Follow-up|1|||
163149677|NCT04913610|589261503|FG000|Randomized Participants|Did Not Receive Treatment|0|||
163149678|NCT04913610|589261504|FG001|Randomized Participants|Did Not Receive Treatment|0|||
163149679|NCT04913610|589261505|FG002|Randomized Participants|Did Not Receive Treatment|1|||
163149680|NCT04913610|589261506|FG003|Randomized Participants|Did Not Receive Treatment|1|||
163149681|NCT04913610|589261507|FG004|Randomized Participants|Did Not Receive Treatment|0|||
163149682|NCT04913610|589261503|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
163149683|NCT04913610|589261504|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149684|NCT04913610|589261505|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149685|NCT04913610|589261506|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
163149686|NCT04913610|589261507|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
163149687|NCT03186209|589261508|FG000|Overall Study|Withdrawal by Subject|11|||
163149688|NCT03186209|589261509|FG001|Overall Study|Withdrawal by Subject|22|||
163149689|NCT03186209|589261508|FG000|Overall Study|Pregnancy|1|||
163149690|NCT03186209|589261509|FG001|Overall Study|Pregnancy|0|||
163149691|NCT03186209|589261508|FG000|Overall Study|Adverse Event|4|||
163149692|NCT03186209|589261509|FG001|Overall Study|Adverse Event|0|||
163149693|NCT03186209|589261508|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
163149694|NCT03186209|589261509|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
163149695|NCT03186209|589261508|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
163149696|NCT03186209|589261509|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
163149697|NCT03186209|589261508|FG000|Overall Study|Fail to meet randomization criteria|0|||
163149698|NCT03186209|589261509|FG001|Overall Study|Fail to meet randomization criteria|1|||
163149699|NCT03186209|589261508|FG000|Overall Study|Lost to Follow-up|0|||
163149700|NCT03186209|589261509|FG001|Overall Study|Lost to Follow-up|1|||
163149701|NCT00953667|589261515|FG000|Overall Study|Lost to Follow-up|11|||
163149702|NCT00953667|589261515|FG000|Overall Study|Physician Decision|35|||
163149703|NCT00953667|589261515|FG000|Overall Study|Withdrawal by Subject|63|||
163149704|NCT00953667|589261515|FG000|Overall Study|Adverse Event|10|||
163149705|NCT00953667|589261515|FG000|Overall Study|poor venous access,unable to draw blood|4|||
162669061|NCT01024387|587498030|FG000|Overall Study|Radiographic Progression|29|||
162721753|NCT02459899|587688332|FG001|Overall Study|Withdrawal by Subject|3|||
162721754|NCT02459899|587688333|FG002|Overall Study|Withdrawal by Subject|0|||
162721755|NCT02459899|587688334|FG003|Overall Study|Withdrawal by Subject|0|||
162721756|NCT02739035|587688335|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
162669062|NCT01024387|587498030|FG000|Overall Study|Symptomatic Progression|10|||
162669063|NCT01024387|587498030|FG000|Overall Study|Physician Decision|5|||
162669064|NCT01024387|587498030|FG000|Overall Study|Withdrawal by Subject|5|||
162721757|NCT02739035|587688336|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
162721758|NCT02739035|587688335|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
162721759|NCT02739035|587688336|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
163149706|NCT00551759|589261516|FG000|Overall Study|Adverse Event|7|||
163149707|NCT00551759|589261516|FG000|Overall Study|Death|5|||
163149708|NCT00551759|589261516|FG000|Overall Study|Ineligible|1|||
163149709|NCT03521570|589261517|FG000|Overall Study|Not eligible|11|||
163149710|NCT00322881|589261519|FG000|Overall Study|Death|2|||
163149711|NCT00322881|589261519|FG000|Overall Study|Adverse Event|1|||
163149712|NCT00322881|589261519|FG000|Overall Study|Disease Progression|2|||
163149713|NCT00112736|589261526|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
163149714|NCT00112736|589261527|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
163149715|NCT02138890|589261528|FG000|Overall Study|Adverse Event|1|||
163149716|NCT02138890|589261529|FG001|Overall Study|Adverse Event|0|||
163149717|NCT05435339|589261530|FG000|Overall Study|Death|1|||
163149718|NCT05435339|589261531|FG001|Overall Study|Death|0|||
163149719|NCT05435339|589261532|FG002|Overall Study|Death|3|||
163149720|NCT05435339|589261533|FG003|Overall Study|Death|1|||
163149721|NCT05435339|589261534|FG004|Overall Study|Death|3|||
163149722|NCT05435339|589261535|FG005|Overall Study|Death|2|||
163149723|NCT05435339|589261536|FG006|Overall Study|Death|4|||
163149724|NCT05435339|589261537|FG007|Overall Study|Death|6|||
163149725|NCT05435339|589261530|FG000|Overall Study|Sponsor Decision|0|||
163149726|NCT05435339|589261531|FG001|Overall Study|Sponsor Decision|1|||
163149727|NCT05435339|589261532|FG002|Overall Study|Sponsor Decision|0|||
163149728|NCT05435339|589261533|FG003|Overall Study|Sponsor Decision|0|||
163149729|NCT05435339|589261534|FG004|Overall Study|Sponsor Decision|2|||
163149730|NCT05435339|589261535|FG005|Overall Study|Sponsor Decision|1|||
163149731|NCT05435339|589261536|FG006|Overall Study|Sponsor Decision|2|||
163149732|NCT05435339|589261537|FG007|Overall Study|Sponsor Decision|2|||
163149733|NCT05435339|589261530|FG000|Overall Study|Withdrawal by Subject|0|||
163149734|NCT05435339|589261531|FG001|Overall Study|Withdrawal by Subject|0|||
163149735|NCT05435339|589261532|FG002|Overall Study|Withdrawal by Subject|0|||
163149736|NCT05435339|589261533|FG003|Overall Study|Withdrawal by Subject|0|||
163149737|NCT05435339|589261534|FG004|Overall Study|Withdrawal by Subject|1|||
163149738|NCT05435339|589261535|FG005|Overall Study|Withdrawal by Subject|0|||
163149739|NCT05435339|589261536|FG006|Overall Study|Withdrawal by Subject|1|||
163149740|NCT05435339|589261537|FG007|Overall Study|Withdrawal by Subject|1|||
163149741|NCT01446159|589261539|FG000|Overall Study|Withdrawal by Subject|1|||
163149742|NCT01446159|589261540|FG001|Overall Study|Withdrawal by Subject|0|||
163149743|NCT01446159|589261541|FG002|Overall Study|Withdrawal by Subject|14|||
163149744|NCT01446159|589261542|FG003|Overall Study|Withdrawal by Subject|11|||
163149745|NCT01446159|589261539|FG000|Overall Study|Lost to Follow-up|0|||
163149746|NCT01446159|589261540|FG001|Overall Study|Lost to Follow-up|0|||
163149747|NCT01446159|589261541|FG002|Overall Study|Lost to Follow-up|1|||
163149748|NCT01446159|589261542|FG003|Overall Study|Lost to Follow-up|2|||
163149749|NCT01446159|589261539|FG000|Overall Study|Death|2|||
163149750|NCT01446159|589261540|FG001|Overall Study|Death|3|||
163149751|NCT01446159|589261541|FG002|Overall Study|Death|43|||
163149752|NCT01446159|589261542|FG003|Overall Study|Death|36|||
163149753|NCT01446159|589261539|FG000|Overall Study|Other|0|||
163149754|NCT01446159|589261540|FG001|Overall Study|Other|0|||
163149755|NCT01446159|589261541|FG002|Overall Study|Other|13|||
163149756|NCT01446159|589261542|FG003|Overall Study|Other|13|||
163149757|NCT05135871|589261551|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
163149758|NCT05135871|589261552|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149759|NCT05135871|589261553|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149760|NCT05135871|589261554|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
163149761|NCT04258423|589261555|FG000|Overall Study|Study Closure|2|||
163149762|NCT04258423|589261556|FG001|Overall Study|Study Closure|2|||
163149763|NCT03980730|589261557|FG000|Overall Study|Study Terminated by Sponsor|0|||
163149764|NCT03980730|589261558|FG001|Overall Study|Study Terminated by Sponsor|3|||
163149765|NCT03980730|589261557|FG000|Overall Study|Adverse Event|2|||
163149766|NCT03980730|589261558|FG001|Overall Study|Adverse Event|0|||
163149767|NCT03980730|589261557|FG000|Overall Study|Sponsor Request|0|||
163149768|NCT03980730|589261558|FG001|Overall Study|Sponsor Request|1|||
163149769|NCT00880620|589261559|FG000|Overall Study|Adverse Event|4|||
163149770|NCT00880620|589261560|FG001|Overall Study|Adverse Event|5|||
163149771|NCT00880620|589261561|FG002|Overall Study|Adverse Event|15|||
163149772|NCT00880620|589261562|FG003|Overall Study|Adverse Event|15|||
163149773|NCT00880620|589261559|FG000|Overall Study|Death|0|||
163149774|NCT00880620|589261560|FG001|Overall Study|Death|0|||
163149775|NCT00880620|589261561|FG002|Overall Study|Death|1|||
163149776|NCT00880620|589261562|FG003|Overall Study|Death|0|||
163149777|NCT00880620|589261559|FG000|Overall Study|Lack of Efficacy|12|||
163149778|NCT00880620|589261560|FG001|Overall Study|Lack of Efficacy|4|||
163149779|NCT00880620|589261561|FG002|Overall Study|Lack of Efficacy|0|||
163149780|NCT00880620|589261562|FG003|Overall Study|Lack of Efficacy|1|||
163149781|NCT00880620|589261559|FG000|Overall Study|Lost to Follow-up|0|||
163149782|NCT00880620|589261560|FG001|Overall Study|Lost to Follow-up|1|||
162669065|NCT01024387|587498030|FG000|Overall Study|Death|2|||
162669066|NCT01024387|587498030|FG000|Overall Study|Prolonged Treatment Delay|1|||
162669067|NCT01024387|587498030|FG000|Overall Study|Adverse Event|3|||
162669068|NCT01024387|587498030|FG000|Overall Study|Other|5|||
162669069|NCT03855189|587498031|FG000|Overall Study|Adverse Event|5|||
162669070|NCT03855189|587498032|FG001|Overall Study|Adverse Event|2|||
162669071|NCT03855189|587498033|FG002|Overall Study|Adverse Event|4|||
162669072|NCT03855189|587498031|FG000|Overall Study|Treatment Failure|1|||
162669073|NCT03855189|587498032|FG001|Overall Study|Treatment Failure|1|||
162669074|NCT03855189|587498033|FG002|Overall Study|Treatment Failure|2|||
162669075|NCT03855189|587498031|FG000|Overall Study|Noncompliance with Protocol|0|||
162669076|NCT03855189|587498032|FG001|Overall Study|Noncompliance with Protocol|1|||
162669077|NCT03855189|587498033|FG002|Overall Study|Noncompliance with Protocol|0|||
162669078|NCT03855189|587498031|FG000|Overall Study|Did Not Return|4|||
162669079|NCT03855189|587498032|FG001|Overall Study|Did Not Return|3|||
162669080|NCT03855189|587498033|FG002|Overall Study|Did Not Return|0|||
162669081|NCT01143259|587498034|FG000|Overall Study|Withdrawal by Subject|3|||
162669082|NCT01143259|587498035|FG001|Overall Study|Withdrawal by Subject|2|||
162669083|NCT01143259|587498034|FG000|Overall Study|Protocol Violation|13|||
162669084|NCT01143259|587498035|FG001|Overall Study|Protocol Violation|9|||
162669085|NCT01143259|587498034|FG000|Overall Study|Screen Failure|7|||
162669086|NCT01143259|587498035|FG001|Overall Study|Screen Failure|9|||
162669087|NCT04307186|587498038|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
162721760|NCT02739035|587688335|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
162721761|NCT02739035|587688336|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
162669088|NCT04307186|587498038|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
162669089|NCT04307186|587498038|FG000|Washout 3-14 Days|Progressive disease|1|||
162669090|NCT04307186|587498038|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
162669091|NCT04307186|587498038|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
162669092|NCT01618838|587498041|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
162669093|NCT01434602|587498042|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162669094|NCT01434602|587498043|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
162669095|NCT01434602|587498044|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162669096|NCT01434602|587498045|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162721762|NCT02739035|587688335|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
162721763|NCT02739035|587688336|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
162721764|NCT00940992|587688339|FG000|Overall Study|Adverse Event|2|||
162721765|NCT00940992|587688340|FG001|Overall Study|Adverse Event|0|||
162721766|NCT00940992|587688341|FG002|Overall Study|Adverse Event|1|||
162721767|NCT00940992|587688339|FG000|Overall Study|subject request|2|||
162721768|NCT00940992|587688340|FG001|Overall Study|subject request|1|||
162721769|NCT00940992|587688341|FG002|Overall Study|subject request|0|||
162669097|NCT01434602|587498046|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162669098|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
163149783|NCT00880620|589261561|FG002|Overall Study|Lost to Follow-up|1|||
163149784|NCT00880620|589261562|FG003|Overall Study|Lost to Follow-up|0|||
163149785|NCT00880620|589261559|FG000|Overall Study|Protocol Violation|0|||
163149786|NCT00880620|589261560|FG001|Overall Study|Protocol Violation|1|||
163149787|NCT00880620|589261561|FG002|Overall Study|Protocol Violation|0|||
163149788|NCT00880620|589261562|FG003|Overall Study|Protocol Violation|2|||
163149789|NCT00880620|589261559|FG000|Overall Study|Withdrawal by Subject|4|||
163149790|NCT00880620|589261560|FG001|Overall Study|Withdrawal by Subject|3|||
163149791|NCT00880620|589261561|FG002|Overall Study|Withdrawal by Subject|1|||
163149792|NCT00880620|589261562|FG003|Overall Study|Withdrawal by Subject|3|||
163149793|NCT00880620|589261559|FG000|Overall Study|Noncompliance|0|||
163149794|NCT00880620|589261560|FG001|Overall Study|Noncompliance|0|||
163149795|NCT00880620|589261561|FG002|Overall Study|Noncompliance|1|||
163149796|NCT00880620|589261562|FG003|Overall Study|Noncompliance|1|||
163149797|NCT00880620|589261559|FG000|Overall Study|Other|1|||
163149798|NCT00880620|589261560|FG001|Overall Study|Other|1|||
163149799|NCT00880620|589261561|FG002|Overall Study|Other|2|||
163149800|NCT00880620|589261562|FG003|Overall Study|Other|2|||
163149801|NCT01775501|589263496|FG000|Overall Study|Discontinued prior to treatment|1|||
163149802|NCT03037385|589263497|FG000|Overall Study|Adverse Event|0|||
163149803|NCT03037385|589263498|FG001|Overall Study|Adverse Event|0|||
163149804|NCT03037385|589263499|FG002|Overall Study|Adverse Event|1|||
163149805|NCT03037385|589263500|FG003|Overall Study|Adverse Event|0|||
163149806|NCT03037385|589263501|FG004|Overall Study|Adverse Event|0|||
163149807|NCT03037385|589263502|FG005|Overall Study|Adverse Event|0|||
163149808|NCT03037385|589263503|FG006|Overall Study|Adverse Event|0|||
163149809|NCT03037385|589263504|FG007|Overall Study|Adverse Event|0|||
163149810|NCT03037385|589263505|FG008|Overall Study|Adverse Event|0|||
163149811|NCT03037385|589263506|FG009|Overall Study|Adverse Event|6|||
163149812|NCT03037385|589263497|FG000|Overall Study|Death|1|||
163149813|NCT03037385|589263498|FG001|Overall Study|Death|4|||
163149814|NCT03037385|589263499|FG002|Overall Study|Death|2|||
163149815|NCT03037385|589263500|FG003|Overall Study|Death|2|||
163149816|NCT03037385|589263501|FG004|Overall Study|Death|5|||
163149817|NCT03037385|589263502|FG005|Overall Study|Death|2|||
163149818|NCT03037385|589263503|FG006|Overall Study|Death|1|||
163149819|NCT03037385|589263504|FG007|Overall Study|Death|4|||
163149820|NCT03037385|589263505|FG008|Overall Study|Death|3|||
163149821|NCT03037385|589263506|FG009|Overall Study|Death|240|||
163149822|NCT03037385|589263497|FG000|Overall Study|Initiation of Another Therapy|1|||
163149823|NCT03037385|589263498|FG001|Overall Study|Initiation of Another Therapy|0|||
163149824|NCT03037385|589263499|FG002|Overall Study|Initiation of Another Therapy|0|||
163149825|NCT03037385|589263500|FG003|Overall Study|Initiation of Another Therapy|0|||
163149826|NCT03037385|589263501|FG004|Overall Study|Initiation of Another Therapy|0|||
163149827|NCT03037385|589263502|FG005|Overall Study|Initiation of Another Therapy|0|||
163149828|NCT03037385|589263503|FG006|Overall Study|Initiation of Another Therapy|0|||
163149829|NCT03037385|589263504|FG007|Overall Study|Initiation of Another Therapy|1|||
163149830|NCT03037385|589263505|FG008|Overall Study|Initiation of Another Therapy|0|||
163149831|NCT03037385|589263506|FG009|Overall Study|Initiation of Another Therapy|2|||
163149832|NCT03037385|589263497|FG000|Overall Study|Lost to Follow-up|0|||
163149833|NCT03037385|589263498|FG001|Overall Study|Lost to Follow-up|0|||
163149834|NCT03037385|589263499|FG002|Overall Study|Lost to Follow-up|0|||
163149835|NCT03037385|589263500|FG003|Overall Study|Lost to Follow-up|0|||
163149836|NCT03037385|589263501|FG004|Overall Study|Lost to Follow-up|0|||
163149837|NCT03037385|589263502|FG005|Overall Study|Lost to Follow-up|1|||
163149838|NCT03037385|589263503|FG006|Overall Study|Lost to Follow-up|0|||
163149839|NCT03037385|589263504|FG007|Overall Study|Lost to Follow-up|0|||
163149840|NCT03037385|589263505|FG008|Overall Study|Lost to Follow-up|0|||
163149841|NCT03037385|589263506|FG009|Overall Study|Lost to Follow-up|16|||
163149842|NCT03037385|589263497|FG000|Overall Study|Physician Decision|0|||
163149843|NCT03037385|589263498|FG001|Overall Study|Physician Decision|0|||
163149844|NCT03037385|589263499|FG002|Overall Study|Physician Decision|0|||
163149845|NCT03037385|589263500|FG003|Overall Study|Physician Decision|0|||
163149846|NCT03037385|589263501|FG004|Overall Study|Physician Decision|0|||
163149847|NCT03037385|589263502|FG005|Overall Study|Physician Decision|0|||
163149848|NCT03037385|589263503|FG006|Overall Study|Physician Decision|0|||
163149849|NCT03037385|589263504|FG007|Overall Study|Physician Decision|0|||
163149850|NCT03037385|589263505|FG008|Overall Study|Physician Decision|0|||
163149851|NCT03037385|589263506|FG009|Overall Study|Physician Decision|1|||
163149852|NCT03037385|589263497|FG000|Overall Study|Progressive Disease|0|||
163149853|NCT03037385|589263498|FG001|Overall Study|Progressive Disease|1|||
163149854|NCT03037385|589263499|FG002|Overall Study|Progressive Disease|1|||
163149855|NCT03037385|589263500|FG003|Overall Study|Progressive Disease|5|||
163149856|NCT03037385|589263501|FG004|Overall Study|Progressive Disease|2|||
163149857|NCT03037385|589263502|FG005|Overall Study|Progressive Disease|0|||
163149858|NCT03037385|589263503|FG006|Overall Study|Progressive Disease|1|||
163149859|NCT03037385|589263504|FG007|Overall Study|Progressive Disease|0|||
163149860|NCT03037385|589263505|FG008|Overall Study|Progressive Disease|0|||
163149861|NCT03037385|589263506|FG009|Overall Study|Progressive Disease|30|||
162721770|NCT00940992|587688339|FG000|Overall Study|Lost to Follow-up|0|||
162721771|NCT00940992|587688340|FG001|Overall Study|Lost to Follow-up|1|||
162669099|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162721772|NCT00940992|587688341|FG002|Overall Study|Lost to Follow-up|1|||
162721773|NCT04446117|587688342|FG000|Overall Study|No Study Treatment Given|4|||
162721774|NCT04446117|587688343|FG001|Overall Study|No Study Treatment Given|3|||
162721775|NCT04446117|587688342|FG000|Overall Study|Radiographic Disease Progression|132|||
162721776|NCT04446117|587688343|FG001|Overall Study|Radiographic Disease Progression|158|||
162721777|NCT04446117|587688342|FG000|Overall Study|Adverse Event|79|||
162721778|NCT04446117|587688343|FG001|Overall Study|Adverse Event|43|||
162721779|NCT04446117|587688342|FG000|Overall Study|Lack of Clinical Benefit|1|||
162721780|NCT04446117|587688343|FG001|Overall Study|Lack of Clinical Benefit|1|||
162721781|NCT04446117|587688342|FG000|Overall Study|Withdrawal by Subject|24|||
162721782|NCT04446117|587688343|FG001|Overall Study|Withdrawal by Subject|22|||
162721783|NCT04446117|587688342|FG000|Overall Study|Lost to Follow-up|0|||
162721784|NCT04446117|587688343|FG001|Overall Study|Lost to Follow-up|3|||
162721785|NCT04446117|587688342|FG000|Overall Study|Miscellaneous|26|||
162721786|NCT04446117|587688343|FG001|Overall Study|Miscellaneous|36|||
162721787|NCT04446117|587688342|FG000|Overall Study|Missing Data/Data not yet Received|1|||
162721788|NCT04446117|587688343|FG001|Overall Study|Missing Data/Data not yet Received|0|||
162721791|NCT01837641|587688350|FG000|Overall Study|Sponsor decision|1|||
162721792|NCT01837641|587688351|FG001|Overall Study|Sponsor decision|0|||
162721793|NCT01837641|587688352|FG002|Overall Study|Sponsor decision|0|||
162721794|NCT01837641|587688353|FG003|Overall Study|Sponsor decision|0|||
162721795|NCT01837641|587688354|FG004|Overall Study|Sponsor decision|0|||
162721796|NCT01837641|587688355|FG005|Overall Study|Sponsor decision|1|||
162721797|NCT01837641|587688356|FG006|Overall Study|Sponsor decision|0|||
162721798|NCT01837641|587688357|FG007|Overall Study|Sponsor decision|0|||
162721799|NCT01837641|587688350|FG000|Overall Study|Adverse Event|0|||
162721800|NCT01837641|587688351|FG001|Overall Study|Adverse Event|0|||
162721801|NCT01837641|587688352|FG002|Overall Study|Adverse Event|0|||
162721802|NCT01837641|587688353|FG003|Overall Study|Adverse Event|0|||
162721803|NCT01837641|587688354|FG004|Overall Study|Adverse Event|0|||
162721804|NCT01837641|587688355|FG005|Overall Study|Adverse Event|1|||
162721805|NCT01837641|587688356|FG006|Overall Study|Adverse Event|0|||
162721806|NCT01837641|587688357|FG007|Overall Study|Adverse Event|0|||
162721807|NCT01837641|587688350|FG000|Overall Study|Withdrawal by Subject|0|||
162721808|NCT01837641|587688351|FG001|Overall Study|Withdrawal by Subject|0|||
162721809|NCT01837641|587688352|FG002|Overall Study|Withdrawal by Subject|0|||
162669100|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162669101|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
162669102|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162669103|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162669104|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162669105|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162669106|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
162669107|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162669108|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162669109|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162669110|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162669111|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
162669112|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162669113|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162669114|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162669115|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162669116|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
162669117|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162669118|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162669119|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162669120|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162669121|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
162669122|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162669123|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162669124|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162669125|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162669126|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162669127|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
162669128|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162669129|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162669130|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162669131|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
162669132|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
162669133|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162669134|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162669135|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162669136|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
162669137|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162669138|NCT01434602|587498042|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162669139|NCT01434602|587498043|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162669140|NCT01434602|587498044|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162669141|NCT01434602|587498045|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
162669142|NCT01434602|587498046|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162669143|NCT01587651|587498051|FG000|Overall Study|Adverse Event|0|||
162669144|NCT01587651|587498052|FG001|Overall Study|Adverse Event|1|||
162669145|NCT01587651|587498053|FG002|Overall Study|Adverse Event|0|||
162669146|NCT01587651|587498051|FG000|Overall Study|Protocol Violation|0|||
162669147|NCT01587651|587498052|FG001|Overall Study|Protocol Violation|1|||
162669148|NCT01587651|587498053|FG002|Overall Study|Protocol Violation|1|||
162669149|NCT01587651|587498051|FG000|Overall Study|Withdrawal by Subject|0|||
162669150|NCT01587651|587498052|FG001|Overall Study|Withdrawal by Subject|1|||
162669151|NCT01587651|587498053|FG002|Overall Study|Withdrawal by Subject|0|||
162669152|NCT03864900|587498056|FG000|Overall Study|Withdrawal by Subject|1|||
162669153|NCT03864900|587498057|FG001|Overall Study|Withdrawal by Subject|1|||
162669154|NCT03864900|587498056|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
162669155|NCT03864900|587498057|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
162669156|NCT00759109|587498060|FG000|Overall Study|Adverse Event|17|||
162669157|NCT00759109|587498061|FG001|Overall Study|Adverse Event|12|||
162669158|NCT00759109|587498060|FG000|Overall Study|Inability to comply|1|||
162669159|NCT00759109|587498061|FG001|Overall Study|Inability to comply|1|||
162669160|NCT00759109|587498060|FG000|Overall Study|Withdrawal by Subject|9|||
163149862|NCT03037385|589263497|FG000|Overall Study|Withdrawal by Subject|0|||
163149863|NCT03037385|589263498|FG001|Overall Study|Withdrawal by Subject|0|||
163149864|NCT03037385|589263499|FG002|Overall Study|Withdrawal by Subject|1|||
163149865|NCT03037385|589263500|FG003|Overall Study|Withdrawal by Subject|2|||
163149866|NCT03037385|589263501|FG004|Overall Study|Withdrawal by Subject|1|||
163149867|NCT03037385|589263502|FG005|Overall Study|Withdrawal by Subject|3|||
163149868|NCT03037385|589263503|FG006|Overall Study|Withdrawal by Subject|0|||
163149869|NCT03037385|589263504|FG007|Overall Study|Withdrawal by Subject|0|||
163149870|NCT03037385|589263505|FG008|Overall Study|Withdrawal by Subject|0|||
163149871|NCT03037385|589263506|FG009|Overall Study|Withdrawal by Subject|52|||
163149872|NCT03037385|589263497|FG000|Overall Study|Reason Not Specified|0|||
163149873|NCT03037385|589263498|FG001|Overall Study|Reason Not Specified|1|||
163149874|NCT03037385|589263499|FG002|Overall Study|Reason Not Specified|0|||
163149875|NCT03037385|589263500|FG003|Overall Study|Reason Not Specified|4|||
163149876|NCT03037385|589263501|FG004|Overall Study|Reason Not Specified|3|||
163149877|NCT03037385|589263502|FG005|Overall Study|Reason Not Specified|6|||
163149878|NCT03037385|589263503|FG006|Overall Study|Reason Not Specified|2|||
163149879|NCT03037385|589263504|FG007|Overall Study|Reason Not Specified|0|||
163149880|NCT03037385|589263505|FG008|Overall Study|Reason Not Specified|1|||
163149881|NCT03037385|589263506|FG009|Overall Study|Reason Not Specified|181|||
163149882|NCT02318706|589263507|FG000|Double-blind Phase|Adverse Event|7|||
163149883|NCT02318706|589263508|FG001|Double-blind Phase|Adverse Event|4|||
163149884|NCT02318706|589263509|FG002|Double-blind Phase|Adverse Event|3|||
163149885|NCT02318706|589263510|FG003|Double-blind Phase|Adverse Event|10|||
163149886|NCT02318706|589263511|FG004|Double-blind Phase|Adverse Event|0|||
163149887|NCT02318706|589263507|FG000|Double-blind Phase|Lost to Follow-up|1|||
163149888|NCT02318706|589263508|FG001|Double-blind Phase|Lost to Follow-up|0|||
163149889|NCT02318706|589263509|FG002|Double-blind Phase|Lost to Follow-up|0|||
163149890|NCT02318706|589263510|FG003|Double-blind Phase|Lost to Follow-up|0|||
163149891|NCT02318706|589263511|FG004|Double-blind Phase|Lost to Follow-up|0|||
163149892|NCT02318706|589263507|FG000|Double-blind Phase|Protocol Violation|4|||
163149893|NCT02318706|589263508|FG001|Double-blind Phase|Protocol Violation|2|||
163149894|NCT02318706|589263509|FG002|Double-blind Phase|Protocol Violation|4|||
163149895|NCT02318706|589263510|FG003|Double-blind Phase|Protocol Violation|3|||
163149896|NCT02318706|589263511|FG004|Double-blind Phase|Protocol Violation|0|||
163149897|NCT02318706|589263507|FG000|Double-blind Phase|Withdrawal by Subject|9|||
163149898|NCT02318706|589263508|FG001|Double-blind Phase|Withdrawal by Subject|5|||
163149899|NCT02318706|589263509|FG002|Double-blind Phase|Withdrawal by Subject|7|||
163149900|NCT02318706|589263510|FG003|Double-blind Phase|Withdrawal by Subject|10|||
163149901|NCT02318706|589263511|FG004|Double-blind Phase|Withdrawal by Subject|0|||
162669161|NCT00759109|587498061|FG001|Overall Study|Withdrawal by Subject|5|||
162669162|NCT00759109|587498060|FG000|Overall Study|Death|4|||
162669163|NCT00759109|587498061|FG001|Overall Study|Death|3|||
162669164|NCT00759109|587498060|FG000|Overall Study|Lost to Follow-up|4|||
162669165|NCT00759109|587498061|FG001|Overall Study|Lost to Follow-up|6|||
162669166|NCT00759109|587498060|FG000|Overall Study|Started new therapy|2|||
162669167|NCT00759109|587498061|FG001|Overall Study|Started new therapy|6|||
162669168|NCT00759109|587498060|FG000|Overall Study|HCV RNA negative|1|||
162669169|NCT00759109|587498061|FG001|Overall Study|HCV RNA negative|0|||
162669170|NCT00759109|587498060|FG000|Overall Study|Participant moved to a different city|0|||
162669171|NCT00759109|587498061|FG001|Overall Study|Participant moved to a different city|1|||
162669172|NCT00759109|587498060|FG000|Overall Study|Participant had a liver transplant|0|||
162669173|NCT00759109|587498061|FG001|Overall Study|Participant had a liver transplant|1|||
162669174|NCT00759109|587498060|FG000|Overall Study|Lost during study|1|||
162669175|NCT00759109|587498061|FG001|Overall Study|Lost during study|0|||
162669176|NCT03238001|587498062|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
162669177|NCT03238001|587498062|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
162669178|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
162669179|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
162669180|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
162669181|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
162669182|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
162669183|NCT03238001|587498062|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
162669184|NCT01349569|587499946|FG000|Overall Study|Lack of Efficacy|4|||
162669185|NCT03581305|587499947|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
162669186|NCT03581305|587499948|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
162669187|NCT03581305|587499947|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
162669188|NCT03581305|587499948|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
162669189|NCT03581305|587499947|FG000|Serotonergic Study|Withdrawal by Subject|5|||
162669190|NCT03581305|587499948|FG001|Serotonergic Study|Withdrawal by Subject|1|||
162669191|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
162669192|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
162669193|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
162669194|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
162669195|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
162669196|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
162669197|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
162669198|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
162669199|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
162669200|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
162669201|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
162669202|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
162669203|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
162669204|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
162669205|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
162669206|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
162669207|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
162669208|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
162669209|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
162669210|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
162669211|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
162669212|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
162669213|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
162669214|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
162669215|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669216|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669217|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669218|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669219|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669220|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162721810|NCT01837641|587688353|FG003|Overall Study|Withdrawal by Subject|0|||
162721811|NCT01837641|587688354|FG004|Overall Study|Withdrawal by Subject|1|||
162721812|NCT01837641|587688355|FG005|Overall Study|Withdrawal by Subject|0|||
162669221|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669222|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669223|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669224|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669225|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669226|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669227|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162721813|NCT01837641|587688356|FG006|Overall Study|Withdrawal by Subject|1|||
162669228|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669229|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669230|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162669231|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669232|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669233|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
162669234|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
162669235|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
162669236|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669237|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669238|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669239|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669240|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669241|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669242|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669243|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669244|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669245|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669246|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669247|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669248|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669249|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669250|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162669251|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
162669252|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
162669253|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
162669254|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
162669255|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
162669256|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
162669257|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
162669258|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
162669259|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
162669260|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
162669261|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
162669262|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
162669263|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
162669264|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
162669265|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
162669266|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
162669267|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
162669268|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
162669269|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
162669270|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
162669271|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
162669272|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669273|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669274|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669275|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669276|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669277|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669278|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669279|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669280|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669281|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669282|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669283|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669284|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669285|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669286|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669287|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669288|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669289|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
162721814|NCT01837641|587688357|FG007|Overall Study|Withdrawal by Subject|0|||
162721815|NCT01579916|587688358|FG000|Overall Study|Lost to Follow-up|6|||
162721816|NCT01579916|587688359|FG001|Overall Study|Lost to Follow-up|1|||
162721817|NCT01579916|587688358|FG000|Overall Study|Withdrawal by Subject|1|||
162721818|NCT01579916|587688359|FG001|Overall Study|Withdrawal by Subject|1|||
162721819|NCT01579916|587688358|FG000|Overall Study|Death|1|||
162669290|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
162669291|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162669292|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162669293|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669294|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
162669295|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162669296|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669297|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669298|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669299|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669300|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669301|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669302|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669303|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669304|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669305|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669306|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669307|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669308|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669309|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669310|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162669311|NCT01490632|587499949|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669312|NCT01490632|587499950|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669313|NCT01490632|587499951|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669314|NCT01490632|587499952|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669315|NCT01490632|587499953|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
162669316|NCT01490632|587499954|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669317|NCT01490632|587499955|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669318|NCT01490632|587499956|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669319|NCT01490632|587499957|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669320|NCT01490632|587499958|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669321|NCT01490632|587499959|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669322|NCT01490632|587499960|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669323|NCT01490632|587499961|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669324|NCT01490632|587499962|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669325|NCT01490632|587499963|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669326|NCT01490632|587499964|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669327|NCT01490632|587499965|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669328|NCT01490632|587499966|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669329|NCT01490632|587499967|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669330|NCT01490632|587499968|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162669331|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669332|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669333|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669334|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669335|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669336|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
162669337|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
162669338|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669339|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669340|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
162669341|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
162669342|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
162669343|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669344|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669345|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669346|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669347|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669348|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669349|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669350|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
162669351|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669352|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669353|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669354|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669355|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669356|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669357|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162669358|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669359|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162669360|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
162721820|NCT01579916|587688359|FG001|Overall Study|Death|0|||
162669361|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162669362|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669363|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669364|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669365|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669366|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669367|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669368|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669369|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669370|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162669371|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669372|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669373|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669374|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669375|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669376|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669377|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
162669378|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669379|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162721821|NCT03264456|587688360|FG000|Overall Study|Withdrawal by Subject|3|||
162669380|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
162669381|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669382|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669383|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669384|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669385|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669386|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669387|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669388|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669389|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669390|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162669391|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669392|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669393|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669394|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669395|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669396|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669397|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
162669398|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669399|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669400|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669401|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669402|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669403|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669404|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669405|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669406|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669407|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669408|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669409|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669410|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
162669411|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669412|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669413|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669414|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669415|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669416|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
162669417|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669418|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669419|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669420|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669421|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669422|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669423|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669424|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669425|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669426|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669427|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669428|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669429|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669430|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162669431|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669432|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669433|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669434|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669435|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669436|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669437|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162669438|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669439|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162669440|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669441|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162669442|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
162669443|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669444|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669445|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669446|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669447|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162721822|NCT03264456|587688360|FG000|Overall Study|Lost to Follow-up|1|||
162669448|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669449|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669450|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162669451|NCT01490632|587499949|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669452|NCT01490632|587499950|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669453|NCT01490632|587499951|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669454|NCT01490632|587499952|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669455|NCT01490632|587499953|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669456|NCT01490632|587499954|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
162669457|NCT01490632|587499955|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
162721823|NCT06119113|587689343|FG000|Overall Study|Lost to Follow-up|15|||
163149902|NCT02318706|589263507|FG000|Double-blind Phase|Other|4|||
163149903|NCT02318706|589263508|FG001|Double-blind Phase|Other|1|||
163149904|NCT02318706|589263509|FG002|Double-blind Phase|Other|2|||
163149905|NCT02318706|589263510|FG003|Double-blind Phase|Other|1|||
163149906|NCT02318706|589263511|FG004|Double-blind Phase|Other|0|||
163149907|NCT02318706|589263507|FG000|Double-blind Phase|Death|0|||
163149908|NCT02318706|589263508|FG001|Double-blind Phase|Death|0|||
163149909|NCT02318706|589263509|FG002|Double-blind Phase|Death|2|||
163149910|NCT02318706|589263510|FG003|Double-blind Phase|Death|0|||
163149911|NCT02318706|589263511|FG004|Double-blind Phase|Death|0|||
163149912|NCT02318706|589263507|FG000|Open-label Extension Phase|Adverse Event|0|||
163149913|NCT02318706|589263508|FG001|Open-label Extension Phase|Adverse Event|0|||
163149914|NCT02318706|589263509|FG002|Open-label Extension Phase|Adverse Event|0|||
163149915|NCT02318706|589263510|FG003|Open-label Extension Phase|Adverse Event|0|||
163149916|NCT02318706|589263511|FG004|Open-label Extension Phase|Adverse Event|21|||
163149917|NCT02318706|589263507|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
163149918|NCT02318706|589263508|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
163149919|NCT02318706|589263509|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
163149920|NCT02318706|589263510|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
163149921|NCT02318706|589263511|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
163149922|NCT02318706|589263507|FG000|Open-label Extension Phase|Death|0|||
163149923|NCT02318706|589263508|FG001|Open-label Extension Phase|Death|0|||
163149924|NCT02318706|589263509|FG002|Open-label Extension Phase|Death|0|||
163149925|NCT02318706|589263510|FG003|Open-label Extension Phase|Death|0|||
163149926|NCT02318706|589263511|FG004|Open-label Extension Phase|Death|1|||
163149927|NCT02318706|589263507|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
163149928|NCT02318706|589263508|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
163149929|NCT02318706|589263509|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
163149930|NCT02318706|589263510|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
163149931|NCT02318706|589263511|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
163149932|NCT04328077|589263512|FG000|Overall Study|Lost to Follow-up|0|||
163149933|NCT04328077|589263513|FG001|Overall Study|Lost to Follow-up|1|||
163149934|NCT04328077|589263514|FG002|Overall Study|Lost to Follow-up|0|||
163149935|NCT04328077|589263515|FG003|Overall Study|Lost to Follow-up|0|||
163149936|NCT04328077|589263512|FG000|Overall Study|Withdrawal by Subject|0|||
163149937|NCT04328077|589263513|FG001|Overall Study|Withdrawal by Subject|1|||
163149938|NCT04328077|589263514|FG002|Overall Study|Withdrawal by Subject|1|||
163149939|NCT04328077|589263515|FG003|Overall Study|Withdrawal by Subject|3|||
163149940|NCT02326155|589263521|FG000|Overall Study|Adverse Event|21|||
163149941|NCT02326155|589263522|FG001|Overall Study|Adverse Event|5|||
163149942|NCT02326155|589263521|FG000|Overall Study|Death|3|||
163149943|NCT02326155|589263522|FG001|Overall Study|Death|0|||
163149944|NCT02326155|589263521|FG000|Overall Study|Lack of Efficacy|49|||
163149945|NCT02326155|589263522|FG001|Overall Study|Lack of Efficacy|5|||
163149946|NCT02326155|589263521|FG000|Overall Study|Lost to Follow-up|14|||
163149947|NCT02326155|589263522|FG001|Overall Study|Lost to Follow-up|3|||
163149948|NCT02326155|589263521|FG000|Overall Study|Protocol Violation|2|||
163149949|NCT02326155|589263522|FG001|Overall Study|Protocol Violation|0|||
163149950|NCT02326155|589263521|FG000|Overall Study|Withdrawal by Subject|34|||
163149951|NCT02326155|589263522|FG001|Overall Study|Withdrawal by Subject|11|||
163149952|NCT02326155|589263521|FG000|Overall Study|Disease progression|37|||
163149953|NCT02326155|589263522|FG001|Overall Study|Disease progression|4|||
163149954|NCT02326155|589263521|FG000|Overall Study|Study close|188|||
163149955|NCT02326155|589263522|FG001|Overall Study|Study close|21|||
163149956|NCT02326155|589263521|FG000|Overall Study|except for study close|46|||
163149957|NCT02326155|589263522|FG001|Overall Study|except for study close|13|||
163149958|NCT01499940|589263528|FG000|Overall Study|Study was withdrawn before completion.|9|||
163149959|NCT04739982|589263530|FG000|Overall Study|Lost to Follow-up|176|||
163149960|NCT04739982|589263531|FG001|Overall Study|Lost to Follow-up|65|||
163149961|NCT04739982|589263530|FG000|Overall Study|Withdrawal by Subject|19|||
163149962|NCT04739982|589263531|FG001|Overall Study|Withdrawal by Subject|0|||
163149963|NCT04739982|589263530|FG000|Overall Study|Protocol Violation|0|||
163149964|NCT04739982|589263531|FG001|Overall Study|Protocol Violation|5|||
163149965|NCT04914364|589263533|FG000|Overall Study|No longer eligible for study|1|||
163149966|NCT04914364|589263533|FG000|Overall Study|Lost to Follow-up|2|||
163149967|NCT00537394|589263534|FG000|First Year of Follow-up|Death|7|||
163149968|NCT00537394|589263535|FG001|First Year of Follow-up|Death|0|||
163149969|NCT00537394|589263536|FG002|First Year of Follow-up|Death|0|||
163149970|NCT00537394|589263534|FG000|First Year of Follow-up|Severe debilitation|1|||
163149971|NCT00537394|589263535|FG001|First Year of Follow-up|Severe debilitation|0|||
163149972|NCT00537394|589263536|FG002|First Year of Follow-up|Severe debilitation|1|||
163149973|NCT00537394|589263534|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
163149974|NCT00537394|589263535|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
163149975|NCT00537394|589263536|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
163149976|NCT00537394|589263534|FG000|First Year of Follow-up|Lost to Follow-up|1|||
163149977|NCT00537394|589263535|FG001|First Year of Follow-up|Lost to Follow-up|5|||
163149978|NCT00537394|589263536|FG002|First Year of Follow-up|Lost to Follow-up|1|||
163149979|NCT00537394|589263534|FG000|2nd Year of Follow-up|Death|4|||
162669458|NCT01490632|587499956|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
162669459|NCT01490632|587499957|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
162669460|NCT01490632|587499958|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
162669461|NCT01490632|587499959|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
162669462|NCT01490632|587499960|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
162669463|NCT01490632|587499961|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162721824|NCT06119113|587689344|FG001|Overall Study|Lost to Follow-up|13|||
162669464|NCT01490632|587499962|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669465|NCT01490632|587499963|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669466|NCT01490632|587499964|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669467|NCT01490632|587499965|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669468|NCT01490632|587499966|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669469|NCT01490632|587499967|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669470|NCT01490632|587499968|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162669471|NCT01490632|587499949|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669472|NCT01490632|587499950|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669473|NCT01490632|587499951|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669474|NCT01490632|587499952|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669475|NCT01490632|587499953|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669476|NCT01490632|587499954|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669477|NCT01490632|587499955|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669478|NCT01490632|587499956|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669479|NCT01490632|587499957|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669480|NCT01490632|587499958|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669481|NCT01490632|587499959|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669482|NCT01490632|587499960|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669483|NCT01490632|587499961|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669484|NCT01490632|587499962|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669485|NCT01490632|587499963|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
162669486|NCT01490632|587499964|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
162669487|NCT01490632|587499965|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669488|NCT01490632|587499966|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669489|NCT01490632|587499967|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
162669490|NCT01490632|587499968|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
162721825|NCT06119113|587689345|FG002|Overall Study|Lost to Follow-up|21|||
162721826|NCT05136443|587689348|FG000|Overall Study|Lost to Follow-up|2|||
162669491|NCT01490632|587499949|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162721827|NCT05136443|587689348|FG000|Overall Study|Adverse Event|2|||
162721828|NCT01786564|587689355|FG000|Overall Study|Lost to Follow-up|47|||
162721829|NCT01786564|587689355|FG000|Overall Study|Ineligible|17|||
162669492|NCT01490632|587499950|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162721830|NCT00424762|587689358|FG000|Overall Study|Withdrawal by Subject|18|||
162669493|NCT01490632|587499951|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669494|NCT01490632|587499952|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669495|NCT01490632|587499953|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669496|NCT01490632|587499954|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669497|NCT01490632|587499955|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669498|NCT01490632|587499956|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669499|NCT01490632|587499957|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162721831|NCT00424762|587689359|FG001|Overall Study|Withdrawal by Subject|19|||
162669500|NCT01490632|587499958|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669501|NCT01490632|587499959|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162721832|NCT00424762|587689358|FG000|Overall Study|Lost to Follow-up|2|||
162721833|NCT00424762|587689359|FG001|Overall Study|Lost to Follow-up|3|||
162721834|NCT01145885|587689360|FG000|Overall Study|Progressive Disease|7|||
162721835|NCT05299606|587689361|FG000|Overall Study|Death|1|||
162721836|NCT03460756|587689363|FG000|Overall Study|Adverse Event|0|||
162721837|NCT03460756|587689364|FG001|Overall Study|Adverse Event|0|||
162721838|NCT03460756|587689365|FG002|Overall Study|Adverse Event|0|||
163149980|NCT00537394|589263535|FG001|2nd Year of Follow-up|Death|1|||
163149981|NCT00537394|589263536|FG002|2nd Year of Follow-up|Death|2|||
163149982|NCT00537394|589263534|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
163149983|NCT00537394|589263535|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
163149984|NCT00537394|589263536|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
163149985|NCT00537394|589263534|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
163149986|NCT00537394|589263535|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
163149987|NCT00537394|589263536|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
163149988|NCT00537394|589263534|FG000|2nd Year of Follow-up|Clinic site closure|1|||
163149989|NCT00537394|589263535|FG001|2nd Year of Follow-up|Clinic site closure|0|||
163149990|NCT00537394|589263536|FG002|2nd Year of Follow-up|Clinic site closure|0|||
163149991|NCT01283139|589263537|FG000|Overall Study|Lost to Follow-up|5|||
163149992|NCT01283139|589263538|FG001|Overall Study|Lost to Follow-up|2|||
163149993|NCT01283139|589263539|FG002|Overall Study|Lost to Follow-up|3|||
163149994|NCT01283139|589263540|FG003|Overall Study|Lost to Follow-up|1|||
163149995|NCT01283139|589263537|FG000|Overall Study|Withdrawal by Subject|8|||
163149996|NCT01283139|589263538|FG001|Overall Study|Withdrawal by Subject|8|||
163149997|NCT01283139|589263539|FG002|Overall Study|Withdrawal by Subject|6|||
163149998|NCT01283139|589263540|FG003|Overall Study|Withdrawal by Subject|8|||
163149999|NCT01283139|589263537|FG000|Overall Study|Death|2|||
163150000|NCT01283139|589263538|FG001|Overall Study|Death|0|||
163150001|NCT01283139|589263539|FG002|Overall Study|Death|2|||
163150002|NCT01283139|589263540|FG003|Overall Study|Death|2|||
163150003|NCT01283139|589263537|FG000|Overall Study|Lack of Efficacy|1|||
163150004|NCT01283139|589263538|FG001|Overall Study|Lack of Efficacy|2|||
163150005|NCT01283139|589263539|FG002|Overall Study|Lack of Efficacy|2|||
163150006|NCT01283139|589263540|FG003|Overall Study|Lack of Efficacy|1|||
163150007|NCT01283139|589263537|FG000|Overall Study|Early termination due to AE/SAE|1|||
163150008|NCT01283139|589263538|FG001|Overall Study|Early termination due to AE/SAE|1|||
163150009|NCT01283139|589263539|FG002|Overall Study|Early termination due to AE/SAE|0|||
163150010|NCT01283139|589263540|FG003|Overall Study|Early termination due to AE/SAE|0|||
163150011|NCT01283139|589263537|FG000|Overall Study|Participant's refusal to continue|0|||
163150012|NCT01283139|589263538|FG001|Overall Study|Participant's refusal to continue|3|||
163150013|NCT01283139|589263539|FG002|Overall Study|Participant's refusal to continue|1|||
163150014|NCT01283139|589263540|FG003|Overall Study|Participant's refusal to continue|1|||
163150015|NCT01283139|589263537|FG000|Overall Study|Pregnancy|0|||
163150016|NCT01283139|589263538|FG001|Overall Study|Pregnancy|1|||
163150017|NCT01283139|589263539|FG002|Overall Study|Pregnancy|1|||
163150018|NCT01283139|589263540|FG003|Overall Study|Pregnancy|0|||
163150019|NCT01283139|589263537|FG000|Overall Study|Missed follow-up visit|0|||
163150020|NCT01283139|589263538|FG001|Overall Study|Missed follow-up visit|1|||
163150021|NCT01283139|589263539|FG002|Overall Study|Missed follow-up visit|2|||
163150022|NCT01283139|589263540|FG003|Overall Study|Missed follow-up visit|2|||
163150023|NCT01283139|589263537|FG000|Overall Study|Participant randomized in error|0|||
163150024|NCT01283139|589263538|FG001|Overall Study|Participant randomized in error|0|||
163150025|NCT01283139|589263539|FG002|Overall Study|Participant randomized in error|1|||
163150026|NCT01283139|589263540|FG003|Overall Study|Participant randomized in error|0|||
163150027|NCT00004563|589263545|FG000|Overall Study|Withdrawal by Subject|20|||
163150028|NCT00004563|589263546|FG001|Overall Study|Withdrawal by Subject|16|||
163150029|NCT00004563|589263545|FG000|Overall Study|Lack of Efficacy|3|||
163150030|NCT00004563|589263546|FG001|Overall Study|Lack of Efficacy|5|||
163150031|NCT00004563|589263545|FG000|Overall Study|Death|2|||
163150032|NCT00004563|589263546|FG001|Overall Study|Death|3|||
163150033|NCT01056822|589263547|FG000|Overall Study|Adverse Event|0|||
163150034|NCT01056822|589263548|FG001|Overall Study|Adverse Event|1|||
163150035|NCT01056822|589263547|FG000|Overall Study|Protocol Violation|6|||
163150036|NCT01056822|589263548|FG001|Overall Study|Protocol Violation|5|||
163150037|NCT01056822|589263547|FG000|Overall Study|Withdrawal by Subject|1|||
163150038|NCT01056822|589263548|FG001|Overall Study|Withdrawal by Subject|1|||
162669502|NCT01490632|587499960|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
163150039|NCT01056822|589263547|FG000|Overall Study|Lost to Follow-up|1|||
163150040|NCT01056822|589263548|FG001|Overall Study|Lost to Follow-up|0|||
163150041|NCT01844765|589263551|FG000|Overall Study|Adverse Event|6|||
163150042|NCT01844765|589263552|FG001|Overall Study|Adverse Event|8|||
163150043|NCT01844765|589263551|FG000|Overall Study|Withdrawal by Subject|2|||
163150044|NCT01844765|589263552|FG001|Overall Study|Withdrawal by Subject|3|||
163150045|NCT01844765|589263551|FG000|Overall Study|Disease progression|1|||
163150046|NCT01844765|589263552|FG001|Overall Study|Disease progression|0|||
163150047|NCT01844765|589263551|FG000|Overall Study|Administrative problems|3|||
163150048|NCT01844765|589263552|FG001|Overall Study|Administrative problems|4|||
163150049|NCT01844765|589263551|FG000|Overall Study|Protocol deviation|2|||
163150050|NCT01844765|589263552|FG001|Overall Study|Protocol deviation|0|||
163150051|NCT01844765|589263551|FG000|Overall Study|Untreated|1|||
163150052|NCT01844765|589263552|FG001|Overall Study|Untreated|0|||
163150053|NCT02025179|589263553|FG000|Overall Study|Lost to Follow-up|0|||
163150054|NCT02025179|589263554|FG001|Overall Study|Lost to Follow-up|0|||
163150055|NCT02025179|589263555|FG002|Overall Study|Lost to Follow-up|1|||
163150056|NCT00556075|589263556|FG000|Overall Study|Lost to Follow-up|3|||
163150057|NCT00556075|589263557|FG001|Overall Study|Lost to Follow-up|0|||
163150058|NCT00556075|589263558|FG002|Overall Study|Lost to Follow-up|3|||
163150059|NCT00556075|589263556|FG000|Overall Study|Withdrawal by Subject|3|||
163150060|NCT00556075|589263557|FG001|Overall Study|Withdrawal by Subject|3|||
163150061|NCT00556075|589263558|FG002|Overall Study|Withdrawal by Subject|0|||
163150062|NCT00556075|589263556|FG000|Overall Study|Protocol Violation|1|||
163150063|NCT00556075|589263557|FG001|Overall Study|Protocol Violation|1|||
163150064|NCT00556075|589263558|FG002|Overall Study|Protocol Violation|3|||
163150065|NCT00556075|589263556|FG000|Overall Study|Not eligible|1|||
163150066|NCT00556075|589263557|FG001|Overall Study|Not eligible|1|||
163150067|NCT00556075|589263558|FG002|Overall Study|Not eligible|2|||
163150068|NCT00556075|589263556|FG000|Overall Study|Adverse Event|1|||
163150069|NCT00556075|589263557|FG001|Overall Study|Adverse Event|2|||
163150070|NCT00556075|589263558|FG002|Overall Study|Adverse Event|0|||
163150071|NCT00556075|589263556|FG000|Overall Study|Personal issues|4|||
163150072|NCT00556075|589263557|FG001|Overall Study|Personal issues|1|||
163150073|NCT00556075|589263558|FG002|Overall Study|Personal issues|0|||
163150074|NCT00556075|589263556|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
163150075|NCT00556075|589263557|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
163150076|NCT00556075|589263558|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
163150077|NCT00601835|589263559|FG000|Overall Study|Withdrawal by Subject|9|||
163150078|NCT00601835|589263560|FG001|Overall Study|Withdrawal by Subject|6|||
163150079|NCT00601835|589263559|FG000|Overall Study|Physician Decision|1|||
163150080|NCT00601835|589263560|FG001|Overall Study|Physician Decision|0|||
163150081|NCT00601835|589263559|FG000|Overall Study|Lost to Follow-up|37|||
163150082|NCT00601835|589263560|FG001|Overall Study|Lost to Follow-up|5|||
163150083|NCT00601835|589263559|FG000|Overall Study|Adverse Event|1|||
163150084|NCT00601835|589263560|FG001|Overall Study|Adverse Event|1|||
163150085|NCT00601835|589263559|FG000|Overall Study|Relocate|12|||
163150086|NCT00601835|589263560|FG001|Overall Study|Relocate|2|||
163150087|NCT01927497|589263561|FG000|Overall Study|Death|0|||
163150088|NCT01927497|589263562|FG001|Overall Study|Death|1|||
163150089|NCT01927497|589263561|FG000|Overall Study|Protocol Violation|2|||
163150090|NCT01927497|589263562|FG001|Overall Study|Protocol Violation|0|||
163150091|NCT00395746|589263563|FG000|Overall Study|Adverse Event|5|||
163150092|NCT00395746|589263564|FG001|Overall Study|Adverse Event|2|||
163150093|NCT00395746|589263565|FG002|Overall Study|Adverse Event|2|||
163150094|NCT00395746|589263563|FG000|Overall Study|Protocol Violation|0|||
163150095|NCT00395746|589263564|FG001|Overall Study|Protocol Violation|1|||
163150096|NCT00395746|589263565|FG002|Overall Study|Protocol Violation|0|||
163150097|NCT00395746|589263563|FG000|Overall Study|Lack of Efficacy|2|||
163150098|NCT00395746|589263564|FG001|Overall Study|Lack of Efficacy|0|||
163150099|NCT00395746|589263565|FG002|Overall Study|Lack of Efficacy|17|||
163150100|NCT00395746|589263563|FG000|Overall Study|Hypoglycaemia|2|||
163150101|NCT00395746|589263564|FG001|Overall Study|Hypoglycaemia|1|||
163150102|NCT00395746|589263565|FG002|Overall Study|Hypoglycaemia|0|||
163150103|NCT00395746|589263563|FG000|Overall Study|Subject decision|0|||
163150104|NCT00395746|589263564|FG001|Overall Study|Subject decision|0|||
163150105|NCT00395746|589263565|FG002|Overall Study|Subject decision|1|||
163150106|NCT00395746|589263563|FG000|Overall Study|Withdrawal of consent|0|||
163150107|NCT00395746|589263564|FG001|Overall Study|Withdrawal of consent|0|||
163150108|NCT00395746|589263565|FG002|Overall Study|Withdrawal of consent|1|||
163150109|NCT00395746|589263563|FG000|Overall Study|Difficultulty in use of device|0|||
163150110|NCT00395746|589263564|FG001|Overall Study|Difficultulty in use of device|0|||
163150111|NCT00395746|589263565|FG002|Overall Study|Difficultulty in use of device|1|||
163150112|NCT00395746|589263563|FG000|Overall Study|Unable to visit site on schedule|1|||
163150113|NCT00395746|589263564|FG001|Overall Study|Unable to visit site on schedule|0|||
163150114|NCT00395746|589263565|FG002|Overall Study|Unable to visit site on schedule|0|||
163150115|NCT04528641|589263566|FG000|Overall Study|Withdrawal by Subject|0|||
163150116|NCT04528641|589263567|FG001|Overall Study|Withdrawal by Subject|0|||
162669503|NCT01490632|587499961|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669504|NCT01490632|587499962|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
162669505|NCT01490632|587499963|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669506|NCT01490632|587499964|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669507|NCT01490632|587499965|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669508|NCT01490632|587499966|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669509|NCT01490632|587499967|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669510|NCT01490632|587499968|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162669511|NCT01490632|587499949|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669512|NCT01490632|587499950|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669513|NCT01490632|587499951|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669514|NCT01490632|587499952|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669515|NCT01490632|587499953|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669516|NCT01490632|587499954|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669517|NCT01490632|587499955|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669518|NCT01490632|587499956|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669519|NCT01490632|587499957|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669520|NCT01490632|587499958|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669521|NCT01490632|587499959|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669522|NCT01490632|587499960|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669523|NCT01490632|587499961|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669524|NCT01490632|587499962|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669525|NCT01490632|587499963|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
162669526|NCT01490632|587499964|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
162669527|NCT01490632|587499965|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
163150117|NCT04528641|589263568|FG002|Overall Study|Withdrawal by Subject|0|||
163150118|NCT04528641|589263569|FG003|Overall Study|Withdrawal by Subject|1|||
163150119|NCT04528641|589263570|FG004|Overall Study|Withdrawal by Subject|0|||
163150120|NCT04528641|589263571|FG005|Overall Study|Withdrawal by Subject|1|||
163150121|NCT03914417|589263572|FG000|Overall Study|Withdrawal by Subject|2|||
163150122|NCT00517296|589263577|FG000|Overall Study|Withdrawal by Subject|1|||
163150123|NCT00517296|589263578|FG001|Overall Study|Withdrawal by Subject|0|||
163150124|NCT04764162|589263581|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
163150125|NCT04764162|589263582|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
163150126|NCT00795704|589263583|FG000|Overall Study|Withdrawal by Subject|3|||
163150127|NCT00795704|589263584|FG001|Overall Study|Withdrawal by Subject|2|||
163150128|NCT00795704|589263583|FG000|Overall Study|Adverse Event|1|||
163150129|NCT00795704|589263584|FG001|Overall Study|Adverse Event|1|||
163150130|NCT01300728|589263585|FG000|Overall Study|Withdrawal by Subject|1|||
163150131|NCT01300728|589263586|FG001|Overall Study|Withdrawal by Subject|1|||
163150132|NCT01300728|589263585|FG000|Overall Study|Physician Decision|1|||
163150133|NCT01300728|589263586|FG001|Overall Study|Physician Decision|0|||
163150134|NCT01247324|589263587|FG000|Overall Study|Death|6|||
163150135|NCT01247324|589263588|FG001|Overall Study|Death|10|||
163150136|NCT01247324|589263587|FG000|Overall Study|Physician Decision|2|||
163150137|NCT01247324|589263588|FG001|Overall Study|Physician Decision|3|||
163150138|NCT01247324|589263587|FG000|Overall Study|Non-compliance with study drug|3|||
163150139|NCT01247324|589263588|FG001|Overall Study|Non-compliance with study drug|0|||
163150140|NCT01247324|589263587|FG000|Overall Study|Lack of Efficacy|24|||
163150141|NCT01247324|589263588|FG001|Overall Study|Lack of Efficacy|14|||
163150142|NCT01247324|589263587|FG000|Overall Study|Non-compliance|3|||
163150143|NCT01247324|589263588|FG001|Overall Study|Non-compliance|2|||
163150144|NCT01247324|589263587|FG000|Overall Study|Pregnancy|5|||
163150145|NCT01247324|589263588|FG001|Overall Study|Pregnancy|10|||
163150146|NCT01247324|589263587|FG000|Overall Study|Protocol Violation|1|||
163150147|NCT01247324|589263588|FG001|Overall Study|Protocol Violation|1|||
163150148|NCT01247324|589263587|FG000|Overall Study|Reason not specified|42|||
163150149|NCT01247324|589263588|FG001|Overall Study|Reason not specified|32|||
163150150|NCT01247324|589263587|FG000|Overall Study|Consent withdrawn by participant|41|||
163150151|NCT01247324|589263588|FG001|Overall Study|Consent withdrawn by participant|56|||
163150152|NCT01247324|589263587|FG000|Overall Study|Adverse Event|49|||
163150153|NCT01247324|589263588|FG001|Overall Study|Adverse Event|35|||
163150154|NCT01247324|589263587|FG000|Overall Study|Lost to Follow-up|3|||
163150155|NCT01247324|589263588|FG001|Overall Study|Lost to Follow-up|6|||
163150156|NCT01247324|589263587|FG000|Overall Study|Study Terminated by Sponsor|4|||
163150157|NCT01247324|589263588|FG001|Overall Study|Study Terminated by Sponsor|1|||
163150158|NCT01247324|589263587|FG000|Overall Study|Missing|2|||
163150159|NCT01247324|589263588|FG001|Overall Study|Missing|1|||
163150160|NCT00506350|589263589|FG000|Overall Study|Serious Adverse Event|1|||
163150161|NCT00506350|589263590|FG001|Overall Study|Serious Adverse Event|0|||
163150162|NCT00506350|589263591|FG002|Overall Study|Serious Adverse Event|0|||
163150163|NCT00506350|589263592|FG003|Overall Study|Serious Adverse Event|0|||
163150164|NCT00506350|589263593|FG004|Overall Study|Serious Adverse Event|0|||
163150165|NCT00506350|589263594|FG005|Overall Study|Serious Adverse Event|0|||
163150166|NCT00506350|589263595|FG006|Overall Study|Serious Adverse Event|0|||
163150167|NCT00506350|589263596|FG007|Overall Study|Serious Adverse Event|0|||
163150168|NCT00506350|589263597|FG008|Overall Study|Serious Adverse Event|0|||
163150169|NCT00506350|589263589|FG000|Overall Study|Adverse Event|0|||
163150170|NCT00506350|589263590|FG001|Overall Study|Adverse Event|0|||
163150171|NCT00506350|589263591|FG002|Overall Study|Adverse Event|0|||
163150172|NCT00506350|589263592|FG003|Overall Study|Adverse Event|0|||
163150173|NCT00506350|589263593|FG004|Overall Study|Adverse Event|0|||
163150174|NCT00506350|589263594|FG005|Overall Study|Adverse Event|0|||
163150175|NCT00506350|589263595|FG006|Overall Study|Adverse Event|0|||
163150176|NCT00506350|589263596|FG007|Overall Study|Adverse Event|1|||
163150177|NCT00506350|589263597|FG008|Overall Study|Adverse Event|1|||
163150178|NCT00506350|589263589|FG000|Overall Study|Protocol Violation|0|||
163150179|NCT00506350|589263590|FG001|Overall Study|Protocol Violation|0|||
163150180|NCT00506350|589263591|FG002|Overall Study|Protocol Violation|1|||
163150181|NCT00506350|589263592|FG003|Overall Study|Protocol Violation|0|||
163150182|NCT00506350|589263593|FG004|Overall Study|Protocol Violation|0|||
163150183|NCT00506350|589263594|FG005|Overall Study|Protocol Violation|0|||
163150184|NCT00506350|589263595|FG006|Overall Study|Protocol Violation|1|||
163150185|NCT00506350|589263596|FG007|Overall Study|Protocol Violation|0|||
163150186|NCT00506350|589263597|FG008|Overall Study|Protocol Violation|0|||
163150187|NCT00506350|589263589|FG000|Overall Study|Withdrawal by Subject|0|||
163150188|NCT00506350|589263590|FG001|Overall Study|Withdrawal by Subject|1|||
163150189|NCT00506350|589263591|FG002|Overall Study|Withdrawal by Subject|1|||
163150190|NCT00506350|589263592|FG003|Overall Study|Withdrawal by Subject|1|||
163150191|NCT00506350|589263593|FG004|Overall Study|Withdrawal by Subject|4|||
162721839|NCT03460756|587689366|FG003|Overall Study|Adverse Event|1|||
162669528|NCT01490632|587499966|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669529|NCT01490632|587499967|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669530|NCT01490632|587499968|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162669531|NCT01490632|587499949|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669532|NCT01490632|587499950|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669533|NCT01490632|587499951|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669534|NCT01490632|587499952|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669535|NCT01490632|587499953|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669536|NCT01490632|587499954|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669537|NCT01490632|587499955|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669538|NCT01490632|587499956|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669539|NCT01490632|587499957|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669540|NCT01490632|587499958|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669541|NCT01490632|587499959|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669542|NCT01490632|587499960|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669543|NCT01490632|587499961|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
162669544|NCT01490632|587499962|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
162669545|NCT01490632|587499963|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
162669546|NCT01490632|587499964|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
162669547|NCT01490632|587499965|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669548|NCT01490632|587499966|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669549|NCT01490632|587499967|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669550|NCT01490632|587499968|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162669551|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
162669552|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
162669553|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
162669554|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
162669555|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
162669556|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
162669557|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
162669558|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
162669559|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
162669560|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
162669561|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
162669562|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
162669563|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
162669564|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
162669565|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
162669566|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
162669567|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
162669568|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
162669569|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
162669570|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
162669571|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Death|0|||
162669572|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Death|0|||
162669573|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Death|0|||
162669574|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Death|0|||
162669575|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Death|0|||
162669576|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Death|0|||
162669577|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Death|0|||
162669578|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Death|0|||
162669579|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Death|0|||
162669580|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Death|0|||
162669581|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Death|0|||
162669582|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Death|0|||
162669583|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Death|0|||
162669584|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Death|0|||
162669585|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Death|0|||
162669586|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Death|0|||
162669587|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Death|0|||
162669588|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Death|0|||
162669589|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Death|1|||
162669590|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Death|0|||
162669591|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669592|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669593|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162721840|NCT03460756|587689363|FG000|Overall Study|Lack of Efficacy|0|||
162669594|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669595|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669596|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669597|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669598|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669599|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669600|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669601|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669602|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669603|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669604|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669605|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669606|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669607|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162669608|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
162669609|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
162669610|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
162669611|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669612|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669613|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669614|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669615|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669616|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669617|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669618|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669619|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669620|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669621|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669622|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669623|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669624|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669625|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669626|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669627|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669628|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669629|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
162669630|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162669631|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
162669632|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
162669633|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
162669634|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
162669635|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
162669636|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
162669637|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
162721841|NCT03460756|587689364|FG001|Overall Study|Lack of Efficacy|0|||
162669638|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
162669639|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
162669640|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
162669641|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
162669642|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
162669643|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
162721842|NCT03460756|587689365|FG002|Overall Study|Lack of Efficacy|0|||
162721843|NCT03460756|587689366|FG003|Overall Study|Lack of Efficacy|2|||
162721844|NCT03460756|587689363|FG000|Overall Study|Lost to Follow-up|0|||
162721845|NCT03460756|587689364|FG001|Overall Study|Lost to Follow-up|1|||
162669644|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
162669645|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
162669646|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
162669647|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
162669648|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
162669649|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
162669650|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
162669651|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
162669652|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
162669653|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
162669654|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
162669655|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
162669656|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
162669657|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
162669658|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
162669659|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
162669660|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
162669661|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
162669662|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
162669663|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
162669664|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
162669665|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
162669666|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
162669667|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
162669668|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
162669669|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
162669670|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
162669671|NCT01490632|587499949|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669672|NCT01490632|587499950|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669673|NCT01490632|587499951|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669674|NCT01490632|587499952|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669675|NCT01490632|587499953|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669676|NCT01490632|587499954|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669677|NCT01490632|587499955|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669678|NCT01490632|587499956|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669679|NCT01490632|587499957|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669680|NCT01490632|587499958|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669681|NCT01490632|587499959|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669682|NCT01490632|587499960|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669683|NCT01490632|587499961|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669684|NCT01490632|587499962|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669685|NCT01490632|587499963|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669686|NCT01490632|587499964|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669687|NCT01490632|587499965|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162669688|NCT01490632|587499966|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162669689|NCT01490632|587499967|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162669690|NCT01490632|587499968|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162669691|NCT02332720|587499969|FG000|Part A and Part B|Lost to Follow-up|1|||
163150192|NCT00506350|589263594|FG005|Overall Study|Withdrawal by Subject|1|||
163150193|NCT00506350|589263595|FG006|Overall Study|Withdrawal by Subject|1|||
163150194|NCT00506350|589263596|FG007|Overall Study|Withdrawal by Subject|2|||
163150195|NCT00506350|589263597|FG008|Overall Study|Withdrawal by Subject|0|||
163150196|NCT00506350|589263589|FG000|Overall Study|Lost to Follow-up|1|||
163150197|NCT00506350|589263590|FG001|Overall Study|Lost to Follow-up|1|||
163150198|NCT00506350|589263591|FG002|Overall Study|Lost to Follow-up|1|||
163150199|NCT00506350|589263592|FG003|Overall Study|Lost to Follow-up|1|||
163150200|NCT00506350|589263593|FG004|Overall Study|Lost to Follow-up|2|||
163150201|NCT00506350|589263594|FG005|Overall Study|Lost to Follow-up|1|||
163150202|NCT00506350|589263595|FG006|Overall Study|Lost to Follow-up|0|||
163150203|NCT00506350|589263596|FG007|Overall Study|Lost to Follow-up|0|||
163150204|NCT00506350|589263597|FG008|Overall Study|Lost to Follow-up|2|||
163150205|NCT00506350|589263589|FG000|Overall Study|Medical Reason|0|||
163150206|NCT00506350|589263590|FG001|Overall Study|Medical Reason|0|||
163150207|NCT00506350|589263591|FG002|Overall Study|Medical Reason|0|||
163150208|NCT00506350|589263592|FG003|Overall Study|Medical Reason|0|||
163150209|NCT00506350|589263593|FG004|Overall Study|Medical Reason|1|||
163150210|NCT00506350|589263594|FG005|Overall Study|Medical Reason|0|||
163150211|NCT00506350|589263595|FG006|Overall Study|Medical Reason|0|||
163150212|NCT00506350|589263596|FG007|Overall Study|Medical Reason|0|||
163150213|NCT00506350|589263597|FG008|Overall Study|Medical Reason|0|||
163150214|NCT00506350|589263589|FG000|Overall Study|Other|1|||
163150215|NCT00506350|589263590|FG001|Overall Study|Other|1|||
163150216|NCT00506350|589263591|FG002|Overall Study|Other|3|||
162669692|NCT02332720|587499970|FG001|Part A and Part B|Lost to Follow-up|0|||
162721846|NCT03460756|587689365|FG002|Overall Study|Lost to Follow-up|2|||
163150217|NCT00506350|589263592|FG003|Overall Study|Other|0|||
163150218|NCT00506350|589263593|FG004|Overall Study|Other|3|||
163150219|NCT00506350|589263594|FG005|Overall Study|Other|0|||
163150220|NCT00506350|589263595|FG006|Overall Study|Other|0|||
163150221|NCT00506350|589263596|FG007|Overall Study|Other|2|||
163150222|NCT00506350|589263597|FG008|Overall Study|Other|2|||
163150223|NCT03474588|589263598|FG000|Overall Study|Withdrawal by Subject|4|||
163150224|NCT03474588|589263599|FG001|Overall Study|Withdrawal by Subject|3|||
162669693|NCT02332720|587499971|FG002|Part A and Part B|Lost to Follow-up|0|||
162669694|NCT02332720|587499972|FG003|Part A and Part B|Lost to Follow-up|0|||
162669695|NCT02332720|587499973|FG004|Part A and Part B|Lost to Follow-up|0|||
162669696|NCT02332720|587499974|FG005|Part A and Part B|Lost to Follow-up|2|||
162669697|NCT02332720|587499975|FG006|Part A and Part B|Lost to Follow-up|1|||
162669698|NCT02332720|587499976|FG007|Part A and Part B|Lost to Follow-up|1|||
162669699|NCT02332720|587499977|FG008|Part A and Part B|Lost to Follow-up|0|||
162669700|NCT02332720|587499978|FG009|Part A and Part B|Lost to Follow-up|0|||
162669701|NCT02332720|587499979|FG010|Part A and Part B|Lost to Follow-up|0|||
162669702|NCT02332720|587499980|FG011|Part A and Part B|Lost to Follow-up|0|||
162669703|NCT02332720|587499981|FG012|Part A and Part B|Lost to Follow-up|0|||
162669704|NCT02332720|587499982|FG013|Part A and Part B|Lost to Follow-up|0|||
162669705|NCT02332720|587499983|FG014|Part A and Part B|Lost to Follow-up|0|||
162669706|NCT02332720|587499984|FG015|Part A and Part B|Lost to Follow-up|1|||
162669707|NCT02332720|587499985|FG016|Part A and Part B|Lost to Follow-up|0|||
162669708|NCT02332720|587499986|FG017|Part A and Part B|Lost to Follow-up|0|||
162669709|NCT02332720|587499987|FG018|Part A and Part B|Lost to Follow-up|0|||
162669710|NCT02332720|587499988|FG019|Part A and Part B|Lost to Follow-up|0|||
162669711|NCT02332720|587499989|FG020|Part A and Part B|Lost to Follow-up|0|||
162669712|NCT02332720|587499990|FG021|Part A and Part B|Lost to Follow-up|0|||
162669713|NCT02332720|587499991|FG022|Part A and Part B|Lost to Follow-up|0|||
163150225|NCT03474588|589263598|FG000|Overall Study|Death|0|||
163150226|NCT03474588|589263599|FG001|Overall Study|Death|1|||
163150227|NCT01607957|589263600|FG000|Overall Study|Not treated|1|||
163150228|NCT01607957|589263601|FG001|Overall Study|Not treated|1|||
163150229|NCT01607957|589263600|FG000|Overall Study|Death|367|||
163150230|NCT01607957|589263601|FG001|Overall Study|Death|211|||
163150231|NCT01607957|589263600|FG000|Overall Study|Lost to Follow-up|3|||
163150232|NCT01607957|589263601|FG001|Overall Study|Lost to Follow-up|3|||
163150233|NCT01607957|589263600|FG000|Overall Study|Participant refusal|1|||
163150234|NCT01607957|589263601|FG001|Overall Study|Participant refusal|0|||
163150235|NCT01691794|589263602|FG000|Overall Study|Poor/Non-Compliance|1|||
163150236|NCT01691794|589263603|FG001|Overall Study|Poor/Non-Compliance|4|||
163150237|NCT01691794|589263604|FG002|Overall Study|Poor/Non-Compliance|1|||
163150238|NCT01691794|589263602|FG000|Overall Study|Death|0|||
163150239|NCT01691794|589263603|FG001|Overall Study|Death|0|||
163150240|NCT01691794|589263604|FG002|Overall Study|Death|1|||
163150241|NCT01691794|589263602|FG000|Overall Study|Lack of Efficacy|0|||
163150242|NCT01691794|589263603|FG001|Overall Study|Lack of Efficacy|7|||
163150243|NCT01691794|589263604|FG002|Overall Study|Lack of Efficacy|1|||
163150244|NCT01691794|589263602|FG000|Overall Study|Participant request to discontinue|0|||
163150245|NCT01691794|589263603|FG001|Overall Study|Participant request to discontinue|1|||
163150246|NCT01691794|589263604|FG002|Overall Study|Participant request to discontinue|0|||
163150247|NCT01691794|589263602|FG000|Overall Study|Adverse Event|0|||
163150248|NCT01691794|589263603|FG001|Overall Study|Adverse Event|1|||
163150249|NCT01691794|589263604|FG002|Overall Study|Adverse Event|1|||
163150250|NCT01691794|589263602|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
163150251|NCT01691794|589263603|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
163150252|NCT01691794|589263604|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
163150253|NCT01691794|589263602|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
163150254|NCT01691794|589263603|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
163150255|NCT01691794|589263604|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
163150256|NCT04972786|589263605|FG000|First Intervention (1 Day)|Adverse Event|1|||
163150257|NCT04972786|589263606|FG001|First Intervention (1 Day)|Adverse Event|0|||
163150258|NCT03905096|589263607|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
163150259|NCT03905096|589263608|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
163150260|NCT02016781|589263610|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
163150261|NCT02016781|589263611|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
163150262|NCT02016781|589263610|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
163150263|NCT02016781|589263611|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
163150264|NCT02016781|589263610|FG000|Final Database Lock|Withdrawal by Subject|2|||
163150265|NCT02016781|589263611|FG001|Final Database Lock|Withdrawal by Subject|1|||
163150266|NCT02016781|589263610|FG000|Final Database Lock|Lost to Follow-up|11|||
163150267|NCT02016781|589263611|FG001|Final Database Lock|Lost to Follow-up|4|||
163150268|NCT02016781|589263610|FG000|Final Database Lock|Missing data|0|||
163150269|NCT02016781|589263611|FG001|Final Database Lock|Missing data|3|||
163150270|NCT00945009|589263612|FG000|Overall Study|Lack of Efficacy|10|||
163150271|NCT00945009|589263613|FG001|Overall Study|Lack of Efficacy|0|||
163150272|NCT00945009|589263614|FG002|Overall Study|Lack of Efficacy|0|||
163150273|NCT00945009|589263612|FG000|Overall Study|Physician Decision|21|||
163150274|NCT00945009|589263613|FG001|Overall Study|Physician Decision|4|||
163150275|NCT00945009|589263614|FG002|Overall Study|Physician Decision|3|||
163150276|NCT00945009|589263612|FG000|Overall Study|Protocol Violation|6|||
163150277|NCT00945009|589263613|FG001|Overall Study|Protocol Violation|1|||
163150278|NCT00945009|589263614|FG002|Overall Study|Protocol Violation|0|||
163150279|NCT00945009|589263612|FG000|Overall Study|Withdrawal by Subject|1|||
162669714|NCT02332720|587499969|FG000|Part A and Part B|Adverse Event|0|||
162669715|NCT02332720|587499970|FG001|Part A and Part B|Adverse Event|0|||
163150280|NCT00945009|589263613|FG001|Overall Study|Withdrawal by Subject|0|||
163150281|NCT00945009|589263614|FG002|Overall Study|Withdrawal by Subject|0|||
162669716|NCT02332720|587499971|FG002|Part A and Part B|Adverse Event|0|||
162669717|NCT02332720|587499972|FG003|Part A and Part B|Adverse Event|0|||
162669718|NCT02332720|587499973|FG004|Part A and Part B|Adverse Event|0|||
162669719|NCT02332720|587499974|FG005|Part A and Part B|Adverse Event|0|||
162669720|NCT02332720|587499975|FG006|Part A and Part B|Adverse Event|0|||
162669721|NCT02332720|587499976|FG007|Part A and Part B|Adverse Event|0|||
162669722|NCT02332720|587499977|FG008|Part A and Part B|Adverse Event|0|||
162669723|NCT02332720|587499978|FG009|Part A and Part B|Adverse Event|0|||
162669724|NCT02332720|587499979|FG010|Part A and Part B|Adverse Event|0|||
162669725|NCT02332720|587499980|FG011|Part A and Part B|Adverse Event|0|||
162669726|NCT02332720|587499981|FG012|Part A and Part B|Adverse Event|0|||
162669727|NCT02332720|587499982|FG013|Part A and Part B|Adverse Event|0|||
162669728|NCT02332720|587499983|FG014|Part A and Part B|Adverse Event|0|||
162669729|NCT02332720|587499984|FG015|Part A and Part B|Adverse Event|0|||
162669730|NCT02332720|587499985|FG016|Part A and Part B|Adverse Event|0|||
162669731|NCT02332720|587499986|FG017|Part A and Part B|Adverse Event|1|||
162669732|NCT02332720|587499987|FG018|Part A and Part B|Adverse Event|0|||
162669733|NCT02332720|587499988|FG019|Part A and Part B|Adverse Event|0|||
162669734|NCT02332720|587499989|FG020|Part A and Part B|Adverse Event|0|||
162669735|NCT02332720|587499990|FG021|Part A and Part B|Adverse Event|0|||
162669736|NCT02332720|587499991|FG022|Part A and Part B|Adverse Event|0|||
162669737|NCT02332720|587499969|FG000|Part A and Part B|Physician Decision|0|||
162669738|NCT02332720|587499970|FG001|Part A and Part B|Physician Decision|0|||
162669739|NCT02332720|587499971|FG002|Part A and Part B|Physician Decision|0|||
162669740|NCT02332720|587499972|FG003|Part A and Part B|Physician Decision|0|||
162669741|NCT02332720|587499973|FG004|Part A and Part B|Physician Decision|0|||
162669742|NCT02332720|587499974|FG005|Part A and Part B|Physician Decision|0|||
162669743|NCT02332720|587499975|FG006|Part A and Part B|Physician Decision|0|||
162669744|NCT02332720|587499976|FG007|Part A and Part B|Physician Decision|0|||
162669745|NCT02332720|587499977|FG008|Part A and Part B|Physician Decision|0|||
162669746|NCT02332720|587499978|FG009|Part A and Part B|Physician Decision|0|||
162669747|NCT02332720|587499979|FG010|Part A and Part B|Physician Decision|0|||
162669748|NCT02332720|587499980|FG011|Part A and Part B|Physician Decision|0|||
162669749|NCT02332720|587499981|FG012|Part A and Part B|Physician Decision|0|||
162669750|NCT02332720|587499982|FG013|Part A and Part B|Physician Decision|0|||
162669751|NCT02332720|587499983|FG014|Part A and Part B|Physician Decision|0|||
162669752|NCT02332720|587499984|FG015|Part A and Part B|Physician Decision|0|||
162669753|NCT02332720|587499985|FG016|Part A and Part B|Physician Decision|0|||
162669754|NCT02332720|587499986|FG017|Part A and Part B|Physician Decision|0|||
162669755|NCT02332720|587499987|FG018|Part A and Part B|Physician Decision|1|||
162669756|NCT02332720|587499988|FG019|Part A and Part B|Physician Decision|0|||
162669757|NCT02332720|587499989|FG020|Part A and Part B|Physician Decision|0|||
162669758|NCT02332720|587499990|FG021|Part A and Part B|Physician Decision|0|||
162669759|NCT02332720|587499991|FG022|Part A and Part B|Physician Decision|0|||
162669760|NCT02332720|587499969|FG000|Part A and Part B|Withdrawal by Subject|0|||
162669761|NCT02332720|587499970|FG001|Part A and Part B|Withdrawal by Subject|0|||
162669762|NCT02332720|587499971|FG002|Part A and Part B|Withdrawal by Subject|0|||
162669763|NCT02332720|587499972|FG003|Part A and Part B|Withdrawal by Subject|0|||
162721847|NCT03460756|587689366|FG003|Overall Study|Lost to Follow-up|1|||
162721848|NCT03460756|587689363|FG000|Overall Study|Pregnancy|0|||
162721849|NCT03460756|587689364|FG001|Overall Study|Pregnancy|0|||
163150282|NCT00945009|589263612|FG000|Overall Study|Ineligible|6|||
162669764|NCT02332720|587499973|FG004|Part A and Part B|Withdrawal by Subject|0|||
162669765|NCT02332720|587499974|FG005|Part A and Part B|Withdrawal by Subject|1|||
162669766|NCT02332720|587499975|FG006|Part A and Part B|Withdrawal by Subject|0|||
162669767|NCT02332720|587499976|FG007|Part A and Part B|Withdrawal by Subject|0|||
162669768|NCT02332720|587499977|FG008|Part A and Part B|Withdrawal by Subject|0|||
162669769|NCT02332720|587499978|FG009|Part A and Part B|Withdrawal by Subject|0|||
162669770|NCT02332720|587499979|FG010|Part A and Part B|Withdrawal by Subject|0|||
162669771|NCT02332720|587499980|FG011|Part A and Part B|Withdrawal by Subject|0|||
162669772|NCT02332720|587499981|FG012|Part A and Part B|Withdrawal by Subject|0|||
162669773|NCT02332720|587499982|FG013|Part A and Part B|Withdrawal by Subject|0|||
162669774|NCT02332720|587499983|FG014|Part A and Part B|Withdrawal by Subject|0|||
162669775|NCT02332720|587499984|FG015|Part A and Part B|Withdrawal by Subject|0|||
162669776|NCT02332720|587499985|FG016|Part A and Part B|Withdrawal by Subject|0|||
162669777|NCT02332720|587499986|FG017|Part A and Part B|Withdrawal by Subject|0|||
162669778|NCT02332720|587499987|FG018|Part A and Part B|Withdrawal by Subject|0|||
162669779|NCT02332720|587499988|FG019|Part A and Part B|Withdrawal by Subject|1|||
162669780|NCT02332720|587499989|FG020|Part A and Part B|Withdrawal by Subject|0|||
162669781|NCT02332720|587499990|FG021|Part A and Part B|Withdrawal by Subject|0|||
162669782|NCT02332720|587499991|FG022|Part A and Part B|Withdrawal by Subject|0|||
162669783|NCT05732454|587499992|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
162669784|NCT05732454|587499993|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
162669785|NCT05732454|587499992|FG000|Part 1: DB Period|Adverse Event|1|||
162669786|NCT05732454|587499993|FG001|Part 1: DB Period|Adverse Event|0|||
162669787|NCT05732454|587499992|FG000|Part 1: DB Period|Lost to Follow-up|1|||
162669788|NCT05732454|587499993|FG001|Part 1: DB Period|Lost to Follow-up|0|||
162669789|NCT05732454|587499992|FG000|Part 1: DB Period|Protocol Violation|0|||
162669790|NCT05732454|587499993|FG001|Part 1: DB Period|Protocol Violation|1|||
162669791|NCT05732454|587499992|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
162669792|NCT05732454|587499993|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
162669793|NCT05732454|587499992|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
162669794|NCT05732454|587499993|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
162669795|NCT05732454|587499992|FG000|Part 1: OLE Period|Adverse Event|0|||
162669796|NCT05732454|587499993|FG001|Part 1: OLE Period|Adverse Event|1|||
162669797|NCT05732454|587499992|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
162669798|NCT05732454|587499993|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
162669799|NCT00838110|587499996|FG000|Overall Study|Death|0|||
162669800|NCT00838110|587499997|FG001|Overall Study|Death|0|||
162669801|NCT00838110|587499998|FG002|Overall Study|Death|1|||
162669802|NCT00838110|587499999|FG003|Overall Study|Death|2|||
162669803|NCT00838110|587499996|FG000|Overall Study|Adverse Event|11|||
162669804|NCT00838110|587499997|FG001|Overall Study|Adverse Event|10|||
162669805|NCT00838110|587499998|FG002|Overall Study|Adverse Event|8|||
162669806|NCT00838110|587499999|FG003|Overall Study|Adverse Event|7|||
162669807|NCT00838110|587499996|FG000|Overall Study|Withdrawal by Subject|5|||
162669808|NCT00838110|587499997|FG001|Overall Study|Withdrawal by Subject|6|||
162669809|NCT00838110|587499998|FG002|Overall Study|Withdrawal by Subject|3|||
162721850|NCT03460756|587689365|FG002|Overall Study|Pregnancy|0|||
163150283|NCT00945009|589263613|FG001|Overall Study|Ineligible|1|||
163150284|NCT00945009|589263614|FG002|Overall Study|Ineligible|0|||
163150285|NCT00945009|589263612|FG000|Overall Study|Inevaluable|0|||
163150286|NCT00945009|589263613|FG001|Overall Study|Inevaluable|1|||
163150287|NCT00945009|589263614|FG002|Overall Study|Inevaluable|0|||
163150288|NCT00945009|589263612|FG000|Overall Study|Refusal of further protocol|1|||
163150289|NCT00945009|589263613|FG001|Overall Study|Refusal of further protocol|0|||
163150290|NCT00945009|589263614|FG002|Overall Study|Refusal of further protocol|0|||
163150291|NCT04886154|589263615|FG000|Overall Study|Adverse Event|0|||
163150292|NCT04886154|589263616|FG001|Overall Study|Adverse Event|0|||
163150293|NCT04886154|589263617|FG002|Overall Study|Adverse Event|0|||
163150294|NCT04886154|589263618|FG003|Overall Study|Adverse Event|0|||
163150295|NCT04886154|589263619|FG004|Overall Study|Adverse Event|1|||
163150296|NCT04886154|589263620|FG005|Overall Study|Adverse Event|0|||
163150297|NCT04886154|589263621|FG006|Overall Study|Adverse Event|0|||
163150298|NCT04886154|589263622|FG007|Overall Study|Adverse Event|1|||
163150299|NCT04886154|589263623|FG008|Overall Study|Adverse Event|1|||
163150300|NCT04886154|589263624|FG009|Overall Study|Adverse Event|0|||
163150301|NCT04886154|589263625|FG010|Overall Study|Adverse Event|0|||
163150302|NCT04886154|589263626|FG011|Overall Study|Adverse Event|1|||
163150303|NCT04886154|589263627|FG012|Overall Study|Adverse Event|0|||
163150304|NCT04886154|589263628|FG013|Overall Study|Adverse Event|0|||
163150305|NCT04886154|589263629|FG014|Overall Study|Adverse Event|3|||
162669810|NCT00838110|587499999|FG003|Overall Study|Withdrawal by Subject|4|||
162669811|NCT00838110|587499996|FG000|Overall Study|Other|3|||
162669812|NCT00838110|587499997|FG001|Overall Study|Other|3|||
162669813|NCT00838110|587499998|FG002|Overall Study|Other|3|||
162669814|NCT00838110|587499999|FG003|Overall Study|Other|2|||
162669815|NCT00838110|587499996|FG000|Overall Study|Protocol Violation|0|||
162669816|NCT00838110|587499997|FG001|Overall Study|Protocol Violation|2|||
162669817|NCT00838110|587499998|FG002|Overall Study|Protocol Violation|1|||
162669818|NCT00838110|587499999|FG003|Overall Study|Protocol Violation|1|||
162669819|NCT00838110|587499996|FG000|Overall Study|Lost to Follow-up|3|||
162669820|NCT00838110|587499997|FG001|Overall Study|Lost to Follow-up|0|||
162669821|NCT00838110|587499998|FG002|Overall Study|Lost to Follow-up|0|||
162669822|NCT00838110|587499999|FG003|Overall Study|Lost to Follow-up|0|||
162669823|NCT00838110|587499996|FG000|Overall Study|Did not meet eligibility criteria|0|||
162669824|NCT00838110|587499997|FG001|Overall Study|Did not meet eligibility criteria|0|||
162669825|NCT00838110|587499998|FG002|Overall Study|Did not meet eligibility criteria|1|||
162721851|NCT03460756|587689366|FG003|Overall Study|Pregnancy|1|||
162721852|NCT03460756|587689363|FG000|Overall Study|Protocol Violation|0|||
162721853|NCT03460756|587689364|FG001|Overall Study|Protocol Violation|0|||
163150306|NCT04886154|589263615|FG000|Overall Study|Lost to Follow-up|1|||
163150307|NCT04886154|589263616|FG001|Overall Study|Lost to Follow-up|0|||
163150308|NCT04886154|589263617|FG002|Overall Study|Lost to Follow-up|2|||
163150309|NCT04886154|589263618|FG003|Overall Study|Lost to Follow-up|0|||
163150310|NCT04886154|589263619|FG004|Overall Study|Lost to Follow-up|17|||
163150311|NCT04886154|589263620|FG005|Overall Study|Lost to Follow-up|7|||
163150312|NCT04886154|589263621|FG006|Overall Study|Lost to Follow-up|8|||
163150313|NCT04886154|589263622|FG007|Overall Study|Lost to Follow-up|7|||
163150314|NCT04886154|589263623|FG008|Overall Study|Lost to Follow-up|8|||
163150315|NCT04886154|589263624|FG009|Overall Study|Lost to Follow-up|0|||
163150316|NCT04886154|589263625|FG010|Overall Study|Lost to Follow-up|2|||
163150317|NCT04886154|589263626|FG011|Overall Study|Lost to Follow-up|0|||
163150318|NCT04886154|589263627|FG012|Overall Study|Lost to Follow-up|0|||
163150319|NCT04886154|589263628|FG013|Overall Study|Lost to Follow-up|0|||
163150320|NCT04886154|589263629|FG014|Overall Study|Lost to Follow-up|0|||
163150321|NCT04886154|589263615|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150322|NCT04886154|589263616|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150323|NCT04886154|589263617|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150324|NCT04886154|589263618|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150325|NCT04886154|589263619|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150326|NCT04886154|589263620|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150327|NCT04886154|589263621|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
163150328|NCT04886154|589263622|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150329|NCT04886154|589263623|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150330|NCT04886154|589263624|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150331|NCT04886154|589263625|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150332|NCT04886154|589263626|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150333|NCT04886154|589263627|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150334|NCT04886154|589263628|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150335|NCT04886154|589263629|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
163150336|NCT04886154|589263615|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150337|NCT04886154|589263616|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150338|NCT04886154|589263617|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150339|NCT04886154|589263618|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150340|NCT04886154|589263619|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150341|NCT04886154|589263620|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150342|NCT04886154|589263621|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163150343|NCT04886154|589263622|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150344|NCT04886154|589263623|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150345|NCT04886154|589263624|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150346|NCT04886154|589263625|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150347|NCT04886154|589263626|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150348|NCT04886154|589263627|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150349|NCT04886154|589263628|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
163150350|NCT04886154|589263629|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163150351|NCT04886154|589263615|FG000|Overall Study|Other, Not Specified|0|||
163150352|NCT04886154|589263616|FG001|Overall Study|Other, Not Specified|0|||
163150353|NCT04886154|589263617|FG002|Overall Study|Other, Not Specified|0|||
163150354|NCT04886154|589263618|FG003|Overall Study|Other, Not Specified|0|||
163150355|NCT04886154|589263619|FG004|Overall Study|Other, Not Specified|11|||
163150356|NCT04886154|589263620|FG005|Overall Study|Other, Not Specified|8|||
163150357|NCT04886154|589263621|FG006|Overall Study|Other, Not Specified|9|||
163150358|NCT04886154|589263622|FG007|Overall Study|Other, Not Specified|10|||
162669826|NCT00838110|587499999|FG003|Overall Study|Did not meet eligibility criteria|2|||
163150359|NCT04886154|589263623|FG008|Overall Study|Other, Not Specified|6|||
163150360|NCT04886154|589263624|FG009|Overall Study|Other, Not Specified|1|||
163150361|NCT04886154|589263625|FG010|Overall Study|Other, Not Specified|1|||
163150362|NCT04886154|589263626|FG011|Overall Study|Other, Not Specified|2|||
162721854|NCT03460756|587689365|FG002|Overall Study|Protocol Violation|0|||
162721855|NCT03460756|587689366|FG003|Overall Study|Protocol Violation|1|||
162721856|NCT03460756|587689363|FG000|Overall Study|Withdrawal by Subject|0|||
162721857|NCT03460756|587689364|FG001|Overall Study|Withdrawal by Subject|4|||
162721858|NCT03460756|587689365|FG002|Overall Study|Withdrawal by Subject|7|||
162721859|NCT03460756|587689366|FG003|Overall Study|Withdrawal by Subject|3|||
162721860|NCT00723450|587689368|FG000|Open-Label Phase|Adverse Event|26|||
162721861|NCT00723450|587689369|FG001|Open-Label Phase|Adverse Event|0|||
162721862|NCT00723450|587689370|FG002|Open-Label Phase|Adverse Event|0|||
162669827|NCT00838110|587499996|FG000|Overall Study|Randomized but not treated|0|||
162669828|NCT00838110|587499997|FG001|Overall Study|Randomized but not treated|1|||
162669829|NCT00838110|587499998|FG002|Overall Study|Randomized but not treated|0|||
162669830|NCT00838110|587499999|FG003|Overall Study|Randomized but not treated|0|||
162669831|NCT00352365|587500000|FG000|Induction Therapy|Adverse Event|7|||
162669832|NCT00352365|587500000|FG000|Induction Therapy|Progression/Relapse|8|||
162669833|NCT00352365|587500000|FG000|Induction Therapy|Death|7|||
162669834|NCT00352365|587500000|FG000|Induction Therapy|Not protocol specified|1|||
162669835|NCT00352365|587500000|FG000|Induction Therapy|Not eligible|3|||
162669836|NCT00352365|587500000|FG000|Induction Therapy|Death before starting protocol therapy|1|||
162669837|NCT00352365|587500000|FG000|Maintenance Therapy|Progression/Relapse|3|||
162669838|NCT00352365|587500000|FG000|Maintenance Therapy|Death|2|||
162669839|NCT00352365|587500000|FG000|Maintenance Therapy|Not protocol specified|3|||
162669840|NCT00352365|587500000|FG000|Maintenance Therapy|Not eligible|4|||
162669841|NCT01262651|587500001|FG000|Overall Study|Adverse Event|40|||
162669842|NCT01262651|587500002|FG001|Overall Study|Adverse Event|35|||
162669843|NCT01262651|587500001|FG000|Overall Study|Withdrawal by Subject|15|||
162669844|NCT01262651|587500002|FG001|Overall Study|Withdrawal by Subject|11|||
162669845|NCT01262651|587500001|FG000|Overall Study|Withdrawal by Investigator|2|||
162669846|NCT01262651|587500002|FG001|Overall Study|Withdrawal by Investigator|2|||
162721863|NCT00723450|587689368|FG000|Open-Label Phase|Lack of Efficacy|18|||
162721864|NCT00723450|587689369|FG001|Open-Label Phase|Lack of Efficacy|0|||
162721865|NCT00723450|587689370|FG002|Open-Label Phase|Lack of Efficacy|0|||
162669847|NCT01262651|587500001|FG000|Overall Study|Met Withdrawal Criteria|1|||
162721866|NCT00723450|587689368|FG000|Open-Label Phase|Protocol Violation|35|||
162669848|NCT01262651|587500002|FG001|Overall Study|Met Withdrawal Criteria|0|||
162669849|NCT04743908|587500003|FG000|Overall Study|Death|1|||
162669850|NCT04743908|587500004|FG001|Overall Study|Death|0|||
162669851|NCT04743908|587500003|FG000|Overall Study|Lost to Follow-up|181|||
162669852|NCT04743908|587500004|FG001|Overall Study|Lost to Follow-up|180|||
162669853|NCT04743908|587500003|FG000|Overall Study|Withdrawal by Subject|1|||
162669854|NCT04743908|587500004|FG001|Overall Study|Withdrawal by Subject|2|||
162669855|NCT03822533|587500005|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
162669856|NCT03822533|587500006|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
162669857|NCT03822533|587500005|FG000|3 Month Follow-up|Lost to Follow-up|2|||
162669858|NCT03822533|587500006|FG001|3 Month Follow-up|Lost to Follow-up|2|||
162669859|NCT03822533|587500005|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162669860|NCT03822533|587500006|FG001|6 Month Follow-up|Lost to Follow-up|0|||
162669861|NCT03822533|587500005|FG000|12 Month Follow-up|Lost to Follow-up|2|||
162669862|NCT03822533|587500006|FG001|12 Month Follow-up|Lost to Follow-up|3|||
162669863|NCT03822533|587500005|FG000|12 Month Follow-up|Pregnancy|0|||
162669864|NCT03822533|587500006|FG001|12 Month Follow-up|Pregnancy|1|||
162669865|NCT03822533|587500005|FG000|12 Month Follow-up|Surgery|2|||
162669866|NCT03822533|587500006|FG001|12 Month Follow-up|Surgery|0|||
162669867|NCT03822533|587500005|FG000|12 Month Follow-up|Wrong address|1|||
162669868|NCT03822533|587500006|FG001|12 Month Follow-up|Wrong address|0|||
162669869|NCT03822533|587500005|FG000|12 Month Follow-up|No symptoms|1|||
162669870|NCT03822533|587500006|FG001|12 Month Follow-up|No symptoms|0|||
162669871|NCT03822533|587500005|FG000|12 Month Follow-up|Changed primary care center|0|||
162669872|NCT03822533|587500006|FG001|12 Month Follow-up|Changed primary care center|1|||
162669873|NCT01412944|587500007|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162669874|NCT01412944|587500008|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162669875|NCT01412944|587500009|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
162669876|NCT01412944|587500010|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162669877|NCT01412944|587500011|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162669878|NCT01412944|587500012|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162669879|NCT01412944|587500007|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162669880|NCT01412944|587500008|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162669881|NCT01412944|587500009|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162669882|NCT01412944|587500010|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162669883|NCT01412944|587500011|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162669884|NCT01412944|587500012|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
162669885|NCT01412944|587500007|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162669886|NCT01412944|587500008|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162669887|NCT01412944|587500009|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162669888|NCT01412944|587500010|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162669889|NCT01412944|587500011|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162669890|NCT01412944|587500012|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
162669891|NCT01412944|587500007|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
162669892|NCT01412944|587500008|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162669893|NCT01412944|587500009|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162669894|NCT01412944|587500010|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162669895|NCT01412944|587500011|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162669896|NCT01412944|587500012|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
163150363|NCT04886154|589263627|FG012|Overall Study|Other, Not Specified|1|||
163150364|NCT04886154|589263628|FG013|Overall Study|Other, Not Specified|2|||
163150365|NCT04886154|589263629|FG014|Overall Study|Other, Not Specified|3|||
163150366|NCT03919773|589263630|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
163150367|NCT03919773|589263631|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
163150368|NCT03919773|589263630|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
163150369|NCT03919773|589263631|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
163150370|NCT02702492|589263632|FG000|Overall Study|Disease progression|3|||
163150371|NCT02702492|589263633|FG001|Overall Study|Disease progression|3|||
163150372|NCT02702492|589263634|FG002|Overall Study|Disease progression|2|||
163150373|NCT02702492|589263635|FG003|Overall Study|Disease progression|4|||
163150374|NCT02702492|589263636|FG004|Overall Study|Disease progression|4|||
163150375|NCT02702492|589263637|FG005|Overall Study|Disease progression|1|||
163150376|NCT02702492|589263638|FG006|Overall Study|Disease progression|2|||
163150377|NCT02702492|589263639|FG007|Overall Study|Disease progression|8|||
163150378|NCT02702492|589263640|FG008|Overall Study|Disease progression|5|||
163150379|NCT02702492|589263641|FG009|Overall Study|Disease progression|1|||
163150380|NCT02702492|589263642|FG010|Overall Study|Disease progression|0|||
163150381|NCT02702492|589263643|FG011|Overall Study|Disease progression|3|||
163150382|NCT02702492|589263644|FG012|Overall Study|Disease progression|2|||
163150383|NCT02702492|589263632|FG000|Overall Study|Clinical progression|0|||
163150384|NCT02702492|589263633|FG001|Overall Study|Clinical progression|0|||
163150385|NCT02702492|589263634|FG002|Overall Study|Clinical progression|2|||
163150386|NCT02702492|589263635|FG003|Overall Study|Clinical progression|1|||
163150387|NCT02702492|589263636|FG004|Overall Study|Clinical progression|0|||
163150388|NCT02702492|589263637|FG005|Overall Study|Clinical progression|2|||
163150389|NCT02702492|589263638|FG006|Overall Study|Clinical progression|1|||
162669897|NCT01412944|587500007|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
162669898|NCT01412944|587500008|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
162669899|NCT01412944|587500009|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
162669900|NCT01412944|587500010|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
162669901|NCT01412944|587500011|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
162669902|NCT01412944|587500012|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
162669903|NCT01412944|587500007|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162669904|NCT01412944|587500008|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
162669905|NCT01412944|587500009|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162669906|NCT01412944|587500010|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162669907|NCT01412944|587500011|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162669908|NCT01412944|587500012|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162669909|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669910|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669911|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162669912|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162669913|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162669914|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669915|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Adverse Event|0|||
162669916|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Adverse Event|0|||
162669917|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Adverse Event|0|||
162669918|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Adverse Event|0|||
162669919|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Adverse Event|1|||
162669920|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Adverse Event|0|||
162669921|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
162669922|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
162669923|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
162669924|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
162669925|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
162669926|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
162669927|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669928|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669929|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669930|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669931|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669932|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
162669933|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669934|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669935|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669936|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669937|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
162669938|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669939|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
162669940|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162669941|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669942|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669943|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669944|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162669945|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
162669946|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
162669947|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
162669948|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
162669949|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
162669950|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
162669951|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669952|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
162669953|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669954|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
162721867|NCT00723450|587689369|FG001|Open-Label Phase|Protocol Violation|0|||
162721868|NCT00723450|587689370|FG002|Open-Label Phase|Protocol Violation|0|||
162721869|NCT00723450|587689368|FG000|Open-Label Phase|Lost to Follow-up|7|||
162669955|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669956|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
162669957|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669958|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
162721870|NCT00723450|587689369|FG001|Open-Label Phase|Lost to Follow-up|0|||
162721871|NCT00723450|587689370|FG002|Open-Label Phase|Lost to Follow-up|0|||
162721872|NCT00723450|587689368|FG000|Open-Label Phase|Physician Decision|2|||
162721873|NCT00723450|587689369|FG001|Open-Label Phase|Physician Decision|0|||
162669959|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669960|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669961|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
162721874|NCT00723450|587689370|FG002|Open-Label Phase|Physician Decision|0|||
162721875|NCT00723450|587689368|FG000|Open-Label Phase|Withdrawal by Subject|37|||
162721876|NCT00723450|587689369|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162721877|NCT00723450|587689370|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162721878|NCT00723450|587689368|FG000|Randomized Phase|Adverse Event|0|||
162721879|NCT00723450|587689369|FG001|Randomized Phase|Adverse Event|26|||
162721880|NCT00723450|587689370|FG002|Randomized Phase|Adverse Event|17|||
162669962|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
162669963|NCT01412944|587500007|FG000|Entire: IV + Maintenance|Adverse Event|0|||
162669964|NCT01412944|587500008|FG001|Entire: IV + Maintenance|Adverse Event|1|||
162669965|NCT01412944|587500009|FG002|Entire: IV + Maintenance|Adverse Event|0|||
162669966|NCT01412944|587500010|FG003|Entire: IV + Maintenance|Adverse Event|0|||
162669967|NCT01412944|587500011|FG004|Entire: IV + Maintenance|Adverse Event|0|||
162669968|NCT01412944|587500012|FG005|Entire: IV + Maintenance|Adverse Event|0|||
162669969|NCT01990950|587500013|FG000|Overall Study|Death|3|||
162721881|NCT00723450|587689368|FG000|Randomized Phase|Lack of Efficacy|0|||
162721882|NCT00723450|587689369|FG001|Randomized Phase|Lack of Efficacy|11|||
162721883|NCT00723450|587689370|FG002|Randomized Phase|Lack of Efficacy|11|||
163150390|NCT02702492|589263639|FG007|Overall Study|Clinical progression|4|||
163150391|NCT02702492|589263640|FG008|Overall Study|Clinical progression|0|||
163150392|NCT02702492|589263641|FG009|Overall Study|Clinical progression|0|||
163150393|NCT02702492|589263642|FG010|Overall Study|Clinical progression|1|||
163150394|NCT02702492|589263643|FG011|Overall Study|Clinical progression|2|||
163150395|NCT02702492|589263644|FG012|Overall Study|Clinical progression|0|||
163150396|NCT02702492|589263632|FG000|Overall Study|Adverse Event|0|||
163150397|NCT02702492|589263633|FG001|Overall Study|Adverse Event|0|||
163150398|NCT02702492|589263634|FG002|Overall Study|Adverse Event|1|||
163150399|NCT02702492|589263635|FG003|Overall Study|Adverse Event|2|||
163150400|NCT02702492|589263636|FG004|Overall Study|Adverse Event|1|||
163150401|NCT02702492|589263637|FG005|Overall Study|Adverse Event|0|||
163150402|NCT02702492|589263638|FG006|Overall Study|Adverse Event|1|||
163150403|NCT02702492|589263639|FG007|Overall Study|Adverse Event|0|||
163150404|NCT02702492|589263640|FG008|Overall Study|Adverse Event|2|||
163150405|NCT02702492|589263641|FG009|Overall Study|Adverse Event|0|||
163150406|NCT02702492|589263642|FG010|Overall Study|Adverse Event|0|||
163150407|NCT02702492|589263643|FG011|Overall Study|Adverse Event|0|||
163150408|NCT02702492|589263644|FG012|Overall Study|Adverse Event|1|||
163150409|NCT02702492|589263632|FG000|Overall Study|Other|0|||
163150410|NCT02702492|589263633|FG001|Overall Study|Other|0|||
163150411|NCT02702492|589263634|FG002|Overall Study|Other|0|||
163150412|NCT02702492|589263635|FG003|Overall Study|Other|0|||
163150413|NCT02702492|589263636|FG004|Overall Study|Other|0|||
163150414|NCT02702492|589263637|FG005|Overall Study|Other|0|||
163150415|NCT02702492|589263638|FG006|Overall Study|Other|0|||
163150416|NCT02702492|589263639|FG007|Overall Study|Other|0|||
163150417|NCT02702492|589263640|FG008|Overall Study|Other|0|||
163150418|NCT02702492|589263641|FG009|Overall Study|Other|0|||
163150419|NCT02702492|589263642|FG010|Overall Study|Other|0|||
163150420|NCT02702492|589263643|FG011|Overall Study|Other|0|||
163150421|NCT02702492|589263644|FG012|Overall Study|Other|1|||
163150422|NCT04972162|589263649|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
163150423|NCT04972162|589263650|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
163150424|NCT02429830|589263651|FG000|Overall Study|Lost to Follow-up|1|||
163150425|NCT02429830|589263651|FG000|Overall Study|Device Explant|2|||
163150426|NCT00199381|589265269|FG000|Overall Study|Withdrawal by Subject|38|||
162669970|NCT01990950|587500013|FG000|Overall Study|Lost to Follow-up|2|||
162669971|NCT01990950|587500013|FG000|Overall Study|Withdrawal by Subject|6|||
162669972|NCT02863926|587500014|FG000|Overall Study|Physician Decision|1|||
162669973|NCT02863926|587500015|FG001|Overall Study|Physician Decision|0|||
162669974|NCT02863926|587500014|FG000|Overall Study|Lost to Follow-up|1|||
162721884|NCT00723450|587689368|FG000|Randomized Phase|Protocol Violation|0|||
162721885|NCT00723450|587689369|FG001|Randomized Phase|Protocol Violation|9|||
162721886|NCT00723450|587689370|FG002|Randomized Phase|Protocol Violation|13|||
162721887|NCT00723450|587689368|FG000|Randomized Phase|Lost to Follow-up|0|||
163150427|NCT00199381|589265269|FG000|Overall Study|Adverse Event|73|||
163150428|NCT00199381|589265269|FG000|Overall Study|Protocol Violation|6|||
163150429|NCT00199381|589265269|FG000|Overall Study|Lack of Efficacy|27|||
163150430|NCT00199381|589265269|FG000|Overall Study|Not including due to early termination|37|||
163150431|NCT00199381|589265269|FG000|Overall Study|Study termination by Sponsor|323|||
163150432|NCT00385671|589265271|FG000|Overall Study|Adverse Event|14|||
163150433|NCT00385671|589265272|FG001|Overall Study|Adverse Event|27|||
163150434|NCT00385671|589265273|FG002|Overall Study|Adverse Event|18|||
163150435|NCT00385671|589265271|FG000|Overall Study|Lack of Efficacy|5|||
163150436|NCT00385671|589265272|FG001|Overall Study|Lack of Efficacy|9|||
162669975|NCT02863926|587500015|FG001|Overall Study|Lost to Follow-up|1|||
162669976|NCT00455195|587500019|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
162669977|NCT00455195|587500020|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
162669978|NCT00455195|587500019|FG000|Double-blind Study AGLU02704|Death|1|||
162669979|NCT00455195|587500020|FG001|Double-blind Study AGLU02704|Death|0|||
162669980|NCT00455195|587500019|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
162669981|NCT00455195|587500020|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
162669982|NCT00455195|587500019|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
162669983|NCT00455195|587500020|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
162669984|NCT01286779|587500021|FG000|Overall Study|Withdrawal by Subject|9|||
162669985|NCT01286779|587500021|FG000|Overall Study|Protocol Violation|5|||
162669986|NCT01286779|587500021|FG000|Overall Study|Physician Decision|2|||
162669987|NCT01286779|587500021|FG000|Overall Study|Participant had scheduled surgery|1|||
162669988|NCT01286779|587500021|FG000|Overall Study|Participant moved to another country|1|||
162669989|NCT01286779|587500021|FG000|Overall Study|Discontinued by sponsor|1|||
162669990|NCT00304070|587500022|FG000|Overall Study|Death|0|||
162669991|NCT00304070|587500023|FG001|Overall Study|Death|0|||
162669992|NCT00304070|587500024|FG002|Overall Study|Death|3|||
162669993|NCT00304070|587500022|FG000|Overall Study|Lost to Follow-up|0|||
162669994|NCT00304070|587500023|FG001|Overall Study|Lost to Follow-up|0|||
162669995|NCT00304070|587500024|FG002|Overall Study|Lost to Follow-up|1|||
162669996|NCT00304070|587500022|FG000|Overall Study|Physician Decision|0|||
162669997|NCT00304070|587500023|FG001|Overall Study|Physician Decision|0|||
162669998|NCT00304070|587500024|FG002|Overall Study|Physician Decision|3|||
162669999|NCT00304070|587500022|FG000|Overall Study|Withdrawal by Subject|0|||
162670000|NCT00304070|587500023|FG001|Overall Study|Withdrawal by Subject|0|||
162670001|NCT00304070|587500024|FG002|Overall Study|Withdrawal by Subject|1|||
162670002|NCT00304070|587500022|FG000|Overall Study|Progressive Disease|3|||
162670003|NCT00304070|587500023|FG001|Overall Study|Progressive Disease|7|||
162670004|NCT00304070|587500024|FG002|Overall Study|Progressive Disease|4|||
162670005|NCT00779246|587500033|FG000|Overall Study|Missing sufficient data for analysis|33|||
162670006|NCT00779246|587500034|FG001|Overall Study|Missing sufficient data for analysis|53|||
162670007|NCT02844946|587500035|FG000|Overall Study|Lost to Follow-up|7|||
162670008|NCT02844946|587500036|FG001|Overall Study|Lost to Follow-up|0|||
162670009|NCT02806986|587500037|FG000|Treatment Stage 1|Adverse Event|1|||
162670010|NCT02806986|587500037|FG000|Treatment Stage 2|Adverse Event|3|||
162670011|NCT02806986|587500037|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
162670012|NCT03646513|587500039|FG000|Overall Study|Premature study termination|4|||
162670013|NCT02334748|587500040|FG000|Overall Study|Adverse Event|1|||
162670014|NCT02334748|587500040|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
162670015|NCT02334748|587500040|FG000|Overall Study|Patient no longer required study drug|2|||
162670016|NCT02334748|587500040|FG000|Overall Study|Lack of Efficacy|4|||
162670017|NCT01046643|587500041|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162670018|NCT01046643|587500042|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
162670019|NCT01046643|587500043|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162670020|NCT01046643|587500044|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162670021|NCT00093145|587500045|FG000|Overall Study|Unacceptable Toxicity Only|2|||
162670022|NCT00093145|587500045|FG000|Overall Study|Physician Decision|5|||
162670023|NCT00093145|587500045|FG000|Overall Study|Withdrawal by Subject|9|||
162670024|NCT00093145|587500045|FG000|Overall Study|Other|1|||
162670025|NCT01310036|587500046|FG000|Overall Study|Administrative/other|10|||
162670026|NCT01310036|587500046|FG000|Overall Study|Withdrew Consent|11|||
162670027|NCT01310036|587500046|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
162670028|NCT01310036|587500046|FG000|Overall Study|Progression of Disease|164|||
162670029|NCT01310036|587500046|FG000|Overall Study|Death|1|||
162670030|NCT01310036|587500046|FG000|Overall Study|Adverse event or intercurrent illness|12|||
162670031|NCT01175668|587500047|FG000|Overall Study|Withdrawal by Subject|2|||
162670032|NCT01175668|587500048|FG001|Overall Study|Withdrawal by Subject|0|||
162670033|NCT00817089|587500049|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
162670034|NCT00817089|587500050|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
162670035|NCT00817089|587500051|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
162670036|NCT00817089|587500052|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
162670037|NCT00817089|587500049|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
162670038|NCT00817089|587500050|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
162670039|NCT00817089|587500051|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
162670040|NCT00817089|587500052|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
162670041|NCT00709722|587500053|FG000|Overall Study|Adverse Event|1|||
162670042|NCT02043782|587500054|FG000|Period 1|Adverse Event|0|||
162670043|NCT02043782|587500055|FG001|Period 1|Adverse Event|0|||
162670044|NCT02043782|587500056|FG002|Period 1|Adverse Event|1|||
162670045|NCT02043782|587500057|FG003|Period 1|Adverse Event|0|||
162670046|NCT02043782|587500058|FG004|Period 1|Adverse Event|0|||
162670047|NCT02043782|587500059|FG005|Period 1|Adverse Event|0|||
162670048|NCT04667117|587500060|FG000|Investigational Period|Lost to Follow-up|0|||
162670049|NCT04667117|587500061|FG001|Investigational Period|Lost to Follow-up|0|||
162670050|NCT04667117|587500062|FG002|Investigational Period|Lost to Follow-up|1|||
162670051|NCT04667117|587500060|FG000|Investigational Period|Protocol Deviation|0|||
162670052|NCT04667117|587500061|FG001|Investigational Period|Protocol Deviation|1|||
162670053|NCT04667117|587500062|FG002|Investigational Period|Protocol Deviation|0|||
162670054|NCT04667117|587500060|FG000|Extension Period|Lost to Follow-up|1|||
162670055|NCT04667117|587500061|FG001|Extension Period|Lost to Follow-up|0|||
162670056|NCT04667117|587500062|FG002|Extension Period|Lost to Follow-up|0|||
162670057|NCT03359096|587500063|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
162670058|NCT03359096|587500064|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
162670059|NCT03359096|587500063|FG000|First Intervention (4 Weeks)|Death|1|||
162670060|NCT03359096|587500064|FG001|First Intervention (4 Weeks)|Death|0|||
162670061|NCT03359096|587500063|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
162670062|NCT03359096|587500064|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
162670063|NCT02007577|587500075|FG000|Overall Study|Adverse Event|1|||
162670064|NCT02007577|587500076|FG001|Overall Study|Adverse Event|0|||
162670065|NCT02007577|587500075|FG000|Overall Study|Withdrawal by Subject|0|||
162670066|NCT02007577|587500076|FG001|Overall Study|Withdrawal by Subject|1|||
162670067|NCT01953926|587500077|FG000|Overall Study|Withdrawal by Subject|23|||
162670068|NCT01953926|587500078|FG001|Overall Study|Withdrawal by Subject|3|||
162670069|NCT01953926|587500079|FG002|Overall Study|Withdrawal by Subject|3|||
162670070|NCT01953926|587500080|FG003|Overall Study|Withdrawal by Subject|5|||
162670071|NCT01953926|587500081|FG004|Overall Study|Withdrawal by Subject|6|||
162670072|NCT01953926|587500082|FG005|Overall Study|Withdrawal by Subject|0|||
162670073|NCT01953926|587500083|FG006|Overall Study|Withdrawal by Subject|1|||
162670074|NCT01953926|587500077|FG000|Overall Study|Physician Decision|1|||
162670075|NCT01953926|587500078|FG001|Overall Study|Physician Decision|0|||
162670076|NCT01953926|587500079|FG002|Overall Study|Physician Decision|0|||
162670077|NCT01953926|587500080|FG003|Overall Study|Physician Decision|0|||
162670078|NCT01953926|587500081|FG004|Overall Study|Physician Decision|2|||
162670079|NCT01953926|587500082|FG005|Overall Study|Physician Decision|0|||
162670080|NCT01953926|587500083|FG006|Overall Study|Physician Decision|0|||
162670081|NCT01953926|587500077|FG000|Overall Study|Lost to Follow-up|18|||
162670082|NCT01953926|587500078|FG001|Overall Study|Lost to Follow-up|3|||
162670083|NCT01953926|587500079|FG002|Overall Study|Lost to Follow-up|0|||
162670084|NCT01953926|587500080|FG003|Overall Study|Lost to Follow-up|5|||
162670085|NCT01953926|587500081|FG004|Overall Study|Lost to Follow-up|3|||
162670086|NCT01953926|587500082|FG005|Overall Study|Lost to Follow-up|0|||
162670087|NCT01953926|587500083|FG006|Overall Study|Lost to Follow-up|0|||
162670088|NCT01953926|587500077|FG000|Overall Study|Protocol Violation|1|||
162670089|NCT01953926|587500078|FG001|Overall Study|Protocol Violation|0|||
162670090|NCT01953926|587500079|FG002|Overall Study|Protocol Violation|0|||
162670091|NCT01953926|587500080|FG003|Overall Study|Protocol Violation|0|||
162670092|NCT01953926|587500081|FG004|Overall Study|Protocol Violation|0|||
162670093|NCT01953926|587500082|FG005|Overall Study|Protocol Violation|0|||
162670094|NCT01953926|587500083|FG006|Overall Study|Protocol Violation|0|||
162670095|NCT01953926|587500077|FG000|Overall Study|Other, Disease progression|2|||
162670096|NCT01953926|587500078|FG001|Overall Study|Other, Disease progression|1|||
162670097|NCT01953926|587500079|FG002|Overall Study|Other, Disease progression|0|||
162670098|NCT01953926|587500080|FG003|Overall Study|Other, Disease progression|0|||
162670099|NCT01953926|587500081|FG004|Overall Study|Other, Disease progression|1|||
162670100|NCT01953926|587500082|FG005|Overall Study|Other, Disease progression|0|||
162670101|NCT01953926|587500083|FG006|Overall Study|Other, Disease progression|0|||
162670102|NCT01953926|587500077|FG000|Overall Study|Discontinuation of study by sponsor|41|||
162670103|NCT01953926|587500078|FG001|Overall Study|Discontinuation of study by sponsor|7|||
162670104|NCT01953926|587500079|FG002|Overall Study|Discontinuation of study by sponsor|5|||
162670105|NCT01953926|587500080|FG003|Overall Study|Discontinuation of study by sponsor|12|||
162670106|NCT01953926|587500081|FG004|Overall Study|Discontinuation of study by sponsor|46|||
162670107|NCT01953926|587500082|FG005|Overall Study|Discontinuation of study by sponsor|5|||
162670108|NCT01953926|587500083|FG006|Overall Study|Discontinuation of study by sponsor|6|||
162670109|NCT01953926|587500077|FG000|Overall Study|Not Treated|1|||
163150437|NCT00385671|589265273|FG002|Overall Study|Lack of Efficacy|5|||
163150438|NCT00385671|589265271|FG000|Overall Study|Lost to Follow-up|6|||
163150439|NCT00385671|589265272|FG001|Overall Study|Lost to Follow-up|6|||
163150440|NCT00385671|589265273|FG002|Overall Study|Lost to Follow-up|5|||
163150441|NCT00385671|589265271|FG000|Overall Study|Physician Decision|2|||
163150442|NCT00385671|589265272|FG001|Overall Study|Physician Decision|1|||
163150443|NCT00385671|589265273|FG002|Overall Study|Physician Decision|2|||
162670110|NCT01953926|587500078|FG001|Overall Study|Not Treated|0|||
163150444|NCT00385671|589265271|FG000|Overall Study|Protocol Violation|5|||
163150445|NCT00385671|589265272|FG001|Overall Study|Protocol Violation|2|||
163150446|NCT00385671|589265273|FG002|Overall Study|Protocol Violation|1|||
163150447|NCT00385671|589265271|FG000|Overall Study|Sponsor Decision|2|||
162670111|NCT01953926|587500079|FG002|Overall Study|Not Treated|1|||
162670112|NCT01953926|587500080|FG003|Overall Study|Not Treated|0|||
162670113|NCT01953926|587500081|FG004|Overall Study|Not Treated|0|||
162670114|NCT01953926|587500082|FG005|Overall Study|Not Treated|0|||
162670115|NCT01953926|587500083|FG006|Overall Study|Not Treated|0|||
162670116|NCT04102501|587500087|FG000|Overall Study|Withdrawal by Subject|7|||
162670117|NCT04102501|587500088|FG001|Overall Study|Withdrawal by Subject|9|||
162670118|NCT04102501|587500087|FG000|Overall Study|Adverse Event|1|||
162670119|NCT04102501|587500088|FG001|Overall Study|Adverse Event|3|||
162670120|NCT02338362|587500089|FG000|Overall Study|Withdrawal by Subject|1|||
162670121|NCT02338362|587500090|FG001|Overall Study|Withdrawal by Subject|1|||
162670122|NCT00968617|587500091|FG000|Overall Study|Study terminated by sponsor|6|||
162670123|NCT04433767|587500092|FG000|Overall Study|Adverse Event|1|||
162670124|NCT03325712|587500100|FG000|Overall Study|Protocol Violation|0|||
162670125|NCT03325712|587500101|FG001|Overall Study|Protocol Violation|0|||
162670126|NCT03325712|587500102|FG002|Overall Study|Protocol Violation|0|||
162670127|NCT03325712|587500103|FG003|Overall Study|Protocol Violation|0|||
162670128|NCT03325712|587500104|FG004|Overall Study|Protocol Violation|1|||
162670129|NCT03325712|587500105|FG005|Overall Study|Protocol Violation|0|||
162670130|NCT03325712|587500106|FG006|Overall Study|Protocol Violation|0|||
162670131|NCT03325712|587500107|FG007|Overall Study|Protocol Violation|0|||
162670132|NCT03325712|587500100|FG000|Overall Study|Adverse Event|0|||
162670133|NCT03325712|587500101|FG001|Overall Study|Adverse Event|0|||
162670134|NCT03325712|587500102|FG002|Overall Study|Adverse Event|0|||
162670135|NCT03325712|587500103|FG003|Overall Study|Adverse Event|0|||
162670136|NCT03325712|587500104|FG004|Overall Study|Adverse Event|1|||
162670137|NCT03325712|587500105|FG005|Overall Study|Adverse Event|0|||
162670138|NCT03325712|587500106|FG006|Overall Study|Adverse Event|0|||
162670139|NCT03325712|587500107|FG007|Overall Study|Adverse Event|0|||
162670140|NCT02265237|587500108|FG000|As Treated (Overall Study)|Adverse Event|1|||
162670141|NCT02265237|587500109|FG001|As Treated (Overall Study)|Adverse Event|1|||
162670142|NCT02265237|587500110|FG002|As Treated (Overall Study)|Adverse Event|0|||
162670143|NCT02265237|587500111|FG003|As Treated (Overall Study)|Adverse Event|0|||
162670144|NCT02265237|587500108|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
162670145|NCT02265237|587500109|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
162670146|NCT02265237|587500110|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
162670147|NCT02265237|587500111|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
162670148|NCT02265237|587500108|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
162670149|NCT02265237|587500109|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
162670150|NCT02265237|587500110|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
162670151|NCT02265237|587500111|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
162670152|NCT02265237|587500108|FG000|As Treated (Overall Study)|Other|2|||
162670153|NCT02265237|587500109|FG001|As Treated (Overall Study)|Other|0|||
162670154|NCT02265237|587500110|FG002|As Treated (Overall Study)|Other|3|||
162670155|NCT02265237|587500111|FG003|As Treated (Overall Study)|Other|1|||
162670156|NCT01178853|587500113|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
162670157|NCT01178853|587500114|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
162670158|NCT01178853|587500113|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
162670159|NCT01178853|587500114|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
162670160|NCT01178853|587500113|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
162670161|NCT01178853|587500114|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
162670162|NCT01178853|587500113|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
162670163|NCT01178853|587500114|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
162670164|NCT01178853|587500113|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
163150448|NCT00385671|589265272|FG001|Overall Study|Sponsor Decision|2|||
163150449|NCT00385671|589265273|FG002|Overall Study|Sponsor Decision|1|||
163150450|NCT00385671|589265271|FG000|Overall Study|Withdrawal by Subject|4|||
163150451|NCT00385671|589265272|FG001|Overall Study|Withdrawal by Subject|4|||
163150452|NCT00385671|589265273|FG002|Overall Study|Withdrawal by Subject|4|||
163150453|NCT02608684|589265274|FG000|Overall Study|Physician Decision|2|||
163150454|NCT02608684|589265274|FG000|Overall Study|Withdrawal by Subject|1|||
163150455|NCT00751296|589265275|FG000|Overall Study|Adverse Event|2|||
163150456|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
162670165|NCT01178853|587500114|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
162670166|NCT03550313|587500115|FG000|Overall Study|Adverse Event|0|||
162670167|NCT03550313|587500116|FG001|Overall Study|Adverse Event|1|||
162670168|NCT03550313|587500117|FG002|Overall Study|Adverse Event|0|||
163150457|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
163150458|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
163150459|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
163150460|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
163150461|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
163150462|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
163150463|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
163150464|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150465|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
163150466|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150467|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
163150468|NCT01972217|589265276|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
163150469|NCT01972217|589265277|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
163150470|NCT01972217|589265278|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
162670169|NCT03550313|587500115|FG000|Overall Study|Lost to Follow-up|5|||
162670170|NCT03550313|587500116|FG001|Overall Study|Lost to Follow-up|7|||
162670171|NCT03550313|587500117|FG002|Overall Study|Lost to Follow-up|12|||
162670172|NCT03550313|587500115|FG000|Overall Study|Study terminated by sponsor|44|||
162670173|NCT03550313|587500116|FG001|Overall Study|Study terminated by sponsor|37|||
162670174|NCT03550313|587500117|FG002|Overall Study|Study terminated by sponsor|48|||
162670175|NCT03550313|587500115|FG000|Overall Study|No longer met eligibility criteria|3|||
162670176|NCT03550313|587500116|FG001|Overall Study|No longer met eligibility criteria|5|||
162670177|NCT03550313|587500117|FG002|Overall Study|No longer met eligibility criteria|6|||
162670178|NCT03550313|587500115|FG000|Overall Study|Withdrawal by parent/guardian|20|||
162670179|NCT03550313|587500116|FG001|Overall Study|Withdrawal by parent/guardian|18|||
162670180|NCT03550313|587500117|FG002|Overall Study|Withdrawal by parent/guardian|26|||
162721888|NCT00723450|587689369|FG001|Randomized Phase|Lost to Follow-up|2|||
162670181|NCT03550313|587500115|FG000|Overall Study|Other|4|||
162721889|NCT00723450|587689370|FG002|Randomized Phase|Lost to Follow-up|3|||
162721890|NCT00723450|587689368|FG000|Randomized Phase|Physician Decision|0|||
162670182|NCT03550313|587500116|FG001|Overall Study|Other|2|||
162670183|NCT03550313|587500117|FG002|Overall Study|Other|2|||
162670184|NCT03550313|587500115|FG000|Overall Study|Randomized but not vaccinated|3|||
162670185|NCT03550313|587500116|FG001|Overall Study|Randomized but not vaccinated|23|||
162670186|NCT03550313|587500117|FG002|Overall Study|Randomized but not vaccinated|2|||
162670187|NCT03550313|587500115|FG000|Overall Study|Sites terminated due to quality issues|18|||
162670188|NCT03550313|587500116|FG001|Overall Study|Sites terminated due to quality issues|17|||
162670189|NCT03550313|587500117|FG002|Overall Study|Sites terminated due to quality issues|18|||
162670190|NCT00839072|587500118|FG000|First Intervention Period|Withdrawal by Subject|1|||
162670191|NCT00839072|587500119|FG001|First Intervention Period|Withdrawal by Subject|0|||
162670192|NCT00839072|587500118|FG000|First Intervention Period|Adverse Event|1|||
162670193|NCT00839072|587500119|FG001|First Intervention Period|Adverse Event|1|||
162670194|NCT00839072|587500118|FG000|Second Intervention Period|Withdrawal by Subject|1|||
162670195|NCT00839072|587500119|FG001|Second Intervention Period|Withdrawal by Subject|0|||
162670196|NCT00380068|587500120|FG000|Overall Study|Adverse Event|40|||
163150471|NCT01972217|589265279|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
163150472|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Death|0|||
163150473|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Death|0|||
163150474|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Death|43|||
163150475|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Death|44|||
163150476|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150477|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150478|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
163150479|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
163150480|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
163150481|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
163150482|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
163150483|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
163150484|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
163150485|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
163150486|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
163150487|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
163150488|NCT01972217|589265276|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150489|NCT01972217|589265277|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150490|NCT01972217|589265278|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
163150491|NCT01972217|589265279|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
163150492|NCT01456039|589265280|FG000|Phase 1 (First Step)|Disease Progression|1|||
163150493|NCT01456039|589265281|FG001|Phase 1 (First Step)|Disease Progression|1|||
163150494|NCT01456039|589265282|FG002|Phase 1 (First Step)|Disease Progression|0|||
163150495|NCT01456039|589265280|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
163150496|NCT01456039|589265281|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
163150497|NCT01456039|589265282|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
163150498|NCT01456039|589265280|FG000|Phase 1 (First Step)|Adverse Event|0|||
163150499|NCT01456039|589265281|FG001|Phase 1 (First Step)|Adverse Event|3|||
163150500|NCT01456039|589265282|FG002|Phase 1 (First Step)|Adverse Event|0|||
163150501|NCT01456039|589265280|FG000|Phase 1 (First Step)|Other|0|||
163150502|NCT01456039|589265281|FG001|Phase 1 (First Step)|Other|1|||
163150503|NCT01456039|589265282|FG002|Phase 1 (First Step)|Other|0|||
163150504|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Disease Progression|0|||
163150505|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Disease Progression|0|||
163150506|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Disease Progression|17|||
163150507|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Adverse Event|0|||
163150508|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Adverse Event|0|||
163150509|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Adverse Event|10|||
163150510|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
163150511|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
163150512|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
163150513|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
163150514|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
163150515|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
163150516|NCT01456039|589265280|FG000|Phase 2 (Second Step)|Other|0|||
163150517|NCT01456039|589265281|FG001|Phase 2 (Second Step)|Other|0|||
163150518|NCT01456039|589265282|FG002|Phase 2 (Second Step)|Other|1|||
163150519|NCT01702311|589265286|FG000|Overall Study|Withdrawal by Subject|3|||
163150520|NCT01702311|589265287|FG001|Overall Study|Withdrawal by Subject|2|||
163150521|NCT01702311|589265286|FG000|Overall Study|Discharge less than 24 hours|10|||
163150522|NCT01702311|589265287|FG001|Overall Study|Discharge less than 24 hours|7|||
163150523|NCT01702311|589265286|FG000|Overall Study|Physician Decision|3|||
163150524|NCT01702311|589265287|FG001|Overall Study|Physician Decision|4|||
163150525|NCT04106557|589265289|FG000|Overall Study|Physician Decision|0|||
163150526|NCT04106557|589265290|FG001|Overall Study|Physician Decision|1|||
163150527|NCT04106557|589265291|FG002|Overall Study|Physician Decision|0|||
163150528|NCT04106557|589265289|FG000|Overall Study|Protocol Violation|0|||
162670197|NCT00380068|587500120|FG000|Overall Study|Withdrawal by Subject|10|||
162670198|NCT00380068|587500120|FG000|Overall Study|Not compliant|6|||
163150529|NCT04106557|589265290|FG001|Overall Study|Protocol Violation|1|||
162670199|NCT00380068|587500120|FG000|Overall Study|Lost to Follow-up|1|||
162670200|NCT00380068|587500120|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
162670201|NCT00380068|587500120|FG000|Overall Study|Lung transplant|3|||
162670202|NCT00380068|587500120|FG000|Overall Study|Physician Decision|2|||
162670203|NCT00380068|587500120|FG000|Overall Study|Partipant moved away|1|||
162670204|NCT00380068|587500120|FG000|Overall Study|Lack of Efficacy|5|||
162670205|NCT01297062|587500121|FG000|Overall Study|Adverse Event|2|||
162670206|NCT01297062|587500122|FG001|Overall Study|Adverse Event|0|||
162670207|NCT01297062|587500123|FG002|Overall Study|Adverse Event|1|||
162670208|NCT01297062|587500124|FG003|Overall Study|Adverse Event|0|||
162670209|NCT01297062|587500125|FG004|Overall Study|Adverse Event|0|||
162670210|NCT01297062|587500126|FG005|Overall Study|Adverse Event|0|||
162721891|NCT00723450|587689369|FG001|Randomized Phase|Physician Decision|3|||
162721892|NCT00723450|587689370|FG002|Randomized Phase|Physician Decision|1|||
162721893|NCT00723450|587689368|FG000|Randomized Phase|Withdrawal by Subject|0|||
162721894|NCT00723450|587689369|FG001|Randomized Phase|Withdrawal by Subject|14|||
162721895|NCT00723450|587689370|FG002|Randomized Phase|Withdrawal by Subject|22|||
162670211|NCT01297062|587500127|FG006|Overall Study|Adverse Event|0|||
162670212|NCT01297062|587500121|FG000|Overall Study|Physician Decision|1|||
162670213|NCT01297062|587500122|FG001|Overall Study|Physician Decision|0|||
162670214|NCT01297062|587500123|FG002|Overall Study|Physician Decision|1|||
162670215|NCT01297062|587500124|FG003|Overall Study|Physician Decision|0|||
162670216|NCT01297062|587500125|FG004|Overall Study|Physician Decision|0|||
162670217|NCT01297062|587500126|FG005|Overall Study|Physician Decision|0|||
162670218|NCT01297062|587500127|FG006|Overall Study|Physician Decision|6|||
162670219|NCT01297062|587500121|FG000|Overall Study|Protocol Violation|0|||
162670220|NCT01297062|587500122|FG001|Overall Study|Protocol Violation|0|||
162670221|NCT01297062|587500123|FG002|Overall Study|Protocol Violation|0|||
163150530|NCT04106557|589265291|FG002|Overall Study|Protocol Violation|0|||
163150531|NCT00313014|589265292|FG000|Overall Study|Withdrawal by Subject|11|||
163150532|NCT00313014|589265293|FG001|Overall Study|Withdrawal by Subject|7|||
163150533|NCT00313014|589265294|FG002|Overall Study|Withdrawal by Subject|5|||
163150534|NCT00313014|589265292|FG000|Overall Study|Adverse Event|14|||
163150535|NCT00313014|589265293|FG001|Overall Study|Adverse Event|29|||
163150536|NCT00313014|589265294|FG002|Overall Study|Adverse Event|16|||
163150537|NCT00313014|589265292|FG000|Overall Study|Lost to Follow-up|7|||
163150538|NCT00313014|589265293|FG001|Overall Study|Lost to Follow-up|6|||
163150539|NCT00313014|589265294|FG002|Overall Study|Lost to Follow-up|10|||
163150540|NCT00313014|589265292|FG000|Overall Study|Administrative|9|||
163150541|NCT00313014|589265293|FG001|Overall Study|Administrative|6|||
163150542|NCT00313014|589265294|FG002|Overall Study|Administrative|14|||
163150543|NCT00313014|589265292|FG000|Overall Study|Lack of Efficacy|52|||
163150544|NCT00313014|589265293|FG001|Overall Study|Lack of Efficacy|25|||
163150545|NCT00313014|589265294|FG002|Overall Study|Lack of Efficacy|16|||
163150546|NCT03714672|589265295|FG000|Overall Study|Adverse Event|0|||
163150547|NCT03714672|589265296|FG001|Overall Study|Adverse Event|0|||
163150548|NCT03714672|589265297|FG002|Overall Study|Adverse Event|3|||
163150549|NCT03714672|589265298|FG003|Overall Study|Adverse Event|0|||
163150550|NCT03714672|589265295|FG000|Overall Study|Physician Decision|0|||
163150551|NCT03714672|589265296|FG001|Overall Study|Physician Decision|1|||
163150552|NCT03714672|589265297|FG002|Overall Study|Physician Decision|0|||
163150553|NCT03714672|589265298|FG003|Overall Study|Physician Decision|0|||
163150554|NCT03714672|589265295|FG000|Overall Study|Other Reason|1|||
163150555|NCT03714672|589265296|FG001|Overall Study|Other Reason|2|||
163150556|NCT03714672|589265297|FG002|Overall Study|Other Reason|1|||
163150557|NCT03714672|589265298|FG003|Overall Study|Other Reason|1|||
163150558|NCT03714672|589265295|FG000|Overall Study|Lost to Follow-up|1|||
163150559|NCT03714672|589265296|FG001|Overall Study|Lost to Follow-up|1|||
163150560|NCT03714672|589265297|FG002|Overall Study|Lost to Follow-up|0|||
163150561|NCT03714672|589265298|FG003|Overall Study|Lost to Follow-up|0|||
163150562|NCT00419393|589265303|FG000|Overall Study|Adverse Event|5|||
163150563|NCT00419393|589265303|FG000|Overall Study|Protocol Violation|5|||
163150564|NCT00419393|589265303|FG000|Overall Study|Withdrawal by Subject|7|||
163150565|NCT00419393|589265303|FG000|Overall Study|Other: Sponsor request|3|||
163150566|NCT00419393|589265303|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
163150567|NCT00419393|589265303|FG000|Overall Study|Other: Site closure|1|||
163150568|NCT00419393|589265303|FG000|Overall Study|Other: Other health problems|1|||
163150569|NCT00419393|589265303|FG000|Overall Study|Other: Investigator decision|1|||
163150570|NCT01231984|589265306|FG000|Study Period 1|Withdrawal by Subject|0|||
163150571|NCT01231984|589265307|FG001|Study Period 1|Withdrawal by Subject|0|||
163150572|NCT01231984|589265308|FG002|Study Period 1|Withdrawal by Subject|0|||
163150573|NCT01231984|589265309|FG003|Study Period 1|Withdrawal by Subject|1|||
162670222|NCT01297062|587500124|FG003|Overall Study|Protocol Violation|0|||
162670223|NCT01297062|587500125|FG004|Overall Study|Protocol Violation|1|||
162670224|NCT01297062|587500126|FG005|Overall Study|Protocol Violation|0|||
163150574|NCT01231984|589265306|FG000|Study Period 1|Lost to Follow-up|1|||
163150575|NCT01231984|589265307|FG001|Study Period 1|Lost to Follow-up|1|||
163150576|NCT01231984|589265308|FG002|Study Period 1|Lost to Follow-up|1|||
163150577|NCT01231984|589265309|FG003|Study Period 1|Lost to Follow-up|0|||
163150578|NCT01231984|589265306|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150579|NCT01231984|589265307|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150580|NCT01231984|589265308|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150581|NCT01231984|589265309|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
163150582|NCT01231984|589265306|FG000|Study Period 1|Screen Failure|0|||
163150583|NCT01231984|589265307|FG001|Study Period 1|Screen Failure|0|||
163150584|NCT01231984|589265308|FG002|Study Period 1|Screen Failure|0|||
163150585|NCT01231984|589265309|FG003|Study Period 1|Screen Failure|1|||
163150586|NCT01231984|589265306|FG000|Study Period 1|Non-compliance with study requirements|5|||
163150587|NCT01231984|589265307|FG001|Study Period 1|Non-compliance with study requirements|0|||
163150588|NCT01231984|589265308|FG002|Study Period 1|Non-compliance with study requirements|2|||
163150589|NCT01231984|589265309|FG003|Study Period 1|Non-compliance with study requirements|1|||
162721896|NCT02950558|587689374|FG000|Overall Study|Lost to Follow-up|2|||
163150590|NCT01231984|589265306|FG000|Study Period 1|Protocol Violation|3|||
162670225|NCT01297062|587500127|FG006|Overall Study|Protocol Violation|0|||
162670226|NCT01297062|587500121|FG000|Overall Study|Subject Decision|1|||
163150591|NCT01231984|589265307|FG001|Study Period 1|Protocol Violation|4|||
163150592|NCT01231984|589265308|FG002|Study Period 1|Protocol Violation|2|||
163150593|NCT01231984|589265309|FG003|Study Period 1|Protocol Violation|3|||
163150594|NCT01231984|589265306|FG000|Study Period 1|Adverse Event|1|||
163150595|NCT01231984|589265307|FG001|Study Period 1|Adverse Event|0|||
163150596|NCT01231984|589265308|FG002|Study Period 1|Adverse Event|0|||
163150597|NCT01231984|589265309|FG003|Study Period 1|Adverse Event|0|||
163150598|NCT01231984|589265306|FG000|Study Period 1|Other|0|||
163150599|NCT01231984|589265307|FG001|Study Period 1|Other|0|||
163150600|NCT01231984|589265308|FG002|Study Period 1|Other|0|||
163150601|NCT01231984|589265309|FG003|Study Period 1|Other|1|||
163150602|NCT01231984|589265306|FG000|Study Period 2|Withdrawal by Subject|1|||
163150603|NCT01231984|589265307|FG001|Study Period 2|Withdrawal by Subject|1|||
163150604|NCT01231984|589265308|FG002|Study Period 2|Withdrawal by Subject|0|||
163150605|NCT01231984|589265309|FG003|Study Period 2|Withdrawal by Subject|0|||
163150606|NCT01231984|589265306|FG000|Study Period 2|Lost to Follow-up|1|||
163150607|NCT01231984|589265307|FG001|Study Period 2|Lost to Follow-up|0|||
163150608|NCT01231984|589265308|FG002|Study Period 2|Lost to Follow-up|0|||
163150609|NCT01231984|589265309|FG003|Study Period 2|Lost to Follow-up|3|||
163150610|NCT01231984|589265306|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150611|NCT01231984|589265307|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150612|NCT01231984|589265308|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
163150613|NCT01231984|589265309|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
163150614|NCT02939287|589265310|FG000|Overall Study|met exclusion criteria|1|||
163150615|NCT02939287|589265311|FG001|Overall Study|met exclusion criteria|1|||
163150616|NCT02939287|589265312|FG002|Overall Study|met exclusion criteria|1|||
163150617|NCT02939287|589265310|FG000|Overall Study|Did not complete survey|2|||
163150618|NCT02939287|589265311|FG001|Overall Study|Did not complete survey|2|||
163150619|NCT02939287|589265312|FG002|Overall Study|Did not complete survey|0|||
163150620|NCT02939287|589265310|FG000|Overall Study|Withdrawal by Subject|1|||
163150621|NCT02939287|589265311|FG001|Overall Study|Withdrawal by Subject|1|||
163150622|NCT02939287|589265312|FG002|Overall Study|Withdrawal by Subject|0|||
163150623|NCT05236270|589265314|FG000|Overall Study|Lost to Follow-up|3|||
163150624|NCT05236270|589265315|FG001|Overall Study|Lost to Follow-up|2|||
163150625|NCT05236270|589265316|FG002|Overall Study|Lost to Follow-up|0|||
163150626|NCT05236270|589265317|FG003|Overall Study|Lost to Follow-up|0|||
163150627|NCT05236270|589265318|FG004|Overall Study|Lost to Follow-up|2|||
163150628|NCT05236270|589265319|FG005|Overall Study|Lost to Follow-up|0|||
163150629|NCT05236270|589265320|FG006|Overall Study|Lost to Follow-up|1|||
163150630|NCT05236270|589265321|FG007|Overall Study|Lost to Follow-up|3|||
163150631|NCT02476617|589265322|FG000|Overall Study|Adverse Event|1|||
163150632|NCT02476617|589265322|FG000|Overall Study|Lost to Follow-up|1|||
163150633|NCT01383928|589265323|FG000|Overall Study|Initiation of ASCT|2|||
163150634|NCT01383928|589265324|FG001|Overall Study|Initiation of ASCT|1|||
163150635|NCT01383928|589265325|FG002|Overall Study|Initiation of ASCT|18|||
163150636|NCT01383928|589265323|FG000|Overall Study|Adverse Event|1|||
163150637|NCT01383928|589265324|FG001|Overall Study|Adverse Event|2|||
163150638|NCT01383928|589265325|FG002|Overall Study|Adverse Event|8|||
163150639|NCT01383928|589265323|FG000|Overall Study|Other|1|||
163150640|NCT01383928|589265324|FG001|Overall Study|Other|3|||
163150641|NCT01383928|589265325|FG002|Overall Study|Other|4|||
163150642|NCT01383928|589265323|FG000|Overall Study|Progressive Disease|1|||
163150643|NCT01383928|589265324|FG001|Overall Study|Progressive Disease|1|||
163150644|NCT01383928|589265325|FG002|Overall Study|Progressive Disease|5|||
163150645|NCT01383928|589265323|FG000|Overall Study|Withdrawal by Subject|0|||
163150646|NCT01383928|589265324|FG001|Overall Study|Withdrawal by Subject|0|||
163150647|NCT01383928|589265325|FG002|Overall Study|Withdrawal by Subject|4|||
163150648|NCT01383928|589265323|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
163150649|NCT01383928|589265324|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163150650|NCT01383928|589265325|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
163150651|NCT03486912|589265326|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150652|NCT03486912|589265327|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
163150653|NCT03486912|589265328|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150654|NCT03486912|589265329|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
163150655|NCT03486912|589265326|FG000|Treatment Period|Withdrawal by Subject|3|||
163150656|NCT03486912|589265327|FG001|Treatment Period|Withdrawal by Subject|3|||
163150657|NCT03486912|589265328|FG002|Treatment Period|Withdrawal by Subject|3|||
163150658|NCT03486912|589265329|FG003|Treatment Period|Withdrawal by Subject|2|||
163150659|NCT03486912|589265326|FG000|Treatment Period|Other Reasons|0|||
163150660|NCT03486912|589265327|FG001|Treatment Period|Other Reasons|2|||
163150661|NCT03486912|589265328|FG002|Treatment Period|Other Reasons|1|||
163150662|NCT03486912|589265329|FG003|Treatment Period|Other Reasons|1|||
163150663|NCT03486912|589265326|FG000|Treatment Period|Adverse Event|0|||
163150664|NCT03486912|589265327|FG001|Treatment Period|Adverse Event|1|||
163150665|NCT03486912|589265328|FG002|Treatment Period|Adverse Event|1|||
163150666|NCT03486912|589265329|FG003|Treatment Period|Adverse Event|0|||
162721897|NCT02950558|587689375|FG001|Overall Study|Lost to Follow-up|0|||
163150667|NCT03486912|589265326|FG000|Treatment Period|Lost to Follow-up|1|||
162721898|NCT02537522|587689381|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
162721899|NCT02537522|587689382|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
162721900|NCT02537522|587689383|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
162721901|NCT02537522|587689384|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
162721902|NCT02537522|587689381|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
162721903|NCT02537522|587689382|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
162670227|NCT01297062|587500122|FG001|Overall Study|Subject Decision|1|||
162670228|NCT01297062|587500123|FG002|Overall Study|Subject Decision|0|||
162670229|NCT01297062|587500124|FG003|Overall Study|Subject Decision|1|||
162670230|NCT01297062|587500125|FG004|Overall Study|Subject Decision|1|||
162670231|NCT01297062|587500126|FG005|Overall Study|Subject Decision|1|||
162670232|NCT01297062|587500127|FG006|Overall Study|Subject Decision|2|||
162670233|NCT03191903|587500128|FG000|Overall Study|Withdrawal by Subject|6|||
162670234|NCT03191903|587500129|FG001|Overall Study|Withdrawal by Subject|5|||
162670235|NCT03191903|587500130|FG002|Overall Study|Withdrawal by Subject|4|||
162670236|NCT03191903|587500128|FG000|Overall Study|Adverse Event|1|||
162670237|NCT03191903|587500129|FG001|Overall Study|Adverse Event|0|||
162670238|NCT03191903|587500130|FG002|Overall Study|Adverse Event|0|||
162670239|NCT03149328|587500131|FG000|Overall Study|Withdrawal by Subject|30|||
162670240|NCT03149328|587500132|FG001|Overall Study|Withdrawal by Subject|26|||
162670241|NCT03149328|587500131|FG000|Overall Study|Changed Dialysis Modality|18|||
162721904|NCT02537522|587689383|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
162721905|NCT02537522|587689384|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
162721906|NCT02537522|587689381|FG000|Phase I - Contralateral|incorrect randomization|0|||
162721907|NCT02537522|587689382|FG001|Phase I - Contralateral|incorrect randomization|1|||
162721908|NCT02537522|587689383|FG002|Phase I - Contralateral|incorrect randomization|0|||
162721909|NCT02537522|587689384|FG003|Phase I - Contralateral|incorrect randomization|0|||
162721910|NCT02537522|587689381|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
162721911|NCT02537522|587689382|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
162721912|NCT02537522|587689383|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
162721913|NCT02537522|587689384|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
162721914|NCT02537522|587689381|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
162721915|NCT02537522|587689382|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
162721916|NCT02537522|587689383|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
162721917|NCT02537522|587689384|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
162721918|NCT03920215|587689386|FG000|Overall Study|Lost to Follow-up|1|||
162721919|NCT03920215|587689387|FG001|Overall Study|Lost to Follow-up|2|||
162721920|NCT03920215|587689388|FG002|Overall Study|Lost to Follow-up|0|||
162721921|NCT03920215|587689389|FG003|Overall Study|Lost to Follow-up|0|||
162721922|NCT03920215|587689386|FG000|Overall Study|Death|0|||
162721923|NCT03920215|587689387|FG001|Overall Study|Death|0|||
162721924|NCT03920215|587689388|FG002|Overall Study|Death|0|||
162721925|NCT03920215|587689389|FG003|Overall Study|Death|1|||
162721926|NCT00585533|587689390|FG000|Overall Study|objective or symptomatic progression|9|||
162721927|NCT02547922|587689391|FG000|Overall Study|Withdrawal by Subject|9|||
162721928|NCT02547922|587689392|FG001|Overall Study|Withdrawal by Subject|6|||
162721929|NCT02547922|587689393|FG002|Overall Study|Withdrawal by Subject|10|||
162670242|NCT03149328|587500132|FG001|Overall Study|Changed Dialysis Modality|1|||
162670243|NCT03149328|587500131|FG000|Overall Study|Transplant|9|||
162670244|NCT03149328|587500132|FG001|Overall Study|Transplant|1|||
162670245|NCT03149328|587500131|FG000|Overall Study|Lost to Follow-up|25|||
162670246|NCT03149328|587500132|FG001|Overall Study|Lost to Follow-up|16|||
162670247|NCT03149328|587500131|FG000|Overall Study|Left Study Site|1|||
162670248|NCT03149328|587500132|FG001|Overall Study|Left Study Site|2|||
162670249|NCT03149328|587500131|FG000|Overall Study|Language Barrier|1|||
162670250|NCT03149328|587500132|FG001|Overall Study|Language Barrier|0|||
162670251|NCT00503685|587500136|FG000|Overall Study|Adverse Event|0|||
162670252|NCT00503685|587500137|FG001|Overall Study|Adverse Event|0|||
162670253|NCT00503685|587500138|FG002|Overall Study|Adverse Event|2|||
162670254|NCT00503685|587500136|FG000|Overall Study|Withdrawal by Subject|0|||
162670255|NCT00503685|587500137|FG001|Overall Study|Withdrawal by Subject|1|||
162670256|NCT00503685|587500138|FG002|Overall Study|Withdrawal by Subject|0|||
162670257|NCT00503685|587500136|FG000|Overall Study|Protocol Violation|0|||
162670258|NCT00503685|587500137|FG001|Overall Study|Protocol Violation|1|||
162670259|NCT00503685|587500138|FG002|Overall Study|Protocol Violation|0|||
162670260|NCT00503685|587500136|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162670261|NCT00503685|587500137|FG001|Overall Study|Eligibility Criteria Not Met|1|||
162670262|NCT00503685|587500138|FG002|Overall Study|Eligibility Criteria Not Met|0|||
162670263|NCT00927927|587500141|FG000|Overall Study|Withdrawal by Subject|0|||
162670264|NCT00927927|587500142|FG001|Overall Study|Withdrawal by Subject|0|||
162670265|NCT00927927|587500143|FG002|Overall Study|Withdrawal by Subject|0|||
162670266|NCT00927927|587500144|FG003|Overall Study|Withdrawal by Subject|0|||
162670267|NCT00927927|587500145|FG004|Overall Study|Withdrawal by Subject|0|||
162670268|NCT00927927|587500146|FG005|Overall Study|Withdrawal by Subject|0|||
162670269|NCT00927927|587500147|FG006|Overall Study|Withdrawal by Subject|0|||
162670270|NCT00927927|587500148|FG007|Overall Study|Withdrawal by Subject|2|||
162670271|NCT00927927|587500149|FG008|Overall Study|Withdrawal by Subject|0|||
162670272|NCT00927927|587500150|FG009|Overall Study|Withdrawal by Subject|0|||
162670273|NCT00927927|587500151|FG010|Overall Study|Withdrawal by Subject|0|||
162670274|NCT00927927|587500152|FG011|Overall Study|Withdrawal by Subject|2|||
162670275|NCT00927927|587500153|FG012|Overall Study|Withdrawal by Subject|0|||
162670276|NCT00927927|587500154|FG013|Overall Study|Withdrawal by Subject|0|||
162670277|NCT00927927|587500155|FG014|Overall Study|Withdrawal by Subject|0|||
162721930|NCT02547922|587689391|FG000|Overall Study|Adverse Event|3|||
162670278|NCT01110239|587500160|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
162721931|NCT02547922|587689392|FG001|Overall Study|Adverse Event|1|||
162721932|NCT02547922|587689393|FG002|Overall Study|Adverse Event|2|||
162721933|NCT02547922|587689391|FG000|Overall Study|Lost to Follow-up|1|||
162670279|NCT01110239|587500161|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
162670280|NCT01110239|587500162|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
162670281|NCT01110239|587500163|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
162670282|NCT01110239|587500160|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
162670283|NCT01110239|587500161|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
162670284|NCT01110239|587500162|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
162721934|NCT02547922|587689392|FG001|Overall Study|Lost to Follow-up|0|||
162721935|NCT02547922|587689393|FG002|Overall Study|Lost to Follow-up|0|||
162721936|NCT02547922|587689391|FG000|Overall Study|Lack of Efficacy|5|||
162721937|NCT02547922|587689392|FG001|Overall Study|Lack of Efficacy|7|||
162721938|NCT02547922|587689393|FG002|Overall Study|Lack of Efficacy|4|||
162721939|NCT02547922|587689391|FG000|Overall Study|Death|1|||
162721940|NCT02547922|587689392|FG001|Overall Study|Death|0|||
162721941|NCT02547922|587689393|FG002|Overall Study|Death|0|||
162721942|NCT02547922|587689391|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
162670285|NCT01110239|587500163|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
162670286|NCT00080223|587500168|FG000|Overall Study|Adverse Event|23|||
162670287|NCT00080223|587500168|FG000|Overall Study|Death|21|||
162670288|NCT00080223|587500168|FG000|Overall Study|Withdrawal by Subject|13|||
162670289|NCT00080223|587500168|FG000|Overall Study|Lung Transplantation|9|||
162670290|NCT00080223|587500168|FG000|Overall Study|Non-compliance With Study Treatment|7|||
162670291|NCT00080223|587500168|FG000|Overall Study|Participant unwilling to continue|2|||
162670292|NCT00080223|587500168|FG000|Overall Study|Physician Decision|1|||
162670293|NCT00924287|587501989|FG000|Overall Study|Death|1|||
162670294|NCT00156065|587501996|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
162670295|NCT00156065|587501997|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
162670296|NCT00156065|587501998|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
162670297|NCT00156065|587501996|FG000|Overall Study|Adverse Event|8|||
162670298|NCT00156065|587501997|FG001|Overall Study|Adverse Event|11|||
162670299|NCT00156065|587501998|FG002|Overall Study|Adverse Event|4|||
162670300|NCT00156065|587501996|FG000|Overall Study|Lack of Efficacy|2|||
162670301|NCT00156065|587501997|FG001|Overall Study|Lack of Efficacy|9|||
162670302|NCT00156065|587501998|FG002|Overall Study|Lack of Efficacy|3|||
162670303|NCT00156065|587501996|FG000|Overall Study|Withdrawal by Subject|13|||
162670304|NCT00156065|587501997|FG001|Overall Study|Withdrawal by Subject|26|||
162670305|NCT00156065|587501998|FG002|Overall Study|Withdrawal by Subject|16|||
162670306|NCT00156065|587501996|FG000|Overall Study|Lost to Follow-up|5|||
162670307|NCT00156065|587501997|FG001|Overall Study|Lost to Follow-up|7|||
162670308|NCT00156065|587501998|FG002|Overall Study|Lost to Follow-up|1|||
162670309|NCT00156065|587501996|FG000|Overall Study|Other|2|||
162670310|NCT00156065|587501997|FG001|Overall Study|Other|9|||
162670311|NCT00156065|587501998|FG002|Overall Study|Other|3|||
162670312|NCT01432366|587501999|FG000|Overall Study|Non-Responder|7|||
162670313|NCT01432366|587501999|FG000|Overall Study|Adverse Event|8|||
162670314|NCT01432366|587501999|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
162670315|NCT01432366|587501999|FG000|Overall Study|Pregnancy|1|||
162670316|NCT01432366|587501999|FG000|Overall Study|Lost to Follow-up|13|||
162670317|NCT01432366|587501999|FG000|Overall Study|Lack of Efficacy|1|||
162670318|NCT01432366|587501999|FG000|Overall Study|Site Closed|20|||
162670319|NCT01432366|587501999|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
162670320|NCT01432366|587501999|FG000|Overall Study|Other|14|||
162670321|NCT02395120|587502000|FG000|Overall Study|Missed follow-up dental exam|57|||
162670322|NCT02395120|587502001|FG001|Overall Study|Missed follow-up dental exam|62|||
162670323|NCT02395120|587502002|FG002|Overall Study|Missed follow-up dental exam|6|||
162670324|NCT02395120|587502003|FG003|Overall Study|Missed follow-up dental exam|6|||
162670325|NCT02395120|587502004|FG004|Overall Study|Missed follow-up dental exam|51|||
162670326|NCT04546581|587502006|FG000|Overall Study|Adverse Event|9|||
162670327|NCT04546581|587502007|FG001|Overall Study|Adverse Event|3|||
162670328|NCT04546581|587502006|FG000|Overall Study|Physician Decision|0|||
162670329|NCT04546581|587502007|FG001|Overall Study|Physician Decision|1|||
162670330|NCT04546581|587502006|FG000|Overall Study|Protocol Violation|1|||
162670331|NCT04546581|587502007|FG001|Overall Study|Protocol Violation|2|||
162670332|NCT04546581|587502006|FG000|Overall Study|Withdrawal by Subject|3|||
162670333|NCT04546581|587502007|FG001|Overall Study|Withdrawal by Subject|7|||
162670334|NCT02526693|587502008|FG000|Overall Study|Physician Decision|3|||
162670335|NCT02526693|587502009|FG001|Overall Study|Physician Decision|1|||
162670336|NCT01798927|587502010|FG000|Overall Study|Withdrawal by Subject|1|||
162670337|NCT01159691|587502011|FG000|Overall Study|Lost to Follow-up|2|||
162670338|NCT01159691|587502011|FG000|Overall Study|Unknown reasons|1|||
162670339|NCT01159691|587502011|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
162670340|NCT01159691|587502011|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
162670341|NCT01159691|587502011|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
162670342|NCT01159691|587502011|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
162670343|NCT01159691|587502011|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
162670344|NCT01159691|587502011|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
162670345|NCT04579757|587502022|FG000|Overall Study|Adverse Event|0|||
162670346|NCT04579757|587502023|FG001|Overall Study|Adverse Event|0|||
162670347|NCT04579757|587502024|FG002|Overall Study|Adverse Event|0|||
162670348|NCT04579757|587502025|FG003|Overall Study|Adverse Event|2|||
162670349|NCT04579757|587502026|FG004|Overall Study|Adverse Event|1|||
162670350|NCT04579757|587502027|FG005|Overall Study|Adverse Event|1|||
162670351|NCT04579757|587502028|FG006|Overall Study|Adverse Event|0|||
162670352|NCT04579757|587502029|FG007|Overall Study|Adverse Event|0|||
162670353|NCT04579757|587502030|FG008|Overall Study|Adverse Event|0|||
162670354|NCT04579757|587502022|FG000|Overall Study|Death|4|||
162670355|NCT04579757|587502023|FG001|Overall Study|Death|1|||
162670356|NCT04579757|587502024|FG002|Overall Study|Death|14|||
162670357|NCT04579757|587502025|FG003|Overall Study|Death|3|||
162670358|NCT04579757|587502026|FG004|Overall Study|Death|2|||
162670359|NCT04579757|587502027|FG005|Overall Study|Death|7|||
162670360|NCT04579757|587502028|FG006|Overall Study|Death|0|||
162670361|NCT04579757|587502029|FG007|Overall Study|Death|1|||
162670362|NCT04579757|587502030|FG008|Overall Study|Death|3|||
162670363|NCT04579757|587502022|FG000|Overall Study|Physician Decision|0|||
162670364|NCT04579757|587502023|FG001|Overall Study|Physician Decision|0|||
162670365|NCT04579757|587502024|FG002|Overall Study|Physician Decision|0|||
162670366|NCT04579757|587502025|FG003|Overall Study|Physician Decision|2|||
162670367|NCT04579757|587502026|FG004|Overall Study|Physician Decision|1|||
162670368|NCT04579757|587502027|FG005|Overall Study|Physician Decision|1|||
162670369|NCT04579757|587502028|FG006|Overall Study|Physician Decision|1|||
162670370|NCT04579757|587502029|FG007|Overall Study|Physician Decision|0|||
162670371|NCT04579757|587502030|FG008|Overall Study|Physician Decision|0|||
162670372|NCT04579757|587502022|FG000|Overall Study|Study Terminated By Sponsor|0|||
162670373|NCT04579757|587502023|FG001|Overall Study|Study Terminated By Sponsor|0|||
162670374|NCT04579757|587502024|FG002|Overall Study|Study Terminated By Sponsor|0|||
162670375|NCT04579757|587502025|FG003|Overall Study|Study Terminated By Sponsor|0|||
162670376|NCT04579757|587502026|FG004|Overall Study|Study Terminated By Sponsor|2|||
162670377|NCT04579757|587502027|FG005|Overall Study|Study Terminated By Sponsor|0|||
162670378|NCT04579757|587502028|FG006|Overall Study|Study Terminated By Sponsor|0|||
162670379|NCT04579757|587502029|FG007|Overall Study|Study Terminated By Sponsor|2|||
162670380|NCT04579757|587502030|FG008|Overall Study|Study Terminated By Sponsor|0|||
162670381|NCT04579757|587502022|FG000|Overall Study|Withdrawal by Subject|1|||
162670382|NCT04579757|587502023|FG001|Overall Study|Withdrawal by Subject|1|||
162670383|NCT04579757|587502024|FG002|Overall Study|Withdrawal by Subject|0|||
162670384|NCT04579757|587502025|FG003|Overall Study|Withdrawal by Subject|0|||
162670385|NCT04579757|587502026|FG004|Overall Study|Withdrawal by Subject|2|||
162670386|NCT04579757|587502027|FG005|Overall Study|Withdrawal by Subject|1|||
162670387|NCT04579757|587502028|FG006|Overall Study|Withdrawal by Subject|0|||
162670388|NCT04579757|587502029|FG007|Overall Study|Withdrawal by Subject|3|||
162670389|NCT04579757|587502030|FG008|Overall Study|Withdrawal by Subject|0|||
162670390|NCT04579757|587502022|FG000|Overall Study|Radiological or Clinical PD|1|||
162670391|NCT04579757|587502023|FG001|Overall Study|Radiological or Clinical PD|4|||
162670392|NCT04579757|587502024|FG002|Overall Study|Radiological or Clinical PD|1|||
162670393|NCT04579757|587502025|FG003|Overall Study|Radiological or Clinical PD|3|||
162670394|NCT04579757|587502026|FG004|Overall Study|Radiological or Clinical PD|9|||
162670395|NCT04579757|587502027|FG005|Overall Study|Radiological or Clinical PD|4|||
162670396|NCT04579757|587502028|FG006|Overall Study|Radiological or Clinical PD|2|||
162670397|NCT04579757|587502029|FG007|Overall Study|Radiological or Clinical PD|2|||
162670398|NCT04579757|587502030|FG008|Overall Study|Radiological or Clinical PD|0|||
162670399|NCT04579757|587502022|FG000|Overall Study|Start of New Therapy|0|||
162670400|NCT04579757|587502023|FG001|Overall Study|Start of New Therapy|0|||
162670401|NCT04579757|587502024|FG002|Overall Study|Start of New Therapy|0|||
162670402|NCT04579757|587502025|FG003|Overall Study|Start of New Therapy|0|||
162670403|NCT04579757|587502026|FG004|Overall Study|Start of New Therapy|2|||
162670404|NCT04579757|587502027|FG005|Overall Study|Start of New Therapy|1|||
162670405|NCT04579757|587502028|FG006|Overall Study|Start of New Therapy|0|||
162670406|NCT04579757|587502029|FG007|Overall Study|Start of New Therapy|0|||
162670407|NCT04579757|587502030|FG008|Overall Study|Start of New Therapy|0|||
162670408|NCT01153633|587502031|FG000|Overall Study|Protocol Violation|1|||
162670409|NCT01153633|587502032|FG001|Overall Study|Protocol Violation|1|||
162670410|NCT01153633|587502031|FG000|Overall Study|Therapeutic failure|3|||
162670411|NCT01153633|587502032|FG001|Overall Study|Therapeutic failure|3|||
162670412|NCT00384085|587502033|FG000|Overall Study|Adverse Event|5|||
162670413|NCT00384085|587502034|FG001|Overall Study|Adverse Event|5|||
162670414|NCT00384085|587502035|FG002|Overall Study|Adverse Event|4|||
162670415|NCT00384085|587502033|FG000|Overall Study|Lack of Efficacy|0|||
162670416|NCT00384085|587502034|FG001|Overall Study|Lack of Efficacy|3|||
162670417|NCT00384085|587502035|FG002|Overall Study|Lack of Efficacy|2|||
162670418|NCT00384085|587502033|FG000|Overall Study|No longer Requires Study Treatment|1|||
162670419|NCT00384085|587502034|FG001|Overall Study|No longer Requires Study Treatment|0|||
162670420|NCT00384085|587502035|FG002|Overall Study|No longer Requires Study Treatment|1|||
162670421|NCT00384085|587502033|FG000|Overall Study|Protocol Violation|2|||
162670422|NCT00384085|587502034|FG001|Overall Study|Protocol Violation|2|||
162670423|NCT00384085|587502035|FG002|Overall Study|Protocol Violation|2|||
162670424|NCT00384085|587502033|FG000|Overall Study|Lost to Follow-up|9|||
162670425|NCT00384085|587502034|FG001|Overall Study|Lost to Follow-up|9|||
162670426|NCT00384085|587502035|FG002|Overall Study|Lost to Follow-up|10|||
162670427|NCT00384085|587502033|FG000|Overall Study|Progressive Disease|0|||
162670428|NCT00384085|587502034|FG001|Overall Study|Progressive Disease|1|||
162670429|NCT00384085|587502035|FG002|Overall Study|Progressive Disease|0|||
162670430|NCT00384085|587502033|FG000|Overall Study|Withdrawal by Subject|14|||
162670431|NCT00384085|587502034|FG001|Overall Study|Withdrawal by Subject|19|||
162670432|NCT00384085|587502035|FG002|Overall Study|Withdrawal by Subject|29|||
162670433|NCT00384085|587502033|FG000|Overall Study|Patient non-compliant|4|||
162670434|NCT00384085|587502034|FG001|Overall Study|Patient non-compliant|4|||
162670435|NCT00384085|587502035|FG002|Overall Study|Patient non-compliant|5|||
162670436|NCT00384085|587502033|FG000|Overall Study|Physician Decision|1|||
162670437|NCT00384085|587502034|FG001|Overall Study|Physician Decision|0|||
162670438|NCT00384085|587502035|FG002|Overall Study|Physician Decision|0|||
162670439|NCT00384085|587502033|FG000|Overall Study|Loss of site personnel|1|||
162670440|NCT00384085|587502034|FG001|Overall Study|Loss of site personnel|0|||
162670441|NCT00384085|587502035|FG002|Overall Study|Loss of site personnel|1|||
162670442|NCT00384085|587502033|FG000|Overall Study|Sponsor decision|1|||
162670443|NCT00384085|587502034|FG001|Overall Study|Sponsor decision|2|||
162670444|NCT00384085|587502035|FG002|Overall Study|Sponsor decision|1|||
162670445|NCT00384085|587502033|FG000|Overall Study|Patient moved|1|||
162670446|NCT00384085|587502034|FG001|Overall Study|Patient moved|0|||
162670447|NCT00384085|587502035|FG002|Overall Study|Patient moved|1|||
162670448|NCT00384085|587502033|FG000|Overall Study|Patient required surgery|0|||
162670449|NCT00384085|587502034|FG001|Overall Study|Patient required surgery|1|||
162670450|NCT00384085|587502035|FG002|Overall Study|Patient required surgery|0|||
162670451|NCT05912400|587502036|FG000|Overall Study|Lost to Follow-up|1|||
162670452|NCT05912400|587502037|FG001|Overall Study|Lost to Follow-up|0|||
162670453|NCT05912400|587502036|FG000|Overall Study|Physician Decision|6|||
162670454|NCT05912400|587502037|FG001|Overall Study|Physician Decision|0|||
162670455|NCT05912400|587502036|FG000|Overall Study|Withdrawal by Subject|1|||
162670456|NCT05912400|587502037|FG001|Overall Study|Withdrawal by Subject|0|||
162670457|NCT01944631|587502041|FG000|Overall Study|Adverse Event|1|||
162670458|NCT01944631|587502042|FG001|Overall Study|Adverse Event|0|||
162670459|NCT01944631|587502041|FG000|Overall Study|Lost to Follow-up|3|||
162670460|NCT01944631|587502042|FG001|Overall Study|Lost to Follow-up|1|||
162670461|NCT01944631|587502041|FG000|Overall Study|Withdrawal by Subject|0|||
162670462|NCT01944631|587502042|FG001|Overall Study|Withdrawal by Subject|1|||
162670463|NCT01843192|587502043|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
162670464|NCT01843192|587502044|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
162670465|NCT01843192|587502045|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
162670466|NCT00328510|587502048|FG000|Overall Study|Gag disorder, could not use frame|4|||
162670467|NCT00328510|587502049|FG001|Overall Study|Gag disorder, could not use frame|0|||
162670468|NCT00328510|587502048|FG000|Overall Study|Dentition problems, could not use frame|1|||
162670469|NCT00328510|587502049|FG001|Overall Study|Dentition problems, could not use frame|0|||
162670470|NCT00328510|587502048|FG000|Overall Study|Withdrawal by Subject|4|||
162670471|NCT00328510|587502049|FG001|Overall Study|Withdrawal by Subject|2|||
162670472|NCT00328510|587502048|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
162670473|NCT00328510|587502049|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
162670474|NCT00328510|587502048|FG000|Overall Study|Treatment changed to a single fraction|1|||
162670475|NCT00328510|587502049|FG001|Overall Study|Treatment changed to a single fraction|1|||
162670476|NCT02261363|587502051|FG000|Overall Study|Lost to Follow-up|21|||
162721943|NCT02547922|587689392|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
162721944|NCT02547922|587689393|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
162721945|NCT02547922|587689391|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
162721946|NCT02547922|587689392|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
162721947|NCT02547922|587689393|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
162721948|NCT02547922|587689391|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
163150668|NCT03486912|589265327|FG001|Treatment Period|Lost to Follow-up|0|||
163150669|NCT03486912|589265328|FG002|Treatment Period|Lost to Follow-up|0|||
163150670|NCT03486912|589265329|FG003|Treatment Period|Lost to Follow-up|2|||
163150671|NCT02491684|589265330|FG000|Treatment Phase|Adverse Event|2|||
163150672|NCT02491684|589265331|FG001|Treatment Phase|Adverse Event|2|||
163150673|NCT02491684|589265330|FG000|Treatment Phase|Incorrect randomisation|1|||
163150674|NCT02491684|589265331|FG001|Treatment Phase|Incorrect randomisation|0|||
163150675|NCT02491684|589265330|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
163150676|NCT02491684|589265331|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
163150677|NCT01149096|589265332|FG000|Overall Study|Lost to Follow-up|0|||
163150678|NCT01149096|589265333|FG001|Overall Study|Lost to Follow-up|1|||
163150679|NCT01263769|589265334|FG000|Overall Study|Non-Compliant with treatment|1|||
163150680|NCT03267277|589265335|FG000|Overall Study|Withdrawal by Subject|1|||
163150681|NCT00468169|589265336|FG000|Overall Study|Withdrawal by Subject|1|||
163150682|NCT00468169|589265337|FG001|Overall Study|Withdrawal by Subject|0|||
163150683|NCT01126749|589265342|FG000|Phase 1b|Other|0|||
163150684|NCT01126749|589265343|FG001|Phase 1b|Other|1|||
163150685|NCT01126749|589265344|FG002|Phase 1b|Other|0|||
163150686|NCT01126749|589265345|FG003|Phase 1b|Other|0|||
163150687|NCT01126749|589265342|FG000|Phase 1b|Withdrawal by Subject|0|||
163150688|NCT01126749|589265343|FG001|Phase 1b|Withdrawal by Subject|1|||
163150689|NCT01126749|589265344|FG002|Phase 1b|Withdrawal by Subject|0|||
163150690|NCT01126749|589265345|FG003|Phase 1b|Withdrawal by Subject|0|||
163150691|NCT01126749|589265342|FG000|Phase 1b|Death|3|||
163150692|NCT01126749|589265343|FG001|Phase 1b|Death|4|||
163150693|NCT01126749|589265344|FG002|Phase 1b|Death|0|||
163150694|NCT01126749|589265345|FG003|Phase 1b|Death|0|||
163150695|NCT01126749|589265342|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
163150696|NCT01126749|589265343|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
163150697|NCT01126749|589265344|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
163150698|NCT01126749|589265345|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
163150699|NCT01126749|589265342|FG000|Phase 2|Study Termination by Sponsor|0|||
163150700|NCT01126749|589265343|FG001|Phase 2|Study Termination by Sponsor|0|||
163150701|NCT01126749|589265344|FG002|Phase 2|Study Termination by Sponsor|12|||
163150702|NCT01126749|589265345|FG003|Phase 2|Study Termination by Sponsor|6|||
163150703|NCT01126749|589265342|FG000|Phase 2|Other|0|||
163150704|NCT01126749|589265343|FG001|Phase 2|Other|0|||
163150705|NCT01126749|589265344|FG002|Phase 2|Other|4|||
163150706|NCT01126749|589265345|FG003|Phase 2|Other|2|||
163150707|NCT01126749|589265342|FG000|Phase 2|Withdrawal by Subject|0|||
163150708|NCT01126749|589265343|FG001|Phase 2|Withdrawal by Subject|0|||
163150709|NCT01126749|589265344|FG002|Phase 2|Withdrawal by Subject|0|||
163150710|NCT01126749|589265345|FG003|Phase 2|Withdrawal by Subject|2|||
163150711|NCT01126749|589265342|FG000|Phase 2|Lost to Follow-up|0|||
163150712|NCT01126749|589265343|FG001|Phase 2|Lost to Follow-up|0|||
163150713|NCT01126749|589265344|FG002|Phase 2|Lost to Follow-up|0|||
163150714|NCT01126749|589265345|FG003|Phase 2|Lost to Follow-up|1|||
163150715|NCT01126749|589265342|FG000|Phase 2|Death|0|||
163150716|NCT01126749|589265343|FG001|Phase 2|Death|0|||
163150717|NCT01126749|589265344|FG002|Phase 2|Death|22|||
163150718|NCT01126749|589265345|FG003|Phase 2|Death|22|||
163150719|NCT01126749|589265342|FG000|Phase 2|Adverse Event|0|||
163150720|NCT01126749|589265343|FG001|Phase 2|Adverse Event|0|||
163150721|NCT01126749|589265344|FG002|Phase 2|Adverse Event|0|||
163150722|NCT01126749|589265345|FG003|Phase 2|Adverse Event|1|||
163150723|NCT03668873|589265346|FG000|Overall Study|Lost to Follow-up|6|||
163150724|NCT03668873|589265347|FG001|Overall Study|Lost to Follow-up|3|||
163150725|NCT02183675|589265348|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150726|NCT02183675|589265349|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150727|NCT02183675|589265350|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150728|NCT02183675|589265351|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150729|NCT02183675|589265352|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
163150730|NCT02183675|589265353|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
163150731|NCT01521117|589265354|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
163150732|NCT01521117|589265355|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
163150733|NCT01521117|589265354|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
162721949|NCT02547922|587689392|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
163150734|NCT01521117|589265355|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
163150735|NCT01521117|589265354|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163150736|NCT01521117|589265355|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
163150737|NCT00784563|589265358|FG000|Years 1 & 2|Withdrawal by Subject|3|||
163150738|NCT00784563|589265359|FG001|Years 1 & 2|Withdrawal by Subject|2|||
163150739|NCT00784563|589265360|FG002|Years 1 & 2|Withdrawal by Subject|0|||
162670477|NCT01517802|587502052|FG000|Overall Study|Death|1|||
162670478|NCT02605954|587502053|FG000|Overall Study|Adverse Event|5|||
162670479|NCT02605954|587502054|FG001|Overall Study|Adverse Event|1|||
162670480|NCT02605954|587502053|FG000|Overall Study|Investigator's Discretion|1|||
162670481|NCT02605954|587502054|FG001|Overall Study|Investigator's Discretion|0|||
162670482|NCT02605954|587502053|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162670483|NCT02605954|587502054|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162670484|NCT02605954|587502053|FG000|Overall Study|Withdrew Consent|2|||
162670485|NCT02605954|587502054|FG001|Overall Study|Withdrew Consent|2|||
162670486|NCT02605954|587502053|FG000|Overall Study|Lost to Follow-up|3|||
162670487|NCT02605954|587502054|FG001|Overall Study|Lost to Follow-up|0|||
162670488|NCT02605954|587502053|FG000|Overall Study|Randomized but not treated|0|||
162670489|NCT02605954|587502054|FG001|Overall Study|Randomized but not treated|1|||
162670490|NCT02301143|587502055|FG000|Induction Period|Enrolled But Not Treated|1|||
162670491|NCT02301143|587502056|FG001|Induction Period|Enrolled But Not Treated|0|||
162670492|NCT02301143|587502055|FG000|Induction Period|Death|1|||
162670493|NCT02301143|587502056|FG001|Induction Period|Death|0|||
162670494|NCT02301143|587502055|FG000|Induction Period|Adverse Event|22|||
162670495|NCT02301143|587502056|FG001|Induction Period|Adverse Event|0|||
162670496|NCT02301143|587502055|FG000|Induction Period|Progressive Disease|8|||
162670497|NCT02301143|587502056|FG001|Induction Period|Progressive Disease|0|||
162670498|NCT02301143|587502055|FG000|Induction Period|Withdrawal by Subject|3|||
162670499|NCT02301143|587502056|FG001|Induction Period|Withdrawal by Subject|0|||
162670500|NCT02301143|587502055|FG000|Induction Period|Noncompliance with Study Drug|1|||
162670501|NCT02301143|587502056|FG001|Induction Period|Noncompliance with Study Drug|0|||
162670502|NCT02301143|587502055|FG000|Induction Period|Physician Decision|4|||
162670503|NCT02301143|587502056|FG001|Induction Period|Physician Decision|0|||
162670504|NCT02301143|587502055|FG000|Induction Period|Symptomatic Deterioration|2|||
162670505|NCT02301143|587502056|FG001|Induction Period|Symptomatic Deterioration|0|||
162670506|NCT02301143|587502055|FG000|Induction Period|Protocol Violation|2|||
162670507|NCT02301143|587502056|FG001|Induction Period|Protocol Violation|0|||
162670508|NCT02301143|587502055|FG000|Induction Period|Other|1|||
162670509|NCT02301143|587502056|FG001|Induction Period|Other|0|||
162670510|NCT02301143|587502055|FG000|Investigator's Choice|Adverse Event|0|||
162670511|NCT02301143|587502056|FG001|Investigator's Choice|Adverse Event|3|||
162670512|NCT02301143|587502055|FG000|Investigator's Choice|Progressive Disease|0|||
162670513|NCT02301143|587502056|FG001|Investigator's Choice|Progressive Disease|3|||
162670514|NCT02301143|587502055|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
162670515|NCT02301143|587502056|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
162670516|NCT02301143|587502055|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
162670517|NCT02301143|587502056|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
162670518|NCT02301143|587502055|FG000|Investigator's Choice|Other|0|||
162670519|NCT02301143|587502056|FG001|Investigator's Choice|Other|1|||
162670520|NCT02301143|587502055|FG000|Investigator's Choice|Unresectable Surgery|0|||
162670521|NCT02301143|587502056|FG001|Investigator's Choice|Unresectable Surgery|1|||
163150740|NCT00784563|589265358|FG000|Years 1 & 2|Adverse Event|0|||
163150741|NCT00784563|589265359|FG001|Years 1 & 2|Adverse Event|3|||
163150742|NCT00784563|589265360|FG002|Years 1 & 2|Adverse Event|0|||
163150743|NCT00784563|589265358|FG000|Year 3|Withdrawal by Subject|0|||
163150744|NCT00784563|589265359|FG001|Year 3|Withdrawal by Subject|0|||
163150745|NCT00784563|589265360|FG002|Year 3|Withdrawal by Subject|2|||
163150746|NCT00784563|589265358|FG000|Year 3|Adverse Event|0|||
163150747|NCT00784563|589265359|FG001|Year 3|Adverse Event|0|||
163150748|NCT00784563|589265360|FG002|Year 3|Adverse Event|1|||
163150749|NCT00762164|589265361|FG000|Overall Study|Lost to Follow-up|1|||
163150750|NCT00762164|589265362|FG001|Overall Study|Lost to Follow-up|1|||
163150751|NCT00762164|589265361|FG000|Overall Study|Discontinued medication|2|||
163150752|NCT00762164|589265362|FG001|Overall Study|Discontinued medication|0|||
163150753|NCT00762164|589265361|FG000|Overall Study|Withdrawal by Subject|0|||
163150754|NCT00762164|589265362|FG001|Overall Study|Withdrawal by Subject|1|||
163150755|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
163150756|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
163150757|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
163150758|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
163150759|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
163150760|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
163150761|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
163150762|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
162670522|NCT03214367|587502059|FG000|Lead-in Period|Withdrawal by Subject|50|||
163150763|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150764|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
163150765|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150766|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
163150767|NCT02657889|589265369|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150768|NCT02657889|589265370|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
163150769|NCT02657889|589265371|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150770|NCT02657889|589265372|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
163150771|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
163150772|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
163150773|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
163150774|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
163150775|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
163150776|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
163150777|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
163150778|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
162670523|NCT03214367|587502060|FG001|Lead-in Period|Withdrawal by Subject|0|||
163150779|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
162670524|NCT03214367|587502061|FG002|Lead-in Period|Withdrawal by Subject|0|||
162670525|NCT03214367|587502062|FG003|Lead-in Period|Withdrawal by Subject|0|||
162670526|NCT03214367|587502063|FG004|Lead-in Period|Withdrawal by Subject|2|||
162670527|NCT03214367|587502064|FG005|Lead-in Period|Withdrawal by Subject|0|||
162670528|NCT03214367|587502065|FG006|Lead-in Period|Withdrawal by Subject|0|||
162670529|NCT03214367|587502066|FG007|Lead-in Period|Withdrawal by Subject|0|||
162670530|NCT03214367|587502059|FG000|Lead-in Period|Adverse Event|3|||
162670531|NCT03214367|587502060|FG001|Lead-in Period|Adverse Event|0|||
162670532|NCT03214367|587502061|FG002|Lead-in Period|Adverse Event|0|||
162670533|NCT03214367|587502062|FG003|Lead-in Period|Adverse Event|0|||
162670534|NCT03214367|587502063|FG004|Lead-in Period|Adverse Event|0|||
162670535|NCT03214367|587502064|FG005|Lead-in Period|Adverse Event|0|||
162670536|NCT03214367|587502065|FG006|Lead-in Period|Adverse Event|0|||
162670537|NCT03214367|587502066|FG007|Lead-in Period|Adverse Event|0|||
162670538|NCT03214367|587502059|FG000|Lead-in Period|Lost to Follow-up|12|||
162670539|NCT03214367|587502060|FG001|Lead-in Period|Lost to Follow-up|0|||
162670540|NCT03214367|587502061|FG002|Lead-in Period|Lost to Follow-up|0|||
162670541|NCT03214367|587502062|FG003|Lead-in Period|Lost to Follow-up|0|||
162670542|NCT03214367|587502063|FG004|Lead-in Period|Lost to Follow-up|0|||
162670543|NCT03214367|587502064|FG005|Lead-in Period|Lost to Follow-up|0|||
162670544|NCT03214367|587502065|FG006|Lead-in Period|Lost to Follow-up|0|||
162670545|NCT03214367|587502066|FG007|Lead-in Period|Lost to Follow-up|0|||
162670546|NCT03214367|587502059|FG000|Lead-in Period|Sponsor Decision|11|||
162670547|NCT03214367|587502060|FG001|Lead-in Period|Sponsor Decision|0|||
162670548|NCT03214367|587502061|FG002|Lead-in Period|Sponsor Decision|0|||
162670549|NCT03214367|587502062|FG003|Lead-in Period|Sponsor Decision|0|||
162670550|NCT03214367|587502063|FG004|Lead-in Period|Sponsor Decision|0|||
162670551|NCT03214367|587502064|FG005|Lead-in Period|Sponsor Decision|0|||
162670552|NCT03214367|587502065|FG006|Lead-in Period|Sponsor Decision|0|||
162670553|NCT03214367|587502066|FG007|Lead-in Period|Sponsor Decision|0|||
162670554|NCT03214367|587502059|FG000|Lead-in Period|Physician Decision|12|||
162670555|NCT03214367|587502060|FG001|Lead-in Period|Physician Decision|0|||
162670556|NCT03214367|587502061|FG002|Lead-in Period|Physician Decision|0|||
162670557|NCT03214367|587502062|FG003|Lead-in Period|Physician Decision|0|||
162670558|NCT03214367|587502063|FG004|Lead-in Period|Physician Decision|0|||
162670559|NCT03214367|587502064|FG005|Lead-in Period|Physician Decision|0|||
162670560|NCT03214367|587502065|FG006|Lead-in Period|Physician Decision|0|||
162670561|NCT03214367|587502066|FG007|Lead-in Period|Physician Decision|0|||
162670562|NCT03214367|587502059|FG000|Lead-in Period|Protocol Violation|5|||
162670563|NCT03214367|587502060|FG001|Lead-in Period|Protocol Violation|0|||
162670564|NCT03214367|587502061|FG002|Lead-in Period|Protocol Violation|0|||
162670565|NCT03214367|587502062|FG003|Lead-in Period|Protocol Violation|0|||
162670566|NCT03214367|587502063|FG004|Lead-in Period|Protocol Violation|0|||
162670567|NCT03214367|587502064|FG005|Lead-in Period|Protocol Violation|0|||
162670568|NCT03214367|587502065|FG006|Lead-in Period|Protocol Violation|0|||
162670569|NCT03214367|587502066|FG007|Lead-in Period|Protocol Violation|0|||
162670570|NCT03214367|587502059|FG000|Lead-in Period|Treatment Interruption|1|||
162670571|NCT03214367|587502060|FG001|Lead-in Period|Treatment Interruption|0|||
162670572|NCT03214367|587502061|FG002|Lead-in Period|Treatment Interruption|0|||
162670573|NCT03214367|587502062|FG003|Lead-in Period|Treatment Interruption|0|||
162670574|NCT03214367|587502063|FG004|Lead-in Period|Treatment Interruption|0|||
162670575|NCT03214367|587502064|FG005|Lead-in Period|Treatment Interruption|0|||
162670576|NCT03214367|587502065|FG006|Lead-in Period|Treatment Interruption|0|||
162670577|NCT03214367|587502066|FG007|Lead-in Period|Treatment Interruption|0|||
162670578|NCT03214367|587502059|FG000|Treatment Period|Adverse Event|0|||
162670579|NCT03214367|587502060|FG001|Treatment Period|Adverse Event|1|||
162670580|NCT03214367|587502061|FG002|Treatment Period|Adverse Event|4|||
162670581|NCT03214367|587502062|FG003|Treatment Period|Adverse Event|2|||
162670582|NCT03214367|587502063|FG004|Treatment Period|Adverse Event|0|||
162670583|NCT03214367|587502064|FG005|Treatment Period|Adverse Event|0|||
162670584|NCT03214367|587502065|FG006|Treatment Period|Adverse Event|0|||
162670585|NCT03214367|587502066|FG007|Treatment Period|Adverse Event|0|||
162670586|NCT03214367|587502059|FG000|Treatment Period|Death|0|||
162670587|NCT03214367|587502060|FG001|Treatment Period|Death|1|||
162670588|NCT03214367|587502061|FG002|Treatment Period|Death|1|||
162670589|NCT03214367|587502062|FG003|Treatment Period|Death|1|||
162670590|NCT03214367|587502063|FG004|Treatment Period|Death|0|||
162670591|NCT03214367|587502064|FG005|Treatment Period|Death|0|||
162670592|NCT03214367|587502065|FG006|Treatment Period|Death|0|||
162670593|NCT03214367|587502066|FG007|Treatment Period|Death|0|||
162670594|NCT03214367|587502059|FG000|Treatment Period|Lost to Follow-up|0|||
162670595|NCT03214367|587502060|FG001|Treatment Period|Lost to Follow-up|5|||
162670596|NCT03214367|587502061|FG002|Treatment Period|Lost to Follow-up|3|||
162670597|NCT03214367|587502062|FG003|Treatment Period|Lost to Follow-up|2|||
162670598|NCT03214367|587502063|FG004|Treatment Period|Lost to Follow-up|0|||
162670599|NCT03214367|587502064|FG005|Treatment Period|Lost to Follow-up|2|||
162670600|NCT03214367|587502065|FG006|Treatment Period|Lost to Follow-up|1|||
162670601|NCT03214367|587502066|FG007|Treatment Period|Lost to Follow-up|0|||
162670602|NCT03214367|587502059|FG000|Treatment Period|Sponsor Decision|0|||
162670603|NCT03214367|587502060|FG001|Treatment Period|Sponsor Decision|3|||
162670604|NCT03214367|587502061|FG002|Treatment Period|Sponsor Decision|0|||
162670605|NCT03214367|587502062|FG003|Treatment Period|Sponsor Decision|0|||
162670606|NCT03214367|587502063|FG004|Treatment Period|Sponsor Decision|0|||
162670607|NCT03214367|587502064|FG005|Treatment Period|Sponsor Decision|0|||
162670608|NCT03214367|587502065|FG006|Treatment Period|Sponsor Decision|0|||
162670609|NCT03214367|587502066|FG007|Treatment Period|Sponsor Decision|0|||
162670610|NCT03214367|587502059|FG000|Treatment Period|Physician Decision|0|||
162670611|NCT03214367|587502060|FG001|Treatment Period|Physician Decision|1|||
162670612|NCT03214367|587502061|FG002|Treatment Period|Physician Decision|2|||
162670613|NCT03214367|587502062|FG003|Treatment Period|Physician Decision|0|||
162670614|NCT03214367|587502063|FG004|Treatment Period|Physician Decision|0|||
162670615|NCT03214367|587502064|FG005|Treatment Period|Physician Decision|0|||
162670616|NCT03214367|587502065|FG006|Treatment Period|Physician Decision|0|||
162670617|NCT03214367|587502066|FG007|Treatment Period|Physician Decision|0|||
162670618|NCT03214367|587502059|FG000|Treatment Period|Protocol Violation|0|||
162670619|NCT03214367|587502060|FG001|Treatment Period|Protocol Violation|3|||
162670620|NCT03214367|587502061|FG002|Treatment Period|Protocol Violation|0|||
162670621|NCT03214367|587502062|FG003|Treatment Period|Protocol Violation|0|||
162670622|NCT03214367|587502063|FG004|Treatment Period|Protocol Violation|0|||
162670623|NCT03214367|587502064|FG005|Treatment Period|Protocol Violation|0|||
162670624|NCT03214367|587502065|FG006|Treatment Period|Protocol Violation|0|||
162670625|NCT03214367|587502066|FG007|Treatment Period|Protocol Violation|0|||
162670626|NCT03214367|587502059|FG000|Treatment Period|Withdrawal by Subject|0|||
162670627|NCT03214367|587502060|FG001|Treatment Period|Withdrawal by Subject|20|||
162670628|NCT03214367|587502061|FG002|Treatment Period|Withdrawal by Subject|23|||
162670629|NCT03214367|587502062|FG003|Treatment Period|Withdrawal by Subject|14|||
162670630|NCT03214367|587502063|FG004|Treatment Period|Withdrawal by Subject|0|||
162670631|NCT03214367|587502064|FG005|Treatment Period|Withdrawal by Subject|1|||
162670632|NCT03214367|587502065|FG006|Treatment Period|Withdrawal by Subject|1|||
162670633|NCT03214367|587502066|FG007|Treatment Period|Withdrawal by Subject|1|||
162670634|NCT03268811|587502069|FG000|Overall Study|Adverse Event|0|||
162670635|NCT03268811|587502070|FG001|Overall Study|Adverse Event|1|||
162670636|NCT04726709|587502071|FG000|Overall Study|Withdrawal by Subject|2|||
162670637|NCT04726709|587502072|FG001|Overall Study|Withdrawal by Subject|2|||
162670638|NCT02117570|587502073|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
162670639|NCT02117570|587502074|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
162670640|NCT02117570|587502075|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
162670641|NCT02117570|587502073|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
162670642|NCT02117570|587502074|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
162670643|NCT02117570|587502075|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
162670644|NCT02117570|587502073|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
162670645|NCT02117570|587502074|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
162670646|NCT02117570|587502075|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
162670647|NCT02117570|587502073|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
162670648|NCT02117570|587502074|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
162670649|NCT02117570|587502075|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
162670650|NCT02117570|587502073|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
162670651|NCT02117570|587502074|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
162670652|NCT02117570|587502075|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
162670653|NCT02117570|587502073|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
162670654|NCT02117570|587502074|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
162670655|NCT02117570|587502075|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
162670656|NCT02117570|587502073|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
162670657|NCT02117570|587502074|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
162670658|NCT02117570|587502075|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
162670659|NCT02148250|587502076|FG000|Screening|Withdrawal by Subject|5|||
162670660|NCT02148250|587502077|FG001|Screening|Withdrawal by Subject|0|||
162670661|NCT00563784|587502078|FG000|Overall Study|Withdrawal by Subject|2|||
162670662|NCT00563784|587502078|FG000|Overall Study|Screen Failures|20|||
162670663|NCT04004611|587502079|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670664|NCT04004611|587502080|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670665|NCT04004611|587502081|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670666|NCT04004611|587502082|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670667|NCT04004611|587502083|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670668|NCT04004611|587502084|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670669|NCT04004611|587502085|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670670|NCT04004611|587502086|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162670671|NCT04004611|587502087|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
162670672|NCT04004611|587502079|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162670673|NCT04004611|587502080|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162721950|NCT02547922|587689393|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
163150780|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
163150781|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
163150782|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
163150783|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
163150784|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
163150785|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
163150786|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
163150787|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
163150788|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
163150789|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
163150790|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
163150791|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150792|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150793|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
163150794|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
163150795|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
163150796|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
163150797|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
163150798|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
163150799|NCT02657889|589265369|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150800|NCT02657889|589265370|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150801|NCT02657889|589265371|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
163150802|NCT02657889|589265372|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
163150803|NCT03050801|589265379|FG000|Experiment 1|Lost to Follow-up|0|||
163150804|NCT03050801|589265380|FG001|Experiment 1|Lost to Follow-up|1|||
163150805|NCT03050801|589265381|FG002|Experiment 1|Lost to Follow-up|0|||
163150806|NCT03050801|589265382|FG003|Experiment 1|Lost to Follow-up|0|||
163150807|NCT03050801|589265383|FG004|Experiment 1|Lost to Follow-up|0|||
163150808|NCT03050801|589265384|FG005|Experiment 1|Lost to Follow-up|0|||
163150809|NCT03050801|589265379|FG000|Experiment 1|Physician Decision|0|||
163150810|NCT03050801|589265380|FG001|Experiment 1|Physician Decision|3|||
163150811|NCT03050801|589265381|FG002|Experiment 1|Physician Decision|0|||
163150812|NCT03050801|589265382|FG003|Experiment 1|Physician Decision|0|||
163150813|NCT03050801|589265383|FG004|Experiment 1|Physician Decision|0|||
163150814|NCT03050801|589265384|FG005|Experiment 1|Physician Decision|0|||
163150815|NCT03050801|589265379|FG000|Experiment 1|Change of experimental design|0|||
163150816|NCT03050801|589265380|FG001|Experiment 1|Change of experimental design|3|||
163150817|NCT03050801|589265381|FG002|Experiment 1|Change of experimental design|0|||
163150818|NCT03050801|589265382|FG003|Experiment 1|Change of experimental design|0|||
163150819|NCT03050801|589265383|FG004|Experiment 1|Change of experimental design|0|||
163150820|NCT03050801|589265384|FG005|Experiment 1|Change of experimental design|0|||
163150821|NCT03050801|589265379|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150822|NCT03050801|589265380|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150823|NCT03050801|589265381|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
163150824|NCT03050801|589265382|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150825|NCT03050801|589265383|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150826|NCT03050801|589265384|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
163150827|NCT03050801|589265379|FG000|Experiment 2|Lost to Follow-up|0|||
163150828|NCT03050801|589265380|FG001|Experiment 2|Lost to Follow-up|0|||
163150829|NCT03050801|589265381|FG002|Experiment 2|Lost to Follow-up|0|||
163150830|NCT03050801|589265382|FG003|Experiment 2|Lost to Follow-up|1|||
163150831|NCT03050801|589265383|FG004|Experiment 2|Lost to Follow-up|1|||
163150832|NCT03050801|589265384|FG005|Experiment 2|Lost to Follow-up|0|||
163150833|NCT03050801|589265379|FG000|Experiment 2|Physician Decision|0|||
163150834|NCT03050801|589265380|FG001|Experiment 2|Physician Decision|0|||
163150835|NCT03050801|589265381|FG002|Experiment 2|Physician Decision|0|||
163150836|NCT03050801|589265382|FG003|Experiment 2|Physician Decision|0|||
163150837|NCT03050801|589265383|FG004|Experiment 2|Physician Decision|1|||
163150838|NCT03050801|589265384|FG005|Experiment 2|Physician Decision|0|||
163150839|NCT03050801|589265379|FG000|Experiment 2|Pregnancy|0|||
163150840|NCT03050801|589265380|FG001|Experiment 2|Pregnancy|0|||
163150841|NCT03050801|589265381|FG002|Experiment 2|Pregnancy|0|||
163150842|NCT03050801|589265382|FG003|Experiment 2|Pregnancy|0|||
163150843|NCT03050801|589265383|FG004|Experiment 2|Pregnancy|1|||
163150844|NCT03050801|589265384|FG005|Experiment 2|Pregnancy|0|||
163150845|NCT03050801|589265379|FG000|Experiment 2|Withdrawal by Subject|0|||
163150846|NCT03050801|589265380|FG001|Experiment 2|Withdrawal by Subject|0|||
163150847|NCT03050801|589265381|FG002|Experiment 2|Withdrawal by Subject|0|||
163150848|NCT03050801|589265382|FG003|Experiment 2|Withdrawal by Subject|1|||
163150849|NCT03050801|589265383|FG004|Experiment 2|Withdrawal by Subject|0|||
163150850|NCT03050801|589265384|FG005|Experiment 2|Withdrawal by Subject|0|||
163150851|NCT03050801|589265379|FG000|Experiment 2|Poor data quality|0|||
163150852|NCT03050801|589265380|FG001|Experiment 2|Poor data quality|0|||
163150853|NCT03050801|589265381|FG002|Experiment 2|Poor data quality|0|||
163150854|NCT03050801|589265382|FG003|Experiment 2|Poor data quality|4|||
163150855|NCT03050801|589265383|FG004|Experiment 2|Poor data quality|1|||
163150856|NCT03050801|589265384|FG005|Experiment 2|Poor data quality|0|||
163150857|NCT03050801|589265379|FG000|Experiment 2|Discomfort during stimulation|0|||
163150858|NCT03050801|589265380|FG001|Experiment 2|Discomfort during stimulation|0|||
163150859|NCT03050801|589265381|FG002|Experiment 2|Discomfort during stimulation|0|||
163150860|NCT03050801|589265382|FG003|Experiment 2|Discomfort during stimulation|0|||
163150861|NCT03050801|589265383|FG004|Experiment 2|Discomfort during stimulation|0|||
163150862|NCT03050801|589265384|FG005|Experiment 2|Discomfort during stimulation|2|||
163150863|NCT01576341|589265385|FG000|Overall Study|Withdrawal by Subject|24|||
163150864|NCT01576341|589265385|FG000|Overall Study|Adverse Event|10|||
163150865|NCT01576341|589265385|FG000|Overall Study|Death|21|||
163150866|NCT01576341|589265385|FG000|Overall Study|Physician Decision|2|||
163150867|NCT01576341|589265385|FG000|Overall Study|Lost to Follow-up|2|||
163150868|NCT01576341|589265385|FG000|Overall Study|Kidney transplantation|10|||
163150869|NCT01576341|589265385|FG000|Overall Study|Protocol Violation|12|||
163150870|NCT01576341|589265385|FG000|Overall Study|Other|12|||
163150871|NCT03836625|589265386|FG000|Overall Study|Lost to Follow-up|9|||
163150872|NCT03836625|589265387|FG001|Overall Study|Lost to Follow-up|9|||
163150873|NCT03836625|589265386|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
163150874|NCT03836625|589265387|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
163150875|NCT03836625|589265386|FG000|Overall Study|Death|0|||
163150876|NCT03836625|589265387|FG001|Overall Study|Death|1|||
163150877|NCT03836625|589265386|FG000|Overall Study|Refused follow-up|0|||
163150878|NCT03836625|589265387|FG001|Overall Study|Refused follow-up|1|||
163150879|NCT00791934|589265390|FG000|Overall Study|Withdrawal by Subject|2|||
163150880|NCT00791934|589265390|FG000|Overall Study|Did not consent for extended follow-up|13|||
163150881|NCT03413891|589265392|FG000|Overall Study|Lost to Follow-up|2|||
163150882|NCT03413891|589265393|FG001|Overall Study|Lost to Follow-up|1|||
163150883|NCT03413891|589265392|FG000|Overall Study|Protocol Violation|0|||
163150884|NCT03413891|589265393|FG001|Overall Study|Protocol Violation|1|||
163150885|NCT03077542|589265398|FG000|Overall Study|Death|4|||
163150886|NCT03077542|589265399|FG001|Overall Study|Death|0|||
163150887|NCT03077542|589265398|FG000|Overall Study|Physician Decision|6|||
163150888|NCT03077542|589265399|FG001|Overall Study|Physician Decision|1|||
163150889|NCT03077542|589265398|FG000|Overall Study|Withdrawal by Subject|0|||
163150890|NCT03077542|589265399|FG001|Overall Study|Withdrawal by Subject|1|||
163150891|NCT00301808|589265400|FG000|Overall Study|Adverse Event|5|||
163150892|NCT00301808|589265400|FG000|Overall Study|Death|3|||
163150893|NCT00301808|589265400|FG000|Overall Study|Lack of Efficacy|4|||
163150894|NCT00844844|589265401|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
163150895|NCT00844844|589265401|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
163150896|NCT00844844|589265401|FG000|Extension Treatment Period|Adverse Event|2|||
163150897|NCT00844844|589265401|FG000|Post Treatment Period|Withdrawal by Subject|1|||
163150898|NCT04659044|589265414|FG000|Induction|Physician Decision|1|||
163150899|NCT04659044|589265414|FG000|Induction|Adverse Event|2|||
163150900|NCT04966013|589265416|FG000|Overall Study|Withdrawal by Subject|0|||
163150901|NCT04966013|589265417|FG001|Overall Study|Withdrawal by Subject|2|||
163150902|NCT04966013|589265418|FG002|Overall Study|Withdrawal by Subject|1|||
163150903|NCT04966013|589265416|FG000|Overall Study|Adverse Event|2|||
163150904|NCT04966013|589265417|FG001|Overall Study|Adverse Event|1|||
163150905|NCT04966013|589265418|FG002|Overall Study|Adverse Event|1|||
163150906|NCT04875975|589265422|FG000|Overall Study|Adverse Event|1|||
163150907|NCT04875975|589265423|FG001|Overall Study|Adverse Event|2|||
163150908|NCT04875975|589265422|FG000|Overall Study|Lack of Efficacy|2|||
163150909|NCT04875975|589265423|FG001|Overall Study|Lack of Efficacy|2|||
163150910|NCT04875975|589265422|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
163150911|NCT04875975|589265423|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
163150912|NCT04875975|589265422|FG000|Overall Study|Relapse With Insults|0|||
163150913|NCT04875975|589265423|FG001|Overall Study|Relapse With Insults|1|||
163150914|NCT04875975|589265422|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
163150915|NCT04875975|589265423|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
163150916|NCT01910298|589265424|FG000|Overall Study|Adverse Event|1|||
163150917|NCT01910298|589265425|FG001|Overall Study|Adverse Event|0|||
163150918|NCT01910298|589265424|FG000|Overall Study|Withdrawal by Subject|2|||
163150919|NCT01910298|589265425|FG001|Overall Study|Withdrawal by Subject|7|||
163150920|NCT01910298|589265424|FG000|Overall Study|Protocol Deviation|0|||
163150921|NCT01910298|589265425|FG001|Overall Study|Protocol Deviation|5|||
163150922|NCT01910298|589265424|FG000|Overall Study|Lost to Follow-up|1|||
163150923|NCT01910298|589265425|FG001|Overall Study|Lost to Follow-up|1|||
163150924|NCT01910298|589265424|FG000|Overall Study|Study Terminated by Sponsor|1|||
163150925|NCT01910298|589265425|FG001|Overall Study|Study Terminated by Sponsor|17|||
162670674|NCT04004611|587502081|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162670675|NCT04004611|587502082|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162670676|NCT04004611|587502083|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162670677|NCT04004611|587502084|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
162670678|NCT04004611|587502085|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
162670679|NCT04004611|587502086|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162670680|NCT04004611|587502087|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
162670681|NCT04004611|587502079|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670682|NCT04004611|587502080|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670683|NCT04004611|587502081|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670684|NCT04004611|587502082|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670685|NCT04004611|587502083|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
162670686|NCT04004611|587502084|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670687|NCT04004611|587502085|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670688|NCT04004611|587502086|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670689|NCT04004611|587502087|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162670690|NCT04004611|587502079|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
162670691|NCT04004611|587502080|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
162670692|NCT04004611|587502081|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
162670693|NCT04004611|587502082|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
162670694|NCT04004611|587502083|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
162670695|NCT04004611|587502084|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
162670696|NCT04004611|587502085|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
162670697|NCT04004611|587502086|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
162670698|NCT04004611|587502087|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
162670699|NCT04004611|587502079|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
162670700|NCT04004611|587502080|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670701|NCT04004611|587502081|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
162670702|NCT04004611|587502082|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670703|NCT04004611|587502083|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670704|NCT04004611|587502084|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670705|NCT04004611|587502085|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670706|NCT04004611|587502086|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670707|NCT04004611|587502087|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162670708|NCT04004611|587502079|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670709|NCT04004611|587502080|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
162670710|NCT04004611|587502081|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670711|NCT04004611|587502082|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670712|NCT04004611|587502083|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670713|NCT04004611|587502084|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670714|NCT04004611|587502085|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670715|NCT04004611|587502086|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670716|NCT04004611|587502087|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162670717|NCT00320216|587502088|FG000|Overall Study|Adverse Event|0|||
162670718|NCT00320216|587502089|FG001|Overall Study|Adverse Event|6|||
162670719|NCT00320216|587502090|FG002|Overall Study|Adverse Event|0|||
162670720|NCT00320216|587502091|FG003|Overall Study|Adverse Event|2|||
162670721|NCT00320216|587502092|FG004|Overall Study|Adverse Event|2|||
162670722|NCT00320216|587502088|FG000|Overall Study|Lack of Efficacy|6|||
162670723|NCT00320216|587502089|FG001|Overall Study|Lack of Efficacy|2|||
162670724|NCT00320216|587502090|FG002|Overall Study|Lack of Efficacy|1|||
162670725|NCT00320216|587502091|FG003|Overall Study|Lack of Efficacy|0|||
162670726|NCT00320216|587502092|FG004|Overall Study|Lack of Efficacy|1|||
162670727|NCT00320216|587502088|FG000|Overall Study|Lost to Follow-up|3|||
162670728|NCT00320216|587502089|FG001|Overall Study|Lost to Follow-up|0|||
162670729|NCT00320216|587502090|FG002|Overall Study|Lost to Follow-up|0|||
162670730|NCT00320216|587502091|FG003|Overall Study|Lost to Follow-up|0|||
162670731|NCT00320216|587502092|FG004|Overall Study|Lost to Follow-up|0|||
162670732|NCT00320216|587502088|FG000|Overall Study|Other|7|||
162670733|NCT00320216|587502089|FG001|Overall Study|Other|2|||
162670734|NCT00320216|587502090|FG002|Overall Study|Other|5|||
162670735|NCT00320216|587502091|FG003|Overall Study|Other|1|||
162670736|NCT00320216|587502092|FG004|Overall Study|Other|3|||
162670737|NCT03950739|587502094|FG000|Treatment Phase|Adverse Event|2|||
162670738|NCT03950739|587502094|FG000|Optional Extension Phase|Death|1|||
162670739|NCT03950739|587502094|FG000|Optional Extension Phase|Progressive Disease|5|||
162670740|NCT03950739|587502094|FG000|Optional Extension Phase|Adverse Event|7|||
162670741|NCT03950739|587502094|FG000|Optional Extension Phase|Lost to Follow-up|2|||
162670742|NCT03950739|587502094|FG000|Optional Extension Phase|Site Closure|2|||
162670743|NCT03950739|587502094|FG000|Optional Extension Phase|Pregnancy|1|||
162670744|NCT03625570|587502095|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
162670745|NCT03625570|587502096|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
162670746|NCT03625570|587502095|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
162670747|NCT03625570|587502096|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
162670748|NCT03625570|587502095|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
162670749|NCT03625570|587502096|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
162670750|NCT00345579|587502097|FG000|Overall Study|Adverse Event|9|||
162670751|NCT00345579|587502098|FG001|Overall Study|Adverse Event|6|||
162670752|NCT00345579|587502097|FG000|Overall Study|Protocol Violation|14|||
162670753|NCT00345579|587502098|FG001|Overall Study|Protocol Violation|5|||
162670754|NCT00345579|587502097|FG000|Overall Study|Withdrawal by Subject|50|||
162670755|NCT00345579|587502098|FG001|Overall Study|Withdrawal by Subject|17|||
162670756|NCT00345579|587502097|FG000|Overall Study|Lost to Follow-up|82|||
162670757|NCT00345579|587502098|FG001|Overall Study|Lost to Follow-up|36|||
162670758|NCT00345579|587502097|FG000|Overall Study|Other|9|||
162670759|NCT00345579|587502098|FG001|Overall Study|Other|1|||
162670760|NCT01949480|587502099|FG000|Overall Study|Physician Decision|5|||
162670761|NCT01949480|587502100|FG001|Overall Study|Physician Decision|8|||
162670762|NCT00144339|587502101|FG000|Overall Study|Adverse Event|746|||
162670763|NCT00144339|587502102|FG001|Overall Study|Adverse Event|627|||
162670764|NCT00144339|587502101|FG000|Overall Study|Protocol Violation|75|||
162670765|NCT00144339|587502102|FG001|Overall Study|Protocol Violation|48|||
162670766|NCT00144339|587502101|FG000|Overall Study|Withdrawal by Subject|403|||
162670767|NCT00144339|587502102|FG001|Overall Study|Withdrawal by Subject|300|||
162670768|NCT00144339|587502101|FG000|Overall Study|Lost to Follow-up|76|||
162670769|NCT00144339|587502102|FG001|Overall Study|Lost to Follow-up|64|||
162670770|NCT00144339|587502101|FG000|Overall Study|Other|58|||
162670771|NCT00144339|587502102|FG001|Overall Study|Other|60|||
162670772|NCT00305058|587502103|FG000|Overall Study|Participant too young|1|||
162670773|NCT00305058|587502104|FG001|Overall Study|Participant too young|0|||
162670774|NCT00305058|587502103|FG000|Overall Study|Missing data collection instrument|3|||
162670775|NCT00305058|587502104|FG001|Overall Study|Missing data collection instrument|2|||
162670776|NCT00305058|587502103|FG000|Overall Study|Missing outcome data|3|||
162670777|NCT00305058|587502104|FG001|Overall Study|Missing outcome data|2|||
162670778|NCT04798586|587502106|FG000|Overall Study|Death|2|||
162670779|NCT03538626|587502108|FG000|Overall Study|Withdrawal by Subject|0|||
162670780|NCT03538626|587502109|FG001|Overall Study|Withdrawal by Subject|1|||
162670781|NCT03538626|587502110|FG002|Overall Study|Withdrawal by Subject|0|||
162670782|NCT03538626|587502111|FG003|Overall Study|Withdrawal by Subject|0|||
162670783|NCT03538626|587502112|FG004|Overall Study|Withdrawal by Subject|0|||
162670784|NCT03538626|587502113|FG005|Overall Study|Withdrawal by Subject|0|||
162670785|NCT03538626|587502114|FG006|Overall Study|Withdrawal by Subject|0|||
162670786|NCT03538626|587502115|FG007|Overall Study|Withdrawal by Subject|0|||
162670787|NCT03538626|587502108|FG000|Overall Study|Lost to Follow-up|0|||
162670788|NCT03538626|587502109|FG001|Overall Study|Lost to Follow-up|0|||
162670789|NCT03538626|587502110|FG002|Overall Study|Lost to Follow-up|0|||
162670790|NCT03538626|587502111|FG003|Overall Study|Lost to Follow-up|0|||
162670791|NCT03538626|587502112|FG004|Overall Study|Lost to Follow-up|0|||
162670792|NCT03538626|587502113|FG005|Overall Study|Lost to Follow-up|0|||
162670793|NCT03538626|587502114|FG006|Overall Study|Lost to Follow-up|1|||
162670794|NCT03538626|587502115|FG007|Overall Study|Lost to Follow-up|0|||
162670795|NCT00288587|587502116|FG000|Overall Study|Death|4|||
162670796|NCT00288587|587502117|FG001|Overall Study|Death|4|||
162670797|NCT00288587|587502116|FG000|Overall Study|Transplant|0|||
162670798|NCT00288587|587502117|FG001|Overall Study|Transplant|3|||
162670799|NCT00288587|587502116|FG000|Overall Study|Adverse Event|0|||
162670800|NCT00288587|587502117|FG001|Overall Study|Adverse Event|1|||
162721951|NCT02547922|587689391|FG000|Overall Study|Physician Decision|2|||
162721952|NCT02547922|587689392|FG001|Overall Study|Physician Decision|1|||
162721953|NCT02547922|587689393|FG002|Overall Study|Physician Decision|2|||
162721954|NCT02547922|587689391|FG000|Overall Study|Patients did not receive IP|1|||
162721955|NCT02547922|587689392|FG001|Overall Study|Patients did not receive IP|1|||
162721956|NCT02547922|587689393|FG002|Overall Study|Patients did not receive IP|0|||
163150926|NCT01910298|589265424|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162670801|NCT00288587|587502116|FG000|Overall Study|Physician Decision|0|||
162670802|NCT00288587|587502117|FG001|Overall Study|Physician Decision|2|||
162670803|NCT00288587|587502116|FG000|Overall Study|Severe Aortic Stenosis|1|||
162670804|NCT00288587|587502117|FG001|Overall Study|Severe Aortic Stenosis|0|||
162670805|NCT02232893|587502123|FG000|Overall Study|Withdrawal by Subject|4|||
162670806|NCT02232893|587502124|FG001|Overall Study|Withdrawal by Subject|1|||
162670807|NCT02232893|587502123|FG000|Overall Study|Adverse Event|0|||
162670808|NCT02232893|587502124|FG001|Overall Study|Adverse Event|1|||
162721957|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
163150927|NCT01910298|589265425|FG001|Overall Study|Other Miscellaneous Reasons|2|||
162670809|NCT02232893|587502123|FG000|Overall Study|Sponsor request early termination|0|||
162670810|NCT02232893|587502124|FG001|Overall Study|Sponsor request early termination|1|||
162670811|NCT02232893|587502123|FG000|Overall Study|Developed exclusion criteria|0|||
162670812|NCT02232893|587502124|FG001|Overall Study|Developed exclusion criteria|1|||
162670813|NCT02232893|587502123|FG000|Overall Study|Other|0|||
162670814|NCT02232893|587502124|FG001|Overall Study|Other|3|||
162670815|NCT01764945|587502125|FG000|Overall Study|Adverse Event|0|||
162670816|NCT01764945|587502126|FG001|Overall Study|Adverse Event|1|||
162670817|NCT01764945|587502127|FG002|Overall Study|Adverse Event|0|||
162670818|NCT01764945|587502128|FG003|Overall Study|Adverse Event|0|||
162670819|NCT01764945|587502129|FG004|Overall Study|Adverse Event|0|||
162670820|NCT01764945|587502130|FG005|Overall Study|Adverse Event|0|||
162670821|NCT01764945|587502131|FG006|Overall Study|Adverse Event|1|||
162670822|NCT01764945|587502132|FG007|Overall Study|Adverse Event|0|||
162670823|NCT05077267|587502135|FG000|Treatment Period|Lost to Follow-up|0|||
162670824|NCT05077267|587502136|FG001|Treatment Period|Lost to Follow-up|1|||
162670825|NCT05077267|587502137|FG002|Treatment Period|Lost to Follow-up|0|||
162670826|NCT05077267|587502135|FG000|Treatment Period|Withdrawal by Subject|0|||
162670827|NCT05077267|587502136|FG001|Treatment Period|Withdrawal by Subject|1|||
162670828|NCT05077267|587502137|FG002|Treatment Period|Withdrawal by Subject|0|||
162670829|NCT05077267|587502135|FG000|Follow-up Period|Lost to Follow-up|0|||
162670830|NCT05077267|587502136|FG001|Follow-up Period|Lost to Follow-up|5|||
162670831|NCT05077267|587502137|FG002|Follow-up Period|Lost to Follow-up|7|||
162670832|NCT05077267|587502135|FG000|Follow-up Period|Withdrawal by Subject|0|||
162670833|NCT05077267|587502136|FG001|Follow-up Period|Withdrawal by Subject|2|||
162670834|NCT05077267|587502137|FG002|Follow-up Period|Withdrawal by Subject|5|||
162670835|NCT05077267|587502135|FG000|Follow-up Period|Study terminated by sponsor|0|||
162670836|NCT05077267|587502136|FG001|Follow-up Period|Study terminated by sponsor|27|||
162670837|NCT05077267|587502137|FG002|Follow-up Period|Study terminated by sponsor|23|||
162670838|NCT05077267|587502135|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
162670839|NCT05077267|587502136|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
162670840|NCT05077267|587502137|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
162670841|NCT05077267|587502135|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
162670842|NCT05077267|587502136|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
162670843|NCT05077267|587502137|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
162670844|NCT02911948|587502138|FG000|Overall Study|Protocol Violation|0|||
162670845|NCT02911948|587502139|FG001|Overall Study|Protocol Violation|1|||
162670846|NCT02911948|587502138|FG000|Overall Study|Withdrawal by Subject|0|||
162670847|NCT02911948|587502139|FG001|Overall Study|Withdrawal by Subject|2|||
162670848|NCT02911948|587502138|FG000|Overall Study|Lack of Efficacy|0|||
162670849|NCT02911948|587502139|FG001|Overall Study|Lack of Efficacy|1|||
162670850|NCT02911948|587502138|FG000|Overall Study|Unclassified|0|||
162670851|NCT02911948|587502139|FG001|Overall Study|Unclassified|3|||
162670852|NCT00586105|587502146|FG000|Overall Study|Adverse Event|4|||
162670853|NCT00586105|587502146|FG000|Overall Study|Death|2|||
162670854|NCT00586105|587502146|FG000|Overall Study|Protocol Violation|1|||
162670855|NCT00586105|587502146|FG000|Overall Study|Withdrawal by Subject|3|||
162670856|NCT00586105|587502146|FG000|Overall Study|Disease progression|19|||
162670857|NCT00586105|587502146|FG000|Overall Study|Switched to commercial drug|9|||
162670858|NCT00586105|587502146|FG000|Overall Study|Reason not reported|1|||
162670859|NCT01136291|587502150|FG000|Overall Study|Lost to Follow-up|1|||
162670860|NCT01136291|587502151|FG001|Overall Study|Lost to Follow-up|1|||
162670861|NCT03965052|587502152|FG000|Overall Study|Protocol Violation|1|||
162670862|NCT03965052|587502153|FG001|Overall Study|Protocol Violation|0|||
162670863|NCT03165045|587502163|FG000|Visit 1|No registration after visit 1|9|||
162670864|NCT03165045|587502163|FG000|Visit 1|No treatment documented|10|||
162670865|NCT03165045|587502163|FG000|Visit 1|No visit 1|10|||
162670866|NCT03165045|587502163|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
162670867|NCT03165045|587502163|FG000|Visit 2|No available total CCQ score at all|29|||
162670868|NCT03165045|587502163|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
162670869|NCT02308033|587502164|FG000|Overall Study|Normal Gram stain at Baseline|13|||
162670870|NCT02308033|587502165|FG001|Overall Study|Normal Gram stain at Baseline|10|||
162670871|NCT02308033|587502164|FG000|Overall Study|Positive for STD at Baseline|7|||
162670872|NCT02308033|587502165|FG001|Overall Study|Positive for STD at Baseline|4|||
162670873|NCT02308033|587502164|FG000|Overall Study|Lost to Follow-up|6|||
162670874|NCT02308033|587502165|FG001|Overall Study|Lost to Follow-up|5|||
162670875|NCT04964089|587502168|FG000|Overall Study|Adverse Event|8|||
162670876|NCT04964089|587502169|FG001|Overall Study|Adverse Event|6|||
162670877|NCT04964089|587502168|FG000|Overall Study|Non-compliance with study schedule|1|||
162670878|NCT04964089|587502169|FG001|Overall Study|Non-compliance with study schedule|0|||
162670879|NCT04964089|587502168|FG000|Overall Study|Withdrawal by Subject|6|||
162670880|NCT04964089|587502169|FG001|Overall Study|Withdrawal by Subject|5|||
162670881|NCT04964089|587502168|FG000|Overall Study|Lost to Follow-up|1|||
162670882|NCT04964089|587502169|FG001|Overall Study|Lost to Follow-up|1|||
162670883|NCT04964089|587502168|FG000|Overall Study|Progressive disease|4|||
162670884|NCT04964089|587502169|FG001|Overall Study|Progressive disease|0|||
162670885|NCT04964089|587502168|FG000|Overall Study|Physician Decision|1|||
162670886|NCT04964089|587502169|FG001|Overall Study|Physician Decision|0|||
162670887|NCT04964089|587502168|FG000|Overall Study|Participant did not want to continue study treatment|1|||
162670888|NCT04964089|587502169|FG001|Overall Study|Participant did not want to continue study treatment|0|||
162670889|NCT04964089|587502168|FG000|Overall Study|Participant moved to different state|1|||
162670890|NCT04964089|587502169|FG001|Overall Study|Participant moved to different state|0|||
162670891|NCT04964089|587502168|FG000|Overall Study|Participant decided to discontinue|0|||
162670892|NCT04964089|587502169|FG001|Overall Study|Participant decided to discontinue|1|||
162670893|NCT04447404|587503932|FG000|Overall Study|Death|2|||
162670894|NCT04447404|587503933|FG001|Overall Study|Death|0|||
162670895|NCT00574080|587503934|FG000|Overall Study|Death|10|||
162670896|NCT00574080|587503935|FG001|Overall Study|Death|10|||
162670897|NCT01221597|587503936|FG000|Overall Study|Adverse Event|4|||
162670898|NCT01221597|587503937|FG001|Overall Study|Adverse Event|1|||
162670899|NCT01221597|587503936|FG000|Overall Study|Withdrawal by Subject|20|||
162670900|NCT01221597|587503937|FG001|Overall Study|Withdrawal by Subject|6|||
162670901|NCT01221597|587503936|FG000|Overall Study|Lost to Follow-up|6|||
162670902|NCT01221597|587503937|FG001|Overall Study|Lost to Follow-up|5|||
162670903|NCT01221597|587503936|FG000|Overall Study|Protocol Violation|1|||
162670904|NCT01221597|587503937|FG001|Overall Study|Protocol Violation|0|||
162670905|NCT01221597|587503936|FG000|Overall Study|Other|3|||
162670906|NCT01221597|587503937|FG001|Overall Study|Other|4|||
162670907|NCT01221597|587503936|FG000|Overall Study|Death|2|||
162670908|NCT01221597|587503937|FG001|Overall Study|Death|0|||
162670909|NCT00148343|587503941|FG000|Overall Study|Withdrawal by Subject|12|||
162670910|NCT00148343|587503942|FG001|Overall Study|Withdrawal by Subject|7|||
162670911|NCT00148343|587503941|FG000|Overall Study|Physician Decision|3|||
162670912|NCT00148343|587503942|FG001|Overall Study|Physician Decision|4|||
162670913|NCT02384759|587503953|FG000|Overall Study|Patients not treated|3|||
162670914|NCT02384759|587503954|FG001|Overall Study|Patients not treated|2|||
162670915|NCT01605617|587503955|FG000|First Intervention|Adverse Event|0|||
162670916|NCT01605617|587503956|FG001|First Intervention|Adverse Event|1|||
162670917|NCT01605617|587503955|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
162670918|NCT01605617|587503956|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
162670919|NCT00121238|587503957|FG000|Overall Study|disease progression before intervention|1|||
162670920|NCT00121238|587503957|FG000|Overall Study|Protocol Violation|2|||
162670921|NCT01380327|587503958|FG000|Overall Study|Lost to Follow-up|0|||
162670922|NCT01380327|587503959|FG001|Overall Study|Lost to Follow-up|1|||
162670923|NCT01380327|587503960|FG002|Overall Study|Lost to Follow-up|1|||
162670924|NCT01380327|587503958|FG000|Overall Study|Protocol Violation|3|||
162670925|NCT01380327|587503959|FG001|Overall Study|Protocol Violation|2|||
162670926|NCT01380327|587503960|FG002|Overall Study|Protocol Violation|3|||
162670927|NCT01380327|587503958|FG000|Overall Study|Withdrawal by Subject|0|||
162670928|NCT01380327|587503959|FG001|Overall Study|Withdrawal by Subject|0|||
162670929|NCT01380327|587503960|FG002|Overall Study|Withdrawal by Subject|1|||
162670930|NCT01380327|587503958|FG000|Overall Study|Housing situation precluded ability to k|0|||
162670931|NCT01380327|587503959|FG001|Overall Study|Housing situation precluded ability to k|0|||
162670932|NCT01380327|587503960|FG002|Overall Study|Housing situation precluded ability to k|1|||
162670933|NCT01380327|587503958|FG000|Overall Study|Questionable onset of epilepsy|0|||
162670934|NCT01380327|587503959|FG001|Overall Study|Questionable onset of epilepsy|0|||
162670935|NCT01380327|587503960|FG002|Overall Study|Questionable onset of epilepsy|1|||
162670936|NCT03043664|587503961|FG000|Overall Study|Lost to Follow-up|1|||
162670937|NCT01540851|587503962|FG000|Overall Study|Lost to Follow-up|14|||
162670938|NCT01540851|587503963|FG001|Overall Study|Lost to Follow-up|15|||
162670939|NCT01540851|587503962|FG000|Overall Study|Withdrawal by Subject|7|||
162670940|NCT01540851|587503963|FG001|Overall Study|Withdrawal by Subject|3|||
162670941|NCT00325468|587503964|FG000|Overall Study|Adverse Event|1|||
162670942|NCT00325468|587503965|FG001|Overall Study|Adverse Event|1|||
162670943|NCT00325468|587503966|FG002|Overall Study|Adverse Event|0|||
162670944|NCT00325468|587503967|FG003|Overall Study|Adverse Event|5|||
162670945|NCT00325468|587503968|FG004|Overall Study|Adverse Event|1|||
162670946|NCT00325468|587503964|FG000|Overall Study|Death|2|||
162670947|NCT00325468|587503965|FG001|Overall Study|Death|0|||
162670948|NCT00325468|587503966|FG002|Overall Study|Death|2|||
162670949|NCT00325468|587503967|FG003|Overall Study|Death|4|||
162670950|NCT00325468|587503968|FG004|Overall Study|Death|0|||
162670951|NCT00325468|587503964|FG000|Overall Study|Lost to Follow-up|0|||
162670952|NCT00325468|587503965|FG001|Overall Study|Lost to Follow-up|0|||
162670953|NCT00325468|587503966|FG002|Overall Study|Lost to Follow-up|1|||
162670954|NCT00325468|587503967|FG003|Overall Study|Lost to Follow-up|2|||
162670955|NCT00325468|587503968|FG004|Overall Study|Lost to Follow-up|2|||
162670956|NCT00325468|587503964|FG000|Overall Study|Physician Decision|1|||
162670957|NCT00325468|587503965|FG001|Overall Study|Physician Decision|1|||
162670958|NCT00325468|587503966|FG002|Overall Study|Physician Decision|0|||
162670959|NCT00325468|587503967|FG003|Overall Study|Physician Decision|1|||
162670960|NCT00325468|587503968|FG004|Overall Study|Physician Decision|0|||
162670961|NCT00325468|587503964|FG000|Overall Study|Withdrawal by Subject|3|||
162670962|NCT00325468|587503965|FG001|Overall Study|Withdrawal by Subject|1|||
162670963|NCT00325468|587503966|FG002|Overall Study|Withdrawal by Subject|0|||
162670964|NCT00325468|587503967|FG003|Overall Study|Withdrawal by Subject|14|||
162670965|NCT00325468|587503968|FG004|Overall Study|Withdrawal by Subject|4|||
162670966|NCT00325468|587503964|FG000|Overall Study|site closure etc|4|||
162670967|NCT00325468|587503965|FG001|Overall Study|site closure etc|2|||
162670968|NCT00325468|587503966|FG002|Overall Study|site closure etc|1|||
162670969|NCT00325468|587503967|FG003|Overall Study|site closure etc|8|||
162670970|NCT00325468|587503968|FG004|Overall Study|site closure etc|1|||
162670971|NCT03732209|587503969|FG000|Overall Study|Lost to Follow-up|4|||
162670972|NCT03732209|587503970|FG001|Overall Study|Lost to Follow-up|4|||
162670973|NCT03732209|587503969|FG000|Overall Study|Withdrawal by Subject|8|||
162670974|NCT03732209|587503970|FG001|Overall Study|Withdrawal by Subject|9|||
162670975|NCT05046795|587503971|FG000|Overall Study|Adverse Event|13|||
162670976|NCT05046795|587503972|FG001|Overall Study|Adverse Event|15|||
162670977|NCT05046795|587503971|FG000|Overall Study|Withdrawal by Subject|4|||
162670978|NCT05046795|587503972|FG001|Overall Study|Withdrawal by Subject|7|||
162670979|NCT05046795|587503971|FG000|Overall Study|Physician Decision|1|||
162670980|NCT05046795|587503972|FG001|Overall Study|Physician Decision|2|||
162670981|NCT05046795|587503971|FG000|Overall Study|Protocol Violation|1|||
162670982|NCT05046795|587503972|FG001|Overall Study|Protocol Violation|2|||
162670983|NCT05046795|587503971|FG000|Overall Study|Death|1|||
162670984|NCT05046795|587503972|FG001|Overall Study|Death|0|||
162670985|NCT05046795|587503971|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
162670986|NCT05046795|587503972|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
162670987|NCT01127178|587503973|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
162670988|NCT01127178|587503974|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
162670989|NCT01127178|587503973|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
162670990|NCT01127178|587503974|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
162670991|NCT01127178|587503973|FG000|Dose Escalation: Treatment Phase|Other|2|||
162670992|NCT01127178|587503974|FG001|Dose Escalation: Treatment Phase|Other|0|||
162670993|NCT01127178|587503973|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
162670994|NCT01127178|587503974|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
162670995|NCT01127178|587503973|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
162670996|NCT01127178|587503974|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
162670997|NCT01127178|587503973|FG000|Dose Escalation: Extension Phase|Other|1|||
162670998|NCT01127178|587503974|FG001|Dose Escalation: Extension Phase|Other|0|||
162670999|NCT04139317|587503975|FG000|Overall Study|Adverse Event|10|||
162671000|NCT04139317|587503976|FG001|Overall Study|Adverse Event|2|||
162671001|NCT04139317|587503975|FG000|Overall Study|Death|6|||
162671002|NCT04139317|587503976|FG001|Overall Study|Death|4|||
162671003|NCT04139317|587503975|FG000|Overall Study|Lost to Follow-up|1|||
162671004|NCT04139317|587503976|FG001|Overall Study|Lost to Follow-up|0|||
162671005|NCT04139317|587503975|FG000|Overall Study|Physician Decision|3|||
162671006|NCT04139317|587503976|FG001|Overall Study|Physician Decision|1|||
162671007|NCT04139317|587503975|FG000|Overall Study|Progressive Disease|19|||
162671008|NCT04139317|587503976|FG001|Overall Study|Progressive Disease|9|||
162671009|NCT04139317|587503975|FG000|Overall Study|Subject Decision|2|||
162671010|NCT04139317|587503976|FG001|Overall Study|Subject Decision|2|||
162671011|NCT00782340|587503979|FG000|Open Label Titration|Adverse Event|12|||
162671012|NCT00782340|587503980|FG001|Open Label Titration|Adverse Event|0|||
162671013|NCT00782340|587503981|FG002|Open Label Titration|Adverse Event|0|||
162671014|NCT00782340|587503979|FG000|Open Label Titration|Treatment failure|50|||
162671015|NCT00782340|587503980|FG001|Open Label Titration|Treatment failure|0|||
162671016|NCT00782340|587503981|FG002|Open Label Titration|Treatment failure|0|||
162671017|NCT00782340|587503979|FG000|Open Label Titration|Protocol Violation|5|||
162671018|NCT00782340|587503980|FG001|Open Label Titration|Protocol Violation|0|||
162671019|NCT00782340|587503981|FG002|Open Label Titration|Protocol Violation|0|||
162671020|NCT00782340|587503979|FG000|Open Label Titration|Withdrawal by Subject|5|||
162671021|NCT00782340|587503980|FG001|Open Label Titration|Withdrawal by Subject|0|||
162671022|NCT00782340|587503981|FG002|Open Label Titration|Withdrawal by Subject|0|||
162671023|NCT00782340|587503979|FG000|Open Label Titration|Enrollment capped|16|||
162671024|NCT00782340|587503980|FG001|Open Label Titration|Enrollment capped|0|||
162671025|NCT00782340|587503981|FG002|Open Label Titration|Enrollment capped|0|||
162671026|NCT00782340|587503979|FG000|Open Label Titration|Did not meet responder criteria|2|||
162671027|NCT00782340|587503980|FG001|Open Label Titration|Did not meet responder criteria|0|||
162671028|NCT00782340|587503981|FG002|Open Label Titration|Did not meet responder criteria|0|||
162671029|NCT00782340|587503979|FG000|Open Label Titration|Lost to Follow-up|5|||
162671030|NCT00782340|587503980|FG001|Open Label Titration|Lost to Follow-up|0|||
162671031|NCT00782340|587503981|FG002|Open Label Titration|Lost to Follow-up|0|||
162671032|NCT00782340|587503979|FG000|Open Label Titration|Randomized in error|6|||
162671033|NCT00782340|587503980|FG001|Open Label Titration|Randomized in error|0|||
162671034|NCT00782340|587503981|FG002|Open Label Titration|Randomized in error|0|||
162671035|NCT02365467|587503982|FG000|Overall Study|Death|3|||
162671036|NCT01306162|587503983|FG000|Period 1|Adverse Event|0|||
162671037|NCT01306162|587503984|FG001|Period 1|Adverse Event|0|||
162671038|NCT01306162|587503985|FG002|Period 1|Adverse Event|0|||
162671039|NCT01306162|587503986|FG003|Period 1|Adverse Event|1|||
162671040|NCT01306162|587503983|FG000|Washout 1|Non-compliance to protocol|0|||
162671041|NCT01306162|587503984|FG001|Washout 1|Non-compliance to protocol|1|||
162671042|NCT01306162|587503985|FG002|Washout 1|Non-compliance to protocol|0|||
162671043|NCT01306162|587503986|FG003|Washout 1|Non-compliance to protocol|0|||
162671044|NCT01109992|587503987|FG000|Overall Study|Withdrawal by Subject|0|||
162671045|NCT01109992|587503988|FG001|Overall Study|Withdrawal by Subject|1|||
162671046|NCT01109992|587503987|FG000|Overall Study|Movement during rest scan.|0|||
162671047|NCT01109992|587503988|FG001|Overall Study|Movement during rest scan.|1|||
162671048|NCT00690755|587503989|FG000|Overall Study|Physician Decision|2|||
162671049|NCT00690755|587503990|FG001|Overall Study|Physician Decision|0|||
162671050|NCT00690755|587503991|FG002|Overall Study|Physician Decision|46|||
162671051|NCT00690755|587503992|FG003|Overall Study|Physician Decision|5|||
162671052|NCT00690755|587503993|FG004|Overall Study|Physician Decision|0|||
162671053|NCT00690755|587503994|FG005|Overall Study|Physician Decision|4|||
162671054|NCT00690755|587503995|FG006|Overall Study|Physician Decision|0|||
162671055|NCT04287920|587503999|FG000|Overall Study|Lost to Follow-up|1|||
162671056|NCT04287920|587504000|FG001|Overall Study|Lost to Follow-up|1|||
162671057|NCT04287920|587503999|FG000|Overall Study|Withdrawal by Subject|0|||
162671058|NCT04287920|587504000|FG001|Overall Study|Withdrawal by Subject|3|||
162671059|NCT02952924|587504005|FG000|Overall Study|Protocol Violation|0|||
162671060|NCT02952924|587504006|FG001|Overall Study|Protocol Violation|0|||
162671061|NCT02952924|587504007|FG002|Overall Study|Protocol Violation|0|||
162671062|NCT02952924|587504008|FG003|Overall Study|Protocol Violation|0|||
162671063|NCT02952924|587504009|FG004|Overall Study|Protocol Violation|0|||
162671064|NCT02952924|587504010|FG005|Overall Study|Protocol Violation|0|||
162671065|NCT02952924|587504011|FG006|Overall Study|Protocol Violation|0|||
162671066|NCT02952924|587504012|FG007|Overall Study|Protocol Violation|0|||
162671067|NCT02952924|587504013|FG008|Overall Study|Protocol Violation|0|||
162671068|NCT02952924|587504014|FG009|Overall Study|Protocol Violation|0|||
162671069|NCT02952924|587504015|FG010|Overall Study|Protocol Violation|0|||
162671070|NCT02952924|587504016|FG011|Overall Study|Protocol Violation|0|||
163150928|NCT00781768|589266966|FG000|Overall Study|Not transplanted.|0|||
162671071|NCT02952924|587504017|FG012|Overall Study|Protocol Violation|0|||
162671072|NCT02952924|587504018|FG013|Overall Study|Protocol Violation|0|||
162671073|NCT02952924|587504019|FG014|Overall Study|Protocol Violation|0|||
162671074|NCT02952924|587504020|FG015|Overall Study|Protocol Violation|0|||
162671075|NCT02952924|587504021|FG016|Overall Study|Protocol Violation|0|||
162671076|NCT02952924|587504022|FG017|Overall Study|Protocol Violation|0|||
162671077|NCT02952924|587504023|FG018|Overall Study|Protocol Violation|0|||
162671078|NCT02952924|587504024|FG019|Overall Study|Protocol Violation|1|||
162671079|NCT02952924|587504025|FG020|Overall Study|Protocol Violation|0|||
162671080|NCT02952924|587504026|FG021|Overall Study|Protocol Violation|0|||
162671081|NCT02952924|587504005|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
163150929|NCT00781768|589266967|FG001|Overall Study|Not transplanted.|2|||
163150930|NCT00079417|589266974|FG000|Overall Study|Physician Decision|2|||
163150931|NCT00079417|589266974|FG000|Overall Study|Ineligible|7|||
163150932|NCT02458313|589266975|FG000|Overall Study|Withdrawal by Subject|6|||
163150933|NCT02458313|589266976|FG001|Overall Study|Withdrawal by Subject|8|||
163150934|NCT02458313|589266975|FG000|Overall Study|Excluded for motion during MRI|1|||
163150935|NCT02458313|589266976|FG001|Overall Study|Excluded for motion during MRI|2|||
163150936|NCT01615939|589266977|FG000|Overall Study|Lost to Follow-up|5|||
163150937|NCT01615939|589266978|FG001|Overall Study|Lost to Follow-up|0|||
163150938|NCT03453164|589266985|FG000|Overall Study|Lack of Efficacy|16|||
163150939|NCT03453164|589266985|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
163150940|NCT01428258|589266986|FG000|Intervention 1|Withdrawal by Subject|2|||
163150941|NCT01428258|589266987|FG001|Intervention 1|Withdrawal by Subject|0|||
163150942|NCT01074502|589266990|FG000|Overall Study|Withdrawal by Subject|1|||
163150943|NCT03459079|589266991|FG000|Overall Study|Adverse Event|4|||
163150944|NCT03459079|589266992|FG001|Overall Study|Adverse Event|2|||
163150945|NCT03459079|589266993|FG002|Overall Study|Adverse Event|0|||
163150946|NCT03459079|589266991|FG000|Overall Study|Withdrawal by Subject|2|||
163150947|NCT03459079|589266992|FG001|Overall Study|Withdrawal by Subject|2|||
163150948|NCT03459079|589266993|FG002|Overall Study|Withdrawal by Subject|0|||
163150949|NCT00674817|589267001|FG000|Period 1|Withdrawal by Subject|2|||
163150950|NCT00674817|589267001|FG000|Period 1|Protocol Violation|1|||
163150951|NCT00674817|589267001|FG000|Period 3|Adverse Event|1|||
163150952|NCT00674817|589267001|FG000|Period 3|Protocol Violation|1|||
162671082|NCT02952924|587504006|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
162671083|NCT02952924|587504007|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
162671084|NCT02952924|587504008|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
162671085|NCT02952924|587504009|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
162671086|NCT02952924|587504010|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
162671087|NCT02952924|587504011|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
162671088|NCT02952924|587504012|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
162671089|NCT02952924|587504013|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
162671090|NCT02952924|587504014|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
162671091|NCT02952924|587504015|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
162671092|NCT02952924|587504016|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
162671093|NCT02952924|587504017|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
162671094|NCT02952924|587504018|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
162671095|NCT02952924|587504019|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
162671096|NCT02952924|587504020|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
162671097|NCT02952924|587504021|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
162671098|NCT02952924|587504022|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
162671099|NCT02952924|587504023|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
162671100|NCT02952924|587504024|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
162671101|NCT02952924|587504025|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
162671102|NCT02952924|587504026|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
162671103|NCT02952924|587504005|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671104|NCT02952924|587504006|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671105|NCT02952924|587504007|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671106|NCT02952924|587504008|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671107|NCT02952924|587504009|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671108|NCT02952924|587504010|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671109|NCT02952924|587504011|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671110|NCT02952924|587504012|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671111|NCT02952924|587504013|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671112|NCT02952924|587504014|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671113|NCT02952924|587504015|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671114|NCT02952924|587504016|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671115|NCT02952924|587504017|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671116|NCT02952924|587504018|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671117|NCT02952924|587504019|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671118|NCT02952924|587504020|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671119|NCT02952924|587504021|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671120|NCT02952924|587504022|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671121|NCT02952924|587504023|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671122|NCT02952924|587504024|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671123|NCT02952924|587504025|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
162671124|NCT02952924|587504026|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
162671125|NCT02952924|587504005|FG000|Overall Study|Noncompliance with study drug|0|||
162671126|NCT02952924|587504006|FG001|Overall Study|Noncompliance with study drug|0|||
162671127|NCT02952924|587504007|FG002|Overall Study|Noncompliance with study drug|0|||
162671128|NCT02952924|587504008|FG003|Overall Study|Noncompliance with study drug|0|||
162671129|NCT02952924|587504009|FG004|Overall Study|Noncompliance with study drug|0|||
162671130|NCT02952924|587504010|FG005|Overall Study|Noncompliance with study drug|0|||
162671131|NCT02952924|587504011|FG006|Overall Study|Noncompliance with study drug|0|||
162671132|NCT02952924|587504012|FG007|Overall Study|Noncompliance with study drug|0|||
162671133|NCT02952924|587504013|FG008|Overall Study|Noncompliance with study drug|0|||
162671134|NCT02952924|587504014|FG009|Overall Study|Noncompliance with study drug|0|||
162671135|NCT02952924|587504015|FG010|Overall Study|Noncompliance with study drug|0|||
162671136|NCT02952924|587504016|FG011|Overall Study|Noncompliance with study drug|0|||
162671137|NCT02952924|587504017|FG012|Overall Study|Noncompliance with study drug|0|||
162671138|NCT02952924|587504018|FG013|Overall Study|Noncompliance with study drug|0|||
162671139|NCT02952924|587504019|FG014|Overall Study|Noncompliance with study drug|0|||
162671140|NCT02952924|587504020|FG015|Overall Study|Noncompliance with study drug|0|||
162671141|NCT02952924|587504021|FG016|Overall Study|Noncompliance with study drug|0|||
162671142|NCT02952924|587504022|FG017|Overall Study|Noncompliance with study drug|0|||
162671143|NCT02952924|587504023|FG018|Overall Study|Noncompliance with study drug|0|||
162671144|NCT02952924|587504024|FG019|Overall Study|Noncompliance with study drug|0|||
162671145|NCT02952924|587504025|FG020|Overall Study|Noncompliance with study drug|0|||
162671146|NCT02952924|587504026|FG021|Overall Study|Noncompliance with study drug|1|||
162671147|NCT01435577|587504027|FG000|Overall Study|Adverse Event|10|||
162671148|NCT01435577|587504028|FG001|Overall Study|Adverse Event|0|||
162671149|NCT01435577|587504027|FG000|Overall Study|Lack of Efficacy|7|||
162671150|NCT01435577|587504028|FG001|Overall Study|Lack of Efficacy|51|||
162671151|NCT01435577|587504027|FG000|Overall Study|Alternative treatment started|0|||
162671152|NCT01435577|587504028|FG001|Overall Study|Alternative treatment started|1|||
162671153|NCT01934218|587504030|FG000|Double-blind Phase|Adverse Event|8|||
162671154|NCT01934218|587504031|FG001|Double-blind Phase|Adverse Event|8|||
162671155|NCT01934218|587504030|FG000|Double-blind Phase|Lack of Efficacy|6|||
162671156|NCT01934218|587504031|FG001|Double-blind Phase|Lack of Efficacy|7|||
162671157|NCT01934218|587504030|FG000|Double-blind Phase|Lost to Follow-up|7|||
162671158|NCT01934218|587504031|FG001|Double-blind Phase|Lost to Follow-up|14|||
162671159|NCT01934218|587504030|FG000|Double-blind Phase|Physician Decision|1|||
162671160|NCT01934218|587504031|FG001|Double-blind Phase|Physician Decision|2|||
162671161|NCT01934218|587504030|FG000|Double-blind Phase|Protocol Violation|4|||
162671162|NCT01934218|587504031|FG001|Double-blind Phase|Protocol Violation|0|||
162671163|NCT01934218|587504030|FG000|Double-blind Phase|Withdrawal by Subject|16|||
162671164|NCT01934218|587504031|FG001|Double-blind Phase|Withdrawal by Subject|13|||
162671165|NCT01934218|587504030|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
162671166|NCT01934218|587504031|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
162671167|NCT01934218|587504030|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
162671168|NCT01934218|587504031|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
162671169|NCT01934218|587504030|FG000|Open-Label Phase|Adverse Event|2|||
162671170|NCT01934218|587504031|FG001|Open-Label Phase|Adverse Event|4|||
162671171|NCT01934218|587504030|FG000|Open-Label Phase|Lack of Efficacy|1|||
162671172|NCT01934218|587504031|FG001|Open-Label Phase|Lack of Efficacy|4|||
162671173|NCT01934218|587504030|FG000|Open-Label Phase|Lost to Follow-up|4|||
162671174|NCT01934218|587504031|FG001|Open-Label Phase|Lost to Follow-up|2|||
162671175|NCT01934218|587504030|FG000|Open-Label Phase|Physician Decision|1|||
162671176|NCT01934218|587504031|FG001|Open-Label Phase|Physician Decision|0|||
162671177|NCT01934218|587504030|FG000|Open-Label Phase|Protocol Violation|1|||
162671178|NCT01934218|587504031|FG001|Open-Label Phase|Protocol Violation|0|||
162671179|NCT01934218|587504030|FG000|Open-Label Phase|Withdrawal by Subject|13|||
162671180|NCT01934218|587504031|FG001|Open-Label Phase|Withdrawal by Subject|11|||
162671181|NCT01934218|587504030|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
162671182|NCT01934218|587504031|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
162671183|NCT01934218|587504030|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
162671184|NCT01934218|587504031|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
162671185|NCT03273946|587504035|FG000|Overall Study|Withdrawal by Subject|5|||
162671186|NCT03273946|587504035|FG000|Overall Study|Unwillingness of the guardian|1|||
162671187|NCT03273946|587504035|FG000|Overall Study|Participant refused to use the drug|2|||
162671188|NCT03273946|587504035|FG000|Overall Study|Participant relative refused to use drug|1|||
162671189|NCT01220557|587504036|FG000|Overall Study|Lost to Follow-up|5|||
162671190|NCT01220557|587504037|FG001|Overall Study|Lost to Follow-up|3|||
162671191|NCT01220557|587504036|FG000|Overall Study|attended less than 6 lessons|1|||
162671192|NCT01220557|587504037|FG001|Overall Study|attended less than 6 lessons|2|||
162671193|NCT04323436|587504040|FG000|Overall Study|Adverse Event|7|||
162671194|NCT04323436|587504041|FG001|Overall Study|Adverse Event|0|||
162671195|NCT04323436|587504042|FG002|Overall Study|Adverse Event|0|||
162671196|NCT04323436|587504040|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
162671197|NCT04323436|587504041|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
162671198|NCT04323436|587504042|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
162671199|NCT04323436|587504040|FG000|Overall Study|Death|1|||
162671200|NCT04323436|587504041|FG001|Overall Study|Death|0|||
162671201|NCT04323436|587504042|FG002|Overall Study|Death|0|||
162671202|NCT04323436|587504040|FG000|Overall Study|Physician Decision|2|||
162671203|NCT04323436|587504041|FG001|Overall Study|Physician Decision|0|||
162721958|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163150953|NCT00674817|589267001|FG000|Period 4|Adverse Event|1|||
162671204|NCT04323436|587504042|FG002|Overall Study|Physician Decision|0|||
162671205|NCT04323436|587504040|FG000|Overall Study|Progressive disease|10|||
162671206|NCT04323436|587504041|FG001|Overall Study|Progressive disease|0|||
162671207|NCT04323436|587504042|FG002|Overall Study|Progressive disease|0|||
162671208|NCT04323436|587504040|FG000|Overall Study|Subject decision|3|||
162671209|NCT04323436|587504041|FG001|Overall Study|Subject decision|0|||
162671210|NCT04323436|587504042|FG002|Overall Study|Subject decision|0|||
162671211|NCT01682837|587504045|FG000|Baseline|Withdrawal by Subject|5|||
162671212|NCT01664078|587504046|FG000|Overall Study|Death|9|||
162671213|NCT01664078|587504046|FG000|Overall Study|Withdrawal by Subject|4|||
162671214|NCT01664078|587504046|FG000|Overall Study|Lost to Follow-up|2|||
162671215|NCT01664078|587504046|FG000|Overall Study|missed 5 year visit|1|||
162671216|NCT01664078|587504046|FG000|Overall Study|Other|53|||
162671217|NCT04782323|587504047|FG000|Overall Study|Death|1|||
162671218|NCT04782323|587504048|FG001|Overall Study|Death|0|||
162671219|NCT04782323|587504049|FG002|Overall Study|Death|0|||
162671220|NCT04782323|587504050|FG003|Overall Study|Death|0|||
162671221|NCT04782323|587504051|FG004|Overall Study|Death|1|||
162671222|NCT04782323|587504052|FG005|Overall Study|Death|1|||
162671223|NCT04782323|587504053|FG006|Overall Study|Death|1|||
162671224|NCT04782323|587504054|FG007|Overall Study|Death|0|||
162671225|NCT04782323|587504047|FG000|Overall Study|Withdrawal by Subject|0|||
162671226|NCT04782323|587504048|FG001|Overall Study|Withdrawal by Subject|0|||
162671227|NCT04782323|587504049|FG002|Overall Study|Withdrawal by Subject|1|||
162671228|NCT04782323|587504050|FG003|Overall Study|Withdrawal by Subject|0|||
162671229|NCT04782323|587504051|FG004|Overall Study|Withdrawal by Subject|0|||
162671230|NCT04782323|587504052|FG005|Overall Study|Withdrawal by Subject|1|||
162671231|NCT04782323|587504053|FG006|Overall Study|Withdrawal by Subject|0|||
162671232|NCT04782323|587504054|FG007|Overall Study|Withdrawal by Subject|1|||
162671233|NCT04782323|587504047|FG000|Overall Study|Lost to Follow-up|0|||
162671234|NCT04782323|587504048|FG001|Overall Study|Lost to Follow-up|1|||
162671235|NCT04782323|587504049|FG002|Overall Study|Lost to Follow-up|1|||
162671236|NCT04782323|587504050|FG003|Overall Study|Lost to Follow-up|0|||
162671237|NCT04782323|587504051|FG004|Overall Study|Lost to Follow-up|0|||
162671238|NCT04782323|587504052|FG005|Overall Study|Lost to Follow-up|1|||
162671239|NCT04782323|587504053|FG006|Overall Study|Lost to Follow-up|1|||
162671240|NCT04782323|587504054|FG007|Overall Study|Lost to Follow-up|2|||
162671241|NCT04782323|587504047|FG000|Overall Study|randomization in error|1|||
162671242|NCT04782323|587504048|FG001|Overall Study|randomization in error|0|||
162671243|NCT04782323|587504049|FG002|Overall Study|randomization in error|0|||
162671244|NCT04782323|587504050|FG003|Overall Study|randomization in error|0|||
162671245|NCT04782323|587504051|FG004|Overall Study|randomization in error|0|||
162671246|NCT04782323|587504052|FG005|Overall Study|randomization in error|0|||
162671247|NCT04782323|587504053|FG006|Overall Study|randomization in error|0|||
162671248|NCT04782323|587504054|FG007|Overall Study|randomization in error|0|||
162671249|NCT04369469|587504057|FG000|Overall Study|Lost to Follow-up|2|||
162671250|NCT04369469|587504058|FG001|Overall Study|Lost to Follow-up|4|||
162671251|NCT04369469|587504057|FG000|Overall Study|Physician Decision|2|||
162671252|NCT04369469|587504058|FG001|Overall Study|Physician Decision|1|||
162671253|NCT04369469|587504057|FG000|Overall Study|Withdrawal by Subject|2|||
162671254|NCT04369469|587504058|FG001|Overall Study|Withdrawal by Subject|3|||
162671255|NCT04369469|587504057|FG000|Overall Study|Adverse Event|1|||
162671256|NCT04369469|587504058|FG001|Overall Study|Adverse Event|0|||
162671257|NCT04369469|587504057|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
162671258|NCT04369469|587504058|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
162671259|NCT04369469|587504057|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
162671260|NCT04369469|587504058|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
162671261|NCT04369469|587504057|FG000|Overall Study|Unable to Provide Consent|0|||
162671262|NCT04369469|587504058|FG001|Overall Study|Unable to Provide Consent|1|||
162671263|NCT03135522|587504059|FG000|Overall Study|Adverse Event|1|||
162671264|NCT03135522|587504060|FG001|Overall Study|Adverse Event|0|||
162671265|NCT03832192|587504063|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
162671266|NCT03832192|587504064|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
162671267|NCT00499369|587504067|FG000|Overall Study|Adverse Event|2|||
162671268|NCT00499369|587504068|FG001|Overall Study|Adverse Event|2|||
162671269|NCT00499369|587504069|FG002|Overall Study|Adverse Event|3|||
162671270|NCT00499369|587504070|FG003|Overall Study|Adverse Event|1|||
162671271|NCT00499369|587504071|FG004|Overall Study|Adverse Event|2|||
162671272|NCT00499369|587504067|FG000|Overall Study|Withdrawal by Subject|0|||
162671273|NCT00499369|587504068|FG001|Overall Study|Withdrawal by Subject|1|||
162671274|NCT00499369|587504069|FG002|Overall Study|Withdrawal by Subject|1|||
162671275|NCT00499369|587504070|FG003|Overall Study|Withdrawal by Subject|0|||
162671276|NCT00499369|587504071|FG004|Overall Study|Withdrawal by Subject|0|||
162671277|NCT00499369|587504067|FG000|Overall Study|Progression|10|||
162671278|NCT00499369|587504068|FG001|Overall Study|Progression|12|||
162671279|NCT00499369|587504069|FG002|Overall Study|Progression|9|||
162671280|NCT00499369|587504070|FG003|Overall Study|Progression|6|||
162671281|NCT00499369|587504071|FG004|Overall Study|Progression|10|||
162671282|NCT00499369|587504067|FG000|Overall Study|Death|0|||
162671283|NCT00499369|587504068|FG001|Overall Study|Death|1|||
162671284|NCT00499369|587504069|FG002|Overall Study|Death|0|||
162671285|NCT00499369|587504070|FG003|Overall Study|Death|0|||
162671286|NCT00499369|587504071|FG004|Overall Study|Death|0|||
162671287|NCT00499369|587504067|FG000|Overall Study|Not protocol specified|2|||
162671288|NCT00499369|587504068|FG001|Overall Study|Not protocol specified|0|||
162671289|NCT00499369|587504069|FG002|Overall Study|Not protocol specified|3|||
163150954|NCT04945733|589267005|FG000|Overall Study|Physician Decision|1|||
163150955|NCT04945733|589267006|FG001|Overall Study|Physician Decision|3|||
163150956|NCT04945733|589267007|FG002|Overall Study|Physician Decision|0|||
163150957|NCT04945733|589267005|FG000|Overall Study|Withdrawal by Subject|3|||
163150958|NCT04945733|589267006|FG001|Overall Study|Withdrawal by Subject|3|||
163150959|NCT04945733|589267007|FG002|Overall Study|Withdrawal by Subject|0|||
163150960|NCT05660577|589267008|FG000|Overall Study|Discontinued|9|||
163150961|NCT03363841|589267013|FG000|Overall Study|Adverse Event|1|||
163150962|NCT03363841|589267013|FG000|Overall Study|Withdrawal by Subject|1|||
163150963|NCT03363841|589267013|FG000|Overall Study|Death|7|||
163150964|NCT03363841|589267013|FG000|Overall Study|Physician Decision|1|||
163150965|NCT02156076|589267018|FG000|Treatment Period|no longer meets study criteria|0|||
163150966|NCT02156076|589267019|FG001|Treatment Period|no longer meets study criteria|0|||
163150967|NCT02156076|589267020|FG002|Treatment Period|no longer meets study criteria|1|||
163150968|NCT02156076|589267021|FG003|Treatment Period|no longer meets study criteria|0|||
163150969|NCT02156076|589267018|FG000|Treatment Period|Poor/non-compliance|0|||
163150970|NCT02156076|589267019|FG001|Treatment Period|Poor/non-compliance|1|||
163150971|NCT02156076|589267020|FG002|Treatment Period|Poor/non-compliance|0|||
163150972|NCT02156076|589267021|FG003|Treatment Period|Poor/non-compliance|0|||
163150973|NCT02156076|589267018|FG000|Treatment Period|Lost to Follow-up|0|||
163150974|NCT02156076|589267019|FG001|Treatment Period|Lost to Follow-up|0|||
163150975|NCT02156076|589267020|FG002|Treatment Period|Lost to Follow-up|0|||
163150976|NCT02156076|589267021|FG003|Treatment Period|Lost to Follow-up|1|||
163150977|NCT02156076|589267018|FG000|Treatment Period|Withdrawal by Subject|0|||
163150978|NCT02156076|589267019|FG001|Treatment Period|Withdrawal by Subject|0|||
163150979|NCT02156076|589267020|FG002|Treatment Period|Withdrawal by Subject|1|||
163150980|NCT02156076|589267021|FG003|Treatment Period|Withdrawal by Subject|0|||
163150981|NCT02156076|589267018|FG000|Treatment Period|Subject request to discontinue treatment|0|||
163150982|NCT02156076|589267019|FG001|Treatment Period|Subject request to discontinue treatment|1|||
163150983|NCT02156076|589267020|FG002|Treatment Period|Subject request to discontinue treatment|0|||
163150984|NCT02156076|589267021|FG003|Treatment Period|Subject request to discontinue treatment|0|||
163150985|NCT02156076|589267018|FG000|Treatment Period|Adverse Event|0|||
163150986|NCT02156076|589267019|FG001|Treatment Period|Adverse Event|0|||
163150987|NCT02156076|589267020|FG002|Treatment Period|Adverse Event|0|||
163150988|NCT02156076|589267021|FG003|Treatment Period|Adverse Event|1|||
163150989|NCT02156076|589267018|FG000|Follow-up Period|Withdrawal by Subject|1|||
163150990|NCT02156076|589267019|FG001|Follow-up Period|Withdrawal by Subject|0|||
163150991|NCT02156076|589267020|FG002|Follow-up Period|Withdrawal by Subject|0|||
163150992|NCT02156076|589267021|FG003|Follow-up Period|Withdrawal by Subject|0|||
163150993|NCT03566511|589267025|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
163150994|NCT03566511|589267026|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
163150995|NCT00981656|589267032|FG000|Overall Study|Protocol Violation|1|||
163150996|NCT00981656|589267032|FG000|Overall Study|Did not start protocol treatment|2|||
163150997|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
163150998|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
163150999|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163151000|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
163151001|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163151002|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163151003|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
163151004|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163151005|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
163151006|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163151007|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163151008|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163151009|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151010|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151011|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
163151012|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
163151013|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
163151014|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
163151015|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
162671290|NCT00499369|587504070|FG003|Overall Study|Not protocol specified|1|||
162671291|NCT00499369|587504071|FG004|Overall Study|Not protocol specified|0|||
162671292|NCT00499369|587504067|FG000|Overall Study|Ineligible|2|||
162671293|NCT00499369|587504068|FG001|Overall Study|Ineligible|2|||
162671294|NCT00499369|587504069|FG002|Overall Study|Ineligible|1|||
162671295|NCT00499369|587504070|FG003|Overall Study|Ineligible|1|||
162671296|NCT00499369|587504071|FG004|Overall Study|Ineligible|0|||
162671297|NCT01898195|587504072|FG000|Smoking Abstinence|Did not have good measurements|35|||
162671298|NCT01898195|587504073|FG001|Smoking Abstinence|Did not have good measurements|38|||
162671299|NCT01898195|587504074|FG002|Smoking Abstinence|Did not have good measurements|36|||
162671300|NCT01337245|587504075|FG000|Overall Study|Lost to Follow-up|1|||
162671301|NCT04095858|587504076|FG000|Overall Study|Death|1|||
162671302|NCT04095858|587504077|FG001|Overall Study|Death|0|||
162671303|NCT04095858|587504076|FG000|Overall Study|Study terminated by Sponsor|2|||
162671304|NCT04095858|587504077|FG001|Overall Study|Study terminated by Sponsor|4|||
162671305|NCT01344460|587504078|FG000|Overall Study|Withdrawal by Subject|1|||
162671306|NCT01344460|587504078|FG000|Overall Study|Lost to Follow-up|2|||
162671307|NCT02838017|587504080|FG000|Overall Study|Lost to Follow-up|14|||
162671308|NCT02838017|587504081|FG001|Overall Study|Lost to Follow-up|11|||
162671309|NCT01692197|587504082|FG000|Overall Study|Failed Screening|3|||
162671310|NCT02120924|587504083|FG000|Overall Study|Lack of Efficacy|1|||
162671311|NCT02120924|587504084|FG001|Overall Study|Lack of Efficacy|2|||
162671312|NCT02120924|587504085|FG002|Overall Study|Lack of Efficacy|3|||
162671313|NCT02120924|587504083|FG000|Overall Study|Adverse Event|0|||
162671314|NCT02120924|587504084|FG001|Overall Study|Adverse Event|1|||
162671315|NCT02120924|587504085|FG002|Overall Study|Adverse Event|3|||
162671316|NCT02120924|587504083|FG000|Overall Study|Withdrawal by Subject|16|||
162671317|NCT02120924|587504084|FG001|Overall Study|Withdrawal by Subject|20|||
162671318|NCT02120924|587504085|FG002|Overall Study|Withdrawal by Subject|8|||
162671319|NCT02120924|587504083|FG000|Overall Study|Lost to Follow-up|14|||
162671320|NCT02120924|587504084|FG001|Overall Study|Lost to Follow-up|14|||
162671321|NCT02120924|587504085|FG002|Overall Study|Lost to Follow-up|11|||
162671322|NCT02120924|587504083|FG000|Overall Study|Pregnancy|2|||
162671323|NCT02120924|587504084|FG001|Overall Study|Pregnancy|0|||
162671324|NCT02120924|587504085|FG002|Overall Study|Pregnancy|0|||
162671325|NCT02120924|587504083|FG000|Overall Study|Protocol Violation|3|||
162671326|NCT02120924|587504084|FG001|Overall Study|Protocol Violation|7|||
162671327|NCT02120924|587504085|FG002|Overall Study|Protocol Violation|2|||
162671328|NCT02120924|587504083|FG000|Overall Study|Physician Decision|0|||
162671329|NCT02120924|587504084|FG001|Overall Study|Physician Decision|1|||
162671330|NCT02120924|587504085|FG002|Overall Study|Physician Decision|1|||
162671331|NCT02120924|587504083|FG000|Overall Study|Death|1|||
162671332|NCT02120924|587504084|FG001|Overall Study|Death|0|||
162671333|NCT02120924|587504085|FG002|Overall Study|Death|0|||
162671334|NCT02120924|587504083|FG000|Overall Study|Compliance with IP|5|||
162671335|NCT02120924|587504084|FG001|Overall Study|Compliance with IP|1|||
162671336|NCT02120924|587504085|FG002|Overall Study|Compliance with IP|1|||
162671337|NCT03483623|587504086|FG000|Overall Study|43 complete sets achieved|1|||
162671338|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
162671339|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
162671340|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
162671341|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
162671342|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
162671343|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
162671344|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
162671345|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
162671346|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
162671347|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
162671348|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
162671349|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
162671350|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
162671351|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
162671352|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
162671353|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162671354|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
162671355|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162671356|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
162671357|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
162671358|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
162671359|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
162671360|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
162671361|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
162671362|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
162671363|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
162671364|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
162671365|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
162671366|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
162671367|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
162671368|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
162671369|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
162671370|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
162671371|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
162671372|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
162671373|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
162671374|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
162671375|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
162671376|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
162671377|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
162671378|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
162671379|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
162671380|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
162671381|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
163151016|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
163151017|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
163151018|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
163151019|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163151020|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163151021|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151022|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
163151023|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151024|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
163151025|NCT04026113|589267033|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151026|NCT04026113|589267034|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
163151027|NCT04026113|589267035|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151028|NCT04026113|589267036|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163151029|NCT04026113|589267033|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
163151030|NCT04026113|589267034|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
163151031|NCT04026113|589267035|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
163151032|NCT04026113|589267036|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
163151033|NCT00687596|589267037|FG000|Overall Study|Adverse Event (AE)|10|||
163151034|NCT00687596|589267038|FG001|Overall Study|Adverse Event (AE)|3|||
163151035|NCT00687596|589267037|FG000|Overall Study|Radiological Disease Progression|6|||
163151036|NCT00687596|589267038|FG001|Overall Study|Radiological Disease Progression|2|||
163151037|NCT00687596|589267037|FG000|Overall Study|Clinical Disease Progression|1|||
163151038|NCT00687596|589267038|FG001|Overall Study|Clinical Disease Progression|3|||
163151039|NCT00687596|589267037|FG000|Overall Study|Investigator Discretion|3|||
163151040|NCT00687596|589267038|FG001|Overall Study|Investigator Discretion|1|||
163151041|NCT00687596|589267037|FG000|Overall Study|Sponsor Terminated Study|6|||
163151042|NCT00687596|589267038|FG001|Overall Study|Sponsor Terminated Study|17|||
163151043|NCT01527149|589267039|FG000|Overall Study|Death|2|||
163151044|NCT01709721|589267040|FG000|Open Label Phase|Withdrawal by Subject|0|||
163151045|NCT01709721|589267041|FG001|Open Label Phase|Withdrawal by Subject|0|||
163151046|NCT01709721|589267042|FG002|Open Label Phase|Withdrawal by Subject|5|||
163151047|NCT01709721|589267040|FG000|Open Label Phase|Adverse Event|0|||
163151048|NCT01709721|589267041|FG001|Open Label Phase|Adverse Event|0|||
163151049|NCT01709721|589267042|FG002|Open Label Phase|Adverse Event|8|||
163151050|NCT01709721|589267040|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
163151051|NCT01709721|589267041|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
162671382|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
162671383|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
162671384|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
162671385|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
162671386|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
162671387|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162671388|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
162671389|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
162671390|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
162671391|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
162671392|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
162671393|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
162671394|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
162671395|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
162671396|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
162671397|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
162671398|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
162671399|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
162671400|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
162671401|NCT01884350|587504087|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
162671402|NCT01884350|587504088|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
162671403|NCT01884350|587504089|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
162671404|NCT03403634|587504096|FG000|Overall Study|Disease progression|3|||
162671405|NCT03403634|587504096|FG000|Overall Study|Did not meet eligibility criteria|4|||
162671406|NCT01850004|587504097|FG000|Overall Study|Poor/Non-compliance|1|||
162671407|NCT01850004|587504097|FG000|Overall Study|Participant Withdrew Consent|9|||
162671408|NCT01850004|587504097|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
162671409|NCT01850004|587504097|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
162671410|NCT01850004|587504097|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
162671411|NCT01850004|587504097|FG000|Overall Study|Other Reasons|2|||
162671412|NCT01850004|587504097|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
162671413|NCT01850004|587504097|FG000|Overall Study|Maximum Clinical Benefit|4|||
162671414|NCT02536508|587505761|FG000|Overall Study|Withdrawal by Subject|18|||
162671415|NCT02536508|587505762|FG001|Overall Study|Withdrawal by Subject|13|||
162671416|NCT02536508|587505763|FG002|Overall Study|Withdrawal by Subject|7|||
162671417|NCT02536508|587505761|FG000|Overall Study|Adverse Event|14|||
162671418|NCT02536508|587505762|FG001|Overall Study|Adverse Event|13|||
162671419|NCT02536508|587505763|FG002|Overall Study|Adverse Event|6|||
162671420|NCT02536508|587505761|FG000|Overall Study|Lost to Follow-up|12|||
162671421|NCT02536508|587505762|FG001|Overall Study|Lost to Follow-up|4|||
162671422|NCT02536508|587505763|FG002|Overall Study|Lost to Follow-up|0|||
162671423|NCT02536508|587505761|FG000|Overall Study|Lack of Efficacy|3|||
162671424|NCT02536508|587505762|FG001|Overall Study|Lack of Efficacy|5|||
162671425|NCT02536508|587505763|FG002|Overall Study|Lack of Efficacy|4|||
162671426|NCT02536508|587505761|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
162671427|NCT02536508|587505762|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
162671428|NCT02536508|587505763|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
162671429|NCT02536508|587505761|FG000|Overall Study|Physician Decision|0|||
162671430|NCT02536508|587505762|FG001|Overall Study|Physician Decision|4|||
162671431|NCT02536508|587505763|FG002|Overall Study|Physician Decision|2|||
162671432|NCT02536508|587505761|FG000|Overall Study|Major Protocol Deviation|2|||
162671433|NCT02536508|587505762|FG001|Overall Study|Major Protocol Deviation|2|||
162671434|NCT02536508|587505763|FG002|Overall Study|Major Protocol Deviation|2|||
162671435|NCT02536508|587505761|FG000|Overall Study|Administrative Reasons|0|||
162671436|NCT02536508|587505762|FG001|Overall Study|Administrative Reasons|1|||
162671437|NCT02536508|587505763|FG002|Overall Study|Administrative Reasons|0|||
162671438|NCT00434057|587505765|FG000|Overall Study|Withdrawal by Subject|1|||
162671439|NCT00823719|587505770|FG000|Overall Study|Adverse Event|1|||
162671440|NCT00823719|587505771|FG001|Overall Study|Adverse Event|2|||
162671441|NCT00823719|587505770|FG000|Overall Study|Physician Decision|1|||
162671442|NCT00823719|587505771|FG001|Overall Study|Physician Decision|4|||
162671443|NCT00823719|587505770|FG000|Overall Study|Withdrawal by Subject|0|||
162671444|NCT00823719|587505771|FG001|Overall Study|Withdrawal by Subject|1|||
162671445|NCT00823719|587505770|FG000|Overall Study|Disease Progression|4|||
162671446|NCT00823719|587505771|FG001|Overall Study|Disease Progression|4|||
162671447|NCT02370602|587505772|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162671448|NCT02370602|587505773|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162671449|NCT02370602|587505774|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162671450|NCT02370602|587505775|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
162671451|NCT02370602|587505776|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162671452|NCT02370602|587505777|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162671453|NCT02103439|587505779|FG000|Overall Study|Adverse Event|0|||
162671454|NCT02103439|587505780|FG001|Overall Study|Adverse Event|2|||
162671455|NCT02103439|587505779|FG000|Overall Study|Withdrawal by Subject|3|||
162671456|NCT02103439|587505780|FG001|Overall Study|Withdrawal by Subject|1|||
162671457|NCT00784810|587505781|FG000|Overall Study|Adverse Event|32|||
162671458|NCT00784810|587505782|FG001|Overall Study|Adverse Event|20|||
162671459|NCT00784810|587505781|FG000|Overall Study|Lack of Efficacy|14|||
162671460|NCT00784810|587505782|FG001|Overall Study|Lack of Efficacy|11|||
162671461|NCT00784810|587505781|FG000|Overall Study|Withdrawal by Subject|11|||
162671462|NCT00784810|587505782|FG001|Overall Study|Withdrawal by Subject|9|||
162671463|NCT00784810|587505781|FG000|Overall Study|Administrative|5|||
162671464|NCT00784810|587505782|FG001|Overall Study|Administrative|8|||
162671465|NCT00784810|587505781|FG000|Overall Study|Lost to Follow-up|1|||
162671466|NCT00784810|587505782|FG001|Overall Study|Lost to Follow-up|1|||
162671467|NCT03305016|587505785|FG000|Overall Study|Withdrawal by Subject|2|||
162671468|NCT02119416|587505786|FG000|Overall Study|Protocol Violation|1|||
162671469|NCT02119416|587505787|FG001|Overall Study|Protocol Violation|1|||
162671470|NCT02119416|587505788|FG002|Overall Study|Protocol Violation|1|||
162671471|NCT02119416|587505786|FG000|Overall Study|wrong pubertal stage|1|||
162671472|NCT02119416|587505787|FG001|Overall Study|wrong pubertal stage|0|||
162671473|NCT02119416|587505788|FG002|Overall Study|wrong pubertal stage|1|||
162671474|NCT04420689|587505789|FG000|Overall Study|COVID-19 related hospitalization|0|||
162671475|NCT04420689|587505790|FG001|Overall Study|COVID-19 related hospitalization|0|||
162671476|NCT04420689|587505791|FG002|Overall Study|COVID-19 related hospitalization|0|||
162671477|NCT04420689|587505792|FG003|Overall Study|COVID-19 related hospitalization|0|||
162671478|NCT04420689|587505793|FG004|Overall Study|COVID-19 related hospitalization|1|||
162671479|NCT04420689|587505794|FG005|Overall Study|COVID-19 related hospitalization|0|||
162671480|NCT04420689|587505795|FG006|Overall Study|COVID-19 related hospitalization|0|||
162671481|NCT04420689|587505789|FG000|Overall Study|Physician Decision|0|||
162671482|NCT04420689|587505790|FG001|Overall Study|Physician Decision|0|||
162671483|NCT04420689|587505791|FG002|Overall Study|Physician Decision|0|||
162671484|NCT04420689|587505792|FG003|Overall Study|Physician Decision|0|||
162671485|NCT04420689|587505793|FG004|Overall Study|Physician Decision|0|||
162671486|NCT04420689|587505794|FG005|Overall Study|Physician Decision|1|||
162671487|NCT04420689|587505795|FG006|Overall Study|Physician Decision|0|||
162671488|NCT03434119|587505796|FG000|Overall Study|Randomized but not treated|1|||
162671489|NCT03434119|587505797|FG001|Overall Study|Randomized but not treated|0|||
162671490|NCT03434119|587505796|FG000|Overall Study|Adverse Event|1|||
162671491|NCT03434119|587505797|FG001|Overall Study|Adverse Event|0|||
162671492|NCT03434119|587505796|FG000|Overall Study|Poor Compliance to Protocol|0|||
162671493|NCT03434119|587505797|FG001|Overall Study|Poor Compliance to Protocol|1|||
162671494|NCT03434119|587505796|FG000|Overall Study|Study Terminated by Sponsor|91|||
162671495|NCT03434119|587505797|FG001|Overall Study|Study Terminated by Sponsor|102|||
162671496|NCT03434119|587505796|FG000|Overall Study|Withdrawal by Subject|7|||
162671497|NCT03434119|587505797|FG001|Overall Study|Withdrawal by Subject|5|||
162671498|NCT03434119|587505796|FG000|Overall Study|Other than specified|7|||
162671499|NCT03434119|587505797|FG001|Overall Study|Other than specified|5|||
162671500|NCT04360824|587505800|FG000|Overall Study|Withdrawal by Subject|2|||
162671501|NCT04360824|587505801|FG001|Overall Study|Withdrawal by Subject|1|||
162671502|NCT04360824|587505800|FG000|Overall Study|Did not receive assigned treatment|1|||
162671503|NCT04360824|587505801|FG001|Overall Study|Did not receive assigned treatment|3|||
162671504|NCT02278328|587505805|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
162671505|NCT02278328|587505806|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
162671506|NCT02278328|587505807|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
162671507|NCT02278328|587505805|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
162671508|NCT02278328|587505806|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
162671509|NCT02278328|587505807|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
162671510|NCT02278328|587505805|FG000|Neuropsych Screening|incomplete consent|0|||
162671511|NCT02278328|587505806|FG001|Neuropsych Screening|incomplete consent|0|||
162671512|NCT02278328|587505807|FG002|Neuropsych Screening|incomplete consent|2|||
162671513|NCT00377676|587505808|FG000|Overall Study|Adverse Event|498|||
162671514|NCT00377676|587505809|FG001|Overall Study|Adverse Event|107|||
162671515|NCT00377676|587505808|FG000|Overall Study|Protocol Violation|33|||
162671516|NCT00377676|587505809|FG001|Overall Study|Protocol Violation|27|||
162671517|NCT00377676|587505808|FG000|Overall Study|Death|5|||
162671518|NCT00377676|587505809|FG001|Overall Study|Death|2|||
162671519|NCT00377676|587505808|FG000|Overall Study|Withdrawal by Subject|187|||
162671520|NCT00377676|587505809|FG001|Overall Study|Withdrawal by Subject|72|||
162671521|NCT00377676|587505808|FG000|Overall Study|Lost to Follow-up|120|||
162671522|NCT00377676|587505809|FG001|Overall Study|Lost to Follow-up|56|||
162671523|NCT00377676|587505808|FG000|Overall Study|Other|118|||
162671524|NCT00377676|587505809|FG001|Overall Study|Other|58|||
162671525|NCT03834779|587505815|FG000|Overall Study|Death|1|||
162671526|NCT03834779|587505816|FG001|Overall Study|Death|2|||
162671527|NCT03834779|587505815|FG000|Overall Study|Lost to Follow-up|6|||
162671528|NCT03834779|587505816|FG001|Overall Study|Lost to Follow-up|4|||
162671529|NCT03579459|587505817|FG000|Overall Study|Adverse Event|7|||
162671530|NCT03579459|587505818|FG001|Overall Study|Adverse Event|6|||
162671531|NCT03579459|587505819|FG002|Overall Study|Adverse Event|2|||
162671532|NCT03579459|587505820|FG003|Overall Study|Adverse Event|6|||
162671533|NCT03579459|587505817|FG000|Overall Study|Death|1|||
162671534|NCT03579459|587505818|FG001|Overall Study|Death|0|||
162671535|NCT03579459|587505819|FG002|Overall Study|Death|1|||
162671536|NCT03579459|587505820|FG003|Overall Study|Death|2|||
162671537|NCT03579459|587505817|FG000|Overall Study|Lost to Follow-up|6|||
162671538|NCT03579459|587505818|FG001|Overall Study|Lost to Follow-up|2|||
162671539|NCT03579459|587505819|FG002|Overall Study|Lost to Follow-up|4|||
162671540|NCT03579459|587505820|FG003|Overall Study|Lost to Follow-up|1|||
162671541|NCT03579459|587505817|FG000|Overall Study|Physician Decision|0|||
162671542|NCT03579459|587505818|FG001|Overall Study|Physician Decision|1|||
162671543|NCT03579459|587505819|FG002|Overall Study|Physician Decision|0|||
162671544|NCT03579459|587505820|FG003|Overall Study|Physician Decision|1|||
162671545|NCT03579459|587505817|FG000|Overall Study|Protocol Violation|1|||
162671546|NCT03579459|587505818|FG001|Overall Study|Protocol Violation|2|||
162671547|NCT03579459|587505819|FG002|Overall Study|Protocol Violation|3|||
162671548|NCT03579459|587505820|FG003|Overall Study|Protocol Violation|5|||
162671549|NCT03579459|587505817|FG000|Overall Study|Withdrawal by Subject|12|||
162671550|NCT03579459|587505818|FG001|Overall Study|Withdrawal by Subject|8|||
162671551|NCT03579459|587505819|FG002|Overall Study|Withdrawal by Subject|11|||
162671552|NCT03579459|587505820|FG003|Overall Study|Withdrawal by Subject|8|||
162671553|NCT03579459|587505817|FG000|Overall Study|Medication error without associated adverse event|2|||
162671554|NCT03579459|587505818|FG001|Overall Study|Medication error without associated adverse event|1|||
162671555|NCT03579459|587505819|FG002|Overall Study|Medication error without associated adverse event|1|||
162671556|NCT03579459|587505820|FG003|Overall Study|Medication error without associated adverse event|0|||
162671557|NCT03579459|587505817|FG000|Overall Study|Other|0|||
162671558|NCT03579459|587505818|FG001|Overall Study|Other|1|||
162671559|NCT03579459|587505819|FG002|Overall Study|Other|1|||
162671560|NCT03579459|587505820|FG003|Overall Study|Other|0|||
162671561|NCT03579459|587505817|FG000|Overall Study|Randomized not vaccinated|0|||
162671562|NCT03579459|587505818|FG001|Overall Study|Randomized not vaccinated|2|||
162671563|NCT03579459|587505819|FG002|Overall Study|Randomized not vaccinated|0|||
162671564|NCT03579459|587505820|FG003|Overall Study|Randomized not vaccinated|1|||
162671565|NCT02528214|587505821|FG000|Overall Study|Protocol Violation|0|||
162671566|NCT02528214|587505822|FG001|Overall Study|Protocol Violation|1|||
162671567|NCT02528214|587505821|FG000|Overall Study|Adverse Event|0|||
162671568|NCT02528214|587505822|FG001|Overall Study|Adverse Event|1|||
162671569|NCT02528214|587505821|FG000|Overall Study|Other than specified above|0|||
162671570|NCT02528214|587505822|FG001|Overall Study|Other than specified above|1|||
162671571|NCT00407537|587505823|FG000|Overall Study|Death|5|||
162721959|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162721960|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162721961|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163151052|NCT01709721|589267042|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
163151053|NCT01709721|589267040|FG000|Open Label Phase|Investigator Decision|0|||
163151054|NCT01709721|589267041|FG001|Open Label Phase|Investigator Decision|0|||
163151055|NCT01709721|589267042|FG002|Open Label Phase|Investigator Decision|1|||
162671572|NCT00407537|587505824|FG001|Overall Study|Death|2|||
162671573|NCT00407537|587505823|FG000|Overall Study|Adverse Event|36|||
162671574|NCT00407537|587505824|FG001|Overall Study|Adverse Event|0|||
162671575|NCT00407537|587505823|FG000|Overall Study|Lost to Follow-up|12|||
162671576|NCT00407537|587505824|FG001|Overall Study|Lost to Follow-up|19|||
162671577|NCT00407537|587505823|FG000|Overall Study|Other|6|||
162671578|NCT00407537|587505824|FG001|Overall Study|Other|7|||
162671579|NCT00407537|587505823|FG000|Overall Study|Withdrawal by Subject|34|||
162671580|NCT00407537|587505824|FG001|Overall Study|Withdrawal by Subject|16|||
162671581|NCT03593655|587505826|FG000|First Product Use Period|Withdrawal by Subject|1|||
162671582|NCT03593655|587505827|FG001|First Product Use Period|Withdrawal by Subject|1|||
162671583|NCT03593655|587505826|FG000|First Product Use Period|Lost to Follow-up|1|||
162671584|NCT03593655|587505827|FG001|First Product Use Period|Lost to Follow-up|3|||
162671585|NCT03593655|587505826|FG000|Second Product Use Period|Withdrawal by Subject|1|||
162671586|NCT03593655|587505827|FG001|Second Product Use Period|Withdrawal by Subject|1|||
162671587|NCT03593655|587505826|FG000|Second Product Use Period|Lost to Follow-up|1|||
162671588|NCT03593655|587505827|FG001|Second Product Use Period|Lost to Follow-up|0|||
162671589|NCT03593655|587505826|FG000|Third Product Use Period|Lost to Follow-up|1|||
162671590|NCT03593655|587505827|FG001|Third Product Use Period|Lost to Follow-up|2|||
162671591|NCT03593655|587505826|FG000|Third Product Use Period|Physician Decision|0|||
162671592|NCT03593655|587505827|FG001|Third Product Use Period|Physician Decision|1|||
162671593|NCT03593655|587505826|FG000|Third Product Use Period|Withdrawal by Subject|0|||
162671594|NCT03593655|587505827|FG001|Third Product Use Period|Withdrawal by Subject|1|||
162671595|NCT01090453|587505829|FG000|Overall Study|Withdrawal by Subject|1|||
162671596|NCT01090453|587505830|FG001|Overall Study|Withdrawal by Subject|2|||
162671597|NCT01090453|587505829|FG000|Overall Study|Lost to Follow-up|7|||
162671598|NCT01090453|587505830|FG001|Overall Study|Lost to Follow-up|7|||
162671599|NCT01090453|587505829|FG000|Overall Study|Non serious AEs|1|||
162671600|NCT01090453|587505830|FG001|Overall Study|Non serious AEs|0|||
162671601|NCT01090453|587505829|FG000|Overall Study|Protocol Violation|2|||
162671602|NCT01090453|587505830|FG001|Overall Study|Protocol Violation|0|||
162671603|NCT01090453|587505829|FG000|Overall Study|Other|2|||
162671604|NCT01090453|587505830|FG001|Overall Study|Other|4|||
162671605|NCT01090453|587505829|FG000|Overall Study|Eligibility Criteria|0|||
162671606|NCT01090453|587505830|FG001|Overall Study|Eligibility Criteria|1|||
162671607|NCT00142909|587505836|FG000|Randomization|Various Reasons|7|||
162671608|NCT00142909|587505837|FG001|Randomization|Various Reasons|10|||
162671609|NCT00142909|587505836|FG000|Medications Begin|Protocol Violation|2|||
162671610|NCT00142909|587505837|FG001|Medications Begin|Protocol Violation|0|||
162671611|NCT00142909|587505836|FG000|Medications Begin|Withdrawal by Subject|5|||
162671612|NCT00142909|587505837|FG001|Medications Begin|Withdrawal by Subject|3|||
162671613|NCT00142909|587505836|FG000|Medications Begin|Withdrawal by Subject|2|||
162671614|NCT00142909|587505837|FG001|Medications Begin|Withdrawal by Subject|0|||
162671615|NCT01660763|587505841|FG000|Overall Study|Lack of Efficacy|45|||
162671616|NCT01660763|587505842|FG001|Overall Study|Lack of Efficacy|50|||
162671617|NCT01660763|587505841|FG000|Overall Study|Adverse Event|22|||
162671618|NCT01660763|587505842|FG001|Overall Study|Adverse Event|7|||
162671619|NCT01660763|587505841|FG000|Overall Study|Protocol Violation|1|||
162671620|NCT01660763|587505842|FG001|Overall Study|Protocol Violation|0|||
162671621|NCT01660763|587505841|FG000|Overall Study|Withdrawal by Subject|4|||
162671622|NCT01660763|587505842|FG001|Overall Study|Withdrawal by Subject|0|||
162671623|NCT01660763|587505841|FG000|Overall Study|Patient ready for early discharge|28|||
162671624|NCT01660763|587505842|FG001|Overall Study|Patient ready for early discharge|4|||
162671625|NCT00345397|587505843|FG000|Overall Study|Death|1|||
162671626|NCT01870843|587505844|FG000|Overall Study|Adverse Event|10|||
162671627|NCT01870843|587505844|FG000|Overall Study|Lost to Follow-up|24|||
162671628|NCT01870843|587505844|FG000|Overall Study|Death|1|||
162671629|NCT01870843|587505844|FG000|Overall Study|Withdrawal by Subject|18|||
162671630|NCT01365494|587505846|FG000|Overall Study|Adverse Event|1|||
162671631|NCT01365494|587505847|FG001|Overall Study|Adverse Event|0|||
162671632|NCT01365494|587505846|FG000|Overall Study|Withdrawal by Subject|0|||
162671633|NCT01365494|587505847|FG001|Overall Study|Withdrawal by Subject|1|||
162671634|NCT01365494|587505846|FG000|Overall Study|Lost to Follow-up|1|||
162671635|NCT01365494|587505847|FG001|Overall Study|Lost to Follow-up|2|||
162671636|NCT03021187|587505850|FG000|Overall Study|Death|0|||
162671637|NCT03021187|587505851|FG001|Overall Study|Death|0|||
162671638|NCT03021187|587505852|FG002|Overall Study|Death|3|||
162671639|NCT03021187|587505853|FG003|Overall Study|Death|0|||
162671640|NCT03021187|587505850|FG000|Overall Study|Withdrawal by Subject|0|||
162671641|NCT03021187|587505851|FG001|Overall Study|Withdrawal by Subject|6|||
162671642|NCT03021187|587505852|FG002|Overall Study|Withdrawal by Subject|2|||
162671643|NCT03021187|587505853|FG003|Overall Study|Withdrawal by Subject|5|||
162671644|NCT03021187|587505850|FG000|Overall Study|Lost to Follow-up|10|||
162671645|NCT03021187|587505851|FG001|Overall Study|Lost to Follow-up|3|||
162671646|NCT03021187|587505852|FG002|Overall Study|Lost to Follow-up|1|||
162671647|NCT03021187|587505853|FG003|Overall Study|Lost to Follow-up|4|||
162671648|NCT03351049|587505854|FG000|Overall Study|Withdrawal|26|||
162671649|NCT03351049|587505855|FG001|Overall Study|Withdrawal|22|||
162671650|NCT00718718|587505856|FG000|Prior to Week 12|Adverse Event|0|||
162671651|NCT00718718|587505857|FG001|Prior to Week 12|Adverse Event|0|||
162671652|NCT00718718|587505858|FG002|Prior to Week 12|Adverse Event|0|||
162671653|NCT00718718|587505859|FG003|Prior to Week 12|Adverse Event|0|||
162671654|NCT00718718|587505860|FG004|Prior to Week 12|Adverse Event|0|||
162671655|NCT00718718|587505861|FG005|Prior to Week 12|Adverse Event|0|||
162671656|NCT00718718|587505862|FG006|Prior to Week 12|Adverse Event|0|||
162671657|NCT00718718|587505863|FG007|Prior to Week 12|Adverse Event|1|||
162671658|NCT00718718|587505864|FG008|Prior to Week 12|Adverse Event|1|||
162671659|NCT00718718|587505865|FG009|Prior to Week 12|Adverse Event|0|||
162721962|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
162721963|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162721964|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162671660|NCT00718718|587505856|FG000|Prior to Week 12|Withdrawal by Subject|0|||
162671661|NCT00718718|587505857|FG001|Prior to Week 12|Withdrawal by Subject|0|||
162671662|NCT00718718|587505858|FG002|Prior to Week 12|Withdrawal by Subject|0|||
162671663|NCT00718718|587505859|FG003|Prior to Week 12|Withdrawal by Subject|0|||
162671664|NCT00718718|587505860|FG004|Prior to Week 12|Withdrawal by Subject|3|||
162671665|NCT00718718|587505861|FG005|Prior to Week 12|Withdrawal by Subject|0|||
162671666|NCT00718718|587505862|FG006|Prior to Week 12|Withdrawal by Subject|1|||
162671667|NCT00718718|587505863|FG007|Prior to Week 12|Withdrawal by Subject|1|||
162671668|NCT00718718|587505864|FG008|Prior to Week 12|Withdrawal by Subject|1|||
162671669|NCT00718718|587505865|FG009|Prior to Week 12|Withdrawal by Subject|0|||
162671670|NCT00718718|587505856|FG000|Prior to Week 12|Other|1|||
162671671|NCT00718718|587505857|FG001|Prior to Week 12|Other|0|||
162671672|NCT00718718|587505858|FG002|Prior to Week 12|Other|1|||
162721965|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162671673|NCT00718718|587505859|FG003|Prior to Week 12|Other|0|||
162671674|NCT00718718|587505860|FG004|Prior to Week 12|Other|0|||
162671675|NCT00718718|587505861|FG005|Prior to Week 12|Other|0|||
162671676|NCT00718718|587505862|FG006|Prior to Week 12|Other|0|||
162671677|NCT00718718|587505863|FG007|Prior to Week 12|Other|0|||
162671678|NCT00718718|587505864|FG008|Prior to Week 12|Other|0|||
162671679|NCT00718718|587505865|FG009|Prior to Week 12|Other|0|||
162671680|NCT00718718|587505856|FG000|Week 12 to End of Study|Adverse Event|0|||
162671681|NCT00718718|587505857|FG001|Week 12 to End of Study|Adverse Event|0|||
162671682|NCT00718718|587505858|FG002|Week 12 to End of Study|Adverse Event|0|||
162671683|NCT00718718|587505859|FG003|Week 12 to End of Study|Adverse Event|0|||
162671684|NCT00718718|587505860|FG004|Week 12 to End of Study|Adverse Event|0|||
162671685|NCT00718718|587505861|FG005|Week 12 to End of Study|Adverse Event|0|||
162671686|NCT00718718|587505862|FG006|Week 12 to End of Study|Adverse Event|0|||
162671687|NCT00718718|587505863|FG007|Week 12 to End of Study|Adverse Event|1|||
162671688|NCT00718718|587505864|FG008|Week 12 to End of Study|Adverse Event|0|||
162671689|NCT00718718|587505865|FG009|Week 12 to End of Study|Adverse Event|0|||
162671690|NCT00718718|587505856|FG000|Week 12 to End of Study|Death|0|||
162671691|NCT00718718|587505857|FG001|Week 12 to End of Study|Death|0|||
162671692|NCT00718718|587505858|FG002|Week 12 to End of Study|Death|0|||
162671693|NCT00718718|587505859|FG003|Week 12 to End of Study|Death|0|||
162671694|NCT00718718|587505860|FG004|Week 12 to End of Study|Death|0|||
162721966|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163151056|NCT01709721|589267040|FG000|Open Label Phase|Sponsor Decision|0|||
163151057|NCT01709721|589267041|FG001|Open Label Phase|Sponsor Decision|0|||
163151058|NCT01709721|589267042|FG002|Open Label Phase|Sponsor Decision|2|||
163151059|NCT01709721|589267040|FG000|Open Label Phase|Protocol Violation|0|||
163151060|NCT01709721|589267041|FG001|Open Label Phase|Protocol Violation|0|||
163151061|NCT01709721|589267042|FG002|Open Label Phase|Protocol Violation|1|||
163151062|NCT01709721|589267040|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
163151063|NCT01709721|589267041|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
163151064|NCT01709721|589267042|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
163151065|NCT01709721|589267040|FG000|Open Label Phase|Inadequate Pain Control|0|||
163151066|NCT01709721|589267041|FG001|Open Label Phase|Inadequate Pain Control|0|||
163151067|NCT01709721|589267042|FG002|Open Label Phase|Inadequate Pain Control|37|||
163151068|NCT01709721|589267040|FG000|Open Label Phase|Other, Specify in text field in database|0|||
163151069|NCT01709721|589267041|FG001|Open Label Phase|Other, Specify in text field in database|0|||
163151070|NCT01709721|589267042|FG002|Open Label Phase|Other, Specify in text field in database|14|||
163151071|NCT01709721|589267040|FG000|Randomized Phase|Adverse Event|0|||
163151072|NCT01709721|589267041|FG001|Randomized Phase|Adverse Event|1|||
163151073|NCT01709721|589267042|FG002|Randomized Phase|Adverse Event|0|||
163151074|NCT01709721|589267040|FG000|Randomized Phase|Lost to Follow-up|1|||
163151075|NCT01709721|589267041|FG001|Randomized Phase|Lost to Follow-up|0|||
163151076|NCT01709721|589267042|FG002|Randomized Phase|Lost to Follow-up|0|||
163151077|NCT01709721|589267040|FG000|Randomized Phase|Inadequate Pain Control|1|||
163151078|NCT01709721|589267041|FG001|Randomized Phase|Inadequate Pain Control|2|||
163151079|NCT01709721|589267042|FG002|Randomized Phase|Inadequate Pain Control|0|||
163151080|NCT01709721|589267040|FG000|Randomized Phase|Other, Specify text field in database|1|||
163151081|NCT01709721|589267041|FG001|Randomized Phase|Other, Specify text field in database|3|||
163151082|NCT01709721|589267042|FG002|Randomized Phase|Other, Specify text field in database|0|||
163151083|NCT02230410|589267045|FG000|Overall Study|Screen Failure|3|||
163151084|NCT02558894|589267051|FG000|Overall Study|Death; any cause, entire study duration|28|||
163151085|NCT02558894|589267052|FG001|Overall Study|Death; any cause, entire study duration|31|||
163151086|NCT02558894|589267051|FG000|Overall Study|Withdrawal by Subject|2|||
163151087|NCT02558894|589267052|FG001|Overall Study|Withdrawal by Subject|1|||
163151088|NCT02558894|589267051|FG000|Overall Study|Closure of Part A|2|||
163151089|NCT02558894|589267052|FG001|Overall Study|Closure of Part A|1|||
163151090|NCT02992288|589267053|FG000|Overall Study|Adverse Event|8|||
163151091|NCT02992288|589267054|FG001|Overall Study|Adverse Event|2|||
163151092|NCT02992288|589267055|FG002|Overall Study|Adverse Event|2|||
163151093|NCT02992288|589267056|FG003|Overall Study|Adverse Event|2|||
163151094|NCT02992288|589267057|FG004|Overall Study|Adverse Event|2|||
163151095|NCT02992288|589267058|FG005|Overall Study|Adverse Event|7|||
163151096|NCT02992288|589267053|FG000|Overall Study|Non-compliance with study drug|0|||
163151097|NCT02992288|589267054|FG001|Overall Study|Non-compliance with study drug|1|||
163151098|NCT02992288|589267055|FG002|Overall Study|Non-compliance with study drug|1|||
163151099|NCT02992288|589267056|FG003|Overall Study|Non-compliance with study drug|0|||
163151100|NCT02992288|589267057|FG004|Overall Study|Non-compliance with study drug|1|||
163151101|NCT02992288|589267058|FG005|Overall Study|Non-compliance with study drug|0|||
163151102|NCT02992288|589267053|FG000|Overall Study|Physician Decision|3|||
163151103|NCT02992288|589267054|FG001|Overall Study|Physician Decision|0|||
163151104|NCT02992288|589267055|FG002|Overall Study|Physician Decision|1|||
163151105|NCT02992288|589267056|FG003|Overall Study|Physician Decision|0|||
163151106|NCT02992288|589267057|FG004|Overall Study|Physician Decision|0|||
163151107|NCT02992288|589267058|FG005|Overall Study|Physician Decision|1|||
163151108|NCT02992288|589267053|FG000|Overall Study|Death|2|||
163151109|NCT02992288|589267054|FG001|Overall Study|Death|0|||
163151110|NCT02992288|589267055|FG002|Overall Study|Death|2|||
163151111|NCT02992288|589267056|FG003|Overall Study|Death|1|||
163151112|NCT02992288|589267057|FG004|Overall Study|Death|2|||
163151113|NCT02992288|589267058|FG005|Overall Study|Death|0|||
163151114|NCT02992288|589267053|FG000|Overall Study|Lost to Follow-up|0|||
163151115|NCT02992288|589267054|FG001|Overall Study|Lost to Follow-up|0|||
163151116|NCT02992288|589267055|FG002|Overall Study|Lost to Follow-up|0|||
163151117|NCT02992288|589267056|FG003|Overall Study|Lost to Follow-up|1|||
163151118|NCT02992288|589267057|FG004|Overall Study|Lost to Follow-up|0|||
163151119|NCT02992288|589267058|FG005|Overall Study|Lost to Follow-up|0|||
163151120|NCT02992288|589267053|FG000|Overall Study|Protocol Violation|0|||
163151121|NCT02992288|589267054|FG001|Overall Study|Protocol Violation|0|||
163151122|NCT02992288|589267055|FG002|Overall Study|Protocol Violation|0|||
163151123|NCT02992288|589267056|FG003|Overall Study|Protocol Violation|0|||
163151124|NCT02992288|589267057|FG004|Overall Study|Protocol Violation|0|||
163151125|NCT02992288|589267058|FG005|Overall Study|Protocol Violation|1|||
163151126|NCT02992288|589267053|FG000|Overall Study|Withdrawal by Subject|4|||
163151127|NCT02992288|589267054|FG001|Overall Study|Withdrawal by Subject|2|||
163151128|NCT02992288|589267055|FG002|Overall Study|Withdrawal by Subject|1|||
163151129|NCT02992288|589267056|FG003|Overall Study|Withdrawal by Subject|5|||
163151130|NCT02992288|589267057|FG004|Overall Study|Withdrawal by Subject|3|||
163151131|NCT02992288|589267058|FG005|Overall Study|Withdrawal by Subject|4|||
163151132|NCT00499486|589267059|FG000|Overall Study|Withdrawal by Subject|16|||
163151133|NCT00656513|589267060|FG000|Overall Study|Protocol Violation|1|||
163151134|NCT00656513|589267061|FG001|Overall Study|Protocol Violation|0|||
163151135|NCT00656513|589267062|FG002|Overall Study|Protocol Violation|2|||
163151136|NCT00656513|589267060|FG000|Overall Study|Withdrawal by Subject|0|||
163151137|NCT00656513|589267061|FG001|Overall Study|Withdrawal by Subject|11|||
163151138|NCT00656513|589267062|FG002|Overall Study|Withdrawal by Subject|4|||
163151139|NCT00656513|589267060|FG000|Overall Study|Death|0|||
163151140|NCT00656513|589267061|FG001|Overall Study|Death|0|||
163151141|NCT00656513|589267062|FG002|Overall Study|Death|1|||
163151142|NCT00656513|589267060|FG000|Overall Study|Missing data|0|||
163151143|NCT00656513|589267061|FG001|Overall Study|Missing data|11|||
163151144|NCT00656513|589267062|FG002|Overall Study|Missing data|9|||
163151145|NCT00656513|589267060|FG000|Overall Study|Incomplete treatment|3|||
163151146|NCT00656513|589267061|FG001|Overall Study|Incomplete treatment|0|||
163151147|NCT00656513|589267062|FG002|Overall Study|Incomplete treatment|0|||
163151148|NCT00656513|589267060|FG000|Overall Study|Treatment completed outside of timeframe|0|||
163151149|NCT00656513|589267061|FG001|Overall Study|Treatment completed outside of timeframe|3|||
163151150|NCT00656513|589267062|FG002|Overall Study|Treatment completed outside of timeframe|1|||
163151151|NCT00656513|589267060|FG000|Overall Study|Missing baseline form|0|||
163151152|NCT00656513|589267061|FG001|Overall Study|Missing baseline form|5|||
163151153|NCT00656513|589267062|FG002|Overall Study|Missing baseline form|5|||
163151154|NCT03796728|589267067|FG000|Overall Study|Lost to Follow-up|8|||
163151155|NCT03796728|589267067|FG000|Overall Study|Reason not Specified|16|||
163151156|NCT00333775|589267068|FG000|Overall Study|Death|144|||
163151157|NCT00333775|589267069|FG001|Overall Study|Death|149|||
163151158|NCT00333775|589267070|FG002|Overall Study|Death|143|||
163151159|NCT00333775|589267068|FG000|Overall Study|In Follow-up When Study Stopped|87|||
163151160|NCT00333775|589267069|FG001|Overall Study|In Follow-up When Study Stopped|92|||
163151161|NCT00333775|589267070|FG002|Overall Study|In Follow-up When Study Stopped|96|||
163151162|NCT00333775|589267068|FG000|Overall Study|Lost to Follow-up|10|||
163151163|NCT00333775|589267069|FG001|Overall Study|Lost to Follow-up|7|||
163151164|NCT00333775|589267070|FG002|Overall Study|Lost to Follow-up|8|||
163151165|NCT00412984|589267076|FG000|Overall Study|Death|331|||
163151166|NCT00412984|589267077|FG001|Overall Study|Death|349|||
163151167|NCT00412984|589267076|FG000|Overall Study|Adverse Event|679|||
163151168|NCT00412984|589267077|FG001|Overall Study|Adverse Event|738|||
163151169|NCT00412984|589267076|FG000|Overall Study|Withdrawal by Subject|921|||
163151170|NCT00412984|589267077|FG001|Overall Study|Withdrawal by Subject|989|||
163151171|NCT00412984|589267076|FG000|Overall Study|Lost to Follow-up|51|||
163151172|NCT00412984|589267077|FG001|Overall Study|Lost to Follow-up|39|||
163151173|NCT00412984|589267076|FG000|Overall Study|Poor/Noncompliance|57|||
163151174|NCT00412984|589267077|FG001|Overall Study|Poor/Noncompliance|77|||
163151175|NCT00412984|589267076|FG000|Overall Study|Pregnancy|1|||
163151176|NCT00412984|589267077|FG001|Overall Study|Pregnancy|0|||
163151177|NCT00412984|589267076|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
163151178|NCT00412984|589267077|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
163151179|NCT00412984|589267076|FG000|Overall Study|Administrative Reason by Sponsor|11|||
163151180|NCT00412984|589267077|FG001|Overall Study|Administrative Reason by Sponsor|8|||
163151181|NCT00412984|589267076|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
163151182|NCT00412984|589267077|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
163151183|NCT00412984|589267076|FG000|Overall Study|Other Reason|80|||
163151184|NCT00412984|589267077|FG001|Overall Study|Other Reason|92|||
163151185|NCT00412984|589267076|FG000|Overall Study|Not Reported|11|||
163151186|NCT00412984|589267077|FG001|Overall Study|Not Reported|12|||
163151187|NCT03651765|589267078|FG000|Overall Study|Adverse Event|6|||
162671695|NCT00718718|587505861|FG005|Week 12 to End of Study|Death|1|||
162671696|NCT00718718|587505862|FG006|Week 12 to End of Study|Death|0|||
162671697|NCT00718718|587505863|FG007|Week 12 to End of Study|Death|0|||
162671698|NCT00718718|587505864|FG008|Week 12 to End of Study|Death|0|||
162671699|NCT00718718|587505865|FG009|Week 12 to End of Study|Death|0|||
162671700|NCT00718718|587505856|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
162671701|NCT00718718|587505857|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
162671702|NCT00718718|587505858|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
162671703|NCT00718718|587505859|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
162671704|NCT00718718|587505860|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
162671705|NCT00718718|587505861|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
162671706|NCT00718718|587505862|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
162671707|NCT00718718|587505863|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
162671708|NCT00718718|587505864|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
162671709|NCT00718718|587505865|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
162671710|NCT00718718|587505856|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
162671711|NCT00718718|587505857|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
162671712|NCT00718718|587505858|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
162671713|NCT00718718|587505859|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
162671714|NCT00718718|587505860|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
162671715|NCT00718718|587505861|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
162671716|NCT00718718|587505862|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
162671717|NCT00718718|587505863|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
162671718|NCT00718718|587505864|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
162671719|NCT00718718|587505865|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
162671720|NCT00718718|587505856|FG000|Week 12 to End of Study|Other|0|||
162671721|NCT00718718|587505857|FG001|Week 12 to End of Study|Other|1|||
162671722|NCT00718718|587505858|FG002|Week 12 to End of Study|Other|0|||
162671723|NCT00718718|587505859|FG003|Week 12 to End of Study|Other|1|||
162671724|NCT00718718|587505860|FG004|Week 12 to End of Study|Other|0|||
162671725|NCT00718718|587505861|FG005|Week 12 to End of Study|Other|0|||
162671726|NCT00718718|587505862|FG006|Week 12 to End of Study|Other|1|||
162671727|NCT00718718|587505863|FG007|Week 12 to End of Study|Other|0|||
162671728|NCT00718718|587505864|FG008|Week 12 to End of Study|Other|0|||
162671729|NCT00718718|587505865|FG009|Week 12 to End of Study|Other|0|||
162671730|NCT03099382|587505866|FG000|Overall Study|Protocol Violation|2|||
162671731|NCT03099382|587505867|FG001|Overall Study|Protocol Violation|3|||
162671732|NCT01802411|587505870|FG000|Overall Study|Death|2|||
162671733|NCT01802411|587505871|FG001|Overall Study|Death|1|||
162671734|NCT01802411|587505870|FG000|Overall Study|Adverse Event|2|||
162671735|NCT01802411|587505871|FG001|Overall Study|Adverse Event|7|||
162671736|NCT01802411|587505870|FG000|Overall Study|Lack of Efficacy|8|||
162671737|NCT01802411|587505871|FG001|Overall Study|Lack of Efficacy|10|||
162671738|NCT01802411|587505870|FG000|Overall Study|Withdrawal by Subject|0|||
162671739|NCT01802411|587505871|FG001|Overall Study|Withdrawal by Subject|2|||
162671740|NCT01802411|587505870|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
162671741|NCT01802411|587505871|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
162671742|NCT01802411|587505870|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
162671743|NCT01802411|587505871|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
162671744|NCT01802411|587505870|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
162671745|NCT01802411|587505871|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
162671746|NCT03930745|587505877|FG000|Overall Study|Lost to Follow-up|10|||
162671747|NCT03930745|587505878|FG001|Overall Study|Lost to Follow-up|5|||
162671748|NCT03930745|587505877|FG000|Overall Study|Withdrawal by Subject|1|||
162671749|NCT03930745|587505878|FG001|Overall Study|Withdrawal by Subject|2|||
162671750|NCT03930745|587505877|FG000|Overall Study|Protocol Violation|2|||
162671751|NCT03930745|587505878|FG001|Overall Study|Protocol Violation|2|||
162671752|NCT03930745|587505877|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
162671753|NCT03930745|587505878|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
162671754|NCT03930745|587505877|FG000|Overall Study|Adverse Event|0|||
162671755|NCT03930745|587505878|FG001|Overall Study|Adverse Event|1|||
162671756|NCT03930745|587505877|FG000|Overall Study|Pregnancy|0|||
162671757|NCT03930745|587505878|FG001|Overall Study|Pregnancy|1|||
162671758|NCT02715765|587505881|FG000|Overall Study|Study Termination|3|||
162671759|NCT02715765|587505882|FG001|Overall Study|Study Termination|0|||
162671760|NCT02715765|587505883|FG002|Overall Study|Study Termination|0|||
162671761|NCT03588572|587505884|FG000|Visitation 1|Lack of Efficacy|1|||
162671762|NCT03588572|587505885|FG001|Visitation 1|Lack of Efficacy|1|||
162671763|NCT03588572|587505884|FG000|Visitation 2|Lost to Follow-up|1|||
162671764|NCT03588572|587505885|FG001|Visitation 2|Lost to Follow-up|1|||
162671765|NCT03588572|587505884|FG000|Visitation 2|Lack of Efficacy|0|||
162671766|NCT03588572|587505885|FG001|Visitation 2|Lack of Efficacy|1|||
162671767|NCT03588572|587505884|FG000|Visitation 2|Withdrawal by Subject|1|||
162671768|NCT03588572|587505885|FG001|Visitation 2|Withdrawal by Subject|0|||
162671769|NCT03588572|587505884|FG000|Visitation 3|Lost to Follow-up|1|||
162671770|NCT03588572|587505885|FG001|Visitation 3|Lost to Follow-up|1|||
162671771|NCT03588572|587505884|FG000|Visitation 3|Physician Decision|1|||
162671772|NCT03588572|587505885|FG001|Visitation 3|Physician Decision|1|||
162671773|NCT03588572|587505884|FG000|Visitation 3|Withdrawal by Subject|1|||
162671774|NCT03588572|587505885|FG001|Visitation 3|Withdrawal by Subject|0|||
162671775|NCT01165281|587505886|FG000|Overall Study|Adverse Event|12|||
162671776|NCT01165281|587505887|FG001|Overall Study|Adverse Event|14|||
162671777|NCT01165281|587505886|FG000|Overall Study|Death|3|||
162671778|NCT01165281|587505887|FG001|Overall Study|Death|4|||
162671779|NCT01165281|587505886|FG000|Overall Study|Lack of Efficacy|4|||
162671780|NCT01165281|587505887|FG001|Overall Study|Lack of Efficacy|1|||
162671781|NCT01165281|587505886|FG000|Overall Study|Lost to Follow-up|0|||
162671782|NCT01165281|587505887|FG001|Overall Study|Lost to Follow-up|1|||
162671783|NCT01165281|587505886|FG000|Overall Study|Physician Decision|8|||
162671784|NCT01165281|587505887|FG001|Overall Study|Physician Decision|1|||
162671785|NCT01165281|587505886|FG000|Overall Study|Protocol Violation|6|||
162671786|NCT01165281|587505887|FG001|Overall Study|Protocol Violation|5|||
162671787|NCT01165281|587505886|FG000|Overall Study|Withdrawal by Subject|8|||
162671788|NCT01165281|587505887|FG001|Overall Study|Withdrawal by Subject|7|||
162671789|NCT01165281|587505886|FG000|Overall Study|Noncompliance with Study Drug|1|||
162671790|NCT01165281|587505887|FG001|Overall Study|Noncompliance with Study Drug|4|||
162671791|NCT01165281|587505886|FG000|Overall Study|Progressive Disease|10|||
162671792|NCT01165281|587505887|FG001|Overall Study|Progressive Disease|14|||
162671793|NCT01165281|587505886|FG000|Overall Study|Other|6|||
162671794|NCT01165281|587505887|FG001|Overall Study|Other|0|||
162671795|NCT02863991|587505888|FG000|Overall Study|Death|0|||
162671796|NCT02863991|587505889|FG001|Overall Study|Death|3|||
162671797|NCT02863991|587505888|FG000|Overall Study|Lack of Efficacy|0|||
162671798|NCT02863991|587505889|FG001|Overall Study|Lack of Efficacy|1|||
162671799|NCT02863991|587505888|FG000|Overall Study|Study Terminated|2|||
162671800|NCT02863991|587505889|FG001|Overall Study|Study Terminated|8|||
162671801|NCT00364858|587505890|FG000|Overall Study|Adverse Event|1|||
162671802|NCT00364858|587505891|FG001|Overall Study|Adverse Event|5|||
162671803|NCT00364858|587505890|FG000|Overall Study|Withdrawal by Subject|1|||
162671804|NCT00364858|587505891|FG001|Overall Study|Withdrawal by Subject|1|||
162671805|NCT00364858|587505890|FG000|Overall Study|Pregnancy|1|||
162671806|NCT00364858|587505891|FG001|Overall Study|Pregnancy|1|||
162671807|NCT00364858|587505890|FG000|Overall Study|Clinical failure|2|||
162671808|NCT00364858|587505891|FG001|Overall Study|Clinical failure|13|||
162671809|NCT00364858|587505890|FG000|Overall Study|Discontinuation at baseline|1|||
162671810|NCT00364858|587505891|FG001|Overall Study|Discontinuation at baseline|0|||
162671811|NCT00364858|587505890|FG000|Overall Study|Non-compliant|1|||
162671812|NCT00364858|587505891|FG001|Overall Study|Non-compliant|0|||
162671813|NCT00364858|587505890|FG000|Overall Study|Return to Q2 regimen|0|||
162671814|NCT00364858|587505891|FG001|Overall Study|Return to Q2 regimen|1|||
162671815|NCT00364858|587505890|FG000|Overall Study|Clinical baseline issue|0|||
162671816|NCT00364858|587505891|FG001|Overall Study|Clinical baseline issue|1|||
162671817|NCT00363766|587505892|FG000|Overall Study|Progressive Disease|15|||
162671818|NCT00363766|587505893|FG001|Overall Study|Progressive Disease|9|||
162671819|NCT00363766|587505892|FG000|Overall Study|Adverse Event|10|||
162671820|NCT00363766|587505893|FG001|Overall Study|Adverse Event|2|||
162671821|NCT00363766|587505892|FG000|Overall Study|Disease Related Death|1|||
162671822|NCT00363766|587505893|FG001|Overall Study|Disease Related Death|3|||
162671823|NCT00363766|587505892|FG000|Overall Study|Not Disease Related Death|3|||
162671824|NCT00363766|587505893|FG001|Overall Study|Not Disease Related Death|4|||
162671825|NCT00363766|587505892|FG000|Overall Study|Withdrawal by Subject|2|||
162671826|NCT00363766|587505893|FG001|Overall Study|Withdrawal by Subject|0|||
162671827|NCT00363766|587505892|FG000|Overall Study|Physician Decision|1|||
162671828|NCT00363766|587505893|FG001|Overall Study|Physician Decision|2|||
162671829|NCT00558285|587505894|FG000|Overall Study|Adverse Event|1|||
162671830|NCT00558285|587505895|FG001|Overall Study|Adverse Event|1|||
162671831|NCT00558285|587505896|FG002|Overall Study|Adverse Event|4|||
162671832|NCT00558285|587505897|FG003|Overall Study|Adverse Event|1|||
162671833|NCT00558285|587505898|FG004|Overall Study|Adverse Event|2|||
162671834|NCT00558285|587505894|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162671835|NCT00558285|587505895|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162671836|NCT00558285|587505896|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162671837|NCT00558285|587505897|FG003|Overall Study|Abnormal test procedure result(s)|0|||
162671838|NCT00558285|587505898|FG004|Overall Study|Abnormal test procedure result(s)|0|||
162671839|NCT00558285|587505894|FG000|Overall Study|Subject withdrew consent|2|||
162671840|NCT00558285|587505895|FG001|Overall Study|Subject withdrew consent|0|||
162671841|NCT00558285|587505896|FG002|Overall Study|Subject withdrew consent|1|||
162671842|NCT00558285|587505897|FG003|Overall Study|Subject withdrew consent|1|||
162671843|NCT00558285|587505898|FG004|Overall Study|Subject withdrew consent|1|||
162671844|NCT00558285|587505894|FG000|Overall Study|Lost to Follow-up|1|||
162671845|NCT00558285|587505895|FG001|Overall Study|Lost to Follow-up|1|||
162671846|NCT00558285|587505896|FG002|Overall Study|Lost to Follow-up|0|||
162671847|NCT00558285|587505897|FG003|Overall Study|Lost to Follow-up|0|||
162671848|NCT00558285|587505898|FG004|Overall Study|Lost to Follow-up|0|||
162671849|NCT00558285|587505894|FG000|Overall Study|Administrative problems|0|||
162671850|NCT00558285|587505895|FG001|Overall Study|Administrative problems|0|||
162671851|NCT00558285|587505896|FG002|Overall Study|Administrative problems|0|||
162671852|NCT00558285|587505897|FG003|Overall Study|Administrative problems|1|||
162671853|NCT00558285|587505898|FG004|Overall Study|Administrative problems|1|||
162671854|NCT00558285|587505894|FG000|Overall Study|Protocol deviation|1|||
162671855|NCT00558285|587505895|FG001|Overall Study|Protocol deviation|1|||
162671856|NCT00558285|587505896|FG002|Overall Study|Protocol deviation|0|||
162671857|NCT00558285|587505897|FG003|Overall Study|Protocol deviation|1|||
162671858|NCT00558285|587505898|FG004|Overall Study|Protocol deviation|0|||
162671859|NCT02730819|587505905|FG000|Overall Study|Lost to Follow-up|9|||
162671860|NCT02345512|587505906|FG000|Overall Study|Adverse Event|1|||
162671861|NCT02345512|587505906|FG000|Overall Study|Withdrawal by Subject|1|||
162671862|NCT01660906|587505907|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
162671863|NCT02121847|587505908|FG000|Overall Study|Administrative Reasons|1|||
162671864|NCT02121847|587505908|FG000|Overall Study|Adverse Event|2|||
162671865|NCT03478891|587505916|FG000|Overall Study|Enrolled, but product never administered|0|||
162671866|NCT03478891|587505917|FG001|Overall Study|Enrolled, but product never administered|0|||
162671867|NCT03478891|587505918|FG002|Overall Study|Enrolled, but product never administered|1|||
162671868|NCT03478891|587505916|FG000|Overall Study|Moved from area|0|||
162671869|NCT03478891|587505917|FG001|Overall Study|Moved from area|0|||
162671870|NCT03478891|587505918|FG002|Overall Study|Moved from area|1|||
162671871|NCT03478891|587505916|FG000|Overall Study|Lost to Follow-up|1|||
162671872|NCT03478891|587505917|FG001|Overall Study|Lost to Follow-up|0|||
162671873|NCT03478891|587505918|FG002|Overall Study|Lost to Follow-up|1|||
162671874|NCT01308580|587505920|FG000|Overall Study|Lost to Follow-up|12|||
162671875|NCT01308580|587505921|FG001|Overall Study|Lost to Follow-up|7|||
162671876|NCT03823651|587505922|FG000|Overall Study|Death|5|||
162671877|NCT03823651|587505923|FG001|Overall Study|Death|0|||
162671878|NCT03823651|587505922|FG000|Overall Study|Physician Decision|1|||
162671879|NCT03823651|587505923|FG001|Overall Study|Physician Decision|0|||
162671880|NCT03823651|587505922|FG000|Overall Study|Caregiver to patient who died|0|||
163151188|NCT03651765|589267078|FG000|Overall Study|Lack of Efficacy|18|||
163151189|NCT03651765|589267078|FG000|Overall Study|Lost to Follow-up|5|||
163151190|NCT03651765|589267078|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163151191|NCT03651765|589267078|FG000|Overall Study|Physician Decision|6|||
163151192|NCT03651765|589267078|FG000|Overall Study|Pregnancy|1|||
163151193|NCT03651765|589267078|FG000|Overall Study|Discontinued by Sponsor|40|||
163151194|NCT03651765|589267078|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
163151195|NCT03651765|589267078|FG000|Overall Study|Withdrawal by Subject|24|||
163151196|NCT03651765|589267078|FG000|Overall Study|Miscellaneous|6|||
163151197|NCT04097678|589267081|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
163151198|NCT04097678|589267082|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
163151199|NCT03694678|589267083|FG000|Overall Study|Withdrawal by Subject|2|||
163151200|NCT03694678|589267084|FG001|Overall Study|Withdrawal by Subject|0|||
163151201|NCT03694678|589267083|FG000|Overall Study|Lost to Follow-up|2|||
163151202|NCT03694678|589267084|FG001|Overall Study|Lost to Follow-up|3|||
163151203|NCT02435212|589267085|FG000|Core Phase|Adverse Event|8|||
163151204|NCT02435212|589267086|FG001|Core Phase|Adverse Event|5|||
163151205|NCT02435212|589267085|FG000|Core Phase|Withdrawal by Subject|3|||
163151206|NCT02435212|589267086|FG001|Core Phase|Withdrawal by Subject|0|||
163151207|NCT02435212|589267085|FG000|Core Phase|Withdrawal by parent/guardian|9|||
163151208|NCT02435212|589267086|FG001|Core Phase|Withdrawal by parent/guardian|4|||
163151209|NCT02435212|589267085|FG000|Core Phase|Protocol Violation|1|||
163151210|NCT02435212|589267086|FG001|Core Phase|Protocol Violation|2|||
163151211|NCT02435212|589267085|FG000|Core Phase|Physician Decision|3|||
163151212|NCT02435212|589267086|FG001|Core Phase|Physician Decision|0|||
163151213|NCT02435212|589267085|FG000|Core Phase|Lost to Follow-up|0|||
163151214|NCT02435212|589267086|FG001|Core Phase|Lost to Follow-up|1|||
163151215|NCT02435212|589267085|FG000|Core Phase|Lack of Efficacy|0|||
163151216|NCT02435212|589267086|FG001|Core Phase|Lack of Efficacy|1|||
163151217|NCT02435212|589267085|FG000|Core Phase|Recovery|1|||
163151218|NCT02435212|589267086|FG001|Core Phase|Recovery|0|||
163151219|NCT02435212|589267085|FG000|Optional Extension Phase|Adverse Event|3|||
163151220|NCT02435212|589267086|FG001|Optional Extension Phase|Adverse Event|9|||
163151221|NCT02435212|589267085|FG000|Optional Extension Phase|Physician Decision|6|||
163151222|NCT02435212|589267086|FG001|Optional Extension Phase|Physician Decision|8|||
163151223|NCT02435212|589267085|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
163151224|NCT02435212|589267086|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
163151225|NCT02435212|589267085|FG000|Optional Extension Phase|Lack of Efficacy|2|||
163151226|NCT02435212|589267086|FG001|Optional Extension Phase|Lack of Efficacy|3|||
163151227|NCT02435212|589267085|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
163151228|NCT02435212|589267086|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
163151229|NCT02435212|589267085|FG000|Optional Extension Phase|Protocol Violation|0|||
163151230|NCT02435212|589267086|FG001|Optional Extension Phase|Protocol Violation|1|||
163151231|NCT02435212|589267085|FG000|Optional Extension Phase|Recovery|1|||
162671881|NCT03823651|587505923|FG001|Overall Study|Caregiver to patient who died|5|||
162671882|NCT03823651|587505922|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
162671883|NCT03823651|587505923|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
162671884|NCT03864614|587505924|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
162671885|NCT03864614|587505925|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
162671886|NCT03864614|587505926|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
162671887|NCT03864614|587505927|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
162671888|NCT03864614|587505924|FG000|Overall Study|Withdrawal by Subject|72|||
162671889|NCT03864614|587505925|FG001|Overall Study|Withdrawal by Subject|100|||
162671890|NCT03864614|587505926|FG002|Overall Study|Withdrawal by Subject|1|||
162671891|NCT03864614|587505927|FG003|Overall Study|Withdrawal by Subject|21|||
162671892|NCT03864614|587505924|FG000|Overall Study|Lost to Follow-up|45|||
162671893|NCT03864614|587505925|FG001|Overall Study|Lost to Follow-up|54|||
162671894|NCT03864614|587505926|FG002|Overall Study|Lost to Follow-up|0|||
162671895|NCT03864614|587505927|FG003|Overall Study|Lost to Follow-up|9|||
162671896|NCT03864614|587505924|FG000|Overall Study|Adverse Event|42|||
162671897|NCT03864614|587505925|FG001|Overall Study|Adverse Event|30|||
162671898|NCT03864614|587505926|FG002|Overall Study|Adverse Event|1|||
162671899|NCT03864614|587505927|FG003|Overall Study|Adverse Event|9|||
162671900|NCT03864614|587505924|FG000|Overall Study|Protocol Deviation|6|||
162671901|NCT03864614|587505925|FG001|Overall Study|Protocol Deviation|26|||
162671902|NCT03864614|587505926|FG002|Overall Study|Protocol Deviation|0|||
162671903|NCT03864614|587505927|FG003|Overall Study|Protocol Deviation|1|||
162671904|NCT03864614|587505924|FG000|Overall Study|Physician Decision|7|||
162671905|NCT03864614|587505925|FG001|Overall Study|Physician Decision|10|||
162671906|NCT03864614|587505926|FG002|Overall Study|Physician Decision|1|||
162671907|NCT03864614|587505927|FG003|Overall Study|Physician Decision|5|||
162671908|NCT03864614|587505924|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
162671909|NCT03864614|587505925|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
162671910|NCT03864614|587505926|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
162671911|NCT03864614|587505927|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
162671912|NCT03864614|587505924|FG000|Overall Study|Sponsor Decision|1|||
162671913|NCT03864614|587505925|FG001|Overall Study|Sponsor Decision|2|||
162671914|NCT03864614|587505926|FG002|Overall Study|Sponsor Decision|0|||
162671915|NCT03864614|587505927|FG003|Overall Study|Sponsor Decision|0|||
162671916|NCT03864614|587505924|FG000|Overall Study|Pregnancy|0|||
162671917|NCT03864614|587505925|FG001|Overall Study|Pregnancy|1|||
162671918|NCT03864614|587505926|FG002|Overall Study|Pregnancy|0|||
162671919|NCT03864614|587505927|FG003|Overall Study|Pregnancy|0|||
162671920|NCT03864614|587505924|FG000|Overall Study|Other|7|||
162671921|NCT03864614|587505925|FG001|Overall Study|Other|9|||
162671922|NCT03864614|587505926|FG002|Overall Study|Other|1|||
162671923|NCT03864614|587505927|FG003|Overall Study|Other|4|||
162671924|NCT03864614|587505924|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
162671925|NCT03864614|587505925|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
162671926|NCT03864614|587505926|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
162671927|NCT03864614|587505927|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
162671928|NCT01983293|587508159|FG000|Overall Study|Withdrawal by Subject|29|||
162671929|NCT01983293|587508160|FG001|Overall Study|Withdrawal by Subject|15|||
162671930|NCT01983293|587508159|FG000|Overall Study|Missing 12-month visit|3|||
162671931|NCT01983293|587508160|FG001|Overall Study|Missing 12-month visit|3|||
162671932|NCT01983293|587508159|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
162671933|NCT01983293|587508160|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
162671934|NCT03147248|587508161|FG000|Overall Study|Adverse Event|0|||
162671935|NCT03147248|587508162|FG001|Overall Study|Adverse Event|2|||
162671936|NCT03147248|587508163|FG002|Overall Study|Adverse Event|2|||
162671937|NCT03147248|587508164|FG003|Overall Study|Adverse Event|2|||
162671938|NCT03147248|587508165|FG004|Overall Study|Adverse Event|6|||
162671939|NCT03147248|587508166|FG005|Overall Study|Adverse Event|11|||
162671940|NCT03147248|587508161|FG000|Overall Study|Disease progression|1|||
162671941|NCT03147248|587508162|FG001|Overall Study|Disease progression|0|||
162671942|NCT03147248|587508163|FG002|Overall Study|Disease progression|0|||
162671943|NCT03147248|587508164|FG003|Overall Study|Disease progression|0|||
162671944|NCT03147248|587508165|FG004|Overall Study|Disease progression|0|||
162671945|NCT03147248|587508166|FG005|Overall Study|Disease progression|2|||
162671946|NCT03147248|587508161|FG000|Overall Study|Withdrawal by Subject|0|||
162671947|NCT03147248|587508162|FG001|Overall Study|Withdrawal by Subject|0|||
162671948|NCT03147248|587508163|FG002|Overall Study|Withdrawal by Subject|0|||
162671949|NCT03147248|587508164|FG003|Overall Study|Withdrawal by Subject|0|||
162671950|NCT03147248|587508165|FG004|Overall Study|Withdrawal by Subject|12|||
162671951|NCT03147248|587508166|FG005|Overall Study|Withdrawal by Subject|9|||
162671952|NCT03147248|587508161|FG000|Overall Study|Protocol Violation|0|||
162671953|NCT03147248|587508162|FG001|Overall Study|Protocol Violation|0|||
162671954|NCT03147248|587508163|FG002|Overall Study|Protocol Violation|0|||
162671955|NCT03147248|587508164|FG003|Overall Study|Protocol Violation|0|||
162671956|NCT03147248|587508165|FG004|Overall Study|Protocol Violation|2|||
162671957|NCT03147248|587508166|FG005|Overall Study|Protocol Violation|0|||
162671958|NCT03147248|587508161|FG000|Overall Study|Lost to Follow-up|0|||
162671959|NCT03147248|587508162|FG001|Overall Study|Lost to Follow-up|0|||
162671960|NCT03147248|587508163|FG002|Overall Study|Lost to Follow-up|0|||
162671961|NCT03147248|587508164|FG003|Overall Study|Lost to Follow-up|0|||
162671962|NCT03147248|587508165|FG004|Overall Study|Lost to Follow-up|2|||
162671963|NCT03147248|587508166|FG005|Overall Study|Lost to Follow-up|0|||
162671964|NCT03147248|587508161|FG000|Overall Study|Pregnancy|0|||
162671965|NCT03147248|587508162|FG001|Overall Study|Pregnancy|0|||
162671966|NCT03147248|587508163|FG002|Overall Study|Pregnancy|0|||
162671967|NCT03147248|587508164|FG003|Overall Study|Pregnancy|0|||
162671968|NCT03147248|587508165|FG004|Overall Study|Pregnancy|1|||
162671969|NCT03147248|587508166|FG005|Overall Study|Pregnancy|0|||
162671970|NCT03147248|587508161|FG000|Overall Study|Death|0|||
162671971|NCT03147248|587508162|FG001|Overall Study|Death|0|||
162671972|NCT03147248|587508163|FG002|Overall Study|Death|0|||
162671973|NCT03147248|587508164|FG003|Overall Study|Death|0|||
162671974|NCT03147248|587508165|FG004|Overall Study|Death|0|||
162671975|NCT03147248|587508166|FG005|Overall Study|Death|4|||
162671976|NCT03147248|587508161|FG000|Overall Study|Physician Decision|0|||
162671977|NCT03147248|587508162|FG001|Overall Study|Physician Decision|0|||
162671978|NCT03147248|587508163|FG002|Overall Study|Physician Decision|0|||
162671979|NCT03147248|587508164|FG003|Overall Study|Physician Decision|0|||
162671980|NCT03147248|587508165|FG004|Overall Study|Physician Decision|2|||
162671981|NCT03147248|587508166|FG005|Overall Study|Physician Decision|4|||
162671982|NCT03147248|587508161|FG000|Overall Study|Prolonged Dosing Interval|0|||
162671983|NCT03147248|587508162|FG001|Overall Study|Prolonged Dosing Interval|0|||
162671984|NCT03147248|587508163|FG002|Overall Study|Prolonged Dosing Interval|0|||
162671985|NCT03147248|587508164|FG003|Overall Study|Prolonged Dosing Interval|0|||
162671986|NCT03147248|587508165|FG004|Overall Study|Prolonged Dosing Interval|1|||
162671987|NCT03147248|587508166|FG005|Overall Study|Prolonged Dosing Interval|1|||
162671988|NCT01914926|587508169|FG000|Overall Study|Adverse Event|1|||
162671989|NCT01914926|587508170|FG001|Overall Study|Adverse Event|0|||
162671990|NCT01914926|587508169|FG000|Overall Study|uncooperative, agitated and removed|0|||
162671991|NCT01914926|587508170|FG001|Overall Study|uncooperative, agitated and removed|1|||
162671992|NCT00856856|587508177|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
162671993|NCT00856856|587508177|FG000|4-year Clinical Follow-up|Missed visit|1|||
162671994|NCT03073603|587508179|FG000|Overall Study|Noncompliance|3|||
162671995|NCT03073603|587508180|FG001|Overall Study|Noncompliance|1|||
162671996|NCT03073603|587508179|FG000|Overall Study|Adverse Event|5|||
162671997|NCT03073603|587508180|FG001|Overall Study|Adverse Event|3|||
162671998|NCT03073603|587508179|FG000|Overall Study|Physician Decision|1|||
162671999|NCT03073603|587508180|FG001|Overall Study|Physician Decision|2|||
162672000|NCT03073603|587508179|FG000|Overall Study|Required treatment not allowed by protocol|1|||
162672001|NCT03073603|587508180|FG001|Overall Study|Required treatment not allowed by protocol|0|||
162672002|NCT03073603|587508179|FG000|Overall Study|Financial or insurance-related|8|||
162672003|NCT03073603|587508180|FG001|Overall Study|Financial or insurance-related|0|||
162672004|NCT03073603|587508179|FG000|Overall Study|Withdrawal by Subject|0|||
162672005|NCT03073603|587508180|FG001|Overall Study|Withdrawal by Subject|1|||
162672006|NCT03073603|587508179|FG000|Overall Study|Discontinued DMT|4|||
162672007|NCT03073603|587508180|FG001|Overall Study|Discontinued DMT|0|||
162672008|NCT03073603|587508179|FG000|Overall Study|Restarted DMT|0|||
162672009|NCT03073603|587508180|FG001|Overall Study|Restarted DMT|1|||
162672010|NCT02473952|587508181|FG000|Overall Study|Adverse Event|2|||
162672011|NCT02473952|587508182|FG001|Overall Study|Adverse Event|2|||
162672012|NCT02473952|587508181|FG000|Overall Study|Withdrawal by Subject|0|||
162672013|NCT02473952|587508182|FG001|Overall Study|Withdrawal by Subject|6|||
162672014|NCT00922428|587508183|FG000|Overall Study|retrospective/extremely implausible data|2|||
162672015|NCT00922428|587508183|FG000|Overall Study|no medication use or questionable use|13|||
162672016|NCT04757649|587508184|FG000|Overall Study|Withdrawal by Subject|1|||
162672017|NCT04757649|587508184|FG000|Overall Study|Adverse Event|1|||
162672018|NCT02508311|587508192|FG000|Overall Study|Withdrawal by Subject|1|||
162672019|NCT02508311|587508193|FG001|Overall Study|Withdrawal by Subject|0|||
162672020|NCT04862143|587508194|FG000|Overall Study|Adverse Event|1|||
162672021|NCT04862143|587508194|FG000|Overall Study|Study terminated by sponsor|1|||
162672022|NCT04955639|587508195|FG000|Overall Study|Withdrawal by Subject|2|||
162672023|NCT04955639|587508196|FG001|Overall Study|Withdrawal by Subject|2|||
162672024|NCT04955639|587508195|FG000|Overall Study|Week 26 survey not completed|2|||
162672025|NCT04955639|587508196|FG001|Overall Study|Week 26 survey not completed|2|||
162672026|NCT00413153|587508197|FG000|Overall Study|Withdrawal by Subject|1|||
162672027|NCT00413153|587508198|FG001|Overall Study|Withdrawal by Subject|1|||
162672028|NCT00413153|587508197|FG000|Overall Study|Adverse Event|1|||
162672029|NCT00413153|587508198|FG001|Overall Study|Adverse Event|0|||
162672030|NCT00599326|587508201|FG000|Overall Study|Lost to Follow-up|1|||
162672031|NCT00599326|587508201|FG000|Overall Study|Noncompliant|1|||
162672032|NCT02862106|587508204|FG000|Overall Study|Adverse Event|4|||
162672033|NCT02862106|587508205|FG001|Overall Study|Adverse Event|0|||
162672034|NCT02862106|587508204|FG000|Overall Study|Protocol Violation|16|||
162672035|NCT02862106|587508205|FG001|Overall Study|Protocol Violation|1|||
162672036|NCT02862106|587508204|FG000|Overall Study|Lost to Follow-up|15|||
162672037|NCT02862106|587508205|FG001|Overall Study|Lost to Follow-up|5|||
162672038|NCT02862106|587508204|FG000|Overall Study|Withdrawal by Subject|2|||
162672039|NCT02862106|587508205|FG001|Overall Study|Withdrawal by Subject|0|||
162672040|NCT02862106|587508204|FG000|Overall Study|Subjects moved to other city|1|||
162721967|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
162721968|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162721969|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162721970|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162672041|NCT02862106|587508205|FG001|Overall Study|Subjects moved to other city|0|||
163151232|NCT02435212|589267086|FG001|Optional Extension Phase|Recovery|1|||
163151233|NCT02435212|589267085|FG000|Optional Extension Phase|Death|1|||
162672042|NCT03966157|587508208|FG000|Overall Study|Physician Decision|1|||
162672043|NCT03966157|587508209|FG001|Overall Study|Physician Decision|0|||
162672044|NCT04969250|587508210|FG000|Overall Study|Protocol Violation|0|||
162672045|NCT04969250|587508211|FG001|Overall Study|Protocol Violation|2|||
162672046|NCT04969250|587508212|FG002|Overall Study|Protocol Violation|3|||
162672047|NCT04969250|587508213|FG003|Overall Study|Protocol Violation|8|||
162672048|NCT04969250|587508210|FG000|Overall Study|Withdrawal by Subject|0|||
162672049|NCT04969250|587508211|FG001|Overall Study|Withdrawal by Subject|1|||
163151234|NCT02435212|589267086|FG001|Optional Extension Phase|Death|0|||
163151235|NCT02435212|589267085|FG000|Optional Extension Phase|Technical problems|2|||
163151236|NCT02435212|589267086|FG001|Optional Extension Phase|Technical problems|0|||
163151237|NCT01346358|589267087|FG000|Overall Study|Withdrawal by Subject|1|||
163151238|NCT01346358|589267088|FG001|Overall Study|Withdrawal by Subject|0|||
163151239|NCT01346358|589267089|FG002|Overall Study|Withdrawal by Subject|1|||
163151240|NCT01346358|589267090|FG003|Overall Study|Withdrawal by Subject|1|||
163151241|NCT01346358|589267091|FG004|Overall Study|Withdrawal by Subject|0|||
163151242|NCT01346358|589267092|FG005|Overall Study|Withdrawal by Subject|2|||
163151243|NCT01346358|589267093|FG006|Overall Study|Withdrawal by Subject|1|||
163151244|NCT01346358|589267094|FG007|Overall Study|Withdrawal by Subject|1|||
163151245|NCT01346358|589267095|FG008|Overall Study|Withdrawal by Subject|1|||
163151246|NCT01346358|589267087|FG000|Overall Study|Adverse Event|1|||
162672050|NCT04969250|587508212|FG002|Overall Study|Withdrawal by Subject|0|||
162672051|NCT04969250|587508213|FG003|Overall Study|Withdrawal by Subject|0|||
162672052|NCT03526250|587508214|FG000|Overall Study|Adverse Event|4|||
162672053|NCT03526250|587508214|FG000|Overall Study|Progressive Disease|16|||
162672054|NCT03526250|587508214|FG000|Overall Study|No Treatment|3|||
162672055|NCT04420221|587508215|FG000|Overall Study|Withdrawal by Subject|0|||
162672056|NCT04420221|587508216|FG001|Overall Study|Withdrawal by Subject|0|||
162672057|NCT04420221|587508217|FG002|Overall Study|Withdrawal by Subject|0|||
162672058|NCT04420221|587508218|FG003|Overall Study|Withdrawal by Subject|0|||
162672059|NCT04420221|587508219|FG004|Overall Study|Withdrawal by Subject|0|||
162672060|NCT04420221|587508220|FG005|Overall Study|Withdrawal by Subject|20|||
162672061|NCT04420221|587508221|FG006|Overall Study|Withdrawal by Subject|5|||
162672062|NCT04420221|587508215|FG000|Overall Study|Other|0|||
162672063|NCT04420221|587508216|FG001|Overall Study|Other|0|||
162672064|NCT04420221|587508217|FG002|Overall Study|Other|0|||
162672065|NCT04420221|587508218|FG003|Overall Study|Other|0|||
162672066|NCT04420221|587508219|FG004|Overall Study|Other|0|||
162672067|NCT04420221|587508220|FG005|Overall Study|Other|1|||
162672068|NCT04420221|587508221|FG006|Overall Study|Other|1|||
162672069|NCT04420221|587508215|FG000|Overall Study|Lost to Follow-up|0|||
162672070|NCT04420221|587508216|FG001|Overall Study|Lost to Follow-up|0|||
162672071|NCT04420221|587508217|FG002|Overall Study|Lost to Follow-up|0|||
162672072|NCT04420221|587508218|FG003|Overall Study|Lost to Follow-up|0|||
162672073|NCT04420221|587508219|FG004|Overall Study|Lost to Follow-up|0|||
162672074|NCT04420221|587508220|FG005|Overall Study|Lost to Follow-up|3|||
162672075|NCT04420221|587508221|FG006|Overall Study|Lost to Follow-up|2|||
162672076|NCT04420221|587508215|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
162672077|NCT04420221|587508216|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
162672078|NCT04420221|587508217|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
162672079|NCT04420221|587508218|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
162672080|NCT04420221|587508219|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
162672081|NCT04420221|587508220|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
162672082|NCT04420221|587508221|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
162672083|NCT05348681|587508222|FG000|Overall Study|Study terminated by Sponsor|8|||
162672084|NCT05348681|587508223|FG001|Overall Study|Study terminated by Sponsor|3|||
162672085|NCT05348681|587508222|FG000|Overall Study|Withdrawal by Subject|1|||
162672086|NCT05348681|587508223|FG001|Overall Study|Withdrawal by Subject|1|||
162672087|NCT05348681|587508222|FG000|Overall Study|Lost to Follow-up|1|||
162672088|NCT05348681|587508223|FG001|Overall Study|Lost to Follow-up|1|||
162672089|NCT05348681|587508222|FG000|Overall Study|Adverse Event|1|||
162672090|NCT05348681|587508223|FG001|Overall Study|Adverse Event|0|||
162672091|NCT05348681|587508222|FG000|Overall Study|Other|2|||
162672092|NCT05348681|587508223|FG001|Overall Study|Other|1|||
162672093|NCT01040130|587508224|FG000|Overall Study|Adverse Event|1|||
162672094|NCT01040130|587508225|FG001|Overall Study|Adverse Event|1|||
162672095|NCT01040130|587508226|FG002|Overall Study|Adverse Event|0|||
162672096|NCT01040130|587508227|FG003|Overall Study|Adverse Event|5|||
162672097|NCT01040130|587508228|FG004|Overall Study|Adverse Event|0|||
162672098|NCT01040130|587508229|FG005|Overall Study|Adverse Event|3|||
162672099|NCT01040130|587508224|FG000|Overall Study|Protocol Violation|0|||
162672100|NCT01040130|587508225|FG001|Overall Study|Protocol Violation|0|||
162672101|NCT01040130|587508226|FG002|Overall Study|Protocol Violation|2|||
162672102|NCT01040130|587508227|FG003|Overall Study|Protocol Violation|0|||
162672103|NCT01040130|587508228|FG004|Overall Study|Protocol Violation|0|||
162672104|NCT01040130|587508229|FG005|Overall Study|Protocol Violation|0|||
162672105|NCT01040130|587508224|FG000|Overall Study|Withdrawal by Subject|0|||
162672106|NCT01040130|587508225|FG001|Overall Study|Withdrawal by Subject|2|||
162672107|NCT01040130|587508226|FG002|Overall Study|Withdrawal by Subject|0|||
162672108|NCT01040130|587508227|FG003|Overall Study|Withdrawal by Subject|0|||
162672109|NCT01040130|587508228|FG004|Overall Study|Withdrawal by Subject|0|||
162672110|NCT01040130|587508229|FG005|Overall Study|Withdrawal by Subject|1|||
162672111|NCT01040130|587508224|FG000|Overall Study|Other reasons not listed above|2|||
162672112|NCT01040130|587508225|FG001|Overall Study|Other reasons not listed above|0|||
163151247|NCT01346358|589267088|FG001|Overall Study|Adverse Event|0|||
162672113|NCT01040130|587508226|FG002|Overall Study|Other reasons not listed above|0|||
162672114|NCT01040130|587508227|FG003|Overall Study|Other reasons not listed above|0|||
162672115|NCT01040130|587508228|FG004|Overall Study|Other reasons not listed above|0|||
162672116|NCT01040130|587508229|FG005|Overall Study|Other reasons not listed above|0|||
162672117|NCT00553267|587508234|FG000|Overall Study|Adverse Event|8|||
162672118|NCT00553267|587508235|FG001|Overall Study|Adverse Event|10|||
162672119|NCT00553267|587508236|FG002|Overall Study|Adverse Event|5|||
163151248|NCT01346358|589267089|FG002|Overall Study|Adverse Event|0|||
163151249|NCT01346358|589267090|FG003|Overall Study|Adverse Event|0|||
162672120|NCT00553267|587508234|FG000|Overall Study|Non compliant with protocol|3|||
162672121|NCT00553267|587508235|FG001|Overall Study|Non compliant with protocol|3|||
162672122|NCT00553267|587508236|FG002|Overall Study|Non compliant with protocol|2|||
162672123|NCT00553267|587508234|FG000|Overall Study|Lost to Follow-up|0|||
163151250|NCT01346358|589267091|FG004|Overall Study|Adverse Event|1|||
163151251|NCT01346358|589267092|FG005|Overall Study|Adverse Event|0|||
163151252|NCT01346358|589267093|FG006|Overall Study|Adverse Event|0|||
163151253|NCT01346358|589267094|FG007|Overall Study|Adverse Event|0|||
163151254|NCT01346358|589267095|FG008|Overall Study|Adverse Event|1|||
163151255|NCT01346358|589267087|FG000|Overall Study|Non-Compliance|0|||
163151256|NCT01346358|589267088|FG001|Overall Study|Non-Compliance|0|||
163151257|NCT01346358|589267089|FG002|Overall Study|Non-Compliance|0|||
163151258|NCT01346358|589267090|FG003|Overall Study|Non-Compliance|0|||
163151259|NCT01346358|589267091|FG004|Overall Study|Non-Compliance|0|||
163151260|NCT01346358|589267092|FG005|Overall Study|Non-Compliance|0|||
163151261|NCT01346358|589267093|FG006|Overall Study|Non-Compliance|0|||
163151262|NCT01346358|589267094|FG007|Overall Study|Non-Compliance|2|||
163151263|NCT01346358|589267095|FG008|Overall Study|Non-Compliance|0|||
163151264|NCT01346358|589267087|FG000|Overall Study|Physician Decision|0|||
163151265|NCT01346358|589267088|FG001|Overall Study|Physician Decision|1|||
163151266|NCT01346358|589267089|FG002|Overall Study|Physician Decision|0|||
163151267|NCT01346358|589267090|FG003|Overall Study|Physician Decision|0|||
163151268|NCT01346358|589267091|FG004|Overall Study|Physician Decision|0|||
163151269|NCT01346358|589267092|FG005|Overall Study|Physician Decision|0|||
163151270|NCT01346358|589267093|FG006|Overall Study|Physician Decision|0|||
163151271|NCT01346358|589267094|FG007|Overall Study|Physician Decision|1|||
163151272|NCT01346358|589267095|FG008|Overall Study|Physician Decision|1|||
163151273|NCT05058365|589267098|FG000|Overall Study|Migration|1|||
163151274|NCT05058365|589267099|FG001|Overall Study|Migration|1|||
163151275|NCT00702702|589267100|FG000|Overall Study|Study prematurely terminated|56|||
163151276|NCT04819945|589267101|FG000|Overall Study|Lost to Follow-up|1|||
163151277|NCT04531176|589267108|FG000|Overall Study|Study was stopped early|24|||
163151278|NCT04531176|589267109|FG001|Overall Study|Study was stopped early|26|||
163151279|NCT04531176|589267110|FG002|Overall Study|Study was stopped early|24|||
163151280|NCT00561652|589267113|FG000|Overall Study|Withdrawal by Subject|0|||
163151281|NCT00561652|589267114|FG001|Overall Study|Withdrawal by Subject|1|||
163151282|NCT01451606|589267115|FG000|Overall Study|Withdrawal by Subject|4|||
163151283|NCT01451606|589267116|FG001|Overall Study|Withdrawal by Subject|3|||
163151284|NCT00685165|589267118|FG000|Washout Period of 14 Days|Adverse Event|1|||
163151285|NCT00685165|589267119|FG001|Washout Period of 14 Days|Adverse Event|0|||
163151286|NCT03155724|589267121|FG000|Overall Study|Death|3|||
163151287|NCT03155724|589267121|FG000|Overall Study|Physician Decision|1|||
163151288|NCT03155724|589267121|FG000|Overall Study|Study closure|7|||
163151289|NCT03361137|589267124|FG000|Overall Study|Reason not specified|1|||
163151290|NCT03361137|589267125|FG001|Overall Study|Reason not specified|0|||
163151291|NCT03361137|589267126|FG002|Overall Study|Reason not specified|0|||
163151292|NCT03361137|589267127|FG003|Overall Study|Reason not specified|0|||
163151293|NCT03361137|589267128|FG004|Overall Study|Reason not specified|0|||
163151294|NCT01586364|589269348|FG000|Overall Study|Withdrawal by Subject|40|||
163151295|NCT01586364|589269348|FG000|Overall Study|Adverse Event|37|||
163151296|NCT01586364|589269348|FG000|Overall Study|Lost to Follow-up|17|||
163151297|NCT01586364|589269348|FG000|Overall Study|Protocol Violation|16|||
163151298|NCT01586364|589269348|FG000|Overall Study|Lack of Efficacy|1|||
163151299|NCT01586364|589269348|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
163151300|NCT01586364|589269348|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
163151301|NCT01586364|589269348|FG000|Overall Study|Other-Site closure due to PI illness|1|||
163151302|NCT01586364|589269348|FG000|Overall Study|Other-PI discretion, site closing|2|||
163151303|NCT01586364|589269348|FG000|Overall Study|Other-Not specified|1|||
163151304|NCT02121535|589269349|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
163151305|NCT02121535|589269350|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
163151306|NCT02121535|589269349|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
163151307|NCT02121535|589269350|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
163151308|NCT04944992|589269351|FG000|Overall Study|Lost to Follow-up|1|||
163151309|NCT04944992|589269352|FG001|Overall Study|Lost to Follow-up|1|||
163151310|NCT04944992|589269351|FG000|Overall Study|Physician Decision|1|||
163151311|NCT04944992|589269352|FG001|Overall Study|Physician Decision|0|||
163151312|NCT04944992|589269351|FG000|Overall Study|Withdrawal by Subject|6|||
163151313|NCT04944992|589269352|FG001|Overall Study|Withdrawal by Subject|1|||
163151314|NCT05366738|589269353|FG000|Overall Study|Adverse Event|0|||
163151315|NCT05366738|589269354|FG001|Overall Study|Adverse Event|1|||
163151316|NCT05366738|589269355|FG002|Overall Study|Adverse Event|0|||
163151317|NCT05024032|589269362|FG000|Overall Study|Withdrawal by Subject|0|||
163151318|NCT05024032|589269363|FG001|Overall Study|Withdrawal by Subject|3|||
163151319|NCT05024032|589269364|FG002|Overall Study|Withdrawal by Subject|4|||
163151320|NCT05024032|589269362|FG000|Overall Study|Adverse Event|0|||
163151321|NCT05024032|589269363|FG001|Overall Study|Adverse Event|1|||
163151322|NCT05024032|589269364|FG002|Overall Study|Adverse Event|0|||
163151323|NCT05024032|589269362|FG000|Overall Study|Protocol Deviation|1|||
163151324|NCT05024032|589269363|FG001|Overall Study|Protocol Deviation|0|||
163151325|NCT05024032|589269364|FG002|Overall Study|Protocol Deviation|0|||
163151326|NCT00939393|589269365|FG000|Overall Study|Withdrawal by Subject|1|||
163151327|NCT00939393|589269366|FG001|Overall Study|Withdrawal by Subject|0|||
163151328|NCT00939393|589269365|FG000|Overall Study|Lost to Follow-up|3|||
162721971|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162721972|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
162672124|NCT00553267|587508235|FG001|Overall Study|Lost to Follow-up|0|||
162672125|NCT00553267|587508236|FG002|Overall Study|Lost to Follow-up|1|||
162672126|NCT00553267|587508234|FG000|Overall Study|Consent withdrawn|2|||
162672127|NCT00553267|587508235|FG001|Overall Study|Consent withdrawn|3|||
162672128|NCT00553267|587508236|FG002|Overall Study|Consent withdrawn|1|||
162672129|NCT00553267|587508234|FG000|Overall Study|Specified category|1|||
162672130|NCT00553267|587508235|FG001|Overall Study|Specified category|2|||
162672131|NCT00553267|587508236|FG002|Overall Study|Specified category|1|||
162672132|NCT04389840|587508237|FG000|Overall Study|Adverse Event|0|||
162672133|NCT04389840|587508238|FG001|Overall Study|Adverse Event|0|||
162672134|NCT04389840|587508239|FG002|Overall Study|Adverse Event|0|||
162672135|NCT04389840|587508240|FG003|Overall Study|Adverse Event|1|||
162672136|NCT04389840|587508241|FG004|Overall Study|Adverse Event|0|||
162672137|NCT04389840|587508242|FG005|Overall Study|Adverse Event|0|||
162672138|NCT04389840|587508237|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
162672139|NCT04389840|587508238|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
162672140|NCT04389840|587508239|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
162672141|NCT04389840|587508240|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
162672142|NCT04389840|587508241|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
162672143|NCT04389840|587508242|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
162672144|NCT04389840|587508237|FG000|Overall Study|Death|0|||
162672145|NCT04389840|587508238|FG001|Overall Study|Death|1|||
162672146|NCT04389840|587508239|FG002|Overall Study|Death|0|||
162672147|NCT04389840|587508240|FG003|Overall Study|Death|0|||
162672148|NCT04389840|587508241|FG004|Overall Study|Death|0|||
162672149|NCT04389840|587508242|FG005|Overall Study|Death|0|||
162672150|NCT01618864|587508243|FG000|Overall Study|Withdrawal by Subject|2|||
162672151|NCT01618864|587508243|FG000|Overall Study|Lost to Follow-up|2|||
162672152|NCT00096135|587508249|FG000|Overall Study|Physician Decision|20|||
162672153|NCT00096135|587508250|FG001|Overall Study|Physician Decision|4|||
162672154|NCT00096135|587508249|FG000|Overall Study|Refusal of further protocol therapy|4|||
162672155|NCT00096135|587508250|FG001|Overall Study|Refusal of further protocol therapy|1|||
162672156|NCT00096135|587508249|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
162672157|NCT00096135|587508250|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
162672158|NCT00096135|587508249|FG000|Overall Study|Other, specify|15|||
162672159|NCT00096135|587508250|FG001|Overall Study|Other, specify|3|||
162672160|NCT00096135|587508249|FG000|Overall Study|Ineligible|2|||
162672161|NCT00096135|587508250|FG001|Overall Study|Ineligible|0|||
162672162|NCT00833989|587508259|FG000|Overall Study|Physician Decision|0|||
162672163|NCT00833989|587508260|FG001|Overall Study|Physician Decision|0|||
162672164|NCT00833989|587508261|FG002|Overall Study|Physician Decision|0|||
162672165|NCT00833989|587508262|FG003|Overall Study|Physician Decision|1|||
162672166|NCT00833989|587508259|FG000|Overall Study|Withdrawal by Subject|3|||
162672167|NCT00833989|587508260|FG001|Overall Study|Withdrawal by Subject|0|||
162672168|NCT00833989|587508261|FG002|Overall Study|Withdrawal by Subject|1|||
162672169|NCT00833989|587508262|FG003|Overall Study|Withdrawal by Subject|1|||
162672170|NCT02310750|587508265|FG000|HP Period 1|Lost to Follow-up|0|||
162672171|NCT02310750|587508266|FG001|HP Period 1|Lost to Follow-up|0|||
162672172|NCT02310750|587508267|FG002|HP Period 1|Lost to Follow-up|0|||
162672173|NCT02310750|587508268|FG003|HP Period 1|Lost to Follow-up|0|||
162672174|NCT02310750|587508269|FG004|HP Period 1|Lost to Follow-up|0|||
162672175|NCT02310750|587508270|FG005|HP Period 1|Lost to Follow-up|0|||
162672176|NCT02310750|587508271|FG006|HP Period 1|Lost to Follow-up|1|||
162672177|NCT02310750|587508272|FG007|HP Period 1|Lost to Follow-up|0|||
162672178|NCT02310750|587508273|FG008|HP Period 1|Lost to Follow-up|0|||
162672179|NCT02310750|587508274|FG009|HP Period 1|Lost to Follow-up|0|||
162672180|NCT02310750|587508275|FG010|HP Period 1|Lost to Follow-up|0|||
162672181|NCT02310750|587508276|FG011|HP Period 1|Lost to Follow-up|0|||
162672182|NCT02310750|587508277|FG012|HP Period 1|Lost to Follow-up|0|||
162672183|NCT02310750|587508278|FG013|HP Period 1|Lost to Follow-up|0|||
162672184|NCT02310750|587508279|FG014|HP Period 1|Lost to Follow-up|0|||
162672185|NCT02310750|587508280|FG015|HP Period 1|Lost to Follow-up|0|||
162672186|NCT02310750|587508265|FG000|HP Period 1|Withdrawal by Subject|1|||
162672187|NCT02310750|587508266|FG001|HP Period 1|Withdrawal by Subject|0|||
162672188|NCT02310750|587508267|FG002|HP Period 1|Withdrawal by Subject|0|||
162672189|NCT02310750|587508268|FG003|HP Period 1|Withdrawal by Subject|1|||
162672190|NCT02310750|587508269|FG004|HP Period 1|Withdrawal by Subject|0|||
162672191|NCT02310750|587508270|FG005|HP Period 1|Withdrawal by Subject|0|||
162672192|NCT02310750|587508271|FG006|HP Period 1|Withdrawal by Subject|0|||
162672193|NCT02310750|587508272|FG007|HP Period 1|Withdrawal by Subject|0|||
162672194|NCT02310750|587508273|FG008|HP Period 1|Withdrawal by Subject|0|||
162721973|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162721974|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162672195|NCT02310750|587508274|FG009|HP Period 1|Withdrawal by Subject|0|||
162672196|NCT02310750|587508275|FG010|HP Period 1|Withdrawal by Subject|0|||
162672197|NCT02310750|587508276|FG011|HP Period 1|Withdrawal by Subject|0|||
162672198|NCT02310750|587508277|FG012|HP Period 1|Withdrawal by Subject|0|||
162672199|NCT02310750|587508278|FG013|HP Period 1|Withdrawal by Subject|0|||
162672200|NCT02310750|587508279|FG014|HP Period 1|Withdrawal by Subject|0|||
162672201|NCT02310750|587508280|FG015|HP Period 1|Withdrawal by Subject|0|||
162672202|NCT02310750|587508265|FG000|HP Washout 1|Lost to Follow-up|0|||
162672203|NCT02310750|587508266|FG001|HP Washout 1|Lost to Follow-up|0|||
162672204|NCT02310750|587508267|FG002|HP Washout 1|Lost to Follow-up|1|||
162672205|NCT02310750|587508268|FG003|HP Washout 1|Lost to Follow-up|1|||
162672206|NCT02310750|587508269|FG004|HP Washout 1|Lost to Follow-up|2|||
162672207|NCT02310750|587508270|FG005|HP Washout 1|Lost to Follow-up|2|||
162672208|NCT02310750|587508271|FG006|HP Washout 1|Lost to Follow-up|3|||
162672209|NCT02310750|587508272|FG007|HP Washout 1|Lost to Follow-up|0|||
162672210|NCT02310750|587508273|FG008|HP Washout 1|Lost to Follow-up|0|||
162672211|NCT02310750|587508274|FG009|HP Washout 1|Lost to Follow-up|0|||
162672212|NCT02310750|587508275|FG010|HP Washout 1|Lost to Follow-up|0|||
162672213|NCT02310750|587508276|FG011|HP Washout 1|Lost to Follow-up|0|||
162672214|NCT02310750|587508277|FG012|HP Washout 1|Lost to Follow-up|0|||
162672215|NCT02310750|587508278|FG013|HP Washout 1|Lost to Follow-up|0|||
162672216|NCT02310750|587508279|FG014|HP Washout 1|Lost to Follow-up|0|||
162721975|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162721976|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162721977|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
162721978|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162721979|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162721980|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162721981|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162721982|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
162672217|NCT02310750|587508280|FG015|HP Washout 1|Lost to Follow-up|0|||
162672218|NCT02310750|587508265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672219|NCT02310750|587508266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672220|NCT02310750|587508267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672221|NCT02310750|587508268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
162672222|NCT02310750|587508269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672223|NCT02310750|587508270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
162672224|NCT02310750|587508271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672225|NCT02310750|587508272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672226|NCT02310750|587508273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
162672227|NCT02310750|587508274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
162672228|NCT02310750|587508275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672229|NCT02310750|587508276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672230|NCT02310750|587508277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672231|NCT02310750|587508278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672232|NCT02310750|587508279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672233|NCT02310750|587508280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162672234|NCT02310750|587508265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672235|NCT02310750|587508266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672236|NCT02310750|587508267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672237|NCT02310750|587508268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672238|NCT02310750|587508269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672239|NCT02310750|587508270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672240|NCT02310750|587508271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672241|NCT02310750|587508272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672242|NCT02310750|587508273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672243|NCT02310750|587508274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
162672244|NCT02310750|587508275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672245|NCT02310750|587508276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672246|NCT02310750|587508277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672247|NCT02310750|587508278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672248|NCT02310750|587508279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672249|NCT02310750|587508280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162672250|NCT02310750|587508265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672251|NCT02310750|587508266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672252|NCT02310750|587508267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672253|NCT02310750|587508268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672254|NCT02310750|587508269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672255|NCT02310750|587508270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672256|NCT02310750|587508271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672257|NCT02310750|587508272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162672258|NCT02310750|587508273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162672259|NCT02310750|587508274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162672260|NCT02310750|587508275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672261|NCT02310750|587508276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672262|NCT02310750|587508277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672263|NCT02310750|587508278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672264|NCT02310750|587508279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162672265|NCT02310750|587508280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162721983|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162721984|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162672266|NCT02310750|587508265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672267|NCT02310750|587508266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162721985|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163151329|NCT00939393|589269366|FG001|Overall Study|Lost to Follow-up|0|||
163151330|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
163151331|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151332|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151333|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151334|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151335|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151336|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
163151337|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
163151338|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151339|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151340|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
162672268|NCT02310750|587508267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672269|NCT02310750|587508268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672270|NCT02310750|587508269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672271|NCT02310750|587508270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672272|NCT02310750|587508271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672273|NCT02310750|587508272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
162672274|NCT02310750|587508273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
162672275|NCT02310750|587508274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672276|NCT02310750|587508275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672277|NCT02310750|587508276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672278|NCT02310750|587508277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672279|NCT02310750|587508278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672280|NCT02310750|587508279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672281|NCT02310750|587508280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162672282|NCT02310750|587508265|FG000|HP Washout 2|Lost to Follow-up|0|||
162672283|NCT02310750|587508266|FG001|HP Washout 2|Lost to Follow-up|0|||
162672284|NCT02310750|587508267|FG002|HP Washout 2|Lost to Follow-up|0|||
162672285|NCT02310750|587508268|FG003|HP Washout 2|Lost to Follow-up|0|||
162672286|NCT02310750|587508269|FG004|HP Washout 2|Lost to Follow-up|1|||
162672287|NCT02310750|587508270|FG005|HP Washout 2|Lost to Follow-up|0|||
162672288|NCT02310750|587508271|FG006|HP Washout 2|Lost to Follow-up|7|||
162672289|NCT02310750|587508272|FG007|HP Washout 2|Lost to Follow-up|0|||
162672290|NCT02310750|587508273|FG008|HP Washout 2|Lost to Follow-up|0|||
162672291|NCT02310750|587508274|FG009|HP Washout 2|Lost to Follow-up|0|||
162672292|NCT02310750|587508275|FG010|HP Washout 2|Lost to Follow-up|0|||
162672293|NCT02310750|587508276|FG011|HP Washout 2|Lost to Follow-up|0|||
162672294|NCT02310750|587508277|FG012|HP Washout 2|Lost to Follow-up|0|||
162672295|NCT02310750|587508278|FG013|HP Washout 2|Lost to Follow-up|0|||
162672296|NCT02310750|587508279|FG014|HP Washout 2|Lost to Follow-up|0|||
162672297|NCT02310750|587508280|FG015|HP Washout 2|Lost to Follow-up|0|||
162672298|NCT03585244|587508281|FG000|Overall Study|Withdrawal by Subject|15|||
162672299|NCT02199028|587508286|FG000|Week 1|Adverse Event|1|||
162672300|NCT02199028|587508287|FG001|Week 1|Adverse Event|0|||
162672301|NCT02199028|587508286|FG000|Week 3|Adverse Event|1|||
162672302|NCT02199028|587508287|FG001|Week 3|Adverse Event|0|||
162672303|NCT01881126|587508288|FG000|Overall Study|Non-compliance|1|||
162672304|NCT01881126|587508289|FG001|Overall Study|Non-compliance|1|||
162672305|NCT01881126|587508288|FG000|Overall Study|Adverse Event|0|||
162672306|NCT01881126|587508289|FG001|Overall Study|Adverse Event|1|||
162672307|NCT05045625|587508292|FG000|Overall Study|Lost to Follow-up|3|||
162672308|NCT01617629|587508293|FG000|Overall Study|Death|2|||
162672309|NCT01617629|587508293|FG000|Overall Study|Investigator's Clinical Judgement|1|||
162672310|NCT01617629|587508293|FG000|Overall Study|Reason Not Specified|1|||
162672311|NCT01617629|587508293|FG000|Overall Study|Participant Withdrew Consent|2|||
162672312|NCT01663636|587508294|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
162672313|NCT01663636|587508295|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
162672314|NCT03277313|587508305|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
162672315|NCT03277313|587508306|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
162672316|NCT03277313|587508305|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
162672317|NCT03277313|587508306|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
162672318|NCT03277313|587508305|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
162672319|NCT03277313|587508306|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
162672320|NCT03277313|587508305|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
162672321|NCT03277313|587508306|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
162672322|NCT03277313|587508305|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
162672323|NCT03277313|587508306|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
162672324|NCT02663817|587508307|FG000|Overall Study|Screen failure|2|||
162672325|NCT00932893|587508315|FG000|Overall Study|Death|115|||
162672326|NCT00932893|587508316|FG001|Overall Study|Death|24|||
162672327|NCT00932893|587508315|FG000|Overall Study|Lost to Follow-up|8|||
162672328|NCT00932893|587508316|FG001|Overall Study|Lost to Follow-up|0|||
162672329|NCT00932893|587508315|FG000|Overall Study|Withdrawal by Subject|5|||
162672330|NCT00932893|587508316|FG001|Overall Study|Withdrawal by Subject|2|||
162672331|NCT00932893|587508315|FG000|Overall Study|Other|5|||
162672332|NCT00932893|587508316|FG001|Overall Study|Other|144|||
162672333|NCT05350449|587508321|FG000|Overall Study|Withdrawal by Subject|4|||
162672334|NCT05350449|587508322|FG001|Overall Study|Withdrawal by Subject|8|||
162672335|NCT01912612|587510659|FG000|Overall Study|Adverse Event|4|||
162672336|NCT01912612|587510660|FG001|Overall Study|Adverse Event|0|||
162672337|NCT01912612|587510661|FG002|Overall Study|Adverse Event|0|||
162672338|NCT01912612|587510659|FG000|Overall Study|Withdrew consent|1|||
162672339|NCT01912612|587510660|FG001|Overall Study|Withdrew consent|0|||
162672340|NCT01912612|587510661|FG002|Overall Study|Withdrew consent|0|||
162672341|NCT01912612|587510659|FG000|Overall Study|Study design change|0|||
162672342|NCT01912612|587510660|FG001|Overall Study|Study design change|0|||
162672343|NCT01912612|587510661|FG002|Overall Study|Study design change|3|||
162672344|NCT01588184|587510662|FG000|Overall Study|Death|1|||
162672345|NCT01588184|587510663|FG001|Overall Study|Death|0|||
162672346|NCT01588184|587510664|FG002|Overall Study|Death|0|||
162672347|NCT01588184|587510665|FG003|Overall Study|Death|1|||
162672348|NCT01588184|587510666|FG004|Overall Study|Death|1|||
162672349|NCT01588184|587510667|FG005|Overall Study|Death|1|||
162672350|NCT01588184|587510662|FG000|Overall Study|Withdrawal by Subject|2|||
162672351|NCT01588184|587510663|FG001|Overall Study|Withdrawal by Subject|4|||
162672352|NCT01588184|587510664|FG002|Overall Study|Withdrawal by Subject|0|||
162672353|NCT01588184|587510665|FG003|Overall Study|Withdrawal by Subject|1|||
162672354|NCT01588184|587510666|FG004|Overall Study|Withdrawal by Subject|0|||
162672355|NCT01588184|587510667|FG005|Overall Study|Withdrawal by Subject|0|||
162672356|NCT01588184|587510662|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
162721986|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162672357|NCT01588184|587510663|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
162672358|NCT01588184|587510664|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
162672359|NCT01588184|587510665|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
162672360|NCT01588184|587510666|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
162672361|NCT01588184|587510667|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
162672362|NCT01588184|587510662|FG000|Overall Study|multiple reasons|0|||
162672363|NCT01588184|587510663|FG001|Overall Study|multiple reasons|3|||
162672364|NCT01588184|587510664|FG002|Overall Study|multiple reasons|0|||
162672365|NCT01588184|587510665|FG003|Overall Study|multiple reasons|1|||
162672366|NCT01588184|587510666|FG004|Overall Study|multiple reasons|0|||
162672367|NCT01588184|587510667|FG005|Overall Study|multiple reasons|0|||
162672368|NCT03750552|587510668|FG000|Overall Study|Adverse Event|5|||
162672369|NCT03750552|587510669|FG001|Overall Study|Adverse Event|1|||
162672370|NCT03750552|587510668|FG000|Overall Study|Withdrawal by Subject|1|||
162672371|NCT03750552|587510669|FG001|Overall Study|Withdrawal by Subject|1|||
162672372|NCT03750552|587510668|FG000|Overall Study|Other|2|||
162672373|NCT03750552|587510669|FG001|Overall Study|Other|0|||
162672374|NCT02062632|587510670|FG000|Overall Study|No treatment data|1|||
162672375|NCT00773968|587510673|FG000|Overall Study|Adverse Event|2|||
162672376|NCT00773968|587510673|FG000|Overall Study|Death|1|||
162672377|NCT00773968|587510673|FG000|Overall Study|Failure to Return|2|||
162672378|NCT00773968|587510673|FG000|Overall Study|Lack of Efficacy|3|||
162672379|NCT00773968|587510673|FG000|Overall Study|Protocol Violation|1|||
162672380|NCT00773968|587510673|FG000|Overall Study|Withdrawal by Subject|11|||
162672381|NCT00773968|587510673|FG000|Overall Study|Screen Failure|17|||
162672382|NCT00773968|587510673|FG000|Overall Study|Other|8|||
162672383|NCT02008890|587510676|FG000|Period 1|Withdrawal by Subject|7|||
162672384|NCT02008890|587510677|FG001|Period 1|Withdrawal by Subject|7|||
162672385|NCT02008890|587510678|FG002|Period 1|Withdrawal by Subject|5|||
162672386|NCT02008890|587510679|FG003|Period 1|Withdrawal by Subject|0|||
162672387|NCT02008890|587510680|FG004|Period 1|Withdrawal by Subject|0|||
162672388|NCT02008890|587510676|FG000|Period 1|Pregnancy|1|||
162672389|NCT02008890|587510677|FG001|Period 1|Pregnancy|0|||
162672390|NCT02008890|587510678|FG002|Period 1|Pregnancy|0|||
162672391|NCT02008890|587510679|FG003|Period 1|Pregnancy|0|||
162672392|NCT02008890|587510680|FG004|Period 1|Pregnancy|0|||
162672393|NCT02008890|587510676|FG000|Period 1|Physician Decision|1|||
162672394|NCT02008890|587510677|FG001|Period 1|Physician Decision|0|||
162672395|NCT02008890|587510678|FG002|Period 1|Physician Decision|1|||
162672396|NCT02008890|587510679|FG003|Period 1|Physician Decision|0|||
162672397|NCT02008890|587510680|FG004|Period 1|Physician Decision|0|||
162672398|NCT02008890|587510676|FG000|Period 1|Adverse Event|6|||
162672399|NCT02008890|587510677|FG001|Period 1|Adverse Event|8|||
162672400|NCT02008890|587510678|FG002|Period 1|Adverse Event|6|||
162672401|NCT02008890|587510679|FG003|Period 1|Adverse Event|0|||
162672402|NCT02008890|587510680|FG004|Period 1|Adverse Event|0|||
162672403|NCT02008890|587510676|FG000|Period 2|Adverse Event|12|||
162672404|NCT02008890|587510677|FG001|Period 2|Adverse Event|7|||
162672405|NCT02008890|587510678|FG002|Period 2|Adverse Event|0|||
162672406|NCT02008890|587510679|FG003|Period 2|Adverse Event|5|||
162672407|NCT02008890|587510680|FG004|Period 2|Adverse Event|5|||
162672408|NCT02008890|587510676|FG000|Period 2|Withdrawal by Subject|11|||
162672409|NCT02008890|587510677|FG001|Period 2|Withdrawal by Subject|8|||
162672410|NCT02008890|587510678|FG002|Period 2|Withdrawal by Subject|0|||
162672411|NCT02008890|587510679|FG003|Period 2|Withdrawal by Subject|7|||
162672412|NCT02008890|587510680|FG004|Period 2|Withdrawal by Subject|2|||
162672413|NCT02008890|587510676|FG000|Period 2|Physician Decision|4|||
162672414|NCT02008890|587510677|FG001|Period 2|Physician Decision|0|||
162672415|NCT02008890|587510678|FG002|Period 2|Physician Decision|0|||
162672416|NCT02008890|587510679|FG003|Period 2|Physician Decision|2|||
162672417|NCT02008890|587510680|FG004|Period 2|Physician Decision|1|||
162672418|NCT02008890|587510676|FG000|Period 2|Lost to Follow-up|0|||
162672419|NCT02008890|587510677|FG001|Period 2|Lost to Follow-up|0|||
162672420|NCT02008890|587510678|FG002|Period 2|Lost to Follow-up|1|||
162672421|NCT02008890|587510679|FG003|Period 2|Lost to Follow-up|0|||
162672422|NCT02008890|587510680|FG004|Period 2|Lost to Follow-up|0|||
162672423|NCT02008890|587510676|FG000|Extension Period|Withdrawal by Subject|3|||
162672424|NCT02008890|587510677|FG001|Extension Period|Withdrawal by Subject|2|||
162672425|NCT02008890|587510678|FG002|Extension Period|Withdrawal by Subject|0|||
162672426|NCT02008890|587510679|FG003|Extension Period|Withdrawal by Subject|4|||
162672427|NCT02008890|587510680|FG004|Extension Period|Withdrawal by Subject|2|||
162672428|NCT02008890|587510676|FG000|Extension Period|Lost to Follow-up|1|||
162672429|NCT02008890|587510677|FG001|Extension Period|Lost to Follow-up|0|||
162672430|NCT02008890|587510678|FG002|Extension Period|Lost to Follow-up|0|||
162672431|NCT02008890|587510679|FG003|Extension Period|Lost to Follow-up|0|||
162672432|NCT02008890|587510680|FG004|Extension Period|Lost to Follow-up|0|||
162672433|NCT02008890|587510676|FG000|Extension Period|Adverse Event|1|||
162672434|NCT02008890|587510677|FG001|Extension Period|Adverse Event|3|||
162672435|NCT02008890|587510678|FG002|Extension Period|Adverse Event|0|||
162672436|NCT02008890|587510679|FG003|Extension Period|Adverse Event|0|||
162672437|NCT02008890|587510680|FG004|Extension Period|Adverse Event|2|||
162672438|NCT02207816|587510681|FG000|Overall Study|Serious Adverse Event|0|||
162672439|NCT02207816|587510682|FG001|Overall Study|Serious Adverse Event|5|||
162672440|NCT02207816|587510683|FG002|Overall Study|Serious Adverse Event|2|||
162672441|NCT02207816|587510681|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162672442|NCT02207816|587510682|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
162672443|NCT02207816|587510683|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162672444|NCT02207816|587510681|FG000|Overall Study|Withdrawal by Subject|4|||
162672445|NCT02207816|587510682|FG001|Overall Study|Withdrawal by Subject|9|||
162672446|NCT02207816|587510683|FG002|Overall Study|Withdrawal by Subject|7|||
162672447|NCT02207816|587510681|FG000|Overall Study|Migrated/Moved From Study Area|41|||
162672448|NCT02207816|587510682|FG001|Overall Study|Migrated/Moved From Study Area|60|||
162672449|NCT02207816|587510683|FG002|Overall Study|Migrated/Moved From Study Area|51|||
162672450|NCT02207816|587510681|FG000|Overall Study|Lost to Follow-up|3|||
162672451|NCT02207816|587510682|FG001|Overall Study|Lost to Follow-up|9|||
162672452|NCT02207816|587510683|FG002|Overall Study|Lost to Follow-up|1|||
162672453|NCT02207816|587510681|FG000|Overall Study|Other|1|||
162672454|NCT02207816|587510682|FG001|Overall Study|Other|2|||
162672455|NCT02207816|587510683|FG002|Overall Study|Other|4|||
162672456|NCT02522494|587510684|FG000|Overall Study|Lost to Follow-up|6|||
162672457|NCT02522494|587510685|FG001|Overall Study|Lost to Follow-up|2|||
162672458|NCT02522494|587510684|FG000|Overall Study|Withdrawal by Subject|1|||
162672459|NCT02522494|587510685|FG001|Overall Study|Withdrawal by Subject|0|||
162672460|NCT02522494|587510684|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
162672461|NCT02522494|587510685|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
162672462|NCT02522494|587510684|FG000|Overall Study|Participant did not watch the video|1|||
162672463|NCT02522494|587510685|FG001|Overall Study|Participant did not watch the video|0|||
162672464|NCT02522494|587510684|FG000|Overall Study|Death|0|||
162672465|NCT02522494|587510685|FG001|Overall Study|Death|1|||
162672466|NCT02349295|587510688|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
162672467|NCT02349295|587510689|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
162672468|NCT02349295|587510690|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
162672469|NCT02349295|587510691|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672470|NCT02349295|587510692|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672471|NCT02349295|587510693|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672472|NCT02349295|587510694|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672473|NCT02349295|587510695|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672474|NCT02349295|587510696|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672475|NCT02349295|587510697|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672476|NCT02349295|587510698|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672477|NCT02349295|587510699|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672478|NCT02349295|587510700|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672479|NCT02349295|587510701|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162672480|NCT02349295|587510688|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
162672481|NCT02349295|587510689|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
162672482|NCT02349295|587510690|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
162672483|NCT02349295|587510691|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672484|NCT02349295|587510692|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672485|NCT02349295|587510693|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672486|NCT02349295|587510694|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672487|NCT02349295|587510695|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672488|NCT02349295|587510696|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162721987|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
163151341|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151342|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151343|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
163151344|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
163151345|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151346|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151347|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151348|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151349|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151350|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
163151351|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
163151352|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151353|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151354|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151355|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151356|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
163151357|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162672489|NCT02349295|587510697|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672490|NCT02349295|587510698|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672491|NCT02349295|587510699|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672492|NCT02349295|587510700|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672493|NCT02349295|587510701|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162672494|NCT02349295|587510688|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
162672495|NCT02349295|587510689|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
162672496|NCT02349295|587510690|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
162672497|NCT02349295|587510691|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672498|NCT02349295|587510692|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672499|NCT02349295|587510693|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672500|NCT02349295|587510694|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672501|NCT02349295|587510695|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672502|NCT02349295|587510696|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672503|NCT02349295|587510697|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672504|NCT02349295|587510698|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672505|NCT02349295|587510699|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672506|NCT02349295|587510700|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672507|NCT02349295|587510701|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162672508|NCT02349295|587510688|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
162672509|NCT02349295|587510689|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
162672510|NCT02349295|587510690|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
162672511|NCT02349295|587510691|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672512|NCT02349295|587510692|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672513|NCT02349295|587510693|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672514|NCT02349295|587510694|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672515|NCT02349295|587510695|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672516|NCT02349295|587510696|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672517|NCT02349295|587510697|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672518|NCT02349295|587510698|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672519|NCT02349295|587510699|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672520|NCT02349295|587510700|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672521|NCT02349295|587510701|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162672522|NCT02349295|587510688|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672523|NCT02349295|587510689|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
162672524|NCT02349295|587510690|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
162672525|NCT02349295|587510691|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672526|NCT02349295|587510692|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672527|NCT02349295|587510693|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672528|NCT02349295|587510694|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672529|NCT02349295|587510695|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672530|NCT02349295|587510696|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672531|NCT02349295|587510697|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672532|NCT02349295|587510698|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672533|NCT02349295|587510699|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672534|NCT02349295|587510700|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672535|NCT02349295|587510701|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162672536|NCT02349295|587510688|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
162672537|NCT02349295|587510689|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
162672538|NCT02349295|587510690|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
162672539|NCT02349295|587510691|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
162672540|NCT02349295|587510692|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
162672541|NCT02349295|587510693|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
162672542|NCT02349295|587510694|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
162672543|NCT02349295|587510695|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
162672544|NCT02349295|587510696|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
162672545|NCT02349295|587510697|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
162672546|NCT02349295|587510698|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
162672547|NCT02349295|587510699|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
162672548|NCT02349295|587510700|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
162672549|NCT02349295|587510701|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
162672550|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672551|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672552|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672553|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672554|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672555|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162721988|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162721989|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162721990|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162721991|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162672556|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672557|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
162672558|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
162672559|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
162672560|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
162672561|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672562|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672563|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162672564|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672565|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672566|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672567|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672568|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672569|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672570|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672571|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
162672572|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
162672573|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
162672574|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
162672575|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672576|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672577|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162672578|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672579|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672580|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672581|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672582|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672583|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672584|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672585|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
162672586|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163151358|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
163151359|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151360|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
162672587|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
162672588|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672589|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672590|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
163151361|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151362|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151363|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151364|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
163151365|NCT01054885|589269367|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
163151366|NCT01054885|589269368|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151367|NCT01054885|589269369|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151368|NCT01054885|589269370|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151369|NCT01054885|589269371|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151370|NCT01054885|589269372|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151371|NCT01054885|589269373|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
163151372|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
163151373|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
163151374|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
163151375|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
163151376|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
163151377|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
163151378|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
163151379|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151380|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151381|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
163151382|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
163151383|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151384|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
163151385|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
163151386|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
163151387|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
163151388|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
163151389|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
163151390|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
163151391|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
163151392|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
163151393|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162672591|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162672592|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
162672593|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
162672594|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
162672595|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
162672596|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
162672597|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
162672598|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
162672599|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
162672600|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
162672601|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
162672602|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
162672603|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
162672604|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
162672605|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
162672606|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672607|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672608|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672609|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672610|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672611|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672612|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672613|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
162672614|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
162672615|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
162672616|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
162672617|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672618|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672619|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162672620|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672621|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672622|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672623|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672624|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672625|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672626|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672627|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
162672628|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
162672629|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672630|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672631|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672632|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672633|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162672634|NCT02349295|587510688|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672635|NCT02349295|587510689|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672636|NCT02349295|587510690|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672637|NCT02349295|587510691|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672638|NCT02349295|587510692|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672639|NCT02349295|587510693|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672640|NCT02349295|587510694|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672641|NCT02349295|587510695|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
162672642|NCT02349295|587510696|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
162672643|NCT02349295|587510697|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672644|NCT02349295|587510698|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672645|NCT02349295|587510699|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672646|NCT02349295|587510700|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672647|NCT02349295|587510701|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162672648|NCT02349295|587510688|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672649|NCT02349295|587510689|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672650|NCT02349295|587510690|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672651|NCT02349295|587510691|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672652|NCT02349295|587510692|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672653|NCT02349295|587510693|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162721992|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
162672654|NCT02349295|587510694|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672655|NCT02349295|587510695|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672656|NCT02349295|587510696|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672657|NCT02349295|587510697|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672658|NCT02349295|587510698|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162672659|NCT02349295|587510699|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
162672660|NCT02349295|587510700|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
162672661|NCT02349295|587510701|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
162672662|NCT02349295|587510688|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672663|NCT02349295|587510689|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672664|NCT02349295|587510690|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672665|NCT02349295|587510691|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672666|NCT02349295|587510692|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672667|NCT02349295|587510693|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672668|NCT02349295|587510694|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672669|NCT02349295|587510695|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672670|NCT02349295|587510696|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672671|NCT02349295|587510697|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672672|NCT02349295|587510698|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672673|NCT02349295|587510699|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
162672674|NCT02349295|587510700|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
162672675|NCT02349295|587510701|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162672676|NCT02349295|587510688|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672677|NCT02349295|587510689|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672678|NCT02349295|587510690|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672679|NCT02349295|587510691|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672680|NCT02349295|587510692|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672681|NCT02349295|587510693|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672682|NCT02349295|587510694|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672683|NCT02349295|587510695|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672684|NCT02349295|587510696|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672685|NCT02349295|587510697|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672686|NCT02349295|587510698|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672687|NCT02349295|587510699|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
162672688|NCT02349295|587510700|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
162672689|NCT02349295|587510701|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162672690|NCT02349295|587510688|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672691|NCT02349295|587510689|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672692|NCT02349295|587510690|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672693|NCT02349295|587510691|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672694|NCT02349295|587510692|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672695|NCT02349295|587510693|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672696|NCT02349295|587510694|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672697|NCT02349295|587510695|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672698|NCT02349295|587510696|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672699|NCT02349295|587510697|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672700|NCT02349295|587510698|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672701|NCT02349295|587510699|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
162672702|NCT02349295|587510700|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672703|NCT02349295|587510701|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162672704|NCT02349295|587510688|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672705|NCT02349295|587510689|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672706|NCT02349295|587510690|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672707|NCT02349295|587510691|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672708|NCT02349295|587510692|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672709|NCT02349295|587510693|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672710|NCT02349295|587510694|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672711|NCT02349295|587510695|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672712|NCT02349295|587510696|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672713|NCT02349295|587510697|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672714|NCT02349295|587510698|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672715|NCT02349295|587510699|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
162672716|NCT02349295|587510700|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672717|NCT02349295|587510701|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162672718|NCT03240588|587510702|FG000|Overall Study|Death|3|||
162672719|NCT03240588|587510703|FG001|Overall Study|Death|0|||
162672720|NCT03240588|587510704|FG002|Overall Study|Death|0|||
162672721|NCT03240588|587510702|FG000|Overall Study|Adverse Event|5|||
162672722|NCT03240588|587510703|FG001|Overall Study|Adverse Event|4|||
162672723|NCT03240588|587510704|FG002|Overall Study|Adverse Event|0|||
162672724|NCT03240588|587510702|FG000|Overall Study|Lost to Follow-up|9|||
162672725|NCT03240588|587510703|FG001|Overall Study|Lost to Follow-up|4|||
162672726|NCT03240588|587510704|FG002|Overall Study|Lost to Follow-up|0|||
162672727|NCT03240588|587510702|FG000|Overall Study|Physician Decision|3|||
162672728|NCT03240588|587510703|FG001|Overall Study|Physician Decision|2|||
162672729|NCT03240588|587510704|FG002|Overall Study|Physician Decision|0|||
162672730|NCT03240588|587510702|FG000|Overall Study|Did not meet eligibility criteria|0|||
162672731|NCT03240588|587510703|FG001|Overall Study|Did not meet eligibility criteria|6|||
162672732|NCT03240588|587510704|FG002|Overall Study|Did not meet eligibility criteria|0|||
162672733|NCT03240588|587510702|FG000|Overall Study|No longer meets protocol criteria|12|||
162672734|NCT03240588|587510703|FG001|Overall Study|No longer meets protocol criteria|7|||
162672735|NCT03240588|587510704|FG002|Overall Study|No longer meets protocol criteria|0|||
162672736|NCT03240588|587510702|FG000|Overall Study|Withdrawal by Subject|60|||
162672737|NCT03240588|587510703|FG001|Overall Study|Withdrawal by Subject|52|||
162672738|NCT03240588|587510704|FG002|Overall Study|Withdrawal by Subject|7|||
162672739|NCT03240588|587510702|FG000|Overall Study|Other, additional details not available.|0|||
162672740|NCT03240588|587510703|FG001|Overall Study|Other, additional details not available.|12|||
162672741|NCT03240588|587510704|FG002|Overall Study|Other, additional details not available.|1|||
162672742|NCT03240588|587510702|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
162672743|NCT03240588|587510703|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
162672744|NCT03240588|587510704|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
162672745|NCT03240588|587510702|FG000|Overall Study|Closure of study|55|||
162672746|NCT03240588|587510703|FG001|Overall Study|Closure of study|3|||
162672747|NCT03240588|587510704|FG002|Overall Study|Closure of study|0|||
162672748|NCT03240588|587510702|FG000|Overall Study|Subject non-compliance|23|||
162672749|NCT03240588|587510703|FG001|Overall Study|Subject non-compliance|2|||
162672750|NCT03240588|587510704|FG002|Overall Study|Subject non-compliance|1|||
162672751|NCT03240588|587510702|FG000|Overall Study|Device Deficiency|1|||
162672752|NCT03240588|587510703|FG001|Overall Study|Device Deficiency|0|||
162672753|NCT03240588|587510704|FG002|Overall Study|Device Deficiency|0|||
162672754|NCT03240588|587510702|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
162672755|NCT03240588|587510703|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
162672756|NCT03240588|587510704|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
162672757|NCT01259713|587510706|FG000|Overall Study|Adverse Event|54|||
162672758|NCT01259713|587510707|FG001|Overall Study|Adverse Event|23|||
162672759|NCT01259713|587510706|FG000|Overall Study|Death Not Related to IFI|8|||
162672760|NCT01259713|587510707|FG001|Overall Study|Death Not Related to IFI|1|||
162672761|NCT01259713|587510706|FG000|Overall Study|Investigators Discretion|14|||
162672762|NCT01259713|587510707|FG001|Overall Study|Investigators Discretion|6|||
162672763|NCT01259713|587510706|FG000|Overall Study|Lack of Efficacy|2|||
162672764|NCT01259713|587510707|FG001|Overall Study|Lack of Efficacy|0|||
162672765|NCT01259713|587510706|FG000|Overall Study|Protocol Violation|5|||
162672766|NCT01259713|587510707|FG001|Overall Study|Protocol Violation|4|||
162672767|NCT01259713|587510706|FG000|Overall Study|Subject Withdrew Consent|12|||
162672768|NCT01259713|587510707|FG001|Overall Study|Subject Withdrew Consent|7|||
162672769|NCT02091726|587510708|FG000|Overall Study|Lost to Follow-up|6|||
162672770|NCT06111742|587510715|FG000|Overall Study|Did not receive intervention|1|||
162672771|NCT06111742|587510716|FG001|Overall Study|Did not receive intervention|0|||
162672772|NCT06111742|587510717|FG002|Overall Study|Did not receive intervention|0|||
162672773|NCT06111742|587510715|FG000|Overall Study|Withdrawal by Subject|2|||
162672774|NCT06111742|587510716|FG001|Overall Study|Withdrawal by Subject|0|||
162672775|NCT06111742|587510717|FG002|Overall Study|Withdrawal by Subject|0|||
162672776|NCT03461003|587510718|FG000|Overall Study|Lost to Follow-up|2|||
162672777|NCT03461003|587510719|FG001|Overall Study|Lost to Follow-up|2|||
162672778|NCT03461003|587510718|FG000|Overall Study|Withdrawal by Subject|3|||
162672779|NCT03461003|587510719|FG001|Overall Study|Withdrawal by Subject|1|||
162672780|NCT00620750|587510723|FG000|Overall Study|Lost to Follow-up|25|||
162672781|NCT04477187|587510724|FG000|Overall Study|Lost to Follow-up|2|||
162672782|NCT03508843|587510726|FG000|Overall Study|Withdrawal by Subject|1|||
162672783|NCT03508843|587510726|FG000|Overall Study|technical difficulties|2|||
162672784|NCT04717596|587510727|FG000|Overall Study|Withdrawal by Subject|4|||
162672785|NCT00765843|587510728|FG000|Overall Study|Lost to Follow-up|1|||
163151394|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
163151395|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
163151396|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163151397|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
163151398|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
163151399|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
163151400|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
163151401|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151402|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
163151403|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151404|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
163151405|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
163151406|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
163151407|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151408|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151409|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
163151410|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151411|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151412|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
163151413|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
163151414|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163151415|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
163151416|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
162672786|NCT00765843|587510729|FG001|Overall Study|Lost to Follow-up|3|||
162672787|NCT00765843|587510730|FG002|Overall Study|Lost to Follow-up|2|||
162721993|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162721994|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162721995|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162721996|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162721997|NCT02709655|587689394|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
162721998|NCT02709655|587689395|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162721999|NCT02709655|587689396|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162722000|NCT02709655|587689397|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162722001|NCT02709655|587689398|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162722002|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
162722003|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
162722004|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
162722005|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
162722006|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
162722007|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162722008|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
162722009|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162722010|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162722011|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
162722012|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
162722013|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
162722014|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
162722015|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
162722016|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
162722017|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162722018|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
162722019|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162722020|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162722021|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162722022|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
162722023|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162722024|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162722025|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162722026|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
162722027|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162722028|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
162722029|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162722030|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
162722031|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162722032|NCT02709655|587689394|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
162722033|NCT02709655|587689395|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
162722034|NCT02709655|587689396|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
162722035|NCT02709655|587689397|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
162722036|NCT02709655|587689398|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
162722037|NCT00102063|587689399|FG000|Overall Study|Lack of Efficacy|5|||
162722038|NCT00102063|587689400|FG001|Overall Study|Lack of Efficacy|1|||
162722039|NCT00102063|587689401|FG002|Overall Study|Lack of Efficacy|1|||
162722040|NCT00102063|587689399|FG000|Overall Study|Adverse Event|7|||
162722041|NCT00102063|587689400|FG001|Overall Study|Adverse Event|4|||
162722042|NCT00102063|587689401|FG002|Overall Study|Adverse Event|2|||
162722043|NCT00102063|587689399|FG000|Overall Study|Withdrawal by Subject|4|||
162722044|NCT00102063|587689400|FG001|Overall Study|Withdrawal by Subject|12|||
162722045|NCT00102063|587689401|FG002|Overall Study|Withdrawal by Subject|5|||
162722046|NCT00102063|587689399|FG000|Overall Study|Lost to Follow-up|0|||
162722047|NCT00102063|587689400|FG001|Overall Study|Lost to Follow-up|0|||
162672788|NCT00765843|587510728|FG000|Overall Study|did not return to receive intervention|0|||
162672789|NCT00765843|587510729|FG001|Overall Study|did not return to receive intervention|1|||
162672790|NCT00765843|587510730|FG002|Overall Study|did not return to receive intervention|0|||
162672791|NCT00765843|587510728|FG000|Overall Study|Adverse Event|0|||
162672792|NCT00765843|587510729|FG001|Overall Study|Adverse Event|0|||
162672793|NCT00765843|587510730|FG002|Overall Study|Adverse Event|1|||
162672794|NCT03555396|587510731|FG000|Overall Study|Death|3|||
162672795|NCT03555396|587510732|FG001|Overall Study|Death|1|||
162672796|NCT03555396|587510731|FG000|Overall Study|Lost to Follow-up|0|||
162722048|NCT00102063|587689401|FG002|Overall Study|Lost to Follow-up|1|||
162722049|NCT00102063|587689399|FG000|Overall Study|Protocol Violation|0|||
162722050|NCT00102063|587689400|FG001|Overall Study|Protocol Violation|1|||
162722051|NCT00102063|587689401|FG002|Overall Study|Protocol Violation|1|||
162722052|NCT00857649|587689402|FG000|Overall Study|Adverse Event|15|||
162722053|NCT00857649|587689403|FG001|Overall Study|Adverse Event|10|||
162722054|NCT00857649|587689402|FG000|Overall Study|Non-compliance|1|||
162722055|NCT00857649|587689403|FG001|Overall Study|Non-compliance|1|||
162672797|NCT03555396|587510732|FG001|Overall Study|Lost to Follow-up|2|||
162672798|NCT02460991|587510733|FG000|Overall Study|Withdrawal by Subject|0|||
162672799|NCT02460991|587510734|FG001|Overall Study|Withdrawal by Subject|2|||
162672800|NCT02564523|587510735|FG000|Overall Study|Withdrawal by Subject|3|||
162672801|NCT02564523|587510736|FG001|Overall Study|Withdrawal by Subject|0|||
162672802|NCT02564523|587510737|FG002|Overall Study|Withdrawal by Subject|1|||
162672803|NCT02564523|587510738|FG003|Overall Study|Withdrawal by Subject|0|||
162672804|NCT02564523|587510739|FG004|Overall Study|Withdrawal by Subject|1|||
162672805|NCT02564523|587510740|FG005|Overall Study|Withdrawal by Subject|0|||
162672806|NCT02564523|587510741|FG006|Overall Study|Withdrawal by Subject|1|||
162672807|NCT02564523|587510742|FG007|Overall Study|Withdrawal by Subject|0|||
162672808|NCT02564523|587510743|FG008|Overall Study|Withdrawal by Subject|0|||
162672809|NCT02564523|587510744|FG009|Overall Study|Withdrawal by Subject|0|||
162672810|NCT02564523|587510745|FG010|Overall Study|Withdrawal by Subject|1|||
162672811|NCT02564523|587510746|FG011|Overall Study|Withdrawal by Subject|0|||
162672812|NCT02564523|587510747|FG012|Overall Study|Withdrawal by Subject|1|||
162672813|NCT02564523|587510748|FG013|Overall Study|Withdrawal by Subject|0|||
162672814|NCT02564523|587510749|FG014|Overall Study|Withdrawal by Subject|0|||
162672815|NCT02564523|587510750|FG015|Overall Study|Withdrawal by Subject|0|||
162672816|NCT02564523|587510751|FG016|Overall Study|Withdrawal by Subject|0|||
162672817|NCT02564523|587510752|FG017|Overall Study|Withdrawal by Subject|0|||
162672818|NCT02564523|587510735|FG000|Overall Study|Adverse Event|0|||
162672819|NCT02564523|587510736|FG001|Overall Study|Adverse Event|0|||
162672820|NCT02564523|587510737|FG002|Overall Study|Adverse Event|0|||
162672821|NCT02564523|587510738|FG003|Overall Study|Adverse Event|0|||
162672822|NCT02564523|587510739|FG004|Overall Study|Adverse Event|0|||
162672823|NCT02564523|587510740|FG005|Overall Study|Adverse Event|0|||
162672824|NCT02564523|587510741|FG006|Overall Study|Adverse Event|0|||
162672825|NCT02564523|587510742|FG007|Overall Study|Adverse Event|0|||
162672826|NCT02564523|587510743|FG008|Overall Study|Adverse Event|0|||
162672827|NCT02564523|587510744|FG009|Overall Study|Adverse Event|0|||
162672828|NCT02564523|587510745|FG010|Overall Study|Adverse Event|0|||
162672829|NCT02564523|587510746|FG011|Overall Study|Adverse Event|0|||
162672830|NCT02564523|587510747|FG012|Overall Study|Adverse Event|0|||
162672831|NCT02564523|587510748|FG013|Overall Study|Adverse Event|0|||
162672832|NCT02564523|587510749|FG014|Overall Study|Adverse Event|0|||
162672833|NCT02564523|587510750|FG015|Overall Study|Adverse Event|0|||
162672834|NCT02564523|587510751|FG016|Overall Study|Adverse Event|0|||
162672835|NCT02564523|587510752|FG017|Overall Study|Adverse Event|1|||
162672836|NCT02564523|587510735|FG000|Overall Study|Death|0|||
162672837|NCT02564523|587510736|FG001|Overall Study|Death|0|||
162672838|NCT02564523|587510737|FG002|Overall Study|Death|0|||
162672839|NCT02564523|587510738|FG003|Overall Study|Death|0|||
162672840|NCT02564523|587510739|FG004|Overall Study|Death|0|||
162672841|NCT02564523|587510740|FG005|Overall Study|Death|0|||
162672842|NCT02564523|587510741|FG006|Overall Study|Death|1|||
162672843|NCT02564523|587510742|FG007|Overall Study|Death|0|||
162672844|NCT02564523|587510743|FG008|Overall Study|Death|0|||
162672845|NCT02564523|587510744|FG009|Overall Study|Death|0|||
162672846|NCT02564523|587510745|FG010|Overall Study|Death|1|||
162672847|NCT02564523|587510746|FG011|Overall Study|Death|0|||
162672848|NCT02564523|587510747|FG012|Overall Study|Death|0|||
162672849|NCT02564523|587510748|FG013|Overall Study|Death|0|||
162672850|NCT02564523|587510749|FG014|Overall Study|Death|0|||
162672851|NCT02564523|587510750|FG015|Overall Study|Death|0|||
162672852|NCT02564523|587510751|FG016|Overall Study|Death|0|||
162672853|NCT02564523|587510752|FG017|Overall Study|Death|0|||
162672854|NCT02564523|587510735|FG000|Overall Study|Lost to Follow-up|2|||
162672855|NCT02564523|587510736|FG001|Overall Study|Lost to Follow-up|1|||
162672856|NCT02564523|587510737|FG002|Overall Study|Lost to Follow-up|4|||
162672857|NCT02564523|587510738|FG003|Overall Study|Lost to Follow-up|0|||
162672858|NCT02564523|587510739|FG004|Overall Study|Lost to Follow-up|1|||
162672859|NCT02564523|587510740|FG005|Overall Study|Lost to Follow-up|0|||
162672860|NCT02564523|587510741|FG006|Overall Study|Lost to Follow-up|1|||
162672861|NCT02564523|587510742|FG007|Overall Study|Lost to Follow-up|0|||
162672862|NCT02564523|587510743|FG008|Overall Study|Lost to Follow-up|0|||
162672863|NCT02564523|587510744|FG009|Overall Study|Lost to Follow-up|0|||
162672864|NCT02564523|587510745|FG010|Overall Study|Lost to Follow-up|0|||
162672865|NCT02564523|587510746|FG011|Overall Study|Lost to Follow-up|1|||
162672866|NCT02564523|587510747|FG012|Overall Study|Lost to Follow-up|1|||
162672867|NCT02564523|587510748|FG013|Overall Study|Lost to Follow-up|0|||
162672868|NCT02564523|587510749|FG014|Overall Study|Lost to Follow-up|0|||
162672869|NCT02564523|587510750|FG015|Overall Study|Lost to Follow-up|0|||
163151417|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162672870|NCT02564523|587510751|FG016|Overall Study|Lost to Follow-up|0|||
162672871|NCT02564523|587510752|FG017|Overall Study|Lost to Follow-up|0|||
162672872|NCT02564523|587510735|FG000|Overall Study|Physician Decision|0|||
162672873|NCT02564523|587510736|FG001|Overall Study|Physician Decision|0|||
162672874|NCT02564523|587510737|FG002|Overall Study|Physician Decision|0|||
162672875|NCT02564523|587510738|FG003|Overall Study|Physician Decision|0|||
162672876|NCT02564523|587510739|FG004|Overall Study|Physician Decision|1|||
162672877|NCT02564523|587510740|FG005|Overall Study|Physician Decision|0|||
162672878|NCT02564523|587510741|FG006|Overall Study|Physician Decision|0|||
162672879|NCT02564523|587510742|FG007|Overall Study|Physician Decision|0|||
162672880|NCT02564523|587510743|FG008|Overall Study|Physician Decision|0|||
162672881|NCT02564523|587510744|FG009|Overall Study|Physician Decision|0|||
162672882|NCT02564523|587510745|FG010|Overall Study|Physician Decision|1|||
162672883|NCT02564523|587510746|FG011|Overall Study|Physician Decision|0|||
162672884|NCT02564523|587510747|FG012|Overall Study|Physician Decision|0|||
162672885|NCT02564523|587510748|FG013|Overall Study|Physician Decision|0|||
162672886|NCT02564523|587510749|FG014|Overall Study|Physician Decision|0|||
162672887|NCT02564523|587510750|FG015|Overall Study|Physician Decision|0|||
162672888|NCT02564523|587510751|FG016|Overall Study|Physician Decision|0|||
162672889|NCT02564523|587510752|FG017|Overall Study|Physician Decision|0|||
162672890|NCT02564523|587510735|FG000|Overall Study|Protocol Violation|2|||
162672891|NCT02564523|587510736|FG001|Overall Study|Protocol Violation|2|||
162672892|NCT02564523|587510737|FG002|Overall Study|Protocol Violation|5|||
162672893|NCT02564523|587510738|FG003|Overall Study|Protocol Violation|0|||
162672894|NCT02564523|587510739|FG004|Overall Study|Protocol Violation|1|||
162672895|NCT02564523|587510740|FG005|Overall Study|Protocol Violation|0|||
162672896|NCT02564523|587510741|FG006|Overall Study|Protocol Violation|0|||
162672897|NCT02564523|587510742|FG007|Overall Study|Protocol Violation|0|||
162672898|NCT02564523|587510743|FG008|Overall Study|Protocol Violation|0|||
162672899|NCT02564523|587510744|FG009|Overall Study|Protocol Violation|0|||
162672900|NCT02564523|587510745|FG010|Overall Study|Protocol Violation|0|||
162672901|NCT02564523|587510746|FG011|Overall Study|Protocol Violation|0|||
162672902|NCT02564523|587510747|FG012|Overall Study|Protocol Violation|0|||
162672903|NCT02564523|587510748|FG013|Overall Study|Protocol Violation|0|||
162672904|NCT02564523|587510749|FG014|Overall Study|Protocol Violation|0|||
162672905|NCT02564523|587510750|FG015|Overall Study|Protocol Violation|0|||
162672906|NCT02564523|587510751|FG016|Overall Study|Protocol Violation|0|||
162672907|NCT02564523|587510752|FG017|Overall Study|Protocol Violation|0|||
162672908|NCT02564523|587510735|FG000|Overall Study|Other|3|||
162672909|NCT02564523|587510736|FG001|Overall Study|Other|0|||
162672910|NCT02564523|587510737|FG002|Overall Study|Other|0|||
162672911|NCT02564523|587510738|FG003|Overall Study|Other|1|||
162672912|NCT02564523|587510739|FG004|Overall Study|Other|0|||
162672913|NCT02564523|587510740|FG005|Overall Study|Other|0|||
162672914|NCT02564523|587510741|FG006|Overall Study|Other|0|||
162672915|NCT02564523|587510742|FG007|Overall Study|Other|0|||
162672916|NCT02564523|587510743|FG008|Overall Study|Other|0|||
162672917|NCT02564523|587510744|FG009|Overall Study|Other|0|||
162672918|NCT02564523|587510745|FG010|Overall Study|Other|0|||
162672919|NCT02564523|587510746|FG011|Overall Study|Other|0|||
162672920|NCT02564523|587510747|FG012|Overall Study|Other|0|||
162672921|NCT02564523|587510748|FG013|Overall Study|Other|0|||
162672922|NCT02564523|587510749|FG014|Overall Study|Other|0|||
162672923|NCT02564523|587510750|FG015|Overall Study|Other|0|||
162672924|NCT02564523|587510751|FG016|Overall Study|Other|0|||
162672925|NCT02564523|587510752|FG017|Overall Study|Other|0|||
162672926|NCT03701555|587510758|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
162672927|NCT03701555|587510759|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
162672928|NCT03701555|587510760|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
162672929|NCT03701555|587510761|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
162672930|NCT03701555|587510762|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
162672931|NCT03701555|587510763|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
162672932|NCT03701555|587510764|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
162672933|NCT03701555|587510765|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
162672934|NCT03701555|587510766|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
162672935|NCT03701555|587510767|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
162672936|NCT03701555|587510768|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
162672937|NCT03701555|587510769|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
162672938|NCT03701555|587510770|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
162672939|NCT03701555|587510771|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
162672940|NCT03701555|587510772|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
162672941|NCT03701555|587510773|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
162672942|NCT03701555|587510774|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
162672943|NCT03701555|587510775|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
162672944|NCT03701555|587510776|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
162672945|NCT03701555|587510777|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
162672946|NCT03701555|587510778|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
162672947|NCT03701555|587510779|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
162672948|NCT03701555|587510780|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
162672949|NCT03701555|587510781|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
162672950|NCT03701555|587510782|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
162672951|NCT03701555|587510783|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
162672952|NCT03701555|587510784|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
162672953|NCT03701555|587510785|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
162672954|NCT03701555|587510786|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
162672955|NCT03701555|587510787|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
162672956|NCT03701555|587510788|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
162672957|NCT03701555|587510789|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
162672958|NCT03701555|587510790|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
162672959|NCT03701555|587510791|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
162672960|NCT03701555|587510792|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
162672961|NCT03701555|587510793|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
162672962|NCT03701555|587510758|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
162672963|NCT03701555|587510759|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
162672964|NCT03701555|587510760|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
162672965|NCT03701555|587510761|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
162672966|NCT03701555|587510762|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
162672967|NCT03701555|587510763|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
162672968|NCT03701555|587510764|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
162672969|NCT03701555|587510765|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
162672970|NCT03701555|587510766|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
162672971|NCT03701555|587510767|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
162672972|NCT03701555|587510768|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
162672973|NCT03701555|587510769|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
162672974|NCT03701555|587510770|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
162672975|NCT03701555|587510771|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
162672976|NCT03701555|587510772|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
162672977|NCT03701555|587510773|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
162672978|NCT03701555|587510774|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
162672979|NCT03701555|587510775|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
162722056|NCT00857649|587689402|FG000|Overall Study|Protocol Violation|2|||
162672980|NCT03701555|587510776|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
162672981|NCT03701555|587510777|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
162722057|NCT00857649|587689403|FG001|Overall Study|Protocol Violation|2|||
162722058|NCT00857649|587689402|FG000|Overall Study|Withdrawal of Consent|10|||
162672982|NCT03701555|587510778|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
162672983|NCT03701555|587510779|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
162672984|NCT03701555|587510780|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
162672985|NCT03701555|587510781|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
162672986|NCT03701555|587510782|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
162672987|NCT03701555|587510783|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
162672988|NCT03701555|587510784|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
162672989|NCT03701555|587510785|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
162672990|NCT03701555|587510786|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
162672991|NCT03701555|587510787|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
162672992|NCT03701555|587510788|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
162672993|NCT03701555|587510789|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
162672994|NCT03701555|587510790|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
162672995|NCT03701555|587510791|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
162672996|NCT03701555|587510792|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
162672997|NCT03701555|587510793|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
162672998|NCT03701555|587510758|FG000|Part 2 (Day 1)|Other|0|||
162672999|NCT03701555|587510759|FG001|Part 2 (Day 1)|Other|0|||
162673000|NCT03701555|587510760|FG002|Part 2 (Day 1)|Other|0|||
162673001|NCT03701555|587510761|FG003|Part 2 (Day 1)|Other|0|||
162673002|NCT03701555|587510762|FG004|Part 2 (Day 1)|Other|0|||
162673003|NCT03701555|587510763|FG005|Part 2 (Day 1)|Other|0|||
162673004|NCT03701555|587510764|FG006|Part 2 (Day 1)|Other|0|||
162673005|NCT03701555|587510765|FG007|Part 2 (Day 1)|Other|0|||
162673006|NCT03701555|587510766|FG008|Part 2 (Day 1)|Other|0|||
162673007|NCT03701555|587510767|FG009|Part 2 (Day 1)|Other|0|||
162673008|NCT03701555|587510768|FG010|Part 2 (Day 1)|Other|3|||
162673009|NCT03701555|587510769|FG011|Part 2 (Day 1)|Other|1|||
162673010|NCT03701555|587510770|FG012|Part 2 (Day 1)|Other|0|||
162673011|NCT03701555|587510771|FG013|Part 2 (Day 1)|Other|1|||
162673012|NCT03701555|587510772|FG014|Part 2 (Day 1)|Other|0|||
162673013|NCT03701555|587510773|FG015|Part 2 (Day 1)|Other|2|||
162673014|NCT03701555|587510774|FG016|Part 2 (Day 1)|Other|2|||
162673015|NCT03701555|587510775|FG017|Part 2 (Day 1)|Other|0|||
162673016|NCT03701555|587510776|FG018|Part 2 (Day 1)|Other|0|||
162673017|NCT03701555|587510777|FG019|Part 2 (Day 1)|Other|0|||
162673018|NCT03701555|587510778|FG020|Part 2 (Day 1)|Other|0|||
162673019|NCT03701555|587510779|FG021|Part 2 (Day 1)|Other|0|||
162673020|NCT03701555|587510780|FG022|Part 2 (Day 1)|Other|0|||
162673021|NCT03701555|587510781|FG023|Part 2 (Day 1)|Other|0|||
162673022|NCT03701555|587510782|FG024|Part 2 (Day 1)|Other|0|||
162673023|NCT03701555|587510783|FG025|Part 2 (Day 1)|Other|0|||
162673024|NCT03701555|587510784|FG026|Part 2 (Day 1)|Other|0|||
162673025|NCT03701555|587510785|FG027|Part 2 (Day 1)|Other|0|||
162673026|NCT03701555|587510786|FG028|Part 2 (Day 1)|Other|0|||
162673027|NCT03701555|587510787|FG029|Part 2 (Day 1)|Other|0|||
162673028|NCT03701555|587510788|FG030|Part 2 (Day 1)|Other|0|||
162673029|NCT03701555|587510789|FG031|Part 2 (Day 1)|Other|0|||
162673030|NCT03701555|587510790|FG032|Part 2 (Day 1)|Other|0|||
162673031|NCT03701555|587510791|FG033|Part 2 (Day 1)|Other|0|||
162673032|NCT03701555|587510792|FG034|Part 2 (Day 1)|Other|0|||
162673033|NCT03701555|587510793|FG035|Part 2 (Day 1)|Other|0|||
162673034|NCT03701555|587510758|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
162673035|NCT03701555|587510759|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
162673036|NCT03701555|587510760|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
162673037|NCT03701555|587510761|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
162673038|NCT03701555|587510762|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
162673039|NCT03701555|587510763|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
162673040|NCT03701555|587510764|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
162673041|NCT03701555|587510765|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
162673042|NCT03701555|587510766|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
162673043|NCT03701555|587510767|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
162673044|NCT03701555|587510768|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
162673045|NCT03701555|587510769|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
162673046|NCT03701555|587510770|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
162673047|NCT03701555|587510771|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
162673048|NCT03701555|587510772|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
162673049|NCT03701555|587510773|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
162673050|NCT03701555|587510774|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
162673051|NCT03701555|587510775|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
162673052|NCT03701555|587510776|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
162673053|NCT03701555|587510777|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
162673054|NCT03701555|587510778|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
162673055|NCT03701555|587510779|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
162673056|NCT03701555|587510780|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
162673057|NCT03701555|587510781|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
162673058|NCT03701555|587510782|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
162673059|NCT03701555|587510783|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
162673060|NCT03701555|587510784|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
162673061|NCT03701555|587510785|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
162673062|NCT03701555|587510786|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
162673063|NCT03701555|587510787|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
162673064|NCT03701555|587510788|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
162673065|NCT03701555|587510789|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
162673066|NCT03701555|587510790|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
162673067|NCT03701555|587510791|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
162673068|NCT03701555|587510792|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
162673069|NCT03701555|587510793|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
162673070|NCT03701555|587510758|FG000|Part 3 (Day 1)|Subject Decision|0|||
162673071|NCT03701555|587510759|FG001|Part 3 (Day 1)|Subject Decision|0|||
162673072|NCT03701555|587510760|FG002|Part 3 (Day 1)|Subject Decision|0|||
162673073|NCT03701555|587510761|FG003|Part 3 (Day 1)|Subject Decision|0|||
162673074|NCT03701555|587510762|FG004|Part 3 (Day 1)|Subject Decision|0|||
162673075|NCT03701555|587510763|FG005|Part 3 (Day 1)|Subject Decision|0|||
162673076|NCT03701555|587510764|FG006|Part 3 (Day 1)|Subject Decision|0|||
162673077|NCT03701555|587510765|FG007|Part 3 (Day 1)|Subject Decision|0|||
162673078|NCT03701555|587510766|FG008|Part 3 (Day 1)|Subject Decision|0|||
162673079|NCT03701555|587510767|FG009|Part 3 (Day 1)|Subject Decision|0|||
162673080|NCT03701555|587510768|FG010|Part 3 (Day 1)|Subject Decision|0|||
162673081|NCT03701555|587510769|FG011|Part 3 (Day 1)|Subject Decision|0|||
162673082|NCT03701555|587510770|FG012|Part 3 (Day 1)|Subject Decision|0|||
162673083|NCT03701555|587510771|FG013|Part 3 (Day 1)|Subject Decision|0|||
162673084|NCT03701555|587510772|FG014|Part 3 (Day 1)|Subject Decision|0|||
162673085|NCT03701555|587510773|FG015|Part 3 (Day 1)|Subject Decision|0|||
162673086|NCT03701555|587510774|FG016|Part 3 (Day 1)|Subject Decision|0|||
162673087|NCT03701555|587510775|FG017|Part 3 (Day 1)|Subject Decision|0|||
162673088|NCT03701555|587510776|FG018|Part 3 (Day 1)|Subject Decision|0|||
162673089|NCT03701555|587510777|FG019|Part 3 (Day 1)|Subject Decision|0|||
162673090|NCT03701555|587510778|FG020|Part 3 (Day 1)|Subject Decision|0|||
162673091|NCT03701555|587510779|FG021|Part 3 (Day 1)|Subject Decision|0|||
162673092|NCT03701555|587510780|FG022|Part 3 (Day 1)|Subject Decision|0|||
162673093|NCT03701555|587510781|FG023|Part 3 (Day 1)|Subject Decision|0|||
162673094|NCT03701555|587510782|FG024|Part 3 (Day 1)|Subject Decision|0|||
162673095|NCT03701555|587510783|FG025|Part 3 (Day 1)|Subject Decision|0|||
162673096|NCT03701555|587510784|FG026|Part 3 (Day 1)|Subject Decision|1|||
162673097|NCT03701555|587510785|FG027|Part 3 (Day 1)|Subject Decision|0|||
162673098|NCT03701555|587510786|FG028|Part 3 (Day 1)|Subject Decision|0|||
162673099|NCT03701555|587510787|FG029|Part 3 (Day 1)|Subject Decision|0|||
162673100|NCT03701555|587510788|FG030|Part 3 (Day 1)|Subject Decision|0|||
162673101|NCT03701555|587510789|FG031|Part 3 (Day 1)|Subject Decision|2|||
162673102|NCT03701555|587510790|FG032|Part 3 (Day 1)|Subject Decision|1|||
162673103|NCT03701555|587510791|FG033|Part 3 (Day 1)|Subject Decision|1|||
162673104|NCT03701555|587510792|FG034|Part 3 (Day 1)|Subject Decision|0|||
162673105|NCT03701555|587510793|FG035|Part 3 (Day 1)|Subject Decision|0|||
162673106|NCT03701555|587510758|FG000|Part 3 (Day 1)|Other|0|||
162673107|NCT03701555|587510759|FG001|Part 3 (Day 1)|Other|0|||
162673108|NCT03701555|587510760|FG002|Part 3 (Day 1)|Other|0|||
162673109|NCT03701555|587510761|FG003|Part 3 (Day 1)|Other|0|||
162673110|NCT03701555|587510762|FG004|Part 3 (Day 1)|Other|0|||
162673111|NCT03701555|587510763|FG005|Part 3 (Day 1)|Other|0|||
162722059|NCT00857649|587689403|FG001|Overall Study|Withdrawal of Consent|7|||
162673112|NCT03701555|587510764|FG006|Part 3 (Day 1)|Other|0|||
162673113|NCT03701555|587510765|FG007|Part 3 (Day 1)|Other|0|||
162673114|NCT03701555|587510766|FG008|Part 3 (Day 1)|Other|0|||
162673115|NCT03701555|587510767|FG009|Part 3 (Day 1)|Other|0|||
162673116|NCT03701555|587510768|FG010|Part 3 (Day 1)|Other|0|||
162673117|NCT03701555|587510769|FG011|Part 3 (Day 1)|Other|0|||
162673118|NCT03701555|587510770|FG012|Part 3 (Day 1)|Other|0|||
162673119|NCT03701555|587510771|FG013|Part 3 (Day 1)|Other|0|||
162673120|NCT03701555|587510772|FG014|Part 3 (Day 1)|Other|0|||
162673121|NCT03701555|587510773|FG015|Part 3 (Day 1)|Other|0|||
162673122|NCT03701555|587510774|FG016|Part 3 (Day 1)|Other|0|||
162673123|NCT03701555|587510775|FG017|Part 3 (Day 1)|Other|0|||
162673124|NCT03701555|587510776|FG018|Part 3 (Day 1)|Other|0|||
162673125|NCT03701555|587510777|FG019|Part 3 (Day 1)|Other|0|||
162673126|NCT03701555|587510778|FG020|Part 3 (Day 1)|Other|0|||
162673127|NCT03701555|587510779|FG021|Part 3 (Day 1)|Other|0|||
162673128|NCT03701555|587510780|FG022|Part 3 (Day 1)|Other|0|||
162673129|NCT03701555|587510781|FG023|Part 3 (Day 1)|Other|0|||
162673130|NCT03701555|587510782|FG024|Part 3 (Day 1)|Other|1|||
162673131|NCT03701555|587510783|FG025|Part 3 (Day 1)|Other|1|||
162673132|NCT03701555|587510784|FG026|Part 3 (Day 1)|Other|0|||
162673133|NCT03701555|587510785|FG027|Part 3 (Day 1)|Other|0|||
162673134|NCT03701555|587510786|FG028|Part 3 (Day 1)|Other|0|||
162673135|NCT03701555|587510787|FG029|Part 3 (Day 1)|Other|1|||
162673136|NCT03701555|587510788|FG030|Part 3 (Day 1)|Other|1|||
162673137|NCT03701555|587510789|FG031|Part 3 (Day 1)|Other|0|||
162673138|NCT03701555|587510790|FG032|Part 3 (Day 1)|Other|1|||
162673139|NCT03701555|587510791|FG033|Part 3 (Day 1)|Other|1|||
162673140|NCT03701555|587510792|FG034|Part 3 (Day 1)|Other|0|||
162673141|NCT03701555|587510793|FG035|Part 3 (Day 1)|Other|0|||
162673142|NCT00448539|587510794|FG000|Overall Study|Medication non-compliance|4|||
162673143|NCT00448539|587510795|FG001|Overall Study|Medication non-compliance|1|||
162673144|NCT00448539|587510794|FG000|Overall Study|Protocol Violation|1|||
162673145|NCT00448539|587510795|FG001|Overall Study|Protocol Violation|0|||
162673146|NCT00448539|587510794|FG000|Overall Study|Request of the investigator or sponsor|67|||
162673147|NCT00448539|587510795|FG001|Overall Study|Request of the investigator or sponsor|54|||
162673148|NCT00448539|587510794|FG000|Overall Study|Withdrawal by Subject|20|||
162673149|NCT00448539|587510795|FG001|Overall Study|Withdrawal by Subject|24|||
162673150|NCT00448539|587510794|FG000|Overall Study|Diary non-compliance|1|||
162673151|NCT00448539|587510795|FG001|Overall Study|Diary non-compliance|0|||
162673152|NCT00448539|587510794|FG000|Overall Study|Adverse Event|9|||
162673153|NCT00448539|587510795|FG001|Overall Study|Adverse Event|26|||
162673154|NCT00448539|587510794|FG000|Overall Study|Lack of Efficacy|27|||
162673155|NCT00448539|587510795|FG001|Overall Study|Lack of Efficacy|40|||
162673156|NCT00448539|587510794|FG000|Overall Study|Miscellaneous|2|||
162673157|NCT00448539|587510795|FG001|Overall Study|Miscellaneous|1|||
162673158|NCT00448539|587510794|FG000|Overall Study|Change of meds|2|||
162673159|NCT00448539|587510795|FG001|Overall Study|Change of meds|3|||
162673160|NCT00448539|587510794|FG000|Overall Study|Lost to Follow-up|1|||
162673161|NCT00448539|587510795|FG001|Overall Study|Lost to Follow-up|3|||
162673162|NCT03349710|587510796|FG000|Treatment Period|Death|0|||
162673163|NCT03349710|587510797|FG001|Treatment Period|Death|0|||
162673164|NCT03349710|587510798|FG002|Treatment Period|Death|1|||
162673165|NCT03349710|587510799|FG003|Treatment Period|Death|0|||
162673166|NCT03349710|587510796|FG000|Treatment Period|Disease Progression|0|||
162673167|NCT03349710|587510797|FG001|Treatment Period|Disease Progression|2|||
162673168|NCT03349710|587510798|FG002|Treatment Period|Disease Progression|0|||
162673169|NCT03349710|587510799|FG003|Treatment Period|Disease Progression|1|||
162673170|NCT03349710|587510796|FG000|Treatment Period|Study Drug Toxicity|1|||
162673171|NCT03349710|587510797|FG001|Treatment Period|Study Drug Toxicity|0|||
162673172|NCT03349710|587510798|FG002|Treatment Period|Study Drug Toxicity|1|||
162673173|NCT03349710|587510799|FG003|Treatment Period|Study Drug Toxicity|1|||
162673174|NCT03349710|587510796|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
162673175|NCT03349710|587510797|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
162673176|NCT03349710|587510798|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
162673177|NCT03349710|587510799|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
162673178|NCT03349710|587510796|FG000|Treatment Period|admin reason by sponsor|0|||
162673179|NCT03349710|587510797|FG001|Treatment Period|admin reason by sponsor|7|||
162673180|NCT03349710|587510798|FG002|Treatment Period|admin reason by sponsor|0|||
162673181|NCT03349710|587510799|FG003|Treatment Period|admin reason by sponsor|19|||
162673182|NCT03349710|587510796|FG000|Treatment Period|Other Reason|2|||
162673183|NCT03349710|587510797|FG001|Treatment Period|Other Reason|0|||
162673184|NCT03349710|587510798|FG002|Treatment Period|Other Reason|2|||
162673185|NCT03349710|587510799|FG003|Treatment Period|Other Reason|1|||
162673186|NCT03349710|587510796|FG000|Treatment Period|completed|6|||
162673187|NCT03349710|587510797|FG001|Treatment Period|completed|0|||
162673188|NCT03349710|587510798|FG002|Treatment Period|completed|18|||
162673189|NCT03349710|587510799|FG003|Treatment Period|completed|1|||
162673190|NCT03349710|587510796|FG000|Treatment Period|participant request to discontinue|0|||
162673191|NCT03349710|587510797|FG001|Treatment Period|participant request to discontinue|0|||
162673192|NCT03349710|587510798|FG002|Treatment Period|participant request to discontinue|4|||
162673193|NCT03349710|587510799|FG003|Treatment Period|participant request to discontinue|0|||
162673194|NCT03349710|587510796|FG000|Treatment Period|participant withdrew consent|1|||
162722060|NCT00857649|587689402|FG000|Overall Study|Nursing Home Placement|2|||
162673195|NCT03349710|587510797|FG001|Treatment Period|participant withdrew consent|0|||
162673196|NCT03349710|587510798|FG002|Treatment Period|participant withdrew consent|0|||
162673197|NCT03349710|587510799|FG003|Treatment Period|participant withdrew consent|0|||
162673198|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
162673199|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
162673200|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
162673201|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
162673202|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
162673203|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
162673204|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
162673205|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
162673206|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
162673207|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
162673208|NCT00695903|587510800|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
162673209|NCT00695903|587510801|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
162673210|NCT00695903|587510800|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
162673211|NCT00695903|587510801|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
162673212|NCT00695903|587510800|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
162673213|NCT00695903|587510801|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
162673214|NCT00695903|587510800|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
162673215|NCT00695903|587510801|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
162673216|NCT01296568|587510804|FG000|Continued Access Phase|Lost to Follow-up|1|||
162673217|NCT01296568|587510804|FG000|Continued Access Phase|Withdrawal by Subject|1|||
162673218|NCT01296568|587510804|FG000|Continued Access Phase|Disease Progression|1|||
162673219|NCT00321854|587510810|FG000|Overall Study|Adverse Event|41|||
162673220|NCT00321854|587510811|FG001|Overall Study|Adverse Event|43|||
162673221|NCT00321854|587510810|FG000|Overall Study|Lack of Efficacy|9|||
162673222|NCT00321854|587510811|FG001|Overall Study|Lack of Efficacy|14|||
162673223|NCT00321854|587510810|FG000|Overall Study|Protocol Violation|6|||
162673224|NCT00321854|587510811|FG001|Overall Study|Protocol Violation|5|||
162673225|NCT00321854|587510810|FG000|Overall Study|Lost to Follow-up|0|||
162673226|NCT00321854|587510811|FG001|Overall Study|Lost to Follow-up|2|||
162673227|NCT00321854|587510810|FG000|Overall Study|Withdrawal by Subject|6|||
162673228|NCT00321854|587510811|FG001|Overall Study|Withdrawal by Subject|17|||
162673229|NCT00321854|587510810|FG000|Overall Study|Other|1|||
162673230|NCT00321854|587510811|FG001|Overall Study|Other|1|||
162673231|NCT01369342|587510812|FG000|Overall Study|Withdrawal by Subject|7|||
162673232|NCT01369342|587510813|FG001|Overall Study|Withdrawal by Subject|7|||
162673233|NCT01369342|587510814|FG002|Overall Study|Withdrawal by Subject|2|||
162673234|NCT01369342|587510812|FG000|Overall Study|Lost to Follow-up|5|||
162673235|NCT01369342|587510813|FG001|Overall Study|Lost to Follow-up|2|||
162673236|NCT01369342|587510814|FG002|Overall Study|Lost to Follow-up|1|||
162673237|NCT01369342|587510812|FG000|Overall Study|Not Treated|1|||
162673238|NCT01369342|587510813|FG001|Overall Study|Not Treated|0|||
162673239|NCT01369342|587510814|FG002|Overall Study|Not Treated|0|||
162673240|NCT01816594|587510815|FG000|Overall Study|Local Progress|0|||
162673241|NCT01816594|587510816|FG001|Overall Study|Local Progress|2|||
162673242|NCT01816594|587510815|FG000|Overall Study|Adverse Event|9|||
162673243|NCT01816594|587510816|FG001|Overall Study|Adverse Event|0|||
162673244|NCT01816594|587510815|FG000|Overall Study|Withdrawal by Subject|1|||
162673245|NCT01816594|587510816|FG001|Overall Study|Withdrawal by Subject|0|||
162673246|NCT01816594|587510815|FG000|Overall Study|Physician Decision|1|||
162673247|NCT01816594|587510816|FG001|Overall Study|Physician Decision|0|||
162673248|NCT03905655|587510817|FG000|Overall Study|Adverse Event|1|||
162673249|NCT03905655|587510818|FG001|Overall Study|Adverse Event|0|||
162673250|NCT03905655|587510819|FG002|Overall Study|Adverse Event|1|||
162673251|NCT03905655|587510820|FG003|Overall Study|Adverse Event|1|||
162673252|NCT04723576|587510821|FG000|Overall Study|Withdrawal by Subject|2133|||
162673253|NCT04723576|587510822|FG001|Overall Study|Withdrawal by Subject|3234|||
162673254|NCT03204279|587510826|FG000|Overall Study|Withdrawal by Subject|0|||
162673255|NCT03204279|587510827|FG001|Overall Study|Withdrawal by Subject|1|||
162673256|NCT04827212|587510828|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
162673257|NCT04827212|587510829|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
162673258|NCT04827212|587510828|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
162673259|NCT04827212|587510829|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
162673260|NCT03927950|587510835|FG000|Overall Study|Adverse Event|9|||
162673261|NCT03263429|587510836|FG000|Overall Study|Withdrawal by Subject|0|||
162673262|NCT03263429|587510837|FG001|Overall Study|Withdrawal by Subject|1|||
162673263|NCT03263429|587510838|FG002|Overall Study|Withdrawal by Subject|0|||
162673264|NCT03263429|587510836|FG000|Overall Study|Follow-Up Period Completed|0|||
162673265|NCT03263429|587510837|FG001|Overall Study|Follow-Up Period Completed|2|||
162673266|NCT03263429|587510838|FG002|Overall Study|Follow-Up Period Completed|0|||
162673267|NCT03263429|587510836|FG000|Overall Study|Death|3|||
162673268|NCT03263429|587510837|FG001|Overall Study|Death|5|||
162673269|NCT03263429|587510838|FG002|Overall Study|Death|16|||
162673270|NCT03263429|587510836|FG000|Overall Study|Participant unable to return|0|||
162673271|NCT03263429|587510837|FG001|Overall Study|Participant unable to return|0|||
162673272|NCT03263429|587510838|FG002|Overall Study|Participant unable to return|1|||
162722061|NCT00857649|587689403|FG001|Overall Study|Nursing Home Placement|9|||
162722062|NCT00857649|587689402|FG000|Overall Study|Other Reasons|1|||
162722063|NCT00857649|587689403|FG001|Overall Study|Other Reasons|3|||
162673273|NCT03263429|587510836|FG000|Overall Study|Study Closed|0|||
162673274|NCT03263429|587510837|FG001|Overall Study|Study Closed|0|||
162673275|NCT03263429|587510838|FG002|Overall Study|Study Closed|1|||
162673276|NCT04530448|587510839|FG000|Overall Study|Physician Decision|3|||
162673277|NCT04530448|587510840|FG001|Overall Study|Physician Decision|0|||
162673278|NCT01519206|587510841|FG000|Overall Study|Lost to Follow-up|3|||
162673279|NCT01519206|587510841|FG000|Overall Study|Missed Visit|2|||
162722064|NCT02517307|587689408|FG000|Overall Study|Withdrawal by Subject|1|||
162673280|NCT02014116|587510842|FG000|Overall Study|Progressive Disease|3|||
162722065|NCT02517307|587689409|FG001|Overall Study|Withdrawal by Subject|0|||
162722066|NCT02517307|587689410|FG002|Overall Study|Withdrawal by Subject|1|||
162722067|NCT02517307|587689411|FG003|Overall Study|Withdrawal by Subject|0|||
162722068|NCT02517307|587689408|FG000|Overall Study|Protocol Violation|0|||
162722069|NCT02517307|587689409|FG001|Overall Study|Protocol Violation|0|||
162722070|NCT02517307|587689410|FG002|Overall Study|Protocol Violation|1|||
162722071|NCT02517307|587689411|FG003|Overall Study|Protocol Violation|1|||
162722072|NCT00843882|587689412|FG000|Step 1|Lack of Efficacy|14|||
162722073|NCT00843882|587689413|FG001|Step 1|Lack of Efficacy|10|||
162722074|NCT00843882|587689414|FG002|Step 1|Lack of Efficacy|21|||
162722075|NCT00843882|587689412|FG000|Step 1|Adverse Event|8|||
162722076|NCT00843882|587689413|FG001|Step 1|Adverse Event|17|||
162722077|NCT00843882|587689414|FG002|Step 1|Adverse Event|20|||
162722078|NCT00843882|587689412|FG000|Step 1|Death|1|||
162722079|NCT00843882|587689413|FG001|Step 1|Death|2|||
162673281|NCT02014116|587510843|FG001|Overall Study|Progressive Disease|4|||
162673282|NCT02014116|587510844|FG002|Overall Study|Progressive Disease|2|||
162673283|NCT02014116|587510845|FG003|Overall Study|Progressive Disease|6|||
162673284|NCT02014116|587510846|FG004|Overall Study|Progressive Disease|1|||
162673285|NCT02014116|587510847|FG005|Overall Study|Progressive Disease|13|||
162673286|NCT02014116|587510848|FG006|Overall Study|Progressive Disease|1|||
162673287|NCT02014116|587510849|FG007|Overall Study|Progressive Disease|3|||
162673288|NCT02014116|587510850|FG008|Overall Study|Progressive Disease|7|||
162673289|NCT02014116|587510842|FG000|Overall Study|Adverse Event|0|||
162673290|NCT02014116|587510843|FG001|Overall Study|Adverse Event|0|||
162673291|NCT02014116|587510844|FG002|Overall Study|Adverse Event|0|||
162673292|NCT02014116|587510845|FG003|Overall Study|Adverse Event|0|||
162673293|NCT02014116|587510846|FG004|Overall Study|Adverse Event|1|||
162673294|NCT02014116|587510847|FG005|Overall Study|Adverse Event|0|||
162673295|NCT02014116|587510848|FG006|Overall Study|Adverse Event|0|||
162673296|NCT02014116|587510849|FG007|Overall Study|Adverse Event|1|||
162673297|NCT02014116|587510850|FG008|Overall Study|Adverse Event|0|||
162673298|NCT02014116|587510842|FG000|Overall Study|Lost to Follow-up|0|||
162673299|NCT02014116|587510843|FG001|Overall Study|Lost to Follow-up|0|||
162673300|NCT02014116|587510844|FG002|Overall Study|Lost to Follow-up|0|||
162673301|NCT02014116|587510845|FG003|Overall Study|Lost to Follow-up|0|||
162673302|NCT02014116|587510846|FG004|Overall Study|Lost to Follow-up|0|||
162673303|NCT02014116|587510847|FG005|Overall Study|Lost to Follow-up|1|||
162673304|NCT02014116|587510848|FG006|Overall Study|Lost to Follow-up|0|||
162673305|NCT02014116|587510849|FG007|Overall Study|Lost to Follow-up|0|||
162673306|NCT02014116|587510850|FG008|Overall Study|Lost to Follow-up|1|||
162673307|NCT02014116|587510842|FG000|Overall Study|Death|0|||
162673308|NCT02014116|587510843|FG001|Overall Study|Death|0|||
162673309|NCT02014116|587510844|FG002|Overall Study|Death|0|||
162673310|NCT02014116|587510845|FG003|Overall Study|Death|0|||
162673311|NCT02014116|587510846|FG004|Overall Study|Death|0|||
162673312|NCT02014116|587510847|FG005|Overall Study|Death|0|||
162673313|NCT02014116|587510848|FG006|Overall Study|Death|0|||
162673314|NCT02014116|587510849|FG007|Overall Study|Death|1|||
162673315|NCT02014116|587510850|FG008|Overall Study|Death|1|||
162673316|NCT02014116|587510842|FG000|Overall Study|Withdrawal by Subject|0|||
162673317|NCT02014116|587510843|FG001|Overall Study|Withdrawal by Subject|0|||
162722080|NCT00843882|587689414|FG002|Step 1|Death|4|||
162722081|NCT00843882|587689412|FG000|Step 1|Withdrawal by Subject|6|||
162673318|NCT02014116|587510844|FG002|Overall Study|Withdrawal by Subject|1|||
162673319|NCT02014116|587510845|FG003|Overall Study|Withdrawal by Subject|1|||
162722082|NCT00843882|587689413|FG001|Step 1|Withdrawal by Subject|12|||
162673320|NCT02014116|587510846|FG004|Overall Study|Withdrawal by Subject|0|||
162673321|NCT02014116|587510847|FG005|Overall Study|Withdrawal by Subject|1|||
162673322|NCT02014116|587510848|FG006|Overall Study|Withdrawal by Subject|0|||
162673323|NCT02014116|587510849|FG007|Overall Study|Withdrawal by Subject|0|||
162673324|NCT02014116|587510850|FG008|Overall Study|Withdrawal by Subject|0|||
162673325|NCT02014116|587510842|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
162673326|NCT02014116|587510843|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
162673327|NCT02014116|587510844|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
162673328|NCT02014116|587510845|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
162673329|NCT02014116|587510846|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
162673330|NCT02014116|587510847|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
162673331|NCT02014116|587510848|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
162673332|NCT02014116|587510849|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
162673333|NCT02014116|587510850|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
162673334|NCT02014116|587510842|FG000|Overall Study|Physician Decision|0|||
162673335|NCT02014116|587510843|FG001|Overall Study|Physician Decision|0|||
162673336|NCT02014116|587510844|FG002|Overall Study|Physician Decision|0|||
162673337|NCT02014116|587510845|FG003|Overall Study|Physician Decision|0|||
162673338|NCT02014116|587510846|FG004|Overall Study|Physician Decision|0|||
162673339|NCT02014116|587510847|FG005|Overall Study|Physician Decision|0|||
162673340|NCT02014116|587510848|FG006|Overall Study|Physician Decision|0|||
162673341|NCT02014116|587510849|FG007|Overall Study|Physician Decision|0|||
162673342|NCT02014116|587510850|FG008|Overall Study|Physician Decision|1|||
162673343|NCT01491854|587510851|FG000|Overall Study|mainly due to premature termination|93|||
162673344|NCT01491854|587510851|FG000|Overall Study|Death|1|||
162673345|NCT01491854|587510851|FG000|Overall Study|Withdrawal by Subject|3|||
162673346|NCT01491854|587510851|FG000|Overall Study|Lost to Follow-up|33|||
162673347|NCT02395042|587510853|FG000|Treatment 1 Period|Adverse Event|1|||
162673348|NCT02395042|587510854|FG001|Treatment 1 Period|Adverse Event|3|||
162673349|NCT02395042|587510855|FG002|Treatment 1 Period|Adverse Event|1|||
162673350|NCT02395042|587510853|FG000|Treatment 1 Period|Lack of Efficacy|1|||
162673351|NCT02395042|587510854|FG001|Treatment 1 Period|Lack of Efficacy|1|||
162673352|NCT02395042|587510855|FG002|Treatment 1 Period|Lack of Efficacy|0|||
162673353|NCT02395042|587510853|FG000|Treatment 1 Period|Lost to Follow-up|1|||
162673354|NCT02395042|587510854|FG001|Treatment 1 Period|Lost to Follow-up|0|||
162673355|NCT02395042|587510855|FG002|Treatment 1 Period|Lost to Follow-up|0|||
162673356|NCT02395042|587510853|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
162673357|NCT02395042|587510854|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
162673358|NCT02395042|587510855|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
162673359|NCT02395042|587510853|FG000|Treatment 2 Period|Lack of Efficacy|1|||
162673360|NCT02395042|587510854|FG001|Treatment 2 Period|Lack of Efficacy|1|||
162673361|NCT02395042|587510855|FG002|Treatment 2 Period|Lack of Efficacy|0|||
162673362|NCT03638141|587510856|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
162673363|NCT03579563|587510857|FG000|Overall Study|Lost to Follow-up|0|||
162673364|NCT03579563|587510858|FG001|Overall Study|Lost to Follow-up|0|||
162673365|NCT03579563|587510859|FG002|Overall Study|Lost to Follow-up|0|||
162673366|NCT03579563|587510860|FG003|Overall Study|Lost to Follow-up|0|||
162673367|NCT03579563|587510861|FG004|Overall Study|Lost to Follow-up|1|||
162673368|NCT03579563|587510862|FG005|Overall Study|Lost to Follow-up|0|||
162673369|NCT03579563|587510857|FG000|Overall Study|Lack of Efficacy|1|||
162673370|NCT03579563|587510858|FG001|Overall Study|Lack of Efficacy|1|||
162673371|NCT03579563|587510859|FG002|Overall Study|Lack of Efficacy|4|||
162673372|NCT03579563|587510860|FG003|Overall Study|Lack of Efficacy|1|||
162673373|NCT03579563|587510861|FG004|Overall Study|Lack of Efficacy|2|||
162673374|NCT03579563|587510862|FG005|Overall Study|Lack of Efficacy|3|||
162673375|NCT03579563|587510857|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162673376|NCT03579563|587510858|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162673377|NCT03579563|587510859|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162673378|NCT03579563|587510860|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
162673379|NCT03579563|587510861|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162673380|NCT03579563|587510862|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162673381|NCT03579563|587510857|FG000|Overall Study|Time/distance concern|0|||
162673382|NCT03579563|587510858|FG001|Overall Study|Time/distance concern|0|||
162673383|NCT03579563|587510859|FG002|Overall Study|Time/distance concern|1|||
162673384|NCT03579563|587510860|FG003|Overall Study|Time/distance concern|0|||
162673385|NCT03579563|587510861|FG004|Overall Study|Time/distance concern|0|||
162673386|NCT03579563|587510862|FG005|Overall Study|Time/distance concern|1|||
162722083|NCT00843882|587689414|FG002|Step 1|Withdrawal by Subject|9|||
162673387|NCT03579563|587510857|FG000|Overall Study|COVID shutdown|2|||
162673388|NCT03579563|587510858|FG001|Overall Study|COVID shutdown|3|||
162673389|NCT03579563|587510859|FG002|Overall Study|COVID shutdown|4|||
162673390|NCT03579563|587510860|FG003|Overall Study|COVID shutdown|3|||
162673391|NCT03579563|587510861|FG004|Overall Study|COVID shutdown|1|||
162673392|NCT03579563|587510862|FG005|Overall Study|COVID shutdown|2|||
162722084|NCT00843882|587689412|FG000|Step 1|Physician Decision|0|||
162673393|NCT03579563|587510857|FG000|Overall Study|Protocol administration error|1|||
162673394|NCT03579563|587510858|FG001|Overall Study|Protocol administration error|0|||
162673395|NCT03579563|587510859|FG002|Overall Study|Protocol administration error|1|||
162673396|NCT03579563|587510860|FG003|Overall Study|Protocol administration error|0|||
162673397|NCT03579563|587510861|FG004|Overall Study|Protocol administration error|1|||
162673398|NCT03579563|587510862|FG005|Overall Study|Protocol administration error|5|||
162673399|NCT03621696|587510863|FG000|Overall Study|Not eligible|0|||
162673400|NCT03621696|587510864|FG001|Overall Study|Not eligible|0|||
162673401|NCT03621696|587510865|FG002|Overall Study|Not eligible|0|||
162673402|NCT03621696|587510866|FG003|Overall Study|Not eligible|5|||
162673403|NCT03621696|587510863|FG000|Overall Study|Withdrawal by Subject|1|||
162673404|NCT03621696|587510864|FG001|Overall Study|Withdrawal by Subject|1|||
162673405|NCT03621696|587510865|FG002|Overall Study|Withdrawal by Subject|1|||
162673406|NCT03621696|587510866|FG003|Overall Study|Withdrawal by Subject|0|||
162673407|NCT03621696|587510863|FG000|Overall Study|Physician Decision|0|||
162673408|NCT03621696|587510864|FG001|Overall Study|Physician Decision|0|||
162673409|NCT03621696|587510865|FG002|Overall Study|Physician Decision|1|||
162673410|NCT03621696|587510866|FG003|Overall Study|Physician Decision|0|||
162673411|NCT03867734|587510867|FG000|Overall Study|Lost to Follow-up|2|||
162673412|NCT01827904|587510868|FG000|Main Study|Withdrawal by Subject|1|||
162673413|NCT01827904|587510869|FG001|Main Study|Withdrawal by Subject|0|||
162673414|NCT01827904|587510870|FG002|Main Study|Withdrawal by Subject|0|||
162673415|NCT01827904|587510868|FG000|Main Study|Adverse Event|1|||
162673416|NCT01827904|587510869|FG001|Main Study|Adverse Event|0|||
162673417|NCT01827904|587510870|FG002|Main Study|Adverse Event|0|||
162673418|NCT01827904|587510868|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
162673419|NCT01827904|587510869|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
162673420|NCT01827904|587510870|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
162673421|NCT01827904|587510868|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
162673422|NCT01827904|587510869|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
162673423|NCT01827904|587510870|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
162673424|NCT01827904|587510868|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
162673425|NCT01827904|587510869|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
162673426|NCT01827904|587510870|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
162673427|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
162673428|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
162673429|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
162673430|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
162673431|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
162673432|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
162673433|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
162673434|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
162673435|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
162673436|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
162673437|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
162673438|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
162673439|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Physician Decision|1|||
162673440|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Physician Decision|0|||
162673441|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Physician Decision|0|||
162673442|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
162673443|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
162673444|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
162673445|NCT01827904|587510868|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
162673446|NCT01827904|587510869|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
162673447|NCT01827904|587510870|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
162673448|NCT01910519|587510871|FG000|Overall Study|Withdrawal by Subject|2|||
162673449|NCT01910519|587510872|FG001|Overall Study|Withdrawal by Subject|0|||
162673450|NCT01910519|587510871|FG000|Overall Study|Adverse Event|2|||
162673451|NCT01910519|587510872|FG001|Overall Study|Adverse Event|0|||
162673452|NCT04266028|587510873|FG000|Overall Study|Adverse Event|0|||
162673453|NCT04266028|587510874|FG001|Overall Study|Adverse Event|0|||
162673454|NCT04266028|587510875|FG002|Overall Study|Adverse Event|1|||
162673455|NCT04266028|587510876|FG003|Overall Study|Adverse Event|0|||
162673456|NCT04266028|587510877|FG004|Overall Study|Adverse Event|1|||
162673457|NCT04266028|587510878|FG005|Overall Study|Adverse Event|0|||
162673458|NCT04266028|587510879|FG006|Overall Study|Adverse Event|2|||
162673459|NCT04266028|587510880|FG007|Overall Study|Adverse Event|0|||
162673460|NCT04266028|587510873|FG000|Overall Study|temporary halt of the study|0|||
162673461|NCT04266028|587510874|FG001|Overall Study|temporary halt of the study|0|||
162673462|NCT04266028|587510875|FG002|Overall Study|temporary halt of the study|0|||
162673463|NCT04266028|587510876|FG003|Overall Study|temporary halt of the study|0|||
162673464|NCT04266028|587510877|FG004|Overall Study|temporary halt of the study|0|||
162673465|NCT04266028|587510878|FG005|Overall Study|temporary halt of the study|0|||
162673466|NCT04266028|587510879|FG006|Overall Study|temporary halt of the study|2|||
162673467|NCT04266028|587510880|FG007|Overall Study|temporary halt of the study|1|||
162673468|NCT04266028|587510873|FG000|Overall Study|Onset of birch pollen season|0|||
162673469|NCT04266028|587510874|FG001|Overall Study|Onset of birch pollen season|0|||
162673470|NCT04266028|587510875|FG002|Overall Study|Onset of birch pollen season|0|||
162673471|NCT04266028|587510876|FG003|Overall Study|Onset of birch pollen season|0|||
162673472|NCT04266028|587510877|FG004|Overall Study|Onset of birch pollen season|1|||
162673473|NCT04266028|587510878|FG005|Overall Study|Onset of birch pollen season|0|||
162673474|NCT04266028|587510879|FG006|Overall Study|Onset of birch pollen season|0|||
162722085|NCT00843882|587689413|FG001|Step 1|Physician Decision|5|||
162673475|NCT04266028|587510880|FG007|Overall Study|Onset of birch pollen season|0|||
162673476|NCT01458574|587510881|FG000|Overall Study|Adverse Event|5|||
162673477|NCT01458574|587510882|FG001|Overall Study|Adverse Event|9|||
162673478|NCT01458574|587510883|FG002|Overall Study|Adverse Event|7|||
162673479|NCT01458574|587510881|FG000|Overall Study|Lack of Efficacy|70|||
162673480|NCT01458574|587510882|FG001|Overall Study|Lack of Efficacy|53|||
162673481|NCT01458574|587510883|FG002|Overall Study|Lack of Efficacy|132|||
162673482|NCT01458574|587510881|FG000|Overall Study|Lost to Follow-up|3|||
162673483|NCT01458574|587510882|FG001|Overall Study|Lost to Follow-up|2|||
162673484|NCT01458574|587510883|FG002|Overall Study|Lost to Follow-up|1|||
162673485|NCT01458574|587510881|FG000|Overall Study|Pregnancy|1|||
162673486|NCT01458574|587510882|FG001|Overall Study|Pregnancy|1|||
162673487|NCT01458574|587510883|FG002|Overall Study|Pregnancy|0|||
162673488|NCT01458574|587510881|FG000|Overall Study|Protocol Violation|0|||
162673489|NCT01458574|587510882|FG001|Overall Study|Protocol Violation|1|||
162673490|NCT01458574|587510883|FG002|Overall Study|Protocol Violation|0|||
162673491|NCT01458574|587510881|FG000|Overall Study|Withdrawal by Subject|6|||
162673492|NCT01458574|587510882|FG001|Overall Study|Withdrawal by Subject|3|||
162673493|NCT01458574|587510883|FG002|Overall Study|Withdrawal by Subject|5|||
162673494|NCT01458574|587510881|FG000|Overall Study|Other|2|||
162673495|NCT01458574|587510882|FG001|Overall Study|Other|1|||
162673496|NCT01458574|587510883|FG002|Overall Study|Other|0|||
162673497|NCT01458574|587510881|FG000|Overall Study|Randomized but not treated|0|||
162673498|NCT01458574|587510882|FG001|Overall Study|Randomized but not treated|1|||
162673499|NCT01458574|587510883|FG002|Overall Study|Randomized but not treated|0|||
162673500|NCT02125786|587510884|FG000|Overall Study|Still in Follow-up|3|||
162673501|NCT02125786|587510884|FG000|Overall Study|Screen Failure|2|||
162673502|NCT02125786|587510884|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
162673503|NCT02125786|587510884|FG000|Overall Study|Progressive Disease|44|||
162673504|NCT02125786|587510884|FG000|Overall Study|Death|8|||
162673505|NCT02663128|587510888|FG000|Period 2|Physician Decision|0|||
162673506|NCT02663128|587510889|FG001|Period 2|Physician Decision|0|||
162673507|NCT02663128|587510890|FG002|Period 2|Physician Decision|0|||
162673508|NCT02663128|587510891|FG003|Period 2|Physician Decision|0|||
162673509|NCT02663128|587510892|FG004|Period 2|Physician Decision|1|||
162673510|NCT02663128|587510893|FG005|Period 2|Physician Decision|0|||
162673511|NCT02720484|587510894|FG000|Treatment on Study|Adverse Event|1|||
162673512|NCT02720484|587510894|FG000|Treatment on Study|Withdrawal by Subject|1|||
162673513|NCT02720484|587510894|FG000|Treatment on Study|Progressive Disease|4|||
162673514|NCT02720484|587510894|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
162673515|NCT02720484|587510894|FG000|Follow Up for 2 Years|Death|3|||
162673516|NCT02720484|587510894|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
162673517|NCT05070897|587510895|FG000|Overall Study|Protocol Violation|123|||
162673518|NCT05070897|587510896|FG001|Overall Study|Protocol Violation|68|||
162673519|NCT03832946|587510899|FG000|Overall Study|Adverse Event|3|||
162673520|NCT03832946|587510900|FG001|Overall Study|Adverse Event|1|||
162673521|NCT03832946|587510899|FG000|Overall Study|Lost to Follow-up|1|||
162673522|NCT03832946|587510900|FG001|Overall Study|Lost to Follow-up|0|||
162673523|NCT03832946|587510899|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
162673524|NCT03832946|587510900|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
162673525|NCT03832946|587510899|FG000|Overall Study|Lack of Efficacy|1|||
162673526|NCT03832946|587510900|FG001|Overall Study|Lack of Efficacy|0|||
162673527|NCT03832946|587510899|FG000|Overall Study|Withdrawal by Subject|12|||
162673528|NCT03832946|587510900|FG001|Overall Study|Withdrawal by Subject|9|||
162673529|NCT01003249|587510901|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162673530|NCT01003249|587510902|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162673531|NCT01003249|587510901|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
162673532|NCT01003249|587510902|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
162673533|NCT01003249|587510901|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162673534|NCT01003249|587510902|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162673535|NCT01003249|587510901|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
162673536|NCT01003249|587510902|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
162673537|NCT03394924|587510905|FG000|Overall Study|Adverse Event|0|||
162673538|NCT03394924|587510906|FG001|Overall Study|Adverse Event|5|||
162673539|NCT03394924|587510907|FG002|Overall Study|Adverse Event|0|||
162673540|NCT03394924|587510905|FG000|Overall Study|Withdrawal by Subject|2|||
162673541|NCT03394924|587510906|FG001|Overall Study|Withdrawal by Subject|0|||
162673542|NCT03394924|587510907|FG002|Overall Study|Withdrawal by Subject|0|||
162673543|NCT03394924|587510905|FG000|Overall Study|Lost to Follow-up|0|||
162673544|NCT03394924|587510906|FG001|Overall Study|Lost to Follow-up|1|||
162673545|NCT03394924|587510907|FG002|Overall Study|Lost to Follow-up|0|||
162673546|NCT03394924|587510905|FG000|Overall Study|Did not meet all inclusion criteria|1|||
162673547|NCT03394924|587510906|FG001|Overall Study|Did not meet all inclusion criteria|0|||
162673548|NCT03394924|587510907|FG002|Overall Study|Did not meet all inclusion criteria|0|||
162673549|NCT00110617|587510908|FG000|Overall Study|Adverse Event|2|||
162673550|NCT00110617|587510909|FG001|Overall Study|Adverse Event|4|||
162673551|NCT00110617|587510908|FG000|Overall Study|Abnormal Laboratory Value|4|||
162722086|NCT00843882|587689414|FG002|Step 1|Physician Decision|1|||
162722087|NCT00843882|587689412|FG000|Step 1|Patient and physician's decision|0|||
162722088|NCT00843882|587689413|FG001|Step 1|Patient and physician's decision|0|||
162722089|NCT00843882|587689414|FG002|Step 1|Patient and physician's decision|1|||
162673552|NCT00110617|587510909|FG001|Overall Study|Abnormal Laboratory Value|2|||
162673553|NCT00110617|587510908|FG000|Overall Study|Lack of Efficacy|1|||
162673554|NCT00110617|587510909|FG001|Overall Study|Lack of Efficacy|0|||
162673555|NCT00110617|587510908|FG000|Overall Study|Patient no longer requires study drug|1|||
162673556|NCT00110617|587510909|FG001|Overall Study|Patient no longer requires study drug|0|||
162673557|NCT00110617|587510908|FG000|Overall Study|Protocol Violation|5|||
162673558|NCT00110617|587510909|FG001|Overall Study|Protocol Violation|0|||
162673559|NCT00110617|587510908|FG000|Overall Study|Withdrawal by Subject|10|||
162673560|NCT00110617|587510909|FG001|Overall Study|Withdrawal by Subject|4|||
162673561|NCT00110617|587510908|FG000|Overall Study|Lost to Follow-up|9|||
162673562|NCT00110617|587510909|FG001|Overall Study|Lost to Follow-up|1|||
162673563|NCT00110617|587510908|FG000|Overall Study|Administrative problems|6|||
162673564|NCT00110617|587510909|FG001|Overall Study|Administrative problems|5|||
162673565|NCT00110617|587510908|FG000|Overall Study|Death|1|||
163151418|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163151419|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
163151420|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163151421|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
163151422|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
163151423|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151424|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
163151425|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
163151426|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151427|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
163151428|NCT01054885|589269367|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163151429|NCT01054885|589269368|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
163151430|NCT01054885|589269369|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163151431|NCT01054885|589269370|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
163151432|NCT01054885|589269371|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
163151433|NCT01054885|589269372|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
163151434|NCT01054885|589269373|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
163151435|NCT00804908|589269374|FG000|Overall Study|Other|115|||
163151436|NCT00804908|589269375|FG001|Overall Study|Other|116|||
163151437|NCT00804908|589269376|FG002|Overall Study|Other|114|||
163151438|NCT01280903|589269377|FG000|Overall Study|Lost to Follow-up|23|||
163151439|NCT01280903|589269378|FG001|Overall Study|Lost to Follow-up|16|||
163151440|NCT03829228|589269379|FG000|Overall Study|Protocol Violation|1|||
163151441|NCT02177695|589269380|FG000|ITT Analysis|Ineligible|5|||
163151442|NCT02177695|589269381|FG001|ITT Analysis|Ineligible|5|||
163151443|NCT02177695|589269380|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
163151444|NCT02177695|589269381|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
163151445|NCT02177695|589269380|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
163151446|NCT02177695|589269381|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
163151447|NCT02177695|589269380|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
163151448|NCT02177695|589269381|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
163151449|NCT00744497|589269384|FG000|Overall Study|Withdrawal by Subject|21|||
163151450|NCT00744497|589269385|FG001|Overall Study|Withdrawal by Subject|18|||
163151451|NCT00744497|589269384|FG000|Overall Study|Death|11|||
163151452|NCT00744497|589269385|FG001|Overall Study|Death|9|||
163151453|NCT00744497|589269384|FG000|Overall Study|Lost to Follow-up|4|||
163151454|NCT00744497|589269385|FG001|Overall Study|Lost to Follow-up|2|||
163151455|NCT00744497|589269384|FG000|Overall Study|Poor compliance/noncompliance|9|||
163151456|NCT00744497|589269385|FG001|Overall Study|Poor compliance/noncompliance|5|||
163151457|NCT00744497|589269384|FG000|Overall Study|No longer meets study criteria|7|||
163151458|NCT00744497|589269385|FG001|Overall Study|No longer meets study criteria|3|||
163151459|NCT00744497|589269384|FG000|Overall Study|Administrative Reason By Sponsor|25|||
163151460|NCT00744497|589269385|FG001|Overall Study|Administrative Reason By Sponsor|8|||
163151461|NCT00744497|589269384|FG000|Overall Study|Disease progression|312|||
163151462|NCT00744497|589269385|FG001|Overall Study|Disease progression|219|||
163151463|NCT00744497|589269384|FG000|Overall Study|Study drug toxicity|68|||
163151464|NCT00744497|589269385|FG001|Overall Study|Study drug toxicity|141|||
163151465|NCT00744497|589269384|FG000|Overall Study|Adverse event unrelated to study drug|78|||
163151466|NCT00744497|589269385|FG001|Overall Study|Adverse event unrelated to study drug|122|||
163151467|NCT00744497|589269384|FG000|Overall Study|Patient requested to stop study drug|65|||
163151468|NCT00744497|589269385|FG001|Overall Study|Patient requested to stop study drug|80|||
163151469|NCT00744497|589269384|FG000|Overall Study|Maximum clinical benefit|141|||
163151470|NCT00744497|589269385|FG001|Overall Study|Maximum clinical benefit|142|||
163151471|NCT00744497|589269384|FG000|Overall Study|Not defined|19|||
163151472|NCT00744497|589269385|FG001|Overall Study|Not defined|13|||
163151473|NCT02443688|589269386|FG000|Overall Study|Adverse Event|2|||
163151474|NCT02443688|589269387|FG001|Overall Study|Adverse Event|3|||
163151475|NCT02443688|589269388|FG002|Overall Study|Adverse Event|2|||
163151476|NCT02443688|589269386|FG000|Overall Study|Lost to Follow-up|1|||
163151477|NCT02443688|589269387|FG001|Overall Study|Lost to Follow-up|0|||
163151478|NCT02443688|589269388|FG002|Overall Study|Lost to Follow-up|0|||
163151479|NCT02443688|589269386|FG000|Overall Study|Physician Decision|3|||
163151480|NCT02443688|589269387|FG001|Overall Study|Physician Decision|0|||
163151481|NCT02443688|589269388|FG002|Overall Study|Physician Decision|1|||
163151482|NCT02443688|589269386|FG000|Overall Study|Pregnancy|0|||
163151483|NCT02443688|589269387|FG001|Overall Study|Pregnancy|0|||
163151484|NCT02443688|589269388|FG002|Overall Study|Pregnancy|1|||
163151485|NCT02443688|589269386|FG000|Overall Study|Withdrawal by Subject|3|||
163151486|NCT02443688|589269387|FG001|Overall Study|Withdrawal by Subject|3|||
163151487|NCT02443688|589269388|FG002|Overall Study|Withdrawal by Subject|4|||
163151488|NCT02443688|589269386|FG000|Overall Study|Non-compliance with study drug|1|||
163151489|NCT02443688|589269387|FG001|Overall Study|Non-compliance with study drug|2|||
163151490|NCT02443688|589269388|FG002|Overall Study|Non-compliance with study drug|4|||
163151491|NCT02443688|589269386|FG000|Overall Study|Sponsor Request|2|||
163151492|NCT02443688|589269387|FG001|Overall Study|Sponsor Request|1|||
163151493|NCT02443688|589269388|FG002|Overall Study|Sponsor Request|0|||
163151494|NCT00726063|589269390|FG000|Overall Study|Adverse Event|9|||
163151495|NCT00726063|589269391|FG001|Overall Study|Adverse Event|7|||
163151496|NCT02007096|589269392|FG000|Overall Study|medication not available|2|||
163151497|NCT02007096|589269393|FG001|Overall Study|medication not available|0|||
163151498|NCT02007096|589269392|FG000|Overall Study|did not inject saline|0|||
163151499|NCT02007096|589269393|FG001|Overall Study|did not inject saline|3|||
163151500|NCT02007096|589269392|FG000|Overall Study|did not follow postoperative protocol|8|||
163151501|NCT02007096|589269393|FG001|Overall Study|did not follow postoperative protocol|11|||
163151502|NCT02007096|589269392|FG000|Overall Study|converted to open surgery|1|||
163151503|NCT02007096|589269393|FG001|Overall Study|converted to open surgery|1|||
163151504|NCT02007096|589269392|FG000|Overall Study|no mesh placed|0|||
163151505|NCT02007096|589269393|FG001|Overall Study|no mesh placed|1|||
163151506|NCT00837434|589269395|FG000|Overall Study|Physician Decision|3|||
163151507|NCT00837434|589269396|FG001|Overall Study|Physician Decision|0|||
163151508|NCT00837434|589269395|FG000|Overall Study|Lost to Follow-up|1|||
163151509|NCT00837434|589269396|FG001|Overall Study|Lost to Follow-up|1|||
163151510|NCT00837434|589269395|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
163151511|NCT00837434|589269396|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
163151512|NCT00837434|589269395|FG000|Overall Study|Noncompliant|2|||
163151513|NCT00837434|589269396|FG001|Overall Study|Noncompliant|0|||
163151514|NCT00837434|589269395|FG000|Overall Study|Baseline assessments not done in time|1|||
163151515|NCT00837434|589269396|FG001|Overall Study|Baseline assessments not done in time|0|||
163151516|NCT00837434|589269395|FG000|Overall Study|Unable to obtain study drug|1|||
163151517|NCT00837434|589269396|FG001|Overall Study|Unable to obtain study drug|0|||
163151518|NCT03044106|589269397|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
163151519|NCT03044106|589269398|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
163151520|NCT01207414|589269399|FG000|Overall Study|Adverse Event|25|||
163151521|NCT01207414|589269400|FG001|Overall Study|Adverse Event|39|||
163151522|NCT01207414|589269399|FG000|Overall Study|Abnormal test procedure results|0|||
163151523|NCT01207414|589269400|FG001|Overall Study|Abnormal test procedure results|1|||
163151524|NCT01207414|589269399|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163151525|NCT01207414|589269400|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163151526|NCT01207414|589269399|FG000|Overall Study|Patient withdrew consent|14|||
162673566|NCT00110617|587510909|FG001|Overall Study|Death|1|||
162673567|NCT00110617|587510908|FG000|Overall Study|Did not receive study drug|0|||
162673568|NCT00110617|587510909|FG001|Overall Study|Did not receive study drug|12|||
162673569|NCT01949311|587513773|FG000|Overall Study|Lost to Follow-up|73|||
162673570|NCT01949311|587513773|FG000|Overall Study|Terminated by Sponsor|708|||
162673571|NCT01949311|587513773|FG000|Overall Study|Withdrawal by Subject|375|||
162673572|NCT01949311|587513773|FG000|Overall Study|Lack of Efficacy|50|||
162673573|NCT01949311|587513773|FG000|Overall Study|Protocol Deviation|34|||
162673574|NCT01949311|587513773|FG000|Overall Study|Pregnancy|20|||
162673575|NCT01949311|587513773|FG000|Overall Study|Physician Decision|9|||
162673576|NCT01949311|587513773|FG000|Overall Study|Other|4|||
162673577|NCT01949311|587513773|FG000|Overall Study|Adverse Event|107|||
162673578|NCT00951041|587513776|FG000|Overall Study|Withdrawal by Subject|1|||
162673579|NCT00951041|587513777|FG001|Overall Study|Withdrawal by Subject|1|||
162673580|NCT00951041|587513776|FG000|Overall Study|Lost to Follow-up|1|||
162673581|NCT00951041|587513777|FG001|Overall Study|Lost to Follow-up|0|||
162673582|NCT00951041|587513776|FG000|Overall Study|Other|3|||
162673583|NCT00951041|587513777|FG001|Overall Study|Other|0|||
162673584|NCT02388724|587513778|FG000|Overall Study|Reason not Specified|0|||
162673585|NCT02388724|587513779|FG001|Overall Study|Reason not Specified|1|||
162673586|NCT02388724|587513778|FG000|Overall Study|Major Protocol Deviation|3|||
162673587|NCT02388724|587513779|FG001|Overall Study|Major Protocol Deviation|3|||
162673588|NCT02388724|587513778|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162673589|NCT02388724|587513779|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
162673590|NCT02388724|587513778|FG000|Overall Study|Voluntary Withdrawal|6|||
162673591|NCT02388724|587513779|FG001|Overall Study|Voluntary Withdrawal|5|||
162673592|NCT02388724|587513778|FG000|Overall Study|Randomized but not Treated|0|||
162673593|NCT02388724|587513779|FG001|Overall Study|Randomized but not Treated|2|||
162673594|NCT04066114|587513780|FG000|Overall Study|Adverse Event|1|||
162673595|NCT04066114|587513781|FG001|Overall Study|Adverse Event|0|||
162673596|NCT04066114|587513782|FG002|Overall Study|Adverse Event|0|||
162673597|NCT04066114|587513780|FG000|Overall Study|Withdrawal by Subject|1|||
162673598|NCT04066114|587513781|FG001|Overall Study|Withdrawal by Subject|0|||
162673599|NCT04066114|587513782|FG002|Overall Study|Withdrawal by Subject|0|||
162673600|NCT04066114|587513780|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162673601|NCT04066114|587513781|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
162673602|NCT04066114|587513782|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
162673603|NCT02277106|587513783|FG000|Stage 2|Adverse Event|0|||
162673604|NCT02277106|587513784|FG001|Stage 2|Adverse Event|0|||
162673605|NCT02277106|587513785|FG002|Stage 2|Adverse Event|1|||
162673606|NCT01064739|587513786|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
162673607|NCT02479412|587513787|FG000|Overall Study|Adverse Event|0|||
162673608|NCT02479412|587513788|FG001|Overall Study|Adverse Event|0|||
162673609|NCT02479412|587513789|FG002|Overall Study|Adverse Event|1|||
162673610|NCT02479412|587513790|FG003|Overall Study|Adverse Event|0|||
162673611|NCT02479412|587513791|FG004|Overall Study|Adverse Event|0|||
162673612|NCT02479412|587513792|FG005|Overall Study|Adverse Event|0|||
162673613|NCT02479412|587513793|FG006|Overall Study|Adverse Event|0|||
162673614|NCT02479412|587513794|FG007|Overall Study|Adverse Event|0|||
162673615|NCT02479412|587513795|FG008|Overall Study|Adverse Event|0|||
162673616|NCT02479412|587513787|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162722090|NCT00843882|587689412|FG000|Step 1|Other complicating disease|1|||
162673617|NCT02479412|587513788|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162673618|NCT02479412|587513789|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162673619|NCT02479412|587513790|FG003|Overall Study|Study-specific withdrawal criteria|1|||
162673620|NCT02479412|587513791|FG004|Overall Study|Study-specific withdrawal criteria|0|||
162673621|NCT02479412|587513792|FG005|Overall Study|Study-specific withdrawal criteria|0|||
162673622|NCT02479412|587513793|FG006|Overall Study|Study-specific withdrawal criteria|0|||
162673623|NCT02479412|587513794|FG007|Overall Study|Study-specific withdrawal criteria|1|||
162673624|NCT02479412|587513795|FG008|Overall Study|Study-specific withdrawal criteria|1|||
162673625|NCT02479412|587513787|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
162673626|NCT02479412|587513788|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
162673627|NCT02479412|587513789|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
162673628|NCT02479412|587513790|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
162673629|NCT02479412|587513791|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
162673630|NCT02479412|587513792|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
162673631|NCT02479412|587513793|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
162673632|NCT02479412|587513794|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
162673633|NCT02479412|587513795|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
162673634|NCT00454051|587513796|FG000|Overall Study|Adverse Event|1|||
162673635|NCT00454051|587513797|FG001|Overall Study|Adverse Event|2|||
162673636|NCT00454051|587513796|FG000|Overall Study|Withdrawal by Subject|1|||
162673637|NCT00454051|587513797|FG001|Overall Study|Withdrawal by Subject|0|||
162673638|NCT00454051|587513796|FG000|Overall Study|Protocol Violation|1|||
162673639|NCT00454051|587513797|FG001|Overall Study|Protocol Violation|1|||
162673640|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
162673641|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
162673642|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
162673643|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
162673644|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
162673645|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
162673646|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
162673647|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
162673648|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
162673649|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
162673650|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
162673651|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
162673652|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
162673653|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
162673654|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
162673655|NCT01571362|587513798|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
162673656|NCT01571362|587513799|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
162673657|NCT01571362|587513800|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
162673658|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162673659|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
162673660|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
162673661|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162673662|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
162673663|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
162673664|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162673665|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Adverse Event|9|||
162673666|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Adverse Event|14|||
162673667|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162673668|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
162673669|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
162673670|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
162673671|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
162673672|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
162673673|NCT01571362|587513798|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
162673674|NCT01571362|587513799|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
162673675|NCT01571362|587513800|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
162673676|NCT04258020|587513801|FG000|Overall Study|Withdrawal by Subject|1|||
162673677|NCT04258020|587513802|FG001|Overall Study|Withdrawal by Subject|0|||
162673678|NCT02097472|587513805|FG000|Received Vaccination 2|Adverse Event|0|||
162673679|NCT02097472|587513806|FG001|Received Vaccination 2|Adverse Event|0|||
162673680|NCT02097472|587513807|FG002|Received Vaccination 2|Adverse Event|0|||
162673681|NCT02097472|587513808|FG003|Received Vaccination 2|Adverse Event|0|||
162673682|NCT02097472|587513809|FG004|Received Vaccination 2|Adverse Event|0|||
162673683|NCT02097472|587513810|FG005|Received Vaccination 2|Adverse Event|0|||
162673684|NCT02097472|587513811|FG006|Received Vaccination 2|Adverse Event|1|||
162673685|NCT02097472|587513812|FG007|Received Vaccination 2|Adverse Event|0|||
162673686|NCT01669629|587513813|FG000|Period 1|protocol deviation|1|||
162673687|NCT01669629|587513814|FG001|Period 1|protocol deviation|2|||
162673688|NCT04402866|587513817|FG000|Overall Study|Discontinued Prior to Treatment|0|||
162673689|NCT04402866|587513818|FG001|Overall Study|Discontinued Prior to Treatment|0|||
162673690|NCT04402866|587513819|FG002|Overall Study|Discontinued Prior to Treatment|0|||
162673691|NCT04402866|587513820|FG003|Overall Study|Discontinued Prior to Treatment|0|||
162673692|NCT04402866|587513821|FG004|Overall Study|Discontinued Prior to Treatment|2|||
162673693|NCT04402866|587513822|FG005|Overall Study|Discontinued Prior to Treatment|3|||
162673694|NCT04402866|587513817|FG000|Overall Study|Adverse Event|2|||
162673695|NCT04402866|587513818|FG001|Overall Study|Adverse Event|1|||
162673696|NCT04402866|587513819|FG002|Overall Study|Adverse Event|0|||
162673697|NCT04402866|587513820|FG003|Overall Study|Adverse Event|0|||
162673698|NCT04402866|587513821|FG004|Overall Study|Adverse Event|13|||
162673699|NCT04402866|587513822|FG005|Overall Study|Adverse Event|8|||
162673700|NCT04402866|587513817|FG000|Overall Study|Miscellaneous|0|||
162673701|NCT04402866|587513818|FG001|Overall Study|Miscellaneous|0|||
162673702|NCT04402866|587513819|FG002|Overall Study|Miscellaneous|1|||
162673703|NCT04402866|587513820|FG003|Overall Study|Miscellaneous|0|||
162673704|NCT04402866|587513821|FG004|Overall Study|Miscellaneous|0|||
162673705|NCT04402866|587513822|FG005|Overall Study|Miscellaneous|0|||
162673706|NCT04402866|587513817|FG000|Overall Study|Lost to Follow-up|0|||
162673707|NCT04402866|587513818|FG001|Overall Study|Lost to Follow-up|0|||
162673708|NCT04402866|587513819|FG002|Overall Study|Lost to Follow-up|0|||
162673709|NCT04402866|587513820|FG003|Overall Study|Lost to Follow-up|0|||
162673710|NCT04402866|587513821|FG004|Overall Study|Lost to Follow-up|0|||
162673711|NCT04402866|587513822|FG005|Overall Study|Lost to Follow-up|1|||
162673712|NCT04402866|587513817|FG000|Overall Study|Withdrawal by Subject|0|||
162673713|NCT04402866|587513818|FG001|Overall Study|Withdrawal by Subject|0|||
162673714|NCT04402866|587513819|FG002|Overall Study|Withdrawal by Subject|0|||
162673715|NCT04402866|587513820|FG003|Overall Study|Withdrawal by Subject|0|||
162673716|NCT04402866|587513821|FG004|Overall Study|Withdrawal by Subject|0|||
162673717|NCT04402866|587513822|FG005|Overall Study|Withdrawal by Subject|2|||
162673718|NCT03667053|587513823|FG000|Overall Study|Withdrawal by Subject|1|||
162673719|NCT03667053|587513824|FG001|Overall Study|Withdrawal by Subject|0|||
162673720|NCT03667053|587513825|FG002|Overall Study|Withdrawal by Subject|0|||
162673721|NCT01292928|587513827|FG000|Overall Study|Death|8|||
162673722|NCT01292928|587513827|FG000|Overall Study|Withdrawal by Subject|8|||
162673723|NCT01292928|587513827|FG000|Overall Study|Lost to Follow-up|6|||
162673724|NCT01292928|587513827|FG000|Overall Study|Physician Decision|2|||
162673725|NCT00130533|587513828|FG000|Overall Study|Withdrawal by Subject|33|||
162673726|NCT00130533|587513829|FG001|Overall Study|Withdrawal by Subject|6|||
162673727|NCT00130533|587513828|FG000|Overall Study|Adverse Event|34|||
162673728|NCT00130533|587513829|FG001|Overall Study|Adverse Event|1|||
162673729|NCT00130533|587513828|FG000|Overall Study|Disease relapse|9|||
162673730|NCT00130533|587513829|FG001|Overall Study|Disease relapse|13|||
162673731|NCT00130533|587513828|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
162673732|NCT00130533|587513829|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
162673733|NCT00130533|587513828|FG000|Overall Study|Death|4|||
162673734|NCT00130533|587513829|FG001|Overall Study|Death|2|||
162673735|NCT00130533|587513828|FG000|Overall Study|Protocol Violation|5|||
162673736|NCT00130533|587513829|FG001|Overall Study|Protocol Violation|1|||
162673737|NCT00130533|587513828|FG000|Overall Study|Lost to Follow-up|1|||
162673738|NCT00130533|587513829|FG001|Overall Study|Lost to Follow-up|1|||
162673739|NCT00130533|587513828|FG000|Overall Study|Sponsor´s decision|2|||
162673740|NCT00130533|587513829|FG001|Overall Study|Sponsor´s decision|0|||
162673741|NCT00130533|587513828|FG000|Overall Study|Second Primary Malignancy|0|||
162673742|NCT00130533|587513829|FG001|Overall Study|Second Primary Malignancy|1|||
162673743|NCT00130533|587513828|FG000|Overall Study|Other|12|||
162673744|NCT00130533|587513829|FG001|Overall Study|Other|5|||
162673745|NCT01059565|587513830|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
162673746|NCT01059565|587513831|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
162673747|NCT01059565|587513830|FG000|24-Week Randomized Phase|Adverse Event|5|||
162673748|NCT01059565|587513831|FG001|24-Week Randomized Phase|Adverse Event|0|||
162673749|NCT01059565|587513830|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
162673750|NCT01059565|587513831|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
162673751|NCT01059565|587513830|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
162673752|NCT01059565|587513831|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
162673753|NCT01059565|587513830|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
162673754|NCT01059565|587513831|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
162673755|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Adverse Event|2|||
162673756|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Adverse Event|0|||
162673757|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
162673758|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
162673759|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
162673760|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
162673761|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
162673762|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
162673763|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
162673764|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
162673765|NCT01059565|587513830|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
162673766|NCT01059565|587513831|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
162673767|NCT02732938|587513832|FG000|Overall Study|Death|0|||
162673768|NCT02732938|587513833|FG001|Overall Study|Death|11|||
162673769|NCT02732938|587513834|FG002|Overall Study|Death|0|||
162673770|NCT02732938|587513832|FG000|Overall Study|Randomized but did not receive treatment|0|||
162673771|NCT02732938|587513833|FG001|Overall Study|Randomized but did not receive treatment|1|||
162673772|NCT02732938|587513834|FG002|Overall Study|Randomized but did not receive treatment|0|||
162673773|NCT02732938|587513832|FG000|Overall Study|Refused further follow-up|1|||
162673774|NCT02732938|587513833|FG001|Overall Study|Refused further follow-up|0|||
162673775|NCT02732938|587513834|FG002|Overall Study|Refused further follow-up|0|||
162673776|NCT02732938|587513832|FG000|Overall Study|Study terminated by sponsor|3|||
162673777|NCT02732938|587513833|FG001|Overall Study|Study terminated by sponsor|6|||
162673778|NCT02732938|587513834|FG002|Overall Study|Study terminated by sponsor|0|||
162673779|NCT01026974|587513845|FG000|Overall Study|Withdrawal by Subject|0|||
162673780|NCT01026974|587513846|FG001|Overall Study|Withdrawal by Subject|1|||
162673781|NCT01026974|587513847|FG002|Overall Study|Withdrawal by Subject|7|||
162673782|NCT01026974|587513848|FG003|Overall Study|Withdrawal by Subject|2|||
162673783|NCT01026974|587513845|FG000|Overall Study|Lost to Follow-up|1|||
162673784|NCT01026974|587513846|FG001|Overall Study|Lost to Follow-up|1|||
162673785|NCT01026974|587513847|FG002|Overall Study|Lost to Follow-up|4|||
162673786|NCT01026974|587513848|FG003|Overall Study|Lost to Follow-up|0|||
162673787|NCT01026974|587513845|FG000|Overall Study|Adverse Event|0|||
162673788|NCT01026974|587513846|FG001|Overall Study|Adverse Event|0|||
162673789|NCT01026974|587513847|FG002|Overall Study|Adverse Event|0|||
162673790|NCT01026974|587513848|FG003|Overall Study|Adverse Event|1|||
162673791|NCT01026974|587513845|FG000|Overall Study|Inappropriate enrollment|0|||
162673792|NCT01026974|587513846|FG001|Overall Study|Inappropriate enrollment|0|||
162673793|NCT01026974|587513847|FG002|Overall Study|Inappropriate enrollment|1|||
162673794|NCT01026974|587513848|FG003|Overall Study|Inappropriate enrollment|0|||
162673795|NCT02864082|587513855|FG000|Overall Study|Adverse Event|1|||
162673796|NCT02864082|587513856|FG001|Overall Study|Adverse Event|1|||
162673797|NCT02864082|587513855|FG000|Overall Study|Lost to Follow-up|0|||
162673798|NCT02864082|587513856|FG001|Overall Study|Lost to Follow-up|1|||
162673799|NCT02864082|587513855|FG000|Overall Study|Withdrawal by Subject|2|||
162673800|NCT02864082|587513856|FG001|Overall Study|Withdrawal by Subject|2|||
162673801|NCT05545072|587513864|FG000|Overall Study|Lost to Follow-up|1|||
162673802|NCT05545072|587513865|FG001|Overall Study|Lost to Follow-up|0|||
162673803|NCT05545072|587513864|FG000|Overall Study|Study ended prematurely due to funding|2|||
162673804|NCT05545072|587513865|FG001|Overall Study|Study ended prematurely due to funding|2|||
162673805|NCT03996473|587513866|FG000|Treatment Assignment|Withdrawal by Subject|1|||
162673806|NCT03996473|587513866|FG000|Treatment Assignment|Progressive disease|6|||
162673807|NCT03996473|587513866|FG000|Treatment Assignment|Study drug never administered|1|||
162673808|NCT03996473|587513866|FG000|Active Follow-up|Death|1|||
162673809|NCT03996473|587513866|FG000|Long-term Follow-up|Death|5|||
162673810|NCT03759873|587513867|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
162673811|NCT03759873|587513868|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
162673812|NCT03759873|587513869|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
162673813|NCT03759873|587513870|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
162673814|NCT03759873|587513867|FG000|Overall Study|Moved outside eligible area|0|||
162673815|NCT03759873|587513868|FG001|Overall Study|Moved outside eligible area|2|||
162673816|NCT03759873|587513869|FG002|Overall Study|Moved outside eligible area|0|||
162673817|NCT03759873|587513870|FG003|Overall Study|Moved outside eligible area|0|||
162673818|NCT03759873|587513867|FG000|Overall Study|Withdrawal by Subject|0|||
162673819|NCT03759873|587513868|FG001|Overall Study|Withdrawal by Subject|0|||
162673820|NCT03759873|587513869|FG002|Overall Study|Withdrawal by Subject|1|||
162673821|NCT03759873|587513870|FG003|Overall Study|Withdrawal by Subject|0|||
162673822|NCT04349553|587513873|FG000|Overall Study|Withdrawal by Subject|1|||
162673823|NCT04349553|587513874|FG001|Overall Study|Withdrawal by Subject|0|||
162673824|NCT04349553|587513875|FG002|Overall Study|Withdrawal by Subject|1|||
162673825|NCT04349553|587513876|FG003|Overall Study|Withdrawal by Subject|0|||
162673826|NCT01869491|587513879|FG000|Overall Study|Adverse Event|3|||
162673827|NCT01869491|587513880|FG001|Overall Study|Adverse Event|5|||
162673828|NCT01869491|587513879|FG000|Overall Study|Lack of Efficacy|0|||
162673829|NCT01869491|587513880|FG001|Overall Study|Lack of Efficacy|3|||
162673830|NCT01869491|587513879|FG000|Overall Study|Withdrawal by Subject|6|||
162673831|NCT01869491|587513880|FG001|Overall Study|Withdrawal by Subject|7|||
162673832|NCT01869491|587513879|FG000|Overall Study|Lost to Follow-up|11|||
162673833|NCT01869491|587513880|FG001|Overall Study|Lost to Follow-up|9|||
162673834|NCT01869491|587513879|FG000|Overall Study|No further need of investigational product|1|||
162673835|NCT01869491|587513880|FG001|Overall Study|No further need of investigational product|0|||
162673836|NCT05177770|587513881|FG000|Overall Study|Death|4|||
162673837|NCT05177770|587513881|FG000|Overall Study|Withdrawal by Subject|1|||
162673838|NCT05177770|587513881|FG000|Overall Study|Adverse Event prior to dosing|1|||
162673839|NCT01272934|587513885|FG000|Overall Study|Adverse Event|0|||
162673840|NCT01272934|587513886|FG001|Overall Study|Adverse Event|1|||
162673841|NCT01272934|587513885|FG000|Overall Study|Abnormal Laboratory Value|0|||
162673842|NCT01272934|587513886|FG001|Overall Study|Abnormal Laboratory Value|1|||
162673843|NCT02105948|587513887|FG000|Overall Study|Adverse Event|10|||
162673844|NCT02105948|587513888|FG001|Overall Study|Adverse Event|7|||
162673845|NCT02105948|587513889|FG002|Overall Study|Adverse Event|11|||
162673846|NCT02105948|587513890|FG003|Overall Study|Adverse Event|11|||
162673847|NCT02105948|587513887|FG000|Overall Study|Lack of Efficacy|0|||
162673848|NCT02105948|587513888|FG001|Overall Study|Lack of Efficacy|1|||
162673849|NCT02105948|587513889|FG002|Overall Study|Lack of Efficacy|3|||
162673850|NCT02105948|587513890|FG003|Overall Study|Lack of Efficacy|2|||
162673851|NCT02105948|587513887|FG000|Overall Study|Lost to Follow-up|0|||
162673852|NCT02105948|587513888|FG001|Overall Study|Lost to Follow-up|0|||
162673853|NCT02105948|587513889|FG002|Overall Study|Lost to Follow-up|2|||
162673854|NCT02105948|587513890|FG003|Overall Study|Lost to Follow-up|1|||
162673855|NCT02105948|587513887|FG000|Overall Study|Physician Decision|2|||
162673856|NCT02105948|587513888|FG001|Overall Study|Physician Decision|2|||
162673857|NCT02105948|587513889|FG002|Overall Study|Physician Decision|2|||
162673858|NCT02105948|587513890|FG003|Overall Study|Physician Decision|2|||
162673859|NCT02105948|587513887|FG000|Overall Study|Withdrawal by Subject|15|||
162673860|NCT02105948|587513888|FG001|Overall Study|Withdrawal by Subject|10|||
162673861|NCT02105948|587513889|FG002|Overall Study|Withdrawal by Subject|10|||
162673862|NCT02105948|587513890|FG003|Overall Study|Withdrawal by Subject|11|||
162673863|NCT04558346|587513891|FG000|Overall Study|Withdrawal by Subject|2|||
162673864|NCT04558346|587513892|FG001|Overall Study|Withdrawal by Subject|0|||
162673865|NCT04558346|587513891|FG000|Overall Study|Lost to Follow-up|0|||
162673866|NCT04558346|587513892|FG001|Overall Study|Lost to Follow-up|1|||
162673867|NCT04558346|587513891|FG000|Overall Study|Adverse Event|0|||
162673868|NCT04558346|587513892|FG001|Overall Study|Adverse Event|1|||
162673869|NCT00724971|587513895|FG000|Overall Study|Adverse Event|5|||
162673870|NCT00724971|587513895|FG000|Overall Study|Withdrawal by Subject|1|||
162673871|NCT01962974|587513896|FG000|Overall Study|Study termination|7|||
162673872|NCT02276482|587513899|FG000|Overall Study|Adverse Event|1|||
162673873|NCT02276482|587513900|FG001|Overall Study|Adverse Event|0|||
162673874|NCT02276482|587513899|FG000|Overall Study|Withdrawal by Subject|1|||
162673875|NCT02276482|587513900|FG001|Overall Study|Withdrawal by Subject|0|||
162673876|NCT02276482|587513899|FG000|Overall Study|Gram-negative infection|1|||
162673877|NCT02276482|587513900|FG001|Overall Study|Gram-negative infection|0|||
162673878|NCT02276482|587513899|FG000|Overall Study|Reason not specified|0|||
162673879|NCT02276482|587513900|FG001|Overall Study|Reason not specified|1|||
162673880|NCT02005471|587513907|FG000|Main Study|Adverse Event|0|||
162673881|NCT02005471|587513908|FG001|Main Study|Adverse Event|1|||
162673882|NCT02005471|587513909|FG002|Main Study|Adverse Event|0|||
162673883|NCT02005471|587513910|FG003|Main Study|Adverse Event|0|||
162673884|NCT02005471|587513907|FG000|Main Study|Death|83|||
162673885|NCT02005471|587513908|FG001|Main Study|Death|52|||
162673886|NCT02005471|587513909|FG002|Main Study|Death|0|||
162673887|NCT02005471|587513910|FG003|Main Study|Death|0|||
162673888|NCT02005471|587513907|FG000|Main Study|Lost to Follow-up|4|||
162673889|NCT02005471|587513908|FG001|Main Study|Lost to Follow-up|5|||
162673890|NCT02005471|587513909|FG002|Main Study|Lost to Follow-up|0|||
162673891|NCT02005471|587513910|FG003|Main Study|Lost to Follow-up|0|||
162673892|NCT02005471|587513907|FG000|Main Study|Physician Decision|3|||
162673893|NCT02005471|587513908|FG001|Main Study|Physician Decision|1|||
162673894|NCT02005471|587513909|FG002|Main Study|Physician Decision|0|||
162673895|NCT02005471|587513910|FG003|Main Study|Physician Decision|0|||
162673896|NCT02005471|587513907|FG000|Main Study|Withdrawal by Subject|26|||
162673897|NCT02005471|587513908|FG001|Main Study|Withdrawal by Subject|11|||
162673898|NCT02005471|587513909|FG002|Main Study|Withdrawal by Subject|0|||
162673899|NCT02005471|587513910|FG003|Main Study|Withdrawal by Subject|0|||
162673900|NCT02005471|587513907|FG000|Main Study|Reason not Specified|0|||
162673901|NCT02005471|587513908|FG001|Main Study|Reason not Specified|6|||
162673902|NCT02005471|587513909|FG002|Main Study|Reason not Specified|0|||
162673903|NCT02005471|587513910|FG003|Main Study|Reason not Specified|0|||
162673904|NCT02005471|587513907|FG000|Main Study|Randomized but not Dosed|8|||
162673905|NCT02005471|587513908|FG001|Main Study|Randomized but not Dosed|0|||
162673906|NCT02005471|587513909|FG002|Main Study|Randomized but not Dosed|0|||
162673907|NCT02005471|587513910|FG003|Main Study|Randomized but not Dosed|0|||
162673908|NCT02005471|587513907|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162673909|NCT02005471|587513908|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162673910|NCT02005471|587513909|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162673911|NCT02005471|587513910|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
162673912|NCT02005471|587513907|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
162673913|NCT02005471|587513908|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
162673914|NCT02005471|587513909|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
162673915|NCT02005471|587513910|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
162722091|NCT00843882|587689413|FG001|Step 1|Other complicating disease|3|||
162673916|NCT02005471|587513907|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
162673917|NCT02005471|587513908|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
162673918|NCT02005471|587513909|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
162673919|NCT02005471|587513910|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
162673920|NCT00627705|587513912|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
162673921|NCT00627705|587513913|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
162673922|NCT00627705|587513912|FG000|Overall Study|Adverse Event|1|||
162673923|NCT00627705|587513913|FG001|Overall Study|Adverse Event|0|||
162673924|NCT00627705|587513912|FG000|Overall Study|Withdrawal by Subject|0|||
162673925|NCT00627705|587513913|FG001|Overall Study|Withdrawal by Subject|2|||
162673926|NCT00627705|587513912|FG000|Overall Study|Lost to Follow-up|0|||
162673927|NCT00627705|587513913|FG001|Overall Study|Lost to Follow-up|1|||
162673928|NCT01410448|587513919|FG000|Overall Study|No conversion to everolimus|0|||
162673929|NCT01410448|587513920|FG001|Overall Study|No conversion to everolimus|24|||
162673930|NCT01410448|587513919|FG000|Overall Study|Graft loss|4|||
162673931|NCT01410448|587513920|FG001|Overall Study|Graft loss|1|||
162673932|NCT01410448|587513919|FG000|Overall Study|Administrative issues|2|||
162673933|NCT01410448|587513920|FG001|Overall Study|Administrative issues|1|||
162673934|NCT01410448|587513919|FG000|Overall Study|Lost to Follow-up|1|||
162673935|NCT01410448|587513920|FG001|Overall Study|Lost to Follow-up|0|||
162673936|NCT01410448|587513919|FG000|Overall Study|Withdrawal by Subject|3|||
162673937|NCT01410448|587513920|FG001|Overall Study|Withdrawal by Subject|2|||
162673938|NCT01410448|587513919|FG000|Overall Study|Protocol Violation|0|||
162673939|NCT01410448|587513920|FG001|Overall Study|Protocol Violation|4|||
162673940|NCT01410448|587513919|FG000|Overall Study|Death|2|||
162673941|NCT01410448|587513920|FG001|Overall Study|Death|3|||
162673942|NCT02535065|587513921|FG000|Overall Study|Death|13|||
162673943|NCT02535065|587513921|FG000|Overall Study|Lost to Follow-up|1|||
162673944|NCT02535065|587513921|FG000|Overall Study|Withdrawal by Subject|6|||
162673945|NCT03712917|587513923|FG000|Overall Study|Pregnancy|0|||
162673946|NCT03712917|587513924|FG001|Overall Study|Pregnancy|0|||
162673947|NCT03712917|587513925|FG002|Overall Study|Pregnancy|1|||
162673948|NCT03712917|587513923|FG000|Overall Study|Adverse Event|0|||
162673949|NCT03712917|587513924|FG001|Overall Study|Adverse Event|4|||
162673950|NCT03712917|587513925|FG002|Overall Study|Adverse Event|3|||
162673951|NCT03712917|587513923|FG000|Overall Study|Lost to Follow-up|9|||
162673952|NCT03712917|587513924|FG001|Overall Study|Lost to Follow-up|4|||
162673953|NCT03712917|587513925|FG002|Overall Study|Lost to Follow-up|5|||
162673954|NCT04764396|587513926|FG000|Overall Study|Physician Decision|1|||
162673955|NCT04764396|587513927|FG001|Overall Study|Physician Decision|0|||
162673956|NCT03230916|587513928|FG000|Overall Study|Withdrawal by Subject|0|||
162673957|NCT03230916|587513929|FG001|Overall Study|Withdrawal by Subject|0|||
162673958|NCT03230916|587513930|FG002|Overall Study|Withdrawal by Subject|0|||
162673959|NCT03230916|587513931|FG003|Overall Study|Withdrawal by Subject|0|||
162673960|NCT03230916|587513932|FG004|Overall Study|Withdrawal by Subject|0|||
162673961|NCT03230916|587513933|FG005|Overall Study|Withdrawal by Subject|1|||
162673962|NCT03230916|587513934|FG006|Overall Study|Withdrawal by Subject|0|||
162673963|NCT03230916|587513935|FG007|Overall Study|Withdrawal by Subject|0|||
162673964|NCT03230916|587513936|FG008|Overall Study|Withdrawal by Subject|0|||
162673965|NCT03230916|587513937|FG009|Overall Study|Withdrawal by Subject|0|||
162673966|NCT03230916|587513938|FG010|Overall Study|Withdrawal by Subject|0|||
162673967|NCT01438541|587513943|FG000|Overall Study|Physician Decision|1|||
162673968|NCT01438541|587513943|FG000|Overall Study|Withdrawal by Subject|1|||
162673969|NCT01438541|587513943|FG000|Overall Study|discharge from the hospital|5|||
162673970|NCT02091167|587513944|FG000|Overall Study|Lost to Follow-up|0|||
162673971|NCT02091167|587513945|FG001|Overall Study|Lost to Follow-up|2|||
162673972|NCT01218646|587513946|FG000|Overall Study|Adverse Event|0|||
162673973|NCT01218646|587513947|FG001|Overall Study|Adverse Event|0|||
162673974|NCT01218646|587513948|FG002|Overall Study|Adverse Event|1|||
162673975|NCT01218646|587513949|FG003|Overall Study|Adverse Event|0|||
162673976|NCT01218646|587513946|FG000|Overall Study|Lost to Follow-up|1|||
162673977|NCT01218646|587513947|FG001|Overall Study|Lost to Follow-up|0|||
162673978|NCT01218646|587513948|FG002|Overall Study|Lost to Follow-up|0|||
162673979|NCT01218646|587513949|FG003|Overall Study|Lost to Follow-up|0|||
162673980|NCT01218646|587513946|FG000|Overall Study|Protocol Violation|0|||
162673981|NCT01218646|587513947|FG001|Overall Study|Protocol Violation|0|||
162673982|NCT01218646|587513948|FG002|Overall Study|Protocol Violation|1|||
162673983|NCT01218646|587513949|FG003|Overall Study|Protocol Violation|1|||
162673984|NCT00722761|587513950|FG000|Overall Study|Lost to Follow-up|1|||
162673985|NCT00722761|587513951|FG001|Overall Study|Lost to Follow-up|4|||
162673986|NCT00722761|587513950|FG000|Overall Study|Withdrawal by Subject|5|||
162673987|NCT00722761|587513951|FG001|Overall Study|Withdrawal by Subject|2|||
162673988|NCT02693665|587513955|FG000|Overall Study|Death|3|||
162673989|NCT02693665|587513956|FG001|Overall Study|Death|2|||
162722092|NCT00843882|587689414|FG002|Step 1|Other complicating disease|4|||
162673990|NCT02693665|587513955|FG000|Overall Study|Lost to Follow-up|7|||
162673991|NCT02693665|587513956|FG001|Overall Study|Lost to Follow-up|3|||
162673992|NCT02693665|587513955|FG000|Overall Study|Protocol Violation|1|||
162722093|NCT00843882|587689412|FG000|Step 1|Alternative therapy|0|||
162673993|NCT02693665|587513956|FG001|Overall Study|Protocol Violation|0|||
162673994|NCT02693665|587513955|FG000|Overall Study|Withdrawal by Subject|2|||
162673995|NCT02693665|587513956|FG001|Overall Study|Withdrawal by Subject|0|||
162673996|NCT02693665|587513955|FG000|Overall Study|patient wanted to leave it behind|1|||
162673997|NCT02693665|587513956|FG001|Overall Study|patient wanted to leave it behind|0|||
162673998|NCT02693665|587513955|FG000|Overall Study|anxiety|1|||
162673999|NCT02693665|587513956|FG001|Overall Study|anxiety|0|||
162674000|NCT02693665|587513955|FG000|Overall Study|family issues|1|||
162674001|NCT02693665|587513956|FG001|Overall Study|family issues|0|||
162674002|NCT02693665|587513955|FG000|Overall Study|no reason given|1|||
162674003|NCT02693665|587513956|FG001|Overall Study|no reason given|0|||
162674004|NCT03096782|587513957|FG000|Overall Study|Death|1|||
162674005|NCT03096782|587513957|FG000|Overall Study|Participant Relapsed|1|||
162674006|NCT03156023|587513958|FG000|Overall Study|Withdrawal by Subject|1|||
162674007|NCT03156023|587513959|FG001|Overall Study|Withdrawal by Subject|0|||
162674008|NCT03156023|587513960|FG002|Overall Study|Withdrawal by Subject|2|||
162674009|NCT03156023|587513961|FG003|Overall Study|Withdrawal by Subject|1|||
162674010|NCT03156023|587513962|FG004|Overall Study|Withdrawal by Subject|1|||
162674011|NCT03156023|587513958|FG000|Overall Study|Lost to Follow-up|0|||
162674012|NCT03156023|587513959|FG001|Overall Study|Lost to Follow-up|0|||
162674013|NCT03156023|587513960|FG002|Overall Study|Lost to Follow-up|0|||
162674014|NCT03156023|587513961|FG003|Overall Study|Lost to Follow-up|0|||
162674015|NCT03156023|587513962|FG004|Overall Study|Lost to Follow-up|1|||
162674016|NCT02075593|587513963|FG000|Overall Study|Withdrawal by Subject|1|||
162674017|NCT05819749|587513968|FG000|Overall Study|Lost to Follow-up|1|||
162674018|NCT00844857|587516320|FG000|Overall Study|Adverse Event|24|||
162674019|NCT00844857|587516321|FG001|Overall Study|Adverse Event|5|||
162674020|NCT00844857|587516320|FG000|Overall Study|Sponsor Decision|1|||
162674021|NCT00844857|587516321|FG001|Overall Study|Sponsor Decision|1|||
162674022|NCT00844857|587516320|FG000|Overall Study|Physician Decision|2|||
162674023|NCT00844857|587516321|FG001|Overall Study|Physician Decision|0|||
162674024|NCT00844857|587516320|FG000|Overall Study|Parent/Caregiver Decision|6|||
162674025|NCT00844857|587516321|FG001|Overall Study|Parent/Caregiver Decision|2|||
162674026|NCT00844857|587516320|FG000|Overall Study|Withdrawal by Subject|8|||
162674027|NCT00844857|587516321|FG001|Overall Study|Withdrawal by Subject|7|||
162674028|NCT00844857|587516320|FG000|Overall Study|Protocol Violation|6|||
162674029|NCT00844857|587516321|FG001|Overall Study|Protocol Violation|0|||
162674030|NCT00844857|587516320|FG000|Overall Study|Lack of Efficacy|5|||
162674031|NCT00844857|587516321|FG001|Overall Study|Lack of Efficacy|5|||
162674032|NCT00844857|587516320|FG000|Overall Study|Clinical Relapse|0|||
162674033|NCT00844857|587516321|FG001|Overall Study|Clinical Relapse|1|||
162674034|NCT00844857|587516320|FG000|Overall Study|Entry Criteria Not Met|0|||
162674035|NCT00844857|587516321|FG001|Overall Study|Entry Criteria Not Met|1|||
162674036|NCT00844857|587516320|FG000|Overall Study|Lost to Follow-up|2|||
162674037|NCT00844857|587516321|FG001|Overall Study|Lost to Follow-up|3|||
162674038|NCT00844857|587516320|FG000|Overall Study|Did Not Take Study Drug|3|||
162674039|NCT00844857|587516321|FG001|Overall Study|Did Not Take Study Drug|1|||
162674040|NCT00844857|587516320|FG000|Overall Study|Good Clinical Practice Violations|21|||
162674041|NCT00844857|587516321|FG001|Overall Study|Good Clinical Practice Violations|11|||
162674042|NCT00570674|587516322|FG000|Overall Study|Withdrawal by Subject|0|||
162674043|NCT00570674|587516323|FG001|Overall Study|Withdrawal by Subject|0|||
162674044|NCT00570674|587516324|FG002|Overall Study|Withdrawal by Subject|1|||
162674045|NCT00570674|587516325|FG003|Overall Study|Withdrawal by Subject|0|||
162674046|NCT00570674|587516326|FG004|Overall Study|Withdrawal by Subject|0|||
162674047|NCT00570674|587516327|FG005|Overall Study|Withdrawal by Subject|0|||
162674048|NCT00570674|587516328|FG006|Overall Study|Withdrawal by Subject|0|||
162674049|NCT03069482|587516329|FG000|Overall Study|Lost to Follow-up|0|||
162674050|NCT03069482|587516330|FG001|Overall Study|Lost to Follow-up|1|||
162674051|NCT03069482|587516329|FG000|Overall Study|Physician Decision|1|||
162674052|NCT03069482|587516330|FG001|Overall Study|Physician Decision|0|||
162674053|NCT02338154|587516342|FG000|Overall Study|Death|46|||
162674054|NCT02338154|587516342|FG000|Overall Study|Valve Implant Failure|17|||
162674055|NCT02338154|587516342|FG000|Overall Study|Valve Explant|11|||
162674056|NCT02338154|587516342|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
162674057|NCT02338154|587516342|FG000|Overall Study|Lost to Follow-up|8|||
162674058|NCT02338154|587516342|FG000|Overall Study|Other Reason|3|||
162674059|NCT02338154|587516342|FG000|Overall Study|Patients Without Exit Form|47|||
162674060|NCT02338154|587516342|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
162674061|NCT03393000|587516347|FG000|Overall Study|Death|11|||
162674062|NCT03393000|587516347|FG000|Overall Study|Withdrawal by Subject|2|||
162674063|NCT03393000|587516347|FG000|Overall Study|Physician Decision|1|||
162674064|NCT01773070|587516348|FG000|Overall Study|Withdrawal by Subject|24|||
162674065|NCT01773070|587516348|FG000|Overall Study|Lost to Follow-up|39|||
162674066|NCT01773070|587516348|FG000|Overall Study|Other|15|||
162674067|NCT01773070|587516348|FG000|Overall Study|Death (unrelated to study procedures)|3|||
162674068|NCT01559844|587516349|FG000|Overall Study|Consent Withdrawn|7|||
162674069|NCT01559844|587516349|FG000|Overall Study|Death|5|||
162674070|NCT01559844|587516349|FG000|Overall Study|Efficacy Failure|10|||
162674071|NCT01559844|587516349|FG000|Overall Study|No Longer A Transplant Candidate|3|||
162674072|NCT02181803|587516350|FG000|Overall Study|Withdrawal by Subject|0|||
162674073|NCT02181803|587516351|FG001|Overall Study|Withdrawal by Subject|2|||
162674074|NCT02181803|587516352|FG002|Overall Study|Withdrawal by Subject|0|||
162674075|NCT02181803|587516353|FG003|Overall Study|Withdrawal by Subject|0|||
162674076|NCT02181803|587516354|FG004|Overall Study|Withdrawal by Subject|0|||
162674077|NCT02181803|587516355|FG005|Overall Study|Withdrawal by Subject|0|||
162674078|NCT02181803|587516356|FG006|Overall Study|Withdrawal by Subject|0|||
162674079|NCT02181803|587516357|FG007|Overall Study|Withdrawal by Subject|0|||
162674080|NCT02181803|587516358|FG008|Overall Study|Withdrawal by Subject|0|||
162674081|NCT02181803|587516350|FG000|Overall Study|Physician Decision|0|||
162674082|NCT02181803|587516351|FG001|Overall Study|Physician Decision|0|||
162674083|NCT02181803|587516352|FG002|Overall Study|Physician Decision|0|||
162674084|NCT02181803|587516353|FG003|Overall Study|Physician Decision|1|||
162674085|NCT02181803|587516354|FG004|Overall Study|Physician Decision|0|||
162674086|NCT02181803|587516355|FG005|Overall Study|Physician Decision|0|||
162674087|NCT02181803|587516356|FG006|Overall Study|Physician Decision|0|||
162674088|NCT02181803|587516357|FG007|Overall Study|Physician Decision|1|||
162674089|NCT02181803|587516358|FG008|Overall Study|Physician Decision|0|||
162674090|NCT02181803|587516350|FG000|Overall Study|Adverse Event|0|||
162674091|NCT02181803|587516351|FG001|Overall Study|Adverse Event|2|||
162674092|NCT02181803|587516352|FG002|Overall Study|Adverse Event|0|||
162674093|NCT02181803|587516353|FG003|Overall Study|Adverse Event|1|||
162674094|NCT02181803|587516354|FG004|Overall Study|Adverse Event|0|||
162674095|NCT02181803|587516355|FG005|Overall Study|Adverse Event|0|||
162674096|NCT02181803|587516356|FG006|Overall Study|Adverse Event|1|||
162674097|NCT02181803|587516357|FG007|Overall Study|Adverse Event|0|||
162674098|NCT02181803|587516358|FG008|Overall Study|Adverse Event|0|||
162674099|NCT04786444|587516363|FG000|Overall Study|Withdrawal by Subject|4|||
162674100|NCT04786444|587516364|FG001|Overall Study|Withdrawal by Subject|7|||
162674101|NCT04786444|587516365|FG002|Overall Study|Withdrawal by Subject|2|||
162674102|NCT04786444|587516363|FG000|Overall Study|Lost to Follow-up|11|||
162674103|NCT04786444|587516364|FG001|Overall Study|Lost to Follow-up|9|||
162674104|NCT04786444|587516365|FG002|Overall Study|Lost to Follow-up|10|||
162674105|NCT04786444|587516363|FG000|Overall Study|Subject would like to become pregnant|0|||
162674106|NCT04786444|587516364|FG001|Overall Study|Subject would like to become pregnant|1|||
162674107|NCT04786444|587516365|FG002|Overall Study|Subject would like to become pregnant|0|||
162674108|NCT03166618|587516366|FG000|Overall Study|Study was Terminated|0|||
162674109|NCT03166618|587516367|FG001|Overall Study|Study was Terminated|1|||
162674110|NCT01925950|587516368|FG000|Part 2|Withdrawal by Subject|1|||
162674111|NCT01925950|587516369|FG001|Part 2|Withdrawal by Subject|0|||
162674112|NCT03137303|587516371|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
162674113|NCT03137303|587516372|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
162674114|NCT03137303|587516371|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
162674115|NCT03137303|587516372|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
162674116|NCT03137303|587516371|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
162674117|NCT03137303|587516372|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
162674118|NCT03137303|587516371|FG000|T3: 9-month Follow-up|Death|1|||
162674119|NCT03137303|587516372|FG001|T3: 9-month Follow-up|Death|0|||
162674120|NCT03137303|587516371|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
162674121|NCT03137303|587516372|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
162674122|NCT03137303|587516371|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
162674123|NCT03137303|587516372|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
162674124|NCT03137303|587516371|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
162674125|NCT03137303|587516372|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
162674126|NCT01217073|587516373|FG000|Base Period|Adverse Event|1|||
162674127|NCT01217073|587516374|FG001|Base Period|Adverse Event|0|||
162674128|NCT01217073|587516375|FG002|Base Period|Adverse Event|1|||
162674129|NCT01217073|587516376|FG003|Base Period|Adverse Event|0|||
162674130|NCT01217073|587516377|FG004|Base Period|Adverse Event|4|||
162674131|NCT01217073|587516378|FG005|Base Period|Adverse Event|1|||
162674132|NCT01217073|587516379|FG006|Base Period|Adverse Event|0|||
162674133|NCT01217073|587516380|FG007|Base Period|Adverse Event|0|||
162674134|NCT01217073|587516373|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
162674135|NCT01217073|587516374|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674136|NCT01217073|587516375|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162722094|NCT00843882|587689413|FG001|Step 1|Alternative therapy|1|||
162722095|NCT00843882|587689414|FG002|Step 1|Alternative therapy|1|||
162674137|NCT01217073|587516376|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674138|NCT01217073|587516377|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674139|NCT01217073|587516378|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674140|NCT01217073|587516379|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674141|NCT01217073|587516380|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162674142|NCT01217073|587516373|FG000|Base Period|Excluded medication|0|||
162674143|NCT01217073|587516374|FG001|Base Period|Excluded medication|0|||
162674144|NCT01217073|587516375|FG002|Base Period|Excluded medication|0|||
162674145|NCT01217073|587516376|FG003|Base Period|Excluded medication|0|||
162674146|NCT01217073|587516377|FG004|Base Period|Excluded medication|1|||
162674147|NCT01217073|587516378|FG005|Base Period|Excluded medication|0|||
162674148|NCT01217073|587516379|FG006|Base Period|Excluded medication|0|||
162674149|NCT01217073|587516380|FG007|Base Period|Excluded medication|0|||
162674150|NCT01217073|587516373|FG000|Base Period|Lack of Efficacy|0|||
162674151|NCT01217073|587516374|FG001|Base Period|Lack of Efficacy|0|||
162674152|NCT01217073|587516375|FG002|Base Period|Lack of Efficacy|0|||
162674153|NCT01217073|587516376|FG003|Base Period|Lack of Efficacy|0|||
162674154|NCT01217073|587516377|FG004|Base Period|Lack of Efficacy|0|||
162674155|NCT01217073|587516378|FG005|Base Period|Lack of Efficacy|1|||
162674156|NCT01217073|587516379|FG006|Base Period|Lack of Efficacy|0|||
162674157|NCT01217073|587516380|FG007|Base Period|Lack of Efficacy|0|||
162674158|NCT01217073|587516373|FG000|Base Period|Lost to Follow-up|0|||
162674159|NCT01217073|587516374|FG001|Base Period|Lost to Follow-up|0|||
162674160|NCT01217073|587516375|FG002|Base Period|Lost to Follow-up|1|||
162674161|NCT01217073|587516376|FG003|Base Period|Lost to Follow-up|1|||
162674162|NCT01217073|587516377|FG004|Base Period|Lost to Follow-up|3|||
162674163|NCT01217073|587516378|FG005|Base Period|Lost to Follow-up|0|||
162674164|NCT01217073|587516379|FG006|Base Period|Lost to Follow-up|0|||
162674165|NCT01217073|587516380|FG007|Base Period|Lost to Follow-up|0|||
162674166|NCT01217073|587516373|FG000|Base Period|Physician Decision|0|||
162674167|NCT01217073|587516374|FG001|Base Period|Physician Decision|0|||
162674168|NCT01217073|587516375|FG002|Base Period|Physician Decision|0|||
162674169|NCT01217073|587516376|FG003|Base Period|Physician Decision|0|||
162674170|NCT01217073|587516377|FG004|Base Period|Physician Decision|1|||
162674171|NCT01217073|587516378|FG005|Base Period|Physician Decision|0|||
162674172|NCT01217073|587516379|FG006|Base Period|Physician Decision|0|||
162674173|NCT01217073|587516380|FG007|Base Period|Physician Decision|0|||
162674174|NCT01217073|587516373|FG000|Base Period|Protocol Violation|1|||
162674175|NCT01217073|587516374|FG001|Base Period|Protocol Violation|0|||
162674176|NCT01217073|587516375|FG002|Base Period|Protocol Violation|0|||
162674177|NCT01217073|587516376|FG003|Base Period|Protocol Violation|0|||
162674178|NCT01217073|587516377|FG004|Base Period|Protocol Violation|1|||
162674179|NCT01217073|587516378|FG005|Base Period|Protocol Violation|2|||
162674180|NCT01217073|587516379|FG006|Base Period|Protocol Violation|0|||
162674181|NCT01217073|587516380|FG007|Base Period|Protocol Violation|0|||
162674182|NCT01217073|587516373|FG000|Base Period|Withdrawal by Subject|4|||
162674183|NCT01217073|587516374|FG001|Base Period|Withdrawal by Subject|5|||
162674184|NCT01217073|587516375|FG002|Base Period|Withdrawal by Subject|5|||
162674185|NCT01217073|587516376|FG003|Base Period|Withdrawal by Subject|1|||
162674186|NCT01217073|587516377|FG004|Base Period|Withdrawal by Subject|5|||
162674187|NCT01217073|587516378|FG005|Base Period|Withdrawal by Subject|5|||
162674188|NCT01217073|587516379|FG006|Base Period|Withdrawal by Subject|0|||
162674189|NCT01217073|587516380|FG007|Base Period|Withdrawal by Subject|0|||
162674190|NCT01217073|587516373|FG000|Extension Period|Adverse Event|0|||
162674191|NCT01217073|587516374|FG001|Extension Period|Adverse Event|0|||
162674192|NCT01217073|587516375|FG002|Extension Period|Adverse Event|0|||
162674193|NCT01217073|587516376|FG003|Extension Period|Adverse Event|0|||
162674194|NCT01217073|587516377|FG004|Extension Period|Adverse Event|0|||
162674195|NCT01217073|587516378|FG005|Extension Period|Adverse Event|0|||
162674196|NCT01217073|587516379|FG006|Extension Period|Adverse Event|19|||
162674197|NCT01217073|587516380|FG007|Extension Period|Adverse Event|5|||
162674198|NCT01217073|587516373|FG000|Extension Period|ALT/AST|0|||
162674199|NCT01217073|587516374|FG001|Extension Period|ALT/AST|0|||
162674200|NCT01217073|587516375|FG002|Extension Period|ALT/AST|0|||
162674201|NCT01217073|587516376|FG003|Extension Period|ALT/AST|0|||
162674202|NCT01217073|587516377|FG004|Extension Period|ALT/AST|0|||
162674203|NCT01217073|587516378|FG005|Extension Period|ALT/AST|0|||
162674204|NCT01217073|587516379|FG006|Extension Period|ALT/AST|2|||
162674205|NCT01217073|587516380|FG007|Extension Period|ALT/AST|0|||
162674206|NCT01217073|587516373|FG000|Extension Period|Contraindication to study medication|0|||
162674207|NCT01217073|587516374|FG001|Extension Period|Contraindication to study medication|0|||
162674208|NCT01217073|587516375|FG002|Extension Period|Contraindication to study medication|0|||
162674209|NCT01217073|587516376|FG003|Extension Period|Contraindication to study medication|0|||
162674210|NCT01217073|587516377|FG004|Extension Period|Contraindication to study medication|0|||
162674211|NCT01217073|587516378|FG005|Extension Period|Contraindication to study medication|0|||
162674212|NCT01217073|587516379|FG006|Extension Period|Contraindication to study medication|1|||
162674213|NCT01217073|587516380|FG007|Extension Period|Contraindication to study medication|0|||
162674214|NCT01217073|587516373|FG000|Extension Period|Creatinine/eGFR|0|||
162674215|NCT01217073|587516374|FG001|Extension Period|Creatinine/eGFR|0|||
162674216|NCT01217073|587516375|FG002|Extension Period|Creatinine/eGFR|0|||
162674217|NCT01217073|587516376|FG003|Extension Period|Creatinine/eGFR|0|||
162674218|NCT01217073|587516377|FG004|Extension Period|Creatinine/eGFR|0|||
162674219|NCT01217073|587516378|FG005|Extension Period|Creatinine/eGFR|0|||
162674220|NCT01217073|587516379|FG006|Extension Period|Creatinine/eGFR|11|||
162674221|NCT01217073|587516380|FG007|Extension Period|Creatinine/eGFR|1|||
162674222|NCT01217073|587516373|FG000|Extension Period|Death|0|||
162674223|NCT01217073|587516374|FG001|Extension Period|Death|0|||
162674224|NCT01217073|587516375|FG002|Extension Period|Death|0|||
162674225|NCT01217073|587516376|FG003|Extension Period|Death|0|||
162674226|NCT01217073|587516377|FG004|Extension Period|Death|0|||
162674227|NCT01217073|587516378|FG005|Extension Period|Death|0|||
162674228|NCT01217073|587516379|FG006|Extension Period|Death|1|||
162674229|NCT01217073|587516380|FG007|Extension Period|Death|0|||
162674230|NCT01217073|587516373|FG000|Extension Period|Excluded medication|0|||
162674231|NCT01217073|587516374|FG001|Extension Period|Excluded medication|0|||
162674232|NCT01217073|587516375|FG002|Extension Period|Excluded medication|0|||
162674233|NCT01217073|587516376|FG003|Extension Period|Excluded medication|0|||
162674234|NCT01217073|587516377|FG004|Extension Period|Excluded medication|0|||
162674235|NCT01217073|587516378|FG005|Extension Period|Excluded medication|0|||
162674236|NCT01217073|587516379|FG006|Extension Period|Excluded medication|2|||
162674237|NCT01217073|587516380|FG007|Extension Period|Excluded medication|0|||
162674238|NCT01217073|587516373|FG000|Extension Period|Lack of Efficacy|0|||
162674239|NCT01217073|587516374|FG001|Extension Period|Lack of Efficacy|0|||
162674240|NCT01217073|587516375|FG002|Extension Period|Lack of Efficacy|0|||
162674241|NCT01217073|587516376|FG003|Extension Period|Lack of Efficacy|0|||
162674242|NCT01217073|587516377|FG004|Extension Period|Lack of Efficacy|0|||
162674243|NCT01217073|587516378|FG005|Extension Period|Lack of Efficacy|0|||
162674244|NCT01217073|587516379|FG006|Extension Period|Lack of Efficacy|3|||
162674245|NCT01217073|587516380|FG007|Extension Period|Lack of Efficacy|0|||
162674246|NCT01217073|587516373|FG000|Extension Period|Lost to Follow-up|0|||
162674247|NCT01217073|587516374|FG001|Extension Period|Lost to Follow-up|0|||
162674248|NCT01217073|587516375|FG002|Extension Period|Lost to Follow-up|0|||
162674249|NCT01217073|587516376|FG003|Extension Period|Lost to Follow-up|0|||
162674250|NCT01217073|587516377|FG004|Extension Period|Lost to Follow-up|0|||
162674251|NCT01217073|587516378|FG005|Extension Period|Lost to Follow-up|0|||
162674252|NCT01217073|587516379|FG006|Extension Period|Lost to Follow-up|9|||
162674253|NCT01217073|587516380|FG007|Extension Period|Lost to Follow-up|1|||
162674254|NCT01217073|587516373|FG000|Extension Period|Non-compliance with study drug|0|||
162674255|NCT01217073|587516374|FG001|Extension Period|Non-compliance with study drug|0|||
162674256|NCT01217073|587516375|FG002|Extension Period|Non-compliance with study drug|0|||
162674257|NCT01217073|587516376|FG003|Extension Period|Non-compliance with study drug|0|||
162674258|NCT01217073|587516377|FG004|Extension Period|Non-compliance with study drug|0|||
162674259|NCT01217073|587516378|FG005|Extension Period|Non-compliance with study drug|0|||
162674260|NCT01217073|587516379|FG006|Extension Period|Non-compliance with study drug|0|||
162674261|NCT01217073|587516380|FG007|Extension Period|Non-compliance with study drug|1|||
162674262|NCT01217073|587516373|FG000|Extension Period|Physician Decision|0|||
162674263|NCT01217073|587516374|FG001|Extension Period|Physician Decision|0|||
162674264|NCT01217073|587516375|FG002|Extension Period|Physician Decision|0|||
162674265|NCT01217073|587516376|FG003|Extension Period|Physician Decision|0|||
162674266|NCT01217073|587516377|FG004|Extension Period|Physician Decision|0|||
162674267|NCT01217073|587516378|FG005|Extension Period|Physician Decision|0|||
162674268|NCT01217073|587516379|FG006|Extension Period|Physician Decision|4|||
162674269|NCT01217073|587516380|FG007|Extension Period|Physician Decision|1|||
162674270|NCT01217073|587516373|FG000|Extension Period|Protocol Violation|0|||
162674271|NCT01217073|587516374|FG001|Extension Period|Protocol Violation|0|||
162674272|NCT01217073|587516375|FG002|Extension Period|Protocol Violation|0|||
162674273|NCT01217073|587516376|FG003|Extension Period|Protocol Violation|0|||
162674274|NCT01217073|587516377|FG004|Extension Period|Protocol Violation|0|||
162674275|NCT01217073|587516378|FG005|Extension Period|Protocol Violation|0|||
162674276|NCT01217073|587516379|FG006|Extension Period|Protocol Violation|2|||
162674277|NCT01217073|587516380|FG007|Extension Period|Protocol Violation|1|||
162674278|NCT01217073|587516373|FG000|Extension Period|Site discontinued study participation|0|||
162674279|NCT01217073|587516374|FG001|Extension Period|Site discontinued study participation|0|||
162674280|NCT01217073|587516375|FG002|Extension Period|Site discontinued study participation|0|||
162674281|NCT01217073|587516376|FG003|Extension Period|Site discontinued study participation|0|||
162674282|NCT01217073|587516377|FG004|Extension Period|Site discontinued study participation|0|||
162674283|NCT01217073|587516378|FG005|Extension Period|Site discontinued study participation|0|||
162674284|NCT01217073|587516379|FG006|Extension Period|Site discontinued study participation|7|||
162674285|NCT01217073|587516380|FG007|Extension Period|Site discontinued study participation|2|||
162674286|NCT01217073|587516373|FG000|Extension Period|Withdrawal by Subject|0|||
162674287|NCT01217073|587516374|FG001|Extension Period|Withdrawal by Subject|0|||
162674288|NCT01217073|587516375|FG002|Extension Period|Withdrawal by Subject|0|||
162674289|NCT01217073|587516376|FG003|Extension Period|Withdrawal by Subject|0|||
162674290|NCT01217073|587516377|FG004|Extension Period|Withdrawal by Subject|0|||
162674291|NCT01217073|587516378|FG005|Extension Period|Withdrawal by Subject|0|||
162722096|NCT00843882|587689412|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
162722097|NCT00843882|587689413|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
162674292|NCT01217073|587516379|FG006|Extension Period|Withdrawal by Subject|30|||
162674293|NCT01217073|587516380|FG007|Extension Period|Withdrawal by Subject|8|||
162674294|NCT03561090|587516381|FG000|Overall Study|Adverse Event|11|||
162674295|NCT03561090|587516382|FG001|Overall Study|Adverse Event|7|||
162674296|NCT03561090|587516381|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162674297|NCT03561090|587516382|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162674298|NCT03561090|587516381|FG000|Overall Study|Protocol Violation|2|||
162674299|NCT03561090|587516382|FG001|Overall Study|Protocol Violation|2|||
162674300|NCT03561090|587516381|FG000|Overall Study|Withdrawal by Subject|7|||
162674301|NCT03561090|587516382|FG001|Overall Study|Withdrawal by Subject|7|||
163151527|NCT01207414|589269400|FG001|Overall Study|Patient withdrew consent|11|||
163151528|NCT01207414|589269399|FG000|Overall Study|Lost to Follow-up|15|||
163151529|NCT01207414|589269400|FG001|Overall Study|Lost to Follow-up|17|||
163151530|NCT01207414|589269399|FG000|Overall Study|Administrative problems|1|||
163151531|NCT01207414|589269400|FG001|Overall Study|Administrative problems|1|||
163151532|NCT01207414|589269399|FG000|Overall Study|Protocol deviation|12|||
163151533|NCT01207414|589269400|FG001|Overall Study|Protocol deviation|9|||
163151534|NCT01207414|589269399|FG000|Overall Study|Randomized in error|1|||
163151535|NCT01207414|589269400|FG001|Overall Study|Randomized in error|0|||
163151536|NCT01748292|589269401|FG000|Overall Study|Adverse Event|2|||
163151537|NCT01748292|589269402|FG001|Overall Study|Adverse Event|4|||
163151538|NCT01748292|589269401|FG000|Overall Study|Lost to Follow-up|0|||
163151539|NCT01748292|589269402|FG001|Overall Study|Lost to Follow-up|3|||
163151540|NCT01748292|589269401|FG000|Overall Study|Death|0|||
163151541|NCT01748292|589269402|FG001|Overall Study|Death|3|||
163151542|NCT01748292|589269401|FG000|Overall Study|Withdrawal by Subject|0|||
163151543|NCT01748292|589269402|FG001|Overall Study|Withdrawal by Subject|2|||
163151544|NCT02057250|589269403|FG000|AID Assessment Phase|Adverse Event|3|||
163151545|NCT02057250|589269404|FG001|AID Assessment Phase|Adverse Event|2|||
163151546|NCT02057250|589269405|FG002|AID Assessment Phase|Adverse Event|6|||
163151547|NCT02057250|589269406|FG003|AID Assessment Phase|Adverse Event|1|||
163151548|NCT02057250|589269407|FG004|AID Assessment Phase|Adverse Event|0|||
163151549|NCT02057250|589269403|FG000|AID Assessment Phase|Other than specified above|1|||
163151550|NCT02057250|589269404|FG001|AID Assessment Phase|Other than specified above|1|||
163151551|NCT02057250|589269405|FG002|AID Assessment Phase|Other than specified above|1|||
163151552|NCT02057250|589269406|FG003|AID Assessment Phase|Other than specified above|1|||
163151553|NCT02057250|589269407|FG004|AID Assessment Phase|Other than specified above|0|||
163151554|NCT02057250|589269403|FG000|Extension Phase|Adverse Event|0|||
163151555|NCT02057250|589269404|FG001|Extension Phase|Adverse Event|0|||
163151556|NCT02057250|589269405|FG002|Extension Phase|Adverse Event|0|||
163151557|NCT02057250|589269406|FG003|Extension Phase|Adverse Event|0|||
163151558|NCT02057250|589269407|FG004|Extension Phase|Adverse Event|15|||
163151559|NCT02057250|589269403|FG000|Extension Phase|Lack of Efficacy|0|||
163151560|NCT02057250|589269404|FG001|Extension Phase|Lack of Efficacy|0|||
163151561|NCT02057250|589269405|FG002|Extension Phase|Lack of Efficacy|0|||
163151562|NCT02057250|589269406|FG003|Extension Phase|Lack of Efficacy|0|||
163151563|NCT02057250|589269407|FG004|Extension Phase|Lack of Efficacy|10|||
163151564|NCT02057250|589269403|FG000|Extension Phase|Entered in this period but not treated|0|||
163151565|NCT02057250|589269404|FG001|Extension Phase|Entered in this period but not treated|0|||
163151566|NCT02057250|589269405|FG002|Extension Phase|Entered in this period but not treated|0|||
163151567|NCT02057250|589269406|FG003|Extension Phase|Entered in this period but not treated|0|||
163151568|NCT02057250|589269407|FG004|Extension Phase|Entered in this period but not treated|4|||
163151569|NCT02057250|589269403|FG000|Extension Phase|Other than specified above|0|||
163151570|NCT02057250|589269404|FG001|Extension Phase|Other than specified above|0|||
163151571|NCT02057250|589269405|FG002|Extension Phase|Other than specified above|0|||
163151572|NCT02057250|589269406|FG003|Extension Phase|Other than specified above|0|||
163151573|NCT02057250|589269407|FG004|Extension Phase|Other than specified above|7|||
163151574|NCT03199976|589269409|FG000|Overall Study|Lack of Efficacy|3|||
163151575|NCT03199976|589269410|FG001|Overall Study|Lack of Efficacy|6|||
163151576|NCT03199976|589269411|FG002|Overall Study|Lack of Efficacy|13|||
163151577|NCT03199976|589269409|FG000|Overall Study|Withdrawal by Subject|1|||
163151578|NCT03199976|589269410|FG001|Overall Study|Withdrawal by Subject|0|||
163151579|NCT03199976|589269411|FG002|Overall Study|Withdrawal by Subject|0|||
163151580|NCT03199976|589269409|FG000|Overall Study|Lost to Follow-up|0|||
163151581|NCT03199976|589269410|FG001|Overall Study|Lost to Follow-up|1|||
163151582|NCT03199976|589269411|FG002|Overall Study|Lost to Follow-up|1|||
163151583|NCT03367793|589269412|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151584|NCT03367793|589269413|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151585|NCT03367793|589269414|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
163151586|NCT03367793|589269415|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151587|NCT03367793|589269416|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151588|NCT03367793|589269417|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
163151589|NCT04218240|589269420|FG000|Overall Study|Withdrawal by Subject|6|||
163151590|NCT04218240|589269421|FG001|Overall Study|Withdrawal by Subject|0|||
163151591|NCT04218240|589269420|FG000|Overall Study|Lack of Efficacy|24|||
163151592|NCT04218240|589269421|FG001|Overall Study|Lack of Efficacy|19|||
163151593|NCT04218240|589269420|FG000|Overall Study|Physician Decision|0|||
163151594|NCT04218240|589269421|FG001|Overall Study|Physician Decision|1|||
163151595|NCT04218240|589269420|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
163151596|NCT04218240|589269421|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
163151597|NCT04711850|589269425|FG000|Overall Study|Graft loss|2|||
163151598|NCT04711850|589269426|FG001|Overall Study|Graft loss|1|||
163151599|NCT04711850|589269425|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
163151600|NCT04711850|589269426|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
163151601|NCT04711850|589269425|FG000|Overall Study|Study terminated by sponsor|5|||
162722098|NCT00843882|587689414|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
162722099|NCT00843882|587689412|FG000|Step 1|Off treatment reason unknown|0|||
162674302|NCT03561090|587516381|FG000|Overall Study|Lost to Follow-up|7|||
162674303|NCT03561090|587516382|FG001|Overall Study|Lost to Follow-up|2|||
162674304|NCT03561090|587516381|FG000|Overall Study|Study Terminated by Sponsor|10|||
162674305|NCT03561090|587516382|FG001|Overall Study|Study Terminated by Sponsor|15|||
162674306|NCT03561090|587516381|FG000|Overall Study|Randomized by Mistake|1|||
162674307|NCT03561090|587516382|FG001|Overall Study|Randomized by Mistake|1|||
162674308|NCT03561090|587516381|FG000|Overall Study|Other Not Specified|0|||
162674309|NCT03561090|587516382|FG001|Overall Study|Other Not Specified|2|||
162674310|NCT00725452|587516391|FG000|Overall Study|Adverse Event|3|||
162674311|NCT00725452|587516391|FG000|Overall Study|Lack of Efficacy|2|||
162674312|NCT00725452|587516391|FG000|Overall Study|Reason not specified|1|||
162674313|NCT00725452|587516391|FG000|Overall Study|Physician Decision|1|||
162674314|NCT00725452|587516391|FG000|Overall Study|Withdrawal by Subject|3|||
162674315|NCT00725452|587516391|FG000|Overall Study|Lost to Follow-up|1|||
162674316|NCT02047045|587516393|FG000|Baseline|Withdrawal by Subject|3|||
162674317|NCT02047045|587516394|FG001|Baseline|Withdrawal by Subject|2|||
162674318|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
162674319|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
162674320|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
162674321|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
162674322|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
162674323|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
162674324|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
162674325|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
162674326|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
162674327|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
162674328|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
162674329|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
162674330|NCT02047045|587516393|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
162674331|NCT02047045|587516394|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
162674332|NCT02047045|587516393|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
162674333|NCT02047045|587516394|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
162674334|NCT02696317|587516397|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
162674335|NCT02696317|587516398|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
162674336|NCT02696317|587516397|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
162674337|NCT02696317|587516398|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
162674338|NCT01343368|587516399|FG000|Overall Study|Death|1|||
162674339|NCT01343368|587516400|FG001|Overall Study|Death|0|||
162674340|NCT01343368|587516399|FG000|Overall Study|Lost to Follow-up|1|||
162674341|NCT01343368|587516400|FG001|Overall Study|Lost to Follow-up|0|||
162674342|NCT00237744|587516401|FG000|Overall Study|Withdrawal by Subject|3|||
162674343|NCT00237744|587516402|FG001|Overall Study|Withdrawal by Subject|1|||
162674344|NCT00237744|587516403|FG002|Overall Study|Withdrawal by Subject|0|||
162674345|NCT03117738|587516404|FG000|Overall Study|Withdrawal by Subject|3|||
162674346|NCT03117738|587516405|FG001|Overall Study|Withdrawal by Subject|1|||
162674347|NCT03117738|587516404|FG000|Overall Study|Lost to Follow-up|1|||
162674348|NCT03117738|587516405|FG001|Overall Study|Lost to Follow-up|4|||
162674349|NCT02015676|587516406|FG000|Overall Study|Adverse Event|2|||
162674350|NCT02015676|587516407|FG001|Overall Study|Adverse Event|18|||
162674351|NCT02015676|587516408|FG002|Overall Study|Adverse Event|0|||
162674352|NCT02015676|587516406|FG000|Overall Study|Lack of Efficacy|2|||
162674353|NCT02015676|587516407|FG001|Overall Study|Lack of Efficacy|4|||
162674354|NCT02015676|587516408|FG002|Overall Study|Lack of Efficacy|0|||
162674355|NCT02015676|587516406|FG000|Overall Study|Protocol Violation|1|||
162674356|NCT02015676|587516407|FG001|Overall Study|Protocol Violation|0|||
162674357|NCT02015676|587516408|FG002|Overall Study|Protocol Violation|0|||
162674358|NCT02015676|587516406|FG000|Overall Study|Withdrawal by Subject|1|||
162674359|NCT02015676|587516407|FG001|Overall Study|Withdrawal by Subject|7|||
162674360|NCT02015676|587516408|FG002|Overall Study|Withdrawal by Subject|1|||
162674361|NCT02015676|587516406|FG000|Overall Study|Administrative reasons|0|||
162674362|NCT02015676|587516407|FG001|Overall Study|Administrative reasons|3|||
162674363|NCT02015676|587516408|FG002|Overall Study|Administrative reasons|1|||
163151602|NCT04711850|589269426|FG001|Overall Study|Study terminated by sponsor|3|||
162674364|NCT02015676|587516406|FG000|Overall Study|Death|0|||
162674365|NCT02015676|587516407|FG001|Overall Study|Death|1|||
162674366|NCT02015676|587516408|FG002|Overall Study|Death|0|||
162674367|NCT02015676|587516406|FG000|Overall Study|Disease progression|3|||
162674368|NCT02015676|587516407|FG001|Overall Study|Disease progression|1|||
162674369|NCT02015676|587516408|FG002|Overall Study|Disease progression|1|||
162674370|NCT00476476|587516410|FG000|Overall Study|Adverse Event|2|||
162674371|NCT00476476|587516411|FG001|Overall Study|Adverse Event|7|||
162674372|NCT00476476|587516410|FG000|Overall Study|Progressive Disease|0|||
162674373|NCT00476476|587516411|FG001|Overall Study|Progressive Disease|17|||
162674374|NCT00971048|587516412|FG000|Overall Study|Protocol Violation|1|||
163151603|NCT04711850|589269425|FG000|Overall Study|Sponsor decision|0|||
162674375|NCT00971048|587516413|FG001|Overall Study|Protocol Violation|2|||
162674376|NCT00971048|587516414|FG002|Overall Study|Protocol Violation|0|||
162674377|NCT00971048|587516415|FG003|Overall Study|Protocol Violation|1|||
162674378|NCT00971048|587516412|FG000|Overall Study|Adverse Event|0|||
162674379|NCT00971048|587516413|FG001|Overall Study|Adverse Event|0|||
162674380|NCT00971048|587516414|FG002|Overall Study|Adverse Event|1|||
162674381|NCT00971048|587516415|FG003|Overall Study|Adverse Event|0|||
162674382|NCT00971048|587516412|FG000|Overall Study|Physician Decision|0|||
162674383|NCT00971048|587516413|FG001|Overall Study|Physician Decision|0|||
162674384|NCT00971048|587516414|FG002|Overall Study|Physician Decision|0|||
162674385|NCT00971048|587516415|FG003|Overall Study|Physician Decision|1|||
162674386|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
162674387|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
162674388|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
162674389|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
162674390|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
162674391|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162674392|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162674393|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162674394|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
162674395|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162674396|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162674397|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162674398|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
162674399|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162674400|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162674401|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162674402|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
162674403|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162674404|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162674405|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162674406|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
162674407|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162674408|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162674409|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162674410|NCT01715805|587516422|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
162674411|NCT01715805|587516423|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162674412|NCT01715805|587516424|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162674413|NCT01715805|587516425|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162674414|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162674415|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162674416|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162674417|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
162674418|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
162674419|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
162674420|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
162674421|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
162674422|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
162674423|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
162674424|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
162674425|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
162674426|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
162674427|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
162674428|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
162674429|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
162674430|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
162674431|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
162674432|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
162674433|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
162674434|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
162674435|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
162722100|NCT00843882|587689413|FG001|Step 1|Off treatment reason unknown|1|||
162674436|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
162674437|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
162674438|NCT01715805|587516422|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162674439|NCT01715805|587516423|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
162674440|NCT01715805|587516424|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162674441|NCT01715805|587516425|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162674442|NCT00214136|587516428|FG000|Overall Study|Death|5|||
162674443|NCT04313634|587516429|FG000|Overall Study|Adverse Event|2|||
162674444|NCT04313634|587516430|FG001|Overall Study|Adverse Event|2|||
162674445|NCT04313634|587516431|FG002|Overall Study|Adverse Event|0|||
162674446|NCT04313634|587516429|FG000|Overall Study|Withdrawal by Subject|1|||
162674447|NCT04313634|587516430|FG001|Overall Study|Withdrawal by Subject|0|||
162674448|NCT04313634|587516431|FG002|Overall Study|Withdrawal by Subject|1|||
162674449|NCT04313634|587516429|FG000|Overall Study|Protocol Violation|0|||
162674450|NCT04313634|587516430|FG001|Overall Study|Protocol Violation|0|||
162674451|NCT04313634|587516431|FG002|Overall Study|Protocol Violation|1|||
162674452|NCT00319098|587516434|FG000|Overall Study|Serious adverse event|3|||
162674453|NCT00319098|587516435|FG001|Overall Study|Serious adverse event|0|||
162674454|NCT00319098|587516434|FG000|Overall Study|Adverse Event|20|||
162674455|NCT00319098|587516435|FG001|Overall Study|Adverse Event|1|||
162674456|NCT00319098|587516434|FG000|Overall Study|Withdrawal by Subject|37|||
162674457|NCT00319098|587516435|FG001|Overall Study|Withdrawal by Subject|8|||
162674458|NCT00319098|587516434|FG000|Overall Study|Migrated/moved from study area|2|||
162674459|NCT00319098|587516435|FG001|Overall Study|Migrated/moved from study area|1|||
162674460|NCT00319098|587516434|FG000|Overall Study|Lost to Follow-up|37|||
162674461|NCT00319098|587516435|FG001|Overall Study|Lost to Follow-up|13|||
162674462|NCT00319098|587516434|FG000|Overall Study|Others|33|||
162674463|NCT00319098|587516435|FG001|Overall Study|Others|8|||
162674464|NCT00319098|587516434|FG000|Overall Study|Protocol Violation|3|||
162674465|NCT00319098|587516435|FG001|Overall Study|Protocol Violation|1|||
162674466|NCT03449030|587516436|FG000|Overall Study|Withdrawal by Subject|0|||
162674467|NCT03449030|587516437|FG001|Overall Study|Withdrawal by Subject|0|||
162674468|NCT03449030|587516438|FG002|Overall Study|Withdrawal by Subject|0|||
162674469|NCT03449030|587516439|FG003|Overall Study|Withdrawal by Subject|1|||
162674470|NCT03449030|587516440|FG004|Overall Study|Withdrawal by Subject|1|||
162674471|NCT03449030|587516441|FG005|Overall Study|Withdrawal by Subject|1|||
162674472|NCT03449030|587516442|FG006|Overall Study|Withdrawal by Subject|1|||
162674473|NCT03449030|587516443|FG007|Overall Study|Withdrawal by Subject|2|||
162674474|NCT03449030|587516444|FG008|Overall Study|Withdrawal by Subject|0|||
162674475|NCT03449030|587516445|FG009|Overall Study|Withdrawal by Subject|0|||
162674476|NCT03449030|587516436|FG000|Overall Study|Symptomatic Deterioration|0|||
162674477|NCT03449030|587516437|FG001|Overall Study|Symptomatic Deterioration|1|||
162674478|NCT03449030|587516438|FG002|Overall Study|Symptomatic Deterioration|0|||
162674479|NCT03449030|587516439|FG003|Overall Study|Symptomatic Deterioration|0|||
162674480|NCT03449030|587516440|FG004|Overall Study|Symptomatic Deterioration|0|||
162674481|NCT03449030|587516441|FG005|Overall Study|Symptomatic Deterioration|1|||
162674482|NCT03449030|587516442|FG006|Overall Study|Symptomatic Deterioration|1|||
162674483|NCT03449030|587516443|FG007|Overall Study|Symptomatic Deterioration|0|||
162674484|NCT03449030|587516444|FG008|Overall Study|Symptomatic Deterioration|2|||
162674485|NCT03449030|587516445|FG009|Overall Study|Symptomatic Deterioration|0|||
162674486|NCT03449030|587516436|FG000|Overall Study|Progressive Disease|1|||
162674487|NCT03449030|587516437|FG001|Overall Study|Progressive Disease|0|||
162674488|NCT03449030|587516438|FG002|Overall Study|Progressive Disease|1|||
162674489|NCT03449030|587516439|FG003|Overall Study|Progressive Disease|4|||
162674490|NCT03449030|587516440|FG004|Overall Study|Progressive Disease|5|||
162674491|NCT03449030|587516441|FG005|Overall Study|Progressive Disease|3|||
162674492|NCT03449030|587516442|FG006|Overall Study|Progressive Disease|0|||
162674493|NCT03449030|587516443|FG007|Overall Study|Progressive Disease|1|||
162674494|NCT03449030|587516444|FG008|Overall Study|Progressive Disease|1|||
162674495|NCT03449030|587516445|FG009|Overall Study|Progressive Disease|1|||
162674496|NCT03449030|587516436|FG000|Overall Study|Adverse Event|0|||
162674497|NCT03449030|587516437|FG001|Overall Study|Adverse Event|0|||
162674498|NCT03449030|587516438|FG002|Overall Study|Adverse Event|0|||
162674499|NCT03449030|587516439|FG003|Overall Study|Adverse Event|0|||
162674500|NCT03449030|587516440|FG004|Overall Study|Adverse Event|0|||
162674501|NCT03449030|587516441|FG005|Overall Study|Adverse Event|2|||
162674502|NCT03449030|587516442|FG006|Overall Study|Adverse Event|0|||
162674503|NCT03449030|587516443|FG007|Overall Study|Adverse Event|0|||
162674504|NCT03449030|587516444|FG008|Overall Study|Adverse Event|0|||
162674505|NCT03449030|587516445|FG009|Overall Study|Adverse Event|0|||
162674506|NCT03449030|587516436|FG000|Overall Study|Death|0|||
162674507|NCT03449030|587516437|FG001|Overall Study|Death|0|||
162674508|NCT03449030|587516438|FG002|Overall Study|Death|0|||
162674509|NCT03449030|587516439|FG003|Overall Study|Death|0|||
162674510|NCT03449030|587516440|FG004|Overall Study|Death|1|||
162674511|NCT03449030|587516441|FG005|Overall Study|Death|0|||
162674512|NCT03449030|587516442|FG006|Overall Study|Death|0|||
162722101|NCT00843882|587689414|FG002|Step 1|Off treatment reason unknown|4|||
162722102|NCT00843882|587689412|FG000|Step 1|Never started treatment|2|||
162722103|NCT00843882|587689413|FG001|Step 1|Never started treatment|0|||
162722104|NCT00843882|587689414|FG002|Step 1|Never started treatment|0|||
162722105|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
162722106|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
162722107|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
162722108|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
162722109|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
162722110|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
162722111|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
162722112|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
162722113|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
162722114|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
162722115|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
162722116|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
162722117|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
162674513|NCT03449030|587516443|FG007|Overall Study|Death|0|||
162674514|NCT03449030|587516444|FG008|Overall Study|Death|0|||
162674515|NCT03449030|587516445|FG009|Overall Study|Death|0|||
162674516|NCT03595904|587516446|FG000|Overall Study|Protocol Violation|3|||
162674517|NCT03595904|587516447|FG001|Overall Study|Protocol Violation|1|||
162674518|NCT03595904|587516446|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
162674519|NCT03595904|587516447|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
162674520|NCT03595904|587516446|FG000|Overall Study|Insurance complications|1|||
162674521|NCT03595904|587516447|FG001|Overall Study|Insurance complications|0|||
162674522|NCT03595904|587516446|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
162674523|NCT03595904|587516447|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
162674524|NCT02187991|587516448|FG000|Overall Study|Adverse Event|13|||
162674525|NCT02187991|587516449|FG001|Overall Study|Adverse Event|14|||
162674526|NCT02187991|587516450|FG002|Overall Study|Adverse Event|3|||
162674527|NCT02187991|587516451|FG003|Overall Study|Adverse Event|2|||
162674528|NCT02187991|587516448|FG000|Overall Study|Withdrawal by Subject|9|||
162674529|NCT02187991|587516449|FG001|Overall Study|Withdrawal by Subject|6|||
162674530|NCT02187991|587516450|FG002|Overall Study|Withdrawal by Subject|3|||
162674531|NCT02187991|587516451|FG003|Overall Study|Withdrawal by Subject|2|||
162674532|NCT02187991|587516448|FG000|Overall Study|Physician Decision|4|||
162674533|NCT02187991|587516449|FG001|Overall Study|Physician Decision|4|||
162674534|NCT02187991|587516450|FG002|Overall Study|Physician Decision|0|||
162674535|NCT02187991|587516451|FG003|Overall Study|Physician Decision|2|||
162674536|NCT02187991|587516448|FG000|Overall Study|Other, unrelated complication|7|||
162674537|NCT02187991|587516449|FG001|Overall Study|Other, unrelated complication|1|||
162674538|NCT02187991|587516450|FG002|Overall Study|Other, unrelated complication|1|||
162722118|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
162722119|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
162722120|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
162674539|NCT02187991|587516451|FG003|Overall Study|Other, unrelated complication|2|||
162674540|NCT02187991|587516448|FG000|Overall Study|Death|1|||
162674541|NCT02187991|587516449|FG001|Overall Study|Death|3|||
162674542|NCT02187991|587516450|FG002|Overall Study|Death|0|||
162674543|NCT02187991|587516451|FG003|Overall Study|Death|0|||
162674544|NCT01392560|587516454|FG000|Overall Study|Adverse Event|2|||
162674545|NCT01392560|587516454|FG000|Overall Study|not entered|8|||
162674546|NCT01392560|587516454|FG000|Overall Study|discontinued during placebo run-in|2|||
162674547|NCT00522275|587516458|FG000|Overall Study|Adverse Event|35|||
162674548|NCT00522275|587516458|FG000|Overall Study|Lack of Efficacy|80|||
162674549|NCT00522275|587516458|FG000|Overall Study|Subject withdrew consent|16|||
162674550|NCT00522275|587516458|FG000|Overall Study|Protocol deviation|1|||
162674551|NCT00522275|587516458|FG000|Overall Study|Unsatisfactory compliance|11|||
162674552|NCT00522275|587516458|FG000|Overall Study|Lost to Follow-up|8|||
162674553|NCT00522275|587516458|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
162674554|NCT00522275|587516458|FG000|Overall Study|Other: Subject is pregnant|2|||
162674555|NCT00522275|587516458|FG000|Overall Study|Other: Subject relocated|2|||
162674556|NCT00522275|587516458|FG000|Overall Study|Other: Subject arrested|1|||
162674557|NCT00522275|587516458|FG000|Overall Study|Other: Site / clinic closed|4|||
162674558|NCT00522275|587516458|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
162674559|NCT00522275|587516458|FG000|Overall Study|Other: Sponsor request|2|||
162674560|NCT00522275|587516458|FG000|Overall Study|Other: Subject ran out of medication|1|||
162674561|NCT00522275|587516458|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
162674562|NCT04656847|587516460|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
162674563|NCT03301051|587516461|FG000|Overall Study|Adverse Event|0|||
162674564|NCT03301051|587516462|FG001|Overall Study|Adverse Event|4|||
162674565|NCT03301051|587516461|FG000|Overall Study|Withdrawal by Subject|59|||
162674566|NCT03301051|587516462|FG001|Overall Study|Withdrawal by Subject|65|||
162674567|NCT03301051|587516461|FG000|Overall Study|Lost to Follow-up|263|||
162674568|NCT03301051|587516462|FG001|Overall Study|Lost to Follow-up|282|||
162674569|NCT03301051|587516461|FG000|Overall Study|Protocol Violation|1|||
162674570|NCT03301051|587516462|FG001|Overall Study|Protocol Violation|3|||
162674571|NCT03301051|587516461|FG000|Overall Study|Physician Decision|1|||
162674572|NCT03301051|587516462|FG001|Overall Study|Physician Decision|3|||
162674573|NCT03301051|587516461|FG000|Overall Study|Death|1|||
162674574|NCT03301051|587516462|FG001|Overall Study|Death|1|||
162674575|NCT03301051|587516461|FG000|Overall Study|Miscellaneous|8|||
162674576|NCT03301051|587516462|FG001|Overall Study|Miscellaneous|4|||
162674577|NCT03301051|587516461|FG000|Overall Study|Randomized, not vaccinated|13|||
162674578|NCT03301051|587516462|FG001|Overall Study|Randomized, not vaccinated|10|||
162674579|NCT00047879|587516463|FG000|Overall Study|Progressive disease|4|||
162674580|NCT00047879|587516464|FG001|Overall Study|Progressive disease|3|||
162674581|NCT01196975|587516465|FG000|Overall Study|Adverse Event|2|||
162674582|NCT01196975|587516466|FG001|Overall Study|Adverse Event|2|||
162674583|NCT01196975|587516467|FG002|Overall Study|Adverse Event|0|||
162674584|NCT01196975|587516468|FG003|Overall Study|Adverse Event|0|||
162674585|NCT01196975|587516469|FG004|Overall Study|Adverse Event|2|||
162674586|NCT01196975|587516465|FG000|Overall Study|Withdrawal by Subject|2|||
162674587|NCT01196975|587516466|FG001|Overall Study|Withdrawal by Subject|1|||
162674588|NCT01196975|587516467|FG002|Overall Study|Withdrawal by Subject|0|||
162674589|NCT01196975|587516468|FG003|Overall Study|Withdrawal by Subject|1|||
162674590|NCT01196975|587516469|FG004|Overall Study|Withdrawal by Subject|0|||
162674591|NCT01196975|587516465|FG000|Overall Study|Lost to Follow-up|11|||
162674592|NCT01196975|587516466|FG001|Overall Study|Lost to Follow-up|6|||
162674593|NCT01196975|587516467|FG002|Overall Study|Lost to Follow-up|5|||
162674594|NCT01196975|587516468|FG003|Overall Study|Lost to Follow-up|5|||
162674595|NCT01196975|587516469|FG004|Overall Study|Lost to Follow-up|11|||
162674596|NCT01358526|587516475|FG000|Open-label Titration Period|Adverse Event|95|||
162674597|NCT01358526|587516476|FG001|Open-label Titration Period|Adverse Event|0|||
162674598|NCT01358526|587516477|FG002|Open-label Titration Period|Adverse Event|0|||
162674599|NCT01358526|587516475|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
162674600|NCT01358526|587516476|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
162674601|NCT01358526|587516477|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
162674602|NCT01358526|587516475|FG000|Open-label Titration Period|Lost to Follow-up|25|||
162674603|NCT01358526|587516476|FG001|Open-label Titration Period|Lost to Follow-up|0|||
162674604|NCT01358526|587516477|FG002|Open-label Titration Period|Lost to Follow-up|0|||
162674605|NCT01358526|587516475|FG000|Open-label Titration Period|Lack of Efficacy|107|||
162674606|NCT01358526|587516476|FG001|Open-label Titration Period|Lack of Efficacy|0|||
162674607|NCT01358526|587516477|FG002|Open-label Titration Period|Lack of Efficacy|0|||
162674608|NCT01358526|587516475|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
162674609|NCT01358526|587516476|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
162674610|NCT01358526|587516477|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
162674611|NCT01358526|587516475|FG000|Open-label Titration Period|Administrative|8|||
162674612|NCT01358526|587516476|FG001|Open-label Titration Period|Administrative|0|||
162674613|NCT01358526|587516477|FG002|Open-label Titration Period|Administrative|0|||
162674614|NCT01358526|587516475|FG000|Open-label Titration Period|Did not qualify|178|||
163151604|NCT04711850|589269426|FG001|Overall Study|Sponsor decision|2|||
162722121|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
162722122|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
162722123|NCT00843882|587689412|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
162722124|NCT00843882|587689413|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
162722125|NCT00843882|587689414|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
162722126|NCT02248480|587689415|FG000|Overall Study|Lack of Efficacy|4|||
162722127|NCT02248480|587689416|FG001|Overall Study|Lack of Efficacy|6|||
162722128|NCT02248480|587689415|FG000|Overall Study|Adverse Event|11|||
162722129|NCT02248480|587689416|FG001|Overall Study|Adverse Event|2|||
162722130|NCT02248480|587689415|FG000|Overall Study|Withdrawal by Subject|2|||
162722131|NCT02248480|587689416|FG001|Overall Study|Withdrawal by Subject|4|||
162722132|NCT02248480|587689415|FG000|Overall Study|Entry Criteria Not Met|0|||
162722133|NCT02248480|587689416|FG001|Overall Study|Entry Criteria Not Met|1|||
162722134|NCT02248480|587689415|FG000|Overall Study|Other:Physician Decision|0|||
162722135|NCT02248480|587689416|FG001|Overall Study|Other:Physician Decision|1|||
162722136|NCT00630786|587689417|FG000|Overall Study|Physician Decision|0|||
162722137|NCT00630786|587689418|FG001|Overall Study|Physician Decision|0|||
162722138|NCT00630786|587689419|FG002|Overall Study|Physician Decision|1|||
162722139|NCT00630786|587689417|FG000|Overall Study|Withdrawal by Subject|0|||
162722140|NCT00630786|587689418|FG001|Overall Study|Withdrawal by Subject|1|||
162722141|NCT00630786|587689419|FG002|Overall Study|Withdrawal by Subject|1|||
162722142|NCT00630786|587689417|FG000|Overall Study|Lost to Follow-up|0|||
162722143|NCT00630786|587689418|FG001|Overall Study|Lost to Follow-up|1|||
162722144|NCT00630786|587689419|FG002|Overall Study|Lost to Follow-up|0|||
162722145|NCT00630786|587689417|FG000|Overall Study|Other|1|||
162722146|NCT00630786|587689418|FG001|Overall Study|Other|0|||
162722147|NCT00630786|587689419|FG002|Overall Study|Other|0|||
162722148|NCT01582269|587689420|FG000|Overall Study|Withdrawal by Subject|1|||
162722149|NCT01582269|587689421|FG001|Overall Study|Withdrawal by Subject|0|||
162722150|NCT01582269|587689422|FG002|Overall Study|Withdrawal by Subject|0|||
162722151|NCT02770248|587689423|FG000|Overall Study|Adverse Event|0|||
162722152|NCT02770248|587689424|FG001|Overall Study|Adverse Event|1|||
162722153|NCT02770248|587689423|FG000|Overall Study|Randomized in error, prior to treatment|0|||
162722154|NCT02770248|587689424|FG001|Overall Study|Randomized in error, prior to treatment|1|||
162722155|NCT02486588|587689427|FG000|Overall Study|Randomized in error- ineligible|738|||
162722156|NCT02486588|587689428|FG001|Overall Study|Randomized in error- ineligible|750|||
162722157|NCT02486588|587689429|FG002|Overall Study|Randomized in error- ineligible|755|||
162722158|NCT02486588|587689430|FG003|Overall Study|Randomized in error- ineligible|738|||
162722159|NCT02486588|587689431|FG004|Overall Study|Randomized in error- ineligible|746|||
162722160|NCT02486588|587689432|FG005|Overall Study|Randomized in error- ineligible|746|||
162722161|NCT00546871|587689433|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
162722162|NCT00546871|587689434|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
162722163|NCT00546871|587689433|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
162722164|NCT00546871|587689434|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
162674615|NCT01358526|587516476|FG001|Open-label Titration Period|Did not qualify|0|||
162674616|NCT01358526|587516477|FG002|Open-label Titration Period|Did not qualify|0|||
162674617|NCT01358526|587516475|FG000|Double-blind Phase|Adverse Event|0|||
162674618|NCT01358526|587516476|FG001|Double-blind Phase|Adverse Event|24|||
162674619|NCT01358526|587516477|FG002|Double-blind Phase|Adverse Event|23|||
162674620|NCT01358526|587516475|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162674621|NCT01358526|587516476|FG001|Double-blind Phase|Withdrawal by Subject|10|||
162674622|NCT01358526|587516477|FG002|Double-blind Phase|Withdrawal by Subject|8|||
162674623|NCT01358526|587516475|FG000|Double-blind Phase|Lost to Follow-up|0|||
162674624|NCT01358526|587516476|FG001|Double-blind Phase|Lost to Follow-up|4|||
162674625|NCT01358526|587516477|FG002|Double-blind Phase|Lost to Follow-up|1|||
162674626|NCT01358526|587516475|FG000|Double-blind Phase|Lack of Efficacy|0|||
162674627|NCT01358526|587516476|FG001|Double-blind Phase|Lack of Efficacy|31|||
162674628|NCT01358526|587516477|FG002|Double-blind Phase|Lack of Efficacy|73|||
162674629|NCT01358526|587516475|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
162674630|NCT01358526|587516476|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
162674631|NCT01358526|587516477|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
162674632|NCT01358526|587516475|FG000|Double-blind Phase|Administrative|0|||
162674633|NCT01358526|587516476|FG001|Double-blind Phase|Administrative|6|||
162674634|NCT01358526|587516477|FG002|Double-blind Phase|Administrative|10|||
162674635|NCT01462344|587516484|FG000|Overall Study|Withdrawal by Subject|245|||
162674636|NCT01462344|587516485|FG001|Overall Study|Withdrawal by Subject|226|||
162674637|NCT01462344|587516484|FG000|Overall Study|Adverse Event|24|||
162674638|NCT01462344|587516485|FG001|Overall Study|Adverse Event|23|||
162674639|NCT01462344|587516484|FG000|Overall Study|Asthma Exacerbation|34|||
162674640|NCT01462344|587516485|FG001|Overall Study|Asthma Exacerbation|35|||
162674641|NCT01462344|587516484|FG000|Overall Study|Lack of Efficacy|5|||
162674642|NCT01462344|587516485|FG001|Overall Study|Lack of Efficacy|6|||
162674643|NCT01462344|587516484|FG000|Overall Study|Protocol Violation|68|||
162674644|NCT01462344|587516485|FG001|Overall Study|Protocol Violation|53|||
162674645|NCT01462344|587516484|FG000|Overall Study|Lost to Follow-up|7|||
162674646|NCT01462344|587516485|FG001|Overall Study|Lost to Follow-up|7|||
162674647|NCT00360529|587516486|FG000|Overall Study|Adverse Event|10|||
162674648|NCT00360529|587516487|FG001|Overall Study|Adverse Event|23|||
162674649|NCT00360529|587516488|FG002|Overall Study|Adverse Event|33|||
162674650|NCT00360529|587516486|FG000|Overall Study|Protocol Violation|3|||
162674651|NCT00360529|587516487|FG001|Overall Study|Protocol Violation|3|||
162674652|NCT00360529|587516488|FG002|Overall Study|Protocol Violation|11|||
162674653|NCT00360529|587516486|FG000|Overall Study|Lost to Follow-up|14|||
162674654|NCT00360529|587516487|FG001|Overall Study|Lost to Follow-up|10|||
162674655|NCT00360529|587516488|FG002|Overall Study|Lost to Follow-up|13|||
162674656|NCT00360529|587516486|FG000|Overall Study|Withdrawal by Subject|22|||
162674657|NCT00360529|587516487|FG001|Overall Study|Withdrawal by Subject|14|||
162674658|NCT00360529|587516488|FG002|Overall Study|Withdrawal by Subject|18|||
162674659|NCT00360529|587516486|FG000|Overall Study|Lack of Efficacy|8|||
162674660|NCT00360529|587516487|FG001|Overall Study|Lack of Efficacy|6|||
162674661|NCT00360529|587516488|FG002|Overall Study|Lack of Efficacy|5|||
162674662|NCT00360529|587516486|FG000|Overall Study|Reason discontinued not explained above|4|||
162674663|NCT00360529|587516487|FG001|Overall Study|Reason discontinued not explained above|9|||
162674664|NCT00360529|587516488|FG002|Overall Study|Reason discontinued not explained above|11|||
162674665|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
162674666|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
162674667|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
162674668|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
162674669|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
162674670|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
162674671|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
162674672|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
162674673|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
162674674|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
162674675|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
162674676|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
162674677|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
162674678|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
162674679|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
162674680|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
162722165|NCT00546871|587689433|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
162722166|NCT00546871|587689434|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
162674681|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
162674682|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
162674683|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
162674684|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
162674685|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
162722167|NCT00546871|587689433|FG000|Study Extension Period|Protocol Violation|1|||
162674686|NCT01781572|587516493|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
162674687|NCT01781572|587516494|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
162674688|NCT01781572|587516495|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
162674689|NCT01781572|587516493|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
162674690|NCT01781572|587516494|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
162674691|NCT01781572|587516495|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
162674692|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
162674693|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
162674694|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
162674695|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
162674696|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
162674697|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
162674698|NCT01781572|587516493|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
162674699|NCT01781572|587516494|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
162674700|NCT01781572|587516495|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
162674701|NCT01781572|587516493|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
162674702|NCT01781572|587516494|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
162674703|NCT01781572|587516495|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
162674704|NCT01781572|587516493|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
162674705|NCT01781572|587516494|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
162674706|NCT01781572|587516495|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
162674707|NCT01781572|587516493|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
162674708|NCT01781572|587516494|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
162674709|NCT01781572|587516495|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
162674710|NCT01781572|587516493|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
162674711|NCT01781572|587516494|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
162674712|NCT01781572|587516495|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
162674713|NCT01781572|587516493|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
162674714|NCT01781572|587516494|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
162674715|NCT01781572|587516495|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
162674716|NCT01781572|587516493|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
162674717|NCT01781572|587516494|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
162674718|NCT01781572|587516495|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
162674719|NCT01218438|587516496|FG000|Epoch 1|Physician Decision|2|||
162674720|NCT01218438|587516496|FG000|Epoch 1|Adverse Event|1|||
162674721|NCT01218438|587516496|FG000|Epoch 3|Withdrawal by Subject|3|||
162674722|NCT01218438|587516496|FG000|Epoch 3|Adverse Event|1|||
162674723|NCT01218438|587516496|FG000|Epoch 4|Physician Decision|1|||
162674724|NCT01218438|587516496|FG000|Epoch 4|Withdrawal by Subject|2|||
162674725|NCT06167031|587516499|FG000|Overall Study|Lost to Follow-up|5|||
162674726|NCT06167031|587516500|FG001|Overall Study|Lost to Follow-up|1|||
162674727|NCT00907153|587518546|FG000|Overall Study|Lost to Follow-up|1|||
162674728|NCT00907153|587518547|FG001|Overall Study|Lost to Follow-up|1|||
162674729|NCT00907153|587518546|FG000|Overall Study|Withdrawal by Subject|1|||
162674730|NCT00907153|587518547|FG001|Overall Study|Withdrawal by Subject|3|||
162674731|NCT00713648|587518553|FG000|Overall Study|Adverse Event|1|||
162674732|NCT00713648|587518553|FG000|Overall Study|Unclassified|2|||
162674733|NCT00713648|587518553|FG000|Overall Study|According to Protocol|2|||
162674734|NCT00713648|587518553|FG000|Overall Study|Development of antibodies|3|||
162674735|NCT02566031|587518556|FG000|Overall Study|Patient/guardian decision|14|||
162674736|NCT02566031|587518557|FG001|Overall Study|Patient/guardian decision|7|||
162674737|NCT02566031|587518556|FG000|Overall Study|Protocol deviation|2|||
162674738|NCT02566031|587518557|FG001|Overall Study|Protocol deviation|3|||
162674739|NCT02566031|587518556|FG000|Overall Study|Adverse Event|3|||
162674740|NCT02566031|587518557|FG001|Overall Study|Adverse Event|1|||
162674741|NCT02566031|587518556|FG000|Overall Study|Lost to Follow-up|1|||
162674742|NCT02566031|587518557|FG001|Overall Study|Lost to Follow-up|1|||
162674743|NCT03031938|587518558|FG000|Overall Study|Death|1|||
162674744|NCT03031938|587518559|FG001|Overall Study|Death|0|||
162674745|NCT02647359|587518566|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
162674746|NCT02647359|587518567|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
162674747|NCT02647359|587518566|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
162722168|NCT00546871|587689434|FG001|Study Extension Period|Protocol Violation|0|||
162722169|NCT00546871|587689433|FG000|Study Extension Period|Withdrawal by Subject|0|||
162674748|NCT02647359|587518567|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
162674749|NCT02647359|587518566|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
162674750|NCT02647359|587518567|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
162674751|NCT02647359|587518566|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
162674752|NCT02647359|587518567|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
162722170|NCT00546871|587689434|FG001|Study Extension Period|Withdrawal by Subject|1|||
162722171|NCT06001177|587690396|FG000|Treatment Phase|Adverse Event|1|||
162674753|NCT02647359|587518566|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
162674754|NCT02647359|587518567|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
162674755|NCT02647359|587518566|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
162674756|NCT02647359|587518567|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
162674757|NCT00413413|587518568|FG000|Single-Blind|Adverse Event|0|||
162674758|NCT00413413|587518569|FG001|Single-Blind|Adverse Event|9|||
162674759|NCT00413413|587518570|FG002|Single-Blind|Adverse Event|0|||
162674760|NCT00413413|587518568|FG000|Single-Blind|Lack of Efficacy|0|||
162674761|NCT00413413|587518569|FG001|Single-Blind|Lack of Efficacy|5|||
162674762|NCT00413413|587518570|FG002|Single-Blind|Lack of Efficacy|0|||
162674763|NCT00413413|587518568|FG000|Single-Blind|Subject no longer requires study drug|0|||
162674764|NCT00413413|587518569|FG001|Single-Blind|Subject no longer requires study drug|151|||
162674765|NCT00413413|587518570|FG002|Single-Blind|Subject no longer requires study drug|0|||
162674766|NCT00413413|587518568|FG000|Single-Blind|Protocol Violation|0|||
162674767|NCT00413413|587518569|FG001|Single-Blind|Protocol Violation|16|||
162674768|NCT00413413|587518570|FG002|Single-Blind|Protocol Violation|0|||
162674769|NCT00413413|587518568|FG000|Single-Blind|Withdrawal by Subject|0|||
162674770|NCT00413413|587518569|FG001|Single-Blind|Withdrawal by Subject|27|||
162674771|NCT00413413|587518570|FG002|Single-Blind|Withdrawal by Subject|0|||
162674772|NCT00413413|587518568|FG000|Single-Blind|Lost to Follow-up|0|||
162674773|NCT00413413|587518569|FG001|Single-Blind|Lost to Follow-up|8|||
162674774|NCT00413413|587518570|FG002|Single-Blind|Lost to Follow-up|0|||
162674775|NCT00413413|587518568|FG000|Double-Blind|Adverse Event|6|||
162674776|NCT00413413|587518569|FG001|Double-Blind|Adverse Event|0|||
162674777|NCT00413413|587518570|FG002|Double-Blind|Adverse Event|5|||
162674778|NCT00413413|587518568|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
162674779|NCT00413413|587518569|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
162674780|NCT00413413|587518570|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
162674781|NCT00413413|587518568|FG000|Double-Blind|Protocol deviation|1|||
162674782|NCT00413413|587518569|FG001|Double-Blind|Protocol deviation|2|||
162674783|NCT00413413|587518570|FG002|Double-Blind|Protocol deviation|1|||
162674784|NCT00413413|587518568|FG000|Double-Blind|Subject withdrew consent|4|||
162674785|NCT00413413|587518569|FG001|Double-Blind|Subject withdrew consent|6|||
162674786|NCT00413413|587518570|FG002|Double-Blind|Subject withdrew consent|9|||
162674787|NCT00413413|587518568|FG000|Double-Blind|Lost to Follow-up|3|||
162674788|NCT00413413|587518569|FG001|Double-Blind|Lost to Follow-up|4|||
162674789|NCT00413413|587518570|FG002|Double-Blind|Lost to Follow-up|2|||
162674790|NCT02219932|587518577|FG000|Overall Study|Other|5|||
162674791|NCT02219932|587518578|FG001|Overall Study|Other|11|||
162674792|NCT02219932|587518577|FG000|Overall Study|Death|1|||
162674793|NCT02219932|587518578|FG001|Overall Study|Death|1|||
162674794|NCT02219932|587518577|FG000|Overall Study|Investigator Decision|0|||
162674795|NCT02219932|587518578|FG001|Overall Study|Investigator Decision|1|||
162674796|NCT02219932|587518577|FG000|Overall Study|Consent Withdrawn|11|||
162674797|NCT02219932|587518578|FG001|Overall Study|Consent Withdrawn|7|||
162674798|NCT02219932|587518577|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
162674799|NCT02219932|587518578|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
162674800|NCT02219932|587518577|FG000|Overall Study|Protocol Violation|10|||
162674801|NCT02219932|587518578|FG001|Overall Study|Protocol Violation|6|||
162674802|NCT02219932|587518577|FG000|Overall Study|Pregnancy|1|||
162674803|NCT02219932|587518578|FG001|Overall Study|Pregnancy|0|||
162674804|NCT02219932|587518577|FG000|Overall Study|Lost to Follow-up|4|||
162674805|NCT02219932|587518578|FG001|Overall Study|Lost to Follow-up|2|||
162674806|NCT02219932|587518577|FG000|Overall Study|Adverse Event|23|||
162674807|NCT02219932|587518578|FG001|Overall Study|Adverse Event|21|||
162674808|NCT00511004|587518581|FG000|Overall Study|Lost to Follow-up|0|||
162674809|NCT00511004|587518582|FG001|Overall Study|Lost to Follow-up|0|||
162674810|NCT00511004|587518583|FG002|Overall Study|Lost to Follow-up|4|||
162674811|NCT04642638|587518584|FG000|Overall Study|Withdrawal by Subject|23|||
162674812|NCT04642638|587518585|FG001|Overall Study|Withdrawal by Subject|29|||
162674813|NCT04642638|587518586|FG002|Overall Study|Withdrawal by Subject|9|||
162674814|NCT04642638|587518587|FG003|Overall Study|Withdrawal by Subject|7|||
162674815|NCT04642638|587518588|FG004|Overall Study|Withdrawal by Subject|61|||
162674816|NCT04642638|587518589|FG005|Overall Study|Withdrawal by Subject|27|||
162674817|NCT04642638|587518584|FG000|Overall Study|Lost to Follow-up|17|||
162674818|NCT04642638|587518585|FG001|Overall Study|Lost to Follow-up|18|||
162674819|NCT04642638|587518586|FG002|Overall Study|Lost to Follow-up|5|||
162674820|NCT04642638|587518587|FG003|Overall Study|Lost to Follow-up|5|||
162674821|NCT04642638|587518588|FG004|Overall Study|Lost to Follow-up|6|||
162674822|NCT04642638|587518589|FG005|Overall Study|Lost to Follow-up|3|||
162674823|NCT04642638|587518584|FG000|Overall Study|Adverse Event|0|||
162674824|NCT04642638|587518585|FG001|Overall Study|Adverse Event|0|||
162674825|NCT04642638|587518586|FG002|Overall Study|Adverse Event|1|||
162674826|NCT04642638|587518587|FG003|Overall Study|Adverse Event|0|||
162674827|NCT04642638|587518588|FG004|Overall Study|Adverse Event|10|||
162674828|NCT04642638|587518589|FG005|Overall Study|Adverse Event|3|||
162674829|NCT04642638|587518584|FG000|Overall Study|Reason Not Specified|1|||
162674830|NCT04642638|587518585|FG001|Overall Study|Reason Not Specified|4|||
162674831|NCT04642638|587518586|FG002|Overall Study|Reason Not Specified|0|||
162674832|NCT04642638|587518587|FG003|Overall Study|Reason Not Specified|0|||
162674833|NCT04642638|587518588|FG004|Overall Study|Reason Not Specified|38|||
162674834|NCT04642638|587518589|FG005|Overall Study|Reason Not Specified|16|||
162674835|NCT04642638|587518584|FG000|Overall Study|Physician Decision|0|||
162674836|NCT04642638|587518585|FG001|Overall Study|Physician Decision|0|||
162674837|NCT04642638|587518586|FG002|Overall Study|Physician Decision|0|||
162722172|NCT06001177|587690397|FG001|Treatment Phase|Adverse Event|0|||
162722173|NCT06001177|587690396|FG000|Treatment Phase|Withdrawal by Subject|1|||
162722174|NCT06001177|587690397|FG001|Treatment Phase|Withdrawal by Subject|0|||
162722175|NCT06001177|587690396|FG000|Observation Phase|Adverse Event|1|||
162722176|NCT06001177|587690397|FG001|Observation Phase|Adverse Event|1|||
162722177|NCT06001177|587690396|FG000|Observation Phase|Withdrawal by Subject|0|||
162722178|NCT06001177|587690397|FG001|Observation Phase|Withdrawal by Subject|1|||
162722179|NCT03593876|587690398|FG000|Overall Study|Withdrawal by Subject|1|||
162722180|NCT03593876|587690398|FG000|Overall Study|Discharged home before intervention completion|2|||
162722181|NCT05309668|587690399|FG000|Overall Study|Ongoing at data cut-off|14|||
162722182|NCT05309668|587690400|FG001|Overall Study|Ongoing at data cut-off|17|||
162722183|NCT05309668|587690401|FG002|Overall Study|Ongoing at data cut-off|4|||
162722184|NCT02696707|587690402|FG000|Per Protocol Population|Physician Decision|2|||
162722185|NCT02696707|587690403|FG001|Per Protocol Population|Physician Decision|1|||
162722186|NCT02696707|587690402|FG000|Per Protocol Population|Participant Decision|0|||
162722187|NCT02696707|587690403|FG001|Per Protocol Population|Participant Decision|2|||
162722188|NCT02696707|587690402|FG000|Completed Study as Planned|Reason = LVEF|2|||
162722189|NCT02696707|587690403|FG001|Completed Study as Planned|Reason = LVEF|2|||
162722190|NCT02696707|587690402|FG000|Completed Study as Planned|Protocol Violation|2|||
162722191|NCT02696707|587690403|FG001|Completed Study as Planned|Protocol Violation|6|||
162722192|NCT02696707|587690402|FG000|Completed Study as Planned|Metastatic disease|3|||
162722193|NCT02696707|587690403|FG001|Completed Study as Planned|Metastatic disease|0|||
162722194|NCT02696707|587690402|FG000|Completed Study as Planned|Location|1|||
162722195|NCT02696707|587690403|FG001|Completed Study as Planned|Location|1|||
162722196|NCT00071799|587690404|FG000|Overall Study|Adverse Event|19|||
162722197|NCT00071799|587690405|FG001|Overall Study|Adverse Event|10|||
162722198|NCT00071799|587690404|FG000|Overall Study|Protocol Violation|1|||
162722199|NCT00071799|587690405|FG001|Overall Study|Protocol Violation|7|||
162722200|NCT00071799|587690404|FG000|Overall Study|Lost to Follow-up|1|||
162722201|NCT00071799|587690405|FG001|Overall Study|Lost to Follow-up|1|||
162722202|NCT00071799|587690404|FG000|Overall Study|Withdrawal by Subject|15|||
162722203|NCT00071799|587690405|FG001|Overall Study|Withdrawal by Subject|37|||
162722204|NCT00071799|587690404|FG000|Overall Study|Physician Decision|0|||
162722205|NCT00071799|587690405|FG001|Overall Study|Physician Decision|2|||
162722206|NCT00071799|587690404|FG000|Overall Study|Lack of Efficacy|11|||
162722207|NCT00071799|587690405|FG001|Overall Study|Lack of Efficacy|18|||
162722208|NCT00071799|587690404|FG000|Overall Study|Disease Progression|23|||
162722209|NCT00071799|587690405|FG001|Overall Study|Disease Progression|20|||
162722210|NCT00071799|587690404|FG000|Overall Study|Different Central+Local Pathology Review|0|||
162722211|NCT00071799|587690405|FG001|Overall Study|Different Central+Local Pathology Review|1|||
162722212|NCT00071799|587690404|FG000|Overall Study|Not Documented|0|||
162722213|NCT00071799|587690405|FG001|Overall Study|Not Documented|2|||
162722214|NCT00814346|587690406|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
162722215|NCT00814346|587690407|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
162722216|NCT00814346|587690406|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
162722217|NCT00814346|587690407|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
162722218|NCT00814346|587690406|FG000|Open Phase (17 Months)|Adverse Event|5|||
162722219|NCT00814346|587690407|FG001|Open Phase (17 Months)|Adverse Event|0|||
162722220|NCT00814346|587690406|FG000|Open Phase (17 Months)|Consent|2|||
162722221|NCT00814346|587690407|FG001|Open Phase (17 Months)|Consent|0|||
162722222|NCT00814346|587690406|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
162722223|NCT00814346|587690407|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
162722224|NCT00814346|587690406|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
162722225|NCT00814346|587690407|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
162722226|NCT03034915|587690415|FG000|Overall Study|Adverse Event|29|||
162722227|NCT03034915|587690416|FG001|Overall Study|Adverse Event|32|||
162722228|NCT03034915|587690417|FG002|Overall Study|Adverse Event|22|||
162722229|NCT03034915|587690415|FG000|Overall Study|Lost to Follow-up|5|||
163151605|NCT02738801|589269449|FG000|Overall Study|Adverse Event|1|||
163151606|NCT02738801|589269450|FG001|Overall Study|Adverse Event|1|||
163151607|NCT02738801|589269449|FG000|Overall Study|Withdrawal by Subject|0|||
163151608|NCT02738801|589269450|FG001|Overall Study|Withdrawal by Subject|1|||
163151609|NCT03279081|589269451|FG000|Overall Study|Withdrawal by Subject|12|||
163151610|NCT03279081|589269452|FG001|Overall Study|Withdrawal by Subject|20|||
163151611|NCT03279081|589269451|FG000|Overall Study|Physician Decision|4|||
163151612|NCT03279081|589269452|FG001|Overall Study|Physician Decision|1|||
162722230|NCT03034915|587690416|FG001|Overall Study|Lost to Follow-up|13|||
162722231|NCT03034915|587690417|FG002|Overall Study|Lost to Follow-up|3|||
162722232|NCT03034915|587690415|FG000|Overall Study|Withdrawal by Subject|29|||
162722233|NCT03034915|587690416|FG001|Overall Study|Withdrawal by Subject|46|||
162722234|NCT03034915|587690417|FG002|Overall Study|Withdrawal by Subject|41|||
162722235|NCT03034915|587690415|FG000|Overall Study|Protocol Deviation|2|||
162722236|NCT03034915|587690416|FG001|Overall Study|Protocol Deviation|14|||
162722237|NCT03034915|587690417|FG002|Overall Study|Protocol Deviation|7|||
162722238|NCT03034915|587690415|FG000|Overall Study|Lack of Efficacy|8|||
163151613|NCT03279081|589269451|FG000|Overall Study|Lost to Follow-up|8|||
162674838|NCT04642638|587518587|FG003|Overall Study|Physician Decision|0|||
162674839|NCT04642638|587518588|FG004|Overall Study|Physician Decision|2|||
162674840|NCT04642638|587518589|FG005|Overall Study|Physician Decision|1|||
162674841|NCT04642638|587518584|FG000|Overall Study|Protocol Deviation|0|||
162674842|NCT04642638|587518585|FG001|Overall Study|Protocol Deviation|0|||
162674843|NCT04642638|587518586|FG002|Overall Study|Protocol Deviation|0|||
162674844|NCT04642638|587518587|FG003|Overall Study|Protocol Deviation|0|||
162674845|NCT04642638|587518588|FG004|Overall Study|Protocol Deviation|1|||
162674846|NCT04642638|587518589|FG005|Overall Study|Protocol Deviation|3|||
162674847|NCT04642638|587518584|FG000|Overall Study|Study Terminated|0|||
162674848|NCT04642638|587518585|FG001|Overall Study|Study Terminated|0|||
162674849|NCT04642638|587518586|FG002|Overall Study|Study Terminated|0|||
162674850|NCT04642638|587518587|FG003|Overall Study|Study Terminated|0|||
162674851|NCT04642638|587518588|FG004|Overall Study|Study Terminated|484|||
162674852|NCT04642638|587518589|FG005|Overall Study|Study Terminated|250|||
162674853|NCT04642638|587518584|FG000|Overall Study|Pregnancy|0|||
162674854|NCT04642638|587518585|FG001|Overall Study|Pregnancy|0|||
162674855|NCT04642638|587518586|FG002|Overall Study|Pregnancy|0|||
162674856|NCT04642638|587518587|FG003|Overall Study|Pregnancy|0|||
162674857|NCT04642638|587518588|FG004|Overall Study|Pregnancy|1|||
162674858|NCT04642638|587518589|FG005|Overall Study|Pregnancy|0|||
162674859|NCT00990652|587518590|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
162674860|NCT00990652|587518590|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
162674861|NCT01672801|587518592|FG000|Overall Study|Screen Failure|0|||
162674862|NCT01672801|587518593|FG001|Overall Study|Screen Failure|1|||
162674863|NCT06476366|587518594|FG000|Overall Study|Lost to Follow-up|1|||
162674864|NCT06476366|587518595|FG001|Overall Study|Lost to Follow-up|3|||
162674865|NCT06476366|587518594|FG000|Overall Study|Adverse Event|1|||
162674866|NCT06476366|587518595|FG001|Overall Study|Adverse Event|0|||
162674867|NCT04313881|587518600|FG000|Overall Study|Death|138|||
162674868|NCT04313881|587518601|FG001|Overall Study|Death|126|||
162674869|NCT04313881|587518600|FG000|Overall Study|Study terminated by sponsor|108|||
162674870|NCT04313881|587518601|FG001|Overall Study|Study terminated by sponsor|129|||
162674871|NCT04313881|587518600|FG000|Overall Study|Consent withdrawn|19|||
162674872|NCT04313881|587518601|FG001|Overall Study|Consent withdrawn|15|||
162674873|NCT04313881|587518600|FG000|Overall Study|Reason not Specified|3|||
162674874|NCT04313881|587518601|FG001|Overall Study|Reason not Specified|1|||
162674875|NCT00727272|587518602|FG000|Washout Period A|Adverse Event|0|||
162674876|NCT00727272|587518603|FG001|Washout Period A|Adverse Event|0|||
162674877|NCT00727272|587518604|FG002|Washout Period A|Adverse Event|1|||
162674878|NCT00727272|587518602|FG000|Washout Period B|Withdrawal by Subject|0|||
162674879|NCT00727272|587518603|FG001|Washout Period B|Withdrawal by Subject|0|||
162674880|NCT00727272|587518604|FG002|Washout Period B|Withdrawal by Subject|1|||
162674881|NCT00651664|587518605|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
162674882|NCT00651664|587518606|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
162674883|NCT00651664|587518607|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
162674884|NCT00651664|587518608|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
162674885|NCT00651664|587518609|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
162674886|NCT00651664|587518610|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
162674887|NCT00651664|587518611|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
162674888|NCT00651664|587518612|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
162674889|NCT00651664|587518613|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
162674890|NCT00651664|587518614|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
162674891|NCT00651664|587518605|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674892|NCT00651664|587518606|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674893|NCT00651664|587518607|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674894|NCT00651664|587518608|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674895|NCT00651664|587518609|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
162674896|NCT00651664|587518610|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
162674897|NCT00651664|587518611|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674898|NCT00651664|587518612|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
162674899|NCT00651664|587518613|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
162674900|NCT00651664|587518614|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
162674901|NCT00651664|587518605|FG000|Overall Study|Progressive Disease|3|||
162674902|NCT00651664|587518606|FG001|Overall Study|Progressive Disease|3|||
162674903|NCT00651664|587518607|FG002|Overall Study|Progressive Disease|3|||
162674904|NCT00651664|587518608|FG003|Overall Study|Progressive Disease|12|||
162674905|NCT00651664|587518609|FG004|Overall Study|Progressive Disease|4|||
162674906|NCT00651664|587518610|FG005|Overall Study|Progressive Disease|1|||
162674907|NCT00651664|587518611|FG006|Overall Study|Progressive Disease|3|||
162674908|NCT00651664|587518612|FG007|Overall Study|Progressive Disease|6|||
162674909|NCT00651664|587518613|FG008|Overall Study|Progressive Disease|5|||
162674910|NCT00651664|587518614|FG009|Overall Study|Progressive Disease|5|||
162674911|NCT00651664|587518605|FG000|Overall Study|Patient Declined Further Treatment|0|||
162674912|NCT00651664|587518606|FG001|Overall Study|Patient Declined Further Treatment|0|||
162674913|NCT00651664|587518607|FG002|Overall Study|Patient Declined Further Treatment|0|||
162674914|NCT00651664|587518608|FG003|Overall Study|Patient Declined Further Treatment|1|||
162674915|NCT00651664|587518609|FG004|Overall Study|Patient Declined Further Treatment|1|||
162674916|NCT00651664|587518610|FG005|Overall Study|Patient Declined Further Treatment|1|||
162674917|NCT00651664|587518611|FG006|Overall Study|Patient Declined Further Treatment|0|||
162674918|NCT00651664|587518612|FG007|Overall Study|Patient Declined Further Treatment|0|||
162674919|NCT00651664|587518613|FG008|Overall Study|Patient Declined Further Treatment|0|||
162674920|NCT00651664|587518614|FG009|Overall Study|Patient Declined Further Treatment|1|||
162674921|NCT00651664|587518605|FG000|Overall Study|Symptomatic Deterioration|0|||
162674922|NCT00651664|587518606|FG001|Overall Study|Symptomatic Deterioration|0|||
162674923|NCT00651664|587518607|FG002|Overall Study|Symptomatic Deterioration|0|||
162674924|NCT00651664|587518608|FG003|Overall Study|Symptomatic Deterioration|1|||
162674925|NCT00651664|587518609|FG004|Overall Study|Symptomatic Deterioration|0|||
162674926|NCT00651664|587518610|FG005|Overall Study|Symptomatic Deterioration|0|||
162674927|NCT00651664|587518611|FG006|Overall Study|Symptomatic Deterioration|1|||
162674928|NCT00651664|587518612|FG007|Overall Study|Symptomatic Deterioration|0|||
162674929|NCT00651664|587518613|FG008|Overall Study|Symptomatic Deterioration|1|||
162674930|NCT00651664|587518614|FG009|Overall Study|Symptomatic Deterioration|0|||
162674931|NCT00651664|587518605|FG000|Overall Study|Reason not Specified|0|||
162674932|NCT00651664|587518606|FG001|Overall Study|Reason not Specified|0|||
162674933|NCT00651664|587518607|FG002|Overall Study|Reason not Specified|0|||
162674934|NCT00651664|587518608|FG003|Overall Study|Reason not Specified|0|||
162674935|NCT00651664|587518609|FG004|Overall Study|Reason not Specified|0|||
162674936|NCT00651664|587518610|FG005|Overall Study|Reason not Specified|0|||
162674937|NCT00651664|587518611|FG006|Overall Study|Reason not Specified|1|||
162674938|NCT00651664|587518612|FG007|Overall Study|Reason not Specified|0|||
162674939|NCT00651664|587518613|FG008|Overall Study|Reason not Specified|0|||
162674940|NCT00651664|587518614|FG009|Overall Study|Reason not Specified|0|||
162674941|NCT01910129|587518620|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
162674942|NCT01910129|587518621|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
162674943|NCT01910129|587518622|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
162674944|NCT01910129|587518620|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
162674945|NCT01910129|587518621|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
162674946|NCT01910129|587518622|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
162674947|NCT00965523|587518623|FG000|Study 221|Progressive Disease|4|||
162674948|NCT00965523|587518623|FG000|Study 221|Physician Decision|3|||
162674949|NCT00965523|587518623|FG000|Study 224|Progressive Disease|5|||
162674950|NCT00965523|587518623|FG000|Study 224|Physician Decision|1|||
162674951|NCT02415400|587518626|FG000|Overall Study|Adverse Event|0|||
162674952|NCT02415400|587518627|FG001|Overall Study|Adverse Event|1|||
162674953|NCT02415400|587518628|FG002|Overall Study|Adverse Event|1|||
162674954|NCT02415400|587518629|FG003|Overall Study|Adverse Event|2|||
162674955|NCT02415400|587518626|FG000|Overall Study|Participant request to stop therapy|4|||
162674956|NCT02415400|587518627|FG001|Overall Study|Participant request to stop therapy|3|||
162674957|NCT02415400|587518628|FG002|Overall Study|Participant request to stop therapy|8|||
162674958|NCT02415400|587518629|FG003|Overall Study|Participant request to stop therapy|6|||
162674959|NCT02415400|587518626|FG000|Overall Study|Participant withdrew consent|14|||
162674960|NCT02415400|587518627|FG001|Overall Study|Participant withdrew consent|12|||
162674961|NCT02415400|587518628|FG002|Overall Study|Participant withdrew consent|30|||
162674962|NCT02415400|587518629|FG003|Overall Study|Participant withdrew consent|21|||
162674963|NCT02415400|587518626|FG000|Overall Study|Death|39|||
162674964|NCT02415400|587518627|FG001|Overall Study|Death|41|||
162674965|NCT02415400|587518628|FG002|Overall Study|Death|35|||
162674966|NCT02415400|587518629|FG003|Overall Study|Death|42|||
162674967|NCT02415400|587518626|FG000|Overall Study|Lost to Follow-up|3|||
162674968|NCT02415400|587518627|FG001|Overall Study|Lost to Follow-up|3|||
162674969|NCT02415400|587518628|FG002|Overall Study|Lost to Follow-up|2|||
162674970|NCT02415400|587518629|FG003|Overall Study|Lost to Follow-up|5|||
162674971|NCT02415400|587518626|FG000|Overall Study|Poor/Non-Compliance|0|||
162674972|NCT02415400|587518627|FG001|Overall Study|Poor/Non-Compliance|1|||
162674973|NCT02415400|587518628|FG002|Overall Study|Poor/Non-Compliance|3|||
162674974|NCT02415400|587518629|FG003|Overall Study|Poor/Non-Compliance|4|||
162674975|NCT02415400|587518626|FG000|Overall Study|Participant no longer meets criteria|2|||
162674976|NCT02415400|587518627|FG001|Overall Study|Participant no longer meets criteria|0|||
162674977|NCT02415400|587518628|FG002|Overall Study|Participant no longer meets criteria|0|||
162674978|NCT02415400|587518629|FG003|Overall Study|Participant no longer meets criteria|1|||
162674979|NCT02415400|587518626|FG000|Overall Study|Participant doesn't answer phone|1|||
162674980|NCT02415400|587518627|FG001|Overall Study|Participant doesn't answer phone|0|||
162674981|NCT02415400|587518628|FG002|Overall Study|Participant doesn't answer phone|0|||
162674982|NCT02415400|587518629|FG003|Overall Study|Participant doesn't answer phone|0|||
163151614|NCT03279081|589269452|FG001|Overall Study|Lost to Follow-up|8|||
163151615|NCT03279081|589269451|FG000|Overall Study|Death|0|||
163151616|NCT03279081|589269452|FG001|Overall Study|Death|1|||
162674983|NCT02415400|587518626|FG000|Overall Study|Participant wanted home visits|1|||
162674984|NCT02415400|587518627|FG001|Overall Study|Participant wanted home visits|0|||
162674985|NCT02415400|587518628|FG002|Overall Study|Participant wanted home visits|0|||
162722239|NCT03034915|587690416|FG001|Overall Study|Lack of Efficacy|16|||
162674986|NCT02415400|587518629|FG003|Overall Study|Participant wanted home visits|0|||
162674987|NCT02415400|587518626|FG000|Overall Study|Randomized in error|2|||
162674988|NCT02415400|587518627|FG001|Overall Study|Randomized in error|0|||
162674989|NCT02415400|587518628|FG002|Overall Study|Randomized in error|0|||
162674990|NCT02415400|587518629|FG003|Overall Study|Randomized in error|0|||
162674991|NCT02415400|587518626|FG000|Overall Study|No study drug on site|0|||
162674992|NCT02415400|587518627|FG001|Overall Study|No study drug on site|1|||
162674993|NCT02415400|587518628|FG002|Overall Study|No study drug on site|0|||
162674994|NCT02415400|587518629|FG003|Overall Study|No study drug on site|0|||
162674995|NCT02415400|587518626|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
162674996|NCT02415400|587518627|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
162674997|NCT02415400|587518628|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
162674998|NCT02415400|587518629|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
162674999|NCT02415400|587518626|FG000|Overall Study|Coagulation values cannot be set|0|||
162675000|NCT02415400|587518627|FG001|Overall Study|Coagulation values cannot be set|0|||
162675001|NCT02415400|587518628|FG002|Overall Study|Coagulation values cannot be set|1|||
162675002|NCT02415400|587518629|FG003|Overall Study|Coagulation values cannot be set|0|||
162675003|NCT02415400|587518626|FG000|Overall Study|State regulations prevent participation|0|||
162675004|NCT02415400|587518627|FG001|Overall Study|State regulations prevent participation|0|||
162675005|NCT02415400|587518628|FG002|Overall Study|State regulations prevent participation|1|||
162675006|NCT02415400|587518629|FG003|Overall Study|State regulations prevent participation|0|||
162675007|NCT02415400|587518626|FG000|Overall Study|Poor treatment monitoring|0|||
162675008|NCT02415400|587518627|FG001|Overall Study|Poor treatment monitoring|0|||
162675009|NCT02415400|587518628|FG002|Overall Study|Poor treatment monitoring|1|||
162675010|NCT02415400|587518629|FG003|Overall Study|Poor treatment monitoring|0|||
162675011|NCT02415400|587518626|FG000|Overall Study|Participant in jail|0|||
162675012|NCT02415400|587518627|FG001|Overall Study|Participant in jail|0|||
162675013|NCT02415400|587518628|FG002|Overall Study|Participant in jail|1|||
162675014|NCT02415400|587518629|FG003|Overall Study|Participant in jail|0|||
162675015|NCT02415400|587518626|FG000|Overall Study|Investigator decision|0|||
162675016|NCT02415400|587518627|FG001|Overall Study|Investigator decision|0|||
162675017|NCT02415400|587518628|FG002|Overall Study|Investigator decision|1|||
162675018|NCT02415400|587518629|FG003|Overall Study|Investigator decision|1|||
162675019|NCT02415400|587518626|FG000|Overall Study|Site closure; participant won't transfer|0|||
162675020|NCT02415400|587518627|FG001|Overall Study|Site closure; participant won't transfer|0|||
162675021|NCT02415400|587518628|FG002|Overall Study|Site closure; participant won't transfer|0|||
162675022|NCT02415400|587518629|FG003|Overall Study|Site closure; participant won't transfer|1|||
162675023|NCT01226745|587518632|FG000|Overall Study|Did not complete schedule of assessments|8|||
162675024|NCT01226745|587518633|FG001|Overall Study|Did not complete schedule of assessments|3|||
162675025|NCT01226745|587518634|FG002|Overall Study|Did not complete schedule of assessments|6|||
162675026|NCT01226745|587518635|FG003|Overall Study|Did not complete schedule of assessments|0|||
162675027|NCT01226745|587518636|FG004|Overall Study|Did not complete schedule of assessments|0|||
162675028|NCT01226745|587518637|FG005|Overall Study|Did not complete schedule of assessments|1|||
162675029|NCT01226745|587518632|FG000|Overall Study|Lost to Follow-up|2|||
162675030|NCT01226745|587518633|FG001|Overall Study|Lost to Follow-up|6|||
162675031|NCT01226745|587518634|FG002|Overall Study|Lost to Follow-up|6|||
162675032|NCT01226745|587518635|FG003|Overall Study|Lost to Follow-up|1|||
162675033|NCT01226745|587518636|FG004|Overall Study|Lost to Follow-up|1|||
162675034|NCT01226745|587518637|FG005|Overall Study|Lost to Follow-up|2|||
162675035|NCT01226745|587518632|FG000|Overall Study|Death|1|||
162675036|NCT01226745|587518633|FG001|Overall Study|Death|0|||
162675037|NCT01226745|587518634|FG002|Overall Study|Death|0|||
162675038|NCT01226745|587518635|FG003|Overall Study|Death|0|||
162675039|NCT01226745|587518636|FG004|Overall Study|Death|0|||
162675040|NCT01226745|587518637|FG005|Overall Study|Death|1|||
162675041|NCT01226745|587518632|FG000|Overall Study|Other|6|||
162675042|NCT01226745|587518633|FG001|Overall Study|Other|7|||
162675043|NCT01226745|587518634|FG002|Overall Study|Other|8|||
162675044|NCT01226745|587518635|FG003|Overall Study|Other|4|||
162675045|NCT01226745|587518636|FG004|Overall Study|Other|3|||
162675046|NCT01226745|587518637|FG005|Overall Study|Other|1|||
162675047|NCT01581281|587518644|FG000|Overall Study|Early Study Closure|15|||
163151617|NCT03279081|589269451|FG000|Overall Study|Adverse Event|1|||
163151618|NCT03279081|589269452|FG001|Overall Study|Adverse Event|0|||
163151619|NCT03279081|589269451|FG000|Overall Study|Reason not Specified|14|||
162675048|NCT01581281|587518645|FG001|Overall Study|Early Study Closure|6|||
162675049|NCT01581281|587518646|FG002|Overall Study|Early Study Closure|12|||
162675050|NCT00295750|587518649|FG000|Overall Study|Adverse Event|19|||
162675051|NCT00295750|587518650|FG001|Overall Study|Adverse Event|15|||
162675052|NCT00295750|587518651|FG002|Overall Study|Adverse Event|12|||
162675053|NCT00295750|587518649|FG000|Overall Study|Lack of Efficacy|1|||
162675054|NCT00295750|587518650|FG001|Overall Study|Lack of Efficacy|1|||
162675055|NCT00295750|587518651|FG002|Overall Study|Lack of Efficacy|0|||
162675056|NCT00295750|587518649|FG000|Overall Study|Lost to Follow-up|1|||
162675057|NCT00295750|587518650|FG001|Overall Study|Lost to Follow-up|4|||
162675058|NCT00295750|587518651|FG002|Overall Study|Lost to Follow-up|1|||
162675059|NCT00295750|587518649|FG000|Overall Study|Taking prohibited therapy|2|||
162675060|NCT00295750|587518650|FG001|Overall Study|Taking prohibited therapy|3|||
162675061|NCT00295750|587518651|FG002|Overall Study|Taking prohibited therapy|2|||
162675062|NCT00295750|587518649|FG000|Overall Study|Administrative errors|2|||
162675063|NCT00295750|587518650|FG001|Overall Study|Administrative errors|4|||
162675064|NCT00295750|587518651|FG002|Overall Study|Administrative errors|5|||
162675065|NCT00295750|587518649|FG000|Overall Study|Trial drug errors|1|||
162675066|NCT00295750|587518650|FG001|Overall Study|Trial drug errors|1|||
162675067|NCT00295750|587518651|FG002|Overall Study|Trial drug errors|0|||
162675068|NCT00295750|587518649|FG000|Overall Study|Disease progression|2|||
162675069|NCT00295750|587518650|FG001|Overall Study|Disease progression|1|||
162675070|NCT00295750|587518651|FG002|Overall Study|Disease progression|0|||
162675071|NCT00295750|587518649|FG000|Overall Study|Personal reasons|0|||
162675072|NCT00295750|587518650|FG001|Overall Study|Personal reasons|1|||
162675073|NCT00295750|587518651|FG002|Overall Study|Personal reasons|0|||
162675074|NCT00295750|587518649|FG000|Overall Study|Randomized but never received trial drug|4|||
162675075|NCT00295750|587518650|FG001|Overall Study|Randomized but never received trial drug|3|||
162675076|NCT00295750|587518651|FG002|Overall Study|Randomized but never received trial drug|3|||
162675077|NCT00295750|587518649|FG000|Overall Study|Withdrawal by Subject|9|||
162675078|NCT00295750|587518650|FG001|Overall Study|Withdrawal by Subject|4|||
162675079|NCT00295750|587518651|FG002|Overall Study|Withdrawal by Subject|7|||
162675080|NCT00295750|587518649|FG000|Overall Study|Protocol Violation|2|||
162675081|NCT00295750|587518650|FG001|Overall Study|Protocol Violation|4|||
162675082|NCT00295750|587518651|FG002|Overall Study|Protocol Violation|2|||
162675083|NCT01650259|587518652|FG000|Overall Study|Improvement|105|||
162675084|NCT01650259|587518653|FG001|Overall Study|Improvement|0|||
162675085|NCT01650259|587518652|FG000|Overall Study|Adverse Event|127|||
162675086|NCT01650259|587518653|FG001|Overall Study|Adverse Event|0|||
162675087|NCT01650259|587518652|FG000|Overall Study|Lack of Efficacy|143|||
162675088|NCT01650259|587518653|FG001|Overall Study|Lack of Efficacy|0|||
162675089|NCT01650259|587518652|FG000|Overall Study|Lost to Follow-up|435|||
162675090|NCT01650259|587518653|FG001|Overall Study|Lost to Follow-up|0|||
162675091|NCT01650259|587518652|FG000|Overall Study|Patients had no visit after entry|70|||
162675092|NCT01650259|587518653|FG001|Overall Study|Patients had no visit after entry|0|||
162675093|NCT01650259|587518652|FG000|Overall Study|CRF not collected|98|||
162675094|NCT01650259|587518653|FG001|Overall Study|CRF not collected|82|||
162675095|NCT01650259|587518652|FG000|Overall Study|Not treated|1|||
162675096|NCT01650259|587518653|FG001|Overall Study|Not treated|7|||
162675097|NCT01650259|587518652|FG000|Overall Study|Other than listed|64|||
162675098|NCT01650259|587518653|FG001|Overall Study|Other than listed|146|||
162675099|NCT00584727|587518661|FG000|First Intervention|Discontinuation|0|||
162675100|NCT00584727|587518662|FG001|First Intervention|Discontinuation|0|||
162675101|NCT00584727|587518663|FG002|First Intervention|Discontinuation|1|||
162675102|NCT00584727|587518664|FG003|First Intervention|Discontinuation|0|||
162675103|NCT00584727|587518665|FG004|First Intervention|Discontinuation|0|||
162675104|NCT00584727|587518666|FG005|First Intervention|Discontinuation|0|||
162675105|NCT00584727|587518661|FG000|Third Intervention|Protocol Violation|0|||
162675106|NCT00584727|587518662|FG001|Third Intervention|Protocol Violation|0|||
162675107|NCT00584727|587518663|FG002|Third Intervention|Protocol Violation|1|||
162675108|NCT00584727|587518664|FG003|Third Intervention|Protocol Violation|0|||
162675109|NCT00584727|587518665|FG004|Third Intervention|Protocol Violation|4|||
162675110|NCT00584727|587518666|FG005|Third Intervention|Protocol Violation|2|||
162675111|NCT04072159|587518667|FG000|Overall Study|Lost to Follow-up|6|||
162675112|NCT04072159|587518668|FG001|Overall Study|Lost to Follow-up|6|||
162675113|NCT04072159|587518667|FG000|Overall Study|Withdrawal by Subject|2|||
162675114|NCT04072159|587518668|FG001|Overall Study|Withdrawal by Subject|0|||
162675115|NCT00989287|587518672|FG000|Overall Study|Adverse Event|1|||
162675116|NCT00989287|587518673|FG001|Overall Study|Adverse Event|0|||
162675117|NCT00989287|587518672|FG000|Overall Study|Lost to Follow-up|0|||
162675118|NCT00989287|587518673|FG001|Overall Study|Lost to Follow-up|1|||
162675119|NCT00695669|587518674|FG000|Overall Study|Adverse Event|0|||
162675120|NCT00695669|587518675|FG001|Overall Study|Adverse Event|0|||
162675121|NCT00695669|587518676|FG002|Overall Study|Adverse Event|2|||
162675122|NCT00695669|587518677|FG003|Overall Study|Adverse Event|0|||
162675123|NCT00695669|587518674|FG000|Overall Study|Lost to Follow-up|4|||
162675124|NCT00695669|587518675|FG001|Overall Study|Lost to Follow-up|4|||
162675125|NCT00695669|587518676|FG002|Overall Study|Lost to Follow-up|1|||
162675126|NCT00695669|587518677|FG003|Overall Study|Lost to Follow-up|4|||
162675127|NCT00092131|587518678|FG000|Treatment Period I|Adverse Event|1|||
162675128|NCT00092131|587518679|FG001|Treatment Period I|Adverse Event|0|||
162675129|NCT00092131|587518678|FG000|Treatment Period II|Adverse Event|0|||
162675130|NCT00092131|587518679|FG001|Treatment Period II|Adverse Event|1|||
162675131|NCT02341417|587518680|FG000|Overall Study|Withdrawal by Subject|0|||
162675132|NCT02341417|587518681|FG001|Overall Study|Withdrawal by Subject|2|||
162675133|NCT02341417|587518682|FG002|Overall Study|Withdrawal by Subject|0|||
162675134|NCT02341417|587518680|FG000|Overall Study|Decision by sponsor|2|||
162675135|NCT02341417|587518681|FG001|Overall Study|Decision by sponsor|0|||
162675136|NCT02341417|587518682|FG002|Overall Study|Decision by sponsor|0|||
162722240|NCT03034915|587690417|FG002|Overall Study|Lack of Efficacy|18|||
162722241|NCT03034915|587690415|FG000|Overall Study|Site closed|2|||
162722242|NCT03034915|587690416|FG001|Overall Study|Site closed|2|||
162722243|NCT03034915|587690417|FG002|Overall Study|Site closed|4|||
162722244|NCT03034915|587690415|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
162722245|NCT03034915|587690416|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
162722246|NCT03034915|587690417|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
162722247|NCT03034915|587690415|FG000|Overall Study|Physician Decision|1|||
162722248|NCT03034915|587690416|FG001|Overall Study|Physician Decision|5|||
162722249|NCT03034915|587690417|FG002|Overall Study|Physician Decision|2|||
162722250|NCT03861767|587690418|FG000|Overall Study|Withdrawal by Subject|2|||
162722251|NCT03861767|587690419|FG001|Overall Study|Withdrawal by Subject|1|||
162722252|NCT03861767|587690420|FG002|Overall Study|Withdrawal by Subject|0|||
162722253|NCT03861767|587690421|FG003|Overall Study|Withdrawal by Subject|5|||
162722254|NCT03861767|587690422|FG004|Overall Study|Withdrawal by Subject|2|||
162722255|NCT03861767|587690423|FG005|Overall Study|Withdrawal by Subject|1|||
162722256|NCT03861767|587690424|FG006|Overall Study|Withdrawal by Subject|3|||
162722257|NCT03861767|587690425|FG007|Overall Study|Withdrawal by Subject|1|||
162722258|NCT03861767|587690426|FG008|Overall Study|Withdrawal by Subject|0|||
162722259|NCT03861767|587690427|FG009|Overall Study|Withdrawal by Subject|5|||
162722260|NCT00346333|587690428|FG000|Overall Study|Death|1|||
162722261|NCT00346333|587690429|FG001|Overall Study|Death|0|||
162722262|NCT00346333|587690428|FG000|Overall Study|unwilling or unable to continue|4|||
162722263|NCT00346333|587690429|FG001|Overall Study|unwilling or unable to continue|8|||
162722264|NCT00117286|587690435|FG000|Overall Study|Adverse Event|12|||
162722265|NCT00117286|587690436|FG001|Overall Study|Adverse Event|6|||
162722266|NCT00117286|587690435|FG000|Overall Study|Lost to Follow-up|2|||
162722267|NCT00117286|587690436|FG001|Overall Study|Lost to Follow-up|0|||
162722268|NCT00117286|587690435|FG000|Overall Study|Protocol Violation|3|||
162722269|NCT00117286|587690436|FG001|Overall Study|Protocol Violation|3|||
162722270|NCT00117286|587690435|FG000|Overall Study|Withdrawal by Subject|6|||
162722271|NCT00117286|587690436|FG001|Overall Study|Withdrawal by Subject|2|||
162722272|NCT00117286|587690435|FG000|Overall Study|Physician Decision|3|||
162722273|NCT00117286|587690436|FG001|Overall Study|Physician Decision|7|||
162722274|NCT00117286|587690435|FG000|Overall Study|Lack of Efficacy|2|||
162722275|NCT00117286|587690436|FG001|Overall Study|Lack of Efficacy|1|||
162722276|NCT00117286|587690435|FG000|Overall Study|Research site closing|0|||
162722277|NCT00117286|587690436|FG001|Overall Study|Research site closing|2|||
162722278|NCT00189202|587690437|FG000|Overall Study|Physician Decision|5|||
162722279|NCT02798835|587690442|FG000|Overall Study|Protocol Violation|0|||
162675137|NCT02341417|587518680|FG000|Overall Study|Death|0|||
162675138|NCT02341417|587518681|FG001|Overall Study|Death|0|||
162675139|NCT02341417|587518682|FG002|Overall Study|Death|1|||
162675140|NCT03570619|587518698|FG000|Overall Study|Adverse Event|2|||
162675141|NCT03570619|587518699|FG001|Overall Study|Adverse Event|0|||
162675142|NCT03570619|587518700|FG002|Overall Study|Adverse Event|1|||
162675143|NCT03570619|587518698|FG000|Overall Study|new diagnosis of new malignancy|1|||
162675144|NCT03570619|587518699|FG001|Overall Study|new diagnosis of new malignancy|0|||
162675145|NCT03570619|587518700|FG002|Overall Study|new diagnosis of new malignancy|0|||
162675146|NCT03570619|587518698|FG000|Overall Study|Physician Decision|1|||
162675147|NCT03570619|587518699|FG001|Overall Study|Physician Decision|1|||
162675148|NCT03570619|587518700|FG002|Overall Study|Physician Decision|0|||
162675149|NCT03570619|587518698|FG000|Overall Study|Withdrawal by Subject|0|||
162675150|NCT03570619|587518699|FG001|Overall Study|Withdrawal by Subject|2|||
162675151|NCT03570619|587518700|FG002|Overall Study|Withdrawal by Subject|0|||
162675152|NCT04773587|587518701|FG000|Overall Study|Lost to Follow-up|11|||
162675153|NCT04773587|587518702|FG001|Overall Study|Lost to Follow-up|3|||
162675154|NCT04773587|587518701|FG000|Overall Study|Adverse Event|6|||
162675155|NCT04773587|587518702|FG001|Overall Study|Adverse Event|3|||
162675156|NCT04773587|587518701|FG000|Overall Study|Lack of Efficacy|5|||
162675157|NCT04773587|587518702|FG001|Overall Study|Lack of Efficacy|2|||
162675158|NCT04773587|587518701|FG000|Overall Study|Withdrawal by Subject|4|||
162675159|NCT04773587|587518702|FG001|Overall Study|Withdrawal by Subject|5|||
162675160|NCT04773587|587518701|FG000|Overall Study|Noncompliance|1|||
162675161|NCT04773587|587518702|FG001|Overall Study|Noncompliance|0|||
162675162|NCT04773587|587518701|FG000|Overall Study|Protocol Violation|1|||
162675163|NCT04773587|587518702|FG001|Overall Study|Protocol Violation|0|||
162675164|NCT04773587|587518701|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
162675165|NCT04773587|587518702|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
162675166|NCT00659334|587518709|FG000|Overall Study|Screen Failure|8|||
162675167|NCT00659334|587518710|FG001|Overall Study|Screen Failure|5|||
162675168|NCT00659334|587518711|FG002|Overall Study|Screen Failure|0|||
162675169|NCT00659334|587518712|FG003|Overall Study|Screen Failure|0|||
162675170|NCT00659334|587518713|FG004|Overall Study|Screen Failure|0|||
162675171|NCT00659334|587518714|FG005|Overall Study|Screen Failure|0|||
162675172|NCT00659334|587518715|FG006|Overall Study|Screen Failure|1|||
162675173|NCT03034577|587518716|FG000|Overall Study|Withdrawal by Subject|6|||
162675174|NCT03034577|587518717|FG001|Overall Study|Withdrawal by Subject|9|||
162675175|NCT03034577|587518716|FG000|Overall Study|Lost to Follow-up|25|||
162675176|NCT03034577|587518717|FG001|Overall Study|Lost to Follow-up|26|||
162675177|NCT01174342|587518718|FG000|Overall Study|Conversion to cesarean section|4|||
162675178|NCT02625623|587518719|FG000|Overall Study|Participants randomized but not treated|9|||
162675179|NCT02625623|587518720|FG001|Overall Study|Participants randomized but not treated|1|||
162675180|NCT02298192|587518726|FG000|Overall Study|Unclassified|3|||
162675181|NCT02298192|587518727|FG001|Overall Study|Unclassified|2|||
162675182|NCT02298192|587518726|FG000|Overall Study|Withdrawal criteria|2|||
162675183|NCT02298192|587518727|FG001|Overall Study|Withdrawal criteria|0|||
162675184|NCT02298192|587518726|FG000|Overall Study|Withdrawal by Subject|6|||
162675185|NCT02298192|587518727|FG001|Overall Study|Withdrawal by Subject|1|||
162675186|NCT02298192|587518726|FG000|Overall Study|Lost to Follow-up|2|||
162675187|NCT02298192|587518727|FG001|Overall Study|Lost to Follow-up|1|||
162675188|NCT02298192|587518726|FG000|Overall Study|Adverse Event|6|||
162675189|NCT02298192|587518727|FG001|Overall Study|Adverse Event|2|||
162675190|NCT02352948|587518732|FG000|Overall Study|Death|47|||
162675191|NCT02352948|587518733|FG001|Overall Study|Death|48|||
162675192|NCT02352948|587518734|FG002|Overall Study|Death|114|||
162675193|NCT02352948|587518735|FG003|Overall Study|Death|74|||
162675194|NCT02352948|587518736|FG004|Overall Study|Death|77|||
162675195|NCT02352948|587518737|FG005|Overall Study|Death|44|||
162675196|NCT02352948|587518732|FG000|Overall Study|Lost to Follow-up|1|||
162675197|NCT02352948|587518733|FG001|Overall Study|Lost to Follow-up|0|||
162675198|NCT02352948|587518734|FG002|Overall Study|Lost to Follow-up|2|||
162675199|NCT02352948|587518735|FG003|Overall Study|Lost to Follow-up|1|||
163151620|NCT03279081|589269452|FG001|Overall Study|Reason not Specified|4|||
163151621|NCT00771914|589269453|FG000|Overall Study|Physician Decision|0|||
163151622|NCT00771914|589269454|FG001|Overall Study|Physician Decision|0|||
163151623|NCT00771914|589269455|FG002|Overall Study|Physician Decision|0|||
163151624|NCT00771914|589269456|FG003|Overall Study|Physician Decision|1|||
163151625|NCT00771914|589269453|FG000|Overall Study|Lost to Follow-up|0|||
163151626|NCT00771914|589269454|FG001|Overall Study|Lost to Follow-up|0|||
163151627|NCT00771914|589269455|FG002|Overall Study|Lost to Follow-up|0|||
163151628|NCT00771914|589269456|FG003|Overall Study|Lost to Follow-up|1|||
163151629|NCT04484961|589269465|FG000|Overall Study|Lost to Follow-up|9|||
163151630|NCT04484961|589269466|FG001|Overall Study|Lost to Follow-up|9|||
162675200|NCT02352948|587518736|FG004|Overall Study|Lost to Follow-up|2|||
162675201|NCT02352948|587518737|FG005|Overall Study|Lost to Follow-up|1|||
162675202|NCT02352948|587518732|FG000|Overall Study|Withdrawal by Subject|1|||
162675203|NCT02352948|587518733|FG001|Overall Study|Withdrawal by Subject|10|||
163151631|NCT00388349|589269467|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
162675204|NCT02352948|587518734|FG002|Overall Study|Withdrawal by Subject|11|||
162675205|NCT02352948|587518735|FG003|Overall Study|Withdrawal by Subject|23|||
162675206|NCT02352948|587518736|FG004|Overall Study|Withdrawal by Subject|9|||
162675207|NCT02352948|587518737|FG005|Overall Study|Withdrawal by Subject|4|||
162675208|NCT02352948|587518732|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162675209|NCT02352948|587518733|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162675210|NCT02352948|587518734|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
162675211|NCT02352948|587518735|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162675212|NCT02352948|587518736|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
162675213|NCT02352948|587518737|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
162675214|NCT02352948|587518732|FG000|Overall Study|Other|0|||
162675215|NCT02352948|587518733|FG001|Overall Study|Other|0|||
162675216|NCT02352948|587518734|FG002|Overall Study|Other|2|||
162675217|NCT02352948|587518735|FG003|Overall Study|Other|0|||
162675218|NCT02352948|587518736|FG004|Overall Study|Other|0|||
162675219|NCT02352948|587518737|FG005|Overall Study|Other|0|||
162675220|NCT01453595|587518741|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162675221|NCT01453595|587518742|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162675222|NCT01453595|587518743|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162675223|NCT03762473|587518744|FG000|Overall Study|Death|1|||
162675224|NCT03762473|587518745|FG001|Overall Study|Death|0|||
162675225|NCT01128413|587518746|FG000|Overall Study|Withdrawal by Subject|1|||
162675226|NCT01128413|587518747|FG001|Overall Study|Withdrawal by Subject|0|||
162675227|NCT01128413|587518746|FG000|Overall Study|NICOM Monitor Problems|2|||
162675228|NCT01128413|587518747|FG001|Overall Study|NICOM Monitor Problems|1|||
162675229|NCT01128413|587518746|FG000|Overall Study|Pt made DNR|1|||
162675230|NCT01128413|587518747|FG001|Overall Study|Pt made DNR|0|||
162675231|NCT00045110|587518748|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
162675232|NCT00045110|587518749|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
162675233|NCT00045110|587518750|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
162675234|NCT00045110|587518748|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
162675235|NCT00045110|587518749|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
162675236|NCT00045110|587518750|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
162675237|NCT00045110|587518748|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
162675238|NCT00045110|587518749|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
162675239|NCT00045110|587518750|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
162675240|NCT03662750|587518752|FG000|Overall Study|Withdrawal by Subject|1|||
162675241|NCT02010060|587518753|FG000|Overall Study|Lost to Follow-up|1|||
162675242|NCT02010060|587518754|FG001|Overall Study|Lost to Follow-up|2|||
162675243|NCT02010060|587518755|FG002|Overall Study|Lost to Follow-up|2|||
162675244|NCT02010060|587518753|FG000|Overall Study|Injury|0|||
162675245|NCT02010060|587518754|FG001|Overall Study|Injury|1|||
162675246|NCT02010060|587518755|FG002|Overall Study|Injury|0|||
162675247|NCT00660010|587518756|FG000|Overall Study|Withdrawal by Subject|2|||
162675248|NCT00660010|587518756|FG000|Overall Study|Lost to Follow-up|3|||
162675249|NCT00660010|587518756|FG000|Overall Study|Adverse Event|1|||
162675250|NCT00660010|587518756|FG000|Overall Study|Noncompliance with visit schedule|3|||
162675251|NCT00726752|587518757|FG000|Overall Study|Lack of Efficacy|6|||
162675252|NCT01292603|587520844|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162675253|NCT01292603|587520845|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162675254|NCT01292603|587520846|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162675255|NCT01292603|587520847|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
162675256|NCT01292603|587520848|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162675257|NCT01292603|587520849|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162675258|NCT01292603|587520844|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
162675259|NCT01292603|587520845|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
162675260|NCT01292603|587520846|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
162675261|NCT01292603|587520847|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
162675262|NCT01292603|587520848|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
162675263|NCT01292603|587520849|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
162675264|NCT01292603|587520844|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162675265|NCT01292603|587520845|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162675266|NCT01292603|587520846|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162675267|NCT01292603|587520847|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
162675268|NCT01292603|587520848|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162675269|NCT01292603|587520849|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162675270|NCT01292603|587520844|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162675271|NCT01292603|587520845|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162675272|NCT01292603|587520846|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162675273|NCT01292603|587520847|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
162675274|NCT01292603|587520848|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162675275|NCT01292603|587520849|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162675276|NCT01292603|587520844|FG000|Part 1: Regular Follow-Up Period|Death|3|||
162675277|NCT01292603|587520845|FG001|Part 1: Regular Follow-Up Period|Death|1|||
162675278|NCT01292603|587520846|FG002|Part 1: Regular Follow-Up Period|Death|3|||
162675279|NCT01292603|587520847|FG003|Part 1: Regular Follow-Up Period|Death|1|||
162675280|NCT01292603|587520848|FG004|Part 1: Regular Follow-Up Period|Death|0|||
162675281|NCT01292603|587520849|FG005|Part 1: Regular Follow-Up Period|Death|0|||
162675282|NCT01292603|587520844|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
162675283|NCT01292603|587520845|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
162675284|NCT01292603|587520846|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
162675285|NCT01292603|587520847|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162675286|NCT01292603|587520848|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162675287|NCT01292603|587520849|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162675288|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Death|0|||
162675289|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Death|0|||
162675290|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Death|0|||
162675291|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Death|0|||
162675292|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Death|1|||
162675293|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Death|0|||
162675294|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
162675295|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
162675296|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
162675297|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
162675298|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
162675299|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
162675300|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162675301|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162675302|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162675303|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162675304|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
162675305|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
162675306|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
162675307|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
162675308|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
162675309|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
162675310|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
162675311|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
162675312|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162675313|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162675314|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162675315|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162675316|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
162675317|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
162675318|NCT01292603|587520844|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162675319|NCT01292603|587520845|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162675320|NCT01292603|587520846|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162675321|NCT01292603|587520847|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162675322|NCT01292603|587520848|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162675323|NCT01292603|587520849|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
162675324|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Death|0|||
162675325|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Death|0|||
162675326|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Death|0|||
162675327|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Death|0|||
162675328|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Death|6|||
162675329|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Death|3|||
162675330|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
162675331|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
162675332|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
162675333|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
162675334|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
162675335|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
162675336|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
162675337|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
162675338|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
162675339|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
162675340|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
162675341|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
162675342|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162675343|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162675344|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162675345|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162722280|NCT02798835|587690443|FG001|Overall Study|Protocol Violation|0|||
162722281|NCT02798835|587690444|FG002|Overall Study|Protocol Violation|3|||
162722282|NCT03024606|587690449|FG000|Overall Study|Withdrawal by Subject|9|||
162722283|NCT03024606|587690450|FG001|Overall Study|Withdrawal by Subject|10|||
162675346|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162675347|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
162675348|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
162675349|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
162675350|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
162675351|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
162675352|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
162675353|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
162675354|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
162675355|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
162675356|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
162675357|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
162675358|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
162675359|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
162675360|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162675361|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162675362|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162675363|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162675364|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
162675365|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
162675366|NCT01292603|587520844|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
162675367|NCT01292603|587520845|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
162675368|NCT01292603|587520846|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
162675369|NCT01292603|587520847|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
162675370|NCT01292603|587520848|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
162675371|NCT01292603|587520849|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
162675372|NCT01292603|587520844|FG000|Overall Survival Status|Death|3|||
162675373|NCT01292603|587520845|FG001|Overall Survival Status|Death|1|||
162675374|NCT01292603|587520846|FG002|Overall Survival Status|Death|3|||
162675375|NCT01292603|587520847|FG003|Overall Survival Status|Death|1|||
162675376|NCT01292603|587520848|FG004|Overall Survival Status|Death|16|||
162675377|NCT01292603|587520849|FG005|Overall Survival Status|Death|10|||
162675378|NCT04307004|587520854|FG000|Randomization 1|Withdrawal by Subject|25|||
162675379|NCT04307004|587520855|FG001|Randomization 1|Withdrawal by Subject|26|||
162675380|NCT04307004|587520856|FG002|Randomization 1|Withdrawal by Subject|0|||
162675381|NCT04307004|587520857|FG003|Randomization 1|Withdrawal by Subject|0|||
162675382|NCT04307004|587520854|FG000|Randomization 2|Withdrawal by Subject|0|||
162675383|NCT04307004|587520855|FG001|Randomization 2|Withdrawal by Subject|0|||
162675384|NCT04307004|587520856|FG002|Randomization 2|Withdrawal by Subject|28|||
162675385|NCT04307004|587520857|FG003|Randomization 2|Withdrawal by Subject|23|||
162675386|NCT02807558|587520858|FG000|Overall Study|Consent withdrawn by participant|4|||
162675387|NCT02807558|587520859|FG001|Overall Study|Consent withdrawn by participant|0|||
162675388|NCT02807558|587520860|FG002|Overall Study|Consent withdrawn by participant|4|||
162675389|NCT02807558|587520861|FG003|Overall Study|Consent withdrawn by participant|2|||
162675390|NCT02807558|587520862|FG004|Overall Study|Consent withdrawn by participant|1|||
162675391|NCT02807558|587520863|FG005|Overall Study|Consent withdrawn by participant|0|||
162675392|NCT02807558|587520858|FG000|Overall Study|Non-compliance with Study Drug|0|||
162675393|NCT02807558|587520859|FG001|Overall Study|Non-compliance with Study Drug|0|||
162675394|NCT02807558|587520860|FG002|Overall Study|Non-compliance with Study Drug|1|||
162675395|NCT02807558|587520861|FG003|Overall Study|Non-compliance with Study Drug|0|||
162675396|NCT02807558|587520862|FG004|Overall Study|Non-compliance with Study Drug|0|||
162675397|NCT02807558|587520863|FG005|Overall Study|Non-compliance with Study Drug|0|||
162675398|NCT02807558|587520858|FG000|Overall Study|Adverse Event|0|||
162675399|NCT02807558|587520859|FG001|Overall Study|Adverse Event|0|||
162675400|NCT02807558|587520860|FG002|Overall Study|Adverse Event|9|||
162675401|NCT02807558|587520861|FG003|Overall Study|Adverse Event|0|||
162675402|NCT02807558|587520862|FG004|Overall Study|Adverse Event|0|||
162675403|NCT02807558|587520863|FG005|Overall Study|Adverse Event|0|||
162675404|NCT02807558|587520858|FG000|Overall Study|Death|23|||
163151632|NCT00388349|589269468|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
163151633|NCT01667900|589269473|FG000|Part B|Death|0|||
163151634|NCT01667900|589269474|FG001|Part B|Death|0|||
163151635|NCT01667900|589269475|FG002|Part B|Death|0|||
163151636|NCT01667900|589269476|FG003|Part B|Death|0|||
163151637|NCT01667900|589269477|FG004|Part B|Death|0|||
163151638|NCT01667900|589269478|FG005|Part B|Death|0|||
163151639|NCT01667900|589269479|FG006|Part B|Death|0|||
163151640|NCT01667900|589269480|FG007|Part B|Death|0|||
163151641|NCT01667900|589269481|FG008|Part B|Death|0|||
163151642|NCT01667900|589269482|FG009|Part B|Death|0|||
163151643|NCT01667900|589269483|FG010|Part B|Death|0|||
162675405|NCT02807558|587520859|FG001|Overall Study|Death|2|||
162675406|NCT02807558|587520860|FG002|Overall Study|Death|3|||
162675407|NCT02807558|587520861|FG003|Overall Study|Death|43|||
163151644|NCT01667900|589269484|FG011|Part B|Death|0|||
163151645|NCT01667900|589269485|FG012|Part B|Death|0|||
163151646|NCT01667900|589269486|FG013|Part B|Death|0|||
163151647|NCT01667900|589269487|FG014|Part B|Death|0|||
162722284|NCT01595061|587690461|FG000|Overall Study|Never Treated|3|||
162722285|NCT01595061|587690461|FG000|Overall Study|Inadequate Pathology|1|||
162722286|NCT04697628|587690467|FG000|Overall Study|Withdrawal by Subject|17|||
162722287|NCT04697628|587690468|FG001|Overall Study|Withdrawal by Subject|23|||
162722288|NCT04697628|587690467|FG000|Overall Study|Lost to Follow-up|0|||
162722289|NCT04697628|587690468|FG001|Overall Study|Lost to Follow-up|4|||
162722290|NCT04697628|587690467|FG000|Overall Study|On-going in study|122|||
162722291|NCT04697628|587690468|FG001|Overall Study|On-going in study|91|||
162722292|NCT03388632|587690469|FG000|Triplet C|Clinical progression|0|||
162722293|NCT03388632|587690470|FG001|Triplet C|Clinical progression|0|||
162722294|NCT03388632|587690471|FG002|Triplet C|Clinical progression|0|||
162722295|NCT03388632|587690472|FG003|Triplet C|Clinical progression|0|||
162722296|NCT03388632|587690473|FG004|Triplet C|Clinical progression|1|||
162722297|NCT03388632|587690474|FG005|Triplet C|Clinical progression|0|||
162722298|NCT03388632|587690475|FG006|Triplet C|Clinical progression|0|||
162722299|NCT03388632|587690476|FG007|Triplet C|Clinical progression|0|||
162722300|NCT03388632|587690477|FG008|Triplet C|Clinical progression|0|||
162722301|NCT03388632|587690469|FG000|Triplet C|42-day lapse in tx|0|||
162722302|NCT03388632|587690470|FG001|Triplet C|42-day lapse in tx|0|||
162722303|NCT03388632|587690471|FG002|Triplet C|42-day lapse in tx|0|||
162722304|NCT03388632|587690472|FG003|Triplet C|42-day lapse in tx|0|||
162722305|NCT03388632|587690473|FG004|Triplet C|42-day lapse in tx|1|||
162722306|NCT03388632|587690474|FG005|Triplet C|42-day lapse in tx|0|||
162722307|NCT03388632|587690475|FG006|Triplet C|42-day lapse in tx|0|||
162722308|NCT03388632|587690476|FG007|Triplet C|42-day lapse in tx|0|||
162722309|NCT03388632|587690477|FG008|Triplet C|42-day lapse in tx|0|||
162722310|NCT03388632|587690469|FG000|Triplet C|Adverse Event|0|||
162722311|NCT03388632|587690470|FG001|Triplet C|Adverse Event|0|||
162722312|NCT03388632|587690471|FG002|Triplet C|Adverse Event|0|||
162722313|NCT03388632|587690472|FG003|Triplet C|Adverse Event|0|||
162722314|NCT03388632|587690473|FG004|Triplet C|Adverse Event|0|||
162722315|NCT03388632|587690474|FG005|Triplet C|Adverse Event|0|||
162722316|NCT03388632|587690475|FG006|Triplet C|Adverse Event|0|||
162722317|NCT03388632|587690476|FG007|Triplet C|Adverse Event|0|||
162722318|NCT03388632|587690477|FG008|Triplet C|Adverse Event|1|||
162722319|NCT03388632|587690469|FG000|Triplet C|Switched to alternative treatment|0|||
162722320|NCT03388632|587690470|FG001|Triplet C|Switched to alternative treatment|0|||
162722321|NCT03388632|587690471|FG002|Triplet C|Switched to alternative treatment|0|||
162722322|NCT03388632|587690472|FG003|Triplet C|Switched to alternative treatment|0|||
162722323|NCT03388632|587690473|FG004|Triplet C|Switched to alternative treatment|0|||
162722324|NCT03388632|587690474|FG005|Triplet C|Switched to alternative treatment|0|||
162722325|NCT03388632|587690475|FG006|Triplet C|Switched to alternative treatment|0|||
162722326|NCT03388632|587690476|FG007|Triplet C|Switched to alternative treatment|1|||
162722327|NCT03388632|587690477|FG008|Triplet C|Switched to alternative treatment|0|||
162722328|NCT03388632|587690469|FG000|Triplet C|Participant choice|0|||
162722329|NCT03388632|587690470|FG001|Triplet C|Participant choice|0|||
162722330|NCT03388632|587690471|FG002|Triplet C|Participant choice|0|||
162722331|NCT03388632|587690472|FG003|Triplet C|Participant choice|0|||
162722332|NCT03388632|587690473|FG004|Triplet C|Participant choice|0|||
162722333|NCT03388632|587690474|FG005|Triplet C|Participant choice|1|||
162722334|NCT03388632|587690475|FG006|Triplet C|Participant choice|0|||
162722335|NCT03388632|587690476|FG007|Triplet C|Participant choice|0|||
162722336|NCT03388632|587690477|FG008|Triplet C|Participant choice|0|||
162722337|NCT06218251|587690480|FG000|Overall Study|Lost to Follow-up|4|||
162722338|NCT00997386|587690483|FG000|Overall Study|Death|7|||
162722339|NCT03492177|587690484|FG000|Overall Study|Adverse Event|1|||
162722340|NCT03492177|587690485|FG001|Overall Study|Adverse Event|0|||
162722341|NCT03492177|587690486|FG002|Overall Study|Adverse Event|0|||
162722342|NCT03492177|587690484|FG000|Overall Study|Death|3|||
162722343|NCT03492177|587690485|FG001|Overall Study|Death|0|||
162722344|NCT03492177|587690486|FG002|Overall Study|Death|3|||
162722345|NCT03492177|587690484|FG000|Overall Study|Lack of Efficacy|1|||
162722346|NCT03492177|587690485|FG001|Overall Study|Lack of Efficacy|2|||
162722347|NCT03492177|587690486|FG002|Overall Study|Lack of Efficacy|0|||
162722348|NCT03492177|587690484|FG000|Overall Study|Other|1|||
162722349|NCT03492177|587690485|FG001|Overall Study|Other|0|||
162722350|NCT03492177|587690486|FG002|Overall Study|Other|0|||
162722351|NCT03492177|587690484|FG000|Overall Study|Ongoing|16|||
162722352|NCT03492177|587690485|FG001|Overall Study|Ongoing|19|||
162722353|NCT03492177|587690486|FG002|Overall Study|Ongoing|17|||
162722354|NCT01713946|587690487|FG000|Overall Study|Death|0|||
162722355|NCT01713946|587690488|FG001|Overall Study|Death|2|||
162722356|NCT01713946|587690489|FG002|Overall Study|Death|2|||
162722357|NCT01713946|587690487|FG000|Overall Study|Adverse Event|19|||
162722358|NCT01713946|587690488|FG001|Overall Study|Adverse Event|14|||
162722359|NCT01713946|587690489|FG002|Overall Study|Adverse Event|13|||
162722360|NCT01713946|587690487|FG000|Overall Study|Withdrawal by Subject|12|||
162722361|NCT01713946|587690488|FG001|Overall Study|Withdrawal by Subject|12|||
163151648|NCT01667900|589269488|FG015|Part B|Death|0|||
163151649|NCT01667900|589269489|FG016|Part B|Death|1|||
162722362|NCT01713946|587690489|FG002|Overall Study|Withdrawal by Subject|8|||
162722363|NCT01713946|587690487|FG000|Overall Study|Lack of Efficacy|8|||
162722364|NCT01713946|587690488|FG001|Overall Study|Lack of Efficacy|8|||
162722365|NCT01713946|587690489|FG002|Overall Study|Lack of Efficacy|14|||
162722366|NCT01713946|587690487|FG000|Overall Study|Protocol Violation|2|||
162722367|NCT01713946|587690488|FG001|Overall Study|Protocol Violation|4|||
162722368|NCT01713946|587690489|FG002|Overall Study|Protocol Violation|1|||
162722369|NCT01713946|587690487|FG000|Overall Study|Lost to Follow-up|0|||
162722370|NCT01713946|587690488|FG001|Overall Study|Lost to Follow-up|0|||
162722371|NCT01713946|587690489|FG002|Overall Study|Lost to Follow-up|1|||
162722372|NCT01713946|587690487|FG000|Overall Study|Administrative problems|1|||
162722373|NCT01713946|587690488|FG001|Overall Study|Administrative problems|0|||
162722374|NCT01713946|587690489|FG002|Overall Study|Administrative problems|0|||
162722375|NCT01713946|587690487|FG000|Overall Study|Did not continue in Ext|0|||
162722376|NCT01713946|587690488|FG001|Overall Study|Did not continue in Ext|3|||
163151650|NCT01667900|589269490|FG017|Part B|Death|0|||
163151651|NCT01667900|589269491|FG018|Part B|Death|0|||
162675408|NCT02807558|587520862|FG004|Overall Study|Death|24|||
162675409|NCT02807558|587520863|FG005|Overall Study|Death|15|||
162675410|NCT02807558|587520858|FG000|Overall Study|Progressive Disease|0|||
162675411|NCT02807558|587520859|FG001|Overall Study|Progressive Disease|0|||
162675412|NCT02807558|587520860|FG002|Overall Study|Progressive Disease|1|||
162675413|NCT02807558|587520861|FG003|Overall Study|Progressive Disease|0|||
162675414|NCT02807558|587520862|FG004|Overall Study|Progressive Disease|0|||
162675415|NCT02807558|587520863|FG005|Overall Study|Progressive Disease|0|||
162675416|NCT02807558|587520858|FG000|Overall Study|Other than specified|1|||
162675417|NCT02807558|587520859|FG001|Overall Study|Other than specified|0|||
162675418|NCT02807558|587520860|FG002|Overall Study|Other than specified|2|||
162675419|NCT02807558|587520861|FG003|Overall Study|Other than specified|0|||
162675420|NCT02807558|587520862|FG004|Overall Study|Other than specified|1|||
162675421|NCT02807558|587520863|FG005|Overall Study|Other than specified|1|||
162675422|NCT02807558|587520858|FG000|Overall Study|Lack of Efficacy|0|||
162675423|NCT02807558|587520859|FG001|Overall Study|Lack of Efficacy|0|||
162675424|NCT02807558|587520860|FG002|Overall Study|Lack of Efficacy|9|||
162675425|NCT02807558|587520861|FG003|Overall Study|Lack of Efficacy|0|||
162675426|NCT02807558|587520862|FG004|Overall Study|Lack of Efficacy|0|||
162675427|NCT02807558|587520863|FG005|Overall Study|Lack of Efficacy|0|||
162675428|NCT01972841|587520864|FG000|Overall Study|Randomized but Never Received Treatment|2|||
162675429|NCT01972841|587520865|FG001|Overall Study|Randomized but Never Received Treatment|5|||
162675430|NCT01972841|587520866|FG002|Overall Study|Randomized but Never Received Treatment|4|||
162675431|NCT01972841|587520867|FG003|Overall Study|Randomized but Never Received Treatment|2|||
162675432|NCT01972841|587520868|FG004|Overall Study|Randomized but Never Received Treatment|6|||
162675433|NCT01972841|587520869|FG005|Overall Study|Randomized but Never Received Treatment|13|||
162675434|NCT01972841|587520864|FG000|Overall Study|Adverse Event|13|||
162675435|NCT01972841|587520865|FG001|Overall Study|Adverse Event|8|||
162675436|NCT01972841|587520866|FG002|Overall Study|Adverse Event|12|||
162675437|NCT01972841|587520867|FG003|Overall Study|Adverse Event|9|||
162675438|NCT01972841|587520868|FG004|Overall Study|Adverse Event|21|||
162675439|NCT01972841|587520869|FG005|Overall Study|Adverse Event|26|||
162675440|NCT01972841|587520864|FG000|Overall Study|Lack of Efficacy|1|||
162675441|NCT01972841|587520865|FG001|Overall Study|Lack of Efficacy|0|||
162675442|NCT01972841|587520866|FG002|Overall Study|Lack of Efficacy|0|||
162675443|NCT01972841|587520867|FG003|Overall Study|Lack of Efficacy|2|||
162675444|NCT01972841|587520868|FG004|Overall Study|Lack of Efficacy|4|||
162675445|NCT01972841|587520869|FG005|Overall Study|Lack of Efficacy|1|||
162675446|NCT01972841|587520864|FG000|Overall Study|Lost to Follow-up|4|||
162675447|NCT01972841|587520865|FG001|Overall Study|Lost to Follow-up|2|||
162675448|NCT01972841|587520866|FG002|Overall Study|Lost to Follow-up|4|||
162675449|NCT01972841|587520867|FG003|Overall Study|Lost to Follow-up|2|||
162675450|NCT01972841|587520868|FG004|Overall Study|Lost to Follow-up|9|||
162675451|NCT01972841|587520869|FG005|Overall Study|Lost to Follow-up|3|||
162675452|NCT01972841|587520864|FG000|Overall Study|Protocol Violation|2|||
162675453|NCT01972841|587520865|FG001|Overall Study|Protocol Violation|2|||
162675454|NCT01972841|587520866|FG002|Overall Study|Protocol Violation|3|||
162675455|NCT01972841|587520867|FG003|Overall Study|Protocol Violation|5|||
162675456|NCT01972841|587520868|FG004|Overall Study|Protocol Violation|9|||
162675457|NCT01972841|587520869|FG005|Overall Study|Protocol Violation|4|||
162675458|NCT01972841|587520864|FG000|Overall Study|Withdrawal by participants|21|||
162675459|NCT01972841|587520865|FG001|Overall Study|Withdrawal by participants|27|||
162675460|NCT01972841|587520866|FG002|Overall Study|Withdrawal by participants|23|||
162675461|NCT01972841|587520867|FG003|Overall Study|Withdrawal by participants|16|||
162675462|NCT01972841|587520868|FG004|Overall Study|Withdrawal by participants|33|||
162675463|NCT01972841|587520869|FG005|Overall Study|Withdrawal by participants|34|||
162675464|NCT01972841|587520864|FG000|Overall Study|Miscellaneous|0|||
162675465|NCT01972841|587520865|FG001|Overall Study|Miscellaneous|0|||
162675466|NCT01972841|587520866|FG002|Overall Study|Miscellaneous|4|||
162675467|NCT01972841|587520867|FG003|Overall Study|Miscellaneous|1|||
162675468|NCT01972841|587520868|FG004|Overall Study|Miscellaneous|0|||
162675469|NCT01972841|587520869|FG005|Overall Study|Miscellaneous|4|||
162675470|NCT01972841|587520864|FG000|Overall Study|Did not have end of treatment page|0|||
162675471|NCT01972841|587520865|FG001|Overall Study|Did not have end of treatment page|0|||
162675472|NCT01972841|587520866|FG002|Overall Study|Did not have end of treatment page|0|||
162675473|NCT01972841|587520867|FG003|Overall Study|Did not have end of treatment page|0|||
162675474|NCT01972841|587520868|FG004|Overall Study|Did not have end of treatment page|1|||
162675475|NCT01972841|587520869|FG005|Overall Study|Did not have end of treatment page|0|||
162675476|NCT00688636|587520874|FG000|Overall Study|Adverse Event|2|||
162675477|NCT00688636|587520875|FG001|Overall Study|Adverse Event|1|||
162722377|NCT01713946|587690489|FG002|Overall Study|Did not continue in Ext|0|||
162675478|NCT01572727|587520876|FG000|Overall Study|Adverse Event|43|||
162722378|NCT01713946|587690487|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
162675479|NCT01572727|587520877|FG001|Overall Study|Adverse Event|15|||
162675480|NCT01572727|587520876|FG000|Overall Study|Lost to Follow-up|1|||
162675481|NCT01572727|587520877|FG001|Overall Study|Lost to Follow-up|1|||
162675482|NCT01572727|587520876|FG000|Overall Study|Physician Decision|23|||
162675483|NCT01572727|587520877|FG001|Overall Study|Physician Decision|9|||
162675484|NCT01572727|587520876|FG000|Overall Study|Progressive disease|59|||
162722379|NCT01713946|587690488|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
162722380|NCT01713946|587690489|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
162722381|NCT01713946|587690487|FG000|Overall Study|Patients never switched to everolimus|0|||
162722382|NCT01713946|587690488|FG001|Overall Study|Patients never switched to everolimus|0|||
162722383|NCT01713946|587690489|FG002|Overall Study|Patients never switched to everolimus|5|||
162722384|NCT05644444|587691763|FG000|Tolerance Phase|Adverse Event|0|||
162722385|NCT05644444|587691764|FG001|Tolerance Phase|Adverse Event|2|||
162722386|NCT05644444|587691763|FG000|Treatment Phase|Adverse Event|0|||
162722387|NCT05644444|587691764|FG001|Treatment Phase|Adverse Event|2|||
162722388|NCT03723616|587691766|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
162722389|NCT03723616|587691767|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
162722390|NCT03723616|587691768|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
162722391|NCT03723616|587691769|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
162722392|NCT03723616|587691770|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
162722393|NCT03723616|587691771|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
162722394|NCT00493649|587691774|FG000|Overall Study|Adverse Event|44|||
162722395|NCT00493649|587691774|FG000|Overall Study|Patient Request|21|||
162722396|NCT00493649|587691774|FG000|Overall Study|Investigator Request|2|||
162722397|NCT00493649|587691774|FG000|Overall Study|Disease Progression|1|||
162722398|NCT00493649|587691774|FG000|Overall Study|Lost to Follow-up|1|||
162722399|NCT00493649|587691774|FG000|Overall Study|Other|13|||
162722400|NCT00925899|587691777|FG000|Part 1|Death|1|||
162722401|NCT00925899|587691778|FG001|Part 1|Death|2|||
162722402|NCT00925899|587691777|FG000|Part 1|Withdrawal by Subject|10|||
162722403|NCT00925899|587691778|FG001|Part 1|Withdrawal by Subject|9|||
162722404|NCT00683696|587691779|FG000|Overall Study|Withdrawn due to study closure|337|||
162722405|NCT00683696|587691780|FG001|Overall Study|Withdrawn due to study closure|338|||
162722406|NCT00683696|587691779|FG000|Overall Study|Withdrawn prior to study closure|13|||
162722407|NCT00683696|587691780|FG001|Overall Study|Withdrawn prior to study closure|28|||
162722408|NCT00683696|587691779|FG000|Overall Study|Lost to Follow-up|5|||
162722409|NCT00683696|587691780|FG001|Overall Study|Lost to Follow-up|6|||
162722410|NCT00683696|587691779|FG000|Overall Study|Vital status follow-up only|3|||
163151652|NCT01667900|589269492|FG019|Part B|Death|0|||
163151653|NCT00774046|589269495|FG000|Screening|Not eligible|56|||
163151654|NCT00774046|589269495|FG000|Enrollment|Desired other therapy/refused|28|||
163151655|NCT00774046|589269495|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
163151656|NCT00976274|589269496|FG000|Overall Study|Lost to Follow-up|5|||
163151657|NCT00976274|589269497|FG001|Overall Study|Lost to Follow-up|5|||
162722411|NCT00683696|587691780|FG001|Overall Study|Vital status follow-up only|3|||
162722412|NCT00683696|587691779|FG000|Overall Study|Death|46|||
162722413|NCT00683696|587691780|FG001|Overall Study|Death|30|||
162722414|NCT03648762|587691783|FG000|Overall Study|Lost to Follow-up|1|||
162722415|NCT03648762|587691784|FG001|Overall Study|Lost to Follow-up|2|||
162722416|NCT03648762|587691785|FG002|Overall Study|Lost to Follow-up|0|||
162722417|NCT03648762|587691783|FG000|Overall Study|Withdrawal by Subject|5|||
162722418|NCT03648762|587691784|FG001|Overall Study|Withdrawal by Subject|2|||
162722419|NCT03648762|587691785|FG002|Overall Study|Withdrawal by Subject|1|||
162722420|NCT01662336|587691795|FG000|Overall Study|Adverse Event|1|||
162722421|NCT01662336|587691795|FG000|Overall Study|No longer on LPV/r|30|||
162722422|NCT01662336|587691795|FG000|Overall Study|Other|29|||
162722423|NCT01662336|587691795|FG000|Overall Study|Withdrawal by Subject|6|||
162722424|NCT02189252|587691796|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162722425|NCT02189252|587691797|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
162722426|NCT02189252|587691798|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162722427|NCT02189252|587691799|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162722428|NCT02189252|587691796|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162722429|NCT02189252|587691797|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
162722430|NCT02189252|587691798|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162722431|NCT02189252|587691799|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162722432|NCT03454529|587691802|FG000|Overall Study|Did not receive treatment|6|||
162722433|NCT03454529|587691802|FG000|Overall Study|Received < 80% doses|1|||
162722434|NCT01040689|587691804|FG000|Overall Study|Adverse Event|0|||
162722435|NCT01040689|587691805|FG001|Overall Study|Adverse Event|0|||
162722436|NCT01040689|587691806|FG002|Overall Study|Adverse Event|2|||
162722437|NCT01040689|587691807|FG003|Overall Study|Adverse Event|4|||
162722438|NCT01040689|587691804|FG000|Overall Study|Lack of Efficacy|0|||
162722439|NCT01040689|587691805|FG001|Overall Study|Lack of Efficacy|0|||
162722440|NCT01040689|587691806|FG002|Overall Study|Lack of Efficacy|1|||
162722441|NCT01040689|587691807|FG003|Overall Study|Lack of Efficacy|0|||
162722442|NCT01040689|587691804|FG000|Overall Study|Lost to Follow-up|1|||
162722443|NCT01040689|587691805|FG001|Overall Study|Lost to Follow-up|0|||
162722444|NCT01040689|587691806|FG002|Overall Study|Lost to Follow-up|0|||
162722445|NCT01040689|587691807|FG003|Overall Study|Lost to Follow-up|0|||
162722446|NCT01040689|587691804|FG000|Overall Study|Withdrawal by Subject|2|||
163151658|NCT00976274|589269496|FG000|Overall Study|Withdrawal by Subject|1|||
162722447|NCT01040689|587691805|FG001|Overall Study|Withdrawal by Subject|1|||
162722448|NCT01040689|587691806|FG002|Overall Study|Withdrawal by Subject|1|||
162722449|NCT01040689|587691807|FG003|Overall Study|Withdrawal by Subject|0|||
162722450|NCT01040689|587691804|FG000|Overall Study|Other reasons not listed above|0|||
162675485|NCT01572727|587520877|FG001|Overall Study|Progressive disease|82|||
162675486|NCT01572727|587520876|FG000|Overall Study|Protocol Violation|0|||
162675487|NCT01572727|587520877|FG001|Overall Study|Protocol Violation|1|||
162675488|NCT01572727|587520876|FG000|Overall Study|Study terminated by sponsor|61|||
162675489|NCT01572727|587520877|FG001|Overall Study|Study terminated by sponsor|83|||
162675490|NCT01572727|587520876|FG000|Overall Study|Parent/guardian decision|14|||
162675491|NCT01572727|587520877|FG001|Overall Study|Parent/guardian decision|9|||
162675492|NCT01572727|587520876|FG000|Overall Study|Death|2|||
162675493|NCT01572727|587520877|FG001|Overall Study|Death|2|||
162675494|NCT01572727|587520876|FG000|Overall Study|Untreated|4|||
162675495|NCT01572727|587520877|FG001|Overall Study|Untreated|7|||
162675496|NCT04053764|587520878|FG000|Overall Study|Withdrawal by Subject|6|||
162675497|NCT04053764|587520879|FG001|Overall Study|Withdrawal by Subject|2|||
162675498|NCT04053764|587520878|FG000|Overall Study|Physician Decision|2|||
162675499|NCT04053764|587520879|FG001|Overall Study|Physician Decision|1|||
162675500|NCT04053764|587520878|FG000|Overall Study|Adverse Event|1|||
162675501|NCT04053764|587520879|FG001|Overall Study|Adverse Event|0|||
162675502|NCT04053764|587520878|FG000|Overall Study|Pregnancy|1|||
162675503|NCT04053764|587520879|FG001|Overall Study|Pregnancy|0|||
162675504|NCT02384954|587520883|FG000|Phase 1|Progressive Disease|2|||
162675505|NCT02384954|587520884|FG001|Phase 1|Progressive Disease|0|||
162675506|NCT02384954|587520885|FG002|Phase 1|Progressive Disease|1|||
162675507|NCT02384954|587520886|FG003|Phase 1|Progressive Disease|1|||
162675508|NCT02384954|587520887|FG004|Phase 1|Progressive Disease|0|||
162675509|NCT02384954|587520888|FG005|Phase 1|Progressive Disease|0|||
162675510|NCT02384954|587520889|FG006|Phase 1|Progressive Disease|0|||
162675511|NCT02384954|587520890|FG007|Phase 1|Progressive Disease|0|||
162675512|NCT02384954|587520891|FG008|Phase 1|Progressive Disease|0|||
162675513|NCT02384954|587520883|FG000|Phase 1|Adverse Event|0|||
162675514|NCT02384954|587520884|FG001|Phase 1|Adverse Event|0|||
162675515|NCT02384954|587520885|FG002|Phase 1|Adverse Event|1|||
162675516|NCT02384954|587520886|FG003|Phase 1|Adverse Event|0|||
162675517|NCT02384954|587520887|FG004|Phase 1|Adverse Event|0|||
162675518|NCT02384954|587520888|FG005|Phase 1|Adverse Event|0|||
162675519|NCT02384954|587520889|FG006|Phase 1|Adverse Event|0|||
162675520|NCT02384954|587520890|FG007|Phase 1|Adverse Event|0|||
162722451|NCT01040689|587691805|FG001|Overall Study|Other reasons not listed above|1|||
162722452|NCT01040689|587691806|FG002|Overall Study|Other reasons not listed above|0|||
162722453|NCT01040689|587691807|FG003|Overall Study|Other reasons not listed above|0|||
162675521|NCT02384954|587520891|FG008|Phase 1|Adverse Event|0|||
162722454|NCT05764161|587691810|FG000|12-week DBVC Period|Lack of Efficacy|2|||
162722455|NCT05764161|587691811|FG001|12-week DBVC Period|Lack of Efficacy|1|||
162675522|NCT02384954|587520883|FG000|Phase 2|Progressive Disease|0|||
162675523|NCT02384954|587520884|FG001|Phase 2|Progressive Disease|0|||
162675524|NCT02384954|587520885|FG002|Phase 2|Progressive Disease|0|||
162675525|NCT02384954|587520886|FG003|Phase 2|Progressive Disease|0|||
162675526|NCT02384954|587520887|FG004|Phase 2|Progressive Disease|0|||
162675527|NCT02384954|587520888|FG005|Phase 2|Progressive Disease|0|||
162675528|NCT02384954|587520889|FG006|Phase 2|Progressive Disease|0|||
162722456|NCT05764161|587691810|FG000|12-week DBVC Period|Lost to Follow-up|0|||
162722457|NCT05764161|587691811|FG001|12-week DBVC Period|Lost to Follow-up|2|||
162722458|NCT05764161|587691810|FG000|12-week DBVC Period|Protocol Violation|2|||
162722459|NCT05764161|587691811|FG001|12-week DBVC Period|Protocol Violation|4|||
162722460|NCT05764161|587691810|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
162722461|NCT05764161|587691811|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
162722462|NCT05764161|587691810|FG000|40-week OLE Period|Lack of Efficacy|0|||
162722463|NCT05764161|587691811|FG001|40-week OLE Period|Lack of Efficacy|1|||
162722464|NCT05764161|587691810|FG000|40-week OLE Period|Lost to Follow-up|1|||
162722465|NCT05764161|587691811|FG001|40-week OLE Period|Lost to Follow-up|4|||
162722466|NCT05764161|587691810|FG000|40-week OLE Period|Withdrawal by Subject|2|||
162722467|NCT05764161|587691811|FG001|40-week OLE Period|Withdrawal by Subject|7|||
162722468|NCT05764161|587691810|FG000|40-week OLE Period|Extended Travel|0|||
162722469|NCT05764161|587691811|FG001|40-week OLE Period|Extended Travel|1|||
162722470|NCT05764161|587691810|FG000|40-week OLE Period|Ongoing|66|||
162722471|NCT05764161|587691811|FG001|40-week OLE Period|Ongoing|59|||
162722472|NCT00507689|587691812|FG000|Pre-Randomization Period|Adverse Event|1|||
162722473|NCT00507689|587691813|FG001|Pre-Randomization Period|Adverse Event|0|||
162722474|NCT00507689|587691812|FG000|Pre-Randomization Period|Physician Decision|1|||
162722475|NCT00507689|587691813|FG001|Pre-Randomization Period|Physician Decision|0|||
162722476|NCT00507689|587691812|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
162722477|NCT00507689|587691813|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
162722478|NCT00507689|587691812|FG000|Randomized Period|Adverse Event|1|||
162722479|NCT00507689|587691813|FG001|Randomized Period|Adverse Event|1|||
162722480|NCT00507689|587691812|FG000|Randomized Period|Withdrawal by Subject|0|||
162722481|NCT00507689|587691813|FG001|Randomized Period|Withdrawal by Subject|1|||
162722482|NCT01241292|587691814|FG000|Overall Study|Administrative Reason by Sponsor|1|||
162722483|NCT01241292|587691815|FG001|Overall Study|Administrative Reason by Sponsor|0|||
162722484|NCT01241292|587691814|FG000|Overall Study|Disease Progression|2|||
162722485|NCT01241292|587691815|FG001|Overall Study|Disease Progression|0|||
162722486|NCT01241292|587691814|FG000|Overall Study|Study Drug Toxicity|0|||
162722487|NCT01241292|587691815|FG001|Overall Study|Study Drug Toxicity|1|||
162722488|NCT01241292|587691814|FG000|Overall Study|Participant Discontinued Treatment|0|||
162722489|NCT01241292|587691815|FG001|Overall Study|Participant Discontinued Treatment|2|||
162722490|NCT03194958|587691816|FG000|Overall Study|Death|0|||
162722491|NCT03194958|587691817|FG001|Overall Study|Death|1|||
163151659|NCT00976274|589269497|FG001|Overall Study|Withdrawal by Subject|1|||
163151660|NCT00976274|589269496|FG000|Overall Study|Physician Decision|1|||
163151661|NCT00976274|589269497|FG001|Overall Study|Physician Decision|2|||
163151662|NCT01614249|589269499|FG000|Overall Study|Lost to Follow-up|11|||
163151663|NCT01614249|589269500|FG001|Overall Study|Lost to Follow-up|23|||
163151664|NCT02954536|589269501|FG000|Overall Study|Adverse Event|2|||
163151665|NCT02954536|589269501|FG000|Overall Study|Death|12|||
163151666|NCT05498649|589269502|FG000|Overall Study|Lost to Follow-up|1|||
163151667|NCT02946580|589269503|FG000|Overall Study|Withdrawal by Subject|1|||
163151668|NCT02946580|589269504|FG001|Overall Study|Withdrawal by Subject|2|||
163151669|NCT02946580|589269503|FG000|Overall Study|Adverse Event|0|||
163151670|NCT02946580|589269504|FG001|Overall Study|Adverse Event|2|||
163151671|NCT02946580|589269503|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
163151672|NCT02946580|589269504|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
163151673|NCT03094416|589269505|FG000|Run-in|Screening failure|8|||
163151674|NCT03094416|589269505|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
163151675|NCT03094416|589269505|FG000|Run-in|Withdrawal by Subject|3|||
163151676|NCT03094416|589269505|FG000|Treatment Period|Withdrawal by Subject|2|||
163151677|NCT00321789|589269508|FG000|Overall Study|Lost to Follow-up|4|||
163151678|NCT00321789|589269509|FG001|Overall Study|Lost to Follow-up|7|||
163151679|NCT00321789|589269508|FG000|Overall Study|Withdrawal by Subject|6|||
163151680|NCT00321789|589269509|FG001|Overall Study|Withdrawal by Subject|6|||
163151681|NCT00321789|589269508|FG000|Overall Study|Protocol Violation|5|||
163151682|NCT00321789|589269509|FG001|Overall Study|Protocol Violation|3|||
162675529|NCT02384954|587520890|FG007|Phase 2|Progressive Disease|1|||
162675530|NCT02384954|587520891|FG008|Phase 2|Progressive Disease|2|||
163151683|NCT00005780|589269510|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
163151684|NCT00374140|589269511|FG000|Overall Study|Lost to Follow-up|1|||
163151685|NCT00374140|589269511|FG000|Overall Study|Protocol Violation|1|||
163151686|NCT02485691|589269512|FG000|Overall Study|Adverse Event|25|||
163151687|NCT02485691|589269513|FG001|Overall Study|Adverse Event|11|||
163151688|NCT02485691|589269512|FG000|Overall Study|Poor compliance to protocol|0|||
163151689|NCT02485691|589269513|FG001|Overall Study|Poor compliance to protocol|1|||
163151690|NCT02485691|589269512|FG000|Overall Study|Disease progression|57|||
163151691|NCT02485691|589269513|FG001|Overall Study|Disease progression|92|||
163151692|NCT02485691|589269512|FG000|Overall Study|Investigator's decision|23|||
163151693|NCT02485691|589269513|FG001|Overall Study|Investigator's decision|5|||
163151694|NCT02485691|589269512|FG000|Overall Study|Participant's request|13|||
163151695|NCT02485691|589269513|FG001|Overall Study|Participant's request|6|||
163151696|NCT02485691|589269512|FG000|Overall Study|Other reason|8|||
163151697|NCT02485691|589269513|FG001|Overall Study|Other reason|9|||
163151698|NCT02485691|589269512|FG000|Overall Study|Randomized and not treated|3|||
163151699|NCT02485691|589269513|FG001|Overall Study|Randomized and not treated|2|||
163151700|NCT04292535|589269514|FG000|Overall Study|Withdrawal by Subject|0|||
163151701|NCT04292535|589269515|FG001|Overall Study|Withdrawal by Subject|0|||
163151702|NCT04292535|589269516|FG002|Overall Study|Withdrawal by Subject|0|||
163151703|NCT04292535|589269517|FG003|Overall Study|Withdrawal by Subject|0|||
163151704|NCT04292535|589269518|FG004|Overall Study|Withdrawal by Subject|0|||
163151705|NCT04292535|589269519|FG005|Overall Study|Withdrawal by Subject|0|||
163151706|NCT04292535|589269520|FG006|Overall Study|Withdrawal by Subject|0|||
163151707|NCT04292535|589269521|FG007|Overall Study|Withdrawal by Subject|1|||
163151708|NCT04292535|589269522|FG008|Overall Study|Withdrawal by Subject|0|||
163151709|NCT04292535|589269523|FG009|Overall Study|Withdrawal by Subject|0|||
163151710|NCT04292535|589269524|FG010|Overall Study|Withdrawal by Subject|0|||
163151711|NCT04292535|589269525|FG011|Overall Study|Withdrawal by Subject|0|||
163151712|NCT04292535|589269526|FG012|Overall Study|Withdrawal by Subject|0|||
163151713|NCT04292535|589269527|FG013|Overall Study|Withdrawal by Subject|0|||
163151714|NCT04292535|589269514|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151715|NCT04292535|589269515|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151716|NCT04292535|589269516|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151717|NCT04292535|589269517|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151718|NCT04292535|589269518|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151719|NCT04292535|589269519|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151720|NCT04292535|589269520|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151721|NCT04292535|589269521|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151722|NCT04292535|589269522|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151723|NCT04292535|589269523|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151724|NCT04292535|589269524|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151725|NCT04292535|589269525|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
163151726|NCT04292535|589269526|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151727|NCT04292535|589269527|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163151728|NCT04292535|589269514|FG000|Overall Study|Report of Dizziness|0|||
163151729|NCT04292535|589269515|FG001|Overall Study|Report of Dizziness|0|||
163151730|NCT04292535|589269516|FG002|Overall Study|Report of Dizziness|0|||
163151731|NCT04292535|589269517|FG003|Overall Study|Report of Dizziness|0|||
163151732|NCT04292535|589269518|FG004|Overall Study|Report of Dizziness|0|||
163151733|NCT04292535|589269519|FG005|Overall Study|Report of Dizziness|0|||
163151734|NCT04292535|589269520|FG006|Overall Study|Report of Dizziness|0|||
163151735|NCT04292535|589269521|FG007|Overall Study|Report of Dizziness|0|||
163151736|NCT04292535|589269522|FG008|Overall Study|Report of Dizziness|0|||
163151737|NCT04292535|589269523|FG009|Overall Study|Report of Dizziness|0|||
163151738|NCT04292535|589269524|FG010|Overall Study|Report of Dizziness|0|||
163151739|NCT04292535|589269525|FG011|Overall Study|Report of Dizziness|0|||
163151740|NCT04292535|589269526|FG012|Overall Study|Report of Dizziness|0|||
163151741|NCT04292535|589269527|FG013|Overall Study|Report of Dizziness|1|||
163151742|NCT04292535|589269514|FG000|Overall Study|Equipment Failure|0|||
163151743|NCT04292535|589269515|FG001|Overall Study|Equipment Failure|0|||
163151744|NCT04292535|589269516|FG002|Overall Study|Equipment Failure|0|||
163151745|NCT04292535|589269517|FG003|Overall Study|Equipment Failure|0|||
163151746|NCT04292535|589269518|FG004|Overall Study|Equipment Failure|0|||
163151747|NCT04292535|589269519|FG005|Overall Study|Equipment Failure|0|||
163151748|NCT04292535|589269520|FG006|Overall Study|Equipment Failure|0|||
163151749|NCT04292535|589269521|FG007|Overall Study|Equipment Failure|0|||
163151750|NCT04292535|589269522|FG008|Overall Study|Equipment Failure|0|||
163151751|NCT04292535|589269523|FG009|Overall Study|Equipment Failure|0|||
163151752|NCT04292535|589269524|FG010|Overall Study|Equipment Failure|0|||
163151753|NCT04292535|589269525|FG011|Overall Study|Equipment Failure|1|||
163151754|NCT04292535|589269526|FG012|Overall Study|Equipment Failure|0|||
162722492|NCT03194958|587691818|FG002|Overall Study|Death|1|||
162722493|NCT03194958|587691819|FG003|Overall Study|Death|1|||
162722494|NCT03194958|587691816|FG000|Overall Study|Withdrawal by Subject|24|||
162722495|NCT03194958|587691817|FG001|Overall Study|Withdrawal by Subject|27|||
162722496|NCT03194958|587691818|FG002|Overall Study|Withdrawal by Subject|7|||
162722497|NCT03194958|587691819|FG003|Overall Study|Withdrawal by Subject|22|||
162722498|NCT03194958|587691816|FG000|Overall Study|Lost to Follow-up|168|||
162675531|NCT02384954|587520883|FG000|Phase 2|Adverse Event|0|||
162675532|NCT02384954|587520884|FG001|Phase 2|Adverse Event|0|||
162675533|NCT02384954|587520885|FG002|Phase 2|Adverse Event|0|||
162675534|NCT02384954|587520886|FG003|Phase 2|Adverse Event|0|||
162675535|NCT02384954|587520887|FG004|Phase 2|Adverse Event|0|||
162675536|NCT02384954|587520888|FG005|Phase 2|Adverse Event|0|||
162675537|NCT02384954|587520889|FG006|Phase 2|Adverse Event|0|||
162675538|NCT02384954|587520890|FG007|Phase 2|Adverse Event|1|||
162675539|NCT02384954|587520891|FG008|Phase 2|Adverse Event|1|||
162675540|NCT02384954|587520883|FG000|Phase 2|Failure to meet continuation criteria|0|||
162675541|NCT02384954|587520884|FG001|Phase 2|Failure to meet continuation criteria|0|||
162675542|NCT02384954|587520885|FG002|Phase 2|Failure to meet continuation criteria|0|||
162675543|NCT02384954|587520886|FG003|Phase 2|Failure to meet continuation criteria|0|||
162675544|NCT02384954|587520887|FG004|Phase 2|Failure to meet continuation criteria|0|||
162675545|NCT02384954|587520888|FG005|Phase 2|Failure to meet continuation criteria|0|||
162722499|NCT03194958|587691817|FG001|Overall Study|Lost to Follow-up|196|||
162722500|NCT03194958|587691818|FG002|Overall Study|Lost to Follow-up|174|||
162722501|NCT03194958|587691819|FG003|Overall Study|Lost to Follow-up|186|||
162722502|NCT00356265|587691820|FG000|Overall Study|Withdrawal by Subject|0|||
162722503|NCT00356265|587691821|FG001|Overall Study|Withdrawal by Subject|0|||
162722504|NCT00356265|587691822|FG002|Overall Study|Withdrawal by Subject|1|||
162722505|NCT00588770|587691827|FG000|Overall Study|Disease progression|85|||
162722506|NCT00588770|587691828|FG001|Overall Study|Disease progression|68|||
162722507|NCT00588770|587691827|FG000|Overall Study|Adverse Event|29|||
162722508|NCT00588770|587691828|FG001|Overall Study|Adverse Event|58|||
162722509|NCT00588770|587691827|FG000|Overall Study|Death|13|||
162722510|NCT00588770|587691828|FG001|Overall Study|Death|22|||
162722511|NCT00588770|587691827|FG000|Overall Study|Withdrawal by Subject|15|||
162722512|NCT00588770|587691828|FG001|Overall Study|Withdrawal by Subject|25|||
162722513|NCT00588770|587691827|FG000|Overall Study|Alternative therapy|2|||
162722514|NCT00588770|587691828|FG001|Overall Study|Alternative therapy|4|||
162722515|NCT00588770|587691827|FG000|Overall Study|Other complicating disease|3|||
162722516|NCT00588770|587691828|FG001|Overall Study|Other complicating disease|2|||
162722517|NCT00588770|587691827|FG000|Overall Study|Not start protocol therapy|0|||
162722518|NCT00588770|587691828|FG001|Overall Study|Not start protocol therapy|9|||
162722519|NCT00588770|587691827|FG000|Overall Study|Lack of Efficacy|8|||
162722520|NCT00588770|587691828|FG001|Overall Study|Lack of Efficacy|10|||
162722521|NCT00588770|587691827|FG000|Overall Study|Physician discretion|2|||
162722522|NCT00588770|587691828|FG001|Overall Study|Physician discretion|0|||
162722523|NCT00588770|587691827|FG000|Overall Study|Patient non-compliance|2|||
162722524|NCT00588770|587691828|FG001|Overall Study|Patient non-compliance|2|||
162722525|NCT04177394|587691829|FG000|Overall Study|Death|16|||
162722526|NCT04177394|587691829|FG000|Overall Study|Withdrawal by Subject|19|||
162722527|NCT04177394|587691829|FG000|Overall Study|Missed visits|61|||
162722528|NCT04177394|587691829|FG000|Overall Study|Expected Visits|15|||
162722529|NCT02115282|587691830|FG000|Overall Study|Disease progression during treatment|216|||
162722530|NCT02115282|587691831|FG001|Overall Study|Disease progression during treatment|229|||
162722531|NCT02115282|587691830|FG000|Overall Study|Adverse Event|49|||
162722532|NCT02115282|587691831|FG001|Overall Study|Adverse Event|23|||
162722533|NCT02115282|587691830|FG000|Overall Study|Death|1|||
162722534|NCT02115282|587691831|FG001|Overall Study|Death|3|||
162722535|NCT02115282|587691830|FG000|Overall Study|Alternative therapy|1|||
162722536|NCT02115282|587691831|FG001|Overall Study|Alternative therapy|1|||
162722537|NCT02115282|587691830|FG000|Overall Study|Complicating disease|0|||
162722538|NCT02115282|587691831|FG001|Overall Study|Complicating disease|3|||
162722539|NCT02115282|587691830|FG000|Overall Study|Withdrawal by Subject|12|||
162722540|NCT02115282|587691831|FG001|Overall Study|Withdrawal by Subject|10|||
162722541|NCT02115282|587691830|FG000|Overall Study|Symptomatic progression/deterioration|7|||
162722542|NCT02115282|587691831|FG001|Overall Study|Symptomatic progression/deterioration|18|||
162722543|NCT02115282|587691830|FG000|Overall Study|Non-compliance|5|||
162722544|NCT02115282|587691831|FG001|Overall Study|Non-compliance|1|||
163151755|NCT04292535|589269527|FG013|Overall Study|Equipment Failure|0|||
163151756|NCT01420861|589269528|FG000|Overall Study|Adverse Event|2|||
163151757|NCT01420861|589269528|FG000|Overall Study|Study terminated by Sponsor|7|||
163151758|NCT01420861|589269528|FG000|Overall Study|Screen failure|7|||
163151759|NCT01420861|589269528|FG000|Overall Study|Randomized not Treated|2|||
163151760|NCT03341299|589269529|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151761|NCT03341299|589269530|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151762|NCT03341299|589269531|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
163151763|NCT03341299|589269532|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
163151764|NCT04905134|589269535|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
163151765|NCT04905134|589269535|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
163151766|NCT03009058|589269536|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
163151767|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151768|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
163151769|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151770|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151771|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
163151772|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151773|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
163151774|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
162722545|NCT02115282|587691830|FG000|Overall Study|Protocol Violation|2|||
162722546|NCT02115282|587691831|FG001|Overall Study|Protocol Violation|2|||
162722547|NCT02115282|587691830|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
162722548|NCT02115282|587691831|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
162722549|NCT02115282|587691830|FG000|Overall Study|Not start protocol therapy|9|||
162722550|NCT02115282|587691831|FG001|Overall Study|Not start protocol therapy|10|||
162722551|NCT00256243|587691832|FG000|Overall Study|Lost to Follow-up|2|||
162675546|NCT02384954|587520889|FG006|Phase 2|Failure to meet continuation criteria|0|||
162675547|NCT02384954|587520890|FG007|Phase 2|Failure to meet continuation criteria|1|||
162675548|NCT02384954|587520891|FG008|Phase 2|Failure to meet continuation criteria|0|||
162675549|NCT04732286|587520892|FG000|Overall Study|Progressive Disease|2|||
162675550|NCT04732286|587520892|FG000|Overall Study|Physician Decision|1|||
162675551|NCT04732286|587520892|FG000|Overall Study|Study Terminated by Sponsor|31|||
162675552|NCT04732286|587520892|FG000|Overall Study|Withdrawal by Subject|10|||
162675553|NCT04732286|587520892|FG000|Overall Study|Non-compliance With Study Drug|1|||
162675554|NCT04732286|587520892|FG000|Overall Study|Lost to Follow-up|4|||
162675555|NCT04732286|587520892|FG000|Overall Study|Death|51|||
162675556|NCT01474681|587520896|FG000|Overall Study|Death|0|||
162675557|NCT01474681|587520897|FG001|Overall Study|Death|3|||
162675558|NCT01474681|587520898|FG002|Overall Study|Death|2|||
162675559|NCT01474681|587520899|FG003|Overall Study|Death|6|||
162675560|NCT02372396|587520905|FG000|Overall Study|Lost to Follow-up|7|||
162675561|NCT02372396|587520906|FG001|Overall Study|Lost to Follow-up|9|||
162675562|NCT01483924|587520909|FG000|Overall Study|Withdrawal by Subject|2|||
162675563|NCT01483924|587520910|FG001|Overall Study|Withdrawal by Subject|0|||
162675564|NCT01483924|587520911|FG002|Overall Study|Withdrawal by Subject|0|||
162675565|NCT01483924|587520912|FG003|Overall Study|Withdrawal by Subject|1|||
162675566|NCT01483924|587520913|FG004|Overall Study|Withdrawal by Subject|1|||
162675567|NCT01483924|587520909|FG000|Overall Study|Adverse Event|0|||
162675568|NCT01483924|587520910|FG001|Overall Study|Adverse Event|0|||
162675569|NCT01483924|587520911|FG002|Overall Study|Adverse Event|1|||
162675570|NCT01483924|587520912|FG003|Overall Study|Adverse Event|1|||
162675571|NCT01483924|587520913|FG004|Overall Study|Adverse Event|0|||
162675572|NCT01483924|587520909|FG000|Overall Study|Non-compliance|0|||
162675573|NCT01483924|587520910|FG001|Overall Study|Non-compliance|0|||
162675574|NCT01483924|587520911|FG002|Overall Study|Non-compliance|0|||
162675575|NCT01483924|587520912|FG003|Overall Study|Non-compliance|1|||
162675576|NCT01483924|587520913|FG004|Overall Study|Non-compliance|1|||
162675577|NCT01483924|587520909|FG000|Overall Study|Sponsor concern over ECG result|0|||
162675578|NCT01483924|587520910|FG001|Overall Study|Sponsor concern over ECG result|0|||
162675579|NCT01483924|587520911|FG002|Overall Study|Sponsor concern over ECG result|0|||
162675580|NCT01483924|587520912|FG003|Overall Study|Sponsor concern over ECG result|1|||
162675581|NCT01483924|587520913|FG004|Overall Study|Sponsor concern over ECG result|0|||
162675582|NCT00003298|587520914|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
162675583|NCT00003298|587520914|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
162675584|NCT00003298|587520914|FG000|Surgery|Unresectable at surgery|3|||
162675585|NCT00003298|587520914|FG000|Surgery|Progression before surgery|2|||
162675586|NCT00003298|587520914|FG000|Surgery|Unevaluable and off study|2|||
162675587|NCT00003298|587520914|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
162675588|NCT00003298|587520914|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
162675589|NCT00003298|587520914|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
162675590|NCT00003298|587520914|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
162675591|NCT00003298|587520914|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
162722552|NCT00256243|587691832|FG000|Overall Study|Death|7|||
162675592|NCT00003298|587520914|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
162675593|NCT00003298|587520914|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
162675594|NCT00003298|587520914|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
162675595|NCT00003298|587520914|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
162675596|NCT00003298|587520914|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
162675597|NCT00335322|587520918|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
162675598|NCT00335322|587520919|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
162675599|NCT00335322|587520920|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
162675600|NCT02195986|587520921|FG000|Overall Study|Adverse Event|3|||
162675601|NCT02195986|587520922|FG001|Overall Study|Adverse Event|0|||
162675602|NCT02195986|587520923|FG002|Overall Study|Adverse Event|0|||
162675603|NCT02195986|587520921|FG000|Overall Study|Withdrawal by Subject|0|||
162675604|NCT02195986|587520922|FG001|Overall Study|Withdrawal by Subject|3|||
162675605|NCT02195986|587520923|FG002|Overall Study|Withdrawal by Subject|0|||
162675606|NCT02195986|587520921|FG000|Overall Study|Family Emergency|0|||
162675607|NCT02195986|587520922|FG001|Overall Study|Family Emergency|0|||
162675608|NCT02195986|587520923|FG002|Overall Study|Family Emergency|1|||
162675609|NCT02195986|587520921|FG000|Overall Study|Protocol Violation|0|||
162675610|NCT02195986|587520922|FG001|Overall Study|Protocol Violation|1|||
162675611|NCT02195986|587520923|FG002|Overall Study|Protocol Violation|1|||
162675612|NCT02195986|587520921|FG000|Overall Study|Non-compliance|0|||
162675613|NCT02195986|587520922|FG001|Overall Study|Non-compliance|1|||
162675614|NCT02195986|587520923|FG002|Overall Study|Non-compliance|0|||
162675615|NCT02834780|587520926|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
162675616|NCT02834780|587520927|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162675617|NCT02834780|587520928|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
162675618|NCT02834780|587520929|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
162675619|NCT02834780|587520930|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
162675620|NCT02834780|587520931|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
162675621|NCT02834780|587520932|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
162675622|NCT02834780|587520933|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
162675623|NCT02834780|587520934|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162675624|NCT02834780|587520935|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
162675625|NCT02834780|587520936|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162675626|NCT02834780|587520937|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
162675627|NCT02834780|587520938|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
162675628|NCT02834780|587520926|FG000|Overall Study|Withdrawal by Subject|0|||
162675629|NCT02834780|587520927|FG001|Overall Study|Withdrawal by Subject|0|||
162675630|NCT02834780|587520928|FG002|Overall Study|Withdrawal by Subject|1|||
162675631|NCT02834780|587520929|FG003|Overall Study|Withdrawal by Subject|0|||
162675632|NCT02834780|587520930|FG004|Overall Study|Withdrawal by Subject|0|||
162675633|NCT02834780|587520931|FG005|Overall Study|Withdrawal by Subject|0|||
162675634|NCT02834780|587520932|FG006|Overall Study|Withdrawal by Subject|0|||
162675635|NCT02834780|587520933|FG007|Overall Study|Withdrawal by Subject|0|||
162675636|NCT02834780|587520934|FG008|Overall Study|Withdrawal by Subject|0|||
162675637|NCT02834780|587520935|FG009|Overall Study|Withdrawal by Subject|0|||
162675638|NCT02834780|587520936|FG010|Overall Study|Withdrawal by Subject|1|||
162675639|NCT02834780|587520937|FG011|Overall Study|Withdrawal by Subject|0|||
162675640|NCT02834780|587520938|FG012|Overall Study|Withdrawal by Subject|0|||
162675641|NCT02834780|587520926|FG000|Overall Study|Adverse Event|0|||
162675642|NCT02834780|587520927|FG001|Overall Study|Adverse Event|0|||
162675643|NCT02834780|587520928|FG002|Overall Study|Adverse Event|0|||
162675644|NCT02834780|587520929|FG003|Overall Study|Adverse Event|0|||
162722553|NCT00256243|587691832|FG000|Overall Study|Not treated|1|||
163151775|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151776|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
163151777|NCT05556265|589269537|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151778|NCT05556265|589269538|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
163151779|NCT05556265|589269539|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151780|NCT05556265|589269540|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151781|NCT05556265|589269541|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
163151782|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
163151783|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
163151784|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
163151785|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
163151786|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
163151787|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
163151788|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
163151789|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
162722554|NCT06129045|587691833|FG000|Overall Study|Lost to Follow-up|1|||
162722555|NCT06129045|587691834|FG001|Overall Study|Lost to Follow-up|1|||
162722556|NCT06129045|587691835|FG002|Overall Study|Lost to Follow-up|4|||
162722557|NCT02031471|587691836|FG000|24 Week Treatment Period|Adverse Event|6|||
162722558|NCT02031471|587691836|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
162722559|NCT02031471|587691836|FG000|24 Week Treatment Period|Protocol Violation|1|||
162722560|NCT02031471|587691836|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
162722561|NCT02031471|587691836|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
162722562|NCT02031471|587691836|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
162722563|NCT02031471|587691836|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
162722564|NCT05797155|587691843|FG000|Overall Study|Lost to Follow-up|33|||
162722565|NCT05797155|587691844|FG001|Overall Study|Lost to Follow-up|12|||
162722566|NCT00617201|587691850|FG000|Overall Study|Lost to Follow-up|9|||
162722567|NCT00617201|587691851|FG001|Overall Study|Lost to Follow-up|13|||
162722568|NCT01350804|587691852|FG000|Core Study|Withdrawal by Subject|11|||
162722569|NCT01350804|587691853|FG001|Core Study|Withdrawal by Subject|17|||
162722570|NCT01350804|587691854|FG002|Core Study|Withdrawal by Subject|16|||
162722571|NCT01350804|587691855|FG003|Core Study|Withdrawal by Subject|7|||
162722572|NCT01350804|587691852|FG000|Core Study|Study terminated by Sponsor|0|||
162722573|NCT01350804|587691853|FG001|Core Study|Study terminated by Sponsor|0|||
162722574|NCT01350804|587691854|FG002|Core Study|Study terminated by Sponsor|0|||
162722575|NCT01350804|587691855|FG003|Core Study|Study terminated by Sponsor|2|||
162675645|NCT02834780|587520930|FG004|Overall Study|Adverse Event|1|||
162675646|NCT02834780|587520931|FG005|Overall Study|Adverse Event|0|||
162675647|NCT02834780|587520932|FG006|Overall Study|Adverse Event|1|||
162675648|NCT02834780|587520933|FG007|Overall Study|Adverse Event|1|||
162675649|NCT02834780|587520934|FG008|Overall Study|Adverse Event|0|||
162675650|NCT02834780|587520935|FG009|Overall Study|Adverse Event|2|||
162675651|NCT02834780|587520936|FG010|Overall Study|Adverse Event|0|||
162675652|NCT02834780|587520937|FG011|Overall Study|Adverse Event|3|||
162675653|NCT02834780|587520938|FG012|Overall Study|Adverse Event|2|||
162675654|NCT02834780|587520926|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675655|NCT02834780|587520927|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
162675656|NCT02834780|587520928|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
162675657|NCT02834780|587520929|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675658|NCT02834780|587520930|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675659|NCT02834780|587520931|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675660|NCT02834780|587520932|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675661|NCT02834780|587520933|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
162675662|NCT02834780|587520934|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
162675663|NCT02834780|587520935|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
162675664|NCT02834780|587520936|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
162675665|NCT02834780|587520937|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
162675666|NCT02834780|587520938|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
162675667|NCT02834780|587520926|FG000|Overall Study|Other|1|||
162675668|NCT02834780|587520927|FG001|Overall Study|Other|0|||
162675669|NCT02834780|587520928|FG002|Overall Study|Other|1|||
162675670|NCT02834780|587520929|FG003|Overall Study|Other|2|||
162675671|NCT02834780|587520930|FG004|Overall Study|Other|0|||
162675672|NCT02834780|587520931|FG005|Overall Study|Other|0|||
162675673|NCT02834780|587520932|FG006|Overall Study|Other|0|||
162675674|NCT02834780|587520933|FG007|Overall Study|Other|0|||
162675675|NCT02834780|587520934|FG008|Overall Study|Other|0|||
162675676|NCT02834780|587520935|FG009|Overall Study|Other|0|||
162675677|NCT02834780|587520936|FG010|Overall Study|Other|0|||
162675678|NCT02834780|587520937|FG011|Overall Study|Other|0|||
162722576|NCT01350804|587691852|FG000|Core Study|Protocol deviation|1|||
163151790|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
163151791|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
163151792|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
163151793|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
163151794|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
163151795|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
163151796|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
163151797|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151798|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
163151799|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151800|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
163151801|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
163151802|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151803|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151804|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
163151805|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
163151806|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
163151807|NCT05556265|589269537|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151808|NCT05556265|589269538|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151809|NCT05556265|589269539|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
163151810|NCT05556265|589269540|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
163151811|NCT05556265|589269541|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
163151812|NCT01486966|589269546|FG000|Overall Study|Adverse Event|0|||
163151813|NCT01486966|589269547|FG001|Overall Study|Adverse Event|1|||
163151814|NCT01486966|589269546|FG000|Overall Study|Withdrawal by Subject|0|||
163151815|NCT01486966|589269547|FG001|Overall Study|Withdrawal by Subject|1|||
163151816|NCT03518086|589269550|FG000|Overall Study|Adverse Event|23|||
163151817|NCT03518086|589269551|FG001|Overall Study|Adverse Event|15|||
163151818|NCT03518086|589269552|FG002|Overall Study|Adverse Event|3|||
163151819|NCT03518086|589269553|FG003|Overall Study|Adverse Event|2|||
163151820|NCT03518086|589269550|FG000|Overall Study|Withdrawal by Subject|8|||
163151821|NCT03518086|589269551|FG001|Overall Study|Withdrawal by Subject|5|||
163151822|NCT03518086|589269552|FG002|Overall Study|Withdrawal by Subject|1|||
163151823|NCT03518086|589269553|FG003|Overall Study|Withdrawal by Subject|0|||
163151824|NCT03518086|589269550|FG000|Overall Study|Lack of Efficacy|5|||
163151825|NCT03518086|589269551|FG001|Overall Study|Lack of Efficacy|5|||
163151826|NCT03518086|589269552|FG002|Overall Study|Lack of Efficacy|0|||
163151827|NCT03518086|589269553|FG003|Overall Study|Lack of Efficacy|2|||
163151828|NCT03518086|589269550|FG000|Overall Study|Protocol Violation|1|||
163151829|NCT03518086|589269551|FG001|Overall Study|Protocol Violation|5|||
163151830|NCT03518086|589269552|FG002|Overall Study|Protocol Violation|1|||
163151831|NCT03518086|589269553|FG003|Overall Study|Protocol Violation|3|||
163151832|NCT03518086|589269550|FG000|Overall Study|Lost to Follow-up|0|||
163151833|NCT03518086|589269551|FG001|Overall Study|Lost to Follow-up|3|||
163151834|NCT03518086|589269552|FG002|Overall Study|Lost to Follow-up|0|||
163151835|NCT03518086|589269553|FG003|Overall Study|Lost to Follow-up|0|||
163151836|NCT03518086|589269550|FG000|Overall Study|Insufficient Diary Data|0|||
163151837|NCT03518086|589269551|FG001|Overall Study|Insufficient Diary Data|2|||
163151838|NCT03518086|589269552|FG002|Overall Study|Insufficient Diary Data|0|||
163151839|NCT03518086|589269553|FG003|Overall Study|Insufficient Diary Data|0|||
163151840|NCT03518086|589269550|FG000|Overall Study|Non- compliance to Protocol|0|||
163151841|NCT03518086|589269551|FG001|Overall Study|Non- compliance to Protocol|1|||
163151842|NCT03518086|589269552|FG002|Overall Study|Non- compliance to Protocol|0|||
163151843|NCT03518086|589269553|FG003|Overall Study|Non- compliance to Protocol|0|||
163151844|NCT03518086|589269550|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
163151845|NCT03518086|589269551|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
163151846|NCT03518086|589269552|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
163151847|NCT03518086|589269553|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
163151848|NCT03518086|589269550|FG000|Overall Study|Site Terminated by Sponsor|0|||
163151849|NCT03518086|589269551|FG001|Overall Study|Site Terminated by Sponsor|1|||
163151850|NCT03518086|589269552|FG002|Overall Study|Site Terminated by Sponsor|0|||
163151851|NCT03518086|589269553|FG003|Overall Study|Site Terminated by Sponsor|0|||
163151852|NCT03518086|589269550|FG000|Overall Study|Pregnancy|0|||
163151853|NCT03518086|589269551|FG001|Overall Study|Pregnancy|0|||
163151854|NCT03518086|589269552|FG002|Overall Study|Pregnancy|0|||
163151855|NCT03518086|589269553|FG003|Overall Study|Pregnancy|2|||
163151856|NCT02336282|589269554|FG000|Overall Study|Unrelated illness|1|||
163151857|NCT02336282|589269554|FG000|Overall Study|Uncomfortable with technology|1|||
163151858|NCT02336282|589269554|FG000|Overall Study|Lost to Follow-up|1|||
163151859|NCT02336282|589269554|FG000|Overall Study|Not enough time to complete sessions|2|||
162722577|NCT01350804|587691853|FG001|Core Study|Protocol deviation|0|||
162722578|NCT01350804|587691854|FG002|Core Study|Protocol deviation|1|||
162722579|NCT01350804|587691855|FG003|Core Study|Protocol deviation|0|||
162675679|NCT02834780|587520938|FG012|Overall Study|Other|1|||
162675680|NCT03150056|587520939|FG000|Overall Study|Withdrawal by Subject|0|||
162675681|NCT03150056|587520940|FG001|Overall Study|Withdrawal by Subject|0|||
162675682|NCT03150056|587520941|FG002|Overall Study|Withdrawal by Subject|0|||
162675683|NCT03150056|587520942|FG003|Overall Study|Withdrawal by Subject|0|||
162675684|NCT03150056|587520943|FG004|Overall Study|Withdrawal by Subject|0|||
162675685|NCT03150056|587520944|FG005|Overall Study|Withdrawal by Subject|2|||
162675686|NCT03150056|587520939|FG000|Overall Study|Study terminated by Sponsor|1|||
162675687|NCT03150056|587520940|FG001|Overall Study|Study terminated by Sponsor|3|||
162722580|NCT01350804|587691852|FG000|Core Study|Physician Decision|1|||
162675688|NCT03150056|587520941|FG002|Overall Study|Study terminated by Sponsor|1|||
162675689|NCT03150056|587520942|FG003|Overall Study|Study terminated by Sponsor|1|||
162675690|NCT03150056|587520943|FG004|Overall Study|Study terminated by Sponsor|5|||
162675691|NCT03150056|587520944|FG005|Overall Study|Study terminated by Sponsor|6|||
162675692|NCT03150056|587520939|FG000|Overall Study|Death|9|||
162675693|NCT03150056|587520940|FG001|Overall Study|Death|2|||
162675694|NCT03150056|587520941|FG002|Overall Study|Death|2|||
162675695|NCT03150056|587520942|FG003|Overall Study|Death|7|||
162675696|NCT03150056|587520943|FG004|Overall Study|Death|8|||
162675697|NCT03150056|587520944|FG005|Overall Study|Death|10|||
162675698|NCT02270450|587520949|FG000|Overall Study|Refusal unrelated to adverse event|3|||
162675699|NCT02270450|587520950|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162675700|NCT02270450|587520951|FG002|Overall Study|Refusal unrelated to adverse event|5|||
162675701|NCT02270450|587520952|FG003|Overall Study|Refusal unrelated to adverse event|14|||
162675702|NCT02270450|587520949|FG000|Overall Study|Progression/relapse|1|||
162675703|NCT02270450|587520950|FG001|Overall Study|Progression/relapse|2|||
162675704|NCT02270450|587520951|FG002|Overall Study|Progression/relapse|4|||
162675705|NCT02270450|587520952|FG003|Overall Study|Progression/relapse|9|||
162675706|NCT02270450|587520949|FG000|Overall Study|Death|19|||
162675707|NCT02270450|587520950|FG001|Overall Study|Death|19|||
162675708|NCT02270450|587520951|FG002|Overall Study|Death|31|||
162675709|NCT02270450|587520952|FG003|Overall Study|Death|59|||
162675710|NCT02363738|587520953|FG000|Overall Study|Adverse Event|5|||
162675711|NCT02363738|587520954|FG001|Overall Study|Adverse Event|2|||
162675712|NCT02363738|587520953|FG000|Overall Study|Lack of Efficacy|1|||
162675713|NCT02363738|587520954|FG001|Overall Study|Lack of Efficacy|2|||
162675714|NCT02363738|587520953|FG000|Overall Study|Lost to Follow-up|2|||
162675715|NCT02363738|587520954|FG001|Overall Study|Lost to Follow-up|1|||
162675716|NCT02081846|587520959|FG000|Overall Study|Withdrawal by Subject|1|||
162675717|NCT02081846|587520960|FG001|Overall Study|Withdrawal by Subject|0|||
162675718|NCT02081846|587520959|FG000|Overall Study|invalid consent|1|||
162675719|NCT02081846|587520960|FG001|Overall Study|invalid consent|0|||
162675720|NCT03265600|587520961|FG000|Overall Study|Lost to Follow-up|17|||
162675721|NCT03265600|587520962|FG001|Overall Study|Lost to Follow-up|5|||
162675722|NCT03265600|587520961|FG000|Overall Study|Withdrawal by Subject|4|||
162675723|NCT03265600|587520962|FG001|Overall Study|Withdrawal by Subject|2|||
162675724|NCT03265600|587520961|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
162675725|NCT03265600|587520962|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
162675726|NCT00535730|587520963|FG000|Overall Study|Adverse Event|1|||
162675727|NCT00535730|587520964|FG001|Overall Study|Adverse Event|1|||
162675728|NCT00535730|587520963|FG000|Overall Study|Lost to Follow-up|0|||
162675729|NCT00535730|587520964|FG001|Overall Study|Lost to Follow-up|1|||
162675730|NCT00535730|587520963|FG000|Overall Study|Physician Decision|0|||
162675731|NCT00535730|587520964|FG001|Overall Study|Physician Decision|1|||
162675732|NCT00535730|587520963|FG000|Overall Study|Protocol Violation|1|||
162675733|NCT00535730|587520964|FG001|Overall Study|Protocol Violation|0|||
162675734|NCT00535730|587520963|FG000|Overall Study|Withdrawal by Subject|0|||
162675735|NCT00535730|587520964|FG001|Overall Study|Withdrawal by Subject|4|||
162675736|NCT00936858|587520965|FG000|Overall Study|Death|3|||
162675737|NCT00936858|587520965|FG000|Overall Study|Progression|29|||
162675738|NCT00936858|587520965|FG000|Overall Study|Withdrawal by Subject|5|||
162675739|NCT00936858|587520965|FG000|Overall Study|Adverse Event|1|||
162675740|NCT00936858|587520965|FG000|Overall Study|Physician Decision|7|||
162675741|NCT00936858|587520965|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
162675742|NCT00936858|587520965|FG000|Overall Study|Lost to Follow-up|1|||
162675743|NCT02372409|587520969|FG000|Overall Study|Lost to Follow-up|1|||
162675744|NCT02372409|587520970|FG001|Overall Study|Lost to Follow-up|0|||
162675745|NCT02372409|587520969|FG000|Overall Study|Disease progression|1|||
162675746|NCT02372409|587520970|FG001|Overall Study|Disease progression|1|||
162675747|NCT01808313|587520973|FG000|Overall Study|Adverse Event|5|||
163151860|NCT04163341|589269556|FG000|Overall Study|Withdrawal by Subject|2|||
163151861|NCT04163341|589269557|FG001|Overall Study|Withdrawal by Subject|0|||
163151862|NCT04163341|589269556|FG000|Overall Study|Lost to Follow-up|3|||
163151863|NCT04163341|589269557|FG001|Overall Study|Lost to Follow-up|4|||
163151864|NCT00303069|589271325|FG000|Overall Study|Lost to Follow-up|1|||
163151865|NCT00303069|589271326|FG001|Overall Study|Lost to Follow-up|0|||
163151866|NCT00303069|589271327|FG002|Overall Study|Lost to Follow-up|0|||
163151867|NCT00303069|589271328|FG003|Overall Study|Lost to Follow-up|2|||
163151868|NCT00303069|589271325|FG000|Overall Study|subject moved|1|||
163151869|NCT00303069|589271326|FG001|Overall Study|subject moved|0|||
163151870|NCT00303069|589271327|FG002|Overall Study|subject moved|0|||
163151871|NCT00303069|589271328|FG003|Overall Study|subject moved|0|||
163151872|NCT00303069|589271325|FG000|Overall Study|Recruitment into Army Reserves|0|||
163151873|NCT00303069|589271326|FG001|Overall Study|Recruitment into Army Reserves|0|||
163151874|NCT00303069|589271327|FG002|Overall Study|Recruitment into Army Reserves|1|||
163151875|NCT00303069|589271328|FG003|Overall Study|Recruitment into Army Reserves|0|||
163151876|NCT00092417|589271329|FG000|Overall Study|Lost to Follow-up|2|||
163151877|NCT00092417|589271330|FG001|Overall Study|Lost to Follow-up|0|||
163151878|NCT00092417|589271329|FG000|Overall Study|Withdrawal by Subject|2|||
163151879|NCT00092417|589271330|FG001|Overall Study|Withdrawal by Subject|1|||
163151880|NCT00092417|589271329|FG000|Overall Study|Other|1|||
163151881|NCT00092417|589271330|FG001|Overall Study|Other|0|||
163151882|NCT01084655|589271333|FG000|Overall Study|Radiographic disease progression|3|||
163151883|NCT01084655|589271334|FG001|Overall Study|Radiographic disease progression|2|||
163151884|NCT01084655|589271335|FG002|Overall Study|Radiographic disease progression|8|||
163151885|NCT01084655|589271333|FG000|Overall Study|Withdrawal by Subject|1|||
163151886|NCT01084655|589271334|FG001|Overall Study|Withdrawal by Subject|0|||
163151887|NCT01084655|589271335|FG002|Overall Study|Withdrawal by Subject|4|||
163151888|NCT01084655|589271333|FG000|Overall Study|Adverse Event|2|||
163151889|NCT01084655|589271334|FG001|Overall Study|Adverse Event|1|||
163151890|NCT01084655|589271335|FG002|Overall Study|Adverse Event|2|||
163151891|NCT01084655|589271333|FG000|Overall Study|Other|0|||
163151892|NCT01084655|589271334|FG001|Overall Study|Other|3|||
163151893|NCT01084655|589271335|FG002|Overall Study|Other|2|||
163151894|NCT01084655|589271333|FG000|Overall Study|Symptomatic deterioration|0|||
163151895|NCT01084655|589271334|FG001|Overall Study|Symptomatic deterioration|0|||
163151896|NCT01084655|589271335|FG002|Overall Study|Symptomatic deterioration|2|||
163151897|NCT01084655|589271333|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
163151898|NCT01084655|589271334|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
163151899|NCT01084655|589271335|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
163151900|NCT03182374|589271342|FG000|Overall Study|Lost to Follow-up|3|||
163151901|NCT03182374|589271343|FG001|Overall Study|Lost to Follow-up|2|||
163151902|NCT03182374|589271342|FG000|Overall Study|Lack of Efficacy|8|||
163151903|NCT03182374|589271343|FG001|Overall Study|Lack of Efficacy|14|||
163151904|NCT03182374|589271342|FG000|Overall Study|Withdrawal by Subject|1|||
163151905|NCT03182374|589271343|FG001|Overall Study|Withdrawal by Subject|1|||
163151906|NCT03182374|589271342|FG000|Overall Study|exit for non-compliance|1|||
163151907|NCT03182374|589271343|FG001|Overall Study|exit for non-compliance|1|||
163151908|NCT03182374|589271342|FG000|Overall Study|one subject was randomized but not treated|1|||
163151909|NCT03182374|589271343|FG001|Overall Study|one subject was randomized but not treated|0|||
163151910|NCT03182374|589271342|FG000|Overall Study|Other reasons|0|||
163151911|NCT03182374|589271343|FG001|Overall Study|Other reasons|3|||
163151912|NCT01462370|589271344|FG000|Overall Study|Lack of Qualifying Event|1|||
163151913|NCT01462370|589271345|FG001|Overall Study|Lack of Qualifying Event|1|||
163151914|NCT01462370|589271344|FG000|Overall Study|Physician Decision|0|||
162675748|NCT01808313|587520973|FG000|Overall Study|Protocol Violation|2|||
162675749|NCT01808313|587520973|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162675750|NCT01808313|587520973|FG000|Overall Study|Lost to Follow-up|1|||
162675751|NCT01808313|587520973|FG000|Overall Study|Physician Decision|1|||
162675752|NCT03086447|587520983|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162675753|NCT03086447|587520984|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
162675754|NCT03086447|587520983|FG000|Overall Study|Lost Lens|2|||
162675755|NCT03086447|587520984|FG001|Overall Study|Lost Lens|5|||
162675756|NCT03086447|587520983|FG000|Overall Study|Product quality complaint|0|||
163151915|NCT01462370|589271345|FG001|Overall Study|Physician Decision|1|||
163151916|NCT01462370|589271344|FG000|Overall Study|Withdrawal by Subject|0|||
163151917|NCT01462370|589271345|FG001|Overall Study|Withdrawal by Subject|3|||
163151918|NCT00473564|589271348|FG000|Overall Study|robot surgery aborted in OR|23|||
163151919|NCT00914316|589271351|FG000|Phase 1|Physician Decision|4|||
163151920|NCT00914316|589271352|FG001|Phase 1|Physician Decision|0|||
163151921|NCT00914316|589271353|FG002|Phase 1|Physician Decision|1|||
163151922|NCT00914316|589271354|FG003|Phase 1|Physician Decision|2|||
163151923|NCT00914316|589271351|FG000|Phase 1|Withdrawal by Subject|0|||
163151924|NCT00914316|589271352|FG001|Phase 1|Withdrawal by Subject|2|||
163151925|NCT00914316|589271353|FG002|Phase 1|Withdrawal by Subject|4|||
163151926|NCT00914316|589271354|FG003|Phase 1|Withdrawal by Subject|0|||
163151927|NCT00914316|589271351|FG000|Phase 1|Adverse Event|1|||
163151928|NCT00914316|589271352|FG001|Phase 1|Adverse Event|0|||
163151929|NCT00914316|589271353|FG002|Phase 1|Adverse Event|0|||
163151930|NCT00914316|589271354|FG003|Phase 1|Adverse Event|0|||
163151931|NCT00914316|589271351|FG000|Phase 2|Withdrawal by Subject|1|||
163151932|NCT00914316|589271352|FG001|Phase 2|Withdrawal by Subject|0|||
162722581|NCT01350804|587691853|FG001|Core Study|Physician Decision|0|||
162675757|NCT03086447|587520984|FG001|Overall Study|Product quality complaint|1|||
162675758|NCT03086447|587520983|FG000|Overall Study|Lens Damage|1|||
162675759|NCT03086447|587520984|FG001|Overall Study|Lens Damage|6|||
162675760|NCT03086447|587520983|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162722582|NCT01350804|587691854|FG002|Core Study|Physician Decision|1|||
162722583|NCT01350804|587691855|FG003|Core Study|Physician Decision|3|||
162722584|NCT01350804|587691852|FG000|Core Study|Lost to Follow-up|3|||
162722585|NCT01350804|587691853|FG001|Core Study|Lost to Follow-up|0|||
162722586|NCT01350804|587691854|FG002|Core Study|Lost to Follow-up|2|||
162722587|NCT01350804|587691855|FG003|Core Study|Lost to Follow-up|1|||
162722588|NCT01350804|587691852|FG000|Core Study|Lack of Efficacy|16|||
162722589|NCT01350804|587691853|FG001|Core Study|Lack of Efficacy|19|||
162722590|NCT01350804|587691854|FG002|Core Study|Lack of Efficacy|18|||
162722591|NCT01350804|587691855|FG003|Core Study|Lack of Efficacy|5|||
162722592|NCT01350804|587691852|FG000|Core Study|Death|1|||
162722593|NCT01350804|587691853|FG001|Core Study|Death|1|||
162722594|NCT01350804|587691854|FG002|Core Study|Death|1|||
162722595|NCT01350804|587691855|FG003|Core Study|Death|0|||
162722596|NCT01350804|587691852|FG000|Core Study|Adverse Event|8|||
162722597|NCT01350804|587691853|FG001|Core Study|Adverse Event|10|||
162722598|NCT01350804|587691854|FG002|Core Study|Adverse Event|8|||
162722599|NCT01350804|587691855|FG003|Core Study|Adverse Event|8|||
162722600|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
162722601|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
162722602|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
162722603|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
162722604|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
162722605|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
163151933|NCT00914316|589271353|FG002|Phase 2|Withdrawal by Subject|1|||
163151934|NCT00914316|589271354|FG003|Phase 2|Withdrawal by Subject|0|||
163151935|NCT02177123|589271355|FG000|Overall Study|Lost to Follow-up|6|||
163151936|NCT02177123|589271355|FG000|Overall Study|Withdrawal by Subject|4|||
163151937|NCT02177123|589271355|FG000|Overall Study|Adverse Event|4|||
163151938|NCT02177123|589271355|FG000|Overall Study|Physician Decision|3|||
163151939|NCT02177123|589271355|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
162722606|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
162722607|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
162722608|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
162722609|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
162722610|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
162722611|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
162722612|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162722613|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
162722614|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162722615|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162722616|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
162722617|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
162722618|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
162722619|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
162722620|NCT01350804|587691852|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
162722621|NCT01350804|587691853|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
162722622|NCT01350804|587691854|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
162722623|NCT01350804|587691855|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
162722624|NCT01170026|587692553|FG000|Overall Study|Lost to Follow-up|4|||
162722625|NCT01170026|587692554|FG001|Overall Study|Lost to Follow-up|2|||
162722626|NCT03889925|587692555|FG000|Overall Study|Lost to Follow-up|11|||
162722627|NCT03889925|587692556|FG001|Overall Study|Lost to Follow-up|10|||
162722628|NCT05777785|587692557|FG000|Overall Study|Withdrawal by Subject|5|||
162722629|NCT05777785|587692557|FG000|Overall Study|Lost to Follow-up|1|||
162722630|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
162722631|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
162722632|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
162722633|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
162722634|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
162722635|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
162722636|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
162722637|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
162722638|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
162722639|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
162722640|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
162722641|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
162722642|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
162722643|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
163151940|NCT02177123|589271355|FG000|Overall Study|Excluded for medical reasons|2|||
163151941|NCT02177123|589271355|FG000|Overall Study|Death|1|||
163151942|NCT02177123|589271355|FG000|Overall Study|Other|1|||
162675761|NCT03086447|587520984|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162675762|NCT03086447|587520983|FG000|Overall Study|Test Article No Longer Available|1|||
162675763|NCT03086447|587520984|FG001|Overall Study|Test Article No Longer Available|0|||
162675764|NCT03086447|587520983|FG000|Overall Study|Protocol Violation|2|||
162722644|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
162722645|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
162722646|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
162722647|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
162722648|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
162722649|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
162722650|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
162722651|NCT00304031|587692558|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
162722652|NCT00304031|587692559|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
162722653|NCT00304031|587692560|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
162722654|NCT00304031|587692558|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
162722655|NCT00304031|587692559|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
162722656|NCT00304031|587692560|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
162722657|NCT00089544|587692561|FG000|Overall Study|Ineligible|1|||
162722658|NCT00089544|587692562|FG001|Overall Study|Ineligible|0|||
162722659|NCT01823536|587692563|FG000|Overall Study|Lost to Follow-up|1|||
162722660|NCT01823536|587692564|FG001|Overall Study|Lost to Follow-up|0|||
162722661|NCT01823536|587692565|FG002|Overall Study|Lost to Follow-up|0|||
162722662|NCT01823536|587692566|FG003|Overall Study|Lost to Follow-up|1|||
162722663|NCT01823536|587692567|FG004|Overall Study|Lost to Follow-up|1|||
162722664|NCT01823536|587692568|FG005|Overall Study|Lost to Follow-up|0|||
162722665|NCT01823536|587692563|FG000|Overall Study|Protocol Violation|0|||
162722666|NCT01823536|587692564|FG001|Overall Study|Protocol Violation|1|||
162722667|NCT01823536|587692565|FG002|Overall Study|Protocol Violation|0|||
162722668|NCT01823536|587692566|FG003|Overall Study|Protocol Violation|0|||
162722669|NCT01823536|587692567|FG004|Overall Study|Protocol Violation|0|||
162722670|NCT01823536|587692568|FG005|Overall Study|Protocol Violation|0|||
162722671|NCT01823536|587692563|FG000|Overall Study|Withdrawal by Subject|1|||
162722672|NCT01823536|587692564|FG001|Overall Study|Withdrawal by Subject|1|||
162722673|NCT01823536|587692565|FG002|Overall Study|Withdrawal by Subject|0|||
162722674|NCT01823536|587692566|FG003|Overall Study|Withdrawal by Subject|0|||
162722675|NCT01823536|587692567|FG004|Overall Study|Withdrawal by Subject|0|||
162722676|NCT01823536|587692568|FG005|Overall Study|Withdrawal by Subject|0|||
162722677|NCT01823536|587692563|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162722678|NCT01823536|587692564|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162722679|NCT01823536|587692565|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
162722680|NCT01823536|587692566|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162722681|NCT01823536|587692567|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162722682|NCT01823536|587692568|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162722683|NCT01823536|587692563|FG000|Overall Study|Met exclusion criterion No 6|0|||
162722684|NCT01823536|587692564|FG001|Overall Study|Met exclusion criterion No 6|0|||
162675765|NCT03086447|587520984|FG001|Overall Study|Protocol Violation|4|||
162675766|NCT03086447|587520983|FG000|Overall Study|Lost to Follow-up|0|||
162675767|NCT03086447|587520984|FG001|Overall Study|Lost to Follow-up|1|||
162675768|NCT03086447|587520983|FG000|Overall Study|Adverse Event|3|||
162675769|NCT03086447|587520984|FG001|Overall Study|Adverse Event|0|||
162675770|NCT03086447|587520983|FG000|Overall Study|Lens Discomfort|2|||
162675771|NCT03086447|587520984|FG001|Overall Study|Lens Discomfort|1|||
162675772|NCT00435370|587520988|FG000|Overall Study|Adverse Event|8|||
162675773|NCT00435370|587520989|FG001|Overall Study|Adverse Event|8|||
162722685|NCT01823536|587692565|FG002|Overall Study|Met exclusion criterion No 6|0|||
162722686|NCT01823536|587692566|FG003|Overall Study|Met exclusion criterion No 6|1|||
162722687|NCT01823536|587692567|FG004|Overall Study|Met exclusion criterion No 6|0|||
162722688|NCT01823536|587692568|FG005|Overall Study|Met exclusion criterion No 6|0|||
162722689|NCT01823536|587692563|FG000|Overall Study|Subject moved out of the state|0|||
162722690|NCT01823536|587692564|FG001|Overall Study|Subject moved out of the state|0|||
162675774|NCT00435370|587520988|FG000|Overall Study|Withdrawal by Subject|10|||
162675775|NCT00435370|587520989|FG001|Overall Study|Withdrawal by Subject|10|||
162675776|NCT00435370|587520988|FG000|Overall Study|Antipsychotic medication changed|4|||
162675777|NCT00435370|587520989|FG001|Overall Study|Antipsychotic medication changed|2|||
162675778|NCT02132611|587520990|FG000|Overall Study|Death|2|||
162675779|NCT01965834|587520991|FG000|Overall Study|Lack of Efficacy|4|||
162675780|NCT03674177|587520995|FG000|Overall Study|Lost to Follow-up|2|||
162675781|NCT03674177|587520996|FG001|Overall Study|Lost to Follow-up|1|||
162675782|NCT03674177|587520997|FG002|Overall Study|Lost to Follow-up|0|||
162675783|NCT03674177|587520998|FG003|Overall Study|Lost to Follow-up|2|||
162675784|NCT03387852|587520999|FG000|Overall Study|Adverse event (AE)|3|||
162722691|NCT01823536|587692565|FG002|Overall Study|Subject moved out of the state|0|||
162675785|NCT03387852|587521000|FG001|Overall Study|Adverse event (AE)|0|||
162675786|NCT03387852|587521001|FG002|Overall Study|Adverse event (AE)|2|||
162675787|NCT03387852|587521002|FG003|Overall Study|Adverse event (AE)|0|||
162675788|NCT03387852|587520999|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
162675789|NCT03387852|587521000|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
162675790|NCT03387852|587521001|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
162675791|NCT03387852|587521002|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
162675792|NCT03387852|587520999|FG000|Overall Study|Withdrawal by participant|1|||
162675793|NCT03387852|587521000|FG001|Overall Study|Withdrawal by participant|1|||
162675794|NCT03387852|587521001|FG002|Overall Study|Withdrawal by participant|3|||
162675795|NCT03387852|587521002|FG003|Overall Study|Withdrawal by participant|2|||
162675796|NCT03387852|587520999|FG000|Overall Study|Other- Unspecified|1|||
162675797|NCT03387852|587521000|FG001|Overall Study|Other- Unspecified|1|||
162675798|NCT03387852|587521001|FG002|Overall Study|Other- Unspecified|2|||
162675799|NCT03387852|587521002|FG003|Overall Study|Other- Unspecified|1|||
162675800|NCT03387852|587520999|FG000|Overall Study|Poor compliance to protocol|0|||
162675801|NCT03387852|587521000|FG001|Overall Study|Poor compliance to protocol|0|||
162675802|NCT03387852|587521001|FG002|Overall Study|Poor compliance to protocol|0|||
162675803|NCT03387852|587521002|FG003|Overall Study|Poor compliance to protocol|1|||
162675804|NCT03387852|587520999|FG000|Overall Study|Randomized and not treated|0|||
162675805|NCT03387852|587521000|FG001|Overall Study|Randomized and not treated|0|||
162675806|NCT03387852|587521001|FG002|Overall Study|Randomized and not treated|0|||
162675807|NCT03387852|587521002|FG003|Overall Study|Randomized and not treated|1|||
162675808|NCT02493127|587521003|FG000|Overall Study|Lost to Follow-up|1|||
162675809|NCT02493127|587521004|FG001|Overall Study|Lost to Follow-up|1|||
162675810|NCT00253864|587521005|FG000|Overall Study|Lost to Follow-up|5|||
162675811|NCT00253864|587521006|FG001|Overall Study|Lost to Follow-up|8|||
162722692|NCT01823536|587692566|FG003|Overall Study|Subject moved out of the state|0|||
162722693|NCT01823536|587692567|FG004|Overall Study|Subject moved out of the state|1|||
162722694|NCT01823536|587692568|FG005|Overall Study|Subject moved out of the state|0|||
162722695|NCT00566735|587692572|FG000|Overall Study|Withdrawal by Subject|0|||
163151943|NCT02177123|589271355|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
163151944|NCT01391546|589271356|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
163151945|NCT01391546|589271357|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
163151946|NCT06271993|589271358|FG000|Overall Study|Not reactive to histamine|5|||
163151947|NCT06271993|589271359|FG001|Overall Study|Not reactive to histamine|5|||
163151948|NCT06271993|589271360|FG002|Overall Study|Not reactive to histamine|5|||
163151949|NCT01980017|589271365|FG000|Overall Study|Lost to Follow-up|30|||
163151950|NCT01980017|589271366|FG001|Overall Study|Lost to Follow-up|21|||
163151951|NCT01980017|589271365|FG000|Overall Study|Death|0|||
163151952|NCT01980017|589271366|FG001|Overall Study|Death|1|||
163151953|NCT01435382|589271369|FG000|Overall Study|Lost to Follow-up|1|||
163151954|NCT01435382|589271370|FG001|Overall Study|Lost to Follow-up|0|||
163151955|NCT01435382|589271371|FG002|Overall Study|Lost to Follow-up|1|||
163151956|NCT01435382|589271372|FG003|Overall Study|Lost to Follow-up|0|||
163151957|NCT01435382|589271369|FG000|Overall Study|Withdrawal by Subject|0|||
163151958|NCT01435382|589271370|FG001|Overall Study|Withdrawal by Subject|2|||
163151959|NCT01435382|589271371|FG002|Overall Study|Withdrawal by Subject|0|||
163151960|NCT01435382|589271372|FG003|Overall Study|Withdrawal by Subject|1|||
163151961|NCT00910650|589271373|FG000|Overall Study|Death|2|||
163151962|NCT00260533|589271374|FG000|Overall Study|Other|3|||
163151963|NCT00260533|589271375|FG001|Overall Study|Other|3|||
163151964|NCT01761877|589271378|FG000|Overall Study|Adverse Event|7|||
163151965|NCT01761877|589271379|FG001|Overall Study|Adverse Event|0|||
163151966|NCT01761877|589271378|FG000|Overall Study|Withdrawal by Subject|6|||
163151967|NCT01761877|589271379|FG001|Overall Study|Withdrawal by Subject|4|||
163151968|NCT01761877|589271378|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
163151969|NCT01761877|589271379|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
163151970|NCT01761877|589271378|FG000|Overall Study|Death|0|||
163151971|NCT01761877|589271379|FG001|Overall Study|Death|1|||
163151972|NCT01761877|589271378|FG000|Overall Study|MRI intolerant|1|||
163151973|NCT01761877|589271379|FG001|Overall Study|MRI intolerant|6|||
163151974|NCT01310777|589271381|FG000|Overall Study|Adverse Event|23|||
163151975|NCT01310777|589271382|FG001|Overall Study|Adverse Event|1|||
163151976|NCT01310777|589271383|FG002|Overall Study|Adverse Event|15|||
163151977|NCT01310777|589271381|FG000|Overall Study|Lost to Follow-up|0|||
163151978|NCT01310777|589271382|FG001|Overall Study|Lost to Follow-up|4|||
163151979|NCT01310777|589271383|FG002|Overall Study|Lost to Follow-up|1|||
163151980|NCT01310777|589271381|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
163151981|NCT01310777|589271382|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
163151982|NCT01310777|589271383|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
163151983|NCT01310777|589271381|FG000|Overall Study|Inadequate Control of IOP|5|||
163151984|NCT01310777|589271382|FG001|Overall Study|Inadequate Control of IOP|7|||
163151985|NCT01310777|589271383|FG002|Overall Study|Inadequate Control of IOP|10|||
163151986|NCT01310777|589271381|FG000|Overall Study|Other|4|||
163151987|NCT01310777|589271382|FG001|Overall Study|Other|1|||
163151988|NCT01310777|589271383|FG002|Overall Study|Other|2|||
163151989|NCT03962491|589271384|FG000|Overall Study|Lost to Follow-up|4|||
163151990|NCT03962491|589271385|FG001|Overall Study|Lost to Follow-up|5|||
163151991|NCT03697252|589271392|FG000|Overall Study|Adverse Event|3|||
163151992|NCT03697252|589271393|FG001|Overall Study|Adverse Event|2|||
163151993|NCT03697252|589271392|FG000|Overall Study|Withdrawal by Subject|14|||
163151994|NCT03697252|589271393|FG001|Overall Study|Withdrawal by Subject|14|||
163151995|NCT03697252|589271392|FG000|Overall Study|Lost to Follow-up|0|||
163151996|NCT03697252|589271393|FG001|Overall Study|Lost to Follow-up|1|||
163151997|NCT03697252|589271392|FG000|Overall Study|Physician Decision|1|||
163151998|NCT03697252|589271393|FG001|Overall Study|Physician Decision|1|||
163151999|NCT03697252|589271392|FG000|Overall Study|Other|0|||
163152000|NCT03697252|589271393|FG001|Overall Study|Other|1|||
163152001|NCT00106704|589271394|FG000|Overall Study|Adverse Event|10|||
163152002|NCT00106704|589271395|FG001|Overall Study|Adverse Event|7|||
163152003|NCT00106704|589271394|FG000|Overall Study|Death|2|||
163152004|NCT00106704|589271395|FG001|Overall Study|Death|1|||
163152005|NCT00106704|589271394|FG000|Overall Study|Lack of Efficacy|67|||
163152006|NCT00106704|589271395|FG001|Overall Study|Lack of Efficacy|69|||
163152007|NCT00106704|589271394|FG000|Overall Study|Lost to Follow-up|7|||
163152008|NCT00106704|589271395|FG001|Overall Study|Lost to Follow-up|3|||
163152009|NCT00106704|589271394|FG000|Overall Study|Pregnancy|1|||
163152010|NCT00106704|589271395|FG001|Overall Study|Pregnancy|0|||
163152011|NCT00106704|589271394|FG000|Overall Study|Protocol Violation|4|||
163152012|NCT00106704|589271395|FG001|Overall Study|Protocol Violation|7|||
163152013|NCT00106704|589271394|FG000|Overall Study|Withdrawal by Subject|14|||
163152014|NCT00106704|589271395|FG001|Overall Study|Withdrawal by Subject|21|||
163152015|NCT00106704|589271394|FG000|Overall Study|Patient moved|1|||
163152016|NCT00106704|589271395|FG001|Overall Study|Patient moved|0|||
163152017|NCT00106704|589271394|FG000|Overall Study|Site terminated|0|||
163152018|NCT00106704|589271395|FG001|Overall Study|Site terminated|1|||
163152019|NCT00106704|589271394|FG000|Overall Study|Planned major surgery|1|||
163152020|NCT00106704|589271395|FG001|Overall Study|Planned major surgery|0|||
163152021|NCT00106704|589271394|FG000|Overall Study|Patient Received Glycemic Medication|22|||
163152022|NCT00106704|589271395|FG001|Overall Study|Patient Received Glycemic Medication|41|||
163152023|NCT00106704|589271394|FG000|Overall Study|Unable to re-enter US|1|||
163152024|NCT00106704|589271395|FG001|Overall Study|Unable to re-enter US|0|||
163152025|NCT00106704|589271394|FG000|Overall Study|Laboratory test|1|||
163152026|NCT00106704|589271395|FG001|Overall Study|Laboratory test|1|||
163152027|NCT01780506|589271396|FG000|Double-Blind Phase|Randomized but not Treated|3|||
163152028|NCT01780506|589271397|FG001|Double-Blind Phase|Randomized but not Treated|2|||
163152029|NCT01780506|589271396|FG000|Double-Blind Phase|Adverse Event|4|||
163152030|NCT01780506|589271397|FG001|Double-Blind Phase|Adverse Event|14|||
163152031|NCT01780506|589271396|FG000|Double-Blind Phase|Death|1|||
162675812|NCT00744653|587521007|FG000|Overall Study|antineoplastic treatment|11|||
162675813|NCT00744653|587521007|FG000|Overall Study|Death|1|||
162675814|NCT00744653|587521007|FG000|Overall Study|Lost to Follow-up|1|||
162675815|NCT00744653|587521007|FG000|Overall Study|Physician Decision|3|||
162675816|NCT03826667|587521008|FG000|Overall Study|Protocol deviation|21|||
163152032|NCT01780506|589271397|FG001|Double-Blind Phase|Death|2|||
163152033|NCT01780506|589271396|FG000|Double-Blind Phase|Pregnancy|2|||
163152034|NCT01780506|589271397|FG001|Double-Blind Phase|Pregnancy|1|||
163152035|NCT01780506|589271396|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163152036|NCT01780506|589271397|FG001|Double-Blind Phase|Lack of Efficacy|1|||
163152037|NCT01780506|589271396|FG000|Double-Blind Phase|Investigator's Discretion|5|||
163152038|NCT01780506|589271397|FG001|Double-Blind Phase|Investigator's Discretion|2|||
163152039|NCT01780506|589271396|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
163152040|NCT01780506|589271397|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
163152041|NCT01780506|589271396|FG000|Double-Blind Phase|Protocol Violation|4|||
163152042|NCT01780506|589271397|FG001|Double-Blind Phase|Protocol Violation|3|||
163152043|NCT01780506|589271396|FG000|Double-Blind Phase|Withdrew Consent|23|||
163152044|NCT01780506|589271397|FG001|Double-Blind Phase|Withdrew Consent|24|||
163152045|NCT01780506|589271396|FG000|Double-Blind Phase|Lost to Follow-up|23|||
163152046|NCT01780506|589271397|FG001|Double-Blind Phase|Lost to Follow-up|26|||
163152047|NCT01780506|589271396|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
163152048|NCT01780506|589271397|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
163152049|NCT01867671|589271401|FG000|Overall Study|Adverse Event|5|||
163152050|NCT01867671|589271402|FG001|Overall Study|Adverse Event|3|||
163152051|NCT01867671|589271401|FG000|Overall Study|Anaphylaxis|0|||
163152052|NCT01867671|589271402|FG001|Overall Study|Anaphylaxis|1|||
163152053|NCT01867671|589271401|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
163152054|NCT01867671|589271402|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
163152055|NCT01867671|589271401|FG000|Overall Study|Lost to Follow-up|0|||
163152056|NCT01867671|589271402|FG001|Overall Study|Lost to Follow-up|1|||
163152057|NCT01867671|589271401|FG000|Overall Study|Non-compliance with Study Drug|1|||
163152058|NCT01867671|589271402|FG001|Overall Study|Non-compliance with Study Drug|2|||
163152059|NCT01867671|589271401|FG000|Overall Study|Withdrawal by Subject|21|||
163152060|NCT01867671|589271402|FG001|Overall Study|Withdrawal by Subject|21|||
163152061|NCT04852302|589271403|FG000|Overall Study|Withdrawal by Subject|2|||
163152062|NCT04852302|589271403|FG000|Overall Study|Did not complete CALM therapy.|2|||
163152063|NCT05249582|589271404|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
163152064|NCT05249582|589271405|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
163152065|NCT05249582|589271404|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
163152066|NCT05249582|589271405|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
163152067|NCT05249582|589271404|FG000|Overall Study|Declined to use virtual reality headset|1|||
163152068|NCT05249582|589271405|FG001|Overall Study|Declined to use virtual reality headset|0|||
162675817|NCT00808808|587521009|FG000|Overall Study|Vaccinated; survey not completed|131|||
162675818|NCT00808808|587521010|FG001|Overall Study|Vaccinated; survey not completed|169|||
162675819|NCT00808808|587521011|FG002|Overall Study|Vaccinated; survey not completed|302|||
162675820|NCT00808808|587521009|FG000|Overall Study|Employee was not vaccinated.|2686|||
163152069|NCT01743469|589271406|FG000|Active Treatment Phase|Adverse Event|10|||
163152070|NCT01743469|589271407|FG001|Active Treatment Phase|Adverse Event|5|||
163152071|NCT01743469|589271408|FG002|Active Treatment Phase|Adverse Event|8|||
163152072|NCT01743469|589271409|FG003|Active Treatment Phase|Adverse Event|1|||
163152073|NCT01743469|589271406|FG000|Active Treatment Phase|Disease Progression|40|||
163152074|NCT01743469|589271407|FG001|Active Treatment Phase|Disease Progression|47|||
163152075|NCT01743469|589271408|FG002|Active Treatment Phase|Disease Progression|30|||
163152076|NCT01743469|589271409|FG003|Active Treatment Phase|Disease Progression|20|||
163152077|NCT01743469|589271406|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
163152078|NCT01743469|589271407|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
163152079|NCT01743469|589271408|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
163152080|NCT01743469|589271409|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
163152081|NCT01743469|589271406|FG000|Active Treatment Phase|Missing|1|||
163152082|NCT01743469|589271407|FG001|Active Treatment Phase|Missing|0|||
163152083|NCT01743469|589271408|FG002|Active Treatment Phase|Missing|0|||
163152084|NCT01743469|589271409|FG003|Active Treatment Phase|Missing|0|||
163152085|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
163152086|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
163152087|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
163152088|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
163152089|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Death|43|||
163152090|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Death|47|||
163152091|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Death|22|||
163152092|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Death|16|||
163152093|NCT01743469|589271406|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
163152094|NCT01743469|589271407|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
163152095|NCT01743469|589271408|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
163152096|NCT01743469|589271409|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
163152097|NCT00317473|589271410|FG000|Overall Study|Withdrawal by Subject|2|||
163152098|NCT00317473|589271411|FG001|Overall Study|Withdrawal by Subject|1|||
163152099|NCT00317473|589271412|FG002|Overall Study|Withdrawal by Subject|2|||
163152100|NCT00317473|589271413|FG003|Overall Study|Withdrawal by Subject|1|||
163152101|NCT00317473|589271414|FG004|Overall Study|Withdrawal by Subject|3|||
163152102|NCT00317473|589271415|FG005|Overall Study|Withdrawal by Subject|1|||
163152103|NCT00317473|589271410|FG000|Overall Study|Relocation|1|||
163152104|NCT00317473|589271411|FG001|Overall Study|Relocation|0|||
163152105|NCT00317473|589271412|FG002|Overall Study|Relocation|1|||
163152106|NCT00317473|589271413|FG003|Overall Study|Relocation|1|||
163152107|NCT00317473|589271414|FG004|Overall Study|Relocation|5|||
163152108|NCT00317473|589271415|FG005|Overall Study|Relocation|2|||
163152109|NCT00317473|589271410|FG000|Overall Study|Death|1|||
163152110|NCT00317473|589271411|FG001|Overall Study|Death|0|||
163152111|NCT00317473|589271412|FG002|Overall Study|Death|0|||
163152112|NCT00317473|589271413|FG003|Overall Study|Death|0|||
163152113|NCT00317473|589271414|FG004|Overall Study|Death|0|||
163152114|NCT00317473|589271415|FG005|Overall Study|Death|0|||
163152115|NCT00317473|589271410|FG000|Overall Study|Other|0|||
163152116|NCT00317473|589271411|FG001|Overall Study|Other|2|||
163152117|NCT00317473|589271412|FG002|Overall Study|Other|0|||
163152118|NCT00317473|589271413|FG003|Overall Study|Other|0|||
163152119|NCT00317473|589271414|FG004|Overall Study|Other|0|||
163152120|NCT00317473|589271415|FG005|Overall Study|Other|0|||
163152121|NCT03253796|589271416|FG000|Period 1: Run-In|Adverse Event|4|||
163152122|NCT03253796|589271417|FG001|Period 1: Run-In|Adverse Event|0|||
163152123|NCT03253796|589271418|FG002|Period 1: Run-In|Adverse Event|0|||
163152124|NCT03253796|589271419|FG003|Period 1: Run-In|Adverse Event|0|||
163152125|NCT03253796|589271420|FG004|Period 1: Run-In|Adverse Event|0|||
163152126|NCT03253796|589271416|FG000|Period 1: Run-In|Lack of Efficacy|1|||
163152127|NCT03253796|589271417|FG001|Period 1: Run-In|Lack of Efficacy|0|||
163152128|NCT03253796|589271418|FG002|Period 1: Run-In|Lack of Efficacy|0|||
163152129|NCT03253796|589271419|FG003|Period 1: Run-In|Lack of Efficacy|0|||
163152130|NCT03253796|589271420|FG004|Period 1: Run-In|Lack of Efficacy|0|||
163152131|NCT03253796|589271416|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
163152132|NCT03253796|589271417|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
163152133|NCT03253796|589271418|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
163152134|NCT03253796|589271419|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
163152135|NCT03253796|589271420|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
163152136|NCT03253796|589271416|FG000|Period 1: Run-In|Protocol Violation|5|||
163152137|NCT03253796|589271417|FG001|Period 1: Run-In|Protocol Violation|0|||
163152138|NCT03253796|589271418|FG002|Period 1: Run-In|Protocol Violation|0|||
163152139|NCT03253796|589271419|FG003|Period 1: Run-In|Protocol Violation|0|||
163152140|NCT03253796|589271420|FG004|Period 1: Run-In|Protocol Violation|0|||
163152141|NCT03253796|589271416|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
163152142|NCT03253796|589271417|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
163152143|NCT03253796|589271418|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
163152144|NCT03253796|589271419|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
163152145|NCT03253796|589271420|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
163152146|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152147|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152148|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
163152149|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152150|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
163152151|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152152|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152153|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
163152154|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152155|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
163152156|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152157|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152158|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
163152159|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
163152160|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
163152161|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152162|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152163|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
163152164|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152165|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
163152166|NCT03253796|589271416|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
163152167|NCT03253796|589271417|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
162675821|NCT00808808|587521010|FG001|Overall Study|Employee was not vaccinated.|2268|||
163152168|NCT03253796|589271418|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
163152169|NCT03253796|589271419|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
163152170|NCT03253796|589271420|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
163152171|NCT03253796|589271416|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152172|NCT03253796|589271417|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152173|NCT03253796|589271418|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152174|NCT03253796|589271419|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
163152175|NCT03253796|589271420|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
163152176|NCT02285855|589271421|FG000|Overall Study|Withdrawal by Subject|2|||
163152177|NCT02285855|589271422|FG001|Overall Study|Withdrawal by Subject|1|||
163152178|NCT00528112|589271423|FG000|Treatment up to 3 Years|Adverse Event|313|||
163152179|NCT00528112|589271424|FG001|Treatment up to 3 Years|Adverse Event|278|||
163152180|NCT00528112|589271423|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
163152181|NCT00528112|589271424|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
163152182|NCT00528112|589271423|FG000|Treatment up to 3 Years|Protocol Violation|16|||
163152183|NCT00528112|589271424|FG001|Treatment up to 3 Years|Protocol Violation|16|||
163152184|NCT00528112|589271423|FG000|Treatment up to 3 Years|Death|0|||
163152185|NCT00528112|589271424|FG001|Treatment up to 3 Years|Death|1|||
163152186|NCT00528112|589271423|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
162675822|NCT00808808|587521011|FG002|Overall Study|Employee was not vaccinated.|2255|||
162675823|NCT01864564|587521018|FG000|Overall Study|Lost to Follow-up|17|||
162675824|NCT01864564|587521019|FG001|Overall Study|Lost to Follow-up|23|||
162675825|NCT01864564|587521018|FG000|Overall Study|Withdrawal by Subject|20|||
162675826|NCT01864564|587521019|FG001|Overall Study|Withdrawal by Subject|11|||
162675827|NCT01864564|587521018|FG000|Overall Study|Protocol Violation|0|||
162675828|NCT01864564|587521019|FG001|Overall Study|Protocol Violation|27|||
162675829|NCT01864564|587521018|FG000|Overall Study|not reported|0|||
162675830|NCT01864564|587521019|FG001|Overall Study|not reported|34|||
162675831|NCT02269670|587521020|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
162675832|NCT00126438|587521021|FG000|Overall Study|Withdrawal due to adverse event|1|||
162675833|NCT00126438|587521022|FG001|Overall Study|Withdrawal due to adverse event|0|||
162675834|NCT00126438|587521021|FG000|Overall Study|Lost to Follow-up|22|||
162675835|NCT00126438|587521022|FG001|Overall Study|Lost to Follow-up|0|||
162675836|NCT00126438|587521021|FG000|Overall Study|Protocol Violation|8|||
162675837|NCT00126438|587521022|FG001|Overall Study|Protocol Violation|8|||
162675838|NCT00126438|587521021|FG000|Overall Study|Withdrawal by Subject|3|||
162675839|NCT00126438|587521022|FG001|Overall Study|Withdrawal by Subject|2|||
162675840|NCT02313428|587521023|FG000|Overall Study|Lost to Follow-up|1|||
162675841|NCT02313428|587521024|FG001|Overall Study|Lost to Follow-up|1|||
162675842|NCT04414696|587521026|FG000|3-month Follow up|Withdrawal by Subject|1|||
162675843|NCT04414696|587521027|FG001|3-month Follow up|Withdrawal by Subject|0|||
162675844|NCT04414696|587521026|FG000|3-month Follow up|Lost to Follow-up|22|||
162675845|NCT04414696|587521027|FG001|3-month Follow up|Lost to Follow-up|23|||
162675846|NCT04414696|587521026|FG000|6-month Follow up|Withdrawal by Subject|1|||
162675847|NCT04414696|587521027|FG001|6-month Follow up|Withdrawal by Subject|2|||
162675848|NCT04414696|587521026|FG000|6-month Follow up|Lost to Follow-up|5|||
162675849|NCT04414696|587521027|FG001|6-month Follow up|Lost to Follow-up|2|||
162675850|NCT02160314|587522813|FG000|Overall Study|Adverse Event|0|||
163152187|NCT00528112|589271424|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
163152188|NCT00528112|589271423|FG000|Treatment up to 3 Years|Pregnancy|9|||
163152189|NCT00528112|589271424|FG001|Treatment up to 3 Years|Pregnancy|10|||
163152190|NCT00528112|589271423|FG000|Treatment up to 3 Years|Other reasons|186|||
163152191|NCT00528112|589271424|FG001|Treatment up to 3 Years|Other reasons|186|||
163152192|NCT00528112|589271423|FG000|Extension Phase|Withdrawal by Subject|0|||
163152193|NCT00528112|589271424|FG001|Extension Phase|Withdrawal by Subject|3|||
163152194|NCT00528112|589271423|FG000|Extension Phase|Other reasons|0|||
163152195|NCT00528112|589271424|FG001|Extension Phase|Other reasons|100|||
163152196|NCT00528112|589271423|FG000|Extension Phase|Pregnancy|0|||
163152197|NCT00528112|589271424|FG001|Extension Phase|Pregnancy|3|||
163152198|NCT00528112|589271423|FG000|Extension Phase|Lost to Follow-up|0|||
163152199|NCT00528112|589271424|FG001|Extension Phase|Lost to Follow-up|12|||
163152200|NCT00528112|589271423|FG000|Extension Phase|Death|0|||
163152201|NCT00528112|589271424|FG001|Extension Phase|Death|1|||
163152202|NCT00528112|589271423|FG000|Extension Phase|Adverse Event|0|||
163152203|NCT00528112|589271424|FG001|Extension Phase|Adverse Event|36|||
163152204|NCT00528112|589271423|FG000|Extension Phase|Protocol Violation|0|||
163152205|NCT00528112|589271424|FG001|Extension Phase|Protocol Violation|2|||
163152206|NCT02718898|589271427|FG000|Blinded Treatment Period|Adverse Event|5|||
163152207|NCT02718898|589271428|FG001|Blinded Treatment Period|Adverse Event|1|||
163152208|NCT02718898|589271429|FG002|Blinded Treatment Period|Adverse Event|0|||
163152209|NCT02718898|589271430|FG003|Blinded Treatment Period|Adverse Event|0|||
163152210|NCT02718898|589271431|FG004|Blinded Treatment Period|Adverse Event|0|||
163152211|NCT02718898|589271432|FG005|Blinded Treatment Period|Adverse Event|0|||
163152212|NCT02718898|589271433|FG006|Blinded Treatment Period|Adverse Event|0|||
163152213|NCT02718898|589271427|FG000|Blinded Treatment Period|Physician Decision|1|||
163152214|NCT02718898|589271428|FG001|Blinded Treatment Period|Physician Decision|0|||
163152215|NCT02718898|589271429|FG002|Blinded Treatment Period|Physician Decision|0|||
163152216|NCT02718898|589271430|FG003|Blinded Treatment Period|Physician Decision|0|||
163152217|NCT02718898|589271431|FG004|Blinded Treatment Period|Physician Decision|0|||
163152218|NCT02718898|589271432|FG005|Blinded Treatment Period|Physician Decision|0|||
163152219|NCT02718898|589271433|FG006|Blinded Treatment Period|Physician Decision|0|||
163152220|NCT02718898|589271427|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
162675851|NCT02160314|587522814|FG001|Overall Study|Adverse Event|6|||
162675852|NCT02160314|587522813|FG000|Overall Study|Protocol Violation|0|||
162675853|NCT02160314|587522814|FG001|Overall Study|Protocol Violation|4|||
162675854|NCT02160314|587522813|FG000|Overall Study|Withdrawal by Subject|1|||
162675855|NCT02160314|587522814|FG001|Overall Study|Withdrawal by Subject|2|||
162675856|NCT02160314|587522813|FG000|Overall Study|Lost to Follow-up|0|||
162675857|NCT02160314|587522814|FG001|Overall Study|Lost to Follow-up|1|||
162675858|NCT00593567|587522815|FG000|Overall Study|Adverse Event|2|||
162675859|NCT00593567|587522816|FG001|Overall Study|Adverse Event|0|||
162675860|NCT00593567|587522815|FG000|Overall Study|Physician Decision|2|||
162675861|NCT00593567|587522816|FG001|Overall Study|Physician Decision|0|||
162675862|NCT00593567|587522815|FG000|Overall Study|Protocol Violation|13|||
162675863|NCT00593567|587522816|FG001|Overall Study|Protocol Violation|7|||
162675864|NCT00593567|587522815|FG000|Overall Study|Lack of Efficacy|2|||
162675865|NCT00593567|587522816|FG001|Overall Study|Lack of Efficacy|1|||
162675866|NCT00593567|587522815|FG000|Overall Study|Withdrawal by Subject|1|||
162675867|NCT00593567|587522816|FG001|Overall Study|Withdrawal by Subject|2|||
162675868|NCT00785291|587522821|FG000|Overall Study|Never began treatment|8|||
162675869|NCT00785291|587522822|FG001|Overall Study|Never began treatment|4|||
162675870|NCT00785291|587522823|FG002|Overall Study|Never began treatment|4|||
162675871|NCT00785291|587522821|FG000|Overall Study|Adverse Event|39|||
162675872|NCT00785291|587522822|FG001|Overall Study|Adverse Event|70|||
162675873|NCT00785291|587522823|FG002|Overall Study|Adverse Event|56|||
162675874|NCT00785291|587522821|FG000|Overall Study|Death|7|||
162675875|NCT00785291|587522822|FG001|Overall Study|Death|4|||
162675876|NCT00785291|587522823|FG002|Overall Study|Death|3|||
162675877|NCT00785291|587522821|FG000|Overall Study|Withdrawal by Subject|35|||
162675878|NCT00785291|587522822|FG001|Overall Study|Withdrawal by Subject|36|||
162675879|NCT00785291|587522823|FG002|Overall Study|Withdrawal by Subject|17|||
162675880|NCT00785291|587522821|FG000|Overall Study|Alternative Therapy|12|||
162675881|NCT00785291|587522822|FG001|Overall Study|Alternative Therapy|6|||
162675882|NCT00785291|587522823|FG002|Overall Study|Alternative Therapy|7|||
162675883|NCT00785291|587522821|FG000|Overall Study|Complicating illness|6|||
162675884|NCT00785291|587522822|FG001|Overall Study|Complicating illness|4|||
162675885|NCT00785291|587522823|FG002|Overall Study|Complicating illness|4|||
162675886|NCT00785291|587522821|FG000|Overall Study|Other Medical Reasons|29|||
162675887|NCT00785291|587522822|FG001|Overall Study|Other Medical Reasons|25|||
162675888|NCT00785291|587522823|FG002|Overall Study|Other Medical Reasons|15|||
162675889|NCT02119260|587522824|FG000|Overall Study|Adverse Event|1|||
162675890|NCT02119260|587522825|FG001|Overall Study|Adverse Event|0|||
162675891|NCT02119260|587522826|FG002|Overall Study|Adverse Event|0|||
162675892|NCT02119260|587522827|FG003|Overall Study|Adverse Event|0|||
162675893|NCT02119260|587522828|FG004|Overall Study|Adverse Event|0|||
162675894|NCT02119260|587522829|FG005|Overall Study|Adverse Event|0|||
162675895|NCT02119260|587522830|FG006|Overall Study|Adverse Event|0|||
162675896|NCT02119260|587522824|FG000|Overall Study|Withdrew consent|0|||
162675897|NCT02119260|587522825|FG001|Overall Study|Withdrew consent|1|||
162675898|NCT02119260|587522826|FG002|Overall Study|Withdrew consent|1|||
162675899|NCT02119260|587522827|FG003|Overall Study|Withdrew consent|0|||
162675900|NCT02119260|587522828|FG004|Overall Study|Withdrew consent|0|||
162675901|NCT02119260|587522829|FG005|Overall Study|Withdrew consent|0|||
162675902|NCT02119260|587522830|FG006|Overall Study|Withdrew consent|0|||
162675903|NCT01877408|587522835|FG000|Overall Study|Lost to Follow-up|0|||
162675904|NCT01877408|587522836|FG001|Overall Study|Lost to Follow-up|2|||
162675905|NCT03870763|587522839|FG000|Overall Study|Study terminated by sponsor|0|||
162675906|NCT03870763|587522840|FG001|Overall Study|Study terminated by sponsor|2|||
162675907|NCT03870763|587522841|FG002|Overall Study|Study terminated by sponsor|0|||
162675908|NCT03870763|587522839|FG000|Overall Study|Withdrawal by Subject|0|||
162675909|NCT03870763|587522840|FG001|Overall Study|Withdrawal by Subject|1|||
162675910|NCT03870763|587522841|FG002|Overall Study|Withdrawal by Subject|0|||
162675911|NCT03870763|587522839|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
162675912|NCT03870763|587522840|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
162675913|NCT03870763|587522841|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
162675914|NCT04279314|587522842|FG000|Overall Study|Adverse Event|55|||
162675915|NCT04279314|587522842|FG000|Overall Study|Withdrawal by Subject|5|||
162675916|NCT04279314|587522842|FG000|Overall Study|Lack of Efficacy|5|||
162675917|NCT04279314|587522842|FG000|Overall Study|Protocol Violation|3|||
163152221|NCT02718898|589271428|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
163152222|NCT02718898|589271429|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
163152223|NCT02718898|589271430|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
163152224|NCT02718898|589271431|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
163152225|NCT02718898|589271432|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
163152226|NCT02718898|589271433|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
163152227|NCT02718898|589271427|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
163152228|NCT02718898|589271428|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
163152229|NCT02718898|589271429|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
163152230|NCT02718898|589271430|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
163152231|NCT02718898|589271431|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
163152232|NCT02718898|589271432|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
163152233|NCT02718898|589271433|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
163152234|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152235|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152236|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
163152237|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
163152238|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152239|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152240|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
163152241|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152242|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152243|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152244|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
163152245|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152246|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152247|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
163152248|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152249|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152250|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163152251|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
163152252|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152253|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152254|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152255|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152256|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152257|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
163152258|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
163152259|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152260|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152261|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
163152262|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152263|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152264|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152265|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
163152266|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152267|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152268|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
163152269|NCT02718898|589271427|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152270|NCT02718898|589271428|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152271|NCT02718898|589271429|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152272|NCT02718898|589271430|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
163152273|NCT02718898|589271431|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152274|NCT02718898|589271432|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152275|NCT02718898|589271433|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
163152276|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
163152277|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
163152278|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
163152279|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
163152280|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
163152281|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
163152282|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
163152283|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152284|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152285|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
163152286|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
162675918|NCT04279314|587522842|FG000|Overall Study|Other (not COVID-19 related)|2|||
162675919|NCT02120027|587522843|FG000|Overall Study|Adverse Event|4|||
162675920|NCT02120027|587522844|FG001|Overall Study|Adverse Event|5|||
162675921|NCT02120027|587522843|FG000|Overall Study|Lack of Efficacy|3|||
162675922|NCT02120027|587522844|FG001|Overall Study|Lack of Efficacy|5|||
162675923|NCT02120027|587522843|FG000|Overall Study|Lost to Follow-up|5|||
162675924|NCT02120027|587522844|FG001|Overall Study|Lost to Follow-up|13|||
162675925|NCT02120027|587522843|FG000|Overall Study|Other|4|||
162675926|NCT02120027|587522844|FG001|Overall Study|Other|0|||
162675927|NCT02120027|587522843|FG000|Overall Study|Physician Decision|4|||
162675928|NCT02120027|587522844|FG001|Overall Study|Physician Decision|3|||
162675929|NCT02120027|587522843|FG000|Overall Study|Protocol Violation|18|||
162675930|NCT02120027|587522844|FG001|Overall Study|Protocol Violation|21|||
162675931|NCT02120027|587522843|FG000|Overall Study|Study terminated by Sponsor|45|||
162675932|NCT02120027|587522844|FG001|Overall Study|Study terminated by Sponsor|47|||
162675933|NCT02120027|587522843|FG000|Overall Study|Withdrawal by Subject|33|||
162675934|NCT02120027|587522844|FG001|Overall Study|Withdrawal by Subject|25|||
162675935|NCT01471054|587522849|FG000|Overall Study|Study terminated prematurely|4|||
162675936|NCT01471054|587522850|FG001|Overall Study|Study terminated prematurely|0|||
162675937|NCT00360308|587522851|FG000|Overall Study|Adverse Event|15|||
162675938|NCT00360308|587522852|FG001|Overall Study|Adverse Event|14|||
162675939|NCT00360308|587522853|FG002|Overall Study|Adverse Event|25|||
162675940|NCT00360308|587522851|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162675941|NCT00360308|587522852|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162675942|NCT00360308|587522853|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162675943|NCT00360308|587522851|FG000|Overall Study|Protocol Violation|2|||
162675944|NCT00360308|587522852|FG001|Overall Study|Protocol Violation|1|||
162675945|NCT00360308|587522853|FG002|Overall Study|Protocol Violation|2|||
162675946|NCT00360308|587522851|FG000|Overall Study|Withdrawal by Subject|11|||
162675947|NCT00360308|587522852|FG001|Overall Study|Withdrawal by Subject|7|||
162675948|NCT00360308|587522853|FG002|Overall Study|Withdrawal by Subject|14|||
162675949|NCT00360308|587522851|FG000|Overall Study|Lack of Efficacy|3|||
162675950|NCT00360308|587522852|FG001|Overall Study|Lack of Efficacy|0|||
162675951|NCT00360308|587522853|FG002|Overall Study|Lack of Efficacy|2|||
162675952|NCT00360308|587522851|FG000|Overall Study|Other|2|||
162675953|NCT00360308|587522852|FG001|Overall Study|Other|1|||
162675954|NCT00360308|587522853|FG002|Overall Study|Other|1|||
162675955|NCT00360308|587522851|FG000|Overall Study|Study termination by sponsor|43|||
162675956|NCT00360308|587522852|FG001|Overall Study|Study termination by sponsor|55|||
162675957|NCT00360308|587522853|FG002|Overall Study|Study termination by sponsor|44|||
162675958|NCT03162224|587522854|FG000|Overall Study|Death|4|||
162675959|NCT03162224|587522855|FG001|Overall Study|Death|5|||
162675960|NCT03162224|587522856|FG002|Overall Study|Death|8|||
162675961|NCT03162224|587522854|FG000|Overall Study|Withdrawal by Subject|1|||
162675962|NCT03162224|587522855|FG001|Overall Study|Withdrawal by Subject|0|||
162675963|NCT03162224|587522856|FG002|Overall Study|Withdrawal by Subject|1|||
162675964|NCT03162224|587522854|FG000|Overall Study|Lost to Follow-up|0|||
162675965|NCT03162224|587522855|FG001|Overall Study|Lost to Follow-up|1|||
162675966|NCT03162224|587522856|FG002|Overall Study|Lost to Follow-up|0|||
162675967|NCT03162224|587522854|FG000|Overall Study|Other|6|||
162675968|NCT03162224|587522855|FG001|Overall Study|Other|2|||
162675969|NCT03162224|587522856|FG002|Overall Study|Other|1|||
162675970|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
162675971|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
162675972|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
162675973|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
162675974|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
162675975|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
162675976|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
162675977|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
162675978|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
162675979|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
162675980|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
162675981|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
162675982|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
162675983|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
162675984|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
162675985|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
162675986|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
162675987|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
162675988|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
162675989|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
162675990|NCT04162769|587522857|FG000|Double-blind Treatment (12-Week)|Other|0|||
162675991|NCT04162769|587522858|FG001|Double-blind Treatment (12-Week)|Other|1|||
162675992|NCT04162769|587522859|FG002|Double-blind Treatment (12-Week)|Other|1|||
162675993|NCT04162769|587522860|FG003|Double-blind Treatment (12-Week)|Other|0|||
162675994|NCT04162769|587522857|FG000|OLE Period (52-Week)|Adverse Event|0|||
162675995|NCT04162769|587522858|FG001|OLE Period (52-Week)|Adverse Event|0|||
162675996|NCT04162769|587522859|FG002|OLE Period (52-Week)|Adverse Event|0|||
162675997|NCT04162769|587522860|FG003|OLE Period (52-Week)|Adverse Event|5|||
162675998|NCT04162769|587522857|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
162675999|NCT04162769|587522858|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
162676000|NCT04162769|587522859|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
162676001|NCT04162769|587522860|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
162676002|NCT04162769|587522857|FG000|OLE Period (52-Week)|Physician Decision|0|||
162676003|NCT04162769|587522858|FG001|OLE Period (52-Week)|Physician Decision|0|||
162676004|NCT04162769|587522859|FG002|OLE Period (52-Week)|Physician Decision|0|||
162676005|NCT04162769|587522860|FG003|OLE Period (52-Week)|Physician Decision|1|||
162676006|NCT04162769|587522857|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
162676007|NCT04162769|587522858|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
162676008|NCT04162769|587522859|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
162676009|NCT04162769|587522860|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
162676010|NCT04162769|587522857|FG000|OLE Period (52-Week)|Protocol deviation|0|||
162676011|NCT04162769|587522858|FG001|OLE Period (52-Week)|Protocol deviation|0|||
162676012|NCT04162769|587522859|FG002|OLE Period (52-Week)|Protocol deviation|0|||
162676013|NCT04162769|587522860|FG003|OLE Period (52-Week)|Protocol deviation|2|||
162676014|NCT00082173|587522861|FG000|Overall Study|Withdrawal by Subject|3|||
162676015|NCT00082173|587522862|FG001|Overall Study|Withdrawal by Subject|5|||
162676016|NCT00082173|587522861|FG000|Overall Study|Lost to Follow-up|1|||
162676017|NCT00082173|587522862|FG001|Overall Study|Lost to Follow-up|0|||
162676018|NCT00082173|587522861|FG000|Overall Study|Adverse Event|1|||
162676019|NCT00082173|587522862|FG001|Overall Study|Adverse Event|0|||
162676020|NCT00082173|587522861|FG000|Overall Study|Culture negative or resistant at baselin|5|||
162676021|NCT00082173|587522862|FG001|Overall Study|Culture negative or resistant at baselin|6|||
162676022|NCT01733732|587522863|FG000|Overall Study|Adverse Event|1|||
162676023|NCT01733732|587522864|FG001|Overall Study|Adverse Event|0|||
162676024|NCT01733732|587522863|FG000|Overall Study|Did not attend all study visits|1|||
162676025|NCT01733732|587522864|FG001|Overall Study|Did not attend all study visits|0|||
162676026|NCT03280121|587522870|FG000|Overall Study|Physician Decision|1|||
162676027|NCT03280121|587522870|FG000|Overall Study|Lost to Follow-up|1|||
162676028|NCT03280121|587522870|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
162676029|NCT02633137|587522883|FG000|Overall Study|Adverse Event|1|||
162676030|NCT02633137|587522883|FG000|Overall Study|Lack of Efficacy|2|||
162676031|NCT02633137|587522883|FG000|Overall Study|Withdrawal by Subject|1|||
162676032|NCT01324271|587522884|FG000|Overall Study|Lost to Follow-up|3|||
162676033|NCT01324271|587522885|FG001|Overall Study|Lost to Follow-up|0|||
162676034|NCT01324271|587522884|FG000|Overall Study|Physician Decision|1|||
162676035|NCT01324271|587522885|FG001|Overall Study|Physician Decision|0|||
162676036|NCT06116591|587522886|FG000|Overall Study|No longer met eligibility criteria|0|||
162676037|NCT06116591|587522887|FG001|Overall Study|No longer met eligibility criteria|1|||
162676038|NCT06116591|587522886|FG000|Overall Study|Other: Change in life situation|0|||
162676039|NCT06116591|587522887|FG001|Overall Study|Other: Change in life situation|1|||
162676040|NCT05585307|587522888|FG000|Overall Study|Lost to Follow-up|0|||
162676041|NCT05585307|587522889|FG001|Overall Study|Lost to Follow-up|0|||
162676042|NCT05585307|587522890|FG002|Overall Study|Lost to Follow-up|0|||
162676043|NCT05585307|587522891|FG003|Overall Study|Lost to Follow-up|0|||
162676044|NCT05585307|587522892|FG004|Overall Study|Lost to Follow-up|0|||
162676045|NCT05585307|587522893|FG005|Overall Study|Lost to Follow-up|0|||
162676046|NCT05585307|587522894|FG006|Overall Study|Lost to Follow-up|1|||
162676047|NCT05585307|587522895|FG007|Overall Study|Lost to Follow-up|0|||
162676048|NCT04391023|587522896|FG000|Overall Study|Withdrawal by Subject|2|||
162676049|NCT04391023|587522897|FG001|Overall Study|Withdrawal by Subject|2|||
162676050|NCT01270347|587522899|FG000|Core Phase|Adverse Event|1|||
162676051|NCT01270347|587522900|FG001|Core Phase|Adverse Event|6|||
162676052|NCT01270347|587522899|FG000|Core Phase|Withdrawal by Subject|1|||
162676053|NCT01270347|587522900|FG001|Core Phase|Withdrawal by Subject|2|||
162676054|NCT01270347|587522899|FG000|Core Phase|Lost to Follow-up|0|||
162676055|NCT01270347|587522900|FG001|Core Phase|Lost to Follow-up|1|||
162676056|NCT01270347|587522899|FG000|Core Phase|Miscellaneous|8|||
162676057|NCT01270347|587522900|FG001|Core Phase|Miscellaneous|14|||
162676058|NCT01270347|587522899|FG000|Extension Phase|Adverse Event|1|||
162676059|NCT01270347|587522900|FG001|Extension Phase|Adverse Event|3|||
162676060|NCT01270347|587522899|FG000|Extension Phase|Withdrawal by Subject|3|||
162676061|NCT01270347|587522900|FG001|Extension Phase|Withdrawal by Subject|4|||
162676062|NCT01270347|587522899|FG000|Extension Phase|Miscellaneous|2|||
162676063|NCT01270347|587522900|FG001|Extension Phase|Miscellaneous|2|||
163152287|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
163152288|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
163152289|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
163152290|NCT02718898|589271427|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152291|NCT02718898|589271428|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152292|NCT02718898|589271429|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152293|NCT02718898|589271430|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152294|NCT02718898|589271431|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163152295|NCT02718898|589271432|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
163152296|NCT02718898|589271433|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
163152297|NCT02163538|589271434|FG000|Overall Study|Protocol Violation|1|||
163152298|NCT02163538|589271435|FG001|Overall Study|Protocol Violation|0|||
163152299|NCT02163538|589271434|FG000|Overall Study|Physician Decision|0|||
163152300|NCT02163538|589271435|FG001|Overall Study|Physician Decision|1|||
163152301|NCT01345240|589271436|FG000|Overall Study|Adverse Event|3|||
163152302|NCT01345240|589271437|FG001|Overall Study|Adverse Event|5|||
163152303|NCT01345240|589271438|FG002|Overall Study|Adverse Event|4|||
163152304|NCT01345240|589271439|FG003|Overall Study|Adverse Event|2|||
163152305|NCT01345240|589271440|FG004|Overall Study|Adverse Event|1|||
163152306|NCT01345240|589271436|FG000|Overall Study|Lost to Follow-up|8|||
163152307|NCT01345240|589271437|FG001|Overall Study|Lost to Follow-up|9|||
163152308|NCT01345240|589271438|FG002|Overall Study|Lost to Follow-up|14|||
163152309|NCT01345240|589271439|FG003|Overall Study|Lost to Follow-up|7|||
163152310|NCT01345240|589271440|FG004|Overall Study|Lost to Follow-up|9|||
163152311|NCT00231816|589271443|FG000|Overall Study|Adverse Event|1|||
163152312|NCT00231816|589271444|FG001|Overall Study|Adverse Event|0|||
163152313|NCT00231816|589271443|FG000|Overall Study|Lost to Follow-up|8|||
163152314|NCT00231816|589271444|FG001|Overall Study|Lost to Follow-up|5|||
163152315|NCT00231816|589271443|FG000|Overall Study|Protocol Violation|2|||
163152316|NCT00231816|589271444|FG001|Overall Study|Protocol Violation|3|||
163152317|NCT00231816|589271443|FG000|Overall Study|Withdrawal by Subject|3|||
163152318|NCT00231816|589271444|FG001|Overall Study|Withdrawal by Subject|3|||
163152319|NCT00231816|589271443|FG000|Overall Study|Other|2|||
163152320|NCT00231816|589271444|FG001|Overall Study|Other|1|||
163152321|NCT02158442|589271446|FG000|Overall Study|Withdrawal by Subject|1|||
163152322|NCT02158442|589271447|FG001|Overall Study|Withdrawal by Subject|0|||
163152323|NCT02158442|589271446|FG000|Overall Study|Perfusion staff not available|1|||
163152324|NCT02158442|589271447|FG001|Overall Study|Perfusion staff not available|0|||
163152325|NCT02651675|589271449|FG000|Overall Study|Death|0|||
163152326|NCT02651675|589271450|FG001|Overall Study|Death|0|||
163152327|NCT02651675|589271451|FG002|Overall Study|Death|1|||
163152328|NCT02246530|589271452|FG000|Overall Study|Lost to Follow-up|4|||
163152329|NCT02246530|589271453|FG001|Overall Study|Lost to Follow-up|0|||
163152330|NCT00617734|589271454|FG000|Overall Study|Withdrew Consent|2|||
163152331|NCT00617734|589271455|FG001|Overall Study|Withdrew Consent|0|||
163152332|NCT00617734|589271454|FG000|Overall Study|Adverse Event|4|||
163152333|NCT00617734|589271455|FG001|Overall Study|Adverse Event|1|||
163152334|NCT00617734|589271454|FG000|Overall Study|Protocol Violation|1|||
163152335|NCT00617734|589271455|FG001|Overall Study|Protocol Violation|0|||
163152336|NCT00617734|589271454|FG000|Overall Study|Found Ineligible After Randomization|1|||
163152337|NCT00617734|589271455|FG001|Overall Study|Found Ineligible After Randomization|4|||
163152338|NCT00617734|589271454|FG000|Overall Study|Lost to Follow-up|0|||
163152339|NCT00617734|589271455|FG001|Overall Study|Lost to Follow-up|1|||
163152340|NCT05712460|589271456|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152341|NCT05712460|589271457|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152342|NCT05712460|589271458|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152343|NCT05712460|589271459|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152344|NCT05712460|589271460|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152345|NCT05712460|589271461|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152346|NCT05712460|589271462|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152347|NCT05712460|589271463|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
163152348|NCT05712460|589271464|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152349|NCT05712460|589271465|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152350|NCT05712460|589271466|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162676064|NCT02085408|587522901|FG000|Step 1: Induction|Disease Progression|19|||
162676065|NCT02085408|587522902|FG001|Step 1: Induction|Disease Progression|19|||
162676066|NCT02085408|587522901|FG000|Step 1: Induction|Adverse Event|18|||
162676067|NCT02085408|587522902|FG001|Step 1: Induction|Adverse Event|17|||
162676068|NCT02085408|587522901|FG000|Step 1: Induction|Death|33|||
162676069|NCT02085408|587522902|FG001|Step 1: Induction|Death|30|||
162676070|NCT02085408|587522901|FG000|Step 1: Induction|Withdrawal by Subject|16|||
162676071|NCT02085408|587522902|FG001|Step 1: Induction|Withdrawal by Subject|8|||
162676072|NCT02085408|587522901|FG000|Step 1: Induction|Alternative Therapy|15|||
163152351|NCT05712460|589271467|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
163152352|NCT05135767|589271471|FG000|Baseline|Lost to Follow-up|1|||
163152353|NCT05135767|589271472|FG001|Baseline|Lost to Follow-up|1|||
163152354|NCT05135767|589271471|FG000|Baseline|Withdrawal by Subject|0|||
163152355|NCT05135767|589271472|FG001|Baseline|Withdrawal by Subject|2|||
163152356|NCT05135767|589271471|FG000|Active Study Phase|Lost to Follow-up|2|||
163152357|NCT05135767|589271472|FG001|Active Study Phase|Lost to Follow-up|0|||
163152358|NCT02694185|589271473|FG000|Overall Study|Withdrawal by Subject|45|||
163152359|NCT02694185|589271474|FG001|Overall Study|Withdrawal by Subject|0|||
163152360|NCT05082857|589271475|FG000|Overall Study|participants relocated and could not continue|2|||
163152361|NCT05082857|589271476|FG001|Overall Study|participants relocated and could not continue|1|||
163152362|NCT05082857|589271475|FG000|Overall Study|Lost to Follow-up|1|||
163152363|NCT05082857|589271476|FG001|Overall Study|Lost to Follow-up|3|||
163152364|NCT04366349|589271477|FG000|Overall Study|Withdrawal by Subject|1|||
163152365|NCT04366349|589271478|FG001|Overall Study|Withdrawal by Subject|0|||
163152366|NCT04366349|589271479|FG002|Overall Study|Withdrawal by Subject|0|||
163152367|NCT04366349|589271480|FG003|Overall Study|Withdrawal by Subject|0|||
163152368|NCT04366349|589271481|FG004|Overall Study|Withdrawal by Subject|0|||
163152369|NCT04366349|589271482|FG005|Overall Study|Withdrawal by Subject|0|||
163152370|NCT02331134|589271489|FG000|Overall Study|Withdrawal by Subject|1|||
163152371|NCT05967260|589271490|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
163152372|NCT05967260|589271491|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
163152373|NCT05565742|589271492|FG000|Overall Study|Withdrawal by Subject|0|||
163152374|NCT05565742|589271493|FG001|Overall Study|Withdrawal by Subject|0|||
163152375|NCT05565742|589271494|FG002|Overall Study|Withdrawal by Subject|2|||
163152376|NCT05565742|589271495|FG003|Overall Study|Withdrawal by Subject|2|||
163152377|NCT05565742|589271496|FG004|Overall Study|Withdrawal by Subject|2|||
163152378|NCT05565742|589271492|FG000|Overall Study|Death|1|||
163152379|NCT05565742|589271493|FG001|Overall Study|Death|0|||
163152380|NCT05565742|589271494|FG002|Overall Study|Death|0|||
163152381|NCT05565742|589271495|FG003|Overall Study|Death|0|||
163152382|NCT05565742|589271496|FG004|Overall Study|Death|0|||
163152383|NCT05565742|589271492|FG000|Overall Study|Participant Travelled Abroad|0|||
163152384|NCT05565742|589271493|FG001|Overall Study|Participant Travelled Abroad|0|||
163152385|NCT05565742|589271494|FG002|Overall Study|Participant Travelled Abroad|0|||
163152386|NCT05565742|589271495|FG003|Overall Study|Participant Travelled Abroad|0|||
163152387|NCT05565742|589271496|FG004|Overall Study|Participant Travelled Abroad|1|||
163152388|NCT00668148|589271497|FG000|Overall Study|Adverse Event|5|||
163152389|NCT00668148|589271497|FG000|Overall Study|Subject Non-compliance|1|||
163152390|NCT00668148|589271497|FG000|Overall Study|Progressive Disease Before Treatment|2|||
163152391|NCT00668148|589271497|FG000|Overall Study|Withdrawal of Consent|2|||
163152392|NCT05472090|589271499|FG000|Overall Study|Adverse Event|2|||
163152393|NCT05472090|589271500|FG001|Overall Study|Adverse Event|3|||
163152394|NCT05472090|589271499|FG000|Overall Study|Lack of Efficacy|1|||
163152395|NCT05472090|589271500|FG001|Overall Study|Lack of Efficacy|0|||
163152396|NCT05472090|589271499|FG000|Overall Study|Physician Decision|1|||
163152397|NCT05472090|589271500|FG001|Overall Study|Physician Decision|0|||
163152398|NCT05472090|589271499|FG000|Overall Study|Withdrawal by Subject|2|||
163152399|NCT05472090|589271500|FG001|Overall Study|Withdrawal by Subject|0|||
163152400|NCT05472090|589271499|FG000|Overall Study|Lost to Follow-up|0|||
163152401|NCT05472090|589271500|FG001|Overall Study|Lost to Follow-up|3|||
163152402|NCT00425269|589274526|FG000|Overall Study|Pregnancy|5|||
163152403|NCT00425269|589274527|FG001|Overall Study|Pregnancy|7|||
163152404|NCT00425269|589274526|FG000|Overall Study|Lost to Follow-up|9|||
163152405|NCT00425269|589274527|FG001|Overall Study|Lost to Follow-up|9|||
163152406|NCT00425269|589274526|FG000|Overall Study|moved or medical reason|5|||
163152407|NCT00425269|589274527|FG001|Overall Study|moved or medical reason|4|||
163152408|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
163152409|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
163152410|NCT00335777|589274534|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
163152411|NCT00335777|589274534|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
163152412|NCT00335777|589274534|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
163152413|NCT00992108|589274535|FG000|Overall Study|Lost to Follow-up|0|||
163152414|NCT00992108|589274536|FG001|Overall Study|Lost to Follow-up|1|||
163152415|NCT04639245|589274537|FG000|Overall Study|Death|1|||
162676073|NCT02085408|587522902|FG001|Step 1: Induction|Alternative Therapy|19|||
162676074|NCT02085408|587522901|FG000|Step 1: Induction|Complicating Disease|2|||
162676075|NCT02085408|587522902|FG001|Step 1: Induction|Complicating Disease|3|||
162676076|NCT02085408|587522901|FG000|Step 1: Induction|Other|27|||
162676077|NCT02085408|587522902|FG001|Step 1: Induction|Other|39|||
162676078|NCT02085408|587522901|FG000|Step 1: Induction|Never started treatment|6|||
162676079|NCT02085408|587522902|FG001|Step 1: Induction|Never started treatment|4|||
162676080|NCT02085408|587522901|FG000|Step 2: Consolidation|Disease Progression|5|||
162676081|NCT02085408|587522902|FG001|Step 2: Consolidation|Disease Progression|20|||
162676082|NCT02085408|587522901|FG000|Step 2: Consolidation|Adverse Event|9|||
162676083|NCT02085408|587522902|FG001|Step 2: Consolidation|Adverse Event|8|||
162676084|NCT02085408|587522901|FG000|Step 2: Consolidation|Death|4|||
162676085|NCT02085408|587522902|FG001|Step 2: Consolidation|Death|3|||
162676086|NCT02085408|587522901|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
162676087|NCT02085408|587522902|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
162676088|NCT02085408|587522901|FG000|Step 2: Consolidation|Alternative Therapy|9|||
162676089|NCT02085408|587522902|FG001|Step 2: Consolidation|Alternative Therapy|3|||
162676090|NCT02085408|587522901|FG000|Step 2: Consolidation|Complicating Disease|0|||
162676091|NCT02085408|587522902|FG001|Step 2: Consolidation|Complicating Disease|2|||
162676092|NCT02085408|587522901|FG000|Step 2: Consolidation|Other|6|||
162676093|NCT02085408|587522902|FG001|Step 2: Consolidation|Other|6|||
162676094|NCT02085408|587522901|FG000|Step 2: Consolidation|Never started treatment|4|||
162676095|NCT02085408|587522902|FG001|Step 2: Consolidation|Never started treatment|3|||
162676096|NCT02085408|587522901|FG000|Step 3: Maintenance|Disease Progression|13|||
162676097|NCT02085408|587522902|FG001|Step 3: Maintenance|Disease Progression|11|||
162676098|NCT02085408|587522901|FG000|Step 3: Maintenance|Adverse Event|2|||
162676099|NCT02085408|587522902|FG001|Step 3: Maintenance|Adverse Event|4|||
162676100|NCT02085408|587522901|FG000|Step 3: Maintenance|Death|1|||
162676101|NCT02085408|587522902|FG001|Step 3: Maintenance|Death|2|||
162676102|NCT02085408|587522901|FG000|Step 3: Maintenance|Alternative Therapy|1|||
162676103|NCT02085408|587522902|FG001|Step 3: Maintenance|Alternative Therapy|1|||
162676104|NCT02085408|587522901|FG000|Step 3: Maintenance|Complicating Disease|0|||
162676105|NCT02085408|587522902|FG001|Step 3: Maintenance|Complicating Disease|1|||
162676106|NCT02085408|587522901|FG000|Step 3: Maintenance|Other|3|||
162676107|NCT02085408|587522902|FG001|Step 3: Maintenance|Other|2|||
162676108|NCT02085408|587522901|FG000|Step 3: Maintenance|Never started treatment|5|||
162676109|NCT02085408|587522902|FG001|Step 3: Maintenance|Never started treatment|1|||
162676110|NCT00492284|587522903|FG000|Overall Study|Adverse Event|0|||
162676111|NCT00492284|587522904|FG001|Overall Study|Adverse Event|1|||
162676112|NCT00492284|587522905|FG002|Overall Study|Adverse Event|1|||
162676113|NCT00492284|587522906|FG003|Overall Study|Adverse Event|2|||
162676114|NCT00492284|587522903|FG000|Overall Study|Lost to Follow-up|0|||
162676115|NCT00492284|587522904|FG001|Overall Study|Lost to Follow-up|0|||
162676116|NCT00492284|587522905|FG002|Overall Study|Lost to Follow-up|3|||
162676117|NCT00492284|587522906|FG003|Overall Study|Lost to Follow-up|1|||
162676118|NCT00492284|587522903|FG000|Overall Study|Death|0|||
162676119|NCT00492284|587522904|FG001|Overall Study|Death|3|||
162676120|NCT00492284|587522905|FG002|Overall Study|Death|2|||
162676121|NCT00492284|587522906|FG003|Overall Study|Death|5|||
162676122|NCT00492284|587522903|FG000|Overall Study|Withdrawal by Subject|1|||
162676123|NCT00492284|587522904|FG001|Overall Study|Withdrawal by Subject|0|||
162676124|NCT00492284|587522905|FG002|Overall Study|Withdrawal by Subject|0|||
162676125|NCT00492284|587522906|FG003|Overall Study|Withdrawal by Subject|2|||
163152416|NCT02419001|589274540|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
163152417|NCT02419001|589274541|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
163152418|NCT00535496|589274542|FG000|Overall Study|Lost to Follow-up|0|||
163152419|NCT00535496|589274543|FG001|Overall Study|Lost to Follow-up|1|||
163152420|NCT00535496|589274544|FG002|Overall Study|Lost to Follow-up|0|||
163152421|NCT00535496|589274545|FG003|Overall Study|Lost to Follow-up|0|||
163152422|NCT00535496|589274542|FG000|Overall Study|Not treated with sugammadex|0|||
163152423|NCT00535496|589274543|FG001|Overall Study|Not treated with sugammadex|1|||
163152424|NCT00535496|589274544|FG002|Overall Study|Not treated with sugammadex|0|||
163152425|NCT00535496|589274545|FG003|Overall Study|Not treated with sugammadex|0|||
163152426|NCT01209689|589274549|FG000|Overall Study|Insufficient Therapeutic Response|7|||
163152427|NCT01209689|589274550|FG001|Overall Study|Insufficient Therapeutic Response|2|||
163152428|NCT01209689|589274549|FG000|Overall Study|Refused Treatment|8|||
163152429|NCT01209689|589274550|FG001|Overall Study|Refused Treatment|3|||
163152430|NCT01209689|589274549|FG000|Overall Study|Adverse Event|4|||
163152431|NCT01209689|589274550|FG001|Overall Study|Adverse Event|0|||
163152432|NCT01209689|589274549|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163152433|NCT01209689|589274550|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163152434|NCT01209689|589274549|FG000|Overall Study|Failure to Return|3|||
163152435|NCT01209689|589274550|FG001|Overall Study|Failure to Return|0|||
163152436|NCT01209689|589274549|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
163152437|NCT01209689|589274550|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
163152438|NCT03780244|589274553|FG000|Overall Study|Lost to Follow-up|1|||
163152439|NCT03780244|589274554|FG001|Overall Study|Lost to Follow-up|0|||
163152440|NCT01083771|589274555|FG000|Overall Study|non-compliant|2|||
163152441|NCT01083771|589274555|FG000|Overall Study|Withdrawal by Subject|3|||
163152442|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152443|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152444|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
163152445|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
163152446|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152447|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
163152448|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
163152449|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152450|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152451|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163152452|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163152453|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
163152454|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152455|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163152456|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152457|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152458|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
163152459|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
163152460|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163152461|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
163152462|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
163152463|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
163152464|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
163152465|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
163152466|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
163152467|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152468|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152469|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163152470|NCT03175367|589274556|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152471|NCT03175367|589274557|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152472|NCT03175367|589274558|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163152473|NCT03175367|589274559|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152474|NCT03175367|589274560|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163152475|NCT03175367|589274561|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152476|NCT03175367|589274562|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163152477|NCT03175367|589274556|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152478|NCT03175367|589274557|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152479|NCT03175367|589274558|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152480|NCT03175367|589274559|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152481|NCT03175367|589274560|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152482|NCT03175367|589274561|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
163152483|NCT03175367|589274562|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
163152484|NCT03175367|589274556|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152485|NCT03175367|589274557|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162676126|NCT02734212|587522909|FG000|Overall Study|Lost to Follow-up|5|||
163152486|NCT03175367|589274558|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152487|NCT03175367|589274559|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152488|NCT03175367|589274560|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
163152489|NCT03175367|589274561|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
163152490|NCT03175367|589274562|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
163152491|NCT02851615|589274563|FG000|Overall Study|Cognitive Issue|1|||
163152492|NCT02851615|589274564|FG001|Overall Study|Cognitive Issue|0|||
163152493|NCT02851615|589274563|FG000|Overall Study|Lost to Follow-up|0|||
163152494|NCT02851615|589274564|FG001|Overall Study|Lost to Follow-up|4|||
163152495|NCT02345070|589274566|FG000|Overall Study|Adverse Event|12|||
163152496|NCT02345070|589274567|FG001|Overall Study|Adverse Event|8|||
163152497|NCT02345070|589274568|FG002|Overall Study|Adverse Event|16|||
163152498|NCT02345070|589274566|FG000|Overall Study|Poor compliance to protocol|2|||
163152499|NCT02345070|589274567|FG001|Overall Study|Poor compliance to protocol|0|||
163152500|NCT02345070|589274568|FG002|Overall Study|Poor compliance to protocol|0|||
163152501|NCT02345070|589274566|FG000|Overall Study|Other than specified above|6|||
163152502|NCT02345070|589274567|FG001|Overall Study|Other than specified above|3|||
163152503|NCT02345070|589274568|FG002|Overall Study|Other than specified above|7|||
163152504|NCT02151058|589274569|FG000|Overall Study|Withdrawal by Subject|1|||
163152505|NCT02151058|589274570|FG001|Overall Study|Withdrawal by Subject|1|||
163152506|NCT02151058|589274571|FG002|Overall Study|Withdrawal by Subject|3|||
163152507|NCT02151058|589274569|FG000|Overall Study|Lost to Follow-up|1|||
163152508|NCT02151058|589274570|FG001|Overall Study|Lost to Follow-up|0|||
163152509|NCT02151058|589274571|FG002|Overall Study|Lost to Follow-up|2|||
163152510|NCT00321620|589274573|FG000|Overall Study|Death|269|||
163152511|NCT00321620|589274574|FG001|Overall Study|Death|294|||
163152512|NCT00321620|589274573|FG000|Overall Study|Withdrawal by Subject|164|||
163152513|NCT00321620|589274574|FG001|Overall Study|Withdrawal by Subject|147|||
163152514|NCT00321620|589274573|FG000|Overall Study|Disease progression|113|||
163152515|NCT00321620|589274574|FG001|Overall Study|Disease progression|117|||
163152516|NCT00321620|589274573|FG000|Overall Study|Adverse Event|43|||
163152517|NCT00321620|589274574|FG001|Overall Study|Adverse Event|56|||
163152518|NCT00321620|589274573|FG000|Overall Study|Lost to Follow-up|13|||
163152519|NCT00321620|589274574|FG001|Overall Study|Lost to Follow-up|9|||
163152520|NCT00321620|589274573|FG000|Overall Study|Physician Decision|4|||
163152521|NCT00321620|589274574|FG001|Overall Study|Physician Decision|1|||
163152522|NCT00321620|589274573|FG000|Overall Study|Noncompliance|14|||
163152523|NCT00321620|589274574|FG001|Overall Study|Noncompliance|7|||
163152524|NCT00321620|589274573|FG000|Overall Study|Protocol deviation|4|||
163152525|NCT00321620|589274574|FG001|Overall Study|Protocol deviation|3|||
163152526|NCT00321620|589274573|FG000|Overall Study|Ineligibility determined|2|||
163152527|NCT00321620|589274574|FG001|Overall Study|Ineligibility determined|3|||
163152528|NCT00321620|589274573|FG000|Overall Study|Participant request|75|||
163152529|NCT00321620|589274574|FG001|Overall Study|Participant request|52|||
163152530|NCT00321620|589274573|FG000|Overall Study|Other|42|||
163152531|NCT00321620|589274574|FG001|Overall Study|Other|33|||
163152532|NCT03337477|589274575|FG000|Overall Study|not categorized into the listed ones|11|||
163152533|NCT03337477|589274576|FG001|Overall Study|not categorized into the listed ones|9|||
163152534|NCT03337477|589274575|FG000|Overall Study|Withdrawal by Subject|0|||
163152535|NCT03337477|589274576|FG001|Overall Study|Withdrawal by Subject|1|||
163152536|NCT03337477|589274575|FG000|Overall Study|Death|0|||
163152537|NCT03337477|589274576|FG001|Overall Study|Death|1|||
163152538|NCT03337477|589274575|FG000|Overall Study|Lost to Follow-up|0|||
163152539|NCT03337477|589274576|FG001|Overall Study|Lost to Follow-up|2|||
163152540|NCT03198715|589274578|FG000|Overall Study|Death|0|||
163152541|NCT03198715|589274579|FG001|Overall Study|Death|0|||
163152542|NCT03198715|589274580|FG002|Overall Study|Death|1|||
163152543|NCT03198715|589274581|FG003|Overall Study|Death|0|||
163152544|NCT03198715|589274582|FG004|Overall Study|Death|2|||
163152545|NCT03198715|589274578|FG000|Overall Study|Other|0|||
163152546|NCT03198715|589274579|FG001|Overall Study|Other|1|||
163152547|NCT03198715|589274580|FG002|Overall Study|Other|1|||
163152548|NCT03198715|589274581|FG003|Overall Study|Other|0|||
163152549|NCT03198715|589274582|FG004|Overall Study|Other|0|||
163152550|NCT02379728|589274583|FG000|Overall Study|Lost to Follow-up|1|||
163152551|NCT02379728|589274584|FG001|Overall Study|Lost to Follow-up|0|||
163152552|NCT02379728|589274585|FG002|Overall Study|Lost to Follow-up|3|||
163152553|NCT02379728|589274586|FG003|Overall Study|Lost to Follow-up|0|||
163152554|NCT02379728|589274583|FG000|Overall Study|Withdrawal by Subject|5|||
163152555|NCT02379728|589274584|FG001|Overall Study|Withdrawal by Subject|0|||
163152556|NCT02379728|589274585|FG002|Overall Study|Withdrawal by Subject|5|||
163152557|NCT02379728|589274586|FG003|Overall Study|Withdrawal by Subject|3|||
163152558|NCT02379728|589274583|FG000|Overall Study|Protocol Violation|0|||
163152559|NCT02379728|589274584|FG001|Overall Study|Protocol Violation|0|||
163152560|NCT02379728|589274585|FG002|Overall Study|Protocol Violation|2|||
163152561|NCT02379728|589274586|FG003|Overall Study|Protocol Violation|0|||
163152562|NCT01112917|589274588|FG000|Overall Study|Death|2|||
163152563|NCT01112917|589274589|FG001|Overall Study|Death|11|||
163152564|NCT01112917|589274588|FG000|Overall Study|Lost to Follow-up|1|||
163152565|NCT01112917|589274589|FG001|Overall Study|Lost to Follow-up|1|||
163152566|NCT01112917|589274588|FG000|Overall Study|Withdrawal by Subject|1|||
163152567|NCT01112917|589274589|FG001|Overall Study|Withdrawal by Subject|3|||
163152568|NCT01112917|589274588|FG000|Overall Study|Unable to Convert Filter|3|||
163152569|NCT01112917|589274589|FG001|Overall Study|Unable to Convert Filter|0|||
163152570|NCT05101122|589274590|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
163152571|NCT05101122|589274590|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
163152572|NCT05101122|589274590|FG000|AD313 80/5|Withdrawal by Subject|1|||
163152573|NCT05101122|589274590|FG000|AD313 80/10|Physician Decision|1|||
163152574|NCT03131219|589274591|FG000|Initial Evaluation Period|Adverse Event|2|||
163152575|NCT03131219|589274592|FG001|Initial Evaluation Period|Adverse Event|0|||
163152576|NCT03131219|589274591|FG000|Initial Evaluation Period|Protocol Violation|1|||
163152577|NCT03131219|589274592|FG001|Initial Evaluation Period|Protocol Violation|0|||
163152578|NCT03131219|589274591|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
163152579|NCT03131219|589274592|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
163152580|NCT03131219|589274591|FG000|Initial Evaluation Period|Physician Decision|1|||
163152581|NCT03131219|589274592|FG001|Initial Evaluation Period|Physician Decision|0|||
163152582|NCT03131219|589274591|FG000|Extension Period|Physician Decision|1|||
163152583|NCT03131219|589274592|FG001|Extension Period|Physician Decision|0|||
163152584|NCT00616759|589274594|FG000|Overall Study|Physician Decision|2|||
163152585|NCT00616759|589274595|FG001|Overall Study|Physician Decision|0|||
163152586|NCT00616759|589274594|FG000|Overall Study|Withdrawal by Subject|1|||
163152587|NCT00616759|589274595|FG001|Overall Study|Withdrawal by Subject|2|||
163152588|NCT02399163|589274598|FG000|Overall Study|Adverse Event|2|||
163152589|NCT02399163|589274598|FG000|Overall Study|Protocol Deviation|2|||
163152590|NCT02399163|589274598|FG000|Overall Study|Withdrawal by Participant|5|||
163152591|NCT04613362|589274609|FG000|3 Month Follow-up|Lost to Follow-up|1|||
163152592|NCT04613362|589274610|FG001|3 Month Follow-up|Lost to Follow-up|2|||
163152593|NCT04613362|589274609|FG000|6 Month Follow-up|Lost to Follow-up|0|||
163152594|NCT04613362|589274610|FG001|6 Month Follow-up|Lost to Follow-up|1|||
163152595|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152596|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
163152597|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152598|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152599|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152600|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152601|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152602|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152603|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152604|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152605|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152606|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
163152607|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152608|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152609|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
163152610|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152611|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152612|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152613|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152614|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152615|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152616|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152617|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152618|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
163152619|NCT04225897|589274611|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152620|NCT04225897|589274612|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152621|NCT04225897|589274613|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
163152622|NCT04225897|589274614|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152623|NCT04225897|589274615|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152624|NCT04225897|589274616|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152625|NCT04225897|589274617|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152626|NCT04225897|589274618|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152627|NCT04225897|589274619|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152628|NCT04225897|589274620|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152629|NCT04225897|589274621|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152630|NCT04225897|589274622|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
163152631|NCT04225897|589274611|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152632|NCT04225897|589274612|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152633|NCT04225897|589274613|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152634|NCT04225897|589274614|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152635|NCT04225897|589274615|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152636|NCT04225897|589274616|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152637|NCT04225897|589274617|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152638|NCT04225897|589274618|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
163152639|NCT04225897|589274619|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152640|NCT04225897|589274620|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152641|NCT04225897|589274621|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152642|NCT04225897|589274622|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
163152643|NCT00074711|589274624|FG000|Overall Study|Withdrawal by Subject|1|||
163152644|NCT00074711|589274625|FG001|Overall Study|Withdrawal by Subject|1|||
163152645|NCT00074711|589274624|FG000|Overall Study|Lost to Follow-up|10|||
163152646|NCT00074711|589274625|FG001|Overall Study|Lost to Follow-up|8|||
163152647|NCT00074711|589274624|FG000|Overall Study|Participant stopped study drug|4|||
163152648|NCT00074711|589274625|FG001|Overall Study|Participant stopped study drug|6|||
163152649|NCT03466658|589274626|FG000|Overall Study|Withdrawal by Subject|3|||
163152650|NCT01921205|589274627|FG000|Overall Study|Adverse Event|12|||
163152651|NCT01921205|589274628|FG001|Overall Study|Adverse Event|7|||
163152652|NCT01921205|589274627|FG000|Overall Study|Lack of Efficacy|1|||
163152653|NCT01921205|589274628|FG001|Overall Study|Lack of Efficacy|0|||
163152654|NCT01921205|589274627|FG000|Overall Study|Protocol Violation|1|||
163152655|NCT01921205|589274628|FG001|Overall Study|Protocol Violation|3|||
163152656|NCT01921205|589274627|FG000|Overall Study|Lost to Follow-up|1|||
163152657|NCT01921205|589274628|FG001|Overall Study|Lost to Follow-up|1|||
163152658|NCT01921205|589274627|FG000|Overall Study|Withdrawal by Subject|6|||
163152659|NCT01921205|589274628|FG001|Overall Study|Withdrawal by Subject|5|||
163152660|NCT01921205|589274627|FG000|Overall Study|Use Of Prohibited Medication|0|||
163152661|NCT01921205|589274628|FG001|Overall Study|Use Of Prohibited Medication|1|||
163152662|NCT01921205|589274627|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
163152663|NCT01921205|589274628|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
163152664|NCT01921205|589274627|FG000|Overall Study|Non Compliance Of The Parent|0|||
163152665|NCT01921205|589274628|FG001|Overall Study|Non Compliance Of The Parent|1|||
163152666|NCT01921205|589274627|FG000|Overall Study|Non Compliance Of Child|0|||
163152667|NCT01921205|589274628|FG001|Overall Study|Non Compliance Of Child|1|||
163152668|NCT00456846|589274629|FG000|Overall Study|Adverse Event|2|||
163152669|NCT00456846|589274630|FG001|Overall Study|Adverse Event|15|||
163152670|NCT00456846|589274629|FG000|Overall Study|Physician Decision|11|||
163152671|NCT00456846|589274630|FG001|Overall Study|Physician Decision|6|||
163152672|NCT00456846|589274629|FG000|Overall Study|Protocol Deviation|2|||
163152673|NCT00456846|589274630|FG001|Overall Study|Protocol Deviation|0|||
163152674|NCT00456846|589274629|FG000|Overall Study|Participant Discretion|1|||
163152675|NCT00456846|589274630|FG001|Overall Study|Participant Discretion|5|||
163152676|NCT00456846|589274629|FG000|Overall Study|Other|0|||
163152677|NCT00456846|589274630|FG001|Overall Study|Other|2|||
163152678|NCT00886379|589274631|FG000|Overall Study|Transferred Schools|0|||
163152679|NCT00886379|589274632|FG001|Overall Study|Transferred Schools|0|||
163152680|NCT00886379|589274633|FG002|Overall Study|Transferred Schools|2|||
163152681|NCT00886379|589274634|FG003|Overall Study|Transferred Schools|1|||
163152682|NCT00886379|589274635|FG004|Overall Study|Transferred Schools|1|||
163152683|NCT00886379|589274631|FG000|Overall Study|Final blood draw not obtained|3|||
163152684|NCT00886379|589274632|FG001|Overall Study|Final blood draw not obtained|3|||
163152685|NCT00886379|589274633|FG002|Overall Study|Final blood draw not obtained|4|||
163152686|NCT00886379|589274634|FG003|Overall Study|Final blood draw not obtained|2|||
163152687|NCT00886379|589274635|FG004|Overall Study|Final blood draw not obtained|2|||
163152688|NCT03137381|589274636|FG000|Overall Study|Adverse Event|3|||
163152689|NCT03137381|589274637|FG001|Overall Study|Adverse Event|0|||
163152690|NCT03137381|589274638|FG002|Overall Study|Adverse Event|2|||
163152691|NCT03137381|589274639|FG003|Overall Study|Adverse Event|0|||
163152692|NCT03137381|589274636|FG000|Overall Study|Lost to Follow-up|2|||
163152693|NCT03137381|589274637|FG001|Overall Study|Lost to Follow-up|1|||
163152694|NCT03137381|589274638|FG002|Overall Study|Lost to Follow-up|1|||
163152695|NCT03137381|589274639|FG003|Overall Study|Lost to Follow-up|0|||
163152696|NCT03137381|589274636|FG000|Overall Study|Protocol deviation|1|||
163152697|NCT03137381|589274637|FG001|Overall Study|Protocol deviation|1|||
163152698|NCT03137381|589274638|FG002|Overall Study|Protocol deviation|0|||
163152699|NCT03137381|589274639|FG003|Overall Study|Protocol deviation|1|||
163152700|NCT03137381|589274636|FG000|Overall Study|Withdrawal by Investigator|0|||
163152701|NCT03137381|589274637|FG001|Overall Study|Withdrawal by Investigator|1|||
163152702|NCT03137381|589274638|FG002|Overall Study|Withdrawal by Investigator|1|||
163152703|NCT03137381|589274639|FG003|Overall Study|Withdrawal by Investigator|0|||
163152704|NCT03137381|589274636|FG000|Overall Study|Withdrawal by Subject|3|||
163152705|NCT03137381|589274637|FG001|Overall Study|Withdrawal by Subject|4|||
163152706|NCT03137381|589274638|FG002|Overall Study|Withdrawal by Subject|3|||
163152707|NCT03137381|589274639|FG003|Overall Study|Withdrawal by Subject|0|||
163152708|NCT03137381|589274636|FG000|Overall Study|Pregnancy|0|||
163152709|NCT03137381|589274637|FG001|Overall Study|Pregnancy|0|||
163152710|NCT03137381|589274638|FG002|Overall Study|Pregnancy|1|||
163152711|NCT03137381|589274639|FG003|Overall Study|Pregnancy|0|||
163152712|NCT00459316|589274644|FG000|Steps 1 & 2|Other eligibility failure|1|||
163152713|NCT00459316|589274645|FG001|Steps 1 & 2|Other eligibility failure|1|||
163152714|NCT00459316|589274646|FG002|Steps 1 & 2|Other eligibility failure|0|||
163152715|NCT00459316|589274644|FG000|Steps 1 & 2|Death|1|||
163152716|NCT00459316|589274645|FG001|Steps 1 & 2|Death|1|||
163152717|NCT00459316|589274646|FG002|Steps 1 & 2|Death|0|||
163152718|NCT00459316|589274644|FG000|Steps 1 & 2|Not able to get to clinic|7|||
163152719|NCT00459316|589274645|FG001|Steps 1 & 2|Not able to get to clinic|4|||
163152720|NCT00459316|589274646|FG002|Steps 1 & 2|Not able to get to clinic|0|||
163152721|NCT00459316|589274644|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
163152722|NCT00459316|589274645|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
163152723|NCT00459316|589274646|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
163152724|NCT00459316|589274644|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
163152725|NCT00459316|589274645|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
163152726|NCT00459316|589274646|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
163152727|NCT00459316|589274644|FG000|Steps 1 & 2|Lost to Follow-up|5|||
163152728|NCT00459316|589274645|FG001|Steps 1 & 2|Lost to Follow-up|0|||
163152729|NCT00459316|589274646|FG002|Steps 1 & 2|Lost to Follow-up|2|||
163152730|NCT00459316|589274644|FG000|Step 3|Withdrawal by Subject|3|||
162676127|NCT02734212|587522910|FG001|Overall Study|Lost to Follow-up|10|||
162676128|NCT01939028|587522911|FG000|Overall Study|Withdrawal by Subject|5|||
162676129|NCT01939028|587522911|FG000|Overall Study|Physician Decision|7|||
162676130|NCT03282227|587522914|FG000|Overall Study|Exposure Goals Achieved|60|||
162676131|NCT03282227|587522914|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
162676132|NCT03282227|587522914|FG000|Overall Study|Adverse Event|15|||
162676133|NCT03282227|587522914|FG000|Overall Study|Lost to Follow-up|21|||
162676134|NCT03282227|587522914|FG000|Overall Study|Withdrawal by Subject|20|||
162676135|NCT03282227|587522914|FG000|Overall Study|Lack of Efficacy|12|||
162676136|NCT03282227|587522914|FG000|Overall Study|Sponsor decision|3|||
162676137|NCT03282227|587522914|FG000|Overall Study|Physician Decision|2|||
162676138|NCT03282227|587522914|FG000|Overall Study|Pregnancy|2|||
162676139|NCT03282227|587522914|FG000|Overall Study|Other|1|||
162676140|NCT02576678|587522915|FG000|Overall Study|Adverse Event|0|||
162676141|NCT02576678|587522916|FG001|Overall Study|Adverse Event|0|||
162676142|NCT02576678|587522917|FG002|Overall Study|Adverse Event|2|||
162676143|NCT02576678|587522915|FG000|Overall Study|Withdrawal by Subject|3|||
162676144|NCT02576678|587522916|FG001|Overall Study|Withdrawal by Subject|1|||
162676145|NCT02576678|587522917|FG002|Overall Study|Withdrawal by Subject|2|||
162676146|NCT02576678|587522915|FG000|Overall Study|Lost to Follow-up|0|||
162676147|NCT02576678|587522916|FG001|Overall Study|Lost to Follow-up|0|||
162676148|NCT02576678|587522917|FG002|Overall Study|Lost to Follow-up|1|||
162676149|NCT02576678|587522915|FG000|Overall Study|Miscellaneous|2|||
162676150|NCT02576678|587522916|FG001|Overall Study|Miscellaneous|0|||
162676151|NCT02576678|587522917|FG002|Overall Study|Miscellaneous|0|||
162676152|NCT00700401|587522928|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
162676153|NCT00700401|587522928|FG000|Overall Study|Adverse Event|5|||
162676154|NCT00700401|587522928|FG000|Overall Study|Refused Treatment|2|||
162676155|NCT00700401|587522928|FG000|Overall Study|Lost to Follow-up|1|||
162676156|NCT00700401|587522928|FG000|Overall Study|Treatment never started|1|||
162676157|NCT00700401|587522928|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
162676158|NCT00700401|587522928|FG000|Overall Study|Withdrawal by Subject|2|||
162676159|NCT02491671|587522929|FG000|Overall Study|Adverse Event|6|||
162676160|NCT02491671|587522930|FG001|Overall Study|Adverse Event|8|||
162676161|NCT02491671|587522929|FG000|Overall Study|Death|0|||
162676162|NCT02491671|587522930|FG001|Overall Study|Death|2|||
162676163|NCT02491671|587522929|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
162676164|NCT02491671|587522930|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
162676165|NCT02251990|587522934|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
162676166|NCT02251990|587522935|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
162676167|NCT02251990|587522934|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
162676168|NCT02251990|587522935|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
162676169|NCT02251990|587522934|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
162676170|NCT02251990|587522935|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
162676171|NCT02251990|587522934|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
162676172|NCT02251990|587522935|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
162676173|NCT02251990|587522934|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
162676174|NCT02251990|587522935|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
162676175|NCT02251990|587522934|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
162676176|NCT02251990|587522935|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
162676177|NCT02293538|587522936|FG000|Overall Study|Adverse Event|0|||
162676178|NCT02293538|587522937|FG001|Overall Study|Adverse Event|1|||
162676179|NCT02293538|587522936|FG000|Overall Study|Lost to Follow-up|1|||
162676180|NCT02293538|587522937|FG001|Overall Study|Lost to Follow-up|0|||
162676181|NCT02293538|587522936|FG000|Overall Study|Withdrawal by Subject|0|||
162676182|NCT02293538|587522937|FG001|Overall Study|Withdrawal by Subject|1|||
162676183|NCT00322348|587522938|FG000|Overall Study|Adverse Event|0|||
162676184|NCT00322348|587522939|FG001|Overall Study|Adverse Event|1|||
162676185|NCT00322348|587522938|FG000|Overall Study|Withdrawal by Subject|1|||
162676186|NCT00322348|587522939|FG001|Overall Study|Withdrawal by Subject|4|||
162676187|NCT00322348|587522938|FG000|Overall Study|Lost to Follow-up|1|||
162676188|NCT00322348|587522939|FG001|Overall Study|Lost to Follow-up|0|||
162676189|NCT00322348|587522938|FG000|Overall Study|Death|0|||
162676190|NCT00322348|587522939|FG001|Overall Study|Death|2|||
162676191|NCT00322348|587522938|FG000|Overall Study|Disease Progression|30|||
162676192|NCT00322348|587522939|FG001|Overall Study|Disease Progression|25|||
162676193|NCT00322348|587522938|FG000|Overall Study|Reasons not specified|5|||
162676194|NCT00322348|587522939|FG001|Overall Study|Reasons not specified|1|||
162676195|NCT01041638|587522941|FG000|Overall Study|Adverse Event|4|||
162676196|NCT01041638|587522941|FG000|Overall Study|Death|1|||
162676197|NCT01041638|587522941|FG000|Overall Study|Lack of Efficacy|7|||
162676198|NCT01041638|587522941|FG000|Overall Study|Physician Decision|4|||
162676199|NCT01041638|587522941|FG000|Overall Study|Withdrawal by Subject|11|||
162676200|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
162676201|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
162676202|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
162676203|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
162676204|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
162676205|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162676206|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
162676207|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162676208|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162676209|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162676210|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
162676211|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
162676212|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
162676213|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
162676214|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
162676215|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162676216|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162676217|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162676218|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162676219|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162676220|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162676221|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162676222|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
162676223|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162676224|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162676225|NCT03152552|587522942|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162676226|NCT03152552|587522943|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162676227|NCT03152552|587522944|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162676228|NCT03152552|587522945|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
162676229|NCT03152552|587522946|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162676230|NCT03152552|587522942|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
162676231|NCT03152552|587522943|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
162676232|NCT03152552|587522944|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
162676233|NCT03152552|587522945|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
162676234|NCT03152552|587522946|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
162676235|NCT00683644|587522952|FG000|Overall Study|Withdrawal by Subject|4|||
162676236|NCT00683644|587522953|FG001|Overall Study|Withdrawal by Subject|2|||
162676237|NCT00683644|587522952|FG000|Overall Study|Lost to Follow-up|1|||
162676238|NCT00683644|587522953|FG001|Overall Study|Lost to Follow-up|4|||
162676239|NCT00683644|587522952|FG000|Overall Study|Adverse Event|1|||
162676240|NCT00683644|587522953|FG001|Overall Study|Adverse Event|2|||
162676241|NCT00683644|587522952|FG000|Overall Study|Low copper, other health problems,|7|||
162676242|NCT00683644|587522953|FG001|Overall Study|Low copper, other health problems,|6|||
162676243|NCT03240692|587522954|FG000|Overall Study|Physician Decision|1|||
163152731|NCT00459316|589274645|FG001|Step 3|Withdrawal by Subject|0|||
163152732|NCT00459316|589274646|FG002|Step 3|Withdrawal by Subject|1|||
163152733|NCT01614886|589274647|FG000|Overall Study|Adverse Event|15|||
163152734|NCT01614886|589274648|FG001|Overall Study|Adverse Event|20|||
163152735|NCT01614886|589274647|FG000|Overall Study|Withdrawal by Subject|4|||
163152736|NCT01614886|589274648|FG001|Overall Study|Withdrawal by Subject|4|||
163152737|NCT01614886|589274647|FG000|Overall Study|Death|1|||
163152738|NCT01614886|589274648|FG001|Overall Study|Death|0|||
163152739|NCT01614886|589274647|FG000|Overall Study|Protocol deviation|0|||
163152740|NCT01614886|589274648|FG001|Overall Study|Protocol deviation|2|||
163152741|NCT03379818|589274650|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
163152742|NCT03379818|589274651|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
163152743|NCT03379818|589274650|FG000|Overall Study|Withdrawal by Subject|2|||
163152744|NCT03379818|589274651|FG001|Overall Study|Withdrawal by Subject|3|||
163152745|NCT03379818|589274650|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
163152746|NCT03379818|589274651|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
163152747|NCT00423579|589274652|FG000|Overall Study|Lost to Follow-up|3|||
163152748|NCT00423579|589274653|FG001|Overall Study|Lost to Follow-up|0|||
163152749|NCT00423579|589274652|FG000|Overall Study|Protocol Violation|1|||
163152750|NCT00423579|589274653|FG001|Overall Study|Protocol Violation|3|||
163152751|NCT00423579|589274652|FG000|Overall Study|Diagnosis of diabetes|0|||
163152752|NCT00423579|589274653|FG001|Overall Study|Diagnosis of diabetes|1|||
163152753|NCT04004988|589274655|FG000|Period 1|Physician Decision|2|||
163152754|NCT04004988|589274656|FG001|Period 1|Physician Decision|0|||
163152755|NCT04004988|589274655|FG000|Period 1|Withdrawal by Subject|0|||
163152756|NCT04004988|589274656|FG001|Period 1|Withdrawal by Subject|1|||
163152757|NCT04004988|589274655|FG000|Period 1|Adverse Event|1|||
163152758|NCT04004988|589274656|FG001|Period 1|Adverse Event|2|||
163152759|NCT03873116|589274657|FG000|Part 1|Study drug discontinuation due to rash|0|||
163152760|NCT03873116|589274658|FG001|Part 1|Study drug discontinuation due to rash|0|||
163152761|NCT03873116|589274659|FG002|Part 1|Study drug discontinuation due to rash|0|||
163152762|NCT03873116|589274660|FG003|Part 1|Study drug discontinuation due to rash|0|||
163152763|NCT03873116|589274661|FG004|Part 1|Study drug discontinuation due to rash|0|||
163152764|NCT03873116|589274662|FG005|Part 1|Study drug discontinuation due to rash|1|||
163152765|NCT03873116|589274657|FG000|Part 2|Withdrawal by Subject|0|||
163152766|NCT03873116|589274658|FG001|Part 2|Withdrawal by Subject|0|||
163152767|NCT03873116|589274659|FG002|Part 2|Withdrawal by Subject|1|||
163152768|NCT03873116|589274660|FG003|Part 2|Withdrawal by Subject|0|||
163152769|NCT03873116|589274661|FG004|Part 2|Withdrawal by Subject|0|||
163152770|NCT03873116|589274662|FG005|Part 2|Withdrawal by Subject|0|||
163152771|NCT03873116|589274657|FG000|Part 2|Lab abnormality or AE|0|||
163152772|NCT03873116|589274658|FG001|Part 2|Lab abnormality or AE|0|||
163152773|NCT03873116|589274659|FG002|Part 2|Lab abnormality or AE|0|||
163152774|NCT03873116|589274660|FG003|Part 2|Lab abnormality or AE|0|||
163152775|NCT03873116|589274661|FG004|Part 2|Lab abnormality or AE|1|||
163152776|NCT03873116|589274662|FG005|Part 2|Lab abnormality or AE|0|||
163152777|NCT03873116|589274657|FG000|Part 3|Withdrawal by Subject|0|||
163152778|NCT03873116|589274658|FG001|Part 3|Withdrawal by Subject|0|||
163152779|NCT03873116|589274659|FG002|Part 3|Withdrawal by Subject|0|||
163152780|NCT03873116|589274660|FG003|Part 3|Withdrawal by Subject|0|||
163152781|NCT03873116|589274661|FG004|Part 3|Withdrawal by Subject|1|||
163152782|NCT03873116|589274662|FG005|Part 3|Withdrawal by Subject|0|||
163152783|NCT00003475|589274663|FG000|Overall Study|Not evaluable|13|||
163152784|NCT04682366|589274664|FG000|Overall Study|Lost to Follow-up|1|||
163152785|NCT04682366|589274665|FG001|Overall Study|Lost to Follow-up|1|||
163152786|NCT03125395|589274666|FG000|Overall Study|Adverse Event|2|||
163152787|NCT03125395|589274666|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163152788|NCT03125395|589274666|FG000|Overall Study|Physician Decision|2|||
163152789|NCT03125395|589274666|FG000|Overall Study|Commercial drug is available|5|||
163152790|NCT02531802|589274667|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
163152791|NCT02531802|589274668|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
163152792|NCT02531802|589274669|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
163152793|NCT02531802|589274670|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
163152794|NCT02531802|589274671|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
163152795|NCT02531802|589274672|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
163152796|NCT02531802|589274673|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
163152797|NCT02531802|589274674|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
163152798|NCT02531802|589274675|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
163152799|NCT02531802|589274676|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
163152800|NCT02531802|589274677|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
163152801|NCT02531802|589274678|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
163152802|NCT02531802|589274679|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
163152803|NCT02531802|589274680|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
163152804|NCT02531802|589274681|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
163152805|NCT02531802|589274682|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
163152806|NCT02531802|589274683|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
163152807|NCT02531802|589274684|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
163152808|NCT02531802|589274685|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
163152809|NCT02531802|589274686|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
163152810|NCT02531802|589274687|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
163152811|NCT02531802|589274667|FG000|Received Vaccination 2|Physician Decision|0|||
163152812|NCT02531802|589274668|FG001|Received Vaccination 2|Physician Decision|0|||
163152813|NCT02531802|589274669|FG002|Received Vaccination 2|Physician Decision|0|||
163152814|NCT02531802|589274670|FG003|Received Vaccination 2|Physician Decision|0|||
163152815|NCT02531802|589274671|FG004|Received Vaccination 2|Physician Decision|0|||
163152816|NCT02531802|589274672|FG005|Received Vaccination 2|Physician Decision|1|||
163152817|NCT02531802|589274673|FG006|Received Vaccination 2|Physician Decision|0|||
163152818|NCT02531802|589274674|FG007|Received Vaccination 2|Physician Decision|0|||
163152819|NCT02531802|589274675|FG008|Received Vaccination 2|Physician Decision|0|||
163152820|NCT02531802|589274676|FG009|Received Vaccination 2|Physician Decision|2|||
163152821|NCT02531802|589274677|FG010|Received Vaccination 2|Physician Decision|0|||
163152822|NCT02531802|589274678|FG011|Received Vaccination 2|Physician Decision|0|||
163152823|NCT02531802|589274679|FG012|Received Vaccination 2|Physician Decision|0|||
163152824|NCT02531802|589274680|FG013|Received Vaccination 2|Physician Decision|1|||
163152825|NCT02531802|589274681|FG014|Received Vaccination 2|Physician Decision|0|||
163152826|NCT02531802|589274682|FG015|Received Vaccination 2|Physician Decision|0|||
163152827|NCT02531802|589274683|FG016|Received Vaccination 2|Physician Decision|0|||
163152828|NCT02531802|589274684|FG017|Received Vaccination 2|Physician Decision|1|||
163152829|NCT02531802|589274685|FG018|Received Vaccination 2|Physician Decision|0|||
163152830|NCT02531802|589274686|FG019|Received Vaccination 2|Physician Decision|0|||
163152831|NCT02531802|589274687|FG020|Received Vaccination 2|Physician Decision|0|||
163152832|NCT02531802|589274667|FG000|Received Vaccination 2|Adverse Event|0|||
163152833|NCT02531802|589274668|FG001|Received Vaccination 2|Adverse Event|0|||
163152834|NCT02531802|589274669|FG002|Received Vaccination 2|Adverse Event|0|||
163152835|NCT02531802|589274670|FG003|Received Vaccination 2|Adverse Event|0|||
163152836|NCT02531802|589274671|FG004|Received Vaccination 2|Adverse Event|0|||
163152837|NCT02531802|589274672|FG005|Received Vaccination 2|Adverse Event|2|||
163152838|NCT02531802|589274673|FG006|Received Vaccination 2|Adverse Event|0|||
163152839|NCT02531802|589274674|FG007|Received Vaccination 2|Adverse Event|0|||
163152840|NCT02531802|589274675|FG008|Received Vaccination 2|Adverse Event|0|||
163152841|NCT02531802|589274676|FG009|Received Vaccination 2|Adverse Event|0|||
163152842|NCT02531802|589274677|FG010|Received Vaccination 2|Adverse Event|0|||
163152843|NCT02531802|589274678|FG011|Received Vaccination 2|Adverse Event|0|||
163152844|NCT02531802|589274679|FG012|Received Vaccination 2|Adverse Event|0|||
162676244|NCT03240692|587522954|FG000|Overall Study|Withdrawal by Subject|1|||
162676245|NCT01857531|587522955|FG000|Overall Study|Withdrawal by Subject|4|||
162676246|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
162676247|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
162676248|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
162676249|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
162676250|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
162676251|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
162676252|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
162676253|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
162676254|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
162676255|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
162676256|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
162676257|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
162676258|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
162676259|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
162676260|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
162676261|NCT00355082|587522956|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
162676262|NCT00355082|587522957|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
162676263|NCT00355082|587522958|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
162676264|NCT00355082|587522956|FG000|Continuation Phase|Adverse Event|2|||
162676265|NCT00355082|587522957|FG001|Continuation Phase|Adverse Event|0|||
162676266|NCT00355082|587522958|FG002|Continuation Phase|Adverse Event|1|||
162676267|NCT00355082|587522956|FG000|Continuation Phase|Lost to Follow-up|2|||
162676268|NCT00355082|587522957|FG001|Continuation Phase|Lost to Follow-up|0|||
162676269|NCT00355082|587522958|FG002|Continuation Phase|Lost to Follow-up|1|||
162676270|NCT00355082|587522956|FG000|Continuation Phase|Protocol Violation|1|||
162676271|NCT00355082|587522957|FG001|Continuation Phase|Protocol Violation|0|||
162676272|NCT00355082|587522958|FG002|Continuation Phase|Protocol Violation|1|||
162676273|NCT00355082|587522956|FG000|Continuation Phase|Withdrawal by Subject|4|||
162676274|NCT00355082|587522957|FG001|Continuation Phase|Withdrawal by Subject|0|||
162676275|NCT00355082|587522958|FG002|Continuation Phase|Withdrawal by Subject|0|||
162676276|NCT00355082|587522956|FG000|Continuation Phase|Lack of Efficacy|5|||
162676277|NCT00355082|587522957|FG001|Continuation Phase|Lack of Efficacy|0|||
162676278|NCT00355082|587522958|FG002|Continuation Phase|Lack of Efficacy|0|||
162676279|NCT00355082|587522956|FG000|Continuation Phase|Site Closed by Sponsor|8|||
162676280|NCT00355082|587522957|FG001|Continuation Phase|Site Closed by Sponsor|0|||
162676281|NCT00355082|587522958|FG002|Continuation Phase|Site Closed by Sponsor|0|||
162676282|NCT00355082|587522956|FG000|Continuation Phase|Scheduling Error|1|||
162676283|NCT00355082|587522957|FG001|Continuation Phase|Scheduling Error|0|||
162676284|NCT00355082|587522958|FG002|Continuation Phase|Scheduling Error|0|||
162676285|NCT00355082|587522956|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
162676286|NCT00355082|587522957|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
162676287|NCT00355082|587522958|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
162676288|NCT02576067|587522959|FG000|Overall Study|Death|0|||
162676289|NCT02576067|587522960|FG001|Overall Study|Death|1|||
162676290|NCT02576067|587522959|FG000|Overall Study|Lack of Efficacy|1|||
162676291|NCT02576067|587522960|FG001|Overall Study|Lack of Efficacy|0|||
162676292|NCT02576067|587522959|FG000|Overall Study|Lost to Follow-up|11|||
162676293|NCT02576067|587522960|FG001|Overall Study|Lost to Follow-up|0|||
162676294|NCT02576067|587522959|FG000|Overall Study|Withdrawal by Subject|11|||
162676295|NCT02576067|587522960|FG001|Overall Study|Withdrawal by Subject|2|||
162676296|NCT02576067|587522959|FG000|Overall Study|study closure of main CIRT trial)|0|||
162676297|NCT02576067|587522960|FG001|Overall Study|study closure of main CIRT trial)|8|||
162676298|NCT02576067|587522959|FG000|Overall Study|not randomized, failed run-in|7|||
162676299|NCT02576067|587522960|FG001|Overall Study|not randomized, failed run-in|0|||
162676300|NCT02576067|587522959|FG000|Overall Study|screen failure/ re-enrolled|0|||
162676301|NCT02576067|587522960|FG001|Overall Study|screen failure/ re-enrolled|25|||
162676302|NCT02576067|587522959|FG000|Overall Study|Physician Decision|4|||
162676303|NCT02576067|587522960|FG001|Overall Study|Physician Decision|0|||
162676304|NCT04084314|587522961|FG000|Overall Study|Subject/guardian decision|91|||
162676305|NCT04084314|587522961|FG000|Overall Study|Adverse Event|24|||
162676306|NCT04084314|587522961|FG000|Overall Study|Lost to Follow-up|19|||
162676307|NCT04084314|587522961|FG000|Overall Study|New therapy for study indication|9|||
162676308|NCT04084314|587522961|FG000|Overall Study|Pregnancy|9|||
162676309|NCT04084314|587522961|FG000|Overall Study|Withdrawal of informed consent|8|||
162676310|NCT04084314|587522961|FG000|Overall Study|Physician Decision|4|||
162676311|NCT04084314|587522961|FG000|Overall Study|Protocol Deviation|3|||
162676312|NCT00622167|587522962|FG000|Overall Study|Did not meet angiographic criteria|20|||
162676313|NCT02194621|587522969|FG000|Overall Study|6 withdrew prior to randomization|2|||
162676314|NCT02194621|587522970|FG001|Overall Study|6 withdrew prior to randomization|2|||
162676315|NCT02194621|587522971|FG002|Overall Study|6 withdrew prior to randomization|2|||
162676316|NCT02194621|587522969|FG000|Overall Study|Withdrawal by Subject|4|||
163152845|NCT02531802|589274680|FG013|Received Vaccination 2|Adverse Event|0|||
163152846|NCT02531802|589274681|FG014|Received Vaccination 2|Adverse Event|0|||
163152847|NCT02531802|589274682|FG015|Received Vaccination 2|Adverse Event|0|||
163152848|NCT02531802|589274683|FG016|Received Vaccination 2|Adverse Event|0|||
163152849|NCT02531802|589274684|FG017|Received Vaccination 2|Adverse Event|2|||
163152850|NCT02531802|589274685|FG018|Received Vaccination 2|Adverse Event|1|||
163152851|NCT02531802|589274686|FG019|Received Vaccination 2|Adverse Event|0|||
163152852|NCT02531802|589274687|FG020|Received Vaccination 2|Adverse Event|1|||
163152853|NCT02531802|589274667|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
163152854|NCT02531802|589274668|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
163152855|NCT02531802|589274669|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
163152856|NCT02531802|589274670|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
163152857|NCT02531802|589274671|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
163152858|NCT02531802|589274672|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
163152859|NCT02531802|589274673|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
163152860|NCT02531802|589274674|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
163152861|NCT02531802|589274675|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
163152862|NCT02531802|589274676|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
163152863|NCT02531802|589274677|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
163152864|NCT02531802|589274678|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
163152865|NCT02531802|589274679|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
163152866|NCT02531802|589274680|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
163152867|NCT02531802|589274681|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
163152868|NCT02531802|589274682|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
163152869|NCT02531802|589274683|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
163152870|NCT02531802|589274684|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
163152871|NCT02531802|589274685|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
163152872|NCT02531802|589274686|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
163152873|NCT02531802|589274687|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
163152874|NCT00482053|589274688|FG000|Inter-treatment Period|Disease progression|1|||
163152875|NCT04842747|589274692|FG000|Overall Study|Withdrawal by Subject|6|||
163152876|NCT04842747|589274693|FG001|Overall Study|Withdrawal by Subject|2|||
163152877|NCT04842747|589274692|FG000|Overall Study|Lost to Follow-up|1|||
163152878|NCT04842747|589274693|FG001|Overall Study|Lost to Follow-up|2|||
163152879|NCT04842747|589274692|FG000|Overall Study|Physician Decision|1|||
163152880|NCT04842747|589274693|FG001|Overall Study|Physician Decision|0|||
163152881|NCT04842747|589274692|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
163152882|NCT04842747|589274693|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
163152883|NCT02559622|589274695|FG000|Overall Study|Progressive disease|0|||
163152884|NCT02559622|589274696|FG001|Overall Study|Progressive disease|1|||
163152885|NCT02559622|589274697|FG002|Overall Study|Progressive disease|0|||
163152886|NCT02559622|589274698|FG003|Overall Study|Progressive disease|0|||
163152887|NCT02559622|589274695|FG000|Overall Study|Adverse Event|0|||
163152888|NCT02559622|589274696|FG001|Overall Study|Adverse Event|2|||
163152889|NCT02559622|589274697|FG002|Overall Study|Adverse Event|2|||
163152890|NCT02559622|589274698|FG003|Overall Study|Adverse Event|2|||
163152891|NCT02559622|589274695|FG000|Overall Study|Patient/guardian decision|1|||
163152892|NCT02559622|589274696|FG001|Overall Study|Patient/guardian decision|2|||
163152893|NCT02559622|589274697|FG002|Overall Study|Patient/guardian decision|0|||
163152894|NCT02559622|589274698|FG003|Overall Study|Patient/guardian decision|1|||
163152895|NCT04011540|589274699|FG000|Overall Study|Lost to Follow-up|9|||
163152896|NCT04011540|589274700|FG001|Overall Study|Lost to Follow-up|6|||
163152897|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
163152898|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
163152899|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
163152900|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
163152901|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
163152902|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
163152903|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
163152904|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
163152905|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
163152906|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
163152907|NCT01668784|589274714|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
163152908|NCT01668784|589274715|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
163152909|NCT01668784|589274714|FG000|Treatment Period|Disease Progression|316|||
163152910|NCT01668784|589274715|FG001|Treatment Period|Disease Progression|293|||
163152911|NCT01668784|589274714|FG000|Treatment Period|Study Drug Toxicity|46|||
163152912|NCT01668784|589274715|FG001|Treatment Period|Study Drug Toxicity|53|||
163152913|NCT01668784|589274714|FG000|Treatment Period|Death|1|||
163152914|NCT01668784|589274715|FG001|Treatment Period|Death|1|||
163152915|NCT01668784|589274714|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
163152916|NCT01668784|589274715|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
163152917|NCT01668784|589274714|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
163152918|NCT01668784|589274715|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
163152919|NCT01668784|589274714|FG000|Treatment Period|Withdrawal by Subject|5|||
163152920|NCT01668784|589274715|FG001|Treatment Period|Withdrawal by Subject|3|||
163152921|NCT01668784|589274714|FG000|Treatment Period|Maximal Clinical Benefit|3|||
163152922|NCT01668784|589274715|FG001|Treatment Period|Maximal Clinical Benefit|3|||
163152923|NCT01668784|589274714|FG000|Treatment Period|Other|2|||
163152924|NCT01668784|589274715|FG001|Treatment Period|Other|8|||
163152925|NCT01668784|589274714|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
163152926|NCT01668784|589274715|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
163152927|NCT02761330|589274716|FG000|Treatment Week 1|Withdrawal by Subject|0|||
163152928|NCT02761330|589274717|FG001|Treatment Week 1|Withdrawal by Subject|0|||
163152929|NCT02761330|589274718|FG002|Treatment Week 1|Withdrawal by Subject|0|||
163152930|NCT02761330|589274719|FG003|Treatment Week 1|Withdrawal by Subject|1|||
163152931|NCT02761330|589274720|FG004|Treatment Week 1|Withdrawal by Subject|0|||
163152932|NCT02761330|589274721|FG005|Treatment Week 1|Withdrawal by Subject|1|||
163152933|NCT05386329|589274722|FG000|Overall Study|Lost to Follow-up|3|||
163152934|NCT03043313|589274725|FG000|Overall Study|Withdrawal by Subject|5|||
163152935|NCT03043313|589274726|FG001|Overall Study|Withdrawal by Subject|1|||
163152936|NCT03043313|589274727|FG002|Overall Study|Withdrawal by Subject|1|||
163152937|NCT03043313|589274725|FG000|Overall Study|Lost to Follow-up|1|||
163152938|NCT03043313|589274726|FG001|Overall Study|Lost to Follow-up|1|||
163152939|NCT03043313|589274727|FG002|Overall Study|Lost to Follow-up|0|||
163152940|NCT03043313|589274725|FG000|Overall Study|Death|28|||
163152941|NCT03043313|589274726|FG001|Overall Study|Death|26|||
163152942|NCT03043313|589274727|FG002|Overall Study|Death|17|||
163152943|NCT03043313|589274725|FG000|Overall Study|Participation terminated by sponsor|11|||
163152944|NCT03043313|589274726|FG001|Overall Study|Participation terminated by sponsor|13|||
163152945|NCT03043313|589274727|FG002|Overall Study|Participation terminated by sponsor|13|||
163152946|NCT04973449|589274730|FG000|Overall Study|Withdrawal by Subject|3|||
163152947|NCT04973449|589274731|FG001|Overall Study|Withdrawal by Subject|3|||
163152948|NCT04973449|589274732|FG002|Overall Study|Withdrawal by Subject|2|||
163152949|NCT04973449|589274733|FG003|Overall Study|Withdrawal by Subject|5|||
163152950|NCT04973449|589274734|FG004|Overall Study|Withdrawal by Subject|5|||
163152951|NCT04973449|589274735|FG005|Overall Study|Withdrawal by Subject|4|||
163152952|NCT04973449|589274736|FG006|Overall Study|Withdrawal by Subject|7|||
163152953|NCT04973449|589274737|FG007|Overall Study|Withdrawal by Subject|5|||
163152954|NCT04973449|589274730|FG000|Overall Study|Lost to Follow-up|15|||
163152955|NCT04973449|589274731|FG001|Overall Study|Lost to Follow-up|16|||
163152956|NCT04973449|589274732|FG002|Overall Study|Lost to Follow-up|16|||
163152957|NCT04973449|589274733|FG003|Overall Study|Lost to Follow-up|13|||
163152958|NCT04973449|589274734|FG004|Overall Study|Lost to Follow-up|5|||
163152959|NCT04973449|589274735|FG005|Overall Study|Lost to Follow-up|6|||
163152960|NCT04973449|589274736|FG006|Overall Study|Lost to Follow-up|10|||
163152961|NCT04973449|589274737|FG007|Overall Study|Lost to Follow-up|6|||
163152962|NCT04973449|589274730|FG000|Overall Study|Death|1|||
163152963|NCT04973449|589274731|FG001|Overall Study|Death|0|||
163152964|NCT04973449|589274732|FG002|Overall Study|Death|0|||
163152965|NCT04973449|589274733|FG003|Overall Study|Death|0|||
162676317|NCT02194621|587522970|FG001|Overall Study|Withdrawal by Subject|4|||
162676318|NCT02194621|587522971|FG002|Overall Study|Withdrawal by Subject|7|||
162676319|NCT00714168|587522979|FG000|Overall Study|Pregnancy|5|||
162676320|NCT00714168|587522980|FG001|Overall Study|Pregnancy|4|||
162676321|NCT00714168|587522979|FG000|Overall Study|Lost to Follow-up|32|||
162676322|NCT00714168|587522980|FG001|Overall Study|Lost to Follow-up|50|||
162676323|NCT00714168|587522979|FG000|Overall Study|Relocation|4|||
162676324|NCT00714168|587522980|FG001|Overall Study|Relocation|3|||
162676325|NCT00714168|587522979|FG000|Overall Study|Non-study medical condition|3|||
162676326|NCT00714168|587522980|FG001|Overall Study|Non-study medical condition|2|||
162676327|NCT00809757|587522981|FG000|Overall Study|Adverse Event|2|||
162676328|NCT00809757|587522982|FG001|Overall Study|Adverse Event|3|||
162676329|NCT00809757|587522983|FG002|Overall Study|Adverse Event|3|||
162676330|NCT00809757|587522981|FG000|Overall Study|Lost to Follow-up|0|||
162676331|NCT00809757|587522982|FG001|Overall Study|Lost to Follow-up|0|||
162676332|NCT00809757|587522983|FG002|Overall Study|Lost to Follow-up|1|||
162676333|NCT00809757|587522981|FG000|Overall Study|Protocol Violation|1|||
162676334|NCT00809757|587522982|FG001|Overall Study|Protocol Violation|1|||
162676335|NCT00809757|587522983|FG002|Overall Study|Protocol Violation|1|||
162676336|NCT00809757|587522981|FG000|Overall Study|Withdrawal by Subject|2|||
162676337|NCT00809757|587522982|FG001|Overall Study|Withdrawal by Subject|1|||
162676338|NCT00809757|587522983|FG002|Overall Study|Withdrawal by Subject|3|||
162676339|NCT00809757|587522981|FG000|Overall Study|Subject Uncooperative|1|||
162676340|NCT00809757|587522982|FG001|Overall Study|Subject Uncooperative|0|||
162676341|NCT00809757|587522983|FG002|Overall Study|Subject Uncooperative|2|||
162676342|NCT00809757|587522981|FG000|Overall Study|Noncompliance with Medication|0|||
162676343|NCT00809757|587522982|FG001|Overall Study|Noncompliance with Medication|0|||
162676344|NCT00809757|587522983|FG002|Overall Study|Noncompliance with Medication|1|||
162676345|NCT03077724|587522984|FG000|Overall Study|Lost to Follow-up|5|||
162676346|NCT03077724|587522985|FG001|Overall Study|Lost to Follow-up|1|||
162676347|NCT03077724|587522984|FG000|Overall Study|Withdrawal by Subject|3|||
162676348|NCT03077724|587522985|FG001|Overall Study|Withdrawal by Subject|1|||
162676349|NCT00234065|587522986|FG000|Overall Study|Adverse Event|268|||
162676350|NCT00234065|587522987|FG001|Overall Study|Adverse Event|166|||
162676351|NCT00234065|587522986|FG000|Overall Study|Withdrawal by Subject|73|||
162676352|NCT00234065|587522987|FG001|Overall Study|Withdrawal by Subject|56|||
162676353|NCT00234065|587522986|FG000|Overall Study|Physician Decision|23|||
162676354|NCT00234065|587522987|FG001|Overall Study|Physician Decision|22|||
162676355|NCT00234065|587522986|FG000|Overall Study|Not Classified|111|||
162676356|NCT00234065|587522987|FG001|Overall Study|Not Classified|112|||
162676357|NCT05374421|587522988|FG000|Overall Study|Withdrawal by Subject|3|||
162676358|NCT05374421|587522989|FG001|Overall Study|Withdrawal by Subject|4|||
162676359|NCT00003508|587524916|FG000|Overall Study|Not evaluable|5|||
162676360|NCT03576768|587524918|FG000|Overall Study|Lost to Follow-up|3|||
162676361|NCT03576768|587524919|FG001|Overall Study|Lost to Follow-up|3|||
162676362|NCT03576768|587524920|FG002|Overall Study|Lost to Follow-up|0|||
162676363|NCT03576768|587524921|FG003|Overall Study|Lost to Follow-up|0|||
162676364|NCT00590902|587524922|FG000|Overall Study|Death|1|||
162676365|NCT02057874|587524923|FG000|Overall Study|participant did not return for scan|1|||
162676366|NCT02979639|587524924|FG000|Overall Study|Withdrawal based on medical judgement|1|||
162676367|NCT02979639|587524924|FG000|Overall Study|Lost to Follow-up|8|||
162676368|NCT02979639|587524924|FG000|Overall Study|Withdrawal by Subject|3|||
162676369|NCT02979639|587524924|FG000|Overall Study|Adverse Event|2|||
162676370|NCT01738984|587524927|FG000|Overall Study|Pregnancy|4|||
162676371|NCT01738984|587524928|FG001|Overall Study|Pregnancy|0|||
162676372|NCT01738984|587524927|FG000|Overall Study|Withdrawal by Subject|1|||
162676373|NCT01738984|587524928|FG001|Overall Study|Withdrawal by Subject|0|||
162676374|NCT01738984|587524927|FG000|Overall Study|Lost to Follow-up|59|||
162676375|NCT01738984|587524928|FG001|Overall Study|Lost to Follow-up|39|||
162676376|NCT02621931|587524933|FG000|Overall Study|Death|0|||
162676377|NCT02621931|587524934|FG001|Overall Study|Death|1|||
162676378|NCT02621931|587524935|FG002|Overall Study|Death|0|||
162676379|NCT02621931|587524933|FG000|Overall Study|Adverse Event|8|||
162676380|NCT02621931|587524934|FG001|Overall Study|Adverse Event|5|||
162676381|NCT02621931|587524935|FG002|Overall Study|Adverse Event|7|||
162676382|NCT02621931|587524933|FG000|Overall Study|Withdrawal by Subject|12|||
162676383|NCT02621931|587524934|FG001|Overall Study|Withdrawal by Subject|10|||
162676384|NCT02621931|587524935|FG002|Overall Study|Withdrawal by Subject|11|||
162676385|NCT02621931|587524933|FG000|Overall Study|Protocol Violation|2|||
162676386|NCT02621931|587524934|FG001|Overall Study|Protocol Violation|2|||
162676387|NCT02621931|587524935|FG002|Overall Study|Protocol Violation|2|||
162676388|NCT02621931|587524933|FG000|Overall Study|Pregnancy|2|||
162676389|NCT02621931|587524934|FG001|Overall Study|Pregnancy|0|||
162676390|NCT02621931|587524935|FG002|Overall Study|Pregnancy|0|||
162676391|NCT02621931|587524933|FG000|Overall Study|Noncompliance to study procedures|0|||
162676392|NCT02621931|587524934|FG001|Overall Study|Noncompliance to study procedures|1|||
162676393|NCT02621931|587524935|FG002|Overall Study|Noncompliance to study procedures|2|||
162676394|NCT02621931|587524933|FG000|Overall Study|Lost to Follow-up|8|||
162676395|NCT02621931|587524934|FG001|Overall Study|Lost to Follow-up|7|||
163152966|NCT04973449|589274734|FG004|Overall Study|Death|0|||
163152967|NCT04973449|589274735|FG005|Overall Study|Death|1|||
163152968|NCT04973449|589274736|FG006|Overall Study|Death|0|||
163152969|NCT04973449|589274737|FG007|Overall Study|Death|0|||
163152970|NCT04973449|589274730|FG000|Overall Study|Other|1|||
163152971|NCT04973449|589274731|FG001|Overall Study|Other|1|||
163152972|NCT04973449|589274732|FG002|Overall Study|Other|2|||
163152973|NCT04973449|589274733|FG003|Overall Study|Other|1|||
163152974|NCT04973449|589274734|FG004|Overall Study|Other|4|||
163152975|NCT04973449|589274735|FG005|Overall Study|Other|0|||
163152976|NCT04973449|589274736|FG006|Overall Study|Other|2|||
163152977|NCT04973449|589274737|FG007|Overall Study|Other|2|||
163152978|NCT01506596|589274738|FG000|Overall Study|ineligible pathology|1|||
163152979|NCT03137992|589274740|FG000|Washout Period 1|Adverse Event|1|||
163152980|NCT03137992|589274741|FG001|Washout Period 1|Adverse Event|1|||
163152981|NCT03137992|589274742|FG002|Washout Period 1|Adverse Event|0|||
163152982|NCT03137992|589274743|FG003|Washout Period 1|Adverse Event|0|||
163152983|NCT03137992|589274744|FG004|Washout Period 1|Adverse Event|0|||
163152984|NCT03137992|589274745|FG005|Washout Period 1|Adverse Event|1|||
163152985|NCT03137992|589274740|FG000|Washout Period 1|Withdrawal by Subject|0|||
163152986|NCT03137992|589274741|FG001|Washout Period 1|Withdrawal by Subject|1|||
163152987|NCT03137992|589274742|FG002|Washout Period 1|Withdrawal by Subject|1|||
163152988|NCT03137992|589274743|FG003|Washout Period 1|Withdrawal by Subject|0|||
163152989|NCT03137992|589274744|FG004|Washout Period 1|Withdrawal by Subject|0|||
163152990|NCT03137992|589274745|FG005|Washout Period 1|Withdrawal by Subject|0|||
163152991|NCT03137992|589274740|FG000|Washout Period 1|Principal Investigator Discretion|0|||
163152992|NCT03137992|589274741|FG001|Washout Period 1|Principal Investigator Discretion|1|||
163152993|NCT03137992|589274742|FG002|Washout Period 1|Principal Investigator Discretion|0|||
163152994|NCT03137992|589274743|FG003|Washout Period 1|Principal Investigator Discretion|0|||
163152995|NCT03137992|589274744|FG004|Washout Period 1|Principal Investigator Discretion|0|||
163152996|NCT03137992|589274745|FG005|Washout Period 1|Principal Investigator Discretion|0|||
163152997|NCT03137992|589274740|FG000|Washout Period 1|COPD Exacerbation|1|||
163152998|NCT03137992|589274741|FG001|Washout Period 1|COPD Exacerbation|1|||
163152999|NCT03137992|589274742|FG002|Washout Period 1|COPD Exacerbation|1|||
163153000|NCT03137992|589274743|FG003|Washout Period 1|COPD Exacerbation|0|||
163153001|NCT03137992|589274744|FG004|Washout Period 1|COPD Exacerbation|1|||
163153002|NCT03137992|589274745|FG005|Washout Period 1|COPD Exacerbation|1|||
163153003|NCT03137992|589274740|FG000|Washout Period 1|Subject Noncompliance|1|||
163153004|NCT03137992|589274741|FG001|Washout Period 1|Subject Noncompliance|0|||
163153005|NCT03137992|589274742|FG002|Washout Period 1|Subject Noncompliance|0|||
163153006|NCT03137992|589274743|FG003|Washout Period 1|Subject Noncompliance|0|||
163153007|NCT03137992|589274744|FG004|Washout Period 1|Subject Noncompliance|1|||
163153008|NCT03137992|589274745|FG005|Washout Period 1|Subject Noncompliance|0|||
163153009|NCT03137992|589274740|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
163153010|NCT03137992|589274741|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
163153011|NCT03137992|589274742|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153012|NCT03137992|589274743|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153013|NCT03137992|589274744|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
163153014|NCT03137992|589274745|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
163153015|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
163153016|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163153017|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163153018|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
163153019|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
163153020|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
163153021|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Adverse Event|0|||
163153022|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Adverse Event|1|||
163153023|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Adverse Event|0|||
163153024|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Adverse Event|0|||
163153025|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Adverse Event|0|||
163153026|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Adverse Event|0|||
163153027|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153028|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153029|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153030|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
163153031|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153032|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
163153033|NCT03137992|589274740|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153034|NCT03137992|589274741|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
163153035|NCT03137992|589274742|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153036|NCT03137992|589274743|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153037|NCT03137992|589274744|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
163153038|NCT03137992|589274745|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
163153039|NCT03137992|589274740|FG000|Washout Period 2|COPD Exacerbation|1|||
163153040|NCT03137992|589274741|FG001|Washout Period 2|COPD Exacerbation|1|||
163153041|NCT03137992|589274742|FG002|Washout Period 2|COPD Exacerbation|0|||
163153042|NCT03137992|589274743|FG003|Washout Period 2|COPD Exacerbation|0|||
163153043|NCT03137992|589274744|FG004|Washout Period 2|COPD Exacerbation|1|||
163153044|NCT03137992|589274745|FG005|Washout Period 2|COPD Exacerbation|0|||
163153045|NCT03137992|589274740|FG000|Washout Period 2|Subject Non-compliance|0|||
163153046|NCT03137992|589274741|FG001|Washout Period 2|Subject Non-compliance|1|||
163153047|NCT03137992|589274742|FG002|Washout Period 2|Subject Non-compliance|0|||
163153048|NCT03137992|589274743|FG003|Washout Period 2|Subject Non-compliance|0|||
163153049|NCT03137992|589274744|FG004|Washout Period 2|Subject Non-compliance|0|||
163153050|NCT03137992|589274745|FG005|Washout Period 2|Subject Non-compliance|0|||
163153051|NCT03137992|589274740|FG000|Washout Period 2|Adverse Event|0|||
163153052|NCT03137992|589274741|FG001|Washout Period 2|Adverse Event|0|||
163153053|NCT03137992|589274742|FG002|Washout Period 2|Adverse Event|0|||
163153054|NCT03137992|589274743|FG003|Washout Period 2|Adverse Event|1|||
163153055|NCT03137992|589274744|FG004|Washout Period 2|Adverse Event|1|||
163153056|NCT03137992|589274745|FG005|Washout Period 2|Adverse Event|0|||
163153057|NCT03137992|589274740|FG000|Washout Period 2|Withdrawal by Subject|1|||
163153058|NCT03137992|589274741|FG001|Washout Period 2|Withdrawal by Subject|0|||
163153059|NCT03137992|589274742|FG002|Washout Period 2|Withdrawal by Subject|0|||
163153060|NCT03137992|589274743|FG003|Washout Period 2|Withdrawal by Subject|0|||
163153061|NCT03137992|589274744|FG004|Washout Period 2|Withdrawal by Subject|1|||
163153062|NCT03137992|589274745|FG005|Washout Period 2|Withdrawal by Subject|0|||
163153063|NCT03137992|589274740|FG000|Washout Period 2|Sponsor Decision|0|||
163153064|NCT03137992|589274741|FG001|Washout Period 2|Sponsor Decision|0|||
163153065|NCT03137992|589274742|FG002|Washout Period 2|Sponsor Decision|0|||
163153066|NCT03137992|589274743|FG003|Washout Period 2|Sponsor Decision|0|||
162676396|NCT02621931|587524935|FG002|Overall Study|Lost to Follow-up|10|||
162676397|NCT02621931|587524933|FG000|Overall Study|Lack of Efficacy|0|||
162676398|NCT02621931|587524934|FG001|Overall Study|Lack of Efficacy|0|||
162676399|NCT02621931|587524935|FG002|Overall Study|Lack of Efficacy|1|||
162676400|NCT02621931|587524933|FG000|Overall Study|Other|1|||
162676401|NCT02621931|587524934|FG001|Overall Study|Other|1|||
162676402|NCT02621931|587524935|FG002|Overall Study|Other|3|||
162676403|NCT00920426|587524936|FG000|ITZ111451|Adverse Event|1|||
162676404|NCT00920426|587524937|FG001|ITZ111451|Adverse Event|0|||
162676405|NCT00920426|587524938|FG002|ITZ111451|Adverse Event|0|||
162676406|NCT00920426|587524939|FG003|ITZ111451|Adverse Event|0|||
162676407|NCT00955357|587524944|FG000|Titration Phase|Adverse Event|9|||
162676408|NCT00955357|587524945|FG001|Titration Phase|Adverse Event|46|||
162676409|NCT00955357|587524944|FG000|Titration Phase|Lack of Efficacy|0|||
162676410|NCT00955357|587524945|FG001|Titration Phase|Lack of Efficacy|2|||
162676411|NCT00955357|587524944|FG000|Titration Phase|Protocol Violation|3|||
162676412|NCT00955357|587524945|FG001|Titration Phase|Protocol Violation|7|||
162676413|NCT00955357|587524944|FG000|Titration Phase|Lost to Follow-up|1|||
162676414|NCT00955357|587524945|FG001|Titration Phase|Lost to Follow-up|3|||
162676415|NCT00955357|587524944|FG000|Titration Phase|Withdrawal by Subject|3|||
162676416|NCT00955357|587524945|FG001|Titration Phase|Withdrawal by Subject|5|||
162676417|NCT00955357|587524944|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
162676418|NCT00955357|587524945|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
162676419|NCT00955357|587524944|FG000|Titration Phase|Study medication not tolerated|0|||
162676420|NCT00955357|587524945|FG001|Titration Phase|Study medication not tolerated|1|||
162676421|NCT00955357|587524944|FG000|Titration Phase|Non compliance to study procedures|0|||
162676422|NCT00955357|587524945|FG001|Titration Phase|Non compliance to study procedures|1|||
162676423|NCT00955357|587524944|FG000|Maintenance Phase|Adverse Event|3|||
162676424|NCT00955357|587524945|FG001|Maintenance Phase|Adverse Event|23|||
162676425|NCT00955357|587524944|FG000|Maintenance Phase|Lack of Efficacy|0|||
162676426|NCT00955357|587524945|FG001|Maintenance Phase|Lack of Efficacy|4|||
162676427|NCT00955357|587524944|FG000|Maintenance Phase|Protocol Violation|2|||
162676428|NCT00955357|587524945|FG001|Maintenance Phase|Protocol Violation|6|||
162676429|NCT00955357|587524944|FG000|Maintenance Phase|Lost to Follow-up|2|||
162676430|NCT00955357|587524945|FG001|Maintenance Phase|Lost to Follow-up|7|||
162676431|NCT00955357|587524944|FG000|Maintenance Phase|Withdrawal by Subject|4|||
162676432|NCT00955357|587524945|FG001|Maintenance Phase|Withdrawal by Subject|4|||
162676433|NCT00955357|587524944|FG000|Maintenance Phase|Patient moving out of area|0|||
162676434|NCT00955357|587524945|FG001|Maintenance Phase|Patient moving out of area|1|||
162676435|NCT00955357|587524944|FG000|Maintenance Phase|Non compliance to study procedures|1|||
162676436|NCT00955357|587524945|FG001|Maintenance Phase|Non compliance to study procedures|0|||
162676437|NCT00886340|587524946|FG000|Overall Study|Withdrawal by Subject|0|||
162676438|NCT00886340|587524947|FG001|Overall Study|Withdrawal by Subject|7|||
162676439|NCT02985866|587524948|FG000|Overall Study|Poor CGM data|1|||
162676440|NCT02985866|587524949|FG001|Overall Study|Poor CGM data|1|||
162676441|NCT03224182|587524950|FG000|Overall Study|Study Drug Not Instilled|6|||
162676442|NCT03224182|587524951|FG001|Overall Study|Study Drug Not Instilled|1|||
162676443|NCT03224182|587524950|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
162676444|NCT03224182|587524951|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
162676445|NCT03224182|587524950|FG000|Overall Study|Withdrew of Consent|4|||
162676446|NCT03224182|587524951|FG001|Overall Study|Withdrew of Consent|2|||
162676447|NCT03224182|587524950|FG000|Overall Study|Investigator Decision|3|||
162676448|NCT03224182|587524951|FG001|Overall Study|Investigator Decision|1|||
162676449|NCT03224182|587524950|FG000|Overall Study|Sponsor Decision|26|||
162676450|NCT03224182|587524951|FG001|Overall Study|Sponsor Decision|12|||
162676451|NCT03224182|587524950|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
162676452|NCT03224182|587524951|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
162676453|NCT03224182|587524950|FG000|Overall Study|Lost to Follow-up|1|||
162676454|NCT03224182|587524951|FG001|Overall Study|Lost to Follow-up|0|||
162676455|NCT03224182|587524950|FG000|Overall Study|Participant Had Recurrence|11|||
162676456|NCT03224182|587524951|FG001|Overall Study|Participant Had Recurrence|5|||
162676457|NCT03224182|587524950|FG000|Overall Study|Death|0|||
162676458|NCT03224182|587524951|FG001|Overall Study|Death|1|||
162676459|NCT03224182|587524950|FG000|Overall Study|Reason not Specified|3|||
162676460|NCT03224182|587524951|FG001|Overall Study|Reason not Specified|3|||
162676461|NCT03224182|587524950|FG000|Overall Study|Other|1|||
162676462|NCT03224182|587524951|FG001|Overall Study|Other|0|||
162676463|NCT02925455|587524955|FG000|Overall Study|Withdrawal by Subject|2|||
162676464|NCT02925455|587524956|FG001|Overall Study|Withdrawal by Subject|0|||
162676465|NCT00686166|587524960|FG000|Overall Study|Adverse Event|7|||
162676466|NCT00686166|587524960|FG000|Overall Study|Withdrawal by Subject|1|||
162676467|NCT00686166|587524960|FG000|Overall Study|Progression/Relapse|1|||
162676468|NCT00686166|587524960|FG000|Overall Study|Death|1|||
162676469|NCT00686166|587524960|FG000|Overall Study|Not Protocol Specified|1|||
162676470|NCT00686166|587524960|FG000|Overall Study|Ineligible|5|||
162676471|NCT00686166|587524960|FG000|Overall Study|Did not begin protocol therapy|4|||
162676472|NCT00985725|587524961|FG000|Overall Study|Adverse Event|4|||
162676473|NCT00985725|587524962|FG001|Overall Study|Adverse Event|1|||
162676474|NCT00985725|587524961|FG000|Overall Study|Protocol Violation|1|||
162676475|NCT00985725|587524962|FG001|Overall Study|Protocol Violation|3|||
162676476|NCT00985725|587524961|FG000|Overall Study|Withdrawal by Subject|4|||
162676477|NCT00985725|587524962|FG001|Overall Study|Withdrawal by Subject|4|||
162676478|NCT00985725|587524961|FG000|Overall Study|Lost to Follow-up|1|||
162676479|NCT00985725|587524962|FG001|Overall Study|Lost to Follow-up|1|||
162676480|NCT00985725|587524961|FG000|Overall Study|Lack of Efficacy|0|||
162676481|NCT00985725|587524962|FG001|Overall Study|Lack of Efficacy|1|||
162676482|NCT00985725|587524961|FG000|Overall Study|Non-compliance|1|||
162676483|NCT00985725|587524962|FG001|Overall Study|Non-compliance|2|||
163153067|NCT03137992|589274744|FG004|Washout Period 2|Sponsor Decision|0|||
163153068|NCT03137992|589274745|FG005|Washout Period 2|Sponsor Decision|1|||
163153069|NCT03137992|589274740|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
163153070|NCT03137992|589274741|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
163153071|NCT03137992|589274742|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
163153072|NCT03137992|589274743|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
163153073|NCT03137992|589274744|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
163153074|NCT03137992|589274745|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
163153075|NCT03137992|589274740|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153076|NCT03137992|589274741|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
163153077|NCT03137992|589274742|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
163153078|NCT03137992|589274743|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153079|NCT03137992|589274744|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
163153080|NCT03137992|589274745|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
163153081|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
163153082|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153083|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
163153084|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153085|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153086|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
163153087|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153088|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153089|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153090|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
163153091|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153092|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
163153093|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Per study team|1|||
163153094|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Per study team|0|||
163153095|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Per study team|0|||
163153096|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Per study team|0|||
163153097|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Per study team|0|||
163153098|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Per study team|0|||
163153099|NCT03137992|589274740|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153100|NCT03137992|589274741|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153101|NCT03137992|589274742|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153102|NCT03137992|589274743|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153103|NCT03137992|589274744|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
163153104|NCT03137992|589274745|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
163153105|NCT04609319|589274746|FG000|Overall Study|Death|64|||
163153106|NCT04609319|589274747|FG001|Overall Study|Death|49|||
162676484|NCT00985725|587524961|FG000|Overall Study|Out-of-window visits|0|||
162676485|NCT00985725|587524962|FG001|Overall Study|Out-of-window visits|1|||
162676486|NCT02314624|587524966|FG000|Overall Study|No participating patient|16|||
162676487|NCT02314624|587524967|FG001|Overall Study|No participating patient|13|||
162676488|NCT02314624|587524966|FG000|Overall Study|Participant withdrew|7|||
162676489|NCT02314624|587524967|FG001|Overall Study|Participant withdrew|2|||
162676490|NCT02314624|587524966|FG000|Overall Study|Lost to Follow-up|2|||
162676491|NCT02314624|587524967|FG001|Overall Study|Lost to Follow-up|5|||
162676492|NCT02314624|587524966|FG000|Overall Study|Dropped/Excluded by PI|6|||
162676493|NCT02314624|587524967|FG001|Overall Study|Dropped/Excluded by PI|6|||
162676494|NCT03151005|587524968|FG000|Overall Study|Lost to Follow-up|5|||
162676495|NCT03151005|587524969|FG001|Overall Study|Lost to Follow-up|5|||
162676496|NCT03912259|587524970|FG000|Overall Study|Adverse Event (AE)|2|||
162676497|NCT03912259|587524971|FG001|Overall Study|Adverse Event (AE)|4|||
162676498|NCT03912259|587524970|FG000|Overall Study|Lack of Efficacy|4|||
162676499|NCT03912259|587524971|FG001|Overall Study|Lack of Efficacy|1|||
162676500|NCT03912259|587524970|FG000|Overall Study|Withdrawal by Subject|11|||
162676501|NCT03912259|587524971|FG001|Overall Study|Withdrawal by Subject|1|||
162676502|NCT01549613|587524974|FG000|Overall Study|Lost to Follow-up|11|||
162676503|NCT01549613|587524975|FG001|Overall Study|Lost to Follow-up|11|||
162676504|NCT02131272|587524976|FG000|Overall Study|Withdrawal by parent|0|||
162676505|NCT02131272|587524977|FG001|Overall Study|Withdrawal by parent|1|||
162676506|NCT02131272|587524976|FG000|Overall Study|Withdrawal by Subject|0|||
162676507|NCT02131272|587524977|FG001|Overall Study|Withdrawal by Subject|1|||
162676508|NCT02131272|587524976|FG000|Overall Study|Withdrawal Criteria|1|||
162676509|NCT02131272|587524977|FG001|Overall Study|Withdrawal Criteria|0|||
162676510|NCT00381940|587524978|FG000|Overall Study|Lack of Efficacy|3|||
162676511|NCT00381940|587524978|FG000|Overall Study|Protocol Violation|1|||
162676512|NCT00381940|587524978|FG000|Overall Study|Ineligible|1|||
162676513|NCT00464815|587524979|FG000|Overall Study|Withdrawal by Subject|6|||
162676514|NCT00464815|587524980|FG001|Overall Study|Withdrawal by Subject|3|||
162676515|NCT03643952|587524984|FG000|Overall Study|Lack of Efficacy|1|||
163153107|NCT04609319|589274748|FG002|Overall Study|Death|1|||
163153108|NCT04609319|589274746|FG000|Overall Study|Withdrawal of consent|15|||
163153109|NCT04609319|589274747|FG001|Overall Study|Withdrawal of consent|3|||
163153110|NCT04609319|589274748|FG002|Overall Study|Withdrawal of consent|0|||
163153111|NCT04609319|589274746|FG000|Overall Study|Lost to Follow-up|20|||
163153112|NCT04609319|589274747|FG001|Overall Study|Lost to Follow-up|33|||
163153113|NCT04609319|589274748|FG002|Overall Study|Lost to Follow-up|0|||
163153114|NCT04609319|589274746|FG000|Overall Study|Alive until end of follow-up|60|||
163153115|NCT04609319|589274747|FG001|Overall Study|Alive until end of follow-up|53|||
163153116|NCT04609319|589274748|FG002|Overall Study|Alive until end of follow-up|1|||
163153117|NCT03221556|589274749|FG000|Allocation|post-randomization exclusion|0|||
163153118|NCT03221556|589274750|FG001|Allocation|post-randomization exclusion|1|||
163153119|NCT03221556|589274749|FG000|Follow-Up|Withdrawal by Subject|0|||
163153120|NCT03221556|589274750|FG001|Follow-Up|Withdrawal by Subject|1|||
163153121|NCT04825574|589274754|FG000|Overall Study|Commercial treatment became available|1|||
163153122|NCT04825574|589274754|FG000|Overall Study|Disease progression|1|||
163153123|NCT01520506|589276196|FG000|Overall Study|Missed Visit|4|||
163153124|NCT01520506|589276196|FG000|Overall Study|Lost to Follow-up|1|||
163153125|NCT01520506|589276196|FG000|Overall Study|Withdrawal by Subject|1|||
163153126|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
163153127|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
163153128|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
163153129|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
163153130|NCT00906204|589276197|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
163153131|NCT00906204|589276198|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
163153132|NCT00906204|589276197|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
163153133|NCT00906204|589276198|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
163153134|NCT00906204|589276197|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
163153135|NCT00906204|589276198|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
163153136|NCT00696072|589276199|FG000|Overall Study|continuing active treatment|10|||
163153137|NCT00696072|589276200|FG001|Overall Study|continuing active treatment|13|||
163153138|NCT00696072|589276199|FG000|Overall Study|Adverse Event|10|||
163153139|NCT00696072|589276200|FG001|Overall Study|Adverse Event|6|||
163153140|NCT00696072|589276199|FG000|Overall Study|Patient Request|3|||
163153141|NCT00696072|589276200|FG001|Overall Study|Patient Request|7|||
163153142|NCT00696072|589276199|FG000|Overall Study|Investigator Request|1|||
163153143|NCT00696072|589276200|FG001|Overall Study|Investigator Request|4|||
163153144|NCT00696072|589276199|FG000|Overall Study|Sponsor Request|0|||
163153145|NCT00696072|589276200|FG001|Overall Study|Sponsor Request|1|||
163153146|NCT00696072|589276199|FG000|Overall Study|Disease Progression|32|||
163153147|NCT00696072|589276200|FG001|Overall Study|Disease Progression|30|||
163153148|NCT00696072|589276199|FG000|Overall Study|Non-specified|1|||
162676516|NCT01358968|587524985|FG000|Period 2|Adverse Event|0|||
162676517|NCT01358968|587524986|FG001|Period 2|Adverse Event|1|||
162676518|NCT01358968|587524987|FG002|Period 2|Adverse Event|0|||
162676519|NCT01358968|587524988|FG003|Period 2|Adverse Event|0|||
162676520|NCT01358968|587524985|FG000|Continued Access Phase|Progression of Disease|0|||
162676521|NCT01358968|587524986|FG001|Continued Access Phase|Progression of Disease|0|||
163153149|NCT00696072|589276200|FG001|Overall Study|Non-specified|2|||
163153150|NCT01597596|589276201|FG000|Overall Study|Study terminated by sponsor|1|||
163153151|NCT01597596|589276202|FG001|Overall Study|Study terminated by sponsor|0|||
163153152|NCT01597596|589276201|FG000|Overall Study|Physician Decision|0|||
163153153|NCT01597596|589276202|FG001|Overall Study|Physician Decision|1|||
163153154|NCT00371150|589276203|FG000|Overall Study|Lost to Follow-up|3|||
163153155|NCT00371150|589276204|FG001|Overall Study|Lost to Follow-up|2|||
163153156|NCT00124943|589276206|FG000|Phase II|Adverse Event|0|||
163153157|NCT00124943|589276207|FG001|Phase II|Adverse Event|2|||
163153158|NCT00124943|589276208|FG002|Phase II|Adverse Event|0|||
163153159|NCT00124943|589276209|FG003|Phase II|Adverse Event|1|||
163153160|NCT00124943|589276206|FG000|Phase II|Protocol Violation|0|||
163153161|NCT00124943|589276207|FG001|Phase II|Protocol Violation|0|||
162676522|NCT01358968|587524987|FG002|Continued Access Phase|Progression of Disease|8|||
162676523|NCT01358968|587524988|FG003|Continued Access Phase|Progression of Disease|4|||
162676524|NCT01358968|587524985|FG000|Continued Access Phase|Protocol Violation|0|||
162676525|NCT01358968|587524986|FG001|Continued Access Phase|Protocol Violation|0|||
162676526|NCT01358968|587524987|FG002|Continued Access Phase|Protocol Violation|0|||
162676527|NCT01358968|587524988|FG003|Continued Access Phase|Protocol Violation|2|||
162676528|NCT01358968|587524985|FG000|Continued Access Phase|Withdrawal by Subject|0|||
162676529|NCT01358968|587524986|FG001|Continued Access Phase|Withdrawal by Subject|0|||
162676530|NCT01358968|587524987|FG002|Continued Access Phase|Withdrawal by Subject|3|||
163153162|NCT00124943|589276208|FG002|Phase II|Protocol Violation|0|||
163153163|NCT00124943|589276209|FG003|Phase II|Protocol Violation|1|||
163153164|NCT00124943|589276206|FG000|Phase II|Lost to Follow-up|0|||
163153165|NCT00124943|589276207|FG001|Phase II|Lost to Follow-up|0|||
163153166|NCT00124943|589276208|FG002|Phase II|Lost to Follow-up|0|||
163153167|NCT00124943|589276209|FG003|Phase II|Lost to Follow-up|1|||
163153168|NCT00124943|589276206|FG000|Phase II|Withdrawal by Subject|0|||
163153169|NCT00124943|589276207|FG001|Phase II|Withdrawal by Subject|0|||
163153170|NCT00124943|589276208|FG002|Phase II|Withdrawal by Subject|0|||
163153171|NCT00124943|589276209|FG003|Phase II|Withdrawal by Subject|2|||
163153172|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
163153173|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
163153174|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
163153175|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
163153176|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
163153177|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
163153178|NCT03181932|589276210|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
163153179|NCT03181932|589276211|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
163153180|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
163153181|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
163153182|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
163153183|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
163153184|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
163153185|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
162676531|NCT01358968|587524988|FG003|Continued Access Phase|Withdrawal by Subject|0|||
162676532|NCT01358968|587524985|FG000|Continued Access Phase|Death|0|||
162676533|NCT01358968|587524986|FG001|Continued Access Phase|Death|0|||
163153186|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
163153187|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
163153188|NCT03181932|589276210|FG000|Period 2 (Open-label Period)|Reason missing|2|||
163153189|NCT03181932|589276211|FG001|Period 2 (Open-label Period)|Reason missing|0|||
163153190|NCT03304626|589276212|FG000|Overall Study|Adverse Event|1|||
163153191|NCT03304626|589276213|FG001|Overall Study|Adverse Event|0|||
163153192|NCT03304626|589276212|FG000|Overall Study|Lack of Efficacy|1|||
163153193|NCT03304626|589276213|FG001|Overall Study|Lack of Efficacy|1|||
163153194|NCT00408317|589276220|FG000|First Intervention Period|Adverse Event|0|||
163153195|NCT00408317|589276221|FG001|First Intervention Period|Adverse Event|1|||
163153196|NCT00408317|589276220|FG000|Second Intervention Period|Adverse Event|2|||
163153197|NCT00408317|589276221|FG001|Second Intervention Period|Adverse Event|0|||
163153198|NCT00408317|589276220|FG000|Second Intervention Period|Protocol Violation|0|||
163153199|NCT00408317|589276221|FG001|Second Intervention Period|Protocol Violation|1|||
163153200|NCT00408317|589276220|FG000|Second Intervention Period|Withdrawal of consent|0|||
163153201|NCT00408317|589276221|FG001|Second Intervention Period|Withdrawal of consent|1|||
163153202|NCT01747876|589276222|FG000|Overall Study|Adverse Event|1|||
163153203|NCT01747876|589276223|FG001|Overall Study|Adverse Event|0|||
163153204|NCT01747876|589276224|FG002|Overall Study|Adverse Event|2|||
163153205|NCT01747876|589276222|FG000|Overall Study|Withdrawal by Subject|0|||
163153206|NCT01747876|589276223|FG001|Overall Study|Withdrawal by Subject|1|||
163153207|NCT01747876|589276224|FG002|Overall Study|Withdrawal by Subject|1|||
163153208|NCT01747876|589276222|FG000|Overall Study|Disease progression|4|||
163153209|NCT01747876|589276223|FG001|Overall Study|Disease progression|13|||
163153210|NCT01747876|589276224|FG002|Overall Study|Disease progression|8|||
163153211|NCT01747876|589276222|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
163153212|NCT01747876|589276223|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
163153213|NCT01747876|589276224|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
163153214|NCT00853307|589276227|FG000|Overall Study|Adverse Event|1|||
163153215|NCT00853307|589276228|FG001|Overall Study|Adverse Event|2|||
163153216|NCT00853307|589276227|FG000|Overall Study|Withdrawal by Subject|1|||
163153217|NCT00853307|589276228|FG001|Overall Study|Withdrawal by Subject|2|||
163153218|NCT00853307|589276227|FG000|Overall Study|Reason Not Specified|0|||
163153219|NCT00853307|589276228|FG001|Overall Study|Reason Not Specified|1|||
163153220|NCT03331315|589276235|FG000|Overall Study|Physician Decision|18|||
163153221|NCT03331315|589276236|FG001|Overall Study|Physician Decision|14|||
163153222|NCT00360230|589276237|FG000|Overall Study|Withdrawal by Subject|1|||
163153223|NCT00360230|589276238|FG001|Overall Study|Withdrawal by Subject|1|||
163153224|NCT00360230|589276239|FG002|Overall Study|Withdrawal by Subject|0|||
163153225|NCT00360230|589276240|FG003|Overall Study|Withdrawal by Subject|1|||
163153226|NCT00360230|589276241|FG004|Overall Study|Withdrawal by Subject|1|||
163153227|NCT00360230|589276242|FG005|Overall Study|Withdrawal by Subject|1|||
163153228|NCT00360230|589276243|FG006|Overall Study|Withdrawal by Subject|0|||
163153229|NCT00360230|589276237|FG000|Overall Study|Migrated|4|||
163153230|NCT00360230|589276238|FG001|Overall Study|Migrated|1|||
163153231|NCT00360230|589276239|FG002|Overall Study|Migrated|3|||
163153232|NCT00360230|589276240|FG003|Overall Study|Migrated|1|||
162676534|NCT01358968|587524987|FG002|Continued Access Phase|Death|1|||
163153233|NCT00360230|589276241|FG004|Overall Study|Migrated|4|||
163153234|NCT00360230|589276242|FG005|Overall Study|Migrated|1|||
163153235|NCT00360230|589276243|FG006|Overall Study|Migrated|1|||
163153236|NCT00360230|589276237|FG000|Overall Study|Other|1|||
163153237|NCT00360230|589276238|FG001|Overall Study|Other|0|||
163153238|NCT00360230|589276239|FG002|Overall Study|Other|0|||
163153239|NCT00360230|589276240|FG003|Overall Study|Other|0|||
163153240|NCT00360230|589276241|FG004|Overall Study|Other|0|||
163153241|NCT00360230|589276242|FG005|Overall Study|Other|0|||
163153242|NCT00360230|589276243|FG006|Overall Study|Other|0|||
163153243|NCT00360230|589276237|FG000|Overall Study|Protocol Violation|0|||
163153244|NCT00360230|589276238|FG001|Overall Study|Protocol Violation|0|||
163153245|NCT00360230|589276239|FG002|Overall Study|Protocol Violation|0|||
163153246|NCT00360230|589276240|FG003|Overall Study|Protocol Violation|0|||
163153247|NCT00360230|589276241|FG004|Overall Study|Protocol Violation|0|||
163153248|NCT00360230|589276242|FG005|Overall Study|Protocol Violation|1|||
163153249|NCT00360230|589276243|FG006|Overall Study|Protocol Violation|0|||
163153250|NCT00360230|589276237|FG000|Overall Study|Death|0|||
163153251|NCT00360230|589276238|FG001|Overall Study|Death|1|||
163153252|NCT00360230|589276239|FG002|Overall Study|Death|0|||
163153253|NCT00360230|589276240|FG003|Overall Study|Death|0|||
163153254|NCT00360230|589276241|FG004|Overall Study|Death|0|||
163153255|NCT00360230|589276242|FG005|Overall Study|Death|1|||
163153256|NCT00360230|589276243|FG006|Overall Study|Death|1|||
163153257|NCT02703597|589276244|FG000|Assignment to Baseline|Lost to Follow-up|17|||
163153258|NCT02703597|589276245|FG001|Assignment to Baseline|Lost to Follow-up|16|||
163153259|NCT02703597|589276244|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
163153260|NCT02703597|589276245|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
163153261|NCT02703597|589276244|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
163153262|NCT02703597|589276245|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
163153263|NCT02703597|589276244|FG000|First Post-test to First Follow-up|Site drop out|0|||
163153264|NCT02703597|589276245|FG001|First Post-test to First Follow-up|Site drop out|58|||
163153265|NCT02703597|589276244|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
163153266|NCT02703597|589276245|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
163153267|NCT02703597|589276244|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
163153268|NCT02703597|589276245|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
163153269|NCT02703597|589276244|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
163153270|NCT02703597|589276245|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
163153271|NCT00481832|589276246|FG000|Enrollment|Physician Decision|8|||
163153272|NCT00481832|589276246|FG000|Enrollment|Unable to collect enough stem cells|2|||
163153273|NCT00481832|589276246|FG000|Inter-transplant Period|Adverse Event|4|||
163153274|NCT00481832|589276246|FG000|Inter-transplant Period|Death|3|||
163153275|NCT00481832|589276246|FG000|Inter-transplant Period|Physician Decision|4|||
163153276|NCT00481832|589276246|FG000|Inter-transplant Period|Disease relapse|11|||
163153277|NCT00481832|589276246|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
163153278|NCT00581308|589276247|FG000|Pre Discharge|Lost to Follow-up|1|||
163153279|NCT00581308|589276247|FG000|Pre Discharge|Device Removed|1|||
163153280|NCT00581308|589276247|FG000|Month 1|Lost to Follow-up|3|||
163153281|NCT00581308|589276247|FG000|Month 1|Withdrawal by Subject|2|||
163153282|NCT00581308|589276247|FG000|Month 1|Device Removed|2|||
163153283|NCT00581308|589276247|FG000|Month 1|Uknown|1|||
163153284|NCT00581308|589276247|FG000|Month 6|Lost to Follow-up|1|||
163153285|NCT00581308|589276247|FG000|Month 6|Withdrawal by Subject|2|||
163153286|NCT00581308|589276247|FG000|Month 12|Death|1|||
163153287|NCT00581308|589276247|FG000|Month 12|Lost to Follow-up|14|||
163153288|NCT00581308|589276247|FG000|Month 12|Withdrawal by Subject|3|||
163153289|NCT00581308|589276247|FG000|Month 12|Device Removed|1|||
163153290|NCT00581308|589276247|FG000|Month 12|Other|1|||
163153291|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
163153292|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
163153293|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
163153294|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
163153295|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
163153296|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153297|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153298|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
163153299|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153300|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
163153301|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
163153302|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
163153303|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
163153304|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
163153305|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
163153306|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Other|1|||
163153307|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Other|5|||
163153308|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Other|0|||
163153309|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Other|2|||
163153310|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Other|3|||
163153311|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
163153312|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
163153313|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
163153314|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
163153315|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
163153316|NCT02006472|589276251|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153317|NCT02006472|589276252|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
163153318|NCT02006472|589276253|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153319|NCT02006472|589276254|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
163153320|NCT02006472|589276255|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
163153321|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163153322|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
163153323|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
163153324|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163153325|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
163153326|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
163153327|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
163153328|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
163153329|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
163153330|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
163153331|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
163153332|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
163153333|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
163153334|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
163153335|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
163153336|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Other|0|||
163153337|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Other|1|||
163153338|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Other|0|||
163153339|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Other|1|||
163153340|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Other|0|||
163153341|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Not treated|0|||
163153342|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Not treated|0|||
163153343|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Not treated|2|||
163153344|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Not treated|0|||
163153345|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Not treated|0|||
163153346|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
163153347|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
163153348|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
163153349|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
163153350|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
163153351|NCT02006472|589276251|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
163153352|NCT02006472|589276252|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
163153353|NCT02006472|589276253|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
163153354|NCT02006472|589276254|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
163153355|NCT02006472|589276255|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
163153356|NCT03219723|589276256|FG000|Overall Study|Case Report Forms Uncollected|6|||
163153357|NCT03219723|589276256|FG000|Overall Study|Protocol Deviation|4|||
163153358|NCT04558125|589276257|FG000|Overall Study|Death|1|||
163153359|NCT01710345|589276265|FG000|Overall Study|Adverse Event|0|||
163153360|NCT01710345|589276266|FG001|Overall Study|Adverse Event|2|||
163153361|NCT01710345|589276267|FG002|Overall Study|Adverse Event|0|||
163153362|NCT01710345|589276265|FG000|Overall Study|Lack of Efficacy|2|||
163153363|NCT01710345|589276266|FG001|Overall Study|Lack of Efficacy|3|||
163153364|NCT01710345|589276267|FG002|Overall Study|Lack of Efficacy|1|||
163153365|NCT01710345|589276265|FG000|Overall Study|Drug Dosing Error|1|||
163153366|NCT01710345|589276266|FG001|Overall Study|Drug Dosing Error|0|||
163153367|NCT01710345|589276267|FG002|Overall Study|Drug Dosing Error|0|||
163153368|NCT01033019|589276269|FG000|Overall Study|Withdrawal by Subject|1|||
163153369|NCT01033019|589276270|FG001|Overall Study|Withdrawal by Subject|0|||
163153370|NCT01339832|589276271|FG000|Overall Study|Lost to Follow-up|3|||
163153371|NCT01339832|589276271|FG000|Overall Study|Death|11|||
163153372|NCT01052493|589276272|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
163153373|NCT01052493|589276273|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
163153374|NCT01052493|589276274|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
163153375|NCT01075243|589276280|FG000|Overall Study|Lost to Follow-up|5|||
163153376|NCT01075243|589276281|FG001|Overall Study|Lost to Follow-up|2|||
163153377|NCT01075243|589276282|FG002|Overall Study|Lost to Follow-up|0|||
163153378|NCT01075243|589276280|FG000|Overall Study|Withdrawal by Subject|1|||
163153379|NCT01075243|589276281|FG001|Overall Study|Withdrawal by Subject|1|||
163153380|NCT01075243|589276282|FG002|Overall Study|Withdrawal by Subject|0|||
163153381|NCT00627393|589276283|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
163153382|NCT00627393|589276284|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
163153383|NCT00627393|589276283|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
163153384|NCT00627393|589276284|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
163153385|NCT00627393|589276283|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
163153386|NCT00627393|589276284|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
163153387|NCT00627393|589276283|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
163153388|NCT00627393|589276284|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
163153389|NCT00551642|589276285|FG000|Treatment Period|Protocol Deviation|6|||
163153390|NCT00551642|589276286|FG001|Treatment Period|Protocol Deviation|11|||
163153391|NCT00551642|589276285|FG000|Treatment Period|Delivery device failure|1|||
163153392|NCT00551642|589276286|FG001|Treatment Period|Delivery device failure|3|||
163153393|NCT00551642|589276285|FG000|Treatment Period|Physician Decision|0|||
163153394|NCT00551642|589276286|FG001|Treatment Period|Physician Decision|1|||
163153395|NCT00551642|589276285|FG000|Treatment Period|Death|33|||
163153396|NCT00551642|589276286|FG001|Treatment Period|Death|31|||
163153397|NCT00551642|589276285|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
163153398|NCT00551642|589276286|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
163153399|NCT00551642|589276285|FG000|Treatment Period|Adverse Event|15|||
163153400|NCT00551642|589276286|FG001|Treatment Period|Adverse Event|12|||
163153401|NCT00551642|589276285|FG000|Treatment Period|Withdrawal by Subject|2|||
163153402|NCT00551642|589276286|FG001|Treatment Period|Withdrawal by Subject|1|||
163153403|NCT03337308|589276287|FG000|Overall Study|Adverse Event|2|||
163153404|NCT03337308|589276288|FG001|Overall Study|Adverse Event|3|||
163153405|NCT03337308|589276289|FG002|Overall Study|Adverse Event|3|||
163153406|NCT03337308|589276290|FG003|Overall Study|Adverse Event|1|||
163153407|NCT03337308|589276287|FG000|Overall Study|Lost to Follow-up|1|||
163153408|NCT03337308|589276288|FG001|Overall Study|Lost to Follow-up|2|||
163153409|NCT03337308|589276289|FG002|Overall Study|Lost to Follow-up|0|||
163153410|NCT03337308|589276290|FG003|Overall Study|Lost to Follow-up|0|||
163153411|NCT03337308|589276287|FG000|Overall Study|Withdrawal by Subject|2|||
163153412|NCT03337308|589276288|FG001|Overall Study|Withdrawal by Subject|1|||
163153413|NCT03337308|589276289|FG002|Overall Study|Withdrawal by Subject|2|||
163153414|NCT03337308|589276290|FG003|Overall Study|Withdrawal by Subject|1|||
163153415|NCT03337308|589276287|FG000|Overall Study|Protocol Violation|0|||
163153416|NCT03337308|589276288|FG001|Overall Study|Protocol Violation|1|||
163153417|NCT03337308|589276289|FG002|Overall Study|Protocol Violation|0|||
163153418|NCT03337308|589276290|FG003|Overall Study|Protocol Violation|0|||
163153419|NCT00283296|589276292|FG000|Overall Study|in-home trial not completed|5|||
163153420|NCT03558737|589276293|FG000|Overall Study|Death|1|||
163153421|NCT03558737|589276294|FG001|Overall Study|Death|1|||
163153422|NCT01294553|589276295|FG000|Overall Study|Duplicated Participants|1|||
163153423|NCT01294553|589276295|FG000|Overall Study|Protocol Violation|268|||
163153424|NCT00888134|589276296|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
163153425|NCT00888134|589276296|FG000|Follow-up|being followed for long-term survival|1|||
163153426|NCT00795535|589276297|FG000|Overall Study|incomplete data and technical problems|20|||
163153427|NCT01903460|589276300|FG000|Overall Study|Adverse Event|0|||
163153428|NCT01903460|589276301|FG001|Overall Study|Adverse Event|0|||
163153429|NCT01903460|589276302|FG002|Overall Study|Adverse Event|0|||
163153430|NCT01903460|589276303|FG003|Overall Study|Adverse Event|1|||
163153431|NCT03104868|589276304|FG000|6 Week Follow up|Lost to Follow-up|5|||
163153432|NCT03104868|589276305|FG001|6 Week Follow up|Lost to Follow-up|8|||
163153433|NCT03104868|589276304|FG000|6 Week Follow up|Death|1|||
163153434|NCT03104868|589276305|FG001|6 Week Follow up|Death|1|||
163153435|NCT03104868|589276304|FG000|6 Week Follow up|Withdrawal by Subject|7|||
163153436|NCT03104868|589276305|FG001|6 Week Follow up|Withdrawal by Subject|6|||
163153437|NCT03104868|589276304|FG000|6 Week Follow up|Completed Later Timepoint|24|||
163153438|NCT03104868|589276305|FG001|6 Week Follow up|Completed Later Timepoint|22|||
163153439|NCT03104868|589276304|FG000|6 Month Follow up|Lost to Follow-up|2|||
163153440|NCT03104868|589276305|FG001|6 Month Follow up|Lost to Follow-up|2|||
163153441|NCT03104868|589276304|FG000|6 Month Follow up|Death|0|||
163153442|NCT03104868|589276305|FG001|6 Month Follow up|Death|1|||
163153443|NCT03104868|589276304|FG000|6 Month Follow up|Completed Later Timepoint|22|||
163153444|NCT03104868|589276305|FG001|6 Month Follow up|Completed Later Timepoint|32|||
163153445|NCT03104868|589276304|FG000|12 Month Follow up|Lost to Follow-up|1|||
163153446|NCT03104868|589276305|FG001|12 Month Follow up|Lost to Follow-up|2|||
163153447|NCT03104868|589276304|FG000|12 Month Follow up|Death|0|||
163153448|NCT03104868|589276305|FG001|12 Month Follow up|Death|1|||
163153449|NCT03104868|589276304|FG000|12 Month Follow up|Withdrawal by Subject|0|||
163153450|NCT03104868|589276305|FG001|12 Month Follow up|Withdrawal by Subject|3|||
163153451|NCT03104868|589276304|FG000|12 Month Follow up|Completed Later Timepoint|32|||
163153452|NCT03104868|589276305|FG001|12 Month Follow up|Completed Later Timepoint|29|||
163153453|NCT03104868|589276304|FG000|18 Month Follow up|Lost to Follow-up|7|||
163153454|NCT03104868|589276305|FG001|18 Month Follow up|Lost to Follow-up|11|||
163153455|NCT03104868|589276304|FG000|18 Month Follow up|Death|2|||
163153456|NCT03104868|589276305|FG001|18 Month Follow up|Death|1|||
163153457|NCT03104868|589276304|FG000|18 Month Follow up|Withdrawal by Subject|1|||
163153458|NCT03104868|589276305|FG001|18 Month Follow up|Withdrawal by Subject|2|||
163153459|NCT03104868|589276304|FG000|18 Month Follow up|Graft Loss|1|||
163153460|NCT03104868|589276305|FG001|18 Month Follow up|Graft Loss|1|||
163153461|NCT03104868|589276304|FG000|18 Month Follow up|Completed Later Timepoint|19|||
163153462|NCT03104868|589276305|FG001|18 Month Follow up|Completed Later Timepoint|20|||
163153463|NCT03104868|589276304|FG000|24 Month Follow up|Lost to Follow-up|15|||
163153464|NCT03104868|589276305|FG001|24 Month Follow up|Lost to Follow-up|16|||
163153465|NCT03104868|589276304|FG000|24 Month Follow up|Death|3|||
163153466|NCT03104868|589276305|FG001|24 Month Follow up|Death|2|||
163153467|NCT03104868|589276304|FG000|24 Month Follow up|Withdrawal by Subject|1|||
163153468|NCT03104868|589276305|FG001|24 Month Follow up|Withdrawal by Subject|0|||
163153469|NCT03104868|589276304|FG000|24 Month Follow up|Graft Loss|2|||
163153470|NCT03104868|589276305|FG001|24 Month Follow up|Graft Loss|0|||
163153471|NCT00888173|589276307|FG000|Overall Study|Wrong Primary|1|||
163153472|NCT00888173|589276307|FG000|Overall Study|Ineligible: required test not done|1|||
163153473|NCT01488890|589276308|FG000|Overall Study|Serious adverse event|2|||
163153474|NCT01488890|589276309|FG001|Overall Study|Serious adverse event|0|||
163153475|NCT01488890|589276310|FG002|Overall Study|Serious adverse event|0|||
163153476|NCT01488890|589276311|FG003|Overall Study|Serious adverse event|0|||
163153477|NCT01488890|589276308|FG000|Overall Study|Protocol Violation|3|||
163153478|NCT01488890|589276309|FG001|Overall Study|Protocol Violation|0|||
163153479|NCT01488890|589276310|FG002|Overall Study|Protocol Violation|4|||
163153480|NCT01488890|589276311|FG003|Overall Study|Protocol Violation|0|||
163153481|NCT01488890|589276308|FG000|Overall Study|Lost to Follow-up|13|||
163153482|NCT01488890|589276309|FG001|Overall Study|Lost to Follow-up|10|||
163153483|NCT01488890|589276310|FG002|Overall Study|Lost to Follow-up|20|||
163153484|NCT01488890|589276311|FG003|Overall Study|Lost to Follow-up|3|||
163153485|NCT01488890|589276308|FG000|Overall Study|Withdrawal by Subject|14|||
163153486|NCT01488890|589276309|FG001|Overall Study|Withdrawal by Subject|10|||
163153487|NCT01488890|589276310|FG002|Overall Study|Withdrawal by Subject|11|||
163153488|NCT01488890|589276311|FG003|Overall Study|Withdrawal by Subject|2|||
163153489|NCT00829426|589276312|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
163153490|NCT00829426|589276313|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
163153491|NCT04408989|589276314|FG000|Overall Study|Lost to Follow-up|0|||
163153492|NCT04408989|589276315|FG001|Overall Study|Lost to Follow-up|0|||
163153493|NCT04408989|589276316|FG002|Overall Study|Lost to Follow-up|1|||
162676535|NCT01358968|587524988|FG003|Continued Access Phase|Death|1|||
162676536|NCT01597050|587524989|FG000|Overall Study|Withdrawal by Subject|1|||
162676537|NCT01597050|587524990|FG001|Overall Study|Withdrawal by Subject|0|||
162676538|NCT00483184|587524991|FG000|Overall Study|Withdrawal by Subject|2|||
162676539|NCT00483184|587524992|FG001|Overall Study|Withdrawal by Subject|2|||
162676540|NCT00483184|587524993|FG002|Overall Study|Withdrawal by Subject|0|||
162676541|NCT00483184|587524991|FG000|Overall Study|Lost to Follow-up|1|||
163153494|NCT04408989|589276314|FG000|Overall Study|Withdrawal by Subject|0|||
163153495|NCT04408989|589276315|FG001|Overall Study|Withdrawal by Subject|0|||
163153496|NCT04408989|589276316|FG002|Overall Study|Withdrawal by Subject|2|||
163153497|NCT02260934|589276331|FG000|Overall Study|Lost to Follow-up|2|||
163153498|NCT02260934|589276332|FG001|Overall Study|Lost to Follow-up|1|||
163153499|NCT02260934|589276331|FG000|Overall Study|Withdrawal by Subject|0|||
163153500|NCT02260934|589276332|FG001|Overall Study|Withdrawal by Subject|2|||
163153501|NCT02260934|589276331|FG000|Overall Study|Participant Relocated|1|||
163153502|NCT02260934|589276332|FG001|Overall Study|Participant Relocated|0|||
163153503|NCT02260934|589276331|FG000|Overall Study|Site error|0|||
163153504|NCT02260934|589276332|FG001|Overall Study|Site error|1|||
163153505|NCT02628873|589276335|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
163153506|NCT02628873|589276336|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
163153507|NCT02628873|589276335|FG000|Second Test (1 Hour)|Physician Decision|1|||
163153508|NCT02628873|589276336|FG001|Second Test (1 Hour)|Physician Decision|0|||
163153509|NCT03597347|589276339|FG000|Overall Study|Withdrawal by Subject|1|||
163153510|NCT03597347|589276340|FG001|Overall Study|Withdrawal by Subject|1|||
163153511|NCT03597347|589276341|FG002|Overall Study|Withdrawal by Subject|0|||
163153512|NCT03597347|589276339|FG000|Overall Study|Withdrawal due to Covid-19|3|||
163153513|NCT03597347|589276340|FG001|Overall Study|Withdrawal due to Covid-19|0|||
163153514|NCT03597347|589276341|FG002|Overall Study|Withdrawal due to Covid-19|0|||
163153515|NCT03597347|589276339|FG000|Overall Study|Sponsor decision to terminate study|3|||
163153516|NCT03597347|589276340|FG001|Overall Study|Sponsor decision to terminate study|2|||
163153517|NCT03597347|589276341|FG002|Overall Study|Sponsor decision to terminate study|4|||
163153518|NCT04606134|589276342|FG000|Overall Study|Adverse Event|0|||
163153519|NCT04606134|589276343|FG001|Overall Study|Adverse Event|1|||
163153520|NCT00107653|589276344|FG000|Overall Study|Adverse Event|24|||
163153521|NCT00107653|589276345|FG001|Overall Study|Adverse Event|43|||
163153522|NCT00107653|589276344|FG000|Overall Study|Insufficient Therapeutic Response|25|||
163153523|NCT00107653|589276345|FG001|Overall Study|Insufficient Therapeutic Response|11|||
163153524|NCT00107653|589276344|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163153525|NCT00107653|589276345|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163153526|NCT00107653|589276344|FG000|Overall Study|Protocol Violation|1|||
163153527|NCT00107653|589276345|FG001|Overall Study|Protocol Violation|0|||
163153528|NCT00107653|589276344|FG000|Overall Study|Withdrawal by Subject|12|||
163153529|NCT00107653|589276345|FG001|Overall Study|Withdrawal by Subject|13|||
163153530|NCT00107653|589276344|FG000|Overall Study|Lost to Follow-up|13|||
163153531|NCT00107653|589276345|FG001|Overall Study|Lost to Follow-up|5|||
163153532|NCT00107653|589276344|FG000|Overall Study|Administrative Reasons|3|||
163153533|NCT00107653|589276345|FG001|Overall Study|Administrative Reasons|3|||
163153534|NCT01099267|589276347|FG000|MDS-003 Study|Adverse Event|37|||
163153535|NCT01099267|589276347|FG000|MDS-003 Study|Lack of Efficacy|52|||
163153536|NCT01099267|589276347|FG000|MDS-003 Study|Withdrawal by Subject|8|||
163153537|NCT01099267|589276347|FG000|MDS-003 Study|Lost to Follow-up|1|||
163153538|NCT01099267|589276347|FG000|MDS-003 Study|Death|11|||
163153539|NCT01099267|589276347|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
163153540|NCT01099267|589276347|FG000|MDS-003 Study|Disease Progression|7|||
163153541|NCT01099267|589276347|FG000|MDS-003 Study|Investigator Decision|2|||
163153542|NCT01099267|589276347|FG000|MDS-003 Study|Non-Compliance|2|||
163153543|NCT01099267|589276347|FG000|MDS-003 Study|Loss of Response|1|||
163153544|NCT01099267|589276347|FG000|MDS-003 Study|Secondary Malign Disease|1|||
163153545|NCT04986904|589276348|FG000|Overall Study|Lost to Follow-up|11|||
163153546|NCT04986904|589276348|FG000|Overall Study|Withdrawal by Subject|1|||
163153547|NCT02532517|589276349|FG000|Overall Study|Did not complete 24-Month visit|4|||
163153548|NCT02532517|589276349|FG000|Overall Study|Failed Angiographic eligibility|1|||
163153549|NCT02532517|589276349|FG000|Overall Study|Lost to Follow-up|4|||
163153550|NCT02532517|589276349|FG000|Overall Study|Withdrawal by Subject|4|||
163153551|NCT02532517|589276349|FG000|Overall Study|Death|4|||
163153552|NCT02234843|589276350|FG000|Overall Study|Death|1|||
163153553|NCT02234843|589276351|FG001|Overall Study|Death|0|||
163153554|NCT02234843|589276352|FG002|Overall Study|Death|0|||
163153555|NCT02234843|589276353|FG003|Overall Study|Death|0|||
163153556|NCT02234843|589276354|FG004|Overall Study|Death|0|||
163153557|NCT02234843|589276355|FG005|Overall Study|Death|0|||
163153558|NCT02234843|589276356|FG006|Overall Study|Death|0|||
163153559|NCT02234843|589276357|FG007|Overall Study|Death|0|||
163153560|NCT02234843|589276358|FG008|Overall Study|Death|0|||
163153561|NCT02234843|589276359|FG009|Overall Study|Death|0|||
163153562|NCT02234843|589276350|FG000|Overall Study|Protocol Violation|1|||
163153563|NCT02234843|589276351|FG001|Overall Study|Protocol Violation|0|||
163153564|NCT02234843|589276352|FG002|Overall Study|Protocol Violation|1|||
163153565|NCT02234843|589276353|FG003|Overall Study|Protocol Violation|0|||
163153566|NCT02234843|589276354|FG004|Overall Study|Protocol Violation|0|||
163153567|NCT02234843|589276355|FG005|Overall Study|Protocol Violation|0|||
163153568|NCT02234843|589276356|FG006|Overall Study|Protocol Violation|0|||
163153569|NCT02234843|589276357|FG007|Overall Study|Protocol Violation|0|||
163153570|NCT02234843|589276358|FG008|Overall Study|Protocol Violation|0|||
163153571|NCT02234843|589276359|FG009|Overall Study|Protocol Violation|0|||
163153572|NCT02234843|589276350|FG000|Overall Study|Efficacy outcome reached|2|||
163153573|NCT02234843|589276351|FG001|Overall Study|Efficacy outcome reached|0|||
163153574|NCT02234843|589276352|FG002|Overall Study|Efficacy outcome reached|0|||
163153575|NCT02234843|589276353|FG003|Overall Study|Efficacy outcome reached|0|||
163153576|NCT02234843|589276354|FG004|Overall Study|Efficacy outcome reached|0|||
163153577|NCT02234843|589276355|FG005|Overall Study|Efficacy outcome reached|2|||
163153578|NCT02234843|589276356|FG006|Overall Study|Efficacy outcome reached|0|||
163153579|NCT02234843|589276357|FG007|Overall Study|Efficacy outcome reached|0|||
163153580|NCT02234843|589276358|FG008|Overall Study|Efficacy outcome reached|0|||
163153581|NCT02234843|589276359|FG009|Overall Study|Efficacy outcome reached|0|||
163153582|NCT02234843|589276350|FG000|Overall Study|Patient convenience|2|||
163153583|NCT02234843|589276351|FG001|Overall Study|Patient convenience|0|||
163153584|NCT02234843|589276352|FG002|Overall Study|Patient convenience|0|||
163153585|NCT02234843|589276353|FG003|Overall Study|Patient convenience|0|||
163153586|NCT02234843|589276354|FG004|Overall Study|Patient convenience|0|||
163153587|NCT02234843|589276355|FG005|Overall Study|Patient convenience|1|||
163153588|NCT02234843|589276356|FG006|Overall Study|Patient convenience|0|||
163153589|NCT02234843|589276357|FG007|Overall Study|Patient convenience|0|||
163153590|NCT02234843|589276358|FG008|Overall Study|Patient convenience|0|||
163153591|NCT02234843|589276359|FG009|Overall Study|Patient convenience|0|||
163153592|NCT02234843|589276350|FG000|Overall Study|Withdrawal by Subject|5|||
163153593|NCT02234843|589276351|FG001|Overall Study|Withdrawal by Subject|1|||
163153594|NCT02234843|589276352|FG002|Overall Study|Withdrawal by Subject|1|||
163153595|NCT02234843|589276353|FG003|Overall Study|Withdrawal by Subject|0|||
163153596|NCT02234843|589276354|FG004|Overall Study|Withdrawal by Subject|0|||
163153597|NCT02234843|589276355|FG005|Overall Study|Withdrawal by Subject|7|||
163153598|NCT02234843|589276356|FG006|Overall Study|Withdrawal by Subject|0|||
163153599|NCT02234843|589276357|FG007|Overall Study|Withdrawal by Subject|0|||
163153600|NCT02234843|589276358|FG008|Overall Study|Withdrawal by Subject|0|||
163153601|NCT02234843|589276359|FG009|Overall Study|Withdrawal by Subject|0|||
163153602|NCT02234843|589276350|FG000|Overall Study|Recovery|1|||
163153603|NCT02234843|589276351|FG001|Overall Study|Recovery|0|||
163153604|NCT02234843|589276352|FG002|Overall Study|Recovery|0|||
163153605|NCT02234843|589276353|FG003|Overall Study|Recovery|0|||
163153606|NCT02234843|589276354|FG004|Overall Study|Recovery|0|||
163153607|NCT02234843|589276355|FG005|Overall Study|Recovery|0|||
163153608|NCT02234843|589276356|FG006|Overall Study|Recovery|0|||
163153609|NCT02234843|589276357|FG007|Overall Study|Recovery|0|||
163153610|NCT02234843|589276358|FG008|Overall Study|Recovery|0|||
163153611|NCT02234843|589276359|FG009|Overall Study|Recovery|0|||
163153612|NCT02234843|589276350|FG000|Overall Study|Other|0|||
163153613|NCT02234843|589276351|FG001|Overall Study|Other|2|||
163153614|NCT02234843|589276352|FG002|Overall Study|Other|0|||
163153615|NCT02234843|589276353|FG003|Overall Study|Other|1|||
163153616|NCT02234843|589276354|FG004|Overall Study|Other|0|||
163153617|NCT02234843|589276355|FG005|Overall Study|Other|1|||
162676542|NCT00483184|587524992|FG001|Overall Study|Lost to Follow-up|0|||
162676543|NCT00483184|587524993|FG002|Overall Study|Lost to Follow-up|0|||
162676544|NCT00483184|587524991|FG000|Overall Study|Adverse Event|1|||
162676545|NCT00483184|587524992|FG001|Overall Study|Adverse Event|2|||
162676546|NCT00483184|587524993|FG002|Overall Study|Adverse Event|2|||
163153618|NCT02234843|589276356|FG006|Overall Study|Other|0|||
163153619|NCT02234843|589276357|FG007|Overall Study|Other|1|||
163153620|NCT02234843|589276358|FG008|Overall Study|Other|0|||
163153621|NCT02234843|589276359|FG009|Overall Study|Other|0|||
163153622|NCT02234843|589276350|FG000|Overall Study|Physician Decision|4|||
163153623|NCT02234843|589276351|FG001|Overall Study|Physician Decision|1|||
163153624|NCT02234843|589276352|FG002|Overall Study|Physician Decision|0|||
163153625|NCT02234843|589276353|FG003|Overall Study|Physician Decision|1|||
163153626|NCT02234843|589276354|FG004|Overall Study|Physician Decision|0|||
163153627|NCT02234843|589276355|FG005|Overall Study|Physician Decision|0|||
163153628|NCT02234843|589276356|FG006|Overall Study|Physician Decision|0|||
163153629|NCT02234843|589276357|FG007|Overall Study|Physician Decision|1|||
163153630|NCT02234843|589276358|FG008|Overall Study|Physician Decision|0|||
163153631|NCT02234843|589276359|FG009|Overall Study|Physician Decision|0|||
163153632|NCT02234843|589276350|FG000|Overall Study|Adverse Event|5|||
163153633|NCT02234843|589276351|FG001|Overall Study|Adverse Event|1|||
163153634|NCT02234843|589276352|FG002|Overall Study|Adverse Event|1|||
163153635|NCT02234843|589276353|FG003|Overall Study|Adverse Event|3|||
163153636|NCT02234843|589276354|FG004|Overall Study|Adverse Event|2|||
162676547|NCT00483184|587524991|FG000|Overall Study|Protocol Violation|1|||
162676548|NCT00483184|587524992|FG001|Overall Study|Protocol Violation|0|||
162676549|NCT00483184|587524993|FG002|Overall Study|Protocol Violation|1|||
162676550|NCT00515502|587525003|FG000|Treatment Period 1|Adverse Event|0|||
162676551|NCT00515502|587525004|FG001|Treatment Period 1|Adverse Event|0|||
162676552|NCT00515502|587525005|FG002|Treatment Period 1|Adverse Event|0|||
162676553|NCT00515502|587525006|FG003|Treatment Period 1|Adverse Event|0|||
162676554|NCT00515502|587525007|FG004|Treatment Period 1|Adverse Event|0|||
162676555|NCT00515502|587525008|FG005|Treatment Period 1|Adverse Event|0|||
162676556|NCT00515502|587525009|FG006|Treatment Period 1|Adverse Event|1|||
163153637|NCT02234843|589276355|FG005|Overall Study|Adverse Event|1|||
163153638|NCT02234843|589276356|FG006|Overall Study|Adverse Event|0|||
163153639|NCT02234843|589276357|FG007|Overall Study|Adverse Event|0|||
163153640|NCT02234843|589276358|FG008|Overall Study|Adverse Event|1|||
163153641|NCT02234843|589276359|FG009|Overall Study|Adverse Event|0|||
163153642|NCT02234843|589276350|FG000|Overall Study|Non-compliance with study drug|1|||
163153643|NCT02234843|589276351|FG001|Overall Study|Non-compliance with study drug|0|||
163153644|NCT02234843|589276352|FG002|Overall Study|Non-compliance with study drug|0|||
163153645|NCT02234843|589276353|FG003|Overall Study|Non-compliance with study drug|0|||
163153646|NCT02234843|589276354|FG004|Overall Study|Non-compliance with study drug|0|||
163153647|NCT02234843|589276355|FG005|Overall Study|Non-compliance with study drug|1|||
163153648|NCT02234843|589276356|FG006|Overall Study|Non-compliance with study drug|1|||
163153649|NCT02234843|589276357|FG007|Overall Study|Non-compliance with study drug|0|||
163153650|NCT02234843|589276358|FG008|Overall Study|Non-compliance with study drug|0|||
163153651|NCT02234843|589276359|FG009|Overall Study|Non-compliance with study drug|0|||
163153652|NCT02234843|589276350|FG000|Overall Study|Lost to Follow-up|0|||
163153653|NCT02234843|589276351|FG001|Overall Study|Lost to Follow-up|1|||
163153654|NCT02234843|589276352|FG002|Overall Study|Lost to Follow-up|0|||
163153655|NCT02234843|589276353|FG003|Overall Study|Lost to Follow-up|0|||
163153656|NCT02234843|589276354|FG004|Overall Study|Lost to Follow-up|0|||
163153657|NCT02234843|589276355|FG005|Overall Study|Lost to Follow-up|0|||
163153658|NCT02234843|589276356|FG006|Overall Study|Lost to Follow-up|1|||
163153659|NCT02234843|589276357|FG007|Overall Study|Lost to Follow-up|0|||
163153660|NCT02234843|589276358|FG008|Overall Study|Lost to Follow-up|0|||
163153661|NCT02234843|589276359|FG009|Overall Study|Lost to Follow-up|0|||
163153662|NCT04272242|589276366|FG000|Overall Study|Withdrawal by Subject|3|||
163153663|NCT04272242|589276366|FG000|Overall Study|Lost to Follow-up|1|||
163153664|NCT04272242|589276366|FG000|Overall Study|Adverse Event|1|||
163153665|NCT03204188|589276370|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
163153666|NCT03204188|589276370|FG000|Immunotherapy Phase (1 Year)|Death|1|||
163153667|NCT03204188|589276370|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
163153668|NCT03204188|589276370|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
163153669|NCT00091949|589278236|FG000|Overall Study|Withdrawal by Subject|117|||
163153670|NCT00091949|589278237|FG001|Overall Study|Withdrawal by Subject|110|||
163153671|NCT00091949|589278236|FG000|Overall Study|Lost to Follow-up|58|||
163153672|NCT00091949|589278237|FG001|Overall Study|Lost to Follow-up|41|||
163153673|NCT01256788|589278240|FG000|Overall Study|Lost to Follow-up|5|||
163153674|NCT01256788|589278241|FG001|Overall Study|Lost to Follow-up|8|||
163153675|NCT01256788|589278242|FG002|Overall Study|Lost to Follow-up|3|||
163153676|NCT05966142|589278243|FG000|Overall Study|Death|3|||
163153677|NCT05966142|589278244|FG001|Overall Study|Death|3|||
163153678|NCT05966142|589278243|FG000|Overall Study|Lost to Follow-up|55|||
163153679|NCT05966142|589278244|FG001|Overall Study|Lost to Follow-up|52|||
163153680|NCT05966142|589278243|FG000|Overall Study|Physician Decision|1|||
163153681|NCT05966142|589278244|FG001|Overall Study|Physician Decision|0|||
163153682|NCT05966142|589278243|FG000|Overall Study|Withdrawal by Subject|9|||
163153683|NCT05966142|589278244|FG001|Overall Study|Withdrawal by Subject|8|||
163153684|NCT05966142|589278243|FG000|Overall Study|Duplicate Enrollment|1|||
163153685|NCT05966142|589278244|FG001|Overall Study|Duplicate Enrollment|0|||
163153686|NCT05966142|589278243|FG000|Overall Study|Study Logistical Reason|1|||
163153687|NCT05966142|589278244|FG001|Overall Study|Study Logistical Reason|0|||
163153688|NCT05966142|589278243|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
163153689|NCT05966142|589278244|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
163153690|NCT04849364|589278245|FG000|Overall Study|Eligibility criteria not meet|0|||
163153691|NCT04849364|589278246|FG001|Overall Study|Eligibility criteria not meet|1|||
163153692|NCT04849364|589278247|FG002|Overall Study|Eligibility criteria not meet|0|||
163153693|NCT00894803|589278248|FG000|Overall Study|Death|20|||
163153694|NCT00894803|589278249|FG001|Overall Study|Death|4|||
163153695|NCT00894803|589278248|FG000|Overall Study|Lost to Follow-up|0|||
163153696|NCT00894803|589278249|FG001|Overall Study|Lost to Follow-up|1|||
163153697|NCT00449696|589278256|FG000|Overall Study|Other Treatment Required|6|||
163153698|NCT00449696|589278257|FG001|Overall Study|Other Treatment Required|1|||
163153699|NCT00449696|589278256|FG000|Overall Study|Withdrawal by Subject|5|||
163153700|NCT00449696|589278257|FG001|Overall Study|Withdrawal by Subject|5|||
163153701|NCT00449696|589278256|FG000|Overall Study|Lost to Follow-up|2|||
163153702|NCT00449696|589278257|FG001|Overall Study|Lost to Follow-up|3|||
163153703|NCT00449696|589278256|FG000|Overall Study|Others|7|||
163153704|NCT00449696|589278257|FG001|Overall Study|Others|0|||
163153705|NCT00307801|589278262|FG000|Overall Study|Adverse Event|12|||
162676557|NCT00515502|587525010|FG007|Treatment Period 1|Adverse Event|0|||
162676558|NCT00515502|587525011|FG008|Treatment Period 1|Adverse Event|1|||
162676559|NCT00515502|587525012|FG009|Treatment Period 1|Adverse Event|0|||
162676560|NCT00515502|587525013|FG010|Treatment Period 1|Adverse Event|0|||
162676561|NCT00515502|587525014|FG011|Treatment Period 1|Adverse Event|1|||
162676562|NCT00515502|587525003|FG000|Treatment Period 2|Adverse Event|0|||
162676563|NCT00515502|587525004|FG001|Treatment Period 2|Adverse Event|1|||
162676564|NCT00515502|587525005|FG002|Treatment Period 2|Adverse Event|0|||
162676565|NCT00515502|587525006|FG003|Treatment Period 2|Adverse Event|0|||
162676566|NCT00515502|587525007|FG004|Treatment Period 2|Adverse Event|0|||
162676567|NCT00515502|587525008|FG005|Treatment Period 2|Adverse Event|0|||
162676568|NCT00515502|587525009|FG006|Treatment Period 2|Adverse Event|0|||
162676569|NCT00515502|587525010|FG007|Treatment Period 2|Adverse Event|0|||
162676570|NCT00515502|587525011|FG008|Treatment Period 2|Adverse Event|0|||
162676571|NCT00515502|587525012|FG009|Treatment Period 2|Adverse Event|0|||
162676572|NCT00515502|587525013|FG010|Treatment Period 2|Adverse Event|0|||
162676573|NCT00515502|587525014|FG011|Treatment Period 2|Adverse Event|0|||
162676574|NCT03252587|587525015|FG000|Overall Study|Adverse Event|3|||
162676575|NCT03252587|587525016|FG001|Overall Study|Adverse Event|8|||
162676576|NCT03252587|587525017|FG002|Overall Study|Adverse Event|6|||
162676577|NCT03252587|587525018|FG003|Overall Study|Adverse Event|12|||
162676578|NCT03252587|587525015|FG000|Overall Study|Lack of Efficacy|7|||
162676579|NCT03252587|587525016|FG001|Overall Study|Lack of Efficacy|2|||
162676580|NCT03252587|587525017|FG002|Overall Study|Lack of Efficacy|2|||
162676581|NCT03252587|587525018|FG003|Overall Study|Lack of Efficacy|4|||
162676582|NCT03252587|587525015|FG000|Overall Study|Lost to Follow-up|2|||
162676583|NCT03252587|587525016|FG001|Overall Study|Lost to Follow-up|0|||
162676584|NCT03252587|587525017|FG002|Overall Study|Lost to Follow-up|0|||
162676585|NCT03252587|587525018|FG003|Overall Study|Lost to Follow-up|2|||
162676586|NCT03252587|587525015|FG000|Overall Study|Pregnancy|2|||
162676587|NCT03252587|587525016|FG001|Overall Study|Pregnancy|1|||
162676588|NCT03252587|587525017|FG002|Overall Study|Pregnancy|0|||
162676589|NCT03252587|587525018|FG003|Overall Study|Pregnancy|1|||
162676590|NCT03252587|587525015|FG000|Overall Study|Withdrawal by Subject|8|||
162676591|NCT03252587|587525016|FG001|Overall Study|Withdrawal by Subject|4|||
162676592|NCT03252587|587525017|FG002|Overall Study|Withdrawal by Subject|4|||
162676593|NCT03252587|587525018|FG003|Overall Study|Withdrawal by Subject|4|||
162676594|NCT03252587|587525015|FG000|Overall Study|Other Reasons|2|||
162676595|NCT03252587|587525016|FG001|Overall Study|Other Reasons|5|||
162676596|NCT03252587|587525017|FG002|Overall Study|Other Reasons|5|||
162676597|NCT03252587|587525018|FG003|Overall Study|Other Reasons|4|||
162676598|NCT04052204|587525019|FG000|Overall Study|Death|1|||
162676599|NCT04052204|587525020|FG001|Overall Study|Death|0|||
162676600|NCT04052204|587525021|FG002|Overall Study|Death|0|||
162676601|NCT04052204|587525019|FG000|Overall Study|Progressive disease|1|||
162676602|NCT04052204|587525020|FG001|Overall Study|Progressive disease|0|||
162676603|NCT04052204|587525021|FG002|Overall Study|Progressive disease|0|||
162676604|NCT04052204|587525019|FG000|Overall Study|Other|1|||
162676605|NCT04052204|587525020|FG001|Overall Study|Other|0|||
162676606|NCT04052204|587525021|FG002|Overall Study|Other|0|||
163153706|NCT00307801|589278263|FG001|Overall Study|Adverse Event|4|||
163153707|NCT00307801|589278262|FG000|Overall Study|Withdrawal by Subject|9|||
163153708|NCT00307801|589278263|FG001|Overall Study|Withdrawal by Subject|4|||
163153709|NCT00307801|589278262|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
163153710|NCT00307801|589278263|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
163153711|NCT00307801|589278262|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
163153712|NCT00307801|589278263|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
163153713|NCT00307801|589278262|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
163153714|NCT00307801|589278263|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
163153715|NCT00307801|589278262|FG000|Overall Study|Wrong Randomization|1|||
163153716|NCT00307801|589278263|FG001|Overall Study|Wrong Randomization|0|||
163153717|NCT00307801|589278262|FG000|Overall Study|Lack of Efficacy|0|||
163153718|NCT00307801|589278263|FG001|Overall Study|Lack of Efficacy|2|||
163153719|NCT00307801|589278262|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
163153720|NCT00307801|589278263|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
163153721|NCT00307801|589278262|FG000|Overall Study|Frustration with e-diary|1|||
163153722|NCT00307801|589278263|FG001|Overall Study|Frustration with e-diary|0|||
163153723|NCT00307801|589278262|FG000|Overall Study|Protocol Violation|3|||
163153724|NCT00307801|589278263|FG001|Overall Study|Protocol Violation|2|||
163153725|NCT00307801|589278262|FG000|Overall Study|No reason specified|2|||
163153726|NCT00307801|589278263|FG001|Overall Study|No reason specified|0|||
163153727|NCT00307801|589278262|FG000|Overall Study|Pregnancy|0|||
163153728|NCT00307801|589278263|FG001|Overall Study|Pregnancy|1|||
163153729|NCT01217229|589278271|FG000|Overall Study|Adverse Event|1|||
162676607|NCT01613248|587525022|FG000|Overall Study|Adverse Event|0|||
162676608|NCT01613248|587525023|FG001|Overall Study|Adverse Event|0|||
162676609|NCT01613248|587525024|FG002|Overall Study|Adverse Event|0|||
163153730|NCT01217229|589278271|FG000|Overall Study|Disease progression, deterioration|2|||
163153731|NCT01217229|589278271|FG000|Overall Study|Disease progression, Cheson criteria|14|||
163153732|NCT01217229|589278271|FG000|Overall Study|Protocol Violation|1|||
163153733|NCT01217229|589278271|FG000|Overall Study|Disease progression not confirmed|2|||
163153734|NCT00577889|589278274|FG000|Overall Study|Withdrawal by Subject|1|||
163153735|NCT00577889|589278275|FG001|Overall Study|Withdrawal by Subject|0|||
163153736|NCT00577889|589278276|FG002|Overall Study|Withdrawal by Subject|0|||
163153737|NCT01523756|589278278|FG000|Baseline Period|Adverse Event|0|||
163153738|NCT01523756|589278279|FG001|Baseline Period|Adverse Event|1|||
163153739|NCT01523756|589278278|FG000|Test Period 1|Adverse Event|1|||
163153740|NCT01523756|589278279|FG001|Test Period 1|Adverse Event|0|||
163153741|NCT01523756|589278278|FG000|Test Period 2|Withdrawal by Subject|0|||
163153742|NCT01523756|589278279|FG001|Test Period 2|Withdrawal by Subject|1|||
163153743|NCT03224819|589278282|FG000|Overall Study|Withdrawal by Subject|0|||
163153744|NCT03224819|589278283|FG001|Overall Study|Withdrawal by Subject|0|||
163153745|NCT03224819|589278284|FG002|Overall Study|Withdrawal by Subject|0|||
163153746|NCT03224819|589278285|FG003|Overall Study|Withdrawal by Subject|0|||
163153747|NCT03224819|589278286|FG004|Overall Study|Withdrawal by Subject|0|||
163153748|NCT03224819|589278287|FG005|Overall Study|Withdrawal by Subject|0|||
163153749|NCT03224819|589278288|FG006|Overall Study|Withdrawal by Subject|0|||
163153750|NCT03224819|589278289|FG007|Overall Study|Withdrawal by Subject|0|||
163153751|NCT03224819|589278290|FG008|Overall Study|Withdrawal by Subject|0|||
163153752|NCT03224819|589278291|FG009|Overall Study|Withdrawal by Subject|0|||
163153753|NCT03224819|589278292|FG010|Overall Study|Withdrawal by Subject|0|||
163153754|NCT03224819|589278293|FG011|Overall Study|Withdrawal by Subject|0|||
163153755|NCT03224819|589278294|FG012|Overall Study|Withdrawal by Subject|1|||
163153756|NCT03224819|589278295|FG013|Overall Study|Withdrawal by Subject|0|||
163153757|NCT03224819|589278282|FG000|Overall Study|Sponsor Decision|0|||
163153758|NCT03224819|589278283|FG001|Overall Study|Sponsor Decision|0|||
163153759|NCT03224819|589278284|FG002|Overall Study|Sponsor Decision|0|||
163153760|NCT03224819|589278285|FG003|Overall Study|Sponsor Decision|1|||
163153761|NCT03224819|589278286|FG004|Overall Study|Sponsor Decision|1|||
163153762|NCT03224819|589278287|FG005|Overall Study|Sponsor Decision|2|||
163153763|NCT03224819|589278288|FG006|Overall Study|Sponsor Decision|1|||
162676610|NCT01613248|587525025|FG003|Overall Study|Adverse Event|1|||
162676611|NCT01613248|587525026|FG004|Overall Study|Adverse Event|0|||
162676612|NCT01613248|587525027|FG005|Overall Study|Adverse Event|0|||
162676613|NCT01613248|587525022|FG000|Overall Study|Withdrawal by Subject|3|||
162676614|NCT01613248|587525023|FG001|Overall Study|Withdrawal by Subject|2|||
162676615|NCT01613248|587525024|FG002|Overall Study|Withdrawal by Subject|2|||
162676616|NCT01613248|587525025|FG003|Overall Study|Withdrawal by Subject|5|||
162676617|NCT01613248|587525026|FG004|Overall Study|Withdrawal by Subject|0|||
162676618|NCT01613248|587525027|FG005|Overall Study|Withdrawal by Subject|1|||
162676619|NCT01613248|587525022|FG000|Overall Study|Lost to Follow-up|5|||
162676620|NCT01613248|587525023|FG001|Overall Study|Lost to Follow-up|7|||
162676621|NCT01613248|587525024|FG002|Overall Study|Lost to Follow-up|4|||
162676622|NCT01613248|587525025|FG003|Overall Study|Lost to Follow-up|8|||
162676623|NCT01613248|587525026|FG004|Overall Study|Lost to Follow-up|4|||
162676624|NCT01613248|587525027|FG005|Overall Study|Lost to Follow-up|2|||
162676625|NCT01613248|587525022|FG000|Overall Study|Study Terminated by Sponsor|4|||
162676626|NCT01613248|587525023|FG001|Overall Study|Study Terminated by Sponsor|6|||
162676627|NCT01613248|587525024|FG002|Overall Study|Study Terminated by Sponsor|8|||
162676628|NCT01613248|587525025|FG003|Overall Study|Study Terminated by Sponsor|8|||
162676629|NCT01613248|587525026|FG004|Overall Study|Study Terminated by Sponsor|9|||
162676630|NCT01613248|587525027|FG005|Overall Study|Study Terminated by Sponsor|11|||
163153764|NCT03224819|589278289|FG007|Overall Study|Sponsor Decision|1|||
163153765|NCT03224819|589278290|FG008|Overall Study|Sponsor Decision|1|||
163153766|NCT03224819|589278291|FG009|Overall Study|Sponsor Decision|2|||
163153767|NCT03224819|589278292|FG010|Overall Study|Sponsor Decision|1|||
163153768|NCT03224819|589278293|FG011|Overall Study|Sponsor Decision|1|||
163153769|NCT03224819|589278294|FG012|Overall Study|Sponsor Decision|1|||
163153770|NCT03224819|589278295|FG013|Overall Study|Sponsor Decision|0|||
163153771|NCT03224819|589278282|FG000|Overall Study|Lost to Follow-up|0|||
163153772|NCT03224819|589278283|FG001|Overall Study|Lost to Follow-up|0|||
163153773|NCT03224819|589278284|FG002|Overall Study|Lost to Follow-up|0|||
163153774|NCT03224819|589278285|FG003|Overall Study|Lost to Follow-up|0|||
163153775|NCT03224819|589278286|FG004|Overall Study|Lost to Follow-up|0|||
163153776|NCT03224819|589278287|FG005|Overall Study|Lost to Follow-up|0|||
163153777|NCT03224819|589278288|FG006|Overall Study|Lost to Follow-up|0|||
163153778|NCT03224819|589278289|FG007|Overall Study|Lost to Follow-up|0|||
163153779|NCT03224819|589278290|FG008|Overall Study|Lost to Follow-up|1|||
163153780|NCT03224819|589278291|FG009|Overall Study|Lost to Follow-up|0|||
163153781|NCT03224819|589278292|FG010|Overall Study|Lost to Follow-up|0|||
163153782|NCT03224819|589278293|FG011|Overall Study|Lost to Follow-up|0|||
163153783|NCT03224819|589278294|FG012|Overall Study|Lost to Follow-up|0|||
163153784|NCT03224819|589278295|FG013|Overall Study|Lost to Follow-up|0|||
163153785|NCT03224819|589278282|FG000|Overall Study|Death|0|||
163153786|NCT03224819|589278283|FG001|Overall Study|Death|1|||
163153787|NCT03224819|589278284|FG002|Overall Study|Death|0|||
163153788|NCT03224819|589278285|FG003|Overall Study|Death|0|||
163153789|NCT03224819|589278286|FG004|Overall Study|Death|0|||
163153790|NCT03224819|589278287|FG005|Overall Study|Death|0|||
163153791|NCT03224819|589278288|FG006|Overall Study|Death|0|||
163153792|NCT03224819|589278289|FG007|Overall Study|Death|1|||
163153793|NCT03224819|589278290|FG008|Overall Study|Death|0|||
163153794|NCT03224819|589278291|FG009|Overall Study|Death|0|||
163153795|NCT03224819|589278292|FG010|Overall Study|Death|0|||
163153796|NCT03224819|589278293|FG011|Overall Study|Death|1|||
163153797|NCT03224819|589278294|FG012|Overall Study|Death|0|||
163153798|NCT03224819|589278295|FG013|Overall Study|Death|0|||
163153799|NCT03783078|589278296|FG000|Overall Study|Death|31|||
163153800|NCT03783078|589278296|FG000|Overall Study|Sponsor Decision|23|||
163153801|NCT03783078|589278296|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163153802|NCT02059278|589278299|FG000|Overall Study|Adverse Event|1|||
163153803|NCT02059278|589278300|FG001|Overall Study|Adverse Event|1|||
163153804|NCT02059278|589278299|FG000|Overall Study|Lost to Follow-up|1|||
163153805|NCT02059278|589278300|FG001|Overall Study|Lost to Follow-up|0|||
163153806|NCT02059278|589278299|FG000|Overall Study|Withdrawal by Subject|0|||
163153807|NCT02059278|589278300|FG001|Overall Study|Withdrawal by Subject|3|||
163153808|NCT02059278|589278299|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
163153809|NCT02059278|589278300|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
163153810|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
163153811|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
162676631|NCT01613248|587525022|FG000|Overall Study|Physician Decision|8|||
162676632|NCT01613248|587525023|FG001|Overall Study|Physician Decision|8|||
163153812|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
163153813|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
163153814|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Adverse Event|2|||
163153815|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Adverse Event|5|||
163153816|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Adverse Event|1|||
163153817|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Adverse Event|2|||
163153818|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Death|13|||
163153819|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Death|17|||
163153820|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Death|1|||
163153821|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Death|0|||
163153822|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
163153823|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
163153824|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
163153825|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
163153826|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Disease Progression|2|||
163153827|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Disease Progression|0|||
163153828|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Disease Progression|0|||
163153829|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Disease Progression|0|||
163153830|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
163153831|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
163153832|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
163153833|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
163153834|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
163153835|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
163153836|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
163153837|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
163153838|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
163153839|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
163153840|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
163153841|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
163153842|NCT03955146|589278301|FG000|DB Period (48 Weeks)|Participant Decision|9|||
163153843|NCT03955146|589278302|FG001|DB Period (48 Weeks)|Participant Decision|12|||
163153844|NCT03955146|589278303|FG002|DB Period (48 Weeks)|Participant Decision|1|||
163153845|NCT03955146|589278304|FG003|DB Period (48 Weeks)|Participant Decision|1|||
163153846|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
163153847|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
163153848|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
163153849|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
163153850|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
163153851|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
163153852|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
163153853|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
163153854|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153855|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
163153856|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153857|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
163153858|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
163153859|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
163153860|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
163153861|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
163153862|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
163153863|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
163153864|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
163153865|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
163153866|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
163153867|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
163153868|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
163153869|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
162676633|NCT01613248|587525024|FG002|Overall Study|Physician Decision|9|||
162676634|NCT01613248|587525025|FG003|Overall Study|Physician Decision|4|||
162676635|NCT01613248|587525026|FG004|Overall Study|Physician Decision|7|||
162676636|NCT01613248|587525027|FG005|Overall Study|Physician Decision|6|||
162676637|NCT01613248|587525022|FG000|Overall Study|Lack of Qualifying Event|9|||
162676638|NCT01613248|587525023|FG001|Overall Study|Lack of Qualifying Event|11|||
162676639|NCT01613248|587525024|FG002|Overall Study|Lack of Qualifying Event|10|||
162676640|NCT01613248|587525025|FG003|Overall Study|Lack of Qualifying Event|11|||
162676641|NCT01613248|587525026|FG004|Overall Study|Lack of Qualifying Event|15|||
163153870|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
163153871|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
163153872|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
163153873|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
163153874|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
163153875|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
163153876|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
163153877|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
163153878|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
163153879|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153880|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153881|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
163153882|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
163153883|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
163153884|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
163153885|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
163153886|NCT03955146|589278301|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
163153887|NCT03955146|589278302|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153888|NCT03955146|589278303|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153889|NCT03955146|589278304|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
163153890|NCT04363320|589278305|FG000|Overall Study|Lost to Follow-up|43|||
163153891|NCT04363320|589278306|FG001|Overall Study|Lost to Follow-up|42|||
163153892|NCT04363320|589278307|FG002|Overall Study|Lost to Follow-up|24|||
163153893|NCT04363320|589278308|FG003|Overall Study|Lost to Follow-up|29|||
163153894|NCT04363320|589278305|FG000|Overall Study|Death|0|||
163153895|NCT04363320|589278306|FG001|Overall Study|Death|0|||
163153896|NCT04363320|589278307|FG002|Overall Study|Death|1|||
163153897|NCT04363320|589278308|FG003|Overall Study|Death|0|||
163153898|NCT00604565|589278309|FG000|Overall Study|Study terminated|0|||
163153899|NCT00604565|589278310|FG001|Overall Study|Study terminated|3|||
163153900|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
163153901|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
163153902|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
163153903|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
163153904|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
163153905|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
163153906|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
162676642|NCT01613248|587525027|FG005|Overall Study|Lack of Qualifying Event|18|||
162676643|NCT01613248|587525022|FG000|Overall Study|Pregnancy|0|||
162676644|NCT01613248|587525023|FG001|Overall Study|Pregnancy|0|||
162676645|NCT01613248|587525024|FG002|Overall Study|Pregnancy|0|||
162676646|NCT01613248|587525025|FG003|Overall Study|Pregnancy|1|||
162676647|NCT01613248|587525026|FG004|Overall Study|Pregnancy|0|||
163153907|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
163153908|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
163153909|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
163153910|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
163153911|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
163153912|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
163153913|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
163153914|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
163153915|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
163153916|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
163153917|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
163153918|NCT03605667|589278311|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
163153919|NCT03605667|589278312|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
163153920|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
163153921|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
163153922|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Other|6|||
163153923|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Other|8|||
163153924|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
163153925|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
163153926|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
163153927|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
163153928|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
163153929|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
163153930|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
163153931|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
163153932|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
163153933|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
163153934|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
163153935|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
163153936|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Death|0|||
163153937|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Death|2|||
163153938|NCT03605667|589278311|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
163153939|NCT03605667|589278312|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
163153940|NCT05632211|589278313|FG000|Overall Study|Withdrawal by Subject|2|||
163153941|NCT05632211|589278314|FG001|Overall Study|Withdrawal by Subject|0|||
163153942|NCT05632211|589278315|FG002|Overall Study|Withdrawal by Subject|2|||
163153943|NCT05632211|589278313|FG000|Overall Study|Other reasons|1|||
163153944|NCT05632211|589278314|FG001|Overall Study|Other reasons|1|||
163153945|NCT05632211|589278315|FG002|Overall Study|Other reasons|1|||
163153946|NCT00541658|589278316|FG000|Overall Study|Adverse Event|28|||
163153947|NCT00541658|589278317|FG001|Overall Study|Adverse Event|37|||
163153948|NCT00541658|589278318|FG002|Overall Study|Adverse Event|25|||
163153949|NCT00541658|589278316|FG000|Overall Study|Physician Decision|0|||
163153950|NCT00541658|589278317|FG001|Overall Study|Physician Decision|0|||
163153951|NCT00541658|589278318|FG002|Overall Study|Physician Decision|4|||
163153952|NCT00541658|589278316|FG000|Overall Study|Lost to Follow-up|3|||
163153953|NCT00541658|589278317|FG001|Overall Study|Lost to Follow-up|3|||
163153954|NCT00541658|589278318|FG002|Overall Study|Lost to Follow-up|6|||
163153955|NCT00541658|589278316|FG000|Overall Study|Protocol Violation|0|||
163153956|NCT00541658|589278317|FG001|Overall Study|Protocol Violation|1|||
163153957|NCT00541658|589278318|FG002|Overall Study|Protocol Violation|1|||
163153958|NCT00541658|589278316|FG000|Overall Study|Withdrawal by Subject|28|||
163153959|NCT00541658|589278317|FG001|Overall Study|Withdrawal by Subject|32|||
163153960|NCT00541658|589278318|FG002|Overall Study|Withdrawal by Subject|32|||
163153961|NCT00541658|589278316|FG000|Overall Study|Took No Study Drug|1|||
163153962|NCT00541658|589278317|FG001|Overall Study|Took No Study Drug|0|||
163153963|NCT00541658|589278318|FG002|Overall Study|Took No Study Drug|0|||
163153964|NCT05194124|589278332|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153965|NCT05194124|589278333|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153966|NCT05194124|589278334|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153967|NCT05194124|589278335|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
163153968|NCT05194124|589278336|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153969|NCT05194124|589278337|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
163153970|NCT05194124|589278338|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153971|NCT05194124|589278339|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153972|NCT05194124|589278340|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153973|NCT05194124|589278341|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
163153974|NCT05194124|589278332|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153975|NCT05194124|589278333|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153976|NCT05194124|589278334|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162676648|NCT01613248|587525027|FG005|Overall Study|Pregnancy|0|||
162676649|NCT01433354|587525028|FG000|Overall Study|Adverse Event|6|||
162676650|NCT01433354|587525028|FG000|Overall Study|Lost to Follow-up|1|||
162676651|NCT01433354|587525028|FG000|Overall Study|Administrative problems|90|||
162676652|NCT01433354|587525028|FG000|Overall Study|Protocol Violation|2|||
162676653|NCT01433354|587525028|FG000|Overall Study|Lack of Efficacy|17|||
162676654|NCT01433354|587525028|FG000|Overall Study|Subject Withdrew Consent|3|||
162676655|NCT04124926|587525041|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
163153977|NCT05194124|589278335|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153978|NCT05194124|589278336|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153979|NCT05194124|589278337|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153980|NCT05194124|589278338|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153981|NCT05194124|589278339|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153982|NCT05194124|589278340|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
163153983|NCT05194124|589278341|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
163153984|NCT05408429|589278346|FG000|Overall Study|Lost to Follow-up|1|||
163153985|NCT05408429|589278347|FG001|Overall Study|Lost to Follow-up|1|||
163153986|NCT05408429|589278348|FG002|Overall Study|Lost to Follow-up|0|||
163153987|NCT05408429|589278346|FG000|Overall Study|Withdrawal by Subject|5|||
163153988|NCT05408429|589278347|FG001|Overall Study|Withdrawal by Subject|0|||
163153989|NCT05408429|589278348|FG002|Overall Study|Withdrawal by Subject|1|||
163153990|NCT03642873|589278349|FG000|Third Intervention (1 Day)|Screen failure|0|||
163153991|NCT03642873|589278350|FG001|Third Intervention (1 Day)|Screen failure|0|||
163153992|NCT03642873|589278351|FG002|Third Intervention (1 Day)|Screen failure|0|||
163153993|NCT03642873|589278352|FG003|Third Intervention (1 Day)|Screen failure|0|||
163153994|NCT03642873|589278353|FG004|Third Intervention (1 Day)|Screen failure|1|||
163153995|NCT03642873|589278354|FG005|Third Intervention (1 Day)|Screen failure|0|||
163153996|NCT01253291|589278356|FG000|Overall Study|Withdrawal by Subject|1|||
163153997|NCT01253291|589278357|FG001|Overall Study|Withdrawal by Subject|1|||
163153998|NCT01253291|589278358|FG002|Overall Study|Withdrawal by Subject|0|||
163153999|NCT01253291|589278359|FG003|Overall Study|Withdrawal by Subject|0|||
163154000|NCT01253291|589278360|FG004|Overall Study|Withdrawal by Subject|0|||
163154001|NCT01253291|589278356|FG000|Overall Study|Adverse Event|0|||
163154002|NCT01253291|589278357|FG001|Overall Study|Adverse Event|1|||
163154003|NCT01253291|589278358|FG002|Overall Study|Adverse Event|0|||
163154004|NCT01253291|589278359|FG003|Overall Study|Adverse Event|0|||
163154005|NCT01253291|589278360|FG004|Overall Study|Adverse Event|0|||
163154006|NCT01253291|589278356|FG000|Overall Study|Lack of Efficacy|1|||
163154007|NCT01253291|589278357|FG001|Overall Study|Lack of Efficacy|0|||
163154008|NCT01253291|589278358|FG002|Overall Study|Lack of Efficacy|0|||
163154009|NCT01253291|589278359|FG003|Overall Study|Lack of Efficacy|0|||
163154010|NCT01253291|589278360|FG004|Overall Study|Lack of Efficacy|0|||
163154011|NCT01253291|589278356|FG000|Overall Study|Physician Decision|2|||
163154012|NCT01253291|589278357|FG001|Overall Study|Physician Decision|0|||
163154013|NCT01253291|589278358|FG002|Overall Study|Physician Decision|0|||
163154014|NCT01253291|589278359|FG003|Overall Study|Physician Decision|0|||
163154015|NCT01253291|589278360|FG004|Overall Study|Physician Decision|2|||
163154016|NCT03312231|589278364|FG000|Overall Study|Lost to Follow-up|2|||
163154017|NCT03312231|589278365|FG001|Overall Study|Lost to Follow-up|6|||
163154018|NCT03312231|589278366|FG002|Overall Study|Lost to Follow-up|1|||
163154019|NCT03312231|589278367|FG003|Overall Study|Lost to Follow-up|3|||
163154020|NCT03312231|589278368|FG004|Overall Study|Lost to Follow-up|1|||
163154021|NCT03312231|589278364|FG000|Overall Study|Withdrawal by Subject|0|||
163154022|NCT03312231|589278365|FG001|Overall Study|Withdrawal by Subject|3|||
163154023|NCT03312231|589278366|FG002|Overall Study|Withdrawal by Subject|1|||
163154024|NCT03312231|589278367|FG003|Overall Study|Withdrawal by Subject|0|||
163154025|NCT03312231|589278368|FG004|Overall Study|Withdrawal by Subject|0|||
163154026|NCT03312231|589278364|FG000|Overall Study|Death|0|||
162676656|NCT04124926|587525042|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
162676657|NCT04124926|587525043|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162676658|NCT04124926|587525044|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162676659|NCT04124926|587525045|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162676660|NCT04124926|587525041|FG000|Healing Phase|Protocol Violation|0|||
162676661|NCT04124926|587525042|FG001|Healing Phase|Protocol Violation|1|||
162676662|NCT04124926|587525043|FG002|Healing Phase|Protocol Violation|0|||
162676663|NCT04124926|587525044|FG003|Healing Phase|Protocol Violation|0|||
162676664|NCT04124926|587525045|FG004|Healing Phase|Protocol Violation|0|||
162676665|NCT04124926|587525041|FG000|Healing Phase|Lost to Follow-up|5|||
162676666|NCT04124926|587525042|FG001|Healing Phase|Lost to Follow-up|4|||
162676667|NCT04124926|587525043|FG002|Healing Phase|Lost to Follow-up|0|||
162676668|NCT04124926|587525044|FG003|Healing Phase|Lost to Follow-up|0|||
162676669|NCT04124926|587525045|FG004|Healing Phase|Lost to Follow-up|0|||
162676670|NCT04124926|587525041|FG000|Healing Phase|Voluntary Withdrawal|10|||
162676671|NCT04124926|587525042|FG001|Healing Phase|Voluntary Withdrawal|7|||
162676672|NCT04124926|587525043|FG002|Healing Phase|Voluntary Withdrawal|0|||
162676673|NCT04124926|587525044|FG003|Healing Phase|Voluntary Withdrawal|0|||
162676674|NCT04124926|587525045|FG004|Healing Phase|Voluntary Withdrawal|0|||
162676675|NCT04124926|587525041|FG000|Healing Phase|Withdrawal of Consent|5|||
162676676|NCT04124926|587525042|FG001|Healing Phase|Withdrawal of Consent|3|||
162676677|NCT04124926|587525043|FG002|Healing Phase|Withdrawal of Consent|0|||
162676678|NCT04124926|587525044|FG003|Healing Phase|Withdrawal of Consent|0|||
162676679|NCT04124926|587525045|FG004|Healing Phase|Withdrawal of Consent|0|||
162676680|NCT04124926|587525041|FG000|Healing Phase|Miscellaneous|8|||
162676681|NCT04124926|587525042|FG001|Healing Phase|Miscellaneous|7|||
162676682|NCT04124926|587525043|FG002|Healing Phase|Miscellaneous|0|||
162676683|NCT04124926|587525044|FG003|Healing Phase|Miscellaneous|0|||
162676684|NCT04124926|587525045|FG004|Healing Phase|Miscellaneous|0|||
162676685|NCT04124926|587525041|FG000|Healing Phase|Randomized but not Treated|0|||
162676686|NCT04124926|587525042|FG001|Healing Phase|Randomized but not Treated|3|||
162676687|NCT04124926|587525043|FG002|Healing Phase|Randomized but not Treated|0|||
162676688|NCT04124926|587525044|FG003|Healing Phase|Randomized but not Treated|0|||
162676689|NCT04124926|587525045|FG004|Healing Phase|Randomized but not Treated|0|||
162676690|NCT04124926|587525041|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
162676691|NCT04124926|587525042|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
162676692|NCT04124926|587525043|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
162676693|NCT04124926|587525044|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
162676694|NCT04124926|587525045|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
162676695|NCT04124926|587525041|FG000|Maintenance Phase|Protocol Violation|0|||
162676696|NCT04124926|587525042|FG001|Maintenance Phase|Protocol Violation|0|||
162676697|NCT04124926|587525043|FG002|Maintenance Phase|Protocol Violation|3|||
162676698|NCT04124926|587525044|FG003|Maintenance Phase|Protocol Violation|0|||
162676699|NCT04124926|587525045|FG004|Maintenance Phase|Protocol Violation|0|||
162676700|NCT04124926|587525041|FG000|Maintenance Phase|Lost to Follow-up|0|||
162676701|NCT04124926|587525042|FG001|Maintenance Phase|Lost to Follow-up|0|||
162676702|NCT04124926|587525043|FG002|Maintenance Phase|Lost to Follow-up|7|||
162676703|NCT04124926|587525044|FG003|Maintenance Phase|Lost to Follow-up|8|||
162676704|NCT04124926|587525045|FG004|Maintenance Phase|Lost to Follow-up|9|||
162676705|NCT04124926|587525041|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
162676706|NCT04124926|587525042|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
162676707|NCT04124926|587525043|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
162676708|NCT04124926|587525044|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
162676709|NCT04124926|587525045|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
163154027|NCT03312231|589278365|FG001|Overall Study|Death|1|||
163154028|NCT03312231|589278366|FG002|Overall Study|Death|1|||
163154029|NCT03312231|589278367|FG003|Overall Study|Death|0|||
163154030|NCT03312231|589278368|FG004|Overall Study|Death|0|||
163154031|NCT03312231|589278364|FG000|Overall Study|Study Vaccination not Received|1|||
163154032|NCT03312231|589278365|FG001|Overall Study|Study Vaccination not Received|1|||
163154033|NCT03312231|589278366|FG002|Overall Study|Study Vaccination not Received|1|||
163154034|NCT03312231|589278367|FG003|Overall Study|Study Vaccination not Received|0|||
163154035|NCT03312231|589278368|FG004|Overall Study|Study Vaccination not Received|0|||
163154036|NCT03157830|589278372|FG000|Overall Study|Lost to Follow-up|1|||
163154037|NCT03157830|589278372|FG000|Overall Study|Withdrawal by Subject|1|||
163154038|NCT02195518|589278373|FG000|Overall Study|Adverse Event|1|||
163154039|NCT02195518|589278373|FG000|Overall Study|Protocol Violation|4|||
163154040|NCT02195518|589278373|FG000|Overall Study|Pregnancy|2|||
163154041|NCT02195518|589278373|FG000|Overall Study|Withdrawal by Subject|1|||
163154042|NCT02195518|589278373|FG000|Overall Study|Lost to Follow-up|1|||
163154043|NCT03694353|589278374|FG000|Overall Study|Withdrawal by Subject|1|||
163154044|NCT03694353|589278374|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
163154045|NCT03804528|589278379|FG000|Overall Study|Time Commitment|18|||
163154046|NCT03804528|589278379|FG000|Overall Study|Health Reasons|5|||
163154047|NCT00651742|589278381|FG000|Overall Study|Objective Disease Progression|22|||
163154048|NCT00651742|589278381|FG000|Overall Study|Toxicity|3|||
163154049|NCT00651742|589278381|FG000|Overall Study|Investigator Judgment|1|||
163154050|NCT00651742|589278381|FG000|Overall Study|Withdrawal of Consent|1|||
163154051|NCT00651742|589278381|FG000|Overall Study|Enrolled but not treated|1|||
163154052|NCT01074970|589278382|FG000|Overall Study|Never Treated|0|||
163154053|NCT01074970|589278383|FG001|Overall Study|Never Treated|0|||
163154054|NCT01074970|589278384|FG002|Overall Study|Never Treated|8|||
163154055|NCT01074970|589278385|FG003|Overall Study|Never Treated|1|||
163154056|NCT01074970|589278382|FG000|Overall Study|Adverse Event|1|||
163154057|NCT01074970|589278383|FG001|Overall Study|Adverse Event|0|||
163154058|NCT01074970|589278384|FG002|Overall Study|Adverse Event|4|||
163154059|NCT01074970|589278385|FG003|Overall Study|Adverse Event|3|||
163154060|NCT01074970|589278382|FG000|Overall Study|Disease progression during treatment|3|||
163154061|NCT01074970|589278383|FG001|Overall Study|Disease progression during treatment|1|||
163154062|NCT01074970|589278384|FG002|Overall Study|Disease progression during treatment|2|||
163154063|NCT01074970|589278385|FG003|Overall Study|Disease progression during treatment|9|||
163154064|NCT01074970|589278382|FG000|Overall Study|Lost to Follow-up|0|||
163154065|NCT01074970|589278383|FG001|Overall Study|Lost to Follow-up|0|||
163154066|NCT01074970|589278384|FG002|Overall Study|Lost to Follow-up|1|||
163154067|NCT01074970|589278385|FG003|Overall Study|Lost to Follow-up|0|||
163154068|NCT01074970|589278382|FG000|Overall Study|Withdrawal by Subject|0|||
163154069|NCT01074970|589278383|FG001|Overall Study|Withdrawal by Subject|0|||
163154070|NCT01074970|589278384|FG002|Overall Study|Withdrawal by Subject|6|||
163154071|NCT01074970|589278385|FG003|Overall Study|Withdrawal by Subject|4|||
163154072|NCT00734149|589278387|FG000|Overall Study|Withdrawal by Subject|1|||
163154073|NCT04314284|589278388|FG000|Overall Study|Withdrawal by Subject|4|||
163154074|NCT04314284|589278389|FG001|Overall Study|Withdrawal by Subject|7|||
163154075|NCT04314284|589278388|FG000|Overall Study|Consented but did not complete survey|0|||
163154076|NCT04314284|589278389|FG001|Overall Study|Consented but did not complete survey|6|||
163154077|NCT01652235|589278392|FG000|Overall Study|Death|9|||
163154078|NCT01652235|589278392|FG000|Overall Study|Lost to Follow-up|5|||
163154079|NCT01652235|589278392|FG000|Overall Study|Withdrawal by Subject|2|||
163154080|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
163154081|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154082|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154083|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154084|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154085|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154086|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154087|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154088|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154089|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154090|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154091|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154092|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154093|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154094|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154095|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163154096|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154097|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
163154098|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154099|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154100|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154101|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154102|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154103|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154104|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
163154105|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154106|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154107|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154108|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154109|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154110|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154111|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
163154112|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154113|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
163154114|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154115|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154116|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
163154117|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154118|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154119|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154120|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154121|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154122|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154123|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154124|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154125|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154126|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154127|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
163154128|NCT05138653|589278393|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154129|NCT05138653|589278394|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154130|NCT05138653|589278395|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154131|NCT05138653|589278396|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154132|NCT05138653|589278397|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154133|NCT05138653|589278398|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154134|NCT05138653|589278399|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
163154135|NCT05138653|589278400|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154136|NCT05138653|589278401|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154137|NCT05138653|589278402|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154138|NCT05138653|589278403|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154139|NCT05138653|589278404|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154140|NCT05138653|589278405|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154141|NCT05138653|589278406|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154142|NCT05138653|589278407|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154143|NCT05138653|589278408|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
163154144|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154145|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154146|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154147|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154148|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154149|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154150|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154151|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154152|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154153|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154154|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154155|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154156|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154157|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154158|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
163154159|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163154160|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154161|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154162|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154163|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154164|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154165|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154166|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154167|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154168|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154169|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154170|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154171|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154172|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154173|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154174|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
163154175|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
163154176|NCT05138653|589278393|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154177|NCT05138653|589278394|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154178|NCT05138653|589278395|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154179|NCT05138653|589278396|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154180|NCT05138653|589278397|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154181|NCT05138653|589278398|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154182|NCT05138653|589278399|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154183|NCT05138653|589278400|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154184|NCT05138653|589278401|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154185|NCT05138653|589278402|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154186|NCT05138653|589278403|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154187|NCT05138653|589278404|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154188|NCT05138653|589278405|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154189|NCT05138653|589278406|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
163154190|NCT05138653|589278407|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154191|NCT05138653|589278408|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
163154192|NCT02023086|589278411|FG000|Overall Study|Withdrawal by Subject|2|||
163154193|NCT02023086|589278412|FG001|Overall Study|Withdrawal by Subject|0|||
163154194|NCT04607005|589278413|FG000|Overall Study|Adverse Event|0|||
163154195|NCT04607005|589278414|FG001|Overall Study|Adverse Event|1|||
163154196|NCT04607005|589278413|FG000|Overall Study|Lack of Efficacy|1|||
163154197|NCT04607005|589278414|FG001|Overall Study|Lack of Efficacy|6|||
163154198|NCT04607005|589278413|FG000|Overall Study|Withdrawal by Subject|4|||
163154199|NCT04607005|589278414|FG001|Overall Study|Withdrawal by Subject|9|||
163154200|NCT04607005|589278413|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
163154201|NCT04607005|589278414|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
163154202|NCT01148979|589280029|FG000|Overall Study|Lost to Follow-up|0|||
163154203|NCT01148979|589280030|FG001|Overall Study|Lost to Follow-up|1|||
163154204|NCT00777153|589280031|FG000|Overall Study|Lost to Follow-up|1|||
163154205|NCT00777153|589280032|FG001|Overall Study|Lost to Follow-up|1|||
163154206|NCT00777153|589280033|FG002|Overall Study|Lost to Follow-up|0|||
163154207|NCT00777153|589280031|FG000|Overall Study|Death|85|||
163154208|NCT00777153|589280032|FG001|Overall Study|Death|73|||
163154209|NCT00777153|589280033|FG002|Overall Study|Death|33|||
163154210|NCT00777153|589280031|FG000|Overall Study|Withdrawal by Subject|3|||
163154211|NCT00777153|589280032|FG001|Overall Study|Withdrawal by Subject|4|||
163154212|NCT00777153|589280033|FG002|Overall Study|Withdrawal by Subject|3|||
163154213|NCT00777153|589280031|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
163154214|NCT00777153|589280032|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
163154215|NCT00777153|589280033|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
163154216|NCT02266888|589280044|FG000|Overall Study|Death|2|||
163154217|NCT02266888|589280045|FG001|Overall Study|Death|2|||
163154218|NCT02266888|589280046|FG002|Overall Study|Death|4|||
163154219|NCT02266888|589280047|FG003|Overall Study|Death|2|||
163154220|NCT02266888|589280044|FG000|Overall Study|Physician Decision|0|||
163154221|NCT02266888|589280045|FG001|Overall Study|Physician Decision|1|||
163154222|NCT02266888|589280046|FG002|Overall Study|Physician Decision|2|||
163154223|NCT02266888|589280047|FG003|Overall Study|Physician Decision|2|||
163154224|NCT02266888|589280044|FG000|Overall Study|Study Terminated|5|||
163154225|NCT02266888|589280045|FG001|Overall Study|Study Terminated|1|||
163154226|NCT02266888|589280046|FG002|Overall Study|Study Terminated|0|||
163154227|NCT02266888|589280047|FG003|Overall Study|Study Terminated|0|||
163154228|NCT02266888|589280044|FG000|Overall Study|No Longer Eligible|0|||
163154229|NCT02266888|589280045|FG001|Overall Study|No Longer Eligible|0|||
163154230|NCT02266888|589280046|FG002|Overall Study|No Longer Eligible|0|||
163154231|NCT02266888|589280047|FG003|Overall Study|No Longer Eligible|2|||
163154232|NCT02266888|589280044|FG000|Overall Study|Randomization Closed|0|||
163154233|NCT02266888|589280045|FG001|Overall Study|Randomization Closed|0|||
163154234|NCT02266888|589280046|FG002|Overall Study|Randomization Closed|4|||
163154235|NCT02266888|589280047|FG003|Overall Study|Randomization Closed|0|||
163154236|NCT02266888|589280044|FG000|Overall Study|Personnel unavailable at transplant|0|||
163154237|NCT02266888|589280045|FG001|Overall Study|Personnel unavailable at transplant|0|||
163154238|NCT02266888|589280046|FG002|Overall Study|Personnel unavailable at transplant|0|||
163154239|NCT02266888|589280047|FG003|Overall Study|Personnel unavailable at transplant|1|||
163154240|NCT02266888|589280044|FG000|Overall Study|Transfer of care|0|||
163154241|NCT02266888|589280045|FG001|Overall Study|Transfer of care|0|||
163154242|NCT02266888|589280046|FG002|Overall Study|Transfer of care|1|||
163154243|NCT02266888|589280047|FG003|Overall Study|Transfer of care|0|||
163154244|NCT02224560|589280052|FG000|Overall Study|Protocol Deviation|1|||
163154245|NCT02224560|589280053|FG001|Overall Study|Protocol Deviation|0|||
163154246|NCT02224560|589280054|FG002|Overall Study|Protocol Deviation|0|||
163154247|NCT02224560|589280052|FG000|Overall Study|Withdrawal by Subject|2|||
163154248|NCT02224560|589280053|FG001|Overall Study|Withdrawal by Subject|0|||
163154249|NCT02224560|589280054|FG002|Overall Study|Withdrawal by Subject|1|||
163154250|NCT02224560|589280052|FG000|Overall Study|Met Withdrawal Criteria|1|||
163154251|NCT02224560|589280053|FG001|Overall Study|Met Withdrawal Criteria|0|||
163154252|NCT02224560|589280054|FG002|Overall Study|Met Withdrawal Criteria|0|||
163154253|NCT02224560|589280052|FG000|Overall Study|Adverse Event|4|||
163154254|NCT02224560|589280053|FG001|Overall Study|Adverse Event|1|||
163154255|NCT02224560|589280054|FG002|Overall Study|Adverse Event|1|||
163154256|NCT02224560|589280052|FG000|Overall Study|Withdrawn by Investigator|1|||
163154257|NCT02224560|589280053|FG001|Overall Study|Withdrawn by Investigator|1|||
163154258|NCT02224560|589280054|FG002|Overall Study|Withdrawn by Investigator|0|||
163154259|NCT00728689|589280055|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
163154260|NCT00728689|589280056|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
163154261|NCT01523366|589280057|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163154262|NCT01523366|589280058|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163154263|NCT01523366|589280057|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
163154264|NCT01523366|589280058|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
163154265|NCT02461758|589280059|FG000|Overall Study|Lost to Follow-up|0|||
163154266|NCT02461758|589280060|FG001|Overall Study|Lost to Follow-up|1|||
163154267|NCT02461758|589280061|FG002|Overall Study|Lost to Follow-up|1|||
163154268|NCT02461758|589280062|FG003|Overall Study|Lost to Follow-up|0|||
163154269|NCT04543279|589280064|FG000|Overall Study|Withdrawal by Subject|1|||
163154270|NCT04543279|589280065|FG001|Overall Study|Withdrawal by Subject|0|||
163154271|NCT04543279|589280064|FG000|Overall Study|Adverse Event|1|||
163154272|NCT04543279|589280065|FG001|Overall Study|Adverse Event|0|||
163154273|NCT04543279|589280064|FG000|Overall Study|Physician Decision|1|||
163154274|NCT04543279|589280065|FG001|Overall Study|Physician Decision|0|||
162676710|NCT04124926|587525041|FG000|Maintenance Phase|Pregnancy|0|||
162676711|NCT04124926|587525042|FG001|Maintenance Phase|Pregnancy|0|||
162676712|NCT04124926|587525043|FG002|Maintenance Phase|Pregnancy|0|||
162676713|NCT04124926|587525044|FG003|Maintenance Phase|Pregnancy|1|||
162676714|NCT04124926|587525045|FG004|Maintenance Phase|Pregnancy|0|||
162676715|NCT04124926|587525041|FG000|Maintenance Phase|Lack of Efficacy|0|||
162676716|NCT04124926|587525042|FG001|Maintenance Phase|Lack of Efficacy|0|||
162676717|NCT04124926|587525043|FG002|Maintenance Phase|Lack of Efficacy|0|||
162676718|NCT04124926|587525044|FG003|Maintenance Phase|Lack of Efficacy|0|||
162676719|NCT04124926|587525045|FG004|Maintenance Phase|Lack of Efficacy|1|||
162676720|NCT04124926|587525041|FG000|Maintenance Phase|Withdrawal of Consent|0|||
162676721|NCT04124926|587525042|FG001|Maintenance Phase|Withdrawal of Consent|0|||
162676722|NCT04124926|587525043|FG002|Maintenance Phase|Withdrawal of Consent|5|||
162676723|NCT04124926|587525044|FG003|Maintenance Phase|Withdrawal of Consent|5|||
162676724|NCT04124926|587525045|FG004|Maintenance Phase|Withdrawal of Consent|5|||
162676725|NCT04124926|587525041|FG000|Maintenance Phase|Miscellaneous|0|||
162676726|NCT04124926|587525042|FG001|Maintenance Phase|Miscellaneous|0|||
162676727|NCT04124926|587525043|FG002|Maintenance Phase|Miscellaneous|1|||
162676728|NCT04124926|587525044|FG003|Maintenance Phase|Miscellaneous|2|||
162676729|NCT04124926|587525045|FG004|Maintenance Phase|Miscellaneous|4|||
162676730|NCT04124926|587525041|FG000|Maintenance Phase|Randomized but not Treated|0|||
162676731|NCT04124926|587525042|FG001|Maintenance Phase|Randomized but not Treated|0|||
162676732|NCT04124926|587525043|FG002|Maintenance Phase|Randomized but not Treated|2|||
162676733|NCT04124926|587525044|FG003|Maintenance Phase|Randomized but not Treated|2|||
163154275|NCT00929695|589280068|FG000|Overall Study|Death|2|||
163154276|NCT00929695|589280069|FG001|Overall Study|Death|1|||
163154277|NCT00929695|589280068|FG000|Overall Study|Withdrawal by Subject|0|||
163154278|NCT00929695|589280069|FG001|Overall Study|Withdrawal by Subject|2|||
163154279|NCT00929695|589280068|FG000|Overall Study|discharge home|4|||
163154280|NCT00929695|589280069|FG001|Overall Study|discharge home|3|||
163154281|NCT00929695|589280068|FG000|Overall Study|incorrect stratification|2|||
162676734|NCT04124926|587525045|FG004|Maintenance Phase|Randomized but not Treated|0|||
162676735|NCT03321396|587525051|FG000|Overall Study|Physician Decision|1|||
162676736|NCT00937924|587525054|FG000|Overall Study|Lost to Follow-up|44|||
163154282|NCT00929695|589280069|FG001|Overall Study|incorrect stratification|0|||
163154283|NCT04030143|589280070|FG000|Overall Study|Adverse Event|5|||
163154284|NCT04030143|589280071|FG001|Overall Study|Adverse Event|10|||
163154285|NCT04030143|589280070|FG000|Overall Study|Lost to Follow-up|3|||
163154286|NCT04030143|589280071|FG001|Overall Study|Lost to Follow-up|7|||
163154287|NCT04030143|589280070|FG000|Overall Study|Protocol Deviation|2|||
163154288|NCT04030143|589280071|FG001|Overall Study|Protocol Deviation|2|||
163154289|NCT04030143|589280070|FG000|Overall Study|Withdrawal by Subject|16|||
163154290|NCT04030143|589280071|FG001|Overall Study|Withdrawal by Subject|18|||
163154291|NCT04030143|589280070|FG000|Overall Study|Physician Decision|1|||
163154292|NCT04030143|589280071|FG001|Overall Study|Physician Decision|1|||
163154293|NCT04030143|589280070|FG000|Overall Study|Due to Covid-19|2|||
163154294|NCT04030143|589280071|FG001|Overall Study|Due to Covid-19|3|||
163154295|NCT04030143|589280070|FG000|Overall Study|Not Due to Covid-19|1|||
163154296|NCT04030143|589280071|FG001|Overall Study|Not Due to Covid-19|1|||
163154297|NCT03216226|589280072|FG000|Overall Study|Adverse Event|3|||
163154298|NCT03216226|589280073|FG001|Overall Study|Adverse Event|0|||
163154299|NCT03216226|589280072|FG000|Overall Study|Protocol Violation|1|||
163154300|NCT03216226|589280073|FG001|Overall Study|Protocol Violation|3|||
163154301|NCT03216226|589280072|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
163154302|NCT03216226|589280073|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
163154303|NCT03216226|589280072|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
163154304|NCT03216226|589280073|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
163154305|NCT03216226|589280072|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
163154306|NCT03216226|589280073|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
163154307|NCT01352715|589280075|FG000|Overall Study|Death|3|||
163154308|NCT01352715|589280076|FG001|Overall Study|Death|3|||
163154309|NCT01352715|589280075|FG000|Overall Study|Lost to Follow-up|5|||
163154310|NCT01352715|589280076|FG001|Overall Study|Lost to Follow-up|7|||
163154311|NCT01352715|589280075|FG000|Overall Study|Withdrawal by Subject|4|||
163154312|NCT01352715|589280076|FG001|Overall Study|Withdrawal by Subject|8|||
163154313|NCT01352715|589280075|FG000|Overall Study|site closure|16|||
163154314|NCT01352715|589280076|FG001|Overall Study|site closure|15|||
163154315|NCT01352715|589280075|FG000|Overall Study|no final visit in closeout period|15|||
163154316|NCT01352715|589280076|FG001|Overall Study|no final visit in closeout period|12|||
163154317|NCT01352715|589280075|FG000|Overall Study|major ineligibility|2|||
163154318|NCT01352715|589280076|FG001|Overall Study|major ineligibility|1|||
163154319|NCT02000440|589280078|FG000|Overall Study|Adverse Event|3|||
163154320|NCT02000440|589280078|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
163154321|NCT02383576|589280079|FG000|Overall Study|Death|53|||
163154322|NCT02383576|589280080|FG001|Overall Study|Death|33|||
163154323|NCT02383576|589280079|FG000|Overall Study|Lost to Follow-up|7|||
163154324|NCT02383576|589280080|FG001|Overall Study|Lost to Follow-up|1|||
163154325|NCT02383576|589280079|FG000|Overall Study|Withdrew Consent|1|||
163154326|NCT02383576|589280080|FG001|Overall Study|Withdrew Consent|6|||
163154327|NCT02383576|589280079|FG000|Overall Study|Investigator's Decision|0|||
163154328|NCT02383576|589280080|FG001|Overall Study|Investigator's Decision|1|||
163154329|NCT02383576|589280079|FG000|Overall Study|Administrative/Other|2|||
163154330|NCT02383576|589280080|FG001|Overall Study|Administrative/Other|4|||
163154331|NCT00871975|589280081|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
163154332|NCT00871975|589280081|FG000|Overall Study|Catheters could not be inserted|1|||
163154333|NCT00871975|589280081|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
163154334|NCT00871975|589280081|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
163154335|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
163154336|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
163154337|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
163154338|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
163154339|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
163154340|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
163154341|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
163154342|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163154343|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
163154344|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
163154345|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163154346|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
163154347|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
163154348|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
163154349|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
163154350|NCT01436149|589280082|FG000|Antidepressant Lead-in Phase|Other|119|||
163154351|NCT01436149|589280083|FG001|Antidepressant Lead-in Phase|Other|0|||
163154352|NCT01436149|589280084|FG002|Antidepressant Lead-in Phase|Other|0|||
163154353|NCT01436149|589280082|FG000|Randomized Phase|Adverse Event|9|||
162676737|NCT00937924|587525055|FG001|Overall Study|Lost to Follow-up|44|||
162676738|NCT00937924|587525056|FG002|Overall Study|Lost to Follow-up|41|||
162676739|NCT04009291|587525057|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162676740|NCT04009291|587525058|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162676741|NCT04009291|587525059|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162676742|NCT04009291|587525060|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162676743|NCT04009291|587525061|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
162676744|NCT04009291|587525057|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162676745|NCT04009291|587525058|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162676746|NCT04009291|587525059|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162676747|NCT04009291|587525060|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162676748|NCT04009291|587525061|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
162676749|NCT01922076|587525069|FG000|Overall Study|Adverse Event|0|||
162676750|NCT01922076|587525070|FG001|Overall Study|Adverse Event|0|||
162676751|NCT01922076|587525071|FG002|Overall Study|Adverse Event|0|||
162676752|NCT01922076|587525072|FG003|Overall Study|Adverse Event|0|||
162676753|NCT01922076|587525073|FG004|Overall Study|Adverse Event|1|||
162676754|NCT01922076|587525074|FG005|Overall Study|Adverse Event|0|||
162676755|NCT01922076|587525075|FG006|Overall Study|Adverse Event|0|||
162676756|NCT01922076|587525069|FG000|Overall Study|Physician Decision|0|||
162676757|NCT01922076|587525070|FG001|Overall Study|Physician Decision|0|||
162676758|NCT01922076|587525071|FG002|Overall Study|Physician Decision|1|||
162676759|NCT01922076|587525072|FG003|Overall Study|Physician Decision|0|||
162676760|NCT01922076|587525073|FG004|Overall Study|Physician Decision|0|||
162676761|NCT01922076|587525074|FG005|Overall Study|Physician Decision|0|||
162676762|NCT01922076|587525075|FG006|Overall Study|Physician Decision|0|||
162676763|NCT01922076|587525069|FG000|Overall Study|Withdrawal by Subject|0|||
162676764|NCT01922076|587525070|FG001|Overall Study|Withdrawal by Subject|0|||
162676765|NCT01922076|587525071|FG002|Overall Study|Withdrawal by Subject|0|||
162676766|NCT01922076|587525072|FG003|Overall Study|Withdrawal by Subject|1|||
162676767|NCT01922076|587525073|FG004|Overall Study|Withdrawal by Subject|0|||
162676768|NCT01922076|587525074|FG005|Overall Study|Withdrawal by Subject|1|||
162676769|NCT01922076|587525075|FG006|Overall Study|Withdrawal by Subject|1|||
162676770|NCT03738150|587525080|FG000|Base Study|Withdrawal by Subject|1|||
162676771|NCT03738150|587525080|FG000|Extension Study|Withdrawal by Subject|1|||
162676772|NCT04598152|587525083|FG000|Overall Study|Lost to Follow-up|0|||
162676773|NCT04598152|587525084|FG001|Overall Study|Lost to Follow-up|1|||
162676774|NCT03346759|587525089|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
162676775|NCT03346759|587525090|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
162676776|NCT03346759|587525089|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
162676777|NCT03346759|587525090|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
162676778|NCT03346759|587525089|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
162676779|NCT03346759|587525090|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
162676780|NCT03943095|587525091|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
162676781|NCT03943095|587525092|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
162676782|NCT03943095|587525091|FG000|Overall Study|Withdrawal by Subject|1|||
162676783|NCT03943095|587525092|FG001|Overall Study|Withdrawal by Subject|0|||
162676784|NCT04988308|587525093|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
162676785|NCT04988308|587525094|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162676786|NCT04988308|587525095|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162676787|NCT04988308|587525096|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162676788|NCT04988308|587525097|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162676789|NCT04988308|587525098|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162676790|NCT04988308|587525093|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162676791|NCT04988308|587525094|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162676792|NCT04988308|587525095|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
162676793|NCT04988308|587525096|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162676794|NCT04988308|587525097|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162676795|NCT04988308|587525098|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162676796|NCT04988308|587525093|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
162676797|NCT04988308|587525094|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
162676798|NCT04988308|587525095|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162676799|NCT04988308|587525096|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162676800|NCT04988308|587525097|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162676801|NCT04988308|587525098|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162676802|NCT04988308|587525093|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
162676803|NCT04988308|587525094|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
162676804|NCT04988308|587525095|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
162676805|NCT04988308|587525096|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162676806|NCT04988308|587525097|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162676807|NCT04988308|587525098|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162722696|NCT00566735|587692573|FG001|Overall Study|Withdrawal by Subject|1|||
163154354|NCT01436149|589280083|FG001|Randomized Phase|Adverse Event|10|||
163154355|NCT01436149|589280084|FG002|Randomized Phase|Adverse Event|11|||
163154356|NCT01436149|589280082|FG000|Randomized Phase|Protocol Violation|4|||
163154357|NCT01436149|589280083|FG001|Randomized Phase|Protocol Violation|5|||
163154358|NCT01436149|589280084|FG002|Randomized Phase|Protocol Violation|0|||
163154359|NCT01436149|589280082|FG000|Randomized Phase|Withdrawal by Subject|16|||
163154360|NCT01436149|589280083|FG001|Randomized Phase|Withdrawal by Subject|10|||
163154361|NCT01436149|589280084|FG002|Randomized Phase|Withdrawal by Subject|10|||
163154362|NCT01436149|589280082|FG000|Randomized Phase|Lost to Follow-up|34|||
163154363|NCT01436149|589280083|FG001|Randomized Phase|Lost to Follow-up|5|||
163154364|NCT01436149|589280084|FG002|Randomized Phase|Lost to Follow-up|6|||
163154365|NCT01436149|589280082|FG000|Randomized Phase|Lack of Efficacy|0|||
163154366|NCT01436149|589280083|FG001|Randomized Phase|Lack of Efficacy|0|||
163154367|NCT01436149|589280084|FG002|Randomized Phase|Lack of Efficacy|1|||
163154368|NCT01436149|589280082|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
163154369|NCT01436149|589280083|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
163154370|NCT01436149|589280084|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
163154371|NCT01436149|589280082|FG000|Randomized Phase|Other|12|||
163154372|NCT01436149|589280083|FG001|Randomized Phase|Other|5|||
163154373|NCT01436149|589280084|FG002|Randomized Phase|Other|11|||
163154374|NCT01690143|589280085|FG000|Overall Study|Withdrawal by Subject|1|||
163154375|NCT01643668|589280086|FG000|Overall Study|Death|1|||
163154376|NCT01409707|589280087|FG000|Overall Study|Withdrawal by Subject|5|||
163154377|NCT01409707|589280088|FG001|Overall Study|Withdrawal by Subject|17|||
163154378|NCT01409707|589280089|FG002|Overall Study|Withdrawal by Subject|16|||
163154379|NCT00632229|589280090|FG000|Overall Study|Adverse Event|6|||
163154380|NCT00632229|589280091|FG001|Overall Study|Adverse Event|0|||
163154381|NCT00632229|589280090|FG000|Overall Study|Lost to Follow-up|0|||
163154382|NCT00632229|589280091|FG001|Overall Study|Lost to Follow-up|3|||
163154383|NCT00632229|589280090|FG000|Overall Study|Lack of Efficacy|0|||
163154384|NCT00632229|589280091|FG001|Overall Study|Lack of Efficacy|2|||
163154385|NCT00632229|589280090|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
163154386|NCT00632229|589280091|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
163154387|NCT01716234|589280092|FG000|Overall Study|Protocol Violation|0|||
163154388|NCT01716234|589280093|FG001|Overall Study|Protocol Violation|0|||
163154389|NCT01716234|589280094|FG002|Overall Study|Protocol Violation|0|||
163154390|NCT01716234|589280095|FG003|Overall Study|Protocol Violation|1|||
163154391|NCT01716234|589280096|FG004|Overall Study|Protocol Violation|1|||
163154392|NCT01716234|589280097|FG005|Overall Study|Protocol Violation|1|||
163154393|NCT01716234|589280098|FG006|Overall Study|Protocol Violation|0|||
163154394|NCT01716234|589280092|FG000|Overall Study|Lack of Efficacy|0|||
163154395|NCT01716234|589280093|FG001|Overall Study|Lack of Efficacy|0|||
163154396|NCT01716234|589280094|FG002|Overall Study|Lack of Efficacy|0|||
163154397|NCT01716234|589280095|FG003|Overall Study|Lack of Efficacy|1|||
163154398|NCT01716234|589280096|FG004|Overall Study|Lack of Efficacy|0|||
163154399|NCT01716234|589280097|FG005|Overall Study|Lack of Efficacy|0|||
163154400|NCT01716234|589280098|FG006|Overall Study|Lack of Efficacy|0|||
163154401|NCT01716234|589280092|FG000|Overall Study|Did not meet protocol eligibility|0|||
163154402|NCT01716234|589280093|FG001|Overall Study|Did not meet protocol eligibility|0|||
163154403|NCT01716234|589280094|FG002|Overall Study|Did not meet protocol eligibility|1|||
163154404|NCT01716234|589280095|FG003|Overall Study|Did not meet protocol eligibility|0|||
163154405|NCT01716234|589280096|FG004|Overall Study|Did not meet protocol eligibility|0|||
163154406|NCT01716234|589280097|FG005|Overall Study|Did not meet protocol eligibility|4|||
163154407|NCT01716234|589280098|FG006|Overall Study|Did not meet protocol eligibility|0|||
163154408|NCT01716234|589280092|FG000|Overall Study|Adverse Event|7|||
163154409|NCT01716234|589280093|FG001|Overall Study|Adverse Event|10|||
163154410|NCT01716234|589280094|FG002|Overall Study|Adverse Event|2|||
163154411|NCT01716234|589280095|FG003|Overall Study|Adverse Event|8|||
163154412|NCT01716234|589280096|FG004|Overall Study|Adverse Event|3|||
163154413|NCT01716234|589280097|FG005|Overall Study|Adverse Event|6|||
163154414|NCT01716234|589280098|FG006|Overall Study|Adverse Event|0|||
163154415|NCT01716234|589280092|FG000|Overall Study|Withdrawal by Subject|3|||
163154416|NCT01716234|589280093|FG001|Overall Study|Withdrawal by Subject|0|||
163154417|NCT01716234|589280094|FG002|Overall Study|Withdrawal by Subject|2|||
163154418|NCT01716234|589280095|FG003|Overall Study|Withdrawal by Subject|2|||
163154419|NCT01716234|589280096|FG004|Overall Study|Withdrawal by Subject|1|||
163154420|NCT01716234|589280097|FG005|Overall Study|Withdrawal by Subject|3|||
163154421|NCT01716234|589280098|FG006|Overall Study|Withdrawal by Subject|0|||
163154422|NCT01467960|589280099|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154423|NCT01467960|589280100|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154424|NCT01467960|589280101|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
163154425|NCT01467960|589280102|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154426|NCT01467960|589280103|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154427|NCT01467960|589280104|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
163154428|NCT00474812|589280105|FG000|Overall Study|Withdrawal by Subject|5|||
163154429|NCT00474812|589280105|FG000|Overall Study|No Initiation of treatment|2|||
163154430|NCT00737672|589280114|FG000|Overall Study|Graft Abandonment|48|||
163154431|NCT00737672|589280115|FG001|Overall Study|Graft Abandonment|56|||
163154432|NCT00737672|589280114|FG000|Overall Study|Death|23|||
163154433|NCT00737672|589280115|FG001|Overall Study|Death|22|||
163154434|NCT00737672|589280114|FG000|Overall Study|Withdrawal by Subject|1|||
163154435|NCT00737672|589280115|FG001|Overall Study|Withdrawal by Subject|2|||
163154436|NCT00737672|589280114|FG000|Overall Study|Lost to Follow-up|1|||
163154437|NCT00737672|589280115|FG001|Overall Study|Lost to Follow-up|0|||
163154438|NCT00737672|589280114|FG000|Overall Study|Miscellaneous|7|||
163154439|NCT00737672|589280115|FG001|Overall Study|Miscellaneous|1|||
163154440|NCT00737672|589280114|FG000|Overall Study|Physician Decision|0|||
163154441|NCT00737672|589280115|FG001|Overall Study|Physician Decision|2|||
163154442|NCT02002598|589280122|FG000|Dose Level 1|Withdrawal by Subject|1|||
163154443|NCT02002598|589280123|FG001|Dose Level 1|Withdrawal by Subject|0|||
163154444|NCT02002598|589280124|FG002|Dose Level 1|Withdrawal by Subject|0|||
163154445|NCT02002598|589280125|FG003|Dose Level 1|Withdrawal by Subject|0|||
163154446|NCT02002598|589280126|FG004|Dose Level 1|Withdrawal by Subject|0|||
163154447|NCT02018562|589280128|FG000|Overall Study|Withdrawal by Subject|2|||
163154448|NCT02018562|589280129|FG001|Overall Study|Withdrawal by Subject|0|||
163154449|NCT02018562|589280128|FG000|Overall Study|Discharged prior to study completion|1|||
163154450|NCT02018562|589280129|FG001|Overall Study|Discharged prior to study completion|0|||
163154451|NCT03435211|589280130|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
163154452|NCT01838395|589280131|FG000|Overall Study|Withdrawal by Subject|0|||
163154453|NCT01838395|589280132|FG001|Overall Study|Withdrawal by Subject|0|||
163154454|NCT01838395|589280133|FG002|Overall Study|Withdrawal by Subject|0|||
163154455|NCT01838395|589280134|FG003|Overall Study|Withdrawal by Subject|0|||
163154456|NCT01838395|589280135|FG004|Overall Study|Withdrawal by Subject|1|||
163154457|NCT01838395|589280136|FG005|Overall Study|Withdrawal by Subject|0|||
163154458|NCT01838395|589280131|FG000|Overall Study|Death|0|||
163154459|NCT01838395|589280132|FG001|Overall Study|Death|0|||
163154460|NCT01838395|589280133|FG002|Overall Study|Death|1|||
163154461|NCT01838395|589280134|FG003|Overall Study|Death|0|||
162676808|NCT04988308|587525093|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
162676809|NCT04988308|587525094|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
162676810|NCT04988308|587525095|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
162676811|NCT04988308|587525096|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162676812|NCT04988308|587525097|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162676813|NCT04988308|587525098|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162676814|NCT04988308|587525093|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162676815|NCT04988308|587525094|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162676816|NCT04988308|587525095|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162676817|NCT04988308|587525096|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
162676818|NCT04988308|587525097|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
162676819|NCT04988308|587525098|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
162676820|NCT04988308|587525093|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162676821|NCT04988308|587525094|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162676822|NCT04988308|587525095|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162676823|NCT04988308|587525096|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162676824|NCT04988308|587525097|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162676825|NCT04988308|587525098|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
162676826|NCT04988308|587525093|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162676827|NCT04988308|587525094|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162676828|NCT04988308|587525095|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162676829|NCT04988308|587525096|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
162676830|NCT04988308|587525097|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
162676831|NCT04988308|587525098|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
162676832|NCT04988308|587525093|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162676833|NCT04988308|587525094|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162676834|NCT04988308|587525095|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162676835|NCT04988308|587525096|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
162676836|NCT04988308|587525097|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
162676837|NCT04988308|587525098|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
163154462|NCT01838395|589280135|FG004|Overall Study|Death|0|||
163154463|NCT01838395|589280136|FG005|Overall Study|Death|0|||
163154464|NCT01838395|589280131|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154465|NCT01838395|589280132|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
163154466|NCT01838395|589280133|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154467|NCT01838395|589280134|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154468|NCT01838395|589280135|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154469|NCT01838395|589280136|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
163154470|NCT05972993|589280137|FG000|Overall Study|Lost to Follow-up|2|||
163154471|NCT05972993|589280138|FG001|Overall Study|Lost to Follow-up|0|||
163154472|NCT05972993|589280139|FG002|Overall Study|Lost to Follow-up|1|||
163154473|NCT05972993|589280140|FG003|Overall Study|Lost to Follow-up|0|||
163154474|NCT05972993|589280141|FG004|Overall Study|Lost to Follow-up|0|||
163154475|NCT05972993|589280142|FG005|Overall Study|Lost to Follow-up|0|||
163154476|NCT05972993|589280143|FG006|Overall Study|Lost to Follow-up|0|||
163154477|NCT05972993|589280144|FG007|Overall Study|Lost to Follow-up|2|||
163154478|NCT05972993|589280145|FG008|Overall Study|Lost to Follow-up|0|||
163154479|NCT05720897|589280152|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
163154480|NCT05720897|589280153|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
163154481|NCT00400179|589280154|FG000|Overall Study|Adverse Event|2|||
163154482|NCT00400179|589280155|FG001|Overall Study|Adverse Event|2|||
163154483|NCT00400179|589280154|FG000|Overall Study|Death|1|||
163154484|NCT00400179|589280155|FG001|Overall Study|Death|2|||
163154485|NCT00400179|589280154|FG000|Overall Study|Withdrew Consent|1|||
163154486|NCT00400179|589280155|FG001|Overall Study|Withdrew Consent|5|||
163154487|NCT00400179|589280154|FG000|Overall Study|Disease progression|1|||
163154488|NCT00400179|589280155|FG001|Overall Study|Disease progression|1|||
163154489|NCT00400179|589280154|FG000|Overall Study|Intercurrent illness|0|||
163154490|NCT00400179|589280155|FG001|Overall Study|Intercurrent illness|1|||
163154491|NCT00400179|589280154|FG000|Overall Study|Investigator judgment|0|||
163154492|NCT00400179|589280155|FG001|Overall Study|Investigator judgment|1|||
163154493|NCT00400179|589280154|FG000|Overall Study|Randomization error/patient ineligible|1|||
163154494|NCT00400179|589280155|FG001|Overall Study|Randomization error/patient ineligible|6|||
163154495|NCT04780061|589280156|FG000|Overall Study|Withdrawal by Subject|5|||
163154496|NCT04780061|589280157|FG001|Overall Study|Withdrawal by Subject|8|||
163154497|NCT04780061|589280156|FG000|Overall Study|Adverse Event|2|||
163154498|NCT04780061|589280157|FG001|Overall Study|Adverse Event|2|||
163154499|NCT04780061|589280156|FG000|Overall Study|Lost to Follow-up|1|||
163154500|NCT04780061|589280157|FG001|Overall Study|Lost to Follow-up|5|||
163154501|NCT04050553|589280159|FG000|Period 1|Physician Decision|2|||
163154502|NCT04050553|589280160|FG001|Period 1|Physician Decision|2|||
163154503|NCT04050553|589280159|FG000|Period 1|Adverse Event|1|||
163154504|NCT04050553|589280160|FG001|Period 1|Adverse Event|1|||
163154505|NCT04050553|589280159|FG000|Period 1|Withdrawal by Subject|0|||
163154506|NCT04050553|589280160|FG001|Period 1|Withdrawal by Subject|1|||
163154507|NCT04050553|589280159|FG000|Wash-out|Adverse Event|0|||
163154508|NCT04050553|589280160|FG001|Wash-out|Adverse Event|1|||
163154509|NCT04050553|589280159|FG000|Wash-out|Withdrawal by Subject|0|||
163154510|NCT04050553|589280160|FG001|Wash-out|Withdrawal by Subject|1|||
163154511|NCT01535040|589280161|FG000|Overall Study|Physician Decision|0|||
163154512|NCT01535040|589280162|FG001|Overall Study|Physician Decision|1|||
163154513|NCT01535040|589280161|FG000|Overall Study|Withdrawal by Subject|13|||
163154514|NCT01535040|589280162|FG001|Overall Study|Withdrawal by Subject|10|||
163154515|NCT01535040|589280161|FG000|Overall Study|Never Started|9|||
163154516|NCT01535040|589280162|FG001|Overall Study|Never Started|4|||
163154517|NCT01535040|589280161|FG000|Overall Study|Toxicity|7|||
163154518|NCT01535040|589280162|FG001|Overall Study|Toxicity|5|||
163154519|NCT01535040|589280161|FG000|Overall Study|Multiple Reasons|1|||
163154520|NCT01535040|589280162|FG001|Overall Study|Multiple Reasons|1|||
163154521|NCT03589859|589280170|FG000|Overall Study|Withdrawal by Subject|0|||
163154522|NCT03589859|589280171|FG001|Overall Study|Withdrawal by Subject|6|||
163154523|NCT03043794|589280174|FG000|Overall Study|Lost to Follow-up|1|||
163154524|NCT00626106|589280176|FG000|Overall Study|Withdrawal by Subject|2|||
163154525|NCT00626106|589280177|FG001|Overall Study|Withdrawal by Subject|1|||
163154526|NCT00626106|589280176|FG000|Overall Study|Lost to Follow-up|1|||
163154527|NCT00626106|589280177|FG001|Overall Study|Lost to Follow-up|4|||
163154528|NCT00626106|589280176|FG000|Overall Study|Death|64|||
163154529|NCT00626106|589280177|FG001|Overall Study|Death|19|||
163154530|NCT03472885|589280178|FG000|24-Week Treatment Period|Adverse Event|1|||
163154531|NCT05417438|589280179|FG000|Overall Study|Withdrawal by Subject|3|||
163154532|NCT02201953|589280184|FG000|Overall Study|Randomized but Never Treated|1|||
163154533|NCT02201953|589280185|FG001|Overall Study|Randomized but Never Treated|5|||
163154534|NCT02201953|589280184|FG000|Overall Study|Lack of Efficacy|9|||
163154535|NCT02201953|589280185|FG001|Overall Study|Lack of Efficacy|30|||
163154536|NCT02201953|589280184|FG000|Overall Study|Lost to Follow-up|8|||
162676838|NCT04177758|587525108|FG000|Overall Study|Lost to Follow-up|19|||
162676839|NCT04177758|587525109|FG001|Overall Study|Lost to Follow-up|11|||
163154537|NCT02201953|589280185|FG001|Overall Study|Lost to Follow-up|8|||
163154538|NCT02201953|589280184|FG000|Overall Study|Withdrew Consent|2|||
163154539|NCT02201953|589280185|FG001|Overall Study|Withdrew Consent|5|||
163154540|NCT02201953|589280184|FG000|Overall Study|Adverse Event|0|||
163154541|NCT02201953|589280185|FG001|Overall Study|Adverse Event|5|||
163154542|NCT02201953|589280184|FG000|Overall Study|Death|0|||
163154543|NCT02201953|589280185|FG001|Overall Study|Death|3|||
163154544|NCT03312634|589281298|FG000|Overall Study|Adverse Event|11|||
163154545|NCT03312634|589281299|FG001|Overall Study|Adverse Event|0|||
163154546|NCT03312634|589281298|FG000|Overall Study|Sponsor request|2|||
163154547|NCT03312634|589281299|FG001|Overall Study|Sponsor request|0|||
163154548|NCT03312634|589281298|FG000|Overall Study|Withdrawal by Subject|31|||
163154549|NCT03312634|589281299|FG001|Overall Study|Withdrawal by Subject|9|||
163154550|NCT03312634|589281298|FG000|Overall Study|Enrolled in an interventional study|0|||
163154551|NCT03312634|589281299|FG001|Overall Study|Enrolled in an interventional study|52|||
163154552|NCT03312634|589281298|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
163154553|NCT03312634|589281299|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
163154554|NCT03312634|589281298|FG000|Overall Study|Death|0|||
163154555|NCT03312634|589281299|FG001|Overall Study|Death|1|||
163154556|NCT03312634|589281298|FG000|Overall Study|Non-compliance|0|||
163154557|NCT03312634|589281299|FG001|Overall Study|Non-compliance|2|||
163154558|NCT03312634|589281298|FG000|Overall Study|Lost to Follow-up|0|||
163154559|NCT03312634|589281299|FG001|Overall Study|Lost to Follow-up|1|||
163154560|NCT03312634|589281298|FG000|Overall Study|Enrolled into non-interventional study|0|||
163154561|NCT03312634|589281299|FG001|Overall Study|Enrolled into non-interventional study|5|||
163154562|NCT03312634|589281298|FG000|Overall Study|Worsening clinical condition|0|||
163154563|NCT03312634|589281299|FG001|Overall Study|Worsening clinical condition|1|||
163154564|NCT03312634|589281298|FG000|Overall Study|Participant did not want to travel|0|||
163154565|NCT03312634|589281299|FG001|Overall Study|Participant did not want to travel|1|||
163154566|NCT03312634|589281298|FG000|Overall Study|Physician Decision|1|||
163154567|NCT03312634|589281299|FG001|Overall Study|Physician Decision|0|||
163154568|NCT03312634|589281298|FG000|Overall Study|Other|13|||
163154569|NCT03312634|589281299|FG001|Overall Study|Other|0|||
163154570|NCT04610281|589281300|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
163154571|NCT04610281|589281301|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
163154572|NCT01942837|589281302|FG000|Overall Study|Death|1|||
163154573|NCT01942837|589281302|FG000|Overall Study|Symptomatic or radiographic progression|49|||
163154574|NCT01942837|589281302|FG000|Overall Study|Adverse Event|6|||
163154575|NCT01942837|589281302|FG000|Overall Study|Physician Decision|3|||
163154576|NCT01942837|589281302|FG000|Overall Study|Withdrawal by Subject|2|||
163154577|NCT01942837|589281302|FG000|Overall Study|Intercurrent Illness|1|||
163154578|NCT01942837|589281302|FG000|Overall Study|On treatment|3|||
163154579|NCT01942837|589281302|FG000|Overall Study|Never initiate the treatment|2|||
163154580|NCT01298648|589281303|FG000|Overall Study|Withdrawal by Subject|2|||
163154581|NCT01298648|589281303|FG000|Overall Study|Lost to Follow-up|21|||
163154582|NCT01458392|589281308|FG000|Overall Study|Death|2|||
163154583|NCT01458392|589281309|FG001|Overall Study|Death|11|||
163154584|NCT01458392|589281310|FG002|Overall Study|Death|22|||
163154585|NCT01458392|589281308|FG000|Overall Study|At the discretion of the sponsor|0|||
163154586|NCT01458392|589281309|FG001|Overall Study|At the discretion of the sponsor|2|||
163154587|NCT01458392|589281310|FG002|Overall Study|At the discretion of the sponsor|7|||
163154588|NCT01458392|589281308|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
163154589|NCT01458392|589281309|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
163154590|NCT01458392|589281310|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
163154591|NCT00918255|589281311|FG000|Overall Study|Adverse Event|1|||
163154592|NCT00918255|589281312|FG001|Overall Study|Adverse Event|0|||
163154593|NCT00918255|589281313|FG002|Overall Study|Adverse Event|0|||
163154594|NCT00918255|589281311|FG000|Overall Study|Withdrawal by Subject|1|||
163154595|NCT00918255|589281312|FG001|Overall Study|Withdrawal by Subject|0|||
163154596|NCT00918255|589281313|FG002|Overall Study|Withdrawal by Subject|2|||
163154597|NCT00918255|589281311|FG000|Overall Study|Lack of Efficacy|1|||
163154598|NCT00918255|589281312|FG001|Overall Study|Lack of Efficacy|0|||
163154599|NCT00918255|589281313|FG002|Overall Study|Lack of Efficacy|0|||
163154600|NCT00918255|589281311|FG000|Overall Study|Lost to Follow-up|1|||
163154601|NCT00918255|589281312|FG001|Overall Study|Lost to Follow-up|0|||
163154602|NCT00918255|589281313|FG002|Overall Study|Lost to Follow-up|2|||
163154603|NCT00918255|589281311|FG000|Overall Study|Exceeded allowed number of interventions|0|||
163154604|NCT00918255|589281312|FG001|Overall Study|Exceeded allowed number of interventions|0|||
163154605|NCT00918255|589281313|FG002|Overall Study|Exceeded allowed number of interventions|1|||
163154606|NCT00918255|589281311|FG000|Overall Study|Non-compliance|1|||
163154607|NCT00918255|589281312|FG001|Overall Study|Non-compliance|0|||
163154608|NCT00918255|589281313|FG002|Overall Study|Non-compliance|0|||
163154609|NCT00918255|589281311|FG000|Overall Study|Investigator discretion|1|||
163154610|NCT00918255|589281312|FG001|Overall Study|Investigator discretion|0|||
163154611|NCT00918255|589281313|FG002|Overall Study|Investigator discretion|0|||
162676840|NCT00679939|587525110|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
162676841|NCT00679939|587525111|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
162676842|NCT00679939|587525110|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
162676843|NCT00679939|587525111|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
162676844|NCT00679939|587525110|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
162676845|NCT00679939|587525111|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
162676846|NCT00679939|587525110|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
162676847|NCT00679939|587525111|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
162676848|NCT00679939|587525110|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
162676849|NCT00679939|587525111|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
162676850|NCT00679939|587525110|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
162676851|NCT00679939|587525111|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
162676852|NCT00679939|587525110|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
162676853|NCT00679939|587525111|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
162676854|NCT00679939|587525110|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
162676855|NCT00679939|587525111|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
162676856|NCT00679939|587525110|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
162676857|NCT00679939|587525111|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
162676858|NCT00679939|587525110|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
162676859|NCT00679939|587525111|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
162676860|NCT02763384|587525112|FG000|Overall Study|Physician Decision|1|||
162676861|NCT02763384|587525112|FG000|Overall Study|Rapid decline - went on hospice|1|||
162676862|NCT04657211|587525113|FG000|Overall Study|Withdrawal by Subject|21|||
162676863|NCT04657211|587525113|FG000|Overall Study|Lost to Follow-up|113|||
162676864|NCT04657211|587525113|FG000|Overall Study|Death|47|||
162676865|NCT04657211|587525113|FG000|Overall Study|Transfer to another institution|21|||
162676866|NCT04657211|587525113|FG000|Overall Study|Other|29|||
162676867|NCT02943408|587526774|FG000|Overall Study|Lost to Follow-up|7|||
162676868|NCT02943408|587526775|FG001|Overall Study|Lost to Follow-up|1|||
162676869|NCT02943408|587526774|FG000|Overall Study|Withdrawal by Subject|0|||
162676870|NCT02943408|587526775|FG001|Overall Study|Withdrawal by Subject|1|||
162676871|NCT01621126|587526778|FG000|Overall Study|Physician Decision|6|||
162676872|NCT03751631|587526779|FG000|Overall Study|Withdrawal by Subject|0|||
162676873|NCT03751631|587526780|FG001|Overall Study|Withdrawal by Subject|0|||
162676874|NCT03751631|587526781|FG002|Overall Study|Withdrawal by Subject|1|||
162676875|NCT03751631|587526782|FG003|Overall Study|Withdrawal by Subject|1|||
162676876|NCT03751631|587526783|FG004|Overall Study|Withdrawal by Subject|0|||
162676877|NCT03751631|587526784|FG005|Overall Study|Withdrawal by Subject|0|||
162676878|NCT02481310|587526785|FG000|Follow up|Still in follow up|0|||
162676879|NCT02481310|587526786|FG001|Follow up|Still in follow up|3|||
162676880|NCT02481310|587526787|FG002|Follow up|Still in follow up|0|||
162676881|NCT00643916|587526789|FG000|Overall Study|Protocol Violation|0|||
162676882|NCT00643916|587526790|FG001|Overall Study|Protocol Violation|1|||
162676883|NCT00643916|587526791|FG002|Overall Study|Protocol Violation|1|||
162676884|NCT00643916|587526792|FG003|Overall Study|Protocol Violation|1|||
162676885|NCT00643916|587526793|FG004|Overall Study|Protocol Violation|0|||
162676886|NCT00643916|587526794|FG005|Overall Study|Protocol Violation|0|||
162676887|NCT00643916|587526789|FG000|Overall Study|Lost to Follow-up|0|||
162676888|NCT00643916|587526790|FG001|Overall Study|Lost to Follow-up|1|||
162676889|NCT00643916|587526791|FG002|Overall Study|Lost to Follow-up|0|||
162676890|NCT00643916|587526792|FG003|Overall Study|Lost to Follow-up|0|||
162676891|NCT00643916|587526793|FG004|Overall Study|Lost to Follow-up|0|||
162676892|NCT00643916|587526794|FG005|Overall Study|Lost to Follow-up|0|||
162676893|NCT00643916|587526789|FG000|Overall Study|Withdrawal by Subject|2|||
162676894|NCT00643916|587526790|FG001|Overall Study|Withdrawal by Subject|2|||
162676895|NCT00643916|587526791|FG002|Overall Study|Withdrawal by Subject|2|||
162676896|NCT00643916|587526792|FG003|Overall Study|Withdrawal by Subject|1|||
162676897|NCT00643916|587526793|FG004|Overall Study|Withdrawal by Subject|0|||
162676898|NCT00643916|587526794|FG005|Overall Study|Withdrawal by Subject|1|||
162676899|NCT00643916|587526789|FG000|Overall Study|Not Vaccinated|2|||
162676900|NCT00643916|587526790|FG001|Overall Study|Not Vaccinated|2|||
162676901|NCT00643916|587526791|FG002|Overall Study|Not Vaccinated|3|||
162676902|NCT00643916|587526792|FG003|Overall Study|Not Vaccinated|0|||
162676903|NCT00643916|587526793|FG004|Overall Study|Not Vaccinated|2|||
162676904|NCT00643916|587526794|FG005|Overall Study|Not Vaccinated|0|||
162676905|NCT00677833|587526796|FG000|Overall Study|Withdrawal by Subject|4|||
162676906|NCT00677833|587526797|FG001|Overall Study|Withdrawal by Subject|0|||
162676907|NCT00677833|587526798|FG002|Overall Study|Withdrawal by Subject|1|||
162676908|NCT00677833|587526799|FG003|Overall Study|Withdrawal by Subject|3|||
162676909|NCT00677833|587526796|FG000|Overall Study|Lost to Follow-up|0|||
162676910|NCT00677833|587526797|FG001|Overall Study|Lost to Follow-up|0|||
162676911|NCT00677833|587526798|FG002|Overall Study|Lost to Follow-up|1|||
162676912|NCT00677833|587526799|FG003|Overall Study|Lost to Follow-up|0|||
162676913|NCT02606279|587526800|FG000|Overall Study|Lost to Follow-up|0|||
162676914|NCT02606279|587526801|FG001|Overall Study|Lost to Follow-up|1|||
162676915|NCT02184611|587526802|FG000|Overall Study|Lack of Efficacy|11|||
163154612|NCT02038933|589281314|FG000|Overall Study|Disease progression|104|||
163154613|NCT02038933|589281314|FG000|Overall Study|Study drug toxicity|6|||
163154614|NCT02038933|589281314|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163154615|NCT02038933|589281314|FG000|Overall Study|Participant request to discontinue treatment|2|||
163154616|NCT02038933|589281314|FG000|Overall Study|Lost to Follow-up|1|||
163154617|NCT02038933|589281314|FG000|Overall Study|Other reasons|2|||
163154618|NCT03250273|589281347|FG000|Overall Study|Disease Progression|2|||
163154619|NCT03250273|589281348|FG001|Overall Study|Disease Progression|11|||
163154620|NCT03250273|589281347|FG000|Overall Study|Death|0|||
162676916|NCT02184611|587526803|FG001|Overall Study|Lack of Efficacy|15|||
162676917|NCT02184611|587526802|FG000|Overall Study|Withdrawal by Subject|5|||
162676918|NCT02184611|587526803|FG001|Overall Study|Withdrawal by Subject|6|||
162676919|NCT02184611|587526802|FG000|Overall Study|Adverse Event|4|||
162676920|NCT02184611|587526803|FG001|Overall Study|Adverse Event|5|||
162676921|NCT02184611|587526802|FG000|Overall Study|Protocol Violation|1|||
162676922|NCT02184611|587526803|FG001|Overall Study|Protocol Violation|1|||
162676923|NCT02184611|587526802|FG000|Overall Study|Protocol defined stopping criteria|0|||
162676924|NCT02184611|587526803|FG001|Overall Study|Protocol defined stopping criteria|1|||
162676925|NCT01514448|587526806|FG000|Overall Study|Death|7|||
162676926|NCT01514448|587526807|FG001|Overall Study|Death|8|||
163154621|NCT03250273|589281348|FG001|Overall Study|Death|1|||
163154622|NCT04154904|589281349|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
163154623|NCT04154904|589281350|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
163154624|NCT04154904|589281351|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
163154625|NCT02392624|589281352|FG000|Overall Study|Withdrawal by Subject|15|||
163154626|NCT02392624|589281353|FG001|Overall Study|Withdrawal by Subject|12|||
163154627|NCT02392624|589281354|FG002|Overall Study|Withdrawal by Subject|9|||
163154628|NCT02392624|589281352|FG000|Overall Study|Adverse Event|4|||
163154629|NCT02392624|589281353|FG001|Overall Study|Adverse Event|1|||
163154630|NCT02392624|589281354|FG002|Overall Study|Adverse Event|2|||
163154631|NCT02392624|589281352|FG000|Overall Study|Pregnancy|1|||
163154632|NCT02392624|589281353|FG001|Overall Study|Pregnancy|0|||
163154633|NCT02392624|589281354|FG002|Overall Study|Pregnancy|0|||
163154634|NCT02392624|589281352|FG000|Overall Study|Protocol Violation|0|||
163154635|NCT02392624|589281353|FG001|Overall Study|Protocol Violation|0|||
163154636|NCT02392624|589281354|FG002|Overall Study|Protocol Violation|1|||
163154637|NCT02392624|589281352|FG000|Overall Study|Sponsor/Investigator Decision|2|||
163154638|NCT02392624|589281353|FG001|Overall Study|Sponsor/Investigator Decision|1|||
163154639|NCT02392624|589281354|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163154640|NCT02392624|589281352|FG000|Overall Study|Other|49|||
163154641|NCT02392624|589281353|FG001|Overall Study|Other|1|||
163154642|NCT02392624|589281354|FG002|Overall Study|Other|1|||
163154643|NCT00936715|589281355|FG000|Overall Study|Investigators Discretion|1|||
163154644|NCT00936715|589281355|FG000|Overall Study|Protocol Violation|1|||
163154645|NCT00936715|589281355|FG000|Overall Study|Safety or Tolerability Reasons|4|||
163154646|NCT03841604|589281358|FG000|Overall Study|Withdrawal by Subject|3|||
163154647|NCT03841604|589281359|FG001|Overall Study|Withdrawal by Subject|1|||
163154648|NCT03841604|589281358|FG000|Overall Study|Adverse Event|4|||
163154649|NCT03841604|589281359|FG001|Overall Study|Adverse Event|2|||
163154650|NCT03841604|589281358|FG000|Overall Study|Physician Decision|1|||
163154651|NCT03841604|589281359|FG001|Overall Study|Physician Decision|0|||
163154652|NCT01337960|589281360|FG000|Overall Study|Lost to Follow-up|1|||
163154653|NCT01337960|589281361|FG001|Overall Study|Lost to Follow-up|0|||
163154654|NCT01337960|589281362|FG002|Overall Study|Lost to Follow-up|0|||
163154655|NCT01337960|589281360|FG000|Overall Study|Withdrawal by Subject|1|||
163154656|NCT01337960|589281361|FG001|Overall Study|Withdrawal by Subject|0|||
163154657|NCT01337960|589281362|FG002|Overall Study|Withdrawal by Subject|0|||
163154658|NCT03877510|589281363|FG000|Overall Study|Death|6|||
163154659|NCT03877510|589281363|FG000|Overall Study|Lost to Follow-up|2|||
163154660|NCT03877510|589281363|FG000|Overall Study|Non-compliance with study drug|2|||
163154661|NCT03877510|589281363|FG000|Overall Study|Lack of Efficacy|14|||
163154662|NCT03877510|589281363|FG000|Overall Study|Adverse Event|20|||
163154663|NCT03877510|589281363|FG000|Overall Study|Withdrawal by Subject|22|||
163154664|NCT03877510|589281363|FG000|Overall Study|Miscellaneous|1|||
163154665|NCT03763877|589281365|FG000|Overall Study|Withdrawal by Subject|3|||
163154666|NCT03763877|589281366|FG001|Overall Study|Withdrawal by Subject|1|||
163154667|NCT03763877|589281367|FG002|Overall Study|Withdrawal by Subject|3|||
163154668|NCT03763877|589281368|FG003|Overall Study|Withdrawal by Subject|4|||
163154669|NCT03763877|589281365|FG000|Overall Study|Adverse Event|1|||
163154670|NCT03763877|589281366|FG001|Overall Study|Adverse Event|1|||
163154671|NCT03763877|589281367|FG002|Overall Study|Adverse Event|3|||
163154672|NCT03763877|589281368|FG003|Overall Study|Adverse Event|1|||
163154673|NCT03763877|589281365|FG000|Overall Study|Protocol Violation|1|||
163154674|NCT03763877|589281366|FG001|Overall Study|Protocol Violation|1|||
163154675|NCT03763877|589281367|FG002|Overall Study|Protocol Violation|0|||
163154676|NCT03763877|589281368|FG003|Overall Study|Protocol Violation|0|||
163154677|NCT03763877|589281365|FG000|Overall Study|Lost to Follow-up|0|||
163154678|NCT03763877|589281366|FG001|Overall Study|Lost to Follow-up|1|||
163154679|NCT03763877|589281367|FG002|Overall Study|Lost to Follow-up|1|||
163154680|NCT03763877|589281368|FG003|Overall Study|Lost to Follow-up|0|||
163154681|NCT03040336|589281369|FG000|Overall Study|Death|1|||
163154682|NCT03040336|589281370|FG001|Overall Study|Death|0|||
163154683|NCT03040336|589281369|FG000|Overall Study|Withdrawal by Subject|2|||
163154684|NCT03040336|589281370|FG001|Overall Study|Withdrawal by Subject|3|||
163154685|NCT01524796|589281379|FG000|Overall Study|Adverse Event|13|||
163154686|NCT01524796|589281379|FG000|Overall Study|Lack of Efficacy|3|||
163154687|NCT01524796|589281379|FG000|Overall Study|Lost to Follow-up|1|||
163154688|NCT01524796|589281379|FG000|Overall Study|The price|1|||
163154689|NCT01524796|589281379|FG000|Overall Study|Withdrawal by Subject|4|||
163154690|NCT01524796|589281379|FG000|Overall Study|Move|1|||
163154691|NCT01524796|589281379|FG000|Overall Study|Deterioration of pains|1|||
163154692|NCT01524796|589281379|FG000|Overall Study|Gall stone surgery|1|||
163154693|NCT01524796|589281379|FG000|Overall Study|Nervous about confidentiality|1|||
163154694|NCT01524796|589281379|FG000|Overall Study|Switch to carbamazapine|1|||
163154695|NCT01524796|589281379|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
163154696|NCT03938259|589281380|FG000|Overall Study|unable to establish baseline for ventilation|1|||
162676927|NCT01514448|587526806|FG000|Overall Study|Withdrawal by Subject|2|||
162676928|NCT01514448|587526807|FG001|Overall Study|Withdrawal by Subject|0|||
162676929|NCT01514448|587526806|FG000|Overall Study|Lost to Follow-up|2|||
162676930|NCT01514448|587526807|FG001|Overall Study|Lost to Follow-up|0|||
162676931|NCT01514448|587526806|FG000|Overall Study|New Cancer Therapy|1|||
162676932|NCT01514448|587526807|FG001|Overall Study|New Cancer Therapy|0|||
162676933|NCT05159622|587526808|FG000|Overall Study|Lost to Follow-up|4|||
162676934|NCT05159622|587526809|FG001|Overall Study|Lost to Follow-up|5|||
162676935|NCT02723864|587526810|FG000|Overall Study|Refused further treatment|1|||
162676936|NCT02723864|587526811|FG001|Overall Study|Refused further treatment|0|||
162676937|NCT02723864|587526812|FG002|Overall Study|Refused further treatment|0|||
162676938|NCT02723864|587526813|FG003|Overall Study|Refused further treatment|0|||
162676939|NCT02723864|587526814|FG004|Overall Study|Refused further treatment|1|||
162676940|NCT02723864|587526815|FG005|Overall Study|Refused further treatment|2|||
162676941|NCT02723864|587526816|FG006|Overall Study|Refused further treatment|0|||
162676942|NCT02723864|587526810|FG000|Overall Study|Exceed treatment hold time|0|||
162676943|NCT02723864|587526811|FG001|Overall Study|Exceed treatment hold time|1|||
162676944|NCT02723864|587526812|FG002|Overall Study|Exceed treatment hold time|0|||
162676945|NCT02723864|587526813|FG003|Overall Study|Exceed treatment hold time|0|||
162676946|NCT02723864|587526814|FG004|Overall Study|Exceed treatment hold time|0|||
162676947|NCT02723864|587526815|FG005|Overall Study|Exceed treatment hold time|0|||
162676948|NCT02723864|587526816|FG006|Overall Study|Exceed treatment hold time|0|||
162676949|NCT02723864|587526810|FG000|Overall Study|Clinical progression|0|||
162676950|NCT02723864|587526811|FG001|Overall Study|Clinical progression|0|||
162676951|NCT02723864|587526812|FG002|Overall Study|Clinical progression|1|||
162676952|NCT02723864|587526813|FG003|Overall Study|Clinical progression|0|||
162676953|NCT02723864|587526814|FG004|Overall Study|Clinical progression|0|||
162676954|NCT02723864|587526815|FG005|Overall Study|Clinical progression|3|||
162676955|NCT02723864|587526816|FG006|Overall Study|Clinical progression|1|||
162676956|NCT02723864|587526810|FG000|Overall Study|Physician Decision|0|||
162676957|NCT02723864|587526811|FG001|Overall Study|Physician Decision|0|||
162676958|NCT02723864|587526812|FG002|Overall Study|Physician Decision|0|||
162676959|NCT02723864|587526813|FG003|Overall Study|Physician Decision|0|||
162676960|NCT02723864|587526814|FG004|Overall Study|Physician Decision|0|||
162676961|NCT02723864|587526815|FG005|Overall Study|Physician Decision|0|||
162676962|NCT02723864|587526816|FG006|Overall Study|Physician Decision|1|||
162676963|NCT02723864|587526810|FG000|Overall Study|Changes in patient condition|0|||
162676964|NCT02723864|587526811|FG001|Overall Study|Changes in patient condition|0|||
162676965|NCT02723864|587526812|FG002|Overall Study|Changes in patient condition|0|||
162676966|NCT02723864|587526813|FG003|Overall Study|Changes in patient condition|0|||
162676967|NCT02723864|587526814|FG004|Overall Study|Changes in patient condition|0|||
162676968|NCT02723864|587526815|FG005|Overall Study|Changes in patient condition|1|||
162676969|NCT02723864|587526816|FG006|Overall Study|Changes in patient condition|0|||
162676970|NCT02723864|587526810|FG000|Overall Study|Patient choice|0|||
162676971|NCT02723864|587526811|FG001|Overall Study|Patient choice|0|||
162676972|NCT02723864|587526812|FG002|Overall Study|Patient choice|0|||
162676973|NCT02723864|587526813|FG003|Overall Study|Patient choice|0|||
162676974|NCT02723864|587526814|FG004|Overall Study|Patient choice|0|||
162676975|NCT02723864|587526815|FG005|Overall Study|Patient choice|1|||
162676976|NCT02723864|587526816|FG006|Overall Study|Patient choice|0|||
162676977|NCT02723864|587526810|FG000|Overall Study|Adverse Event|0|||
162676978|NCT02723864|587526811|FG001|Overall Study|Adverse Event|0|||
162676979|NCT02723864|587526812|FG002|Overall Study|Adverse Event|0|||
162676980|NCT02723864|587526813|FG003|Overall Study|Adverse Event|0|||
162676981|NCT02723864|587526814|FG004|Overall Study|Adverse Event|0|||
162676982|NCT02723864|587526815|FG005|Overall Study|Adverse Event|1|||
162676983|NCT02723864|587526816|FG006|Overall Study|Adverse Event|0|||
162676984|NCT02723864|587526810|FG000|Overall Study|Started new treatment|0|||
162676985|NCT02723864|587526811|FG001|Overall Study|Started new treatment|0|||
162676986|NCT02723864|587526812|FG002|Overall Study|Started new treatment|0|||
162676987|NCT02723864|587526813|FG003|Overall Study|Started new treatment|0|||
162676988|NCT02723864|587526814|FG004|Overall Study|Started new treatment|0|||
162676989|NCT02723864|587526815|FG005|Overall Study|Started new treatment|1|||
162676990|NCT02723864|587526816|FG006|Overall Study|Started new treatment|0|||
162676991|NCT02723864|587526810|FG000|Overall Study|Switched to alternative treatment|0|||
162676992|NCT02723864|587526811|FG001|Overall Study|Switched to alternative treatment|0|||
162676993|NCT02723864|587526812|FG002|Overall Study|Switched to alternative treatment|0|||
162676994|NCT02723864|587526813|FG003|Overall Study|Switched to alternative treatment|0|||
162676995|NCT02723864|587526814|FG004|Overall Study|Switched to alternative treatment|0|||
162676996|NCT02723864|587526815|FG005|Overall Study|Switched to alternative treatment|1|||
162676997|NCT02723864|587526816|FG006|Overall Study|Switched to alternative treatment|0|||
162676998|NCT02723864|587526810|FG000|Overall Study|Late determination of ineligibility|0|||
162676999|NCT02723864|587526811|FG001|Overall Study|Late determination of ineligibility|0|||
162677000|NCT02723864|587526812|FG002|Overall Study|Late determination of ineligibility|0|||
162677001|NCT02723864|587526813|FG003|Overall Study|Late determination of ineligibility|0|||
162677002|NCT02723864|587526814|FG004|Overall Study|Late determination of ineligibility|0|||
162677003|NCT02723864|587526815|FG005|Overall Study|Late determination of ineligibility|1|||
162677004|NCT02723864|587526816|FG006|Overall Study|Late determination of ineligibility|0|||
162677005|NCT03232983|587526817|FG000|Period 1|Physician Decision|0|||
162677006|NCT03232983|587526818|FG001|Period 1|Physician Decision|0|||
162677007|NCT03232983|587526819|FG002|Period 1|Physician Decision|1|||
162677008|NCT03232983|587526820|FG003|Period 1|Physician Decision|0|||
162677009|NCT03232983|587526817|FG000|Washout Period 2|Physician Decision|0|||
162677010|NCT03232983|587526818|FG001|Washout Period 2|Physician Decision|0|||
162677011|NCT03232983|587526819|FG002|Washout Period 2|Physician Decision|1|||
162677012|NCT03232983|587526820|FG003|Washout Period 2|Physician Decision|0|||
162677013|NCT03232983|587526817|FG000|Washout Period 2|Withdrawal by Subject|0|||
162677014|NCT03232983|587526818|FG001|Washout Period 2|Withdrawal by Subject|0|||
162677015|NCT03232983|587526819|FG002|Washout Period 2|Withdrawal by Subject|0|||
162677016|NCT03232983|587526820|FG003|Washout Period 2|Withdrawal by Subject|1|||
162677017|NCT03232983|587526817|FG000|Period 4|Withdrawal by Subject|1|||
162677018|NCT03232983|587526818|FG001|Period 4|Withdrawal by Subject|0|||
162677019|NCT03232983|587526819|FG002|Period 4|Withdrawal by Subject|0|||
162677020|NCT03232983|587526820|FG003|Period 4|Withdrawal by Subject|0|||
162677021|NCT00746590|587526821|FG000|Overall Study|Death|1|||
162677022|NCT02633800|587526822|FG000|Overall Study|Death|3|||
162677023|NCT02633800|587526823|FG001|Overall Study|Death|3|||
162677024|NCT02633800|587526822|FG000|Overall Study|Reason not provided|1|||
162677025|NCT02633800|587526823|FG001|Overall Study|Reason not provided|0|||
162677026|NCT02633800|587526822|FG000|Overall Study|Radiologic(al) progression|23|||
162677027|NCT02633800|587526823|FG001|Overall Study|Radiologic(al) progression|23|||
162677028|NCT02633800|587526822|FG000|Overall Study|Clinical progression|3|||
162677029|NCT02633800|587526823|FG001|Overall Study|Clinical progression|6|||
162677030|NCT02633800|587526822|FG000|Overall Study|Study terminated by sponsor|6|||
162677031|NCT02633800|587526823|FG001|Overall Study|Study terminated by sponsor|5|||
162677032|NCT02633800|587526822|FG000|Overall Study|Adverse event, non-fatal|7|||
162677033|NCT02633800|587526823|FG001|Overall Study|Adverse event, non-fatal|2|||
162677034|NCT02633800|587526822|FG000|Overall Study|Withdrawal by Subject|0|||
162677035|NCT02633800|587526823|FG001|Overall Study|Withdrawal by Subject|3|||
162677036|NCT02633800|587526822|FG000|Overall Study|Patient Request|1|||
162677037|NCT02633800|587526823|FG001|Overall Study|Patient Request|1|||
162677038|NCT00815295|587526827|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
162677039|NCT00815295|587526828|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
162677040|NCT00815295|587526829|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
162677041|NCT03647501|587526830|FG000|Overall Study|Lost to Follow-up|1|||
162677042|NCT03647501|587526831|FG001|Overall Study|Lost to Follow-up|1|||
162677043|NCT03647501|587526830|FG000|Overall Study|Withdrawal by Subject|0|||
162677044|NCT03647501|587526831|FG001|Overall Study|Withdrawal by Subject|1|||
162677045|NCT03945188|587526832|FG000|Overall Study|Protocol Violation|1|||
162677046|NCT03945188|587526833|FG001|Overall Study|Protocol Violation|0|||
162677047|NCT03945188|587526832|FG000|Overall Study|Disease worsening|79|||
162677048|NCT03945188|587526833|FG001|Overall Study|Disease worsening|73|||
162677049|NCT03945188|587526832|FG000|Overall Study|Physician Decision|2|||
162677050|NCT03945188|587526833|FG001|Overall Study|Physician Decision|2|||
162677051|NCT03945188|587526832|FG000|Overall Study|Lack of Efficacy|7|||
162677052|NCT03945188|587526833|FG001|Overall Study|Lack of Efficacy|4|||
162677053|NCT03945188|587526832|FG000|Overall Study|Pregnancy|2|||
162677054|NCT03945188|587526833|FG001|Overall Study|Pregnancy|0|||
162677055|NCT03945188|587526832|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
162677056|NCT03945188|587526833|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
162677057|NCT03945188|587526832|FG000|Overall Study|Adverse Event|10|||
162677058|NCT03945188|587526833|FG001|Overall Study|Adverse Event|5|||
162677059|NCT03945188|587526832|FG000|Overall Study|Other|2|||
162677060|NCT03945188|587526833|FG001|Overall Study|Other|2|||
162677061|NCT03945188|587526832|FG000|Overall Study|Lost to Follow-up|1|||
162677062|NCT03945188|587526833|FG001|Overall Study|Lost to Follow-up|2|||
162677063|NCT04794803|587526834|FG000|Overall Study|Death|1|||
162677064|NCT04794803|587526835|FG001|Overall Study|Death|3|||
162677065|NCT04794803|587526834|FG000|Overall Study|Lost to Follow-up|2|||
162677066|NCT04794803|587526835|FG001|Overall Study|Lost to Follow-up|2|||
162677067|NCT04794803|587526834|FG000|Overall Study|Withdrawal by Subject|1|||
162677068|NCT04794803|587526835|FG001|Overall Study|Withdrawal by Subject|0|||
162677069|NCT04794803|587526834|FG000|Overall Study|Physician Decision|1|||
162677070|NCT04794803|587526835|FG001|Overall Study|Physician Decision|1|||
162677071|NCT04794803|587526834|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
162677072|NCT04794803|587526835|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
162677073|NCT04794803|587526834|FG000|Overall Study|Refused to continue the treatment|1|||
162677074|NCT04794803|587526835|FG001|Overall Study|Refused to continue the treatment|0|||
162677075|NCT04794803|587526834|FG000|Overall Study|Patient admitted to ICU|0|||
162677076|NCT04794803|587526835|FG001|Overall Study|Patient admitted to ICU|1|||
162677077|NCT01618162|587526836|FG000|Overall Study|Protocol Violation|13|||
162677078|NCT01618162|587526837|FG001|Overall Study|Protocol Violation|10|||
162677079|NCT01618162|587526836|FG000|Overall Study|Adverse Event|9|||
162677080|NCT01618162|587526837|FG001|Overall Study|Adverse Event|2|||
162677081|NCT01618162|587526836|FG000|Overall Study|Withdrawal Criteria|2|||
162677082|NCT01618162|587526837|FG001|Overall Study|Withdrawal Criteria|10|||
162677083|NCT01618162|587526836|FG000|Overall Study|Unclassified|14|||
162677084|NCT01618162|587526837|FG001|Overall Study|Unclassified|13|||
162677085|NCT02013622|587526838|FG000|Overall Study|Lost to Follow-up|10|||
162677086|NCT02013622|587526838|FG000|Overall Study|Adverse Event|3|||
162677087|NCT02013622|587526838|FG000|Overall Study|Met Withdrawal Criteria|3|||
162677088|NCT02013622|587526838|FG000|Overall Study|Withdrawal by Subject|6|||
162677089|NCT02013622|587526838|FG000|Overall Study|Protocol Deviation|1|||
162677090|NCT02013622|587526838|FG000|Overall Study|Lack of Efficacy|1|||
162677091|NCT00224874|587526841|FG000|Overall Study|Withdrawal by Subject|0|||
162677092|NCT00224874|587526842|FG001|Overall Study|Withdrawal by Subject|0|||
162677093|NCT00224874|587526843|FG002|Overall Study|Withdrawal by Subject|1|||
162677094|NCT00224874|587526844|FG003|Overall Study|Withdrawal by Subject|0|||
162677095|NCT02355002|587526845|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
162677096|NCT02355002|587526846|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
162677097|NCT02355002|587526845|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
162677098|NCT02355002|587526846|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
162677099|NCT02355002|587526845|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
162677100|NCT02355002|587526846|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
162677101|NCT02355002|587526845|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
162677102|NCT02355002|587526846|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
162677103|NCT02355002|587526845|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
162677104|NCT02355002|587526846|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
162677105|NCT02355002|587526845|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
162677106|NCT02355002|587526846|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
162677107|NCT02355002|587526845|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
162677108|NCT02355002|587526846|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
162677109|NCT03644186|587526847|FG000|Overall Study|Withdrawal by Subject|1|||
162677110|NCT03644186|587526848|FG001|Overall Study|Withdrawal by Subject|1|||
162677111|NCT02477111|587526850|FG000|Overall Study|Death|28|||
162677112|NCT02477111|587526850|FG000|Overall Study|Withdrawal by Subject|19|||
162677113|NCT02477111|587526850|FG000|Overall Study|Lost to Follow-up|4|||
162677114|NCT02192502|587526851|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
162722697|NCT00566735|587692572|FG000|Overall Study|Refused neuropsychological testing|2|||
162677115|NCT02192502|587526852|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
162677116|NCT02192502|587526851|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
162677117|NCT02192502|587526852|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
162677118|NCT02192502|587526851|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
162677119|NCT02192502|587526852|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
162722698|NCT00566735|587692573|FG001|Overall Study|Refused neuropsychological testing|5|||
162722699|NCT00566735|587692572|FG000|Overall Study|Switched into a manic episode|0|||
162722700|NCT00566735|587692573|FG001|Overall Study|Switched into a manic episode|1|||
162722701|NCT04603924|587692574|FG000|Overall Study|Not Dosed|2|||
162722702|NCT04603924|587692575|FG001|Overall Study|Not Dosed|1|||
162722703|NCT04603924|587692574|FG000|Overall Study|Withdrawal by Subject|6|||
162722704|NCT04603924|587692575|FG001|Overall Study|Withdrawal by Subject|6|||
162722705|NCT04603924|587692574|FG000|Overall Study|Adverse Event|2|||
162722706|NCT04603924|587692575|FG001|Overall Study|Adverse Event|2|||
162722707|NCT03762668|587692576|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
162722708|NCT03762668|587692577|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
162722709|NCT00768664|587692581|FG000|Overall Study|Death|57|||
162722710|NCT00768664|587692581|FG000|Overall Study|Lost to Follow-up|2|||
162722711|NCT00768664|587692581|FG000|Overall Study|Other|9|||
162722712|NCT00768664|587692581|FG000|Overall Study|Participant refused|1|||
162722713|NCT02544152|587692582|FG000|Overall Study|Adverse Event|0|||
162722714|NCT02544152|587692583|FG001|Overall Study|Adverse Event|4|||
162722715|NCT02544152|587692582|FG000|Overall Study|Withdrawal by Subject|0|||
162722716|NCT02544152|587692583|FG001|Overall Study|Withdrawal by Subject|3|||
162722717|NCT02544152|587692582|FG000|Overall Study|Other|1|||
162722718|NCT02544152|587692583|FG001|Overall Study|Other|0|||
162722719|NCT00465816|587692586|FG000|Overall Study|Lost to Follow-up|0|||
162722720|NCT00465816|587692587|FG001|Overall Study|Lost to Follow-up|0|||
162722721|NCT00465816|587692588|FG002|Overall Study|Lost to Follow-up|2|||
162722722|NCT00818454|587692589|FG000|Treatment Period 1|Adverse Event|0|||
162722723|NCT00818454|587692590|FG001|Treatment Period 1|Adverse Event|1|||
162722724|NCT00818454|587692591|FG002|Treatment Period 1|Adverse Event|0|||
162722725|NCT00818454|587692592|FG003|Treatment Period 1|Adverse Event|0|||
162722726|NCT00818454|587692589|FG000|Treatment Period 1|Other|3|||
162722727|NCT00818454|587692590|FG001|Treatment Period 1|Other|0|||
162722728|NCT00818454|587692591|FG002|Treatment Period 1|Other|0|||
162722729|NCT00818454|587692592|FG003|Treatment Period 1|Other|0|||
162722730|NCT00818454|587692589|FG000|Washout Period of 1 Week|Adverse Event|1|||
162722731|NCT00818454|587692590|FG001|Washout Period of 1 Week|Adverse Event|1|||
162722732|NCT00818454|587692591|FG002|Washout Period of 1 Week|Adverse Event|0|||
162722733|NCT00818454|587692592|FG003|Washout Period of 1 Week|Adverse Event|0|||
162722734|NCT00818454|587692589|FG000|Washout Period of 1 Week|Protocol Violation|2|||
162722735|NCT00818454|587692590|FG001|Washout Period of 1 Week|Protocol Violation|0|||
162722736|NCT00818454|587692591|FG002|Washout Period of 1 Week|Protocol Violation|0|||
162722737|NCT00818454|587692592|FG003|Washout Period of 1 Week|Protocol Violation|0|||
162722738|NCT00818454|587692589|FG000|Washout Period of 1 Week|Other|1|||
162722739|NCT00818454|587692590|FG001|Washout Period of 1 Week|Other|2|||
162722740|NCT00818454|587692591|FG002|Washout Period of 1 Week|Other|0|||
162722741|NCT00818454|587692592|FG003|Washout Period of 1 Week|Other|0|||
162722742|NCT00818454|587692589|FG000|Treatment Period 2|Other|2|||
162722743|NCT00818454|587692590|FG001|Treatment Period 2|Other|1|||
162722744|NCT00818454|587692591|FG002|Treatment Period 2|Other|0|||
162722745|NCT00818454|587692592|FG003|Treatment Period 2|Other|0|||
162722746|NCT00818454|587692589|FG000|Treatment Period 3|Adverse Event|0|||
162722747|NCT00818454|587692590|FG001|Treatment Period 3|Adverse Event|0|||
162722748|NCT00818454|587692591|FG002|Treatment Period 3|Adverse Event|0|||
162722749|NCT00818454|587692592|FG003|Treatment Period 3|Adverse Event|1|||
162722750|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
162722751|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162722752|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162722753|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162722754|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
162722755|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162722756|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162722757|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162722758|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
162722759|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162722760|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162722761|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162722762|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
162722763|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162722764|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162722765|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162722766|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
162722767|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
162722768|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
162722769|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
162722770|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
162722771|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162722772|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162722773|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162722774|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
162722775|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162722776|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162722777|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162722778|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
162722779|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162722780|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162722781|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162722782|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
162722783|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162722784|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162722785|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162722786|NCT03593213|587692606|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
162722787|NCT03593213|587692607|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162722788|NCT03593213|587692608|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162722789|NCT03593213|587692609|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162722790|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
162722791|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
162722792|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
162722793|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
162722794|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
162722795|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
162722796|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
162722797|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
162722798|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
162722799|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
162722800|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
162722801|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
162722802|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
162722803|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
162722804|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
162722805|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
162722806|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162722807|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162722808|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162722809|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
162722810|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
162722811|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
162722812|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
162722813|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
162722814|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
162677120|NCT02189798|587526853|FG000|Extended Use Phase|Withdrawal by Subject|0|||
162677121|NCT02189798|587526854|FG001|Extended Use Phase|Withdrawal by Subject|4|||
162677122|NCT02189798|587526853|FG000|Extended Use Phase|Physician Decision|1|||
162677123|NCT02189798|587526854|FG001|Extended Use Phase|Physician Decision|0|||
162677124|NCT02189798|587526853|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
162677125|NCT02189798|587526854|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
162677126|NCT02189798|587526853|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
162677127|NCT02189798|587526854|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
162677128|NCT02189798|587526853|FG000|Extended Use Phase|Travel Issues|2|||
162677129|NCT02189798|587526854|FG001|Extended Use Phase|Travel Issues|1|||
162677130|NCT02189798|587526853|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
162677131|NCT02189798|587526854|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
162677132|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
162677133|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
162677134|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
162722815|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
162722816|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
162722817|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
162722818|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
162722819|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
162722820|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
162722821|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
162722822|NCT03593213|587692606|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
162722823|NCT03593213|587692607|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
162722824|NCT03593213|587692608|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
162722825|NCT03593213|587692609|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
162722826|NCT03184558|587692610|FG000|Overall Study|Withdrawal by Subject|2|||
162722827|NCT03184558|587692610|FG000|Overall Study|Death|16|||
162722828|NCT03184558|587692610|FG000|Overall Study|Lost to Follow-up|2|||
162722829|NCT03184558|587692610|FG000|Overall Study|Other|9|||
162722830|NCT01179334|587692613|FG000|Treatment Period|Adverse Event|1|||
162722831|NCT01179334|587692614|FG001|Treatment Period|Adverse Event|0|||
162722832|NCT01179334|587692613|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
162722833|NCT01179334|587692614|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
162722834|NCT01179334|587692613|FG000|Long-term Extension (LTE) Period|Death|3|||
162722835|NCT01179334|587692614|FG001|Long-term Extension (LTE) Period|Death|0|||
162722836|NCT01179334|587692613|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
162722837|NCT01179334|587692614|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
162722838|NCT01152190|587692617|FG000|Overall Study|Adverse Event|2|||
162722839|NCT01152190|587692618|FG001|Overall Study|Adverse Event|4|||
162722840|NCT01152190|587692617|FG000|Overall Study|Death|1|||
162722841|NCT01152190|587692618|FG001|Overall Study|Death|0|||
162722842|NCT01152190|587692617|FG000|Overall Study|Protocol Violation|1|||
162722843|NCT01152190|587692618|FG001|Overall Study|Protocol Violation|1|||
162722844|NCT01152190|587692617|FG000|Overall Study|Withdrawal by Subject|1|||
162722845|NCT01152190|587692618|FG001|Overall Study|Withdrawal by Subject|3|||
162722846|NCT03070483|587692619|FG000|Overall Study|Lost to Follow-up|2|||
162722847|NCT01390402|587692622|FG000|Overall Study|Death|1|||
162722848|NCT01390402|587692622|FG000|Overall Study|Disease Progression|4|||
162722849|NCT00026312|587692625|FG000|Overall Study|Adverse Event|0|||
162722850|NCT00026312|587692626|FG001|Overall Study|Adverse Event|32|||
162722851|NCT00026312|587692625|FG000|Overall Study|Death|1|||
162722852|NCT00026312|587692626|FG001|Overall Study|Death|7|||
162722853|NCT00026312|587692625|FG000|Overall Study|Lack of Efficacy|19|||
162722854|NCT00026312|587692626|FG001|Overall Study|Lack of Efficacy|114|||
162722855|NCT00026312|587692625|FG000|Overall Study|Lost to Follow-up|0|||
162722856|NCT00026312|587692626|FG001|Overall Study|Lost to Follow-up|5|||
162722857|NCT00026312|587692625|FG000|Overall Study|Physician Decision|1|||
162722858|NCT00026312|587692626|FG001|Overall Study|Physician Decision|37|||
162722859|NCT00026312|587692625|FG000|Overall Study|Protocol Violation|0|||
162722860|NCT00026312|587692626|FG001|Overall Study|Protocol Violation|3|||
162722861|NCT00026312|587692625|FG000|Overall Study|Withdrawal by Subject|1|||
162722862|NCT00026312|587692626|FG001|Overall Study|Withdrawal by Subject|6|||
162722863|NCT00026312|587692625|FG000|Overall Study|Ineligible|4|||
162722864|NCT00026312|587692626|FG001|Overall Study|Ineligible|5|||
162722865|NCT00026312|587692625|FG000|Overall Study|Entry onto another COG study|0|||
162722866|NCT00026312|587692626|FG001|Overall Study|Entry onto another COG study|1|||
162722867|NCT00026312|587692625|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
162722868|NCT00026312|587692626|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
162722869|NCT02611037|587692627|FG000|Overall Study|Withdrawal prior to treatment|2|||
162722870|NCT02611037|587692628|FG001|Overall Study|Withdrawal prior to treatment|0|||
162722871|NCT05850520|587692629|FG000|Overall Study|Withdrawal by Subject|8|||
162722872|NCT05850520|587692630|FG001|Overall Study|Withdrawal by Subject|8|||
162722873|NCT05850520|587692631|FG002|Overall Study|Withdrawal by Subject|16|||
162722874|NCT05850520|587692629|FG000|Overall Study|Lost to Follow-up|2|||
162722875|NCT05850520|587692630|FG001|Overall Study|Lost to Follow-up|2|||
162722876|NCT05850520|587692631|FG002|Overall Study|Lost to Follow-up|2|||
162722877|NCT05850520|587692629|FG000|Overall Study|Death|2|||
162722878|NCT05850520|587692630|FG001|Overall Study|Death|2|||
162722879|NCT05850520|587692631|FG002|Overall Study|Death|3|||
162722880|NCT05850520|587692629|FG000|Overall Study|Adverse Event|2|||
162722881|NCT05850520|587692630|FG001|Overall Study|Adverse Event|0|||
162722882|NCT05850520|587692631|FG002|Overall Study|Adverse Event|1|||
162722883|NCT05850520|587692629|FG000|Overall Study|Physician Decision|0|||
162677135|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
162677136|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
162677137|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
162677138|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
162677139|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
162677140|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
162677141|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
162677142|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
162677143|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
162677144|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
162677145|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
162677146|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
162677147|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
162677148|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
162677149|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
162677150|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
162677151|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
162677152|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
162677153|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162677154|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162677155|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162677156|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
162677157|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162677158|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162677159|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162677160|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162677161|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162677162|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
162677163|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162677164|NCT04818346|587526858|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162677165|NCT04818346|587526859|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162677166|NCT04818346|587526860|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162677167|NCT04818346|587526861|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
162677168|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
162677169|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
162677170|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
162677171|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
162677172|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162677173|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
162677174|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162677175|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162677176|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
162677177|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
162677178|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
162677179|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
162677180|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
162677181|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
162677182|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
162677183|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
162677184|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162677185|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
162677186|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162677187|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162677188|NCT04818346|587526858|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162677189|NCT04818346|587526859|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162677190|NCT04818346|587526860|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162677191|NCT04818346|587526861|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
162677192|NCT05553808|587526862|FG000|Overall Study|Death|25|||
162677193|NCT05553808|587526863|FG001|Overall Study|Death|62|||
162677194|NCT05553808|587526862|FG000|Overall Study|Site Closed|6|||
162677195|NCT05553808|587526863|FG001|Overall Study|Site Closed|6|||
162677196|NCT05553808|587526862|FG000|Overall Study|Lost to Follow-up|1|||
162722884|NCT05850520|587692630|FG001|Overall Study|Physician Decision|1|||
162722885|NCT05850520|587692631|FG002|Overall Study|Physician Decision|0|||
162722886|NCT05850520|587692629|FG000|Overall Study|Protocol deviation|0|||
162722887|NCT05850520|587692630|FG001|Overall Study|Protocol deviation|0|||
162722888|NCT05850520|587692631|FG002|Overall Study|Protocol deviation|1|||
162722889|NCT05850520|587692629|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
162722890|NCT05850520|587692630|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
162722891|NCT05850520|587692631|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
162722892|NCT03785782|587693830|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
162722893|NCT03785782|587693831|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
162722894|NCT03785782|587693830|FG000|Overall Study|Withdrawal by Subject|1|||
162722895|NCT03785782|587693831|FG001|Overall Study|Withdrawal by Subject|1|||
162722896|NCT03785782|587693830|FG000|Overall Study|insufficient image quality.|3|||
162722897|NCT03785782|587693831|FG001|Overall Study|insufficient image quality.|0|||
162722898|NCT04817670|587693832|FG000|Overall Study|Withdrawal by Subject|1|||
162722899|NCT04817670|587693833|FG001|Overall Study|Withdrawal by Subject|0|||
162722900|NCT04817670|587693834|FG002|Overall Study|Withdrawal by Subject|0|||
162722901|NCT04817670|587693835|FG003|Overall Study|Withdrawal by Subject|0|||
162722902|NCT04817670|587693836|FG004|Overall Study|Withdrawal by Subject|0|||
162722903|NCT04817670|587693832|FG000|Overall Study|Lost to Follow-up|0|||
162722904|NCT04817670|587693833|FG001|Overall Study|Lost to Follow-up|0|||
162722905|NCT04817670|587693834|FG002|Overall Study|Lost to Follow-up|1|||
162722906|NCT04817670|587693835|FG003|Overall Study|Lost to Follow-up|0|||
162722907|NCT04817670|587693836|FG004|Overall Study|Lost to Follow-up|0|||
162722908|NCT01188655|587693840|FG000|Overall Study|Lack of Efficacy|1|||
162722909|NCT01188655|587693840|FG000|Overall Study|Lost to Follow-up|1|||
162722910|NCT01188655|587693840|FG000|Overall Study|Other|11|||
162722911|NCT02396316|587693841|FG000|Overall Study|Physician Decision|1|||
162722912|NCT02396316|587693842|FG001|Overall Study|Physician Decision|0|||
162722913|NCT02396316|587693841|FG000|Overall Study|Progressive disease|6|||
162722914|NCT02396316|587693842|FG001|Overall Study|Progressive disease|3|||
162722915|NCT02396316|587693841|FG000|Overall Study|Protocol Violation|0|||
162722916|NCT02396316|587693842|FG001|Overall Study|Protocol Violation|1|||
162722917|NCT02396316|587693841|FG000|Overall Study|Treatment unblinded|0|||
162722918|NCT02396316|587693842|FG001|Overall Study|Treatment unblinded|1|||
162722919|NCT00686855|587693845|FG000|Overall Study|Lost to Follow-up|1|||
162722920|NCT00686855|587693846|FG001|Overall Study|Lost to Follow-up|0|||
162722921|NCT00686855|587693845|FG000|Overall Study|Progressive GVHD|0|||
162722922|NCT00686855|587693846|FG001|Overall Study|Progressive GVHD|1|||
162722923|NCT02731755|587693847|FG000|First Intervention|Withdrawal by Subject|0|||
162722924|NCT02731755|587693848|FG001|First Intervention|Withdrawal by Subject|2|||
162722925|NCT02320123|587693849|FG000|Overall Study|Lost to Follow-up|4|||
162722926|NCT02320123|587693850|FG001|Overall Study|Lost to Follow-up|6|||
162722927|NCT02320123|587693849|FG000|Overall Study|Death|6|||
162722928|NCT02320123|587693850|FG001|Overall Study|Death|5|||
162722929|NCT04480827|587693851|FG000|Overall Study|Adverse Event|0|||
162722930|NCT04480827|587693852|FG001|Overall Study|Adverse Event|0|||
162722931|NCT04480827|587693853|FG002|Overall Study|Adverse Event|0|||
162722932|NCT04480827|587693854|FG003|Overall Study|Adverse Event|0|||
162722933|NCT04480827|587693855|FG004|Overall Study|Adverse Event|0|||
162722934|NCT04480827|587693856|FG005|Overall Study|Adverse Event|1|||
162722935|NCT04480827|587693857|FG006|Overall Study|Adverse Event|0|||
162722936|NCT02139046|587693858|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162722937|NCT02139046|587693859|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
162722938|NCT02139046|587693860|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
162722939|NCT02139046|587693861|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
162722940|NCT02139046|587693862|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
162722941|NCT02139046|587693858|FG000|Overall Study|Major Protocol Deviation|9|||
162722942|NCT02139046|587693859|FG001|Overall Study|Major Protocol Deviation|10|||
162722943|NCT02139046|587693860|FG002|Overall Study|Major Protocol Deviation|16|||
162722944|NCT02139046|587693861|FG003|Overall Study|Major Protocol Deviation|12|||
162722945|NCT02139046|587693862|FG004|Overall Study|Major Protocol Deviation|6|||
162722946|NCT02139046|587693858|FG000|Overall Study|Lost to Follow-up|13|||
162722947|NCT02139046|587693859|FG001|Overall Study|Lost to Follow-up|16|||
162722948|NCT02139046|587693860|FG002|Overall Study|Lost to Follow-up|16|||
162722949|NCT02139046|587693861|FG003|Overall Study|Lost to Follow-up|18|||
162722950|NCT02139046|587693862|FG004|Overall Study|Lost to Follow-up|13|||
162722951|NCT02139046|587693858|FG000|Overall Study|Voluntary Withdrawal|20|||
162722952|NCT02139046|587693859|FG001|Overall Study|Voluntary Withdrawal|8|||
162722953|NCT02139046|587693860|FG002|Overall Study|Voluntary Withdrawal|10|||
162677197|NCT05553808|587526863|FG001|Overall Study|Lost to Follow-up|0|||
162677198|NCT05553808|587526862|FG000|Overall Study|Withdrawal by Subject|3|||
162677199|NCT05553808|587526863|FG001|Overall Study|Withdrawal by Subject|2|||
162677200|NCT02273141|587526864|FG000|Overall Study|Adverse Event|0|||
162677201|NCT02273141|587526865|FG001|Overall Study|Adverse Event|1|||
162677202|NCT02273141|587526864|FG000|Overall Study|Lost to Follow-up|1|||
162677203|NCT02273141|587526865|FG001|Overall Study|Lost to Follow-up|3|||
162677204|NCT02273141|587526864|FG000|Overall Study|Withdrawal by Subject|10|||
162677205|NCT02273141|587526865|FG001|Overall Study|Withdrawal by Subject|15|||
162677206|NCT02273141|587526864|FG000|Overall Study|Various|6|||
162677207|NCT02273141|587526865|FG001|Overall Study|Various|6|||
162677208|NCT00529399|587526868|FG000|Overall Study|Lost to Follow-up|1|||
162677209|NCT00529399|587526869|FG001|Overall Study|Lost to Follow-up|0|||
162677210|NCT00529399|587526870|FG002|Overall Study|Lost to Follow-up|1|||
162677211|NCT00529399|587526868|FG000|Overall Study|Withdrawal by Subject|1|||
162677212|NCT00529399|587526869|FG001|Overall Study|Withdrawal by Subject|0|||
162677213|NCT00529399|587526870|FG002|Overall Study|Withdrawal by Subject|1|||
162677214|NCT00529399|587526868|FG000|Overall Study|Non-compliant|0|||
162677215|NCT00529399|587526869|FG001|Overall Study|Non-compliant|1|||
162677216|NCT00529399|587526870|FG002|Overall Study|Non-compliant|0|||
162677217|NCT03695172|587526871|FG000|Overall Study|Withdrawal by Subject|1|||
162677218|NCT03695172|587526872|FG001|Overall Study|Withdrawal by Subject|1|||
162677219|NCT03695172|587526873|FG002|Overall Study|Withdrawal by Subject|0|||
162677220|NCT01506193|587526874|FG000|Overall Study|Protocol Violation|1|||
162677221|NCT01506193|587526875|FG001|Overall Study|Protocol Violation|0|||
162677222|NCT01506193|587526876|FG002|Overall Study|Protocol Violation|1|||
162677223|NCT01506193|587526874|FG000|Overall Study|Migrated/moved from study area|0|||
162677224|NCT01506193|587526875|FG001|Overall Study|Migrated/moved from study area|0|||
162677225|NCT01506193|587526876|FG002|Overall Study|Migrated/moved from study area|1|||
162677226|NCT01506193|587526874|FG000|Overall Study|Adverse event, non-fatal|0|||
162677227|NCT01506193|587526875|FG001|Overall Study|Adverse event, non-fatal|0|||
162677228|NCT01506193|587526876|FG002|Overall Study|Adverse event, non-fatal|1|||
162677229|NCT01506193|587526874|FG000|Overall Study|Withdrawal by Subject|5|||
162677230|NCT01506193|587526875|FG001|Overall Study|Withdrawal by Subject|1|||
162677231|NCT01506193|587526876|FG002|Overall Study|Withdrawal by Subject|8|||
162677232|NCT01506193|587526874|FG000|Overall Study|Lost to Follow-up|8|||
162677233|NCT01506193|587526875|FG001|Overall Study|Lost to Follow-up|3|||
162677234|NCT01506193|587526876|FG002|Overall Study|Lost to Follow-up|3|||
162677235|NCT04575467|587526893|FG000|Overall Study|Adverse Event|0|||
162677236|NCT04575467|587526894|FG001|Overall Study|Adverse Event|1|||
162677237|NCT04575467|587526895|FG002|Overall Study|Adverse Event|0|||
162677238|NCT04575467|587526896|FG003|Overall Study|Adverse Event|0|||
162677239|NCT00729833|587526900|FG000|Overall Study|Death|5|||
162677240|NCT00729833|587526901|FG001|Overall Study|Death|1|||
162677241|NCT00729833|587526902|FG002|Overall Study|Death|3|||
162677242|NCT00729833|587526903|FG003|Overall Study|Death|5|||
162677243|NCT00729833|587526900|FG000|Overall Study|Study Terminated by Sponsor|0|||
162677244|NCT00729833|587526901|FG001|Overall Study|Study Terminated by Sponsor|0|||
162677245|NCT00729833|587526902|FG002|Overall Study|Study Terminated by Sponsor|1|||
162677246|NCT00729833|587526903|FG003|Overall Study|Study Terminated by Sponsor|0|||
162677247|NCT00729833|587526900|FG000|Overall Study|Lost to Follow-up|1|||
162677248|NCT00729833|587526901|FG001|Overall Study|Lost to Follow-up|0|||
162677249|NCT00729833|587526902|FG002|Overall Study|Lost to Follow-up|0|||
162677250|NCT00729833|587526903|FG003|Overall Study|Lost to Follow-up|0|||
162677251|NCT00729833|587526900|FG000|Overall Study|Withdrawal by Subject|3|||
162722954|NCT02139046|587693861|FG003|Overall Study|Voluntary Withdrawal|15|||
162677252|NCT00729833|587526901|FG001|Overall Study|Withdrawal by Subject|1|||
162677253|NCT00729833|587526902|FG002|Overall Study|Withdrawal by Subject|3|||
162677254|NCT00729833|587526903|FG003|Overall Study|Withdrawal by Subject|0|||
162677255|NCT00729833|587526900|FG000|Overall Study|Unspecified Reasons|11|||
162677256|NCT00729833|587526901|FG001|Overall Study|Unspecified Reasons|5|||
162677257|NCT00729833|587526902|FG002|Overall Study|Unspecified Reasons|5|||
162677258|NCT00729833|587526903|FG003|Overall Study|Unspecified Reasons|1|||
162677259|NCT01687257|587526904|FG000|Overall Study|Efficacy Failure|6|||
162677260|NCT01687257|587526905|FG001|Overall Study|Efficacy Failure|0|||
162677261|NCT01687257|587526906|FG002|Overall Study|Efficacy Failure|5|||
162677262|NCT01687257|587526904|FG000|Overall Study|Subject Withdrew Consent|1|||
162677263|NCT01687257|587526905|FG001|Overall Study|Subject Withdrew Consent|1|||
162677264|NCT01687257|587526906|FG002|Overall Study|Subject Withdrew Consent|1|||
162722955|NCT02139046|587693862|FG004|Overall Study|Voluntary Withdrawal|16|||
162722956|NCT02139046|587693858|FG000|Overall Study|Lack of Efficacy|0|||
162722957|NCT02139046|587693859|FG001|Overall Study|Lack of Efficacy|1|||
162722958|NCT02139046|587693860|FG002|Overall Study|Lack of Efficacy|2|||
162722959|NCT02139046|587693861|FG003|Overall Study|Lack of Efficacy|1|||
162722960|NCT02139046|587693862|FG004|Overall Study|Lack of Efficacy|2|||
162722961|NCT02139046|587693858|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
162722962|NCT02139046|587693859|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
162722963|NCT02139046|587693860|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
162722964|NCT02139046|587693861|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
162722965|NCT02139046|587693862|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
162722966|NCT02139046|587693858|FG000|Overall Study|Other Miscellaneous Reasons|10|||
162722967|NCT02139046|587693859|FG001|Overall Study|Other Miscellaneous Reasons|9|||
162722968|NCT02139046|587693860|FG002|Overall Study|Other Miscellaneous Reasons|4|||
162722969|NCT02139046|587693861|FG003|Overall Study|Other Miscellaneous Reasons|9|||
162722970|NCT02139046|587693862|FG004|Overall Study|Other Miscellaneous Reasons|12|||
162722971|NCT01765543|587693869|FG000|Overall Study|Death|1|||
162722972|NCT01765543|587693869|FG000|Overall Study|Withdrawal by Subject|2|||
162722973|NCT01185561|587693870|FG000|Overall Study|Lost to Follow-up|0|||
162722974|NCT01185561|587693871|FG001|Overall Study|Lost to Follow-up|4|||
162722975|NCT01185561|587693870|FG000|Overall Study|Withdrawal by Subject|2|||
162722976|NCT01185561|587693871|FG001|Overall Study|Withdrawal by Subject|8|||
162722977|NCT05876949|587693874|FG000|Overall Study|Withdrawal by Subject|1|||
162722978|NCT05876949|587693875|FG001|Overall Study|Withdrawal by Subject|3|||
162722979|NCT05876949|587693874|FG000|Overall Study|Physician Decision|0|||
162722980|NCT05876949|587693875|FG001|Overall Study|Physician Decision|2|||
162722981|NCT05876949|587693874|FG000|Overall Study|Death|0|||
162722982|NCT05876949|587693875|FG001|Overall Study|Death|1|||
162722983|NCT02755805|587693876|FG000|Overall Study|Lost to Follow-up|1|||
162722984|NCT02755805|587693877|FG001|Overall Study|Lost to Follow-up|2|||
162722985|NCT02755805|587693876|FG000|Overall Study|Refused assessments|1|||
162722986|NCT02755805|587693877|FG001|Overall Study|Refused assessments|0|||
162722987|NCT02755805|587693876|FG000|Overall Study|Withdrawal by Subject|0|||
162722988|NCT02755805|587693877|FG001|Overall Study|Withdrawal by Subject|2|||
162722989|NCT03718767|587693881|FG000|Overall Study|Declined to participate (before treatment started)|0|||
162722990|NCT03718767|587693882|FG001|Overall Study|Declined to participate (before treatment started)|0|||
162722991|NCT03718767|587693883|FG002|Overall Study|Declined to participate (before treatment started)|7|||
162722992|NCT03718767|587693881|FG000|Overall Study|Ineligible|0|||
162722993|NCT03718767|587693882|FG001|Overall Study|Ineligible|0|||
162722994|NCT03718767|587693883|FG002|Overall Study|Ineligible|17|||
162722995|NCT00494442|587693884|FG000|Overall Study|Death|1|||
162722996|NCT00494442|587693885|FG001|Overall Study|Death|1|||
162722997|NCT00494442|587693884|FG000|Overall Study|Lack of Efficacy|16|||
162722998|NCT00494442|587693885|FG001|Overall Study|Lack of Efficacy|10|||
162722999|NCT00494442|587693884|FG000|Overall Study|Adverse Event|0|||
162723000|NCT00494442|587693885|FG001|Overall Study|Adverse Event|2|||
162723001|NCT00494442|587693884|FG000|Overall Study|Physician Decision|0|||
162723002|NCT00494442|587693885|FG001|Overall Study|Physician Decision|1|||
162723003|NCT00494442|587693884|FG000|Overall Study|Non-compliance|0|||
162723004|NCT00494442|587693885|FG001|Overall Study|Non-compliance|1|||
162723005|NCT00494442|587693884|FG000|Overall Study|Intercurrent illness|0|||
162723006|NCT00494442|587693885|FG001|Overall Study|Intercurrent illness|1|||
162723007|NCT03691428|587693890|FG000|Overall Study|Withdrawal by Subject|6|||
162723008|NCT03691428|587693891|FG001|Overall Study|Withdrawal by Subject|8|||
162723009|NCT01460290|587693892|FG000|Overall Study|Adverse Event|3|||
162723010|NCT01460290|587693892|FG000|Overall Study|Elevated liver function|1|||
162723011|NCT01831791|587693893|FG000|Overall Study|Withdrawal by Subject|10|||
162723012|NCT01190007|587693894|FG000|Overall Study|Withdrawal by Subject|4|||
162723013|NCT01190007|587693894|FG000|Overall Study|Adverse Event|8|||
162723014|NCT01190007|587693894|FG000|Overall Study|Difficulty of visit for complications|1|||
162723015|NCT01190007|587693894|FG000|Overall Study|Participant was arrested|1|||
162723016|NCT01254019|587693900|FG000|Overall Study|Adverse Event|0|||
162723017|NCT01254019|587693901|FG001|Overall Study|Adverse Event|2|||
162723018|NCT01254019|587693900|FG000|Overall Study|Protocol Violation|1|||
162723019|NCT01254019|587693901|FG001|Overall Study|Protocol Violation|0|||
162723020|NCT01254019|587693900|FG000|Overall Study|Withdrawal by Subject|0|||
162723021|NCT01254019|587693901|FG001|Overall Study|Withdrawal by Subject|2|||
162723022|NCT03061474|587693902|FG000|Overall Study|Adverse Event|2|||
162723023|NCT03061474|587693903|FG001|Overall Study|Adverse Event|0|||
162723024|NCT03061474|587693902|FG000|Overall Study|Safety Risk|0|||
162723025|NCT03061474|587693903|FG001|Overall Study|Safety Risk|1|||
162723026|NCT03061474|587693902|FG000|Overall Study|Participant unwilling or unable to participate|0|||
162723027|NCT03061474|587693903|FG001|Overall Study|Participant unwilling or unable to participate|2|||
162723028|NCT03061474|587693902|FG000|Overall Study|Lost to Follow-up|0|||
162723029|NCT03061474|587693903|FG001|Overall Study|Lost to Follow-up|1|||
162723030|NCT00845832|587693906|FG000|Treatment Period|Adverse Event|0|||
162723031|NCT00845832|587693907|FG001|Treatment Period|Adverse Event|2|||
162723032|NCT00845832|587693908|FG002|Treatment Period|Adverse Event|0|||
162723033|NCT00845832|587693906|FG000|Treatment Period|Protocol Violation|1|||
162723034|NCT00845832|587693907|FG001|Treatment Period|Protocol Violation|1|||
162723035|NCT00845832|587693908|FG002|Treatment Period|Protocol Violation|0|||
162723036|NCT00845832|587693906|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
162723037|NCT00845832|587693907|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
162723038|NCT00845832|587693908|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
162723039|NCT00845832|587693906|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
162723040|NCT00845832|587693907|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
162723041|NCT00845832|587693908|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
162723042|NCT01391130|587693909|FG000|Overall Study|Withdrawal by Subject|3|||
162723043|NCT01391130|587693910|FG001|Overall Study|Withdrawal by Subject|2|||
162723044|NCT01391130|587693909|FG000|Overall Study|Physician Decision|2|||
162723045|NCT01391130|587693910|FG001|Overall Study|Physician Decision|3|||
162723046|NCT01391130|587693909|FG000|Overall Study|Did not Receive Drug|1|||
162723047|NCT01391130|587693910|FG001|Overall Study|Did not Receive Drug|1|||
162723048|NCT03520413|587693917|FG000|Overall Study|Lost to Follow-up|1|||
162723049|NCT03520413|587693918|FG001|Overall Study|Lost to Follow-up|1|||
162723050|NCT03520413|587693917|FG000|Overall Study|Withdrawal by Subject|1|||
162723051|NCT03520413|587693918|FG001|Overall Study|Withdrawal by Subject|2|||
162723052|NCT03520413|587693917|FG000|Overall Study|Death|0|||
162723053|NCT03520413|587693918|FG001|Overall Study|Death|1|||
162723054|NCT03520413|587693917|FG000|Overall Study|Physician Decision|3|||
162723055|NCT03520413|587693918|FG001|Overall Study|Physician Decision|3|||
162723056|NCT03520413|587693917|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
162723057|NCT03520413|587693918|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
162723058|NCT00869323|587693919|FG000|Maintenance Therapy|concurrent illness|1|||
162723059|NCT02880241|587693920|FG000|Overall Study|Lack of Efficacy|1|||
162723060|NCT02880241|587693921|FG001|Overall Study|Lack of Efficacy|0|||
162723061|NCT02880241|587693922|FG002|Overall Study|Lack of Efficacy|0|||
162723062|NCT02880241|587693923|FG003|Overall Study|Lack of Efficacy|0|||
162723063|NCT02880241|587693924|FG004|Overall Study|Lack of Efficacy|0|||
162723064|NCT02880241|587693925|FG005|Overall Study|Lack of Efficacy|0|||
162723065|NCT00638963|587693926|FG000|Overall Study|Withdrawal by Subject|1|||
162723066|NCT00638963|587693927|FG001|Overall Study|Withdrawal by Subject|0|||
162723067|NCT00566527|587693930|FG000|Overall Study|Reason not provided|3|||
162723068|NCT00566527|587693931|FG001|Overall Study|Reason not provided|11|||
162723069|NCT00566527|587693932|FG002|Overall Study|Reason not provided|10|||
162723070|NCT00566527|587693930|FG000|Overall Study|Adverse Event|2|||
162723071|NCT00566527|587693931|FG001|Overall Study|Adverse Event|0|||
162723072|NCT00566527|587693932|FG002|Overall Study|Adverse Event|1|||
162723073|NCT00566527|587693930|FG000|Overall Study|Physician Decision|3|||
162723074|NCT00566527|587693931|FG001|Overall Study|Physician Decision|8|||
162723075|NCT00566527|587693932|FG002|Overall Study|Physician Decision|20|||
162723076|NCT00566527|587693930|FG000|Overall Study|Lost to Follow-up|3|||
162723077|NCT00566527|587693931|FG001|Overall Study|Lost to Follow-up|4|||
162723078|NCT00566527|587693932|FG002|Overall Study|Lost to Follow-up|4|||
162723079|NCT00566527|587693930|FG000|Overall Study|Withdrawal by Subject|6|||
162723080|NCT00566527|587693931|FG001|Overall Study|Withdrawal by Subject|43|||
162723081|NCT00566527|587693932|FG002|Overall Study|Withdrawal by Subject|43|||
162723082|NCT03654768|587693938|FG000|Overall Study|Adverse Event|1|||
162723083|NCT03654768|587693939|FG001|Overall Study|Adverse Event|6|||
162723084|NCT03654768|587693938|FG000|Overall Study|Loss of response|2|||
162723085|NCT03654768|587693939|FG001|Overall Study|Loss of response|2|||
162723086|NCT03654768|587693938|FG000|Overall Study|Non-compliance|0|||
162723087|NCT03654768|587693939|FG001|Overall Study|Non-compliance|1|||
162723088|NCT03654768|587693938|FG000|Overall Study|Refusal not related to toxicity|1|||
162723089|NCT03654768|587693939|FG001|Overall Study|Refusal not related to toxicity|5|||
162723090|NCT03654768|587693938|FG000|Overall Study|Did not receive protocol therapy|1|||
162723091|NCT03654768|587693939|FG001|Overall Study|Did not receive protocol therapy|1|||
162723092|NCT00547118|587693942|FG000|Overall Study|Did not qualify prior to starting drug|1|||
162723093|NCT00547118|587693943|FG001|Overall Study|Did not qualify prior to starting drug|1|||
162723094|NCT00547118|587693942|FG000|Overall Study|Study suspended|7|||
162723095|NCT00547118|587693943|FG001|Overall Study|Study suspended|8|||
162723096|NCT01585558|587693947|FG000|Overall Study|Withdrawal by Subject|4|||
162723097|NCT01585558|587693948|FG001|Overall Study|Withdrawal by Subject|5|||
162723098|NCT01585558|587693949|FG002|Overall Study|Withdrawal by Subject|8|||
162723099|NCT01585558|587693947|FG000|Overall Study|Lost to Follow-up|2|||
162723100|NCT01585558|587693948|FG001|Overall Study|Lost to Follow-up|0|||
162723101|NCT01585558|587693949|FG002|Overall Study|Lost to Follow-up|3|||
162723102|NCT01585558|587693947|FG000|Overall Study|Adverse Event|3|||
162723103|NCT01585558|587693948|FG001|Overall Study|Adverse Event|4|||
162723104|NCT01585558|587693949|FG002|Overall Study|Adverse Event|1|||
162723105|NCT01585558|587693947|FG000|Overall Study|Protocol Violation|4|||
162723106|NCT01585558|587693948|FG001|Overall Study|Protocol Violation|3|||
162723107|NCT01585558|587693949|FG002|Overall Study|Protocol Violation|2|||
162723108|NCT01585558|587693947|FG000|Overall Study|Lack of Efficacy|0|||
162723109|NCT01585558|587693948|FG001|Overall Study|Lack of Efficacy|0|||
162677265|NCT01687257|587526904|FG000|Overall Study|Adverse Event|1|||
162677266|NCT01687257|587526905|FG001|Overall Study|Adverse Event|0|||
162677267|NCT01687257|587526906|FG002|Overall Study|Adverse Event|0|||
162677268|NCT01687257|587526904|FG000|Overall Study|Investigator's Discretion|0|||
162677269|NCT01687257|587526905|FG001|Overall Study|Investigator's Discretion|3|||
162677270|NCT01687257|587526906|FG002|Overall Study|Investigator's Discretion|0|||
162677271|NCT04899349|587526907|FG000|Overall Study|Study terminated by Sponsor|2|||
162677272|NCT04899349|587526908|FG001|Overall Study|Study terminated by Sponsor|0|||
162677273|NCT03336619|587526910|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
162677274|NCT03336619|587526911|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
162677275|NCT03336619|587526910|FG000|Overall Study|Withdrawal by Subject|17|||
162677276|NCT03336619|587526911|FG001|Overall Study|Withdrawal by Subject|16|||
162677277|NCT03336619|587526910|FG000|Overall Study|Adverse Event|2|||
162677278|NCT03336619|587526911|FG001|Overall Study|Adverse Event|5|||
162677279|NCT03336619|587526910|FG000|Overall Study|Physician Decision|3|||
162677280|NCT03336619|587526911|FG001|Overall Study|Physician Decision|0|||
162677281|NCT01300546|587526912|FG000|Overall Study|Withdrawal by Subject|1|||
162677282|NCT01300546|587526913|FG001|Overall Study|Withdrawal by Subject|0|||
162677283|NCT01300546|587526912|FG000|Overall Study|Lost to Follow-up|0|||
162677284|NCT01300546|587526913|FG001|Overall Study|Lost to Follow-up|2|||
162677285|NCT01300546|587526912|FG000|Overall Study|Lack of Efficacy|0|||
162677286|NCT01300546|587526913|FG001|Overall Study|Lack of Efficacy|3|||
162723110|NCT01585558|587693949|FG002|Overall Study|Lack of Efficacy|1|||
162723111|NCT02994654|587693952|FG000|Overall Study|Lost to Follow-up|1|||
162723112|NCT00732381|587693957|FG000|Overall Study|Adverse Event|1|||
162723113|NCT00732381|587693958|FG001|Overall Study|Adverse Event|0|||
162723114|NCT00732381|587693957|FG000|Overall Study|Treatment Failure|1|||
162723115|NCT00732381|587693958|FG001|Overall Study|Treatment Failure|1|||
162723116|NCT02448446|587695061|FG000|Overall Study|Withdrawal by Subject|1|||
162723117|NCT02448446|587695062|FG001|Overall Study|Withdrawal by Subject|0|||
162723118|NCT00463788|587695063|FG000|Overall Study|Progressive Disease|86|||
162723119|NCT00463788|587695064|FG001|Overall Study|Progressive Disease|42|||
162723120|NCT00463788|587695063|FG000|Overall Study|Adverse Event|6|||
162723121|NCT00463788|587695064|FG001|Overall Study|Adverse Event|2|||
162723122|NCT00463788|587695063|FG000|Overall Study|Withdrawal by Subject|6|||
162723123|NCT00463788|587695064|FG001|Overall Study|Withdrawal by Subject|2|||
162723124|NCT00463788|587695063|FG000|Overall Study|Death|4|||
162723125|NCT00463788|587695064|FG001|Overall Study|Death|3|||
162723126|NCT00463788|587695063|FG000|Overall Study|Symptomatic Deterioration|2|||
162723127|NCT00463788|587695064|FG001|Overall Study|Symptomatic Deterioration|3|||
162723128|NCT00463788|587695063|FG000|Overall Study|Lost to Follow-up|1|||
162723129|NCT00463788|587695064|FG001|Overall Study|Lost to Follow-up|0|||
162723130|NCT00463788|587695063|FG000|Overall Study|Protocol Violation|0|||
162723131|NCT00463788|587695064|FG001|Overall Study|Protocol Violation|1|||
162723132|NCT00463788|587695063|FG000|Overall Study|Other|3|||
162723133|NCT00463788|587695064|FG001|Overall Study|Other|0|||
162723134|NCT00463788|587695063|FG000|Overall Study|Randomized but not treated|1|||
162723135|NCT00463788|587695064|FG001|Overall Study|Randomized but not treated|1|||
162723136|NCT00360698|587695065|FG000|Run-In|Physician Decision|0|||
162723137|NCT00360698|587695066|FG001|Run-In|Physician Decision|1|||
162723138|NCT00360698|587695065|FG000|Run-In|Withdrawal by Subject|0|||
162723139|NCT00360698|587695066|FG001|Run-In|Withdrawal by Subject|2|||
162723140|NCT00360698|587695065|FG000|Run-In|Non compliance with treatment procedure|0|||
162723141|NCT00360698|587695066|FG001|Run-In|Non compliance with treatment procedure|1|||
162723142|NCT00360698|587695065|FG000|Run-In|Sponsor request|0|||
162723143|NCT00360698|587695066|FG001|Run-In|Sponsor request|2|||
162723144|NCT00360698|587695065|FG000|Run-In|Patient did not meet inclusion criteria|0|||
162723145|NCT00360698|587695066|FG001|Run-In|Patient did not meet inclusion criteria|1|||
162723146|NCT00360698|587695065|FG000|Run-In|Patient personal reasons|0|||
162723147|NCT00360698|587695066|FG001|Run-In|Patient personal reasons|2|||
162723148|NCT00360698|587695065|FG000|Run-In|Need of insulin with meals|0|||
162723149|NCT00360698|587695066|FG001|Run-In|Need of insulin with meals|1|||
162723150|NCT00360698|587695065|FG000|Treatment Period|Non compliance with treatment procedure|1|||
162723151|NCT00360698|587695066|FG001|Treatment Period|Non compliance with treatment procedure|0|||
162723152|NCT00360698|587695065|FG000|Treatment Period|Early termination by error|0|||
162723153|NCT00360698|587695066|FG001|Treatment Period|Early termination by error|1|||
162723154|NCT02200770|587695067|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
162677287|NCT01300546|587526912|FG000|Overall Study|Adverse Event|0|||
162677288|NCT01300546|587526913|FG001|Overall Study|Adverse Event|1|||
162677289|NCT02820623|587526914|FG000|Overall Study|Withdrawal by Subject|1|||
162677290|NCT02820623|587526915|FG001|Overall Study|Withdrawal by Subject|3|||
162677291|NCT02820623|587526916|FG002|Overall Study|Withdrawal by Subject|3|||
162677292|NCT02820623|587526914|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
162677293|NCT02820623|587526915|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
162677294|NCT02820623|587526916|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
162677295|NCT02820623|587526914|FG000|Overall Study|Therapist unable to enroll clients|1|||
162677296|NCT02820623|587526915|FG001|Overall Study|Therapist unable to enroll clients|1|||
162677297|NCT02820623|587526916|FG002|Overall Study|Therapist unable to enroll clients|3|||
162677298|NCT02820623|587526914|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
162677299|NCT02820623|587526915|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
162677300|NCT02820623|587526916|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
162677301|NCT05207813|587526919|FG000|Overall Study|Lost to Follow-up|2|||
162677302|NCT01954017|587526920|FG000|Overall Study|Adverse Event|0|||
162677303|NCT01954017|587526921|FG001|Overall Study|Adverse Event|0|||
162677304|NCT01954017|587526922|FG002|Overall Study|Adverse Event|1|||
162677305|NCT01954017|587526920|FG000|Overall Study|Death|2|||
162677306|NCT01954017|587526921|FG001|Overall Study|Death|1|||
162677307|NCT01954017|587526922|FG002|Overall Study|Death|1|||
162677308|NCT01954017|587526920|FG000|Overall Study|Withdrawal by Subject|0|||
162677309|NCT01954017|587526921|FG001|Overall Study|Withdrawal by Subject|1|||
162677310|NCT01954017|587526922|FG002|Overall Study|Withdrawal by Subject|0|||
162677311|NCT01954017|587526920|FG000|Overall Study|Protocol Violation|0|||
162677312|NCT01954017|587526921|FG001|Overall Study|Protocol Violation|3|||
162677313|NCT01954017|587526922|FG002|Overall Study|Protocol Violation|2|||
162677314|NCT01954017|587526920|FG000|Overall Study|Necrotizing enterocolitis|1|||
162677315|NCT01954017|587526921|FG001|Overall Study|Necrotizing enterocolitis|0|||
162677316|NCT01954017|587526922|FG002|Overall Study|Necrotizing enterocolitis|1|||
162677317|NCT01954017|587526920|FG000|Overall Study|Enteral intake stopped >7 days|0|||
162677318|NCT01954017|587526921|FG001|Overall Study|Enteral intake stopped >7 days|1|||
162677319|NCT01954017|587526922|FG002|Overall Study|Enteral intake stopped >7 days|1|||
162677320|NCT01954017|587526920|FG000|Overall Study|All other reasons|2|||
162677321|NCT01954017|587526921|FG001|Overall Study|All other reasons|2|||
162677322|NCT01954017|587526922|FG002|Overall Study|All other reasons|7|||
162677323|NCT02653482|587526925|FG000|Overall Study|Death|1|||
162677324|NCT02653482|587526926|FG001|Overall Study|Death|1|||
162677325|NCT05132699|587526928|FG000|Overall Study|Withdrawal by Subject|3|||
162677326|NCT05132699|587526929|FG001|Overall Study|Withdrawal by Subject|0|||
162677327|NCT04370054|587526930|FG000|Treatment Phase|Lost to Follow-up|1|||
162677328|NCT04370054|587526930|FG000|Treatment Phase|Withdrawal by Subject|1|||
162677329|NCT04370054|587526930|FG000|Follow-Up Phase|Ongoing|75|||
162677330|NCT02096900|587526931|FG000|Overall Study|Did not receive medication|3|||
162677331|NCT02096900|587526932|FG001|Overall Study|Did not receive medication|1|||
162677332|NCT02096900|587526931|FG000|Overall Study|Surgery cancelled- medication received|1|||
162677333|NCT02096900|587526932|FG001|Overall Study|Surgery cancelled- medication received|1|||
162677334|NCT00710424|587526935|FG000|Overall Study|Adverse Event|30|||
162677335|NCT00710424|587526936|FG001|Overall Study|Adverse Event|12|||
162677336|NCT00710424|587526935|FG000|Overall Study|Lack of Efficacy|4|||
162677337|NCT00710424|587526936|FG001|Overall Study|Lack of Efficacy|5|||
162677338|NCT00710424|587526935|FG000|Overall Study|Withdrawal by Subject|5|||
162677339|NCT00710424|587526936|FG001|Overall Study|Withdrawal by Subject|3|||
162677340|NCT00710424|587526935|FG000|Overall Study|Lost to Follow-up|0|||
162677341|NCT00710424|587526936|FG001|Overall Study|Lost to Follow-up|1|||
162677342|NCT00710424|587526935|FG000|Overall Study|Refused medication, no side effects|1|||
162677343|NCT00710424|587526936|FG001|Overall Study|Refused medication, no side effects|0|||
162677344|NCT00710424|587526935|FG000|Overall Study|Non-compliance with stable analgesia|1|||
162677345|NCT00710424|587526936|FG001|Overall Study|Non-compliance with stable analgesia|0|||
162677346|NCT00710424|587526935|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
162677347|NCT00710424|587526936|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
162677348|NCT00710424|587526935|FG000|Overall Study|Subject thought medication changed|1|||
162677349|NCT00710424|587526936|FG001|Overall Study|Subject thought medication changed|0|||
162677350|NCT00710424|587526935|FG000|Overall Study|Ceased treatment due to travel|1|||
162677351|NCT00710424|587526936|FG001|Overall Study|Ceased treatment due to travel|0|||
162677352|NCT00710424|587526935|FG000|Overall Study|Subject preferred paracetamol|0|||
162677353|NCT00710424|587526936|FG001|Overall Study|Subject preferred paracetamol|1|||
162677354|NCT00710424|587526935|FG000|Overall Study|Felt good so stopped treatment|0|||
162677355|NCT00710424|587526936|FG001|Overall Study|Felt good so stopped treatment|1|||
162677356|NCT06273774|587526937|FG000|Overall Study|Participant was out of state.|0|||
162677357|NCT06273774|587526938|FG001|Overall Study|Participant was out of state.|0|||
162677358|NCT06273774|587526939|FG002|Overall Study|Participant was out of state.|0|||
162677359|NCT06273774|587526940|FG003|Overall Study|Participant was out of state.|0|||
162677360|NCT06273774|587526941|FG004|Overall Study|Participant was out of state.|0|||
162677361|NCT06273774|587526942|FG005|Overall Study|Participant was out of state.|1|||
162677362|NCT06273774|587526937|FG000|Overall Study|Lost to Follow-up|0|||
162677363|NCT06273774|587526938|FG001|Overall Study|Lost to Follow-up|0|||
162677364|NCT06273774|587526939|FG002|Overall Study|Lost to Follow-up|0|||
162677365|NCT06273774|587526940|FG003|Overall Study|Lost to Follow-up|0|||
162677366|NCT06273774|587526941|FG004|Overall Study|Lost to Follow-up|1|||
162677367|NCT06273774|587526942|FG005|Overall Study|Lost to Follow-up|0|||
162677368|NCT04918784|587529266|FG000|Overall Study|Amputation - no longer eligible|1|||
162677369|NCT04918784|587529267|FG001|Overall Study|Amputation - no longer eligible|2|||
162677370|NCT04918784|587529266|FG000|Overall Study|Death|1|||
162723155|NCT02200770|587695068|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
162723156|NCT02200770|587695067|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
162723157|NCT02200770|587695068|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
162723158|NCT02200770|587695067|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
162723159|NCT02200770|587695068|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
162723160|NCT02200770|587695067|FG000|Randomized-controlled Period (RCP)|Other|1|||
162723161|NCT02200770|587695068|FG001|Randomized-controlled Period (RCP)|Other|2|||
162723162|NCT02200770|587695067|FG000|Open-label Period (OLP)|Adverse Event|1|||
162723163|NCT02200770|587695068|FG001|Open-label Period (OLP)|Adverse Event|2|||
162723164|NCT02200770|587695067|FG000|Open-label Period (OLP)|Death|1|||
162723165|NCT02200770|587695068|FG001|Open-label Period (OLP)|Death|2|||
162723166|NCT02200770|587695067|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
162723167|NCT02200770|587695068|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
162723168|NCT02200770|587695067|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
162723169|NCT02200770|587695068|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
162723170|NCT02200770|587695067|FG000|Open-label Period (OLP)|Other|6|||
162723171|NCT02200770|587695068|FG001|Open-label Period (OLP)|Other|15|||
162723172|NCT05283395|587695072|FG000|Overall Study|Adverse Event|4|||
162723173|NCT05283395|587695073|FG001|Overall Study|Adverse Event|4|||
162723174|NCT05283395|587695074|FG002|Overall Study|Adverse Event|0|||
162723175|NCT05283395|587695072|FG000|Overall Study|Patient Lost to Follow-Up|0|||
162723176|NCT05283395|587695073|FG001|Overall Study|Patient Lost to Follow-Up|0|||
162723177|NCT05283395|587695074|FG002|Overall Study|Patient Lost to Follow-Up|1|||
162723178|NCT05283395|587695072|FG000|Overall Study|Patient Withdrawal|2|||
162723179|NCT05283395|587695073|FG001|Overall Study|Patient Withdrawal|4|||
162723180|NCT05283395|587695074|FG002|Overall Study|Patient Withdrawal|2|||
162723181|NCT05283395|587695072|FG000|Overall Study|Investigator Decision|1|||
162723182|NCT05283395|587695073|FG001|Overall Study|Investigator Decision|0|||
162723183|NCT05283395|587695074|FG002|Overall Study|Investigator Decision|1|||
162723184|NCT05283395|587695072|FG000|Overall Study|Enrolled in error|0|||
162723185|NCT05283395|587695073|FG001|Overall Study|Enrolled in error|0|||
162723186|NCT05283395|587695074|FG002|Overall Study|Enrolled in error|1|||
162723187|NCT00712335|587695075|FG000|Overall Study|Withdrawal by Subject|0|||
162723188|NCT00712335|587695076|FG001|Overall Study|Withdrawal by Subject|7|||
162723189|NCT00712335|587695077|FG002|Overall Study|Withdrawal by Subject|2|||
162723190|NCT00712335|587695078|FG003|Overall Study|Withdrawal by Subject|3|||
162723191|NCT00712335|587695079|FG004|Overall Study|Withdrawal by Subject|0|||
162723192|NCT00712335|587695075|FG000|Overall Study|Lost to Follow-up|2|||
162723193|NCT00712335|587695076|FG001|Overall Study|Lost to Follow-up|5|||
162723194|NCT00712335|587695077|FG002|Overall Study|Lost to Follow-up|0|||
162723195|NCT00712335|587695078|FG003|Overall Study|Lost to Follow-up|1|||
162723196|NCT00712335|587695079|FG004|Overall Study|Lost to Follow-up|0|||
162723197|NCT00712335|587695075|FG000|Overall Study|Protocol Violation|1|||
162723198|NCT00712335|587695076|FG001|Overall Study|Protocol Violation|2|||
162723199|NCT00712335|587695077|FG002|Overall Study|Protocol Violation|1|||
162723200|NCT00712335|587695078|FG003|Overall Study|Protocol Violation|0|||
162723201|NCT00712335|587695079|FG004|Overall Study|Protocol Violation|0|||
162723202|NCT00712335|587695075|FG000|Overall Study|Lack of Efficacy|0|||
162723203|NCT00712335|587695076|FG001|Overall Study|Lack of Efficacy|0|||
162723204|NCT00712335|587695077|FG002|Overall Study|Lack of Efficacy|1|||
162723205|NCT00712335|587695078|FG003|Overall Study|Lack of Efficacy|1|||
162723206|NCT00712335|587695079|FG004|Overall Study|Lack of Efficacy|0|||
162723207|NCT00712335|587695075|FG000|Overall Study|Other Reason|0|||
162723208|NCT00712335|587695076|FG001|Overall Study|Other Reason|3|||
162723209|NCT00712335|587695077|FG002|Overall Study|Other Reason|1|||
162723210|NCT00712335|587695078|FG003|Overall Study|Other Reason|0|||
162723211|NCT00712335|587695079|FG004|Overall Study|Other Reason|0|||
162723212|NCT03401112|587695080|FG000|Overall Study|Adverse Event|1|||
162723213|NCT03401112|587695081|FG001|Overall Study|Adverse Event|2|||
162723214|NCT03401112|587695082|FG002|Overall Study|Adverse Event|3|||
162723215|NCT03401112|587695083|FG003|Overall Study|Adverse Event|2|||
162723216|NCT03401112|587695084|FG004|Overall Study|Adverse Event|0|||
162723217|NCT03401112|587695080|FG000|Overall Study|Lost to Follow-up|1|||
162723218|NCT03401112|587695081|FG001|Overall Study|Lost to Follow-up|0|||
162723219|NCT03401112|587695082|FG002|Overall Study|Lost to Follow-up|0|||
162723220|NCT03401112|587695083|FG003|Overall Study|Lost to Follow-up|0|||
162723221|NCT03401112|587695084|FG004|Overall Study|Lost to Follow-up|0|||
162723222|NCT03401112|587695080|FG000|Overall Study|Noncompliance|1|||
162723223|NCT03401112|587695081|FG001|Overall Study|Noncompliance|2|||
162723224|NCT03401112|587695082|FG002|Overall Study|Noncompliance|3|||
162723225|NCT03401112|587695083|FG003|Overall Study|Noncompliance|0|||
162723226|NCT03401112|587695084|FG004|Overall Study|Noncompliance|0|||
162723227|NCT03401112|587695080|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
162723228|NCT03401112|587695081|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
162723229|NCT03401112|587695082|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
162723230|NCT03401112|587695083|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
162723231|NCT03401112|587695084|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
162723232|NCT03401112|587695080|FG000|Overall Study|Withdrawal by Subject|0|||
162723233|NCT03401112|587695081|FG001|Overall Study|Withdrawal by Subject|3|||
162723234|NCT03401112|587695082|FG002|Overall Study|Withdrawal by Subject|2|||
162723235|NCT03401112|587695083|FG003|Overall Study|Withdrawal by Subject|1|||
162723236|NCT03401112|587695084|FG004|Overall Study|Withdrawal by Subject|0|||
162723237|NCT03401112|587695080|FG000|Overall Study|Physician Decision|0|||
162723238|NCT03401112|587695081|FG001|Overall Study|Physician Decision|0|||
162723239|NCT03401112|587695082|FG002|Overall Study|Physician Decision|0|||
162723240|NCT03401112|587695083|FG003|Overall Study|Physician Decision|2|||
162723241|NCT03401112|587695084|FG004|Overall Study|Physician Decision|0|||
162723242|NCT03401112|587695080|FG000|Overall Study|Study was Terminated by Sponsor|0|||
162723243|NCT03401112|587695081|FG001|Overall Study|Study was Terminated by Sponsor|0|||
162723244|NCT03401112|587695082|FG002|Overall Study|Study was Terminated by Sponsor|0|||
162723245|NCT03401112|587695083|FG003|Overall Study|Study was Terminated by Sponsor|1|||
162723246|NCT03401112|587695084|FG004|Overall Study|Study was Terminated by Sponsor|0|||
162723247|NCT03401112|587695080|FG000|Overall Study|Day 1 Assessment not Done|1|||
162723248|NCT03401112|587695081|FG001|Overall Study|Day 1 Assessment not Done|0|||
162723249|NCT03401112|587695082|FG002|Overall Study|Day 1 Assessment not Done|0|||
162723250|NCT03401112|587695083|FG003|Overall Study|Day 1 Assessment not Done|0|||
162723251|NCT03401112|587695084|FG004|Overall Study|Day 1 Assessment not Done|0|||
162723252|NCT03401112|587695080|FG000|Overall Study|Not Dosed|0|||
162723253|NCT03401112|587695081|FG001|Overall Study|Not Dosed|0|||
162723254|NCT03401112|587695082|FG002|Overall Study|Not Dosed|1|||
162723255|NCT03401112|587695083|FG003|Overall Study|Not Dosed|0|||
162723256|NCT03401112|587695084|FG004|Overall Study|Not Dosed|0|||
162723257|NCT03401112|587695080|FG000|Overall Study|Missed Clinical Visit|0|||
162723258|NCT03401112|587695081|FG001|Overall Study|Missed Clinical Visit|0|||
162723259|NCT03401112|587695082|FG002|Overall Study|Missed Clinical Visit|1|||
162723260|NCT03401112|587695083|FG003|Overall Study|Missed Clinical Visit|0|||
162723261|NCT03401112|587695084|FG004|Overall Study|Missed Clinical Visit|0|||
162723262|NCT03401112|587695080|FG000|Overall Study|Missed Doses|0|||
162723263|NCT03401112|587695081|FG001|Overall Study|Missed Doses|0|||
162723264|NCT03401112|587695082|FG002|Overall Study|Missed Doses|1|||
162723265|NCT03401112|587695083|FG003|Overall Study|Missed Doses|0|||
162723266|NCT03401112|587695084|FG004|Overall Study|Missed Doses|0|||
162723267|NCT01264679|587695085|FG000|Overall Study|Participation in Another Clinical Trial|1|||
162723268|NCT01264679|587695085|FG000|Overall Study|Physician Decision|1|||
162723269|NCT01264679|587695085|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
162723270|NCT01264679|587695085|FG000|Overall Study|Withdrawal by Subject|1|||
162723271|NCT03475316|587695086|FG000|6 Month Intervention|Adverse Event|2|||
162723272|NCT03475316|587695087|FG001|6 Month Intervention|Adverse Event|1|||
162723273|NCT03475316|587695086|FG000|6 Month Intervention|Withdrawal by Subject|2|||
162723274|NCT03475316|587695087|FG001|6 Month Intervention|Withdrawal by Subject|0|||
162723275|NCT03475316|587695086|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
162723276|NCT03475316|587695087|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
162723277|NCT03475316|587695086|FG000|9 Months|Study stopped due to COVID pandemic|3|||
162723278|NCT03475316|587695087|FG001|9 Months|Study stopped due to COVID pandemic|4|||
162723279|NCT00424645|587695092|FG000|Overall Study|Death|1|||
162723280|NCT00424645|587695093|FG001|Overall Study|Death|0|||
162723281|NCT02555215|587695094|FG000|Overall Study|Other|1|||
162723282|NCT02555215|587695094|FG000|Overall Study|Investigator Decision|2|||
162723283|NCT00529789|587695095|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
162723284|NCT00529789|587695095|FG000|Study Period II/III|Adverse Event|3|||
162723285|NCT00529789|587695095|FG000|Study Period II/III|Lack of Efficacy|2|||
162723286|NCT00529789|587695095|FG000|Study Period II/III|Withdrawal by Subject|1|||
162723287|NCT00529789|587695095|FG000|Study Period II/III|Protocol Violation|3|||
162723288|NCT00529789|587695095|FG000|Study Period II/III|Physician Decision|3|||
162723289|NCT00529789|587695095|FG000|Study Period II/III|Lost to Follow-up|3|||
162723290|NCT00529789|587695095|FG000|Study Period IV|Parent/Caregiver Decision|1|||
162723291|NCT00529789|587695095|FG000|Study Period IV|Adverse Event|1|||
162723292|NCT00529789|587695095|FG000|Study Period IV|Lack of Efficacy|1|||
162723293|NCT00529789|587695095|FG000|Study Period IV|Lost to Follow-up|3|||
162723294|NCT02204982|587695096|FG000|Overall Study|Patient ineligible-medical monitor|1|||
162723295|NCT02204982|587695097|FG001|Overall Study|Patient ineligible-medical monitor|0|||
162723296|NCT02204982|587695096|FG000|Overall Study|Withdrawal by Subject|1|||
162723297|NCT02204982|587695097|FG001|Overall Study|Withdrawal by Subject|0|||
162723298|NCT02204982|587695096|FG000|Overall Study|Adverse Event|1|||
162723299|NCT02204982|587695097|FG001|Overall Study|Adverse Event|0|||
162677371|NCT04918784|587529267|FG001|Overall Study|Death|0|||
162677372|NCT04918784|587529266|FG000|Overall Study|patient non-compliance|3|||
162677373|NCT04918784|587529267|FG001|Overall Study|patient non-compliance|1|||
162677374|NCT04918784|587529266|FG000|Overall Study|Adverse Event|1|||
162677375|NCT04918784|587529267|FG001|Overall Study|Adverse Event|0|||
162677376|NCT01986881|587529268|FG000|Overall Study|Death|228|||
162677377|NCT01986881|587529269|FG001|Overall Study|Death|233|||
162677378|NCT01986881|587529270|FG002|Overall Study|Death|247|||
162677379|NCT01986881|587529268|FG000|Overall Study|Lost to Follow-up|51|||
162677380|NCT01986881|587529269|FG001|Overall Study|Lost to Follow-up|44|||
162677381|NCT01986881|587529270|FG002|Overall Study|Lost to Follow-up|55|||
162677382|NCT01986881|587529268|FG000|Overall Study|Physician Decision|7|||
162677383|NCT01986881|587529269|FG001|Overall Study|Physician Decision|4|||
162677384|NCT01986881|587529270|FG002|Overall Study|Physician Decision|6|||
162677385|NCT01986881|587529268|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
162677386|NCT01986881|587529269|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
162677387|NCT01986881|587529270|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
162677388|NCT01986881|587529268|FG000|Overall Study|Withdrawal by Subject|41|||
162677389|NCT01986881|587529269|FG001|Overall Study|Withdrawal by Subject|60|||
162677390|NCT01986881|587529270|FG002|Overall Study|Withdrawal by Subject|45|||
162677391|NCT01986881|587529268|FG000|Overall Study|Subject Moved|0|||
162677392|NCT01986881|587529269|FG001|Overall Study|Subject Moved|1|||
162677393|NCT01986881|587529270|FG002|Overall Study|Subject Moved|0|||
162677394|NCT01986881|587529268|FG000|Overall Study|Other|1|||
162677395|NCT01986881|587529269|FG001|Overall Study|Other|2|||
162677396|NCT01986881|587529270|FG002|Overall Study|Other|2|||
162677397|NCT04050865|587529271|FG000|Overall Study|Adverse Event|1|||
162677398|NCT04050865|587529272|FG001|Overall Study|Adverse Event|0|||
162677399|NCT04050865|587529271|FG000|Overall Study|no insert|1|||
162677400|NCT04050865|587529272|FG001|Overall Study|no insert|0|||
162677401|NCT04050865|587529271|FG000|Overall Study|Only 1 insert|2|||
162677402|NCT04050865|587529272|FG001|Overall Study|Only 1 insert|3|||
162677403|NCT04050865|587529271|FG000|Overall Study|Physician Decision|0|||
162677404|NCT04050865|587529272|FG001|Overall Study|Physician Decision|1|||
162677405|NCT04050865|587529271|FG000|Overall Study|Withdrawal by Subject|0|||
162677406|NCT04050865|587529272|FG001|Overall Study|Withdrawal by Subject|1|||
162677407|NCT02035332|587529273|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
162677408|NCT01258608|587529274|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
162677409|NCT01258608|587529275|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
162677410|NCT01258608|587529274|FG000|Overall Study|Clinical progression|1|||
162677411|NCT01258608|587529275|FG001|Overall Study|Clinical progression|0|||
162677412|NCT01258608|587529274|FG000|Overall Study|Sponsor decision|0|||
162677413|NCT01258608|587529275|FG001|Overall Study|Sponsor decision|1|||
162677414|NCT01258608|587529274|FG000|Overall Study|Physician Decision|6|||
162677415|NCT01258608|587529275|FG001|Overall Study|Physician Decision|1|||
162677416|NCT01258608|587529274|FG000|Overall Study|Lost to Follow-up|0|||
162677417|NCT01258608|587529275|FG001|Overall Study|Lost to Follow-up|1|||
162677418|NCT01258608|587529274|FG000|Overall Study|Lack of compliance|1|||
162677419|NCT01258608|587529275|FG001|Overall Study|Lack of compliance|0|||
162677420|NCT01258608|587529274|FG000|Overall Study|Lack of Efficacy|0|||
162677421|NCT01258608|587529275|FG001|Overall Study|Lack of Efficacy|1|||
162723300|NCT02204982|587695096|FG000|Overall Study|Adverse Event and Investigator decision|1|||
162723301|NCT02204982|587695097|FG001|Overall Study|Adverse Event and Investigator decision|0|||
162723302|NCT02204982|587695096|FG000|Overall Study|Physician Decision|0|||
162723303|NCT02204982|587695097|FG001|Overall Study|Physician Decision|2|||
162723304|NCT02204982|587695096|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
162723305|NCT02204982|587695097|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
162723306|NCT02204982|587695096|FG000|Overall Study|Termination of Study bySponsor|0|||
162723307|NCT02204982|587695097|FG001|Overall Study|Termination of Study bySponsor|1|||
162723308|NCT01968226|587695098|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
162723309|NCT00457743|587695101|FG000|Overall Study|Adverse Event|0|||
162723310|NCT00457743|587695102|FG001|Overall Study|Adverse Event|4|||
162723311|NCT00457743|587695103|FG002|Overall Study|Adverse Event|0|||
162723312|NCT00457743|587695101|FG000|Overall Study|Lack of Efficacy|3|||
162723313|NCT00457743|587695102|FG001|Overall Study|Lack of Efficacy|23|||
162723314|NCT00457743|587695103|FG002|Overall Study|Lack of Efficacy|3|||
162723315|NCT00959946|587695104|FG000|Overall Study|Adverse Event|0|||
162723316|NCT00959946|587695105|FG001|Overall Study|Adverse Event|0|||
162723317|NCT00959946|587695106|FG002|Overall Study|Adverse Event|2|||
162723318|NCT00959946|587695107|FG003|Overall Study|Adverse Event|1|||
162723319|NCT00959946|587695108|FG004|Overall Study|Adverse Event|0|||
162723320|NCT00959946|587695109|FG005|Overall Study|Adverse Event|1|||
162723321|NCT00959946|587695110|FG006|Overall Study|Adverse Event|0|||
162723322|NCT00959946|587695111|FG007|Overall Study|Adverse Event|0|||
162723323|NCT00959946|587695104|FG000|Overall Study|Death|0|||
162723324|NCT00959946|587695105|FG001|Overall Study|Death|0|||
162723325|NCT00959946|587695106|FG002|Overall Study|Death|0|||
162723326|NCT00959946|587695107|FG003|Overall Study|Death|0|||
162723327|NCT00959946|587695108|FG004|Overall Study|Death|0|||
162723328|NCT00959946|587695109|FG005|Overall Study|Death|1|||
162723329|NCT00959946|587695110|FG006|Overall Study|Death|0|||
162723330|NCT00959946|587695111|FG007|Overall Study|Death|0|||
162723331|NCT00959946|587695104|FG000|Overall Study|Disease Progression|2|||
162723332|NCT00959946|587695105|FG001|Overall Study|Disease Progression|4|||
162677422|NCT01258608|587529274|FG000|Overall Study|Adverse Event|6|||
162677423|NCT01258608|587529275|FG001|Overall Study|Adverse Event|10|||
162677424|NCT01258608|587529274|FG000|Overall Study|Withdrawal by Subject|6|||
162677425|NCT01258608|587529275|FG001|Overall Study|Withdrawal by Subject|5|||
162677426|NCT04205630|587529276|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
162677427|NCT04205630|587529276|FG000|Overall Study|Disease clinical progression|7|||
162677428|NCT04205630|587529276|FG000|Overall Study|Withdrawal by Subject|2|||
162677429|NCT04205630|587529276|FG000|Overall Study|Adverse Event|17|||
162677430|NCT04205630|587529276|FG000|Overall Study|Other|1|||
162677431|NCT00447057|587529283|FG000|Overall Study|Adverse Event|4|||
162677432|NCT00447057|587529284|FG001|Overall Study|Adverse Event|10|||
162677433|NCT00447057|587529285|FG002|Overall Study|Adverse Event|0|||
162677434|NCT00447057|587529286|FG003|Overall Study|Adverse Event|3|||
162677435|NCT00447057|587529283|FG000|Overall Study|Death due to study disease|6|||
162677436|NCT00447057|587529284|FG001|Overall Study|Death due to study disease|4|||
162677437|NCT00447057|587529285|FG002|Overall Study|Death due to study disease|1|||
162677438|NCT00447057|587529286|FG003|Overall Study|Death due to study disease|1|||
162677439|NCT00447057|587529283|FG000|Overall Study|Lost to Follow-up|0|||
162677440|NCT00447057|587529284|FG001|Overall Study|Lost to Follow-up|1|||
162677441|NCT00447057|587529285|FG002|Overall Study|Lost to Follow-up|0|||
162677442|NCT00447057|587529286|FG003|Overall Study|Lost to Follow-up|0|||
162677443|NCT00447057|587529283|FG000|Overall Study|Entry criteria not met|1|||
162677444|NCT00447057|587529284|FG001|Overall Study|Entry criteria not met|1|||
162677445|NCT00447057|587529285|FG002|Overall Study|Entry criteria not met|0|||
162677446|NCT00447057|587529286|FG003|Overall Study|Entry criteria not met|0|||
162677447|NCT00447057|587529283|FG000|Overall Study|Protocol Violation|0|||
162677448|NCT00447057|587529284|FG001|Overall Study|Protocol Violation|1|||
162677449|NCT00447057|587529285|FG002|Overall Study|Protocol Violation|0|||
162677450|NCT00447057|587529286|FG003|Overall Study|Protocol Violation|0|||
162677451|NCT00447057|587529283|FG000|Overall Study|Withdrawal by Subject|4|||
162677452|NCT00447057|587529284|FG001|Overall Study|Withdrawal by Subject|5|||
162723333|NCT00959946|587695106|FG002|Overall Study|Disease Progression|2|||
162723334|NCT00959946|587695107|FG003|Overall Study|Disease Progression|4|||
162723335|NCT00959946|587695108|FG004|Overall Study|Disease Progression|4|||
162723336|NCT00959946|587695109|FG005|Overall Study|Disease Progression|6|||
162723337|NCT00959946|587695110|FG006|Overall Study|Disease Progression|2|||
162723338|NCT00959946|587695111|FG007|Overall Study|Disease Progression|2|||
162723339|NCT00959946|587695104|FG000|Overall Study|Withdrawal by Subject|0|||
162723340|NCT00959946|587695105|FG001|Overall Study|Withdrawal by Subject|0|||
162723341|NCT00959946|587695106|FG002|Overall Study|Withdrawal by Subject|0|||
162723342|NCT00959946|587695107|FG003|Overall Study|Withdrawal by Subject|0|||
162723343|NCT00959946|587695108|FG004|Overall Study|Withdrawal by Subject|0|||
162723344|NCT00959946|587695109|FG005|Overall Study|Withdrawal by Subject|1|||
162723345|NCT00959946|587695110|FG006|Overall Study|Withdrawal by Subject|0|||
162723346|NCT00959946|587695111|FG007|Overall Study|Withdrawal by Subject|0|||
162723347|NCT01837966|587695113|FG000|Overall Study|Withdrawal by Subject|2|||
162723348|NCT01837966|587695114|FG001|Overall Study|Withdrawal by Subject|1|||
162723349|NCT04975308|587695118|FG000|Overall Study|Withdrawal by Subject|6|||
162723350|NCT04975308|587695119|FG001|Overall Study|Withdrawal by Subject|16|||
162723351|NCT04975308|587695120|FG002|Overall Study|Withdrawal by Subject|6|||
162723352|NCT04975308|587695118|FG000|Overall Study|Physician Decision|0|||
162723353|NCT04975308|587695119|FG001|Overall Study|Physician Decision|3|||
162723354|NCT04975308|587695120|FG002|Overall Study|Physician Decision|1|||
162723355|NCT04975308|587695118|FG000|Overall Study|Adverse Event|10|||
162723356|NCT04975308|587695119|FG001|Overall Study|Adverse Event|1|||
162723357|NCT04975308|587695120|FG002|Overall Study|Adverse Event|12|||
162723358|NCT04975308|587695118|FG000|Overall Study|On study treatment (Ongoing)|65|||
162723359|NCT04975308|587695119|FG001|Overall Study|On study treatment (Ongoing)|43|||
162723360|NCT04975308|587695120|FG002|Overall Study|On study treatment (Ongoing)|75|||
162723361|NCT04975308|587695118|FG000|Overall Study|Protocol Deviation|4|||
162723362|NCT04975308|587695119|FG001|Overall Study|Protocol Deviation|3|||
162723363|NCT04975308|587695120|FG002|Overall Study|Protocol Deviation|2|||
162723364|NCT00468910|587695121|FG000|Overall Study|Lost to Follow-up|2|||
162723365|NCT00468910|587695122|FG001|Overall Study|Lost to Follow-up|1|||
162723366|NCT00468910|587695121|FG000|Overall Study|Withdrawal by Subject|2|||
162723367|NCT00468910|587695122|FG001|Overall Study|Withdrawal by Subject|1|||
162723368|NCT00468910|587695121|FG000|Overall Study|Medical Contraindication|0|||
162723369|NCT00468910|587695122|FG001|Overall Study|Medical Contraindication|1|||
162723370|NCT01909778|587695123|FG000|Overall Study|failed screening|1|||
162723371|NCT01943916|587695124|FG000|Overall Study|Technically invalid images|10|||
162723372|NCT01943916|587695124|FG000|Overall Study|Enrollment Failure|23|||
162723373|NCT01943916|587695124|FG000|Overall Study|Pilot Phase exclusion|100|||
162723374|NCT01943916|587695124|FG000|Overall Study|Quality Assurance Reader Fail|130|||
162723375|NCT01943916|587695124|FG000|Overall Study|Technical Failure|39|||
162723376|NCT01943916|587695124|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
162723377|NCT01943916|587695124|FG000|Overall Study|No Truth Panel Review|38|||
162723378|NCT01943916|587695124|FG000|Overall Study|Protocol Deviation|1|||
162723379|NCT00919763|587695125|FG000|Overall Study|Adverse Event|7|||
162723380|NCT00919763|587695126|FG001|Overall Study|Adverse Event|1|||
162723381|NCT00919763|587695125|FG000|Overall Study|Lost to Follow-up|1|||
162723382|NCT00919763|587695126|FG001|Overall Study|Lost to Follow-up|0|||
162723383|NCT00919763|587695125|FG000|Overall Study|Protocol Violation|1|||
162723384|NCT00919763|587695126|FG001|Overall Study|Protocol Violation|1|||
162723385|NCT00919763|587695125|FG000|Overall Study|Withdrawal by Subject|3|||
162723386|NCT00919763|587695126|FG001|Overall Study|Withdrawal by Subject|1|||
162723387|NCT00919763|587695125|FG000|Overall Study|Non-compliance|0|||
162723388|NCT00919763|587695126|FG001|Overall Study|Non-compliance|1|||
162723389|NCT05323734|587695127|FG000|Overall Study|Adverse Event|5|||
162723390|NCT05323734|587695128|FG001|Overall Study|Adverse Event|2|||
162723391|NCT05323734|587695127|FG000|Overall Study|Physician Decision|1|||
162723392|NCT05323734|587695128|FG001|Overall Study|Physician Decision|0|||
162723393|NCT05323734|587695127|FG000|Overall Study|Lack of Efficacy|1|||
162723394|NCT05323734|587695128|FG001|Overall Study|Lack of Efficacy|2|||
162723395|NCT05323734|587695127|FG000|Overall Study|Withdrawal by Subject|2|||
162723396|NCT05323734|587695128|FG001|Overall Study|Withdrawal by Subject|0|||
162723397|NCT05323734|587695127|FG000|Overall Study|Participant Withdrawn Due|0|||
162723398|NCT05323734|587695128|FG001|Overall Study|Participant Withdrawn Due|1|||
162723399|NCT01595321|587695129|FG000|Overall Study|Adverse Event|1|||
162723400|NCT01595321|587695130|FG001|Overall Study|Adverse Event|1|||
162723401|NCT01595321|587695131|FG002|Overall Study|Adverse Event|1|||
162723402|NCT01595321|587695129|FG000|Overall Study|Lack of Efficacy|0|||
162723403|NCT01595321|587695130|FG001|Overall Study|Lack of Efficacy|0|||
162723404|NCT01595321|587695131|FG002|Overall Study|Lack of Efficacy|4|||
162723405|NCT00834834|587695132|FG000|Overall Study|Withdrawal by Subject|4|||
162723406|NCT00834834|587695133|FG001|Overall Study|Withdrawal by Subject|3|||
162723407|NCT00373529|587695134|FG000|Overall Study|Physician Decision|19|||
162723408|NCT00373529|587695134|FG000|Overall Study|Withdrawal by Subject|7|||
162677453|NCT00447057|587529285|FG002|Overall Study|Withdrawal by Subject|1|||
162677454|NCT00447057|587529286|FG003|Overall Study|Withdrawal by Subject|1|||
162677455|NCT00447057|587529283|FG000|Overall Study|Physician Decision|9|||
162677456|NCT00447057|587529284|FG001|Overall Study|Physician Decision|6|||
162677457|NCT00447057|587529285|FG002|Overall Study|Physician Decision|3|||
162677458|NCT00447057|587529286|FG003|Overall Study|Physician Decision|1|||
162677459|NCT00447057|587529283|FG000|Overall Study|Sponsor decision|1|||
162677460|NCT00447057|587529284|FG001|Overall Study|Sponsor decision|1|||
162677461|NCT00447057|587529285|FG002|Overall Study|Sponsor decision|0|||
162677462|NCT00447057|587529286|FG003|Overall Study|Sponsor decision|0|||
162677463|NCT00447057|587529283|FG000|Overall Study|Progressive disease|58|||
162677464|NCT00447057|587529284|FG001|Overall Study|Progressive disease|43|||
162677465|NCT00447057|587529285|FG002|Overall Study|Progressive disease|13|||
162677466|NCT00447057|587529286|FG003|Overall Study|Progressive disease|18|||
162677467|NCT00447057|587529283|FG000|Overall Study|Death due to adverse event|0|||
162677468|NCT00447057|587529284|FG001|Overall Study|Death due to adverse event|0|||
162677469|NCT00447057|587529285|FG002|Overall Study|Death due to adverse event|1|||
162677470|NCT00447057|587529286|FG003|Overall Study|Death due to adverse event|2|||
162677471|NCT00447057|587529283|FG000|Overall Study|Death, study drug related|0|||
162677472|NCT00447057|587529284|FG001|Overall Study|Death, study drug related|1|||
162677473|NCT00447057|587529285|FG002|Overall Study|Death, study drug related|0|||
162677474|NCT00447057|587529286|FG003|Overall Study|Death, study drug related|0|||
162677475|NCT04493216|587529291|FG000|Overall Study|Study terminated by sponsor|30|||
162677476|NCT04493216|587529292|FG001|Overall Study|Study terminated by sponsor|33|||
162677477|NCT04493216|587529293|FG002|Overall Study|Study terminated by sponsor|28|||
162677478|NCT04493216|587529294|FG003|Overall Study|Study terminated by sponsor|27|||
162677479|NCT04493216|587529291|FG000|Overall Study|Withdrawal by Subject|2|||
162677480|NCT04493216|587529292|FG001|Overall Study|Withdrawal by Subject|1|||
162677481|NCT04493216|587529293|FG002|Overall Study|Withdrawal by Subject|1|||
162677482|NCT04493216|587529294|FG003|Overall Study|Withdrawal by Subject|2|||
162677483|NCT04493216|587529291|FG000|Overall Study|Protocol Violation|1|||
162677484|NCT04493216|587529292|FG001|Overall Study|Protocol Violation|2|||
162677485|NCT04493216|587529293|FG002|Overall Study|Protocol Violation|0|||
162677486|NCT04493216|587529294|FG003|Overall Study|Protocol Violation|2|||
162677487|NCT04493216|587529291|FG000|Overall Study|Physician Decision|0|||
162677488|NCT04493216|587529292|FG001|Overall Study|Physician Decision|0|||
162677489|NCT04493216|587529293|FG002|Overall Study|Physician Decision|1|||
162723409|NCT00373529|587695134|FG000|Overall Study|Adverse Event|7|||
162723410|NCT00373529|587695134|FG000|Overall Study|Treatment failure|36|||
162723411|NCT00373529|587695134|FG000|Overall Study|Disease recurrence|10|||
162723412|NCT00373529|587695134|FG000|Overall Study|Death|16|||
162723413|NCT00373529|587695134|FG000|Overall Study|Need for treatment prohibited by study|1|||
162723414|NCT00373529|587695134|FG000|Overall Study|Other|8|||
162723415|NCT00373529|587695134|FG000|Overall Study|Failed independent confirmation of AML|3|||
162723416|NCT00373529|587695134|FG000|Overall Study|Consent violation|1|||
162723417|NCT04795752|587695135|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
162723418|NCT04795752|587695136|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
162723419|NCT04795752|587695135|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
162723420|NCT04795752|587695136|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
162723421|NCT04795752|587695135|FG000|Primary Endpoint Phase|Physician Decision|2|||
162723422|NCT04795752|587695136|FG001|Primary Endpoint Phase|Physician Decision|0|||
162723423|NCT04795752|587695135|FG000|Primary Endpoint Phase|Other|4|||
162723424|NCT04795752|587695136|FG001|Primary Endpoint Phase|Other|1|||
162723425|NCT04795752|587695135|FG000|Primary Endpoint Phase|Protocol Violation|1|||
162723426|NCT04795752|587695136|FG001|Primary Endpoint Phase|Protocol Violation|0|||
162723427|NCT04795752|587695135|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
162723428|NCT04795752|587695136|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
162723429|NCT04795752|587695135|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
162723430|NCT04795752|587695136|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
162723431|NCT04795752|587695135|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
162723432|NCT04795752|587695136|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
162723433|NCT04795752|587695135|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
162723434|NCT04795752|587695136|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
162723435|NCT04795752|587695135|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
162723436|NCT04795752|587695136|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
162723437|NCT00792948|587695137|FG000|Overall Study|Adverse Event|6|||
162723438|NCT00792948|587695137|FG000|Overall Study|Death|4|||
162723439|NCT00792948|587695137|FG000|Overall Study|Withdrawal by Subject|3|||
162723440|NCT00792948|587695137|FG000|Overall Study|Ineligible|2|||
162723441|NCT00792948|587695137|FG000|Overall Study|Insurance denial - not treated|1|||
162723442|NCT00792948|587695137|FG000|Overall Study|Physician Decision|11|||
162723443|NCT00792948|587695137|FG000|Overall Study|Protocol Violation|1|||
162723444|NCT00841035|587695146|FG000|Phase 1 Overall Study|Physician Decision|13|||
162723445|NCT00433199|587695151|FG000|Double-Blind Period|Adverse Event|0|||
162723446|NCT00433199|587695152|FG001|Double-Blind Period|Adverse Event|25|||
162723447|NCT00433199|587695151|FG000|Double-Blind Period|Lack of Efficacy|0|||
162723448|NCT00433199|587695152|FG001|Double-Blind Period|Lack of Efficacy|2|||
162723449|NCT00433199|587695151|FG000|Double-Blind Period|Lost to Follow-up|2|||
162723450|NCT00433199|587695152|FG001|Double-Blind Period|Lost to Follow-up|5|||
162723451|NCT00433199|587695151|FG000|Double-Blind Period|Withdrawal by Subject|8|||
162723452|NCT00433199|587695152|FG001|Double-Blind Period|Withdrawal by Subject|19|||
162723453|NCT00433199|587695151|FG000|Double-Blind Period|Protocol Violation|1|||
162723454|NCT00433199|587695152|FG001|Double-Blind Period|Protocol Violation|10|||
162723455|NCT00433199|587695151|FG000|Double-Blind Period|Administrative|1|||
162723456|NCT00433199|587695152|FG001|Double-Blind Period|Administrative|5|||
162723457|NCT00433199|587695151|FG000|Open-Label Period|Adverse Event|0|||
162723458|NCT00433199|587695152|FG001|Open-Label Period|Adverse Event|19|||
162723459|NCT00433199|587695151|FG000|Open-Label Period|Lack of Efficacy|0|||
162723460|NCT00433199|587695152|FG001|Open-Label Period|Lack of Efficacy|2|||
162723461|NCT00433199|587695151|FG000|Open-Label Period|Lost to Follow-up|0|||
162723462|NCT00433199|587695152|FG001|Open-Label Period|Lost to Follow-up|3|||
162723463|NCT00433199|587695151|FG000|Open-Label Period|Withdrawal by Subject|0|||
162723464|NCT00433199|587695152|FG001|Open-Label Period|Withdrawal by Subject|7|||
162723465|NCT00433199|587695151|FG000|Open-Label Period|Protocol Violation|0|||
162723466|NCT00433199|587695152|FG001|Open-Label Period|Protocol Violation|2|||
162723467|NCT00433199|587695151|FG000|Open-Label Period|Administrative|0|||
162723468|NCT00433199|587695152|FG001|Open-Label Period|Administrative|1|||
162723469|NCT00357097|587695153|FG000|Overall Study|Did not meet inclusion criteria|5|||
162723470|NCT00357097|587695154|FG001|Overall Study|Did not meet inclusion criteria|3|||
162723471|NCT00357097|587695153|FG000|Overall Study|Adverse Event|34|||
162723472|NCT00357097|587695154|FG001|Overall Study|Adverse Event|6|||
162723473|NCT00357097|587695153|FG000|Overall Study|Withdrawal by Subject|8|||
162723474|NCT00357097|587695154|FG001|Overall Study|Withdrawal by Subject|7|||
162723475|NCT00357097|587695153|FG000|Overall Study|Non-compliance|1|||
162723476|NCT00357097|587695154|FG001|Overall Study|Non-compliance|2|||
162723477|NCT00357097|587695153|FG000|Overall Study|Lack of Efficacy|2|||
162723478|NCT00357097|587695154|FG001|Overall Study|Lack of Efficacy|8|||
162723479|NCT00357097|587695153|FG000|Overall Study|Met Exclusion Criteria|3|||
162723480|NCT00357097|587695154|FG001|Overall Study|Met Exclusion Criteria|1|||
162723481|NCT00357097|587695153|FG000|Overall Study|Other|1|||
162723482|NCT00357097|587695154|FG001|Overall Study|Other|1|||
162723483|NCT00357097|587695153|FG000|Overall Study|Increase of RLS Symptoms|0|||
162723484|NCT00357097|587695154|FG001|Overall Study|Increase of RLS Symptoms|1|||
162723485|NCT00658996|587695155|FG000|First Intervention|Positive slit lamp finding|1|||
162677490|NCT04493216|587529294|FG003|Overall Study|Physician Decision|0|||
162677491|NCT04493216|587529291|FG000|Overall Study|Lost to Follow-up|2|||
162677492|NCT04493216|587529292|FG001|Overall Study|Lost to Follow-up|1|||
162677493|NCT04493216|587529293|FG002|Overall Study|Lost to Follow-up|0|||
162677494|NCT04493216|587529294|FG003|Overall Study|Lost to Follow-up|1|||
162677495|NCT04493216|587529291|FG000|Overall Study|Adverse Event|1|||
162677496|NCT04493216|587529292|FG001|Overall Study|Adverse Event|4|||
162677497|NCT04493216|587529293|FG002|Overall Study|Adverse Event|5|||
162677498|NCT04493216|587529294|FG003|Overall Study|Adverse Event|2|||
162677499|NCT04493216|587529291|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
162677500|NCT04493216|587529292|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
162677501|NCT04493216|587529293|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
162677502|NCT04493216|587529294|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
162677503|NCT04605978|587529297|FG000|Overall Study|Adverse Event|2|||
162677504|NCT04605978|587529298|FG001|Overall Study|Adverse Event|1|||
162677505|NCT04605978|587529297|FG000|Overall Study|Withdrawal nonmedical reason|1|||
162677506|NCT04605978|587529298|FG001|Overall Study|Withdrawal nonmedical reason|1|||
162677507|NCT01690130|587529299|FG000|Overall Study|Subject have cancelled visit.|1|||
162677508|NCT01690130|587529300|FG001|Overall Study|Subject have cancelled visit.|0|||
162677509|NCT02216123|587529301|FG000|Overall Study|Lost to Follow-up|4|||
162677510|NCT02216123|587529302|FG001|Overall Study|Lost to Follow-up|2|||
162677511|NCT02216123|587529301|FG000|Overall Study|Withdrawal by Subject|2|||
162677512|NCT02216123|587529302|FG001|Overall Study|Withdrawal by Subject|0|||
162677513|NCT03318523|587529305|FG000|PC Period: Up to Year 1|Adverse Event|1|||
162677514|NCT03318523|587529306|FG001|PC Period: Up to Year 1|Adverse Event|0|||
162677515|NCT03318523|587529307|FG002|PC Period: Up to Year 1|Adverse Event|2|||
162677516|NCT03318523|587529308|FG003|PC Period: Up to Year 1|Adverse Event|0|||
162677517|NCT03318523|587529309|FG004|PC Period: Up to Year 1|Adverse Event|0|||
162677518|NCT03318523|587529310|FG005|PC Period: Up to Year 1|Adverse Event|0|||
162677519|NCT03318523|587529311|FG006|PC Period: Up to Year 1|Adverse Event|0|||
162677520|NCT03318523|587529312|FG007|PC Period: Up to Year 1|Adverse Event|0|||
162677521|NCT03318523|587529313|FG008|PC Period: Up to Year 1|Adverse Event|0|||
162677522|NCT03318523|587529314|FG009|PC Period: Up to Year 1|Adverse Event|0|||
162677523|NCT03318523|587529305|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
162677524|NCT03318523|587529306|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
162677525|NCT03318523|587529307|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677526|NCT03318523|587529308|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
162677527|NCT03318523|587529309|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677528|NCT03318523|587529310|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677529|NCT03318523|587529311|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677530|NCT03318523|587529312|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677531|NCT03318523|587529313|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677532|NCT03318523|587529314|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
162677533|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677534|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677535|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677536|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677537|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
162677538|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677539|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677540|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
162677541|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162677542|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
162677543|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677544|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677545|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677546|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677547|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
162677548|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677549|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162677550|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
162677551|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
162677552|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
162677553|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677554|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677555|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677556|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677557|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677558|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
162677559|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677560|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677561|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677562|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162677563|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677564|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677565|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677566|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677567|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677568|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677569|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677570|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677571|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162677572|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
162677573|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162677574|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162677575|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162677576|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162677577|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
162677578|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
162677579|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
162677580|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
162677581|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
162677582|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
162677583|NCT03318523|587529305|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677584|NCT03318523|587529306|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677585|NCT03318523|587529307|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677586|NCT03318523|587529308|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677587|NCT03318523|587529309|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
162677588|NCT03318523|587529310|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677589|NCT03318523|587529311|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677590|NCT03318523|587529312|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
162677591|NCT03318523|587529313|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
162677592|NCT03318523|587529314|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162677593|NCT02163733|587529315|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
162677594|NCT02163733|587529316|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
162677595|NCT02163733|587529317|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
162677596|NCT02163733|587529315|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
162677597|NCT02163733|587529316|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
162677598|NCT02163733|587529317|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
162677599|NCT00487162|587529321|FG000|Overall Study|Adverse Event|0|||
162677600|NCT00487162|587529322|FG001|Overall Study|Adverse Event|1|||
162677601|NCT00487162|587529321|FG000|Overall Study|Physician Decision|0|||
162677602|NCT00487162|587529322|FG001|Overall Study|Physician Decision|1|||
162677603|NCT00487162|587529321|FG000|Overall Study|Withdrawal by Subject|2|||
162677604|NCT00487162|587529322|FG001|Overall Study|Withdrawal by Subject|3|||
162677605|NCT00530855|587529323|FG000|Overall Study|Lack of Efficacy|20|||
162677606|NCT00530855|587529323|FG000|Overall Study|Withdrawal by Subject|30|||
162677607|NCT00530855|587529323|FG000|Overall Study|Fatal Serious AE|3|||
162677608|NCT00530855|587529323|FG000|Overall Study|Non Fatal Serious AE|7|||
162677609|NCT00530855|587529323|FG000|Overall Study|Non Fatal Non Serious AE|12|||
162677610|NCT00530855|587529323|FG000|Overall Study|Protocol Violation|3|||
162677611|NCT00530855|587529323|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
162677612|NCT00530855|587529323|FG000|Overall Study|Lost to Follow-up|9|||
162677613|NCT00530855|587529323|FG000|Overall Study|Other reason for premature termination|17|||
162677614|NCT01654549|587529342|FG000|Overall Study|H.pylori eradication not successful|0|||
162677615|NCT01654549|587529343|FG001|Overall Study|H.pylori eradication not successful|1|||
162677616|NCT03152526|587529344|FG000|Overall Study|Withdrawal by Subject|0|||
162677617|NCT03152526|587529345|FG001|Overall Study|Withdrawal by Subject|1|||
162677618|NCT05554237|587529346|FG000|Part 2 (7 Days)|Adverse Event|0|||
162677619|NCT05554237|587529347|FG001|Part 2 (7 Days)|Adverse Event|0|||
162677620|NCT05554237|587529348|FG002|Part 2 (7 Days)|Adverse Event|0|||
162677621|NCT05554237|587529349|FG003|Part 2 (7 Days)|Adverse Event|0|||
162677622|NCT05554237|587529350|FG004|Part 2 (7 Days)|Adverse Event|2|||
162677623|NCT05554237|587529351|FG005|Part 2 (7 Days)|Adverse Event|0|||
162677624|NCT05554237|587529352|FG006|Part 2 (7 Days)|Adverse Event|0|||
162677625|NCT05554237|587529353|FG007|Part 2 (7 Days)|Adverse Event|0|||
162677626|NCT05554237|587529354|FG008|Part 2 (7 Days)|Adverse Event|0|||
162677627|NCT05554237|587529355|FG009|Part 2 (7 Days)|Adverse Event|1|||
162677628|NCT05554237|587529356|FG010|Part 2 (7 Days)|Adverse Event|0|||
162677629|NCT05554237|587529357|FG011|Part 2 (7 Days)|Adverse Event|0|||
162677630|NCT05554237|587529358|FG012|Part 2 (7 Days)|Adverse Event|1|||
162677631|NCT05554237|587529359|FG013|Part 2 (7 Days)|Adverse Event|0|||
162677632|NCT05130970|587529360|FG000|Overall Study|Adverse Event|1|||
162677633|NCT05130970|587529361|FG001|Overall Study|Adverse Event|1|||
162677634|NCT05130970|587529360|FG000|Overall Study|Death|0|||
162677635|NCT05130970|587529361|FG001|Overall Study|Death|1|||
162677636|NCT05130970|587529360|FG000|Overall Study|Lost to Follow-up|0|||
162677637|NCT05130970|587529361|FG001|Overall Study|Lost to Follow-up|1|||
162677638|NCT05130970|587529360|FG000|Overall Study|Physician Decision|0|||
162677639|NCT05130970|587529361|FG001|Overall Study|Physician Decision|1|||
162677640|NCT05130970|587529360|FG000|Overall Study|Withdrawal by Subject|1|||
162677641|NCT05130970|587529361|FG001|Overall Study|Withdrawal by Subject|1|||
162677642|NCT04969198|587529362|FG000|Overall Study|Withdrawal by Subject|20|||
162677643|NCT04969198|587529362|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
162677644|NCT04969198|587529362|FG000|Overall Study|Lost to Follow-up|20|||
162677645|NCT02701985|587529363|FG000|Overall Study|Withdrawal by Subject|1|||
162677646|NCT02701985|587529364|FG001|Overall Study|Withdrawal by Subject|1|||
162677647|NCT02701985|587529363|FG000|Overall Study|Lost to Follow-up|1|||
162723486|NCT00658996|587695156|FG001|First Intervention|Positive slit lamp finding|0|||
162723487|NCT00658996|587695155|FG000|First Intervention|Lack of lenses|0|||
162723488|NCT00658996|587695156|FG001|First Intervention|Lack of lenses|1|||
162723489|NCT00658996|587695155|FG000|Crossover Period|Physician Decision|1|||
162723490|NCT00658996|587695156|FG001|Crossover Period|Physician Decision|0|||
162723491|NCT00658996|587695155|FG000|Crossover Period|Ineligible|1|||
162723492|NCT00658996|587695156|FG001|Crossover Period|Ineligible|1|||
162723493|NCT00658996|587695155|FG000|Second Intervention|Developed a stye on upper lid|1|||
162723494|NCT00658996|587695156|FG001|Second Intervention|Developed a stye on upper lid|0|||
162723495|NCT00658996|587695155|FG000|Second Intervention|Positive slit lamp finding|0|||
162723496|NCT00658996|587695156|FG001|Second Intervention|Positive slit lamp finding|1|||
162723497|NCT03603717|587695163|FG000|Overall Study|Lost to Follow-up|20|||
162723498|NCT03603717|587695164|FG001|Overall Study|Lost to Follow-up|20|||
162723499|NCT03603717|587695163|FG000|Overall Study|Withdrawal by Subject|16|||
162723500|NCT03603717|587695164|FG001|Overall Study|Withdrawal by Subject|10|||
162723501|NCT01810263|587695165|FG000|Overall Study|Lost to Follow-up|8|||
162723502|NCT01810263|587695166|FG001|Overall Study|Lost to Follow-up|7|||
162723503|NCT00457691|587695167|FG000|Overall Study|Adverse Event|4|||
162723504|NCT00457691|587695168|FG001|Overall Study|Adverse Event|1|||
162723505|NCT00457691|587695167|FG000|Overall Study|Death|163|||
162723506|NCT00457691|587695168|FG001|Overall Study|Death|148|||
162723507|NCT00457691|587695167|FG000|Overall Study|Protocol Violation|1|||
162723508|NCT00457691|587695168|FG001|Overall Study|Protocol Violation|3|||
162723509|NCT00457691|587695167|FG000|Overall Study|Lost to Follow-up|23|||
162723510|NCT00457691|587695168|FG001|Overall Study|Lost to Follow-up|14|||
162723511|NCT00457691|587695167|FG000|Overall Study|Study terminated by Sponsor|1|||
162723512|NCT00457691|587695168|FG001|Overall Study|Study terminated by Sponsor|1|||
162723513|NCT00457691|587695167|FG000|Overall Study|Subject refused (reason other than AE)|14|||
162723514|NCT00457691|587695168|FG001|Overall Study|Subject refused (reason other than AE)|19|||
162723515|NCT00457691|587695167|FG000|Overall Study|Disease progression, study terminated|180|||
162723516|NCT00457691|587695168|FG001|Overall Study|Disease progression, study terminated|196|||
162723517|NCT00414544|587696271|FG000|Overall Study|Lost to Follow-up|14|||
162723518|NCT01599104|587696272|FG000|Overall Study|Withdrawal by Subject|1|||
162723519|NCT01599104|587696273|FG001|Overall Study|Withdrawal by Subject|1|||
162723520|NCT01599104|587696274|FG002|Overall Study|Withdrawal by Subject|2|||
162723521|NCT01599104|587696272|FG000|Overall Study|Technical Problems|1|||
162723522|NCT01599104|587696273|FG001|Overall Study|Technical Problems|0|||
162723523|NCT01599104|587696274|FG002|Overall Study|Technical Problems|0|||
162723524|NCT01599104|587696272|FG000|Overall Study|Physician Decision|3|||
162723525|NCT01599104|587696273|FG001|Overall Study|Physician Decision|2|||
162723526|NCT01599104|587696274|FG002|Overall Study|Physician Decision|2|||
162723527|NCT01599104|587696272|FG000|Overall Study|Non-compliance with study treatment|0|||
162723528|NCT01599104|587696273|FG001|Overall Study|Non-compliance with study treatment|1|||
162723529|NCT01599104|587696274|FG002|Overall Study|Non-compliance with study treatment|0|||
162723530|NCT01599104|587696272|FG000|Overall Study|Lack of Efficacy|4|||
162723531|NCT01599104|587696273|FG001|Overall Study|Lack of Efficacy|4|||
162723532|NCT01599104|587696274|FG002|Overall Study|Lack of Efficacy|10|||
162723533|NCT01599104|587696272|FG000|Overall Study|Adverse Event|7|||
162723534|NCT01599104|587696273|FG001|Overall Study|Adverse Event|6|||
162723535|NCT01599104|587696274|FG002|Overall Study|Adverse Event|12|||
162723536|NCT00714714|587696275|FG000|Overall Study|Adverse Event|1|||
162723537|NCT00585052|587696278|FG000|Overall Study|Withdrawal by Subject|1|||
162723538|NCT02616900|587696279|FG000|Overall Study|Lack of Efficacy|7|||
162723539|NCT02616900|587696279|FG000|Overall Study|Lost to Follow-up|2|||
162723540|NCT02616900|587696279|FG000|Overall Study|Protocol Violation|5|||
162723541|NCT02616900|587696279|FG000|Overall Study|Withdrawal by Subject|3|||
162723542|NCT02616900|587696279|FG000|Overall Study|Incomplete data|6|||
162723543|NCT04425863|587696280|FG000|Overall Study|Death|0|||
162723544|NCT04425863|587696281|FG001|Overall Study|Death|0|||
162723545|NCT04425863|587696282|FG002|Overall Study|Death|1|||
162723546|NCT02613871|587696284|FG000|Overall Study|Death|2|||
162723547|NCT02613871|587696284|FG000|Overall Study|Withdrew Consent|1|||
162723548|NCT02527148|587696285|FG000|Overall Study|Did not receive study intervention|1|||
162723549|NCT02527148|587696286|FG001|Overall Study|Did not receive study intervention|0|||
162723550|NCT02918279|587696287|FG000|Overall Study|Lost to Follow-up|3|||
162723551|NCT02918279|587696288|FG001|Overall Study|Lost to Follow-up|6|||
162723552|NCT02918279|587696287|FG000|Overall Study|Withdrawal by Subject|5|||
162723553|NCT02918279|587696288|FG001|Overall Study|Withdrawal by Subject|15|||
162723554|NCT02918279|587696287|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162723555|NCT02918279|587696288|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162723556|NCT02918279|587696287|FG000|Overall Study|Other|3|||
162723557|NCT02918279|587696288|FG001|Overall Study|Other|1|||
162723558|NCT00309907|587696289|FG000|Overall Study|Death|4|||
162723559|NCT00309907|587696289|FG000|Overall Study|Physician Decision|1|||
162723560|NCT00309907|587696289|FG000|Overall Study|Ineligible|11|||
162723561|NCT00309907|587696289|FG000|Overall Study|Major infectious event|4|||
162723562|NCT00494780|587696290|FG000|Overall Study|Adverse Event|1|||
162723563|NCT00494780|587696291|FG001|Overall Study|Adverse Event|0|||
162723564|NCT00494780|587696290|FG000|Overall Study|Withdrew before Dosed|0|||
162723565|NCT00494780|587696291|FG001|Overall Study|Withdrew before Dosed|1|||
162723566|NCT00494780|587696290|FG000|Overall Study|Progression of Study Disease|7|||
162723567|NCT00494780|587696291|FG001|Overall Study|Progression of Study Disease|8|||
162723568|NCT00494780|587696290|FG000|Overall Study|New Treatment|2|||
162723569|NCT00494780|587696291|FG001|Overall Study|New Treatment|2|||
162723570|NCT00494780|587696290|FG000|Overall Study|Non-compliance|1|||
162723571|NCT00494780|587696291|FG001|Overall Study|Non-compliance|0|||
162723572|NCT00494780|587696290|FG000|Overall Study|Residual Tumour Mass|0|||
162723573|NCT00494780|587696291|FG001|Overall Study|Residual Tumour Mass|1|||
162723574|NCT00494780|587696290|FG000|Overall Study|Insurance Issues|0|||
162723575|NCT00494780|587696291|FG001|Overall Study|Insurance Issues|1|||
162723576|NCT00869258|587696292|FG000|Overall Study|Physician Decision|1|||
162723577|NCT01641198|587696293|FG000|After 12 Months of Function|Lost to Follow-up|3|||
162723578|NCT01641198|587696294|FG001|After 12 Months of Function|Lost to Follow-up|2|||
162723579|NCT01641198|587696295|FG002|After 12 Months of Function|Lost to Follow-up|2|||
162723580|NCT01641198|587696293|FG000|After 12 Months of Function|Protocol Violation|1|||
162723581|NCT01641198|587696294|FG001|After 12 Months of Function|Protocol Violation|0|||
162723582|NCT01641198|587696295|FG002|After 12 Months of Function|Protocol Violation|0|||
162723583|NCT01641198|587696293|FG000|After 12 Months of Function|Adverse Event|0|||
162723584|NCT01641198|587696294|FG001|After 12 Months of Function|Adverse Event|1|||
162723585|NCT01641198|587696295|FG002|After 12 Months of Function|Adverse Event|0|||
162723586|NCT01641198|587696293|FG000|After 24 Months of Function|Lost to Follow-up|4|||
162723587|NCT01641198|587696294|FG001|After 24 Months of Function|Lost to Follow-up|9|||
162723588|NCT01641198|587696295|FG002|After 24 Months of Function|Lost to Follow-up|6|||
162723589|NCT01641198|587696293|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
162723590|NCT01641198|587696294|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
162723591|NCT01641198|587696295|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
162723592|NCT01641198|587696293|FG000|At 15-20 Years of Function|Death|1|||
162723593|NCT01641198|587696294|FG001|At 15-20 Years of Function|Death|0|||
162723594|NCT01641198|587696295|FG002|At 15-20 Years of Function|Death|1|||
162723595|NCT00980330|587696297|FG000|Overall Study|Adverse Event|0|||
162723596|NCT00980330|587696298|FG001|Overall Study|Adverse Event|0|||
162723597|NCT00980330|587696299|FG002|Overall Study|Adverse Event|0|||
162723598|NCT00980330|587696300|FG003|Overall Study|Adverse Event|1|||
162723599|NCT00980330|587696301|FG004|Overall Study|Adverse Event|0|||
162723600|NCT00980330|587696302|FG005|Overall Study|Adverse Event|0|||
162723601|NCT00980330|587696303|FG006|Overall Study|Adverse Event|0|||
162723602|NCT00980330|587696297|FG000|Overall Study|Lost to Follow-up|1|||
162723603|NCT00980330|587696298|FG001|Overall Study|Lost to Follow-up|1|||
162723604|NCT00980330|587696299|FG002|Overall Study|Lost to Follow-up|4|||
162723605|NCT00980330|587696300|FG003|Overall Study|Lost to Follow-up|2|||
162723606|NCT00980330|587696301|FG004|Overall Study|Lost to Follow-up|1|||
162723607|NCT00980330|587696302|FG005|Overall Study|Lost to Follow-up|1|||
162723608|NCT00980330|587696303|FG006|Overall Study|Lost to Follow-up|2|||
162723609|NCT00980330|587696297|FG000|Overall Study|Withdrawal by Subject|2|||
162723610|NCT00980330|587696298|FG001|Overall Study|Withdrawal by Subject|4|||
162723611|NCT00980330|587696299|FG002|Overall Study|Withdrawal by Subject|4|||
162723612|NCT00980330|587696300|FG003|Overall Study|Withdrawal by Subject|1|||
162723613|NCT00980330|587696301|FG004|Overall Study|Withdrawal by Subject|3|||
162723614|NCT00980330|587696302|FG005|Overall Study|Withdrawal by Subject|2|||
162723615|NCT00980330|587696303|FG006|Overall Study|Withdrawal by Subject|5|||
162723616|NCT00980330|587696297|FG000|Overall Study|(not specified)|2|||
162723617|NCT00980330|587696298|FG001|Overall Study|(not specified)|0|||
162723618|NCT00980330|587696299|FG002|Overall Study|(not specified)|0|||
162723619|NCT00980330|587696300|FG003|Overall Study|(not specified)|1|||
162723620|NCT00980330|587696301|FG004|Overall Study|(not specified)|1|||
162723621|NCT00980330|587696302|FG005|Overall Study|(not specified)|1|||
162723622|NCT00980330|587696303|FG006|Overall Study|(not specified)|0|||
162723623|NCT00346151|587696304|FG000|Overall Study|Withdrawal by Subject|3|||
162723624|NCT01075217|587696305|FG000|Overall Study|Adverse Event|1|||
162723625|NCT01075217|587696306|FG001|Overall Study|Adverse Event|1|||
162723626|NCT01075217|587696305|FG000|Overall Study|Physician Decision|1|||
162723627|NCT01075217|587696306|FG001|Overall Study|Physician Decision|0|||
162723628|NCT03260140|587696308|FG000|Overall Study|Death|4|||
162723629|NCT03260140|587696309|FG001|Overall Study|Death|1|||
162723630|NCT03260140|587696308|FG000|Overall Study|Withdrawal by Subject|1|||
162723631|NCT03260140|587696309|FG001|Overall Study|Withdrawal by Subject|4|||
162723632|NCT01692938|587696319|FG000|Overall Study|Protocol Deviation|1|||
162723633|NCT01692938|587696320|FG001|Overall Study|Protocol Deviation|1|||
162723634|NCT01692938|587696319|FG000|Overall Study|Study completed prior to site completion|3|||
162723635|NCT01692938|587696320|FG001|Overall Study|Study completed prior to site completion|3|||
162723636|NCT01444417|587696325|FG000|Overall Study|Ineligibility Determined|0|||
162723637|NCT01444417|587696326|FG001|Overall Study|Ineligibility Determined|1|||
162723638|NCT01444417|587696325|FG000|Overall Study|Withdrawal by Subject|2|||
162723639|NCT01444417|587696326|FG001|Overall Study|Withdrawal by Subject|0|||
162723640|NCT02423291|587696327|FG000|Overall Study|Lack of Efficacy|14|||
162723641|NCT02423291|587696327|FG000|Overall Study|Adverse Event|1|||
162723642|NCT02214160|587696330|FG000|Overall Study|Withdrawal by Subject|1|||
162723643|NCT02214160|587696331|FG001|Overall Study|Withdrawal by Subject|0|||
162723644|NCT02214160|587696332|FG002|Overall Study|Withdrawal by Subject|6|||
162723645|NCT02214160|587696330|FG000|Overall Study|Death|2|||
162723646|NCT02214160|587696331|FG001|Overall Study|Death|2|||
162723647|NCT02214160|587696332|FG002|Overall Study|Death|1|||
162723648|NCT02214160|587696330|FG000|Overall Study|Subject Non-Compliance|0|||
162723649|NCT02214160|587696331|FG001|Overall Study|Subject Non-Compliance|3|||
162723650|NCT02214160|587696332|FG002|Overall Study|Subject Non-Compliance|1|||
162723651|NCT02214160|587696330|FG000|Overall Study|Adverse Event|0|||
162723652|NCT02214160|587696331|FG001|Overall Study|Adverse Event|1|||
162723653|NCT02214160|587696332|FG002|Overall Study|Adverse Event|1|||
162723654|NCT02214160|587696330|FG000|Overall Study|Sponsor Decision|0|||
162723655|NCT02214160|587696331|FG001|Overall Study|Sponsor Decision|2|||
162723656|NCT02214160|587696332|FG002|Overall Study|Sponsor Decision|0|||
162723657|NCT02214160|587696330|FG000|Overall Study|Protocol Violation|1|||
162723658|NCT02214160|587696331|FG001|Overall Study|Protocol Violation|0|||
162723659|NCT02214160|587696332|FG002|Overall Study|Protocol Violation|0|||
162723660|NCT02214160|587696330|FG000|Overall Study|Physician Decision|0|||
162723661|NCT02214160|587696331|FG001|Overall Study|Physician Decision|0|||
162723662|NCT02214160|587696332|FG002|Overall Study|Physician Decision|1|||
162723663|NCT01063972|587696333|FG000|Overall Study|Death|12|||
162723664|NCT01063972|587696334|FG001|Overall Study|Death|11|||
162723665|NCT01063972|587696333|FG000|Overall Study|Incarcerated|2|||
162723666|NCT01063972|587696334|FG001|Overall Study|Incarcerated|1|||
162723667|NCT01510717|587696336|FG000|Overall Study|Adverse Event|1|||
162723668|NCT01510717|587696337|FG001|Overall Study|Adverse Event|2|||
162723669|NCT01510717|587696336|FG000|Overall Study|Death|1|||
162723670|NCT01510717|587696337|FG001|Overall Study|Death|0|||
162723671|NCT01510717|587696336|FG000|Overall Study|Lost to Follow-up|0|||
162723672|NCT01510717|587696337|FG001|Overall Study|Lost to Follow-up|1|||
162723673|NCT01510717|587696336|FG000|Overall Study|Withdrawal by Subject|0|||
162723674|NCT01510717|587696337|FG001|Overall Study|Withdrawal by Subject|2|||
162723675|NCT01430611|587696339|FG000|Overall Study|Adverse Event|0|||
162723676|NCT01430611|587696340|FG001|Overall Study|Adverse Event|1|||
162723677|NCT01430611|587696339|FG000|Overall Study|Protocol Violation|1|||
162723678|NCT01430611|587696340|FG001|Overall Study|Protocol Violation|0|||
162723679|NCT01430611|587696339|FG000|Overall Study|Lost to Follow-up|1|||
162723680|NCT01430611|587696340|FG001|Overall Study|Lost to Follow-up|0|||
162723681|NCT01430611|587696339|FG000|Overall Study|Withdrawal by Subject|15|||
162723682|NCT01430611|587696340|FG001|Overall Study|Withdrawal by Subject|14|||
162723683|NCT02115139|587696341|FG000|Overall Study|Protocol Violation|1|||
162723684|NCT02115139|587696341|FG000|Overall Study|treatment discontinuation|6|||
162723685|NCT04740164|587696342|FG000|Overall Study|Lack of Efficacy|4|||
162723686|NCT04740164|587696343|FG001|Overall Study|Lack of Efficacy|0|||
162723687|NCT04740164|587696342|FG000|Overall Study|Physician Decision|3|||
162723688|NCT04740164|587696343|FG001|Overall Study|Physician Decision|3|||
162723689|NCT00258895|587696349|FG000|Overall Study|Lost to Follow-up|3|||
162723690|NCT00258895|587696350|FG001|Overall Study|Lost to Follow-up|1|||
162723691|NCT00258895|587696349|FG000|Overall Study|Protocol Violation|6|||
162723692|NCT00258895|587696350|FG001|Overall Study|Protocol Violation|2|||
162723693|NCT00258895|587696349|FG000|Overall Study|Withdrawal by Subject|1|||
162723694|NCT00258895|587696350|FG001|Overall Study|Withdrawal by Subject|0|||
162723695|NCT00442117|587696351|FG000|Overall Study|Adverse Event|3|||
162723696|NCT00442117|587696352|FG001|Overall Study|Adverse Event|2|||
162723697|NCT00442117|587696351|FG000|Overall Study|Lack of Efficacy|2|||
162723698|NCT00442117|587696352|FG001|Overall Study|Lack of Efficacy|6|||
162723699|NCT00442117|587696351|FG000|Overall Study|Lost to Follow-up|1|||
162723700|NCT00442117|587696352|FG001|Overall Study|Lost to Follow-up|2|||
162723701|NCT00442117|587696351|FG000|Overall Study|Withdrawal by Subject|2|||
162723702|NCT00442117|587696352|FG001|Overall Study|Withdrawal by Subject|2|||
162723703|NCT00442117|587696351|FG000|Overall Study|Major Deviation|25|||
162723704|NCT00442117|587696352|FG001|Overall Study|Major Deviation|20|||
162723705|NCT00442117|587696351|FG000|Overall Study|Non compliance with protocol|3|||
162723706|NCT00442117|587696352|FG001|Overall Study|Non compliance with protocol|5|||
162723707|NCT00442117|587696351|FG000|Overall Study|Met Withdrawal Criteria|2|||
162723708|NCT00442117|587696352|FG001|Overall Study|Met Withdrawal Criteria|1|||
162723709|NCT01121549|587696361|FG000|Overall Study|Adverse Event|10|||
162723710|NCT01121549|587696361|FG000|Overall Study|Lack of Efficacy|11|||
162723711|NCT01121549|587696361|FG000|Overall Study|Lost to Follow-up|12|||
162723712|NCT01121549|587696361|FG000|Overall Study|Did not meet entrance criteria|9|||
162723713|NCT01121549|587696361|FG000|Overall Study|Study terminated by sponsor|197|||
162723714|NCT01121549|587696361|FG000|Overall Study|Pregnancy|1|||
162723715|NCT01121549|587696361|FG000|Overall Study|Protocol Violation|33|||
162723716|NCT01121549|587696361|FG000|Overall Study|Withdrawal by Subject|16|||
162723717|NCT01121549|587696361|FG000|Overall Study|Other|58|||
162723718|NCT02763319|587697708|FG000|Overall Study|Adverse Event|12|||
162677648|NCT02701985|587529364|FG001|Overall Study|Lost to Follow-up|0|||
162677649|NCT02701985|587529363|FG000|Overall Study|Death|1|||
162677650|NCT02701985|587529364|FG001|Overall Study|Death|0|||
162677651|NCT02701985|587529363|FG000|Overall Study|Adverse Event|0|||
162677652|NCT02701985|587529364|FG001|Overall Study|Adverse Event|5|||
162677653|NCT01640808|587529365|FG000|Overall Study|Unable to continue dynamic CT|14|||
162677654|NCT01640808|587529366|FG001|Overall Study|Unable to continue dynamic CT|4|||
162677655|NCT01640808|587529365|FG000|Overall Study|Withdrawal by Subject|12|||
162677656|NCT01640808|587529366|FG001|Overall Study|Withdrawal by Subject|4|||
162677657|NCT01640808|587529365|FG000|Overall Study|Lost to Follow-up|4|||
162677658|NCT01640808|587529366|FG001|Overall Study|Lost to Follow-up|0|||
162677659|NCT01640808|587529365|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
162677660|NCT01640808|587529366|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
162677661|NCT01640808|587529365|FG000|Overall Study|Administration of anticancer drugs|2|||
162677662|NCT01640808|587529366|FG001|Overall Study|Administration of anticancer drugs|1|||
162677663|NCT01640808|587529365|FG000|Overall Study|Physician Decision|19|||
162677664|NCT01640808|587529366|FG001|Overall Study|Physician Decision|5|||
162677665|NCT01640808|587529365|FG000|Overall Study|Randomized but not treated|4|||
162677666|NCT01640808|587529366|FG001|Overall Study|Randomized but not treated|2|||
162677667|NCT01381692|587529368|FG000|Overall Study|Adverse Event|1|||
162677668|NCT01381692|587529369|FG001|Overall Study|Adverse Event|0|||
162677669|NCT01381692|587529370|FG002|Overall Study|Adverse Event|0|||
162677670|NCT01381692|587529371|FG003|Overall Study|Adverse Event|0|||
162677671|NCT01381692|587529372|FG004|Overall Study|Adverse Event|0|||
162677672|NCT01381692|587529373|FG005|Overall Study|Adverse Event|0|||
162677673|NCT01362140|587529374|FG000|Overall Study|Noncompliance|1|||
162677674|NCT01362140|587529375|FG001|Overall Study|Noncompliance|0|||
162677675|NCT01362140|587529374|FG000|Overall Study|Adverse Event|2|||
162677676|NCT01362140|587529375|FG001|Overall Study|Adverse Event|2|||
162677677|NCT01362140|587529374|FG000|Overall Study|Withdrawal by Subject|3|||
162677678|NCT01362140|587529375|FG001|Overall Study|Withdrawal by Subject|3|||
162677679|NCT01362140|587529374|FG000|Overall Study|Administrative Decision|0|||
162677680|NCT01362140|587529375|FG001|Overall Study|Administrative Decision|1|||
162677681|NCT01362140|587529374|FG000|Overall Study|Death|2|||
162677682|NCT01362140|587529375|FG001|Overall Study|Death|1|||
162677683|NCT01362140|587529374|FG000|Overall Study|Other|1|||
162677684|NCT01362140|587529375|FG001|Overall Study|Other|1|||
162677685|NCT01362140|587529374|FG000|Overall Study|Protocol-specified Criteria|1|||
162677686|NCT01362140|587529375|FG001|Overall Study|Protocol-specified Criteria|2|||
162677687|NCT01362140|587529374|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
162677688|NCT01362140|587529375|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
162677689|NCT01556438|587529376|FG000|Overall Study|Adverse Event|4|||
162677690|NCT01556438|587529377|FG001|Overall Study|Adverse Event|2|||
162677691|NCT01556438|587529376|FG000|Overall Study|Sponsor Decision|0|||
162677692|NCT01556438|587529377|FG001|Overall Study|Sponsor Decision|2|||
162677693|NCT01556438|587529376|FG000|Overall Study|Progressive Disease|0|||
162677694|NCT01556438|587529377|FG001|Overall Study|Progressive Disease|6|||
162677695|NCT01556438|587529376|FG000|Overall Study|Death|0|||
162677696|NCT01556438|587529377|FG001|Overall Study|Death|1|||
162677697|NCT01388816|587529378|FG000|Overall Study|Adverse Event|0|||
162677698|NCT01388816|587529379|FG001|Overall Study|Adverse Event|2|||
162677699|NCT01388816|587529380|FG002|Overall Study|Adverse Event|0|||
162677700|NCT01388816|587529381|FG003|Overall Study|Adverse Event|0|||
162677701|NCT01388816|587529378|FG000|Overall Study|Lost to Follow-up|0|||
162677702|NCT01388816|587529379|FG001|Overall Study|Lost to Follow-up|1|||
162677703|NCT01388816|587529380|FG002|Overall Study|Lost to Follow-up|0|||
162677704|NCT01388816|587529381|FG003|Overall Study|Lost to Follow-up|0|||
162677705|NCT01388816|587529378|FG000|Overall Study|Withdrawal by Subject|2|||
162677706|NCT01388816|587529379|FG001|Overall Study|Withdrawal by Subject|1|||
162677707|NCT01388816|587529380|FG002|Overall Study|Withdrawal by Subject|1|||
162677708|NCT01388816|587529381|FG003|Overall Study|Withdrawal by Subject|0|||
162677709|NCT01388816|587529378|FG000|Overall Study|Protocol Violation|0|||
162677710|NCT01388816|587529379|FG001|Overall Study|Protocol Violation|0|||
162677711|NCT01388816|587529380|FG002|Overall Study|Protocol Violation|2|||
162677712|NCT01388816|587529381|FG003|Overall Study|Protocol Violation|0|||
162677713|NCT00743366|587529382|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
162677714|NCT00743366|587529383|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
162677715|NCT01328574|587529384|FG000|Overall Study|Refused further treatment|1|||
162677716|NCT03206203|587529385|FG000|Treatment|Death|38|||
162677717|NCT03206203|587529386|FG001|Treatment|Death|26|||
162677718|NCT03206203|587529387|FG002|Treatment|Death|0|||
162677719|NCT03206203|587529385|FG000|Treatment|Withdrawal by Subject|1|||
162677720|NCT03206203|587529386|FG001|Treatment|Withdrawal by Subject|0|||
162677721|NCT03206203|587529387|FG002|Treatment|Withdrawal by Subject|0|||
162677722|NCT03206203|587529385|FG000|Treatment|Lost to Follow-up|4|||
162677723|NCT03206203|587529386|FG001|Treatment|Lost to Follow-up|0|||
162677724|NCT03206203|587529387|FG002|Treatment|Lost to Follow-up|0|||
162677725|NCT03206203|587529385|FG000|Treatment|N/A in Follow-Up|8|||
162677726|NCT03206203|587529386|FG001|Treatment|N/A in Follow-Up|1|||
162677727|NCT03206203|587529387|FG002|Treatment|N/A in Follow-Up|0|||
162677728|NCT03206203|587529385|FG000|Treatment|Disease progression|0|||
162677729|NCT03206203|587529386|FG001|Treatment|Disease progression|1|||
162677730|NCT03206203|587529387|FG002|Treatment|Disease progression|0|||
162677731|NCT03206203|587529385|FG000|Treatment|Refused follow-up|0|||
162677732|NCT03206203|587529386|FG001|Treatment|Refused follow-up|1|||
162677733|NCT03206203|587529387|FG002|Treatment|Refused follow-up|0|||
162677734|NCT03206203|587529385|FG000|Treatment|Cross over to Arm 1|0|||
162677735|NCT03206203|587529386|FG001|Treatment|Cross over to Arm 1|19|||
162677736|NCT03206203|587529387|FG002|Treatment|Cross over to Arm 1|0|||
162677737|NCT03206203|587529385|FG000|Optional Cross-Over|Death|0|||
162677738|NCT03206203|587529386|FG001|Optional Cross-Over|Death|0|||
162677739|NCT03206203|587529387|FG002|Optional Cross-Over|Death|14|||
162677740|NCT03206203|587529385|FG000|Optional Cross-Over|Refused follow-up|0|||
162677741|NCT03206203|587529386|FG001|Optional Cross-Over|Refused follow-up|0|||
162677742|NCT03206203|587529387|FG002|Optional Cross-Over|Refused follow-up|2|||
162677743|NCT03998618|587529390|FG000|Overall Study|Death|7|||
162677744|NCT03998618|587529391|FG001|Overall Study|Death|11|||
162677745|NCT03998618|587529390|FG000|Overall Study|hospice enrollment|3|||
162677746|NCT03998618|587529391|FG001|Overall Study|hospice enrollment|3|||
162677747|NCT03998618|587529390|FG000|Overall Study|Not feeling well/health problems|3|||
162677748|NCT03998618|587529391|FG001|Overall Study|Not feeling well/health problems|5|||
162677749|NCT03998618|587529390|FG000|Overall Study|Lost to Follow-up|6|||
162677750|NCT03998618|587529391|FG001|Overall Study|Lost to Follow-up|6|||
162677751|NCT03998618|587529390|FG000|Overall Study|Withdrawal by Subject|0|||
162677752|NCT03998618|587529391|FG001|Overall Study|Withdrawal by Subject|4|||
162677753|NCT01152580|587529396|FG000|Overall Study|Withdrawal by Subject|0|||
162677754|NCT01152580|587529397|FG001|Overall Study|Withdrawal by Subject|1|||
162677755|NCT02308748|587529398|FG000|Period 1|Withdrawal by Subject|0|||
162677756|NCT02308748|587529399|FG001|Period 1|Withdrawal by Subject|0|||
162677757|NCT02308748|587529400|FG002|Period 1|Withdrawal by Subject|1|||
162677758|NCT02308748|587529401|FG003|Period 1|Withdrawal by Subject|0|||
162677759|NCT02308748|587529402|FG004|Period 1|Withdrawal by Subject|0|||
162677760|NCT02308748|587529403|FG005|Period 1|Withdrawal by Subject|0|||
162677761|NCT02308748|587529404|FG006|Period 1|Withdrawal by Subject|0|||
162677762|NCT02308748|587529405|FG007|Period 1|Withdrawal by Subject|0|||
162677763|NCT02308748|587529406|FG008|Period 1|Withdrawal by Subject|0|||
162677764|NCT02308748|587529407|FG009|Period 1|Withdrawal by Subject|0|||
162677765|NCT02308748|587529398|FG000|Period 2|Adverse Event|0|||
162677766|NCT02308748|587529399|FG001|Period 2|Adverse Event|0|||
162677767|NCT02308748|587529400|FG002|Period 2|Adverse Event|0|||
162677768|NCT02308748|587529401|FG003|Period 2|Adverse Event|0|||
162677769|NCT02308748|587529402|FG004|Period 2|Adverse Event|0|||
162677770|NCT02308748|587529403|FG005|Period 2|Adverse Event|0|||
162677771|NCT02308748|587529404|FG006|Period 2|Adverse Event|0|||
162677772|NCT02308748|587529405|FG007|Period 2|Adverse Event|1|||
162677773|NCT02308748|587529406|FG008|Period 2|Adverse Event|0|||
162677774|NCT02308748|587529407|FG009|Period 2|Adverse Event|0|||
162677775|NCT02308748|587529398|FG000|Period 3|Protocol Violation|0|||
162677776|NCT02308748|587529399|FG001|Period 3|Protocol Violation|0|||
162677777|NCT02308748|587529400|FG002|Period 3|Protocol Violation|0|||
162677778|NCT02308748|587529401|FG003|Period 3|Protocol Violation|0|||
162677779|NCT02308748|587529402|FG004|Period 3|Protocol Violation|0|||
162677780|NCT02308748|587529403|FG005|Period 3|Protocol Violation|0|||
162677781|NCT02308748|587529404|FG006|Period 3|Protocol Violation|0|||
162677782|NCT02308748|587529405|FG007|Period 3|Protocol Violation|0|||
162677783|NCT02308748|587529406|FG008|Period 3|Protocol Violation|0|||
162677784|NCT02308748|587529407|FG009|Period 3|Protocol Violation|1|||
162677785|NCT02308748|587529398|FG000|Period 5|Adverse Event|1|||
162677786|NCT02308748|587529399|FG001|Period 5|Adverse Event|0|||
162677787|NCT02308748|587529400|FG002|Period 5|Adverse Event|0|||
162677788|NCT02308748|587529401|FG003|Period 5|Adverse Event|0|||
162677789|NCT02308748|587529402|FG004|Period 5|Adverse Event|0|||
162677790|NCT02308748|587529403|FG005|Period 5|Adverse Event|0|||
162677791|NCT02308748|587529404|FG006|Period 5|Adverse Event|0|||
162677792|NCT02308748|587529405|FG007|Period 5|Adverse Event|0|||
162677793|NCT02308748|587529406|FG008|Period 5|Adverse Event|1|||
162677794|NCT02308748|587529407|FG009|Period 5|Adverse Event|0|||
162677795|NCT01994954|587529409|FG000|Overall Study|Death|1|||
162677796|NCT01994954|587529410|FG001|Overall Study|Death|0|||
162677797|NCT01994954|587529409|FG000|Overall Study|Withdrawal by Subject|9|||
162677798|NCT01994954|587529410|FG001|Overall Study|Withdrawal by Subject|14|||
162677799|NCT01994954|587529409|FG000|Overall Study|Physician Decision|2|||
162677800|NCT01994954|587529410|FG001|Overall Study|Physician Decision|2|||
162677801|NCT01994954|587529409|FG000|Overall Study|Lost to Follow-up|8|||
162677802|NCT01994954|587529410|FG001|Overall Study|Lost to Follow-up|10|||
162677803|NCT01994954|587529409|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
162677804|NCT01994954|587529410|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
162677805|NCT00449176|587529411|FG000|Overall Study|Withdrawal by Subject|39|||
162677806|NCT00449176|587529412|FG001|Overall Study|Withdrawal by Subject|43|||
162677807|NCT00449176|587529413|FG002|Overall Study|Withdrawal by Subject|59|||
162677808|NCT00449176|587529411|FG000|Overall Study|Lost to Follow-up|13|||
162677809|NCT00449176|587529412|FG001|Overall Study|Lost to Follow-up|8|||
162677810|NCT00449176|587529413|FG002|Overall Study|Lost to Follow-up|12|||
162677811|NCT00449176|587529411|FG000|Overall Study|Adverse Event|51|||
162677812|NCT00449176|587529412|FG001|Overall Study|Adverse Event|107|||
162677813|NCT00449176|587529413|FG002|Overall Study|Adverse Event|15|||
162677814|NCT00449176|587529411|FG000|Overall Study|Lack of Efficacy|13|||
162677815|NCT00449176|587529412|FG001|Overall Study|Lack of Efficacy|7|||
162677816|NCT00449176|587529413|FG002|Overall Study|Lack of Efficacy|50|||
162677817|NCT00449176|587529411|FG000|Overall Study|Study drug non-compliant|14|||
162677818|NCT00449176|587529412|FG001|Overall Study|Study drug non-compliant|11|||
162677819|NCT00449176|587529413|FG002|Overall Study|Study drug non-compliant|11|||
162677820|NCT00449176|587529411|FG000|Overall Study|all other|22|||
162677821|NCT00449176|587529412|FG001|Overall Study|all other|19|||
162677822|NCT00449176|587529413|FG002|Overall Study|all other|20|||
162677823|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
162677824|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
162677825|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|disease progression|58|||
162677826|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|disease progression|47|||
162677827|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Death|3|||
162677828|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Death|6|||
162677829|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
162677830|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
162677831|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
162677832|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
162677833|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
162677834|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
162677835|NCT02472964|587529414|FG000|Part 1 (up to Week 24)|Other|2|||
162677836|NCT02472964|587529415|FG001|Part 1 (up to Week 24)|Other|1|||
162677837|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
162677838|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
162677839|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
162677840|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
162677841|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Death|0|||
162677842|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Death|1|||
162677843|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
162677844|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
162677845|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
162677846|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
162723719|NCT02763319|587697709|FG001|Overall Study|Adverse Event|3|||
162723720|NCT02763319|587697708|FG000|Overall Study|Death|123|||
162723721|NCT02763319|587697709|FG001|Overall Study|Death|123|||
162723722|NCT02763319|587697708|FG000|Overall Study|Lost to Follow-up|6|||
162723723|NCT02763319|587697709|FG001|Overall Study|Lost to Follow-up|7|||
162723724|NCT02763319|587697708|FG000|Overall Study|Noncompliance with Study Drug|2|||
162723725|NCT02763319|587697709|FG001|Overall Study|Noncompliance with Study Drug|0|||
162723726|NCT02763319|587697708|FG000|Overall Study|"Captured as Other in Database"|29|||
162723727|NCT02763319|587697709|FG001|Overall Study|"Captured as Other in Database"|34|||
162723728|NCT02763319|587697708|FG000|Overall Study|Physician Decision|1|||
162723729|NCT02763319|587697709|FG001|Overall Study|Physician Decision|7|||
162723730|NCT02763319|587697708|FG000|Overall Study|Progressive Disease|24|||
162723731|NCT02763319|587697709|FG001|Overall Study|Progressive Disease|27|||
162723732|NCT02763319|587697708|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
162723733|NCT02763319|587697709|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
162723734|NCT02763319|587697708|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
162723735|NCT02763319|587697709|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
162723736|NCT02763319|587697708|FG000|Overall Study|Withdrawal by Subject|26|||
162723737|NCT02763319|587697709|FG001|Overall Study|Withdrawal by Subject|25|||
162723738|NCT00722046|587697711|FG000|Overall Study|Adverse Event|0|||
162723739|NCT00722046|587697712|FG001|Overall Study|Adverse Event|1|||
162723740|NCT00722046|587697713|FG002|Overall Study|Adverse Event|2|||
162723741|NCT00722046|587697714|FG003|Overall Study|Adverse Event|1|||
162723742|NCT00722046|587697715|FG004|Overall Study|Adverse Event|2|||
162723743|NCT00722046|587697716|FG005|Overall Study|Adverse Event|1|||
162723744|NCT00722046|587697717|FG006|Overall Study|Adverse Event|0|||
162723745|NCT00722046|587697711|FG000|Overall Study|Death|0|||
162723746|NCT00722046|587697712|FG001|Overall Study|Death|1|||
162723747|NCT00722046|587697713|FG002|Overall Study|Death|0|||
162723748|NCT00722046|587697714|FG003|Overall Study|Death|0|||
162723749|NCT00722046|587697715|FG004|Overall Study|Death|0|||
162723750|NCT00722046|587697716|FG005|Overall Study|Death|0|||
162723751|NCT00722046|587697717|FG006|Overall Study|Death|2|||
162723752|NCT00722046|587697711|FG000|Overall Study|Protocol Violation|1|||
162723753|NCT00722046|587697712|FG001|Overall Study|Protocol Violation|0|||
162723754|NCT00722046|587697713|FG002|Overall Study|Protocol Violation|0|||
162723755|NCT00722046|587697714|FG003|Overall Study|Protocol Violation|0|||
162723756|NCT00722046|587697715|FG004|Overall Study|Protocol Violation|0|||
162723757|NCT00722046|587697716|FG005|Overall Study|Protocol Violation|1|||
162723758|NCT00722046|587697717|FG006|Overall Study|Protocol Violation|0|||
162723759|NCT00722046|587697711|FG000|Overall Study|Withdrawal by Subject|3|||
162723760|NCT00722046|587697712|FG001|Overall Study|Withdrawal by Subject|3|||
162723761|NCT00722046|587697713|FG002|Overall Study|Withdrawal by Subject|4|||
162723762|NCT00722046|587697714|FG003|Overall Study|Withdrawal by Subject|4|||
162723763|NCT00722046|587697715|FG004|Overall Study|Withdrawal by Subject|4|||
162723764|NCT00722046|587697716|FG005|Overall Study|Withdrawal by Subject|7|||
162723765|NCT00722046|587697717|FG006|Overall Study|Withdrawal by Subject|3|||
162723766|NCT00722046|587697711|FG000|Overall Study|Randomized, but not treated|1|||
162723767|NCT00722046|587697712|FG001|Overall Study|Randomized, but not treated|1|||
162723768|NCT00722046|587697713|FG002|Overall Study|Randomized, but not treated|0|||
162723769|NCT00722046|587697714|FG003|Overall Study|Randomized, but not treated|2|||
162723770|NCT00722046|587697715|FG004|Overall Study|Randomized, but not treated|0|||
162723771|NCT00722046|587697716|FG005|Overall Study|Randomized, but not treated|0|||
162723772|NCT00722046|587697717|FG006|Overall Study|Randomized, but not treated|0|||
162723773|NCT00722046|587697711|FG000|Overall Study|Other|0|||
162723774|NCT00722046|587697712|FG001|Overall Study|Other|0|||
162723775|NCT00722046|587697713|FG002|Overall Study|Other|1|||
162723776|NCT00722046|587697714|FG003|Overall Study|Other|1|||
162723777|NCT00722046|587697715|FG004|Overall Study|Other|3|||
162723778|NCT00722046|587697716|FG005|Overall Study|Other|2|||
162723779|NCT00722046|587697717|FG006|Overall Study|Other|1|||
162723780|NCT01460446|587697721|FG000|Overall Study|Non-compliance|2|||
162723781|NCT01460446|587697722|FG001|Overall Study|Non-compliance|9|||
162723782|NCT01460446|587697721|FG000|Overall Study|Consent Withdrawn|0|||
162723783|NCT01460446|587697722|FG001|Overall Study|Consent Withdrawn|4|||
162723784|NCT01460446|587697721|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
162723785|NCT01460446|587697722|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
162723786|NCT01460446|587697721|FG000|Overall Study|Surgery/Illness|1|||
162723787|NCT01460446|587697722|FG001|Overall Study|Surgery/Illness|1|||
162723788|NCT01460446|587697721|FG000|Overall Study|Pregnancy|1|||
162723789|NCT01460446|587697722|FG001|Overall Study|Pregnancy|0|||
162723790|NCT01460446|587697721|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
162723791|NCT01460446|587697722|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
162723792|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
162723793|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
162723794|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
162723795|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
162723796|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
162677847|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
162677848|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
162677849|NCT02472964|587529414|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
162677850|NCT02472964|587529415|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
162677851|NCT01454583|587529416|FG000|1st Year|Lost to Follow-up|1057|||
162677852|NCT01454583|587529417|FG001|1st Year|Lost to Follow-up|318|||
162677853|NCT01454583|587529418|FG002|1st Year|Lost to Follow-up|180|||
162677854|NCT01454583|587529416|FG000|2nd Year|Lost to Follow-up|3965|||
162677855|NCT01454583|587529417|FG001|2nd Year|Lost to Follow-up|1049|||
162677856|NCT01454583|587529418|FG002|2nd Year|Lost to Follow-up|737|||
162677857|NCT01454583|587529416|FG000|3rd Year|Lost to Follow-up|1959|||
162677858|NCT01454583|587529417|FG001|3rd Year|Lost to Follow-up|512|||
162677859|NCT01454583|587529418|FG002|3rd Year|Lost to Follow-up|297|||
162677860|NCT04330638|587529421|FG000|Overall Study|Adverse Event|9|||
162677861|NCT04330638|587529422|FG001|Overall Study|Adverse Event|10|||
162677862|NCT04330638|587529423|FG002|Overall Study|Adverse Event|15|||
162677863|NCT04330638|587529424|FG003|Overall Study|Adverse Event|6|||
162677864|NCT04330638|587529425|FG004|Overall Study|Adverse Event|10|||
162677865|NCT04330638|587529426|FG005|Overall Study|Adverse Event|5|||
162677866|NCT04330638|587529421|FG000|Overall Study|Other|2|||
162677867|NCT04330638|587529422|FG001|Overall Study|Other|2|||
162677868|NCT04330638|587529423|FG002|Overall Study|Other|5|||
162677869|NCT04330638|587529424|FG003|Overall Study|Other|1|||
162677870|NCT04330638|587529425|FG004|Overall Study|Other|3|||
162677871|NCT04330638|587529426|FG005|Overall Study|Other|2|||
162677872|NCT04330638|587529421|FG000|Overall Study|Withdrawal by Subject|4|||
162677873|NCT04330638|587529422|FG001|Overall Study|Withdrawal by Subject|0|||
162677874|NCT04330638|587529423|FG002|Overall Study|Withdrawal by Subject|0|||
162677875|NCT04330638|587529424|FG003|Overall Study|Withdrawal by Subject|0|||
162677876|NCT04330638|587529425|FG004|Overall Study|Withdrawal by Subject|0|||
162677877|NCT04330638|587529426|FG005|Overall Study|Withdrawal by Subject|0|||
162677878|NCT04330638|587529421|FG000|Overall Study|Lost to Follow-up|3|||
162677879|NCT04330638|587529422|FG001|Overall Study|Lost to Follow-up|2|||
162677880|NCT04330638|587529423|FG002|Overall Study|Lost to Follow-up|3|||
162677881|NCT04330638|587529424|FG003|Overall Study|Lost to Follow-up|2|||
162677882|NCT04330638|587529425|FG004|Overall Study|Lost to Follow-up|3|||
162677883|NCT04330638|587529426|FG005|Overall Study|Lost to Follow-up|0|||
162677884|NCT01967732|587529428|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162677885|NCT01967732|587529429|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
162677886|NCT01967732|587529430|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162677887|NCT01967732|587529431|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162677888|NCT01967732|587529428|FG000|First Intervention (Day 1)|Poor venous access|0|||
162677889|NCT01967732|587529429|FG001|First Intervention (Day 1)|Poor venous access|1|||
162677890|NCT01967732|587529430|FG002|First Intervention (Day 1)|Poor venous access|0|||
162677891|NCT01967732|587529431|FG003|First Intervention (Day 1)|Poor venous access|0|||
162677892|NCT01988779|587529440|FG000|Overall Study|Withdrawal by Subject|2|||
162677893|NCT01988779|587529441|FG001|Overall Study|Withdrawal by Subject|2|||
162677894|NCT01988779|587529440|FG000|Overall Study|Protocol Violation|1|||
162677895|NCT01988779|587529441|FG001|Overall Study|Protocol Violation|0|||
162677896|NCT00377403|587529442|FG000|Overall Study|Unable to contact for telephone intervie|4|||
162677897|NCT00377403|587529443|FG001|Overall Study|Unable to contact for telephone intervie|7|||
162677898|NCT02275065|587529444|FG000|Overall Study|Randomized but not treated|1|||
162677899|NCT02275065|587529445|FG001|Overall Study|Randomized but not treated|0|||
162677900|NCT02275065|587529446|FG002|Overall Study|Randomized but not treated|1|||
162677901|NCT02275065|587529447|FG003|Overall Study|Randomized but not treated|1|||
162677902|NCT02275065|587529448|FG004|Overall Study|Randomized but not treated|0|||
162677903|NCT00417079|587529450|FG000|Overall Study|Disease progression|267|||
162677904|NCT00417079|587529451|FG001|Overall Study|Disease progression|180|||
162677905|NCT00417079|587529450|FG000|Overall Study|Adverse Event|32|||
162677906|NCT00417079|587529451|FG001|Overall Study|Adverse Event|67|||
162677907|NCT00417079|587529450|FG000|Overall Study|Non-compliance to protocol|0|||
162677908|NCT00417079|587529451|FG001|Overall Study|Non-compliance to protocol|1|||
162677909|NCT00417079|587529450|FG000|Overall Study|Lost to Follow-up|2|||
162677910|NCT00417079|587529451|FG001|Overall Study|Lost to Follow-up|0|||
162677911|NCT00417079|587529450|FG000|Overall Study|Withdrawal by Subject|17|||
162677912|NCT00417079|587529451|FG001|Overall Study|Withdrawal by Subject|8|||
162677913|NCT00417079|587529450|FG000|Overall Study|Not treated|6|||
162677914|NCT00417079|587529451|FG001|Overall Study|Not treated|7|||
162677915|NCT00417079|587529450|FG000|Overall Study|Screened failure|2|||
162677916|NCT00417079|587529451|FG001|Overall Study|Screened failure|1|||
162677917|NCT00417079|587529450|FG000|Overall Study|Investigator's decision|1|||
162677918|NCT00417079|587529451|FG001|Overall Study|Investigator's decision|4|||
162677919|NCT00417079|587529450|FG000|Overall Study|Non-confirmed Disease progression|1|||
162677920|NCT00417079|587529451|FG001|Overall Study|Non-confirmed Disease progression|1|||
162677921|NCT00417079|587529450|FG000|Overall Study|Clinical deterioration|1|||
162677922|NCT00417079|587529451|FG001|Overall Study|Clinical deterioration|0|||
162677923|NCT00417079|587529450|FG000|Overall Study|Screening error|2|||
162677924|NCT00417079|587529451|FG001|Overall Study|Screening error|1|||
162677925|NCT00417079|587529450|FG000|Overall Study|Withdrawal by subject's family|0|||
162677926|NCT00417079|587529451|FG001|Overall Study|Withdrawal by subject's family|1|||
162677927|NCT00417079|587529450|FG000|Overall Study|Patient unable to come to the clinic|0|||
162677928|NCT00417079|587529451|FG001|Overall Study|Patient unable to come to the clinic|1|||
162677929|NCT00417079|587529450|FG000|Overall Study|abnormal liver function tests|0|||
162677930|NCT00417079|587529451|FG001|Overall Study|abnormal liver function tests|1|||
162677931|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
162677932|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
162677933|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
162677934|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
162677935|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
162677936|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
162677937|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
162677938|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
162677939|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
162677940|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
162677941|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
162677942|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
162677943|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162677944|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162677945|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162677946|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
162677947|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
162677948|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
162677949|NCT00833638|587529452|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
162677950|NCT00833638|587529453|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
162677951|NCT00833638|587529454|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
162677952|NCT00833638|587529452|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
162677953|NCT00833638|587529453|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
162677954|NCT00833638|587529454|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
162677955|NCT00833638|587529452|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
162677956|NCT00833638|587529453|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
162677957|NCT00833638|587529454|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
162677958|NCT01178086|587529455|FG000|Overall Study|Participant refusal|7|||
162677959|NCT01178086|587529455|FG000|Overall Study|Physician Decision|44|||
162677960|NCT01178086|587529455|FG000|Overall Study|Switch to other CLL therapy|113|||
162677961|NCT01178086|587529455|FG000|Overall Study|Death|59|||
162677962|NCT01178086|587529455|FG000|Overall Study|Other unspecified|89|||
162677963|NCT01178086|587529455|FG000|Overall Study|Excluded from EAS|20|||
162677964|NCT02097108|587529456|FG000|Overall Study|Adverse Event|1|||
162677965|NCT02097108|587529456|FG000|Overall Study|patient was abroad for 6 months|1|||
162677966|NCT00127608|587529459|FG000|Overall Study|VZV DNA negative|1|||
162677967|NCT01712009|587530814|FG000|Overall Study|Withdrawal by Subject|24|||
162677968|NCT01712009|587530815|FG001|Overall Study|Withdrawal by Subject|15|||
162677969|NCT01712009|587530816|FG002|Overall Study|Withdrawal by Subject|8|||
162677970|NCT01712009|587530814|FG000|Overall Study|Lost to Follow-up|2|||
162677971|NCT01712009|587530815|FG001|Overall Study|Lost to Follow-up|0|||
162677972|NCT01712009|587530816|FG002|Overall Study|Lost to Follow-up|1|||
162677973|NCT01712009|587530814|FG000|Overall Study|Decision by Sponsor|12|||
162677974|NCT01712009|587530815|FG001|Overall Study|Decision by Sponsor|14|||
162677975|NCT01712009|587530816|FG002|Overall Study|Decision by Sponsor|12|||
162677976|NCT01111123|587530818|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
162677977|NCT01111123|587530819|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
162677978|NCT01111123|587530818|FG000|Maintenance Phase|Lost to Follow-up|0|||
162677979|NCT01111123|587530819|FG001|Maintenance Phase|Lost to Follow-up|2|||
162677980|NCT00160680|587530825|FG000|Overall Study|Adverse Event|0|||
162677981|NCT00160680|587530826|FG001|Overall Study|Adverse Event|1|||
162677982|NCT00160680|587530825|FG000|Overall Study|Lack of Efficacy|2|||
162677983|NCT00160680|587530826|FG001|Overall Study|Lack of Efficacy|1|||
162677984|NCT00160680|587530825|FG000|Overall Study|Lost to Follow-up|3|||
162677985|NCT00160680|587530826|FG001|Overall Study|Lost to Follow-up|2|||
162677986|NCT00160680|587530825|FG000|Overall Study|Withdrawal by Subject|4|||
162677987|NCT00160680|587530826|FG001|Overall Study|Withdrawal by Subject|9|||
162677988|NCT02583425|587530837|FG000|Screening|Did not meet entry criteria|12|||
162677989|NCT02583425|587530837|FG000|Baseline|Did not meet continued criteria|5|||
162677990|NCT02583425|587530837|FG000|Treatment Period|Adverse Event|1|||
162677991|NCT01644734|587530838|FG000|Overall Study|Adverse Event|4|||
162677992|NCT01644734|587530838|FG000|Overall Study|Lost to Follow-up|17|||
162677993|NCT01644734|587530838|FG000|Overall Study|Reasons other than stated above|7|||
162677994|NCT01644734|587530838|FG000|Overall Study|Missing documentation|238|||
162677995|NCT01615328|587530843|FG000|Overall Study|Lost to Follow-up|3|||
162677996|NCT01615328|587530844|FG001|Overall Study|Lost to Follow-up|5|||
162677997|NCT02157779|587530845|FG000|Overall Study|Logistical|9|||
162677998|NCT02157779|587530846|FG001|Overall Study|Logistical|3|||
162677999|NCT02157779|587530845|FG000|Overall Study|Stopped attending, reason unknown|11|||
162678000|NCT02157779|587530846|FG001|Overall Study|Stopped attending, reason unknown|7|||
162678001|NCT02157779|587530845|FG000|Overall Study|No response to outreach after Baseline|1|||
162678002|NCT02157779|587530846|FG001|Overall Study|No response to outreach after Baseline|1|||
162678003|NCT02157779|587530845|FG000|Overall Study|Moved|1|||
162678004|NCT02157779|587530846|FG001|Overall Study|Moved|0|||
162678005|NCT02157779|587530845|FG000|Overall Study|Medical|1|||
162678006|NCT02157779|587530846|FG001|Overall Study|Medical|0|||
162678007|NCT02157779|587530845|FG000|Overall Study|Legal issue|1|||
162678008|NCT02157779|587530846|FG001|Overall Study|Legal issue|0|||
162678009|NCT02548455|587530847|FG000|Overall Study|Withdrawal by Subject|27|||
162678010|NCT02548455|587530847|FG000|Overall Study|Death|26|||
162678011|NCT02548455|587530847|FG000|Overall Study|Lost to Follow-up|14|||
162678012|NCT02548455|587530847|FG000|Overall Study|Visit not completed|173|||
162678013|NCT02525874|587530852|FG000|Overall Study|Other|1|||
162678014|NCT02525874|587530852|FG000|Overall Study|Investigator Decision|1|||
162678015|NCT02525874|587530852|FG000|Overall Study|Consent withdrawn|22|||
162678016|NCT02525874|587530852|FG000|Overall Study|Non-compliance with study drug|3|||
162678017|NCT02525874|587530852|FG000|Overall Study|Adverse Event|17|||
162678018|NCT02525874|587530852|FG000|Overall Study|Lost to Follow-up|7|||
162678019|NCT02525874|587530852|FG000|Overall Study|Disease progression, defined by protocol|2|||
162678020|NCT02525874|587530852|FG000|Overall Study|Disease relapse|4|||
162678021|NCT02525874|587530852|FG000|Overall Study|Alternative Treatment for MS|2|||
162678022|NCT02525874|587530852|FG000|Overall Study|New lesions in Brain|1|||
162678023|NCT02794285|587530853|FG000|Overall Study|Adverse Event|11|||
162678024|NCT02794285|587530854|FG001|Overall Study|Adverse Event|4|||
162678025|NCT02794285|587530855|FG002|Overall Study|Adverse Event|5|||
162678026|NCT02794285|587530856|FG003|Overall Study|Adverse Event|8|||
162678027|NCT02794285|587530853|FG000|Overall Study|Condition Under Investigation Improved|1|||
162678028|NCT02794285|587530854|FG001|Overall Study|Condition Under Investigation Improved|0|||
162678029|NCT02794285|587530855|FG002|Overall Study|Condition Under Investigation Improved|0|||
162678030|NCT02794285|587530856|FG003|Overall Study|Condition Under Investigation Improved|0|||
162678031|NCT02794285|587530853|FG000|Overall Study|Condition Under Investigation Worsened|0|||
162678032|NCT02794285|587530854|FG001|Overall Study|Condition Under Investigation Worsened|2|||
162678033|NCT02794285|587530855|FG002|Overall Study|Condition Under Investigation Worsened|1|||
162678034|NCT02794285|587530856|FG003|Overall Study|Condition Under Investigation Worsened|0|||
162678035|NCT02794285|587530853|FG000|Overall Study|Death|2|||
162678036|NCT02794285|587530854|FG001|Overall Study|Death|1|||
162678037|NCT02794285|587530855|FG002|Overall Study|Death|2|||
162678038|NCT02794285|587530856|FG003|Overall Study|Death|0|||
162678039|NCT02794285|587530853|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
162678040|NCT02794285|587530854|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
162678041|NCT02794285|587530855|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
162678042|NCT02794285|587530856|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
162678043|NCT02794285|587530853|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
162678044|NCT02794285|587530854|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
162678045|NCT02794285|587530855|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
162678046|NCT02794285|587530856|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
162678047|NCT02794285|587530853|FG000|Overall Study|Lack of Efficacy|10|||
162678048|NCT02794285|587530854|FG001|Overall Study|Lack of Efficacy|6|||
162678049|NCT02794285|587530855|FG002|Overall Study|Lack of Efficacy|3|||
162678050|NCT02794285|587530856|FG003|Overall Study|Lack of Efficacy|3|||
162678051|NCT02794285|587530853|FG000|Overall Study|Lost to Follow-up|5|||
162678052|NCT02794285|587530854|FG001|Overall Study|Lost to Follow-up|6|||
162678053|NCT02794285|587530855|FG002|Overall Study|Lost to Follow-up|3|||
162678054|NCT02794285|587530856|FG003|Overall Study|Lost to Follow-up|1|||
162678055|NCT02794285|587530853|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
162678056|NCT02794285|587530854|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
162678057|NCT02794285|587530855|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
162678058|NCT02794285|587530856|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
162723797|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
162723798|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
162723799|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
162723800|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
162723801|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
162723802|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
162723803|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
162723804|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
162723805|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
162723806|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
162723807|NCT00516321|587697723|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
162723808|NCT00516321|587697724|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
162723809|NCT00516321|587697725|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
162723810|NCT00516321|587697723|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
162723811|NCT00516321|587697724|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
162723812|NCT00516321|587697725|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
162723813|NCT00516321|587697723|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
162723814|NCT00516321|587697724|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
162723815|NCT00516321|587697725|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
162723816|NCT00516321|587697723|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
162678059|NCT02794285|587530853|FG000|Overall Study|Withdrawal by Subject|38|||
162678060|NCT02794285|587530854|FG001|Overall Study|Withdrawal by Subject|29|||
162678061|NCT02794285|587530855|FG002|Overall Study|Withdrawal by Subject|20|||
162678062|NCT02794285|587530856|FG003|Overall Study|Withdrawal by Subject|12|||
162678063|NCT02794285|587530853|FG000|Overall Study|Missing|1|||
162678064|NCT02794285|587530854|FG001|Overall Study|Missing|0|||
162678065|NCT02794285|587530855|FG002|Overall Study|Missing|0|||
162678066|NCT02794285|587530856|FG003|Overall Study|Missing|0|||
162678067|NCT02794285|587530853|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
162678068|NCT02794285|587530854|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
162678069|NCT02794285|587530855|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
162678070|NCT02794285|587530856|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
162678071|NCT02794285|587530853|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
162678072|NCT02794285|587530854|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
162678073|NCT02794285|587530855|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
162678074|NCT02794285|587530856|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
162678075|NCT00423176|587530857|FG000|Overall Study|Adverse Event|4|||
162678076|NCT00423176|587530858|FG001|Overall Study|Adverse Event|6|||
162678077|NCT00423176|587530857|FG000|Overall Study|Treatment Failure|1|||
162678078|NCT00423176|587530858|FG001|Overall Study|Treatment Failure|6|||
162678079|NCT00423176|587530857|FG000|Overall Study|Lost to Follow-up|4|||
162678080|NCT00423176|587530858|FG001|Overall Study|Lost to Follow-up|7|||
162678081|NCT00423176|587530857|FG000|Overall Study|Withdrawal by Subject|4|||
162678082|NCT00423176|587530858|FG001|Overall Study|Withdrawal by Subject|3|||
162678083|NCT00423176|587530857|FG000|Overall Study|Protocol Violation|1|||
162678084|NCT00423176|587530858|FG001|Overall Study|Protocol Violation|3|||
162678085|NCT00423176|587530857|FG000|Overall Study|Did not meet protocol eligibility|2|||
162678086|NCT00423176|587530858|FG001|Overall Study|Did not meet protocol eligibility|4|||
162678087|NCT04535947|587530859|FG000|Overall Study|Adverse Event|1|||
162678088|NCT04535947|587530860|FG001|Overall Study|Adverse Event|4|||
162678089|NCT04535947|587530859|FG000|Overall Study|Other reasons not specified|2|||
162678090|NCT04535947|587530860|FG001|Overall Study|Other reasons not specified|0|||
162678091|NCT04535947|587530859|FG000|Overall Study|Withdrawal by Subject|1|||
162678092|NCT04535947|587530860|FG001|Overall Study|Withdrawal by Subject|1|||
162678093|NCT04867369|587530866|FG000|Overall Study|Withdrawal by Subject|1|||
162678094|NCT04867369|587530867|FG001|Overall Study|Withdrawal by Subject|0|||
162678095|NCT03896035|587530873|FG000|Overall Study|Lost to Follow-up|2|||
162678096|NCT03896035|587530874|FG001|Overall Study|Lost to Follow-up|6|||
162678097|NCT03896035|587530873|FG000|Overall Study|Withdrawal by Subject|0|||
162723817|NCT00516321|587697724|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
162678098|NCT03896035|587530874|FG001|Overall Study|Withdrawal by Subject|1|||
162678099|NCT03896035|587530873|FG000|Overall Study|Health/family health issues during COVID|0|||
162678100|NCT03896035|587530874|FG001|Overall Study|Health/family health issues during COVID|4|||
162678101|NCT00675766|587530884|FG000|Overall Study|Lost to Follow-up|6|||
162678102|NCT00675766|587530885|FG001|Overall Study|Lost to Follow-up|5|||
162678103|NCT00675766|587530886|FG002|Overall Study|Lost to Follow-up|21|||
162678104|NCT00675766|587530887|FG003|Overall Study|Lost to Follow-up|26|||
162678105|NCT01749982|587530890|FG000|Overall Study|Physician Decision|0|||
162678106|NCT01749982|587530891|FG001|Overall Study|Physician Decision|0|||
162678107|NCT01749982|587530892|FG002|Overall Study|Physician Decision|0|||
162678108|NCT01749982|587530893|FG003|Overall Study|Physician Decision|1|||
162678109|NCT01749982|587530890|FG000|Overall Study|Lost to Follow-up|0|||
162678110|NCT01749982|587530891|FG001|Overall Study|Lost to Follow-up|0|||
162678111|NCT01749982|587530892|FG002|Overall Study|Lost to Follow-up|0|||
162678112|NCT01749982|587530893|FG003|Overall Study|Lost to Follow-up|1|||
162678113|NCT01749982|587530890|FG000|Overall Study|Withdrawal by Subject|0|||
162678114|NCT01749982|587530891|FG001|Overall Study|Withdrawal by Subject|0|||
162678115|NCT01749982|587530892|FG002|Overall Study|Withdrawal by Subject|0|||
162678116|NCT01749982|587530893|FG003|Overall Study|Withdrawal by Subject|1|||
162678117|NCT02677116|587530894|FG000|Overall Study|Adverse Event|0|||
162678118|NCT02677116|587530895|FG001|Overall Study|Adverse Event|1|||
162678119|NCT02677116|587530896|FG002|Overall Study|Adverse Event|0|||
162678120|NCT02677116|587530897|FG003|Overall Study|Adverse Event|0|||
162678121|NCT02677116|587530898|FG004|Overall Study|Adverse Event|0|||
162678122|NCT02677116|587530899|FG005|Overall Study|Adverse Event|1|||
162678123|NCT02677116|587530900|FG006|Overall Study|Adverse Event|1|||
162678124|NCT02677116|587530901|FG007|Overall Study|Adverse Event|0|||
162678125|NCT02677116|587530902|FG008|Overall Study|Adverse Event|0|||
162678126|NCT02677116|587530894|FG000|Overall Study|Physician Decision|0|||
162678127|NCT02677116|587530895|FG001|Overall Study|Physician Decision|2|||
162678128|NCT02677116|587530896|FG002|Overall Study|Physician Decision|3|||
162678129|NCT02677116|587530897|FG003|Overall Study|Physician Decision|2|||
162678130|NCT02677116|587530898|FG004|Overall Study|Physician Decision|1|||
162678131|NCT02677116|587530899|FG005|Overall Study|Physician Decision|3|||
162678132|NCT02677116|587530900|FG006|Overall Study|Physician Decision|1|||
162678133|NCT02677116|587530901|FG007|Overall Study|Physician Decision|1|||
162678134|NCT02677116|587530902|FG008|Overall Study|Physician Decision|2|||
162678135|NCT02677116|587530894|FG000|Overall Study|Withdrawal by parent or guardian|2|||
162678136|NCT02677116|587530895|FG001|Overall Study|Withdrawal by parent or guardian|1|||
162678137|NCT02677116|587530896|FG002|Overall Study|Withdrawal by parent or guardian|0|||
162678138|NCT02677116|587530897|FG003|Overall Study|Withdrawal by parent or guardian|1|||
162678139|NCT02677116|587530898|FG004|Overall Study|Withdrawal by parent or guardian|0|||
162678140|NCT02677116|587530899|FG005|Overall Study|Withdrawal by parent or guardian|0|||
162678141|NCT02677116|587530900|FG006|Overall Study|Withdrawal by parent or guardian|2|||
162678142|NCT02677116|587530901|FG007|Overall Study|Withdrawal by parent or guardian|1|||
162678143|NCT02677116|587530902|FG008|Overall Study|Withdrawal by parent or guardian|0|||
162678144|NCT02677116|587530894|FG000|Overall Study|Withdrawal by Subject|1|||
162678145|NCT02677116|587530895|FG001|Overall Study|Withdrawal by Subject|0|||
162678146|NCT02677116|587530896|FG002|Overall Study|Withdrawal by Subject|0|||
162678147|NCT02677116|587530897|FG003|Overall Study|Withdrawal by Subject|0|||
162678148|NCT02677116|587530898|FG004|Overall Study|Withdrawal by Subject|0|||
162678149|NCT02677116|587530899|FG005|Overall Study|Withdrawal by Subject|0|||
162678150|NCT02677116|587530900|FG006|Overall Study|Withdrawal by Subject|0|||
162678151|NCT02677116|587530901|FG007|Overall Study|Withdrawal by Subject|0|||
162678152|NCT02677116|587530902|FG008|Overall Study|Withdrawal by Subject|0|||
162678153|NCT01207102|587530907|FG000|Overall Study|Withdrawal by Subject|5|||
162678154|NCT01207102|587530907|FG000|Overall Study|Adverse Event|2|||
162678155|NCT01207102|587530907|FG000|Overall Study|progression|2|||
162678156|NCT01207102|587530907|FG000|Overall Study|Withdrawal by Treating Physician|1|||
162678157|NCT01018394|587530908|FG000|Overall Study|Withdrawal by Subject|5|||
162678158|NCT01018394|587530909|FG001|Overall Study|Withdrawal by Subject|5|||
162678159|NCT01018394|587530908|FG000|Overall Study|Lost to Follow-up|4|||
162678160|NCT01018394|587530909|FG001|Overall Study|Lost to Follow-up|3|||
162678161|NCT03792126|587530910|FG000|Overall Study|Adverse Event|1|||
162678162|NCT03792126|587530911|FG001|Overall Study|Adverse Event|2|||
162678163|NCT03792126|587530910|FG000|Overall Study|Death|0|||
162678164|NCT03792126|587530911|FG001|Overall Study|Death|1|||
162678165|NCT03792126|587530910|FG000|Overall Study|Lost to Follow-up|1|||
162678166|NCT03792126|587530911|FG001|Overall Study|Lost to Follow-up|0|||
162678167|NCT03792126|587530910|FG000|Overall Study|Withdrawal by Subject|0|||
162678168|NCT03792126|587530911|FG001|Overall Study|Withdrawal by Subject|1|||
162678169|NCT03792126|587530910|FG000|Overall Study|COVID-19 Restrictions|1|||
162678170|NCT03792126|587530911|FG001|Overall Study|COVID-19 Restrictions|3|||
162678171|NCT03792126|587530910|FG000|Overall Study|Symptoms resolved|0|||
162678172|NCT03792126|587530911|FG001|Overall Study|Symptoms resolved|3|||
162678173|NCT00490646|587530912|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
162678174|NCT00490646|587530913|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
162678175|NCT00490646|587530912|FG000|Overall Study|Never Treated (had an adverse event)|1|||
162678176|NCT00490646|587530913|FG001|Overall Study|Never Treated (had an adverse event)|0|||
162678177|NCT00490646|587530912|FG000|Overall Study|Never Treated (withdrew consent)|0|||
162678178|NCT00490646|587530913|FG001|Overall Study|Never Treated (withdrew consent)|1|||
162678179|NCT01400503|587530915|FG000|Overall Study|Withdrawal by Subject|1|||
162678180|NCT01400503|587530915|FG000|Overall Study|Study Terminated by Sponsor|58|||
162678181|NCT01400503|587530915|FG000|Overall Study|Other|1|||
162678182|NCT00983073|587530916|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
162678183|NCT00983073|587530916|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
162678184|NCT00983073|587530916|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
162678185|NCT00983073|587530916|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
162678186|NCT00983073|587530916|FG000|Titration and Optimal Dose Period|Other reason|4|||
162678187|NCT00983073|587530916|FG000|Maintenance Period|Adverse Event|5|||
162678188|NCT00983073|587530916|FG000|Maintenance Period|Withdrawal by Subject|2|||
162678189|NCT00983073|587530916|FG000|Maintenance Period|Lack of Efficacy|2|||
162678190|NCT00983073|587530916|FG000|Maintenance Period|Other Reason|7|||
162678191|NCT01669122|587530919|FG000|Period I|Lost to Follow-up|1|||
162678192|NCT01669122|587530919|FG000|Washout Period II|Protocol Violation|2|||
162678193|NCT02962908|587530920|FG000|Overall Study|Lost to Follow-up|0|||
162678194|NCT02962908|587530921|FG001|Overall Study|Lost to Follow-up|3|||
162678195|NCT02962908|587530922|FG002|Overall Study|Lost to Follow-up|0|||
162678196|NCT02962908|587530923|FG003|Overall Study|Lost to Follow-up|1|||
162678197|NCT02962908|587530920|FG000|Overall Study|Withdrawal by Subject|0|||
162678198|NCT02962908|587530921|FG001|Overall Study|Withdrawal by Subject|3|||
162678199|NCT02962908|587530922|FG002|Overall Study|Withdrawal by Subject|0|||
162678200|NCT02962908|587530923|FG003|Overall Study|Withdrawal by Subject|2|||
162678201|NCT02962908|587530920|FG000|Overall Study|Protocol Violation|0|||
162678202|NCT02962908|587530921|FG001|Overall Study|Protocol Violation|1|||
162678203|NCT02962908|587530922|FG002|Overall Study|Protocol Violation|0|||
162678204|NCT02962908|587530923|FG003|Overall Study|Protocol Violation|0|||
162678205|NCT02962908|587530920|FG000|Overall Study|Physician Decision|0|||
162678206|NCT02962908|587530921|FG001|Overall Study|Physician Decision|1|||
162678207|NCT02962908|587530922|FG002|Overall Study|Physician Decision|0|||
162678208|NCT02962908|587530923|FG003|Overall Study|Physician Decision|0|||
162678209|NCT03543254|587530924|FG000|Overall Study|Lost to Follow-up|1|||
162678210|NCT02077166|587530925|FG000|Overall Study|Death|6|||
162678211|NCT02077166|587530926|FG001|Overall Study|Death|7|||
162678212|NCT02077166|587530927|FG002|Overall Study|Death|5|||
162678213|NCT02077166|587530928|FG003|Overall Study|Death|6|||
162678214|NCT02077166|587530929|FG004|Overall Study|Death|4|||
162678215|NCT02077166|587530930|FG005|Overall Study|Death|32|||
162678216|NCT02077166|587530931|FG006|Overall Study|Death|22|||
162678217|NCT02077166|587530925|FG000|Overall Study|Study Closure by Sponsor|3|||
162678218|NCT02077166|587530926|FG001|Overall Study|Study Closure by Sponsor|0|||
162678219|NCT02077166|587530927|FG002|Overall Study|Study Closure by Sponsor|2|||
162678220|NCT02077166|587530928|FG003|Overall Study|Study Closure by Sponsor|2|||
162678221|NCT02077166|587530929|FG004|Overall Study|Study Closure by Sponsor|2|||
162678222|NCT02077166|587530930|FG005|Overall Study|Study Closure by Sponsor|12|||
162678223|NCT02077166|587530931|FG006|Overall Study|Study Closure by Sponsor|4|||
162678224|NCT02077166|587530925|FG000|Overall Study|Lost to Follow-up|0|||
162678225|NCT02077166|587530926|FG001|Overall Study|Lost to Follow-up|0|||
162678226|NCT02077166|587530927|FG002|Overall Study|Lost to Follow-up|0|||
162678227|NCT02077166|587530928|FG003|Overall Study|Lost to Follow-up|0|||
162678228|NCT02077166|587530929|FG004|Overall Study|Lost to Follow-up|0|||
162678229|NCT02077166|587530930|FG005|Overall Study|Lost to Follow-up|1|||
162678230|NCT02077166|587530931|FG006|Overall Study|Lost to Follow-up|0|||
162678231|NCT02077166|587530925|FG000|Overall Study|Withdrawal by Subject|3|||
162678232|NCT02077166|587530926|FG001|Overall Study|Withdrawal by Subject|0|||
162678233|NCT02077166|587530927|FG002|Overall Study|Withdrawal by Subject|1|||
162678234|NCT02077166|587530928|FG003|Overall Study|Withdrawal by Subject|1|||
162678235|NCT02077166|587530929|FG004|Overall Study|Withdrawal by Subject|1|||
162678236|NCT02077166|587530930|FG005|Overall Study|Withdrawal by Subject|3|||
162678237|NCT02077166|587530931|FG006|Overall Study|Withdrawal by Subject|0|||
162678238|NCT02077166|587530925|FG000|Overall Study|Other, Not Specified|0|||
162723818|NCT00516321|587697725|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
162678239|NCT02077166|587530926|FG001|Overall Study|Other, Not Specified|0|||
162678240|NCT02077166|587530927|FG002|Overall Study|Other, Not Specified|1|||
162678241|NCT02077166|587530928|FG003|Overall Study|Other, Not Specified|0|||
162678242|NCT02077166|587530929|FG004|Overall Study|Other, Not Specified|1|||
162678243|NCT02077166|587530930|FG005|Overall Study|Other, Not Specified|7|||
162678244|NCT02077166|587530931|FG006|Overall Study|Other, Not Specified|8|||
162723819|NCT00516321|587697723|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
162678245|NCT01261338|587530932|FG000|Overall Study|Withdrawal by Subject|3|||
162678246|NCT01261338|587530933|FG001|Overall Study|Withdrawal by Subject|2|||
162678247|NCT02899728|587530939|FG000|Overall Study|Withdrawal by Subject|1|||
162678248|NCT02899728|587530940|FG001|Overall Study|Withdrawal by Subject|1|||
162678249|NCT05557942|587530941|FG000|Overall Study|Death|0|||
162678250|NCT05557942|587530942|FG001|Overall Study|Death|0|||
162678251|NCT05557942|587530943|FG002|Overall Study|Death|0|||
162678252|NCT05557942|587530944|FG003|Overall Study|Death|2|||
162723820|NCT00516321|587697724|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
162723821|NCT00516321|587697725|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
162723822|NCT00516321|587697723|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
162723823|NCT00516321|587697724|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
162723824|NCT00516321|587697725|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
162723825|NCT01318382|587697729|FG000|Overall Study|Physician Decision|2|||
162723826|NCT01318382|587697729|FG000|Overall Study|Device Malfunction|10|||
162723827|NCT01318382|587697729|FG000|Overall Study|Protocol Violation|1|||
162723828|NCT01308567|587697732|FG000|Overall Study|Lost to Follow-up|2|||
162723829|NCT01308567|587697733|FG001|Overall Study|Lost to Follow-up|4|||
162723830|NCT01308567|587697734|FG002|Overall Study|Lost to Follow-up|4|||
162723831|NCT01571596|587697735|FG000|Overall Study|Adverse Event|2|||
162723832|NCT01571596|587697736|FG001|Overall Study|Adverse Event|0|||
162723833|NCT01571596|587697737|FG002|Overall Study|Adverse Event|0|||
162723834|NCT01571596|587697735|FG000|Overall Study|Study Terminated by the Sponsor|0|||
162723835|NCT01571596|587697736|FG001|Overall Study|Study Terminated by the Sponsor|1|||
162723836|NCT01571596|587697737|FG002|Overall Study|Study Terminated by the Sponsor|1|||
162723837|NCT01582100|587697742|FG000|Overall Study|Adverse Event|1|||
162723838|NCT01582100|587697742|FG000|Overall Study|Withdrawal by Subject|1|||
162723839|NCT01078116|587697749|FG000|Overall Study|Lost to Follow-up|17|||
162723840|NCT01078116|587697749|FG000|Overall Study|Adverse Event|5|||
162723841|NCT01078116|587697749|FG000|Overall Study|Withdrawal by Subject|8|||
162723842|NCT01078116|587697749|FG000|Overall Study|Lack of effectiveness|15|||
162723843|NCT01078116|587697749|FG000|Overall Study|Case report form not completed|3|||
162723844|NCT02499159|587697750|FG000|Randomization|Protocol Violation|1|||
162723845|NCT02499159|587697751|FG001|Randomization|Protocol Violation|1|||
162723846|NCT02499159|587697750|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
162723847|NCT02499159|587697751|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
162723848|NCT02499159|587697750|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
162723849|NCT02499159|587697751|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
162723850|NCT02499159|587697750|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
162723851|NCT02499159|587697751|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
162723852|NCT02499159|587697750|FG000|30-Day Follow-Up Phone Call|Other|1|||
162723853|NCT02499159|587697751|FG001|30-Day Follow-Up Phone Call|Other|0|||
162723854|NCT02242487|587697752|FG000|Overall Study|Adverse Event|13|||
162723855|NCT02242487|587697753|FG001|Overall Study|Adverse Event|15|||
162723856|NCT02242487|587697752|FG000|Overall Study|Lack of Efficacy|4|||
162723857|NCT02242487|587697753|FG001|Overall Study|Lack of Efficacy|6|||
162723858|NCT02242487|587697752|FG000|Overall Study|Protocol Violation|2|||
162723859|NCT02242487|587697753|FG001|Overall Study|Protocol Violation|0|||
162723860|NCT02242487|587697752|FG000|Overall Study|Lost to Follow-up|2|||
162723861|NCT02242487|587697753|FG001|Overall Study|Lost to Follow-up|1|||
162723862|NCT02242487|587697752|FG000|Overall Study|Other - Miscellaneous|4|||
162723863|NCT02242487|587697753|FG001|Overall Study|Other - Miscellaneous|6|||
162678253|NCT05557942|587530945|FG004|Overall Study|Death|1|||
162678254|NCT05557942|587530946|FG005|Overall Study|Death|1|||
162678255|NCT05557942|587530941|FG000|Overall Study|Physician Decision|1|||
162678256|NCT05557942|587530942|FG001|Overall Study|Physician Decision|1|||
162678257|NCT05557942|587530943|FG002|Overall Study|Physician Decision|2|||
162678258|NCT05557942|587530944|FG003|Overall Study|Physician Decision|3|||
162678259|NCT05557942|587530945|FG004|Overall Study|Physician Decision|0|||
162678260|NCT05557942|587530946|FG005|Overall Study|Physician Decision|2|||
162678261|NCT05557942|587530941|FG000|Overall Study|Study terminated by sponsor|17|||
162678262|NCT05557942|587530942|FG001|Overall Study|Study terminated by sponsor|17|||
162678263|NCT05557942|587530943|FG002|Overall Study|Study terminated by sponsor|14|||
162678264|NCT05557942|587530944|FG003|Overall Study|Study terminated by sponsor|40|||
162678265|NCT05557942|587530945|FG004|Overall Study|Study terminated by sponsor|45|||
162678266|NCT05557942|587530946|FG005|Overall Study|Study terminated by sponsor|37|||
162678267|NCT05557942|587530941|FG000|Overall Study|Protocol Violation|0|||
162678268|NCT05557942|587530942|FG001|Overall Study|Protocol Violation|0|||
162678269|NCT05557942|587530943|FG002|Overall Study|Protocol Violation|0|||
162678270|NCT05557942|587530944|FG003|Overall Study|Protocol Violation|0|||
162678271|NCT05557942|587530945|FG004|Overall Study|Protocol Violation|0|||
162678272|NCT05557942|587530946|FG005|Overall Study|Protocol Violation|1|||
162678273|NCT05557942|587530941|FG000|Overall Study|Withdrawal by Subject|0|||
162678274|NCT05557942|587530942|FG001|Overall Study|Withdrawal by Subject|0|||
162678275|NCT05557942|587530943|FG002|Overall Study|Withdrawal by Subject|0|||
162678276|NCT05557942|587530944|FG003|Overall Study|Withdrawal by Subject|0|||
162678277|NCT05557942|587530945|FG004|Overall Study|Withdrawal by Subject|2|||
162678278|NCT05557942|587530946|FG005|Overall Study|Withdrawal by Subject|0|||
162678279|NCT01962493|587530947|FG000|Overall Study|Adverse Event|1|||
162678280|NCT01962493|587530948|FG001|Overall Study|Adverse Event|2|||
162678281|NCT01962493|587530947|FG000|Overall Study|Protocol Violation|0|||
162678282|NCT01962493|587530948|FG001|Overall Study|Protocol Violation|1|||
162678283|NCT01962493|587530947|FG000|Overall Study|Withdrawal by Subject|4|||
162723864|NCT02242487|587697752|FG000|Overall Study|Withdrawal by Subject|37|||
162723865|NCT02242487|587697753|FG001|Overall Study|Withdrawal by Subject|19|||
162723866|NCT03644849|587697754|FG000|Overall Study|Lost to Follow-up|1|||
162678284|NCT01962493|587530948|FG001|Overall Study|Withdrawal by Subject|2|||
162678285|NCT01951625|587530949|FG000|Treatment Period|Protocol Violation|2|||
162678286|NCT01951625|587530950|FG001|Treatment Period|Protocol Violation|0|||
162678287|NCT01951625|587530951|FG002|Treatment Period|Protocol Violation|1|||
162678288|NCT01951625|587530952|FG003|Treatment Period|Protocol Violation|3|||
162678289|NCT01951625|587530953|FG004|Treatment Period|Protocol Violation|2|||
162678290|NCT01951625|587530949|FG000|Treatment Period|Physician Decision|0|||
162678291|NCT01951625|587530950|FG001|Treatment Period|Physician Decision|0|||
162678292|NCT01951625|587530951|FG002|Treatment Period|Physician Decision|0|||
162678293|NCT01951625|587530952|FG003|Treatment Period|Physician Decision|0|||
162678294|NCT01951625|587530953|FG004|Treatment Period|Physician Decision|1|||
162678295|NCT01951625|587530949|FG000|Treatment Period|Protocol driven decision point|0|||
162678296|NCT01951625|587530950|FG001|Treatment Period|Protocol driven decision point|5|||
162678297|NCT01951625|587530951|FG002|Treatment Period|Protocol driven decision point|0|||
162678298|NCT01951625|587530952|FG003|Treatment Period|Protocol driven decision point|2|||
162678299|NCT01951625|587530953|FG004|Treatment Period|Protocol driven decision point|1|||
162678300|NCT01951625|587530949|FG000|Treatment Period|Non compliance with study drug|1|||
162678301|NCT01951625|587530950|FG001|Treatment Period|Non compliance with study drug|2|||
162678302|NCT01951625|587530951|FG002|Treatment Period|Non compliance with study drug|2|||
162678303|NCT01951625|587530952|FG003|Treatment Period|Non compliance with study drug|0|||
162678304|NCT01951625|587530953|FG004|Treatment Period|Non compliance with study drug|0|||
162678305|NCT01951625|587530949|FG000|Treatment Period|Death|3|||
162678306|NCT01951625|587530950|FG001|Treatment Period|Death|2|||
162678307|NCT01951625|587530951|FG002|Treatment Period|Death|2|||
162678308|NCT01951625|587530952|FG003|Treatment Period|Death|1|||
162678309|NCT01951625|587530953|FG004|Treatment Period|Death|2|||
162678310|NCT01951625|587530949|FG000|Treatment Period|Adverse Event|7|||
162678311|NCT01951625|587530950|FG001|Treatment Period|Adverse Event|10|||
162678312|NCT01951625|587530951|FG002|Treatment Period|Adverse Event|9|||
162678313|NCT01951625|587530952|FG003|Treatment Period|Adverse Event|8|||
162678314|NCT01951625|587530953|FG004|Treatment Period|Adverse Event|8|||
162678315|NCT01951625|587530949|FG000|Treatment Period|Withdrawal by Subject|5|||
162678316|NCT01951625|587530950|FG001|Treatment Period|Withdrawal by Subject|2|||
162678317|NCT01951625|587530951|FG002|Treatment Period|Withdrawal by Subject|1|||
162678318|NCT01951625|587530952|FG003|Treatment Period|Withdrawal by Subject|7|||
162678319|NCT01951625|587530953|FG004|Treatment Period|Withdrawal by Subject|3|||
162678320|NCT01951625|587530949|FG000|Treatment Period|Lost to Follow-up|1|||
162678321|NCT01951625|587530950|FG001|Treatment Period|Lost to Follow-up|0|||
162678322|NCT01951625|587530951|FG002|Treatment Period|Lost to Follow-up|0|||
162678323|NCT01951625|587530952|FG003|Treatment Period|Lost to Follow-up|1|||
162678324|NCT01951625|587530953|FG004|Treatment Period|Lost to Follow-up|0|||
162678325|NCT01951625|587530949|FG000|Follow Up Period|Non-compliance with study drug|1|||
162678326|NCT01951625|587530950|FG001|Follow Up Period|Non-compliance with study drug|0|||
162678327|NCT01951625|587530951|FG002|Follow Up Period|Non-compliance with study drug|0|||
162678328|NCT01951625|587530952|FG003|Follow Up Period|Non-compliance with study drug|0|||
162678329|NCT01951625|587530953|FG004|Follow Up Period|Non-compliance with study drug|0|||
162723867|NCT03644849|587697755|FG001|Overall Study|Lost to Follow-up|3|||
162723868|NCT02564744|587697756|FG000|Overall Study|Investigator decision|0|||
162678330|NCT01951625|587530949|FG000|Follow Up Period|Death|1|||
162678331|NCT01951625|587530950|FG001|Follow Up Period|Death|3|||
162678332|NCT01951625|587530951|FG002|Follow Up Period|Death|2|||
162678333|NCT01951625|587530952|FG003|Follow Up Period|Death|2|||
162678334|NCT01951625|587530953|FG004|Follow Up Period|Death|1|||
162723869|NCT02564744|587697757|FG001|Overall Study|Investigator decision|0|||
162723870|NCT02564744|587697758|FG002|Overall Study|Investigator decision|0|||
162723871|NCT02564744|587697759|FG003|Overall Study|Investigator decision|0|||
162723872|NCT02564744|587697760|FG004|Overall Study|Investigator decision|1|||
162723873|NCT02564744|587697756|FG000|Overall Study|Death|10|||
162723874|NCT02564744|587697757|FG001|Overall Study|Death|5|||
162723875|NCT02564744|587697758|FG002|Overall Study|Death|4|||
162723876|NCT02564744|587697759|FG003|Overall Study|Death|16|||
162723877|NCT02564744|587697760|FG004|Overall Study|Death|16|||
162678335|NCT01951625|587530949|FG000|Follow Up Period|Logistical difficulties|1|||
162678336|NCT01951625|587530950|FG001|Follow Up Period|Logistical difficulties|2|||
162678337|NCT01951625|587530951|FG002|Follow Up Period|Logistical difficulties|0|||
162678338|NCT01951625|587530952|FG003|Follow Up Period|Logistical difficulties|0|||
162678339|NCT01951625|587530953|FG004|Follow Up Period|Logistical difficulties|0|||
162678340|NCT01951625|587530949|FG000|Follow Up Period|Adverse Event|0|||
162678341|NCT01951625|587530950|FG001|Follow Up Period|Adverse Event|3|||
162678342|NCT01951625|587530951|FG002|Follow Up Period|Adverse Event|2|||
162678343|NCT01951625|587530952|FG003|Follow Up Period|Adverse Event|3|||
162678344|NCT01951625|587530953|FG004|Follow Up Period|Adverse Event|5|||
162678345|NCT01951625|587530949|FG000|Follow Up Period|Withdrawal by Subject|4|||
162678346|NCT01951625|587530950|FG001|Follow Up Period|Withdrawal by Subject|1|||
162678347|NCT01951625|587530951|FG002|Follow Up Period|Withdrawal by Subject|0|||
162678348|NCT01951625|587530952|FG003|Follow Up Period|Withdrawal by Subject|5|||
162678349|NCT01951625|587530953|FG004|Follow Up Period|Withdrawal by Subject|3|||
162678350|NCT01951625|587530949|FG000|Follow Up Period|Lost to Follow-up|1|||
162678351|NCT01951625|587530950|FG001|Follow Up Period|Lost to Follow-up|0|||
162678352|NCT01951625|587530951|FG002|Follow Up Period|Lost to Follow-up|0|||
162678353|NCT01951625|587530952|FG003|Follow Up Period|Lost to Follow-up|1|||
162678354|NCT01951625|587530953|FG004|Follow Up Period|Lost to Follow-up|1|||
162678355|NCT03754803|587530956|FG000|Overall Study|Withdrawal by Subject|2|||
162678356|NCT05338333|587530957|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
162678357|NCT05338333|587530958|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
162678358|NCT04348604|587530961|FG000|Week 8|Withdrawal by Subject|1|||
162678359|NCT04348604|587530962|FG001|Week 8|Withdrawal by Subject|1|||
162678360|NCT04348604|587530961|FG000|Week 8|Lost to Follow-up|1|||
162678361|NCT04348604|587530962|FG001|Week 8|Lost to Follow-up|2|||
162678362|NCT04348604|587530961|FG000|Week 8|Suspended|0|||
162678363|NCT04348604|587530962|FG001|Week 8|Suspended|1|||
162678364|NCT04348604|587530961|FG000|Week 12|Lost to Follow-up|1|||
162678365|NCT04348604|587530962|FG001|Week 12|Lost to Follow-up|2|||
162678366|NCT04348604|587530961|FG000|Week 12|Withdrawal by Subject|1|||
162678367|NCT04348604|587530962|FG001|Week 12|Withdrawal by Subject|0|||
162678368|NCT04348604|587530961|FG000|Week 24|Lost to Follow-up|2|||
162678369|NCT04348604|587530962|FG001|Week 24|Lost to Follow-up|1|||
162678370|NCT02822222|587532102|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
162678371|NCT02822222|587532103|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
162678372|NCT00833560|587532104|FG000|Overall Study|Toxicity|13|||
162678373|NCT00833560|587532104|FG000|Overall Study|Adverse Event|11|||
162678374|NCT00833560|587532104|FG000|Overall Study|Protocol Violation|6|||
162678375|NCT00833560|587532104|FG000|Overall Study|Lack of Efficacy|4|||
162678376|NCT00833560|587532104|FG000|Overall Study|Death|2|||
162723878|NCT02564744|587697756|FG000|Overall Study|End of study Page Missing|0|||
162723879|NCT02564744|587697757|FG001|Overall Study|End of study Page Missing|0|||
162723880|NCT02564744|587697758|FG002|Overall Study|End of study Page Missing|3|||
162678377|NCT00833560|587532104|FG000|Overall Study|Pregression of other disease|1|||
162678378|NCT00833560|587532104|FG000|Overall Study|Other|5|||
162723881|NCT02564744|587697759|FG003|Overall Study|End of study Page Missing|3|||
162723882|NCT02564744|587697760|FG004|Overall Study|End of study Page Missing|0|||
162723883|NCT02564744|587697756|FG000|Overall Study|Subject Withdrew Consent|1|||
162723884|NCT02564744|587697757|FG001|Overall Study|Subject Withdrew Consent|1|||
162723885|NCT02564744|587697758|FG002|Overall Study|Subject Withdrew Consent|1|||
162723886|NCT02564744|587697759|FG003|Overall Study|Subject Withdrew Consent|0|||
162723887|NCT02564744|587697760|FG004|Overall Study|Subject Withdrew Consent|2|||
162723888|NCT02564744|587697756|FG000|Overall Study|Lost to Follow-up|0|||
162723889|NCT02564744|587697757|FG001|Overall Study|Lost to Follow-up|1|||
162723890|NCT02564744|587697758|FG002|Overall Study|Lost to Follow-up|0|||
162723891|NCT02564744|587697759|FG003|Overall Study|Lost to Follow-up|0|||
162723892|NCT02564744|587697760|FG004|Overall Study|Lost to Follow-up|1|||
162723893|NCT02564744|587697756|FG000|Overall Study|Reason not specified|1|||
162723894|NCT02564744|587697757|FG001|Overall Study|Reason not specified|0|||
162723895|NCT02564744|587697758|FG002|Overall Study|Reason not specified|0|||
162723896|NCT02564744|587697759|FG003|Overall Study|Reason not specified|0|||
162723897|NCT02564744|587697760|FG004|Overall Study|Reason not specified|0|||
162723898|NCT00979992|587697762|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162723899|NCT00979992|587697762|FG000|Overall Study|Ineligible - wrong cell type|2|||
162723900|NCT00979992|587697762|FG000|Overall Study|Refused - Never Treated|2|||
162723901|NCT01140048|587697768|FG000|Overall Study|Physician Decision|1|||
162723902|NCT01140048|587697768|FG000|Overall Study|Withdrawal by Subject|13|||
162723903|NCT01140048|587697768|FG000|Overall Study|Lost to Follow-up|31|||
162723904|NCT02888080|587697769|FG000|Overall Study|Subject / Guardian decision|1|||
162723905|NCT02888080|587697770|FG001|Overall Study|Subject / Guardian decision|3|||
162723906|NCT02888080|587697769|FG000|Overall Study|New Therapy for study indication|1|||
162723907|NCT02888080|587697770|FG001|Overall Study|New Therapy for study indication|0|||
162723908|NCT02888080|587697769|FG000|Overall Study|Lack of Efficacy|0|||
162723909|NCT02888080|587697770|FG001|Overall Study|Lack of Efficacy|1|||
162723910|NCT02888080|587697769|FG000|Overall Study|Adverse Event|0|||
162723911|NCT02888080|587697770|FG001|Overall Study|Adverse Event|1|||
162723912|NCT03737240|587697775|FG000|Overall Study|Lost to Follow-up|16|||
162723913|NCT03737240|587697776|FG001|Overall Study|Lost to Follow-up|15|||
162723914|NCT02512965|587697779|FG000|Overall Study|Withdrawal by Subject|0|||
162723915|NCT02512965|587697780|FG001|Overall Study|Withdrawal by Subject|4|||
162723916|NCT05001945|587697784|FG000|Overall Study|Adverse Event|0|||
162723917|NCT05001945|587697785|FG001|Overall Study|Adverse Event|0|||
162723918|NCT05001945|587697786|FG002|Overall Study|Adverse Event|0|||
162723919|NCT05001945|587697787|FG003|Overall Study|Adverse Event|1|||
162723920|NCT05001945|587697788|FG004|Overall Study|Adverse Event|0|||
162723921|NCT05001945|587697789|FG005|Overall Study|Adverse Event|0|||
162723922|NCT05001945|587697790|FG006|Overall Study|Adverse Event|0|||
162723923|NCT05001945|587697791|FG007|Overall Study|Adverse Event|0|||
162723924|NCT05001945|587697784|FG000|Overall Study|Lost to Follow-up|0|||
162723925|NCT05001945|587697785|FG001|Overall Study|Lost to Follow-up|1|||
162723926|NCT05001945|587697786|FG002|Overall Study|Lost to Follow-up|1|||
162723927|NCT05001945|587697787|FG003|Overall Study|Lost to Follow-up|2|||
162723928|NCT05001945|587697788|FG004|Overall Study|Lost to Follow-up|0|||
162723929|NCT05001945|587697789|FG005|Overall Study|Lost to Follow-up|1|||
162723930|NCT05001945|587697790|FG006|Overall Study|Lost to Follow-up|0|||
162723931|NCT05001945|587697791|FG007|Overall Study|Lost to Follow-up|0|||
162723932|NCT05001945|587697784|FG000|Overall Study|Protocol Violation|1|||
162723933|NCT05001945|587697785|FG001|Overall Study|Protocol Violation|0|||
162723934|NCT05001945|587697786|FG002|Overall Study|Protocol Violation|1|||
162723935|NCT05001945|587697787|FG003|Overall Study|Protocol Violation|1|||
162723936|NCT05001945|587697788|FG004|Overall Study|Protocol Violation|0|||
162723937|NCT05001945|587697789|FG005|Overall Study|Protocol Violation|1|||
162723938|NCT05001945|587697790|FG006|Overall Study|Protocol Violation|0|||
162723939|NCT05001945|587697791|FG007|Overall Study|Protocol Violation|0|||
162723940|NCT05001945|587697784|FG000|Overall Study|Withdrawal by Subject|0|||
162723941|NCT05001945|587697785|FG001|Overall Study|Withdrawal by Subject|0|||
162723942|NCT05001945|587697786|FG002|Overall Study|Withdrawal by Subject|0|||
162723943|NCT05001945|587697787|FG003|Overall Study|Withdrawal by Subject|1|||
162723944|NCT05001945|587697788|FG004|Overall Study|Withdrawal by Subject|1|||
162723945|NCT05001945|587697789|FG005|Overall Study|Withdrawal by Subject|1|||
162723946|NCT05001945|587697790|FG006|Overall Study|Withdrawal by Subject|0|||
162723947|NCT05001945|587697791|FG007|Overall Study|Withdrawal by Subject|1|||
162723948|NCT05001945|587697784|FG000|Overall Study|Not specified by Investigator|0|||
162723949|NCT05001945|587697785|FG001|Overall Study|Not specified by Investigator|3|||
162723950|NCT05001945|587697786|FG002|Overall Study|Not specified by Investigator|0|||
162723951|NCT05001945|587697787|FG003|Overall Study|Not specified by Investigator|0|||
162723952|NCT05001945|587697788|FG004|Overall Study|Not specified by Investigator|1|||
162723953|NCT05001945|587697789|FG005|Overall Study|Not specified by Investigator|0|||
162723954|NCT05001945|587697790|FG006|Overall Study|Not specified by Investigator|0|||
162723955|NCT05001945|587697791|FG007|Overall Study|Not specified by Investigator|0|||
162723956|NCT02570711|587697792|FG000|Overall Study|Death|1|||
162723957|NCT02570711|587697793|FG001|Overall Study|Death|0|||
162723958|NCT02570711|587697792|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
162723959|NCT02570711|587697793|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
162723960|NCT01369498|587697794|FG000|Overall Study|Lack of Efficacy|9|||
162723961|NCT01369498|587697795|FG001|Overall Study|Lack of Efficacy|9|||
162723962|NCT01369498|587697796|FG002|Overall Study|Lack of Efficacy|1|||
162723963|NCT01369498|587697797|FG003|Overall Study|Lack of Efficacy|3|||
162723964|NCT01369498|587697794|FG000|Overall Study|Adverse Event|1|||
162723965|NCT01369498|587697795|FG001|Overall Study|Adverse Event|2|||
162723966|NCT01369498|587697796|FG002|Overall Study|Adverse Event|0|||
162723967|NCT01369498|587697797|FG003|Overall Study|Adverse Event|1|||
162723968|NCT01369498|587697794|FG000|Overall Study|Withdrawal of Consent|0|||
162723969|NCT01369498|587697795|FG001|Overall Study|Withdrawal of Consent|1|||
162723970|NCT01369498|587697796|FG002|Overall Study|Withdrawal of Consent|1|||
162723971|NCT01369498|587697797|FG003|Overall Study|Withdrawal of Consent|1|||
162723972|NCT01369498|587697794|FG000|Overall Study|Death|0|||
162723973|NCT01369498|587697795|FG001|Overall Study|Death|0|||
162723974|NCT01369498|587697796|FG002|Overall Study|Death|1|||
162723975|NCT01369498|587697797|FG003|Overall Study|Death|0|||
162723976|NCT01369498|587697794|FG000|Overall Study|Investigator's Discretion|1|||
162723977|NCT01369498|587697795|FG001|Overall Study|Investigator's Discretion|0|||
162723978|NCT01369498|587697796|FG002|Overall Study|Investigator's Discretion|1|||
162723979|NCT01369498|587697797|FG003|Overall Study|Investigator's Discretion|3|||
162723980|NCT01369498|587697794|FG000|Overall Study|Unknown Reason|1|||
162678379|NCT00440531|587532108|FG000|Overall Study|Adverse Event|1|||
162678380|NCT00440531|587532109|FG001|Overall Study|Adverse Event|0|||
162678381|NCT00440531|587532110|FG002|Overall Study|Adverse Event|2|||
162678382|NCT00440531|587532108|FG000|Overall Study|Withdrawal by Subject|2|||
162678383|NCT00440531|587532109|FG001|Overall Study|Withdrawal by Subject|0|||
162678384|NCT00440531|587532110|FG002|Overall Study|Withdrawal by Subject|0|||
162678385|NCT00440531|587532108|FG000|Overall Study|Protocol Violation|1|||
162678386|NCT00440531|587532109|FG001|Overall Study|Protocol Violation|2|||
162678387|NCT00440531|587532110|FG002|Overall Study|Protocol Violation|0|||
162678388|NCT00440531|587532108|FG000|Overall Study|Lost to Follow-up|4|||
162678389|NCT00440531|587532109|FG001|Overall Study|Lost to Follow-up|3|||
162678390|NCT00440531|587532110|FG002|Overall Study|Lost to Follow-up|5|||
162678391|NCT00440531|587532108|FG000|Overall Study|see pre-assignment details|2|||
162678392|NCT00440531|587532109|FG001|Overall Study|see pre-assignment details|0|||
162678393|NCT00440531|587532110|FG002|Overall Study|see pre-assignment details|0|||
162678394|NCT01791725|587532111|FG000|Overall Study|Withdrawal by Subject|0|||
162678395|NCT01791725|587532112|FG001|Overall Study|Withdrawal by Subject|1|||
162678396|NCT01791725|587532113|FG002|Overall Study|Withdrawal by Subject|0|||
162678397|NCT02690974|587532116|FG000|Overall Study|Adverse Event|16|||
162678398|NCT02690974|587532116|FG000|Overall Study|Death|9|||
162678399|NCT02690974|587532116|FG000|Overall Study|Subject/guardian decision|4|||
162678400|NCT02690974|587532116|FG000|Overall Study|Lost to Follow-up|3|||
162678401|NCT02690974|587532116|FG000|Overall Study|Withdrawal of Informed Consent|3|||
162678402|NCT02690974|587532116|FG000|Overall Study|Physician Decision|2|||
162678403|NCT02690974|587532116|FG000|Overall Study|Non-compliance with study treatment|1|||
162678404|NCT02690974|587532116|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162678405|NCT02690974|587532116|FG000|Overall Study|Protocol Deviation|1|||
162678406|NCT01666951|587532119|FG000|Overall Study|Not dosed|1|||
162678407|NCT01666951|587532120|FG001|Overall Study|Not dosed|1|||
162678408|NCT00254982|587532136|FG000|Overall Study|Other|2|||
162678409|NCT00254982|587532137|FG001|Overall Study|Other|1|||
162678410|NCT00254982|587532136|FG000|Overall Study|Lack of Efficacy|5|||
162723981|NCT01369498|587697795|FG001|Overall Study|Unknown Reason|0|||
162723982|NCT01369498|587697796|FG002|Overall Study|Unknown Reason|11|||
162723983|NCT01369498|587697797|FG003|Overall Study|Unknown Reason|6|||
162723984|NCT01369498|587697794|FG000|Overall Study|Disease Progression|0|||
162723985|NCT01369498|587697795|FG001|Overall Study|Disease Progression|0|||
162723986|NCT01369498|587697796|FG002|Overall Study|Disease Progression|0|||
162678411|NCT00254982|587532137|FG001|Overall Study|Lack of Efficacy|3|||
162678412|NCT00254982|587532136|FG000|Overall Study|Lost to Follow-up|5|||
162678413|NCT00254982|587532137|FG001|Overall Study|Lost to Follow-up|3|||
162678414|NCT00254982|587532136|FG000|Overall Study|Adverse Event|18|||
162678415|NCT00254982|587532137|FG001|Overall Study|Adverse Event|16|||
162678416|NCT00254982|587532136|FG000|Overall Study|Withdrawal by Subject|1|||
162678417|NCT00254982|587532137|FG001|Overall Study|Withdrawal by Subject|1|||
162678418|NCT00254982|587532136|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
162678419|NCT00254982|587532137|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
162723987|NCT01369498|587697797|FG003|Overall Study|Disease Progression|1|||
162723988|NCT00545077|587697799|FG000|Overall Study|Treatment not received|5|||
162678420|NCT00254982|587532136|FG000|Overall Study|Protocol deviation|1|||
162678421|NCT00254982|587532137|FG001|Overall Study|Protocol deviation|1|||
162678422|NCT00254982|587532136|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
162678423|NCT00254982|587532137|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
162678424|NCT00254982|587532136|FG000|Overall Study|Malignancy|0|||
162678425|NCT00254982|587532137|FG001|Overall Study|Malignancy|2|||
162678426|NCT00254982|587532136|FG000|Overall Study|Opportunistic infection|1|||
162678427|NCT00254982|587532137|FG001|Overall Study|Opportunistic infection|0|||
162678428|NCT00254982|587532136|FG000|Overall Study|Abnormal liver function tests|2|||
162678429|NCT00254982|587532137|FG001|Overall Study|Abnormal liver function tests|1|||
162678430|NCT02570126|587532138|FG000|Overall Study|Lost to Follow-up|2|||
162678431|NCT02570126|587532139|FG001|Overall Study|Lost to Follow-up|0|||
162678432|NCT02570126|587532138|FG000|Overall Study|Unable To Arrange Visit 3|1|||
162678433|NCT02570126|587532139|FG001|Overall Study|Unable To Arrange Visit 3|0|||
162678434|NCT02570126|587532138|FG000|Overall Study|Violation Of Procedures GSK|0|||
162678435|NCT02570126|587532139|FG001|Overall Study|Violation Of Procedures GSK|1|||
162678436|NCT02570126|587532138|FG000|Overall Study|Protocol Violation|0|||
162678437|NCT02570126|587532139|FG001|Overall Study|Protocol Violation|1|||
162678438|NCT02570126|587532138|FG000|Overall Study|Withdrawal by Subject|3|||
162678439|NCT02570126|587532139|FG001|Overall Study|Withdrawal by Subject|7|||
162678440|NCT00626028|587532140|FG000|Overall Study|Adverse Event|1|||
162678441|NCT00626028|587532141|FG001|Overall Study|Adverse Event|1|||
162678442|NCT00626028|587532140|FG000|Overall Study|Device Failure|0|||
162678443|NCT00626028|587532141|FG001|Overall Study|Device Failure|1|||
162678444|NCT00626028|587532140|FG000|Overall Study|Physician Decision|2|||
162678445|NCT00626028|587532141|FG001|Overall Study|Physician Decision|1|||
162678446|NCT00626028|587532140|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
162678447|NCT00626028|587532141|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
162678448|NCT05224050|587532143|FG000|Overall Study|Withdrawal by Subject|9|||
162678449|NCT05224050|587532143|FG000|Overall Study|Lost to Follow-up|3|||
162678450|NCT01292876|587532144|FG000|Overall Study|Physician Decision|4|||
162678451|NCT00917579|587532145|FG000|Washout >= 2 Weeks|Adverse Event|1|||
162678452|NCT00917579|587532146|FG001|Washout >= 2 Weeks|Adverse Event|0|||
162678453|NCT00917579|587532145|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
162678454|NCT00917579|587532146|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
162678455|NCT01627327|587532147|FG000|Overall Study|Adverse Event|6|||
162678456|NCT01627327|587532148|FG001|Overall Study|Adverse Event|12|||
162678457|NCT01627327|587532147|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
162678458|NCT01627327|587532148|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
162678459|NCT01627327|587532147|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
162678460|NCT01627327|587532148|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
162678461|NCT01627327|587532147|FG000|Overall Study|Protocol Violation|4|||
162678462|NCT01627327|587532148|FG001|Overall Study|Protocol Violation|10|||
162678463|NCT01627327|587532147|FG000|Overall Study|Lost to Follow-up|1|||
162678464|NCT01627327|587532148|FG001|Overall Study|Lost to Follow-up|3|||
162678465|NCT01627327|587532147|FG000|Overall Study|Physician Decision|1|||
162678466|NCT01627327|587532148|FG001|Overall Study|Physician Decision|0|||
162678467|NCT01627327|587532147|FG000|Overall Study|Withdrawal by Subject|3|||
162678468|NCT01627327|587532148|FG001|Overall Study|Withdrawal by Subject|3|||
162678469|NCT05763628|587532154|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
162678470|NCT05763628|587532155|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
162678471|NCT05763628|587532154|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
162678472|NCT05763628|587532155|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
162678473|NCT05763628|587532154|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
162678474|NCT05763628|587532155|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
162678475|NCT01137474|587532156|FG000|Overall Study|Adverse Event|3|||
162678476|NCT01137474|587532157|FG001|Overall Study|Adverse Event|5|||
162678477|NCT01137474|587532158|FG002|Overall Study|Adverse Event|1|||
162678478|NCT01137474|587532159|FG003|Overall Study|Adverse Event|3|||
162678479|NCT01137474|587532156|FG000|Overall Study|Withdrawal by Subject|7|||
162678480|NCT01137474|587532157|FG001|Overall Study|Withdrawal by Subject|2|||
162678481|NCT01137474|587532158|FG002|Overall Study|Withdrawal by Subject|6|||
162678482|NCT01137474|587532159|FG003|Overall Study|Withdrawal by Subject|9|||
162678483|NCT01137474|587532156|FG000|Overall Study|No longer met study criteria|6|||
162678484|NCT01137474|587532157|FG001|Overall Study|No longer met study criteria|1|||
162678485|NCT01137474|587532158|FG002|Overall Study|No longer met study criteria|0|||
162723989|NCT00545077|587697800|FG001|Overall Study|Treatment not received|1|||
162678486|NCT01137474|587532159|FG003|Overall Study|No longer met study criteria|5|||
162723990|NCT00545077|587697799|FG000|Overall Study|Disease Progression|131|||
162723991|NCT00545077|587697800|FG001|Overall Study|Disease Progression|98|||
162723992|NCT00545077|587697799|FG000|Overall Study|Withdrawal by Subject|3|||
162678487|NCT01137474|587532156|FG000|Overall Study|Lost to Follow-up|5|||
162678488|NCT01137474|587532157|FG001|Overall Study|Lost to Follow-up|1|||
162678489|NCT01137474|587532158|FG002|Overall Study|Lost to Follow-up|0|||
162678490|NCT01137474|587532159|FG003|Overall Study|Lost to Follow-up|2|||
162678491|NCT01137474|587532156|FG000|Overall Study|Lack of Efficacy|0|||
162678492|NCT01137474|587532157|FG001|Overall Study|Lack of Efficacy|0|||
162678493|NCT01137474|587532158|FG002|Overall Study|Lack of Efficacy|0|||
162678494|NCT01137474|587532159|FG003|Overall Study|Lack of Efficacy|2|||
162678495|NCT01137474|587532156|FG000|Overall Study|Other|3|||
162678496|NCT01137474|587532157|FG001|Overall Study|Other|1|||
162678497|NCT01137474|587532158|FG002|Overall Study|Other|0|||
162678498|NCT01137474|587532159|FG003|Overall Study|Other|0|||
162678499|NCT01137474|587532156|FG000|Overall Study|Pregnancy|0|||
162678500|NCT01137474|587532157|FG001|Overall Study|Pregnancy|1|||
162678501|NCT01137474|587532158|FG002|Overall Study|Pregnancy|0|||
162678502|NCT01137474|587532159|FG003|Overall Study|Pregnancy|0|||
162678503|NCT01137474|587532156|FG000|Overall Study|Administrative reason by sponsor|0|||
162678504|NCT01137474|587532157|FG001|Overall Study|Administrative reason by sponsor|1|||
162678505|NCT01137474|587532158|FG002|Overall Study|Administrative reason by sponsor|0|||
162678506|NCT01137474|587532159|FG003|Overall Study|Administrative reason by sponsor|0|||
162678507|NCT00868439|587532165|FG000|Overall Study|Adverse Event|4|||
162678508|NCT00868439|587532166|FG001|Overall Study|Adverse Event|3|||
162678509|NCT00868439|587532165|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
162678510|NCT00868439|587532166|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
162678511|NCT00868439|587532165|FG000|Overall Study|Death|0|||
162678512|NCT00868439|587532166|FG001|Overall Study|Death|1|||
162678513|NCT00868439|587532165|FG000|Overall Study|Protocol Violation|1|||
162678514|NCT00868439|587532166|FG001|Overall Study|Protocol Violation|1|||
162678515|NCT00868439|587532165|FG000|Overall Study|Physician Decision|1|||
162678516|NCT00868439|587532166|FG001|Overall Study|Physician Decision|0|||
162678517|NCT00868439|587532165|FG000|Overall Study|Withdrawal by Subject|0|||
162678518|NCT00868439|587532166|FG001|Overall Study|Withdrawal by Subject|1|||
162678519|NCT01132326|587532167|FG000|Overall Study|Lack of Efficacy|25|||
162678520|NCT01132326|587532167|FG000|Overall Study|Adverse Event|37|||
162678521|NCT01132326|587532167|FG000|Overall Study|Protocol Violation|1|||
162678522|NCT01132326|587532167|FG000|Overall Study|Lost to Follow-up|16|||
162678523|NCT01132326|587532167|FG000|Overall Study|Withdrawal by Subject|40|||
162678524|NCT01132326|587532167|FG000|Overall Study|Physician Decision|10|||
162678525|NCT01132326|587532167|FG000|Overall Study|Study Termination|80|||
162678526|NCT01132326|587532167|FG000|Overall Study|Declining Health|1|||
162678527|NCT01132326|587532167|FG000|Overall Study|Pregnancy|1|||
162678528|NCT01132326|587532167|FG000|Overall Study|Caregiver Withdrew Consent|1|||
162678529|NCT01132326|587532167|FG000|Overall Study|Death|5|||
162678530|NCT01132326|587532167|FG000|Overall Study|Subject Unable to Come To Visits|1|||
162678531|NCT00338884|587532170|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
162678532|NCT00338884|587532170|FG000|Overall Study|Adverse Event|14|||
162678533|NCT00338884|587532170|FG000|Overall Study|Death|8|||
162678534|NCT00338884|587532170|FG000|Overall Study|Other|4|||
162678535|NCT00338884|587532170|FG000|Overall Study|Global Deterioration of Health Status|3|||
162678536|NCT00338884|587532170|FG000|Overall Study|Withdrawal by Subject|3|||
162678537|NCT00338884|587532170|FG000|Overall Study|Lost to Follow-up|1|||
162678538|NCT00338884|587532170|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
162678539|NCT00911534|587532171|FG000|Overall Study|Adverse Event|4|||
162678540|NCT00911534|587532172|FG001|Overall Study|Adverse Event|4|||
162678541|NCT00911534|587532171|FG000|Overall Study|Lost to Follow-up|2|||
162678542|NCT00911534|587532172|FG001|Overall Study|Lost to Follow-up|4|||
162678543|NCT00911534|587532171|FG000|Overall Study|Withdrawal by Subject|2|||
162678544|NCT00911534|587532172|FG001|Overall Study|Withdrawal by Subject|1|||
162678545|NCT00911534|587532171|FG000|Overall Study|Lack of Efficacy|4|||
162678546|NCT00911534|587532172|FG001|Overall Study|Lack of Efficacy|1|||
162678547|NCT00911534|587532171|FG000|Overall Study|Withdrawal of consent|1|||
162678548|NCT00911534|587532172|FG001|Overall Study|Withdrawal of consent|4|||
162678549|NCT00911534|587532171|FG000|Overall Study|Other|2|||
162678550|NCT00911534|587532172|FG001|Overall Study|Other|2|||
162678551|NCT03492281|587532174|FG000|Overall Study|Withdrawal by Subject|21|||
162678552|NCT03492281|587532175|FG001|Overall Study|Withdrawal by Subject|14|||
162678553|NCT03492281|587532176|FG002|Overall Study|Withdrawal by Subject|13|||
162678554|NCT03492281|587532174|FG000|Overall Study|Lost to Follow-up|14|||
162678555|NCT03492281|587532175|FG001|Overall Study|Lost to Follow-up|15|||
162678556|NCT03492281|587532176|FG002|Overall Study|Lost to Follow-up|10|||
162678557|NCT03492281|587532174|FG000|Overall Study|Adverse Event|6|||
162678558|NCT03492281|587532175|FG001|Overall Study|Adverse Event|8|||
162678559|NCT03492281|587532176|FG002|Overall Study|Adverse Event|13|||
162678560|NCT03492281|587532174|FG000|Overall Study|Lack of Efficacy|3|||
162678561|NCT03492281|587532175|FG001|Overall Study|Lack of Efficacy|0|||
162678562|NCT03492281|587532176|FG002|Overall Study|Lack of Efficacy|1|||
162678563|NCT03492281|587532174|FG000|Overall Study|Physician Decision|1|||
162678564|NCT03492281|587532175|FG001|Overall Study|Physician Decision|0|||
162678565|NCT03492281|587532176|FG002|Overall Study|Physician Decision|3|||
162678566|NCT03492281|587532174|FG000|Overall Study|Protocol Violation|0|||
162678567|NCT03492281|587532175|FG001|Overall Study|Protocol Violation|2|||
162678568|NCT03492281|587532176|FG002|Overall Study|Protocol Violation|1|||
162678569|NCT03492281|587532174|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
162678570|NCT03492281|587532175|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
162678571|NCT03492281|587532176|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
162678572|NCT03492281|587532174|FG000|Overall Study|Death|0|||
162678573|NCT03492281|587532175|FG001|Overall Study|Death|0|||
162678574|NCT03492281|587532176|FG002|Overall Study|Death|1|||
162678575|NCT03492281|587532174|FG000|Overall Study|Captured as Other in Database|8|||
162678576|NCT03492281|587532175|FG001|Overall Study|Captured as Other in Database|6|||
162678577|NCT03492281|587532176|FG002|Overall Study|Captured as Other in Database|3|||
162678578|NCT03342638|587532177|FG000|Overall Study|Withdrawal by Subject|1|||
162678579|NCT03342638|587532178|FG001|Overall Study|Withdrawal by Subject|0|||
162678580|NCT03342638|587532177|FG000|Overall Study|Physician Decision|0|||
162678581|NCT03342638|587532178|FG001|Overall Study|Physician Decision|1|||
162678582|NCT00113568|587532190|FG000|Overall Study|Adverse Event|97|||
162678583|NCT00113568|587532190|FG000|Overall Study|Death|1|||
162678584|NCT00113568|587532190|FG000|Overall Study|Lack of Efficacy|30|||
162678585|NCT00113568|587532190|FG000|Overall Study|Lost to Follow-up|156|||
162678586|NCT00113568|587532190|FG000|Overall Study|Protocol Violation|32|||
162678587|NCT00113568|587532190|FG000|Overall Study|Withdrawal by Subject|117|||
162678588|NCT00113568|587532190|FG000|Overall Study|Other|112|||
162678589|NCT02191267|587532192|FG000|Overall Study|Withdrawal by Subject|1|||
162678590|NCT02191267|587532193|FG001|Overall Study|Withdrawal by Subject|0|||
162678591|NCT02191267|587532194|FG002|Overall Study|Withdrawal by Subject|0|||
162678592|NCT03213158|587532197|FG000|Overall Study|Withdrawal by Subject|1|||
162678593|NCT03213158|587532197|FG000|Overall Study|Physician Decision|2|||
162678594|NCT00587964|587532198|FG000|Overall Study|Withdrawal by Subject|1|||
162678595|NCT00587964|587532198|FG000|Overall Study|Lost to Follow-up|1|||
162678596|NCT00587964|587532198|FG000|Overall Study|Patient found to be ineligible|1|||
162678597|NCT00587964|587532198|FG000|Overall Study|Patient did not receive intervention|5|||
162678598|NCT00587964|587532198|FG000|Overall Study|Progression of Disease|4|||
162678599|NCT01569438|587532200|FG000|Overall Study|Lack of Efficacy|1|||
162678600|NCT01569438|587532201|FG001|Overall Study|Lack of Efficacy|2|||
162678601|NCT01569438|587532200|FG000|Overall Study|Withdrawal by Subject|0|||
162678602|NCT01569438|587532201|FG001|Overall Study|Withdrawal by Subject|3|||
162678603|NCT01569438|587532200|FG000|Overall Study|Adverse Event|2|||
162678604|NCT01569438|587532201|FG001|Overall Study|Adverse Event|15|||
162678605|NCT01569438|587532200|FG000|Overall Study|Protocol Violation|2|||
162678606|NCT01569438|587532201|FG001|Overall Study|Protocol Violation|0|||
162678607|NCT01569438|587532200|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
162678608|NCT01569438|587532201|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
162678609|NCT01569438|587532200|FG000|Overall Study|Sponsor/Physician decision|1|||
162678610|NCT01569438|587532201|FG001|Overall Study|Sponsor/Physician decision|1|||
162678611|NCT01569438|587532200|FG000|Overall Study|Unable to adhere to study schedule|0|||
162678612|NCT01569438|587532201|FG001|Overall Study|Unable to adhere to study schedule|1|||
162678613|NCT03649230|587532203|FG000|Overall Study|Adverse Event|12|||
162678614|NCT03649230|587532203|FG000|Overall Study|Death|8|||
162678615|NCT03649230|587532203|FG000|Overall Study|Withdrawal by Subject|6|||
162678616|NCT03649230|587532203|FG000|Overall Study|Physician Decision|5|||
162678617|NCT03649230|587532203|FG000|Overall Study|Disease progression|5|||
162678618|NCT03649230|587532203|FG000|Overall Study|Switched to non-HEC|5|||
162678619|NCT03649230|587532203|FG000|Overall Study|Chemotherapy discontinued|4|||
162678620|NCT03649230|587532203|FG000|Overall Study|Received only 3 HEC cycles|4|||
162678621|NCT03649230|587532203|FG000|Overall Study|Screen Failure|3|||
162678622|NCT03649230|587532203|FG000|Overall Study|Patient stopped treatment|2|||
162678623|NCT03649230|587532203|FG000|Overall Study|Protocol Violation|1|||
162678624|NCT03649230|587532203|FG000|Overall Study|Non-compliance|1|||
162678625|NCT03649230|587532203|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
162678626|NCT01693068|587532207|FG000|Randomization Period|On-study|2|||
162678627|NCT01693068|587532208|FG001|Randomization Period|On-study|5|||
162678628|NCT01693068|587532209|FG002|Randomization Period|On-study|0|||
162678629|NCT01693068|587532207|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
162678630|NCT01693068|587532208|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
162678631|NCT01693068|587532209|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
162678632|NCT04302350|587532212|FG000|Overall Study|Physician Decision|1|||
162678633|NCT04302350|587532213|FG001|Overall Study|Physician Decision|1|||
162678634|NCT04302350|587532214|FG002|Overall Study|Physician Decision|2|||
162678635|NCT04302350|587532212|FG000|Overall Study|Lack of Efficacy|1|||
162678636|NCT04302350|587532213|FG001|Overall Study|Lack of Efficacy|1|||
162678637|NCT04302350|587532214|FG002|Overall Study|Lack of Efficacy|4|||
162678638|NCT04302350|587532212|FG000|Overall Study|Adverse Event|0|||
162678639|NCT04302350|587532213|FG001|Overall Study|Adverse Event|1|||
162678640|NCT04302350|587532214|FG002|Overall Study|Adverse Event|2|||
162678641|NCT00617344|587532215|FG000|Overall Study|Serious adverse event|1|||
162678642|NCT00617344|587532216|FG001|Overall Study|Serious adverse event|0|||
162678643|NCT00617344|587532217|FG002|Overall Study|Serious adverse event|0|||
162678644|NCT00617344|587532215|FG000|Overall Study|Other Adverse Event|1|||
162678645|NCT00617344|587532216|FG001|Overall Study|Other Adverse Event|1|||
162678646|NCT00617344|587532217|FG002|Overall Study|Other Adverse Event|0|||
162678647|NCT00617344|587532215|FG000|Overall Study|Protocol Violation|10|||
162678648|NCT00617344|587532216|FG001|Overall Study|Protocol Violation|8|||
162678649|NCT00617344|587532217|FG002|Overall Study|Protocol Violation|5|||
162678650|NCT00617344|587532215|FG000|Overall Study|Lost to Follow-up|5|||
162678651|NCT00617344|587532216|FG001|Overall Study|Lost to Follow-up|4|||
162678652|NCT00617344|587532217|FG002|Overall Study|Lost to Follow-up|1|||
162678653|NCT00617344|587532215|FG000|Overall Study|Withdrawal by Subject|8|||
162678654|NCT00617344|587532216|FG001|Overall Study|Withdrawal by Subject|9|||
162678655|NCT00617344|587532217|FG002|Overall Study|Withdrawal by Subject|2|||
162678656|NCT02747238|587532219|FG000|Overall Study|Lack of Efficacy|0|||
162678657|NCT02747238|587532220|FG001|Overall Study|Lack of Efficacy|1|||
162678658|NCT02747238|587532219|FG000|Overall Study|Data lost|3|||
162678659|NCT02747238|587532220|FG001|Overall Study|Data lost|5|||
162678660|NCT05245864|587532225|FG000|Overall Study|Withdrawal by Subject|1|||
162678661|NCT05245864|587532226|FG001|Overall Study|Withdrawal by Subject|1|||
162678662|NCT01475136|587532227|FG000|Overall Study|Sponsor Decision|0|||
162678663|NCT01475136|587532228|FG001|Overall Study|Sponsor Decision|1|||
162678664|NCT01475136|587532229|FG002|Overall Study|Sponsor Decision|0|||
162678665|NCT01475136|587532230|FG003|Overall Study|Sponsor Decision|0|||
162678666|NCT01475136|587532227|FG000|Overall Study|Entry Criteria Not Met|0|||
162678667|NCT01475136|587532228|FG001|Overall Study|Entry Criteria Not Met|2|||
162678668|NCT01475136|587532229|FG002|Overall Study|Entry Criteria Not Met|3|||
162678669|NCT01475136|587532230|FG003|Overall Study|Entry Criteria Not Met|1|||
162678670|NCT01475136|587532227|FG000|Overall Study|Withdrawal by Subject|0|||
162678671|NCT01475136|587532228|FG001|Overall Study|Withdrawal by Subject|0|||
162678672|NCT01475136|587532229|FG002|Overall Study|Withdrawal by Subject|0|||
162678673|NCT01475136|587532230|FG003|Overall Study|Withdrawal by Subject|2|||
162678674|NCT01475136|587532227|FG000|Overall Study|Adverse Event|1|||
162678675|NCT01475136|587532228|FG001|Overall Study|Adverse Event|0|||
162678676|NCT01475136|587532229|FG002|Overall Study|Adverse Event|0|||
162678677|NCT01475136|587532230|FG003|Overall Study|Adverse Event|1|||
162678678|NCT01475136|587532227|FG000|Overall Study|Death|0|||
162678679|NCT01475136|587532228|FG001|Overall Study|Death|0|||
162678680|NCT01475136|587532229|FG002|Overall Study|Death|0|||
162678681|NCT01475136|587532230|FG003|Overall Study|Death|1|||
162678682|NCT01323530|587534447|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
162678683|NCT01323530|587534448|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162723993|NCT00545077|587697800|FG001|Overall Study|Withdrawal by Subject|14|||
162723994|NCT00545077|587697799|FG000|Overall Study|Physician Decision|6|||
162723995|NCT00545077|587697800|FG001|Overall Study|Physician Decision|3|||
162723996|NCT00545077|587697799|FG000|Overall Study|Lost to Follow-up|2|||
162723997|NCT00545077|587697800|FG001|Overall Study|Lost to Follow-up|0|||
162723998|NCT00545077|587697799|FG000|Overall Study|Protocol Violation|1|||
162723999|NCT00545077|587697800|FG001|Overall Study|Protocol Violation|0|||
162724000|NCT00545077|587697799|FG000|Overall Study|Adverse Event|0|||
162724001|NCT00545077|587697800|FG001|Overall Study|Adverse Event|31|||
162724002|NCT00545077|587697799|FG000|Overall Study|Death|0|||
162724003|NCT00545077|587697800|FG001|Overall Study|Death|8|||
162724004|NCT02957136|587697807|FG000|Overall Study|Withdrawal by Subject|2|||
162724005|NCT02957136|587697808|FG001|Overall Study|Withdrawal by Subject|1|||
162724006|NCT00439569|587697809|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
162724007|NCT00439569|587697809|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
162724008|NCT00439569|587697809|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
162724009|NCT02755116|587697811|FG000|Overall Study|surgery converted to open, pt admitted|3|||
162724010|NCT02755116|587697812|FG001|Overall Study|surgery converted to open, pt admitted|1|||
162724011|NCT01124734|587697813|FG000|Overall Study|Disease progression|13|||
162724012|NCT01124734|587697813|FG000|Overall Study|Adverse Event|1|||
162724013|NCT01124734|587697813|FG000|Overall Study|Withdrawal by Subject|1|||
162724014|NCT01124734|587697813|FG000|Overall Study|Elected for alternative treatment|2|||
162724015|NCT02423798|587697814|FG000|Overall Study|Withdrawal by Subject|3|||
162724016|NCT00939510|587697815|FG000|Overall Study|Withdrawal by Subject|1|||
162724017|NCT01202955|587697816|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
162724018|NCT01202955|587697817|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
162724019|NCT00159783|587697822|FG000|Overall Study|Adverse Event|5|||
162724020|NCT00159783|587697823|FG001|Overall Study|Adverse Event|7|||
162724021|NCT00159783|587697824|FG002|Overall Study|Adverse Event|9|||
162724022|NCT00159783|587697822|FG000|Overall Study|Lack of Efficacy|1|||
162724023|NCT00159783|587697823|FG001|Overall Study|Lack of Efficacy|2|||
162724024|NCT00159783|587697824|FG002|Overall Study|Lack of Efficacy|3|||
162724025|NCT00159783|587697822|FG000|Overall Study|Withdrawal by Subject|7|||
162724026|NCT00159783|587697823|FG001|Overall Study|Withdrawal by Subject|11|||
162724027|NCT00159783|587697824|FG002|Overall Study|Withdrawal by Subject|12|||
162724028|NCT00159783|587697822|FG000|Overall Study|Lost to Follow-up|6|||
162724029|NCT00159783|587697823|FG001|Overall Study|Lost to Follow-up|5|||
162724030|NCT00159783|587697824|FG002|Overall Study|Lost to Follow-up|11|||
162724031|NCT00159783|587697822|FG000|Overall Study|Other|0|||
162724032|NCT00159783|587697823|FG001|Overall Study|Other|2|||
162724033|NCT00159783|587697824|FG002|Overall Study|Other|4|||
162724034|NCT00305695|587697825|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
162724035|NCT00305695|587697826|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
162724036|NCT00305695|587697825|FG000|Overall Study|Did not have baseline scan|1|||
162724037|NCT00305695|587697826|FG001|Overall Study|Did not have baseline scan|1|||
162724038|NCT01597258|587697827|FG000|Overall Study|No Drug Administration|1|||
162724039|NCT04789408|587697828|FG000|Overall Study|Death|4|||
162724040|NCT04789408|587697829|FG001|Overall Study|Death|3|||
162724041|NCT04789408|587697830|FG002|Overall Study|Death|6|||
162724042|NCT04789408|587697828|FG000|Overall Study|Did not meet eligibility criteria|1|||
162724043|NCT04789408|587697829|FG001|Overall Study|Did not meet eligibility criteria|0|||
162724044|NCT04789408|587697830|FG002|Overall Study|Did not meet eligibility criteria|0|||
162724045|NCT04789408|587697828|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
162724046|NCT04789408|587697829|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
162724047|NCT04789408|587697830|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
162724048|NCT03073941|587699768|FG000|Overall Study|Received non-study device intraoperatively|0|||
162724049|NCT03073941|587699769|FG001|Overall Study|Received non-study device intraoperatively|2|||
162724050|NCT03073941|587699768|FG000|Overall Study|Death|1|||
162724051|NCT03073941|587699769|FG001|Overall Study|Death|0|||
162724052|NCT03073941|587699768|FG000|Overall Study|Withdrawal by Subject|1|||
162724053|NCT03073941|587699769|FG001|Overall Study|Withdrawal by Subject|3|||
162724054|NCT03073941|587699768|FG000|Overall Study|Lost to Follow-up|5|||
162724055|NCT03073941|587699769|FG001|Overall Study|Lost to Follow-up|4|||
162724056|NCT03073941|587699768|FG000|Overall Study|Adverse Event|4|||
162724057|NCT03073941|587699769|FG001|Overall Study|Adverse Event|2|||
162724058|NCT03073941|587699768|FG000|Overall Study|Met an exclusion criterion|0|||
162724059|NCT03073941|587699769|FG001|Overall Study|Met an exclusion criterion|1|||
162724060|NCT04250883|587699770|FG000|Overall Study|Lost to Follow-up|1|||
162724061|NCT04250883|587699771|FG001|Overall Study|Lost to Follow-up|0|||
162724062|NCT03936660|587699772|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
162724063|NCT03936660|587699773|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
162724064|NCT00840177|587699774|FG000|Overall Study|Adverse Event|5|||
162724065|NCT00840177|587699775|FG001|Overall Study|Adverse Event|1|||
162724066|NCT00840177|587699776|FG002|Overall Study|Adverse Event|1|||
162724067|NCT00840177|587699774|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162724068|NCT00840177|587699775|FG001|Overall Study|Refusal unrelated to adverse events|0|||
162678684|NCT01323530|587534449|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162678685|NCT01323530|587534450|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162678686|NCT01323530|587534451|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162678687|NCT01323530|587534452|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
162678688|NCT01323530|587534453|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162678689|NCT01323530|587534447|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162678690|NCT01323530|587534448|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162678691|NCT01323530|587534449|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162678692|NCT01323530|587534450|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162678693|NCT01323530|587534451|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
162678694|NCT01323530|587534452|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162678695|NCT01323530|587534453|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162678696|NCT01323530|587534447|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162678697|NCT01323530|587534448|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162678698|NCT01323530|587534449|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162678699|NCT01323530|587534450|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162678700|NCT01323530|587534451|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162678701|NCT01323530|587534452|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162678702|NCT01323530|587534453|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162678703|NCT01323530|587534447|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678704|NCT01323530|587534448|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678705|NCT01323530|587534449|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678706|NCT01323530|587534450|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678707|NCT01323530|587534451|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678708|NCT01323530|587534452|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162678709|NCT01323530|587534453|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
162678710|NCT01323530|587534447|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678711|NCT01323530|587534448|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678712|NCT01323530|587534449|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678713|NCT01323530|587534450|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678714|NCT01323530|587534451|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678715|NCT01323530|587534452|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162678716|NCT01323530|587534453|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
162678717|NCT01323530|587534447|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678718|NCT01323530|587534448|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678719|NCT01323530|587534449|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678720|NCT01323530|587534450|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678721|NCT01323530|587534451|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678722|NCT01323530|587534452|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162678723|NCT01323530|587534453|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
162678724|NCT01323530|587534447|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678725|NCT01323530|587534448|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678726|NCT01323530|587534449|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678727|NCT01323530|587534450|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678728|NCT01323530|587534451|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678729|NCT01323530|587534452|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162678730|NCT01323530|587534453|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
162678731|NCT01323530|587534447|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678732|NCT01323530|587534448|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678733|NCT01323530|587534449|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678734|NCT01323530|587534450|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678735|NCT01323530|587534451|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678736|NCT01323530|587534452|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162678737|NCT01323530|587534453|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
162678738|NCT01194570|587534456|FG000|Overall Study|Adverse Event|22|||
162678739|NCT01194570|587534457|FG001|Overall Study|Adverse Event|40|||
162678740|NCT01194570|587534456|FG000|Overall Study|Death|6|||
162678741|NCT01194570|587534457|FG001|Overall Study|Death|20|||
162678742|NCT01194570|587534456|FG000|Overall Study|Lack of Efficacy|32|||
162678743|NCT01194570|587534457|FG001|Overall Study|Lack of Efficacy|33|||
162678744|NCT01194570|587534456|FG000|Overall Study|Lost to Follow-up|4|||
162678745|NCT01194570|587534457|FG001|Overall Study|Lost to Follow-up|15|||
162678746|NCT01194570|587534456|FG000|Overall Study|Non-Compliance|2|||
162678747|NCT01194570|587534457|FG001|Overall Study|Non-Compliance|2|||
162678748|NCT01194570|587534456|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162678749|NCT01194570|587534457|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162678750|NCT01194570|587534456|FG000|Overall Study|Other|18|||
162678751|NCT01194570|587534457|FG001|Overall Study|Other|47|||
162678752|NCT01194570|587534456|FG000|Overall Study|Physician Decision|10|||
162724069|NCT00840177|587699776|FG002|Overall Study|Refusal unrelated to adverse events|1|||
162724070|NCT00840177|587699774|FG000|Overall Study|Progression/relapse|2|||
162724071|NCT00840177|587699775|FG001|Overall Study|Progression/relapse|0|||
162724072|NCT00840177|587699776|FG002|Overall Study|Progression/relapse|0|||
162724073|NCT00840177|587699774|FG000|Overall Study|Death|4|||
162724074|NCT00840177|587699775|FG001|Overall Study|Death|5|||
162724075|NCT00840177|587699776|FG002|Overall Study|Death|5|||
162724076|NCT00840177|587699774|FG000|Overall Study|not protocol specified|6|||
162724077|NCT00840177|587699775|FG001|Overall Study|not protocol specified|3|||
162724078|NCT00840177|587699776|FG002|Overall Study|not protocol specified|0|||
162724079|NCT00840177|587699774|FG000|Overall Study|Ineligible|0|||
162724080|NCT00840177|587699775|FG001|Overall Study|Ineligible|0|||
162724081|NCT00840177|587699776|FG002|Overall Study|Ineligible|3|||
162724082|NCT00840177|587699774|FG000|Overall Study|Did not start treatment|0|||
162724083|NCT00840177|587699775|FG001|Overall Study|Did not start treatment|0|||
162724084|NCT00840177|587699776|FG002|Overall Study|Did not start treatment|1|||
162724085|NCT00925587|587699779|FG000|Overall Study|Protocol Specified Criteria|6|||
162724086|NCT00925587|587699780|FG001|Overall Study|Protocol Specified Criteria|6|||
162724087|NCT00925587|587699779|FG000|Overall Study|Physician Decision|4|||
162724088|NCT00925587|587699780|FG001|Overall Study|Physician Decision|1|||
162724089|NCT00925587|587699779|FG000|Overall Study|Protocol Violation|6|||
162724090|NCT00925587|587699780|FG001|Overall Study|Protocol Violation|4|||
162724091|NCT00925587|587699779|FG000|Overall Study|Withdrawal by Subject|9|||
162724092|NCT00925587|587699780|FG001|Overall Study|Withdrawal by Subject|6|||
162724093|NCT00925587|587699779|FG000|Overall Study|Death|5|||
162724094|NCT00925587|587699780|FG001|Overall Study|Death|5|||
162724095|NCT00925587|587699779|FG000|Overall Study|Adverse Event|6|||
162724096|NCT00925587|587699780|FG001|Overall Study|Adverse Event|2|||
162724097|NCT00925587|587699779|FG000|Overall Study|Lost to Follow-up|0|||
162724098|NCT00925587|587699780|FG001|Overall Study|Lost to Follow-up|1|||
162724099|NCT02271854|587699785|FG000|Overall Study|Withdrawal by Subject|2|||
162724100|NCT02271854|587699785|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
162724101|NCT02271854|587699785|FG000|Overall Study|Lost to Follow-up|1|||
162724102|NCT00774397|587699786|FG000|Overall Study|Adverse Event|1|||
162724103|NCT00774397|587699787|FG001|Overall Study|Adverse Event|3|||
162724104|NCT00774397|587699788|FG002|Overall Study|Adverse Event|16|||
162724105|NCT00774397|587699789|FG003|Overall Study|Adverse Event|8|||
162724106|NCT00774397|587699790|FG004|Overall Study|Adverse Event|8|||
162724107|NCT00774397|587699791|FG005|Overall Study|Adverse Event|3|||
162724108|NCT00774397|587699792|FG006|Overall Study|Adverse Event|16|||
162724109|NCT00774397|587699786|FG000|Overall Study|Lack of Efficacy|11|||
162724110|NCT00774397|587699787|FG001|Overall Study|Lack of Efficacy|4|||
162724111|NCT00774397|587699788|FG002|Overall Study|Lack of Efficacy|5|||
162724112|NCT00774397|587699789|FG003|Overall Study|Lack of Efficacy|3|||
162724113|NCT00774397|587699790|FG004|Overall Study|Lack of Efficacy|27|||
162724114|NCT00774397|587699791|FG005|Overall Study|Lack of Efficacy|15|||
162724115|NCT00774397|587699792|FG006|Overall Study|Lack of Efficacy|9|||
162724116|NCT00774397|587699786|FG000|Overall Study|Protocol Violation|0|||
162724117|NCT00774397|587699787|FG001|Overall Study|Protocol Violation|1|||
162724118|NCT00774397|587699788|FG002|Overall Study|Protocol Violation|3|||
162724119|NCT00774397|587699789|FG003|Overall Study|Protocol Violation|1|||
162724120|NCT00774397|587699790|FG004|Overall Study|Protocol Violation|2|||
162724121|NCT00774397|587699791|FG005|Overall Study|Protocol Violation|1|||
162724122|NCT00774397|587699792|FG006|Overall Study|Protocol Violation|0|||
162724123|NCT00774397|587699786|FG000|Overall Study|Lost to Follow-up|0|||
162724124|NCT00774397|587699787|FG001|Overall Study|Lost to Follow-up|1|||
162724125|NCT00774397|587699788|FG002|Overall Study|Lost to Follow-up|1|||
162724126|NCT00774397|587699789|FG003|Overall Study|Lost to Follow-up|1|||
162724127|NCT00774397|587699790|FG004|Overall Study|Lost to Follow-up|0|||
162724128|NCT00774397|587699791|FG005|Overall Study|Lost to Follow-up|1|||
162724129|NCT00774397|587699792|FG006|Overall Study|Lost to Follow-up|0|||
162724130|NCT00774397|587699786|FG000|Overall Study|Refused to continue trial medication|1|||
162724131|NCT00774397|587699787|FG001|Overall Study|Refused to continue trial medication|3|||
162724132|NCT00774397|587699788|FG002|Overall Study|Refused to continue trial medication|2|||
162724133|NCT00774397|587699789|FG003|Overall Study|Refused to continue trial medication|2|||
162724134|NCT00774397|587699790|FG004|Overall Study|Refused to continue trial medication|6|||
162724135|NCT00774397|587699791|FG005|Overall Study|Refused to continue trial medication|2|||
162724136|NCT00774397|587699792|FG006|Overall Study|Refused to continue trial medication|3|||
162724137|NCT00774397|587699786|FG000|Overall Study|Not treated|0|||
162724138|NCT00774397|587699787|FG001|Overall Study|Not treated|0|||
162724139|NCT00774397|587699788|FG002|Overall Study|Not treated|0|||
162724140|NCT00774397|587699789|FG003|Overall Study|Not treated|0|||
162724141|NCT00774397|587699790|FG004|Overall Study|Not treated|1|||
162724142|NCT00774397|587699791|FG005|Overall Study|Not treated|0|||
162724143|NCT00774397|587699792|FG006|Overall Study|Not treated|1|||
162724144|NCT00774397|587699786|FG000|Overall Study|Other than those stated above|1|||
162724145|NCT00774397|587699787|FG001|Overall Study|Other than those stated above|1|||
162724146|NCT00774397|587699788|FG002|Overall Study|Other than those stated above|3|||
162724147|NCT00774397|587699789|FG003|Overall Study|Other than those stated above|2|||
162724148|NCT00774397|587699790|FG004|Overall Study|Other than those stated above|2|||
162724149|NCT00774397|587699791|FG005|Overall Study|Other than those stated above|0|||
162724150|NCT00774397|587699792|FG006|Overall Study|Other than those stated above|1|||
162724151|NCT01599793|587699793|FG000|Overall Study|Adverse Event|2|||
162724152|NCT02652442|587699806|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
162724153|NCT02252042|587699807|FG000|Overall Study|Adverse Event|9|||
162724154|NCT02252042|587699808|FG001|Overall Study|Adverse Event|6|||
162724155|NCT02252042|587699807|FG000|Overall Study|Death|209|||
162724156|NCT02252042|587699808|FG001|Overall Study|Death|217|||
162724157|NCT02252042|587699807|FG000|Overall Study|Physician Decision|0|||
162724158|NCT02252042|587699808|FG001|Overall Study|Physician Decision|2|||
162724159|NCT02252042|587699807|FG000|Overall Study|Transferred to Extension Study|7|||
162724160|NCT02252042|587699808|FG001|Overall Study|Transferred to Extension Study|1|||
162724161|NCT02252042|587699807|FG000|Overall Study|Did Not Continue on Extension Study|7|||
162724162|NCT02252042|587699808|FG001|Overall Study|Did Not Continue on Extension Study|2|||
162724163|NCT02252042|587699807|FG000|Overall Study|Withdrawal by Subject|15|||
162724164|NCT02252042|587699808|FG001|Overall Study|Withdrawal by Subject|20|||
162724165|NCT02593149|587699811|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
162724166|NCT02593149|587699812|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
162724167|NCT02593149|587699811|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
162724168|NCT02593149|587699812|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
162724169|NCT01177670|587699813|FG000|Overall Study|Study Terminated|115|||
162724170|NCT01177670|587699813|FG000|Overall Study|Physician Decision|50|||
162724171|NCT01177670|587699813|FG000|Overall Study|Withdrawal by Subject|4|||
162724172|NCT01636687|587699816|FG000|Induction Period|Withdrawal by Subject|1|||
162724173|NCT01636687|587699817|FG001|Induction Period|Withdrawal by Subject|0|||
162724174|NCT01636687|587699818|FG002|Induction Period|Withdrawal by Subject|0|||
162724175|NCT01636687|587699819|FG003|Induction Period|Withdrawal by Subject|0|||
162724176|NCT01636687|587699820|FG004|Induction Period|Withdrawal by Subject|0|||
162724177|NCT01636687|587699816|FG000|Induction Period|Adverse Event|1|||
162724178|NCT01636687|587699817|FG001|Induction Period|Adverse Event|0|||
162724179|NCT01636687|587699818|FG002|Induction Period|Adverse Event|0|||
162724180|NCT01636687|587699819|FG003|Induction Period|Adverse Event|0|||
162724181|NCT01636687|587699820|FG004|Induction Period|Adverse Event|1|||
162678753|NCT01194570|587534457|FG001|Overall Study|Physician Decision|25|||
162678754|NCT01194570|587534456|FG000|Overall Study|Protocol Violation|1|||
162678755|NCT01194570|587534457|FG001|Overall Study|Protocol Violation|2|||
162678756|NCT01194570|587534456|FG000|Overall Study|Study Terminated By Sponsor|0|||
162678757|NCT01194570|587534457|FG001|Overall Study|Study Terminated By Sponsor|1|||
162678758|NCT01194570|587534456|FG000|Overall Study|Withdrawal by Subject|57|||
162678759|NCT01194570|587534457|FG001|Overall Study|Withdrawal by Subject|82|||
162678760|NCT01194570|587534456|FG000|Overall Study|Pregnancy|1|||
162678761|NCT01194570|587534457|FG001|Overall Study|Pregnancy|1|||
162678762|NCT01377480|587534464|FG000|Overall Study|Protocol Violation|0|||
162678763|NCT01377480|587534465|FG001|Overall Study|Protocol Violation|0|||
162678764|NCT01377480|587534466|FG002|Overall Study|Protocol Violation|0|||
162678765|NCT01377480|587534467|FG003|Overall Study|Protocol Violation|4|||
162678766|NCT01377480|587534464|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
162678767|NCT01377480|587534465|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
162678768|NCT01377480|587534466|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
162678769|NCT01377480|587534467|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
162678770|NCT01377480|587534464|FG000|Overall Study|Withdrawal by Subject|0|||
162678771|NCT01377480|587534465|FG001|Overall Study|Withdrawal by Subject|0|||
162678772|NCT01377480|587534466|FG002|Overall Study|Withdrawal by Subject|1|||
162678773|NCT01377480|587534467|FG003|Overall Study|Withdrawal by Subject|0|||
162678774|NCT01377480|587534464|FG000|Overall Study|Serious adverse event|0|||
162678775|NCT01377480|587534465|FG001|Overall Study|Serious adverse event|0|||
162678776|NCT01377480|587534466|FG002|Overall Study|Serious adverse event|1|||
162678777|NCT01377480|587534467|FG003|Overall Study|Serious adverse event|1|||
162678778|NCT01377480|587534464|FG000|Overall Study|Other|0|||
162678779|NCT01377480|587534465|FG001|Overall Study|Other|0|||
162678780|NCT01377480|587534466|FG002|Overall Study|Other|7|||
162678781|NCT01377480|587534467|FG003|Overall Study|Other|6|||
162678782|NCT01203930|587534472|FG000|Overall Study|Disease Progression|0|||
162678783|NCT01203930|587534473|FG001|Overall Study|Disease Progression|4|||
162678784|NCT01203930|587534472|FG000|Overall Study|Death|3|||
162678785|NCT01203930|587534473|FG001|Overall Study|Death|1|||
162678786|NCT01203930|587534472|FG000|Overall Study|Withdrew Consent|1|||
162678787|NCT01203930|587534473|FG001|Overall Study|Withdrew Consent|10|||
162678788|NCT01203930|587534472|FG000|Overall Study|Investigator Request|0|||
162678789|NCT01203930|587534473|FG001|Overall Study|Investigator Request|8|||
162678790|NCT01203930|587534472|FG000|Overall Study|Study Terminated by Sponsor|0|||
162678791|NCT01203930|587534473|FG001|Overall Study|Study Terminated by Sponsor|12|||
162678792|NCT01203930|587534472|FG000|Overall Study|Poor tolerance of study drug|0|||
162678793|NCT01203930|587534473|FG001|Overall Study|Poor tolerance of study drug|1|||
162678794|NCT01203930|587534472|FG000|Overall Study|Adverse Event|17|||
162678795|NCT01203930|587534473|FG001|Overall Study|Adverse Event|5|||
162678796|NCT01266850|587534476|FG000|Overall Study|Lost to Follow-up|19|||
162678797|NCT01266850|587534477|FG001|Overall Study|Lost to Follow-up|19|||
162678798|NCT01266850|587534478|FG002|Overall Study|Lost to Follow-up|13|||
162678799|NCT01266850|587534479|FG003|Overall Study|Lost to Follow-up|13|||
162678800|NCT01266850|587534480|FG004|Overall Study|Lost to Follow-up|12|||
162678801|NCT01266850|587534476|FG000|Overall Study|Withdrawal by Subject|8|||
162678802|NCT01266850|587534477|FG001|Overall Study|Withdrawal by Subject|9|||
162678803|NCT01266850|587534478|FG002|Overall Study|Withdrawal by Subject|6|||
162678804|NCT01266850|587534479|FG003|Overall Study|Withdrawal by Subject|9|||
162678805|NCT01266850|587534480|FG004|Overall Study|Withdrawal by Subject|12|||
162678806|NCT01266850|587534476|FG000|Overall Study|Physician Decision|3|||
162678807|NCT01266850|587534477|FG001|Overall Study|Physician Decision|6|||
162678808|NCT01266850|587534478|FG002|Overall Study|Physician Decision|4|||
162678809|NCT01266850|587534479|FG003|Overall Study|Physician Decision|4|||
162678810|NCT01266850|587534480|FG004|Overall Study|Physician Decision|3|||
162678811|NCT01266850|587534476|FG000|Overall Study|Protocol Violation|0|||
162678812|NCT01266850|587534477|FG001|Overall Study|Protocol Violation|1|||
162678813|NCT01266850|587534478|FG002|Overall Study|Protocol Violation|0|||
162678814|NCT01266850|587534479|FG003|Overall Study|Protocol Violation|1|||
162678815|NCT01266850|587534480|FG004|Overall Study|Protocol Violation|2|||
162678816|NCT01266850|587534476|FG000|Overall Study|Adverse Event|0|||
162678817|NCT01266850|587534477|FG001|Overall Study|Adverse Event|0|||
162678818|NCT01266850|587534478|FG002|Overall Study|Adverse Event|0|||
162678819|NCT01266850|587534479|FG003|Overall Study|Adverse Event|0|||
162678820|NCT01266850|587534480|FG004|Overall Study|Adverse Event|1|||
162678821|NCT01266850|587534476|FG000|Overall Study|Site Closure|0|||
162678822|NCT01266850|587534477|FG001|Overall Study|Site Closure|1|||
162678823|NCT01266850|587534478|FG002|Overall Study|Site Closure|1|||
162678824|NCT01266850|587534479|FG003|Overall Study|Site Closure|1|||
162678825|NCT01266850|587534480|FG004|Overall Study|Site Closure|0|||
162678826|NCT00857207|587534484|FG000|Overall Study|Withdrawal by Subject|13|||
162678827|NCT00857207|587534485|FG001|Overall Study|Withdrawal by Subject|0|||
162678828|NCT00857207|587534484|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
162678829|NCT00857207|587534485|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
162724182|NCT01636687|587699816|FG000|Induction Period|Lack of Efficacy|0|||
162724183|NCT01636687|587699817|FG001|Induction Period|Lack of Efficacy|0|||
162724184|NCT01636687|587699818|FG002|Induction Period|Lack of Efficacy|0|||
162724185|NCT01636687|587699819|FG003|Induction Period|Lack of Efficacy|0|||
162724186|NCT01636687|587699820|FG004|Induction Period|Lack of Efficacy|1|||
162724187|NCT01636687|587699816|FG000|Induction Period|Physician Decision|1|||
162724188|NCT01636687|587699817|FG001|Induction Period|Physician Decision|0|||
162724189|NCT01636687|587699818|FG002|Induction Period|Physician Decision|0|||
162724190|NCT01636687|587699819|FG003|Induction Period|Physician Decision|0|||
162724191|NCT01636687|587699820|FG004|Induction Period|Physician Decision|0|||
162724192|NCT01636687|587699816|FG000|Maintenance Period|Withdrawal by Subject|2|||
162724193|NCT01636687|587699817|FG001|Maintenance Period|Withdrawal by Subject|0|||
162724194|NCT01636687|587699818|FG002|Maintenance Period|Withdrawal by Subject|2|||
162724195|NCT01636687|587699819|FG003|Maintenance Period|Withdrawal by Subject|0|||
162724196|NCT01636687|587699820|FG004|Maintenance Period|Withdrawal by Subject|0|||
162724197|NCT01636687|587699816|FG000|Maintenance Period|Adverse Event|1|||
162724198|NCT01636687|587699817|FG001|Maintenance Period|Adverse Event|0|||
162724199|NCT01636687|587699818|FG002|Maintenance Period|Adverse Event|0|||
162724200|NCT01636687|587699819|FG003|Maintenance Period|Adverse Event|0|||
162724201|NCT01636687|587699820|FG004|Maintenance Period|Adverse Event|0|||
162724202|NCT01636687|587699816|FG000|Maintenance Period|Lack of Efficacy|4|||
162724203|NCT01636687|587699817|FG001|Maintenance Period|Lack of Efficacy|1|||
162724204|NCT01636687|587699818|FG002|Maintenance Period|Lack of Efficacy|0|||
162724205|NCT01636687|587699819|FG003|Maintenance Period|Lack of Efficacy|0|||
162724206|NCT01636687|587699820|FG004|Maintenance Period|Lack of Efficacy|0|||
162724207|NCT01636687|587699816|FG000|Maintenance Period|Lost to Follow-up|1|||
162724208|NCT01636687|587699817|FG001|Maintenance Period|Lost to Follow-up|1|||
162724209|NCT01636687|587699818|FG002|Maintenance Period|Lost to Follow-up|0|||
162724210|NCT01636687|587699819|FG003|Maintenance Period|Lost to Follow-up|0|||
162724211|NCT01636687|587699820|FG004|Maintenance Period|Lost to Follow-up|1|||
162724212|NCT01636687|587699816|FG000|Maintenance Period|Physician Decision|0|||
162724213|NCT01636687|587699817|FG001|Maintenance Period|Physician Decision|0|||
162724214|NCT01636687|587699818|FG002|Maintenance Period|Physician Decision|0|||
162724215|NCT01636687|587699819|FG003|Maintenance Period|Physician Decision|0|||
162724216|NCT01636687|587699820|FG004|Maintenance Period|Physician Decision|1|||
162724217|NCT01636687|587699816|FG000|Extension Period|technical problems|0|||
162724218|NCT01636687|587699817|FG001|Extension Period|technical problems|1|||
162724219|NCT01636687|587699818|FG002|Extension Period|technical problems|2|||
162724220|NCT01636687|587699819|FG003|Extension Period|technical problems|1|||
162724221|NCT01636687|587699820|FG004|Extension Period|technical problems|0|||
162724222|NCT01636687|587699816|FG000|Extension Period|Adverse Event|4|||
162724223|NCT01636687|587699817|FG001|Extension Period|Adverse Event|3|||
162724224|NCT01636687|587699818|FG002|Extension Period|Adverse Event|2|||
162724225|NCT01636687|587699819|FG003|Extension Period|Adverse Event|1|||
162724226|NCT01636687|587699820|FG004|Extension Period|Adverse Event|0|||
162724227|NCT01636687|587699816|FG000|Extension Period|Lack of Efficacy|7|||
162724228|NCT01636687|587699817|FG001|Extension Period|Lack of Efficacy|0|||
162724229|NCT01636687|587699818|FG002|Extension Period|Lack of Efficacy|2|||
162724230|NCT01636687|587699819|FG003|Extension Period|Lack of Efficacy|1|||
162724231|NCT01636687|587699820|FG004|Extension Period|Lack of Efficacy|0|||
162724232|NCT01636687|587699816|FG000|Extension Period|Lost to Follow-up|1|||
162724233|NCT01636687|587699817|FG001|Extension Period|Lost to Follow-up|0|||
162724234|NCT01636687|587699818|FG002|Extension Period|Lost to Follow-up|1|||
162724235|NCT01636687|587699819|FG003|Extension Period|Lost to Follow-up|0|||
162724236|NCT01636687|587699820|FG004|Extension Period|Lost to Follow-up|0|||
162724237|NCT01636687|587699816|FG000|Extension Period|Physician Decision|1|||
162724238|NCT01636687|587699817|FG001|Extension Period|Physician Decision|0|||
162724239|NCT01636687|587699818|FG002|Extension Period|Physician Decision|0|||
162724240|NCT01636687|587699819|FG003|Extension Period|Physician Decision|1|||
162724241|NCT01636687|587699820|FG004|Extension Period|Physician Decision|0|||
162724242|NCT01636687|587699816|FG000|Extension Period|study terminated by sponsor|33|||
162724243|NCT01636687|587699817|FG001|Extension Period|study terminated by sponsor|50|||
162724244|NCT01636687|587699818|FG002|Extension Period|study terminated by sponsor|17|||
162724245|NCT01636687|587699819|FG003|Extension Period|study terminated by sponsor|23|||
162724246|NCT01636687|587699820|FG004|Extension Period|study terminated by sponsor|0|||
162724247|NCT01636687|587699816|FG000|Extension Period|Withdrawal by Subject|1|||
162724248|NCT01636687|587699817|FG001|Extension Period|Withdrawal by Subject|0|||
162724249|NCT01636687|587699818|FG002|Extension Period|Withdrawal by Subject|1|||
162724250|NCT01636687|587699819|FG003|Extension Period|Withdrawal by Subject|1|||
162724251|NCT01636687|587699820|FG004|Extension Period|Withdrawal by Subject|0|||
162724252|NCT01636687|587699816|FG000|Follow-up Period|Withdrawal by Subject|1|||
162724253|NCT01636687|587699817|FG001|Follow-up Period|Withdrawal by Subject|0|||
162724254|NCT01636687|587699818|FG002|Follow-up Period|Withdrawal by Subject|0|||
162724255|NCT01636687|587699819|FG003|Follow-up Period|Withdrawal by Subject|0|||
162724256|NCT01636687|587699820|FG004|Follow-up Period|Withdrawal by Subject|1|||
162724257|NCT00636207|587699823|FG000|Overall Study|Adverse Event|1|||
162724258|NCT00636207|587699824|FG001|Overall Study|Adverse Event|0|||
162724259|NCT00636207|587699825|FG002|Overall Study|Adverse Event|0|||
162724260|NCT00636207|587699826|FG003|Overall Study|Adverse Event|0|||
162724261|NCT00636207|587699827|FG004|Overall Study|Adverse Event|0|||
162724262|NCT00636207|587699828|FG005|Overall Study|Adverse Event|0|||
162724263|NCT00636207|587699829|FG006|Overall Study|Adverse Event|0|||
162724264|NCT00636207|587699823|FG000|Overall Study|Withdrawal by Subject|0|||
162724265|NCT00636207|587699824|FG001|Overall Study|Withdrawal by Subject|1|||
162678830|NCT00857207|587534484|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
162678831|NCT00857207|587534485|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
162678832|NCT02030015|587534486|FG000|Overall Study|Withdrawal by Subject|3|||
162678833|NCT02030015|587534486|FG000|Overall Study|Death|13|||
162678834|NCT04098406|587534487|FG000|Overall Study|Adverse Event|2|||
162678835|NCT04098406|587534488|FG001|Overall Study|Adverse Event|1|||
162678836|NCT04098406|587534487|FG000|Overall Study|Withdrawal by Subject|1|||
162678837|NCT04098406|587534488|FG001|Overall Study|Withdrawal by Subject|0|||
162678838|NCT03014674|587534489|FG000|Overall Study|Withdrawal by Subject|1|||
162678839|NCT03014674|587534490|FG001|Overall Study|Withdrawal by Subject|0|||
162678840|NCT03014674|587534491|FG002|Overall Study|Withdrawal by Subject|0|||
162678841|NCT01332227|587534492|FG000|Overall Study|Adverse Event|4|||
162678842|NCT01332227|587534493|FG001|Overall Study|Adverse Event|1|||
162678843|NCT01332227|587534492|FG000|Overall Study|Withdrawal by Subject|5|||
162678844|NCT01332227|587534493|FG001|Overall Study|Withdrawal by Subject|1|||
162678845|NCT01332227|587534492|FG000|Overall Study|Lost to Follow-up|2|||
162678846|NCT01332227|587534493|FG001|Overall Study|Lost to Follow-up|0|||
162678847|NCT01332227|587534492|FG000|Overall Study|Lack of Efficacy|3|||
162678848|NCT01332227|587534493|FG001|Overall Study|Lack of Efficacy|1|||
162678849|NCT01332227|587534492|FG000|Overall Study|Poor compliance/noncompliance|1|||
162678850|NCT01332227|587534493|FG001|Overall Study|Poor compliance/noncompliance|1|||
162678851|NCT01332227|587534492|FG000|Overall Study|Patient moved from area|1|||
162678852|NCT01332227|587534493|FG001|Overall Study|Patient moved from area|0|||
162678853|NCT01332227|587534492|FG000|Overall Study|Patient began prohibited medication|0|||
162678854|NCT01332227|587534493|FG001|Overall Study|Patient began prohibited medication|1|||
162678855|NCT03382782|587534498|FG000|Cohort 1|Withdrawal by Subject|11|||
162678856|NCT03382782|587534499|FG001|Cohort 1|Withdrawal by Subject|5|||
162678857|NCT03382782|587534500|FG002|Cohort 1|Withdrawal by Subject|0|||
162724266|NCT00636207|587699825|FG002|Overall Study|Withdrawal by Subject|0|||
162724267|NCT00636207|587699826|FG003|Overall Study|Withdrawal by Subject|0|||
162724268|NCT00636207|587699827|FG004|Overall Study|Withdrawal by Subject|1|||
162724269|NCT00636207|587699828|FG005|Overall Study|Withdrawal by Subject|0|||
162724270|NCT00636207|587699829|FG006|Overall Study|Withdrawal by Subject|0|||
162724271|NCT00666276|587699832|FG000|Overall Study|Protocol Violation|34|||
162724272|NCT01039688|587699833|FG000|Overall Study|Adverse Event|38|||
162724273|NCT01039688|587699834|FG001|Overall Study|Adverse Event|39|||
162724274|NCT01039688|587699835|FG002|Overall Study|Adverse Event|24|||
162724275|NCT01039688|587699833|FG000|Overall Study|Lack of Efficacy|20|||
162724276|NCT01039688|587699834|FG001|Overall Study|Lack of Efficacy|11|||
162724277|NCT01039688|587699835|FG002|Overall Study|Lack of Efficacy|26|||
162724278|NCT01039688|587699833|FG000|Overall Study|Lost to Follow-up|11|||
162724279|NCT01039688|587699834|FG001|Overall Study|Lost to Follow-up|9|||
162724280|NCT01039688|587699835|FG002|Overall Study|Lost to Follow-up|5|||
162724281|NCT01039688|587699833|FG000|Overall Study|Other|13|||
162724282|NCT01039688|587699834|FG001|Overall Study|Other|25|||
162724283|NCT01039688|587699835|FG002|Overall Study|Other|12|||
162724284|NCT01039688|587699833|FG000|Overall Study|Withdrawal by Subject|23|||
162678858|NCT03382782|587534498|FG000|Cohort 2|Withdrawal by Subject|1|||
162678859|NCT03382782|587534499|FG001|Cohort 2|Withdrawal by Subject|1|||
162678860|NCT03382782|587534500|FG002|Cohort 2|Withdrawal by Subject|0|||
162724285|NCT01039688|587699834|FG001|Overall Study|Withdrawal by Subject|27|||
162724286|NCT01039688|587699835|FG002|Overall Study|Withdrawal by Subject|13|||
162724287|NCT01039688|587699833|FG000|Overall Study|Death|2|||
162724288|NCT01039688|587699834|FG001|Overall Study|Death|0|||
162724289|NCT01039688|587699835|FG002|Overall Study|Death|0|||
162724290|NCT02594735|587699836|FG000|Overall Study|Adverse Event|1|||
162724291|NCT03844269|587699838|FG000|Overall Study|Withdrawal pre-intervention|1|||
162724292|NCT03844269|587699838|FG000|Overall Study|Did not complete the intervention|2|||
162724293|NCT00101010|587699844|FG000|Overall Study|Physician Decision|1|||
162724294|NCT00364013|587699853|FG000|Overall Study|Ineligibility determined|4|||
162724295|NCT00364013|587699854|FG001|Overall Study|Ineligibility determined|2|||
162724296|NCT00364013|587699853|FG000|Overall Study|Adverse Event|4|||
162724297|NCT00364013|587699854|FG001|Overall Study|Adverse Event|3|||
162724298|NCT00364013|587699853|FG000|Overall Study|Withdrawal by Subject|13|||
162724299|NCT00364013|587699854|FG001|Overall Study|Withdrawal by Subject|18|||
162724300|NCT00364013|587699853|FG000|Overall Study|Physician Decision|3|||
162724301|NCT00364013|587699854|FG001|Overall Study|Physician Decision|3|||
162724302|NCT00364013|587699853|FG000|Overall Study|Lost to Follow-up|10|||
162724303|NCT00364013|587699854|FG001|Overall Study|Lost to Follow-up|3|||
162724304|NCT00364013|587699853|FG000|Overall Study|Protocol-specified criteria|6|||
162678861|NCT03382782|587534498|FG000|Cohort 3|Withdrawal by Subject|1|||
162678862|NCT03382782|587534499|FG001|Cohort 3|Withdrawal by Subject|2|||
162678863|NCT03382782|587534500|FG002|Cohort 3|Withdrawal by Subject|0|||
162678864|NCT00428090|587534505|FG000|Overall Study|Adverse Event|10|||
162678865|NCT00428090|587534506|FG001|Overall Study|Adverse Event|8|||
162678866|NCT00428090|587534507|FG002|Overall Study|Adverse Event|10|||
162678867|NCT00428090|587534508|FG003|Overall Study|Adverse Event|11|||
162678868|NCT00428090|587534505|FG000|Overall Study|Lost to Follow-up|3|||
162678869|NCT00428090|587534506|FG001|Overall Study|Lost to Follow-up|6|||
162678870|NCT00428090|587534507|FG002|Overall Study|Lost to Follow-up|1|||
162678871|NCT00428090|587534508|FG003|Overall Study|Lost to Follow-up|4|||
162678872|NCT00428090|587534505|FG000|Overall Study|Protocol Violation|3|||
162678873|NCT00428090|587534506|FG001|Overall Study|Protocol Violation|1|||
162678874|NCT00428090|587534507|FG002|Overall Study|Protocol Violation|3|||
162678875|NCT00428090|587534508|FG003|Overall Study|Protocol Violation|3|||
162678876|NCT00428090|587534505|FG000|Overall Study|Withdrawal by Subject|10|||
162678877|NCT00428090|587534506|FG001|Overall Study|Withdrawal by Subject|12|||
162678878|NCT00428090|587534507|FG002|Overall Study|Withdrawal by Subject|15|||
162678879|NCT00428090|587534508|FG003|Overall Study|Withdrawal by Subject|5|||
162678880|NCT00428090|587534505|FG000|Overall Study|Sponsor terminated study|0|||
162678881|NCT00428090|587534506|FG001|Overall Study|Sponsor terminated study|1|||
162678882|NCT00428090|587534507|FG002|Overall Study|Sponsor terminated study|0|||
162678883|NCT00428090|587534508|FG003|Overall Study|Sponsor terminated study|0|||
162678884|NCT00428090|587534505|FG000|Overall Study|Non-compliance|4|||
162678885|NCT00428090|587534506|FG001|Overall Study|Non-compliance|0|||
162678886|NCT00428090|587534507|FG002|Overall Study|Non-compliance|1|||
162678887|NCT00428090|587534508|FG003|Overall Study|Non-compliance|3|||
162678888|NCT00428090|587534505|FG000|Overall Study|Par. did not returned to visit|1|||
162678889|NCT00428090|587534506|FG001|Overall Study|Par. did not returned to visit|0|||
162678890|NCT00428090|587534507|FG002|Overall Study|Par. did not returned to visit|0|||
162678891|NCT00428090|587534508|FG003|Overall Study|Par. did not returned to visit|1|||
162678892|NCT00428090|587534505|FG000|Overall Study|Follow-Up visit not possible|1|||
162678893|NCT00428090|587534506|FG001|Overall Study|Follow-Up visit not possible|0|||
162678894|NCT00428090|587534507|FG002|Overall Study|Follow-Up visit not possible|0|||
162678895|NCT00428090|587534508|FG003|Overall Study|Follow-Up visit not possible|0|||
162678896|NCT00428090|587534505|FG000|Overall Study|Prohibited medication used for SAE|1|||
162678897|NCT00428090|587534506|FG001|Overall Study|Prohibited medication used for SAE|0|||
162678898|NCT00428090|587534507|FG002|Overall Study|Prohibited medication used for SAE|0|||
162678899|NCT00428090|587534508|FG003|Overall Study|Prohibited medication used for SAE|0|||
162678900|NCT00428090|587534505|FG000|Overall Study|Death of par.|1|||
162678901|NCT00428090|587534506|FG001|Overall Study|Death of par.|0|||
162678902|NCT00428090|587534507|FG002|Overall Study|Death of par.|1|||
162678903|NCT00428090|587534508|FG003|Overall Study|Death of par.|0|||
162678904|NCT00428090|587534505|FG000|Overall Study|Visit 7 exceed the visit window|0|||
162678905|NCT00428090|587534506|FG001|Overall Study|Visit 7 exceed the visit window|1|||
162678906|NCT00428090|587534507|FG002|Overall Study|Visit 7 exceed the visit window|0|||
162678907|NCT00428090|587534508|FG003|Overall Study|Visit 7 exceed the visit window|0|||
162678908|NCT00428090|587534505|FG000|Overall Study|Medical monitor terminated par.|0|||
162678909|NCT00428090|587534506|FG001|Overall Study|Medical monitor terminated par.|1|||
162678910|NCT00428090|587534507|FG002|Overall Study|Medical monitor terminated par.|0|||
162678911|NCT00428090|587534508|FG003|Overall Study|Medical monitor terminated par.|0|||
162678912|NCT00428090|587534505|FG000|Overall Study|Mental status of par. was|0|||
162678913|NCT00428090|587534506|FG001|Overall Study|Mental status of par. was|1|||
162678914|NCT00428090|587534507|FG002|Overall Study|Mental status of par. was|0|||
162678915|NCT00428090|587534508|FG003|Overall Study|Mental status of par. was|0|||
162678916|NCT00428090|587534505|FG000|Overall Study|Worsening of AD|0|||
162678917|NCT00428090|587534506|FG001|Overall Study|Worsening of AD|0|||
162678918|NCT00428090|587534507|FG002|Overall Study|Worsening of AD|1|||
162678919|NCT00428090|587534508|FG003|Overall Study|Worsening of AD|0|||
162678920|NCT00428090|587534505|FG000|Overall Study|Excluded for concerning QTc value|0|||
162678921|NCT00428090|587534506|FG001|Overall Study|Excluded for concerning QTc value|0|||
162678922|NCT00428090|587534507|FG002|Overall Study|Excluded for concerning QTc value|1|||
162678923|NCT00428090|587534508|FG003|Overall Study|Excluded for concerning QTc value|0|||
162678924|NCT00428090|587534505|FG000|Overall Study|Insufficient AD documentation|0|||
162678925|NCT00428090|587534506|FG001|Overall Study|Insufficient AD documentation|0|||
162678926|NCT00428090|587534507|FG002|Overall Study|Insufficient AD documentation|1|||
162678927|NCT00428090|587534508|FG003|Overall Study|Insufficient AD documentation|0|||
162678928|NCT00428090|587534505|FG000|Overall Study|High MMSE scores|0|||
162678929|NCT00428090|587534506|FG001|Overall Study|High MMSE scores|0|||
162678930|NCT00428090|587534507|FG002|Overall Study|High MMSE scores|1|||
162678931|NCT00428090|587534508|FG003|Overall Study|High MMSE scores|0|||
162678932|NCT00428090|587534505|FG000|Overall Study|Deterioration of cognitive status|0|||
162678933|NCT00428090|587534506|FG001|Overall Study|Deterioration of cognitive status|0|||
162678934|NCT00428090|587534507|FG002|Overall Study|Deterioration of cognitive status|1|||
162678935|NCT00428090|587534508|FG003|Overall Study|Deterioration of cognitive status|0|||
162724305|NCT00364013|587699854|FG001|Overall Study|Protocol-specified criteria|6|||
162724306|NCT00364013|587699853|FG000|Overall Study|Other|41|||
162724307|NCT00364013|587699854|FG001|Overall Study|Other|47|||
162724308|NCT00364013|587699853|FG000|Overall Study|Ongoing|20|||
162724309|NCT00364013|587699854|FG001|Overall Study|Ongoing|13|||
162724310|NCT00891930|587699855|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
162724311|NCT00891930|587699855|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
162724312|NCT00891930|587699855|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
162724313|NCT00891930|587699855|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
162724314|NCT00891930|587699855|FG000|Part 2 Panitumumab + AMG479|Death|30|||
162724315|NCT00835770|587699862|FG000|Overall Study|MS Relapse|17|||
162724316|NCT00835770|587699863|FG001|Overall Study|MS Relapse|23|||
162724317|NCT00835770|587699862|FG000|Overall Study|MS Progression|14|||
162724318|NCT00835770|587699863|FG001|Overall Study|MS Progression|9|||
162724319|NCT00835770|587699862|FG000|Overall Study|Adverse Event|113|||
162724320|NCT00835770|587699863|FG001|Overall Study|Adverse Event|124|||
162724321|NCT00835770|587699862|FG000|Overall Study|Lost to Follow-up|22|||
162724322|NCT00835770|587699863|FG001|Overall Study|Lost to Follow-up|19|||
162724323|NCT00835770|587699862|FG000|Overall Study|Consent Withdrawn|144|||
162724324|NCT00835770|587699863|FG001|Overall Study|Consent Withdrawn|156|||
162724325|NCT00835770|587699862|FG000|Overall Study|Investigator Decision|42|||
162724326|NCT00835770|587699863|FG001|Overall Study|Investigator Decision|42|||
162724327|NCT00835770|587699862|FG000|Overall Study|Participant Non-Compliance|11|||
162724328|NCT00835770|587699863|FG001|Overall Study|Participant Non-Compliance|9|||
162724329|NCT00835770|587699862|FG000|Overall Study|Death|4|||
162724330|NCT00835770|587699863|FG001|Overall Study|Death|6|||
162724331|NCT00835770|587699862|FG000|Overall Study|Other|115|||
162724332|NCT00835770|587699863|FG001|Overall Study|Other|104|||
162724333|NCT00835770|587699862|FG000|Overall Study|Other|2|||
162724334|NCT00835770|587699863|FG001|Overall Study|Other|1|||
162724335|NCT01185782|587699864|FG000|Overall Study|Adverse Event|0|||
162724336|NCT01185782|587699865|FG001|Overall Study|Adverse Event|1|||
162724337|NCT01185782|587699864|FG000|Overall Study|Protocol Violation|1|||
162724338|NCT01185782|587699865|FG001|Overall Study|Protocol Violation|0|||
162724339|NCT01185782|587699864|FG000|Overall Study|Poor Response to Treatment|3|||
162724340|NCT01185782|587699865|FG001|Overall Study|Poor Response to Treatment|1|||
162724341|NCT01185782|587699864|FG000|Overall Study|Other|2|||
162724342|NCT01185782|587699865|FG001|Overall Study|Other|5|||
162724343|NCT01185782|587699864|FG000|Overall Study|Randomized but not treated|0|||
162724344|NCT01185782|587699865|FG001|Overall Study|Randomized but not treated|4|||
162724345|NCT02507752|587699866|FG000|Overall Study|Adverse Event|1|||
162724346|NCT02507752|587699866|FG000|Overall Study|Protocol Violation|6|||
162724347|NCT02507752|587699866|FG000|Overall Study|Lost to Follow-up|7|||
162724348|NCT02507752|587699866|FG000|Overall Study|Infusion reaction at first infusion|1|||
162724349|NCT02507752|587699866|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
162724350|NCT02507752|587699866|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
162724351|NCT02202499|587699870|FG000|Overall Study|Cancer diagnosis|0|||
162724352|NCT02202499|587699871|FG001|Overall Study|Cancer diagnosis|0|||
162724353|NCT02202499|587699872|FG002|Overall Study|Cancer diagnosis|1|||
162724354|NCT02202499|587699870|FG000|Overall Study|Moved from area|0|||
162724355|NCT02202499|587699871|FG001|Overall Study|Moved from area|0|||
162724356|NCT02202499|587699872|FG002|Overall Study|Moved from area|1|||
162724357|NCT02202499|587699870|FG000|Overall Study|Declined before randomization|1|||
162724358|NCT02202499|587699871|FG001|Overall Study|Declined before randomization|0|||
162724359|NCT02202499|587699872|FG002|Overall Study|Declined before randomization|0|||
162724360|NCT02202499|587699870|FG000|Overall Study|Auto accident|1|||
162724361|NCT02202499|587699871|FG001|Overall Study|Auto accident|0|||
162724362|NCT02202499|587699872|FG002|Overall Study|Auto accident|0|||
162724363|NCT00535145|587699874|FG000|Phase I|Adverse Event|3|||
162724364|NCT00535145|587699874|FG000|Phase I|Lost to Follow-up|7|||
162724365|NCT00535145|587699874|FG000|Phase I|Withdrawal by Subject|6|||
162724366|NCT00535145|587699874|FG000|Phase I|(eligibility)|8|||
162724367|NCT00535145|587699874|FG000|Phase I|(protocol violation)|1|||
162724368|NCT00535145|587699874|FG000|Phase I|(PI decision)|1|||
162724369|NCT00535145|587699874|FG000|Phase I|(diagnosis)|3|||
162724370|NCT00535145|587699874|FG000|Phase II|Adverse Event|2|||
162724371|NCT00535145|587699874|FG000|Phase II|Lack of Efficacy|1|||
162724372|NCT00535145|587699874|FG000|Phase II|Lost to Follow-up|5|||
162724373|NCT00535145|587699874|FG000|Phase II|Withdrawal by Subject|5|||
162724374|NCT00535145|587699874|FG000|Phase II|Subject non-compliance|2|||
162724375|NCT05082935|587699877|FG000|Overall Study|Lost to Follow-up|549|||
162724376|NCT05082935|587699878|FG001|Overall Study|Lost to Follow-up|631|||
162724377|NCT05082935|587699877|FG000|Overall Study|Withdrawal by Subject|27|||
162724378|NCT05082935|587699878|FG001|Overall Study|Withdrawal by Subject|58|||
162724379|NCT02928224|587699882|FG000|Overall Study|Lost to Follow-up|1|||
162724380|NCT02928224|587699883|FG001|Overall Study|Lost to Follow-up|1|||
162724381|NCT02928224|587699884|FG002|Overall Study|Lost to Follow-up|3|||
162724382|NCT02928224|587699885|FG003|Overall Study|Lost to Follow-up|0|||
162724383|NCT02928224|587699882|FG000|Overall Study|Death|30|||
162724384|NCT02928224|587699883|FG001|Overall Study|Death|209|||
162678936|NCT00428090|587534505|FG000|Overall Study|Serious adverse event|0|||
162678937|NCT00428090|587534506|FG001|Overall Study|Serious adverse event|0|||
162678938|NCT00428090|587534507|FG002|Overall Study|Serious adverse event|1|||
162678939|NCT00428090|587534508|FG003|Overall Study|Serious adverse event|0|||
162678940|NCT00428090|587534505|FG000|Overall Study|Excluded for heart insufficiency|0|||
162678941|NCT00428090|587534506|FG001|Overall Study|Excluded for heart insufficiency|0|||
162724385|NCT02928224|587699884|FG002|Overall Study|Death|193|||
162678942|NCT00428090|587534507|FG002|Overall Study|Excluded for heart insufficiency|1|||
162678943|NCT00428090|587534508|FG003|Overall Study|Excluded for heart insufficiency|0|||
162678944|NCT00428090|587534505|FG000|Overall Study|Raised Creatinine Value|0|||
162724386|NCT02928224|587699885|FG003|Overall Study|Death|198|||
162724387|NCT02928224|587699882|FG000|Overall Study|Withdrawal by Subject|0|||
162724388|NCT02928224|587699883|FG001|Overall Study|Withdrawal by Subject|3|||
162724389|NCT02928224|587699884|FG002|Overall Study|Withdrawal by Subject|7|||
162724390|NCT02928224|587699885|FG003|Overall Study|Withdrawal by Subject|20|||
162724391|NCT02928224|587699882|FG000|Overall Study|Study participation terminated by sponsor|3|||
162724392|NCT02928224|587699883|FG001|Overall Study|Study participation terminated by sponsor|8|||
162724393|NCT02928224|587699884|FG002|Overall Study|Study participation terminated by sponsor|12|||
162724394|NCT02928224|587699885|FG003|Overall Study|Study participation terminated by sponsor|3|||
162724395|NCT02928224|587699882|FG000|Overall Study|Other|3|||
162724396|NCT02928224|587699883|FG001|Overall Study|Other|3|||
162724397|NCT02928224|587699884|FG002|Overall Study|Other|5|||
162724398|NCT02928224|587699885|FG003|Overall Study|Other|0|||
162724399|NCT02538107|587699886|FG000|Overall Study|Did not receive any Mircera dose|11|||
162724400|NCT02538107|587699886|FG000|Overall Study|Missing|5|||
162724401|NCT02538107|587699886|FG000|Overall Study|Necessity of dialysis|20|||
162724402|NCT02538107|587699886|FG000|Overall Study|Administration of other ESA|11|||
162724403|NCT02538107|587699886|FG000|Overall Study|No further treatment necessary|18|||
162724404|NCT02538107|587699886|FG000|Overall Study|Withdrawal by Subject|17|||
162724405|NCT02538107|587699886|FG000|Overall Study|Death|4|||
162724406|NCT02538107|587699886|FG000|Overall Study|Administrative reason|5|||
162724407|NCT02538107|587699886|FG000|Overall Study|Adverse Event|4|||
162724408|NCT02538107|587699886|FG000|Overall Study|Surgery|1|||
162724409|NCT02538107|587699886|FG000|Overall Study|Other|7|||
162724410|NCT02538107|587699886|FG000|Overall Study|Not recorded|7|||
162724411|NCT01278394|587699887|FG000|Overall Study|Lost to Follow-up|1|||
162724412|NCT02471755|587699888|FG000|Overall Study|Withdrawal by Subject|1|||
162724413|NCT02471755|587699889|FG001|Overall Study|Withdrawal by Subject|0|||
162724414|NCT02471755|587699888|FG000|Overall Study|Lost to Follow-up|0|||
162724415|NCT02471755|587699889|FG001|Overall Study|Lost to Follow-up|1|||
162724416|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
162724417|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
162724418|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
162724419|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
162724420|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
162724421|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
162724422|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
162724423|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
162724424|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
162724425|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
162724426|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
162724427|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
162724428|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
162724429|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
162724430|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
162724431|NCT00958633|587699892|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
162724432|NCT00958633|587699893|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
162724433|NCT00958633|587699894|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
162724434|NCT00958633|587699892|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
162724435|NCT00958633|587699893|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
162724436|NCT00958633|587699894|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
162724437|NCT00094575|587699899|FG000|Overall Study|Death|146|||
162724438|NCT00094575|587699900|FG001|Overall Study|Death|146|||
162724439|NCT00794118|587699901|FG000|Overall Study|Lost to Follow-up|16|||
162724440|NCT00794118|587699901|FG000|Overall Study|Withdrawal by Subject|9|||
162724441|NCT00794118|587699901|FG000|Overall Study|Changed hospital center|2|||
162724442|NCT04411056|587701599|FG000|Overall Study|surgery cancelled|1|||
162724443|NCT04411056|587701600|FG001|Overall Study|surgery cancelled|0|||
162724444|NCT04411056|587701599|FG000|Overall Study|Equipment problem during intubation|0|||
162724445|NCT04411056|587701600|FG001|Overall Study|Equipment problem during intubation|1|||
162724446|NCT04623008|587701601|FG000|Baseline to T2|Withdrawal by Subject|4|||
162724447|NCT04623008|587701602|FG001|Baseline to T2|Withdrawal by Subject|2|||
162724448|NCT04623008|587701601|FG000|Baseline to T3|Withdrawal by Subject|4|||
162724449|NCT04623008|587701602|FG001|Baseline to T3|Withdrawal by Subject|2|||
162724450|NCT05985044|587701618|FG000|Overall Study|Death|6|||
162724451|NCT05985044|587701618|FG000|Overall Study|Lost to Follow-up|4|||
162724452|NCT05985044|587701618|FG000|Overall Study|Incapacitation|3|||
162724453|NCT05985044|587701618|FG000|Overall Study|Withdrawal by Subject|2|||
162724454|NCT05938413|587701622|FG000|Overall Study|Lost to Follow-up|1|||
162724455|NCT05938413|587701623|FG001|Overall Study|Lost to Follow-up|7|||
162724456|NCT05938413|587701622|FG000|Overall Study|Withdrawal by Subject|1|||
162724457|NCT05938413|587701623|FG001|Overall Study|Withdrawal by Subject|1|||
162724458|NCT03312907|587701624|FG000|Overall Study|Adverse Event|1|||
162724459|NCT03312907|587701625|FG001|Overall Study|Adverse Event|6|||
162724460|NCT03312907|587701626|FG002|Overall Study|Adverse Event|1|||
162724461|NCT03312907|587701624|FG000|Overall Study|Protocol Violation|2|||
162724462|NCT03312907|587701625|FG001|Overall Study|Protocol Violation|3|||
162724463|NCT03312907|587701626|FG002|Overall Study|Protocol Violation|4|||
162724464|NCT03312907|587701624|FG000|Overall Study|Lost to Follow-up|2|||
162724465|NCT03312907|587701625|FG001|Overall Study|Lost to Follow-up|3|||
162724466|NCT03312907|587701626|FG002|Overall Study|Lost to Follow-up|2|||
162724467|NCT03312907|587701624|FG000|Overall Study|Physician Decision|3|||
162724468|NCT03312907|587701625|FG001|Overall Study|Physician Decision|4|||
162724469|NCT03312907|587701626|FG002|Overall Study|Physician Decision|2|||
162724470|NCT03312907|587701624|FG000|Overall Study|Withdrawal by Subject|9|||
162724471|NCT03312907|587701625|FG001|Overall Study|Withdrawal by Subject|14|||
162724472|NCT03312907|587701626|FG002|Overall Study|Withdrawal by Subject|10|||
162724473|NCT04688450|587701627|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
162724474|NCT04688450|587701627|FG000|Overall Study|Withdrawal by Subject|1|||
162724475|NCT03481777|587701632|FG000|Overall Study|Withdrawal by Subject|36|||
162724476|NCT03481777|587701633|FG001|Overall Study|Withdrawal by Subject|31|||
162724477|NCT03481777|587701632|FG000|Overall Study|Non stroke = non target population|277|||
162724478|NCT03481777|587701633|FG001|Overall Study|Non stroke = non target population|254|||
162678945|NCT00428090|587534506|FG001|Overall Study|Raised Creatinine Value|0|||
162678946|NCT00428090|587534507|FG002|Overall Study|Raised Creatinine Value|0|||
162678947|NCT00428090|587534508|FG003|Overall Study|Raised Creatinine Value|1|||
162678948|NCT03409666|587534509|FG000|Overall Study|Physician Decision|0|||
162678949|NCT03409666|587534510|FG001|Overall Study|Physician Decision|1|||
162678950|NCT03409666|587534509|FG000|Overall Study|Protocol Violation|0|||
162678951|NCT03409666|587534510|FG001|Overall Study|Protocol Violation|3|||
162678952|NCT00512148|587534514|FG000|Primay Study Period|Withdrawal by Subject|1|||
162678953|NCT02623322|587534515|FG000|Overall Study|Lost to Follow-up|2|||
162678954|NCT02623322|587534516|FG001|Overall Study|Lost to Follow-up|1|||
162678955|NCT02623322|587534517|FG002|Overall Study|Lost to Follow-up|0|||
162678956|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
162678957|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
162678958|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
162678959|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
162678960|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
162678961|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162678962|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
162678963|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
162678964|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
162678965|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
162678966|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
162678967|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
162678968|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Death|6|||
162678969|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Death|3|||
162678970|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Death|0|||
162678971|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Death|1|||
162678972|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Death|1|||
162678973|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Death|0|||
162678974|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
162678975|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
162678976|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
162678977|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
162678978|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
162678979|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
162678980|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162678981|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
162678982|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
162678983|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162678984|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162678985|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162678986|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
162678987|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
162678988|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
162678989|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
162678990|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
162678991|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
162678992|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
162678993|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
162678994|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
162678995|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
162678996|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
162678997|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
162678998|NCT03104699|587534518|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
162678999|NCT03104699|587534519|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
162679000|NCT03104699|587534520|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
162679001|NCT03104699|587534521|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
162679002|NCT03104699|587534522|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
162679003|NCT03104699|587534523|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
162679004|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162679005|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162679006|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162679007|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162679008|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162679009|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
162679010|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Death|0|||
162679011|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Death|0|||
162679012|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Death|0|||
162679013|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Death|0|||
162679014|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Death|0|||
162679015|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Death|107|||
162679016|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162679017|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162679018|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162679019|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162679020|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162679021|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
162679022|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162679023|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162679024|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162679025|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162679026|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162679027|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
162679028|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162679029|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162679030|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162679031|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162679032|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162679033|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
162679034|NCT03104699|587534518|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
162679035|NCT03104699|587534519|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
162679036|NCT03104699|587534520|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
162679037|NCT03104699|587534521|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
162679038|NCT03104699|587534522|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
162679039|NCT03104699|587534523|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
162679040|NCT02450331|587534524|FG000|Overall Study|Death|162|||
162679041|NCT02450331|587534525|FG001|Overall Study|Death|171|||
162679042|NCT02450331|587534524|FG000|Overall Study|Lost to Follow-up|14|||
162679043|NCT02450331|587534525|FG001|Overall Study|Lost to Follow-up|12|||
162679044|NCT02450331|587534524|FG000|Overall Study|Withdrawal by Subject|55|||
162679045|NCT02450331|587534525|FG001|Overall Study|Withdrawal by Subject|44|||
162679046|NCT02450331|587534524|FG000|Overall Study|Non-specified other|1|||
162679047|NCT02450331|587534525|FG001|Overall Study|Non-specified other|1|||
162679048|NCT02080871|587534526|FG000|Overall Study|Death|1|||
162679049|NCT02080871|587534526|FG000|Overall Study|Lost to Follow-up|1|||
162679050|NCT00234052|587534527|FG000|Treatment|Withdrawal by Subject|3|||
162679051|NCT00234052|587534527|FG000|Treatment|Adverse Event|5|||
162679052|NCT00234052|587534527|FG000|Treatment|Death|2|||
162679053|NCT00234052|587534527|FG000|Treatment|Progressive Disease|11|||
162679054|NCT00234052|587534527|FG000|Follow-up for 5 Years|Death|41|||
162679055|NCT00234052|587534527|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
162679056|NCT00234052|587534527|FG000|Follow-up for 5 Years|Other|7|||
162679057|NCT01410474|587534528|FG000|Overall Study|Withdrawal by Subject|0|||
162679058|NCT01410474|587534529|FG001|Overall Study|Withdrawal by Subject|1|||
162679059|NCT02428296|587534530|FG000|Overall Study|Adverse Event|7|||
162679060|NCT02428296|587534530|FG000|Overall Study|Withdrawal by Subject|2|||
162679061|NCT04493931|587534534|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
162679062|NCT04493931|587534535|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679063|NCT04493931|587534536|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679064|NCT04493931|587534537|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679065|NCT04493931|587534538|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679066|NCT04493931|587534539|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679067|NCT04493931|587534540|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162679068|NCT04493931|587534534|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679069|NCT04493931|587534535|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
162679070|NCT04493931|587534536|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679071|NCT04493931|587534537|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679072|NCT04493931|587534538|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679073|NCT04493931|587534539|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679074|NCT04493931|587534540|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162679075|NCT04493931|587534534|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679076|NCT04493931|587534535|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
162679077|NCT04493931|587534536|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679078|NCT04493931|587534537|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679079|NCT04493931|587534538|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679080|NCT04493931|587534539|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679081|NCT04493931|587534540|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162679082|NCT04493931|587534534|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679083|NCT04493931|587534535|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679084|NCT04493931|587534536|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
162679085|NCT04493931|587534537|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679086|NCT04493931|587534538|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679087|NCT04493931|587534539|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679088|NCT04493931|587534540|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162679089|NCT03338894|587534541|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
162679090|NCT00420199|587534543|FG000|Overall Study|Participant no longer met study criteria|1|||
162679091|NCT00420199|587534544|FG001|Overall Study|Participant no longer met study criteria|0|||
162679092|NCT02261493|587534545|FG000|Overall Study|Noncompliance|0|||
162679093|NCT02261493|587534546|FG001|Overall Study|Noncompliance|0|||
162679094|NCT02261493|587534547|FG002|Overall Study|Noncompliance|2|||
162679095|NCT02261493|587534545|FG000|Overall Study|Physician Decision|0|||
162679096|NCT02261493|587534546|FG001|Overall Study|Physician Decision|1|||
162679097|NCT02261493|587534547|FG002|Overall Study|Physician Decision|0|||
162679098|NCT02261493|587534545|FG000|Overall Study|Undisclosed alcohol abuse|0|||
162679099|NCT02261493|587534546|FG001|Overall Study|Undisclosed alcohol abuse|1|||
162679100|NCT02261493|587534547|FG002|Overall Study|Undisclosed alcohol abuse|0|||
162679101|NCT02261493|587534545|FG000|Overall Study|Protocol Violation|1|||
162679102|NCT02261493|587534546|FG001|Overall Study|Protocol Violation|0|||
162679103|NCT02261493|587534547|FG002|Overall Study|Protocol Violation|0|||
162679104|NCT02261493|587534545|FG000|Overall Study|Personal Reasons|14|||
162679105|NCT02261493|587534546|FG001|Overall Study|Personal Reasons|14|||
162679106|NCT02261493|587534547|FG002|Overall Study|Personal Reasons|16|||
162679107|NCT02261493|587534545|FG000|Overall Study|Lost to Follow-up|14|||
162679108|NCT02261493|587534546|FG001|Overall Study|Lost to Follow-up|27|||
162679109|NCT02261493|587534547|FG002|Overall Study|Lost to Follow-up|8|||
162679110|NCT02261493|587534545|FG000|Overall Study|Pregnancy|1|||
162679111|NCT02261493|587534546|FG001|Overall Study|Pregnancy|2|||
162679112|NCT02261493|587534547|FG002|Overall Study|Pregnancy|0|||
162679113|NCT02261493|587534545|FG000|Overall Study|Lack of Efficacy|0|||
162679114|NCT02261493|587534546|FG001|Overall Study|Lack of Efficacy|1|||
162679115|NCT02261493|587534547|FG002|Overall Study|Lack of Efficacy|0|||
162679116|NCT02261493|587534545|FG000|Overall Study|Adverse Event|0|||
162679117|NCT02261493|587534546|FG001|Overall Study|Adverse Event|1|||
162679118|NCT02261493|587534547|FG002|Overall Study|Adverse Event|0|||
162679119|NCT00558428|587534548|FG000|Overall Study|Adverse Event|6|||
162679120|NCT00558428|587534549|FG001|Overall Study|Adverse Event|22|||
162679121|NCT00558428|587534550|FG002|Overall Study|Adverse Event|3|||
162679122|NCT00558428|587534551|FG003|Overall Study|Adverse Event|4|||
162679123|NCT00558428|587534548|FG000|Overall Study|Lost to Follow-up|0|||
162679124|NCT00558428|587534549|FG001|Overall Study|Lost to Follow-up|1|||
162679125|NCT00558428|587534550|FG002|Overall Study|Lost to Follow-up|0|||
162679126|NCT00558428|587534551|FG003|Overall Study|Lost to Follow-up|0|||
162679127|NCT00558428|587534548|FG000|Overall Study|Lack of Efficacy|0|||
162679128|NCT00558428|587534549|FG001|Overall Study|Lack of Efficacy|0|||
162679129|NCT00558428|587534550|FG002|Overall Study|Lack of Efficacy|1|||
162679130|NCT00558428|587534551|FG003|Overall Study|Lack of Efficacy|2|||
162679131|NCT00558428|587534548|FG000|Overall Study|Non compliant with protocol|1|||
162679132|NCT00558428|587534549|FG001|Overall Study|Non compliant with protocol|0|||
162679133|NCT00558428|587534550|FG002|Overall Study|Non compliant with protocol|0|||
162679134|NCT00558428|587534551|FG003|Overall Study|Non compliant with protocol|3|||
162679135|NCT00558428|587534548|FG000|Overall Study|Consent withdrawn|2|||
162679136|NCT00558428|587534549|FG001|Overall Study|Consent withdrawn|1|||
162679137|NCT00558428|587534550|FG002|Overall Study|Consent withdrawn|0|||
162679138|NCT00558428|587534551|FG003|Overall Study|Consent withdrawn|1|||
162679139|NCT00558428|587534548|FG000|Overall Study|Other|3|||
162679140|NCT00558428|587534549|FG001|Overall Study|Other|0|||
162679141|NCT00558428|587534550|FG002|Overall Study|Other|0|||
162679142|NCT00558428|587534551|FG003|Overall Study|Other|1|||
162679143|NCT00754338|587534552|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162679144|NCT00754338|587534553|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
162679145|NCT00754338|587534554|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
162679146|NCT00754338|587534555|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162679147|NCT00754338|587534552|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162679148|NCT00754338|587534553|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
162724479|NCT03189524|587701634|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
162724480|NCT03189524|587701635|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
162724481|NCT03189524|587701636|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
162724482|NCT03189524|587701634|FG000|Overall Study|Death|2|||
162724483|NCT03189524|587701635|FG001|Overall Study|Death|2|||
162724484|NCT03189524|587701636|FG002|Overall Study|Death|1|||
162724485|NCT03189524|587701634|FG000|Overall Study|Lost to Follow-up|1|||
162724486|NCT03189524|587701635|FG001|Overall Study|Lost to Follow-up|0|||
162724487|NCT03189524|587701636|FG002|Overall Study|Lost to Follow-up|8|||
162724488|NCT03189524|587701634|FG000|Overall Study|Withdrawal by Subject|1|||
162724489|NCT03189524|587701635|FG001|Overall Study|Withdrawal by Subject|1|||
162724490|NCT03189524|587701636|FG002|Overall Study|Withdrawal by Subject|3|||
162724491|NCT03189524|587701634|FG000|Overall Study|Progressive Disease|0|||
162724492|NCT03189524|587701635|FG001|Overall Study|Progressive Disease|2|||
162724493|NCT03189524|587701636|FG002|Overall Study|Progressive Disease|0|||
162724494|NCT01780298|587701638|FG000|Overall Study|Physician Decision|1|||
162724495|NCT01780298|587701639|FG001|Overall Study|Physician Decision|5|||
162724496|NCT01780298|587701640|FG002|Overall Study|Physician Decision|1|||
162724497|NCT01780298|587701641|FG003|Overall Study|Physician Decision|1|||
162724498|NCT01780298|587701638|FG000|Overall Study|Subject not matched|1|||
162724499|NCT01780298|587701639|FG001|Overall Study|Subject not matched|0|||
162724500|NCT01780298|587701640|FG002|Overall Study|Subject not matched|1|||
162724501|NCT01780298|587701641|FG003|Overall Study|Subject not matched|0|||
162724502|NCT01780298|587701638|FG000|Overall Study|Adverse Event|0|||
162724503|NCT01780298|587701639|FG001|Overall Study|Adverse Event|0|||
162724504|NCT01780298|587701640|FG002|Overall Study|Adverse Event|2|||
162724505|NCT01780298|587701641|FG003|Overall Study|Adverse Event|0|||
162724506|NCT02300298|587701658|FG000|Disposition for Nintedanib|Progressive disease|10|||
162724507|NCT02300298|587701659|FG001|Disposition for Nintedanib|Progressive disease|0|||
162724508|NCT02300298|587701658|FG000|Disposition for Docetaxel|Progressive disease|0|||
162724509|NCT02300298|587701659|FG001|Disposition for Docetaxel|Progressive disease|6|||
162724510|NCT02300298|587701658|FG000|Disposition for Docetaxel|other adverse event|0|||
162724511|NCT02300298|587701659|FG001|Disposition for Docetaxel|other adverse event|4|||
162724512|NCT02407249|587701660|FG000|Overall Study|Did not complete 12-month follow-up|13|||
162724513|NCT02407249|587701660|FG000|Overall Study|Not treated|13|||
162724514|NCT01391832|587701661|FG000|Overall Study|Withdrawal by Subject|21|||
162724515|NCT01391832|587701662|FG001|Overall Study|Withdrawal by Subject|22|||
162724516|NCT01391832|587701661|FG000|Overall Study|Lost to Follow-up|0|||
162724517|NCT01391832|587701662|FG001|Overall Study|Lost to Follow-up|1|||
162724518|NCT03345901|587701666|FG000|Overall Study|The study was terminated|18|||
162724519|NCT04252586|587701667|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162724520|NCT04252586|587701667|FG000|Overall Study|Adverse Event|1|||
162724521|NCT04252586|587701667|FG000|Overall Study|Death|2|||
162724522|NCT04252586|587701667|FG000|Overall Study|Study terminated by sponsor|4|||
162724523|NCT04252586|587701667|FG000|Overall Study|Sponsor request|10|||
162724524|NCT04252586|587701667|FG000|Overall Study|Did not complete treatment period|1|||
162724525|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Death|186|||
162724526|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Death|222|||
162724527|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Death|0|||
162724528|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
162724529|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
162724530|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
162724531|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
162724532|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
162724533|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
162724534|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
162724535|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
162724536|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
162724537|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Adverse Event|83|||
162724538|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Adverse Event|100|||
162724539|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Adverse Event|0|||
162724540|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Other|70|||
162724541|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Other|75|||
162724542|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Other|0|||
162724543|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
162724544|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
162724545|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
162724546|NCT00232180|587701668|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
162724547|NCT00232180|587701669|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
162724548|NCT00232180|587701670|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
162724549|NCT00232180|587701668|FG000|Open Label Phase|Death|0|||
162724550|NCT00232180|587701669|FG001|Open Label Phase|Death|0|||
162724551|NCT00232180|587701670|FG002|Open Label Phase|Death|48|||
162724552|NCT00232180|587701668|FG000|Open Label Phase|Lost to Follow-up|0|||
162724553|NCT00232180|587701669|FG001|Open Label Phase|Lost to Follow-up|0|||
162724554|NCT00232180|587701670|FG002|Open Label Phase|Lost to Follow-up|5|||
162724555|NCT00232180|587701668|FG000|Open Label Phase|Protocol Violation|0|||
162724556|NCT00232180|587701669|FG001|Open Label Phase|Protocol Violation|0|||
162724557|NCT00232180|587701670|FG002|Open Label Phase|Protocol Violation|3|||
162724558|NCT00232180|587701668|FG000|Open Label Phase|Study terminated by sponsor|0|||
162724559|NCT00232180|587701669|FG001|Open Label Phase|Study terminated by sponsor|0|||
162724560|NCT00232180|587701670|FG002|Open Label Phase|Study terminated by sponsor|3|||
162724561|NCT00232180|587701668|FG000|Open Label Phase|Withdrawal by Subject|0|||
162724562|NCT00232180|587701669|FG001|Open Label Phase|Withdrawal by Subject|0|||
162724563|NCT00232180|587701670|FG002|Open Label Phase|Withdrawal by Subject|37|||
162724564|NCT00232180|587701668|FG000|Open Label Phase|Other|0|||
162724565|NCT00232180|587701669|FG001|Open Label Phase|Other|0|||
162724566|NCT00232180|587701670|FG002|Open Label Phase|Other|16|||
162724567|NCT00232180|587701668|FG000|Open Label Phase|Adverse Event|0|||
162724568|NCT00232180|587701669|FG001|Open Label Phase|Adverse Event|0|||
162724569|NCT00232180|587701670|FG002|Open Label Phase|Adverse Event|25|||
162724570|NCT00232180|587701668|FG000|Open Label Phase|Laboratory abnormality|0|||
162724571|NCT00232180|587701669|FG001|Open Label Phase|Laboratory abnormality|0|||
162724572|NCT00232180|587701670|FG002|Open Label Phase|Laboratory abnormality|10|||
162724573|NCT00232180|587701668|FG000|Open Label Phase|Randomized but not treated|0|||
162724574|NCT00232180|587701669|FG001|Open Label Phase|Randomized but not treated|0|||
162724575|NCT00232180|587701670|FG002|Open Label Phase|Randomized but not treated|1|||
162724576|NCT02748317|587701671|FG000|Overall Study|Withdrawal by Subject|14|||
162724577|NCT02748317|587701671|FG000|Overall Study|Lost to Follow-up|8|||
162724578|NCT02748317|587701671|FG000|Overall Study|Death|1|||
162724579|NCT03452189|587701672|FG000|First Intervention (3 Months)|Adverse Event|1|||
162724580|NCT03452189|587701673|FG001|First Intervention (3 Months)|Adverse Event|0|||
162724581|NCT03452189|587701672|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
162724582|NCT03452189|587701673|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
162724583|NCT02724592|587701674|FG000|Overall Study|Lost to Follow-up|4|||
162724584|NCT02724592|587701675|FG001|Overall Study|Lost to Follow-up|1|||
162724585|NCT00434304|587701676|FG000|Overall Study|Adverse Event|14|||
162724586|NCT00434304|587701676|FG000|Overall Study|Lack of Efficacy|2|||
162724587|NCT00434304|587701676|FG000|Overall Study|Withdrawal by Subject|4|||
162724588|NCT05262738|587701677|FG000|Overall Study|Withdrawal by Subject|1|||
162724589|NCT05262738|587701678|FG001|Overall Study|Withdrawal by Subject|0|||
162724590|NCT01424397|587701682|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724591|NCT01424397|587701683|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724592|NCT01424397|587701684|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
162724593|NCT01424397|587701685|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724594|NCT01424397|587701686|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724595|NCT01424397|587701687|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724596|NCT01424397|587701688|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724597|NCT01424397|587701689|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724598|NCT01424397|587701690|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724599|NCT01424397|587701691|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724600|NCT01424397|587701692|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724601|NCT01424397|587701693|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
162724602|NCT01149369|587701694|FG000|Overall Study|Adverse Event|6|||
162679149|NCT00754338|587534554|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162679150|NCT00754338|587534555|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
162679151|NCT00831779|587534558|FG000|Overall Study|Lost to Follow-up|1|||
162679152|NCT00831779|587534559|FG001|Overall Study|Lost to Follow-up|0|||
162679153|NCT00831779|587534558|FG000|Overall Study|No longer met criteria|0|||
162679154|NCT00831779|587534559|FG001|Overall Study|No longer met criteria|1|||
162679155|NCT04020341|587534560|FG000|Overall Study|Adverse Event|8|||
162679156|NCT04020341|587534561|FG001|Overall Study|Adverse Event|6|||
162679157|NCT04020341|587534560|FG000|Overall Study|Lost to Follow-up|8|||
162679158|NCT04020341|587534561|FG001|Overall Study|Lost to Follow-up|2|||
162679159|NCT04020341|587534560|FG000|Overall Study|Withdrawal by Subject|16|||
162679160|NCT04020341|587534561|FG001|Overall Study|Withdrawal by Subject|16|||
162679161|NCT04020341|587534560|FG000|Overall Study|Participant not able to swallow the tablet|1|||
162679162|NCT04020341|587534561|FG001|Overall Study|Participant not able to swallow the tablet|0|||
162679163|NCT04020341|587534560|FG000|Overall Study|Physician Decision|0|||
162679164|NCT04020341|587534561|FG001|Overall Study|Physician Decision|2|||
162679165|NCT04020341|587534560|FG000|Overall Study|Protocol Deviation|0|||
162679166|NCT04020341|587534561|FG001|Overall Study|Protocol Deviation|2|||
162679167|NCT04528069|587534562|FG000|Overall Study|Adverse Event|1|||
162679168|NCT04528069|587534562|FG000|Overall Study|Lost to Follow-up|1|||
162679169|NCT04528069|587534562|FG000|Overall Study|Patient Unable to Come|1|||
162679170|NCT04528069|587534562|FG000|Overall Study|Patient Unable to Attend|1|||
162679171|NCT01814371|587534564|FG000|Overall Study|Lost to Follow-up|30|||
162679172|NCT01814371|587534565|FG001|Overall Study|Lost to Follow-up|27|||
162679173|NCT04683926|587534566|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
162679174|NCT04683926|587534567|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
162679175|NCT04683926|587534568|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
162679176|NCT04683926|587534569|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
162679177|NCT01692782|587534571|FG000|Overall Study|Adverse Event|12|||
162679178|NCT01692782|587534572|FG001|Overall Study|Adverse Event|32|||
162679179|NCT01692782|587534573|FG002|Overall Study|Adverse Event|2|||
162679180|NCT01692782|587534571|FG000|Overall Study|Lack of Efficacy|1|||
162679181|NCT01692782|587534572|FG001|Overall Study|Lack of Efficacy|2|||
162679182|NCT01692782|587534573|FG002|Overall Study|Lack of Efficacy|0|||
162679183|NCT01692782|587534571|FG000|Overall Study|Lost to Follow-up|2|||
162679184|NCT01692782|587534572|FG001|Overall Study|Lost to Follow-up|7|||
162679185|NCT01692782|587534573|FG002|Overall Study|Lost to Follow-up|1|||
162679186|NCT01692782|587534571|FG000|Overall Study|Pregnancy|1|||
162679187|NCT01692782|587534572|FG001|Overall Study|Pregnancy|0|||
162679188|NCT01692782|587534573|FG002|Overall Study|Pregnancy|0|||
162679189|NCT01692782|587534571|FG000|Overall Study|Protocol Violation|1|||
162679190|NCT01692782|587534572|FG001|Overall Study|Protocol Violation|0|||
162679191|NCT01692782|587534573|FG002|Overall Study|Protocol Violation|2|||
162679192|NCT01692782|587534571|FG000|Overall Study|Non-complance with study drug|0|||
162679193|NCT01692782|587534572|FG001|Overall Study|Non-complance with study drug|4|||
162679194|NCT01692782|587534573|FG002|Overall Study|Non-complance with study drug|1|||
162679195|NCT01692782|587534571|FG000|Overall Study|Non-compliant with study visits|0|||
162679196|NCT01692782|587534572|FG001|Overall Study|Non-compliant with study visits|0|||
162679197|NCT01692782|587534573|FG002|Overall Study|Non-compliant with study visits|1|||
162679198|NCT01692782|587534571|FG000|Overall Study|SAE not related to study drug|0|||
162679199|NCT01692782|587534572|FG001|Overall Study|SAE not related to study drug|1|||
162679200|NCT01692782|587534573|FG002|Overall Study|SAE not related to study drug|0|||
162679201|NCT01692782|587534571|FG000|Overall Study|Withdrawal by Subject|3|||
162679202|NCT01692782|587534572|FG001|Overall Study|Withdrawal by Subject|10|||
162679203|NCT01692782|587534573|FG002|Overall Study|Withdrawal by Subject|3|||
162679204|NCT00952367|587534582|FG000|Overall Study|Withdrawal by Subject|2|||
162679205|NCT00952367|587534582|FG000|Overall Study|Noncoordination|1|||
162679206|NCT00952367|587534582|FG000|Overall Study|Protocol Violation|3|||
162679207|NCT05072080|587534585|FG000|Overall Study|Death|0|||
162679208|NCT05072080|587534586|FG001|Overall Study|Death|0|||
162679209|NCT05072080|587534587|FG002|Overall Study|Death|1|||
162679210|NCT05072080|587534588|FG003|Overall Study|Death|0|||
162679211|NCT05072080|587534585|FG000|Overall Study|Lost to Follow-up|65|||
162724603|NCT01149369|587701695|FG001|Overall Study|Adverse Event|3|||
162679212|NCT05072080|587534586|FG001|Overall Study|Lost to Follow-up|70|||
162679213|NCT05072080|587534587|FG002|Overall Study|Lost to Follow-up|58|||
162724604|NCT02767765|587701696|FG000|Overall Study|Adverse Event|4|||
162679214|NCT05072080|587534588|FG003|Overall Study|Lost to Follow-up|23|||
162679215|NCT05072080|587534585|FG000|Overall Study|Physician Decision|2|||
162679216|NCT05072080|587534586|FG001|Overall Study|Physician Decision|1|||
162679217|NCT05072080|587534587|FG002|Overall Study|Physician Decision|1|||
162679218|NCT05072080|587534588|FG003|Overall Study|Physician Decision|0|||
162679219|NCT05072080|587534585|FG000|Overall Study|Withdrawal by Subject|45|||
162679220|NCT05072080|587534586|FG001|Overall Study|Withdrawal by Subject|30|||
162679221|NCT05072080|587534587|FG002|Overall Study|Withdrawal by Subject|27|||
162679222|NCT05072080|587534588|FG003|Overall Study|Withdrawal by Subject|7|||
162679223|NCT05072080|587534585|FG000|Overall Study|Sponsor Decision|0|||
162679224|NCT05072080|587534586|FG001|Overall Study|Sponsor Decision|1|||
162679225|NCT05072080|587534587|FG002|Overall Study|Sponsor Decision|0|||
162679226|NCT05072080|587534588|FG003|Overall Study|Sponsor Decision|0|||
162679227|NCT05072080|587534585|FG000|Overall Study|Subject moved|1|||
162679228|NCT05072080|587534586|FG001|Overall Study|Subject moved|3|||
162679229|NCT05072080|587534587|FG002|Overall Study|Subject moved|5|||
162679230|NCT05072080|587534588|FG003|Overall Study|Subject moved|2|||
162679231|NCT05072080|587534585|FG000|Overall Study|Withdrawal by parent|0|||
162679232|NCT05072080|587534586|FG001|Overall Study|Withdrawal by parent|0|||
162679233|NCT05072080|587534587|FG002|Overall Study|Withdrawal by parent|1|||
162679234|NCT05072080|587534588|FG003|Overall Study|Withdrawal by parent|0|||
162679235|NCT05072080|587534585|FG000|Overall Study|Subject was deployed|0|||
162679236|NCT05072080|587534586|FG001|Overall Study|Subject was deployed|1|||
162679237|NCT05072080|587534587|FG002|Overall Study|Subject was deployed|0|||
162679238|NCT05072080|587534588|FG003|Overall Study|Subject was deployed|0|||
162679239|NCT05072080|587534585|FG000|Overall Study|Subject left site without receiving dose|0|||
162679240|NCT05072080|587534586|FG001|Overall Study|Subject left site without receiving dose|1|||
162679241|NCT05072080|587534587|FG002|Overall Study|Subject left site without receiving dose|0|||
162679242|NCT05072080|587534588|FG003|Overall Study|Subject left site without receiving dose|0|||
162724605|NCT02767765|587701696|FG000|Overall Study|Death|1|||
162724606|NCT02767765|587701696|FG000|Overall Study|Insufficient response|1|||
162724607|NCT02767765|587701696|FG000|Overall Study|Lost to Follow-up|2|||
162679243|NCT05072080|587534585|FG000|Overall Study|Subject incarcerated|0|||
162679244|NCT05072080|587534586|FG001|Overall Study|Subject incarcerated|1|||
162679245|NCT05072080|587534587|FG002|Overall Study|Subject incarcerated|0|||
162679246|NCT05072080|587534588|FG003|Overall Study|Subject incarcerated|1|||
162724608|NCT02767765|587701696|FG000|Overall Study|Investigator decision|1|||
162724609|NCT02767765|587701696|FG000|Overall Study|Non-Compliance|1|||
162724610|NCT02767765|587701696|FG000|Overall Study|Withdrawal by Subject|1|||
162724611|NCT01951170|587701697|FG000|Overall Study|Investigator decision|1|||
162724612|NCT01972724|587701702|FG000|Double-Blind|Rescue Criteria Met|1|||
162724613|NCT01972724|587701703|FG001|Double-Blind|Rescue Criteria Met|0|||
162724614|NCT01972724|587701704|FG002|Double-Blind|Rescue Criteria Met|0|||
162724615|NCT01972724|587701702|FG000|Double-Blind|Adverse Event|1|||
162724616|NCT01972724|587701703|FG001|Double-Blind|Adverse Event|0|||
162724617|NCT01972724|587701704|FG002|Double-Blind|Adverse Event|0|||
162724618|NCT01972724|587701702|FG000|Double-Blind|Withdrawal of Consent|2|||
162724619|NCT01972724|587701703|FG001|Double-Blind|Withdrawal of Consent|1|||
162724620|NCT01972724|587701704|FG002|Double-Blind|Withdrawal of Consent|0|||
162724621|NCT01972724|587701702|FG000|Double-Blind|Significant Protocol Deviation|5|||
162724622|NCT01972724|587701703|FG001|Double-Blind|Significant Protocol Deviation|8|||
162724623|NCT01972724|587701704|FG002|Double-Blind|Significant Protocol Deviation|0|||
162724624|NCT01972724|587701702|FG000|Open-Label|Withdrew Consent|0|||
162724625|NCT01972724|587701703|FG001|Open-Label|Withdrew Consent|0|||
162724626|NCT01972724|587701704|FG002|Open-Label|Withdrew Consent|3|||
162724627|NCT01972724|587701702|FG000|Open-Label|Significant Protocol Deviation|0|||
162724628|NCT01972724|587701703|FG001|Open-Label|Significant Protocol Deviation|0|||
162724629|NCT01972724|587701704|FG002|Open-Label|Significant Protocol Deviation|2|||
162724630|NCT00277355|587701705|FG000|Overall Study|Withdrawal by Subject|3|||
162724631|NCT00277355|587701706|FG001|Overall Study|Withdrawal by Subject|3|||
162724632|NCT00277355|587701705|FG000|Overall Study|Lost to Follow-up|2|||
162724633|NCT00277355|587701706|FG001|Overall Study|Lost to Follow-up|2|||
162724634|NCT00277355|587701705|FG000|Overall Study|Adverse Event|5|||
162724635|NCT00277355|587701706|FG001|Overall Study|Adverse Event|0|||
162724636|NCT00277355|587701705|FG000|Overall Study|Death|3|||
162724637|NCT00277355|587701706|FG001|Overall Study|Death|0|||
162724638|NCT00277355|587701705|FG000|Overall Study|Physician Decision|1|||
162724639|NCT00277355|587701706|FG001|Overall Study|Physician Decision|0|||
162724640|NCT02675244|587701709|FG000|Overall Study|Death|9|||
162724641|NCT02675244|587701710|FG001|Overall Study|Death|6|||
162724642|NCT02675244|587701709|FG000|Overall Study|Withdrawal by Subject|3|||
162724643|NCT02675244|587701710|FG001|Overall Study|Withdrawal by Subject|6|||
162724644|NCT02675244|587701709|FG000|Overall Study|Lost to Follow-up|1|||
162724645|NCT02675244|587701710|FG001|Overall Study|Lost to Follow-up|1|||
162724646|NCT02675244|587701709|FG000|Overall Study|Ongoing at 2 Years|190|||
162724647|NCT02675244|587701710|FG001|Overall Study|Ongoing at 2 Years|185|||
162724648|NCT04054635|587701714|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
162724649|NCT04054635|587701715|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
162724650|NCT04054635|587701716|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
162724651|NCT04054635|587701714|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
162724652|NCT04054635|587701715|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
162724653|NCT04054635|587701716|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
162724654|NCT01254188|587701722|FG000|Overall Study|Disease Progression|6|||
162724655|NCT01254188|587701722|FG000|Overall Study|Protocol Violation|6|||
162724656|NCT01254188|587701722|FG000|Overall Study|Pregnancy|2|||
162724657|NCT01254188|587701722|FG000|Overall Study|Death|4|||
162724658|NCT01254188|587701722|FG000|Overall Study|Lost to Follow-up|5|||
162724659|NCT01254188|587701722|FG000|Overall Study|Withdrawal by Subject|7|||
162724660|NCT01254188|587701722|FG000|Overall Study|Adverse Event|43|||
162724661|NCT01254188|587701722|FG000|Overall Study|per investigator discretion|20|||
162724662|NCT04530747|587701724|FG000|Overall Study|Withdrawal by Subject|1|||
162724663|NCT04530747|587701725|FG001|Overall Study|Withdrawal by Subject|0|||
162724664|NCT03292913|587701726|FG000|Overall Study|Death|9|||
162724665|NCT03292913|587701727|FG001|Overall Study|Death|3|||
162724666|NCT03292913|587701726|FG000|Overall Study|Lost to Follow-up|49|||
162724667|NCT03292913|587701727|FG001|Overall Study|Lost to Follow-up|49|||
162724668|NCT03292913|587701726|FG000|Overall Study|Withdrawal by Subject|2|||
162724669|NCT03292913|587701727|FG001|Overall Study|Withdrawal by Subject|0|||
162724670|NCT03292913|587701726|FG000|Overall Study|Clinic closed due to COVID|22|||
162724671|NCT03292913|587701727|FG001|Overall Study|Clinic closed due to COVID|36|||
162724672|NCT03950622|587701728|FG000|Overall Study|Withdrawal by Subject|1|||
162724673|NCT03950622|587701729|FG001|Overall Study|Withdrawal by Subject|0|||
162724674|NCT03950622|587701728|FG000|Overall Study|Protocol Deviation|0|||
162724675|NCT03950622|587701729|FG001|Overall Study|Protocol Deviation|1|||
162724676|NCT03950622|587701728|FG000|Overall Study|Physician Decision|1|||
162724677|NCT03950622|587701729|FG001|Overall Study|Physician Decision|0|||
162724678|NCT03950622|587701728|FG000|Overall Study|Lost to Follow-up|5|||
162724679|NCT03950622|587701729|FG001|Overall Study|Lost to Follow-up|5|||
162724680|NCT03950622|587701728|FG000|Overall Study|Death|1|||
162724681|NCT03950622|587701729|FG001|Overall Study|Death|1|||
162724682|NCT03531840|587701733|FG000|Overall Study|Death on study|3|||
162724683|NCT03531840|587701734|FG001|Overall Study|Death on study|2|||
162724684|NCT03531840|587701735|FG002|Overall Study|Death on study|1|||
162724685|NCT03531840|587701736|FG003|Overall Study|Death on study|2|||
162724686|NCT03531840|587701733|FG000|Overall Study|Death during follow up|2|||
162724687|NCT03531840|587701734|FG001|Overall Study|Death during follow up|3|||
162679247|NCT05072080|587534585|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
162679248|NCT05072080|587534586|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
162679249|NCT05072080|587534587|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
162679250|NCT05072080|587534588|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
162679251|NCT05072080|587534585|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
162679252|NCT05072080|587534586|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
162679253|NCT05072080|587534587|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
162679254|NCT05072080|587534588|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
162679255|NCT00736645|587534597|FG000|Overall Study|Adverse Event|0|||
162679256|NCT00736645|587534598|FG001|Overall Study|Adverse Event|2|||
162679257|NCT00736645|587534599|FG002|Overall Study|Adverse Event|0|||
162679258|NCT00736645|587534600|FG003|Overall Study|Adverse Event|0|||
162679259|NCT02300220|587534604|FG000|Overall Study|Lost to Follow-up|1|||
162679260|NCT02300220|587534605|FG001|Overall Study|Lost to Follow-up|2|||
162679261|NCT02300220|587534604|FG000|Overall Study|Death|1|||
162679262|NCT02300220|587534605|FG001|Overall Study|Death|1|||
162679263|NCT02300220|587534604|FG000|Overall Study|Adverse Event|1|||
162679264|NCT02300220|587534605|FG001|Overall Study|Adverse Event|1|||
162679265|NCT02300220|587534604|FG000|Overall Study|Protocol Violation|1|||
162679266|NCT02300220|587534605|FG001|Overall Study|Protocol Violation|0|||
162679267|NCT02300220|587534604|FG000|Overall Study|Withdrawal by Subject|0|||
162679268|NCT02300220|587534605|FG001|Overall Study|Withdrawal by Subject|2|||
162679269|NCT02300220|587534604|FG000|Overall Study|Did not tolerate IMP|0|||
162679270|NCT02300220|587534605|FG001|Overall Study|Did not tolerate IMP|1|||
162679271|NCT04322682|587534606|FG000|Overall Study|Withdrawal by Subject|33|||
162679272|NCT04322682|587534607|FG001|Overall Study|Withdrawal by Subject|47|||
162679273|NCT04322682|587534606|FG000|Overall Study|Death|5|||
162679274|NCT04322682|587534607|FG001|Overall Study|Death|9|||
162679275|NCT04322682|587534606|FG000|Overall Study|Lost to Follow-up|4|||
162679276|NCT04322682|587534607|FG001|Overall Study|Lost to Follow-up|8|||
162679277|NCT04322682|587534606|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
162679278|NCT04322682|587534607|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
162679279|NCT02238379|587534608|FG000|Overall Study|Lost to Follow-up|1|||
162679280|NCT02238379|587534609|FG001|Overall Study|Lost to Follow-up|0|||
162679281|NCT04123067|587534610|FG000|Overall Study|Lost to Follow-up|0|||
162679282|NCT04123067|587534611|FG001|Overall Study|Lost to Follow-up|1|||
162679283|NCT03085485|587534612|FG000|Overall Study|Death|1|||
162679284|NCT03085485|587534613|FG001|Overall Study|Death|0|||
162679285|NCT03085485|587534612|FG000|Overall Study|Lost to Follow-up|1|||
162679286|NCT03085485|587534613|FG001|Overall Study|Lost to Follow-up|0|||
162679287|NCT00605280|587534614|FG000|Year 1|Protocol Violation|0|||
162679288|NCT00605280|587534615|FG001|Year 1|Protocol Violation|0|||
162679289|NCT00605280|587534616|FG002|Year 1|Protocol Violation|0|||
162679290|NCT00605280|587534617|FG003|Year 1|Protocol Violation|1|||
162679291|NCT00605280|587534614|FG000|Year 1|Adverse Event|3|||
162679292|NCT00605280|587534615|FG001|Year 1|Adverse Event|1|||
162679293|NCT00605280|587534616|FG002|Year 1|Adverse Event|1|||
162679294|NCT00605280|587534617|FG003|Year 1|Adverse Event|5|||
162679295|NCT00605280|587534614|FG000|Year 1|Physician Decision|7|||
162679296|NCT00605280|587534615|FG001|Year 1|Physician Decision|4|||
162679297|NCT00605280|587534616|FG002|Year 1|Physician Decision|0|||
162679298|NCT00605280|587534617|FG003|Year 1|Physician Decision|6|||
162679299|NCT00605280|587534614|FG000|Year 1|Withdrawal by Subject|2|||
162679300|NCT00605280|587534615|FG001|Year 1|Withdrawal by Subject|4|||
162679301|NCT00605280|587534616|FG002|Year 1|Withdrawal by Subject|0|||
162679302|NCT00605280|587534617|FG003|Year 1|Withdrawal by Subject|4|||
162679303|NCT00605280|587534614|FG000|Year 1|Other|2|||
162679304|NCT00605280|587534615|FG001|Year 1|Other|1|||
162679305|NCT00605280|587534616|FG002|Year 1|Other|0|||
162679306|NCT00605280|587534617|FG003|Year 1|Other|1|||
162679307|NCT00605280|587534614|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
162679308|NCT00605280|587534615|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
162679309|NCT00605280|587534616|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
162679310|NCT00605280|587534617|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
162679311|NCT00605280|587534614|FG000|Year 2|Adverse Event|4|||
162679312|NCT00605280|587534615|FG001|Year 2|Adverse Event|0|||
162724688|NCT03531840|587701735|FG002|Overall Study|Death during follow up|4|||
162724689|NCT03531840|587701736|FG003|Overall Study|Death during follow up|1|||
162724690|NCT02267824|587701738|FG000|Overall Study|Pregnancy|1|||
162724691|NCT02267824|587701739|FG001|Overall Study|Pregnancy|1|||
162724692|NCT02267824|587701738|FG000|Overall Study|Lost to Follow-up|4|||
162724693|NCT02267824|587701739|FG001|Overall Study|Lost to Follow-up|0|||
162724694|NCT02267824|587701738|FG000|Overall Study|Protocol Violation|3|||
162724695|NCT02267824|587701739|FG001|Overall Study|Protocol Violation|0|||
162724696|NCT02267824|587701738|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
162724697|NCT02267824|587701739|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
162724698|NCT01546753|587701740|FG000|Overall Study|anxiety|1|||
162724699|NCT01546753|587701741|FG001|Overall Study|anxiety|1|||
162724700|NCT01546753|587701740|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
162724701|NCT01546753|587701741|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
162724702|NCT01102231|587701743|FG000|Overall Study|Protocol Violation|3|||
162724703|NCT01102231|587701743|FG000|Overall Study|Lack of Efficacy|2|||
162724704|NCT01102231|587701743|FG000|Overall Study|Death|2|||
162724705|NCT01102231|587701743|FG000|Overall Study|Adverse Event|3|||
162724706|NCT01102231|587701743|FG000|Overall Study|Withdrawal by Subject|1|||
162724707|NCT01102231|587701743|FG000|Overall Study|Did not received the treatment|4|||
162724708|NCT01236560|587701750|FG000|Overall Study|Adverse Event|0|||
162724709|NCT01236560|587701751|FG001|Overall Study|Adverse Event|2|||
162724710|NCT01236560|587701752|FG002|Overall Study|Adverse Event|1|||
162724711|NCT01236560|587701753|FG003|Overall Study|Adverse Event|3|||
162724712|NCT01236560|587701754|FG004|Overall Study|Adverse Event|0|||
162724713|NCT01236560|587701755|FG005|Overall Study|Adverse Event|0|||
162724714|NCT01236560|587701750|FG000|Overall Study|Death|0|||
162724715|NCT01236560|587701751|FG001|Overall Study|Death|1|||
162724716|NCT01236560|587701752|FG002|Overall Study|Death|0|||
162724717|NCT01236560|587701753|FG003|Overall Study|Death|1|||
162724718|NCT01236560|587701754|FG004|Overall Study|Death|0|||
162724719|NCT01236560|587701755|FG005|Overall Study|Death|0|||
162724720|NCT01236560|587701750|FG000|Overall Study|Lost to Follow-up|0|||
162724721|NCT01236560|587701751|FG001|Overall Study|Lost to Follow-up|1|||
162724722|NCT01236560|587701752|FG002|Overall Study|Lost to Follow-up|1|||
162724723|NCT01236560|587701753|FG003|Overall Study|Lost to Follow-up|0|||
162724724|NCT01236560|587701754|FG004|Overall Study|Lost to Follow-up|0|||
162724725|NCT01236560|587701755|FG005|Overall Study|Lost to Follow-up|0|||
162724726|NCT01236560|587701750|FG000|Overall Study|Physician Decision|0|||
162724727|NCT01236560|587701751|FG001|Overall Study|Physician Decision|1|||
162724728|NCT01236560|587701752|FG002|Overall Study|Physician Decision|8|||
162724729|NCT01236560|587701753|FG003|Overall Study|Physician Decision|0|||
162724730|NCT01236560|587701754|FG004|Overall Study|Physician Decision|0|||
162724731|NCT01236560|587701755|FG005|Overall Study|Physician Decision|0|||
162724732|NCT01236560|587701750|FG000|Overall Study|Withdrawal by Subject|0|||
162724733|NCT01236560|587701751|FG001|Overall Study|Withdrawal by Subject|0|||
162724734|NCT01236560|587701752|FG002|Overall Study|Withdrawal by Subject|1|||
162724735|NCT01236560|587701753|FG003|Overall Study|Withdrawal by Subject|2|||
162724736|NCT01236560|587701754|FG004|Overall Study|Withdrawal by Subject|0|||
162724737|NCT01236560|587701755|FG005|Overall Study|Withdrawal by Subject|0|||
162724738|NCT01236560|587701750|FG000|Overall Study|Progressive disease|5|||
162724739|NCT01236560|587701751|FG001|Overall Study|Progressive disease|19|||
162724740|NCT01236560|587701752|FG002|Overall Study|Progressive disease|9|||
162724741|NCT01236560|587701753|FG003|Overall Study|Progressive disease|16|||
162724742|NCT01236560|587701754|FG004|Overall Study|Progressive disease|0|||
162724743|NCT01236560|587701755|FG005|Overall Study|Progressive disease|0|||
162724744|NCT01576484|587701758|FG000|Overall Study|Adverse Event|1|||
162724745|NCT01576484|587701759|FG001|Overall Study|Adverse Event|1|||
162724746|NCT01576484|587701758|FG000|Overall Study|Protocol Violation|0|||
162724747|NCT01576484|587701759|FG001|Overall Study|Protocol Violation|2|||
162724748|NCT01576484|587701758|FG000|Overall Study|Sponsor Decision|2|||
162724749|NCT01576484|587701759|FG001|Overall Study|Sponsor Decision|8|||
162724750|NCT01576484|587701758|FG000|Overall Study|Withdrawal by Subject|0|||
162724751|NCT01576484|587701759|FG001|Overall Study|Withdrawal by Subject|3|||
162724752|NCT01576484|587701758|FG000|Overall Study|Other|2|||
162724753|NCT01576484|587701759|FG001|Overall Study|Other|5|||
162724754|NCT00837616|587701764|FG000|Overall Study|Withdrawal by Subject|0|||
162724755|NCT00837616|587701765|FG001|Overall Study|Withdrawal by Subject|1|||
162724756|NCT03512756|587701771|FG000|Part 1|Death|23|||
162724757|NCT03512756|587701772|FG001|Part 1|Death|18|||
162724758|NCT03512756|587701773|FG002|Part 1|Death|0|||
162724759|NCT03512756|587701774|FG003|Part 1|Death|0|||
162724760|NCT03512756|587701771|FG000|Part 1|Lost to Follow-up|0|||
162724761|NCT03512756|587701772|FG001|Part 1|Lost to Follow-up|3|||
162724762|NCT03512756|587701773|FG002|Part 1|Lost to Follow-up|0|||
162724763|NCT03512756|587701774|FG003|Part 1|Lost to Follow-up|0|||
162724764|NCT03512756|587701771|FG000|Part 1|Physician Decision|0|||
162724765|NCT03512756|587701772|FG001|Part 1|Physician Decision|1|||
162724766|NCT03512756|587701773|FG002|Part 1|Physician Decision|0|||
162724767|NCT03512756|587701774|FG003|Part 1|Physician Decision|0|||
162724768|NCT03512756|587701771|FG000|Part 1|Withdrawal by Subject|2|||
162724769|NCT03512756|587701772|FG001|Part 1|Withdrawal by Subject|2|||
162724770|NCT03512756|587701773|FG002|Part 1|Withdrawal by Subject|0|||
162724771|NCT03512756|587701774|FG003|Part 1|Withdrawal by Subject|0|||
162724772|NCT03512756|587701771|FG000|Part 2|Death|0|||
162724773|NCT03512756|587701772|FG001|Part 2|Death|0|||
162724774|NCT03512756|587701773|FG002|Part 2|Death|32|||
162724775|NCT03512756|587701774|FG003|Part 2|Death|21|||
162724776|NCT03512756|587701771|FG000|Part 2|Lost to Follow-up|0|||
162724777|NCT03512756|587701772|FG001|Part 2|Lost to Follow-up|0|||
162724778|NCT03512756|587701773|FG002|Part 2|Lost to Follow-up|1|||
162724779|NCT03512756|587701774|FG003|Part 2|Lost to Follow-up|0|||
162724780|NCT03512756|587701771|FG000|Part 2|Physician Decision|0|||
162724781|NCT03512756|587701772|FG001|Part 2|Physician Decision|0|||
162724782|NCT03512756|587701773|FG002|Part 2|Physician Decision|2|||
162724783|NCT03512756|587701774|FG003|Part 2|Physician Decision|4|||
162724784|NCT03512756|587701771|FG000|Part 2|Study Terminated by Sponsor|0|||
162724785|NCT03512756|587701772|FG001|Part 2|Study Terminated by Sponsor|0|||
162724786|NCT03512756|587701773|FG002|Part 2|Study Terminated by Sponsor|2|||
162724787|NCT03512756|587701774|FG003|Part 2|Study Terminated by Sponsor|6|||
162724788|NCT03512756|587701771|FG000|Part 2|Protocol Violation|0|||
162724789|NCT03512756|587701772|FG001|Part 2|Protocol Violation|0|||
162724790|NCT03512756|587701773|FG002|Part 2|Protocol Violation|1|||
162679313|NCT00605280|587534616|FG002|Year 2|Adverse Event|2|||
162679314|NCT00605280|587534617|FG003|Year 2|Adverse Event|4|||
162679315|NCT00605280|587534614|FG000|Year 2|Physician Decision|11|||
162679316|NCT00605280|587534615|FG001|Year 2|Physician Decision|6|||
162679317|NCT00605280|587534616|FG002|Year 2|Physician Decision|4|||
162679318|NCT00605280|587534617|FG003|Year 2|Physician Decision|11|||
162679319|NCT00605280|587534614|FG000|Year 2|Withdrawal by Subject|4|||
162679320|NCT00605280|587534615|FG001|Year 2|Withdrawal by Subject|0|||
162679321|NCT00605280|587534616|FG002|Year 2|Withdrawal by Subject|0|||
162679322|NCT00605280|587534617|FG003|Year 2|Withdrawal by Subject|4|||
162679323|NCT00605280|587534614|FG000|Year 2|Other|1|||
162679324|NCT00605280|587534615|FG001|Year 2|Other|0|||
162679325|NCT00605280|587534616|FG002|Year 2|Other|0|||
162679326|NCT00605280|587534617|FG003|Year 2|Other|1|||
162679327|NCT00605280|587534614|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
162679328|NCT00605280|587534615|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
162679329|NCT00605280|587534616|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
162679330|NCT00605280|587534617|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
162679331|NCT00605280|587534614|FG000|Year 3 Extension|Adverse Event|2|||
162679332|NCT00605280|587534615|FG001|Year 3 Extension|Adverse Event|0|||
162679333|NCT00605280|587534616|FG002|Year 3 Extension|Adverse Event|0|||
162679334|NCT00605280|587534617|FG003|Year 3 Extension|Adverse Event|2|||
162679335|NCT00605280|587534614|FG000|Year 3 Extension|Physician Decision|0|||
162679336|NCT00605280|587534615|FG001|Year 3 Extension|Physician Decision|0|||
162679337|NCT00605280|587534616|FG002|Year 3 Extension|Physician Decision|0|||
162679338|NCT00605280|587534617|FG003|Year 3 Extension|Physician Decision|2|||
162679339|NCT00605280|587534614|FG000|Year 3 Extension|Withdrawal by Subject|2|||
162679340|NCT00605280|587534615|FG001|Year 3 Extension|Withdrawal by Subject|0|||
162679341|NCT00605280|587534616|FG002|Year 3 Extension|Withdrawal by Subject|0|||
162679342|NCT00605280|587534617|FG003|Year 3 Extension|Withdrawal by Subject|5|||
162679343|NCT00605280|587534614|FG000|Year 3 Extension|Other|2|||
162679344|NCT00605280|587534615|FG001|Year 3 Extension|Other|0|||
162679345|NCT00605280|587534616|FG002|Year 3 Extension|Other|0|||
162679346|NCT00605280|587534617|FG003|Year 3 Extension|Other|0|||
162679347|NCT00605280|587534614|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
162679348|NCT00605280|587534615|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162679349|NCT00605280|587534616|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162679350|NCT00605280|587534617|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162679351|NCT02137369|587534623|FG000|Overall Study|Withdrawal by Subject|3|||
162679352|NCT02137369|587534624|FG001|Overall Study|Withdrawal by Subject|2|||
162679353|NCT02137369|587534623|FG000|Overall Study|Adverse Event|2|||
162679354|NCT02137369|587534624|FG001|Overall Study|Adverse Event|0|||
162679355|NCT02137369|587534623|FG000|Overall Study|Lost to Follow-up|1|||
162679356|NCT02137369|587534624|FG001|Overall Study|Lost to Follow-up|0|||
162679357|NCT02137369|587534623|FG000|Overall Study|Moved away|2|||
162679358|NCT02137369|587534624|FG001|Overall Study|Moved away|0|||
162679359|NCT01329029|587534637|FG000|Overall Study|Withdrawal by Subject|117|||
162679360|NCT01329029|587534638|FG001|Overall Study|Withdrawal by Subject|87|||
162679361|NCT01329029|587534637|FG000|Overall Study|Adverse Event|82|||
162679362|NCT01329029|587534638|FG001|Overall Study|Adverse Event|29|||
162679363|NCT01329029|587534637|FG000|Overall Study|Death|16|||
162679364|NCT01329029|587534638|FG001|Overall Study|Death|19|||
162679365|NCT01329029|587534637|FG000|Overall Study|Other|14|||
162679366|NCT01329029|587534638|FG001|Overall Study|Other|20|||
162679367|NCT01329029|587534637|FG000|Overall Study|COPD Exacerbation|11|||
162679368|NCT01329029|587534638|FG001|Overall Study|COPD Exacerbation|18|||
162679369|NCT01329029|587534637|FG000|Overall Study|Physician Decision|16|||
162679370|NCT01329029|587534638|FG001|Overall Study|Physician Decision|13|||
162724791|NCT03512756|587701774|FG003|Part 2|Protocol Violation|0|||
162724792|NCT03512756|587701771|FG000|Part 2|Withdrawal by Subject|0|||
162724793|NCT03512756|587701772|FG001|Part 2|Withdrawal by Subject|0|||
162724794|NCT03512756|587701773|FG002|Part 2|Withdrawal by Subject|3|||
162724795|NCT03512756|587701774|FG003|Part 2|Withdrawal by Subject|9|||
162724796|NCT01212991|587701775|FG000|Double-blind|Lost to Follow-up|8|||
162724797|NCT01212991|587701776|FG001|Double-blind|Lost to Follow-up|4|||
162724798|NCT01212991|587701777|FG002|Double-blind|Lost to Follow-up|0|||
162724799|NCT01212991|587701775|FG000|Double-blind|Death|699|||
162724800|NCT01212991|587701776|FG001|Double-blind|Death|550|||
162724801|NCT01212991|587701777|FG002|Double-blind|Death|0|||
162724802|NCT01212991|587701775|FG000|Double-blind|Withdrawal by Subject|16|||
162724803|NCT01212991|587701776|FG001|Double-blind|Withdrawal by Subject|19|||
162724804|NCT01212991|587701777|FG002|Double-blind|Withdrawal by Subject|0|||
162724805|NCT01212991|587701775|FG000|Double-blind|Other|7|||
162724806|NCT01212991|587701776|FG001|Double-blind|Other|0|||
162724807|NCT01212991|587701777|FG002|Double-blind|Other|0|||
162724808|NCT01212991|587701775|FG000|Double-blind|Sponsor decision|142|||
162724809|NCT01212991|587701776|FG001|Double-blind|Sponsor decision|38|||
162724810|NCT01212991|587701777|FG002|Double-blind|Sponsor decision|0|||
162724811|NCT01212991|587701775|FG000|Open-label|Death|0|||
162724812|NCT01212991|587701776|FG001|Open-label|Death|0|||
162724813|NCT01212991|587701777|FG002|Open-label|Death|166|||
162724814|NCT01212991|587701775|FG000|Open-label|Lost to Follow-up|0|||
162724815|NCT01212991|587701776|FG001|Open-label|Lost to Follow-up|0|||
162724816|NCT01212991|587701777|FG002|Open-label|Lost to Follow-up|5|||
162724817|NCT01212991|587701775|FG000|Open-label|Withdrawal by Subject|0|||
162724818|NCT01212991|587701776|FG001|Open-label|Withdrawal by Subject|0|||
162724819|NCT01212991|587701777|FG002|Open-label|Withdrawal by Subject|7|||
162724820|NCT01212991|587701775|FG000|Open-label|Sponsor decision|0|||
162724821|NCT01212991|587701776|FG001|Open-label|Sponsor decision|0|||
162724822|NCT01212991|587701777|FG002|Open-label|Sponsor decision|53|||
162724823|NCT01212991|587701775|FG000|Open-label|Other|0|||
162724824|NCT01212991|587701776|FG001|Open-label|Other|0|||
162724825|NCT01212991|587701777|FG002|Open-label|Other|3|||
162724826|NCT03122886|587702987|FG000|Overall Study|Withdrawal by Subject|1|||
162724827|NCT03122886|587702988|FG001|Overall Study|Withdrawal by Subject|2|||
162724828|NCT02279095|587702989|FG000|Overall Study|Non-Compliance|1|||
162724829|NCT02279095|587702989|FG000|Overall Study|Withdrawal by Subject|8|||
162724830|NCT02279095|587702989|FG000|Overall Study|Adverse Event|2|||
162724831|NCT02279095|587702989|FG000|Overall Study|Other|7|||
162724832|NCT02279095|587702989|FG000|Overall Study|Lost to Follow-up|1|||
162724833|NCT02544074|587702992|FG000|Overall Study|Withdrawal by Subject|0|||
162724834|NCT02544074|587702993|FG001|Overall Study|Withdrawal by Subject|1|||
162724835|NCT02544074|587702994|FG002|Overall Study|Withdrawal by Subject|0|||
162724836|NCT02544074|587702995|FG003|Overall Study|Withdrawal by Subject|0|||
162724837|NCT02544074|587702996|FG004|Overall Study|Withdrawal by Subject|0|||
162724838|NCT02544074|587702997|FG005|Overall Study|Withdrawal by Subject|0|||
162724839|NCT02544074|587702998|FG006|Overall Study|Withdrawal by Subject|0|||
162724840|NCT02544074|587702999|FG007|Overall Study|Withdrawal by Subject|0|||
162724841|NCT02544074|587703000|FG008|Overall Study|Withdrawal by Subject|0|||
162724842|NCT02544074|587703001|FG009|Overall Study|Withdrawal by Subject|0|||
162724843|NCT02544074|587703002|FG010|Overall Study|Withdrawal by Subject|0|||
162724844|NCT02544074|587703003|FG011|Overall Study|Withdrawal by Subject|0|||
162724845|NCT02544074|587703004|FG012|Overall Study|Withdrawal by Subject|0|||
162724846|NCT02544074|587703005|FG013|Overall Study|Withdrawal by Subject|0|||
162724847|NCT02544074|587703006|FG014|Overall Study|Withdrawal by Subject|0|||
162724848|NCT02544074|587703007|FG015|Overall Study|Withdrawal by Subject|0|||
162724849|NCT02544074|587703008|FG016|Overall Study|Withdrawal by Subject|0|||
162724850|NCT02544074|587703009|FG017|Overall Study|Withdrawal by Subject|0|||
162724851|NCT02544074|587703010|FG018|Overall Study|Withdrawal by Subject|0|||
162724852|NCT02544074|587703011|FG019|Overall Study|Withdrawal by Subject|0|||
162724853|NCT02544074|587703012|FG020|Overall Study|Withdrawal by Subject|0|||
162724854|NCT02544074|587702992|FG000|Overall Study|Tablet error|0|||
162724855|NCT02544074|587702993|FG001|Overall Study|Tablet error|0|||
162724856|NCT02544074|587702994|FG002|Overall Study|Tablet error|0|||
162724857|NCT02544074|587702995|FG003|Overall Study|Tablet error|0|||
162724858|NCT02544074|587702996|FG004|Overall Study|Tablet error|0|||
162724859|NCT02544074|587702997|FG005|Overall Study|Tablet error|1|||
162724860|NCT02544074|587702998|FG006|Overall Study|Tablet error|0|||
162724861|NCT02544074|587702999|FG007|Overall Study|Tablet error|0|||
162724862|NCT02544074|587703000|FG008|Overall Study|Tablet error|0|||
162724863|NCT02544074|587703001|FG009|Overall Study|Tablet error|1|||
162724864|NCT02544074|587703002|FG010|Overall Study|Tablet error|0|||
162724865|NCT02544074|587703003|FG011|Overall Study|Tablet error|0|||
162724866|NCT02544074|587703004|FG012|Overall Study|Tablet error|0|||
162724867|NCT02544074|587703005|FG013|Overall Study|Tablet error|0|||
162724868|NCT02544074|587703006|FG014|Overall Study|Tablet error|0|||
162724869|NCT02544074|587703007|FG015|Overall Study|Tablet error|0|||
162724870|NCT02544074|587703008|FG016|Overall Study|Tablet error|0|||
162724871|NCT02544074|587703009|FG017|Overall Study|Tablet error|0|||
162724872|NCT02544074|587703010|FG018|Overall Study|Tablet error|0|||
162724873|NCT02544074|587703011|FG019|Overall Study|Tablet error|0|||
162724874|NCT02544074|587703012|FG020|Overall Study|Tablet error|0|||
162724875|NCT03613740|587703013|FG000|Overall Study|Lost to Follow-up|1|||
162724876|NCT03613740|587703014|FG001|Overall Study|Lost to Follow-up|1|||
162724877|NCT01693120|587703015|FG000|Enrollment|Lost to Follow-up|1|||
162724878|NCT01693120|587703015|FG000|Enrollment|Withdrawal by Subject|10|||
162724879|NCT01693120|587703015|FG000|Enrollment|Protocol Violation|46|||
162724880|NCT01693120|587703015|FG000|Enrollment|Physician Decision|3|||
162724881|NCT01693120|587703015|FG000|Enrollment|Adverse Event|1|||
162724882|NCT01693120|587703015|FG000|Enrollment|Study closed|8|||
162724883|NCT01693120|587703015|FG000|Enrollment|Other|1|||
162724884|NCT01693120|587703015|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
162724885|NCT01693120|587703015|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
162724886|NCT01693120|587703015|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
162724887|NCT01693120|587703015|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
162724888|NCT01693120|587703015|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
162724889|NCT02597920|587703027|FG000|Overall Study|Worsening of other pre-existing disease|0|||
162724890|NCT02597920|587703028|FG001|Overall Study|Worsening of other pre-existing disease|1|||
162724891|NCT02597920|587703029|FG002|Overall Study|Worsening of other pre-existing disease|0|||
162724892|NCT02597920|587703027|FG000|Overall Study|Other adverse event|20|||
162724893|NCT02597920|587703028|FG001|Overall Study|Other adverse event|30|||
162724894|NCT02597920|587703029|FG002|Overall Study|Other adverse event|0|||
162724895|NCT02597920|587703027|FG000|Overall Study|Lost to Follow-up|7|||
162724896|NCT02597920|587703028|FG001|Overall Study|Lost to Follow-up|9|||
162724897|NCT02597920|587703029|FG002|Overall Study|Lost to Follow-up|0|||
162724898|NCT02597920|587703027|FG000|Overall Study|Refuse to continue in the study|3|||
162724899|NCT02597920|587703028|FG001|Overall Study|Refuse to continue in the study|13|||
162724900|NCT02597920|587703029|FG002|Overall Study|Refuse to continue in the study|1|||
162724901|NCT02597920|587703027|FG000|Overall Study|Other than specified|10|||
162724902|NCT02597920|587703028|FG001|Overall Study|Other than specified|31|||
162724903|NCT02597920|587703029|FG002|Overall Study|Other than specified|5|||
162724904|NCT02597920|587703027|FG000|Overall Study|Other|1|||
162724905|NCT02597920|587703028|FG001|Overall Study|Other|0|||
162724906|NCT02597920|587703029|FG002|Overall Study|Other|0|||
162724907|NCT00668863|587703030|FG000|Overall Study|Objective Progression or Relapse|42|||
162724908|NCT00668863|587703030|FG000|Overall Study|Adverse Event|13|||
162724909|NCT00668863|587703030|FG000|Overall Study|Study Terminated by Sponsor|8|||
162724910|NCT00668863|587703030|FG000|Overall Study|Global Deterioration of Health Status|4|||
162724911|NCT00668863|587703030|FG000|Overall Study|Withdrawal by Subject|1|||
162724912|NCT00668863|587703030|FG000|Overall Study|Surgery|1|||
162724913|NCT00668863|587703030|FG000|Overall Study|Subject's work scheduling problem|1|||
162724914|NCT00668863|587703030|FG000|Overall Study|Physician Decision|1|||
162724915|NCT00960141|587703036|FG000|Overall Study|Adverse Event|4|||
162724916|NCT00960141|587703037|FG001|Overall Study|Adverse Event|8|||
162724917|NCT00960141|587703038|FG002|Overall Study|Adverse Event|2|||
162724918|NCT00960141|587703036|FG000|Overall Study|Lack of Efficacy|3|||
162724919|NCT00960141|587703037|FG001|Overall Study|Lack of Efficacy|4|||
162724920|NCT00960141|587703038|FG002|Overall Study|Lack of Efficacy|2|||
162724921|NCT00960141|587703036|FG000|Overall Study|Lost to Follow-up|1|||
162724922|NCT00960141|587703037|FG001|Overall Study|Lost to Follow-up|0|||
162724923|NCT00960141|587703038|FG002|Overall Study|Lost to Follow-up|0|||
162724924|NCT00960141|587703036|FG000|Overall Study|Protocol Violation|1|||
162724925|NCT00960141|587703037|FG001|Overall Study|Protocol Violation|3|||
162724926|NCT00960141|587703038|FG002|Overall Study|Protocol Violation|2|||
162724927|NCT00960141|587703036|FG000|Overall Study|Withdrawal by Subject|1|||
162724928|NCT00960141|587703037|FG001|Overall Study|Withdrawal by Subject|2|||
162724929|NCT00960141|587703038|FG002|Overall Study|Withdrawal by Subject|1|||
162724930|NCT03036813|587703039|FG000|Overall Study|Adverse Event|6|||
162724931|NCT03036813|587703040|FG001|Overall Study|Adverse Event|11|||
162724932|NCT03036813|587703041|FG002|Overall Study|Adverse Event|6|||
162724933|NCT03036813|587703039|FG000|Overall Study|Withdrawal by Subject|12|||
162724934|NCT03036813|587703040|FG001|Overall Study|Withdrawal by Subject|6|||
162724935|NCT03036813|587703041|FG002|Overall Study|Withdrawal by Subject|10|||
162724936|NCT03036813|587703039|FG000|Overall Study|Lost to Follow-up|1|||
162724937|NCT03036813|587703040|FG001|Overall Study|Lost to Follow-up|1|||
162724938|NCT03036813|587703041|FG002|Overall Study|Lost to Follow-up|0|||
162724939|NCT03036813|587703039|FG000|Overall Study|Physician Decision|2|||
162724940|NCT03036813|587703040|FG001|Overall Study|Physician Decision|1|||
162724941|NCT03036813|587703041|FG002|Overall Study|Physician Decision|1|||
162724942|NCT03036813|587703039|FG000|Overall Study|Non-Compliance|1|||
162724943|NCT03036813|587703040|FG001|Overall Study|Non-Compliance|5|||
162724944|NCT03036813|587703041|FG002|Overall Study|Non-Compliance|3|||
162724945|NCT03036813|587703039|FG000|Overall Study|Pregnancy|0|||
162724946|NCT03036813|587703040|FG001|Overall Study|Pregnancy|0|||
162724947|NCT03036813|587703041|FG002|Overall Study|Pregnancy|1|||
162724948|NCT03036813|587703039|FG000|Overall Study|Other|0|||
162724949|NCT03036813|587703040|FG001|Overall Study|Other|3|||
162724950|NCT03036813|587703041|FG002|Overall Study|Other|5|||
162724951|NCT00546754|587703042|FG000|Overall Study|Serious Adverse Event|1|||
162724952|NCT00546754|587703043|FG001|Overall Study|Serious Adverse Event|1|||
162724953|NCT00546754|587703042|FG000|Overall Study|Adverse Event|11|||
162724954|NCT00546754|587703043|FG001|Overall Study|Adverse Event|16|||
162724955|NCT00546754|587703042|FG000|Overall Study|Lack of Efficacy|1|||
162724956|NCT00546754|587703043|FG001|Overall Study|Lack of Efficacy|1|||
162724957|NCT00546754|587703042|FG000|Overall Study|Lost to Follow-up|9|||
162724958|NCT00546754|587703043|FG001|Overall Study|Lost to Follow-up|15|||
162724959|NCT00546754|587703042|FG000|Overall Study|Protocol Violation|3|||
162724960|NCT00546754|587703043|FG001|Overall Study|Protocol Violation|0|||
162724961|NCT00546754|587703042|FG000|Overall Study|Withdrawal by Subject|6|||
162724962|NCT00546754|587703043|FG001|Overall Study|Withdrawal by Subject|7|||
162724963|NCT00546754|587703042|FG000|Overall Study|Dyspnea|1|||
162724964|NCT00546754|587703043|FG001|Overall Study|Dyspnea|0|||
162724965|NCT00546754|587703042|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
162724966|NCT00546754|587703043|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
162724967|NCT00546754|587703042|FG000|Overall Study|Hip Replacement|1|||
162724968|NCT00546754|587703043|FG001|Overall Study|Hip Replacement|0|||
162724969|NCT00546754|587703042|FG000|Overall Study|Suicide|1|||
162724970|NCT00546754|587703043|FG001|Overall Study|Suicide|0|||
162724971|NCT00546754|587703042|FG000|Overall Study|Missing Cooperation|1|||
162724972|NCT00546754|587703043|FG001|Overall Study|Missing Cooperation|0|||
162724973|NCT00546754|587703042|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
162724974|NCT00546754|587703043|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
162724975|NCT00546754|587703042|FG000|Overall Study|Patient's Decision|0|||
162724976|NCT00546754|587703043|FG001|Overall Study|Patient's Decision|1|||
162724977|NCT00546754|587703042|FG000|Overall Study|Missing|14|||
162724978|NCT00546754|587703043|FG001|Overall Study|Missing|7|||
162724979|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162724980|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162724981|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162724982|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724983|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724984|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724985|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724986|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724987|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724988|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724989|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724990|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162724991|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
162724992|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
162724993|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
162724994|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
162724995|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
162724996|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
162724997|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
162724998|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
162724999|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
162725000|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
162725001|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
162725002|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
162725003|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
162725004|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725005|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725006|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725007|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725008|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725009|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725010|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725011|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725012|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725013|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725014|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162725015|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725016|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725017|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
162725018|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725019|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725020|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725021|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725022|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725023|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725024|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725025|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725026|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162725027|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
162725028|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
162725029|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
162725030|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
162725031|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725032|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725033|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725034|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725035|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725036|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725037|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725038|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162725039|NCT05061693|587703050|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162725040|NCT05061693|587703051|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
162725041|NCT05061693|587703052|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162725042|NCT05061693|587703053|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162725043|NCT05061693|587703054|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725044|NCT05061693|587703055|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725045|NCT05061693|587703056|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725046|NCT05061693|587703057|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725047|NCT05061693|587703058|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725048|NCT05061693|587703059|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725049|NCT05061693|587703060|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725050|NCT05061693|587703061|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162725051|NCT05061693|587703050|FG000|24-week Extension Period|Adverse Event|0|||
162725052|NCT05061693|587703051|FG001|24-week Extension Period|Adverse Event|0|||
162725053|NCT05061693|587703052|FG002|24-week Extension Period|Adverse Event|0|||
162725054|NCT05061693|587703053|FG003|24-week Extension Period|Adverse Event|0|||
162725055|NCT05061693|587703054|FG004|24-week Extension Period|Adverse Event|0|||
162725056|NCT05061693|587703055|FG005|24-week Extension Period|Adverse Event|0|||
162725057|NCT05061693|587703056|FG006|24-week Extension Period|Adverse Event|0|||
162725058|NCT05061693|587703057|FG007|24-week Extension Period|Adverse Event|2|||
162725059|NCT05061693|587703058|FG008|24-week Extension Period|Adverse Event|2|||
162725060|NCT05061693|587703059|FG009|24-week Extension Period|Adverse Event|0|||
162725061|NCT05061693|587703060|FG010|24-week Extension Period|Adverse Event|1|||
162725062|NCT05061693|587703061|FG011|24-week Extension Period|Adverse Event|3|||
162725063|NCT05061693|587703050|FG000|24-week Extension Period|Lack of Efficacy|0|||
162725064|NCT05061693|587703051|FG001|24-week Extension Period|Lack of Efficacy|0|||
162725065|NCT05061693|587703052|FG002|24-week Extension Period|Lack of Efficacy|0|||
162725066|NCT05061693|587703053|FG003|24-week Extension Period|Lack of Efficacy|0|||
162725067|NCT05061693|587703054|FG004|24-week Extension Period|Lack of Efficacy|0|||
162725068|NCT05061693|587703055|FG005|24-week Extension Period|Lack of Efficacy|0|||
162725069|NCT05061693|587703056|FG006|24-week Extension Period|Lack of Efficacy|0|||
162725070|NCT05061693|587703057|FG007|24-week Extension Period|Lack of Efficacy|0|||
162725071|NCT05061693|587703058|FG008|24-week Extension Period|Lack of Efficacy|0|||
162725072|NCT05061693|587703059|FG009|24-week Extension Period|Lack of Efficacy|0|||
162725073|NCT05061693|587703060|FG010|24-week Extension Period|Lack of Efficacy|2|||
162725074|NCT05061693|587703061|FG011|24-week Extension Period|Lack of Efficacy|0|||
162725075|NCT05061693|587703050|FG000|24-week Extension Period|Lost to Follow-up|0|||
162725076|NCT05061693|587703051|FG001|24-week Extension Period|Lost to Follow-up|0|||
162725077|NCT05061693|587703052|FG002|24-week Extension Period|Lost to Follow-up|0|||
162725078|NCT05061693|587703053|FG003|24-week Extension Period|Lost to Follow-up|0|||
162725079|NCT05061693|587703054|FG004|24-week Extension Period|Lost to Follow-up|0|||
162725080|NCT05061693|587703055|FG005|24-week Extension Period|Lost to Follow-up|0|||
162725081|NCT05061693|587703056|FG006|24-week Extension Period|Lost to Follow-up|1|||
162725082|NCT05061693|587703057|FG007|24-week Extension Period|Lost to Follow-up|0|||
162725083|NCT05061693|587703058|FG008|24-week Extension Period|Lost to Follow-up|1|||
162725084|NCT05061693|587703059|FG009|24-week Extension Period|Lost to Follow-up|1|||
162725085|NCT05061693|587703060|FG010|24-week Extension Period|Lost to Follow-up|0|||
162725086|NCT05061693|587703061|FG011|24-week Extension Period|Lost to Follow-up|0|||
162725087|NCT05061693|587703050|FG000|24-week Extension Period|Withdrawal by Subject|0|||
162725088|NCT05061693|587703051|FG001|24-week Extension Period|Withdrawal by Subject|0|||
162725089|NCT05061693|587703052|FG002|24-week Extension Period|Withdrawal by Subject|0|||
162725090|NCT05061693|587703053|FG003|24-week Extension Period|Withdrawal by Subject|0|||
162725091|NCT05061693|587703054|FG004|24-week Extension Period|Withdrawal by Subject|0|||
162725092|NCT05061693|587703055|FG005|24-week Extension Period|Withdrawal by Subject|0|||
162725093|NCT05061693|587703056|FG006|24-week Extension Period|Withdrawal by Subject|0|||
162725094|NCT05061693|587703057|FG007|24-week Extension Period|Withdrawal by Subject|0|||
162725095|NCT05061693|587703058|FG008|24-week Extension Period|Withdrawal by Subject|1|||
162725096|NCT05061693|587703059|FG009|24-week Extension Period|Withdrawal by Subject|2|||
162725097|NCT05061693|587703060|FG010|24-week Extension Period|Withdrawal by Subject|2|||
162725098|NCT05061693|587703061|FG011|24-week Extension Period|Withdrawal by Subject|1|||
162725099|NCT05061693|587703050|FG000|24-week Extension Period|Sponsor Decision|0|||
162679371|NCT01329029|587534637|FG000|Overall Study|Lost to Follow-up|8|||
162679372|NCT01329029|587534638|FG001|Overall Study|Lost to Follow-up|5|||
162679373|NCT01329029|587534637|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
162679374|NCT01329029|587534638|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
162679375|NCT01735201|587537355|FG000|Overall Study|Adverse Event|1|||
162679376|NCT01735201|587537356|FG001|Overall Study|Adverse Event|1|||
162679377|NCT01735201|587537357|FG002|Overall Study|Adverse Event|0|||
162679378|NCT01735201|587537358|FG003|Overall Study|Adverse Event|1|||
162679379|NCT01735201|587537359|FG004|Overall Study|Adverse Event|1|||
162679380|NCT01735201|587537360|FG005|Overall Study|Adverse Event|3|||
162679381|NCT01735201|587537361|FG006|Overall Study|Adverse Event|2|||
162679382|NCT01735201|587537362|FG007|Overall Study|Adverse Event|1|||
162679383|NCT01735201|587537355|FG000|Overall Study|Personal Reasons|1|||
162679384|NCT01735201|587537356|FG001|Overall Study|Personal Reasons|0|||
162679385|NCT01735201|587537357|FG002|Overall Study|Personal Reasons|0|||
162679386|NCT01735201|587537358|FG003|Overall Study|Personal Reasons|0|||
162679387|NCT01735201|587537359|FG004|Overall Study|Personal Reasons|0|||
162679388|NCT01735201|587537360|FG005|Overall Study|Personal Reasons|0|||
162679389|NCT01735201|587537361|FG006|Overall Study|Personal Reasons|0|||
162679390|NCT01735201|587537362|FG007|Overall Study|Personal Reasons|0|||
162679391|NCT01735201|587537355|FG000|Overall Study|Protocol Violation|1|||
162679392|NCT01735201|587537356|FG001|Overall Study|Protocol Violation|0|||
162679393|NCT01735201|587537357|FG002|Overall Study|Protocol Violation|0|||
162679394|NCT01735201|587537358|FG003|Overall Study|Protocol Violation|0|||
162679395|NCT01735201|587537359|FG004|Overall Study|Protocol Violation|0|||
162679396|NCT01735201|587537360|FG005|Overall Study|Protocol Violation|0|||
162679397|NCT01735201|587537361|FG006|Overall Study|Protocol Violation|0|||
162679398|NCT01735201|587537362|FG007|Overall Study|Protocol Violation|0|||
162679399|NCT01735201|587537355|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162679400|NCT01735201|587537356|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162679401|NCT01735201|587537357|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162679402|NCT01735201|587537358|FG003|Overall Study|Other Miscellaneous Reasons|1|||
162679403|NCT01735201|587537359|FG004|Overall Study|Other Miscellaneous Reasons|0|||
162679404|NCT01735201|587537360|FG005|Overall Study|Other Miscellaneous Reasons|2|||
162679405|NCT01735201|587537361|FG006|Overall Study|Other Miscellaneous Reasons|1|||
162679406|NCT01735201|587537362|FG007|Overall Study|Other Miscellaneous Reasons|1|||
162679407|NCT02178059|587537368|FG000|Washout|Physician Decision|1|||
162679408|NCT02178059|587537369|FG001|Washout|Physician Decision|0|||
162679409|NCT04128293|587537370|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162679410|NCT04128293|587537371|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162679411|NCT04128293|587537372|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162679412|NCT04128293|587537373|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162679413|NCT00514943|587537376|FG000|Stage 1|Progressive disease|4|||
162679414|NCT00514943|587537377|FG001|Stage 1|Progressive disease|8|||
162679415|NCT00514943|587537376|FG000|Stage 1|Other Adverse Event|16|||
162725100|NCT05061693|587703051|FG001|24-week Extension Period|Sponsor Decision|0|||
162725101|NCT05061693|587703052|FG002|24-week Extension Period|Sponsor Decision|0|||
162725102|NCT05061693|587703053|FG003|24-week Extension Period|Sponsor Decision|0|||
162725103|NCT05061693|587703054|FG004|24-week Extension Period|Sponsor Decision|0|||
162725104|NCT05061693|587703055|FG005|24-week Extension Period|Sponsor Decision|0|||
162679416|NCT00514943|587537377|FG001|Stage 1|Other Adverse Event|6|||
162679417|NCT00514943|587537376|FG000|Stage 1|Not treated|1|||
162679418|NCT00514943|587537377|FG001|Stage 1|Not treated|2|||
162679419|NCT00514943|587537376|FG000|Stage 1|Patient refused to continue study meds|8|||
162679420|NCT00514943|587537377|FG001|Stage 1|Patient refused to continue study meds|3|||
162679421|NCT00514943|587537376|FG000|Stage 1|Other than stated above|1|||
162679422|NCT00514943|587537377|FG001|Stage 1|Other than stated above|7|||
162679423|NCT00514943|587537376|FG000|Stage 2|Progressive disease|27|||
162679424|NCT00514943|587537377|FG001|Stage 2|Progressive disease|24|||
162679425|NCT00514943|587537376|FG000|Stage 2|Other Adverse Event|3|||
162679426|NCT00514943|587537377|FG001|Stage 2|Other Adverse Event|10|||
162679427|NCT00514943|587537376|FG000|Stage 2|Patient refused to continue study meds|2|||
162679428|NCT00514943|587537377|FG001|Stage 2|Patient refused to continue study meds|0|||
162679429|NCT00514943|587537376|FG000|Stage 2|Other than stated above|0|||
162679430|NCT00514943|587537377|FG001|Stage 2|Other than stated above|2|||
162679431|NCT00499031|587537378|FG000|Overall Study|Improper pre-protocol treatment|1|||
162679432|NCT00499031|587537378|FG000|Overall Study|Required test not done|1|||
162679433|NCT00499031|587537378|FG000|Overall Study|Never treated|1|||
162679434|NCT02001194|587537380|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
162679435|NCT02001194|587537381|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
162679436|NCT02001194|587537382|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
162679437|NCT02001194|587537383|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
162679438|NCT02001194|587537380|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
162679439|NCT02001194|587537381|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
162679440|NCT02001194|587537382|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
162679441|NCT02001194|587537383|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
162679442|NCT02366910|587537388|FG000|Overall Study|Withdrawal by Subject|2|||
162679443|NCT02366910|587537388|FG000|Overall Study|Screen Failure|3|||
162679444|NCT03284788|587537389|FG000|Overall Study|Withdrawal by Subject|2|||
162679445|NCT01786512|587537390|FG000|Overall Study|Lost to Follow-up|0|||
162679446|NCT01786512|587537391|FG001|Overall Study|Lost to Follow-up|0|||
162679447|NCT01786512|587537392|FG002|Overall Study|Lost to Follow-up|0|||
162679448|NCT01786512|587537393|FG003|Overall Study|Lost to Follow-up|0|||
162679449|NCT01786512|587537394|FG004|Overall Study|Lost to Follow-up|0|||
162679450|NCT01786512|587537395|FG005|Overall Study|Lost to Follow-up|0|||
162679451|NCT01786512|587537396|FG006|Overall Study|Lost to Follow-up|0|||
162679452|NCT01786512|587537397|FG007|Overall Study|Lost to Follow-up|0|||
162679453|NCT01786512|587537398|FG008|Overall Study|Lost to Follow-up|0|||
162725105|NCT05061693|587703056|FG006|24-week Extension Period|Sponsor Decision|0|||
162725106|NCT05061693|587703057|FG007|24-week Extension Period|Sponsor Decision|1|||
162725107|NCT05061693|587703058|FG008|24-week Extension Period|Sponsor Decision|0|||
162725108|NCT05061693|587703059|FG009|24-week Extension Period|Sponsor Decision|0|||
162725109|NCT05061693|587703060|FG010|24-week Extension Period|Sponsor Decision|0|||
162725110|NCT05061693|587703061|FG011|24-week Extension Period|Sponsor Decision|0|||
162725111|NCT05061693|587703050|FG000|24-week Extension Period|Site Closure|0|||
162725112|NCT05061693|587703051|FG001|24-week Extension Period|Site Closure|0|||
162679454|NCT01786512|587537399|FG009|Overall Study|Lost to Follow-up|1|||
162679455|NCT01786512|587537400|FG010|Overall Study|Lost to Follow-up|0|||
162679456|NCT01786512|587537390|FG000|Overall Study|Decision by sponsor|0|||
162679457|NCT01786512|587537391|FG001|Overall Study|Decision by sponsor|0|||
162679458|NCT01786512|587537392|FG002|Overall Study|Decision by sponsor|0|||
162679459|NCT01786512|587537393|FG003|Overall Study|Decision by sponsor|0|||
162679460|NCT01786512|587537394|FG004|Overall Study|Decision by sponsor|0|||
162679461|NCT01786512|587537395|FG005|Overall Study|Decision by sponsor|0|||
162679462|NCT01786512|587537396|FG006|Overall Study|Decision by sponsor|0|||
162679463|NCT01786512|587537397|FG007|Overall Study|Decision by sponsor|0|||
162679464|NCT01786512|587537398|FG008|Overall Study|Decision by sponsor|0|||
162679465|NCT01786512|587537399|FG009|Overall Study|Decision by sponsor|0|||
162679466|NCT01786512|587537400|FG010|Overall Study|Decision by sponsor|2|||
162679467|NCT01786512|587537390|FG000|Overall Study|Withdrawal by Subject|0|||
162679468|NCT01786512|587537391|FG001|Overall Study|Withdrawal by Subject|1|||
162679469|NCT01786512|587537392|FG002|Overall Study|Withdrawal by Subject|0|||
162679470|NCT01786512|587537393|FG003|Overall Study|Withdrawal by Subject|0|||
162679471|NCT01786512|587537394|FG004|Overall Study|Withdrawal by Subject|0|||
162679472|NCT01786512|587537395|FG005|Overall Study|Withdrawal by Subject|0|||
162679473|NCT01786512|587537396|FG006|Overall Study|Withdrawal by Subject|1|||
162679474|NCT01786512|587537397|FG007|Overall Study|Withdrawal by Subject|0|||
162679475|NCT01786512|587537398|FG008|Overall Study|Withdrawal by Subject|0|||
162679476|NCT01786512|587537399|FG009|Overall Study|Withdrawal by Subject|3|||
162679477|NCT01786512|587537400|FG010|Overall Study|Withdrawal by Subject|7|||
162679478|NCT01786512|587537390|FG000|Overall Study|Death|0|||
162679479|NCT01786512|587537391|FG001|Overall Study|Death|0|||
162679480|NCT01786512|587537392|FG002|Overall Study|Death|0|||
162679481|NCT01786512|587537393|FG003|Overall Study|Death|0|||
162679482|NCT01786512|587537394|FG004|Overall Study|Death|0|||
162679483|NCT01786512|587537395|FG005|Overall Study|Death|0|||
162679484|NCT01786512|587537396|FG006|Overall Study|Death|0|||
162679485|NCT01786512|587537397|FG007|Overall Study|Death|0|||
162679486|NCT01786512|587537398|FG008|Overall Study|Death|4|||
162679487|NCT01786512|587537399|FG009|Overall Study|Death|1|||
162679488|NCT01786512|587537400|FG010|Overall Study|Death|3|||
162725113|NCT05061693|587703052|FG002|24-week Extension Period|Site Closure|0|||
162725114|NCT05061693|587703053|FG003|24-week Extension Period|Site Closure|0|||
162679489|NCT00605293|587537401|FG000|Overall Study|Death|2|||
162725115|NCT05061693|587703054|FG004|24-week Extension Period|Site Closure|0|||
162679490|NCT00605293|587537402|FG001|Overall Study|Death|1|||
162679491|NCT00605293|587537401|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162679492|NCT00605293|587537402|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162679493|NCT00605293|587537401|FG000|Overall Study|Adverse Event|1|||
162725116|NCT05061693|587703055|FG005|24-week Extension Period|Site Closure|0|||
162725117|NCT05061693|587703056|FG006|24-week Extension Period|Site Closure|0|||
162725118|NCT05061693|587703057|FG007|24-week Extension Period|Site Closure|0|||
162725119|NCT05061693|587703058|FG008|24-week Extension Period|Site Closure|1|||
162725120|NCT05061693|587703059|FG009|24-week Extension Period|Site Closure|0|||
162725121|NCT05061693|587703060|FG010|24-week Extension Period|Site Closure|0|||
162725122|NCT05061693|587703061|FG011|24-week Extension Period|Site Closure|1|||
162725123|NCT03823911|587703062|FG000|Overall Study|Lost to Follow-up|1|||
162725124|NCT03823911|587703063|FG001|Overall Study|Lost to Follow-up|5|||
162725125|NCT03823911|587703064|FG002|Overall Study|Lost to Follow-up|2|||
162725126|NCT03823911|587703062|FG000|Overall Study|Did not meet eligibility criteria|13|||
162725127|NCT03823911|587703063|FG001|Overall Study|Did not meet eligibility criteria|7|||
162725128|NCT03823911|587703064|FG002|Overall Study|Did not meet eligibility criteria|4|||
162725129|NCT03823911|587703062|FG000|Overall Study|Death|0|||
162725130|NCT03823911|587703063|FG001|Overall Study|Death|1|||
162679494|NCT00605293|587537402|FG001|Overall Study|Adverse Event|0|||
162679495|NCT00605293|587537401|FG000|Overall Study|Holidays Dialysis Out|1|||
162679496|NCT00605293|587537402|FG001|Overall Study|Holidays Dialysis Out|0|||
162679497|NCT00605293|587537401|FG000|Overall Study|Blood Transfusion|7|||
162679498|NCT00605293|587537402|FG001|Overall Study|Blood Transfusion|1|||
162679499|NCT00605293|587537401|FG000|Overall Study|Renal Transplantation|3|||
162679500|NCT00605293|587537402|FG001|Overall Study|Renal Transplantation|1|||
162679501|NCT00605293|587537401|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
162679502|NCT00605293|587537402|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
162679503|NCT00605293|587537401|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
162679504|NCT00605293|587537402|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
162679505|NCT00605293|587537401|FG000|Overall Study|Principal Investigator Decision|0|||
162679506|NCT00605293|587537402|FG001|Overall Study|Principal Investigator Decision|1|||
162679507|NCT00781391|587537405|FG000|Overall Study|never received study drug|24|||
162679508|NCT00781391|587537406|FG001|Overall Study|never received study drug|23|||
162679509|NCT00781391|587537407|FG002|Overall Study|never received study drug|32|||
162679510|NCT00781391|587537405|FG000|Overall Study|Protocol Violation|19|||
162679511|NCT00781391|587537406|FG001|Overall Study|Protocol Violation|17|||
162679512|NCT00781391|587537407|FG002|Overall Study|Protocol Violation|20|||
162679513|NCT00781391|587537405|FG000|Overall Study|Death|789|||
162679514|NCT00781391|587537406|FG001|Overall Study|Death|730|||
162679515|NCT00781391|587537407|FG002|Overall Study|Death|706|||
162679516|NCT00781391|587537405|FG000|Overall Study|Withdrawal by Subject|47|||
162679517|NCT00781391|587537406|FG001|Overall Study|Withdrawal by Subject|37|||
162679518|NCT00781391|587537407|FG002|Overall Study|Withdrawal by Subject|25|||
162679519|NCT00781391|587537405|FG000|Overall Study|Lost to Follow-up|0|||
162679520|NCT00781391|587537406|FG001|Overall Study|Lost to Follow-up|0|||
162679521|NCT00781391|587537407|FG002|Overall Study|Lost to Follow-up|1|||
162679522|NCT01984684|587537408|FG000|Overall Study|Lost to Follow-up|25|||
162679523|NCT01984684|587537409|FG001|Overall Study|Lost to Follow-up|24|||
162679524|NCT01984684|587537408|FG000|Overall Study|Adverse Event|8|||
162679525|NCT01984684|587537409|FG001|Overall Study|Adverse Event|12|||
162679526|NCT01984684|587537408|FG000|Overall Study|Withdrawal by Subject|9|||
162679527|NCT01984684|587537409|FG001|Overall Study|Withdrawal by Subject|9|||
162679528|NCT01984684|587537408|FG000|Overall Study|Lack of Efficacy|3|||
162679529|NCT01984684|587537409|FG001|Overall Study|Lack of Efficacy|6|||
162679530|NCT01984684|587537408|FG000|Overall Study|Physician Decision|4|||
162679531|NCT01984684|587537409|FG001|Overall Study|Physician Decision|2|||
162679532|NCT01984684|587537408|FG000|Overall Study|Protocol Violation|4|||
162679533|NCT01984684|587537409|FG001|Overall Study|Protocol Violation|2|||
162679534|NCT01984684|587537408|FG000|Overall Study|Death|0|||
162679535|NCT01984684|587537409|FG001|Overall Study|Death|1|||
162679536|NCT01984684|587537408|FG000|Overall Study|Noncompliance with study drug|2|||
162679537|NCT01984684|587537409|FG001|Overall Study|Noncompliance with study drug|1|||
162679538|NCT01984684|587537408|FG000|Overall Study|Subject incarcerated|1|||
162679539|NCT01984684|587537409|FG001|Overall Study|Subject incarcerated|0|||
162679540|NCT01984684|587537408|FG000|Overall Study|Study drug not available at site|1|||
162679541|NCT01984684|587537409|FG001|Overall Study|Study drug not available at site|1|||
162679542|NCT01984684|587537408|FG000|Overall Study|Subject had inadequate IV access|0|||
162679543|NCT01984684|587537409|FG001|Overall Study|Subject had inadequate IV access|1|||
162679544|NCT03205371|587537419|FG000|Overall Study|Withdrawal by Subject|4|||
162725131|NCT03823911|587703064|FG002|Overall Study|Death|0|||
162679545|NCT03205371|587537420|FG001|Overall Study|Withdrawal by Subject|1|||
162679546|NCT03205371|587537421|FG002|Overall Study|Withdrawal by Subject|0|||
162679547|NCT03205371|587537422|FG003|Overall Study|Withdrawal by Subject|0|||
162679548|NCT03205371|587537423|FG004|Overall Study|Withdrawal by Subject|0|||
162679549|NCT03205371|587537424|FG005|Overall Study|Withdrawal by Subject|0|||
162679550|NCT03205371|587537425|FG006|Overall Study|Withdrawal by Subject|4|||
162679551|NCT03205371|587537426|FG007|Overall Study|Withdrawal by Subject|0|||
162679552|NCT03205371|587537427|FG008|Overall Study|Withdrawal by Subject|2|||
162725132|NCT00396084|587703065|FG000|Overall Study|Adverse Event|0|||
162679553|NCT03205371|587537428|FG009|Overall Study|Withdrawal by Subject|0|||
162679554|NCT03205371|587537429|FG010|Overall Study|Withdrawal by Subject|0|||
162679555|NCT03205371|587537430|FG011|Overall Study|Withdrawal by Subject|1|||
162679556|NCT03205371|587537419|FG000|Overall Study|Lost to Follow-up|0|||
162679557|NCT03205371|587537420|FG001|Overall Study|Lost to Follow-up|0|||
162679558|NCT03205371|587537421|FG002|Overall Study|Lost to Follow-up|0|||
162679559|NCT03205371|587537422|FG003|Overall Study|Lost to Follow-up|0|||
162679560|NCT03205371|587537423|FG004|Overall Study|Lost to Follow-up|0|||
162679561|NCT03205371|587537424|FG005|Overall Study|Lost to Follow-up|0|||
162679562|NCT03205371|587537425|FG006|Overall Study|Lost to Follow-up|5|||
162679563|NCT03205371|587537426|FG007|Overall Study|Lost to Follow-up|2|||
162679564|NCT03205371|587537427|FG008|Overall Study|Lost to Follow-up|3|||
162679565|NCT03205371|587537428|FG009|Overall Study|Lost to Follow-up|0|||
162679566|NCT03205371|587537429|FG010|Overall Study|Lost to Follow-up|0|||
162679567|NCT03205371|587537430|FG011|Overall Study|Lost to Follow-up|0|||
162679568|NCT03205371|587537419|FG000|Overall Study|Protocol Violation|0|||
162679569|NCT03205371|587537420|FG001|Overall Study|Protocol Violation|0|||
162679570|NCT03205371|587537421|FG002|Overall Study|Protocol Violation|0|||
162679571|NCT03205371|587537422|FG003|Overall Study|Protocol Violation|0|||
162679572|NCT03205371|587537423|FG004|Overall Study|Protocol Violation|0|||
162679573|NCT03205371|587537424|FG005|Overall Study|Protocol Violation|0|||
162679574|NCT03205371|587537425|FG006|Overall Study|Protocol Violation|1|||
162679575|NCT03205371|587537426|FG007|Overall Study|Protocol Violation|0|||
162679576|NCT03205371|587537427|FG008|Overall Study|Protocol Violation|0|||
162679577|NCT03205371|587537428|FG009|Overall Study|Protocol Violation|0|||
162679578|NCT03205371|587537429|FG010|Overall Study|Protocol Violation|0|||
162679579|NCT03205371|587537430|FG011|Overall Study|Protocol Violation|0|||
162679580|NCT03205371|587537419|FG000|Overall Study|Adverse Event|0|||
162679581|NCT03205371|587537420|FG001|Overall Study|Adverse Event|0|||
162679582|NCT03205371|587537421|FG002|Overall Study|Adverse Event|0|||
162679583|NCT03205371|587537422|FG003|Overall Study|Adverse Event|0|||
162679584|NCT03205371|587537423|FG004|Overall Study|Adverse Event|0|||
162679585|NCT03205371|587537424|FG005|Overall Study|Adverse Event|0|||
162679586|NCT03205371|587537425|FG006|Overall Study|Adverse Event|0|||
162679587|NCT03205371|587537426|FG007|Overall Study|Adverse Event|1|||
162679588|NCT03205371|587537427|FG008|Overall Study|Adverse Event|0|||
162679589|NCT03205371|587537428|FG009|Overall Study|Adverse Event|0|||
162679590|NCT03205371|587537429|FG010|Overall Study|Adverse Event|0|||
162679591|NCT03205371|587537430|FG011|Overall Study|Adverse Event|0|||
162679592|NCT02835339|587537431|FG000|Overall Study|Did not receive allocated intervention|13|||
162679593|NCT02835339|587537432|FG001|Overall Study|Did not receive allocated intervention|16|||
162679594|NCT01077544|587537433|FG000|Overall Study|New Cancer Therapy|3|||
162679595|NCT01077544|587537434|FG001|Overall Study|New Cancer Therapy|3|||
162679596|NCT01077544|587537433|FG000|Overall Study|Adverse Event|0|||
162679597|NCT01077544|587537434|FG001|Overall Study|Adverse Event|1|||
162679598|NCT01077544|587537433|FG000|Overall Study|Disease Progression|0|||
162679599|NCT01077544|587537434|FG001|Overall Study|Disease Progression|1|||
162679600|NCT00295022|587537436|FG000|Overall Study|Adverse Event|1|||
162679601|NCT00295022|587537437|FG001|Overall Study|Adverse Event|1|||
162679602|NCT00295022|587537438|FG002|Overall Study|Adverse Event|2|||
162679603|NCT00295022|587537436|FG000|Overall Study|Lost to Follow-up|0|||
162679604|NCT00295022|587537437|FG001|Overall Study|Lost to Follow-up|0|||
162679605|NCT00295022|587537438|FG002|Overall Study|Lost to Follow-up|1|||
162679606|NCT00295022|587537436|FG000|Overall Study|Withdrawal by Subject|0|||
162679607|NCT00295022|587537437|FG001|Overall Study|Withdrawal by Subject|0|||
162679608|NCT00295022|587537438|FG002|Overall Study|Withdrawal by Subject|2|||
162679609|NCT00734630|587537440|FG000|Overall Study|Lack of Efficacy|4|||
162679610|NCT00734630|587537441|FG001|Overall Study|Lack of Efficacy|4|||
162679611|NCT00734630|587537440|FG000|Overall Study|Withdrawal by Subject|7|||
162679612|NCT00734630|587537441|FG001|Overall Study|Withdrawal by Subject|9|||
162679613|NCT00734630|587537440|FG000|Overall Study|Lost to Follow-up|13|||
162679614|NCT00734630|587537441|FG001|Overall Study|Lost to Follow-up|7|||
162679615|NCT00734630|587537440|FG000|Overall Study|Protocol Violation|0|||
162679616|NCT00734630|587537441|FG001|Overall Study|Protocol Violation|3|||
162679617|NCT00734630|587537440|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
162679618|NCT00734630|587537441|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
162679619|NCT00734630|587537440|FG000|Overall Study|Adverse Event|3|||
162679620|NCT00734630|587537441|FG001|Overall Study|Adverse Event|6|||
162679621|NCT00734630|587537440|FG000|Overall Study|Randomized in Error|0|||
162679622|NCT00734630|587537441|FG001|Overall Study|Randomized in Error|1|||
162679623|NCT00734630|587537440|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
162679624|NCT00734630|587537441|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
162679625|NCT00734630|587537440|FG000|Overall Study|Poor Compliance|1|||
162679626|NCT00734630|587537441|FG001|Overall Study|Poor Compliance|1|||
162679627|NCT01239030|587537442|FG000|Double Blind|Adverse Event|0|||
162679628|NCT01239030|587537443|FG001|Double Blind|Adverse Event|1|||
162679629|NCT01239030|587537444|FG002|Double Blind|Adverse Event|0|||
162679630|NCT01239030|587537445|FG003|Double Blind|Adverse Event|2|||
162679631|NCT01239030|587537446|FG004|Double Blind|Adverse Event|0|||
162725133|NCT00396084|587703066|FG001|Overall Study|Adverse Event|0|||
162725134|NCT00396084|587703067|FG002|Overall Study|Adverse Event|0|||
162725135|NCT00396084|587703068|FG003|Overall Study|Adverse Event|0|||
162725136|NCT00396084|587703069|FG004|Overall Study|Adverse Event|1|||
162725137|NCT00396084|587703070|FG005|Overall Study|Adverse Event|2|||
162725138|NCT00396084|587703065|FG000|Overall Study|Withdrawal by Subject|0|||
162725139|NCT00396084|587703066|FG001|Overall Study|Withdrawal by Subject|0|||
162725140|NCT00396084|587703067|FG002|Overall Study|Withdrawal by Subject|0|||
162725141|NCT00396084|587703068|FG003|Overall Study|Withdrawal by Subject|1|||
162725142|NCT00396084|587703069|FG004|Overall Study|Withdrawal by Subject|0|||
162725143|NCT00396084|587703070|FG005|Overall Study|Withdrawal by Subject|0|||
162725144|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
162725145|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
162725146|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
162725147|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
162725148|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
162725149|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
162725150|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
162725151|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
162725152|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
162725153|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
162725154|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
162725155|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
162725156|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
162725157|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
162725158|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
162725159|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
162725160|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
162725161|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
162725162|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
162725163|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
162725164|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
162725165|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
162725166|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
162725167|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
162725168|NCT00311363|587703073|FG000|24-Week Single-Blind Treatment Period|Death|1|||
162725169|NCT00311363|587703074|FG001|24-Week Single-Blind Treatment Period|Death|0|||
162725170|NCT00311363|587703075|FG002|24-Week Single-Blind Treatment Period|Death|0|||
162725171|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
162725172|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
162725173|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
162725174|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
162725175|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
162725176|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162725177|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
162725178|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
162725179|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
162725180|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
162725181|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
162725182|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
162725183|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
162725184|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
162725185|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
162725186|NCT00311363|587703073|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
162725187|NCT00311363|587703074|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
162725188|NCT00311363|587703075|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
162725189|NCT04009577|587703076|FG000|Core Study|Adverse Event|1|||
162725190|NCT04009577|587703077|FG001|Core Study|Adverse Event|0|||
162725191|NCT04009577|587703078|FG002|Core Study|Adverse Event|2|||
162725192|NCT04009577|587703079|FG003|Core Study|Adverse Event|4|||
162725193|NCT04009577|587703076|FG000|Core Study|Withdrawal by Subject|0|||
162725194|NCT04009577|587703077|FG001|Core Study|Withdrawal by Subject|0|||
162725195|NCT04009577|587703078|FG002|Core Study|Withdrawal by Subject|2|||
162725196|NCT04009577|587703079|FG003|Core Study|Withdrawal by Subject|0|||
162725197|NCT04009577|587703076|FG000|Core Study|Other|0|||
162725198|NCT04009577|587703077|FG001|Core Study|Other|0|||
162725199|NCT04009577|587703078|FG002|Core Study|Other|0|||
162725200|NCT04009577|587703079|FG003|Core Study|Other|1|||
162725201|NCT04009577|587703076|FG000|Extension Phase|Adverse Event|0|||
162725202|NCT04009577|587703077|FG001|Extension Phase|Adverse Event|0|||
162679632|NCT01239030|587537442|FG000|Double Blind|Withdrawal by Subject|0|||
162679633|NCT01239030|587537443|FG001|Double Blind|Withdrawal by Subject|1|||
162679634|NCT01239030|587537444|FG002|Double Blind|Withdrawal by Subject|1|||
162679635|NCT01239030|587537445|FG003|Double Blind|Withdrawal by Subject|0|||
162725203|NCT04009577|587703078|FG002|Extension Phase|Adverse Event|0|||
162679636|NCT01239030|587537446|FG004|Double Blind|Withdrawal by Subject|1|||
162679637|NCT01239030|587537442|FG000|Double Blind|Lost to Follow-up|1|||
162679638|NCT01239030|587537443|FG001|Double Blind|Lost to Follow-up|1|||
162679639|NCT01239030|587537444|FG002|Double Blind|Lost to Follow-up|0|||
162679640|NCT01239030|587537445|FG003|Double Blind|Lost to Follow-up|0|||
162679641|NCT01239030|587537446|FG004|Double Blind|Lost to Follow-up|0|||
162679642|NCT01239030|587537442|FG000|Double Blind|Physician Decision|0|||
162679643|NCT01239030|587537443|FG001|Double Blind|Physician Decision|1|||
162679644|NCT01239030|587537444|FG002|Double Blind|Physician Decision|0|||
162679645|NCT01239030|587537445|FG003|Double Blind|Physician Decision|0|||
162679646|NCT01239030|587537446|FG004|Double Blind|Physician Decision|0|||
162679647|NCT01239030|587537442|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
162679648|NCT01239030|587537443|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
162679649|NCT01239030|587537444|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
162679650|NCT01239030|587537445|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
162679651|NCT01239030|587537446|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
162679652|NCT01239030|587537442|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
162679653|NCT01239030|587537443|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
162679654|NCT01239030|587537444|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
162679655|NCT01239030|587537445|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
162679656|NCT01239030|587537446|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
162679657|NCT01239030|587537442|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162679658|NCT01239030|587537443|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162679659|NCT01239030|587537444|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
162679660|NCT01239030|587537445|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
162679661|NCT01239030|587537446|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162679662|NCT01239030|587537442|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
162679663|NCT01239030|587537443|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
162679664|NCT01239030|587537444|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
162679665|NCT01239030|587537445|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
162679666|NCT01239030|587537446|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
162679667|NCT04403698|587537447|FG000|Overall Study|Adverse Event|1|||
162679668|NCT04403698|587537448|FG001|Overall Study|Adverse Event|1|||
162679669|NCT04403698|587537447|FG000|Overall Study|Lost to Follow-up|1|||
162679670|NCT04403698|587537448|FG001|Overall Study|Lost to Follow-up|0|||
162679671|NCT04403698|587537447|FG000|Overall Study|Protocol Violation|0|||
162679672|NCT04403698|587537448|FG001|Overall Study|Protocol Violation|1|||
162679673|NCT00977665|587537449|FG000|Overall Study|Withdrawal by Subject|1|||
162679674|NCT00977665|587537450|FG001|Overall Study|Withdrawal by Subject|3|||
162679675|NCT00977665|587537449|FG000|Overall Study|Physician Decision|2|||
162679676|NCT00977665|587537450|FG001|Overall Study|Physician Decision|1|||
162679677|NCT00977665|587537449|FG000|Overall Study|Sponsor requested withdrawal|0|||
162679678|NCT00977665|587537450|FG001|Overall Study|Sponsor requested withdrawal|1|||
162679679|NCT00977665|587537449|FG000|Overall Study|Lost to Follow-up|1|||
162679680|NCT00977665|587537450|FG001|Overall Study|Lost to Follow-up|0|||
162679681|NCT00977665|587537449|FG000|Overall Study|Death|3|||
162679682|NCT00977665|587537450|FG001|Overall Study|Death|2|||
162679683|NCT00977665|587537449|FG000|Overall Study|Adverse Event|14|||
162679684|NCT00977665|587537450|FG001|Overall Study|Adverse Event|7|||
162679685|NCT00977665|587537449|FG000|Overall Study|Treatment failure|0|||
162679686|NCT00977665|587537450|FG001|Overall Study|Treatment failure|1|||
162679687|NCT01330433|587537451|FG000|Overall Study|Death|1|||
162679688|NCT01330433|587537452|FG001|Overall Study|Death|3|||
162679689|NCT01330433|587537451|FG000|Overall Study|Lost to Follow-up|1|||
162679690|NCT01330433|587537452|FG001|Overall Study|Lost to Follow-up|0|||
162679691|NCT00441090|587537455|FG000|Overall Study|Adverse Event|0|||
162679692|NCT00441090|587537456|FG001|Overall Study|Adverse Event|1|||
162679693|NCT00441090|587537457|FG002|Overall Study|Adverse Event|1|||
162679694|NCT00441090|587537458|FG003|Overall Study|Adverse Event|0|||
162679695|NCT00441090|587537459|FG004|Overall Study|Adverse Event|0|||
162679696|NCT00441090|587537455|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162679697|NCT00441090|587537456|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162679698|NCT00441090|587537457|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162679699|NCT00441090|587537458|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
162679700|NCT00441090|587537459|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162679701|NCT00441090|587537455|FG000|Overall Study|Withdrawal by Subject|1|||
162679702|NCT00441090|587537456|FG001|Overall Study|Withdrawal by Subject|0|||
162679703|NCT00441090|587537457|FG002|Overall Study|Withdrawal by Subject|1|||
162679704|NCT00441090|587537458|FG003|Overall Study|Withdrawal by Subject|0|||
162679705|NCT00441090|587537459|FG004|Overall Study|Withdrawal by Subject|0|||
162679706|NCT00441090|587537455|FG000|Overall Study|Lack of Efficacy|1|||
162679707|NCT00441090|587537456|FG001|Overall Study|Lack of Efficacy|0|||
162679708|NCT00441090|587537457|FG002|Overall Study|Lack of Efficacy|0|||
162679709|NCT00441090|587537458|FG003|Overall Study|Lack of Efficacy|0|||
162679710|NCT00441090|587537459|FG004|Overall Study|Lack of Efficacy|0|||
162679711|NCT01441102|587537460|FG000|Overall Study|Adverse Event|1|||
162679712|NCT01441102|587537460|FG000|Overall Study|Withdrawal by Subject|2|||
162679713|NCT00518115|587537464|FG000|Overall Study|Adverse Event|6|||
162679714|NCT00518115|587537465|FG001|Overall Study|Adverse Event|1|||
162679715|NCT00518115|587537466|FG002|Overall Study|Adverse Event|5|||
162679716|NCT00518115|587537467|FG003|Overall Study|Adverse Event|6|||
162679717|NCT00518115|587537468|FG004|Overall Study|Adverse Event|5|||
162679718|NCT00518115|587537469|FG005|Overall Study|Adverse Event|5|||
162679719|NCT00518115|587537470|FG006|Overall Study|Adverse Event|5|||
162679720|NCT00518115|587537471|FG007|Overall Study|Adverse Event|10|||
162679721|NCT00518115|587537472|FG008|Overall Study|Adverse Event|2|||
162679722|NCT00518115|587537473|FG009|Overall Study|Adverse Event|9|||
162679723|NCT00518115|587537464|FG000|Overall Study|Lost to Follow-up|0|||
162679724|NCT00518115|587537465|FG001|Overall Study|Lost to Follow-up|0|||
162679725|NCT00518115|587537466|FG002|Overall Study|Lost to Follow-up|2|||
162679726|NCT00518115|587537467|FG003|Overall Study|Lost to Follow-up|3|||
162679727|NCT00518115|587537468|FG004|Overall Study|Lost to Follow-up|1|||
162679728|NCT00518115|587537469|FG005|Overall Study|Lost to Follow-up|3|||
162679729|NCT00518115|587537470|FG006|Overall Study|Lost to Follow-up|0|||
162679730|NCT00518115|587537471|FG007|Overall Study|Lost to Follow-up|1|||
162679731|NCT00518115|587537472|FG008|Overall Study|Lost to Follow-up|1|||
162679732|NCT00518115|587537473|FG009|Overall Study|Lost to Follow-up|1|||
162679733|NCT00518115|587537464|FG000|Overall Study|Protocol Violation|1|||
162679734|NCT00518115|587537465|FG001|Overall Study|Protocol Violation|3|||
162679735|NCT00518115|587537466|FG002|Overall Study|Protocol Violation|1|||
162679736|NCT00518115|587537467|FG003|Overall Study|Protocol Violation|0|||
162679737|NCT00518115|587537468|FG004|Overall Study|Protocol Violation|0|||
162679738|NCT00518115|587537469|FG005|Overall Study|Protocol Violation|0|||
162679739|NCT00518115|587537470|FG006|Overall Study|Protocol Violation|0|||
162679740|NCT00518115|587537471|FG007|Overall Study|Protocol Violation|0|||
162679741|NCT00518115|587537472|FG008|Overall Study|Protocol Violation|0|||
162679742|NCT00518115|587537473|FG009|Overall Study|Protocol Violation|0|||
162679743|NCT00518115|587537464|FG000|Overall Study|Withdrawal by Subject|1|||
162679744|NCT00518115|587537465|FG001|Overall Study|Withdrawal by Subject|1|||
162679745|NCT00518115|587537466|FG002|Overall Study|Withdrawal by Subject|5|||
162679746|NCT00518115|587537467|FG003|Overall Study|Withdrawal by Subject|0|||
162679747|NCT00518115|587537468|FG004|Overall Study|Withdrawal by Subject|2|||
162679748|NCT00518115|587537469|FG005|Overall Study|Withdrawal by Subject|1|||
162679749|NCT00518115|587537470|FG006|Overall Study|Withdrawal by Subject|0|||
162679750|NCT00518115|587537471|FG007|Overall Study|Withdrawal by Subject|2|||
162679751|NCT00518115|587537472|FG008|Overall Study|Withdrawal by Subject|1|||
162679752|NCT00518115|587537473|FG009|Overall Study|Withdrawal by Subject|3|||
162679753|NCT00518115|587537464|FG000|Overall Study|Lack of Efficacy|1|||
162679754|NCT00518115|587537465|FG001|Overall Study|Lack of Efficacy|0|||
162679755|NCT00518115|587537466|FG002|Overall Study|Lack of Efficacy|1|||
162679756|NCT00518115|587537467|FG003|Overall Study|Lack of Efficacy|1|||
162679757|NCT00518115|587537468|FG004|Overall Study|Lack of Efficacy|0|||
162679758|NCT00518115|587537469|FG005|Overall Study|Lack of Efficacy|0|||
162679759|NCT00518115|587537470|FG006|Overall Study|Lack of Efficacy|0|||
162679760|NCT00518115|587537471|FG007|Overall Study|Lack of Efficacy|1|||
162679761|NCT00518115|587537472|FG008|Overall Study|Lack of Efficacy|0|||
162679762|NCT00518115|587537473|FG009|Overall Study|Lack of Efficacy|0|||
162679763|NCT00518115|587537464|FG000|Overall Study|Non-Compliance|1|||
162679764|NCT00518115|587537465|FG001|Overall Study|Non-Compliance|0|||
162679765|NCT00518115|587537466|FG002|Overall Study|Non-Compliance|1|||
162679766|NCT00518115|587537467|FG003|Overall Study|Non-Compliance|0|||
162679767|NCT00518115|587537468|FG004|Overall Study|Non-Compliance|1|||
162679768|NCT00518115|587537469|FG005|Overall Study|Non-Compliance|1|||
162679769|NCT00518115|587537470|FG006|Overall Study|Non-Compliance|1|||
162679770|NCT00518115|587537471|FG007|Overall Study|Non-Compliance|1|||
162679771|NCT00518115|587537472|FG008|Overall Study|Non-Compliance|0|||
162679772|NCT00518115|587537473|FG009|Overall Study|Non-Compliance|1|||
162679773|NCT00518115|587537464|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
162679774|NCT00518115|587537465|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
162679775|NCT00518115|587537466|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679776|NCT00518115|587537467|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679777|NCT00518115|587537468|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679778|NCT00518115|587537469|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
162679779|NCT00518115|587537470|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679780|NCT00518115|587537471|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679781|NCT00518115|587537472|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679782|NCT00518115|587537473|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162679783|NCT00518115|587537464|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
162679784|NCT00518115|587537465|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679785|NCT00518115|587537466|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679786|NCT00518115|587537467|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679787|NCT00518115|587537468|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679788|NCT00518115|587537469|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679789|NCT00518115|587537470|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679790|NCT00518115|587537471|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679791|NCT00518115|587537472|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679792|NCT00518115|587537473|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162679793|NCT00518115|587537464|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679794|NCT00518115|587537465|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679795|NCT00518115|587537466|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
162679796|NCT00518115|587537467|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679797|NCT00518115|587537468|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679798|NCT00518115|587537469|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679799|NCT00518115|587537470|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679800|NCT00518115|587537471|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679801|NCT00518115|587537472|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
162679802|NCT00518115|587537473|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
162679803|NCT00518115|587537464|FG000|Overall Study|Wrong Monotherapy Administered|0|||
162679804|NCT00518115|587537465|FG001|Overall Study|Wrong Monotherapy Administered|0|||
162679805|NCT00518115|587537466|FG002|Overall Study|Wrong Monotherapy Administered|1|||
162679806|NCT00518115|587537467|FG003|Overall Study|Wrong Monotherapy Administered|0|||
162679807|NCT00518115|587537468|FG004|Overall Study|Wrong Monotherapy Administered|0|||
162679808|NCT00518115|587537469|FG005|Overall Study|Wrong Monotherapy Administered|0|||
162679809|NCT00518115|587537470|FG006|Overall Study|Wrong Monotherapy Administered|1|||
162679810|NCT00518115|587537471|FG007|Overall Study|Wrong Monotherapy Administered|0|||
162679811|NCT00518115|587537472|FG008|Overall Study|Wrong Monotherapy Administered|0|||
162679812|NCT00518115|587537473|FG009|Overall Study|Wrong Monotherapy Administered|0|||
162679813|NCT00518115|587537464|FG000|Overall Study|Violation of Exclusion Criteria|0|||
162679814|NCT00518115|587537465|FG001|Overall Study|Violation of Exclusion Criteria|0|||
162679815|NCT00518115|587537466|FG002|Overall Study|Violation of Exclusion Criteria|0|||
162679816|NCT00518115|587537467|FG003|Overall Study|Violation of Exclusion Criteria|1|||
162679817|NCT00518115|587537468|FG004|Overall Study|Violation of Exclusion Criteria|0|||
162679818|NCT00518115|587537469|FG005|Overall Study|Violation of Exclusion Criteria|0|||
162679819|NCT00518115|587537470|FG006|Overall Study|Violation of Exclusion Criteria|1|||
162679820|NCT00518115|587537471|FG007|Overall Study|Violation of Exclusion Criteria|0|||
162679821|NCT00518115|587537472|FG008|Overall Study|Violation of Exclusion Criteria|0|||
162679822|NCT00518115|587537473|FG009|Overall Study|Violation of Exclusion Criteria|0|||
162679823|NCT00518115|587537464|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
162679824|NCT00518115|587537465|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
162679825|NCT00518115|587537466|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
162679826|NCT00518115|587537467|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
162679827|NCT00518115|587537468|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
162679828|NCT00518115|587537469|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
162679829|NCT00518115|587537470|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
162679830|NCT00518115|587537471|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
162679831|NCT00518115|587537472|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
162679832|NCT00518115|587537473|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
162679833|NCT00518115|587537464|FG000|Overall Study|Withdrew Consent|0|||
162679834|NCT00518115|587537465|FG001|Overall Study|Withdrew Consent|0|||
162679835|NCT00518115|587537466|FG002|Overall Study|Withdrew Consent|0|||
162679836|NCT00518115|587537467|FG003|Overall Study|Withdrew Consent|0|||
162679837|NCT00518115|587537468|FG004|Overall Study|Withdrew Consent|0|||
162679838|NCT00518115|587537469|FG005|Overall Study|Withdrew Consent|1|||
162679839|NCT00518115|587537470|FG006|Overall Study|Withdrew Consent|0|||
162679840|NCT00518115|587537471|FG007|Overall Study|Withdrew Consent|0|||
162679841|NCT00518115|587537472|FG008|Overall Study|Withdrew Consent|0|||
162679842|NCT00518115|587537473|FG009|Overall Study|Withdrew Consent|0|||
162679843|NCT00518115|587537464|FG000|Overall Study|Moved Out of State|0|||
162679844|NCT00518115|587537465|FG001|Overall Study|Moved Out of State|0|||
162679845|NCT00518115|587537466|FG002|Overall Study|Moved Out of State|0|||
162679846|NCT00518115|587537467|FG003|Overall Study|Moved Out of State|0|||
162679847|NCT00518115|587537468|FG004|Overall Study|Moved Out of State|0|||
162679848|NCT00518115|587537469|FG005|Overall Study|Moved Out of State|0|||
162679849|NCT00518115|587537470|FG006|Overall Study|Moved Out of State|0|||
162679850|NCT00518115|587537471|FG007|Overall Study|Moved Out of State|0|||
162679851|NCT00518115|587537472|FG008|Overall Study|Moved Out of State|0|||
162679852|NCT00518115|587537473|FG009|Overall Study|Moved Out of State|1|||
162679853|NCT04891419|587537474|FG000|Overall Study|Withdrawal by Subject|4|||
162679854|NCT04891419|587537475|FG001|Overall Study|Withdrawal by Subject|0|||
162679855|NCT04891419|587537474|FG000|Overall Study|Lost to Follow-up|1|||
162679856|NCT04891419|587537475|FG001|Overall Study|Lost to Follow-up|3|||
162679857|NCT00827918|587537479|FG000|Overall Study|Adverse Event|4|||
162679858|NCT00827918|587537480|FG001|Overall Study|Adverse Event|0|||
162679859|NCT00827918|587537481|FG002|Overall Study|Adverse Event|0|||
162679860|NCT00827918|587537479|FG000|Overall Study|Lack of Efficacy|16|||
162679861|NCT00827918|587537480|FG001|Overall Study|Lack of Efficacy|4|||
162679862|NCT00827918|587537481|FG002|Overall Study|Lack of Efficacy|15|||
162679863|NCT00827918|587537479|FG000|Overall Study|Physician Decision|1|||
162679864|NCT00827918|587537480|FG001|Overall Study|Physician Decision|0|||
162679865|NCT00827918|587537481|FG002|Overall Study|Physician Decision|0|||
162679866|NCT00827918|587537479|FG000|Overall Study|Pregnancy|0|||
162679867|NCT00827918|587537480|FG001|Overall Study|Pregnancy|1|||
162679868|NCT00827918|587537481|FG002|Overall Study|Pregnancy|0|||
162679869|NCT00827918|587537479|FG000|Overall Study|Progressive Disease|1|||
162679870|NCT00827918|587537480|FG001|Overall Study|Progressive Disease|1|||
162679871|NCT00827918|587537481|FG002|Overall Study|Progressive Disease|0|||
162679872|NCT00827918|587537479|FG000|Overall Study|Protocol Violation|0|||
162679873|NCT00827918|587537480|FG001|Overall Study|Protocol Violation|1|||
162679874|NCT00827918|587537481|FG002|Overall Study|Protocol Violation|0|||
162679875|NCT00827918|587537479|FG000|Overall Study|Withdrawal by Subject|6|||
162679876|NCT00827918|587537480|FG001|Overall Study|Withdrawal by Subject|2|||
162679877|NCT00827918|587537481|FG002|Overall Study|Withdrawal by Subject|6|||
162679878|NCT00802074|587537482|FG000|Overall Study|Adverse Event|1|||
162679879|NCT00802074|587537483|FG001|Overall Study|Adverse Event|1|||
162679880|NCT00802074|587537484|FG002|Overall Study|Adverse Event|1|||
162679881|NCT00802074|587537485|FG003|Overall Study|Adverse Event|0|||
162679882|NCT00802074|587537486|FG004|Overall Study|Adverse Event|0|||
162679883|NCT00802074|587537487|FG005|Overall Study|Adverse Event|0|||
162679884|NCT00802074|587537482|FG000|Overall Study|Withdrawal by Subject|1|||
162679885|NCT00802074|587537483|FG001|Overall Study|Withdrawal by Subject|0|||
162679886|NCT00802074|587537484|FG002|Overall Study|Withdrawal by Subject|0|||
162679887|NCT00802074|587537485|FG003|Overall Study|Withdrawal by Subject|0|||
162679888|NCT00802074|587537486|FG004|Overall Study|Withdrawal by Subject|0|||
162679889|NCT00802074|587537487|FG005|Overall Study|Withdrawal by Subject|0|||
162679890|NCT02291614|587537490|FG000|Overall Study|Lost to Follow-up|0|||
162679891|NCT02291614|587537491|FG001|Overall Study|Lost to Follow-up|0|||
162679892|NCT02291614|587537492|FG002|Overall Study|Lost to Follow-up|0|||
162679893|NCT02291614|587537493|FG003|Overall Study|Lost to Follow-up|0|||
162679894|NCT02291614|587537494|FG004|Overall Study|Lost to Follow-up|0|||
162679895|NCT02291614|587537495|FG005|Overall Study|Lost to Follow-up|0|||
162679896|NCT02291614|587537496|FG006|Overall Study|Lost to Follow-up|0|||
162679897|NCT02291614|587537497|FG007|Overall Study|Lost to Follow-up|1|||
162679898|NCT02291614|587537498|FG008|Overall Study|Lost to Follow-up|0|||
162679899|NCT02291614|587537499|FG009|Overall Study|Lost to Follow-up|0|||
162679900|NCT02291614|587537500|FG010|Overall Study|Lost to Follow-up|0|||
162679901|NCT02291614|587537490|FG000|Overall Study|Withdrawal by Subject|0|||
162679902|NCT02291614|587537491|FG001|Overall Study|Withdrawal by Subject|1|||
162679903|NCT02291614|587537492|FG002|Overall Study|Withdrawal by Subject|0|||
162679904|NCT02291614|587537493|FG003|Overall Study|Withdrawal by Subject|0|||
162679905|NCT02291614|587537494|FG004|Overall Study|Withdrawal by Subject|0|||
162679906|NCT02291614|587537495|FG005|Overall Study|Withdrawal by Subject|0|||
162679907|NCT02291614|587537496|FG006|Overall Study|Withdrawal by Subject|0|||
162679908|NCT02291614|587537497|FG007|Overall Study|Withdrawal by Subject|0|||
162679909|NCT02291614|587537498|FG008|Overall Study|Withdrawal by Subject|0|||
162679910|NCT02291614|587537499|FG009|Overall Study|Withdrawal by Subject|2|||
162679911|NCT02291614|587537500|FG010|Overall Study|Withdrawal by Subject|2|||
162679912|NCT02291614|587537490|FG000|Overall Study|Decision by sponsor|0|||
162679913|NCT02291614|587537491|FG001|Overall Study|Decision by sponsor|0|||
162679914|NCT02291614|587537492|FG002|Overall Study|Decision by sponsor|0|||
162679915|NCT02291614|587537493|FG003|Overall Study|Decision by sponsor|1|||
162679916|NCT02291614|587537494|FG004|Overall Study|Decision by sponsor|0|||
162679917|NCT02291614|587537495|FG005|Overall Study|Decision by sponsor|0|||
162679918|NCT02291614|587537496|FG006|Overall Study|Decision by sponsor|0|||
162679919|NCT02291614|587537497|FG007|Overall Study|Decision by sponsor|0|||
162679920|NCT02291614|587537498|FG008|Overall Study|Decision by sponsor|0|||
162679921|NCT02291614|587537499|FG009|Overall Study|Decision by sponsor|0|||
162679922|NCT02291614|587537500|FG010|Overall Study|Decision by sponsor|0|||
162679923|NCT02291614|587537490|FG000|Overall Study|Death|0|||
162679924|NCT02291614|587537491|FG001|Overall Study|Death|0|||
162679925|NCT02291614|587537492|FG002|Overall Study|Death|1|||
162679926|NCT02291614|587537493|FG003|Overall Study|Death|0|||
162679927|NCT02291614|587537494|FG004|Overall Study|Death|1|||
162679928|NCT02291614|587537495|FG005|Overall Study|Death|1|||
162679929|NCT02291614|587537496|FG006|Overall Study|Death|1|||
162679930|NCT02291614|587537497|FG007|Overall Study|Death|0|||
162679931|NCT02291614|587537498|FG008|Overall Study|Death|0|||
162679932|NCT02291614|587537499|FG009|Overall Study|Death|0|||
162679933|NCT02291614|587537500|FG010|Overall Study|Death|0|||
162679934|NCT00127101|587537501|FG000|Base Protocol|Adverse Event|0|||
162679935|NCT00127101|587537502|FG001|Base Protocol|Adverse Event|2|||
162679936|NCT00127101|587537503|FG002|Base Protocol|Adverse Event|1|||
162679937|NCT00127101|587537504|FG003|Base Protocol|Adverse Event|0|||
162679938|NCT00127101|587537505|FG004|Base Protocol|Adverse Event|0|||
162679939|NCT00127101|587537506|FG005|Base Protocol|Adverse Event|0|||
162679940|NCT00127101|587537501|FG000|Base Protocol|Lack of Efficacy|1|||
162679941|NCT00127101|587537502|FG001|Base Protocol|Lack of Efficacy|0|||
162679942|NCT00127101|587537503|FG002|Base Protocol|Lack of Efficacy|0|||
162679943|NCT00127101|587537504|FG003|Base Protocol|Lack of Efficacy|0|||
162679944|NCT00127101|587537505|FG004|Base Protocol|Lack of Efficacy|2|||
162679945|NCT00127101|587537506|FG005|Base Protocol|Lack of Efficacy|0|||
162679946|NCT00127101|587537501|FG000|Base Protocol|Withdrawal by Subject|1|||
162679947|NCT00127101|587537502|FG001|Base Protocol|Withdrawal by Subject|2|||
162679948|NCT00127101|587537503|FG002|Base Protocol|Withdrawal by Subject|1|||
162679949|NCT00127101|587537504|FG003|Base Protocol|Withdrawal by Subject|0|||
162679950|NCT00127101|587537505|FG004|Base Protocol|Withdrawal by Subject|0|||
162679951|NCT00127101|587537506|FG005|Base Protocol|Withdrawal by Subject|1|||
162679952|NCT00127101|587537501|FG000|Continuation Phase|Adverse Event|0|||
162679953|NCT00127101|587537502|FG001|Continuation Phase|Adverse Event|0|||
162679954|NCT00127101|587537503|FG002|Continuation Phase|Adverse Event|0|||
162679955|NCT00127101|587537504|FG003|Continuation Phase|Adverse Event|0|||
162679956|NCT00127101|587537505|FG004|Continuation Phase|Adverse Event|1|||
162679957|NCT00127101|587537506|FG005|Continuation Phase|Adverse Event|1|||
162679958|NCT00127101|587537501|FG000|Continuation Phase|Lack of Efficacy|0|||
162679959|NCT00127101|587537502|FG001|Continuation Phase|Lack of Efficacy|0|||
162679960|NCT00127101|587537503|FG002|Continuation Phase|Lack of Efficacy|0|||
162679961|NCT00127101|587537504|FG003|Continuation Phase|Lack of Efficacy|0|||
162679962|NCT00127101|587537505|FG004|Continuation Phase|Lack of Efficacy|0|||
162679963|NCT00127101|587537506|FG005|Continuation Phase|Lack of Efficacy|1|||
162679964|NCT00127101|587537501|FG000|Continuation Phase|Withdrawal by Subject|0|||
162679965|NCT00127101|587537502|FG001|Continuation Phase|Withdrawal by Subject|0|||
162679966|NCT00127101|587537503|FG002|Continuation Phase|Withdrawal by Subject|1|||
162679967|NCT00127101|587537504|FG003|Continuation Phase|Withdrawal by Subject|0|||
162679968|NCT00127101|587537505|FG004|Continuation Phase|Withdrawal by Subject|2|||
162679969|NCT00127101|587537506|FG005|Continuation Phase|Withdrawal by Subject|1|||
162679970|NCT00843167|587537507|FG000|Treatment Period|Adverse Event|1|||
162679971|NCT00843167|587537508|FG001|Treatment Period|Adverse Event|5|||
162679972|NCT00843167|587537507|FG000|Treatment Period|Withdrawal by Subject|2|||
162679973|NCT00843167|587537508|FG001|Treatment Period|Withdrawal by Subject|3|||
162679974|NCT03743038|587537509|FG000|Overall Study|Physician Decision|1|||
162679975|NCT01830127|587537510|FG000|Overall Study|Adverse Event|1|||
162679976|NCT01830127|587537511|FG001|Overall Study|Adverse Event|6|||
162679977|NCT01830127|587537510|FG000|Overall Study|Lack of Efficacy|3|||
162679978|NCT01830127|587537511|FG001|Overall Study|Lack of Efficacy|0|||
162679979|NCT01830127|587537510|FG000|Overall Study|Withdrawal by Subject|1|||
162679980|NCT01830127|587537511|FG001|Overall Study|Withdrawal by Subject|1|||
162679981|NCT01830127|587537510|FG000|Overall Study|Other reason not defined above|0|||
162679982|NCT01830127|587537511|FG001|Overall Study|Other reason not defined above|2|||
162679983|NCT01302847|587537514|FG000|Overall Study|Death|0|||
162679984|NCT01302847|587537515|FG001|Overall Study|Death|1|||
162679985|NCT01302847|587537516|FG002|Overall Study|Death|0|||
162679986|NCT01302847|587537517|FG003|Overall Study|Death|0|||
162679987|NCT01302847|587537518|FG004|Overall Study|Death|0|||
162679988|NCT01302847|587537519|FG005|Overall Study|Death|1|||
162679989|NCT01302847|587537520|FG006|Overall Study|Death|1|||
162679990|NCT01302847|587537521|FG007|Overall Study|Death|0|||
162679991|NCT01302847|587537514|FG000|Overall Study|Pregnancy|2|||
162679992|NCT01302847|587537515|FG001|Overall Study|Pregnancy|0|||
162679993|NCT01302847|587537516|FG002|Overall Study|Pregnancy|0|||
162679994|NCT01302847|587537517|FG003|Overall Study|Pregnancy|0|||
162679995|NCT01302847|587537518|FG004|Overall Study|Pregnancy|0|||
162679996|NCT01302847|587537519|FG005|Overall Study|Pregnancy|0|||
162679997|NCT01302847|587537520|FG006|Overall Study|Pregnancy|0|||
162679998|NCT01302847|587537521|FG007|Overall Study|Pregnancy|0|||
162679999|NCT01302847|587537514|FG000|Overall Study|Virologic failure|0|||
162680000|NCT01302847|587537515|FG001|Overall Study|Virologic failure|2|||
162680001|NCT01302847|587537516|FG002|Overall Study|Virologic failure|0|||
162680002|NCT01302847|587537517|FG003|Overall Study|Virologic failure|2|||
162680003|NCT01302847|587537518|FG004|Overall Study|Virologic failure|1|||
162680004|NCT01302847|587537519|FG005|Overall Study|Virologic failure|3|||
162680005|NCT01302847|587537520|FG006|Overall Study|Virologic failure|1|||
162680006|NCT01302847|587537521|FG007|Overall Study|Virologic failure|2|||
162680007|NCT01302847|587537514|FG000|Overall Study|Severe debilitation, unable to continue|0|||
162680008|NCT01302847|587537515|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162680009|NCT01302847|587537516|FG002|Overall Study|Severe debilitation, unable to continue|0|||
162680010|NCT01302847|587537517|FG003|Overall Study|Severe debilitation, unable to continue|0|||
162680011|NCT01302847|587537518|FG004|Overall Study|Severe debilitation, unable to continue|0|||
162680012|NCT01302847|587537519|FG005|Overall Study|Severe debilitation, unable to continue|1|||
162680013|NCT01302847|587537520|FG006|Overall Study|Severe debilitation, unable to continue|1|||
162680014|NCT01302847|587537521|FG007|Overall Study|Severe debilitation, unable to continue|0|||
162680015|NCT01302847|587537514|FG000|Overall Study|Not able to get to clinic|1|||
162680016|NCT01302847|587537515|FG001|Overall Study|Not able to get to clinic|1|||
162680017|NCT01302847|587537516|FG002|Overall Study|Not able to get to clinic|0|||
162680018|NCT01302847|587537517|FG003|Overall Study|Not able to get to clinic|0|||
162680019|NCT01302847|587537518|FG004|Overall Study|Not able to get to clinic|0|||
162680020|NCT01302847|587537519|FG005|Overall Study|Not able to get to clinic|0|||
162680021|NCT01302847|587537520|FG006|Overall Study|Not able to get to clinic|0|||
162680022|NCT01302847|587537521|FG007|Overall Study|Not able to get to clinic|0|||
162680023|NCT01302847|587537514|FG000|Overall Study|Site closing|2|||
162680024|NCT01302847|587537515|FG001|Overall Study|Site closing|2|||
162680025|NCT01302847|587537516|FG002|Overall Study|Site closing|0|||
162680026|NCT01302847|587537517|FG003|Overall Study|Site closing|0|||
162680027|NCT01302847|587537518|FG004|Overall Study|Site closing|0|||
162680028|NCT01302847|587537519|FG005|Overall Study|Site closing|0|||
162680029|NCT01302847|587537520|FG006|Overall Study|Site closing|0|||
162680030|NCT01302847|587537521|FG007|Overall Study|Site closing|0|||
162680031|NCT01302847|587537514|FG000|Overall Study|Withdrawal by Subject|1|||
162680032|NCT01302847|587537515|FG001|Overall Study|Withdrawal by Subject|0|||
162680033|NCT01302847|587537516|FG002|Overall Study|Withdrawal by Subject|0|||
162680034|NCT01302847|587537517|FG003|Overall Study|Withdrawal by Subject|0|||
162680035|NCT01302847|587537518|FG004|Overall Study|Withdrawal by Subject|1|||
162680036|NCT01302847|587537519|FG005|Overall Study|Withdrawal by Subject|0|||
162680037|NCT01302847|587537520|FG006|Overall Study|Withdrawal by Subject|0|||
162680038|NCT01302847|587537521|FG007|Overall Study|Withdrawal by Subject|1|||
162680039|NCT01302847|587537514|FG000|Overall Study|Not willing to adhere to requirements|5|||
162680040|NCT01302847|587537515|FG001|Overall Study|Not willing to adhere to requirements|0|||
162680041|NCT01302847|587537516|FG002|Overall Study|Not willing to adhere to requirements|1|||
162680042|NCT01302847|587537517|FG003|Overall Study|Not willing to adhere to requirements|0|||
162680043|NCT01302847|587537518|FG004|Overall Study|Not willing to adhere to requirements|0|||
162680044|NCT01302847|587537519|FG005|Overall Study|Not willing to adhere to requirements|0|||
162680045|NCT01302847|587537520|FG006|Overall Study|Not willing to adhere to requirements|0|||
162680046|NCT01302847|587537521|FG007|Overall Study|Not willing to adhere to requirements|2|||
162680047|NCT01302847|587537514|FG000|Overall Study|Site unable to contact participant|2|||
162680048|NCT01302847|587537515|FG001|Overall Study|Site unable to contact participant|1|||
162680049|NCT01302847|587537516|FG002|Overall Study|Site unable to contact participant|0|||
162680050|NCT01302847|587537517|FG003|Overall Study|Site unable to contact participant|0|||
162680051|NCT01302847|587537518|FG004|Overall Study|Site unable to contact participant|0|||
162680052|NCT01302847|587537519|FG005|Overall Study|Site unable to contact participant|0|||
162680053|NCT01302847|587537520|FG006|Overall Study|Site unable to contact participant|2|||
162680054|NCT01302847|587537521|FG007|Overall Study|Site unable to contact participant|0|||
162725204|NCT04009577|587703079|FG003|Extension Phase|Adverse Event|1|||
162680055|NCT01565707|587537522|FG000|Overall Study|Adverse Event|1|||
162680056|NCT01565707|587537523|FG001|Overall Study|Adverse Event|6|||
162680057|NCT01565707|587537524|FG002|Overall Study|Adverse Event|2|||
162680058|NCT01565707|587537525|FG003|Overall Study|Adverse Event|1|||
162725205|NCT04009577|587703076|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162725206|NCT04009577|587703077|FG001|Extension Phase|Inadequate therapeutic effect|0|||
162725207|NCT04009577|587703078|FG002|Extension Phase|Inadequate therapeutic effect|1|||
162680059|NCT01565707|587537522|FG000|Overall Study|Lost to Follow-up|1|||
162680060|NCT01565707|587537523|FG001|Overall Study|Lost to Follow-up|0|||
162680061|NCT01565707|587537524|FG002|Overall Study|Lost to Follow-up|0|||
162680062|NCT01565707|587537525|FG003|Overall Study|Lost to Follow-up|0|||
162680063|NCT01565707|587537522|FG000|Overall Study|Protocol Violation|1|||
162680064|NCT01565707|587537523|FG001|Overall Study|Protocol Violation|0|||
162680065|NCT01565707|587537524|FG002|Overall Study|Protocol Violation|0|||
162725208|NCT04009577|587703079|FG003|Extension Phase|Inadequate therapeutic effect|0|||
162725209|NCT04009577|587703076|FG000|Extension Phase|Withdrawal by Subject|0|||
162725210|NCT04009577|587703077|FG001|Extension Phase|Withdrawal by Subject|0|||
162725211|NCT04009577|587703078|FG002|Extension Phase|Withdrawal by Subject|1|||
162725212|NCT04009577|587703079|FG003|Extension Phase|Withdrawal by Subject|0|||
162725213|NCT04009577|587703076|FG000|Extension Phase|Not Treated|0|||
162725214|NCT04009577|587703077|FG001|Extension Phase|Not Treated|0|||
162725215|NCT04009577|587703078|FG002|Extension Phase|Not Treated|2|||
162725216|NCT04009577|587703079|FG003|Extension Phase|Not Treated|0|||
162725217|NCT01832480|587703080|FG000|Overall Study|Lost to Follow-up|33|||
162725218|NCT01832480|587703081|FG001|Overall Study|Lost to Follow-up|30|||
162725219|NCT01832480|587703080|FG000|Overall Study|Withdrawal by Subject|0|||
162725220|NCT01832480|587703081|FG001|Overall Study|Withdrawal by Subject|2|||
162725221|NCT01832480|587703080|FG000|Overall Study|post randomization ineligible|8|||
162725222|NCT01832480|587703081|FG001|Overall Study|post randomization ineligible|10|||
162725223|NCT02261467|587703083|FG000|Overall Study|Enrolled in Error|1|||
162725224|NCT02261467|587703084|FG001|Overall Study|Enrolled in Error|0|||
162725225|NCT02261467|587703083|FG000|Overall Study|Protocol Violation|0|||
162725226|NCT02261467|587703084|FG001|Overall Study|Protocol Violation|1|||
162725227|NCT02261467|587703083|FG000|Overall Study|Personal Reasons|17|||
162725228|NCT02261467|587703084|FG001|Overall Study|Personal Reasons|22|||
162725229|NCT02261467|587703083|FG000|Overall Study|Lost to Follow-up|2|||
162725230|NCT02261467|587703084|FG001|Overall Study|Lost to Follow-up|13|||
162725231|NCT02261467|587703083|FG000|Overall Study|Adverse Event|1|||
162725232|NCT02261467|587703084|FG001|Overall Study|Adverse Event|1|||
162725233|NCT04305405|587703087|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162725234|NCT04305405|587703088|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162725235|NCT00206375|587703089|FG000|Overall Study|Lost to Follow-up|1|||
162725236|NCT00206375|587703090|FG001|Overall Study|Lost to Follow-up|0|||
162725237|NCT00206375|587703091|FG002|Overall Study|Lost to Follow-up|0|||
162725238|NCT00206375|587703089|FG000|Overall Study|Withdrawal by Subject|2|||
162725239|NCT00206375|587703090|FG001|Overall Study|Withdrawal by Subject|1|||
162725240|NCT00206375|587703091|FG002|Overall Study|Withdrawal by Subject|3|||
162725241|NCT00206375|587703089|FG000|Overall Study|Study terminated due to lack of funds|0|||
162725242|NCT00206375|587703090|FG001|Overall Study|Study terminated due to lack of funds|1|||
162725243|NCT00206375|587703091|FG002|Overall Study|Study terminated due to lack of funds|1|||
162725244|NCT01685606|587703097|FG000|Overall Study|Withdrawal by Subject|1|||
162725245|NCT01787760|587703098|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
162680066|NCT01565707|587537525|FG003|Overall Study|Protocol Violation|1|||
162680067|NCT01565707|587537522|FG000|Overall Study|Withdrawal by Subject|3|||
162680068|NCT01565707|587537523|FG001|Overall Study|Withdrawal by Subject|1|||
162680069|NCT01565707|587537524|FG002|Overall Study|Withdrawal by Subject|1|||
162680070|NCT01565707|587537525|FG003|Overall Study|Withdrawal by Subject|1|||
162680071|NCT01565707|587537522|FG000|Overall Study|Randomized but not evaluable|2|||
162680072|NCT01565707|587537523|FG001|Overall Study|Randomized but not evaluable|0|||
162680073|NCT01565707|587537524|FG002|Overall Study|Randomized but not evaluable|0|||
162680074|NCT01565707|587537525|FG003|Overall Study|Randomized but not evaluable|0|||
162680075|NCT01565707|587537522|FG000|Overall Study|Miscellaneous|1|||
162680076|NCT01565707|587537523|FG001|Overall Study|Miscellaneous|1|||
162680077|NCT01565707|587537524|FG002|Overall Study|Miscellaneous|0|||
162680078|NCT01565707|587537525|FG003|Overall Study|Miscellaneous|2|||
162680079|NCT01371851|587537526|FG000|Overall Study|Lost to Follow-up|5|||
162680080|NCT01371851|587537527|FG001|Overall Study|Lost to Follow-up|8|||
162680081|NCT01371851|587537526|FG000|Overall Study|was arrested and put in jail|0|||
162680082|NCT01371851|587537527|FG001|Overall Study|was arrested and put in jail|1|||
162680083|NCT01371851|587537526|FG000|Overall Study|non study related adverse event|1|||
162680084|NCT01371851|587537527|FG001|Overall Study|non study related adverse event|0|||
162680085|NCT01371851|587537526|FG000|Overall Study|Blood Pressure outside study parameters|2|||
162680086|NCT01371851|587537527|FG001|Overall Study|Blood Pressure outside study parameters|0|||
162680087|NCT05608629|587537538|FG000|Overall Study|Lost to Follow-up|2|||
162680088|NCT03969719|587537539|FG000|Overall Study|Other reasons not specified|1|||
162680089|NCT03969719|587537540|FG001|Overall Study|Other reasons not specified|1|||
162680090|NCT03969719|587537541|FG002|Overall Study|Other reasons not specified|3|||
162680091|NCT03969719|587537539|FG000|Overall Study|Withdrawal by Subject|2|||
162680092|NCT03969719|587537540|FG001|Overall Study|Withdrawal by Subject|3|||
162680093|NCT03969719|587537541|FG002|Overall Study|Withdrawal by Subject|2|||
162680094|NCT03969719|587537539|FG000|Overall Study|Protocol Violation|1|||
162680095|NCT03969719|587537540|FG001|Overall Study|Protocol Violation|2|||
162680096|NCT03969719|587537541|FG002|Overall Study|Protocol Violation|0|||
162680097|NCT03969719|587537539|FG000|Overall Study|Adverse Event|0|||
162680098|NCT03969719|587537540|FG001|Overall Study|Adverse Event|2|||
162680099|NCT03969719|587537541|FG002|Overall Study|Adverse Event|0|||
162725246|NCT01787760|587703099|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
162725247|NCT01787760|587703100|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
162725248|NCT01787760|587703098|FG000|Overall Study|Decompensated on left exotropia|0|||
162680100|NCT03969719|587537539|FG000|Overall Study|Lost to Follow-up|0|||
162680101|NCT03969719|587537540|FG001|Overall Study|Lost to Follow-up|1|||
162680102|NCT03969719|587537541|FG002|Overall Study|Lost to Follow-up|0|||
162680103|NCT02130193|587537542|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
162680104|NCT02130193|587537543|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
162680105|NCT02130193|587537544|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
162680106|NCT02130193|587537542|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
162680107|NCT02130193|587537543|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
162680108|NCT02130193|587537544|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
162680109|NCT02130193|587537542|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
162680110|NCT02130193|587537543|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
162680111|NCT02130193|587537544|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
162680112|NCT02130193|587537542|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
162680113|NCT02130193|587537543|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
162680114|NCT02130193|587537544|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
162725249|NCT01787760|587703099|FG001|Overall Study|Decompensated on left exotropia|0|||
162725250|NCT01787760|587703100|FG002|Overall Study|Decompensated on left exotropia|1|||
162725251|NCT01787760|587703098|FG000|Overall Study|Dryness|0|||
162725252|NCT01787760|587703099|FG001|Overall Study|Dryness|1|||
162725253|NCT01787760|587703100|FG002|Overall Study|Dryness|0|||
162680115|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
162680116|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
162680117|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
162680118|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680119|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680120|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680121|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680122|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680123|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162680124|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
162680125|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
162725254|NCT01787760|587703098|FG000|Overall Study|Relocation|1|||
162680126|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
162680127|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680128|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680129|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680130|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680131|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680132|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162680133|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
162680134|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
162680135|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
162680136|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680137|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680138|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680139|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680140|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680141|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162680142|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162680143|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680144|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
162680145|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680146|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680147|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680148|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680149|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680150|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162680151|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680152|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680153|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162680154|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680155|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680156|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680157|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162725255|NCT01787760|587703099|FG001|Overall Study|Relocation|1|||
162725256|NCT01787760|587703100|FG002|Overall Study|Relocation|0|||
162725257|NCT01787760|587703098|FG000|Overall Study|Lens discomfort|3|||
162725258|NCT01787760|587703099|FG001|Overall Study|Lens discomfort|0|||
162680158|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680159|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162680160|NCT01212770|587537545|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
162680161|NCT01212770|587537546|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
162680162|NCT01212770|587537547|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
162680163|NCT01212770|587537548|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680164|NCT01212770|587537549|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680165|NCT01212770|587537550|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680166|NCT01212770|587537551|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680167|NCT01212770|587537552|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680168|NCT01212770|587537553|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162680169|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162680170|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
162680171|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
162680172|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
162680173|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162680174|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162680175|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
162680176|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162680177|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162680178|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162680179|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
162680180|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
162680181|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
162680182|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
162680183|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
162680184|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162680185|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162680186|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162680187|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162680188|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
162680189|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
162680190|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
162680191|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162680192|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162680193|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162680194|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162680195|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162680196|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680197|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680198|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
162680199|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680200|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680201|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680202|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680203|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680204|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162680205|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680206|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680207|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680208|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
162680209|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680210|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680211|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680212|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680213|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162680214|NCT01212770|587537545|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680215|NCT01212770|587537546|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680216|NCT01212770|587537547|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
162680217|NCT01212770|587537548|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
162680218|NCT01212770|587537549|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162725259|NCT01787760|587703100|FG002|Overall Study|Lens discomfort|0|||
162680219|NCT01212770|587537550|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680220|NCT01212770|587537551|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680221|NCT01212770|587537552|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680222|NCT01212770|587537553|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162680223|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680224|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
162680225|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
162680226|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680227|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680228|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680229|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680230|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162680231|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
162680232|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162680233|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
162680234|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
162680235|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162680236|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162680237|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162680238|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162680239|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
162680240|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
162680241|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680242|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
162680243|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680244|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680245|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680246|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680247|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680248|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680249|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162680250|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162680251|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
162680252|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
162680253|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162680254|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162680255|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162680256|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162680257|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162680258|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162680259|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162680260|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
162680261|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162680262|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162680263|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162680264|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162680265|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162680266|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162680267|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162680268|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680269|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
162680270|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162680271|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680272|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680273|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680274|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680275|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162680276|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162680277|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162680278|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162680279|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162680280|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162680281|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162680282|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162680283|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162680284|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162680285|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
162680286|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162680287|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
162680288|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
162680289|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162680290|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162680291|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162680292|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162680293|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162680294|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162680295|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162680296|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
162680297|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
162680298|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162680299|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162680300|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162680301|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162680302|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162680303|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162680304|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680305|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
162680306|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680307|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680308|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680309|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680310|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680311|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680312|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162680313|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680314|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680315|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680316|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680317|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680318|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680319|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680320|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
162680321|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162680322|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162680323|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
162680324|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162680325|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162680326|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162680327|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162680328|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162680329|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162680330|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162680331|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680332|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162680333|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162680334|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680335|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680336|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680337|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680338|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162680339|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162680340|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680341|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
162680342|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
162680343|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680344|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680345|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680346|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680347|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
162680348|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162680349|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680350|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162680351|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162680352|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680353|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680354|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680355|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680356|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162680357|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162680358|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680359|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
162680360|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
162680361|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680362|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680363|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680364|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680365|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680366|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162680367|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680368|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680369|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
162680370|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680371|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680372|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680373|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680374|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680375|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162680376|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680377|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
162680378|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680379|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680380|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680381|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680382|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680383|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162680384|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
162680385|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
162680386|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
162680387|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
162680388|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
162680389|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
162680390|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
162680391|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
162680392|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
162680393|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
162680394|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680395|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680396|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
162680397|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680398|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680399|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680400|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680401|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680402|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162680403|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680404|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680405|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
162680406|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680407|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680408|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680409|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680410|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162680411|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
162680412|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680413|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680414|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
162680415|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680416|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680417|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680418|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680419|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680420|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162680421|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680422|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
162680423|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162680424|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680425|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680426|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680427|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680428|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162680429|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162680430|NCT01212770|587537545|FG000|Long-term Safety Phase (Year 5)|Death|0|||
162680431|NCT01212770|587537546|FG001|Long-term Safety Phase (Year 5)|Death|0|||
162680432|NCT01212770|587537547|FG002|Long-term Safety Phase (Year 5)|Death|0|||
162680433|NCT01212770|587537548|FG003|Long-term Safety Phase (Year 5)|Death|0|||
162680434|NCT01212770|587537549|FG004|Long-term Safety Phase (Year 5)|Death|0|||
162680435|NCT01212770|587537550|FG005|Long-term Safety Phase (Year 5)|Death|0|||
162680436|NCT01212770|587537551|FG006|Long-term Safety Phase (Year 5)|Death|0|||
162680437|NCT01212770|587537552|FG007|Long-term Safety Phase (Year 5)|Death|1|||
162680438|NCT01212770|587537553|FG008|Long-term Safety Phase (Year 5)|Death|0|||
162680439|NCT01297959|587537554|FG000|Overall Study|Adverse Event|0|||
162680440|NCT01297959|587537555|FG001|Overall Study|Adverse Event|1|||
162680441|NCT01297959|587537554|FG000|Overall Study|Protocol Violation|2|||
162680442|NCT01297959|587537555|FG001|Overall Study|Protocol Violation|1|||
162680443|NCT01297959|587537554|FG000|Overall Study|Withdrawal by Subject|5|||
162680444|NCT01297959|587537555|FG001|Overall Study|Withdrawal by Subject|4|||
162680445|NCT01297959|587537554|FG000|Overall Study|Physician Decision|0|||
162680446|NCT01297959|587537555|FG001|Overall Study|Physician Decision|1|||
162680447|NCT01297959|587537554|FG000|Overall Study|Unrelated medical illness / complication|0|||
162680448|NCT01297959|587537555|FG001|Overall Study|Unrelated medical illness / complication|2|||
162680449|NCT01297959|587537554|FG000|Overall Study|Other|13|||
162680450|NCT01297959|587537555|FG001|Overall Study|Other|7|||
162680451|NCT03519854|587537558|FG000|Overall Study|Technical Error|0|||
162680452|NCT03519854|587537559|FG001|Overall Study|Technical Error|0|||
162680453|NCT03519854|587537560|FG002|Overall Study|Technical Error|1|||
162680454|NCT03519854|587537561|FG003|Overall Study|Technical Error|0|||
162680455|NCT03519854|587537562|FG004|Overall Study|Technical Error|0|||
162680456|NCT03519854|587537563|FG005|Overall Study|Technical Error|0|||
162680457|NCT03519854|587537564|FG006|Overall Study|Technical Error|0|||
162680458|NCT03519854|587537565|FG007|Overall Study|Technical Error|0|||
162680459|NCT03519854|587537566|FG008|Overall Study|Technical Error|0|||
162680460|NCT03519854|587537567|FG009|Overall Study|Technical Error|0|||
162680461|NCT03519854|587537568|FG010|Overall Study|Technical Error|0|||
162680462|NCT03519854|587537569|FG011|Overall Study|Technical Error|0|||
162680463|NCT03519854|587537570|FG012|Overall Study|Technical Error|0|||
162680464|NCT03519854|587537571|FG013|Overall Study|Technical Error|0|||
162680465|NCT03519854|587537572|FG014|Overall Study|Technical Error|0|||
162680466|NCT03519854|587537573|FG015|Overall Study|Technical Error|0|||
162680467|NCT03519854|587537574|FG016|Overall Study|Technical Error|0|||
162680468|NCT03519854|587537575|FG017|Overall Study|Technical Error|0|||
162680469|NCT00951275|587537576|FG000|Overall Study|Administrative Reason|1|||
162680470|NCT00951275|587537576|FG000|Overall Study|Adverse Event|7|||
162680471|NCT00951275|587537576|FG000|Overall Study|Withdrawal by Subject|4|||
162680472|NCT00951275|587537576|FG000|Overall Study|Protocol Violation|1|||
162680473|NCT02925676|587537577|FG000|Overall Study|Withdrawal by Subject|1|||
162680474|NCT02048072|587537581|FG000|Overall Study|Adverse Event|3|||
162680475|NCT02048072|587537581|FG000|Overall Study|Lost to Follow-up|1|||
162680476|NCT04304833|587537582|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
162680477|NCT04304833|587537583|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
162680478|NCT03776136|587537584|FG000|Overall Study|Death|85|||
162680479|NCT03776136|587537584|FG000|Overall Study|Withdrawal by Subject|3|||
162680480|NCT03776136|587537584|FG000|Overall Study|Sponsor Decision|15|||
162680481|NCT02858895|587537585|FG000|Overall Study|Disease progression|31|||
162680482|NCT02858895|587537585|FG000|Overall Study|Death|2|||
162680483|NCT02858895|587537585|FG000|Overall Study|Adverse Event|1|||
162680484|NCT02858895|587537585|FG000|Overall Study|Withdrawal by Subject|3|||
162680485|NCT02858895|587537585|FG000|Overall Study|hospice,|1|||
162680486|NCT02858895|587537585|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
162680487|NCT00680407|587537593|FG000|Overall Study|Lost to Follow-up|3|||
162680488|NCT00680407|587537594|FG001|Overall Study|Lost to Follow-up|3|||
162680489|NCT00680407|587537595|FG002|Overall Study|Lost to Follow-up|1|||
162680490|NCT00680407|587537593|FG000|Overall Study|Withdrawal by Subject|5|||
162680491|NCT00680407|587537594|FG001|Overall Study|Withdrawal by Subject|2|||
162680492|NCT00680407|587537595|FG002|Overall Study|Withdrawal by Subject|2|||
162680493|NCT02543658|587539316|FG000|Overall Study|Lack of Efficacy|0|||
162680494|NCT02543658|587539317|FG001|Overall Study|Lack of Efficacy|4|||
162680495|NCT01699022|587539324|FG000|Overall Study|Early discontinuation from the study|3|||
162680502|NCT04539821|587539327|FG000|Overall Study|Withdrawal by Subject|2|||
162680503|NCT04539821|587539327|FG000|Overall Study|continued care with their physician|20|||
162680504|NCT04539821|587539327|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
162680505|NCT03813238|587539334|FG000|Overall Study|Adverse Event|0|||
162680506|NCT03813238|587539335|FG001|Overall Study|Adverse Event|6|||
162680507|NCT03813238|587539334|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162680508|NCT03813238|587539335|FG001|Overall Study|Withdrawal by parent/guardian|2|||
162680509|NCT03813238|587539334|FG000|Overall Study|Lost to Follow-up|0|||
162680510|NCT03813238|587539335|FG001|Overall Study|Lost to Follow-up|1|||
162680511|NCT03813238|587539334|FG000|Overall Study|Other than specified|1|||
162680512|NCT03813238|587539335|FG001|Overall Study|Other than specified|2|||
162680513|NCT02066402|587539336|FG000|Overall Study|Adverse Event|1|||
162680514|NCT02066402|587539337|FG001|Overall Study|Adverse Event|2|||
162680515|NCT02066402|587539336|FG000|Overall Study|Lost to Follow-up|11|||
162680516|NCT02066402|587539337|FG001|Overall Study|Lost to Follow-up|8|||
162680517|NCT02066402|587539336|FG000|Overall Study|Withdrawal by Subject|14|||
162680518|NCT02066402|587539337|FG001|Overall Study|Withdrawal by Subject|11|||
162680519|NCT02066402|587539336|FG000|Overall Study|Progressive disease-clinical progression|0|||
162680520|NCT02066402|587539337|FG001|Overall Study|Progressive disease-clinical progression|1|||
162680521|NCT02066402|587539336|FG000|Overall Study|Protocol driven decision point|0|||
162680522|NCT02066402|587539337|FG001|Overall Study|Protocol driven decision point|1|||
162680523|NCT02462876|587539338|FG000|Overall Study|Death|3|||
162680524|NCT02462876|587539338|FG000|Overall Study|Lost to Follow-up|7|||
162680525|NCT02462876|587539338|FG000|Overall Study|Surgical Bypass|9|||
162680526|NCT02462876|587539338|FG000|Overall Study|Amputation Above the Metatarsals|1|||
162680527|NCT02462876|587539338|FG000|Overall Study|36 months follow-up visit missed|1|||
162680528|NCT02462876|587539338|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
162680529|NCT02462876|587539338|FG000|Overall Study|Patient did not come back to the vascular department|1|||
162680530|NCT02462876|587539338|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
162680531|NCT02462876|587539338|FG000|Overall Study|Patient refused to come back|1|||
162680532|NCT02462876|587539338|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
162680533|NCT02462876|587539338|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
162680534|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
162680535|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
162680536|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
162680537|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
162680538|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
162680539|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
162680540|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
162680541|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
162680542|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Other|18|||
162680543|NCT02565914|587539339|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
162680544|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
162680545|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Other|1|||
162680546|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
162680547|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
162680548|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
162680549|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
162680550|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
162680551|NCT02565914|587539339|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
162680552|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
162680553|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
162680554|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
162680555|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
162680556|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
162680557|NCT02565914|587539339|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
162680558|NCT03581981|587539340|FG000|Overall Study|Withdrawal by Subject|12|||
162680559|NCT03581981|587539341|FG001|Overall Study|Withdrawal by Subject|13|||
162680560|NCT03581981|587539340|FG000|Overall Study|Physician Decision|1|||
162680561|NCT03581981|587539341|FG001|Overall Study|Physician Decision|2|||
162680562|NCT03581981|587539340|FG000|Overall Study|Lost to Follow-up|0|||
162680563|NCT03581981|587539341|FG001|Overall Study|Lost to Follow-up|4|||
162680564|NCT00828984|587539342|FG000|Overall Study|Adverse Event|2|||
162680565|NCT00828984|587539343|FG001|Overall Study|Adverse Event|3|||
162680566|NCT00828984|587539344|FG002|Overall Study|Adverse Event|0|||
162680567|NCT00828984|587539342|FG000|Overall Study|Lost to Follow-up|5|||
162680568|NCT00828984|587539343|FG001|Overall Study|Lost to Follow-up|3|||
162680569|NCT00828984|587539344|FG002|Overall Study|Lost to Follow-up|1|||
162680570|NCT00828984|587539342|FG000|Overall Study|Withdrawal by Subject|4|||
162680571|NCT00828984|587539343|FG001|Overall Study|Withdrawal by Subject|4|||
162680572|NCT00828984|587539344|FG002|Overall Study|Withdrawal by Subject|4|||
162680573|NCT00828984|587539342|FG000|Overall Study|Ineligable|1|||
162680574|NCT00828984|587539343|FG001|Overall Study|Ineligable|2|||
162680575|NCT00828984|587539344|FG002|Overall Study|Ineligable|0|||
162680576|NCT00828984|587539342|FG000|Overall Study|Medical Contraindication|0|||
162680577|NCT00828984|587539343|FG001|Overall Study|Medical Contraindication|1|||
162680578|NCT00828984|587539344|FG002|Overall Study|Medical Contraindication|0|||
162680579|NCT00828984|587539342|FG000|Overall Study|Noncompliant|1|||
162680580|NCT00828984|587539343|FG001|Overall Study|Noncompliant|2|||
162680581|NCT00828984|587539344|FG002|Overall Study|Noncompliant|3|||
162680582|NCT00828984|587539342|FG000|Overall Study|ConMed|1|||
162680583|NCT00828984|587539343|FG001|Overall Study|ConMed|1|||
162680584|NCT00828984|587539344|FG002|Overall Study|ConMed|1|||
162680585|NCT00863655|587539345|FG000|Overall Study|Protocol Violation|4|||
162680586|NCT00863655|587539346|FG001|Overall Study|Protocol Violation|0|||
162680587|NCT00863655|587539345|FG000|Overall Study|Adverse Event|52|||
162680588|NCT00863655|587539346|FG001|Overall Study|Adverse Event|8|||
162680589|NCT00863655|587539345|FG000|Overall Study|Withdrawal by Subject|47|||
162680590|NCT00863655|587539346|FG001|Overall Study|Withdrawal by Subject|7|||
162680591|NCT00863655|587539345|FG000|Overall Study|Administrative problems|1|||
162680592|NCT00863655|587539346|FG001|Overall Study|Administrative problems|0|||
162680593|NCT00863655|587539345|FG000|Overall Study|Death|7|||
162680594|NCT00863655|587539346|FG001|Overall Study|Death|1|||
162680595|NCT00863655|587539345|FG000|Overall Study|New cancer therapy|5|||
162680596|NCT00863655|587539346|FG001|Overall Study|New cancer therapy|1|||
162680597|NCT00863655|587539345|FG000|Overall Study|Disease progression|364|||
162680598|NCT00863655|587539346|FG001|Overall Study|Disease progression|221|||
162680599|NCT00863655|587539345|FG000|Overall Study|Treatment completed as per protocol|5|||
162680600|NCT00863655|587539346|FG001|Overall Study|Treatment completed as per protocol|1|||
162680601|NCT00716092|587539357|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
162680602|NCT00716092|587539358|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
162680603|NCT00716092|587539359|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
162680604|NCT02436330|587539360|FG000|Cohort 1|Lost to Follow-up|5|||
162680605|NCT02436330|587539361|FG001|Cohort 1|Lost to Follow-up|2|||
162680606|NCT02436330|587539360|FG000|Cohort 1|Withdrawal by Subject|0|||
162680607|NCT02436330|587539361|FG001|Cohort 1|Withdrawal by Subject|1|||
162680608|NCT02436330|587539360|FG000|Cohort 2|Lost to Follow-up|2|||
162680609|NCT02436330|587539361|FG001|Cohort 2|Lost to Follow-up|0|||
162680610|NCT02436330|587539360|FG000|Cohort 2|Withdrawal by Subject|2|||
162680611|NCT02436330|587539361|FG001|Cohort 2|Withdrawal by Subject|3|||
162680612|NCT02436330|587539360|FG000|Cohort 3|Lost to Follow-up|1|||
162680613|NCT02436330|587539361|FG001|Cohort 3|Lost to Follow-up|0|||
162680614|NCT02436330|587539360|FG000|Cohort 3|Withdrawal by Subject|4|||
162680615|NCT02436330|587539361|FG001|Cohort 3|Withdrawal by Subject|0|||
162680616|NCT02436330|587539360|FG000|Cohort 4|Lost to Follow-up|1|||
162680617|NCT02436330|587539361|FG001|Cohort 4|Lost to Follow-up|0|||
162680618|NCT02436330|587539360|FG000|Cohort 4|Withdrawal by Subject|1|||
162680619|NCT02436330|587539361|FG001|Cohort 4|Withdrawal by Subject|0|||
162680620|NCT02436330|587539360|FG000|Cohort 5|Lost to Follow-up|3|||
162680621|NCT02436330|587539361|FG001|Cohort 5|Lost to Follow-up|2|||
162680622|NCT02436330|587539360|FG000|Cohort 5|Withdrawal by Subject|3|||
162680623|NCT02436330|587539361|FG001|Cohort 5|Withdrawal by Subject|2|||
162680624|NCT02436330|587539360|FG000|Cohort 6|Lost to Follow-up|2|||
162725260|NCT01787760|587703098|FG000|Overall Study|Lens handling difficulty|1|||
162680625|NCT02436330|587539361|FG001|Cohort 6|Lost to Follow-up|0|||
162680626|NCT02436330|587539360|FG000|Cohort 6|Withdrawal by Subject|1|||
162680627|NCT02436330|587539361|FG001|Cohort 6|Withdrawal by Subject|1|||
162680628|NCT02054806|587539362|FG000|Overall Study|Sponsor Decision|31|||
162680629|NCT02054806|587539362|FG000|Overall Study|Withdrawal by Subject|43|||
162680630|NCT02054806|587539362|FG000|Overall Study|Protocol Violation|2|||
162680631|NCT02054806|587539362|FG000|Overall Study|Lost to Follow-up|10|||
162680632|NCT02054806|587539362|FG000|Overall Study|Death|391|||
162680633|NCT00677235|587539363|FG000|Overall Study|Withdrawal by Subject|1|||
162680634|NCT00677235|587539364|FG001|Overall Study|Withdrawal by Subject|1|||
162680635|NCT00677235|587539363|FG000|Overall Study|Lost to Follow-up|2|||
162680636|NCT00677235|587539364|FG001|Overall Study|Lost to Follow-up|1|||
162680637|NCT00677235|587539363|FG000|Overall Study|Death|37|||
162680638|NCT00677235|587539364|FG001|Overall Study|Death|36|||
162680639|NCT00677235|587539363|FG000|Overall Study|Adverse Experience|1|||
162680640|NCT00677235|587539364|FG001|Overall Study|Adverse Experience|0|||
162680641|NCT01040260|587539365|FG000|Overall Study|Withdrawal by Subject|12|||
162680642|NCT01040260|587539366|FG001|Overall Study|Withdrawal by Subject|6|||
162680643|NCT01040260|587539365|FG000|Overall Study|Lost to Follow-up|3|||
162680644|NCT01040260|587539366|FG001|Overall Study|Lost to Follow-up|5|||
162680645|NCT00708916|587539371|FG000|Overall Study|Subject Noncompliance|2|||
162680646|NCT00708916|587539371|FG000|Overall Study|Adverse Event|2|||
162680647|NCT03923959|587539374|FG000|Overall Study|Death|16|||
162680648|NCT03923959|587539375|FG001|Overall Study|Death|12|||
162680649|NCT03923959|587539374|FG000|Overall Study|Lost to Follow-up|56|||
162680650|NCT03923959|587539375|FG001|Overall Study|Lost to Follow-up|56|||
162680651|NCT03923959|587539374|FG000|Overall Study|Withdrawal by Subject|1|||
162680652|NCT03923959|587539375|FG001|Overall Study|Withdrawal by Subject|1|||
162725261|NCT01787760|587703099|FG001|Overall Study|Lens handling difficulty|2|||
162680653|NCT03923959|587539374|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
162680654|NCT03923959|587539375|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
162680655|NCT04212091|587539376|FG000|Overall Study|Lost to Follow-up|0|||
162680656|NCT04212091|587539377|FG001|Overall Study|Lost to Follow-up|0|||
162680657|NCT04212091|587539378|FG002|Overall Study|Lost to Follow-up|0|||
162680658|NCT04212091|587539379|FG003|Overall Study|Lost to Follow-up|0|||
162680659|NCT04212091|587539380|FG004|Overall Study|Lost to Follow-up|1|||
162680660|NCT04212091|587539381|FG005|Overall Study|Lost to Follow-up|1|||
162680661|NCT04212091|587539376|FG000|Overall Study|Participant unable to adhere to visit|0|||
162680662|NCT04212091|587539377|FG001|Overall Study|Participant unable to adhere to visit|0|||
162680663|NCT04212091|587539378|FG002|Overall Study|Participant unable to adhere to visit|0|||
162680664|NCT04212091|587539379|FG003|Overall Study|Participant unable to adhere to visit|0|||
162680665|NCT04212091|587539380|FG004|Overall Study|Participant unable to adhere to visit|1|||
162680666|NCT04212091|587539381|FG005|Overall Study|Participant unable to adhere to visit|0|||
162680667|NCT04575051|587539382|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
162680668|NCT04575051|587539383|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
162680669|NCT04575051|587539384|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
162680670|NCT04575051|587539385|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
162680671|NCT04575051|587539386|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
162680672|NCT04575051|587539382|FG000|Time Period 1|Missing follow up|1|||
162680673|NCT04575051|587539383|FG001|Time Period 1|Missing follow up|3|||
162680674|NCT04575051|587539384|FG002|Time Period 1|Missing follow up|1|||
162680675|NCT04575051|587539385|FG003|Time Period 1|Missing follow up|3|||
162680676|NCT04575051|587539386|FG004|Time Period 1|Missing follow up|2|||
162680677|NCT04575051|587539382|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
162680678|NCT04575051|587539383|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
162680679|NCT04575051|587539384|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
162680680|NCT04575051|587539385|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
162680681|NCT04575051|587539386|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
162680682|NCT04575051|587539382|FG000|Time Period 2|Missing follow up|1|||
162680683|NCT04575051|587539383|FG001|Time Period 2|Missing follow up|8|||
162680684|NCT04575051|587539384|FG002|Time Period 2|Missing follow up|7|||
162680685|NCT04575051|587539385|FG003|Time Period 2|Missing follow up|0|||
162680686|NCT04575051|587539386|FG004|Time Period 2|Missing follow up|1|||
162680687|NCT04575051|587539382|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
162680688|NCT04575051|587539383|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
162680689|NCT04575051|587539384|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
162680690|NCT04575051|587539385|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
162680691|NCT04575051|587539386|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
162680692|NCT04575051|587539382|FG000|Time Period 3|Missing follow up|8|||
162680693|NCT04575051|587539383|FG001|Time Period 3|Missing follow up|6|||
162680694|NCT04575051|587539384|FG002|Time Period 3|Missing follow up|4|||
162680695|NCT04575051|587539385|FG003|Time Period 3|Missing follow up|3|||
162680696|NCT04575051|587539386|FG004|Time Period 3|Missing follow up|0|||
162680697|NCT04575051|587539382|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
162680698|NCT04575051|587539383|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
162680699|NCT04575051|587539384|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
162680700|NCT04575051|587539385|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
162680701|NCT04575051|587539386|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
162680702|NCT04575051|587539382|FG000|Time Period 4|Missing follow up|17|||
162680703|NCT04575051|587539383|FG001|Time Period 4|Missing follow up|3|||
162680704|NCT04575051|587539384|FG002|Time Period 4|Missing follow up|4|||
162680705|NCT04575051|587539385|FG003|Time Period 4|Missing follow up|2|||
162680706|NCT04575051|587539386|FG004|Time Period 4|Missing follow up|1|||
162680707|NCT04575051|587539382|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
162680708|NCT04575051|587539383|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
162680709|NCT04575051|587539384|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
162680710|NCT04575051|587539385|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
162680711|NCT04575051|587539386|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
162680712|NCT04575051|587539382|FG000|Time Period 5|Missing follow up|11|||
162680713|NCT04575051|587539383|FG001|Time Period 5|Missing follow up|8|||
162680714|NCT04575051|587539384|FG002|Time Period 5|Missing follow up|12|||
162680715|NCT04575051|587539385|FG003|Time Period 5|Missing follow up|3|||
162680716|NCT04575051|587539386|FG004|Time Period 5|Missing follow up|11|||
162680717|NCT00951483|587539387|FG000|Overall Study|Physician Decision|4|||
162680718|NCT00951483|587539388|FG001|Overall Study|Physician Decision|0|||
162680719|NCT00951483|587539387|FG000|Overall Study|Withdrawal by Subject|15|||
162680720|NCT00951483|587539388|FG001|Overall Study|Withdrawal by Subject|0|||
162680721|NCT03565887|587539389|FG000|Overall Study|Adverse Event|1|||
162680722|NCT03565887|587539390|FG001|Overall Study|Adverse Event|0|||
162680723|NCT03565887|587539389|FG000|Overall Study|Withdrawal by Subject|0|||
162680724|NCT03565887|587539390|FG001|Overall Study|Withdrawal by Subject|2|||
162680725|NCT00689221|587539391|FG000|Overall Study|Ongoing at cut-off date|39|||
162680726|NCT00689221|587539392|FG001|Overall Study|Ongoing at cut-off date|36|||
162680727|NCT03182868|587539393|FG000|Overall Study|Protocol Violation|3|||
162680728|NCT03182868|587539394|FG001|Overall Study|Protocol Violation|0|||
162680729|NCT03182868|587539395|FG002|Overall Study|Protocol Violation|4|||
162680730|NCT03182868|587539396|FG003|Overall Study|Protocol Violation|1|||
162680731|NCT03182868|587539397|FG004|Overall Study|Protocol Violation|8|||
162680732|NCT01292239|587539398|FG000|Overall Study|Other|1|||
162680733|NCT01292239|587539399|FG001|Overall Study|Other|1|||
162680734|NCT01292239|587539398|FG000|Overall Study|Withdrawal by Subject|3|||
162680735|NCT01292239|587539399|FG001|Overall Study|Withdrawal by Subject|6|||
162680736|NCT00262821|587539400|FG000|Overall Study|Ineligible - wrong stage|0|||
162680737|NCT00262821|587539401|FG001|Overall Study|Ineligible - wrong stage|3|||
162680738|NCT00262821|587539400|FG000|Overall Study|Ineligible - wrong cell type|2|||
162680739|NCT00262821|587539401|FG001|Overall Study|Ineligible - wrong cell type|2|||
162680740|NCT00262821|587539400|FG000|Overall Study|Ineligible - wrong primary|0|||
162680741|NCT00262821|587539401|FG001|Overall Study|Ineligible - wrong primary|1|||
162680742|NCT00262821|587539400|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162680743|NCT00262821|587539401|FG001|Overall Study|Ineligible - inadequate pathology|3|||
162680744|NCT00262821|587539400|FG000|Overall Study|Ineligible - elevated creatinine|0|||
162680745|NCT00262821|587539401|FG001|Overall Study|Ineligible - elevated creatinine|2|||
162680746|NCT00262821|587539400|FG000|Overall Study|Ineligible - required test not done|1|||
162680747|NCT00262821|587539401|FG001|Overall Study|Ineligible - required test not done|4|||
162680748|NCT00262821|587539400|FG000|Overall Study|Inevaluable - inadequate data|0|||
162680749|NCT00262821|587539401|FG001|Overall Study|Inevaluable - inadequate data|4|||
162680750|NCT00765388|587539402|FG000|Period 1|Lack of Efficacy|1|||
162680751|NCT00765388|587539403|FG001|Period 1|Lack of Efficacy|2|||
162680752|NCT00765388|587539402|FG000|Period 1|Lost to Follow-up|0|||
162680753|NCT00765388|587539403|FG001|Period 1|Lost to Follow-up|1|||
162680754|NCT00765388|587539402|FG000|Period 1|Herpes Zoster|0|||
162680755|NCT00765388|587539403|FG001|Period 1|Herpes Zoster|1|||
162680756|NCT00765388|587539402|FG000|Period 1|Hip operation|0|||
162680757|NCT00765388|587539403|FG001|Period 1|Hip operation|1|||
162680758|NCT03923933|587539404|FG000|Overall Study|Lost to Follow-up|1|||
162680759|NCT03923933|587539405|FG001|Overall Study|Lost to Follow-up|0|||
162680760|NCT03923933|587539404|FG000|Overall Study|Withdrawal by Subject|0|||
162680761|NCT03923933|587539405|FG001|Overall Study|Withdrawal by Subject|1|||
162680762|NCT01995461|587539406|FG000|Overall Study|Death|1|||
162680763|NCT01995461|587539406|FG000|Overall Study|Lost to Follow-up|2|||
162680764|NCT01995461|587539406|FG000|Overall Study|Withdrawal by Subject|2|||
162680765|NCT01777854|587539408|FG000|Overall Study|Physician Decision|3|||
162680766|NCT01777854|587539409|FG001|Overall Study|Physician Decision|3|||
162680767|NCT03311373|587539410|FG000|Overall Study|Adverse Event|1|||
162680768|NCT03311373|587539410|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
162680769|NCT03311373|587539410|FG000|Overall Study|Lost to Follow-up|1|||
162680770|NCT03311373|587539410|FG000|Overall Study|Physician Decision|1|||
162680771|NCT03311373|587539410|FG000|Overall Study|Withdrawal by Subject|3|||
162680772|NCT01939548|587539411|FG000|Overall Study|Non compliance|0|||
162680773|NCT01939548|587539412|FG001|Overall Study|Non compliance|2|||
162680774|NCT01939548|587539413|FG002|Overall Study|Non compliance|0|||
162680775|NCT01939548|587539411|FG000|Overall Study|Study Terminated by Sponsor|17|||
162680776|NCT01939548|587539412|FG001|Overall Study|Study Terminated by Sponsor|19|||
162680777|NCT01939548|587539413|FG002|Overall Study|Study Terminated by Sponsor|12|||
162680778|NCT01939548|587539411|FG000|Overall Study|Insufficient Clinical Response|1|||
162680779|NCT01939548|587539412|FG001|Overall Study|Insufficient Clinical Response|0|||
162680780|NCT01939548|587539413|FG002|Overall Study|Insufficient Clinical Response|0|||
162680781|NCT01939548|587539411|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162680782|NCT01939548|587539412|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
162680783|NCT01939548|587539413|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
162680784|NCT01939548|587539411|FG000|Overall Study|Withdrawal by Subject|4|||
162680785|NCT01939548|587539412|FG001|Overall Study|Withdrawal by Subject|4|||
162680786|NCT01939548|587539413|FG002|Overall Study|Withdrawal by Subject|1|||
162680787|NCT01939548|587539411|FG000|Overall Study|Protocol Violation|7|||
162680788|NCT01939548|587539412|FG001|Overall Study|Protocol Violation|6|||
162680789|NCT01939548|587539413|FG002|Overall Study|Protocol Violation|5|||
162680790|NCT01939548|587539411|FG000|Overall Study|Lost to Follow-up|5|||
162680791|NCT01939548|587539412|FG001|Overall Study|Lost to Follow-up|5|||
162680792|NCT01939548|587539413|FG002|Overall Study|Lost to Follow-up|3|||
162680793|NCT01939548|587539411|FG000|Overall Study|Adverse Event|2|||
162680794|NCT01939548|587539412|FG001|Overall Study|Adverse Event|9|||
162680795|NCT01939548|587539413|FG002|Overall Study|Adverse Event|7|||
162680796|NCT01939548|587539411|FG000|Overall Study|Death|0|||
162680797|NCT01939548|587539412|FG001|Overall Study|Death|0|||
162680798|NCT01939548|587539413|FG002|Overall Study|Death|1|||
162680799|NCT01939548|587539411|FG000|Overall Study|Participant dropped|0|||
162680800|NCT01939548|587539412|FG001|Overall Study|Participant dropped|0|||
162680801|NCT01939548|587539413|FG002|Overall Study|Participant dropped|1|||
162680802|NCT01939548|587539411|FG000|Overall Study|Participant unwilling to continue|0|||
162680803|NCT01939548|587539412|FG001|Overall Study|Participant unwilling to continue|1|||
162680804|NCT01939548|587539413|FG002|Overall Study|Participant unwilling to continue|0|||
162680805|NCT01939548|587539411|FG000|Overall Study|Participant withdrew consent|0|||
162680806|NCT01939548|587539412|FG001|Overall Study|Participant withdrew consent|2|||
162680807|NCT01939548|587539413|FG002|Overall Study|Participant withdrew consent|0|||
162680808|NCT01939548|587539411|FG000|Overall Study|Did not complete follow-up|0|||
162680809|NCT01939548|587539412|FG001|Overall Study|Did not complete follow-up|1|||
162680810|NCT01939548|587539413|FG002|Overall Study|Did not complete follow-up|0|||
162680811|NCT01022762|587539416|FG000|Overall Study|Adverse Event|3|||
162680812|NCT01022762|587539417|FG001|Overall Study|Adverse Event|1|||
162680813|NCT01022762|587539416|FG000|Overall Study|Lack of Efficacy|0|||
162680814|NCT01022762|587539417|FG001|Overall Study|Lack of Efficacy|1|||
162680815|NCT01022762|587539416|FG000|Overall Study|Protocol Violation|7|||
162680816|NCT01022762|587539417|FG001|Overall Study|Protocol Violation|6|||
162680817|NCT01022762|587539416|FG000|Overall Study|Unclassified|12|||
162680818|NCT01022762|587539417|FG001|Overall Study|Unclassified|20|||
162680819|NCT01302119|587539418|FG000|Overall Study|Withdrawal by Subject|30|||
162680820|NCT01302119|587539419|FG001|Overall Study|Withdrawal by Subject|20|||
162680821|NCT01302119|587539418|FG000|Overall Study|Lost to Follow-up|10|||
162680822|NCT01302119|587539419|FG001|Overall Study|Lost to Follow-up|4|||
162680823|NCT01302119|587539418|FG000|Overall Study|Adverse Event|2|||
162680824|NCT01302119|587539419|FG001|Overall Study|Adverse Event|1|||
162680825|NCT01302119|587539418|FG000|Overall Study|Non-compliance|4|||
162680826|NCT01302119|587539419|FG001|Overall Study|Non-compliance|2|||
162680827|NCT01302119|587539418|FG000|Overall Study|Non-specific|4|||
162680828|NCT01302119|587539419|FG001|Overall Study|Non-specific|1|||
162680829|NCT01775904|587539420|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
162680830|NCT01775904|587539420|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
162680831|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
162680832|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
162680833|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
162680834|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
162680835|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
162680836|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
162680837|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162680838|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162680839|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162680840|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162680841|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
162680842|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162680843|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162680844|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162680845|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162680846|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
162680847|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
162680848|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
162680849|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
162680850|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
162680851|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
162680852|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162680853|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162680854|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162680855|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162680856|NCT01662310|587539423|FG000|Run-In or Stabilization Phase|Other|1|||
162680857|NCT01662310|587539424|FG001|Run-In or Stabilization Phase|Other|0|||
162680858|NCT01662310|587539425|FG002|Run-In or Stabilization Phase|Other|0|||
162680859|NCT01662310|587539426|FG003|Run-In or Stabilization Phase|Other|0|||
162680860|NCT01662310|587539427|FG004|Run-In or Stabilization Phase|Other|0|||
162680861|NCT01662310|587539423|FG000|Double-Blind Phase|Adverse Event|0|||
162680862|NCT01662310|587539424|FG001|Double-Blind Phase|Adverse Event|0|||
162680863|NCT01662310|587539425|FG002|Double-Blind Phase|Adverse Event|1|||
162680864|NCT01662310|587539426|FG003|Double-Blind Phase|Adverse Event|0|||
162680865|NCT01662310|587539427|FG004|Double-Blind Phase|Adverse Event|0|||
162680866|NCT01662310|587539423|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162680867|NCT01662310|587539424|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162680868|NCT01662310|587539425|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162680869|NCT01662310|587539426|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162680870|NCT01662310|587539427|FG004|Double-Blind Phase|Lost to Follow-up|0|||
162680871|NCT01662310|587539423|FG000|Double-Blind Phase|Pregnancy|0|||
162680872|NCT01662310|587539424|FG001|Double-Blind Phase|Pregnancy|2|||
162680873|NCT01662310|587539425|FG002|Double-Blind Phase|Pregnancy|0|||
162680874|NCT01662310|587539426|FG003|Double-Blind Phase|Pregnancy|0|||
162680875|NCT01662310|587539427|FG004|Double-Blind Phase|Pregnancy|0|||
162680876|NCT01662310|587539423|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162680877|NCT01662310|587539424|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
162680878|NCT01662310|587539425|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
162680879|NCT01662310|587539426|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162680880|NCT01662310|587539427|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
162680881|NCT01662310|587539423|FG000|Double-Blind Phase|Other|0|||
162680882|NCT01662310|587539424|FG001|Double-Blind Phase|Other|0|||
162680883|NCT01662310|587539425|FG002|Double-Blind Phase|Other|1|||
162680884|NCT01662310|587539426|FG003|Double-Blind Phase|Other|0|||
162680885|NCT01662310|587539427|FG004|Double-Blind Phase|Other|0|||
162680886|NCT01662310|587539423|FG000|Double-Blind Phase|Randomized but not treated|0|||
162680887|NCT01662310|587539424|FG001|Double-Blind Phase|Randomized but not treated|1|||
162680888|NCT01662310|587539425|FG002|Double-Blind Phase|Randomized but not treated|0|||
162680889|NCT01662310|587539426|FG003|Double-Blind Phase|Randomized but not treated|0|||
162680890|NCT01662310|587539427|FG004|Double-Blind Phase|Randomized but not treated|0|||
162680891|NCT01662310|587539423|FG000|Open-Label Extension Phase|Adverse Event|0|||
162680892|NCT01662310|587539424|FG001|Open-Label Extension Phase|Adverse Event|0|||
162680893|NCT01662310|587539425|FG002|Open-Label Extension Phase|Adverse Event|0|||
162680894|NCT01662310|587539426|FG003|Open-Label Extension Phase|Adverse Event|3|||
162680895|NCT01662310|587539427|FG004|Open-Label Extension Phase|Adverse Event|0|||
162680896|NCT01662310|587539423|FG000|Open-Label Extension Phase|Death|0|||
162680897|NCT01662310|587539424|FG001|Open-Label Extension Phase|Death|0|||
162680898|NCT01662310|587539425|FG002|Open-Label Extension Phase|Death|0|||
162680899|NCT01662310|587539426|FG003|Open-Label Extension Phase|Death|1|||
162680900|NCT01662310|587539427|FG004|Open-Label Extension Phase|Death|0|||
162680901|NCT01662310|587539423|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
162680902|NCT01662310|587539424|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
162680903|NCT01662310|587539425|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
162680904|NCT01662310|587539426|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
162680905|NCT01662310|587539427|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
162680906|NCT01662310|587539423|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162680907|NCT01662310|587539424|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162680908|NCT01662310|587539425|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162680909|NCT01662310|587539426|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
162680910|NCT01662310|587539427|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
162680911|NCT01662310|587539423|FG000|Open-Label Extension Phase|Pregnancy|0|||
162680912|NCT01662310|587539424|FG001|Open-Label Extension Phase|Pregnancy|0|||
162680913|NCT01662310|587539425|FG002|Open-Label Extension Phase|Pregnancy|0|||
162680914|NCT01662310|587539426|FG003|Open-Label Extension Phase|Pregnancy|1|||
162680915|NCT01662310|587539427|FG004|Open-Label Extension Phase|Pregnancy|0|||
162680916|NCT01662310|587539423|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
162680917|NCT01662310|587539424|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
162680918|NCT01662310|587539425|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162680919|NCT01662310|587539426|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
162680920|NCT01662310|587539427|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
162680921|NCT02432105|587539431|FG000|Overall Study|Lost to Follow-up|1|||
162680922|NCT02432105|587539432|FG001|Overall Study|Lost to Follow-up|1|||
162680923|NCT02432105|587539433|FG002|Overall Study|Lost to Follow-up|0|||
162680924|NCT02432105|587539431|FG000|Overall Study|Withdrawal by Subject|1|||
162680925|NCT02432105|587539432|FG001|Overall Study|Withdrawal by Subject|0|||
162680926|NCT02432105|587539433|FG002|Overall Study|Withdrawal by Subject|1|||
162680927|NCT02432105|587539431|FG000|Overall Study|Culture positive for yeast|0|||
162680928|NCT02432105|587539432|FG001|Overall Study|Culture positive for yeast|1|||
162680929|NCT02432105|587539433|FG002|Overall Study|Culture positive for yeast|0|||
162680930|NCT02432105|587539431|FG000|Overall Study|Randomized in error|0|||
162680931|NCT02432105|587539432|FG001|Overall Study|Randomized in error|0|||
162680932|NCT02432105|587539433|FG002|Overall Study|Randomized in error|2|||
162680933|NCT00450411|587539435|FG000|Overall Study|Protocol Violation|6|||
162680934|NCT00450411|587539435|FG000|Overall Study|No protocol treatment|2|||
162680935|NCT00829387|587539438|FG000|Overall Study|Withdrawal by Subject|2|||
162680936|NCT00829387|587539439|FG001|Overall Study|Withdrawal by Subject|3|||
162680937|NCT00829387|587539438|FG000|Overall Study|Disqualified by PI|1|||
162680938|NCT00829387|587539439|FG001|Overall Study|Disqualified by PI|0|||
162680939|NCT00707031|587539440|FG000|Overall Study|Adverse Event|45|||
162680940|NCT00707031|587539441|FG001|Overall Study|Adverse Event|45|||
162680941|NCT00707031|587539440|FG000|Overall Study|Lack of Efficacy|19|||
162680942|NCT00707031|587539441|FG001|Overall Study|Lack of Efficacy|6|||
162680943|NCT00707031|587539440|FG000|Overall Study|Lost to Follow-up|2|||
162680944|NCT00707031|587539441|FG001|Overall Study|Lost to Follow-up|1|||
162680945|NCT00707031|587539440|FG000|Overall Study|Protocol Violation|1|||
162680946|NCT00707031|587539441|FG001|Overall Study|Protocol Violation|0|||
162680947|NCT00707031|587539440|FG000|Overall Study|Withdrawal by Subject|7|||
162680948|NCT00707031|587539441|FG001|Overall Study|Withdrawal by Subject|8|||
162680949|NCT00707031|587539440|FG000|Overall Study|Poor Compliance to Protocol|7|||
162680950|NCT00707031|587539441|FG001|Overall Study|Poor Compliance to Protocol|13|||
162680951|NCT00707031|587539440|FG000|Overall Study|Familial or Personal Reasons|12|||
162680952|NCT00707031|587539441|FG001|Overall Study|Familial or Personal Reasons|15|||
162680953|NCT00707031|587539440|FG000|Overall Study|Serious Noncompliance|2|||
162680954|NCT00707031|587539441|FG001|Overall Study|Serious Noncompliance|3|||
162680955|NCT00707031|587539440|FG000|Overall Study|Sponsor Decision|9|||
162680956|NCT00707031|587539441|FG001|Overall Study|Sponsor Decision|8|||
162725262|NCT01787760|587703100|FG002|Overall Study|Lens handling difficulty|0|||
162725263|NCT01787760|587703098|FG000|Overall Study|Protocol Violation|6|||
162725264|NCT01787760|587703099|FG001|Overall Study|Protocol Violation|0|||
162725265|NCT01787760|587703100|FG002|Overall Study|Protocol Violation|1|||
162725266|NCT01787760|587703098|FG000|Overall Study|Withdrawal by Subject|5|||
162725267|NCT01787760|587703099|FG001|Overall Study|Withdrawal by Subject|1|||
162725268|NCT01787760|587703100|FG002|Overall Study|Withdrawal by Subject|2|||
162725269|NCT01787760|587703098|FG000|Overall Study|Lost to Follow-up|1|||
162725270|NCT01787760|587703099|FG001|Overall Study|Lost to Follow-up|0|||
162725271|NCT01787760|587703100|FG002|Overall Study|Lost to Follow-up|1|||
162725272|NCT01787760|587703098|FG000|Overall Study|Stroke|1|||
162680957|NCT02085252|587539442|FG000|Overall Study|Withdrawal of Consent|1|||
162680958|NCT02085252|587539443|FG001|Overall Study|Withdrawal of Consent|0|||
162680959|NCT02085252|587539442|FG000|Overall Study|Adverse Event|0|||
162680960|NCT02085252|587539443|FG001|Overall Study|Adverse Event|1|||
162680961|NCT02085252|587539442|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
162680962|NCT02085252|587539443|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
162680963|NCT02085252|587539442|FG000|Overall Study|Reason Not Specified|0|||
162680964|NCT02085252|587539443|FG001|Overall Study|Reason Not Specified|1|||
162680965|NCT02085252|587539442|FG000|Overall Study|Reason Unknown|0|||
162680966|NCT02085252|587539443|FG001|Overall Study|Reason Unknown|1|||
162680967|NCT03260868|587539445|FG000|Overall Study|Poor Compliance to Protocol|0|||
162680968|NCT03260868|587539446|FG001|Overall Study|Poor Compliance to Protocol|2|||
162680969|NCT03260868|587539445|FG000|Overall Study|Study Terminated By Sponsor|2|||
162680970|NCT03260868|587539446|FG001|Overall Study|Study Terminated By Sponsor|1|||
162680971|NCT03260868|587539445|FG000|Overall Study|Other than specified above|1|||
162680972|NCT03260868|587539446|FG001|Overall Study|Other than specified above|0|||
162680973|NCT03645759|587539450|FG000|Overall Study|Lost to Follow-up|3|||
162680974|NCT03645759|587539451|FG001|Overall Study|Lost to Follow-up|2|||
162680975|NCT02693743|587539454|FG000|Overall Study|Physician Decision|1|||
162680976|NCT02693743|587539455|FG001|Overall Study|Physician Decision|0|||
162680977|NCT02626780|587539456|FG000|Overall Study|Withdrawal by Subject|3|||
162680978|NCT05540522|587539457|FG000|Overall Study|Adverse Event|1|||
162680979|NCT05540522|587539458|FG001|Overall Study|Adverse Event|0|||
162680980|NCT05540522|587539459|FG002|Overall Study|Adverse Event|2|||
162680981|NCT05540522|587539460|FG003|Overall Study|Adverse Event|5|||
162680982|NCT05540522|587539457|FG000|Overall Study|Lost to Follow-up|487|||
162680983|NCT05540522|587539458|FG001|Overall Study|Lost to Follow-up|427|||
162680984|NCT05540522|587539459|FG002|Overall Study|Lost to Follow-up|146|||
162680985|NCT05540522|587539460|FG003|Overall Study|Lost to Follow-up|166|||
162680986|NCT05540522|587539457|FG000|Overall Study|Physician Decision|11|||
162680987|NCT05540522|587539458|FG001|Overall Study|Physician Decision|19|||
162680988|NCT05540522|587539459|FG002|Overall Study|Physician Decision|8|||
162680989|NCT05540522|587539460|FG003|Overall Study|Physician Decision|13|||
162680990|NCT05540522|587539457|FG000|Overall Study|Pregnancy|1|||
162680991|NCT05540522|587539458|FG001|Overall Study|Pregnancy|0|||
162680992|NCT05540522|587539459|FG002|Overall Study|Pregnancy|0|||
162680993|NCT05540522|587539460|FG003|Overall Study|Pregnancy|0|||
162680994|NCT05540522|587539457|FG000|Overall Study|Protocol Violation|3|||
162680995|NCT05540522|587539458|FG001|Overall Study|Protocol Violation|1|||
162680996|NCT05540522|587539459|FG002|Overall Study|Protocol Violation|9|||
162680997|NCT05540522|587539460|FG003|Overall Study|Protocol Violation|7|||
162680998|NCT05540522|587539457|FG000|Overall Study|Withdrawal by Subject|168|||
162680999|NCT05540522|587539458|FG001|Overall Study|Withdrawal by Subject|134|||
162681000|NCT05540522|587539459|FG002|Overall Study|Withdrawal by Subject|331|||
162681001|NCT05540522|587539460|FG003|Overall Study|Withdrawal by Subject|322|||
162725273|NCT01787760|587703099|FG001|Overall Study|Stroke|0|||
162681002|NCT05540522|587539457|FG000|Overall Study|Death|7|||
162725274|NCT01787760|587703100|FG002|Overall Study|Stroke|0|||
162725275|NCT01787760|587703098|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
162725276|NCT01787760|587703099|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
162725277|NCT01787760|587703100|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
162681003|NCT05540522|587539458|FG001|Overall Study|Death|9|||
162681004|NCT05540522|587539459|FG002|Overall Study|Death|49|||
162681005|NCT05540522|587539460|FG003|Overall Study|Death|46|||
162681006|NCT05540522|587539457|FG000|Overall Study|Not vaccinated|34|||
162681007|NCT05540522|587539458|FG001|Overall Study|Not vaccinated|53|||
162681008|NCT05540522|587539459|FG002|Overall Study|Not vaccinated|57|||
162725278|NCT01787760|587703098|FG000|Overall Study|Unsatisfactory physiological response|2|||
162681009|NCT05540522|587539460|FG003|Overall Study|Not vaccinated|50|||
162681010|NCT05540522|587539457|FG000|Overall Study|No longer meets eligibility criteria|0|||
162681011|NCT05540522|587539458|FG001|Overall Study|No longer meets eligibility criteria|0|||
162681012|NCT05540522|587539459|FG002|Overall Study|No longer meets eligibility criteria|3|||
162681013|NCT05540522|587539460|FG003|Overall Study|No longer meets eligibility criteria|2|||
162681014|NCT05540522|587539457|FG000|Overall Study|Other (Unspecified)|8|||
162681015|NCT05540522|587539458|FG001|Overall Study|Other (Unspecified)|10|||
162681016|NCT05540522|587539459|FG002|Overall Study|Other (Unspecified)|4|||
162681017|NCT05540522|587539460|FG003|Overall Study|Other (Unspecified)|2|||
162681018|NCT00789815|587541136|FG000|Overall Study|Protocol Violation|6|||
162681019|NCT00789815|587541137|FG001|Overall Study|Protocol Violation|1|||
162681020|NCT00789815|587541136|FG000|Overall Study|Intubation due to massive bleeding|1|||
162681021|NCT00789815|587541137|FG001|Overall Study|Intubation due to massive bleeding|0|||
162681022|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
162681023|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
162681024|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
162681025|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
162681026|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
162681027|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
162681028|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Death|1|||
162681029|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Death|0|||
162681030|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Adverse Event|1|||
162681031|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Adverse Event|0|||
162681032|NCT02586025|587541140|FG000|Neoadjuvant Treatment|Physician Decision|2|||
162681033|NCT02586025|587541141|FG001|Neoadjuvant Treatment|Physician Decision|1|||
162681034|NCT02586025|587541140|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
162681035|NCT02586025|587541141|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
162681036|NCT02586025|587541140|FG000|Adjuvant Treatment|Recurrent Disease|4|||
162681037|NCT02586025|587541141|FG001|Adjuvant Treatment|Recurrent Disease|5|||
162681038|NCT02586025|587541140|FG000|Adjuvant Treatment|Physician Decision|0|||
162681039|NCT02586025|587541141|FG001|Adjuvant Treatment|Physician Decision|1|||
162681040|NCT02586025|587541140|FG000|Adjuvant Treatment|Pregnancy|1|||
162681041|NCT02586025|587541141|FG001|Adjuvant Treatment|Pregnancy|0|||
162681042|NCT02586025|587541140|FG000|Treatment-Free Follow-Up|Death|11|||
162681043|NCT02586025|587541141|FG001|Treatment-Free Follow-Up|Death|11|||
162681044|NCT02586025|587541140|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
162681045|NCT02586025|587541141|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
162681046|NCT02586025|587541140|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
162681047|NCT02586025|587541141|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
162681048|NCT02586025|587541140|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
162681049|NCT02586025|587541141|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
162681050|NCT02586025|587541140|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
162681051|NCT02586025|587541141|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
162681052|NCT03822117|587541142|FG000|Overall Study|Death|18|||
162681053|NCT03822117|587541143|FG001|Overall Study|Death|17|||
162681054|NCT03822117|587541144|FG002|Overall Study|Death|12|||
162681055|NCT03822117|587541145|FG003|Overall Study|Death|4|||
162681056|NCT03822117|587541142|FG000|Overall Study|Lost to Follow-up|1|||
162681057|NCT03822117|587541143|FG001|Overall Study|Lost to Follow-up|2|||
162681058|NCT03822117|587541144|FG002|Overall Study|Lost to Follow-up|3|||
162681059|NCT03822117|587541145|FG003|Overall Study|Lost to Follow-up|0|||
162681060|NCT03822117|587541142|FG000|Overall Study|Study Terminated by Sponsor|25|||
162681061|NCT03822117|587541143|FG001|Overall Study|Study Terminated by Sponsor|11|||
162681062|NCT03822117|587541144|FG002|Overall Study|Study Terminated by Sponsor|6|||
162681063|NCT03822117|587541145|FG003|Overall Study|Study Terminated by Sponsor|0|||
162681064|NCT03822117|587541142|FG000|Overall Study|Withdrawal by Subject|4|||
162681065|NCT03822117|587541143|FG001|Overall Study|Withdrawal by Subject|0|||
162681066|NCT03822117|587541144|FG002|Overall Study|Withdrawal by Subject|3|||
162681067|NCT03822117|587541145|FG003|Overall Study|Withdrawal by Subject|0|||
162681068|NCT03822117|587541142|FG000|Overall Study|Disease Progression|1|||
162681069|NCT03822117|587541143|FG001|Overall Study|Disease Progression|2|||
162681070|NCT03822117|587541144|FG002|Overall Study|Disease Progression|1|||
162681071|NCT03822117|587541145|FG003|Overall Study|Disease Progression|0|||
162681072|NCT03822117|587541142|FG000|Overall Study|Never Returned to Hospital|0|||
162681073|NCT03822117|587541143|FG001|Overall Study|Never Returned to Hospital|0|||
162681074|NCT03822117|587541144|FG002|Overall Study|Never Returned to Hospital|1|||
162681075|NCT03822117|587541145|FG003|Overall Study|Never Returned to Hospital|0|||
162681076|NCT00415610|587541147|FG000|Overall Study|Death|3|||
162681077|NCT00415610|587541148|FG001|Overall Study|Death|2|||
162681078|NCT00415610|587541149|FG002|Overall Study|Death|5|||
162681079|NCT01357616|587541153|FG000|Overall Study|Adverse Event|1|||
162681080|NCT01357616|587541154|FG001|Overall Study|Adverse Event|1|||
162681081|NCT01357616|587541153|FG000|Overall Study|Lost to Follow-up|4|||
162681082|NCT01357616|587541154|FG001|Overall Study|Lost to Follow-up|3|||
162681083|NCT01357616|587541153|FG000|Overall Study|Protocol Violation|0|||
162681084|NCT01357616|587541154|FG001|Overall Study|Protocol Violation|2|||
162681085|NCT01357616|587541153|FG000|Overall Study|Inadequate Control of IOP|1|||
162681086|NCT01357616|587541154|FG001|Overall Study|Inadequate Control of IOP|2|||
162681087|NCT01357616|587541153|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
162681088|NCT01357616|587541154|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
162681089|NCT01357616|587541153|FG000|Overall Study|Withdrawal by Subject|1|||
162681090|NCT01357616|587541154|FG001|Overall Study|Withdrawal by Subject|0|||
162681091|NCT03255824|587541161|FG000|Overall Study|Under-sedation|2|||
162681092|NCT03255824|587541162|FG001|Overall Study|Under-sedation|1|||
162681093|NCT03432364|587541167|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
162681094|NCT00522301|587541168|FG000|Overall Study|Withdrawal by Subject|1|||
162681095|NCT00522301|587541168|FG000|Overall Study|Adverse Event|5|||
162681096|NCT03040713|587541169|FG000|Overall Study|Positive amyloid scan|3|||
162681097|NCT00152464|587541174|FG000|Overall Study|Adverse Event|3|||
162681098|NCT00152464|587541175|FG001|Overall Study|Adverse Event|6|||
162681099|NCT00152464|587541174|FG000|Overall Study|Lost to Follow-up|8|||
162681100|NCT00152464|587541175|FG001|Overall Study|Lost to Follow-up|4|||
162681101|NCT00152464|587541174|FG000|Overall Study|Protocol Violation|3|||
162681102|NCT00152464|587541175|FG001|Overall Study|Protocol Violation|1|||
162681103|NCT00152464|587541174|FG000|Overall Study|Withdrawal by Subject|21|||
162681104|NCT00152464|587541175|FG001|Overall Study|Withdrawal by Subject|22|||
162681105|NCT00152464|587541174|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
162681106|NCT00152464|587541175|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
162681107|NCT00152464|587541174|FG000|Overall Study|Eczema deterioration|0|||
162681108|NCT00152464|587541175|FG001|Overall Study|Eczema deterioration|1|||
162681109|NCT00152464|587541174|FG000|Overall Study|Parent decision|1|||
162681110|NCT00152464|587541175|FG001|Overall Study|Parent decision|1|||
162681111|NCT00152464|587541174|FG000|Overall Study|Investigator decision|1|||
162681112|NCT00152464|587541175|FG001|Overall Study|Investigator decision|0|||
162681113|NCT00152464|587541174|FG000|Overall Study|Lack of Efficacy|1|||
162681114|NCT00152464|587541175|FG001|Overall Study|Lack of Efficacy|0|||
162681115|NCT00152464|587541174|FG000|Overall Study|Eczema poorly controlled|1|||
162681116|NCT00152464|587541175|FG001|Overall Study|Eczema poorly controlled|0|||
162681117|NCT00152464|587541174|FG000|Overall Study|Patient relocated|1|||
162681118|NCT00152464|587541175|FG001|Overall Study|Patient relocated|0|||
162681119|NCT04465357|587541178|FG000|Overall Study|Adverse Event|2|||
162681120|NCT04465357|587541178|FG000|Overall Study|Lack of Efficacy|1|||
162681121|NCT04465357|587541178|FG000|Overall Study|Lost to Follow-up|2|||
162681122|NCT04465357|587541178|FG000|Overall Study|Withdrawal by Subject|6|||
162681123|NCT04465357|587541178|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
162681124|NCT00430248|587541189|FG000|Overall Study|Adverse Event|49|||
162681125|NCT00430248|587541190|FG001|Overall Study|Adverse Event|61|||
162681126|NCT00430248|587541191|FG002|Overall Study|Adverse Event|64|||
162681127|NCT00430248|587541189|FG000|Overall Study|Protocol Violation|10|||
162681128|NCT00430248|587541190|FG001|Overall Study|Protocol Violation|2|||
162681129|NCT00430248|587541191|FG002|Overall Study|Protocol Violation|4|||
162681130|NCT00430248|587541189|FG000|Overall Study|Personal Reasons|12|||
162681131|NCT00430248|587541190|FG001|Overall Study|Personal Reasons|24|||
162681132|NCT00430248|587541191|FG002|Overall Study|Personal Reasons|9|||
162681133|NCT00430248|587541189|FG000|Overall Study|Lost to Follow-up|28|||
162681134|NCT00430248|587541190|FG001|Overall Study|Lost to Follow-up|33|||
162681135|NCT00430248|587541191|FG002|Overall Study|Lost to Follow-up|28|||
162681136|NCT00430248|587541189|FG000|Overall Study|Therapeutic Failure|1|||
162681137|NCT00430248|587541190|FG001|Overall Study|Therapeutic Failure|1|||
162681138|NCT00430248|587541191|FG002|Overall Study|Therapeutic Failure|1|||
162681139|NCT00430248|587541189|FG000|Overall Study|Withdrawal by Subject|14|||
162681140|NCT00430248|587541190|FG001|Overall Study|Withdrawal by Subject|20|||
162681141|NCT00430248|587541191|FG002|Overall Study|Withdrawal by Subject|16|||
162681142|NCT00430248|587541189|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162681143|NCT00430248|587541190|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
162681144|NCT00430248|587541191|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162681145|NCT00430248|587541189|FG000|Overall Study|Gout Flare|3|||
162681146|NCT00430248|587541190|FG001|Overall Study|Gout Flare|7|||
162681147|NCT00430248|587541191|FG002|Overall Study|Gout Flare|2|||
162681148|NCT00430248|587541189|FG000|Overall Study|Reason Not Specified|8|||
162681149|NCT00430248|587541190|FG001|Overall Study|Reason Not Specified|8|||
162681150|NCT00430248|587541191|FG002|Overall Study|Reason Not Specified|11|||
162681151|NCT00002558|587541194|FG000|Overall Study|Withdrawal by Subject|0|||
162681152|NCT00002558|587541195|FG001|Overall Study|Withdrawal by Subject|1|||
162681153|NCT01260350|587541197|FG000|Overall Study|Lack of Efficacy|0|||
162681154|NCT01260350|587541198|FG001|Overall Study|Lack of Efficacy|0|||
162681155|NCT01260350|587541199|FG002|Overall Study|Lack of Efficacy|0|||
162681156|NCT01260350|587541200|FG003|Overall Study|Lack of Efficacy|0|||
162681157|NCT01260350|587541201|FG004|Overall Study|Lack of Efficacy|0|||
162681158|NCT01260350|587541202|FG005|Overall Study|Lack of Efficacy|0|||
162681159|NCT01260350|587541203|FG006|Overall Study|Lack of Efficacy|0|||
162681160|NCT01260350|587541204|FG007|Overall Study|Lack of Efficacy|0|||
162681161|NCT01260350|587541205|FG008|Overall Study|Lack of Efficacy|0|||
162681162|NCT01260350|587541206|FG009|Overall Study|Lack of Efficacy|0|||
162681163|NCT01260350|587541207|FG010|Overall Study|Lack of Efficacy|0|||
162681164|NCT01260350|587541208|FG011|Overall Study|Lack of Efficacy|0|||
162681165|NCT01260350|587541209|FG012|Overall Study|Lack of Efficacy|0|||
162681166|NCT01260350|587541210|FG013|Overall Study|Lack of Efficacy|0|||
162681167|NCT01260350|587541211|FG014|Overall Study|Lack of Efficacy|0|||
162681168|NCT01260350|587541212|FG015|Overall Study|Lack of Efficacy|0|||
162681169|NCT01260350|587541213|FG016|Overall Study|Lack of Efficacy|0|||
162681170|NCT01260350|587541214|FG017|Overall Study|Lack of Efficacy|1|||
162681171|NCT01260350|587541215|FG018|Overall Study|Lack of Efficacy|0|||
162681172|NCT01260350|587541216|FG019|Overall Study|Lack of Efficacy|0|||
162681173|NCT01260350|587541217|FG020|Overall Study|Lack of Efficacy|3|||
162681174|NCT01260350|587541218|FG021|Overall Study|Lack of Efficacy|0|||
162681175|NCT01260350|587541197|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681176|NCT01260350|587541198|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681177|NCT01260350|587541199|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681178|NCT01260350|587541200|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681179|NCT01260350|587541201|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681180|NCT01260350|587541202|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681181|NCT01260350|587541203|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681182|NCT01260350|587541204|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681183|NCT01260350|587541205|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
162681184|NCT01260350|587541206|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681185|NCT01260350|587541207|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681186|NCT01260350|587541208|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681187|NCT01260350|587541209|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681188|NCT01260350|587541210|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681189|NCT01260350|587541211|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681190|NCT01260350|587541212|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681191|NCT01260350|587541213|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681192|NCT01260350|587541214|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681193|NCT01260350|587541215|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681194|NCT01260350|587541216|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681195|NCT01260350|587541217|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681196|NCT01260350|587541218|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162681197|NCT04385368|587541221|FG000|Overall Study|Death|5|||
162681198|NCT04385368|587541222|FG001|Overall Study|Death|5|||
162681199|NCT04385368|587541221|FG000|Overall Study|Physician Decision|3|||
162681200|NCT04385368|587541222|FG001|Overall Study|Physician Decision|0|||
162681201|NCT04385368|587541221|FG000|Overall Study|Withdrawal by Subject|4|||
162681202|NCT04385368|587541222|FG001|Overall Study|Withdrawal by Subject|3|||
162681203|NCT02123108|587541223|FG000|Overall Study|Death|2|||
162681204|NCT02123108|587541224|FG001|Overall Study|Death|3|||
162681205|NCT02219048|587541228|FG000|Overall Study|Adverse Event|2|||
162681206|NCT02219048|587541229|FG001|Overall Study|Adverse Event|5|||
162681207|NCT02219048|587541228|FG000|Overall Study|No longer meets eligibility criteria|1|||
162681208|NCT02219048|587541229|FG001|Overall Study|No longer meets eligibility criteria|0|||
162681209|NCT02219048|587541228|FG000|Overall Study|Study terminated by sponsor|16|||
162681210|NCT02219048|587541229|FG001|Overall Study|Study terminated by sponsor|15|||
162681211|NCT02219048|587541228|FG000|Overall Study|Withdrawal by Subject|2|||
162681212|NCT02219048|587541229|FG001|Overall Study|Withdrawal by Subject|0|||
162681213|NCT02219048|587541228|FG000|Overall Study|Other|0|||
162681214|NCT02219048|587541229|FG001|Overall Study|Other|1|||
162681215|NCT04721925|587541230|FG000|2-Month Assessment|Lost to Follow-up|5|||
162681216|NCT04721925|587541231|FG001|2-Month Assessment|Lost to Follow-up|3|||
162681217|NCT04721925|587541230|FG000|4-Month Assessment|Lost to Follow-up|3|||
162681218|NCT04721925|587541231|FG001|4-Month Assessment|Lost to Follow-up|6|||
162681219|NCT01274182|587541240|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162681220|NCT01274182|587541241|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162681221|NCT01274182|587541242|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
162681222|NCT01274182|587541240|FG000|Overall Study|Adverse Event|4|||
162681223|NCT01274182|587541241|FG001|Overall Study|Adverse Event|5|||
162681224|NCT01274182|587541242|FG002|Overall Study|Adverse Event|3|||
162681225|NCT01274182|587541240|FG000|Overall Study|Withdrawal by Subject|5|||
162681226|NCT01274182|587541241|FG001|Overall Study|Withdrawal by Subject|5|||
162681227|NCT01274182|587541242|FG002|Overall Study|Withdrawal by Subject|3|||
162681228|NCT01274182|587541240|FG000|Overall Study|Lost to Follow-up|2|||
162681229|NCT01274182|587541241|FG001|Overall Study|Lost to Follow-up|3|||
162681230|NCT01274182|587541242|FG002|Overall Study|Lost to Follow-up|1|||
162681231|NCT01274182|587541240|FG000|Overall Study|Protocol Violation|3|||
162681232|NCT01274182|587541241|FG001|Overall Study|Protocol Violation|2|||
162681233|NCT01274182|587541242|FG002|Overall Study|Protocol Violation|0|||
162681234|NCT01274182|587541240|FG000|Overall Study|Death|1|||
162681235|NCT01274182|587541241|FG001|Overall Study|Death|0|||
162681236|NCT01274182|587541242|FG002|Overall Study|Death|1|||
162681237|NCT01970982|587541243|FG000|Overall Study|Withdrawal by Subject|0|||
162681238|NCT01970982|587541244|FG001|Overall Study|Withdrawal by Subject|0|||
162681239|NCT01970982|587541245|FG002|Overall Study|Withdrawal by Subject|2|||
162681240|NCT04040751|587541250|FG000|Overall Study|Withdrawal by Subject|2|||
162681241|NCT04040751|587541251|FG001|Overall Study|Withdrawal by Subject|0|||
162681242|NCT04040751|587541252|FG002|Overall Study|Withdrawal by Subject|2|||
162681243|NCT04040751|587541253|FG003|Overall Study|Withdrawal by Subject|0|||
162681244|NCT02862457|587541254|FG000|Overall Study|Death|1|||
162681245|NCT02862457|587541255|FG001|Overall Study|Death|3|||
162681246|NCT02862457|587541256|FG002|Overall Study|Death|2|||
162681247|NCT02862457|587541257|FG003|Overall Study|Death|3|||
162681248|NCT02862457|587541258|FG004|Overall Study|Death|0|||
162681249|NCT02862457|587541259|FG005|Overall Study|Death|2|||
162681250|NCT02862457|587541260|FG006|Overall Study|Death|1|||
162681251|NCT02862457|587541254|FG000|Overall Study|Lost to Follow-up|1|||
162681252|NCT02862457|587541255|FG001|Overall Study|Lost to Follow-up|0|||
162681253|NCT02862457|587541256|FG002|Overall Study|Lost to Follow-up|0|||
162681254|NCT02862457|587541257|FG003|Overall Study|Lost to Follow-up|1|||
162681255|NCT02862457|587541258|FG004|Overall Study|Lost to Follow-up|0|||
162681256|NCT02862457|587541259|FG005|Overall Study|Lost to Follow-up|0|||
162681257|NCT02862457|587541260|FG006|Overall Study|Lost to Follow-up|0|||
162681258|NCT02862457|587541254|FG000|Overall Study|Withdrawal by Subject|0|||
162681259|NCT02862457|587541255|FG001|Overall Study|Withdrawal by Subject|0|||
162681260|NCT02862457|587541256|FG002|Overall Study|Withdrawal by Subject|1|||
162681261|NCT02862457|587541257|FG003|Overall Study|Withdrawal by Subject|0|||
162681262|NCT02862457|587541258|FG004|Overall Study|Withdrawal by Subject|0|||
162681263|NCT02862457|587541259|FG005|Overall Study|Withdrawal by Subject|1|||
162681264|NCT02862457|587541260|FG006|Overall Study|Withdrawal by Subject|0|||
162681265|NCT03364751|587541261|FG000|Overall Study|Withdrawal by Subject|1|||
162681266|NCT03364751|587541262|FG001|Overall Study|Withdrawal by Subject|0|||
162681267|NCT03364751|587541263|FG002|Overall Study|Withdrawal by Subject|0|||
162681268|NCT03364751|587541264|FG003|Overall Study|Withdrawal by Subject|0|||
162681269|NCT03364751|587541261|FG000|Overall Study|Lost to Follow-up|0|||
162681270|NCT03364751|587541262|FG001|Overall Study|Lost to Follow-up|1|||
162681271|NCT03364751|587541263|FG002|Overall Study|Lost to Follow-up|0|||
162681272|NCT03364751|587541264|FG003|Overall Study|Lost to Follow-up|0|||
162681273|NCT02342886|587541266|FG000|Overall Study|Treatment non-compliance|1|||
162681274|NCT02342886|587541267|FG001|Overall Study|Treatment non-compliance|0|||
162681275|NCT02342886|587541268|FG002|Overall Study|Treatment non-compliance|0|||
162681276|NCT02342886|587541269|FG003|Overall Study|Treatment non-compliance|1|||
162681277|NCT02342886|587541270|FG004|Overall Study|Treatment non-compliance|0|||
162681278|NCT02342886|587541266|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
162681279|NCT02342886|587541267|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
162681280|NCT02342886|587541268|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
162681281|NCT02342886|587541269|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
162681282|NCT02342886|587541270|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
162681283|NCT02342886|587541266|FG000|Overall Study|Adverse event/specific toxicity|4|||
162681284|NCT02342886|587541267|FG001|Overall Study|Adverse event/specific toxicity|3|||
162681285|NCT02342886|587541268|FG002|Overall Study|Adverse event/specific toxicity|11|||
162681286|NCT02342886|587541269|FG003|Overall Study|Adverse event/specific toxicity|2|||
162681287|NCT02342886|587541270|FG004|Overall Study|Adverse event/specific toxicity|1|||
162681288|NCT02342886|587541266|FG000|Overall Study|Lost to Follow-up|1|||
162681289|NCT02342886|587541267|FG001|Overall Study|Lost to Follow-up|0|||
162681290|NCT02342886|587541268|FG002|Overall Study|Lost to Follow-up|0|||
162681291|NCT02342886|587541269|FG003|Overall Study|Lost to Follow-up|0|||
162681292|NCT02342886|587541270|FG004|Overall Study|Lost to Follow-up|0|||
162681293|NCT02342886|587541266|FG000|Overall Study|Death|1|||
162681294|NCT02342886|587541267|FG001|Overall Study|Death|2|||
162681295|NCT02342886|587541268|FG002|Overall Study|Death|1|||
162681296|NCT02342886|587541269|FG003|Overall Study|Death|0|||
162681297|NCT02342886|587541270|FG004|Overall Study|Death|1|||
162681298|NCT02342886|587541266|FG000|Overall Study|Withdrawal by Subject|0|||
162681299|NCT02342886|587541267|FG001|Overall Study|Withdrawal by Subject|1|||
162681300|NCT02342886|587541268|FG002|Overall Study|Withdrawal by Subject|0|||
162681301|NCT02342886|587541269|FG003|Overall Study|Withdrawal by Subject|1|||
162681302|NCT02342886|587541270|FG004|Overall Study|Withdrawal by Subject|0|||
162681303|NCT02342886|587541266|FG000|Overall Study|Investigator/sponsor decision|0|||
162681304|NCT02342886|587541267|FG001|Overall Study|Investigator/sponsor decision|2|||
162681305|NCT02342886|587541268|FG002|Overall Study|Investigator/sponsor decision|0|||
162681306|NCT02342886|587541269|FG003|Overall Study|Investigator/sponsor decision|3|||
162681307|NCT02342886|587541270|FG004|Overall Study|Investigator/sponsor decision|1|||
162681308|NCT02342886|587541266|FG000|Overall Study|Pregnancy|0|||
162681309|NCT02342886|587541267|FG001|Overall Study|Pregnancy|0|||
162681310|NCT02342886|587541268|FG002|Overall Study|Pregnancy|2|||
162681311|NCT02342886|587541269|FG003|Overall Study|Pregnancy|0|||
162681312|NCT02342886|587541270|FG004|Overall Study|Pregnancy|0|||
162681313|NCT02342886|587541266|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162681314|NCT02342886|587541267|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162681315|NCT02342886|587541268|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
162681316|NCT02342886|587541269|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162681317|NCT02342886|587541270|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162681318|NCT02342886|587541266|FG000|Overall Study|Protocol Violation|0|||
162681319|NCT02342886|587541267|FG001|Overall Study|Protocol Violation|0|||
162681320|NCT02342886|587541268|FG002|Overall Study|Protocol Violation|0|||
162681321|NCT02342886|587541269|FG003|Overall Study|Protocol Violation|2|||
162681322|NCT02342886|587541270|FG004|Overall Study|Protocol Violation|0|||
162681323|NCT00862134|587541271|FG000|Overall Study|Death|1|||
162681324|NCT00862134|587541272|FG001|Overall Study|Death|0|||
162681325|NCT00862134|587541271|FG000|Overall Study|Physician Decision|0|||
162681326|NCT00862134|587541272|FG001|Overall Study|Physician Decision|1|||
162681327|NCT00862134|587541271|FG000|Overall Study|Withdrawal by Subject|1|||
162681328|NCT00862134|587541272|FG001|Overall Study|Withdrawal by Subject|2|||
162681329|NCT00862134|587541271|FG000|Overall Study|Sponsor terminated study|5|||
162681330|NCT00862134|587541272|FG001|Overall Study|Sponsor terminated study|7|||
162681331|NCT00862134|587541271|FG000|Overall Study|Adverse Event|2|||
162681332|NCT00862134|587541272|FG001|Overall Study|Adverse Event|2|||
162681333|NCT00862134|587541271|FG000|Overall Study|Withdrew prior to dosing|2|||
162681334|NCT00862134|587541272|FG001|Overall Study|Withdrew prior to dosing|0|||
162681335|NCT00765674|587541273|FG000|Overall Study|Adverse Event|7|||
162681336|NCT00765674|587541274|FG001|Overall Study|Adverse Event|2|||
162681337|NCT00765674|587541275|FG002|Overall Study|Adverse Event|8|||
162681338|NCT00765674|587541276|FG003|Overall Study|Adverse Event|11|||
162681339|NCT00765674|587541273|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162681340|NCT00765674|587541274|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
162681341|NCT00765674|587541275|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
162681342|NCT00765674|587541276|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
162681343|NCT00765674|587541273|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
162681344|NCT00765674|587541274|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
162681345|NCT00765674|587541275|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
162681346|NCT00765674|587541276|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
162681347|NCT00765674|587541273|FG000|Overall Study|Lack of Efficacy|2|||
162681348|NCT00765674|587541274|FG001|Overall Study|Lack of Efficacy|3|||
162681349|NCT00765674|587541275|FG002|Overall Study|Lack of Efficacy|1|||
162681350|NCT00765674|587541276|FG003|Overall Study|Lack of Efficacy|2|||
162681351|NCT00765674|587541273|FG000|Overall Study|Protocol Violation|2|||
162681352|NCT00765674|587541274|FG001|Overall Study|Protocol Violation|0|||
162681353|NCT00765674|587541275|FG002|Overall Study|Protocol Violation|1|||
162681354|NCT00765674|587541276|FG003|Overall Study|Protocol Violation|0|||
162681355|NCT00765674|587541273|FG000|Overall Study|Withdrawal by Subject|5|||
162681356|NCT00765674|587541274|FG001|Overall Study|Withdrawal by Subject|7|||
162681357|NCT00765674|587541275|FG002|Overall Study|Withdrawal by Subject|3|||
162681358|NCT00765674|587541276|FG003|Overall Study|Withdrawal by Subject|8|||
162681359|NCT00765674|587541273|FG000|Overall Study|Lost to Follow-up|4|||
162681360|NCT00765674|587541274|FG001|Overall Study|Lost to Follow-up|6|||
162681361|NCT00765674|587541275|FG002|Overall Study|Lost to Follow-up|2|||
162681362|NCT00765674|587541276|FG003|Overall Study|Lost to Follow-up|1|||
162681363|NCT00765674|587541273|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
162681364|NCT00765674|587541274|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
162681365|NCT00765674|587541275|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
162681366|NCT00765674|587541276|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
162681367|NCT03015402|587541277|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162681368|NCT03015402|587541278|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
162681369|NCT03015402|587541277|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162681370|NCT03015402|587541278|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
162681371|NCT01813474|587541279|FG000|Overall Study|Withdrawal by Subject|0|||
162681372|NCT01813474|587541280|FG001|Overall Study|Withdrawal by Subject|0|||
162681373|NCT01813474|587541281|FG002|Overall Study|Withdrawal by Subject|1|||
162681374|NCT01813474|587541279|FG000|Overall Study|Adverse Event|1|||
162681375|NCT01813474|587541280|FG001|Overall Study|Adverse Event|1|||
162681376|NCT01813474|587541281|FG002|Overall Study|Adverse Event|0|||
162681377|NCT01813474|587541279|FG000|Overall Study|Lack of Efficacy|2|||
162681378|NCT01813474|587541280|FG001|Overall Study|Lack of Efficacy|6|||
162681379|NCT01813474|587541281|FG002|Overall Study|Lack of Efficacy|9|||
162681380|NCT01813474|587541279|FG000|Overall Study|Death|0|||
162681381|NCT01813474|587541280|FG001|Overall Study|Death|0|||
162681382|NCT01813474|587541281|FG002|Overall Study|Death|1|||
162681383|NCT00316082|587541287|FG000|Overall Study|Lack of Efficacy|2|||
162681384|NCT00316082|587541288|FG001|Overall Study|Lack of Efficacy|3|||
162681385|NCT00316082|587541289|FG002|Overall Study|Lack of Efficacy|3|||
162681386|NCT00316082|587541290|FG003|Overall Study|Lack of Efficacy|4|||
162681387|NCT00316082|587541291|FG004|Overall Study|Lack of Efficacy|6|||
162681388|NCT00316082|587541287|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
162681389|NCT00316082|587541288|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
162681390|NCT00316082|587541289|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
162681391|NCT00316082|587541290|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
162681392|NCT00316082|587541291|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
162681393|NCT00316082|587541287|FG000|Overall Study|Lost to Follow-up|7|||
162725279|NCT01787760|587703099|FG001|Overall Study|Unsatisfactory physiological response|4|||
162681394|NCT00316082|587541288|FG001|Overall Study|Lost to Follow-up|6|||
162681395|NCT00316082|587541289|FG002|Overall Study|Lost to Follow-up|7|||
162681396|NCT00316082|587541290|FG003|Overall Study|Lost to Follow-up|8|||
162681397|NCT00316082|587541291|FG004|Overall Study|Lost to Follow-up|6|||
162681398|NCT00316082|587541287|FG000|Overall Study|Poor/noncompliance|6|||
162681399|NCT00316082|587541288|FG001|Overall Study|Poor/noncompliance|1|||
162681400|NCT00316082|587541289|FG002|Overall Study|Poor/noncompliance|4|||
162681401|NCT00316082|587541290|FG003|Overall Study|Poor/noncompliance|1|||
162681402|NCT00316082|587541291|FG004|Overall Study|Poor/noncompliance|4|||
162681403|NCT00316082|587541287|FG000|Overall Study|Adverse Event|4|||
162681404|NCT00316082|587541288|FG001|Overall Study|Adverse Event|2|||
162681405|NCT00316082|587541289|FG002|Overall Study|Adverse Event|5|||
162681406|NCT00316082|587541290|FG003|Overall Study|Adverse Event|1|||
162681407|NCT00316082|587541291|FG004|Overall Study|Adverse Event|3|||
162681408|NCT00316082|587541287|FG000|Overall Study|Subject no longer meets study criteria|3|||
162681409|NCT00316082|587541288|FG001|Overall Study|Subject no longer meets study criteria|1|||
162681410|NCT00316082|587541289|FG002|Overall Study|Subject no longer meets study criteria|2|||
162681411|NCT00316082|587541290|FG003|Overall Study|Subject no longer meets study criteria|2|||
162681412|NCT00316082|587541291|FG004|Overall Study|Subject no longer meets study criteria|1|||
162681413|NCT00316082|587541287|FG000|Overall Study|Physician Decision|1|||
162681414|NCT00316082|587541288|FG001|Overall Study|Physician Decision|1|||
162681415|NCT00316082|587541289|FG002|Overall Study|Physician Decision|2|||
162681416|NCT00316082|587541290|FG003|Overall Study|Physician Decision|1|||
162681417|NCT00316082|587541291|FG004|Overall Study|Physician Decision|1|||
162681418|NCT00316082|587541287|FG000|Overall Study|Death|0|||
162681419|NCT00316082|587541288|FG001|Overall Study|Death|0|||
162681420|NCT00316082|587541289|FG002|Overall Study|Death|1|||
162681421|NCT00316082|587541290|FG003|Overall Study|Death|0|||
162681422|NCT00316082|587541291|FG004|Overall Study|Death|0|||
162681423|NCT00316082|587541287|FG000|Overall Study|Administrative reason by sponsor|0|||
162681424|NCT00316082|587541288|FG001|Overall Study|Administrative reason by sponsor|0|||
162681425|NCT00316082|587541289|FG002|Overall Study|Administrative reason by sponsor|1|||
162681426|NCT00316082|587541290|FG003|Overall Study|Administrative reason by sponsor|0|||
162681427|NCT00316082|587541291|FG004|Overall Study|Administrative reason by sponsor|0|||
162681428|NCT02216773|587541292|FG000|Overall Study|Disease progression|4|||
162681429|NCT02216773|587541293|FG001|Overall Study|Disease progression|2|||
162681430|NCT02216773|587541292|FG000|Overall Study|Insufficient FLRV|4|||
162681431|NCT02216773|587541293|FG001|Overall Study|Insufficient FLRV|0|||
162681432|NCT02216773|587541292|FG000|Overall Study|Abandoned|4|||
162681433|NCT02216773|587541293|FG001|Overall Study|Abandoned|3|||
162681434|NCT00528775|587541294|FG000|Overall Study|Other not specified|1|||
162681435|NCT00941330|587541310|FG000|Overall Study|Other|1|||
162681436|NCT00941330|587541311|FG001|Overall Study|Other|0|||
162681437|NCT00941330|587541310|FG000|Overall Study|Physician Decision|0|||
162681438|NCT00941330|587541311|FG001|Overall Study|Physician Decision|2|||
162681439|NCT00541450|587541312|FG000|Phase A|Adverse Event|3|||
162681440|NCT00541450|587541313|FG001|Phase A|Adverse Event|0|||
162681441|NCT00541450|587541312|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
162681442|NCT00541450|587541313|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
162725280|NCT01787760|587703100|FG002|Overall Study|Unsatisfactory physiological response|0|||
162725281|NCT01787760|587703098|FG000|Overall Study|Unsatisfactory visual response|1|||
162725282|NCT01787760|587703099|FG001|Overall Study|Unsatisfactory visual response|1|||
162725283|NCT01787760|587703100|FG002|Overall Study|Unsatisfactory visual response|0|||
162725284|NCT01787760|587703098|FG000|Overall Study|Near vision blur|1|||
162725285|NCT01787760|587703099|FG001|Overall Study|Near vision blur|0|||
162725286|NCT01787760|587703100|FG002|Overall Study|Near vision blur|0|||
162725287|NCT01353963|587703101|FG000|Overall Study|Adverse Event|2|||
162725288|NCT03473340|587703102|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
162725289|NCT03473340|587703103|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
162725290|NCT03473340|587703102|FG000|Overall Study|Withdrawal by Subject|1|||
162681443|NCT00541450|587541312|FG000|Phase A|Hyperglycemia|0|||
162681444|NCT00541450|587541313|FG001|Phase A|Hyperglycemia|1|||
162725291|NCT03473340|587703103|FG001|Overall Study|Withdrawal by Subject|0|||
162725292|NCT03473340|587703102|FG000|Overall Study|Lost to Follow-up|1|||
162725293|NCT03473340|587703103|FG001|Overall Study|Lost to Follow-up|2|||
162725294|NCT02079844|587703104|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
162725295|NCT02079844|587703105|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
162725296|NCT02079844|587703106|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
162725297|NCT02079844|587703104|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
162681445|NCT00541450|587541312|FG000|Phase A|Lost to Follow-up|6|||
162681446|NCT00541450|587541313|FG001|Phase A|Lost to Follow-up|4|||
162725298|NCT02079844|587703105|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
162681447|NCT00541450|587541312|FG000|Phase A|Physician Decision|2|||
162681448|NCT00541450|587541313|FG001|Phase A|Physician Decision|0|||
162681449|NCT00541450|587541312|FG000|Phase A|Protocol Violation|2|||
162681450|NCT00541450|587541313|FG001|Phase A|Protocol Violation|3|||
162681451|NCT00541450|587541312|FG000|Phase A|Withdrawal by Subject|7|||
162681452|NCT00541450|587541313|FG001|Phase A|Withdrawal by Subject|7|||
162681453|NCT00541450|587541312|FG000|Phase B|Adverse Event|6|||
162681454|NCT00541450|587541313|FG001|Phase B|Adverse Event|6|||
162681455|NCT00541450|587541312|FG000|Phase B|Hyperglycemia|10|||
162681456|NCT00541450|587541313|FG001|Phase B|Hyperglycemia|9|||
162681457|NCT00541450|587541312|FG000|Phase B|Lost to Follow-up|6|||
162681458|NCT00541450|587541313|FG001|Phase B|Lost to Follow-up|4|||
162681459|NCT00541450|587541312|FG000|Phase B|Physician Decision|4|||
162681460|NCT00541450|587541313|FG001|Phase B|Physician Decision|2|||
162681461|NCT00541450|587541312|FG000|Phase B|Pregnancy|0|||
162681462|NCT00541450|587541313|FG001|Phase B|Pregnancy|1|||
162681463|NCT00541450|587541312|FG000|Phase B|Protocol Violation|3|||
162681464|NCT00541450|587541313|FG001|Phase B|Protocol Violation|3|||
162681465|NCT00541450|587541312|FG000|Phase B|Withdrawal by Subject|8|||
162681466|NCT00541450|587541313|FG001|Phase B|Withdrawal by Subject|6|||
162681467|NCT00981084|587541314|FG000|Post Intervention (Data Analysis)|poor effort|1|||
162681468|NCT00981084|587541315|FG001|Post Intervention (Data Analysis)|poor effort|1|||
162681469|NCT00981084|587541314|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
162681470|NCT00981084|587541315|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
162681471|NCT01112579|587541316|FG000|Overall Study|Missed Visit|1|||
162681472|NCT01112579|587541317|FG001|Overall Study|Missed Visit|1|||
162681473|NCT01112579|587541316|FG000|Overall Study|Death|0|||
162681474|NCT01112579|587541317|FG001|Overall Study|Death|2|||
162681475|NCT01648270|587541318|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
162681476|NCT01389973|587541319|FG000|Overall Study|Lost to Follow-up|1|||
162681477|NCT01389973|587541319|FG000|Overall Study|Trial Stopped by Sponsor|9|||
162681478|NCT01389973|587541319|FG000|Overall Study|Other|10|||
162681479|NCT00725296|587541320|FG000|Overall Study|Adverse Event|11|||
162681480|NCT00725296|587541320|FG000|Overall Study|Lack of Efficacy|7|||
162681481|NCT00725296|587541320|FG000|Overall Study|Withdrawal by Subject|3|||
162681482|NCT00725296|587541320|FG000|Overall Study|Non-Compliance|2|||
162681483|NCT00725296|587541320|FG000|Overall Study|Lost to Follow-up|1|||
162681484|NCT00725296|587541320|FG000|Overall Study|Other|38|||
162681485|NCT03360942|587541321|FG000|Overall Study|Device explanted|2|||
162681486|NCT03360942|587541321|FG000|Overall Study|Study closure|1|||
162681487|NCT03360942|587541321|FG000|Overall Study|Withdrawal by Subject|2|||
162681488|NCT03456700|587541322|FG000|Overall Study|Withdrawal by Subject|1|||
162681489|NCT00613951|587541323|FG000|Overall Study|Adverse Event|1|||
162681490|NCT00613951|587541324|FG001|Overall Study|Adverse Event|0|||
162681491|NCT00613951|587541325|FG002|Overall Study|Adverse Event|1|||
162681492|NCT00613951|587541323|FG000|Overall Study|Lack of Efficacy|0|||
162681493|NCT00613951|587541324|FG001|Overall Study|Lack of Efficacy|1|||
162681494|NCT00613951|587541325|FG002|Overall Study|Lack of Efficacy|1|||
162681495|NCT00613951|587541323|FG000|Overall Study|Protocol Violation|1|||
162681496|NCT00613951|587541324|FG001|Overall Study|Protocol Violation|1|||
162681497|NCT00613951|587541325|FG002|Overall Study|Protocol Violation|1|||
162681498|NCT00613951|587541323|FG000|Overall Study|Unclassified|5|||
162681499|NCT00613951|587541324|FG001|Overall Study|Unclassified|3|||
162681500|NCT00613951|587541325|FG002|Overall Study|Unclassified|2|||
162681501|NCT03053050|587541326|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
162681502|NCT03053050|587541327|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
162681503|NCT03053050|587541328|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
162681504|NCT03053050|587541329|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
162681505|NCT03053050|587541326|FG000|Randomized Phase|Withdrew Consent|16|||
162681506|NCT03053050|587541327|FG001|Randomized Phase|Withdrew Consent|8|||
162681507|NCT03053050|587541328|FG002|Randomized Phase|Withdrew Consent|9|||
162681508|NCT03053050|587541329|FG003|Randomized Phase|Withdrew Consent|0|||
162681509|NCT03053050|587541326|FG000|Randomized Phase|Investigator's Discretion|6|||
162681510|NCT03053050|587541327|FG001|Randomized Phase|Investigator's Discretion|6|||
162681511|NCT03053050|587541328|FG002|Randomized Phase|Investigator's Discretion|3|||
162681512|NCT03053050|587541329|FG003|Randomized Phase|Investigator's Discretion|0|||
162681513|NCT03053050|587541326|FG000|Randomized Phase|Lost to Follow-up|5|||
162681514|NCT03053050|587541327|FG001|Randomized Phase|Lost to Follow-up|1|||
162681515|NCT03053050|587541328|FG002|Randomized Phase|Lost to Follow-up|1|||
162681516|NCT03053050|587541329|FG003|Randomized Phase|Lost to Follow-up|0|||
162681517|NCT03053050|587541326|FG000|Randomized Phase|Adverse Event|0|||
162681518|NCT03053050|587541327|FG001|Randomized Phase|Adverse Event|1|||
162681519|NCT03053050|587541328|FG002|Randomized Phase|Adverse Event|0|||
162681520|NCT03053050|587541329|FG003|Randomized Phase|Adverse Event|0|||
162681521|NCT03053050|587541326|FG000|Randomized Phase|Randomized but Never Treated|2|||
162681522|NCT03053050|587541327|FG001|Randomized Phase|Randomized but Never Treated|2|||
162681523|NCT03053050|587541328|FG002|Randomized Phase|Randomized but Never Treated|2|||
162681524|NCT03053050|587541329|FG003|Randomized Phase|Randomized but Never Treated|0|||
162681525|NCT03053050|587541326|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
162681526|NCT03053050|587541327|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
162681527|NCT03053050|587541328|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
162681528|NCT03053050|587541329|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
162681529|NCT03053050|587541326|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
162725299|NCT02079844|587703106|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
162725300|NCT01420549|587703107|FG000|Overall Study|Adverse Event|1|||
162725301|NCT01420549|587703108|FG001|Overall Study|Adverse Event|1|||
162725302|NCT01420549|587703107|FG000|Overall Study|Lost to Follow-up|2|||
162725303|NCT01420549|587703108|FG001|Overall Study|Lost to Follow-up|2|||
162725304|NCT01420549|587703107|FG000|Overall Study|Protocol Violation|0|||
162725305|NCT01420549|587703108|FG001|Overall Study|Protocol Violation|1|||
162725306|NCT01420549|587703107|FG000|Overall Study|Non-adherence to medication|4|||
162725307|NCT01420549|587703108|FG001|Overall Study|Non-adherence to medication|1|||
162725308|NCT03394885|587703109|FG000|Overall Study|Adverse Event|4|||
162681530|NCT03053050|587541327|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
162681531|NCT03053050|587541328|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
162681532|NCT03053050|587541329|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
162681533|NCT03053050|587541326|FG000|Open-label Phase|Withdrew Consent|0|||
162681534|NCT03053050|587541327|FG001|Open-label Phase|Withdrew Consent|0|||
162681535|NCT03053050|587541328|FG002|Open-label Phase|Withdrew Consent|0|||
162681536|NCT03053050|587541329|FG003|Open-label Phase|Withdrew Consent|6|||
162681537|NCT03053050|587541326|FG000|Open-label Phase|Investigator's Discretion|0|||
162725309|NCT03394885|587703109|FG000|Overall Study|Lack of Efficacy|1|||
162725310|NCT03394885|587703109|FG000|Overall Study|Physician Decision|1|||
162725311|NCT03394885|587703109|FG000|Overall Study|Withdrawal by Subject|8|||
162725312|NCT03394885|587703109|FG000|Overall Study|Alternative Therapy|1|||
162725313|NCT00203411|587703110|FG000|Follow-up|Progressive Disease|4|||
162725314|NCT04980755|587703111|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
162725315|NCT04980755|587703111|FG000|Body Reprogramming Courses|Work commitment|2|||
162725316|NCT04980755|587703111|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
162725317|NCT04980755|587703111|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
162725318|NCT00632424|587703118|FG000|Overall Study|Disease Progression|17|||
162725319|NCT00632424|587703118|FG000|Overall Study|Study Drug Toxicity|1|||
162725320|NCT02531113|587703119|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
162725321|NCT02531113|587703119|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
162725322|NCT02531113|587703119|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
162725323|NCT02531113|587703119|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
162725324|NCT02531113|587703119|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
162725325|NCT02531113|587703119|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
162725326|NCT02531113|587703119|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
162725327|NCT02531113|587703119|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
162725328|NCT00801983|587703120|FG000|Period 1|Lost to Follow-up|2|||
162725329|NCT00801983|587703121|FG001|Period 1|Lost to Follow-up|0|||
162725330|NCT00801983|587703120|FG000|Period 1|Withdrawal by Subject|2|||
162725331|NCT00801983|587703121|FG001|Period 1|Withdrawal by Subject|8|||
162725332|NCT00801983|587703120|FG000|Period 2|Withdrawal by Subject|2|||
162681538|NCT03053050|587541327|FG001|Open-label Phase|Investigator's Discretion|0|||
162681539|NCT03053050|587541328|FG002|Open-label Phase|Investigator's Discretion|0|||
162681540|NCT03053050|587541329|FG003|Open-label Phase|Investigator's Discretion|4|||
162681541|NCT00655980|587541330|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
162681542|NCT00655980|587541331|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
162681543|NCT00655980|587541332|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
162681544|NCT00251745|587541338|FG000|Overall Study|Adverse Event|7|||
162681545|NCT00251745|587541339|FG001|Overall Study|Adverse Event|9|||
162681546|NCT00251745|587541340|FG002|Overall Study|Adverse Event|11|||
162681547|NCT00251745|587541338|FG000|Overall Study|Lost to Follow-up|4|||
162681548|NCT00251745|587541339|FG001|Overall Study|Lost to Follow-up|2|||
162681549|NCT00251745|587541340|FG002|Overall Study|Lost to Follow-up|5|||
162681550|NCT00251745|587541338|FG000|Overall Study|Withdrawal by Subject|13|||
162681551|NCT00251745|587541339|FG001|Overall Study|Withdrawal by Subject|7|||
162681552|NCT00251745|587541340|FG002|Overall Study|Withdrawal by Subject|3|||
162681553|NCT00251745|587541338|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
162681554|NCT00251745|587541339|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
162681555|NCT00251745|587541340|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
162681556|NCT00251745|587541338|FG000|Overall Study|Lack of Efficacy|3|||
162681557|NCT00251745|587541339|FG001|Overall Study|Lack of Efficacy|0|||
162681558|NCT00251745|587541340|FG002|Overall Study|Lack of Efficacy|0|||
162681559|NCT00251745|587541338|FG000|Overall Study|Noncompliant|0|||
162681560|NCT00251745|587541339|FG001|Overall Study|Noncompliant|2|||
162681561|NCT00251745|587541340|FG002|Overall Study|Noncompliant|2|||
162681562|NCT00251745|587541338|FG000|Overall Study|Pregnancy|0|||
162681563|NCT00251745|587541339|FG001|Overall Study|Pregnancy|1|||
162681564|NCT00251745|587541340|FG002|Overall Study|Pregnancy|0|||
162681565|NCT00251745|587541338|FG000|Overall Study|Per Subject Request|0|||
162725333|NCT00801983|587703121|FG001|Period 2|Withdrawal by Subject|1|||
162725334|NCT04714320|587704550|FG000|Overall Study|Voluntary Withdrawal|4|||
162725335|NCT04714320|587704551|FG001|Overall Study|Voluntary Withdrawal|1|||
162725336|NCT04714320|587704552|FG002|Overall Study|Voluntary Withdrawal|2|||
162725337|NCT04714320|587704550|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
162681566|NCT00251745|587541339|FG001|Overall Study|Per Subject Request|0|||
162681567|NCT00251745|587541340|FG002|Overall Study|Per Subject Request|1|||
162681568|NCT00251745|587541338|FG000|Overall Study|Per Investigator Request|1|||
162681569|NCT00251745|587541339|FG001|Overall Study|Per Investigator Request|0|||
162681570|NCT00251745|587541340|FG002|Overall Study|Per Investigator Request|0|||
162681571|NCT04508699|587541345|FG000|Overall Study|Lack of Efficacy|2|||
162681572|NCT04508699|587541346|FG001|Overall Study|Lack of Efficacy|15|||
162681573|NCT04508699|587541345|FG000|Overall Study|Withdrawal by Subject|0|||
162681574|NCT04508699|587541346|FG001|Overall Study|Withdrawal by Subject|2|||
162681575|NCT01553318|587542596|FG000|Overall Study|Protocol Violation|3|||
162681576|NCT01553318|587542597|FG001|Overall Study|Protocol Violation|2|||
162681577|NCT02293395|587542598|FG000|Overall Study|Lost to Follow-up|1|||
162681578|NCT02293395|587542599|FG001|Overall Study|Lost to Follow-up|0|||
162681579|NCT02293395|587542598|FG000|Overall Study|Withdrawal by Subject|8|||
162681580|NCT02293395|587542599|FG001|Overall Study|Withdrawal by Subject|7|||
162681581|NCT01464021|587542600|FG000|Overall Study|Withdrawal by Subject|13|||
162681582|NCT01464021|587542600|FG000|Overall Study|Lost to Follow-up|1|||
162681583|NCT01464021|587542600|FG000|Overall Study|Lack of Efficacy|1|||
162681584|NCT01464021|587542600|FG000|Overall Study|various|11|||
162681585|NCT01106430|587542606|FG000|Overall Study|Adverse Event|8|||
162681586|NCT01106430|587542607|FG001|Overall Study|Adverse Event|10|||
162681587|NCT01106430|587542606|FG000|Overall Study|Lack of Efficacy|2|||
162681588|NCT01106430|587542607|FG001|Overall Study|Lack of Efficacy|13|||
162681589|NCT01106430|587542606|FG000|Overall Study|Lost to Follow-up|5|||
162681590|NCT01106430|587542607|FG001|Overall Study|Lost to Follow-up|1|||
162681591|NCT01106430|587542606|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
162681592|NCT01106430|587542607|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
162681593|NCT01106430|587542606|FG000|Overall Study|Moved Out Of State|0|||
162681594|NCT01106430|587542607|FG001|Overall Study|Moved Out Of State|1|||
162681595|NCT01106430|587542606|FG000|Overall Study|Refused To Take Medication|0|||
162681596|NCT01106430|587542607|FG001|Overall Study|Refused To Take Medication|1|||
162681597|NCT01106430|587542606|FG000|Overall Study|Noncompliance|0|||
162681598|NCT01106430|587542607|FG001|Overall Study|Noncompliance|1|||
162681599|NCT01106430|587542606|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
162681600|NCT01106430|587542607|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
162681601|NCT01106430|587542606|FG000|Overall Study|Previous Use Of Marijuana|1|||
162681602|NCT01106430|587542607|FG001|Overall Study|Previous Use Of Marijuana|0|||
162681603|NCT01106430|587542606|FG000|Overall Study|Protocol Violation|7|||
162681604|NCT01106430|587542607|FG001|Overall Study|Protocol Violation|2|||
162681605|NCT01106430|587542606|FG000|Overall Study|Withdrawal by Subject|8|||
162681606|NCT01106430|587542607|FG001|Overall Study|Withdrawal by Subject|4|||
162681607|NCT00175825|587542610|FG000|Overall Study|Adverse Event|3|||
162681608|NCT00175825|587542611|FG001|Overall Study|Adverse Event|2|||
162681609|NCT00175825|587542612|FG002|Overall Study|Adverse Event|1|||
162681610|NCT00175825|587542613|FG003|Overall Study|Adverse Event|1|||
162681611|NCT00175825|587542610|FG000|Overall Study|Lost to Follow-up|1|||
162681612|NCT00175825|587542611|FG001|Overall Study|Lost to Follow-up|2|||
162681613|NCT00175825|587542612|FG002|Overall Study|Lost to Follow-up|0|||
162681614|NCT00175825|587542613|FG003|Overall Study|Lost to Follow-up|0|||
162681615|NCT00175825|587542610|FG000|Overall Study|Withdrawal by Subject|1|||
162681616|NCT00175825|587542611|FG001|Overall Study|Withdrawal by Subject|0|||
162681617|NCT00175825|587542612|FG002|Overall Study|Withdrawal by Subject|0|||
162681618|NCT00175825|587542613|FG003|Overall Study|Withdrawal by Subject|0|||
162681619|NCT03704584|587542614|FG000|Overall Study|Withdrawal by Subject|1|||
162681620|NCT03704584|587542615|FG001|Overall Study|Withdrawal by Subject|0|||
162681621|NCT03412812|587542616|FG000|Level 1|Death|3|||
162681622|NCT03412812|587542617|FG001|Level 1|Death|0|||
162681623|NCT03412812|587542616|FG000|Level 1|Adverse Event|0|||
162681624|NCT03412812|587542617|FG001|Level 1|Adverse Event|1|||
162681625|NCT02127372|587542618|FG000|Overall Study|Withdrawal by Subject|1|||
162681626|NCT02127372|587542619|FG001|Overall Study|Withdrawal by Subject|0|||
162681627|NCT03548207|587542622|FG000|Overall Study|Death|10|||
162681628|NCT03548207|587542623|FG001|Overall Study|Death|23|||
162681629|NCT03548207|587542624|FG002|Overall Study|Death|3|||
162681630|NCT03548207|587542622|FG000|Overall Study|Lost to Follow-up|0|||
162681631|NCT03548207|587542623|FG001|Overall Study|Lost to Follow-up|2|||
162681632|NCT03548207|587542624|FG002|Overall Study|Lost to Follow-up|0|||
162681633|NCT03548207|587542622|FG000|Overall Study|Withdrawal by Subject|0|||
162681634|NCT03548207|587542623|FG001|Overall Study|Withdrawal by Subject|3|||
162681635|NCT03548207|587542624|FG002|Overall Study|Withdrawal by Subject|0|||
162681636|NCT03548207|587542622|FG000|Overall Study|Sponsor decision|19|||
162681637|NCT03548207|587542623|FG001|Overall Study|Sponsor decision|40|||
162681638|NCT03548207|587542624|FG002|Overall Study|Sponsor decision|6|||
162681639|NCT03548207|587542622|FG000|Overall Study|Randomized but not treated|6|||
162681640|NCT03548207|587542623|FG001|Overall Study|Randomized but not treated|10|||
162681641|NCT03548207|587542624|FG002|Overall Study|Randomized but not treated|4|||
162681642|NCT01756352|587542625|FG000|Overall Study|moved away and lost to followup|1|||
162681643|NCT02641392|587542628|FG000|Overall Study|Lost to Follow-up|0|||
162681644|NCT02641392|587542629|FG001|Overall Study|Lost to Follow-up|0|||
162725338|NCT04714320|587704551|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
162725339|NCT04714320|587704552|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
162681645|NCT02641392|587542630|FG002|Overall Study|Lost to Follow-up|2|||
162681646|NCT02641392|587542628|FG000|Overall Study|Withdrawal by Subject|0|||
162681647|NCT02641392|587542629|FG001|Overall Study|Withdrawal by Subject|0|||
162681648|NCT02641392|587542630|FG002|Overall Study|Withdrawal by Subject|17|||
162681649|NCT02641392|587542628|FG000|Overall Study|Adverse Event|0|||
162681650|NCT02641392|587542629|FG001|Overall Study|Adverse Event|1|||
162681651|NCT02641392|587542630|FG002|Overall Study|Adverse Event|25|||
162725340|NCT04714320|587704550|FG000|Overall Study|Reason Not Specified|1|||
162725341|NCT04714320|587704551|FG001|Overall Study|Reason Not Specified|3|||
162725342|NCT04714320|587704552|FG002|Overall Study|Reason Not Specified|3|||
162725343|NCT04755660|587704557|FG000|Overall Study|Lost to Follow-up|1|||
162725344|NCT04755660|587704558|FG001|Overall Study|Lost to Follow-up|1|||
162725345|NCT04755660|587704559|FG002|Overall Study|Lost to Follow-up|0|||
162725346|NCT04755660|587704557|FG000|Overall Study|Withdrawal by Subject|0|||
162725347|NCT04755660|587704558|FG001|Overall Study|Withdrawal by Subject|1|||
162725348|NCT04755660|587704559|FG002|Overall Study|Withdrawal by Subject|1|||
162725349|NCT04755660|587704557|FG000|Overall Study|Physician Decision|0|||
162725350|NCT04755660|587704558|FG001|Overall Study|Physician Decision|0|||
162725351|NCT04755660|587704559|FG002|Overall Study|Physician Decision|1|||
162725352|NCT05672667|587704561|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
162681652|NCT02641392|587542628|FG000|Overall Study|Study Terminated by Sponsor|4|||
162681653|NCT02641392|587542629|FG001|Overall Study|Study Terminated by Sponsor|12|||
162681654|NCT02641392|587542630|FG002|Overall Study|Study Terminated by Sponsor|144|||
162681655|NCT02641392|587542628|FG000|Overall Study|Lack of Efficacy|0|||
162681656|NCT02641392|587542629|FG001|Overall Study|Lack of Efficacy|0|||
162681657|NCT02641392|587542630|FG002|Overall Study|Lack of Efficacy|101|||
162681658|NCT02641392|587542628|FG000|Overall Study|Miscellaneous|0|||
162725353|NCT04524390|587704562|FG000|Double Blind|Consent Withdrawal by subject|2|||
162725354|NCT04524390|587704563|FG001|Double Blind|Consent Withdrawal by subject|1|||
162725355|NCT04524390|587704564|FG002|Double Blind|Consent Withdrawal by subject|0|||
162725356|NCT04524390|587704562|FG000|Double Blind|Adverse Event|5|||
162725357|NCT04524390|587704563|FG001|Double Blind|Adverse Event|3|||
162725358|NCT04524390|587704564|FG002|Double Blind|Adverse Event|0|||
162725359|NCT04524390|587704562|FG000|Double Blind|Liver Transplant|5|||
162725360|NCT04524390|587704563|FG001|Double Blind|Liver Transplant|6|||
162725361|NCT04524390|587704564|FG002|Double Blind|Liver Transplant|0|||
162725362|NCT04524390|587704562|FG000|Double Blind|Disease Progression|0|||
162725363|NCT04524390|587704563|FG001|Double Blind|Disease Progression|1|||
162725364|NCT04524390|587704564|FG002|Double Blind|Disease Progression|0|||
162725365|NCT04524390|587704562|FG000|Open-Label|Drug interruption criteria|0|||
162725366|NCT04524390|587704563|FG001|Open-Label|Drug interruption criteria|0|||
162725367|NCT04524390|587704564|FG002|Open-Label|Drug interruption criteria|1|||
162725368|NCT04524390|587704562|FG000|Open-Label|Liver Transplant|0|||
162725369|NCT04524390|587704563|FG001|Open-Label|Liver Transplant|0|||
162725370|NCT04524390|587704564|FG002|Open-Label|Liver Transplant|1|||
162725371|NCT04524390|587704562|FG000|Open-Label|Disease Progression|0|||
162725372|NCT04524390|587704563|FG001|Open-Label|Disease Progression|0|||
162725373|NCT04524390|587704564|FG002|Open-Label|Disease Progression|1|||
162725374|NCT04524390|587704562|FG000|Open-Label|Adverse Event|0|||
162725375|NCT04524390|587704563|FG001|Open-Label|Adverse Event|0|||
162725376|NCT04524390|587704564|FG002|Open-Label|Adverse Event|3|||
162725377|NCT04524390|587704562|FG000|Open-Label|Study Termination by sponsor|0|||
162725378|NCT04524390|587704563|FG001|Open-Label|Study Termination by sponsor|0|||
162725379|NCT04524390|587704564|FG002|Open-Label|Study Termination by sponsor|45|||
162725380|NCT03873779|587704565|FG000|Overall Study|Withdrawal by Subject|1|||
162725381|NCT02581215|587704566|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
162681659|NCT02641392|587542629|FG001|Overall Study|Miscellaneous|0|||
162725382|NCT02581215|587704567|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
162725383|NCT02581215|587704566|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162725384|NCT02581215|587704567|FG001|Overall Study|Eligibility Criteria Not Met|1|||
162725385|NCT04279574|587704570|FG000|Overall Study|Death|1|||
162725386|NCT04279574|587704571|FG001|Overall Study|Death|0|||
162725387|NCT04279574|587704570|FG000|Overall Study|lost restoration, tooth fracture|1|||
162725388|NCT04279574|587704571|FG001|Overall Study|lost restoration, tooth fracture|0|||
162681660|NCT02641392|587542630|FG002|Overall Study|Miscellaneous|3|||
162681661|NCT02641392|587542628|FG000|Overall Study|Death|0|||
162681662|NCT02641392|587542629|FG001|Overall Study|Death|0|||
162725389|NCT04279574|587704570|FG000|Overall Study|Lost to Follow-up|0|||
162725390|NCT04279574|587704571|FG001|Overall Study|Lost to Follow-up|1|||
162725391|NCT04153565|587704573|FG000|Overall Study|Death|13|||
162681663|NCT02641392|587542630|FG002|Overall Study|Death|1|||
162725392|NCT00858117|587704579|FG000|Treatment on Study|Adverse Event|2|||
162725393|NCT00858117|587704579|FG000|Follow up for 5 Years|Death|4|||
162725394|NCT00858117|587704579|FG000|Follow up for 5 Years|No further data collected for study|9|||
162725395|NCT00371787|587704580|FG000|Overall Study|Withdrawal by Subject|3|||
162681664|NCT03466086|587542631|FG000|Period 1|Sponsor decision due to study timeline|1|||
162681665|NCT03466086|587542632|FG001|Period 1|Sponsor decision due to study timeline|0|||
162681666|NCT03466086|587542631|FG000|Period 1|Withdrawal by Subject|1|||
162681667|NCT03466086|587542632|FG001|Period 1|Withdrawal by Subject|0|||
162681668|NCT01113502|587542633|FG000|Overall Study|Withdrawal by Subject|1|||
162681669|NCT01113502|587542634|FG001|Overall Study|Withdrawal by Subject|0|||
162681670|NCT01113502|587542635|FG002|Overall Study|Withdrawal by Subject|1|||
162681671|NCT01113502|587542636|FG003|Overall Study|Withdrawal by Subject|1|||
162681672|NCT01113502|587542637|FG004|Overall Study|Withdrawal by Subject|0|||
162681673|NCT01113502|587542633|FG000|Overall Study|Adverse Event|0|||
162681674|NCT01113502|587542634|FG001|Overall Study|Adverse Event|0|||
162681675|NCT01113502|587542635|FG002|Overall Study|Adverse Event|3|||
162681676|NCT01113502|587542636|FG003|Overall Study|Adverse Event|2|||
162681677|NCT01113502|587542637|FG004|Overall Study|Adverse Event|0|||
162681678|NCT03802123|587542640|FG000|Overall Study|Withdrawal by Subject|3|||
162681679|NCT03802123|587542640|FG000|Overall Study|Physician Decision|1|||
162681680|NCT03802123|587542640|FG000|Overall Study|Subject moved to hospice care|1|||
162681681|NCT03802123|587542640|FG000|Overall Study|technician error|1|||
162681682|NCT03802123|587542640|FG000|Overall Study|Death|3|||
162681683|NCT04555096|587542642|FG000|Overall Study|Death|4|||
162681684|NCT04555096|587542643|FG001|Overall Study|Death|4|||
162681685|NCT04555096|587542642|FG000|Overall Study|Withdrawal by Subject|1|||
162681686|NCT04555096|587542643|FG001|Overall Study|Withdrawal by Subject|0|||
162681687|NCT04555096|587542642|FG000|Overall Study|Other|0|||
162681688|NCT04555096|587542643|FG001|Overall Study|Other|1|||
162681689|NCT03575325|587542648|FG000|Overall Study|Death|1|||
162681690|NCT03440372|587542649|FG000|Treatment|Adverse Event|16|||
162681691|NCT03440372|587542650|FG001|Treatment|Adverse Event|8|||
162681692|NCT03440372|587542649|FG000|Treatment|Lack of Efficacy|4|||
162681693|NCT03440372|587542650|FG001|Treatment|Lack of Efficacy|2|||
162681694|NCT03440372|587542649|FG000|Treatment|Withdrawal by Subject|12|||
162681695|NCT03440372|587542650|FG001|Treatment|Withdrawal by Subject|8|||
162681696|NCT03440372|587542649|FG000|Treatment|Lost to Follow-up|1|||
162681697|NCT03440372|587542650|FG001|Treatment|Lost to Follow-up|0|||
162681698|NCT03440372|587542649|FG000|Treatment|Pregnancy|1|||
162681699|NCT03440372|587542650|FG001|Treatment|Pregnancy|0|||
162681700|NCT03440372|587542649|FG000|Treatment|Study Terminated by Sponsor|2|||
162681701|NCT03440372|587542650|FG001|Treatment|Study Terminated by Sponsor|1|||
162681702|NCT03440372|587542649|FG000|Treatment|Other Reason|2|||
162681703|NCT03440372|587542650|FG001|Treatment|Other Reason|3|||
162681704|NCT05711641|587542651|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
162681705|NCT05711641|587542652|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
162681706|NCT05711641|587542651|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
162681707|NCT05711641|587542652|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
162681708|NCT03574597|587542653|FG000|Overall Study|Withdrawal by Subject|67|||
162681709|NCT03574597|587542654|FG001|Overall Study|Withdrawal by Subject|96|||
162681710|NCT03574597|587542653|FG000|Overall Study|Lost to Follow-up|192|||
162681711|NCT03574597|587542654|FG001|Overall Study|Lost to Follow-up|188|||
162681712|NCT03804710|587542655|FG000|Overall Study|Adverse Event|0|||
162681713|NCT03804710|587542656|FG001|Overall Study|Adverse Event|3|||
162681714|NCT03804710|587542655|FG000|Overall Study|Withdrawal by Subject|2|||
162681715|NCT03804710|587542656|FG001|Overall Study|Withdrawal by Subject|1|||
162681716|NCT03804710|587542655|FG000|Overall Study|Other|0|||
162681717|NCT03804710|587542656|FG001|Overall Study|Other|1|||
162681718|NCT04542018|587542657|FG000|Overall Study|Withdrawal by Subject|0|||
162681719|NCT04542018|587542658|FG001|Overall Study|Withdrawal by Subject|0|||
162681720|NCT04542018|587542659|FG002|Overall Study|Withdrawal by Subject|4|||
162681721|NCT04542018|587542657|FG000|Overall Study|Protocol Violation|0|||
162681722|NCT04542018|587542658|FG001|Overall Study|Protocol Violation|0|||
162681723|NCT04542018|587542659|FG002|Overall Study|Protocol Violation|2|||
162681724|NCT03583554|587542660|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
162681725|NCT03583554|587542661|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
162681726|NCT03583554|587542662|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
162681727|NCT03178266|587542663|FG000|Overall Study|Death|0|||
162681728|NCT03178266|587542664|FG001|Overall Study|Death|1|||
162681729|NCT03178266|587542663|FG000|Overall Study|Disont. Early|0|||
162681730|NCT03178266|587542664|FG001|Overall Study|Disont. Early|1|||
162681731|NCT03178266|587542663|FG000|Overall Study|Withdrawal by Subject|0|||
162681732|NCT03178266|587542664|FG001|Overall Study|Withdrawal by Subject|2|||
162681733|NCT01596582|587542676|FG000|Overall Study|Deemed ineligible after study visit|3|||
162681734|NCT01596582|587542677|FG001|Overall Study|Deemed ineligible after study visit|6|||
162681735|NCT01596582|587542676|FG000|Overall Study|Missing all outcome data|1|||
162681736|NCT01596582|587542677|FG001|Overall Study|Missing all outcome data|1|||
162681737|NCT02012491|587542682|FG000|Overall Study|Lost to Follow-up|1|||
162681738|NCT02012491|587542683|FG001|Overall Study|Lost to Follow-up|0|||
162681739|NCT02012491|587542682|FG000|Overall Study|Protocol Violation|0|||
162681740|NCT02012491|587542683|FG001|Overall Study|Protocol Violation|1|||
162681741|NCT02012491|587542682|FG000|Overall Study|Withdrawal by Subject|1|||
162681742|NCT02012491|587542683|FG001|Overall Study|Withdrawal by Subject|0|||
162681743|NCT01667432|587542684|FG000|Overall Study|Premature Study Termination|26|||
162681744|NCT01667432|587542684|FG000|Overall Study|Failure to Return|10|||
162681745|NCT01667432|587542684|FG000|Overall Study|Moved to Another Center|3|||
162681746|NCT01667432|587542684|FG000|Overall Study|Lost to Follow-up|3|||
162681747|NCT01667432|587542684|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
162681748|NCT01667432|587542684|FG000|Overall Study|Insufficient Therapeutic Response|4|||
162681749|NCT01667432|587542684|FG000|Overall Study|Adverse Event|1|||
162681750|NCT01667432|587542684|FG000|Overall Study|Protocol Deviation|2|||
162681751|NCT01667432|587542684|FG000|Overall Study|Principal Investigator Decision|1|||
162681752|NCT01667432|587542684|FG000|Overall Study|Reason Not Specified|2|||
162681753|NCT01667432|587542684|FG000|Overall Study|Missing Information|4|||
162681754|NCT00553696|587542691|FG000|Overall Study|Adverse Event|2|||
162681755|NCT00553696|587542692|FG001|Overall Study|Adverse Event|4|||
162681756|NCT00553696|587542693|FG002|Overall Study|Adverse Event|0|||
162681757|NCT00553696|587542694|FG003|Overall Study|Adverse Event|1|||
162681758|NCT00553696|587542691|FG000|Overall Study|Global deterioration of health status|0|||
162681759|NCT00553696|587542692|FG001|Overall Study|Global deterioration of health status|2|||
162681760|NCT00553696|587542693|FG002|Overall Study|Global deterioration of health status|0|||
162681761|NCT00553696|587542694|FG003|Overall Study|Global deterioration of health status|0|||
162681762|NCT00553696|587542691|FG000|Overall Study|Objective progression or relapse|2|||
162681763|NCT00553696|587542692|FG001|Overall Study|Objective progression or relapse|9|||
162681764|NCT00553696|587542693|FG002|Overall Study|Objective progression or relapse|6|||
162681765|NCT00553696|587542694|FG003|Overall Study|Objective progression or relapse|0|||
162681766|NCT00553696|587542691|FG000|Overall Study|Withdrawal by Subject|0|||
162681767|NCT00553696|587542692|FG001|Overall Study|Withdrawal by Subject|1|||
162681768|NCT00553696|587542693|FG002|Overall Study|Withdrawal by Subject|0|||
162681769|NCT00553696|587542694|FG003|Overall Study|Withdrawal by Subject|0|||
162681770|NCT00686881|587542695|FG000|Overall Study|Withdrawal by Subject|11|||
162681771|NCT00686881|587542696|FG001|Overall Study|Withdrawal by Subject|18|||
162681772|NCT00686881|587542695|FG000|Overall Study|Lost to Follow-up|0|||
162681773|NCT00686881|587542696|FG001|Overall Study|Lost to Follow-up|1|||
162681774|NCT00686881|587542695|FG000|Overall Study|Treatment-related adverse event|10|||
162681775|NCT00686881|587542696|FG001|Overall Study|Treatment-related adverse event|9|||
162681776|NCT00686881|587542695|FG000|Overall Study|Met discontinuation criteria|5|||
162681777|NCT00686881|587542696|FG001|Overall Study|Met discontinuation criteria|0|||
162681778|NCT00686881|587542695|FG000|Overall Study|Onset of malignant tumor|11|||
162681779|NCT00686881|587542696|FG001|Overall Study|Onset of malignant tumor|11|||
162681780|NCT00686881|587542695|FG000|Overall Study|Lack of Efficacy|4|||
162681781|NCT00686881|587542696|FG001|Overall Study|Lack of Efficacy|3|||
162681782|NCT00686881|587542695|FG000|Overall Study|Physician Decision|1|||
162681783|NCT00686881|587542696|FG001|Overall Study|Physician Decision|0|||
162681784|NCT00686881|587542695|FG000|Overall Study|Circumstances of site|1|||
162681785|NCT00686881|587542696|FG001|Overall Study|Circumstances of site|1|||
162681786|NCT00686881|587542695|FG000|Overall Study|Did not meet protocol eligibility|1|||
162681787|NCT00686881|587542696|FG001|Overall Study|Did not meet protocol eligibility|0|||
162681788|NCT00686881|587542695|FG000|Overall Study|Irregular visits|1|||
162681789|NCT00686881|587542696|FG001|Overall Study|Irregular visits|0|||
162681790|NCT00686881|587542695|FG000|Overall Study|Study discontinuation|35|||
162681791|NCT00686881|587542696|FG001|Overall Study|Study discontinuation|32|||
162681792|NCT00686881|587542695|FG000|Overall Study|Never received study drug|2|||
162681793|NCT00686881|587542696|FG001|Overall Study|Never received study drug|6|||
162681794|NCT00671931|587542699|FG000|Overall Study|Physician Decision|1|||
162681795|NCT00671931|587542700|FG001|Overall Study|Physician Decision|0|||
162681796|NCT00671931|587542701|FG002|Overall Study|Physician Decision|0|||
162681797|NCT00671931|587542702|FG003|Overall Study|Physician Decision|2|||
162681798|NCT00671931|587542703|FG004|Overall Study|Physician Decision|1|||
162681799|NCT01298999|587542704|FG000|Overall Study|Physician Decision|0|||
162681800|NCT01298999|587542705|FG001|Overall Study|Physician Decision|1|||
162681801|NCT01298999|587542704|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
162681802|NCT01298999|587542705|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
162681803|NCT02816138|587542706|FG000|Overall Study|Adverse Event|1|||
162681804|NCT00818753|587542707|FG000|Overall Study|Protocol Violation|1|||
162681805|NCT00818753|587542708|FG001|Overall Study|Protocol Violation|0|||
162681806|NCT00818753|587542709|FG002|Overall Study|Protocol Violation|0|||
162681807|NCT00818753|587542707|FG000|Overall Study|Other reason (not specified)|0|||
162681808|NCT00818753|587542708|FG001|Overall Study|Other reason (not specified)|0|||
162681809|NCT00818753|587542709|FG002|Overall Study|Other reason (not specified)|1|||
162681810|NCT00818753|587542707|FG000|Overall Study|Randomised and not treated|2|||
162681811|NCT00818753|587542708|FG001|Overall Study|Randomised and not treated|0|||
162681812|NCT00818753|587542709|FG002|Overall Study|Randomised and not treated|0|||
162681813|NCT00902694|587542710|FG000|Overall Study|Death|1|||
162681814|NCT00902694|587542711|FG001|Overall Study|Death|3|||
162681815|NCT00902694|587542710|FG000|Overall Study|Lost to Follow-up|1|||
162681816|NCT00902694|587542711|FG001|Overall Study|Lost to Follow-up|0|||
162681817|NCT00902694|587542710|FG000|Overall Study|Censored per protocol|3|||
162681818|NCT00902694|587542711|FG001|Overall Study|Censored per protocol|1|||
162681819|NCT00902694|587542710|FG000|Overall Study|Pregnancy|1|||
162681820|NCT00902694|587542711|FG001|Overall Study|Pregnancy|1|||
162681821|NCT00902694|587542710|FG000|Overall Study|Incarceration|1|||
162681822|NCT00902694|587542711|FG001|Overall Study|Incarceration|0|||
162681823|NCT04969263|587542712|FG000|Overall Study|Death|1|||
162681824|NCT04969263|587542712|FG000|Overall Study|Lost to Follow-up|2|||
162681825|NCT04969263|587542712|FG000|Overall Study|Withdrawal by Subject|5|||
162681826|NCT04969263|587542712|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
162681827|NCT04154787|587542713|FG000|Overall Study|Adverse Event|0|||
162681828|NCT04154787|587542714|FG001|Overall Study|Adverse Event|1|||
162681829|NCT04154787|587542715|FG002|Overall Study|Adverse Event|0|||
162681830|NCT04154787|587542713|FG000|Overall Study|Patient Requires Other Treatment|0|||
162681831|NCT04154787|587542714|FG001|Overall Study|Patient Requires Other Treatment|1|||
162681832|NCT04154787|587542715|FG002|Overall Study|Patient Requires Other Treatment|0|||
162681833|NCT04154787|587542713|FG000|Overall Study|Study Terminated By Sponsor|0|||
162681834|NCT04154787|587542714|FG001|Overall Study|Study Terminated By Sponsor|6|||
162681835|NCT04154787|587542715|FG002|Overall Study|Study Terminated By Sponsor|1|||
162681836|NCT04154787|587542713|FG000|Overall Study|Subject Decision|0|||
162681837|NCT04154787|587542714|FG001|Overall Study|Subject Decision|1|||
162681838|NCT04154787|587542715|FG002|Overall Study|Subject Decision|0|||
162681839|NCT04154787|587542713|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
162681840|NCT04154787|587542714|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
162681841|NCT04154787|587542715|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
162681842|NCT02459574|587542719|FG000|Overall Study|Withdrawal by Subject|6|||
162681843|NCT02459574|587542720|FG001|Overall Study|Withdrawal by Subject|6|||
162681844|NCT02459574|587542721|FG002|Overall Study|Withdrawal by Subject|2|||
162681845|NCT02459574|587542719|FG000|Overall Study|Lost to Follow-up|1|||
162681846|NCT02459574|587542720|FG001|Overall Study|Lost to Follow-up|1|||
162681847|NCT02459574|587542721|FG002|Overall Study|Lost to Follow-up|0|||
162681848|NCT02459574|587542719|FG000|Overall Study|Death|0|||
162681849|NCT02459574|587542720|FG001|Overall Study|Death|1|||
162681850|NCT02459574|587542721|FG002|Overall Study|Death|0|||
162681851|NCT04866017|587542722|FG000|Overall Study|Study Terminated by Sponsor|13|||
162681852|NCT04866017|587542723|FG001|Overall Study|Study Terminated by Sponsor|14|||
162681853|NCT04866017|587542724|FG002|Overall Study|Study Terminated by Sponsor|13|||
162681854|NCT04866017|587542722|FG000|Overall Study|Death|8|||
162681855|NCT04866017|587542723|FG001|Overall Study|Death|4|||
162681856|NCT04866017|587542724|FG002|Overall Study|Death|8|||
162681857|NCT04866017|587542722|FG000|Overall Study|Withdrawal by Subject|1|||
162681858|NCT04866017|587542723|FG001|Overall Study|Withdrawal by Subject|0|||
162681859|NCT04866017|587542724|FG002|Overall Study|Withdrawal by Subject|1|||
162681860|NCT04866017|587542722|FG000|Overall Study|Physician Decision|0|||
162681861|NCT04866017|587542723|FG001|Overall Study|Physician Decision|1|||
162681862|NCT04866017|587542724|FG002|Overall Study|Physician Decision|0|||
162681863|NCT01266642|587542725|FG000|Overall Study|Protocol Violation|0|||
162681864|NCT01266642|587542726|FG001|Overall Study|Protocol Violation|1|||
162681865|NCT01337674|587544465|FG000|Treatment Period 1|Adverse Event|0|||
162681866|NCT01337674|587544466|FG001|Treatment Period 1|Adverse Event|1|||
162681867|NCT01337674|587544467|FG002|Treatment Period 1|Adverse Event|0|||
162681868|NCT01337674|587544468|FG003|Treatment Period 1|Adverse Event|0|||
162681869|NCT01337674|587544465|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
162681870|NCT01337674|587544466|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
162681871|NCT01337674|587544467|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
162681872|NCT01337674|587544468|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
162681873|NCT01337674|587544465|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162681874|NCT01337674|587544466|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162681875|NCT01337674|587544467|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162681876|NCT01337674|587544468|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162681877|NCT00695786|587544469|FG000|Overall Study|Adverse Event|0|||
162681878|NCT00695786|587544470|FG001|Overall Study|Adverse Event|3|||
162681879|NCT00695786|587544471|FG002|Overall Study|Adverse Event|4|||
162681880|NCT00695786|587544472|FG003|Overall Study|Adverse Event|2|||
162681881|NCT00695786|587544469|FG000|Overall Study|Lost to Follow-up|0|||
162681882|NCT00695786|587544470|FG001|Overall Study|Lost to Follow-up|5|||
162681883|NCT00695786|587544471|FG002|Overall Study|Lost to Follow-up|1|||
162681884|NCT00695786|587544472|FG003|Overall Study|Lost to Follow-up|1|||
162681885|NCT00695786|587544469|FG000|Overall Study|Withdrawal by Subject|0|||
162681886|NCT00695786|587544470|FG001|Overall Study|Withdrawal by Subject|4|||
162681887|NCT00695786|587544471|FG002|Overall Study|Withdrawal by Subject|3|||
162681888|NCT00695786|587544472|FG003|Overall Study|Withdrawal by Subject|1|||
162681889|NCT00695786|587544469|FG000|Overall Study|Deemed Ineligible|1|||
162681890|NCT00695786|587544470|FG001|Overall Study|Deemed Ineligible|0|||
162681891|NCT00695786|587544471|FG002|Overall Study|Deemed Ineligible|0|||
162681892|NCT00695786|587544472|FG003|Overall Study|Deemed Ineligible|0|||
162681893|NCT00695786|587544469|FG000|Overall Study|Lack of Efficacy|0|||
162681894|NCT00695786|587544470|FG001|Overall Study|Lack of Efficacy|0|||
162681895|NCT00695786|587544471|FG002|Overall Study|Lack of Efficacy|0|||
162681896|NCT00695786|587544472|FG003|Overall Study|Lack of Efficacy|4|||
162681897|NCT04244396|587544476|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
162681898|NCT04244396|587544476|FG000|Overall Study|Withdrawal by Subject|2|||
162681899|NCT04244396|587544476|FG000|Overall Study|Study termination|37|||
162681900|NCT01787097|587544477|FG000|Overall Study|Withdrawal by Subject|1|||
162681901|NCT01787097|587544478|FG001|Overall Study|Withdrawal by Subject|0|||
162681902|NCT01787097|587544479|FG002|Overall Study|Withdrawal by Subject|0|||
162681903|NCT01787097|587544480|FG003|Overall Study|Withdrawal by Subject|0|||
162681904|NCT00245102|587544481|FG000|Overall Study|Not Treated|1|||
162681905|NCT00245102|587544482|FG001|Overall Study|Not Treated|0|||
162681906|NCT00245102|587544483|FG002|Overall Study|Not Treated|1|||
162681907|NCT00245102|587544484|FG003|Overall Study|Not Treated|0|||
162681908|NCT00245102|587544485|FG004|Overall Study|Not Treated|0|||
162681909|NCT00245102|587544486|FG005|Overall Study|Not Treated|0|||
162681910|NCT00245102|587544481|FG000|Overall Study|Protocol Violation|1|||
162681911|NCT00245102|587544482|FG001|Overall Study|Protocol Violation|0|||
162681912|NCT00245102|587544483|FG002|Overall Study|Protocol Violation|0|||
162681913|NCT00245102|587544484|FG003|Overall Study|Protocol Violation|0|||
162681914|NCT00245102|587544485|FG004|Overall Study|Protocol Violation|0|||
162681915|NCT00245102|587544486|FG005|Overall Study|Protocol Violation|0|||
162681916|NCT00245102|587544481|FG000|Overall Study|Death|0|||
162681917|NCT00245102|587544482|FG001|Overall Study|Death|0|||
162681918|NCT00245102|587544483|FG002|Overall Study|Death|0|||
162681919|NCT00245102|587544484|FG003|Overall Study|Death|1|||
162681920|NCT00245102|587544485|FG004|Overall Study|Death|0|||
162681921|NCT00245102|587544486|FG005|Overall Study|Death|0|||
162681922|NCT00245102|587544481|FG000|Overall Study|Adverse Event|4|||
162681923|NCT00245102|587544482|FG001|Overall Study|Adverse Event|2|||
162681924|NCT00245102|587544483|FG002|Overall Study|Adverse Event|5|||
162681925|NCT00245102|587544484|FG003|Overall Study|Adverse Event|1|||
162681926|NCT00245102|587544485|FG004|Overall Study|Adverse Event|0|||
162681927|NCT00245102|587544486|FG005|Overall Study|Adverse Event|2|||
162681928|NCT00245102|587544481|FG000|Overall Study|Decline in performance|0|||
162681929|NCT00245102|587544482|FG001|Overall Study|Decline in performance|2|||
162681930|NCT00245102|587544483|FG002|Overall Study|Decline in performance|0|||
162681931|NCT00245102|587544484|FG003|Overall Study|Decline in performance|1|||
162681932|NCT00245102|587544485|FG004|Overall Study|Decline in performance|0|||
162681933|NCT00245102|587544486|FG005|Overall Study|Decline in performance|2|||
162681934|NCT00245102|587544481|FG000|Overall Study|Participant needed surgery|0|||
162681935|NCT00245102|587544482|FG001|Overall Study|Participant needed surgery|0|||
162681936|NCT00245102|587544483|FG002|Overall Study|Participant needed surgery|1|||
162681937|NCT00245102|587544484|FG003|Overall Study|Participant needed surgery|0|||
162681938|NCT00245102|587544485|FG004|Overall Study|Participant needed surgery|0|||
162681939|NCT00245102|587544486|FG005|Overall Study|Participant needed surgery|0|||
162681940|NCT00245102|587544481|FG000|Overall Study|Clinical progression|1|||
162681941|NCT00245102|587544482|FG001|Overall Study|Clinical progression|0|||
162681942|NCT00245102|587544483|FG002|Overall Study|Clinical progression|0|||
162681943|NCT00245102|587544484|FG003|Overall Study|Clinical progression|0|||
162681944|NCT00245102|587544485|FG004|Overall Study|Clinical progression|0|||
162681945|NCT00245102|587544486|FG005|Overall Study|Clinical progression|0|||
162681946|NCT00289887|587544487|FG000|Overall Study|Adverse Event|3|||
162681947|NCT00289887|587544488|FG001|Overall Study|Adverse Event|3|||
162681948|NCT00289887|587544487|FG000|Overall Study|Lack of Efficacy|3|||
162681949|NCT00289887|587544488|FG001|Overall Study|Lack of Efficacy|11|||
162681950|NCT00289887|587544487|FG000|Overall Study|Lost to Follow-up|3|||
162681951|NCT00289887|587544488|FG001|Overall Study|Lost to Follow-up|3|||
162681952|NCT00289887|587544487|FG000|Overall Study|Protocol Violation|3|||
162681953|NCT00289887|587544488|FG001|Overall Study|Protocol Violation|1|||
162681954|NCT00289887|587544487|FG000|Overall Study|Withdrawal by Subject|3|||
162681955|NCT00289887|587544488|FG001|Overall Study|Withdrawal by Subject|8|||
162681956|NCT00289887|587544487|FG000|Overall Study|Other|7|||
162681957|NCT00289887|587544488|FG001|Overall Study|Other|3|||
162681958|NCT00224770|587544491|FG000|Overall Study|Lost to Follow-up|4|||
162681959|NCT00224770|587544492|FG001|Overall Study|Lost to Follow-up|2|||
162681960|NCT00224770|587544493|FG002|Overall Study|Lost to Follow-up|0|||
162681961|NCT00437645|587544494|FG000|Overall Study|Adverse Event|15|||
162681962|NCT00437645|587544495|FG001|Overall Study|Adverse Event|84|||
162681963|NCT00437645|587544494|FG000|Overall Study|Withdrawal by Subject|10|||
162681964|NCT00437645|587544495|FG001|Overall Study|Withdrawal by Subject|22|||
162681965|NCT00437645|587544494|FG000|Overall Study|Protocol Violation|3|||
162681966|NCT00437645|587544495|FG001|Overall Study|Protocol Violation|3|||
162681967|NCT00437645|587544494|FG000|Overall Study|Lost to Follow-up|2|||
162681968|NCT00437645|587544495|FG001|Overall Study|Lost to Follow-up|3|||
162681969|NCT00437645|587544494|FG000|Overall Study|Administrative problems|2|||
162681970|NCT00437645|587544495|FG001|Overall Study|Administrative problems|1|||
162681971|NCT00437645|587544494|FG000|Overall Study|Lack of Efficacy|2|||
162681972|NCT00437645|587544495|FG001|Overall Study|Lack of Efficacy|1|||
162681973|NCT00437645|587544494|FG000|Overall Study|Condition no longer requires study drug|1|||
162681974|NCT00437645|587544495|FG001|Overall Study|Condition no longer requires study drug|1|||
162681975|NCT00989092|587544498|FG000|Overall Study|Physician Decision|9|||
162681976|NCT00989092|587544499|FG001|Overall Study|Physician Decision|6|||
162681977|NCT00989092|587544498|FG000|Overall Study|Adverse Event|20|||
162681978|NCT00989092|587544499|FG001|Overall Study|Adverse Event|1|||
162681979|NCT00989092|587544498|FG000|Overall Study|Chemotherapy initiated|12|||
162681980|NCT00989092|587544499|FG001|Overall Study|Chemotherapy initiated|4|||
162681981|NCT00989092|587544498|FG000|Overall Study|Withdrawal by Subject|17|||
162681982|NCT00989092|587544499|FG001|Overall Study|Withdrawal by Subject|9|||
162681983|NCT00989092|587544498|FG000|Overall Study|Death|14|||
162681984|NCT00989092|587544499|FG001|Overall Study|Death|2|||
162681985|NCT00989092|587544498|FG000|Overall Study|Ineligibility determined|3|||
162681986|NCT00989092|587544499|FG001|Overall Study|Ineligibility determined|3|||
162681987|NCT00989092|587544498|FG000|Overall Study|Lost to Follow-up|6|||
162681988|NCT00989092|587544499|FG001|Overall Study|Lost to Follow-up|2|||
162681989|NCT00989092|587544498|FG000|Overall Study|Other|3|||
162681990|NCT00989092|587544499|FG001|Overall Study|Other|1|||
162681991|NCT00989092|587544498|FG000|Overall Study|Protocol deviation|2|||
162681992|NCT00989092|587544499|FG001|Overall Study|Protocol deviation|0|||
162681993|NCT00989092|587544498|FG000|Overall Study|Erythropoietin therapy initiated|2|||
162681994|NCT00989092|587544499|FG001|Overall Study|Erythropoietin therapy initiated|0|||
162681995|NCT00989092|587544498|FG000|Overall Study|Did not receive study drug|2|||
162681996|NCT00989092|587544499|FG001|Overall Study|Did not receive study drug|0|||
162681997|NCT03837509|587544504|FG000|Phase 1|Death|5|||
162681998|NCT03837509|587544505|FG001|Phase 1|Death|2|||
162681999|NCT03837509|587544506|FG002|Phase 1|Death|0|||
162682000|NCT03837509|587544507|FG003|Phase 1|Death|0|||
162682001|NCT03837509|587544508|FG004|Phase 1|Death|0|||
162682002|NCT03837509|587544504|FG000|Phase 2|Death|0|||
162682003|NCT03837509|587544505|FG001|Phase 2|Death|0|||
162682004|NCT03837509|587544506|FG002|Phase 2|Death|0|||
162682005|NCT03837509|587544507|FG003|Phase 2|Death|1|||
162682006|NCT03837509|587544508|FG004|Phase 2|Death|1|||
162682007|NCT01256411|587544517|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
162682008|NCT01256411|587544518|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
162682009|NCT01256411|587544519|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
162682010|NCT01256411|587544520|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
162682011|NCT01256411|587544521|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
162682012|NCT01256411|587544522|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
162682013|NCT01256411|587544517|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
162682014|NCT01256411|587544518|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
162682015|NCT01256411|587544519|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
162682016|NCT01256411|587544520|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
162682017|NCT01256411|587544521|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
162682018|NCT01256411|587544522|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
162682019|NCT01256411|587544517|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
162682020|NCT01256411|587544518|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
162682021|NCT01256411|587544519|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
162682022|NCT01256411|587544520|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162682023|NCT01256411|587544521|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162682024|NCT01256411|587544522|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162682025|NCT01256411|587544517|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
162682026|NCT01256411|587544518|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
162682027|NCT01256411|587544519|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
162682028|NCT01256411|587544520|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
162682029|NCT01256411|587544521|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
162682030|NCT01256411|587544522|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
162682031|NCT01256411|587544517|FG000|Extension by Maximum Treatment|Adverse Event|4|||
162682032|NCT01256411|587544518|FG001|Extension by Maximum Treatment|Adverse Event|2|||
162682033|NCT01256411|587544519|FG002|Extension by Maximum Treatment|Adverse Event|1|||
162682034|NCT01256411|587544520|FG003|Extension by Maximum Treatment|Adverse Event|0|||
162682035|NCT01256411|587544521|FG004|Extension by Maximum Treatment|Adverse Event|0|||
162682036|NCT01256411|587544522|FG005|Extension by Maximum Treatment|Adverse Event|0|||
162682037|NCT01256411|587544517|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
162682038|NCT01256411|587544518|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
162682039|NCT01256411|587544519|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
162682040|NCT01256411|587544520|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
162682041|NCT01256411|587544521|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
162682042|NCT01256411|587544522|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
162725396|NCT00371787|587704581|FG001|Overall Study|Withdrawal by Subject|1|||
162682043|NCT01256411|587544517|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162682044|NCT01256411|587544518|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162682045|NCT01256411|587544519|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162725397|NCT00077675|587704582|FG000|Overall Study|Adverse Event|1|||
162682046|NCT01256411|587544520|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162682047|NCT01256411|587544521|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162682048|NCT01256411|587544522|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
162682049|NCT01256411|587544517|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162682050|NCT01256411|587544518|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162682051|NCT01256411|587544519|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162682052|NCT01256411|587544520|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162682053|NCT01256411|587544521|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
162682054|NCT01256411|587544522|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162682055|NCT01256411|587544517|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162682056|NCT01256411|587544518|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162682057|NCT01256411|587544519|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162682058|NCT01256411|587544520|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162682059|NCT01256411|587544521|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
162682060|NCT01256411|587544522|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
162682061|NCT01256411|587544517|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162682062|NCT01256411|587544518|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162682063|NCT01256411|587544519|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162682064|NCT01256411|587544520|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162682065|NCT01256411|587544521|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
162682066|NCT01256411|587544522|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
162682067|NCT02274857|587544523|FG000|Overall Study|Adverse Event|1|||
162682068|NCT02274857|587544524|FG001|Overall Study|Adverse Event|0|||
162682069|NCT02274857|587544523|FG000|Overall Study|Death|1|||
162682070|NCT02274857|587544524|FG001|Overall Study|Death|2|||
162682071|NCT02274857|587544523|FG000|Overall Study|Lost to Follow-up|3|||
162682072|NCT02274857|587544524|FG001|Overall Study|Lost to Follow-up|0|||
162682073|NCT02274857|587544523|FG000|Overall Study|Physician Decision|2|||
162682074|NCT02274857|587544524|FG001|Overall Study|Physician Decision|0|||
162682075|NCT02274857|587544523|FG000|Overall Study|Trial screen failure|0|||
162682076|NCT02274857|587544524|FG001|Overall Study|Trial screen failure|2|||
162682077|NCT02274857|587544523|FG000|Overall Study|Withdrawal by Subject|11|||
162682078|NCT02274857|587544524|FG001|Overall Study|Withdrawal by Subject|2|||
162682079|NCT02274857|587544523|FG000|Overall Study|Other|2|||
162682080|NCT02274857|587544524|FG001|Overall Study|Other|0|||
162682081|NCT00117676|587544525|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
162682082|NCT00117676|587544526|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
162682083|NCT00117676|587544525|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
162682084|NCT00117676|587544526|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
162682085|NCT00117676|587544525|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
162682086|NCT00117676|587544526|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
162682087|NCT00117676|587544525|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
162682088|NCT00117676|587544526|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
162682089|NCT00117676|587544525|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
162682090|NCT00117676|587544526|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
162682091|NCT00117676|587544525|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
162682092|NCT00117676|587544526|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
162682093|NCT00117676|587544525|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
162682094|NCT00117676|587544526|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
162682095|NCT00117676|587544525|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
162682096|NCT00117676|587544526|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
162682097|NCT00117676|587544525|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
162682098|NCT00117676|587544526|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
162682099|NCT00117676|587544525|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
162682100|NCT00117676|587544526|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
162682101|NCT00117676|587544525|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
162682102|NCT00117676|587544526|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
162682103|NCT00117676|587544525|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
162682104|NCT00117676|587544526|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
162682105|NCT00117676|587544525|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
162682106|NCT00117676|587544526|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
162682107|NCT00117676|587544525|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
162682108|NCT00117676|587544526|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
162682109|NCT00117676|587544525|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
162682110|NCT00117676|587544526|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
162682111|NCT00117676|587544525|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
162682112|NCT00117676|587544526|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
162682113|NCT00117676|587544525|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162682114|NCT00117676|587544526|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
162682115|NCT00117676|587544525|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
162682116|NCT00117676|587544526|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
162682117|NCT00117676|587544525|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
162682118|NCT00117676|587544526|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
162682119|NCT00117676|587544525|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
162682120|NCT00117676|587544526|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
162682121|NCT00117676|587544525|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
162682122|NCT00117676|587544526|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
162682123|NCT00117676|587544525|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
162682124|NCT00117676|587544526|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
162682125|NCT00117676|587544525|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
162682126|NCT00117676|587544526|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
162682127|NCT00117676|587544525|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
162682128|NCT00117676|587544526|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
162682129|NCT00117676|587544525|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
162682130|NCT00117676|587544526|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
162682131|NCT00117676|587544525|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
162682132|NCT00117676|587544526|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
162682133|NCT00117676|587544525|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
162682134|NCT00117676|587544526|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
162682135|NCT00117676|587544525|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
162682136|NCT00117676|587544526|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
162682137|NCT00117676|587544525|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
162682138|NCT00117676|587544526|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
162682139|NCT00117676|587544525|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
162682140|NCT00117676|587544526|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
162682141|NCT00117676|587544525|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
162682142|NCT00117676|587544526|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
162682143|NCT00117676|587544525|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
162682144|NCT00117676|587544526|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
162682145|NCT00117676|587544525|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
162682146|NCT00117676|587544526|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
162682147|NCT00117676|587544525|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
162682148|NCT00117676|587544526|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
162682149|NCT00117676|587544525|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
162682150|NCT00117676|587544526|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
162682151|NCT00952822|587544527|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162682152|NCT00952822|587544528|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
162682153|NCT00952822|587544529|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162682154|NCT00952822|587544530|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162682155|NCT00952822|587544527|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162682156|NCT00952822|587544528|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162682157|NCT00952822|587544529|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
162682158|NCT00952822|587544530|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162682159|NCT00691938|587544531|FG000|Overall Study|QTc prolongation|1|||
162682160|NCT00691938|587544532|FG001|Overall Study|QTc prolongation|0|||
162682161|NCT00691938|587544533|FG002|Overall Study|QTc prolongation|0|||
162682162|NCT00691938|587544534|FG003|Overall Study|QTc prolongation|0|||
162682163|NCT00691938|587544535|FG004|Overall Study|QTc prolongation|0|||
162682164|NCT00691938|587544536|FG005|Overall Study|QTc prolongation|0|||
162682165|NCT00691938|587544537|FG006|Overall Study|QTc prolongation|0|||
162682166|NCT00594854|587544539|FG000|Overall Study|Study terminated|7|||
162682167|NCT00594854|587544540|FG001|Overall Study|Study terminated|10|||
162682168|NCT04918147|587544551|FG000|Overall Study|Disease flare as defined in protocol|0|||
162682169|NCT04918147|587544552|FG001|Overall Study|Disease flare as defined in protocol|2|||
162682170|NCT03292146|587544553|FG000|Baseline to 12 months|Relocation|1|||
162682171|NCT03292146|587544554|FG001|Baseline to 12 months|Relocation|0|||
162682172|NCT03292146|587544553|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
162682173|NCT03292146|587544554|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
162682174|NCT03292146|587544553|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
162682175|NCT03292146|587544554|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
162682176|NCT03292146|587544553|FG000|12 months to 24 months|Planning pregnancy|2|||
162682177|NCT03292146|587544554|FG001|12 months to 24 months|Planning pregnancy|2|||
162682178|NCT03292146|587544553|FG000|12 months to 24 months|Personal reasons|1|||
162682179|NCT03292146|587544554|FG001|12 months to 24 months|Personal reasons|0|||
162682180|NCT03292146|587544553|FG000|12 months to 24 months|Lost to Follow-up|0|||
162682181|NCT03292146|587544554|FG001|12 months to 24 months|Lost to Follow-up|1|||
162682182|NCT06134180|587544555|FG000|Overall Study|Lost to Follow-up|4|||
162682183|NCT01362439|587544556|FG000|Overall Study|Adverse Event|1|||
162682184|NCT01362439|587544556|FG000|Overall Study|Lack of Efficacy|3|||
162682185|NCT01362439|587544556|FG000|Overall Study|Lost to Follow-up|2|||
162682186|NCT01362439|587544556|FG000|Overall Study|Study medication non-compliant|1|||
162682187|NCT01362439|587544556|FG000|Overall Study|Participant who withdrew consent|8|||
162682188|NCT02712905|587544559|FG000|Monotherapy|Death|2|||
162682189|NCT02712905|587544560|FG001|Monotherapy|Death|5|||
162682190|NCT02712905|587544561|FG002|Monotherapy|Death|0|||
162682191|NCT02712905|587544562|FG003|Monotherapy|Death|3|||
162682192|NCT02712905|587544563|FG004|Monotherapy|Death|15|||
162682193|NCT02712905|587544564|FG005|Monotherapy|Death|1|||
162682194|NCT02712905|587544565|FG006|Monotherapy|Death|3|||
162682195|NCT02712905|587544566|FG007|Monotherapy|Death|3|||
162682196|NCT02712905|587544567|FG008|Monotherapy|Death|0|||
162682197|NCT02712905|587544568|FG009|Monotherapy|Death|27|||
162682198|NCT02712905|587544569|FG010|Monotherapy|Death|2|||
162682199|NCT02712905|587544570|FG011|Monotherapy|Death|5|||
162682200|NCT02712905|587544571|FG012|Monotherapy|Death|0|||
162682201|NCT02712905|587544572|FG013|Monotherapy|Death|0|||
162682202|NCT02712905|587544573|FG014|Monotherapy|Death|0|||
162682203|NCT02712905|587544574|FG015|Monotherapy|Death|0|||
162682204|NCT02712905|587544575|FG016|Monotherapy|Death|0|||
162682205|NCT02712905|587544576|FG017|Monotherapy|Death|0|||
162682206|NCT02712905|587544559|FG000|Monotherapy|Lost to Follow-up|0|||
162682207|NCT02712905|587544560|FG001|Monotherapy|Lost to Follow-up|1|||
162682208|NCT02712905|587544561|FG002|Monotherapy|Lost to Follow-up|0|||
162682209|NCT02712905|587544562|FG003|Monotherapy|Lost to Follow-up|1|||
162682210|NCT02712905|587544563|FG004|Monotherapy|Lost to Follow-up|0|||
162682211|NCT02712905|587544564|FG005|Monotherapy|Lost to Follow-up|0|||
162682212|NCT02712905|587544565|FG006|Monotherapy|Lost to Follow-up|0|||
162682213|NCT02712905|587544566|FG007|Monotherapy|Lost to Follow-up|0|||
162682214|NCT02712905|587544567|FG008|Monotherapy|Lost to Follow-up|0|||
162682215|NCT02712905|587544568|FG009|Monotherapy|Lost to Follow-up|2|||
162682216|NCT02712905|587544569|FG010|Monotherapy|Lost to Follow-up|0|||
162682217|NCT02712905|587544570|FG011|Monotherapy|Lost to Follow-up|0|||
162682218|NCT02712905|587544571|FG012|Monotherapy|Lost to Follow-up|0|||
162682219|NCT02712905|587544572|FG013|Monotherapy|Lost to Follow-up|0|||
162682220|NCT02712905|587544573|FG014|Monotherapy|Lost to Follow-up|0|||
162682221|NCT02712905|587544574|FG015|Monotherapy|Lost to Follow-up|0|||
162682222|NCT02712905|587544575|FG016|Monotherapy|Lost to Follow-up|0|||
162682223|NCT02712905|587544576|FG017|Monotherapy|Lost to Follow-up|0|||
162682224|NCT02712905|587544559|FG000|Monotherapy|Physician Decision|1|||
162682225|NCT02712905|587544560|FG001|Monotherapy|Physician Decision|0|||
162682226|NCT02712905|587544561|FG002|Monotherapy|Physician Decision|0|||
162682227|NCT02712905|587544562|FG003|Monotherapy|Physician Decision|1|||
162682228|NCT02712905|587544563|FG004|Monotherapy|Physician Decision|0|||
162682229|NCT02712905|587544564|FG005|Monotherapy|Physician Decision|0|||
162682230|NCT02712905|587544565|FG006|Monotherapy|Physician Decision|0|||
162682231|NCT02712905|587544566|FG007|Monotherapy|Physician Decision|0|||
162682232|NCT02712905|587544567|FG008|Monotherapy|Physician Decision|0|||
162682233|NCT02712905|587544568|FG009|Monotherapy|Physician Decision|1|||
162682234|NCT02712905|587544569|FG010|Monotherapy|Physician Decision|0|||
162682235|NCT02712905|587544570|FG011|Monotherapy|Physician Decision|0|||
162682236|NCT02712905|587544571|FG012|Monotherapy|Physician Decision|0|||
162682237|NCT02712905|587544572|FG013|Monotherapy|Physician Decision|0|||
162682238|NCT02712905|587544573|FG014|Monotherapy|Physician Decision|0|||
162682239|NCT02712905|587544574|FG015|Monotherapy|Physician Decision|0|||
162682240|NCT02712905|587544575|FG016|Monotherapy|Physician Decision|0|||
162682241|NCT02712905|587544576|FG017|Monotherapy|Physician Decision|0|||
162682242|NCT02712905|587544559|FG000|Monotherapy|Study Terminated by Sponsor|0|||
162682243|NCT02712905|587544560|FG001|Monotherapy|Study Terminated by Sponsor|0|||
162682244|NCT02712905|587544561|FG002|Monotherapy|Study Terminated by Sponsor|0|||
162682245|NCT02712905|587544562|FG003|Monotherapy|Study Terminated by Sponsor|0|||
162682246|NCT02712905|587544563|FG004|Monotherapy|Study Terminated by Sponsor|1|||
162682247|NCT02712905|587544564|FG005|Monotherapy|Study Terminated by Sponsor|0|||
162682248|NCT02712905|587544565|FG006|Monotherapy|Study Terminated by Sponsor|0|||
162682249|NCT02712905|587544566|FG007|Monotherapy|Study Terminated by Sponsor|0|||
162682250|NCT02712905|587544567|FG008|Monotherapy|Study Terminated by Sponsor|0|||
162682251|NCT02712905|587544568|FG009|Monotherapy|Study Terminated by Sponsor|2|||
162682252|NCT02712905|587544569|FG010|Monotherapy|Study Terminated by Sponsor|0|||
162682253|NCT02712905|587544570|FG011|Monotherapy|Study Terminated by Sponsor|0|||
162682254|NCT02712905|587544571|FG012|Monotherapy|Study Terminated by Sponsor|0|||
162682255|NCT02712905|587544572|FG013|Monotherapy|Study Terminated by Sponsor|0|||
162682256|NCT02712905|587544573|FG014|Monotherapy|Study Terminated by Sponsor|0|||
162682257|NCT02712905|587544574|FG015|Monotherapy|Study Terminated by Sponsor|0|||
162682258|NCT02712905|587544575|FG016|Monotherapy|Study Terminated by Sponsor|0|||
162725398|NCT00077675|587704583|FG001|Overall Study|Adverse Event|2|||
162725399|NCT00077675|587704582|FG000|Overall Study|Lost to Follow-up|6|||
162725400|NCT00077675|587704583|FG001|Overall Study|Lost to Follow-up|3|||
162725401|NCT00077675|587704582|FG000|Overall Study|Withdrawal by Subject|1|||
162725402|NCT00077675|587704583|FG001|Overall Study|Withdrawal by Subject|0|||
162725403|NCT00077675|587704582|FG000|Overall Study|Other|0|||
162725404|NCT00077675|587704583|FG001|Overall Study|Other|1|||
162725405|NCT00077675|587704582|FG000|Overall Study|Never received study treatment|3|||
162725406|NCT00077675|587704583|FG001|Overall Study|Never received study treatment|3|||
162725407|NCT02601820|587704584|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
162725408|NCT02601820|587704584|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
162725409|NCT02601820|587704584|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
162725410|NCT02601820|587704584|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
162725411|NCT04532528|587704585|FG000|Overall Study|Adverse Event|12|||
162725412|NCT04532528|587704586|FG001|Overall Study|Adverse Event|17|||
162725413|NCT04532528|587704585|FG000|Overall Study|Withdrawal of consent|16|||
162725414|NCT04532528|587704586|FG001|Overall Study|Withdrawal of consent|17|||
162725415|NCT04532528|587704585|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
162725416|NCT04532528|587704586|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
162725417|NCT04532528|587704585|FG000|Overall Study|Lost to Follow-up|69|||
162725418|NCT04532528|587704586|FG001|Overall Study|Lost to Follow-up|68|||
162725419|NCT04532528|587704585|FG000|Overall Study|Administrative problems|12|||
162725420|NCT04532528|587704586|FG001|Overall Study|Administrative problems|14|||
162725421|NCT04532528|587704585|FG000|Overall Study|Death|3|||
162725422|NCT04532528|587704586|FG001|Overall Study|Death|3|||
162725423|NCT04532528|587704585|FG000|Overall Study|Other|38|||
162725424|NCT04532528|587704586|FG001|Overall Study|Other|46|||
162725425|NCT00665444|587704587|FG000|Overall Study|Physician Decision|1|||
162682259|NCT02712905|587544576|FG017|Monotherapy|Study Terminated by Sponsor|0|||
162682260|NCT02712905|587544559|FG000|Monotherapy|Withdrawal by Subject|0|||
162682261|NCT02712905|587544560|FG001|Monotherapy|Withdrawal by Subject|0|||
162682262|NCT02712905|587544561|FG002|Monotherapy|Withdrawal by Subject|1|||
162682263|NCT02712905|587544562|FG003|Monotherapy|Withdrawal by Subject|0|||
162682264|NCT02712905|587544563|FG004|Monotherapy|Withdrawal by Subject|2|||
162682265|NCT02712905|587544564|FG005|Monotherapy|Withdrawal by Subject|0|||
162682266|NCT02712905|587544565|FG006|Monotherapy|Withdrawal by Subject|0|||
162682267|NCT02712905|587544566|FG007|Monotherapy|Withdrawal by Subject|0|||
162682268|NCT02712905|587544567|FG008|Monotherapy|Withdrawal by Subject|0|||
162682269|NCT02712905|587544568|FG009|Monotherapy|Withdrawal by Subject|4|||
162682270|NCT02712905|587544569|FG010|Monotherapy|Withdrawal by Subject|1|||
162682271|NCT02712905|587544570|FG011|Monotherapy|Withdrawal by Subject|2|||
162682272|NCT02712905|587544571|FG012|Monotherapy|Withdrawal by Subject|0|||
162682273|NCT02712905|587544572|FG013|Monotherapy|Withdrawal by Subject|0|||
162682274|NCT02712905|587544573|FG014|Monotherapy|Withdrawal by Subject|0|||
162682275|NCT02712905|587544574|FG015|Monotherapy|Withdrawal by Subject|0|||
162682276|NCT02712905|587544575|FG016|Monotherapy|Withdrawal by Subject|0|||
162682277|NCT02712905|587544576|FG017|Monotherapy|Withdrawal by Subject|0|||
162682278|NCT02712905|587544559|FG000|Monotherapy|Started New Cancer Drug|0|||
162682279|NCT02712905|587544560|FG001|Monotherapy|Started New Cancer Drug|0|||
162682280|NCT02712905|587544561|FG002|Monotherapy|Started New Cancer Drug|0|||
162682281|NCT02712905|587544562|FG003|Monotherapy|Started New Cancer Drug|0|||
162682282|NCT02712905|587544563|FG004|Monotherapy|Started New Cancer Drug|0|||
162682283|NCT02712905|587544564|FG005|Monotherapy|Started New Cancer Drug|1|||
162682284|NCT02712905|587544565|FG006|Monotherapy|Started New Cancer Drug|0|||
162682285|NCT02712905|587544566|FG007|Monotherapy|Started New Cancer Drug|0|||
162682286|NCT02712905|587544567|FG008|Monotherapy|Started New Cancer Drug|0|||
162682287|NCT02712905|587544568|FG009|Monotherapy|Started New Cancer Drug|0|||
162682288|NCT02712905|587544569|FG010|Monotherapy|Started New Cancer Drug|0|||
162682289|NCT02712905|587544570|FG011|Monotherapy|Started New Cancer Drug|0|||
162682290|NCT02712905|587544571|FG012|Monotherapy|Started New Cancer Drug|0|||
162682291|NCT02712905|587544572|FG013|Monotherapy|Started New Cancer Drug|0|||
162682292|NCT02712905|587544573|FG014|Monotherapy|Started New Cancer Drug|0|||
162682293|NCT02712905|587544574|FG015|Monotherapy|Started New Cancer Drug|0|||
162682294|NCT02712905|587544575|FG016|Monotherapy|Started New Cancer Drug|0|||
162682295|NCT02712905|587544576|FG017|Monotherapy|Started New Cancer Drug|0|||
162682296|NCT02712905|587544559|FG000|Monotherapy|Adverse Event|0|||
162682297|NCT02712905|587544560|FG001|Monotherapy|Adverse Event|0|||
162682298|NCT02712905|587544561|FG002|Monotherapy|Adverse Event|0|||
162682299|NCT02712905|587544562|FG003|Monotherapy|Adverse Event|0|||
162682300|NCT02712905|587544563|FG004|Monotherapy|Adverse Event|0|||
162725426|NCT00665444|587704587|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
162725427|NCT01068743|587704588|FG000|Period 3|Adverse Event|0|||
162725428|NCT01068743|587704589|FG001|Period 3|Adverse Event|1|||
162725429|NCT01068743|587704590|FG002|Period 3|Adverse Event|0|||
162725430|NCT01068743|587704591|FG003|Period 3|Adverse Event|0|||
162725431|NCT00293293|587704592|FG000|Overall Study|Withdrawal by Subject|1|||
162725432|NCT00293293|587704593|FG001|Overall Study|Withdrawal by Subject|1|||
162725433|NCT00293293|587704592|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
162725434|NCT00293293|587704593|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
162725435|NCT00293293|587704592|FG000|Overall Study|Patient discontinued chemotherapy|0|||
162725436|NCT00293293|587704593|FG001|Overall Study|Patient discontinued chemotherapy|1|||
162725437|NCT03740009|587704597|FG000|Overall Study|Physician Decision|9|||
162725438|NCT03740009|587704597|FG000|Overall Study|Lost to Follow-up|1|||
162725439|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
162725440|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
162725441|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
162725442|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
162725443|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
162725444|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
162725445|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
162725446|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
162725447|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
162725448|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
162725449|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
162725450|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
162725451|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
162725452|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
162725453|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
162725454|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
162725455|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
162725456|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
162725457|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
162725458|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
162725459|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
162725460|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
162725461|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
162725462|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
162725463|NCT01061151|587704598|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
162725464|NCT01061151|587704599|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
162725465|NCT01061151|587704600|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
162725466|NCT01061151|587704601|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
162725467|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
162725468|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
162725469|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
162725470|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
162725471|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
162725472|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162725473|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162725474|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162725475|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
162725476|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
162725477|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
162725478|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
162725479|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
162725480|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
162725481|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
162725482|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
162725483|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
162725484|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
162725485|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
162725486|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
162725487|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
162725488|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
162725489|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
162725490|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
162725491|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
162725492|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
162725493|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
162725494|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
162725495|NCT01061151|587704598|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
162725496|NCT01061151|587704599|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
162725497|NCT01061151|587704600|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
162725498|NCT01061151|587704601|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
162682301|NCT02712905|587544564|FG005|Monotherapy|Adverse Event|0|||
162682302|NCT02712905|587544565|FG006|Monotherapy|Adverse Event|0|||
162682303|NCT02712905|587544566|FG007|Monotherapy|Adverse Event|0|||
162682304|NCT02712905|587544567|FG008|Monotherapy|Adverse Event|1|||
162682305|NCT02712905|587544568|FG009|Monotherapy|Adverse Event|0|||
162682306|NCT02712905|587544569|FG010|Monotherapy|Adverse Event|0|||
162682307|NCT02712905|587544570|FG011|Monotherapy|Adverse Event|0|||
162682308|NCT02712905|587544571|FG012|Monotherapy|Adverse Event|0|||
162682309|NCT02712905|587544572|FG013|Monotherapy|Adverse Event|0|||
162682310|NCT02712905|587544573|FG014|Monotherapy|Adverse Event|0|||
162682311|NCT02712905|587544574|FG015|Monotherapy|Adverse Event|0|||
162682312|NCT02712905|587544575|FG016|Monotherapy|Adverse Event|0|||
162682313|NCT02712905|587544576|FG017|Monotherapy|Adverse Event|0|||
162682314|NCT02712905|587544559|FG000|Combination Therapy|Death|0|||
162682315|NCT02712905|587544560|FG001|Combination Therapy|Death|0|||
162682316|NCT02712905|587544561|FG002|Combination Therapy|Death|0|||
162682317|NCT02712905|587544562|FG003|Combination Therapy|Death|0|||
162682318|NCT02712905|587544563|FG004|Combination Therapy|Death|0|||
162682319|NCT02712905|587544564|FG005|Combination Therapy|Death|0|||
162682320|NCT02712905|587544565|FG006|Combination Therapy|Death|0|||
162682321|NCT02712905|587544566|FG007|Combination Therapy|Death|0|||
162682322|NCT02712905|587544567|FG008|Combination Therapy|Death|0|||
162682323|NCT02712905|587544568|FG009|Combination Therapy|Death|0|||
162682324|NCT02712905|587544569|FG010|Combination Therapy|Death|0|||
162682325|NCT02712905|587544570|FG011|Combination Therapy|Death|0|||
162682326|NCT02712905|587544571|FG012|Combination Therapy|Death|5|||
162682327|NCT02712905|587544572|FG013|Combination Therapy|Death|6|||
162682328|NCT02712905|587544573|FG014|Combination Therapy|Death|1|||
162682329|NCT02712905|587544574|FG015|Combination Therapy|Death|3|||
162682330|NCT02712905|587544575|FG016|Combination Therapy|Death|1|||
162682331|NCT02712905|587544576|FG017|Combination Therapy|Death|3|||
162682332|NCT02712905|587544559|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
162682333|NCT02712905|587544560|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
162682334|NCT02712905|587544561|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
162682335|NCT02712905|587544562|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
162682336|NCT02712905|587544563|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
162682337|NCT02712905|587544564|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
162682338|NCT02712905|587544565|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
162682339|NCT02712905|587544566|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
162682340|NCT02712905|587544567|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
162682341|NCT02712905|587544568|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
162682342|NCT02712905|587544569|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
162682343|NCT02712905|587544570|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
162682344|NCT02712905|587544571|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
162682345|NCT02712905|587544572|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
162682346|NCT02712905|587544573|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
162682347|NCT02712905|587544574|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
162682348|NCT02712905|587544575|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
162682349|NCT02712905|587544576|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
162682350|NCT02712905|587544559|FG000|Combination Therapy|Withdrawal by Subject|0|||
162682351|NCT02712905|587544560|FG001|Combination Therapy|Withdrawal by Subject|0|||
162682352|NCT02712905|587544561|FG002|Combination Therapy|Withdrawal by Subject|0|||
162682353|NCT02712905|587544562|FG003|Combination Therapy|Withdrawal by Subject|0|||
162682354|NCT02712905|587544563|FG004|Combination Therapy|Withdrawal by Subject|0|||
162682355|NCT02712905|587544564|FG005|Combination Therapy|Withdrawal by Subject|0|||
162682356|NCT02712905|587544565|FG006|Combination Therapy|Withdrawal by Subject|0|||
162682357|NCT02712905|587544566|FG007|Combination Therapy|Withdrawal by Subject|0|||
162682358|NCT02712905|587544567|FG008|Combination Therapy|Withdrawal by Subject|0|||
162682359|NCT02712905|587544568|FG009|Combination Therapy|Withdrawal by Subject|0|||
162682360|NCT02712905|587544569|FG010|Combination Therapy|Withdrawal by Subject|0|||
162682361|NCT02712905|587544570|FG011|Combination Therapy|Withdrawal by Subject|0|||
162682362|NCT02712905|587544571|FG012|Combination Therapy|Withdrawal by Subject|0|||
162682363|NCT02712905|587544572|FG013|Combination Therapy|Withdrawal by Subject|0|||
162682364|NCT02712905|587544573|FG014|Combination Therapy|Withdrawal by Subject|0|||
162682365|NCT02712905|587544574|FG015|Combination Therapy|Withdrawal by Subject|1|||
162682366|NCT02712905|587544575|FG016|Combination Therapy|Withdrawal by Subject|0|||
162682367|NCT02712905|587544576|FG017|Combination Therapy|Withdrawal by Subject|2|||
162682368|NCT02712905|587544559|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682369|NCT02712905|587544560|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682370|NCT02712905|587544561|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682371|NCT02712905|587544562|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682372|NCT02712905|587544563|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682373|NCT02712905|587544564|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682374|NCT02712905|587544565|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162725499|NCT01266122|587704610|FG000|Overall Study|Lost to Follow-up|6|||
162682375|NCT02712905|587544566|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682376|NCT02712905|587544567|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682377|NCT02712905|587544568|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682378|NCT02712905|587544569|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682379|NCT02712905|587544570|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682380|NCT02712905|587544571|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682381|NCT02712905|587544572|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682382|NCT02712905|587544573|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682383|NCT02712905|587544574|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
162682384|NCT02712905|587544575|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682385|NCT02712905|587544576|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162682386|NCT03624504|587544577|FG000|Overall Study|Unsuccessful Implant|1|||
162682387|NCT02975973|587544578|FG000|Overall Study|Adverse Event|1|||
162682388|NCT02975973|587544579|FG001|Overall Study|Adverse Event|1|||
162682389|NCT02975973|587544580|FG002|Overall Study|Adverse Event|1|||
162682390|NCT02975973|587544581|FG003|Overall Study|Adverse Event|0|||
162682391|NCT01812655|587544582|FG000|Overall Study|Protocol Violation|1|||
162682392|NCT01812655|587544583|FG001|Overall Study|Protocol Violation|1|||
162682393|NCT01812655|587544584|FG002|Overall Study|Protocol Violation|0|||
162682394|NCT01428076|587544585|FG000|Overall Study|Adverse Event|0|||
162682395|NCT01428076|587544586|FG001|Overall Study|Adverse Event|1|||
162682396|NCT04435665|587544587|FG000|Overall Study|Lost to Follow-up|0|||
162682397|NCT04435665|587544588|FG001|Overall Study|Lost to Follow-up|0|||
162682398|NCT04435665|587544589|FG002|Overall Study|Lost to Follow-up|0|||
162682399|NCT04435665|587544590|FG003|Overall Study|Lost to Follow-up|1|||
162682400|NCT02454101|587544591|FG000|Overall Study|Adverse Event|2|||
162682401|NCT02454101|587544592|FG001|Overall Study|Adverse Event|3|||
162682402|NCT02454101|587544591|FG000|Overall Study|Lost to Follow-up|3|||
162682403|NCT02454101|587544592|FG001|Overall Study|Lost to Follow-up|4|||
162682404|NCT00419263|587544593|FG000|Overall Study|Lost to Follow-up|2|||
162682405|NCT00419263|587544594|FG001|Overall Study|Lost to Follow-up|1|||
162682406|NCT00419263|587544595|FG002|Overall Study|Lost to Follow-up|1|||
162682407|NCT00419263|587544593|FG000|Overall Study|Randomized in Error, Not Treated|1|||
162682408|NCT00419263|587544594|FG001|Overall Study|Randomized in Error, Not Treated|1|||
162682409|NCT00419263|587544595|FG002|Overall Study|Randomized in Error, Not Treated|0|||
162682410|NCT00419263|587544593|FG000|Overall Study|Adverse Event|0|||
162682411|NCT00419263|587544594|FG001|Overall Study|Adverse Event|0|||
162682412|NCT00419263|587544595|FG002|Overall Study|Adverse Event|1|||
162682413|NCT00419263|587544593|FG000|Overall Study|Withdrawal by Subject|0|||
162682414|NCT00419263|587544594|FG001|Overall Study|Withdrawal by Subject|0|||
162682415|NCT00419263|587544595|FG002|Overall Study|Withdrawal by Subject|1|||
162682416|NCT00540124|587544599|FG000|Overall Study|Adverse Event|0|||
162682417|NCT00540124|587544600|FG001|Overall Study|Adverse Event|2|||
162682418|NCT00540124|587544601|FG002|Overall Study|Adverse Event|1|||
162682419|NCT00540124|587544599|FG000|Overall Study|Entry Criteria Not Met|2|||
162682420|NCT00540124|587544600|FG001|Overall Study|Entry Criteria Not Met|0|||
162682421|NCT00540124|587544601|FG002|Overall Study|Entry Criteria Not Met|0|||
162682422|NCT00540124|587544599|FG000|Overall Study|Lack of Efficacy|1|||
162682423|NCT00540124|587544600|FG001|Overall Study|Lack of Efficacy|0|||
162682424|NCT00540124|587544601|FG002|Overall Study|Lack of Efficacy|0|||
162682425|NCT00540124|587544599|FG000|Overall Study|Withdrawal by Subject|1|||
162682426|NCT00540124|587544600|FG001|Overall Study|Withdrawal by Subject|1|||
162682427|NCT00540124|587544601|FG002|Overall Study|Withdrawal by Subject|0|||
162682428|NCT02124265|587544602|FG000|Overall Study|Adverse Event|1|||
162682429|NCT00058123|587544603|FG000|Overall Study|Wrong histology|9|||
162682430|NCT00058123|587544603|FG000|Overall Study|Received >3 prior treatments|1|||
162682431|NCT00344461|587544606|FG000|Overall Study|Adverse Event|6|||
162682432|NCT00344461|587544606|FG000|Overall Study|Death|1|||
162682433|NCT00344461|587544606|FG000|Overall Study|Lack of Efficacy|2|||
162682434|NCT00344461|587544606|FG000|Overall Study|Lost to Follow-up|2|||
162682435|NCT00344461|587544606|FG000|Overall Study|Physician Decision|2|||
162682436|NCT00344461|587544606|FG000|Overall Study|Protocol Violation|6|||
162682437|NCT00344461|587544606|FG000|Overall Study|Withdrawal by Subject|2|||
162682438|NCT04839965|587544611|FG000|Overall Study|Death|6|||
162682439|NCT04839965|587544612|FG001|Overall Study|Death|6|||
162682440|NCT04839965|587544611|FG000|Overall Study|Lost to Follow-up|1|||
162682441|NCT04839965|587544612|FG001|Overall Study|Lost to Follow-up|0|||
162682442|NCT02291679|587544613|FG000|Overall Study|Adverse Event|2|||
162682443|NCT02291679|587544614|FG001|Overall Study|Adverse Event|12|||
162682444|NCT02291679|587544615|FG002|Overall Study|Adverse Event|19|||
162682445|NCT02291679|587544613|FG000|Overall Study|Protocol Violation|5|||
162682446|NCT02291679|587544614|FG001|Overall Study|Protocol Violation|1|||
162682447|NCT02291679|587544615|FG002|Overall Study|Protocol Violation|7|||
162725500|NCT01266122|587704611|FG001|Overall Study|Lost to Follow-up|6|||
162682448|NCT02291679|587544613|FG000|Overall Study|Withdrew Consent|18|||
162682449|NCT02291679|587544614|FG001|Overall Study|Withdrew Consent|10|||
162682450|NCT02291679|587544615|FG002|Overall Study|Withdrew Consent|15|||
162725501|NCT03756571|587704612|FG000|Overall Study|Lost to Follow-up|1|||
162725502|NCT03756571|587704613|FG001|Overall Study|Lost to Follow-up|1|||
162725503|NCT03752151|587704614|FG000|Overall Study|Withdrawal by Subject|1|||
162725504|NCT03752151|587704614|FG000|Overall Study|Protocol Violation|1|||
162725505|NCT00529516|587704615|FG000|Overall Study|Adverse Event|2|||
162725506|NCT00529516|587704616|FG001|Overall Study|Adverse Event|1|||
162725507|NCT00529516|587704617|FG002|Overall Study|Adverse Event|0|||
162725508|NCT00529516|587704615|FG000|Overall Study|Withdrawal by Subject|1|||
162725509|NCT00529516|587704616|FG001|Overall Study|Withdrawal by Subject|1|||
162725510|NCT00529516|587704617|FG002|Overall Study|Withdrawal by Subject|0|||
162725511|NCT00529516|587704615|FG000|Overall Study|Lost to Follow-up|0|||
162725512|NCT00529516|587704616|FG001|Overall Study|Lost to Follow-up|0|||
162725513|NCT00529516|587704617|FG002|Overall Study|Lost to Follow-up|1|||
162725514|NCT04056624|587704618|FG000|Overall Study|Withdrawal by Subject|0|||
162725515|NCT04056624|587704619|FG001|Overall Study|Withdrawal by Subject|0|||
162725516|NCT04056624|587704620|FG002|Overall Study|Withdrawal by Subject|1|||
162725517|NCT04056624|587704618|FG000|Overall Study|Protocol Violation|1|||
162725518|NCT04056624|587704619|FG001|Overall Study|Protocol Violation|2|||
162725519|NCT04056624|587704620|FG002|Overall Study|Protocol Violation|0|||
162725520|NCT00703820|587704624|FG000|Overall Study|Adverse Event|12|||
162725521|NCT00703820|587704625|FG001|Overall Study|Adverse Event|17|||
162725522|NCT00703820|587704624|FG000|Overall Study|Death|5|||
162725523|NCT00703820|587704625|FG001|Overall Study|Death|0|||
162725524|NCT00703820|587704624|FG000|Overall Study|Lack of Efficacy|11|||
162725525|NCT00703820|587704625|FG001|Overall Study|Lack of Efficacy|11|||
162725526|NCT00703820|587704624|FG000|Overall Study|Received non-protocol therapy|1|||
162725527|NCT00703820|587704625|FG001|Overall Study|Received non-protocol therapy|0|||
162725528|NCT00703820|587704624|FG000|Overall Study|Physician Decision|4|||
162725529|NCT00703820|587704625|FG001|Overall Study|Physician Decision|5|||
162725530|NCT00703820|587704624|FG000|Overall Study|Withdrawal by Subject|2|||
162725531|NCT00703820|587704625|FG001|Overall Study|Withdrawal by Subject|1|||
162725532|NCT02092116|587704629|FG000|Overall Study|Withdrawal by Subject|0|||
162725533|NCT02092116|587704630|FG001|Overall Study|Withdrawal by Subject|3|||
162725534|NCT02092116|587704629|FG000|Overall Study|Adverse Event|0|||
162725535|NCT02092116|587704630|FG001|Overall Study|Adverse Event|1|||
162725536|NCT01007396|587704631|FG000|Overall Study|Lost to Follow-up|47|||
162725537|NCT01792830|587704632|FG000|Overall Study|Withdrawal by Subject|22|||
162725538|NCT01792830|587704633|FG001|Overall Study|Withdrawal by Subject|0|||
162725539|NCT01792830|587704634|FG002|Overall Study|Withdrawal by Subject|0|||
162725540|NCT01792830|587704635|FG003|Overall Study|Withdrawal by Subject|2|||
162725541|NCT01792830|587704636|FG004|Overall Study|Withdrawal by Subject|1|||
162725542|NCT01792830|587704637|FG005|Overall Study|Withdrawal by Subject|1|||
162725543|NCT01792830|587704638|FG006|Overall Study|Withdrawal by Subject|1|||
162725544|NCT01792830|587704639|FG007|Overall Study|Withdrawal by Subject|1|||
162725545|NCT01792830|587704640|FG008|Overall Study|Withdrawal by Subject|7|||
162725546|NCT01792830|587704641|FG009|Overall Study|Withdrawal by Subject|0|||
162725547|NCT01792830|587704642|FG010|Overall Study|Withdrawal by Subject|2|||
162725548|NCT01792830|587704632|FG000|Overall Study|Death|3|||
162725549|NCT01792830|587704633|FG001|Overall Study|Death|0|||
162682451|NCT02291679|587544613|FG000|Overall Study|Lost to Follow-up|12|||
162682452|NCT02291679|587544614|FG001|Overall Study|Lost to Follow-up|10|||
162682453|NCT02291679|587544615|FG002|Overall Study|Lost to Follow-up|9|||
162682454|NCT02291679|587544613|FG000|Overall Study|Insufficient Therapeutic Response|5|||
162682455|NCT02291679|587544614|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162682456|NCT02291679|587544615|FG002|Overall Study|Insufficient Therapeutic Response|7|||
162682457|NCT02291679|587544613|FG000|Overall Study|Other|2|||
162682458|NCT02291679|587544614|FG001|Overall Study|Other|4|||
162682459|NCT02291679|587544615|FG002|Overall Study|Other|2|||
162725550|NCT01792830|587704634|FG002|Overall Study|Death|0|||
162725551|NCT01792830|587704635|FG003|Overall Study|Death|1|||
162682460|NCT02355028|587544616|FG000|Overall Study|Adverse Event|2|||
162682461|NCT02355028|587544617|FG001|Overall Study|Adverse Event|0|||
162682462|NCT02355028|587544616|FG000|Overall Study|Withdrawal by Subject|1|||
162682463|NCT02355028|587544617|FG001|Overall Study|Withdrawal by Subject|1|||
162725552|NCT01792830|587704636|FG004|Overall Study|Death|0|||
162725553|NCT01792830|587704637|FG005|Overall Study|Death|0|||
162725554|NCT01792830|587704638|FG006|Overall Study|Death|1|||
162725555|NCT01792830|587704639|FG007|Overall Study|Death|0|||
162725556|NCT01792830|587704640|FG008|Overall Study|Death|1|||
162725557|NCT01792830|587704641|FG009|Overall Study|Death|0|||
162725558|NCT01792830|587704642|FG010|Overall Study|Death|1|||
162725559|NCT01792830|587704632|FG000|Overall Study|Adverse Event|0|||
162725560|NCT01792830|587704633|FG001|Overall Study|Adverse Event|0|||
162725561|NCT01792830|587704634|FG002|Overall Study|Adverse Event|0|||
162725562|NCT01792830|587704635|FG003|Overall Study|Adverse Event|0|||
162725563|NCT01792830|587704636|FG004|Overall Study|Adverse Event|0|||
162725564|NCT01792830|587704637|FG005|Overall Study|Adverse Event|0|||
162725565|NCT01792830|587704638|FG006|Overall Study|Adverse Event|0|||
162725566|NCT01792830|587704639|FG007|Overall Study|Adverse Event|0|||
162725567|NCT01792830|587704640|FG008|Overall Study|Adverse Event|1|||
162725568|NCT01792830|587704641|FG009|Overall Study|Adverse Event|0|||
162725569|NCT01792830|587704642|FG010|Overall Study|Adverse Event|0|||
162725570|NCT05274217|587704658|FG000|Overall Study|Study terminated.|11|||
162725571|NCT05274217|587704659|FG001|Overall Study|Study terminated.|0|||
162725572|NCT01697969|587704660|FG000|Overall Study|Did not meet inc/exc criteria|3|||
162725573|NCT02674750|587704666|FG000|Overall Study|Death|4|||
162725574|NCT02674750|587704667|FG001|Overall Study|Death|5|||
162725575|NCT02674750|587704668|FG002|Overall Study|Death|8|||
162725576|NCT02674750|587704666|FG000|Overall Study|Lost to Follow-up|0|||
162725577|NCT02674750|587704667|FG001|Overall Study|Lost to Follow-up|8|||
162725578|NCT02674750|587704668|FG002|Overall Study|Lost to Follow-up|0|||
162725579|NCT02674750|587704666|FG000|Overall Study|Lack of Efficacy|1|||
162725580|NCT02674750|587704667|FG001|Overall Study|Lack of Efficacy|17|||
162725581|NCT02674750|587704668|FG002|Overall Study|Lack of Efficacy|3|||
162725582|NCT02674750|587704666|FG000|Overall Study|Withdrawal by Subject|0|||
162725583|NCT02674750|587704667|FG001|Overall Study|Withdrawal by Subject|7|||
162725584|NCT02674750|587704668|FG002|Overall Study|Withdrawal by Subject|1|||
162725585|NCT02674750|587704666|FG000|Overall Study|Other|0|||
162725586|NCT02674750|587704667|FG001|Overall Study|Other|8|||
162725587|NCT02674750|587704668|FG002|Overall Study|Other|0|||
162725588|NCT00736853|587704669|FG000|Open-Label Period|Physician Decision|2|||
162725589|NCT00736853|587704670|FG001|Open-Label Period|Physician Decision|0|||
162725590|NCT00736853|587704671|FG002|Open-Label Period|Physician Decision|0|||
162725591|NCT00736853|587704669|FG000|Open-Label Period|Adverse Event|31|||
162725592|NCT00736853|587704670|FG001|Open-Label Period|Adverse Event|0|||
162725593|NCT00736853|587704671|FG002|Open-Label Period|Adverse Event|0|||
162725594|NCT00736853|587704669|FG000|Open-Label Period|Withdrawal by Subject|16|||
162725595|NCT00736853|587704670|FG001|Open-Label Period|Withdrawal by Subject|0|||
162725596|NCT00736853|587704671|FG002|Open-Label Period|Withdrawal by Subject|0|||
162725597|NCT00736853|587704669|FG000|Open-Label Period|Started but not treated|42|||
162725598|NCT00736853|587704670|FG001|Open-Label Period|Started but not treated|0|||
162725599|NCT00736853|587704671|FG002|Open-Label Period|Started but not treated|0|||
162725600|NCT00736853|587704669|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
162682464|NCT02355028|587544616|FG000|Overall Study|Deemed ineligible after randomization|8|||
162725601|NCT00736853|587704670|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
162725602|NCT00736853|587704671|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
162725603|NCT00736853|587704669|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
162725604|NCT00736853|587704670|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
162725605|NCT00736853|587704671|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
162725606|NCT00736853|587704669|FG000|Double-Blind Period|Lack of Efficacy|0|||
162725607|NCT00736853|587704670|FG001|Double-Blind Period|Lack of Efficacy|19|||
162725608|NCT00736853|587704671|FG002|Double-Blind Period|Lack of Efficacy|42|||
162725609|NCT00736853|587704669|FG000|Double-Blind Period|Adverse Event|0|||
162725610|NCT00736853|587704670|FG001|Double-Blind Period|Adverse Event|3|||
162725611|NCT00736853|587704671|FG002|Double-Blind Period|Adverse Event|2|||
162725612|NCT00736853|587704669|FG000|Double-Blind Period|Withdrawal by Subject|0|||
162682465|NCT02355028|587544617|FG001|Overall Study|Deemed ineligible after randomization|4|||
162682466|NCT02276222|587544618|FG000|Overall Study|Adverse Event|62|||
162682467|NCT02276222|587544619|FG001|Overall Study|Adverse Event|11|||
162682468|NCT02276222|587544618|FG000|Overall Study|Death|3|||
162682469|NCT02276222|587544619|FG001|Overall Study|Death|4|||
162682470|NCT02276222|587544618|FG000|Overall Study|Lack of Efficacy|13|||
162682471|NCT02276222|587544619|FG001|Overall Study|Lack of Efficacy|3|||
162682472|NCT02276222|587544618|FG000|Overall Study|Protocol Violation|3|||
162682473|NCT02276222|587544619|FG001|Overall Study|Protocol Violation|2|||
162682474|NCT02276222|587544618|FG000|Overall Study|Withdrawal by Subject|79|||
162682475|NCT02276222|587544619|FG001|Overall Study|Withdrawal by Subject|33|||
162682476|NCT02276222|587544618|FG000|Overall Study|non compliance with study medication|6|||
162682477|NCT02276222|587544619|FG001|Overall Study|non compliance with study medication|2|||
162725613|NCT00736853|587704670|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162725614|NCT00736853|587704671|FG002|Double-Blind Period|Withdrawal by Subject|4|||
162725615|NCT00736853|587704669|FG000|Double-Blind Period|Ineligible to participate the study|0|||
162725616|NCT00736853|587704670|FG001|Double-Blind Period|Ineligible to participate the study|1|||
162682478|NCT02276222|587544618|FG000|Overall Study|sponsor decision|0|||
162682479|NCT02276222|587544619|FG001|Overall Study|sponsor decision|3|||
162682480|NCT02276222|587544618|FG000|Overall Study|Lost to Follow-up|15|||
162725617|NCT00736853|587704671|FG002|Double-Blind Period|Ineligible to participate the study|0|||
162725618|NCT01764464|587704672|FG000|First Intervention|Withdrawal by Subject|1|||
162725619|NCT01764464|587704673|FG001|First Intervention|Withdrawal by Subject|0|||
162725620|NCT01764464|587704672|FG000|First Intervention|Lost to Follow-up|1|||
162725621|NCT01764464|587704673|FG001|First Intervention|Lost to Follow-up|0|||
162682481|NCT02276222|587544619|FG001|Overall Study|Lost to Follow-up|5|||
162725622|NCT01764464|587704672|FG000|First Intervention|Adverse Event|0|||
162725623|NCT01764464|587704673|FG001|First Intervention|Adverse Event|2|||
162725624|NCT01764464|587704672|FG000|First Intervention|did not receive study drug|0|||
162725625|NCT01764464|587704673|FG001|First Intervention|did not receive study drug|1|||
162725626|NCT01764464|587704672|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
162725627|NCT01764464|587704673|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
162725628|NCT01616459|587704675|FG000|Overall Study|Adverse Event|1|||
162725629|NCT01616459|587704676|FG001|Overall Study|Adverse Event|1|||
162725630|NCT01616459|587704677|FG002|Overall Study|Adverse Event|2|||
162725631|NCT01616459|587704678|FG003|Overall Study|Adverse Event|0|||
162725632|NCT01616459|587704675|FG000|Overall Study|Lost to Follow-up|1|||
162725633|NCT01616459|587704676|FG001|Overall Study|Lost to Follow-up|11|||
162725634|NCT01616459|587704677|FG002|Overall Study|Lost to Follow-up|3|||
162725635|NCT01616459|587704678|FG003|Overall Study|Lost to Follow-up|2|||
162725636|NCT01616459|587704675|FG000|Overall Study|Protocol Violation|0|||
162725637|NCT01616459|587704676|FG001|Overall Study|Protocol Violation|0|||
162725638|NCT01616459|587704677|FG002|Overall Study|Protocol Violation|0|||
162725639|NCT01616459|587704678|FG003|Overall Study|Protocol Violation|2|||
162682482|NCT02276222|587544618|FG000|Overall Study|Physician Decision|2|||
162682483|NCT02276222|587544619|FG001|Overall Study|Physician Decision|1|||
162682484|NCT02276222|587544618|FG000|Overall Study|sheduling conflict|1|||
162682485|NCT02276222|587544619|FG001|Overall Study|sheduling conflict|0|||
162682486|NCT02276222|587544618|FG000|Overall Study|subject withdrew after randomization|1|||
162682487|NCT02276222|587544619|FG001|Overall Study|subject withdrew after randomization|0|||
162682488|NCT02170025|587544620|FG000|Overall Study|Adverse Event|2|||
162682489|NCT02170025|587544621|FG001|Overall Study|Adverse Event|0|||
162682490|NCT01525602|587544622|FG000|Overall Study|Adverse Event|1|||
162682491|NCT01525602|587544623|FG001|Overall Study|Adverse Event|0|||
162682492|NCT01525602|587544624|FG002|Overall Study|Adverse Event|1|||
162682493|NCT01525602|587544625|FG003|Overall Study|Adverse Event|1|||
162682494|NCT01525602|587544626|FG004|Overall Study|Adverse Event|3|||
162682495|NCT01525602|587544627|FG005|Overall Study|Adverse Event|3|||
162682496|NCT01525602|587544628|FG006|Overall Study|Adverse Event|0|||
162682497|NCT01525602|587544629|FG007|Overall Study|Adverse Event|1|||
162682498|NCT01525602|587544622|FG000|Overall Study|Disease progression|6|||
162682499|NCT01525602|587544623|FG001|Overall Study|Disease progression|3|||
162682500|NCT01525602|587544624|FG002|Overall Study|Disease progression|2|||
162682501|NCT01525602|587544625|FG003|Overall Study|Disease progression|5|||
162682502|NCT01525602|587544626|FG004|Overall Study|Disease progression|22|||
162682503|NCT01525602|587544627|FG005|Overall Study|Disease progression|2|||
162682504|NCT01525602|587544628|FG006|Overall Study|Disease progression|3|||
162682505|NCT01525602|587544629|FG007|Overall Study|Disease progression|3|||
162682506|NCT01525602|587544622|FG000|Overall Study|Clinical progression|2|||
162682507|NCT01525602|587544623|FG001|Overall Study|Clinical progression|0|||
162682508|NCT01525602|587544624|FG002|Overall Study|Clinical progression|0|||
162682509|NCT01525602|587544625|FG003|Overall Study|Clinical progression|0|||
162682510|NCT01525602|587544626|FG004|Overall Study|Clinical progression|0|||
162682511|NCT01525602|587544627|FG005|Overall Study|Clinical progression|0|||
162682512|NCT01525602|587544628|FG006|Overall Study|Clinical progression|1|||
162682513|NCT01525602|587544629|FG007|Overall Study|Clinical progression|1|||
162682514|NCT01525602|587544622|FG000|Overall Study|Non-compliance|0|||
162682515|NCT01525602|587544623|FG001|Overall Study|Non-compliance|0|||
162682516|NCT01525602|587544624|FG002|Overall Study|Non-compliance|0|||
162682517|NCT01525602|587544625|FG003|Overall Study|Non-compliance|0|||
162682518|NCT01525602|587544626|FG004|Overall Study|Non-compliance|1|||
162682519|NCT01525602|587544627|FG005|Overall Study|Non-compliance|0|||
162682520|NCT01525602|587544628|FG006|Overall Study|Non-compliance|0|||
162682521|NCT01525602|587544629|FG007|Overall Study|Non-compliance|0|||
162682522|NCT01525602|587544622|FG000|Overall Study|Withdrawal by Subject|0|||
162682523|NCT01525602|587544623|FG001|Overall Study|Withdrawal by Subject|0|||
162682524|NCT01525602|587544624|FG002|Overall Study|Withdrawal by Subject|0|||
162682525|NCT01525602|587544625|FG003|Overall Study|Withdrawal by Subject|0|||
162682526|NCT01525602|587544626|FG004|Overall Study|Withdrawal by Subject|3|||
162682527|NCT01525602|587544627|FG005|Overall Study|Withdrawal by Subject|1|||
162682528|NCT01525602|587544628|FG006|Overall Study|Withdrawal by Subject|0|||
162682529|NCT01525602|587544629|FG007|Overall Study|Withdrawal by Subject|1|||
162682530|NCT01525602|587544622|FG000|Overall Study|Physician Decision|0|||
162682531|NCT01525602|587544623|FG001|Overall Study|Physician Decision|0|||
162682532|NCT01525602|587544624|FG002|Overall Study|Physician Decision|0|||
162682533|NCT01525602|587544625|FG003|Overall Study|Physician Decision|0|||
162682534|NCT01525602|587544626|FG004|Overall Study|Physician Decision|3|||
162725640|NCT01616459|587704675|FG000|Overall Study|Withdrawal by Subject|2|||
162725641|NCT01616459|587704676|FG001|Overall Study|Withdrawal by Subject|4|||
162725642|NCT01616459|587704677|FG002|Overall Study|Withdrawal by Subject|4|||
162725643|NCT01616459|587704678|FG003|Overall Study|Withdrawal by Subject|4|||
162725644|NCT01616459|587704675|FG000|Overall Study|Other reason|0|||
162725645|NCT01616459|587704676|FG001|Overall Study|Other reason|1|||
162682535|NCT01525602|587544627|FG005|Overall Study|Physician Decision|0|||
162682536|NCT01525602|587544628|FG006|Overall Study|Physician Decision|1|||
162682537|NCT01525602|587544629|FG007|Overall Study|Physician Decision|0|||
162682538|NCT01525602|587544622|FG000|Overall Study|Death|0|||
162682539|NCT01525602|587544623|FG001|Overall Study|Death|0|||
162682540|NCT01525602|587544624|FG002|Overall Study|Death|0|||
162682541|NCT01525602|587544625|FG003|Overall Study|Death|0|||
162682542|NCT01525602|587544626|FG004|Overall Study|Death|1|||
162682543|NCT01525602|587544627|FG005|Overall Study|Death|1|||
162682544|NCT01525602|587544628|FG006|Overall Study|Death|0|||
162725646|NCT01616459|587704677|FG002|Overall Study|Other reason|1|||
162682545|NCT01525602|587544629|FG007|Overall Study|Death|0|||
162682546|NCT01525602|587544622|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682547|NCT01525602|587544623|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682548|NCT01525602|587544624|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682549|NCT01525602|587544625|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682550|NCT01525602|587544626|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682551|NCT01525602|587544627|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
162682552|NCT01525602|587544628|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
162682553|NCT01525602|587544629|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
162682554|NCT03703466|587544635|FG000|Overall Study|Death|2|||
162682555|NCT03703466|587544636|FG001|Overall Study|Death|1|||
162682556|NCT03703466|587544637|FG002|Overall Study|Death|0|||
162682557|NCT03703466|587544635|FG000|Overall Study|Withdrawal by Subject|0|||
162682558|NCT03703466|587544636|FG001|Overall Study|Withdrawal by Subject|3|||
162682559|NCT03703466|587544637|FG002|Overall Study|Withdrawal by Subject|0|||
162682560|NCT03703466|587544635|FG000|Overall Study|Completed < 3 Cycles|2|||
162682561|NCT03703466|587544636|FG001|Overall Study|Completed < 3 Cycles|2|||
162682562|NCT03703466|587544637|FG002|Overall Study|Completed < 3 Cycles|2|||
162682563|NCT02412137|587544638|FG000|Overall Study|Withdrawal by Subject|2|||
162682564|NCT02412137|587544639|FG001|Overall Study|Withdrawal by Subject|0|||
162682565|NCT02412137|587544638|FG000|Overall Study|Lost to Follow-up|21|||
162682566|NCT02412137|587544639|FG001|Overall Study|Lost to Follow-up|14|||
162682567|NCT02412137|587544638|FG000|Overall Study|Physician Decision|28|||
162682568|NCT02412137|587544639|FG001|Overall Study|Physician Decision|9|||
162682569|NCT00506493|587544640|FG000|Overall Study|Death|6|||
162682570|NCT00506493|587544640|FG000|Overall Study|Withdrawal by Subject|5|||
162682571|NCT02532179|587546264|FG000|Overall Study|Lost to Follow-up|1|||
162682572|NCT02532179|587546264|FG000|Overall Study|Pregnancy|1|||
162682573|NCT02532179|587546264|FG000|Overall Study|Subject received depot steroid injection|1|||
162682574|NCT02240108|587546265|FG000|Overall Study|Other than specified|8|||
162682575|NCT02240108|587546266|FG001|Overall Study|Other than specified|6|||
162682576|NCT02240108|587546265|FG000|Overall Study|Adverse Event|1|||
162682577|NCT02240108|587546266|FG001|Overall Study|Adverse Event|9|||
162682578|NCT02240108|587546265|FG000|Overall Study|Pregnancy|1|||
162682579|NCT02240108|587546266|FG001|Overall Study|Pregnancy|0|||
162682580|NCT02240108|587546265|FG000|Overall Study|Withdrawal by Subject|4|||
162682581|NCT02240108|587546266|FG001|Overall Study|Withdrawal by Subject|9|||
162682582|NCT02240108|587546265|FG000|Overall Study|StudyTerminated by Sponsor|0|||
162682583|NCT02240108|587546266|FG001|Overall Study|StudyTerminated by Sponsor|1|||
162682584|NCT00119405|587546267|FG000|Overall Study|Withdrawal by Subject|1|||
162682585|NCT00939484|587546269|FG000|Overall Study|Progression/Relapse|8|||
162682586|NCT00939484|587546270|FG001|Overall Study|Progression/Relapse|20|||
162682587|NCT00939484|587546271|FG002|Overall Study|Progression/Relapse|3|||
162682588|NCT04233372|587546272|FG000|Overall Study|Lost to Follow-up|104|||
162682589|NCT04233372|587546272|FG000|Overall Study|Adverse Event|8|||
162682590|NCT04233372|587546272|FG000|Overall Study|Withdrawal by Subject|2|||
162682591|NCT04958785|587546273|FG000|Overall Study|Study Terminated by Sponsor|4|||
162682592|NCT04958785|587546274|FG001|Overall Study|Study Terminated by Sponsor|10|||
162682593|NCT04958785|587546275|FG002|Overall Study|Study Terminated by Sponsor|7|||
162682594|NCT04958785|587546276|FG003|Overall Study|Study Terminated by Sponsor|6|||
162682595|NCT04958785|587546277|FG004|Overall Study|Study Terminated by Sponsor|34|||
162682596|NCT04958785|587546273|FG000|Overall Study|Death|2|||
162682597|NCT04958785|587546274|FG001|Overall Study|Death|3|||
162682598|NCT04958785|587546275|FG002|Overall Study|Death|4|||
162682599|NCT04958785|587546276|FG003|Overall Study|Death|5|||
162682600|NCT04958785|587546277|FG004|Overall Study|Death|5|||
162682601|NCT04958785|587546273|FG000|Overall Study|Withdrew consent|2|||
162682602|NCT04958785|587546274|FG001|Overall Study|Withdrew consent|0|||
162682603|NCT04958785|587546275|FG002|Overall Study|Withdrew consent|3|||
162682604|NCT04958785|587546276|FG003|Overall Study|Withdrew consent|1|||
162682605|NCT04958785|587546277|FG004|Overall Study|Withdrew consent|0|||
162682606|NCT04958785|587546273|FG000|Overall Study|Investigator's discretion|0|||
162682607|NCT04958785|587546274|FG001|Overall Study|Investigator's discretion|1|||
162682608|NCT04958785|587546275|FG002|Overall Study|Investigator's discretion|0|||
162682609|NCT04958785|587546276|FG003|Overall Study|Investigator's discretion|1|||
162682610|NCT04958785|587546277|FG004|Overall Study|Investigator's discretion|2|||
162682611|NCT04958785|587546273|FG000|Overall Study|Adverse Event|0|||
162682612|NCT04958785|587546274|FG001|Overall Study|Adverse Event|0|||
162682613|NCT04958785|587546275|FG002|Overall Study|Adverse Event|0|||
162725647|NCT01616459|587704678|FG003|Overall Study|Other reason|0|||
162725648|NCT03237481|587705949|FG000|Overall Study|Lost to Follow-up|1|||
162725649|NCT03237481|587705950|FG001|Overall Study|Lost to Follow-up|0|||
162682614|NCT04958785|587546276|FG003|Overall Study|Adverse Event|0|||
162682615|NCT04958785|587546277|FG004|Overall Study|Adverse Event|1|||
162682616|NCT04958785|587546273|FG000|Overall Study|Lost to Follow-up|0|||
162682617|NCT04958785|587546274|FG001|Overall Study|Lost to Follow-up|0|||
162682618|NCT04958785|587546275|FG002|Overall Study|Lost to Follow-up|0|||
162682619|NCT04958785|587546276|FG003|Overall Study|Lost to Follow-up|0|||
162682620|NCT04958785|587546277|FG004|Overall Study|Lost to Follow-up|1|||
162682621|NCT01090310|587546278|FG000|Core Study|Adverse Event|2|||
162682622|NCT01090310|587546279|FG001|Core Study|Adverse Event|2|||
162725650|NCT03237481|587705951|FG002|Overall Study|Lost to Follow-up|0|||
162725651|NCT03237481|587705949|FG000|Overall Study|Protocol Violation|1|||
162725652|NCT03237481|587705950|FG001|Overall Study|Protocol Violation|0|||
162725653|NCT03237481|587705951|FG002|Overall Study|Protocol Violation|0|||
162725654|NCT03237481|587705949|FG000|Overall Study|Withdrawal by Subject|3|||
162725655|NCT03237481|587705950|FG001|Overall Study|Withdrawal by Subject|2|||
162725656|NCT03237481|587705951|FG002|Overall Study|Withdrawal by Subject|1|||
162725657|NCT02991807|587705952|FG000|Overall Study|Withdrawal by Subject|2|||
162725658|NCT02991807|587705953|FG001|Overall Study|Withdrawal by Subject|1|||
162725659|NCT02991807|587705952|FG000|Overall Study|Physician Decision|0|||
162725660|NCT02991807|587705953|FG001|Overall Study|Physician Decision|1|||
162725661|NCT02991807|587705952|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
162725662|NCT02991807|587705953|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
162725663|NCT02566902|587705954|FG000|Overall Study|Protocol Violation|2|||
162725664|NCT02566902|587705955|FG001|Overall Study|Protocol Violation|1|||
162725665|NCT01875848|587705956|FG000|Overall Study|Withdrawal by Subject|2|||
162725666|NCT01875848|587705957|FG001|Overall Study|Withdrawal by Subject|0|||
162725667|NCT02411084|587705958|FG000|Overall Study|Lack of Efficacy|6|||
162725668|NCT02411084|587705959|FG001|Overall Study|Lack of Efficacy|3|||
162725669|NCT02411084|587705958|FG000|Overall Study|Death|5|||
162725670|NCT02411084|587705959|FG001|Overall Study|Death|4|||
162725671|NCT02411084|587705958|FG000|Overall Study|Adverse Event|2|||
162725672|NCT02411084|587705959|FG001|Overall Study|Adverse Event|1|||
162725673|NCT02411084|587705958|FG000|Overall Study|Other reasons|0|||
162725674|NCT02411084|587705959|FG001|Overall Study|Other reasons|5|||
162725675|NCT02374463|587705960|FG000|Overall Study|Withdrawal by Subject|3|||
162725676|NCT02374463|587705961|FG001|Overall Study|Withdrawal by Subject|3|||
162725677|NCT04723394|587705970|FG000|Overall Study|Adverse Event|0|||
162725678|NCT04723394|587705971|FG001|Overall Study|Adverse Event|3|||
162725679|NCT04723394|587705970|FG000|Overall Study|Death|8|||
162725680|NCT04723394|587705971|FG001|Overall Study|Death|8|||
162725681|NCT04723394|587705970|FG000|Overall Study|Lost to Follow-up|20|||
162725682|NCT04723394|587705971|FG001|Overall Study|Lost to Follow-up|17|||
162725683|NCT04723394|587705970|FG000|Overall Study|Physician Decision|1|||
162725684|NCT04723394|587705971|FG001|Overall Study|Physician Decision|0|||
162725685|NCT04723394|587705970|FG000|Overall Study|Withdrawal by Subject|20|||
162725686|NCT04723394|587705971|FG001|Overall Study|Withdrawal by Subject|34|||
162725687|NCT04723394|587705970|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
162725688|NCT04723394|587705971|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
162725689|NCT00446459|587705972|FG000|8 Months|Protocol Violation|12|||
162725690|NCT00446459|587705972|FG000|12 Months|Protocol Violation|4|||
162725691|NCT00446459|587705972|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
162725692|NCT02647905|587705975|FG000|Overall Study|Lost to Follow-up|1|||
162725693|NCT02647905|587705975|FG000|Overall Study|Withdrawal by Subject|2|||
162725694|NCT02765100|587705976|FG000|Overall Study|subject found ineligible after baseline|1|||
162725695|NCT02765100|587705977|FG001|Overall Study|subject found ineligible after baseline|1|||
162725696|NCT02765100|587705976|FG000|Overall Study|Lost to Follow-up|0|||
162725697|NCT02765100|587705977|FG001|Overall Study|Lost to Follow-up|1|||
162682623|NCT01090310|587546280|FG002|Core Study|Adverse Event|1|||
162682624|NCT01090310|587546281|FG003|Core Study|Adverse Event|1|||
162682625|NCT01090310|587546278|FG000|Core Study|Subject withdrew consent|0|||
162682626|NCT01090310|587546279|FG001|Core Study|Subject withdrew consent|3|||
162725698|NCT00642850|587705981|FG000|Overall Study|Death|7|||
162725699|NCT00642850|587705981|FG000|Overall Study|Adverse Event|2|||
162725700|NCT00642850|587705981|FG000|Overall Study|Lack of Efficacy|1|||
162725701|NCT00642850|587705981|FG000|Overall Study|Protocol Violation|2|||
162725702|NCT00642850|587705981|FG000|Overall Study|Kidney transplantation|8|||
162725703|NCT00642850|587705981|FG000|Overall Study|Blood transfusion|6|||
162725704|NCT00642850|587705981|FG000|Overall Study|Other reasons|7|||
162725705|NCT00244855|587705988|FG000|Overall Study|Withdrawal by Subject|0|||
162725706|NCT00244855|587705989|FG001|Overall Study|Withdrawal by Subject|1|||
162725707|NCT01236001|587705990|FG000|Overall Study|Adverse Event|5|||
162725708|NCT01236001|587705991|FG001|Overall Study|Adverse Event|14|||
162725709|NCT01236001|587705990|FG000|Overall Study|Lack of Efficacy|6|||
162725710|NCT01236001|587705991|FG001|Overall Study|Lack of Efficacy|6|||
162682627|NCT01090310|587546280|FG002|Core Study|Subject withdrew consent|1|||
162682628|NCT01090310|587546281|FG003|Core Study|Subject withdrew consent|1|||
162682629|NCT01090310|587546278|FG000|Core Study|Abnormal test procedure result|0|||
162682630|NCT01090310|587546279|FG001|Core Study|Abnormal test procedure result|0|||
162682631|NCT01090310|587546280|FG002|Core Study|Abnormal test procedure result|1|||
162682632|NCT01090310|587546281|FG003|Core Study|Abnormal test procedure result|0|||
162682633|NCT01090310|587546278|FG000|Core Study|Administrative reasons|5|||
162682634|NCT01090310|587546279|FG001|Core Study|Administrative reasons|6|||
162682635|NCT01090310|587546280|FG002|Core Study|Administrative reasons|4|||
162682636|NCT01090310|587546281|FG003|Core Study|Administrative reasons|4|||
162682637|NCT01090310|587546278|FG000|Core Study|Protocol deviation|1|||
162682638|NCT01090310|587546279|FG001|Core Study|Protocol deviation|0|||
162682639|NCT01090310|587546280|FG002|Core Study|Protocol deviation|0|||
162682640|NCT01090310|587546281|FG003|Core Study|Protocol deviation|1|||
162682641|NCT01090310|587546278|FG000|Extension Study|Aministrative problems|13|||
162682642|NCT01090310|587546279|FG001|Extension Study|Aministrative problems|15|||
162682643|NCT01090310|587546280|FG002|Extension Study|Aministrative problems|14|||
162682644|NCT01090310|587546281|FG003|Extension Study|Aministrative problems|18|||
162682645|NCT01090310|587546278|FG000|Extension Study|Adverse Event|0|||
162682646|NCT01090310|587546279|FG001|Extension Study|Adverse Event|0|||
162682647|NCT01090310|587546280|FG002|Extension Study|Adverse Event|0|||
162682648|NCT01090310|587546281|FG003|Extension Study|Adverse Event|1|||
162682649|NCT01090310|587546278|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
162682650|NCT01090310|587546279|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
162682651|NCT01090310|587546280|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
162682652|NCT01090310|587546281|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
162682653|NCT01090310|587546278|FG000|Extension Study|Subject withdrew consent|0|||
162682654|NCT01090310|587546279|FG001|Extension Study|Subject withdrew consent|1|||
162682655|NCT01090310|587546280|FG002|Extension Study|Subject withdrew consent|0|||
162682656|NCT01090310|587546281|FG003|Extension Study|Subject withdrew consent|0|||
162682657|NCT01224925|587546282|FG000|Overall Study|Lost to Follow-up|3|||
162682658|NCT01224925|587546283|FG001|Overall Study|Lost to Follow-up|2|||
162682659|NCT02472652|587546288|FG000|Overall Study|Lost to Follow-up|1|||
162682660|NCT03185832|587546289|FG000|Overall Study|Death|9|||
162682661|NCT03185832|587546290|FG001|Overall Study|Death|14|||
162682662|NCT03185832|587546291|FG002|Overall Study|Death|9|||
162682663|NCT03185832|587546292|FG003|Overall Study|Death|7|||
162682664|NCT03185832|587546289|FG000|Overall Study|Withdrawn - vital status available|0|||
162682665|NCT03185832|587546290|FG001|Overall Study|Withdrawn - vital status available|1|||
162682666|NCT03185832|587546291|FG002|Overall Study|Withdrawn - vital status available|1|||
162682667|NCT03185832|587546292|FG003|Overall Study|Withdrawn - vital status available|4|||
162682668|NCT01083641|587546294|FG000|Overall Study|Withdrawal by Subject|2|||
162682669|NCT03439189|587546295|FG000|Overall Study|Protocol Violation|19|||
162682670|NCT03439189|587546295|FG000|Overall Study|Lack of Efficacy|63|||
162682671|NCT01777321|587546296|FG000|Overall Study|Withdrawal by Subject|0|||
162682672|NCT01777321|587546297|FG001|Overall Study|Withdrawal by Subject|1|||
162682673|NCT02173548|587546298|FG000|Overall Study|Lost to Follow-up|0|||
162682674|NCT02173548|587546299|FG001|Overall Study|Lost to Follow-up|2|||
162682675|NCT02173548|587546298|FG000|Overall Study|Withdrawal by Subject|1|||
162682676|NCT02173548|587546299|FG001|Overall Study|Withdrawal by Subject|0|||
162682677|NCT03597568|587546300|FG000|Overall Study|Withdrawal by Subject|1|||
162682678|NCT03597568|587546301|FG001|Overall Study|Withdrawal by Subject|1|||
162682679|NCT03597568|587546300|FG000|Overall Study|Unable to analyze vascular data|1|||
162682680|NCT03597568|587546301|FG001|Overall Study|Unable to analyze vascular data|1|||
162682681|NCT00999466|587546304|FG000|Main Part|Withdrawal by Subject|0|||
162682682|NCT00999466|587546305|FG001|Main Part|Withdrawal by Subject|0|||
162682683|NCT00999466|587546306|FG002|Main Part|Withdrawal by Subject|2|||
162682684|NCT00999466|587546304|FG000|Main Part|Adverse Event|0|||
162682685|NCT00999466|587546305|FG001|Main Part|Adverse Event|4|||
162682686|NCT00999466|587546306|FG002|Main Part|Adverse Event|2|||
162682687|NCT05131165|587546307|FG000|Overall Study|Death|1|||
162682688|NCT05131165|587546308|FG001|Overall Study|Death|1|||
162682689|NCT05131165|587546309|FG002|Overall Study|Death|0|||
162682690|NCT05131165|587546307|FG000|Overall Study|Lost to Follow-up|2|||
162725711|NCT01236001|587705990|FG000|Overall Study|Lost to Follow-up|6|||
162725712|NCT01236001|587705991|FG001|Overall Study|Lost to Follow-up|1|||
162682691|NCT05131165|587546308|FG001|Overall Study|Lost to Follow-up|2|||
162682692|NCT05131165|587546309|FG002|Overall Study|Lost to Follow-up|5|||
162682693|NCT05131165|587546307|FG000|Overall Study|Transferred out of clinic|1|||
162682694|NCT05131165|587546308|FG001|Overall Study|Transferred out of clinic|0|||
162682695|NCT05131165|587546309|FG002|Overall Study|Transferred out of clinic|3|||
162682696|NCT05131165|587546307|FG000|Overall Study|Dropped out|1|||
162682697|NCT05131165|587546308|FG001|Overall Study|Dropped out|2|||
162725713|NCT01236001|587705990|FG000|Overall Study|Incompliance|1|||
162682698|NCT05131165|587546309|FG002|Overall Study|Dropped out|0|||
162682699|NCT00526630|587546310|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
162682700|NCT00526630|587546311|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
162682701|NCT00526630|587546310|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
162682702|NCT00526630|587546311|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
162682703|NCT00337272|587546312|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
162682704|NCT00337272|587546313|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
162682705|NCT00337272|587546312|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
162682706|NCT00337272|587546313|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
162725714|NCT01236001|587705991|FG001|Overall Study|Incompliance|0|||
162682707|NCT00337272|587546312|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
162682708|NCT00337272|587546313|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
162682709|NCT00337272|587546312|FG000|Treatment Period|Non-compliance|1|||
162682710|NCT00337272|587546313|FG001|Treatment Period|Non-compliance|1|||
162682711|NCT00337272|587546312|FG000|Treatment Period|Withdrawal by Subject|0|||
162682712|NCT00337272|587546313|FG001|Treatment Period|Withdrawal by Subject|1|||
162682713|NCT00337272|587546312|FG000|Withdrawal Period|Non-compliance|0|||
162682714|NCT00337272|587546313|FG001|Withdrawal Period|Non-compliance|1|||
162682715|NCT03320018|587546319|FG000|Treatment Period|Withdrawal by Subject|1|||
162682716|NCT03320018|587546320|FG001|Treatment Period|Withdrawal by Subject|0|||
162682717|NCT03320018|587546319|FG000|Day 90 Follow up|Death|0|||
162682718|NCT03320018|587546320|FG001|Day 90 Follow up|Death|1|||
162682719|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
162682720|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
162682721|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
162682722|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
162682723|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
162682724|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
162682725|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
162682726|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
162682727|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
162682728|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
162682729|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
162682730|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
162682731|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
162682732|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
162682733|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
162682734|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
162682735|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
162682736|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
162682737|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
162682738|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
162682739|NCT00549757|587546321|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
162682740|NCT00549757|587546322|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
162682741|NCT00549757|587546321|FG000|Extension Period (in Average 9 Months)|Death|143|||
162682742|NCT00549757|587546322|FG001|Extension Period (in Average 9 Months)|Death|136|||
162682743|NCT00549757|587546321|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
162682744|NCT00549757|587546322|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
162682745|NCT00549757|587546321|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
162682746|NCT00549757|587546322|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
162682747|NCT00549757|587546321|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
162682748|NCT00549757|587546322|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
162682749|NCT05906368|587546337|FG000|Overall Study|Withdrawal by Subject|1|||
162682750|NCT05906368|587546338|FG001|Overall Study|Withdrawal by Subject|1|||
162682751|NCT05906368|587546337|FG000|Overall Study|Ineligibility criteria identified|2|||
162682752|NCT05906368|587546338|FG001|Overall Study|Ineligibility criteria identified|0|||
162682753|NCT01127646|587546339|FG000|Overall Study|Entry Criteria Not Met|1|||
162682754|NCT01127646|587546340|FG001|Overall Study|Entry Criteria Not Met|0|||
162682755|NCT01127646|587546339|FG000|Overall Study|Protocol Violation|0|||
162682756|NCT01127646|587546340|FG001|Overall Study|Protocol Violation|1|||
162682757|NCT00595504|587546344|FG000|Overall Study|Withdrawal by Subject|1|||
162682758|NCT00595504|587546345|FG001|Overall Study|Withdrawal by Subject|3|||
162682759|NCT00595504|587546344|FG000|Overall Study|Physician Decision|1|||
162682760|NCT00595504|587546345|FG001|Overall Study|Physician Decision|0|||
162682761|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
162682762|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
162682763|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162682764|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162682765|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
162682766|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
162682767|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
162682768|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162682769|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162682770|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162682771|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162682772|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162682773|NCT00293267|587546349|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
162682774|NCT00293267|587546350|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
162682775|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
162682776|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
162682777|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
162682778|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
162682779|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
162682780|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
162682781|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
162682782|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
162682783|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Death|3|||
162682784|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Death|0|||
162682785|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
162682786|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
162682787|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
162682788|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
162682789|NCT00293267|587546349|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
162682790|NCT00293267|587546350|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
162682791|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
162682792|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
162682793|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
162682794|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
162682795|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
162682796|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
162682797|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
162682798|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
162682799|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
162682800|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
162682801|NCT00293267|587546349|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
162682802|NCT00293267|587546350|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
162682803|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
162682804|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
162682805|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
162682806|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
162682807|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
162682808|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
162682809|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
162682810|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
162682811|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
162682812|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
162682813|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
162682814|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
162682815|NCT00293267|587546349|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
162682816|NCT00293267|587546350|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
162682817|NCT01804816|587546351|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
162682818|NCT01804816|587546351|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
162682819|NCT01754467|587546352|FG000|Overall Study|Lost to Follow-up|1|||
162682820|NCT01123382|587546355|FG000|Overall Study|Withdrawal by Subject|1|||
162682821|NCT01123382|587546356|FG001|Overall Study|Withdrawal by Subject|4|||
162682822|NCT01123382|587546355|FG000|Overall Study|Lost to Follow-up|1|||
162682823|NCT01123382|587546356|FG001|Overall Study|Lost to Follow-up|2|||
162682824|NCT02403180|587546357|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
162682825|NCT02403180|587546358|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
162682826|NCT02403180|587546357|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
162682827|NCT02403180|587546358|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
162682828|NCT02230956|587546361|FG000|Overall Study|Adverse Event|1|||
162682829|NCT02230956|587546362|FG001|Overall Study|Adverse Event|1|||
162682830|NCT02230956|587546363|FG002|Overall Study|Adverse Event|0|||
162682831|NCT02230956|587546361|FG000|Overall Study|Lack of Efficacy|1|||
162682832|NCT02230956|587546362|FG001|Overall Study|Lack of Efficacy|1|||
162682833|NCT02230956|587546363|FG002|Overall Study|Lack of Efficacy|1|||
162682834|NCT02230956|587546361|FG000|Overall Study|Lost to Follow-up|1|||
162682835|NCT02230956|587546362|FG001|Overall Study|Lost to Follow-up|1|||
162682836|NCT02230956|587546363|FG002|Overall Study|Lost to Follow-up|2|||
162682837|NCT02230956|587546361|FG000|Overall Study|Personal Reasons|2|||
162682838|NCT02230956|587546362|FG001|Overall Study|Personal Reasons|1|||
162682839|NCT02230956|587546363|FG002|Overall Study|Personal Reasons|1|||
162682840|NCT02230956|587546361|FG000|Overall Study|Protocol Violation|0|||
162682841|NCT02230956|587546362|FG001|Overall Study|Protocol Violation|1|||
162682842|NCT02230956|587546363|FG002|Overall Study|Protocol Violation|1|||
162682843|NCT02230956|587546361|FG000|Overall Study|Other Miscellaneous Reason|0|||
162682844|NCT02230956|587546362|FG001|Overall Study|Other Miscellaneous Reason|1|||
162682845|NCT02230956|587546363|FG002|Overall Study|Other Miscellaneous Reason|2|||
162682846|NCT01445652|587546364|FG000|Overall Study|Not comfortable in lenses|5|||
162682847|NCT01445652|587546365|FG001|Overall Study|Not comfortable in lenses|0|||
162682848|NCT01445652|587546364|FG000|Overall Study|Failed to attend scheduled visit|2|||
162682849|NCT01445652|587546365|FG001|Overall Study|Failed to attend scheduled visit|3|||
162682850|NCT01445652|587546364|FG000|Overall Study|Failed teach session|2|||
162682851|NCT01445652|587546365|FG001|Overall Study|Failed teach session|0|||
162682852|NCT01445652|587546364|FG000|Overall Study|Adverse Event|1|||
162682853|NCT01445652|587546365|FG001|Overall Study|Adverse Event|0|||
162682854|NCT03002610|587546366|FG000|Overall Study|Withdrawal by Subject|6|||
162682855|NCT03002610|587546367|FG001|Overall Study|Withdrawal by Subject|25|||
162682856|NCT03002610|587546368|FG002|Overall Study|Withdrawal by Subject|13|||
162682857|NCT00929162|587546369|FG000|Overall Study|Adverse Event|8|||
162682858|NCT00929162|587546370|FG001|Overall Study|Adverse Event|5|||
162682859|NCT00929162|587546369|FG000|Overall Study|Withdrawal by Subject|3|||
162682860|NCT00929162|587546370|FG001|Overall Study|Withdrawal by Subject|1|||
162682861|NCT00929162|587546369|FG000|Overall Study|Protocol Violation|32|||
162682862|NCT00929162|587546370|FG001|Overall Study|Protocol Violation|30|||
162682863|NCT00929162|587546369|FG000|Overall Study|Other termination reason|5|||
162682864|NCT00929162|587546370|FG001|Overall Study|Other termination reason|6|||
162682865|NCT01822587|587546371|FG000|Overall Study|Lost to Follow-up|7|||
162682866|NCT01822587|587546372|FG001|Overall Study|Lost to Follow-up|9|||
162682867|NCT01822587|587546373|FG002|Overall Study|Lost to Follow-up|12|||
162682868|NCT01822587|587546371|FG000|Overall Study|Physician Decision|9|||
162682869|NCT01822587|587546372|FG001|Overall Study|Physician Decision|6|||
162682870|NCT01822587|587546373|FG002|Overall Study|Physician Decision|6|||
162682871|NCT00658567|587546375|FG000|Overall Study|Adverse Event|5|||
162682872|NCT00658567|587546376|FG001|Overall Study|Adverse Event|2|||
162682873|NCT00658567|587546377|FG002|Overall Study|Adverse Event|3|||
162682874|NCT00658567|587546375|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
162682875|NCT00658567|587546376|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
162682876|NCT00658567|587546377|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
162682877|NCT00658567|587546375|FG000|Overall Study|Physician Decision|0|||
162682878|NCT00658567|587546376|FG001|Overall Study|Physician Decision|1|||
162682879|NCT00658567|587546377|FG002|Overall Study|Physician Decision|0|||
162682880|NCT00658567|587546375|FG000|Overall Study|At Discretion of Sponsor|1|||
162682881|NCT00658567|587546376|FG001|Overall Study|At Discretion of Sponsor|1|||
162682882|NCT00658567|587546377|FG002|Overall Study|At Discretion of Sponsor|1|||
162682883|NCT01755702|587546378|FG000|Wash Out Period I|Other Reason|3|||
162682884|NCT01755702|587546378|FG000|Washout Period II|Other Reason|5|||
162682885|NCT04860518|587546380|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
162682886|NCT04860518|587546381|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
162682887|NCT00636610|587546386|FG000|Overall Study|Adverse Event|4|||
162682888|NCT00636610|587546387|FG001|Overall Study|Adverse Event|4|||
162682889|NCT00636610|587546386|FG000|Overall Study|Death|6|||
162682890|NCT00636610|587546387|FG001|Overall Study|Death|3|||
162682891|NCT00636610|587546386|FG000|Overall Study|Physician decision to withdraw patient|15|||
162682892|NCT00636610|587546387|FG001|Overall Study|Physician decision to withdraw patient|9|||
162682893|NCT00636610|587546386|FG000|Overall Study|Subject decision to withdraw|15|||
162682894|NCT00636610|587546387|FG001|Overall Study|Subject decision to withdraw|11|||
162682895|NCT00636610|587546386|FG000|Overall Study|Disease progression - radiographic|41|||
162682896|NCT00636610|587546387|FG001|Overall Study|Disease progression - radiographic|51|||
162682897|NCT00636610|587546386|FG000|Overall Study|Disease progression - clinical|8|||
162682898|NCT00636610|587546387|FG001|Overall Study|Disease progression - clinical|3|||
162682899|NCT00636610|587546386|FG000|Overall Study|Reason for discontinuation not available|3|||
162682900|NCT00636610|587546387|FG001|Overall Study|Reason for discontinuation not available|2|||
162682901|NCT02151266|587546390|FG000|Overall Study|Lost to Follow-up|1|||
162682902|NCT02151266|587546391|FG001|Overall Study|Lost to Follow-up|4|||
162682903|NCT02151266|587546392|FG002|Overall Study|Lost to Follow-up|1|||
162682904|NCT02151266|587546390|FG000|Overall Study|Did NOT receive intervention|3|||
162682905|NCT02151266|587546391|FG001|Overall Study|Did NOT receive intervention|6|||
162682906|NCT02151266|587546392|FG002|Overall Study|Did NOT receive intervention|2|||
162682907|NCT02151266|587546390|FG000|Overall Study|Not able to exercise|4|||
162682908|NCT02151266|587546391|FG001|Overall Study|Not able to exercise|5|||
162682909|NCT02151266|587546392|FG002|Overall Study|Not able to exercise|4|||
162682910|NCT01169675|587546393|FG000|Overall Study|Progressive disease|13|||
162682911|NCT01169675|587546394|FG001|Overall Study|Progressive disease|2|||
162682912|NCT01169675|587546395|FG002|Overall Study|Progressive disease|5|||
162682913|NCT01169675|587546396|FG003|Overall Study|Progressive disease|15|||
162682914|NCT01169675|587546397|FG004|Overall Study|Progressive disease|1|||
162682915|NCT01169675|587546393|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162682916|NCT01169675|587546394|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162682917|NCT01169675|587546395|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162682918|NCT01169675|587546396|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162682919|NCT01169675|587546397|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162682920|NCT01169675|587546393|FG000|Overall Study|Adverse Event|5|||
162682921|NCT01169675|587546394|FG001|Overall Study|Adverse Event|1|||
162682922|NCT01169675|587546395|FG002|Overall Study|Adverse Event|2|||
162682923|NCT01169675|587546396|FG003|Overall Study|Adverse Event|0|||
162682924|NCT01169675|587546397|FG004|Overall Study|Adverse Event|0|||
162682925|NCT01169675|587546393|FG000|Overall Study|Withdrawal by Subject|1|||
162682926|NCT01169675|587546394|FG001|Overall Study|Withdrawal by Subject|0|||
162682927|NCT01169675|587546395|FG002|Overall Study|Withdrawal by Subject|0|||
162682928|NCT01169675|587546396|FG003|Overall Study|Withdrawal by Subject|1|||
162682929|NCT01169675|587546397|FG004|Overall Study|Withdrawal by Subject|2|||
162682930|NCT01169675|587546393|FG000|Overall Study|Other Reason Not Defined Above|0|||
162682931|NCT01169675|587546394|FG001|Overall Study|Other Reason Not Defined Above|0|||
162682932|NCT01169675|587546395|FG002|Overall Study|Other Reason Not Defined Above|0|||
162682933|NCT01169675|587546396|FG003|Overall Study|Other Reason Not Defined Above|1|||
162682934|NCT01169675|587546397|FG004|Overall Study|Other Reason Not Defined Above|1|||
162682935|NCT04102579|587546400|FG000|Overall Study|Withdrawal by Subject|3|||
162682936|NCT04102579|587546401|FG001|Overall Study|Withdrawal by Subject|4|||
162682937|NCT04102579|587546400|FG000|Overall Study|Lost to Follow-up|0|||
162682938|NCT04102579|587546401|FG001|Overall Study|Lost to Follow-up|1|||
162682939|NCT04102579|587546400|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
162682940|NCT04102579|587546401|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
162682941|NCT04102579|587546400|FG000|Overall Study|Other than Specified|1|||
162682942|NCT04102579|587546401|FG001|Overall Study|Other than Specified|0|||
162682943|NCT04102579|587546400|FG000|Overall Study|Not Dosed with Study Drug|0|||
162682944|NCT04102579|587546401|FG001|Overall Study|Not Dosed with Study Drug|1|||
162682945|NCT05899686|587546402|FG000|Overall Study|Protocol Violation|1|||
162682946|NCT00572195|587546403|FG000|Overall Study|Withdrawal by Subject|50|||
162682947|NCT00572195|587546403|FG000|Overall Study|Death|9|||
162682948|NCT00572195|587546403|FG000|Overall Study|Adverse Event|4|||
162682949|NCT00572195|587546403|FG000|Overall Study|Lost to Follow-up|5|||
162682950|NCT03076970|587547963|FG000|Washout Period 2|Adverse Event|0|||
162682951|NCT03076970|587547964|FG001|Washout Period 2|Adverse Event|0|||
162682952|NCT03076970|587547965|FG002|Washout Period 2|Adverse Event|0|||
162682953|NCT03076970|587547966|FG003|Washout Period 2|Adverse Event|0|||
162682954|NCT03076970|587547967|FG004|Washout Period 2|Adverse Event|1|||
162682955|NCT03076970|587547968|FG005|Washout Period 2|Adverse Event|0|||
162682956|NCT03076970|587547963|FG000|Period 3|Withdrawal by Subject|0|||
162682957|NCT03076970|587547964|FG001|Period 3|Withdrawal by Subject|0|||
162682958|NCT03076970|587547965|FG002|Period 3|Withdrawal by Subject|0|||
162682959|NCT03076970|587547966|FG003|Period 3|Withdrawal by Subject|0|||
162682960|NCT03076970|587547967|FG004|Period 3|Withdrawal by Subject|0|||
162682961|NCT03076970|587547968|FG005|Period 3|Withdrawal by Subject|1|||
162682962|NCT03076970|587547963|FG000|Period 3|Failure to meet I/E criteria|0|||
162682963|NCT03076970|587547964|FG001|Period 3|Failure to meet I/E criteria|0|||
162682964|NCT03076970|587547965|FG002|Period 3|Failure to meet I/E criteria|0|||
162682965|NCT03076970|587547966|FG003|Period 3|Failure to meet I/E criteria|0|||
162682966|NCT03076970|587547967|FG004|Period 3|Failure to meet I/E criteria|1|||
162682967|NCT03076970|587547968|FG005|Period 3|Failure to meet I/E criteria|0|||
162682968|NCT00949884|587547969|FG000|Overall Study|Adverse Event|14|||
162682969|NCT00949884|587547970|FG001|Overall Study|Adverse Event|3|||
162682970|NCT00949884|587547971|FG002|Overall Study|Adverse Event|12|||
162682971|NCT00949884|587547969|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
162682972|NCT00949884|587547970|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
162682973|NCT00949884|587547971|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
162682974|NCT00949884|587547969|FG000|Overall Study|Lost to Follow-up|7|||
162682975|NCT00949884|587547970|FG001|Overall Study|Lost to Follow-up|5|||
162682976|NCT00949884|587547971|FG002|Overall Study|Lost to Follow-up|5|||
162682977|NCT00949884|587547969|FG000|Overall Study|Physician Decision|5|||
162682978|NCT00949884|587547970|FG001|Overall Study|Physician Decision|0|||
162725715|NCT01236001|587705990|FG000|Overall Study|Planned Visit After End of Study|0|||
162682979|NCT00949884|587547971|FG002|Overall Study|Physician Decision|6|||
162682980|NCT00949884|587547969|FG000|Overall Study|Treatment non-compliance|5|||
162682981|NCT00949884|587547970|FG001|Overall Study|Treatment non-compliance|0|||
162682982|NCT00949884|587547971|FG002|Overall Study|Treatment non-compliance|8|||
162682983|NCT00949884|587547969|FG000|Overall Study|Withdrawal by Subject|13|||
162682984|NCT00949884|587547970|FG001|Overall Study|Withdrawal by Subject|4|||
162682985|NCT00949884|587547971|FG002|Overall Study|Withdrawal by Subject|16|||
162682986|NCT00949884|587547969|FG000|Overall Study|Lack of Efficacy|4|||
162682987|NCT00949884|587547970|FG001|Overall Study|Lack of Efficacy|2|||
162682988|NCT00949884|587547971|FG002|Overall Study|Lack of Efficacy|7|||
162682989|NCT00949884|587547969|FG000|Overall Study|Study terminated by sponsor|0|||
162682990|NCT00949884|587547970|FG001|Overall Study|Study terminated by sponsor|0|||
162682991|NCT00949884|587547971|FG002|Overall Study|Study terminated by sponsor|1|||
162682992|NCT03391765|587547979|FG000|Overall Study|Adverse Event|2|||
162682993|NCT03391765|587547980|FG001|Overall Study|Adverse Event|0|||
162682994|NCT03391765|587547981|FG002|Overall Study|Adverse Event|0|||
162682995|NCT03391765|587547982|FG003|Overall Study|Adverse Event|2|||
162682996|NCT03391765|587547979|FG000|Overall Study|Withdrew consent|5|||
162682997|NCT03391765|587547980|FG001|Overall Study|Withdrew consent|7|||
162682998|NCT03391765|587547981|FG002|Overall Study|Withdrew consent|2|||
162682999|NCT03391765|587547982|FG003|Overall Study|Withdrew consent|5|||
162683000|NCT03391765|587547979|FG000|Overall Study|Other, not specified|44|||
162683001|NCT03391765|587547980|FG001|Overall Study|Other, not specified|38|||
162683002|NCT03391765|587547981|FG002|Overall Study|Other, not specified|21|||
162683003|NCT03391765|587547982|FG003|Overall Study|Other, not specified|16|||
162683004|NCT00662857|587547987|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
162683005|NCT00662857|587547988|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
162683006|NCT00662857|587547987|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
162683007|NCT00662857|587547988|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
162683008|NCT00662857|587547987|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
162683009|NCT00662857|587547988|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
162683010|NCT03966053|587547989|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
162683011|NCT02832622|587547991|FG000|Overall Study|MPP not programmed|1259|||
162683012|NCT02832622|587547991|FG000|Overall Study|Withdrawal by Subject|123|||
162683013|NCT02832622|587547991|FG000|Overall Study|Death|119|||
162683014|NCT02832622|587547991|FG000|Overall Study|Unsuccessful CRT implant|93|||
162683015|NCT02832622|587547991|FG000|Overall Study|Lost to Follow-up|45|||
162725716|NCT01236001|587705991|FG001|Overall Study|Planned Visit After End of Study|1|||
162725717|NCT01414738|587705992|FG000|Overall Study|Death|26|||
162725718|NCT01414738|587705992|FG000|Overall Study|Refused testing|5|||
162725719|NCT01414738|587705992|FG000|Overall Study|Lost to Follow-up|2|||
162725720|NCT01414738|587705992|FG000|Overall Study|Refused, disease progression|8|||
162725721|NCT01414738|587705992|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
162725722|NCT02379819|587705993|FG000|Overall Study|Withdrawal by Subject|10|||
162725723|NCT02379819|587705993|FG000|Overall Study|Death|2|||
162725724|NCT02379819|587705993|FG000|Overall Study|Lack of Efficacy|1|||
162725725|NCT02379819|587705993|FG000|Overall Study|Lost to Follow-up|1|||
162725726|NCT03451721|587705994|FG000|Overall Study|Death|1|||
162725727|NCT03076515|587705997|FG000|Overall Study|DMC decision based on interim analysis|25|||
162725728|NCT03076515|587705998|FG001|Overall Study|DMC decision based on interim analysis|29|||
162725729|NCT00174382|587705999|FG000|Overall Study|Death|2|||
162725730|NCT00174382|587705999|FG000|Overall Study|Adverse Event|19|||
162725731|NCT00174382|587705999|FG000|Overall Study|Withdrawal by Subject|6|||
162725732|NCT00174382|587705999|FG000|Overall Study|Protocol Violation|3|||
162725733|NCT00174382|587705999|FG000|Overall Study|Arrived early for last visit in error|1|||
162725734|NCT00174382|587705999|FG000|Overall Study|Subject felt pill not effective enough|1|||
162725735|NCT00174382|587705999|FG000|Overall Study|Lost to Follow-up|1|||
162725736|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
162725737|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
162725738|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
162725739|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
162725740|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
162725741|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
162725742|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
162725743|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
162725744|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162725745|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162725746|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162683016|NCT02832622|587547991|FG000|Overall Study|Patient non-compliance|42|||
162683017|NCT02832622|587547991|FG000|Overall Study|Withdrawal by other reasons|25|||
162683018|NCT02832622|587547991|FG000|Overall Study|System explant|24|||
162683019|NCT02832622|587547991|FG000|Overall Study|Physician Decision|6|||
162683020|NCT04586569|587547992|FG000|Overall Study|Withdrawal by Subject|0|||
162683021|NCT04586569|587547993|FG001|Overall Study|Withdrawal by Subject|2|||
162683022|NCT04586569|587547992|FG000|Overall Study|No longer eligible|2|||
162725747|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162725748|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
162725749|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
162725750|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162725751|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162725752|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162683023|NCT04586569|587547993|FG001|Overall Study|No longer eligible|3|||
162725753|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162725754|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162725755|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162725756|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162725757|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162725758|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
162725759|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
162725760|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725761|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
162725762|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725763|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725764|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725765|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725766|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
162683024|NCT04586569|587547992|FG000|Overall Study|Physician Decision|1|||
162683025|NCT04586569|587547993|FG001|Overall Study|Physician Decision|0|||
162683026|NCT00998400|587547994|FG000|Overall Study|Lack of interest/motivation|1|||
162683027|NCT00998400|587547995|FG001|Overall Study|Lack of interest/motivation|2|||
162683028|NCT00998400|587547994|FG000|Overall Study|Logistical problems|1|||
162683029|NCT00998400|587547995|FG001|Overall Study|Logistical problems|0|||
162683030|NCT00800202|587547997|FG000|Overall Study|Adverse Event|7|||
162683031|NCT00800202|587547998|FG001|Overall Study|Adverse Event|6|||
162683032|NCT00800202|587547997|FG000|Overall Study|Death|1|||
162683033|NCT00800202|587547998|FG001|Overall Study|Death|0|||
162683034|NCT00800202|587547997|FG000|Overall Study|Other|5|||
162683035|NCT00800202|587547998|FG001|Overall Study|Other|0|||
162683036|NCT00800202|587547997|FG000|Overall Study|Disease Progression|54|||
162683037|NCT00800202|587547998|FG001|Overall Study|Disease Progression|18|||
162683038|NCT05674890|587548001|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
162683039|NCT05674890|587548002|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
162683040|NCT05674890|587548001|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
162683041|NCT05674890|587548002|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
162683042|NCT05674890|587548001|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
162683043|NCT05674890|587548002|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
162683044|NCT02691182|587548003|FG000|Overall Study|Withdrawal by Subject|4|||
162683045|NCT02691182|587548004|FG001|Overall Study|Withdrawal by Subject|7|||
162683046|NCT02691182|587548005|FG002|Overall Study|Withdrawal by Subject|6|||
162683047|NCT02691182|587548006|FG003|Overall Study|Withdrawal by Subject|8|||
162683048|NCT02691182|587548003|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
162683049|NCT02691182|587548004|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
162683050|NCT02691182|587548005|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
162683051|NCT02691182|587548006|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
162683052|NCT02691182|587548003|FG000|Overall Study|Lost to Follow-up|8|||
162683053|NCT02691182|587548004|FG001|Overall Study|Lost to Follow-up|33|||
162683054|NCT02691182|587548005|FG002|Overall Study|Lost to Follow-up|19|||
162683055|NCT02691182|587548006|FG003|Overall Study|Lost to Follow-up|22|||
162683056|NCT02691182|587548003|FG000|Overall Study|Adverse Event|3|||
162683057|NCT02691182|587548004|FG001|Overall Study|Adverse Event|10|||
162683058|NCT02691182|587548005|FG002|Overall Study|Adverse Event|10|||
162683059|NCT02691182|587548006|FG003|Overall Study|Adverse Event|11|||
162683060|NCT02691182|587548003|FG000|Overall Study|Physician Decision|3|||
162683061|NCT02691182|587548004|FG001|Overall Study|Physician Decision|7|||
162683062|NCT02691182|587548005|FG002|Overall Study|Physician Decision|14|||
162683063|NCT02691182|587548006|FG003|Overall Study|Physician Decision|8|||
162683064|NCT02691182|587548003|FG000|Overall Study|Lack of Efficacy|0|||
162683065|NCT02691182|587548004|FG001|Overall Study|Lack of Efficacy|0|||
162683066|NCT02691182|587548005|FG002|Overall Study|Lack of Efficacy|0|||
162683067|NCT02691182|587548006|FG003|Overall Study|Lack of Efficacy|4|||
162683068|NCT02691182|587548003|FG000|Overall Study|Protocol Violation|2|||
162683069|NCT02691182|587548004|FG001|Overall Study|Protocol Violation|6|||
162683070|NCT02691182|587548005|FG002|Overall Study|Protocol Violation|6|||
162683071|NCT02691182|587548006|FG003|Overall Study|Protocol Violation|8|||
162683072|NCT02691182|587548003|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
162683073|NCT02691182|587548004|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
162683074|NCT02691182|587548005|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
162683075|NCT02691182|587548006|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
162683076|NCT02691182|587548003|FG000|Overall Study|Missing|0|||
162683077|NCT02691182|587548004|FG001|Overall Study|Missing|5|||
162683078|NCT02691182|587548005|FG002|Overall Study|Missing|1|||
162725767|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
162725768|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725769|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725770|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725771|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
162725772|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
162725773|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725774|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725775|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
162725776|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725777|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725778|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725779|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
162725780|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725781|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725782|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725783|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162725784|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162725785|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
162725786|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162725787|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162725788|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
162725789|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162725790|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
162725791|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
162725792|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
162725793|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162683079|NCT02691182|587548006|FG003|Overall Study|Missing|5|||
162683080|NCT00105235|587548007|FG000|Overall Study|Death|4|||
162683081|NCT00105235|587548007|FG000|Overall Study|Physician Decision|1|||
162683082|NCT00105235|587548007|FG000|Overall Study|Withdrawal by Subject|2|||
162683083|NCT02052310|587548008|FG000|Overall Study|Death|64|||
162683084|NCT02052310|587548009|FG001|Overall Study|Death|54|||
162683085|NCT02052310|587548008|FG000|Overall Study|Withdrawal by Subject|37|||
162683086|NCT02052310|587548009|FG001|Overall Study|Withdrawal by Subject|49|||
162683087|NCT02052310|587548008|FG000|Overall Study|Other than specified|32|||
162683088|NCT02052310|587548009|FG001|Overall Study|Other than specified|29|||
162725794|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162725795|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162725796|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162725797|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
162725798|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162725799|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162725800|NCT03903822|587706000|FG000|Treatment Phase (6 Weeks)|Other|2|||
162683089|NCT02052310|587548008|FG000|Overall Study|Adverse Event|29|||
162683090|NCT02052310|587548009|FG001|Overall Study|Adverse Event|22|||
162683091|NCT02052310|587548008|FG000|Overall Study|Kidney Transplant|23|||
162683092|NCT02052310|587548009|FG001|Overall Study|Kidney Transplant|29|||
162683093|NCT02052310|587548008|FG000|Overall Study|Physician Decision|14|||
162683094|NCT02052310|587548009|FG001|Overall Study|Physician Decision|7|||
162683095|NCT02052310|587548008|FG000|Overall Study|Lack of Efficacy|6|||
162683096|NCT02052310|587548009|FG001|Overall Study|Lack of Efficacy|1|||
162683097|NCT02052310|587548008|FG000|Overall Study|Site Terminated by Sponsor|5|||
162683098|NCT02052310|587548009|FG001|Overall Study|Site Terminated by Sponsor|13|||
162683099|NCT02052310|587548008|FG000|Overall Study|Lost to Follow-up|4|||
162683100|NCT02052310|587548009|FG001|Overall Study|Lost to Follow-up|2|||
162683101|NCT02052310|587548008|FG000|Overall Study|Protocol Violation|1|||
162683102|NCT02052310|587548009|FG001|Overall Study|Protocol Violation|6|||
162683103|NCT01964326|587548010|FG000|Overall Study|Adverse Event|48|||
162683104|NCT01964326|587548010|FG000|Overall Study|Death|2|||
162683105|NCT01964326|587548010|FG000|Overall Study|Protocol Violation|4|||
162683106|NCT01964326|587548010|FG000|Overall Study|Lost to Follow-up|88|||
162683107|NCT01964326|587548010|FG000|Overall Study|Withdrawal by Subject|87|||
162683108|NCT01964326|587548010|FG000|Overall Study|Pregnancy|1|||
162683109|NCT01964326|587548010|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
162725801|NCT03903822|587706001|FG001|Treatment Phase (6 Weeks)|Other|1|||
162725802|NCT03903822|587706002|FG002|Treatment Phase (6 Weeks)|Other|0|||
162725803|NCT03903822|587706003|FG003|Treatment Phase (6 Weeks)|Other|0|||
162725804|NCT03903822|587706004|FG004|Treatment Phase (6 Weeks)|Other|1|||
162725805|NCT03903822|587706005|FG005|Treatment Phase (6 Weeks)|Other|1|||
162683110|NCT01964326|587548010|FG000|Overall Study|Physician Decision|55|||
162683111|NCT01964326|587548010|FG000|Overall Study|Investigator Discretion|1|||
162683112|NCT01964326|587548010|FG000|Overall Study|Other|9|||
162683113|NCT01964326|587548010|FG000|Overall Study|Did not meet eligibility criteria|1|||
162725806|NCT03903822|587706006|FG006|Treatment Phase (6 Weeks)|Other|0|||
162683114|NCT02563002|587548013|FG000|Overall Study|Death|72|||
162683115|NCT02563002|587548014|FG001|Overall Study|Death|87|||
162683116|NCT02563002|587548013|FG000|Overall Study|Lost to Follow-up|5|||
162683117|NCT02563002|587548014|FG001|Overall Study|Lost to Follow-up|0|||
162683118|NCT02563002|587548013|FG000|Overall Study|Physician Decision|0|||
162683119|NCT02563002|587548014|FG001|Overall Study|Physician Decision|2|||
162683120|NCT02563002|587548013|FG000|Overall Study|Withdrawal by Subject|2|||
162683121|NCT02563002|587548014|FG001|Overall Study|Withdrawal by Subject|10|||
162683122|NCT02563002|587548013|FG000|Overall Study|Sponsor decision|74|||
162683123|NCT02563002|587548014|FG001|Overall Study|Sponsor decision|55|||
162683124|NCT03518125|587548015|FG000|Overall Study|Lost to Follow-up|0|||
162683125|NCT03518125|587548016|FG001|Overall Study|Lost to Follow-up|2|||
162683126|NCT03518125|587548017|FG002|Overall Study|Lost to Follow-up|0|||
162683127|NCT03518125|587548018|FG003|Overall Study|Lost to Follow-up|0|||
162683128|NCT03518125|587548019|FG004|Overall Study|Lost to Follow-up|3|||
162683129|NCT03518125|587548020|FG005|Overall Study|Lost to Follow-up|5|||
162683130|NCT03518125|587548015|FG000|Overall Study|Physician Decision|0|||
162683131|NCT03518125|587548016|FG001|Overall Study|Physician Decision|1|||
162683132|NCT03518125|587548017|FG002|Overall Study|Physician Decision|0|||
162683133|NCT03518125|587548018|FG003|Overall Study|Physician Decision|0|||
162683134|NCT03518125|587548019|FG004|Overall Study|Physician Decision|0|||
162683135|NCT03518125|587548020|FG005|Overall Study|Physician Decision|0|||
162683136|NCT03518125|587548015|FG000|Overall Study|Withdrawal by Subject|1|||
162683137|NCT03518125|587548016|FG001|Overall Study|Withdrawal by Subject|1|||
162683138|NCT03518125|587548017|FG002|Overall Study|Withdrawal by Subject|0|||
162683139|NCT03518125|587548018|FG003|Overall Study|Withdrawal by Subject|1|||
162683140|NCT03518125|587548019|FG004|Overall Study|Withdrawal by Subject|1|||
162683141|NCT03518125|587548020|FG005|Overall Study|Withdrawal by Subject|3|||
162725807|NCT03903822|587706007|FG007|Treatment Phase (6 Weeks)|Other|0|||
162725808|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
162725809|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
162725810|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
162725811|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
162725812|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
162683142|NCT03518125|587548015|FG000|Overall Study|Missed Day 394 Visit|1|||
162683143|NCT03518125|587548016|FG001|Overall Study|Missed Day 394 Visit|0|||
162683144|NCT03518125|587548017|FG002|Overall Study|Missed Day 394 Visit|0|||
162683145|NCT03518125|587548018|FG003|Overall Study|Missed Day 394 Visit|0|||
162683146|NCT03518125|587548019|FG004|Overall Study|Missed Day 394 Visit|0|||
162683147|NCT03518125|587548020|FG005|Overall Study|Missed Day 394 Visit|0|||
162683148|NCT02093663|587548025|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
162683149|NCT02093663|587548026|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162683150|NCT02093663|587548027|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162683151|NCT02093663|587548028|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162683152|NCT02093663|587548029|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162683153|NCT02093663|587548025|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
162683154|NCT02093663|587548026|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683155|NCT02093663|587548027|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683156|NCT02093663|587548028|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683157|NCT02093663|587548029|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683158|NCT02093663|587548025|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
162683159|NCT02093663|587548026|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
162683160|NCT02093663|587548027|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162683161|NCT02093663|587548028|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162683162|NCT02093663|587548029|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162683163|NCT02093663|587548025|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162683164|NCT02093663|587548026|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162683165|NCT02093663|587548027|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
162683166|NCT02093663|587548028|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162683167|NCT02093663|587548029|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162683168|NCT02093663|587548025|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683169|NCT02093663|587548026|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683170|NCT02093663|587548027|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
162683171|NCT02093663|587548028|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162725813|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
162683172|NCT02093663|587548029|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162683173|NCT02093663|587548025|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162683174|NCT02093663|587548026|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162725814|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
162725815|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
162683175|NCT02093663|587548027|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162683176|NCT02093663|587548028|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
162683177|NCT02093663|587548029|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
162683178|NCT02093663|587548025|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162683179|NCT02093663|587548026|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162683180|NCT02093663|587548027|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162683181|NCT02093663|587548028|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
162683182|NCT02093663|587548029|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
162683183|NCT02093663|587548025|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162683184|NCT02093663|587548026|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162683185|NCT02093663|587548027|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162683186|NCT02093663|587548028|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
162683187|NCT02093663|587548029|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
162683188|NCT02093663|587548025|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162683189|NCT02093663|587548026|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162683190|NCT02093663|587548027|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162683191|NCT02093663|587548028|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162683192|NCT02093663|587548029|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
162683193|NCT00508404|587548030|FG000|Overall Study|Ongoing at Data Cut-off|12|||
162683194|NCT00508404|587548030|FG000|Overall Study|Adverse Event|2|||
162683195|NCT00508404|587548030|FG000|Overall Study|Death|16|||
162683196|NCT00508404|587548030|FG000|Overall Study|Physician Decision|2|||
162683197|NCT00508404|587548030|FG000|Overall Study|Withdrawal by Subject|3|||
162683198|NCT00508404|587548030|FG000|Overall Study|Protocol-specified Criteria|2|||
162683199|NCT00508404|587548030|FG000|Overall Study|Lost to Follow-up|2|||
162683200|NCT00508404|587548030|FG000|Overall Study|Other - Not Specified|3|||
162683201|NCT05453110|587548031|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
162683202|NCT05453110|587548032|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
162683203|NCT05453110|587548033|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
162683204|NCT01505387|587548034|FG000|Overall Study|Protocol Violation|1|||
162683205|NCT01505387|587548035|FG001|Overall Study|Protocol Violation|0|||
162683206|NCT01505387|587548034|FG000|Overall Study|Withdrawal by Subject|1|||
162683207|NCT01505387|587548035|FG001|Overall Study|Withdrawal by Subject|1|||
162683208|NCT01197508|587548036|FG000|Overall Study|Withdrawal by Subject|8|||
162683209|NCT01197508|587548037|FG001|Overall Study|Withdrawal by Subject|7|||
162683210|NCT01197508|587548038|FG002|Overall Study|Withdrawal by Subject|15|||
162683211|NCT01197508|587548039|FG003|Overall Study|Withdrawal by Subject|4|||
162683212|NCT01197508|587548036|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
162683213|NCT01197508|587548037|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
162683214|NCT01197508|587548038|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
162683215|NCT01197508|587548039|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
162683216|NCT01197508|587548036|FG000|Overall Study|Adverse Event|10|||
162683217|NCT01197508|587548037|FG001|Overall Study|Adverse Event|13|||
162683218|NCT01197508|587548038|FG002|Overall Study|Adverse Event|23|||
162683219|NCT01197508|587548039|FG003|Overall Study|Adverse Event|3|||
162683220|NCT01197508|587548036|FG000|Overall Study|Severe non-compliance to protocol|0|||
162683221|NCT01197508|587548037|FG001|Overall Study|Severe non-compliance to protocol|3|||
162683222|NCT01197508|587548038|FG002|Overall Study|Severe non-compliance to protocol|1|||
162683223|NCT01197508|587548039|FG003|Overall Study|Severe non-compliance to protocol|3|||
162683224|NCT01197508|587548036|FG000|Overall Study|Condition under investigation worsened|1|||
162683225|NCT01197508|587548037|FG001|Overall Study|Condition under investigation worsened|1|||
162683226|NCT01197508|587548038|FG002|Overall Study|Condition under investigation worsened|1|||
162683227|NCT01197508|587548039|FG003|Overall Study|Condition under investigation worsened|1|||
162683228|NCT01197508|587548036|FG000|Overall Study|Lack of Efficacy|1|||
162683229|NCT01197508|587548037|FG001|Overall Study|Lack of Efficacy|2|||
162683230|NCT01197508|587548038|FG002|Overall Study|Lack of Efficacy|2|||
162683231|NCT01197508|587548039|FG003|Overall Study|Lack of Efficacy|1|||
162683232|NCT01197508|587548036|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162683233|NCT01197508|587548037|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162683234|NCT01197508|587548038|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162683235|NCT01197508|587548039|FG003|Overall Study|Study-specific withdrawal criteria|2|||
162683236|NCT01197508|587548036|FG000|Overall Study|Lost to Follow-up|1|||
162683237|NCT01197508|587548037|FG001|Overall Study|Lost to Follow-up|1|||
162683238|NCT01197508|587548038|FG002|Overall Study|Lost to Follow-up|2|||
162683239|NCT01197508|587548039|FG003|Overall Study|Lost to Follow-up|0|||
162683240|NCT01197508|587548036|FG000|Overall Study|Other|2|||
162683241|NCT01197508|587548037|FG001|Overall Study|Other|3|||
162683242|NCT01197508|587548038|FG002|Overall Study|Other|2|||
162683243|NCT01197508|587548039|FG003|Overall Study|Other|2|||
162683244|NCT00266825|587548040|FG000|Completed Follow-Up|Lost to Follow-up|14|||
162683245|NCT00266825|587548041|FG001|Completed Follow-Up|Lost to Follow-up|19|||
162683246|NCT00266825|587548040|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
162683247|NCT00266825|587548041|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
162683248|NCT02799784|587548044|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
162683249|NCT02799784|587548045|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
162683250|NCT02799784|587548044|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
162683251|NCT02799784|587548045|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
162683252|NCT02799784|587548044|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
162683253|NCT02799784|587548045|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
162683254|NCT02799784|587548044|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
162683255|NCT02799784|587548045|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
162683256|NCT02799784|587548044|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
162683257|NCT02799784|587548045|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
162683258|NCT02799784|587548044|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
162683259|NCT02799784|587548045|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
162683260|NCT01662063|587548046|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
162683261|NCT01662063|587548047|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
162683262|NCT01662063|587548048|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
162683263|NCT01662063|587548046|FG000|Overall Study|Lack of Efficacy|1|||
162683264|NCT01662063|587548047|FG001|Overall Study|Lack of Efficacy|6|||
162683265|NCT01662063|587548048|FG002|Overall Study|Lack of Efficacy|0|||
162683266|NCT01662063|587548046|FG000|Overall Study|Lost to Follow-up|0|||
162683267|NCT01662063|587548047|FG001|Overall Study|Lost to Follow-up|4|||
162683268|NCT01662063|587548048|FG002|Overall Study|Lost to Follow-up|0|||
162683269|NCT01662063|587548046|FG000|Overall Study|Protocol Violation|1|||
162683270|NCT01662063|587548047|FG001|Overall Study|Protocol Violation|0|||
162683271|NCT01662063|587548048|FG002|Overall Study|Protocol Violation|0|||
162683272|NCT01662063|587548046|FG000|Overall Study|Withdrawal by Subject|2|||
162683273|NCT01662063|587548047|FG001|Overall Study|Withdrawal by Subject|4|||
162683274|NCT01662063|587548048|FG002|Overall Study|Withdrawal by Subject|1|||
162683275|NCT01662063|587548046|FG000|Overall Study|Physician Decision|0|||
162683276|NCT01662063|587548047|FG001|Overall Study|Physician Decision|2|||
162683277|NCT01662063|587548048|FG002|Overall Study|Physician Decision|0|||
162683278|NCT01662063|587548046|FG000|Overall Study|Other|0|||
162683279|NCT01662063|587548047|FG001|Overall Study|Other|1|||
162683280|NCT01662063|587548048|FG002|Overall Study|Other|0|||
162683281|NCT01949870|587548049|FG000|Overall Study|Lack of Efficacy|2|||
162683282|NCT01949870|587548049|FG000|Overall Study|Adverse Event|1|||
162683283|NCT01949870|587548049|FG000|Overall Study|Study termination|1|||
162683284|NCT01949870|587548049|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
162683285|NCT01477853|587548050|FG000|Phase A|Adverse Event|1|||
162683286|NCT01477853|587548051|FG001|Phase A|Adverse Event|2|||
162683287|NCT01477853|587548052|FG002|Phase A|Adverse Event|2|||
162683288|NCT01477853|587548050|FG000|Phase A|Lost to Follow-up|4|||
162683289|NCT01477853|587548051|FG001|Phase A|Lost to Follow-up|3|||
162683290|NCT01477853|587548052|FG002|Phase A|Lost to Follow-up|2|||
162683291|NCT01477853|587548050|FG000|Phase A|Physician Decision|1|||
162683292|NCT01477853|587548051|FG001|Phase A|Physician Decision|0|||
162683293|NCT01477853|587548052|FG002|Phase A|Physician Decision|1|||
162683294|NCT01477853|587548050|FG000|Phase A|Study terminated by sponsor|37|||
162683295|NCT01477853|587548051|FG001|Phase A|Study terminated by sponsor|40|||
162683296|NCT01477853|587548052|FG002|Phase A|Study terminated by sponsor|39|||
162683297|NCT01477853|587548050|FG000|Phase B|Lost to Follow-up|0|||
162683298|NCT01477853|587548051|FG001|Phase B|Lost to Follow-up|1|||
162683299|NCT01477853|587548052|FG002|Phase B|Lost to Follow-up|0|||
162683300|NCT01477853|587548050|FG000|Phase B|Study terminated by sponsor|12|||
162683301|NCT01477853|587548051|FG001|Phase B|Study terminated by sponsor|10|||
162683302|NCT01477853|587548052|FG002|Phase B|Study terminated by sponsor|11|||
162683303|NCT01050816|587548053|FG000|Overall Study|Lost to Follow-up|2|||
162683304|NCT01050816|587548053|FG000|Overall Study|patient's refusal|2|||
162683305|NCT03086330|587548054|FG000|Overall Study|Withdrawal by Subject|3|||
162683306|NCT03086330|587548055|FG001|Overall Study|Withdrawal by Subject|2|||
162683307|NCT03086330|587548054|FG000|Overall Study|Lost to Follow-up|1|||
162683308|NCT03086330|587548055|FG001|Overall Study|Lost to Follow-up|2|||
162683309|NCT01970462|587548056|FG000|Overall Study|Lost to Follow-up|0|||
162683310|NCT01970462|587548057|FG001|Overall Study|Lost to Follow-up|2|||
162683311|NCT01235546|587548058|FG000|Overall Study|Staff error, medication not administered|1|||
162683312|NCT01235546|587548059|FG001|Overall Study|Staff error, medication not administered|0|||
162683313|NCT01235546|587548058|FG000|Overall Study|Protocol Violation|1|||
162683314|NCT01235546|587548059|FG001|Overall Study|Protocol Violation|1|||
162683315|NCT02740049|587548060|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
162683316|NCT00330174|587548063|FG000|Overall Study|Withdrawal by Subject|7|||
162683317|NCT00330174|587548064|FG001|Overall Study|Withdrawal by Subject|7|||
162683318|NCT00330174|587548063|FG000|Overall Study|Lost to Follow-up|4|||
162683319|NCT00330174|587548064|FG001|Overall Study|Lost to Follow-up|1|||
162683320|NCT00330174|587548063|FG000|Overall Study|Clinical deterioration|1|||
162683321|NCT00330174|587548064|FG001|Overall Study|Clinical deterioration|2|||
162683322|NCT00330174|587548063|FG000|Overall Study|Excessive missed visits|3|||
162683323|NCT00330174|587548064|FG001|Overall Study|Excessive missed visits|8|||
162725816|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162683324|NCT00330174|587548063|FG000|Overall Study|Miscellaneous reasons|7|||
162725817|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725818|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725819|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725820|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
162725821|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725822|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725823|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162725824|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
162725825|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162725826|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162725827|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162725828|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162725829|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162725830|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
162725831|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
162725832|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725833|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725834|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725835|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
162725836|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
162725837|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725838|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725839|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
162725840|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162725841|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
162725842|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162725843|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162725844|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162725845|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162725846|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162725847|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162725848|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725849|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725850|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725851|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725852|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725853|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
162725854|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725855|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162725856|NCT03903822|587706000|FG000|Follow up Phase (4 Weeks)|Other|1|||
162725857|NCT03903822|587706001|FG001|Follow up Phase (4 Weeks)|Other|1|||
162725858|NCT03903822|587706002|FG002|Follow up Phase (4 Weeks)|Other|0|||
162725859|NCT03903822|587706003|FG003|Follow up Phase (4 Weeks)|Other|0|||
162725860|NCT03903822|587706004|FG004|Follow up Phase (4 Weeks)|Other|0|||
162725861|NCT03903822|587706005|FG005|Follow up Phase (4 Weeks)|Other|0|||
162725862|NCT03903822|587706006|FG006|Follow up Phase (4 Weeks)|Other|0|||
162725863|NCT03903822|587706007|FG007|Follow up Phase (4 Weeks)|Other|0|||
162725864|NCT00296036|587706008|FG000|Overall Study|Withdrawal by Subject|1|||
162725865|NCT00296036|587706009|FG001|Overall Study|Withdrawal by Subject|0|||
162725866|NCT00296036|587706010|FG002|Overall Study|Withdrawal by Subject|2|||
162725867|NCT00296036|587706011|FG003|Overall Study|Withdrawal by Subject|1|||
162725868|NCT00296036|587706012|FG004|Overall Study|Withdrawal by Subject|2|||
162725869|NCT00296036|587706013|FG005|Overall Study|Withdrawal by Subject|1|||
162725870|NCT00296036|587706008|FG000|Overall Study|Protocol Violation|0|||
162725871|NCT00296036|587706009|FG001|Overall Study|Protocol Violation|0|||
162725872|NCT00296036|587706010|FG002|Overall Study|Protocol Violation|0|||
162725873|NCT00296036|587706011|FG003|Overall Study|Protocol Violation|0|||
162725874|NCT00296036|587706012|FG004|Overall Study|Protocol Violation|0|||
162725875|NCT00296036|587706013|FG005|Overall Study|Protocol Violation|3|||
162725876|NCT00785512|587706016|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
162725877|NCT00785512|587706017|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
162725878|NCT00785512|587706016|FG000|Overall Study|Adverse Event|0|||
162725879|NCT00785512|587706017|FG001|Overall Study|Adverse Event|0|||
162725880|NCT00785512|587706016|FG000|Overall Study|Lack of Efficacy|0|||
162725881|NCT00785512|587706017|FG001|Overall Study|Lack of Efficacy|2|||
162725882|NCT00785512|587706016|FG000|Overall Study|Withdrawal by Subject|0|||
162725883|NCT00785512|587706017|FG001|Overall Study|Withdrawal by Subject|1|||
162725884|NCT00785512|587706016|FG000|Overall Study|Lost to Follow-up|3|||
162725885|NCT00785512|587706017|FG001|Overall Study|Lost to Follow-up|0|||
162725886|NCT00785512|587706016|FG000|Overall Study|Precedure Refused|0|||
162725887|NCT00785512|587706017|FG001|Overall Study|Precedure Refused|0|||
162725888|NCT00785512|587706016|FG000|Overall Study|IVRS Programing Error|0|||
162725889|NCT00785512|587706017|FG001|Overall Study|IVRS Programing Error|0|||
162683325|NCT00330174|587548064|FG001|Overall Study|Miscellaneous reasons|1|||
162683326|NCT04570436|587548068|FG000|Overall Study|Adverse Event|0|||
162683327|NCT04570436|587548069|FG001|Overall Study|Adverse Event|0|||
162683328|NCT04570436|587548070|FG002|Overall Study|Adverse Event|1|||
162683329|NCT04570436|587548071|FG003|Overall Study|Adverse Event|0|||
162683330|NCT04570436|587548072|FG004|Overall Study|Adverse Event|0|||
162683331|NCT04570436|587548073|FG005|Overall Study|Adverse Event|0|||
162683332|NCT04570436|587548074|FG006|Overall Study|Adverse Event|0|||
162683333|NCT04570436|587548075|FG007|Overall Study|Adverse Event|0|||
162683334|NCT04570436|587548076|FG008|Overall Study|Adverse Event|0|||
162683335|NCT04570436|587548077|FG009|Overall Study|Adverse Event|0|||
162683336|NCT04570436|587548068|FG000|Overall Study|Physician Decision|1|||
162683337|NCT04570436|587548069|FG001|Overall Study|Physician Decision|0|||
162683338|NCT04570436|587548070|FG002|Overall Study|Physician Decision|0|||
162683339|NCT04570436|587548071|FG003|Overall Study|Physician Decision|0|||
162683340|NCT04570436|587548072|FG004|Overall Study|Physician Decision|0|||
162683341|NCT04570436|587548073|FG005|Overall Study|Physician Decision|0|||
162683342|NCT04570436|587548074|FG006|Overall Study|Physician Decision|0|||
162683343|NCT04570436|587548075|FG007|Overall Study|Physician Decision|0|||
162683344|NCT04570436|587548076|FG008|Overall Study|Physician Decision|0|||
162683345|NCT04570436|587548077|FG009|Overall Study|Physician Decision|0|||
162683346|NCT00645164|587548078|FG000|Overall Study|Lost to Follow-up|2|||
162683347|NCT00645164|587548078|FG000|Overall Study|Withdrawal by Subject|4|||
162683348|NCT00645164|587548078|FG000|Overall Study|Protocol Violation|1|||
162683349|NCT03172702|587548079|FG000|Overall Study|Adverse Event|9|||
162683350|NCT03172702|587548079|FG000|Overall Study|Death|2|||
162683351|NCT03172702|587548079|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
162683352|NCT03172702|587548079|FG000|Overall Study|Withdrawal by Subject|5|||
162683353|NCT03172702|587548079|FG000|Overall Study|Other|2|||
162683354|NCT02355743|587548082|FG000|Overall Study|Withdrawal by Subject|1|||
162683355|NCT02355743|587548082|FG000|Overall Study|Lost to Follow-up|1|||
162683356|NCT02279043|587548088|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
162683357|NCT02279043|587548089|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
162683358|NCT02279043|587548090|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
162683359|NCT02279043|587548088|FG000|Overall Study|Lost to Follow-up|46|||
162683360|NCT02279043|587548089|FG001|Overall Study|Lost to Follow-up|88|||
162683361|NCT02279043|587548090|FG002|Overall Study|Lost to Follow-up|0|||
162683362|NCT00490282|587548091|FG000|Overall Study|Withdrawal by Subject|3|||
162683363|NCT01256567|587548097|FG000|Overall Study|Withdrawal by Subject|1|||
162683364|NCT00567190|587548098|FG000|Overall Study|Death|235|||
162683365|NCT00567190|587548099|FG001|Overall Study|Death|280|||
162683366|NCT00567190|587548098|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
162683367|NCT00567190|587548099|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
162683368|NCT00374322|587548103|FG000|Overall Study|Lost to Follow-up|92|||
162683369|NCT00374322|587548104|FG001|Overall Study|Lost to Follow-up|90|||
162683370|NCT00374322|587548103|FG000|Overall Study|Protocol Violation|8|||
162683371|NCT00374322|587548104|FG001|Overall Study|Protocol Violation|3|||
162683372|NCT00374322|587548103|FG000|Overall Study|Withdrawal by Subject|235|||
162683373|NCT00374322|587548104|FG001|Overall Study|Withdrawal by Subject|167|||
162683374|NCT00374322|587548103|FG000|Overall Study|Sponsor Terminated Study|866|||
162683375|NCT00374322|587548104|FG001|Overall Study|Sponsor Terminated Study|990|||
162683376|NCT00374322|587548103|FG000|Overall Study|Physician Decision|36|||
162683377|NCT00374322|587548104|FG001|Overall Study|Physician Decision|32|||
162683378|NCT00374322|587548103|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
162683379|NCT00374322|587548104|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
162683380|NCT00374322|587548103|FG000|Overall Study|Sponsor Decision|2|||
162683381|NCT00374322|587548104|FG001|Overall Study|Sponsor Decision|3|||
162683382|NCT00374322|587548103|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
162683383|NCT00374322|587548104|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
162683384|NCT00374322|587548103|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
162683385|NCT00374322|587548104|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
162683386|NCT00374322|587548103|FG000|Overall Study|Severe Toxicity|1|||
162683387|NCT00374322|587548104|FG001|Overall Study|Severe Toxicity|0|||
162683388|NCT00374322|587548103|FG000|Overall Study|Site Closed|2|||
162683389|NCT00374322|587548104|FG001|Overall Study|Site Closed|2|||
162683390|NCT00374322|587548103|FG000|Overall Study|Participant Changed Physician|1|||
162683391|NCT00374322|587548104|FG001|Overall Study|Participant Changed Physician|0|||
162683392|NCT00374322|587548103|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
162683393|NCT00374322|587548104|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
162683394|NCT00374322|587548103|FG000|Overall Study|Noncompliance with Study Requirements|0|||
162683395|NCT00374322|587548104|FG001|Overall Study|Noncompliance with Study Requirements|1|||
162683396|NCT00374322|587548103|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
162683397|NCT00374322|587548104|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
162683398|NCT00374322|587548103|FG000|Overall Study|Did Not Receive Study Medication|8|||
162683399|NCT00374322|587548104|FG001|Overall Study|Did Not Receive Study Medication|6|||
162683400|NCT02495025|587548108|FG000|Overall Study|Lost to Follow-up|21|||
162683401|NCT02495025|587548109|FG001|Overall Study|Lost to Follow-up|14|||
162683402|NCT02495025|587548108|FG000|Overall Study|Withdrawal by Subject|5|||
162683403|NCT02495025|587548109|FG001|Overall Study|Withdrawal by Subject|0|||
162683404|NCT01984697|587550247|FG000|Overall Study|Adverse Event|0|||
162683405|NCT01984697|587550248|FG001|Overall Study|Adverse Event|0|||
162683406|NCT01984697|587550249|FG002|Overall Study|Adverse Event|2|||
162683407|NCT01984697|587550250|FG003|Overall Study|Adverse Event|0|||
162683408|NCT01984697|587550251|FG004|Overall Study|Adverse Event|0|||
162683409|NCT01984697|587550247|FG000|Overall Study|Lost to Follow-up|14|||
162683410|NCT01984697|587550248|FG001|Overall Study|Lost to Follow-up|5|||
162683411|NCT01984697|587550249|FG002|Overall Study|Lost to Follow-up|10|||
162683412|NCT01984697|587550250|FG003|Overall Study|Lost to Follow-up|6|||
162683413|NCT01984697|587550251|FG004|Overall Study|Lost to Follow-up|21|||
162683414|NCT01984697|587550247|FG000|Overall Study|Physician Decision|3|||
162683415|NCT01984697|587550248|FG001|Overall Study|Physician Decision|0|||
162683416|NCT01984697|587550249|FG002|Overall Study|Physician Decision|0|||
162683417|NCT01984697|587550250|FG003|Overall Study|Physician Decision|1|||
162683418|NCT01984697|587550251|FG004|Overall Study|Physician Decision|0|||
162683419|NCT01984697|587550247|FG000|Overall Study|Protocol Violation|8|||
162683420|NCT01984697|587550248|FG001|Overall Study|Protocol Violation|5|||
162683421|NCT01984697|587550249|FG002|Overall Study|Protocol Violation|3|||
162683422|NCT01984697|587550250|FG003|Overall Study|Protocol Violation|2|||
162683423|NCT01984697|587550251|FG004|Overall Study|Protocol Violation|0|||
162683424|NCT01984697|587550247|FG000|Overall Study|Withdrawal by Subject|15|||
162683425|NCT01984697|587550248|FG001|Overall Study|Withdrawal by Subject|21|||
162683426|NCT01984697|587550249|FG002|Overall Study|Withdrawal by Subject|13|||
162683427|NCT01984697|587550250|FG003|Overall Study|Withdrawal by Subject|11|||
162683428|NCT01984697|587550251|FG004|Overall Study|Withdrawal by Subject|13|||
162683429|NCT01984697|587550247|FG000|Overall Study|Missed last follow-up visit|1|||
162683430|NCT01984697|587550248|FG001|Overall Study|Missed last follow-up visit|0|||
162683431|NCT01984697|587550249|FG002|Overall Study|Missed last follow-up visit|0|||
162683432|NCT01984697|587550250|FG003|Overall Study|Missed last follow-up visit|0|||
162683433|NCT01984697|587550251|FG004|Overall Study|Missed last follow-up visit|0|||
162683434|NCT01984697|587550247|FG000|Overall Study|Death|0|||
162683435|NCT01984697|587550248|FG001|Overall Study|Death|0|||
162683436|NCT01984697|587550249|FG002|Overall Study|Death|0|||
162683437|NCT01984697|587550250|FG003|Overall Study|Death|1|||
162683438|NCT01984697|587550251|FG004|Overall Study|Death|0|||
162683439|NCT01984697|587550247|FG000|Overall Study|Pregnancy|2|||
162683440|NCT01984697|587550248|FG001|Overall Study|Pregnancy|0|||
162683441|NCT01984697|587550249|FG002|Overall Study|Pregnancy|1|||
162683442|NCT01984697|587550250|FG003|Overall Study|Pregnancy|0|||
162683443|NCT01984697|587550251|FG004|Overall Study|Pregnancy|1|||
162683444|NCT01345630|587550252|FG000|Overall Study|Adverse Event|22|||
162683445|NCT01345630|587550253|FG001|Overall Study|Adverse Event|23|||
162683446|NCT01345630|587550252|FG000|Overall Study|Lost to Follow-up|17|||
162683447|NCT01345630|587550253|FG001|Overall Study|Lost to Follow-up|16|||
162683448|NCT01345630|587550252|FG000|Overall Study|Protocol Violation|4|||
162683449|NCT01345630|587550253|FG001|Overall Study|Protocol Violation|1|||
162683450|NCT01345630|587550252|FG000|Overall Study|Medication error without associated AE|0|||
162683451|NCT01345630|587550253|FG001|Overall Study|Medication error without associated AE|1|||
162683452|NCT01345630|587550252|FG000|Overall Study|Study terminated by sponsor|254|||
162683453|NCT01345630|587550253|FG001|Overall Study|Study terminated by sponsor|285|||
162683454|NCT01345630|587550252|FG000|Overall Study|Other reasons|6|||
162683455|NCT01345630|587550253|FG001|Overall Study|Other reasons|8|||
162683456|NCT01345630|587550252|FG000|Overall Study|Withdrawn due to pregnancy|1|||
162683457|NCT01345630|587550253|FG001|Overall Study|Withdrawn due to pregnancy|2|||
162683458|NCT01345630|587550252|FG000|Overall Study|No longer willing to participate|9|||
162683459|NCT01345630|587550253|FG001|Overall Study|No longer willing to participate|12|||
162683460|NCT01345630|587550252|FG000|Overall Study|Insufficient clinical response|48|||
162683461|NCT01345630|587550253|FG001|Overall Study|Insufficient clinical response|11|||
162683462|NCT01364922|587550261|FG000|Open-label (OL) Period|Adverse Event|7|||
162683463|NCT01364922|587550262|FG001|Open-label (OL) Period|Adverse Event|0|||
162683464|NCT01364922|587550263|FG002|Open-label (OL) Period|Adverse Event|0|||
162683465|NCT01364922|587550261|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
162683466|NCT01364922|587550262|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
162683467|NCT01364922|587550263|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
162683468|NCT01364922|587550261|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
162683469|NCT01364922|587550262|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
162683470|NCT01364922|587550263|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
162683471|NCT01364922|587550261|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
162683472|NCT01364922|587550262|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
162683473|NCT01364922|587550263|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
162683474|NCT01364922|587550261|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
162683475|NCT01364922|587550262|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
162683476|NCT01364922|587550263|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
162683477|NCT01364922|587550261|FG000|Open-label (OL) Period|Other, Unspecified|1|||
162683478|NCT01364922|587550262|FG001|Open-label (OL) Period|Other, Unspecified|0|||
162683479|NCT01364922|587550263|FG002|Open-label (OL) Period|Other, Unspecified|0|||
162683480|NCT01364922|587550261|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
162683481|NCT01364922|587550262|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
162683482|NCT01364922|587550263|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
162683483|NCT01364922|587550261|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
162683484|NCT01364922|587550262|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
162683485|NCT01364922|587550263|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
162683486|NCT01364922|587550261|FG000|Double-Blind (DB) Period|Adverse Event|0|||
162683487|NCT01364922|587550262|FG001|Double-Blind (DB) Period|Adverse Event|0|||
162683488|NCT01364922|587550263|FG002|Double-Blind (DB) Period|Adverse Event|1|||
162683489|NCT01364922|587550261|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
162683490|NCT01364922|587550262|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
162683491|NCT01364922|587550263|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
162683492|NCT05178121|587550264|FG000|Overall Study|Other|4|||
162683493|NCT05178121|587550264|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
162683494|NCT01953003|587550265|FG000|Overall Study|Not treated|0|||
162683495|NCT01953003|587550266|FG001|Overall Study|Not treated|1|||
162683496|NCT01953003|587550265|FG000|Overall Study|Progressive disease|35|||
162683497|NCT01953003|587550266|FG001|Overall Study|Progressive disease|45|||
162683498|NCT01953003|587550265|FG000|Overall Study|Related Adverse events|7|||
162683499|NCT01953003|587550266|FG001|Overall Study|Related Adverse events|2|||
162683500|NCT01953003|587550265|FG000|Overall Study|Non-related adverse events|0|||
162683501|NCT01953003|587550266|FG001|Overall Study|Non-related adverse events|2|||
162683502|NCT01953003|587550265|FG000|Overall Study|Protocol Violation|0|||
162683503|NCT01953003|587550266|FG001|Overall Study|Protocol Violation|1|||
162683504|NCT01953003|587550265|FG000|Overall Study|Withdrawal by Subject|14|||
162683505|NCT01953003|587550266|FG001|Overall Study|Withdrawal by Subject|4|||
162683506|NCT01582789|587550268|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
162683507|NCT01582789|587550269|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
162683508|NCT04044456|587550276|FG000|Overall Study|Lost to Follow-up|4|||
162683509|NCT04044456|587550277|FG001|Overall Study|Lost to Follow-up|1|||
162683510|NCT04044456|587550276|FG000|Overall Study|Withdrawal by Subject|1|||
162683511|NCT04044456|587550277|FG001|Overall Study|Withdrawal by Subject|0|||
162683512|NCT02316769|587550279|FG000|Overall Study|Physician Decision|1|||
162683513|NCT02316769|587550280|FG001|Overall Study|Physician Decision|0|||
162683514|NCT02316769|587550279|FG000|Overall Study|Withdrawal by Subject|1|||
162683515|NCT02316769|587550280|FG001|Overall Study|Withdrawal by Subject|0|||
162683516|NCT04209725|587550287|FG000|Overall Study|Adverse Event|1|||
162683517|NCT01281644|587550290|FG000|Overall Study|Lost to Follow-up|3|||
162683518|NCT01281644|587550290|FG000|Overall Study|Withdrawal by Subject|2|||
162683519|NCT02954354|587550291|FG000|Overall Study|Adverse Event|2|||
162683520|NCT02954354|587550292|FG001|Overall Study|Adverse Event|2|||
162683521|NCT02954354|587550293|FG002|Overall Study|Adverse Event|4|||
162683522|NCT02954354|587550291|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
162683523|NCT02954354|587550292|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
162683524|NCT02954354|587550293|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
162683525|NCT02954354|587550291|FG000|Overall Study|Lack of Efficacy|0|||
162683526|NCT02954354|587550292|FG001|Overall Study|Lack of Efficacy|2|||
162683527|NCT02954354|587550293|FG002|Overall Study|Lack of Efficacy|0|||
162683528|NCT02954354|587550291|FG000|Overall Study|Withdrawal by Subject|17|||
162683529|NCT02954354|587550292|FG001|Overall Study|Withdrawal by Subject|9|||
162683530|NCT02954354|587550293|FG002|Overall Study|Withdrawal by Subject|11|||
162683531|NCT02954354|587550291|FG000|Overall Study|Lost to Follow-up|12|||
162683532|NCT02954354|587550292|FG001|Overall Study|Lost to Follow-up|5|||
162683533|NCT02954354|587550293|FG002|Overall Study|Lost to Follow-up|0|||
162683534|NCT02954354|587550291|FG000|Overall Study|Miscellaneous|2|||
162683535|NCT02954354|587550292|FG001|Overall Study|Miscellaneous|2|||
162683536|NCT02954354|587550293|FG002|Overall Study|Miscellaneous|1|||
162683537|NCT03039023|587550296|FG000|Overall Study|Withdrawal by Subject|1|||
162683538|NCT03039023|587550297|FG001|Overall Study|Withdrawal by Subject|0|||
162683539|NCT03039023|587550298|FG002|Overall Study|Withdrawal by Subject|1|||
162683540|NCT03039023|587550299|FG003|Overall Study|Withdrawal by Subject|1|||
162683541|NCT03039023|587550300|FG004|Overall Study|Withdrawal by Subject|0|||
162683542|NCT03039023|587550296|FG000|Overall Study|Physician Decision|0|||
162683543|NCT03039023|587550297|FG001|Overall Study|Physician Decision|0|||
162683544|NCT03039023|587550298|FG002|Overall Study|Physician Decision|0|||
162683545|NCT03039023|587550299|FG003|Overall Study|Physician Decision|1|||
162683546|NCT03039023|587550300|FG004|Overall Study|Physician Decision|0|||
162683547|NCT03338829|587550302|FG000|Overall Study|Lost to Follow-up|4|||
162683548|NCT03338829|587550303|FG001|Overall Study|Lost to Follow-up|2|||
162683549|NCT03338829|587550304|FG002|Overall Study|Lost to Follow-up|4|||
162683550|NCT03338829|587550302|FG000|Overall Study|Pregnancy loss|1|||
162683551|NCT03338829|587550303|FG001|Overall Study|Pregnancy loss|1|||
162683552|NCT03338829|587550304|FG002|Overall Study|Pregnancy loss|0|||
162683553|NCT03338829|587550302|FG000|Overall Study|Protocol Violation|0|||
162683554|NCT03338829|587550303|FG001|Overall Study|Protocol Violation|1|||
162683555|NCT03338829|587550304|FG002|Overall Study|Protocol Violation|0|||
162683556|NCT00448448|587550308|FG000|Overall Study|Withdrawal by Subject|13|||
162683557|NCT00448448|587550309|FG001|Overall Study|Withdrawal by Subject|2|||
162683558|NCT00448448|587550308|FG000|Overall Study|On protocol when study ended|83|||
162683559|NCT00448448|587550309|FG001|Overall Study|On protocol when study ended|36|||
162683560|NCT00448448|587550308|FG000|Overall Study|Lost to Follow-up|2|||
162683561|NCT00448448|587550309|FG001|Overall Study|Lost to Follow-up|1|||
162683562|NCT00448448|587550308|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
162683563|NCT00448448|587550309|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
162683564|NCT00448448|587550308|FG000|Overall Study|Signed consent lost|0|||
162683565|NCT00448448|587550309|FG001|Overall Study|Signed consent lost|1|||
162683566|NCT02340026|587550310|FG000|Treatment Phase|Withdrawal by Subject|2|||
162683567|NCT02340026|587550311|FG001|Treatment Phase|Withdrawal by Subject|2|||
162683568|NCT02340026|587550310|FG000|Follow-up Phase|Lost to Follow-up|1|||
162683569|NCT02340026|587550311|FG001|Follow-up Phase|Lost to Follow-up|0|||
162683570|NCT02684006|587550312|FG000|Overall Study|Other|18|||
162683571|NCT02684006|587550313|FG001|Overall Study|Other|6|||
162683572|NCT02684006|587550312|FG000|Overall Study|Protocol Violation|2|||
162683573|NCT02684006|587550313|FG001|Overall Study|Protocol Violation|1|||
162683574|NCT02684006|587550312|FG000|Overall Study|Non-compliance with study drug|1|||
162683575|NCT02684006|587550313|FG001|Overall Study|Non-compliance with study drug|1|||
162683576|NCT02684006|587550312|FG000|Overall Study|No longer met eligibility criteria|6|||
162683577|NCT02684006|587550313|FG001|Overall Study|No longer met eligibility criteria|2|||
162683578|NCT02684006|587550312|FG000|Overall Study|Lost to Follow-up|0|||
162683579|NCT02684006|587550313|FG001|Overall Study|Lost to Follow-up|1|||
162683580|NCT02684006|587550312|FG000|Overall Study|Death|25|||
162683581|NCT02684006|587550313|FG001|Overall Study|Death|22|||
162683582|NCT02684006|587550312|FG000|Overall Study|Global deterioration of health status|18|||
162683583|NCT02684006|587550313|FG001|Overall Study|Global deterioration of health status|20|||
162683584|NCT02684006|587550312|FG000|Overall Study|Physician Decision|15|||
162683585|NCT02684006|587550313|FG001|Overall Study|Physician Decision|8|||
162683586|NCT02684006|587550312|FG000|Overall Study|Adverse Event|86|||
162683587|NCT02684006|587550313|FG001|Overall Study|Adverse Event|65|||
162683588|NCT02684006|587550312|FG000|Overall Study|Withdrawal by Subject|29|||
162683589|NCT02684006|587550313|FG001|Overall Study|Withdrawal by Subject|43|||
162683590|NCT02684006|587550312|FG000|Overall Study|Progressive disease|236|||
162683591|NCT02684006|587550313|FG001|Overall Study|Progressive disease|266|||
162683592|NCT02684006|587550312|FG000|Overall Study|Participation terminated by sponsor|6|||
162683593|NCT02684006|587550313|FG001|Overall Study|Participation terminated by sponsor|9|||
162683594|NCT04642898|587550314|FG000|Overall Study|Withdrawal by Subject|2|||
162683595|NCT04642898|587550315|FG001|Overall Study|Withdrawal by Subject|4|||
162683596|NCT04642898|587550316|FG002|Overall Study|Withdrawal by Subject|4|||
162683597|NCT04642898|587550317|FG003|Overall Study|Withdrawal by Subject|6|||
162683598|NCT04642898|587550318|FG004|Overall Study|Withdrawal by Subject|2|||
162683599|NCT04642898|587550319|FG005|Overall Study|Withdrawal by Subject|6|||
162683600|NCT04642898|587550314|FG000|Overall Study|Lost to Follow-up|0|||
162683601|NCT04642898|587550315|FG001|Overall Study|Lost to Follow-up|0|||
162683602|NCT04642898|587550316|FG002|Overall Study|Lost to Follow-up|0|||
162683603|NCT04642898|587550317|FG003|Overall Study|Lost to Follow-up|2|||
162683604|NCT04642898|587550318|FG004|Overall Study|Lost to Follow-up|0|||
162683605|NCT04642898|587550319|FG005|Overall Study|Lost to Follow-up|1|||
162683606|NCT04642898|587550314|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
162683607|NCT04642898|587550315|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
162683608|NCT04642898|587550316|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
162683609|NCT04642898|587550317|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
162683610|NCT04642898|587550318|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
162683611|NCT04642898|587550319|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
162683612|NCT04642898|587550314|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162683613|NCT04642898|587550315|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162683614|NCT04642898|587550316|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162683615|NCT04642898|587550317|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162683616|NCT04642898|587550318|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
162683617|NCT04642898|587550319|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162683618|NCT04495179|587550320|FG000|Overall Study|Lost to Follow-up|0|||
162683619|NCT04495179|587550321|FG001|Overall Study|Lost to Follow-up|1|||
162683620|NCT04495179|587550320|FG000|Overall Study|Withdrawal by Subject|2|||
162683621|NCT04495179|587550321|FG001|Overall Study|Withdrawal by Subject|4|||
162683622|NCT04495179|587550320|FG000|Overall Study|Study terminated by sponsor|0|||
162683623|NCT04495179|587550321|FG001|Overall Study|Study terminated by sponsor|18|||
162683624|NCT04495179|587550320|FG000|Overall Study|Death|0|||
162683625|NCT04495179|587550321|FG001|Overall Study|Death|4|||
162683626|NCT04495179|587550320|FG000|Overall Study|Adverse Event|0|||
162683627|NCT04495179|587550321|FG001|Overall Study|Adverse Event|1|||
162683628|NCT04280562|587550322|FG000|Study|Adverse Event|2|||
162683629|NCT04280562|587550323|FG001|Study|Adverse Event|0|||
162683630|NCT04280562|587550322|FG000|Study|Lost to Follow-up|3|||
162683631|NCT04280562|587550323|FG001|Study|Lost to Follow-up|3|||
162683632|NCT03434678|587550324|FG000|Overall Study|Withdrawal by Subject|13|||
162683633|NCT03434678|587550325|FG001|Overall Study|Withdrawal by Subject|13|||
162683634|NCT03434678|587550324|FG000|Overall Study|Found to be ineligible post randomization|2|||
162683635|NCT03434678|587550325|FG001|Overall Study|Found to be ineligible post randomization|1|||
162683636|NCT00162370|587550329|FG000|Efficacy Population|Lost to Follow-up|51|||
162683637|NCT02061202|587550330|FG000|Overall Study|Lost to Follow-up|1|||
162683638|NCT02061202|587550331|FG001|Overall Study|Lost to Follow-up|1|||
162683639|NCT04559568|587550332|FG000|Overall Study|Physician Decision|0|||
162683640|NCT04559568|587550333|FG001|Overall Study|Physician Decision|0|||
162683641|NCT04559568|587550334|FG002|Overall Study|Physician Decision|0|||
162683642|NCT04559568|587550335|FG003|Overall Study|Physician Decision|0|||
162683643|NCT04559568|587550336|FG004|Overall Study|Physician Decision|0|||
162683644|NCT04559568|587550337|FG005|Overall Study|Physician Decision|0|||
162683645|NCT04559568|587550338|FG006|Overall Study|Physician Decision|0|||
162683646|NCT04559568|587550339|FG007|Overall Study|Physician Decision|0|||
162683647|NCT04559568|587550340|FG008|Overall Study|Physician Decision|0|||
162683648|NCT04559568|587550341|FG009|Overall Study|Physician Decision|1|||
162683649|NCT04559568|587550342|FG010|Overall Study|Physician Decision|0|||
162683650|NCT04559568|587550332|FG000|Overall Study|Withdrawal by Subject|0|||
162683651|NCT04559568|587550333|FG001|Overall Study|Withdrawal by Subject|0|||
162683652|NCT04559568|587550334|FG002|Overall Study|Withdrawal by Subject|0|||
162683653|NCT04559568|587550335|FG003|Overall Study|Withdrawal by Subject|0|||
162683654|NCT04559568|587550336|FG004|Overall Study|Withdrawal by Subject|0|||
162683655|NCT04559568|587550337|FG005|Overall Study|Withdrawal by Subject|0|||
162683656|NCT04559568|587550338|FG006|Overall Study|Withdrawal by Subject|0|||
162683657|NCT04559568|587550339|FG007|Overall Study|Withdrawal by Subject|0|||
162683658|NCT04559568|587550340|FG008|Overall Study|Withdrawal by Subject|0|||
162683659|NCT04559568|587550341|FG009|Overall Study|Withdrawal by Subject|0|||
162683660|NCT04559568|587550342|FG010|Overall Study|Withdrawal by Subject|1|||
162683661|NCT03721965|587550345|FG000|Overall Study|Death|1|||
162683662|NCT03721965|587550345|FG000|Overall Study|Study Terminated by Sponsor|1|||
162683663|NCT04085328|587550347|FG000|Overall Study|Witihdrew Consent|16|||
162683664|NCT04085328|587550348|FG001|Overall Study|Witihdrew Consent|16|||
162683665|NCT04085328|587550347|FG000|Overall Study|Adverse Event|8|||
162683666|NCT04085328|587550348|FG001|Overall Study|Adverse Event|7|||
162683667|NCT04085328|587550347|FG000|Overall Study|Lost to Follow-up|7|||
162683668|NCT04085328|587550348|FG001|Overall Study|Lost to Follow-up|2|||
162683669|NCT04085328|587550347|FG000|Overall Study|Physician Decision|0|||
162683670|NCT04085328|587550348|FG001|Overall Study|Physician Decision|1|||
162683671|NCT04085328|587550347|FG000|Overall Study|Pregnancy|0|||
162683672|NCT04085328|587550348|FG001|Overall Study|Pregnancy|1|||
162683673|NCT04085328|587550347|FG000|Overall Study|Reasons Related to COVID-19|5|||
162683674|NCT04085328|587550348|FG001|Overall Study|Reasons Related to COVID-19|8|||
162683675|NCT04085328|587550347|FG000|Overall Study|Did not meet inclusion criteria|1|||
162683676|NCT04085328|587550348|FG001|Overall Study|Did not meet inclusion criteria|1|||
162683677|NCT04085328|587550347|FG000|Overall Study|Early termination|1|||
162683678|NCT04085328|587550348|FG001|Overall Study|Early termination|0|||
162683679|NCT05608499|587550349|FG000|Overall Study|Lack of Efficacy|1|||
162683680|NCT05608499|587550350|FG001|Overall Study|Lack of Efficacy|0|||
162683681|NCT05608499|587550349|FG000|Overall Study|Lost to Follow-up|0|||
162683682|NCT05608499|587550350|FG001|Overall Study|Lost to Follow-up|1|||
162683683|NCT01422408|587550353|FG000|Overall Study|Adverse Event|1|||
162683684|NCT01422408|587550353|FG000|Overall Study|Withdrawal by Subject|3|||
162683685|NCT00724152|587550360|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
162683686|NCT00724152|587550361|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
162683687|NCT00724152|587550362|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
162683688|NCT00724152|587550360|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
162683689|NCT00724152|587550361|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
162683690|NCT00724152|587550362|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
162683691|NCT01328080|587550364|FG000|Overall Study|Lost to Follow-up|5|||
162683692|NCT00045305|587550365|FG000|Overall Study|Lack of Efficacy|6|||
162683693|NCT00045305|587550365|FG000|Overall Study|Adverse Event|3|||
162725890|NCT00785512|587706016|FG000|Overall Study|Physician Decision|0|||
162683694|NCT00045305|587550365|FG000|Overall Study|Death|3|||
162683695|NCT00045305|587550365|FG000|Overall Study|site error|2|||
162683696|NCT03266770|587550366|FG000|Overall Study|Physician Decision|3|||
162683697|NCT03266770|587550366|FG000|Overall Study|Insufficient study supplies|1|||
162683698|NCT03266770|587550366|FG000|Overall Study|Adverse Event|1|||
162683699|NCT04274894|587550367|FG000|Overall Study|Adverse Event|7|||
162683700|NCT04274894|587550367|FG000|Overall Study|Withdrew consent|5|||
162683701|NCT04274894|587550367|FG000|Overall Study|Lost to Follow-up|9|||
162683702|NCT04274894|587550367|FG000|Overall Study|COVID-19 infection|1|||
162683703|NCT04274894|587550367|FG000|Overall Study|Other, not specified|20|||
162683704|NCT01936857|587550368|FG000|Overall Study|Sent to prison or 06 center|11|||
162683705|NCT01936857|587550369|FG001|Overall Study|Sent to prison or 06 center|12|||
162683706|NCT01936857|587550368|FG000|Overall Study|Lost to Follow-up|10|||
162683707|NCT01936857|587550369|FG001|Overall Study|Lost to Follow-up|7|||
162683708|NCT01936857|587550368|FG000|Overall Study|Death|7|||
162683709|NCT01936857|587550369|FG001|Overall Study|Death|3|||
162683710|NCT01936857|587550368|FG000|Overall Study|Moved|2|||
162683711|NCT01936857|587550369|FG001|Overall Study|Moved|1|||
162683712|NCT01936857|587550368|FG000|Overall Study|Withdrawal by Subject|1|||
162683713|NCT01936857|587550369|FG001|Overall Study|Withdrawal by Subject|0|||
162683714|NCT01936857|587550368|FG000|Overall Study|Side effect of medication|1|||
162683715|NCT01936857|587550369|FG001|Overall Study|Side effect of medication|0|||
162683716|NCT01936857|587550368|FG000|Overall Study|Other|2|||
162683717|NCT01936857|587550369|FG001|Overall Study|Other|2|||
162683718|NCT03848403|587550370|FG000|Period 2 (Day 8)|Adverse Event|1|||
162683719|NCT03848403|587550371|FG001|Period 2 (Day 8)|Adverse Event|2|||
162683720|NCT03848403|587550372|FG002|Period 2 (Day 8)|Adverse Event|2|||
162683721|NCT03848403|587550370|FG000|Period 2 (Day 8)|Physician Decision|0|||
162683722|NCT03848403|587550371|FG001|Period 2 (Day 8)|Physician Decision|1|||
162683723|NCT03848403|587550372|FG002|Period 2 (Day 8)|Physician Decision|0|||
162683724|NCT03848403|587550370|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
162683725|NCT03848403|587550371|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
162683726|NCT03848403|587550372|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
162683727|NCT00168038|587550373|FG000|Overall Study|Adverse Event|1|||
162683728|NCT00168038|587550373|FG000|Overall Study|Therapy failure|1|||
162683729|NCT01494584|587550381|FG000|Overall Study|Study Closed/Terminated|1|||
162683730|NCT01218126|587550386|FG000|Overall Study|Adverse Event|8|||
162683731|NCT01218126|587550387|FG001|Overall Study|Adverse Event|10|||
162683732|NCT01218126|587550388|FG002|Overall Study|Adverse Event|12|||
162683733|NCT01218126|587550389|FG003|Overall Study|Adverse Event|16|||
162683734|NCT01218126|587550386|FG000|Overall Study|Lack of Efficacy|7|||
162683735|NCT01218126|587550387|FG001|Overall Study|Lack of Efficacy|2|||
162683736|NCT01218126|587550388|FG002|Overall Study|Lack of Efficacy|2|||
162683737|NCT01218126|587550389|FG003|Overall Study|Lack of Efficacy|6|||
162683738|NCT01218126|587550386|FG000|Overall Study|Protocol Violation|5|||
162683739|NCT01218126|587550387|FG001|Overall Study|Protocol Violation|2|||
162683740|NCT01218126|587550388|FG002|Overall Study|Protocol Violation|2|||
162683741|NCT01218126|587550389|FG003|Overall Study|Protocol Violation|3|||
162683742|NCT01218126|587550386|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162683743|NCT01218126|587550387|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162683744|NCT01218126|587550388|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162683745|NCT01218126|587550389|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162683746|NCT01218126|587550386|FG000|Overall Study|Lost to Follow-up|0|||
162683747|NCT01218126|587550387|FG001|Overall Study|Lost to Follow-up|0|||
162683748|NCT01218126|587550388|FG002|Overall Study|Lost to Follow-up|0|||
162683749|NCT01218126|587550389|FG003|Overall Study|Lost to Follow-up|2|||
162683750|NCT01218126|587550386|FG000|Overall Study|Physician Decision|1|||
162683751|NCT01218126|587550387|FG001|Overall Study|Physician Decision|2|||
162683752|NCT01218126|587550388|FG002|Overall Study|Physician Decision|4|||
162683753|NCT01218126|587550389|FG003|Overall Study|Physician Decision|2|||
162683754|NCT01218126|587550386|FG000|Overall Study|Withdrawal by Subject|2|||
162683755|NCT01218126|587550387|FG001|Overall Study|Withdrawal by Subject|5|||
162683756|NCT01218126|587550388|FG002|Overall Study|Withdrawal by Subject|4|||
162683757|NCT01218126|587550389|FG003|Overall Study|Withdrawal by Subject|6|||
162683758|NCT05380947|587550393|FG000|Washout Period 1|Not attend visit|1|||
162683759|NCT05380947|587550394|FG001|Washout Period 1|Not attend visit|0|||
162683760|NCT05380947|587550395|FG002|Washout Period 1|Not attend visit|0|||
162683761|NCT05380947|587550396|FG003|Washout Period 1|Not attend visit|0|||
162683762|NCT05380947|587550393|FG000|Washout Period 2|Adverse Event|1|||
162683763|NCT05380947|587550394|FG001|Washout Period 2|Adverse Event|0|||
162683764|NCT05380947|587550395|FG002|Washout Period 2|Adverse Event|0|||
162683765|NCT05380947|587550396|FG003|Washout Period 2|Adverse Event|0|||
162683766|NCT05380947|587550393|FG000|Washout Period 3|Adverse Event|0|||
162683767|NCT05380947|587550394|FG001|Washout Period 3|Adverse Event|1|||
162683768|NCT05380947|587550395|FG002|Washout Period 3|Adverse Event|0|||
162683769|NCT05380947|587550396|FG003|Washout Period 3|Adverse Event|0|||
162683770|NCT05380947|587550393|FG000|Washout Period 3|Not attend visit|0|||
162683771|NCT05380947|587550394|FG001|Washout Period 3|Not attend visit|1|||
162683772|NCT05380947|587550395|FG002|Washout Period 3|Not attend visit|0|||
162683773|NCT05380947|587550396|FG003|Washout Period 3|Not attend visit|1|||
162683774|NCT01563536|587550397|FG000|Overall Study|Withdrawal by Subject|0|||
162683775|NCT01563536|587550398|FG001|Overall Study|Withdrawal by Subject|2|||
162683776|NCT01563536|587550397|FG000|Overall Study|Lost to Follow-up|1|||
162683777|NCT01563536|587550398|FG001|Overall Study|Lost to Follow-up|0|||
162683778|NCT01860703|587550399|FG000|Overall Study|Adverse Event|1|||
162683779|NCT01860703|587550400|FG001|Overall Study|Adverse Event|4|||
162683780|NCT01860703|587550401|FG002|Overall Study|Adverse Event|0|||
162683781|NCT01860703|587550402|FG003|Overall Study|Adverse Event|2|||
162683782|NCT01860703|587550399|FG000|Overall Study|Withdrawal by Subject|0|||
162683783|NCT01860703|587550400|FG001|Overall Study|Withdrawal by Subject|1|||
162683784|NCT01860703|587550401|FG002|Overall Study|Withdrawal by Subject|0|||
162683785|NCT01860703|587550402|FG003|Overall Study|Withdrawal by Subject|0|||
162683786|NCT01860703|587550399|FG000|Overall Study|Personal reason|1|||
162683787|NCT01860703|587550400|FG001|Overall Study|Personal reason|0|||
162683788|NCT01860703|587550401|FG002|Overall Study|Personal reason|1|||
162683789|NCT01860703|587550402|FG003|Overall Study|Personal reason|0|||
162683790|NCT06213701|587550406|FG000|Overall Study|Withdrawal by Subject|2|||
162683791|NCT06213701|587550407|FG001|Overall Study|Withdrawal by Subject|1|||
162683792|NCT06213701|587550408|FG002|Overall Study|Withdrawal by Subject|0|||
162683793|NCT00538590|587550409|FG000|Overall Study|Death|1|||
162683794|NCT00538590|587550410|FG001|Overall Study|Death|0|||
162683795|NCT03184792|587550420|FG000|Overall Study|Pandemic|2|||
162683796|NCT03184792|587550421|FG001|Overall Study|Pandemic|2|||
162683797|NCT00313820|587550422|FG000|Assigned to Treatment|Other|1|||
162683798|NCT00313820|587550423|FG001|Assigned to Treatment|Other|0|||
162683799|NCT00313820|587550422|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
162683800|NCT00313820|587550423|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
162683801|NCT00313820|587550422|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
162683802|NCT00313820|587550423|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
162683803|NCT00313820|587550422|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
162683804|NCT00313820|587550423|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
162683805|NCT00313820|587550422|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
162683806|NCT00313820|587550423|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
162683807|NCT00313820|587550422|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
162683808|NCT00313820|587550423|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
162683809|NCT02453685|587550427|FG000|Overall Study|Adverse Event|0|||
162683810|NCT02453685|587550428|FG001|Overall Study|Adverse Event|1|||
162683811|NCT02453685|587550427|FG000|Overall Study|Protocol Violation|7|||
162683812|NCT02453685|587550428|FG001|Overall Study|Protocol Violation|4|||
162683813|NCT02453685|587550427|FG000|Overall Study|Lost to Follow-up|0|||
162683814|NCT02453685|587550428|FG001|Overall Study|Lost to Follow-up|1|||
162683815|NCT02453685|587550427|FG000|Overall Study|Withdrawal by Subject|8|||
162683816|NCT02453685|587550428|FG001|Overall Study|Withdrawal by Subject|4|||
162683817|NCT02453685|587550427|FG000|Overall Study|Unclassified|4|||
162683818|NCT02453685|587550428|FG001|Overall Study|Unclassified|2|||
162683819|NCT02778100|587550431|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
162683820|NCT02778100|587550432|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
162683821|NCT01515748|587550438|FG000|Overall Study|Withdrawal by Subject|32|||
162683822|NCT01515748|587550439|FG001|Overall Study|Withdrawal by Subject|41|||
162683823|NCT01515748|587550438|FG000|Overall Study|Lost to Follow-up|2|||
162683824|NCT01515748|587550439|FG001|Overall Study|Lost to Follow-up|4|||
162683825|NCT01515748|587550438|FG000|Overall Study|Other than specified above|5|||
162683826|NCT01515748|587550439|FG001|Overall Study|Other than specified above|10|||
162683827|NCT03221387|587550440|FG000|Overall Study|Lost to Follow-up|1|||
162683828|NCT03221387|587550440|FG000|Overall Study|Lung transplant|1|||
162683829|NCT04120233|587550446|FG000|Overall Study|Adverse Event|0|||
162683830|NCT04120233|587550447|FG001|Overall Study|Adverse Event|0|||
162683831|NCT04120233|587550448|FG002|Overall Study|Adverse Event|0|||
162683832|NCT04120233|587550449|FG003|Overall Study|Adverse Event|0|||
162683833|NCT04120233|587550450|FG004|Overall Study|Adverse Event|1|||
162683834|NCT04120233|587550451|FG005|Overall Study|Adverse Event|0|||
162683835|NCT06223373|587550452|FG000|Overall Study|Lost to Follow-up|1|||
162683836|NCT06223373|587550453|FG001|Overall Study|Lost to Follow-up|2|||
162683837|NCT05809596|587550454|FG000|Overall Study|Death|16|||
162683838|NCT05809596|587550454|FG000|Overall Study|Withdrawal by Subject|4|||
162683839|NCT05809596|587550454|FG000|Overall Study|Physician Decision|1|||
162683840|NCT05809596|587550454|FG000|Overall Study|Missed Visit|2|||
162683841|NCT05809596|587550454|FG000|Overall Study|Other|3|||
162683842|NCT03770494|587550455|FG000|Overall Study|Lost to Follow-up|0|||
162683843|NCT03770494|587550456|FG001|Overall Study|Lost to Follow-up|0|||
162683844|NCT03770494|587550457|FG002|Overall Study|Lost to Follow-up|1|||
162683845|NCT03770494|587550458|FG003|Overall Study|Lost to Follow-up|1|||
162683846|NCT03770494|587550459|FG004|Overall Study|Lost to Follow-up|1|||
162683847|NCT03770494|587550460|FG005|Overall Study|Lost to Follow-up|0|||
162683848|NCT03770494|587550461|FG006|Overall Study|Lost to Follow-up|0|||
162683849|NCT03770494|587550462|FG007|Overall Study|Lost to Follow-up|0|||
162683850|NCT03770494|587550463|FG008|Overall Study|Lost to Follow-up|0|||
162683851|NCT03770494|587550464|FG009|Overall Study|Lost to Follow-up|0|||
162683852|NCT03770494|587550465|FG010|Overall Study|Lost to Follow-up|0|||
162683853|NCT03770494|587550466|FG011|Overall Study|Lost to Follow-up|0|||
162683854|NCT03770494|587550467|FG012|Overall Study|Lost to Follow-up|0|||
162683855|NCT03770494|587550468|FG013|Overall Study|Lost to Follow-up|0|||
162683856|NCT03770494|587550455|FG000|Overall Study|Study terminated by sponsor|1|||
162683857|NCT03770494|587550456|FG001|Overall Study|Study terminated by sponsor|2|||
162683858|NCT03770494|587550457|FG002|Overall Study|Study terminated by sponsor|1|||
162683859|NCT03770494|587550458|FG003|Overall Study|Study terminated by sponsor|1|||
162683860|NCT03770494|587550459|FG004|Overall Study|Study terminated by sponsor|1|||
162683861|NCT03770494|587550460|FG005|Overall Study|Study terminated by sponsor|2|||
162725891|NCT00785512|587706017|FG001|Overall Study|Physician Decision|0|||
162725892|NCT00785512|587706016|FG000|Overall Study|Lack of compliance|0|||
162725893|NCT00785512|587706017|FG001|Overall Study|Lack of compliance|1|||
162725894|NCT03811574|587706018|FG000|Overall Study|Withdrawal by Subject|2|||
162725895|NCT03811574|587706019|FG001|Overall Study|Withdrawal by Subject|4|||
162725896|NCT03811574|587706020|FG002|Overall Study|Withdrawal by Subject|0|||
162725897|NCT03144674|587706023|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
162725898|NCT03144674|587706024|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
162725899|NCT03144674|587706025|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
162725900|NCT03144674|587706026|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
162725901|NCT03144674|587706023|FG000|Overall Study|Death|3|||
162725902|NCT03144674|587706024|FG001|Overall Study|Death|2|||
162725903|NCT03144674|587706025|FG002|Overall Study|Death|6|||
162725904|NCT03144674|587706026|FG003|Overall Study|Death|24|||
162725905|NCT03144674|587706023|FG000|Overall Study|Lost to Follow-up|0|||
162725906|NCT03144674|587706024|FG001|Overall Study|Lost to Follow-up|1|||
162725907|NCT03144674|587706025|FG002|Overall Study|Lost to Follow-up|0|||
162725908|NCT03144674|587706026|FG003|Overall Study|Lost to Follow-up|4|||
162725909|NCT03144674|587706023|FG000|Overall Study|Withdrawal by Participant|0|||
162725910|NCT03144674|587706024|FG001|Overall Study|Withdrawal by Participant|0|||
162725911|NCT03144674|587706025|FG002|Overall Study|Withdrawal by Participant|2|||
162725912|NCT03144674|587706026|FG003|Overall Study|Withdrawal by Participant|6|||
162725913|NCT03144674|587706023|FG000|Overall Study|Discharged from the Trust|0|||
162725914|NCT03144674|587706024|FG001|Overall Study|Discharged from the Trust|0|||
162725915|NCT03144674|587706025|FG002|Overall Study|Discharged from the Trust|1|||
162725916|NCT03144674|587706026|FG003|Overall Study|Discharged from the Trust|0|||
162725917|NCT03144674|587706023|FG000|Overall Study|Exclusion Criteria Met|0|||
162725918|NCT03144674|587706024|FG001|Overall Study|Exclusion Criteria Met|0|||
162725919|NCT03144674|587706025|FG002|Overall Study|Exclusion Criteria Met|1|||
162725920|NCT03144674|587706026|FG003|Overall Study|Exclusion Criteria Met|0|||
162725921|NCT03144674|587706023|FG000|Overall Study|Changed Physicians|0|||
162725922|NCT03144674|587706024|FG001|Overall Study|Changed Physicians|0|||
162725923|NCT03144674|587706025|FG002|Overall Study|Changed Physicians|0|||
162725924|NCT03144674|587706026|FG003|Overall Study|Changed Physicians|1|||
162725925|NCT03144674|587706023|FG000|Overall Study|Removed for Safety|0|||
162725926|NCT03144674|587706024|FG001|Overall Study|Removed for Safety|0|||
162725927|NCT03144674|587706025|FG002|Overall Study|Removed for Safety|0|||
162725928|NCT03144674|587706026|FG003|Overall Study|Removed for Safety|1|||
162725929|NCT03144674|587706023|FG000|Overall Study|Site Closed|0|||
162725930|NCT03144674|587706024|FG001|Overall Study|Site Closed|0|||
162725931|NCT03144674|587706025|FG002|Overall Study|Site Closed|0|||
162725932|NCT03144674|587706026|FG003|Overall Study|Site Closed|1|||
162725933|NCT03144674|587706023|FG000|Overall Study|Histological Criteria Not Met|0|||
162725934|NCT03144674|587706024|FG001|Overall Study|Histological Criteria Not Met|0|||
162725935|NCT03144674|587706025|FG002|Overall Study|Histological Criteria Not Met|0|||
162725936|NCT03144674|587706026|FG003|Overall Study|Histological Criteria Not Met|1|||
162725937|NCT03144674|587706023|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
162725938|NCT03144674|587706024|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
162725939|NCT03144674|587706025|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
162725940|NCT03144674|587706026|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
162725941|NCT03144674|587706023|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162725942|NCT03144674|587706024|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162725943|NCT03144674|587706025|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162725944|NCT03144674|587706026|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
162725945|NCT05510245|587706027|FG000|Overall Study|Withdrawal by Subject|1|||
162725946|NCT05510245|587706028|FG001|Overall Study|Withdrawal by Subject|0|||
162725947|NCT05510245|587706029|FG002|Overall Study|Withdrawal by Subject|0|||
162725948|NCT01373346|587706030|FG000|Overall Study|Death|1|||
162725949|NCT01198028|587706031|FG000|Overall Study|Adverse Event|5|||
162725950|NCT01198028|587706031|FG000|Overall Study|Death|3|||
162725951|NCT01198028|587706031|FG000|Overall Study|Physician Decision|2|||
162725952|NCT01395758|587706033|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
162725953|NCT01395758|587706034|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162725954|NCT01395758|587706035|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
162725955|NCT01565148|587706036|FG000|Overall Study|Withdrawal by Subject|1|||
162725956|NCT01565148|587706037|FG001|Overall Study|Withdrawal by Subject|1|||
162725957|NCT01565148|587706038|FG002|Overall Study|Withdrawal by Subject|1|||
162725958|NCT01565148|587706039|FG003|Overall Study|Withdrawal by Subject|2|||
162725959|NCT01565148|587706036|FG000|Overall Study|Lost to Follow-up|4|||
162725960|NCT01565148|587706037|FG001|Overall Study|Lost to Follow-up|4|||
162725961|NCT01565148|587706038|FG002|Overall Study|Lost to Follow-up|0|||
162725962|NCT01565148|587706039|FG003|Overall Study|Lost to Follow-up|3|||
162725963|NCT01565148|587706036|FG000|Overall Study|Rescue Therapy|8|||
162725964|NCT01565148|587706037|FG001|Overall Study|Rescue Therapy|5|||
162725965|NCT01565148|587706038|FG002|Overall Study|Rescue Therapy|5|||
162725966|NCT01565148|587706039|FG003|Overall Study|Rescue Therapy|8|||
162725967|NCT01565148|587706036|FG000|Overall Study|Death|0|||
162683862|NCT03770494|587550461|FG006|Overall Study|Study terminated by sponsor|1|||
162683863|NCT03770494|587550462|FG007|Overall Study|Study terminated by sponsor|2|||
162683864|NCT03770494|587550463|FG008|Overall Study|Study terminated by sponsor|1|||
162683865|NCT03770494|587550464|FG009|Overall Study|Study terminated by sponsor|2|||
162683866|NCT03770494|587550465|FG010|Overall Study|Study terminated by sponsor|1|||
162683867|NCT03770494|587550466|FG011|Overall Study|Study terminated by sponsor|2|||
162683868|NCT03770494|587550467|FG012|Overall Study|Study terminated by sponsor|0|||
162683869|NCT03770494|587550468|FG013|Overall Study|Study terminated by sponsor|0|||
162683870|NCT03770494|587550455|FG000|Overall Study|Withdrawal by Subject|1|||
162683871|NCT03770494|587550456|FG001|Overall Study|Withdrawal by Subject|1|||
162683872|NCT03770494|587550457|FG002|Overall Study|Withdrawal by Subject|0|||
162683873|NCT03770494|587550458|FG003|Overall Study|Withdrawal by Subject|0|||
162683874|NCT03770494|587550459|FG004|Overall Study|Withdrawal by Subject|2|||
162683875|NCT03770494|587550460|FG005|Overall Study|Withdrawal by Subject|2|||
162683876|NCT03770494|587550461|FG006|Overall Study|Withdrawal by Subject|2|||
162683877|NCT03770494|587550462|FG007|Overall Study|Withdrawal by Subject|0|||
162683878|NCT03770494|587550463|FG008|Overall Study|Withdrawal by Subject|2|||
162683879|NCT03770494|587550464|FG009|Overall Study|Withdrawal by Subject|3|||
162683880|NCT03770494|587550465|FG010|Overall Study|Withdrawal by Subject|1|||
162683881|NCT03770494|587550466|FG011|Overall Study|Withdrawal by Subject|0|||
162683882|NCT03770494|587550467|FG012|Overall Study|Withdrawal by Subject|0|||
162683883|NCT03770494|587550468|FG013|Overall Study|Withdrawal by Subject|0|||
162683884|NCT00553501|587552364|FG000|Overall Study|Adverse Event|2|||
162683885|NCT00553501|587552364|FG000|Overall Study|Death|1|||
162683886|NCT00553501|587552364|FG000|Overall Study|Progression|1|||
162683887|NCT00949715|587552367|FG000|Overall Study|Physician Decision|1|||
162683888|NCT00949715|587552368|FG001|Overall Study|Physician Decision|0|||
162683889|NCT00949715|587552367|FG000|Overall Study|Lost to Follow-up|1|||
162683890|NCT00949715|587552368|FG001|Overall Study|Lost to Follow-up|0|||
162683891|NCT00949715|587552367|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
162683892|NCT00949715|587552368|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
162683893|NCT05050578|587552372|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
162683894|NCT05050578|587552373|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
162683895|NCT05050578|587552372|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
162683896|NCT05050578|587552373|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
162683897|NCT05050578|587552372|FG000|Period 2, 30 Days|Protocol Violation|0|||
162683898|NCT05050578|587552373|FG001|Period 2, 30 Days|Protocol Violation|1|||
162683899|NCT02243280|587552374|FG000|Treated|Adverse Event|1|||
162683900|NCT02243280|587552375|FG001|Treated|Adverse Event|0|||
162683901|NCT02243280|587552376|FG002|Treated|Adverse Event|0|||
162683902|NCT02243280|587552377|FG003|Treated|Adverse Event|0|||
162683903|NCT02243280|587552378|FG004|Treated|Adverse Event|0|||
162683904|NCT02243280|587552379|FG005|Treated|Adverse Event|0|||
162683905|NCT02243280|587552380|FG006|Treated|Adverse Event|0|||
162683906|NCT02243280|587552381|FG007|Treated|Adverse Event|0|||
162683907|NCT02243280|587552382|FG008|Treated|Adverse Event|0|||
162683908|NCT02243280|587552383|FG009|Treated|Adverse Event|0|||
162683909|NCT02243280|587552384|FG010|Treated|Adverse Event|1|||
162683910|NCT02243280|587552374|FG000|Treated|Lost to Follow-up|0|||
162683911|NCT02243280|587552375|FG001|Treated|Lost to Follow-up|0|||
162683912|NCT02243280|587552376|FG002|Treated|Lost to Follow-up|0|||
162683913|NCT02243280|587552377|FG003|Treated|Lost to Follow-up|0|||
162683914|NCT02243280|587552378|FG004|Treated|Lost to Follow-up|0|||
162683915|NCT02243280|587552379|FG005|Treated|Lost to Follow-up|0|||
162683916|NCT02243280|587552380|FG006|Treated|Lost to Follow-up|0|||
162683917|NCT02243280|587552381|FG007|Treated|Lost to Follow-up|0|||
162683918|NCT02243280|587552382|FG008|Treated|Lost to Follow-up|1|||
162683919|NCT02243280|587552383|FG009|Treated|Lost to Follow-up|0|||
162683920|NCT02243280|587552384|FG010|Treated|Lost to Follow-up|2|||
162683921|NCT03386032|587552393|FG000|Overall Study|Lack of Efficacy|6|||
162683922|NCT03386032|587552394|FG001|Overall Study|Lack of Efficacy|2|||
162683923|NCT03386032|587552395|FG002|Overall Study|Lack of Efficacy|0|||
162683924|NCT03386032|587552393|FG000|Overall Study|Adverse Event|2|||
162683925|NCT03386032|587552394|FG001|Overall Study|Adverse Event|2|||
162683926|NCT03386032|587552395|FG002|Overall Study|Adverse Event|0|||
162683927|NCT03386032|587552393|FG000|Overall Study|Withdrawal by Subject|1|||
162683928|NCT03386032|587552394|FG001|Overall Study|Withdrawal by Subject|0|||
162683929|NCT03386032|587552395|FG002|Overall Study|Withdrawal by Subject|0|||
162683930|NCT03386032|587552393|FG000|Overall Study|Lost to Follow-up|9|||
162683931|NCT03386032|587552394|FG001|Overall Study|Lost to Follow-up|3|||
162683932|NCT03386032|587552395|FG002|Overall Study|Lost to Follow-up|0|||
162683933|NCT04525547|587552404|FG000|Overall Study|Not treated with Ofev|2|||
162683934|NCT04525547|587552404|FG000|Overall Study|Off-label use|2|||
162683935|NCT04525547|587552404|FG000|Overall Study|Lost to Follow-up|1|||
162683936|NCT03122119|587552405|FG000|Overall Study|Did not meet eligibility critria|1|||
162683937|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
162683938|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
162683939|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
162683940|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
162683941|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
162683942|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
162683943|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
162683944|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
162683945|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
162683946|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
162683947|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
162683948|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162683949|NCT01493687|587552412|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
162683950|NCT01493687|587552413|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
162683951|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
162683952|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
162683953|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
162683954|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
162683955|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
162683956|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
162683957|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
162683958|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
162683959|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
162683960|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
162683961|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
162683962|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
162683963|NCT01493687|587552412|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
162683964|NCT01493687|587552413|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
162683965|NCT01493687|587552412|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
162683966|NCT01493687|587552413|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
162683967|NCT02364180|587552414|FG000|Overall Study|Screen Fail|1|||
162683968|NCT01783418|587552415|FG000|Overall Study|Withdrawal by Subject|1|||
162683969|NCT01783418|587552416|FG001|Overall Study|Withdrawal by Subject|0|||
162683970|NCT00521144|587552417|FG000|Overall Study|Not Treated|0|||
162683971|NCT00521144|587552418|FG001|Overall Study|Not Treated|0|||
162683972|NCT00521144|587552419|FG002|Overall Study|Not Treated|0|||
162683973|NCT00521144|587552420|FG003|Overall Study|Not Treated|1|||
162683974|NCT00521144|587552421|FG004|Overall Study|Not Treated|0|||
162683975|NCT00521144|587552417|FG000|Overall Study|Adverse Event|0|||
162683976|NCT00521144|587552418|FG001|Overall Study|Adverse Event|1|||
162683977|NCT00521144|587552419|FG002|Overall Study|Adverse Event|0|||
162683978|NCT00521144|587552420|FG003|Overall Study|Adverse Event|0|||
162683979|NCT00521144|587552421|FG004|Overall Study|Adverse Event|1|||
162683980|NCT00521144|587552417|FG000|Overall Study|Progressive Disease|4|||
162683981|NCT00521144|587552418|FG001|Overall Study|Progressive Disease|2|||
162683982|NCT00521144|587552419|FG002|Overall Study|Progressive Disease|2|||
162683983|NCT00521144|587552420|FG003|Overall Study|Progressive Disease|0|||
162683984|NCT00521144|587552421|FG004|Overall Study|Progressive Disease|6|||
162683985|NCT00508261|587552423|FG000|Overall Study|Other|0|||
162683986|NCT00508261|587552424|FG001|Overall Study|Other|1|||
162683987|NCT00508261|587552425|FG002|Overall Study|Other|1|||
162683988|NCT00508261|587552426|FG003|Overall Study|Other|0|||
162683989|NCT00508261|587552423|FG000|Overall Study|Serious Adverse Event|0|||
162683990|NCT00508261|587552424|FG001|Overall Study|Serious Adverse Event|1|||
162683991|NCT00508261|587552425|FG002|Overall Study|Serious Adverse Event|0|||
162683992|NCT00508261|587552426|FG003|Overall Study|Serious Adverse Event|0|||
162683993|NCT00508261|587552423|FG000|Overall Study|Withdrawal by Subject|3|||
162683994|NCT00508261|587552424|FG001|Overall Study|Withdrawal by Subject|4|||
162683995|NCT00508261|587552425|FG002|Overall Study|Withdrawal by Subject|4|||
162683996|NCT00508261|587552426|FG003|Overall Study|Withdrawal by Subject|0|||
162683997|NCT00508261|587552423|FG000|Overall Study|Migrated/ moved from study area|0|||
162683998|NCT00508261|587552424|FG001|Overall Study|Migrated/ moved from study area|1|||
162683999|NCT00508261|587552425|FG002|Overall Study|Migrated/ moved from study area|0|||
162684000|NCT00508261|587552426|FG003|Overall Study|Migrated/ moved from study area|0|||
162684001|NCT00508261|587552423|FG000|Overall Study|Lost to Follow-up|0|||
162684002|NCT00508261|587552424|FG001|Overall Study|Lost to Follow-up|1|||
162684003|NCT00508261|587552425|FG002|Overall Study|Lost to Follow-up|1|||
162684004|NCT00508261|587552426|FG003|Overall Study|Lost to Follow-up|1|||
162684005|NCT00180479|587552427|FG000|Overall Study|Death|4|||
162684006|NCT00180479|587552428|FG001|Overall Study|Death|2|||
162684007|NCT00180479|587552427|FG000|Overall Study|Lost to Follow-up|9|||
162684008|NCT00180479|587552428|FG001|Overall Study|Lost to Follow-up|7|||
162684009|NCT00180479|587552427|FG000|Overall Study|Withdrawal by Subject|3|||
162684010|NCT00180479|587552428|FG001|Overall Study|Withdrawal by Subject|3|||
162684011|NCT00180479|587552427|FG000|Overall Study|Informed consent not signed|0|||
162684012|NCT00180479|587552428|FG001|Overall Study|Informed consent not signed|1|||
162684013|NCT03315143|587552433|FG000|Overall Study|Death|240|||
162684014|NCT03315143|587552434|FG001|Overall Study|Death|246|||
162684015|NCT03315143|587552433|FG000|Overall Study|Withdrawal by Subject|57|||
162684016|NCT03315143|587552434|FG001|Overall Study|Withdrawal by Subject|68|||
162684017|NCT03315143|587552433|FG000|Overall Study|Site Terminated by Sponsor|256|||
162684018|NCT03315143|587552434|FG001|Overall Study|Site Terminated by Sponsor|282|||
162684019|NCT03315143|587552433|FG000|Overall Study|Study Terminated by Sponsor|4723|||
162684020|NCT03315143|587552434|FG001|Overall Study|Study Terminated by Sponsor|4664|||
162684021|NCT03315143|587552433|FG000|Overall Study|Reason not Specified|16|||
162684022|NCT03315143|587552434|FG001|Overall Study|Reason not Specified|32|||
162684023|NCT00840801|587552435|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
162684024|NCT00840801|587552436|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
162684025|NCT00840801|587552437|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
162684026|NCT00840801|587552435|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
162684027|NCT00840801|587552436|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
162684028|NCT00840801|587552437|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
162684029|NCT00840801|587552435|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
162684030|NCT00840801|587552436|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
162684031|NCT00840801|587552437|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
162684032|NCT00840801|587552435|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
162684033|NCT00840801|587552436|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
162684034|NCT00840801|587552437|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
162684035|NCT00335452|587552438|FG000|Overall Study|Death|156|||
162684036|NCT00335452|587552439|FG001|Overall Study|Death|144|||
162684037|NCT00335452|587552440|FG002|Overall Study|Death|158|||
162684038|NCT00335452|587552441|FG003|Overall Study|Death|129|||
162684039|NCT00335452|587552438|FG000|Overall Study|Lost to Follow-up|2|||
162684040|NCT00335452|587552439|FG001|Overall Study|Lost to Follow-up|3|||
162684041|NCT00335452|587552440|FG002|Overall Study|Lost to Follow-up|1|||
162684042|NCT00335452|587552441|FG003|Overall Study|Lost to Follow-up|2|||
162684043|NCT02736825|587552442|FG000|Overall Study|Lost to Follow-up|10|||
162684044|NCT02736825|587552443|FG001|Overall Study|Lost to Follow-up|11|||
162684045|NCT02736825|587552442|FG000|Overall Study|Early Termination|0|||
162684046|NCT02736825|587552443|FG001|Overall Study|Early Termination|1|||
162684047|NCT00790452|587552444|FG000|Overall Study|Drug supply issue|1|||
162684048|NCT00790452|587552445|FG001|Overall Study|Drug supply issue|0|||
162684049|NCT02901626|587552446|FG000|Overall Study|Lost to Follow-up|1|||
162684050|NCT02901626|587552447|FG001|Overall Study|Lost to Follow-up|1|||
162684051|NCT04082884|587552448|FG000|Overall Study|Withdrawal by Subject|1|||
162684052|NCT02421666|587552451|FG000|6-month Follow-up|Lost to Follow-up|8|||
162684053|NCT02421666|587552452|FG001|6-month Follow-up|Lost to Follow-up|7|||
162684054|NCT02421666|587552451|FG000|6-month Follow-up|Withdrawal by Subject|5|||
162684055|NCT02421666|587552452|FG001|6-month Follow-up|Withdrawal by Subject|6|||
162684056|NCT02421666|587552451|FG000|12-month Follow-up|Lost to Follow-up|5|||
162684057|NCT02421666|587552452|FG001|12-month Follow-up|Lost to Follow-up|5|||
162684058|NCT02421666|587552451|FG000|12-month Follow-up|Withdrawal by Subject|6|||
162684059|NCT02421666|587552452|FG001|12-month Follow-up|Withdrawal by Subject|11|||
162684060|NCT01078155|587552454|FG000|Overall Study|Adverse Event|7|||
162684061|NCT01078155|587552454|FG000|Overall Study|Lack of Efficacy|16|||
162684062|NCT01078155|587552454|FG000|Overall Study|Participant's Decision|6|||
162684063|NCT01078155|587552454|FG000|Overall Study|Lost to Follow-up|15|||
162684064|NCT01621880|587552455|FG000|Overall Study|Adverse Event|5|||
162684065|NCT01621880|587552456|FG001|Overall Study|Adverse Event|1|||
162684066|NCT01621880|587552455|FG000|Overall Study|Withdrawal by Subject|5|||
162684067|NCT01621880|587552456|FG001|Overall Study|Withdrawal by Subject|4|||
162684068|NCT03701399|587552467|FG000|Overall Study|Adverse Event|3|||
162684069|NCT03701399|587552468|FG001|Overall Study|Adverse Event|5|||
162684070|NCT03701399|587552467|FG000|Overall Study|Withdrawal by Subject|6|||
162684071|NCT03701399|587552468|FG001|Overall Study|Withdrawal by Subject|3|||
162684072|NCT03701399|587552467|FG000|Overall Study|Investigators decision|1|||
162684073|NCT03701399|587552468|FG001|Overall Study|Investigators decision|2|||
162684074|NCT03701399|587552467|FG000|Overall Study|Lost to Follow-up|1|||
162684075|NCT03701399|587552468|FG001|Overall Study|Lost to Follow-up|2|||
162684076|NCT03701399|587552467|FG000|Overall Study|Death|1|||
162684077|NCT03701399|587552468|FG001|Overall Study|Death|1|||
162684078|NCT03701399|587552467|FG000|Overall Study|Randomized but not treated|1|||
162684079|NCT03701399|587552468|FG001|Overall Study|Randomized but not treated|0|||
162684080|NCT04179032|587552469|FG000|Part B (Up to Week 52)|Adverse Event|1|||
162684081|NCT04179032|587552469|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
162684082|NCT04179032|587552469|FG000|Access Extension Phase|Ongoing|11|||
162684083|NCT03945292|587552470|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
162684084|NCT03945292|587552471|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684085|NCT03945292|587552472|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
162684086|NCT03945292|587552473|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684087|NCT03945292|587552474|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684088|NCT03945292|587552475|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684089|NCT03945292|587552476|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684090|NCT03945292|587552477|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162684091|NCT03945292|587552470|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684092|NCT03945292|587552471|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684093|NCT03945292|587552472|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
162684094|NCT03945292|587552473|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684095|NCT03945292|587552474|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684096|NCT03945292|587552475|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684097|NCT03945292|587552476|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684098|NCT03945292|587552477|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162684099|NCT03945292|587552470|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684100|NCT03945292|587552471|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684101|NCT03945292|587552472|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684102|NCT03945292|587552473|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684103|NCT03945292|587552474|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684104|NCT03945292|587552475|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684105|NCT03945292|587552476|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162684106|NCT03945292|587552477|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
162684107|NCT03033225|587552478|FG000|Overall Study|Withdrawal by Subject|5|||
162684108|NCT00946296|587552479|FG000|Overall Study|Physician Decision|3|||
162684109|NCT00946296|587552480|FG001|Overall Study|Physician Decision|0|||
162684110|NCT02618967|587552483|FG000|Overall Study|Lost to Follow-up|0|||
162684111|NCT02618967|587552484|FG001|Overall Study|Lost to Follow-up|0|||
162684112|NCT02618967|587552485|FG002|Overall Study|Lost to Follow-up|1|||
162684113|NCT02618967|587552486|FG003|Overall Study|Lost to Follow-up|0|||
162684114|NCT02618967|587552487|FG004|Overall Study|Lost to Follow-up|2|||
162684115|NCT02618967|587552488|FG005|Overall Study|Lost to Follow-up|0|||
162684116|NCT02618967|587552489|FG006|Overall Study|Lost to Follow-up|0|||
162684117|NCT02618967|587552490|FG007|Overall Study|Lost to Follow-up|0|||
162684118|NCT02618967|587552483|FG000|Overall Study|Withdrawal by Subject|1|||
162684119|NCT02618967|587552484|FG001|Overall Study|Withdrawal by Subject|0|||
162684120|NCT02618967|587552485|FG002|Overall Study|Withdrawal by Subject|0|||
162684121|NCT02618967|587552486|FG003|Overall Study|Withdrawal by Subject|0|||
162684122|NCT02618967|587552487|FG004|Overall Study|Withdrawal by Subject|0|||
162684123|NCT02618967|587552488|FG005|Overall Study|Withdrawal by Subject|0|||
162684124|NCT02618967|587552489|FG006|Overall Study|Withdrawal by Subject|0|||
162684125|NCT02618967|587552490|FG007|Overall Study|Withdrawal by Subject|0|||
162684126|NCT01368965|587552491|FG000|Overall Study|Lost to Follow-up|12|||
162684127|NCT06060457|587552492|FG000|Overall Study|Adverse Event|1|||
162684128|NCT06060457|587552493|FG001|Overall Study|Adverse Event|1|||
162684129|NCT06060457|587552492|FG000|Overall Study|Death|2|||
162684130|NCT06060457|587552493|FG001|Overall Study|Death|2|||
162684131|NCT06060457|587552492|FG000|Overall Study|Lost to Follow-up|17|||
162684132|NCT06060457|587552493|FG001|Overall Study|Lost to Follow-up|19|||
162684133|NCT06060457|587552492|FG000|Overall Study|Physician Decision|0|||
162684134|NCT06060457|587552493|FG001|Overall Study|Physician Decision|1|||
162684135|NCT06060457|587552492|FG000|Overall Study|Protocol Violation|1|||
162684136|NCT06060457|587552493|FG001|Overall Study|Protocol Violation|1|||
162684137|NCT06060457|587552492|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
162684138|NCT06060457|587552493|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
162684139|NCT06060457|587552492|FG000|Overall Study|Withdrawal by Subject|12|||
162684140|NCT06060457|587552493|FG001|Overall Study|Withdrawal by Subject|15|||
162684141|NCT06060457|587552492|FG000|Overall Study|Other Than Specified|2|||
162684142|NCT06060457|587552493|FG001|Overall Study|Other Than Specified|1|||
162684143|NCT00569582|587552507|FG000|Overall Study|Withdrawal by Subject|5|||
162684144|NCT00569582|587552507|FG000|Overall Study|Death|2|||
162684145|NCT00569582|587552507|FG000|Overall Study|Adverse Event|7|||
162684146|NCT00569582|587552507|FG000|Overall Study|Subject was too ill to travel.|1|||
162684147|NCT00569582|587552507|FG000|Overall Study|Subject was non-compliant.|1|||
162684148|NCT05103384|587552510|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
162684149|NCT02612311|587552511|FG000|Overall Study|Adverse Event|16|||
162684150|NCT02612311|587552512|FG001|Overall Study|Adverse Event|12|||
162684151|NCT02612311|587552513|FG002|Overall Study|Adverse Event|7|||
162684152|NCT02612311|587552514|FG003|Overall Study|Adverse Event|13|||
162684153|NCT02612311|587552511|FG000|Overall Study|Death|29|||
162684154|NCT02612311|587552512|FG001|Overall Study|Death|10|||
162684155|NCT02612311|587552513|FG002|Overall Study|Death|11|||
162684156|NCT02612311|587552514|FG003|Overall Study|Death|11|||
162684157|NCT02612311|587552511|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
162684158|NCT02612311|587552512|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
162684159|NCT02612311|587552513|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
162684160|NCT02612311|587552514|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
162684161|NCT02612311|587552511|FG000|Overall Study|Investigator's Decision|11|||
162684162|NCT02612311|587552512|FG001|Overall Study|Investigator's Decision|15|||
162684163|NCT02612311|587552513|FG002|Overall Study|Investigator's Decision|6|||
162684164|NCT02612311|587552514|FG003|Overall Study|Investigator's Decision|6|||
162684165|NCT02612311|587552511|FG000|Overall Study|Lack of Efficacy|0|||
162684166|NCT02612311|587552512|FG001|Overall Study|Lack of Efficacy|0|||
162684167|NCT02612311|587552513|FG002|Overall Study|Lack of Efficacy|1|||
162684168|NCT02612311|587552514|FG003|Overall Study|Lack of Efficacy|1|||
162684169|NCT02612311|587552511|FG000|Overall Study|Lost to Follow-up|2|||
162684170|NCT02612311|587552512|FG001|Overall Study|Lost to Follow-up|2|||
162684171|NCT02612311|587552513|FG002|Overall Study|Lost to Follow-up|1|||
162684172|NCT02612311|587552514|FG003|Overall Study|Lost to Follow-up|2|||
162684173|NCT02612311|587552511|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
162684174|NCT02612311|587552512|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
162684175|NCT02612311|587552513|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
162684176|NCT02612311|587552514|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
162684177|NCT02612311|587552511|FG000|Overall Study|Site Terminated by Sponsor|29|||
162684178|NCT02612311|587552512|FG001|Overall Study|Site Terminated by Sponsor|12|||
162684179|NCT02612311|587552513|FG002|Overall Study|Site Terminated by Sponsor|13|||
162684180|NCT02612311|587552514|FG003|Overall Study|Site Terminated by Sponsor|5|||
162684181|NCT02612311|587552511|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
162684182|NCT02612311|587552512|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
162684183|NCT02612311|587552513|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
162684184|NCT02612311|587552514|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
162684185|NCT02612311|587552511|FG000|Overall Study|Reason Not Specified|3|||
162725968|NCT01565148|587706037|FG001|Overall Study|Death|0|||
162725969|NCT01565148|587706038|FG002|Overall Study|Death|1|||
162725970|NCT01565148|587706039|FG003|Overall Study|Death|0|||
162725971|NCT01565148|587706036|FG000|Overall Study|Physician Decision|2|||
162725972|NCT01565148|587706037|FG001|Overall Study|Physician Decision|5|||
162725973|NCT01565148|587706038|FG002|Overall Study|Physician Decision|0|||
162725974|NCT01565148|587706039|FG003|Overall Study|Physician Decision|0|||
162725975|NCT01759771|587706040|FG000|Overall Study|Withdrawal by Subject|1|||
162725976|NCT01759771|587706041|FG001|Overall Study|Withdrawal by Subject|1|||
162725977|NCT00529659|587706044|FG000|Overall Study|Adverse Event|8|||
162725978|NCT00529659|587706045|FG001|Overall Study|Adverse Event|7|||
162725979|NCT00529659|587706044|FG000|Overall Study|Lost to Follow-up|0|||
162725980|NCT00529659|587706045|FG001|Overall Study|Lost to Follow-up|2|||
162725981|NCT00529659|587706044|FG000|Overall Study|Physician Decision|0|||
162725982|NCT00529659|587706045|FG001|Overall Study|Physician Decision|2|||
162725983|NCT00529659|587706044|FG000|Overall Study|Protocol Violation|2|||
162725984|NCT00529659|587706045|FG001|Overall Study|Protocol Violation|6|||
162725985|NCT00529659|587706044|FG000|Overall Study|Withdrawal by Subject|1|||
162725986|NCT00529659|587706045|FG001|Overall Study|Withdrawal by Subject|6|||
162725987|NCT01692730|587706048|FG000|Overall Study|Lost to Follow-up|225|||
162725988|NCT01692730|587706049|FG001|Overall Study|Lost to Follow-up|227|||
162725989|NCT01415349|587706050|FG000|Treatment Period 1|Adverse Event|0|||
162725990|NCT01415349|587706051|FG001|Treatment Period 1|Adverse Event|1|||
162725991|NCT01415349|587706050|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162725992|NCT01415349|587706051|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162725993|NCT02139943|587706052|FG000|Overall Study|Adverse Event|0|||
162725994|NCT02139943|587706053|FG001|Overall Study|Adverse Event|1|||
162725995|NCT02139943|587706054|FG002|Overall Study|Adverse Event|2|||
162725996|NCT02139943|587706052|FG000|Overall Study|Lost to Follow-up|3|||
162725997|NCT02139943|587706053|FG001|Overall Study|Lost to Follow-up|2|||
162725998|NCT02139943|587706054|FG002|Overall Study|Lost to Follow-up|2|||
162725999|NCT02139943|587706052|FG000|Overall Study|Withdrawal by Subject|4|||
162726000|NCT02139943|587706053|FG001|Overall Study|Withdrawal by Subject|3|||
162726001|NCT02139943|587706054|FG002|Overall Study|Withdrawal by Subject|0|||
162726002|NCT02139943|587706052|FG000|Overall Study|Other|0|||
162726003|NCT02139943|587706053|FG001|Overall Study|Other|0|||
162684186|NCT02612311|587552512|FG001|Overall Study|Reason Not Specified|7|||
162684187|NCT02612311|587552513|FG002|Overall Study|Reason Not Specified|4|||
162684188|NCT02612311|587552514|FG003|Overall Study|Reason Not Specified|5|||
162684189|NCT02612311|587552511|FG000|Overall Study|Unknown/Missing|10|||
162684190|NCT02612311|587552512|FG001|Overall Study|Unknown/Missing|13|||
162684191|NCT02612311|587552513|FG002|Overall Study|Unknown/Missing|4|||
162684192|NCT02612311|587552514|FG003|Overall Study|Unknown/Missing|0|||
162684193|NCT02612311|587552511|FG000|Overall Study|Non-Compliance with Study|1|||
162726004|NCT02139943|587706054|FG002|Overall Study|Other|1|||
162726005|NCT02139943|587706052|FG000|Overall Study|Participant wishes to discontinue|2|||
162726006|NCT02139943|587706053|FG001|Overall Study|Participant wishes to discontinue|0|||
162726007|NCT02139943|587706054|FG002|Overall Study|Participant wishes to discontinue|0|||
162726008|NCT02139943|587706052|FG000|Overall Study|Participant in Poor Compliance|1|||
162726009|NCT02139943|587706053|FG001|Overall Study|Participant in Poor Compliance|0|||
162726010|NCT02139943|587706054|FG002|Overall Study|Participant in Poor Compliance|1|||
162726011|NCT02139943|587706052|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
162726012|NCT02139943|587706053|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
162684194|NCT02612311|587552512|FG001|Overall Study|Non-Compliance with Study|0|||
162684195|NCT02612311|587552513|FG002|Overall Study|Non-Compliance with Study|0|||
162684196|NCT02612311|587552514|FG003|Overall Study|Non-Compliance with Study|0|||
162684197|NCT00514735|587552518|FG000|Overall Study|Withdrawal by Subject|13|||
162684198|NCT00514735|587552519|FG001|Overall Study|Withdrawal by Subject|5|||
162684199|NCT00514735|587552518|FG000|Overall Study|Death|1|||
162684200|NCT00514735|587552519|FG001|Overall Study|Death|0|||
162684201|NCT00514735|587552518|FG000|Overall Study|Lost to Follow-up|0|||
162684202|NCT00514735|587552519|FG001|Overall Study|Lost to Follow-up|1|||
162684203|NCT04751942|587552521|FG000|Overall Study|Lost to Follow-up|9|||
162684204|NCT04751942|587552522|FG001|Overall Study|Lost to Follow-up|6|||
162684205|NCT04510675|587552523|FG000|Overall Study|Withdrawal by Subject|5|||
162684206|NCT01499082|587552524|FG000|Overall Study|Randomized but not Treated|0|||
162684207|NCT01499082|587552525|FG001|Overall Study|Randomized but not Treated|1|||
162684208|NCT01499082|587552524|FG000|Overall Study|Adverse Event|12|||
162684209|NCT01499082|587552525|FG001|Overall Study|Adverse Event|16|||
162684210|NCT01499082|587552524|FG000|Overall Study|Lack of Efficacy|1|||
162684211|NCT01499082|587552525|FG001|Overall Study|Lack of Efficacy|1|||
162684212|NCT01499082|587552524|FG000|Overall Study|Protocol Violation|6|||
162684213|NCT01499082|587552525|FG001|Overall Study|Protocol Violation|8|||
162684214|NCT01499082|587552524|FG000|Overall Study|Diverse Reasons|18|||
162684215|NCT01499082|587552525|FG001|Overall Study|Diverse Reasons|14|||
162684216|NCT01499082|587552524|FG000|Overall Study|Site Closure for Noncompliance|5|||
162684217|NCT01499082|587552525|FG001|Overall Study|Site Closure for Noncompliance|2|||
162684218|NCT01499082|587552524|FG000|Overall Study|Hypoglycemia|2|||
162684219|NCT01499082|587552525|FG001|Overall Study|Hypoglycemia|3|||
162684220|NCT01499082|587552524|FG000|Overall Study|Lost to Follow-up|1|||
162684221|NCT01499082|587552525|FG001|Overall Study|Lost to Follow-up|3|||
162684222|NCT00522626|587552536|FG000|Overall Study|Lost to Follow-up|7|||
162684223|NCT00803452|587552537|FG000|Overall Study|Adverse Event|0|||
162684224|NCT00803452|587552538|FG001|Overall Study|Adverse Event|2|||
162684225|NCT00803452|587552537|FG000|Overall Study|Lost to Follow-up|0|||
162684226|NCT00803452|587552538|FG001|Overall Study|Lost to Follow-up|3|||
162684227|NCT02365519|587552540|FG000|Randomized and Treated|Adverse Event|0|||
162684228|NCT02365519|587552541|FG001|Randomized and Treated|Adverse Event|1|||
162684229|NCT02365519|587552542|FG002|Randomized and Treated|Adverse Event|0|||
162684230|NCT02365519|587552540|FG000|Randomized and Treated|Withdrawal by Subject|0|||
162684231|NCT02365519|587552541|FG001|Randomized and Treated|Withdrawal by Subject|1|||
162684232|NCT02365519|587552542|FG002|Randomized and Treated|Withdrawal by Subject|1|||
162684233|NCT01971723|587552543|FG000|Overall Study|Withdrawal by Subject|1|||
162684234|NCT01971723|587552544|FG001|Overall Study|Withdrawal by Subject|1|||
162684235|NCT01971723|587552543|FG000|Overall Study|Protocol Violation|1|||
162684236|NCT01971723|587552544|FG001|Overall Study|Protocol Violation|2|||
162684237|NCT03017079|587552545|FG000|Overall Study|Physician Decision|1|||
162684238|NCT03017079|587552546|FG001|Overall Study|Physician Decision|1|||
162684239|NCT03017079|587552545|FG000|Overall Study|Death|3|||
162684240|NCT03017079|587552546|FG001|Overall Study|Death|2|||
162684241|NCT03017079|587552545|FG000|Overall Study|Lack of Efficacy|2|||
162684242|NCT03017079|587552546|FG001|Overall Study|Lack of Efficacy|2|||
162684243|NCT03017079|587552545|FG000|Overall Study|Protocol Violation|0|||
162684244|NCT03017079|587552546|FG001|Overall Study|Protocol Violation|1|||
162684245|NCT01255592|587554325|FG000|Overall Study|Adverse Event|5|||
162684246|NCT01255592|587554326|FG001|Overall Study|Adverse Event|0|||
162684247|NCT01255592|587554325|FG000|Overall Study|Withdrawal by Subject|1|||
162684248|NCT01255592|587554326|FG001|Overall Study|Withdrawal by Subject|0|||
162684249|NCT01255592|587554325|FG000|Overall Study|Other|0|||
162684250|NCT01255592|587554326|FG001|Overall Study|Other|1|||
162684251|NCT02882282|587554327|FG000|Overall Study|Adverse Event|1|||
162684252|NCT02882282|587554328|FG001|Overall Study|Adverse Event|0|||
162684253|NCT03928028|587554329|FG000|Overall Study|Physician Decision|9|||
162684254|NCT03928028|587554330|FG001|Overall Study|Physician Decision|6|||
162684255|NCT03928028|587554331|FG002|Overall Study|Physician Decision|3|||
162684256|NCT03928028|587554329|FG000|Overall Study|Withdrawal by Subject|12|||
162684257|NCT03928028|587554330|FG001|Overall Study|Withdrawal by Subject|3|||
162684258|NCT03928028|587554331|FG002|Overall Study|Withdrawal by Subject|3|||
162684259|NCT02710292|587554338|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
162684260|NCT02710292|587554339|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
162684261|NCT02710292|587554338|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
162684262|NCT02710292|587554339|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
162684263|NCT02323646|587554350|FG000|Treatment Course 1|Adverse Event|1|||
162684264|NCT02323646|587554351|FG001|Treatment Course 1|Adverse Event|0|||
162684265|NCT02323646|587554352|FG002|Treatment Course 1|Adverse Event|1|||
162684266|NCT02323646|587554350|FG000|Treatment Course 1|Heavy Bleeding|1|||
162684267|NCT02323646|587554351|FG001|Treatment Course 1|Heavy Bleeding|1|||
162684268|NCT02323646|587554352|FG002|Treatment Course 1|Heavy Bleeding|0|||
162684269|NCT02323646|587554350|FG000|Treatment Course 1|Lost to Follow-up|1|||
162726013|NCT02139943|587706054|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
162726014|NCT01041417|587706055|FG000|Overall Study|Adverse Event|5|||
162726015|NCT01041417|587706056|FG001|Overall Study|Adverse Event|2|||
162726016|NCT01041417|587706055|FG000|Overall Study|Lost to Follow-up|1|||
162726017|NCT01041417|587706056|FG001|Overall Study|Lost to Follow-up|1|||
162726018|NCT01041417|587706055|FG000|Overall Study|Death|1|||
162684270|NCT02323646|587554351|FG001|Treatment Course 1|Lost to Follow-up|0|||
162684271|NCT02323646|587554352|FG002|Treatment Course 1|Lost to Follow-up|2|||
162684272|NCT02323646|587554350|FG000|Treatment Course 1|Withdrawal by Subject|0|||
162684273|NCT02323646|587554351|FG001|Treatment Course 1|Withdrawal by Subject|2|||
162684274|NCT02323646|587554352|FG002|Treatment Course 1|Withdrawal by Subject|0|||
162684275|NCT02323646|587554350|FG000|Treatment Course 2|Adverse Event|1|||
162684276|NCT02323646|587554351|FG001|Treatment Course 2|Adverse Event|0|||
162684277|NCT02323646|587554352|FG002|Treatment Course 2|Adverse Event|1|||
162726019|NCT01041417|587706056|FG001|Overall Study|Death|0|||
162726020|NCT02918071|587706064|FG000|Overall Study|Withdrawal by Subject|2|||
162726021|NCT02918071|587706064|FG000|Overall Study|Lost to Follow-up|1|||
162726022|NCT03960463|587708151|FG000|Overall Study|Withdrawal by Subject|2|||
162726023|NCT03960463|587708152|FG001|Overall Study|Withdrawal by Subject|0|||
162726024|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
162726025|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
162726026|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
162726027|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
162726028|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
162726029|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
162726030|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
162726031|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
162726032|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
162726033|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
162726034|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
162726035|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
162726036|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162726037|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
162726038|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
162726039|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162726040|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162726041|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162726042|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
162726043|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
162726044|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
162726045|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
162726046|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
162726047|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
162726048|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162726049|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
162726050|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162726051|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162726052|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162726053|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162726054|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
162726055|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162726056|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162726057|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162726058|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162726059|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162726060|NCT04043455|587708153|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162726061|NCT04043455|587708154|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
162726062|NCT04043455|587708155|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162726063|NCT04043455|587708156|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162726064|NCT04043455|587708157|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162726065|NCT04043455|587708158|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162726066|NCT04043455|587708153|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
162684278|NCT02323646|587554350|FG000|Treatment Course 2|Lost to Follow-up|0|||
162684279|NCT02323646|587554351|FG001|Treatment Course 2|Lost to Follow-up|0|||
162684280|NCT02323646|587554352|FG002|Treatment Course 2|Lost to Follow-up|1|||
162684281|NCT02323646|587554350|FG000|Treatment Course 2|Non-compliance|0|||
162684282|NCT02323646|587554351|FG001|Treatment Course 2|Non-compliance|1|||
162684283|NCT02323646|587554352|FG002|Treatment Course 2|Non-compliance|1|||
162684284|NCT00089141|587554353|FG000|Overall Study|Termination of trial|18|||
162684285|NCT00089141|587554354|FG001|Overall Study|Termination of trial|24|||
162684286|NCT02459262|587554357|FG000|Overall Study|Withdrawal by Subject|0|||
162684287|NCT02459262|587554358|FG001|Overall Study|Withdrawal by Subject|0|||
162684288|NCT02459262|587554359|FG002|Overall Study|Withdrawal by Subject|0|||
162684289|NCT02459262|587554360|FG003|Overall Study|Withdrawal by Subject|0|||
162684290|NCT02459262|587554361|FG004|Overall Study|Withdrawal by Subject|0|||
162684291|NCT02459262|587554362|FG005|Overall Study|Withdrawal by Subject|0|||
162684292|NCT02459262|587554363|FG006|Overall Study|Withdrawal by Subject|0|||
162684293|NCT02459262|587554364|FG007|Overall Study|Withdrawal by Subject|0|||
162684294|NCT02459262|587554365|FG008|Overall Study|Withdrawal by Subject|0|||
162684295|NCT02459262|587554366|FG009|Overall Study|Withdrawal by Subject|1|||
162684296|NCT02459262|587554367|FG010|Overall Study|Withdrawal by Subject|0|||
162684297|NCT05168579|587554368|FG000|Overall Study|Lack of Consent|1|||
162684298|NCT05168579|587554369|FG001|Overall Study|Lack of Consent|0|||
162684299|NCT05168579|587554368|FG000|Overall Study|Conflicts with time|2|||
162684300|NCT05168579|587554369|FG001|Overall Study|Conflicts with time|0|||
162684301|NCT05168579|587554368|FG000|Overall Study|Time slots were full|3|||
162684302|NCT05168579|587554369|FG001|Overall Study|Time slots were full|0|||
162684303|NCT05168579|587554368|FG000|Overall Study|Lost to Follow-up|0|||
162684304|NCT05168579|587554369|FG001|Overall Study|Lost to Follow-up|15|||
162684305|NCT01242748|587554370|FG000|Overall Study|Adverse Event|10|||
162684306|NCT01242748|587554371|FG001|Overall Study|Adverse Event|5|||
162684307|NCT01242748|587554370|FG000|Overall Study|Lost to Follow-up|6|||
162684308|NCT01242748|587554371|FG001|Overall Study|Lost to Follow-up|2|||
162684309|NCT01242748|587554370|FG000|Overall Study|Physician Decision|3|||
162684310|NCT01242748|587554371|FG001|Overall Study|Physician Decision|2|||
162684311|NCT01242748|587554370|FG000|Overall Study|Protocol Violation|1|||
162684312|NCT01242748|587554371|FG001|Overall Study|Protocol Violation|0|||
162684313|NCT01242748|587554370|FG000|Overall Study|Withdrawal by Subject|10|||
162684314|NCT01242748|587554371|FG001|Overall Study|Withdrawal by Subject|2|||
162684315|NCT01242748|587554370|FG000|Overall Study|Miscellaneous reasons|8|||
162684316|NCT01242748|587554371|FG001|Overall Study|Miscellaneous reasons|3|||
162684317|NCT00387894|587554372|FG000|Overall Study|Withdrawal by Subject|1|||
162684318|NCT00659490|587554375|FG000|Overall Study|Lost to Follow-up|2|||
162684319|NCT00659490|587554376|FG001|Overall Study|Lost to Follow-up|0|||
162684320|NCT00659490|587554377|FG002|Overall Study|Lost to Follow-up|1|||
162684321|NCT00827541|587554378|FG000|Overall Study|Exitus|1|||
162684322|NCT00827541|587554379|FG001|Overall Study|Exitus|8|||
162684323|NCT00827541|587554378|FG000|Overall Study|Other|1|||
162684324|NCT00827541|587554379|FG001|Overall Study|Other|3|||
162684325|NCT00827541|587554378|FG000|Overall Study|Pathogen not susceptible|1|||
162684326|NCT00827541|587554379|FG001|Overall Study|Pathogen not susceptible|0|||
162684327|NCT00827541|587554378|FG000|Overall Study|Lack of effectiveness|1|||
162684328|NCT00827541|587554379|FG001|Overall Study|Lack of effectiveness|0|||
162684329|NCT01649232|587554380|FG000|Overall Study|Physician Decision|2|||
162684330|NCT01649232|587554381|FG001|Overall Study|Physician Decision|0|||
162684331|NCT01750879|587554382|FG000|Overall Study|Adverse Event|8|||
162684332|NCT01750879|587554383|FG001|Overall Study|Adverse Event|0|||
162684333|NCT01750879|587554382|FG000|Overall Study|Lack of Efficacy|1|||
162684334|NCT01750879|587554383|FG001|Overall Study|Lack of Efficacy|0|||
162684335|NCT01750879|587554382|FG000|Overall Study|Withdrawal by Subject|1|||
162684336|NCT01750879|587554383|FG001|Overall Study|Withdrawal by Subject|0|||
162684337|NCT01750879|587554382|FG000|Overall Study|Did not complete per protocol|0|||
162684338|NCT01750879|587554383|FG001|Overall Study|Did not complete per protocol|3|||
162684339|NCT02347657|587554384|FG000|Overall Study|Physician Decision|0|||
162684340|NCT02347657|587554385|FG001|Overall Study|Physician Decision|1|||
162684341|NCT02347657|587554384|FG000|Overall Study|Adverse Event|8|||
162684342|NCT02347657|587554385|FG001|Overall Study|Adverse Event|4|||
162684343|NCT02347657|587554384|FG000|Overall Study|Withdrawal by Subject|6|||
162684344|NCT02347657|587554385|FG001|Overall Study|Withdrawal by Subject|7|||
162684345|NCT02347657|587554384|FG000|Overall Study|Randomized but not treated|1|||
162684346|NCT02347657|587554385|FG001|Overall Study|Randomized but not treated|0|||
162684347|NCT02347657|587554384|FG000|Overall Study|Other|3|||
162684348|NCT02347657|587554385|FG001|Overall Study|Other|3|||
162684349|NCT00677352|587554388|FG000|Treatment Phase|Adverse Event|14|||
162684350|NCT00677352|587554389|FG001|Treatment Phase|Adverse Event|22|||
162684351|NCT00677352|587554388|FG000|Treatment Phase|Lack of Efficacy|2|||
162684352|NCT00677352|587554389|FG001|Treatment Phase|Lack of Efficacy|3|||
162684353|NCT00677352|587554388|FG000|Treatment Phase|Lost to Follow-up|0|||
162684354|NCT00677352|587554389|FG001|Treatment Phase|Lost to Follow-up|1|||
162684355|NCT00677352|587554388|FG000|Treatment Phase|Withdrawal by Subject|7|||
162684356|NCT00677352|587554389|FG001|Treatment Phase|Withdrawal by Subject|7|||
162684357|NCT00677352|587554388|FG000|Treatment Phase|Physician Decision|1|||
162684358|NCT00677352|587554389|FG001|Treatment Phase|Physician Decision|0|||
162684359|NCT00677352|587554388|FG000|Treatment Phase|Pregnancy|0|||
162684360|NCT00677352|587554389|FG001|Treatment Phase|Pregnancy|1|||
162684361|NCT00677352|587554388|FG000|Treatment Phase|Protocol Violation|1|||
162684362|NCT00677352|587554389|FG001|Treatment Phase|Protocol Violation|1|||
162684363|NCT00677352|587554388|FG000|Treatment Phase|Transference or work related matter|0|||
162684364|NCT00677352|587554389|FG001|Treatment Phase|Transference or work related matter|5|||
162684365|NCT00677352|587554388|FG000|Treatment Phase|Not treated|0|||
162684366|NCT00677352|587554389|FG001|Treatment Phase|Not treated|2|||
162684367|NCT00677352|587554388|FG000|Tapering Phase|Adverse Event|1|||
162684368|NCT00677352|587554389|FG001|Tapering Phase|Adverse Event|5|||
162684369|NCT00677352|587554388|FG000|Tapering Phase|Withdrawal by Subject|5|||
162684370|NCT00677352|587554389|FG001|Tapering Phase|Withdrawal by Subject|3|||
162684371|NCT00677352|587554388|FG000|Tapering Phase|Pregnancy|0|||
162684372|NCT00677352|587554389|FG001|Tapering Phase|Pregnancy|1|||
162684373|NCT00677352|587554388|FG000|Tapering Phase|Job transfer|0|||
162684374|NCT00677352|587554389|FG001|Tapering Phase|Job transfer|1|||
162684375|NCT02182973|587554390|FG000|Overall Study|Withdrawal by Subject|3|||
162684376|NCT02182973|587554391|FG001|Overall Study|Withdrawal by Subject|0|||
162684377|NCT05614089|587554395|FG000|Overall Study|Pregnancy|5|||
162684378|NCT05614089|587554396|FG001|Overall Study|Pregnancy|2|||
162684379|NCT05614089|587554395|FG000|Overall Study|Lost to Follow-up|5|||
162684380|NCT05614089|587554396|FG001|Overall Study|Lost to Follow-up|1|||
162684381|NCT05614089|587554395|FG000|Overall Study|Death|0|||
162684382|NCT05614089|587554396|FG001|Overall Study|Death|1|||
162684383|NCT05614089|587554395|FG000|Overall Study|Adverse Event|1|||
162684384|NCT05614089|587554396|FG001|Overall Study|Adverse Event|0|||
162684385|NCT03937219|587554402|FG000|Overall Study|Death|223|||
162684386|NCT03937219|587554403|FG001|Overall Study|Death|211|||
162684387|NCT03937219|587554402|FG000|Overall Study|Withdrawal by Subject|17|||
162684388|NCT03937219|587554403|FG001|Overall Study|Withdrawal by Subject|25|||
162726067|NCT04043455|587708154|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
162726068|NCT04043455|587708155|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
162726069|NCT04043455|587708156|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
162726070|NCT04043455|587708157|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
162726071|NCT04043455|587708158|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
162726072|NCT04043455|587708153|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162726073|NCT04043455|587708154|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162726074|NCT04043455|587708155|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162726075|NCT04043455|587708156|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162726076|NCT04043455|587708157|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
162726077|NCT04043455|587708158|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
162726078|NCT04043455|587708153|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162726079|NCT04043455|587708154|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162726080|NCT04043455|587708155|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162726081|NCT04043455|587708156|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162726082|NCT04043455|587708157|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
162726083|NCT04043455|587708158|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162726084|NCT04043455|587708153|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162726085|NCT04043455|587708154|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162726086|NCT04043455|587708155|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162726087|NCT04043455|587708156|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162726088|NCT04043455|587708157|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
162726089|NCT04043455|587708158|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
162726090|NCT03422276|587708159|FG000|Overall Study|Withdrawal by Subject|21|||
162726091|NCT03422276|587708160|FG001|Overall Study|Withdrawal by Subject|25|||
162726092|NCT03422276|587708161|FG002|Overall Study|Withdrawal by Subject|14|||
162726093|NCT03422276|587708162|FG003|Overall Study|Withdrawal by Subject|16|||
162726094|NCT03422276|587708159|FG000|Overall Study|Death|14|||
162726095|NCT03422276|587708160|FG001|Overall Study|Death|21|||
162726096|NCT03422276|587708161|FG002|Overall Study|Death|3|||
162726097|NCT03422276|587708162|FG003|Overall Study|Death|1|||
162726098|NCT03422276|587708159|FG000|Overall Study|Discontinued, ineligible|4|||
162726099|NCT03422276|587708160|FG001|Overall Study|Discontinued, ineligible|3|||
162726100|NCT03422276|587708161|FG002|Overall Study|Discontinued, ineligible|0|||
162726101|NCT03422276|587708162|FG003|Overall Study|Discontinued, ineligible|0|||
162726102|NCT03422276|587708159|FG000|Overall Study|Lost to Follow-up|15|||
162726103|NCT03422276|587708160|FG001|Overall Study|Lost to Follow-up|8|||
162726104|NCT03422276|587708161|FG002|Overall Study|Lost to Follow-up|13|||
162726105|NCT03422276|587708162|FG003|Overall Study|Lost to Follow-up|4|||
162684389|NCT03937219|587554402|FG000|Overall Study|Lost to Follow-up|3|||
162684390|NCT03937219|587554403|FG001|Overall Study|Lost to Follow-up|4|||
162684391|NCT04393441|587554404|FG000|Overall Study|Adverse Event|0|||
162684392|NCT04393441|587554405|FG001|Overall Study|Adverse Event|3|||
162684393|NCT04393441|587554404|FG000|Overall Study|Withdrawal by Subject|5|||
162684394|NCT04393441|587554405|FG001|Overall Study|Withdrawal by Subject|7|||
162684395|NCT04393441|587554404|FG000|Overall Study|Lost to Follow-up|0|||
162684396|NCT04393441|587554405|FG001|Overall Study|Lost to Follow-up|2|||
162684397|NCT04393441|587554404|FG000|Overall Study|Protocol Deviation|2|||
162684398|NCT04393441|587554405|FG001|Overall Study|Protocol Deviation|1|||
162684399|NCT04393441|587554404|FG000|Overall Study|Reason not Specified|1|||
162684400|NCT04393441|587554405|FG001|Overall Study|Reason not Specified|1|||
162684401|NCT02782169|587554406|FG000|Overall Study|Lost to Follow-up|1|||
162684402|NCT02782169|587554407|FG001|Overall Study|Lost to Follow-up|2|||
162684403|NCT04003610|587554408|FG000|Overall Study|Lost to Follow-up|0|||
162684404|NCT04003610|587554409|FG001|Overall Study|Lost to Follow-up|1|||
162684405|NCT04003610|587554410|FG002|Overall Study|Lost to Follow-up|0|||
162684406|NCT04003610|587554408|FG000|Overall Study|Death|0|||
162684407|NCT04003610|587554409|FG001|Overall Study|Death|0|||
162684408|NCT04003610|587554410|FG002|Overall Study|Death|3|||
162684409|NCT04003610|587554408|FG000|Overall Study|Study Terminated by Sponsor|0|||
162684410|NCT04003610|587554409|FG001|Overall Study|Study Terminated by Sponsor|0|||
162684411|NCT04003610|587554410|FG002|Overall Study|Study Terminated by Sponsor|3|||
162684412|NCT00771810|587554411|FG000|Overall Study|Adverse Event|3|||
162684413|NCT00771810|587554412|FG001|Overall Study|Adverse Event|0|||
162684414|NCT00771810|587554413|FG002|Overall Study|Adverse Event|2|||
162684415|NCT00771810|587554411|FG000|Overall Study|Lost to Follow-up|0|||
162684416|NCT00771810|587554412|FG001|Overall Study|Lost to Follow-up|0|||
162684417|NCT00771810|587554413|FG002|Overall Study|Lost to Follow-up|1|||
162684418|NCT00771810|587554411|FG000|Overall Study|Physician Decision|1|||
162684419|NCT00771810|587554412|FG001|Overall Study|Physician Decision|2|||
162684420|NCT00771810|587554413|FG002|Overall Study|Physician Decision|2|||
162684421|NCT00771810|587554411|FG000|Overall Study|Protocol Violation|0|||
162684422|NCT00771810|587554412|FG001|Overall Study|Protocol Violation|1|||
162684423|NCT00771810|587554413|FG002|Overall Study|Protocol Violation|1|||
162684424|NCT00771810|587554411|FG000|Overall Study|Withdrawal by Subject|1|||
162684425|NCT00771810|587554412|FG001|Overall Study|Withdrawal by Subject|2|||
162684426|NCT00771810|587554413|FG002|Overall Study|Withdrawal by Subject|0|||
162684427|NCT00771810|587554411|FG000|Overall Study|Other|0|||
162684428|NCT00771810|587554412|FG001|Overall Study|Other|0|||
162684429|NCT00771810|587554413|FG002|Overall Study|Other|1|||
162684430|NCT02660827|587554418|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
162684431|NCT02660827|587554418|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
162684432|NCT02660827|587554418|FG000|From Study to End of Continued Access|Adverse Event|3|||
162684433|NCT02660827|587554418|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
162684434|NCT02660827|587554418|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
162684435|NCT02660827|587554418|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
162684436|NCT02660827|587554418|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
162684437|NCT02660827|587554418|FG000|Period 2: Continued Access Period|Adverse Event|3|||
162684438|NCT02953938|587554419|FG000|Overall Study|Adverse Event|0|||
162684439|NCT02953938|587554420|FG001|Overall Study|Adverse Event|1|||
162684440|NCT02953938|587554419|FG000|Overall Study|Withdrawal by Subject|1|||
162684441|NCT02953938|587554420|FG001|Overall Study|Withdrawal by Subject|1|||
162684442|NCT02657031|587554427|FG000|Overall Study|Adverse Event|1|||
162684443|NCT02657031|587554428|FG001|Overall Study|Adverse Event|2|||
162684444|NCT04198805|587554429|FG000|Overall Study|Death|0|||
162684445|NCT04198805|587554430|FG001|Overall Study|Death|0|||
162684446|NCT04198805|587554431|FG002|Overall Study|Death|0|||
162684447|NCT04198805|587554432|FG003|Overall Study|Death|1|||
162684448|NCT04198805|587554429|FG000|Overall Study|Early Termination|8|||
162684449|NCT04198805|587554430|FG001|Overall Study|Early Termination|4|||
162684450|NCT04198805|587554431|FG002|Overall Study|Early Termination|6|||
162684451|NCT04198805|587554432|FG003|Overall Study|Early Termination|9|||
162684452|NCT03078816|587554433|FG000|Overall Study|Withdrawal by Subject|1|||
162684453|NCT02114151|587554434|FG000|Overall Study|Death|1|||
162684454|NCT02114151|587554434|FG000|Overall Study|Lost to Follow-up|1|||
162684455|NCT02114151|587554434|FG000|Overall Study|Withdrawal by Subject|5|||
162684456|NCT03599349|587554435|FG000|Overall Study|Lost to Follow-up|1|||
162684457|NCT00810264|587554438|FG000|Overall Study|Lost to Follow-up|191|||
162684458|NCT00810264|587554438|FG000|Overall Study|Withdrawal by subject or physician|721|||
162684459|NCT00810264|587554438|FG000|Overall Study|Death|641|||
162726106|NCT03422276|587708159|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
162726107|NCT03422276|587708160|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
162684460|NCT00500903|587554439|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
162684461|NCT00500903|587554440|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
162684462|NCT00500903|587554441|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
162684463|NCT00500903|587554439|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
162684464|NCT00500903|587554440|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162684465|NCT00500903|587554441|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162684466|NCT00500903|587554439|FG000|Overall Study|Progressive Disease|41|||
162684467|NCT00500903|587554440|FG001|Overall Study|Progressive Disease|2|||
162684468|NCT00500903|587554441|FG002|Overall Study|Progressive Disease|15|||
162684469|NCT00500903|587554439|FG000|Overall Study|Patient Declined Further Treatment|0|||
162684470|NCT00500903|587554440|FG001|Overall Study|Patient Declined Further Treatment|0|||
162684471|NCT00500903|587554441|FG002|Overall Study|Patient Declined Further Treatment|3|||
162684472|NCT00500903|587554439|FG000|Overall Study|Symptomatic Deterioration|2|||
162684473|NCT00500903|587554440|FG001|Overall Study|Symptomatic Deterioration|0|||
162684474|NCT00500903|587554441|FG002|Overall Study|Symptomatic Deterioration|0|||
162684475|NCT00500903|587554439|FG000|Overall Study|Reason Not Specified|10|||
162684476|NCT00500903|587554440|FG001|Overall Study|Reason Not Specified|0|||
162684477|NCT00500903|587554441|FG002|Overall Study|Reason Not Specified|2|||
162684478|NCT01648348|587554444|FG000|Overall Study|Cancel|1|||
162684479|NCT01648348|587554445|FG001|Overall Study|Cancel|0|||
162684480|NCT01648348|587554446|FG002|Overall Study|Cancel|0|||
162684481|NCT01648348|587554447|FG003|Overall Study|Cancel|0|||
162684482|NCT01648348|587554448|FG004|Overall Study|Cancel|3|||
162684483|NCT01648348|587554449|FG005|Overall Study|Cancel|6|||
162684484|NCT01648348|587554444|FG000|Overall Study|Replaced for MTD analysis|1|||
162684485|NCT01648348|587554445|FG001|Overall Study|Replaced for MTD analysis|0|||
162684486|NCT01648348|587554446|FG002|Overall Study|Replaced for MTD analysis|1|||
162684487|NCT01648348|587554447|FG003|Overall Study|Replaced for MTD analysis|0|||
162684488|NCT01648348|587554448|FG004|Overall Study|Replaced for MTD analysis|0|||
162684489|NCT01648348|587554449|FG005|Overall Study|Replaced for MTD analysis|0|||
162684490|NCT00696410|587554450|FG000|Overall Study|Lost to Follow-up|2|||
162684491|NCT00696410|587554451|FG001|Overall Study|Lost to Follow-up|0|||
162684492|NCT00696410|587554450|FG000|Overall Study|Withdrawal by Subject|8|||
162684493|NCT00696410|587554451|FG001|Overall Study|Withdrawal by Subject|0|||
162684494|NCT00696410|587554450|FG000|Overall Study|Physician Decision|3|||
162684495|NCT00696410|587554451|FG001|Overall Study|Physician Decision|0|||
162684496|NCT00265889|587554455|FG000|Overall Study|Physician Decision|1|||
162684497|NCT00265889|587554455|FG000|Overall Study|Protocol Violation|1|||
162684498|NCT00265889|587554455|FG000|Overall Study|Insurance denied the request|3|||
162684499|NCT02134587|587554456|FG000|Overall Study|Did not completed all meetings|30|||
162684500|NCT00453986|587554460|FG000|Overall Study|Lost to Follow-up|6|||
162684501|NCT00453986|587554461|FG001|Overall Study|Lost to Follow-up|5|||
162684502|NCT00453986|587554462|FG002|Overall Study|Lost to Follow-up|6|||
162684503|NCT00453986|587554463|FG003|Overall Study|Lost to Follow-up|2|||
162684504|NCT00453986|587554464|FG004|Overall Study|Lost to Follow-up|0|||
162684505|NCT03419364|587554468|FG000|Overall Study|Delivery due to maternal condition|2|||
162684506|NCT03419364|587554469|FG001|Overall Study|Delivery due to maternal condition|0|||
162684507|NCT03419364|587554470|FG002|Overall Study|Delivery due to maternal condition|0|||
162726108|NCT03422276|587708161|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
162726109|NCT03422276|587708162|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
162726110|NCT03422276|587708159|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
162726111|NCT03422276|587708160|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
162726112|NCT03422276|587708161|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
162726113|NCT03422276|587708162|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
162726114|NCT03422276|587708159|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
162726115|NCT03422276|587708160|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
162726116|NCT03422276|587708161|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
162726117|NCT03422276|587708162|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
162726118|NCT03422276|587708159|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
162726119|NCT03422276|587708160|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
162726120|NCT03422276|587708161|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
162726121|NCT03422276|587708162|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
162726122|NCT03422276|587708159|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162726123|NCT03422276|587708160|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162726124|NCT03422276|587708161|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
162726125|NCT03422276|587708162|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162726126|NCT05194917|587708163|FG000|Overall Study|Lost to Follow-up|7|||
162726127|NCT05194917|587708164|FG001|Overall Study|Lost to Follow-up|5|||
162726128|NCT05194917|587708165|FG002|Overall Study|Lost to Follow-up|6|||
162726129|NCT05194917|587708166|FG003|Overall Study|Lost to Follow-up|5|||
162726130|NCT04922021|587708167|FG000|Overall Study|Withdrawal by Subject|4|||
162726131|NCT04922021|587708168|FG001|Overall Study|Withdrawal by Subject|10|||
162726132|NCT04922021|587708167|FG000|Overall Study|Adverse Event|2|||
162726133|NCT04922021|587708168|FG001|Overall Study|Adverse Event|2|||
162726134|NCT04922021|587708167|FG000|Overall Study|Lack of Efficacy|0|||
162684508|NCT03355326|587554478|FG000|Overall Study|Protocol Violation|3|||
162684509|NCT03355326|587554479|FG001|Overall Study|Protocol Violation|3|||
162684510|NCT00608582|587554484|FG000|Overall Study|Lost to Follow-up|2|||
162684511|NCT00608582|587554485|FG001|Overall Study|Lost to Follow-up|0|||
162684512|NCT00608582|587554484|FG000|Overall Study|No Best Response in Phase 1 located|1|||
162684513|NCT00608582|587554485|FG001|Overall Study|No Best Response in Phase 1 located|1|||
162684514|NCT00608582|587554484|FG000|Overall Study|Illicit Drug Use|1|||
162684515|NCT00608582|587554485|FG001|Overall Study|Illicit Drug Use|0|||
162684516|NCT00608582|587554484|FG000|Overall Study|Early stage Design Change|0|||
162684517|NCT00608582|587554485|FG001|Overall Study|Early stage Design Change|3|||
162684518|NCT04922554|587554486|FG000|Overall Study|Adverse Event|4|||
162684519|NCT04922554|587554487|FG001|Overall Study|Adverse Event|0|||
162684520|NCT04922554|587554486|FG000|Overall Study|Withdrawal by Subject|1|||
162684521|NCT04922554|587554487|FG001|Overall Study|Withdrawal by Subject|0|||
162684522|NCT03308825|587555908|FG000|Overall Study|Lost to Follow-up|2|||
162684523|NCT03308825|587555909|FG001|Overall Study|Lost to Follow-up|2|||
162684524|NCT03308825|587555910|FG002|Overall Study|Lost to Follow-up|1|||
162684525|NCT03308825|587555911|FG003|Overall Study|Lost to Follow-up|0|||
162684526|NCT03308825|587555908|FG000|Overall Study|Protocol Violation|0|||
162684527|NCT03308825|587555909|FG001|Overall Study|Protocol Violation|2|||
162684528|NCT03308825|587555910|FG002|Overall Study|Protocol Violation|0|||
162684529|NCT03308825|587555911|FG003|Overall Study|Protocol Violation|0|||
162684530|NCT03559218|587555912|FG000|Overall Study|Withdrawal by Subject|1|||
162684531|NCT03559218|587555913|FG001|Overall Study|Withdrawal by Subject|0|||
162684532|NCT04737109|587555923|FG000|Study Treatment|Disease Progression|5|||
162684533|NCT04737109|587555924|FG001|Study Treatment|Disease Progression|0|||
162684534|NCT04737109|587555925|FG002|Study Treatment|Disease Progression|0|||
162684535|NCT04737109|587555926|FG003|Study Treatment|Disease Progression|0|||
162684536|NCT04737109|587555923|FG000|Study Treatment|Death on study|1|||
162684537|NCT04737109|587555924|FG001|Study Treatment|Death on study|0|||
162684538|NCT04737109|587555925|FG002|Study Treatment|Death on study|0|||
162684539|NCT04737109|587555926|FG003|Study Treatment|Death on study|0|||
162684540|NCT03092375|587555927|FG000|Overall Study|Lack of Efficacy|0|||
162684541|NCT03092375|587555928|FG001|Overall Study|Lack of Efficacy|1|||
162684542|NCT03092375|587555929|FG002|Overall Study|Lack of Efficacy|1|||
162684543|NCT03092375|587555930|FG003|Overall Study|Lack of Efficacy|0|||
162684544|NCT01679301|587555931|FG000|Screening Period|screen failure|3|||
162684545|NCT01679301|587555932|FG001|Screening Period|screen failure|0|||
162684546|NCT01679301|587555933|FG002|Screening Period|screen failure|0|||
162684547|NCT03328143|587555936|FG000|Overall Study|Declined|3|||
162684548|NCT03328143|587555936|FG000|Overall Study|Required increased sedation|4|||
162684549|NCT03328143|587555936|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
162684550|NCT03328143|587555936|FG000|Overall Study|Surgery cancelled|1|||
162684551|NCT00861614|587555937|FG000|Overall Study|Disease Progression|182|||
162684552|NCT00861614|587555938|FG001|Overall Study|Disease Progression|263|||
162684553|NCT00861614|587555937|FG000|Overall Study|Study Drug Toxicity|79|||
162684554|NCT00861614|587555938|FG001|Overall Study|Study Drug Toxicity|6|||
162684555|NCT00861614|587555937|FG000|Overall Study|Death|32|||
162684556|NCT00861614|587555938|FG001|Overall Study|Death|19|||
162684557|NCT00861614|587555937|FG000|Overall Study|Adverse Event|27|||
162726135|NCT04922021|587708168|FG001|Overall Study|Lack of Efficacy|1|||
162726136|NCT04922021|587708167|FG000|Overall Study|Multiple reasons|1|||
162726137|NCT04922021|587708168|FG001|Overall Study|Multiple reasons|0|||
162726138|NCT04941287|587708178|FG000|Overall Study|Rapid decline before starting treatment|3|||
162726139|NCT04941287|587708179|FG001|Overall Study|Rapid decline before starting treatment|1|||
162726140|NCT01998984|587708184|FG000|Overall Study|Adverse Event|0|||
162726141|NCT01998984|587708185|FG001|Overall Study|Adverse Event|0|||
162726142|NCT01998984|587708186|FG002|Overall Study|Adverse Event|0|||
162726143|NCT01998984|587708187|FG003|Overall Study|Adverse Event|1|||
162726144|NCT01998984|587708184|FG000|Overall Study|Lost to Follow-up|0|||
162726145|NCT01998984|587708185|FG001|Overall Study|Lost to Follow-up|1|||
162726146|NCT01998984|587708186|FG002|Overall Study|Lost to Follow-up|0|||
162726147|NCT01998984|587708187|FG003|Overall Study|Lost to Follow-up|1|||
162726148|NCT01998984|587708184|FG000|Overall Study|Withdrawal by Subject|0|||
162726149|NCT01998984|587708185|FG001|Overall Study|Withdrawal by Subject|0|||
162726150|NCT01998984|587708186|FG002|Overall Study|Withdrawal by Subject|1|||
162726151|NCT01998984|587708187|FG003|Overall Study|Withdrawal by Subject|0|||
162726152|NCT01998984|587708184|FG000|Overall Study|Other|0|||
162726153|NCT01998984|587708185|FG001|Overall Study|Other|0|||
162684558|NCT00861614|587555938|FG001|Overall Study|Adverse Event|23|||
162684559|NCT00861614|587555937|FG000|Overall Study|Withdrawal by Subject|34|||
162684560|NCT00861614|587555938|FG001|Overall Study|Withdrawal by Subject|35|||
162684561|NCT00861614|587555937|FG000|Overall Study|Other|17|||
162684562|NCT00861614|587555938|FG001|Overall Study|Other|22|||
162684563|NCT00944658|587555939|FG000|Treatment 12 Weeks|Adverse Event|0|||
162684564|NCT00944658|587555940|FG001|Treatment 12 Weeks|Adverse Event|2|||
162684565|NCT02259517|587555941|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
162684566|NCT02259517|587555942|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
162684567|NCT02259517|587555943|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
162684568|NCT02259517|587555941|FG000|Overall Study|Withdrawal by Subject|0|||
162726154|NCT01998984|587708186|FG002|Overall Study|Other|0|||
162726155|NCT01998984|587708187|FG003|Overall Study|Other|1|||
162726156|NCT02652260|587708188|FG000|Base Study|Pregnancy|0|||
162726157|NCT02652260|587708189|FG001|Base Study|Pregnancy|1|||
162726158|NCT02652260|587708188|FG000|Base Study|Withdrawal by Subject|0|||
162726159|NCT02652260|587708189|FG001|Base Study|Withdrawal by Subject|1|||
162684569|NCT02259517|587555942|FG001|Overall Study|Withdrawal by Subject|0|||
162684570|NCT02259517|587555943|FG002|Overall Study|Withdrawal by Subject|3|||
162684571|NCT01289418|587555947|FG000|Day 8 Survey|email address invalid|283|||
162684572|NCT01289418|587555947|FG000|Day 8 Survey|participants did not complete the survey|1935|||
162684573|NCT01289418|587555947|FG000|Day 29 Survey|email address invalid|283|||
162684574|NCT01289418|587555947|FG000|Day 29 Survey|participants did not complete the survey|2185|||
162684575|NCT01352585|587555949|FG000|Overall Study|Adverse Event|2|||
162684576|NCT01352585|587555950|FG001|Overall Study|Adverse Event|1|||
162684577|NCT01352585|587555949|FG000|Overall Study|Lost to Follow-up|1|||
162684578|NCT01352585|587555950|FG001|Overall Study|Lost to Follow-up|0|||
162684579|NCT01352585|587555949|FG000|Overall Study|Other|5|||
162684580|NCT01352585|587555950|FG001|Overall Study|Other|2|||
162684581|NCT00838682|587555953|FG000|Overall Study|Lost to Follow-up|21|||
162684582|NCT00838682|587555954|FG001|Overall Study|Lost to Follow-up|14|||
162684583|NCT00838682|587555953|FG000|Overall Study|detection of exclusion criteria|4|||
162684584|NCT00838682|587555954|FG001|Overall Study|detection of exclusion criteria|3|||
162684585|NCT00838682|587555953|FG000|Overall Study|Protocol Violation|0|||
162684586|NCT00838682|587555954|FG001|Overall Study|Protocol Violation|1|||
162684587|NCT00838682|587555953|FG000|Overall Study|Withdrawal by Subject|0|||
162684588|NCT00838682|587555954|FG001|Overall Study|Withdrawal by Subject|1|||
162684589|NCT02305381|587555955|FG000|Overall Study|Unclassified|5|||
162684590|NCT02305381|587555956|FG001|Overall Study|Unclassified|5|||
162684591|NCT02305381|587555957|FG002|Overall Study|Unclassified|7|||
162684592|NCT02276066|587555958|FG000|Overall Study|Lost to Follow-up|21|||
162684593|NCT02276066|587555959|FG001|Overall Study|Lost to Follow-up|11|||
162684594|NCT01807156|587555960|FG000|Overall Study|Physician Decision|1|||
162684595|NCT01370525|587555961|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
162684596|NCT01370525|587555962|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
162684597|NCT01370525|587555961|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162684598|NCT01370525|587555962|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162684599|NCT01370525|587555961|FG000|Overall Study|Adverse Event|0|||
162684600|NCT01370525|587555962|FG001|Overall Study|Adverse Event|1|||
162684601|NCT01370525|587555961|FG000|Overall Study|Protocol Violation|2|||
162684602|NCT01370525|587555962|FG001|Overall Study|Protocol Violation|1|||
162684603|NCT01370525|587555961|FG000|Overall Study|Lost to follow up|2|||
162684604|NCT01370525|587555962|FG001|Overall Study|Lost to follow up|6|||
162684605|NCT03642938|587555964|FG000|Overall Study|Withdrawal by Subject|0|||
162684606|NCT03642938|587555965|FG001|Overall Study|Withdrawal by Subject|0|||
162684607|NCT03642938|587555966|FG002|Overall Study|Withdrawal by Subject|0|||
162684608|NCT03642938|587555967|FG003|Overall Study|Withdrawal by Subject|1|||
162684609|NCT01424930|587555968|FG000|Overall Study|Adverse Event|0|||
162684610|NCT01424930|587555969|FG001|Overall Study|Adverse Event|1|||
162684611|NCT01424930|587555968|FG000|Overall Study|Death|1|||
162684612|NCT01424930|587555969|FG001|Overall Study|Death|0|||
162684613|NCT01424930|587555968|FG000|Overall Study|Progressive Disease|3|||
162684614|NCT01424930|587555969|FG001|Overall Study|Progressive Disease|6|||
162684615|NCT01424930|587555968|FG000|Overall Study|Screen Failure|0|||
162684616|NCT01424930|587555969|FG001|Overall Study|Screen Failure|1|||
162684617|NCT01424930|587555968|FG000|Overall Study|Reason not specified|0|||
162684618|NCT01424930|587555969|FG001|Overall Study|Reason not specified|6|||
162684619|NCT03286751|587555974|FG000|Washout Period 1|Withdrawal by Subject|0|||
162684620|NCT03286751|587555975|FG001|Washout Period 1|Withdrawal by Subject|0|||
162684621|NCT03286751|587555976|FG002|Washout Period 1|Withdrawal by Subject|0|||
162684622|NCT03286751|587555977|FG003|Washout Period 1|Withdrawal by Subject|0|||
162684623|NCT03286751|587555978|FG004|Washout Period 1|Withdrawal by Subject|1|||
162684624|NCT03286751|587555979|FG005|Washout Period 1|Withdrawal by Subject|0|||
162684625|NCT03286751|587555974|FG000|Washout Period 2|Personal Reasons|0|||
162684626|NCT03286751|587555975|FG001|Washout Period 2|Personal Reasons|1|||
162684627|NCT03286751|587555976|FG002|Washout Period 2|Personal Reasons|0|||
162684628|NCT03286751|587555977|FG003|Washout Period 2|Personal Reasons|0|||
162684629|NCT03286751|587555978|FG004|Washout Period 2|Personal Reasons|0|||
162684630|NCT03286751|587555979|FG005|Washout Period 2|Personal Reasons|0|||
162684631|NCT03286751|587555974|FG000|Washout Period 5|Adverse Event|0|||
162684632|NCT03286751|587555975|FG001|Washout Period 5|Adverse Event|0|||
162684633|NCT03286751|587555976|FG002|Washout Period 5|Adverse Event|0|||
162684634|NCT03286751|587555977|FG003|Washout Period 5|Adverse Event|0|||
162684635|NCT03286751|587555978|FG004|Washout Period 5|Adverse Event|1|||
162684636|NCT03286751|587555979|FG005|Washout Period 5|Adverse Event|0|||
162684637|NCT01119768|587555980|FG000|Treatment Period|Lack of Efficacy|18|||
162684638|NCT01119768|587555981|FG001|Treatment Period|Lack of Efficacy|25|||
162684639|NCT01301391|587555982|FG000|Overall Study|Death|13|||
162684640|NCT01301391|587555982|FG000|Overall Study|Lost to Follow-up|3|||
162684641|NCT01301391|587555982|FG000|Overall Study|Physician Decision|2|||
162684642|NCT01301391|587555982|FG000|Overall Study|Sponsor's decision|8|||
162684643|NCT01059643|587555983|FG000|Overall Study|Adverse Event|3|||
162684644|NCT01059643|587555983|FG000|Overall Study|Withdrawal by Subject|2|||
162684645|NCT01059643|587555983|FG000|Overall Study|Physician Decision|1|||
162684646|NCT00106184|587555984|FG000|Overall Study|Withdrawal by Subject|3|||
162684647|NCT00106184|587555985|FG001|Overall Study|Withdrawal by Subject|2|||
162684648|NCT05292534|587555991|FG000|Overall Study|Protocol Violation|3|||
162684649|NCT05292534|587555992|FG001|Overall Study|Protocol Violation|4|||
162684650|NCT05292534|587555991|FG000|Overall Study|Withdrawal by Subject|0|||
162684651|NCT05292534|587555992|FG001|Overall Study|Withdrawal by Subject|1|||
162684652|NCT00238433|587555998|FG000|Overall Study|Screen failure|1|||
162684653|NCT00238433|587555998|FG000|Overall Study|Lost to Follow-up|1|||
162684654|NCT00238433|587555998|FG000|Overall Study|Death|1|||
162684655|NCT01814748|587555999|FG000|Overall Study|Lost to Follow-up|1|||
162684656|NCT01814748|587556000|FG001|Overall Study|Lost to Follow-up|2|||
162684657|NCT01814748|587555999|FG000|Overall Study|Study site terminated by sponsor|1|||
162684658|NCT01814748|587556000|FG001|Overall Study|Study site terminated by sponsor|1|||
162684659|NCT01814748|587555999|FG000|Overall Study|Withdrawal by Subject|6|||
162684660|NCT01814748|587556000|FG001|Overall Study|Withdrawal by Subject|4|||
162684661|NCT00409682|587556006|FG000|Open-label Induction Period|Adverse Event|1|||
162684662|NCT00409682|587556007|FG001|Open-label Induction Period|Adverse Event|0|||
162684663|NCT00409682|587556008|FG002|Open-label Induction Period|Adverse Event|0|||
162684664|NCT00409682|587556006|FG000|Open-label Induction Period|Lack of Efficacy|1|||
162684665|NCT00409682|587556007|FG001|Open-label Induction Period|Lack of Efficacy|0|||
162684666|NCT00409682|587556008|FG002|Open-label Induction Period|Lack of Efficacy|0|||
162684667|NCT00409682|587556006|FG000|Open-label Induction Period|Protocol Violation|1|||
162684668|NCT00409682|587556007|FG001|Open-label Induction Period|Protocol Violation|0|||
162684669|NCT00409682|587556008|FG002|Open-label Induction Period|Protocol Violation|0|||
162684670|NCT00409682|587556006|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
162684671|NCT00409682|587556007|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
162684672|NCT00409682|587556008|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
162684673|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
162684674|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
162684675|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
162684676|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
162684677|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
162684678|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
162684679|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
162684680|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
162684681|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
162684682|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
162684683|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
162684684|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
162684685|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
162684686|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
162684687|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
162684688|NCT00409682|587556006|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
162684689|NCT00409682|587556007|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
162684690|NCT00409682|587556008|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
162684691|NCT04710927|587556012|FG000|Overall Study|Lost to Follow-up|7|||
162684692|NCT04710927|587556013|FG001|Overall Study|Lost to Follow-up|6|||
162684693|NCT04710927|587556014|FG002|Overall Study|Lost to Follow-up|5|||
162684694|NCT03595332|587556015|FG000|Overall Study|Lost to Follow-up|16|||
162684695|NCT03595332|587556016|FG001|Overall Study|Lost to Follow-up|22|||
162684696|NCT03595332|587556015|FG000|Overall Study|Unable to retrieve ID from school|0|||
162684697|NCT03595332|587556016|FG001|Overall Study|Unable to retrieve ID from school|2|||
162684698|NCT02227875|587556017|FG000|Overall Study|Protocol Violation|10|||
162684699|NCT02227875|587556018|FG001|Overall Study|Protocol Violation|7|||
162684700|NCT02227875|587556017|FG000|Overall Study|Other|1|||
162684701|NCT02227875|587556018|FG001|Overall Study|Other|3|||
162684702|NCT02227875|587556017|FG000|Overall Study|Physician Decision|1|||
162684703|NCT02227875|587556018|FG001|Overall Study|Physician Decision|0|||
162684704|NCT02227875|587556017|FG000|Overall Study|Adverse Event|3|||
162684705|NCT02227875|587556018|FG001|Overall Study|Adverse Event|0|||
162684706|NCT02227875|587556017|FG000|Overall Study|Withdrawal by Subject|12|||
162684707|NCT02227875|587556018|FG001|Overall Study|Withdrawal by Subject|13|||
162684708|NCT02227875|587556017|FG000|Overall Study|Lost to Follow-up|10|||
162684709|NCT02227875|587556018|FG001|Overall Study|Lost to Follow-up|10|||
162684710|NCT01201811|587556019|FG000|Overall Study|Adverse Event|6|||
162684711|NCT01201811|587556019|FG000|Overall Study|Disease progression|3|||
162684712|NCT01201811|587556019|FG000|Overall Study|Withdrawal by Subject|3|||
162684713|NCT01201811|587556019|FG000|Overall Study|Death|4|||
162684714|NCT01201811|587556019|FG000|Overall Study|Treatment Failure|2|||
162684715|NCT01201811|587556019|FG000|Overall Study|Physician Decision|1|||
162684716|NCT02857426|587556020|FG000|Overall Study|Disease progression|34|||
162684717|NCT02857426|587556021|FG001|Overall Study|Disease progression|13|||
162684718|NCT02857426|587556020|FG000|Overall Study|Study drug toxicity|4|||
162684719|NCT02857426|587556021|FG001|Overall Study|Study drug toxicity|1|||
162684720|NCT02857426|587556020|FG000|Overall Study|Death|1|||
162684721|NCT02857426|587556021|FG001|Overall Study|Death|0|||
162684722|NCT02857426|587556020|FG000|Overall Study|Adverse event unrelated to study drug|6|||
162684723|NCT02857426|587556021|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162684724|NCT02857426|587556020|FG000|Overall Study|Participant withdrew consent|1|||
162684725|NCT02857426|587556021|FG001|Overall Study|Participant withdrew consent|1|||
162684726|NCT02857426|587556020|FG000|Overall Study|Maximum clinical benefit|1|||
162684727|NCT02857426|587556021|FG001|Overall Study|Maximum clinical benefit|0|||
162684728|NCT02857426|587556020|FG000|Overall Study|Completed treatment|0|||
162684729|NCT02857426|587556021|FG001|Overall Study|Completed treatment|2|||
162684730|NCT01960725|587556022|FG000|Overall Study|Lost to Follow-up|4|||
162684731|NCT01960725|587556023|FG001|Overall Study|Lost to Follow-up|3|||
162684732|NCT01960725|587556022|FG000|Overall Study|Withdrawal by Subject|1|||
162684733|NCT01960725|587556023|FG001|Overall Study|Withdrawal by Subject|0|||
162684734|NCT01960725|587556022|FG000|Overall Study|unable to obtain blood sample|1|||
162684735|NCT01960725|587556023|FG001|Overall Study|unable to obtain blood sample|2|||
162684736|NCT02831257|587556024|FG000|Overall Study|Lack of Efficacy|3|||
162684737|NCT02831257|587556024|FG000|Overall Study|Adverse Event|2|||
162684738|NCT02831257|587556024|FG000|Overall Study|Physician Decision|1|||
162684739|NCT02831257|587556024|FG000|Overall Study|Withdrawal by Subject|6|||
162684740|NCT00611858|587556025|FG000|Overall Study|Adverse Event|2|||
162684741|NCT00611858|587556025|FG000|Overall Study|Withdrawal by Subject|2|||
162684742|NCT01844284|587556026|FG000|Overall Study|Lost to Follow-up|12|||
162684743|NCT01844284|587556027|FG001|Overall Study|Lost to Follow-up|7|||
162684744|NCT03138733|587556029|FG000|Overall Study|Death|17|||
162684745|NCT03138733|587556030|FG001|Overall Study|Death|18|||
162684746|NCT03138733|587556029|FG000|Overall Study|Withdrawal by Subject|11|||
162684747|NCT03138733|587556030|FG001|Overall Study|Withdrawal by Subject|6|||
162684748|NCT03138733|587556029|FG000|Overall Study|Lost to Follow-up|3|||
162684749|NCT03138733|587556030|FG001|Overall Study|Lost to Follow-up|2|||
162684750|NCT03138733|587556029|FG000|Overall Study|Adverse Event|1|||
162684751|NCT03138733|587556030|FG001|Overall Study|Adverse Event|0|||
162684752|NCT03138733|587556029|FG000|Overall Study|Protocol Violation|1|||
162684753|NCT03138733|587556030|FG001|Overall Study|Protocol Violation|3|||
162684754|NCT03138733|587556029|FG000|Overall Study|Administrative or logistical reason|1|||
162684755|NCT03138733|587556030|FG001|Overall Study|Administrative or logistical reason|0|||
162684756|NCT03138733|587556029|FG000|Overall Study|The patient was transferred to another hospital|1|||
162684757|NCT03138733|587556030|FG001|Overall Study|The patient was transferred to another hospital|0|||
162684758|NCT03641313|587556031|FG000|Overall Study|Death|1|||
162684759|NCT03641313|587556031|FG000|Overall Study|Withdrawal by Subject|2|||
162684760|NCT03641313|587556031|FG000|Overall Study|Declining health|1|||
162684761|NCT03641313|587556031|FG000|Overall Study|Adverse Event|1|||
162684762|NCT02521285|587556034|FG000|Overall Study|Lost to Follow-up|1|||
162684763|NCT02521285|587556035|FG001|Overall Study|Lost to Follow-up|1|||
162684764|NCT02521285|587556034|FG000|Overall Study|Withdrawal by Subject|1|||
162684765|NCT02521285|587556035|FG001|Overall Study|Withdrawal by Subject|1|||
162684766|NCT02521285|587556034|FG000|Overall Study|Adverse Event|0|||
162684767|NCT02521285|587556035|FG001|Overall Study|Adverse Event|1|||
162684768|NCT05701995|587556037|FG000|Pre-Treatment|Randomization Error|1|||
162684769|NCT05701995|587556038|FG001|Pre-Treatment|Randomization Error|1|||
162684770|NCT05701995|587556037|FG000|Treatment|Withdrawal by Subject|8|||
162684771|NCT05701995|587556038|FG001|Treatment|Withdrawal by Subject|4|||
162684772|NCT05701995|587556037|FG000|Treatment|Lost to Follow-up|2|||
162684773|NCT05701995|587556038|FG001|Treatment|Lost to Follow-up|3|||
162684774|NCT05701995|587556037|FG000|Treatment|Adverse Event|3|||
162684775|NCT05701995|587556038|FG001|Treatment|Adverse Event|1|||
162684776|NCT05701995|587556037|FG000|Treatment|Other Reason|1|||
162684777|NCT05701995|587556038|FG001|Treatment|Other Reason|1|||
162684778|NCT05701995|587556037|FG000|Treatment|Death|1|||
162684779|NCT05701995|587556038|FG001|Treatment|Death|0|||
162684780|NCT05701995|587556037|FG000|Treatment|Physician Decision|0|||
162684781|NCT05701995|587556038|FG001|Treatment|Physician Decision|1|||
162684782|NCT00715429|587556039|FG000|Overall Study|Did not complete the study diary|0|||
162684783|NCT00715429|587556040|FG001|Overall Study|Did not complete the study diary|1|||
162684784|NCT04899245|587556045|FG000|Overall Study|Withdrawal by Subject|3|||
162684785|NCT04899245|587556046|FG001|Overall Study|Withdrawal by Subject|5|||
162684786|NCT04899245|587556047|FG002|Overall Study|Withdrawal by Subject|2|||
162684787|NCT04899245|587556045|FG000|Overall Study|No longer eligible - Left staff position|0|||
162684788|NCT04899245|587556046|FG001|Overall Study|No longer eligible - Left staff position|0|||
162684789|NCT04899245|587556047|FG002|Overall Study|No longer eligible - Left staff position|1|||
162684790|NCT04899245|587556045|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
162684791|NCT04899245|587556046|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
162684792|NCT04899245|587556047|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
162684793|NCT04899245|587556045|FG000|Overall Study|No longer eligible - Moved away from area|2|||
162684794|NCT04899245|587556046|FG001|Overall Study|No longer eligible - Moved away from area|2|||
162684795|NCT04899245|587556047|FG002|Overall Study|No longer eligible - Moved away from area|0|||
162684796|NCT02790073|587558028|FG000|Overall Study|Death|1|||
162726160|NCT02652260|587708188|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
162726161|NCT02652260|587708189|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
162726162|NCT02652260|587708188|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
162726163|NCT02652260|587708189|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
162726164|NCT02652260|587708188|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
162726165|NCT02652260|587708189|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
162726166|NCT02652260|587708188|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
162726167|NCT02652260|587708189|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
162726168|NCT02652260|587708188|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
162726169|NCT02652260|587708189|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
162726170|NCT02652260|587708188|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
162726171|NCT02652260|587708189|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
162726172|NCT02652260|587708188|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
162726173|NCT02652260|587708189|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
162726174|NCT02652260|587708188|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
162726175|NCT02652260|587708189|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
162726176|NCT02652260|587708188|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
162726177|NCT02652260|587708189|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
162726178|NCT02652260|587708188|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
162726179|NCT02652260|587708189|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
162726180|NCT02652260|587708188|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
162726181|NCT02652260|587708189|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
162726182|NCT02652260|587708188|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
162726183|NCT02652260|587708189|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
162726184|NCT04300647|587708190|FG000|Pre-Crossover|Death|19|||
162726185|NCT04300647|587708191|FG001|Pre-Crossover|Death|58|||
162726186|NCT04300647|587708192|FG002|Pre-Crossover|Death|0|||
162726187|NCT04300647|587708190|FG000|Pre-Crossover|Lost to Follow-up|0|||
162726188|NCT04300647|587708191|FG001|Pre-Crossover|Lost to Follow-up|3|||
162726189|NCT04300647|587708192|FG002|Pre-Crossover|Lost to Follow-up|0|||
162726190|NCT04300647|587708190|FG000|Pre-Crossover|Withdrawal by Subject|2|||
162726191|NCT04300647|587708191|FG001|Pre-Crossover|Withdrawal by Subject|4|||
162726192|NCT04300647|587708192|FG002|Pre-Crossover|Withdrawal by Subject|0|||
162726193|NCT04300647|587708190|FG000|Pre-Crossover|On-going in Study|24|||
162726194|NCT04300647|587708191|FG001|Pre-Crossover|On-going in Study|61|||
162726195|NCT04300647|587708192|FG002|Pre-Crossover|On-going in Study|0|||
162726196|NCT04300647|587708190|FG000|Post-Crossover|Death|0|||
162684797|NCT02790073|587558028|FG000|Overall Study|Withdrawal from HD|1|||
162684798|NCT02790073|587558028|FG000|Overall Study|Withdrawal by Subject|1|||
162684799|NCT00514683|587558029|FG000|Overall Study|Not treated|2|||
162684800|NCT00514683|587558030|FG001|Overall Study|Not treated|1|||
162684801|NCT00514683|587558031|FG002|Overall Study|Not treated|0|||
162684802|NCT00514683|587558032|FG003|Overall Study|Not treated|0|||
162684803|NCT00514683|587558033|FG004|Overall Study|Not treated|1|||
162684804|NCT00514683|587558029|FG000|Overall Study|Adverse Event|21|||
162684805|NCT00514683|587558030|FG001|Overall Study|Adverse Event|20|||
162684806|NCT00514683|587558031|FG002|Overall Study|Adverse Event|15|||
162684807|NCT00514683|587558032|FG003|Overall Study|Adverse Event|13|||
162684808|NCT00514683|587558033|FG004|Overall Study|Adverse Event|27|||
162684809|NCT00514683|587558029|FG000|Overall Study|Protocol Violation|1|||
162684810|NCT00514683|587558030|FG001|Overall Study|Protocol Violation|1|||
162684811|NCT00514683|587558031|FG002|Overall Study|Protocol Violation|0|||
162684812|NCT00514683|587558032|FG003|Overall Study|Protocol Violation|1|||
162726197|NCT04300647|587708191|FG001|Post-Crossover|Death|0|||
162726198|NCT04300647|587708192|FG002|Post-Crossover|Death|3|||
162726199|NCT04300647|587708190|FG000|Post-Crossover|Lost to Follow-up|0|||
162684813|NCT00514683|587558033|FG004|Overall Study|Protocol Violation|0|||
162726200|NCT04300647|587708191|FG001|Post-Crossover|Lost to Follow-up|0|||
162726201|NCT04300647|587708192|FG002|Post-Crossover|Lost to Follow-up|1|||
162726202|NCT04300647|587708190|FG000|Post-Crossover|Withdrawal by Subject|0|||
162726203|NCT04300647|587708191|FG001|Post-Crossover|Withdrawal by Subject|0|||
162684814|NCT00514683|587558029|FG000|Overall Study|Withdrawal by Subject|2|||
162726204|NCT04300647|587708192|FG002|Post-Crossover|Withdrawal by Subject|1|||
162726205|NCT04300647|587708190|FG000|Post-Crossover|On-going in Study|0|||
162684815|NCT00514683|587558030|FG001|Overall Study|Withdrawal by Subject|2|||
162684816|NCT00514683|587558031|FG002|Overall Study|Withdrawal by Subject|1|||
162684817|NCT00514683|587558032|FG003|Overall Study|Withdrawal by Subject|0|||
162684818|NCT00514683|587558033|FG004|Overall Study|Withdrawal by Subject|4|||
162684819|NCT00514683|587558029|FG000|Overall Study|Reason other than listed above|0|||
162684820|NCT00514683|587558030|FG001|Overall Study|Reason other than listed above|1|||
162684821|NCT00514683|587558031|FG002|Overall Study|Reason other than listed above|2|||
162684822|NCT00514683|587558032|FG003|Overall Study|Reason other than listed above|0|||
162726206|NCT04300647|587708191|FG001|Post-Crossover|On-going in Study|0|||
162726207|NCT04300647|587708192|FG002|Post-Crossover|On-going in Study|8|||
162726208|NCT05056246|587708193|FG000|Overall Study|Adverse Event|0|||
162726209|NCT05056246|587708194|FG001|Overall Study|Adverse Event|0|||
162684823|NCT00514683|587558033|FG004|Overall Study|Reason other than listed above|1|||
162684824|NCT00643123|587558036|FG000|Overall Study|Lost to Follow-up|4|||
162684825|NCT00643123|587558037|FG001|Overall Study|Lost to Follow-up|0|||
162684826|NCT00643123|587558036|FG000|Overall Study|Withdrawal by Subject|1|||
162684827|NCT00643123|587558037|FG001|Overall Study|Withdrawal by Subject|1|||
162684828|NCT01896869|587558039|FG000|Overall Study|Withdrawal by Subject|0|||
162684829|NCT01896869|587558040|FG001|Overall Study|Withdrawal by Subject|6|||
162684830|NCT01896869|587558039|FG000|Overall Study|Lost to Follow-up|1|||
162684831|NCT01896869|587558040|FG001|Overall Study|Lost to Follow-up|0|||
162684832|NCT00454571|587558047|FG000|Overall Study|Adverse Event|2|||
162684833|NCT00454571|587558048|FG001|Overall Study|Adverse Event|0|||
162684834|NCT00454571|587558047|FG000|Overall Study|Physician Decision|0|||
162684835|NCT00454571|587558048|FG001|Overall Study|Physician Decision|1|||
162684836|NCT00454571|587558047|FG000|Overall Study|Protocol Violation|1|||
162684837|NCT00454571|587558048|FG001|Overall Study|Protocol Violation|0|||
162684838|NCT00454571|587558047|FG000|Overall Study|Withdrawal by Subject|10|||
162684839|NCT00454571|587558048|FG001|Overall Study|Withdrawal by Subject|5|||
162684840|NCT01376323|587558049|FG000|Overall Study|Adverse Event|1|||
162684841|NCT01376323|587558050|FG001|Overall Study|Adverse Event|0|||
162684842|NCT01376323|587558051|FG002|Overall Study|Adverse Event|0|||
162684843|NCT01376323|587558052|FG003|Overall Study|Adverse Event|2|||
162684844|NCT01376323|587558053|FG004|Overall Study|Adverse Event|0|||
162684845|NCT01376323|587558049|FG000|Overall Study|Lost to Follow-up|0|||
162684846|NCT01376323|587558050|FG001|Overall Study|Lost to Follow-up|0|||
162684847|NCT01376323|587558051|FG002|Overall Study|Lost to Follow-up|0|||
162684848|NCT01376323|587558052|FG003|Overall Study|Lost to Follow-up|2|||
162684849|NCT01376323|587558053|FG004|Overall Study|Lost to Follow-up|0|||
162684850|NCT01376323|587558049|FG000|Overall Study|Physician Decision|1|||
162684851|NCT01376323|587558050|FG001|Overall Study|Physician Decision|0|||
162684852|NCT01376323|587558051|FG002|Overall Study|Physician Decision|2|||
162684853|NCT01376323|587558052|FG003|Overall Study|Physician Decision|1|||
162684854|NCT01376323|587558053|FG004|Overall Study|Physician Decision|1|||
162684855|NCT01376323|587558049|FG000|Overall Study|Withdrawal by Subject|0|||
162684856|NCT01376323|587558050|FG001|Overall Study|Withdrawal by Subject|1|||
162684857|NCT01376323|587558051|FG002|Overall Study|Withdrawal by Subject|1|||
162684858|NCT01376323|587558052|FG003|Overall Study|Withdrawal by Subject|0|||
162684859|NCT01376323|587558053|FG004|Overall Study|Withdrawal by Subject|0|||
162684860|NCT04681729|587558054|FG000|Overall Study|Lack of Efficacy|2|||
162684861|NCT04681729|587558055|FG001|Overall Study|Lack of Efficacy|2|||
162684862|NCT04681729|587558054|FG000|Overall Study|Withdrawal by Subject|8|||
162684863|NCT04681729|587558055|FG001|Overall Study|Withdrawal by Subject|9|||
162684864|NCT02436811|587558056|FG000|Overall Study|Lost to Follow-up|2|||
162684865|NCT02436811|587558057|FG001|Overall Study|Lost to Follow-up|9|||
162684866|NCT02436811|587558058|FG002|Overall Study|Lost to Follow-up|7|||
162684867|NCT00792103|587558059|FG000|Overall Study|Enrolled, not treated|15|||
162684868|NCT00792103|587558059|FG000|Overall Study|Lost to Follow-up|17|||
162684869|NCT00792103|587558059|FG000|Overall Study|Adverse Event|25|||
162684870|NCT00792103|587558059|FG000|Overall Study|Withdrawal by Subject|52|||
162684871|NCT00792103|587558059|FG000|Overall Study|Protocol Violation|10|||
162684872|NCT00792103|587558059|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
162684873|NCT02856113|587558060|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162684874|NCT02856113|587558061|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162684875|NCT02856113|587558060|FG000|Overall Study|Significant Protocol Deviation|1|||
162684876|NCT02856113|587558061|FG001|Overall Study|Significant Protocol Deviation|0|||
162684877|NCT02856113|587558060|FG000|Overall Study|Lost to Follow-up|3|||
162684878|NCT02856113|587558061|FG001|Overall Study|Lost to Follow-up|5|||
162684879|NCT02856113|587558060|FG000|Overall Study|Voluntary Withdrawal|3|||
162684880|NCT02856113|587558061|FG001|Overall Study|Voluntary Withdrawal|5|||
162684881|NCT02856113|587558060|FG000|Overall Study|Pregnancy|0|||
162684882|NCT02856113|587558061|FG001|Overall Study|Pregnancy|1|||
162684883|NCT02856113|587558060|FG000|Overall Study|Principal Investigator Discretion|2|||
162684884|NCT02856113|587558061|FG001|Overall Study|Principal Investigator Discretion|1|||
162684885|NCT02856113|587558060|FG000|Overall Study|Randomized but not Treated|1|||
162684886|NCT02856113|587558061|FG001|Overall Study|Randomized but not Treated|0|||
162684887|NCT02856113|587558060|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
162684888|NCT02856113|587558061|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
162684889|NCT03494166|587558062|FG000|Overall Study|Death|0|||
162684890|NCT03494166|587558063|FG001|Overall Study|Death|0|||
162684891|NCT03494166|587558064|FG002|Overall Study|Death|0|||
162684892|NCT03494166|587558065|FG003|Overall Study|Death|1|||
162684893|NCT03494166|587558066|FG004|Overall Study|Death|3|||
162684894|NCT03494166|587558067|FG005|Overall Study|Death|0|||
162684895|NCT03494166|587558062|FG000|Overall Study|Lost to Follow-up|2|||
162684896|NCT03494166|587558063|FG001|Overall Study|Lost to Follow-up|2|||
162684897|NCT03494166|587558064|FG002|Overall Study|Lost to Follow-up|2|||
162684898|NCT03494166|587558065|FG003|Overall Study|Lost to Follow-up|2|||
162684899|NCT03494166|587558066|FG004|Overall Study|Lost to Follow-up|14|||
162684900|NCT03494166|587558067|FG005|Overall Study|Lost to Follow-up|0|||
162684901|NCT03494166|587558062|FG000|Overall Study|Withdrawal by Subject|10|||
162684902|NCT03494166|587558063|FG001|Overall Study|Withdrawal by Subject|7|||
162684903|NCT03494166|587558064|FG002|Overall Study|Withdrawal by Subject|0|||
162684904|NCT03494166|587558065|FG003|Overall Study|Withdrawal by Subject|5|||
162684905|NCT03494166|587558066|FG004|Overall Study|Withdrawal by Subject|3|||
162684906|NCT03494166|587558067|FG005|Overall Study|Withdrawal by Subject|17|||
162684907|NCT03494166|587558062|FG000|Overall Study|Screen failure|1|||
162684908|NCT03494166|587558063|FG001|Overall Study|Screen failure|0|||
162684909|NCT03494166|587558064|FG002|Overall Study|Screen failure|0|||
162684910|NCT03494166|587558065|FG003|Overall Study|Screen failure|0|||
162684911|NCT03494166|587558066|FG004|Overall Study|Screen failure|1|||
162684912|NCT03494166|587558067|FG005|Overall Study|Screen failure|0|||
162684913|NCT02110901|587558072|FG000|Overall Study|Death|6|||
162684914|NCT02110901|587558073|FG001|Overall Study|Death|3|||
162684915|NCT02110901|587558072|FG000|Overall Study|Lost to Follow-up|12|||
162684916|NCT02110901|587558073|FG001|Overall Study|Lost to Follow-up|8|||
162684917|NCT02110901|587558072|FG000|Overall Study|Withdrawal by Subject|7|||
162684918|NCT02110901|587558073|FG001|Overall Study|Withdrawal by Subject|3|||
162684919|NCT02110901|587558072|FG000|Overall Study|received a kidney transplant|5|||
162684920|NCT02110901|587558073|FG001|Overall Study|received a kidney transplant|0|||
162684921|NCT00855595|587558075|FG000|Overall Study|Withdrawal by Subject|1|||
162684922|NCT00855595|587558076|FG001|Overall Study|Withdrawal by Subject|2|||
162684923|NCT00855595|587558075|FG000|Overall Study|Lost to Follow-up|3|||
162684924|NCT00855595|587558076|FG001|Overall Study|Lost to Follow-up|3|||
162684925|NCT00855595|587558075|FG000|Overall Study|Adverse Event|1|||
162684926|NCT00855595|587558076|FG001|Overall Study|Adverse Event|1|||
162684927|NCT00855595|587558075|FG000|Overall Study|patient moved out of state|1|||
162684928|NCT00855595|587558076|FG001|Overall Study|patient moved out of state|0|||
162684929|NCT00855595|587558075|FG000|Overall Study|patient left country|0|||
162684930|NCT00855595|587558076|FG001|Overall Study|patient left country|1|||
162684931|NCT01058304|587558078|FG000|Overall Study|Withdrawal by Subject|8|||
162684932|NCT01058304|587558079|FG001|Overall Study|Withdrawal by Subject|5|||
162684933|NCT01058304|587558078|FG000|Overall Study|Lost to Follow-up|13|||
162684934|NCT01058304|587558079|FG001|Overall Study|Lost to Follow-up|16|||
162684935|NCT01058304|587558078|FG000|Overall Study|Developed exclusion criterion|6|||
162684936|NCT01058304|587558079|FG001|Overall Study|Developed exclusion criterion|12|||
162684937|NCT01820559|587558080|FG000|Overall Study|Adverse Event|4|||
162684938|NCT01820559|587558081|FG001|Overall Study|Adverse Event|6|||
162684939|NCT01820559|587558082|FG002|Overall Study|Adverse Event|13|||
162684940|NCT01820559|587558080|FG000|Overall Study|Withdrawal by Subject|1|||
162684941|NCT01820559|587558081|FG001|Overall Study|Withdrawal by Subject|2|||
162684942|NCT01820559|587558082|FG002|Overall Study|Withdrawal by Subject|5|||
162684943|NCT01820559|587558080|FG000|Overall Study|Protocol Violation|2|||
162684944|NCT01820559|587558081|FG001|Overall Study|Protocol Violation|1|||
162684945|NCT01820559|587558082|FG002|Overall Study|Protocol Violation|3|||
162684946|NCT01820559|587558080|FG000|Overall Study|Subject's non-compliance|1|||
162684947|NCT01820559|587558081|FG001|Overall Study|Subject's non-compliance|0|||
162684948|NCT01820559|587558082|FG002|Overall Study|Subject's non-compliance|2|||
162684949|NCT01820559|587558080|FG000|Overall Study|Lost to Follow-up|3|||
162684950|NCT01820559|587558081|FG001|Overall Study|Lost to Follow-up|2|||
162684951|NCT01820559|587558082|FG002|Overall Study|Lost to Follow-up|2|||
162684952|NCT01820559|587558080|FG000|Overall Study|At sponsor request|0|||
162684953|NCT01820559|587558081|FG001|Overall Study|At sponsor request|0|||
162684954|NCT01820559|587558082|FG002|Overall Study|At sponsor request|1|||
162684955|NCT01820559|587558080|FG000|Overall Study|Lack of Efficacy|3|||
162684956|NCT01820559|587558081|FG001|Overall Study|Lack of Efficacy|2|||
162684957|NCT01820559|587558082|FG002|Overall Study|Lack of Efficacy|3|||
162684958|NCT02496767|587558083|FG000|Open-label Lead-in Phase|Adverse Event|176|||
162684959|NCT02496767|587558084|FG001|Open-label Lead-in Phase|Adverse Event|0|||
162684960|NCT02496767|587558085|FG002|Open-label Lead-in Phase|Adverse Event|0|||
162684961|NCT02496767|587558086|FG003|Open-label Lead-in Phase|Adverse Event|0|||
162684962|NCT02496767|587558087|FG004|Open-label Lead-in Phase|Adverse Event|0|||
162684963|NCT02496767|587558088|FG005|Open-label Lead-in Phase|Adverse Event|0|||
162684964|NCT02496767|587558089|FG006|Open-label Lead-in Phase|Adverse Event|0|||
162684965|NCT02496767|587558090|FG007|Open-label Lead-in Phase|Adverse Event|0|||
162684966|NCT02496767|587558083|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
162684967|NCT02496767|587558084|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
162684968|NCT02496767|587558085|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
162684969|NCT02496767|587558086|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
162684970|NCT02496767|587558087|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
162684971|NCT02496767|587558088|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
162684972|NCT02496767|587558089|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
162684973|NCT02496767|587558090|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
162684974|NCT02496767|587558083|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
162684975|NCT02496767|587558084|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684976|NCT02496767|587558085|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
162726210|NCT05056246|587708195|FG002|Overall Study|Adverse Event|0|||
162684977|NCT02496767|587558086|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684978|NCT02496767|587558087|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684979|NCT02496767|587558088|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684980|NCT02496767|587558089|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684981|NCT02496767|587558090|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
162684982|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162684983|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
162684984|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
162684985|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
162684986|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
162684987|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162684988|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162684989|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162684990|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162684991|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
162684992|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
162684993|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
162684994|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
162684995|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162684996|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162684997|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162684998|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
162684999|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
162685000|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
162685001|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
162685002|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
162685003|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
162685004|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
162685005|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
162685006|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
162685007|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
162685008|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
162685009|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
162685010|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
162685011|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
162685012|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
162685013|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
162685014|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162685015|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
162685016|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
162685017|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
162685018|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
162685019|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162685020|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162685021|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162685022|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685023|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
162685024|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
162685025|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685026|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685027|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685028|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685029|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162685030|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162685031|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
162685032|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162685033|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
162685034|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
162685035|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162685036|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162685037|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162685038|NCT02496767|587558083|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685039|NCT02496767|587558084|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
162685040|NCT02496767|587558085|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685041|NCT02496767|587558086|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685042|NCT02496767|587558087|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685043|NCT02496767|587558088|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685044|NCT02496767|587558089|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685045|NCT02496767|587558090|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162685046|NCT02496767|587558083|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685047|NCT02496767|587558084|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685048|NCT02496767|587558085|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685049|NCT02496767|587558086|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685050|NCT02496767|587558087|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685051|NCT02496767|587558088|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
162685052|NCT02496767|587558089|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
162685053|NCT02496767|587558090|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
162685054|NCT02496767|587558083|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
162685055|NCT02496767|587558084|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
162685056|NCT02496767|587558085|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
162685057|NCT02496767|587558086|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
162685058|NCT02496767|587558087|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
162685059|NCT02496767|587558088|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
162685060|NCT02496767|587558089|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
162685061|NCT02496767|587558090|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
162685062|NCT02496767|587558083|FG000|Double-blind, Withdrawal Phase|Death|0|||
162685063|NCT02496767|587558084|FG001|Double-blind, Withdrawal Phase|Death|0|||
162685064|NCT02496767|587558085|FG002|Double-blind, Withdrawal Phase|Death|0|||
162685065|NCT02496767|587558086|FG003|Double-blind, Withdrawal Phase|Death|0|||
162685066|NCT02496767|587558087|FG004|Double-blind, Withdrawal Phase|Death|0|||
162685067|NCT02496767|587558088|FG005|Double-blind, Withdrawal Phase|Death|0|||
162685068|NCT02496767|587558089|FG006|Double-blind, Withdrawal Phase|Death|1|||
162685069|NCT02496767|587558090|FG007|Double-blind, Withdrawal Phase|Death|2|||
162685070|NCT02496767|587558083|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162685071|NCT02496767|587558084|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162685072|NCT02496767|587558085|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162685073|NCT02496767|587558086|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162685074|NCT02496767|587558087|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162685075|NCT02496767|587558088|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162685076|NCT02496767|587558089|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162685077|NCT02496767|587558090|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162685078|NCT00166296|587558091|FG000|Overall Study|Withdrawal by Subject|1|||
162685079|NCT00166296|587558092|FG001|Overall Study|Withdrawal by Subject|3|||
162685080|NCT00166296|587558091|FG000|Overall Study|Adverse Event|2|||
162685081|NCT00166296|587558092|FG001|Overall Study|Adverse Event|4|||
162685082|NCT00166296|587558091|FG000|Overall Study|Lost to Follow-up|4|||
162685083|NCT00166296|587558092|FG001|Overall Study|Lost to Follow-up|2|||
162685084|NCT04035200|587558098|FG000|Overall Study|Lost to Follow-up|0|||
162685085|NCT04035200|587558099|FG001|Overall Study|Lost to Follow-up|1|||
162685086|NCT04035200|587558100|FG002|Overall Study|Lost to Follow-up|0|||
162685087|NCT04035200|587558098|FG000|Overall Study|Withdrawal by Subject|1|||
162685088|NCT04035200|587558099|FG001|Overall Study|Withdrawal by Subject|4|||
162685089|NCT04035200|587558100|FG002|Overall Study|Withdrawal by Subject|4|||
162685090|NCT04035200|587558098|FG000|Overall Study|COVID-19|1|||
162685091|NCT04035200|587558099|FG001|Overall Study|COVID-19|0|||
162685092|NCT04035200|587558100|FG002|Overall Study|COVID-19|0|||
162685093|NCT04035200|587558098|FG000|Overall Study|Early Termination|0|||
162685094|NCT04035200|587558099|FG001|Overall Study|Early Termination|1|||
162685095|NCT04035200|587558100|FG002|Overall Study|Early Termination|0|||
162685096|NCT04035200|587558098|FG000|Overall Study|Non-compliance|0|||
162685097|NCT04035200|587558099|FG001|Overall Study|Non-compliance|1|||
162685098|NCT04035200|587558100|FG002|Overall Study|Non-compliance|0|||
162685099|NCT02277990|587558101|FG000|Overall Study|Death|170|||
162685100|NCT02277990|587558102|FG001|Overall Study|Death|188|||
162685101|NCT02277990|587558101|FG000|Overall Study|Withdrawal by Subject|64|||
162685102|NCT02277990|587558102|FG001|Overall Study|Withdrawal by Subject|53|||
162685103|NCT02277990|587558101|FG000|Overall Study|Physician Decision|40|||
162685104|NCT02277990|587558102|FG001|Overall Study|Physician Decision|34|||
162685105|NCT02277990|587558101|FG000|Overall Study|Lost to Follow-up|66|||
162685106|NCT02277990|587558102|FG001|Overall Study|Lost to Follow-up|69|||
162685107|NCT02277990|587558101|FG000|Overall Study|Had other reason|26|||
162685108|NCT02277990|587558102|FG001|Overall Study|Had other reason|32|||
162685109|NCT04581200|587558103|FG000|Overall Study|Lost to Follow-up|6|||
162685110|NCT04581200|587558104|FG001|Overall Study|Lost to Follow-up|5|||
162685111|NCT04711603|587558105|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
162685112|NCT04711603|587558106|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
162685113|NCT04711603|587558107|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
162685114|NCT04711603|587558108|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
162685115|NCT04711603|587558105|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162685116|NCT04711603|587558106|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
162685117|NCT04711603|587558107|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162685118|NCT04711603|587558108|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162685119|NCT04711603|587558105|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162685120|NCT04711603|587558106|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
162685121|NCT04711603|587558107|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162685122|NCT04711603|587558108|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162685123|NCT04711603|587558105|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162685124|NCT04711603|587558106|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
162685125|NCT04711603|587558107|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162685126|NCT04711603|587558108|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162685127|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
162685128|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
162685129|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
162685130|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
162685131|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162685132|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162685133|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162685134|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
162685135|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
162685136|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
162685137|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
162685138|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
162685139|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
162685140|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
162685141|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
162685142|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
162685143|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162685144|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162685145|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162685146|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
162685147|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162685148|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162685149|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162685150|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
162685151|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162685152|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162685153|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162685154|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
162685155|NCT04711603|587558105|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162685156|NCT04711603|587558106|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162685157|NCT04711603|587558107|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
162685158|NCT04711603|587558108|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162685159|NCT03351738|587558109|FG000|Overall Study|Withdrawal by Subject|0|||
162685160|NCT03351738|587558110|FG001|Overall Study|Withdrawal by Subject|1|||
162685161|NCT03351738|587558111|FG002|Overall Study|Withdrawal by Subject|0|||
162685162|NCT03351738|587558112|FG003|Overall Study|Withdrawal by Subject|1|||
162685163|NCT03351738|587558113|FG004|Overall Study|Withdrawal by Subject|0|||
162685164|NCT03351738|587558114|FG005|Overall Study|Withdrawal by Subject|0|||
162685165|NCT01089374|587558119|FG000|Overall Study|Lost to Follow-up|3|||
162685166|NCT01089374|587558120|FG001|Overall Study|Lost to Follow-up|0|||
162685167|NCT01089374|587558119|FG000|Overall Study|Withdrawal by Subject|1|||
162685168|NCT01089374|587558120|FG001|Overall Study|Withdrawal by Subject|0|||
162685169|NCT01089374|587558119|FG000|Overall Study|Study closed early - low accrual|6|||
162685170|NCT01089374|587558120|FG001|Overall Study|Study closed early - low accrual|0|||
162685171|NCT02597036|587558131|FG000|Overall Study|Progressive Disease|0|||
162685172|NCT02597036|587558132|FG001|Overall Study|Progressive Disease|0|||
162685173|NCT02597036|587558133|FG002|Overall Study|Progressive Disease|0|||
162685174|NCT02597036|587558134|FG003|Overall Study|Progressive Disease|0|||
162685175|NCT02597036|587558135|FG004|Overall Study|Progressive Disease|1|||
162685176|NCT02597036|587558136|FG005|Overall Study|Progressive Disease|1|||
162685177|NCT02597036|587558137|FG006|Overall Study|Progressive Disease|1|||
162685178|NCT02597036|587558138|FG007|Overall Study|Progressive Disease|0|||
162685179|NCT02597036|587558139|FG008|Overall Study|Progressive Disease|0|||
162685180|NCT02597036|587558140|FG009|Overall Study|Progressive Disease|0|||
162685181|NCT02597036|587558141|FG010|Overall Study|Progressive Disease|0|||
162685182|NCT02597036|587558142|FG011|Overall Study|Progressive Disease|0|||
162685183|NCT02597036|587558131|FG000|Overall Study|Adverse Event|0|||
162685184|NCT02597036|587558132|FG001|Overall Study|Adverse Event|0|||
162685185|NCT02597036|587558133|FG002|Overall Study|Adverse Event|0|||
162685186|NCT02597036|587558134|FG003|Overall Study|Adverse Event|0|||
162685187|NCT02597036|587558135|FG004|Overall Study|Adverse Event|0|||
162685188|NCT02597036|587558136|FG005|Overall Study|Adverse Event|0|||
162685189|NCT02597036|587558137|FG006|Overall Study|Adverse Event|0|||
162685190|NCT02597036|587558138|FG007|Overall Study|Adverse Event|1|||
162685191|NCT02597036|587558139|FG008|Overall Study|Adverse Event|0|||
162685192|NCT02597036|587558140|FG009|Overall Study|Adverse Event|0|||
162685193|NCT02597036|587558141|FG010|Overall Study|Adverse Event|0|||
162685194|NCT02597036|587558142|FG011|Overall Study|Adverse Event|1|||
162685195|NCT02597036|587558131|FG000|Overall Study|Death|0|||
162685196|NCT02597036|587558132|FG001|Overall Study|Death|0|||
162685197|NCT02597036|587558133|FG002|Overall Study|Death|0|||
162685198|NCT02597036|587558134|FG003|Overall Study|Death|0|||
162685199|NCT02597036|587558135|FG004|Overall Study|Death|0|||
162685200|NCT02597036|587558136|FG005|Overall Study|Death|0|||
162685201|NCT02597036|587558137|FG006|Overall Study|Death|0|||
162685202|NCT02597036|587558138|FG007|Overall Study|Death|0|||
162685203|NCT02597036|587558139|FG008|Overall Study|Death|0|||
162685204|NCT02597036|587558140|FG009|Overall Study|Death|1|||
162685205|NCT02597036|587558141|FG010|Overall Study|Death|1|||
162685206|NCT02597036|587558142|FG011|Overall Study|Death|0|||
162685207|NCT02597036|587558131|FG000|Overall Study|Lost to Follow-up|0|||
162685208|NCT02597036|587558132|FG001|Overall Study|Lost to Follow-up|0|||
162685209|NCT02597036|587558133|FG002|Overall Study|Lost to Follow-up|0|||
162685210|NCT02597036|587558134|FG003|Overall Study|Lost to Follow-up|0|||
162685211|NCT02597036|587558135|FG004|Overall Study|Lost to Follow-up|0|||
162685212|NCT02597036|587558136|FG005|Overall Study|Lost to Follow-up|0|||
162685213|NCT02597036|587558137|FG006|Overall Study|Lost to Follow-up|0|||
162685214|NCT02597036|587558138|FG007|Overall Study|Lost to Follow-up|0|||
162685215|NCT02597036|587558139|FG008|Overall Study|Lost to Follow-up|0|||
162685216|NCT02597036|587558140|FG009|Overall Study|Lost to Follow-up|0|||
162685217|NCT02597036|587558141|FG010|Overall Study|Lost to Follow-up|1|||
162685218|NCT02597036|587558142|FG011|Overall Study|Lost to Follow-up|0|||
162685219|NCT02597036|587558131|FG000|Overall Study|Withdrawal by Subject|0|||
162685220|NCT02597036|587558132|FG001|Overall Study|Withdrawal by Subject|0|||
162685221|NCT02597036|587558133|FG002|Overall Study|Withdrawal by Subject|0|||
162685222|NCT02597036|587558134|FG003|Overall Study|Withdrawal by Subject|0|||
162685223|NCT02597036|587558135|FG004|Overall Study|Withdrawal by Subject|0|||
162685224|NCT02597036|587558136|FG005|Overall Study|Withdrawal by Subject|0|||
162685225|NCT02597036|587558137|FG006|Overall Study|Withdrawal by Subject|0|||
162685226|NCT02597036|587558138|FG007|Overall Study|Withdrawal by Subject|0|||
162685227|NCT02597036|587558139|FG008|Overall Study|Withdrawal by Subject|0|||
162685228|NCT02597036|587558140|FG009|Overall Study|Withdrawal by Subject|0|||
162685229|NCT02597036|587558141|FG010|Overall Study|Withdrawal by Subject|0|||
162685230|NCT02597036|587558142|FG011|Overall Study|Withdrawal by Subject|1|||
162685231|NCT01533493|587558145|FG000|Overall Study|Adverse Event|2|||
162685232|NCT01533493|587558146|FG001|Overall Study|Adverse Event|1|||
162685233|NCT01533493|587558145|FG000|Overall Study|Withdrawal by Subject|1|||
162685234|NCT01533493|587558146|FG001|Overall Study|Withdrawal by Subject|2|||
162685235|NCT01533493|587558145|FG000|Overall Study|Lost to Follow-up|2|||
162685236|NCT01533493|587558146|FG001|Overall Study|Lost to Follow-up|0|||
162685237|NCT05163522|587558152|FG000|Overall Study|Withdrawal by Subject|0|||
162685238|NCT05163522|587558153|FG001|Overall Study|Withdrawal by Subject|0|||
162685239|NCT05163522|587558154|FG002|Overall Study|Withdrawal by Subject|1|||
162685240|NCT05163522|587558155|FG003|Overall Study|Withdrawal by Subject|0|||
162685241|NCT05163522|587558156|FG004|Overall Study|Withdrawal by Subject|0|||
162685242|NCT05163522|587558157|FG005|Overall Study|Withdrawal by Subject|0|||
162685243|NCT05163522|587558158|FG006|Overall Study|Withdrawal by Subject|0|||
162685244|NCT05163522|587558159|FG007|Overall Study|Withdrawal by Subject|0|||
162685245|NCT05163522|587558160|FG008|Overall Study|Withdrawal by Subject|0|||
162685246|NCT05163522|587558161|FG009|Overall Study|Withdrawal by Subject|0|||
162685247|NCT05163522|587558162|FG010|Overall Study|Withdrawal by Subject|0|||
162685248|NCT04672941|587558167|FG000|Overall Study|Investigator decision|1|||
162685249|NCT04672941|587558167|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
162685250|NCT04672941|587558167|FG000|Overall Study|COVID-19 related but no adverse event|1|||
162685251|NCT04672941|587558167|FG000|Overall Study|Adverse Event|2|||
162685252|NCT04672941|587558167|FG000|Overall Study|Lost to Follow-up|2|||
162685253|NCT00386022|587558173|FG000|Plus Estrogen|Lost to Follow-up|2|||
162685254|NCT00386022|587558174|FG001|Plus Estrogen|Lost to Follow-up|0|||
162685255|NCT00386022|587558173|FG000|Plus Estrogen|Adverse Event|0|||
162685256|NCT00386022|587558174|FG001|Plus Estrogen|Adverse Event|1|||
162685257|NCT00504426|587558177|FG000|Overall Study|Adverse Event|0|||
162685258|NCT00504426|587558178|FG001|Overall Study|Adverse Event|0|||
162685259|NCT00504426|587558179|FG002|Overall Study|Adverse Event|2|||
162685260|NCT00504426|587558180|FG003|Overall Study|Adverse Event|0|||
162685261|NCT00504426|587558177|FG000|Overall Study|Protocol Violation|1|||
162685262|NCT00504426|587558178|FG001|Overall Study|Protocol Violation|1|||
162685263|NCT00504426|587558179|FG002|Overall Study|Protocol Violation|2|||
162685264|NCT00504426|587558180|FG003|Overall Study|Protocol Violation|0|||
162685265|NCT00504426|587558177|FG000|Overall Study|Withdrawal by Subject|2|||
162685266|NCT00504426|587558178|FG001|Overall Study|Withdrawal by Subject|0|||
162685267|NCT00504426|587558179|FG002|Overall Study|Withdrawal by Subject|0|||
162685268|NCT00504426|587558180|FG003|Overall Study|Withdrawal by Subject|0|||
162685269|NCT03685591|587558184|FG000|Overall Study|Global Deterioration of Health Status|0|||
162685270|NCT03685591|587558185|FG001|Overall Study|Global Deterioration of Health Status|0|||
162685271|NCT03685591|587558186|FG002|Overall Study|Global Deterioration of Health Status|0|||
162685272|NCT03685591|587558187|FG003|Overall Study|Global Deterioration of Health Status|1|||
162685273|NCT03685591|587558188|FG004|Overall Study|Global Deterioration of Health Status|2|||
162685274|NCT03685591|587558189|FG005|Overall Study|Global Deterioration of Health Status|4|||
162685275|NCT03685591|587558190|FG006|Overall Study|Global Deterioration of Health Status|1|||
162685276|NCT03685591|587558191|FG007|Overall Study|Global Deterioration of Health Status|1|||
162685277|NCT03685591|587558192|FG008|Overall Study|Global Deterioration of Health Status|0|||
162685278|NCT03685591|587558184|FG000|Overall Study|Progressive Disease|1|||
162685279|NCT03685591|587558185|FG001|Overall Study|Progressive Disease|1|||
162685280|NCT03685591|587558186|FG002|Overall Study|Progressive Disease|0|||
162685281|NCT03685591|587558187|FG003|Overall Study|Progressive Disease|3|||
162685282|NCT03685591|587558188|FG004|Overall Study|Progressive Disease|5|||
162685283|NCT03685591|587558189|FG005|Overall Study|Progressive Disease|4|||
162685284|NCT03685591|587558190|FG006|Overall Study|Progressive Disease|3|||
162685285|NCT03685591|587558191|FG007|Overall Study|Progressive Disease|2|||
162685286|NCT03685591|587558192|FG008|Overall Study|Progressive Disease|1|||
162685287|NCT03685591|587558184|FG000|Overall Study|Other|0|||
162685288|NCT03685591|587558185|FG001|Overall Study|Other|0|||
162685289|NCT03685591|587558186|FG002|Overall Study|Other|1|||
162685290|NCT03685591|587558187|FG003|Overall Study|Other|0|||
162685291|NCT03685591|587558188|FG004|Overall Study|Other|2|||
162685292|NCT03685591|587558189|FG005|Overall Study|Other|3|||
162685293|NCT03685591|587558190|FG006|Overall Study|Other|0|||
162685294|NCT03685591|587558191|FG007|Overall Study|Other|0|||
162685295|NCT03685591|587558192|FG008|Overall Study|Other|0|||
162685296|NCT03685591|587558184|FG000|Overall Study|Withdrawal by Subject|0|||
162685297|NCT03685591|587558185|FG001|Overall Study|Withdrawal by Subject|0|||
162685298|NCT03685591|587558186|FG002|Overall Study|Withdrawal by Subject|0|||
162685299|NCT03685591|587558187|FG003|Overall Study|Withdrawal by Subject|0|||
162685300|NCT03685591|587558188|FG004|Overall Study|Withdrawal by Subject|3|||
162685301|NCT03685591|587558189|FG005|Overall Study|Withdrawal by Subject|2|||
162685302|NCT03685591|587558190|FG006|Overall Study|Withdrawal by Subject|0|||
162685303|NCT03685591|587558191|FG007|Overall Study|Withdrawal by Subject|0|||
162685304|NCT03685591|587558192|FG008|Overall Study|Withdrawal by Subject|1|||
162685305|NCT03685591|587558184|FG000|Overall Study|Adverse Event|0|||
162685306|NCT03685591|587558185|FG001|Overall Study|Adverse Event|0|||
162685307|NCT03685591|587558186|FG002|Overall Study|Adverse Event|0|||
162685308|NCT03685591|587558187|FG003|Overall Study|Adverse Event|1|||
162685309|NCT03685591|587558188|FG004|Overall Study|Adverse Event|1|||
162685310|NCT03685591|587558189|FG005|Overall Study|Adverse Event|4|||
162685311|NCT03685591|587558190|FG006|Overall Study|Adverse Event|0|||
162685312|NCT03685591|587558191|FG007|Overall Study|Adverse Event|1|||
162685313|NCT03685591|587558192|FG008|Overall Study|Adverse Event|1|||
162685314|NCT03988166|587558199|FG000|Overall Study|Lost to Follow-up|2|||
162685315|NCT03988166|587558199|FG000|Overall Study|Death|1|||
162685316|NCT03933826|587558201|FG000|Overall Study|Withdrawal by Subject|8|||
162685317|NCT03933826|587558202|FG001|Overall Study|Withdrawal by Subject|1|||
162685318|NCT03933826|587558201|FG000|Overall Study|Death|19|||
162685319|NCT03933826|587558202|FG001|Overall Study|Death|11|||
162685320|NCT03933826|587558201|FG000|Overall Study|Lost to Follow-up|41|||
162685321|NCT03933826|587558202|FG001|Overall Study|Lost to Follow-up|13|||
162685322|NCT02638948|587558203|FG000|Overall Study|Withdrawal by Subject|4|||
162685323|NCT02638948|587558204|FG001|Overall Study|Withdrawal by Subject|5|||
162685324|NCT02638948|587558205|FG002|Overall Study|Withdrawal by Subject|3|||
162685325|NCT02638948|587558206|FG003|Overall Study|Withdrawal by Subject|1|||
162685326|NCT02638948|587558203|FG000|Overall Study|Administrative Reason by Sponsor|0|||
162685327|NCT02638948|587558204|FG001|Overall Study|Administrative Reason by Sponsor|1|||
162685328|NCT02638948|587558205|FG002|Overall Study|Administrative Reason by Sponsor|0|||
162685329|NCT02638948|587558206|FG003|Overall Study|Administrative Reason by Sponsor|4|||
162685330|NCT02638948|587558203|FG000|Overall Study|Adverse Event|0|||
162685331|NCT02638948|587558204|FG001|Overall Study|Adverse Event|0|||
162685332|NCT02638948|587558205|FG002|Overall Study|Adverse Event|1|||
162685333|NCT02638948|587558206|FG003|Overall Study|Adverse Event|1|||
162685334|NCT02638948|587558203|FG000|Overall Study|Lack of Efficacy|1|||
162685335|NCT02638948|587558204|FG001|Overall Study|Lack of Efficacy|1|||
162685336|NCT02638948|587558205|FG002|Overall Study|Lack of Efficacy|0|||
162685337|NCT02638948|587558206|FG003|Overall Study|Lack of Efficacy|0|||
162685338|NCT02638948|587558203|FG000|Overall Study|Lost to Follow-up|0|||
162685339|NCT02638948|587558204|FG001|Overall Study|Lost to Follow-up|0|||
162685340|NCT02638948|587558205|FG002|Overall Study|Lost to Follow-up|1|||
162685341|NCT02638948|587558206|FG003|Overall Study|Lost to Follow-up|1|||
162685342|NCT02638948|587558203|FG000|Overall Study|Poor/Non-Compliance|0|||
162685343|NCT02638948|587558204|FG001|Overall Study|Poor/Non-Compliance|2|||
162685344|NCT02638948|587558205|FG002|Overall Study|Poor/Non-Compliance|1|||
162685345|NCT02638948|587558206|FG003|Overall Study|Poor/Non-Compliance|0|||
162685346|NCT02638948|587558203|FG000|Overall Study|Participant no longer met study criteria|0|||
162685347|NCT02638948|587558204|FG001|Overall Study|Participant no longer met study criteria|1|||
162685348|NCT02638948|587558205|FG002|Overall Study|Participant no longer met study criteria|0|||
162685349|NCT02638948|587558206|FG003|Overall Study|Participant no longer met study criteria|0|||
162685350|NCT02638948|587558203|FG000|Overall Study|Other than specified above|4|||
162685351|NCT02638948|587558204|FG001|Overall Study|Other than specified above|1|||
162685352|NCT02638948|587558205|FG002|Overall Study|Other than specified above|1|||
162685353|NCT02638948|587558206|FG003|Overall Study|Other than specified above|1|||
162685354|NCT04992546|587558207|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
162685355|NCT04992546|587558207|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
162685356|NCT04992546|587558207|FG000|Open-Label Treatment Period|Adverse Event|3|||
162685357|NCT04992546|587558207|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
162685358|NCT05007392|587558209|FG000|Overall Study|Randomized but not treated|1|||
162685359|NCT05007392|587558210|FG001|Overall Study|Randomized but not treated|2|||
162685360|NCT05007392|587558209|FG000|Overall Study|Other|5|||
162685361|NCT05007392|587558210|FG001|Overall Study|Other|4|||
162685362|NCT05007392|587558209|FG000|Overall Study|Lost to Follow-up|1|||
162685363|NCT05007392|587558210|FG001|Overall Study|Lost to Follow-up|2|||
162685364|NCT05007392|587558209|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
162685365|NCT05007392|587558210|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
162685366|NCT05007392|587558209|FG000|Overall Study|Use of prohibited concomitant drug|1|||
162685367|NCT05007392|587558210|FG001|Overall Study|Use of prohibited concomitant drug|1|||
162685368|NCT05007392|587558209|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
162685369|NCT05007392|587558210|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
162685370|NCT05007392|587558209|FG000|Overall Study|Adverse Event|10|||
162685371|NCT05007392|587558210|FG001|Overall Study|Adverse Event|6|||
162685372|NCT05007392|587558209|FG000|Overall Study|Participant choice|5|||
162685373|NCT05007392|587558210|FG001|Overall Study|Participant choice|10|||
162685374|NCT05007392|587558209|FG000|Overall Study|Withdrawal of consent|5|||
162685375|NCT05007392|587558210|FG001|Overall Study|Withdrawal of consent|4|||
162685376|NCT04058353|587558214|FG000|Overall Study|Adverse Event|2|||
162685377|NCT04058353|587558215|FG001|Overall Study|Adverse Event|1|||
162685378|NCT04058353|587558214|FG000|Overall Study|Physician Decision|1|||
162685379|NCT04058353|587558215|FG001|Overall Study|Physician Decision|0|||
162685380|NCT04058353|587558214|FG000|Overall Study|Other|1|||
162685381|NCT04058353|587558215|FG001|Overall Study|Other|0|||
162685382|NCT00316173|587558219|FG000|Run-in Phase|Adverse Event|1|||
162685383|NCT00316173|587558220|FG001|Run-in Phase|Adverse Event|0|||
162685384|NCT00316173|587558219|FG000|Run-in Phase|Protocol Violation|1|||
162685385|NCT00316173|587558220|FG001|Run-in Phase|Protocol Violation|0|||
162685386|NCT00316173|587558219|FG000|Run-in Phase|Study Follow-up Stopped|5|||
162685387|NCT00316173|587558220|FG001|Run-in Phase|Study Follow-up Stopped|0|||
162685388|NCT00316173|587558219|FG000|Treatment Phase|Adverse Event|0|||
162685389|NCT00316173|587558220|FG001|Treatment Phase|Adverse Event|1|||
162685390|NCT00316173|587558219|FG000|Treatment Phase|Lack of Efficacy|0|||
162685391|NCT00316173|587558220|FG001|Treatment Phase|Lack of Efficacy|3|||
162685392|NCT00316173|587558219|FG000|Treatment Phase|Lost to Follow-up|0|||
162685393|NCT00316173|587558220|FG001|Treatment Phase|Lost to Follow-up|3|||
162685394|NCT00316173|587558219|FG000|Treatment Phase|Withdrawal by Subject|0|||
162685395|NCT00316173|587558220|FG001|Treatment Phase|Withdrawal by Subject|1|||
162685396|NCT00316173|587558219|FG000|Treatment Phase|Study Follow-up Stopped|0|||
162685397|NCT00316173|587558220|FG001|Treatment Phase|Study Follow-up Stopped|34|||
162685398|NCT02390531|587558221|FG000|Overall Study|Death|0|||
162685399|NCT02390531|587558222|FG001|Overall Study|Death|2|||
162685400|NCT02390531|587558223|FG002|Overall Study|Death|0|||
162685401|NCT02390531|587558224|FG003|Overall Study|Death|1|||
162685402|NCT02390531|587558225|FG004|Overall Study|Death|0|||
162685403|NCT02390531|587558226|FG005|Overall Study|Death|0|||
162685404|NCT02390531|587558227|FG006|Overall Study|Death|0|||
162685405|NCT02390531|587558228|FG007|Overall Study|Death|1|||
162685406|NCT02390531|587558221|FG000|Overall Study|Protocol Violation|0|||
162685407|NCT02390531|587558222|FG001|Overall Study|Protocol Violation|0|||
162685408|NCT02390531|587558223|FG002|Overall Study|Protocol Violation|0|||
162685409|NCT02390531|587558224|FG003|Overall Study|Protocol Violation|0|||
162685410|NCT02390531|587558225|FG004|Overall Study|Protocol Violation|1|||
162685411|NCT02390531|587558226|FG005|Overall Study|Protocol Violation|0|||
162685412|NCT02390531|587558227|FG006|Overall Study|Protocol Violation|2|||
162685413|NCT02390531|587558228|FG007|Overall Study|Protocol Violation|0|||
162685414|NCT03764072|587558232|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162685415|NCT03764072|587558233|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162726211|NCT05056246|587708196|FG003|Overall Study|Adverse Event|0|||
162685416|NCT03764072|587558234|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
162685417|NCT03764072|587558235|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162685418|NCT03764072|587558236|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162685419|NCT03764072|587558237|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162685420|NCT03764072|587558232|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
162685421|NCT03764072|587558233|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
162685422|NCT03764072|587558234|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
162685423|NCT03764072|587558235|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
162685424|NCT03764072|587558236|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
162685425|NCT03764072|587558237|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
162685426|NCT03764072|587558232|FG000|Overall Study|Lost to Follow-up|0|||
162685427|NCT03764072|587558233|FG001|Overall Study|Lost to Follow-up|0|||
162685428|NCT03764072|587558234|FG002|Overall Study|Lost to Follow-up|0|||
162685429|NCT03764072|587558235|FG003|Overall Study|Lost to Follow-up|0|||
162685430|NCT03764072|587558236|FG004|Overall Study|Lost to Follow-up|1|||
162685431|NCT03764072|587558237|FG005|Overall Study|Lost to Follow-up|0|||
162685432|NCT03657277|587558238|FG000|Overall Study|Physician Decision|2|||
162685433|NCT03657277|587558238|FG000|Overall Study|Lost to Follow-up|1|||
162685434|NCT03657277|587558238|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
162685435|NCT01024608|587558241|FG000|Overall Study|Adverse Event|1|||
162685436|NCT01024608|587558242|FG001|Overall Study|Adverse Event|0|||
162685437|NCT01024608|587558241|FG000|Overall Study|Withdrawal by Subject|1|||
162685438|NCT01024608|587558242|FG001|Overall Study|Withdrawal by Subject|0|||
162685439|NCT01024608|587558241|FG000|Overall Study|Lost to Follow-up|0|||
162685440|NCT01024608|587558242|FG001|Overall Study|Lost to Follow-up|1|||
162685441|NCT01024608|587558241|FG000|Overall Study|Protocol Violation|0|||
162685442|NCT01024608|587558242|FG001|Overall Study|Protocol Violation|3|||
162685443|NCT01024608|587558241|FG000|Overall Study|Never received study treatment|2|||
162685444|NCT01024608|587558242|FG001|Overall Study|Never received study treatment|0|||
162685445|NCT02286089|587558243|FG000|Overall Study|Ongoing in Study|1|||
162685446|NCT02286089|587558244|FG001|Overall Study|Ongoing in Study|1|||
162685447|NCT02286089|587558245|FG002|Overall Study|Ongoing in Study|4|||
162685448|NCT02286089|587558246|FG003|Overall Study|Ongoing in Study|10|||
162685449|NCT02286089|587558243|FG000|Overall Study|Withdrawal by Subject|0|||
162685450|NCT02286089|587558244|FG001|Overall Study|Withdrawal by Subject|0|||
162685451|NCT02286089|587558245|FG002|Overall Study|Withdrawal by Subject|2|||
162685452|NCT02286089|587558246|FG003|Overall Study|Withdrawal by Subject|2|||
162685453|NCT00045708|587559489|FG000|Phase 1|early progressive disease|0|||
162685454|NCT00045708|587559490|FG001|Phase 1|early progressive disease|1|||
162685455|NCT00045708|587559491|FG002|Phase 1|early progressive disease|0|||
162685456|NCT00685945|587559493|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
162685457|NCT00847405|587559495|FG000|First Intervention|Adverse Event|0|||
162685458|NCT00847405|587559496|FG001|First Intervention|Adverse Event|1|||
162685459|NCT00847405|587559495|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162726212|NCT05056246|587708197|FG004|Overall Study|Adverse Event|1|||
162726213|NCT05056246|587708193|FG000|Overall Study|Lost to Follow-up|0|||
162726214|NCT05056246|587708194|FG001|Overall Study|Lost to Follow-up|0|||
162726215|NCT05056246|587708195|FG002|Overall Study|Lost to Follow-up|0|||
162726216|NCT05056246|587708196|FG003|Overall Study|Lost to Follow-up|2|||
162726217|NCT05056246|587708197|FG004|Overall Study|Lost to Follow-up|0|||
162685460|NCT00847405|587559496|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162685461|NCT01728792|587559497|FG000|Overall Study|Withdrawal of Consent|1|||
162685462|NCT01728792|587559498|FG001|Overall Study|Withdrawal of Consent|1|||
162685463|NCT01728792|587559499|FG002|Overall Study|Withdrawal of Consent|0|||
162685464|NCT01728792|587559500|FG003|Overall Study|Withdrawal of Consent|1|||
162685465|NCT01728792|587559501|FG004|Overall Study|Withdrawal of Consent|0|||
162685466|NCT01728792|587559497|FG000|Overall Study|Lost to Follow-up|2|||
162685467|NCT01728792|587559498|FG001|Overall Study|Lost to Follow-up|1|||
162685468|NCT01728792|587559499|FG002|Overall Study|Lost to Follow-up|4|||
162685469|NCT01728792|587559500|FG003|Overall Study|Lost to Follow-up|2|||
162685470|NCT01728792|587559501|FG004|Overall Study|Lost to Follow-up|0|||
162726218|NCT05056246|587708193|FG000|Overall Study|Withdrawal by Subject|0|||
162726219|NCT05056246|587708194|FG001|Overall Study|Withdrawal by Subject|1|||
162726220|NCT05056246|587708195|FG002|Overall Study|Withdrawal by Subject|0|||
162685471|NCT04277455|587559502|FG000|Overall Study|Lost to Follow-up|1|||
162685472|NCT04791761|587559504|FG000|Overall Study|Lost to Follow-up|8|||
162685473|NCT04791761|587559505|FG001|Overall Study|Lost to Follow-up|6|||
162685474|NCT04791761|587559506|FG002|Overall Study|Lost to Follow-up|10|||
162685475|NCT04791761|587559504|FG000|Overall Study|Withdrawal by Subject|0|||
162685476|NCT04791761|587559505|FG001|Overall Study|Withdrawal by Subject|1|||
162685477|NCT04791761|587559506|FG002|Overall Study|Withdrawal by Subject|1|||
162726221|NCT05056246|587708196|FG003|Overall Study|Withdrawal by Subject|0|||
162726222|NCT05056246|587708197|FG004|Overall Study|Withdrawal by Subject|0|||
162726223|NCT05386238|587708198|FG000|Overall Study|Lost to Follow-up|3|||
162726224|NCT05386238|587708199|FG001|Overall Study|Lost to Follow-up|2|||
162726225|NCT05386238|587708198|FG000|Overall Study|Withdrawal by Subject|0|||
162685478|NCT04791761|587559504|FG000|Overall Study|Protocol Violation|0|||
162685479|NCT04791761|587559505|FG001|Overall Study|Protocol Violation|1|||
162685480|NCT04791761|587559506|FG002|Overall Study|Protocol Violation|1|||
162685481|NCT04669600|587559507|FG000|Overall Study|Withdrawal by Subject|1|||
162685482|NCT04669600|587559507|FG000|Overall Study|Other|6|||
162685483|NCT00676130|587559514|FG000|Overall Study|Lost to Follow-up|0|||
162685484|NCT00676130|587559515|FG001|Overall Study|Lost to Follow-up|1|||
162685485|NCT00676130|587559514|FG000|Overall Study|Found ineligible|3|||
162685486|NCT00676130|587559515|FG001|Overall Study|Found ineligible|2|||
162685487|NCT00676130|587559514|FG000|Overall Study|Withdrawal by Subject|0|||
162685488|NCT00676130|587559515|FG001|Overall Study|Withdrawal by Subject|1|||
162685489|NCT01564368|587559516|FG000|Overall Study|Ineligible|18|||
162685490|NCT01564368|587559516|FG000|Overall Study|Not Randomized in Parent study|116|||
162685491|NCT01564368|587559516|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
162685492|NCT01564368|587559516|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
162685493|NCT01802437|587559517|FG000|Overall Study|Lost to Follow-up|1|||
162685494|NCT01802437|587559518|FG001|Overall Study|Lost to Follow-up|0|||
162685495|NCT01802437|587559517|FG000|Overall Study|Withdrawal by Subject|3|||
162685496|NCT01802437|587559518|FG001|Overall Study|Withdrawal by Subject|4|||
162685497|NCT04857034|587559523|FG000|Placebo-Controlled Period|Request to discontinue|2|||
162685498|NCT04857034|587559524|FG001|Placebo-Controlled Period|Request to discontinue|2|||
162685499|NCT04857034|587559525|FG002|Placebo-Controlled Period|Request to discontinue|0|||
162685500|NCT04857034|587559526|FG003|Placebo-Controlled Period|Request to discontinue|0|||
162685501|NCT04857034|587559527|FG004|Placebo-Controlled Period|Request to discontinue|0|||
162685502|NCT04857034|587559523|FG000|Placebo-Controlled Period|withdrew consent|1|||
162685503|NCT04857034|587559524|FG001|Placebo-Controlled Period|withdrew consent|1|||
162685504|NCT04857034|587559525|FG002|Placebo-Controlled Period|withdrew consent|2|||
162685505|NCT04857034|587559526|FG003|Placebo-Controlled Period|withdrew consent|0|||
162685506|NCT04857034|587559527|FG004|Placebo-Controlled Period|withdrew consent|0|||
162685507|NCT04857034|587559523|FG000|Placebo-Controlled Period|Pregnancy|1|||
162685508|NCT04857034|587559524|FG001|Placebo-Controlled Period|Pregnancy|1|||
162685509|NCT04857034|587559525|FG002|Placebo-Controlled Period|Pregnancy|0|||
162685510|NCT04857034|587559526|FG003|Placebo-Controlled Period|Pregnancy|0|||
162685511|NCT04857034|587559527|FG004|Placebo-Controlled Period|Pregnancy|0|||
162685512|NCT04857034|587559523|FG000|Placebo-Controlled Period|Ongoing study period|0|||
162685513|NCT04857034|587559524|FG001|Placebo-Controlled Period|Ongoing study period|1|||
162685514|NCT04857034|587559525|FG002|Placebo-Controlled Period|Ongoing study period|0|||
162685515|NCT04857034|587559526|FG003|Placebo-Controlled Period|Ongoing study period|0|||
162685516|NCT04857034|587559527|FG004|Placebo-Controlled Period|Ongoing study period|0|||
162685517|NCT04857034|587559523|FG000|Active Treatment Period|Lack of Efficacy|1|||
162685518|NCT04857034|587559524|FG001|Active Treatment Period|Lack of Efficacy|0|||
162685519|NCT04857034|587559525|FG002|Active Treatment Period|Lack of Efficacy|0|||
162685520|NCT04857034|587559526|FG003|Active Treatment Period|Lack of Efficacy|0|||
162685521|NCT04857034|587559527|FG004|Active Treatment Period|Lack of Efficacy|0|||
162685522|NCT04857034|587559523|FG000|Active Treatment Period|request to discontinue|0|||
162685523|NCT04857034|587559524|FG001|Active Treatment Period|request to discontinue|1|||
162685524|NCT04857034|587559525|FG002|Active Treatment Period|request to discontinue|0|||
162685525|NCT04857034|587559526|FG003|Active Treatment Period|request to discontinue|1|||
162685526|NCT04857034|587559527|FG004|Active Treatment Period|request to discontinue|0|||
162685527|NCT04857034|587559523|FG000|Active Treatment Period|administrative reason by sponsor|1|||
162685528|NCT04857034|587559524|FG001|Active Treatment Period|administrative reason by sponsor|5|||
162685529|NCT04857034|587559525|FG002|Active Treatment Period|administrative reason by sponsor|0|||
162685530|NCT04857034|587559526|FG003|Active Treatment Period|administrative reason by sponsor|2|||
162685531|NCT04857034|587559527|FG004|Active Treatment Period|administrative reason by sponsor|2|||
162685532|NCT04857034|587559523|FG000|Active Treatment Period|other reasons|1|||
162685533|NCT04857034|587559524|FG001|Active Treatment Period|other reasons|1|||
162685534|NCT04857034|587559525|FG002|Active Treatment Period|other reasons|0|||
162685535|NCT04857034|587559526|FG003|Active Treatment Period|other reasons|0|||
162685536|NCT04857034|587559527|FG004|Active Treatment Period|other reasons|1|||
162685537|NCT04857034|587559523|FG000|Active Treatment Period|Ongoing Study Period|2|||
162685538|NCT04857034|587559524|FG001|Active Treatment Period|Ongoing Study Period|4|||
162685539|NCT04857034|587559525|FG002|Active Treatment Period|Ongoing Study Period|0|||
162685540|NCT04857034|587559526|FG003|Active Treatment Period|Ongoing Study Period|1|||
162685541|NCT04857034|587559527|FG004|Active Treatment Period|Ongoing Study Period|0|||
162685542|NCT04810221|587559528|FG000|Overall Study|Physician Decision|3|||
162726226|NCT05386238|587708199|FG001|Overall Study|Withdrawal by Subject|1|||
162685543|NCT01181726|587559531|FG000|First Intervention|Adverse Event|1|||
162685544|NCT01181726|587559532|FG001|First Intervention|Adverse Event|0|||
162685545|NCT01264380|587559533|FG000|Period C|Disease Progression|0|||
162685546|NCT01264380|587559534|FG001|Period C|Disease Progression|0|||
162685547|NCT01264380|587559535|FG002|Period C|Disease Progression|4|||
162685548|NCT01264380|587559533|FG000|Period C|Death|0|||
162685549|NCT01264380|587559534|FG001|Period C|Death|0|||
162726227|NCT04907474|587708200|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
162685550|NCT01264380|587559535|FG002|Period C|Death|2|||
162685551|NCT01264380|587559533|FG000|Period C|Follow-up for survival status|0|||
162685552|NCT01264380|587559534|FG001|Period C|Follow-up for survival status|0|||
162685553|NCT01264380|587559535|FG002|Period C|Follow-up for survival status|6|||
162685554|NCT01264380|587559533|FG000|Period C|Withdrawal by Subject|0|||
162685555|NCT01264380|587559534|FG001|Period C|Withdrawal by Subject|0|||
162685556|NCT01264380|587559535|FG002|Period C|Withdrawal by Subject|1|||
162685557|NCT01264380|587559533|FG000|Period C|Adverse Event|0|||
162685558|NCT01264380|587559534|FG001|Period C|Adverse Event|0|||
162685559|NCT01264380|587559535|FG002|Period C|Adverse Event|1|||
162685560|NCT04998604|587559537|FG000|Overall Study|Adverse Event|3|||
162685561|NCT04998604|587559538|FG001|Overall Study|Adverse Event|2|||
162685562|NCT04998604|587559537|FG000|Overall Study|Withdrawal by Subject|2|||
162685563|NCT04998604|587559538|FG001|Overall Study|Withdrawal by Subject|4|||
162685564|NCT04998604|587559537|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
162685565|NCT04998604|587559538|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
162685566|NCT03953898|587559541|FG000|Overall Study|Lack of Efficacy|8|||
162726228|NCT04907474|587708201|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
162726229|NCT01353313|587708204|FG000|Overall Study|Lost to Follow-up|22|||
162726230|NCT01353313|587708205|FG001|Overall Study|Lost to Follow-up|23|||
162726231|NCT01353313|587708204|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
162726232|NCT01353313|587708205|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
162726233|NCT01631214|587708209|FG000|Overall Study|Withdrawal by Subject|276|||
162685567|NCT03953898|587559541|FG000|Overall Study|Death|3|||
162685568|NCT03953898|587559541|FG000|Overall Study|Withdrawal by Subject|2|||
162685569|NCT03953898|587559541|FG000|Overall Study|Adverse Event|1|||
162685570|NCT01520402|587559546|FG000|Overall Study|Withdrawal by Subject|2|||
162685571|NCT01520402|587559546|FG000|Overall Study|Physician Decision|3|||
162685572|NCT01722162|587559547|FG000|Overall Study|Withdrawal by Subject|1|||
162685573|NCT01722162|587559548|FG001|Overall Study|Withdrawal by Subject|1|||
162685574|NCT01722162|587559547|FG000|Overall Study|Found ineligible|1|||
162685575|NCT01722162|587559548|FG001|Overall Study|Found ineligible|0|||
162685576|NCT01722162|587559547|FG000|Overall Study|Unrelated to study adverse event|2|||
162685577|NCT01722162|587559548|FG001|Overall Study|Unrelated to study adverse event|2|||
162685578|NCT01722162|587559547|FG000|Overall Study|Adverse Event|1|||
162685579|NCT01722162|587559548|FG001|Overall Study|Adverse Event|1|||
162685580|NCT01722162|587559547|FG000|Overall Study|Insurance denial post enrollment|0|||
162685581|NCT01722162|587559548|FG001|Overall Study|Insurance denial post enrollment|1|||
162685582|NCT01722162|587559547|FG000|Overall Study|Noncompliance|0|||
162685583|NCT01722162|587559548|FG001|Overall Study|Noncompliance|1|||
162685584|NCT01538472|587559549|FG000|Overall Study|Disease Progression|3|||
162685585|NCT01538472|587559549|FG000|Overall Study|Death|1|||
162726234|NCT01631214|587708210|FG001|Overall Study|Withdrawal by Subject|290|||
162726235|NCT01631214|587708209|FG000|Overall Study|Death|113|||
162726236|NCT01631214|587708210|FG001|Overall Study|Death|106|||
162726237|NCT01631214|587708209|FG000|Overall Study|Lost to Follow-up|54|||
162726238|NCT01631214|587708210|FG001|Overall Study|Lost to Follow-up|40|||
162726239|NCT01631214|587708209|FG000|Overall Study|Adverse Event|45|||
162726240|NCT01631214|587708210|FG001|Overall Study|Adverse Event|45|||
162726241|NCT01631214|587708209|FG000|Overall Study|Other|22|||
162726242|NCT01631214|587708210|FG001|Overall Study|Other|19|||
162726243|NCT01631214|587708209|FG000|Overall Study|Noncompliance|16|||
162726244|NCT01631214|587708210|FG001|Overall Study|Noncompliance|15|||
162726245|NCT01631214|587708209|FG000|Overall Study|Requirement for Alternative Therapy|8|||
162726246|NCT01631214|587708210|FG001|Overall Study|Requirement for Alternative Therapy|3|||
162726247|NCT01631214|587708209|FG000|Overall Study|Protocol Deviation|4|||
162685586|NCT02133872|587559550|FG000|Overall Study|Withdrawal by Subject|5|||
162685587|NCT02133872|587559551|FG001|Overall Study|Withdrawal by Subject|3|||
162685588|NCT02133872|587559552|FG002|Overall Study|Withdrawal by Subject|0|||
162685589|NCT02923739|587559553|FG000|Overall Study|Withdrawal by Subject|2|||
162685590|NCT02923739|587559554|FG001|Overall Study|Withdrawal by Subject|0|||
162685591|NCT02923739|587559555|FG002|Overall Study|Withdrawal by Subject|0|||
162726248|NCT01631214|587708210|FG001|Overall Study|Protocol Deviation|3|||
162726249|NCT01631214|587708209|FG000|Overall Study|Ineligibility determined|5|||
162685592|NCT02923739|587559556|FG003|Overall Study|Withdrawal by Subject|0|||
162685593|NCT02923739|587559553|FG000|Overall Study|Failed Screening|3|||
162726250|NCT01631214|587708210|FG001|Overall Study|Ineligibility determined|2|||
162726251|NCT01631214|587708209|FG000|Overall Study|Administrative Decision|1|||
162726252|NCT01631214|587708210|FG001|Overall Study|Administrative Decision|0|||
162685594|NCT02923739|587559554|FG001|Overall Study|Failed Screening|0|||
162685595|NCT02923739|587559555|FG002|Overall Study|Failed Screening|0|||
162685596|NCT02923739|587559556|FG003|Overall Study|Failed Screening|0|||
162685597|NCT00948974|587559561|FG000|Overall Study|Lost to Follow-up|23|||
162685598|NCT00948974|587559562|FG001|Overall Study|Lost to Follow-up|20|||
162685599|NCT02487810|587559563|FG000|Overall Study|Withdrawal by Subject|1|||
162726253|NCT03575052|587708211|FG000|Overall Study|Adverse Event|6|||
162726254|NCT03575052|587708212|FG001|Overall Study|Adverse Event|10|||
162685600|NCT02487810|587559564|FG001|Overall Study|Withdrawal by Subject|0|||
162685601|NCT01972529|587559565|FG000|Overall Study|Adverse Event|0|||
162685602|NCT01972529|587559566|FG001|Overall Study|Adverse Event|1|||
162685603|NCT01972529|587559567|FG002|Overall Study|Adverse Event|0|||
162685604|NCT01972529|587559568|FG003|Overall Study|Adverse Event|0|||
162685605|NCT01972529|587559565|FG000|Overall Study|Lost to Follow-up|1|||
162685606|NCT01972529|587559566|FG001|Overall Study|Lost to Follow-up|0|||
162685607|NCT01972529|587559567|FG002|Overall Study|Lost to Follow-up|0|||
162685608|NCT01972529|587559568|FG003|Overall Study|Lost to Follow-up|0|||
162685609|NCT01972529|587559565|FG000|Overall Study|Participant Choice|0|||
162685610|NCT01972529|587559566|FG001|Overall Study|Participant Choice|1|||
162685611|NCT01972529|587559567|FG002|Overall Study|Participant Choice|0|||
162685612|NCT01972529|587559568|FG003|Overall Study|Participant Choice|0|||
162685613|NCT01972529|587559565|FG000|Overall Study|Withdrawl of Consent|1|||
162685614|NCT01972529|587559566|FG001|Overall Study|Withdrawl of Consent|2|||
162685615|NCT01972529|587559567|FG002|Overall Study|Withdrawl of Consent|0|||
162685616|NCT01972529|587559568|FG003|Overall Study|Withdrawl of Consent|1|||
162685617|NCT01972529|587559565|FG000|Overall Study|Other|0|||
162685618|NCT01972529|587559566|FG001|Overall Study|Other|0|||
162685619|NCT01972529|587559567|FG002|Overall Study|Other|0|||
162685620|NCT01972529|587559568|FG003|Overall Study|Other|2|||
162685621|NCT01972529|587559565|FG000|Overall Study|Not treated|0|||
162685622|NCT01972529|587559566|FG001|Overall Study|Not treated|1|||
162685623|NCT01972529|587559567|FG002|Overall Study|Not treated|2|||
162685624|NCT01972529|587559568|FG003|Overall Study|Not treated|1|||
162685625|NCT01889186|587559569|FG000|Overall Study|Adverse event- not related to progression|18|||
162685626|NCT01889186|587559570|FG001|Overall Study|Adverse event- not related to progression|5|||
162685627|NCT01889186|587559569|FG000|Overall Study|Adverse event- related to progression|7|||
162685628|NCT01889186|587559570|FG001|Overall Study|Adverse event- related to progression|2|||
162685629|NCT01889186|587559569|FG000|Overall Study|COVID-19 logistical restrictions|1|||
162685630|NCT01889186|587559570|FG001|Overall Study|COVID-19 logistical restrictions|0|||
162685631|NCT01889186|587559569|FG000|Overall Study|Investigator request|1|||
162685632|NCT01889186|587559570|FG001|Overall Study|Investigator request|1|||
162685633|NCT01889186|587559569|FG000|Overall Study|Progressive disease- Richter's|12|||
162685634|NCT01889186|587559570|FG001|Overall Study|Progressive disease- Richter's|7|||
162685635|NCT01889186|587559569|FG000|Overall Study|Progressive disease per protocol|46|||
162685636|NCT01889186|587559570|FG001|Overall Study|Progressive disease per protocol|17|||
162685637|NCT01889186|587559569|FG000|Overall Study|Stem cell transplant|2|||
162685638|NCT01889186|587559570|FG001|Overall Study|Stem cell transplant|1|||
162685639|NCT01889186|587559569|FG000|Overall Study|Withdrew consent|2|||
162685640|NCT01889186|587559570|FG001|Overall Study|Withdrew consent|3|||
162685641|NCT01889186|587559569|FG000|Overall Study|Other, not specified|18|||
162685642|NCT01889186|587559570|FG001|Overall Study|Other, not specified|15|||
162685643|NCT00118716|587559574|FG000|Overall Study|Adverse Event|2|||
162685644|NCT00118716|587559575|FG001|Overall Study|Adverse Event|7|||
162685645|NCT00118716|587559574|FG000|Overall Study|Protocol Violation|5|||
162685646|NCT00118716|587559575|FG001|Overall Study|Protocol Violation|4|||
162685647|NCT00118716|587559574|FG000|Overall Study|Withdrawal by Subject|0|||
162685648|NCT00118716|587559575|FG001|Overall Study|Withdrawal by Subject|1|||
162685649|NCT00118716|587559574|FG000|Overall Study|Exacerbation|2|||
162685650|NCT00118716|587559575|FG001|Overall Study|Exacerbation|2|||
162685651|NCT00118716|587559574|FG000|Overall Study|Discontinued by sponsor|1|||
162685652|NCT00118716|587559575|FG001|Overall Study|Discontinued by sponsor|1|||
162685653|NCT00118716|587559574|FG000|Overall Study|Non-compliance|1|||
162685654|NCT00118716|587559575|FG001|Overall Study|Non-compliance|3|||
162685655|NCT00118716|587559574|FG000|Overall Study|misrandomized|1|||
162685656|NCT00118716|587559575|FG001|Overall Study|misrandomized|1|||
162685657|NCT00118716|587559574|FG000|Overall Study|Expired drug use|1|||
162685658|NCT00118716|587559575|FG001|Overall Study|Expired drug use|2|||
162685659|NCT00118716|587559574|FG000|Overall Study|Investigator discretion|0|||
162685660|NCT00118716|587559575|FG001|Overall Study|Investigator discretion|1|||
162685661|NCT00621543|587559576|FG000|Overall Study|Lost to Follow-up|23|||
162685662|NCT00855062|587559577|FG000|Step1|Early Study Closure|5|||
162685663|NCT00855062|587559578|FG001|Step1|Early Study Closure|7|||
162685664|NCT00855062|587559577|FG000|Step1|Adverse Event|1|||
162685665|NCT00855062|587559578|FG001|Step1|Adverse Event|1|||
162685666|NCT00855062|587559577|FG000|Step1|Protocol Violation|1|||
162685667|NCT00855062|587559578|FG001|Step1|Protocol Violation|0|||
162685668|NCT00855062|587559577|FG000|Step1|Pregnancy|1|||
162685669|NCT00855062|587559578|FG001|Step1|Pregnancy|0|||
162685670|NCT00855062|587559577|FG000|Step1|Withdrawal by Subject|2|||
162685671|NCT00855062|587559578|FG001|Step1|Withdrawal by Subject|3|||
162685672|NCT00855062|587559577|FG000|Step2|Early Study Closure|6|||
162685673|NCT00855062|587559578|FG001|Step2|Early Study Closure|2|||
162685674|NCT00855062|587559577|FG000|Step2|Adverse Event|0|||
162685675|NCT00855062|587559578|FG001|Step2|Adverse Event|3|||
162685676|NCT00855062|587559577|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
162685677|NCT00855062|587559578|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
162685678|NCT02755597|587559579|FG000|Overall Study|Withdrew consent|27|||
162685679|NCT02755597|587559580|FG001|Overall Study|Withdrew consent|11|||
162685680|NCT02755597|587559579|FG000|Overall Study|Lost to Follow-up|1|||
162685681|NCT02755597|587559580|FG001|Overall Study|Lost to Follow-up|0|||
162685682|NCT02755597|587559579|FG000|Overall Study|Death|78|||
162685683|NCT02755597|587559580|FG001|Overall Study|Death|36|||
162685684|NCT02755597|587559579|FG000|Overall Study|Study terminated by Sponsor|67|||
162685685|NCT02755597|587559580|FG001|Overall Study|Study terminated by Sponsor|47|||
162685686|NCT02755597|587559579|FG000|Overall Study|Other, not specified|20|||
162685687|NCT02755597|587559580|FG001|Overall Study|Other, not specified|3|||
162685688|NCT02755597|587559579|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
162685689|NCT02755597|587559580|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
162685690|NCT04252742|587559581|FG000|Overall Study|Decision by sponsor|0|||
162685691|NCT04252742|587559582|FG001|Overall Study|Decision by sponsor|2|||
162685692|NCT04252742|587559581|FG000|Overall Study|Withdrawal by Subject|15|||
162685693|NCT04252742|587559582|FG001|Overall Study|Withdrawal by Subject|9|||
162685694|NCT04252742|587559581|FG000|Overall Study|Lost to Follow-up|0|||
162685695|NCT04252742|587559582|FG001|Overall Study|Lost to Follow-up|1|||
162685696|NCT03759834|587559583|FG000|Overall Study|Withdrawal by Subject|1|||
162685697|NCT00031486|587559586|FG000|Overall Study|Adverse Event|1|||
162685698|NCT00031486|587559587|FG001|Overall Study|Adverse Event|0|||
162685699|NCT00031486|587559586|FG000|Overall Study|Lost to Follow-up|0|||
162685700|NCT00031486|587559587|FG001|Overall Study|Lost to Follow-up|1|||
162685701|NCT00031486|587559586|FG000|Overall Study|Withdrawal by Subject|3|||
162685702|NCT00031486|587559587|FG001|Overall Study|Withdrawal by Subject|2|||
162685703|NCT00031486|587559586|FG000|Overall Study|Death|0|||
162685704|NCT00031486|587559587|FG001|Overall Study|Death|3|||
162685705|NCT00031486|587559586|FG000|Overall Study|Non-compliant|0|||
162685706|NCT00031486|587559587|FG001|Overall Study|Non-compliant|4|||
162685707|NCT00031486|587559586|FG000|Overall Study|Did not meet eligibility requirement|2|||
162685708|NCT00031486|587559587|FG001|Overall Study|Did not meet eligibility requirement|1|||
162685709|NCT00031486|587559586|FG000|Overall Study|Other|1|||
162685710|NCT00031486|587559587|FG001|Overall Study|Other|1|||
162685711|NCT01685138|587559588|FG000|Overall Study|Lost to Follow-up|1|||
162685712|NCT01685138|587559588|FG000|Overall Study|Protocol Violation|1|||
162685713|NCT01685138|587559588|FG000|Overall Study|No longer requires treatment|1|||
162685714|NCT01685138|587559588|FG000|Overall Study|Subject/guardian decision|2|||
162685715|NCT01685138|587559588|FG000|Overall Study|Physician Decision|6|||
162685716|NCT01685138|587559588|FG000|Overall Study|Death|10|||
162685717|NCT01685138|587559588|FG000|Overall Study|Adverse Event|18|||
162685718|NCT01685138|587559588|FG000|Overall Study|Progressive disease|53|||
162685719|NCT00689026|587559591|FG000|Overall Study|Withdrawal by Subject|13|||
162685720|NCT00689026|587559592|FG001|Overall Study|Withdrawal by Subject|6|||
162685721|NCT03996291|587559597|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
162685722|NCT03996291|587559598|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
162685723|NCT03996291|587559599|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
162685724|NCT03996291|587559600|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
162685725|NCT03996291|587559601|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
162685726|NCT03996291|587559602|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
162685727|NCT03996291|587559603|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
162685728|NCT03996291|587559604|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
162685729|NCT03996291|587559597|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685730|NCT03996291|587559598|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685731|NCT03996291|587559599|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685732|NCT03996291|587559600|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685733|NCT03996291|587559601|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685734|NCT03996291|587559602|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
162685735|NCT03996291|587559603|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
162685736|NCT03996291|587559604|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162685737|NCT03996291|587559597|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685738|NCT03996291|587559598|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685739|NCT03996291|587559599|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685740|NCT03996291|587559600|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685741|NCT03996291|587559601|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
162685742|NCT03996291|587559602|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685743|NCT03996291|587559603|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
162685744|NCT03996291|587559604|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162685745|NCT03996291|587559597|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
162685746|NCT03996291|587559598|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
162685747|NCT03996291|587559599|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
162685748|NCT03996291|587559600|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
162685749|NCT03996291|587559601|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
162685750|NCT03996291|587559602|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
162685751|NCT03996291|587559603|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
162685752|NCT03996291|587559604|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
162685753|NCT03996291|587559597|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685754|NCT03996291|587559598|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685755|NCT03996291|587559599|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685756|NCT03996291|587559600|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685757|NCT03996291|587559601|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
162685758|NCT03996291|587559602|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685759|NCT03996291|587559603|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685760|NCT03996291|587559604|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162685761|NCT02703922|587559605|FG000|Overall Study|Death|5|||
162685762|NCT02703922|587559606|FG001|Overall Study|Death|8|||
162685763|NCT02703922|587559605|FG000|Overall Study|Lost to Follow-up|10|||
162685764|NCT02703922|587559606|FG001|Overall Study|Lost to Follow-up|10|||
162685765|NCT05805657|587559608|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
162685766|NCT05805657|587559609|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
162685767|NCT01951638|587559610|FG000|Treatment Period|Protocol Violation|0|||
162685768|NCT01951638|587559611|FG001|Treatment Period|Protocol Violation|0|||
162685769|NCT01951638|587559612|FG002|Treatment Period|Protocol Violation|0|||
162685770|NCT01951638|587559613|FG003|Treatment Period|Protocol Violation|2|||
162685771|NCT01951638|587559614|FG004|Treatment Period|Protocol Violation|0|||
162685772|NCT01951638|587559610|FG000|Treatment Period|Protocol-driven decision point|1|||
162685773|NCT01951638|587559611|FG001|Treatment Period|Protocol-driven decision point|3|||
162685774|NCT01951638|587559612|FG002|Treatment Period|Protocol-driven decision point|0|||
162685775|NCT01951638|587559613|FG003|Treatment Period|Protocol-driven decision point|0|||
162685776|NCT01951638|587559614|FG004|Treatment Period|Protocol-driven decision point|0|||
162685777|NCT01951638|587559610|FG000|Treatment Period|Logistical difficulties|0|||
162685778|NCT01951638|587559611|FG001|Treatment Period|Logistical difficulties|1|||
162685779|NCT01951638|587559612|FG002|Treatment Period|Logistical difficulties|1|||
162685780|NCT01951638|587559613|FG003|Treatment Period|Logistical difficulties|0|||
162685781|NCT01951638|587559614|FG004|Treatment Period|Logistical difficulties|0|||
162685782|NCT01951638|587559610|FG000|Treatment Period|Withdrawal by Subject|9|||
162685783|NCT01951638|587559611|FG001|Treatment Period|Withdrawal by Subject|6|||
162685784|NCT01951638|587559612|FG002|Treatment Period|Withdrawal by Subject|4|||
162685785|NCT01951638|587559613|FG003|Treatment Period|Withdrawal by Subject|5|||
162685786|NCT01951638|587559614|FG004|Treatment Period|Withdrawal by Subject|4|||
162685787|NCT01951638|587559610|FG000|Treatment Period|Death|0|||
162685788|NCT01951638|587559611|FG001|Treatment Period|Death|0|||
162685789|NCT01951638|587559612|FG002|Treatment Period|Death|0|||
162685790|NCT01951638|587559613|FG003|Treatment Period|Death|3|||
162685791|NCT01951638|587559614|FG004|Treatment Period|Death|1|||
162685792|NCT01951638|587559610|FG000|Treatment Period|Adverse Event|3|||
162685793|NCT01951638|587559611|FG001|Treatment Period|Adverse Event|4|||
162685794|NCT01951638|587559612|FG002|Treatment Period|Adverse Event|8|||
162685795|NCT01951638|587559613|FG003|Treatment Period|Adverse Event|6|||
162685796|NCT01951638|587559614|FG004|Treatment Period|Adverse Event|5|||
162685797|NCT01951638|587559610|FG000|Follow-up Period|Protocol Violation|0|||
162685798|NCT01951638|587559611|FG001|Follow-up Period|Protocol Violation|0|||
162685799|NCT01951638|587559612|FG002|Follow-up Period|Protocol Violation|0|||
162685800|NCT01951638|587559613|FG003|Follow-up Period|Protocol Violation|1|||
162685801|NCT01951638|587559614|FG004|Follow-up Period|Protocol Violation|0|||
162685802|NCT01951638|587559610|FG000|Follow-up Period|Logistical difficulties|0|||
162685803|NCT01951638|587559611|FG001|Follow-up Period|Logistical difficulties|2|||
162685804|NCT01951638|587559612|FG002|Follow-up Period|Logistical difficulties|0|||
162685805|NCT01951638|587559613|FG003|Follow-up Period|Logistical difficulties|0|||
162685806|NCT01951638|587559614|FG004|Follow-up Period|Logistical difficulties|1|||
162685807|NCT01951638|587559610|FG000|Follow-up Period|Withdrawal by Subject|1|||
162685808|NCT01951638|587559611|FG001|Follow-up Period|Withdrawal by Subject|5|||
162685809|NCT01951638|587559612|FG002|Follow-up Period|Withdrawal by Subject|2|||
162685810|NCT01951638|587559613|FG003|Follow-up Period|Withdrawal by Subject|1|||
162685811|NCT01951638|587559614|FG004|Follow-up Period|Withdrawal by Subject|2|||
162685812|NCT01951638|587559610|FG000|Follow-up Period|Lost to Follow-up|0|||
162685813|NCT01951638|587559611|FG001|Follow-up Period|Lost to Follow-up|1|||
162685814|NCT01951638|587559612|FG002|Follow-up Period|Lost to Follow-up|0|||
162685815|NCT01951638|587559613|FG003|Follow-up Period|Lost to Follow-up|1|||
162685816|NCT01951638|587559614|FG004|Follow-up Period|Lost to Follow-up|0|||
162685817|NCT01951638|587559610|FG000|Follow-up Period|Death|1|||
162685818|NCT01951638|587559611|FG001|Follow-up Period|Death|0|||
162685819|NCT01951638|587559612|FG002|Follow-up Period|Death|1|||
162685820|NCT01951638|587559613|FG003|Follow-up Period|Death|4|||
162685821|NCT01951638|587559614|FG004|Follow-up Period|Death|1|||
162685822|NCT01951638|587559610|FG000|Follow-up Period|Adverse Event|0|||
162685823|NCT01951638|587559611|FG001|Follow-up Period|Adverse Event|1|||
162685824|NCT01951638|587559612|FG002|Follow-up Period|Adverse Event|2|||
162685825|NCT01951638|587559613|FG003|Follow-up Period|Adverse Event|1|||
162685826|NCT01951638|587559614|FG004|Follow-up Period|Adverse Event|1|||
162685827|NCT00552084|587559615|FG000|Overall Study|Adverse Event|2|||
162685828|NCT00552084|587559616|FG001|Overall Study|Adverse Event|3|||
162685829|NCT00552084|587559615|FG000|Overall Study|Withdrawal by Subject|4|||
162685830|NCT00552084|587559616|FG001|Overall Study|Withdrawal by Subject|5|||
162685831|NCT00552084|587559615|FG000|Overall Study|Protocol Violation|1|||
162685832|NCT00552084|587559616|FG001|Overall Study|Protocol Violation|0|||
162685833|NCT00552084|587559615|FG000|Overall Study|change in anti-arrythmic drug|1|||
162685834|NCT00552084|587559616|FG001|Overall Study|change in anti-arrythmic drug|1|||
162685835|NCT01338025|587559617|FG000|Overall Study|Unexpected closure of study|10|||
162685836|NCT01338025|587559618|FG001|Overall Study|Unexpected closure of study|9|||
162685837|NCT01338025|587559617|FG000|Overall Study|Withdrawal by Subject|0|||
162685838|NCT01338025|587559618|FG001|Overall Study|Withdrawal by Subject|2|||
162685839|NCT01338025|587559617|FG000|Overall Study|Found ineligible after starting|1|||
162685840|NCT01338025|587559618|FG001|Overall Study|Found ineligible after starting|0|||
162685841|NCT03188055|587559619|FG000|Overall Study|Unavailable for training|0|||
162685842|NCT03188055|587559620|FG001|Overall Study|Unavailable for training|0|||
162685843|NCT03188055|587559621|FG002|Overall Study|Unavailable for training|19|||
162685844|NCT03188055|587559622|FG003|Overall Study|Unavailable for training|0|||
162685845|NCT03188055|587559623|FG004|Overall Study|Unavailable for training|0|||
162685846|NCT03188055|587559624|FG005|Overall Study|Unavailable for training|0|||
162685847|NCT03188055|587559619|FG000|Overall Study|Lost to Follow-up|0|||
162685848|NCT03188055|587559620|FG001|Overall Study|Lost to Follow-up|18|||
162685849|NCT03188055|587559621|FG002|Overall Study|Lost to Follow-up|0|||
162685850|NCT03188055|587559622|FG003|Overall Study|Lost to Follow-up|11|||
162685851|NCT03188055|587559623|FG004|Overall Study|Lost to Follow-up|0|||
162685852|NCT03188055|587559624|FG005|Overall Study|Lost to Follow-up|0|||
162685853|NCT03188055|587559619|FG000|Overall Study|Withdrawal by Subject|0|||
162685854|NCT03188055|587559620|FG001|Overall Study|Withdrawal by Subject|1|||
162685855|NCT03188055|587559621|FG002|Overall Study|Withdrawal by Subject|0|||
162685856|NCT03188055|587559622|FG003|Overall Study|Withdrawal by Subject|1|||
162685857|NCT03188055|587559623|FG004|Overall Study|Withdrawal by Subject|0|||
162685858|NCT03188055|587559624|FG005|Overall Study|Withdrawal by Subject|0|||
162685859|NCT04349280|587559625|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
162685860|NCT04349280|587559626|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
162685861|NCT04349280|587559625|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
162685862|NCT04349280|587559626|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
162685863|NCT04349280|587559625|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
162685864|NCT04349280|587559626|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
162685865|NCT00657618|587559631|FG000|Overall Study|Adverse Event|32|||
162685866|NCT00657618|587559631|FG000|Overall Study|Withdrawal by Subject|8|||
162685867|NCT00657618|587559631|FG000|Overall Study|negative for leishmaniasis|2|||
162685868|NCT00657618|587559631|FG000|Overall Study|didn't start due to schedule conflicts|1|||
162685869|NCT01659151|587559632|FG000|Overall Study|Inadequate TIL growth|1|||
162685870|NCT05774197|587559633|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
162685871|NCT05073133|587559634|FG000|Overall Study|Death|2|||
162685872|NCT04981678|587559635|FG000|Overall Study|Lost to Follow-up|0|||
162685873|NCT04981678|587559636|FG001|Overall Study|Lost to Follow-up|1|||
162685874|NCT00284141|587561520|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
162685875|NCT00284141|587561520|FG000|Overall Study|Adverse Event|19|||
162685876|NCT00284141|587561520|FG000|Overall Study|Participant's request|9|||
162685877|NCT00284141|587561520|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
162685878|NCT00284141|587561520|FG000|Overall Study|Clinical deterioration / death|2|||
162685879|NCT00284141|587561520|FG000|Overall Study|General decline|1|||
162685880|NCT00284141|587561520|FG000|Overall Study|Pneumonia|1|||
162685881|NCT00284141|587561520|FG000|Overall Study|Did not take study medication|2|||
162685882|NCT00284141|587561520|FG000|Overall Study|Ongoing treatment|2|||
162685883|NCT01782742|587561522|FG000|Double-blind Treatment Phase|Adverse Event|1|||
162685884|NCT01782742|587561523|FG001|Double-blind Treatment Phase|Adverse Event|0|||
162685885|NCT04170686|587561524|FG000|Screening|Physician Decision|12|||
162685886|NCT04170686|587561525|FG001|Screening|Physician Decision|13|||
162685887|NCT04170686|587561524|FG000|Randomization and Treatment|Lost to Follow-up|26|||
162685888|NCT04170686|587561525|FG001|Randomization and Treatment|Lost to Follow-up|15|||
162685889|NCT04425902|587561528|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
162685890|NCT01191840|587561529|FG000|Overall Study|withdrew consent|2|||
162685891|NCT01191840|587561530|FG001|Overall Study|withdrew consent|1|||
162685892|NCT01191840|587561529|FG000|Overall Study|Subject discontinued treatment|1|||
162685893|NCT01191840|587561530|FG001|Overall Study|Subject discontinued treatment|2|||
162685894|NCT01191840|587561529|FG000|Overall Study|Lost to Follow-up|4|||
162685895|NCT01191840|587561530|FG001|Overall Study|Lost to Follow-up|6|||
162685896|NCT01191840|587561529|FG000|Overall Study|Non Staph Infection|4|||
162685897|NCT01191840|587561530|FG001|Overall Study|Non Staph Infection|3|||
162685898|NCT01191840|587561529|FG000|Overall Study|ineligible at enrollment|1|||
162685899|NCT01191840|587561530|FG001|Overall Study|ineligible at enrollment|0|||
162685900|NCT01191840|587561529|FG000|Overall Study|IRB approval lapse|0|||
162685901|NCT01191840|587561530|FG001|Overall Study|IRB approval lapse|2|||
162685902|NCT01191840|587561529|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
162685903|NCT01191840|587561530|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
162685904|NCT01191840|587561529|FG000|Overall Study|Withdrawal by Subject|2|||
162685905|NCT01191840|587561530|FG001|Overall Study|Withdrawal by Subject|0|||
162685906|NCT02940574|587561537|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
162685907|NCT02940574|587561538|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
162685908|NCT02940574|587561537|FG000|1-year Follow-up|Lost to Follow-up|3|||
162685909|NCT02940574|587561538|FG001|1-year Follow-up|Lost to Follow-up|4|||
162685910|NCT00520975|587561539|FG000|Overall Study|Disease progression|31|||
162685911|NCT00520975|587561540|FG001|Overall Study|Disease progression|23|||
162685912|NCT00520975|587561539|FG000|Overall Study|Adverse Event|7|||
162685913|NCT00520975|587561540|FG001|Overall Study|Adverse Event|10|||
162685914|NCT00520975|587561539|FG000|Overall Study|Death|0|||
162685915|NCT00520975|587561540|FG001|Overall Study|Death|2|||
162685916|NCT00520975|587561539|FG000|Overall Study|Withdrawal by Subject|3|||
162685917|NCT00520975|587561540|FG001|Overall Study|Withdrawal by Subject|5|||
162685918|NCT00520975|587561539|FG000|Overall Study|Other therapy|2|||
162685919|NCT00520975|587561540|FG001|Overall Study|Other therapy|4|||
162685920|NCT00520975|587561539|FG000|Overall Study|Other reasons|4|||
162685921|NCT00520975|587561540|FG001|Overall Study|Other reasons|2|||
162685922|NCT00520975|587561539|FG000|Overall Study|Not start protocol therapy|1|||
162685923|NCT00520975|587561540|FG001|Overall Study|Not start protocol therapy|2|||
162685924|NCT01682213|587561541|FG000|Overall Study|Withdrawal by Subject|2|||
162685925|NCT04382924|587561542|FG000|Overall Study|Death|2|||
162685926|NCT04382924|587561543|FG001|Overall Study|Death|5|||
162685927|NCT04382924|587561544|FG002|Overall Study|Death|4|||
162685928|NCT04382924|587561542|FG000|Overall Study|Protocol Violation|0|||
162685929|NCT04382924|587561543|FG001|Overall Study|Protocol Violation|1|||
162685930|NCT04382924|587561544|FG002|Overall Study|Protocol Violation|1|||
162685931|NCT04382924|587561542|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
162685932|NCT04382924|587561543|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
162685933|NCT04382924|587561544|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
162685934|NCT04382924|587561542|FG000|Overall Study|Withdrawal by Subject|6|||
162685935|NCT04382924|587561543|FG001|Overall Study|Withdrawal by Subject|3|||
162685936|NCT04382924|587561544|FG002|Overall Study|Withdrawal by Subject|6|||
162685937|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
162685938|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
162685939|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
162685940|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
162685941|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
162685942|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
162685943|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
162685944|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
162685945|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
162685946|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
162685947|NCT00261495|587561547|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
162685948|NCT00261495|587561548|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
162685949|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
162685950|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
162685951|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
162685952|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
162685953|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
162685954|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
162685955|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
162685956|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
162685957|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
162685958|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
162685959|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
162685960|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
162726255|NCT03575052|587708211|FG000|Overall Study|Not further specified|5|||
162726256|NCT03575052|587708212|FG001|Overall Study|Not further specified|7|||
162726257|NCT03575052|587708211|FG000|Overall Study|Withdrawal by Subject|5|||
162726258|NCT03575052|587708212|FG001|Overall Study|Withdrawal by Subject|6|||
162726259|NCT03575052|587708211|FG000|Overall Study|Lost to Follow-up|3|||
162726260|NCT03575052|587708212|FG001|Overall Study|Lost to Follow-up|0|||
162685961|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
162685962|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
162685963|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
162685964|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
162685965|NCT00261495|587561547|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
162685966|NCT00261495|587561548|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
162685967|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
162685968|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
162685969|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
162685970|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162685971|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
162685972|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
162685973|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162685974|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
162685975|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
162685976|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
162685977|NCT00261495|587561547|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
162685978|NCT00261495|587561548|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162685979|NCT00642902|587561549|FG000|Overall Study|Adverse Event|0|||
162685980|NCT00642902|587561550|FG001|Overall Study|Adverse Event|1|||
162685981|NCT00642902|587561551|FG002|Overall Study|Adverse Event|3|||
162685982|NCT00642902|587561552|FG003|Overall Study|Adverse Event|1|||
162685983|NCT00642902|587561549|FG000|Overall Study|Lost to Follow-up|1|||
162685984|NCT00642902|587561550|FG001|Overall Study|Lost to Follow-up|1|||
162685985|NCT00642902|587561551|FG002|Overall Study|Lost to Follow-up|0|||
162685986|NCT00642902|587561552|FG003|Overall Study|Lost to Follow-up|0|||
162685987|NCT00642902|587561549|FG000|Overall Study|Lack of Efficacy|0|||
162685988|NCT00642902|587561550|FG001|Overall Study|Lack of Efficacy|3|||
162685989|NCT00642902|587561551|FG002|Overall Study|Lack of Efficacy|3|||
162685990|NCT00642902|587561552|FG003|Overall Study|Lack of Efficacy|0|||
162685991|NCT00642902|587561549|FG000|Overall Study|Death|1|||
162685992|NCT00642902|587561550|FG001|Overall Study|Death|0|||
162685993|NCT00642902|587561551|FG002|Overall Study|Death|0|||
162685994|NCT00642902|587561552|FG003|Overall Study|Death|0|||
162685995|NCT00642902|587561549|FG000|Overall Study|Premature termination of clinical trial|37|||
162685996|NCT00642902|587561550|FG001|Overall Study|Premature termination of clinical trial|32|||
162685997|NCT00642902|587561551|FG002|Overall Study|Premature termination of clinical trial|35|||
162685998|NCT00642902|587561552|FG003|Overall Study|Premature termination of clinical trial|35|||
162685999|NCT00642902|587561549|FG000|Overall Study|Randomized, but not treated|0|||
162686000|NCT00642902|587561550|FG001|Overall Study|Randomized, but not treated|0|||
162686001|NCT00642902|587561551|FG002|Overall Study|Randomized, but not treated|1|||
162686002|NCT00642902|587561552|FG003|Overall Study|Randomized, but not treated|0|||
162686003|NCT00642902|587561549|FG000|Overall Study|Other|1|||
162686004|NCT00642902|587561550|FG001|Overall Study|Other|5|||
162686005|NCT00642902|587561551|FG002|Overall Study|Other|1|||
162686006|NCT00642902|587561552|FG003|Overall Study|Other|4|||
162686007|NCT00429663|587561553|FG000|Overall Study|Lost to Follow-up|24|||
162686008|NCT00429663|587561554|FG001|Overall Study|Lost to Follow-up|31|||
162686009|NCT00429663|587561553|FG000|Overall Study|Physician Decision|6|||
162686010|NCT00429663|587561554|FG001|Overall Study|Physician Decision|3|||
162686011|NCT00429663|587561553|FG000|Overall Study|Withdrawal by Subject|2|||
162686012|NCT00429663|587561554|FG001|Overall Study|Withdrawal by Subject|5|||
162686013|NCT00429663|587561553|FG000|Overall Study|Death|4|||
162686014|NCT00429663|587561554|FG001|Overall Study|Death|0|||
162686015|NCT04207840|587561555|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
162686016|NCT04207840|587561556|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
162686017|NCT04207840|587561557|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
162686018|NCT04207840|587561555|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
162686019|NCT04207840|587561556|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
162686020|NCT04207840|587561557|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
162686021|NCT03243422|587561560|FG000|Overall Study|Death|20|||
162686022|NCT03243422|587561561|FG001|Overall Study|Death|21|||
162686023|NCT03243422|587561560|FG000|Overall Study|Lost to Follow-up|9|||
162686024|NCT03243422|587561561|FG001|Overall Study|Lost to Follow-up|21|||
162686025|NCT03243422|587561560|FG000|Overall Study|Withdrawal by Subject|22|||
162686026|NCT03243422|587561561|FG001|Overall Study|Withdrawal by Subject|8|||
162686027|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
162686028|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
162686029|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
162686030|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
162686031|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
162686032|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
162686033|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
162686034|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162686035|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162686036|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162686037|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
162686038|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
162686039|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162686040|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162686041|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162686042|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
162686043|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
162686044|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162686045|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162686046|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162686047|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Death|2|||
162686048|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Death|2|||
162686049|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Death|0|||
162686050|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Death|0|||
162686051|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Death|0|||
162686052|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
162686053|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
162686054|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
162686055|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
162686056|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
162686057|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162686058|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
162686059|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162686060|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162686061|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162686062|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
162686063|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
162686064|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162686065|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162686066|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162686067|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
162686068|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162686069|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162686070|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162686071|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162686072|NCT03420781|587561564|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
162686073|NCT03420781|587561565|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162686074|NCT03420781|587561566|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162686075|NCT03420781|587561567|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162686076|NCT03420781|587561568|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162686077|NCT03420781|587561564|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162686078|NCT03420781|587561565|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162686079|NCT03420781|587561566|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162686080|NCT03420781|587561567|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
162686081|NCT03420781|587561568|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162686082|NCT03420781|587561564|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162686083|NCT03420781|587561565|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162686084|NCT03420781|587561566|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162686085|NCT03420781|587561567|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162686086|NCT03420781|587561568|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
162686087|NCT03420781|587561564|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
162686088|NCT03420781|587561565|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
162686089|NCT03420781|587561566|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
162686090|NCT03420781|587561567|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
162686091|NCT03420781|587561568|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
162686092|NCT01226511|587561573|FG000|Acute Treatment Period|Adverse Event|7|||
162686093|NCT01226511|587561574|FG001|Acute Treatment Period|Adverse Event|6|||
162686094|NCT01226511|587561573|FG000|Acute Treatment Period|Lack of Efficacy|2|||
162686095|NCT01226511|587561574|FG001|Acute Treatment Period|Lack of Efficacy|1|||
162686096|NCT01226511|587561573|FG000|Acute Treatment Period|Lost to Follow-up|3|||
162686097|NCT01226511|587561574|FG001|Acute Treatment Period|Lost to Follow-up|6|||
162686098|NCT01226511|587561573|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
162686099|NCT01226511|587561574|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
162686100|NCT01226511|587561573|FG000|Acute Treatment Period|Protocol Violation|5|||
162686101|NCT01226511|587561574|FG001|Acute Treatment Period|Protocol Violation|5|||
162686102|NCT01226511|587561573|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
162686103|NCT01226511|587561574|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
162686104|NCT01226511|587561573|FG000|Extension Treatment Period|Adverse Event|8|||
162686105|NCT01226511|587561574|FG001|Extension Treatment Period|Adverse Event|8|||
162686106|NCT01226511|587561573|FG000|Extension Treatment Period|Lack of Efficacy|3|||
162686107|NCT01226511|587561574|FG001|Extension Treatment Period|Lack of Efficacy|2|||
162686108|NCT01226511|587561573|FG000|Extension Treatment Period|Lost to Follow-up|4|||
162686109|NCT01226511|587561574|FG001|Extension Treatment Period|Lost to Follow-up|3|||
162686110|NCT01226511|587561573|FG000|Extension Treatment Period|Protocol Violation|2|||
162686111|NCT01226511|587561574|FG001|Extension Treatment Period|Protocol Violation|2|||
162686112|NCT01226511|587561573|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
162686113|NCT01226511|587561574|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
162686114|NCT01226511|587561573|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
162686115|NCT01226511|587561574|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
162686116|NCT01226511|587561573|FG000|Extension Treatment Period|Sponsor Decision|1|||
162686117|NCT01226511|587561574|FG001|Extension Treatment Period|Sponsor Decision|1|||
162686118|NCT01226511|587561573|FG000|Taper Period|Adverse Event|1|||
162686119|NCT01226511|587561574|FG001|Taper Period|Adverse Event|0|||
162686120|NCT01226511|587561573|FG000|Taper Period|Lost to Follow-up|2|||
162686121|NCT01226511|587561574|FG001|Taper Period|Lost to Follow-up|2|||
162686122|NCT01226511|587561573|FG000|Taper Period|Protocol Violation|1|||
162686123|NCT01226511|587561574|FG001|Taper Period|Protocol Violation|0|||
162686124|NCT01226511|587561573|FG000|Taper Period|Parent/Caregiver Decision|1|||
162686125|NCT01226511|587561574|FG001|Taper Period|Parent/Caregiver Decision|1|||
162686126|NCT02696564|587561575|FG000|Overall Study|Death|1|||
162686127|NCT02696564|587561576|FG001|Overall Study|Death|2|||
162686128|NCT02696564|587561575|FG000|Overall Study|Withdrawal by Subject|3|||
162686129|NCT02696564|587561576|FG001|Overall Study|Withdrawal by Subject|2|||
162686130|NCT02696564|587561575|FG000|Overall Study|Lost to Follow-up|3|||
162686131|NCT02696564|587561576|FG001|Overall Study|Lost to Follow-up|3|||
162686132|NCT02696564|587561575|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
162686133|NCT02696564|587561576|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
162686134|NCT02696564|587561575|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
162686135|NCT02696564|587561576|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
162686136|NCT02696564|587561575|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
162686137|NCT02696564|587561576|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
162686138|NCT02696564|587561575|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
162686139|NCT02696564|587561576|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
162686140|NCT02696564|587561575|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
162686141|NCT02696564|587561576|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
162686142|NCT05267600|587561577|FG000|Overall Study|Adverse Event|1|||
162686143|NCT05267600|587561578|FG001|Overall Study|Adverse Event|4|||
162686144|NCT05267600|587561577|FG000|Overall Study|Death|1|||
162686145|NCT05267600|587561578|FG001|Overall Study|Death|2|||
162686146|NCT05267600|587561577|FG000|Overall Study|Lack of Efficacy|1|||
162686147|NCT05267600|587561578|FG001|Overall Study|Lack of Efficacy|2|||
162686148|NCT05267600|587561577|FG000|Overall Study|Lost to Follow-up|3|||
162686149|NCT05267600|587561578|FG001|Overall Study|Lost to Follow-up|0|||
162686150|NCT05267600|587561577|FG000|Overall Study|Physician Decision|4|||
162686151|NCT05267600|587561578|FG001|Overall Study|Physician Decision|0|||
162686152|NCT05267600|587561577|FG000|Overall Study|Treatment Unblinded|0|||
162686153|NCT05267600|587561578|FG001|Overall Study|Treatment Unblinded|1|||
162686154|NCT05267600|587561577|FG000|Overall Study|Withdrawal by Subject|5|||
162686155|NCT05267600|587561578|FG001|Overall Study|Withdrawal by Subject|4|||
162686156|NCT04067401|587561579|FG000|Overall Study|Withdrawal by Subject|7|||
162686157|NCT04067401|587561580|FG001|Overall Study|Withdrawal by Subject|0|||
162686158|NCT04067401|587561579|FG000|Overall Study|no data provided|1|||
162686159|NCT04067401|587561580|FG001|Overall Study|no data provided|0|||
162686160|NCT03633929|587561583|FG000|Overall Study|Lost to Follow-up|1|||
162686161|NCT03633929|587561583|FG000|Overall Study|Did not login to software. Did not participate|3|||
162686162|NCT02287584|587561585|FG000|the Double-blind Phase|Adverse Event|17|||
162686163|NCT02287584|587561586|FG001|the Double-blind Phase|Adverse Event|17|||
162686164|NCT02287584|587561587|FG002|the Double-blind Phase|Adverse Event|12|||
162686165|NCT02287584|587561588|FG003|the Double-blind Phase|Adverse Event|0|||
162686166|NCT02287584|587561589|FG004|the Double-blind Phase|Adverse Event|0|||
162686167|NCT02287584|587561590|FG005|the Double-blind Phase|Adverse Event|0|||
162686168|NCT02287584|587561585|FG000|the Double-blind Phase|Lack of Efficacy|18|||
162686169|NCT02287584|587561586|FG001|the Double-blind Phase|Lack of Efficacy|8|||
162686170|NCT02287584|587561587|FG002|the Double-blind Phase|Lack of Efficacy|8|||
162686171|NCT02287584|587561588|FG003|the Double-blind Phase|Lack of Efficacy|0|||
162686172|NCT02287584|587561589|FG004|the Double-blind Phase|Lack of Efficacy|0|||
162686173|NCT02287584|587561590|FG005|the Double-blind Phase|Lack of Efficacy|0|||
162686174|NCT02287584|587561585|FG000|the Double-blind Phase|Lost to Follow-up|0|||
162686175|NCT02287584|587561586|FG001|the Double-blind Phase|Lost to Follow-up|1|||
162686176|NCT02287584|587561587|FG002|the Double-blind Phase|Lost to Follow-up|1|||
162686177|NCT02287584|587561588|FG003|the Double-blind Phase|Lost to Follow-up|0|||
162686178|NCT02287584|587561589|FG004|the Double-blind Phase|Lost to Follow-up|0|||
162686179|NCT02287584|587561590|FG005|the Double-blind Phase|Lost to Follow-up|0|||
162686180|NCT02287584|587561585|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
162686181|NCT02287584|587561586|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
162686182|NCT02287584|587561587|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
162686183|NCT02287584|587561588|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
162686184|NCT02287584|587561589|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
162686185|NCT02287584|587561590|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
162686186|NCT02287584|587561585|FG000|the Double-blind Phase|Pregnancy|0|||
162686187|NCT02287584|587561586|FG001|the Double-blind Phase|Pregnancy|1|||
162686188|NCT02287584|587561587|FG002|the Double-blind Phase|Pregnancy|0|||
162686189|NCT02287584|587561588|FG003|the Double-blind Phase|Pregnancy|0|||
162686190|NCT02287584|587561589|FG004|the Double-blind Phase|Pregnancy|0|||
162686191|NCT02287584|587561590|FG005|the Double-blind Phase|Pregnancy|0|||
162686192|NCT02287584|587561585|FG000|the Double-blind Phase|Protocol Violation|0|||
162686193|NCT02287584|587561586|FG001|the Double-blind Phase|Protocol Violation|3|||
162686194|NCT02287584|587561587|FG002|the Double-blind Phase|Protocol Violation|0|||
162686195|NCT02287584|587561588|FG003|the Double-blind Phase|Protocol Violation|0|||
162686196|NCT02287584|587561589|FG004|the Double-blind Phase|Protocol Violation|0|||
162686197|NCT02287584|587561590|FG005|the Double-blind Phase|Protocol Violation|0|||
162686198|NCT02287584|587561585|FG000|the Double-blind Phase|other reasons|0|||
162686199|NCT02287584|587561586|FG001|the Double-blind Phase|other reasons|0|||
162686200|NCT02287584|587561587|FG002|the Double-blind Phase|other reasons|1|||
162686201|NCT02287584|587561588|FG003|the Double-blind Phase|other reasons|0|||
162686202|NCT02287584|587561589|FG004|the Double-blind Phase|other reasons|0|||
162686203|NCT02287584|587561590|FG005|the Double-blind Phase|other reasons|0|||
162686204|NCT02287584|587561585|FG000|the Open-label Phase|Did not receive drug|0|||
162686205|NCT02287584|587561586|FG001|the Open-label Phase|Did not receive drug|0|||
162686206|NCT02287584|587561587|FG002|the Open-label Phase|Did not receive drug|0|||
162686207|NCT02287584|587561588|FG003|the Open-label Phase|Did not receive drug|7|||
162686208|NCT02287584|587561589|FG004|the Open-label Phase|Did not receive drug|6|||
162686209|NCT02287584|587561590|FG005|the Open-label Phase|Did not receive drug|4|||
162686210|NCT02287584|587561585|FG000|the Open-label Phase|Adverse Event|0|||
162686211|NCT02287584|587561586|FG001|the Open-label Phase|Adverse Event|0|||
162686212|NCT02287584|587561587|FG002|the Open-label Phase|Adverse Event|0|||
162686213|NCT02287584|587561588|FG003|the Open-label Phase|Adverse Event|15|||
162686214|NCT02287584|587561589|FG004|the Open-label Phase|Adverse Event|12|||
162686215|NCT02287584|587561590|FG005|the Open-label Phase|Adverse Event|16|||
162686216|NCT02287584|587561585|FG000|the Open-label Phase|Lack of Efficacy|0|||
162686217|NCT02287584|587561586|FG001|the Open-label Phase|Lack of Efficacy|0|||
162686218|NCT02287584|587561587|FG002|the Open-label Phase|Lack of Efficacy|0|||
162686219|NCT02287584|587561588|FG003|the Open-label Phase|Lack of Efficacy|8|||
162686220|NCT02287584|587561589|FG004|the Open-label Phase|Lack of Efficacy|3|||
162686221|NCT02287584|587561590|FG005|the Open-label Phase|Lack of Efficacy|7|||
162686222|NCT02287584|587561585|FG000|the Open-label Phase|Lost to Follow-up|0|||
162686223|NCT02287584|587561586|FG001|the Open-label Phase|Lost to Follow-up|0|||
162686224|NCT02287584|587561587|FG002|the Open-label Phase|Lost to Follow-up|0|||
162686225|NCT02287584|587561588|FG003|the Open-label Phase|Lost to Follow-up|4|||
162686226|NCT02287584|587561589|FG004|the Open-label Phase|Lost to Follow-up|1|||
162686227|NCT02287584|587561590|FG005|the Open-label Phase|Lost to Follow-up|2|||
162686228|NCT02287584|587561585|FG000|the Open-label Phase|Withdrawal by Subject|0|||
162686229|NCT02287584|587561586|FG001|the Open-label Phase|Withdrawal by Subject|0|||
162686230|NCT02287584|587561587|FG002|the Open-label Phase|Withdrawal by Subject|0|||
162686231|NCT02287584|587561588|FG003|the Open-label Phase|Withdrawal by Subject|18|||
162686232|NCT02287584|587561589|FG004|the Open-label Phase|Withdrawal by Subject|29|||
162686233|NCT02287584|587561590|FG005|the Open-label Phase|Withdrawal by Subject|21|||
162686234|NCT02287584|587561585|FG000|the Open-label Phase|non-compliance|0|||
162686235|NCT02287584|587561586|FG001|the Open-label Phase|non-compliance|0|||
162686236|NCT02287584|587561587|FG002|the Open-label Phase|non-compliance|0|||
162686237|NCT02287584|587561588|FG003|the Open-label Phase|non-compliance|2|||
162686238|NCT02287584|587561589|FG004|the Open-label Phase|non-compliance|5|||
162686239|NCT02287584|587561590|FG005|the Open-label Phase|non-compliance|1|||
162686240|NCT02287584|587561585|FG000|the Open-label Phase|other reasons|0|||
162686241|NCT02287584|587561586|FG001|the Open-label Phase|other reasons|0|||
162686242|NCT02287584|587561587|FG002|the Open-label Phase|other reasons|0|||
162686243|NCT02287584|587561588|FG003|the Open-label Phase|other reasons|3|||
162686244|NCT02287584|587561589|FG004|the Open-label Phase|other reasons|6|||
162686245|NCT02287584|587561590|FG005|the Open-label Phase|other reasons|6|||
162686246|NCT03086018|587561596|FG000|Final Testing for End of Trial|Adverse Event|1|||
162686247|NCT03086018|587561596|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
162686248|NCT01892345|587561597|FG000|Overall Study|Adverse Event|0|||
162686249|NCT01892345|587561598|FG001|Overall Study|Adverse Event|2|||
162686250|NCT01892345|587561597|FG000|Overall Study|Death|1|||
162686251|NCT01892345|587561598|FG001|Overall Study|Death|0|||
162686252|NCT01892345|587561597|FG000|Overall Study|Lost to Follow-up|3|||
162686253|NCT01892345|587561598|FG001|Overall Study|Lost to Follow-up|0|||
162686254|NCT01892345|587561597|FG000|Overall Study|Withdrawal by Subject|12|||
162686255|NCT01892345|587561598|FG001|Overall Study|Withdrawal by Subject|1|||
162686256|NCT00659984|587561601|FG000|Overall Study|Adverse Event|1|||
162686257|NCT03745222|587561602|FG000|Overall Study|Withdrawal by Subject|0|||
162686258|NCT03745222|587561603|FG001|Overall Study|Withdrawal by Subject|1|||
162686259|NCT03745222|587561604|FG002|Overall Study|Withdrawal by Subject|0|||
162686260|NCT02657317|587561605|FG000|Overall Study|Withdrawal by Subject|2|||
162686261|NCT02657317|587561606|FG001|Overall Study|Withdrawal by Subject|0|||
162686262|NCT02657317|587561605|FG000|Overall Study|Lost to Follow-up|3|||
162686263|NCT02657317|587561606|FG001|Overall Study|Lost to Follow-up|3|||
162686264|NCT01784068|587561610|FG000|NTCS Phase|Adverse Event|5|||
162686265|NCT01784068|587561611|FG001|NTCS Phase|Adverse Event|0|||
162686266|NCT01784068|587561610|FG000|NTCS Phase|Physician Decision|2|||
162686267|NCT01784068|587561611|FG001|NTCS Phase|Physician Decision|0|||
162686268|NCT01784068|587561610|FG000|NTCS Phase|Patient/guardian decision|3|||
162686269|NCT01784068|587561611|FG001|NTCS Phase|Patient/guardian decision|0|||
162686270|NCT01784068|587561610|FG000|NTCS Phase|Death|2|||
162686271|NCT01784068|587561611|FG001|NTCS Phase|Death|0|||
162686272|NCT01784068|587561610|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
162686273|NCT01784068|587561611|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
162686274|NCT01784068|587561610|FG000|TFR Phase|Physician Decision|0|||
162686275|NCT01784068|587561611|FG001|TFR Phase|Physician Decision|1|||
162686276|NCT01784068|587561610|FG000|TFR Phase|Patient/guardian decision|0|||
162686277|NCT01784068|587561611|FG001|TFR Phase|Patient/guardian decision|3|||
162686278|NCT01784068|587561610|FG000|TFR Phase|Death|0|||
162686279|NCT01784068|587561611|FG001|TFR Phase|Death|1|||
162686280|NCT01784068|587561610|FG000|TFR Phase|Lack of Efficacy|0|||
162686281|NCT01784068|587561611|FG001|TFR Phase|Lack of Efficacy|88|||
162686282|NCT06351371|587561612|FG000|Overall Study|Mutation Status Not Confirmed|9|||
162686283|NCT06351371|587561612|FG000|Overall Study|Ineligible|1|||
162686284|NCT06351371|587561612|FG000|Overall Study|Adverse Event|4|||
162686285|NCT06351371|587561612|FG000|Overall Study|Death|1|||
162686286|NCT06351371|587561612|FG000|Overall Study|Disease progression|14|||
162686287|NCT06351371|587561612|FG000|Overall Study|Withdrawal by Subject|3|||
162686288|NCT06351371|587561612|FG000|Overall Study|Physician Decision|3|||
162686289|NCT04359784|587561613|FG000|Overall Study|Death|2|||
162686290|NCT02063828|587561614|FG000|Overall Study|Withdrawal by Subject|4|||
162686291|NCT02063828|587561615|FG001|Overall Study|Withdrawal by Subject|6|||
162686292|NCT02063828|587561616|FG002|Overall Study|Withdrawal by Subject|3|||
162686293|NCT02063828|587561614|FG000|Overall Study|Death|0|||
162686294|NCT02063828|587561615|FG001|Overall Study|Death|0|||
162686295|NCT02063828|587561616|FG002|Overall Study|Death|1|||
162686296|NCT02753595|587561617|FG000|Overall Study|Sponsor termination|2|||
162686297|NCT02753595|587561618|FG001|Overall Study|Sponsor termination|2|||
162686298|NCT02515279|587561622|FG000|Overall Study|Adverse Event|7|||
162686299|NCT02515279|587561622|FG000|Overall Study|Lack of Efficacy|31|||
162686300|NCT02515279|587561622|FG000|Overall Study|Lost to Follow-up|9|||
162686301|NCT02515279|587561622|FG000|Overall Study|Withdrawal by Subject|18|||
162686302|NCT02515279|587561622|FG000|Overall Study|End-of-treatment visit not attended|17|||
162686303|NCT02515279|587561622|FG000|Overall Study|Other|22|||
162686304|NCT01800968|587561623|FG000|Overall Study|Death|23|||
162686305|NCT01800968|587561624|FG001|Overall Study|Death|16|||
162686306|NCT01800968|587561623|FG000|Overall Study|Lost to Follow-up|5|||
162686307|NCT01800968|587561624|FG001|Overall Study|Lost to Follow-up|7|||
162686308|NCT01800968|587561623|FG000|Overall Study|Withdrawal by Subject|7|||
162686309|NCT01800968|587561624|FG001|Overall Study|Withdrawal by Subject|9|||
162686310|NCT01800968|587561623|FG000|Overall Study|Physician Decision|1|||
162686311|NCT01800968|587561624|FG001|Overall Study|Physician Decision|0|||
162686312|NCT04987762|587561626|FG000|Overall Study|Study was Terminated by Sponsor|103|||
162686313|NCT02068495|587561627|FG000|Overall Study|Case Report Forms Uncollected|60|||
162686314|NCT02068495|587561627|FG000|Overall Study|Protocol Deviation|49|||
162686315|NCT01666808|587561630|FG000|Overall Study|Lost to Follow-up|9|||
162686316|NCT01666808|587561631|FG001|Overall Study|Lost to Follow-up|15|||
162686317|NCT01666808|587561630|FG000|Overall Study|Withdrawal by Subject|3|||
162686318|NCT01666808|587561631|FG001|Overall Study|Withdrawal by Subject|1|||
162686319|NCT01666808|587561630|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
162686320|NCT01666808|587561631|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
162686321|NCT02220894|587561632|FG000|Overall Study|Adverse Event|127|||
162686322|NCT02220894|587561633|FG001|Overall Study|Adverse Event|74|||
162686323|NCT02220894|587561632|FG000|Overall Study|Death|418|||
162686324|NCT02220894|587561633|FG001|Overall Study|Death|508|||
162686325|NCT02220894|587561632|FG000|Overall Study|Lost to Follow-up|0|||
162686326|NCT02220894|587561633|FG001|Overall Study|Lost to Follow-up|4|||
162686327|NCT02220894|587561632|FG000|Overall Study|Site Terminated by Sponsor|2|||
162686328|NCT02220894|587561633|FG001|Overall Study|Site Terminated by Sponsor|0|||
162686329|NCT02220894|587561632|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
162686330|NCT02220894|587561633|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
162686331|NCT02220894|587561632|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162686332|NCT02220894|587561633|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162686333|NCT02220894|587561632|FG000|Overall Study|Withdrawal by Subject|10|||
162686334|NCT02220894|587561633|FG001|Overall Study|Withdrawal by Subject|9|||
162686335|NCT03217747|587561634|FG000|Overall Study|Adverse Event|0|||
162686336|NCT03217747|587561635|FG001|Overall Study|Adverse Event|1|||
162686337|NCT03217747|587561636|FG002|Overall Study|Adverse Event|0|||
162686338|NCT03217747|587561637|FG003|Overall Study|Adverse Event|0|||
162686339|NCT03217747|587561638|FG004|Overall Study|Adverse Event|0|||
162686340|NCT03217747|587561639|FG005|Overall Study|Adverse Event|0|||
162686341|NCT03217747|587561640|FG006|Overall Study|Adverse Event|0|||
162686342|NCT03217747|587561641|FG007|Overall Study|Adverse Event|0|||
162686343|NCT03217747|587561642|FG008|Overall Study|Adverse Event|0|||
162686344|NCT03217747|587561643|FG009|Overall Study|Adverse Event|0|||
162686345|NCT03217747|587561644|FG010|Overall Study|Adverse Event|0|||
162686346|NCT03217747|587561645|FG011|Overall Study|Adverse Event|0|||
162686347|NCT03217747|587561646|FG012|Overall Study|Adverse Event|1|||
162686348|NCT03217747|587561647|FG013|Overall Study|Adverse Event|1|||
162686349|NCT03217747|587561634|FG000|Overall Study|Death|0|||
162686350|NCT03217747|587561635|FG001|Overall Study|Death|0|||
162686351|NCT03217747|587561636|FG002|Overall Study|Death|0|||
162686352|NCT03217747|587561637|FG003|Overall Study|Death|0|||
162686353|NCT03217747|587561638|FG004|Overall Study|Death|0|||
162686354|NCT03217747|587561639|FG005|Overall Study|Death|0|||
162686355|NCT03217747|587561640|FG006|Overall Study|Death|0|||
162686356|NCT03217747|587561641|FG007|Overall Study|Death|0|||
162686357|NCT03217747|587561642|FG008|Overall Study|Death|1|||
162686358|NCT03217747|587561643|FG009|Overall Study|Death|0|||
162686359|NCT03217747|587561644|FG010|Overall Study|Death|0|||
162686360|NCT03217747|587561645|FG011|Overall Study|Death|0|||
162686361|NCT03217747|587561646|FG012|Overall Study|Death|0|||
162686362|NCT03217747|587561647|FG013|Overall Study|Death|0|||
162686363|NCT03217747|587561634|FG000|Overall Study|Lack of Efficacy|12|||
162686364|NCT03217747|587561635|FG001|Overall Study|Lack of Efficacy|6|||
162686365|NCT03217747|587561636|FG002|Overall Study|Lack of Efficacy|15|||
162686366|NCT03217747|587561637|FG003|Overall Study|Lack of Efficacy|11|||
162686367|NCT03217747|587561638|FG004|Overall Study|Lack of Efficacy|3|||
162686368|NCT03217747|587561639|FG005|Overall Study|Lack of Efficacy|14|||
162686369|NCT03217747|587561640|FG006|Overall Study|Lack of Efficacy|10|||
162686370|NCT03217747|587561641|FG007|Overall Study|Lack of Efficacy|4|||
162686371|NCT03217747|587561642|FG008|Overall Study|Lack of Efficacy|2|||
162686372|NCT03217747|587561643|FG009|Overall Study|Lack of Efficacy|7|||
162686373|NCT03217747|587561644|FG010|Overall Study|Lack of Efficacy|3|||
162686374|NCT03217747|587561645|FG011|Overall Study|Lack of Efficacy|1|||
162686375|NCT03217747|587561646|FG012|Overall Study|Lack of Efficacy|3|||
162686376|NCT03217747|587561647|FG013|Overall Study|Lack of Efficacy|1|||
162686377|NCT03217747|587561634|FG000|Overall Study|Withdrawal by Subject|2|||
162686378|NCT03217747|587561635|FG001|Overall Study|Withdrawal by Subject|1|||
162686379|NCT03217747|587561636|FG002|Overall Study|Withdrawal by Subject|1|||
162686380|NCT03217747|587561637|FG003|Overall Study|Withdrawal by Subject|1|||
162686381|NCT03217747|587561638|FG004|Overall Study|Withdrawal by Subject|1|||
162686382|NCT03217747|587561639|FG005|Overall Study|Withdrawal by Subject|2|||
162686383|NCT03217747|587561640|FG006|Overall Study|Withdrawal by Subject|1|||
162686384|NCT03217747|587561641|FG007|Overall Study|Withdrawal by Subject|0|||
162686385|NCT03217747|587561642|FG008|Overall Study|Withdrawal by Subject|0|||
162686386|NCT03217747|587561643|FG009|Overall Study|Withdrawal by Subject|0|||
162686387|NCT03217747|587561644|FG010|Overall Study|Withdrawal by Subject|0|||
162686388|NCT03217747|587561645|FG011|Overall Study|Withdrawal by Subject|1|||
162686389|NCT03217747|587561646|FG012|Overall Study|Withdrawal by Subject|0|||
162686390|NCT03217747|587561647|FG013|Overall Study|Withdrawal by Subject|1|||
162686391|NCT03217747|587561634|FG000|Overall Study|Toxicity and progression|1|||
162686392|NCT03217747|587561635|FG001|Overall Study|Toxicity and progression|0|||
162686393|NCT03217747|587561636|FG002|Overall Study|Toxicity and progression|0|||
162686394|NCT03217747|587561637|FG003|Overall Study|Toxicity and progression|0|||
162686395|NCT03217747|587561638|FG004|Overall Study|Toxicity and progression|0|||
162686396|NCT03217747|587561639|FG005|Overall Study|Toxicity and progression|0|||
162686397|NCT03217747|587561640|FG006|Overall Study|Toxicity and progression|0|||
162686398|NCT03217747|587561641|FG007|Overall Study|Toxicity and progression|0|||
162686399|NCT03217747|587561642|FG008|Overall Study|Toxicity and progression|0|||
162686400|NCT03217747|587561643|FG009|Overall Study|Toxicity and progression|0|||
162686401|NCT03217747|587561644|FG010|Overall Study|Toxicity and progression|0|||
162686402|NCT03217747|587561645|FG011|Overall Study|Toxicity and progression|0|||
162686403|NCT03217747|587561646|FG012|Overall Study|Toxicity and progression|0|||
162686404|NCT03217747|587561647|FG013|Overall Study|Toxicity and progression|0|||
162686405|NCT03217747|587561634|FG000|Overall Study|Removal of sole target lesion|1|||
162686406|NCT03217747|587561635|FG001|Overall Study|Removal of sole target lesion|0|||
162686407|NCT03217747|587561636|FG002|Overall Study|Removal of sole target lesion|0|||
162686408|NCT03217747|587561637|FG003|Overall Study|Removal of sole target lesion|0|||
162686409|NCT03217747|587561638|FG004|Overall Study|Removal of sole target lesion|0|||
162686410|NCT03217747|587561639|FG005|Overall Study|Removal of sole target lesion|0|||
162686411|NCT03217747|587561640|FG006|Overall Study|Removal of sole target lesion|0|||
162686412|NCT03217747|587561641|FG007|Overall Study|Removal of sole target lesion|0|||
162686413|NCT03217747|587561642|FG008|Overall Study|Removal of sole target lesion|0|||
162726261|NCT03575052|587708211|FG000|Overall Study|Death|2|||
162686414|NCT03217747|587561643|FG009|Overall Study|Removal of sole target lesion|0|||
162686415|NCT03217747|587561644|FG010|Overall Study|Removal of sole target lesion|0|||
162686416|NCT03217747|587561645|FG011|Overall Study|Removal of sole target lesion|0|||
162686417|NCT03217747|587561646|FG012|Overall Study|Removal of sole target lesion|0|||
162686418|NCT03217747|587561647|FG013|Overall Study|Removal of sole target lesion|0|||
162686419|NCT03217747|587561634|FG000|Overall Study|Stroke|0|||
162686420|NCT03217747|587561635|FG001|Overall Study|Stroke|0|||
162686421|NCT03217747|587561636|FG002|Overall Study|Stroke|0|||
162686422|NCT03217747|587561637|FG003|Overall Study|Stroke|0|||
162686423|NCT03217747|587561638|FG004|Overall Study|Stroke|0|||
162686424|NCT03217747|587561639|FG005|Overall Study|Stroke|1|||
162686425|NCT03217747|587561640|FG006|Overall Study|Stroke|0|||
162686426|NCT03217747|587561641|FG007|Overall Study|Stroke|0|||
162686427|NCT03217747|587561642|FG008|Overall Study|Stroke|0|||
162686428|NCT03217747|587561643|FG009|Overall Study|Stroke|0|||
162686429|NCT03217747|587561644|FG010|Overall Study|Stroke|0|||
162686430|NCT03217747|587561645|FG011|Overall Study|Stroke|1|||
162686431|NCT03217747|587561646|FG012|Overall Study|Stroke|0|||
162686432|NCT03217747|587561647|FG013|Overall Study|Stroke|0|||
162686433|NCT03248375|587561648|FG000|Overall Study|Lost to Follow-up|5|||
162686434|NCT00394355|587561649|FG000|Overall Study|Adverse Event|10|||
162686435|NCT00394355|587561650|FG001|Overall Study|Adverse Event|6|||
162686436|NCT00394355|587561651|FG002|Overall Study|Adverse Event|7|||
162686437|NCT00394355|587561652|FG003|Overall Study|Adverse Event|8|||
162686438|NCT00394355|587561649|FG000|Overall Study|Did not meet protocol eligibility|1|||
162686439|NCT00394355|587561650|FG001|Overall Study|Did not meet protocol eligibility|5|||
162686440|NCT00394355|587561651|FG002|Overall Study|Did not meet protocol eligibility|4|||
162686441|NCT00394355|587561652|FG003|Overall Study|Did not meet protocol eligibility|2|||
162686442|NCT00394355|587561649|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
162686443|NCT00394355|587561650|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
162686444|NCT00394355|587561651|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
162726262|NCT03575052|587708212|FG001|Overall Study|Death|1|||
162726263|NCT03575052|587708211|FG000|Overall Study|Lack of Efficacy|2|||
162726264|NCT03575052|587708212|FG001|Overall Study|Lack of Efficacy|1|||
162726265|NCT03575052|587708211|FG000|Overall Study|Study drug noncompliance|1|||
162726266|NCT03575052|587708212|FG001|Overall Study|Study drug noncompliance|2|||
162726267|NCT03575052|587708211|FG000|Overall Study|Protocol Violation|0|||
162726268|NCT03575052|587708212|FG001|Overall Study|Protocol Violation|2|||
162726269|NCT03575052|587708211|FG000|Overall Study|Physician Decision|1|||
162726270|NCT03575052|587708212|FG001|Overall Study|Physician Decision|0|||
162726271|NCT01622868|587708222|FG000|Overall Study|Protocol Violation|7|||
162726272|NCT01622868|587708223|FG001|Overall Study|Protocol Violation|0|||
162726273|NCT03285763|587708225|FG000|Overall Study|Death|470|||
162726274|NCT03285763|587708225|FG000|Overall Study|Lost to Follow-up|18|||
162726275|NCT03285763|587708225|FG000|Overall Study|Physician Decision|2|||
162726276|NCT03285763|587708225|FG000|Overall Study|Study Terminated By Sponsor|79|||
162726277|NCT03285763|587708225|FG000|Overall Study|Withdrawal by Subject|33|||
162726278|NCT03624972|587708226|FG000|Overall Study|Lost to Follow-up|2|||
162726279|NCT03624972|587708227|FG001|Overall Study|Lost to Follow-up|0|||
162726280|NCT03624972|587708228|FG002|Overall Study|Lost to Follow-up|0|||
162726281|NCT03624972|587708226|FG000|Overall Study|Withdrawal by Subject|0|||
162686445|NCT00394355|587561652|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
162686446|NCT00394355|587561649|FG000|Overall Study|Subject withdrawal - related to drug|1|||
162686447|NCT00394355|587561650|FG001|Overall Study|Subject withdrawal - related to drug|0|||
162686448|NCT00394355|587561651|FG002|Overall Study|Subject withdrawal - related to drug|0|||
162686449|NCT00394355|587561652|FG003|Overall Study|Subject withdrawal - related to drug|0|||
162686450|NCT00394355|587561649|FG000|Overall Study|Lost to Follow-up|7|||
162686451|NCT00394355|587561650|FG001|Overall Study|Lost to Follow-up|5|||
162686452|NCT00394355|587561651|FG002|Overall Study|Lost to Follow-up|4|||
162686453|NCT00394355|587561652|FG003|Overall Study|Lost to Follow-up|3|||
162686454|NCT00394355|587561649|FG000|Overall Study|Noncompliance with protocol|4|||
162686455|NCT00394355|587561650|FG001|Overall Study|Noncompliance with protocol|3|||
162726282|NCT03624972|587708227|FG001|Overall Study|Withdrawal by Subject|2|||
162726283|NCT03624972|587708228|FG002|Overall Study|Withdrawal by Subject|0|||
162726284|NCT03112174|587708229|FG000|Overall Study|Withdrawal by Subject|3|||
162686456|NCT00394355|587561651|FG002|Overall Study|Noncompliance with protocol|10|||
162686457|NCT00394355|587561652|FG003|Overall Study|Noncompliance with protocol|8|||
162686458|NCT00394355|587561649|FG000|Overall Study|Administrative|0|||
162686459|NCT00394355|587561650|FG001|Overall Study|Administrative|1|||
162686460|NCT00394355|587561651|FG002|Overall Study|Administrative|1|||
162686461|NCT00394355|587561652|FG003|Overall Study|Administrative|1|||
162686462|NCT00394355|587561649|FG000|Overall Study|Lack of Efficacy|0|||
162726285|NCT03112174|587708230|FG001|Overall Study|Withdrawal by Subject|0|||
162726286|NCT03112174|587708231|FG002|Overall Study|Withdrawal by Subject|11|||
162726287|NCT03112174|587708232|FG003|Overall Study|Withdrawal by Subject|9|||
162686463|NCT00394355|587561650|FG001|Overall Study|Lack of Efficacy|0|||
162686464|NCT00394355|587561651|FG002|Overall Study|Lack of Efficacy|2|||
162726288|NCT03112174|587708233|FG004|Overall Study|Withdrawal by Subject|7|||
162686465|NCT00394355|587561652|FG003|Overall Study|Lack of Efficacy|3|||
162686466|NCT02618616|587561655|FG000|Overall Study|Lack of Efficacy|4|||
162686467|NCT02618616|587561656|FG001|Overall Study|Lack of Efficacy|0|||
162686468|NCT02618616|587561655|FG000|Overall Study|Pregnancy|0|||
162686469|NCT02618616|587561656|FG001|Overall Study|Pregnancy|1|||
162686470|NCT02618616|587561655|FG000|Overall Study|Adverse Event|8|||
162686471|NCT02618616|587561656|FG001|Overall Study|Adverse Event|0|||
162686472|NCT02618616|587561655|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
162686473|NCT02618616|587561656|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
162686474|NCT02618616|587561655|FG000|Overall Study|Consent withdrawn by subject|8|||
162686475|NCT02618616|587561656|FG001|Overall Study|Consent withdrawn by subject|5|||
162686476|NCT02618616|587561655|FG000|Overall Study|Lost to Follow-up|0|||
162686477|NCT02618616|587561656|FG001|Overall Study|Lost to Follow-up|1|||
162686478|NCT03904043|587561657|FG000|Overall Study|Adverse Event|1|||
162686479|NCT03904043|587561658|FG001|Overall Study|Adverse Event|1|||
162686480|NCT03904043|587561657|FG000|Overall Study|Withdrawal by Subject|1|||
162686481|NCT03904043|587561658|FG001|Overall Study|Withdrawal by Subject|0|||
162686482|NCT03904043|587561657|FG000|Overall Study|Non-compliance|1|||
162686483|NCT03904043|587561658|FG001|Overall Study|Non-compliance|0|||
162686484|NCT03904043|587561657|FG000|Overall Study|Did not start treatment|1|||
162686485|NCT03904043|587561658|FG001|Overall Study|Did not start treatment|0|||
162686486|NCT05002218|587561666|FG000|Overall Study|Lost to Follow-up|5|||
162686487|NCT05002218|587561667|FG001|Overall Study|Lost to Follow-up|6|||
162686488|NCT03779906|587561668|FG000|Overall Study|Lost to Follow-up|7|||
162686489|NCT03779906|587561668|FG000|Overall Study|COVID pandemic|1|||
162686490|NCT03421808|587561669|FG000|Overall Study|COVID related problems|2|||
162686491|NCT03421808|587561670|FG001|Overall Study|COVID related problems|0|||
162686492|NCT03421808|587561669|FG000|Overall Study|Withdrawal by Subject|1|||
162686493|NCT03421808|587561670|FG001|Overall Study|Withdrawal by Subject|0|||
162686494|NCT03421808|587561669|FG000|Overall Study|Protocol Violation|0|||
162686495|NCT03421808|587561670|FG001|Overall Study|Protocol Violation|1|||
162686496|NCT00766675|587563027|FG000|Overall Study|Adverse Event|16|||
162686497|NCT00766675|587563027|FG000|Overall Study|Lost to Follow-up|2|||
162686498|NCT00766675|587563027|FG000|Overall Study|Withdrawal by Subject|11|||
162686499|NCT00766675|587563027|FG000|Overall Study|Protocol Violation|8|||
162686500|NCT00766675|587563027|FG000|Overall Study|Participant took prohibited medication|1|||
162686501|NCT00766675|587563027|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
162686502|NCT00766675|587563027|FG000|Overall Study|Insufficient therapy|1|||
162686503|NCT02044848|587563028|FG000|Overall Study|Administrative Problems|2|||
162686504|NCT02044848|587563029|FG001|Overall Study|Administrative Problems|3|||
162686505|NCT03183388|587563030|FG000|Overall Study|Lost to Follow-up|3|||
162686506|NCT03183388|587563031|FG001|Overall Study|Lost to Follow-up|5|||
162686507|NCT03183388|587563030|FG000|Overall Study|Physician Decision|1|||
162686508|NCT03183388|587563031|FG001|Overall Study|Physician Decision|4|||
162686509|NCT03183388|587563030|FG000|Overall Study|Withdrawal by Subject|4|||
162686510|NCT03183388|587563031|FG001|Overall Study|Withdrawal by Subject|1|||
162686511|NCT03183388|587563030|FG000|Overall Study|Moved|1|||
162686512|NCT03183388|587563031|FG001|Overall Study|Moved|0|||
162686513|NCT03183388|587563030|FG000|Overall Study|Met Exclusion Criteria|2|||
162686514|NCT03183388|587563031|FG001|Overall Study|Met Exclusion Criteria|2|||
162686515|NCT03183388|587563030|FG000|Overall Study|COVID Pandemic Related|2|||
162686516|NCT03183388|587563031|FG001|Overall Study|COVID Pandemic Related|4|||
162686517|NCT01679236|587563032|FG000|Overall Study|Lost to Follow-up|15|||
162686518|NCT01679236|587563033|FG001|Overall Study|Lost to Follow-up|15|||
162686519|NCT03935217|587563036|FG000|Overall Study|Adverse Event|1|||
162686520|NCT03935217|587563037|FG001|Overall Study|Adverse Event|0|||
162686521|NCT03935217|587563036|FG000|Overall Study|Lost to Follow-up|0|||
162686522|NCT03935217|587563037|FG001|Overall Study|Lost to Follow-up|1|||
162686523|NCT03935217|587563036|FG000|Overall Study|Withdrawal by Subject|0|||
162686524|NCT03935217|587563037|FG001|Overall Study|Withdrawal by Subject|2|||
162686525|NCT00803101|587563046|FG000|Overall Study|Death / Serious Adverse Event|4|||
162686526|NCT00803101|587563047|FG001|Overall Study|Death / Serious Adverse Event|6|||
162686527|NCT00803101|587563046|FG000|Overall Study|Withdrawal by Subject|6|||
162686528|NCT00803101|587563047|FG001|Overall Study|Withdrawal by Subject|4|||
162686529|NCT00803101|587563046|FG000|Overall Study|Lost to Follow-up|2|||
162686530|NCT00803101|587563047|FG001|Overall Study|Lost to Follow-up|2|||
162726289|NCT03112174|587708229|FG000|Overall Study|Lost to Follow-up|1|||
162686531|NCT00803101|587563046|FG000|Overall Study|Protocol Violation|1|||
162686532|NCT00803101|587563047|FG001|Overall Study|Protocol Violation|7|||
162686533|NCT00803101|587563046|FG000|Overall Study|Surgery finished outside protocol window|1|||
162686534|NCT00803101|587563047|FG001|Overall Study|Surgery finished outside protocol window|1|||
162686535|NCT00803101|587563046|FG000|Overall Study|Patient died outside SAE report period|1|||
162686536|NCT00803101|587563047|FG001|Overall Study|Patient died outside SAE report period|0|||
162686537|NCT00803101|587563046|FG000|Overall Study|Patient did not attend scheduled visit|2|||
162686538|NCT00803101|587563047|FG001|Overall Study|Patient did not attend scheduled visit|1|||
162686539|NCT00803101|587563046|FG000|Overall Study|Patient did not have surgery|1|||
162726290|NCT03112174|587708230|FG001|Overall Study|Lost to Follow-up|1|||
162686540|NCT00803101|587563047|FG001|Overall Study|Patient did not have surgery|1|||
162686541|NCT02026232|587563050|FG000|Overall Study|incomplete visit/missing data|3|||
162686542|NCT02026232|587563051|FG001|Overall Study|incomplete visit/missing data|2|||
162686543|NCT01529008|587563052|FG000|Bone Marrow Harvesting|Physician Decision|1|||
162686544|NCT01529008|587563053|FG001|Bone Marrow Harvesting|Physician Decision|1|||
162686545|NCT01529008|587563052|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
162686546|NCT01529008|587563053|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
162686547|NCT01529008|587563052|FG000|Treatment|Adverse Event|6|||
162686548|NCT01529008|587563053|FG001|Treatment|Adverse Event|0|||
162686549|NCT01529008|587563052|FG000|Treatment|Other|3|||
162686550|NCT01529008|587563053|FG001|Treatment|Other|1|||
162686551|NCT01529008|587563052|FG000|Efficacy Analysis|Protocol Violation|2|||
162686552|NCT01529008|587563053|FG001|Efficacy Analysis|Protocol Violation|0|||
162686553|NCT01529008|587563052|FG000|Efficacy Analysis|Physician Decision|0|||
162686554|NCT01529008|587563053|FG001|Efficacy Analysis|Physician Decision|1|||
162686555|NCT01529008|587563052|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
162686556|NCT01529008|587563053|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
162686557|NCT02487498|587563054|FG000|Period: Period 1|Adverse Event|2|||
162686558|NCT02487498|587563055|FG001|Period: Period 1|Adverse Event|4|||
162686559|NCT02487498|587563054|FG000|Period: Period 1|Subject/guardian decision|2|||
162686560|NCT02487498|587563055|FG001|Period: Period 1|Subject/guardian decision|4|||
162686561|NCT02487498|587563054|FG000|Period: Period 1|Lost to Follow-up|0|||
162686562|NCT02487498|587563055|FG001|Period: Period 1|Lost to Follow-up|2|||
162726291|NCT03112174|587708231|FG002|Overall Study|Lost to Follow-up|2|||
162726292|NCT03112174|587708232|FG003|Overall Study|Lost to Follow-up|3|||
162726293|NCT03112174|587708233|FG004|Overall Study|Lost to Follow-up|2|||
162726294|NCT03112174|587708229|FG000|Overall Study|Death|8|||
162726295|NCT03112174|587708230|FG001|Overall Study|Death|3|||
162726296|NCT03112174|587708231|FG002|Overall Study|Death|67|||
162726297|NCT03112174|587708232|FG003|Overall Study|Death|73|||
162726298|NCT03112174|587708233|FG004|Overall Study|Death|18|||
162726299|NCT03112174|587708229|FG000|Overall Study|Other, Not Specified|1|||
162726300|NCT03112174|587708230|FG001|Overall Study|Other, Not Specified|0|||
162726301|NCT03112174|587708231|FG002|Overall Study|Other, Not Specified|1|||
162726302|NCT03112174|587708232|FG003|Overall Study|Other, Not Specified|2|||
162726303|NCT03112174|587708233|FG004|Overall Study|Other, Not Specified|0|||
162726304|NCT04425629|587708234|FG000|Overall Study|Adverse Event|0|||
162726305|NCT04425629|587708235|FG001|Overall Study|Adverse Event|0|||
162726306|NCT04425629|587708236|FG002|Overall Study|Adverse Event|0|||
162726307|NCT04425629|587708237|FG003|Overall Study|Adverse Event|0|||
162726308|NCT04425629|587708238|FG004|Overall Study|Adverse Event|1|||
162726309|NCT04425629|587708239|FG005|Overall Study|Adverse Event|0|||
162726310|NCT04425629|587708240|FG006|Overall Study|Adverse Event|0|||
162726311|NCT04425629|587708241|FG007|Overall Study|Adverse Event|0|||
162726312|NCT04425629|587708242|FG008|Overall Study|Adverse Event|0|||
162726313|NCT04425629|587708243|FG009|Overall Study|Adverse Event|3|||
162726314|NCT04425629|587708244|FG010|Overall Study|Adverse Event|2|||
162726315|NCT04425629|587708245|FG011|Overall Study|Adverse Event|1|||
162726316|NCT04425629|587708246|FG012|Overall Study|Adverse Event|1|||
162686563|NCT02487498|587563054|FG000|Period: Period 1|Lack of Efficacy|1|||
162686564|NCT02487498|587563055|FG001|Period: Period 1|Lack of Efficacy|0|||
162686565|NCT02487498|587563054|FG000|Period: Period 1|Physician Decision|0|||
162686566|NCT02487498|587563055|FG001|Period: Period 1|Physician Decision|1|||
162686567|NCT02487498|587563054|FG000|Period: Period 1|Protocol deviation|1|||
162686568|NCT02487498|587563055|FG001|Period: Period 1|Protocol deviation|0|||
162686569|NCT02487498|587563054|FG000|Period: Washout|Subject/guardian decision|0|||
162686570|NCT02487498|587563055|FG001|Period: Washout|Subject/guardian decision|5|||
162686571|NCT02487498|587563054|FG000|Period: Washout|Lack of Efficacy|1|||
162686572|NCT02487498|587563055|FG001|Period: Washout|Lack of Efficacy|1|||
162686573|NCT02487498|587563054|FG000|Period: Washout|Physician Decision|1|||
162686574|NCT02487498|587563055|FG001|Period: Washout|Physician Decision|0|||
162686575|NCT02487498|587563054|FG000|Period: Washout|Non-compliance with study treatment|0|||
162686576|NCT02487498|587563055|FG001|Period: Washout|Non-compliance with study treatment|1|||
162686577|NCT02487498|587563054|FG000|Period: Period 2|Adverse Event|2|||
162686578|NCT02487498|587563055|FG001|Period: Period 2|Adverse Event|2|||
162686579|NCT02487498|587563054|FG000|Period: Period 2|Subject/guardian decision|2|||
162686580|NCT02487498|587563055|FG001|Period: Period 2|Subject/guardian decision|1|||
162686581|NCT02487498|587563054|FG000|Period: Period 2|Lost to Follow-up|1|||
162686582|NCT02487498|587563055|FG001|Period: Period 2|Lost to Follow-up|1|||
162686583|NCT02487498|587563054|FG000|Period: Period 2|Death|0|||
162686584|NCT02487498|587563055|FG001|Period: Period 2|Death|1|||
162686585|NCT02487498|587563054|FG000|Period: Period 2|Physician Decision|1|||
162686586|NCT02487498|587563055|FG001|Period: Period 2|Physician Decision|0|||
162686587|NCT00755222|587563056|FG000|Overall Study|Withdrawal by Subject|4|||
162726317|NCT04425629|587708247|FG013|Overall Study|Adverse Event|0|||
162726318|NCT04425629|587708248|FG014|Overall Study|Adverse Event|0|||
162726319|NCT04425629|587708249|FG015|Overall Study|Adverse Event|0|||
162726320|NCT04425629|587708250|FG016|Overall Study|Adverse Event|0|||
162686588|NCT00755222|587563057|FG001|Overall Study|Withdrawal by Subject|2|||
162686589|NCT00755222|587563056|FG000|Overall Study|Adverse Event|2|||
162686590|NCT00755222|587563057|FG001|Overall Study|Adverse Event|0|||
162686591|NCT00755222|587563056|FG000|Overall Study|Protocol Violation|2|||
162686592|NCT00755222|587563057|FG001|Overall Study|Protocol Violation|0|||
162686593|NCT00331344|587563058|FG000|Phase I|Adverse Event|0|||
162686594|NCT00331344|587563059|FG001|Phase I|Adverse Event|0|||
162686595|NCT00331344|587563060|FG002|Phase I|Adverse Event|0|||
162686596|NCT00331344|587563061|FG003|Phase I|Adverse Event|1|||
162686597|NCT00331344|587563062|FG004|Phase I|Adverse Event|2|||
162726321|NCT04425629|587708251|FG017|Overall Study|Adverse Event|0|||
162726322|NCT04425629|587708252|FG018|Overall Study|Adverse Event|0|||
162726323|NCT04425629|587708234|FG000|Overall Study|Lost to Follow-up|1|||
162726324|NCT04425629|587708235|FG001|Overall Study|Lost to Follow-up|3|||
162726325|NCT04425629|587708236|FG002|Overall Study|Lost to Follow-up|1|||
162726326|NCT04425629|587708237|FG003|Overall Study|Lost to Follow-up|7|||
162726327|NCT04425629|587708238|FG004|Overall Study|Lost to Follow-up|1|||
162726328|NCT04425629|587708239|FG005|Overall Study|Lost to Follow-up|2|||
162726329|NCT04425629|587708240|FG006|Overall Study|Lost to Follow-up|1|||
162726330|NCT04425629|587708241|FG007|Overall Study|Lost to Follow-up|0|||
162726331|NCT04425629|587708242|FG008|Overall Study|Lost to Follow-up|1|||
162726332|NCT04425629|587708243|FG009|Overall Study|Lost to Follow-up|64|||
162726333|NCT04425629|587708244|FG010|Overall Study|Lost to Follow-up|70|||
162726334|NCT04425629|587708245|FG011|Overall Study|Lost to Follow-up|98|||
162726335|NCT04425629|587708246|FG012|Overall Study|Lost to Follow-up|30|||
162726336|NCT04425629|587708247|FG013|Overall Study|Lost to Follow-up|0|||
162726337|NCT04425629|587708248|FG014|Overall Study|Lost to Follow-up|5|||
162726338|NCT04425629|587708249|FG015|Overall Study|Lost to Follow-up|4|||
162726339|NCT04425629|587708250|FG016|Overall Study|Lost to Follow-up|0|||
162726340|NCT04425629|587708251|FG017|Overall Study|Lost to Follow-up|3|||
162726341|NCT04425629|587708252|FG018|Overall Study|Lost to Follow-up|1|||
162726342|NCT04425629|587708234|FG000|Overall Study|Subject Decision|0|||
162726343|NCT04425629|587708235|FG001|Overall Study|Subject Decision|2|||
162726344|NCT04425629|587708236|FG002|Overall Study|Subject Decision|1|||
162726345|NCT04425629|587708237|FG003|Overall Study|Subject Decision|3|||
162726346|NCT04425629|587708238|FG004|Overall Study|Subject Decision|6|||
162726347|NCT04425629|587708239|FG005|Overall Study|Subject Decision|6|||
162726348|NCT04425629|587708240|FG006|Overall Study|Subject Decision|3|||
162726349|NCT04425629|587708241|FG007|Overall Study|Subject Decision|3|||
162726350|NCT04425629|587708242|FG008|Overall Study|Subject Decision|1|||
162726351|NCT04425629|587708243|FG009|Overall Study|Subject Decision|70|||
162726352|NCT04425629|587708244|FG010|Overall Study|Subject Decision|95|||
162726353|NCT04425629|587708245|FG011|Overall Study|Subject Decision|124|||
162726354|NCT04425629|587708246|FG012|Overall Study|Subject Decision|25|||
162726355|NCT04425629|587708247|FG013|Overall Study|Subject Decision|0|||
162726356|NCT04425629|587708248|FG014|Overall Study|Subject Decision|1|||
162726357|NCT04425629|587708249|FG015|Overall Study|Subject Decision|4|||
162726358|NCT04425629|587708250|FG016|Overall Study|Subject Decision|1|||
162726359|NCT04425629|587708251|FG017|Overall Study|Subject Decision|0|||
162726360|NCT04425629|587708252|FG018|Overall Study|Subject Decision|2|||
162726361|NCT04425629|587708234|FG000|Overall Study|Death|0|||
162726362|NCT04425629|587708235|FG001|Overall Study|Death|0|||
162686598|NCT00331344|587563063|FG005|Phase I|Adverse Event|2|||
162686599|NCT00331344|587563064|FG006|Phase I|Adverse Event|0|||
162686600|NCT00331344|587563065|FG007|Phase I|Adverse Event|1|||
162686601|NCT00331344|587563066|FG008|Phase I|Adverse Event|0|||
162686602|NCT00331344|587563058|FG000|Phase II|Death|0|||
162686603|NCT00331344|587563059|FG001|Phase II|Death|0|||
162686604|NCT00331344|587563060|FG002|Phase II|Death|0|||
162726363|NCT04425629|587708236|FG002|Overall Study|Death|0|||
162726364|NCT04425629|587708237|FG003|Overall Study|Death|0|||
162726365|NCT04425629|587708238|FG004|Overall Study|Death|0|||
162726366|NCT04425629|587708239|FG005|Overall Study|Death|0|||
162726367|NCT04425629|587708240|FG006|Overall Study|Death|0|||
162726368|NCT04425629|587708241|FG007|Overall Study|Death|0|||
162726369|NCT04425629|587708242|FG008|Overall Study|Death|0|||
162686605|NCT00331344|587563061|FG003|Phase II|Death|0|||
162726370|NCT04425629|587708243|FG009|Overall Study|Death|11|||
162726371|NCT04425629|587708244|FG010|Overall Study|Death|2|||
162726372|NCT04425629|587708245|FG011|Overall Study|Death|4|||
162726373|NCT04425629|587708246|FG012|Overall Study|Death|0|||
162726374|NCT04425629|587708247|FG013|Overall Study|Death|0|||
162726375|NCT04425629|587708248|FG014|Overall Study|Death|0|||
162726376|NCT04425629|587708249|FG015|Overall Study|Death|0|||
162726377|NCT04425629|587708250|FG016|Overall Study|Death|0|||
162726378|NCT04425629|587708251|FG017|Overall Study|Death|0|||
162726379|NCT04425629|587708252|FG018|Overall Study|Death|0|||
162726380|NCT04425629|587708234|FG000|Overall Study|Sponsor Request|0|||
162726381|NCT04425629|587708235|FG001|Overall Study|Sponsor Request|0|||
162686606|NCT00331344|587563062|FG004|Phase II|Death|0|||
162686607|NCT00331344|587563063|FG005|Phase II|Death|0|||
162686608|NCT00331344|587563064|FG006|Phase II|Death|0|||
162726382|NCT04425629|587708236|FG002|Overall Study|Sponsor Request|0|||
162726383|NCT04425629|587708237|FG003|Overall Study|Sponsor Request|2|||
162686609|NCT00331344|587563065|FG007|Phase II|Death|0|||
162686610|NCT00331344|587563066|FG008|Phase II|Death|4|||
162686611|NCT04538144|587563072|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
162686612|NCT04538144|587563073|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
162686613|NCT04538144|587563074|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
162686614|NCT04538144|587563075|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
162686615|NCT02228967|587563076|FG000|Overall Study|Lost to Follow-up|146|||
162686616|NCT02228967|587563077|FG001|Overall Study|Lost to Follow-up|142|||
162686617|NCT02228967|587563076|FG000|Overall Study|Withdrawal by Subject|13|||
162686618|NCT02228967|587563077|FG001|Overall Study|Withdrawal by Subject|18|||
162686619|NCT01995539|587563079|FG000|Overall Study|Screening Failure|1|||
162686620|NCT01995539|587563079|FG000|Overall Study|Withdrawal by Investigator|15|||
162686621|NCT01995539|587563079|FG000|Overall Study|Withdrawal by Subject|11|||
162686622|NCT01995539|587563079|FG000|Overall Study|Lost to Follow-up|5|||
162686623|NCT01995539|587563079|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
162686624|NCT03261271|587563083|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
162686625|NCT03261271|587563084|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
162686626|NCT02173054|587563085|FG000|Overall Study|lack of compliance|1|||
162686627|NCT02173054|587563086|FG001|Overall Study|lack of compliance|0|||
162686628|NCT02173054|587563087|FG002|Overall Study|lack of compliance|0|||
162686629|NCT02173054|587563085|FG000|Overall Study|Withdrawal by Subject|0|||
162686630|NCT02173054|587563086|FG001|Overall Study|Withdrawal by Subject|0|||
162686631|NCT02173054|587563087|FG002|Overall Study|Withdrawal by Subject|1|||
162686632|NCT01932697|587563088|FG000|Overall Study|Received a different amount of tx|1|||
162686633|NCT01932697|587563089|FG001|Overall Study|Received a different amount of tx|0|||
162686634|NCT01932697|587563088|FG000|Overall Study|Ineligible|1|||
162686635|NCT01932697|587563089|FG001|Overall Study|Ineligible|0|||
162686636|NCT01330316|587563090|FG000|Overall Study|Adverse Event|2|||
162686637|NCT01330316|587563091|FG001|Overall Study|Adverse Event|2|||
162686638|NCT01330316|587563090|FG000|Overall Study|Lack of Efficacy|0|||
162686639|NCT01330316|587563091|FG001|Overall Study|Lack of Efficacy|10|||
162686640|NCT01330316|587563090|FG000|Overall Study|Lost to Follow-up|0|||
162686641|NCT01330316|587563091|FG001|Overall Study|Lost to Follow-up|1|||
162686642|NCT01330316|587563090|FG000|Overall Study|Withdrawal by Subject|0|||
162686643|NCT01330316|587563091|FG001|Overall Study|Withdrawal by Subject|1|||
162686644|NCT01330316|587563090|FG000|Overall Study|other than above|0|||
162686645|NCT01330316|587563091|FG001|Overall Study|other than above|1|||
162686646|NCT00215540|587563092|FG000|Overall Study|Withdrew from study medication|1|||
162686647|NCT00215540|587563093|FG001|Overall Study|Withdrew from study medication|0|||
162686648|NCT00215540|587563094|FG002|Overall Study|Withdrew from study medication|0|||
162686649|NCT00246337|587563097|FG000|Overall Study|Lost to Follow-up|3|||
162686650|NCT00246337|587563098|FG001|Overall Study|Lost to Follow-up|0|||
162686651|NCT00246337|587563099|FG002|Overall Study|Lost to Follow-up|0|||
162686652|NCT00246337|587563100|FG003|Overall Study|Lost to Follow-up|0|||
162686653|NCT00246337|587563101|FG004|Overall Study|Lost to Follow-up|2|||
162686654|NCT00246337|587563102|FG005|Overall Study|Lost to Follow-up|2|||
162686655|NCT00246337|587563103|FG006|Overall Study|Lost to Follow-up|1|||
162686656|NCT00246337|587563104|FG007|Overall Study|Lost to Follow-up|2|||
162686657|NCT00246337|587563105|FG008|Overall Study|Lost to Follow-up|0|||
162686658|NCT00246337|587563097|FG000|Overall Study|Protocol Violation|1|||
162686659|NCT00246337|587563098|FG001|Overall Study|Protocol Violation|0|||
162686660|NCT00246337|587563099|FG002|Overall Study|Protocol Violation|0|||
162686661|NCT00246337|587563100|FG003|Overall Study|Protocol Violation|0|||
162686662|NCT00246337|587563101|FG004|Overall Study|Protocol Violation|1|||
162686663|NCT00246337|587563102|FG005|Overall Study|Protocol Violation|0|||
162686664|NCT00246337|587563103|FG006|Overall Study|Protocol Violation|1|||
162686665|NCT00246337|587563104|FG007|Overall Study|Protocol Violation|1|||
162686666|NCT00246337|587563105|FG008|Overall Study|Protocol Violation|0|||
162686667|NCT00246337|587563097|FG000|Overall Study|Withdrawal by Subject|2|||
162686668|NCT00246337|587563098|FG001|Overall Study|Withdrawal by Subject|0|||
162686669|NCT00246337|587563099|FG002|Overall Study|Withdrawal by Subject|0|||
162686670|NCT00246337|587563100|FG003|Overall Study|Withdrawal by Subject|0|||
162686671|NCT00246337|587563101|FG004|Overall Study|Withdrawal by Subject|0|||
162686672|NCT00246337|587563102|FG005|Overall Study|Withdrawal by Subject|0|||
162686673|NCT00246337|587563103|FG006|Overall Study|Withdrawal by Subject|1|||
162686674|NCT00246337|587563104|FG007|Overall Study|Withdrawal by Subject|1|||
162686675|NCT00246337|587563105|FG008|Overall Study|Withdrawal by Subject|0|||
162686676|NCT00246337|587563097|FG000|Overall Study|Lack of Qualifying Event|8|||
162686677|NCT00246337|587563098|FG001|Overall Study|Lack of Qualifying Event|2|||
162686678|NCT00246337|587563099|FG002|Overall Study|Lack of Qualifying Event|1|||
162686679|NCT00246337|587563100|FG003|Overall Study|Lack of Qualifying Event|1|||
162686680|NCT00246337|587563101|FG004|Overall Study|Lack of Qualifying Event|1|||
162686681|NCT00246337|587563102|FG005|Overall Study|Lack of Qualifying Event|3|||
162686682|NCT00246337|587563103|FG006|Overall Study|Lack of Qualifying Event|3|||
162686683|NCT00246337|587563104|FG007|Overall Study|Lack of Qualifying Event|2|||
162686684|NCT00246337|587563105|FG008|Overall Study|Lack of Qualifying Event|5|||
162686685|NCT00246337|587563097|FG000|Overall Study|Site Terminated|10|||
162726384|NCT04425629|587708238|FG004|Overall Study|Sponsor Request|2|||
162726385|NCT04425629|587708239|FG005|Overall Study|Sponsor Request|2|||
162726386|NCT04425629|587708240|FG006|Overall Study|Sponsor Request|1|||
162726387|NCT04425629|587708241|FG007|Overall Study|Sponsor Request|0|||
162726388|NCT04425629|587708242|FG008|Overall Study|Sponsor Request|0|||
162726389|NCT04425629|587708243|FG009|Overall Study|Sponsor Request|9|||
162726390|NCT04425629|587708244|FG010|Overall Study|Sponsor Request|9|||
162726391|NCT04425629|587708245|FG011|Overall Study|Sponsor Request|10|||
162726392|NCT04425629|587708246|FG012|Overall Study|Sponsor Request|8|||
162726393|NCT04425629|587708247|FG013|Overall Study|Sponsor Request|0|||
162726394|NCT04425629|587708248|FG014|Overall Study|Sponsor Request|0|||
162726395|NCT04425629|587708249|FG015|Overall Study|Sponsor Request|1|||
162726396|NCT04425629|587708250|FG016|Overall Study|Sponsor Request|0|||
162726397|NCT04425629|587708251|FG017|Overall Study|Sponsor Request|0|||
162726398|NCT04425629|587708252|FG018|Overall Study|Sponsor Request|0|||
162726399|NCT04425629|587708234|FG000|Overall Study|Physician Decision|0|||
162726400|NCT04425629|587708235|FG001|Overall Study|Physician Decision|0|||
162726401|NCT04425629|587708236|FG002|Overall Study|Physician Decision|0|||
162726402|NCT04425629|587708237|FG003|Overall Study|Physician Decision|0|||
162726403|NCT04425629|587708238|FG004|Overall Study|Physician Decision|0|||
162726404|NCT04425629|587708239|FG005|Overall Study|Physician Decision|0|||
162726405|NCT04425629|587708240|FG006|Overall Study|Physician Decision|0|||
162726406|NCT04425629|587708241|FG007|Overall Study|Physician Decision|0|||
162726407|NCT04425629|587708242|FG008|Overall Study|Physician Decision|0|||
162726408|NCT04425629|587708243|FG009|Overall Study|Physician Decision|4|||
162726409|NCT04425629|587708244|FG010|Overall Study|Physician Decision|3|||
162726410|NCT04425629|587708245|FG011|Overall Study|Physician Decision|5|||
162726411|NCT04425629|587708246|FG012|Overall Study|Physician Decision|1|||
162726412|NCT04425629|587708247|FG013|Overall Study|Physician Decision|0|||
162726413|NCT04425629|587708248|FG014|Overall Study|Physician Decision|0|||
162726414|NCT04425629|587708249|FG015|Overall Study|Physician Decision|1|||
162726415|NCT04425629|587708250|FG016|Overall Study|Physician Decision|0|||
162726416|NCT04425629|587708251|FG017|Overall Study|Physician Decision|0|||
162686686|NCT00246337|587563098|FG001|Overall Study|Site Terminated|0|||
162686687|NCT00246337|587563099|FG002|Overall Study|Site Terminated|0|||
162686688|NCT00246337|587563100|FG003|Overall Study|Site Terminated|0|||
162686689|NCT00246337|587563101|FG004|Overall Study|Site Terminated|0|||
162686690|NCT00246337|587563102|FG005|Overall Study|Site Terminated|7|||
162686691|NCT00246337|587563103|FG006|Overall Study|Site Terminated|1|||
162686692|NCT00246337|587563104|FG007|Overall Study|Site Terminated|6|||
162686693|NCT00246337|587563105|FG008|Overall Study|Site Terminated|2|||
162686694|NCT00246337|587563097|FG000|Overall Study|Abnormal baseline lab values|7|||
162686695|NCT00246337|587563098|FG001|Overall Study|Abnormal baseline lab values|0|||
162686696|NCT00246337|587563099|FG002|Overall Study|Abnormal baseline lab values|2|||
162686697|NCT00246337|587563100|FG003|Overall Study|Abnormal baseline lab values|0|||
162686698|NCT00246337|587563101|FG004|Overall Study|Abnormal baseline lab values|0|||
162686699|NCT00246337|587563102|FG005|Overall Study|Abnormal baseline lab values|2|||
162686700|NCT00246337|587563103|FG006|Overall Study|Abnormal baseline lab values|2|||
162686701|NCT00246337|587563104|FG007|Overall Study|Abnormal baseline lab values|0|||
162686702|NCT00246337|587563105|FG008|Overall Study|Abnormal baseline lab values|4|||
162686703|NCT00246337|587563097|FG000|Overall Study|Overwhelmed|0|||
162686704|NCT00246337|587563098|FG001|Overall Study|Overwhelmed|0|||
162686705|NCT00246337|587563099|FG002|Overall Study|Overwhelmed|0|||
162686706|NCT00246337|587563100|FG003|Overall Study|Overwhelmed|0|||
162686707|NCT00246337|587563101|FG004|Overall Study|Overwhelmed|0|||
162686708|NCT00246337|587563102|FG005|Overall Study|Overwhelmed|1|||
162686709|NCT00246337|587563103|FG006|Overall Study|Overwhelmed|0|||
162686710|NCT00246337|587563104|FG007|Overall Study|Overwhelmed|0|||
162686711|NCT00246337|587563105|FG008|Overall Study|Overwhelmed|0|||
162686712|NCT00246337|587563097|FG000|Overall Study|Protocol Violator|1|||
162686713|NCT00246337|587563098|FG001|Overall Study|Protocol Violator|0|||
162686714|NCT00246337|587563099|FG002|Overall Study|Protocol Violator|0|||
162686715|NCT00246337|587563100|FG003|Overall Study|Protocol Violator|0|||
162686716|NCT00246337|587563101|FG004|Overall Study|Protocol Violator|0|||
162686717|NCT00246337|587563102|FG005|Overall Study|Protocol Violator|0|||
162686718|NCT00246337|587563103|FG006|Overall Study|Protocol Violator|0|||
162686719|NCT00246337|587563104|FG007|Overall Study|Protocol Violator|0|||
162686720|NCT00246337|587563105|FG008|Overall Study|Protocol Violator|0|||
162686721|NCT00246337|587563097|FG000|Overall Study|Reported as completing trial in error|0|||
162686722|NCT00246337|587563098|FG001|Overall Study|Reported as completing trial in error|0|||
162686723|NCT00246337|587563099|FG002|Overall Study|Reported as completing trial in error|0|||
162686724|NCT00246337|587563100|FG003|Overall Study|Reported as completing trial in error|0|||
162686725|NCT00246337|587563101|FG004|Overall Study|Reported as completing trial in error|0|||
162686726|NCT00246337|587563102|FG005|Overall Study|Reported as completing trial in error|0|||
162686727|NCT00246337|587563103|FG006|Overall Study|Reported as completing trial in error|0|||
162686728|NCT00246337|587563104|FG007|Overall Study|Reported as completing trial in error|1|||
162726417|NCT04425629|587708252|FG018|Overall Study|Physician Decision|0|||
162726418|NCT04425629|587708234|FG000|Overall Study|Lack of Efficacy|0|||
162726419|NCT04425629|587708235|FG001|Overall Study|Lack of Efficacy|0|||
162686729|NCT00246337|587563105|FG008|Overall Study|Reported as completing trial in error|0|||
162686730|NCT00674570|587563107|FG000|Overall Study|Withdrawal by Subject|0|||
162686731|NCT00674570|587563108|FG001|Overall Study|Withdrawal by Subject|2|||
162686732|NCT00674570|587563109|FG002|Overall Study|Withdrawal by Subject|0|||
162686733|NCT03430063|587563110|FG000|Overall Study|Adverse Event|0|||
162686734|NCT03430063|587563111|FG001|Overall Study|Adverse Event|1|||
162686735|NCT03430063|587563112|FG002|Overall Study|Adverse Event|0|||
162686736|NCT03430063|587563110|FG000|Overall Study|Death|3|||
162686737|NCT03430063|587563111|FG001|Overall Study|Death|2|||
162686738|NCT03430063|587563112|FG002|Overall Study|Death|3|||
162686739|NCT03430063|587563110|FG000|Overall Study|Lost to Follow-up|0|||
162686740|NCT03430063|587563111|FG001|Overall Study|Lost to Follow-up|1|||
162686741|NCT03430063|587563112|FG002|Overall Study|Lost to Follow-up|0|||
162686742|NCT03430063|587563110|FG000|Overall Study|Withdrawal by Subject|0|||
162686743|NCT03430063|587563111|FG001|Overall Study|Withdrawal by Subject|0|||
162686744|NCT03430063|587563112|FG002|Overall Study|Withdrawal by Subject|1|||
162686745|NCT03430063|587563110|FG000|Overall Study|Withdrawal of consent|3|||
162686746|NCT03430063|587563111|FG001|Overall Study|Withdrawal of consent|1|||
162686747|NCT03430063|587563112|FG002|Overall Study|Withdrawal of consent|2|||
162686748|NCT03430063|587563110|FG000|Overall Study|Progressive disease|1|||
162686749|NCT03430063|587563111|FG001|Overall Study|Progressive disease|2|||
162686750|NCT03430063|587563112|FG002|Overall Study|Progressive disease|1|||
162686751|NCT03430063|587563110|FG000|Overall Study|Other un-specified|1|||
162686752|NCT03430063|587563111|FG001|Overall Study|Other un-specified|1|||
162686753|NCT03430063|587563112|FG002|Overall Study|Other un-specified|0|||
162686754|NCT03430063|587563110|FG000|Overall Study|Randomized, but never treated|0|||
162686755|NCT03430063|587563111|FG001|Overall Study|Randomized, but never treated|0|||
162686756|NCT03430063|587563112|FG002|Overall Study|Randomized, but never treated|1|||
162686757|NCT03124199|587563113|FG000|Overall Study|Lost to Follow-up|4|||
162686758|NCT02798211|587563114|FG000|Period 1|Adverse Event|1|||
162686759|NCT02798211|587563115|FG001|Period 1|Adverse Event|1|||
162686760|NCT02798211|587563116|FG002|Period 1|Adverse Event|0|||
162686761|NCT02798211|587563117|FG003|Period 1|Adverse Event|0|||
162686762|NCT02798211|587563118|FG004|Period 1|Adverse Event|0|||
162686763|NCT02798211|587563119|FG005|Period 1|Adverse Event|0|||
162686764|NCT02798211|587563114|FG000|Period 1|Lost to Follow-up|2|||
162686765|NCT02798211|587563115|FG001|Period 1|Lost to Follow-up|1|||
162686766|NCT02798211|587563116|FG002|Period 1|Lost to Follow-up|0|||
162686767|NCT02798211|587563117|FG003|Period 1|Lost to Follow-up|0|||
162686768|NCT02798211|587563118|FG004|Period 1|Lost to Follow-up|0|||
162686769|NCT02798211|587563119|FG005|Period 1|Lost to Follow-up|0|||
162686770|NCT02798211|587563114|FG000|Period 1|Protocol Violation|0|||
162686771|NCT02798211|587563115|FG001|Period 1|Protocol Violation|0|||
162686772|NCT02798211|587563116|FG002|Period 1|Protocol Violation|2|||
162686773|NCT02798211|587563117|FG003|Period 1|Protocol Violation|0|||
162686774|NCT02798211|587563118|FG004|Period 1|Protocol Violation|0|||
162686775|NCT02798211|587563119|FG005|Period 1|Protocol Violation|0|||
162686776|NCT02798211|587563114|FG000|Period 1|Withdrawal by Subject|1|||
162686777|NCT02798211|587563115|FG001|Period 1|Withdrawal by Subject|1|||
162686778|NCT02798211|587563116|FG002|Period 1|Withdrawal by Subject|0|||
162686779|NCT02798211|587563117|FG003|Period 1|Withdrawal by Subject|0|||
162686780|NCT02798211|587563118|FG004|Period 1|Withdrawal by Subject|0|||
162686781|NCT02798211|587563119|FG005|Period 1|Withdrawal by Subject|0|||
162686782|NCT02798211|587563114|FG000|Period 1|Death|0|||
162686783|NCT02798211|587563115|FG001|Period 1|Death|0|||
162686784|NCT02798211|587563116|FG002|Period 1|Death|1|||
162686785|NCT02798211|587563117|FG003|Period 1|Death|0|||
162686786|NCT02798211|587563118|FG004|Period 1|Death|0|||
162686787|NCT02798211|587563119|FG005|Period 1|Death|0|||
162686788|NCT02798211|587563114|FG000|Period 1|Withdrawal of Informed Consent|2|||
162686789|NCT02798211|587563115|FG001|Period 1|Withdrawal of Informed Consent|7|||
162686790|NCT02798211|587563116|FG002|Period 1|Withdrawal of Informed Consent|3|||
162686791|NCT02798211|587563117|FG003|Period 1|Withdrawal of Informed Consent|0|||
162686792|NCT02798211|587563118|FG004|Period 1|Withdrawal of Informed Consent|0|||
162686793|NCT02798211|587563119|FG005|Period 1|Withdrawal of Informed Consent|0|||
162686794|NCT02798211|587563114|FG000|Period 2|Withdrawal by Subject|2|||
162686795|NCT02798211|587563115|FG001|Period 2|Withdrawal by Subject|0|||
162686796|NCT02798211|587563116|FG002|Period 2|Withdrawal by Subject|0|||
162686797|NCT02798211|587563117|FG003|Period 2|Withdrawal by Subject|0|||
162686798|NCT02798211|587563118|FG004|Period 2|Withdrawal by Subject|2|||
162686799|NCT02798211|587563119|FG005|Period 2|Withdrawal by Subject|2|||
162686800|NCT02798211|587563114|FG000|Period 2|Adverse Event|5|||
162686801|NCT02798211|587563115|FG001|Period 2|Adverse Event|0|||
162686802|NCT02798211|587563116|FG002|Period 2|Adverse Event|0|||
162686803|NCT02798211|587563117|FG003|Period 2|Adverse Event|0|||
162686804|NCT02798211|587563118|FG004|Period 2|Adverse Event|1|||
162686805|NCT02798211|587563119|FG005|Period 2|Adverse Event|0|||
162686806|NCT02798211|587563114|FG000|Period 2|Lack of Efficacy|1|||
162686807|NCT02798211|587563115|FG001|Period 2|Lack of Efficacy|0|||
162686808|NCT02798211|587563116|FG002|Period 2|Lack of Efficacy|0|||
162686809|NCT02798211|587563117|FG003|Period 2|Lack of Efficacy|1|||
162686810|NCT02798211|587563118|FG004|Period 2|Lack of Efficacy|0|||
162726420|NCT04425629|587708236|FG002|Overall Study|Lack of Efficacy|0|||
162726421|NCT04425629|587708237|FG003|Overall Study|Lack of Efficacy|0|||
162726422|NCT04425629|587708238|FG004|Overall Study|Lack of Efficacy|0|||
162726423|NCT04425629|587708239|FG005|Overall Study|Lack of Efficacy|0|||
162726424|NCT04425629|587708240|FG006|Overall Study|Lack of Efficacy|0|||
162726425|NCT04425629|587708241|FG007|Overall Study|Lack of Efficacy|0|||
162726426|NCT04425629|587708242|FG008|Overall Study|Lack of Efficacy|0|||
162726427|NCT04425629|587708243|FG009|Overall Study|Lack of Efficacy|0|||
162726428|NCT04425629|587708244|FG010|Overall Study|Lack of Efficacy|1|||
162726429|NCT04425629|587708245|FG011|Overall Study|Lack of Efficacy|0|||
162726430|NCT04425629|587708246|FG012|Overall Study|Lack of Efficacy|0|||
162726431|NCT04425629|587708247|FG013|Overall Study|Lack of Efficacy|0|||
162726432|NCT04425629|587708248|FG014|Overall Study|Lack of Efficacy|0|||
162726433|NCT04425629|587708249|FG015|Overall Study|Lack of Efficacy|0|||
162726434|NCT04425629|587708250|FG016|Overall Study|Lack of Efficacy|0|||
162726435|NCT04425629|587708251|FG017|Overall Study|Lack of Efficacy|0|||
162726436|NCT04425629|587708252|FG018|Overall Study|Lack of Efficacy|0|||
162726437|NCT00610649|587708255|FG000|Overall Study|Adverse Event|1|||
162726438|NCT00610649|587708256|FG001|Overall Study|Adverse Event|0|||
162726439|NCT00610649|587708257|FG002|Overall Study|Adverse Event|0|||
162726440|NCT00610649|587708258|FG003|Overall Study|Adverse Event|0|||
162726441|NCT00610649|587708259|FG004|Overall Study|Adverse Event|0|||
162726442|NCT00610649|587708260|FG005|Overall Study|Adverse Event|0|||
162726443|NCT00610649|587708261|FG006|Overall Study|Adverse Event|0|||
162726444|NCT00610649|587708262|FG007|Overall Study|Adverse Event|0|||
162726445|NCT00610649|587708263|FG008|Overall Study|Adverse Event|0|||
162726446|NCT00610649|587708264|FG009|Overall Study|Adverse Event|0|||
162726447|NCT00610649|587708265|FG010|Overall Study|Adverse Event|1|||
162726448|NCT00610649|587708255|FG000|Overall Study|Family Emergency|0|||
162726449|NCT00610649|587708256|FG001|Overall Study|Family Emergency|1|||
162726450|NCT00610649|587708257|FG002|Overall Study|Family Emergency|0|||
162726451|NCT00610649|587708258|FG003|Overall Study|Family Emergency|0|||
162726452|NCT00610649|587708259|FG004|Overall Study|Family Emergency|0|||
162726453|NCT00610649|587708260|FG005|Overall Study|Family Emergency|0|||
162726454|NCT00610649|587708261|FG006|Overall Study|Family Emergency|0|||
162726455|NCT00610649|587708262|FG007|Overall Study|Family Emergency|0|||
162726456|NCT00610649|587708263|FG008|Overall Study|Family Emergency|0|||
162726457|NCT00610649|587708264|FG009|Overall Study|Family Emergency|0|||
162726458|NCT00610649|587708265|FG010|Overall Study|Family Emergency|0|||
162726459|NCT00610649|587708255|FG000|Overall Study|Withdrawal by Subject|0|||
162726460|NCT00610649|587708256|FG001|Overall Study|Withdrawal by Subject|0|||
162726461|NCT00610649|587708257|FG002|Overall Study|Withdrawal by Subject|0|||
162726462|NCT00610649|587708258|FG003|Overall Study|Withdrawal by Subject|0|||
162726463|NCT00610649|587708259|FG004|Overall Study|Withdrawal by Subject|0|||
162726464|NCT00610649|587708260|FG005|Overall Study|Withdrawal by Subject|0|||
162726465|NCT00610649|587708261|FG006|Overall Study|Withdrawal by Subject|0|||
162726466|NCT00610649|587708262|FG007|Overall Study|Withdrawal by Subject|0|||
162726467|NCT00610649|587708263|FG008|Overall Study|Withdrawal by Subject|0|||
162726468|NCT00610649|587708264|FG009|Overall Study|Withdrawal by Subject|1|||
162726469|NCT00610649|587708265|FG010|Overall Study|Withdrawal by Subject|0|||
162726470|NCT04259450|587708269|FG000|Overall Study|Adverse event/ Toxicity|0|||
162726471|NCT04259450|587708270|FG001|Overall Study|Adverse event/ Toxicity|3|||
162726472|NCT04259450|587708271|FG002|Overall Study|Adverse event/ Toxicity|0|||
162726473|NCT04259450|587708272|FG003|Overall Study|Adverse event/ Toxicity|1|||
162726474|NCT04259450|587708273|FG004|Overall Study|Adverse event/ Toxicity|0|||
162726475|NCT04259450|587708274|FG005|Overall Study|Adverse event/ Toxicity|0|||
162726476|NCT04259450|587708275|FG006|Overall Study|Adverse event/ Toxicity|0|||
162726477|NCT04259450|587708276|FG007|Overall Study|Adverse event/ Toxicity|1|||
162726478|NCT04259450|587708277|FG008|Overall Study|Adverse event/ Toxicity|0|||
162726479|NCT04259450|587708278|FG009|Overall Study|Adverse event/ Toxicity|3|||
162726480|NCT04259450|587708269|FG000|Overall Study|Disease progression|2|||
162726481|NCT04259450|587708270|FG001|Overall Study|Disease progression|3|||
162726482|NCT04259450|587708271|FG002|Overall Study|Disease progression|4|||
162726483|NCT04259450|587708272|FG003|Overall Study|Disease progression|4|||
162726484|NCT04259450|587708273|FG004|Overall Study|Disease progression|6|||
162726485|NCT04259450|587708274|FG005|Overall Study|Disease progression|6|||
162726486|NCT04259450|587708275|FG006|Overall Study|Disease progression|6|||
162726487|NCT04259450|587708276|FG007|Overall Study|Disease progression|15|||
162726488|NCT04259450|587708277|FG008|Overall Study|Disease progression|6|||
162726489|NCT04259450|587708278|FG009|Overall Study|Disease progression|18|||
162726490|NCT04259450|587708269|FG000|Overall Study|Death|0|||
162726491|NCT04259450|587708270|FG001|Overall Study|Death|0|||
162726492|NCT04259450|587708271|FG002|Overall Study|Death|0|||
162726493|NCT04259450|587708272|FG003|Overall Study|Death|0|||
162726494|NCT04259450|587708273|FG004|Overall Study|Death|0|||
162726495|NCT04259450|587708274|FG005|Overall Study|Death|0|||
162726496|NCT04259450|587708275|FG006|Overall Study|Death|0|||
162726497|NCT04259450|587708276|FG007|Overall Study|Death|1|||
162726498|NCT04259450|587708277|FG008|Overall Study|Death|1|||
162726499|NCT04259450|587708278|FG009|Overall Study|Death|0|||
162726500|NCT04259450|587708269|FG000|Overall Study|Withdrawal by Subject|0|||
162726501|NCT04259450|587708270|FG001|Overall Study|Withdrawal by Subject|0|||
162726502|NCT04259450|587708271|FG002|Overall Study|Withdrawal by Subject|0|||
162726503|NCT04259450|587708272|FG003|Overall Study|Withdrawal by Subject|0|||
162726504|NCT04259450|587708273|FG004|Overall Study|Withdrawal by Subject|0|||
162726505|NCT04259450|587708274|FG005|Overall Study|Withdrawal by Subject|0|||
162726506|NCT04259450|587708275|FG006|Overall Study|Withdrawal by Subject|0|||
162726507|NCT04259450|587708276|FG007|Overall Study|Withdrawal by Subject|1|||
162726508|NCT04259450|587708277|FG008|Overall Study|Withdrawal by Subject|0|||
162726509|NCT04259450|587708278|FG009|Overall Study|Withdrawal by Subject|0|||
162726510|NCT04259450|587708269|FG000|Overall Study|Other than listed|0|||
162726511|NCT04259450|587708270|FG001|Overall Study|Other than listed|0|||
162726512|NCT04259450|587708271|FG002|Overall Study|Other than listed|0|||
162726513|NCT04259450|587708272|FG003|Overall Study|Other than listed|0|||
162726514|NCT04259450|587708273|FG004|Overall Study|Other than listed|0|||
162726515|NCT04259450|587708274|FG005|Overall Study|Other than listed|0|||
162726516|NCT04259450|587708275|FG006|Overall Study|Other than listed|0|||
162726517|NCT04259450|587708276|FG007|Overall Study|Other than listed|1|||
162726518|NCT04259450|587708277|FG008|Overall Study|Other than listed|1|||
162726519|NCT04259450|587708278|FG009|Overall Study|Other than listed|2|||
162726520|NCT00332241|587708279|FG000|Overall Study|Lack of Efficacy|6|||
162726521|NCT00332241|587708280|FG001|Overall Study|Lack of Efficacy|1|||
162726522|NCT00332241|587708279|FG000|Overall Study|Adverse Event|3|||
162726523|NCT00332241|587708280|FG001|Overall Study|Adverse Event|5|||
162726524|NCT00332241|587708279|FG000|Overall Study|Withdrawal by Subject|2|||
162726525|NCT00332241|587708280|FG001|Overall Study|Withdrawal by Subject|1|||
162726526|NCT00332241|587708279|FG000|Overall Study|Lost to Follow-up|4|||
162726527|NCT00332241|587708280|FG001|Overall Study|Lost to Follow-up|1|||
162726528|NCT00542789|587708288|FG000|Overall Study|Adverse Event|18|||
162726529|NCT00542789|587708289|FG001|Overall Study|Adverse Event|17|||
162726530|NCT00542789|587708288|FG000|Overall Study|Withdrawal by Subject|7|||
162726531|NCT00542789|587708289|FG001|Overall Study|Withdrawal by Subject|3|||
162726532|NCT00542789|587708288|FG000|Overall Study|Protocol Violation|8|||
162726533|NCT00542789|587708289|FG001|Overall Study|Protocol Violation|1|||
162726534|NCT00542789|587708288|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
162726535|NCT00542789|587708289|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
162726536|NCT02584829|587708291|FG000|Overall Study|Physician Decision|1|||
162726537|NCT02584829|587708292|FG001|Overall Study|Physician Decision|0|||
162726538|NCT02584829|587708291|FG000|Overall Study|Withdrawal by Subject|0|||
162726539|NCT02584829|587708292|FG001|Overall Study|Withdrawal by Subject|1|||
162726540|NCT02584829|587708291|FG000|Overall Study|Progressive Disease|0|||
162726541|NCT02584829|587708292|FG001|Overall Study|Progressive Disease|3|||
162726542|NCT00106080|587708305|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
162726543|NCT00106080|587708306|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
162726544|NCT01839331|587708307|FG000|Overall Study|Early Termination|3|||
162726545|NCT01839331|587708308|FG001|Overall Study|Early Termination|0|||
162726546|NCT01839331|587708309|FG002|Overall Study|Early Termination|1|||
162726547|NCT01839331|587708310|FG003|Overall Study|Early Termination|2|||
162726548|NCT01839331|587708307|FG000|Overall Study|Protocol Violation|1|||
162686811|NCT02798211|587563119|FG005|Period 2|Lack of Efficacy|1|||
162686812|NCT02798211|587563114|FG000|Period 2|Lost to Follow-up|3|||
162686813|NCT02798211|587563115|FG001|Period 2|Lost to Follow-up|0|||
162686814|NCT02798211|587563116|FG002|Period 2|Lost to Follow-up|0|||
162686815|NCT02798211|587563117|FG003|Period 2|Lost to Follow-up|0|||
162686816|NCT02798211|587563118|FG004|Period 2|Lost to Follow-up|2|||
162686817|NCT02798211|587563119|FG005|Period 2|Lost to Follow-up|0|||
162726549|NCT01839331|587708308|FG001|Overall Study|Protocol Violation|6|||
162726550|NCT01839331|587708309|FG002|Overall Study|Protocol Violation|4|||
162726551|NCT01839331|587708310|FG003|Overall Study|Protocol Violation|3|||
162726552|NCT00761605|587708311|FG000|Overall Study|Adverse Event|26|||
162726553|NCT00761605|587708311|FG000|Overall Study|Death|2|||
162726554|NCT00761605|587708311|FG000|Overall Study|Lack of Efficacy|26|||
162686818|NCT02798211|587563114|FG000|Period 2|Physician Decision|1|||
162726555|NCT00761605|587708311|FG000|Overall Study|Lost to Follow-up|29|||
162726556|NCT00761605|587708311|FG000|Overall Study|Withdrawal by Subject|37|||
162726557|NCT00761605|587708311|FG000|Overall Study|Other|21|||
162726558|NCT03074331|587708312|FG000|Overall Study|Enrolled but Not Treated|1|||
162726559|NCT03074331|587708312|FG000|Overall Study|Lost to Follow-up|5|||
162726560|NCT03074331|587708312|FG000|Overall Study|Withdrew Consent|1|||
162726561|NCT00350792|587708314|FG000|Overall Study|Adverse Event|11|||
162726562|NCT00350792|587708314|FG000|Overall Study|Death from Study Disease|1|||
162726563|NCT00350792|587708314|FG000|Overall Study|Death from Study Drug Toxicity|1|||
162726564|NCT00350792|587708314|FG000|Overall Study|Death Not Study Drug Related|2|||
162726565|NCT00350792|587708314|FG000|Overall Study|Protocol Violation|1|||
162726566|NCT00350792|587708314|FG000|Overall Study|Withdrawal by Subject|4|||
162726567|NCT00350792|587708314|FG000|Overall Study|Physician Decision|2|||
162726568|NCT00350792|587708314|FG000|Overall Study|Lack of Efficacy|11|||
162686819|NCT02798211|587563115|FG001|Period 2|Physician Decision|0|||
162686820|NCT02798211|587563116|FG002|Period 2|Physician Decision|0|||
162686821|NCT02798211|587563117|FG003|Period 2|Physician Decision|1|||
162686822|NCT02798211|587563118|FG004|Period 2|Physician Decision|1|||
162686823|NCT02798211|587563119|FG005|Period 2|Physician Decision|0|||
162686824|NCT02798211|587563114|FG000|Period 2|Pregnancy|0|||
162686825|NCT02798211|587563115|FG001|Period 2|Pregnancy|0|||
162686826|NCT02798211|587563116|FG002|Period 2|Pregnancy|0|||
162686827|NCT02798211|587563117|FG003|Period 2|Pregnancy|2|||
162686828|NCT02798211|587563118|FG004|Period 2|Pregnancy|0|||
162686829|NCT02798211|587563119|FG005|Period 2|Pregnancy|0|||
162686830|NCT02798211|587563114|FG000|Period 2|Technical problems|1|||
162686831|NCT02798211|587563115|FG001|Period 2|Technical problems|0|||
162686832|NCT02798211|587563116|FG002|Period 2|Technical problems|0|||
162686833|NCT02798211|587563117|FG003|Period 2|Technical problems|1|||
162686834|NCT02798211|587563118|FG004|Period 2|Technical problems|0|||
162686835|NCT02798211|587563119|FG005|Period 2|Technical problems|0|||
162686836|NCT02798211|587563114|FG000|Period 2|Withdrawal of Informed Consent|1|||
162686837|NCT02798211|587563115|FG001|Period 2|Withdrawal of Informed Consent|0|||
162686838|NCT02798211|587563116|FG002|Period 2|Withdrawal of Informed Consent|0|||
162686839|NCT02798211|587563117|FG003|Period 2|Withdrawal of Informed Consent|2|||
162686840|NCT02798211|587563118|FG004|Period 2|Withdrawal of Informed Consent|2|||
162686841|NCT02798211|587563119|FG005|Period 2|Withdrawal of Informed Consent|3|||
162686842|NCT02309112|587563121|FG000|Overall Study|Withdrawal by Subject|1|||
162686843|NCT02309112|587563122|FG001|Overall Study|Withdrawal by Subject|0|||
162686844|NCT02309112|587563123|FG002|Overall Study|Withdrawal by Subject|1|||
162686845|NCT02309112|587563121|FG000|Overall Study|Lost to Follow-up|0|||
162686846|NCT02309112|587563122|FG001|Overall Study|Lost to Follow-up|1|||
162686847|NCT02309112|587563123|FG002|Overall Study|Lost to Follow-up|0|||
162686848|NCT03505476|587563125|FG000|Overall Study|Physician Decision|18|||
162686849|NCT03505476|587563125|FG000|Overall Study|Device Malfunctioned|101|||
162686850|NCT03505476|587563125|FG000|Overall Study|Data Corrupt|6|||
162686851|NCT03505476|587563125|FG000|Overall Study|Device application insufficiant|3|||
162686852|NCT01287611|587563127|FG000|Overall Study|Lost to Follow-up|29|||
162686853|NCT01287611|587563128|FG001|Overall Study|Lost to Follow-up|16|||
162686854|NCT01287611|587563127|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
162686855|NCT01287611|587563128|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
162686856|NCT02255357|587563133|FG000|Overall Study|Physician Decision|10|||
162686857|NCT02255357|587563134|FG001|Overall Study|Physician Decision|24|||
162686858|NCT02192970|587563135|FG000|Overall Study|Lost to Follow-up|6|||
162686859|NCT02192970|587563136|FG001|Overall Study|Lost to Follow-up|0|||
162686860|NCT04074590|587563139|FG000|Overall Study|Adverse Event|1|||
162686861|NCT04074590|587563140|FG001|Overall Study|Adverse Event|0|||
162686862|NCT04074590|587563139|FG000|Overall Study|Physician Decision|1|||
162686863|NCT04074590|587563140|FG001|Overall Study|Physician Decision|0|||
162686864|NCT04074590|587563139|FG000|Overall Study|Withdrawal by Subject|2|||
162686865|NCT04074590|587563140|FG001|Overall Study|Withdrawal by Subject|0|||
162686866|NCT00509236|587563143|FG000|Overall Study|Adverse Event|7|||
162686867|NCT00509236|587563144|FG001|Overall Study|Adverse Event|9|||
162686868|NCT00509236|587563143|FG000|Overall Study|Withdrawal by Subject|5|||
162686869|NCT00509236|587563144|FG001|Overall Study|Withdrawal by Subject|10|||
162686870|NCT00509236|587563143|FG000|Overall Study|Protocol Violation|3|||
162686871|NCT00509236|587563144|FG001|Overall Study|Protocol Violation|0|||
162686872|NCT00509236|587563143|FG000|Overall Study|Excluded Medication|1|||
162686873|NCT00509236|587563144|FG001|Overall Study|Excluded Medication|1|||
162686874|NCT00509236|587563143|FG000|Overall Study|Scheduled Kidney Transplant|1|||
162686875|NCT00509236|587563144|FG001|Overall Study|Scheduled Kidney Transplant|0|||
162686876|NCT02709005|587563156|FG000|Overall Study|Lost to Follow-up|1|||
162686877|NCT02709005|587563157|FG001|Overall Study|Lost to Follow-up|1|||
162686878|NCT02709005|587563156|FG000|Overall Study|Withdrawal by Subject|3|||
162686879|NCT02709005|587563157|FG001|Overall Study|Withdrawal by Subject|0|||
162686880|NCT01572389|587563158|FG000|Overall Study|Death|1|||
162686881|NCT01572389|587563159|FG001|Overall Study|Death|3|||
162686882|NCT01572389|587563158|FG000|Overall Study|Withdrawal by Subject|14|||
162686883|NCT01572389|587563159|FG001|Overall Study|Withdrawal by Subject|2|||
162686884|NCT01572389|587563158|FG000|Overall Study|Lost to Follow-up|25|||
162686885|NCT01572389|587563159|FG001|Overall Study|Lost to Follow-up|14|||
162686886|NCT01572389|587563158|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
162686887|NCT01572389|587563159|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
162686888|NCT02634788|587563160|FG000|Overall Study|Adverse Event|0|||
162686889|NCT02634788|587563161|FG001|Overall Study|Adverse Event|8|||
162686890|NCT02634788|587563162|FG002|Overall Study|Adverse Event|3|||
162686891|NCT02634788|587563163|FG003|Overall Study|Adverse Event|1|||
162686892|NCT02634788|587563160|FG000|Overall Study|Lack of Efficacy|4|||
162686893|NCT02634788|587563161|FG001|Overall Study|Lack of Efficacy|0|||
162686894|NCT02634788|587563162|FG002|Overall Study|Lack of Efficacy|1|||
162686895|NCT02634788|587563163|FG003|Overall Study|Lack of Efficacy|4|||
162686896|NCT02634788|587563160|FG000|Overall Study|Lost to Follow-up|0|||
162686897|NCT02634788|587563161|FG001|Overall Study|Lost to Follow-up|1|||
162686898|NCT02634788|587563162|FG002|Overall Study|Lost to Follow-up|0|||
162686899|NCT02634788|587563163|FG003|Overall Study|Lost to Follow-up|0|||
162686900|NCT02634788|587563160|FG000|Overall Study|Withdrawal by Subject|0|||
162686901|NCT02634788|587563161|FG001|Overall Study|Withdrawal by Subject|1|||
162686902|NCT02634788|587563162|FG002|Overall Study|Withdrawal by Subject|1|||
162686903|NCT02634788|587563163|FG003|Overall Study|Withdrawal by Subject|0|||
162686904|NCT00758459|587563164|FG000|Overall Study|Adverse Event|3|||
162686905|NCT00758459|587563165|FG001|Overall Study|Adverse Event|2|||
162686906|NCT00758459|587563164|FG000|Overall Study|Protocol Violation|0|||
162686907|NCT00758459|587563165|FG001|Overall Study|Protocol Violation|1|||
162686908|NCT00758459|587563164|FG000|Overall Study|Withdrawal by Subject|0|||
162686909|NCT00758459|587563165|FG001|Overall Study|Withdrawal by Subject|1|||
162686910|NCT01780935|587563169|FG000|Overall Study|Admin problems due to early termination|321|||
162686911|NCT01780935|587563170|FG001|Overall Study|Admin problems due to early termination|309|||
162686912|NCT01780935|587563169|FG000|Overall Study|Adverse Event|2|||
162686913|NCT01780935|587563170|FG001|Overall Study|Adverse Event|4|||
162686914|NCT01780935|587563169|FG000|Overall Study|Death|1|||
162686915|NCT01780935|587563170|FG001|Overall Study|Death|6|||
162686916|NCT01780935|587563169|FG000|Overall Study|Lost to Follow-up|2|||
162686917|NCT01780935|587563170|FG001|Overall Study|Lost to Follow-up|6|||
162686918|NCT01780935|587563169|FG000|Overall Study|Physician Decision|1|||
162686919|NCT01780935|587563170|FG001|Overall Study|Physician Decision|1|||
162686920|NCT01780935|587563169|FG000|Overall Study|Protocol deviation|0|||
162686921|NCT01780935|587563170|FG001|Overall Study|Protocol deviation|1|||
162686922|NCT01780935|587563169|FG000|Overall Study|Patient withdrew consent|8|||
162686923|NCT01780935|587563170|FG001|Overall Study|Patient withdrew consent|9|||
162686924|NCT01281202|587563171|FG000|Overall Study|Adverse Event|2|||
162686925|NCT01281202|587563172|FG001|Overall Study|Adverse Event|0|||
162686926|NCT01281202|587563171|FG000|Overall Study|Withdrawal by Subject|2|||
162686927|NCT01281202|587563172|FG001|Overall Study|Withdrawal by Subject|2|||
162686928|NCT01281202|587563171|FG000|Overall Study|Protocol Violation|11|||
162686929|NCT01281202|587563172|FG001|Overall Study|Protocol Violation|10|||
162686930|NCT01281202|587563171|FG000|Overall Study|Administrative|2|||
162686931|NCT01281202|587563172|FG001|Overall Study|Administrative|8|||
162686932|NCT01281202|587563171|FG000|Overall Study|Lost to Follow-up|11|||
162686933|NCT01281202|587563172|FG001|Overall Study|Lost to Follow-up|13|||
162686934|NCT01281202|587563171|FG000|Overall Study|Incarceration|0|||
162686935|NCT01281202|587563172|FG001|Overall Study|Incarceration|3|||
162686936|NCT01215357|587563173|FG000|Overall Study|Withdrawal by Subject|3|||
162686937|NCT01215357|587563173|FG000|Overall Study|Protocol Violation|9|||
162686938|NCT05479604|587563174|FG000|Overall Study|Lost to Follow-up|1|||
162686939|NCT05479604|587563175|FG001|Overall Study|Lost to Follow-up|5|||
162686940|NCT01591382|587563176|FG000|Overall Study|Discharged Prior to Study Completion|2|||
162686941|NCT01591382|587563177|FG001|Overall Study|Discharged Prior to Study Completion|1|||
162686942|NCT01591382|587563176|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
162686943|NCT01591382|587563177|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
162686944|NCT00701038|587563181|FG000|Overall Study|study amended pilot group of patients|4|||
162686945|NCT00701038|587563182|FG001|Overall Study|study amended pilot group of patients|4|||
162686946|NCT05099926|587563187|FG000|Overall Study|Lost to Follow-up|1|||
162686947|NCT00459342|587563193|FG000|Overall Study|Not eligible|1|||
162686948|NCT00558064|587563194|FG000|Overall Study|Adverse Event|3|||
162686949|NCT00558064|587563195|FG001|Overall Study|Adverse Event|2|||
162686950|NCT00558064|587563194|FG000|Overall Study|Lack of Efficacy|0|||
162686951|NCT00558064|587563195|FG001|Overall Study|Lack of Efficacy|1|||
162686952|NCT00558064|587563194|FG000|Overall Study|Protocol Violation|1|||
162686953|NCT00558064|587563195|FG001|Overall Study|Protocol Violation|0|||
162686954|NCT00558064|587563194|FG000|Overall Study|Lost to Follow-up|0|||
162686955|NCT00558064|587563195|FG001|Overall Study|Lost to Follow-up|1|||
162686956|NCT00558064|587563194|FG000|Overall Study|Withdrawal by Subject|0|||
162686957|NCT00558064|587563195|FG001|Overall Study|Withdrawal by Subject|1|||
162686958|NCT00558064|587563194|FG000|Overall Study|No visit within allowance period|1|||
162686959|NCT00558064|587563195|FG001|Overall Study|No visit within allowance period|0|||
162686960|NCT02027402|587563196|FG000|Overall Study|Withdrawal by Subject|4|||
162686961|NCT02027402|587563197|FG001|Overall Study|Withdrawal by Subject|1|||
162686962|NCT04108000|587563200|FG000|Overall Study|Death of patient|1|||
162686963|NCT04108000|587563201|FG001|Overall Study|Death of patient|0|||
162686964|NCT04108000|587563202|FG002|Overall Study|Death of patient|1|||
162686965|NCT04108000|587563203|FG003|Overall Study|Death of patient|0|||
162686966|NCT04108000|587563200|FG000|Overall Study|Withdrawal by Subject|2|||
162686967|NCT04108000|587563201|FG001|Overall Study|Withdrawal by Subject|2|||
162686968|NCT04108000|587563202|FG002|Overall Study|Withdrawal by Subject|0|||
162686969|NCT04108000|587563203|FG003|Overall Study|Withdrawal by Subject|0|||
162686970|NCT04108000|587563200|FG000|Overall Study|Death of surrogate partner|0|||
162686971|NCT04108000|587563201|FG001|Overall Study|Death of surrogate partner|1|||
162686972|NCT04108000|587563202|FG002|Overall Study|Death of surrogate partner|0|||
162686973|NCT04108000|587563203|FG003|Overall Study|Death of surrogate partner|1|||
162686974|NCT03764774|587563206|FG000|Overall Study|Withdrawal by Subject|0|||
162686975|NCT03764774|587563207|FG001|Overall Study|Withdrawal by Subject|0|||
162686976|NCT03764774|587563208|FG002|Overall Study|Withdrawal by Subject|0|||
162726569|NCT03283371|587708315|FG000|Placebo-controlled|Adverse Event|1|||
162726570|NCT03283371|587708316|FG001|Placebo-controlled|Adverse Event|1|||
162726571|NCT03283371|587708317|FG002|Placebo-controlled|Adverse Event|0|||
162726572|NCT03283371|587708318|FG003|Placebo-controlled|Adverse Event|0|||
162726573|NCT03283371|587708315|FG000|Placebo-controlled|Lack of Efficacy|1|||
162726574|NCT03283371|587708316|FG001|Placebo-controlled|Lack of Efficacy|0|||
162726575|NCT03283371|587708317|FG002|Placebo-controlled|Lack of Efficacy|0|||
162726576|NCT03283371|587708318|FG003|Placebo-controlled|Lack of Efficacy|0|||
162726577|NCT03283371|587708315|FG000|Placebo-controlled|Withdrawal by Subject|1|||
162726578|NCT03283371|587708316|FG001|Placebo-controlled|Withdrawal by Subject|1|||
162726579|NCT03283371|587708317|FG002|Placebo-controlled|Withdrawal by Subject|0|||
162726580|NCT03283371|587708318|FG003|Placebo-controlled|Withdrawal by Subject|0|||
162726581|NCT03283371|587708315|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162726582|NCT03283371|587708316|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
162726583|NCT03283371|587708317|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162726584|NCT03283371|587708318|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162726585|NCT03283371|587708315|FG000|Open-label Phase|Adverse Event|0|||
162726586|NCT03283371|587708316|FG001|Open-label Phase|Adverse Event|0|||
162726587|NCT03283371|587708317|FG002|Open-label Phase|Adverse Event|2|||
162726588|NCT03283371|587708318|FG003|Open-label Phase|Adverse Event|0|||
162726589|NCT03283371|587708315|FG000|Open-label Phase|Withdrawal by Subject|0|||
162726590|NCT03283371|587708316|FG001|Open-label Phase|Withdrawal by Subject|0|||
162726591|NCT03283371|587708317|FG002|Open-label Phase|Withdrawal by Subject|1|||
162726592|NCT03283371|587708318|FG003|Open-label Phase|Withdrawal by Subject|0|||
162726593|NCT03283371|587708315|FG000|Open-label Phase|Other|0|||
162726594|NCT03283371|587708316|FG001|Open-label Phase|Other|0|||
162726595|NCT03283371|587708317|FG002|Open-label Phase|Other|1|||
162726596|NCT03283371|587708318|FG003|Open-label Phase|Other|1|||
162726597|NCT01290341|587708319|FG000|Overall Study|Protocol Violation|7|||
162726598|NCT01290341|587708320|FG001|Overall Study|Protocol Violation|3|||
162726599|NCT01290341|587708319|FG000|Overall Study|Adverse Event|1|||
162726600|NCT01290341|587708320|FG001|Overall Study|Adverse Event|0|||
162726601|NCT01290341|587708319|FG000|Overall Study|Lost to Follow-up|21|||
162726602|NCT01290341|587708320|FG001|Overall Study|Lost to Follow-up|10|||
162686977|NCT03764774|587563209|FG003|Overall Study|Withdrawal by Subject|0|||
162686978|NCT03764774|587563210|FG004|Overall Study|Withdrawal by Subject|0|||
162686979|NCT03764774|587563211|FG005|Overall Study|Withdrawal by Subject|0|||
162686980|NCT03764774|587563212|FG006|Overall Study|Withdrawal by Subject|0|||
162686981|NCT03764774|587563213|FG007|Overall Study|Withdrawal by Subject|0|||
162686982|NCT03764774|587563214|FG008|Overall Study|Withdrawal by Subject|0|||
162686983|NCT03764774|587563215|FG009|Overall Study|Withdrawal by Subject|0|||
162686984|NCT03764774|587563216|FG010|Overall Study|Withdrawal by Subject|1|||
162686985|NCT03764774|587563217|FG011|Overall Study|Withdrawal by Subject|0|||
162726603|NCT01290341|587708319|FG000|Overall Study|Withdrawal by Subject|19|||
162726604|NCT01290341|587708320|FG001|Overall Study|Withdrawal by Subject|5|||
162726605|NCT01290341|587708319|FG000|Overall Study|Negative baseline culture and others|44|||
162726606|NCT01290341|587708320|FG001|Overall Study|Negative baseline culture and others|11|||
162726607|NCT01943799|587708328|FG000|Overall Study|Lost to Follow-up|0|||
162726608|NCT01943799|587708329|FG001|Overall Study|Lost to Follow-up|1|||
162726609|NCT01943799|587708330|FG002|Overall Study|Lost to Follow-up|1|||
162726610|NCT01943799|587708331|FG003|Overall Study|Lost to Follow-up|0|||
162726611|NCT01943799|587708328|FG000|Overall Study|Protocol Violation|1|||
162726612|NCT01943799|587708329|FG001|Overall Study|Protocol Violation|0|||
162726613|NCT01943799|587708330|FG002|Overall Study|Protocol Violation|0|||
162726614|NCT01943799|587708331|FG003|Overall Study|Protocol Violation|0|||
162686986|NCT03764774|587563218|FG012|Overall Study|Withdrawal by Subject|0|||
162686987|NCT03764774|587563219|FG013|Overall Study|Withdrawal by Subject|0|||
162686988|NCT03764774|587563206|FG000|Overall Study|Adverse Event|0|||
162686989|NCT03764774|587563207|FG001|Overall Study|Adverse Event|0|||
162686990|NCT03764774|587563208|FG002|Overall Study|Adverse Event|0|||
162686991|NCT03764774|587563209|FG003|Overall Study|Adverse Event|0|||
162686992|NCT03764774|587563210|FG004|Overall Study|Adverse Event|0|||
162686993|NCT03764774|587563211|FG005|Overall Study|Adverse Event|0|||
162686994|NCT03764774|587563212|FG006|Overall Study|Adverse Event|0|||
162726615|NCT01943799|587708328|FG000|Overall Study|Withdrawal by Subject|4|||
162726616|NCT01943799|587708329|FG001|Overall Study|Withdrawal by Subject|2|||
162726617|NCT01943799|587708330|FG002|Overall Study|Withdrawal by Subject|1|||
162726618|NCT01943799|587708331|FG003|Overall Study|Withdrawal by Subject|0|||
162726619|NCT04594759|587708332|FG000|Overall Study|Lost to Follow-up|3|||
162686995|NCT03764774|587563213|FG007|Overall Study|Adverse Event|0|||
162686996|NCT03764774|587563214|FG008|Overall Study|Adverse Event|0|||
162686997|NCT03764774|587563215|FG009|Overall Study|Adverse Event|0|||
162686998|NCT03764774|587563216|FG010|Overall Study|Adverse Event|0|||
162686999|NCT03764774|587563217|FG011|Overall Study|Adverse Event|0|||
162687000|NCT03764774|587563218|FG012|Overall Study|Adverse Event|2|||
162726620|NCT03485950|587708335|FG000|Overall Study|Adverse Event|1|||
162726621|NCT03485950|587708336|FG001|Overall Study|Adverse Event|0|||
162726622|NCT03485950|587708335|FG000|Overall Study|Death|3|||
162687001|NCT03764774|587563219|FG013|Overall Study|Adverse Event|0|||
162687002|NCT03764774|587563206|FG000|Overall Study|Lost to Follow-up|0|||
162687003|NCT03764774|587563207|FG001|Overall Study|Lost to Follow-up|0|||
162687004|NCT03764774|587563208|FG002|Overall Study|Lost to Follow-up|0|||
162687005|NCT03764774|587563209|FG003|Overall Study|Lost to Follow-up|0|||
162687006|NCT03764774|587563210|FG004|Overall Study|Lost to Follow-up|0|||
162687007|NCT03764774|587563211|FG005|Overall Study|Lost to Follow-up|0|||
162726623|NCT03485950|587708336|FG001|Overall Study|Death|2|||
162726624|NCT03485950|587708335|FG000|Overall Study|Withdrawal by Subject|3|||
162726625|NCT03485950|587708336|FG001|Overall Study|Withdrawal by Subject|0|||
162726626|NCT04556981|587708338|FG000|Overall Study|Death|0|||
162726627|NCT04556981|587708339|FG001|Overall Study|Death|1|||
162726628|NCT04556981|587708338|FG000|Overall Study|Lost to Follow-up|2|||
162726629|NCT04556981|587708339|FG001|Overall Study|Lost to Follow-up|11|||
162726630|NCT04556981|587708338|FG000|Overall Study|Moved from the study area|1|||
162726631|NCT04556981|587708339|FG001|Overall Study|Moved from the study area|4|||
162726632|NCT04556981|587708338|FG000|Overall Study|Withdrawal by Subject|2|||
162726633|NCT04556981|587708339|FG001|Overall Study|Withdrawal by Subject|2|||
162726634|NCT04556981|587708338|FG000|Overall Study|Other|2|||
162726635|NCT04556981|587708339|FG001|Overall Study|Other|1|||
162726636|NCT03764475|587708340|FG000|Overall Study|Adverse Event|11|||
162726637|NCT03764475|587708341|FG001|Overall Study|Adverse Event|2|||
162726638|NCT03764475|587708340|FG000|Overall Study|Lost to Follow-up|24|||
162726639|NCT03764475|587708341|FG001|Overall Study|Lost to Follow-up|10|||
162726640|NCT03764475|587708340|FG000|Overall Study|Withdrawal by Subject|26|||
162726641|NCT03764475|587708341|FG001|Overall Study|Withdrawal by Subject|10|||
162726642|NCT03764475|587708340|FG000|Overall Study|Lack of Efficacy|3|||
162726643|NCT03764475|587708341|FG001|Overall Study|Lack of Efficacy|0|||
162726644|NCT03764475|587708340|FG000|Overall Study|COVID-19 Disruption|2|||
162726645|NCT03764475|587708341|FG001|Overall Study|COVID-19 Disruption|0|||
162726646|NCT00580866|587708342|FG000|Overall Study|Lost to Follow-up|2|||
162726647|NCT00580866|587708343|FG001|Overall Study|Lost to Follow-up|2|||
162726648|NCT02574455|587708344|FG000|Overall Study|Death|197|||
162726649|NCT02574455|587708345|FG001|Overall Study|Death|210|||
162726650|NCT02574455|587708344|FG000|Overall Study|Withdrawal of Consent|11|||
162726651|NCT02574455|587708345|FG001|Overall Study|Withdrawal of Consent|28|||
162726652|NCT02574455|587708344|FG000|Overall Study|Lost to Follow-up|4|||
162726653|NCT02574455|587708345|FG001|Overall Study|Lost to Follow-up|4|||
162726654|NCT02574455|587708344|FG000|Overall Study|Sponsor's Decision|55|||
162726655|NCT02574455|587708345|FG001|Overall Study|Sponsor's Decision|20|||
162736240|NCT03699709|587744923|FG001|Overall Study|scheduled, but no show|1|||
162736241|NCT02907099|587744924|FG000|Overall Study|Adverse Event|1|||
162736242|NCT02907099|587744924|FG000|Overall Study|Withdrawal by Subject|2|||
162736243|NCT02907099|587744924|FG000|Overall Study|Screen Fail|2|||
162736244|NCT05784662|587744925|FG000|Overall Study|Lost to Follow-up|21|||
162736245|NCT05784662|587744926|FG001|Overall Study|Lost to Follow-up|17|||
162736246|NCT04739956|587744927|FG000|Overall Study|Withdrawal by Subject|1|||
162736247|NCT04739956|587744928|FG001|Overall Study|Withdrawal by Subject|1|||
162736248|NCT03519581|587744931|FG000|Overall Study|Lost to Follow-up|3|||
162736249|NCT03519581|587744932|FG001|Overall Study|Lost to Follow-up|2|||
162736250|NCT03519581|587744931|FG000|Overall Study|Adverse Event|5|||
162736251|NCT03519581|587744932|FG001|Overall Study|Adverse Event|2|||
162736252|NCT03519581|587744931|FG000|Overall Study|Withdrawal by Subject|2|||
162687008|NCT03764774|587563212|FG006|Overall Study|Lost to Follow-up|0|||
162687009|NCT03764774|587563213|FG007|Overall Study|Lost to Follow-up|0|||
162687010|NCT03764774|587563214|FG008|Overall Study|Lost to Follow-up|0|||
162687011|NCT03764774|587563215|FG009|Overall Study|Lost to Follow-up|0|||
162736253|NCT03519581|587744932|FG001|Overall Study|Withdrawal by Subject|0|||
162736254|NCT03519581|587744931|FG000|Overall Study|Change to insurance|2|||
162736255|NCT03519581|587744932|FG001|Overall Study|Change to insurance|1|||
162736256|NCT03519581|587744931|FG000|Overall Study|Other|2|||
162736257|NCT03519581|587744932|FG001|Overall Study|Other|4|||
162736258|NCT03110315|587744934|FG000|Overall Study|Withdrawal by Subject|1|||
162736259|NCT03110315|587744935|FG001|Overall Study|Withdrawal by Subject|0|||
162736260|NCT05371652|587744939|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
162736261|NCT05371652|587744939|FG000|Overall Study|Withdrawal by Subject|12|||
162687012|NCT03764774|587563216|FG010|Overall Study|Lost to Follow-up|0|||
162687013|NCT03764774|587563217|FG011|Overall Study|Lost to Follow-up|0|||
162736262|NCT05371652|587744939|FG000|Overall Study|Adverse Event|1|||
162736263|NCT05371652|587744939|FG000|Overall Study|Other|11|||
162736264|NCT05256706|587744941|FG000|Overall Study|Lost to Follow-up|9|||
162736265|NCT05256706|587744942|FG001|Overall Study|Lost to Follow-up|3|||
162736266|NCT05256706|587744941|FG000|Overall Study|Withdrawal by Subject|7|||
162736267|NCT05256706|587744942|FG001|Overall Study|Withdrawal by Subject|11|||
162736268|NCT05256706|587744941|FG000|Overall Study|Screen Failures|3|||
162736269|NCT05256706|587744942|FG001|Overall Study|Screen Failures|0|||
162736270|NCT04410042|587744943|FG000|Overall Study|Not Eligible|1|||
162687014|NCT03764774|587563218|FG012|Overall Study|Lost to Follow-up|0|||
162687015|NCT03764774|587563219|FG013|Overall Study|Lost to Follow-up|1|||
162736271|NCT04410042|587744944|FG001|Overall Study|Not Eligible|1|||
162687016|NCT03764774|587563206|FG000|Overall Study|Physician Decision|0|||
162726656|NCT03783026|587710326|FG000|Treatment Phase|Adverse Event|15|||
162726657|NCT03783026|587710326|FG000|Treatment Phase|Lack of Efficacy|11|||
162726658|NCT03783026|587710326|FG000|Treatment Phase|Withdrawal by Subject|6|||
162726659|NCT03783026|587710326|FG000|Treatment Phase|Lost to Follow-up|2|||
162726660|NCT03783026|587710326|FG000|Treatment Phase|Protocol Deviation|8|||
162726661|NCT03783026|587710326|FG000|Treatment Phase|Did Not Receive Treatment|1|||
162726662|NCT03783026|587710326|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
162726663|NCT04814186|587710327|FG000|Treatment Phase|Adverse Event|1|||
162726664|NCT04814186|587710327|FG000|Treatment Phase|Death|6|||
162726665|NCT04814186|587710327|FG000|Treatment Phase|Withdrawal by Subject|2|||
162726666|NCT04814186|587710327|FG000|Treatment Phase|Other|1|||
162726667|NCT04814186|587710327|FG000|Follow-Up Phase|Adverse Event|1|||
162726668|NCT04814186|587710327|FG000|Follow-Up Phase|Death|6|||
162726669|NCT04814186|587710327|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
162726670|NCT04814186|587710327|FG000|Follow-Up Phase|Other|1|||
162687017|NCT03764774|587563207|FG001|Overall Study|Physician Decision|0|||
162687018|NCT03764774|587563208|FG002|Overall Study|Physician Decision|0|||
162687019|NCT03764774|587563209|FG003|Overall Study|Physician Decision|0|||
162687020|NCT03764774|587563210|FG004|Overall Study|Physician Decision|0|||
162687021|NCT03764774|587563211|FG005|Overall Study|Physician Decision|0|||
162687022|NCT03764774|587563212|FG006|Overall Study|Physician Decision|0|||
162687023|NCT03764774|587563213|FG007|Overall Study|Physician Decision|0|||
162687024|NCT03764774|587563214|FG008|Overall Study|Physician Decision|0|||
162687025|NCT03764774|587563215|FG009|Overall Study|Physician Decision|4|||
162687026|NCT03764774|587563216|FG010|Overall Study|Physician Decision|1|||
162687027|NCT03764774|587563217|FG011|Overall Study|Physician Decision|4|||
162687028|NCT03764774|587563218|FG012|Overall Study|Physician Decision|9|||
162687029|NCT03764774|587563219|FG013|Overall Study|Physician Decision|0|||
162687030|NCT03764774|587563206|FG000|Overall Study|Study Termination|0|||
162687031|NCT03764774|587563207|FG001|Overall Study|Study Termination|0|||
162687032|NCT03764774|587563208|FG002|Overall Study|Study Termination|0|||
162687033|NCT03764774|587563209|FG003|Overall Study|Study Termination|0|||
162687034|NCT03764774|587563210|FG004|Overall Study|Study Termination|0|||
162687035|NCT03764774|587563211|FG005|Overall Study|Study Termination|0|||
162687036|NCT03764774|587563212|FG006|Overall Study|Study Termination|0|||
162687037|NCT03764774|587563213|FG007|Overall Study|Study Termination|0|||
162687038|NCT03764774|587563214|FG008|Overall Study|Study Termination|0|||
162687039|NCT03764774|587563215|FG009|Overall Study|Study Termination|1|||
162687040|NCT03764774|587563216|FG010|Overall Study|Study Termination|0|||
162687041|NCT03764774|587563217|FG011|Overall Study|Study Termination|0|||
162687042|NCT03764774|587563218|FG012|Overall Study|Study Termination|0|||
162687043|NCT03764774|587563219|FG013|Overall Study|Study Termination|2|||
162687044|NCT01337986|587564729|FG000|Overall Study|Adverse Event|2|||
162687045|NCT01337986|587564730|FG001|Overall Study|Adverse Event|2|||
162687046|NCT01337986|587564729|FG000|Overall Study|Lost to Follow-up|1|||
162687047|NCT01337986|587564730|FG001|Overall Study|Lost to Follow-up|0|||
162687048|NCT01337986|587564729|FG000|Overall Study|Protocol Violation|0|||
162687049|NCT01337986|587564730|FG001|Overall Study|Protocol Violation|3|||
162687050|NCT02313909|587564731|FG000|Overall Study|Consent withdrawn by participant|33|||
162687051|NCT02313909|587564732|FG001|Overall Study|Consent withdrawn by participant|33|||
162687052|NCT02313909|587564731|FG000|Overall Study|Lost to Follow-up|24|||
162687053|NCT02313909|587564732|FG001|Overall Study|Lost to Follow-up|17|||
162687054|NCT01782872|587564733|FG000|Overall Study|Protocol Violation|0|||
162687055|NCT01782872|587564734|FG001|Overall Study|Protocol Violation|0|||
162687056|NCT01782872|587564735|FG002|Overall Study|Protocol Violation|0|||
162687057|NCT01782872|587564736|FG003|Overall Study|Protocol Violation|1|||
162687058|NCT01782872|587564733|FG000|Overall Study|Withdrawal by Subject|0|||
162687059|NCT01782872|587564734|FG001|Overall Study|Withdrawal by Subject|1|||
162687060|NCT01782872|587564735|FG002|Overall Study|Withdrawal by Subject|0|||
162687061|NCT01782872|587564736|FG003|Overall Study|Withdrawal by Subject|0|||
162687062|NCT04026165|587564737|FG000|Run-in Placebo Period|Enrollment Error|13|||
162687063|NCT04026165|587564738|FG001|Run-in Placebo Period|Enrollment Error|0|||
162687064|NCT04026165|587564739|FG002|Run-in Placebo Period|Enrollment Error|0|||
162726671|NCT05505045|587710332|FG000|Overall Study|Withdrawal by Subject|2|||
162726672|NCT05505045|587710333|FG001|Overall Study|Withdrawal by Subject|1|||
162726673|NCT01643070|587710334|FG000|Overall Study|Withdrawal by Subject|3|||
162726674|NCT01643070|587710335|FG001|Overall Study|Withdrawal by Subject|1|||
162687065|NCT04026165|587564740|FG003|Run-in Placebo Period|Enrollment Error|0|||
162687066|NCT04026165|587564737|FG000|Run-in Placebo Period|Run-in Failure|4|||
162687067|NCT04026165|587564738|FG001|Run-in Placebo Period|Run-in Failure|0|||
162687068|NCT04026165|587564739|FG002|Run-in Placebo Period|Run-in Failure|0|||
162687069|NCT04026165|587564740|FG003|Run-in Placebo Period|Run-in Failure|0|||
162687070|NCT04026165|587564737|FG000|Run-in Placebo Period|Protocol Violation|2|||
162687071|NCT04026165|587564738|FG001|Run-in Placebo Period|Protocol Violation|0|||
162687072|NCT04026165|587564739|FG002|Run-in Placebo Period|Protocol Violation|0|||
162687073|NCT04026165|587564740|FG003|Run-in Placebo Period|Protocol Violation|0|||
162687074|NCT04026165|587564737|FG000|Run-in Placebo Period|Withdrew Consent|2|||
162726675|NCT01643070|587710334|FG000|Overall Study|Death|1|||
162726676|NCT01643070|587710335|FG001|Overall Study|Death|0|||
162726677|NCT01643070|587710334|FG000|Overall Study|Pregressive disease|0|||
162726678|NCT01643070|587710335|FG001|Overall Study|Pregressive disease|2|||
162726679|NCT04201834|587710339|FG000|Overall Study|Screen fail|1|||
162726680|NCT04104321|587710343|FG000|Overall Study|didn't take the study drug|3|||
162726681|NCT04842500|587710344|FG000|Overall Study|Withdrawal by Subject|4|||
162726682|NCT04842500|587710345|FG001|Overall Study|Withdrawal by Subject|1|||
162726683|NCT04842500|587710346|FG002|Overall Study|Withdrawal by Subject|2|||
162726684|NCT04842500|587710347|FG003|Overall Study|Withdrawal by Subject|3|||
162726685|NCT04842500|587710344|FG000|Overall Study|Protocol Violation|1|||
162726686|NCT04842500|587710345|FG001|Overall Study|Protocol Violation|0|||
162726687|NCT04842500|587710346|FG002|Overall Study|Protocol Violation|0|||
162726688|NCT04842500|587710347|FG003|Overall Study|Protocol Violation|1|||
162726689|NCT02980276|587710348|FG000|Overall Study|Withdrawal by Subject|4|||
162726690|NCT02980276|587710349|FG001|Overall Study|Withdrawal by Subject|4|||
162726691|NCT02980276|587710348|FG000|Overall Study|Physician Decision|0|||
162726692|NCT02980276|587710349|FG001|Overall Study|Physician Decision|1|||
162726693|NCT02980276|587710348|FG000|Overall Study|Lost to Follow-up|18|||
162726694|NCT02980276|587710349|FG001|Overall Study|Lost to Follow-up|18|||
162726695|NCT02980276|587710348|FG000|Overall Study|Death|1|||
162726696|NCT02980276|587710349|FG001|Overall Study|Death|0|||
162726697|NCT02980276|587710348|FG000|Overall Study|Miscellaneous other|10|||
162726698|NCT02980276|587710349|FG001|Overall Study|Miscellaneous other|4|||
162726699|NCT02824029|587710354|FG000|Overall Study|Didn't receive treatment|2|||
162726700|NCT02824029|587710354|FG000|Overall Study|Patient decision to discontinue treatment|3|||
162726701|NCT02824029|587710354|FG000|Overall Study|Non-compliant|5|||
162726702|NCT02824029|587710354|FG000|Overall Study|Progression of disease|15|||
162726703|NCT02824029|587710354|FG000|Overall Study|Inadequate response to therapy|2|||
162726704|NCT02824029|587710354|FG000|Overall Study|Possible progression per treating physician|1|||
162726705|NCT04512482|587710357|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
162726706|NCT04512482|587710358|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
162726707|NCT05119855|587710359|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
162726708|NCT05119855|587710360|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
162726709|NCT05119855|587710359|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
162726710|NCT05119855|587710360|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
162726711|NCT05119855|587710359|FG000|Overall Study|Lost to Follow-up|6|||
162726712|NCT05119855|587710360|FG001|Overall Study|Lost to Follow-up|8|||
162726713|NCT00391898|587710365|FG000|Overall Study|Adverse Event|3|||
162726714|NCT00391898|587710366|FG001|Overall Study|Adverse Event|0|||
162726715|NCT00391898|587710365|FG000|Overall Study|Other|8|||
162726716|NCT00391898|587710366|FG001|Overall Study|Other|10|||
162726717|NCT05489484|587710367|FG000|Overall Study|withdrawn|1|||
162726718|NCT02529995|587710368|FG000|Part A|Ongoing Study at Data Cut-off|14|||
162726719|NCT02529995|587710369|FG001|Part A|Ongoing Study at Data Cut-off|16|||
162726720|NCT02529995|587710368|FG000|Part A|Discontinued Study|1|||
162726721|NCT02529995|587710369|FG001|Part A|Discontinued Study|0|||
162726722|NCT02529995|587710368|FG000|Part B|Ongoing Study at Data Cut-off|0|||
162726723|NCT02529995|587710369|FG001|Part B|Ongoing Study at Data Cut-off|7|||
162726724|NCT02529995|587710368|FG000|Part B|Discontinued Study|6|||
162726725|NCT02529995|587710369|FG001|Part B|Discontinued Study|5|||
162726726|NCT00444600|587710370|FG000|Overall Study|Death|7|||
162726727|NCT00444600|587710371|FG001|Overall Study|Death|5|||
162726728|NCT00444600|587710372|FG002|Overall Study|Death|3|||
162726729|NCT00444600|587710373|FG003|Overall Study|Death|2|||
162726730|NCT00444600|587710370|FG000|Overall Study|Dropped|11|||
162726731|NCT00444600|587710371|FG001|Overall Study|Dropped|11|||
162726732|NCT00444600|587710372|FG002|Overall Study|Dropped|7|||
162726733|NCT00444600|587710373|FG003|Overall Study|Dropped|7|||
162726734|NCT00444600|587710370|FG000|Overall Study|Missed visit|1|||
162726735|NCT00444600|587710371|FG001|Overall Study|Missed visit|0|||
162726736|NCT00444600|587710372|FG002|Overall Study|Missed visit|0|||
162726737|NCT00444600|587710373|FG003|Overall Study|Missed visit|1|||
162726738|NCT05132478|587710374|FG000|Overall Study|did not complete survey after consent|1|||
162726739|NCT05132478|587710375|FG001|Overall Study|did not complete survey after consent|1|||
162726740|NCT05132478|587710374|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
162726741|NCT05132478|587710375|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
162726742|NCT02549170|587710376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
162726743|NCT02549170|587710377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
162726744|NCT02549170|587710378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162726745|NCT02549170|587710379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162726746|NCT02549170|587710380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162726747|NCT02549170|587710376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
162726748|NCT02549170|587710377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
162726749|NCT02549170|587710378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162726750|NCT02549170|587710379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162726751|NCT02549170|587710380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162726752|NCT02549170|587710376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
162726753|NCT02549170|587710377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
162726754|NCT02549170|587710378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162726755|NCT02549170|587710379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162726756|NCT02549170|587710380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162726757|NCT02988817|587710381|FG000|Overall Study|Withdrawal by Subject|1|||
162726758|NCT02988817|587710382|FG001|Overall Study|Withdrawal by Subject|0|||
162726759|NCT02988817|587710383|FG002|Overall Study|Withdrawal by Subject|0|||
162726760|NCT02988817|587710384|FG003|Overall Study|Withdrawal by Subject|1|||
162726761|NCT02988817|587710385|FG004|Overall Study|Withdrawal by Subject|3|||
162726762|NCT02988817|587710386|FG005|Overall Study|Withdrawal by Subject|1|||
162726763|NCT02988817|587710387|FG006|Overall Study|Withdrawal by Subject|2|||
162726764|NCT02988817|587710388|FG007|Overall Study|Withdrawal by Subject|1|||
162726765|NCT02988817|587710389|FG008|Overall Study|Withdrawal by Subject|1|||
162726766|NCT02988817|587710390|FG009|Overall Study|Withdrawal by Subject|1|||
162726767|NCT02988817|587710391|FG010|Overall Study|Withdrawal by Subject|1|||
162726768|NCT02988817|587710392|FG011|Overall Study|Withdrawal by Subject|12|||
162726769|NCT02988817|587710393|FG012|Overall Study|Withdrawal by Subject|6|||
162726770|NCT02988817|587710394|FG013|Overall Study|Withdrawal by Subject|6|||
162726771|NCT02988817|587710395|FG014|Overall Study|Withdrawal by Subject|4|||
162687075|NCT04026165|587564738|FG001|Run-in Placebo Period|Withdrew Consent|0|||
162687076|NCT04026165|587564739|FG002|Run-in Placebo Period|Withdrew Consent|0|||
162687077|NCT04026165|587564740|FG003|Run-in Placebo Period|Withdrew Consent|0|||
162687078|NCT04026165|587564737|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
162687079|NCT04026165|587564738|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162687080|NCT04026165|587564739|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162687081|NCT04026165|587564740|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162687082|NCT04026165|587564737|FG000|Run-in SEL Period|Run-in Failure|0|||
162687083|NCT04026165|587564738|FG001|Run-in SEL Period|Run-in Failure|26|||
162687084|NCT04026165|587564739|FG002|Run-in SEL Period|Run-in Failure|0|||
162687085|NCT04026165|587564740|FG003|Run-in SEL Period|Run-in Failure|0|||
162687086|NCT04026165|587564737|FG000|Run-in SEL Period|Withdrew Consent|0|||
162687087|NCT04026165|587564738|FG001|Run-in SEL Period|Withdrew Consent|10|||
162687088|NCT04026165|587564739|FG002|Run-in SEL Period|Withdrew Consent|0|||
162687089|NCT04026165|587564740|FG003|Run-in SEL Period|Withdrew Consent|0|||
162687090|NCT04026165|587564737|FG000|Run-in SEL Period|Enrollment Error|0|||
162687091|NCT04026165|587564738|FG001|Run-in SEL Period|Enrollment Error|4|||
162726772|NCT02988817|587710396|FG015|Overall Study|Withdrawal by Subject|5|||
162726773|NCT02988817|587710397|FG016|Overall Study|Withdrawal by Subject|4|||
162726774|NCT02988817|587710398|FG017|Overall Study|Withdrawal by Subject|11|||
162726775|NCT02988817|587710399|FG018|Overall Study|Withdrawal by Subject|4|||
162726776|NCT02988817|587710400|FG019|Overall Study|Withdrawal by Subject|2|||
162726777|NCT02988817|587710381|FG000|Overall Study|Death|0|||
162726778|NCT02988817|587710382|FG001|Overall Study|Death|1|||
162726779|NCT02988817|587710383|FG002|Overall Study|Death|3|||
162726780|NCT02988817|587710384|FG003|Overall Study|Death|1|||
162726781|NCT02988817|587710385|FG004|Overall Study|Death|6|||
162726782|NCT02988817|587710386|FG005|Overall Study|Death|10|||
162726783|NCT02988817|587710387|FG006|Overall Study|Death|1|||
162726784|NCT02988817|587710388|FG007|Overall Study|Death|2|||
162726785|NCT02988817|587710389|FG008|Overall Study|Death|1|||
162726786|NCT02988817|587710390|FG009|Overall Study|Death|5|||
162726787|NCT02988817|587710391|FG010|Overall Study|Death|1|||
162726788|NCT02988817|587710392|FG011|Overall Study|Death|8|||
162726789|NCT02988817|587710393|FG012|Overall Study|Death|9|||
162726790|NCT02988817|587710394|FG013|Overall Study|Death|17|||
162726791|NCT02988817|587710395|FG014|Overall Study|Death|18|||
162726792|NCT02988817|587710396|FG015|Overall Study|Death|30|||
162726793|NCT02988817|587710397|FG016|Overall Study|Death|17|||
162726794|NCT02988817|587710398|FG017|Overall Study|Death|38|||
162726795|NCT02988817|587710399|FG018|Overall Study|Death|14|||
162687092|NCT04026165|587564739|FG002|Run-in SEL Period|Enrollment Error|0|||
162726796|NCT02988817|587710400|FG019|Overall Study|Death|16|||
162726797|NCT02988817|587710381|FG000|Overall Study|Other|0|||
162726798|NCT02988817|587710382|FG001|Overall Study|Other|0|||
162687093|NCT04026165|587564740|FG003|Run-in SEL Period|Enrollment Error|0|||
162687094|NCT04026165|587564737|FG000|Run-in SEL Period|Protocol Violation|0|||
162687095|NCT04026165|587564738|FG001|Run-in SEL Period|Protocol Violation|3|||
162726799|NCT02988817|587710383|FG002|Overall Study|Other|0|||
162726800|NCT02988817|587710384|FG003|Overall Study|Other|1|||
162726801|NCT02988817|587710385|FG004|Overall Study|Other|1|||
162726802|NCT02988817|587710386|FG005|Overall Study|Other|0|||
162726803|NCT02988817|587710387|FG006|Overall Study|Other|0|||
162687096|NCT04026165|587564739|FG002|Run-in SEL Period|Protocol Violation|0|||
162726804|NCT02988817|587710388|FG007|Overall Study|Other|0|||
162687097|NCT04026165|587564740|FG003|Run-in SEL Period|Protocol Violation|0|||
162687098|NCT04026165|587564737|FG000|Run-in SEL Period|Investigator's Discretion|0|||
162687099|NCT04026165|587564738|FG001|Run-in SEL Period|Investigator's Discretion|2|||
162687100|NCT04026165|587564739|FG002|Run-in SEL Period|Investigator's Discretion|0|||
162687101|NCT04026165|587564740|FG003|Run-in SEL Period|Investigator's Discretion|0|||
162687102|NCT04026165|587564737|FG000|Run-in SEL Period|Death|0|||
162687103|NCT04026165|587564738|FG001|Run-in SEL Period|Death|1|||
162687104|NCT04026165|587564739|FG002|Run-in SEL Period|Death|0|||
162687105|NCT04026165|587564740|FG003|Run-in SEL Period|Death|0|||
162687106|NCT04026165|587564737|FG000|Randomized Period|Withdrew Consent|0|||
162687107|NCT04026165|587564738|FG001|Randomized Period|Withdrew Consent|0|||
162687108|NCT04026165|587564739|FG002|Randomized Period|Withdrew Consent|5|||
162687109|NCT04026165|587564740|FG003|Randomized Period|Withdrew Consent|8|||
162687110|NCT04026165|587564737|FG000|Randomized Period|Death|0|||
162687111|NCT04026165|587564738|FG001|Randomized Period|Death|0|||
162687112|NCT04026165|587564739|FG002|Randomized Period|Death|5|||
162687113|NCT04026165|587564740|FG003|Randomized Period|Death|7|||
162687114|NCT04026165|587564737|FG000|Randomized Period|Investigator's Discretion|0|||
162687115|NCT04026165|587564738|FG001|Randomized Period|Investigator's Discretion|0|||
162687116|NCT04026165|587564739|FG002|Randomized Period|Investigator's Discretion|2|||
162687117|NCT04026165|587564740|FG003|Randomized Period|Investigator's Discretion|2|||
162687118|NCT04026165|587564737|FG000|Randomized Period|Lost to Follow-up|0|||
162687119|NCT04026165|587564738|FG001|Randomized Period|Lost to Follow-up|0|||
162687120|NCT04026165|587564739|FG002|Randomized Period|Lost to Follow-up|2|||
162687121|NCT04026165|587564740|FG003|Randomized Period|Lost to Follow-up|2|||
162687122|NCT01059630|587564743|FG000|Overall Study|Death|100|||
162687123|NCT01059630|587564744|FG001|Overall Study|Death|84|||
162687124|NCT01059630|587564743|FG000|Overall Study|Lost to Follow-up|4|||
162687125|NCT01059630|587564744|FG001|Overall Study|Lost to Follow-up|1|||
162687126|NCT01059630|587564743|FG000|Overall Study|Physician Decision|2|||
162687127|NCT01059630|587564744|FG001|Overall Study|Physician Decision|4|||
162687128|NCT01059630|587564743|FG000|Overall Study|Withdrawal by Subject|21|||
162687129|NCT01059630|587564744|FG001|Overall Study|Withdrawal by Subject|14|||
162687130|NCT02569437|587564745|FG000|Overall Study|Lost to Follow-up|12|||
162687131|NCT02569437|587564746|FG001|Overall Study|Lost to Follow-up|14|||
162687132|NCT00441701|587564747|FG000|Overall Study|Adverse Event|3|||
162687133|NCT00441701|587564748|FG001|Overall Study|Adverse Event|2|||
162687134|NCT00441701|587564749|FG002|Overall Study|Adverse Event|1|||
162687135|NCT00441701|587564750|FG003|Overall Study|Adverse Event|0|||
162687136|NCT00441701|587564751|FG004|Overall Study|Adverse Event|2|||
162687137|NCT00441701|587564752|FG005|Overall Study|Adverse Event|2|||
162687138|NCT00441701|587564753|FG006|Overall Study|Adverse Event|0|||
162687139|NCT00441701|587564754|FG007|Overall Study|Adverse Event|0|||
162687140|NCT00441701|587564755|FG008|Overall Study|Adverse Event|0|||
162687141|NCT00441701|587564756|FG009|Overall Study|Adverse Event|0|||
162687142|NCT00441701|587564747|FG000|Overall Study|Lack of Efficacy|2|||
162687143|NCT00441701|587564748|FG001|Overall Study|Lack of Efficacy|0|||
162687144|NCT00441701|587564749|FG002|Overall Study|Lack of Efficacy|2|||
162687145|NCT00441701|587564750|FG003|Overall Study|Lack of Efficacy|2|||
162687146|NCT00441701|587564751|FG004|Overall Study|Lack of Efficacy|0|||
162687147|NCT00441701|587564752|FG005|Overall Study|Lack of Efficacy|1|||
162687148|NCT00441701|587564753|FG006|Overall Study|Lack of Efficacy|0|||
162687149|NCT00441701|587564754|FG007|Overall Study|Lack of Efficacy|0|||
162687150|NCT00441701|587564755|FG008|Overall Study|Lack of Efficacy|0|||
162687151|NCT00441701|587564756|FG009|Overall Study|Lack of Efficacy|0|||
162687152|NCT00441701|587564747|FG000|Overall Study|Withdrawal by Subject|0|||
162687153|NCT00441701|587564748|FG001|Overall Study|Withdrawal by Subject|2|||
162687154|NCT00441701|587564749|FG002|Overall Study|Withdrawal by Subject|1|||
162687155|NCT00441701|587564750|FG003|Overall Study|Withdrawal by Subject|1|||
162687156|NCT00441701|587564751|FG004|Overall Study|Withdrawal by Subject|0|||
162687157|NCT00441701|587564752|FG005|Overall Study|Withdrawal by Subject|0|||
162687158|NCT00441701|587564753|FG006|Overall Study|Withdrawal by Subject|0|||
162687159|NCT00441701|587564754|FG007|Overall Study|Withdrawal by Subject|0|||
162687160|NCT00441701|587564755|FG008|Overall Study|Withdrawal by Subject|0|||
162687161|NCT00441701|587564756|FG009|Overall Study|Withdrawal by Subject|0|||
162687162|NCT00985985|587564760|FG000|Overall Study|Adverse Event|4|||
162687163|NCT00985985|587564761|FG001|Overall Study|Adverse Event|2|||
162687164|NCT00985985|587564762|FG002|Overall Study|Adverse Event|2|||
162687165|NCT00985985|587564763|FG003|Overall Study|Adverse Event|2|||
162687166|NCT00985985|587564760|FG000|Overall Study|Lost to Follow-up|4|||
162687167|NCT00985985|587564761|FG001|Overall Study|Lost to Follow-up|11|||
162687168|NCT00985985|587564762|FG002|Overall Study|Lost to Follow-up|2|||
162687169|NCT00985985|587564763|FG003|Overall Study|Lost to Follow-up|3|||
162687170|NCT00985985|587564760|FG000|Overall Study|Protocol Violation|1|||
162687171|NCT00985985|587564761|FG001|Overall Study|Protocol Violation|2|||
162687172|NCT00985985|587564762|FG002|Overall Study|Protocol Violation|0|||
162687173|NCT00985985|587564763|FG003|Overall Study|Protocol Violation|1|||
162687174|NCT00985985|587564760|FG000|Overall Study|Lack of Efficacy|5|||
162687175|NCT00985985|587564761|FG001|Overall Study|Lack of Efficacy|6|||
162687176|NCT00985985|587564762|FG002|Overall Study|Lack of Efficacy|1|||
162687177|NCT00985985|587564763|FG003|Overall Study|Lack of Efficacy|3|||
162687178|NCT00985985|587564760|FG000|Overall Study|Withdrawal by Subject|4|||
162687179|NCT00985985|587564761|FG001|Overall Study|Withdrawal by Subject|2|||
162687180|NCT00985985|587564762|FG002|Overall Study|Withdrawal by Subject|2|||
162687181|NCT00985985|587564763|FG003|Overall Study|Withdrawal by Subject|2|||
162687182|NCT00985985|587564760|FG000|Overall Study|Other Reason|6|||
162687183|NCT00985985|587564761|FG001|Overall Study|Other Reason|1|||
162687184|NCT00985985|587564762|FG002|Overall Study|Other Reason|4|||
162687185|NCT00985985|587564763|FG003|Overall Study|Other Reason|2|||
162687186|NCT02535364|587564771|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
162687187|NCT02535364|587564771|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
162687188|NCT02535364|587564771|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
162687189|NCT02535364|587564771|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
162687190|NCT02535364|587564771|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
162687191|NCT02535364|587564771|FG000|Part B Screening|Death|2|||
162687192|NCT02535364|587564771|FG000|Part B Screening|Physician Decision|1|||
162687193|NCT02535364|587564771|FG000|Part B Screening|Withdrawal by Subject|1|||
162687194|NCT02535364|587564771|FG000|Part B Screening|Adverse Event|1|||
162687195|NCT02535364|587564771|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
162687196|NCT02535364|587564771|FG000|Study Treatment|Death|1|||
162687197|NCT02535364|587564771|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
162687198|NCT02535364|587564771|FG000|12-Month Follow-up Period|Disease progression|22|||
162687199|NCT02535364|587564771|FG000|12-Month Follow-up Period|Death|5|||
162687200|NCT02535364|587564771|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
162687201|NCT02535364|587564771|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
162687202|NCT02535364|587564771|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
162687203|NCT00499863|587564772|FG000|Overall Study|Lack of Efficacy|21|||
162687204|NCT00499863|587564773|FG001|Overall Study|Lack of Efficacy|27|||
162687205|NCT00499863|587564772|FG000|Overall Study|Protocol Violation|12|||
162687206|NCT00499863|587564773|FG001|Overall Study|Protocol Violation|7|||
162687207|NCT00499863|587564772|FG000|Overall Study|Withdrawal by Subject|6|||
162687208|NCT00499863|587564773|FG001|Overall Study|Withdrawal by Subject|4|||
162687209|NCT00499863|587564772|FG000|Overall Study|Adverse Event|8|||
162687210|NCT00499863|587564773|FG001|Overall Study|Adverse Event|2|||
162687211|NCT00499863|587564772|FG000|Overall Study|Sponsor decision|2|||
162687212|NCT00499863|587564773|FG001|Overall Study|Sponsor decision|2|||
162687213|NCT00499863|587564772|FG000|Overall Study|Lost to Follow-up|1|||
162687214|NCT00499863|587564773|FG001|Overall Study|Lost to Follow-up|1|||
162687215|NCT00571701|587564774|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
162687216|NCT00571701|587564775|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
162687217|NCT00571701|587564774|FG000|First Intervention 12 Months|Death|1|||
162687218|NCT00571701|587564775|FG001|First Intervention 12 Months|Death|0|||
162687219|NCT00571701|587564774|FG000|Second Intervention 12 Months|Adverse Event|0|||
162687220|NCT00571701|587564775|FG001|Second Intervention 12 Months|Adverse Event|1|||
162687221|NCT00571701|587564774|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
162687222|NCT00571701|587564775|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
162687223|NCT00691132|587564776|FG000|Overall Study|Adverse Event|2|||
162687224|NCT00691132|587564777|FG001|Overall Study|Adverse Event|3|||
162687225|NCT00691132|587564776|FG000|Overall Study|Withdrawal by Subject|10|||
162687226|NCT00691132|587564777|FG001|Overall Study|Withdrawal by Subject|10|||
162687227|NCT01959347|587564788|FG000|Overall Study|Protocol Violation|9|||
162687228|NCT01959347|587564789|FG001|Overall Study|Protocol Violation|7|||
162687229|NCT01282801|587564790|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
162687230|NCT01282801|587564791|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
162687231|NCT02889133|587564795|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
162687232|NCT02889133|587564796|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
162687233|NCT02889133|587564795|FG000|Completed Primary Outcome|Manufacturing error|3|||
162687234|NCT02889133|587564796|FG001|Completed Primary Outcome|Manufacturing error|8|||
162687235|NCT02889133|587564795|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
162687236|NCT02889133|587564796|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
162687237|NCT02889133|587564795|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
162687238|NCT02889133|587564796|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
162687239|NCT02889133|587564795|FG000|Completed Primary Outcome|Protocol Violation|1|||
162687240|NCT02889133|587564796|FG001|Completed Primary Outcome|Protocol Violation|0|||
162687241|NCT02889133|587564795|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
162687242|NCT02889133|587564796|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
162687243|NCT02889133|587564795|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
162687244|NCT02889133|587564796|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
162687245|NCT02889133|587564795|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
162687246|NCT02889133|587564796|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
162726805|NCT02988817|587710389|FG008|Overall Study|Other|0|||
162726806|NCT02988817|587710390|FG009|Overall Study|Other|0|||
162726807|NCT02988817|587710391|FG010|Overall Study|Other|0|||
162726808|NCT02988817|587710392|FG011|Overall Study|Other|0|||
162726809|NCT02988817|587710393|FG012|Overall Study|Other|0|||
162726810|NCT02988817|587710394|FG013|Overall Study|Other|0|||
162726811|NCT02988817|587710395|FG014|Overall Study|Other|0|||
162726812|NCT02988817|587710396|FG015|Overall Study|Other|1|||
162726813|NCT02988817|587710397|FG016|Overall Study|Other|0|||
162726814|NCT02988817|587710398|FG017|Overall Study|Other|0|||
162726815|NCT02988817|587710399|FG018|Overall Study|Other|0|||
162726816|NCT02988817|587710400|FG019|Overall Study|Other|0|||
162726817|NCT02988817|587710381|FG000|Overall Study|Lost to Follow-up|0|||
162726818|NCT02988817|587710382|FG001|Overall Study|Lost to Follow-up|0|||
162726819|NCT02988817|587710383|FG002|Overall Study|Lost to Follow-up|0|||
162726820|NCT02988817|587710384|FG003|Overall Study|Lost to Follow-up|0|||
162726821|NCT02988817|587710385|FG004|Overall Study|Lost to Follow-up|0|||
162726822|NCT02988817|587710386|FG005|Overall Study|Lost to Follow-up|0|||
162726823|NCT02988817|587710387|FG006|Overall Study|Lost to Follow-up|0|||
162726824|NCT02988817|587710388|FG007|Overall Study|Lost to Follow-up|0|||
162726825|NCT02988817|587710389|FG008|Overall Study|Lost to Follow-up|1|||
162726826|NCT02988817|587710390|FG009|Overall Study|Lost to Follow-up|0|||
162726827|NCT02988817|587710391|FG010|Overall Study|Lost to Follow-up|1|||
162726828|NCT02988817|587710392|FG011|Overall Study|Lost to Follow-up|1|||
162726829|NCT02988817|587710393|FG012|Overall Study|Lost to Follow-up|0|||
162726830|NCT02988817|587710394|FG013|Overall Study|Lost to Follow-up|0|||
162726831|NCT02988817|587710395|FG014|Overall Study|Lost to Follow-up|1|||
162726832|NCT02988817|587710396|FG015|Overall Study|Lost to Follow-up|1|||
162726833|NCT02988817|587710397|FG016|Overall Study|Lost to Follow-up|2|||
162726834|NCT02988817|587710398|FG017|Overall Study|Lost to Follow-up|3|||
162726835|NCT02988817|587710399|FG018|Overall Study|Lost to Follow-up|0|||
162726836|NCT02988817|587710400|FG019|Overall Study|Lost to Follow-up|0|||
162726837|NCT02988817|587710381|FG000|Overall Study|Sponsor decision|0|||
162726838|NCT02988817|587710382|FG001|Overall Study|Sponsor decision|0|||
162726839|NCT02988817|587710383|FG002|Overall Study|Sponsor decision|0|||
162726840|NCT02988817|587710384|FG003|Overall Study|Sponsor decision|0|||
162726841|NCT02988817|587710385|FG004|Overall Study|Sponsor decision|0|||
162726842|NCT02988817|587710386|FG005|Overall Study|Sponsor decision|0|||
162726843|NCT02988817|587710387|FG006|Overall Study|Sponsor decision|0|||
162726844|NCT02988817|587710388|FG007|Overall Study|Sponsor decision|0|||
162726845|NCT02988817|587710389|FG008|Overall Study|Sponsor decision|0|||
162726846|NCT02988817|587710390|FG009|Overall Study|Sponsor decision|0|||
162726847|NCT02988817|587710391|FG010|Overall Study|Sponsor decision|0|||
162726848|NCT02988817|587710392|FG011|Overall Study|Sponsor decision|1|||
162726849|NCT02988817|587710393|FG012|Overall Study|Sponsor decision|1|||
162726850|NCT02988817|587710394|FG013|Overall Study|Sponsor decision|2|||
162726851|NCT02988817|587710395|FG014|Overall Study|Sponsor decision|2|||
162726852|NCT02988817|587710396|FG015|Overall Study|Sponsor decision|6|||
162726853|NCT02988817|587710397|FG016|Overall Study|Sponsor decision|2|||
162726854|NCT02988817|587710398|FG017|Overall Study|Sponsor decision|3|||
162726855|NCT02988817|587710399|FG018|Overall Study|Sponsor decision|2|||
162726856|NCT02988817|587710400|FG019|Overall Study|Sponsor decision|7|||
162726857|NCT02988817|587710381|FG000|Overall Study|Physician Decision|0|||
162726858|NCT02988817|587710382|FG001|Overall Study|Physician Decision|0|||
162726859|NCT02988817|587710383|FG002|Overall Study|Physician Decision|0|||
162726860|NCT02988817|587710384|FG003|Overall Study|Physician Decision|0|||
162726861|NCT02988817|587710385|FG004|Overall Study|Physician Decision|0|||
162726862|NCT02988817|587710386|FG005|Overall Study|Physician Decision|0|||
162726863|NCT02988817|587710387|FG006|Overall Study|Physician Decision|0|||
162726864|NCT02988817|587710388|FG007|Overall Study|Physician Decision|0|||
162726865|NCT02988817|587710389|FG008|Overall Study|Physician Decision|0|||
162726866|NCT02988817|587710390|FG009|Overall Study|Physician Decision|0|||
162726867|NCT02988817|587710391|FG010|Overall Study|Physician Decision|0|||
162726868|NCT02988817|587710392|FG011|Overall Study|Physician Decision|0|||
162726869|NCT02988817|587710393|FG012|Overall Study|Physician Decision|0|||
162726870|NCT02988817|587710394|FG013|Overall Study|Physician Decision|0|||
162726871|NCT02988817|587710395|FG014|Overall Study|Physician Decision|0|||
162726872|NCT02988817|587710396|FG015|Overall Study|Physician Decision|1|||
162726873|NCT02988817|587710397|FG016|Overall Study|Physician Decision|0|||
162726874|NCT02988817|587710398|FG017|Overall Study|Physician Decision|0|||
162726875|NCT02988817|587710399|FG018|Overall Study|Physician Decision|1|||
162726876|NCT02988817|587710400|FG019|Overall Study|Physician Decision|1|||
162726877|NCT00421889|587710401|FG000|Overall Study|Adverse Event|1|||
162726878|NCT00421889|587710402|FG001|Overall Study|Adverse Event|0|||
162726879|NCT00421889|587710403|FG002|Overall Study|Adverse Event|1|||
162726880|NCT00421889|587710404|FG003|Overall Study|Adverse Event|1|||
162726881|NCT00421889|587710405|FG004|Overall Study|Adverse Event|1|||
162726882|NCT00421889|587710406|FG005|Overall Study|Adverse Event|4|||
162726883|NCT00421889|587710407|FG006|Overall Study|Adverse Event|1|||
162726884|NCT00421889|587710408|FG007|Overall Study|Adverse Event|0|||
162726885|NCT00421889|587710409|FG008|Overall Study|Adverse Event|2|||
162726886|NCT00421889|587710401|FG000|Overall Study|Withdrawal by Subject|1|||
162726887|NCT00421889|587710402|FG001|Overall Study|Withdrawal by Subject|3|||
162726888|NCT00421889|587710403|FG002|Overall Study|Withdrawal by Subject|0|||
162726889|NCT00421889|587710404|FG003|Overall Study|Withdrawal by Subject|0|||
162726890|NCT00421889|587710405|FG004|Overall Study|Withdrawal by Subject|2|||
162726891|NCT00421889|587710406|FG005|Overall Study|Withdrawal by Subject|0|||
162726892|NCT00421889|587710407|FG006|Overall Study|Withdrawal by Subject|0|||
162726893|NCT00421889|587710408|FG007|Overall Study|Withdrawal by Subject|0|||
162726894|NCT00421889|587710409|FG008|Overall Study|Withdrawal by Subject|0|||
162726895|NCT00421889|587710401|FG000|Overall Study|Death|0|||
162726896|NCT00421889|587710402|FG001|Overall Study|Death|0|||
162726897|NCT00421889|587710403|FG002|Overall Study|Death|0|||
162726898|NCT00421889|587710404|FG003|Overall Study|Death|0|||
162726899|NCT00421889|587710405|FG004|Overall Study|Death|1|||
162726900|NCT00421889|587710406|FG005|Overall Study|Death|1|||
162726901|NCT00421889|587710407|FG006|Overall Study|Death|0|||
162726902|NCT00421889|587710408|FG007|Overall Study|Death|0|||
162726903|NCT00421889|587710409|FG008|Overall Study|Death|0|||
162726904|NCT00421889|587710401|FG000|Overall Study|Progressive disease|3|||
162726905|NCT00421889|587710402|FG001|Overall Study|Progressive disease|2|||
162726906|NCT00421889|587710403|FG002|Overall Study|Progressive disease|2|||
162726907|NCT00421889|587710404|FG003|Overall Study|Progressive disease|3|||
162726908|NCT00421889|587710405|FG004|Overall Study|Progressive disease|2|||
162726909|NCT00421889|587710406|FG005|Overall Study|Progressive disease|21|||
162726910|NCT00421889|587710407|FG006|Overall Study|Progressive disease|3|||
162726911|NCT00421889|587710408|FG007|Overall Study|Progressive disease|1|||
162726912|NCT00421889|587710409|FG008|Overall Study|Progressive disease|5|||
162726913|NCT00421889|587710401|FG000|Overall Study|Patient/Investigator request|0|||
162726914|NCT00421889|587710402|FG001|Overall Study|Patient/Investigator request|0|||
162726915|NCT00421889|587710403|FG002|Overall Study|Patient/Investigator request|0|||
162726916|NCT00421889|587710404|FG003|Overall Study|Patient/Investigator request|0|||
162726917|NCT00421889|587710405|FG004|Overall Study|Patient/Investigator request|0|||
162726918|NCT00421889|587710406|FG005|Overall Study|Patient/Investigator request|9|||
162726919|NCT00421889|587710407|FG006|Overall Study|Patient/Investigator request|0|||
162726920|NCT00421889|587710408|FG007|Overall Study|Patient/Investigator request|1|||
162726921|NCT00421889|587710409|FG008|Overall Study|Patient/Investigator request|3|||
162726922|NCT00421889|587710401|FG000|Overall Study|Lost to Follow-up|0|||
162726923|NCT00421889|587710402|FG001|Overall Study|Lost to Follow-up|0|||
162726924|NCT00421889|587710403|FG002|Overall Study|Lost to Follow-up|0|||
162726925|NCT00421889|587710404|FG003|Overall Study|Lost to Follow-up|0|||
162726926|NCT00421889|587710405|FG004|Overall Study|Lost to Follow-up|0|||
162726927|NCT00421889|587710406|FG005|Overall Study|Lost to Follow-up|0|||
162726928|NCT00421889|587710407|FG006|Overall Study|Lost to Follow-up|0|||
162726929|NCT00421889|587710408|FG007|Overall Study|Lost to Follow-up|0|||
162726930|NCT00421889|587710409|FG008|Overall Study|Lost to Follow-up|1|||
162726931|NCT03051165|587710413|FG000|Overall Study|Withdrawal by Subject|1|||
162726932|NCT03051165|587710413|FG000|Overall Study|Early termination of study|12|||
162726933|NCT03684044|587710418|FG000|Overall Study|Adverse Event|3|||
162726934|NCT03684044|587710419|FG001|Overall Study|Adverse Event|0|||
162726935|NCT03684044|587710418|FG000|Overall Study|Death|4|||
162726936|NCT03684044|587710419|FG001|Overall Study|Death|7|||
162726937|NCT03684044|587710418|FG000|Overall Study|Lost to Follow-up|3|||
162726938|NCT03684044|587710419|FG001|Overall Study|Lost to Follow-up|2|||
162726939|NCT03684044|587710418|FG000|Overall Study|Patient Not Available|0|||
162726940|NCT03684044|587710419|FG001|Overall Study|Patient Not Available|2|||
162726941|NCT03684044|587710418|FG000|Overall Study|Physician Decision|1|||
162726942|NCT03684044|587710419|FG001|Overall Study|Physician Decision|0|||
162726943|NCT03684044|587710418|FG000|Overall Study|Withdrawal by Subject|11|||
162726944|NCT03684044|587710419|FG001|Overall Study|Withdrawal by Subject|9|||
162726945|NCT03703336|587710420|FG000|Overall Study|Parent withdrew consent|29|||
162726946|NCT03703336|587710421|FG001|Overall Study|Parent withdrew consent|8|||
162726947|NCT03703336|587710420|FG000|Overall Study|Migration|3|||
162726948|NCT03703336|587710421|FG001|Overall Study|Migration|3|||
162726949|NCT03703336|587710420|FG000|Overall Study|Protocol Violation|3|||
162726950|NCT03703336|587710421|FG001|Overall Study|Protocol Violation|1|||
162726951|NCT03703336|587710420|FG000|Overall Study|Physician Decision|2|||
162726952|NCT03703336|587710421|FG001|Overall Study|Physician Decision|0|||
162726953|NCT03703336|587710420|FG000|Overall Study|Adverse Event|0|||
162726954|NCT03703336|587710421|FG001|Overall Study|Adverse Event|2|||
162726955|NCT03703336|587710420|FG000|Overall Study|Lost to Follow-up|1|||
162726956|NCT03703336|587710421|FG001|Overall Study|Lost to Follow-up|0|||
162726957|NCT00595413|587710422|FG000|Overall Study|Adverse Event|0|||
162726958|NCT00595413|587710423|FG001|Overall Study|Adverse Event|2|||
162726959|NCT00595413|587710424|FG002|Overall Study|Adverse Event|1|||
162726960|NCT00595413|587710425|FG003|Overall Study|Adverse Event|1|||
162726961|NCT00595413|587710422|FG000|Overall Study|Lost to Follow-up|2|||
162726962|NCT00595413|587710423|FG001|Overall Study|Lost to Follow-up|2|||
162726963|NCT00595413|587710424|FG002|Overall Study|Lost to Follow-up|1|||
162726964|NCT00595413|587710425|FG003|Overall Study|Lost to Follow-up|3|||
162726965|NCT00595413|587710422|FG000|Overall Study|Death|0|||
162726966|NCT00595413|587710423|FG001|Overall Study|Death|0|||
162726967|NCT00595413|587710424|FG002|Overall Study|Death|1|||
162726968|NCT00595413|587710425|FG003|Overall Study|Death|0|||
162726969|NCT00595413|587710422|FG000|Overall Study|Other|5|||
162726970|NCT00595413|587710423|FG001|Overall Study|Other|1|||
162726971|NCT00595413|587710424|FG002|Overall Study|Other|5|||
162726972|NCT00595413|587710425|FG003|Overall Study|Other|0|||
162726973|NCT00807937|587710426|FG000|Overall Study|Adverse Event|12|||
162726974|NCT00807937|587710427|FG001|Overall Study|Adverse Event|12|||
162726975|NCT00807937|587710428|FG002|Overall Study|Adverse Event|5|||
162726976|NCT00807937|587710429|FG003|Overall Study|Adverse Event|4|||
162726977|NCT00807937|587710426|FG000|Overall Study|Protocol Violation|4|||
162726978|NCT00807937|587710427|FG001|Overall Study|Protocol Violation|5|||
162726979|NCT00807937|587710428|FG002|Overall Study|Protocol Violation|3|||
162726980|NCT00807937|587710429|FG003|Overall Study|Protocol Violation|3|||
162726981|NCT00807937|587710426|FG000|Overall Study|Withdrawal by Subject|5|||
162726982|NCT00807937|587710427|FG001|Overall Study|Withdrawal by Subject|4|||
162726983|NCT00807937|587710428|FG002|Overall Study|Withdrawal by Subject|1|||
162726984|NCT00807937|587710429|FG003|Overall Study|Withdrawal by Subject|4|||
162687247|NCT02889133|587564795|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
162687248|NCT02889133|587564796|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
162687249|NCT02889133|587564795|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
162687250|NCT02889133|587564796|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
162726985|NCT00807937|587710426|FG000|Overall Study|Lost to Follow-up|4|||
162726986|NCT00807937|587710427|FG001|Overall Study|Lost to Follow-up|0|||
162726987|NCT00807937|587710428|FG002|Overall Study|Lost to Follow-up|2|||
162726988|NCT00807937|587710429|FG003|Overall Study|Lost to Follow-up|1|||
162687251|NCT01781390|587564798|FG000|Overall Study|Withdrawal of Consent|0|||
162687252|NCT01781390|587564799|FG001|Overall Study|Withdrawal of Consent|3|||
162687253|NCT01781390|587564800|FG002|Overall Study|Withdrawal of Consent|1|||
162687254|NCT01781390|587564798|FG000|Overall Study|Lost to Follow-up|1|||
162687255|NCT01781390|587564799|FG001|Overall Study|Lost to Follow-up|1|||
162687256|NCT01781390|587564800|FG002|Overall Study|Lost to Follow-up|1|||
162687257|NCT01781390|587564798|FG000|Overall Study|Adverse Event|1|||
162687258|NCT01781390|587564799|FG001|Overall Study|Adverse Event|2|||
162687259|NCT01781390|587564800|FG002|Overall Study|Adverse Event|1|||
162687260|NCT01781390|587564798|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
162687261|NCT01781390|587564799|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
162687262|NCT01781390|587564800|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
162687263|NCT01862796|587564801|FG000|Overall Study|Prohibited medications|0|||
162687264|NCT01862796|587564802|FG001|Overall Study|Prohibited medications|0|||
162687265|NCT01862796|587564803|FG002|Overall Study|Prohibited medications|1|||
162687266|NCT01375205|587564808|FG000|Overall Study|Lost to Follow-up|15|||
162687267|NCT01375205|587564809|FG001|Overall Study|Lost to Follow-up|12|||
162687268|NCT01375205|587564808|FG000|Overall Study|Withdrawal by Subject|6|||
162687269|NCT01375205|587564809|FG001|Overall Study|Withdrawal by Subject|1|||
162687270|NCT01859793|587564810|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
162687271|NCT01859793|587564811|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
162687272|NCT01859793|587564810|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
162687273|NCT01859793|587564811|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
162687274|NCT01859793|587564810|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162687275|NCT01859793|587564811|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162687276|NCT01859793|587564810|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162687277|NCT01859793|587564811|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162687278|NCT03185481|587564822|FG000|Overall Study|Adverse Event|1|||
162687279|NCT03185481|587564822|FG000|Overall Study|Study Terminated by Sponsor|4|||
162687280|NCT03371940|587564823|FG000|Overall Study|Withdrawal by Subject|8|||
162687281|NCT03371940|587564824|FG001|Overall Study|Withdrawal by Subject|1|||
162687282|NCT03371940|587564825|FG002|Overall Study|Withdrawal by Subject|3|||
162687283|NCT03371940|587564826|FG003|Overall Study|Withdrawal by Subject|4|||
162687284|NCT01064297|587564827|FG000|Overall Study|Lost to Follow-up|791|||
162687285|NCT01064297|587564828|FG001|Overall Study|Lost to Follow-up|48|||
162687286|NCT01064297|587564829|FG002|Overall Study|Lost to Follow-up|133|||
162687287|NCT00511875|587564841|FG000|Overall Study|Lost to Follow-up|4|||
162687288|NCT00511875|587564842|FG001|Overall Study|Lost to Follow-up|0|||
162687289|NCT00511875|587564841|FG000|Overall Study|Missing variables|1|||
162687290|NCT00511875|587564842|FG001|Overall Study|Missing variables|0|||
162687291|NCT02686034|587564844|FG000|Run-In Period 1|Eligibility|12|||
162687292|NCT02686034|587564845|FG001|Run-In Period 1|Eligibility|10|||
162687293|NCT02686034|587564844|FG000|Run-In Period 1|Withdrawal by Subject|4|||
162687294|NCT02686034|587564845|FG001|Run-In Period 1|Withdrawal by Subject|3|||
162687295|NCT02686034|587564844|FG000|Run-In Period 1|Lost to Follow-up|4|||
162687296|NCT02686034|587564845|FG001|Run-In Period 1|Lost to Follow-up|4|||
162687297|NCT02686034|587564844|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
162687298|NCT02686034|587564845|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
162687299|NCT02686034|587564844|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
162687300|NCT02686034|587564845|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
162687301|NCT02686034|587564844|FG000|Randomized Controlled Period 2|Adverse Event|0|||
162687302|NCT02686034|587564845|FG001|Randomized Controlled Period 2|Adverse Event|2|||
162687303|NCT02686034|587564844|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
162687304|NCT02686034|587564845|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
162687305|NCT02686034|587564844|FG000|Open Label Period 3|Lost to Follow-up|0|||
162687306|NCT02686034|587564845|FG001|Open Label Period 3|Lost to Follow-up|1|||
162687307|NCT00542880|587564846|FG000|Period 1|Eligibility criteria not fulfilled|2|||
162687308|NCT00542880|587564847|FG001|Period 1|Eligibility criteria not fulfilled|6|||
162687309|NCT00542880|587564846|FG000|Period 1|Adverse Event|2|||
162687310|NCT00542880|587564847|FG001|Period 1|Adverse Event|2|||
162687311|NCT00542880|587564846|FG000|Period 1|Development of study-specific criteria|1|||
162687312|NCT00542880|587564847|FG001|Period 1|Development of study-specific criteria|2|||
162687313|NCT00542880|587564846|FG000|Period 1|Withdrawal by Subject|1|||
162687314|NCT00542880|587564847|FG001|Period 1|Withdrawal by Subject|1|||
162687315|NCT00542880|587564846|FG000|Period 1|Protocol Violation|0|||
162687316|NCT00542880|587564847|FG001|Period 1|Protocol Violation|1|||
162687317|NCT00542880|587564846|FG000|Period 2|Adverse Event|5|||
162687318|NCT00542880|587564847|FG001|Period 2|Adverse Event|7|||
162687319|NCT00542880|587564846|FG000|Period 2|Eligibility not fulfilled|0|||
162687320|NCT00542880|587564847|FG001|Period 2|Eligibility not fulfilled|1|||
162687321|NCT00542880|587564846|FG000|Period 2|Discontinuation criteria|2|||
162687322|NCT00542880|587564847|FG001|Period 2|Discontinuation criteria|0|||
162687323|NCT00542880|587564846|FG000|Period 2|Severe non-compliance|0|||
162687324|NCT00542880|587564847|FG001|Period 2|Severe non-compliance|1|||
162687325|NCT00542880|587564846|FG000|Period 2|Other|0|||
162687326|NCT00542880|587564847|FG001|Period 2|Other|1|||
162687327|NCT00542880|587564846|FG000|Period 3|Adverse Event|0|||
162687328|NCT00542880|587564847|FG001|Period 3|Adverse Event|2|||
162687329|NCT01678131|587564848|FG000|Overall Study|Adverse Event|0|||
162687330|NCT01678131|587564849|FG001|Overall Study|Adverse Event|1|||
162687331|NCT01678131|587564850|FG002|Overall Study|Adverse Event|0|||
162687332|NCT01678131|587564848|FG000|Overall Study|Withdrawal by Subject|0|||
162687333|NCT01678131|587564849|FG001|Overall Study|Withdrawal by Subject|0|||
162687334|NCT01678131|587564850|FG002|Overall Study|Withdrawal by Subject|2|||
162687335|NCT00982930|587564854|FG000|Overall Study|Adverse Event|1|||
162687336|NCT00982930|587564854|FG000|Overall Study|Withdrawal by Subject|1|||
162687337|NCT00982930|587564854|FG000|Overall Study|Administrative Problems|2|||
162687338|NCT00941798|587564855|FG000|Overall Study|Withdrawal by Subject|72|||
162687339|NCT00941798|587564856|FG001|Overall Study|Withdrawal by Subject|74|||
162687340|NCT00941798|587564855|FG000|Overall Study|Adverse Event|43|||
162687341|NCT00941798|587564856|FG001|Overall Study|Adverse Event|23|||
162687342|NCT00941798|587564855|FG000|Overall Study|Lost to Follow-up|29|||
162687343|NCT00941798|587564856|FG001|Overall Study|Lost to Follow-up|23|||
162687344|NCT00941798|587564855|FG000|Overall Study|Protocol Violation|17|||
162687345|NCT00941798|587564856|FG001|Overall Study|Protocol Violation|20|||
162687346|NCT00941798|587564855|FG000|Overall Study|Administrative problems|13|||
162687347|NCT00941798|587564856|FG001|Overall Study|Administrative problems|23|||
162687348|NCT00941798|587564855|FG000|Overall Study|Lack of Efficacy|10|||
162687349|NCT00941798|587564856|FG001|Overall Study|Lack of Efficacy|17|||
162687350|NCT00941798|587564855|FG000|Overall Study|Patient's inability to use device|6|||
162687351|NCT00941798|587564856|FG001|Overall Study|Patient's inability to use device|1|||
162687352|NCT00941798|587564855|FG000|Overall Study|Abnormal test procedure results|3|||
162687353|NCT00941798|587564856|FG001|Overall Study|Abnormal test procedure results|1|||
162687354|NCT00941798|587564855|FG000|Overall Study|Abnormal laboratory values|1|||
162687355|NCT00941798|587564856|FG001|Overall Study|Abnormal laboratory values|2|||
162687356|NCT00941798|587564855|FG000|Overall Study|Death|0|||
162687357|NCT00941798|587564856|FG001|Overall Study|Death|1|||
162687358|NCT05597722|587564857|FG000|Overall Study|Study was terminated|6|||
162687359|NCT05597722|587564858|FG001|Overall Study|Study was terminated|1|||
162687360|NCT00404495|587564859|FG000|Overall Study|Death|37|||
162687361|NCT00404495|587564860|FG001|Overall Study|Death|11|||
162687362|NCT00404495|587564859|FG000|Overall Study|Lost to Follow-up|5|||
162687363|NCT00404495|587564860|FG001|Overall Study|Lost to Follow-up|0|||
162687364|NCT00404495|587564859|FG000|Overall Study|Other|1|||
162687365|NCT00404495|587564860|FG001|Overall Study|Other|0|||
162687366|NCT00404495|587564859|FG000|Overall Study|Withdrawal by Subject|1|||
162687367|NCT00404495|587564860|FG001|Overall Study|Withdrawal by Subject|0|||
162687368|NCT03750006|587564865|FG000|Overall Study|Withdrawal by Subject|8|||
162687369|NCT03750006|587564865|FG000|Overall Study|COVID PANDEMIC|11|||
162687370|NCT03538951|587564866|FG000|Overall Study|Withdrawal by Subject|1|||
162687371|NCT03538951|587564867|FG001|Overall Study|Withdrawal by Subject|2|||
162687372|NCT06027619|587564868|FG000|Overall Study|Adverse Event|0|||
162687373|NCT06027619|587564869|FG001|Overall Study|Adverse Event|0|||
162687374|NCT06027619|587564870|FG002|Overall Study|Adverse Event|1|||
162687375|NCT01493960|587566188|FG000|Overall Study|Adverse Event|0|||
162687376|NCT01493960|587566189|FG001|Overall Study|Adverse Event|1|||
162726989|NCT00807937|587710426|FG000|Overall Study|Lack of Efficacy|0|||
162726990|NCT00807937|587710427|FG001|Overall Study|Lack of Efficacy|0|||
162726991|NCT00807937|587710428|FG002|Overall Study|Lack of Efficacy|1|||
162726992|NCT00807937|587710429|FG003|Overall Study|Lack of Efficacy|2|||
162726993|NCT00807937|587710426|FG000|Overall Study|Intake of prohibited medicine|0|||
162726994|NCT00807937|587710427|FG001|Overall Study|Intake of prohibited medicine|0|||
162726995|NCT00807937|587710428|FG002|Overall Study|Intake of prohibited medicine|2|||
162726996|NCT00807937|587710429|FG003|Overall Study|Intake of prohibited medicine|0|||
162726997|NCT00807937|587710426|FG000|Overall Study|All other reasons (not provided)|2|||
162726998|NCT00807937|587710427|FG001|Overall Study|All other reasons (not provided)|4|||
162726999|NCT00807937|587710428|FG002|Overall Study|All other reasons (not provided)|0|||
162727000|NCT00807937|587710429|FG003|Overall Study|All other reasons (not provided)|1|||
162727001|NCT04629950|587710432|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
162727002|NCT04629950|587710433|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
162727003|NCT04629950|587710434|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
162727004|NCT04629950|587710435|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
162727005|NCT04629950|587710432|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162727006|NCT04629950|587710433|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
162727007|NCT04629950|587710434|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162727008|NCT04629950|587710435|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162727009|NCT04629950|587710432|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162727010|NCT04629950|587710433|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
162727011|NCT04629950|587710434|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162727012|NCT04629950|587710435|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162727013|NCT04629950|587710432|FG000|Extension Study|Withdrawal by Subject|0|||
162727014|NCT04629950|587710433|FG001|Extension Study|Withdrawal by Subject|0|||
162727015|NCT04629950|587710434|FG002|Extension Study|Withdrawal by Subject|1|||
162727016|NCT04629950|587710435|FG003|Extension Study|Withdrawal by Subject|0|||
162727017|NCT04629950|587710432|FG000|Extension Study|Adverse Event|0|||
162727018|NCT04629950|587710433|FG001|Extension Study|Adverse Event|0|||
162727019|NCT04629950|587710434|FG002|Extension Study|Adverse Event|0|||
162727020|NCT04629950|587710435|FG003|Extension Study|Adverse Event|1|||
162727021|NCT03233633|587710436|FG000|Overall Study|Adverse Event|2|||
162727022|NCT03233633|587710436|FG000|Overall Study|Less Than 3 Days of Data|6|||
162727023|NCT02708108|587710437|FG000|Overall Study|Death|1|||
162727024|NCT02708108|587710438|FG001|Overall Study|Death|2|||
162727025|NCT02708108|587710437|FG000|Overall Study|Regimen change|1|||
162727026|NCT02708108|587710438|FG001|Overall Study|Regimen change|0|||
162727027|NCT02708108|587710437|FG000|Overall Study|No MRD and no imaging available|0|||
162727028|NCT02708108|587710438|FG001|Overall Study|No MRD and no imaging available|1|||
162727029|NCT02568683|587710440|FG000|Overall Study|Death|0|||
162727030|NCT02568683|587710441|FG001|Overall Study|Death|2|||
162727031|NCT02568683|587710440|FG000|Overall Study|Withdrew Consent|1|||
162727032|NCT02568683|587710441|FG001|Overall Study|Withdrew Consent|0|||
162727033|NCT02568683|587710440|FG000|Overall Study|Study Terminated By Sponsor|5|||
162727034|NCT02568683|587710441|FG001|Overall Study|Study Terminated By Sponsor|2|||
162727035|NCT01561989|587710444|FG000|Overall Study|accural target not met.|5|||
162727036|NCT01561989|587710445|FG001|Overall Study|accural target not met.|6|||
162727037|NCT02477605|587710452|FG000|Overall Study|Discontinued prior to treatment|1|||
162727038|NCT02477605|587710453|FG001|Overall Study|Discontinued prior to treatment|0|||
162727039|NCT02477605|587710452|FG000|Overall Study|Lost to Follow-up|0|||
162727040|NCT02477605|587710453|FG001|Overall Study|Lost to Follow-up|2|||
162727041|NCT02477605|587710452|FG000|Overall Study|Withdrawal by Subject|0|||
162727042|NCT02477605|587710453|FG001|Overall Study|Withdrawal by Subject|1|||
162727043|NCT02477605|587710452|FG000|Overall Study|Administered gas during surgery|0|||
162727044|NCT02477605|587710453|FG001|Overall Study|Administered gas during surgery|1|||
162727045|NCT00970359|587710460|FG000|Overall Study|Not Treated|4|||
162727046|NCT01388361|587710461|FG000|Overall Study|Adverse Event|0|||
162727047|NCT01388361|587710462|FG001|Overall Study|Adverse Event|5|||
162727048|NCT01388361|587710463|FG002|Overall Study|Adverse Event|1|||
162727049|NCT01388361|587710461|FG000|Overall Study|Protocol Violation|0|||
162727050|NCT01388361|587710462|FG001|Overall Study|Protocol Violation|0|||
162727051|NCT01388361|587710463|FG002|Overall Study|Protocol Violation|2|||
162727052|NCT01388361|587710461|FG000|Overall Study|Withdrawal criteria|12|||
162727053|NCT01388361|587710462|FG001|Overall Study|Withdrawal criteria|7|||
162727054|NCT01388361|587710463|FG002|Overall Study|Withdrawal criteria|10|||
162727055|NCT01388361|587710461|FG000|Overall Study|Unclassified|0|||
162727056|NCT01388361|587710462|FG001|Overall Study|Unclassified|0|||
162727057|NCT01388361|587710463|FG002|Overall Study|Unclassified|1|||
162727058|NCT05368831|587710466|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
162727059|NCT03565315|587710468|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162727060|NCT03565315|587710469|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162727061|NCT03565315|587710470|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162727062|NCT03565315|587710471|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
162687377|NCT01493960|587566188|FG000|Overall Study|Lack of Efficacy|15|||
162687378|NCT01493960|587566189|FG001|Overall Study|Lack of Efficacy|9|||
162687379|NCT01493960|587566188|FG000|Overall Study|Protocol Violation|3|||
162687380|NCT01493960|587566189|FG001|Overall Study|Protocol Violation|0|||
162687381|NCT01493960|587566188|FG000|Overall Study|Withdrawal by Subject|10|||
162687382|NCT01493960|587566189|FG001|Overall Study|Withdrawal by Subject|4|||
162687383|NCT01493960|587566188|FG000|Overall Study|Non-specified|4|||
162687384|NCT01493960|587566189|FG001|Overall Study|Non-specified|4|||
162687385|NCT01160484|587566190|FG000|Overall Study|Lack of Efficacy|9|||
162687386|NCT01160484|587566190|FG000|Overall Study|Adverse Event|6|||
162687387|NCT01160484|587566190|FG000|Overall Study|Withdrawal by Subject|2|||
162687388|NCT01160484|587566190|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
162687389|NCT01382602|587566191|FG000|Overall Study|Protocol Violation|0|||
162687390|NCT01382602|587566192|FG001|Overall Study|Protocol Violation|3|||
162687391|NCT01382602|587566191|FG000|Overall Study|Withdrawal by Subject|0|||
162687392|NCT01382602|587566192|FG001|Overall Study|Withdrawal by Subject|1|||
162687393|NCT01392300|587566200|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
162687394|NCT01392300|587566201|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
162687395|NCT01392300|587566202|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
162687396|NCT01392300|587566200|FG000|Main Period (MP)|Withdrawal by Subject|5|||
162687397|NCT01392300|587566201|FG001|Main Period (MP)|Withdrawal by Subject|1|||
162687398|NCT01392300|587566202|FG002|Main Period (MP)|Withdrawal by Subject|0|||
162687399|NCT01392300|587566200|FG000|Main Period (MP)|Lost to Follow-up|3|||
162687400|NCT01392300|587566201|FG001|Main Period (MP)|Lost to Follow-up|3|||
162687401|NCT01392300|587566202|FG002|Main Period (MP)|Lost to Follow-up|0|||
162687402|NCT01392300|587566200|FG000|Main Period (MP)|Non-compliance|1|||
162687403|NCT01392300|587566201|FG001|Main Period (MP)|Non-compliance|0|||
162687404|NCT01392300|587566202|FG002|Main Period (MP)|Non-compliance|0|||
162687405|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
162687406|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
162687407|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
162687408|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
162687409|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
162687410|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
162687411|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
162687412|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
162687413|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
162687414|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Death|0|||
162687415|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Death|0|||
162687416|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Death|4|||
162687417|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
162687418|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
162687419|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
162687420|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
162687421|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
162687422|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
162687423|NCT01392300|587566200|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
162687424|NCT01392300|587566201|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
162687425|NCT01392300|587566202|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
162687426|NCT01147822|587566207|FG000|Overall Study|Lost to Follow-up|14|||
162687427|NCT01147822|587566208|FG001|Overall Study|Lost to Follow-up|6|||
162687428|NCT01147822|587566207|FG000|Overall Study|Withdrawal by Subject|10|||
162687429|NCT01147822|587566208|FG001|Overall Study|Withdrawal by Subject|16|||
162687430|NCT01147822|587566207|FG000|Overall Study|Physician Decision|9|||
162687431|NCT01147822|587566208|FG001|Overall Study|Physician Decision|8|||
162687432|NCT01147822|587566207|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
162687433|NCT01147822|587566208|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
162687434|NCT01147822|587566207|FG000|Overall Study|Protocol Violation|1|||
162687435|NCT01147822|587566208|FG001|Overall Study|Protocol Violation|1|||
162687436|NCT03010462|587566212|FG000|Overall Study|Withdrawal by Subject|3|||
162687437|NCT03010462|587566213|FG001|Overall Study|Withdrawal by Subject|1|||
162687438|NCT01966003|587566214|FG000|Overall Study|Death|43|||
162687439|NCT01966003|587566215|FG001|Overall Study|Death|36|||
162687440|NCT01966003|587566214|FG000|Overall Study|Protocol Violation|6|||
162687441|NCT01966003|587566215|FG001|Overall Study|Protocol Violation|4|||
162687442|NCT01966003|587566214|FG000|Overall Study|Lost to Follow-up|4|||
162687443|NCT01966003|587566215|FG001|Overall Study|Lost to Follow-up|3|||
162687444|NCT01966003|587566214|FG000|Overall Study|Physician Decision|12|||
162687445|NCT01966003|587566215|FG001|Overall Study|Physician Decision|13|||
162687446|NCT01966003|587566214|FG000|Overall Study|Withdrawal by Subject|29|||
162687447|NCT01966003|587566215|FG001|Overall Study|Withdrawal by Subject|19|||
162687448|NCT01966003|587566214|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
162687449|NCT01966003|587566215|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
162727063|NCT01170962|587710472|FG000|Treatment Period|Lack of Efficacy|96|||
162687450|NCT01966003|587566214|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
162687451|NCT01966003|587566215|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
162687452|NCT01966003|587566214|FG000|Overall Study|Other|1|||
162687453|NCT01966003|587566215|FG001|Overall Study|Other|1|||
162687454|NCT02748694|587566222|FG000|Overall Study|Voluntary Withdrawal|0|||
162687455|NCT02748694|587566223|FG001|Overall Study|Voluntary Withdrawal|0|||
162687456|NCT02748694|587566224|FG002|Overall Study|Voluntary Withdrawal|0|||
162687457|NCT02748694|587566225|FG003|Overall Study|Voluntary Withdrawal|0|||
162687458|NCT02748694|587566226|FG004|Overall Study|Voluntary Withdrawal|0|||
162687459|NCT02748694|587566227|FG005|Overall Study|Voluntary Withdrawal|0|||
162687460|NCT02748694|587566228|FG006|Overall Study|Voluntary Withdrawal|0|||
162687461|NCT02748694|587566229|FG007|Overall Study|Voluntary Withdrawal|0|||
162687462|NCT02748694|587566230|FG008|Overall Study|Voluntary Withdrawal|0|||
162687463|NCT02748694|587566231|FG009|Overall Study|Voluntary Withdrawal|0|||
162687464|NCT02748694|587566232|FG010|Overall Study|Voluntary Withdrawal|0|||
162687465|NCT02748694|587566233|FG011|Overall Study|Voluntary Withdrawal|0|||
162687466|NCT02748694|587566234|FG012|Overall Study|Voluntary Withdrawal|0|||
162687467|NCT02748694|587566235|FG013|Overall Study|Voluntary Withdrawal|0|||
162687468|NCT02748694|587566236|FG014|Overall Study|Voluntary Withdrawal|2|||
162687469|NCT00077064|587566237|FG000|Overall Study|Adverse Event|0|||
162687470|NCT00077064|587566238|FG001|Overall Study|Adverse Event|4|||
162687471|NCT00077064|587566237|FG000|Overall Study|Patient refusal|0|||
162687472|NCT00077064|587566238|FG001|Overall Study|Patient refusal|2|||
162687473|NCT00927355|587566239|FG000|Overall Study|Adverse Event|1|||
162687474|NCT00927355|587566240|FG001|Overall Study|Adverse Event|1|||
162687475|NCT03299686|587566241|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
162687476|NCT03299686|587566242|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
162687477|NCT03299686|587566241|FG000|Treatment Epoch|Physician Decision|1|||
162687478|NCT03299686|587566242|FG001|Treatment Epoch|Physician Decision|0|||
162687479|NCT03299686|587566241|FG000|Treatment Epoch|Adverse Event|8|||
162687480|NCT03299686|587566242|FG001|Treatment Epoch|Adverse Event|4|||
162687481|NCT03299686|587566241|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
162687482|NCT03299686|587566242|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
162687483|NCT01060553|587566244|FG000|Overall Study|Lost to Follow-up|3|||
162687484|NCT01060553|587566245|FG001|Overall Study|Lost to Follow-up|5|||
162687485|NCT01060553|587566244|FG000|Overall Study|Withdrawal by Subject|5|||
162687486|NCT01060553|587566245|FG001|Overall Study|Withdrawal by Subject|5|||
162687487|NCT01060553|587566244|FG000|Overall Study|Lack of Efficacy|1|||
162687488|NCT01060553|587566245|FG001|Overall Study|Lack of Efficacy|0|||
162687489|NCT01446796|587566246|FG000|Overall Study|Withdrawal by Subject|1|||
162687490|NCT01446796|587566247|FG001|Overall Study|Withdrawal by Subject|0|||
162687491|NCT03131960|587566251|FG000|Overall Study|Adverse Event|0|||
162687492|NCT03131960|587566252|FG001|Overall Study|Adverse Event|1|||
162687493|NCT04707196|587566253|FG000|Overall Study|Withdrawal by Subject|9|||
162687494|NCT04707196|587566254|FG001|Overall Study|Withdrawal by Subject|6|||
162687495|NCT04707196|587566253|FG000|Overall Study|Lost to Follow-up|1|||
162687496|NCT04707196|587566254|FG001|Overall Study|Lost to Follow-up|0|||
162687497|NCT04707196|587566253|FG000|Overall Study|Protocol Violation|4|||
162687498|NCT04707196|587566254|FG001|Overall Study|Protocol Violation|1|||
162687499|NCT04707196|587566253|FG000|Overall Study|Adverse Event|2|||
162687500|NCT04707196|587566254|FG001|Overall Study|Adverse Event|2|||
162687501|NCT04707196|587566253|FG000|Overall Study|Death|3|||
162687502|NCT04707196|587566254|FG001|Overall Study|Death|1|||
162687503|NCT04707196|587566253|FG000|Overall Study|Non-compliance with study drug|1|||
162687504|NCT04707196|587566254|FG001|Overall Study|Non-compliance with study drug|0|||
162687505|NCT04707196|587566253|FG000|Overall Study|Progressive disease|9|||
162687506|NCT04707196|587566254|FG001|Overall Study|Progressive disease|10|||
162687507|NCT01462162|587566258|FG000|Overall Study|Adverse Event|5|||
162687508|NCT01462162|587566258|FG000|Overall Study|Lack of Efficacy|4|||
162687509|NCT01462162|587566258|FG000|Overall Study|Abnormal laboratory parameters|1|||
162687510|NCT01462162|587566258|FG000|Overall Study|Other|2|||
162687511|NCT03485911|587566259|FG000|Part 1|Perceived lack of efficacy|1|||
162687512|NCT03485911|587566260|FG001|Part 1|Perceived lack of efficacy|1|||
162687513|NCT03485911|587566261|FG002|Part 1|Perceived lack of efficacy|2|||
162687514|NCT03485911|587566262|FG003|Part 1|Perceived lack of efficacy|0|||
162687515|NCT03485911|587566259|FG000|Part 1|Subject withdrew consent|0|||
162687516|NCT03485911|587566260|FG001|Part 1|Subject withdrew consent|1|||
162687517|NCT03485911|587566261|FG002|Part 1|Subject withdrew consent|0|||
162687518|NCT03485911|587566262|FG003|Part 1|Subject withdrew consent|1|||
162687519|NCT03485911|587566259|FG000|Part 1|Lab abnormalities/AEs|3|||
162687520|NCT03485911|587566260|FG001|Part 1|Lab abnormalities/AEs|1|||
162687521|NCT03485911|587566261|FG002|Part 1|Lab abnormalities/AEs|1|||
162687522|NCT03485911|587566262|FG003|Part 1|Lab abnormalities/AEs|0|||
162687523|NCT03485911|587566259|FG000|Part 1|Withdrew Consent prior to dosing|0|||
162687524|NCT03485911|587566260|FG001|Part 1|Withdrew Consent prior to dosing|0|||
162687525|NCT03485911|587566261|FG002|Part 1|Withdrew Consent prior to dosing|0|||
162687526|NCT03485911|587566262|FG003|Part 1|Withdrew Consent prior to dosing|1|||
162727064|NCT01170962|587710473|FG001|Treatment Period|Lack of Efficacy|91|||
162727065|NCT01170962|587710474|FG002|Treatment Period|Lack of Efficacy|7|||
162727066|NCT01170962|587710472|FG000|Treatment Period|Adverse Event|11|||
162727067|NCT01170962|587710473|FG001|Treatment Period|Adverse Event|12|||
162727068|NCT01170962|587710474|FG002|Treatment Period|Adverse Event|3|||
162727069|NCT01170962|587710472|FG000|Treatment Period|Withdrawal by Subject|2|||
162727070|NCT01170962|587710473|FG001|Treatment Period|Withdrawal by Subject|1|||
162727071|NCT01170962|587710474|FG002|Treatment Period|Withdrawal by Subject|0|||
162727072|NCT01170962|587710472|FG000|Treatment Period|Lost to Follow-up|1|||
162727073|NCT01170962|587710473|FG001|Treatment Period|Lost to Follow-up|1|||
162727074|NCT01170962|587710474|FG002|Treatment Period|Lost to Follow-up|1|||
162727075|NCT01170962|587710472|FG000|Treatment Period|Participant no longer meets criteria|0|||
162727076|NCT01170962|587710473|FG001|Treatment Period|Participant no longer meets criteria|1|||
162727077|NCT01170962|587710474|FG002|Treatment Period|Participant no longer meets criteria|0|||
162727078|NCT01170962|587710472|FG000|Treatment Period|Request to discontinue treatment|7|||
162727079|NCT01170962|587710473|FG001|Treatment Period|Request to discontinue treatment|3|||
162727080|NCT01170962|587710474|FG002|Treatment Period|Request to discontinue treatment|1|||
162727081|NCT01170962|587710472|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
162727082|NCT01170962|587710473|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
162727083|NCT01170962|587710474|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
162727084|NCT01170962|587710472|FG000|Follow up Period|Withdrawal by Subject|14|||
162727085|NCT01170962|587710473|FG001|Follow up Period|Withdrawal by Subject|10|||
162727086|NCT01170962|587710474|FG002|Follow up Period|Withdrawal by Subject|2|||
162727087|NCT01170962|587710472|FG000|Follow up Period|Lost to Follow-up|13|||
162727088|NCT01170962|587710473|FG001|Follow up Period|Lost to Follow-up|8|||
162727089|NCT01170962|587710474|FG002|Follow up Period|Lost to Follow-up|1|||
162727090|NCT01170962|587710472|FG000|Follow up Period|Death|2|||
162727091|NCT01170962|587710473|FG001|Follow up Period|Death|2|||
162727092|NCT01170962|587710474|FG002|Follow up Period|Death|0|||
162727093|NCT01170962|587710472|FG000|Follow up Period|Others|10|||
162727094|NCT01170962|587710473|FG001|Follow up Period|Others|7|||
162727095|NCT01170962|587710474|FG002|Follow up Period|Others|3|||
162727096|NCT03887650|587710475|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
162727097|NCT03887650|587710476|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
162727098|NCT03887650|587710475|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
162727099|NCT03887650|587710476|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
162727100|NCT03887650|587710475|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
162727101|NCT03887650|587710476|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
162727102|NCT01083316|587710477|FG000|Overall Study|Adverse Event|2|||
162727103|NCT01083316|587710477|FG000|Overall Study|Withdrawal by Subject|1|||
162727104|NCT04200365|587710478|FG000|Overall Study|Adverse Event|2|||
162727105|NCT04200365|587710478|FG000|Overall Study|Progressive Disease|4|||
162727106|NCT04200365|587710478|FG000|Overall Study|Lack of Efficacy|1|||
162727107|NCT04200365|587710478|FG000|Overall Study|Study Closure|4|||
162727108|NCT03942042|587710479|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
162727109|NCT03942042|587710480|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
162727110|NCT03942042|587710479|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
162727111|NCT03942042|587710480|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
162727112|NCT01499199|587710483|FG000|Overall Study|Adverse Event|1|||
162727113|NCT01499199|587710483|FG000|Overall Study|Lack of Efficacy|1|||
162727114|NCT01199705|587710484|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
162727115|NCT01849055|587710485|FG000|Overall Study|Withdrawal by Subject|0|||
162727116|NCT01849055|587710486|FG001|Overall Study|Withdrawal by Subject|0|||
162727117|NCT01849055|587710487|FG002|Overall Study|Withdrawal by Subject|1|||
162727118|NCT01849055|587710488|FG003|Overall Study|Withdrawal by Subject|0|||
162727119|NCT01849055|587710489|FG004|Overall Study|Withdrawal by Subject|0|||
162727120|NCT01849055|587710490|FG005|Overall Study|Withdrawal by Subject|0|||
162727121|NCT00933400|587710491|FG000|Overall Study|Withdrawal by Subject|21|||
162727122|NCT00933400|587710492|FG001|Overall Study|Withdrawal by Subject|1|||
162727123|NCT01199575|587710493|FG000|Overall Study|Withdrawal by Subject|5|||
162727124|NCT00223795|587710494|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
162727125|NCT00223795|587710495|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
162727126|NCT00223795|587710494|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
162727127|NCT00223795|587710495|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
162727128|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
162727129|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162727130|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162727131|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162727132|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162727133|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
162727134|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162727135|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162687527|NCT03485911|587566259|FG000|Part 1|Other NOS|0|||
162687528|NCT03485911|587566260|FG001|Part 1|Other NOS|0|||
162687529|NCT03485911|587566261|FG002|Part 1|Other NOS|0|||
162687530|NCT03485911|587566262|FG003|Part 1|Other NOS|1|||
162687531|NCT03485911|587566259|FG000|Part 2|Perceived lack of efficacy|5|||
162687532|NCT03485911|587566260|FG001|Part 2|Perceived lack of efficacy|3|||
162687533|NCT03485911|587566261|FG002|Part 2|Perceived lack of efficacy|0|||
162687534|NCT03485911|587566262|FG003|Part 2|Perceived lack of efficacy|2|||
162687535|NCT03485911|587566259|FG000|Part 2|Subject withdrew consent|1|||
162687536|NCT03485911|587566260|FG001|Part 2|Subject withdrew consent|0|||
162687537|NCT03485911|587566261|FG002|Part 2|Subject withdrew consent|2|||
162687538|NCT03485911|587566262|FG003|Part 2|Subject withdrew consent|1|||
162687539|NCT03485911|587566259|FG000|Part 2|Lab abnormalities/AEs|1|||
162687540|NCT03485911|587566260|FG001|Part 2|Lab abnormalities/AEs|2|||
162687541|NCT03485911|587566261|FG002|Part 2|Lab abnormalities/AEs|0|||
162687542|NCT03485911|587566262|FG003|Part 2|Lab abnormalities/AEs|0|||
162687543|NCT03485911|587566259|FG000|Part 2|Other NOS|0|||
162687544|NCT03485911|587566260|FG001|Part 2|Other NOS|1|||
162687545|NCT03485911|587566261|FG002|Part 2|Other NOS|0|||
162687546|NCT03485911|587566262|FG003|Part 2|Other NOS|0|||
162687547|NCT03485911|587566259|FG000|Part 2|Intercurrent illness/new medical condition|1|||
162687548|NCT03485911|587566260|FG001|Part 2|Intercurrent illness/new medical condition|0|||
162687549|NCT03485911|587566261|FG002|Part 2|Intercurrent illness/new medical condition|0|||
162687550|NCT03485911|587566262|FG003|Part 2|Intercurrent illness/new medical condition|0|||
162687551|NCT03485911|587566259|FG000|Part 2|Investigator judgement|1|||
162687552|NCT03485911|587566260|FG001|Part 2|Investigator judgement|0|||
162687553|NCT03485911|587566261|FG002|Part 2|Investigator judgement|0|||
162687554|NCT03485911|587566262|FG003|Part 2|Investigator judgement|0|||
162687555|NCT03485911|587566259|FG000|Part 3|Perceived lack of efficacy|2|||
162687556|NCT03485911|587566260|FG001|Part 3|Perceived lack of efficacy|2|||
162687557|NCT03485911|587566261|FG002|Part 3|Perceived lack of efficacy|2|||
162687558|NCT03485911|587566262|FG003|Part 3|Perceived lack of efficacy|0|||
162687559|NCT03485911|587566259|FG000|Part 3|Subject withdrew consent|1|||
162687560|NCT03485911|587566260|FG001|Part 3|Subject withdrew consent|4|||
162687561|NCT03485911|587566261|FG002|Part 3|Subject withdrew consent|0|||
162687562|NCT03485911|587566262|FG003|Part 3|Subject withdrew consent|1|||
162687563|NCT03485911|587566259|FG000|Part 3|Lab abnormalities/AEs|1|||
162687564|NCT03485911|587566260|FG001|Part 3|Lab abnormalities/AEs|1|||
162687565|NCT03485911|587566261|FG002|Part 3|Lab abnormalities/AEs|0|||
162687566|NCT03485911|587566262|FG003|Part 3|Lab abnormalities/AEs|2|||
162687567|NCT03485911|587566259|FG000|Part 3|Other NOS|1|||
162687568|NCT03485911|587566260|FG001|Part 3|Other NOS|1|||
162687569|NCT03485911|587566261|FG002|Part 3|Other NOS|0|||
162687570|NCT03485911|587566262|FG003|Part 3|Other NOS|0|||
162687571|NCT03485911|587566259|FG000|Part 3|Intercurrent illness/new medical condition|0|||
162687572|NCT03485911|587566260|FG001|Part 3|Intercurrent illness/new medical condition|1|||
162687573|NCT03485911|587566261|FG002|Part 3|Intercurrent illness/new medical condition|1|||
162687574|NCT03485911|587566262|FG003|Part 3|Intercurrent illness/new medical condition|0|||
162687575|NCT03485911|587566259|FG000|Part 3|Sponsor discontinuation|1|||
162687576|NCT03485911|587566260|FG001|Part 3|Sponsor discontinuation|0|||
162687577|NCT03485911|587566261|FG002|Part 3|Sponsor discontinuation|0|||
162687578|NCT03485911|587566262|FG003|Part 3|Sponsor discontinuation|0|||
162687579|NCT03485911|587566259|FG000|Part 3|Berotralstat provided by alternative means|13|||
162687580|NCT03485911|587566260|FG001|Part 3|Berotralstat provided by alternative means|13|||
162687581|NCT03485911|587566261|FG002|Part 3|Berotralstat provided by alternative means|7|||
162687582|NCT03485911|587566262|FG003|Part 3|Berotralstat provided by alternative means|7|||
162687583|NCT03333928|587566263|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
162687584|NCT03333928|587566264|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
162687585|NCT03333928|587566265|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
162687586|NCT03333928|587566263|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
162687587|NCT03333928|587566264|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
162687588|NCT03333928|587566265|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
162687589|NCT03333928|587566263|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
162687590|NCT03333928|587566264|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
162687591|NCT03333928|587566265|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
162687592|NCT03333928|587566263|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
162687593|NCT03333928|587566264|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
162687594|NCT03333928|587566265|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
162687595|NCT03333928|587566263|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
162687596|NCT03333928|587566264|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
162687597|NCT03333928|587566265|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
162687598|NCT03333928|587566263|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
162687599|NCT03333928|587566264|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
162687600|NCT03333928|587566265|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
162687601|NCT03333928|587566263|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
162687602|NCT03333928|587566264|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
162687603|NCT03333928|587566265|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
162687604|NCT03333928|587566263|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
162687605|NCT03333928|587566264|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
162687606|NCT03333928|587566265|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
162687607|NCT00728962|587566266|FG000|Implant Placement Surgery|Adverse Event|8|||
162687608|NCT00728962|587566266|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
162687609|NCT00728962|587566266|FG000|Implant Placement Surgery|Protocol Violation|1|||
162687610|NCT00728962|587566266|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
162687611|NCT00728962|587566266|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
162687612|NCT04954586|587566267|FG000|Overall Study|Withdrawal by Subject|5|||
162687613|NCT01987817|587566279|FG000|Overall Study|Adverse Event|4|||
162687614|NCT01987817|587566280|FG001|Overall Study|Adverse Event|0|||
162687615|NCT01987817|587566279|FG000|Overall Study|Withdrawal by Subject|1|||
162687616|NCT01987817|587566280|FG001|Overall Study|Withdrawal by Subject|1|||
162687617|NCT01987817|587566279|FG000|Overall Study|Physician Decision|1|||
162687618|NCT01987817|587566280|FG001|Overall Study|Physician Decision|0|||
162687619|NCT05918978|587566285|FG000|Overall Study|Study Terminated by Sponsor|17|||
162687620|NCT05918978|587566286|FG001|Overall Study|Study Terminated by Sponsor|11|||
162687621|NCT05918978|587566285|FG000|Overall Study|Withdrawal by Subject|1|||
162687622|NCT05918978|587566286|FG001|Overall Study|Withdrawal by Subject|1|||
162687623|NCT05918978|587566285|FG000|Overall Study|Adverse Event|1|||
162687624|NCT05918978|587566286|FG001|Overall Study|Adverse Event|0|||
162687625|NCT05918978|587566285|FG000|Overall Study|Other|0|||
162687626|NCT05918978|587566286|FG001|Overall Study|Other|1|||
162687627|NCT00622180|587566287|FG000|Overall Study|Lost to Follow-up|1|||
162687628|NCT00622180|587566288|FG001|Overall Study|Lost to Follow-up|2|||
162687629|NCT04179721|587566301|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
162687630|NCT04179721|587566302|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
162687631|NCT04179721|587566301|FG000|Overall Study|Lost to Follow-up|0|||
162687632|NCT04179721|587566302|FG001|Overall Study|Lost to Follow-up|1|||
162687633|NCT05559866|587566303|FG000|Overall Study|Withdrawal by Subject|1|||
162687634|NCT05559866|587566304|FG001|Overall Study|Withdrawal by Subject|0|||
162687635|NCT03444376|587566306|FG000|Part A|Disease relapse or Progression|1|||
162687636|NCT03444376|587566306|FG000|Part A|Withdrawal by Subject|2|||
162687637|NCT03444376|587566306|FG000|Part A|Adverse Event|1|||
162687638|NCT03444376|587566306|FG000|Part B|Disease relapse or Progression|18|||
162687639|NCT03444376|587566306|FG000|Part B|Withdrawal by Subject|2|||
162687640|NCT03444376|587566306|FG000|Part B|Adverse Event|2|||
162687641|NCT03444376|587566306|FG000|Part B|Physician Decision|1|||
162687642|NCT03444376|587566306|FG000|Part C|Disease relapse or Progression|43|||
162687643|NCT03444376|587566306|FG000|Part C|Withdrawal by Subject|5|||
162687644|NCT03444376|587566306|FG000|Part C|Adverse Event|2|||
162687645|NCT03444376|587566306|FG000|Part C|Physician Decision|2|||
162687646|NCT03444376|587566306|FG000|Part C|Death|1|||
162687647|NCT00856167|587566308|FG000|Period 1|Withdrawal by Subject|1|||
162687648|NCT00856167|587566309|FG001|Period 1|Withdrawal by Subject|4|||
162687649|NCT00856167|587566310|FG002|Period 1|Withdrawal by Subject|0|||
162687650|NCT00856167|587566311|FG003|Period 1|Withdrawal by Subject|0|||
162687651|NCT00856167|587566308|FG000|Period 1|Lost to Follow-up|2|||
162687652|NCT00856167|587566309|FG001|Period 1|Lost to Follow-up|1|||
162687653|NCT00856167|587566310|FG002|Period 1|Lost to Follow-up|0|||
162687654|NCT00856167|587566311|FG003|Period 1|Lost to Follow-up|0|||
162687655|NCT00856167|587566308|FG000|Period 2|Lost to Follow-up|0|||
162687656|NCT00856167|587566309|FG001|Period 2|Lost to Follow-up|0|||
162687657|NCT00856167|587566310|FG002|Period 2|Lost to Follow-up|3|||
162687658|NCT00856167|587566311|FG003|Period 2|Lost to Follow-up|1|||
162687659|NCT00856167|587566308|FG000|Period 2|Withdrawal by Subject|0|||
162687660|NCT00856167|587566309|FG001|Period 2|Withdrawal by Subject|0|||
162687661|NCT00856167|587566310|FG002|Period 2|Withdrawal by Subject|2|||
162687662|NCT00856167|587566311|FG003|Period 2|Withdrawal by Subject|4|||
162687663|NCT01061333|587566314|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
162687664|NCT01061333|587566315|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
162687665|NCT01816763|587568145|FG000|Overall Study|The main reason for an incomplete survey|4|||
162687666|NCT01816763|587568146|FG001|Overall Study|The main reason for an incomplete survey|15|||
162687667|NCT01816763|587568147|FG002|Overall Study|The main reason for an incomplete survey|11|||
162687668|NCT01186328|587568152|FG000|Overall Study|Death|1|||
162687669|NCT01186328|587568153|FG001|Overall Study|Death|0|||
162687670|NCT01186328|587568154|FG002|Overall Study|Death|0|||
162687671|NCT00871403|587568155|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
162687672|NCT00871403|587568156|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
162687673|NCT00871403|587568157|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
162687674|NCT00871403|587568155|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
162687675|NCT00871403|587568156|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
162687676|NCT00871403|587568157|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
162687677|NCT00871403|587568155|FG000|Combination Treatment Phase|Adverse Event|0|||
162727136|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162727137|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162727138|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
162727139|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162727140|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162727141|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162727142|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162727143|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
162727144|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162727145|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162727146|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162727147|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162727148|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
162727149|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162727150|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162727151|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162727152|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162727153|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
162727154|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162727155|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162727156|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162727157|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162687678|NCT00871403|587568156|FG001|Combination Treatment Phase|Adverse Event|17|||
162687679|NCT00871403|587568157|FG002|Combination Treatment Phase|Adverse Event|2|||
162687680|NCT00871403|587568155|FG000|Combination Treatment Phase|Disease Progression|0|||
162687681|NCT00871403|587568156|FG001|Combination Treatment Phase|Disease Progression|8|||
162687682|NCT00871403|587568157|FG002|Combination Treatment Phase|Disease Progression|5|||
162687683|NCT00871403|587568155|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
162687684|NCT00871403|587568156|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
162687685|NCT00871403|587568157|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
162687686|NCT00871403|587568155|FG000|Combination Treatment Phase|Physician Decision|0|||
162687687|NCT00871403|587568156|FG001|Combination Treatment Phase|Physician Decision|1|||
162687688|NCT00871403|587568157|FG002|Combination Treatment Phase|Physician Decision|3|||
162687689|NCT00871403|587568155|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
162687690|NCT00871403|587568156|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
162687691|NCT00871403|587568157|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
162687692|NCT00871403|587568155|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
162687693|NCT00871403|587568156|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
162687694|NCT00871403|587568157|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
162687695|NCT03170375|587568160|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
162687696|NCT03170375|587568161|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
162687697|NCT03170375|587568162|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
162687698|NCT03170375|587568160|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
162687699|NCT03170375|587568161|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
162687700|NCT03170375|587568162|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
162687701|NCT02007434|587568163|FG000|Overall Study|Lost to Follow-up|0|||
162687702|NCT02007434|587568164|FG001|Overall Study|Lost to Follow-up|1|||
162687703|NCT02007434|587568165|FG002|Overall Study|Lost to Follow-up|0|||
162687704|NCT02007434|587568166|FG003|Overall Study|Lost to Follow-up|0|||
162687705|NCT02007434|587568167|FG004|Overall Study|Lost to Follow-up|0|||
162687706|NCT02007434|587568168|FG005|Overall Study|Lost to Follow-up|0|||
162687707|NCT02007434|587568169|FG006|Overall Study|Lost to Follow-up|0|||
162687708|NCT02007434|587568170|FG007|Overall Study|Lost to Follow-up|0|||
162687709|NCT02007434|587568163|FG000|Overall Study|Non-compliance|1|||
162687710|NCT02007434|587568164|FG001|Overall Study|Non-compliance|0|||
162687711|NCT02007434|587568165|FG002|Overall Study|Non-compliance|1|||
162687712|NCT02007434|587568166|FG003|Overall Study|Non-compliance|0|||
162687713|NCT02007434|587568167|FG004|Overall Study|Non-compliance|0|||
162687714|NCT02007434|587568168|FG005|Overall Study|Non-compliance|0|||
162687715|NCT02007434|587568169|FG006|Overall Study|Non-compliance|0|||
162687716|NCT02007434|587568170|FG007|Overall Study|Non-compliance|0|||
162687717|NCT00763958|587568171|FG000|Overall Study|did not meet final criteria|4|||
162687718|NCT00763958|587568172|FG001|Overall Study|did not meet final criteria|4|||
162687719|NCT00763958|587568171|FG000|Overall Study|Lost to Follow-up|10|||
162687720|NCT00763958|587568172|FG001|Overall Study|Lost to Follow-up|2|||
162687721|NCT00763958|587568171|FG000|Overall Study|Believed they were receiving placebo|0|||
162687722|NCT00763958|587568172|FG001|Overall Study|Believed they were receiving placebo|5|||
162687723|NCT01691521|587568173|FG000|Overall Study|Adverse Event|4|||
162687724|NCT01691521|587568174|FG001|Overall Study|Adverse Event|0|||
162687725|NCT01691521|587568175|FG002|Overall Study|Adverse Event|1|||
162727158|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
162727159|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162727160|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162727161|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162727162|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162727163|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
162727164|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162727165|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162727166|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162727167|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162727168|NCT02409667|587710498|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
162727169|NCT02409667|587710499|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162727170|NCT02409667|587710500|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162727171|NCT02409667|587710501|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162727172|NCT02409667|587710502|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162727173|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
162727174|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
162727175|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
162727176|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
162727177|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
162727178|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162727179|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162727180|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162727181|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
162687726|NCT01691521|587568173|FG000|Overall Study|Lack of Efficacy|1|||
162687727|NCT01691521|587568174|FG001|Overall Study|Lack of Efficacy|1|||
162687728|NCT01691521|587568175|FG002|Overall Study|Lack of Efficacy|2|||
162687729|NCT01691521|587568173|FG000|Overall Study|Protocol Violation|0|||
162687730|NCT01691521|587568174|FG001|Overall Study|Protocol Violation|3|||
162687731|NCT01691521|587568175|FG002|Overall Study|Protocol Violation|0|||
162687732|NCT01691521|587568173|FG000|Overall Study|Lost to Follow-up|0|||
162687733|NCT01691521|587568174|FG001|Overall Study|Lost to Follow-up|2|||
162687734|NCT01691521|587568175|FG002|Overall Study|Lost to Follow-up|2|||
162687735|NCT01691521|587568173|FG000|Overall Study|Physician Decision|2|||
162687736|NCT01691521|587568174|FG001|Overall Study|Physician Decision|1|||
162687737|NCT01691521|587568175|FG002|Overall Study|Physician Decision|0|||
162687738|NCT01691521|587568173|FG000|Overall Study|Withdrawal by Subject|5|||
162687739|NCT01691521|587568174|FG001|Overall Study|Withdrawal by Subject|9|||
162687740|NCT01691521|587568175|FG002|Overall Study|Withdrawal by Subject|4|||
162687741|NCT02343003|587568176|FG000|Overall Study|Withdrawal by Subject|9|||
162687742|NCT02343003|587568177|FG001|Overall Study|Withdrawal by Subject|4|||
162687743|NCT02343003|587568176|FG000|Overall Study|Lost to Follow-up|5|||
162687744|NCT02343003|587568177|FG001|Overall Study|Lost to Follow-up|1|||
162687745|NCT02343003|587568176|FG000|Overall Study|Protocol Violation|1|||
162687746|NCT02343003|587568177|FG001|Overall Study|Protocol Violation|0|||
162687747|NCT02343003|587568176|FG000|Overall Study|Death|0|||
162687748|NCT02343003|587568177|FG001|Overall Study|Death|1|||
162687749|NCT02343003|587568176|FG000|Overall Study|exclusion criteria met|1|||
162687750|NCT02343003|587568177|FG001|Overall Study|exclusion criteria met|1|||
162687751|NCT02343003|587568176|FG000|Overall Study|terminated by sponsor|2|||
162687752|NCT02343003|587568177|FG001|Overall Study|terminated by sponsor|0|||
162687753|NCT00954733|587568182|FG000|Overall Study|blood gas machine did not work|1|||
162687754|NCT00622713|587568183|FG000|Overall Study|Adverse Event|35|||
162687755|NCT00622713|587568183|FG000|Overall Study|Administrative problems|4|||
162687756|NCT00622713|587568183|FG000|Overall Study|Withdrawal by Subject|11|||
162687757|NCT00622713|587568183|FG000|Overall Study|Lost to Follow-up|5|||
162687758|NCT00622713|587568183|FG000|Overall Study|Death|2|||
162687759|NCT00622713|587568183|FG000|Overall Study|Subject no longer required study drug|1|||
162687760|NCT00622713|587568183|FG000|Overall Study|Did not meet eligibility criteria|1|||
162687761|NCT04404478|587568184|FG000|Overall Study|Withdrawal by Subject|1|||
162687762|NCT04404478|587568185|FG001|Overall Study|Withdrawal by Subject|3|||
162687763|NCT00879996|587568195|FG000|Overall Study|Lost to Follow-up|7|||
162687764|NCT00879996|587568196|FG001|Overall Study|Lost to Follow-up|6|||
162687765|NCT00879996|587568195|FG000|Overall Study|non-compliance|6|||
162687766|NCT00879996|587568196|FG001|Overall Study|non-compliance|4|||
162687767|NCT00879996|587568195|FG000|Overall Study|Physician Decision|1|||
162687768|NCT00879996|587568196|FG001|Overall Study|Physician Decision|2|||
162687769|NCT00879996|587568195|FG000|Overall Study|psychiatric problem|0|||
162687770|NCT00879996|587568196|FG001|Overall Study|psychiatric problem|1|||
162687771|NCT00879996|587568195|FG000|Overall Study|put on parole|1|||
162687772|NCT00879996|587568196|FG001|Overall Study|put on parole|0|||
162687773|NCT01148862|587568201|FG000|Second Intervention|Withdrawal by Subject|0|||
162687774|NCT01148862|587568202|FG001|Second Intervention|Withdrawal by Subject|2|||
162727182|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162727183|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
162727184|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
162727185|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
162727186|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
162727187|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
162727188|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162727189|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
162727190|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
162727191|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162727192|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162727193|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
162727194|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
162727195|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
162727196|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
162727197|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
162727198|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162727199|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162727200|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
162727201|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162727202|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
162727203|NCT02409667|587710498|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162727204|NCT02409667|587710499|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162727205|NCT02409667|587710500|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
162727206|NCT02409667|587710501|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162727207|NCT02409667|587710502|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162727208|NCT01925339|587710503|FG000|Overall Study|Adverse Event|2|||
162727209|NCT01925339|587710504|FG001|Overall Study|Adverse Event|0|||
162727210|NCT04139668|587712373|FG000|Overall Study|Withdrawal by Subject|1|||
162727211|NCT03025789|587712374|FG000|Overall Study|Lack of Efficacy|6|||
162727212|NCT03025789|587712375|FG001|Overall Study|Lack of Efficacy|1|||
162727213|NCT03025789|587712374|FG000|Overall Study|Death|1|||
162727214|NCT03025789|587712375|FG001|Overall Study|Death|0|||
162727215|NCT03025789|587712374|FG000|Overall Study|Withdrawal by Subject|0|||
162727216|NCT03025789|587712375|FG001|Overall Study|Withdrawal by Subject|2|||
162727217|NCT03554265|587712376|FG000|Overall Study|Withdrawal by Subject|2|||
162727218|NCT03554265|587712377|FG001|Overall Study|Withdrawal by Subject|2|||
162727219|NCT03554265|587712378|FG002|Overall Study|Withdrawal by Subject|3|||
162727220|NCT03554265|587712376|FG000|Overall Study|Physician Decision|0|||
162727221|NCT03554265|587712377|FG001|Overall Study|Physician Decision|0|||
162727222|NCT03554265|587712378|FG002|Overall Study|Physician Decision|1|||
162727223|NCT04999085|587712381|FG000|Overall Study|Death|1|||
162727224|NCT05057897|587712382|FG000|Overall Study|Site closure|2|||
162727225|NCT05057897|587712383|FG001|Overall Study|Site closure|2|||
162727226|NCT05057897|587712382|FG000|Overall Study|Death|1|||
162727227|NCT05057897|587712383|FG001|Overall Study|Death|0|||
162727228|NCT04540913|587712385|FG000|Overall Study|Withdrawal by Subject|14|||
162727229|NCT04540913|587712386|FG001|Overall Study|Withdrawal by Subject|3|||
162727230|NCT04440176|587712387|FG000|Overall Study|Withdrawal by Subject|5|||
162727231|NCT04440176|587712388|FG001|Overall Study|Withdrawal by Subject|3|||
162727232|NCT04440176|587712387|FG000|Overall Study|Withdrawal by parent/guardian|4|||
162687775|NCT03056534|587568203|FG000|Overall Study|Participant withdrew consent|8|||
162687776|NCT03056534|587568203|FG000|Overall Study|Participant not able to return|6|||
162687777|NCT03056534|587568203|FG000|Overall Study|Lost to Follow-up|37|||
162687778|NCT03056534|587568203|FG000|Overall Study|Investigator judgment|1|||
162687779|NCT03056534|587568203|FG000|Overall Study|Death|4|||
162687780|NCT03056534|587568203|FG000|Overall Study|Adverse Event|1|||
162687781|NCT03056534|587568203|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
162687782|NCT04543188|587568204|FG000|Phase 1a|Adverse Event|0|||
162687783|NCT04543188|587568205|FG001|Phase 1a|Adverse Event|0|||
162687784|NCT04543188|587568206|FG002|Phase 1a|Adverse Event|0|||
162687785|NCT04543188|587568207|FG003|Phase 1a|Adverse Event|1|||
162687786|NCT04543188|587568208|FG004|Phase 1a|Adverse Event|0|||
162687787|NCT04543188|587568209|FG005|Phase 1a|Adverse Event|0|||
162687788|NCT04543188|587568210|FG006|Phase 1a|Adverse Event|1|||
162687789|NCT04543188|587568211|FG007|Phase 1a|Adverse Event|0|||
162687790|NCT04543188|587568212|FG008|Phase 1a|Adverse Event|0|||
162687791|NCT04543188|587568213|FG009|Phase 1a|Adverse Event|0|||
162687792|NCT04543188|587568214|FG010|Phase 1a|Adverse Event|0|||
162687793|NCT04543188|587568215|FG011|Phase 1a|Adverse Event|0|||
162687794|NCT04543188|587568216|FG012|Phase 1a|Adverse Event|0|||
162687795|NCT04543188|587568217|FG013|Phase 1a|Adverse Event|0|||
162687796|NCT04543188|587568218|FG014|Phase 1a|Adverse Event|0|||
162727233|NCT04440176|587712388|FG001|Overall Study|Withdrawal by parent/guardian|5|||
162727234|NCT04440176|587712387|FG000|Overall Study|Adverse Event|2|||
162727235|NCT04440176|587712388|FG001|Overall Study|Adverse Event|6|||
162727236|NCT04440176|587712387|FG000|Overall Study|Lost to Follow-up|22|||
162727237|NCT04440176|587712388|FG001|Overall Study|Lost to Follow-up|23|||
162727238|NCT04440176|587712387|FG000|Overall Study|Medication error without associated adverse event|0|||
162727239|NCT04440176|587712388|FG001|Overall Study|Medication error without associated adverse event|1|||
162727240|NCT04440176|587712387|FG000|Overall Study|No longer met eligibility criteria|7|||
162727241|NCT04440176|587712388|FG001|Overall Study|No longer met eligibility criteria|1|||
162727242|NCT04440176|587712387|FG000|Overall Study|Other|1|||
162727243|NCT04440176|587712388|FG001|Overall Study|Other|2|||
162727244|NCT04440176|587712387|FG000|Overall Study|Protocol deviation|6|||
162727245|NCT04440176|587712388|FG001|Overall Study|Protocol deviation|8|||
162727246|NCT04440176|587712387|FG000|Overall Study|Randomized but not vaccinated|6|||
162727247|NCT04440176|587712388|FG001|Overall Study|Randomized but not vaccinated|3|||
162727248|NCT04188379|587712389|FG000|Overall Study|Withdrawal by Subject|10|||
162727249|NCT04188379|587712390|FG001|Overall Study|Withdrawal by Subject|3|||
162727250|NCT04188379|587712389|FG000|Overall Study|Physician Decision|0|||
162727251|NCT04188379|587712390|FG001|Overall Study|Physician Decision|1|||
162727252|NCT04188379|587712389|FG000|Overall Study|Adverse Event|3|||
162727253|NCT04188379|587712390|FG001|Overall Study|Adverse Event|1|||
162727254|NCT04188379|587712389|FG000|Overall Study|Pregnancy|1|||
162727255|NCT04188379|587712390|FG001|Overall Study|Pregnancy|0|||
162727256|NCT04188379|587712389|FG000|Overall Study|Lack of Efficacy|8|||
162727257|NCT04188379|587712390|FG001|Overall Study|Lack of Efficacy|5|||
162727258|NCT04188379|587712389|FG000|Overall Study|Other|0|||
162727259|NCT04188379|587712390|FG001|Overall Study|Other|3|||
162727260|NCT05288283|587712391|FG000|Overall Study|Study Terminated Early|1|||
162727261|NCT05288283|587712392|FG001|Overall Study|Study Terminated Early|1|||
162727262|NCT03990649|587712397|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
162727263|NCT03990649|587712398|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
162727264|NCT03990649|587712399|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
162727265|NCT03990649|587712397|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
162727266|NCT03990649|587712398|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
162727267|NCT03990649|587712399|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
162727268|NCT03990649|587712397|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
162727269|NCT03990649|587712398|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
162727270|NCT03990649|587712399|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
162727271|NCT03990649|587712397|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
162727272|NCT03990649|587712398|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
162727273|NCT03990649|587712399|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
162727274|NCT03990649|587712397|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
162727275|NCT03990649|587712398|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
162727276|NCT03990649|587712399|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
162727277|NCT03990649|587712397|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
162727278|NCT03990649|587712398|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
162727279|NCT03990649|587712399|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
162727280|NCT03990649|587712397|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
162727281|NCT03990649|587712398|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
162727282|NCT03990649|587712399|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
162727283|NCT03050814|587712400|FG000|Overall Study|Screen failures|0|||
162727284|NCT03050814|587712401|FG001|Overall Study|Screen failures|0|||
162727285|NCT03050814|587712402|FG002|Overall Study|Screen failures|4|||
162727286|NCT02706717|587712403|FG000|Overall Study|Withdrawal by Subject|1|||
162727287|NCT02706717|587712404|FG001|Overall Study|Withdrawal by Subject|8|||
162727288|NCT02706717|587712403|FG000|Overall Study|Lost to Follow-up|0|||
162727289|NCT02706717|587712404|FG001|Overall Study|Lost to Follow-up|1|||
162727290|NCT02706717|587712403|FG000|Overall Study|Physician Decision|0|||
162727291|NCT02706717|587712404|FG001|Overall Study|Physician Decision|1|||
162687797|NCT04543188|587568204|FG000|Phase 1a|Other (Death)|0|||
162687798|NCT04543188|587568205|FG001|Phase 1a|Other (Death)|1|||
162687799|NCT04543188|587568206|FG002|Phase 1a|Other (Death)|0|||
162687800|NCT04543188|587568207|FG003|Phase 1a|Other (Death)|0|||
162687801|NCT04543188|587568208|FG004|Phase 1a|Other (Death)|1|||
162687802|NCT04543188|587568209|FG005|Phase 1a|Other (Death)|0|||
162687803|NCT04543188|587568210|FG006|Phase 1a|Other (Death)|0|||
162687804|NCT04543188|587568211|FG007|Phase 1a|Other (Death)|0|||
162687805|NCT04543188|587568212|FG008|Phase 1a|Other (Death)|0|||
162687806|NCT04543188|587568213|FG009|Phase 1a|Other (Death)|1|||
162727292|NCT02706717|587712403|FG000|Overall Study|Death|0|||
162727293|NCT02706717|587712404|FG001|Overall Study|Death|1|||
162687807|NCT04543188|587568214|FG010|Phase 1a|Other (Death)|0|||
162687808|NCT04543188|587568215|FG011|Phase 1a|Other (Death)|0|||
162687809|NCT04543188|587568216|FG012|Phase 1a|Other (Death)|0|||
162687810|NCT04543188|587568217|FG013|Phase 1a|Other (Death)|0|||
162687811|NCT04543188|587568218|FG014|Phase 1a|Other (Death)|0|||
162687812|NCT04543188|587568204|FG000|Phase 1a|Lost to Follow-up|0|||
162687813|NCT04543188|587568205|FG001|Phase 1a|Lost to Follow-up|0|||
162687814|NCT04543188|587568206|FG002|Phase 1a|Lost to Follow-up|0|||
162687815|NCT04543188|587568207|FG003|Phase 1a|Lost to Follow-up|0|||
162687816|NCT04543188|587568208|FG004|Phase 1a|Lost to Follow-up|0|||
162687817|NCT04543188|587568209|FG005|Phase 1a|Lost to Follow-up|0|||
162687818|NCT04543188|587568210|FG006|Phase 1a|Lost to Follow-up|0|||
162687819|NCT04543188|587568211|FG007|Phase 1a|Lost to Follow-up|0|||
162687820|NCT04543188|587568212|FG008|Phase 1a|Lost to Follow-up|0|||
162687821|NCT04543188|587568213|FG009|Phase 1a|Lost to Follow-up|0|||
162687822|NCT04543188|587568214|FG010|Phase 1a|Lost to Follow-up|1|||
162687823|NCT04543188|587568215|FG011|Phase 1a|Lost to Follow-up|0|||
162687824|NCT04543188|587568216|FG012|Phase 1a|Lost to Follow-up|0|||
162687825|NCT04543188|587568217|FG013|Phase 1a|Lost to Follow-up|0|||
162687826|NCT04543188|587568218|FG014|Phase 1a|Lost to Follow-up|0|||
162687827|NCT04543188|587568204|FG000|Phase 1a|Progressive Disease|2|||
162687828|NCT04543188|587568205|FG001|Phase 1a|Progressive Disease|2|||
162687829|NCT04543188|587568206|FG002|Phase 1a|Progressive Disease|3|||
162687830|NCT04543188|587568207|FG003|Phase 1a|Progressive Disease|1|||
162687831|NCT04543188|587568208|FG004|Phase 1a|Progressive Disease|4|||
162687832|NCT04543188|587568209|FG005|Phase 1a|Progressive Disease|2|||
162687833|NCT04543188|587568210|FG006|Phase 1a|Progressive Disease|3|||
162687834|NCT04543188|587568211|FG007|Phase 1a|Progressive Disease|4|||
162687835|NCT04543188|587568212|FG008|Phase 1a|Progressive Disease|1|||
162687836|NCT04543188|587568213|FG009|Phase 1a|Progressive Disease|0|||
162687837|NCT04543188|587568214|FG010|Phase 1a|Progressive Disease|4|||
162687838|NCT04543188|587568215|FG011|Phase 1a|Progressive Disease|0|||
162687839|NCT04543188|587568216|FG012|Phase 1a|Progressive Disease|0|||
162687840|NCT04543188|587568217|FG013|Phase 1a|Progressive Disease|0|||
162687841|NCT04543188|587568218|FG014|Phase 1a|Progressive Disease|0|||
162687842|NCT04543188|587568204|FG000|Phase 1a|Study terminated by sponsor|0|||
162687843|NCT04543188|587568205|FG001|Phase 1a|Study terminated by sponsor|0|||
162687844|NCT04543188|587568206|FG002|Phase 1a|Study terminated by sponsor|0|||
162687845|NCT04543188|587568207|FG003|Phase 1a|Study terminated by sponsor|0|||
162687846|NCT04543188|587568208|FG004|Phase 1a|Study terminated by sponsor|1|||
162687847|NCT04543188|587568209|FG005|Phase 1a|Study terminated by sponsor|0|||
162687848|NCT04543188|587568210|FG006|Phase 1a|Study terminated by sponsor|0|||
162687849|NCT04543188|587568211|FG007|Phase 1a|Study terminated by sponsor|0|||
162687850|NCT04543188|587568212|FG008|Phase 1a|Study terminated by sponsor|0|||
162687851|NCT04543188|587568213|FG009|Phase 1a|Study terminated by sponsor|0|||
162687852|NCT04543188|587568214|FG010|Phase 1a|Study terminated by sponsor|1|||
162687853|NCT04543188|587568215|FG011|Phase 1a|Study terminated by sponsor|0|||
162687854|NCT04543188|587568216|FG012|Phase 1a|Study terminated by sponsor|0|||
162687855|NCT04543188|587568217|FG013|Phase 1a|Study terminated by sponsor|0|||
162687856|NCT04543188|587568218|FG014|Phase 1a|Study terminated by sponsor|0|||
162687857|NCT04543188|587568204|FG000|Phase 1a|Withdrawal by Subject|0|||
162687858|NCT04543188|587568205|FG001|Phase 1a|Withdrawal by Subject|0|||
162687859|NCT04543188|587568206|FG002|Phase 1a|Withdrawal by Subject|0|||
162687860|NCT04543188|587568207|FG003|Phase 1a|Withdrawal by Subject|0|||
162687861|NCT04543188|587568208|FG004|Phase 1a|Withdrawal by Subject|3|||
162687862|NCT04543188|587568209|FG005|Phase 1a|Withdrawal by Subject|0|||
162687863|NCT04543188|587568210|FG006|Phase 1a|Withdrawal by Subject|0|||
162687864|NCT04543188|587568211|FG007|Phase 1a|Withdrawal by Subject|0|||
162687865|NCT04543188|587568212|FG008|Phase 1a|Withdrawal by Subject|1|||
162687866|NCT04543188|587568213|FG009|Phase 1a|Withdrawal by Subject|1|||
162687867|NCT04543188|587568214|FG010|Phase 1a|Withdrawal by Subject|2|||
162687868|NCT04543188|587568215|FG011|Phase 1a|Withdrawal by Subject|0|||
162687869|NCT04543188|587568216|FG012|Phase 1a|Withdrawal by Subject|0|||
162687870|NCT04543188|587568217|FG013|Phase 1a|Withdrawal by Subject|0|||
162687871|NCT04543188|587568218|FG014|Phase 1a|Withdrawal by Subject|0|||
162687872|NCT04543188|587568204|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
162687873|NCT04543188|587568205|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
162687874|NCT04543188|587568206|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
162687875|NCT04543188|587568207|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
162687876|NCT04543188|587568208|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
162687877|NCT04543188|587568209|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
162687878|NCT04543188|587568210|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
162687879|NCT04543188|587568211|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
162687880|NCT04543188|587568212|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
162687881|NCT04543188|587568213|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
162687882|NCT04543188|587568214|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
162687883|NCT04543188|587568215|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
162687884|NCT04543188|587568216|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
162687885|NCT04543188|587568217|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
162687886|NCT04543188|587568218|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
162687887|NCT04543188|587568204|FG000|Phase 1a|Other|0|||
162687888|NCT04543188|587568205|FG001|Phase 1a|Other|0|||
162727294|NCT00978042|587712406|FG000|Initial Treatment Period|Treated in Error|0|||
162727295|NCT00978042|587712407|FG001|Initial Treatment Period|Treated in Error|3|||
162727296|NCT00978042|587712406|FG000|Initial Treatment Period|Ineligibility|1|||
162727297|NCT00978042|587712407|FG001|Initial Treatment Period|Ineligibility|0|||
162727298|NCT00978042|587712406|FG000|Initial Treatment Period|Lost to Follow-up|21|||
162727299|NCT00978042|587712407|FG001|Initial Treatment Period|Lost to Follow-up|3|||
162727300|NCT00978042|587712406|FG000|Initial Treatment Period|Adverse Event|2|||
162727301|NCT00978042|587712407|FG001|Initial Treatment Period|Adverse Event|0|||
162727302|NCT00978042|587712406|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
162727303|NCT00978042|587712407|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
162727304|NCT00978042|587712406|FG000|Initial Treatment Period|Consent withdrawn|22|||
162727305|NCT00978042|587712407|FG001|Initial Treatment Period|Consent withdrawn|9|||
162727306|NCT00978042|587712406|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
162727307|NCT00978042|587712407|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
162727308|NCT00111813|587712408|FG000|Overall Study|Adverse Event|1|||
162727309|NCT00111813|587712409|FG001|Overall Study|Adverse Event|2|||
162727310|NCT00111813|587712410|FG002|Overall Study|Adverse Event|4|||
162727311|NCT00111813|587712411|FG003|Overall Study|Adverse Event|2|||
162727312|NCT00111813|587712412|FG004|Overall Study|Adverse Event|2|||
162727313|NCT00111813|587712413|FG005|Overall Study|Adverse Event|2|||
162727314|NCT00111813|587712408|FG000|Overall Study|Progressive disease|2|||
162727315|NCT00111813|587712409|FG001|Overall Study|Progressive disease|1|||
162727316|NCT00111813|587712410|FG002|Overall Study|Progressive disease|5|||
162727317|NCT00111813|587712411|FG003|Overall Study|Progressive disease|3|||
162727318|NCT00111813|587712412|FG004|Overall Study|Progressive disease|4|||
162727319|NCT00111813|587712413|FG005|Overall Study|Progressive disease|3|||
162727320|NCT00111813|587712408|FG000|Overall Study|Lack of Efficacy|0|||
162727321|NCT00111813|587712409|FG001|Overall Study|Lack of Efficacy|0|||
162727322|NCT00111813|587712410|FG002|Overall Study|Lack of Efficacy|0|||
162727323|NCT00111813|587712411|FG003|Overall Study|Lack of Efficacy|0|||
162727324|NCT00111813|587712412|FG004|Overall Study|Lack of Efficacy|0|||
162727325|NCT00111813|587712413|FG005|Overall Study|Lack of Efficacy|1|||
162727326|NCT00111813|587712408|FG000|Overall Study|Other|0|||
162727327|NCT00111813|587712409|FG001|Overall Study|Other|0|||
162727328|NCT00111813|587712410|FG002|Overall Study|Other|1|||
162727329|NCT00111813|587712411|FG003|Overall Study|Other|0|||
162727330|NCT00111813|587712412|FG004|Overall Study|Other|0|||
162727331|NCT00111813|587712413|FG005|Overall Study|Other|0|||
162727332|NCT01610297|587712414|FG000|Overall Study|Lost to Follow-up|1|||
162727333|NCT00818246|587712415|FG000|Overall Study|Impossible to match pictures|5|||
162727334|NCT02121002|587712416|FG000|Overall Study|Physician Decision|2|||
162727335|NCT02121002|587712417|FG001|Overall Study|Physician Decision|0|||
162727336|NCT02121002|587712418|FG002|Overall Study|Physician Decision|0|||
162727337|NCT02121002|587712416|FG000|Overall Study|Withdrawal by Subject|3|||
162727338|NCT02121002|587712417|FG001|Overall Study|Withdrawal by Subject|1|||
162727339|NCT02121002|587712418|FG002|Overall Study|Withdrawal by Subject|4|||
162727340|NCT02121002|587712416|FG000|Overall Study|Protocol Violation|1|||
162727341|NCT02121002|587712417|FG001|Overall Study|Protocol Violation|2|||
162727342|NCT02121002|587712418|FG002|Overall Study|Protocol Violation|4|||
162727343|NCT02121002|587712416|FG000|Overall Study|Concomitant therapy|0|||
162727344|NCT02121002|587712417|FG001|Overall Study|Concomitant therapy|1|||
162727345|NCT02121002|587712418|FG002|Overall Study|Concomitant therapy|1|||
162727346|NCT02121002|587712416|FG000|Overall Study|Others|1|||
162727347|NCT02121002|587712417|FG001|Overall Study|Others|0|||
162727348|NCT02121002|587712418|FG002|Overall Study|Others|1|||
162727349|NCT02590432|587712419|FG000|Open-label Treatment Period|Adverse Event|97|||
162727350|NCT02590432|587712420|FG001|Open-label Treatment Period|Adverse Event|79|||
162727351|NCT02590432|587712421|FG002|Open-label Treatment Period|Adverse Event|0|||
162727352|NCT02590432|587712422|FG003|Open-label Treatment Period|Adverse Event|0|||
162727353|NCT02590432|587712423|FG004|Open-label Treatment Period|Adverse Event|0|||
162727354|NCT02590432|587712424|FG005|Open-label Treatment Period|Adverse Event|0|||
162727355|NCT02590432|587712425|FG006|Open-label Treatment Period|Adverse Event|0|||
162727356|NCT02590432|587712426|FG007|Open-label Treatment Period|Adverse Event|0|||
162727357|NCT02590432|587712427|FG008|Open-label Treatment Period|Adverse Event|0|||
162727358|NCT02590432|587712419|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
162727359|NCT02590432|587712420|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
162727360|NCT02590432|587712421|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
162727361|NCT02590432|587712422|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
162727362|NCT02590432|587712423|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
162727363|NCT02590432|587712424|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
162727364|NCT02590432|587712425|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
162727365|NCT02590432|587712426|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
162727366|NCT02590432|587712427|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
162727367|NCT02590432|587712419|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
162727368|NCT02590432|587712420|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
162727369|NCT02590432|587712421|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
162687889|NCT04543188|587568206|FG002|Phase 1a|Other|0|||
162687890|NCT04543188|587568207|FG003|Phase 1a|Other|0|||
162687891|NCT04543188|587568208|FG004|Phase 1a|Other|0|||
162687892|NCT04543188|587568209|FG005|Phase 1a|Other|0|||
162687893|NCT04543188|587568210|FG006|Phase 1a|Other|0|||
162687894|NCT04543188|587568211|FG007|Phase 1a|Other|0|||
162687895|NCT04543188|587568212|FG008|Phase 1a|Other|0|||
162687896|NCT04543188|587568213|FG009|Phase 1a|Other|1|||
162687897|NCT04543188|587568214|FG010|Phase 1a|Other|0|||
162687898|NCT04543188|587568215|FG011|Phase 1a|Other|0|||
162687899|NCT04543188|587568216|FG012|Phase 1a|Other|0|||
162687900|NCT04543188|587568217|FG013|Phase 1a|Other|0|||
162687901|NCT04543188|587568218|FG014|Phase 1a|Other|0|||
162687902|NCT04543188|587568204|FG000|Phase 1b|Adverse Event|0|||
162687903|NCT04543188|587568205|FG001|Phase 1b|Adverse Event|0|||
162687904|NCT04543188|587568206|FG002|Phase 1b|Adverse Event|0|||
162687905|NCT04543188|587568207|FG003|Phase 1b|Adverse Event|0|||
162687906|NCT04543188|587568208|FG004|Phase 1b|Adverse Event|0|||
162687907|NCT04543188|587568209|FG005|Phase 1b|Adverse Event|0|||
162687908|NCT04543188|587568210|FG006|Phase 1b|Adverse Event|0|||
162687909|NCT04543188|587568211|FG007|Phase 1b|Adverse Event|0|||
162687910|NCT04543188|587568212|FG008|Phase 1b|Adverse Event|0|||
162687911|NCT04543188|587568213|FG009|Phase 1b|Adverse Event|0|||
162687912|NCT04543188|587568214|FG010|Phase 1b|Adverse Event|0|||
162687913|NCT04543188|587568215|FG011|Phase 1b|Adverse Event|0|||
162687914|NCT04543188|587568216|FG012|Phase 1b|Adverse Event|0|||
162687915|NCT04543188|587568217|FG013|Phase 1b|Adverse Event|0|||
162687916|NCT04543188|587568218|FG014|Phase 1b|Adverse Event|2|||
162687917|NCT04543188|587568204|FG000|Phase 1b|Other (Death)|0|||
162687918|NCT04543188|587568205|FG001|Phase 1b|Other (Death)|0|||
162687919|NCT04543188|587568206|FG002|Phase 1b|Other (Death)|0|||
162687920|NCT04543188|587568207|FG003|Phase 1b|Other (Death)|0|||
162687921|NCT04543188|587568208|FG004|Phase 1b|Other (Death)|0|||
162687922|NCT04543188|587568209|FG005|Phase 1b|Other (Death)|0|||
162687923|NCT04543188|587568210|FG006|Phase 1b|Other (Death)|0|||
162687924|NCT04543188|587568211|FG007|Phase 1b|Other (Death)|0|||
162687925|NCT04543188|587568212|FG008|Phase 1b|Other (Death)|0|||
162687926|NCT04543188|587568213|FG009|Phase 1b|Other (Death)|0|||
162687927|NCT04543188|587568214|FG010|Phase 1b|Other (Death)|0|||
162687928|NCT04543188|587568215|FG011|Phase 1b|Other (Death)|0|||
162687929|NCT04543188|587568216|FG012|Phase 1b|Other (Death)|1|||
162687930|NCT04543188|587568217|FG013|Phase 1b|Other (Death)|0|||
162687931|NCT04543188|587568218|FG014|Phase 1b|Other (Death)|1|||
162687932|NCT04543188|587568204|FG000|Phase 1b|Progressive Disease|0|||
162687933|NCT04543188|587568205|FG001|Phase 1b|Progressive Disease|0|||
162687934|NCT04543188|587568206|FG002|Phase 1b|Progressive Disease|0|||
162687935|NCT04543188|587568207|FG003|Phase 1b|Progressive Disease|0|||
162687936|NCT04543188|587568208|FG004|Phase 1b|Progressive Disease|0|||
162687937|NCT04543188|587568209|FG005|Phase 1b|Progressive Disease|0|||
162687938|NCT04543188|587568210|FG006|Phase 1b|Progressive Disease|0|||
162687939|NCT04543188|587568211|FG007|Phase 1b|Progressive Disease|0|||
162687940|NCT04543188|587568212|FG008|Phase 1b|Progressive Disease|0|||
162687941|NCT04543188|587568213|FG009|Phase 1b|Progressive Disease|0|||
162687942|NCT04543188|587568214|FG010|Phase 1b|Progressive Disease|0|||
162687943|NCT04543188|587568215|FG011|Phase 1b|Progressive Disease|0|||
162687944|NCT04543188|587568216|FG012|Phase 1b|Progressive Disease|2|||
162687945|NCT04543188|587568217|FG013|Phase 1b|Progressive Disease|1|||
162687946|NCT04543188|587568218|FG014|Phase 1b|Progressive Disease|5|||
162687947|NCT04543188|587568204|FG000|Phase 1b|Study Terminated By Sponsor|0|||
162687948|NCT04543188|587568205|FG001|Phase 1b|Study Terminated By Sponsor|0|||
162687949|NCT04543188|587568206|FG002|Phase 1b|Study Terminated By Sponsor|0|||
162687950|NCT04543188|587568207|FG003|Phase 1b|Study Terminated By Sponsor|0|||
162687951|NCT04543188|587568208|FG004|Phase 1b|Study Terminated By Sponsor|0|||
162687952|NCT04543188|587568209|FG005|Phase 1b|Study Terminated By Sponsor|0|||
162687953|NCT04543188|587568210|FG006|Phase 1b|Study Terminated By Sponsor|0|||
162687954|NCT04543188|587568211|FG007|Phase 1b|Study Terminated By Sponsor|0|||
162687955|NCT04543188|587568212|FG008|Phase 1b|Study Terminated By Sponsor|0|||
162687956|NCT04543188|587568213|FG009|Phase 1b|Study Terminated By Sponsor|0|||
162687957|NCT04543188|587568214|FG010|Phase 1b|Study Terminated By Sponsor|0|||
162687958|NCT04543188|587568215|FG011|Phase 1b|Study Terminated By Sponsor|1|||
162687959|NCT04543188|587568216|FG012|Phase 1b|Study Terminated By Sponsor|1|||
162687960|NCT04543188|587568217|FG013|Phase 1b|Study Terminated By Sponsor|0|||
162687961|NCT04543188|587568218|FG014|Phase 1b|Study Terminated By Sponsor|1|||
162687962|NCT04543188|587568204|FG000|Phase 1b|Withdrawal by Subject|0|||
162687963|NCT04543188|587568205|FG001|Phase 1b|Withdrawal by Subject|0|||
162687964|NCT04543188|587568206|FG002|Phase 1b|Withdrawal by Subject|0|||
162687965|NCT04543188|587568207|FG003|Phase 1b|Withdrawal by Subject|0|||
162687966|NCT04543188|587568208|FG004|Phase 1b|Withdrawal by Subject|0|||
162687967|NCT04543188|587568209|FG005|Phase 1b|Withdrawal by Subject|0|||
162687968|NCT04543188|587568210|FG006|Phase 1b|Withdrawal by Subject|0|||
162687969|NCT04543188|587568211|FG007|Phase 1b|Withdrawal by Subject|0|||
162687970|NCT04543188|587568212|FG008|Phase 1b|Withdrawal by Subject|0|||
162687971|NCT04543188|587568213|FG009|Phase 1b|Withdrawal by Subject|0|||
162687972|NCT04543188|587568214|FG010|Phase 1b|Withdrawal by Subject|0|||
162727370|NCT02590432|587712422|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
162727371|NCT02590432|587712423|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
162727372|NCT02590432|587712424|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
162727373|NCT02590432|587712425|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
162727374|NCT02590432|587712426|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
162727375|NCT02590432|587712427|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
162727376|NCT02590432|587712419|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
162727377|NCT02590432|587712420|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
162727378|NCT02590432|587712421|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
162727379|NCT02590432|587712422|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
162727380|NCT02590432|587712423|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
162727381|NCT02590432|587712424|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
162727382|NCT02590432|587712425|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
162727383|NCT02590432|587712426|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
162727384|NCT02590432|587712427|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
162727385|NCT02590432|587712419|FG000|Open-label Treatment Period|Protocol Violation|10|||
162727386|NCT02590432|587712420|FG001|Open-label Treatment Period|Protocol Violation|4|||
162727387|NCT02590432|587712421|FG002|Open-label Treatment Period|Protocol Violation|0|||
162727388|NCT02590432|587712422|FG003|Open-label Treatment Period|Protocol Violation|0|||
162727389|NCT02590432|587712423|FG004|Open-label Treatment Period|Protocol Violation|0|||
162727390|NCT02590432|587712424|FG005|Open-label Treatment Period|Protocol Violation|0|||
162727391|NCT02590432|587712425|FG006|Open-label Treatment Period|Protocol Violation|0|||
162727392|NCT02590432|587712426|FG007|Open-label Treatment Period|Protocol Violation|0|||
162727393|NCT02590432|587712427|FG008|Open-label Treatment Period|Protocol Violation|0|||
162727394|NCT02590432|587712419|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
162727395|NCT02590432|587712420|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
162727396|NCT02590432|587712421|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727397|NCT02590432|587712422|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727398|NCT02590432|587712423|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727399|NCT02590432|587712424|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727400|NCT02590432|587712425|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727401|NCT02590432|587712426|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727402|NCT02590432|587712427|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162727403|NCT02590432|587712419|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
162727404|NCT02590432|587712420|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
162727405|NCT02590432|587712421|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727406|NCT02590432|587712422|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727407|NCT02590432|587712423|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727408|NCT02590432|587712424|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727409|NCT02590432|587712425|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727410|NCT02590432|587712426|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727411|NCT02590432|587712427|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162727412|NCT02590432|587712419|FG000|Double-blind Treatment Period|Adverse Event|0|||
162727413|NCT02590432|587712420|FG001|Double-blind Treatment Period|Adverse Event|0|||
162727414|NCT02590432|587712421|FG002|Double-blind Treatment Period|Adverse Event|14|||
162727415|NCT02590432|587712422|FG003|Double-blind Treatment Period|Adverse Event|12|||
162727416|NCT02590432|587712423|FG004|Double-blind Treatment Period|Adverse Event|6|||
162727417|NCT02590432|587712424|FG005|Double-blind Treatment Period|Adverse Event|22|||
162727418|NCT02590432|587712425|FG006|Double-blind Treatment Period|Adverse Event|20|||
162727419|NCT02590432|587712426|FG007|Double-blind Treatment Period|Adverse Event|0|||
162727420|NCT02590432|587712427|FG008|Double-blind Treatment Period|Adverse Event|0|||
162727421|NCT02590432|587712419|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
162727422|NCT02590432|587712420|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
162727423|NCT02590432|587712421|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
162727424|NCT02590432|587712422|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
162727425|NCT02590432|587712423|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
162727426|NCT02590432|587712424|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
162727427|NCT02590432|587712425|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
162727428|NCT02590432|587712426|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
162727429|NCT02590432|587712427|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
162727430|NCT02590432|587712419|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
162727431|NCT02590432|587712420|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
162727432|NCT02590432|587712421|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
162727433|NCT02590432|587712422|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
162727434|NCT02590432|587712423|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
162727435|NCT02590432|587712424|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
162727436|NCT02590432|587712425|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
162727437|NCT02590432|587712426|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
162687973|NCT04543188|587568215|FG011|Phase 1b|Withdrawal by Subject|0|||
162687974|NCT04543188|587568216|FG012|Phase 1b|Withdrawal by Subject|0|||
162687975|NCT04543188|587568217|FG013|Phase 1b|Withdrawal by Subject|0|||
162687976|NCT04543188|587568218|FG014|Phase 1b|Withdrawal by Subject|2|||
162687977|NCT03815019|587568221|FG000|Overall Study|Withdrawal by Subject|6|||
162687978|NCT03815019|587568222|FG001|Overall Study|Withdrawal by Subject|8|||
162687979|NCT05398796|587568223|FG000|Overall Study|Participant moved from the area|0|||
162687980|NCT05398796|587568224|FG001|Overall Study|Participant moved from the area|1|||
162687981|NCT05398796|587568225|FG002|Overall Study|Participant moved from the area|0|||
162687982|NCT05398796|587568226|FG003|Overall Study|Participant moved from the area|0|||
162687983|NCT04270747|587568228|FG000|Through Week 16|Adverse Event|1|||
162687984|NCT04270747|587568229|FG001|Through Week 16|Adverse Event|2|||
162687985|NCT04270747|587568230|FG002|Through Week 16|Adverse Event|0|||
162687986|NCT04270747|587568228|FG000|Through Week 16|Death|0|||
162687987|NCT04270747|587568229|FG001|Through Week 16|Death|2|||
162687988|NCT04270747|587568230|FG002|Through Week 16|Death|0|||
162687989|NCT04270747|587568228|FG000|Through Week 16|Consent Withdrawn|3|||
162687990|NCT04270747|587568229|FG001|Through Week 16|Consent Withdrawn|3|||
162687991|NCT04270747|587568230|FG002|Through Week 16|Consent Withdrawn|0|||
162687992|NCT04270747|587568228|FG000|Through Week 16|Physician Decision|1|||
162687993|NCT04270747|587568229|FG001|Through Week 16|Physician Decision|1|||
162687994|NCT04270747|587568230|FG002|Through Week 16|Physician Decision|0|||
162687995|NCT04270747|587568228|FG000|Through Week 16|Lost to Follow-up|2|||
162687996|NCT04270747|587568229|FG001|Through Week 16|Lost to Follow-up|0|||
162687997|NCT04270747|587568230|FG002|Through Week 16|Lost to Follow-up|0|||
162687998|NCT04270747|587568228|FG000|Through Week 16|Protocol Violation|1|||
162687999|NCT04270747|587568229|FG001|Through Week 16|Protocol Violation|2|||
162688000|NCT04270747|587568230|FG002|Through Week 16|Protocol Violation|0|||
162688001|NCT04270747|587568228|FG000|Through Week 16|Protocol Specified Criteria|6|||
162688002|NCT04270747|587568229|FG001|Through Week 16|Protocol Specified Criteria|7|||
162688003|NCT04270747|587568230|FG002|Through Week 16|Protocol Specified Criteria|0|||
162688004|NCT04270747|587568228|FG000|Through Week 16|Miscellaneous|1|||
162688005|NCT04270747|587568229|FG001|Through Week 16|Miscellaneous|1|||
162688006|NCT04270747|587568230|FG002|Through Week 16|Miscellaneous|0|||
162688007|NCT04270747|587568228|FG000|Post Week 16|Adverse Event|7|||
162688008|NCT04270747|587568229|FG001|Post Week 16|Adverse Event|5|||
162688009|NCT04270747|587568230|FG002|Post Week 16|Adverse Event|1|||
162688010|NCT04270747|587568228|FG000|Post Week 16|Death|2|||
162688011|NCT04270747|587568229|FG001|Post Week 16|Death|0|||
162688012|NCT04270747|587568230|FG002|Post Week 16|Death|2|||
162688013|NCT04270747|587568228|FG000|Post Week 16|Consent Withdrawn|4|||
162688014|NCT04270747|587568229|FG001|Post Week 16|Consent Withdrawn|3|||
162688015|NCT04270747|587568230|FG002|Post Week 16|Consent Withdrawn|6|||
162688016|NCT04270747|587568228|FG000|Post Week 16|Physician Decision|3|||
162688017|NCT04270747|587568229|FG001|Post Week 16|Physician Decision|1|||
162688018|NCT04270747|587568230|FG002|Post Week 16|Physician Decision|1|||
162688019|NCT04270747|587568228|FG000|Post Week 16|Lost to Follow-up|2|||
162688020|NCT04270747|587568229|FG001|Post Week 16|Lost to Follow-up|1|||
162688021|NCT04270747|587568230|FG002|Post Week 16|Lost to Follow-up|0|||
162688022|NCT04270747|587568228|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
162688023|NCT04270747|587568229|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
162688024|NCT04270747|587568230|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
162688025|NCT04270747|587568228|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
162688026|NCT04270747|587568229|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
162688027|NCT04270747|587568230|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
162688028|NCT04270747|587568228|FG000|Post Week 16|Miscellaneous|1|||
162688029|NCT04270747|587568229|FG001|Post Week 16|Miscellaneous|0|||
162688030|NCT04270747|587568230|FG002|Post Week 16|Miscellaneous|1|||
162688031|NCT05004688|587568231|FG000|Overall Study|Protocol Violation|7|||
162688032|NCT05004688|587568231|FG000|Overall Study|Physician Decision|2|||
162688033|NCT05004688|587568231|FG000|Overall Study|Withdrawal by Subject|2|||
162688034|NCT05960097|587568232|FG000|Overall Study|Lost to Follow-up|3|||
162688035|NCT05960097|587568233|FG001|Overall Study|Lost to Follow-up|1|||
162688036|NCT05960097|587568234|FG002|Overall Study|Lost to Follow-up|1|||
162688037|NCT05960097|587568235|FG003|Overall Study|Lost to Follow-up|2|||
162688038|NCT05960097|587568236|FG004|Overall Study|Lost to Follow-up|1|||
162688039|NCT05960097|587568237|FG005|Overall Study|Lost to Follow-up|1|||
162688040|NCT05960097|587568238|FG006|Overall Study|Lost to Follow-up|2|||
162688041|NCT05960097|587568239|FG007|Overall Study|Lost to Follow-up|3|||
162688042|NCT05960097|587568232|FG000|Overall Study|Physician Decision|0|||
162688043|NCT05960097|587568233|FG001|Overall Study|Physician Decision|0|||
162688044|NCT05960097|587568234|FG002|Overall Study|Physician Decision|0|||
162688045|NCT05960097|587568235|FG003|Overall Study|Physician Decision|0|||
162688046|NCT05960097|587568236|FG004|Overall Study|Physician Decision|0|||
162688047|NCT05960097|587568237|FG005|Overall Study|Physician Decision|0|||
162688048|NCT05960097|587568238|FG006|Overall Study|Physician Decision|1|||
162688049|NCT05960097|587568239|FG007|Overall Study|Physician Decision|0|||
162688050|NCT05960097|587568232|FG000|Overall Study|Withdrawal by Subject|1|||
162727438|NCT02590432|587712427|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
162727439|NCT02590432|587712419|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162727440|NCT02590432|587712420|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162727441|NCT02590432|587712421|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
162727442|NCT02590432|587712422|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162727443|NCT02590432|587712423|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
162727444|NCT02590432|587712424|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
162727445|NCT02590432|587712425|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
162727446|NCT02590432|587712426|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
162727447|NCT02590432|587712427|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
162727448|NCT02590432|587712419|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727449|NCT02590432|587712420|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727450|NCT02590432|587712421|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727451|NCT02590432|587712422|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727452|NCT02590432|587712423|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727453|NCT02590432|587712424|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
162727454|NCT02590432|587712425|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727455|NCT02590432|587712426|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727456|NCT02590432|587712427|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162727457|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727458|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727459|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727460|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727461|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727462|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727463|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162727464|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
162727465|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
162727466|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727467|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727468|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727469|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727470|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727471|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727472|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727473|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
162727474|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162727475|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162727476|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162727477|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162688051|NCT05960097|587568233|FG001|Overall Study|Withdrawal by Subject|0|||
162688052|NCT05960097|587568234|FG002|Overall Study|Withdrawal by Subject|0|||
162688053|NCT05960097|587568235|FG003|Overall Study|Withdrawal by Subject|1|||
162688054|NCT05960097|587568236|FG004|Overall Study|Withdrawal by Subject|1|||
162688055|NCT05960097|587568237|FG005|Overall Study|Withdrawal by Subject|0|||
162688056|NCT05960097|587568238|FG006|Overall Study|Withdrawal by Subject|0|||
162688057|NCT05960097|587568239|FG007|Overall Study|Withdrawal by Subject|0|||
162688058|NCT05960097|587568232|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688059|NCT05960097|587568233|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688060|NCT05960097|587568234|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
162688061|NCT05960097|587568235|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688062|NCT05960097|587568236|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688063|NCT05960097|587568237|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688064|NCT05960097|587568238|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688065|NCT05960097|587568239|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162688066|NCT02134925|587568240|FG000|Overall Study|Withdrawal by Subject|1|||
162688067|NCT02134925|587568241|FG001|Overall Study|Withdrawal by Subject|0|||
162688068|NCT02134925|587568240|FG000|Overall Study|Cancel|1|||
162688069|NCT02134925|587568241|FG001|Overall Study|Cancel|6|||
162688070|NCT02158884|587568242|FG000|Baseline Assessment|Missed performance assessment|3|||
162688071|NCT02158884|587568242|FG000|Baseline Assessment|Missed SMFA|1|||
162688072|NCT02158884|587568242|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
162688073|NCT02158884|587568242|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
162688074|NCT02158884|587568242|FG000|6 Month Assessment|Missed SMFA|20|||
162688075|NCT02158884|587568242|FG000|12 Month Assessment|Missed SMFA|17|||
162688076|NCT05158296|587568243|FG000|Overall Study|Sponsor Decision|2|||
162727478|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162727479|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162688077|NCT05158296|587568244|FG001|Overall Study|Sponsor Decision|3|||
162688078|NCT05158296|587568245|FG002|Overall Study|Sponsor Decision|2|||
162688079|NCT04098250|587568248|FG000|Overall Study|Withdrawal by Subject|1|||
162688080|NCT04098250|587568249|FG001|Overall Study|Withdrawal by Subject|0|||
162688081|NCT04098250|587568248|FG000|Overall Study|Lost to Follow-up|0|||
162688082|NCT04098250|587568249|FG001|Overall Study|Lost to Follow-up|1|||
162688083|NCT00633464|587568254|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
162688084|NCT00633464|587568255|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
162688085|NCT00633464|587568254|FG000|Overall Study|Never Treated (Randomized in error)|0|||
162688086|NCT00633464|587568255|FG001|Overall Study|Never Treated (Randomized in error)|1|||
162688087|NCT02612064|587568257|FG000|Overall Study|Withdrawal by Subject|1|||
162688088|NCT02612064|587568258|FG001|Overall Study|Withdrawal by Subject|1|||
162688089|NCT02612064|587568257|FG000|Overall Study|Other|0|||
162688090|NCT02612064|587568258|FG001|Overall Study|Other|2|||
162688091|NCT06387472|587568259|FG000|Overall Study|Withdrawal by Subject|1|||
162688092|NCT06387472|587568259|FG000|Overall Study|Lost to Follow-up|2|||
162688093|NCT06387472|587568259|FG000|Overall Study|Physician Decision|1|||
162688094|NCT04182880|587568260|FG000|Overall Study|Pregnancy|1|||
162688095|NCT04182880|587568261|FG001|Overall Study|Pregnancy|0|||
162688096|NCT02036645|587568262|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688097|NCT02036645|587568263|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688098|NCT02036645|587568264|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688099|NCT02036645|587568265|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688100|NCT02036645|587568266|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688101|NCT02036645|587568267|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688102|NCT02036645|587568268|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
162688103|NCT02036645|587568269|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688104|NCT02036645|587568270|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688105|NCT02036645|587568271|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688106|NCT02036645|587568272|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688107|NCT02036645|587568273|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162688108|NCT02036645|587568262|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688109|NCT02036645|587568263|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688110|NCT02036645|587568264|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688111|NCT02036645|587568265|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
162688112|NCT02036645|587568266|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688113|NCT02036645|587568267|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688114|NCT02036645|587568268|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688115|NCT02036645|587568269|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688116|NCT02036645|587568270|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688117|NCT02036645|587568271|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688118|NCT02036645|587568272|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688119|NCT02036645|587568273|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162688120|NCT00717860|587568278|FG000|Overall Study|Clinical adverse experience|5|||
162688121|NCT00717860|587568279|FG001|Overall Study|Clinical adverse experience|9|||
162688122|NCT00717860|587568278|FG000|Overall Study|Laboratory adverse experience|2|||
162688123|NCT00717860|587568279|FG001|Overall Study|Laboratory adverse experience|2|||
162688124|NCT00717860|587568278|FG000|Overall Study|Lack of Efficacy|7|||
162688125|NCT00717860|587568279|FG001|Overall Study|Lack of Efficacy|13|||
162688126|NCT00717860|587568278|FG000|Overall Study|Discontinued for other reason|6|||
162688127|NCT00717860|587568279|FG001|Overall Study|Discontinued for other reason|1|||
162688128|NCT00717860|587568278|FG000|Overall Study|Withdrew consent|7|||
162688129|NCT00717860|587568279|FG001|Overall Study|Withdrew consent|3|||
162688130|NCT00698646|587568280|FG000|Overall Study|Adverse Event|8|||
162688131|NCT00698646|587568281|FG001|Overall Study|Adverse Event|7|||
162688132|NCT00698646|587568282|FG002|Overall Study|Adverse Event|8|||
162688133|NCT00698646|587568280|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
162688134|NCT00698646|587568281|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
162688135|NCT00698646|587568282|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
162688136|NCT00698646|587568280|FG000|Overall Study|Protocol Deviation|6|||
162688137|NCT00698646|587568281|FG001|Overall Study|Protocol Deviation|2|||
162688138|NCT00698646|587568282|FG002|Overall Study|Protocol Deviation|3|||
162688139|NCT00698646|587568280|FG000|Overall Study|Withdrawal by Subject|10|||
162688140|NCT00698646|587568281|FG001|Overall Study|Withdrawal by Subject|11|||
162688141|NCT00698646|587568282|FG002|Overall Study|Withdrawal by Subject|8|||
162688142|NCT00698646|587568280|FG000|Overall Study|Lost to Follow-up|0|||
162688143|NCT00698646|587568281|FG001|Overall Study|Lost to Follow-up|0|||
162688144|NCT00698646|587568282|FG002|Overall Study|Lost to Follow-up|2|||
162688145|NCT00698646|587568280|FG000|Overall Study|Administrative problems|1|||
162688146|NCT00698646|587568281|FG001|Overall Study|Administrative problems|0|||
162688147|NCT00698646|587568282|FG002|Overall Study|Administrative problems|1|||
162688148|NCT00279201|587568285|FG000|Initiation|Death|1|||
162727480|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162727481|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162727482|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
162727483|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
162727484|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727485|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727486|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727487|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727488|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727489|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727490|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727491|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162727492|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
162727493|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727494|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727495|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727496|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727497|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727498|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727499|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727500|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162727501|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
162727502|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162688149|NCT00279201|587568286|FG001|Initiation|Death|5|||
162688150|NCT00279201|587568287|FG002|Initiation|Death|0|||
162688151|NCT00279201|587568288|FG003|Initiation|Death|0|||
162688152|NCT00279201|587568289|FG004|Initiation|Death|0|||
162688153|NCT00279201|587568290|FG005|Initiation|Death|0|||
162688154|NCT00279201|587568285|FG000|Initiation|Adverse Event|6|||
162688155|NCT00279201|587568286|FG001|Initiation|Adverse Event|15|||
162688156|NCT00279201|587568287|FG002|Initiation|Adverse Event|0|||
162688157|NCT00279201|587568288|FG003|Initiation|Adverse Event|0|||
162688158|NCT00279201|587568289|FG004|Initiation|Adverse Event|0|||
162688159|NCT00279201|587568290|FG005|Initiation|Adverse Event|0|||
162688160|NCT00279201|587568285|FG000|Initiation|Lost to Follow-up|42|||
162688161|NCT00279201|587568286|FG001|Initiation|Lost to Follow-up|41|||
162688162|NCT00279201|587568287|FG002|Initiation|Lost to Follow-up|0|||
162688163|NCT00279201|587568288|FG003|Initiation|Lost to Follow-up|0|||
162688164|NCT00279201|587568289|FG004|Initiation|Lost to Follow-up|0|||
162688165|NCT00279201|587568290|FG005|Initiation|Lost to Follow-up|0|||
162688166|NCT00279201|587568285|FG000|Initiation|Entry Criteria Exclusion|7|||
162688167|NCT00279201|587568286|FG001|Initiation|Entry Criteria Exclusion|9|||
162688168|NCT00279201|587568287|FG002|Initiation|Entry Criteria Exclusion|0|||
162688169|NCT00279201|587568288|FG003|Initiation|Entry Criteria Exclusion|0|||
162688170|NCT00279201|587568289|FG004|Initiation|Entry Criteria Exclusion|0|||
162688171|NCT00279201|587568290|FG005|Initiation|Entry Criteria Exclusion|0|||
162688172|NCT00279201|587568285|FG000|Initiation|Protocol Violation|9|||
162688173|NCT00279201|587568286|FG001|Initiation|Protocol Violation|10|||
162688174|NCT00279201|587568287|FG002|Initiation|Protocol Violation|0|||
162688175|NCT00279201|587568288|FG003|Initiation|Protocol Violation|0|||
162688176|NCT00279201|587568289|FG004|Initiation|Protocol Violation|0|||
162688177|NCT00279201|587568290|FG005|Initiation|Protocol Violation|0|||
162688178|NCT00279201|587568285|FG000|Initiation|Withdrawal by Subject|35|||
162688179|NCT00279201|587568286|FG001|Initiation|Withdrawal by Subject|41|||
162688180|NCT00279201|587568287|FG002|Initiation|Withdrawal by Subject|0|||
162688181|NCT00279201|587568288|FG003|Initiation|Withdrawal by Subject|0|||
162688182|NCT00279201|587568289|FG004|Initiation|Withdrawal by Subject|0|||
162688183|NCT00279201|587568290|FG005|Initiation|Withdrawal by Subject|0|||
162688184|NCT00279201|587568285|FG000|Initiation|Physician Decision|15|||
162688185|NCT00279201|587568286|FG001|Initiation|Physician Decision|18|||
162688186|NCT00279201|587568287|FG002|Initiation|Physician Decision|0|||
162688187|NCT00279201|587568288|FG003|Initiation|Physician Decision|0|||
162688188|NCT00279201|587568289|FG004|Initiation|Physician Decision|0|||
162688189|NCT00279201|587568290|FG005|Initiation|Physician Decision|0|||
162688190|NCT00279201|587568285|FG000|Initiation|Sponsor Decision|13|||
162688191|NCT00279201|587568286|FG001|Initiation|Sponsor Decision|5|||
162688192|NCT00279201|587568287|FG002|Initiation|Sponsor Decision|0|||
162688193|NCT00279201|587568288|FG003|Initiation|Sponsor Decision|0|||
162688194|NCT00279201|587568289|FG004|Initiation|Sponsor Decision|0|||
162688195|NCT00279201|587568290|FG005|Initiation|Sponsor Decision|0|||
162688196|NCT00279201|587568285|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162688197|NCT00279201|587568286|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
162688198|NCT00279201|587568287|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162688199|NCT00279201|587568288|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162688200|NCT00279201|587568289|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162688201|NCT00279201|587568290|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162688202|NCT00279201|587568285|FG000|Maintenance|Lack of Efficacy|32|||
162688203|NCT00279201|587568286|FG001|Maintenance|Lack of Efficacy|30|||
162688204|NCT00279201|587568287|FG002|Maintenance|Lack of Efficacy|0|||
162688205|NCT00279201|587568288|FG003|Maintenance|Lack of Efficacy|0|||
162688206|NCT00279201|587568289|FG004|Maintenance|Lack of Efficacy|0|||
162688207|NCT00279201|587568290|FG005|Maintenance|Lack of Efficacy|0|||
162688208|NCT00279201|587568285|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
162688209|NCT00279201|587568286|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
162688210|NCT00279201|587568287|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162688211|NCT00279201|587568288|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162688212|NCT00279201|587568289|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162688213|NCT00279201|587568290|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162688214|NCT00279201|587568285|FG000|Maintenance|Adverse Event|4|||
162688215|NCT00279201|587568286|FG001|Maintenance|Adverse Event|4|||
162688216|NCT00279201|587568287|FG002|Maintenance|Adverse Event|0|||
162688217|NCT00279201|587568288|FG003|Maintenance|Adverse Event|0|||
162688218|NCT00279201|587568289|FG004|Maintenance|Adverse Event|0|||
162688219|NCT00279201|587568290|FG005|Maintenance|Adverse Event|0|||
162688220|NCT00279201|587568285|FG000|Maintenance|Death|4|||
162688221|NCT00279201|587568286|FG001|Maintenance|Death|4|||
162688222|NCT00279201|587568287|FG002|Maintenance|Death|0|||
162688223|NCT00279201|587568288|FG003|Maintenance|Death|0|||
162688224|NCT00279201|587568289|FG004|Maintenance|Death|0|||
162688225|NCT00279201|587568290|FG005|Maintenance|Death|0|||
162688226|NCT00279201|587568285|FG000|Maintenance|Lost to Follow-up|17|||
162688227|NCT00279201|587568286|FG001|Maintenance|Lost to Follow-up|13|||
162688228|NCT00279201|587568287|FG002|Maintenance|Lost to Follow-up|0|||
162688229|NCT00279201|587568288|FG003|Maintenance|Lost to Follow-up|0|||
162688230|NCT00279201|587568289|FG004|Maintenance|Lost to Follow-up|0|||
162688231|NCT00279201|587568290|FG005|Maintenance|Lost to Follow-up|0|||
162688232|NCT00279201|587568285|FG000|Maintenance|Entry Criteria Exclusion|1|||
162688233|NCT00279201|587568286|FG001|Maintenance|Entry Criteria Exclusion|4|||
162688234|NCT00279201|587568287|FG002|Maintenance|Entry Criteria Exclusion|0|||
162688235|NCT00279201|587568288|FG003|Maintenance|Entry Criteria Exclusion|0|||
162688236|NCT00279201|587568289|FG004|Maintenance|Entry Criteria Exclusion|0|||
162688237|NCT00279201|587568290|FG005|Maintenance|Entry Criteria Exclusion|0|||
162688238|NCT00279201|587568285|FG000|Maintenance|Protocol Violation|16|||
162688239|NCT00279201|587568286|FG001|Maintenance|Protocol Violation|24|||
162688240|NCT00279201|587568287|FG002|Maintenance|Protocol Violation|0|||
162688241|NCT00279201|587568288|FG003|Maintenance|Protocol Violation|0|||
162688242|NCT00279201|587568289|FG004|Maintenance|Protocol Violation|0|||
162688243|NCT00279201|587568290|FG005|Maintenance|Protocol Violation|0|||
162688244|NCT00279201|587568285|FG000|Maintenance|Withdrawal by Subject|18|||
162688245|NCT00279201|587568286|FG001|Maintenance|Withdrawal by Subject|18|||
162688246|NCT00279201|587568287|FG002|Maintenance|Withdrawal by Subject|0|||
162688247|NCT00279201|587568288|FG003|Maintenance|Withdrawal by Subject|0|||
162688248|NCT00279201|587568289|FG004|Maintenance|Withdrawal by Subject|0|||
162688249|NCT00279201|587568290|FG005|Maintenance|Withdrawal by Subject|0|||
162688250|NCT00279201|587568285|FG000|Maintenance|Physician Decision|9|||
162688251|NCT00279201|587568286|FG001|Maintenance|Physician Decision|9|||
162688252|NCT00279201|587568287|FG002|Maintenance|Physician Decision|0|||
162688253|NCT00279201|587568288|FG003|Maintenance|Physician Decision|0|||
162688254|NCT00279201|587568289|FG004|Maintenance|Physician Decision|0|||
162688255|NCT00279201|587568290|FG005|Maintenance|Physician Decision|0|||
162688256|NCT00279201|587568285|FG000|Maintenance|Sponsor Decision|4|||
162688257|NCT00279201|587568286|FG001|Maintenance|Sponsor Decision|0|||
162688258|NCT00279201|587568287|FG002|Maintenance|Sponsor Decision|0|||
162688259|NCT00279201|587568288|FG003|Maintenance|Sponsor Decision|0|||
162688260|NCT00279201|587568289|FG004|Maintenance|Sponsor Decision|0|||
162688261|NCT00279201|587568290|FG005|Maintenance|Sponsor Decision|0|||
162688262|NCT00279201|587568285|FG000|Maintenance|HbA1c>7.5%|123|||
162688263|NCT00279201|587568286|FG001|Maintenance|HbA1c>7.5%|126|||
162688264|NCT00279201|587568287|FG002|Maintenance|HbA1c>7.5%|0|||
162688265|NCT00279201|587568288|FG003|Maintenance|HbA1c>7.5%|0|||
162688266|NCT00279201|587568289|FG004|Maintenance|HbA1c>7.5%|0|||
162688267|NCT00279201|587568290|FG005|Maintenance|HbA1c>7.5%|0|||
162688268|NCT00279201|587568285|FG000|Intensification Addendum|Withdrawal by Subject|0|||
162688269|NCT00279201|587568286|FG001|Intensification Addendum|Withdrawal by Subject|0|||
162688270|NCT00279201|587568287|FG002|Intensification Addendum|Withdrawal by Subject|12|||
162688271|NCT00279201|587568288|FG003|Intensification Addendum|Withdrawal by Subject|14|||
162688272|NCT00279201|587568289|FG004|Intensification Addendum|Withdrawal by Subject|9|||
162688273|NCT00279201|587568290|FG005|Intensification Addendum|Withdrawal by Subject|18|||
162688274|NCT00279201|587568285|FG000|Intensification Addendum|Lost to Follow-up|0|||
162688275|NCT00279201|587568286|FG001|Intensification Addendum|Lost to Follow-up|0|||
162688276|NCT00279201|587568287|FG002|Intensification Addendum|Lost to Follow-up|4|||
162688277|NCT00279201|587568288|FG003|Intensification Addendum|Lost to Follow-up|6|||
162688278|NCT00279201|587568289|FG004|Intensification Addendum|Lost to Follow-up|7|||
162688279|NCT00279201|587568290|FG005|Intensification Addendum|Lost to Follow-up|7|||
162688280|NCT00279201|587568285|FG000|Intensification Addendum|Protocol Violation|0|||
162688281|NCT00279201|587568286|FG001|Intensification Addendum|Protocol Violation|0|||
162688282|NCT00279201|587568287|FG002|Intensification Addendum|Protocol Violation|2|||
162688283|NCT00279201|587568288|FG003|Intensification Addendum|Protocol Violation|2|||
162688284|NCT00279201|587568289|FG004|Intensification Addendum|Protocol Violation|6|||
162688285|NCT00279201|587568290|FG005|Intensification Addendum|Protocol Violation|6|||
162688286|NCT00279201|587568285|FG000|Intensification Addendum|Adverse Event|0|||
162688287|NCT00279201|587568286|FG001|Intensification Addendum|Adverse Event|0|||
162688288|NCT00279201|587568287|FG002|Intensification Addendum|Adverse Event|0|||
162688289|NCT00279201|587568288|FG003|Intensification Addendum|Adverse Event|4|||
162688290|NCT00279201|587568289|FG004|Intensification Addendum|Adverse Event|1|||
162688291|NCT00279201|587568290|FG005|Intensification Addendum|Adverse Event|3|||
162688292|NCT00279201|587568285|FG000|Intensification Addendum|Physician Decision|0|||
162688293|NCT00279201|587568286|FG001|Intensification Addendum|Physician Decision|0|||
162688294|NCT00279201|587568287|FG002|Intensification Addendum|Physician Decision|4|||
162688295|NCT00279201|587568288|FG003|Intensification Addendum|Physician Decision|1|||
162688296|NCT00279201|587568289|FG004|Intensification Addendum|Physician Decision|3|||
162688297|NCT00279201|587568290|FG005|Intensification Addendum|Physician Decision|2|||
162688298|NCT00279201|587568285|FG000|Intensification Addendum|Sponsor Decision|0|||
162688299|NCT00279201|587568286|FG001|Intensification Addendum|Sponsor Decision|0|||
162688300|NCT00279201|587568287|FG002|Intensification Addendum|Sponsor Decision|0|||
162688301|NCT00279201|587568288|FG003|Intensification Addendum|Sponsor Decision|0|||
162688302|NCT00279201|587568289|FG004|Intensification Addendum|Sponsor Decision|1|||
162688303|NCT00279201|587568290|FG005|Intensification Addendum|Sponsor Decision|1|||
162688304|NCT00279201|587568285|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
162688305|NCT00279201|587568286|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
162688306|NCT00279201|587568287|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
162688307|NCT00279201|587568288|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
162688308|NCT00279201|587568289|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
162688309|NCT00279201|587568290|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
162688310|NCT00279201|587568285|FG000|Intensification Addendum|Lack of Efficacy|0|||
162688311|NCT00279201|587568286|FG001|Intensification Addendum|Lack of Efficacy|0|||
162688312|NCT00279201|587568287|FG002|Intensification Addendum|Lack of Efficacy|0|||
162688313|NCT00279201|587568288|FG003|Intensification Addendum|Lack of Efficacy|1|||
162688314|NCT00279201|587568289|FG004|Intensification Addendum|Lack of Efficacy|1|||
162688315|NCT00279201|587568290|FG005|Intensification Addendum|Lack of Efficacy|0|||
162688316|NCT00279201|587568285|FG000|Intensification Addendum|Death|0|||
162688317|NCT00279201|587568286|FG001|Intensification Addendum|Death|0|||
162688318|NCT00279201|587568287|FG002|Intensification Addendum|Death|0|||
162688319|NCT00279201|587568288|FG003|Intensification Addendum|Death|0|||
162688320|NCT00279201|587568289|FG004|Intensification Addendum|Death|1|||
162688321|NCT00279201|587568290|FG005|Intensification Addendum|Death|0|||
162688322|NCT00696384|587568296|FG000|Open Label Phase|Adverse Event|27|||
162688323|NCT00696384|587568297|FG001|Open Label Phase|Adverse Event|0|||
162688324|NCT00696384|587568298|FG002|Open Label Phase|Adverse Event|0|||
162688325|NCT00696384|587568296|FG000|Open Label Phase|Protocol Violation|18|||
162688326|NCT00696384|587568297|FG001|Open Label Phase|Protocol Violation|0|||
162688327|NCT00696384|587568298|FG002|Open Label Phase|Protocol Violation|0|||
162688328|NCT00696384|587568296|FG000|Open Label Phase|Lost to Follow-up|24|||
162688329|NCT00696384|587568297|FG001|Open Label Phase|Lost to Follow-up|0|||
162688330|NCT00696384|587568298|FG002|Open Label Phase|Lost to Follow-up|0|||
162688331|NCT00696384|587568296|FG000|Open Label Phase|Withdrawal by Subject|37|||
162688332|NCT00696384|587568297|FG001|Open Label Phase|Withdrawal by Subject|0|||
162688333|NCT00696384|587568298|FG002|Open Label Phase|Withdrawal by Subject|0|||
162688334|NCT00696384|587568296|FG000|Open Label Phase|Other|6|||
162688335|NCT00696384|587568297|FG001|Open Label Phase|Other|0|||
162688336|NCT00696384|587568298|FG002|Open Label Phase|Other|0|||
162688337|NCT00696384|587568296|FG000|Open Label Phase|Lack of Efficacy|3|||
162688338|NCT00696384|587568297|FG001|Open Label Phase|Lack of Efficacy|0|||
162688339|NCT00696384|587568298|FG002|Open Label Phase|Lack of Efficacy|0|||
162688340|NCT00696384|587568296|FG000|Open Label Phase|Physician Decision|4|||
162688341|NCT00696384|587568297|FG001|Open Label Phase|Physician Decision|0|||
162688342|NCT00696384|587568298|FG002|Open Label Phase|Physician Decision|0|||
162688343|NCT00696384|587568296|FG000|Double Blind Phase|Adverse Event|0|||
162688344|NCT00696384|587568297|FG001|Double Blind Phase|Adverse Event|2|||
162688345|NCT00696384|587568298|FG002|Double Blind Phase|Adverse Event|2|||
162688346|NCT00696384|587568296|FG000|Double Blind Phase|Lost to Follow-up|0|||
162688347|NCT00696384|587568297|FG001|Double Blind Phase|Lost to Follow-up|2|||
162688348|NCT00696384|587568298|FG002|Double Blind Phase|Lost to Follow-up|1|||
162688349|NCT00696384|587568296|FG000|Double Blind Phase|Withdrawal by Subject|0|||
162688350|NCT00696384|587568297|FG001|Double Blind Phase|Withdrawal by Subject|4|||
162688351|NCT00696384|587568298|FG002|Double Blind Phase|Withdrawal by Subject|3|||
162688352|NCT00696384|587568296|FG000|Double Blind Phase|Lack of Efficacy|0|||
162688353|NCT00696384|587568297|FG001|Double Blind Phase|Lack of Efficacy|1|||
162688354|NCT00696384|587568298|FG002|Double Blind Phase|Lack of Efficacy|0|||
162688355|NCT00696384|587568296|FG000|Double Blind Phase|Physician Decision|0|||
162688356|NCT00696384|587568297|FG001|Double Blind Phase|Physician Decision|2|||
162688357|NCT00696384|587568298|FG002|Double Blind Phase|Physician Decision|0|||
162688358|NCT03995784|587568299|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
162688359|NCT01489189|587568300|FG000|Overall Study|Withdrawal by Subject|20|||
162688360|NCT01489189|587568301|FG001|Overall Study|Withdrawal by Subject|23|||
162688361|NCT01489189|587568300|FG000|Overall Study|Death|10|||
162688362|NCT01489189|587568301|FG001|Overall Study|Death|8|||
162688363|NCT01489189|587568300|FG000|Overall Study|Missed Visit|1|||
162688364|NCT01489189|587568301|FG001|Overall Study|Missed Visit|4|||
162688365|NCT00112580|587568302|FG000|Overall Study|Adverse Event|1|||
162688366|NCT00112580|587568303|FG001|Overall Study|Adverse Event|2|||
162688367|NCT00112580|587568302|FG000|Overall Study|Disease progression|5|||
162688368|NCT00112580|587568303|FG001|Overall Study|Disease progression|16|||
162688369|NCT00112580|587568302|FG000|Overall Study|Participant withdrew consent|2|||
162688370|NCT00112580|587568303|FG001|Overall Study|Participant withdrew consent|1|||
162688371|NCT03881696|587568310|FG000|Overall Study|Adverse Event|2|||
162688372|NCT03881696|587568311|FG001|Overall Study|Adverse Event|0|||
162688373|NCT03881696|587568310|FG000|Overall Study|Withdrawal by Subject|2|||
162688374|NCT03881696|587568311|FG001|Overall Study|Withdrawal by Subject|0|||
162688375|NCT03881696|587568310|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
162688376|NCT03881696|587568311|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
162688377|NCT03881696|587568310|FG000|Overall Study|Failure to meet continuation criteria|1|||
162688378|NCT03881696|587568311|FG001|Overall Study|Failure to meet continuation criteria|0|||
162688379|NCT02202434|587569796|FG000|Overall Study|Death|70|||
162688380|NCT02202434|587569797|FG001|Overall Study|Death|39|||
162688381|NCT02202434|587569798|FG002|Overall Study|Death|13|||
162688382|NCT02202434|587569799|FG003|Overall Study|Death|27|||
162688383|NCT02202434|587569796|FG000|Overall Study|Lost to Follow-up|1|||
162688384|NCT02202434|587569797|FG001|Overall Study|Lost to Follow-up|1|||
162688385|NCT02202434|587569798|FG002|Overall Study|Lost to Follow-up|1|||
162688386|NCT02202434|587569799|FG003|Overall Study|Lost to Follow-up|0|||
162688387|NCT02202434|587569796|FG000|Overall Study|Physician Decision|2|||
162688388|NCT02202434|587569797|FG001|Overall Study|Physician Decision|3|||
162688389|NCT02202434|587569798|FG002|Overall Study|Physician Decision|0|||
162688390|NCT02202434|587569799|FG003|Overall Study|Physician Decision|0|||
162688391|NCT02202434|587569796|FG000|Overall Study|Withdrawal by Subject|13|||
162688392|NCT02202434|587569797|FG001|Overall Study|Withdrawal by Subject|14|||
162688393|NCT02202434|587569798|FG002|Overall Study|Withdrawal by Subject|1|||
162688394|NCT02202434|587569799|FG003|Overall Study|Withdrawal by Subject|4|||
162688395|NCT02202434|587569796|FG000|Overall Study|Completed Study|1|||
162688396|NCT02202434|587569797|FG001|Overall Study|Completed Study|0|||
162688397|NCT02202434|587569798|FG002|Overall Study|Completed Study|0|||
162688398|NCT02202434|587569799|FG003|Overall Study|Completed Study|0|||
162688399|NCT02202434|587569796|FG000|Overall Study|Visit Missed|21|||
162688400|NCT02202434|587569797|FG001|Overall Study|Visit Missed|12|||
162688401|NCT02202434|587569798|FG002|Overall Study|Visit Missed|0|||
162688402|NCT02202434|587569799|FG003|Overall Study|Visit Missed|5|||
162688403|NCT02202434|587569796|FG000|Overall Study|Other|1|||
162688404|NCT02202434|587569797|FG001|Overall Study|Other|0|||
162688405|NCT02202434|587569798|FG002|Overall Study|Other|0|||
162688406|NCT02202434|587569799|FG003|Overall Study|Other|1|||
162688407|NCT00710606|587569806|FG000|Overall Study|Adverse Event|0|||
162688408|NCT00710606|587569807|FG001|Overall Study|Adverse Event|2|||
162688409|NCT02670538|587569812|FG000|Overall Study|Withdrawal of Consent|8|||
162688410|NCT02670538|587569813|FG001|Overall Study|Withdrawal of Consent|6|||
162688411|NCT02670538|587569814|FG002|Overall Study|Withdrawal of Consent|5|||
162688412|NCT02670538|587569812|FG000|Overall Study|Lost to Follow-up|8|||
162688413|NCT02670538|587569813|FG001|Overall Study|Lost to Follow-up|12|||
162688414|NCT02670538|587569814|FG002|Overall Study|Lost to Follow-up|7|||
162688415|NCT02670538|587569812|FG000|Overall Study|Adverse Event|5|||
162688416|NCT02670538|587569813|FG001|Overall Study|Adverse Event|5|||
162688417|NCT02670538|587569814|FG002|Overall Study|Adverse Event|11|||
162688418|NCT02670538|587569812|FG000|Overall Study|Lack of Efficacy|7|||
162688419|NCT02670538|587569813|FG001|Overall Study|Lack of Efficacy|1|||
162688420|NCT02670538|587569814|FG002|Overall Study|Lack of Efficacy|2|||
162688421|NCT02670538|587569812|FG000|Overall Study|Protocol Violation|3|||
162688422|NCT02670538|587569813|FG001|Overall Study|Protocol Violation|4|||
162688423|NCT02670538|587569814|FG002|Overall Study|Protocol Violation|1|||
162688424|NCT02670538|587569812|FG000|Overall Study|Noncompliance with Study Drug|1|||
162688425|NCT02670538|587569813|FG001|Overall Study|Noncompliance with Study Drug|3|||
162688426|NCT02670538|587569814|FG002|Overall Study|Noncompliance with Study Drug|2|||
162688427|NCT02670538|587569812|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162688428|NCT02670538|587569813|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162688429|NCT02670538|587569814|FG002|Overall Study|Other Miscellaneous Reasons|2|||
162688430|NCT02243202|587569815|FG000|Overall Study|Adverse Event|5|||
162727503|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727504|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727505|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727506|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727507|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727508|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727509|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
162727510|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162727511|NCT02590432|587712419|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727512|NCT02590432|587712420|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727513|NCT02590432|587712421|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727514|NCT02590432|587712422|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727515|NCT02590432|587712423|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727516|NCT02590432|587712424|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727517|NCT02590432|587712425|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727518|NCT02590432|587712426|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
162727519|NCT02590432|587712427|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162727520|NCT04788641|587712428|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162727521|NCT04788641|587712429|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162727522|NCT04788641|587712430|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
162727523|NCT04788641|587712431|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162727524|NCT04788641|587712428|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
162727525|NCT04788641|587712429|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162727526|NCT04788641|587712430|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162727527|NCT04788641|587712431|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162727528|NCT04788641|587712428|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
162727529|NCT04788641|587712429|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
162727530|NCT04788641|587712430|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
162727531|NCT04788641|587712431|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
162727532|NCT01250769|587712432|FG000|Overall Study|Withdrawal by Subject|0|||
162727533|NCT01250769|587712433|FG001|Overall Study|Withdrawal by Subject|1|||
162727534|NCT01250769|587712434|FG002|Overall Study|Withdrawal by Subject|1|||
162727535|NCT01250769|587712435|FG003|Overall Study|Withdrawal by Subject|0|||
162727536|NCT01250769|587712432|FG000|Overall Study|Adverse Event|0|||
162727537|NCT01250769|587712433|FG001|Overall Study|Adverse Event|0|||
162727538|NCT01250769|587712434|FG002|Overall Study|Adverse Event|1|||
162727539|NCT01250769|587712435|FG003|Overall Study|Adverse Event|0|||
162727540|NCT03951805|587712440|FG000|Overall Study|Adverse Event|1|||
162727541|NCT03951805|587712441|FG001|Overall Study|Adverse Event|0|||
162727542|NCT03951805|587712442|FG002|Overall Study|Adverse Event|0|||
162727543|NCT03951805|587712443|FG003|Overall Study|Adverse Event|0|||
162727544|NCT01198145|587712446|FG000|Overall Study|Withdrawal by Subject|1|||
162727545|NCT01198145|587712447|FG001|Overall Study|Withdrawal by Subject|1|||
162727546|NCT02528188|587712448|FG000|Overall Study|Adverse Event|23|||
162727547|NCT02528188|587712449|FG001|Overall Study|Adverse Event|22|||
162727548|NCT02528188|587712450|FG002|Overall Study|Adverse Event|8|||
162727549|NCT02528188|587712448|FG000|Overall Study|Protocol Violation|4|||
162727550|NCT02528188|587712449|FG001|Overall Study|Protocol Violation|6|||
162727551|NCT02528188|587712450|FG002|Overall Study|Protocol Violation|4|||
162727552|NCT02528188|587712448|FG000|Overall Study|Lack of Efficacy|19|||
162727553|NCT02528188|587712449|FG001|Overall Study|Lack of Efficacy|21|||
162727554|NCT02528188|587712450|FG002|Overall Study|Lack of Efficacy|22|||
162727555|NCT02528188|587712448|FG000|Overall Study|Withdrawal by Subject|97|||
162727556|NCT02528188|587712449|FG001|Overall Study|Withdrawal by Subject|104|||
162727557|NCT02528188|587712450|FG002|Overall Study|Withdrawal by Subject|100|||
162727558|NCT02528188|587712448|FG000|Overall Study|Lost to Follow-up|25|||
162727559|NCT02528188|587712449|FG001|Overall Study|Lost to Follow-up|21|||
162727560|NCT02528188|587712450|FG002|Overall Study|Lost to Follow-up|31|||
162727561|NCT02528188|587712448|FG000|Overall Study|Death|4|||
162727562|NCT02528188|587712449|FG001|Overall Study|Death|4|||
162727563|NCT02528188|587712450|FG002|Overall Study|Death|0|||
162727564|NCT02528188|587712448|FG000|Overall Study|Other|89|||
162727565|NCT02528188|587712449|FG001|Overall Study|Other|91|||
162727566|NCT02528188|587712450|FG002|Overall Study|Other|74|||
162727567|NCT02528188|587712448|FG000|Overall Study|Randomized but not treated|6|||
162727568|NCT02528188|587712449|FG001|Overall Study|Randomized but not treated|7|||
162727569|NCT02528188|587712450|FG002|Overall Study|Randomized but not treated|12|||
162727570|NCT01239316|587712457|FG000|Overall Study|Progression/Relapse|11|||
162727571|NCT01239316|587712457|FG000|Overall Study|Adverse Event|1|||
162727572|NCT02299375|587712462|FG000|Overall Study|Adverse Event, serious fatal|1|||
162688431|NCT02243202|587569816|FG001|Overall Study|Adverse Event|6|||
162727573|NCT02299375|587712463|FG001|Overall Study|Adverse Event, serious fatal|3|||
162727574|NCT02299375|587712462|FG000|Overall Study|Adverse Event, non-fatal|8|||
162727575|NCT02299375|587712463|FG001|Overall Study|Adverse Event, non-fatal|9|||
162727576|NCT02299375|587712462|FG000|Overall Study|Lack of Efficacy|1|||
162727577|NCT02299375|587712463|FG001|Overall Study|Lack of Efficacy|3|||
162727578|NCT02299375|587712462|FG000|Overall Study|Protocol Violation|1|||
162727579|NCT02299375|587712463|FG001|Overall Study|Protocol Violation|3|||
162727580|NCT02299375|587712462|FG000|Overall Study|Other: Met stopping criteria|1|||
162727581|NCT02299375|587712463|FG001|Overall Study|Other: Met stopping criteria|0|||
162727582|NCT02299375|587712462|FG000|Overall Study|Other: Study closed/terminated|66|||
162727583|NCT02299375|587712463|FG001|Overall Study|Other: Study closed/terminated|55|||
162727584|NCT02299375|587712462|FG000|Overall Study|Lost to Follow-up|0|||
162727585|NCT02299375|587712463|FG001|Overall Study|Lost to Follow-up|2|||
162727586|NCT02299375|587712462|FG000|Overall Study|Physician Decision|1|||
162727587|NCT02299375|587712463|FG001|Overall Study|Physician Decision|1|||
162727588|NCT02299375|587712462|FG000|Overall Study|Withdrawal by Subject|1|||
162727589|NCT02299375|587712463|FG001|Overall Study|Withdrawal by Subject|4|||
162727590|NCT00704184|587712469|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
162688432|NCT02243202|587569817|FG002|Overall Study|Adverse Event|10|||
162688433|NCT02243202|587569818|FG003|Overall Study|Adverse Event|4|||
162688434|NCT02243202|587569815|FG000|Overall Study|Lost to Follow-up|9|||
162688435|NCT02243202|587569816|FG001|Overall Study|Lost to Follow-up|9|||
162688436|NCT02243202|587569817|FG002|Overall Study|Lost to Follow-up|14|||
162688437|NCT02243202|587569818|FG003|Overall Study|Lost to Follow-up|11|||
162688438|NCT02243202|587569815|FG000|Overall Study|Protocol Violation|3|||
162688439|NCT02243202|587569816|FG001|Overall Study|Protocol Violation|1|||
162688440|NCT02243202|587569817|FG002|Overall Study|Protocol Violation|2|||
162688441|NCT02243202|587569818|FG003|Overall Study|Protocol Violation|1|||
162688442|NCT02243202|587569815|FG000|Overall Study|Withdrawal by Subject|7|||
162688443|NCT02243202|587569816|FG001|Overall Study|Withdrawal by Subject|6|||
162688444|NCT02243202|587569817|FG002|Overall Study|Withdrawal by Subject|4|||
162688445|NCT02243202|587569818|FG003|Overall Study|Withdrawal by Subject|4|||
162688446|NCT02243202|587569815|FG000|Overall Study|Other|1|||
162688447|NCT02243202|587569816|FG001|Overall Study|Other|3|||
162688448|NCT02243202|587569817|FG002|Overall Study|Other|1|||
162688449|NCT02243202|587569818|FG003|Overall Study|Other|2|||
162688450|NCT02243202|587569815|FG000|Overall Study|Randomized but not received treatment|0|||
162688451|NCT02243202|587569816|FG001|Overall Study|Randomized but not received treatment|0|||
162688452|NCT02243202|587569817|FG002|Overall Study|Randomized but not received treatment|0|||
162688453|NCT02243202|587569818|FG003|Overall Study|Randomized but not received treatment|1|||
162688454|NCT02207725|587569822|FG000|Overall Study|Did Not Receive Treatment|0|||
162688455|NCT02207725|587569823|FG001|Overall Study|Did Not Receive Treatment|1|||
162688456|NCT02207725|587569824|FG002|Overall Study|Did Not Receive Treatment|1|||
162688457|NCT02207725|587569825|FG003|Overall Study|Did Not Receive Treatment|1|||
162688458|NCT00058422|587569829|FG000|Overall Study|Not treated|2|||
162688459|NCT00185640|587569830|FG000|Overall Study|Not Eligible|4|||
162688460|NCT00185640|587569830|FG000|Overall Study|Withdrawal by Subject|3|||
162688461|NCT00185640|587569830|FG000|Overall Study|Death|138|||
162688462|NCT00708435|587569833|FG000|Overall Study|Death / Serious Adverse Event|10|||
162688463|NCT00708435|587569834|FG001|Overall Study|Death / Serious Adverse Event|5|||
162688464|NCT00708435|587569833|FG000|Overall Study|Lost to Follow-up|9|||
162688465|NCT00708435|587569834|FG001|Overall Study|Lost to Follow-up|4|||
162688466|NCT00708435|587569833|FG000|Overall Study|Withdrawal by Subject|3|||
162688467|NCT00708435|587569834|FG001|Overall Study|Withdrawal by Subject|7|||
162688468|NCT00708435|587569833|FG000|Overall Study|Adverse Event|1|||
162688469|NCT00708435|587569834|FG001|Overall Study|Adverse Event|0|||
162688470|NCT00708435|587569833|FG000|Overall Study|Protocol Violation|0|||
162688471|NCT00708435|587569834|FG001|Overall Study|Protocol Violation|1|||
162688472|NCT00708435|587569833|FG000|Overall Study|Intervention by primary care physician|1|||
162688473|NCT00708435|587569834|FG001|Overall Study|Intervention by primary care physician|0|||
162688474|NCT00708435|587569833|FG000|Overall Study|Refused hospitalization|1|||
162727591|NCT00704184|587712470|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
162727592|NCT00704184|587712471|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
162688475|NCT00708435|587569834|FG001|Overall Study|Refused hospitalization|0|||
162688476|NCT04766086|587569835|FG000|Overall Study|Lost to Follow-up|3|||
162688477|NCT04766086|587569836|FG001|Overall Study|Lost to Follow-up|5|||
162688478|NCT04766086|587569837|FG002|Overall Study|Lost to Follow-up|3|||
162688479|NCT04766086|587569835|FG000|Overall Study|Withdrawal by Subject|1|||
162688480|NCT04766086|587569836|FG001|Overall Study|Withdrawal by Subject|1|||
162688481|NCT04766086|587569837|FG002|Overall Study|Withdrawal by Subject|2|||
162688482|NCT04766086|587569835|FG000|Overall Study|Other|0|||
162688483|NCT04766086|587569836|FG001|Overall Study|Other|0|||
162688484|NCT04766086|587569837|FG002|Overall Study|Other|1|||
162688485|NCT02635724|587569840|FG000|Overall Study|Withdrawal by Subject|0|||
162688486|NCT02635724|587569841|FG001|Overall Study|Withdrawal by Subject|1|||
162727593|NCT00704184|587712472|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
162688487|NCT02635724|587569842|FG002|Overall Study|Withdrawal by Subject|0|||
162688488|NCT03579290|587569843|FG000|Overall Study|Lost to Follow-up|9|||
162688489|NCT01674621|587569850|FG000|Overall Study|Adverse Event|3|||
162688490|NCT01674621|587569851|FG001|Overall Study|Adverse Event|2|||
162688491|NCT01674621|587569852|FG002|Overall Study|Adverse Event|5|||
162688492|NCT01674621|587569853|FG003|Overall Study|Adverse Event|5|||
162688493|NCT01674621|587569854|FG004|Overall Study|Adverse Event|1|||
162688494|NCT01674621|587569850|FG000|Overall Study|Inability to Complete Study Procedures|0|||
162688495|NCT01674621|587569851|FG001|Overall Study|Inability to Complete Study Procedures|0|||
162688496|NCT01674621|587569852|FG002|Overall Study|Inability to Complete Study Procedures|0|||
162688497|NCT01674621|587569853|FG003|Overall Study|Inability to Complete Study Procedures|0|||
162688498|NCT01674621|587569854|FG004|Overall Study|Inability to Complete Study Procedures|2|||
162688499|NCT01674621|587569850|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162688500|NCT01674621|587569851|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162688501|NCT01674621|587569852|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162688502|NCT01674621|587569853|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
162688503|NCT01674621|587569854|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162688504|NCT01674621|587569850|FG000|Overall Study|Withdrawal by Subject|2|||
162688505|NCT01674621|587569851|FG001|Overall Study|Withdrawal by Subject|5|||
162688506|NCT01674621|587569852|FG002|Overall Study|Withdrawal by Subject|2|||
162688507|NCT01674621|587569853|FG003|Overall Study|Withdrawal by Subject|0|||
162688508|NCT01674621|587569854|FG004|Overall Study|Withdrawal by Subject|1|||
162688509|NCT01674621|587569850|FG000|Overall Study|Other than specified|0|||
162688510|NCT01674621|587569851|FG001|Overall Study|Other than specified|1|||
162688511|NCT01674621|587569852|FG002|Overall Study|Other than specified|0|||
162688512|NCT01674621|587569853|FG003|Overall Study|Other than specified|0|||
162688513|NCT01674621|587569854|FG004|Overall Study|Other than specified|2|||
162688514|NCT01725386|587569855|FG000|Overall Study|Death|84|||
162688515|NCT01725386|587569856|FG001|Overall Study|Death|40|||
162688516|NCT01725386|587569855|FG000|Overall Study|Lost to Follow-up|81|||
162688517|NCT01725386|587569856|FG001|Overall Study|Lost to Follow-up|6|||
162688518|NCT01725386|587569855|FG000|Overall Study|Withdrawal by Subject|10|||
162688519|NCT01725386|587569856|FG001|Overall Study|Withdrawal by Subject|0|||
162688520|NCT01216163|587569861|FG000|Overall Study|Withdrawal by Subject|1|||
162688521|NCT01216163|587569862|FG001|Overall Study|Withdrawal by Subject|1|||
162688522|NCT01216163|587569863|FG002|Overall Study|Withdrawal by Subject|0|||
162688523|NCT02914314|587569864|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162688524|NCT02914314|587569865|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162688525|NCT02914314|587569866|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162688526|NCT02914314|587569867|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
162688527|NCT02914314|587569864|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162688528|NCT02914314|587569865|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162688529|NCT02914314|587569866|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162688530|NCT02914314|587569867|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
162688531|NCT02914314|587569864|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162688532|NCT02914314|587569865|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162688533|NCT02914314|587569866|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
162688534|NCT02914314|587569867|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162688535|NCT02914314|587569864|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162688536|NCT02914314|587569865|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162688537|NCT02914314|587569866|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
162688538|NCT02914314|587569867|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162688539|NCT02914314|587569864|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162688540|NCT02914314|587569865|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162688541|NCT02914314|587569866|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
162688542|NCT02914314|587569867|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162688543|NCT00532155|587569868|FG000|Overall Study|Adverse Event|66|||
162688544|NCT00532155|587569869|FG001|Overall Study|Adverse Event|123|||
162688545|NCT00532155|587569868|FG000|Overall Study|Lack of Efficacy|332|||
162688546|NCT00532155|587569869|FG001|Overall Study|Lack of Efficacy|255|||
162688547|NCT00532155|587569868|FG000|Overall Study|Protocol Violation|1|||
162688548|NCT00532155|587569869|FG001|Overall Study|Protocol Violation|3|||
162688549|NCT00532155|587569868|FG000|Overall Study|Lost to Follow-up|2|||
162688550|NCT00532155|587569869|FG001|Overall Study|Lost to Follow-up|0|||
162688551|NCT00532155|587569868|FG000|Overall Study|Physician Decision|16|||
162688552|NCT00532155|587569869|FG001|Overall Study|Physician Decision|15|||
162688553|NCT00532155|587569868|FG000|Overall Study|Withdrawal by Subject|23|||
162688554|NCT00532155|587569869|FG001|Overall Study|Withdrawal by Subject|44|||
162688555|NCT00532155|587569868|FG000|Overall Study|Consent withdrawn|5|||
162688556|NCT00532155|587569869|FG001|Overall Study|Consent withdrawn|7|||
162688557|NCT00532155|587569868|FG000|Overall Study|Moved|1|||
162688558|NCT00532155|587569869|FG001|Overall Study|Moved|0|||
162688559|NCT00532155|587569868|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
162688560|NCT00532155|587569869|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
162688561|NCT00532155|587569868|FG000|Overall Study|Occurence of a second cancer|0|||
162688562|NCT00532155|587569869|FG001|Overall Study|Occurence of a second cancer|1|||
162688563|NCT00532155|587569868|FG000|Overall Study|Occurence of a secondary cancer|0|||
162688564|NCT00532155|587569869|FG001|Overall Study|Occurence of a secondary cancer|1|||
162688565|NCT00532155|587569868|FG000|Overall Study|Promotor ended study|1|||
162688566|NCT00532155|587569869|FG001|Overall Study|Promotor ended study|0|||
162688567|NCT00532155|587569868|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
162688568|NCT00532155|587569869|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
162688569|NCT00532155|587569868|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
162688570|NCT00532155|587569869|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
162688571|NCT00532155|587569868|FG000|Overall Study|Study stopped|1|||
162688572|NCT00532155|587569869|FG001|Overall Study|Study stopped|0|||
162688573|NCT00532155|587569868|FG000|Overall Study|Study terminated by sponsor|1|||
162688574|NCT00532155|587569869|FG001|Overall Study|Study terminated by sponsor|0|||
162688575|NCT00532155|587569868|FG000|Overall Study|Study termination stop further treatment|4|||
162688576|NCT00532155|587569869|FG001|Overall Study|Study termination stop further treatment|0|||
162688577|NCT00532155|587569868|FG000|Overall Study|Did not receive study medication|2|||
162688578|NCT00532155|587569869|FG001|Overall Study|Did not receive study medication|6|||
162688579|NCT03483038|587569870|FG000|Overall Study|Subjects still in follow-up|18|||
162688580|NCT00654901|587569871|FG000|Overall Study|Lost to Follow-up|1|||
162688581|NCT00654901|587569872|FG001|Overall Study|Lost to Follow-up|0|||
162688582|NCT00654901|587569873|FG002|Overall Study|Lost to Follow-up|1|||
162688583|NCT00654901|587569874|FG003|Overall Study|Lost to Follow-up|0|||
162688584|NCT00654901|587569871|FG000|Overall Study|Withdrawal by Subject|3|||
162688585|NCT00654901|587569872|FG001|Overall Study|Withdrawal by Subject|0|||
162688586|NCT00654901|587569873|FG002|Overall Study|Withdrawal by Subject|1|||
162688587|NCT00654901|587569874|FG003|Overall Study|Withdrawal by Subject|0|||
162688588|NCT04843930|587569876|FG000|Randomization|Withdrawal by Subject|6|||
162688589|NCT04843930|587569877|FG001|Randomization|Withdrawal by Subject|6|||
162688590|NCT04843930|587569878|FG002|Randomization|Withdrawal by Subject|0|||
162688591|NCT04843930|587569879|FG003|Randomization|Withdrawal by Subject|0|||
162688592|NCT04843930|587569876|FG000|Week 6 Assessment|Adverse Event|3|||
162688593|NCT04843930|587569877|FG001|Week 6 Assessment|Adverse Event|0|||
162688594|NCT04843930|587569878|FG002|Week 6 Assessment|Adverse Event|0|||
162688595|NCT04843930|587569879|FG003|Week 6 Assessment|Adverse Event|0|||
162688596|NCT04843930|587569876|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
162688597|NCT04843930|587569877|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
162688598|NCT04843930|587569878|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
162688599|NCT04843930|587569879|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
162688600|NCT04843930|587569876|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
162688601|NCT04843930|587569877|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
162688602|NCT04843930|587569878|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
162688603|NCT04843930|587569879|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
162688604|NCT02552238|587569880|FG000|Overall Study|Withdrawal by Subject|2|||
162688605|NCT02552238|587569880|FG000|Overall Study|Adverse Event|2|||
162688606|NCT01576718|587569881|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
162688607|NCT01576718|587569882|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688608|NCT01576718|587569883|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688609|NCT01576718|587569884|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688610|NCT01576718|587569885|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688611|NCT01576718|587569886|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688612|NCT01576718|587569887|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162688613|NCT01576718|587569881|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
162688614|NCT01576718|587569882|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688615|NCT01576718|587569883|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688616|NCT01576718|587569884|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688617|NCT01576718|587569885|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688618|NCT01576718|587569886|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688619|NCT01576718|587569887|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162688620|NCT01576718|587569881|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
162688621|NCT01576718|587569882|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688622|NCT01576718|587569883|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688623|NCT01576718|587569884|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688624|NCT01576718|587569885|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688625|NCT01576718|587569886|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688626|NCT01576718|587569887|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162688627|NCT01576718|587569881|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
162688628|NCT01576718|587569882|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688629|NCT01576718|587569883|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688630|NCT01576718|587569884|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688631|NCT01576718|587569885|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688632|NCT01576718|587569886|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688633|NCT01576718|587569887|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162688634|NCT01576718|587569881|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
162688635|NCT01576718|587569882|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688636|NCT01576718|587569883|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688637|NCT01576718|587569884|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688638|NCT01576718|587569885|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688639|NCT01576718|587569886|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688640|NCT01576718|587569887|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162688641|NCT01576718|587569881|FG000|Treatment Period|Adverse Event|0|||
162688642|NCT01576718|587569882|FG001|Treatment Period|Adverse Event|1|||
162688643|NCT01576718|587569883|FG002|Treatment Period|Adverse Event|1|||
162688644|NCT01576718|587569884|FG003|Treatment Period|Adverse Event|1|||
162688645|NCT01576718|587569885|FG004|Treatment Period|Adverse Event|1|||
162688646|NCT01576718|587569886|FG005|Treatment Period|Adverse Event|1|||
162688647|NCT01576718|587569887|FG006|Treatment Period|Adverse Event|0|||
162688648|NCT01576718|587569881|FG000|Treatment Period|Withdrawal by Subject|0|||
162688649|NCT01576718|587569882|FG001|Treatment Period|Withdrawal by Subject|1|||
162688650|NCT01576718|587569883|FG002|Treatment Period|Withdrawal by Subject|1|||
162688651|NCT01576718|587569884|FG003|Treatment Period|Withdrawal by Subject|0|||
162688652|NCT01576718|587569885|FG004|Treatment Period|Withdrawal by Subject|2|||
162688653|NCT01576718|587569886|FG005|Treatment Period|Withdrawal by Subject|4|||
162688654|NCT01576718|587569887|FG006|Treatment Period|Withdrawal by Subject|2|||
162688655|NCT01576718|587569881|FG000|Treatment Period|Physician Decision|0|||
162688656|NCT01576718|587569882|FG001|Treatment Period|Physician Decision|1|||
162688657|NCT01576718|587569883|FG002|Treatment Period|Physician Decision|1|||
162688658|NCT01576718|587569884|FG003|Treatment Period|Physician Decision|1|||
162688659|NCT01576718|587569885|FG004|Treatment Period|Physician Decision|1|||
162688660|NCT01576718|587569886|FG005|Treatment Period|Physician Decision|0|||
162688661|NCT01576718|587569887|FG006|Treatment Period|Physician Decision|0|||
162688662|NCT01576718|587569881|FG000|Treatment Period|Protocol Violation|0|||
162688663|NCT01576718|587569882|FG001|Treatment Period|Protocol Violation|5|||
162688664|NCT01576718|587569883|FG002|Treatment Period|Protocol Violation|4|||
162688665|NCT01576718|587569884|FG003|Treatment Period|Protocol Violation|10|||
162688666|NCT01576718|587569885|FG004|Treatment Period|Protocol Violation|6|||
162688667|NCT01576718|587569886|FG005|Treatment Period|Protocol Violation|8|||
162688668|NCT01576718|587569887|FG006|Treatment Period|Protocol Violation|12|||
162688669|NCT01576718|587569881|FG000|Treatment Period|Sponsor request|0|||
162688670|NCT01576718|587569882|FG001|Treatment Period|Sponsor request|1|||
162688671|NCT01576718|587569883|FG002|Treatment Period|Sponsor request|0|||
162688672|NCT01576718|587569884|FG003|Treatment Period|Sponsor request|0|||
162688673|NCT01576718|587569885|FG004|Treatment Period|Sponsor request|0|||
162688674|NCT01576718|587569886|FG005|Treatment Period|Sponsor request|1|||
162688675|NCT01576718|587569887|FG006|Treatment Period|Sponsor request|0|||
162688676|NCT01576718|587569881|FG000|Treatment Period|Met stopping criteria|0|||
162688677|NCT01576718|587569882|FG001|Treatment Period|Met stopping criteria|16|||
162688678|NCT01576718|587569883|FG002|Treatment Period|Met stopping criteria|13|||
162688679|NCT01576718|587569884|FG003|Treatment Period|Met stopping criteria|19|||
162688680|NCT01576718|587569885|FG004|Treatment Period|Met stopping criteria|16|||
162688681|NCT01576718|587569886|FG005|Treatment Period|Met stopping criteria|33|||
162688682|NCT01576718|587569887|FG006|Treatment Period|Met stopping criteria|15|||
162688683|NCT01576718|587569881|FG000|Treatment Period|Lost to Follow-up|0|||
162688684|NCT01576718|587569882|FG001|Treatment Period|Lost to Follow-up|0|||
162688685|NCT01576718|587569883|FG002|Treatment Period|Lost to Follow-up|0|||
162688686|NCT01576718|587569884|FG003|Treatment Period|Lost to Follow-up|0|||
162688687|NCT01576718|587569885|FG004|Treatment Period|Lost to Follow-up|1|||
162688688|NCT01576718|587569886|FG005|Treatment Period|Lost to Follow-up|0|||
162688689|NCT01576718|587569887|FG006|Treatment Period|Lost to Follow-up|0|||
162688690|NCT01576718|587569881|FG000|Treatment Period|Noncompliance to study medication|0|||
162688691|NCT01576718|587569882|FG001|Treatment Period|Noncompliance to study medication|0|||
162688692|NCT01576718|587569883|FG002|Treatment Period|Noncompliance to study medication|0|||
162688693|NCT01576718|587569884|FG003|Treatment Period|Noncompliance to study medication|0|||
162688694|NCT01576718|587569885|FG004|Treatment Period|Noncompliance to study medication|0|||
162688695|NCT01576718|587569886|FG005|Treatment Period|Noncompliance to study medication|1|||
162688696|NCT01576718|587569887|FG006|Treatment Period|Noncompliance to study medication|1|||
162688697|NCT04631705|587569888|FG000|Overall Study|Withdrawal by Subject|0|||
162688698|NCT04631705|587569889|FG001|Overall Study|Withdrawal by Subject|0|||
162688699|NCT04631705|587569890|FG002|Overall Study|Withdrawal by Subject|0|||
162688700|NCT04631705|587569891|FG003|Overall Study|Withdrawal by Subject|0|||
162688701|NCT04631705|587569892|FG004|Overall Study|Withdrawal by Subject|0|||
162727594|NCT00704184|587712473|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
162727595|NCT00704184|587712469|FG000|Open-Label Treatment|Adverse Event|0|||
162727596|NCT00704184|587712470|FG001|Open-Label Treatment|Adverse Event|0|||
162727597|NCT00704184|587712471|FG002|Open-Label Treatment|Adverse Event|2|||
162727598|NCT00704184|587712472|FG003|Open-Label Treatment|Adverse Event|0|||
162727599|NCT00704184|587712473|FG004|Open-Label Treatment|Adverse Event|1|||
162727600|NCT00704184|587712469|FG000|Open-Label Treatment|Lack of Efficacy|0|||
162727601|NCT00704184|587712470|FG001|Open-Label Treatment|Lack of Efficacy|2|||
162727602|NCT00704184|587712471|FG002|Open-Label Treatment|Lack of Efficacy|2|||
162727603|NCT00704184|587712472|FG003|Open-Label Treatment|Lack of Efficacy|2|||
162727604|NCT00704184|587712473|FG004|Open-Label Treatment|Lack of Efficacy|1|||
162727605|NCT00704184|587712469|FG000|Open-Label Treatment|Physician Decision|0|||
162727606|NCT00704184|587712470|FG001|Open-Label Treatment|Physician Decision|0|||
162727607|NCT00704184|587712471|FG002|Open-Label Treatment|Physician Decision|0|||
162727608|NCT00704184|587712472|FG003|Open-Label Treatment|Physician Decision|0|||
162727609|NCT00704184|587712473|FG004|Open-Label Treatment|Physician Decision|1|||
162727610|NCT00704184|587712469|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
162727611|NCT00704184|587712470|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
162727612|NCT00704184|587712471|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
162727613|NCT00704184|587712472|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
162727614|NCT00704184|587712473|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
162727615|NCT00716859|587712476|FG000|Overall Study|Adverse Event|4|||
162727616|NCT00716859|587712477|FG001|Overall Study|Adverse Event|1|||
162727617|NCT00716859|587712476|FG000|Overall Study|Lack of Efficacy|3|||
162727618|NCT00716859|587712477|FG001|Overall Study|Lack of Efficacy|0|||
162727619|NCT00716859|587712476|FG000|Overall Study|Withdrawal by Subject|1|||
162727620|NCT00716859|587712477|FG001|Overall Study|Withdrawal by Subject|3|||
162727621|NCT00716859|587712476|FG000|Overall Study|Not treated|1|||
162727622|NCT00716859|587712477|FG001|Overall Study|Not treated|1|||
162727623|NCT02178098|587712478|FG000|Overall Study|Withdrawal by Subject|0|||
162727624|NCT02178098|587712479|FG001|Overall Study|Withdrawal by Subject|6|||
162727625|NCT02178098|587712478|FG000|Overall Study|Adverse Event|1|||
162727626|NCT02178098|587712479|FG001|Overall Study|Adverse Event|2|||
162727627|NCT02178098|587712478|FG000|Overall Study|Protocol Violation|1|||
162727628|NCT02178098|587712479|FG001|Overall Study|Protocol Violation|1|||
162727629|NCT02178098|587712478|FG000|Overall Study|Lost to Follow-up|0|||
162727630|NCT02178098|587712479|FG001|Overall Study|Lost to Follow-up|1|||
162727631|NCT02178098|587712478|FG000|Overall Study|Sponsor Request|1|||
162727632|NCT02178098|587712479|FG001|Overall Study|Sponsor Request|0|||
162727633|NCT02178098|587712478|FG000|Overall Study|Other|2|||
162727634|NCT02178098|587712479|FG001|Overall Study|Other|2|||
162727635|NCT01109524|587712485|FG000|Overall Study|Disease Progression|29|||
162727636|NCT01109524|587712485|FG000|Overall Study|Study Drug toxicity|6|||
162727637|NCT01109524|587712485|FG000|Overall Study|Adverse Event|4|||
162727638|NCT01109524|587712485|FG000|Overall Study|Withdrawal by Subject|2|||
162727639|NCT01109524|587712485|FG000|Overall Study|Maximum clinical benefit|3|||
162727640|NCT01109524|587712485|FG000|Overall Study|Death|2|||
162727641|NCT01109524|587712485|FG000|Overall Study|No longer meets criteria|2|||
162727642|NCT01109524|587712485|FG000|Overall Study|Participant requested to end treatment|4|||
162727643|NCT01109524|587712485|FG000|Overall Study|Other|5|||
162727644|NCT00411216|587712486|FG000|Overall Study|Ten participants were entered into the c|0|||
162727645|NCT00411216|587712487|FG001|Overall Study|Ten participants were entered into the c|2|||
162727646|NCT01205048|587712488|FG000|Overall Study|Withdrawal by Subject|14|||
162727647|NCT01205048|587712488|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
162727648|NCT01205048|587712488|FG000|Overall Study|Lost to Follow-up|4|||
162727649|NCT01205048|587712488|FG000|Overall Study|Other|2|||
162727650|NCT00823472|587712489|FG000|Overall Study|Physician Decision|24|||
162727651|NCT00823472|587712490|FG001|Overall Study|Physician Decision|28|||
162727652|NCT02769858|587712504|FG000|Overall Study|Withdrawal by Subject|2|||
162727653|NCT04939246|587712505|FG000|After Treatment|Death|4|||
162727654|NCT04939246|587712505|FG000|After Treatment|Lost to Follow-up|1|||
162727655|NCT04939246|587712505|FG000|After Treatment|Discharged to hospice|2|||
162727656|NCT01853748|587714806|FG000|Allocation|Withdrawal by Subject|1|||
162727657|NCT01853748|587714807|FG001|Allocation|Withdrawal by Subject|13|||
162727658|NCT01853748|587714806|FG000|Allocation|not sufficient to receive intervention|0|||
162727659|NCT01853748|587714807|FG001|Allocation|not sufficient to receive intervention|1|||
162727660|NCT01853748|587714806|FG000|Follow-Up|Withdrawal by Subject|7|||
162727661|NCT01853748|587714807|FG001|Follow-Up|Withdrawal by Subject|6|||
162727662|NCT01853748|587714806|FG000|Follow-Up|Adverse Event|67|||
162727663|NCT01853748|587714807|FG001|Follow-Up|Adverse Event|7|||
162727664|NCT01853748|587714806|FG000|Follow-Up|not available for data collection|16|||
162727665|NCT01853748|587714807|FG001|Follow-Up|not available for data collection|4|||
162727666|NCT00780416|587714812|FG000|Overall Study|Physician Decision|3|||
162727667|NCT00780416|587714813|FG001|Overall Study|Physician Decision|3|||
162727668|NCT00780416|587714812|FG000|Overall Study|Protocol Violation|1|||
162727669|NCT00780416|587714813|FG001|Overall Study|Protocol Violation|0|||
162727670|NCT00780416|587714812|FG000|Overall Study|Withdrawal by Subject|8|||
162727671|NCT00780416|587714813|FG001|Overall Study|Withdrawal by Subject|6|||
162727672|NCT02916706|587714814|FG000|Overall Study|Adverse Event|0|||
162727673|NCT02916706|587714815|FG001|Overall Study|Adverse Event|1|||
162727674|NCT02916706|587714814|FG000|Overall Study|Lost to Follow-up|0|||
162727675|NCT02916706|587714815|FG001|Overall Study|Lost to Follow-up|1|||
162727676|NCT02916706|587714814|FG000|Overall Study|Physician Decision|1|||
162727677|NCT02916706|587714815|FG001|Overall Study|Physician Decision|0|||
162727678|NCT02916706|587714814|FG000|Overall Study|Protocol Violation|3|||
162727679|NCT02916706|587714815|FG001|Overall Study|Protocol Violation|1|||
162727680|NCT02916706|587714814|FG000|Overall Study|Withdrawal by Subject|6|||
162727681|NCT02916706|587714815|FG001|Overall Study|Withdrawal by Subject|9|||
162727682|NCT02916706|587714814|FG000|Overall Study|Other|5|||
162727683|NCT02916706|587714815|FG001|Overall Study|Other|19|||
162727684|NCT02723955|587714816|FG000|Escalation Phase|Death|1|||
162727685|NCT02723955|587714817|FG001|Escalation Phase|Death|1|||
162727686|NCT02723955|587714818|FG002|Escalation Phase|Death|2|||
162727687|NCT02723955|587714819|FG003|Escalation Phase|Death|7|||
162727688|NCT02723955|587714820|FG004|Escalation Phase|Death|18|||
162727689|NCT02723955|587714821|FG005|Escalation Phase|Death|17|||
162727690|NCT02723955|587714822|FG006|Escalation Phase|Death|11|||
162727691|NCT02723955|587714823|FG007|Escalation Phase|Death|21|||
162727692|NCT02723955|587714824|FG008|Escalation Phase|Death|3|||
162727693|NCT02723955|587714825|FG009|Escalation Phase|Death|0|||
162727694|NCT02723955|587714826|FG010|Escalation Phase|Death|0|||
162727695|NCT02723955|587714827|FG011|Escalation Phase|Death|0|||
162727696|NCT02723955|587714828|FG012|Escalation Phase|Death|2|||
162727697|NCT02723955|587714829|FG013|Escalation Phase|Death|4|||
162727698|NCT02723955|587714830|FG014|Escalation Phase|Death|5|||
162727699|NCT02723955|587714831|FG015|Escalation Phase|Death|6|||
162727700|NCT02723955|587714832|FG016|Escalation Phase|Death|6|||
162727701|NCT02723955|587714833|FG017|Escalation Phase|Death|7|||
162727702|NCT02723955|587714834|FG018|Escalation Phase|Death|1|||
162727703|NCT02723955|587714835|FG019|Escalation Phase|Death|3|||
162727704|NCT02723955|587714836|FG020|Escalation Phase|Death|13|||
162727705|NCT02723955|587714837|FG021|Escalation Phase|Death|3|||
162727706|NCT02723955|587714838|FG022|Escalation Phase|Death|2|||
162727707|NCT02723955|587714839|FG023|Escalation Phase|Death|4|||
162727708|NCT02723955|587714840|FG024|Escalation Phase|Death|31|||
162727709|NCT02723955|587714841|FG025|Escalation Phase|Death|7|||
162727710|NCT02723955|587714842|FG026|Escalation Phase|Death|13|||
162727711|NCT02723955|587714843|FG027|Escalation Phase|Death|0|||
162727712|NCT02723955|587714844|FG028|Escalation Phase|Death|1|||
162727713|NCT02723955|587714845|FG029|Escalation Phase|Death|0|||
162727714|NCT02723955|587714846|FG030|Escalation Phase|Death|0|||
162727715|NCT02723955|587714847|FG031|Escalation Phase|Death|0|||
162727716|NCT02723955|587714848|FG032|Escalation Phase|Death|0|||
162727717|NCT02723955|587714849|FG033|Escalation Phase|Death|0|||
162727718|NCT02723955|587714850|FG034|Escalation Phase|Death|0|||
162688702|NCT04631705|587569893|FG005|Overall Study|Withdrawal by Subject|0|||
162688703|NCT04631705|587569894|FG006|Overall Study|Withdrawal by Subject|1|||
162688704|NCT04631705|587569895|FG007|Overall Study|Withdrawal by Subject|0|||
162688705|NCT04631705|587569896|FG008|Overall Study|Withdrawal by Subject|0|||
162688706|NCT02070484|587569902|FG000|Overall Study|Withdrawal by Subject|1|||
162688707|NCT02070484|587569903|FG001|Overall Study|Withdrawal by Subject|0|||
162688708|NCT01521884|587569904|FG000|Overall Study|Non Responders|10|||
162688709|NCT01521884|587569904|FG000|Overall Study|Adverse Event|5|||
162688710|NCT01521884|587569904|FG000|Overall Study|Pregnancy|1|||
162688711|NCT01521884|587569904|FG000|Overall Study|Withdrawal by Subject|1|||
162688712|NCT01521884|587569904|FG000|Overall Study|Physician Decision|2|||
162688713|NCT01521884|587569904|FG000|Overall Study|Protocol Violation|3|||
162688714|NCT01521884|587569904|FG000|Overall Study|Participant non-eligible|1|||
162688715|NCT01521884|587569904|FG000|Overall Study|Lost to Follow-up|4|||
162688716|NCT02821819|587569905|FG000|Overall Study|Protocol Violation|1|||
162688717|NCT04241094|587569906|FG000|Overall Study|Dropped out of treatment|4|||
162688718|NCT04241094|587569906|FG000|Overall Study|Ineligible after clinical assessment|2|||
162688719|NCT04241094|587569906|FG000|Overall Study|Lost to Follow-up|2|||
162688720|NCT02332590|587569907|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
162688721|NCT02332590|587569908|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
162688722|NCT02332590|587569907|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
162688723|NCT02332590|587569908|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
162688724|NCT02332590|587569907|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
162688725|NCT02332590|587569908|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
162688726|NCT02332590|587569907|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
162688727|NCT02332590|587569908|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
162688728|NCT02332590|587569907|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
162727719|NCT02723955|587714851|FG035|Escalation Phase|Death|0|||
162727720|NCT02723955|587714852|FG036|Escalation Phase|Death|0|||
162727721|NCT02723955|587714853|FG037|Escalation Phase|Death|0|||
162727722|NCT02723955|587714854|FG038|Escalation Phase|Death|0|||
162727723|NCT02723955|587714855|FG039|Escalation Phase|Death|0|||
162727724|NCT02723955|587714856|FG040|Escalation Phase|Death|0|||
162727725|NCT02723955|587714857|FG041|Escalation Phase|Death|0|||
162727726|NCT02723955|587714858|FG042|Escalation Phase|Death|0|||
162727727|NCT02723955|587714816|FG000|Escalation Phase|Lost to Follow-up|0|||
162727728|NCT02723955|587714817|FG001|Escalation Phase|Lost to Follow-up|0|||
162727729|NCT02723955|587714818|FG002|Escalation Phase|Lost to Follow-up|0|||
162727730|NCT02723955|587714819|FG003|Escalation Phase|Lost to Follow-up|0|||
162727731|NCT02723955|587714820|FG004|Escalation Phase|Lost to Follow-up|0|||
162727732|NCT02723955|587714821|FG005|Escalation Phase|Lost to Follow-up|2|||
162727733|NCT02723955|587714822|FG006|Escalation Phase|Lost to Follow-up|1|||
162727734|NCT02723955|587714823|FG007|Escalation Phase|Lost to Follow-up|1|||
162727735|NCT02723955|587714824|FG008|Escalation Phase|Lost to Follow-up|1|||
162727736|NCT02723955|587714825|FG009|Escalation Phase|Lost to Follow-up|0|||
162727737|NCT02723955|587714826|FG010|Escalation Phase|Lost to Follow-up|0|||
162727738|NCT02723955|587714827|FG011|Escalation Phase|Lost to Follow-up|0|||
162727739|NCT02723955|587714828|FG012|Escalation Phase|Lost to Follow-up|1|||
162727740|NCT02723955|587714829|FG013|Escalation Phase|Lost to Follow-up|0|||
162727741|NCT02723955|587714830|FG014|Escalation Phase|Lost to Follow-up|0|||
162727742|NCT02723955|587714831|FG015|Escalation Phase|Lost to Follow-up|0|||
162727743|NCT02723955|587714832|FG016|Escalation Phase|Lost to Follow-up|1|||
162727744|NCT02723955|587714833|FG017|Escalation Phase|Lost to Follow-up|2|||
162727745|NCT02723955|587714834|FG018|Escalation Phase|Lost to Follow-up|0|||
162727746|NCT02723955|587714835|FG019|Escalation Phase|Lost to Follow-up|1|||
162727747|NCT02723955|587714836|FG020|Escalation Phase|Lost to Follow-up|2|||
162727748|NCT02723955|587714837|FG021|Escalation Phase|Lost to Follow-up|1|||
162727749|NCT02723955|587714838|FG022|Escalation Phase|Lost to Follow-up|0|||
162727750|NCT02723955|587714839|FG023|Escalation Phase|Lost to Follow-up|0|||
162727751|NCT02723955|587714840|FG024|Escalation Phase|Lost to Follow-up|1|||
162727752|NCT02723955|587714841|FG025|Escalation Phase|Lost to Follow-up|1|||
162727753|NCT02723955|587714842|FG026|Escalation Phase|Lost to Follow-up|3|||
162727754|NCT02723955|587714843|FG027|Escalation Phase|Lost to Follow-up|0|||
162727755|NCT02723955|587714844|FG028|Escalation Phase|Lost to Follow-up|1|||
162727756|NCT02723955|587714845|FG029|Escalation Phase|Lost to Follow-up|0|||
162727757|NCT02723955|587714846|FG030|Escalation Phase|Lost to Follow-up|0|||
162727758|NCT02723955|587714847|FG031|Escalation Phase|Lost to Follow-up|0|||
162727759|NCT02723955|587714848|FG032|Escalation Phase|Lost to Follow-up|0|||
162727760|NCT02723955|587714849|FG033|Escalation Phase|Lost to Follow-up|0|||
162727761|NCT02723955|587714850|FG034|Escalation Phase|Lost to Follow-up|0|||
162727762|NCT02723955|587714851|FG035|Escalation Phase|Lost to Follow-up|0|||
162727763|NCT02723955|587714852|FG036|Escalation Phase|Lost to Follow-up|0|||
162727764|NCT02723955|587714853|FG037|Escalation Phase|Lost to Follow-up|0|||
162727765|NCT02723955|587714854|FG038|Escalation Phase|Lost to Follow-up|0|||
162727766|NCT02723955|587714855|FG039|Escalation Phase|Lost to Follow-up|0|||
162727767|NCT02723955|587714856|FG040|Escalation Phase|Lost to Follow-up|0|||
162727768|NCT02723955|587714857|FG041|Escalation Phase|Lost to Follow-up|0|||
162727769|NCT02723955|587714858|FG042|Escalation Phase|Lost to Follow-up|0|||
162727770|NCT02723955|587714816|FG000|Escalation Phase|Physician Decision|0|||
162727771|NCT02723955|587714817|FG001|Escalation Phase|Physician Decision|0|||
162727772|NCT02723955|587714818|FG002|Escalation Phase|Physician Decision|0|||
162727773|NCT02723955|587714819|FG003|Escalation Phase|Physician Decision|0|||
162727774|NCT02723955|587714820|FG004|Escalation Phase|Physician Decision|0|||
162727775|NCT02723955|587714821|FG005|Escalation Phase|Physician Decision|2|||
162727776|NCT02723955|587714822|FG006|Escalation Phase|Physician Decision|0|||
162727777|NCT02723955|587714823|FG007|Escalation Phase|Physician Decision|0|||
162727778|NCT02723955|587714824|FG008|Escalation Phase|Physician Decision|0|||
162727779|NCT02723955|587714825|FG009|Escalation Phase|Physician Decision|0|||
162727780|NCT02723955|587714826|FG010|Escalation Phase|Physician Decision|0|||
162727781|NCT02723955|587714827|FG011|Escalation Phase|Physician Decision|0|||
162688729|NCT02332590|587569908|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
162688730|NCT02332590|587569907|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
162688731|NCT02332590|587569908|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
162688732|NCT02332590|587569907|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
162688733|NCT02332590|587569908|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
162688734|NCT02332590|587569907|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
162688735|NCT02332590|587569908|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
162688736|NCT02332590|587569907|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
162688737|NCT02332590|587569908|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
162727782|NCT02723955|587714828|FG012|Escalation Phase|Physician Decision|0|||
162727783|NCT02723955|587714829|FG013|Escalation Phase|Physician Decision|0|||
162727784|NCT02723955|587714830|FG014|Escalation Phase|Physician Decision|0|||
162727785|NCT02723955|587714831|FG015|Escalation Phase|Physician Decision|0|||
162727786|NCT02723955|587714832|FG016|Escalation Phase|Physician Decision|0|||
162727787|NCT02723955|587714833|FG017|Escalation Phase|Physician Decision|0|||
162727788|NCT02723955|587714834|FG018|Escalation Phase|Physician Decision|0|||
162727789|NCT02723955|587714835|FG019|Escalation Phase|Physician Decision|0|||
162727790|NCT02723955|587714836|FG020|Escalation Phase|Physician Decision|0|||
162688738|NCT04225988|587569910|FG000|Overall Study|Withdrawal by Subject|2|||
162688739|NCT04225988|587569911|FG001|Overall Study|Withdrawal by Subject|0|||
162688740|NCT05619003|587569913|FG000|Overall Study|Adverse Event|1|||
162688741|NCT02272725|587569918|FG000|Overall Study|equipment malfunction|2|||
162688742|NCT02272725|587569919|FG001|Overall Study|equipment malfunction|0|||
162688743|NCT07018999|587569920|FG000|Overall Study|Protocol Violation|0|||
162688744|NCT07018999|587569921|FG001|Overall Study|Protocol Violation|1|||
162688745|NCT07018999|587569920|FG000|Overall Study|Incomplete data entry|4|||
162688746|NCT07018999|587569921|FG001|Overall Study|Incomplete data entry|7|||
162688747|NCT04739761|587569924|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
162688748|NCT04739761|587569925|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
162688749|NCT04739761|587569924|FG000|Overall Study|By complete response from the participant|1|||
162688750|NCT04739761|587569925|FG001|Overall Study|By complete response from the participant|0|||
162688751|NCT04739761|587569924|FG000|Overall Study|Lost to Follow-up|3|||
162688752|NCT04739761|587569925|FG001|Overall Study|Lost to Follow-up|3|||
162688753|NCT04739761|587569924|FG000|Overall Study|Death|13|||
162688754|NCT04739761|587569925|FG001|Overall Study|Death|13|||
162688755|NCT04739761|587569924|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
162688756|NCT04739761|587569925|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
162688757|NCT04739761|587569924|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
162688758|NCT04739761|587569925|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
162688759|NCT04739761|587569924|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
162688760|NCT04739761|587569925|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
162688761|NCT04739761|587569924|FG000|Overall Study|Adverse Event|0|||
162688762|NCT04739761|587569925|FG001|Overall Study|Adverse Event|3|||
162688763|NCT04739761|587569924|FG000|Overall Study|Participant decision|1|||
162688764|NCT04739761|587569925|FG001|Overall Study|Participant decision|0|||
162688765|NCT04739761|587569924|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
162688766|NCT04739761|587569925|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
162688767|NCT04739761|587569924|FG000|Overall Study|Participant immediately started next line of treatment|1|||
162688768|NCT04739761|587569925|FG001|Overall Study|Participant immediately started next line of treatment|0|||
162688769|NCT04739761|587569924|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
162688770|NCT04739761|587569925|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
162688771|NCT04739761|587569924|FG000|Overall Study|Lack of clinical benefit|1|||
162688772|NCT04739761|587569925|FG001|Overall Study|Lack of clinical benefit|0|||
162688773|NCT04739761|587569924|FG000|Overall Study|Disease progression|5|||
162688774|NCT04739761|587569925|FG001|Overall Study|Disease progression|5|||
162688775|NCT04739761|587569924|FG000|Overall Study|Withdrawal by Subject|14|||
162688776|NCT04739761|587569925|FG001|Overall Study|Withdrawal by Subject|13|||
162688777|NCT04739761|587569924|FG000|Overall Study|Protocol Violation|1|||
162688778|NCT04739761|587569925|FG001|Overall Study|Protocol Violation|0|||
162688779|NCT04739761|587569924|FG000|Overall Study|Physician Decision|2|||
162688780|NCT04739761|587569925|FG001|Overall Study|Physician Decision|0|||
162688781|NCT02764775|587572004|FG000|Overall Study|Death|1|||
162688782|NCT02764775|587572004|FG000|Overall Study|Lost to Follow-up|2|||
162688783|NCT02764775|587572004|FG000|Overall Study|Withdrawal by Subject|3|||
162688784|NCT00975221|587572005|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
162688785|NCT00975221|587572006|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
162688786|NCT00975221|587572005|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
162688787|NCT00975221|587572006|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
162688788|NCT00975221|587572005|FG000|Titration Phase (Weeks 1-12)|Other|0|||
162688789|NCT00975221|587572006|FG001|Titration Phase (Weeks 1-12)|Other|1|||
162688790|NCT00975221|587572005|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
162688791|NCT00975221|587572006|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
162688792|NCT00975221|587572005|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
162688793|NCT00975221|587572006|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
162688794|NCT00975221|587572005|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
162688795|NCT00975221|587572006|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
162688796|NCT04022889|587572007|FG000|Stage 1: Period 1|Adverse Event|1|||
162688797|NCT04022889|587572008|FG001|Stage 1: Period 1|Adverse Event|0|||
162688798|NCT04022889|587572009|FG002|Stage 1: Period 1|Adverse Event|0|||
162688799|NCT04022889|587572007|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
162688800|NCT04022889|587572008|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
162688801|NCT04022889|587572009|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
162688802|NCT04022889|587572007|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
162688803|NCT04022889|587572008|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
162688804|NCT04022889|587572009|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
162688805|NCT04022889|587572007|FG000|Stage 2|Screen Failure|0|||
162688806|NCT04022889|587572008|FG001|Stage 2|Screen Failure|0|||
162688807|NCT04022889|587572009|FG002|Stage 2|Screen Failure|3|||
162688808|NCT04022889|587572007|FG000|Stage 2|Ineligible for apheresis donation|0|||
162688809|NCT04022889|587572008|FG001|Stage 2|Ineligible for apheresis donation|0|||
162688810|NCT04022889|587572009|FG002|Stage 2|Ineligible for apheresis donation|2|||
162688811|NCT04022889|587572007|FG000|Stage 2|Adverse Event|0|||
162688812|NCT04022889|587572008|FG001|Stage 2|Adverse Event|0|||
162688813|NCT04022889|587572009|FG002|Stage 2|Adverse Event|2|||
162688814|NCT04022889|587572007|FG000|Stage 2|Protocol Violation|0|||
162688815|NCT04022889|587572008|FG001|Stage 2|Protocol Violation|0|||
162688816|NCT04022889|587572009|FG002|Stage 2|Protocol Violation|1|||
162688817|NCT04022889|587572007|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
162688818|NCT04022889|587572008|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
162688819|NCT04022889|587572009|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
162688820|NCT03237858|587572010|FG000|Overall Study|Death|19|||
162688821|NCT03237858|587572010|FG000|Overall Study|Withdrawal by Subject|37|||
162688822|NCT03015116|587572011|FG000|Overall Study|Lost to Follow-up|3|||
162688823|NCT03015116|587572012|FG001|Overall Study|Lost to Follow-up|0|||
162688824|NCT03015116|587572013|FG002|Overall Study|Lost to Follow-up|2|||
162688825|NCT03015116|587572011|FG000|Overall Study|Withdrawal by Subject|3|||
162688826|NCT03015116|587572012|FG001|Overall Study|Withdrawal by Subject|1|||
162688827|NCT03015116|587572013|FG002|Overall Study|Withdrawal by Subject|0|||
162688828|NCT03015116|587572011|FG000|Overall Study|Subject has New Medical Status|1|||
162688829|NCT03015116|587572012|FG001|Overall Study|Subject has New Medical Status|0|||
162688830|NCT03015116|587572013|FG002|Overall Study|Subject has New Medical Status|0|||
162688831|NCT03015116|587572011|FG000|Overall Study|Physician Decision|0|||
162688832|NCT03015116|587572012|FG001|Overall Study|Physician Decision|1|||
162688833|NCT03015116|587572013|FG002|Overall Study|Physician Decision|0|||
162688834|NCT01862991|587572014|FG000|Overall Study|Lost to Follow-up|2|||
162688835|NCT01862991|587572015|FG001|Overall Study|Lost to Follow-up|1|||
162688836|NCT01862991|587572016|FG002|Overall Study|Lost to Follow-up|1|||
162688837|NCT01862991|587572014|FG000|Overall Study|Protocol Violation|1|||
162688838|NCT01862991|587572015|FG001|Overall Study|Protocol Violation|0|||
162688839|NCT01862991|587572016|FG002|Overall Study|Protocol Violation|0|||
162688840|NCT04858802|587572017|FG000|Overall Study|Lost to Follow-up|1|||
162688841|NCT04858802|587572018|FG001|Overall Study|Lost to Follow-up|1|||
162688842|NCT04858802|587572017|FG000|Overall Study|Withdrawal by Subject|1|||
162688843|NCT04858802|587572018|FG001|Overall Study|Withdrawal by Subject|1|||
162688844|NCT00332332|587572019|FG000|Overall Study|Adverse Event|13|||
162688845|NCT00332332|587572019|FG000|Overall Study|Death|1|||
162688846|NCT00332332|587572019|FG000|Overall Study|Withdrawal by Subject|8|||
162688847|NCT00332332|587572019|FG000|Overall Study|Physician Decision|1|||
162688848|NCT00332332|587572019|FG000|Overall Study|Lost to Follow-up|3|||
162688849|NCT00332332|587572019|FG000|Overall Study|Protocol deviation|4|||
162688850|NCT00332332|587572019|FG000|Overall Study|Noncompliance|2|||
162688851|NCT00332332|587572019|FG000|Overall Study|Disease progression|2|||
162688852|NCT00332332|587572019|FG000|Overall Study|Other|18|||
162688853|NCT00332332|587572019|FG000|Overall Study|Did not receive study treatment|16|||
162688854|NCT01108458|587572020|FG000|Overall Study|Withdrawal by Subject|1|||
162688855|NCT03075501|587572022|FG000|Overall Study|Scheduling difficulties|15|||
162688856|NCT03075501|587572023|FG001|Overall Study|Scheduling difficulties|9|||
162688857|NCT00857805|587572026|FG000|Overall Study|Withdrawal by Subject|1|||
162688858|NCT00857805|587572027|FG001|Overall Study|Withdrawal by Subject|1|||
162688859|NCT01289041|587572028|FG000|Overall Study|Adverse Event|24|||
162688860|NCT01289041|587572028|FG000|Overall Study|Physician Decision|1|||
162688861|NCT01289041|587572028|FG000|Overall Study|Progressive Disease|41|||
162688862|NCT01289041|587572028|FG000|Overall Study|Withdrawal by Subject|3|||
162688863|NCT01289041|587572028|FG000|Overall Study|Death|1|||
162688864|NCT03610737|587572031|FG000|Overall Study|Withdrawal by Subject|1|||
162688865|NCT03610737|587572032|FG001|Overall Study|Withdrawal by Subject|5|||
162688866|NCT03610737|587572031|FG000|Overall Study|Death|1|||
162688867|NCT03610737|587572032|FG001|Overall Study|Death|0|||
162688868|NCT03610737|587572031|FG000|Overall Study|Not treated|5|||
162688869|NCT03610737|587572032|FG001|Overall Study|Not treated|2|||
162688870|NCT03610737|587572031|FG000|Overall Study|Missed Visit|1|||
162688871|NCT03610737|587572032|FG001|Overall Study|Missed Visit|2|||
162688872|NCT02714868|587572037|FG000|Overall Study|Withdrawal by Subject|3|||
162688873|NCT02714868|587572038|FG001|Overall Study|Withdrawal by Subject|0|||
162688874|NCT02714868|587572037|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
162688875|NCT02714868|587572038|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
162688876|NCT02714868|587572037|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
162688877|NCT02714868|587572038|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
162688878|NCT05056870|587572043|FG000|Period 1|Site COVID-19 Related|3|||
162688879|NCT05056870|587572044|FG001|Period 1|Site COVID-19 Related|3|||
162688880|NCT05056870|587572043|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162688881|NCT05056870|587572044|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
162688882|NCT05056870|587572043|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
162688883|NCT05056870|587572044|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162727791|NCT02723955|587714837|FG021|Escalation Phase|Physician Decision|0|||
162727792|NCT02723955|587714838|FG022|Escalation Phase|Physician Decision|0|||
162727793|NCT02723955|587714839|FG023|Escalation Phase|Physician Decision|0|||
162727794|NCT02723955|587714840|FG024|Escalation Phase|Physician Decision|0|||
162727795|NCT02723955|587714841|FG025|Escalation Phase|Physician Decision|0|||
162727796|NCT02723955|587714842|FG026|Escalation Phase|Physician Decision|2|||
162727797|NCT02723955|587714843|FG027|Escalation Phase|Physician Decision|0|||
162727798|NCT02723955|587714844|FG028|Escalation Phase|Physician Decision|0|||
162727799|NCT02723955|587714845|FG029|Escalation Phase|Physician Decision|0|||
162727800|NCT02723955|587714846|FG030|Escalation Phase|Physician Decision|0|||
162727801|NCT02723955|587714847|FG031|Escalation Phase|Physician Decision|0|||
162727802|NCT02723955|587714848|FG032|Escalation Phase|Physician Decision|0|||
162727803|NCT02723955|587714849|FG033|Escalation Phase|Physician Decision|0|||
162727804|NCT02723955|587714850|FG034|Escalation Phase|Physician Decision|0|||
162727805|NCT02723955|587714851|FG035|Escalation Phase|Physician Decision|0|||
162727806|NCT02723955|587714852|FG036|Escalation Phase|Physician Decision|0|||
162727807|NCT02723955|587714853|FG037|Escalation Phase|Physician Decision|0|||
162727808|NCT02723955|587714854|FG038|Escalation Phase|Physician Decision|0|||
162727809|NCT02723955|587714855|FG039|Escalation Phase|Physician Decision|0|||
162727810|NCT02723955|587714856|FG040|Escalation Phase|Physician Decision|0|||
162727811|NCT02723955|587714857|FG041|Escalation Phase|Physician Decision|0|||
162727812|NCT02723955|587714858|FG042|Escalation Phase|Physician Decision|0|||
162727813|NCT02723955|587714816|FG000|Escalation Phase|Withdrawal by Subject|0|||
162727814|NCT02723955|587714817|FG001|Escalation Phase|Withdrawal by Subject|0|||
162727815|NCT02723955|587714818|FG002|Escalation Phase|Withdrawal by Subject|0|||
162727816|NCT02723955|587714819|FG003|Escalation Phase|Withdrawal by Subject|0|||
162727817|NCT02723955|587714820|FG004|Escalation Phase|Withdrawal by Subject|1|||
162727818|NCT02723955|587714821|FG005|Escalation Phase|Withdrawal by Subject|1|||
162727819|NCT02723955|587714822|FG006|Escalation Phase|Withdrawal by Subject|1|||
162727820|NCT02723955|587714823|FG007|Escalation Phase|Withdrawal by Subject|1|||
162727821|NCT02723955|587714824|FG008|Escalation Phase|Withdrawal by Subject|0|||
162727822|NCT02723955|587714825|FG009|Escalation Phase|Withdrawal by Subject|0|||
162727823|NCT02723955|587714826|FG010|Escalation Phase|Withdrawal by Subject|0|||
162727824|NCT02723955|587714827|FG011|Escalation Phase|Withdrawal by Subject|0|||
162727825|NCT02723955|587714828|FG012|Escalation Phase|Withdrawal by Subject|1|||
162727826|NCT02723955|587714829|FG013|Escalation Phase|Withdrawal by Subject|0|||
162727827|NCT02723955|587714830|FG014|Escalation Phase|Withdrawal by Subject|0|||
162727828|NCT02723955|587714831|FG015|Escalation Phase|Withdrawal by Subject|0|||
162727829|NCT02723955|587714832|FG016|Escalation Phase|Withdrawal by Subject|1|||
162727830|NCT02723955|587714833|FG017|Escalation Phase|Withdrawal by Subject|0|||
162727831|NCT02723955|587714834|FG018|Escalation Phase|Withdrawal by Subject|0|||
162727832|NCT02723955|587714835|FG019|Escalation Phase|Withdrawal by Subject|0|||
162727833|NCT02723955|587714836|FG020|Escalation Phase|Withdrawal by Subject|0|||
162727834|NCT02723955|587714837|FG021|Escalation Phase|Withdrawal by Subject|0|||
162727835|NCT02723955|587714838|FG022|Escalation Phase|Withdrawal by Subject|0|||
162727836|NCT02723955|587714839|FG023|Escalation Phase|Withdrawal by Subject|2|||
162727837|NCT02723955|587714840|FG024|Escalation Phase|Withdrawal by Subject|0|||
162727838|NCT02723955|587714841|FG025|Escalation Phase|Withdrawal by Subject|1|||
162727839|NCT02723955|587714842|FG026|Escalation Phase|Withdrawal by Subject|0|||
162727840|NCT02723955|587714843|FG027|Escalation Phase|Withdrawal by Subject|0|||
162727841|NCT02723955|587714844|FG028|Escalation Phase|Withdrawal by Subject|1|||
162727842|NCT02723955|587714845|FG029|Escalation Phase|Withdrawal by Subject|0|||
162727843|NCT02723955|587714846|FG030|Escalation Phase|Withdrawal by Subject|0|||
162727844|NCT02723955|587714847|FG031|Escalation Phase|Withdrawal by Subject|0|||
162727845|NCT02723955|587714848|FG032|Escalation Phase|Withdrawal by Subject|0|||
162727846|NCT02723955|587714849|FG033|Escalation Phase|Withdrawal by Subject|0|||
162727847|NCT02723955|587714850|FG034|Escalation Phase|Withdrawal by Subject|0|||
162688884|NCT05056870|587572043|FG000|Period 2|COVID-19 Related|1|||
162688885|NCT05056870|587572044|FG001|Period 2|COVID-19 Related|0|||
162688886|NCT05056870|587572043|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
162727848|NCT02723955|587714851|FG035|Escalation Phase|Withdrawal by Subject|0|||
162727849|NCT02723955|587714852|FG036|Escalation Phase|Withdrawal by Subject|0|||
162727850|NCT02723955|587714853|FG037|Escalation Phase|Withdrawal by Subject|0|||
162688887|NCT05056870|587572044|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
162688888|NCT05044325|587572047|FG000|Part A:Treatment Period 1|Adverse Event|0|||
162688889|NCT05044325|587572048|FG001|Part A:Treatment Period 1|Adverse Event|0|||
162688890|NCT05044325|587572049|FG002|Part A:Treatment Period 1|Adverse Event|0|||
162688891|NCT05044325|587572050|FG003|Part A:Treatment Period 1|Adverse Event|0|||
162688892|NCT05044325|587572051|FG004|Part A:Treatment Period 1|Adverse Event|0|||
162688893|NCT05044325|587572052|FG005|Part A:Treatment Period 1|Adverse Event|1|||
162688894|NCT05044325|587572053|FG006|Part A:Treatment Period 1|Adverse Event|0|||
162688895|NCT05044325|587572054|FG007|Part A:Treatment Period 1|Adverse Event|1|||
162688896|NCT05044325|587572055|FG008|Part A:Treatment Period 1|Adverse Event|0|||
162688897|NCT05044325|587572056|FG009|Part A:Treatment Period 1|Adverse Event|0|||
162688898|NCT05044325|587572047|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162727851|NCT02723955|587714854|FG038|Escalation Phase|Withdrawal by Subject|0|||
162727852|NCT02723955|587714855|FG039|Escalation Phase|Withdrawal by Subject|0|||
162727853|NCT02723955|587714856|FG040|Escalation Phase|Withdrawal by Subject|0|||
162727854|NCT02723955|587714857|FG041|Escalation Phase|Withdrawal by Subject|0|||
162727855|NCT02723955|587714858|FG042|Escalation Phase|Withdrawal by Subject|0|||
162727856|NCT02723955|587714816|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727857|NCT02723955|587714817|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727858|NCT02723955|587714818|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727859|NCT02723955|587714819|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727860|NCT02723955|587714820|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
162727861|NCT02723955|587714821|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
162727862|NCT02723955|587714822|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
162727863|NCT02723955|587714823|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
162727864|NCT02723955|587714824|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
162727865|NCT02723955|587714825|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727866|NCT02723955|587714826|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727867|NCT02723955|587714827|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162688899|NCT05044325|587572048|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688900|NCT05044325|587572049|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688901|NCT05044325|587572050|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162688902|NCT05044325|587572051|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162688903|NCT05044325|587572052|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162688904|NCT05044325|587572053|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688905|NCT05044325|587572054|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688906|NCT05044325|587572055|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688907|NCT05044325|587572056|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162688908|NCT05044325|587572047|FG000|Part A:Treatment Period 1|Physician Decision|0|||
162688909|NCT05044325|587572048|FG001|Part A:Treatment Period 1|Physician Decision|0|||
162688910|NCT05044325|587572049|FG002|Part A:Treatment Period 1|Physician Decision|0|||
162688911|NCT05044325|587572050|FG003|Part A:Treatment Period 1|Physician Decision|0|||
162688912|NCT05044325|587572051|FG004|Part A:Treatment Period 1|Physician Decision|0|||
162688913|NCT05044325|587572052|FG005|Part A:Treatment Period 1|Physician Decision|0|||
162688914|NCT05044325|587572053|FG006|Part A:Treatment Period 1|Physician Decision|1|||
162688915|NCT05044325|587572054|FG007|Part A:Treatment Period 1|Physician Decision|0|||
162688916|NCT05044325|587572055|FG008|Part A:Treatment Period 1|Physician Decision|0|||
162688917|NCT05044325|587572056|FG009|Part A:Treatment Period 1|Physician Decision|0|||
162688918|NCT05044325|587572047|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688919|NCT05044325|587572048|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688920|NCT05044325|587572049|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
162688921|NCT05044325|587572050|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688922|NCT05044325|587572051|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688923|NCT05044325|587572052|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688924|NCT05044325|587572053|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688925|NCT05044325|587572054|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688926|NCT05044325|587572055|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688927|NCT05044325|587572056|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162688928|NCT05044325|587572047|FG000|Part A:Treatment Period 2|Adverse Event|0|||
162688929|NCT05044325|587572048|FG001|Part A:Treatment Period 2|Adverse Event|1|||
162688930|NCT05044325|587572049|FG002|Part A:Treatment Period 2|Adverse Event|0|||
162688931|NCT05044325|587572050|FG003|Part A:Treatment Period 2|Adverse Event|0|||
162688932|NCT05044325|587572051|FG004|Part A:Treatment Period 2|Adverse Event|1|||
162688933|NCT05044325|587572052|FG005|Part A:Treatment Period 2|Adverse Event|1|||
162688934|NCT05044325|587572053|FG006|Part A:Treatment Period 2|Adverse Event|0|||
162688935|NCT05044325|587572054|FG007|Part A:Treatment Period 2|Adverse Event|0|||
162727868|NCT02723955|587714828|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727869|NCT02723955|587714829|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727870|NCT02723955|587714830|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162688936|NCT05044325|587572055|FG008|Part A:Treatment Period 2|Adverse Event|0|||
162727871|NCT02723955|587714831|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727872|NCT02723955|587714832|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727873|NCT02723955|587714833|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162688937|NCT05044325|587572056|FG009|Part A:Treatment Period 2|Adverse Event|0|||
162688938|NCT05044325|587572047|FG000|Part A:Treatment Period 2|Physician Decision|0|||
162688939|NCT05044325|587572048|FG001|Part A:Treatment Period 2|Physician Decision|0|||
162688940|NCT05044325|587572049|FG002|Part A:Treatment Period 2|Physician Decision|0|||
162727874|NCT02723955|587714834|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727875|NCT02723955|587714835|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727876|NCT02723955|587714836|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727877|NCT02723955|587714837|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727878|NCT02723955|587714838|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727879|NCT02723955|587714839|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727880|NCT02723955|587714840|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727881|NCT02723955|587714841|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727882|NCT02723955|587714842|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727883|NCT02723955|587714843|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727884|NCT02723955|587714844|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727885|NCT02723955|587714845|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727886|NCT02723955|587714846|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727887|NCT02723955|587714847|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727888|NCT02723955|587714848|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727889|NCT02723955|587714849|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727890|NCT02723955|587714850|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727891|NCT02723955|587714851|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727892|NCT02723955|587714852|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727893|NCT02723955|587714853|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727894|NCT02723955|587714854|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727895|NCT02723955|587714855|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727896|NCT02723955|587714856|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727897|NCT02723955|587714857|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727898|NCT02723955|587714858|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162727899|NCT02723955|587714816|FG000|Escalation Phase|Site Closed|0|||
162727900|NCT02723955|587714817|FG001|Escalation Phase|Site Closed|0|||
162727901|NCT02723955|587714818|FG002|Escalation Phase|Site Closed|0|||
162727902|NCT02723955|587714819|FG003|Escalation Phase|Site Closed|0|||
162727903|NCT02723955|587714820|FG004|Escalation Phase|Site Closed|0|||
162727904|NCT02723955|587714821|FG005|Escalation Phase|Site Closed|0|||
162688941|NCT05044325|587572050|FG003|Part A:Treatment Period 2|Physician Decision|0|||
162688942|NCT05044325|587572051|FG004|Part A:Treatment Period 2|Physician Decision|0|||
162688943|NCT05044325|587572052|FG005|Part A:Treatment Period 2|Physician Decision|1|||
162688944|NCT05044325|587572053|FG006|Part A:Treatment Period 2|Physician Decision|0|||
162688945|NCT05044325|587572054|FG007|Part A:Treatment Period 2|Physician Decision|0|||
162688946|NCT05044325|587572055|FG008|Part A:Treatment Period 2|Physician Decision|0|||
162688947|NCT05044325|587572056|FG009|Part A:Treatment Period 2|Physician Decision|0|||
162688948|NCT05044325|587572047|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688949|NCT05044325|587572048|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688950|NCT05044325|587572049|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688951|NCT05044325|587572050|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
162688952|NCT05044325|587572051|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
162688953|NCT05044325|587572052|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688954|NCT05044325|587572053|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688955|NCT05044325|587572054|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688956|NCT05044325|587572055|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688957|NCT05044325|587572056|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162688958|NCT01373931|587572059|FG000|Lead-in Period|Adverse Event|2|||
162688959|NCT01373931|587572060|FG001|Lead-in Period|Adverse Event|0|||
162688960|NCT01373931|587572059|FG000|Period 1|Adverse Event|2|||
162688961|NCT01373931|587572060|FG001|Period 1|Adverse Event|0|||
162688962|NCT01373931|587572059|FG000|Period 1|Withdrawal by Subject|0|||
162688963|NCT01373931|587572060|FG001|Period 1|Withdrawal by Subject|2|||
162688964|NCT00674323|587572061|FG000|Overall Study|Adverse Event|0|||
162688965|NCT00674323|587572062|FG001|Overall Study|Adverse Event|1|||
162688966|NCT00674323|587572063|FG002|Overall Study|Adverse Event|0|||
162688967|NCT00674323|587572061|FG000|Overall Study|Protocol Violation|1|||
162688968|NCT00674323|587572062|FG001|Overall Study|Protocol Violation|0|||
162688969|NCT00674323|587572063|FG002|Overall Study|Protocol Violation|0|||
162727905|NCT02723955|587714822|FG006|Escalation Phase|Site Closed|0|||
162727906|NCT02723955|587714823|FG007|Escalation Phase|Site Closed|0|||
162727907|NCT02723955|587714824|FG008|Escalation Phase|Site Closed|0|||
162727908|NCT02723955|587714825|FG009|Escalation Phase|Site Closed|0|||
162727909|NCT02723955|587714826|FG010|Escalation Phase|Site Closed|0|||
162727910|NCT02723955|587714827|FG011|Escalation Phase|Site Closed|0|||
162727911|NCT02723955|587714828|FG012|Escalation Phase|Site Closed|0|||
162727912|NCT02723955|587714829|FG013|Escalation Phase|Site Closed|0|||
162727913|NCT02723955|587714830|FG014|Escalation Phase|Site Closed|0|||
162727914|NCT02723955|587714831|FG015|Escalation Phase|Site Closed|1|||
162727915|NCT02723955|587714832|FG016|Escalation Phase|Site Closed|0|||
162727916|NCT02723955|587714833|FG017|Escalation Phase|Site Closed|2|||
162727917|NCT02723955|587714834|FG018|Escalation Phase|Site Closed|0|||
162727918|NCT02723955|587714835|FG019|Escalation Phase|Site Closed|0|||
162727919|NCT02723955|587714836|FG020|Escalation Phase|Site Closed|1|||
162727920|NCT02723955|587714837|FG021|Escalation Phase|Site Closed|0|||
162727921|NCT02723955|587714838|FG022|Escalation Phase|Site Closed|0|||
162727922|NCT02723955|587714839|FG023|Escalation Phase|Site Closed|0|||
162727923|NCT02723955|587714840|FG024|Escalation Phase|Site Closed|3|||
162727924|NCT02723955|587714841|FG025|Escalation Phase|Site Closed|1|||
162727925|NCT02723955|587714842|FG026|Escalation Phase|Site Closed|3|||
162727926|NCT02723955|587714843|FG027|Escalation Phase|Site Closed|1|||
162727927|NCT02723955|587714844|FG028|Escalation Phase|Site Closed|1|||
162727928|NCT02723955|587714845|FG029|Escalation Phase|Site Closed|0|||
162727929|NCT02723955|587714846|FG030|Escalation Phase|Site Closed|0|||
162727930|NCT02723955|587714847|FG031|Escalation Phase|Site Closed|0|||
162727931|NCT02723955|587714848|FG032|Escalation Phase|Site Closed|0|||
162727932|NCT02723955|587714849|FG033|Escalation Phase|Site Closed|0|||
162727933|NCT02723955|587714850|FG034|Escalation Phase|Site Closed|0|||
162727934|NCT02723955|587714851|FG035|Escalation Phase|Site Closed|0|||
162727935|NCT02723955|587714852|FG036|Escalation Phase|Site Closed|0|||
162727936|NCT02723955|587714853|FG037|Escalation Phase|Site Closed|0|||
162727937|NCT02723955|587714854|FG038|Escalation Phase|Site Closed|0|||
162727938|NCT02723955|587714855|FG039|Escalation Phase|Site Closed|0|||
162727939|NCT02723955|587714856|FG040|Escalation Phase|Site Closed|0|||
162727940|NCT02723955|587714857|FG041|Escalation Phase|Site Closed|0|||
162727941|NCT02723955|587714858|FG042|Escalation Phase|Site Closed|0|||
162727942|NCT02723955|587714816|FG000|Expansion Phase|Death|0|||
162727943|NCT02723955|587714817|FG001|Expansion Phase|Death|0|||
162727944|NCT02723955|587714818|FG002|Expansion Phase|Death|0|||
162727945|NCT02723955|587714819|FG003|Expansion Phase|Death|0|||
162727946|NCT02723955|587714820|FG004|Expansion Phase|Death|0|||
162727947|NCT02723955|587714821|FG005|Expansion Phase|Death|0|||
162727948|NCT02723955|587714822|FG006|Expansion Phase|Death|0|||
162688970|NCT00742079|587572064|FG000|Overall Study|Lost to Follow-up|0|||
162688971|NCT00742079|587572065|FG001|Overall Study|Lost to Follow-up|1|||
162688972|NCT02013388|587572071|FG000|Overall Study|work emergency|1|||
162688973|NCT02013388|587572072|FG001|Overall Study|work emergency|0|||
162688974|NCT02013388|587572073|FG002|Overall Study|work emergency|0|||
162688975|NCT02013388|587572074|FG003|Overall Study|work emergency|0|||
162688976|NCT02013388|587572075|FG004|Overall Study|work emergency|1|||
162688977|NCT02013388|587572076|FG005|Overall Study|work emergency|0|||
162688978|NCT02013388|587572077|FG006|Overall Study|work emergency|0|||
162688979|NCT02013388|587572078|FG007|Overall Study|work emergency|0|||
162688980|NCT01114204|587572082|FG000|Overall Study|Adverse Event|3|||
162688981|NCT01114204|587572083|FG001|Overall Study|Adverse Event|2|||
162688982|NCT01114204|587572082|FG000|Overall Study|Lost to Follow-up|1|||
162727949|NCT02723955|587714823|FG007|Expansion Phase|Death|0|||
162727950|NCT02723955|587714824|FG008|Expansion Phase|Death|0|||
162727951|NCT02723955|587714825|FG009|Expansion Phase|Death|25|||
162727952|NCT02723955|587714826|FG010|Expansion Phase|Death|69|||
162727953|NCT02723955|587714827|FG011|Expansion Phase|Death|48|||
162727954|NCT02723955|587714828|FG012|Expansion Phase|Death|0|||
162727955|NCT02723955|587714829|FG013|Expansion Phase|Death|0|||
162727956|NCT02723955|587714830|FG014|Expansion Phase|Death|0|||
162727957|NCT02723955|587714831|FG015|Expansion Phase|Death|0|||
162727958|NCT02723955|587714832|FG016|Expansion Phase|Death|0|||
162727959|NCT02723955|587714833|FG017|Expansion Phase|Death|0|||
162727960|NCT02723955|587714834|FG018|Expansion Phase|Death|0|||
162727961|NCT02723955|587714835|FG019|Expansion Phase|Death|0|||
162727962|NCT02723955|587714836|FG020|Expansion Phase|Death|0|||
162727963|NCT02723955|587714837|FG021|Expansion Phase|Death|0|||
162727964|NCT02723955|587714838|FG022|Expansion Phase|Death|0|||
162727965|NCT02723955|587714839|FG023|Expansion Phase|Death|0|||
162727966|NCT02723955|587714840|FG024|Expansion Phase|Death|0|||
162727967|NCT02723955|587714841|FG025|Expansion Phase|Death|0|||
162688983|NCT01114204|587572083|FG001|Overall Study|Lost to Follow-up|0|||
162727968|NCT02723955|587714842|FG026|Expansion Phase|Death|0|||
162727969|NCT02723955|587714843|FG027|Expansion Phase|Death|0|||
162727970|NCT02723955|587714844|FG028|Expansion Phase|Death|0|||
162727971|NCT02723955|587714845|FG029|Expansion Phase|Death|12|||
162727972|NCT02723955|587714846|FG030|Expansion Phase|Death|202|||
162727973|NCT02723955|587714847|FG031|Expansion Phase|Death|31|||
162688984|NCT01114204|587572082|FG000|Overall Study|Withdrawal by Subject|10|||
162727974|NCT02723955|587714848|FG032|Expansion Phase|Death|17|||
162727975|NCT02723955|587714849|FG033|Expansion Phase|Death|2|||
162727976|NCT02723955|587714850|FG034|Expansion Phase|Death|3|||
162727977|NCT02723955|587714851|FG035|Expansion Phase|Death|3|||
162727978|NCT02723955|587714852|FG036|Expansion Phase|Death|1|||
162727979|NCT02723955|587714853|FG037|Expansion Phase|Death|0|||
162688985|NCT01114204|587572083|FG001|Overall Study|Withdrawal by Subject|6|||
162688986|NCT01114204|587572082|FG000|Overall Study|Death|1|||
162688987|NCT01114204|587572083|FG001|Overall Study|Death|0|||
162727980|NCT02723955|587714854|FG038|Expansion Phase|Death|0|||
162727981|NCT02723955|587714855|FG039|Expansion Phase|Death|0|||
162727982|NCT02723955|587714856|FG040|Expansion Phase|Death|0|||
162727983|NCT02723955|587714857|FG041|Expansion Phase|Death|0|||
162727984|NCT02723955|587714858|FG042|Expansion Phase|Death|0|||
162727985|NCT02723955|587714816|FG000|Expansion Phase|Lost to Follow-up|0|||
162727986|NCT02723955|587714817|FG001|Expansion Phase|Lost to Follow-up|0|||
162727987|NCT02723955|587714818|FG002|Expansion Phase|Lost to Follow-up|0|||
162727988|NCT02723955|587714819|FG003|Expansion Phase|Lost to Follow-up|0|||
162727989|NCT02723955|587714820|FG004|Expansion Phase|Lost to Follow-up|0|||
162727990|NCT02723955|587714821|FG005|Expansion Phase|Lost to Follow-up|0|||
162727991|NCT02723955|587714822|FG006|Expansion Phase|Lost to Follow-up|0|||
162727992|NCT02723955|587714823|FG007|Expansion Phase|Lost to Follow-up|0|||
162727993|NCT02723955|587714824|FG008|Expansion Phase|Lost to Follow-up|0|||
162727994|NCT02723955|587714825|FG009|Expansion Phase|Lost to Follow-up|0|||
162727995|NCT02723955|587714826|FG010|Expansion Phase|Lost to Follow-up|4|||
162727996|NCT02723955|587714827|FG011|Expansion Phase|Lost to Follow-up|1|||
162727997|NCT02723955|587714828|FG012|Expansion Phase|Lost to Follow-up|0|||
162727998|NCT02723955|587714829|FG013|Expansion Phase|Lost to Follow-up|0|||
162727999|NCT02723955|587714830|FG014|Expansion Phase|Lost to Follow-up|0|||
162728000|NCT02723955|587714831|FG015|Expansion Phase|Lost to Follow-up|0|||
162728001|NCT02723955|587714832|FG016|Expansion Phase|Lost to Follow-up|0|||
162728002|NCT02723955|587714833|FG017|Expansion Phase|Lost to Follow-up|0|||
162728003|NCT02723955|587714834|FG018|Expansion Phase|Lost to Follow-up|0|||
162728004|NCT02723955|587714835|FG019|Expansion Phase|Lost to Follow-up|0|||
162728005|NCT02723955|587714836|FG020|Expansion Phase|Lost to Follow-up|0|||
162728006|NCT02723955|587714837|FG021|Expansion Phase|Lost to Follow-up|0|||
162728007|NCT02723955|587714838|FG022|Expansion Phase|Lost to Follow-up|0|||
162728008|NCT02723955|587714839|FG023|Expansion Phase|Lost to Follow-up|0|||
162728009|NCT02723955|587714840|FG024|Expansion Phase|Lost to Follow-up|0|||
162728010|NCT02723955|587714841|FG025|Expansion Phase|Lost to Follow-up|0|||
162728011|NCT02723955|587714842|FG026|Expansion Phase|Lost to Follow-up|0|||
162728012|NCT02723955|587714843|FG027|Expansion Phase|Lost to Follow-up|0|||
162728013|NCT02723955|587714844|FG028|Expansion Phase|Lost to Follow-up|0|||
162728014|NCT02723955|587714845|FG029|Expansion Phase|Lost to Follow-up|1|||
162728015|NCT02723955|587714846|FG030|Expansion Phase|Lost to Follow-up|19|||
162728016|NCT02723955|587714847|FG031|Expansion Phase|Lost to Follow-up|2|||
162728017|NCT02723955|587714848|FG032|Expansion Phase|Lost to Follow-up|1|||
162728018|NCT02723955|587714849|FG033|Expansion Phase|Lost to Follow-up|0|||
162728019|NCT02723955|587714850|FG034|Expansion Phase|Lost to Follow-up|0|||
162728020|NCT02723955|587714851|FG035|Expansion Phase|Lost to Follow-up|0|||
162728021|NCT02723955|587714852|FG036|Expansion Phase|Lost to Follow-up|0|||
162728022|NCT02723955|587714853|FG037|Expansion Phase|Lost to Follow-up|0|||
162728023|NCT02723955|587714854|FG038|Expansion Phase|Lost to Follow-up|0|||
162728024|NCT02723955|587714855|FG039|Expansion Phase|Lost to Follow-up|0|||
162728025|NCT02723955|587714856|FG040|Expansion Phase|Lost to Follow-up|0|||
162728026|NCT02723955|587714857|FG041|Expansion Phase|Lost to Follow-up|0|||
162728027|NCT02723955|587714858|FG042|Expansion Phase|Lost to Follow-up|0|||
162728028|NCT02723955|587714816|FG000|Expansion Phase|Physician Decision|0|||
162728029|NCT02723955|587714817|FG001|Expansion Phase|Physician Decision|0|||
162728030|NCT02723955|587714818|FG002|Expansion Phase|Physician Decision|0|||
162728031|NCT02723955|587714819|FG003|Expansion Phase|Physician Decision|0|||
162728032|NCT02723955|587714820|FG004|Expansion Phase|Physician Decision|0|||
162728033|NCT02723955|587714821|FG005|Expansion Phase|Physician Decision|0|||
162728034|NCT02723955|587714822|FG006|Expansion Phase|Physician Decision|0|||
162688988|NCT01114204|587572082|FG000|Overall Study|Other-Personal reasons|2|||
162688989|NCT01114204|587572083|FG001|Overall Study|Other-Personal reasons|0|||
162688990|NCT01114204|587572082|FG000|Overall Study|Other-Medical monitor request|1|||
162688991|NCT01114204|587572083|FG001|Overall Study|Other-Medical monitor request|0|||
162688992|NCT01114204|587572082|FG000|Overall Study|Other-Participant request|2|||
162688993|NCT01114204|587572083|FG001|Overall Study|Other-Participant request|0|||
162688994|NCT01114204|587572082|FG000|Overall Study|Other-Protocol Violation|1|||
162688995|NCT01114204|587572083|FG001|Overall Study|Other-Protocol Violation|0|||
162728035|NCT02723955|587714823|FG007|Expansion Phase|Physician Decision|0|||
162728036|NCT02723955|587714824|FG008|Expansion Phase|Physician Decision|0|||
162728037|NCT02723955|587714825|FG009|Expansion Phase|Physician Decision|0|||
162728038|NCT02723955|587714826|FG010|Expansion Phase|Physician Decision|0|||
162728039|NCT02723955|587714827|FG011|Expansion Phase|Physician Decision|0|||
162728040|NCT02723955|587714828|FG012|Expansion Phase|Physician Decision|0|||
162728041|NCT02723955|587714829|FG013|Expansion Phase|Physician Decision|0|||
162728042|NCT02723955|587714830|FG014|Expansion Phase|Physician Decision|0|||
162688996|NCT00991341|587572088|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
162688997|NCT00991341|587572089|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
162688998|NCT00991341|587572088|FG000|Overall Study|Death|3|||
162688999|NCT00991341|587572089|FG001|Overall Study|Death|0|||
162689000|NCT00991341|587572088|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
162689001|NCT00991341|587572089|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
162689002|NCT00991341|587572088|FG000|Overall Study|Physician Decision|1|||
162689003|NCT00991341|587572089|FG001|Overall Study|Physician Decision|2|||
162689004|NCT00991341|587572088|FG000|Overall Study|Withdrawal by Subject|3|||
162689005|NCT00991341|587572089|FG001|Overall Study|Withdrawal by Subject|4|||
162689006|NCT03145766|587572100|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162689007|NCT03145766|587572101|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162689008|NCT03145766|587572102|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
162689009|NCT03145766|587572103|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162689010|NCT03145766|587572104|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
162689011|NCT03145766|587572100|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
162689012|NCT03145766|587572101|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
162689013|NCT03145766|587572102|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
162689014|NCT03145766|587572103|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
162689015|NCT03145766|587572104|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
162689016|NCT03145766|587572100|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
162689017|NCT03145766|587572101|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
162689018|NCT03145766|587572102|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
162689019|NCT03145766|587572103|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
162689020|NCT03145766|587572104|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
162689021|NCT03145766|587572100|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
162689022|NCT03145766|587572101|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162689023|NCT03145766|587572102|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162689024|NCT03145766|587572103|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162689025|NCT03145766|587572104|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
162689026|NCT03145766|587572100|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
162689027|NCT03145766|587572101|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162689028|NCT03145766|587572102|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162689029|NCT03145766|587572103|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
162689030|NCT03145766|587572104|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162689031|NCT03145766|587572100|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
162689032|NCT03145766|587572101|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
162689033|NCT03145766|587572102|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
162689034|NCT03145766|587572103|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
162689035|NCT03145766|587572104|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
162689036|NCT03145766|587572100|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162689037|NCT03145766|587572101|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162689038|NCT03145766|587572102|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162689039|NCT03145766|587572103|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
162689040|NCT03145766|587572104|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
162689041|NCT02799472|587572105|FG000|Overall Study|Withdrawal by Subject|2|||
162689042|NCT02799472|587572106|FG001|Overall Study|Withdrawal by Subject|4|||
162689043|NCT02799472|587572105|FG000|Overall Study|Lack of Efficacy|2|||
162689044|NCT02799472|587572106|FG001|Overall Study|Lack of Efficacy|0|||
162689045|NCT02799472|587572105|FG000|Overall Study|Lost to Follow-up|0|||
162689046|NCT02799472|587572106|FG001|Overall Study|Lost to Follow-up|1|||
162689047|NCT02801669|587572107|FG000|Overall Study|Death|66|||
162689048|NCT02801669|587572108|FG001|Overall Study|Death|69|||
162689049|NCT02801669|587572107|FG000|Overall Study|Withdrawal by Subject|81|||
162689050|NCT02801669|587572108|FG001|Overall Study|Withdrawal by Subject|77|||
162689051|NCT02801669|587572107|FG000|Overall Study|Other|4|||
162689052|NCT02801669|587572108|FG001|Overall Study|Other|6|||
162689053|NCT04461795|587572109|FG000|Overall Study|Lost to Follow-up|2|||
162689054|NCT04461795|587572109|FG000|Overall Study|Withdrawal by Subject|2|||
162689055|NCT04461795|587572109|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
162689056|NCT00615264|587572110|FG000|Overall Study|Withdrawal by Subject|17|||
162689057|NCT00615264|587572111|FG001|Overall Study|Withdrawal by Subject|19|||
162689058|NCT00615264|587572110|FG000|Overall Study|Lost to Follow-up|6|||
162689059|NCT00615264|587572111|FG001|Overall Study|Lost to Follow-up|13|||
162689060|NCT00615264|587572110|FG000|Overall Study|Adverse Event|8|||
162689061|NCT00615264|587572111|FG001|Overall Study|Adverse Event|5|||
162689062|NCT00615264|587572110|FG000|Overall Study|Death|1|||
162689063|NCT00615264|587572111|FG001|Overall Study|Death|1|||
162728043|NCT02723955|587714831|FG015|Expansion Phase|Physician Decision|0|||
162728044|NCT02723955|587714832|FG016|Expansion Phase|Physician Decision|0|||
162728045|NCT02723955|587714833|FG017|Expansion Phase|Physician Decision|0|||
162728046|NCT02723955|587714834|FG018|Expansion Phase|Physician Decision|0|||
162728047|NCT02723955|587714835|FG019|Expansion Phase|Physician Decision|0|||
162728048|NCT02723955|587714836|FG020|Expansion Phase|Physician Decision|0|||
162728049|NCT02723955|587714837|FG021|Expansion Phase|Physician Decision|0|||
162728050|NCT02723955|587714838|FG022|Expansion Phase|Physician Decision|0|||
162728051|NCT02723955|587714839|FG023|Expansion Phase|Physician Decision|0|||
162728052|NCT02723955|587714840|FG024|Expansion Phase|Physician Decision|0|||
162728053|NCT02723955|587714841|FG025|Expansion Phase|Physician Decision|0|||
162728054|NCT02723955|587714842|FG026|Expansion Phase|Physician Decision|0|||
162728055|NCT02723955|587714843|FG027|Expansion Phase|Physician Decision|0|||
162728056|NCT02723955|587714844|FG028|Expansion Phase|Physician Decision|0|||
162728057|NCT02723955|587714845|FG029|Expansion Phase|Physician Decision|0|||
162728058|NCT02723955|587714846|FG030|Expansion Phase|Physician Decision|1|||
162728059|NCT02723955|587714847|FG031|Expansion Phase|Physician Decision|1|||
162728060|NCT02723955|587714848|FG032|Expansion Phase|Physician Decision|0|||
162728061|NCT02723955|587714849|FG033|Expansion Phase|Physician Decision|0|||
162728062|NCT02723955|587714850|FG034|Expansion Phase|Physician Decision|0|||
162728063|NCT02723955|587714851|FG035|Expansion Phase|Physician Decision|0|||
162728064|NCT02723955|587714852|FG036|Expansion Phase|Physician Decision|0|||
162728065|NCT02723955|587714853|FG037|Expansion Phase|Physician Decision|0|||
162728066|NCT02723955|587714854|FG038|Expansion Phase|Physician Decision|0|||
162728067|NCT02723955|587714855|FG039|Expansion Phase|Physician Decision|0|||
162728068|NCT02723955|587714856|FG040|Expansion Phase|Physician Decision|0|||
162728069|NCT02723955|587714857|FG041|Expansion Phase|Physician Decision|0|||
162728070|NCT02723955|587714858|FG042|Expansion Phase|Physician Decision|0|||
162728071|NCT02723955|587714816|FG000|Expansion Phase|Withdrawal by Subject|0|||
162728072|NCT02723955|587714817|FG001|Expansion Phase|Withdrawal by Subject|0|||
162728073|NCT02723955|587714818|FG002|Expansion Phase|Withdrawal by Subject|0|||
162728074|NCT02723955|587714819|FG003|Expansion Phase|Withdrawal by Subject|0|||
162728075|NCT02723955|587714820|FG004|Expansion Phase|Withdrawal by Subject|0|||
162728076|NCT02723955|587714821|FG005|Expansion Phase|Withdrawal by Subject|0|||
162728077|NCT02723955|587714822|FG006|Expansion Phase|Withdrawal by Subject|0|||
162728078|NCT02723955|587714823|FG007|Expansion Phase|Withdrawal by Subject|0|||
162728079|NCT02723955|587714824|FG008|Expansion Phase|Withdrawal by Subject|0|||
162728080|NCT02723955|587714825|FG009|Expansion Phase|Withdrawal by Subject|2|||
162728081|NCT02723955|587714826|FG010|Expansion Phase|Withdrawal by Subject|1|||
162728082|NCT02723955|587714827|FG011|Expansion Phase|Withdrawal by Subject|0|||
162728083|NCT02723955|587714828|FG012|Expansion Phase|Withdrawal by Subject|0|||
162728084|NCT02723955|587714829|FG013|Expansion Phase|Withdrawal by Subject|0|||
162728085|NCT02723955|587714830|FG014|Expansion Phase|Withdrawal by Subject|0|||
162728086|NCT02723955|587714831|FG015|Expansion Phase|Withdrawal by Subject|0|||
162728087|NCT02723955|587714832|FG016|Expansion Phase|Withdrawal by Subject|0|||
162728088|NCT02723955|587714833|FG017|Expansion Phase|Withdrawal by Subject|0|||
162728089|NCT02723955|587714834|FG018|Expansion Phase|Withdrawal by Subject|0|||
162728090|NCT02723955|587714835|FG019|Expansion Phase|Withdrawal by Subject|0|||
162728091|NCT02723955|587714836|FG020|Expansion Phase|Withdrawal by Subject|0|||
162728092|NCT02723955|587714837|FG021|Expansion Phase|Withdrawal by Subject|0|||
162728093|NCT02723955|587714838|FG022|Expansion Phase|Withdrawal by Subject|0|||
162728094|NCT02723955|587714839|FG023|Expansion Phase|Withdrawal by Subject|0|||
162728095|NCT02723955|587714840|FG024|Expansion Phase|Withdrawal by Subject|0|||
162728096|NCT02723955|587714841|FG025|Expansion Phase|Withdrawal by Subject|0|||
162689064|NCT00615264|587572110|FG000|Overall Study|Protocol Violation|11|||
162689065|NCT00615264|587572111|FG001|Overall Study|Protocol Violation|7|||
162689066|NCT00615264|587572110|FG000|Overall Study|Not defined|7|||
162689067|NCT00615264|587572111|FG001|Overall Study|Not defined|4|||
162689068|NCT00615264|587572110|FG000|Overall Study|Dermal Hypersensitivity|0|||
162689069|NCT00615264|587572111|FG001|Overall Study|Dermal Hypersensitivity|3|||
162689070|NCT00633932|587572112|FG000|Overall Study|Adverse Event|1|||
162689071|NCT00633932|587572113|FG001|Overall Study|Adverse Event|3|||
162689072|NCT00633932|587572114|FG002|Overall Study|Adverse Event|4|||
162689073|NCT00633932|587572112|FG000|Overall Study|Withdrawal by Subject|3|||
162689074|NCT00633932|587572113|FG001|Overall Study|Withdrawal by Subject|9|||
162689075|NCT00633932|587572114|FG002|Overall Study|Withdrawal by Subject|1|||
162689076|NCT00633932|587572112|FG000|Overall Study|Lost to Follow-up|1|||
162689077|NCT00633932|587572113|FG001|Overall Study|Lost to Follow-up|0|||
162689078|NCT00633932|587572114|FG002|Overall Study|Lost to Follow-up|2|||
162689079|NCT00633932|587572112|FG000|Overall Study|Protocol Violation|5|||
162689080|NCT00633932|587572113|FG001|Overall Study|Protocol Violation|2|||
162689081|NCT00633932|587572114|FG002|Overall Study|Protocol Violation|3|||
162689082|NCT00633932|587572112|FG000|Overall Study|Physician Decision|0|||
162689083|NCT00633932|587572113|FG001|Overall Study|Physician Decision|0|||
162689084|NCT00633932|587572114|FG002|Overall Study|Physician Decision|1|||
162689085|NCT00633932|587572112|FG000|Overall Study|Doctor's judgement|1|||
162728097|NCT02723955|587714842|FG026|Expansion Phase|Withdrawal by Subject|0|||
162689086|NCT00633932|587572113|FG001|Overall Study|Doctor's judgement|0|||
162689087|NCT00633932|587572114|FG002|Overall Study|Doctor's judgement|0|||
162689088|NCT00633932|587572112|FG000|Overall Study|Moved Away|1|||
162689089|NCT00633932|587572113|FG001|Overall Study|Moved Away|0|||
162689090|NCT00633932|587572114|FG002|Overall Study|Moved Away|0|||
162689091|NCT04836858|587572115|FG000|Overall Study|Adverse Event|0|||
162689092|NCT04836858|587572116|FG001|Overall Study|Adverse Event|0|||
162689093|NCT04836858|587572117|FG002|Overall Study|Adverse Event|0|||
162689094|NCT04836858|587572118|FG003|Overall Study|Adverse Event|1|||
162689095|NCT04836858|587572115|FG000|Overall Study|Lost to Follow-up|1|||
162689096|NCT04836858|587572116|FG001|Overall Study|Lost to Follow-up|0|||
162689097|NCT04836858|587572117|FG002|Overall Study|Lost to Follow-up|0|||
162689098|NCT04836858|587572118|FG003|Overall Study|Lost to Follow-up|0|||
162689099|NCT04836858|587572115|FG000|Overall Study|Subject/Guardian decision|3|||
162689100|NCT04836858|587572116|FG001|Overall Study|Subject/Guardian decision|0|||
162689101|NCT04836858|587572117|FG002|Overall Study|Subject/Guardian decision|0|||
162689102|NCT04836858|587572118|FG003|Overall Study|Subject/Guardian decision|1|||
162689103|NCT04836858|587572115|FG000|Overall Study|Randomized but not treated|4|||
162689104|NCT04836858|587572116|FG001|Overall Study|Randomized but not treated|0|||
162689105|NCT04836858|587572117|FG002|Overall Study|Randomized but not treated|0|||
162689106|NCT04836858|587572118|FG003|Overall Study|Randomized but not treated|0|||
162689107|NCT01982435|587572120|FG000|Overall Study|Adverse Event|1|||
162689108|NCT01982435|587572121|FG001|Overall Study|Adverse Event|0|||
162689109|NCT03954743|587572122|FG000|Overall Study|Adverse Event|1|||
162689110|NCT03954743|587572123|FG001|Overall Study|Adverse Event|0|||
162689111|NCT03954743|587572122|FG000|Overall Study|Lost to Follow-up|6|||
162689112|NCT03954743|587572123|FG001|Overall Study|Lost to Follow-up|4|||
162689113|NCT03954743|587572122|FG000|Overall Study|Protocol Violation|1|||
162689114|NCT03954743|587572123|FG001|Overall Study|Protocol Violation|0|||
162689115|NCT03954743|587572122|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
162689116|NCT03954743|587572123|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
162689117|NCT03954743|587572122|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
162689118|NCT03954743|587572123|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162689119|NCT03541044|587572124|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
162689120|NCT03541044|587572125|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
162689121|NCT03541044|587572124|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
162689122|NCT03541044|587572125|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
162689123|NCT01153269|587572126|FG000|Overall Study|Withdrawal by Subject|1|||
162689124|NCT01153269|587572126|FG000|Overall Study|Antiretroviral therapy break|1|||
162689125|NCT02281760|587572137|FG000|Overall Study|Withdrawal by Subject|1|||
162689126|NCT00860067|587572138|FG000|Overall Study|Lost to Follow-up|46|||
162689127|NCT00860067|587572139|FG001|Overall Study|Lost to Follow-up|9|||
162689128|NCT00860067|587572140|FG002|Overall Study|Lost to Follow-up|9|||
162689129|NCT00860067|587572138|FG000|Overall Study|Withdrawal by Subject|4|||
162689130|NCT00860067|587572139|FG001|Overall Study|Withdrawal by Subject|0|||
162689131|NCT00860067|587572140|FG002|Overall Study|Withdrawal by Subject|0|||
162689132|NCT00860067|587572138|FG000|Overall Study|Pregnancy|1|||
162689133|NCT00860067|587572139|FG001|Overall Study|Pregnancy|0|||
162689134|NCT00860067|587572140|FG002|Overall Study|Pregnancy|0|||
162689135|NCT00100932|587572145|FG000|Overall Study|Adverse Event|11|||
162689136|NCT00100932|587572146|FG001|Overall Study|Adverse Event|2|||
162689137|NCT00100932|587572145|FG000|Overall Study|Withdrawal by Subject|6|||
162689138|NCT00100932|587572146|FG001|Overall Study|Withdrawal by Subject|0|||
162689139|NCT00100932|587572145|FG000|Overall Study|Progressive Disease|44|||
162689140|NCT00100932|587572146|FG001|Overall Study|Progressive Disease|18|||
162689141|NCT00100932|587572145|FG000|Overall Study|Physician Decision|7|||
162689142|NCT00100932|587572146|FG001|Overall Study|Physician Decision|5|||
162689143|NCT00100932|587572145|FG000|Overall Study|Other|5|||
162689144|NCT00100932|587572146|FG001|Overall Study|Other|2|||
162689145|NCT02387996|587572149|FG000|Overall Study|Disease Progression|167|||
162689146|NCT02387996|587572149|FG000|Overall Study|Study Drug Toxicity|31|||
162689147|NCT02387996|587572149|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
162689148|NCT02387996|587572149|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
162689149|NCT02387996|587572149|FG000|Overall Study|Subject Withdrew Consent|5|||
162689150|NCT02387996|587572149|FG000|Overall Study|Lost to Follow-up|1|||
162689151|NCT02387996|587572149|FG000|Overall Study|Poor/Non-Compliance|1|||
162689152|NCT02387996|587572149|FG000|Overall Study|Other Reasons|5|||
162689153|NCT02387996|587572149|FG000|Overall Study|Death|1|||
162689154|NCT00770432|587572150|FG000|Overall Study|Other|4|||
162689155|NCT00770432|587572151|FG001|Overall Study|Other|6|||
162689156|NCT00770432|587572150|FG000|Overall Study|Non-compliance|0|||
162689157|NCT00770432|587572151|FG001|Overall Study|Non-compliance|1|||
162689158|NCT00312702|587572152|FG000|Immunization Phase|Lost to Follow-up|0|||
162689159|NCT00312702|587572153|FG001|Immunization Phase|Lost to Follow-up|1|||
162689160|NCT00312702|587572154|FG002|Immunization Phase|Lost to Follow-up|0|||
162689161|NCT01453348|587572155|FG000|Overall Study|Death|0|||
162689162|NCT01453348|587572156|FG001|Overall Study|Death|0|||
162689163|NCT01453348|587572157|FG002|Overall Study|Death|1|||
162728098|NCT02723955|587714843|FG027|Expansion Phase|Withdrawal by Subject|0|||
162728099|NCT02723955|587714844|FG028|Expansion Phase|Withdrawal by Subject|0|||
162728100|NCT02723955|587714845|FG029|Expansion Phase|Withdrawal by Subject|0|||
162728101|NCT02723955|587714846|FG030|Expansion Phase|Withdrawal by Subject|8|||
162728102|NCT02723955|587714847|FG031|Expansion Phase|Withdrawal by Subject|4|||
162728103|NCT02723955|587714848|FG032|Expansion Phase|Withdrawal by Subject|0|||
162728104|NCT02723955|587714849|FG033|Expansion Phase|Withdrawal by Subject|0|||
162728105|NCT02723955|587714850|FG034|Expansion Phase|Withdrawal by Subject|0|||
162728106|NCT02723955|587714851|FG035|Expansion Phase|Withdrawal by Subject|1|||
162728107|NCT02723955|587714852|FG036|Expansion Phase|Withdrawal by Subject|0|||
162728108|NCT02723955|587714853|FG037|Expansion Phase|Withdrawal by Subject|0|||
162728109|NCT02723955|587714854|FG038|Expansion Phase|Withdrawal by Subject|0|||
162689164|NCT01453348|587572155|FG000|Overall Study|Withdrawal by Subject|0|||
162689165|NCT01453348|587572156|FG001|Overall Study|Withdrawal by Subject|1|||
162689166|NCT01453348|587572157|FG002|Overall Study|Withdrawal by Subject|0|||
162689167|NCT01453348|587572155|FG000|Overall Study|Protocol Violation|1|||
162689168|NCT01453348|587572156|FG001|Overall Study|Protocol Violation|0|||
162689169|NCT01453348|587572157|FG002|Overall Study|Protocol Violation|0|||
162689170|NCT02756832|587572158|FG000|Overall Study|Lost for Observation after Baseline|6|||
162689171|NCT02756832|587572158|FG000|Overall Study|Lost for Observation|13|||
162689172|NCT02756832|587572158|FG000|Overall Study|Patient's Unwillingness|12|||
162689173|NCT02756832|587572158|FG000|Overall Study|Insufficient Efficacy|2|||
162689174|NCT02756832|587572158|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
162689175|NCT02756832|587572158|FG000|Overall Study|Reason not Specified|9|||
162689176|NCT02756832|587572158|FG000|Overall Study|Protocol Deviation|10|||
162689177|NCT01498822|587572160|FG000|Overall Study|Protocol Violation|8|||
162689178|NCT01498822|587572161|FG001|Overall Study|Protocol Violation|4|||
162689179|NCT01498822|587572160|FG000|Overall Study|Other Reason|5|||
162689180|NCT01498822|587572161|FG001|Overall Study|Other Reason|2|||
162689181|NCT01498822|587572160|FG000|Overall Study|Lack of Efficacy|7|||
162689182|NCT01498822|587572161|FG001|Overall Study|Lack of Efficacy|2|||
162689183|NCT01498822|587572160|FG000|Overall Study|AE, non-serious non-fatal|8|||
162689184|NCT01498822|587572161|FG001|Overall Study|AE, non-serious non-fatal|17|||
162689185|NCT01498822|587572160|FG000|Overall Study|SAE, non-fatal|2|||
162689186|NCT01498822|587572161|FG001|Overall Study|SAE, non-fatal|2|||
162689187|NCT01498822|587572160|FG000|Overall Study|Adverse Event, serious fatal|1|||
162689188|NCT01498822|587572161|FG001|Overall Study|Adverse Event, serious fatal|1|||
162689189|NCT01498822|587572160|FG000|Overall Study|Withdrawal by Subject|15|||
162689190|NCT01498822|587572161|FG001|Overall Study|Withdrawal by Subject|25|||
162689191|NCT01498822|587572160|FG000|Overall Study|Lost to Follow-up|8|||
162689192|NCT01498822|587572161|FG001|Overall Study|Lost to Follow-up|3|||
162689193|NCT03592277|587572162|FG000|Overall Study|Withdrawal by Subject|6|||
162689194|NCT03592277|587572163|FG001|Overall Study|Withdrawal by Subject|8|||
162689195|NCT02917265|587572166|FG000|Overall Study|Physician Decision|1|||
162689196|NCT02917265|587572167|FG001|Overall Study|Physician Decision|0|||
162689197|NCT02917265|587572166|FG000|Overall Study|Withdrawal by Subject|1|||
162689198|NCT02917265|587572167|FG001|Overall Study|Withdrawal by Subject|0|||
162689199|NCT00979602|587572180|FG000|Overall Study|Serious Adverse Event|5|||
162689200|NCT00979602|587572181|FG001|Overall Study|Serious Adverse Event|3|||
162689201|NCT00979602|587572180|FG000|Overall Study|Protocol Violation|3|||
162728110|NCT02723955|587714855|FG039|Expansion Phase|Withdrawal by Subject|0|||
162728111|NCT02723955|587714856|FG040|Expansion Phase|Withdrawal by Subject|0|||
162728112|NCT02723955|587714857|FG041|Expansion Phase|Withdrawal by Subject|0|||
162728113|NCT02723955|587714858|FG042|Expansion Phase|Withdrawal by Subject|0|||
162689202|NCT00979602|587572181|FG001|Overall Study|Protocol Violation|0|||
162689203|NCT00979602|587572180|FG000|Overall Study|Withdrawal by Subject|31|||
162689204|NCT00979602|587572181|FG001|Overall Study|Withdrawal by Subject|25|||
162689205|NCT00979602|587572180|FG000|Overall Study|Lost to Follow-up|100|||
162689206|NCT00979602|587572181|FG001|Overall Study|Lost to Follow-up|96|||
162689207|NCT00979602|587572180|FG000|Overall Study|Migrated/moved from study area|3|||
162689208|NCT00979602|587572181|FG001|Overall Study|Migrated/moved from study area|6|||
162689209|NCT00979602|587572180|FG000|Overall Study|Others|3|||
162689210|NCT00979602|587572181|FG001|Overall Study|Others|3|||
162689211|NCT02002182|587572184|FG000|Overall Study|Withdraw from study|3|||
162689212|NCT02002182|587572185|FG001|Overall Study|Withdraw from study|1|||
162689213|NCT02002182|587572184|FG000|Overall Study|Health Reasons|1|||
162689214|NCT02002182|587572185|FG001|Overall Study|Health Reasons|0|||
162689215|NCT02002182|587572184|FG000|Overall Study|Death|1|||
162689216|NCT02002182|587572185|FG001|Overall Study|Death|0|||
162728114|NCT02723955|587714816|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162689217|NCT03635489|587572196|FG000|Overall Study|Death|19|||
162736272|NCT01494662|587744947|FG000|Overall Study|Withdrawal by Subject|0|||
162689218|NCT03635489|587572197|FG001|Overall Study|Death|13|||
162689219|NCT03635489|587572196|FG000|Overall Study|Lost to Follow-up|1|||
162689220|NCT03635489|587572197|FG001|Overall Study|Lost to Follow-up|2|||
162689221|NCT03635489|587572196|FG000|Overall Study|Withdrawal by Subject|1|||
162689222|NCT03635489|587572197|FG001|Overall Study|Withdrawal by Subject|2|||
162689223|NCT03635489|587572196|FG000|Overall Study|Study Ended by Sponsor|28|||
162689224|NCT03635489|587572197|FG001|Overall Study|Study Ended by Sponsor|34|||
162689225|NCT01368900|587572198|FG000|Overall Study|Lost to Follow-up|7|||
162689226|NCT04027348|587572203|FG000|Overall Study|Adverse Event|2|||
162689227|NCT02487472|587572204|FG000|Overall Study|Did not complete telephonic interviews|9|||
162689228|NCT02487472|587572204|FG000|Overall Study|Other|2|||
162689229|NCT01313286|587572205|FG000|Period 1|Withdrawal by Subject|2|||
162689230|NCT01313286|587572206|FG001|Period 1|Withdrawal by Subject|0|||
162689231|NCT01669798|587572207|FG000|Overall Study|Physician Decision|5|||
162689232|NCT01806584|587572211|FG000|Overall Study|Adverse Event|2|||
162689233|NCT01806584|587572212|FG001|Overall Study|Adverse Event|1|||
162689234|NCT01806584|587572211|FG000|Overall Study|Death|1|||
162689235|NCT01806584|587572212|FG001|Overall Study|Death|0|||
162689236|NCT01806584|587572211|FG000|Overall Study|Lost to Follow-up|0|||
162689237|NCT01806584|587572212|FG001|Overall Study|Lost to Follow-up|2|||
162689238|NCT01806584|587572211|FG000|Overall Study|Study terminated by sponsor|9|||
162689239|NCT01806584|587572212|FG001|Overall Study|Study terminated by sponsor|14|||
162689240|NCT01806584|587572211|FG000|Overall Study|Withdrawal by Subject|1|||
162689241|NCT01806584|587572212|FG001|Overall Study|Withdrawal by Subject|1|||
162689242|NCT01806584|587572211|FG000|Overall Study|Other unspecified|1|||
162689243|NCT01806584|587572212|FG001|Overall Study|Other unspecified|0|||
162689244|NCT00311155|587574053|FG000|Overall Study|Adverse Event|21|||
162689245|NCT00311155|587574053|FG000|Overall Study|Withdrawal by Subject|17|||
162689246|NCT00311155|587574053|FG000|Overall Study|Did not meet entry criteria|55|||
162689247|NCT00976703|587574055|FG000|Overall Study|Physician Decision|1|||
162689248|NCT00976703|587574056|FG001|Overall Study|Physician Decision|1|||
162689249|NCT00976703|587574055|FG000|Overall Study|ineligible for study|2|||
162689250|NCT00976703|587574056|FG001|Overall Study|ineligible for study|2|||
162689251|NCT02243631|587574058|FG000|Overall Study|no synovial fluid on second aspirate|0|||
162689252|NCT02243631|587574059|FG001|Overall Study|no synovial fluid on second aspirate|1|||
162689253|NCT01992549|587574062|FG000|Overall Study|Lost to Follow-up|2|||
162689254|NCT01992549|587574062|FG000|Overall Study|Serious Adverse Event|1|||
162689255|NCT01992549|587574062|FG000|Overall Study|Product Switch to Extend Half Life|1|||
162689256|NCT01785628|587574063|FG000|Overall Study|Lost to Follow-up|2|||
162689257|NCT01785628|587574064|FG001|Overall Study|Lost to Follow-up|3|||
162689258|NCT01250119|587574072|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
162689259|NCT01250119|587574073|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
162689260|NCT01250119|587574072|FG000|Diagnostic Phase|Participants Not Tested|44|||
162689261|NCT01250119|587574073|FG001|Diagnostic Phase|Participants Not Tested|0|||
162689262|NCT01250119|587574072|FG000|Treatment Phase|Progressive Disease|0|||
162689263|NCT01250119|587574073|FG001|Treatment Phase|Progressive Disease|32|||
162689264|NCT01250119|587574072|FG000|Treatment Phase|Death|0|||
162689265|NCT01250119|587574073|FG001|Treatment Phase|Death|2|||
162689266|NCT01250119|587574072|FG000|Treatment Phase|Withdrawal by Subject|0|||
162689267|NCT01250119|587574073|FG001|Treatment Phase|Withdrawal by Subject|1|||
162689268|NCT01250119|587574072|FG000|Treatment Phase|Adverse Event|0|||
162689269|NCT01250119|587574073|FG001|Treatment Phase|Adverse Event|2|||
162689270|NCT01250119|587574072|FG000|Treatment Phase|Unknown reason|0|||
162689271|NCT01250119|587574073|FG001|Treatment Phase|Unknown reason|4|||
162689272|NCT01559454|587574074|FG000|Overall Study|Lost to Follow-up|3|||
162689273|NCT01559454|587574075|FG001|Overall Study|Lost to Follow-up|2|||
162689274|NCT01559454|587574074|FG000|Overall Study|Withdrawal by Subject|0|||
162689275|NCT01559454|587574075|FG001|Overall Study|Withdrawal by Subject|1|||
162689276|NCT01559454|587574074|FG000|Overall Study|Physician Decision|0|||
162689277|NCT01559454|587574075|FG001|Overall Study|Physician Decision|1|||
162689278|NCT01559454|587574074|FG000|Overall Study|Protocol Violation|0|||
162689279|NCT01559454|587574075|FG001|Overall Study|Protocol Violation|1|||
162689280|NCT01559454|587574074|FG000|Overall Study|Lack of Efficacy|0|||
162689281|NCT01559454|587574075|FG001|Overall Study|Lack of Efficacy|1|||
162689282|NCT00462670|587574079|FG000|Overall Study|Adverse Event|3|||
162689283|NCT00462670|587574080|FG001|Overall Study|Adverse Event|5|||
162689284|NCT00462670|587574079|FG000|Overall Study|Lack of Efficacy|1|||
162689285|NCT00462670|587574080|FG001|Overall Study|Lack of Efficacy|0|||
162689286|NCT00462670|587574079|FG000|Overall Study|Protocol Violation|1|||
162689287|NCT00462670|587574080|FG001|Overall Study|Protocol Violation|0|||
162689288|NCT00462670|587574079|FG000|Overall Study|Resolution of signs and symptoms|0|||
162689289|NCT00462670|587574080|FG001|Overall Study|Resolution of signs and symptoms|2|||
162689290|NCT00482274|587574085|FG000|Overall Study|Adverse Event|1|||
162689291|NCT02396537|587574086|FG000|Overall Study|Protocol Violation|0|||
162689292|NCT02396537|587574087|FG001|Overall Study|Protocol Violation|1|||
162689293|NCT00787319|587574091|FG000|Overall Study|Lost to Follow-up|2|||
162689294|NCT00787319|587574091|FG000|Overall Study|Withdrawal by Subject|15|||
162689295|NCT00787319|587574091|FG000|Overall Study|Adverse Event|3|||
162689296|NCT00787319|587574091|FG000|Overall Study|Objective progression or relapse|30|||
162689297|NCT00787319|587574091|FG000|Overall Study|Lack of Efficacy|1|||
162689298|NCT00787319|587574091|FG000|Overall Study|Budget exhausted/exceeded|1|||
162689299|NCT00787319|587574091|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
162689300|NCT00787319|587574091|FG000|Overall Study|No health insurance reimbursement|2|||
162689301|NCT00787319|587574091|FG000|Overall Study|Stabilized disease findings|3|||
162689302|NCT00787319|587574091|FG000|Overall Study|Inactive disease|5|||
162689303|NCT01932294|587574092|FG000|Overall Study|Death|43|||
162689304|NCT01932294|587574092|FG000|Overall Study|Lost to Follow-up|8|||
162689305|NCT01932294|587574092|FG000|Overall Study|VAD Implantation|20|||
162689306|NCT01932294|587574092|FG000|Overall Study|Heart Transplantation|16|||
162689307|NCT01932294|587574092|FG000|Overall Study|Transferred to other hospitals|12|||
162689308|NCT00409786|587574095|FG000|Overall Study|Withdrawal by Subject|3|||
162689309|NCT03075904|587574102|FG000|Overall Study|Physician Decision|3|||
162689310|NCT03075904|587574102|FG000|Overall Study|Need for Medication not Permitted|1|||
162689311|NCT00597714|587574103|FG000|Overall Study|Death|56|||
162689312|NCT00597714|587574104|FG001|Overall Study|Death|46|||
162689313|NCT00597714|587574105|FG002|Overall Study|Death|0|||
162689314|NCT00597714|587574103|FG000|Overall Study|Recipient death|0|||
162689315|NCT00597714|587574104|FG001|Overall Study|Recipient death|0|||
162689316|NCT00597714|587574105|FG002|Overall Study|Recipient death|10|||
162689317|NCT02228395|587574106|FG000|First Intervention Period|No longer willing to participate|1|||
162689318|NCT02228395|587574107|FG001|First Intervention Period|No longer willing to participate|0|||
162689319|NCT02228395|587574108|FG002|First Intervention Period|No longer willing to participate|0|||
162689320|NCT02228395|587574106|FG000|First Intervention Period|Unable to comply with study dates|0|||
162689321|NCT02228395|587574107|FG001|First Intervention Period|Unable to comply with study dates|1|||
162689322|NCT02228395|587574108|FG002|First Intervention Period|Unable to comply with study dates|1|||
162689323|NCT02424591|587574113|FG000|Overall Study|Protocol Violation|2|||
162689324|NCT02424591|587574114|FG001|Overall Study|Protocol Violation|3|||
162689325|NCT00988221|587574115|FG000|Part I|Adverse Event|0|||
162689326|NCT00988221|587574116|FG001|Part I|Adverse Event|1|||
162689327|NCT00988221|587574117|FG002|Part I|Adverse Event|2|||
162689328|NCT00988221|587574118|FG003|Part I|Adverse Event|0|||
162689329|NCT00988221|587574115|FG000|Part I|Insufficient Therapeutic Response|4|||
162689330|NCT00988221|587574116|FG001|Part I|Insufficient Therapeutic Response|6|||
162689331|NCT00988221|587574117|FG002|Part I|Insufficient Therapeutic Response|5|||
162689332|NCT00988221|587574118|FG003|Part I|Insufficient Therapeutic Response|0|||
162689333|NCT00988221|587574115|FG000|Part I|Refused Treatment|0|||
162689334|NCT00988221|587574116|FG001|Part I|Refused Treatment|2|||
162689335|NCT00988221|587574117|FG002|Part I|Refused Treatment|1|||
162689336|NCT00988221|587574118|FG003|Part I|Refused Treatment|0|||
162689337|NCT00988221|587574115|FG000|Part I|Lost to Follow-up|0|||
162689338|NCT00988221|587574116|FG001|Part I|Lost to Follow-up|1|||
162689339|NCT00988221|587574117|FG002|Part I|Lost to Follow-up|0|||
162689340|NCT00988221|587574118|FG003|Part I|Lost to Follow-up|0|||
162689341|NCT00988221|587574115|FG000|Part II|Adverse Event|1|||
162689342|NCT00988221|587574116|FG001|Part II|Adverse Event|0|||
162689343|NCT00988221|587574117|FG002|Part II|Adverse Event|0|||
162689344|NCT00988221|587574118|FG003|Part II|Adverse Event|1|||
162689345|NCT00988221|587574115|FG000|Part II|Withdrawal by Subject|0|||
162689346|NCT00988221|587574116|FG001|Part II|Withdrawal by Subject|0|||
162689347|NCT00988221|587574117|FG002|Part II|Withdrawal by Subject|2|||
162689348|NCT00988221|587574118|FG003|Part II|Withdrawal by Subject|2|||
162689349|NCT00988221|587574115|FG000|Part II|Reason not Specified|0|||
162689350|NCT00988221|587574116|FG001|Part II|Reason not Specified|0|||
162689351|NCT00988221|587574117|FG002|Part II|Reason not Specified|1|||
162689352|NCT00988221|587574118|FG003|Part II|Reason not Specified|0|||
162689353|NCT00988221|587574115|FG000|Part III|Adverse Event|1|||
162689354|NCT00988221|587574116|FG001|Part III|Adverse Event|0|||
162689355|NCT00988221|587574117|FG002|Part III|Adverse Event|1|||
162689356|NCT00988221|587574118|FG003|Part III|Adverse Event|0|||
162689357|NCT00988221|587574115|FG000|Part III|Insufficient Therapeutic Response|0|||
162689358|NCT00988221|587574116|FG001|Part III|Insufficient Therapeutic Response|1|||
162689359|NCT00988221|587574117|FG002|Part III|Insufficient Therapeutic Response|1|||
162689360|NCT00988221|587574118|FG003|Part III|Insufficient Therapeutic Response|0|||
162689361|NCT00988221|587574115|FG000|Part III|Refused Treatment|0|||
162689362|NCT00988221|587574116|FG001|Part III|Refused Treatment|0|||
162689363|NCT00988221|587574117|FG002|Part III|Refused Treatment|1|||
162689364|NCT00988221|587574118|FG003|Part III|Refused Treatment|0|||
162689365|NCT01719237|587574126|FG000|Overall Study|Physician Decision|0|||
162689366|NCT01719237|587574127|FG001|Overall Study|Physician Decision|1|||
162689367|NCT02712398|587574128|FG000|Overall Study|Withdrawal by Subject|6|||
162689368|NCT02712398|587574128|FG000|Overall Study|Lost to Follow-up|6|||
162689369|NCT02712398|587574128|FG000|Overall Study|Sponsor Decision|1|||
162689370|NCT02712398|587574128|FG000|Overall Study|Physician Decision|1|||
162689371|NCT02712398|587574128|FG000|Overall Study|Death|2|||
162689372|NCT02712398|587574128|FG000|Overall Study|Re-operation|21|||
162689373|NCT04772053|587574138|FG000|Overall Study|Physician Decision|2|||
162689374|NCT04772053|587574138|FG000|Overall Study|Withdrawal by Subject|3|||
162689375|NCT04772053|587574138|FG000|Overall Study|Study Terminated by Sponsor|1|||
162689376|NCT04146896|587574143|FG000|Overall Study|Adverse Event|5|||
162689377|NCT04146896|587574144|FG001|Overall Study|Adverse Event|8|||
162728115|NCT02723955|587714817|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728116|NCT02723955|587714818|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728117|NCT02723955|587714819|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728118|NCT02723955|587714820|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728119|NCT02723955|587714821|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728120|NCT02723955|587714822|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728121|NCT02723955|587714823|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728122|NCT02723955|587714824|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728123|NCT02723955|587714825|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
162728124|NCT02723955|587714826|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
162728125|NCT02723955|587714827|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
162728126|NCT02723955|587714828|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728127|NCT02723955|587714829|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728128|NCT02723955|587714830|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728129|NCT02723955|587714831|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728130|NCT02723955|587714832|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728131|NCT02723955|587714833|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728132|NCT02723955|587714834|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728133|NCT02723955|587714835|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728134|NCT02723955|587714836|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728135|NCT02723955|587714837|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728136|NCT02723955|587714838|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728137|NCT02723955|587714839|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728138|NCT02723955|587714840|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728139|NCT02723955|587714841|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728140|NCT02723955|587714842|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728141|NCT02723955|587714843|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728142|NCT02723955|587714844|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728143|NCT02723955|587714845|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728144|NCT02723955|587714846|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
162728145|NCT02723955|587714847|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728146|NCT02723955|587714848|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728147|NCT02723955|587714849|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728148|NCT02723955|587714850|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728149|NCT02723955|587714851|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728150|NCT02723955|587714852|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728151|NCT02723955|587714853|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728152|NCT02723955|587714854|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728153|NCT02723955|587714855|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728154|NCT02723955|587714856|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728155|NCT02723955|587714857|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728156|NCT02723955|587714858|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162728157|NCT02723955|587714816|FG000|Expansion Phase|Site Closed|0|||
162728158|NCT02723955|587714817|FG001|Expansion Phase|Site Closed|0|||
162728159|NCT02723955|587714818|FG002|Expansion Phase|Site Closed|0|||
162728160|NCT02723955|587714819|FG003|Expansion Phase|Site Closed|0|||
162728161|NCT02723955|587714820|FG004|Expansion Phase|Site Closed|0|||
162728162|NCT02723955|587714821|FG005|Expansion Phase|Site Closed|0|||
162728163|NCT02723955|587714822|FG006|Expansion Phase|Site Closed|0|||
162728164|NCT02723955|587714823|FG007|Expansion Phase|Site Closed|0|||
162728165|NCT02723955|587714824|FG008|Expansion Phase|Site Closed|0|||
162728166|NCT02723955|587714825|FG009|Expansion Phase|Site Closed|1|||
162728167|NCT02723955|587714826|FG010|Expansion Phase|Site Closed|2|||
162728168|NCT02723955|587714827|FG011|Expansion Phase|Site Closed|6|||
162728169|NCT02723955|587714828|FG012|Expansion Phase|Site Closed|0|||
162728170|NCT02723955|587714829|FG013|Expansion Phase|Site Closed|0|||
162728171|NCT02723955|587714830|FG014|Expansion Phase|Site Closed|0|||
162728172|NCT02723955|587714831|FG015|Expansion Phase|Site Closed|0|||
162689378|NCT04146896|587574143|FG000|Overall Study|Lack of Efficacy|3|||
162689379|NCT04146896|587574144|FG001|Overall Study|Lack of Efficacy|2|||
162689380|NCT04146896|587574143|FG000|Overall Study|Lost to Follow-up|0|||
162689381|NCT04146896|587574144|FG001|Overall Study|Lost to Follow-up|1|||
162689382|NCT04146896|587574143|FG000|Overall Study|Non-compliance|5|||
162689383|NCT04146896|587574144|FG001|Overall Study|Non-compliance|4|||
162689384|NCT04146896|587574143|FG000|Overall Study|Withdrawal by Subject|3|||
162689385|NCT04146896|587574144|FG001|Overall Study|Withdrawal by Subject|5|||
162689386|NCT04146896|587574143|FG000|Overall Study|Randomized in error|1|||
162689387|NCT04146896|587574144|FG001|Overall Study|Randomized in error|2|||
162689388|NCT03107377|587574145|FG000|Overall Study|Adverse Event|3|||
162689389|NCT03107377|587574146|FG001|Overall Study|Adverse Event|3|||
162689390|NCT03107377|587574145|FG000|Overall Study|Protocol Violation|9|||
162689391|NCT03107377|587574146|FG001|Overall Study|Protocol Violation|12|||
162689392|NCT03107377|587574145|FG000|Overall Study|Physician Decision|3|||
162689393|NCT03107377|587574146|FG001|Overall Study|Physician Decision|6|||
162689394|NCT03107377|587574145|FG000|Overall Study|Pregnancy|7|||
162689395|NCT03107377|587574146|FG001|Overall Study|Pregnancy|7|||
162689396|NCT03107377|587574145|FG000|Overall Study|Withdrawal by Subject|16|||
162689397|NCT03107377|587574146|FG001|Overall Study|Withdrawal by Subject|22|||
162689398|NCT03107377|587574145|FG000|Overall Study|Lost to Follow-up|37|||
162689399|NCT03107377|587574146|FG001|Overall Study|Lost to Follow-up|34|||
162689400|NCT03107377|587574145|FG000|Overall Study|Other reason not specified|16|||
162689401|NCT03107377|587574146|FG001|Overall Study|Other reason not specified|15|||
162689402|NCT01597505|587574147|FG000|Overall Study|Physician Decision|5|||
162689403|NCT01597505|587574148|FG001|Overall Study|Physician Decision|0|||
162689404|NCT01597505|587574147|FG000|Overall Study|Adverse Event|19|||
162689405|NCT01597505|587574148|FG001|Overall Study|Adverse Event|7|||
162689406|NCT01597505|587574147|FG000|Overall Study|Lost to Follow-up|4|||
162689407|NCT01597505|587574148|FG001|Overall Study|Lost to Follow-up|2|||
162689408|NCT01597505|587574147|FG000|Overall Study|Withdrawal by Subject|10|||
162689409|NCT01597505|587574148|FG001|Overall Study|Withdrawal by Subject|18|||
162689410|NCT01597505|587574147|FG000|Overall Study|Other|5|||
162689411|NCT01597505|587574148|FG001|Overall Study|Other|6|||
162689412|NCT01597505|587574147|FG000|Overall Study|Missing|1|||
162689413|NCT01597505|587574148|FG001|Overall Study|Missing|0|||
162689414|NCT02675465|587574150|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
162689415|NCT02675465|587574151|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
162689416|NCT02675465|587574152|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
162689417|NCT02675465|587574153|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
162689418|NCT02675465|587574154|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
162689419|NCT02675465|587574155|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
162689420|NCT02675465|587574150|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162689421|NCT02675465|587574151|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162689422|NCT02675465|587574152|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
162689423|NCT02675465|587574153|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162689424|NCT02675465|587574154|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162689425|NCT02675465|587574155|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162689426|NCT02675465|587574150|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
162689427|NCT02675465|587574151|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
162689428|NCT02675465|587574152|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
162689429|NCT02675465|587574153|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
162689430|NCT02675465|587574154|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
162689431|NCT02675465|587574155|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
162689432|NCT02675465|587574150|FG000|Stage 4: Long Term Extension|Death|0|||
162689433|NCT02675465|587574151|FG001|Stage 4: Long Term Extension|Death|0|||
162689434|NCT02675465|587574152|FG002|Stage 4: Long Term Extension|Death|0|||
162689435|NCT02675465|587574153|FG003|Stage 4: Long Term Extension|Death|1|||
162689436|NCT02675465|587574154|FG004|Stage 4: Long Term Extension|Death|0|||
162689437|NCT02675465|587574155|FG005|Stage 4: Long Term Extension|Death|0|||
162689438|NCT00453102|587574156|FG000|Overall Study|Withdrawal by Subject|2|||
162689439|NCT05031078|587574157|FG000|Overall Study|Withdrawal by Subject|0|||
162689440|NCT05031078|587574158|FG001|Overall Study|Withdrawal by Subject|1|||
162689441|NCT05031078|587574159|FG002|Overall Study|Withdrawal by Subject|0|||
162689442|NCT03728972|587574160|FG000|Overall Study|Death|1|||
162689443|NCT03728972|587574161|FG001|Overall Study|Death|0|||
162689444|NCT03728972|587574160|FG000|Overall Study|Lack of Efficacy|1|||
162689445|NCT03728972|587574161|FG001|Overall Study|Lack of Efficacy|0|||
162689446|NCT03728972|587574160|FG000|Overall Study|Physician Decision|3|||
162689447|NCT03728972|587574161|FG001|Overall Study|Physician Decision|0|||
162689448|NCT03728972|587574160|FG000|Overall Study|Disease progression|4|||
162689449|NCT03728972|587574161|FG001|Overall Study|Disease progression|3|||
162689450|NCT03787680|587574166|FG000|Overall Study|Physician Decision|2|||
162689451|NCT03787680|587574167|FG001|Overall Study|Physician Decision|3|||
162689452|NCT03787680|587574166|FG000|Overall Study|Adverse Event|7|||
162689453|NCT03787680|587574167|FG001|Overall Study|Adverse Event|3|||
162689454|NCT03787680|587574166|FG000|Overall Study|Withdrawal by Subject|2|||
162689455|NCT03787680|587574167|FG001|Overall Study|Withdrawal by Subject|1|||
162689456|NCT05454410|587574170|FG000|Overall Study|Withdrawal by Subject|0|||
162689457|NCT05454410|587574171|FG001|Overall Study|Withdrawal by Subject|0|||
162689458|NCT05454410|587574172|FG002|Overall Study|Withdrawal by Subject|1|||
162689459|NCT05454410|587574173|FG003|Overall Study|Withdrawal by Subject|1|||
162689460|NCT00895622|587574174|FG000|Overall Study|Protocol Violation|5|||
162689461|NCT00895622|587574175|FG001|Overall Study|Protocol Violation|4|||
162689462|NCT00895622|587574176|FG002|Overall Study|Protocol Violation|4|||
162689463|NCT01320943|587574177|FG000|Overall Study|Lost to Follow-up|1|||
162689464|NCT01320943|587574178|FG001|Overall Study|Lost to Follow-up|0|||
162689465|NCT01320943|587574177|FG000|Overall Study|Physician Decision|0|||
162689466|NCT01320943|587574178|FG001|Overall Study|Physician Decision|1|||
162689467|NCT01320943|587574177|FG000|Overall Study|Randomized but not Treated|0|||
162689468|NCT01320943|587574178|FG001|Overall Study|Randomized but not Treated|1|||
162689469|NCT01490125|587574179|FG000|Period I|Adverse Event|4|||
162689470|NCT01490125|587574180|FG001|Period I|Adverse Event|1|||
162689471|NCT01490125|587574181|FG002|Period I|Adverse Event|1|||
162689472|NCT01490125|587574182|FG003|Period I|Adverse Event|3|||
162689473|NCT01490125|587574183|FG004|Period I|Adverse Event|2|||
162689474|NCT01490125|587574184|FG005|Period I|Adverse Event|4|||
162689475|NCT01490125|587574179|FG000|Period I|Protocol Violation|1|||
162689476|NCT01490125|587574180|FG001|Period I|Protocol Violation|1|||
162689477|NCT01490125|587574181|FG002|Period I|Protocol Violation|1|||
162689478|NCT01490125|587574182|FG003|Period I|Protocol Violation|1|||
162689479|NCT01490125|587574183|FG004|Period I|Protocol Violation|0|||
162689480|NCT01490125|587574184|FG005|Period I|Protocol Violation|0|||
162689481|NCT01490125|587574179|FG000|Period I|Withdrawal by Subject|1|||
162689482|NCT01490125|587574180|FG001|Period I|Withdrawal by Subject|3|||
162689483|NCT01490125|587574181|FG002|Period I|Withdrawal by Subject|2|||
162689484|NCT01490125|587574182|FG003|Period I|Withdrawal by Subject|1|||
162689485|NCT01490125|587574183|FG004|Period I|Withdrawal by Subject|2|||
162689486|NCT01490125|587574184|FG005|Period I|Withdrawal by Subject|1|||
162689487|NCT01490125|587574179|FG000|Period II|Adverse Event|2|||
162689488|NCT01490125|587574180|FG001|Period II|Adverse Event|3|||
162689489|NCT01490125|587574181|FG002|Period II|Adverse Event|2|||
162689490|NCT01490125|587574182|FG003|Period II|Adverse Event|2|||
162689491|NCT01490125|587574183|FG004|Period II|Adverse Event|4|||
162689492|NCT01490125|587574184|FG005|Period II|Adverse Event|2|||
162689493|NCT01490125|587574179|FG000|Period II|Protocol Violation|0|||
162689494|NCT01490125|587574180|FG001|Period II|Protocol Violation|0|||
162689495|NCT01490125|587574181|FG002|Period II|Protocol Violation|1|||
162689496|NCT01490125|587574182|FG003|Period II|Protocol Violation|1|||
162689497|NCT01490125|587574183|FG004|Period II|Protocol Violation|0|||
162689498|NCT01490125|587574184|FG005|Period II|Protocol Violation|0|||
162689499|NCT01490125|587574179|FG000|Period II|Lost to Follow-up|0|||
162689500|NCT01490125|587574180|FG001|Period II|Lost to Follow-up|1|||
162689501|NCT01490125|587574181|FG002|Period II|Lost to Follow-up|0|||
162689502|NCT01490125|587574182|FG003|Period II|Lost to Follow-up|0|||
162689503|NCT01490125|587574183|FG004|Period II|Lost to Follow-up|0|||
162689504|NCT01490125|587574184|FG005|Period II|Lost to Follow-up|0|||
162689505|NCT01490125|587574179|FG000|Period II|Withdrawal by Subject|1|||
162689506|NCT01490125|587574180|FG001|Period II|Withdrawal by Subject|0|||
162689507|NCT01490125|587574181|FG002|Period II|Withdrawal by Subject|0|||
162689508|NCT01490125|587574182|FG003|Period II|Withdrawal by Subject|0|||
162689509|NCT01490125|587574183|FG004|Period II|Withdrawal by Subject|0|||
162689510|NCT01490125|587574184|FG005|Period II|Withdrawal by Subject|0|||
162689511|NCT01490125|587574179|FG000|Period III|Adverse Event|3|||
162689512|NCT01490125|587574180|FG001|Period III|Adverse Event|1|||
162689513|NCT01490125|587574181|FG002|Period III|Adverse Event|0|||
162689514|NCT01490125|587574182|FG003|Period III|Adverse Event|1|||
162689515|NCT01490125|587574183|FG004|Period III|Adverse Event|0|||
162689516|NCT01490125|587574184|FG005|Period III|Adverse Event|0|||
162689517|NCT01490125|587574179|FG000|Period III|Death|0|||
162689518|NCT01490125|587574180|FG001|Period III|Death|0|||
162689519|NCT01490125|587574181|FG002|Period III|Death|0|||
162689520|NCT01490125|587574182|FG003|Period III|Death|1|||
162689521|NCT01490125|587574183|FG004|Period III|Death|0|||
162689522|NCT01490125|587574184|FG005|Period III|Death|0|||
162689523|NCT01490125|587574179|FG000|Period III|Lack of Efficacy|0|||
162689524|NCT01490125|587574180|FG001|Period III|Lack of Efficacy|0|||
162689525|NCT01490125|587574181|FG002|Period III|Lack of Efficacy|0|||
162689526|NCT01490125|587574182|FG003|Period III|Lack of Efficacy|0|||
162689527|NCT01490125|587574183|FG004|Period III|Lack of Efficacy|1|||
162689528|NCT01490125|587574184|FG005|Period III|Lack of Efficacy|0|||
162689529|NCT02010632|587574189|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
162689530|NCT02010632|587574190|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
162689531|NCT02404389|587574191|FG000|Overall Study|Adverse Event|1|||
162689532|NCT02404389|587574192|FG001|Overall Study|Adverse Event|0|||
162689533|NCT02404389|587574193|FG002|Overall Study|Adverse Event|1|||
162689534|NCT02404389|587574194|FG003|Overall Study|Adverse Event|0|||
162689535|NCT02404389|587574195|FG004|Overall Study|Adverse Event|2|||
162689536|NCT02404389|587574191|FG000|Overall Study|Subject/guardian decision|1|||
162689537|NCT02404389|587574192|FG001|Overall Study|Subject/guardian decision|0|||
162728173|NCT02723955|587714832|FG016|Expansion Phase|Site Closed|0|||
162728174|NCT02723955|587714833|FG017|Expansion Phase|Site Closed|0|||
162728175|NCT02723955|587714834|FG018|Expansion Phase|Site Closed|0|||
162728176|NCT02723955|587714835|FG019|Expansion Phase|Site Closed|0|||
162728177|NCT02723955|587714836|FG020|Expansion Phase|Site Closed|0|||
162728178|NCT02723955|587714837|FG021|Expansion Phase|Site Closed|0|||
162728179|NCT02723955|587714838|FG022|Expansion Phase|Site Closed|0|||
162728180|NCT02723955|587714839|FG023|Expansion Phase|Site Closed|0|||
162728181|NCT02723955|587714840|FG024|Expansion Phase|Site Closed|0|||
162728182|NCT02723955|587714841|FG025|Expansion Phase|Site Closed|0|||
162728183|NCT02723955|587714842|FG026|Expansion Phase|Site Closed|0|||
162728184|NCT02723955|587714843|FG027|Expansion Phase|Site Closed|0|||
162728185|NCT02723955|587714844|FG028|Expansion Phase|Site Closed|0|||
162728186|NCT02723955|587714845|FG029|Expansion Phase|Site Closed|0|||
162728187|NCT02723955|587714846|FG030|Expansion Phase|Site Closed|8|||
162728188|NCT02723955|587714847|FG031|Expansion Phase|Site Closed|4|||
162728189|NCT02723955|587714848|FG032|Expansion Phase|Site Closed|2|||
162728190|NCT02723955|587714849|FG033|Expansion Phase|Site Closed|2|||
162728191|NCT02723955|587714850|FG034|Expansion Phase|Site Closed|0|||
162728192|NCT02723955|587714851|FG035|Expansion Phase|Site Closed|0|||
162728193|NCT02723955|587714852|FG036|Expansion Phase|Site Closed|0|||
162728194|NCT02723955|587714853|FG037|Expansion Phase|Site Closed|0|||
162728195|NCT02723955|587714854|FG038|Expansion Phase|Site Closed|0|||
162728196|NCT02723955|587714855|FG039|Expansion Phase|Site Closed|0|||
162728197|NCT02723955|587714856|FG040|Expansion Phase|Site Closed|0|||
162728198|NCT02723955|587714857|FG041|Expansion Phase|Site Closed|0|||
162728199|NCT02723955|587714858|FG042|Expansion Phase|Site Closed|0|||
162728200|NCT02723955|587714816|FG000|Crossover/ Re-treatment Phase|Death|0|||
162728201|NCT02723955|587714817|FG001|Crossover/ Re-treatment Phase|Death|0|||
162728202|NCT02723955|587714818|FG002|Crossover/ Re-treatment Phase|Death|0|||
162728203|NCT02723955|587714819|FG003|Crossover/ Re-treatment Phase|Death|0|||
162728204|NCT02723955|587714820|FG004|Crossover/ Re-treatment Phase|Death|0|||
162728205|NCT02723955|587714821|FG005|Crossover/ Re-treatment Phase|Death|0|||
162728206|NCT02723955|587714822|FG006|Crossover/ Re-treatment Phase|Death|0|||
162728207|NCT02723955|587714823|FG007|Crossover/ Re-treatment Phase|Death|0|||
162728208|NCT02723955|587714824|FG008|Crossover/ Re-treatment Phase|Death|0|||
162728209|NCT02723955|587714825|FG009|Crossover/ Re-treatment Phase|Death|0|||
162728210|NCT02723955|587714826|FG010|Crossover/ Re-treatment Phase|Death|0|||
162728211|NCT02723955|587714827|FG011|Crossover/ Re-treatment Phase|Death|0|||
162728212|NCT02723955|587714828|FG012|Crossover/ Re-treatment Phase|Death|0|||
162728213|NCT02723955|587714829|FG013|Crossover/ Re-treatment Phase|Death|0|||
162728214|NCT02723955|587714830|FG014|Crossover/ Re-treatment Phase|Death|0|||
162728215|NCT02723955|587714831|FG015|Crossover/ Re-treatment Phase|Death|0|||
162728216|NCT02723955|587714832|FG016|Crossover/ Re-treatment Phase|Death|0|||
162728217|NCT02723955|587714833|FG017|Crossover/ Re-treatment Phase|Death|0|||
162728218|NCT02723955|587714834|FG018|Crossover/ Re-treatment Phase|Death|0|||
162728219|NCT02723955|587714835|FG019|Crossover/ Re-treatment Phase|Death|0|||
162728220|NCT02723955|587714836|FG020|Crossover/ Re-treatment Phase|Death|0|||
162728221|NCT02723955|587714837|FG021|Crossover/ Re-treatment Phase|Death|0|||
162728222|NCT02723955|587714838|FG022|Crossover/ Re-treatment Phase|Death|0|||
162728223|NCT02723955|587714839|FG023|Crossover/ Re-treatment Phase|Death|0|||
162728224|NCT02723955|587714840|FG024|Crossover/ Re-treatment Phase|Death|0|||
162728225|NCT02723955|587714841|FG025|Crossover/ Re-treatment Phase|Death|0|||
162728226|NCT02723955|587714842|FG026|Crossover/ Re-treatment Phase|Death|0|||
162689538|NCT02404389|587574193|FG002|Overall Study|Subject/guardian decision|0|||
162689539|NCT02404389|587574194|FG003|Overall Study|Subject/guardian decision|1|||
162689540|NCT02404389|587574195|FG004|Overall Study|Subject/guardian decision|1|||
162689541|NCT01919970|587574196|FG000|Overall Study|Withdrawal by Subject|3|||
162689542|NCT01919970|587574197|FG001|Overall Study|Withdrawal by Subject|0|||
162689543|NCT00990340|587574198|FG000|First 14-day Treatment|Not Compliant|2|||
162689544|NCT00990340|587574199|FG001|First 14-day Treatment|Not Compliant|1|||
162689545|NCT00990340|587574198|FG000|First 14-day Treatment|Lost to Follow-up|2|||
162689546|NCT00990340|587574199|FG001|First 14-day Treatment|Lost to Follow-up|1|||
162689547|NCT00990340|587574198|FG000|First 14-day Treatment|Protocol Violation|2|||
162689548|NCT00990340|587574199|FG001|First 14-day Treatment|Protocol Violation|2|||
162689549|NCT04615182|587574200|FG000|Overall Study|Re-transplanted|2|||
162689550|NCT04615182|587574200|FG000|Overall Study|Protocol Violation|6|||
162689551|NCT04615182|587574200|FG000|Overall Study|Death|6|||
162689552|NCT04615182|587574200|FG000|Overall Study|Death and protocol violation|1|||
162689553|NCT01126060|587574201|FG000|Overall Study|Protocol Violation|0|||
162689554|NCT01126060|587574202|FG001|Overall Study|Protocol Violation|2|||
162728227|NCT02723955|587714843|FG027|Crossover/ Re-treatment Phase|Death|0|||
162728228|NCT02723955|587714844|FG028|Crossover/ Re-treatment Phase|Death|0|||
162728229|NCT02723955|587714845|FG029|Crossover/ Re-treatment Phase|Death|0|||
162728230|NCT02723955|587714846|FG030|Crossover/ Re-treatment Phase|Death|0|||
162689555|NCT03565068|587574203|FG000|Overall Study|Protocol Violation|0|||
162689556|NCT03565068|587574204|FG001|Overall Study|Protocol Violation|0|||
162689557|NCT03565068|587574205|FG002|Overall Study|Protocol Violation|0|||
162728231|NCT02723955|587714847|FG031|Crossover/ Re-treatment Phase|Death|0|||
162728232|NCT02723955|587714848|FG032|Crossover/ Re-treatment Phase|Death|0|||
162728233|NCT02723955|587714849|FG033|Crossover/ Re-treatment Phase|Death|0|||
162728234|NCT02723955|587714850|FG034|Crossover/ Re-treatment Phase|Death|0|||
162728235|NCT02723955|587714851|FG035|Crossover/ Re-treatment Phase|Death|0|||
162728236|NCT02723955|587714852|FG036|Crossover/ Re-treatment Phase|Death|0|||
162728237|NCT02723955|587714853|FG037|Crossover/ Re-treatment Phase|Death|1|||
162728238|NCT02723955|587714854|FG038|Crossover/ Re-treatment Phase|Death|14|||
162728239|NCT02723955|587714855|FG039|Crossover/ Re-treatment Phase|Death|32|||
162728240|NCT02723955|587714856|FG040|Crossover/ Re-treatment Phase|Death|2|||
162728241|NCT02723955|587714857|FG041|Crossover/ Re-treatment Phase|Death|1|||
162728242|NCT02723955|587714858|FG042|Crossover/ Re-treatment Phase|Death|0|||
162728243|NCT02723955|587714816|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728244|NCT02723955|587714817|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728245|NCT02723955|587714818|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728246|NCT02723955|587714819|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728247|NCT02723955|587714820|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728248|NCT02723955|587714821|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728249|NCT02723955|587714822|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728250|NCT02723955|587714823|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728251|NCT02723955|587714824|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728252|NCT02723955|587714825|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728253|NCT02723955|587714826|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728254|NCT02723955|587714827|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728255|NCT02723955|587714828|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728256|NCT02723955|587714829|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728257|NCT02723955|587714830|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728258|NCT02723955|587714831|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728259|NCT02723955|587714832|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728260|NCT02723955|587714833|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728261|NCT02723955|587714834|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728262|NCT02723955|587714835|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728263|NCT02723955|587714836|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728264|NCT02723955|587714837|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728265|NCT02723955|587714838|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728266|NCT02723955|587714839|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728267|NCT02723955|587714840|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728268|NCT02723955|587714841|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728269|NCT02723955|587714842|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728270|NCT02723955|587714843|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728271|NCT02723955|587714844|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728272|NCT02723955|587714845|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728273|NCT02723955|587714846|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728274|NCT02723955|587714847|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728275|NCT02723955|587714848|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728276|NCT02723955|587714849|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728277|NCT02723955|587714850|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728278|NCT02723955|587714851|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728279|NCT02723955|587714852|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728280|NCT02723955|587714853|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728281|NCT02723955|587714854|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728282|NCT02723955|587714855|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
162728283|NCT02723955|587714856|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728284|NCT02723955|587714857|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728285|NCT02723955|587714858|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162728286|NCT02723955|587714816|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728287|NCT02723955|587714817|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728288|NCT02723955|587714818|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728289|NCT02723955|587714819|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728290|NCT02723955|587714820|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728291|NCT02723955|587714821|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728292|NCT02723955|587714822|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728293|NCT02723955|587714823|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728294|NCT02723955|587714824|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728295|NCT02723955|587714825|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728296|NCT02723955|587714826|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728297|NCT02723955|587714827|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728298|NCT02723955|587714828|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728299|NCT02723955|587714829|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728300|NCT02723955|587714830|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728301|NCT02723955|587714831|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
162689558|NCT03565068|587574206|FG003|Overall Study|Protocol Violation|0|||
162689559|NCT03565068|587574207|FG004|Overall Study|Protocol Violation|1|||
162689560|NCT03565068|587574208|FG005|Overall Study|Protocol Violation|0|||
162689561|NCT03565068|587574209|FG006|Overall Study|Protocol Violation|0|||
162689562|NCT03565068|587574210|FG007|Overall Study|Protocol Violation|1|||
162689563|NCT03565068|587574211|FG008|Overall Study|Protocol Violation|0|||
162689564|NCT03565068|587574203|FG000|Overall Study|Sponsor decision|0|||
162689565|NCT03565068|587574204|FG001|Overall Study|Sponsor decision|0|||
162689566|NCT03565068|587574205|FG002|Overall Study|Sponsor decision|0|||
162689567|NCT03565068|587574206|FG003|Overall Study|Sponsor decision|0|||
162689568|NCT03565068|587574207|FG004|Overall Study|Sponsor decision|1|||
162689569|NCT03565068|587574208|FG005|Overall Study|Sponsor decision|1|||
162689570|NCT03565068|587574209|FG006|Overall Study|Sponsor decision|0|||
162689571|NCT03565068|587574210|FG007|Overall Study|Sponsor decision|0|||
162689572|NCT03565068|587574211|FG008|Overall Study|Sponsor decision|0|||
162689573|NCT03565068|587574203|FG000|Overall Study|Withdrawal by Subject|0|||
162689574|NCT03565068|587574204|FG001|Overall Study|Withdrawal by Subject|0|||
162689575|NCT03565068|587574205|FG002|Overall Study|Withdrawal by Subject|1|||
162689576|NCT03565068|587574206|FG003|Overall Study|Withdrawal by Subject|0|||
162689577|NCT03565068|587574207|FG004|Overall Study|Withdrawal by Subject|2|||
162689578|NCT03565068|587574208|FG005|Overall Study|Withdrawal by Subject|0|||
162689579|NCT03565068|587574209|FG006|Overall Study|Withdrawal by Subject|1|||
162689580|NCT03565068|587574210|FG007|Overall Study|Withdrawal by Subject|5|||
162689581|NCT03565068|587574211|FG008|Overall Study|Withdrawal by Subject|1|||
162689582|NCT03565068|587574203|FG000|Overall Study|Physician Decision|0|||
162689583|NCT03565068|587574204|FG001|Overall Study|Physician Decision|0|||
162689584|NCT03565068|587574205|FG002|Overall Study|Physician Decision|0|||
162689585|NCT03565068|587574206|FG003|Overall Study|Physician Decision|0|||
162689586|NCT03565068|587574207|FG004|Overall Study|Physician Decision|0|||
162689587|NCT03565068|587574208|FG005|Overall Study|Physician Decision|0|||
162689588|NCT03565068|587574209|FG006|Overall Study|Physician Decision|0|||
162689589|NCT03565068|587574210|FG007|Overall Study|Physician Decision|1|||
162689590|NCT03565068|587574211|FG008|Overall Study|Physician Decision|0|||
162689591|NCT03565068|587574203|FG000|Overall Study|Lost to Follow-up|0|||
162689592|NCT03565068|587574204|FG001|Overall Study|Lost to Follow-up|0|||
162689593|NCT03565068|587574205|FG002|Overall Study|Lost to Follow-up|0|||
162689594|NCT03565068|587574206|FG003|Overall Study|Lost to Follow-up|0|||
162689595|NCT03565068|587574207|FG004|Overall Study|Lost to Follow-up|0|||
162689596|NCT03565068|587574208|FG005|Overall Study|Lost to Follow-up|0|||
162689597|NCT03565068|587574209|FG006|Overall Study|Lost to Follow-up|0|||
162689598|NCT03565068|587574210|FG007|Overall Study|Lost to Follow-up|1|||
162689599|NCT03565068|587574211|FG008|Overall Study|Lost to Follow-up|0|||
162689600|NCT00429494|587576476|FG000|Overall Study|Withdrawal by Subject|9|||
162689601|NCT00429494|587576476|FG000|Overall Study|Death|6|||
162689602|NCT01590771|587576487|FG000|Overall Study|Other Protocol Specified Criteria|5|||
162689603|NCT01590771|587576488|FG001|Overall Study|Other Protocol Specified Criteria|14|||
162689604|NCT01590771|587576487|FG000|Overall Study|Withdrawal by Subject|8|||
162689605|NCT01590771|587576488|FG001|Overall Study|Withdrawal by Subject|15|||
162689606|NCT01590771|587576487|FG000|Overall Study|Protocol Violation|1|||
162689607|NCT01590771|587576488|FG001|Overall Study|Protocol Violation|2|||
162689608|NCT01590771|587576487|FG000|Overall Study|Lost to Follow-up|1|||
162689609|NCT01590771|587576488|FG001|Overall Study|Lost to Follow-up|1|||
162689610|NCT01590771|587576487|FG000|Overall Study|Lack of Efficacy|1|||
162689611|NCT01590771|587576488|FG001|Overall Study|Lack of Efficacy|0|||
162689612|NCT01590771|587576487|FG000|Overall Study|Adverse Event|3|||
162689613|NCT01590771|587576488|FG001|Overall Study|Adverse Event|7|||
162689614|NCT02200939|587576496|FG000|Overall Study|Participant withdrew consent|0|||
162689615|NCT02200939|587576497|FG001|Overall Study|Participant withdrew consent|1|||
162689616|NCT02200939|587576496|FG000|Overall Study|Lost to Follow-up|2|||
162689617|NCT02200939|587576497|FG001|Overall Study|Lost to Follow-up|9|||
162689618|NCT02200939|587576496|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
162689619|NCT02200939|587576497|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
162689620|NCT04567693|587576498|FG000|Overall Study|Death|0|||
162689621|NCT04567693|587576499|FG001|Overall Study|Death|0|||
162689622|NCT04567693|587576500|FG002|Overall Study|Death|2|||
162689623|NCT04567693|587576498|FG000|Overall Study|Lost to Follow-up|1|||
162689624|NCT04567693|587576499|FG001|Overall Study|Lost to Follow-up|0|||
162689625|NCT04567693|587576500|FG002|Overall Study|Lost to Follow-up|2|||
162689626|NCT04567693|587576498|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
162689627|NCT04567693|587576499|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
162689628|NCT04567693|587576500|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
162689629|NCT03722264|587576506|FG000|Overall Study|Physician Decision|3|||
162689630|NCT00957931|587576507|FG000|Overall Study|Death|4|||
162689631|NCT01486758|587576508|FG000|Overall Study|Lost to Follow-up|0|||
162689632|NCT01486758|587576509|FG001|Overall Study|Lost to Follow-up|1|||
162689633|NCT02392611|587576515|FG000|Overall Study|Adverse Event|0|||
162689634|NCT02392611|587576516|FG001|Overall Study|Adverse Event|0|||
162689635|NCT02392611|587576517|FG002|Overall Study|Adverse Event|0|||
162689636|NCT02392611|587576518|FG003|Overall Study|Adverse Event|1|||
162689637|NCT02392611|587576519|FG004|Overall Study|Adverse Event|0|||
162689638|NCT02392611|587576520|FG005|Overall Study|Adverse Event|0|||
162689639|NCT02392611|587576521|FG006|Overall Study|Adverse Event|0|||
162689640|NCT02392611|587576522|FG007|Overall Study|Adverse Event|0|||
162689641|NCT02392611|587576523|FG008|Overall Study|Adverse Event|0|||
162689642|NCT02392611|587576515|FG000|Overall Study|Progressive disease|0|||
162689643|NCT02392611|587576516|FG001|Overall Study|Progressive disease|0|||
162689644|NCT02392611|587576517|FG002|Overall Study|Progressive disease|0|||
162689645|NCT02392611|587576518|FG003|Overall Study|Progressive disease|2|||
162689646|NCT02392611|587576519|FG004|Overall Study|Progressive disease|1|||
162689647|NCT02392611|587576520|FG005|Overall Study|Progressive disease|0|||
162689648|NCT02392611|587576521|FG006|Overall Study|Progressive disease|0|||
162689649|NCT02392611|587576522|FG007|Overall Study|Progressive disease|0|||
162689650|NCT02392611|587576523|FG008|Overall Study|Progressive disease|0|||
162689651|NCT02392611|587576515|FG000|Overall Study|Death|1|||
162689652|NCT02392611|587576516|FG001|Overall Study|Death|0|||
162689653|NCT02392611|587576517|FG002|Overall Study|Death|0|||
162689654|NCT02392611|587576518|FG003|Overall Study|Death|0|||
162689655|NCT02392611|587576519|FG004|Overall Study|Death|0|||
162689656|NCT02392611|587576520|FG005|Overall Study|Death|1|||
162689657|NCT02392611|587576521|FG006|Overall Study|Death|0|||
162689658|NCT02392611|587576522|FG007|Overall Study|Death|0|||
162689659|NCT02392611|587576523|FG008|Overall Study|Death|0|||
162689660|NCT02392611|587576515|FG000|Overall Study|Withdrawal by Subject|0|||
162689661|NCT02392611|587576516|FG001|Overall Study|Withdrawal by Subject|0|||
162689662|NCT02392611|587576517|FG002|Overall Study|Withdrawal by Subject|0|||
162689663|NCT02392611|587576518|FG003|Overall Study|Withdrawal by Subject|1|||
162689664|NCT02392611|587576519|FG004|Overall Study|Withdrawal by Subject|0|||
162689665|NCT02392611|587576520|FG005|Overall Study|Withdrawal by Subject|0|||
162689666|NCT02392611|587576521|FG006|Overall Study|Withdrawal by Subject|0|||
162689667|NCT02392611|587576522|FG007|Overall Study|Withdrawal by Subject|0|||
162689668|NCT02392611|587576523|FG008|Overall Study|Withdrawal by Subject|0|||
162689669|NCT02392611|587576515|FG000|Overall Study|Lost to Follow-up|0|||
162689670|NCT02392611|587576516|FG001|Overall Study|Lost to Follow-up|0|||
162689671|NCT02392611|587576517|FG002|Overall Study|Lost to Follow-up|0|||
162689672|NCT02392611|587576518|FG003|Overall Study|Lost to Follow-up|0|||
162689673|NCT02392611|587576519|FG004|Overall Study|Lost to Follow-up|0|||
162689674|NCT02392611|587576520|FG005|Overall Study|Lost to Follow-up|0|||
162689675|NCT02392611|587576521|FG006|Overall Study|Lost to Follow-up|1|||
162689676|NCT02392611|587576522|FG007|Overall Study|Lost to Follow-up|0|||
162689677|NCT02392611|587576523|FG008|Overall Study|Lost to Follow-up|0|||
162689678|NCT02392611|587576515|FG000|Overall Study|Enrolled, not treated|0|||
162689679|NCT02392611|587576516|FG001|Overall Study|Enrolled, not treated|0|||
162689680|NCT02392611|587576517|FG002|Overall Study|Enrolled, not treated|0|||
162689681|NCT02392611|587576518|FG003|Overall Study|Enrolled, not treated|2|||
162689682|NCT02392611|587576519|FG004|Overall Study|Enrolled, not treated|0|||
162689683|NCT02392611|587576520|FG005|Overall Study|Enrolled, not treated|0|||
162689684|NCT02392611|587576521|FG006|Overall Study|Enrolled, not treated|0|||
162689685|NCT02392611|587576522|FG007|Overall Study|Enrolled, not treated|0|||
162689686|NCT02392611|587576523|FG008|Overall Study|Enrolled, not treated|0|||
162689687|NCT00553202|587576530|FG000|Overall Study|Death|16|||
162689688|NCT00553202|587576530|FG000|Overall Study|Lost to Follow-up|1|||
162689689|NCT00553202|587576530|FG000|Overall Study|Physician Decision|28|||
162689690|NCT00553202|587576530|FG000|Overall Study|Withdrawal by Subject|1|||
162689691|NCT00553202|587576530|FG000|Overall Study|No donor identified|16|||
162689692|NCT00553202|587576530|FG000|Overall Study|Fails to meet organ function|6|||
162689693|NCT00369681|587576531|FG000|Overall Study|Death|1|||
162689694|NCT03239873|587576532|FG000|Overall Study|Lost to Follow-up|15|||
162689695|NCT03239873|587576533|FG001|Overall Study|Lost to Follow-up|16|||
162689696|NCT03239873|587576532|FG000|Overall Study|Physician Decision|1|||
162689697|NCT03239873|587576533|FG001|Overall Study|Physician Decision|0|||
162689698|NCT03239873|587576532|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
162689699|NCT03239873|587576533|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
162689700|NCT03239873|587576532|FG000|Overall Study|Withdrawal by Subject|2|||
162689701|NCT03239873|587576533|FG001|Overall Study|Withdrawal by Subject|0|||
162689702|NCT03239873|587576532|FG000|Overall Study|Contraindication to study medication|1|||
162689703|NCT03239873|587576533|FG001|Overall Study|Contraindication to study medication|0|||
162689704|NCT03239873|587576532|FG000|Overall Study|Protocol Violation|1|||
162689705|NCT03239873|587576533|FG001|Overall Study|Protocol Violation|0|||
162689706|NCT02045433|587576540|FG000|Overall Study|Withdrawal by Subject|1|||
162689707|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
162689708|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
162689709|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Adverse Event|2|||
162689710|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Adverse Event|5|||
162689711|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
162689712|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
162689713|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
162689714|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
162689715|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Randomized by error|0|||
162689716|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Randomized by error|5|||
162689717|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
162689718|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
162689719|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
162689720|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
162689721|NCT02948959|587576543|FG000|52 Weeks Treatment Period|Change of residence location|0|||
162689722|NCT02948959|587576544|FG001|52 Weeks Treatment Period|Change of residence location|1|||
162689723|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
162689724|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
162689725|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
162689726|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
162689727|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
162689728|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
162689729|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
162689730|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
162689731|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
162689732|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
162689733|NCT02948959|587576543|FG000|12 Weeks Follow-up Period|Study site closure|1|||
162689734|NCT02948959|587576544|FG001|12 Weeks Follow-up Period|Study site closure|0|||
162689735|NCT01800201|587576546|FG000|Overall Study|Withdrawal by Subject|2|||
162689736|NCT01800201|587576547|FG001|Overall Study|Withdrawal by Subject|0|||
162689737|NCT01800201|587576546|FG000|Overall Study|patient privacy concerns|1|||
162689738|NCT01800201|587576547|FG001|Overall Study|patient privacy concerns|1|||
162689739|NCT01800201|587576546|FG000|Overall Study|did not want to use device|0|||
162689740|NCT01800201|587576547|FG001|Overall Study|did not want to use device|1|||
162689741|NCT01800201|587576546|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
162689742|NCT01800201|587576547|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
162689743|NCT01480596|587576548|FG000|Overall Study|Adverse Event|3|||
162689744|NCT01480596|587576549|FG001|Overall Study|Adverse Event|0|||
162689745|NCT01480596|587576548|FG000|Overall Study|MG exacerbation or change in medication|2|||
162689746|NCT01480596|587576549|FG001|Overall Study|MG exacerbation or change in medication|2|||
162689747|NCT02904902|587576554|FG000|Overall Study|Withdrawal by Subject|1|||
162689748|NCT05400746|587576561|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
162689749|NCT05400746|587576562|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
162689750|NCT05400746|587576563|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
162689751|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
162689752|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
162689753|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
162689754|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
162689755|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
162689756|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
162689757|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
162689758|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Physician Decision|4|||
162689759|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Physician Decision|1|||
162689760|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Physician Decision|3|||
162689761|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Physician Decision|0|||
162689762|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Physician Decision|0|||
162689763|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Physician Decision|1|||
162689764|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Physician Decision|0|||
162689765|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Other|0|||
162689766|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Other|1|||
162689767|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Other|0|||
162689768|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Other|0|||
162689769|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Other|0|||
162689770|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Other|0|||
162689771|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Other|0|||
162689772|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689773|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689774|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689775|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689776|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689777|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162689778|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
162689779|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
162689780|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
162689781|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
162689782|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
162689783|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
162689784|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
162689785|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
162689786|NCT05375955|587576564|FG000|Treatment (12 Weeks)|Pregnancy|0|||
162689787|NCT05375955|587576565|FG001|Treatment (12 Weeks)|Pregnancy|0|||
162689788|NCT05375955|587576566|FG002|Treatment (12 Weeks)|Pregnancy|1|||
162689789|NCT05375955|587576567|FG003|Treatment (12 Weeks)|Pregnancy|0|||
162689790|NCT05375955|587576568|FG004|Treatment (12 Weeks)|Pregnancy|0|||
162689791|NCT05375955|587576569|FG005|Treatment (12 Weeks)|Pregnancy|0|||
162689792|NCT05375955|587576570|FG006|Treatment (12 Weeks)|Pregnancy|0|||
162689793|NCT05375955|587576564|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689794|NCT05375955|587576565|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689795|NCT05375955|587576566|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
162689796|NCT05375955|587576567|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689797|NCT05375955|587576568|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689798|NCT05375955|587576569|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689799|NCT05375955|587576570|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162689800|NCT05375955|587576564|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162689801|NCT05375955|587576565|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162689802|NCT05375955|587576566|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162689803|NCT05375955|587576567|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162689804|NCT05375955|587576568|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162689805|NCT05375955|587576569|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162689806|NCT05375955|587576570|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162689807|NCT05375955|587576564|FG000|Follow-up (up to 5 Weeks)|Other|0|||
162689808|NCT05375955|587576565|FG001|Follow-up (up to 5 Weeks)|Other|1|||
162689809|NCT05375955|587576566|FG002|Follow-up (up to 5 Weeks)|Other|0|||
162689810|NCT05375955|587576567|FG003|Follow-up (up to 5 Weeks)|Other|0|||
162689811|NCT05375955|587576568|FG004|Follow-up (up to 5 Weeks)|Other|0|||
162689812|NCT05375955|587576569|FG005|Follow-up (up to 5 Weeks)|Other|0|||
162689813|NCT05375955|587576570|FG006|Follow-up (up to 5 Weeks)|Other|0|||
162689814|NCT05375955|587576564|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
162689815|NCT05375955|587576565|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162689816|NCT05375955|587576566|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
162689817|NCT05375955|587576567|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162689818|NCT05375955|587576568|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162689819|NCT05375955|587576569|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162689820|NCT05375955|587576570|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162689821|NCT05375955|587576564|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162689822|NCT05375955|587576565|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
162689823|NCT05375955|587576566|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162689824|NCT05375955|587576567|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
162689825|NCT05375955|587576568|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162689826|NCT05375955|587576569|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162689827|NCT05375955|587576570|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
162689828|NCT03879408|587576580|FG000|Overall Study|Lost to Follow-up|0|||
162689829|NCT03879408|587576581|FG001|Overall Study|Lost to Follow-up|3|||
162689830|NCT03879408|587576582|FG002|Overall Study|Lost to Follow-up|2|||
162689831|NCT03879408|587576583|FG003|Overall Study|Lost to Follow-up|1|||
162689832|NCT03879408|587576584|FG004|Overall Study|Lost to Follow-up|0|||
162689833|NCT03879408|587576580|FG000|Overall Study|Withdrawal by Subject|2|||
162689834|NCT03879408|587576581|FG001|Overall Study|Withdrawal by Subject|1|||
162689835|NCT03879408|587576582|FG002|Overall Study|Withdrawal by Subject|1|||
162689836|NCT03879408|587576583|FG003|Overall Study|Withdrawal by Subject|0|||
162689837|NCT03879408|587576584|FG004|Overall Study|Withdrawal by Subject|1|||
162689838|NCT04522180|587576585|FG000|Overall Study|Investigator judgement|3|||
162689839|NCT04522180|587576586|FG001|Overall Study|Investigator judgement|4|||
162689840|NCT04522180|587576585|FG000|Overall Study|Voluntary withdrawal|1|||
162689841|NCT04522180|587576586|FG001|Overall Study|Voluntary withdrawal|0|||
162689842|NCT04522180|587576585|FG000|Overall Study|Pregnancy|0|||
162689843|NCT04522180|587576586|FG001|Overall Study|Pregnancy|1|||
162689844|NCT04522180|587576585|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
162689845|NCT04522180|587576586|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
162689846|NCT04522180|587576585|FG000|Overall Study|Reason not specified|8|||
162689847|NCT04522180|587576586|FG001|Overall Study|Reason not specified|5|||
162689848|NCT01224158|587576593|FG000|Overall Study|Withdrawal by Subject|1|||
162689849|NCT01224158|587576594|FG001|Overall Study|Withdrawal by Subject|0|||
162689850|NCT02055157|587576597|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162689851|NCT02055157|587576598|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
162689852|NCT02055157|587576599|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162689853|NCT02055157|587576600|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162689854|NCT02055157|587576597|FG000|Initial 6 Months|Adverse Event|0|||
162689855|NCT02055157|587576598|FG001|Initial 6 Months|Adverse Event|0|||
162689856|NCT02055157|587576599|FG002|Initial 6 Months|Adverse Event|0|||
162689857|NCT02055157|587576600|FG003|Initial 6 Months|Adverse Event|1|||
162689858|NCT02055157|587576597|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
162689859|NCT02055157|587576598|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
162689860|NCT02055157|587576599|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
162689861|NCT02055157|587576600|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
162689862|NCT02055157|587576597|FG000|18-month Extension|Investigator decision|0|||
162689863|NCT02055157|587576598|FG001|18-month Extension|Investigator decision|1|||
162689864|NCT02055157|587576599|FG002|18-month Extension|Investigator decision|0|||
162689865|NCT02055157|587576600|FG003|18-month Extension|Investigator decision|0|||
162689866|NCT02055157|587576597|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
162689867|NCT02055157|587576598|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162689868|NCT02055157|587576599|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162689869|NCT02055157|587576600|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162689870|NCT03976466|587576601|FG000|Overall Study|Lost to Follow-up|1|||
162689871|NCT03976466|587576602|FG001|Overall Study|Lost to Follow-up|3|||
162689872|NCT02034708|587576603|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
162689873|NCT02034708|587576604|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
162689874|NCT02034708|587576603|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
162689875|NCT02034708|587576604|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
162689876|NCT02034708|587576603|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
162689877|NCT02034708|587576604|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
162689878|NCT02034708|587576603|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
162689879|NCT02034708|587576604|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
162689880|NCT00733499|587576607|FG000|Pre-operative|Protocol Violation|0|||
162689881|NCT00733499|587576608|FG001|Pre-operative|Protocol Violation|1|||
162689882|NCT00733499|587576607|FG000|3 Months Follow-up|Death|1|||
162689883|NCT00733499|587576608|FG001|3 Months Follow-up|Death|2|||
162689884|NCT00733499|587576607|FG000|6 Months Follow-up|Death|0|||
162689885|NCT00733499|587576608|FG001|6 Months Follow-up|Death|2|||
162689886|NCT00733499|587576607|FG000|6 Months Follow-up|Adverse Event|0|||
162689887|NCT00733499|587576608|FG001|6 Months Follow-up|Adverse Event|1|||
162689888|NCT00733499|587576607|FG000|12 Months Follow-up|Death|2|||
162689889|NCT00733499|587576608|FG001|12 Months Follow-up|Death|1|||
162689890|NCT00733499|587576607|FG000|24 Months Follow-up|Death|0|||
162689891|NCT00733499|587576608|FG001|24 Months Follow-up|Death|1|||
162689892|NCT00733499|587576607|FG000|5 Year Followup|Adverse Event|2|||
162689893|NCT00733499|587576608|FG001|5 Year Followup|Adverse Event|2|||
162689894|NCT00733499|587576607|FG000|5 Year Followup|Non device related AE|0|||
162689895|NCT00733499|587576608|FG001|5 Year Followup|Non device related AE|1|||
162689896|NCT00733499|587576607|FG000|5 Year Followup|Revision of Study Implant|0|||
162689897|NCT00733499|587576608|FG001|5 Year Followup|Revision of Study Implant|1|||
162689898|NCT00733499|587576607|FG000|5 Year Followup|Lost to Follow-up|2|||
162689899|NCT00733499|587576608|FG001|5 Year Followup|Lost to Follow-up|0|||
162689900|NCT00733499|587576607|FG000|5 Year Followup|Death|13|||
162689901|NCT00733499|587576608|FG001|5 Year Followup|Death|19|||
162689902|NCT00733499|587576607|FG000|5 Year Followup|missing, unable to locate|0|||
162689903|NCT00733499|587576608|FG001|5 Year Followup|missing, unable to locate|1|||
162689904|NCT00733499|587576607|FG000|5 Year Followup|Withdrawal by Subject|4|||
162689905|NCT00733499|587576608|FG001|5 Year Followup|Withdrawal by Subject|1|||
162689906|NCT00733499|587576607|FG000|10 Year Followup|Death|9|||
162689907|NCT00733499|587576608|FG001|10 Year Followup|Death|7|||
162689908|NCT00733499|587576607|FG000|10 Year Followup|Adverse Event|3|||
162689909|NCT00733499|587576608|FG001|10 Year Followup|Adverse Event|3|||
162689910|NCT00733499|587576607|FG000|10 Year Followup|Lost to Follow-up|3|||
162689911|NCT00733499|587576608|FG001|10 Year Followup|Lost to Follow-up|2|||
162689912|NCT00733499|587576607|FG000|10 Year Followup|Withdrawal by Subject|5|||
162689913|NCT00733499|587576608|FG001|10 Year Followup|Withdrawal by Subject|5|||
162689914|NCT00733499|587576607|FG000|10 Year Followup|missing, unable to locate|0|||
162689915|NCT00733499|587576608|FG001|10 Year Followup|missing, unable to locate|2|||
162689916|NCT00733980|587576609|FG000|Overall Study|Adverse Event|5|||
162689917|NCT00733980|587576610|FG001|Overall Study|Adverse Event|2|||
162689918|NCT00733980|587576609|FG000|Overall Study|Lack of Efficacy|0|||
162689919|NCT00733980|587576610|FG001|Overall Study|Lack of Efficacy|1|||
162689920|NCT00733980|587576609|FG000|Overall Study|Protocol Violation|2|||
162689921|NCT00733980|587576610|FG001|Overall Study|Protocol Violation|1|||
162689922|NCT00733980|587576609|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
162689923|NCT00733980|587576610|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
162689924|NCT00733980|587576609|FG000|Overall Study|Lost to Follow-up|6|||
162728302|NCT02723955|587714832|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
162689925|NCT00733980|587576610|FG001|Overall Study|Lost to Follow-up|11|||
162689926|NCT00733980|587576609|FG000|Overall Study|Physician Decision|2|||
162689927|NCT00733980|587576610|FG001|Overall Study|Physician Decision|3|||
162689928|NCT00733980|587576609|FG000|Overall Study|Withdrawal by Subject|6|||
162689929|NCT00733980|587576610|FG001|Overall Study|Withdrawal by Subject|2|||
162689930|NCT01931735|587576611|FG000|Randomized Phase|Lost to Follow-up|2|||
162689931|NCT01931735|587576612|FG001|Randomized Phase|Lost to Follow-up|2|||
162689932|NCT01931735|587576613|FG002|Randomized Phase|Lost to Follow-up|5|||
162689933|NCT01931735|587576614|FG003|Randomized Phase|Lost to Follow-up|0|||
162689934|NCT01931735|587576611|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
162689935|NCT01931735|587576612|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
162689936|NCT01931735|587576613|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
162689937|NCT01931735|587576614|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
162689938|NCT01931735|587576611|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162728303|NCT02723955|587714833|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728304|NCT02723955|587714834|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728305|NCT02723955|587714835|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728306|NCT02723955|587714836|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728307|NCT02723955|587714837|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728308|NCT02723955|587714838|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728309|NCT02723955|587714839|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728310|NCT02723955|587714840|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728311|NCT02723955|587714841|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728312|NCT02723955|587714842|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728313|NCT02723955|587714843|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728314|NCT02723955|587714844|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728315|NCT02723955|587714845|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728316|NCT02723955|587714846|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728317|NCT02723955|587714847|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728318|NCT02723955|587714848|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728319|NCT02723955|587714849|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728320|NCT02723955|587714850|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728321|NCT02723955|587714851|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728322|NCT02723955|587714852|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728323|NCT02723955|587714853|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728324|NCT02723955|587714854|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
162728325|NCT02723955|587714855|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
162728326|NCT02723955|587714856|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728327|NCT02723955|587714857|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
162728328|NCT02723955|587714858|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
162728329|NCT02723955|587714816|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
162728330|NCT02723955|587714817|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
162728331|NCT02723955|587714818|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
162728332|NCT02723955|587714819|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
162728333|NCT02723955|587714820|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
162728334|NCT02723955|587714821|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
162728335|NCT02723955|587714822|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
162728336|NCT02723955|587714823|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
162728337|NCT02723955|587714824|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
162728338|NCT02723955|587714825|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
162728339|NCT02723955|587714826|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
162728340|NCT02723955|587714827|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
162728341|NCT02723955|587714828|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
162728342|NCT02723955|587714829|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
162728343|NCT02723955|587714830|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
162728344|NCT02723955|587714831|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
162728345|NCT02723955|587714832|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
162728346|NCT02723955|587714833|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
162728347|NCT02723955|587714834|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
162728348|NCT02723955|587714835|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
162728349|NCT02723955|587714836|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
162728350|NCT02723955|587714837|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
162728351|NCT02723955|587714838|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
162728352|NCT02723955|587714839|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
162728353|NCT02723955|587714840|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
162728354|NCT02723955|587714841|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
162728355|NCT02723955|587714842|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
162728356|NCT02723955|587714843|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
162728357|NCT02723955|587714844|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
162728358|NCT02723955|587714845|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
162728359|NCT02723955|587714846|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
162728360|NCT02723955|587714847|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
162728361|NCT02723955|587714848|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
162728362|NCT02723955|587714849|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
162728363|NCT02723955|587714850|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
162728364|NCT02723955|587714851|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
162728365|NCT02723955|587714852|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
162728366|NCT02723955|587714853|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
162689939|NCT01931735|587576612|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162689940|NCT01931735|587576613|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162689941|NCT01931735|587576614|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
162689942|NCT02719990|587576618|FG000|Overall Study|Physician Decision|2|||
162689943|NCT02719990|587576618|FG000|Overall Study|Withdrawal by Subject|2|||
162689944|NCT02719990|587576618|FG000|Overall Study|Study Terminated By Sponsor|32|||
162689945|NCT03324880|587576622|FG000|Overall Study|Adverse Event|0|||
162689946|NCT03324880|587576623|FG001|Overall Study|Adverse Event|2|||
162689947|NCT03324880|587576622|FG000|Overall Study|Withdrawal by Subject|2|||
162689948|NCT03324880|587576623|FG001|Overall Study|Withdrawal by Subject|2|||
162689949|NCT03324880|587576622|FG000|Overall Study|Lost to Follow-up|0|||
162689950|NCT03324880|587576623|FG001|Overall Study|Lost to Follow-up|1|||
162689951|NCT03324880|587576622|FG000|Overall Study|Product Recall|0|||
162689952|NCT03324880|587576623|FG001|Overall Study|Product Recall|1|||
162689953|NCT00652938|587576624|FG000|Overall Study|Adverse Event|1|||
162689954|NCT00652938|587576625|FG001|Overall Study|Adverse Event|0|||
162689955|NCT00652938|587576626|FG002|Overall Study|Adverse Event|2|||
162689956|NCT00652938|587576624|FG000|Overall Study|Withdrawal by Subject|0|||
162689957|NCT00652938|587576625|FG001|Overall Study|Withdrawal by Subject|6|||
162689958|NCT00652938|587576626|FG002|Overall Study|Withdrawal by Subject|1|||
162689959|NCT00652938|587576624|FG000|Overall Study|Lost to Follow-up|0|||
162689960|NCT00652938|587576625|FG001|Overall Study|Lost to Follow-up|0|||
162689961|NCT00652938|587576626|FG002|Overall Study|Lost to Follow-up|2|||
162689962|NCT00652938|587576624|FG000|Overall Study|fear of blood sampling|0|||
162689963|NCT00652938|587576625|FG001|Overall Study|fear of blood sampling|1|||
162689964|NCT00652938|587576626|FG002|Overall Study|fear of blood sampling|0|||
162689965|NCT01412801|587576630|FG000|Overall Study|Death|0|||
162689966|NCT01412801|587576631|FG001|Overall Study|Death|1|||
162689967|NCT01412801|587576632|FG002|Overall Study|Death|0|||
162689968|NCT01412801|587576633|FG003|Overall Study|Death|4|||
162689969|NCT01412801|587576634|FG004|Overall Study|Death|2|||
162689970|NCT01412801|587576635|FG005|Overall Study|Death|2|||
162689971|NCT01412801|587576630|FG000|Overall Study|Lost to Follow-up|1|||
162689972|NCT01412801|587576631|FG001|Overall Study|Lost to Follow-up|2|||
162689973|NCT01412801|587576632|FG002|Overall Study|Lost to Follow-up|4|||
162689974|NCT01412801|587576633|FG003|Overall Study|Lost to Follow-up|0|||
162689975|NCT01412801|587576634|FG004|Overall Study|Lost to Follow-up|1|||
162689976|NCT01412801|587576635|FG005|Overall Study|Lost to Follow-up|1|||
162689977|NCT01412801|587576630|FG000|Overall Study|Withdrawal by Subject|3|||
162689978|NCT01412801|587576631|FG001|Overall Study|Withdrawal by Subject|2|||
162689979|NCT01412801|587576632|FG002|Overall Study|Withdrawal by Subject|1|||
162689980|NCT01412801|587576633|FG003|Overall Study|Withdrawal by Subject|0|||
162689981|NCT01412801|587576634|FG004|Overall Study|Withdrawal by Subject|0|||
162689982|NCT01412801|587576635|FG005|Overall Study|Withdrawal by Subject|0|||
162689983|NCT01412801|587576630|FG000|Overall Study|Relocated to another area|0|||
162689984|NCT01412801|587576631|FG001|Overall Study|Relocated to another area|0|||
162689985|NCT01412801|587576632|FG002|Overall Study|Relocated to another area|2|||
162689986|NCT01412801|587576633|FG003|Overall Study|Relocated to another area|0|||
162689987|NCT01412801|587576634|FG004|Overall Study|Relocated to another area|0|||
162689988|NCT01412801|587576635|FG005|Overall Study|Relocated to another area|0|||
162689989|NCT01547299|587576638|FG000|Overall Study|Withdrawal by Subject|2|||
162689990|NCT01547299|587576639|FG001|Overall Study|Withdrawal by Subject|2|||
162689991|NCT05076149|587576640|FG000|Overall Study|Adverse Event|3|||
162689992|NCT05076149|587576641|FG001|Overall Study|Adverse Event|9|||
162689993|NCT05076149|587576640|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
162689994|NCT05076149|587576641|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
162689995|NCT05076149|587576640|FG000|Overall Study|Lost to Follow-up|0|||
162689996|NCT05076149|587576641|FG001|Overall Study|Lost to Follow-up|1|||
162689997|NCT05076149|587576640|FG000|Overall Study|Commercial drug is available for participant|0|||
162689998|NCT05076149|587576641|FG001|Overall Study|Commercial drug is available for participant|1|||
162689999|NCT05076149|587576640|FG000|Overall Study|Other non compliance|1|||
162690000|NCT05076149|587576641|FG001|Overall Study|Other non compliance|1|||
162690001|NCT05076149|587576640|FG000|Overall Study|Physician Decision|0|||
162690002|NCT05076149|587576641|FG001|Overall Study|Physician Decision|1|||
162690003|NCT05076149|587576640|FG000|Overall Study|Other|5|||
162690004|NCT05076149|587576641|FG001|Overall Study|Other|4|||
162690005|NCT02087501|587576642|FG000|Overall Study|Death|7|||
162690006|NCT02087501|587576642|FG000|Overall Study|Open repair of aneurysm|1|||
162690007|NCT02087501|587576642|FG000|Overall Study|Lost to Follow-up|2|||
162690008|NCT00094328|587576645|FG000|Overall Study|Lost to Follow-up|1|||
162690009|NCT03682705|587576646|FG000|Overall Study|Adverse Event|1|||
162690010|NCT03682705|587576647|FG001|Overall Study|Adverse Event|1|||
162690011|NCT03682705|587576648|FG002|Overall Study|Adverse Event|1|||
162690012|NCT03682705|587576649|FG003|Overall Study|Adverse Event|0|||
162690013|NCT03682705|587576650|FG004|Overall Study|Adverse Event|1|||
162690014|NCT03682705|587576651|FG005|Overall Study|Adverse Event|1|||
162690015|NCT03682705|587576646|FG000|Overall Study|Withdrawal by Subject|1|||
162690016|NCT03682705|587576647|FG001|Overall Study|Withdrawal by Subject|3|||
162690017|NCT03682705|587576648|FG002|Overall Study|Withdrawal by Subject|2|||
162690018|NCT03682705|587576649|FG003|Overall Study|Withdrawal by Subject|4|||
162690019|NCT03682705|587576650|FG004|Overall Study|Withdrawal by Subject|0|||
162690020|NCT03682705|587576651|FG005|Overall Study|Withdrawal by Subject|1|||
162690021|NCT03682705|587576646|FG000|Overall Study|Other, not specified|0|||
162690022|NCT03682705|587576647|FG001|Overall Study|Other, not specified|0|||
162690023|NCT03682705|587576648|FG002|Overall Study|Other, not specified|0|||
162690024|NCT03682705|587576649|FG003|Overall Study|Other, not specified|1|||
162690025|NCT03682705|587576650|FG004|Overall Study|Other, not specified|2|||
162690026|NCT03682705|587576651|FG005|Overall Study|Other, not specified|0|||
162690027|NCT03682705|587576646|FG000|Overall Study|Lost to Follow-up|0|||
162690028|NCT03682705|587576647|FG001|Overall Study|Lost to Follow-up|0|||
162690029|NCT03682705|587576648|FG002|Overall Study|Lost to Follow-up|0|||
162690030|NCT03682705|587576649|FG003|Overall Study|Lost to Follow-up|0|||
162690031|NCT03682705|587576650|FG004|Overall Study|Lost to Follow-up|3|||
162690032|NCT03682705|587576651|FG005|Overall Study|Lost to Follow-up|0|||
162690033|NCT00117156|587576652|FG000|Overall Study|Adverse Event|9|||
162690034|NCT00117156|587576652|FG000|Overall Study|Physician Decision|1|||
162690035|NCT00117156|587576652|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
162690036|NCT02213328|587576653|FG000|Overall Study|Withdrawal by Subject|10|||
162690037|NCT02213328|587576653|FG000|Overall Study|Physician Decision|2|||
162690038|NCT02213328|587576653|FG000|Overall Study|Lost to Follow-up|16|||
162690039|NCT04043962|587576654|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
162690040|NCT04043962|587576654|FG000|Post-Treatment|Withdrawal by Subject|5|||
162690041|NCT04043962|587576654|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
162690042|NCT01874145|587576655|FG000|Core Period|Non-compliance|1|||
162690043|NCT01874145|587576656|FG001|Core Period|Non-compliance|0|||
162690044|NCT01874145|587576655|FG000|Core Period|Protocol Violation|1|||
162690045|NCT01874145|587576656|FG001|Core Period|Protocol Violation|1|||
162690046|NCT01874145|587576655|FG000|Core Period|Physician Decision|1|||
162690047|NCT01874145|587576656|FG001|Core Period|Physician Decision|1|||
162690048|NCT01874145|587576655|FG000|Core Period|Adverse Event|0|||
162690049|NCT01874145|587576656|FG001|Core Period|Adverse Event|1|||
162690050|NCT01874145|587576655|FG000|Core Period|Withdrawal by Subject|0|||
162690051|NCT01874145|587576656|FG001|Core Period|Withdrawal by Subject|4|||
162690052|NCT01874145|587576655|FG000|Extension Period|Adverse Event|3|||
162690053|NCT01874145|587576656|FG001|Extension Period|Adverse Event|2|||
162690054|NCT01874145|587576655|FG000|Extension Period|Withdrawal by Subject|2|||
162690055|NCT01874145|587576656|FG001|Extension Period|Withdrawal by Subject|1|||
162690056|NCT01874145|587576655|FG000|Extension Period|Lost to Follow-up|1|||
162690057|NCT01874145|587576656|FG001|Extension Period|Lost to Follow-up|1|||
162690058|NCT00402337|587576657|FG000|Overall Study|Adverse Event|0|||
162690059|NCT00402337|587576658|FG001|Overall Study|Adverse Event|2|||
162690060|NCT00402337|587576659|FG002|Overall Study|Adverse Event|2|||
162690061|NCT00402337|587576660|FG003|Overall Study|Adverse Event|3|||
162690062|NCT00402337|587576661|FG004|Overall Study|Adverse Event|2|||
162690063|NCT00402337|587576657|FG000|Overall Study|Noncompliance|0|||
162690064|NCT00402337|587576658|FG001|Overall Study|Noncompliance|0|||
162690065|NCT00402337|587576659|FG002|Overall Study|Noncompliance|0|||
162690066|NCT00402337|587576660|FG003|Overall Study|Noncompliance|0|||
162690067|NCT00402337|587576661|FG004|Overall Study|Noncompliance|2|||
162690068|NCT00402337|587576657|FG000|Overall Study|Withdrawal by Subject|5|||
162690069|NCT00402337|587576658|FG001|Overall Study|Withdrawal by Subject|3|||
162690070|NCT00402337|587576659|FG002|Overall Study|Withdrawal by Subject|1|||
162690071|NCT00402337|587576660|FG003|Overall Study|Withdrawal by Subject|6|||
162690072|NCT00402337|587576661|FG004|Overall Study|Withdrawal by Subject|4|||
162690073|NCT00402337|587576657|FG000|Overall Study|Lost to Follow-up|0|||
162690074|NCT00402337|587576658|FG001|Overall Study|Lost to Follow-up|0|||
162690075|NCT00402337|587576659|FG002|Overall Study|Lost to Follow-up|1|||
162690076|NCT00402337|587576660|FG003|Overall Study|Lost to Follow-up|2|||
162690077|NCT00402337|587576661|FG004|Overall Study|Lost to Follow-up|0|||
162690078|NCT00402337|587576657|FG000|Overall Study|Physician Decision|0|||
162690079|NCT00402337|587576658|FG001|Overall Study|Physician Decision|0|||
162690080|NCT00402337|587576659|FG002|Overall Study|Physician Decision|0|||
162690081|NCT00402337|587576660|FG003|Overall Study|Physician Decision|1|||
162690082|NCT00402337|587576661|FG004|Overall Study|Physician Decision|0|||
162690083|NCT00402337|587576657|FG000|Overall Study|Other Reason|0|||
162690084|NCT00402337|587576658|FG001|Overall Study|Other Reason|1|||
162690085|NCT00402337|587576659|FG002|Overall Study|Other Reason|0|||
162690086|NCT00402337|587576660|FG003|Overall Study|Other Reason|0|||
162690087|NCT00402337|587576661|FG004|Overall Study|Other Reason|0|||
162690088|NCT01654601|587576662|FG000|1st Administration|Withdrawal by Subject|2|||
162690089|NCT01654601|587576663|FG001|1st Administration|Withdrawal by Subject|0|||
162690090|NCT01654601|587576662|FG000|1st Administration|Protocol Violation|0|||
162690091|NCT01654601|587576663|FG001|1st Administration|Protocol Violation|2|||
162690092|NCT01654601|587576662|FG000|2nd Administration|Adverse Event|1|||
162690093|NCT01654601|587576663|FG001|2nd Administration|Adverse Event|0|||
162690094|NCT01654601|587576662|FG000|2nd Administration|Protocol Violation|0|||
162690095|NCT01654601|587576663|FG001|2nd Administration|Protocol Violation|1|||
162690096|NCT02636270|587576664|FG000|Overall Study|Adverse Event|1|||
162690097|NCT02636270|587576665|FG001|Overall Study|Adverse Event|0|||
162690098|NCT02636270|587576666|FG002|Overall Study|Adverse Event|0|||
162690099|NCT02636270|587576664|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
162690100|NCT02636270|587576665|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
162690101|NCT02636270|587576666|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
162690102|NCT00767104|587578923|FG000|Overall Study|Lost to Follow-up|1|||
162690103|NCT00767104|587578924|FG001|Overall Study|Lost to Follow-up|2|||
162690104|NCT00840996|587578925|FG000|Overall Study|Withdrawal by Subject|1|||
162690105|NCT00840996|587578926|FG001|Overall Study|Withdrawal by Subject|0|||
162690106|NCT03285295|587578930|FG000|Alinity s HBsAg|Protocol Violation|11|||
162690107|NCT03285295|587578931|FG001|Alinity s HBsAg|Protocol Violation|0|||
162690108|NCT03285295|587578932|FG002|Alinity s HBsAg|Protocol Violation|0|||
162690109|NCT03285295|587578933|FG003|Alinity s HBsAg|Protocol Violation|0|||
162690110|NCT03285295|587578934|FG004|Alinity s HBsAg|Protocol Violation|0|||
162690111|NCT03285295|587578930|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
162690112|NCT03285295|587578931|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
162690113|NCT03285295|587578932|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
162690114|NCT03285295|587578933|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
162690115|NCT03285295|587578934|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
162690116|NCT03285295|587578930|FG000|Alinity s HBsAg|No Results Generated|74|||
162690117|NCT03285295|587578931|FG001|Alinity s HBsAg|No Results Generated|6|||
162690118|NCT03285295|587578932|FG002|Alinity s HBsAg|No Results Generated|0|||
162690119|NCT03285295|587578933|FG003|Alinity s HBsAg|No Results Generated|0|||
162690120|NCT03285295|587578934|FG004|Alinity s HBsAg|No Results Generated|0|||
162690121|NCT03285295|587578930|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
162690122|NCT03285295|587578931|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
162690123|NCT03285295|587578932|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
162690124|NCT03285295|587578933|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
162690125|NCT03285295|587578934|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
162690126|NCT03285295|587578930|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
162690127|NCT03285295|587578931|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162690128|NCT03285295|587578932|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162690129|NCT03285295|587578933|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162690130|NCT03285295|587578934|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162690131|NCT03285295|587578930|FG000|Alinity s HTLV I/II|No Results Generated|70|||
162690132|NCT03285295|587578931|FG001|Alinity s HTLV I/II|No Results Generated|0|||
162690133|NCT03285295|587578932|FG002|Alinity s HTLV I/II|No Results Generated|0|||
162690134|NCT03285295|587578933|FG003|Alinity s HTLV I/II|No Results Generated|0|||
162690135|NCT03285295|587578934|FG004|Alinity s HTLV I/II|No Results Generated|0|||
162690136|NCT03285295|587578930|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
162690137|NCT03285295|587578931|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162690138|NCT03285295|587578932|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162690139|NCT03285295|587578933|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162690140|NCT03285295|587578934|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162690141|NCT03285295|587578930|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
162690142|NCT03285295|587578931|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
162690143|NCT03285295|587578932|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
162690144|NCT03285295|587578933|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
162690145|NCT03285295|587578934|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
162690146|NCT03285295|587578930|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
162690147|NCT03285295|587578931|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162690148|NCT03285295|587578932|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162690149|NCT03285295|587578933|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162690150|NCT03285295|587578934|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162690151|NCT03285295|587578930|FG000|Alinity s Anti-HCV|No Results Generated|71|||
162690152|NCT03285295|587578931|FG001|Alinity s Anti-HCV|No Results Generated|0|||
162690153|NCT03285295|587578932|FG002|Alinity s Anti-HCV|No Results Generated|0|||
162690154|NCT03285295|587578933|FG003|Alinity s Anti-HCV|No Results Generated|0|||
162690155|NCT03285295|587578934|FG004|Alinity s Anti-HCV|No Results Generated|0|||
162690156|NCT03285295|587578930|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
162690157|NCT03285295|587578931|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162690158|NCT03285295|587578932|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162690159|NCT03285295|587578933|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162690160|NCT03285295|587578934|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162690161|NCT03285295|587578930|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
162690162|NCT03285295|587578931|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162690163|NCT03285295|587578932|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162690164|NCT03285295|587578933|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162728367|NCT02723955|587714854|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
162728368|NCT02723955|587714855|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
162728369|NCT02723955|587714856|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
162728370|NCT02723955|587714857|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
162728371|NCT02723955|587714858|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
162728372|NCT03088813|587714861|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162728373|NCT03088813|587714862|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
162728374|NCT03088813|587714863|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162728375|NCT03088813|587714864|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162728376|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162728377|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162728378|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
162728379|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162728380|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
162728381|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
162728382|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
162728383|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
162728384|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
162728385|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
162728386|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
162728387|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
162728388|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
162728389|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
162728390|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
162728391|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
162728392|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162728393|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162728394|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162728395|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
162728396|NCT03088813|587714861|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162728397|NCT03088813|587714862|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162728398|NCT03088813|587714863|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
162728399|NCT03088813|587714864|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162728400|NCT04878354|587714865|FG000|Overall Study|Adverse Event|4|||
162728401|NCT04878354|587714866|FG001|Overall Study|Adverse Event|13|||
162728402|NCT04878354|587714865|FG000|Overall Study|Withdrawal by Subject|14|||
162728403|NCT04878354|587714866|FG001|Overall Study|Withdrawal by Subject|12|||
162728404|NCT04878354|587714865|FG000|Overall Study|Lost to Follow-up|4|||
162728405|NCT04878354|587714866|FG001|Overall Study|Lost to Follow-up|1|||
162728406|NCT04878354|587714865|FG000|Overall Study|Lack of Efficacy|1|||
162728407|NCT04878354|587714866|FG001|Overall Study|Lack of Efficacy|0|||
162728408|NCT04878354|587714865|FG000|Overall Study|Protocol Violation|0|||
162728409|NCT04878354|587714866|FG001|Overall Study|Protocol Violation|1|||
162728410|NCT04878354|587714865|FG000|Overall Study|"Reason stated as other in CRF"|2|||
162728411|NCT04878354|587714866|FG001|Overall Study|"Reason stated as other in CRF"|3|||
162728412|NCT01903811|587714874|FG000|Overall Study|No measurable disease|1|||
162728413|NCT01903811|587714875|FG001|Overall Study|No measurable disease|1|||
162728414|NCT01903811|587714874|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
162728415|NCT01903811|587714875|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
162728416|NCT01903811|587714874|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
162728417|NCT01903811|587714875|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
162728418|NCT01903811|587714874|FG000|Overall Study|Withdrawal by Subject|0|||
162728419|NCT01903811|587714875|FG001|Overall Study|Withdrawal by Subject|1|||
162728420|NCT02118961|587714876|FG000|Overall Study|Withdrawal by Subject|1|||
162728421|NCT02118961|587714877|FG001|Overall Study|Withdrawal by Subject|0|||
162728422|NCT02992925|587714880|FG000|Cohort 2|Physician Decision|0|||
162728423|NCT02992925|587714881|FG001|Cohort 2|Physician Decision|0|||
162728424|NCT02992925|587714882|FG002|Cohort 2|Physician Decision|1|||
162728425|NCT02992925|587714883|FG003|Cohort 2|Physician Decision|0|||
162728426|NCT02992925|587714880|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
162728427|NCT02992925|587714881|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
162728428|NCT02992925|587714882|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
162728429|NCT02992925|587714883|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
162728430|NCT05678998|587714884|FG000|Overall Study|Withdrawal by Subject|1|||
162728431|NCT05678998|587714885|FG001|Overall Study|Withdrawal by Subject|1|||
162728432|NCT05678998|587714886|FG002|Overall Study|Withdrawal by Subject|3|||
162728433|NCT05678998|587714887|FG003|Overall Study|Withdrawal by Subject|0|||
162728434|NCT05678998|587714888|FG004|Overall Study|Withdrawal by Subject|1|||
162728435|NCT05678998|587714884|FG000|Overall Study|Lost to Follow-up|0|||
162728436|NCT05678998|587714885|FG001|Overall Study|Lost to Follow-up|0|||
162690165|NCT03285295|587578934|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162690166|NCT03285295|587578930|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
162690167|NCT03285295|587578931|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162690168|NCT03285295|587578932|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162690169|NCT03285295|587578933|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162690170|NCT03285295|587578934|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162690171|NCT03285295|587578930|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
162690172|NCT03285295|587578931|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162690173|NCT03285295|587578932|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162690174|NCT03285295|587578933|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162690175|NCT03285295|587578934|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162690176|NCT03285295|587578930|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
162690177|NCT03285295|587578931|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162690178|NCT03285295|587578932|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162690179|NCT03285295|587578933|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162690180|NCT03285295|587578934|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162690181|NCT03285295|587578930|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
162690182|NCT03285295|587578931|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
162690183|NCT03285295|587578932|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
162690184|NCT03285295|587578933|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
162690185|NCT03285295|587578934|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
162690186|NCT03285295|587578930|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
162690187|NCT03285295|587578931|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
162690188|NCT03285295|587578932|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162690189|NCT03285295|587578933|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162690190|NCT03285295|587578934|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162690191|NCT03285295|587578930|FG000|Alinity s Anti-HBc|No Results Generated|70|||
162690192|NCT03285295|587578931|FG001|Alinity s Anti-HBc|No Results Generated|0|||
162690193|NCT03285295|587578932|FG002|Alinity s Anti-HBc|No Results Generated|0|||
162690194|NCT03285295|587578933|FG003|Alinity s Anti-HBc|No Results Generated|0|||
162690195|NCT03285295|587578934|FG004|Alinity s Anti-HBc|No Results Generated|0|||
162690196|NCT03285295|587578930|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
162690197|NCT03285295|587578931|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162690198|NCT03285295|587578932|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162690199|NCT03285295|587578933|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162690200|NCT03285295|587578934|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162690201|NCT03285295|587578930|FG000|Alinity s Chagas|Protocol Violation|76|||
162690202|NCT03285295|587578931|FG001|Alinity s Chagas|Protocol Violation|0|||
162690203|NCT03285295|587578932|FG002|Alinity s Chagas|Protocol Violation|0|||
162690204|NCT03285295|587578933|FG003|Alinity s Chagas|Protocol Violation|0|||
162690205|NCT03285295|587578934|FG004|Alinity s Chagas|Protocol Violation|0|||
162690206|NCT03285295|587578930|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
162690207|NCT03285295|587578931|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
162690208|NCT03285295|587578932|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
162690209|NCT03285295|587578933|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
162690210|NCT03285295|587578934|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
162690211|NCT03285295|587578930|FG000|Alinity s Chagas|No Results Generated|105|||
162690212|NCT03285295|587578931|FG001|Alinity s Chagas|No Results Generated|0|||
162690213|NCT03285295|587578932|FG002|Alinity s Chagas|No Results Generated|0|||
162690214|NCT03285295|587578933|FG003|Alinity s Chagas|No Results Generated|0|||
162690215|NCT03285295|587578934|FG004|Alinity s Chagas|No Results Generated|0|||
162690216|NCT03285295|587578930|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
162690217|NCT03285295|587578931|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162690218|NCT03285295|587578932|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162690219|NCT03285295|587578933|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162690220|NCT03285295|587578934|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162690221|NCT02762981|587578935|FG000|Overall Study|Adverse Event|2|||
162690222|NCT02762981|587578936|FG001|Overall Study|Adverse Event|3|||
162690223|NCT02762981|587578937|FG002|Overall Study|Adverse Event|1|||
162690224|NCT02762981|587578938|FG003|Overall Study|Adverse Event|1|||
162690225|NCT02762981|587578939|FG004|Overall Study|Adverse Event|3|||
162690226|NCT02762981|587578935|FG000|Overall Study|Physician Decision|0|||
162690227|NCT02762981|587578936|FG001|Overall Study|Physician Decision|1|||
162690228|NCT02762981|587578937|FG002|Overall Study|Physician Decision|0|||
162690229|NCT02762981|587578938|FG003|Overall Study|Physician Decision|0|||
162690230|NCT02762981|587578939|FG004|Overall Study|Physician Decision|1|||
162690231|NCT02762981|587578935|FG000|Overall Study|Disease progression|11|||
162690232|NCT02762981|587578936|FG001|Overall Study|Disease progression|23|||
162690233|NCT02762981|587578937|FG002|Overall Study|Disease progression|4|||
162690234|NCT02762981|587578938|FG003|Overall Study|Disease progression|10|||
162690235|NCT02762981|587578939|FG004|Overall Study|Disease progression|1|||
162690236|NCT02762981|587578935|FG000|Overall Study|Enrolled not treated|1|||
162690237|NCT02762981|587578936|FG001|Overall Study|Enrolled not treated|5|||
162728437|NCT05678998|587714886|FG002|Overall Study|Lost to Follow-up|0|||
162690238|NCT02762981|587578937|FG002|Overall Study|Enrolled not treated|0|||
162690239|NCT02762981|587578938|FG003|Overall Study|Enrolled not treated|2|||
162690240|NCT02762981|587578939|FG004|Overall Study|Enrolled not treated|0|||
162690241|NCT02762981|587578935|FG000|Overall Study|Other|2|||
162690242|NCT02762981|587578936|FG001|Overall Study|Other|3|||
162690243|NCT02762981|587578937|FG002|Overall Study|Other|1|||
162690244|NCT02762981|587578938|FG003|Overall Study|Other|0|||
162690245|NCT02762981|587578939|FG004|Overall Study|Other|0|||
162690246|NCT02762981|587578935|FG000|Overall Study|Missing|1|||
162690247|NCT02762981|587578936|FG001|Overall Study|Missing|0|||
162690248|NCT02762981|587578937|FG002|Overall Study|Missing|0|||
162690249|NCT02762981|587578938|FG003|Overall Study|Missing|0|||
162690250|NCT02762981|587578939|FG004|Overall Study|Missing|0|||
162690251|NCT02762981|587578935|FG000|Overall Study|Withdrawal by Subject|0|||
162690252|NCT02762981|587578936|FG001|Overall Study|Withdrawal by Subject|5|||
162690253|NCT02762981|587578937|FG002|Overall Study|Withdrawal by Subject|1|||
162690254|NCT02762981|587578938|FG003|Overall Study|Withdrawal by Subject|3|||
162690255|NCT02762981|587578939|FG004|Overall Study|Withdrawal by Subject|0|||
162690256|NCT04867785|587578941|FG000|Overall Study|Adverse Event|1|||
162690257|NCT04867785|587578942|FG001|Overall Study|Adverse Event|0|||
162690258|NCT04867785|587578943|FG002|Overall Study|Adverse Event|1|||
162690259|NCT04867785|587578944|FG003|Overall Study|Adverse Event|0|||
162690260|NCT04867785|587578945|FG004|Overall Study|Adverse Event|0|||
162690261|NCT04867785|587578946|FG005|Overall Study|Adverse Event|0|||
162690262|NCT04867785|587578947|FG006|Overall Study|Adverse Event|0|||
162690263|NCT04867785|587578948|FG007|Overall Study|Adverse Event|2|||
162690264|NCT04867785|587578941|FG000|Overall Study|Lost to Follow-up|4|||
162690265|NCT04867785|587578942|FG001|Overall Study|Lost to Follow-up|4|||
162690266|NCT04867785|587578943|FG002|Overall Study|Lost to Follow-up|3|||
162690267|NCT04867785|587578944|FG003|Overall Study|Lost to Follow-up|2|||
162690268|NCT04867785|587578945|FG004|Overall Study|Lost to Follow-up|0|||
162690269|NCT04867785|587578946|FG005|Overall Study|Lost to Follow-up|1|||
162690270|NCT04867785|587578947|FG006|Overall Study|Lost to Follow-up|0|||
162690271|NCT04867785|587578948|FG007|Overall Study|Lost to Follow-up|1|||
162690272|NCT04867785|587578941|FG000|Overall Study|Withdrawal by Subject|6|||
162690273|NCT04867785|587578942|FG001|Overall Study|Withdrawal by Subject|2|||
162690274|NCT04867785|587578943|FG002|Overall Study|Withdrawal by Subject|2|||
162690275|NCT04867785|587578944|FG003|Overall Study|Withdrawal by Subject|1|||
162690276|NCT04867785|587578945|FG004|Overall Study|Withdrawal by Subject|2|||
162690277|NCT04867785|587578946|FG005|Overall Study|Withdrawal by Subject|0|||
162690278|NCT04867785|587578947|FG006|Overall Study|Withdrawal by Subject|2|||
162690279|NCT04867785|587578948|FG007|Overall Study|Withdrawal by Subject|5|||
162690280|NCT04867785|587578941|FG000|Overall Study|Physician Decision|0|||
162690281|NCT04867785|587578942|FG001|Overall Study|Physician Decision|0|||
162690282|NCT04867785|587578943|FG002|Overall Study|Physician Decision|0|||
162690283|NCT04867785|587578944|FG003|Overall Study|Physician Decision|0|||
162690284|NCT04867785|587578945|FG004|Overall Study|Physician Decision|0|||
162690285|NCT04867785|587578946|FG005|Overall Study|Physician Decision|0|||
162690286|NCT04867785|587578947|FG006|Overall Study|Physician Decision|0|||
162690287|NCT04867785|587578948|FG007|Overall Study|Physician Decision|1|||
162690288|NCT04867785|587578941|FG000|Overall Study|Inadvertent Enrollment|0|||
162690289|NCT04867785|587578942|FG001|Overall Study|Inadvertent Enrollment|0|||
162690290|NCT04867785|587578943|FG002|Overall Study|Inadvertent Enrollment|0|||
162690291|NCT04867785|587578944|FG003|Overall Study|Inadvertent Enrollment|1|||
162690292|NCT04867785|587578945|FG004|Overall Study|Inadvertent Enrollment|1|||
162690293|NCT04867785|587578946|FG005|Overall Study|Inadvertent Enrollment|0|||
162690294|NCT04867785|587578947|FG006|Overall Study|Inadvertent Enrollment|0|||
162728438|NCT05678998|587714887|FG003|Overall Study|Lost to Follow-up|0|||
162728439|NCT05678998|587714888|FG004|Overall Study|Lost to Follow-up|1|||
162690295|NCT04867785|587578948|FG007|Overall Study|Inadvertent Enrollment|1|||
162690296|NCT04867785|587578941|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162690297|NCT04867785|587578942|FG001|Overall Study|Eligibility Criteria Not Met|0|||
162690298|NCT04867785|587578943|FG002|Overall Study|Eligibility Criteria Not Met|0|||
162690299|NCT04867785|587578944|FG003|Overall Study|Eligibility Criteria Not Met|0|||
162690300|NCT04867785|587578945|FG004|Overall Study|Eligibility Criteria Not Met|0|||
162690301|NCT04867785|587578946|FG005|Overall Study|Eligibility Criteria Not Met|0|||
162690302|NCT04867785|587578947|FG006|Overall Study|Eligibility Criteria Not Met|0|||
162690303|NCT04867785|587578948|FG007|Overall Study|Eligibility Criteria Not Met|1|||
162690304|NCT01062763|587578949|FG000|Overall Study|Adverse Event|3|||
162690305|NCT01062763|587578950|FG001|Overall Study|Adverse Event|4|||
162690306|NCT02494921|587578952|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
162690307|NCT02494921|587578953|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
162690308|NCT02494921|587578954|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
162690309|NCT02494921|587578955|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
162690310|NCT02494921|587578956|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
162690311|NCT02494921|587578952|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
162728440|NCT05678998|587714884|FG000|Overall Study|Death|0|||
162728441|NCT05678998|587714885|FG001|Overall Study|Death|0|||
162728442|NCT05678998|587714886|FG002|Overall Study|Death|0|||
162728443|NCT05678998|587714887|FG003|Overall Study|Death|3|||
162728444|NCT05678998|587714888|FG004|Overall Study|Death|4|||
162728445|NCT05678998|587714884|FG000|Overall Study|Other|0|||
162728446|NCT05678998|587714885|FG001|Overall Study|Other|0|||
162728447|NCT05678998|587714886|FG002|Overall Study|Other|0|||
162728448|NCT05678998|587714887|FG003|Overall Study|Other|2|||
162728449|NCT05678998|587714888|FG004|Overall Study|Other|1|||
162728450|NCT05773313|587714889|FG000|Overall Study|Lost to Follow-up|3|||
162728451|NCT01534494|587714890|FG000|Overall Study|Withdrawal by Subject|1|||
162728452|NCT05137236|587714891|FG000|Part A|Other than Specified|1|||
162728453|NCT05137236|587714892|FG001|Part A|Other than Specified|0|||
162728454|NCT05137236|587714893|FG002|Part A|Other than Specified|0|||
162728455|NCT05137236|587714894|FG003|Part A|Other than Specified|0|||
162728456|NCT05137236|587714895|FG004|Part A|Other than Specified|0|||
162728457|NCT05137236|587714896|FG005|Part A|Other than Specified|0|||
162728458|NCT05137236|587714897|FG006|Part A|Other than Specified|0|||
162728459|NCT05137236|587714898|FG007|Part A|Other than Specified|0|||
162728460|NCT05137236|587714891|FG000|Part A|Withdrawal by Subject|0|||
162728461|NCT05137236|587714892|FG001|Part A|Withdrawal by Subject|4|||
162728462|NCT05137236|587714893|FG002|Part A|Withdrawal by Subject|1|||
162728463|NCT05137236|587714894|FG003|Part A|Withdrawal by Subject|1|||
162728464|NCT05137236|587714895|FG004|Part A|Withdrawal by Subject|3|||
162728465|NCT05137236|587714896|FG005|Part A|Withdrawal by Subject|2|||
162728466|NCT05137236|587714897|FG006|Part A|Withdrawal by Subject|0|||
162728467|NCT05137236|587714898|FG007|Part A|Withdrawal by Subject|0|||
162728468|NCT05137236|587714891|FG000|Part A|Lost to Follow-up|5|||
162728469|NCT05137236|587714892|FG001|Part A|Lost to Follow-up|7|||
162728470|NCT05137236|587714893|FG002|Part A|Lost to Follow-up|1|||
162728471|NCT05137236|587714894|FG003|Part A|Lost to Follow-up|3|||
162728472|NCT05137236|587714895|FG004|Part A|Lost to Follow-up|3|||
162728473|NCT05137236|587714896|FG005|Part A|Lost to Follow-up|8|||
162728474|NCT05137236|587714897|FG006|Part A|Lost to Follow-up|0|||
162728475|NCT05137236|587714898|FG007|Part A|Lost to Follow-up|0|||
162728476|NCT05137236|587714891|FG000|Part B|Withdrawal by Subject|0|||
162728477|NCT05137236|587714892|FG001|Part B|Withdrawal by Subject|0|||
162728478|NCT05137236|587714893|FG002|Part B|Withdrawal by Subject|0|||
162728479|NCT05137236|587714894|FG003|Part B|Withdrawal by Subject|0|||
162728480|NCT05137236|587714895|FG004|Part B|Withdrawal by Subject|0|||
162728481|NCT05137236|587714896|FG005|Part B|Withdrawal by Subject|0|||
162728482|NCT05137236|587714897|FG006|Part B|Withdrawal by Subject|0|||
162728483|NCT05137236|587714898|FG007|Part B|Withdrawal by Subject|2|||
162728484|NCT05137236|587714891|FG000|Part B|Lost to Follow-up|0|||
162728485|NCT05137236|587714892|FG001|Part B|Lost to Follow-up|0|||
162728486|NCT05137236|587714893|FG002|Part B|Lost to Follow-up|0|||
162728487|NCT05137236|587714894|FG003|Part B|Lost to Follow-up|0|||
162728488|NCT05137236|587714895|FG004|Part B|Lost to Follow-up|0|||
162728489|NCT05137236|587714896|FG005|Part B|Lost to Follow-up|0|||
162728490|NCT05137236|587714897|FG006|Part B|Lost to Follow-up|5|||
162728491|NCT05137236|587714898|FG007|Part B|Lost to Follow-up|5|||
162728492|NCT05137236|587714891|FG000|Part B|Death|0|||
162728493|NCT05137236|587714892|FG001|Part B|Death|0|||
162728494|NCT05137236|587714893|FG002|Part B|Death|0|||
162728495|NCT05137236|587714894|FG003|Part B|Death|0|||
162728496|NCT05137236|587714895|FG004|Part B|Death|0|||
162728497|NCT05137236|587714896|FG005|Part B|Death|0|||
162728498|NCT05137236|587714897|FG006|Part B|Death|0|||
162728499|NCT05137236|587714898|FG007|Part B|Death|2|||
162728500|NCT00802464|587714899|FG000|Month 0 - Month 8|Adverse Event|0|||
162728501|NCT00802464|587714900|FG001|Month 0 - Month 8|Adverse Event|1|||
162728502|NCT00802464|587714901|FG002|Month 0 - Month 8|Adverse Event|1|||
162728503|NCT00802464|587714902|FG003|Month 0 - Month 8|Adverse Event|2|||
162728504|NCT00802464|587714899|FG000|Month 0 - Month 8|Protocol Violation|0|||
162728505|NCT00802464|587714900|FG001|Month 0 - Month 8|Protocol Violation|0|||
162728506|NCT00802464|587714901|FG002|Month 0 - Month 8|Protocol Violation|1|||
162728507|NCT00802464|587714902|FG003|Month 0 - Month 8|Protocol Violation|0|||
162728508|NCT00802464|587714899|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
162728509|NCT00802464|587714900|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
162728510|NCT00802464|587714901|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
162728511|NCT00802464|587714902|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
162728512|NCT00802464|587714899|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
162728513|NCT00802464|587714900|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
162728514|NCT00802464|587714901|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
162728515|NCT00802464|587714902|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
162728516|NCT00802464|587714899|FG000|Month 0 - Month 8|Other|0|||
162728517|NCT00802464|587714900|FG001|Month 0 - Month 8|Other|0|||
162728518|NCT00802464|587714901|FG002|Month 0 - Month 8|Other|1|||
162728519|NCT00802464|587714902|FG003|Month 0 - Month 8|Other|0|||
162728520|NCT00802464|587714899|FG000|Month 8 - Month 14|Adverse Event|0|||
162728521|NCT00802464|587714900|FG001|Month 8 - Month 14|Adverse Event|1|||
162728522|NCT00802464|587714901|FG002|Month 8 - Month 14|Adverse Event|0|||
162728523|NCT00802464|587714902|FG003|Month 8 - Month 14|Adverse Event|0|||
162728524|NCT00802464|587714899|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
162728525|NCT00802464|587714900|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
162728526|NCT00802464|587714901|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
162728527|NCT00802464|587714902|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
162728528|NCT00802464|587714899|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
162728529|NCT00802464|587714900|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
162728530|NCT00802464|587714901|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
162728531|NCT00802464|587714902|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
162728532|NCT00402246|587714903|FG000|Overall Study|Death|62|||
162728533|NCT00402246|587714904|FG001|Overall Study|Death|58|||
162728534|NCT00402246|587714903|FG000|Overall Study|Lost to Follow-up|20|||
162728535|NCT00402246|587714904|FG001|Overall Study|Lost to Follow-up|28|||
162728536|NCT00402246|587714903|FG000|Overall Study|Withdrawal by Subject|72|||
162728537|NCT00402246|587714904|FG001|Overall Study|Withdrawal by Subject|87|||
162728538|NCT00402246|587714903|FG000|Overall Study|Physician Decision|24|||
162728539|NCT00402246|587714904|FG001|Overall Study|Physician Decision|26|||
162728540|NCT00402246|587714903|FG000|Overall Study|Protocol Violation|25|||
162728541|NCT00402246|587714904|FG001|Overall Study|Protocol Violation|24|||
162728542|NCT00402246|587714903|FG000|Overall Study|Missed Final Visit|1|||
162728543|NCT00402246|587714904|FG001|Overall Study|Missed Final Visit|2|||
162728544|NCT00402246|587714903|FG000|Overall Study|Insurance Issues|2|||
162728545|NCT00402246|587714904|FG001|Overall Study|Insurance Issues|1|||
162728546|NCT00402246|587714903|FG000|Overall Study|Heart Transplant|0|||
162728547|NCT00402246|587714904|FG001|Overall Study|Heart Transplant|1|||
162728548|NCT00402246|587714903|FG000|Overall Study|Patient's device explanted|6|||
162728549|NCT00402246|587714904|FG001|Overall Study|Patient's device explanted|2|||
162728550|NCT00402246|587714903|FG000|Overall Study|Center Closure|5|||
162690312|NCT02494921|587578953|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
162690313|NCT02494921|587578954|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
162690314|NCT02494921|587578955|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
162690315|NCT02494921|587578956|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
162690316|NCT02494921|587578952|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
162690317|NCT02494921|587578953|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
162690318|NCT02494921|587578954|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
162690319|NCT02494921|587578955|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
162690320|NCT02494921|587578956|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
162690321|NCT02991482|587578959|FG000|Overall Study|Disease progression|56|||
162690322|NCT02991482|587578960|FG001|Overall Study|Disease progression|47|||
162690323|NCT02991482|587578959|FG000|Overall Study|Death|4|||
162690324|NCT02991482|587578960|FG001|Overall Study|Death|4|||
162690325|NCT02991482|587578959|FG000|Overall Study|Adverse Event|1|||
162690326|NCT02991482|587578960|FG001|Overall Study|Adverse Event|6|||
162728551|NCT00402246|587714904|FG001|Overall Study|Center Closure|3|||
162728552|NCT00402246|587714903|FG000|Overall Study|Deterioriating Condition|3|||
162728553|NCT00402246|587714904|FG001|Overall Study|Deterioriating Condition|2|||
162728554|NCT02622568|587714914|FG000|Overall Study|Lost to Follow-up|5|||
162728555|NCT02622568|587714915|FG001|Overall Study|Lost to Follow-up|5|||
162728556|NCT01939899|587714916|FG000|Lead-in Dose Finding Phase|Death|0|||
162728557|NCT01939899|587714917|FG001|Lead-in Dose Finding Phase|Death|3|||
162728558|NCT01939899|587714918|FG002|Lead-in Dose Finding Phase|Death|1|||
162728559|NCT01939899|587714919|FG003|Lead-in Dose Finding Phase|Death|0|||
162728560|NCT01939899|587714920|FG004|Lead-in Dose Finding Phase|Death|0|||
162728561|NCT01939899|587714916|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
162728562|NCT01939899|587714917|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
162728563|NCT01939899|587714918|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
162728564|NCT01939899|587714919|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
162690327|NCT02991482|587578959|FG000|Overall Study|Patient decision|1|||
162728565|NCT01939899|587714920|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
162728566|NCT01939899|587714916|FG000|Lead-in Dose Finding Phase|Other|0|||
162728567|NCT01939899|587714917|FG001|Lead-in Dose Finding Phase|Other|0|||
162728568|NCT01939899|587714918|FG002|Lead-in Dose Finding Phase|Other|1|||
162728569|NCT01939899|587714919|FG003|Lead-in Dose Finding Phase|Other|0|||
162728570|NCT01939899|587714920|FG004|Lead-in Dose Finding Phase|Other|0|||
162728571|NCT01939899|587714916|FG000|Phase 2|Withdrawal by Subject|0|||
162728572|NCT01939899|587714917|FG001|Phase 2|Withdrawal by Subject|0|||
162728573|NCT01939899|587714918|FG002|Phase 2|Withdrawal by Subject|0|||
162728574|NCT01939899|587714919|FG003|Phase 2|Withdrawal by Subject|2|||
162728575|NCT01939899|587714920|FG004|Phase 2|Withdrawal by Subject|0|||
162728576|NCT01939899|587714916|FG000|Phase 2|Disease Progression|0|||
162728577|NCT01939899|587714917|FG001|Phase 2|Disease Progression|0|||
162690328|NCT02991482|587578960|FG001|Overall Study|Patient decision|1|||
162690329|NCT02991482|587578959|FG000|Overall Study|Physician Decision|0|||
162690330|NCT02991482|587578960|FG001|Overall Study|Physician Decision|6|||
162728578|NCT01939899|587714918|FG002|Phase 2|Disease Progression|0|||
162728579|NCT01939899|587714919|FG003|Phase 2|Disease Progression|9|||
162728580|NCT01939899|587714920|FG004|Phase 2|Disease Progression|1|||
162728581|NCT02015520|587714925|FG000|Overall Study|Lack of Efficacy|1|||
162728582|NCT02015520|587714926|FG001|Overall Study|Lack of Efficacy|0|||
162728583|NCT02015520|587714927|FG002|Overall Study|Lack of Efficacy|3|||
162728584|NCT02015520|587714928|FG003|Overall Study|Lack of Efficacy|2|||
162690331|NCT02991482|587578959|FG000|Overall Study|Clinical deterioration|1|||
162690332|NCT02991482|587578960|FG001|Overall Study|Clinical deterioration|0|||
162690333|NCT02991482|587578959|FG000|Overall Study|Patient feeling too unwell|1|||
162690334|NCT02991482|587578960|FG001|Overall Study|Patient feeling too unwell|0|||
162690335|NCT02991482|587578959|FG000|Overall Study|Worsening of performance status|0|||
162690336|NCT02991482|587578960|FG001|Overall Study|Worsening of performance status|1|||
162690337|NCT02991482|587578959|FG000|Overall Study|Death prior to study drug initiation|1|||
162690338|NCT02991482|587578960|FG001|Overall Study|Death prior to study drug initiation|0|||
162690339|NCT02991482|587578959|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
162690340|NCT02991482|587578960|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
162690341|NCT02887989|587578966|FG000|Overall Study|Withdrawal by Subject|8|||
162690342|NCT02887989|587578967|FG001|Overall Study|Withdrawal by Subject|11|||
162690343|NCT02887989|587578966|FG000|Overall Study|Death|1|||
162690344|NCT02887989|587578967|FG001|Overall Study|Death|0|||
162690345|NCT05648357|587578971|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
162690346|NCT00768430|587578972|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
162690347|NCT00768430|587578973|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
162690348|NCT03585296|587578976|FG000|Overall Study|Adverse Event|1|||
162690349|NCT03585296|587578976|FG000|Overall Study|Lost to Follow-up|2|||
162690350|NCT03585296|587578976|FG000|Overall Study|Withdrawal by Subject|2|||
162690351|NCT00041756|587578977|FG000|Overall Study|Adverse Event|4|||
162690352|NCT00041756|587578978|FG001|Overall Study|Adverse Event|10|||
162690353|NCT00041756|587578979|FG002|Overall Study|Adverse Event|6|||
162690354|NCT00041756|587578980|FG003|Overall Study|Adverse Event|11|||
162690355|NCT00041756|587578981|FG004|Overall Study|Adverse Event|34|||
162690356|NCT00041756|587578977|FG000|Overall Study|Protocol Violation|1|||
162690357|NCT00041756|587578978|FG001|Overall Study|Protocol Violation|1|||
162690358|NCT00041756|587578979|FG002|Overall Study|Protocol Violation|2|||
162690359|NCT00041756|587578980|FG003|Overall Study|Protocol Violation|2|||
162690360|NCT00041756|587578981|FG004|Overall Study|Protocol Violation|1|||
162690361|NCT00041756|587578977|FG000|Overall Study|Withdrawal by Subject|3|||
162690362|NCT00041756|587578978|FG001|Overall Study|Withdrawal by Subject|3|||
162690363|NCT00041756|587578979|FG002|Overall Study|Withdrawal by Subject|4|||
162690364|NCT00041756|587578980|FG003|Overall Study|Withdrawal by Subject|2|||
162690365|NCT00041756|587578981|FG004|Overall Study|Withdrawal by Subject|3|||
162690366|NCT00041756|587578977|FG000|Overall Study|Lost to Follow-up|0|||
162690367|NCT00041756|587578978|FG001|Overall Study|Lost to Follow-up|1|||
162690368|NCT00041756|587578979|FG002|Overall Study|Lost to Follow-up|0|||
162690369|NCT00041756|587578980|FG003|Overall Study|Lost to Follow-up|1|||
162690370|NCT00041756|587578981|FG004|Overall Study|Lost to Follow-up|0|||
162690371|NCT00041756|587578977|FG000|Overall Study|Unable to meet protocol criteria|0|||
162690372|NCT00041756|587578978|FG001|Overall Study|Unable to meet protocol criteria|0|||
162690373|NCT00041756|587578979|FG002|Overall Study|Unable to meet protocol criteria|1|||
162690374|NCT00041756|587578980|FG003|Overall Study|Unable to meet protocol criteria|0|||
162690375|NCT00041756|587578981|FG004|Overall Study|Unable to meet protocol criteria|1|||
162690376|NCT00041756|587578977|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
162690377|NCT00041756|587578978|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
162690378|NCT00041756|587578979|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
162690379|NCT00041756|587578980|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
162690380|NCT00041756|587578981|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
162690381|NCT02110732|587578982|FG000|Overall Study|Physician Decision|5|||
162690382|NCT02110732|587578983|FG001|Overall Study|Physician Decision|2|||
162690383|NCT02110732|587578982|FG000|Overall Study|Lost to Follow-up|1|||
162690384|NCT02110732|587578983|FG001|Overall Study|Lost to Follow-up|1|||
162690385|NCT04887948|587578987|FG000|Overall Study|Death|1|||
162690386|NCT04887948|587578988|FG001|Overall Study|Death|0|||
162690387|NCT04887948|587578989|FG002|Overall Study|Death|0|||
162690388|NCT04887948|587578987|FG000|Overall Study|Lost to Follow-up|1|||
162690389|NCT04887948|587578988|FG001|Overall Study|Lost to Follow-up|0|||
162690390|NCT04887948|587578989|FG002|Overall Study|Lost to Follow-up|3|||
162690391|NCT04887948|587578987|FG000|Overall Study|Physician Decision|0|||
162690392|NCT04887948|587578988|FG001|Overall Study|Physician Decision|4|||
162690393|NCT04887948|587578989|FG002|Overall Study|Physician Decision|1|||
162690394|NCT04887948|587578987|FG000|Overall Study|Protocol Violation|1|||
162690395|NCT04887948|587578988|FG001|Overall Study|Protocol Violation|1|||
162690396|NCT04887948|587578989|FG002|Overall Study|Protocol Violation|0|||
162690397|NCT04887948|587578987|FG000|Overall Study|Withdrawal by Subject|0|||
162690398|NCT04887948|587578988|FG001|Overall Study|Withdrawal by Subject|6|||
162690399|NCT04887948|587578989|FG002|Overall Study|Withdrawal by Subject|1|||
162690400|NCT04887948|587578987|FG000|Overall Study|No longer met eligibility criteria|1|||
162690401|NCT04887948|587578988|FG001|Overall Study|No longer met eligibility criteria|2|||
162690402|NCT04887948|587578989|FG002|Overall Study|No longer met eligibility criteria|1|||
162690403|NCT04887948|587578987|FG000|Overall Study|Other|2|||
162690404|NCT04887948|587578988|FG001|Overall Study|Other|1|||
162690405|NCT04887948|587578989|FG002|Overall Study|Other|1|||
162690406|NCT02312856|587578990|FG000|Overall Study|Death|1|||
162728585|NCT02015520|587714925|FG000|Overall Study|Adverse Event|0|||
162728586|NCT02015520|587714926|FG001|Overall Study|Adverse Event|0|||
162728587|NCT02015520|587714927|FG002|Overall Study|Adverse Event|0|||
162728588|NCT02015520|587714928|FG003|Overall Study|Adverse Event|1|||
162728589|NCT02015520|587714925|FG000|Overall Study|Withdrawal by Subject|2|||
162728590|NCT02015520|587714926|FG001|Overall Study|Withdrawal by Subject|2|||
162728591|NCT02015520|587714927|FG002|Overall Study|Withdrawal by Subject|1|||
162728592|NCT02015520|587714928|FG003|Overall Study|Withdrawal by Subject|0|||
162728593|NCT02015520|587714925|FG000|Overall Study|Death|1|||
162728594|NCT02015520|587714926|FG001|Overall Study|Death|0|||
162728595|NCT02015520|587714927|FG002|Overall Study|Death|0|||
162728596|NCT02015520|587714928|FG003|Overall Study|Death|0|||
162728597|NCT02015520|587714925|FG000|Overall Study|Lost to Follow-up|0|||
162728598|NCT02015520|587714926|FG001|Overall Study|Lost to Follow-up|0|||
162728599|NCT02015520|587714927|FG002|Overall Study|Lost to Follow-up|1|||
162728600|NCT02015520|587714928|FG003|Overall Study|Lost to Follow-up|0|||
162728601|NCT02015520|587714925|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162728602|NCT02015520|587714926|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162728603|NCT02015520|587714927|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
162728604|NCT02015520|587714928|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162728605|NCT02015520|587714925|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
162728606|NCT02015520|587714926|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
162728607|NCT02015520|587714927|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
162728608|NCT02015520|587714928|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
162728609|NCT01854385|587714932|FG000|Pre-Treatment|Withdrawal by Subject|4|||
162728610|NCT01854385|587714932|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
162728611|NCT01854385|587714932|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
162728612|NCT01854385|587714932|FG000|Pre-Treatment|Unable to come for study visits|1|||
162728613|NCT01854385|587714932|FG000|Treatment|Lost to Follow-up|1|||
162728614|NCT02932579|587714933|FG000|Overall Study|Withdrawal by Subject|4|||
162728615|NCT02932579|587714934|FG001|Overall Study|Withdrawal by Subject|1|||
162728616|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
162728617|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
162728618|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
162728619|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
162728620|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
162728621|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162728622|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162728623|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
162728624|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162728625|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162728626|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
162728627|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
162728628|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
162728629|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
162728630|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
162728631|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162728632|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
162728633|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
162728634|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162728635|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162728636|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
162728637|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
162728638|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
162728639|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
162728640|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
162728641|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162728642|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162728643|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
162728644|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162728645|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162728646|NCT04759833|587714937|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162728647|NCT04759833|587714938|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
162728648|NCT04759833|587714939|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162728649|NCT04759833|587714940|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162728650|NCT04759833|587714941|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162690407|NCT02312856|587578990|FG000|Overall Study|Lost to Follow-up|3|||
162690408|NCT04415151|587578991|FG000|Overall Study|Death|1|||
162690409|NCT04415151|587578992|FG001|Overall Study|Death|1|||
162690410|NCT04415151|587578991|FG000|Overall Study|Withdrawal by Subject|1|||
162690411|NCT04415151|587578992|FG001|Overall Study|Withdrawal by Subject|0|||
162690412|NCT00638235|587578993|FG000|Overall Study|Lost to Follow-up|31|||
162690413|NCT00638235|587578994|FG001|Overall Study|Lost to Follow-up|3|||
162690414|NCT00638235|587578995|FG002|Overall Study|Lost to Follow-up|18|||
162690415|NCT00638235|587578996|FG003|Overall Study|Lost to Follow-up|10|||
162690416|NCT00638235|587578997|FG004|Overall Study|Lost to Follow-up|13|||
162690417|NCT00638235|587578998|FG005|Overall Study|Lost to Follow-up|26|||
162690418|NCT00638235|587578999|FG006|Overall Study|Lost to Follow-up|0|||
162690419|NCT00638235|587579000|FG007|Overall Study|Lost to Follow-up|1|||
162690420|NCT00638235|587579001|FG008|Overall Study|Lost to Follow-up|18|||
162690421|NCT01588990|587579004|FG000|Phase A|Withdrawal by Subject|5|||
162690422|NCT01588990|587579004|FG000|Phase A|Physician Decision|11|||
162690423|NCT01588990|587579004|FG000|Phase A|Other|14|||
162690424|NCT01588990|587579004|FG000|Phase A|Lost to Follow-up|1|||
162690425|NCT01588990|587579004|FG000|Phase A|Death|5|||
162690426|NCT01588990|587579004|FG000|Phase A|Adverse Event|28|||
162690427|NCT01588990|587579004|FG000|Phase A|Still on therapy at end of study|6|||
162690428|NCT01588990|587579004|FG000|Phase B|Adverse Event|2|||
162690429|NCT01588990|587579004|FG000|Phase B|Still on therapy at end of study|5|||
162690430|NCT01588990|587579004|FG000|Phase B|Withdrawal by Subject|3|||
162690431|NCT01588990|587579004|FG000|Phase B|Physician Decision|4|||
162690432|NCT01588990|587579004|FG000|Phase B|Other|2|||
162690433|NCT02367716|587579005|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
162690434|NCT01473381|587579006|FG000|Overall Study|Adverse Event|8|||
162690435|NCT01473381|587579007|FG001|Overall Study|Adverse Event|20|||
162690436|NCT01473381|587579008|FG002|Overall Study|Adverse Event|25|||
162690437|NCT01473381|587579009|FG003|Overall Study|Adverse Event|17|||
162690438|NCT01473381|587579006|FG000|Overall Study|Insufficient Therapeutic Response|10|||
162690439|NCT01473381|587579007|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162690440|NCT01473381|587579008|FG002|Overall Study|Insufficient Therapeutic Response|2|||
162690441|NCT01473381|587579009|FG003|Overall Study|Insufficient Therapeutic Response|3|||
162690442|NCT01473381|587579006|FG000|Overall Study|Protocol Violation|17|||
162690443|NCT01473381|587579007|FG001|Overall Study|Protocol Violation|23|||
162690444|NCT01473381|587579008|FG002|Overall Study|Protocol Violation|19|||
162690445|NCT01473381|587579009|FG003|Overall Study|Protocol Violation|17|||
162690446|NCT01473381|587579006|FG000|Overall Study|Withdrawal of Consent|20|||
162690447|NCT01473381|587579007|FG001|Overall Study|Withdrawal of Consent|21|||
162690448|NCT01473381|587579008|FG002|Overall Study|Withdrawal of Consent|20|||
162690449|NCT01473381|587579009|FG003|Overall Study|Withdrawal of Consent|26|||
162690450|NCT01473381|587579006|FG000|Overall Study|Lost to Follow-up|25|||
162690451|NCT01473381|587579007|FG001|Overall Study|Lost to Follow-up|28|||
162690452|NCT01473381|587579008|FG002|Overall Study|Lost to Follow-up|35|||
162690453|NCT01473381|587579009|FG003|Overall Study|Lost to Follow-up|23|||
162690454|NCT01473381|587579006|FG000|Overall Study|Other Reasons|0|||
162690455|NCT01473381|587579007|FG001|Overall Study|Other Reasons|0|||
162690456|NCT01473381|587579008|FG002|Overall Study|Other Reasons|1|||
162690457|NCT01473381|587579009|FG003|Overall Study|Other Reasons|3|||
162690458|NCT00539643|587579010|FG000|Overall Study|Adverse Event|1|||
162690459|NCT00539643|587579011|FG001|Overall Study|Adverse Event|0|||
162690460|NCT00539643|587579010|FG000|Overall Study|Death|2|||
162690461|NCT00539643|587579011|FG001|Overall Study|Death|1|||
162690462|NCT00539643|587579010|FG000|Overall Study|Physician Decision|3|||
162690463|NCT00539643|587579011|FG001|Overall Study|Physician Decision|1|||
162690464|NCT00539643|587579010|FG000|Overall Study|Withdrawal by Subject|0|||
162690465|NCT00539643|587579011|FG001|Overall Study|Withdrawal by Subject|1|||
162690466|NCT01641926|587579014|FG000|Overall Study|Adverse Event|5|||
162690467|NCT01641926|587579015|FG001|Overall Study|Adverse Event|2|||
162690468|NCT01641926|587579016|FG002|Overall Study|Adverse Event|3|||
162690469|NCT01641926|587579017|FG003|Overall Study|Adverse Event|1|||
162690470|NCT01641926|587579014|FG000|Overall Study|Lost to Follow-up|2|||
162690471|NCT01641926|587579015|FG001|Overall Study|Lost to Follow-up|2|||
162690472|NCT01641926|587579016|FG002|Overall Study|Lost to Follow-up|1|||
162690473|NCT01641926|587579017|FG003|Overall Study|Lost to Follow-up|0|||
162690474|NCT01641926|587579014|FG000|Overall Study|Physician Decision|6|||
162690475|NCT01641926|587579015|FG001|Overall Study|Physician Decision|5|||
162690476|NCT01641926|587579016|FG002|Overall Study|Physician Decision|0|||
162690477|NCT01641926|587579017|FG003|Overall Study|Physician Decision|1|||
162690478|NCT01641926|587579014|FG000|Overall Study|Protocol Violation|1|||
162690479|NCT01641926|587579015|FG001|Overall Study|Protocol Violation|0|||
162690480|NCT01641926|587579016|FG002|Overall Study|Protocol Violation|0|||
162690481|NCT01641926|587579017|FG003|Overall Study|Protocol Violation|1|||
162690482|NCT01641926|587579014|FG000|Overall Study|Withdrawal by Subject|13|||
162690483|NCT01641926|587579015|FG001|Overall Study|Withdrawal by Subject|5|||
162690484|NCT01641926|587579016|FG002|Overall Study|Withdrawal by Subject|6|||
162690485|NCT01641926|587579017|FG003|Overall Study|Withdrawal by Subject|1|||
162690486|NCT01641926|587579014|FG000|Overall Study|Not Treated|1|||
162728651|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162728652|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162728653|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162728654|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
162728655|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
162728656|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162728657|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162728658|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162728659|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162728660|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
162728661|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162728662|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162728663|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162728664|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
162728665|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
162728666|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162728667|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162728668|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162728669|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
162728670|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
162728671|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162728672|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162728673|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162728674|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
162728675|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
162728676|NCT04759833|587714937|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162728677|NCT04759833|587714938|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162728678|NCT04759833|587714939|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162728679|NCT04759833|587714940|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
162728680|NCT04759833|587714941|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
162728681|NCT00508924|587714942|FG000|Overall Study|Protocol Violation|0|||
162728682|NCT00508924|587714943|FG001|Overall Study|Protocol Violation|0|||
162728683|NCT00508924|587714944|FG002|Overall Study|Protocol Violation|1|||
162728684|NCT00508924|587714945|FG003|Overall Study|Protocol Violation|1|||
162728685|NCT00630058|587714946|FG000|Overall Study|Adverse Event|1|||
162728686|NCT00630058|587714947|FG001|Overall Study|Adverse Event|1|||
162728687|NCT00630058|587714946|FG000|Overall Study|Withdrawal by Subject|0|||
162728688|NCT00630058|587714947|FG001|Overall Study|Withdrawal by Subject|1|||
162728689|NCT00630058|587714946|FG000|Overall Study|stopping criteria|3|||
162728690|NCT00630058|587714947|FG001|Overall Study|stopping criteria|2|||
162728691|NCT00415519|587714952|FG000|Overall Study|Adverse Event|1|||
162728692|NCT00415519|587714953|FG001|Overall Study|Adverse Event|0|||
162728693|NCT00415519|587714952|FG000|Overall Study|Withdrawal by Subject|2|||
162728694|NCT00415519|587714953|FG001|Overall Study|Withdrawal by Subject|0|||
162728695|NCT00415519|587714952|FG000|Overall Study|Patient's convenience|1|||
162728696|NCT00415519|587714953|FG001|Overall Study|Patient's convenience|0|||
162728697|NCT04163718|587714954|FG000|Overall Study|Study terminated|12|||
162728698|NCT00409838|587714958|FG000|Short-term Period|Adverse Event|0|||
162728699|NCT00409838|587714959|FG001|Short-term Period|Adverse Event|1|||
162728700|NCT00409838|587714958|FG000|Short-term Period|Lost to Follow-up|0|||
162728701|NCT00409838|587714959|FG001|Short-term Period|Lost to Follow-up|1|||
162728702|NCT00409838|587714958|FG000|Short-term Period|Withdrawal by Subject|2|||
162728703|NCT00409838|587714959|FG001|Short-term Period|Withdrawal by Subject|3|||
162728704|NCT00409838|587714958|FG000|Short-term Period|Never Treated|1|||
162728705|NCT00409838|587714959|FG001|Short-term Period|Never Treated|0|||
162728706|NCT00409838|587714958|FG000|Long-term Extension Period|Adverse Event|10|||
162728707|NCT00409838|587714959|FG001|Long-term Extension Period|Adverse Event|0|||
162728708|NCT00409838|587714958|FG000|Long-term Extension Period|Death|1|||
162728709|NCT00409838|587714959|FG001|Long-term Extension Period|Death|0|||
162728710|NCT00409838|587714958|FG000|Long-term Extension Period|Lack of Efficacy|2|||
162728711|NCT00409838|587714959|FG001|Long-term Extension Period|Lack of Efficacy|0|||
162728712|NCT00409838|587714958|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
162728713|NCT00409838|587714959|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
162728714|NCT00409838|587714958|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
162728715|NCT00409838|587714959|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
162728716|NCT00409838|587714958|FG000|Long-term Extension Period|Pregnancy|1|||
162728717|NCT00409838|587714959|FG001|Long-term Extension Period|Pregnancy|0|||
162728718|NCT01985334|587714961|FG000|Overall Study|Administrative problems|1|||
162728719|NCT01985334|587714962|FG001|Overall Study|Administrative problems|1|||
162690487|NCT01641926|587579015|FG001|Overall Study|Not Treated|1|||
162690488|NCT01641926|587579016|FG002|Overall Study|Not Treated|1|||
162690489|NCT01641926|587579017|FG003|Overall Study|Not Treated|0|||
162690490|NCT04399356|587579018|FG000|Overall Study|Lost to Follow-up|1|||
162690491|NCT04399356|587579019|FG001|Overall Study|Lost to Follow-up|1|||
162690492|NCT04399356|587579018|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
162690493|NCT04399356|587579019|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
162690494|NCT04399356|587579018|FG000|Overall Study|Withdrawal by Subject|1|||
162690495|NCT04399356|587579019|FG001|Overall Study|Withdrawal by Subject|0|||
162690496|NCT03812536|587579020|FG000|Overall Study|Protocol Violation|2|||
162690497|NCT03812536|587579021|FG001|Overall Study|Protocol Violation|0|||
162690498|NCT03812536|587579020|FG000|Overall Study|Withdrawal by Subject|1|||
162690499|NCT03812536|587579021|FG001|Overall Study|Withdrawal by Subject|1|||
162690500|NCT00152009|587579022|FG000|Overall Study|Adverse Event|9|||
162690501|NCT00152009|587579023|FG001|Overall Study|Adverse Event|13|||
162690502|NCT00152009|587579024|FG002|Overall Study|Adverse Event|20|||
162690503|NCT00152009|587579025|FG003|Overall Study|Adverse Event|1|||
162690504|NCT00152009|587579022|FG000|Overall Study|Protocol Violation|3|||
162690505|NCT00152009|587579023|FG001|Overall Study|Protocol Violation|0|||
162690506|NCT00152009|587579024|FG002|Overall Study|Protocol Violation|0|||
162690507|NCT00152009|587579025|FG003|Overall Study|Protocol Violation|1|||
162690508|NCT00152009|587579022|FG000|Overall Study|Withdrawal by Subject|2|||
162690509|NCT00152009|587579023|FG001|Overall Study|Withdrawal by Subject|3|||
162690510|NCT00152009|587579024|FG002|Overall Study|Withdrawal by Subject|4|||
162690511|NCT00152009|587579025|FG003|Overall Study|Withdrawal by Subject|9|||
162690512|NCT00152009|587579022|FG000|Overall Study|Lost to Follow-up|2|||
162690513|NCT00152009|587579023|FG001|Overall Study|Lost to Follow-up|4|||
162690514|NCT00152009|587579024|FG002|Overall Study|Lost to Follow-up|3|||
162690515|NCT00152009|587579025|FG003|Overall Study|Lost to Follow-up|3|||
162690516|NCT00152009|587579022|FG000|Overall Study|Lack of Efficacy|8|||
162690517|NCT00152009|587579023|FG001|Overall Study|Lack of Efficacy|6|||
162690518|NCT00152009|587579024|FG002|Overall Study|Lack of Efficacy|7|||
162690519|NCT00152009|587579025|FG003|Overall Study|Lack of Efficacy|15|||
162690520|NCT00152009|587579022|FG000|Overall Study|ECG abnormalities|2|||
162690521|NCT00152009|587579023|FG001|Overall Study|ECG abnormalities|2|||
162690522|NCT00152009|587579024|FG002|Overall Study|ECG abnormalities|2|||
162690523|NCT00152009|587579025|FG003|Overall Study|ECG abnormalities|1|||
162690524|NCT00152009|587579022|FG000|Overall Study|Sponsor's decision|3|||
162690525|NCT00152009|587579023|FG001|Overall Study|Sponsor's decision|3|||
162690526|NCT00152009|587579024|FG002|Overall Study|Sponsor's decision|1|||
162690527|NCT00152009|587579025|FG003|Overall Study|Sponsor's decision|3|||
162690528|NCT01306201|587579026|FG000|Overall Study|Arrhythmia|4|||
162690529|NCT01306201|587579026|FG000|Overall Study|Files could not be processed|3|||
162690530|NCT01306201|587579026|FG000|Overall Study|Files unreadable|3|||
162690531|NCT00980005|587579029|FG000|Overall Study|Withdrawal by Subject|6|||
162690532|NCT00980005|587579030|FG001|Overall Study|Withdrawal by Subject|17|||
162690533|NCT00980005|587579029|FG000|Overall Study|Lost to Follow-up|37|||
162690534|NCT00980005|587579030|FG001|Overall Study|Lost to Follow-up|43|||
162690535|NCT00980005|587579029|FG000|Overall Study|Other|4|||
162690536|NCT00980005|587579030|FG001|Overall Study|Other|3|||
162690537|NCT00572624|587579031|FG000|Overall Study|Lost to Follow-up|10|||
162690538|NCT00572624|587579032|FG001|Overall Study|Lost to Follow-up|4|||
162690539|NCT00572624|587579031|FG000|Overall Study|Wanted to do a different diet program|1|||
162690540|NCT00572624|587579032|FG001|Overall Study|Wanted to do a different diet program|0|||
162690541|NCT00572624|587579031|FG000|Overall Study|Medication change|1|||
162690542|NCT00572624|587579032|FG001|Overall Study|Medication change|0|||
162690543|NCT00572624|587579031|FG000|Overall Study|Started a new job-- no time for study|1|||
162690544|NCT00572624|587579032|FG001|Overall Study|Started a new job-- no time for study|0|||
162690545|NCT00572624|587579031|FG000|Overall Study|Admitted to being a smoker|1|||
162690546|NCT00572624|587579032|FG001|Overall Study|Admitted to being a smoker|0|||
162690547|NCT00572624|587579031|FG000|Overall Study|Refused to do the stress test|1|||
162690548|NCT00572624|587579032|FG001|Overall Study|Refused to do the stress test|0|||
162690549|NCT00572624|587579031|FG000|Overall Study|Problem with vascular access|1|||
162690550|NCT00572624|587579032|FG001|Overall Study|Problem with vascular access|0|||
162690551|NCT00572624|587579031|FG000|Overall Study|Health issues unrelated to the study|1|||
162690552|NCT00572624|587579032|FG001|Overall Study|Health issues unrelated to the study|0|||
162690553|NCT00098254|587579037|FG000|Overall Study|Adverse Event|2|||
162690554|NCT00098254|587579037|FG000|Overall Study|Death|1|||
162690555|NCT02118337|587579038|FG000|Overall Study|Other|1|||
162690556|NCT02118337|587579039|FG001|Overall Study|Other|0|||
162690557|NCT02118337|587579040|FG002|Overall Study|Other|0|||
162690558|NCT02118337|587579041|FG003|Overall Study|Other|0|||
162690559|NCT02118337|587579042|FG004|Overall Study|Other|2|||
162690560|NCT02118337|587579043|FG005|Overall Study|Other|3|||
162690561|NCT02118337|587579044|FG006|Overall Study|Other|1|||
162690562|NCT02118337|587579045|FG007|Overall Study|Other|28|||
162690563|NCT02118337|587579046|FG008|Overall Study|Other|15|||
162690564|NCT02118337|587579038|FG000|Overall Study|Lost to Follow-up|0|||
162690565|NCT02118337|587579039|FG001|Overall Study|Lost to Follow-up|0|||
162728720|NCT01985334|587714963|FG002|Overall Study|Administrative problems|0|||
162728721|NCT01985334|587714964|FG003|Overall Study|Administrative problems|2|||
162728722|NCT01985334|587714965|FG004|Overall Study|Administrative problems|0|||
162728723|NCT01985334|587714966|FG005|Overall Study|Administrative problems|1|||
162728724|NCT01985334|587714967|FG006|Overall Study|Administrative problems|1|||
162728725|NCT01985334|587714968|FG007|Overall Study|Administrative problems|3|||
162728726|NCT01985334|587714961|FG000|Overall Study|Death|1|||
162728727|NCT01985334|587714962|FG001|Overall Study|Death|0|||
162728728|NCT01985334|587714963|FG002|Overall Study|Death|0|||
162728729|NCT01985334|587714964|FG003|Overall Study|Death|3|||
162728730|NCT01985334|587714965|FG004|Overall Study|Death|0|||
162728731|NCT01985334|587714966|FG005|Overall Study|Death|0|||
162728732|NCT01985334|587714967|FG006|Overall Study|Death|1|||
162728733|NCT01985334|587714968|FG007|Overall Study|Death|2|||
162728734|NCT01985334|587714961|FG000|Overall Study|Worsening of disease|0|||
162728735|NCT01985334|587714962|FG001|Overall Study|Worsening of disease|0|||
162728736|NCT01985334|587714963|FG002|Overall Study|Worsening of disease|0|||
162728737|NCT01985334|587714964|FG003|Overall Study|Worsening of disease|1|||
162728738|NCT01985334|587714965|FG004|Overall Study|Worsening of disease|0|||
162728739|NCT01985334|587714966|FG005|Overall Study|Worsening of disease|3|||
162728740|NCT01985334|587714967|FG006|Overall Study|Worsening of disease|0|||
162728741|NCT01985334|587714968|FG007|Overall Study|Worsening of disease|1|||
162728742|NCT01985334|587714961|FG000|Overall Study|Other|2|||
162728743|NCT01985334|587714962|FG001|Overall Study|Other|9|||
162690566|NCT02118337|587579040|FG002|Overall Study|Lost to Follow-up|0|||
162690567|NCT02118337|587579041|FG003|Overall Study|Lost to Follow-up|0|||
162690568|NCT02118337|587579042|FG004|Overall Study|Lost to Follow-up|0|||
162690569|NCT02118337|587579043|FG005|Overall Study|Lost to Follow-up|0|||
162690570|NCT02118337|587579044|FG006|Overall Study|Lost to Follow-up|0|||
162690571|NCT02118337|587579045|FG007|Overall Study|Lost to Follow-up|1|||
162690572|NCT02118337|587579046|FG008|Overall Study|Lost to Follow-up|0|||
162690573|NCT02118337|587579038|FG000|Overall Study|Withdrawal by Subject|1|||
162690574|NCT02118337|587579039|FG001|Overall Study|Withdrawal by Subject|3|||
162690575|NCT02118337|587579040|FG002|Overall Study|Withdrawal by Subject|2|||
162690576|NCT02118337|587579041|FG003|Overall Study|Withdrawal by Subject|1|||
162690577|NCT02118337|587579042|FG004|Overall Study|Withdrawal by Subject|2|||
162690578|NCT02118337|587579043|FG005|Overall Study|Withdrawal by Subject|2|||
162690579|NCT02118337|587579044|FG006|Overall Study|Withdrawal by Subject|1|||
162690580|NCT02118337|587579045|FG007|Overall Study|Withdrawal by Subject|4|||
162690581|NCT02118337|587579046|FG008|Overall Study|Withdrawal by Subject|2|||
162690582|NCT02118337|587579038|FG000|Overall Study|Death|2|||
162690583|NCT02118337|587579039|FG001|Overall Study|Death|2|||
162690584|NCT02118337|587579040|FG002|Overall Study|Death|1|||
162690585|NCT02118337|587579041|FG003|Overall Study|Death|2|||
162690586|NCT02118337|587579042|FG004|Overall Study|Death|5|||
162690587|NCT02118337|587579043|FG005|Overall Study|Death|1|||
162690588|NCT02118337|587579044|FG006|Overall Study|Death|2|||
162690589|NCT02118337|587579045|FG007|Overall Study|Death|9|||
162690590|NCT02118337|587579046|FG008|Overall Study|Death|4|||
162690591|NCT00130793|587579048|FG000|Overall Study|Lost to Follow-up|1|||
162690592|NCT00130793|587579049|FG001|Overall Study|Lost to Follow-up|4|||
162690593|NCT00130793|587579048|FG000|Overall Study|Withdrew consent|2|||
162690594|NCT00130793|587579049|FG001|Overall Study|Withdrew consent|0|||
162690595|NCT00211237|587579050|FG000|Baseline|Withdrew|1|||
162690596|NCT00211237|587579051|FG001|Baseline|Withdrew|3|||
162690597|NCT00211237|587579052|FG002|Baseline|Withdrew|0|||
162690598|NCT00211237|587579050|FG000|Baseline|Refused random assignment|1|||
162690599|NCT00211237|587579051|FG001|Baseline|Refused random assignment|0|||
162690600|NCT00211237|587579052|FG002|Baseline|Refused random assignment|0|||
162690601|NCT00211237|587579050|FG000|1 Month|Death|2|||
162690602|NCT00211237|587579051|FG001|1 Month|Death|1|||
162690603|NCT00211237|587579052|FG002|1 Month|Death|0|||
162690604|NCT00211237|587579050|FG000|1 Month|Lost to Follow-up|0|||
162690605|NCT00211237|587579051|FG001|1 Month|Lost to Follow-up|2|||
162690606|NCT00211237|587579052|FG002|1 Month|Lost to Follow-up|0|||
162728744|NCT01985334|587714963|FG002|Overall Study|Other|7|||
162728745|NCT01985334|587714964|FG003|Overall Study|Other|17|||
162728746|NCT01985334|587714965|FG004|Overall Study|Other|4|||
162728747|NCT01985334|587714966|FG005|Overall Study|Other|8|||
162728748|NCT01985334|587714967|FG006|Overall Study|Other|4|||
162728749|NCT01985334|587714968|FG007|Overall Study|Other|7|||
162728750|NCT01985334|587714961|FG000|Overall Study|Protocol deviation|6|||
162728751|NCT01985334|587714962|FG001|Overall Study|Protocol deviation|31|||
162728752|NCT01985334|587714963|FG002|Overall Study|Protocol deviation|25|||
162728753|NCT01985334|587714964|FG003|Overall Study|Protocol deviation|84|||
162728754|NCT01985334|587714965|FG004|Overall Study|Protocol deviation|17|||
162728755|NCT01985334|587714966|FG005|Overall Study|Protocol deviation|47|||
162728756|NCT01985334|587714967|FG006|Overall Study|Protocol deviation|15|||
162728757|NCT01985334|587714968|FG007|Overall Study|Protocol deviation|42|||
162728758|NCT01985334|587714961|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
162728759|NCT01985334|587714962|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
162728760|NCT01985334|587714963|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
162728761|NCT01985334|587714964|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
162728762|NCT01985334|587714965|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
162728763|NCT01985334|587714966|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
162690607|NCT00211237|587579050|FG000|1 Month|Withdrew|0|||
162690608|NCT00211237|587579051|FG001|1 Month|Withdrew|4|||
162690609|NCT00211237|587579052|FG002|1 Month|Withdrew|0|||
162690610|NCT00211237|587579050|FG000|1 Month|Additional surgery needed|1|||
162690611|NCT00211237|587579051|FG001|1 Month|Additional surgery needed|0|||
162690612|NCT00211237|587579052|FG002|1 Month|Additional surgery needed|0|||
162690613|NCT00211237|587579050|FG000|1 Month|Non-medical problem|0|||
162690614|NCT00211237|587579051|FG001|1 Month|Non-medical problem|2|||
162690615|NCT00211237|587579052|FG002|1 Month|Non-medical problem|0|||
162690616|NCT00211237|587579050|FG000|3 Months|Death|7|||
162690617|NCT00211237|587579051|FG001|3 Months|Death|3|||
162690618|NCT00211237|587579052|FG002|3 Months|Death|0|||
162690619|NCT00211237|587579050|FG000|3 Months|Could not comply with protocol|1|||
162690620|NCT00211237|587579051|FG001|3 Months|Could not comply with protocol|0|||
162690621|NCT00211237|587579052|FG002|3 Months|Could not comply with protocol|0|||
162690622|NCT00211237|587579050|FG000|3 Months|Withdrew|0|||
162690623|NCT00211237|587579051|FG001|3 Months|Withdrew|1|||
162690624|NCT00211237|587579052|FG002|3 Months|Withdrew|0|||
162690625|NCT00211237|587579050|FG000|3 Months|Non-medical problem|0|||
162690626|NCT00211237|587579051|FG001|3 Months|Non-medical problem|0|||
162690627|NCT00211237|587579052|FG002|3 Months|Non-medical problem|1|||
162690628|NCT00211237|587579050|FG000|6 Months|Death|6|||
162690629|NCT00211237|587579051|FG001|6 Months|Death|0|||
162690630|NCT00211237|587579052|FG002|6 Months|Death|3|||
162690631|NCT00211237|587579050|FG000|6 Months|Lost to Follow-up|2|||
162690632|NCT00211237|587579051|FG001|6 Months|Lost to Follow-up|0|||
162690633|NCT00211237|587579052|FG002|6 Months|Lost to Follow-up|0|||
162690634|NCT00211237|587579050|FG000|6 Months|Could not comply with protocol|0|||
162690635|NCT00211237|587579051|FG001|6 Months|Could not comply with protocol|2|||
162690636|NCT00211237|587579052|FG002|6 Months|Could not comply with protocol|0|||
162690637|NCT00211237|587579050|FG000|12 Months|Death|8|||
162690638|NCT00211237|587579051|FG001|12 Months|Death|2|||
162690639|NCT00211237|587579052|FG002|12 Months|Death|3|||
162690640|NCT00211237|587579050|FG000|12 Months|Lost to Follow-up|1|||
162690641|NCT00211237|587579051|FG001|12 Months|Lost to Follow-up|0|||
162690642|NCT00211237|587579052|FG002|12 Months|Lost to Follow-up|1|||
162690643|NCT00211237|587579050|FG000|12 Months|Withdrew|0|||
162690644|NCT00211237|587579051|FG001|12 Months|Withdrew|0|||
162690645|NCT00211237|587579052|FG002|12 Months|Withdrew|1|||
162690646|NCT00211237|587579050|FG000|12 Months|unrelated medical problem|0|||
162690647|NCT00211237|587579051|FG001|12 Months|unrelated medical problem|0|||
162690648|NCT00211237|587579052|FG002|12 Months|unrelated medical problem|1|||
162690649|NCT01003639|587579055|FG000|Overall Study|Lost to Follow-up|6|||
162690650|NCT01003639|587579056|FG001|Overall Study|Lost to Follow-up|9|||
162690651|NCT01003639|587579055|FG000|Overall Study|Withdrawal by Subject|9|||
162690652|NCT01003639|587579056|FG001|Overall Study|Withdrawal by Subject|5|||
162690653|NCT01003639|587579055|FG000|Overall Study|Lack of Efficacy|1|||
162690654|NCT01003639|587579056|FG001|Overall Study|Lack of Efficacy|6|||
162690655|NCT01003639|587579055|FG000|Overall Study|Adverse Event|0|||
162690656|NCT01003639|587579056|FG001|Overall Study|Adverse Event|1|||
162690657|NCT01003639|587579055|FG000|Overall Study|Protocol Violation|0|||
162690658|NCT01003639|587579056|FG001|Overall Study|Protocol Violation|1|||
162690659|NCT01003639|587579055|FG000|Overall Study|Physician Decision|1|||
162690660|NCT01003639|587579056|FG001|Overall Study|Physician Decision|0|||
162690661|NCT05458024|587579057|FG000|Overall Study|Withdrawal by Subject|1|||
162690662|NCT05458024|587579058|FG001|Overall Study|Withdrawal by Subject|1|||
162690663|NCT04000594|587579059|FG000|Overall Study|Withdrawal by Subject|1|||
162690664|NCT04000594|587579060|FG001|Overall Study|Withdrawal by Subject|0|||
162690665|NCT04000594|587579061|FG002|Overall Study|Withdrawal by Subject|0|||
162690666|NCT05807919|587579062|FG000|Overall Study|Received antibiotics - excluded|0|||
162690667|NCT05807919|587579063|FG001|Overall Study|Received antibiotics - excluded|1|||
162690668|NCT05807919|587579062|FG000|Overall Study|Withdrawal by Subject|0|||
162690669|NCT05807919|587579063|FG001|Overall Study|Withdrawal by Subject|3|||
162690670|NCT05807919|587579062|FG000|Overall Study|Adverse Event|1|||
162690671|NCT05807919|587579063|FG001|Overall Study|Adverse Event|1|||
162690672|NCT00747123|587579064|FG000|Overall Study|Investigator's request|0|||
162690673|NCT00747123|587579065|FG001|Overall Study|Investigator's request|0|||
162690674|NCT00747123|587579066|FG002|Overall Study|Investigator's request|1|||
162690675|NCT00747123|587579067|FG003|Overall Study|Investigator's request|0|||
162690676|NCT00747123|587579064|FG000|Overall Study|Withdrew consent|0|||
162690677|NCT00747123|587579065|FG001|Overall Study|Withdrew consent|1|||
162690678|NCT00747123|587579066|FG002|Overall Study|Withdrew consent|0|||
162690679|NCT00747123|587579067|FG003|Overall Study|Withdrew consent|0|||
162690680|NCT00747123|587579064|FG000|Overall Study|Adverse Event|0|||
162690681|NCT00747123|587579065|FG001|Overall Study|Adverse Event|1|||
162690682|NCT00747123|587579066|FG002|Overall Study|Adverse Event|0|||
162690683|NCT00747123|587579067|FG003|Overall Study|Adverse Event|1|||
162728764|NCT01985334|587714967|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
162690684|NCT03489057|587579068|FG000|Overall Study|Lost to Follow-up|16|||
162690685|NCT03489057|587579069|FG001|Overall Study|Lost to Follow-up|16|||
162690686|NCT03489057|587579070|FG002|Overall Study|Lost to Follow-up|14|||
162690687|NCT03489057|587579071|FG003|Overall Study|Lost to Follow-up|14|||
162690688|NCT03489057|587579068|FG000|Overall Study|Withdrawal by Subject|12|||
162690689|NCT03489057|587579069|FG001|Overall Study|Withdrawal by Subject|12|||
162690690|NCT03489057|587579070|FG002|Overall Study|Withdrawal by Subject|8|||
162690691|NCT03489057|587579071|FG003|Overall Study|Withdrawal by Subject|8|||
162690692|NCT03489057|587579068|FG000|Overall Study|Protocol Violation|7|||
162690693|NCT03489057|587579069|FG001|Overall Study|Protocol Violation|7|||
162690694|NCT03489057|587579070|FG002|Overall Study|Protocol Violation|2|||
162690695|NCT03489057|587579071|FG003|Overall Study|Protocol Violation|2|||
162690696|NCT02277743|587579074|FG000|Overall Study|Protocol Violation|1|||
162690697|NCT02277743|587579075|FG001|Overall Study|Protocol Violation|1|||
162690698|NCT02277743|587579076|FG002|Overall Study|Protocol Violation|1|||
162690699|NCT02277743|587579074|FG000|Overall Study|Adverse Event|10|||
162690700|NCT02277743|587579075|FG001|Overall Study|Adverse Event|6|||
162690701|NCT02277743|587579076|FG002|Overall Study|Adverse Event|6|||
162690702|NCT02277743|587579074|FG000|Overall Study|Lack of Efficacy|11|||
162690703|NCT02277743|587579075|FG001|Overall Study|Lack of Efficacy|4|||
162690704|NCT02277743|587579076|FG002|Overall Study|Lack of Efficacy|3|||
162690705|NCT02277743|587579074|FG000|Overall Study|Other than specified above|18|||
162690706|NCT02277743|587579075|FG001|Overall Study|Other than specified above|5|||
162690707|NCT02277743|587579076|FG002|Overall Study|Other than specified above|16|||
162690708|NCT00943306|587579082|FG000|Overall Study|Physician Decision|1|||
162690709|NCT00943306|587579082|FG000|Overall Study|Death|1|||
162690710|NCT00943306|587579082|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
162690711|NCT02739347|587579083|FG000|Overall Study|Adverse Event|3|||
162690712|NCT02739347|587579084|FG001|Overall Study|Adverse Event|0|||
162690713|NCT02739347|587579083|FG000|Overall Study|Protocol Violation|0|||
162690714|NCT02739347|587579084|FG001|Overall Study|Protocol Violation|1|||
162690715|NCT02739347|587579083|FG000|Overall Study|Lost to Follow-up|0|||
162690716|NCT02739347|587579084|FG001|Overall Study|Lost to Follow-up|2|||
162690717|NCT01552954|587579085|FG000|Overall Study|Adverse Event|1|||
162690718|NCT01552954|587579086|FG001|Overall Study|Adverse Event|2|||
162690719|NCT01552954|587579085|FG000|Overall Study|Lost to Follow-up|1|||
162690720|NCT01552954|587579086|FG001|Overall Study|Lost to Follow-up|1|||
162690721|NCT01552954|587579085|FG000|Overall Study|Withdrawal by Subject|1|||
162690722|NCT01552954|587579086|FG001|Overall Study|Withdrawal by Subject|1|||
162690723|NCT01552954|587579085|FG000|Overall Study|Protocol Violation|1|||
162690724|NCT01552954|587579086|FG001|Overall Study|Protocol Violation|2|||
162690725|NCT01552954|587579085|FG000|Overall Study|diagnosed DM|1|||
162690726|NCT01552954|587579086|FG001|Overall Study|diagnosed DM|0|||
162690727|NCT00779779|587579087|FG000|Overall Study|Adverse Event|1|||
162690728|NCT00779779|587579087|FG000|Overall Study|Protocol Violation|14|||
162690729|NCT00779779|587579087|FG000|Overall Study|Withdrawal by Subject|4|||
162690730|NCT00779779|587579087|FG000|Overall Study|Lost to Follow-up|5|||
162690731|NCT01395823|587579088|FG000|Overall Study|Death|4|||
162690732|NCT01395823|587579089|FG001|Overall Study|Death|4|||
162690733|NCT01395823|587579088|FG000|Overall Study|Physician Decision|3|||
162690734|NCT01395823|587579089|FG001|Overall Study|Physician Decision|1|||
162690735|NCT01395823|587579088|FG000|Overall Study|Lost to Follow-up|1|||
162690736|NCT01395823|587579089|FG001|Overall Study|Lost to Follow-up|0|||
162690737|NCT01395823|587579088|FG000|Overall Study|Transplant|1|||
162690738|NCT01395823|587579089|FG001|Overall Study|Transplant|0|||
162690739|NCT01395823|587579088|FG000|Overall Study|GI symptoms|1|||
162690740|NCT01395823|587579089|FG001|Overall Study|GI symptoms|0|||
162690741|NCT01395823|587579088|FG000|Overall Study|Withdrawal by Subject|5|||
162690742|NCT01395823|587579089|FG001|Overall Study|Withdrawal by Subject|4|||
162690743|NCT00116272|587579090|FG000|Overall Study|Lost to Follow-up|11|||
162690744|NCT00116272|587579091|FG001|Overall Study|Lost to Follow-up|6|||
162690745|NCT01235403|587579092|FG000|Overall Study|Adverse Event|14|||
162690746|NCT01235403|587579092|FG000|Overall Study|Lost to Follow-up|2|||
162690747|NCT01235403|587579092|FG000|Overall Study|Withdrawal by Subject|4|||
162690748|NCT01235403|587579092|FG000|Overall Study|Lack of Efficacy|2|||
162690749|NCT01235403|587579092|FG000|Overall Study|Other reasons for premature termination|4|||
162690750|NCT05096208|587579093|FG000|Overall Study|Lost to Follow-up|3|||
162690751|NCT05096208|587579094|FG001|Overall Study|Lost to Follow-up|5|||
162690752|NCT05096208|587579095|FG002|Overall Study|Lost to Follow-up|5|||
162690753|NCT05096208|587579096|FG003|Overall Study|Lost to Follow-up|2|||
162690754|NCT05096208|587579093|FG000|Overall Study|Withdrawal by Subject|0|||
162690755|NCT05096208|587579094|FG001|Overall Study|Withdrawal by Subject|1|||
162690756|NCT05096208|587579095|FG002|Overall Study|Withdrawal by Subject|2|||
162690757|NCT05096208|587579096|FG003|Overall Study|Withdrawal by Subject|3|||
162690758|NCT05096208|587579093|FG000|Overall Study|No longer met eligibility criteria|1|||
162690759|NCT05096208|587579094|FG001|Overall Study|No longer met eligibility criteria|0|||
162690760|NCT05096208|587579095|FG002|Overall Study|No longer met eligibility criteria|0|||
162690761|NCT05096208|587579096|FG003|Overall Study|No longer met eligibility criteria|0|||
162690762|NCT05096208|587579093|FG000|Overall Study|Other|0|||
162690763|NCT05096208|587579094|FG001|Overall Study|Other|0|||
162690764|NCT05096208|587579095|FG002|Overall Study|Other|1|||
162690765|NCT05096208|587579096|FG003|Overall Study|Other|0|||
162690766|NCT00782496|587579097|FG000|Overall Study|Lost to Follow-up|14|||
162690767|NCT00782496|587579098|FG001|Overall Study|Lost to Follow-up|15|||
162690768|NCT01833143|587579100|FG000|Overall Study|Not Treated|1|||
162690769|NCT00386308|587580564|FG000|Overall Study|Adverse Event|3|||
162690770|NCT00386308|587580565|FG001|Overall Study|Adverse Event|3|||
162690771|NCT00386308|587580564|FG000|Overall Study|Protocol Violation|2|||
162690772|NCT00386308|587580565|FG001|Overall Study|Protocol Violation|5|||
162690773|NCT00386308|587580564|FG000|Overall Study|Lack of Efficacy|0|||
162690774|NCT00386308|587580565|FG001|Overall Study|Lack of Efficacy|2|||
162690775|NCT00386308|587580564|FG000|Overall Study|Lost to Follow-up|10|||
162690776|NCT00386308|587580565|FG001|Overall Study|Lost to Follow-up|6|||
162690777|NCT00386308|587580564|FG000|Overall Study|Withdrawal by Subject|6|||
162690778|NCT00386308|587580565|FG001|Overall Study|Withdrawal by Subject|2|||
162690779|NCT00386308|587580564|FG000|Overall Study|Other Event|8|||
162690780|NCT00386308|587580565|FG001|Overall Study|Other Event|1|||
162690781|NCT03518658|587580566|FG000|Overall Study|Other|51|||
162690782|NCT03518658|587580567|FG001|Overall Study|Other|0|||
162690783|NCT00649389|587580568|FG000|Overall Study|Adverse Event|22|||
162690784|NCT00649389|587580569|FG001|Overall Study|Adverse Event|46|||
162690785|NCT00649389|587580570|FG002|Overall Study|Adverse Event|38|||
162690786|NCT00649389|587580571|FG003|Overall Study|Adverse Event|48|||
162690787|NCT00649389|587580568|FG000|Overall Study|Lost to Follow-up|15|||
162690788|NCT00649389|587580569|FG001|Overall Study|Lost to Follow-up|17|||
162690789|NCT00649389|587580570|FG002|Overall Study|Lost to Follow-up|21|||
162690790|NCT00649389|587580571|FG003|Overall Study|Lost to Follow-up|26|||
162690791|NCT00649389|587580568|FG000|Overall Study|Protocol Violation|11|||
162690792|NCT00649389|587580569|FG001|Overall Study|Protocol Violation|13|||
162690793|NCT00649389|587580570|FG002|Overall Study|Protocol Violation|9|||
162690794|NCT00649389|587580571|FG003|Overall Study|Protocol Violation|8|||
162690795|NCT00649389|587580568|FG000|Overall Study|Withdrawal by Subject|20|||
162690796|NCT00649389|587580569|FG001|Overall Study|Withdrawal by Subject|21|||
162690797|NCT00649389|587580570|FG002|Overall Study|Withdrawal by Subject|19|||
162690798|NCT00649389|587580571|FG003|Overall Study|Withdrawal by Subject|23|||
162690799|NCT00649389|587580568|FG000|Overall Study|Other|3|||
162690800|NCT00649389|587580569|FG001|Overall Study|Other|9|||
162690801|NCT00649389|587580570|FG002|Overall Study|Other|1|||
162690802|NCT00649389|587580571|FG003|Overall Study|Other|6|||
162690803|NCT02746575|587580574|FG000|Overall Study|Surgery cancelled or time chaned|13|||
162690804|NCT02746575|587580574|FG000|Overall Study|Received epidural|10|||
162690805|NCT02746575|587580574|FG000|Overall Study|Withdrawal by Subject|3|||
162690806|NCT02746575|587580574|FG000|Overall Study|Bradycardia/hypotension|9|||
162690807|NCT02746575|587580574|FG000|Overall Study|Study paused|8|||
162690808|NCT02746575|587580574|FG000|Overall Study|put on beta-blocker|3|||
162690809|NCT02746575|587580574|FG000|Overall Study|type of surgery|1|||
162690810|NCT02746575|587580574|FG000|Overall Study|typ of surgery|1|||
162690811|NCT02746575|587580574|FG000|Overall Study|PI unavailable|1|||
162690812|NCT02746575|587580574|FG000|Overall Study|Unknown history of CVA|1|||
162690813|NCT00976482|587580575|FG000|Overall Study|Death|208|||
162690814|NCT00976482|587580575|FG000|Overall Study|Withdrawal by Subject|45|||
162690815|NCT00976482|587580575|FG000|Overall Study|Center terminated|1|||
162690816|NCT00976482|587580575|FG000|Overall Study|Protocol Violation|5|||
162690817|NCT02959671|587580576|FG000|Overall Study|Adverse Event|2|||
162690818|NCT02959671|587580576|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
162690819|NCT00605319|587580582|FG000|Overall Study|Adverse Event|6|||
162690820|NCT00432835|587580585|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
162690821|NCT00432835|587580586|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
162690822|NCT02002884|587580588|FG000|Main Period (MP)|Other|0|||
162690823|NCT02002884|587580589|FG001|Main Period (MP)|Other|3|||
162690824|NCT02002884|587580590|FG002|Main Period (MP)|Other|3|||
162690825|NCT02002884|587580591|FG003|Main Period (MP)|Other|0|||
162690826|NCT02002884|587580588|FG000|Main Period (MP)|Adverse Event|0|||
162690827|NCT02002884|587580589|FG001|Main Period (MP)|Adverse Event|1|||
162690828|NCT02002884|587580590|FG002|Main Period (MP)|Adverse Event|1|||
162690829|NCT02002884|587580591|FG003|Main Period (MP)|Adverse Event|0|||
162690830|NCT02002884|587580588|FG000|Main Period (MP)|Withdrawal by Subject|6|||
162690831|NCT02002884|587580589|FG001|Main Period (MP)|Withdrawal by Subject|2|||
162690832|NCT02002884|587580590|FG002|Main Period (MP)|Withdrawal by Subject|2|||
162690833|NCT02002884|587580591|FG003|Main Period (MP)|Withdrawal by Subject|0|||
162690834|NCT02002884|587580588|FG000|Main Period (MP)|Lost to Follow-up|0|||
162690835|NCT02002884|587580589|FG001|Main Period (MP)|Lost to Follow-up|0|||
162690836|NCT02002884|587580590|FG002|Main Period (MP)|Lost to Follow-up|2|||
162690837|NCT02002884|587580591|FG003|Main Period (MP)|Lost to Follow-up|0|||
162690838|NCT02002884|587580588|FG000|Open-Label Extension Period (OLEX)|Other|0|||
162690839|NCT02002884|587580589|FG001|Open-Label Extension Period (OLEX)|Other|0|||
162690840|NCT02002884|587580590|FG002|Open-Label Extension Period (OLEX)|Other|0|||
162690841|NCT02002884|587580591|FG003|Open-Label Extension Period (OLEX)|Other|24|||
162690842|NCT02002884|587580588|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162690843|NCT02002884|587580589|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162690844|NCT02002884|587580590|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162690845|NCT02002884|587580591|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
162690846|NCT02002884|587580588|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162690847|NCT02002884|587580589|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162690848|NCT02002884|587580590|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162690849|NCT02002884|587580591|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
162690850|NCT02002884|587580588|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162690851|NCT02002884|587580589|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162690852|NCT02002884|587580590|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162690853|NCT02002884|587580591|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
162690854|NCT02002884|587580588|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162690855|NCT02002884|587580589|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162690856|NCT02002884|587580590|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162690857|NCT02002884|587580591|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
162690858|NCT02508532|587580592|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690859|NCT02508532|587580593|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690860|NCT02508532|587580594|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690861|NCT02508532|587580595|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690862|NCT02508532|587580596|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690863|NCT02508532|587580597|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690864|NCT02508532|587580598|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
162690865|NCT02508532|587580599|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690866|NCT02508532|587580600|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162690867|NCT02508532|587580592|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690868|NCT02508532|587580593|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690869|NCT02508532|587580594|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690870|NCT02508532|587580595|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690871|NCT02508532|587580596|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690872|NCT02508532|587580597|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690873|NCT02508532|587580598|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690874|NCT02508532|587580599|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
162690875|NCT02508532|587580600|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
162690876|NCT02508532|587580592|FG000|Part 2 - Treatment|Disease Progression|0|||
162690877|NCT02508532|587580593|FG001|Part 2 - Treatment|Disease Progression|0|||
162690878|NCT02508532|587580594|FG002|Part 2 - Treatment|Disease Progression|0|||
162690879|NCT02508532|587580595|FG003|Part 2 - Treatment|Disease Progression|0|||
162690880|NCT02508532|587580596|FG004|Part 2 - Treatment|Disease Progression|0|||
162690881|NCT02508532|587580597|FG005|Part 2 - Treatment|Disease Progression|0|||
162690882|NCT02508532|587580598|FG006|Part 2 - Treatment|Disease Progression|0|||
162690883|NCT02508532|587580599|FG007|Part 2 - Treatment|Disease Progression|0|||
162690884|NCT02508532|587580600|FG008|Part 2 - Treatment|Disease Progression|118|||
162690885|NCT02508532|587580592|FG000|Part 2 - Treatment|Adverse Event|0|||
162690886|NCT02508532|587580593|FG001|Part 2 - Treatment|Adverse Event|0|||
162690887|NCT02508532|587580594|FG002|Part 2 - Treatment|Adverse Event|0|||
162690888|NCT02508532|587580595|FG003|Part 2 - Treatment|Adverse Event|0|||
162690889|NCT02508532|587580596|FG004|Part 2 - Treatment|Adverse Event|0|||
162690890|NCT02508532|587580597|FG005|Part 2 - Treatment|Adverse Event|0|||
162690891|NCT02508532|587580598|FG006|Part 2 - Treatment|Adverse Event|0|||
162690892|NCT02508532|587580599|FG007|Part 2 - Treatment|Adverse Event|0|||
162690893|NCT02508532|587580600|FG008|Part 2 - Treatment|Adverse Event|49|||
162690894|NCT02508532|587580592|FG000|Part 2 - Treatment|Physician Decision|0|||
162690895|NCT02508532|587580593|FG001|Part 2 - Treatment|Physician Decision|0|||
162690896|NCT02508532|587580594|FG002|Part 2 - Treatment|Physician Decision|0|||
162690897|NCT02508532|587580595|FG003|Part 2 - Treatment|Physician Decision|0|||
162690898|NCT02508532|587580596|FG004|Part 2 - Treatment|Physician Decision|0|||
162690899|NCT02508532|587580597|FG005|Part 2 - Treatment|Physician Decision|0|||
162690900|NCT02508532|587580598|FG006|Part 2 - Treatment|Physician Decision|0|||
162690901|NCT02508532|587580599|FG007|Part 2 - Treatment|Physician Decision|0|||
162690902|NCT02508532|587580600|FG008|Part 2 - Treatment|Physician Decision|12|||
162690903|NCT02508532|587580592|FG000|Part 2 - Treatment|Administrative|0|||
162690904|NCT02508532|587580593|FG001|Part 2 - Treatment|Administrative|0|||
162690905|NCT02508532|587580594|FG002|Part 2 - Treatment|Administrative|0|||
162690906|NCT02508532|587580595|FG003|Part 2 - Treatment|Administrative|0|||
162690907|NCT02508532|587580596|FG004|Part 2 - Treatment|Administrative|0|||
162690908|NCT02508532|587580597|FG005|Part 2 - Treatment|Administrative|0|||
162690909|NCT02508532|587580598|FG006|Part 2 - Treatment|Administrative|0|||
162690910|NCT02508532|587580599|FG007|Part 2 - Treatment|Administrative|0|||
162690911|NCT02508532|587580600|FG008|Part 2 - Treatment|Administrative|3|||
162690912|NCT02508532|587580592|FG000|Part 2 - Treatment|Sponsor Decision|0|||
162690913|NCT02508532|587580593|FG001|Part 2 - Treatment|Sponsor Decision|0|||
162690914|NCT02508532|587580594|FG002|Part 2 - Treatment|Sponsor Decision|0|||
162690915|NCT02508532|587580595|FG003|Part 2 - Treatment|Sponsor Decision|0|||
162690916|NCT02508532|587580596|FG004|Part 2 - Treatment|Sponsor Decision|0|||
162690917|NCT02508532|587580597|FG005|Part 2 - Treatment|Sponsor Decision|0|||
162690918|NCT02508532|587580598|FG006|Part 2 - Treatment|Sponsor Decision|0|||
162690919|NCT02508532|587580599|FG007|Part 2 - Treatment|Sponsor Decision|0|||
162690920|NCT02508532|587580600|FG008|Part 2 - Treatment|Sponsor Decision|28|||
162690921|NCT02508532|587580592|FG000|Part 2 - Treatment|Death|0|||
162690922|NCT02508532|587580593|FG001|Part 2 - Treatment|Death|0|||
162690923|NCT02508532|587580594|FG002|Part 2 - Treatment|Death|0|||
162690924|NCT02508532|587580595|FG003|Part 2 - Treatment|Death|0|||
162690925|NCT02508532|587580596|FG004|Part 2 - Treatment|Death|0|||
162690926|NCT02508532|587580597|FG005|Part 2 - Treatment|Death|0|||
162690927|NCT02508532|587580598|FG006|Part 2 - Treatment|Death|0|||
162690928|NCT02508532|587580599|FG007|Part 2 - Treatment|Death|0|||
162690929|NCT02508532|587580600|FG008|Part 2 - Treatment|Death|1|||
162690930|NCT02508532|587580592|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
162690931|NCT02508532|587580593|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
162690932|NCT02508532|587580594|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
162690933|NCT02508532|587580595|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
162690934|NCT02508532|587580596|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
162690935|NCT02508532|587580597|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
162690936|NCT02508532|587580598|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
162690937|NCT02508532|587580599|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
162690938|NCT02508532|587580600|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
162690939|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
162690940|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690941|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690942|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690943|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690944|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690945|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
162690946|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
162690947|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
162690948|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
162690949|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690950|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
162690951|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690952|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690953|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690954|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690955|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
162690956|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
162690957|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Death|0|||
162690958|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Death|4|||
162690959|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Death|2|||
162690960|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Death|4|||
162690961|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Death|3|||
162690962|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Death|0|||
162690963|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Death|0|||
162690964|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Death|1|||
162690965|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Death|111|||
162690966|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162690967|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162690968|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162690969|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162690970|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162690971|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162690972|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162690973|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162690974|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
162690975|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690976|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690977|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690978|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690979|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690980|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690981|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690982|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162690983|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
162690984|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690985|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690986|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
162690987|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690988|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
162690989|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690990|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690991|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
162690992|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
162690993|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690994|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690995|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690996|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690997|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690998|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162690999|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162691000|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162691001|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
162691002|NCT02508532|587580592|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162691003|NCT02508532|587580593|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162691004|NCT02508532|587580594|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162691005|NCT02508532|587580595|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162691006|NCT02508532|587580596|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162691007|NCT02508532|587580597|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
162691008|NCT02508532|587580598|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
162691009|NCT02508532|587580599|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162691010|NCT02508532|587580600|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
162691011|NCT01111838|587580601|FG000|Overall Study|Patient Ineligible|2|||
162691012|NCT01111838|587580601|FG000|Overall Study|Not Treated|3|||
162691013|NCT01111838|587580601|FG000|Overall Study|Clinical deterioration|1|||
162691014|NCT01111838|587580601|FG000|Overall Study|Other Complicating Disease|1|||
162691015|NCT01616771|587580603|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
162691016|NCT04359771|587580608|FG000|Overall Study|Lack of Efficacy|2|||
162691017|NCT04359771|587580609|FG001|Overall Study|Lack of Efficacy|2|||
162691018|NCT04041440|587580611|FG000|Overall Study|Withdrawal by Subject|0|||
162691019|NCT04041440|587580612|FG001|Overall Study|Withdrawal by Subject|1|||
162691020|NCT04041440|587580611|FG000|Overall Study|Lost to Follow-up|0|||
162691021|NCT04041440|587580612|FG001|Overall Study|Lost to Follow-up|1|||
162691022|NCT02306265|587580613|FG000|Overall Study|Withdrawal by Subject|1|||
162691023|NCT02247804|587580614|FG000|Treatment Period 1|Adverse Event|9|||
162691024|NCT02247804|587580615|FG001|Treatment Period 1|Adverse Event|2|||
162691025|NCT02247804|587580616|FG002|Treatment Period 1|Adverse Event|0|||
162691026|NCT02247804|587580614|FG000|Treatment Period 1|Lack of Efficacy|0|||
162691027|NCT02247804|587580615|FG001|Treatment Period 1|Lack of Efficacy|0|||
162691028|NCT02247804|587580616|FG002|Treatment Period 1|Lack of Efficacy|2|||
162691029|NCT02247804|587580614|FG000|Treatment Period 1|Lost to Follow-up|1|||
162691030|NCT02247804|587580615|FG001|Treatment Period 1|Lost to Follow-up|0|||
162691031|NCT02247804|587580616|FG002|Treatment Period 1|Lost to Follow-up|2|||
162691032|NCT02247804|587580614|FG000|Treatment Period 1|Personal Reasons|7|||
162691033|NCT02247804|587580615|FG001|Treatment Period 1|Personal Reasons|1|||
162691034|NCT02247804|587580616|FG002|Treatment Period 1|Personal Reasons|2|||
162691035|NCT02247804|587580614|FG000|Treatment Period 1|Protocol Deviation|0|||
162691036|NCT02247804|587580615|FG001|Treatment Period 1|Protocol Deviation|0|||
162691037|NCT02247804|587580616|FG002|Treatment Period 1|Protocol Deviation|1|||
162691038|NCT02247804|587580614|FG000|Treatment Period 1|Randomized but not Treated|5|||
162691039|NCT02247804|587580615|FG001|Treatment Period 1|Randomized but not Treated|1|||
162691040|NCT02247804|587580616|FG002|Treatment Period 1|Randomized but not Treated|1|||
162691041|NCT02247804|587580614|FG000|Treatment Period 2|Adverse Event|6|||
162691042|NCT02247804|587580615|FG001|Treatment Period 2|Adverse Event|3|||
162691043|NCT02247804|587580616|FG002|Treatment Period 2|Adverse Event|3|||
162691044|NCT02247804|587580614|FG000|Treatment Period 2|Lack of Efficacy|0|||
162691045|NCT02247804|587580615|FG001|Treatment Period 2|Lack of Efficacy|0|||
162691046|NCT02247804|587580616|FG002|Treatment Period 2|Lack of Efficacy|1|||
162691047|NCT02247804|587580614|FG000|Treatment Period 2|Lost to Follow-up|0|||
162691048|NCT02247804|587580615|FG001|Treatment Period 2|Lost to Follow-up|1|||
162691049|NCT02247804|587580616|FG002|Treatment Period 2|Lost to Follow-up|1|||
162691050|NCT02247804|587580614|FG000|Treatment Period 2|Personal Reasons|2|||
162691051|NCT02247804|587580615|FG001|Treatment Period 2|Personal Reasons|1|||
162691052|NCT02247804|587580616|FG002|Treatment Period 2|Personal Reasons|1|||
162691053|NCT02247804|587580614|FG000|Treatment Period 2|Reason not Specified|0|||
162691054|NCT02247804|587580615|FG001|Treatment Period 2|Reason not Specified|0|||
162691055|NCT02247804|587580616|FG002|Treatment Period 2|Reason not Specified|2|||
162691056|NCT02247804|587580614|FG000|Treatment Period 3|Adverse Event|4|||
162691057|NCT02247804|587580615|FG001|Treatment Period 3|Adverse Event|3|||
162728765|NCT01985334|587714968|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
162728766|NCT01985334|587714961|FG000|Overall Study|Subject withdrawal of consent|3|||
162728767|NCT01985334|587714962|FG001|Overall Study|Subject withdrawal of consent|6|||
162728768|NCT01985334|587714963|FG002|Overall Study|Subject withdrawal of consent|2|||
162728769|NCT01985334|587714964|FG003|Overall Study|Subject withdrawal of consent|28|||
162728770|NCT01985334|587714965|FG004|Overall Study|Subject withdrawal of consent|4|||
162728771|NCT01985334|587714966|FG005|Overall Study|Subject withdrawal of consent|19|||
162728772|NCT01985334|587714967|FG006|Overall Study|Subject withdrawal of consent|0|||
162728773|NCT01985334|587714968|FG007|Overall Study|Subject withdrawal of consent|20|||
162728774|NCT01985334|587714961|FG000|Overall Study|Adverse Event|0|||
162728775|NCT01985334|587714962|FG001|Overall Study|Adverse Event|8|||
162728776|NCT01985334|587714963|FG002|Overall Study|Adverse Event|2|||
162728777|NCT01985334|587714964|FG003|Overall Study|Adverse Event|26|||
162728778|NCT01985334|587714965|FG004|Overall Study|Adverse Event|3|||
162728779|NCT01985334|587714966|FG005|Overall Study|Adverse Event|18|||
162728780|NCT01985334|587714967|FG006|Overall Study|Adverse Event|3|||
162728781|NCT01985334|587714968|FG007|Overall Study|Adverse Event|15|||
162728782|NCT01985334|587714961|FG000|Overall Study|Other|4|||
162728783|NCT01985334|587714962|FG001|Overall Study|Other|2|||
162728784|NCT01985334|587714963|FG002|Overall Study|Other|3|||
162728785|NCT01985334|587714964|FG003|Overall Study|Other|10|||
162728786|NCT01985334|587714965|FG004|Overall Study|Other|1|||
162728787|NCT01985334|587714966|FG005|Overall Study|Other|6|||
162728788|NCT01985334|587714967|FG006|Overall Study|Other|2|||
162728789|NCT01985334|587714968|FG007|Overall Study|Other|2|||
162728790|NCT01985334|587714961|FG000|Overall Study|Medication non-compliance|0|||
162728791|NCT01985334|587714962|FG001|Overall Study|Medication non-compliance|4|||
162728792|NCT01985334|587714963|FG002|Overall Study|Medication non-compliance|1|||
162728793|NCT01985334|587714964|FG003|Overall Study|Medication non-compliance|6|||
162728794|NCT01985334|587714965|FG004|Overall Study|Medication non-compliance|2|||
162728795|NCT01985334|587714966|FG005|Overall Study|Medication non-compliance|3|||
162728796|NCT01985334|587714967|FG006|Overall Study|Medication non-compliance|1|||
162728797|NCT01985334|587714968|FG007|Overall Study|Medication non-compliance|3|||
162728798|NCT01985334|587714961|FG000|Overall Study|Use of prohibited treatment|1|||
162728799|NCT01985334|587714962|FG001|Overall Study|Use of prohibited treatment|4|||
162728800|NCT01985334|587714963|FG002|Overall Study|Use of prohibited treatment|1|||
162728801|NCT01985334|587714964|FG003|Overall Study|Use of prohibited treatment|2|||
162728802|NCT01985334|587714965|FG004|Overall Study|Use of prohibited treatment|1|||
162728803|NCT01985334|587714966|FG005|Overall Study|Use of prohibited treatment|6|||
162728804|NCT01985334|587714967|FG006|Overall Study|Use of prohibited treatment|2|||
162728805|NCT01985334|587714968|FG007|Overall Study|Use of prohibited treatment|0|||
162728806|NCT01985334|587714961|FG000|Overall Study|Investigator decision|0|||
162728807|NCT01985334|587714962|FG001|Overall Study|Investigator decision|3|||
162728808|NCT01985334|587714963|FG002|Overall Study|Investigator decision|0|||
162728809|NCT01985334|587714964|FG003|Overall Study|Investigator decision|7|||
162728810|NCT01985334|587714965|FG004|Overall Study|Investigator decision|1|||
162728811|NCT01985334|587714966|FG005|Overall Study|Investigator decision|1|||
162728812|NCT01985334|587714967|FG006|Overall Study|Investigator decision|0|||
162728813|NCT01985334|587714968|FG007|Overall Study|Investigator decision|4|||
162728814|NCT01985334|587714961|FG000|Overall Study|Lost to Follow-up|0|||
162728815|NCT01985334|587714962|FG001|Overall Study|Lost to Follow-up|2|||
162728816|NCT01985334|587714963|FG002|Overall Study|Lost to Follow-up|0|||
162728817|NCT01985334|587714964|FG003|Overall Study|Lost to Follow-up|3|||
162728818|NCT01985334|587714965|FG004|Overall Study|Lost to Follow-up|1|||
162728819|NCT01985334|587714966|FG005|Overall Study|Lost to Follow-up|4|||
162728820|NCT01985334|587714967|FG006|Overall Study|Lost to Follow-up|0|||
162728821|NCT01985334|587714968|FG007|Overall Study|Lost to Follow-up|3|||
162728822|NCT00093015|587714969|FG000|Overall Study|Withdrawal by Subject|194|||
162728823|NCT00093015|587714970|FG001|Overall Study|Withdrawal by Subject|171|||
162728824|NCT00093015|587714969|FG000|Overall Study|Lost to Follow-up|96|||
162728825|NCT00093015|587714970|FG001|Overall Study|Lost to Follow-up|108|||
162728826|NCT00093015|587714969|FG000|Overall Study|Death|375|||
162728827|NCT00093015|587714970|FG001|Overall Study|Death|385|||
162728828|NCT04872738|587714971|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
162728829|NCT04872738|587714972|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
162728830|NCT00781274|587714976|FG000|Overall Study|Withdrawal by Subject|2|||
162728831|NCT00603954|587714978|FG000|Overall Study|Protocol Violation|1|||
162728832|NCT00603954|587714979|FG001|Overall Study|Protocol Violation|2|||
162728833|NCT04705480|587714980|FG000|Overall Study|Withdrawal by Subject|1|||
162728834|NCT04705480|587714981|FG001|Overall Study|Withdrawal by Subject|0|||
162728835|NCT04705480|587714982|FG002|Overall Study|Withdrawal by Subject|1|||
162728836|NCT04705480|587714980|FG000|Overall Study|Protocol Violation|2|||
162728837|NCT04705480|587714981|FG001|Overall Study|Protocol Violation|0|||
162728838|NCT04705480|587714982|FG002|Overall Study|Protocol Violation|2|||
162728839|NCT04705480|587714980|FG000|Overall Study|Decision to discharge before intervention|2|||
162728840|NCT04705480|587714981|FG001|Overall Study|Decision to discharge before intervention|0|||
162728841|NCT04705480|587714982|FG002|Overall Study|Decision to discharge before intervention|0|||
162728842|NCT04970654|587714983|FG000|Overall Study|Withdrawal by parents/guardian|1|||
162728843|NCT04970654|587714984|FG001|Overall Study|Withdrawal by parents/guardian|2|||
162728844|NCT04970654|587714983|FG000|Overall Study|Unclassified|2|||
162728845|NCT04970654|587714984|FG001|Overall Study|Unclassified|1|||
162728846|NCT04970654|587714983|FG000|Overall Study|Lost to Follow-up|1|||
162728847|NCT04970654|587714984|FG001|Overall Study|Lost to Follow-up|0|||
162728848|NCT01251354|587714986|FG000|Overall Study|Adverse Event|1|||
162728849|NCT01251354|587714986|FG000|Overall Study|Investigator's Decision|1|||
162728850|NCT01251354|587714986|FG000|Overall Study|Disease Progression|4|||
162728851|NCT04992390|587714993|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
162728852|NCT04992390|587714994|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
162728853|NCT04992390|587714995|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
162728854|NCT04992390|587714993|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
162728855|NCT04992390|587714994|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
162728856|NCT04992390|587714995|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
162728857|NCT04992390|587714993|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
162728858|NCT04992390|587714994|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
162728859|NCT04992390|587714995|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
162728860|NCT04992390|587714993|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
162728861|NCT04992390|587714994|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
162728862|NCT04992390|587714995|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
162728863|NCT04992390|587714993|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
162728864|NCT04992390|587714994|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
162728865|NCT04992390|587714995|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
162728866|NCT04992390|587714993|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
162728867|NCT04992390|587714994|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
162728868|NCT04992390|587714995|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
162691058|NCT02247804|587580616|FG002|Treatment Period 3|Adverse Event|3|||
162691059|NCT02247804|587580614|FG000|Treatment Period 3|Lack of Efficacy|0|||
162691060|NCT02247804|587580615|FG001|Treatment Period 3|Lack of Efficacy|1|||
162691061|NCT02247804|587580616|FG002|Treatment Period 3|Lack of Efficacy|0|||
162691062|NCT02247804|587580614|FG000|Treatment Period 3|Lost to Follow-up|1|||
162691063|NCT02247804|587580615|FG001|Treatment Period 3|Lost to Follow-up|2|||
162691064|NCT02247804|587580616|FG002|Treatment Period 3|Lost to Follow-up|2|||
162691065|NCT02247804|587580614|FG000|Treatment Period 3|Personal Reasons|4|||
162691066|NCT02247804|587580615|FG001|Treatment Period 3|Personal Reasons|3|||
162691067|NCT02247804|587580616|FG002|Treatment Period 3|Personal Reasons|2|||
162691068|NCT02247804|587580614|FG000|Treatment Period 3|Reason not Specified|2|||
162691069|NCT02247804|587580615|FG001|Treatment Period 3|Reason not Specified|1|||
162691070|NCT02247804|587580616|FG002|Treatment Period 3|Reason not Specified|3|||
162691071|NCT01346514|587580623|FG000|Overall Study|Lost to Follow-up|19|||
162691072|NCT01346514|587580624|FG001|Overall Study|Lost to Follow-up|30|||
162691073|NCT01346514|587580623|FG000|Overall Study|Withdrawal by Subject|7|||
162691074|NCT01346514|587580624|FG001|Overall Study|Withdrawal by Subject|3|||
162691075|NCT01346514|587580623|FG000|Overall Study|Death|3|||
162691076|NCT01346514|587580624|FG001|Overall Study|Death|4|||
162691077|NCT00909480|587580625|FG000|Overall Study|Adverse Event|5|||
162691078|NCT00909480|587580626|FG001|Overall Study|Adverse Event|3|||
162691079|NCT00909480|587580625|FG000|Overall Study|Protocol Violation|6|||
162691080|NCT00909480|587580626|FG001|Overall Study|Protocol Violation|8|||
162691081|NCT00909480|587580625|FG000|Overall Study|Withdrawal criteria|9|||
162691082|NCT00909480|587580626|FG001|Overall Study|Withdrawal criteria|11|||
162691083|NCT00909480|587580625|FG000|Overall Study|Unclassified|18|||
162691084|NCT00909480|587580626|FG001|Overall Study|Unclassified|19|||
162691085|NCT03002038|587580630|FG000|Overall Study|Adverse Event|3|||
162691086|NCT03002038|587580631|FG001|Overall Study|Adverse Event|1|||
162691087|NCT03002038|587580630|FG000|Overall Study|Withdrawal by Subject|8|||
162691088|NCT03002038|587580631|FG001|Overall Study|Withdrawal by Subject|4|||
162691089|NCT03002038|587580630|FG000|Overall Study|Immigration to another region|0|||
162691090|NCT03002038|587580631|FG001|Overall Study|Immigration to another region|2|||
162691091|NCT01054573|587580632|FG000|Overall Study|Adverse Event|1|||
162691092|NCT01054573|587580633|FG001|Overall Study|Adverse Event|0|||
162691093|NCT01054573|587580634|FG002|Overall Study|Adverse Event|1|||
162691094|NCT01054573|587580635|FG003|Overall Study|Adverse Event|1|||
162728869|NCT04992390|587714993|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
162728870|NCT04992390|587714994|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
162728871|NCT04992390|587714995|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
162728872|NCT04992390|587714993|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
162691095|NCT01054573|587580632|FG000|Overall Study|Lost to Follow-up|0|||
162691096|NCT01054573|587580633|FG001|Overall Study|Lost to Follow-up|2|||
162691097|NCT01054573|587580634|FG002|Overall Study|Lost to Follow-up|0|||
162691098|NCT01054573|587580635|FG003|Overall Study|Lost to Follow-up|0|||
162691099|NCT01054573|587580632|FG000|Overall Study|Withdrawal by Subject|0|||
162691100|NCT01054573|587580633|FG001|Overall Study|Withdrawal by Subject|2|||
162728873|NCT04992390|587714994|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
162728874|NCT04992390|587714995|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
162728875|NCT04992390|587714993|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
162728876|NCT04992390|587714994|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
162728877|NCT04992390|587714995|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
162728878|NCT04992390|587714993|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
162728879|NCT04992390|587714994|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
162728880|NCT04992390|587714995|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
162728881|NCT04992390|587714993|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
162728882|NCT04992390|587714994|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
162728883|NCT04992390|587714995|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
162728884|NCT04992390|587714993|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
162728885|NCT04992390|587714994|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
162728886|NCT04992390|587714995|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
162728887|NCT04992390|587714993|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
162728888|NCT04992390|587714994|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
162728889|NCT04992390|587714995|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
162728890|NCT04992390|587714993|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
162728891|NCT04992390|587714994|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
162728892|NCT04992390|587714995|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
162728893|NCT04992390|587714993|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
162728894|NCT04992390|587714994|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
162728895|NCT04992390|587714995|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
162728896|NCT04992390|587714993|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
162728897|NCT04992390|587714994|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
162728898|NCT04992390|587714995|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
162728899|NCT02152137|587716487|FG000|Overall Study|Withdrawal by Subject|1|||
162728900|NCT02152137|587716487|FG000|Overall Study|Originally assigned to Arm B|3|||
162728901|NCT03358875|587716488|FG000|Overall Study|Death|409|||
162728902|NCT03358875|587716489|FG001|Overall Study|Death|223|||
162728903|NCT03358875|587716488|FG000|Overall Study|Study Closed by Sponsor|66|||
162728904|NCT03358875|587716489|FG001|Overall Study|Study Closed by Sponsor|29|||
162728905|NCT03358875|587716488|FG000|Overall Study|Withdrawal by Subject|13|||
162728906|NCT03358875|587716489|FG001|Overall Study|Withdrawal by Subject|16|||
162728907|NCT03358875|587716488|FG000|Overall Study|Lost to Follow-up|13|||
162728908|NCT03358875|587716489|FG001|Overall Study|Lost to Follow-up|2|||
162728909|NCT03358875|587716488|FG000|Overall Study|Miscellaneous|33|||
162728910|NCT03358875|587716489|FG001|Overall Study|Miscellaneous|0|||
162728911|NCT03358875|587716488|FG000|Overall Study|Remained on Study|1|||
162728912|NCT03358875|587716489|FG001|Overall Study|Remained on Study|0|||
162728913|NCT05613205|587716504|FG000|Overall Study|Lost to Follow-up|0|||
162728914|NCT05613205|587716505|FG001|Overall Study|Lost to Follow-up|0|||
162728915|NCT05613205|587716506|FG002|Overall Study|Lost to Follow-up|1|||
162728916|NCT05613205|587716507|FG003|Overall Study|Lost to Follow-up|1|||
162728917|NCT05613205|587716508|FG004|Overall Study|Lost to Follow-up|0|||
162728918|NCT05613205|587716504|FG000|Overall Study|Withdrawal by Subject|0|||
162728919|NCT05613205|587716505|FG001|Overall Study|Withdrawal by Subject|0|||
162728920|NCT05613205|587716506|FG002|Overall Study|Withdrawal by Subject|1|||
162728921|NCT05613205|587716507|FG003|Overall Study|Withdrawal by Subject|1|||
162728922|NCT05613205|587716508|FG004|Overall Study|Withdrawal by Subject|0|||
162728923|NCT03103321|587716509|FG000|Overall Study|Protocol Violation|1|||
162691101|NCT01054573|587580634|FG002|Overall Study|Withdrawal by Subject|2|||
162691102|NCT01054573|587580635|FG003|Overall Study|Withdrawal by Subject|1|||
162691103|NCT00393523|587580636|FG000|Overall Study|Lost to Follow-up|0|||
162691104|NCT00393523|587580637|FG001|Overall Study|Lost to Follow-up|0|||
162691105|NCT00393523|587580638|FG002|Overall Study|Lost to Follow-up|0|||
162691106|NCT00393523|587580639|FG003|Overall Study|Lost to Follow-up|2|||
162691107|NCT00393523|587580640|FG004|Overall Study|Lost to Follow-up|1|||
162691108|NCT00393523|587580636|FG000|Overall Study|Protocol Violation|6|||
162691109|NCT00393523|587580637|FG001|Overall Study|Protocol Violation|2|||
162691110|NCT00393523|587580638|FG002|Overall Study|Protocol Violation|0|||
162691111|NCT00393523|587580639|FG003|Overall Study|Protocol Violation|1|||
162691112|NCT00393523|587580640|FG004|Overall Study|Protocol Violation|0|||
162691113|NCT00393523|587580636|FG000|Overall Study|Withdrawal by Subject|6|||
162691114|NCT00393523|587580637|FG001|Overall Study|Withdrawal by Subject|7|||
162728924|NCT03103321|587716510|FG001|Overall Study|Protocol Violation|1|||
162728925|NCT03103321|587716511|FG002|Overall Study|Protocol Violation|1|||
162728926|NCT03103321|587716512|FG003|Overall Study|Protocol Violation|0|||
162728927|NCT03602014|587716515|FG000|Overall Study|Lost to Follow-up|2|||
162728928|NCT03602014|587716516|FG001|Overall Study|Lost to Follow-up|0|||
162728929|NCT03602014|587716517|FG002|Overall Study|Lost to Follow-up|0|||
162691115|NCT00393523|587580638|FG002|Overall Study|Withdrawal by Subject|2|||
162728930|NCT06375421|587716518|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
162728931|NCT06375421|587716519|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
162728932|NCT06375421|587716520|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
162728933|NCT06375421|587716521|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
162728934|NCT05760313|587716527|FG000|Overall Study|Withdrawal by Subject|0|||
162728935|NCT05760313|587716528|FG001|Overall Study|Withdrawal by Subject|0|||
162728936|NCT05760313|587716529|FG002|Overall Study|Withdrawal by Subject|1|||
162728937|NCT05760313|587716527|FG000|Overall Study|Other|1|||
162728938|NCT05760313|587716528|FG001|Overall Study|Other|0|||
162728939|NCT05760313|587716529|FG002|Overall Study|Other|0|||
162728940|NCT00956007|587716530|FG000|Overall Study|Protocol Violation|27|||
162728941|NCT00956007|587716531|FG001|Overall Study|Protocol Violation|23|||
162728942|NCT05228470|587716532|FG000|Overall Study|Death|6|||
162728943|NCT05228470|587716533|FG001|Overall Study|Death|11|||
162728944|NCT05228470|587716532|FG000|Overall Study|Withdrawal by Subject|1|||
162728945|NCT05228470|587716533|FG001|Overall Study|Withdrawal by Subject|8|||
162728946|NCT05228470|587716532|FG000|Overall Study|Ongoing|1|||
162728947|NCT05228470|587716533|FG001|Overall Study|Ongoing|11|||
162728948|NCT03885037|587716534|FG000|Overall Study|Protocol Violation|16|||
162728949|NCT01492686|587716535|FG000|Double-blind Phase|Adverse Event|0|||
162728950|NCT01492686|587716536|FG001|Double-blind Phase|Adverse Event|2|||
162728951|NCT01492686|587716535|FG000|Double-blind Phase|Physician Decision|0|||
162728952|NCT01492686|587716536|FG001|Double-blind Phase|Physician Decision|1|||
162728953|NCT01492686|587716535|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162728954|NCT01492686|587716536|FG001|Double-blind Phase|Withdrawal by Subject|2|||
162728955|NCT01492686|587716535|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
162728956|NCT01492686|587716536|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
162728957|NCT01492686|587716535|FG000|Open-label Phase|Adverse Event|1|||
162728958|NCT01492686|587716536|FG001|Open-label Phase|Adverse Event|2|||
162728959|NCT01492686|587716535|FG000|Open-label Phase|Physician Decision|1|||
162728960|NCT01492686|587716536|FG001|Open-label Phase|Physician Decision|0|||
162728961|NCT01492686|587716535|FG000|Open-label Phase|Withdrawal by Subject|6|||
162728962|NCT01492686|587716536|FG001|Open-label Phase|Withdrawal by Subject|7|||
162728963|NCT01492686|587716535|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
162728964|NCT01492686|587716536|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
162728965|NCT03314987|587716539|FG000|Overall Study|Lost to Follow-up|13|||
162728966|NCT03314987|587716540|FG001|Overall Study|Lost to Follow-up|13|||
162728967|NCT05552963|587716541|FG000|Overall Study|Lost to Follow-up|1|||
162728968|NCT05552963|587716541|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
162728969|NCT00431834|587716544|FG000|Overall Study|Withdrawal by Subject|7|||
162728970|NCT00431834|587716544|FG000|Overall Study|Death|3|||
162728971|NCT00431834|587716544|FG000|Overall Study|Missed Endpoint Visit|2|||
162728972|NCT00431834|587716544|FG000|Overall Study|Lost to Follow-up|1|||
162728973|NCT05529979|587716547|FG000|Overall Study|Lost to Follow-up|6|||
162728974|NCT05529979|587716547|FG000|Overall Study|Physician Decision|1|||
162728975|NCT05529979|587716547|FG000|Overall Study|non-feasibility cases|4|||
162728976|NCT05529979|587716547|FG000|Overall Study|Lack of Efficacy|3|||
162728977|NCT05529979|587716547|FG000|Overall Study|ablation not performed|1|||
162728978|NCT04191499|587716548|FG000|Overall Study|Adverse Event|1|||
162728979|NCT04191499|587716549|FG001|Overall Study|Adverse Event|0|||
162728980|NCT04191499|587716548|FG000|Overall Study|Death|42|||
162728981|NCT04191499|587716549|FG001|Overall Study|Death|55|||
162728982|NCT04191499|587716548|FG000|Overall Study|Lost to Follow-up|4|||
162728983|NCT04191499|587716549|FG001|Overall Study|Lost to Follow-up|1|||
162728984|NCT04191499|587716548|FG000|Overall Study|Physician Decision|1|||
162728985|NCT04191499|587716549|FG001|Overall Study|Physician Decision|0|||
162728986|NCT04191499|587716548|FG000|Overall Study|Progressive Disease|1|||
162728987|NCT04191499|587716549|FG001|Overall Study|Progressive Disease|0|||
162728988|NCT04191499|587716548|FG000|Overall Study|Symptomatic Deterioration|1|||
162728989|NCT04191499|587716549|FG001|Overall Study|Symptomatic Deterioration|0|||
162728990|NCT04191499|587716548|FG000|Overall Study|Withdrawal by Subject|7|||
162728991|NCT04191499|587716549|FG001|Overall Study|Withdrawal by Subject|11|||
162728992|NCT04191499|587716548|FG000|Overall Study|Ongoing in the study|104|||
162728993|NCT04191499|587716549|FG001|Overall Study|Ongoing in the study|97|||
162728994|NCT03403413|587716552|FG000|Overall Study|Lack of Efficacy|2|||
162728995|NCT02924064|587716553|FG000|Overall Study|Adverse Event|2|||
162728996|NCT02924064|587716554|FG001|Overall Study|Adverse Event|2|||
162728997|NCT02924064|587716553|FG000|Overall Study|Lost to Follow-up|0|||
162728998|NCT02924064|587716554|FG001|Overall Study|Lost to Follow-up|2|||
162728999|NCT02924064|587716553|FG000|Overall Study|Physician Decision|0|||
162729000|NCT02924064|587716554|FG001|Overall Study|Physician Decision|2|||
162729001|NCT02924064|587716553|FG000|Overall Study|Protocol Violation|1|||
162729002|NCT02924064|587716554|FG001|Overall Study|Protocol Violation|3|||
162729003|NCT02924064|587716553|FG000|Overall Study|Withdrawal by Subject|4|||
162729004|NCT02924064|587716554|FG001|Overall Study|Withdrawal by Subject|5|||
162729005|NCT02924064|587716553|FG000|Overall Study|Other|17|||
162729006|NCT02924064|587716554|FG001|Overall Study|Other|29|||
162729007|NCT00529100|587716557|FG000|Overall Study|Adverse Event|0|||
162691116|NCT00393523|587580639|FG003|Overall Study|Withdrawal by Subject|3|||
162691117|NCT00393523|587580640|FG004|Overall Study|Withdrawal by Subject|0|||
162691118|NCT00393523|587580636|FG000|Overall Study|Difficulties in specimen collection|0|||
162691119|NCT00393523|587580637|FG001|Overall Study|Difficulties in specimen collection|0|||
162691120|NCT00393523|587580638|FG002|Overall Study|Difficulties in specimen collection|1|||
162691121|NCT00393523|587580639|FG003|Overall Study|Difficulties in specimen collection|0|||
162691122|NCT00393523|587580640|FG004|Overall Study|Difficulties in specimen collection|0|||
162691123|NCT00393523|587580636|FG000|Overall Study|Vaccine supply issue|0|||
162691124|NCT00393523|587580637|FG001|Overall Study|Vaccine supply issue|0|||
162691125|NCT00393523|587580638|FG002|Overall Study|Vaccine supply issue|1|||
162691126|NCT00393523|587580639|FG003|Overall Study|Vaccine supply issue|0|||
162691127|NCT00393523|587580640|FG004|Overall Study|Vaccine supply issue|0|||
162691128|NCT01735396|587580644|FG000|Overall Study|not evaluable|1|||
162691129|NCT03724396|587580647|FG000|Overall Study|Lost to Follow-up|1|||
162691130|NCT03724396|587580648|FG001|Overall Study|Lost to Follow-up|1|||
162691131|NCT03724396|587580647|FG000|Overall Study|Withdrawal by Subject|1|||
162691132|NCT03724396|587580648|FG001|Overall Study|Withdrawal by Subject|0|||
162691133|NCT02237508|587580650|FG000|Overall Study|Withdrawal by Subject|0|||
162691134|NCT02237508|587580651|FG001|Overall Study|Withdrawal by Subject|2|||
162691135|NCT02237508|587580652|FG002|Overall Study|Withdrawal by Subject|0|||
162691136|NCT02237508|587580653|FG003|Overall Study|Withdrawal by Subject|1|||
162691137|NCT02237508|587580654|FG004|Overall Study|Withdrawal by Subject|0|||
162691138|NCT02237508|587580655|FG005|Overall Study|Withdrawal by Subject|1|||
162691139|NCT02237508|587580656|FG006|Overall Study|Withdrawal by Subject|1|||
162691140|NCT02237508|587580657|FG007|Overall Study|Withdrawal by Subject|0|||
162691141|NCT02237508|587580658|FG008|Overall Study|Withdrawal by Subject|1|||
162691142|NCT02237508|587580659|FG009|Overall Study|Withdrawal by Subject|0|||
162691143|NCT02237508|587580650|FG000|Overall Study|Physician Decision|0|||
162691144|NCT02237508|587580651|FG001|Overall Study|Physician Decision|1|||
162691145|NCT02237508|587580652|FG002|Overall Study|Physician Decision|0|||
162691146|NCT02237508|587580653|FG003|Overall Study|Physician Decision|0|||
162691147|NCT02237508|587580654|FG004|Overall Study|Physician Decision|0|||
162691148|NCT02237508|587580655|FG005|Overall Study|Physician Decision|0|||
162691149|NCT02237508|587580656|FG006|Overall Study|Physician Decision|0|||
162691150|NCT02237508|587580657|FG007|Overall Study|Physician Decision|0|||
162691151|NCT02237508|587580658|FG008|Overall Study|Physician Decision|0|||
162691152|NCT02237508|587580659|FG009|Overall Study|Physician Decision|0|||
162691153|NCT02237508|587580650|FG000|Overall Study|Protocol Violation|0|||
162691154|NCT02237508|587580651|FG001|Overall Study|Protocol Violation|0|||
162691155|NCT02237508|587580652|FG002|Overall Study|Protocol Violation|1|||
162691156|NCT02237508|587580653|FG003|Overall Study|Protocol Violation|0|||
162691157|NCT02237508|587580654|FG004|Overall Study|Protocol Violation|0|||
162691158|NCT02237508|587580655|FG005|Overall Study|Protocol Violation|0|||
162691159|NCT02237508|587580656|FG006|Overall Study|Protocol Violation|0|||
162691160|NCT02237508|587580657|FG007|Overall Study|Protocol Violation|0|||
162691161|NCT02237508|587580658|FG008|Overall Study|Protocol Violation|0|||
162691162|NCT02237508|587580659|FG009|Overall Study|Protocol Violation|0|||
162691163|NCT01650519|587580660|FG000|Overall Study|Withdrawal by Subject|1|||
162691164|NCT01650519|587580661|FG001|Overall Study|Withdrawal by Subject|0|||
162691165|NCT03300570|587580664|FG000|Overall Study|Adverse Event|0|||
162691166|NCT03300570|587580665|FG001|Overall Study|Adverse Event|1|||
162691167|NCT03300570|587580664|FG000|Overall Study|Withdrawal by Subject|1|||
162691168|NCT03300570|587580665|FG001|Overall Study|Withdrawal by Subject|0|||
162691169|NCT03300570|587580664|FG000|Overall Study|Inadequate bowel prep|1|||
162691170|NCT03300570|587580665|FG001|Overall Study|Inadequate bowel prep|0|||
162691171|NCT03188120|587580666|FG000|Overall Study|Adverse Event|4|||
162691172|NCT03188120|587580666|FG000|Overall Study|Insufficient Effectiveness|8|||
162691173|NCT03188120|587580666|FG000|Overall Study|Improved|12|||
162691174|NCT03188120|587580666|FG000|Overall Study|Lost to Follow-up|7|||
162691175|NCT03188120|587580666|FG000|Overall Study|Other than specified|3|||
162691176|NCT03188120|587580666|FG000|Overall Study|No visit after the first visit|13|||
162691177|NCT02296190|587580668|FG000|Overall Study|Lost to Follow-up|0|||
162691178|NCT02296190|587580669|FG001|Overall Study|Lost to Follow-up|0|||
162691179|NCT02296190|587580670|FG002|Overall Study|Lost to Follow-up|0|||
162691180|NCT02296190|587580671|FG003|Overall Study|Lost to Follow-up|0|||
162691181|NCT02296190|587580672|FG004|Overall Study|Lost to Follow-up|1|||
162691182|NCT02296190|587580673|FG005|Overall Study|Lost to Follow-up|0|||
162691183|NCT02296190|587580668|FG000|Overall Study|Failure to induce PSVT|6|||
162691184|NCT02296190|587580669|FG001|Overall Study|Failure to induce PSVT|10|||
162691185|NCT02296190|587580670|FG002|Overall Study|Failure to induce PSVT|5|||
162691186|NCT02296190|587580671|FG003|Overall Study|Failure to induce PSVT|13|||
162691187|NCT02296190|587580672|FG004|Overall Study|Failure to induce PSVT|8|||
162691188|NCT02296190|587580673|FG005|Overall Study|Failure to induce PSVT|0|||
162691189|NCT02296190|587580668|FG000|Overall Study|Physician Decision|1|||
162691190|NCT02296190|587580669|FG001|Overall Study|Physician Decision|1|||
162691191|NCT02296190|587580670|FG002|Overall Study|Physician Decision|0|||
162691192|NCT02296190|587580671|FG003|Overall Study|Physician Decision|1|||
162691193|NCT02296190|587580672|FG004|Overall Study|Physician Decision|2|||
162691194|NCT02296190|587580673|FG005|Overall Study|Physician Decision|0|||
162691195|NCT02296190|587580668|FG000|Overall Study|Withdrawal by Subject|0|||
162691196|NCT02296190|587580669|FG001|Overall Study|Withdrawal by Subject|1|||
162691197|NCT02296190|587580670|FG002|Overall Study|Withdrawal by Subject|0|||
162691198|NCT02296190|587580671|FG003|Overall Study|Withdrawal by Subject|0|||
162691199|NCT02296190|587580672|FG004|Overall Study|Withdrawal by Subject|0|||
162691200|NCT02296190|587580673|FG005|Overall Study|Withdrawal by Subject|0|||
162691201|NCT02296190|587580668|FG000|Overall Study|PSVT < 5 minutes|5|||
162691202|NCT02296190|587580669|FG001|Overall Study|PSVT < 5 minutes|6|||
162691203|NCT02296190|587580670|FG002|Overall Study|PSVT < 5 minutes|6|||
162691204|NCT02296190|587580671|FG003|Overall Study|PSVT < 5 minutes|6|||
162691205|NCT02296190|587580672|FG004|Overall Study|PSVT < 5 minutes|5|||
162691206|NCT02296190|587580673|FG005|Overall Study|PSVT < 5 minutes|0|||
162691207|NCT02296190|587580668|FG000|Overall Study|Patient was given Propofol|0|||
162691208|NCT02296190|587580669|FG001|Overall Study|Patient was given Propofol|1|||
162691209|NCT02296190|587580670|FG002|Overall Study|Patient was given Propofol|0|||
162691210|NCT02296190|587580671|FG003|Overall Study|Patient was given Propofol|1|||
162691211|NCT02296190|587580672|FG004|Overall Study|Patient was given Propofol|0|||
162691212|NCT02296190|587580673|FG005|Overall Study|Patient was given Propofol|0|||
162691213|NCT02296190|587580668|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
162691214|NCT02296190|587580669|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
162691215|NCT02296190|587580670|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
162691216|NCT02296190|587580671|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
162691217|NCT02296190|587580672|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
162691218|NCT02296190|587580673|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
162691219|NCT02296190|587580668|FG000|Overall Study|Blood pressure <100 after sedation|0|||
162691220|NCT02296190|587580669|FG001|Overall Study|Blood pressure <100 after sedation|0|||
162691221|NCT02296190|587580670|FG002|Overall Study|Blood pressure <100 after sedation|0|||
162691222|NCT02296190|587580671|FG003|Overall Study|Blood pressure <100 after sedation|1|||
162691223|NCT02296190|587580672|FG004|Overall Study|Blood pressure <100 after sedation|0|||
162691224|NCT02296190|587580673|FG005|Overall Study|Blood pressure <100 after sedation|0|||
162691225|NCT02296190|587580668|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162691226|NCT02296190|587580669|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
162691227|NCT02296190|587580670|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
162691228|NCT02296190|587580671|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162691229|NCT02296190|587580672|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162691230|NCT02296190|587580673|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162691231|NCT02296190|587580668|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
162691232|NCT02296190|587580669|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
162691233|NCT02296190|587580670|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
162691234|NCT02296190|587580671|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
162691235|NCT02296190|587580672|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
162691236|NCT02296190|587580673|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
162691237|NCT02296190|587580668|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162691238|NCT02296190|587580669|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
162691239|NCT02296190|587580670|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162691240|NCT02296190|587580671|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162691241|NCT02296190|587580672|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162691242|NCT02296190|587580673|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162691243|NCT02296190|587580668|FG000|Overall Study|Lab result not available in time|1|||
162691244|NCT02296190|587580669|FG001|Overall Study|Lab result not available in time|0|||
162691245|NCT02296190|587580670|FG002|Overall Study|Lab result not available in time|0|||
162691246|NCT02296190|587580671|FG003|Overall Study|Lab result not available in time|0|||
162691247|NCT02296190|587580672|FG004|Overall Study|Lab result not available in time|0|||
162691248|NCT02296190|587580673|FG005|Overall Study|Lab result not available in time|0|||
162691249|NCT00717314|587580675|FG000|Overall Study|Adverse Event|3|||
162691250|NCT00717314|587580676|FG001|Overall Study|Adverse Event|2|||
162691251|NCT00717314|587580675|FG000|Overall Study|Protocol Violation|1|||
162691252|NCT00717314|587580676|FG001|Overall Study|Protocol Violation|0|||
162691253|NCT00717314|587580675|FG000|Overall Study|Lost to Follow-up|1|||
162691254|NCT00717314|587580676|FG001|Overall Study|Lost to Follow-up|5|||
162691255|NCT00717314|587580675|FG000|Overall Study|Withdrawal by Subject|1|||
162691256|NCT00717314|587580676|FG001|Overall Study|Withdrawal by Subject|3|||
162691257|NCT01483937|587580677|FG000|Overall Study|Withdrawal by Subject|4|||
162691258|NCT01483937|587580678|FG001|Overall Study|Withdrawal by Subject|3|||
162691259|NCT00682643|587580680|FG000|Overall Study|Adverse Event|12|||
162691260|NCT00682643|587580681|FG001|Overall Study|Adverse Event|23|||
162691261|NCT00682643|587580680|FG000|Overall Study|Lack of Efficacy|2|||
162691262|NCT00682643|587580681|FG001|Overall Study|Lack of Efficacy|0|||
162691263|NCT00682643|587580680|FG000|Overall Study|Protocol Violation|38|||
162691264|NCT00682643|587580681|FG001|Overall Study|Protocol Violation|76|||
162691265|NCT00682643|587580680|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
162691266|NCT00682643|587580681|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
162691267|NCT00682643|587580680|FG000|Overall Study|Lost to Follow-up|1|||
162691268|NCT00682643|587580681|FG001|Overall Study|Lost to Follow-up|6|||
162691269|NCT00682643|587580680|FG000|Overall Study|Physician Decision|2|||
162691270|NCT00682643|587580681|FG001|Overall Study|Physician Decision|6|||
162691271|NCT00682643|587580680|FG000|Overall Study|Withdrawal by Subject|19|||
162691272|NCT00682643|587580681|FG001|Overall Study|Withdrawal by Subject|53|||
162691273|NCT00682643|587580680|FG000|Overall Study|Did Not Receive Study Drug|1|||
162691274|NCT00682643|587580681|FG001|Overall Study|Did Not Receive Study Drug|1|||
162691275|NCT01875185|587580682|FG000|Overall Study|study was terminated|52|||
162691276|NCT01875185|587580683|FG001|Overall Study|study was terminated|48|||
162691277|NCT03238300|587580684|FG000|Baseline (Before Intervention)|Physician Decision|0|||
162691278|NCT03238300|587580685|FG001|Baseline (Before Intervention)|Physician Decision|1|||
162691279|NCT03238300|587580684|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
162691280|NCT03238300|587580685|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
162691281|NCT03238300|587580684|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
162691282|NCT03238300|587580685|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
162691283|NCT03238300|587580684|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
162691284|NCT03238300|587580685|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
162691285|NCT00399763|587580692|FG000|Overall Study|Lost to Follow-up|2|||
162691286|NCT00399763|587580693|FG001|Overall Study|Lost to Follow-up|3|||
162691287|NCT03389477|587580696|FG000|Step 1|Withdrawal by Subject|1|||
162691288|NCT03389477|587580697|FG001|Step 1|Withdrawal by Subject|0|||
162691289|NCT03389477|587580696|FG000|Step 2|Withdrawal by Subject|1|||
162691290|NCT03389477|587580697|FG001|Step 2|Withdrawal by Subject|2|||
162691291|NCT03389477|587580696|FG000|Step 2|Disease progression|1|||
162691292|NCT03389477|587580697|FG001|Step 2|Disease progression|0|||
162691293|NCT03389477|587580696|FG000|Step 2|Death|0|||
162691294|NCT03389477|587580697|FG001|Step 2|Death|1|||
162691295|NCT03389477|587580696|FG000|Step 2|Poor performance status and nutrition|0|||
162691296|NCT03389477|587580697|FG001|Step 2|Poor performance status and nutrition|1|||
162691297|NCT03389477|587580696|FG000|Step 3|Withdrawal after 3 cycles|0|||
162691298|NCT03389477|587580697|FG001|Step 3|Withdrawal after 3 cycles|1|||
162691299|NCT03389477|587580696|FG000|Step 3|Still receiving active treatment|4|||
162691300|NCT03389477|587580697|FG001|Step 3|Still receiving active treatment|0|||
162691301|NCT03389477|587580696|FG000|Step 3|Progressive disease after 2 cycles|1|||
162691302|NCT03389477|587580697|FG001|Step 3|Progressive disease after 2 cycles|0|||
162691303|NCT04512066|587580700|FG000|Double-blind Treatment Period|Adverse Event|6|||
162691304|NCT04512066|587580701|FG001|Double-blind Treatment Period|Adverse Event|4|||
162691305|NCT04512066|587580702|FG002|Double-blind Treatment Period|Adverse Event|5|||
162691306|NCT04512066|587580703|FG003|Double-blind Treatment Period|Adverse Event|1|||
162691307|NCT04512066|587580704|FG004|Double-blind Treatment Period|Adverse Event|0|||
162691308|NCT04512066|587580705|FG005|Double-blind Treatment Period|Adverse Event|0|||
162691309|NCT04512066|587580700|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
162691310|NCT04512066|587580701|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
162691311|NCT04512066|587580702|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
162691312|NCT04512066|587580703|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
162691313|NCT04512066|587580704|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
162691314|NCT04512066|587580705|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
162691315|NCT04512066|587580700|FG000|Double-blind Treatment Period|Physician Decision|1|||
162691316|NCT04512066|587580701|FG001|Double-blind Treatment Period|Physician Decision|0|||
162691317|NCT04512066|587580702|FG002|Double-blind Treatment Period|Physician Decision|1|||
162691318|NCT04512066|587580703|FG003|Double-blind Treatment Period|Physician Decision|0|||
162691319|NCT04512066|587580704|FG004|Double-blind Treatment Period|Physician Decision|0|||
162691320|NCT04512066|587580705|FG005|Double-blind Treatment Period|Physician Decision|0|||
162691321|NCT04512066|587580700|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
162691322|NCT04512066|587580701|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
162691323|NCT04512066|587580702|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
162691324|NCT04512066|587580703|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
162691325|NCT04512066|587580704|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
162691326|NCT04512066|587580705|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
162691327|NCT04512066|587580700|FG000|Extension Period|Adverse Event|0|||
162691328|NCT04512066|587580701|FG001|Extension Period|Adverse Event|1|||
162691329|NCT04512066|587580702|FG002|Extension Period|Adverse Event|4|||
162691330|NCT04512066|587580703|FG003|Extension Period|Adverse Event|3|||
162691331|NCT04512066|587580704|FG004|Extension Period|Adverse Event|1|||
162691332|NCT04512066|587580705|FG005|Extension Period|Adverse Event|3|||
162691333|NCT04512066|587580700|FG000|Extension Period|Death|0|||
162691334|NCT04512066|587580701|FG001|Extension Period|Death|0|||
162691335|NCT04512066|587580702|FG002|Extension Period|Death|0|||
162691336|NCT04512066|587580703|FG003|Extension Period|Death|0|||
162691337|NCT04512066|587580704|FG004|Extension Period|Death|0|||
162691338|NCT04512066|587580705|FG005|Extension Period|Death|1|||
162691339|NCT04512066|587580700|FG000|Extension Period|Lack of Efficacy|0|||
162691340|NCT04512066|587580701|FG001|Extension Period|Lack of Efficacy|4|||
162691341|NCT04512066|587580702|FG002|Extension Period|Lack of Efficacy|4|||
162691342|NCT04512066|587580703|FG003|Extension Period|Lack of Efficacy|1|||
162691343|NCT04512066|587580704|FG004|Extension Period|Lack of Efficacy|3|||
162691344|NCT04512066|587580705|FG005|Extension Period|Lack of Efficacy|3|||
162691345|NCT04512066|587580700|FG000|Extension Period|Lost to Follow-up|0|||
162691346|NCT04512066|587580701|FG001|Extension Period|Lost to Follow-up|1|||
162691347|NCT04512066|587580702|FG002|Extension Period|Lost to Follow-up|5|||
162691348|NCT04512066|587580703|FG003|Extension Period|Lost to Follow-up|2|||
162691349|NCT04512066|587580704|FG004|Extension Period|Lost to Follow-up|3|||
162691350|NCT04512066|587580705|FG005|Extension Period|Lost to Follow-up|2|||
162691351|NCT04512066|587580700|FG000|Extension Period|Non-compliance with study drug|0|||
162691352|NCT04512066|587580701|FG001|Extension Period|Non-compliance with study drug|1|||
162691353|NCT04512066|587580702|FG002|Extension Period|Non-compliance with study drug|0|||
162691354|NCT04512066|587580703|FG003|Extension Period|Non-compliance with study drug|0|||
162691355|NCT04512066|587580704|FG004|Extension Period|Non-compliance with study drug|0|||
162691356|NCT04512066|587580705|FG005|Extension Period|Non-compliance with study drug|1|||
162691357|NCT04512066|587580700|FG000|Extension Period|Other|0|||
162691358|NCT04512066|587580701|FG001|Extension Period|Other|2|||
162691359|NCT04512066|587580702|FG002|Extension Period|Other|0|||
162691360|NCT04512066|587580703|FG003|Extension Period|Other|0|||
162691361|NCT04512066|587580704|FG004|Extension Period|Other|0|||
162691362|NCT04512066|587580705|FG005|Extension Period|Other|0|||
162691363|NCT04512066|587580700|FG000|Extension Period|Physician Decision|0|||
162691364|NCT04512066|587580701|FG001|Extension Period|Physician Decision|2|||
162691365|NCT04512066|587580702|FG002|Extension Period|Physician Decision|0|||
162691366|NCT04512066|587580703|FG003|Extension Period|Physician Decision|1|||
162691367|NCT04512066|587580704|FG004|Extension Period|Physician Decision|1|||
162691368|NCT04512066|587580705|FG005|Extension Period|Physician Decision|0|||
162691369|NCT04512066|587580700|FG000|Extension Period|Withdrawal by Subject|0|||
162691370|NCT04512066|587580701|FG001|Extension Period|Withdrawal by Subject|3|||
162691371|NCT04512066|587580702|FG002|Extension Period|Withdrawal by Subject|7|||
162691372|NCT04512066|587580703|FG003|Extension Period|Withdrawal by Subject|11|||
162691373|NCT04512066|587580704|FG004|Extension Period|Withdrawal by Subject|8|||
162691374|NCT04512066|587580705|FG005|Extension Period|Withdrawal by Subject|4|||
162691375|NCT03403426|587580706|FG000|Overall Study|Death|1|||
162691376|NCT03403426|587580706|FG000|Overall Study|Lost to Follow-up|2|||
162691377|NCT01657266|587580711|FG000|Overall Study|Lost to Follow-up|2|||
162691378|NCT01657266|587580712|FG001|Overall Study|Lost to Follow-up|2|||
162691379|NCT01657266|587580711|FG000|Overall Study|Adverse Event|2|||
162691380|NCT01657266|587580712|FG001|Overall Study|Adverse Event|3|||
162691381|NCT03520400|587580713|FG000|Overall Study|Physician Decision|15|||
162691382|NCT03520400|587580714|FG001|Overall Study|Physician Decision|7|||
162691383|NCT00445679|587580715|FG000|Overall Study|Adverse Event|22|||
162691384|NCT00445679|587580716|FG001|Overall Study|Adverse Event|12|||
162691385|NCT00445679|587580717|FG002|Overall Study|Adverse Event|30|||
162691386|NCT00445679|587580718|FG003|Overall Study|Adverse Event|19|||
162691387|NCT00445679|587580715|FG000|Overall Study|Failed to return|1|||
162691388|NCT00445679|587580716|FG001|Overall Study|Failed to return|3|||
162691389|NCT00445679|587580717|FG002|Overall Study|Failed to return|2|||
162691390|NCT00445679|587580718|FG003|Overall Study|Failed to return|2|||
162691391|NCT00445679|587580715|FG000|Overall Study|Physician Decision|0|||
162691392|NCT00445679|587580716|FG001|Overall Study|Physician Decision|0|||
162691393|NCT00445679|587580717|FG002|Overall Study|Physician Decision|1|||
162691394|NCT00445679|587580718|FG003|Overall Study|Physician Decision|0|||
162691395|NCT00445679|587580715|FG000|Overall Study|Lost to Follow-up|10|||
162691396|NCT00445679|587580716|FG001|Overall Study|Lost to Follow-up|6|||
162691397|NCT00445679|587580717|FG002|Overall Study|Lost to Follow-up|6|||
162691398|NCT00445679|587580718|FG003|Overall Study|Lost to Follow-up|5|||
162691399|NCT00445679|587580715|FG000|Overall Study|Compliance|3|||
162691400|NCT00445679|587580716|FG001|Overall Study|Compliance|2|||
162691401|NCT00445679|587580717|FG002|Overall Study|Compliance|1|||
162691402|NCT00445679|587580718|FG003|Overall Study|Compliance|2|||
162691403|NCT00445679|587580715|FG000|Overall Study|Withdrawal of Informed Consent|0|||
162691404|NCT00445679|587580716|FG001|Overall Study|Withdrawal of Informed Consent|0|||
162691405|NCT00445679|587580717|FG002|Overall Study|Withdrawal of Informed Consent|1|||
162691406|NCT00445679|587580718|FG003|Overall Study|Withdrawal of Informed Consent|0|||
162691407|NCT00445679|587580715|FG000|Overall Study|Protocol Violation|2|||
162691408|NCT00445679|587580716|FG001|Overall Study|Protocol Violation|3|||
162691409|NCT00445679|587580717|FG002|Overall Study|Protocol Violation|3|||
162691410|NCT00445679|587580718|FG003|Overall Study|Protocol Violation|1|||
162691411|NCT00445679|587580715|FG000|Overall Study|Withdrawal by Subject|8|||
162691412|NCT00445679|587580716|FG001|Overall Study|Withdrawal by Subject|14|||
162691413|NCT00445679|587580717|FG002|Overall Study|Withdrawal by Subject|20|||
162691414|NCT00445679|587580718|FG003|Overall Study|Withdrawal by Subject|18|||
162691415|NCT00445679|587580715|FG000|Overall Study|Lack of Efficacy|2|||
162691416|NCT00445679|587580716|FG001|Overall Study|Lack of Efficacy|6|||
162691417|NCT00445679|587580717|FG002|Overall Study|Lack of Efficacy|2|||
162691418|NCT00445679|587580718|FG003|Overall Study|Lack of Efficacy|0|||
162691419|NCT00909428|587580722|FG000|Overall Study|Lost to Follow-up|13|||
162691420|NCT00909428|587580723|FG001|Overall Study|Lost to Follow-up|10|||
162691421|NCT00909428|587580724|FG002|Overall Study|Lost to Follow-up|9|||
162691422|NCT00116844|587580727|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
162691423|NCT00116844|587580728|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
162691424|NCT00116844|587580727|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
162691425|NCT00116844|587580728|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
162691426|NCT00116844|587580727|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
162691427|NCT00116844|587580728|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
162691428|NCT00116844|587580727|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
162691429|NCT00116844|587580728|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
162691430|NCT00116844|587580727|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
162691431|NCT00116844|587580728|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
162691432|NCT00116844|587580727|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
162691433|NCT00116844|587580728|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
162691434|NCT00116844|587580727|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
162691435|NCT00116844|587580728|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
162691436|NCT00116844|587580727|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
162691437|NCT00116844|587580728|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
162691438|NCT00116844|587580727|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
162691439|NCT00116844|587580728|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
162691440|NCT01933880|587580729|FG000|Overall Study|Withdrawal by Subject|5|||
162691441|NCT01933880|587580730|FG001|Overall Study|Withdrawal by Subject|0|||
162691442|NCT01933880|587580729|FG000|Overall Study|Lack of Efficacy|1|||
162691443|NCT01933880|587580730|FG001|Overall Study|Lack of Efficacy|0|||
162691444|NCT01933880|587580729|FG000|Overall Study|Concomitant medication Interference|0|||
162691445|NCT01933880|587580730|FG001|Overall Study|Concomitant medication Interference|1|||
162691446|NCT01933880|587580729|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
162691447|NCT01933880|587580730|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
162691448|NCT01933880|587580729|FG000|Overall Study|Other|4|||
162691449|NCT01933880|587580730|FG001|Overall Study|Other|0|||
162691450|NCT01933880|587580729|FG000|Overall Study|Protocol Violation|1|||
162691451|NCT01933880|587580730|FG001|Overall Study|Protocol Violation|0|||
162691452|NCT01125722|587580731|FG000|Overall Study|Withdrawal by Subject|2|||
162691453|NCT01125722|587580732|FG001|Overall Study|Withdrawal by Subject|1|||
162691454|NCT01125722|587580731|FG000|Overall Study|Lost to Follow-up|1|||
162691455|NCT01125722|587580732|FG001|Overall Study|Lost to Follow-up|0|||
162691456|NCT03474549|587580733|FG000|Overall Study|Death|31|||
162691457|NCT03474549|587580733|FG000|Overall Study|Lost to Follow-up|4|||
162691458|NCT03474549|587580733|FG000|Overall Study|Withdrawal by Subject|2|||
162691459|NCT00069784|587580734|FG000|Overall Study|Adverse Event|105|||
162691460|NCT00069784|587580735|FG001|Overall Study|Adverse Event|0|||
162691461|NCT00069784|587580734|FG000|Overall Study|Withdrawal by Subject|1090|||
162691462|NCT00069784|587580735|FG001|Overall Study|Withdrawal by Subject|0|||
162691463|NCT00069784|587580734|FG000|Overall Study|Other|17|||
162691464|NCT00069784|587580735|FG001|Overall Study|Other|0|||
162691465|NCT00926003|587580738|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
162691466|NCT00926003|587580739|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
162691467|NCT00926003|587580740|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
162691468|NCT00926003|587580738|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
162691469|NCT00926003|587580739|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
162691470|NCT00926003|587580740|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
162691471|NCT00709059|587580742|FG000|Overall Study|Lost to Follow-up|34|||
162691472|NCT00709059|587580742|FG000|Overall Study|Withdrawal by Subject|19|||
162691473|NCT00709059|587580742|FG000|Overall Study|Physician Decision|7|||
162691474|NCT00709059|587580742|FG000|Overall Study|Disease complication|3|||
162691475|NCT00709059|587580742|FG000|Overall Study|Side effects|20|||
162691476|NCT00709059|587580742|FG000|Overall Study|Serious side effects|11|||
162691477|NCT01786330|587580743|FG000|Overall Study|Withdrawal by Subject|0|||
162691478|NCT01786330|587580744|FG001|Overall Study|Withdrawal by Subject|1|||
162691479|NCT01786330|587580743|FG000|Overall Study|Lost to Follow-up|0|||
162691480|NCT01786330|587580744|FG001|Overall Study|Lost to Follow-up|1|||
162691481|NCT01786330|587580743|FG000|Overall Study|Excluded intraoperatively|0|||
162691482|NCT01786330|587580744|FG001|Overall Study|Excluded intraoperatively|1|||
162691483|NCT01786330|587580743|FG000|Overall Study|Protocol Violation|1|||
162691484|NCT01786330|587580744|FG001|Overall Study|Protocol Violation|0|||
162691485|NCT01478113|587582705|FG000|Overall Study|Withdrawal by Subject|0|||
162691486|NCT01478113|587582706|FG001|Overall Study|Withdrawal by Subject|1|||
162691487|NCT01478113|587582705|FG000|Overall Study|Physician Decision|1|||
162691488|NCT01478113|587582706|FG001|Overall Study|Physician Decision|0|||
162691489|NCT00289770|587582707|FG000|Year 15|Withdrawal by Subject|1|||
162691490|NCT02966002|587582714|FG000|Overall Study|Withdrawal by Subject|2|||
162691491|NCT02966002|587582714|FG000|Overall Study|Adverse Event|1|||
162691492|NCT02966002|587582714|FG000|Overall Study|Lost to Follow-up|1|||
162691493|NCT00067990|587582716|FG000|Overall Study|Death|5|||
162691494|NCT00067990|587582717|FG001|Overall Study|Death|7|||
162691495|NCT00067990|587582716|FG000|Overall Study|ESRD, Non IF/TA|1|||
162691496|NCT00067990|587582717|FG001|Overall Study|ESRD, Non IF/TA|3|||
162691497|NCT00067990|587582716|FG000|Overall Study|Withdrawal by Subject|4|||
162691498|NCT00067990|587582717|FG001|Overall Study|Withdrawal by Subject|12|||
162691499|NCT02291432|587582718|FG000|Overall Study|Withdrawal by Subject|2|||
162691500|NCT02145078|587582719|FG000|Overall Study|Death|1|||
162691501|NCT02145078|587582719|FG000|Overall Study|Reason not given|3|||
162691502|NCT01350141|587582720|FG000|Overall Study|Lost to Follow-up|1|||
162691503|NCT01350141|587582721|FG001|Overall Study|Lost to Follow-up|0|||
162691504|NCT01350141|587582722|FG002|Overall Study|Lost to Follow-up|1|||
162691505|NCT01350141|587582720|FG000|Overall Study|Withdrawal by Subject|1|||
162691506|NCT01350141|587582721|FG001|Overall Study|Withdrawal by Subject|0|||
162691507|NCT01350141|587582722|FG002|Overall Study|Withdrawal by Subject|0|||
162691508|NCT01350141|587582720|FG000|Overall Study|Randomized but not treated|1|||
162691509|NCT01350141|587582721|FG001|Overall Study|Randomized but not treated|0|||
162691510|NCT01350141|587582722|FG002|Overall Study|Randomized but not treated|0|||
162691511|NCT00810082|587582723|FG000|Overall Study|Lost to Follow-up|0|||
162691512|NCT00810082|587582724|FG001|Overall Study|Lost to Follow-up|4|||
162691513|NCT01454830|587582731|FG000|Overall Study|Withdrawal by Subject|4|||
162691514|NCT01454830|587582732|FG001|Overall Study|Withdrawal by Subject|4|||
162691515|NCT01454830|587582731|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
162691516|NCT01454830|587582732|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
162691517|NCT01454830|587582731|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
162691518|NCT01454830|587582732|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
162691519|NCT01454830|587582731|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
162691520|NCT01454830|587582732|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
162691521|NCT01454830|587582731|FG000|Overall Study|Withdrawal - no polysomnography|3|||
162691522|NCT01454830|587582732|FG001|Overall Study|Withdrawal - no polysomnography|2|||
162691523|NCT03810313|587582733|FG000|Overall Study|Study terminated by sponsor|164|||
162691524|NCT03810313|587582734|FG001|Overall Study|Study terminated by sponsor|159|||
162691525|NCT03810313|587582733|FG000|Overall Study|Subject decision|10|||
162691526|NCT03810313|587582734|FG001|Overall Study|Subject decision|11|||
162691527|NCT03810313|587582733|FG000|Overall Study|Lost to Follow-up|3|||
162691528|NCT03810313|587582734|FG001|Overall Study|Lost to Follow-up|3|||
162691529|NCT03810313|587582733|FG000|Overall Study|Adverse Event|2|||
162691530|NCT03810313|587582734|FG001|Overall Study|Adverse Event|1|||
162691531|NCT03810313|587582733|FG000|Overall Study|Death|2|||
162691532|NCT03810313|587582734|FG001|Overall Study|Death|1|||
162691533|NCT03810313|587582733|FG000|Overall Study|Physician Decision|0|||
162691534|NCT03810313|587582734|FG001|Overall Study|Physician Decision|1|||
162691535|NCT00584805|587582735|FG000|Overall Study|No longer at risk of exposure|39|||
162691536|NCT00584805|587582735|FG000|Overall Study|Relocation|36|||
162691537|NCT00584805|587582735|FG000|Overall Study|Withdrawal by Subject|18|||
162691538|NCT00584805|587582735|FG000|Overall Study|Non-compliance|1|||
162691539|NCT00584805|587582735|FG000|Overall Study|Lost to follow up|3|||
162691540|NCT00584805|587582735|FG000|Overall Study|Screen failures|2|||
162691541|NCT02341456|587582739|FG000|Overall Study|Disease progression|2|||
162691542|NCT02341456|587582740|FG001|Overall Study|Disease progression|3|||
162691543|NCT02341456|587582741|FG002|Overall Study|Disease progression|1|||
162691544|NCT02341456|587582739|FG000|Overall Study|Death|1|||
162691545|NCT02341456|587582740|FG001|Overall Study|Death|1|||
162691546|NCT02341456|587582741|FG002|Overall Study|Death|1|||
162691547|NCT02341456|587582739|FG000|Overall Study|Withdrawal by Subject|0|||
162691548|NCT02341456|587582740|FG001|Overall Study|Withdrawal by Subject|1|||
162691549|NCT02341456|587582741|FG002|Overall Study|Withdrawal by Subject|1|||
162691550|NCT02341456|587582739|FG000|Overall Study|Moved to local access programme.|0|||
162691551|NCT02341456|587582740|FG001|Overall Study|Moved to local access programme.|1|||
162691552|NCT02341456|587582741|FG002|Overall Study|Moved to local access programme.|1|||
162691553|NCT02341456|587582739|FG000|Overall Study|Physician Decision|1|||
162691554|NCT02341456|587582740|FG001|Overall Study|Physician Decision|0|||
162691555|NCT02341456|587582741|FG002|Overall Study|Physician Decision|0|||
162691556|NCT01077362|587582742|FG000|Overall Study|Lack of Efficacy|13|||
162691557|NCT01077362|587582743|FG001|Overall Study|Lack of Efficacy|8|||
162691558|NCT01077362|587582744|FG002|Overall Study|Lack of Efficacy|10|||
162691559|NCT01077362|587582742|FG000|Overall Study|Lost to Follow-up|1|||
162691560|NCT01077362|587582743|FG001|Overall Study|Lost to Follow-up|0|||
162691561|NCT01077362|587582744|FG002|Overall Study|Lost to Follow-up|3|||
162691562|NCT01077362|587582742|FG000|Overall Study|Adverse Event|12|||
162691563|NCT01077362|587582743|FG001|Overall Study|Adverse Event|7|||
162691564|NCT01077362|587582744|FG002|Overall Study|Adverse Event|4|||
162691565|NCT01077362|587582742|FG000|Overall Study|Withdrawal by Subject|5|||
162691566|NCT01077362|587582743|FG001|Overall Study|Withdrawal by Subject|3|||
162691567|NCT01077362|587582744|FG002|Overall Study|Withdrawal by Subject|5|||
162691568|NCT01077362|587582742|FG000|Overall Study|Other|0|||
162691569|NCT01077362|587582743|FG001|Overall Study|Other|1|||
162691570|NCT01077362|587582744|FG002|Overall Study|Other|2|||
162691571|NCT00301080|587582751|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
162691572|NCT00301080|587582752|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162729008|NCT00529100|587716558|FG001|Overall Study|Adverse Event|5|||
162729009|NCT00529100|587716557|FG000|Overall Study|Protocol Violation|0|||
162729010|NCT00529100|587716558|FG001|Overall Study|Protocol Violation|1|||
162729011|NCT00529100|587716557|FG000|Overall Study|Progressive Disease|0|||
162729012|NCT00529100|587716558|FG001|Overall Study|Progressive Disease|1|||
162729013|NCT00529100|587716557|FG000|Overall Study|Withdrawal by Subject|0|||
162729014|NCT00529100|587716558|FG001|Overall Study|Withdrawal by Subject|1|||
162729015|NCT00529100|587716557|FG000|Overall Study|Participant Ineligibility|0|||
162729016|NCT00529100|587716558|FG001|Overall Study|Participant Ineligibility|1|||
162729017|NCT05524454|587716560|FG000|Overall Study|Withdrawal by Subject|1|||
162729018|NCT05999435|587716561|FG000|Overall Study|Adverse Event|1|||
162729019|NCT05999435|587716562|FG001|Overall Study|Adverse Event|0|||
162729020|NCT05999435|587716563|FG002|Overall Study|Adverse Event|0|||
162729021|NCT05999435|587716561|FG000|Overall Study|Withdrawal by Subject|2|||
162729022|NCT05999435|587716562|FG001|Overall Study|Withdrawal by Subject|1|||
162729023|NCT05999435|587716563|FG002|Overall Study|Withdrawal by Subject|0|||
162729024|NCT05054725|587716567|FG000|Overall Study|Withdrawal by Subject|3|||
162729025|NCT05054725|587716568|FG001|Overall Study|Withdrawal by Subject|4|||
162729026|NCT05054725|587716567|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
162729027|NCT05054725|587716568|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
162729028|NCT05054725|587716567|FG000|Overall Study|Death|1|||
162729029|NCT05054725|587716568|FG001|Overall Study|Death|21|||
162729030|NCT05054725|587716567|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
162729031|NCT05054725|587716568|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
162729032|NCT05054725|587716567|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
162729033|NCT05054725|587716568|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
162729034|NCT05054725|587716567|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
162729035|NCT05054725|587716568|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
162729036|NCT05054725|587716567|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
162729037|NCT05054725|587716568|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
162729038|NCT05054725|587716567|FG000|Overall Study|Physician discretion due to subject progression|0|||
162729039|NCT05054725|587716568|FG001|Overall Study|Physician discretion due to subject progression|1|||
162729040|NCT03674411|587716569|FG000|Overall Study|Non-treatment|4|||
162729041|NCT03674411|587716570|FG001|Overall Study|Non-treatment|0|||
162729042|NCT04982315|587716571|FG000|Overall Study|Death|1|||
162729043|NCT04982315|587716572|FG001|Overall Study|Death|0|||
162729044|NCT04982315|587716573|FG002|Overall Study|Death|1|||
162729045|NCT04982315|587716571|FG000|Overall Study|Lack of Efficacy|0|||
162729046|NCT04982315|587716572|FG001|Overall Study|Lack of Efficacy|0|||
162729047|NCT04982315|587716573|FG002|Overall Study|Lack of Efficacy|2|||
162729048|NCT04982315|587716571|FG000|Overall Study|Withdrawal by Subject|24|||
162729049|NCT04982315|587716572|FG001|Overall Study|Withdrawal by Subject|1|||
162729050|NCT04982315|587716573|FG002|Overall Study|Withdrawal by Subject|2|||
162729051|NCT04982315|587716571|FG000|Overall Study|Dealing with health/life issues|3|||
162729052|NCT04982315|587716572|FG001|Overall Study|Dealing with health/life issues|4|||
162729053|NCT04982315|587716573|FG002|Overall Study|Dealing with health/life issues|7|||
162729054|NCT04982315|587716571|FG000|Overall Study|Privacy concerns|1|||
162729055|NCT04982315|587716572|FG001|Overall Study|Privacy concerns|0|||
162729056|NCT04982315|587716573|FG002|Overall Study|Privacy concerns|0|||
162729057|NCT04982315|587716571|FG000|Overall Study|Withdrawal by research team|0|||
162729058|NCT04982315|587716572|FG001|Overall Study|Withdrawal by research team|0|||
162729059|NCT04982315|587716573|FG002|Overall Study|Withdrawal by research team|1|||
162729060|NCT00780910|587716574|FG000|Overall Study|Adverse Event|2|||
162729061|NCT00861692|587716578|FG000|Overall Study|Death|6|||
162729062|NCT06429163|587716579|FG000|Overall Study|uterine fibroid type 7|1|||
162729063|NCT06429163|587716580|FG001|Overall Study|uterine fibroid type 7|1|||
162729064|NCT06429163|587716581|FG002|Overall Study|uterine fibroid type 7|1|||
162729065|NCT06429163|587716579|FG000|Overall Study|severe adhesions|1|||
162729066|NCT06429163|587716580|FG001|Overall Study|severe adhesions|2|||
162729067|NCT06429163|587716581|FG002|Overall Study|severe adhesions|1|||
162729068|NCT06429163|587716579|FG000|Overall Study|conversion to laparotomy|0|||
162729069|NCT06429163|587716580|FG001|Overall Study|conversion to laparotomy|1|||
162729070|NCT06429163|587716581|FG002|Overall Study|conversion to laparotomy|0|||
162729071|NCT06429163|587716579|FG000|Overall Study|concomitant procedure|1|||
162729072|NCT06429163|587716580|FG001|Overall Study|concomitant procedure|0|||
162729073|NCT06429163|587716581|FG002|Overall Study|concomitant procedure|0|||
162729074|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Adverse Event|1|||
162729075|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Adverse Event|6|||
162729076|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Adverse Event|2|||
162729077|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Adverse Event|1|||
162729078|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Adverse Event|0|||
162729079|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Adverse Event|0|||
162729080|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162691573|NCT00301080|587582753|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162691574|NCT00301080|587582754|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162691575|NCT00301080|587582755|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162691576|NCT01287520|587582758|FG000|Overall Study|Adverse Event|2|||
162691577|NCT01287520|587582759|FG001|Overall Study|Adverse Event|2|||
162691578|NCT01287520|587582760|FG002|Overall Study|Adverse Event|2|||
162691579|NCT01287520|587582761|FG003|Overall Study|Adverse Event|1|||
162691580|NCT01287520|587582762|FG004|Overall Study|Adverse Event|1|||
162691581|NCT01287520|587582763|FG005|Overall Study|Adverse Event|2|||
162691582|NCT01287520|587582764|FG006|Overall Study|Adverse Event|0|||
162691583|NCT01287520|587582765|FG007|Overall Study|Adverse Event|2|||
162691584|NCT01287520|587582766|FG008|Overall Study|Adverse Event|0|||
162691585|NCT01287520|587582758|FG000|Overall Study|Physician Decision|1|||
162691586|NCT01287520|587582759|FG001|Overall Study|Physician Decision|1|||
162691587|NCT01287520|587582760|FG002|Overall Study|Physician Decision|2|||
162691588|NCT01287520|587582761|FG003|Overall Study|Physician Decision|0|||
162691589|NCT01287520|587582762|FG004|Overall Study|Physician Decision|1|||
162691590|NCT01287520|587582763|FG005|Overall Study|Physician Decision|1|||
162691591|NCT01287520|587582764|FG006|Overall Study|Physician Decision|0|||
162691592|NCT01287520|587582765|FG007|Overall Study|Physician Decision|1|||
162691593|NCT01287520|587582766|FG008|Overall Study|Physician Decision|0|||
162691594|NCT01287520|587582758|FG000|Overall Study|Progressive disease|0|||
162691595|NCT01287520|587582759|FG001|Overall Study|Progressive disease|4|||
162691596|NCT01287520|587582760|FG002|Overall Study|Progressive disease|1|||
162691597|NCT01287520|587582761|FG003|Overall Study|Progressive disease|6|||
162691598|NCT01287520|587582762|FG004|Overall Study|Progressive disease|1|||
162691599|NCT01287520|587582763|FG005|Overall Study|Progressive disease|0|||
162691600|NCT01287520|587582764|FG006|Overall Study|Progressive disease|2|||
162691601|NCT01287520|587582765|FG007|Overall Study|Progressive disease|2|||
162691602|NCT01287520|587582766|FG008|Overall Study|Progressive disease|4|||
162691603|NCT01287520|587582758|FG000|Overall Study|Withdrawal by Subject|0|||
162691604|NCT01287520|587582759|FG001|Overall Study|Withdrawal by Subject|0|||
162691605|NCT01287520|587582760|FG002|Overall Study|Withdrawal by Subject|0|||
162691606|NCT01287520|587582761|FG003|Overall Study|Withdrawal by Subject|0|||
162691607|NCT01287520|587582762|FG004|Overall Study|Withdrawal by Subject|0|||
162691608|NCT01287520|587582763|FG005|Overall Study|Withdrawal by Subject|1|||
162691609|NCT01287520|587582764|FG006|Overall Study|Withdrawal by Subject|0|||
162691610|NCT01287520|587582765|FG007|Overall Study|Withdrawal by Subject|0|||
162691611|NCT01287520|587582766|FG008|Overall Study|Withdrawal by Subject|1|||
162691612|NCT03587142|587582767|FG000|Overall Study|Lost to Follow-up|5|||
162691613|NCT03587142|587582768|FG001|Overall Study|Lost to Follow-up|3|||
162691614|NCT03587142|587582767|FG000|Overall Study|Did not complete the f4 visit|3|||
162691615|NCT03587142|587582768|FG001|Overall Study|Did not complete the f4 visit|7|||
162691616|NCT02768662|587582769|FG000|Overall Study|Adverse Event|1|||
162691617|NCT02768662|587582769|FG000|Overall Study|Lost to Follow-up|4|||
162691618|NCT02768662|587582769|FG000|Overall Study|Withdrawal by Subject|3|||
162691619|NCT02768662|587582769|FG000|Overall Study|Study terminated by Sponsor|78|||
162691620|NCT03673462|587582770|FG000|Overall Study|Adverse Event|11|||
162691621|NCT03673462|587582771|FG001|Overall Study|Adverse Event|1|||
162691622|NCT03673462|587582770|FG000|Overall Study|Protocol Violation|25|||
162691623|NCT03673462|587582771|FG001|Overall Study|Protocol Violation|11|||
162691624|NCT03673462|587582770|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
162691625|NCT03673462|587582771|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
162691626|NCT03673462|587582770|FG000|Overall Study|Lost to Follow-up|102|||
162691627|NCT03673462|587582771|FG001|Overall Study|Lost to Follow-up|19|||
162691628|NCT02567825|587582776|FG000|Overall Study|No follow-up post-randomization|5|||
162691629|NCT02567825|587582777|FG001|Overall Study|No follow-up post-randomization|1|||
162691630|NCT02567825|587582776|FG000|Overall Study|Follow-up less than 23 months|16|||
162691631|NCT02567825|587582777|FG001|Overall Study|Follow-up less than 23 months|20|||
162691632|NCT03097861|587582784|FG000|Overall Study|Adverse Event|3|||
162691633|NCT03097861|587582785|FG001|Overall Study|Adverse Event|8|||
162691634|NCT03097861|587582786|FG002|Overall Study|Adverse Event|4|||
162691635|NCT03097861|587582784|FG000|Overall Study|Investigator Decision|0|||
162691636|NCT03097861|587582785|FG001|Overall Study|Investigator Decision|1|||
162691637|NCT03097861|587582786|FG002|Overall Study|Investigator Decision|0|||
162691638|NCT03097861|587582784|FG000|Overall Study|Lost to Follow-up|0|||
162691639|NCT03097861|587582785|FG001|Overall Study|Lost to Follow-up|7|||
162691640|NCT03097861|587582786|FG002|Overall Study|Lost to Follow-up|1|||
162691641|NCT03097861|587582784|FG000|Overall Study|Withdrawal by Subject|1|||
162691642|NCT03097861|587582785|FG001|Overall Study|Withdrawal by Subject|5|||
162691643|NCT03097861|587582786|FG002|Overall Study|Withdrawal by Subject|3|||
162691644|NCT03097861|587582784|FG000|Overall Study|Reason not provided|3|||
162691645|NCT03097861|587582785|FG001|Overall Study|Reason not provided|1|||
162691646|NCT03097861|587582786|FG002|Overall Study|Reason not provided|1|||
162691647|NCT05061537|587582787|FG000|Treatment Phase|Progressive disease|0|||
162691648|NCT05061537|587582788|FG001|Treatment Phase|Progressive disease|1|||
162691649|NCT05061537|587582789|FG002|Treatment Phase|Progressive disease|2|||
162691650|NCT05061537|587582790|FG003|Treatment Phase|Progressive disease|0|||
162729081|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162729082|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162729083|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162729084|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162729085|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162729086|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
162729087|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
162729088|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
162729089|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
162729090|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
162729091|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
162729092|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Physician Decision|0|||
162729093|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Physician Decision|2|||
162729094|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Physician Decision|0|||
162729095|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Physician Decision|0|||
162729096|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Physician Decision|0|||
162729097|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Physician Decision|0|||
162729098|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
162729099|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
162729100|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
162729101|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
162729102|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
162729103|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
162729104|NCT04929483|587716582|FG000|Main Study (24 Weeks)|Randomized in error|0|||
162729105|NCT04929483|587716583|FG001|Main Study (24 Weeks)|Randomized in error|1|||
162729106|NCT04929483|587716584|FG002|Main Study (24 Weeks)|Randomized in error|0|||
162729107|NCT04929483|587716585|FG003|Main Study (24 Weeks)|Randomized in error|2|||
162729108|NCT04929483|587716586|FG004|Main Study (24 Weeks)|Randomized in error|0|||
162729109|NCT04929483|587716587|FG005|Main Study (24 Weeks)|Randomized in error|0|||
162729110|NCT04929483|587716582|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162729111|NCT04929483|587716583|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162729112|NCT04929483|587716584|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
162729113|NCT04929483|587716585|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162729114|NCT04929483|587716586|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
162729115|NCT04929483|587716587|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162729116|NCT04929483|587716582|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162729117|NCT04929483|587716583|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162729118|NCT04929483|587716584|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162729119|NCT04929483|587716585|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162729120|NCT04929483|587716586|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162729121|NCT04929483|587716587|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162729122|NCT04929483|587716582|FG000|Extension Study (24 Weeks)|Other than specified|1|||
162729123|NCT04929483|587716583|FG001|Extension Study (24 Weeks)|Other than specified|0|||
162729124|NCT04929483|587716584|FG002|Extension Study (24 Weeks)|Other than specified|1|||
162729125|NCT04929483|587716585|FG003|Extension Study (24 Weeks)|Other than specified|0|||
162691651|NCT05061537|587582791|FG004|Treatment Phase|Progressive disease|0|||
162691652|NCT05061537|587582787|FG000|Treatment Phase|Adverse Event|0|||
162691653|NCT05061537|587582788|FG001|Treatment Phase|Adverse Event|0|||
162691654|NCT05061537|587582789|FG002|Treatment Phase|Adverse Event|2|||
162691655|NCT05061537|587582790|FG003|Treatment Phase|Adverse Event|0|||
162691656|NCT05061537|587582791|FG004|Treatment Phase|Adverse Event|0|||
162691657|NCT05061537|587582787|FG000|Treatment Phase|Global deterioration of health status|0|||
162691658|NCT05061537|587582788|FG001|Treatment Phase|Global deterioration of health status|1|||
162691659|NCT05061537|587582789|FG002|Treatment Phase|Global deterioration of health status|0|||
162691660|NCT05061537|587582790|FG003|Treatment Phase|Global deterioration of health status|0|||
162691661|NCT05061537|587582791|FG004|Treatment Phase|Global deterioration of health status|0|||
162691662|NCT05061537|587582787|FG000|Follow up|Other|2|||
162691663|NCT05061537|587582788|FG001|Follow up|Other|0|||
162691664|NCT05061537|587582789|FG002|Follow up|Other|2|||
162729126|NCT04929483|587716586|FG004|Extension Study (24 Weeks)|Other than specified|1|||
162729127|NCT04929483|587716587|FG005|Extension Study (24 Weeks)|Other than specified|0|||
162729128|NCT04929483|587716582|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
162691665|NCT05061537|587582790|FG003|Follow up|Other|0|||
162691666|NCT05061537|587582791|FG004|Follow up|Other|0|||
162691667|NCT05061537|587582787|FG000|Follow up|Study terminated by sponsor|0|||
162691668|NCT05061537|587582788|FG001|Follow up|Study terminated by sponsor|0|||
162691669|NCT05061537|587582789|FG002|Follow up|Study terminated by sponsor|2|||
162729129|NCT04929483|587716583|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
162729130|NCT04929483|587716584|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
162729131|NCT04929483|587716585|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
162729132|NCT04929483|587716586|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
162729133|NCT04929483|587716587|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
162691670|NCT05061537|587582790|FG003|Follow up|Study terminated by sponsor|0|||
162691671|NCT05061537|587582791|FG004|Follow up|Study terminated by sponsor|0|||
162691672|NCT05061537|587582787|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
162691673|NCT05061537|587582788|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
162691674|NCT05061537|587582789|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
162691675|NCT05061537|587582790|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
162691676|NCT05061537|587582791|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
162691677|NCT05061537|587582787|FG000|Long-term Follow-up|Death|0|||
162691678|NCT05061537|587582788|FG001|Long-term Follow-up|Death|1|||
162691679|NCT05061537|587582789|FG002|Long-term Follow-up|Death|0|||
162691680|NCT05061537|587582790|FG003|Long-term Follow-up|Death|0|||
162691681|NCT05061537|587582791|FG004|Long-term Follow-up|Death|0|||
162691682|NCT03502616|587582793|FG000|Up to Week 16|Withdrawal by Subject|1|||
162691683|NCT03502616|587582794|FG001|Up to Week 16|Withdrawal by Subject|2|||
162691684|NCT03502616|587582793|FG000|Up to Week 16|Lost to Follow-up|0|||
162729134|NCT01626885|587716588|FG000|Overall Study|Adverse Event|8|||
162729135|NCT01626885|587716588|FG000|Overall Study|Withdrawal by Subject|4|||
162729136|NCT04083781|587716595|FG000|Main Part|Physician Decision|0|||
162729137|NCT04083781|587716596|FG001|Main Part|Physician Decision|1|||
162729138|NCT04083781|587716597|FG002|Main Part|Physician Decision|2|||
162729139|NCT04083781|587716598|FG003|Main Part|Physician Decision|0|||
162729140|NCT04083781|587716595|FG000|Main Part|Death|1|||
162729141|NCT04083781|587716596|FG001|Main Part|Death|3|||
162729142|NCT04083781|587716597|FG002|Main Part|Death|1|||
162729143|NCT04083781|587716598|FG003|Main Part|Death|0|||
162729144|NCT04083781|587716595|FG000|Main Part|Withdrawal by Subject|5|||
162729145|NCT04083781|587716596|FG001|Main Part|Withdrawal by Subject|2|||
162729146|NCT04083781|587716597|FG002|Main Part|Withdrawal by Subject|3|||
162729147|NCT04083781|587716598|FG003|Main Part|Withdrawal by Subject|7|||
162729148|NCT04083781|587716595|FG000|Extension Part|Physician Decision|0|||
162729149|NCT04083781|587716596|FG001|Extension Part|Physician Decision|0|||
162729150|NCT04083781|587716597|FG002|Extension Part|Physician Decision|0|||
162729151|NCT04083781|587716598|FG003|Extension Part|Physician Decision|1|||
162729152|NCT04083781|587716595|FG000|Extension Part|Death|0|||
162729153|NCT04083781|587716596|FG001|Extension Part|Death|1|||
162729154|NCT04083781|587716597|FG002|Extension Part|Death|0|||
162729155|NCT04083781|587716598|FG003|Extension Part|Death|1|||
162729156|NCT04083781|587716595|FG000|Extension Part|Withdrawal by Subject|0|||
162729157|NCT04083781|587716596|FG001|Extension Part|Withdrawal by Subject|1|||
162729158|NCT04083781|587716597|FG002|Extension Part|Withdrawal by Subject|0|||
162729159|NCT04083781|587716598|FG003|Extension Part|Withdrawal by Subject|0|||
162729160|NCT04083781|587716595|FG000|Extension Part|Ongoing|13|||
162729161|NCT04083781|587716596|FG001|Extension Part|Ongoing|25|||
162729162|NCT04083781|587716597|FG002|Extension Part|Ongoing|15|||
162729163|NCT04083781|587716598|FG003|Extension Part|Ongoing|51|||
162729164|NCT01143337|587716599|FG000|Overall Study|Adverse Event|3|||
162729165|NCT01143337|587716600|FG001|Overall Study|Adverse Event|9|||
162729166|NCT01143337|587716601|FG002|Overall Study|Adverse Event|5|||
162729167|NCT01143337|587716599|FG000|Overall Study|Lack of Efficacy|6|||
162729168|NCT01143337|587716600|FG001|Overall Study|Lack of Efficacy|2|||
162729169|NCT01143337|587716601|FG002|Overall Study|Lack of Efficacy|1|||
162729170|NCT01143337|587716599|FG000|Overall Study|Protocol Violation|1|||
162729171|NCT01143337|587716600|FG001|Overall Study|Protocol Violation|0|||
162729172|NCT01143337|587716601|FG002|Overall Study|Protocol Violation|0|||
162729173|NCT01143337|587716599|FG000|Overall Study|Withdrawal by Subject|0|||
162729174|NCT01143337|587716600|FG001|Overall Study|Withdrawal by Subject|0|||
162729175|NCT01143337|587716601|FG002|Overall Study|Withdrawal by Subject|1|||
162729176|NCT01143337|587716599|FG000|Overall Study|Other reason|0|||
162729177|NCT01143337|587716600|FG001|Overall Study|Other reason|0|||
162729178|NCT01143337|587716601|FG002|Overall Study|Other reason|5|||
162729179|NCT01466192|587716602|FG000|Overall Study|Physician Decision|1|||
162691685|NCT03502616|587582794|FG001|Up to Week 16|Lost to Follow-up|1|||
162691686|NCT03502616|587582793|FG000|Up to Week 16|Randomized, but not treated|1|||
162691687|NCT03502616|587582794|FG001|Up to Week 16|Randomized, but not treated|0|||
162691688|NCT03502616|587582793|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
162691689|NCT03502616|587582794|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
162691690|NCT03502616|587582793|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
162691691|NCT03502616|587582794|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
162729180|NCT01466192|587716602|FG000|Overall Study|Withdrawal by Subject|3|||
162729181|NCT05600283|587716603|FG000|Overall Study|Withdrawal by Subject|3|||
162729182|NCT05600283|587716604|FG001|Overall Study|Withdrawal by Subject|8|||
162729183|NCT05600283|587716603|FG000|Overall Study|Invalid Vaginal Swab|2|||
162729184|NCT05600283|587716604|FG001|Overall Study|Invalid Vaginal Swab|2|||
162691692|NCT04503096|587582795|FG000|Overall Study|Withdrawal by Subject|3|||
162691693|NCT01785563|587582796|FG000|Overall Study|Physician Decision|10|||
162729185|NCT05600283|587716603|FG000|Overall Study|Missing Clinician Collection|3|||
162729186|NCT05600283|587716604|FG001|Overall Study|Missing Clinician Collection|6|||
162729187|NCT05600283|587716603|FG000|Overall Study|Screen Failure|1|||
162729188|NCT05600283|587716604|FG001|Overall Study|Screen Failure|2|||
162729189|NCT05600283|587716603|FG000|Overall Study|Sample Lost in Transit|1|||
162729190|NCT05600283|587716604|FG001|Overall Study|Sample Lost in Transit|0|||
162729191|NCT01061671|587716605|FG000|Overall Study|Withdrawal by Subject|16|||
162691694|NCT01785563|587582796|FG000|Overall Study|Withdrawal by Subject|1|||
162691695|NCT01785563|587582796|FG000|Overall Study|Protocol Violation|2|||
162691696|NCT01872910|587582798|FG000|Overall Study|Lost to Follow-up|2|||
162691697|NCT01872910|587582799|FG001|Overall Study|Lost to Follow-up|0|||
162691698|NCT01872910|587582800|FG002|Overall Study|Lost to Follow-up|2|||
162691699|NCT01872910|587582801|FG003|Overall Study|Lost to Follow-up|0|||
162691700|NCT01872910|587582802|FG004|Overall Study|Lost to Follow-up|0|||
162691701|NCT01872910|587582803|FG005|Overall Study|Lost to Follow-up|0|||
162691702|NCT00744328|587582806|FG000|Overall Study|Lost to Follow-up|2|||
162691703|NCT00744328|587582807|FG001|Overall Study|Lost to Follow-up|5|||
162691704|NCT00744328|587582808|FG002|Overall Study|Lost to Follow-up|3|||
162691705|NCT00744328|587582806|FG000|Overall Study|Withdrawal by Subject|5|||
162691706|NCT00744328|587582807|FG001|Overall Study|Withdrawal by Subject|3|||
162691707|NCT00744328|587582808|FG002|Overall Study|Withdrawal by Subject|4|||
162691708|NCT00744328|587582806|FG000|Overall Study|Found ineligible after randomization|0|||
162691709|NCT00744328|587582807|FG001|Overall Study|Found ineligible after randomization|0|||
162691710|NCT00744328|587582808|FG002|Overall Study|Found ineligible after randomization|1|||
162691711|NCT01576367|587582809|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162691712|NCT01576367|587582809|FG000|Overall Study|Moved to commercial use after 6 months|1|||
162691713|NCT02387216|587582813|FG000|Overall Study|Progressive disease|2|||
162691714|NCT02387216|587582814|FG001|Overall Study|Progressive disease|0|||
162691715|NCT02387216|587582813|FG000|Overall Study|Withdrawal by Subject|3|||
162691716|NCT02387216|587582814|FG001|Overall Study|Withdrawal by Subject|5|||
162691717|NCT02387216|587582813|FG000|Overall Study|Physician Decision|2|||
162691718|NCT02387216|587582814|FG001|Overall Study|Physician Decision|0|||
162691719|NCT02387216|587582813|FG000|Overall Study|Sponsor Decision|28|||
162691720|NCT02387216|587582814|FG001|Overall Study|Sponsor Decision|12|||
162691721|NCT02387216|587582813|FG000|Overall Study|Death|60|||
162691722|NCT02387216|587582814|FG001|Overall Study|Death|23|||
162691723|NCT02387216|587582813|FG000|Overall Study|Other|5|||
162691724|NCT02387216|587582814|FG001|Overall Study|Other|4|||
162691725|NCT02387216|587582813|FG000|Overall Study|Lost to Follow-up|0|||
162691726|NCT02387216|587582814|FG001|Overall Study|Lost to Follow-up|3|||
162691727|NCT02091739|587582815|FG000|MP: 16 Weeks|Adverse Event|1|||
162691728|NCT02091739|587582816|FG001|MP: 16 Weeks|Adverse Event|1|||
162691729|NCT02091739|587582817|FG002|MP: 16 Weeks|Adverse Event|1|||
162691730|NCT02091739|587582818|FG003|MP: 16 Weeks|Adverse Event|0|||
162691731|NCT02091739|587582819|FG004|MP: 16 Weeks|Adverse Event|0|||
162691732|NCT02091739|587582815|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
162691733|NCT02091739|587582816|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
162691734|NCT02091739|587582817|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
162691735|NCT02091739|587582818|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
162691736|NCT02091739|587582819|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
162691737|NCT02091739|587582815|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
162691738|NCT02091739|587582816|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
162691739|NCT02091739|587582817|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
162691740|NCT02091739|587582818|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
162691741|NCT02091739|587582819|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
162691742|NCT02091739|587582815|FG000|EP: 48 Weeks|Other|0|||
162691743|NCT02091739|587582816|FG001|EP: 48 Weeks|Other|0|||
162691744|NCT02091739|587582817|FG002|EP: 48 Weeks|Other|0|||
162691745|NCT02091739|587582818|FG003|EP: 48 Weeks|Other|1|||
162691746|NCT02091739|587582819|FG004|EP: 48 Weeks|Other|0|||
162691747|NCT02091739|587582815|FG000|EP: 48 Weeks|Death|0|||
162691748|NCT02091739|587582816|FG001|EP: 48 Weeks|Death|0|||
162691749|NCT02091739|587582817|FG002|EP: 48 Weeks|Death|0|||
162691750|NCT02091739|587582818|FG003|EP: 48 Weeks|Death|3|||
162691751|NCT02091739|587582819|FG004|EP: 48 Weeks|Death|2|||
162691752|NCT02091739|587582815|FG000|EP: 48 Weeks|Adverse Event|0|||
162691753|NCT02091739|587582816|FG001|EP: 48 Weeks|Adverse Event|0|||
162691754|NCT02091739|587582817|FG002|EP: 48 Weeks|Adverse Event|0|||
162691755|NCT02091739|587582818|FG003|EP: 48 Weeks|Adverse Event|2|||
162691756|NCT02091739|587582819|FG004|EP: 48 Weeks|Adverse Event|6|||
162691757|NCT02091739|587582815|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
162691758|NCT02091739|587582816|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
162691759|NCT02091739|587582817|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
162691760|NCT02091739|587582818|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
162691761|NCT02091739|587582819|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
162691762|NCT03528174|587582820|FG000|Overall Study|Adverse Event|1|||
162691763|NCT03528174|587582820|FG000|Overall Study|sensors dislodged|1|||
162691764|NCT04251065|587582821|FG000|Overall Study|Death|2|||
162691765|NCT04251065|587582821|FG000|Overall Study|Lack of Efficacy|3|||
162691766|NCT04251065|587582821|FG000|Overall Study|Death|1|||
162691767|NCT01778556|587582822|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
162691768|NCT01778556|587582823|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
162691769|NCT01778556|587582822|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162691770|NCT01778556|587582823|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
162691771|NCT01778556|587582822|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
162691772|NCT01778556|587582823|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
162691773|NCT01778556|587582822|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
162691774|NCT01778556|587582823|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
162691775|NCT00576732|587582824|FG000|DOUBLE BLIND|Adverse Event|0|||
162691776|NCT00576732|587582825|FG001|DOUBLE BLIND|Adverse Event|0|||
162691777|NCT00576732|587582826|FG002|DOUBLE BLIND|Adverse Event|1|||
162691778|NCT00576732|587582827|FG003|DOUBLE BLIND|Adverse Event|0|||
162729192|NCT01061671|587716606|FG001|Overall Study|Withdrawal by Subject|20|||
162729193|NCT01061671|587716605|FG000|Overall Study|Lost to Follow-up|3|||
162729194|NCT01061671|587716606|FG001|Overall Study|Lost to Follow-up|5|||
162729195|NCT01061671|587716605|FG000|Overall Study|Death|28|||
162729196|NCT01061671|587716606|FG001|Overall Study|Death|30|||
162729197|NCT00068601|587716607|FG000|Overall Study|Ineligible|11|||
162729198|NCT00068601|587716608|FG001|Overall Study|Ineligible|13|||
162729199|NCT00068601|587716607|FG000|Overall Study|Not evaluable: withdrew consent|5|||
162729200|NCT00068601|587716608|FG001|Overall Study|Not evaluable: withdrew consent|4|||
162729201|NCT00068601|587716607|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
162729202|NCT00068601|587716608|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
162729203|NCT00068601|587716607|FG000|Overall Study|Death|11|||
162729204|NCT00068601|587716608|FG001|Overall Study|Death|3|||
162729205|NCT00068601|587716607|FG000|Overall Study|Lost to Follow-up|3|||
162729206|NCT00068601|587716608|FG001|Overall Study|Lost to Follow-up|2|||
162729207|NCT00068601|587716607|FG000|Overall Study|Missing primary outcome data|30|||
162729208|NCT00068601|587716608|FG001|Overall Study|Missing primary outcome data|34|||
162729209|NCT02468128|587716609|FG000|Overall Study|Protocol Violation|6|||
162729210|NCT02468128|587716610|FG001|Overall Study|Protocol Violation|6|||
162729211|NCT00440011|587716614|FG000|Overall Study|Adverse Event|2|||
162729212|NCT00440011|587716615|FG001|Overall Study|Adverse Event|0|||
162729213|NCT00440011|587716614|FG000|Overall Study|Lost to Follow-up|0|||
162729214|NCT00440011|587716615|FG001|Overall Study|Lost to Follow-up|2|||
162729215|NCT00440011|587716614|FG000|Overall Study|Protocol Violation|1|||
162729216|NCT00440011|587716615|FG001|Overall Study|Protocol Violation|1|||
162729217|NCT00440011|587716614|FG000|Overall Study|Withdrawal by Subject|1|||
162729218|NCT00440011|587716615|FG001|Overall Study|Withdrawal by Subject|0|||
162729219|NCT02321514|587716621|FG000|Overall Study|Death|15|||
162729220|NCT02321514|587716621|FG000|Overall Study|Missed Visit|7|||
162729221|NCT02321514|587716621|FG000|Overall Study|Study Exit|3|||
162729222|NCT00621296|587716622|FG000|Overall Study|Adverse Event|2|||
162729223|NCT00621296|587716622|FG000|Overall Study|Lack of Efficacy|1|||
162729224|NCT00621296|587716622|FG000|Overall Study|Physician Decision|7|||
162729225|NCT00621296|587716622|FG000|Overall Study|Unmatch Criteria|1|||
162729226|NCT00621296|587716622|FG000|Overall Study|Stopping Criteria|3|||
162729227|NCT04166058|587716623|FG000|Overall Study|Adverse Event|1|||
162729228|NCT04166058|587716624|FG001|Overall Study|Adverse Event|1|||
162729229|NCT04166058|587716625|FG002|Overall Study|Adverse Event|0|||
162729230|NCT04166058|587716626|FG003|Overall Study|Adverse Event|0|||
162729231|NCT04166058|587716623|FG000|Overall Study|Withdrawal by Subject|4|||
162729232|NCT04166058|587716624|FG001|Overall Study|Withdrawal by Subject|4|||
162729233|NCT04166058|587716625|FG002|Overall Study|Withdrawal by Subject|1|||
162729234|NCT04166058|587716626|FG003|Overall Study|Withdrawal by Subject|10|||
162729235|NCT04166058|587716623|FG000|Overall Study|Lost to Follow-up|9|||
162729236|NCT04166058|587716624|FG001|Overall Study|Lost to Follow-up|2|||
162729237|NCT04166058|587716625|FG002|Overall Study|Lost to Follow-up|1|||
162729238|NCT04166058|587716626|FG003|Overall Study|Lost to Follow-up|1|||
162729239|NCT04166058|587716623|FG000|Overall Study|Pregnancy|1|||
162729240|NCT04166058|587716624|FG001|Overall Study|Pregnancy|0|||
162729241|NCT04166058|587716625|FG002|Overall Study|Pregnancy|0|||
162729242|NCT04166058|587716626|FG003|Overall Study|Pregnancy|0|||
162729243|NCT04166058|587716623|FG000|Overall Study|Physician Decision|2|||
162729244|NCT04166058|587716624|FG001|Overall Study|Physician Decision|0|||
162729245|NCT04166058|587716625|FG002|Overall Study|Physician Decision|0|||
162691779|NCT00576732|587582828|FG004|DOUBLE BLIND|Adverse Event|0|||
162691780|NCT00576732|587582829|FG005|DOUBLE BLIND|Adverse Event|0|||
162691781|NCT00576732|587582824|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
162691782|NCT00576732|587582825|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
162729246|NCT04166058|587716626|FG003|Overall Study|Physician Decision|2|||
162729247|NCT04166058|587716623|FG000|Overall Study|Protocol Violation|1|||
162729248|NCT04166058|587716624|FG001|Overall Study|Protocol Violation|0|||
162729249|NCT04166058|587716625|FG002|Overall Study|Protocol Violation|0|||
162729250|NCT04166058|587716626|FG003|Overall Study|Protocol Violation|0|||
162729251|NCT04166058|587716623|FG000|Overall Study|Lack of Efficacy|2|||
162729252|NCT04166058|587716624|FG001|Overall Study|Lack of Efficacy|0|||
162691783|NCT00576732|587582826|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
162729253|NCT04166058|587716625|FG002|Overall Study|Lack of Efficacy|0|||
162729254|NCT04166058|587716626|FG003|Overall Study|Lack of Efficacy|0|||
162729255|NCT04166058|587716623|FG000|Overall Study|Other|1|||
162729256|NCT04166058|587716624|FG001|Overall Study|Other|0|||
162729257|NCT04166058|587716625|FG002|Overall Study|Other|0|||
162729258|NCT04166058|587716626|FG003|Overall Study|Other|1|||
162729259|NCT04166058|587716623|FG000|Overall Study|Non-compliance with study drug|0|||
162729260|NCT04166058|587716624|FG001|Overall Study|Non-compliance with study drug|0|||
162691784|NCT00576732|587582827|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
162691785|NCT00576732|587582828|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
162691786|NCT00576732|587582829|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
162691787|NCT00576732|587582824|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
162691788|NCT00576732|587582825|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
162691789|NCT00576732|587582826|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
162691790|NCT00576732|587582827|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
162691791|NCT00576732|587582828|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
162691792|NCT00576732|587582829|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
162691793|NCT00576732|587582824|FG000|DOUBLE BLIND|OTHER|0|||
162691794|NCT00576732|587582825|FG001|DOUBLE BLIND|OTHER|2|||
162691795|NCT00576732|587582826|FG002|DOUBLE BLIND|OTHER|1|||
162691796|NCT00576732|587582827|FG003|DOUBLE BLIND|OTHER|0|||
162691797|NCT00576732|587582828|FG004|DOUBLE BLIND|OTHER|0|||
162691798|NCT00576732|587582829|FG005|DOUBLE BLIND|OTHER|0|||
162691799|NCT00576732|587582824|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
162691800|NCT00576732|587582825|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
162691801|NCT00576732|587582826|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
162691802|NCT00576732|587582827|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
162691803|NCT00576732|587582828|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
162691804|NCT00576732|587582829|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
162691805|NCT00576732|587582824|FG000|DOUBLE BLIND|Protocol Violation|1|||
162691806|NCT00576732|587582825|FG001|DOUBLE BLIND|Protocol Violation|0|||
162691807|NCT00576732|587582826|FG002|DOUBLE BLIND|Protocol Violation|0|||
162691808|NCT00576732|587582827|FG003|DOUBLE BLIND|Protocol Violation|0|||
162691809|NCT00576732|587582828|FG004|DOUBLE BLIND|Protocol Violation|0|||
162691810|NCT00576732|587582829|FG005|DOUBLE BLIND|Protocol Violation|0|||
162691811|NCT00576732|587582824|FG000|OPEN LABEL|Adverse Event|0|||
162691812|NCT00576732|587582825|FG001|OPEN LABEL|Adverse Event|0|||
162691813|NCT00576732|587582826|FG002|OPEN LABEL|Adverse Event|0|||
162691814|NCT00576732|587582827|FG003|OPEN LABEL|Adverse Event|4|||
162691815|NCT00576732|587582828|FG004|OPEN LABEL|Adverse Event|0|||
162691816|NCT00576732|587582829|FG005|OPEN LABEL|Adverse Event|1|||
162691817|NCT00576732|587582824|FG000|OPEN LABEL|Lost to Follow-up|0|||
162691818|NCT00576732|587582825|FG001|OPEN LABEL|Lost to Follow-up|0|||
162691819|NCT00576732|587582826|FG002|OPEN LABEL|Lost to Follow-up|0|||
162691820|NCT00576732|587582827|FG003|OPEN LABEL|Lost to Follow-up|2|||
162691821|NCT00576732|587582828|FG004|OPEN LABEL|Lost to Follow-up|1|||
162691822|NCT00576732|587582829|FG005|OPEN LABEL|Lost to Follow-up|1|||
162691823|NCT00576732|587582824|FG000|OPEN LABEL|Withdrawal by Subject|0|||
162691824|NCT00576732|587582825|FG001|OPEN LABEL|Withdrawal by Subject|0|||
162691825|NCT00576732|587582826|FG002|OPEN LABEL|Withdrawal by Subject|0|||
162691826|NCT00576732|587582827|FG003|OPEN LABEL|Withdrawal by Subject|1|||
162691827|NCT00576732|587582828|FG004|OPEN LABEL|Withdrawal by Subject|0|||
162691828|NCT00576732|587582829|FG005|OPEN LABEL|Withdrawal by Subject|1|||
162691829|NCT00576732|587582824|FG000|OPEN LABEL|OTHER|0|||
162691830|NCT00576732|587582825|FG001|OPEN LABEL|OTHER|0|||
162691831|NCT00576732|587582826|FG002|OPEN LABEL|OTHER|0|||
162691832|NCT00576732|587582827|FG003|OPEN LABEL|OTHER|0|||
162691833|NCT00576732|587582828|FG004|OPEN LABEL|OTHER|0|||
162691834|NCT00576732|587582829|FG005|OPEN LABEL|OTHER|2|||
162691835|NCT00576732|587582824|FG000|OPEN LABEL|Lack of Efficacy|0|||
162691836|NCT00576732|587582825|FG001|OPEN LABEL|Lack of Efficacy|0|||
162691837|NCT00576732|587582826|FG002|OPEN LABEL|Lack of Efficacy|0|||
162691838|NCT00576732|587582827|FG003|OPEN LABEL|Lack of Efficacy|2|||
162691839|NCT00576732|587582828|FG004|OPEN LABEL|Lack of Efficacy|2|||
162691840|NCT00576732|587582829|FG005|OPEN LABEL|Lack of Efficacy|3|||
162691841|NCT00576732|587582824|FG000|OPEN LABEL|Protocol Violation|0|||
162691842|NCT00576732|587582825|FG001|OPEN LABEL|Protocol Violation|0|||
162691843|NCT00576732|587582826|FG002|OPEN LABEL|Protocol Violation|0|||
162691844|NCT00576732|587582827|FG003|OPEN LABEL|Protocol Violation|2|||
162691845|NCT00576732|587582828|FG004|OPEN LABEL|Protocol Violation|1|||
162691846|NCT00576732|587582829|FG005|OPEN LABEL|Protocol Violation|0|||
162691847|NCT00265330|587582830|FG000|Overall Study|Adverse Event|41|||
162691848|NCT00265330|587582830|FG000|Overall Study|Lost to Follow-up|8|||
162691849|NCT00265330|587582830|FG000|Overall Study|Withdrawal by Subject|34|||
162691850|NCT00265330|587582830|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
162691851|NCT00265330|587582830|FG000|Overall Study|Lack of Efficacy|4|||
162691852|NCT00265330|587582830|FG000|Overall Study|Family Scheduling Conflicts|1|||
162691853|NCT00265330|587582830|FG000|Overall Study|Began Taking Formulary Geodon|1|||
162691854|NCT00265330|587582830|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
162691855|NCT00265330|587582830|FG000|Overall Study|Site Closed by Sponsor|1|||
162691856|NCT00265330|587582830|FG000|Overall Study|Principal Investigators Request|1|||
162691857|NCT00265330|587582830|FG000|Overall Study|Withdrew Consent|1|||
162691858|NCT00265330|587582830|FG000|Overall Study|Protocol Violation|1|||
162691859|NCT02178566|587582838|FG000|Overall Study|patient did not complete due to noncompliance|0|||
162691860|NCT02178566|587582839|FG001|Overall Study|patient did not complete due to noncompliance|1|||
162691861|NCT02658630|587582840|FG000|Overall Study|Withdrawal by Subject|4|||
162691862|NCT00085202|587582841|FG000|Overall Study|Still on therapy|2|||
162691863|NCT00085202|587582842|FG001|Overall Study|Still on therapy|0|||
162691864|NCT00085202|587582841|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
162691865|NCT00085202|587582842|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
162691866|NCT00085202|587582841|FG000|Overall Study|Excessive toxicity|6|||
162691867|NCT00085202|587582842|FG001|Overall Study|Excessive toxicity|5|||
162691868|NCT00085202|587582841|FG000|Overall Study|Non-specified|3|||
162691869|NCT00085202|587582842|FG001|Overall Study|Non-specified|5|||
162729261|NCT04166058|587716625|FG002|Overall Study|Non-compliance with study drug|0|||
162729262|NCT04166058|587716626|FG003|Overall Study|Non-compliance with study drug|2|||
162729263|NCT02998528|587716627|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
162729264|NCT02998528|587716628|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
162729265|NCT02998528|587716629|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
162691870|NCT00085202|587582841|FG000|Overall Study|Withdrawal by Subject|2|||
162691871|NCT00085202|587582842|FG001|Overall Study|Withdrawal by Subject|1|||
162691872|NCT00085202|587582841|FG000|Overall Study|Physician Decision|4|||
162691873|NCT00085202|587582842|FG001|Overall Study|Physician Decision|1|||
162691874|NCT00085202|587582841|FG000|Overall Study|Progressive disease|1|||
162691875|NCT00085202|587582842|FG001|Overall Study|Progressive disease|11|||
162691876|NCT01436201|587582844|FG000|Overall Study|Adverse Event|2|||
162691877|NCT01436201|587582844|FG000|Overall Study|Withdrawal by Subject|1|||
162691878|NCT01436201|587582844|FG000|Overall Study|Protocol Violation|1|||
162691879|NCT00110890|587582845|FG000|Overall Study|Adverse Event|30|||
162691880|NCT00110890|587582846|FG001|Overall Study|Adverse Event|7|||
162691881|NCT00110890|587582845|FG000|Overall Study|Death|16|||
162691882|NCT00110890|587582846|FG001|Overall Study|Death|9|||
162691883|NCT00110890|587582845|FG000|Overall Study|Lost to Follow-up|3|||
162691884|NCT00110890|587582846|FG001|Overall Study|Lost to Follow-up|1|||
162691885|NCT00110890|587582845|FG000|Overall Study|Physician Decision|4|||
162691886|NCT00110890|587582846|FG001|Overall Study|Physician Decision|5|||
162691887|NCT00110890|587582845|FG000|Overall Study|Withdrawal by Subject|17|||
162691888|NCT00110890|587582846|FG001|Overall Study|Withdrawal by Subject|5|||
162691889|NCT00110890|587582845|FG000|Overall Study|Protocol Deviation|1|||
162691890|NCT00110890|587582846|FG001|Overall Study|Protocol Deviation|0|||
162691891|NCT00110890|587582845|FG000|Overall Study|Noncompliance|10|||
162691892|NCT00110890|587582846|FG001|Overall Study|Noncompliance|0|||
162691893|NCT00110890|587582845|FG000|Overall Study|Kidney Transplant|16|||
162691894|NCT00110890|587582846|FG001|Overall Study|Kidney Transplant|12|||
162691895|NCT00110890|587582845|FG000|Overall Study|Invest. Product Commercially Available|217|||
162691896|NCT00110890|587582846|FG001|Overall Study|Invest. Product Commercially Available|110|||
162691897|NCT00110890|587582845|FG000|Overall Study|Other|34|||
162691898|NCT00110890|587582846|FG001|Overall Study|Other|23|||
162691899|NCT00110890|587582845|FG000|Overall Study|Ineligibility determined|3|||
162691900|NCT00110890|587582846|FG001|Overall Study|Ineligibility determined|0|||
162691901|NCT00110890|587582845|FG000|Overall Study|Requirement for alternative therapy|0|||
162691902|NCT00110890|587582846|FG001|Overall Study|Requirement for alternative therapy|1|||
162691903|NCT00110890|587582845|FG000|Overall Study|Disease progression|0|||
162691904|NCT00110890|587582846|FG001|Overall Study|Disease progression|1|||
162691905|NCT00110890|587582845|FG000|Overall Study|Parathyroidectomy|0|||
162691906|NCT00110890|587582846|FG001|Overall Study|Parathyroidectomy|1|||
162691907|NCT00110890|587582845|FG000|Overall Study|Did not enter follow-up phase|10|||
162691908|NCT00110890|587582846|FG001|Overall Study|Did not enter follow-up phase|4|||
162691909|NCT01686581|587582847|FG000|Overall Study|Side-effects or Health Problems|15|||
162691910|NCT01686581|587582847|FG000|Overall Study|Lack of Efficacy|90|||
162691911|NCT01686581|587582847|FG000|Overall Study|Participant Concerned about Risks|6|||
162691912|NCT01686581|587582847|FG000|Overall Study|Thinks Injections Too Painful|8|||
162691913|NCT01686581|587582847|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
162691914|NCT01686581|587582847|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
162691915|NCT01686581|587582847|FG000|Overall Study|Thinks it is Inconvenient|17|||
162691916|NCT01686581|587582847|FG000|Overall Study|Other Miscellaneous Reasons|36|||
162691917|NCT01686581|587582847|FG000|Overall Study|Reason Missing|1|||
162691918|NCT01975220|587582848|FG000|Test Period 1|Not treated|0|||
162691919|NCT01975220|587582849|FG001|Test Period 1|Not treated|1|||
162691920|NCT01975220|587582850|FG002|Test Period 1|Not treated|0|||
162691921|NCT01975220|587582851|FG003|Test Period 1|Not treated|0|||
162691922|NCT01975220|587582852|FG004|Test Period 1|Not treated|0|||
162691923|NCT01975220|587582853|FG005|Test Period 1|Not treated|0|||
162691924|NCT00263328|587582857|FG000|Overall Study|Death|0|||
162691925|NCT00263328|587582858|FG001|Overall Study|Death|0|||
162691926|NCT00263328|587582859|FG002|Overall Study|Death|1|||
162691927|NCT00263328|587582857|FG000|Overall Study|Lost to Follow-up|1|||
162691928|NCT00263328|587582858|FG001|Overall Study|Lost to Follow-up|1|||
162691929|NCT00263328|587582859|FG002|Overall Study|Lost to Follow-up|0|||
162691930|NCT00263328|587582857|FG000|Overall Study|Withdrawal by Subject|3|||
162691931|NCT00263328|587582858|FG001|Overall Study|Withdrawal by Subject|0|||
162691932|NCT00263328|587582859|FG002|Overall Study|Withdrawal by Subject|1|||
162729266|NCT02998528|587716627|FG000|Randomization Period|Participant withdrew consent|0|||
162729267|NCT02998528|587716628|FG001|Randomization Period|Participant withdrew consent|3|||
162691933|NCT00263328|587582857|FG000|Overall Study|Other|3|||
162691934|NCT00263328|587582858|FG001|Overall Study|Other|0|||
162729268|NCT02998528|587716629|FG002|Randomization Period|Participant withdrew consent|0|||
162729269|NCT02998528|587716627|FG000|Randomization Period|Participant no longer meets study criteria|1|||
162729270|NCT02998528|587716628|FG001|Randomization Period|Participant no longer meets study criteria|3|||
162729271|NCT02998528|587716629|FG002|Randomization Period|Participant no longer meets study criteria|2|||
162729272|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
162729273|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
162729274|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
162729275|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
162729276|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
162729277|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
162729278|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
162729279|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
162729280|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
162729281|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
162729282|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
162729283|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
162729284|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
162729285|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
162729286|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
162729287|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Death|1|||
162729288|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Death|0|||
162729289|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Death|0|||
162729290|NCT02998528|587716627|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
162729291|NCT02998528|587716628|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
162729292|NCT02998528|587716629|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
162729293|NCT02998528|587716627|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
162729294|NCT02998528|587716628|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
162729295|NCT02998528|587716629|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
162729296|NCT02998528|587716627|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
162729297|NCT02998528|587716628|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
162729298|NCT02998528|587716629|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
162729299|NCT02998528|587716627|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
162729300|NCT02998528|587716628|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
162729301|NCT02998528|587716629|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
162729302|NCT02998528|587716627|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
162729303|NCT02998528|587716628|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
162729304|NCT02998528|587716629|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
162729305|NCT02998528|587716627|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
162729306|NCT02998528|587716628|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
162729307|NCT02998528|587716629|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
162729308|NCT00591214|587716630|FG000|Overall Study|Physician Decision|7|||
162729309|NCT00591214|587716630|FG000|Overall Study|Withdrawal by Subject|1|||
162729310|NCT01753570|587716634|FG000|Overall Study|Adverse Event|1|||
162729311|NCT01753570|587716635|FG001|Overall Study|Adverse Event|0|||
162729312|NCT01753570|587716636|FG002|Overall Study|Adverse Event|1|||
162691935|NCT00263328|587582859|FG002|Overall Study|Other|1|||
162691936|NCT00263328|587582857|FG000|Overall Study|Adverse Event|1|||
162691937|NCT00263328|587582858|FG001|Overall Study|Adverse Event|1|||
162691938|NCT00263328|587582859|FG002|Overall Study|Adverse Event|4|||
162691939|NCT01008475|587582863|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
162691940|NCT01008475|587582864|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
162691941|NCT01008475|587582865|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
162691942|NCT01008475|587582866|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
162691943|NCT01008475|587582867|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
162691944|NCT01008475|587582868|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
162691945|NCT01008475|587582869|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
162691946|NCT01301274|587582870|FG000|Overall Study|Physician Decision|2|||
162691947|NCT01301274|587582871|FG001|Overall Study|Physician Decision|1|||
162691948|NCT00661661|587582872|FG000|Overall Study|Adverse Event|99|||
162691949|NCT00661661|587582873|FG001|Overall Study|Adverse Event|24|||
162691950|NCT00661661|587582872|FG000|Overall Study|Lack of Efficacy|3|||
162691951|NCT00661661|587582873|FG001|Overall Study|Lack of Efficacy|2|||
162691952|NCT00661661|587582872|FG000|Overall Study|Lost to Follow-up|0|||
162691953|NCT00661661|587582873|FG001|Overall Study|Lost to Follow-up|1|||
162691954|NCT00661661|587582872|FG000|Overall Study|Withdrawal by Subject|15|||
162691955|NCT00661661|587582873|FG001|Overall Study|Withdrawal by Subject|5|||
162691956|NCT00661661|587582872|FG000|Overall Study|Other|22|||
162691957|NCT00661661|587582873|FG001|Overall Study|Other|7|||
162691958|NCT00661661|587582872|FG000|Overall Study|Not assigned treatment|1|||
162691959|NCT00661661|587582873|FG001|Overall Study|Not assigned treatment|0|||
162691960|NCT02917941|587582874|FG000|Treatment Period|Adverse Event|11|||
162691961|NCT02917941|587582874|FG000|Treatment Period|Progressive Disease|11|||
162691962|NCT02917941|587582874|FG000|Treatment Period|Reason not Specified|2|||
162691963|NCT02917941|587582874|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
162691964|NCT02917941|587582874|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
162691965|NCT01893827|587582875|FG000|Overall Study|Lost to Follow-up|19|||
162691966|NCT01893827|587582876|FG001|Overall Study|Lost to Follow-up|26|||
162691967|NCT03021668|587582879|FG000|Overall Study|Physician Decision|0|||
162691968|NCT03021668|587582880|FG001|Overall Study|Physician Decision|1|||
162691969|NCT01167179|587584479|FG000|Overall Study|disease recurrence|4|||
162691970|NCT01167179|587584480|FG001|Overall Study|disease recurrence|4|||
162691971|NCT01167179|587584479|FG000|Overall Study|Death|4|||
162691972|NCT01167179|587584480|FG001|Overall Study|Death|10|||
162691973|NCT01167179|587584479|FG000|Overall Study|Withdrawal by Subject|1|||
162691974|NCT01167179|587584480|FG001|Overall Study|Withdrawal by Subject|2|||
162691975|NCT01167179|587584479|FG000|Overall Study|diverse|6|||
162691976|NCT01167179|587584480|FG001|Overall Study|diverse|5|||
162691977|NCT02769065|587584481|FG000|Overall Study|Voluntary Withdrawal|1|||
162691978|NCT02769065|587584482|FG001|Overall Study|Voluntary Withdrawal|0|||
162691979|NCT02769065|587584483|FG002|Overall Study|Voluntary Withdrawal|0|||
162691980|NCT02769065|587584484|FG003|Overall Study|Voluntary Withdrawal|0|||
162691981|NCT02769065|587584485|FG004|Overall Study|Voluntary Withdrawal|0|||
162691982|NCT02769065|587584486|FG005|Overall Study|Voluntary Withdrawal|0|||
162691983|NCT02769065|587584487|FG006|Overall Study|Voluntary Withdrawal|0|||
162691984|NCT02769065|587584488|FG007|Overall Study|Voluntary Withdrawal|0|||
162691985|NCT02769065|587584489|FG008|Overall Study|Voluntary Withdrawal|0|||
162691986|NCT02769065|587584490|FG009|Overall Study|Voluntary Withdrawal|0|||
162691987|NCT02769065|587584491|FG010|Overall Study|Voluntary Withdrawal|0|||
162691988|NCT02769065|587584492|FG011|Overall Study|Voluntary Withdrawal|0|||
162691989|NCT02769065|587584493|FG012|Overall Study|Voluntary Withdrawal|0|||
162691990|NCT02769065|587584494|FG013|Overall Study|Voluntary Withdrawal|0|||
162691991|NCT02769065|587584495|FG014|Overall Study|Voluntary Withdrawal|0|||
162691992|NCT02769065|587584496|FG015|Overall Study|Voluntary Withdrawal|0|||
162691993|NCT02769065|587584497|FG016|Overall Study|Voluntary Withdrawal|0|||
162691994|NCT02769065|587584498|FG017|Overall Study|Voluntary Withdrawal|0|||
162691995|NCT02769065|587584499|FG018|Overall Study|Voluntary Withdrawal|0|||
162691996|NCT02769065|587584500|FG019|Overall Study|Voluntary Withdrawal|0|||
162691997|NCT02769065|587584501|FG020|Overall Study|Voluntary Withdrawal|0|||
162691998|NCT02769065|587584502|FG021|Overall Study|Voluntary Withdrawal|0|||
162691999|NCT02769065|587584503|FG022|Overall Study|Voluntary Withdrawal|0|||
162692000|NCT02769065|587584504|FG023|Overall Study|Voluntary Withdrawal|0|||
162692001|NCT02769065|587584505|FG024|Overall Study|Voluntary Withdrawal|0|||
162692002|NCT02769065|587584506|FG025|Overall Study|Voluntary Withdrawal|0|||
162692003|NCT02769065|587584507|FG026|Overall Study|Voluntary Withdrawal|0|||
162692004|NCT02769065|587584508|FG027|Overall Study|Voluntary Withdrawal|0|||
162692005|NCT02769065|587584509|FG028|Overall Study|Voluntary Withdrawal|0|||
162692006|NCT02769065|587584510|FG029|Overall Study|Voluntary Withdrawal|0|||
162692007|NCT02769065|587584481|FG000|Overall Study|Reason Not Specified|0|||
162692008|NCT02769065|587584482|FG001|Overall Study|Reason Not Specified|0|||
162692009|NCT02769065|587584483|FG002|Overall Study|Reason Not Specified|0|||
162692010|NCT02769065|587584484|FG003|Overall Study|Reason Not Specified|0|||
162692011|NCT02769065|587584485|FG004|Overall Study|Reason Not Specified|0|||
162692012|NCT02769065|587584486|FG005|Overall Study|Reason Not Specified|0|||
162692013|NCT02769065|587584487|FG006|Overall Study|Reason Not Specified|1|||
162692014|NCT02769065|587584488|FG007|Overall Study|Reason Not Specified|0|||
162692015|NCT02769065|587584489|FG008|Overall Study|Reason Not Specified|0|||
162692016|NCT02769065|587584490|FG009|Overall Study|Reason Not Specified|0|||
162692017|NCT02769065|587584491|FG010|Overall Study|Reason Not Specified|0|||
162692018|NCT02769065|587584492|FG011|Overall Study|Reason Not Specified|0|||
162692019|NCT02769065|587584493|FG012|Overall Study|Reason Not Specified|0|||
162692020|NCT02769065|587584494|FG013|Overall Study|Reason Not Specified|0|||
162692021|NCT02769065|587584495|FG014|Overall Study|Reason Not Specified|0|||
162692022|NCT02769065|587584496|FG015|Overall Study|Reason Not Specified|0|||
162692023|NCT02769065|587584497|FG016|Overall Study|Reason Not Specified|0|||
162692024|NCT02769065|587584498|FG017|Overall Study|Reason Not Specified|0|||
162692025|NCT02769065|587584499|FG018|Overall Study|Reason Not Specified|0|||
162692026|NCT02769065|587584500|FG019|Overall Study|Reason Not Specified|0|||
162692027|NCT02769065|587584501|FG020|Overall Study|Reason Not Specified|0|||
162692028|NCT02769065|587584502|FG021|Overall Study|Reason Not Specified|0|||
162692029|NCT02769065|587584503|FG022|Overall Study|Reason Not Specified|0|||
162692030|NCT02769065|587584504|FG023|Overall Study|Reason Not Specified|0|||
162692031|NCT02769065|587584505|FG024|Overall Study|Reason Not Specified|0|||
162692032|NCT02769065|587584506|FG025|Overall Study|Reason Not Specified|0|||
162692033|NCT02769065|587584507|FG026|Overall Study|Reason Not Specified|0|||
162692034|NCT02769065|587584508|FG027|Overall Study|Reason Not Specified|0|||
162692035|NCT02769065|587584509|FG028|Overall Study|Reason Not Specified|0|||
162692036|NCT02769065|587584510|FG029|Overall Study|Reason Not Specified|0|||
162692037|NCT02769065|587584481|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692038|NCT02769065|587584482|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692039|NCT02769065|587584483|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692040|NCT02769065|587584484|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692041|NCT02769065|587584485|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692042|NCT02769065|587584486|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692043|NCT02769065|587584487|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692044|NCT02769065|587584488|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692045|NCT02769065|587584489|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692046|NCT02769065|587584490|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692047|NCT02769065|587584491|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
162692048|NCT02769065|587584492|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692049|NCT02769065|587584493|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692050|NCT02769065|587584494|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692051|NCT02769065|587584495|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692052|NCT02769065|587584496|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692053|NCT02769065|587584497|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692054|NCT02769065|587584498|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692055|NCT02769065|587584499|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692056|NCT02769065|587584500|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692057|NCT02769065|587584501|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692058|NCT02769065|587584502|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692059|NCT02769065|587584503|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692060|NCT02769065|587584504|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692061|NCT02769065|587584505|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692062|NCT02769065|587584506|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692063|NCT02769065|587584507|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692064|NCT02769065|587584508|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692065|NCT02769065|587584509|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692066|NCT02769065|587584510|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
162692067|NCT03017235|587584511|FG000|Overall Study|Withdrawal by Subject|4|||
162692068|NCT03017235|587584512|FG001|Overall Study|Withdrawal by Subject|3|||
162692069|NCT03017235|587584511|FG000|Overall Study|Lost to Follow-up|2|||
162692070|NCT03017235|587584512|FG001|Overall Study|Lost to Follow-up|7|||
162692071|NCT03017235|587584511|FG000|Overall Study|Adverse Event|0|||
162692072|NCT03017235|587584512|FG001|Overall Study|Adverse Event|1|||
162692073|NCT03017235|587584511|FG000|Overall Study|Protocol Violation|2|||
162692074|NCT03017235|587584512|FG001|Overall Study|Protocol Violation|1|||
162692075|NCT03017235|587584511|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
162692076|NCT03017235|587584512|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
162692077|NCT01382940|587584515|FG000|Overall Study|Adverse Event|19|||
162692078|NCT01382940|587584515|FG000|Overall Study|Lost to Follow-up|4|||
162692079|NCT01382940|587584515|FG000|Overall Study|Physician Decision|7|||
162692080|NCT01382940|587584515|FG000|Overall Study|Withdrawal by Subject|23|||
162692081|NCT01382940|587584515|FG000|Overall Study|Protocol Violation|20|||
162692082|NCT02105636|587584516|FG000|Pre-Treatment|Disease Progression|1|||
162692083|NCT02105636|587584517|FG001|Pre-Treatment|Disease Progression|0|||
162692084|NCT02105636|587584516|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
162692085|NCT02105636|587584517|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
162692086|NCT02105636|587584516|FG000|Pre-Treatment|Participant withdrew consent|0|||
162692087|NCT02105636|587584517|FG001|Pre-Treatment|Participant withdrew consent|6|||
162692088|NCT02105636|587584516|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
162692089|NCT02105636|587584517|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
162692090|NCT02105636|587584516|FG000|Treatment|Study Drug Toxicity|14|||
162692091|NCT02105636|587584517|FG001|Treatment|Study Drug Toxicity|10|||
162692092|NCT02105636|587584516|FG000|Treatment|Adverse event unrelated to study drug|19|||
162692093|NCT02105636|587584517|FG001|Treatment|Adverse event unrelated to study drug|3|||
162692094|NCT02105636|587584516|FG000|Treatment|Participant request to discontinue study treatment|8|||
162692095|NCT02105636|587584517|FG001|Treatment|Participant request to discontinue study treatment|6|||
162692096|NCT02105636|587584516|FG000|Treatment|Participant withdrew consent|5|||
162692097|NCT02105636|587584517|FG001|Treatment|Participant withdrew consent|1|||
162692098|NCT02105636|587584516|FG000|Treatment|Lost to Follow-up|1|||
162692099|NCT02105636|587584517|FG001|Treatment|Lost to Follow-up|0|||
162692100|NCT02105636|587584516|FG000|Treatment|Maximum Clinical Benefit|1|||
162692101|NCT02105636|587584517|FG001|Treatment|Maximum Clinical Benefit|3|||
162692102|NCT02105636|587584516|FG000|Treatment|Poor/Non-compliance|0|||
162692103|NCT02105636|587584517|FG001|Treatment|Poor/Non-compliance|1|||
162692104|NCT02105636|587584516|FG000|Treatment|Participant no longer meets study criteria|1|||
162692105|NCT02105636|587584517|FG001|Treatment|Participant no longer meets study criteria|0|||
162692106|NCT02105636|587584516|FG000|Treatment|Other reasons|1|||
162692107|NCT02105636|587584517|FG001|Treatment|Other reasons|0|||
162692108|NCT02105636|587584516|FG000|Treatment|Disease Progression|185|||
162692109|NCT02105636|587584517|FG001|Treatment|Disease Progression|87|||
162692110|NCT00720902|587584518|FG000|Overall Study|Withdrawal by Subject|1|||
162692111|NCT00720902|587584519|FG001|Overall Study|Withdrawal by Subject|0|||
162692112|NCT00720902|587584518|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
162692113|NCT00720902|587584519|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
162692114|NCT02254408|587584525|FG000|Overall Study|Randomized But Not Treated|1|||
162692115|NCT02254408|587584526|FG001|Overall Study|Randomized But Not Treated|3|||
162692116|NCT02254408|587584525|FG000|Overall Study|Adverse Event|1|||
162692117|NCT02254408|587584526|FG001|Overall Study|Adverse Event|0|||
162692118|NCT02254408|587584525|FG000|Overall Study|Death|2|||
162692119|NCT02254408|587584526|FG001|Overall Study|Death|3|||
162692120|NCT02254408|587584525|FG000|Overall Study|Investigator's Discretion|0|||
162692121|NCT02254408|587584526|FG001|Overall Study|Investigator's Discretion|1|||
162692122|NCT02254408|587584525|FG000|Overall Study|Withdrawal by Subject|3|||
162692123|NCT02254408|587584526|FG001|Overall Study|Withdrawal by Subject|3|||
162692124|NCT02254408|587584525|FG000|Overall Study|Lost to Follow-up|1|||
162692125|NCT02254408|587584526|FG001|Overall Study|Lost to Follow-up|0|||
162692126|NCT01993017|587584527|FG000|Overall Study|Death|23|||
162692127|NCT01993017|587584528|FG001|Overall Study|Death|26|||
162692128|NCT01993017|587584529|FG002|Overall Study|Death|18|||
162692129|NCT01993017|587584527|FG000|Overall Study|Could not be contacted|43|||
162692130|NCT01993017|587584528|FG001|Overall Study|Could not be contacted|42|||
162692131|NCT01993017|587584529|FG002|Overall Study|Could not be contacted|38|||
162692132|NCT01993017|587584527|FG000|Overall Study|Dropped out|19|||
162692133|NCT01993017|587584528|FG001|Overall Study|Dropped out|6|||
162692134|NCT01993017|587584529|FG002|Overall Study|Dropped out|11|||
162692135|NCT01993017|587584527|FG000|Overall Study|Other reasons|17|||
162692136|NCT01993017|587584528|FG001|Overall Study|Other reasons|11|||
162692137|NCT01993017|587584529|FG002|Overall Study|Other reasons|7|||
162692138|NCT01993017|587584527|FG000|Overall Study|Ineligible after randomization|4|||
162692139|NCT01993017|587584528|FG001|Overall Study|Ineligible after randomization|5|||
162692140|NCT01993017|587584529|FG002|Overall Study|Ineligible after randomization|5|||
162692141|NCT00003511|587584530|FG000|Overall Study|Not evaluable|4|||
162692142|NCT00917267|587584531|FG000|Overall Study|Adverse Event|15|||
162692143|NCT00917267|587584532|FG001|Overall Study|Adverse Event|36|||
162692144|NCT00917267|587584531|FG000|Overall Study|Physician Decision|2|||
162692145|NCT00917267|587584532|FG001|Overall Study|Physician Decision|4|||
162692146|NCT00917267|587584531|FG000|Overall Study|Protocol Violation|9|||
162692147|NCT00917267|587584532|FG001|Overall Study|Protocol Violation|18|||
162692148|NCT00917267|587584531|FG000|Overall Study|Withdrawal by Subject|5|||
162692149|NCT00917267|587584532|FG001|Overall Study|Withdrawal by Subject|12|||
162692150|NCT00917267|587584531|FG000|Overall Study|Lost to follow up|0|||
162692151|NCT00917267|587584532|FG001|Overall Study|Lost to follow up|2|||
162692152|NCT00917267|587584531|FG000|Overall Study|Entry Criteria Not Met|1|||
162692153|NCT00917267|587584532|FG001|Overall Study|Entry Criteria Not Met|0|||
162692154|NCT00917267|587584531|FG000|Overall Study|Sponsor Decision|5|||
162692155|NCT00917267|587584532|FG001|Overall Study|Sponsor Decision|5|||
162692156|NCT00917267|587584531|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
162692157|NCT00917267|587584532|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
162692158|NCT03638635|587584533|FG000|Initial Hospitalization|Study terminated prematurely|0|||
162692159|NCT03638635|587584534|FG001|Initial Hospitalization|Study terminated prematurely|1|||
162692160|NCT03638635|587584533|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
162692161|NCT03638635|587584534|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
162692162|NCT03638635|587584533|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
162692163|NCT03638635|587584534|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
162692164|NCT00423293|587584535|FG000|Overall Study|Ineligible / No protocol treatment|11|||
162692165|NCT00519896|587584542|FG000|Overall Study|Protocol Violation|1|||
162692166|NCT00519896|587584542|FG000|Overall Study|Adverse Event|1|||
162692167|NCT03327402|587584543|FG000|Overall Study|Withdrawal by Subject|1|||
162692168|NCT03327402|587584543|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
162692169|NCT01540565|587584549|FG000|Overall Study|Ineligible|2|||
162692170|NCT03469349|587584550|FG000|Overall Study|Withdrawal by Subject|1|||
162692171|NCT03469349|587584551|FG001|Overall Study|Withdrawal by Subject|3|||
162692172|NCT03469349|587584550|FG000|Overall Study|Progressive Disease|0|||
162692173|NCT03469349|587584551|FG001|Overall Study|Progressive Disease|1|||
162692174|NCT03469349|587584550|FG000|Overall Study|Lost to Follow-up|2|||
162692175|NCT03469349|587584551|FG001|Overall Study|Lost to Follow-up|2|||
162692176|NCT03469349|587584550|FG000|Overall Study|Adverse Event|2|||
162692177|NCT03469349|587584551|FG001|Overall Study|Adverse Event|4|||
162692178|NCT01827254|587584552|FG000|Overall Study|Death|10|||
162692179|NCT01827254|587584552|FG000|Overall Study|Case report form not completed|4|||
162692180|NCT01827254|587584552|FG000|Overall Study|Invalidated centre|3|||
162692181|NCT01827254|587584552|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
162692182|NCT01827254|587584552|FG000|Overall Study|Did not complete re-challenge|1|||
162692183|NCT01827254|587584552|FG000|Overall Study|Disease progression|36|||
162692184|NCT01827254|587584552|FG000|Overall Study|Intolerance to treatment|4|||
162692185|NCT04145037|587584558|FG000|Overall Study|Study terminated|2|||
162692186|NCT04145037|587584559|FG001|Overall Study|Study terminated|0|||
162692187|NCT04145037|587584558|FG000|Overall Study|Withdrawal by Subject|1|||
162692188|NCT04145037|587584559|FG001|Overall Study|Withdrawal by Subject|0|||
162692189|NCT04145037|587584558|FG000|Overall Study|Lost to Follow-up|1|||
162692190|NCT04145037|587584559|FG001|Overall Study|Lost to Follow-up|0|||
162692191|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
162692192|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
162692193|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
162692194|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
162692195|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
162692196|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
162692197|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
162692198|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
162692199|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
162692200|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
162692201|NCT02307513|587584562|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
162692202|NCT02307513|587584563|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
162692203|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
162692204|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
162692205|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
162692206|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
162692207|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
162692208|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
162692209|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
162692210|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
162692211|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
162692212|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
162692213|NCT02307513|587584562|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
162692214|NCT02307513|587584563|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
162692215|NCT02307513|587584562|FG000|Long-term Extension|Physician Decision|1|||
162692216|NCT02307513|587584563|FG001|Long-term Extension|Physician Decision|0|||
162692217|NCT00525265|587584571|FG000|Overall Study|Protocol Violation|1|||
162692218|NCT00525265|587584572|FG001|Overall Study|Protocol Violation|0|||
162692219|NCT01107743|587584573|FG000|Overall Study|Protocol Violation|46|||
162692220|NCT00744263|587584576|FG000|Overall Study|Death|3006|||
162692221|NCT00744263|587584577|FG001|Overall Study|Death|3005|||
162692222|NCT00744263|587584576|FG000|Overall Study|Lost to Follow-up|2038|||
162692223|NCT00744263|587584577|FG001|Overall Study|Lost to Follow-up|2135|||
162692224|NCT00744263|587584576|FG000|Overall Study|Withdrawal by Subject|166|||
162692225|NCT00744263|587584577|FG001|Overall Study|Withdrawal by Subject|150|||
162692226|NCT00744263|587584576|FG000|Overall Study|Physician Decision|20|||
162692227|NCT00744263|587584577|FG001|Overall Study|Physician Decision|23|||
162692228|NCT00744263|587584576|FG000|Overall Study|Protocol Violation|3|||
162692229|NCT00744263|587584577|FG001|Overall Study|Protocol Violation|5|||
162692230|NCT00744263|587584576|FG000|Overall Study|Adverse Event|1|||
162692231|NCT00744263|587584577|FG001|Overall Study|Adverse Event|0|||
162692232|NCT00744263|587584576|FG000|Overall Study|Other|2|||
162692233|NCT00744263|587584577|FG001|Overall Study|Other|2|||
162692234|NCT01913639|587584578|FG000|Overall Study|Not Eligible|3|||
162692235|NCT01290822|587584581|FG000|Overall Study|Withdrawal by Subject|1|||
162692236|NCT01290822|587584581|FG000|Overall Study|Physician Decision|10|||
162692237|NCT04078035|587584582|FG000|Session 2|Lost to Follow-up|3|||
162692238|NCT04078035|587584583|FG001|Session 2|Lost to Follow-up|1|||
162692239|NCT04078035|587584582|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
162692240|NCT04078035|587584583|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
162692241|NCT04296890|587584586|FG000|Overall Study|Withdrawal by Subject|1|||
162692242|NCT04296890|587584586|FG000|Overall Study|Death|62|||
162692243|NCT04296890|587584586|FG000|Overall Study|Lost to Follow-up|3|||
162692244|NCT04296890|587584586|FG000|Overall Study|Other than specified|2|||
162692245|NCT02100722|587584587|FG000|Overall Study|Withdrawal pre-procedure|4|||
162692246|NCT02100722|587584588|FG001|Overall Study|Withdrawal pre-procedure|9|||
162692247|NCT02100722|587584587|FG000|Overall Study|Withdrawal post-procedure|0|||
162692248|NCT02100722|587584588|FG001|Overall Study|Withdrawal post-procedure|3|||
162692249|NCT02100722|587584587|FG000|Overall Study|Lost to Follow-up|2|||
162692250|NCT02100722|587584588|FG001|Overall Study|Lost to Follow-up|2|||
162692251|NCT02100722|587584587|FG000|Overall Study|Continuing on study|751|||
162692252|NCT02100722|587584588|FG001|Overall Study|Continuing on study|729|||
162692253|NCT04986982|587584590|FG000|Overall Study|Withdrawal by Subject|3|||
162729313|NCT01753570|587716634|FG000|Overall Study|Physician Decision|0|||
162692254|NCT04986982|587584591|FG001|Overall Study|Withdrawal by Subject|1|||
162692255|NCT04986982|587584590|FG000|Overall Study|Lack of Efficacy|0|||
162692256|NCT04986982|587584591|FG001|Overall Study|Lack of Efficacy|2|||
162692257|NCT04986982|587584590|FG000|Overall Study|Ineligibility|3|||
162692258|NCT04986982|587584591|FG001|Overall Study|Ineligibility|0|||
162692259|NCT04986982|587584590|FG000|Overall Study|Adverse Event|4|||
162692260|NCT04986982|587584591|FG001|Overall Study|Adverse Event|4|||
162692261|NCT04986982|587584590|FG000|Overall Study|Lost to Follow-up|0|||
162692262|NCT04986982|587584591|FG001|Overall Study|Lost to Follow-up|1|||
162692263|NCT04986982|587584590|FG000|Overall Study|Sponsor's discretion|1|||
162692264|NCT04986982|587584591|FG001|Overall Study|Sponsor's discretion|0|||
162692265|NCT03500640|587584592|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
162692266|NCT03500640|587584593|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
162692267|NCT03500640|587584594|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
162692268|NCT03500640|587584592|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
162692269|NCT03500640|587584593|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
162692270|NCT03500640|587584594|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
162692271|NCT03500640|587584592|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
162692272|NCT03500640|587584593|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
162692273|NCT03500640|587584594|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
162692274|NCT03500640|587584592|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
162692275|NCT03500640|587584593|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
162692276|NCT03500640|587584594|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
162692277|NCT03500640|587584592|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
162692278|NCT03500640|587584593|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
162692279|NCT03500640|587584594|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
162692280|NCT03500640|587584592|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
162692281|NCT03500640|587584593|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
162692282|NCT03500640|587584594|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
162692283|NCT03500640|587584592|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
162692284|NCT03500640|587584593|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
162692285|NCT03500640|587584594|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
162692286|NCT03500640|587584592|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
162692287|NCT03500640|587584593|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
162692288|NCT03500640|587584594|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
162692289|NCT03500640|587584592|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
162692290|NCT03500640|587584593|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
162692291|NCT03500640|587584594|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
162692292|NCT03500640|587584592|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
162692293|NCT03500640|587584593|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
162692294|NCT03500640|587584594|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
162692295|NCT02613221|587584595|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
162692296|NCT02613221|587584595|FG000|Overall Study|Adverse Event|2|||
162692297|NCT02613221|587584595|FG000|Overall Study|Voluntary Discontinuation|1|||
162692298|NCT02613221|587584595|FG000|Overall Study|Delayed Treatment|1|||
162692299|NCT02613221|587584595|FG000|Overall Study|Enrolled but Not Treated|1|||
162692300|NCT01119898|587584598|FG000|Overall Study|Adverse Event|4|||
162692301|NCT01119898|587584599|FG001|Overall Study|Adverse Event|5|||
162692302|NCT01119898|587584598|FG000|Overall Study|Withdrawal by Subject|1|||
162692303|NCT01119898|587584599|FG001|Overall Study|Withdrawal by Subject|4|||
162692304|NCT01119898|587584598|FG000|Overall Study|Lack of Efficacy|0|||
162692305|NCT01119898|587584599|FG001|Overall Study|Lack of Efficacy|2|||
162692306|NCT01119898|587584598|FG000|Overall Study|Protocol Violation|1|||
162692307|NCT01119898|587584599|FG001|Overall Study|Protocol Violation|1|||
162692308|NCT01119898|587584598|FG000|Overall Study|Medical procedure|1|||
162692309|NCT01119898|587584599|FG001|Overall Study|Medical procedure|0|||
162692310|NCT01119898|587584598|FG000|Overall Study|Randomized in error did not participate|1|||
162692311|NCT01119898|587584599|FG001|Overall Study|Randomized in error did not participate|0|||
162692312|NCT01807650|587584602|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
162692313|NCT01807650|587584602|FG000|Overall Study|Adverse Event|5|||
162692314|NCT01807650|587584602|FG000|Overall Study|Other|2|||
162692315|NCT02217280|587584603|FG000|Overall Study|Withdrawal by Subject|2|||
162692316|NCT02217280|587584603|FG000|Overall Study|Post-consent sceen fail|2|||
162692317|NCT03573908|587584609|FG000|Treatment Period|Adverse Event|4|||
162692318|NCT03573908|587584610|FG001|Treatment Period|Adverse Event|9|||
162692319|NCT03573908|587584611|FG002|Treatment Period|Adverse Event|0|||
162692320|NCT03573908|587584612|FG003|Treatment Period|Adverse Event|0|||
162692321|NCT03573908|587584613|FG004|Treatment Period|Adverse Event|0|||
162692322|NCT03573908|587584609|FG000|Treatment Period|Protocol Violation|1|||
162692323|NCT03573908|587584610|FG001|Treatment Period|Protocol Violation|0|||
162692324|NCT03573908|587584611|FG002|Treatment Period|Protocol Violation|0|||
162692325|NCT03573908|587584612|FG003|Treatment Period|Protocol Violation|0|||
162692326|NCT03573908|587584613|FG004|Treatment Period|Protocol Violation|0|||
162692327|NCT03573908|587584609|FG000|Treatment Period|Withdrawal by Subject|7|||
162692328|NCT03573908|587584610|FG001|Treatment Period|Withdrawal by Subject|5|||
162692329|NCT03573908|587584611|FG002|Treatment Period|Withdrawal by Subject|0|||
162692330|NCT03573908|587584612|FG003|Treatment Period|Withdrawal by Subject|0|||
162692331|NCT03573908|587584613|FG004|Treatment Period|Withdrawal by Subject|0|||
162692332|NCT03573908|587584609|FG000|Treatment Period|Lost to Follow-up|7|||
162692333|NCT03573908|587584610|FG001|Treatment Period|Lost to Follow-up|6|||
162692334|NCT03573908|587584611|FG002|Treatment Period|Lost to Follow-up|0|||
162692335|NCT03573908|587584612|FG003|Treatment Period|Lost to Follow-up|0|||
162692336|NCT03573908|587584613|FG004|Treatment Period|Lost to Follow-up|0|||
162692337|NCT03573908|587584609|FG000|Treatment Period|Pregnancy|1|||
162692338|NCT03573908|587584610|FG001|Treatment Period|Pregnancy|0|||
162692339|NCT03573908|587584611|FG002|Treatment Period|Pregnancy|0|||
162692340|NCT03573908|587584612|FG003|Treatment Period|Pregnancy|0|||
162692341|NCT03573908|587584613|FG004|Treatment Period|Pregnancy|0|||
162692342|NCT03573908|587584609|FG000|Treatment Period|Other, Not Specified|4|||
162692343|NCT03573908|587584610|FG001|Treatment Period|Other, Not Specified|6|||
162692344|NCT03573908|587584611|FG002|Treatment Period|Other, Not Specified|0|||
162692345|NCT03573908|587584612|FG003|Treatment Period|Other, Not Specified|0|||
162692346|NCT03573908|587584613|FG004|Treatment Period|Other, Not Specified|0|||
162692347|NCT03573908|587584609|FG000|Randomized Withdrawal Period|Adverse Event|0|||
162692348|NCT03573908|587584610|FG001|Randomized Withdrawal Period|Adverse Event|0|||
162692349|NCT03573908|587584611|FG002|Randomized Withdrawal Period|Adverse Event|3|||
162692350|NCT03573908|587584612|FG003|Randomized Withdrawal Period|Adverse Event|0|||
162692351|NCT03573908|587584613|FG004|Randomized Withdrawal Period|Adverse Event|0|||
162692352|NCT03573908|587584609|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162692353|NCT03573908|587584610|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162692354|NCT03573908|587584611|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162692355|NCT03573908|587584612|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162692356|NCT03573908|587584613|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
162692357|NCT03573908|587584609|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
162692358|NCT03573908|587584610|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
162692359|NCT03573908|587584611|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
162692360|NCT03573908|587584612|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
162692361|NCT03573908|587584613|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
162692362|NCT03573908|587584609|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
162692363|NCT03573908|587584610|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
162692364|NCT03573908|587584611|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
162692365|NCT03573908|587584612|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
162692366|NCT03573908|587584613|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
162692367|NCT04006925|587584614|FG000|Overall Study|Side effects|2|||
162692368|NCT04006925|587584615|FG001|Overall Study|Side effects|0|||
162692369|NCT02906683|587585996|FG000|Overall Study|Adverse Event|0|||
162692370|NCT02906683|587585997|FG001|Overall Study|Adverse Event|1|||
162692371|NCT02906683|587585998|FG002|Overall Study|Adverse Event|0|||
162692372|NCT02906683|587585996|FG000|Overall Study|Physician Decision|0|||
162692373|NCT02906683|587585997|FG001|Overall Study|Physician Decision|1|||
162692374|NCT02906683|587585998|FG002|Overall Study|Physician Decision|1|||
162692375|NCT02906683|587585996|FG000|Overall Study|Withdrawal by Subject|0|||
162692376|NCT02906683|587585997|FG001|Overall Study|Withdrawal by Subject|2|||
162692377|NCT02906683|587585998|FG002|Overall Study|Withdrawal by Subject|1|||
162692378|NCT02906683|587585996|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
162692379|NCT02906683|587585997|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
162692380|NCT02906683|587585998|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
162692381|NCT02906683|587585996|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
162692382|NCT02906683|587585997|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162692383|NCT02906683|587585998|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162692384|NCT01158378|587585999|FG000|Overall Study|Death|4|||
162692385|NCT01158378|587586000|FG001|Overall Study|Death|5|||
162692386|NCT01158378|587585999|FG000|Overall Study|Lost to Follow-up|2|||
162692387|NCT01158378|587586000|FG001|Overall Study|Lost to Follow-up|4|||
162692388|NCT01158378|587585999|FG000|Overall Study|Withdrawal by Subject|4|||
162692389|NCT01158378|587586000|FG001|Overall Study|Withdrawal by Subject|0|||
162692390|NCT02531295|587586005|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
162692391|NCT02531295|587586006|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
162692392|NCT02531295|587586007|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
162692393|NCT02531295|587586008|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
162692394|NCT02531295|587586009|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
162729314|NCT01753570|587716635|FG001|Overall Study|Physician Decision|1|||
162729315|NCT01753570|587716636|FG002|Overall Study|Physician Decision|0|||
162729316|NCT01753570|587716634|FG000|Overall Study|Withdrawal by Subject|1|||
162692395|NCT02531295|587586010|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
162692396|NCT00453310|587586011|FG000|Overall Study|Progression of Disease|10|||
162692397|NCT01806740|587586012|FG000|Overall Study|Withdrawal by Subject|4|||
162692398|NCT01806740|587586012|FG000|Overall Study|Physician Decision|1|||
162692399|NCT01806740|587586012|FG000|Overall Study|Patient's refusal of treatment|1|||
162692400|NCT04666922|587586013|FG000|Overall Study|Withdrawal by Subject|1|||
162692401|NCT04666922|587586014|FG001|Overall Study|Withdrawal by Subject|0|||
162692402|NCT04666922|587586015|FG002|Overall Study|Withdrawal by Subject|0|||
162692403|NCT04666922|587586016|FG003|Overall Study|Withdrawal by Subject|0|||
162692404|NCT04666922|587586017|FG004|Overall Study|Withdrawal by Subject|0|||
162692405|NCT04666922|587586018|FG005|Overall Study|Withdrawal by Subject|0|||
162692406|NCT04666922|587586019|FG006|Overall Study|Withdrawal by Subject|0|||
162692407|NCT04651114|587586020|FG000|Overall Study|Withdrawal by Subject|8|||
162692408|NCT03980184|587586023|FG000|Overall Study|Dropped out before treatment|2|||
162692409|NCT03980184|587586024|FG001|Overall Study|Dropped out before treatment|2|||
162692410|NCT03980184|587586023|FG000|Overall Study|Lost to Follow-up|11|||
162692411|NCT03980184|587586024|FG001|Overall Study|Lost to Follow-up|13|||
162692412|NCT02176421|587586025|FG000|Overall Study|Lost to Follow-up|4|||
162692413|NCT02176421|587586025|FG000|Overall Study|Adverse Event|1|||
162692414|NCT01129336|587586029|FG000|Overall Study|Protocol Violation|1|||
162692415|NCT01129336|587586030|FG001|Overall Study|Protocol Violation|0|||
162692416|NCT01129336|587586029|FG000|Overall Study|Disease Progression|1|||
162692417|NCT01129336|587586030|FG001|Overall Study|Disease Progression|4|||
162692418|NCT01129336|587586029|FG000|Overall Study|Lost to Follow-up|1|||
162692419|NCT01129336|587586030|FG001|Overall Study|Lost to Follow-up|0|||
162692420|NCT01129336|587586029|FG000|Overall Study|Withdrawal by Subject|7|||
162692421|NCT01129336|587586030|FG001|Overall Study|Withdrawal by Subject|4|||
162692422|NCT01129336|587586029|FG000|Overall Study|Adverse Event|0|||
162692423|NCT01129336|587586030|FG001|Overall Study|Adverse Event|1|||
162692424|NCT01129336|587586029|FG000|Overall Study|Missing Study Completion Status|2|||
162692425|NCT01129336|587586030|FG001|Overall Study|Missing Study Completion Status|3|||
162692426|NCT01129336|587586029|FG000|Overall Study|Death|0|||
162692427|NCT01129336|587586030|FG001|Overall Study|Death|4|||
162692428|NCT00467142|587586033|FG000|Overall Study|Withdrawal by Subject|1|||
162692429|NCT00467142|587586033|FG000|Overall Study|Adverse Event|1|||
162692430|NCT00467142|587586033|FG000|Overall Study|Protocol Violation|1|||
162692431|NCT00154310|587586034|FG000|Overall Study|Adverse Event|19|||
162692432|NCT00154310|587586035|FG001|Overall Study|Adverse Event|9|||
162692433|NCT00154310|587586034|FG000|Overall Study|Lack of Efficacy|5|||
162692434|NCT00154310|587586035|FG001|Overall Study|Lack of Efficacy|4|||
162692435|NCT00154310|587586034|FG000|Overall Study|Protocol Violation|4|||
162692436|NCT00154310|587586035|FG001|Overall Study|Protocol Violation|2|||
162692437|NCT00154310|587586034|FG000|Overall Study|Withdrawal by Subject|9|||
162692438|NCT00154310|587586035|FG001|Overall Study|Withdrawal by Subject|3|||
162692439|NCT00154310|587586034|FG000|Overall Study|Lost to Follow-up|0|||
162692440|NCT00154310|587586035|FG001|Overall Study|Lost to Follow-up|8|||
162692441|NCT00154310|587586034|FG000|Overall Study|Administrative problems|0|||
162692442|NCT00154310|587586035|FG001|Overall Study|Administrative problems|1|||
162692443|NCT00154310|587586034|FG000|Overall Study|Death|0|||
162692444|NCT00154310|587586035|FG001|Overall Study|Death|1|||
162692445|NCT02086162|587586037|FG000|Overall Study|Withdrawal by Subject|4|||
162692446|NCT02086162|587586038|FG001|Overall Study|Withdrawal by Subject|4|||
162692447|NCT02086162|587586037|FG000|Overall Study|moved|1|||
162692448|NCT02086162|587586038|FG001|Overall Study|moved|1|||
162692449|NCT02086162|587586037|FG000|Overall Study|Lost to Follow-up|4|||
162692450|NCT02086162|587586038|FG001|Overall Study|Lost to Follow-up|2|||
162692451|NCT02086162|587586037|FG000|Overall Study|Death|1|||
162692452|NCT02086162|587586038|FG001|Overall Study|Death|0|||
162692453|NCT03447730|587586039|FG000|Overall Study|Adverse Event|0|||
162692454|NCT03447730|587586040|FG001|Overall Study|Adverse Event|2|||
162692455|NCT03447730|587586041|FG002|Overall Study|Adverse Event|0|||
162692456|NCT01248962|587586045|FG000|Overall Study|Withdrawal by Subject|1|||
162692457|NCT01248962|587586046|FG001|Overall Study|Withdrawal by Subject|1|||
162692458|NCT01248962|587586045|FG000|Overall Study|Adverse Event|2|||
162692459|NCT01248962|587586046|FG001|Overall Study|Adverse Event|1|||
162692460|NCT01248962|587586045|FG000|Overall Study|Complete Response after 4 Cycles|1|||
162692461|NCT01248962|587586046|FG001|Overall Study|Complete Response after 4 Cycles|0|||
162692462|NCT01248962|587586045|FG000|Overall Study|Complete Response after 3 Cycles|0|||
162692463|NCT01248962|587586046|FG001|Overall Study|Complete Response after 3 Cycles|1|||
162692464|NCT01248962|587586045|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
162692465|NCT01248962|587586046|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
162692466|NCT04848662|587586048|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
162692467|NCT04848662|587586049|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
162692468|NCT01350505|587586050|FG000|Overall Study|Lost to Follow-up|4|||
162692469|NCT01834222|587586051|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
162692470|NCT04702568|587586052|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
162692471|NCT04702568|587586053|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
162692472|NCT04702568|587586052|FG000|Overall Study|Pregnancy|1|||
162692473|NCT04702568|587586053|FG001|Overall Study|Pregnancy|0|||
162692474|NCT04702568|587586052|FG000|Overall Study|Bone marrow transplant|1|||
162692475|NCT04702568|587586053|FG001|Overall Study|Bone marrow transplant|0|||
162692476|NCT04702568|587586052|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
162692477|NCT04702568|587586053|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
162692478|NCT04702568|587586052|FG000|Overall Study|Withdrawal by Subject|0|||
162692479|NCT04702568|587586053|FG001|Overall Study|Withdrawal by Subject|2|||
162692480|NCT00423852|587586056|FG000|Overall Study|Removed pior to the high-dose portion|3|||
162692481|NCT00308737|587586059|FG000|Overall Study|Adverse Event|104|||
162692482|NCT00308737|587586060|FG001|Overall Study|Adverse Event|9|||
162692483|NCT00308737|587586061|FG002|Overall Study|Adverse Event|0|||
162692484|NCT00308737|587586059|FG000|Overall Study|Death|4|||
162692485|NCT00308737|587586060|FG001|Overall Study|Death|3|||
162692486|NCT00308737|587586061|FG002|Overall Study|Death|0|||
162692487|NCT00308737|587586059|FG000|Overall Study|Lost to Follow-up|56|||
162692488|NCT00308737|587586060|FG001|Overall Study|Lost to Follow-up|80|||
162692489|NCT00308737|587586061|FG002|Overall Study|Lost to Follow-up|5|||
162692490|NCT00308737|587586059|FG000|Overall Study|Physician Decision|15|||
162692491|NCT00308737|587586060|FG001|Overall Study|Physician Decision|2|||
162692492|NCT00308737|587586061|FG002|Overall Study|Physician Decision|1|||
162729317|NCT01753570|587716635|FG001|Overall Study|Withdrawal by Subject|4|||
162729318|NCT01753570|587716636|FG002|Overall Study|Withdrawal by Subject|0|||
162692493|NCT00308737|587586059|FG000|Overall Study|Protocol Violation|34|||
162692494|NCT00308737|587586060|FG001|Overall Study|Protocol Violation|9|||
162692495|NCT00308737|587586061|FG002|Overall Study|Protocol Violation|5|||
162692496|NCT00308737|587586059|FG000|Overall Study|Withdrawal by Subject|218|||
162692497|NCT00308737|587586060|FG001|Overall Study|Withdrawal by Subject|166|||
162692498|NCT00308737|587586061|FG002|Overall Study|Withdrawal by Subject|18|||
162692499|NCT00308737|587586059|FG000|Overall Study|Various|32|||
162692500|NCT00308737|587586060|FG001|Overall Study|Various|20|||
162692501|NCT00308737|587586061|FG002|Overall Study|Various|8|||
162692502|NCT01225822|587586071|FG000|Overall Study|Adverse Event|13|||
162692503|NCT01225822|587586072|FG001|Overall Study|Adverse Event|31|||
162692504|NCT01225822|587586073|FG002|Overall Study|Adverse Event|18|||
162692505|NCT01225822|587586074|FG003|Overall Study|Adverse Event|23|||
162692506|NCT01225822|587586075|FG004|Overall Study|Adverse Event|14|||
162692507|NCT01225822|587586071|FG000|Overall Study|Protocol Violation|6|||
162692508|NCT01225822|587586072|FG001|Overall Study|Protocol Violation|8|||
162692509|NCT01225822|587586073|FG002|Overall Study|Protocol Violation|6|||
162692510|NCT01225822|587586074|FG003|Overall Study|Protocol Violation|7|||
162692511|NCT01225822|587586075|FG004|Overall Study|Protocol Violation|4|||
162692512|NCT01225822|587586071|FG000|Overall Study|Lost to Follow-up|0|||
162692513|NCT01225822|587586072|FG001|Overall Study|Lost to Follow-up|0|||
162692514|NCT01225822|587586073|FG002|Overall Study|Lost to Follow-up|0|||
162692515|NCT01225822|587586074|FG003|Overall Study|Lost to Follow-up|1|||
162692516|NCT01225822|587586075|FG004|Overall Study|Lost to Follow-up|0|||
162692517|NCT01225822|587586071|FG000|Overall Study|Withdrawal by Subject|6|||
162692518|NCT01225822|587586072|FG001|Overall Study|Withdrawal by Subject|7|||
162692519|NCT01225822|587586073|FG002|Overall Study|Withdrawal by Subject|7|||
162692520|NCT01225822|587586074|FG003|Overall Study|Withdrawal by Subject|11|||
162692521|NCT01225822|587586075|FG004|Overall Study|Withdrawal by Subject|6|||
162692522|NCT01225822|587586071|FG000|Overall Study|Other|13|||
162692523|NCT01225822|587586072|FG001|Overall Study|Other|10|||
162692524|NCT01225822|587586073|FG002|Overall Study|Other|7|||
162692525|NCT01225822|587586074|FG003|Overall Study|Other|10|||
162692526|NCT01225822|587586075|FG004|Overall Study|Other|7|||
162692527|NCT00089895|587586076|FG000|Overall Study|Consent Withdrawn|11|||
162692528|NCT00089895|587586077|FG001|Overall Study|Consent Withdrawn|14|||
162692529|NCT00089895|587586076|FG000|Overall Study|Technical reason|7|||
162692530|NCT00089895|587586077|FG001|Overall Study|Technical reason|2|||
162692531|NCT00089895|587586076|FG000|Overall Study|Surgery|0|||
162692532|NCT00089895|587586077|FG001|Overall Study|Surgery|1|||
162692533|NCT00089895|587586076|FG000|Overall Study|Bleeding|0|||
162692534|NCT00089895|587586077|FG001|Overall Study|Bleeding|2|||
162692535|NCT00089895|587586076|FG000|Overall Study|Physician Decision|3|||
162692536|NCT00089895|587586077|FG001|Overall Study|Physician Decision|7|||
162692537|NCT00089895|587586076|FG000|Overall Study|Exclusion criteria met|6|||
162692538|NCT00089895|587586077|FG001|Overall Study|Exclusion criteria met|6|||
162692539|NCT00089895|587586076|FG000|Overall Study|Not otherwise specified|4|||
162692540|NCT00089895|587586077|FG001|Overall Study|Not otherwise specified|8|||
162692541|NCT00089895|587586076|FG000|Overall Study|Missing|4|||
162692542|NCT00089895|587586077|FG001|Overall Study|Missing|2|||
162692543|NCT05644353|587586078|FG000|Overall Study|Physician Decision|1|||
162692544|NCT05644353|587586079|FG001|Overall Study|Physician Decision|0|||
162692545|NCT05644353|587586080|FG002|Overall Study|Physician Decision|0|||
162692546|NCT05644353|587586081|FG003|Overall Study|Physician Decision|0|||
162692547|NCT05644353|587586082|FG004|Overall Study|Physician Decision|0|||
162692548|NCT05644353|587586083|FG005|Overall Study|Physician Decision|0|||
162729319|NCT05308316|587716637|FG000|Overall Study|Withdrawal by Subject|2|||
162729320|NCT05308316|587716637|FG000|Overall Study|Physician Decision|1|||
162729321|NCT03997916|587716641|FG000|Overall Study|Protocol Violation|35|||
162729322|NCT03671811|587716642|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
162729323|NCT03671811|587716643|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
162729324|NCT03584516|587718088|FG000|Part 1|Death|2|||
162729325|NCT03584516|587718089|FG001|Part 1|Death|3|||
162729326|NCT03584516|587718090|FG002|Part 1|Death|0|||
162729327|NCT03584516|587718091|FG003|Part 1|Death|0|||
162729328|NCT03584516|587718092|FG004|Part 1|Death|0|||
162729329|NCT03584516|587718093|FG005|Part 1|Death|0|||
162729330|NCT03584516|587718088|FG000|Part 1|Withdrawal by Subject|2|||
162729331|NCT03584516|587718089|FG001|Part 1|Withdrawal by Subject|0|||
162729332|NCT03584516|587718090|FG002|Part 1|Withdrawal by Subject|0|||
162729333|NCT03584516|587718091|FG003|Part 1|Withdrawal by Subject|0|||
162729334|NCT03584516|587718092|FG004|Part 1|Withdrawal by Subject|0|||
162729335|NCT03584516|587718093|FG005|Part 1|Withdrawal by Subject|0|||
162729336|NCT03584516|587718088|FG000|Part 1|Lost to Follow-up|1|||
162729337|NCT03584516|587718089|FG001|Part 1|Lost to Follow-up|0|||
162729338|NCT03584516|587718090|FG002|Part 1|Lost to Follow-up|0|||
162729339|NCT03584516|587718091|FG003|Part 1|Lost to Follow-up|0|||
162729340|NCT03584516|587718092|FG004|Part 1|Lost to Follow-up|0|||
162729341|NCT03584516|587718093|FG005|Part 1|Lost to Follow-up|0|||
162729342|NCT03584516|587718088|FG000|Part 1|Study Terminated by Sponsor|0|||
162729343|NCT03584516|587718089|FG001|Part 1|Study Terminated by Sponsor|2|||
162729344|NCT03584516|587718090|FG002|Part 1|Study Terminated by Sponsor|0|||
162729345|NCT03584516|587718091|FG003|Part 1|Study Terminated by Sponsor|0|||
162729346|NCT03584516|587718092|FG004|Part 1|Study Terminated by Sponsor|0|||
162729347|NCT03584516|587718093|FG005|Part 1|Study Terminated by Sponsor|0|||
162729348|NCT03584516|587718088|FG000|Part 1 Expansion|Death|0|||
162729349|NCT03584516|587718089|FG001|Part 1 Expansion|Death|0|||
162729350|NCT03584516|587718090|FG002|Part 1 Expansion|Death|9|||
162729351|NCT03584516|587718091|FG003|Part 1 Expansion|Death|8|||
162729352|NCT03584516|587718092|FG004|Part 1 Expansion|Death|4|||
162729353|NCT03584516|587718093|FG005|Part 1 Expansion|Death|5|||
162729354|NCT03584516|587718088|FG000|Part 1 Expansion|Lost to Follow-up|0|||
162729355|NCT03584516|587718089|FG001|Part 1 Expansion|Lost to Follow-up|0|||
162729356|NCT03584516|587718090|FG002|Part 1 Expansion|Lost to Follow-up|0|||
162729357|NCT03584516|587718091|FG003|Part 1 Expansion|Lost to Follow-up|1|||
162729358|NCT03584516|587718092|FG004|Part 1 Expansion|Lost to Follow-up|0|||
162729359|NCT03584516|587718093|FG005|Part 1 Expansion|Lost to Follow-up|0|||
162729360|NCT03584516|587718088|FG000|Part 1 Expansion|Physician Decision|0|||
162729361|NCT03584516|587718089|FG001|Part 1 Expansion|Physician Decision|0|||
162729362|NCT03584516|587718090|FG002|Part 1 Expansion|Physician Decision|4|||
162729363|NCT03584516|587718091|FG003|Part 1 Expansion|Physician Decision|3|||
162729364|NCT03584516|587718092|FG004|Part 1 Expansion|Physician Decision|2|||
162729365|NCT03584516|587718093|FG005|Part 1 Expansion|Physician Decision|3|||
162729366|NCT03584516|587718088|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
162729367|NCT03584516|587718089|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
162729368|NCT03584516|587718090|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
162729369|NCT03584516|587718091|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
162729370|NCT03584516|587718092|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
162729371|NCT03584516|587718093|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
162729372|NCT03584516|587718088|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
162729373|NCT03584516|587718089|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
162729374|NCT03584516|587718090|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
162729375|NCT03584516|587718091|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
162729376|NCT03584516|587718092|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
162729377|NCT03584516|587718093|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
162729378|NCT03584516|587718088|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162729379|NCT03584516|587718089|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162729380|NCT03584516|587718090|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162729381|NCT03584516|587718091|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
162729382|NCT03584516|587718092|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162729383|NCT03584516|587718093|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162729384|NCT03584516|587718088|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162729385|NCT03584516|587718089|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162729386|NCT03584516|587718090|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162729387|NCT03584516|587718091|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162729388|NCT03584516|587718092|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162729389|NCT03584516|587718093|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
162729390|NCT05846646|587718095|FG000|Overall Study|Physician Decision|1|||
162729391|NCT05846646|587718096|FG001|Overall Study|Physician Decision|0|||
162729392|NCT05846646|587718097|FG002|Overall Study|Physician Decision|0|||
162729393|NCT05846646|587718095|FG000|Overall Study|Lack of Efficacy|1|||
162692549|NCT05644353|587586078|FG000|Overall Study|Protocol Violation|1|||
162692550|NCT05644353|587586079|FG001|Overall Study|Protocol Violation|0|||
162692551|NCT05644353|587586080|FG002|Overall Study|Protocol Violation|0|||
162692552|NCT05644353|587586081|FG003|Overall Study|Protocol Violation|0|||
162692553|NCT05644353|587586082|FG004|Overall Study|Protocol Violation|0|||
162692554|NCT05644353|587586083|FG005|Overall Study|Protocol Violation|0|||
162692555|NCT05644353|587586078|FG000|Overall Study|Withdrawal by Subject|0|||
162692556|NCT05644353|587586079|FG001|Overall Study|Withdrawal by Subject|2|||
162692557|NCT05644353|587586080|FG002|Overall Study|Withdrawal by Subject|0|||
162692558|NCT05644353|587586081|FG003|Overall Study|Withdrawal by Subject|0|||
162692559|NCT05644353|587586082|FG004|Overall Study|Withdrawal by Subject|1|||
162692560|NCT05644353|587586083|FG005|Overall Study|Withdrawal by Subject|0|||
162692561|NCT05644353|587586078|FG000|Overall Study|Lost to Follow-up|0|||
162692562|NCT05644353|587586079|FG001|Overall Study|Lost to Follow-up|0|||
162692563|NCT05644353|587586080|FG002|Overall Study|Lost to Follow-up|1|||
162692564|NCT05644353|587586081|FG003|Overall Study|Lost to Follow-up|0|||
162692565|NCT05644353|587586082|FG004|Overall Study|Lost to Follow-up|0|||
162692566|NCT05644353|587586083|FG005|Overall Study|Lost to Follow-up|0|||
162692567|NCT01535274|587586084|FG000|Overall Study|Determined to be ineligible|0|||
162692568|NCT01535274|587586085|FG001|Overall Study|Determined to be ineligible|1|||
162692569|NCT01535274|587586084|FG000|Overall Study|Misallocated to propofol intervention|0|||
162692570|NCT01535274|587586085|FG001|Overall Study|Misallocated to propofol intervention|1|||
162692571|NCT02954458|587586088|FG000|Overall Study|Adverse Event|0|||
162692572|NCT02954458|587586089|FG001|Overall Study|Adverse Event|0|||
162692573|NCT02954458|587586090|FG002|Overall Study|Adverse Event|0|||
162692574|NCT02954458|587586091|FG003|Overall Study|Adverse Event|1|||
162692575|NCT02954458|587586088|FG000|Overall Study|Withdrawal by Subject|0|||
162692576|NCT02954458|587586089|FG001|Overall Study|Withdrawal by Subject|0|||
162692577|NCT02954458|587586090|FG002|Overall Study|Withdrawal by Subject|0|||
162692578|NCT02954458|587586091|FG003|Overall Study|Withdrawal by Subject|1|||
162692579|NCT02954458|587586088|FG000|Overall Study|Physician Decision|0|||
162692580|NCT02954458|587586089|FG001|Overall Study|Physician Decision|0|||
162692581|NCT02954458|587586090|FG002|Overall Study|Physician Decision|1|||
162692582|NCT02954458|587586091|FG003|Overall Study|Physician Decision|1|||
162692583|NCT02954458|587586088|FG000|Overall Study|Lost to Follow-up|1|||
162692584|NCT02954458|587586089|FG001|Overall Study|Lost to Follow-up|0|||
162692585|NCT02954458|587586090|FG002|Overall Study|Lost to Follow-up|0|||
162692586|NCT02954458|587586091|FG003|Overall Study|Lost to Follow-up|1|||
162692587|NCT02954458|587586088|FG000|Overall Study|Death|0|||
162692588|NCT02954458|587586089|FG001|Overall Study|Death|0|||
162692589|NCT02954458|587586090|FG002|Overall Study|Death|0|||
162692590|NCT02954458|587586091|FG003|Overall Study|Death|1|||
162692591|NCT02954458|587586088|FG000|Overall Study|Other|0|||
162692592|NCT02954458|587586089|FG001|Overall Study|Other|0|||
162692593|NCT02954458|587586090|FG002|Overall Study|Other|0|||
162692594|NCT02954458|587586091|FG003|Overall Study|Other|7|||
162692595|NCT02690077|587586094|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
162692596|NCT02690077|587586095|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
162692597|NCT02690077|587586094|FG000|Overall Study|Withdrawal by Subject|0|||
162692598|NCT02690077|587586095|FG001|Overall Study|Withdrawal by Subject|5|||
162692599|NCT02690077|587586094|FG000|Overall Study|Excluded by IRB|0|||
162692600|NCT02690077|587586095|FG001|Overall Study|Excluded by IRB|2|||
162692601|NCT01845974|587586096|FG000|Overall Study|screen failure|1|||
162729394|NCT05846646|587718096|FG001|Overall Study|Lack of Efficacy|1|||
162729395|NCT05846646|587718097|FG002|Overall Study|Lack of Efficacy|0|||
162729396|NCT05846646|587718095|FG000|Overall Study|Early Study Termination|1|||
162692602|NCT01845974|587586097|FG001|Overall Study|screen failure|0|||
162692603|NCT02667886|587586098|FG000|Dose Escalation (Part A)|Adverse Event|1|||
162692604|NCT02667886|587586099|FG001|Dose Escalation (Part A)|Adverse Event|3|||
162692605|NCT02667886|587586100|FG002|Dose Escalation (Part A)|Adverse Event|1|||
162692606|NCT02667886|587586101|FG003|Dose Escalation (Part A)|Adverse Event|0|||
162692607|NCT02667886|587586102|FG004|Dose Escalation (Part A)|Adverse Event|0|||
162692608|NCT02667886|587586098|FG000|Dose Escalation (Part A)|Disease Progression|1|||
162692609|NCT02667886|587586099|FG001|Dose Escalation (Part A)|Disease Progression|4|||
162692610|NCT02667886|587586100|FG002|Dose Escalation (Part A)|Disease Progression|3|||
162692611|NCT02667886|587586101|FG003|Dose Escalation (Part A)|Disease Progression|0|||
162692612|NCT02667886|587586102|FG004|Dose Escalation (Part A)|Disease Progression|0|||
162692613|NCT02667886|587586098|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162692614|NCT02667886|587586099|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162692615|NCT02667886|587586100|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
162692616|NCT02667886|587586101|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162729397|NCT05846646|587718096|FG001|Overall Study|Early Study Termination|2|||
162692617|NCT02667886|587586102|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162692618|NCT02667886|587586098|FG000|Dose Expansion (Part B)|Adverse Event|0|||
162692619|NCT02667886|587586099|FG001|Dose Expansion (Part B)|Adverse Event|0|||
162692620|NCT02667886|587586100|FG002|Dose Expansion (Part B)|Adverse Event|0|||
162729398|NCT05846646|587718097|FG002|Overall Study|Early Study Termination|0|||
162729399|NCT01443845|587718103|FG000|Overall Study|Protocol Violation|43|||
162729400|NCT01443845|587718104|FG001|Overall Study|Protocol Violation|45|||
162729401|NCT01443845|587718103|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
162729402|NCT01443845|587718104|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
162729403|NCT01443845|587718103|FG000|Overall Study|Deterioration in pulmonary function|1|||
162729404|NCT01443845|587718104|FG001|Overall Study|Deterioration in pulmonary function|4|||
162729405|NCT01443845|587718103|FG000|Overall Study|Lack of Efficacy|10|||
162729406|NCT01443845|587718104|FG001|Overall Study|Lack of Efficacy|5|||
162729407|NCT01443845|587718103|FG000|Overall Study|Adverse Event|64|||
162729408|NCT01443845|587718104|FG001|Overall Study|Adverse Event|138|||
162729409|NCT01443845|587718103|FG000|Overall Study|Withdrawal by Subject|63|||
162729410|NCT01443845|587718104|FG001|Overall Study|Withdrawal by Subject|67|||
162729411|NCT01443845|587718103|FG000|Overall Study|Military Conflict - Site Terminated|20|||
162729412|NCT01443845|587718104|FG001|Overall Study|Military Conflict - Site Terminated|21|||
162729413|NCT01443845|587718103|FG000|Overall Study|Lost to Follow-up|9|||
162729414|NCT01443845|587718104|FG001|Overall Study|Lost to Follow-up|13|||
162729415|NCT01471691|587718105|FG000|Overall Study|Lack of Efficacy|0|||
162729416|NCT01471691|587718106|FG001|Overall Study|Lack of Efficacy|1|||
162729417|NCT01808339|587718107|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729418|NCT01808339|587718108|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729419|NCT01808339|587718109|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729420|NCT01808339|587718110|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162729421|NCT01808339|587718111|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
162729422|NCT01808339|587718112|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162729423|NCT01808339|587718107|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162729424|NCT01808339|587718108|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162729425|NCT01808339|587718109|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162729426|NCT01808339|587718110|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162729427|NCT01808339|587718111|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162729428|NCT01808339|587718112|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162729429|NCT01808339|587718107|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729430|NCT01808339|587718108|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729431|NCT01808339|587718109|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162729432|NCT01808339|587718110|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729433|NCT01808339|587718111|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729434|NCT01808339|587718112|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162729435|NCT02461628|587718113|FG000|Overall Study|Refused to complete survey|4|||
162729436|NCT02461628|587718114|FG001|Overall Study|Refused to complete survey|7|||
162729437|NCT02462759|587718116|FG000|Part 1: Double Blind|Death|1|||
162729438|NCT02462759|587718117|FG001|Part 1: Double Blind|Death|0|||
162729439|NCT02462759|587718118|FG002|Part 1: Double Blind|Death|0|||
162729440|NCT02088853|587718119|FG000|Overall Study|Pregnancy|1|||
162729441|NCT02088853|587718120|FG001|Overall Study|Pregnancy|0|||
162729442|NCT04704284|587718126|FG000|Overall Study|Withdrawal by Subject|1|||
162729443|NCT03930420|587718137|FG000|Overall Study|Withdrawal by Subject|7|||
162729444|NCT03930420|587718138|FG001|Overall Study|Withdrawal by Subject|9|||
162729445|NCT00609336|587718139|FG000|Overall Study|Protocol Violation|3|||
162729446|NCT00609336|587718139|FG000|Overall Study|Death|1|||
162729447|NCT00609336|587718139|FG000|Overall Study|LA or Met at Surgery|9|||
162729448|NCT00567489|587718140|FG000|Overall Study|Adverse Event|6|||
162729449|NCT00567489|587718141|FG001|Overall Study|Adverse Event|14|||
162729450|NCT00567489|587718140|FG000|Overall Study|Physician Decision|0|||
162729451|NCT00567489|587718141|FG001|Overall Study|Physician Decision|4|||
162729452|NCT00567489|587718140|FG000|Overall Study|Withdrawal by Subject|0|||
162729453|NCT00567489|587718141|FG001|Overall Study|Withdrawal by Subject|2|||
162692621|NCT02667886|587586101|FG003|Dose Expansion (Part B)|Adverse Event|9|||
162692622|NCT02667886|587586102|FG004|Dose Expansion (Part B)|Adverse Event|0|||
162692623|NCT02667886|587586098|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
162692624|NCT02667886|587586099|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
162692625|NCT02667886|587586100|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
162692626|NCT02667886|587586101|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
162692627|NCT02667886|587586102|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
162692628|NCT02667886|587586098|FG000|Dose Expansion (Part B)|Disease Progression|0|||
162729454|NCT00567489|587718140|FG000|Overall Study|Renal Transplantation|0|||
162729455|NCT00567489|587718141|FG001|Overall Study|Renal Transplantation|3|||
162692629|NCT02667886|587586099|FG001|Dose Expansion (Part B)|Disease Progression|0|||
162729456|NCT00567489|587718140|FG000|Overall Study|Other|1|||
162729457|NCT00567489|587718141|FG001|Overall Study|Other|0|||
162729458|NCT00419341|587718147|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
162692630|NCT02667886|587586100|FG002|Dose Expansion (Part B)|Disease Progression|0|||
162729459|NCT00419341|587718147|FG000|Wash in/Wash Out Period|Adverse Event|2|||
162729460|NCT00419341|587718147|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
162729461|NCT00419341|587718147|FG000|Efficacy Period|Withdrawal by Subject|6|||
162729462|NCT00419341|587718147|FG000|Efficacy Period|Protocol Violation|1|||
162692631|NCT02667886|587586101|FG003|Dose Expansion (Part B)|Disease Progression|38|||
162692632|NCT02667886|587586102|FG004|Dose Expansion (Part B)|Disease Progression|0|||
162692633|NCT02667886|587586098|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162692634|NCT02667886|587586099|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162692635|NCT02667886|587586100|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162692636|NCT02667886|587586101|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
162692637|NCT02667886|587586102|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162692638|NCT02667886|587586098|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162692639|NCT02667886|587586099|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162692640|NCT02667886|587586100|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162692641|NCT02667886|587586101|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162692642|NCT02667886|587586102|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
162692643|NCT02667886|587586098|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
162692644|NCT02667886|587586099|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
162692645|NCT02667886|587586100|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
162692646|NCT02667886|587586101|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
162692647|NCT02667886|587586102|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
162692648|NCT01905046|587586103|FG000|Months 13-24|Withdrawal by Subject|10|||
162729463|NCT00419341|587718147|FG000|Efficacy Period|Lost to Follow-up|1|||
162729464|NCT00419341|587718147|FG000|Efficacy Period|Non-compliance|1|||
162729465|NCT00419341|587718147|FG000|Efficacy Period|Termination of study site|1|||
162729466|NCT00331136|587718148|FG000|Overall Study|Adverse Event|3|||
162729467|NCT00331136|587718149|FG001|Overall Study|Adverse Event|5|||
162729468|NCT00331136|587718150|FG002|Overall Study|Adverse Event|0|||
162729469|NCT00331136|587718151|FG003|Overall Study|Adverse Event|1|||
162729470|NCT00331136|587718148|FG000|Overall Study|Withdrawal by Subject|0|||
162729471|NCT00331136|587718149|FG001|Overall Study|Withdrawal by Subject|1|||
162729472|NCT00331136|587718150|FG002|Overall Study|Withdrawal by Subject|0|||
162729473|NCT00331136|587718151|FG003|Overall Study|Withdrawal by Subject|0|||
162729474|NCT00331136|587718148|FG000|Overall Study|Lost to Follow-up|0|||
162729475|NCT00331136|587718149|FG001|Overall Study|Lost to Follow-up|1|||
162729476|NCT00331136|587718150|FG002|Overall Study|Lost to Follow-up|0|||
162729477|NCT00331136|587718151|FG003|Overall Study|Lost to Follow-up|0|||
162729478|NCT00331136|587718148|FG000|Overall Study|Protocol Violation|1|||
162729479|NCT00331136|587718149|FG001|Overall Study|Protocol Violation|0|||
162729480|NCT00331136|587718150|FG002|Overall Study|Protocol Violation|0|||
162729481|NCT00331136|587718151|FG003|Overall Study|Protocol Violation|0|||
162729482|NCT00331136|587718148|FG000|Overall Study|Not treated|1|||
162729483|NCT00331136|587718149|FG001|Overall Study|Not treated|0|||
162729484|NCT00331136|587718150|FG002|Overall Study|Not treated|0|||
162729485|NCT00331136|587718151|FG003|Overall Study|Not treated|0|||
162729486|NCT02692417|587718152|FG000|Overall Study|Withdrawal by Subject|5|||
162729487|NCT02692417|587718153|FG001|Overall Study|Withdrawal by Subject|1|||
162729488|NCT02692417|587718152|FG000|Overall Study|Adverse Event|1|||
162729489|NCT02692417|587718153|FG001|Overall Study|Adverse Event|0|||
162729490|NCT04690556|587718169|FG000|Overall Study|Adverse Event|6|||
162729491|NCT04690556|587718170|FG001|Overall Study|Adverse Event|4|||
162729492|NCT04690556|587718169|FG000|Overall Study|Death|3|||
162729493|NCT04690556|587718170|FG001|Overall Study|Death|4|||
162729494|NCT04690556|587718169|FG000|Overall Study|Lost to Follow-up|3|||
162729495|NCT04690556|587718170|FG001|Overall Study|Lost to Follow-up|2|||
162729496|NCT04690556|587718169|FG000|Overall Study|Protocol Violation|1|||
162729497|NCT04690556|587718170|FG001|Overall Study|Protocol Violation|4|||
162729498|NCT04690556|587718169|FG000|Overall Study|Physician Decision|2|||
162729499|NCT04690556|587718170|FG001|Overall Study|Physician Decision|0|||
162729500|NCT04690556|587718169|FG000|Overall Study|Withdrawal by Subject|25|||
162729501|NCT04690556|587718170|FG001|Overall Study|Withdrawal by Subject|17|||
162729502|NCT04690556|587718169|FG000|Overall Study|Prohibited medications and other reasons|3|||
162729503|NCT04690556|587718170|FG001|Overall Study|Prohibited medications and other reasons|1|||
162729504|NCT03891758|587718173|FG000|Overall Study|Adverse Event|2|||
162729505|NCT03891758|587718174|FG001|Overall Study|Adverse Event|0|||
162729506|NCT03891758|587718173|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162729507|NCT03891758|587718174|FG001|Overall Study|Withdrawal by parent/guardian|2|||
162729508|NCT04434729|587718177|FG000|Overall Study|Adverse Event|1|||
162692649|NCT01905046|587586104|FG001|Months 13-24|Withdrawal by Subject|10|||
162692650|NCT01905046|587586103|FG000|Months 13-24|Adverse Event|3|||
162729509|NCT04434729|587718177|FG000|Overall Study|Physician Decision|1|||
162729510|NCT00975819|587718178|FG000|Overall Study|Lack of Efficacy|8|||
162729511|NCT00975819|587718178|FG000|Overall Study|Adverse Event|2|||
162729512|NCT00975819|587718178|FG000|Overall Study|Physician Decision|2|||
162692651|NCT01905046|587586104|FG001|Months 13-24|Adverse Event|2|||
162692652|NCT01905046|587586103|FG000|Months 13-24|Protocol Violation|3|||
162692653|NCT01905046|587586104|FG001|Months 13-24|Protocol Violation|3|||
162692654|NCT01905046|587586103|FG000|Months 13-24|Physician Decision|1|||
162692655|NCT01905046|587586104|FG001|Months 13-24|Physician Decision|0|||
162692656|NCT05672680|587586105|FG000|Overall Study|Patient Did Not Complete the Form|5|||
162692657|NCT05672680|587586106|FG001|Overall Study|Patient Did Not Complete the Form|4|||
162692658|NCT05672680|587586105|FG000|Overall Study|Procedure Aborted|1|||
162692659|NCT05672680|587586106|FG001|Overall Study|Procedure Aborted|0|||
162692660|NCT03929562|587586107|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
162692661|NCT03929562|587586108|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
162692662|NCT03929562|587586107|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
162692663|NCT03929562|587586108|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
162692664|NCT03929562|587586107|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
162692665|NCT03929562|587586108|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
162692666|NCT02778399|587586117|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
162692667|NCT02778399|587586118|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
162692668|NCT02778399|587586119|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
162692669|NCT02778399|587586120|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
162692670|NCT02778399|587586121|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
162692671|NCT02778399|587586122|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
162692672|NCT02778399|587586117|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
162692673|NCT02778399|587586118|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
162692674|NCT02778399|587586119|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
162692675|NCT02778399|587586120|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
162692676|NCT02778399|587586121|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
162692677|NCT02778399|587586122|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
162692678|NCT02778399|587586117|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
162692679|NCT02778399|587586118|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
162692680|NCT02778399|587586119|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
162692681|NCT02778399|587586120|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
162692682|NCT02778399|587586121|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
162692683|NCT02778399|587586122|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
162692684|NCT02778399|587586117|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
162692685|NCT02778399|587586118|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162692686|NCT02778399|587586119|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162692687|NCT02778399|587586120|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162692688|NCT02778399|587586121|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162692689|NCT02778399|587586122|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
162692690|NCT02778399|587586117|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
162692691|NCT02778399|587586118|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
162692692|NCT02778399|587586119|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
162692693|NCT02778399|587586120|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
162692694|NCT02778399|587586121|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
162692695|NCT02778399|587586122|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
162692696|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162692697|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
162692698|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162692699|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
162692700|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
162692701|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162692702|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
162692703|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162692704|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
162692705|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
162692706|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162692707|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162692708|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162692709|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
162692710|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162692711|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162692712|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162692713|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162692714|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
162692715|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
162692716|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
162692717|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
162692718|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
162692719|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
162692720|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
162692721|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162692722|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
162692723|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162692724|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162692725|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162692726|NCT02778399|587586117|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162692727|NCT02778399|587586118|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162692728|NCT02778399|587586119|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162692729|NCT02778399|587586120|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162692730|NCT02778399|587586121|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162692731|NCT02778399|587586122|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162692732|NCT02978443|587586124|FG000|Overall Study|Withdrawal by Subject|1|||
162692733|NCT02978443|587586124|FG000|Overall Study|Adverse Event|3|||
162692734|NCT02978443|587586124|FG000|Overall Study|Disease Progression on study|6|||
162692735|NCT02978443|587586124|FG000|Overall Study|Death|1|||
162692736|NCT02978443|587586124|FG000|Overall Study|Physician Decision|1|||
162692737|NCT02978443|587586124|FG000|Overall Study|Switch to alternative therapy|1|||
162692738|NCT02978443|587586124|FG000|Overall Study|Refused further treatment|1|||
162692739|NCT00405639|587586125|FG000|Overall Study|Withdrawal by Subject|1|||
162692740|NCT00405639|587586126|FG001|Overall Study|Withdrawal by Subject|0|||
162692741|NCT00405639|587586125|FG000|Overall Study|Adverse Event|1|||
162692742|NCT00405639|587586126|FG001|Overall Study|Adverse Event|0|||
162692743|NCT00405639|587586125|FG000|Overall Study|Seizure prior to receiving BNP|1|||
162692744|NCT00405639|587586126|FG001|Overall Study|Seizure prior to receiving BNP|0|||
162692745|NCT00612534|587586130|FG000|Overall Study|Adverse Event|0|||
162692746|NCT00612534|587586131|FG001|Overall Study|Adverse Event|4|||
162692747|NCT00612534|587586132|FG002|Overall Study|Adverse Event|2|||
162692748|NCT00612534|587586133|FG003|Overall Study|Adverse Event|1|||
162692749|NCT00612534|587586130|FG000|Overall Study|Lack of Efficacy|13|||
162692750|NCT00612534|587586131|FG001|Overall Study|Lack of Efficacy|12|||
162692751|NCT00612534|587586132|FG002|Overall Study|Lack of Efficacy|5|||
162692752|NCT00612534|587586133|FG003|Overall Study|Lack of Efficacy|16|||
162692753|NCT00612534|587586130|FG000|Overall Study|Other Reason|0|||
162692754|NCT00612534|587586131|FG001|Overall Study|Other Reason|1|||
162692755|NCT00612534|587586132|FG002|Overall Study|Other Reason|0|||
162692756|NCT00612534|587586133|FG003|Overall Study|Other Reason|0|||
162692757|NCT02130284|587586140|FG000|Overall Study|Withdrawal by Subject|3|||
162692758|NCT02130284|587586140|FG000|Overall Study|Subject Withdrew Consent|1|||
162692759|NCT02130284|587586140|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
162692760|NCT02130284|587586140|FG000|Overall Study|Subject was screened as backup for study|3|||
162692761|NCT02130284|587586140|FG000|Overall Study|Screen Failure|1|||
162692762|NCT01852058|587586142|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
162692763|NCT01852058|587586143|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692764|NCT01852058|587586144|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692765|NCT01852058|587586145|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692766|NCT01852058|587586146|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692767|NCT01852058|587586147|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692768|NCT01852058|587586148|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692769|NCT01852058|587586149|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692770|NCT01852058|587586150|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692771|NCT01852058|587586151|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692772|NCT01852058|587586152|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692773|NCT01852058|587586153|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162692774|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692775|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692776|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692777|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692778|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
162692779|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692780|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692781|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692782|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692783|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692784|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692785|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162692786|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692787|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692788|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692789|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692790|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
162692791|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
162692792|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692793|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692794|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692795|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692796|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692797|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162692798|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692799|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692800|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692801|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692802|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
162692803|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692804|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692805|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692806|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692807|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692808|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692809|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162692810|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692811|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692812|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692813|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692814|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
162692815|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
162692816|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692817|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692818|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692819|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692820|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692821|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162692822|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692823|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692824|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692825|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
162692826|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692827|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692828|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692829|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692830|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692831|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692832|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692833|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162692834|NCT01852058|587586142|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692835|NCT01852058|587586143|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692836|NCT01852058|587586144|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692837|NCT01852058|587586145|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692838|NCT01852058|587586146|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
162692839|NCT01852058|587586147|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
162692840|NCT01852058|587586148|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692841|NCT01852058|587586149|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692842|NCT01852058|587586150|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692843|NCT01852058|587586151|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692844|NCT01852058|587586152|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692845|NCT01852058|587586153|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162692846|NCT01852058|587586142|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692847|NCT01852058|587586143|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692848|NCT01852058|587586144|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692849|NCT01852058|587586145|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692850|NCT01852058|587586146|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692851|NCT01852058|587586147|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692852|NCT01852058|587586148|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692853|NCT01852058|587586149|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
162692854|NCT01852058|587586150|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692855|NCT01852058|587586151|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692856|NCT01852058|587586152|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692857|NCT01852058|587586153|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162692858|NCT01852058|587586142|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692859|NCT01852058|587586143|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692860|NCT01852058|587586144|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692861|NCT01852058|587586145|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692862|NCT01852058|587586146|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692863|NCT01852058|587586147|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692864|NCT01852058|587586148|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692865|NCT01852058|587586149|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692866|NCT01852058|587586150|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
162692867|NCT01852058|587586151|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692868|NCT01852058|587586152|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692869|NCT01852058|587586153|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162692870|NCT01279343|587586154|FG000|Overall Study|Did not receive treatment|2|||
162692871|NCT01279343|587586155|FG001|Overall Study|Did not receive treatment|6|||
162692872|NCT03287414|587586156|FG000|Treatment Epoch|Adverse Event|0|||
162692873|NCT03287414|587586157|FG001|Treatment Epoch|Adverse Event|1|||
162692874|NCT03287414|587586156|FG000|Treatment Epoch|Study terminated by sponsor|2|||
162692875|NCT03287414|587586157|FG001|Treatment Epoch|Study terminated by sponsor|2|||
162692876|NCT03287414|587586156|FG000|Treatment Epoch|Subject/Guardian decision|4|||
162692877|NCT03287414|587586157|FG001|Treatment Epoch|Subject/Guardian decision|0|||
162692878|NCT03287414|587586156|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
162692879|NCT03287414|587586157|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
162692880|NCT03287414|587586156|FG000|Treatment Epoch|Withdrawal by Subject|1|||
162692881|NCT03287414|587586157|FG001|Treatment Epoch|Withdrawal by Subject|0|||
162692882|NCT03287414|587586156|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
162692883|NCT03287414|587586157|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
162692884|NCT03287414|587586156|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
162692885|NCT03287414|587586157|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
162692886|NCT01353222|587586162|FG000|Overall Study|Death|30|||
162692887|NCT01353222|587586163|FG001|Overall Study|Death|30|||
162692888|NCT01353222|587586162|FG000|Overall Study|Withdrawal by Subject|8|||
162692889|NCT01353222|587586163|FG001|Overall Study|Withdrawal by Subject|5|||
162692890|NCT01353222|587586162|FG000|Overall Study|Study Terminated|31|||
162692891|NCT01353222|587586163|FG001|Overall Study|Study Terminated|37|||
162692892|NCT01353222|587586162|FG000|Overall Study|Site closed research department|1|||
162692893|NCT01353222|587586163|FG001|Overall Study|Site closed research department|0|||
162692894|NCT02669095|587586164|FG000|Overall Study|Adverse Event|1|||
162692895|NCT02669095|587586165|FG001|Overall Study|Adverse Event|0|||
162692896|NCT02669095|587586164|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162692897|NCT02669095|587586165|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162692898|NCT02669095|587586164|FG000|Overall Study|Torn Lens|0|||
162692899|NCT02669095|587586165|FG001|Overall Study|Torn Lens|1|||
162692900|NCT02669095|587586164|FG000|Overall Study|Visit 5 assessments not completed|0|||
162692901|NCT02669095|587586165|FG001|Overall Study|Visit 5 assessments not completed|1|||
162692902|NCT00738101|587586167|FG000|Overall Study|Physician Decision|5|||
162692903|NCT00738101|587586167|FG000|Overall Study|Death|1|||
162692904|NCT00738101|587586167|FG000|Overall Study|Repeat enrollment|1|||
162692905|NCT01396317|587586169|FG000|Overall Study|Adverse Event|1|||
162692906|NCT01396317|587586170|FG001|Overall Study|Adverse Event|0|||
162692907|NCT00663117|587587999|FG000|Overall Study|Lack of Efficacy|1|||
162692908|NCT00663117|587588000|FG001|Overall Study|Lack of Efficacy|0|||
162692909|NCT02781506|587588001|FG000|Overall Study|Adverse Event|5|||
162692910|NCT02593539|587588002|FG000|Overall Study|Adverse Event|1|||
162692911|NCT00437125|587588005|FG000|Overall Study|Adverse Event|12|||
162692912|NCT00437125|587588005|FG000|Overall Study|Death|1|||
162729513|NCT00975819|587718178|FG000|Overall Study|Withdrawal by Subject|2|||
162729514|NCT00975819|587718178|FG000|Overall Study|Protocol Violation|1|||
162729515|NCT01968109|587718179|FG000|Overall Study|DISEASE PROGRESSION|4|||
162692913|NCT00437125|587588005|FG000|Overall Study|Clinical Relapse|1|||
162692914|NCT00437125|587588005|FG000|Overall Study|Lack of Efficacy|1|||
162692915|NCT00437125|587588005|FG000|Overall Study|Lost to Follow-up|1|||
162692916|NCT00437125|587588005|FG000|Overall Study|Withdrawal by Subject|13|||
162692917|NCT00437125|587588005|FG000|Overall Study|Withdrawal by Caregiver|2|||
162692918|NCT00437125|587588005|FG000|Overall Study|Physician Decision|1|||
162692919|NCT02248961|587588006|FG000|Overall Study|Adverse Event|1|||
162692920|NCT02248961|587588007|FG001|Overall Study|Adverse Event|0|||
162692921|NCT02248961|587588006|FG000|Overall Study|Withdrawal by Subject|1|||
162692922|NCT02248961|587588007|FG001|Overall Study|Withdrawal by Subject|2|||
162692923|NCT02248961|587588006|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
162692924|NCT02248961|587588007|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
162692925|NCT00244374|587588014|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
162692926|NCT00244374|587588015|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162692927|NCT00244374|587588016|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162692928|NCT00244374|587588017|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162692929|NCT00244374|587588018|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162692930|NCT00244374|587588014|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
162692931|NCT00244374|587588015|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162692932|NCT00244374|587588016|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162692933|NCT00244374|587588017|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162692934|NCT00244374|587588018|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162692935|NCT00244374|587588014|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
162692936|NCT00244374|587588015|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162692937|NCT00244374|587588016|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162692938|NCT00244374|587588017|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162692939|NCT00244374|587588018|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162692940|NCT00244374|587588014|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
162692941|NCT00244374|587588015|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162692942|NCT00244374|587588016|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162692943|NCT00244374|587588017|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162692944|NCT00244374|587588018|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162692945|NCT00244374|587588014|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
162692946|NCT00244374|587588015|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162692947|NCT00244374|587588016|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162692948|NCT00244374|587588017|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162692949|NCT00244374|587588018|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162692950|NCT00244374|587588014|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
162692951|NCT00244374|587588015|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162692952|NCT00244374|587588016|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162692953|NCT00244374|587588017|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162692954|NCT00244374|587588018|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162692955|NCT00244374|587588014|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
162692956|NCT00244374|587588015|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162692957|NCT00244374|587588016|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162692958|NCT00244374|587588017|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162692959|NCT00244374|587588018|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162692960|NCT00244374|587588014|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
162692961|NCT00244374|587588015|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162692962|NCT00244374|587588016|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162692963|NCT00244374|587588017|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162692964|NCT00244374|587588018|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162692965|NCT00244374|587588014|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
162692966|NCT00244374|587588015|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162692967|NCT00244374|587588016|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162692968|NCT00244374|587588017|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162692969|NCT00244374|587588018|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162692970|NCT03462706|587588020|FG000|Overall Study|Polyp was pedunculated|1|||
162692971|NCT03462706|587588021|FG001|Overall Study|Polyp was pedunculated|0|||
162692972|NCT03462706|587588022|FG002|Overall Study|Polyp was pedunculated|1|||
162692973|NCT03462706|587588023|FG003|Overall Study|Polyp was pedunculated|0|||
162692974|NCT03462706|587588020|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
162692975|NCT03462706|587588021|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
162692976|NCT03462706|587588022|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
162692977|NCT03462706|587588023|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
162729516|NCT01968109|587718180|FG001|Overall Study|DISEASE PROGRESSION|4|||
162729517|NCT01968109|587718181|FG002|Overall Study|DISEASE PROGRESSION|3|||
162692978|NCT03661996|587588039|FG000|Overall Study|Adverse Event|0|||
162692979|NCT03661996|587588040|FG001|Overall Study|Adverse Event|0|||
162692980|NCT03661996|587588041|FG002|Overall Study|Adverse Event|1|||
162692981|NCT03661996|587588042|FG003|Overall Study|Adverse Event|1|||
162692982|NCT03661996|587588043|FG004|Overall Study|Adverse Event|0|||
162692983|NCT03661996|587588039|FG000|Overall Study|Lost to Follow-up|5|||
162692984|NCT03661996|587588040|FG001|Overall Study|Lost to Follow-up|1|||
162692985|NCT03661996|587588041|FG002|Overall Study|Lost to Follow-up|2|||
162692986|NCT03661996|587588042|FG003|Overall Study|Lost to Follow-up|2|||
162692987|NCT03661996|587588043|FG004|Overall Study|Lost to Follow-up|6|||
162692988|NCT03661996|587588039|FG000|Overall Study|Physician Decision|1|||
162692989|NCT03661996|587588040|FG001|Overall Study|Physician Decision|1|||
162692990|NCT03661996|587588041|FG002|Overall Study|Physician Decision|1|||
162692991|NCT03661996|587588042|FG003|Overall Study|Physician Decision|2|||
162692992|NCT03661996|587588043|FG004|Overall Study|Physician Decision|0|||
162692993|NCT03661996|587588039|FG000|Overall Study|Protocol Violation|0|||
162692994|NCT03661996|587588040|FG001|Overall Study|Protocol Violation|0|||
162692995|NCT03661996|587588041|FG002|Overall Study|Protocol Violation|0|||
162692996|NCT03661996|587588042|FG003|Overall Study|Protocol Violation|0|||
162692997|NCT03661996|587588043|FG004|Overall Study|Protocol Violation|1|||
162692998|NCT03661996|587588039|FG000|Overall Study|Withdrawal by Subject|3|||
162692999|NCT03661996|587588040|FG001|Overall Study|Withdrawal by Subject|5|||
162693000|NCT03661996|587588041|FG002|Overall Study|Withdrawal by Subject|1|||
162693001|NCT03661996|587588042|FG003|Overall Study|Withdrawal by Subject|7|||
162693002|NCT03661996|587588043|FG004|Overall Study|Withdrawal by Subject|7|||
162693003|NCT03661996|587588039|FG000|Overall Study|Sponsors Decision|2|||
162693004|NCT03661996|587588040|FG001|Overall Study|Sponsors Decision|0|||
162693005|NCT03661996|587588041|FG002|Overall Study|Sponsors Decision|0|||
162693006|NCT03661996|587588042|FG003|Overall Study|Sponsors Decision|0|||
162693007|NCT03661996|587588043|FG004|Overall Study|Sponsors Decision|0|||
162693008|NCT03661996|587588039|FG000|Overall Study|Other|1|||
162693009|NCT03661996|587588040|FG001|Overall Study|Other|1|||
162693010|NCT03661996|587588041|FG002|Overall Study|Other|1|||
162693011|NCT03661996|587588042|FG003|Overall Study|Other|1|||
162693012|NCT03661996|587588043|FG004|Overall Study|Other|0|||
162693013|NCT03321513|587588044|FG000|Overall Study|Death|11|||
162693014|NCT03321513|587588045|FG001|Overall Study|Death|5|||
162693015|NCT03321513|587588044|FG000|Overall Study|Withdrawal by Subject|5|||
162693016|NCT03321513|587588045|FG001|Overall Study|Withdrawal by Subject|10|||
162693017|NCT03321513|587588044|FG000|Overall Study|Lost to Follow-up|10|||
162693018|NCT03321513|587588045|FG001|Overall Study|Lost to Follow-up|11|||
162693019|NCT01161472|587588046|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
162693020|NCT01161472|587588047|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162693021|NCT01161472|587588048|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162693022|NCT01161472|587588049|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162693023|NCT00791921|587588067|FG000|Overall Study|Protocol planed|24|||
162693024|NCT00791921|587588068|FG001|Overall Study|Protocol planed|88|||
162693025|NCT00791921|587588067|FG000|Overall Study|Withdrawal by Subject|1|||
162693026|NCT00791921|587588068|FG001|Overall Study|Withdrawal by Subject|2|||
162693027|NCT00791921|587588067|FG000|Overall Study|Adverse Event|8|||
162693028|NCT00791921|587588068|FG001|Overall Study|Adverse Event|2|||
162693029|NCT00791921|587588067|FG000|Overall Study|Lack of Efficacy|0|||
162693030|NCT00791921|587588068|FG001|Overall Study|Lack of Efficacy|2|||
162693031|NCT00791921|587588067|FG000|Overall Study|Lack of study drug administration|1|||
162693032|NCT00791921|587588068|FG001|Overall Study|Lack of study drug administration|1|||
162693033|NCT00791921|587588067|FG000|Overall Study|Reason other than those above|0|||
162693034|NCT00791921|587588068|FG001|Overall Study|Reason other than those above|1|||
162693035|NCT01965158|587588069|FG000|Overall Study|Adverse Event|14|||
162693036|NCT01965158|587588070|FG001|Overall Study|Adverse Event|5|||
162693037|NCT01965158|587588069|FG000|Overall Study|Withdrawal by Subject|16|||
162693038|NCT01965158|587588070|FG001|Overall Study|Withdrawal by Subject|24|||
162693039|NCT01965158|587588069|FG000|Overall Study|Lost to Follow-up|7|||
162693040|NCT01965158|587588070|FG001|Overall Study|Lost to Follow-up|5|||
162693041|NCT01965158|587588069|FG000|Overall Study|Protocol Violation|1|||
162693042|NCT01965158|587588070|FG001|Overall Study|Protocol Violation|1|||
162693043|NCT01965158|587588069|FG000|Overall Study|Other - Miscellaneous|3|||
162693044|NCT01965158|587588070|FG001|Overall Study|Other - Miscellaneous|0|||
162729518|NCT01968109|587718182|FG003|Overall Study|DISEASE PROGRESSION|9|||
162693045|NCT02912468|587588071|FG000|Overall Study|Adverse Event|3|||
162693046|NCT02912468|587588072|FG001|Overall Study|Adverse Event|2|||
162693047|NCT02912468|587588071|FG000|Overall Study|Withdrawal by Subject|6|||
162693048|NCT02912468|587588072|FG001|Overall Study|Withdrawal by Subject|2|||
162693049|NCT02912468|587588071|FG000|Overall Study|Randomized and not treated|0|||
162693050|NCT02912468|587588072|FG001|Overall Study|Randomized and not treated|1|||
162693051|NCT01515189|587588073|FG000|Induction|Disease Progression|109|||
162693052|NCT01515189|587588074|FG001|Induction|Disease Progression|155|||
162693053|NCT01515189|587588073|FG000|Induction|Study drug toxicity|86|||
162693054|NCT01515189|587588074|FG001|Induction|Study drug toxicity|36|||
162693055|NCT01515189|587588073|FG000|Induction|Death|24|||
162693056|NCT01515189|587588074|FG001|Induction|Death|17|||
162693057|NCT01515189|587588073|FG000|Induction|Adverse Event|14|||
162693058|NCT01515189|587588074|FG001|Induction|Adverse Event|9|||
162693059|NCT01515189|587588073|FG000|Induction|Withdrawal by Subject|3|||
162693060|NCT01515189|587588074|FG001|Induction|Withdrawal by Subject|9|||
162693061|NCT01515189|587588073|FG000|Induction|No longer meets study criteria|0|||
162693062|NCT01515189|587588074|FG001|Induction|No longer meets study criteria|2|||
162693063|NCT01515189|587588073|FG000|Induction|Lost to Follow-up|1|||
162693064|NCT01515189|587588074|FG001|Induction|Lost to Follow-up|0|||
162693065|NCT01515189|587588073|FG000|Induction|Other|0|||
162693066|NCT01515189|587588074|FG001|Induction|Other|4|||
162693067|NCT01515189|587588073|FG000|First Re-Induction Phase|Disease progression|6|||
162693068|NCT01515189|587588074|FG001|First Re-Induction Phase|Disease progression|14|||
162693069|NCT01515189|587588073|FG000|First Re-Induction Phase|Study drug toxicity|5|||
162693070|NCT01515189|587588074|FG001|First Re-Induction Phase|Study drug toxicity|0|||
162693071|NCT01515189|587588073|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
162693072|NCT01515189|587588074|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
162693073|NCT01515189|587588073|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
162693074|NCT01515189|587588074|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
162693075|NCT01515189|587588073|FG000|First Re-Induction Phase|Other|1|||
162693076|NCT01515189|587588074|FG001|First Re-Induction Phase|Other|0|||
162693077|NCT00284089|587588075|FG000|Multiple Dose Phase|Adverse Event|1|||
162693078|NCT00284089|587588076|FG001|Multiple Dose Phase|Adverse Event|0|||
162693079|NCT00284089|587588077|FG002|Multiple Dose Phase|Adverse Event|1|||
162693080|NCT00284089|587588078|FG003|Multiple Dose Phase|Adverse Event|1|||
162693081|NCT00284089|587588075|FG000|Multiple Dose Phase|Protocol Violation|0|||
162693082|NCT00284089|587588076|FG001|Multiple Dose Phase|Protocol Violation|0|||
162693083|NCT00284089|587588077|FG002|Multiple Dose Phase|Protocol Violation|1|||
162693084|NCT00284089|587588078|FG003|Multiple Dose Phase|Protocol Violation|0|||
162693085|NCT00284089|587588075|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
162693086|NCT00284089|587588076|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
162693087|NCT00284089|587588077|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
162693088|NCT00284089|587588078|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
162693089|NCT00284089|587588075|FG000|Multiple Dose Phase|Death|0|||
162693090|NCT00284089|587588076|FG001|Multiple Dose Phase|Death|0|||
162693091|NCT00284089|587588077|FG002|Multiple Dose Phase|Death|1|||
162693092|NCT00284089|587588078|FG003|Multiple Dose Phase|Death|1|||
162693093|NCT00284089|587588075|FG000|Extension Phase|Adverse Event|0|||
162693094|NCT00284089|587588076|FG001|Extension Phase|Adverse Event|0|||
162693095|NCT00284089|587588077|FG002|Extension Phase|Adverse Event|2|||
162693096|NCT00284089|587588078|FG003|Extension Phase|Adverse Event|2|||
162693097|NCT00284089|587588075|FG000|Extension Phase|condition no longer requires study drug|2|||
162693098|NCT00284089|587588076|FG001|Extension Phase|condition no longer requires study drug|0|||
162693099|NCT00284089|587588077|FG002|Extension Phase|condition no longer requires study drug|2|||
162693100|NCT00284089|587588078|FG003|Extension Phase|condition no longer requires study drug|7|||
162693101|NCT00284089|587588075|FG000|Extension Phase|Protocol Violation|0|||
162693102|NCT00284089|587588076|FG001|Extension Phase|Protocol Violation|0|||
162693103|NCT00284089|587588077|FG002|Extension Phase|Protocol Violation|1|||
162693104|NCT00284089|587588078|FG003|Extension Phase|Protocol Violation|0|||
162693105|NCT00284089|587588075|FG000|Extension Phase|Withdrawal by Subject|0|||
162693106|NCT00284089|587588076|FG001|Extension Phase|Withdrawal by Subject|0|||
162693107|NCT00284089|587588077|FG002|Extension Phase|Withdrawal by Subject|1|||
162693108|NCT00284089|587588078|FG003|Extension Phase|Withdrawal by Subject|3|||
162693109|NCT02541383|587588079|FG000|Overall Study|Death|50|||
162693110|NCT02541383|587588080|FG001|Overall Study|Death|37|||
162693111|NCT02541383|587588081|FG002|Overall Study|Death|48|||
162693112|NCT02541383|587588082|FG003|Overall Study|Death|41|||
162693113|NCT02541383|587588083|FG004|Overall Study|Death|21|||
162693114|NCT02541383|587588084|FG005|Overall Study|Death|25|||
162693115|NCT02541383|587588079|FG000|Overall Study|Lost to Follow-up|5|||
162693116|NCT02541383|587588080|FG001|Overall Study|Lost to Follow-up|3|||
162693117|NCT02541383|587588081|FG002|Overall Study|Lost to Follow-up|1|||
162693118|NCT02541383|587588082|FG003|Overall Study|Lost to Follow-up|1|||
162693119|NCT02541383|587588083|FG004|Overall Study|Lost to Follow-up|3|||
162693120|NCT02541383|587588084|FG005|Overall Study|Lost to Follow-up|0|||
162693121|NCT02541383|587588079|FG000|Overall Study|Consent withdrawn|5|||
162693122|NCT02541383|587588080|FG001|Overall Study|Consent withdrawn|6|||
162693123|NCT02541383|587588081|FG002|Overall Study|Consent withdrawn|1|||
162693124|NCT02541383|587588082|FG003|Overall Study|Consent withdrawn|1|||
162693125|NCT02541383|587588083|FG004|Overall Study|Consent withdrawn|0|||
162693126|NCT02541383|587588084|FG005|Overall Study|Consent withdrawn|0|||
162693127|NCT02541383|587588079|FG000|Overall Study|Sponsor's decision|1|||
162693128|NCT02541383|587588080|FG001|Overall Study|Sponsor's decision|1|||
162693129|NCT02541383|587588081|FG002|Overall Study|Sponsor's decision|0|||
162693130|NCT02541383|587588082|FG003|Overall Study|Sponsor's decision|0|||
162693131|NCT02541383|587588083|FG004|Overall Study|Sponsor's decision|0|||
162693132|NCT02541383|587588084|FG005|Overall Study|Sponsor's decision|0|||
162693133|NCT05796518|587588085|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
162693134|NCT00594217|587588086|FG000|Overall Study|Withdrawal by Subject|1|||
162693135|NCT00594217|587588087|FG001|Overall Study|Withdrawal by Subject|3|||
162693136|NCT05778526|587588090|FG000|Overall Study|Lost to Follow-up|0|||
162693137|NCT05778526|587588091|FG001|Overall Study|Lost to Follow-up|1|||
162693138|NCT05778526|587588092|FG002|Overall Study|Lost to Follow-up|3|||
162693139|NCT05778526|587588090|FG000|Overall Study|Protocol Violation|0|||
162693140|NCT05778526|587588091|FG001|Overall Study|Protocol Violation|0|||
162693141|NCT05778526|587588092|FG002|Overall Study|Protocol Violation|8|||
162693142|NCT03108157|587588095|FG000|Overall Study|Protocol Violation|15|||
162693143|NCT03108157|587588096|FG001|Overall Study|Protocol Violation|4|||
162693144|NCT01435655|587588097|FG000|Overall Study|Death|2|||
162693145|NCT01435655|587588097|FG000|Overall Study|Other|1|||
162693146|NCT02839343|587588100|FG000|Overall Study|Withdrawal by Subject|3|||
162693147|NCT02839343|587588101|FG001|Overall Study|Withdrawal by Subject|1|||
162693148|NCT02839343|587588100|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
162693149|NCT02839343|587588101|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
162693150|NCT02839343|587588100|FG000|Overall Study|Adverse Event|1|||
162693151|NCT02839343|587588101|FG001|Overall Study|Adverse Event|0|||
162693152|NCT02223754|587588102|FG000|Period 1|Adverse Event|1|||
162693153|NCT02223754|587588103|FG001|Period 1|Adverse Event|0|||
162693154|NCT02223754|587588102|FG000|Period 1|Lost to Follow-up|0|||
162693155|NCT02223754|587588103|FG001|Period 1|Lost to Follow-up|1|||
162693156|NCT02223754|587588102|FG000|Period 1|Protocol Violation|2|||
162693157|NCT02223754|587588103|FG001|Period 1|Protocol Violation|4|||
162693158|NCT02223754|587588102|FG000|Period 1|Withdrawal by Subject|0|||
162693159|NCT02223754|587588103|FG001|Period 1|Withdrawal by Subject|4|||
162693160|NCT02223754|587588102|FG000|Period 1|Test Article No Longer Available|1|||
162693161|NCT02223754|587588103|FG001|Period 1|Test Article No Longer Available|5|||
162693162|NCT02223754|587588102|FG000|Period 1|Unsatisfactory Visual Response|0|||
162693163|NCT02223754|587588103|FG001|Period 1|Unsatisfactory Visual Response|1|||
162693164|NCT02223754|587588102|FG000|Period 2|Adverse Event|0|||
162693165|NCT02223754|587588103|FG001|Period 2|Adverse Event|1|||
162693166|NCT02223754|587588102|FG000|Period 2|Protocol Violation|1|||
162693167|NCT02223754|587588103|FG001|Period 2|Protocol Violation|0|||
162693168|NCT02223754|587588102|FG000|Period 2|Lens Discomfort|1|||
162693169|NCT02223754|587588103|FG001|Period 2|Lens Discomfort|1|||
162693170|NCT02223754|587588102|FG000|Period 2|Lost to Follow-up|1|||
162693171|NCT02223754|587588103|FG001|Period 2|Lost to Follow-up|0|||
162693172|NCT02223754|587588102|FG000|Period 2|Test Article No Longer Available|0|||
162693173|NCT02223754|587588103|FG001|Period 2|Test Article No Longer Available|1|||
162693174|NCT04395183|587588105|FG000|Overall Study|Withdrawal by Subject|1|||
162693175|NCT04395183|587588106|FG001|Overall Study|Withdrawal by Subject|0|||
162693176|NCT04395183|587588107|FG002|Overall Study|Withdrawal by Subject|2|||
162693177|NCT04395183|587588108|FG003|Overall Study|Withdrawal by Subject|2|||
162693178|NCT02668016|587588109|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
162693179|NCT02668016|587588109|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
162693180|NCT02668016|587588109|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
162693181|NCT02668016|587588109|FG000|Month 4|Withdrawal due to severe symptoms|1|||
162693182|NCT02668016|587588109|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
162693183|NCT02668016|587588109|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
162693184|NCT02668016|587588109|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
162693185|NCT02668016|587588109|FG000|Month 6|Withdrawal due to severe symptoms|2|||
162693186|NCT02668016|587588109|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
162693187|NCT02668016|587588109|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
162693188|NCT02668016|587588109|FG000|Month 8|Withdrawal due to severe symptoms|1|||
162693189|NCT02668016|587588109|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
162693190|NCT02668016|587588109|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
162693191|NCT02668016|587588109|FG000|Month 10|Withdrawal due to severe symptoms|1|||
162693192|NCT02668016|587588109|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
162693193|NCT01122381|587588114|FG000|Overall Study|study terminated early|0|||
162693194|NCT01122381|587588115|FG001|Overall Study|study terminated early|1|||
162693195|NCT00736489|587588116|FG000|Period 1|Lost to Follow-up|1|||
162693196|NCT00736489|587588117|FG001|Period 1|Lost to Follow-up|0|||
162693197|NCT00736489|587588118|FG002|Period 1|Lost to Follow-up|0|||
162693198|NCT00736489|587588119|FG003|Period 1|Lost to Follow-up|0|||
162693199|NCT00736489|587588120|FG004|Period 1|Lost to Follow-up|0|||
162693200|NCT00736489|587588121|FG005|Period 1|Lost to Follow-up|0|||
162693201|NCT00736489|587588116|FG000|Period 1|Withdrawal by Subject|0|||
162693202|NCT00736489|587588117|FG001|Period 1|Withdrawal by Subject|0|||
162693203|NCT00736489|587588118|FG002|Period 1|Withdrawal by Subject|0|||
162693204|NCT00736489|587588119|FG003|Period 1|Withdrawal by Subject|0|||
162693205|NCT00736489|587588120|FG004|Period 1|Withdrawal by Subject|0|||
162693206|NCT00736489|587588121|FG005|Period 1|Withdrawal by Subject|1|||
162693207|NCT02395133|587588122|FG000|Overall Study|Adverse Event|4|||
162693208|NCT02395133|587588123|FG001|Overall Study|Adverse Event|1|||
162693209|NCT02395133|587588124|FG002|Overall Study|Adverse Event|3|||
162693210|NCT02395133|587588125|FG003|Overall Study|Adverse Event|0|||
162693211|NCT02395133|587588122|FG000|Overall Study|Lack of Efficacy|1|||
162693212|NCT02395133|587588123|FG001|Overall Study|Lack of Efficacy|0|||
162693213|NCT02395133|587588124|FG002|Overall Study|Lack of Efficacy|1|||
162693214|NCT02395133|587588125|FG003|Overall Study|Lack of Efficacy|1|||
162693215|NCT02395133|587588122|FG000|Overall Study|Protocol Violation|1|||
162693216|NCT02395133|587588123|FG001|Overall Study|Protocol Violation|1|||
162693217|NCT02395133|587588124|FG002|Overall Study|Protocol Violation|0|||
162693218|NCT02395133|587588125|FG003|Overall Study|Protocol Violation|3|||
162693219|NCT02395133|587588122|FG000|Overall Study|Lost to Follow-up|0|||
162693220|NCT02395133|587588123|FG001|Overall Study|Lost to Follow-up|1|||
162693221|NCT02395133|587588124|FG002|Overall Study|Lost to Follow-up|1|||
162693222|NCT02395133|587588125|FG003|Overall Study|Lost to Follow-up|0|||
162693223|NCT02395133|587588122|FG000|Overall Study|Pregnancy|0|||
162693224|NCT02395133|587588123|FG001|Overall Study|Pregnancy|0|||
162729519|NCT01968109|587718183|FG004|Overall Study|DISEASE PROGRESSION|5|||
162729520|NCT01968109|587718184|FG005|Overall Study|DISEASE PROGRESSION|6|||
162729521|NCT01968109|587718185|FG006|Overall Study|DISEASE PROGRESSION|6|||
162729522|NCT01968109|587718186|FG007|Overall Study|DISEASE PROGRESSION|6|||
162729523|NCT01968109|587718187|FG008|Overall Study|DISEASE PROGRESSION|4|||
162729524|NCT01968109|587718188|FG009|Overall Study|DISEASE PROGRESSION|5|||
162729525|NCT01968109|587718189|FG010|Overall Study|DISEASE PROGRESSION|8|||
162693225|NCT02395133|587588124|FG002|Overall Study|Pregnancy|3|||
162693226|NCT02395133|587588125|FG003|Overall Study|Pregnancy|0|||
162693227|NCT02395133|587588122|FG000|Overall Study|Consent withdrawn with no reason given|1|||
162693228|NCT02395133|587588123|FG001|Overall Study|Consent withdrawn with no reason given|3|||
162693229|NCT02395133|587588124|FG002|Overall Study|Consent withdrawn with no reason given|0|||
162693230|NCT02395133|587588125|FG003|Overall Study|Consent withdrawn with no reason given|2|||
162693231|NCT02395133|587588122|FG000|Overall Study|Consent withdrawn with personal reason|0|||
162693232|NCT02395133|587588123|FG001|Overall Study|Consent withdrawn with personal reason|1|||
162693233|NCT02395133|587588124|FG002|Overall Study|Consent withdrawn with personal reason|0|||
162693234|NCT02395133|587588125|FG003|Overall Study|Consent withdrawn with personal reason|3|||
162693235|NCT02395133|587588122|FG000|Overall Study|Sponsor decision|2|||
162693236|NCT02395133|587588123|FG001|Overall Study|Sponsor decision|0|||
162693237|NCT02395133|587588124|FG002|Overall Study|Sponsor decision|0|||
162693238|NCT02395133|587588125|FG003|Overall Study|Sponsor decision|1|||
162693239|NCT02395133|587588122|FG000|Overall Study|Other than specified above|5|||
162693240|NCT02395133|587588123|FG001|Overall Study|Other than specified above|2|||
162693241|NCT02395133|587588124|FG002|Overall Study|Other than specified above|2|||
162693242|NCT02395133|587588125|FG003|Overall Study|Other than specified above|4|||
162693243|NCT02234063|587588130|FG000|Overall Study|Lost to Follow-up|235|||
162693244|NCT02234063|587588131|FG001|Overall Study|Lost to Follow-up|42|||
162693245|NCT02234063|587588130|FG000|Overall Study|Withdrawal by Subject|20|||
162693246|NCT02234063|587588131|FG001|Overall Study|Withdrawal by Subject|1|||
162693247|NCT00510458|587588134|FG000|Overall Study|5 year not evaluable/missed|21|||
162693248|NCT00510458|587588134|FG000|Overall Study|Death|1|||
162693249|NCT00510458|587588134|FG000|Overall Study|Terminated|14|||
162693250|NCT00510458|587588134|FG000|Overall Study|Lost to Follow-up|6|||
162693251|NCT00510458|587588134|FG000|Overall Study|Withdrawal by Subject|3|||
162693252|NCT00510458|587588134|FG000|Overall Study|Revision|2|||
162693253|NCT02569710|587588135|FG000|Overall Study|Adverse Event|1|||
162693254|NCT02569710|587588136|FG001|Overall Study|Adverse Event|0|||
162693255|NCT02569710|587588137|FG002|Overall Study|Adverse Event|0|||
162693256|NCT02569710|587588138|FG003|Overall Study|Adverse Event|0|||
162693257|NCT02569710|587588139|FG004|Overall Study|Adverse Event|0|||
162693258|NCT02569710|587588140|FG005|Overall Study|Adverse Event|0|||
162693259|NCT02569710|587588141|FG006|Overall Study|Adverse Event|0|||
162693260|NCT02569710|587588142|FG007|Overall Study|Adverse Event|0|||
162693261|NCT02569710|587588143|FG008|Overall Study|Adverse Event|0|||
162693262|NCT02569710|587588144|FG009|Overall Study|Adverse Event|0|||
162693263|NCT02569710|587588135|FG000|Overall Study|Lost to Follow-up|0|||
162693264|NCT02569710|587588136|FG001|Overall Study|Lost to Follow-up|0|||
162729526|NCT01968109|587718190|FG011|Overall Study|DISEASE PROGRESSION|4|||
162729527|NCT01968109|587718191|FG012|Overall Study|DISEASE PROGRESSION|7|||
162693265|NCT02569710|587588137|FG002|Overall Study|Lost to Follow-up|0|||
162693266|NCT02569710|587588138|FG003|Overall Study|Lost to Follow-up|0|||
162693267|NCT02569710|587588139|FG004|Overall Study|Lost to Follow-up|0|||
162693268|NCT02569710|587588140|FG005|Overall Study|Lost to Follow-up|0|||
162693269|NCT02569710|587588141|FG006|Overall Study|Lost to Follow-up|1|||
162693270|NCT02569710|587588142|FG007|Overall Study|Lost to Follow-up|0|||
162693271|NCT02569710|587588143|FG008|Overall Study|Lost to Follow-up|1|||
162729528|NCT01968109|587718192|FG013|Overall Study|DISEASE PROGRESSION|14|||
162729529|NCT01968109|587718193|FG014|Overall Study|DISEASE PROGRESSION|14|||
162693272|NCT02569710|587588144|FG009|Overall Study|Lost to Follow-up|0|||
162693273|NCT02569710|587588135|FG000|Overall Study|Virologic failure|0|||
162729530|NCT01968109|587718194|FG015|Overall Study|DISEASE PROGRESSION|13|||
162693274|NCT02569710|587588136|FG001|Overall Study|Virologic failure|0|||
162693275|NCT02569710|587588137|FG002|Overall Study|Virologic failure|0|||
162693276|NCT02569710|587588138|FG003|Overall Study|Virologic failure|0|||
162693277|NCT02569710|587588139|FG004|Overall Study|Virologic failure|1|||
162693278|NCT02569710|587588140|FG005|Overall Study|Virologic failure|0|||
162693279|NCT02569710|587588141|FG006|Overall Study|Virologic failure|1|||
162693280|NCT02569710|587588142|FG007|Overall Study|Virologic failure|0|||
162693281|NCT02569710|587588143|FG008|Overall Study|Virologic failure|0|||
162693282|NCT02569710|587588144|FG009|Overall Study|Virologic failure|0|||
162693283|NCT02569710|587588135|FG000|Overall Study|Withdrawal by Subject|0|||
162693284|NCT02569710|587588136|FG001|Overall Study|Withdrawal by Subject|0|||
162693285|NCT02569710|587588137|FG002|Overall Study|Withdrawal by Subject|0|||
162693286|NCT02569710|587588138|FG003|Overall Study|Withdrawal by Subject|0|||
162693287|NCT02569710|587588139|FG004|Overall Study|Withdrawal by Subject|0|||
162693288|NCT02569710|587588140|FG005|Overall Study|Withdrawal by Subject|1|||
162693289|NCT02569710|587588141|FG006|Overall Study|Withdrawal by Subject|0|||
162693290|NCT02569710|587588142|FG007|Overall Study|Withdrawal by Subject|0|||
162693291|NCT02569710|587588143|FG008|Overall Study|Withdrawal by Subject|0|||
162693292|NCT02569710|587588144|FG009|Overall Study|Withdrawal by Subject|0|||
162693293|NCT02946918|587588145|FG000|Overall Study|Patient unblinded himself|1|||
162693294|NCT02946918|587588146|FG001|Overall Study|Patient unblinded himself|0|||
162693295|NCT02946918|587588145|FG000|Overall Study|Physician Decision|0|||
162693296|NCT02946918|587588146|FG001|Overall Study|Physician Decision|2|||
162693297|NCT02946918|587588145|FG000|Overall Study|Ran out of study medication|0|||
162693298|NCT02946918|587588146|FG001|Overall Study|Ran out of study medication|1|||
162693299|NCT03203694|587588153|FG000|Overall Study|Withdrawal by Subject|2|||
162693300|NCT03203694|587588154|FG001|Overall Study|Withdrawal by Subject|0|||
162693301|NCT03203694|587588155|FG002|Overall Study|Withdrawal by Subject|0|||
162693302|NCT03203694|587588156|FG003|Overall Study|Withdrawal by Subject|0|||
162693303|NCT03203694|587588157|FG004|Overall Study|Withdrawal by Subject|0|||
162693304|NCT03203694|587588158|FG005|Overall Study|Withdrawal by Subject|0|||
162693305|NCT03535337|587588165|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
162693306|NCT03535337|587588166|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
162693307|NCT03535337|587588167|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
162693308|NCT03535337|587588168|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
162693309|NCT03535337|587588169|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
162693310|NCT03535337|587588170|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
162693311|NCT03535337|587588171|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
162693312|NCT03535337|587588172|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
162693313|NCT03535337|587588173|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
162693314|NCT03535337|587588174|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
162693315|NCT05879198|587588175|FG000|Overall Study|Lost to Follow-up|1|||
162693316|NCT01598298|587588176|FG000|Overall Study|Not eligible|5|||
162693317|NCT01598298|587588177|FG001|Overall Study|Not eligible|5|||
162693318|NCT01598298|587588176|FG000|Overall Study|Adverse Event|21|||
162693319|NCT01598298|587588177|FG001|Overall Study|Adverse Event|19|||
162693320|NCT01598298|587588176|FG000|Overall Study|Progression/relapse|0|||
162693321|NCT01598298|587588177|FG001|Overall Study|Progression/relapse|2|||
162693322|NCT01598298|587588176|FG000|Overall Study|Withdrawal by Subject|10|||
162693323|NCT01598298|587588177|FG001|Overall Study|Withdrawal by Subject|15|||
162693324|NCT01598298|587588176|FG000|Overall Study|Other reason (not protocol specified)|4|||
162693325|NCT01598298|587588177|FG001|Overall Study|Other reason (not protocol specified)|0|||
162693326|NCT04105972|587590324|FG000|Overall Study|Adverse Event|2|||
162693327|NCT04105972|587590325|FG001|Overall Study|Adverse Event|1|||
162693328|NCT02802319|587590326|FG000|Overall Study|Physician Decision|2|||
162693329|NCT02802319|587590327|FG001|Overall Study|Physician Decision|1|||
162693330|NCT02802319|587590326|FG000|Overall Study|Lost to Follow-up|0|||
162693331|NCT02802319|587590327|FG001|Overall Study|Lost to Follow-up|4|||
162693332|NCT01923896|587590328|FG000|Overall Study|Adverse Event|1|||
162693333|NCT01923896|587590329|FG001|Overall Study|Adverse Event|0|||
162693334|NCT03545113|587590332|FG000|Overall Study|Surgery Cancelled|1|||
162693335|NCT03545113|587590333|FG001|Overall Study|Surgery Cancelled|0|||
162693336|NCT03545113|587590332|FG000|Overall Study|Death|1|||
162693337|NCT03545113|587590333|FG001|Overall Study|Death|0|||
162693338|NCT03545113|587590332|FG000|Overall Study|Adverse Event|2|||
162693339|NCT03545113|587590333|FG001|Overall Study|Adverse Event|0|||
162693340|NCT03545113|587590332|FG000|Overall Study|Received different surgery|1|||
162693341|NCT03545113|587590333|FG001|Overall Study|Received different surgery|0|||
162693342|NCT00235443|587590334|FG000|Overall Study|Adverse Event|4|||
162693343|NCT00235443|587590335|FG001|Overall Study|Adverse Event|12|||
162693344|NCT00235443|587590336|FG002|Overall Study|Adverse Event|17|||
162693345|NCT00235443|587590337|FG003|Overall Study|Adverse Event|44|||
162693346|NCT00235443|587590338|FG004|Overall Study|Adverse Event|10|||
162693347|NCT00235443|587590339|FG005|Overall Study|Adverse Event|15|||
162693348|NCT00235443|587590334|FG000|Overall Study|Lack of Efficacy|0|||
162693349|NCT00235443|587590335|FG001|Overall Study|Lack of Efficacy|1|||
162693350|NCT00235443|587590336|FG002|Overall Study|Lack of Efficacy|5|||
162693351|NCT00235443|587590337|FG003|Overall Study|Lack of Efficacy|12|||
162693352|NCT00235443|587590338|FG004|Overall Study|Lack of Efficacy|2|||
162693353|NCT00235443|587590339|FG005|Overall Study|Lack of Efficacy|9|||
162693354|NCT00235443|587590334|FG000|Overall Study|Withdrawal by Subject|3|||
162693355|NCT00235443|587590335|FG001|Overall Study|Withdrawal by Subject|9|||
162693356|NCT00235443|587590336|FG002|Overall Study|Withdrawal by Subject|25|||
162693357|NCT00235443|587590337|FG003|Overall Study|Withdrawal by Subject|24|||
162693358|NCT00235443|587590338|FG004|Overall Study|Withdrawal by Subject|10|||
162693359|NCT00235443|587590339|FG005|Overall Study|Withdrawal by Subject|12|||
162693360|NCT00235443|587590334|FG000|Overall Study|Lost to Follow-up|0|||
162693361|NCT00235443|587590335|FG001|Overall Study|Lost to Follow-up|8|||
162693362|NCT00235443|587590336|FG002|Overall Study|Lost to Follow-up|6|||
162693363|NCT00235443|587590337|FG003|Overall Study|Lost to Follow-up|6|||
162693364|NCT00235443|587590338|FG004|Overall Study|Lost to Follow-up|4|||
162693365|NCT00235443|587590339|FG005|Overall Study|Lost to Follow-up|3|||
162693366|NCT00235443|587590334|FG000|Overall Study|Unsatisfactory compliance|0|||
162693367|NCT00235443|587590335|FG001|Overall Study|Unsatisfactory compliance|2|||
162693368|NCT00235443|587590336|FG002|Overall Study|Unsatisfactory compliance|3|||
162693369|NCT00235443|587590337|FG003|Overall Study|Unsatisfactory compliance|4|||
162693370|NCT00235443|587590338|FG004|Overall Study|Unsatisfactory compliance|1|||
162693371|NCT00235443|587590339|FG005|Overall Study|Unsatisfactory compliance|0|||
162693372|NCT00235443|587590334|FG000|Overall Study|Other reasons for premature termination|1|||
162693373|NCT00235443|587590335|FG001|Overall Study|Other reasons for premature termination|6|||
162693374|NCT00235443|587590336|FG002|Overall Study|Other reasons for premature termination|6|||
162693375|NCT00235443|587590337|FG003|Overall Study|Other reasons for premature termination|7|||
162693376|NCT00235443|587590338|FG004|Overall Study|Other reasons for premature termination|3|||
162693377|NCT00235443|587590339|FG005|Overall Study|Other reasons for premature termination|6|||
162693378|NCT00474929|587590340|FG000|Overall Study|Withdrawal by Subject|0|||
162693379|NCT00474929|587590341|FG001|Overall Study|Withdrawal by Subject|1|||
162693380|NCT00474929|587590342|FG002|Overall Study|Withdrawal by Subject|0|||
162693381|NCT00474929|587590343|FG003|Overall Study|Withdrawal by Subject|0|||
162693382|NCT00474929|587590344|FG004|Overall Study|Withdrawal by Subject|0|||
162693383|NCT00474929|587590340|FG000|Overall Study|Unrelated medical condition|0|||
162693384|NCT00474929|587590341|FG001|Overall Study|Unrelated medical condition|0|||
162693385|NCT00474929|587590342|FG002|Overall Study|Unrelated medical condition|1|||
162693386|NCT00474929|587590343|FG003|Overall Study|Unrelated medical condition|0|||
162693387|NCT00474929|587590344|FG004|Overall Study|Unrelated medical condition|0|||
162693388|NCT00474929|587590340|FG000|Overall Study|Physician Decision|0|||
162693389|NCT00474929|587590341|FG001|Overall Study|Physician Decision|0|||
162693390|NCT00474929|587590342|FG002|Overall Study|Physician Decision|1|||
162693391|NCT00474929|587590343|FG003|Overall Study|Physician Decision|2|||
162693392|NCT00474929|587590344|FG004|Overall Study|Physician Decision|0|||
162693393|NCT03029247|587590347|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
162693394|NCT03029247|587590348|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
162693395|NCT03029247|587590347|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
162693396|NCT03029247|587590348|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
162693397|NCT03029247|587590347|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
162693398|NCT03029247|587590348|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
162693399|NCT03029247|587590347|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
162693400|NCT03029247|587590348|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
162693401|NCT02593305|587590349|FG000|Post 1|Comparison only group. No intervention.|0|||
162693402|NCT02593305|587590350|FG001|Post 1|Comparison only group. No intervention.|0|||
162693403|NCT02593305|587590351|FG002|Post 1|Comparison only group. No intervention.|10|||
162693404|NCT02757521|587590352|FG000|Overall Study|Adverse Event|1|||
162729531|NCT01968109|587718195|FG016|Overall Study|DISEASE PROGRESSION|34|||
162729532|NCT01968109|587718196|FG017|Overall Study|DISEASE PROGRESSION|20|||
162729533|NCT01968109|587718197|FG018|Overall Study|DISEASE PROGRESSION|54|||
162729534|NCT01968109|587718198|FG019|Overall Study|DISEASE PROGRESSION|46|||
162729535|NCT01968109|587718199|FG020|Overall Study|DISEASE PROGRESSION|77|||
162729536|NCT01968109|587718200|FG021|Overall Study|DISEASE PROGRESSION|25|||
162729537|NCT01968109|587718201|FG022|Overall Study|DISEASE PROGRESSION|47|||
162729538|NCT01968109|587718202|FG023|Overall Study|DISEASE PROGRESSION|125|||
162729539|NCT01968109|587718203|FG024|Overall Study|DISEASE PROGRESSION|155|||
162729540|NCT01968109|587718204|FG025|Overall Study|DISEASE PROGRESSION|63|||
162693405|NCT02757521|587590353|FG001|Overall Study|Adverse Event|0|||
162729541|NCT01968109|587718205|FG026|Overall Study|DISEASE PROGRESSION|65|||
162729542|NCT01968109|587718206|FG027|Overall Study|DISEASE PROGRESSION|137|||
162729543|NCT01968109|587718207|FG028|Overall Study|DISEASE PROGRESSION|35|||
162729544|NCT01968109|587718208|FG029|Overall Study|DISEASE PROGRESSION|23|||
162729545|NCT01968109|587718209|FG030|Overall Study|DISEASE PROGRESSION|71|||
162693406|NCT00999661|587590357|FG000|Overall Study|Lost to Follow-up|59|||
162729546|NCT01968109|587718179|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162729547|NCT01968109|587718180|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162693407|NCT00999661|587590357|FG000|Overall Study|Adverse Event|1|||
162729548|NCT01968109|587718181|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729549|NCT01968109|587718182|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162693408|NCT00999661|587590357|FG000|Overall Study|Withdrawal by Subject|1|||
162693409|NCT00999661|587590357|FG000|Overall Study|Not meeting eligibility criteria|9|||
162693410|NCT00312858|587590358|FG000|Overall Study|Adverse Event|0|||
162693411|NCT00312858|587590359|FG001|Overall Study|Adverse Event|1|||
162693412|NCT00312858|587590358|FG000|Overall Study|Lost to Follow-up|25|||
162693413|NCT00312858|587590359|FG001|Overall Study|Lost to Follow-up|42|||
162693414|NCT00312858|587590358|FG000|Overall Study|Protocol Violation|3|||
162693415|NCT00312858|587590359|FG001|Overall Study|Protocol Violation|8|||
162693416|NCT00312858|587590358|FG000|Overall Study|Withdraw by Participant|20|||
162693417|NCT00312858|587590359|FG001|Overall Study|Withdraw by Participant|20|||
162693418|NCT00312858|587590358|FG000|Overall Study|Participant Moved|11|||
162693419|NCT00312858|587590359|FG001|Overall Study|Participant Moved|10|||
162693420|NCT00312858|587590358|FG000|Overall Study|Other|9|||
162693421|NCT00312858|587590359|FG001|Overall Study|Other|12|||
162693422|NCT00854295|587590363|FG000|Overall Study|Death|7|||
162693423|NCT00854295|587590364|FG001|Overall Study|Death|0|||
162693424|NCT00854295|587590365|FG002|Overall Study|Death|1|||
162693425|NCT00854295|587590366|FG003|Overall Study|Death|1|||
162693426|NCT00854295|587590363|FG000|Overall Study|Adverse Event|6|||
162693427|NCT00854295|587590364|FG001|Overall Study|Adverse Event|1|||
162693428|NCT00854295|587590365|FG002|Overall Study|Adverse Event|1|||
162693429|NCT00854295|587590366|FG003|Overall Study|Adverse Event|3|||
162693430|NCT00854295|587590363|FG000|Overall Study|Lost to Follow-up|18|||
162693431|NCT00854295|587590364|FG001|Overall Study|Lost to Follow-up|5|||
162693432|NCT00854295|587590365|FG002|Overall Study|Lost to Follow-up|21|||
162693433|NCT00854295|587590366|FG003|Overall Study|Lost to Follow-up|21|||
162693434|NCT00854295|587590363|FG000|Overall Study|Physician Decision|10|||
162693435|NCT00854295|587590364|FG001|Overall Study|Physician Decision|0|||
162693436|NCT00854295|587590365|FG002|Overall Study|Physician Decision|0|||
162693437|NCT00854295|587590366|FG003|Overall Study|Physician Decision|0|||
162693438|NCT02440594|587590367|FG000|Overall Study|Lost to Follow-up|34|||
162693439|NCT02440594|587590368|FG001|Overall Study|Lost to Follow-up|33|||
162693440|NCT02440594|587590369|FG002|Overall Study|Lost to Follow-up|54|||
162693441|NCT02440594|587590370|FG003|Overall Study|Lost to Follow-up|47|||
162693442|NCT02440594|587590371|FG004|Overall Study|Lost to Follow-up|5|||
162693443|NCT02440594|587590372|FG005|Overall Study|Lost to Follow-up|4|||
162693444|NCT02440594|587590373|FG006|Overall Study|Lost to Follow-up|28|||
162693445|NCT02440594|587590374|FG007|Overall Study|Lost to Follow-up|48|||
162693446|NCT02440594|587590367|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
162693447|NCT02440594|587590368|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
162693448|NCT02440594|587590369|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
162693449|NCT02440594|587590370|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
162693450|NCT02440594|587590371|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
162693451|NCT02440594|587590372|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
162693452|NCT02440594|587590373|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
162693453|NCT02440594|587590374|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
162693454|NCT02440594|587590367|FG000|Overall Study|Withdrawal by Subject|81|||
162693455|NCT02440594|587590368|FG001|Overall Study|Withdrawal by Subject|67|||
162693456|NCT02440594|587590369|FG002|Overall Study|Withdrawal by Subject|59|||
162693457|NCT02440594|587590370|FG003|Overall Study|Withdrawal by Subject|38|||
162693458|NCT02440594|587590371|FG004|Overall Study|Withdrawal by Subject|2|||
162693459|NCT02440594|587590372|FG005|Overall Study|Withdrawal by Subject|2|||
162693460|NCT02440594|587590373|FG006|Overall Study|Withdrawal by Subject|7|||
162693461|NCT02440594|587590374|FG007|Overall Study|Withdrawal by Subject|7|||
162693462|NCT02440594|587590367|FG000|Overall Study|Administratively w/drawn|3|||
162693463|NCT02440594|587590368|FG001|Overall Study|Administratively w/drawn|2|||
162693464|NCT02440594|587590369|FG002|Overall Study|Administratively w/drawn|0|||
162693465|NCT02440594|587590370|FG003|Overall Study|Administratively w/drawn|0|||
162693466|NCT02440594|587590371|FG004|Overall Study|Administratively w/drawn|0|||
162693467|NCT02440594|587590372|FG005|Overall Study|Administratively w/drawn|0|||
162693468|NCT02440594|587590373|FG006|Overall Study|Administratively w/drawn|2|||
162693469|NCT02440594|587590374|FG007|Overall Study|Administratively w/drawn|1|||
162693470|NCT00152763|587590375|FG000|Overall Study|Death|4|||
162693471|NCT00152763|587590376|FG001|Overall Study|Death|1|||
162693472|NCT00152763|587590377|FG002|Overall Study|Death|2|||
162693473|NCT00152763|587590378|FG003|Overall Study|Death|1|||
162693474|NCT00152763|587590375|FG000|Overall Study|Lost to Follow-up|6|||
162693475|NCT00152763|587590376|FG001|Overall Study|Lost to Follow-up|4|||
162693476|NCT00152763|587590377|FG002|Overall Study|Lost to Follow-up|2|||
162693477|NCT00152763|587590378|FG003|Overall Study|Lost to Follow-up|13|||
162693478|NCT04668989|587590379|FG000|First Intervention|Covid-19 related self-isolation|0|||
162729550|NCT01968109|587718183|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162693479|NCT04668989|587590380|FG001|First Intervention|Covid-19 related self-isolation|1|||
162693480|NCT04668989|587590379|FG000|Second Intervention|Adverse Event|0|||
162693481|NCT04668989|587590380|FG001|Second Intervention|Adverse Event|1|||
162693482|NCT01622348|587590384|FG000|Overall Study|Withdrawal by Subject|1|||
162693483|NCT01622348|587590385|FG001|Overall Study|Withdrawal by Subject|0|||
162693484|NCT01622348|587590386|FG002|Overall Study|Withdrawal by Subject|1|||
162693485|NCT00474175|587590389|FG000|Overall Study|Lack of Efficacy|0|||
162693486|NCT00474175|587590390|FG001|Overall Study|Lack of Efficacy|0|||
162693487|NCT00474175|587590391|FG002|Overall Study|Lack of Efficacy|1|||
162693488|NCT00474175|587590389|FG000|Overall Study|Withdrawal by Subject|0|||
162693489|NCT00474175|587590390|FG001|Overall Study|Withdrawal by Subject|1|||
162693490|NCT00474175|587590391|FG002|Overall Study|Withdrawal by Subject|1|||
162693491|NCT00474175|587590389|FG000|Overall Study|Ineligible|1|||
162693492|NCT00474175|587590390|FG001|Overall Study|Ineligible|3|||
162693493|NCT00474175|587590391|FG002|Overall Study|Ineligible|1|||
162693494|NCT00474175|587590389|FG000|Overall Study|Protocol Violation|0|||
162693495|NCT00474175|587590390|FG001|Overall Study|Protocol Violation|2|||
162693496|NCT00474175|587590391|FG002|Overall Study|Protocol Violation|1|||
162693497|NCT00474175|587590389|FG000|Overall Study|Administrative|0|||
162693498|NCT00474175|587590390|FG001|Overall Study|Administrative|1|||
162693499|NCT00474175|587590391|FG002|Overall Study|Administrative|0|||
162693500|NCT01619787|587590392|FG000|Overall Study|Lost to Follow-up|5|||
162693501|NCT04537897|587590393|FG000|Overall Study|Other than listed|0|||
162693502|NCT04537897|587590394|FG001|Overall Study|Other than listed|0|||
162693503|NCT04537897|587590395|FG002|Overall Study|Other than listed|0|||
162693504|NCT04537897|587590396|FG003|Overall Study|Other than listed|0|||
162693505|NCT04537897|587590397|FG004|Overall Study|Other than listed|0|||
162693506|NCT04537897|587590398|FG005|Overall Study|Other than listed|0|||
162693507|NCT04537897|587590399|FG006|Overall Study|Other than listed|1|||
162693508|NCT04537897|587590400|FG007|Overall Study|Other than listed|0|||
162693509|NCT04537897|587590401|FG008|Overall Study|Other than listed|0|||
162693510|NCT04537897|587590393|FG000|Overall Study|Adverse Event|0|||
162693511|NCT04537897|587590394|FG001|Overall Study|Adverse Event|0|||
162693512|NCT04537897|587590395|FG002|Overall Study|Adverse Event|0|||
162693513|NCT04537897|587590396|FG003|Overall Study|Adverse Event|1|||
162693514|NCT04537897|587590397|FG004|Overall Study|Adverse Event|0|||
162693515|NCT04537897|587590398|FG005|Overall Study|Adverse Event|0|||
162693516|NCT04537897|587590399|FG006|Overall Study|Adverse Event|0|||
162693517|NCT04537897|587590400|FG007|Overall Study|Adverse Event|0|||
162693518|NCT04537897|587590401|FG008|Overall Study|Adverse Event|0|||
162693519|NCT04537897|587590393|FG000|Overall Study|Withdrawal by Subject|0|||
162693520|NCT04537897|587590394|FG001|Overall Study|Withdrawal by Subject|1|||
162693521|NCT04537897|587590395|FG002|Overall Study|Withdrawal by Subject|0|||
162693522|NCT04537897|587590396|FG003|Overall Study|Withdrawal by Subject|0|||
162693523|NCT04537897|587590397|FG004|Overall Study|Withdrawal by Subject|0|||
162693524|NCT04537897|587590398|FG005|Overall Study|Withdrawal by Subject|0|||
162693525|NCT04537897|587590399|FG006|Overall Study|Withdrawal by Subject|0|||
162693526|NCT04537897|587590400|FG007|Overall Study|Withdrawal by Subject|0|||
162693527|NCT04537897|587590401|FG008|Overall Study|Withdrawal by Subject|0|||
162693528|NCT00197028|587590405|FG000|Overall Study|Adverse Event|2|||
162693529|NCT00197028|587590406|FG001|Overall Study|Adverse Event|2|||
162693530|NCT00197028|587590405|FG000|Overall Study|Protocol Violation|2|||
162693531|NCT00197028|587590406|FG001|Overall Study|Protocol Violation|1|||
162693532|NCT00197028|587590405|FG000|Overall Study|Withdrawal by Subject|8|||
162693533|NCT00197028|587590406|FG001|Overall Study|Withdrawal by Subject|12|||
162693534|NCT00197028|587590405|FG000|Overall Study|Lost to Follow-up|1|||
162693535|NCT00197028|587590406|FG001|Overall Study|Lost to Follow-up|0|||
162693536|NCT00197028|587590405|FG000|Overall Study|Other|3|||
162693537|NCT00197028|587590406|FG001|Overall Study|Other|6|||
162693538|NCT03893825|587590407|FG000|Overall Study|Death|2|||
162693539|NCT03893825|587590408|FG001|Overall Study|Death|1|||
162693540|NCT03893825|587590407|FG000|Overall Study|Adverse Event|0|||
162693541|NCT03893825|587590408|FG001|Overall Study|Adverse Event|2|||
162693542|NCT03893825|587590407|FG000|Overall Study|Withdrawal by Subject|19|||
162693543|NCT03893825|587590408|FG001|Overall Study|Withdrawal by Subject|21|||
162693544|NCT03893825|587590407|FG000|Overall Study|Protocol deviation|1|||
162693545|NCT03893825|587590408|FG001|Overall Study|Protocol deviation|0|||
162693546|NCT03893825|587590407|FG000|Overall Study|Lost to Follow-up|10|||
162693547|NCT03893825|587590408|FG001|Overall Study|Lost to Follow-up|10|||
162693548|NCT03893825|587590407|FG000|Overall Study|Other than specified|7|||
162693549|NCT03893825|587590408|FG001|Overall Study|Other than specified|6|||
162693550|NCT04488003|587590414|FG000|Assessed for Eligibility|Screen Failure|24|||
162693551|NCT04488003|587590415|FG001|Assessed for Eligibility|Screen Failure|0|||
162693552|NCT04488003|587590416|FG002|Assessed for Eligibility|Screen Failure|0|||
162693553|NCT04488003|587590414|FG000|Assessed for Eligibility|Adverse Event|1|||
162693554|NCT04488003|587590415|FG001|Assessed for Eligibility|Adverse Event|0|||
162693555|NCT04488003|587590416|FG002|Assessed for Eligibility|Adverse Event|0|||
162693556|NCT04488003|587590414|FG000|Assessed for Eligibility|Death|1|||
162693557|NCT04488003|587590415|FG001|Assessed for Eligibility|Death|0|||
162693558|NCT04488003|587590416|FG002|Assessed for Eligibility|Death|0|||
162693559|NCT04488003|587590414|FG000|Assessed for Eligibility|Physician Decision|1|||
162693560|NCT04488003|587590415|FG001|Assessed for Eligibility|Physician Decision|0|||
162693561|NCT04488003|587590416|FG002|Assessed for Eligibility|Physician Decision|0|||
162693562|NCT04488003|587590414|FG000|Allocated to Treatment|Progressive Disease|51|||
162693563|NCT04488003|587590415|FG001|Allocated to Treatment|Progressive Disease|0|||
162693564|NCT04488003|587590416|FG002|Allocated to Treatment|Progressive Disease|0|||
162693565|NCT04488003|587590414|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
162693566|NCT04488003|587590415|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
162693567|NCT04488003|587590416|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
162693568|NCT04488003|587590414|FG000|Allocated to Treatment|Adverse Event|6|||
162693569|NCT04488003|587590415|FG001|Allocated to Treatment|Adverse Event|0|||
162693570|NCT04488003|587590416|FG002|Allocated to Treatment|Adverse Event|0|||
162693571|NCT04488003|587590414|FG000|Allocated to Treatment|Other|5|||
162693572|NCT04488003|587590415|FG001|Allocated to Treatment|Other|0|||
162693573|NCT04488003|587590416|FG002|Allocated to Treatment|Other|0|||
162693574|NCT04488003|587590414|FG000|Allocated to Treatment|Physician Decision|4|||
162693575|NCT04488003|587590415|FG001|Allocated to Treatment|Physician Decision|0|||
162693576|NCT04488003|587590416|FG002|Allocated to Treatment|Physician Decision|0|||
162693577|NCT04488003|587590414|FG000|Allocated to Treatment|Death|4|||
162693578|NCT04488003|587590415|FG001|Allocated to Treatment|Death|0|||
162693579|NCT04488003|587590416|FG002|Allocated to Treatment|Death|0|||
162693580|NCT01468922|587590419|FG000|Overall Study|Screening failure|0|||
162693581|NCT01468922|587590420|FG001|Overall Study|Screening failure|0|||
162693582|NCT01468922|587590421|FG002|Overall Study|Screening failure|0|||
162693583|NCT01468922|587590422|FG003|Overall Study|Screening failure|0|||
162693584|NCT01468922|587590423|FG004|Overall Study|Screening failure|0|||
162693585|NCT01468922|587590424|FG005|Overall Study|Screening failure|0|||
162693586|NCT01468922|587590425|FG006|Overall Study|Screening failure|0|||
162693587|NCT01468922|587590426|FG007|Overall Study|Screening failure|0|||
162693588|NCT01468922|587590427|FG008|Overall Study|Screening failure|1|||
162693589|NCT01468922|587590419|FG000|Overall Study|Per patient choice|1|||
162693590|NCT01468922|587590420|FG001|Overall Study|Per patient choice|0|||
162693591|NCT01468922|587590421|FG002|Overall Study|Per patient choice|0|||
162693592|NCT01468922|587590422|FG003|Overall Study|Per patient choice|0|||
162693593|NCT01468922|587590423|FG004|Overall Study|Per patient choice|0|||
162693594|NCT01468922|587590424|FG005|Overall Study|Per patient choice|0|||
162693595|NCT01468922|587590425|FG006|Overall Study|Per patient choice|0|||
162693596|NCT01468922|587590426|FG007|Overall Study|Per patient choice|0|||
162693597|NCT01468922|587590427|FG008|Overall Study|Per patient choice|0|||
162693598|NCT01468922|587590419|FG000|Overall Study|Switched to alternative treatment|1|||
162693599|NCT01468922|587590420|FG001|Overall Study|Switched to alternative treatment|0|||
162693600|NCT01468922|587590421|FG002|Overall Study|Switched to alternative treatment|0|||
162693601|NCT01468922|587590422|FG003|Overall Study|Switched to alternative treatment|0|||
162693602|NCT01468922|587590423|FG004|Overall Study|Switched to alternative treatment|1|||
162693603|NCT01468922|587590424|FG005|Overall Study|Switched to alternative treatment|0|||
162693604|NCT01468922|587590425|FG006|Overall Study|Switched to alternative treatment|0|||
162693605|NCT01468922|587590426|FG007|Overall Study|Switched to alternative treatment|0|||
162693606|NCT01468922|587590427|FG008|Overall Study|Switched to alternative treatment|0|||
162693607|NCT01468922|587590419|FG000|Overall Study|Enrolled on new protocol|0|||
162693608|NCT01468922|587590420|FG001|Overall Study|Enrolled on new protocol|0|||
162693609|NCT01468922|587590421|FG002|Overall Study|Enrolled on new protocol|0|||
162693610|NCT01468922|587590422|FG003|Overall Study|Enrolled on new protocol|0|||
162693611|NCT01468922|587590423|FG004|Overall Study|Enrolled on new protocol|1|||
162693612|NCT01468922|587590424|FG005|Overall Study|Enrolled on new protocol|0|||
162693613|NCT01468922|587590425|FG006|Overall Study|Enrolled on new protocol|0|||
162693614|NCT01468922|587590426|FG007|Overall Study|Enrolled on new protocol|0|||
162693615|NCT01468922|587590427|FG008|Overall Study|Enrolled on new protocol|0|||
162693616|NCT01468922|587590419|FG000|Overall Study|Adverse Event|0|||
162693617|NCT01468922|587590420|FG001|Overall Study|Adverse Event|0|||
162693618|NCT01468922|587590421|FG002|Overall Study|Adverse Event|0|||
162693619|NCT01468922|587590422|FG003|Overall Study|Adverse Event|0|||
162693620|NCT01468922|587590423|FG004|Overall Study|Adverse Event|0|||
162693621|NCT01468922|587590424|FG005|Overall Study|Adverse Event|0|||
162693622|NCT01468922|587590425|FG006|Overall Study|Adverse Event|0|||
162693623|NCT01468922|587590426|FG007|Overall Study|Adverse Event|1|||
162693624|NCT01468922|587590427|FG008|Overall Study|Adverse Event|0|||
162693625|NCT01468922|587590419|FG000|Overall Study|Infection of blood|0|||
162693626|NCT01468922|587590420|FG001|Overall Study|Infection of blood|0|||
162693627|NCT01468922|587590421|FG002|Overall Study|Infection of blood|0|||
162693628|NCT01468922|587590422|FG003|Overall Study|Infection of blood|0|||
162693629|NCT01468922|587590423|FG004|Overall Study|Infection of blood|0|||
162693630|NCT01468922|587590424|FG005|Overall Study|Infection of blood|0|||
162693631|NCT01468922|587590425|FG006|Overall Study|Infection of blood|0|||
162693632|NCT01468922|587590426|FG007|Overall Study|Infection of blood|1|||
162693633|NCT01468922|587590427|FG008|Overall Study|Infection of blood|0|||
162693634|NCT01468922|587590419|FG000|Overall Study|Patient choice - surgery|0|||
162693635|NCT01468922|587590420|FG001|Overall Study|Patient choice - surgery|0|||
162693636|NCT01468922|587590421|FG002|Overall Study|Patient choice - surgery|0|||
162693637|NCT01468922|587590422|FG003|Overall Study|Patient choice - surgery|0|||
162693638|NCT01468922|587590423|FG004|Overall Study|Patient choice - surgery|0|||
162693639|NCT01468922|587590424|FG005|Overall Study|Patient choice - surgery|0|||
162693640|NCT01468922|587590425|FG006|Overall Study|Patient choice - surgery|0|||
162693641|NCT01468922|587590426|FG007|Overall Study|Patient choice - surgery|1|||
162693642|NCT01468922|587590427|FG008|Overall Study|Patient choice - surgery|0|||
162693643|NCT01468922|587590419|FG000|Overall Study|Refused further treatment|0|||
162693644|NCT01468922|587590420|FG001|Overall Study|Refused further treatment|0|||
162693645|NCT01468922|587590421|FG002|Overall Study|Refused further treatment|0|||
162693646|NCT01468922|587590422|FG003|Overall Study|Refused further treatment|0|||
162693647|NCT01468922|587590423|FG004|Overall Study|Refused further treatment|0|||
162693648|NCT01468922|587590424|FG005|Overall Study|Refused further treatment|0|||
162693649|NCT01468922|587590425|FG006|Overall Study|Refused further treatment|0|||
162693650|NCT01468922|587590426|FG007|Overall Study|Refused further treatment|1|||
162693651|NCT01468922|587590427|FG008|Overall Study|Refused further treatment|0|||
162693652|NCT00007475|587590430|FG000|Overall Study|Withdrawal by Subject|1|||
162693653|NCT00007475|587590431|FG001|Overall Study|Withdrawal by Subject|0|||
162693654|NCT00007475|587590432|FG002|Overall Study|Withdrawal by Subject|0|||
162693655|NCT00007475|587590433|FG003|Overall Study|Withdrawal by Subject|0|||
162693656|NCT00007475|587590430|FG000|Overall Study|Adverse Event|3|||
162693657|NCT00007475|587590431|FG001|Overall Study|Adverse Event|0|||
162693658|NCT00007475|587590432|FG002|Overall Study|Adverse Event|0|||
162693659|NCT00007475|587590433|FG003|Overall Study|Adverse Event|0|||
162693660|NCT01719224|587590434|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
162693661|NCT01719224|587590435|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
162693662|NCT00258440|587590436|FG000|Overall Study|Withdrawal by Subject|0|||
162693663|NCT00258440|587590437|FG001|Overall Study|Withdrawal by Subject|0|||
162693664|NCT00258440|587590438|FG002|Overall Study|Withdrawal by Subject|1|||
162693665|NCT00737061|587590439|FG000|Waiting Period|Lost to Follow-up|6|||
162693666|NCT00737061|587590439|FG000|Waiting Period|Withdrawal by Subject|1|||
162693667|NCT00737061|587590439|FG000|Waiting Period|Bilateral placement failure|34|||
162693668|NCT00737061|587590439|FG000|Waiting Period|Deemed patent following HSG|26|||
162693669|NCT00737061|587590439|FG000|Waiting Period|Alternative contraception failure|3|||
162693670|NCT00737061|587590439|FG000|Waiting Period|Elected surgical tubal ligation|5|||
162693671|NCT00737061|587590439|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
162693672|NCT00737061|587590439|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
162693673|NCT00737061|587590439|FG000|1 Year Wearing Period|Discontinued reilance|3|||
162693674|NCT00737061|587590439|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
162693675|NCT03000673|587590440|FG000|Overall Study|Withdrawal by Subject|1|||
162693676|NCT03000673|587590441|FG001|Overall Study|Withdrawal by Subject|0|||
162693677|NCT03000673|587590442|FG002|Overall Study|Withdrawal by Subject|0|||
162693678|NCT03000673|587590443|FG003|Overall Study|Withdrawal by Subject|0|||
162693679|NCT00692406|587590444|FG000|Overall Study|PI dropped, bad data|57|||
162693680|NCT04186403|587590447|FG000|Overall Study|Adverse Event|1|||
162693681|NCT04186403|587590448|FG001|Overall Study|Adverse Event|8|||
162693682|NCT04186403|587590447|FG000|Overall Study|Lost to Follow-up|7|||
162693683|NCT04186403|587590448|FG001|Overall Study|Lost to Follow-up|3|||
162693684|NCT04186403|587590447|FG000|Overall Study|Physician Decision|1|||
162693685|NCT04186403|587590448|FG001|Overall Study|Physician Decision|0|||
162693686|NCT04186403|587590447|FG000|Overall Study|Withdrawal by Subject|7|||
162693687|NCT04186403|587590448|FG001|Overall Study|Withdrawal by Subject|8|||
162693688|NCT04186403|587590447|FG000|Overall Study|Other: Not Related to Covid-19|3|||
162693689|NCT04186403|587590448|FG001|Overall Study|Other: Not Related to Covid-19|0|||
162693690|NCT01407354|587590453|FG000|First Intervention|Withdrawal by Subject|0|||
162693691|NCT01407354|587590454|FG001|First Intervention|Withdrawal by Subject|2|||
162693692|NCT01407354|587590453|FG000|First Intervention|Adverse Event|1|||
162693693|NCT01407354|587590454|FG001|First Intervention|Adverse Event|0|||
162693694|NCT01407354|587590453|FG000|First Intervention|Physician Decision|1|||
162693695|NCT01407354|587590454|FG001|First Intervention|Physician Decision|0|||
162693696|NCT01036022|587590455|FG000|Overall Study|Adverse Event|1|||
162693697|NCT01036022|587590456|FG001|Overall Study|Adverse Event|3|||
162693698|NCT01036022|587590457|FG002|Overall Study|Adverse Event|2|||
162693699|NCT01036022|587590458|FG003|Overall Study|Adverse Event|1|||
162693700|NCT01036022|587590459|FG004|Overall Study|Adverse Event|0|||
162693701|NCT01036022|587590460|FG005|Overall Study|Adverse Event|2|||
162693702|NCT01036022|587590455|FG000|Overall Study|Lack of Efficacy|1|||
162693703|NCT01036022|587590456|FG001|Overall Study|Lack of Efficacy|1|||
162693704|NCT01036022|587590457|FG002|Overall Study|Lack of Efficacy|1|||
162729551|NCT01968109|587718184|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162693705|NCT01036022|587590458|FG003|Overall Study|Lack of Efficacy|0|||
162693706|NCT01036022|587590459|FG004|Overall Study|Lack of Efficacy|1|||
162693707|NCT01036022|587590460|FG005|Overall Study|Lack of Efficacy|1|||
162693708|NCT01036022|587590455|FG000|Overall Study|Physician Decision|0|||
162693709|NCT01036022|587590456|FG001|Overall Study|Physician Decision|0|||
162729552|NCT01968109|587718185|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162693710|NCT01036022|587590457|FG002|Overall Study|Physician Decision|1|||
162693711|NCT01036022|587590458|FG003|Overall Study|Physician Decision|0|||
162693712|NCT01036022|587590459|FG004|Overall Study|Physician Decision|0|||
162693713|NCT01036022|587590460|FG005|Overall Study|Physician Decision|0|||
162693714|NCT01036022|587590455|FG000|Overall Study|Withdrawal by Subject|0|||
162693715|NCT01036022|587590456|FG001|Overall Study|Withdrawal by Subject|0|||
162693716|NCT01036022|587590457|FG002|Overall Study|Withdrawal by Subject|0|||
162693717|NCT01036022|587590458|FG003|Overall Study|Withdrawal by Subject|1|||
162693718|NCT01036022|587590459|FG004|Overall Study|Withdrawal by Subject|2|||
162693719|NCT01036022|587590460|FG005|Overall Study|Withdrawal by Subject|0|||
162693720|NCT00962247|587590466|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
162693721|NCT00962247|587590466|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
162693722|NCT01555164|587590470|FG000|Overall Study|Adverse Event|5|||
162693723|NCT01555164|587590471|FG001|Overall Study|Adverse Event|7|||
162693724|NCT01555164|587590470|FG000|Overall Study|Hyperglycemia|0|||
162693725|NCT01555164|587590471|FG001|Overall Study|Hyperglycemia|1|||
162693726|NCT01555164|587590470|FG000|Overall Study|Investigator's Discretion|2|||
162693727|NCT01555164|587590471|FG001|Overall Study|Investigator's Discretion|2|||
162693728|NCT01555164|587590470|FG000|Overall Study|Lost to Follow-up|4|||
162693729|NCT01555164|587590471|FG001|Overall Study|Lost to Follow-up|3|||
162693730|NCT01555164|587590470|FG000|Overall Study|Protocol Violation|9|||
162693731|NCT01555164|587590471|FG001|Overall Study|Protocol Violation|5|||
162693732|NCT01555164|587590470|FG000|Overall Study|Subject Non-compliance|14|||
162693733|NCT01555164|587590471|FG001|Overall Study|Subject Non-compliance|6|||
162693734|NCT01555164|587590470|FG000|Overall Study|Subject Withdrew Consent|6|||
162693735|NCT01555164|587590471|FG001|Overall Study|Subject Withdrew Consent|11|||
162693736|NCT00886639|587590474|FG000|Overall Study|acute exacerbation|14|||
162693737|NCT00886639|587590474|FG000|Overall Study|non-compliance|2|||
162693738|NCT01871558|587590475|FG000|Overall Study|Other reason|0|||
162693739|NCT01871558|587590476|FG001|Overall Study|Other reason|1|||
162693740|NCT01871558|587590475|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
162693741|NCT01871558|587590476|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
162693742|NCT01871558|587590475|FG000|Overall Study|Withdrawal by Subject|2|||
162693743|NCT01871558|587590476|FG001|Overall Study|Withdrawal by Subject|0|||
162693744|NCT01709305|587590479|FG000|Phase 1|Clinical Adverse Event|80|||
162729553|NCT01968109|587718186|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162729554|NCT01968109|587718187|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729555|NCT01968109|587718188|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729556|NCT01968109|587718189|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729557|NCT01968109|587718190|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729558|NCT01968109|587718191|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729559|NCT01968109|587718192|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729560|NCT01968109|587718193|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729561|NCT01968109|587718194|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162729562|NCT01968109|587718195|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162693745|NCT01709305|587590480|FG001|Phase 1|Clinical Adverse Event|0|||
162693746|NCT01709305|587590481|FG002|Phase 1|Clinical Adverse Event|0|||
162693747|NCT01709305|587590482|FG003|Phase 1|Clinical Adverse Event|0|||
162693748|NCT01709305|587590483|FG004|Phase 1|Clinical Adverse Event|0|||
162693749|NCT01709305|587590479|FG000|Phase 1|Death|2|||
162693750|NCT01709305|587590480|FG001|Phase 1|Death|0|||
162693751|NCT01709305|587590481|FG002|Phase 1|Death|0|||
162693752|NCT01709305|587590482|FG003|Phase 1|Death|0|||
162693753|NCT01709305|587590483|FG004|Phase 1|Death|0|||
162693754|NCT01709305|587590479|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
162693755|NCT01709305|587590480|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162693756|NCT01709305|587590481|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162729563|NCT01968109|587718196|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162729564|NCT01968109|587718197|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162729565|NCT01968109|587718198|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729566|NCT01968109|587718199|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162729567|NCT01968109|587718200|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162729568|NCT01968109|587718201|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162693757|NCT01709305|587590482|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162693758|NCT01709305|587590483|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162693759|NCT01709305|587590479|FG000|Phase 1|Laboratory Adverse Event|16|||
162693760|NCT01709305|587590480|FG001|Phase 1|Laboratory Adverse Event|0|||
162693761|NCT01709305|587590481|FG002|Phase 1|Laboratory Adverse Event|0|||
162693762|NCT01709305|587590482|FG003|Phase 1|Laboratory Adverse Event|0|||
162693763|NCT01709305|587590483|FG004|Phase 1|Laboratory Adverse Event|0|||
162693764|NCT01709305|587590479|FG000|Phase 1|Lost to Follow-up|147|||
162693765|NCT01709305|587590480|FG001|Phase 1|Lost to Follow-up|0|||
162693766|NCT01709305|587590481|FG002|Phase 1|Lost to Follow-up|0|||
162693767|NCT01709305|587590482|FG003|Phase 1|Lost to Follow-up|0|||
162693768|NCT01709305|587590483|FG004|Phase 1|Lost to Follow-up|0|||
162693769|NCT01709305|587590479|FG000|Phase 1|Travel, moving, etc.|30|||
162693770|NCT01709305|587590480|FG001|Phase 1|Travel, moving, etc.|0|||
162693771|NCT01709305|587590481|FG002|Phase 1|Travel, moving, etc.|0|||
162693772|NCT01709305|587590482|FG003|Phase 1|Travel, moving, etc.|0|||
162693773|NCT01709305|587590483|FG004|Phase 1|Travel, moving, etc.|0|||
162693774|NCT01709305|587590479|FG000|Phase 1|Physician Decision|13|||
162693775|NCT01709305|587590480|FG001|Phase 1|Physician Decision|0|||
162693776|NCT01709305|587590481|FG002|Phase 1|Physician Decision|0|||
162693777|NCT01709305|587590482|FG003|Phase 1|Physician Decision|0|||
162693778|NCT01709305|587590483|FG004|Phase 1|Physician Decision|0|||
162693779|NCT01709305|587590479|FG000|Phase 1|Protocol Violation|118|||
162693780|NCT01709305|587590480|FG001|Phase 1|Protocol Violation|0|||
162693781|NCT01709305|587590481|FG002|Phase 1|Protocol Violation|0|||
162693782|NCT01709305|587590482|FG003|Phase 1|Protocol Violation|0|||
162693783|NCT01709305|587590483|FG004|Phase 1|Protocol Violation|0|||
162693784|NCT01709305|587590479|FG000|Phase 1|Withdrawal by Subject|218|||
162693785|NCT01709305|587590480|FG001|Phase 1|Withdrawal by Subject|0|||
162693786|NCT01709305|587590481|FG002|Phase 1|Withdrawal by Subject|0|||
162693787|NCT01709305|587590482|FG003|Phase 1|Withdrawal by Subject|0|||
162693788|NCT01709305|587590483|FG004|Phase 1|Withdrawal by Subject|0|||
162693789|NCT01709305|587590479|FG000|Phase 2|Clinical Adverse Event|0|||
162693790|NCT01709305|587590480|FG001|Phase 2|Clinical Adverse Event|10|||
162693791|NCT01709305|587590481|FG002|Phase 2|Clinical Adverse Event|10|||
162693792|NCT01709305|587590482|FG003|Phase 2|Clinical Adverse Event|6|||
162693793|NCT01709305|587590483|FG004|Phase 2|Clinical Adverse Event|11|||
162693794|NCT01709305|587590479|FG000|Phase 2|Death|0|||
162693795|NCT01709305|587590480|FG001|Phase 2|Death|0|||
162693796|NCT01709305|587590481|FG002|Phase 2|Death|1|||
162693797|NCT01709305|587590482|FG003|Phase 2|Death|0|||
162693798|NCT01709305|587590483|FG004|Phase 2|Death|0|||
162693799|NCT01709305|587590479|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162693800|NCT01709305|587590480|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162693801|NCT01709305|587590481|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162693802|NCT01709305|587590482|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162693803|NCT01709305|587590483|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
162693804|NCT01709305|587590479|FG000|Phase 2|Laboratory Adverse Event|0|||
162693805|NCT01709305|587590480|FG001|Phase 2|Laboratory Adverse Event|1|||
162693806|NCT01709305|587590481|FG002|Phase 2|Laboratory Adverse Event|0|||
162693807|NCT01709305|587590482|FG003|Phase 2|Laboratory Adverse Event|1|||
162693808|NCT01709305|587590483|FG004|Phase 2|Laboratory Adverse Event|1|||
162693809|NCT01709305|587590479|FG000|Phase 2|Lost to Follow-up|0|||
162693810|NCT01709305|587590480|FG001|Phase 2|Lost to Follow-up|10|||
162693811|NCT01709305|587590481|FG002|Phase 2|Lost to Follow-up|6|||
162693812|NCT01709305|587590482|FG003|Phase 2|Lost to Follow-up|9|||
162693813|NCT01709305|587590483|FG004|Phase 2|Lost to Follow-up|5|||
162693814|NCT01709305|587590479|FG000|Phase 2|Travel, moving, etc.|0|||
162693815|NCT01709305|587590480|FG001|Phase 2|Travel, moving, etc.|2|||
162693816|NCT01709305|587590481|FG002|Phase 2|Travel, moving, etc.|3|||
162693817|NCT01709305|587590482|FG003|Phase 2|Travel, moving, etc.|3|||
162693818|NCT01709305|587590483|FG004|Phase 2|Travel, moving, etc.|5|||
162693819|NCT01709305|587590479|FG000|Phase 2|Physician Decision|0|||
162693820|NCT01709305|587590480|FG001|Phase 2|Physician Decision|2|||
162693821|NCT01709305|587590481|FG002|Phase 2|Physician Decision|0|||
162693822|NCT01709305|587590482|FG003|Phase 2|Physician Decision|1|||
162693823|NCT01709305|587590483|FG004|Phase 2|Physician Decision|2|||
162729569|NCT01968109|587718202|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
162729570|NCT01968109|587718203|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
162729571|NCT01968109|587718204|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162729572|NCT01968109|587718205|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
162729573|NCT01968109|587718206|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162729574|NCT01968109|587718207|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
162729575|NCT01968109|587718208|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
162729576|NCT01968109|587718209|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162693824|NCT01709305|587590479|FG000|Phase 2|Protocol Violation|0|||
162693825|NCT01709305|587590480|FG001|Phase 2|Protocol Violation|19|||
162693826|NCT01709305|587590481|FG002|Phase 2|Protocol Violation|19|||
162693827|NCT01709305|587590482|FG003|Phase 2|Protocol Violation|13|||
162693828|NCT01709305|587590483|FG004|Phase 2|Protocol Violation|9|||
162693829|NCT01709305|587590479|FG000|Phase 2|Withdrawal by Subject|0|||
162693830|NCT01709305|587590480|FG001|Phase 2|Withdrawal by Subject|8|||
162693831|NCT01709305|587590481|FG002|Phase 2|Withdrawal by Subject|6|||
162693832|NCT01709305|587590482|FG003|Phase 2|Withdrawal by Subject|15|||
162693833|NCT01709305|587590483|FG004|Phase 2|Withdrawal by Subject|12|||
162693834|NCT03443713|587590484|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
162693835|NCT03443713|587590485|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
162693836|NCT03443713|587590486|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
162693837|NCT01672853|587590487|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
162693838|NCT01672853|587590488|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
162693839|NCT01672853|587590489|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
162693840|NCT01672853|587590487|FG000|Overall Study|Pregnancy|0|||
162693841|NCT01672853|587590488|FG001|Overall Study|Pregnancy|1|||
162693842|NCT01672853|587590489|FG002|Overall Study|Pregnancy|0|||
162693843|NCT01672853|587590487|FG000|Overall Study|Investigator's Discretion|1|||
162693844|NCT01672853|587590488|FG001|Overall Study|Investigator's Discretion|0|||
162693845|NCT01672853|587590489|FG002|Overall Study|Investigator's Discretion|0|||
162693846|NCT01672853|587590487|FG000|Overall Study|Withdrew Consent|5|||
162693847|NCT01672853|587590488|FG001|Overall Study|Withdrew Consent|5|||
162693848|NCT01672853|587590489|FG002|Overall Study|Withdrew Consent|5|||
162693849|NCT01672853|587590487|FG000|Overall Study|Adverse Event|4|||
162693850|NCT01672853|587590488|FG001|Overall Study|Adverse Event|6|||
162693851|NCT01672853|587590489|FG002|Overall Study|Adverse Event|8|||
162693852|NCT01672853|587590487|FG000|Overall Study|Lost to Follow-up|0|||
162693853|NCT01672853|587590488|FG001|Overall Study|Lost to Follow-up|1|||
162693854|NCT01672853|587590489|FG002|Overall Study|Lost to Follow-up|0|||
162693855|NCT01672853|587590487|FG000|Overall Study|Randomized but Never Treated|0|||
162693856|NCT01672853|587590488|FG001|Overall Study|Randomized but Never Treated|0|||
162693857|NCT01672853|587590489|FG002|Overall Study|Randomized but Never Treated|1|||
162693858|NCT02969525|587590490|FG000|Double-Blind Period|Adverse Event|0|||
162693859|NCT02969525|587590491|FG001|Double-Blind Period|Adverse Event|0|||
162693860|NCT02969525|587590492|FG002|Double-Blind Period|Adverse Event|1|||
162693861|NCT02969525|587590493|FG003|Double-Blind Period|Adverse Event|1|||
162693862|NCT02969525|587590494|FG004|Double-Blind Period|Adverse Event|0|||
162693863|NCT02969525|587590495|FG005|Double-Blind Period|Adverse Event|0|||
162693864|NCT02969525|587590496|FG006|Double-Blind Period|Adverse Event|0|||
162693865|NCT02969525|587590497|FG007|Double-Blind Period|Adverse Event|0|||
162693866|NCT02969525|587590498|FG008|Double-Blind Period|Adverse Event|0|||
162693867|NCT02969525|587590499|FG009|Double-Blind Period|Adverse Event|0|||
162693868|NCT02969525|587590500|FG010|Double-Blind Period|Adverse Event|0|||
162693869|NCT02969525|587590501|FG011|Double-Blind Period|Adverse Event|0|||
162693870|NCT02969525|587590490|FG000|Double-Blind Period|LOW EGFR|0|||
162693871|NCT02969525|587590491|FG001|Double-Blind Period|LOW EGFR|0|||
162693872|NCT02969525|587590492|FG002|Double-Blind Period|LOW EGFR|0|||
162693873|NCT02969525|587590493|FG003|Double-Blind Period|LOW EGFR|1|||
162693874|NCT02969525|587590494|FG004|Double-Blind Period|LOW EGFR|0|||
162693875|NCT02969525|587590495|FG005|Double-Blind Period|LOW EGFR|0|||
162693876|NCT02969525|587590496|FG006|Double-Blind Period|LOW EGFR|0|||
162693877|NCT02969525|587590497|FG007|Double-Blind Period|LOW EGFR|0|||
162693878|NCT02969525|587590498|FG008|Double-Blind Period|LOW EGFR|0|||
162693879|NCT02969525|587590499|FG009|Double-Blind Period|LOW EGFR|0|||
162693880|NCT02969525|587590500|FG010|Double-Blind Period|LOW EGFR|0|||
162693881|NCT02969525|587590501|FG011|Double-Blind Period|LOW EGFR|0|||
162693882|NCT02969525|587590490|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
162693883|NCT02969525|587590491|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162729577|NCT01968109|587718179|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
162729578|NCT01968109|587718180|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
162729579|NCT01968109|587718181|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
162729580|NCT01968109|587718182|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
162729581|NCT01968109|587718183|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
162729582|NCT01968109|587718184|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
162729583|NCT01968109|587718185|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
162729584|NCT01968109|587718186|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
162729585|NCT01968109|587718187|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
162729586|NCT01968109|587718188|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
162729587|NCT01968109|587718189|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
162729588|NCT01968109|587718190|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
162729589|NCT01968109|587718191|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
162729590|NCT01968109|587718192|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
162729591|NCT01968109|587718193|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
162693884|NCT02969525|587590492|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693885|NCT02969525|587590493|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
162729592|NCT01968109|587718194|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
162729593|NCT01968109|587718195|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
162693886|NCT02969525|587590494|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693887|NCT02969525|587590495|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693888|NCT02969525|587590496|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693889|NCT02969525|587590497|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162729594|NCT01968109|587718196|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
162729595|NCT01968109|587718197|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
162693890|NCT02969525|587590498|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693891|NCT02969525|587590499|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693892|NCT02969525|587590500|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693893|NCT02969525|587590501|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162693894|NCT02969525|587590490|FG000|Dose-Blind Period|Adverse Event|0|||
162693895|NCT02969525|587590491|FG001|Dose-Blind Period|Adverse Event|0|||
162729596|NCT01968109|587718198|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
162729597|NCT01968109|587718199|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
162729598|NCT01968109|587718200|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
162729599|NCT01968109|587718201|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
162729600|NCT01968109|587718202|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
162729601|NCT01968109|587718203|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
162729602|NCT01968109|587718204|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
162729603|NCT01968109|587718205|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
162729604|NCT01968109|587718206|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
162729605|NCT01968109|587718207|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
162729606|NCT01968109|587718208|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
162729607|NCT01968109|587718209|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
162729608|NCT01968109|587718179|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729609|NCT01968109|587718180|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729610|NCT01968109|587718181|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729611|NCT01968109|587718182|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729612|NCT01968109|587718183|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729613|NCT01968109|587718184|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729614|NCT01968109|587718185|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729615|NCT01968109|587718186|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729616|NCT01968109|587718187|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729617|NCT01968109|587718188|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729618|NCT01968109|587718189|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729619|NCT01968109|587718190|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729620|NCT01968109|587718191|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729621|NCT01968109|587718192|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729622|NCT01968109|587718193|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729623|NCT01968109|587718194|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729624|NCT01968109|587718195|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729625|NCT01968109|587718196|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729626|NCT01968109|587718197|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729627|NCT01968109|587718198|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162693896|NCT02969525|587590492|FG002|Dose-Blind Period|Adverse Event|0|||
162693897|NCT02969525|587590493|FG003|Dose-Blind Period|Adverse Event|0|||
162693898|NCT02969525|587590494|FG004|Dose-Blind Period|Adverse Event|0|||
162693899|NCT02969525|587590495|FG005|Dose-Blind Period|Adverse Event|0|||
162693900|NCT02969525|587590496|FG006|Dose-Blind Period|Adverse Event|0|||
162693901|NCT02969525|587590497|FG007|Dose-Blind Period|Adverse Event|0|||
162693902|NCT02969525|587590498|FG008|Dose-Blind Period|Adverse Event|0|||
162693903|NCT02969525|587590499|FG009|Dose-Blind Period|Adverse Event|1|||
162693904|NCT02969525|587590500|FG010|Dose-Blind Period|Adverse Event|1|||
162693905|NCT02969525|587590501|FG011|Dose-Blind Period|Adverse Event|1|||
162693906|NCT02969525|587590490|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
162693907|NCT02969525|587590491|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
162693908|NCT02969525|587590492|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
162693909|NCT02969525|587590493|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
162693910|NCT02969525|587590494|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
162693911|NCT02969525|587590495|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
162693912|NCT02969525|587590496|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
162693913|NCT02969525|587590497|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
162693914|NCT02969525|587590498|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
162693915|NCT02969525|587590499|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
162693916|NCT02969525|587590500|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
162693917|NCT02969525|587590501|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
162693918|NCT02969525|587590490|FG000|Dose-Blind Period|Non-cooperating patient|0|||
162693919|NCT02969525|587590491|FG001|Dose-Blind Period|Non-cooperating patient|0|||
162693920|NCT02969525|587590492|FG002|Dose-Blind Period|Non-cooperating patient|0|||
162693921|NCT02969525|587590493|FG003|Dose-Blind Period|Non-cooperating patient|0|||
162693922|NCT02969525|587590494|FG004|Dose-Blind Period|Non-cooperating patient|0|||
162693923|NCT02969525|587590495|FG005|Dose-Blind Period|Non-cooperating patient|0|||
162693924|NCT02969525|587590496|FG006|Dose-Blind Period|Non-cooperating patient|0|||
162693925|NCT02969525|587590497|FG007|Dose-Blind Period|Non-cooperating patient|0|||
162693926|NCT02969525|587590498|FG008|Dose-Blind Period|Non-cooperating patient|0|||
162693927|NCT02969525|587590499|FG009|Dose-Blind Period|Non-cooperating patient|0|||
162693928|NCT02969525|587590500|FG010|Dose-Blind Period|Non-cooperating patient|0|||
162693929|NCT02969525|587590501|FG011|Dose-Blind Period|Non-cooperating patient|1|||
162729628|NCT01968109|587718199|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729629|NCT01968109|587718200|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729630|NCT01968109|587718201|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162729631|NCT01968109|587718202|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162693930|NCT02969525|587590490|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693931|NCT02969525|587590491|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693932|NCT02969525|587590492|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693933|NCT02969525|587590493|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693934|NCT02969525|587590494|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162729632|NCT01968109|587718203|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
162729633|NCT01968109|587718204|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
162729634|NCT01968109|587718205|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729635|NCT01968109|587718206|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
162729636|NCT01968109|587718207|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162693935|NCT02969525|587590495|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693936|NCT02969525|587590496|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693937|NCT02969525|587590497|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693938|NCT02969525|587590498|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693939|NCT02969525|587590499|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693940|NCT02969525|587590500|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
162693941|NCT02969525|587590501|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162693942|NCT02172625|587590502|FG000|Overall Study|Adverse Event|0|||
162693943|NCT02172625|587590503|FG001|Overall Study|Adverse Event|1|||
162693944|NCT02172625|587590502|FG000|Overall Study|Pregnancy|0|||
162693945|NCT02172625|587590503|FG001|Overall Study|Pregnancy|1|||
162693946|NCT02172625|587590502|FG000|Overall Study|car accident|0|||
162693947|NCT02172625|587590503|FG001|Overall Study|car accident|1|||
162693948|NCT03445065|587590504|FG000|Overall Study|Withdrawal by Subject|3|||
162693949|NCT03445065|587590505|FG001|Overall Study|Withdrawal by Subject|6|||
162693950|NCT03445065|587590506|FG002|Overall Study|Withdrawal by Subject|2|||
162693951|NCT03445065|587590507|FG003|Overall Study|Withdrawal by Subject|2|||
162693952|NCT03445065|587590504|FG000|Overall Study|Other|4|||
162693953|NCT03445065|587590505|FG001|Overall Study|Other|3|||
162693954|NCT03445065|587590506|FG002|Overall Study|Other|3|||
162693955|NCT03445065|587590507|FG003|Overall Study|Other|1|||
162693956|NCT03315130|587590508|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162693957|NCT03315130|587590509|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
162693958|NCT03315130|587590510|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162693959|NCT03315130|587590511|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162693960|NCT03315130|587590508|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162693961|NCT03315130|587590509|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
162693962|NCT03315130|587590510|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162693963|NCT03315130|587590511|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162693964|NCT03315130|587590508|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
162693965|NCT03315130|587590509|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162693966|NCT03315130|587590510|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162693967|NCT03315130|587590511|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162693968|NCT03315130|587590508|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162693969|NCT03315130|587590509|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
162693970|NCT03315130|587590510|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162693971|NCT03315130|587590511|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162693972|NCT03315130|587590508|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162693973|NCT03315130|587590509|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
162693974|NCT03315130|587590510|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162693975|NCT03315130|587590511|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162693976|NCT03315130|587590508|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
162693977|NCT03315130|587590509|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
162693978|NCT03315130|587590510|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
162693979|NCT03315130|587590511|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
162693980|NCT00524030|587590512|FG000|Overall Study|Lack of Efficacy|10|||
162693981|NCT00524030|587590513|FG001|Overall Study|Lack of Efficacy|24|||
162693982|NCT00524030|587590512|FG000|Overall Study|Lost to Follow-up|0|||
162693983|NCT00524030|587590513|FG001|Overall Study|Lost to Follow-up|2|||
162693984|NCT00524030|587590512|FG000|Overall Study|Withdrawal by Subject|3|||
162693985|NCT00524030|587590513|FG001|Overall Study|Withdrawal by Subject|8|||
162693986|NCT00524030|587590512|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
162693987|NCT00524030|587590513|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
162693988|NCT00524030|587590512|FG000|Overall Study|Protocol Violation|0|||
162693989|NCT00524030|587590513|FG001|Overall Study|Protocol Violation|1|||
162693990|NCT00524030|587590512|FG000|Overall Study|Pregnancy|1|||
162693991|NCT00524030|587590513|FG001|Overall Study|Pregnancy|0|||
162729637|NCT01968109|587718208|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162693992|NCT00524030|587590512|FG000|Overall Study|Adverse Event|3|||
162693993|NCT00524030|587590513|FG001|Overall Study|Adverse Event|21|||
162693994|NCT00524030|587590512|FG000|Overall Study|Death|0|||
162693995|NCT00524030|587590513|FG001|Overall Study|Death|1|||
162693996|NCT02944656|587590514|FG000|Overall Study|No longer eligible|3|||
162693997|NCT02944656|587590515|FG001|Overall Study|No longer eligible|0|||
162693998|NCT02944656|587590514|FG000|Overall Study|Lost to Follow-up|7|||
162693999|NCT02944656|587590515|FG001|Overall Study|Lost to Follow-up|10|||
162694000|NCT04398537|587590516|FG000|Overall Study|Physician Decision|10|||
162729638|NCT01968109|587718209|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162729639|NCT01968109|587718179|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162694001|NCT04398537|587590517|FG001|Overall Study|Physician Decision|15|||
162694002|NCT00118898|587590518|FG000|Overall Study|Death|6|||
162694003|NCT00118898|587590519|FG001|Overall Study|Death|11|||
162729640|NCT01968109|587718180|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162694004|NCT00118898|587590520|FG002|Overall Study|Death|6|||
162694005|NCT00118898|587590521|FG003|Overall Study|Death|8|||
162694006|NCT00118898|587590518|FG000|Overall Study|Lost to Follow-up|26|||
162694007|NCT00118898|587590519|FG001|Overall Study|Lost to Follow-up|34|||
162694008|NCT00118898|587590520|FG002|Overall Study|Lost to Follow-up|33|||
162694009|NCT00118898|587590521|FG003|Overall Study|Lost to Follow-up|33|||
162694010|NCT00118898|587590518|FG000|Overall Study|Withdrawal by Subject|10|||
162694011|NCT00118898|587590519|FG001|Overall Study|Withdrawal by Subject|5|||
162694012|NCT00118898|587590520|FG002|Overall Study|Withdrawal by Subject|8|||
162694013|NCT00118898|587590521|FG003|Overall Study|Withdrawal by Subject|8|||
162694014|NCT00118898|587590518|FG000|Overall Study|Site Closure|33|||
162694015|NCT00118898|587590519|FG001|Overall Study|Site Closure|31|||
162694016|NCT00118898|587590520|FG002|Overall Study|Site Closure|28|||
162694017|NCT00118898|587590521|FG003|Overall Study|Site Closure|37|||
162694018|NCT00118898|587590518|FG000|Overall Study|Severe debilitation|1|||
162694019|NCT00118898|587590519|FG001|Overall Study|Severe debilitation|4|||
162694020|NCT00118898|587590520|FG002|Overall Study|Severe debilitation|6|||
162694021|NCT00118898|587590521|FG003|Overall Study|Severe debilitation|4|||
162694022|NCT00118898|587590518|FG000|Overall Study|Not compliant with requirements|11|||
162694023|NCT00118898|587590519|FG001|Overall Study|Not compliant with requirements|13|||
162694024|NCT00118898|587590520|FG002|Overall Study|Not compliant with requirements|11|||
162694025|NCT00118898|587590521|FG003|Overall Study|Not compliant with requirements|11|||
162694026|NCT00118898|587590518|FG000|Overall Study|Not able to get to clinic|34|||
162694027|NCT00118898|587590519|FG001|Overall Study|Not able to get to clinic|43|||
162694028|NCT00118898|587590520|FG002|Overall Study|Not able to get to clinic|31|||
162694029|NCT00118898|587590521|FG003|Overall Study|Not able to get to clinic|40|||
162694030|NCT02714205|587590524|FG000|Overall Study|Cannot tolerate medication|1|||
162694031|NCT02714205|587590525|FG001|Overall Study|Cannot tolerate medication|0|||
162694032|NCT02714205|587590524|FG000|Overall Study|Adverse Event|2|||
162694033|NCT02714205|587590525|FG001|Overall Study|Adverse Event|0|||
162694034|NCT02714205|587590524|FG000|Overall Study|Too busy|1|||
162694035|NCT02714205|587590525|FG001|Overall Study|Too busy|0|||
162694036|NCT02714205|587590524|FG000|Overall Study|Incomplete outcome data|0|||
162694037|NCT02714205|587590525|FG001|Overall Study|Incomplete outcome data|1|||
162694038|NCT02073097|587590526|FG000|Overall Study|Adverse Event|0|||
162694039|NCT02073097|587590527|FG001|Overall Study|Adverse Event|0|||
162694040|NCT02073097|587590528|FG002|Overall Study|Adverse Event|0|||
162694041|NCT02073097|587590529|FG003|Overall Study|Adverse Event|0|||
162694042|NCT02073097|587590530|FG004|Overall Study|Adverse Event|0|||
162694043|NCT02073097|587590531|FG005|Overall Study|Adverse Event|0|||
162694044|NCT02073097|587590532|FG006|Overall Study|Adverse Event|0|||
162694045|NCT02073097|587590533|FG007|Overall Study|Adverse Event|2|||
162694046|NCT02073097|587590526|FG000|Overall Study|Withdrawal by Subject|0|||
162694047|NCT02073097|587590527|FG001|Overall Study|Withdrawal by Subject|0|||
162694048|NCT02073097|587590528|FG002|Overall Study|Withdrawal by Subject|0|||
162694049|NCT02073097|587590529|FG003|Overall Study|Withdrawal by Subject|0|||
162694050|NCT02073097|587590530|FG004|Overall Study|Withdrawal by Subject|0|||
162694051|NCT02073097|587590531|FG005|Overall Study|Withdrawal by Subject|0|||
162694052|NCT02073097|587590532|FG006|Overall Study|Withdrawal by Subject|0|||
162694053|NCT02073097|587590533|FG007|Overall Study|Withdrawal by Subject|2|||
162694054|NCT02073097|587590526|FG000|Overall Study|Death|0|||
162694055|NCT02073097|587590527|FG001|Overall Study|Death|0|||
162694056|NCT02073097|587590528|FG002|Overall Study|Death|0|||
162694057|NCT02073097|587590529|FG003|Overall Study|Death|0|||
162694058|NCT02073097|587590530|FG004|Overall Study|Death|0|||
162694059|NCT02073097|587590531|FG005|Overall Study|Death|0|||
162694060|NCT02073097|587590532|FG006|Overall Study|Death|0|||
162694061|NCT02073097|587590533|FG007|Overall Study|Death|1|||
162694062|NCT02073097|587590526|FG000|Overall Study|Physician Decision|0|||
162694063|NCT02073097|587590527|FG001|Overall Study|Physician Decision|0|||
162694064|NCT02073097|587590528|FG002|Overall Study|Physician Decision|0|||
162694065|NCT02073097|587590529|FG003|Overall Study|Physician Decision|0|||
162694066|NCT02073097|587590530|FG004|Overall Study|Physician Decision|0|||
162694067|NCT02073097|587590531|FG005|Overall Study|Physician Decision|0|||
162694068|NCT02073097|587590532|FG006|Overall Study|Physician Decision|0|||
162729641|NCT01968109|587718181|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162694069|NCT02073097|587590533|FG007|Overall Study|Physician Decision|1|||
162694070|NCT03813147|587590536|FG000|Overall Study|Lack of Efficacy|4|||
162694071|NCT03813147|587590537|FG001|Overall Study|Lack of Efficacy|4|||
162694072|NCT03813147|587590536|FG000|Overall Study|Physician Decision|2|||
162694073|NCT03813147|587590537|FG001|Overall Study|Physician Decision|1|||
162694074|NCT01693692|587590538|FG000|Overall Study|Withdrawal by Subject|12|||
162694075|NCT01693692|587590539|FG001|Overall Study|Withdrawal by Subject|10|||
162694076|NCT01693692|587590540|FG002|Overall Study|Withdrawal by Subject|11|||
162694077|NCT01693692|587590538|FG000|Overall Study|Adverse Event|7|||
162694078|NCT01693692|587590539|FG001|Overall Study|Adverse Event|14|||
162694079|NCT01693692|587590540|FG002|Overall Study|Adverse Event|9|||
162694080|NCT01693692|587590538|FG000|Overall Study|Physician Decision|0|||
162694081|NCT01693692|587590539|FG001|Overall Study|Physician Decision|0|||
162694082|NCT01693692|587590540|FG002|Overall Study|Physician Decision|1|||
162694083|NCT01693692|587590538|FG000|Overall Study|Protocol Violation|5|||
162694084|NCT01693692|587590539|FG001|Overall Study|Protocol Violation|4|||
162694085|NCT01693692|587590540|FG002|Overall Study|Protocol Violation|6|||
162694086|NCT01693692|587590538|FG000|Overall Study|Lost to Follow-up|2|||
162694087|NCT01693692|587590539|FG001|Overall Study|Lost to Follow-up|2|||
162694088|NCT01693692|587590540|FG002|Overall Study|Lost to Follow-up|3|||
162694089|NCT01693692|587590538|FG000|Overall Study|Other|4|||
162694090|NCT01693692|587590539|FG001|Overall Study|Other|4|||
162694091|NCT01693692|587590540|FG002|Overall Study|Other|6|||
162694092|NCT04424290|587592446|FG000|Overall Study|Not treated|0|||
162694093|NCT04424290|587592447|FG001|Overall Study|Not treated|0|||
162694094|NCT04424290|587592448|FG002|Overall Study|Not treated|1|||
162694095|NCT04424290|587592449|FG003|Overall Study|Not treated|0|||
162694096|NCT04424290|587592450|FG004|Overall Study|Not treated|1|||
162694097|NCT04424290|587592446|FG000|Overall Study|Adverse Event|0|||
162694098|NCT04424290|587592447|FG001|Overall Study|Adverse Event|0|||
162694099|NCT04424290|587592448|FG002|Overall Study|Adverse Event|0|||
162694100|NCT04424290|587592449|FG003|Overall Study|Adverse Event|2|||
162694101|NCT04424290|587592450|FG004|Overall Study|Adverse Event|0|||
162694102|NCT04424290|587592446|FG000|Overall Study|Withdrawal by Subject|0|||
162694103|NCT04424290|587592447|FG001|Overall Study|Withdrawal by Subject|0|||
162694104|NCT04424290|587592448|FG002|Overall Study|Withdrawal by Subject|0|||
162694105|NCT04424290|587592449|FG003|Overall Study|Withdrawal by Subject|0|||
162694106|NCT04424290|587592450|FG004|Overall Study|Withdrawal by Subject|1|||
162694107|NCT04424290|587592446|FG000|Overall Study|Other than listed|0|||
162694108|NCT04424290|587592447|FG001|Overall Study|Other than listed|0|||
162694109|NCT04424290|587592448|FG002|Overall Study|Other than listed|0|||
162694110|NCT04424290|587592449|FG003|Overall Study|Other than listed|1|||
162694111|NCT04424290|587592450|FG004|Overall Study|Other than listed|0|||
162694112|NCT02914184|587592455|FG000|Overall Study|Lost to Follow-up|7|||
162694113|NCT02914184|587592456|FG001|Overall Study|Lost to Follow-up|10|||
162694114|NCT02914184|587592457|FG002|Overall Study|Lost to Follow-up|8|||
162694115|NCT02914184|587592458|FG003|Overall Study|Lost to Follow-up|7|||
162694116|NCT02914184|587592455|FG000|Overall Study|Withdrawal by Subject|4|||
162694117|NCT02914184|587592456|FG001|Overall Study|Withdrawal by Subject|2|||
162694118|NCT02914184|587592457|FG002|Overall Study|Withdrawal by Subject|7|||
162694119|NCT02914184|587592458|FG003|Overall Study|Withdrawal by Subject|3|||
162694120|NCT02914184|587592455|FG000|Overall Study|Other|1|||
162694121|NCT02914184|587592456|FG001|Overall Study|Other|0|||
162694122|NCT02914184|587592457|FG002|Overall Study|Other|0|||
162694123|NCT02914184|587592458|FG003|Overall Study|Other|0|||
162694124|NCT02914184|587592455|FG000|Overall Study|Migrated/moved from the study area|2|||
162694125|NCT02914184|587592456|FG001|Overall Study|Migrated/moved from the study area|1|||
162694126|NCT02914184|587592457|FG002|Overall Study|Migrated/moved from the study area|2|||
162694127|NCT02914184|587592458|FG003|Overall Study|Migrated/moved from the study area|1|||
162694128|NCT00798174|587592459|FG000|Overall Study|inability to implant azygos coil|3|||
162694129|NCT00798174|587592460|FG001|Overall Study|inability to implant azygos coil|3|||
162694130|NCT00798174|587592459|FG000|Overall Study|Inability to sedate for DFT testing|1|||
162694131|NCT00798174|587592460|FG001|Overall Study|Inability to sedate for DFT testing|0|||
162694132|NCT01683994|587592462|FG000|Overall Study|Withdrawal by Subject|1|||
162694133|NCT01683994|587592463|FG001|Overall Study|Withdrawal by Subject|0|||
162694134|NCT01683994|587592464|FG002|Overall Study|Withdrawal by Subject|0|||
162694135|NCT01683994|587592465|FG003|Overall Study|Withdrawal by Subject|1|||
162694136|NCT01683994|587592466|FG004|Overall Study|Withdrawal by Subject|0|||
162694137|NCT01683994|587592462|FG000|Overall Study|Intercurrent illness|0|||
162694138|NCT01683994|587592463|FG001|Overall Study|Intercurrent illness|0|||
162694139|NCT01683994|587592464|FG002|Overall Study|Intercurrent illness|0|||
162694140|NCT01683994|587592465|FG003|Overall Study|Intercurrent illness|2|||
162694141|NCT01683994|587592466|FG004|Overall Study|Intercurrent illness|1|||
162694142|NCT02318719|587592472|FG000|Double-blind Phase|Adverse Event|7|||
162694143|NCT02318719|587592473|FG001|Double-blind Phase|Adverse Event|6|||
162694144|NCT02318719|587592474|FG002|Double-blind Phase|Adverse Event|12|||
162694145|NCT02318719|587592475|FG003|Double-blind Phase|Adverse Event|4|||
162694146|NCT02318719|587592476|FG004|Double-blind Phase|Adverse Event|0|||
162694147|NCT02318719|587592472|FG000|Double-blind Phase|Lack of Efficacy|5|||
162694148|NCT02318719|587592473|FG001|Double-blind Phase|Lack of Efficacy|0|||
162694149|NCT02318719|587592474|FG002|Double-blind Phase|Lack of Efficacy|1|||
162694150|NCT02318719|587592475|FG003|Double-blind Phase|Lack of Efficacy|1|||
162694151|NCT02318719|587592476|FG004|Double-blind Phase|Lack of Efficacy|0|||
162694152|NCT02318719|587592472|FG000|Double-blind Phase|Protocol Violation|0|||
162694153|NCT02318719|587592473|FG001|Double-blind Phase|Protocol Violation|1|||
162694154|NCT02318719|587592474|FG002|Double-blind Phase|Protocol Violation|3|||
162694155|NCT02318719|587592475|FG003|Double-blind Phase|Protocol Violation|0|||
162694156|NCT02318719|587592476|FG004|Double-blind Phase|Protocol Violation|0|||
162694157|NCT02318719|587592472|FG000|Double-blind Phase|Withdrawal by Subject|25|||
162694158|NCT02318719|587592473|FG001|Double-blind Phase|Withdrawal by Subject|7|||
162694159|NCT02318719|587592474|FG002|Double-blind Phase|Withdrawal by Subject|9|||
162694160|NCT02318719|587592475|FG003|Double-blind Phase|Withdrawal by Subject|10|||
162694161|NCT02318719|587592476|FG004|Double-blind Phase|Withdrawal by Subject|0|||
162694162|NCT02318719|587592472|FG000|Double-blind Phase|Other|1|||
162694163|NCT02318719|587592473|FG001|Double-blind Phase|Other|2|||
162694164|NCT02318719|587592474|FG002|Double-blind Phase|Other|0|||
162694165|NCT02318719|587592475|FG003|Double-blind Phase|Other|0|||
162694166|NCT02318719|587592476|FG004|Double-blind Phase|Other|0|||
162694167|NCT02318719|587592472|FG000|Open-label Extension Phase|Adverse Event|0|||
162694168|NCT02318719|587592473|FG001|Open-label Extension Phase|Adverse Event|0|||
162694169|NCT02318719|587592474|FG002|Open-label Extension Phase|Adverse Event|0|||
162694170|NCT02318719|587592475|FG003|Open-label Extension Phase|Adverse Event|0|||
162694171|NCT02318719|587592476|FG004|Open-label Extension Phase|Adverse Event|15|||
162694172|NCT02318719|587592472|FG000|Open-label Extension Phase|Death|0|||
162694173|NCT02318719|587592473|FG001|Open-label Extension Phase|Death|0|||
162694174|NCT02318719|587592474|FG002|Open-label Extension Phase|Death|0|||
162694175|NCT02318719|587592475|FG003|Open-label Extension Phase|Death|0|||
162694176|NCT02318719|587592476|FG004|Open-label Extension Phase|Death|1|||
162694177|NCT02318719|587592472|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
162694178|NCT02318719|587592473|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
162694179|NCT02318719|587592474|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
162694180|NCT02318719|587592475|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
162694181|NCT02318719|587592476|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
162694182|NCT02318719|587592472|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
162694183|NCT02318719|587592473|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
162694184|NCT02318719|587592474|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
162694185|NCT02318719|587592475|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
162694186|NCT02318719|587592476|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
162694187|NCT02318719|587592472|FG000|Open-label Extension Phase|Other|0|||
162694188|NCT02318719|587592473|FG001|Open-label Extension Phase|Other|0|||
162694189|NCT02318719|587592474|FG002|Open-label Extension Phase|Other|0|||
162694190|NCT02318719|587592475|FG003|Open-label Extension Phase|Other|0|||
162694191|NCT02318719|587592476|FG004|Open-label Extension Phase|Other|7|||
162694192|NCT00802659|587592477|FG000|Overall Study|Physician Decision|0|||
162694193|NCT00802659|587592478|FG001|Overall Study|Physician Decision|1|||
162694194|NCT00802659|587592479|FG002|Overall Study|Physician Decision|0|||
162694195|NCT00802659|587592480|FG003|Overall Study|Physician Decision|0|||
162694196|NCT00806624|587592481|FG000|Overall Study|Adverse Event|2|||
162694197|NCT00806624|587592482|FG001|Overall Study|Adverse Event|8|||
162694198|NCT00806624|587592483|FG002|Overall Study|Adverse Event|0|||
162694199|NCT00806624|587592481|FG000|Overall Study|Death|0|||
162694200|NCT00806624|587592482|FG001|Overall Study|Death|1|||
162694201|NCT00806624|587592483|FG002|Overall Study|Death|1|||
162694202|NCT00806624|587592481|FG000|Overall Study|Lost to Follow-up|1|||
162694203|NCT00806624|587592482|FG001|Overall Study|Lost to Follow-up|0|||
162694204|NCT00806624|587592483|FG002|Overall Study|Lost to Follow-up|1|||
162694205|NCT00806624|587592481|FG000|Overall Study|Withdrawal by Subject|6|||
162694206|NCT00806624|587592482|FG001|Overall Study|Withdrawal by Subject|3|||
162694207|NCT00806624|587592483|FG002|Overall Study|Withdrawal by Subject|3|||
162694208|NCT00806624|587592481|FG000|Overall Study|discontinued before start of treatment|0|||
162694209|NCT00806624|587592482|FG001|Overall Study|discontinued before start of treatment|0|||
162694210|NCT00806624|587592483|FG002|Overall Study|discontinued before start of treatment|1|||
162694211|NCT03093428|587592484|FG000|Overall Study|Not eligible for treatment|2|||
162694212|NCT03093428|587592485|FG001|Overall Study|Not eligible for treatment|1|||
162694213|NCT03093428|587592484|FG000|Overall Study|Progression|14|||
162694214|NCT03093428|587592485|FG001|Overall Study|Progression|4|||
162694215|NCT03093428|587592484|FG000|Overall Study|Death|1|||
162694216|NCT03093428|587592485|FG001|Overall Study|Death|0|||
162694217|NCT03093428|587592484|FG000|Overall Study|Adverse Event|1|||
162694218|NCT03093428|587592485|FG001|Overall Study|Adverse Event|0|||
162694219|NCT03093428|587592484|FG000|Overall Study|Withdrawal by Subject|1|||
162694220|NCT03093428|587592485|FG001|Overall Study|Withdrawal by Subject|1|||
162694221|NCT01336634|587592489|FG000|Overall Study|Study closed/terminated|5|||
162694222|NCT01336634|587592490|FG001|Overall Study|Study closed/terminated|6|||
162694223|NCT01336634|587592491|FG002|Overall Study|Study closed/terminated|6|||
162694224|NCT01336634|587592489|FG000|Overall Study|Lost to Follow-up|2|||
162694225|NCT01336634|587592490|FG001|Overall Study|Lost to Follow-up|1|||
162694226|NCT01336634|587592491|FG002|Overall Study|Lost to Follow-up|1|||
162694227|NCT01336634|587592489|FG000|Overall Study|Physician Decision|1|||
162694228|NCT01336634|587592490|FG001|Overall Study|Physician Decision|1|||
162694229|NCT01336634|587592491|FG002|Overall Study|Physician Decision|0|||
162694230|NCT01336634|587592489|FG000|Overall Study|Withdrawal by Subject|6|||
162694231|NCT01336634|587592490|FG001|Overall Study|Withdrawal by Subject|0|||
162694232|NCT01336634|587592491|FG002|Overall Study|Withdrawal by Subject|2|||
162694233|NCT01973491|587592492|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
162694234|NCT01973491|587592492|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
162694235|NCT01973491|587592492|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
162694236|NCT01863043|587592496|FG000|Overall Study|Death|6|||
162694237|NCT01863043|587592497|FG001|Overall Study|Death|1|||
162694238|NCT01863043|587592496|FG000|Overall Study|Withdrawal by Subject|0|||
162694239|NCT01863043|587592497|FG001|Overall Study|Withdrawal by Subject|2|||
162694240|NCT01863043|587592496|FG000|Overall Study|Adverse Event|7|||
162694241|NCT01863043|587592497|FG001|Overall Study|Adverse Event|8|||
162694242|NCT01863043|587592496|FG000|Overall Study|exclusion criteria found after enrollment|0|||
162694243|NCT01863043|587592497|FG001|Overall Study|exclusion criteria found after enrollment|1|||
162694244|NCT00313911|587592498|FG000|Overall Study|Serious adverse event|6|||
162694245|NCT00313911|587592499|FG001|Overall Study|Serious adverse event|1|||
162694246|NCT00313911|587592498|FG000|Overall Study|Adverse Event|2|||
162694247|NCT00313911|587592499|FG001|Overall Study|Adverse Event|3|||
162694248|NCT00313911|587592498|FG000|Overall Study|Protocol Violation|19|||
162694249|NCT00313911|587592499|FG001|Overall Study|Protocol Violation|10|||
162694250|NCT00313911|587592498|FG000|Overall Study|Lost to Follow-up|27|||
162694251|NCT00313911|587592499|FG001|Overall Study|Lost to Follow-up|14|||
162694252|NCT00313911|587592498|FG000|Overall Study|Withdrawal by Subject|39|||
162694253|NCT00313911|587592499|FG001|Overall Study|Withdrawal by Subject|12|||
162694254|NCT00313911|587592498|FG000|Overall Study|Did not meet age criteria|1|||
162694255|NCT00313911|587592499|FG001|Overall Study|Did not meet age criteria|1|||
162694256|NCT01987596|587592500|FG000|Overall Study|Physician Decision|1|||
162694257|NCT01987596|587592501|FG001|Overall Study|Physician Decision|0|||
162694258|NCT01987596|587592500|FG000|Overall Study|Progressive Disease; missing all period|0|||
162694259|NCT01987596|587592501|FG001|Overall Study|Progressive Disease; missing all period|1|||
162694260|NCT02632786|587592504|FG000|Overall Study|Adverse Event|2|||
162694261|NCT02632786|587592505|FG001|Overall Study|Adverse Event|1|||
162694262|NCT02632786|587592504|FG000|Overall Study|Death|3|||
162694263|NCT02632786|587592505|FG001|Overall Study|Death|2|||
162694264|NCT02632786|587592504|FG000|Overall Study|Physician Decision|5|||
162694265|NCT02632786|587592505|FG001|Overall Study|Physician Decision|4|||
162694266|NCT02632786|587592504|FG000|Overall Study|Withdrawal by Subject|1|||
162694267|NCT02632786|587592505|FG001|Overall Study|Withdrawal by Subject|0|||
162694268|NCT00709592|587592506|FG000|Overall Study|Unable to proceed to transplant|0|||
162694269|NCT00709592|587592507|FG001|Overall Study|Unable to proceed to transplant|1|||
162694270|NCT00451217|587592509|FG000|Overall Study|Lost to Follow-up|0|||
162694271|NCT00451217|587592510|FG001|Overall Study|Lost to Follow-up|1|||
162694272|NCT00451217|587592511|FG002|Overall Study|Lost to Follow-up|1|||
162694273|NCT00451217|587592512|FG003|Overall Study|Lost to Follow-up|1|||
162694274|NCT00451217|587592509|FG000|Overall Study|Withdrawal by Subject|1|||
162694275|NCT00451217|587592510|FG001|Overall Study|Withdrawal by Subject|0|||
162694276|NCT00451217|587592511|FG002|Overall Study|Withdrawal by Subject|0|||
162694277|NCT00451217|587592512|FG003|Overall Study|Withdrawal by Subject|0|||
162694278|NCT00451217|587592509|FG000|Overall Study|Not Treated|1|||
162694279|NCT00451217|587592510|FG001|Overall Study|Not Treated|1|||
162694280|NCT00451217|587592511|FG002|Overall Study|Not Treated|3|||
162694281|NCT00451217|587592512|FG003|Overall Study|Not Treated|4|||
162694282|NCT03154359|587592515|FG000|Overall Study|Adverse Event|1|||
162694283|NCT03154359|587592515|FG000|Overall Study|Lack of Efficacy|2|||
162694284|NCT03154359|587592515|FG000|Overall Study|Lost to Follow-up|3|||
162694285|NCT03154359|587592515|FG000|Overall Study|Physician Decision|3|||
162694286|NCT03154359|587592515|FG000|Overall Study|Protocol Violation|4|||
162694287|NCT03154359|587592515|FG000|Overall Study|Withdrawal by Subject|5|||
162694288|NCT03154359|587592515|FG000|Overall Study|Disruption of study due to COVID-19|4|||
162694289|NCT00569803|587592518|FG000|Overall Study|Lost to Follow-up|1|||
162694290|NCT00569803|587592519|FG001|Overall Study|Lost to Follow-up|0|||
162694291|NCT00569803|587592520|FG002|Overall Study|Lost to Follow-up|0|||
162694292|NCT00569803|587592521|FG003|Overall Study|Lost to Follow-up|0|||
162694293|NCT00569803|587592522|FG004|Overall Study|Lost to Follow-up|0|||
162694294|NCT00569803|587592523|FG005|Overall Study|Lost to Follow-up|0|||
162694295|NCT00569803|587592524|FG006|Overall Study|Lost to Follow-up|0|||
162694296|NCT00569803|587592525|FG007|Overall Study|Lost to Follow-up|0|||
162694297|NCT00569803|587592518|FG000|Overall Study|injection syringe leaked during dosing|0|||
162694298|NCT00569803|587592519|FG001|Overall Study|injection syringe leaked during dosing|0|||
162694299|NCT00569803|587592520|FG002|Overall Study|injection syringe leaked during dosing|0|||
162694300|NCT00569803|587592521|FG003|Overall Study|injection syringe leaked during dosing|1|||
162694301|NCT00569803|587592522|FG004|Overall Study|injection syringe leaked during dosing|0|||
162694302|NCT00569803|587592523|FG005|Overall Study|injection syringe leaked during dosing|0|||
162694303|NCT00569803|587592524|FG006|Overall Study|injection syringe leaked during dosing|0|||
162694304|NCT00569803|587592525|FG007|Overall Study|injection syringe leaked during dosing|0|||
162694305|NCT00569803|587592518|FG000|Overall Study|Withdrawal by Subject|0|||
162694306|NCT00569803|587592519|FG001|Overall Study|Withdrawal by Subject|0|||
162694307|NCT00569803|587592520|FG002|Overall Study|Withdrawal by Subject|0|||
162694308|NCT00569803|587592521|FG003|Overall Study|Withdrawal by Subject|0|||
162694309|NCT00569803|587592522|FG004|Overall Study|Withdrawal by Subject|0|||
162694310|NCT00569803|587592523|FG005|Overall Study|Withdrawal by Subject|0|||
162694311|NCT00569803|587592524|FG006|Overall Study|Withdrawal by Subject|0|||
162694312|NCT00569803|587592525|FG007|Overall Study|Withdrawal by Subject|1|||
162694313|NCT01592695|587592529|FG000|Overall Study|Lost to Follow-up|8|||
162694314|NCT01592695|587592530|FG001|Overall Study|Lost to Follow-up|4|||
162694315|NCT00422799|587592531|FG000|Overall Study|Withdrawal by Subject|6|||
162694316|NCT00422799|587592531|FG000|Overall Study|Adverse Event|7|||
162694317|NCT03029780|587592535|FG000|Overall Study|Disease Progression|20|||
162694318|NCT03029780|587592536|FG001|Overall Study|Disease Progression|22|||
162694319|NCT03029780|587592535|FG000|Overall Study|Study Drug Toxicity|15|||
162694320|NCT03029780|587592536|FG001|Overall Study|Study Drug Toxicity|11|||
162694321|NCT03029780|587592535|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
162694322|NCT03029780|587592536|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
162694323|NCT03029780|587592535|FG000|Overall Study|Participant request to discontinue study treatment|4|||
162694324|NCT03029780|587592536|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162694325|NCT03029780|587592535|FG000|Overall Study|Maximum clinical benefit|1|||
162694326|NCT03029780|587592536|FG001|Overall Study|Maximum clinical benefit|0|||
162694327|NCT03029780|587592535|FG000|Overall Study|Participant no longer meets study criteria|0|||
162694328|NCT03029780|587592536|FG001|Overall Study|Participant no longer meets study criteria|1|||
162694329|NCT03029780|587592535|FG000|Overall Study|Other reasons|6|||
162694330|NCT03029780|587592536|FG001|Overall Study|Other reasons|6|||
162694331|NCT03029780|587592535|FG000|Overall Study|Not reported|1|||
162694332|NCT03029780|587592536|FG001|Overall Study|Not reported|1|||
162694333|NCT03029780|587592535|FG000|Overall Study|Death|2|||
162694334|NCT03029780|587592536|FG001|Overall Study|Death|6|||
162694335|NCT00178256|587592537|FG000|Overall Study|Adverse Event|2|||
162694336|NCT00178256|587592538|FG001|Overall Study|Adverse Event|0|||
162694337|NCT00178256|587592539|FG002|Overall Study|Adverse Event|0|||
162694338|NCT00178256|587592540|FG003|Overall Study|Adverse Event|0|||
162694339|NCT00178256|587592537|FG000|Overall Study|Death|0|||
162694340|NCT00178256|587592538|FG001|Overall Study|Death|1|||
162694341|NCT00178256|587592539|FG002|Overall Study|Death|0|||
162694342|NCT00178256|587592540|FG003|Overall Study|Death|1|||
162694343|NCT00178256|587592537|FG000|Overall Study|Cancer progression|2|||
162694344|NCT00178256|587592538|FG001|Overall Study|Cancer progression|0|||
162694345|NCT00178256|587592539|FG002|Overall Study|Cancer progression|0|||
162694346|NCT00178256|587592540|FG003|Overall Study|Cancer progression|1|||
162694347|NCT03066622|587592541|FG000|Overall Study|Lost to Follow-up|24|||
162694348|NCT03066622|587592542|FG001|Overall Study|Lost to Follow-up|25|||
162694349|NCT03066622|587592541|FG000|Overall Study|Withdrawal by Subject|2|||
162694350|NCT03066622|587592542|FG001|Overall Study|Withdrawal by Subject|1|||
162694351|NCT01763788|587592543|FG000|Overall Study|Lost to Follow-up|0|||
162694352|NCT01763788|587592544|FG001|Overall Study|Lost to Follow-up|0|||
162694353|NCT01763788|587592545|FG002|Overall Study|Lost to Follow-up|1|||
162694354|NCT01763788|587592546|FG003|Overall Study|Lost to Follow-up|0|||
162694355|NCT03321006|587592547|FG000|Overall Study|Death|1|||
162694356|NCT03321006|587592548|FG001|Overall Study|Death|0|||
162694357|NCT03321006|587592547|FG000|Overall Study|Lack of Efficacy|1|||
162694358|NCT03321006|587592548|FG001|Overall Study|Lack of Efficacy|0|||
162694359|NCT02006121|587592551|FG000|Double Blind Phase|Adverse Event|6|||
162694360|NCT02006121|587592552|FG001|Double Blind Phase|Adverse Event|0|||
162694361|NCT02006121|587592551|FG000|Double Blind Phase|Lack of Efficacy|1|||
162694362|NCT02006121|587592552|FG001|Double Blind Phase|Lack of Efficacy|16|||
162694363|NCT02006121|587592551|FG000|Double Blind Phase|Withdrawal by Subject|3|||
162694364|NCT02006121|587592552|FG001|Double Blind Phase|Withdrawal by Subject|4|||
162694365|NCT02006121|587592551|FG000|Double Blind Phase|Non-compliance with study drug|1|||
162694366|NCT02006121|587592552|FG001|Double Blind Phase|Non-compliance with study drug|3|||
162694367|NCT02006121|587592551|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
162694368|NCT02006121|587592552|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
162694369|NCT02006121|587592551|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
162694370|NCT02006121|587592552|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
162694371|NCT02006121|587592551|FG000|Open Label Phase|Adverse Event|15|||
162694372|NCT02006121|587592552|FG001|Open Label Phase|Adverse Event|0|||
162694373|NCT02006121|587592551|FG000|Open Label Phase|Lack of Efficacy|2|||
162694374|NCT02006121|587592552|FG001|Open Label Phase|Lack of Efficacy|0|||
162694375|NCT02006121|587592551|FG000|Open Label Phase|Protocol Violation|2|||
162694376|NCT02006121|587592552|FG001|Open Label Phase|Protocol Violation|0|||
162694377|NCT02006121|587592551|FG000|Open Label Phase|Withdrawal by Subject|3|||
162694378|NCT02006121|587592552|FG001|Open Label Phase|Withdrawal by Subject|0|||
162694379|NCT02006121|587592551|FG000|Open Label Phase|Non-compliance with study drug|3|||
162694380|NCT02006121|587592552|FG001|Open Label Phase|Non-compliance with study drug|0|||
162694381|NCT04498247|587592556|FG000|Overall Study|Lost to Follow-up|0|||
162694382|NCT04498247|587592557|FG001|Overall Study|Lost to Follow-up|0|||
162694383|NCT04498247|587592558|FG002|Overall Study|Lost to Follow-up|0|||
162694384|NCT04498247|587592559|FG003|Overall Study|Lost to Follow-up|1|||
162694385|NCT04498247|587592560|FG004|Overall Study|Lost to Follow-up|0|||
162694386|NCT04498247|587592561|FG005|Overall Study|Lost to Follow-up|0|||
162694387|NCT04498247|587592562|FG006|Overall Study|Lost to Follow-up|0|||
162694388|NCT04498247|587592563|FG007|Overall Study|Lost to Follow-up|0|||
162694389|NCT04498247|587592556|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
162694390|NCT04498247|587592557|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
162729642|NCT01968109|587718182|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729643|NCT01968109|587718183|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729644|NCT01968109|587718184|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729645|NCT01968109|587718185|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729646|NCT01968109|587718186|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729647|NCT01968109|587718187|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162729648|NCT01968109|587718188|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162729649|NCT01968109|587718189|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729650|NCT01968109|587718190|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162729651|NCT01968109|587718191|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729652|NCT01968109|587718192|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162729653|NCT01968109|587718193|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729654|NCT01968109|587718194|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162729655|NCT01968109|587718195|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162729656|NCT01968109|587718196|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162729657|NCT01968109|587718197|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162729658|NCT01968109|587718198|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162729659|NCT01968109|587718199|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162729660|NCT01968109|587718200|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162729661|NCT01968109|587718201|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162729662|NCT01968109|587718202|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162729663|NCT01968109|587718203|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
162729664|NCT01968109|587718204|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
162729665|NCT01968109|587718205|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162729666|NCT01968109|587718206|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162729667|NCT01968109|587718207|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162729668|NCT01968109|587718208|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162729669|NCT01968109|587718209|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162729670|NCT01968109|587718179|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729671|NCT01968109|587718180|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729672|NCT01968109|587718181|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729673|NCT01968109|587718182|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729674|NCT01968109|587718183|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729675|NCT01968109|587718184|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729676|NCT01968109|587718185|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729677|NCT01968109|587718186|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729678|NCT01968109|587718187|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729679|NCT01968109|587718188|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729680|NCT01968109|587718189|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729681|NCT01968109|587718190|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729682|NCT01968109|587718191|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729683|NCT01968109|587718192|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729684|NCT01968109|587718193|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729685|NCT01968109|587718194|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
162729686|NCT01968109|587718195|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
162729687|NCT01968109|587718196|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729688|NCT01968109|587718197|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729689|NCT01968109|587718198|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729690|NCT01968109|587718199|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
162729691|NCT01968109|587718200|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729692|NCT01968109|587718201|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729693|NCT01968109|587718202|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
162729694|NCT01968109|587718203|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
162729695|NCT01968109|587718204|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729696|NCT01968109|587718205|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729697|NCT01968109|587718206|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
162729698|NCT01968109|587718207|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729699|NCT01968109|587718208|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162729700|NCT01968109|587718209|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162729701|NCT01968109|587718179|FG000|Overall Study|OTHER REASONS|0|||
162729702|NCT01968109|587718180|FG001|Overall Study|OTHER REASONS|0|||
162729703|NCT01968109|587718181|FG002|Overall Study|OTHER REASONS|0|||
162729704|NCT01968109|587718182|FG003|Overall Study|OTHER REASONS|1|||
162729705|NCT01968109|587718183|FG004|Overall Study|OTHER REASONS|0|||
162729706|NCT01968109|587718184|FG005|Overall Study|OTHER REASONS|0|||
162729707|NCT01968109|587718185|FG006|Overall Study|OTHER REASONS|0|||
162729708|NCT01968109|587718186|FG007|Overall Study|OTHER REASONS|0|||
162729709|NCT01968109|587718187|FG008|Overall Study|OTHER REASONS|0|||
162729710|NCT01968109|587718188|FG009|Overall Study|OTHER REASONS|0|||
162729711|NCT01968109|587718189|FG010|Overall Study|OTHER REASONS|0|||
162729712|NCT01968109|587718190|FG011|Overall Study|OTHER REASONS|1|||
162729713|NCT01968109|587718191|FG012|Overall Study|OTHER REASONS|0|||
162729714|NCT01968109|587718192|FG013|Overall Study|OTHER REASONS|0|||
162729715|NCT01968109|587718193|FG014|Overall Study|OTHER REASONS|1|||
162729716|NCT01968109|587718194|FG015|Overall Study|OTHER REASONS|1|||
162729717|NCT01968109|587718195|FG016|Overall Study|OTHER REASONS|1|||
162729718|NCT01968109|587718196|FG017|Overall Study|OTHER REASONS|0|||
162729719|NCT01968109|587718197|FG018|Overall Study|OTHER REASONS|0|||
162729720|NCT01968109|587718198|FG019|Overall Study|OTHER REASONS|0|||
162729721|NCT01968109|587718199|FG020|Overall Study|OTHER REASONS|0|||
162729722|NCT01968109|587718200|FG021|Overall Study|OTHER REASONS|2|||
162729723|NCT01968109|587718201|FG022|Overall Study|OTHER REASONS|0|||
162729724|NCT01968109|587718202|FG023|Overall Study|OTHER REASONS|0|||
162729725|NCT01968109|587718203|FG024|Overall Study|OTHER REASONS|3|||
162729726|NCT01968109|587718204|FG025|Overall Study|OTHER REASONS|0|||
162729727|NCT01968109|587718205|FG026|Overall Study|OTHER REASONS|3|||
162729728|NCT01968109|587718206|FG027|Overall Study|OTHER REASONS|3|||
162729729|NCT01968109|587718207|FG028|Overall Study|OTHER REASONS|6|||
162729730|NCT01968109|587718208|FG029|Overall Study|OTHER REASONS|7|||
162729731|NCT01968109|587718209|FG030|Overall Study|OTHER REASONS|3|||
162729732|NCT01968109|587718179|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729733|NCT01968109|587718180|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729734|NCT01968109|587718181|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729735|NCT01968109|587718182|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729736|NCT01968109|587718183|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729737|NCT01968109|587718184|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729738|NCT01968109|587718185|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729739|NCT01968109|587718186|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729740|NCT01968109|587718187|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729741|NCT01968109|587718188|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729742|NCT01968109|587718189|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729743|NCT01968109|587718190|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729744|NCT01968109|587718191|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729745|NCT01968109|587718192|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729746|NCT01968109|587718193|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729747|NCT01968109|587718194|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729748|NCT01968109|587718195|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
162729749|NCT01968109|587718196|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162729750|NCT01968109|587718197|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729751|NCT01968109|587718198|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162729752|NCT01968109|587718199|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162729753|NCT01968109|587718200|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729754|NCT01968109|587718201|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729755|NCT01968109|587718202|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729756|NCT01968109|587718203|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162729757|NCT01968109|587718204|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162729758|NCT01968109|587718205|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162729759|NCT01968109|587718206|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162729760|NCT01968109|587718207|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
162729761|NCT01968109|587718208|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
162729762|NCT01968109|587718209|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162729763|NCT01968109|587718179|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729764|NCT01968109|587718180|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729765|NCT01968109|587718181|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729766|NCT01968109|587718182|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729767|NCT01968109|587718183|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729768|NCT01968109|587718184|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729769|NCT01968109|587718185|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729770|NCT01968109|587718186|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729771|NCT01968109|587718187|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729772|NCT01968109|587718188|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729773|NCT01968109|587718189|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729774|NCT01968109|587718190|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729775|NCT01968109|587718191|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729776|NCT01968109|587718192|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729777|NCT01968109|587718193|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729778|NCT01968109|587718194|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729779|NCT01968109|587718195|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729780|NCT01968109|587718196|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729781|NCT01968109|587718197|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729782|NCT01968109|587718198|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729783|NCT01968109|587718199|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
162729784|NCT01968109|587718200|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729785|NCT01968109|587718201|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729786|NCT01968109|587718202|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
162729787|NCT01968109|587718203|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729788|NCT01968109|587718204|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729789|NCT01968109|587718205|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729790|NCT01968109|587718206|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729791|NCT01968109|587718207|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729792|NCT01968109|587718208|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729793|NCT01968109|587718209|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162729794|NCT01968109|587718179|FG000|Overall Study|Death|0|||
162729795|NCT01968109|587718180|FG001|Overall Study|Death|0|||
162729796|NCT01968109|587718181|FG002|Overall Study|Death|0|||
162729797|NCT01968109|587718182|FG003|Overall Study|Death|0|||
162729798|NCT01968109|587718183|FG004|Overall Study|Death|0|||
162729799|NCT01968109|587718184|FG005|Overall Study|Death|0|||
162729800|NCT01968109|587718185|FG006|Overall Study|Death|0|||
162729801|NCT01968109|587718186|FG007|Overall Study|Death|0|||
162729802|NCT01968109|587718187|FG008|Overall Study|Death|0|||
162729803|NCT01968109|587718188|FG009|Overall Study|Death|0|||
162729804|NCT01968109|587718189|FG010|Overall Study|Death|0|||
162729805|NCT01968109|587718190|FG011|Overall Study|Death|0|||
162729806|NCT01968109|587718191|FG012|Overall Study|Death|0|||
162729807|NCT01968109|587718192|FG013|Overall Study|Death|0|||
162729808|NCT01968109|587718193|FG014|Overall Study|Death|0|||
162729809|NCT01968109|587718194|FG015|Overall Study|Death|0|||
162729810|NCT01968109|587718195|FG016|Overall Study|Death|0|||
162729811|NCT01968109|587718196|FG017|Overall Study|Death|0|||
162729812|NCT01968109|587718197|FG018|Overall Study|Death|0|||
162729813|NCT01968109|587718198|FG019|Overall Study|Death|0|||
162729814|NCT01968109|587718199|FG020|Overall Study|Death|0|||
162729815|NCT01968109|587718200|FG021|Overall Study|Death|1|||
162729816|NCT01968109|587718201|FG022|Overall Study|Death|0|||
162694391|NCT04498247|587592558|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694392|NCT04498247|587592559|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694393|NCT04498247|587592560|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694394|NCT04498247|587592561|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694395|NCT04498247|587592562|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694396|NCT04498247|587592563|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
162694397|NCT04498247|587592556|FG000|Overall Study|Withdrawal by Subject|0|||
162694398|NCT04498247|587592557|FG001|Overall Study|Withdrawal by Subject|8|||
162694399|NCT04498247|587592558|FG002|Overall Study|Withdrawal by Subject|0|||
162694400|NCT04498247|587592559|FG003|Overall Study|Withdrawal by Subject|7|||
162694401|NCT04498247|587592560|FG004|Overall Study|Withdrawal by Subject|0|||
162694402|NCT04498247|587592561|FG005|Overall Study|Withdrawal by Subject|0|||
162694403|NCT04498247|587592562|FG006|Overall Study|Withdrawal by Subject|1|||
162694404|NCT04498247|587592563|FG007|Overall Study|Withdrawal by Subject|0|||
162694405|NCT04498247|587592556|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162694406|NCT04498247|587592557|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
162694407|NCT04498247|587592558|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162694408|NCT04498247|587592559|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
162694409|NCT04498247|587592560|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162694410|NCT04498247|587592561|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162694411|NCT04498247|587592562|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
162694412|NCT04498247|587592563|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162694413|NCT01737996|587592564|FG000|Overall Study|Adverse Event|0|||
162694414|NCT01737996|587592565|FG001|Overall Study|Adverse Event|1|||
162694415|NCT01737996|587592566|FG002|Overall Study|Adverse Event|1|||
162694416|NCT01737996|587592564|FG000|Overall Study|Withdrawal by Subject|0|||
162694417|NCT01737996|587592565|FG001|Overall Study|Withdrawal by Subject|0|||
162694418|NCT01737996|587592566|FG002|Overall Study|Withdrawal by Subject|1|||
162694419|NCT01003184|587592567|FG000|Overall Study|Adverse Event|12|||
162694420|NCT01003184|587592568|FG001|Overall Study|Adverse Event|5|||
162694421|NCT01003184|587592567|FG000|Overall Study|Lost to Follow-up|1|||
162694422|NCT01003184|587592568|FG001|Overall Study|Lost to Follow-up|0|||
162694423|NCT01003184|587592567|FG000|Overall Study|Loss of glucose control|1|||
162694424|NCT01003184|587592568|FG001|Overall Study|Loss of glucose control|1|||
162694425|NCT01003184|587592567|FG000|Overall Study|Protocol Violation|3|||
162729817|NCT01968109|587718202|FG023|Overall Study|Death|0|||
162729818|NCT01968109|587718203|FG024|Overall Study|Death|0|||
162729819|NCT01968109|587718204|FG025|Overall Study|Death|0|||
162729820|NCT01968109|587718205|FG026|Overall Study|Death|0|||
162729821|NCT01968109|587718206|FG027|Overall Study|Death|0|||
162729822|NCT01968109|587718207|FG028|Overall Study|Death|0|||
162729823|NCT01968109|587718208|FG029|Overall Study|Death|0|||
162694426|NCT01003184|587592568|FG001|Overall Study|Protocol Violation|0|||
162694427|NCT01003184|587592567|FG000|Overall Study|Withdrawal by Subject|1|||
162729824|NCT01968109|587718209|FG030|Overall Study|Death|1|||
162729825|NCT06938230|587718210|FG000|Overall Study|Lost to Follow-up|56|||
162729826|NCT06938230|587718211|FG001|Overall Study|Lost to Follow-up|18|||
162729827|NCT04310735|587719227|FG000|Overall Study|Withdrawal by Subject|1|||
162729828|NCT04310735|587719228|FG001|Overall Study|Withdrawal by Subject|3|||
162729829|NCT04310735|587719229|FG002|Overall Study|Withdrawal by Subject|8|||
162729830|NCT04310735|587719227|FG000|Overall Study|Equipment malfunction|0|||
162729831|NCT04310735|587719228|FG001|Overall Study|Equipment malfunction|1|||
162729832|NCT04310735|587719229|FG002|Overall Study|Equipment malfunction|0|||
162729833|NCT03012841|587719230|FG000|Overall Study|Protocol Violation|0|||
162729834|NCT03012841|587719231|FG001|Overall Study|Protocol Violation|10|||
162729835|NCT03012841|587719230|FG000|Overall Study|Lost to Follow-up|6|||
162729836|NCT03012841|587719231|FG001|Overall Study|Lost to Follow-up|1|||
162729837|NCT03012841|587719230|FG000|Overall Study|Withdrawal by Subject|6|||
162729838|NCT03012841|587719231|FG001|Overall Study|Withdrawal by Subject|0|||
162729839|NCT03012841|587719230|FG000|Overall Study|Unable to complete 12 month visit|6|||
162729840|NCT03012841|587719231|FG001|Overall Study|Unable to complete 12 month visit|0|||
162729841|NCT03012841|587719230|FG000|Overall Study|Subject relocation|1|||
162729842|NCT03012841|587719231|FG001|Overall Study|Subject relocation|0|||
162729843|NCT03012841|587719230|FG000|Overall Study|Seasonal winter travel|1|||
162729844|NCT03012841|587719231|FG001|Overall Study|Seasonal winter travel|0|||
162729845|NCT03012841|587719230|FG000|Overall Study|Physician Decision|0|||
162729846|NCT03012841|587719231|FG001|Overall Study|Physician Decision|2|||
162729847|NCT03012841|587719230|FG000|Overall Study|No ablation performed|0|||
162729848|NCT03012841|587719231|FG001|Overall Study|No ablation performed|2|||
162729849|NCT03012841|587719230|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
162729850|NCT03012841|587719231|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
162729851|NCT03012841|587719230|FG000|Overall Study|Insurance change|0|||
162729852|NCT03012841|587719231|FG001|Overall Study|Insurance change|1|||
162729853|NCT05696080|587719232|FG000|Overall Study|Lost to Follow-up|2|||
162729854|NCT05696080|587719233|FG001|Overall Study|Lost to Follow-up|1|||
162729855|NCT05696080|587719232|FG000|Overall Study|Physician Decision|1|||
162729856|NCT05696080|587719233|FG001|Overall Study|Physician Decision|0|||
162729857|NCT05696080|587719232|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162729858|NCT05696080|587719233|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162729859|NCT05696080|587719232|FG000|Overall Study|Withdrawal by Subject|12|||
162729860|NCT05696080|587719233|FG001|Overall Study|Withdrawal by Subject|0|||
162729861|NCT03398200|587719234|FG000|Overall Study|Withdrawal by Subject|0|||
162729862|NCT03398200|587719235|FG001|Overall Study|Withdrawal by Subject|1|||
162729863|NCT04065048|587719236|FG000|Overall Study|Withdrawal by Subject|1|||
162729864|NCT04065048|587719237|FG001|Overall Study|Withdrawal by Subject|2|||
162729865|NCT04065048|587719238|FG002|Overall Study|Withdrawal by Subject|1|||
162729866|NCT04065048|587719239|FG003|Overall Study|Withdrawal by Subject|1|||
162729867|NCT04065048|587719236|FG000|Overall Study|Adverse Event|1|||
162729868|NCT04065048|587719237|FG001|Overall Study|Adverse Event|0|||
162729869|NCT04065048|587719238|FG002|Overall Study|Adverse Event|1|||
162729870|NCT04065048|587719239|FG003|Overall Study|Adverse Event|0|||
162729871|NCT03397108|587719240|FG000|Overall Study|Lost to Follow-up|15|||
162729872|NCT03397108|587719241|FG001|Overall Study|Lost to Follow-up|0|||
162729873|NCT03397108|587719240|FG000|Overall Study|Insufficient milk production|3|||
162729874|NCT03397108|587719241|FG001|Overall Study|Insufficient milk production|2|||
162729875|NCT03397108|587719240|FG000|Overall Study|Withdrawal by Subject|2|||
162729876|NCT03397108|587719241|FG001|Overall Study|Withdrawal by Subject|0|||
162729877|NCT05096819|587719244|FG000|Overall Study|Withdrawal by Subject|3|||
162729878|NCT05096819|587719245|FG001|Overall Study|Withdrawal by Subject|0|||
162729879|NCT03324984|587719246|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
162729880|NCT03324984|587719247|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
162729881|NCT04607044|587719250|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
162729882|NCT04607044|587719250|FG000|Overall Study|Adverse Event|1|||
162729883|NCT04607044|587719250|FG000|Overall Study|Did not receive study device|3|||
162729884|NCT04607044|587719250|FG000|Overall Study|Death|1|||
162729885|NCT05403801|587719251|FG000|Overall Study|Withdrawal by Subject|2|||
162729886|NCT04337372|587719255|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
162729887|NCT04337372|587719256|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
162729888|NCT04337372|587719257|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
162729889|NCT04337372|587719258|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
162729890|NCT04337372|587719255|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
162729891|NCT04337372|587719256|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
162729892|NCT04337372|587719257|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
162729893|NCT04337372|587719258|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
162729894|NCT04337372|587719255|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
162729895|NCT04337372|587719256|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
162729896|NCT04337372|587719257|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
162729897|NCT04337372|587719258|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
162729898|NCT04337372|587719255|FG000|Day 2: EEG Measures|Protocol Violation|6|||
162729899|NCT04337372|587719256|FG001|Day 2: EEG Measures|Protocol Violation|6|||
162694428|NCT01003184|587592568|FG001|Overall Study|Withdrawal by Subject|6|||
162694429|NCT01003184|587592567|FG000|Overall Study|Physician Decision|1|||
162694430|NCT01003184|587592568|FG001|Overall Study|Physician Decision|0|||
162694431|NCT00557622|587592569|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
162694432|NCT00557622|587592570|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
162694433|NCT00557622|587592569|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
162694434|NCT00557622|587592570|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
162694435|NCT00557622|587592569|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
162694436|NCT00557622|587592570|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
162694437|NCT02765490|587592571|FG000|Overall Study|Lost to Follow-up|1|||
162694438|NCT02765490|587592572|FG001|Overall Study|Lost to Follow-up|1|||
162694439|NCT02765490|587592571|FG000|Overall Study|Other|0|||
162694440|NCT02765490|587592572|FG001|Overall Study|Other|1|||
162694441|NCT02765490|587592571|FG000|Overall Study|Death|0|||
162694442|NCT02765490|587592572|FG001|Overall Study|Death|1|||
162694443|NCT01923389|587592573|FG000|Overall Study|Protocol Violation|1|||
162694444|NCT01923389|587592574|FG001|Overall Study|Protocol Violation|0|||
162694445|NCT03237013|587592575|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
162694446|NCT03237013|587592576|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
162694447|NCT03237013|587592577|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
162694448|NCT05266963|587592578|FG000|Drug Period A|Withdrawal by Subject|0|||
162694449|NCT05266963|587592579|FG001|Drug Period A|Withdrawal by Subject|1|||
162694450|NCT00152971|587592580|FG000|Overall Study|Adverse Event|12|||
162694451|NCT00152971|587592581|FG001|Overall Study|Adverse Event|10|||
162694452|NCT00152971|587592582|FG002|Overall Study|Adverse Event|9|||
162694453|NCT00152971|587592580|FG000|Overall Study|Protocol Violation|10|||
162694454|NCT00152971|587592581|FG001|Overall Study|Protocol Violation|11|||
162694455|NCT00152971|587592582|FG002|Overall Study|Protocol Violation|8|||
162694456|NCT00152971|587592580|FG000|Overall Study|Lost to Follow-up|17|||
162694457|NCT00152971|587592581|FG001|Overall Study|Lost to Follow-up|14|||
162694458|NCT00152971|587592582|FG002|Overall Study|Lost to Follow-up|13|||
162694459|NCT00152971|587592580|FG000|Overall Study|Withdrawal by Subject|9|||
162694460|NCT00152971|587592581|FG001|Overall Study|Withdrawal by Subject|8|||
162694461|NCT00152971|587592582|FG002|Overall Study|Withdrawal by Subject|14|||
162694462|NCT00152971|587592580|FG000|Overall Study|Other|3|||
162694463|NCT00152971|587592581|FG001|Overall Study|Other|5|||
162694464|NCT00152971|587592582|FG002|Overall Study|Other|5|||
162694465|NCT00152971|587592580|FG000|Treatment|Adverse Event|49|||
162694466|NCT00152971|587592581|FG001|Treatment|Adverse Event|40|||
162694467|NCT00152971|587592582|FG002|Treatment|Adverse Event|54|||
162694468|NCT00152971|587592580|FG000|Treatment|Protocol Violation|8|||
162694469|NCT00152971|587592581|FG001|Treatment|Protocol Violation|6|||
162694470|NCT00152971|587592582|FG002|Treatment|Protocol Violation|10|||
162694471|NCT00152971|587592580|FG000|Treatment|Lost to Follow-up|1|||
162694472|NCT00152971|587592581|FG001|Treatment|Lost to Follow-up|2|||
162694473|NCT00152971|587592582|FG002|Treatment|Lost to Follow-up|1|||
162694474|NCT00152971|587592580|FG000|Treatment|Withdrawal by Subject|4|||
162694475|NCT00152971|587592581|FG001|Treatment|Withdrawal by Subject|4|||
162694476|NCT00152971|587592582|FG002|Treatment|Withdrawal by Subject|5|||
162694477|NCT00152971|587592580|FG000|Treatment|Other|9|||
162694478|NCT00152971|587592581|FG001|Treatment|Other|11|||
162694479|NCT00152971|587592582|FG002|Treatment|Other|10|||
162694480|NCT04091360|587592583|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694481|NCT04091360|587592584|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694482|NCT04091360|587592585|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694483|NCT04091360|587592586|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694484|NCT04091360|587592587|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694485|NCT04091360|587592588|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694486|NCT04091360|587592589|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694487|NCT04091360|587592590|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162694488|NCT04091360|587592591|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
162694489|NCT04091360|587592592|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
162694490|NCT04091360|587592583|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694491|NCT04091360|587592584|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694492|NCT04091360|587592585|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694493|NCT04091360|587592586|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694494|NCT04091360|587592587|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694495|NCT04091360|587592588|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694496|NCT04091360|587592589|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
162694497|NCT04091360|587592590|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
162694498|NCT04091360|587592591|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694499|NCT04091360|587592592|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162694500|NCT04091360|587592583|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694501|NCT04091360|587592584|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162729900|NCT04337372|587719257|FG002|Day 2: EEG Measures|Protocol Violation|5|||
162729901|NCT04337372|587719258|FG003|Day 2: EEG Measures|Protocol Violation|17|||
162729902|NCT05307783|587719259|FG000|Overall Study|Death|7|||
162729903|NCT05307783|587719259|FG000|Overall Study|Lost to Follow-up|4|||
162729904|NCT04883645|587719260|FG000|Overall Study|Death|1|||
162729905|NCT06194214|587719261|FG000|Overall Study|Adverse Event|1|||
162729906|NCT04847999|587719265|FG000|Overall Study|Lost to Follow-up|0|||
162729907|NCT04847999|587719266|FG001|Overall Study|Lost to Follow-up|1|||
162729908|NCT01704079|587719270|FG000|Overall Study|Withdrawal by Subject|5|||
162729909|NCT01704079|587719271|FG001|Overall Study|Withdrawal by Subject|7|||
162729910|NCT01704079|587719270|FG000|Overall Study|Lost to Follow-up|2|||
162729911|NCT01704079|587719271|FG001|Overall Study|Lost to Follow-up|5|||
162729912|NCT01704079|587719270|FG000|Overall Study|Adverse Event|4|||
162729913|NCT01704079|587719271|FG001|Overall Study|Adverse Event|7|||
162729914|NCT01704079|587719270|FG000|Overall Study|Protocol Violation|1|||
162729915|NCT01704079|587719271|FG001|Overall Study|Protocol Violation|0|||
162729916|NCT01704079|587719270|FG000|Overall Study|Subject noncompliance|2|||
162729917|NCT01704079|587719271|FG001|Overall Study|Subject noncompliance|3|||
162729918|NCT01704079|587719270|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
162729919|NCT01704079|587719271|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
162729920|NCT04300231|587719272|FG000|Overall Study|Protocol Violation|4|||
162729921|NCT04300231|587719273|FG001|Overall Study|Protocol Violation|3|||
162729922|NCT04300231|587719274|FG002|Overall Study|Protocol Violation|0|||
162729923|NCT04300231|587719275|FG003|Overall Study|Protocol Violation|2|||
162729924|NCT00520546|587719284|FG000|Overall Study|Withdrawal by Subject|1|||
162729925|NCT00520546|587719284|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
162729926|NCT02101281|587719286|FG000|Overall Study|Adverse Event|0|||
162729927|NCT02101281|587719287|FG001|Overall Study|Adverse Event|1|||
162729928|NCT05052996|587719288|FG000|Overall Study|Still on study|0|||
162729929|NCT05052996|587719289|FG001|Overall Study|Still on study|0|||
162729930|NCT05052996|587719290|FG002|Overall Study|Still on study|47|||
162729931|NCT05052996|587719291|FG003|Overall Study|Still on study|44|||
162729932|NCT05052996|587719288|FG000|Overall Study|Cohort terminated by sponsor|21|||
162729933|NCT05052996|587719289|FG001|Overall Study|Cohort terminated by sponsor|12|||
162729934|NCT05052996|587719290|FG002|Overall Study|Cohort terminated by sponsor|0|||
162729935|NCT05052996|587719291|FG003|Overall Study|Cohort terminated by sponsor|0|||
162729936|NCT05052996|587719288|FG000|Overall Study|Withdrew consent|1|||
162729937|NCT05052996|587719289|FG001|Overall Study|Withdrew consent|0|||
162729938|NCT05052996|587719290|FG002|Overall Study|Withdrew consent|1|||
162729939|NCT05052996|587719291|FG003|Overall Study|Withdrew consent|2|||
162694502|NCT04091360|587592585|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694503|NCT04091360|587592586|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694504|NCT04091360|587592587|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694505|NCT04091360|587592588|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694506|NCT04091360|587592589|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
162694507|NCT04091360|587592590|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694508|NCT04091360|587592591|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162694509|NCT04091360|587592592|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
162694510|NCT02597933|587592593|FG000|Overall Study|Withdrawal by Subject|7|||
162694511|NCT02597933|587592594|FG001|Overall Study|Withdrawal by Subject|5|||
162694512|NCT02597933|587592593|FG000|Overall Study|Protocol Violation|2|||
162694513|NCT02597933|587592594|FG001|Overall Study|Protocol Violation|2|||
162694514|NCT02597933|587592593|FG000|Overall Study|Adverse Event|20|||
162694515|NCT02597933|587592594|FG001|Overall Study|Adverse Event|28|||
162694516|NCT02597933|587592593|FG000|Overall Study|Not treated|2|||
162694517|NCT02597933|587592594|FG001|Overall Study|Not treated|2|||
162694518|NCT02597933|587592593|FG000|Overall Study|Other than stated above|7|||
162694519|NCT02597933|587592594|FG001|Overall Study|Other than stated above|14|||
162694520|NCT01617005|587592595|FG000|Overall Study|Pregnancy|1|||
162694521|NCT01617005|587592595|FG000|Overall Study|Lack of motivation for treatment|1|||
162694522|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
162694523|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
162694524|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
162694525|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
162729940|NCT05052996|587719288|FG000|Overall Study|Lost to Follow-up|1|||
162694526|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
162729941|NCT05052996|587719289|FG001|Overall Study|Lost to Follow-up|0|||
162729942|NCT05052996|587719290|FG002|Overall Study|Lost to Follow-up|0|||
162729943|NCT05052996|587719291|FG003|Overall Study|Lost to Follow-up|2|||
162729944|NCT05052996|587719288|FG000|Overall Study|Adverse Event|0|||
162729945|NCT05052996|587719289|FG001|Overall Study|Adverse Event|0|||
162729946|NCT05052996|587719290|FG002|Overall Study|Adverse Event|2|||
162729947|NCT05052996|587719291|FG003|Overall Study|Adverse Event|0|||
162729948|NCT05052996|587719288|FG000|Overall Study|Randomized but never treated|0|||
162729949|NCT05052996|587719289|FG001|Overall Study|Randomized but never treated|0|||
162729950|NCT05052996|587719290|FG002|Overall Study|Randomized but never treated|1|||
162729951|NCT05052996|587719291|FG003|Overall Study|Randomized but never treated|1|||
162729952|NCT05052996|587719288|FG000|Overall Study|Protocol Violation|1|||
162729953|NCT05052996|587719289|FG001|Overall Study|Protocol Violation|0|||
162729954|NCT05052996|587719290|FG002|Overall Study|Protocol Violation|0|||
162729955|NCT05052996|587719291|FG003|Overall Study|Protocol Violation|0|||
162729956|NCT01695954|587719292|FG000|Overall Study|Withdrawal by Subject|4|||
162729957|NCT01695954|587719293|FG001|Overall Study|Withdrawal by Subject|0|||
162729958|NCT01695954|587719292|FG000|Overall Study|Adverse Event|0|||
162729959|NCT01695954|587719293|FG001|Overall Study|Adverse Event|2|||
162729960|NCT01248936|587719295|FG000|Overall Study|Sponsor Decision|259|||
162729961|NCT01248936|587719295|FG000|Overall Study|Progression of Disease|50|||
162729962|NCT01248936|587719295|FG000|Overall Study|Death|26|||
162729963|NCT01248936|587719295|FG000|Overall Study|Withdrawal of Consent|20|||
162729964|NCT01248936|587719295|FG000|Overall Study|Adverse Event|8|||
162729965|NCT01248936|587719295|FG000|Overall Study|Lost to Follow-up|7|||
162729966|NCT01248936|587719295|FG000|Overall Study|Refused Treatment|1|||
162729967|NCT01248936|587719295|FG000|Overall Study|Other reason|3|||
162729968|NCT05609032|587719296|FG000|Overall Study|Lost to Follow-up|3|||
162729969|NCT05609032|587719297|FG001|Overall Study|Lost to Follow-up|1|||
162729970|NCT05609032|587719296|FG000|Overall Study|Withdrawal by Subject|1|||
162729971|NCT05609032|587719297|FG001|Overall Study|Withdrawal by Subject|0|||
162729972|NCT04019444|587719307|FG000|Overall Study|Withdrawal by Subject|0|||
162729973|NCT04019444|587719308|FG001|Overall Study|Withdrawal by Subject|1|||
162729974|NCT04019444|587719309|FG002|Overall Study|Withdrawal by Subject|0|||
162729975|NCT04019444|587719310|FG003|Overall Study|Withdrawal by Subject|1|||
162729976|NCT04019444|587719307|FG000|Overall Study|Solicited Event|0|||
162729977|NCT04019444|587719308|FG001|Overall Study|Solicited Event|0|||
162729978|NCT04019444|587719309|FG002|Overall Study|Solicited Event|2|||
162729979|NCT04019444|587719310|FG003|Overall Study|Solicited Event|0|||
162729980|NCT04578106|587719311|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
162729981|NCT00497198|587719312|FG000|Overall Study|Adverse Event|4|||
162729982|NCT00497198|587719313|FG001|Overall Study|Adverse Event|2|||
162694527|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
162694528|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
162694529|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
162694530|NCT01336621|587592602|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
162694531|NCT01336621|587592602|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
162694532|NCT01336621|587592602|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
162694533|NCT01336621|587592602|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
162694534|NCT01336621|587592602|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
162694535|NCT01336621|587592602|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
162694536|NCT02487095|587592603|FG000|Dose Expansion|Unable to scan/restage participant|0|||
162694537|NCT02487095|587592604|FG001|Dose Expansion|Unable to scan/restage participant|0|||
162694538|NCT02487095|587592605|FG002|Dose Expansion|Unable to scan/restage participant|0|||
162694539|NCT02487095|587592606|FG003|Dose Expansion|Unable to scan/restage participant|0|||
162694540|NCT02487095|587592607|FG004|Dose Expansion|Unable to scan/restage participant|1|||
162694541|NCT04534114|587592608|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162694542|NCT04534114|587592609|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
162694543|NCT04534114|587592610|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162694544|NCT04534114|587592611|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162694545|NCT04534114|587592608|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
162694546|NCT04534114|587592609|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
162694547|NCT04534114|587592610|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
162694548|NCT04534114|587592611|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
162694549|NCT04534114|587592608|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
162694550|NCT04534114|587592609|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
162694551|NCT04534114|587592610|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
162694552|NCT04534114|587592611|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
162694553|NCT04534114|587592608|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162694554|NCT04534114|587592609|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
162694555|NCT04534114|587592610|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
162694556|NCT04534114|587592611|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162694557|NCT04534114|587592608|FG000|Main Treatment Period|Physician Decision|0|||
162729983|NCT00497198|587719312|FG000|Overall Study|Physician Decision|1|||
162729984|NCT00497198|587719313|FG001|Overall Study|Physician Decision|2|||
162729985|NCT00497198|587719312|FG000|Overall Study|Withdrawal by Subject|0|||
162729986|NCT00497198|587719313|FG001|Overall Study|Withdrawal by Subject|1|||
162729987|NCT00424463|587719314|FG000|Overall Study|Adverse Event|2|||
162729988|NCT00424463|587719315|FG001|Overall Study|Adverse Event|3|||
162729989|NCT00424463|587719316|FG002|Overall Study|Adverse Event|2|||
162729990|NCT00424463|587719314|FG000|Overall Study|Physician Decision|0|||
162694558|NCT04534114|587592609|FG001|Main Treatment Period|Physician Decision|0|||
162694559|NCT04534114|587592610|FG002|Main Treatment Period|Physician Decision|0|||
162694560|NCT04534114|587592611|FG003|Main Treatment Period|Physician Decision|1|||
162694561|NCT04534114|587592608|FG000|Main Treatment Period|Death|1|||
162694562|NCT04534114|587592609|FG001|Main Treatment Period|Death|0|||
162694563|NCT04534114|587592610|FG002|Main Treatment Period|Death|0|||
162694564|NCT04534114|587592611|FG003|Main Treatment Period|Death|1|||
162694565|NCT04534114|587592608|FG000|Main Treatment Period|Other reason|1|||
162694566|NCT04534114|587592609|FG001|Main Treatment Period|Other reason|1|||
162694567|NCT04534114|587592610|FG002|Main Treatment Period|Other reason|0|||
162694568|NCT04534114|587592611|FG003|Main Treatment Period|Other reason|0|||
162694569|NCT04534114|587592608|FG000|Main Treatment Period|Participant decision|1|||
162694570|NCT04534114|587592609|FG001|Main Treatment Period|Participant decision|3|||
162694571|NCT04534114|587592610|FG002|Main Treatment Period|Participant decision|3|||
162694572|NCT04534114|587592611|FG003|Main Treatment Period|Participant decision|1|||
162694573|NCT04534114|587592608|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
162694574|NCT04534114|587592609|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
162694575|NCT04534114|587592610|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
162694576|NCT04534114|587592611|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
162694577|NCT04534114|587592608|FG000|Main Treatment Period|Adverse Event|4|||
162694578|NCT04534114|587592609|FG001|Main Treatment Period|Adverse Event|2|||
162694579|NCT04534114|587592610|FG002|Main Treatment Period|Adverse Event|1|||
162694580|NCT04534114|587592611|FG003|Main Treatment Period|Adverse Event|2|||
162694581|NCT04534114|587592608|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162694582|NCT04534114|587592609|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162694583|NCT04534114|587592610|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162694584|NCT04534114|587592611|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
162694585|NCT04534114|587592608|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162694586|NCT04534114|587592609|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162694587|NCT04534114|587592610|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162694588|NCT04534114|587592611|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162694589|NCT04534114|587592608|FG000|Extension Treatment Period|Other reason|0|||
162694590|NCT04534114|587592609|FG001|Extension Treatment Period|Other reason|1|||
162694591|NCT04534114|587592610|FG002|Extension Treatment Period|Other reason|0|||
162694592|NCT04534114|587592611|FG003|Extension Treatment Period|Other reason|0|||
162694593|NCT04534114|587592608|FG000|Extension Treatment Period|Death|0|||
162694594|NCT04534114|587592609|FG001|Extension Treatment Period|Death|0|||
162694595|NCT04534114|587592610|FG002|Extension Treatment Period|Death|1|||
162694596|NCT04534114|587592611|FG003|Extension Treatment Period|Death|2|||
162694597|NCT04534114|587592608|FG000|Extension Treatment Period|Adverse Event|0|||
162694598|NCT04534114|587592609|FG001|Extension Treatment Period|Adverse Event|1|||
162694599|NCT04534114|587592610|FG002|Extension Treatment Period|Adverse Event|0|||
162694600|NCT04534114|587592611|FG003|Extension Treatment Period|Adverse Event|1|||
162694601|NCT04534114|587592608|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
162694602|NCT04534114|587592609|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
162694603|NCT04534114|587592610|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
162694604|NCT04534114|587592611|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
162694605|NCT02759185|587592612|FG000|Stage 1|Adverse Event|0|||
162694606|NCT02759185|587592613|FG001|Stage 1|Adverse Event|1|||
162694607|NCT02759185|587592614|FG002|Stage 1|Adverse Event|3|||
162694608|NCT02759185|587592615|FG003|Stage 1|Adverse Event|0|||
162694609|NCT02759185|587592616|FG004|Stage 1|Adverse Event|0|||
162694610|NCT02759185|587592617|FG005|Stage 1|Adverse Event|0|||
162694611|NCT02759185|587592618|FG006|Stage 1|Adverse Event|0|||
162694612|NCT02759185|587592612|FG000|Stage 1|Withdrawal by Subject|1|||
162694613|NCT02759185|587592613|FG001|Stage 1|Withdrawal by Subject|0|||
162694614|NCT02759185|587592614|FG002|Stage 1|Withdrawal by Subject|0|||
162694615|NCT02759185|587592615|FG003|Stage 1|Withdrawal by Subject|0|||
162694616|NCT02759185|587592616|FG004|Stage 1|Withdrawal by Subject|0|||
162694617|NCT02759185|587592617|FG005|Stage 1|Withdrawal by Subject|0|||
162694618|NCT02759185|587592618|FG006|Stage 1|Withdrawal by Subject|0|||
162694619|NCT02759185|587592612|FG000|Stage 2|Adverse Event|0|||
162694620|NCT02759185|587592613|FG001|Stage 2|Adverse Event|0|||
162694621|NCT02759185|587592614|FG002|Stage 2|Adverse Event|0|||
162694622|NCT02759185|587592615|FG003|Stage 2|Adverse Event|0|||
162694623|NCT02759185|587592616|FG004|Stage 2|Adverse Event|1|||
162694624|NCT02759185|587592617|FG005|Stage 2|Adverse Event|2|||
162694625|NCT02759185|587592618|FG006|Stage 2|Adverse Event|0|||
162694626|NCT02759185|587592612|FG000|Stage 2|Withdrawal by Subject|0|||
162694627|NCT02759185|587592613|FG001|Stage 2|Withdrawal by Subject|0|||
162694628|NCT02759185|587592614|FG002|Stage 2|Withdrawal by Subject|0|||
162694629|NCT02759185|587592615|FG003|Stage 2|Withdrawal by Subject|0|||
162694630|NCT02759185|587592616|FG004|Stage 2|Withdrawal by Subject|1|||
162694631|NCT02759185|587592617|FG005|Stage 2|Withdrawal by Subject|1|||
162694632|NCT02759185|587592618|FG006|Stage 2|Withdrawal by Subject|1|||
162694633|NCT02875834|587592621|FG000|Open-label Phase|Withdrawal by Subject|3|||
162694634|NCT02875834|587592622|FG001|Open-label Phase|Withdrawal by Subject|0|||
162694635|NCT02875834|587592623|FG002|Open-label Phase|Withdrawal by Subject|0|||
162694636|NCT02875834|587592624|FG003|Open-label Phase|Withdrawal by Subject|0|||
162694637|NCT02875834|587592621|FG000|Open-label Phase|(Not collected)|4|||
162694638|NCT02875834|587592622|FG001|Open-label Phase|(Not collected)|0|||
162694639|NCT02875834|587592623|FG002|Open-label Phase|(Not collected)|0|||
162694640|NCT02875834|587592624|FG003|Open-label Phase|(Not collected)|0|||
162694641|NCT02875834|587592621|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
162694642|NCT02875834|587592622|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
162694643|NCT02875834|587592623|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
162694644|NCT02875834|587592624|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
162694645|NCT02875834|587592621|FG000|Randomized Treatment Phase|Protocol Violation|0|||
162694646|NCT02875834|587592622|FG001|Randomized Treatment Phase|Protocol Violation|2|||
162694647|NCT02875834|587592623|FG002|Randomized Treatment Phase|Protocol Violation|0|||
162694648|NCT02875834|587592624|FG003|Randomized Treatment Phase|Protocol Violation|0|||
162694649|NCT02875834|587592621|FG000|Randomized Treatment Phase|(Not collected)|0|||
162694650|NCT02875834|587592622|FG001|Randomized Treatment Phase|(Not collected)|9|||
162694651|NCT02875834|587592623|FG002|Randomized Treatment Phase|(Not collected)|10|||
162694652|NCT02875834|587592624|FG003|Randomized Treatment Phase|(Not collected)|9|||
162694653|NCT01302938|587592625|FG000|Overall Study|Withdrawal by Subject|1|||
162694654|NCT01302938|587592626|FG001|Overall Study|Withdrawal by Subject|0|||
162694655|NCT01302938|587592625|FG000|Overall Study|Adverse Event|1|||
162694656|NCT01302938|587592626|FG001|Overall Study|Adverse Event|0|||
162694657|NCT00539279|587592628|FG000|Treatment|Withdrawal by Subject|10|||
162694658|NCT00539279|587592629|FG001|Treatment|Withdrawal by Subject|8|||
162694659|NCT00539279|587592628|FG000|Treatment|Death|1|||
162694660|NCT00539279|587592629|FG001|Treatment|Death|0|||
162694661|NCT00539279|587592628|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
162694662|NCT00539279|587592629|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
162694663|NCT00539279|587592628|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
162694664|NCT00539279|587592629|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
162694665|NCT01811563|587594065|FG000|Overall Study|Lost to Follow-up|5|||
162694666|NCT01811563|587594066|FG001|Overall Study|Lost to Follow-up|2|||
162694667|NCT01811563|587594065|FG000|Overall Study|Incorrect Randomization procedure|0|||
162694668|NCT01811563|587594066|FG001|Overall Study|Incorrect Randomization procedure|1|||
162694669|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
162694670|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
162694671|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
162694672|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
162694673|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
162694674|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
162694675|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Death|0|||
162694676|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Death|1|||
162694677|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Adverse Event|11|||
162694678|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Adverse Event|11|||
162694679|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
162694680|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
162694681|NCT02936037|587594067|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162694682|NCT02936037|587594068|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162694683|NCT02936037|587594067|FG000|Open Label Extension|Adverse Event|0|||
162694684|NCT02936037|587594068|FG001|Open Label Extension|Adverse Event|3|||
162694685|NCT02936037|587594067|FG000|Open Label Extension|Other|0|||
162694686|NCT02936037|587594068|FG001|Open Label Extension|Other|3|||
162694687|NCT02936037|587594067|FG000|Open Label Extension|Withdrawal by Subject|0|||
162694688|NCT02936037|587594068|FG001|Open Label Extension|Withdrawal by Subject|4|||
162694689|NCT01267825|587594069|FG000|Overall Study|study terminated. no data collected.|1|||
162694690|NCT01267825|587594070|FG001|Overall Study|study terminated. no data collected.|0|||
162694691|NCT04249336|587594071|FG000|Overall Study|Lost to Follow-up|3|||
162694692|NCT04249336|587594072|FG001|Overall Study|Lost to Follow-up|3|||
162694693|NCT04249336|587594073|FG002|Overall Study|Lost to Follow-up|3|||
162694694|NCT04249336|587594074|FG003|Overall Study|Lost to Follow-up|3|||
162694695|NCT01189890|587594078|FG000|Overall Study|Adverse Event|3|||
162694696|NCT01189890|587594079|FG001|Overall Study|Adverse Event|4|||
162694697|NCT01189890|587594078|FG000|Overall Study|Lack of Efficacy|7|||
162694698|NCT01189890|587594079|FG001|Overall Study|Lack of Efficacy|2|||
162694699|NCT01189890|587594078|FG000|Overall Study|Lost to Follow-up|1|||
162694700|NCT01189890|587594079|FG001|Overall Study|Lost to Follow-up|7|||
162694701|NCT01189890|587594078|FG000|Overall Study|Protocol Violation|1|||
162694702|NCT01189890|587594079|FG001|Overall Study|Protocol Violation|5|||
162694703|NCT01189890|587594078|FG000|Overall Study|Withdrawal by Subject|15|||
162694704|NCT01189890|587594079|FG001|Overall Study|Withdrawal by Subject|11|||
162694705|NCT01189890|587594078|FG000|Overall Study|Non Compliance|0|||
162694706|NCT01189890|587594079|FG001|Overall Study|Non Compliance|1|||
162729991|NCT00424463|587719315|FG001|Overall Study|Physician Decision|2|||
162694707|NCT01189890|587594078|FG000|Overall Study|Physician Decision|5|||
162694708|NCT01189890|587594079|FG001|Overall Study|Physician Decision|4|||
162694709|NCT01189890|587594078|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
162694710|NCT01189890|587594079|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
162694711|NCT00077636|587594080|FG000|Overall Study|Refused Treatment|9|||
162694712|NCT00077636|587594081|FG001|Overall Study|Refused Treatment|31|||
162694713|NCT00077636|587594080|FG000|Overall Study|Admin|3|||
162694714|NCT00077636|587594081|FG001|Overall Study|Admin|3|||
162694715|NCT00077636|587594080|FG000|Overall Study|Withdrawal by Subject|2|||
162694716|NCT00077636|587594081|FG001|Overall Study|Withdrawal by Subject|2|||
162694717|NCT00077636|587594080|FG000|Overall Study|Adverse Event|17|||
162694718|NCT00077636|587594081|FG001|Overall Study|Adverse Event|34|||
162694719|NCT00077636|587594080|FG000|Overall Study|Protocol Violation|0|||
162694720|NCT00077636|587594081|FG001|Overall Study|Protocol Violation|2|||
162694721|NCT00077636|587594080|FG000|Overall Study|Lost to Follow-up|10|||
162694722|NCT00077636|587594081|FG001|Overall Study|Lost to Follow-up|18|||
162694723|NCT00077636|587594080|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
162694724|NCT00077636|587594081|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
162694725|NCT00068380|587594082|FG000|Overall Study|Withdrawal by Subject|3|||
162694726|NCT00068380|587594082|FG000|Overall Study|Adverse Event|2|||
162694727|NCT01976364|587594083|FG000|Main Study (36 Months)|Adverse Event|63|||
162694728|NCT01976364|587594084|FG001|Main Study (36 Months)|Adverse Event|0|||
162694729|NCT01976364|587594085|FG002|Main Study (36 Months)|Adverse Event|0|||
162694730|NCT01976364|587594083|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
162694731|NCT01976364|587594084|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
162694732|NCT01976364|587594085|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
162694733|NCT01976364|587594083|FG000|Main Study (36 Months)|Other|13|||
162694734|NCT01976364|587594084|FG001|Main Study (36 Months)|Other|0|||
162694735|NCT01976364|587594085|FG002|Main Study (36 Months)|Other|0|||
162694736|NCT01976364|587594083|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
162694737|NCT01976364|587594084|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
162694738|NCT01976364|587594085|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
162694739|NCT01976364|587594083|FG000|Main Study (36 Months)|Medication error|1|||
162694740|NCT01976364|587594084|FG001|Main Study (36 Months)|Medication error|0|||
162694741|NCT01976364|587594085|FG002|Main Study (36 Months)|Medication error|0|||
162694742|NCT01976364|587594083|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
162694743|NCT01976364|587594084|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
162694744|NCT01976364|587594085|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
162729992|NCT00424463|587719316|FG002|Overall Study|Physician Decision|2|||
162729993|NCT00424463|587719314|FG000|Overall Study|Withdrawal by Subject|4|||
162729994|NCT00424463|587719315|FG001|Overall Study|Withdrawal by Subject|2|||
162729995|NCT00424463|587719316|FG002|Overall Study|Withdrawal by Subject|5|||
162729996|NCT00424463|587719314|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
162729997|NCT00424463|587719315|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
162729998|NCT00424463|587719316|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
162729999|NCT00424463|587719314|FG000|Overall Study|Patient's convenience|0|||
162730000|NCT00424463|587719315|FG001|Overall Study|Patient's convenience|0|||
162730001|NCT00424463|587719316|FG002|Overall Study|Patient's convenience|1|||
162730002|NCT03570892|587719318|FG000|Overall Study|Death|51|||
162730003|NCT03570892|587719319|FG001|Overall Study|Death|45|||
162730004|NCT03570892|587719318|FG000|Overall Study|Subject decision|5|||
162730005|NCT03570892|587719319|FG001|Overall Study|Subject decision|3|||
162730006|NCT03570892|587719318|FG000|Overall Study|Protocol Violation|1|||
162730007|NCT03570892|587719319|FG001|Overall Study|Protocol Violation|4|||
162730008|NCT03570892|587719318|FG000|Overall Study|Physician Decision|0|||
162730009|NCT03570892|587719319|FG001|Overall Study|Physician Decision|2|||
162730010|NCT05028582|587719320|FG000|Overall Study|Lost to Follow-up|11|||
162694745|NCT01976364|587594083|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
162694746|NCT01976364|587594084|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
162694747|NCT01976364|587594085|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
162694748|NCT01976364|587594083|FG000|Main Study (36 Months)|Protocol Violation|13|||
162694749|NCT01976364|587594084|FG001|Main Study (36 Months)|Protocol Violation|0|||
162694750|NCT01976364|587594085|FG002|Main Study (36 Months)|Protocol Violation|0|||
162730011|NCT05028582|587719321|FG001|Overall Study|Lost to Follow-up|9|||
162730012|NCT05028582|587719320|FG000|Overall Study|Withdrawal by Subject|9|||
162694751|NCT01976364|587594083|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
162730013|NCT05028582|587719321|FG001|Overall Study|Withdrawal by Subject|10|||
162694752|NCT01976364|587594084|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
162730014|NCT05028582|587719320|FG000|Overall Study|Adverse Event|5|||
162730015|NCT05028582|587719321|FG001|Overall Study|Adverse Event|2|||
162730016|NCT05028582|587719320|FG000|Overall Study|Miscellaneous|3|||
162730017|NCT05028582|587719321|FG001|Overall Study|Miscellaneous|2|||
162730018|NCT05028582|587719320|FG000|Overall Study|Lack of Efficacy|3|||
162730019|NCT05028582|587719321|FG001|Overall Study|Lack of Efficacy|1|||
162730020|NCT05028582|587719320|FG000|Overall Study|Physician Decision|0|||
162730021|NCT05028582|587719321|FG001|Overall Study|Physician Decision|1|||
162694753|NCT01976364|587594085|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
162694754|NCT01976364|587594083|FG000|Main Study (36 Months)|Death|5|||
162694755|NCT01976364|587594084|FG001|Main Study (36 Months)|Death|0|||
162694756|NCT01976364|587594085|FG002|Main Study (36 Months)|Death|0|||
162694757|NCT01976364|587594083|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
162694758|NCT01976364|587594084|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
162694759|NCT01976364|587594085|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
162694760|NCT01976364|587594083|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
162694761|NCT01976364|587594084|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
162694762|NCT01976364|587594085|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
162694763|NCT01976364|587594083|FG000|Sub-study (12 Months)|Protocol Violation|0|||
162694764|NCT01976364|587594084|FG001|Sub-study (12 Months)|Protocol Violation|1|||
162694765|NCT01976364|587594085|FG002|Sub-study (12 Months)|Protocol Violation|1|||
162694766|NCT01976364|587594083|FG000|Sub-study (12 Months)|Adverse Event|0|||
162694767|NCT01976364|587594084|FG001|Sub-study (12 Months)|Adverse Event|4|||
162694768|NCT01976364|587594085|FG002|Sub-study (12 Months)|Adverse Event|3|||
162694769|NCT01190215|587594086|FG000|Up to Month 6|Lost to Follow-up|2|||
162694770|NCT01190215|587594087|FG001|Up to Month 6|Lost to Follow-up|0|||
162694771|NCT04250337|587594089|FG000|Overall Study|Adverse Event|0|||
162694772|NCT04250337|587594090|FG001|Overall Study|Adverse Event|3|||
162694773|NCT04250337|587594089|FG000|Overall Study|Lack of Efficacy|1|||
162694774|NCT04250337|587594090|FG001|Overall Study|Lack of Efficacy|3|||
162694775|NCT04250337|587594089|FG000|Overall Study|Physician Decision|1|||
162694776|NCT04250337|587594090|FG001|Overall Study|Physician Decision|0|||
162694777|NCT04250337|587594089|FG000|Overall Study|Protocol Deviation|2|||
162694778|NCT04250337|587594090|FG001|Overall Study|Protocol Deviation|2|||
162694779|NCT04250337|587594089|FG000|Overall Study|Withdrawal by Subject|4|||
162694780|NCT04250337|587594090|FG001|Overall Study|Withdrawal by Subject|3|||
162694781|NCT01993823|587594091|FG000|Overall Study|Requested by the patient|6|||
162694782|NCT01993823|587594092|FG001|Overall Study|Requested by the patient|11|||
162694783|NCT01993823|587594091|FG000|Overall Study|Protocol Violation|0|||
162694784|NCT01993823|587594092|FG001|Overall Study|Protocol Violation|1|||
162694785|NCT01993823|587594091|FG000|Overall Study|Lost to Follow-up|1|||
162694786|NCT01993823|587594092|FG001|Overall Study|Lost to Follow-up|4|||
162694787|NCT00641719|587594095|FG000|Overall Study|Lack of Efficacy|1|||
162694788|NCT00641719|587594096|FG001|Overall Study|Lack of Efficacy|2|||
162694789|NCT00641719|587594095|FG000|Overall Study|Adverse Event|24|||
162694790|NCT00641719|587594096|FG001|Overall Study|Adverse Event|29|||
162694791|NCT00641719|587594095|FG000|Overall Study|Withdrawal by Subject|4|||
162694792|NCT00641719|587594096|FG001|Overall Study|Withdrawal by Subject|4|||
162694793|NCT00641719|587594095|FG000|Overall Study|Reason Not Specified|1|||
162694794|NCT00641719|587594096|FG001|Overall Study|Reason Not Specified|2|||
162694795|NCT03303469|587594097|FG000|Overall Study|Lost to Follow-up|2|||
162694796|NCT00885352|587594098|FG000|Overall Study|Adverse Event|2|||
162694797|NCT00885352|587594099|FG001|Overall Study|Adverse Event|3|||
162694798|NCT00885352|587594098|FG000|Overall Study|Lost to Follow-up|2|||
162694799|NCT00885352|587594099|FG001|Overall Study|Lost to Follow-up|2|||
162694800|NCT00885352|587594098|FG000|Overall Study|Physician Decision|0|||
162694801|NCT00885352|587594099|FG001|Overall Study|Physician Decision|3|||
162694802|NCT00885352|587594098|FG000|Overall Study|Protocol Violation|0|||
162694803|NCT00885352|587594099|FG001|Overall Study|Protocol Violation|2|||
162694804|NCT00885352|587594098|FG000|Overall Study|Withdrawal by Subject|1|||
162694805|NCT00885352|587594099|FG001|Overall Study|Withdrawal by Subject|5|||
162694806|NCT00885352|587594098|FG000|Overall Study|Contradiction to study medication|0|||
162694807|NCT00885352|587594099|FG001|Overall Study|Contradiction to study medication|2|||
162694808|NCT00885352|587594098|FG000|Overall Study|Excluded medication|2|||
162694809|NCT00885352|587594099|FG001|Overall Study|Excluded medication|2|||
162694810|NCT00885352|587594098|FG000|Overall Study|Lab abnormalities|1|||
162694811|NCT00885352|587594099|FG001|Overall Study|Lab abnormalities|1|||
162694812|NCT03560258|587594100|FG000|Overall Study|Lost to Follow-up|3|||
162694813|NCT03560258|587594101|FG001|Overall Study|Lost to Follow-up|0|||
162694814|NCT03560258|587594102|FG002|Overall Study|Lost to Follow-up|0|||
162694815|NCT03560258|587594100|FG000|Overall Study|Protocol Violation|0|||
162694816|NCT03560258|587594101|FG001|Overall Study|Protocol Violation|1|||
162694817|NCT03560258|587594102|FG002|Overall Study|Protocol Violation|0|||
162694818|NCT03560258|587594100|FG000|Overall Study|Withdrawal by Subject|0|||
162694819|NCT03560258|587594101|FG001|Overall Study|Withdrawal by Subject|0|||
162694820|NCT03560258|587594102|FG002|Overall Study|Withdrawal by Subject|1|||
162694821|NCT01460160|587594103|FG000|Treatment Phase|Lack of Efficacy|3|||
162694822|NCT01460160|587594103|FG000|Treatment Phase|Study Drug Toxicity|2|||
162694823|NCT01460160|587594103|FG000|Treatment Phase|Adverse Event|8|||
162694824|NCT01460160|587594103|FG000|Treatment Phase|Withdrawal by Subject|4|||
162694825|NCT01460160|587594103|FG000|Treatment Phase|Death|2|||
162694826|NCT01460160|587594103|FG000|Treatment Phase|Other reasons|9|||
162694827|NCT01460160|587594103|FG000|Follow-up Phase|Withdrawal by Subject|4|||
162694828|NCT01460160|587594103|FG000|Follow-up Phase|Death|14|||
162694829|NCT01460160|587594103|FG000|Follow-up Phase|Lost to Follow-up|7|||
162694830|NCT01460160|587594103|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
162694831|NCT01460160|587594103|FG000|Follow-up Phase|Other and not reported reasons|5|||
162694832|NCT03101241|587594104|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
162694833|NCT03101241|587594105|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
162694834|NCT03101241|587594104|FG000|Overall Study|Participant withdrew consent|3|||
162694835|NCT03101241|587594105|FG001|Overall Study|Participant withdrew consent|1|||
162694836|NCT03101241|587594104|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
162694837|NCT03101241|587594105|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
162694838|NCT03101241|587594104|FG000|Overall Study|Lost to Follow-up|2|||
162694839|NCT03101241|587594105|FG001|Overall Study|Lost to Follow-up|0|||
162694840|NCT03101241|587594104|FG000|Overall Study|Lack of Efficacy|0|||
162694841|NCT03101241|587594105|FG001|Overall Study|Lack of Efficacy|1|||
162694842|NCT03101241|587594104|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
162694843|NCT03101241|587594105|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
162694844|NCT00669903|587594106|FG000|Overall Study|Adverse Event|0|||
162694845|NCT00669903|587594107|FG001|Overall Study|Adverse Event|1|||
162694846|NCT00669903|587594108|FG002|Overall Study|Adverse Event|3|||
162694847|NCT00669903|587594109|FG003|Overall Study|Adverse Event|1|||
162694848|NCT00669903|587594106|FG000|Overall Study|Withdrawal by Subject|0|||
162694849|NCT00669903|587594107|FG001|Overall Study|Withdrawal by Subject|2|||
162694850|NCT00669903|587594108|FG002|Overall Study|Withdrawal by Subject|2|||
162694851|NCT00669903|587594109|FG003|Overall Study|Withdrawal by Subject|2|||
162694852|NCT00669903|587594106|FG000|Overall Study|Lost to Follow-up|1|||
162694853|NCT00669903|587594107|FG001|Overall Study|Lost to Follow-up|1|||
162694854|NCT00669903|587594108|FG002|Overall Study|Lost to Follow-up|0|||
162694855|NCT00669903|587594109|FG003|Overall Study|Lost to Follow-up|1|||
162694856|NCT00669903|587594106|FG000|Overall Study|Protocol Violation|0|||
162694857|NCT00669903|587594107|FG001|Overall Study|Protocol Violation|1|||
162694858|NCT00669903|587594108|FG002|Overall Study|Protocol Violation|0|||
162694859|NCT00669903|587594109|FG003|Overall Study|Protocol Violation|0|||
162694860|NCT00251927|587594110|FG000|Overall Study|Adverse Event|3|||
162694861|NCT00251927|587594111|FG001|Overall Study|Adverse Event|15|||
162694862|NCT00251927|587594110|FG000|Overall Study|Lack of Efficacy|22|||
162694863|NCT00251927|587594111|FG001|Overall Study|Lack of Efficacy|16|||
162694864|NCT00251927|587594110|FG000|Overall Study|Lost to Follow-up|22|||
162694865|NCT00251927|587594111|FG001|Overall Study|Lost to Follow-up|8|||
162694866|NCT00251927|587594110|FG000|Overall Study|Protocol Violation|1|||
162694867|NCT00251927|587594111|FG001|Overall Study|Protocol Violation|2|||
162694868|NCT00251927|587594110|FG000|Overall Study|Pregnancy|2|||
162694869|NCT00251927|587594111|FG001|Overall Study|Pregnancy|0|||
162694870|NCT00251927|587594110|FG000|Overall Study|Withdrawal by Subject|40|||
162694871|NCT00251927|587594111|FG001|Overall Study|Withdrawal by Subject|25|||
162694872|NCT00251927|587594110|FG000|Overall Study|Study-specific discont. achieved|13|||
162694873|NCT00251927|587594111|FG001|Overall Study|Study-specific discont. achieved|2|||
162694874|NCT00251927|587594110|FG000|Overall Study|Study procedure non-compliance|5|||
162694875|NCT00251927|587594111|FG001|Overall Study|Study procedure non-compliance|6|||
162694876|NCT01678820|587594112|FG000|Overall Study|Study Terminated by Sponsor|45|||
162694877|NCT01678820|587594113|FG001|Overall Study|Study Terminated by Sponsor|43|||
162694878|NCT01678820|587594114|FG002|Overall Study|Study Terminated by Sponsor|43|||
162694879|NCT01678820|587594112|FG000|Overall Study|Withdrawal by Subject|2|||
162694880|NCT01678820|587594113|FG001|Overall Study|Withdrawal by Subject|5|||
162694881|NCT01678820|587594114|FG002|Overall Study|Withdrawal by Subject|2|||
162694882|NCT01678820|587594112|FG000|Overall Study|Protocol Specified Criteria|2|||
162694883|NCT01678820|587594113|FG001|Overall Study|Protocol Specified Criteria|3|||
162694884|NCT01678820|587594114|FG002|Overall Study|Protocol Specified Criteria|1|||
162694885|NCT01678820|587594112|FG000|Overall Study|Adverse Event|2|||
162694886|NCT01678820|587594113|FG001|Overall Study|Adverse Event|2|||
162694887|NCT01678820|587594114|FG002|Overall Study|Adverse Event|2|||
162694888|NCT01678820|587594112|FG000|Overall Study|Lost to Follow-up|7|||
162694889|NCT01678820|587594113|FG001|Overall Study|Lost to Follow-up|2|||
162694890|NCT01678820|587594114|FG002|Overall Study|Lost to Follow-up|2|||
162694891|NCT01678820|587594112|FG000|Overall Study|Non-compliance with study drug|0|||
162694892|NCT01678820|587594113|FG001|Overall Study|Non-compliance with study drug|1|||
162694893|NCT01678820|587594114|FG002|Overall Study|Non-compliance with study drug|0|||
162694894|NCT01678820|587594112|FG000|Overall Study|Physician Decision|0|||
162694895|NCT01678820|587594113|FG001|Overall Study|Physician Decision|0|||
162694896|NCT01678820|587594114|FG002|Overall Study|Physician Decision|1|||
162694897|NCT01678820|587594112|FG000|Overall Study|Protocol Violation|4|||
162694898|NCT01678820|587594113|FG001|Overall Study|Protocol Violation|5|||
162694899|NCT01678820|587594114|FG002|Overall Study|Protocol Violation|4|||
162694900|NCT01678820|587594112|FG000|Overall Study|Not treated with double-blind study drug|0|||
162694901|NCT01678820|587594113|FG001|Overall Study|Not treated with double-blind study drug|2|||
162694902|NCT01678820|587594114|FG002|Overall Study|Not treated with double-blind study drug|2|||
162694903|NCT03283696|587594115|FG000|Overall Study|Physician Decision|5|||
162694904|NCT03283696|587594116|FG001|Overall Study|Physician Decision|6|||
162694905|NCT03283696|587594115|FG000|Overall Study|Withdrawal by Subject|2|||
162694906|NCT03283696|587594116|FG001|Overall Study|Withdrawal by Subject|0|||
162694907|NCT00245856|587594117|FG000|Period Two|Withdrawal by Subject|0|||
162694908|NCT00245856|587594118|FG001|Period Two|Withdrawal by Subject|1|||
162694909|NCT01512745|587594120|FG000|Overall Study|Adverse Event|22|||
162694910|NCT01512745|587594121|FG001|Overall Study|Adverse Event|3|||
162694911|NCT01512745|587594120|FG000|Overall Study|Death|9|||
162694912|NCT01512745|587594121|FG001|Overall Study|Death|13|||
162694913|NCT01512745|587594120|FG000|Overall Study|Withdrawal by Subject|2|||
162694914|NCT01512745|587594121|FG001|Overall Study|Withdrawal by Subject|2|||
162694915|NCT01512745|587594120|FG000|Overall Study|Lost to Follow-up|4|||
162694916|NCT01512745|587594121|FG001|Overall Study|Lost to Follow-up|0|||
162694917|NCT01512745|587594120|FG000|Overall Study|Lack of Efficacy|2|||
162694918|NCT01512745|587594121|FG001|Overall Study|Lack of Efficacy|2|||
162694919|NCT01512745|587594120|FG000|Overall Study|Protocol Violation|1|||
162694920|NCT01512745|587594121|FG001|Overall Study|Protocol Violation|0|||
162694921|NCT02357810|587594122|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
162694922|NCT02357810|587594122|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
162694923|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Adverse Event|5|||
162694924|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
162694925|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
162694926|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
162694927|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Death|1|||
162694928|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Physician Decision|1|||
162694929|NCT02357810|587594122|FG000|Reached 12 Weeks Response|Other|1|||
162694930|NCT02357810|587594122|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
162694931|NCT02357810|587594122|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
162694932|NCT02357810|587594122|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
162694933|NCT02357810|587594122|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
162694934|NCT02357810|587594122|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
162694935|NCT02357810|587594122|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
162694936|NCT00562978|587594123|FG000|Overall Study|Patient had imaging dose only|1|||
162694937|NCT00562978|587594124|FG001|Overall Study|Patient had imaging dose only|11|||
162694938|NCT06173570|587594126|FG000|Overall Study|Adverse Event|1|||
162694939|NCT06173570|587594127|FG001|Overall Study|Adverse Event|0|||
162694940|NCT06173570|587594128|FG002|Overall Study|Adverse Event|0|||
162694941|NCT06173570|587594129|FG003|Overall Study|Adverse Event|2|||
162694942|NCT06173570|587594130|FG004|Overall Study|Adverse Event|0|||
162694943|NCT06173570|587594126|FG000|Overall Study|Lost to Follow-up|1|||
162694944|NCT06173570|587594127|FG001|Overall Study|Lost to Follow-up|0|||
162694945|NCT06173570|587594128|FG002|Overall Study|Lost to Follow-up|0|||
162694946|NCT06173570|587594129|FG003|Overall Study|Lost to Follow-up|0|||
162694947|NCT06173570|587594130|FG004|Overall Study|Lost to Follow-up|2|||
162694948|NCT06173570|587594126|FG000|Overall Study|Protocol Violation|0|||
162694949|NCT06173570|587594127|FG001|Overall Study|Protocol Violation|2|||
162694950|NCT06173570|587594128|FG002|Overall Study|Protocol Violation|0|||
162694951|NCT06173570|587594129|FG003|Overall Study|Protocol Violation|0|||
162694952|NCT06173570|587594130|FG004|Overall Study|Protocol Violation|1|||
162694953|NCT06173570|587594126|FG000|Overall Study|Withdrawal by Subject|0|||
162694954|NCT06173570|587594127|FG001|Overall Study|Withdrawal by Subject|1|||
162694955|NCT06173570|587594128|FG002|Overall Study|Withdrawal by Subject|1|||
162694956|NCT06173570|587594129|FG003|Overall Study|Withdrawal by Subject|1|||
162694957|NCT06173570|587594130|FG004|Overall Study|Withdrawal by Subject|1|||
162694958|NCT06173570|587594126|FG000|Overall Study|Non-compliance with Study Drug|1|||
162694959|NCT06173570|587594127|FG001|Overall Study|Non-compliance with Study Drug|0|||
162694960|NCT06173570|587594128|FG002|Overall Study|Non-compliance with Study Drug|0|||
162694961|NCT06173570|587594129|FG003|Overall Study|Non-compliance with Study Drug|0|||
162694962|NCT06173570|587594130|FG004|Overall Study|Non-compliance with Study Drug|0|||
162694963|NCT06173570|587594126|FG000|Overall Study|Screen Failure|0|||
162694964|NCT06173570|587594127|FG001|Overall Study|Screen Failure|0|||
162694965|NCT06173570|587594128|FG002|Overall Study|Screen Failure|0|||
162694966|NCT06173570|587594129|FG003|Overall Study|Screen Failure|0|||
162694967|NCT06173570|587594130|FG004|Overall Study|Screen Failure|1|||
162694968|NCT06173570|587594126|FG000|Overall Study|Other|2|||
162694969|NCT06173570|587594127|FG001|Overall Study|Other|1|||
162694970|NCT06173570|587594128|FG002|Overall Study|Other|0|||
162694971|NCT06173570|587594129|FG003|Overall Study|Other|2|||
162694972|NCT06173570|587594130|FG004|Overall Study|Other|0|||
162694973|NCT03151395|587594131|FG000|Overall Study|Adverse Event|2|||
162694974|NCT03151395|587594131|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
162694975|NCT03151395|587594131|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
162694976|NCT03151395|587594131|FG000|Overall Study|Unspecified reason|4|||
162694977|NCT00366301|587594132|FG000|Overall Study|Lost to Follow-up|4|||
162694978|NCT00366301|587594133|FG001|Overall Study|Lost to Follow-up|4|||
162694979|NCT00366301|587594134|FG002|Overall Study|Lost to Follow-up|3|||
162694980|NCT00366301|587594135|FG003|Overall Study|Lost to Follow-up|7|||
162730022|NCT03899792|587719325|FG000|Phase 2|Ongoing Treatment|0|||
162730023|NCT03899792|587719326|FG001|Phase 2|Ongoing Treatment|13|||
162730024|NCT03899792|587719327|FG002|Phase 2|Ongoing Treatment|14|||
162730025|NCT03899792|587719328|FG003|Phase 2|Ongoing Treatment|2|||
162730026|NCT03899792|587719325|FG000|Phase 2|Death|0|||
162730027|NCT03899792|587719326|FG001|Phase 2|Death|0|||
162730028|NCT03899792|587719327|FG002|Phase 2|Death|0|||
162730029|NCT03899792|587719328|FG003|Phase 2|Death|4|||
162730030|NCT03899792|587719325|FG000|Phase 2|Lost to Follow-up|0|||
162730031|NCT03899792|587719326|FG001|Phase 2|Lost to Follow-up|1|||
162730032|NCT03899792|587719327|FG002|Phase 2|Lost to Follow-up|1|||
162730033|NCT03899792|587719328|FG003|Phase 2|Lost to Follow-up|0|||
162730034|NCT03899792|587719325|FG000|Phase 2|Withdrawal by Subject|0|||
162730035|NCT03899792|587719326|FG001|Phase 2|Withdrawal by Subject|1|||
162730036|NCT03899792|587719327|FG002|Phase 2|Withdrawal by Subject|0|||
162730037|NCT03899792|587719328|FG003|Phase 2|Withdrawal by Subject|0|||
162730038|NCT00330681|587719329|FG000|Overall Study|Adverse Event|3|||
162730039|NCT00330681|587719330|FG001|Overall Study|Adverse Event|6|||
162730040|NCT00330681|587719329|FG000|Overall Study|Protocol Violation|0|||
162730041|NCT00330681|587719330|FG001|Overall Study|Protocol Violation|1|||
162730042|NCT00330681|587719329|FG000|Overall Study|Withdrawal by Subject|5|||
162730043|NCT00330681|587719330|FG001|Overall Study|Withdrawal by Subject|5|||
162730044|NCT00330681|587719329|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
162730045|NCT00330681|587719330|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
162730046|NCT03954184|587720752|FG000|Overall Study|Lost to Follow-up|500|||
162730047|NCT03954184|587720753|FG001|Overall Study|Lost to Follow-up|0|||
162730048|NCT03460236|587720755|FG000|Overall Study|failed radiographic screening|16|||
162730049|NCT03460236|587720755|FG000|Overall Study|Withdrawal by Subject|11|||
162730050|NCT04869982|587720756|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
162730051|NCT04869982|587720757|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
162730052|NCT04869982|587720756|FG000|Overall Study|Migrated / moved from the study area|1|||
162730053|NCT04869982|587720757|FG001|Overall Study|Migrated / moved from the study area|1|||
162730054|NCT04869982|587720756|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
162730055|NCT04869982|587720757|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
162730056|NCT04869982|587720756|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
162730057|NCT04869982|587720757|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
162730058|NCT04869982|587720756|FG000|Overall Study|Solicited adverse event|2|||
162730059|NCT04869982|587720757|FG001|Overall Study|Solicited adverse event|1|||
162730060|NCT04608045|587720758|FG000|Overall Study|Physician Decision|1|||
162730061|NCT02473250|587720760|FG000|Overall Study|Lost to Follow-up|10|||
162730062|NCT02473250|587720760|FG000|Overall Study|Physician Decision|5|||
162730063|NCT02473250|587720760|FG000|Overall Study|Did not tolerate medication washout|3|||
162730064|NCT02473250|587720760|FG000|Overall Study|Antidepressant effect of divalproex|2|||
162730065|NCT05215847|587720761|FG000|Overall Study|Lost to Follow-up|1|||
162730066|NCT06023082|587720772|FG000|Overall Study|Withdrawal by Subject|2|||
162730067|NCT06023082|587720772|FG000|Overall Study|Lost to Follow-up|15|||
162730068|NCT06023082|587720772|FG000|Overall Study|Side effects|5|||
162730069|NCT05986565|587720773|FG000|Overall Study|Lost to Follow-up|8|||
162730070|NCT05986565|587720774|FG001|Overall Study|Lost to Follow-up|3|||
162730071|NCT05986565|587720773|FG000|Overall Study|Withdrawal by Subject|0|||
162730072|NCT05986565|587720774|FG001|Overall Study|Withdrawal by Subject|1|||
162730073|NCT00670046|587720775|FG000|Overall Study|Lost to Follow-up|1|||
162730074|NCT00670046|587720776|FG001|Overall Study|Lost to Follow-up|1|||
162730075|NCT00670046|587720775|FG000|Overall Study|Withdrawal by Subject|0|||
162730076|NCT00670046|587720776|FG001|Overall Study|Withdrawal by Subject|1|||
162730077|NCT02006758|587720790|FG000|Overall Study|Protocol Violation|1|||
162694981|NCT00366301|587594132|FG000|Overall Study|Withdrawal by Subject|4|||
162694982|NCT00366301|587594133|FG001|Overall Study|Withdrawal by Subject|2|||
162694983|NCT00366301|587594134|FG002|Overall Study|Withdrawal by Subject|1|||
162694984|NCT00366301|587594135|FG003|Overall Study|Withdrawal by Subject|1|||
162694985|NCT01830881|587594136|FG000|Overall Study|Changed decision to have an abortion|0|||
162694986|NCT01830881|587594137|FG001|Overall Study|Changed decision to have an abortion|1|||
162694987|NCT01320735|587594138|FG000|Overall Study|Adverse Event|3|||
162694988|NCT01320735|587594138|FG000|Overall Study|Withdrawal by Subject|3|||
162730078|NCT02006758|587720790|FG000|Overall Study|Death|1|||
162730079|NCT02006758|587720790|FG000|Overall Study|Lost to Follow-up|4|||
162730080|NCT02006758|587720790|FG000|Overall Study|Withdrawal by Subject|4|||
162730081|NCT02006758|587720790|FG000|Overall Study|Procedurally excluded|1|||
162730082|NCT02006758|587720790|FG000|Overall Study|Other|2|||
162694989|NCT01320735|587594138|FG000|Overall Study|Lost to Follow-up|13|||
162730083|NCT02740231|587720791|FG000|Overall Study|Withdrawal by Subject|1|||
162730084|NCT02740231|587720792|FG001|Overall Study|Withdrawal by Subject|1|||
162730085|NCT02740231|587720793|FG002|Overall Study|Withdrawal by Subject|1|||
162730086|NCT02740231|587720794|FG003|Overall Study|Withdrawal by Subject|0|||
162730087|NCT02740231|587720791|FG000|Overall Study|Lack of Efficacy|0|||
162730088|NCT02740231|587720792|FG001|Overall Study|Lack of Efficacy|1|||
162730089|NCT02740231|587720793|FG002|Overall Study|Lack of Efficacy|0|||
162730090|NCT02740231|587720794|FG003|Overall Study|Lack of Efficacy|4|||
162730091|NCT02740231|587720791|FG000|Overall Study|Lost to Follow-up|1|||
162694990|NCT01320735|587594138|FG000|Overall Study|Administrative Reason|6|||
162694991|NCT01320735|587594138|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
162694992|NCT01320735|587594138|FG000|Overall Study|Protocol Violation|1|||
162694993|NCT01320735|587594138|FG000|Overall Study|Other|1|||
162730092|NCT02740231|587720792|FG001|Overall Study|Lost to Follow-up|3|||
162730093|NCT02740231|587720793|FG002|Overall Study|Lost to Follow-up|0|||
162730094|NCT02740231|587720794|FG003|Overall Study|Lost to Follow-up|3|||
162730095|NCT02740231|587720791|FG000|Overall Study|Adverse Event|0|||
162730096|NCT02740231|587720792|FG001|Overall Study|Adverse Event|1|||
162730097|NCT02740231|587720793|FG002|Overall Study|Adverse Event|0|||
162730098|NCT02740231|587720794|FG003|Overall Study|Adverse Event|1|||
162730099|NCT00243503|587720795|FG000|Overall Study|Adverse Event|11|||
162730100|NCT00243503|587720795|FG000|Overall Study|Withdrawal by Subject|1|||
162730101|NCT00243503|587720795|FG000|Overall Study|Lack of Efficacy|44|||
162730102|NCT00243503|587720795|FG000|Overall Study|Death|1|||
162730103|NCT00243503|587720795|FG000|Overall Study|Other|1|||
162730104|NCT00914589|587720796|FG000|Overall Study|Adverse Event|1|||
162730105|NCT00914589|587720797|FG001|Overall Study|Adverse Event|0|||
162730106|NCT00914589|587720798|FG002|Overall Study|Adverse Event|1|||
162730107|NCT00914589|587720796|FG000|Overall Study|Protocol Violation|8|||
162730108|NCT00914589|587720797|FG001|Overall Study|Protocol Violation|6|||
162730109|NCT00914589|587720798|FG002|Overall Study|Protocol Violation|3|||
162730110|NCT00914589|587720796|FG000|Overall Study|unclassified|16|||
162730111|NCT00914589|587720797|FG001|Overall Study|unclassified|9|||
162730112|NCT00914589|587720798|FG002|Overall Study|unclassified|7|||
162730113|NCT00914589|587720796|FG000|Overall Study|Death|0|||
162730114|NCT00914589|587720797|FG001|Overall Study|Death|1|||
162730115|NCT00914589|587720798|FG002|Overall Study|Death|1|||
162730116|NCT03988023|587720799|FG000|Overall Study|Non-compliance|3|||
162694994|NCT01320735|587594138|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
162694995|NCT01320735|587594138|FG000|Overall Study|Investigator Unable to be Contacted|17|||
162694996|NCT04599101|587594139|FG000|Overall Study|Lost to Follow-up|5|||
162694997|NCT04599101|587594140|FG001|Overall Study|Lost to Follow-up|5|||
162694998|NCT05952297|587594141|FG000|Overall Study|Withdrawal by Subject|1|||
162694999|NCT05952297|587594142|FG001|Overall Study|Withdrawal by Subject|0|||
162695000|NCT03856996|587594143|FG000|Overall Study|Withdrawal by Subject|1|||
162695001|NCT03856996|587594144|FG001|Overall Study|Withdrawal by Subject|0|||
162695002|NCT03856996|587594143|FG000|Overall Study|Lost to Follow-up|0|||
162695003|NCT03856996|587594144|FG001|Overall Study|Lost to Follow-up|1|||
162695004|NCT03856996|587594143|FG000|Overall Study|Adverse Event|1|||
162695005|NCT03856996|587594144|FG001|Overall Study|Adverse Event|1|||
162695006|NCT03856996|587594143|FG000|Overall Study|Other|1|||
162695007|NCT03856996|587594144|FG001|Overall Study|Other|0|||
162695008|NCT04362137|587594147|FG000|Overall Study|Death|9|||
162695009|NCT04362137|587594148|FG001|Overall Study|Death|3|||
162695010|NCT04362137|587594147|FG000|Overall Study|Patient decision|6|||
162695011|NCT04362137|587594148|FG001|Overall Study|Patient decision|3|||
162695012|NCT04362137|587594147|FG000|Overall Study|Adverse Event|1|||
162695013|NCT04362137|587594148|FG001|Overall Study|Adverse Event|0|||
162695014|NCT04362137|587594147|FG000|Overall Study|Lost to Follow-up|1|||
162695015|NCT04362137|587594148|FG001|Overall Study|Lost to Follow-up|0|||
162695016|NCT04362137|587594147|FG000|Overall Study|Protocol deviation|1|||
162695017|NCT04362137|587594148|FG001|Overall Study|Protocol deviation|0|||
162695018|NCT03556358|587594156|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
162695019|NCT03556358|587594157|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
162695020|NCT03556358|587594156|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
162695021|NCT03556358|587594157|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
162695022|NCT03556358|587594156|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
162695023|NCT03556358|587594157|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
162695024|NCT03556358|587594156|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
162695025|NCT03556358|587594157|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
162695026|NCT03556358|587594156|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
162695027|NCT03556358|587594157|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
162730117|NCT03988023|587720800|FG001|Overall Study|Non-compliance|0|||
162730118|NCT03988023|587720799|FG000|Overall Study|Withdrawal by Subject|39|||
162730119|NCT03988023|587720800|FG001|Overall Study|Withdrawal by Subject|37|||
162730120|NCT03988023|587720799|FG000|Overall Study|Adverse Event|0|||
162730121|NCT03988023|587720800|FG001|Overall Study|Adverse Event|2|||
162730122|NCT03988023|587720799|FG000|Overall Study|Physician Decision|0|||
162730123|NCT03988023|587720800|FG001|Overall Study|Physician Decision|1|||
162730124|NCT03988023|587720799|FG000|Overall Study|Lost to Follow-up|5|||
162695028|NCT03556358|587594156|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
162695029|NCT03556358|587594157|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
162730125|NCT03988023|587720800|FG001|Overall Study|Lost to Follow-up|8|||
162730126|NCT03988023|587720799|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
162730127|NCT03988023|587720800|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
162730128|NCT03988023|587720799|FG000|Overall Study|Lack of Efficacy|3|||
162730129|NCT03988023|587720800|FG001|Overall Study|Lack of Efficacy|1|||
162730130|NCT03988023|587720799|FG000|Overall Study|COVID-19 pandemic|225|||
162730131|NCT03988023|587720800|FG001|Overall Study|COVID-19 pandemic|227|||
162730132|NCT03733119|587720801|FG000|Overall Study|Physician Decision|2|||
162730133|NCT03733119|587720802|FG001|Overall Study|Physician Decision|1|||
162730134|NCT03733119|587720801|FG000|Overall Study|ineligible to treat per protocol|0|||
162730135|NCT03733119|587720802|FG001|Overall Study|ineligible to treat per protocol|1|||
162730136|NCT02554786|587720805|FG000|Overall Study|Subject/guardian decision|29|||
162730137|NCT02554786|587720806|FG001|Overall Study|Subject/guardian decision|17|||
162730138|NCT02554786|587720807|FG002|Overall Study|Subject/guardian decision|18|||
162730139|NCT02554786|587720808|FG003|Overall Study|Subject/guardian decision|30|||
162730140|NCT02554786|587720809|FG004|Overall Study|Subject/guardian decision|20|||
162730141|NCT02554786|587720805|FG000|Overall Study|Lost to Follow-up|4|||
162730142|NCT02554786|587720806|FG001|Overall Study|Lost to Follow-up|3|||
162730143|NCT02554786|587720807|FG002|Overall Study|Lost to Follow-up|4|||
162730144|NCT02554786|587720808|FG003|Overall Study|Lost to Follow-up|2|||
162730145|NCT02554786|587720809|FG004|Overall Study|Lost to Follow-up|2|||
162730146|NCT02554786|587720805|FG000|Overall Study|Protocol deviation|1|||
162730147|NCT02554786|587720806|FG001|Overall Study|Protocol deviation|3|||
162730148|NCT02554786|587720807|FG002|Overall Study|Protocol deviation|3|||
162730149|NCT02554786|587720808|FG003|Overall Study|Protocol deviation|4|||
162730150|NCT02554786|587720809|FG004|Overall Study|Protocol deviation|2|||
162730151|NCT02554786|587720805|FG000|Overall Study|Technical problems|1|||
162730152|NCT02554786|587720806|FG001|Overall Study|Technical problems|1|||
162730153|NCT02554786|587720807|FG002|Overall Study|Technical problems|0|||
162730154|NCT02554786|587720808|FG003|Overall Study|Technical problems|2|||
162730155|NCT02554786|587720809|FG004|Overall Study|Technical problems|1|||
162730156|NCT02554786|587720805|FG000|Overall Study|Adverse Event|0|||
162730157|NCT02554786|587720806|FG001|Overall Study|Adverse Event|0|||
162730158|NCT02554786|587720807|FG002|Overall Study|Adverse Event|0|||
162730159|NCT02554786|587720808|FG003|Overall Study|Adverse Event|0|||
162730160|NCT02554786|587720809|FG004|Overall Study|Adverse Event|2|||
162730161|NCT02554786|587720805|FG000|Overall Study|Death|0|||
162730162|NCT02554786|587720806|FG001|Overall Study|Death|0|||
162730163|NCT02554786|587720807|FG002|Overall Study|Death|0|||
162730164|NCT02554786|587720808|FG003|Overall Study|Death|1|||
162730165|NCT02554786|587720809|FG004|Overall Study|Death|0|||
162730166|NCT02554786|587720805|FG000|Overall Study|Non-compliance with study treatment|0|||
162730167|NCT02554786|587720806|FG001|Overall Study|Non-compliance with study treatment|1|||
162730168|NCT02554786|587720807|FG002|Overall Study|Non-compliance with study treatment|1|||
162730169|NCT02554786|587720808|FG003|Overall Study|Non-compliance with study treatment|0|||
162730170|NCT02554786|587720809|FG004|Overall Study|Non-compliance with study treatment|1|||
162730171|NCT02554786|587720805|FG000|Overall Study|Physician Decision|0|||
162730172|NCT02554786|587720806|FG001|Overall Study|Physician Decision|1|||
162730173|NCT02554786|587720807|FG002|Overall Study|Physician Decision|4|||
162730174|NCT02554786|587720808|FG003|Overall Study|Physician Decision|1|||
162730175|NCT02554786|587720809|FG004|Overall Study|Physician Decision|1|||
162730176|NCT02554786|587720805|FG000|Overall Study|Pregnancy|0|||
162730177|NCT02554786|587720806|FG001|Overall Study|Pregnancy|0|||
162730178|NCT02554786|587720807|FG002|Overall Study|Pregnancy|0|||
162730179|NCT02554786|587720808|FG003|Overall Study|Pregnancy|1|||
162730180|NCT02554786|587720809|FG004|Overall Study|Pregnancy|1|||
162730181|NCT04583423|587720815|FG000|Overall Study|Lost to Follow-up|0|||
162730182|NCT04583423|587720816|FG001|Overall Study|Lost to Follow-up|1|||
162730183|NCT04583423|587720817|FG002|Overall Study|Lost to Follow-up|0|||
162730184|NCT04583423|587720818|FG003|Overall Study|Lost to Follow-up|2|||
162730185|NCT04583423|587720815|FG000|Overall Study|Study Terminated by Sponsor|32|||
162730186|NCT04583423|587720816|FG001|Overall Study|Study Terminated by Sponsor|35|||
162730187|NCT04583423|587720817|FG002|Overall Study|Study Terminated by Sponsor|36|||
162730188|NCT04583423|587720818|FG003|Overall Study|Study Terminated by Sponsor|33|||
162730189|NCT04583423|587720815|FG000|Overall Study|Withdrawal by Subject|3|||
162730190|NCT04583423|587720816|FG001|Overall Study|Withdrawal by Subject|1|||
162730191|NCT04583423|587720817|FG002|Overall Study|Withdrawal by Subject|2|||
162730192|NCT04583423|587720818|FG003|Overall Study|Withdrawal by Subject|1|||
162730193|NCT05575076|587720819|FG000|Overall Study|Adverse Event|24|||
162730194|NCT05575076|587720819|FG000|Overall Study|Death|7|||
162730195|NCT05575076|587720819|FG000|Overall Study|Lost to Follow-up|16|||
162730196|NCT05575076|587720819|FG000|Overall Study|Non-Compliance|3|||
162730197|NCT05575076|587720819|FG000|Overall Study|Physician Decision|6|||
162730198|NCT05575076|587720819|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
162730199|NCT05575076|587720819|FG000|Overall Study|Withdrawal by Subject|71|||
162730200|NCT05575076|587720819|FG000|Overall Study|Study Terminated by Sponsor|630|||
162730201|NCT05575076|587720819|FG000|Overall Study|Other|17|||
162730202|NCT00510887|587720820|FG000|Overall Study|Lost to Follow-up|1|||
162730203|NCT01736215|587720830|FG000|Overall Study|Early termination of erythropoietin use|1|||
162730204|NCT01736215|587720830|FG000|Overall Study|Adverse Event|4|||
162730205|NCT01736215|587720830|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
162730206|NCT01736215|587720830|FG000|Overall Study|Insufficient data to perform analysis|8|||
162695030|NCT03556358|587594156|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
162695031|NCT03556358|587594157|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
162695032|NCT05067933|587594162|FG000|Overall Study|Withdrawal by Subject|2|||
162695033|NCT05067933|587594163|FG001|Overall Study|Withdrawal by Subject|0|||
162695034|NCT05067933|587594164|FG002|Overall Study|Withdrawal by Subject|0|||
162695035|NCT05067933|587594165|FG003|Overall Study|Withdrawal by Subject|0|||
162695036|NCT05067933|587594166|FG004|Overall Study|Withdrawal by Subject|0|||
162695037|NCT05067933|587594167|FG005|Overall Study|Withdrawal by Subject|0|||
162695038|NCT05067933|587594162|FG000|Overall Study|Lost to Follow-up|1|||
162695039|NCT05067933|587594163|FG001|Overall Study|Lost to Follow-up|1|||
162695040|NCT05067933|587594164|FG002|Overall Study|Lost to Follow-up|1|||
162695041|NCT05067933|587594165|FG003|Overall Study|Lost to Follow-up|2|||
162695042|NCT05067933|587594166|FG004|Overall Study|Lost to Follow-up|1|||
162695043|NCT05067933|587594167|FG005|Overall Study|Lost to Follow-up|0|||
162695044|NCT05067933|587594162|FG000|Overall Study|Miscellaneous|1|||
162695045|NCT05067933|587594163|FG001|Overall Study|Miscellaneous|0|||
162695046|NCT05067933|587594164|FG002|Overall Study|Miscellaneous|0|||
162695047|NCT05067933|587594165|FG003|Overall Study|Miscellaneous|0|||
162695048|NCT05067933|587594166|FG004|Overall Study|Miscellaneous|0|||
162695049|NCT05067933|587594167|FG005|Overall Study|Miscellaneous|0|||
162695050|NCT05067933|587594162|FG000|Overall Study|Death|0|||
162695051|NCT05067933|587594163|FG001|Overall Study|Death|0|||
162695052|NCT05067933|587594164|FG002|Overall Study|Death|0|||
162695053|NCT05067933|587594165|FG003|Overall Study|Death|1|||
162695054|NCT05067933|587594166|FG004|Overall Study|Death|0|||
162695055|NCT05067933|587594167|FG005|Overall Study|Death|0|||
162695056|NCT01065350|587594168|FG000|Overall Study|Received incorrect drug allocation|0|||
162695057|NCT01065350|587594169|FG001|Overall Study|Received incorrect drug allocation|1|||
162695058|NCT02716038|587594176|FG000|Overall Study|Not evaluable|1|||
162695059|NCT02716038|587594176|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
162695060|NCT02716038|587594176|FG000|Overall Study|Unresectable|3|||
162695061|NCT00550550|587594177|FG000|Overall Study|Adverse Event|13|||
162695062|NCT00550550|587594178|FG001|Overall Study|Adverse Event|5|||
162695063|NCT00550550|587594177|FG000|Overall Study|Treatment Failure|0|||
162695064|NCT00550550|587594178|FG001|Overall Study|Treatment Failure|1|||
162695065|NCT00550550|587594177|FG000|Overall Study|Lost to Follow-up|4|||
162695066|NCT00550550|587594178|FG001|Overall Study|Lost to Follow-up|0|||
162695067|NCT00550550|587594177|FG000|Overall Study|Withdrawal by Subject|10|||
162695068|NCT00550550|587594178|FG001|Overall Study|Withdrawal by Subject|8|||
162695069|NCT00550550|587594177|FG000|Overall Study|Protocol Violation|5|||
162695070|NCT00550550|587594178|FG001|Overall Study|Protocol Violation|14|||
162695071|NCT00550550|587594177|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
162695072|NCT00550550|587594178|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
162695073|NCT00550550|587594177|FG000|Overall Study|Randomized But Not Treated|1|||
162695074|NCT00550550|587594178|FG001|Overall Study|Randomized But Not Treated|0|||
162695075|NCT00591864|587594179|FG000|Overall Study|Incomplete Imaging|5|||
162695076|NCT00118092|587594180|FG000|Overall Study|Withdrawal by Subject|1|||
162695077|NCT00118092|587594180|FG000|Overall Study|Protocol Violation|1|||
162695078|NCT02459093|587594185|FG000|Overall Study|Protocol Violation|6|||
162695079|NCT02459093|587594186|FG001|Overall Study|Protocol Violation|11|||
162695080|NCT02459093|587594185|FG000|Overall Study|Lost to Follow-up|6|||
162695081|NCT02459093|587594186|FG001|Overall Study|Lost to Follow-up|7|||
162695082|NCT01103960|587594189|FG000|Overall Study|Adverse Event|2|||
162695083|NCT01103960|587594190|FG001|Overall Study|Adverse Event|1|||
162695084|NCT01103960|587594189|FG000|Overall Study|Withdrawal by Subject|2|||
162695085|NCT01103960|587594190|FG001|Overall Study|Withdrawal by Subject|1|||
162695086|NCT01103960|587594189|FG000|Overall Study|Other|1|||
162695087|NCT01103960|587594190|FG001|Overall Study|Other|0|||
162695088|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162695089|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
162695090|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
162695091|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162695092|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162695093|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162695094|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162695095|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
162695096|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695097|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695098|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695099|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695100|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695101|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162695102|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
162695103|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
162695104|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
162695105|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162730207|NCT03447249|587720833|FG000|Overall Study|Adverse Event|1|||
162730208|NCT03447249|587720834|FG001|Overall Study|Adverse Event|0|||
162730209|NCT03447249|587720833|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
162730210|NCT03447249|587720834|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
162730211|NCT03447249|587720833|FG000|Overall Study|Other|3|||
162730212|NCT03447249|587720834|FG001|Overall Study|Other|0|||
162730213|NCT00988858|587720835|FG000|Overall Study|Adverse Event|7|||
162730214|NCT00988858|587720835|FG000|Overall Study|Death|1|||
162730215|NCT00988858|587720835|FG000|Overall Study|Physician Decision|1|||
162730216|NCT00988858|587720835|FG000|Overall Study|Sponsor Decision|1|||
162730217|NCT02376790|587720836|FG000|Overall Study|Withdrawal by Subject|43|||
162730218|NCT02376790|587720837|FG001|Overall Study|Withdrawal by Subject|36|||
162730219|NCT02376790|587720838|FG002|Overall Study|Withdrawal by Subject|37|||
162730220|NCT02376790|587720836|FG000|Overall Study|Decision by Sponsor|2|||
162730221|NCT02376790|587720837|FG001|Overall Study|Decision by Sponsor|1|||
162730222|NCT02376790|587720838|FG002|Overall Study|Decision by Sponsor|4|||
162730223|NCT02376790|587720836|FG000|Overall Study|Lost to Follow-up|15|||
162730224|NCT02376790|587720837|FG001|Overall Study|Lost to Follow-up|10|||
162730225|NCT02376790|587720838|FG002|Overall Study|Lost to Follow-up|12|||
162730226|NCT02238483|587720839|FG000|Overall Study|Withdrawal by Subject|2|||
162730227|NCT02238483|587720840|FG001|Overall Study|Withdrawal by Subject|7|||
162730228|NCT02238483|587720839|FG000|Overall Study|Lost to Follow-up|1|||
162730229|NCT02238483|587720840|FG001|Overall Study|Lost to Follow-up|1|||
162730230|NCT02238483|587720839|FG000|Overall Study|Protocol Violation|1|||
162730231|NCT02238483|587720840|FG001|Overall Study|Protocol Violation|2|||
162695106|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162730232|NCT02238483|587720839|FG000|Overall Study|Death|1|||
162730233|NCT02238483|587720840|FG001|Overall Study|Death|0|||
162730234|NCT02238483|587720839|FG000|Overall Study|Adverse Event|7|||
162730235|NCT02238483|587720840|FG001|Overall Study|Adverse Event|3|||
162730236|NCT02238483|587720839|FG000|Overall Study|Withdrawn due to physician decision|1|||
162730237|NCT02238483|587720840|FG001|Overall Study|Withdrawn due to physician decision|0|||
162730238|NCT02238483|587720839|FG000|Overall Study|Completion status not recorded|1|||
162730239|NCT02238483|587720840|FG001|Overall Study|Completion status not recorded|1|||
162730240|NCT02238483|587720839|FG000|Overall Study|Illness in family member|1|||
162730241|NCT02238483|587720840|FG001|Overall Study|Illness in family member|0|||
162730242|NCT02538341|587720841|FG000|Overall Study|Lost to Follow-up|51|||
162730243|NCT02538341|587720842|FG001|Overall Study|Lost to Follow-up|46|||
162730244|NCT02538341|587720841|FG000|Overall Study|Withdrawal by Subject|3|||
162730245|NCT02538341|587720842|FG001|Overall Study|Withdrawal by Subject|1|||
162730246|NCT02538341|587720841|FG000|Overall Study|Death|2|||
162730247|NCT02538341|587720842|FG001|Overall Study|Death|0|||
162730248|NCT02372253|587720843|FG000|Overall Study|Non Compliance|2|||
162695107|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162695108|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162695109|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162695110|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
162695111|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
162695112|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162695113|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162695114|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162695115|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162695116|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162695117|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162695118|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
162695119|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162695120|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162730249|NCT02372253|587720844|FG001|Overall Study|Non Compliance|0|||
162730250|NCT01803555|587720845|FG000|Overall Study|Adverse Event|3|||
162730251|NCT01803555|587720846|FG001|Overall Study|Adverse Event|2|||
162730252|NCT01803555|587720845|FG000|Overall Study|Withdrawal by Subject|3|||
162730253|NCT01803555|587720846|FG001|Overall Study|Withdrawal by Subject|3|||
162730254|NCT01803555|587720845|FG000|Overall Study|Non-compliance|1|||
162730255|NCT01803555|587720846|FG001|Overall Study|Non-compliance|1|||
162730256|NCT01803555|587720845|FG000|Overall Study|Protocol Violation|3|||
162730257|NCT01803555|587720846|FG001|Overall Study|Protocol Violation|5|||
162730258|NCT01803555|587720845|FG000|Overall Study|Lost to Follow-up|0|||
162730259|NCT01803555|587720846|FG001|Overall Study|Lost to Follow-up|2|||
162730260|NCT01803555|587720845|FG000|Overall Study|Other than specified|3|||
162695121|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162695122|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162695123|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
162695124|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
162695125|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
162730261|NCT01803555|587720846|FG001|Overall Study|Other than specified|5|||
162730262|NCT00393484|587720847|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
162695126|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162695127|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162695128|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162695129|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162695130|NCT04921969|587594191|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
162695131|NCT04921969|587594192|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
162695132|NCT04921969|587594193|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162695133|NCT04921969|587594194|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162695134|NCT04921969|587594195|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162695135|NCT04921969|587594196|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162695136|NCT04921969|587594197|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162695137|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695138|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695139|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695140|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695141|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695142|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162695143|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
162695144|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162695145|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162695146|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162695147|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
162695148|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162695149|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
162695150|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
162695151|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162695152|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162695153|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162695154|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
162695155|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
162695156|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
162695157|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
162695158|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162695159|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162695160|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162695161|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162695162|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162695163|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162695164|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162695165|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162695166|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162695167|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162695168|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
162695169|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
162695170|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
162695171|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
162695172|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162695173|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162695174|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162695175|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
162695176|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162695177|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
162695178|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
162695179|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162695180|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162695181|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162695182|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
162695183|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162695184|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162695185|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
162695186|NCT04921969|587594191|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162695187|NCT04921969|587594192|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162695188|NCT04921969|587594193|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162695189|NCT04921969|587594194|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162695190|NCT04921969|587594195|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162695191|NCT04921969|587594196|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
162730263|NCT00393484|587720848|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
162730264|NCT00393484|587720847|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
162730265|NCT00393484|587720848|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
162730266|NCT00393484|587720847|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
162730267|NCT00393484|587720848|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
162730268|NCT00393484|587720847|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
162730269|NCT00393484|587720848|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
162730270|NCT00393484|587720847|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
162730271|NCT00393484|587720848|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
162730272|NCT00393484|587720847|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
162730273|NCT00393484|587720848|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
162730274|NCT00393484|587720847|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
162730275|NCT00393484|587720848|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
162730276|NCT00393484|587720847|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
162730277|NCT00393484|587720848|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
162730278|NCT00393484|587720847|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
162730279|NCT00393484|587720848|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
162730280|NCT00393484|587720847|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
162730281|NCT00393484|587720848|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
162730282|NCT03201562|587720849|FG000|Overall Study|Physician Decision|0|||
162730283|NCT03201562|587720850|FG001|Overall Study|Physician Decision|0|||
162730284|NCT03201562|587720851|FG002|Overall Study|Physician Decision|1|||
162730285|NCT03201562|587720849|FG000|Overall Study|Adverse Event|0|||
162730286|NCT03201562|587720850|FG001|Overall Study|Adverse Event|0|||
162730287|NCT03201562|587720851|FG002|Overall Study|Adverse Event|1|||
162730288|NCT03201562|587720849|FG000|Overall Study|Lost to Follow-up|0|||
162730289|NCT03201562|587720850|FG001|Overall Study|Lost to Follow-up|1|||
162730290|NCT03201562|587720851|FG002|Overall Study|Lost to Follow-up|2|||
162730291|NCT01551355|587720864|FG000|Overall Study|Lost to Follow-up|51|||
162730292|NCT01551355|587720865|FG001|Overall Study|Lost to Follow-up|49|||
162730293|NCT01551355|587720866|FG002|Overall Study|Lost to Follow-up|34|||
162730294|NCT01551355|587720867|FG003|Overall Study|Lost to Follow-up|24|||
162730295|NCT01551355|587720868|FG004|Overall Study|Lost to Follow-up|9|||
162730296|NCT01551355|587720869|FG005|Overall Study|Lost to Follow-up|6|||
162730297|NCT00031694|587720870|FG000|Overall Study|Adverse Event|12|||
162730298|NCT00031694|587720870|FG000|Overall Study|Death|2|||
162730299|NCT00031694|587720870|FG000|Overall Study|Withdrawal by Subject|5|||
162730300|NCT01538719|587720875|FG000|Overall Study|Lost to Follow-up|2|||
162730301|NCT01538719|587720876|FG001|Overall Study|Lost to Follow-up|0|||
162730302|NCT01255670|587720879|FG000|Overall Study|Adverse Event|10|||
162730303|NCT01255670|587720880|FG001|Overall Study|Adverse Event|10|||
162730304|NCT01255670|587720879|FG000|Overall Study|Lost to Follow-up|16|||
162730305|NCT01255670|587720880|FG001|Overall Study|Lost to Follow-up|10|||
162730306|NCT03892564|587720881|FG000|Overall Study|Withdrawal by Subject|2|||
162730307|NCT03664960|587720882|FG000|Overall Study|Adverse Event|0|||
162730308|NCT03664960|587720883|FG001|Overall Study|Adverse Event|3|||
162730309|NCT03664960|587720882|FG000|Overall Study|Lost to Follow-up|3|||
162730310|NCT03664960|587720883|FG001|Overall Study|Lost to Follow-up|2|||
162730311|NCT03664960|587720882|FG000|Overall Study|Physician Decision|1|||
162730312|NCT03664960|587720883|FG001|Overall Study|Physician Decision|0|||
162730313|NCT03664960|587720882|FG000|Overall Study|Withdrawal by Subject|3|||
162730314|NCT03664960|587720883|FG001|Overall Study|Withdrawal by Subject|14|||
162730315|NCT03664960|587720882|FG000|Overall Study|Sponsor Decision|1|||
162730316|NCT03664960|587720883|FG001|Overall Study|Sponsor Decision|1|||
162730317|NCT03664960|587720882|FG000|Overall Study|Other|1|||
162730318|NCT03664960|587720883|FG001|Overall Study|Other|2|||
162730319|NCT03807778|587720884|FG000|Overall Study|Adverse Event|0|||
162730320|NCT03807778|587720885|FG001|Overall Study|Adverse Event|0|||
162730321|NCT03807778|587720886|FG002|Overall Study|Adverse Event|3|||
162730322|NCT03807778|587720887|FG003|Overall Study|Adverse Event|5|||
162730323|NCT03807778|587720884|FG000|Overall Study|Progressive Disease|4|||
162730324|NCT03807778|587720885|FG001|Overall Study|Progressive Disease|2|||
162730325|NCT03807778|587720886|FG002|Overall Study|Progressive Disease|8|||
162730326|NCT03807778|587720887|FG003|Overall Study|Progressive Disease|15|||
162730327|NCT03807778|587720884|FG000|Overall Study|Symptomatic Deterioration|0|||
162730328|NCT03807778|587720885|FG001|Overall Study|Symptomatic Deterioration|1|||
162730329|NCT03807778|587720886|FG002|Overall Study|Symptomatic Deterioration|0|||
162730330|NCT03807778|587720887|FG003|Overall Study|Symptomatic Deterioration|1|||
162730331|NCT03807778|587720884|FG000|Overall Study|Withdrawal by Subject|0|||
162730332|NCT03807778|587720885|FG001|Overall Study|Withdrawal by Subject|1|||
162730333|NCT03807778|587720886|FG002|Overall Study|Withdrawal by Subject|0|||
162730334|NCT03807778|587720887|FG003|Overall Study|Withdrawal by Subject|1|||
162730335|NCT03807778|587720884|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
162730336|NCT03807778|587720885|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
162730337|NCT03807778|587720886|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
162695192|NCT04921969|587594197|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
162695193|NCT04287868|587594198|FG000|Overall Study|Screening fail|1|||
162695194|NCT04287868|587594199|FG001|Overall Study|Screening fail|0|||
162695195|NCT02791490|587595642|FG000|Overall Study|Lost to Follow-up|1|||
162695196|NCT02791490|587595643|FG001|Overall Study|Lost to Follow-up|2|||
162695197|NCT02791490|587595642|FG000|Overall Study|Withdrawal by Subject|2|||
162695198|NCT02791490|587595643|FG001|Overall Study|Withdrawal by Subject|6|||
162695199|NCT02960763|587595644|FG000|Step 1|Withdrawal by Subject|10|||
162695200|NCT02960763|587595645|FG001|Step 1|Withdrawal by Subject|8|||
162695201|NCT02960763|587595646|FG002|Step 1|Withdrawal by Subject|13|||
162695202|NCT02960763|587595647|FG003|Step 1|Withdrawal by Subject|0|||
162695203|NCT02960763|587595648|FG004|Step 1|Withdrawal by Subject|0|||
162695204|NCT02960763|587595644|FG000|Step 1|Lost to Follow-up|7|||
162695205|NCT02960763|587595645|FG001|Step 1|Lost to Follow-up|9|||
162695206|NCT02960763|587595646|FG002|Step 1|Lost to Follow-up|12|||
162695207|NCT02960763|587595647|FG003|Step 1|Lost to Follow-up|0|||
162695208|NCT02960763|587595648|FG004|Step 1|Lost to Follow-up|0|||
162695209|NCT02960763|587595644|FG000|Step 1|Death|1|||
162695210|NCT02960763|587595645|FG001|Step 1|Death|1|||
162695211|NCT02960763|587595646|FG002|Step 1|Death|1|||
162695212|NCT02960763|587595647|FG003|Step 1|Death|0|||
162695213|NCT02960763|587595648|FG004|Step 1|Death|0|||
162695214|NCT02960763|587595644|FG000|Step 1|Investigator discretion|1|||
162695215|NCT02960763|587595645|FG001|Step 1|Investigator discretion|0|||
162695216|NCT02960763|587595646|FG002|Step 1|Investigator discretion|1|||
162695217|NCT02960763|587595647|FG003|Step 1|Investigator discretion|0|||
162695218|NCT02960763|587595648|FG004|Step 1|Investigator discretion|0|||
162695219|NCT02960763|587595644|FG000|Step 1|Other|0|||
162695220|NCT02960763|587595645|FG001|Step 1|Other|0|||
162695221|NCT02960763|587595646|FG002|Step 1|Other|1|||
162695222|NCT02960763|587595647|FG003|Step 1|Other|0|||
162695223|NCT02960763|587595648|FG004|Step 1|Other|0|||
162695224|NCT02960763|587595644|FG000|Step 2|Withdrawal by Subject|0|||
162695225|NCT02960763|587595645|FG001|Step 2|Withdrawal by Subject|0|||
162695226|NCT02960763|587595646|FG002|Step 2|Withdrawal by Subject|0|||
162695227|NCT02960763|587595647|FG003|Step 2|Withdrawal by Subject|7|||
162695228|NCT02960763|587595648|FG004|Step 2|Withdrawal by Subject|3|||
162695229|NCT02960763|587595644|FG000|Step 2|Lost to Follow-up|0|||
162695230|NCT02960763|587595645|FG001|Step 2|Lost to Follow-up|0|||
162695231|NCT02960763|587595646|FG002|Step 2|Lost to Follow-up|0|||
162695232|NCT02960763|587595647|FG003|Step 2|Lost to Follow-up|4|||
162695233|NCT02960763|587595648|FG004|Step 2|Lost to Follow-up|1|||
162695234|NCT02960763|587595644|FG000|Step 2|Investigator discretion|0|||
162695235|NCT02960763|587595645|FG001|Step 2|Investigator discretion|0|||
162695236|NCT02960763|587595646|FG002|Step 2|Investigator discretion|0|||
162695237|NCT02960763|587595647|FG003|Step 2|Investigator discretion|0|||
162695238|NCT02960763|587595648|FG004|Step 2|Investigator discretion|1|||
162695239|NCT05340751|587595649|FG000|Overall Study|Physician Decision|3|||
162695240|NCT01014975|587595662|FG000|Overall Study|Withdrawal by Subject|1|||
162695241|NCT01014975|587595663|FG001|Overall Study|Withdrawal by Subject|0|||
162695242|NCT01014975|587595664|FG002|Overall Study|Withdrawal by Subject|1|||
162695243|NCT01014975|587595662|FG000|Overall Study|Death|3|||
162695244|NCT01014975|587595663|FG001|Overall Study|Death|3|||
162695245|NCT01014975|587595664|FG002|Overall Study|Death|4|||
162695246|NCT01014975|587595662|FG000|Overall Study|Lost to Follow-up|0|||
162695247|NCT01014975|587595663|FG001|Overall Study|Lost to Follow-up|0|||
162695248|NCT01014975|587595664|FG002|Overall Study|Lost to Follow-up|1|||
162695249|NCT02961881|587595665|FG000|Overall Study|Adverse Event|1|||
162695250|NCT02961881|587595666|FG001|Overall Study|Adverse Event|2|||
162695251|NCT02961881|587595667|FG002|Overall Study|Adverse Event|2|||
162695252|NCT02961881|587595668|FG003|Overall Study|Adverse Event|0|||
162695253|NCT02961881|587595669|FG004|Overall Study|Adverse Event|1|||
162695254|NCT02961881|587595665|FG000|Overall Study|Participant request|0|||
162695255|NCT02961881|587595666|FG001|Overall Study|Participant request|2|||
162695256|NCT02961881|587595667|FG002|Overall Study|Participant request|0|||
162695257|NCT02961881|587595668|FG003|Overall Study|Participant request|0|||
162695258|NCT02961881|587595669|FG004|Overall Study|Participant request|0|||
162695259|NCT02961881|587595665|FG000|Overall Study|Disease progression|1|||
162695260|NCT02961881|587595666|FG001|Overall Study|Disease progression|0|||
162695261|NCT02961881|587595667|FG002|Overall Study|Disease progression|1|||
162695262|NCT02961881|587595668|FG003|Overall Study|Disease progression|0|||
162695263|NCT02961881|587595669|FG004|Overall Study|Disease progression|0|||
162695264|NCT00636792|587595670|FG000|Overall Study|Adverse Event|16|||
162695265|NCT00636792|587595670|FG000|Overall Study|Physician Decision|7|||
162695266|NCT00636792|587595670|FG000|Overall Study|Progressive Disease|4|||
162695267|NCT00636792|587595670|FG000|Overall Study|Withdrawal by Subject|3|||
162695268|NCT00636792|587595670|FG000|Overall Study|Other|3|||
162695269|NCT01928225|587595671|FG000|Overall Study|Pregnancy|1|||
162695270|NCT01928225|587595672|FG001|Overall Study|Pregnancy|0|||
162695271|NCT01928225|587595671|FG000|Overall Study|basaloid cervical cancer|1|||
162695272|NCT01928225|587595672|FG001|Overall Study|basaloid cervical cancer|0|||
162695273|NCT01928225|587595671|FG000|Overall Study|Lost to Follow-up|1|||
162695274|NCT01928225|587595672|FG001|Overall Study|Lost to Follow-up|3|||
162730338|NCT03807778|587720887|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
162730339|NCT01207492|587720888|FG000|Overall Study|Still on study|1|||
162730340|NCT01207492|587720888|FG000|Overall Study|Withdrawal by Subject|9|||
162730341|NCT01207492|587720888|FG000|Overall Study|Physician Decision|1|||
162730342|NCT01207492|587720888|FG000|Overall Study|Progressive disease|3|||
162730343|NCT01207492|587720888|FG000|Overall Study|Toxicity|1|||
162730344|NCT03582722|587720889|FG000|Overall Study|Lost to Follow-up|1|||
162730345|NCT03582722|587720890|FG001|Overall Study|Lost to Follow-up|4|||
162730346|NCT03582722|587720889|FG000|Overall Study|Withdrawal by Subject|3|||
162730347|NCT03582722|587720890|FG001|Overall Study|Withdrawal by Subject|3|||
162730348|NCT01216176|587722538|FG000|Overall Study|Adverse Event|0|||
162730349|NCT01216176|587722539|FG001|Overall Study|Adverse Event|8|||
162730350|NCT01216176|587722540|FG002|Overall Study|Adverse Event|0|||
162730351|NCT01216176|587722538|FG000|Overall Study|Physician Decision|0|||
162730352|NCT01216176|587722539|FG001|Overall Study|Physician Decision|0|||
162730353|NCT01216176|587722540|FG002|Overall Study|Physician Decision|1|||
162730354|NCT03481660|587722543|FG000|Overall Study|Adverse Event|5|||
162730355|NCT03481660|587722544|FG001|Overall Study|Adverse Event|4|||
162730356|NCT03481660|587722543|FG000|Overall Study|Death|13|||
162730357|NCT03481660|587722544|FG001|Overall Study|Death|9|||
162730358|NCT03481660|587722543|FG000|Overall Study|Lost to Follow-up|2|||
162730359|NCT03481660|587722544|FG001|Overall Study|Lost to Follow-up|2|||
162730360|NCT03481660|587722543|FG000|Overall Study|Physician Decision|2|||
162730361|NCT03481660|587722544|FG001|Overall Study|Physician Decision|3|||
162730362|NCT03481660|587722543|FG000|Overall Study|Withdrawal by Subject|14|||
162730363|NCT03481660|587722544|FG001|Overall Study|Withdrawal by Subject|7|||
162730364|NCT04278586|587722545|FG000|Overall Study|Withdrawal by Subject|13|||
162730365|NCT04278586|587722546|FG001|Overall Study|Withdrawal by Subject|6|||
162730366|NCT04278586|587722545|FG000|Overall Study|Lost to Follow-up|37|||
162730367|NCT04278586|587722546|FG001|Overall Study|Lost to Follow-up|24|||
162730368|NCT03651895|587722553|FG000|First Drug Assignment|Adverse Event|4|||
162730369|NCT03651895|587722554|FG001|First Drug Assignment|Adverse Event|5|||
162730370|NCT03651895|587722553|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
162695275|NCT01235975|587595677|FG000|Overall Study|Serious Adverse Event|0|||
162695276|NCT01235975|587595678|FG001|Overall Study|Serious Adverse Event|1|||
162695277|NCT01235975|587595677|FG000|Overall Study|Withdrawal by Subject|8|||
162695278|NCT01235975|587595678|FG001|Overall Study|Withdrawal by Subject|2|||
162695279|NCT01235975|587595677|FG000|Overall Study|Migrated/moved from study area|2|||
162695280|NCT01235975|587595678|FG001|Overall Study|Migrated/moved from study area|1|||
162695281|NCT01235975|587595677|FG000|Overall Study|Lost to Follow-up|7|||
162695282|NCT01235975|587595678|FG001|Overall Study|Lost to Follow-up|3|||
162695283|NCT01381874|587595679|FG000|Overall Study|Lost to Follow-up|1|||
162695284|NCT01381874|587595680|FG001|Overall Study|Lost to Follow-up|1|||
162695285|NCT01381874|587595681|FG002|Overall Study|Lost to Follow-up|0|||
162695286|NCT01381874|587595679|FG000|Overall Study|Withdrawal by Subject|9|||
162695287|NCT01381874|587595680|FG001|Overall Study|Withdrawal by Subject|10|||
162695288|NCT01381874|587595681|FG002|Overall Study|Withdrawal by Subject|9|||
162695289|NCT01381874|587595679|FG000|Overall Study|Other|67|||
162695290|NCT01381874|587595680|FG001|Overall Study|Other|52|||
162695291|NCT01381874|587595681|FG002|Overall Study|Other|67|||
162695292|NCT03119610|587595685|FG000|Overall Study|Adverse Event|1|||
162695293|NCT03119610|587595686|FG001|Overall Study|Adverse Event|0|||
162695294|NCT03119610|587595685|FG000|Overall Study|Lost to Follow-up|0|||
162695295|NCT03119610|587595686|FG001|Overall Study|Lost to Follow-up|1|||
162695296|NCT00114634|587595687|FG000|Overall Study|failure to return forms|3|||
162695297|NCT00684762|587595690|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
162695298|NCT00684762|587595691|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
162695299|NCT03662997|587595699|FG000|Overall Study|Adverse Event|0|||
162730371|NCT03651895|587722554|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
162730372|NCT02879448|587722555|FG000|Overall Study|Death|251|||
162730373|NCT02879448|587722556|FG001|Overall Study|Death|263|||
162730374|NCT02879448|587722555|FG000|Overall Study|Lost to Follow-up|23|||
162730375|NCT02879448|587722556|FG001|Overall Study|Lost to Follow-up|28|||
162730376|NCT02879448|587722555|FG000|Overall Study|Withdrawal by Subject|42|||
162730377|NCT02879448|587722556|FG001|Overall Study|Withdrawal by Subject|79|||
162730378|NCT02879448|587722555|FG000|Overall Study|Other Reasons|8|||
162730379|NCT02879448|587722556|FG001|Overall Study|Other Reasons|12|||
162695300|NCT03662997|587595700|FG001|Overall Study|Adverse Event|2|||
162695301|NCT03662997|587595701|FG002|Overall Study|Adverse Event|0|||
162695302|NCT03662997|587595702|FG003|Overall Study|Adverse Event|0|||
162730380|NCT03433339|587722557|FG000|Overall Study|Lost to Follow-up|2|||
162730381|NCT03433339|587722558|FG001|Overall Study|Lost to Follow-up|0|||
162730382|NCT03433339|587722557|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
162730383|NCT03433339|587722558|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
162695303|NCT00439179|587595705|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162695304|NCT00439179|587595706|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
162695305|NCT00439179|587595707|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162695306|NCT00439179|587595708|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162695307|NCT02761629|587595709|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
162695308|NCT02761629|587595710|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
162695309|NCT02761629|587595709|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162695310|NCT02761629|587595710|FG001|Overall Study|Insufficient Therapeutic Response|7|||
162695311|NCT02761629|587595709|FG000|Overall Study|Failure to Return|2|||
162695312|NCT02761629|587595710|FG001|Overall Study|Failure to Return|4|||
162695313|NCT02761629|587595709|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
162695314|NCT02761629|587595710|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
162695315|NCT02761629|587595709|FG000|Overall Study|Protocol Violation|2|||
162695316|NCT02761629|587595710|FG001|Overall Study|Protocol Violation|2|||
162695317|NCT02761629|587595709|FG000|Overall Study|Withdrawal by Subject|0|||
162695318|NCT02761629|587595710|FG001|Overall Study|Withdrawal by Subject|3|||
162695319|NCT02761629|587595709|FG000|Overall Study|Other|0|||
162695320|NCT02761629|587595710|FG001|Overall Study|Other|2|||
162695321|NCT02761629|587595709|FG000|Overall Study|Lost to Follow-up|4|||
162695322|NCT02761629|587595710|FG001|Overall Study|Lost to Follow-up|1|||
162695323|NCT02761629|587595709|FG000|Overall Study|Randomized But Not Treated|8|||
162695324|NCT02761629|587595710|FG001|Overall Study|Randomized But Not Treated|4|||
162695325|NCT00675506|587595715|FG000|Overall Study|Lost to Follow-up|1|||
162695326|NCT00675506|587595716|FG001|Overall Study|Lost to Follow-up|5|||
162695327|NCT00675506|587595715|FG000|Overall Study|Lost interest|3|||
162695328|NCT00675506|587595716|FG001|Overall Study|Lost interest|5|||
162695329|NCT00675506|587595715|FG000|Overall Study|Elevated fasting glucose|2|||
162695330|NCT00675506|587595716|FG001|Overall Study|Elevated fasting glucose|1|||
162695331|NCT00675506|587595715|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
162695332|NCT00675506|587595716|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
162695333|NCT00675506|587595715|FG000|Overall Study|Elevated IGF-1|2|||
162695334|NCT00675506|587595716|FG001|Overall Study|Elevated IGF-1|0|||
162695335|NCT00675506|587595715|FG000|Overall Study|Hypersensitivity Reaction|1|||
162695336|NCT00675506|587595716|FG001|Overall Study|Hypersensitivity Reaction|0|||
162695337|NCT00675506|587595715|FG000|Overall Study|Disclosed history of cancer|1|||
162695338|NCT00675506|587595716|FG001|Overall Study|Disclosed history of cancer|0|||
162695339|NCT00675506|587595715|FG000|Overall Study|Declined participation|1|||
162695340|NCT00675506|587595716|FG001|Overall Study|Declined participation|0|||
162695341|NCT00675506|587595715|FG000|Overall Study|Schedule conflict|0|||
162695342|NCT00675506|587595716|FG001|Overall Study|Schedule conflict|1|||
162695343|NCT00936221|587595717|FG000|Overall Study|Withdrawal by Subject|1|||
162695344|NCT00936221|587595718|FG001|Overall Study|Withdrawal by Subject|1|||
162695345|NCT03820323|587595719|FG000|Overall Study|Lost to Follow-up|2|||
162695346|NCT03820323|587595720|FG001|Overall Study|Lost to Follow-up|1|||
162695347|NCT03820323|587595719|FG000|Overall Study|Missed 12-month visit|22|||
162695348|NCT03820323|587595720|FG001|Overall Study|Missed 12-month visit|14|||
162695349|NCT03820323|587595719|FG000|Overall Study|Death|2|||
162695350|NCT03820323|587595720|FG001|Overall Study|Death|1|||
162695351|NCT03820323|587595719|FG000|Overall Study|Transferred out|13|||
162695352|NCT03820323|587595720|FG001|Overall Study|Transferred out|11|||
162695353|NCT03820323|587595719|FG000|Overall Study|Terminated|0|||
162695354|NCT03820323|587595720|FG001|Overall Study|Terminated|3|||
162695355|NCT03820323|587595719|FG000|Overall Study|Withdrawal by Subject|1|||
162695356|NCT03820323|587595720|FG001|Overall Study|Withdrawal by Subject|6|||
162695357|NCT01844115|587595723|FG000|Overall Study|Adverse Event|4|||
162695358|NCT01844115|587595724|FG001|Overall Study|Adverse Event|22|||
162695359|NCT01844115|587595723|FG000|Overall Study|Lack of Efficacy|1|||
162695360|NCT01844115|587595724|FG001|Overall Study|Lack of Efficacy|4|||
162695361|NCT01844115|587595723|FG000|Overall Study|Protocol Violation|12|||
162695362|NCT01844115|587595724|FG001|Overall Study|Protocol Violation|10|||
162695363|NCT01844115|587595723|FG000|Overall Study|Withdrawal by Subject|11|||
162695364|NCT01844115|587595724|FG001|Overall Study|Withdrawal by Subject|11|||
162695365|NCT01844115|587595723|FG000|Overall Study|Lost to Follow-up|11|||
162695366|NCT01844115|587595724|FG001|Overall Study|Lost to Follow-up|10|||
162695367|NCT01844115|587595723|FG000|Overall Study|Pregnancy|0|||
162695368|NCT01844115|587595724|FG001|Overall Study|Pregnancy|1|||
162695369|NCT00545363|587595725|FG000|Overall Study|Adverse Event|6|||
162695370|NCT00545363|587595726|FG001|Overall Study|Adverse Event|7|||
162695371|NCT00545363|587595725|FG000|Overall Study|Withdrawal by Subject|6|||
162695372|NCT00545363|587595726|FG001|Overall Study|Withdrawal by Subject|5|||
162695373|NCT00545363|587595725|FG000|Overall Study|Non-compliance|3|||
162695374|NCT00545363|587595726|FG001|Overall Study|Non-compliance|1|||
162695375|NCT00545363|587595725|FG000|Overall Study|Did not meet entry criteria|1|||
162695376|NCT00545363|587595726|FG001|Overall Study|Did not meet entry criteria|1|||
162695377|NCT00545363|587595725|FG000|Overall Study|Lost to Follow-up|2|||
162695378|NCT00545363|587595726|FG001|Overall Study|Lost to Follow-up|0|||
162695379|NCT00545363|587595725|FG000|Overall Study|Other|1|||
162695380|NCT00545363|587595726|FG001|Overall Study|Other|1|||
162695381|NCT02153359|587595727|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
162730384|NCT03433339|587722557|FG000|Overall Study|Withdrawal by Subject|0|||
162730385|NCT03433339|587722558|FG001|Overall Study|Withdrawal by Subject|2|||
162730386|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162730387|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162730388|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162730389|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162730390|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
162730391|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162730392|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162730393|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162730394|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162730395|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
162730396|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162730397|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162730398|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162730399|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162730400|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
162730401|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162730402|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162730403|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162730404|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162730405|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
162730406|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162730407|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162730408|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162730409|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162730410|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
162730411|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162730412|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162730413|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162730414|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162730415|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
162730416|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162730417|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162730418|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162730419|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162730420|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
162730421|NCT01898494|587722562|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162730422|NCT01898494|587722563|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162730423|NCT01898494|587722564|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162730424|NCT01898494|587722565|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162730425|NCT01898494|587722566|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
162730426|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162730427|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162730428|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
162730429|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
162730430|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162730431|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162730432|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162730433|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
162730434|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
162730435|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162730436|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
162730437|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
162730438|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
162730439|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
162730440|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
162730441|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162730442|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
162730443|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162730444|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162730445|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162730446|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162730447|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162730448|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
162730449|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162730450|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162730451|NCT01898494|587722562|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
162730452|NCT01898494|587722563|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
162695382|NCT02153359|587595728|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
162695383|NCT01372605|587595729|FG000|Overall Study|Death|1|||
162695384|NCT01372605|587595730|FG001|Overall Study|Death|2|||
162695385|NCT01372605|587595729|FG000|Overall Study|Lost to Follow-up|2|||
162695386|NCT01372605|587595730|FG001|Overall Study|Lost to Follow-up|1|||
162695387|NCT01372605|587595729|FG000|Overall Study|Withdrawal by Subject|4|||
162695388|NCT01372605|587595730|FG001|Overall Study|Withdrawal by Subject|7|||
162695389|NCT01372605|587595729|FG000|Overall Study|Moved|3|||
162695390|NCT01372605|587595730|FG001|Overall Study|Moved|0|||
162695391|NCT01372605|587595729|FG000|Overall Study|Changed medical home|2|||
162695392|NCT01372605|587595730|FG001|Overall Study|Changed medical home|0|||
162695393|NCT01348776|587595731|FG000|Overall Study|Lost to Follow-up|3|||
162695394|NCT00210119|587595732|FG000|Overall Study|Protocol Violation|1|||
162695395|NCT00210119|587595732|FG000|Overall Study|Withdrawal by Subject|1|||
162695396|NCT00951509|587595733|FG000|Overall Study|Withdrawal by Subject|2|||
162695397|NCT03125941|587595738|FG000|Overall Study|did not receive intervention|1|||
162695398|NCT03125941|587595739|FG001|Overall Study|did not receive intervention|2|||
162695399|NCT00734214|587595740|FG000|Overall Study|Withdrawal by Subject|3|||
162695400|NCT00734214|587595741|FG001|Overall Study|Withdrawal by Subject|4|||
162695401|NCT00734214|587595740|FG000|Overall Study|MD withdrawal|1|||
162695402|NCT00734214|587595741|FG001|Overall Study|MD withdrawal|0|||
162695403|NCT00406419|587595748|FG000|Overall Study|Death|3|||
162695404|NCT00406419|587595749|FG001|Overall Study|Death|1|||
162695405|NCT00406419|587595750|FG002|Overall Study|Death|4|||
162695406|NCT00406419|587595748|FG000|Overall Study|Protocol Violation|6|||
162695407|NCT00406419|587595749|FG001|Overall Study|Protocol Violation|2|||
162695408|NCT00406419|587595750|FG002|Overall Study|Protocol Violation|5|||
162695409|NCT00406419|587595748|FG000|Overall Study|Study Terminated by Sponsor|260|||
162695410|NCT00406419|587595749|FG001|Overall Study|Study Terminated by Sponsor|288|||
162695411|NCT00406419|587595750|FG002|Overall Study|Study Terminated by Sponsor|282|||
162695412|NCT00406419|587595748|FG000|Overall Study|Withdrawal by Subject|17|||
162695413|NCT00406419|587595749|FG001|Overall Study|Withdrawal by Subject|24|||
162695414|NCT00406419|587595750|FG002|Overall Study|Withdrawal by Subject|26|||
162695415|NCT00406419|587595748|FG000|Overall Study|Lack of Efficacy|12|||
162695416|NCT00406419|587595749|FG001|Overall Study|Lack of Efficacy|1|||
162695417|NCT00406419|587595750|FG002|Overall Study|Lack of Efficacy|6|||
162695418|NCT00406419|587595748|FG000|Overall Study|Non-Compliance with Study Drug|5|||
162695419|NCT00406419|587595749|FG001|Overall Study|Non-Compliance with Study Drug|6|||
162695420|NCT00406419|587595750|FG002|Overall Study|Non-Compliance with Study Drug|3|||
162695421|NCT00406419|587595748|FG000|Overall Study|Adverse Event|10|||
162695422|NCT00406419|587595749|FG001|Overall Study|Adverse Event|12|||
162695423|NCT00406419|587595750|FG002|Overall Study|Adverse Event|16|||
162695424|NCT00406419|587595748|FG000|Overall Study|Lost to Follow-up|11|||
162695425|NCT00406419|587595749|FG001|Overall Study|Lost to Follow-up|10|||
162695426|NCT00406419|587595750|FG002|Overall Study|Lost to Follow-up|5|||
162695427|NCT01461993|587595751|FG000|Overall Study|Withdrawal by Subject|60|||
162695428|NCT01461993|587595752|FG001|Overall Study|Withdrawal by Subject|53|||
162695429|NCT01461993|587595753|FG002|Overall Study|Withdrawal by Subject|16|||
162695430|NCT01461993|587595751|FG000|Overall Study|Lost to Follow-up|44|||
162695431|NCT01461993|587595752|FG001|Overall Study|Lost to Follow-up|48|||
162695432|NCT01461993|587595753|FG002|Overall Study|Lost to Follow-up|22|||
162695433|NCT01461993|587595751|FG000|Overall Study|Protocol Violation|10|||
162695434|NCT01461993|587595752|FG001|Overall Study|Protocol Violation|9|||
162695435|NCT01461993|587595753|FG002|Overall Study|Protocol Violation|7|||
162695436|NCT01461993|587595751|FG000|Overall Study|Adverse Event|9|||
162695437|NCT01461993|587595752|FG001|Overall Study|Adverse Event|11|||
162695438|NCT01461993|587595753|FG002|Overall Study|Adverse Event|3|||
162695439|NCT01461993|587595751|FG000|Overall Study|No longer met eligibility criteria|13|||
162695440|NCT01461993|587595752|FG001|Overall Study|No longer met eligibility criteria|18|||
162695441|NCT01461993|587595753|FG002|Overall Study|No longer met eligibility criteria|10|||
162695442|NCT01461993|587595751|FG000|Overall Study|Did not meet entrance criteria|2|||
162695443|NCT01461993|587595752|FG001|Overall Study|Did not meet entrance criteria|3|||
162695444|NCT01461993|587595753|FG002|Overall Study|Did not meet entrance criteria|0|||
162695445|NCT01461993|587595751|FG000|Overall Study|Other|13|||
162695446|NCT01461993|587595752|FG001|Overall Study|Other|15|||
162695447|NCT01461993|587595753|FG002|Overall Study|Other|6|||
162695448|NCT01821898|587595755|FG000|Overall Study|Withdrawal by Subject|2|||
162695449|NCT01821898|587595756|FG001|Overall Study|Withdrawal by Subject|1|||
162695450|NCT01121484|587595757|FG000|Overall Study|Adverse Event|12|||
162730453|NCT01898494|587722564|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
162730454|NCT01898494|587722565|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
162695451|NCT01121484|587595758|FG001|Overall Study|Adverse Event|5|||
162695452|NCT01121484|587595757|FG000|Overall Study|Lack of Efficacy|3|||
162695453|NCT01121484|587595758|FG001|Overall Study|Lack of Efficacy|11|||
162695454|NCT01121484|587595757|FG000|Overall Study|Lost to Follow-up|5|||
162695455|NCT01121484|587595758|FG001|Overall Study|Lost to Follow-up|9|||
162695456|NCT01121484|587595757|FG000|Overall Study|Physician Decision|0|||
162695457|NCT01121484|587595758|FG001|Overall Study|Physician Decision|3|||
162695458|NCT01121484|587595757|FG000|Overall Study|Protocol Violation|1|||
162695459|NCT01121484|587595758|FG001|Overall Study|Protocol Violation|0|||
162695460|NCT01121484|587595757|FG000|Overall Study|Withdrawal by Subject|8|||
162695461|NCT01121484|587595758|FG001|Overall Study|Withdrawal by Subject|7|||
162695462|NCT01121484|587595757|FG000|Overall Study|Discontinuation of study by sponsor|0|||
162695463|NCT01121484|587595758|FG001|Overall Study|Discontinuation of study by sponsor|1|||
162695464|NCT01121484|587595757|FG000|Overall Study|Other|3|||
162695465|NCT01121484|587595758|FG001|Overall Study|Other|3|||
162695466|NCT01121484|587595757|FG000|Overall Study|Randomized, not treated|1|||
162695467|NCT01121484|587595758|FG001|Overall Study|Randomized, not treated|4|||
162695468|NCT06390826|587595761|FG000|Overall Study|Never Start Protocol Therapy|1|||
162695469|NCT06390826|587595761|FG000|Overall Study|Adverse Event|1|||
162695470|NCT06390826|587595761|FG000|Overall Study|Disease Progression|8|||
162695471|NCT03679767|587595762|FG000|Overall Study|Death|16|||
162695472|NCT03679767|587595763|FG001|Overall Study|Death|11|||
162695473|NCT03679767|587595764|FG002|Overall Study|Death|17|||
162695474|NCT03679767|587595765|FG003|Overall Study|Death|10|||
162695475|NCT03679767|587595762|FG000|Overall Study|Lost to Follow-up|1|||
162695476|NCT03679767|587595763|FG001|Overall Study|Lost to Follow-up|1|||
162695477|NCT03679767|587595764|FG002|Overall Study|Lost to Follow-up|1|||
162695478|NCT03679767|587595765|FG003|Overall Study|Lost to Follow-up|1|||
162695479|NCT03679767|587595762|FG000|Overall Study|Withdrawal by Subject|0|||
162695480|NCT03679767|587595763|FG001|Overall Study|Withdrawal by Subject|0|||
162695481|NCT03679767|587595764|FG002|Overall Study|Withdrawal by Subject|0|||
162695482|NCT03679767|587595765|FG003|Overall Study|Withdrawal by Subject|1|||
162695483|NCT03679767|587595762|FG000|Overall Study|Follow-up Completed|18|||
162695484|NCT03679767|587595763|FG001|Overall Study|Follow-up Completed|11|||
162695485|NCT03679767|587595764|FG002|Overall Study|Follow-up Completed|11|||
162695486|NCT03679767|587595765|FG003|Overall Study|Follow-up Completed|20|||
162695487|NCT03679767|587595762|FG000|Overall Study|Entered Hospice Care|0|||
162695488|NCT03679767|587595763|FG001|Overall Study|Entered Hospice Care|0|||
162695489|NCT03679767|587595764|FG002|Overall Study|Entered Hospice Care|0|||
162695490|NCT03679767|587595765|FG003|Overall Study|Entered Hospice Care|1|||
162695491|NCT03679767|587595762|FG000|Overall Study|Progressive Disease|0|||
162695492|NCT03679767|587595763|FG001|Overall Study|Progressive Disease|0|||
162695493|NCT03679767|587595764|FG002|Overall Study|Progressive Disease|0|||
162695494|NCT03679767|587595765|FG003|Overall Study|Progressive Disease|1|||
162695495|NCT03915951|587595766|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
162695496|NCT03915951|587595767|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
162695497|NCT03915951|587595766|FG000|Overall Study|Adverse Event|12|||
162695498|NCT03915951|587595767|FG001|Overall Study|Adverse Event|6|||
162695499|NCT03915951|587595766|FG000|Overall Study|Disease progression (radiological)|17|||
162695500|NCT03915951|587595767|FG001|Overall Study|Disease progression (radiological)|15|||
162695501|NCT03915951|587595766|FG000|Overall Study|Disease progression (clinical)|4|||
162695502|NCT03915951|587595767|FG001|Overall Study|Disease progression (clinical)|1|||
162695503|NCT03915951|587595766|FG000|Overall Study|Patient decision|0|||
162695504|NCT03915951|587595767|FG001|Overall Study|Patient decision|4|||
162695505|NCT03915951|587595766|FG000|Overall Study|Investigator decision|0|||
162695506|NCT03915951|587595767|FG001|Overall Study|Investigator decision|1|||
162695507|NCT03915951|587595766|FG000|Overall Study|Consent withdrawn|1|||
162695508|NCT03915951|587595767|FG001|Overall Study|Consent withdrawn|1|||
162695509|NCT03915951|587595766|FG000|Overall Study|Death|0|||
162695510|NCT03915951|587595767|FG001|Overall Study|Death|3|||
162695511|NCT05408468|587595768|FG000|Overall Study|Lost to Follow-up|3|||
162695512|NCT05408468|587595769|FG001|Overall Study|Lost to Follow-up|1|||
162695513|NCT05408468|587595768|FG000|Overall Study|Physician Decision|1|||
162695514|NCT05408468|587595769|FG001|Overall Study|Physician Decision|0|||
162695515|NCT05408468|587595768|FG000|Overall Study|Overwhelmed by clinical situation|3|||
162695516|NCT05408468|587595769|FG001|Overall Study|Overwhelmed by clinical situation|0|||
162695517|NCT05408468|587595768|FG000|Overall Study|Personal illness precluding participation|1|||
162695518|NCT05408468|587595769|FG001|Overall Study|Personal illness precluding participation|0|||
162695519|NCT05408468|587595768|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
162695520|NCT05408468|587595769|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
162695521|NCT02204579|587595774|FG000|Overall Study|Screen failures|2|||
162695522|NCT01396395|587595775|FG000|Overall Study|Withdrawal by Subject|10|||
162695523|NCT01396395|587595776|FG001|Overall Study|Withdrawal by Subject|12|||
162695524|NCT01396395|587595775|FG000|Overall Study|Protocol Violation|3|||
162695525|NCT01396395|587595776|FG001|Overall Study|Protocol Violation|1|||
162695526|NCT01396395|587595775|FG000|Overall Study|Adverse Event|10|||
162695527|NCT01396395|587595776|FG001|Overall Study|Adverse Event|2|||
162695528|NCT01396395|587595775|FG000|Overall Study|Lost to Follow-up|17|||
162695529|NCT01396395|587595776|FG001|Overall Study|Lost to Follow-up|11|||
162695530|NCT01396395|587595775|FG000|Overall Study|Other|0|||
162695531|NCT01396395|587595776|FG001|Overall Study|Other|1|||
162695532|NCT02120664|587595777|FG000|Overall Study|Withdrawal by Subject|0|||
162695533|NCT02120664|587595778|FG001|Overall Study|Withdrawal by Subject|0|||
162695534|NCT02120664|587595779|FG002|Overall Study|Withdrawal by Subject|0|||
162695535|NCT02120664|587595780|FG003|Overall Study|Withdrawal by Subject|1|||
162695536|NCT02120664|587595781|FG004|Overall Study|Withdrawal by Subject|0|||
162695537|NCT02460263|587595782|FG000|Transition Period|Withdrawal by Subject|1|||
162695538|NCT02460263|587595782|FG000|Transition Period|Death|1|||
162695539|NCT03916744|587595783|FG000|Overall Study|Withdrawal by Subject|0|||
162695540|NCT03916744|587595784|FG001|Overall Study|Withdrawal by Subject|1|||
162695541|NCT03916744|587595785|FG002|Overall Study|Withdrawal by Subject|2|||
162695542|NCT03176238|587595788|FG000|Overall Study|Unacceptable AEs|15|||
162695543|NCT03176238|587595789|FG001|Overall Study|Unacceptable AEs|8|||
162695544|NCT03176238|587595788|FG000|Overall Study|Abnormal lab value(s)|2|||
162695545|NCT03176238|587595789|FG001|Overall Study|Abnormal lab value(s)|0|||
162695546|NCT03176238|587595788|FG000|Overall Study|Inter-current illness|0|||
162695547|NCT03176238|587595789|FG001|Overall Study|Inter-current illness|1|||
162695548|NCT03176238|587595788|FG000|Overall Study|Consent withdrawal|14|||
162695549|NCT03176238|587595789|FG001|Overall Study|Consent withdrawal|2|||
162695550|NCT03176238|587595788|FG000|Overall Study|Lost to Follow-up|3|||
162695551|NCT03176238|587595789|FG001|Overall Study|Lost to Follow-up|0|||
162695552|NCT03176238|587595788|FG000|Overall Study|Administrative problems|1|||
162695553|NCT03176238|587595789|FG001|Overall Study|Administrative problems|0|||
162695554|NCT03176238|587595788|FG000|Overall Study|Death|3|||
162695555|NCT03176238|587595789|FG001|Overall Study|Death|0|||
162695556|NCT03176238|587595788|FG000|Overall Study|Disease Progression|133|||
162695557|NCT03176238|587595789|FG001|Overall Study|Disease Progression|22|||
162695558|NCT03176238|587595788|FG000|Overall Study|Tx duration completed per EAP|0|||
162695559|NCT03176238|587595789|FG001|Overall Study|Tx duration completed per EAP|1|||
162695560|NCT03176238|587595788|FG000|Overall Study|Patient is switched to commercial drug|16|||
162695561|NCT03176238|587595789|FG001|Overall Study|Patient is switched to commercial drug|1|||
162695562|NCT03176238|587595788|FG000|Overall Study|Protocol Violation|1|||
162695563|NCT03176238|587595789|FG001|Overall Study|Protocol Violation|0|||
162695564|NCT03176238|587595788|FG000|Overall Study|Changes in the patient's condition|2|||
162695565|NCT03176238|587595789|FG001|Overall Study|Changes in the patient's condition|1|||
162695566|NCT03176238|587595788|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
162695567|NCT03176238|587595789|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
162695568|NCT01351025|587595792|FG000|Week 0 - 20|Lost to Follow-up|2|||
162695569|NCT01351025|587595793|FG001|Week 0 - 20|Lost to Follow-up|1|||
162695570|NCT01351025|587595792|FG000|Week 0 - 20|Withdrawal by Subject|1|||
162695571|NCT01351025|587595793|FG001|Week 0 - 20|Withdrawal by Subject|0|||
162695572|NCT01351025|587595792|FG000|Week 24 - 44|Lost to Follow-up|0|||
162695573|NCT01351025|587595793|FG001|Week 24 - 44|Lost to Follow-up|2|||
162695574|NCT01351025|587595792|FG000|Week 24 - 44|Site closed|0|||
162695575|NCT01351025|587595793|FG001|Week 24 - 44|Site closed|1|||
162695576|NCT01351025|587595792|FG000|Week 24 - 44|unable to get to clinic|1|||
162695577|NCT01351025|587595793|FG001|Week 24 - 44|unable to get to clinic|1|||
162695578|NCT02089230|587595805|FG000|Overall Study|Death|0|||
162695579|NCT02089230|587595806|FG001|Overall Study|Death|0|||
162695580|NCT02089230|587595807|FG002|Overall Study|Death|2|||
162695581|NCT02089230|587595805|FG000|Overall Study|Seeking Alternative Therapy|0|||
162695582|NCT02089230|587595806|FG001|Overall Study|Seeking Alternative Therapy|0|||
162695583|NCT02089230|587595807|FG002|Overall Study|Seeking Alternative Therapy|4|||
162695584|NCT01242176|587597298|FG000|Washout Period of 7 Days|Adverse Event|0|||
162695585|NCT01242176|587597299|FG001|Washout Period of 7 Days|Adverse Event|2|||
162695586|NCT01242176|587597298|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
162695587|NCT01242176|587597299|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
162695588|NCT00358215|587597300|FG000|Overall Study|Ineligibility determined|4|||
162695589|NCT00358215|587597301|FG001|Overall Study|Ineligibility determined|3|||
162695590|NCT00358215|587597300|FG000|Overall Study|Adverse Event|83|||
162695591|NCT00358215|587597301|FG001|Overall Study|Adverse Event|65|||
162695592|NCT00358215|587597300|FG000|Overall Study|Withdrawal by Subject|111|||
162695593|NCT00358215|587597301|FG001|Overall Study|Withdrawal by Subject|102|||
162695594|NCT00358215|587597300|FG000|Overall Study|Participant request|65|||
162695595|NCT00358215|587597301|FG001|Overall Study|Participant request|64|||
162695596|NCT00358215|587597300|FG000|Overall Study|Physician Decision|47|||
162695597|NCT00358215|587597301|FG001|Overall Study|Physician Decision|39|||
162695598|NCT00358215|587597300|FG000|Overall Study|Lost to Follow-up|16|||
162695599|NCT00358215|587597301|FG001|Overall Study|Lost to Follow-up|22|||
162695600|NCT00358215|587597300|FG000|Overall Study|Death|265|||
162695601|NCT00358215|587597301|FG001|Overall Study|Death|281|||
162695602|NCT00358215|587597300|FG000|Overall Study|Protocol Violation|64|||
162695603|NCT00358215|587597301|FG001|Overall Study|Protocol Violation|59|||
162695604|NCT00358215|587597300|FG000|Overall Study|Pregnancy|1|||
162695605|NCT00358215|587597301|FG001|Overall Study|Pregnancy|0|||
162695606|NCT00358215|587597300|FG000|Overall Study|Other|21|||
162695607|NCT00358215|587597301|FG001|Overall Study|Other|14|||
162695608|NCT00358215|587597300|FG000|Overall Study|Did not receive investigational product|2|||
162695609|NCT00358215|587597301|FG001|Overall Study|Did not receive investigational product|3|||
162695610|NCT00871351|587597302|FG000|Overall Study|Withdrawal by Subject|1|||
162695611|NCT00871351|587597303|FG001|Overall Study|Withdrawal by Subject|0|||
162695612|NCT00871351|587597304|FG002|Overall Study|Withdrawal by Subject|0|||
162695613|NCT00871351|587597302|FG000|Overall Study|Adverse Event|3|||
162695614|NCT00871351|587597303|FG001|Overall Study|Adverse Event|1|||
162695615|NCT00871351|587597304|FG002|Overall Study|Adverse Event|0|||
162695616|NCT00744237|587597305|FG000|Overall Study|Lack of Efficacy|1|||
162695617|NCT00744237|587597306|FG001|Overall Study|Lack of Efficacy|1|||
162695618|NCT00744237|587597307|FG002|Overall Study|Lack of Efficacy|0|||
162695619|NCT00744237|587597305|FG000|Overall Study|Withdrawal by Subject|9|||
162695620|NCT00744237|587597306|FG001|Overall Study|Withdrawal by Subject|5|||
162695621|NCT00744237|587597307|FG002|Overall Study|Withdrawal by Subject|3|||
162695622|NCT00744237|587597305|FG000|Overall Study|Lost to Follow-up|1|||
162695623|NCT00744237|587597306|FG001|Overall Study|Lost to Follow-up|1|||
162695624|NCT00744237|587597307|FG002|Overall Study|Lost to Follow-up|1|||
162695625|NCT00744237|587597305|FG000|Overall Study|Protocol Violation|3|||
162695626|NCT00744237|587597306|FG001|Overall Study|Protocol Violation|4|||
162695627|NCT00744237|587597307|FG002|Overall Study|Protocol Violation|3|||
162695628|NCT00744237|587597305|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
162695629|NCT00744237|587597306|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
162695630|NCT00744237|587597307|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
162695631|NCT00744237|587597305|FG000|Overall Study|Dosing Error|1|||
162695632|NCT00744237|587597306|FG001|Overall Study|Dosing Error|0|||
162695633|NCT00744237|587597307|FG002|Overall Study|Dosing Error|1|||
162695634|NCT00744237|587597305|FG000|Overall Study|Study Drug Error|1|||
162695635|NCT00744237|587597306|FG001|Overall Study|Study Drug Error|0|||
162695636|NCT00744237|587597307|FG002|Overall Study|Study Drug Error|0|||
162695637|NCT00744237|587597305|FG000|Overall Study|Prohibited Concomitant Medication|0|||
162695638|NCT00744237|587597306|FG001|Overall Study|Prohibited Concomitant Medication|0|||
162695639|NCT00744237|587597307|FG002|Overall Study|Prohibited Concomitant Medication|1|||
162695640|NCT00744237|587597305|FG000|Overall Study|Poor Compliance|0|||
162695641|NCT00744237|587597306|FG001|Overall Study|Poor Compliance|2|||
162695642|NCT00744237|587597307|FG002|Overall Study|Poor Compliance|0|||
162695643|NCT00744237|587597305|FG000|Overall Study|Administrative. Site Closed|1|||
162695644|NCT00744237|587597306|FG001|Overall Study|Administrative. Site Closed|1|||
162695645|NCT00744237|587597307|FG002|Overall Study|Administrative. Site Closed|1|||
162695646|NCT00744237|587597305|FG000|Overall Study|Adverse Event|9|||
162695647|NCT00744237|587597306|FG001|Overall Study|Adverse Event|13|||
162695648|NCT00744237|587597307|FG002|Overall Study|Adverse Event|5|||
162695649|NCT02032173|587597310|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
162695650|NCT02291289|587597314|FG000|Induction Treatment|Withdrawal by Subject|0|||
162695651|NCT02291289|587597315|FG001|Induction Treatment|Withdrawal by Subject|0|||
162695652|NCT02291289|587597316|FG002|Induction Treatment|Withdrawal by Subject|0|||
162695653|NCT02291289|587597317|FG003|Induction Treatment|Withdrawal by Subject|24|||
162695654|NCT02291289|587597318|FG004|Induction Treatment|Withdrawal by Subject|0|||
162695655|NCT02291289|587597319|FG005|Induction Treatment|Withdrawal by Subject|0|||
162695656|NCT02291289|587597320|FG006|Induction Treatment|Withdrawal by Subject|0|||
162695657|NCT02291289|587597321|FG007|Induction Treatment|Withdrawal by Subject|0|||
162695658|NCT02291289|587597322|FG008|Induction Treatment|Withdrawal by Subject|0|||
162695659|NCT02291289|587597323|FG009|Induction Treatment|Withdrawal by Subject|18|||
162695660|NCT02291289|587597324|FG010|Induction Treatment|Withdrawal by Subject|0|||
162695661|NCT02291289|587597325|FG011|Induction Treatment|Withdrawal by Subject|0|||
162695662|NCT02291289|587597326|FG012|Induction Treatment|Withdrawal by Subject|0|||
162695663|NCT02291289|587597314|FG000|Induction Treatment|Adverse Event|0|||
162695664|NCT02291289|587597315|FG001|Induction Treatment|Adverse Event|0|||
162695665|NCT02291289|587597316|FG002|Induction Treatment|Adverse Event|0|||
162695666|NCT02291289|587597317|FG003|Induction Treatment|Adverse Event|3|||
162695667|NCT02291289|587597318|FG004|Induction Treatment|Adverse Event|0|||
162695668|NCT02291289|587597319|FG005|Induction Treatment|Adverse Event|0|||
162695669|NCT02291289|587597320|FG006|Induction Treatment|Adverse Event|0|||
162695670|NCT02291289|587597321|FG007|Induction Treatment|Adverse Event|0|||
162695671|NCT02291289|587597322|FG008|Induction Treatment|Adverse Event|0|||
162695672|NCT02291289|587597323|FG009|Induction Treatment|Adverse Event|1|||
162695673|NCT02291289|587597324|FG010|Induction Treatment|Adverse Event|0|||
162695674|NCT02291289|587597325|FG011|Induction Treatment|Adverse Event|0|||
162695675|NCT02291289|587597326|FG012|Induction Treatment|Adverse Event|0|||
162695676|NCT02291289|587597314|FG000|Induction Treatment|Death|25|||
162695677|NCT02291289|587597315|FG001|Induction Treatment|Death|0|||
162695678|NCT02291289|587597316|FG002|Induction Treatment|Death|0|||
162695679|NCT02291289|587597317|FG003|Induction Treatment|Death|111|||
162695680|NCT02291289|587597318|FG004|Induction Treatment|Death|0|||
162695681|NCT02291289|587597319|FG005|Induction Treatment|Death|0|||
162695682|NCT02291289|587597320|FG006|Induction Treatment|Death|1|||
162695683|NCT02291289|587597321|FG007|Induction Treatment|Death|0|||
162695684|NCT02291289|587597322|FG008|Induction Treatment|Death|0|||
162695685|NCT02291289|587597323|FG009|Induction Treatment|Death|82|||
162695686|NCT02291289|587597324|FG010|Induction Treatment|Death|0|||
162695687|NCT02291289|587597325|FG011|Induction Treatment|Death|0|||
162695688|NCT02291289|587597326|FG012|Induction Treatment|Death|0|||
162695689|NCT02291289|587597314|FG000|Induction Treatment|Lost to Follow-up|1|||
162695690|NCT02291289|587597315|FG001|Induction Treatment|Lost to Follow-up|0|||
162695691|NCT02291289|587597316|FG002|Induction Treatment|Lost to Follow-up|0|||
162695692|NCT02291289|587597317|FG003|Induction Treatment|Lost to Follow-up|12|||
162695693|NCT02291289|587597318|FG004|Induction Treatment|Lost to Follow-up|0|||
162695694|NCT02291289|587597319|FG005|Induction Treatment|Lost to Follow-up|0|||
162695695|NCT02291289|587597320|FG006|Induction Treatment|Lost to Follow-up|0|||
162695696|NCT02291289|587597321|FG007|Induction Treatment|Lost to Follow-up|0|||
162695697|NCT02291289|587597322|FG008|Induction Treatment|Lost to Follow-up|0|||
162695698|NCT02291289|587597323|FG009|Induction Treatment|Lost to Follow-up|9|||
162695699|NCT02291289|587597324|FG010|Induction Treatment|Lost to Follow-up|0|||
162695700|NCT02291289|587597325|FG011|Induction Treatment|Lost to Follow-up|0|||
162695701|NCT02291289|587597326|FG012|Induction Treatment|Lost to Follow-up|0|||
162695702|NCT02291289|587597314|FG000|Induction Treatment|Non-Compliance|0|||
162695703|NCT02291289|587597315|FG001|Induction Treatment|Non-Compliance|0|||
162695704|NCT02291289|587597316|FG002|Induction Treatment|Non-Compliance|0|||
162695705|NCT02291289|587597317|FG003|Induction Treatment|Non-Compliance|1|||
162695706|NCT02291289|587597318|FG004|Induction Treatment|Non-Compliance|0|||
162695707|NCT02291289|587597319|FG005|Induction Treatment|Non-Compliance|0|||
162695708|NCT02291289|587597320|FG006|Induction Treatment|Non-Compliance|0|||
162695709|NCT02291289|587597321|FG007|Induction Treatment|Non-Compliance|0|||
162695710|NCT02291289|587597322|FG008|Induction Treatment|Non-Compliance|0|||
162695711|NCT02291289|587597323|FG009|Induction Treatment|Non-Compliance|1|||
162695712|NCT02291289|587597324|FG010|Induction Treatment|Non-Compliance|0|||
162695713|NCT02291289|587597325|FG011|Induction Treatment|Non-Compliance|0|||
162695714|NCT02291289|587597326|FG012|Induction Treatment|Non-Compliance|0|||
162695715|NCT02291289|587597314|FG000|Induction Treatment|Reason Not Specified|0|||
162695716|NCT02291289|587597315|FG001|Induction Treatment|Reason Not Specified|0|||
162695717|NCT02291289|587597316|FG002|Induction Treatment|Reason Not Specified|0|||
162695718|NCT02291289|587597317|FG003|Induction Treatment|Reason Not Specified|4|||
162695719|NCT02291289|587597318|FG004|Induction Treatment|Reason Not Specified|0|||
162695720|NCT02291289|587597319|FG005|Induction Treatment|Reason Not Specified|0|||
162695721|NCT02291289|587597320|FG006|Induction Treatment|Reason Not Specified|0|||
162695722|NCT02291289|587597321|FG007|Induction Treatment|Reason Not Specified|0|||
162695723|NCT02291289|587597322|FG008|Induction Treatment|Reason Not Specified|0|||
162695724|NCT02291289|587597323|FG009|Induction Treatment|Reason Not Specified|7|||
162695725|NCT02291289|587597324|FG010|Induction Treatment|Reason Not Specified|0|||
162695726|NCT02291289|587597325|FG011|Induction Treatment|Reason Not Specified|0|||
162695727|NCT02291289|587597326|FG012|Induction Treatment|Reason Not Specified|0|||
162695728|NCT02291289|587597314|FG000|Induction Treatment|Physician Decision|0|||
162695729|NCT02291289|587597315|FG001|Induction Treatment|Physician Decision|0|||
162695730|NCT02291289|587597316|FG002|Induction Treatment|Physician Decision|0|||
162695731|NCT02291289|587597317|FG003|Induction Treatment|Physician Decision|3|||
162695732|NCT02291289|587597318|FG004|Induction Treatment|Physician Decision|0|||
162695733|NCT02291289|587597319|FG005|Induction Treatment|Physician Decision|0|||
162695734|NCT02291289|587597320|FG006|Induction Treatment|Physician Decision|0|||
162695735|NCT02291289|587597321|FG007|Induction Treatment|Physician Decision|0|||
162695736|NCT02291289|587597322|FG008|Induction Treatment|Physician Decision|0|||
162695737|NCT02291289|587597323|FG009|Induction Treatment|Physician Decision|1|||
162695738|NCT02291289|587597324|FG010|Induction Treatment|Physician Decision|0|||
162695739|NCT02291289|587597325|FG011|Induction Treatment|Physician Decision|0|||
162695740|NCT02291289|587597326|FG012|Induction Treatment|Physician Decision|0|||
162695741|NCT02291289|587597314|FG000|Induction Treatment|Protocol Violation|0|||
162695742|NCT02291289|587597315|FG001|Induction Treatment|Protocol Violation|0|||
162695743|NCT02291289|587597316|FG002|Induction Treatment|Protocol Violation|0|||
162695744|NCT02291289|587597317|FG003|Induction Treatment|Protocol Violation|3|||
162695745|NCT02291289|587597318|FG004|Induction Treatment|Protocol Violation|0|||
162695746|NCT02291289|587597319|FG005|Induction Treatment|Protocol Violation|0|||
162695747|NCT02291289|587597320|FG006|Induction Treatment|Protocol Violation|0|||
162695748|NCT02291289|587597321|FG007|Induction Treatment|Protocol Violation|0|||
162695749|NCT02291289|587597322|FG008|Induction Treatment|Protocol Violation|0|||
162695750|NCT02291289|587597323|FG009|Induction Treatment|Protocol Violation|2|||
162695751|NCT02291289|587597324|FG010|Induction Treatment|Protocol Violation|0|||
162695752|NCT02291289|587597325|FG011|Induction Treatment|Protocol Violation|0|||
162695753|NCT02291289|587597326|FG012|Induction Treatment|Protocol Violation|0|||
162695754|NCT02291289|587597314|FG000|Induction Treatment|Missing|4|||
162695755|NCT02291289|587597315|FG001|Induction Treatment|Missing|0|||
162695756|NCT02291289|587597316|FG002|Induction Treatment|Missing|0|||
162695757|NCT02291289|587597317|FG003|Induction Treatment|Missing|14|||
162695758|NCT02291289|587597318|FG004|Induction Treatment|Missing|0|||
162695759|NCT02291289|587597319|FG005|Induction Treatment|Missing|0|||
162695760|NCT02291289|587597320|FG006|Induction Treatment|Missing|0|||
162695761|NCT02291289|587597321|FG007|Induction Treatment|Missing|0|||
162695762|NCT02291289|587597322|FG008|Induction Treatment|Missing|0|||
162695763|NCT02291289|587597323|FG009|Induction Treatment|Missing|54|||
162695764|NCT02291289|587597324|FG010|Induction Treatment|Missing|0|||
162695765|NCT02291289|587597325|FG011|Induction Treatment|Missing|0|||
162695766|NCT02291289|587597326|FG012|Induction Treatment|Missing|0|||
162695767|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695768|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695769|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695770|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695771|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
162695772|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
162695773|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695774|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695775|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695776|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695777|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
162695778|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
162695779|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162695780|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Death|0|||
162695781|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Death|29|||
162695782|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Death|16|||
162695783|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Death|0|||
162695784|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Death|188|||
162695785|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Death|107|||
162695786|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Death|0|||
162695787|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Death|1|||
162695788|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Death|1|||
162695789|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Death|0|||
162695790|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Death|46|||
162695791|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Death|19|||
162695792|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Death|0|||
162695793|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162695794|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Adverse Event|0|||
162695795|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Adverse Event|0|||
162695796|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Adverse Event|0|||
162695797|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Adverse Event|1|||
162695798|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Adverse Event|1|||
162695799|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Adverse Event|0|||
162695800|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Adverse Event|0|||
162695801|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Adverse Event|0|||
162695802|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Adverse Event|0|||
162695803|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Adverse Event|0|||
162695804|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Adverse Event|0|||
162695805|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Adverse Event|0|||
162695806|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695807|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
162695808|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695809|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695810|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
162695811|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
162695812|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695813|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
162695814|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695815|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695816|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
162695817|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
162695818|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
162695819|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
162695820|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
162695821|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
162695822|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
162695823|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
162695824|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
162695825|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
162695826|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
162695827|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
162695828|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
162695829|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
162695830|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
162695831|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
162695832|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Physician Decision|0|||
162695833|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Physician Decision|2|||
162695834|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Physician Decision|0|||
162695835|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Physician Decision|0|||
162695836|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Physician Decision|3|||
162695837|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Physician Decision|0|||
162695838|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Physician Decision|0|||
162695839|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Physician Decision|0|||
162695840|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Physician Decision|0|||
162695841|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Physician Decision|0|||
162695842|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Physician Decision|1|||
162695843|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Physician Decision|3|||
162695844|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Physician Decision|0|||
162695845|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Not Treated|0|||
162695846|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Not Treated|0|||
162695847|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Not Treated|2|||
162695848|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Not Treated|0|||
162695849|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Not Treated|0|||
162695850|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Not Treated|0|||
162695851|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Not Treated|0|||
162695852|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Not Treated|0|||
162695853|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Not Treated|0|||
162695854|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Not Treated|0|||
162695855|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Not Treated|0|||
162695856|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Not Treated|0|||
162695857|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Not Treated|0|||
162695858|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695859|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
162695860|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695861|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695862|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695863|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695864|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695865|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695866|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695867|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695868|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695869|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695870|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162695871|NCT02291289|587597314|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
162695872|NCT02291289|587597315|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
162695873|NCT02291289|587597316|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
162695874|NCT02291289|587597317|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
162695875|NCT02291289|587597318|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
162695876|NCT02291289|587597319|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
162695877|NCT02291289|587597320|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
162695878|NCT02291289|587597321|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
162695879|NCT02291289|587597322|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
162695880|NCT02291289|587597323|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
162695881|NCT02291289|587597324|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
162695882|NCT02291289|587597325|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
162695883|NCT02291289|587597326|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
162695884|NCT02291289|587597314|FG000|Early Disease Progression|Death|0|||
162695885|NCT02291289|587597315|FG001|Early Disease Progression|Death|0|||
162695886|NCT02291289|587597316|FG002|Early Disease Progression|Death|0|||
162695887|NCT02291289|587597317|FG003|Early Disease Progression|Death|0|||
162695888|NCT02291289|587597318|FG004|Early Disease Progression|Death|0|||
162695889|NCT02291289|587597319|FG005|Early Disease Progression|Death|0|||
162695890|NCT02291289|587597320|FG006|Early Disease Progression|Death|0|||
162695891|NCT02291289|587597321|FG007|Early Disease Progression|Death|0|||
162695892|NCT02291289|587597322|FG008|Early Disease Progression|Death|0|||
162695893|NCT02291289|587597323|FG009|Early Disease Progression|Death|0|||
162695894|NCT02291289|587597324|FG010|Early Disease Progression|Death|0|||
162695895|NCT02291289|587597325|FG011|Early Disease Progression|Death|0|||
162695896|NCT02291289|587597326|FG012|Early Disease Progression|Death|10|||
162695897|NCT02291289|587597314|FG000|Early Disease Progression|Lost to Follow-up|0|||
162695898|NCT02291289|587597315|FG001|Early Disease Progression|Lost to Follow-up|0|||
162695899|NCT02291289|587597316|FG002|Early Disease Progression|Lost to Follow-up|0|||
162695900|NCT02291289|587597317|FG003|Early Disease Progression|Lost to Follow-up|0|||
162695901|NCT02291289|587597318|FG004|Early Disease Progression|Lost to Follow-up|0|||
162695902|NCT02291289|587597319|FG005|Early Disease Progression|Lost to Follow-up|0|||
162695903|NCT02291289|587597320|FG006|Early Disease Progression|Lost to Follow-up|0|||
162695904|NCT02291289|587597321|FG007|Early Disease Progression|Lost to Follow-up|0|||
162695905|NCT02291289|587597322|FG008|Early Disease Progression|Lost to Follow-up|0|||
162695906|NCT02291289|587597323|FG009|Early Disease Progression|Lost to Follow-up|0|||
162695907|NCT02291289|587597324|FG010|Early Disease Progression|Lost to Follow-up|0|||
162695908|NCT02291289|587597325|FG011|Early Disease Progression|Lost to Follow-up|0|||
162695909|NCT02291289|587597326|FG012|Early Disease Progression|Lost to Follow-up|1|||
162695910|NCT01017120|587597327|FG000|Overall Study|Adverse Event|9|||
162695911|NCT01017120|587597328|FG001|Overall Study|Adverse Event|0|||
162695912|NCT01017120|587597327|FG000|Overall Study|Lost to Follow-up|13|||
162695913|NCT01017120|587597328|FG001|Overall Study|Lost to Follow-up|11|||
162695914|NCT01017120|587597327|FG000|Overall Study|Lack of Efficacy|1|||
162695915|NCT01017120|587597328|FG001|Overall Study|Lack of Efficacy|0|||
162695916|NCT01017120|587597327|FG000|Overall Study|Withdrawal by Subject|39|||
162695917|NCT01017120|587597328|FG001|Overall Study|Withdrawal by Subject|21|||
162695918|NCT01017120|587597327|FG000|Overall Study|Pregnancy|1|||
162695919|NCT01017120|587597328|FG001|Overall Study|Pregnancy|1|||
162695920|NCT01017120|587597327|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
162695921|NCT01017120|587597328|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162695922|NCT01017120|587597327|FG000|Overall Study|Relocated Out of Town|0|||
162695923|NCT01017120|587597328|FG001|Overall Study|Relocated Out of Town|2|||
162695924|NCT01017120|587597327|FG000|Overall Study|Protocol Violation|1|||
162695925|NCT01017120|587597328|FG001|Overall Study|Protocol Violation|0|||
162695926|NCT01017120|587597327|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
162695927|NCT01017120|587597328|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
162695928|NCT01642602|587597329|FG000|Overall Study|Adverse Event|2|||
162695929|NCT01112514|587597330|FG000|Overall Study|Lost to Follow-up|1|||
162695930|NCT01024959|587597331|FG000|Overall Study|ineligible|12|||
162695931|NCT01024959|587597331|FG000|Overall Study|results not evaluable|12|||
162695932|NCT01024959|587597331|FG000|Overall Study|missing results required for analysis|17|||
162695933|NCT01118455|587597332|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
162695934|NCT01118455|587597333|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
162695935|NCT05033743|587597338|FG000|Overall Study|Lost to Follow-up|1|||
162695936|NCT05033743|587597338|FG000|Overall Study|Protocol Violation|2|||
162695937|NCT05033743|587597338|FG000|Overall Study|Withdrawal by Subject|1|||
162695938|NCT00452413|587597343|FG000|Overall Study|Progressive Disease|4|||
162695939|NCT00452413|587597344|FG001|Overall Study|Progressive Disease|11|||
162695940|NCT00452413|587597345|FG002|Overall Study|Progressive Disease|30|||
162695941|NCT00452413|587597343|FG000|Overall Study|Withdrawal by Subject|0|||
162695942|NCT00452413|587597344|FG001|Overall Study|Withdrawal by Subject|1|||
162695943|NCT00452413|587597345|FG002|Overall Study|Withdrawal by Subject|4|||
162695944|NCT00452413|587597343|FG000|Overall Study|Adverse Event|0|||
162695945|NCT00452413|587597344|FG001|Overall Study|Adverse Event|0|||
162695946|NCT00452413|587597345|FG002|Overall Study|Adverse Event|5|||
162695947|NCT00452413|587597343|FG000|Overall Study|Physician Decision|0|||
162695948|NCT00452413|587597344|FG001|Overall Study|Physician Decision|0|||
162695949|NCT00452413|587597345|FG002|Overall Study|Physician Decision|4|||
162695950|NCT00452413|587597343|FG000|Overall Study|Death due to study disease|0|||
162695951|NCT00452413|587597344|FG001|Overall Study|Death due to study disease|0|||
162695952|NCT00452413|587597345|FG002|Overall Study|Death due to study disease|2|||
162695953|NCT00452413|587597343|FG000|Overall Study|Death due to adverse event (AE)|0|||
162695954|NCT00452413|587597344|FG001|Overall Study|Death due to adverse event (AE)|0|||
162695955|NCT00452413|587597345|FG002|Overall Study|Death due to adverse event (AE)|1|||
162695956|NCT00452413|587597343|FG000|Overall Study|On treatment|0|||
162695957|NCT00452413|587597344|FG001|Overall Study|On treatment|0|||
162695958|NCT00452413|587597345|FG002|Overall Study|On treatment|3|||
162695959|NCT02310126|587597356|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
162695960|NCT02310126|587597357|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
162695961|NCT02310126|587597356|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
162695962|NCT02310126|587597357|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
162695963|NCT01539863|587597358|FG000|Overall Study|Lost to Follow-up|5|||
162695964|NCT01539863|587597359|FG001|Overall Study|Lost to Follow-up|4|||
162695965|NCT02693834|587597360|FG000|Baseline Measurement|Withdrawal by Subject|1|||
162695966|NCT02693834|587597361|FG001|Baseline Measurement|Withdrawal by Subject|0|||
162695967|NCT02693834|587597360|FG000|Baseline Measurement|Adverse Event|1|||
162695968|NCT02693834|587597361|FG001|Baseline Measurement|Adverse Event|0|||
162695969|NCT02693834|587597360|FG000|Week 2 Practice|Adverse Event|0|||
162695970|NCT02693834|587597361|FG001|Week 2 Practice|Adverse Event|1|||
162695971|NCT02111213|587597367|FG000|Overall Study|Withdrawal by Subject|3|||
162695972|NCT02111213|587597368|FG001|Overall Study|Withdrawal by Subject|2|||
162695973|NCT02111213|587597367|FG000|Overall Study|Lost to Follow-up|3|||
162695974|NCT02111213|587597368|FG001|Overall Study|Lost to Follow-up|4|||
162695975|NCT02226172|587597373|FG000|Overall Study|Participant refused further follow-up|4|||
162695976|NCT02226172|587597373|FG000|Overall Study|Other|5|||
162695977|NCT02226172|587597373|FG000|Overall Study|Death|1|||
162695978|NCT02226172|587597373|FG000|Overall Study|Study terminated by sponsor|1|||
162695979|NCT02226172|587597373|FG000|Overall Study|Adverse Event|6|||
162695980|NCT00758160|587597382|FG000|Overall Study|No Longer Requires Study Medication|4|||
162695981|NCT00758160|587597382|FG000|Overall Study|Administration Problems|3|||
162695982|NCT00758160|587597382|FG000|Overall Study|Adverse Event|15|||
162695983|NCT00758160|587597382|FG000|Overall Study|Lack of Efficacy|10|||
162695984|NCT00758160|587597382|FG000|Overall Study|Lost to Follow-up|14|||
162695985|NCT00758160|587597382|FG000|Overall Study|Protocol Violation|12|||
162695986|NCT00758160|587597382|FG000|Overall Study|Withdrawal by Subject|8|||
162695987|NCT01108510|587597386|FG000|Overall Study|Randomized but Not Treated|5|||
162695988|NCT01108510|587597387|FG001|Overall Study|Randomized but Not Treated|1|||
162695989|NCT01108510|587597386|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
162695990|NCT01108510|587597387|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
162695991|NCT01108510|587597386|FG000|Overall Study|Adverse Event|26|||
162695992|NCT01108510|587597387|FG001|Overall Study|Adverse Event|19|||
162695993|NCT01108510|587597386|FG000|Overall Study|Lost to Follow-up|20|||
162695994|NCT01108510|587597387|FG001|Overall Study|Lost to Follow-up|17|||
162695995|NCT01108510|587597386|FG000|Overall Study|Withdrew Consent|21|||
162695996|NCT01108510|587597387|FG001|Overall Study|Withdrew Consent|15|||
162695997|NCT01108510|587597386|FG000|Overall Study|Investigator's Discretion|12|||
162695998|NCT01108510|587597387|FG001|Overall Study|Investigator's Discretion|10|||
162695999|NCT01108510|587597386|FG000|Overall Study|Participant Noncompliance|5|||
162696000|NCT01108510|587597387|FG001|Overall Study|Participant Noncompliance|7|||
162696001|NCT01108510|587597386|FG000|Overall Study|Lack of Efficacy|3|||
162696002|NCT01108510|587597387|FG001|Overall Study|Lack of Efficacy|0|||
162696003|NCT01108510|587597386|FG000|Overall Study|Pregnancy|0|||
162696004|NCT01108510|587597387|FG001|Overall Study|Pregnancy|3|||
162696005|NCT01108510|587597386|FG000|Overall Study|Death|1|||
162696006|NCT01108510|587597387|FG001|Overall Study|Death|1|||
162696007|NCT00582491|587597388|FG000|Overall Study|Withdrawal by Subject|1|||
162696008|NCT00582491|587597389|FG001|Overall Study|Withdrawal by Subject|0|||
162696009|NCT00779584|587597392|FG000|Overall Study|Protocol Violation|0|||
162696010|NCT00779584|587597393|FG001|Overall Study|Protocol Violation|0|||
162696011|NCT00779584|587597394|FG002|Overall Study|Protocol Violation|0|||
162696012|NCT00779584|587597395|FG003|Overall Study|Protocol Violation|0|||
162696013|NCT00779584|587597396|FG004|Overall Study|Protocol Violation|0|||
162696014|NCT00779584|587597397|FG005|Overall Study|Protocol Violation|1|||
162696015|NCT00779584|587597398|FG006|Overall Study|Protocol Violation|0|||
162696016|NCT00779584|587597399|FG007|Overall Study|Protocol Violation|0|||
162696017|NCT00779584|587597400|FG008|Overall Study|Protocol Violation|0|||
162696018|NCT00779584|587597392|FG000|Overall Study|Withdrawal by Subject|1|||
162696019|NCT00779584|587597393|FG001|Overall Study|Withdrawal by Subject|1|||
162696020|NCT00779584|587597394|FG002|Overall Study|Withdrawal by Subject|2|||
162696021|NCT00779584|587597395|FG003|Overall Study|Withdrawal by Subject|0|||
162696022|NCT00779584|587597396|FG004|Overall Study|Withdrawal by Subject|0|||
162696023|NCT00779584|587597397|FG005|Overall Study|Withdrawal by Subject|2|||
162696024|NCT00779584|587597398|FG006|Overall Study|Withdrawal by Subject|1|||
162696025|NCT00779584|587597399|FG007|Overall Study|Withdrawal by Subject|0|||
162696026|NCT00779584|587597400|FG008|Overall Study|Withdrawal by Subject|0|||
162696027|NCT00779584|587597392|FG000|Overall Study|Lost to Follow-up|0|||
162696028|NCT00779584|587597393|FG001|Overall Study|Lost to Follow-up|0|||
162696029|NCT00779584|587597394|FG002|Overall Study|Lost to Follow-up|0|||
162696030|NCT00779584|587597395|FG003|Overall Study|Lost to Follow-up|0|||
162696031|NCT00779584|587597396|FG004|Overall Study|Lost to Follow-up|1|||
162696032|NCT00779584|587597397|FG005|Overall Study|Lost to Follow-up|0|||
162696033|NCT00779584|587597398|FG006|Overall Study|Lost to Follow-up|0|||
162696034|NCT00779584|587597399|FG007|Overall Study|Lost to Follow-up|0|||
162696035|NCT00779584|587597400|FG008|Overall Study|Lost to Follow-up|0|||
162696036|NCT00779584|587597392|FG000|Overall Study|Progression of Disease|0|||
162696037|NCT00779584|587597393|FG001|Overall Study|Progression of Disease|1|||
162696038|NCT00779584|587597394|FG002|Overall Study|Progression of Disease|2|||
162696039|NCT00779584|587597395|FG003|Overall Study|Progression of Disease|6|||
162696040|NCT00779584|587597396|FG004|Overall Study|Progression of Disease|5|||
162696041|NCT00779584|587597397|FG005|Overall Study|Progression of Disease|1|||
162696042|NCT00779584|587597398|FG006|Overall Study|Progression of Disease|4|||
162696043|NCT00779584|587597399|FG007|Overall Study|Progression of Disease|2|||
162696044|NCT00779584|587597400|FG008|Overall Study|Progression of Disease|1|||
162696045|NCT00779584|587597392|FG000|Overall Study|Adverse Event|1|||
162696046|NCT00779584|587597393|FG001|Overall Study|Adverse Event|0|||
162696047|NCT00779584|587597394|FG002|Overall Study|Adverse Event|2|||
162696048|NCT00779584|587597395|FG003|Overall Study|Adverse Event|0|||
162696049|NCT00779584|587597396|FG004|Overall Study|Adverse Event|0|||
162730455|NCT01898494|587722566|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
162696050|NCT00779584|587597397|FG005|Overall Study|Adverse Event|0|||
162696051|NCT00779584|587597398|FG006|Overall Study|Adverse Event|2|||
162696052|NCT00779584|587597399|FG007|Overall Study|Adverse Event|1|||
162696053|NCT00779584|587597400|FG008|Overall Study|Adverse Event|1|||
162696054|NCT00779584|587597392|FG000|Overall Study|Symptomatic Deterioration|1|||
162696055|NCT00779584|587597393|FG001|Overall Study|Symptomatic Deterioration|1|||
162696056|NCT00779584|587597394|FG002|Overall Study|Symptomatic Deterioration|1|||
162696057|NCT00779584|587597395|FG003|Overall Study|Symptomatic Deterioration|0|||
162696058|NCT00779584|587597396|FG004|Overall Study|Symptomatic Deterioration|0|||
162696059|NCT00779584|587597397|FG005|Overall Study|Symptomatic Deterioration|1|||
162696060|NCT00779584|587597398|FG006|Overall Study|Symptomatic Deterioration|1|||
162696061|NCT00779584|587597399|FG007|Overall Study|Symptomatic Deterioration|0|||
162696062|NCT00779584|587597400|FG008|Overall Study|Symptomatic Deterioration|0|||
162696063|NCT00779584|587597392|FG000|Overall Study|Ongoing in Study|0|||
162696064|NCT00779584|587597393|FG001|Overall Study|Ongoing in Study|0|||
162696065|NCT00779584|587597394|FG002|Overall Study|Ongoing in Study|0|||
162696066|NCT00779584|587597395|FG003|Overall Study|Ongoing in Study|0|||
162696067|NCT00779584|587597396|FG004|Overall Study|Ongoing in Study|1|||
162696068|NCT00779584|587597397|FG005|Overall Study|Ongoing in Study|1|||
162696069|NCT00779584|587597398|FG006|Overall Study|Ongoing in Study|0|||
162696070|NCT00779584|587597399|FG007|Overall Study|Ongoing in Study|0|||
162696071|NCT00779584|587597400|FG008|Overall Study|Ongoing in Study|0|||
162696072|NCT01115491|587597403|FG000|Overall Study|Death|22|||
162696073|NCT01115491|587597403|FG000|Overall Study|Adverse Event|3|||
162696074|NCT01115491|587597403|FG000|Overall Study|Lost to Follow-up|3|||
162696075|NCT01115491|587597403|FG000|Overall Study|Withdrawal by Subject|1|||
162696076|NCT01115491|587597403|FG000|Overall Study|Physician Decision|1|||
162696077|NCT01868074|587597406|FG000|Overall Study|Lost to Follow-up|3|||
162696078|NCT01868074|587597407|FG001|Overall Study|Lost to Follow-up|2|||
162696079|NCT01868074|587597406|FG000|Overall Study|Withdrawal by Subject|4|||
162696080|NCT01868074|587597407|FG001|Overall Study|Withdrawal by Subject|2|||
162696081|NCT03306043|587597408|FG000|Overall Study|Adverse Event|1|||
162696082|NCT03306043|587597408|FG000|Overall Study|Lost to Follow-up|1|||
162696083|NCT03306043|587597408|FG000|Overall Study|Withdrawal by Subject|2|||
162696084|NCT01544491|587597409|FG000|Overall Study|Withdrawal by Subject|3|||
162696085|NCT01544491|587597410|FG001|Overall Study|Withdrawal by Subject|2|||
162696086|NCT01544491|587597409|FG000|Overall Study|Lost to Follow-up|0|||
162696087|NCT01544491|587597410|FG001|Overall Study|Lost to Follow-up|1|||
162696088|NCT01544491|587597409|FG000|Overall Study|administrative problems|2|||
162696089|NCT01544491|587597410|FG001|Overall Study|administrative problems|0|||
162696090|NCT02494206|587597411|FG000|Overall Study|Adverse Event|1|||
162696091|NCT02494206|587597411|FG000|Overall Study|Disease Progression|1|||
162696092|NCT01013792|587597412|FG000|Overall Study|Study suspended|2|||
162696093|NCT01013792|587597413|FG001|Overall Study|Study suspended|1|||
162696094|NCT01013792|587597412|FG000|Overall Study|Adverse Event|0|||
162696095|NCT01013792|587597413|FG001|Overall Study|Adverse Event|3|||
162696096|NCT01013792|587597412|FG000|Overall Study|Lost to Follow-up|0|||
162696097|NCT01013792|587597413|FG001|Overall Study|Lost to Follow-up|1|||
162696098|NCT01234649|587597414|FG000|Overall Study|Withdrawal by Subject|32|||
162696099|NCT01234649|587597415|FG001|Overall Study|Withdrawal by Subject|26|||
162696100|NCT01234649|587597414|FG000|Overall Study|Pregnancy|6|||
162696101|NCT01234649|587597415|FG001|Overall Study|Pregnancy|6|||
162696102|NCT01234649|587597414|FG000|Overall Study|intolerant to side effects|4|||
162696103|NCT01234649|587597415|FG001|Overall Study|intolerant to side effects|3|||
162696104|NCT01234649|587597414|FG000|Overall Study|Allergic reaction|1|||
162696105|NCT01234649|587597415|FG001|Overall Study|Allergic reaction|0|||
162696106|NCT01234649|587597414|FG000|Overall Study|Lack of Efficacy|0|||
162696107|NCT01234649|587597415|FG001|Overall Study|Lack of Efficacy|3|||
162696108|NCT00680056|587597419|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
162696109|NCT00680056|587597420|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
162696110|NCT00680056|587597419|FG000|Second Intervention|Protocol Violation|3|||
162696111|NCT00680056|587597420|FG001|Second Intervention|Protocol Violation|1|||
162696112|NCT03688711|587597421|FG000|Overall Study|Withdrawal by Subject|0|||
162696113|NCT03688711|587597422|FG001|Overall Study|Withdrawal by Subject|1|||
162696114|NCT05229653|587597423|FG000|Overall Study|Lost to Follow-up|1|||
162696115|NCT05229653|587597424|FG001|Overall Study|Lost to Follow-up|0|||
162696116|NCT01370005|587597425|FG000|Overall Study|Not treated|1|||
162696117|NCT01370005|587597426|FG001|Overall Study|Not treated|0|||
162696118|NCT01370005|587597427|FG002|Overall Study|Not treated|0|||
162696119|NCT01370005|587597425|FG000|Overall Study|Adverse Event|5|||
162696120|NCT01370005|587597426|FG001|Overall Study|Adverse Event|5|||
162696121|NCT01370005|587597427|FG002|Overall Study|Adverse Event|6|||
162696122|NCT01370005|587597425|FG000|Overall Study|Lack of Efficacy|1|||
162696123|NCT01370005|587597426|FG001|Overall Study|Lack of Efficacy|0|||
162696124|NCT01370005|587597427|FG002|Overall Study|Lack of Efficacy|0|||
162696125|NCT01370005|587597425|FG000|Overall Study|Non compliant with protocol|0|||
162696126|NCT01370005|587597426|FG001|Overall Study|Non compliant with protocol|1|||
162696127|NCT01370005|587597427|FG002|Overall Study|Non compliant with protocol|2|||
162696128|NCT01370005|587597425|FG000|Overall Study|Lost to Follow-up|1|||
162696129|NCT01370005|587597426|FG001|Overall Study|Lost to Follow-up|1|||
162696130|NCT01370005|587597427|FG002|Overall Study|Lost to Follow-up|1|||
162696131|NCT01370005|587597425|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
162696132|NCT01370005|587597426|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
162696133|NCT01370005|587597427|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
162696134|NCT01370005|587597425|FG000|Overall Study|Other reason not defined above|3|||
162696135|NCT01370005|587597426|FG001|Overall Study|Other reason not defined above|0|||
162696136|NCT01370005|587597427|FG002|Overall Study|Other reason not defined above|2|||
162696137|NCT03691948|587597428|FG000|Overall Study|Lost to Follow-up|1|||
162696138|NCT03691948|587597429|FG001|Overall Study|Lost to Follow-up|3|||
162696139|NCT02009696|587597430|FG000|Overall Study|Withdrawal by Subject|2|||
162696140|NCT01018563|587597432|FG000|Overall Study|Termination of the study by Sponsor|2|||
162696141|NCT01018563|587597433|FG001|Overall Study|Termination of the study by Sponsor|1|||
162696142|NCT02344537|587597434|FG000|Overall Study|Protocol Violation|1|||
162696143|NCT02344537|587597435|FG001|Overall Study|Protocol Violation|1|||
162730456|NCT02819843|587722569|FG000|Overall Study|Disease progression before RT|0|||
162730457|NCT02819843|587722570|FG001|Overall Study|Disease progression before RT|1|||
162730458|NCT04732494|587722571|FG000|Overall Study|Death|39|||
162730459|NCT04732494|587722572|FG001|Overall Study|Death|36|||
162730460|NCT04732494|587722571|FG000|Overall Study|Study Closed by Sponsor|20|||
162730461|NCT04732494|587722572|FG001|Overall Study|Study Closed by Sponsor|15|||
162730462|NCT04732494|587722571|FG000|Overall Study|Withdrawal by Subject|2|||
162730463|NCT04732494|587722572|FG001|Overall Study|Withdrawal by Subject|7|||
162730464|NCT04732494|587722571|FG000|Overall Study|Lost to Follow-up|1|||
162730465|NCT04732494|587722572|FG001|Overall Study|Lost to Follow-up|5|||
162730466|NCT03055858|587722573|FG000|Overall Study|Death|9|||
162730467|NCT03055858|587722573|FG000|Overall Study|Withdrawal by Subject|11|||
162730468|NCT03055858|587722573|FG000|Overall Study|Lost to Follow-up|6|||
162730469|NCT03055858|587722573|FG000|Overall Study|Missed Follow-Up Visits|18|||
162730470|NCT02728557|587722574|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
162730471|NCT02728557|587722575|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
162730472|NCT02728557|587722574|FG000|Overall Study|Dissatisfaction with research tasks|0|||
162730473|NCT02728557|587722575|FG001|Overall Study|Dissatisfaction with research tasks|1|||
162730474|NCT02728557|587722574|FG000|Overall Study|Scheduling or change in availability|1|||
162730475|NCT02728557|587722575|FG001|Overall Study|Scheduling or change in availability|1|||
162730476|NCT03416010|587722576|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
162730477|NCT03416010|587722577|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
162730478|NCT03416010|587722576|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
162730479|NCT03416010|587722577|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
162730480|NCT03416010|587722576|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
162730481|NCT03416010|587722577|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
162730482|NCT03416010|587722576|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
162730483|NCT03416010|587722577|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
162730484|NCT03416010|587722576|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
162730485|NCT03416010|587722577|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
162730486|NCT03416010|587722576|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
162730487|NCT03416010|587722577|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
162730488|NCT03416010|587722576|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
162730489|NCT03416010|587722577|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
162730490|NCT03948763|587722578|FG000|Overall Study|Sponsor's decision|0|||
162730491|NCT03948763|587722579|FG001|Overall Study|Sponsor's decision|2|||
162730492|NCT03948763|587722580|FG002|Overall Study|Sponsor's decision|6|||
162730493|NCT03948763|587722581|FG003|Overall Study|Sponsor's decision|4|||
162730494|NCT03948763|587722582|FG004|Overall Study|Sponsor's decision|0|||
162730495|NCT03948763|587722578|FG000|Overall Study|Physician Decision|0|||
162730496|NCT03948763|587722579|FG001|Overall Study|Physician Decision|0|||
162730497|NCT03948763|587722580|FG002|Overall Study|Physician Decision|1|||
162730498|NCT03948763|587722581|FG003|Overall Study|Physician Decision|0|||
162730499|NCT03948763|587722582|FG004|Overall Study|Physician Decision|0|||
162730500|NCT03948763|587722578|FG000|Overall Study|Lost to Follow-up|0|||
162730501|NCT03948763|587722579|FG001|Overall Study|Lost to Follow-up|0|||
162730502|NCT03948763|587722580|FG002|Overall Study|Lost to Follow-up|0|||
162730503|NCT03948763|587722581|FG003|Overall Study|Lost to Follow-up|0|||
162730504|NCT03948763|587722582|FG004|Overall Study|Lost to Follow-up|1|||
162730505|NCT03948763|587722578|FG000|Overall Study|Death|2|||
162730506|NCT03948763|587722579|FG001|Overall Study|Death|12|||
162730507|NCT03948763|587722580|FG002|Overall Study|Death|13|||
162696144|NCT02344537|587597434|FG000|Overall Study|Subject started another treatment after wk 6|1|||
162696145|NCT02344537|587597435|FG001|Overall Study|Subject started another treatment after wk 6|0|||
162696146|NCT02344537|587597434|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
162696147|NCT02344537|587597435|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
162696148|NCT05490329|587597438|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
162696149|NCT05490329|587597439|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
162730508|NCT03948763|587722581|FG003|Overall Study|Death|10|||
162730509|NCT03948763|587722582|FG004|Overall Study|Death|11|||
162730510|NCT03948763|587722578|FG000|Overall Study|Withdrawal by Subject|1|||
162730511|NCT03948763|587722579|FG001|Overall Study|Withdrawal by Subject|1|||
162730512|NCT03948763|587722580|FG002|Overall Study|Withdrawal by Subject|0|||
162730513|NCT03948763|587722581|FG003|Overall Study|Withdrawal by Subject|2|||
162730514|NCT03948763|587722582|FG004|Overall Study|Withdrawal by Subject|4|||
162730515|NCT06629454|587722583|FG000|Overall Study|Withdraw by Clinician Decision|1|||
162730516|NCT05136404|587722584|FG000|Period 1|Adverse Event|0|||
162730517|NCT05136404|587722585|FG001|Period 1|Adverse Event|1|||
162730518|NCT05136404|587722586|FG002|Period 1|Adverse Event|1|||
162730519|NCT05136404|587722584|FG000|Period 2|Inappropriate Behavior|0|||
162730520|NCT05136404|587722585|FG001|Period 2|Inappropriate Behavior|0|||
162730521|NCT05136404|587722586|FG002|Period 2|Inappropriate Behavior|1|||
162730522|NCT05136404|587722584|FG000|Period 3|Adverse Event|0|||
162730523|NCT05136404|587722585|FG001|Period 3|Adverse Event|0|||
162730524|NCT05136404|587722586|FG002|Period 3|Adverse Event|1|||
162730525|NCT02553642|587722592|FG000|Overall Study|Withdrawal by Subject|0|||
162730526|NCT02553642|587722593|FG001|Overall Study|Withdrawal by Subject|3|||
162730527|NCT02553642|587722592|FG000|Overall Study|Physician Decision|0|||
162730528|NCT02553642|587722593|FG001|Overall Study|Physician Decision|1|||
162730529|NCT02553642|587722592|FG000|Overall Study|Additional cancer dx|0|||
162730530|NCT02553642|587722593|FG001|Overall Study|Additional cancer dx|1|||
162730531|NCT02553642|587722592|FG000|Overall Study|Never started treatment|0|||
162730532|NCT02553642|587722593|FG001|Overall Study|Never started treatment|1|||
162730533|NCT01820260|587722595|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730534|NCT01820260|587722596|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730535|NCT01820260|587722597|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730536|NCT01820260|587722598|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730537|NCT01820260|587722599|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730538|NCT01820260|587722600|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730539|NCT01820260|587722601|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
162730540|NCT01820260|587722602|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730541|NCT01820260|587722603|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730542|NCT01820260|587722604|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730543|NCT01820260|587722605|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730544|NCT01820260|587722606|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730545|NCT01820260|587722607|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730546|NCT01820260|587722608|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162730547|NCT01820260|587722595|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730548|NCT01820260|587722596|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730549|NCT01820260|587722597|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730550|NCT01820260|587722598|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730551|NCT01820260|587722599|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730552|NCT01820260|587722600|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730553|NCT01820260|587722601|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730554|NCT01820260|587722602|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730555|NCT01820260|587722603|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730556|NCT01820260|587722604|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
162730557|NCT01820260|587722605|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730558|NCT01820260|587722606|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730559|NCT01820260|587722607|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730560|NCT01820260|587722608|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162730561|NCT05444192|587722609|FG000|Overall Study|Lost to Follow-up|1|||
162730562|NCT05444192|587722610|FG001|Overall Study|Lost to Follow-up|0|||
162730563|NCT04424927|587722615|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
162730564|NCT04424927|587722616|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
162730565|NCT04424927|587722617|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
162730566|NCT04424927|587722618|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
162730567|NCT04424927|587722619|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
162730568|NCT04424927|587722615|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
162730569|NCT04424927|587722616|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
162730570|NCT04424927|587722617|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
162730571|NCT04424927|587722618|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
162730572|NCT04424927|587722619|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
162730573|NCT04424927|587722615|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
162730574|NCT04424927|587722616|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162730575|NCT04424927|587722617|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162730576|NCT04424927|587722618|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162730577|NCT04424927|587722619|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162730578|NCT04424927|587722615|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
162730579|NCT04424927|587722616|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162730580|NCT04424927|587722617|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162730581|NCT04424927|587722618|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162730582|NCT04424927|587722619|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162730583|NCT04424927|587722615|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162730584|NCT04424927|587722616|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
162730585|NCT04424927|587722617|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
162730586|NCT04424927|587722618|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162730587|NCT04424927|587722619|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162730588|NCT04424927|587722615|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
162730589|NCT04424927|587722616|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
162730590|NCT04424927|587722617|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
162730591|NCT04424927|587722618|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
162730592|NCT04424927|587722619|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
162730593|NCT04424927|587722615|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162730594|NCT04424927|587722616|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
162730595|NCT04424927|587722617|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162730596|NCT04424927|587722618|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162730597|NCT04424927|587722619|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
162730598|NCT04424927|587722615|FG000|Double-blind Period (24 Weeks)|Other|0|||
162730599|NCT04424927|587722616|FG001|Double-blind Period (24 Weeks)|Other|1|||
162730600|NCT04424927|587722617|FG002|Double-blind Period (24 Weeks)|Other|3|||
162730601|NCT04424927|587722618|FG003|Double-blind Period (24 Weeks)|Other|1|||
162730602|NCT04424927|587722619|FG004|Double-blind Period (24 Weeks)|Other|0|||
162730603|NCT00505934|587722624|FG000|Overall Study|Adverse Event|1|||
162730604|NCT00505934|587722624|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
162730605|NCT00505934|587722624|FG000|Overall Study|Other: IV dose needed to be changed|1|||
162730606|NCT01046136|587722629|FG000|Overall Study|Withdrawal by Subject|0|||
162730607|NCT01046136|587722630|FG001|Overall Study|Withdrawal by Subject|4|||
162730608|NCT01046136|587722629|FG000|Overall Study|Physician Decision|1|||
162730609|NCT01046136|587722630|FG001|Overall Study|Physician Decision|1|||
162730610|NCT01046136|587722629|FG000|Overall Study|Lost to Follow-up|3|||
162730611|NCT01046136|587722630|FG001|Overall Study|Lost to Follow-up|3|||
162730612|NCT02058108|587722631|FG000|Overall Study|Abnormal Laboratory Values|0|||
162730613|NCT02058108|587722632|FG001|Overall Study|Abnormal Laboratory Values|1|||
162730614|NCT02058108|587722631|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
162730615|NCT02058108|587722632|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162730616|NCT02058108|587722631|FG000|Overall Study|No longer requires study drug|0|||
162730617|NCT02058108|587722632|FG001|Overall Study|No longer requires study drug|1|||
162730618|NCT02058108|587722631|FG000|Overall Study|Withdrawal by Subject|1|||
162730619|NCT02058108|587722632|FG001|Overall Study|Withdrawal by Subject|0|||
162730620|NCT02058108|587722631|FG000|Overall Study|Administrative problems|3|||
162730621|NCT02058108|587722632|FG001|Overall Study|Administrative problems|3|||
162730622|NCT02058108|587722631|FG000|Overall Study|Protocol Violation|0|||
162730623|NCT02058108|587722632|FG001|Overall Study|Protocol Violation|1|||
162730624|NCT01376700|587722636|FG000|Overall Study|Sponsor terminated study early|8|||
162730625|NCT01376700|587722636|FG000|Overall Study|Low or high titer inhibitor|8|||
162730626|NCT00727909|587722637|FG000|Overall Study|Withdrawal by Subject|5|||
162730627|NCT00727909|587722638|FG001|Overall Study|Withdrawal by Subject|11|||
162730628|NCT00727909|587722639|FG002|Overall Study|Withdrawal by Subject|8|||
162730629|NCT00727909|587722640|FG003|Overall Study|Withdrawal by Subject|5|||
162730630|NCT00727909|587722637|FG000|Overall Study|Death|0|||
162730631|NCT00727909|587722638|FG001|Overall Study|Death|0|||
162730632|NCT00727909|587722639|FG002|Overall Study|Death|1|||
162730633|NCT00727909|587722640|FG003|Overall Study|Death|0|||
162730634|NCT01696773|587722641|FG000|Days 15-27, Washout|Adverse Event|1|||
162730635|NCT01696773|587722642|FG001|Days 15-27, Washout|Adverse Event|0|||
162730636|NCT01121991|587722643|FG000|Overall Study|Lack of Ovarian Response|2|||
162730637|NCT01121991|587722643|FG000|Overall Study|No Oocytes Retrieved|3|||
162730638|NCT01121991|587722643|FG000|Overall Study|No Fertilization|1|||
162730639|NCT04110054|587722644|FG000|Overall Study|COVID-19 reason other than AE|0|||
162730640|NCT04110054|587722645|FG001|Overall Study|COVID-19 reason other than AE|0|||
162730641|NCT04110054|587722646|FG002|Overall Study|COVID-19 reason other than AE|2|||
162730642|NCT04110054|587722647|FG003|Overall Study|COVID-19 reason other than AE|0|||
162730643|NCT04110054|587722644|FG000|Overall Study|Withdrawal by Subject|0|||
162730644|NCT04110054|587722645|FG001|Overall Study|Withdrawal by Subject|3|||
162730645|NCT04110054|587722646|FG002|Overall Study|Withdrawal by Subject|2|||
162730646|NCT04110054|587722647|FG003|Overall Study|Withdrawal by Subject|0|||
162730647|NCT04110054|587722644|FG000|Overall Study|Adverse Event|1|||
162730648|NCT04110054|587722645|FG001|Overall Study|Adverse Event|1|||
162730649|NCT04110054|587722646|FG002|Overall Study|Adverse Event|4|||
162730650|NCT04110054|587722647|FG003|Overall Study|Adverse Event|3|||
162730651|NCT01000480|587722649|FG000|Induction Phase|Adverse Event|2|||
162730652|NCT01000480|587722649|FG000|Induction Phase|Lost to Follow-up|1|||
162730653|NCT01000480|587722649|FG000|Induction Phase|Physician Decision|1|||
162730654|NCT01000480|587722649|FG000|Induction Phase|Entry Criteria Not Met|3|||
162730655|NCT01000480|587722649|FG000|Concurrent Therapy Phase|Adverse Event|4|||
162730656|NCT01000480|587722649|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
162730657|NCT01000480|587722649|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
162730658|NCT01000480|587722649|FG000|Concurrent Therapy Phase|Physician Decision|1|||
162730659|NCT03655262|587722653|FG000|Overall Study|Withdrawal by Subject|0|||
162730660|NCT03655262|587722654|FG001|Overall Study|Withdrawal by Subject|0|||
162730661|NCT03655262|587722655|FG002|Overall Study|Withdrawal by Subject|1|||
162730662|NCT04149002|587722661|FG000|Overall Study|Lost to Follow-up|1|||
162730663|NCT04149002|587722662|FG001|Overall Study|Lost to Follow-up|0|||
162730664|NCT04149002|587722661|FG000|Overall Study|Withdrawal by Subject|1|||
162730665|NCT04149002|587722662|FG001|Overall Study|Withdrawal by Subject|0|||
162696150|NCT05490329|587597438|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
162696151|NCT05490329|587597439|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
162696152|NCT05490329|587597438|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
162696153|NCT05490329|587597439|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
162696154|NCT04524598|587597440|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
162696155|NCT04524598|587597441|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
162696156|NCT04524598|587597442|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
162696157|NCT04524598|587597443|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
162696158|NCT04524598|587597444|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
162696159|NCT04524598|587597440|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
162696160|NCT04524598|587597441|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
162696161|NCT04524598|587597442|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696162|NCT04524598|587597443|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696163|NCT04524598|587597444|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696164|NCT04524598|587597440|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
162696165|NCT04524598|587597441|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
162696166|NCT04524598|587597442|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
162696167|NCT04524598|587597443|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
162696168|NCT04524598|587597444|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
162696169|NCT04524598|587597440|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
162696170|NCT04524598|587597441|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
162696171|NCT04524598|587597442|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
162696172|NCT04524598|587597443|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
162696173|NCT04524598|587597444|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
162696174|NCT04524598|587597440|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696175|NCT04524598|587597441|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696176|NCT04524598|587597442|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
162696177|NCT04524598|587597443|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
162696178|NCT04524598|587597444|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696179|NCT04524598|587597440|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
162696180|NCT04524598|587597441|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
162696181|NCT04524598|587597442|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
162696182|NCT04524598|587597443|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
162696183|NCT04524598|587597444|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
162696184|NCT04524598|587597440|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696185|NCT04524598|587597441|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696186|NCT04524598|587597442|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696187|NCT04524598|587597443|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162696188|NCT04524598|587597444|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
162696189|NCT02306122|587597445|FG000|Initial Physician Randomization|Physician Decision|0|||
162696190|NCT02306122|587597446|FG001|Initial Physician Randomization|Physician Decision|0|||
162696191|NCT02306122|587597447|FG002|Initial Physician Randomization|Physician Decision|0|||
162696192|NCT02306122|587597448|FG003|Initial Physician Randomization|Physician Decision|0|||
162696193|NCT02306122|587597449|FG004|Initial Physician Randomization|Physician Decision|0|||
162696194|NCT02306122|587597450|FG005|Initial Physician Randomization|Physician Decision|0|||
162696195|NCT02306122|587597451|FG006|Initial Physician Randomization|Physician Decision|0|||
162696196|NCT02306122|587597452|FG007|Initial Physician Randomization|Physician Decision|0|||
162696197|NCT02306122|587597453|FG008|Initial Physician Randomization|Physician Decision|1|||
162696198|NCT02306122|587597454|FG009|Initial Physician Randomization|Physician Decision|0|||
162696199|NCT02306122|587597455|FG010|Initial Physician Randomization|Physician Decision|0|||
162696200|NCT00180713|587597456|FG000|Overall Study|Withdrawal by Subject|2|||
162696201|NCT00180713|587597457|FG001|Overall Study|Withdrawal by Subject|0|||
162696202|NCT00180713|587597456|FG000|Overall Study|Adverse Event|3|||
162696203|NCT00180713|587597457|FG001|Overall Study|Adverse Event|3|||
162696204|NCT05295732|587597458|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
162696205|NCT05295732|587597459|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
162696206|NCT05295732|587597460|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
162696207|NCT05295732|587597461|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
162696208|NCT05295732|587597462|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
162696209|NCT05295732|587597458|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162696210|NCT05295732|587597459|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162696211|NCT05295732|587597460|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162696212|NCT05295732|587597461|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
162696213|NCT05295732|587597462|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
162696214|NCT02322814|587597463|FG000|Overall Study|Death|7|||
162730666|NCT03330795|587722663|FG000|Overall Study|Death|3|||
162730667|NCT03330795|587722663|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
162730668|NCT02539225|587722664|FG000|Part A|Adverse Event|13|||
162730669|NCT02539225|587722665|FG001|Part A|Adverse Event|4|||
162730670|NCT02539225|587722664|FG000|Part A|Withdrawal by Subject|2|||
162730671|NCT02539225|587722665|FG001|Part A|Withdrawal by Subject|4|||
162730672|NCT02539225|587722664|FG000|Part A|Physician Decision|4|||
162730673|NCT02539225|587722665|FG001|Part A|Physician Decision|7|||
162730674|NCT02539225|587722664|FG000|Part A|Did Not Receive study Drug|1|||
162730675|NCT02539225|587722665|FG001|Part A|Did Not Receive study Drug|1|||
162730676|NCT02539225|587722664|FG000|Pre Treatment for Part B|Progressive disease|1|||
162730677|NCT02539225|587722665|FG001|Pre Treatment for Part B|Progressive disease|1|||
162730678|NCT02539225|587722664|FG000|Pre Treatment for Part B|Adverse Event|1|||
162730679|NCT02539225|587722665|FG001|Pre Treatment for Part B|Adverse Event|1|||
162730680|NCT02539225|587722664|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
162730681|NCT02539225|587722665|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
162730682|NCT02539225|587722664|FG000|Pre Treatment for Part B|Physician Decision|2|||
162730683|NCT02539225|587722665|FG001|Pre Treatment for Part B|Physician Decision|0|||
162730684|NCT02539225|587722664|FG000|Part B|Adverse Event|4|||
162730685|NCT02539225|587722665|FG001|Part B|Adverse Event|4|||
162730686|NCT02539225|587722664|FG000|Part B|Withdrawal by Subject|0|||
162730687|NCT02539225|587722665|FG001|Part B|Withdrawal by Subject|3|||
162730688|NCT02539225|587722664|FG000|Part B|Physician Decision|0|||
162730689|NCT02539225|587722665|FG001|Part B|Physician Decision|9|||
162730690|NCT03101371|587722673|FG000|Overall Study|Physician Decision|0|||
162730691|NCT03101371|587722674|FG001|Overall Study|Physician Decision|1|||
162730692|NCT03101371|587722673|FG000|Overall Study|Lost to Follow-up|1|||
162730693|NCT03101371|587722674|FG001|Overall Study|Lost to Follow-up|4|||
162730694|NCT03101371|587722673|FG000|Overall Study|Did not meet eligibility criteria|2|||
162730695|NCT03101371|587722674|FG001|Overall Study|Did not meet eligibility criteria|1|||
162730696|NCT01094184|587722675|FG000|Overall Study|Death|35|||
162730697|NCT01094184|587722676|FG001|Overall Study|Death|11|||
162696215|NCT02322814|587597464|FG001|Overall Study|Death|29|||
162696216|NCT02322814|587597465|FG002|Overall Study|Death|32|||
162696217|NCT02322814|587597466|FG003|Overall Study|Death|23|||
162696218|NCT02322814|587597467|FG004|Overall Study|Death|14|||
162696219|NCT02322814|587597463|FG000|Overall Study|Lost to Follow-up|1|||
162696220|NCT02322814|587597464|FG001|Overall Study|Lost to Follow-up|3|||
162696221|NCT02322814|587597465|FG002|Overall Study|Lost to Follow-up|3|||
162696222|NCT02322814|587597466|FG003|Overall Study|Lost to Follow-up|1|||
162696223|NCT02322814|587597467|FG004|Overall Study|Lost to Follow-up|0|||
162696224|NCT02322814|587597463|FG000|Overall Study|Various Reasons|2|||
162696225|NCT02322814|587597464|FG001|Overall Study|Various Reasons|0|||
162696226|NCT02322814|587597465|FG002|Overall Study|Various Reasons|1|||
162696227|NCT02322814|587597466|FG003|Overall Study|Various Reasons|1|||
162696228|NCT02322814|587597467|FG004|Overall Study|Various Reasons|0|||
162696229|NCT02322814|587597463|FG000|Overall Study|Progressive Disease|0|||
162696230|NCT02322814|587597464|FG001|Overall Study|Progressive Disease|0|||
162696231|NCT02322814|587597465|FG002|Overall Study|Progressive Disease|0|||
162696232|NCT02322814|587597466|FG003|Overall Study|Progressive Disease|1|||
162696233|NCT02322814|587597467|FG004|Overall Study|Progressive Disease|1|||
162696234|NCT02322814|587597463|FG000|Overall Study|Protocol Violation|1|||
162696235|NCT02322814|587597464|FG001|Overall Study|Protocol Violation|0|||
162696236|NCT02322814|587597465|FG002|Overall Study|Protocol Violation|0|||
162696237|NCT02322814|587597466|FG003|Overall Study|Protocol Violation|0|||
162696238|NCT02322814|587597467|FG004|Overall Study|Protocol Violation|0|||
162696239|NCT02322814|587597463|FG000|Overall Study|Study Terminated by Sponsor|0|||
162696240|NCT02322814|587597464|FG001|Overall Study|Study Terminated by Sponsor|7|||
162696241|NCT02322814|587597465|FG002|Overall Study|Study Terminated by Sponsor|9|||
162696242|NCT02322814|587597466|FG003|Overall Study|Study Terminated by Sponsor|5|||
162696243|NCT02322814|587597467|FG004|Overall Study|Study Terminated by Sponsor|13|||
162696244|NCT02322814|587597463|FG000|Overall Study|Withdrawal by Subject|5|||
162696245|NCT02322814|587597464|FG001|Overall Study|Withdrawal by Subject|4|||
162696246|NCT02322814|587597465|FG002|Overall Study|Withdrawal by Subject|2|||
162696247|NCT02322814|587597466|FG003|Overall Study|Withdrawal by Subject|1|||
162696248|NCT02322814|587597467|FG004|Overall Study|Withdrawal by Subject|3|||
162696249|NCT03311230|587597473|FG000|Overall Study|Withdrawal by Subject|1|||
162696250|NCT03311230|587597474|FG001|Overall Study|Withdrawal by Subject|4|||
162696251|NCT03311230|587597475|FG002|Overall Study|Withdrawal by Subject|2|||
162730698|NCT02318134|587722677|FG000|Overall Study|Withdrawal by Subject|2|||
162730699|NCT02318134|587722678|FG001|Overall Study|Withdrawal by Subject|1|||
162730700|NCT03988842|587722679|FG000|Overall Study|Death|1|||
162730701|NCT04766034|587722680|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162696252|NCT03311230|587597476|FG003|Overall Study|Withdrawal by Subject|7|||
162696253|NCT03311230|587597473|FG000|Overall Study|Unrelated injury|0|||
162696254|NCT03311230|587597474|FG001|Overall Study|Unrelated injury|1|||
162696255|NCT03311230|587597475|FG002|Overall Study|Unrelated injury|0|||
162736273|NCT01494662|587744948|FG001|Overall Study|Withdrawal by Subject|0|||
162730702|NCT04766034|587722681|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162730703|NCT04766034|587722682|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162730704|NCT04766034|587722683|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162730705|NCT04766034|587722684|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
162730706|NCT04766034|587722680|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162730707|NCT04766034|587722681|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162730708|NCT04766034|587722682|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162730709|NCT04766034|587722683|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162730710|NCT04766034|587722684|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
162730711|NCT04766034|587722680|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
162730712|NCT04766034|587722681|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
162730713|NCT04766034|587722682|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
162730714|NCT04766034|587722683|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
162730715|NCT04766034|587722684|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
162730716|NCT04766034|587722680|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
162730717|NCT04766034|587722681|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
162730718|NCT04766034|587722682|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
162730719|NCT04766034|587722683|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
162730720|NCT04766034|587722684|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
162730721|NCT01976312|587722685|FG000|Overall Study|Pregnancy|0|||
162730722|NCT01976312|587722686|FG001|Overall Study|Pregnancy|1|||
162730723|NCT01976312|587722685|FG000|Overall Study|Lost to Follow-up|2|||
162730724|NCT01976312|587722686|FG001|Overall Study|Lost to Follow-up|0|||
162730725|NCT01976312|587722685|FG000|Overall Study|Withdrawal by Subject|7|||
162730726|NCT01976312|587722686|FG001|Overall Study|Withdrawal by Subject|2|||
162730727|NCT01976312|587722685|FG000|Overall Study|Adverse Event|6|||
162730728|NCT01976312|587722686|FG001|Overall Study|Adverse Event|6|||
162730729|NCT01976312|587722685|FG000|Overall Study|Protocol Violation|2|||
162730730|NCT01976312|587722686|FG001|Overall Study|Protocol Violation|0|||
162730731|NCT02556138|587722687|FG000|Overall Study|Withdrawal by Subject|1|||
162730732|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
162730733|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
162730734|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
162730735|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
162730736|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
162730737|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
162730738|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
162730739|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
162730740|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
162730741|NCT03939312|587722688|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
162730742|NCT03939312|587722688|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
162730743|NCT03939312|587722688|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
162730744|NCT01609218|587722690|FG000|Period 1|Adverse Event|3|||
162730745|NCT01609218|587722691|FG001|Period 1|Adverse Event|5|||
162730746|NCT01609218|587722690|FG000|Period 1|Sponsor Decision|0|||
162730747|NCT01609218|587722691|FG001|Period 1|Sponsor Decision|1|||
162730748|NCT01609218|587722690|FG000|Period 2|Adverse Event|1|||
162730749|NCT01609218|587722691|FG001|Period 2|Adverse Event|0|||
162730750|NCT02807779|587722694|FG000|Overall Study|Lost to Follow-up|1|||
162730751|NCT02807779|587722695|FG001|Overall Study|Lost to Follow-up|0|||
162730752|NCT02807779|587722696|FG002|Overall Study|Lost to Follow-up|0|||
162730753|NCT02807779|587722694|FG000|Overall Study|Physician Decision|2|||
162730754|NCT02807779|587722695|FG001|Overall Study|Physician Decision|0|||
162730755|NCT02807779|587722696|FG002|Overall Study|Physician Decision|1|||
162730756|NCT02807779|587722694|FG000|Overall Study|Death|1|||
162730757|NCT02807779|587722695|FG001|Overall Study|Death|1|||
162730758|NCT02807779|587722696|FG002|Overall Study|Death|0|||
162730759|NCT02576509|587724782|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
162730760|NCT02576509|587724783|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
162730761|NCT02576509|587724782|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
162730762|NCT02576509|587724783|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
162730763|NCT02576509|587724782|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
162730764|NCT02576509|587724783|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
162730765|NCT02576509|587724782|FG000|Treatment Period|Disease progression|263|||
162730766|NCT02576509|587724783|FG001|Treatment Period|Disease progression|244|||
162730767|NCT02576509|587724782|FG000|Treatment Period|Study drug toxicity|37|||
162730768|NCT02576509|587724783|FG001|Treatment Period|Study drug toxicity|41|||
162730769|NCT02576509|587724782|FG000|Treatment Period|Death|1|||
162730770|NCT02576509|587724783|FG001|Treatment Period|Death|1|||
162730771|NCT02576509|587724782|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
162730772|NCT02576509|587724783|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
162730773|NCT02576509|587724782|FG000|Treatment Period|Participant request to stop treatment|8|||
162730774|NCT02576509|587724783|FG001|Treatment Period|Participant request to stop treatment|18|||
162730775|NCT02576509|587724782|FG000|Treatment Period|Participant withdrew consent|3|||
162730776|NCT02576509|587724783|FG001|Treatment Period|Participant withdrew consent|7|||
162730777|NCT02576509|587724782|FG000|Treatment Period|Lost to Follow-up|0|||
162730778|NCT02576509|587724783|FG001|Treatment Period|Lost to Follow-up|1|||
162730779|NCT02576509|587724782|FG000|Treatment Period|Maximum clinical benefit|1|||
162730780|NCT02576509|587724783|FG001|Treatment Period|Maximum clinical benefit|0|||
162730781|NCT02576509|587724782|FG000|Treatment Period|Poor/non-compliance|1|||
162730782|NCT02576509|587724783|FG001|Treatment Period|Poor/non-compliance|1|||
162730783|NCT02576509|587724782|FG000|Treatment Period|Participant no longer meets criteria|1|||
162730784|NCT02576509|587724783|FG001|Treatment Period|Participant no longer meets criteria|0|||
162730785|NCT02576509|587724782|FG000|Treatment Period|Other reason|12|||
162730786|NCT02576509|587724783|FG001|Treatment Period|Other reason|8|||
162730787|NCT02576509|587724782|FG000|Treatment Period|NOT REPORTED|1|||
162730788|NCT02576509|587724783|FG001|Treatment Period|NOT REPORTED|0|||
162730789|NCT02576509|587724782|FG000|Treatment Period|Administrative reason by sponsor|0|||
162730790|NCT02576509|587724783|FG001|Treatment Period|Administrative reason by sponsor|1|||
162730791|NCT03725722|587724786|FG000|Overall Study|Lack of Efficacy|2|||
162730792|NCT03725722|587724787|FG001|Overall Study|Lack of Efficacy|1|||
162730793|NCT03725722|587724788|FG002|Overall Study|Lack of Efficacy|2|||
162730794|NCT03725722|587724789|FG003|Overall Study|Lack of Efficacy|0|||
162730795|NCT03725722|587724790|FG004|Overall Study|Lack of Efficacy|2|||
162730796|NCT03725722|587724786|FG000|Overall Study|Adverse Event|2|||
162730797|NCT03725722|587724787|FG001|Overall Study|Adverse Event|2|||
162730798|NCT03725722|587724788|FG002|Overall Study|Adverse Event|1|||
162730799|NCT03725722|587724789|FG003|Overall Study|Adverse Event|0|||
162730800|NCT03725722|587724790|FG004|Overall Study|Adverse Event|6|||
162730801|NCT03725722|587724786|FG000|Overall Study|Withdrawal by Subject|4|||
162730802|NCT03725722|587724787|FG001|Overall Study|Withdrawal by Subject|1|||
162730803|NCT03725722|587724788|FG002|Overall Study|Withdrawal by Subject|0|||
162730804|NCT03725722|587724789|FG003|Overall Study|Withdrawal by Subject|4|||
162730805|NCT03725722|587724790|FG004|Overall Study|Withdrawal by Subject|4|||
162730806|NCT03725722|587724786|FG000|Overall Study|Lost to Follow-up|3|||
162730807|NCT03725722|587724787|FG001|Overall Study|Lost to Follow-up|1|||
162730808|NCT03725722|587724788|FG002|Overall Study|Lost to Follow-up|2|||
162730809|NCT03725722|587724789|FG003|Overall Study|Lost to Follow-up|2|||
162730810|NCT03725722|587724790|FG004|Overall Study|Lost to Follow-up|1|||
162730811|NCT03725722|587724786|FG000|Overall Study|Personal reasons|0|||
162730812|NCT03725722|587724787|FG001|Overall Study|Personal reasons|0|||
162730813|NCT03725722|587724788|FG002|Overall Study|Personal reasons|1|||
162730814|NCT03725722|587724789|FG003|Overall Study|Personal reasons|0|||
162730815|NCT03725722|587724790|FG004|Overall Study|Personal reasons|1|||
162730816|NCT03725722|587724786|FG000|Overall Study|COVID-19 situation|0|||
162730817|NCT03725722|587724787|FG001|Overall Study|COVID-19 situation|1|||
162730818|NCT03725722|587724788|FG002|Overall Study|COVID-19 situation|0|||
162730819|NCT03725722|587724789|FG003|Overall Study|COVID-19 situation|0|||
162730820|NCT03725722|587724790|FG004|Overall Study|COVID-19 situation|0|||
162730821|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
162730822|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
162730823|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
162730824|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
162730825|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
162730826|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
162730827|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
162730828|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
162730829|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
162730830|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
162730831|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
162730832|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
162730833|NCT01600014|587724791|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
162730834|NCT01600014|587724792|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
162730835|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
162730836|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
162730837|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
162730838|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
162730839|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
162730840|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
162696256|NCT03311230|587597476|FG003|Overall Study|Unrelated injury|0|||
162696257|NCT02998021|587597477|FG000|Overall Study|Withdrawal by Subject|3|||
162696258|NCT02998021|587597478|FG001|Overall Study|Withdrawal by Subject|1|||
162696259|NCT02998021|587597477|FG000|Overall Study|unsafe home|0|||
162696260|NCT02998021|587597478|FG001|Overall Study|unsafe home|1|||
162696261|NCT05200936|587597479|FG000|Overall Study|Withdrawal by Subject|2|||
162696262|NCT05200936|587597480|FG001|Overall Study|Withdrawal by Subject|2|||
162696263|NCT05200936|587597479|FG000|Overall Study|Lost to Follow-up|2|||
162696264|NCT05200936|587597480|FG001|Overall Study|Lost to Follow-up|0|||
162696265|NCT05200936|587597479|FG000|Overall Study|Pregnancy|0|||
162696266|NCT05200936|587597480|FG001|Overall Study|Pregnancy|1|||
162696267|NCT03713021|587597481|FG000|Overall Study|Did not have CT sim scan available|6|||
162696268|NCT03713021|587597481|FG000|Overall Study|Not eligible|4|||
162696269|NCT03713021|587597481|FG000|Overall Study|Issues with TraceIT markers|5|||
162696270|NCT01338012|587597482|FG000|Overall Study|Death|4|||
162696271|NCT01338012|587597482|FG000|Overall Study|Study terminated|4|||
162730841|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
162730842|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
162730843|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
162730844|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
162730845|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
162730846|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
162730847|NCT01600014|587724791|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
162730848|NCT01600014|587724792|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
162730849|NCT01600014|587724791|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
162730850|NCT01600014|587724792|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
162730851|NCT01600014|587724791|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
162730852|NCT01600014|587724792|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
162730853|NCT01600014|587724791|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
162730854|NCT01600014|587724792|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
162730855|NCT02791230|587724796|FG000|Overall Study|Adverse Event|10|||
162730856|NCT02791230|587724797|FG001|Overall Study|Adverse Event|9|||
162730857|NCT02791230|587724798|FG002|Overall Study|Adverse Event|66|||
162730858|NCT02791230|587724796|FG000|Overall Study|Death|38|||
162730859|NCT02791230|587724797|FG001|Overall Study|Death|25|||
162730860|NCT02791230|587724798|FG002|Overall Study|Death|184|||
162730861|NCT02791230|587724796|FG000|Overall Study|Lack of Efficacy|1|||
162730862|NCT02791230|587724797|FG001|Overall Study|Lack of Efficacy|0|||
162730863|NCT02791230|587724798|FG002|Overall Study|Lack of Efficacy|3|||
162730864|NCT02791230|587724796|FG000|Overall Study|Lost to Follow-up|0|||
162730865|NCT02791230|587724797|FG001|Overall Study|Lost to Follow-up|0|||
162730866|NCT02791230|587724798|FG002|Overall Study|Lost to Follow-up|10|||
162730867|NCT02791230|587724796|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
162730868|NCT02791230|587724797|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
162730869|NCT02791230|587724798|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
162730870|NCT02791230|587724796|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
162730871|NCT02791230|587724797|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
162730872|NCT02791230|587724798|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
162730873|NCT02791230|587724796|FG000|Overall Study|Study sites terminated by sponsor|1|||
162730874|NCT02791230|587724797|FG001|Overall Study|Study sites terminated by sponsor|0|||
162730875|NCT02791230|587724798|FG002|Overall Study|Study sites terminated by sponsor|5|||
162730876|NCT02791230|587724796|FG000|Overall Study|Other|9|||
162730877|NCT02791230|587724797|FG001|Overall Study|Other|1|||
162730878|NCT02791230|587724798|FG002|Overall Study|Other|28|||
162730879|NCT02791230|587724796|FG000|Overall Study|Protocol Violation|0|||
162730880|NCT02791230|587724797|FG001|Overall Study|Protocol Violation|0|||
162730881|NCT02791230|587724798|FG002|Overall Study|Protocol Violation|4|||
162730882|NCT02791230|587724796|FG000|Overall Study|Withdrawal by Subject|24|||
162730883|NCT02791230|587724797|FG001|Overall Study|Withdrawal by Subject|13|||
162730884|NCT02791230|587724798|FG002|Overall Study|Withdrawal by Subject|172|||
162730885|NCT02791230|587724796|FG000|Overall Study|Enrolled but not treated|0|||
162730886|NCT02791230|587724797|FG001|Overall Study|Enrolled but not treated|0|||
162730887|NCT02791230|587724798|FG002|Overall Study|Enrolled but not treated|5|||
162730888|NCT05307978|587724803|FG000|Overall Study|Lost to Follow-up|0|||
162730889|NCT05307978|587724804|FG001|Overall Study|Lost to Follow-up|1|||
162730890|NCT05307978|587724805|FG002|Overall Study|Lost to Follow-up|0|||
162730891|NCT05307978|587724806|FG003|Overall Study|Lost to Follow-up|4|||
162730892|NCT05307978|587724807|FG004|Overall Study|Lost to Follow-up|0|||
162730893|NCT05307978|587724808|FG005|Overall Study|Lost to Follow-up|0|||
162730894|NCT05307978|587724809|FG006|Overall Study|Lost to Follow-up|1|||
162730895|NCT05075408|587724810|FG000|Overall Study|Withdrawal by Subject|5|||
162730896|NCT05075408|587724811|FG001|Overall Study|Withdrawal by Subject|3|||
162730897|NCT05075408|587724812|FG002|Overall Study|Withdrawal by Subject|4|||
162730898|NCT05075408|587724810|FG000|Overall Study|Adverse Event|5|||
162730899|NCT05075408|587724811|FG001|Overall Study|Adverse Event|7|||
162730900|NCT05075408|587724812|FG002|Overall Study|Adverse Event|8|||
162730901|NCT05075408|587724810|FG000|Overall Study|Protocol Violation|0|||
162730902|NCT05075408|587724811|FG001|Overall Study|Protocol Violation|1|||
162730903|NCT05075408|587724812|FG002|Overall Study|Protocol Violation|0|||
162730904|NCT05075408|587724810|FG000|Overall Study|Lost to Follow-up|2|||
162730905|NCT05075408|587724811|FG001|Overall Study|Lost to Follow-up|1|||
162730906|NCT05075408|587724812|FG002|Overall Study|Lost to Follow-up|1|||
162730907|NCT05075408|587724810|FG000|Overall Study|Physician Decision|1|||
162730908|NCT05075408|587724811|FG001|Overall Study|Physician Decision|0|||
162730909|NCT05075408|587724812|FG002|Overall Study|Physician Decision|0|||
162730910|NCT05075408|587724810|FG000|Overall Study|Other-unspecified|3|||
162730911|NCT05075408|587724811|FG001|Overall Study|Other-unspecified|2|||
162730912|NCT05075408|587724812|FG002|Overall Study|Other-unspecified|0|||
162730913|NCT03416023|587724813|FG000|Overall Study|Exclusion criteria failure|1|||
162730914|NCT03416023|587724813|FG000|Overall Study|Withdrawal by Subject|6|||
162730915|NCT03416023|587724813|FG000|Overall Study|Explanted|7|||
162730916|NCT03416023|587724813|FG000|Overall Study|Physician Decision|1|||
162730917|NCT03416023|587724813|FG000|Overall Study|Lost to Follow-up|1|||
162730918|NCT03416023|587724813|FG000|Overall Study|Death|1|||
162730919|NCT02837510|587724814|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
162730920|NCT02837510|587724815|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
162730921|NCT02837510|587724814|FG000|Washout (2 Weeks)|Adverse Event|0|||
162730922|NCT02837510|587724815|FG001|Washout (2 Weeks)|Adverse Event|1|||
162730923|NCT02837510|587724814|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
162730924|NCT02837510|587724815|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
162730925|NCT02837510|587724814|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
162730926|NCT02837510|587724815|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
162730927|NCT02837510|587724814|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
162730928|NCT02837510|587724815|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
162730929|NCT02837510|587724814|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
162730930|NCT02837510|587724815|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
162730931|NCT05419505|587724817|FG000|Overall Study|Adverse Event|0|||
162730932|NCT05419505|587724818|FG001|Overall Study|Adverse Event|0|||
162730933|NCT05419505|587724819|FG002|Overall Study|Adverse Event|0|||
162730934|NCT05419505|587724820|FG003|Overall Study|Adverse Event|1|||
162730935|NCT05419505|587724821|FG004|Overall Study|Adverse Event|0|||
162730936|NCT05419505|587724822|FG005|Overall Study|Adverse Event|0|||
162730937|NCT05419505|587724823|FG006|Overall Study|Adverse Event|0|||
162730938|NCT05419505|587724824|FG007|Overall Study|Adverse Event|0|||
162730939|NCT05419505|587724817|FG000|Overall Study|Withdrawal by Subject|1|||
162730940|NCT05419505|587724818|FG001|Overall Study|Withdrawal by Subject|2|||
162730941|NCT05419505|587724819|FG002|Overall Study|Withdrawal by Subject|0|||
162730942|NCT05419505|587724820|FG003|Overall Study|Withdrawal by Subject|0|||
162730943|NCT05419505|587724821|FG004|Overall Study|Withdrawal by Subject|0|||
162730944|NCT05419505|587724822|FG005|Overall Study|Withdrawal by Subject|0|||
162730945|NCT05419505|587724823|FG006|Overall Study|Withdrawal by Subject|1|||
162730946|NCT05419505|587724824|FG007|Overall Study|Withdrawal by Subject|0|||
162730947|NCT05419505|587724817|FG000|Overall Study|Lost to Follow-up|2|||
162730948|NCT05419505|587724818|FG001|Overall Study|Lost to Follow-up|1|||
162730949|NCT05419505|587724819|FG002|Overall Study|Lost to Follow-up|0|||
162730950|NCT05419505|587724820|FG003|Overall Study|Lost to Follow-up|0|||
162730951|NCT05419505|587724821|FG004|Overall Study|Lost to Follow-up|1|||
162730952|NCT05419505|587724822|FG005|Overall Study|Lost to Follow-up|2|||
162730953|NCT05419505|587724823|FG006|Overall Study|Lost to Follow-up|0|||
162730954|NCT05419505|587724824|FG007|Overall Study|Lost to Follow-up|1|||
162730955|NCT02780388|587724827|FG000|Overall Study|Lost to Follow-up|0|||
162730956|NCT02780388|587724828|FG001|Overall Study|Lost to Follow-up|1|||
162730957|NCT02780388|587724829|FG002|Overall Study|Lost to Follow-up|0|||
162730958|NCT02780388|587724830|FG003|Overall Study|Lost to Follow-up|0|||
162730959|NCT02780388|587724831|FG004|Overall Study|Lost to Follow-up|0|||
162730960|NCT02780388|587724827|FG000|Overall Study|Withdrawal by Subject|1|||
162730961|NCT02780388|587724828|FG001|Overall Study|Withdrawal by Subject|1|||
162730962|NCT02780388|587724829|FG002|Overall Study|Withdrawal by Subject|0|||
162730963|NCT02780388|587724830|FG003|Overall Study|Withdrawal by Subject|0|||
162730964|NCT02780388|587724831|FG004|Overall Study|Withdrawal by Subject|0|||
162730965|NCT04527146|587724832|FG000|Overall Study|Withdrawal by Subject|12|||
162730966|NCT04527146|587724833|FG001|Overall Study|Withdrawal by Subject|15|||
162730967|NCT04527146|587724834|FG002|Overall Study|Withdrawal by Subject|7|||
162730968|NCT04527146|587724835|FG003|Overall Study|Withdrawal by Subject|16|||
162730969|NCT04527146|587724832|FG000|Overall Study|Lost to Follow-up|13|||
162730970|NCT04527146|587724833|FG001|Overall Study|Lost to Follow-up|9|||
162730971|NCT04527146|587724834|FG002|Overall Study|Lost to Follow-up|16|||
162730972|NCT04527146|587724835|FG003|Overall Study|Lost to Follow-up|13|||
162730973|NCT04527146|587724832|FG000|Overall Study|Death|0|||
162730974|NCT04527146|587724833|FG001|Overall Study|Death|1|||
162730975|NCT04527146|587724834|FG002|Overall Study|Death|1|||
162730976|NCT04527146|587724835|FG003|Overall Study|Death|0|||
162730977|NCT04527146|587724832|FG000|Overall Study|Adverse Event|0|||
162730978|NCT04527146|587724833|FG001|Overall Study|Adverse Event|0|||
162730979|NCT04527146|587724834|FG002|Overall Study|Adverse Event|1|||
162730980|NCT04527146|587724835|FG003|Overall Study|Adverse Event|0|||
162730981|NCT04527146|587724832|FG000|Overall Study|Ineligible after randomization|2|||
162730982|NCT04527146|587724833|FG001|Overall Study|Ineligible after randomization|0|||
162730983|NCT04527146|587724834|FG002|Overall Study|Ineligible after randomization|2|||
162730984|NCT04527146|587724835|FG003|Overall Study|Ineligible after randomization|2|||
162730985|NCT04527146|587724832|FG000|Overall Study|Moved to a different group|6|||
162730986|NCT04527146|587724833|FG001|Overall Study|Moved to a different group|3|||
162730987|NCT04527146|587724834|FG002|Overall Study|Moved to a different group|0|||
162730988|NCT04527146|587724835|FG003|Overall Study|Moved to a different group|2|||
162730989|NCT05510232|587724836|FG000|Overall Study|Withdrawal by Subject|2|||
162730990|NCT05510232|587724837|FG001|Overall Study|Withdrawal by Subject|7|||
162730991|NCT05510232|587724838|FG002|Overall Study|Withdrawal by Subject|6|||
162730992|NCT05687903|587724848|FG000|Overall Study|Protocol Deviation|1|||
162730993|NCT05687903|587724849|FG001|Overall Study|Protocol Deviation|1|||
162730994|NCT05687903|587724850|FG002|Overall Study|Protocol Deviation|0|||
162730995|NCT05687903|587724851|FG003|Overall Study|Protocol Deviation|1|||
162730996|NCT05687903|587724852|FG004|Overall Study|Protocol Deviation|0|||
162730997|NCT04468776|587724853|FG000|Overall Study|Lost to Follow-up|4|||
162730998|NCT04468776|587724854|FG001|Overall Study|Lost to Follow-up|3|||
162730999|NCT04468776|587724855|FG002|Overall Study|Lost to Follow-up|4|||
162731000|NCT04468776|587724853|FG000|Overall Study|Withdrawal by Subject|1|||
162731001|NCT04468776|587724854|FG001|Overall Study|Withdrawal by Subject|10|||
162731002|NCT04468776|587724855|FG002|Overall Study|Withdrawal by Subject|4|||
162731003|NCT04468776|587724853|FG000|Overall Study|Physician Decision|0|||
162731004|NCT04468776|587724854|FG001|Overall Study|Physician Decision|1|||
162731005|NCT04468776|587724855|FG002|Overall Study|Physician Decision|1|||
162731006|NCT04855760|587724856|FG000|Overall Study|Adverse Event|21|||
162731007|NCT04855760|587724856|FG000|Overall Study|Withdrawal by Subject|116|||
162731008|NCT04855760|587724856|FG000|Overall Study|Lack of Efficacy|21|||
162731009|NCT04855760|587724856|FG000|Overall Study|Lost to Follow-up|49|||
162731010|NCT04855760|587724856|FG000|Overall Study|Protocol Violation|2|||
162731011|NCT04855760|587724856|FG000|Overall Study|Physician Decision|5|||
162731012|NCT04855760|587724856|FG000|Overall Study|Pregnancy|1|||
162731013|NCT04855760|587724856|FG000|Overall Study|Non-Compliance with Study Drug|11|||
162731014|NCT04855760|587724856|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
162731015|NCT04855760|587724856|FG000|Overall Study|Study Completed by Sponsor|202|||
162731016|NCT04855760|587724856|FG000|Overall Study|Other|13|||
162731017|NCT04840199|587724859|FG000|Overall Study|Study Terminated by Sponsor|8|||
162731018|NCT04840199|587724860|FG001|Overall Study|Study Terminated by Sponsor|9|||
162731019|NCT04840199|587724859|FG000|Overall Study|Lost to Follow-up|0|||
162731020|NCT04840199|587724860|FG001|Overall Study|Lost to Follow-up|2|||
162731021|NCT04840199|587724859|FG000|Overall Study|Withdrawal by Subject|2|||
162731022|NCT04840199|587724860|FG001|Overall Study|Withdrawal by Subject|0|||
162731023|NCT04840199|587724859|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
162731024|NCT04840199|587724860|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
162731025|NCT03857620|587724862|FG000|Overall Study|Death|4|||
162731026|NCT03857620|587724863|FG001|Overall Study|Death|5|||
162731027|NCT03857620|587724864|FG002|Overall Study|Death|7|||
162731028|NCT03857620|587724862|FG000|Overall Study|Lost to Follow-up|2|||
162731029|NCT03857620|587724863|FG001|Overall Study|Lost to Follow-up|5|||
162731030|NCT03857620|587724864|FG002|Overall Study|Lost to Follow-up|3|||
162731031|NCT03857620|587724862|FG000|Overall Study|Disease progression or relapse after study registration|1|||
162731032|NCT03857620|587724863|FG001|Overall Study|Disease progression or relapse after study registration|5|||
162731033|NCT03857620|587724864|FG002|Overall Study|Disease progression or relapse after study registration|1|||
162731034|NCT03857620|587724862|FG000|Overall Study|Ineligible|5|||
162731035|NCT03857620|587724863|FG001|Overall Study|Ineligible|0|||
162731036|NCT03857620|587724864|FG002|Overall Study|Ineligible|2|||
162731037|NCT03857620|587724862|FG000|Overall Study|No malignancy|1|||
162731038|NCT03857620|587724863|FG001|Overall Study|No malignancy|0|||
162731039|NCT03857620|587724864|FG002|Overall Study|No malignancy|1|||
162731040|NCT03857620|587724862|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
162731041|NCT03857620|587724863|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
162731042|NCT03857620|587724864|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
162731043|NCT03857620|587724862|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
162731044|NCT03857620|587724863|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
162731045|NCT03857620|587724864|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
162731046|NCT03857620|587724862|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
162731047|NCT03857620|587724863|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
162731048|NCT03857620|587724864|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
162731049|NCT03857620|587724862|FG000|Overall Study|Surgery not performed, patient decision|0|||
162731050|NCT03857620|587724863|FG001|Overall Study|Surgery not performed, patient decision|3|||
162731051|NCT03857620|587724864|FG002|Overall Study|Surgery not performed, patient decision|1|||
162731052|NCT03857620|587724862|FG000|Overall Study|Surgery not performed, other reason|3|||
162731053|NCT03857620|587724863|FG001|Overall Study|Surgery not performed, other reason|1|||
162731054|NCT03857620|587724864|FG002|Overall Study|Surgery not performed, other reason|4|||
162731055|NCT03857620|587724862|FG000|Overall Study|Worsening performance status after surgery performed|0|||
162731056|NCT03857620|587724863|FG001|Overall Study|Worsening performance status after surgery performed|1|||
162731057|NCT03857620|587724864|FG002|Overall Study|Worsening performance status after surgery performed|1|||
162731058|NCT04118452|587724865|FG000|Overall Study|Lost to Follow-up|5|||
162731059|NCT04118452|587724866|FG001|Overall Study|Lost to Follow-up|5|||
162731060|NCT04118452|587724865|FG000|Overall Study|Withdrawal by Subject|17|||
162731061|NCT04118452|587724866|FG001|Overall Study|Withdrawal by Subject|17|||
162731062|NCT01718743|587724867|FG000|Overall Study|Physician Decision|7|||
162731063|NCT01718743|587724867|FG000|Overall Study|Withdrawal by Subject|14|||
162731064|NCT01718743|587724867|FG000|Overall Study|Progressive Disease|22|||
162731065|NCT01718743|587724867|FG000|Overall Study|Toxicity|1|||
162731066|NCT01718743|587724867|FG000|Overall Study|Malignancy|1|||
162731067|NCT04868110|587724875|FG000|Overall Study|Withdrawal by Subject|3|||
162731068|NCT04868110|587724876|FG001|Overall Study|Withdrawal by Subject|4|||
162731069|NCT02386553|587724878|FG000|Overall Study|Reason Not Specified|1|||
162731070|NCT02386553|587724879|FG001|Overall Study|Reason Not Specified|1|||
162731071|NCT02386553|587724878|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
162731072|NCT02386553|587724879|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
162731073|NCT05623345|587724888|FG000|Overall Study|Withdrawal by Subject|14|||
162731074|NCT05623345|587724889|FG001|Overall Study|Withdrawal by Subject|0|||
162731075|NCT05623345|587724890|FG002|Overall Study|Withdrawal by Subject|9|||
162731076|NCT05623345|587724891|FG003|Overall Study|Withdrawal by Subject|20|||
162731077|NCT05623345|587724888|FG000|Overall Study|Lost to Follow-up|3|||
162731078|NCT05623345|587724889|FG001|Overall Study|Lost to Follow-up|0|||
162731079|NCT05623345|587724890|FG002|Overall Study|Lost to Follow-up|7|||
162731080|NCT05623345|587724891|FG003|Overall Study|Lost to Follow-up|2|||
162731081|NCT05623345|587724888|FG000|Overall Study|Termination of Study By Sponsor|37|||
162731082|NCT05623345|587724889|FG001|Overall Study|Termination of Study By Sponsor|4|||
162731083|NCT05623345|587724890|FG002|Overall Study|Termination of Study By Sponsor|40|||
162731084|NCT05623345|587724891|FG003|Overall Study|Termination of Study By Sponsor|38|||
162731085|NCT05384730|587724892|FG000|Overall Study|Adverse Event|1|||
162731086|NCT05384730|587724893|FG001|Overall Study|Adverse Event|0|||
162731087|NCT05384730|587724892|FG000|Overall Study|Lack of social support|2|||
162731088|NCT05384730|587724893|FG001|Overall Study|Lack of social support|0|||
162731089|NCT05384730|587724892|FG000|Overall Study|Hospital readmission|2|||
162731090|NCT05384730|587724893|FG001|Overall Study|Hospital readmission|0|||
162731091|NCT05384730|587724892|FG000|Overall Study|Disease progression|5|||
162731092|NCT05384730|587724893|FG001|Overall Study|Disease progression|0|||
162731093|NCT05384730|587724892|FG000|Overall Study|Overwhelmed with College commitments|0|||
162731094|NCT05384730|587724893|FG001|Overall Study|Overwhelmed with College commitments|2|||
162731095|NCT01619410|587724896|FG000|Overall Study|Lost to Follow-up|7|||
162731096|NCT01619410|587724897|FG001|Overall Study|Lost to Follow-up|4|||
162731097|NCT06061081|587724910|FG000|Overall Study|Withdrawal by Subject|1|||
162731098|NCT06061081|587724911|FG001|Overall Study|Withdrawal by Subject|0|||
162731099|NCT06061081|587724912|FG002|Overall Study|Withdrawal by Subject|0|||
162731100|NCT06061081|587724913|FG003|Overall Study|Withdrawal by Subject|0|||
162731101|NCT06061081|587724914|FG004|Overall Study|Withdrawal by Subject|0|||
162731102|NCT05782231|587724915|FG000|Overall Study|Withdrawal by Subject|1|||
162731103|NCT02252172|587724916|FG000|Overall Study|Lost to Follow-up|9|||
162731104|NCT02252172|587724917|FG001|Overall Study|Lost to Follow-up|6|||
162731105|NCT02252172|587724916|FG000|Overall Study|Death|218|||
162731106|NCT02252172|587724917|FG001|Overall Study|Death|175|||
162731107|NCT02252172|587724916|FG000|Overall Study|Withdrawal by Subject|20|||
162731108|NCT02252172|587724917|FG001|Overall Study|Withdrawal by Subject|15|||
162731109|NCT02252172|587724916|FG000|Overall Study|Physician Decision|0|||
162731110|NCT02252172|587724917|FG001|Overall Study|Physician Decision|1|||
162731111|NCT02252172|587724916|FG000|Overall Study|End of data collection|122|||
162731112|NCT02252172|587724917|FG001|Overall Study|End of data collection|170|||
162731113|NCT02252172|587724916|FG000|Overall Study|Site closure|0|||
162731114|NCT02252172|587724917|FG001|Overall Study|Site closure|1|||
162731115|NCT03830866|587724918|FG000|Overall Study|Death|90|||
162731116|NCT03830866|587724919|FG001|Overall Study|Death|111|||
162731117|NCT03830866|587724918|FG000|Overall Study|Lost to Follow-up|7|||
162731118|NCT03830866|587724919|FG001|Overall Study|Lost to Follow-up|7|||
162731119|NCT03830866|587724918|FG000|Overall Study|Withdrawal by Subject|19|||
162731120|NCT03830866|587724919|FG001|Overall Study|Withdrawal by Subject|16|||
162731121|NCT03830866|587724918|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
162731122|NCT03830866|587724919|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
162731123|NCT03830866|587724918|FG000|Overall Study|Other|1|||
162731124|NCT03830866|587724919|FG001|Overall Study|Other|1|||
162731125|NCT01426412|587724920|FG000|Overall Study|Withdrawal by Subject|1|||
162731126|NCT01426412|587724921|FG001|Overall Study|Withdrawal by Subject|0|||
162731127|NCT01426412|587724922|FG002|Overall Study|Withdrawal by Subject|0|||
162731128|NCT01426412|587724923|FG003|Overall Study|Withdrawal by Subject|0|||
162731129|NCT01426412|587724924|FG004|Overall Study|Withdrawal by Subject|1|||
162731130|NCT01426412|587724925|FG005|Overall Study|Withdrawal by Subject|0|||
162731131|NCT01426412|587724926|FG006|Overall Study|Withdrawal by Subject|0|||
162731132|NCT01426412|587724927|FG007|Overall Study|Withdrawal by Subject|3|||
162731133|NCT01426412|587724928|FG008|Overall Study|Withdrawal by Subject|1|||
162731134|NCT03014453|587724929|FG000|Overall Study|Lost to Follow-up|12|||
162731135|NCT03014453|587724929|FG000|Overall Study|Discontinued GER|3|||
162731136|NCT03014453|587724929|FG000|Overall Study|Excluded|19|||
162731137|NCT03014453|587724929|FG000|Overall Study|Refused to take part in|37|||
162731138|NCT00262301|587724932|FG000|Double-blind Phase|Lost to Follow-up|1|||
162731139|NCT00262301|587724933|FG001|Double-blind Phase|Lost to Follow-up|0|||
162731140|NCT00262301|587724934|FG002|Double-blind Phase|Lost to Follow-up|0|||
162731141|NCT00262301|587724932|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
162731142|NCT00262301|587724933|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
162731143|NCT00262301|587724934|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
162731144|NCT00976495|587724942|FG000|Overall Study|Withdrawal by Subject|0|||
162731145|NCT00976495|587724943|FG001|Overall Study|Withdrawal by Subject|1|||
162731146|NCT00976495|587724944|FG002|Overall Study|Withdrawal by Subject|0|||
162731147|NCT04154384|587724945|FG000|Overall Study|Lost to Follow-up|24|||
162731148|NCT04154384|587724946|FG001|Overall Study|Lost to Follow-up|33|||
162731149|NCT04154384|587724947|FG002|Overall Study|Lost to Follow-up|0|||
162731150|NCT04154384|587724945|FG000|Overall Study|Withdrawal by Subject|7|||
162731151|NCT04154384|587724946|FG001|Overall Study|Withdrawal by Subject|18|||
162731152|NCT04154384|587724947|FG002|Overall Study|Withdrawal by Subject|0|||
162731153|NCT04154384|587724945|FG000|Overall Study|Missing outcome data|1|||
162731154|NCT04154384|587724946|FG001|Overall Study|Missing outcome data|0|||
162731155|NCT04154384|587724947|FG002|Overall Study|Missing outcome data|0|||
162731156|NCT04732338|587724951|FG000|Overall Study|Lost to Follow-up|3|||
162731157|NCT04732338|587724952|FG001|Overall Study|Lost to Follow-up|3|||
162731158|NCT04484935|587724953|FG000|Overall Study|Other|0|||
162731159|NCT04484935|587724954|FG001|Overall Study|Other|1|||
162731160|NCT04484935|587724953|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162731161|NCT04484935|587724954|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162731162|NCT04484935|587724953|FG000|Overall Study|Lost to Follow-up|1|||
162731163|NCT04484935|587724954|FG001|Overall Study|Lost to Follow-up|0|||
162731164|NCT04484935|587724953|FG000|Overall Study|Death|2|||
162731165|NCT04484935|587724954|FG001|Overall Study|Death|1|||
162731166|NCT03750968|587724955|FG000|Overall Study|Adverse Event|2|||
162731167|NCT03750968|587724956|FG001|Overall Study|Adverse Event|0|||
162731168|NCT03750968|587724955|FG000|Overall Study|Lost to Follow-up|1|||
162731169|NCT03750968|587724956|FG001|Overall Study|Lost to Follow-up|3|||
162731170|NCT02759016|587724957|FG000|Overall Study|Not treated with BI 836826|1|||
162731171|NCT02759016|587724958|FG001|Overall Study|Not treated with BI 836826|0|||
162731172|NCT02759016|587724957|FG000|Overall Study|Progressive disease|1|||
162731173|NCT02759016|587724958|FG001|Overall Study|Progressive disease|0|||
162731174|NCT02759016|587724957|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
162731175|NCT02759016|587724958|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
162731176|NCT02759016|587724957|FG000|Overall Study|Other not defined above|2|||
162731177|NCT02759016|587724958|FG001|Overall Study|Other not defined above|1|||
162731178|NCT03398148|587726590|FG000|Substudy 1 Period 1|Adverse Event|5|||
162731179|NCT03398148|587726591|FG001|Substudy 1 Period 1|Adverse Event|2|||
162731180|NCT03398148|587726592|FG002|Substudy 1 Period 1|Adverse Event|2|||
162731181|NCT03398148|587726593|FG003|Substudy 1 Period 1|Adverse Event|0|||
162731182|NCT03398148|587726594|FG004|Substudy 1 Period 1|Adverse Event|8|||
162731183|NCT03398148|587726595|FG005|Substudy 1 Period 1|Adverse Event|0|||
162731184|NCT03398148|587726596|FG006|Substudy 1 Period 1|Adverse Event|0|||
162731185|NCT03398148|587726597|FG007|Substudy 1 Period 1|Adverse Event|0|||
162731186|NCT03398148|587726598|FG008|Substudy 1 Period 1|Adverse Event|0|||
162731187|NCT03398148|587726599|FG009|Substudy 1 Period 1|Adverse Event|0|||
162731188|NCT03398148|587726600|FG010|Substudy 1 Period 1|Adverse Event|0|||
162731189|NCT03398148|587726601|FG011|Substudy 1 Period 1|Adverse Event|0|||
162731190|NCT03398148|587726602|FG012|Substudy 1 Period 1|Adverse Event|0|||
162731191|NCT03398148|587726603|FG013|Substudy 1 Period 1|Adverse Event|0|||
162731192|NCT03398148|587726604|FG014|Substudy 1 Period 1|Adverse Event|0|||
162731193|NCT03398148|587726590|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
162731194|NCT03398148|587726591|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
162731195|NCT03398148|587726592|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731196|NCT03398148|587726593|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
162731197|NCT03398148|587726594|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
162731198|NCT03398148|587726595|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731199|NCT03398148|587726596|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731200|NCT03398148|587726597|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731201|NCT03398148|587726598|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731202|NCT03398148|587726599|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731203|NCT03398148|587726600|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731204|NCT03398148|587726601|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731205|NCT03398148|587726602|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731206|NCT03398148|587726603|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731207|NCT03398148|587726604|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162731208|NCT03398148|587726590|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
162731209|NCT03398148|587726591|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
162731210|NCT03398148|587726592|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
162731211|NCT03398148|587726593|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
162731212|NCT03398148|587726594|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
162731213|NCT03398148|587726595|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
162731214|NCT03398148|587726596|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
162731215|NCT03398148|587726597|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
162731216|NCT03398148|587726598|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
162731217|NCT03398148|587726599|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
162731218|NCT03398148|587726600|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
162731219|NCT03398148|587726601|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
162731220|NCT03398148|587726602|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
162731221|NCT03398148|587726603|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
162731222|NCT03398148|587726604|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
162731223|NCT03398148|587726590|FG000|Substudy 1 Period 1|Other|0|||
162731224|NCT03398148|587726591|FG001|Substudy 1 Period 1|Other|1|||
162731225|NCT03398148|587726592|FG002|Substudy 1 Period 1|Other|0|||
162731226|NCT03398148|587726593|FG003|Substudy 1 Period 1|Other|0|||
162731227|NCT03398148|587726594|FG004|Substudy 1 Period 1|Other|3|||
162731228|NCT03398148|587726595|FG005|Substudy 1 Period 1|Other|0|||
162731229|NCT03398148|587726596|FG006|Substudy 1 Period 1|Other|0|||
162731230|NCT03398148|587726597|FG007|Substudy 1 Period 1|Other|0|||
162731231|NCT03398148|587726598|FG008|Substudy 1 Period 1|Other|0|||
162731232|NCT03398148|587726599|FG009|Substudy 1 Period 1|Other|0|||
162731233|NCT03398148|587726600|FG010|Substudy 1 Period 1|Other|0|||
162731234|NCT03398148|587726601|FG011|Substudy 1 Period 1|Other|0|||
162731235|NCT03398148|587726602|FG012|Substudy 1 Period 1|Other|0|||
162731236|NCT03398148|587726603|FG013|Substudy 1 Period 1|Other|0|||
162731237|NCT03398148|587726604|FG014|Substudy 1 Period 1|Other|0|||
162731238|NCT03398148|587726590|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731239|NCT03398148|587726591|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731240|NCT03398148|587726592|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731241|NCT03398148|587726593|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731242|NCT03398148|587726594|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
162731243|NCT03398148|587726595|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731244|NCT03398148|587726596|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731245|NCT03398148|587726597|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731246|NCT03398148|587726598|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731247|NCT03398148|587726599|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731248|NCT03398148|587726600|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731249|NCT03398148|587726601|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731250|NCT03398148|587726602|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731251|NCT03398148|587726603|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731252|NCT03398148|587726604|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
162731253|NCT03398148|587726590|FG000|Substudy 1 Period 2|Adverse Event|0|||
162731254|NCT03398148|587726591|FG001|Substudy 1 Period 2|Adverse Event|0|||
162731255|NCT03398148|587726592|FG002|Substudy 1 Period 2|Adverse Event|0|||
162731256|NCT03398148|587726593|FG003|Substudy 1 Period 2|Adverse Event|0|||
162731257|NCT03398148|587726594|FG004|Substudy 1 Period 2|Adverse Event|0|||
162731258|NCT03398148|587726595|FG005|Substudy 1 Period 2|Adverse Event|2|||
162731259|NCT03398148|587726596|FG006|Substudy 1 Period 2|Adverse Event|4|||
162731260|NCT03398148|587726597|FG007|Substudy 1 Period 2|Adverse Event|0|||
162731261|NCT03398148|587726598|FG008|Substudy 1 Period 2|Adverse Event|0|||
162731262|NCT03398148|587726599|FG009|Substudy 1 Period 2|Adverse Event|0|||
162731263|NCT03398148|587726600|FG010|Substudy 1 Period 2|Adverse Event|0|||
162731264|NCT03398148|587726601|FG011|Substudy 1 Period 2|Adverse Event|0|||
162731265|NCT03398148|587726602|FG012|Substudy 1 Period 2|Adverse Event|0|||
162731266|NCT03398148|587726603|FG013|Substudy 1 Period 2|Adverse Event|0|||
162731267|NCT03398148|587726604|FG014|Substudy 1 Period 2|Adverse Event|0|||
162731268|NCT03398148|587726590|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731269|NCT03398148|587726591|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731270|NCT03398148|587726592|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731271|NCT03398148|587726593|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731272|NCT03398148|587726594|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731273|NCT03398148|587726595|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731274|NCT03398148|587726596|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
162731275|NCT03398148|587726597|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
162731276|NCT03398148|587726598|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731277|NCT03398148|587726599|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731278|NCT03398148|587726600|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731279|NCT03398148|587726601|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731280|NCT03398148|587726602|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731281|NCT03398148|587726603|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731282|NCT03398148|587726604|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162731283|NCT03398148|587726590|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
162731284|NCT03398148|587726591|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
162731285|NCT03398148|587726592|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
162731286|NCT03398148|587726593|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
162731287|NCT03398148|587726594|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
162731288|NCT03398148|587726595|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
162731289|NCT03398148|587726596|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
162731290|NCT03398148|587726597|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
162731291|NCT03398148|587726598|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
162731292|NCT03398148|587726599|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
162731293|NCT03398148|587726600|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
162731294|NCT03398148|587726601|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
162731295|NCT03398148|587726602|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
162731296|NCT03398148|587726603|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
162731297|NCT03398148|587726604|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
162731298|NCT03398148|587726590|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731299|NCT03398148|587726591|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731300|NCT03398148|587726592|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731301|NCT03398148|587726593|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731302|NCT03398148|587726594|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731303|NCT03398148|587726595|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731304|NCT03398148|587726596|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
162731305|NCT03398148|587726597|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731306|NCT03398148|587726598|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731307|NCT03398148|587726599|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731308|NCT03398148|587726600|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731309|NCT03398148|587726601|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731310|NCT03398148|587726602|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731311|NCT03398148|587726603|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731312|NCT03398148|587726604|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731313|NCT03398148|587726590|FG000|Substudy 1 Period 2|Other|0|||
162731314|NCT03398148|587726591|FG001|Substudy 1 Period 2|Other|0|||
162731315|NCT03398148|587726592|FG002|Substudy 1 Period 2|Other|0|||
162731316|NCT03398148|587726593|FG003|Substudy 1 Period 2|Other|0|||
162731317|NCT03398148|587726594|FG004|Substudy 1 Period 2|Other|0|||
162731318|NCT03398148|587726595|FG005|Substudy 1 Period 2|Other|0|||
162731319|NCT03398148|587726596|FG006|Substudy 1 Period 2|Other|1|||
162731320|NCT03398148|587726597|FG007|Substudy 1 Period 2|Other|0|||
162731321|NCT03398148|587726598|FG008|Substudy 1 Period 2|Other|0|||
162731322|NCT03398148|587726599|FG009|Substudy 1 Period 2|Other|0|||
162731323|NCT03398148|587726600|FG010|Substudy 1 Period 2|Other|0|||
162731324|NCT03398148|587726601|FG011|Substudy 1 Period 2|Other|0|||
162731325|NCT03398148|587726602|FG012|Substudy 1 Period 2|Other|0|||
162731326|NCT03398148|587726603|FG013|Substudy 1 Period 2|Other|0|||
162731327|NCT03398148|587726604|FG014|Substudy 1 Period 2|Other|0|||
162731328|NCT03398148|587726590|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731329|NCT03398148|587726591|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731330|NCT03398148|587726592|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731331|NCT03398148|587726593|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731332|NCT03398148|587726594|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731333|NCT03398148|587726595|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731334|NCT03398148|587726596|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
162731335|NCT03398148|587726597|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731336|NCT03398148|587726598|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731337|NCT03398148|587726599|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731338|NCT03398148|587726600|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731339|NCT03398148|587726601|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731340|NCT03398148|587726602|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731341|NCT03398148|587726603|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731342|NCT03398148|587726604|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
162731343|NCT03398148|587726590|FG000|Substudy 2 Period 1|Adverse Event|0|||
162731344|NCT03398148|587726591|FG001|Substudy 2 Period 1|Adverse Event|0|||
162731345|NCT03398148|587726592|FG002|Substudy 2 Period 1|Adverse Event|0|||
162731346|NCT03398148|587726593|FG003|Substudy 2 Period 1|Adverse Event|0|||
162731347|NCT03398148|587726594|FG004|Substudy 2 Period 1|Adverse Event|0|||
162731348|NCT03398148|587726595|FG005|Substudy 2 Period 1|Adverse Event|0|||
162731349|NCT03398148|587726596|FG006|Substudy 2 Period 1|Adverse Event|0|||
162731350|NCT03398148|587726597|FG007|Substudy 2 Period 1|Adverse Event|0|||
162731351|NCT03398148|587726598|FG008|Substudy 2 Period 1|Adverse Event|0|||
162731352|NCT03398148|587726599|FG009|Substudy 2 Period 1|Adverse Event|12|||
162731353|NCT03398148|587726600|FG010|Substudy 2 Period 1|Adverse Event|2|||
162731354|NCT03398148|587726601|FG011|Substudy 2 Period 1|Adverse Event|0|||
162731355|NCT03398148|587726602|FG012|Substudy 2 Period 1|Adverse Event|0|||
162731356|NCT03398148|587726603|FG013|Substudy 2 Period 1|Adverse Event|0|||
162731357|NCT03398148|587726604|FG014|Substudy 2 Period 1|Adverse Event|0|||
162731358|NCT03398148|587726590|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731359|NCT03398148|587726591|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731360|NCT03398148|587726592|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731361|NCT03398148|587726593|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731362|NCT03398148|587726594|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731363|NCT03398148|587726595|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731364|NCT03398148|587726596|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731365|NCT03398148|587726597|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731366|NCT03398148|587726598|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731367|NCT03398148|587726599|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
162731368|NCT03398148|587726600|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
162731369|NCT03398148|587726601|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731370|NCT03398148|587726602|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731371|NCT03398148|587726603|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731372|NCT03398148|587726604|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162731373|NCT03398148|587726590|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
162731374|NCT03398148|587726591|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
162731375|NCT03398148|587726592|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
162731376|NCT03398148|587726593|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
162731377|NCT03398148|587726594|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
162731378|NCT03398148|587726595|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
162731379|NCT03398148|587726596|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
162731380|NCT03398148|587726597|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
162731381|NCT03398148|587726598|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
162731382|NCT03398148|587726599|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
162731383|NCT03398148|587726600|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
162731384|NCT03398148|587726601|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
162731385|NCT03398148|587726602|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
162731386|NCT03398148|587726603|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
162731387|NCT03398148|587726604|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
162731388|NCT03398148|587726590|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731389|NCT03398148|587726591|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731390|NCT03398148|587726592|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731391|NCT03398148|587726593|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731392|NCT03398148|587726594|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731393|NCT03398148|587726595|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731394|NCT03398148|587726596|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731395|NCT03398148|587726597|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731396|NCT03398148|587726598|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731397|NCT03398148|587726599|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731398|NCT03398148|587726600|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
162731399|NCT03398148|587726601|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731400|NCT03398148|587726602|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731401|NCT03398148|587726603|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731402|NCT03398148|587726604|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162731403|NCT03398148|587726590|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731404|NCT03398148|587726591|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731405|NCT03398148|587726592|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731406|NCT03398148|587726593|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731407|NCT03398148|587726594|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731408|NCT03398148|587726595|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731409|NCT03398148|587726596|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731410|NCT03398148|587726597|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731411|NCT03398148|587726598|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731412|NCT03398148|587726599|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731413|NCT03398148|587726600|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
162731414|NCT03398148|587726601|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731415|NCT03398148|587726602|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731416|NCT03398148|587726603|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731417|NCT03398148|587726604|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162731418|NCT03398148|587726590|FG000|Substudy 2 Period 1|Other|0|||
162731419|NCT03398148|587726591|FG001|Substudy 2 Period 1|Other|0|||
162731420|NCT03398148|587726592|FG002|Substudy 2 Period 1|Other|0|||
162731421|NCT03398148|587726593|FG003|Substudy 2 Period 1|Other|0|||
162731422|NCT03398148|587726594|FG004|Substudy 2 Period 1|Other|0|||
162731423|NCT03398148|587726595|FG005|Substudy 2 Period 1|Other|0|||
162731424|NCT03398148|587726596|FG006|Substudy 2 Period 1|Other|0|||
162731425|NCT03398148|587726597|FG007|Substudy 2 Period 1|Other|0|||
162731426|NCT03398148|587726598|FG008|Substudy 2 Period 1|Other|0|||
162731427|NCT03398148|587726599|FG009|Substudy 2 Period 1|Other|4|||
162731428|NCT03398148|587726600|FG010|Substudy 2 Period 1|Other|4|||
162731429|NCT03398148|587726601|FG011|Substudy 2 Period 1|Other|0|||
162731430|NCT03398148|587726602|FG012|Substudy 2 Period 1|Other|0|||
162731431|NCT03398148|587726603|FG013|Substudy 2 Period 1|Other|0|||
162731432|NCT03398148|587726604|FG014|Substudy 2 Period 1|Other|0|||
162731433|NCT03398148|587726590|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731434|NCT03398148|587726591|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731435|NCT03398148|587726592|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731436|NCT03398148|587726593|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731437|NCT03398148|587726594|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731438|NCT03398148|587726595|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731439|NCT03398148|587726596|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731440|NCT03398148|587726597|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731441|NCT03398148|587726598|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731442|NCT03398148|587726599|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731443|NCT03398148|587726600|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
162731444|NCT03398148|587726601|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731445|NCT03398148|587726602|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731446|NCT03398148|587726603|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731447|NCT03398148|587726604|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
162731448|NCT03398148|587726590|FG000|Substudy 2 Period 2|Adverse Event|0|||
162731449|NCT03398148|587726591|FG001|Substudy 2 Period 2|Adverse Event|0|||
162731450|NCT03398148|587726592|FG002|Substudy 2 Period 2|Adverse Event|0|||
162731451|NCT03398148|587726593|FG003|Substudy 2 Period 2|Adverse Event|0|||
162731452|NCT03398148|587726594|FG004|Substudy 2 Period 2|Adverse Event|0|||
162731453|NCT03398148|587726595|FG005|Substudy 2 Period 2|Adverse Event|0|||
162731454|NCT03398148|587726596|FG006|Substudy 2 Period 2|Adverse Event|0|||
162731455|NCT03398148|587726597|FG007|Substudy 2 Period 2|Adverse Event|0|||
162731456|NCT03398148|587726598|FG008|Substudy 2 Period 2|Adverse Event|0|||
162731457|NCT03398148|587726599|FG009|Substudy 2 Period 2|Adverse Event|0|||
162731458|NCT03398148|587726600|FG010|Substudy 2 Period 2|Adverse Event|0|||
162731459|NCT03398148|587726601|FG011|Substudy 2 Period 2|Adverse Event|0|||
162731460|NCT03398148|587726602|FG012|Substudy 2 Period 2|Adverse Event|0|||
162731461|NCT03398148|587726603|FG013|Substudy 2 Period 2|Adverse Event|1|||
162731462|NCT03398148|587726604|FG014|Substudy 2 Period 2|Adverse Event|3|||
162731463|NCT03398148|587726590|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
162731464|NCT03398148|587726591|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
162731465|NCT03398148|587726592|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
162731466|NCT03398148|587726593|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
162731467|NCT03398148|587726594|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
162731468|NCT03398148|587726595|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
162731469|NCT03398148|587726596|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
162731470|NCT03398148|587726597|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
162731471|NCT03398148|587726598|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
162731472|NCT03398148|587726599|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
162731473|NCT03398148|587726600|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
162731474|NCT03398148|587726601|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
162731475|NCT03398148|587726602|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
162731476|NCT03398148|587726603|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
162731477|NCT03398148|587726604|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
162731478|NCT03398148|587726590|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731479|NCT03398148|587726591|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731480|NCT03398148|587726592|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731481|NCT03398148|587726593|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731482|NCT03398148|587726594|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731483|NCT03398148|587726595|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731484|NCT03398148|587726596|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731485|NCT03398148|587726597|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731486|NCT03398148|587726598|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731487|NCT03398148|587726599|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731488|NCT03398148|587726600|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731489|NCT03398148|587726601|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
162731490|NCT03398148|587726602|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162731491|NCT03398148|587726603|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
162731492|NCT03398148|587726604|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
162731493|NCT03398148|587726590|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
162731494|NCT03398148|587726591|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
162731495|NCT03398148|587726592|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
162731496|NCT03398148|587726593|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
162731497|NCT03398148|587726594|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
162731498|NCT03398148|587726595|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
162731499|NCT03398148|587726596|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
162731500|NCT03398148|587726597|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
162731501|NCT03398148|587726598|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
162731502|NCT03398148|587726599|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
162731503|NCT03398148|587726600|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
162731504|NCT03398148|587726601|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
162731505|NCT03398148|587726602|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
162731506|NCT03398148|587726603|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
162731507|NCT03398148|587726604|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
162731508|NCT03398148|587726590|FG000|Substudy 2 Period 2|Other|0|||
162731509|NCT03398148|587726591|FG001|Substudy 2 Period 2|Other|0|||
162731510|NCT03398148|587726592|FG002|Substudy 2 Period 2|Other|0|||
162731511|NCT03398148|587726593|FG003|Substudy 2 Period 2|Other|0|||
162731512|NCT03398148|587726594|FG004|Substudy 2 Period 2|Other|0|||
162731513|NCT03398148|587726595|FG005|Substudy 2 Period 2|Other|0|||
162731514|NCT03398148|587726596|FG006|Substudy 2 Period 2|Other|0|||
162731515|NCT03398148|587726597|FG007|Substudy 2 Period 2|Other|0|||
162731516|NCT03398148|587726598|FG008|Substudy 2 Period 2|Other|0|||
162731517|NCT03398148|587726599|FG009|Substudy 2 Period 2|Other|0|||
162731518|NCT03398148|587726600|FG010|Substudy 2 Period 2|Other|0|||
162731519|NCT03398148|587726601|FG011|Substudy 2 Period 2|Other|0|||
162731520|NCT03398148|587726602|FG012|Substudy 2 Period 2|Other|0|||
162731521|NCT03398148|587726603|FG013|Substudy 2 Period 2|Other|1|||
162731522|NCT03398148|587726604|FG014|Substudy 2 Period 2|Other|1|||
162731523|NCT03398148|587726590|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731524|NCT03398148|587726591|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731525|NCT03398148|587726592|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731526|NCT03398148|587726593|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731527|NCT03398148|587726594|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731528|NCT03398148|587726595|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731529|NCT03398148|587726596|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731530|NCT03398148|587726597|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731531|NCT03398148|587726598|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731532|NCT03398148|587726599|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731533|NCT03398148|587726600|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731534|NCT03398148|587726601|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731535|NCT03398148|587726602|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
162731536|NCT03398148|587726603|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
162731537|NCT03398148|587726604|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
162731538|NCT00212355|587726605|FG000|Overall Study|Adverse Event|1|||
162731539|NCT00212355|587726605|FG000|Overall Study|Withdrawal by Subject|1|||
162731540|NCT00212355|587726605|FG000|Overall Study|A change of address|1|||
162731541|NCT00186992|587726611|FG000|Overall Study|Withdrawal by Subject|5|||
162731542|NCT00186992|587726611|FG000|Overall Study|Physician's discretion|13|||
162731543|NCT00186992|587726611|FG000|Overall Study|PI Discretion|4|||
162731544|NCT00186992|587726611|FG000|Overall Study|Ineligible|2|||
162731545|NCT00186992|587726611|FG000|Overall Study|Lost to Follow-up|2|||
162731546|NCT00186992|587726611|FG000|Overall Study|Still on Study|9|||
162731547|NCT03683069|587726612|FG000|Overall Study|see limitations|12|||
162731548|NCT03683069|587726613|FG001|Overall Study|see limitations|13|||
162731549|NCT03821844|587726614|FG000|Overall Study|Death|37|||
162731550|NCT03821844|587726615|FG001|Overall Study|Death|31|||
162731551|NCT03821844|587726614|FG000|Overall Study|Discharged|10|||
162731552|NCT03821844|587726615|FG001|Overall Study|Discharged|14|||
162731553|NCT03821844|587726614|FG000|Overall Study|Not present in facility at followup|2|||
162731554|NCT03821844|587726615|FG001|Overall Study|Not present in facility at followup|3|||
162731555|NCT05104697|587726616|FG000|Overall Study|Withdrawal by Subject|0|||
162731556|NCT05104697|587726617|FG001|Overall Study|Withdrawal by Subject|1|||
162731557|NCT03913195|587726618|FG000|Overall Study|Adverse Event|0|||
162731558|NCT03913195|587726619|FG001|Overall Study|Adverse Event|0|||
162731559|NCT03913195|587726620|FG002|Overall Study|Adverse Event|1|||
162731560|NCT03913195|587726621|FG003|Overall Study|Adverse Event|1|||
162731561|NCT03913195|587726622|FG004|Overall Study|Adverse Event|0|||
162731562|NCT03913195|587726618|FG000|Overall Study|Withdrawal by Subject|0|||
162731563|NCT03913195|587726619|FG001|Overall Study|Withdrawal by Subject|0|||
162731564|NCT03913195|587726620|FG002|Overall Study|Withdrawal by Subject|1|||
162731565|NCT03913195|587726621|FG003|Overall Study|Withdrawal by Subject|0|||
162731566|NCT03913195|587726622|FG004|Overall Study|Withdrawal by Subject|1|||
162731567|NCT03913195|587726618|FG000|Overall Study|non adherence to study|0|||
162731568|NCT03913195|587726619|FG001|Overall Study|non adherence to study|0|||
162731569|NCT03913195|587726620|FG002|Overall Study|non adherence to study|1|||
162731570|NCT03913195|587726621|FG003|Overall Study|non adherence to study|0|||
162731571|NCT03913195|587726622|FG004|Overall Study|non adherence to study|0|||
162731572|NCT03899961|587726623|FG000|Overall Study|-delivery prior to|2|||
162731573|NCT03899961|587726624|FG001|Overall Study|-delivery prior to|7|||
162731574|NCT03899961|587726623|FG000|Overall Study|req general anesth|1|||
162731575|NCT03899961|587726624|FG001|Overall Study|req general anesth|2|||
162731576|NCT03899961|587726623|FG000|Overall Study|capacity|5|||
162731577|NCT03899961|587726624|FG001|Overall Study|capacity|6|||
162731578|NCT03899961|587726623|FG000|Overall Study|Withdrawal by Subject|1|||
162731579|NCT03899961|587726624|FG001|Overall Study|Withdrawal by Subject|1|||
162731580|NCT05107401|587726625|FG000|Overall Study|Lost to Follow-up|13|||
162731581|NCT05107401|587726626|FG001|Overall Study|Lost to Follow-up|12|||
162731582|NCT05952076|587726629|FG000|Overall Study|Death|1|||
162731583|NCT05952076|587726630|FG001|Overall Study|Death|1|||
162731584|NCT05952076|587726629|FG000|Overall Study|Lost to Follow-up|0|||
162731585|NCT05952076|587726630|FG001|Overall Study|Lost to Follow-up|1|||
162731586|NCT04905407|587726632|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
162731587|NCT04905407|587726633|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
162731588|NCT04905407|587726634|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
162731589|NCT04905407|587726635|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
162731590|NCT04905407|587726632|FG000|Part 1 and Part 2|Death|7|||
162731591|NCT04905407|587726633|FG001|Part 1 and Part 2|Death|7|||
162731592|NCT04905407|587726634|FG002|Part 1 and Part 2|Death|7|||
162731593|NCT04905407|587726635|FG003|Part 1 and Part 2|Death|0|||
162731594|NCT04905407|587726632|FG000|Part 1 and Part 2|Other than specified|0|||
162731595|NCT04905407|587726633|FG001|Part 1 and Part 2|Other than specified|0|||
162731596|NCT04905407|587726634|FG002|Part 1 and Part 2|Other than specified|1|||
162731597|NCT04905407|587726635|FG003|Part 1 and Part 2|Other than specified|0|||
162731598|NCT04905407|587726632|FG000|Part 3|Death|0|||
162731599|NCT04905407|587726633|FG001|Part 3|Death|0|||
162731600|NCT04905407|587726634|FG002|Part 3|Death|0|||
162731601|NCT04905407|587726635|FG003|Part 3|Death|2|||
162731602|NCT00150813|587726638|FG000|Overall Study|Adverse Event|1|||
162731603|NCT00150813|587726638|FG000|Overall Study|Lack of Efficacy|1|||
162731604|NCT00150813|587726638|FG000|Overall Study|Lost to Follow-up|5|||
162731605|NCT00150813|587726638|FG000|Overall Study|Withdrawal by Subject|5|||
162731606|NCT00150813|587726638|FG000|Overall Study|Remission|3|||
162731607|NCT00150813|587726638|FG000|Overall Study|Planned pregancy|1|||
162731608|NCT00150813|587726638|FG000|Overall Study|Switch to commercially available LEV|2|||
162731609|NCT00894543|587726639|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
162731610|NCT00894543|587726640|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
162731611|NCT00894543|587726639|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
162731612|NCT00894543|587726640|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
162731613|NCT03446157|587726641|FG000|Overall Study|Death|11|||
162731614|NCT03446157|587726642|FG001|Overall Study|Death|9|||
162731615|NCT03446157|587726641|FG000|Overall Study|Lost to Follow-up|0|||
162731616|NCT03446157|587726642|FG001|Overall Study|Lost to Follow-up|1|||
162731617|NCT03446157|587726641|FG000|Overall Study|Withdrawal by Subject|2|||
162731618|NCT03446157|587726642|FG001|Overall Study|Withdrawal by Subject|1|||
162731619|NCT00411151|587726643|FG000|Overall Study|Death|38|||
162731620|NCT00411151|587726643|FG000|Overall Study|Withdrawal by Subject|2|||
162731621|NCT00411151|587726643|FG000|Overall Study|Lost to Follow-up|2|||
162731622|NCT00411151|587726643|FG000|Overall Study|Protocol Violation|1|||
162731623|NCT00411151|587726643|FG000|Overall Study|Trial prematurely closed|4|||
162731624|NCT04452318|587726645|FG000|Overall Study|Physician Decision|1|||
162731625|NCT04452318|587726646|FG001|Overall Study|Physician Decision|2|||
162731626|NCT04452318|587726647|FG002|Overall Study|Physician Decision|0|||
162731627|NCT04452318|587726648|FG003|Overall Study|Physician Decision|2|||
162731628|NCT04452318|587726649|FG004|Overall Study|Physician Decision|0|||
162731629|NCT04452318|587726650|FG005|Overall Study|Physician Decision|2|||
162731630|NCT04452318|587726651|FG006|Overall Study|Physician Decision|5|||
162731631|NCT04452318|587726645|FG000|Overall Study|Death|2|||
162731632|NCT04452318|587726646|FG001|Overall Study|Death|3|||
162731633|NCT04452318|587726647|FG002|Overall Study|Death|0|||
162731634|NCT04452318|587726648|FG003|Overall Study|Death|0|||
162731635|NCT04452318|587726649|FG004|Overall Study|Death|0|||
162731636|NCT04452318|587726650|FG005|Overall Study|Death|0|||
162731637|NCT04452318|587726651|FG006|Overall Study|Death|0|||
162731638|NCT04452318|587726645|FG000|Overall Study|Lost to Follow-up|38|||
162731639|NCT04452318|587726646|FG001|Overall Study|Lost to Follow-up|28|||
162731640|NCT04452318|587726647|FG002|Overall Study|Lost to Follow-up|0|||
162731641|NCT04452318|587726648|FG003|Overall Study|Lost to Follow-up|3|||
162731642|NCT04452318|587726649|FG004|Overall Study|Lost to Follow-up|3|||
162731643|NCT04452318|587726650|FG005|Overall Study|Lost to Follow-up|2|||
162731644|NCT04452318|587726651|FG006|Overall Study|Lost to Follow-up|1|||
162731645|NCT04452318|587726645|FG000|Overall Study|Withdrawal by Subject|46|||
162731646|NCT04452318|587726646|FG001|Overall Study|Withdrawal by Subject|40|||
162731647|NCT04452318|587726647|FG002|Overall Study|Withdrawal by Subject|0|||
162731648|NCT04452318|587726648|FG003|Overall Study|Withdrawal by Subject|18|||
162731649|NCT04452318|587726649|FG004|Overall Study|Withdrawal by Subject|6|||
162731650|NCT04452318|587726650|FG005|Overall Study|Withdrawal by Subject|8|||
162731651|NCT04452318|587726651|FG006|Overall Study|Withdrawal by Subject|6|||
162731652|NCT03380390|587726652|FG000|Overall Study|Adverse Event|3|||
162731653|NCT01017146|587726653|FG000|Overall Study|Adverse Event|11|||
162731654|NCT01017146|587726654|FG001|Overall Study|Adverse Event|1|||
162731655|NCT01017146|587726653|FG000|Overall Study|Lost to Follow-up|14|||
162731656|NCT01017146|587726654|FG001|Overall Study|Lost to Follow-up|14|||
162731657|NCT01017146|587726653|FG000|Overall Study|Noncompliance with Study Product|1|||
162731658|NCT01017146|587726654|FG001|Overall Study|Noncompliance with Study Product|1|||
162731659|NCT01017146|587726653|FG000|Overall Study|Withdrawal by Subject|32|||
162731660|NCT01017146|587726654|FG001|Overall Study|Withdrawal by Subject|16|||
162731661|NCT01017146|587726653|FG000|Overall Study|Relocation|0|||
162731662|NCT01017146|587726654|FG001|Overall Study|Relocation|4|||
162731663|NCT01017146|587726653|FG000|Overall Study|Pregnancy|2|||
162731664|NCT01017146|587726654|FG001|Overall Study|Pregnancy|1|||
162731665|NCT01017146|587726653|FG000|Overall Study|Protocol Violation|2|||
162731666|NCT01017146|587726654|FG001|Overall Study|Protocol Violation|0|||
162731667|NCT01017146|587726653|FG000|Overall Study|Took Excluded Medication|2|||
162731668|NCT01017146|587726654|FG001|Overall Study|Took Excluded Medication|0|||
162731669|NCT01017146|587726653|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
162731670|NCT01017146|587726654|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
162731671|NCT01017146|587726653|FG000|Overall Study|Change in Work Situation|1|||
162731672|NCT01017146|587726654|FG001|Overall Study|Change in Work Situation|0|||
162731673|NCT02272816|587726658|FG000|Overall Study|Adverse Event|1|||
162731674|NCT04095104|587726667|FG000|Overall Study|Withdrawal by Subject|0|||
162731675|NCT04095104|587726668|FG001|Overall Study|Withdrawal by Subject|1|||
162731676|NCT01136876|587726669|FG000|Overall Study|Lost to Follow-up|0|||
162731677|NCT01136876|587726670|FG001|Overall Study|Lost to Follow-up|1|||
162731678|NCT01136876|587726669|FG000|Overall Study|Physician Decision|3|||
162731679|NCT01136876|587726670|FG001|Overall Study|Physician Decision|5|||
162731680|NCT01136876|587726669|FG000|Overall Study|Missing NGAL measurement|2|||
162731681|NCT01136876|587726670|FG001|Overall Study|Missing NGAL measurement|5|||
162731682|NCT05321069|587726671|FG000|Overall Study|Adverse Event|52|||
162731683|NCT05321069|587726672|FG001|Overall Study|Adverse Event|52|||
162731684|NCT05321069|587726673|FG002|Overall Study|Adverse Event|64|||
162731685|NCT05321069|587726671|FG000|Overall Study|Protocol Violation|1|||
162731686|NCT05321069|587726672|FG001|Overall Study|Protocol Violation|1|||
162731687|NCT05321069|587726673|FG002|Overall Study|Protocol Violation|0|||
162731688|NCT05321069|587726671|FG000|Overall Study|Withdrawal by Subject|23|||
162731689|NCT05321069|587726672|FG001|Overall Study|Withdrawal by Subject|18|||
162731690|NCT05321069|587726673|FG002|Overall Study|Withdrawal by Subject|12|||
162731691|NCT05321069|587726671|FG000|Overall Study|Lost to Follow-up|1|||
162731692|NCT05321069|587726672|FG001|Overall Study|Lost to Follow-up|0|||
162731693|NCT05321069|587726673|FG002|Overall Study|Lost to Follow-up|1|||
162731694|NCT05321069|587726671|FG000|Overall Study|No reason stated by the participants|23|||
162731695|NCT05321069|587726672|FG001|Overall Study|No reason stated by the participants|22|||
162731696|NCT05321069|587726673|FG002|Overall Study|No reason stated by the participants|16|||
162731697|NCT05321069|587726671|FG000|Overall Study|Lack of Efficacy|1|||
162731698|NCT05321069|587726672|FG001|Overall Study|Lack of Efficacy|1|||
162731699|NCT05321069|587726673|FG002|Overall Study|Lack of Efficacy|0|||
162731700|NCT05048186|587726676|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
162731701|NCT05048186|587726677|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
162731702|NCT05048186|587726676|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
162731703|NCT05048186|587726677|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
162731704|NCT02412748|587726678|FG000|Overall Study|Lost to Follow-up|38|||
162731705|NCT02412748|587726679|FG001|Overall Study|Lost to Follow-up|39|||
162731706|NCT04218266|587726682|FG000|Overall Study|Death|1|||
162731707|NCT04218266|587726683|FG001|Overall Study|Death|2|||
162731708|NCT04218266|587726684|FG002|Overall Study|Death|3|||
162731709|NCT04218266|587726682|FG000|Overall Study|Adverse Event|13|||
162731710|NCT04218266|587726683|FG001|Overall Study|Adverse Event|14|||
162731711|NCT04218266|587726684|FG002|Overall Study|Adverse Event|11|||
162731712|NCT04218266|587726682|FG000|Overall Study|Other|7|||
162731713|NCT04218266|587726683|FG001|Overall Study|Other|5|||
162731714|NCT04218266|587726684|FG002|Overall Study|Other|14|||
162731715|NCT04218266|587726682|FG000|Overall Study|Physician Decision|1|||
162731716|NCT04218266|587726683|FG001|Overall Study|Physician Decision|3|||
162731717|NCT04218266|587726684|FG002|Overall Study|Physician Decision|2|||
162731718|NCT04218266|587726682|FG000|Overall Study|Non-compliance with study drug|0|||
162731719|NCT04218266|587726683|FG001|Overall Study|Non-compliance with study drug|0|||
162731720|NCT04218266|587726684|FG002|Overall Study|Non-compliance with study drug|1|||
162731721|NCT04218266|587726682|FG000|Overall Study|Withdrawal by Subject|1|||
162731722|NCT04218266|587726683|FG001|Overall Study|Withdrawal by Subject|3|||
162731723|NCT04218266|587726684|FG002|Overall Study|Withdrawal by Subject|1|||
162731724|NCT04218266|587726682|FG000|Overall Study|Study drug never administered|2|||
162731725|NCT04218266|587726683|FG001|Overall Study|Study drug never administered|0|||
162731726|NCT04218266|587726684|FG002|Overall Study|Study drug never administered|0|||
162731727|NCT00001277|587726686|FG000|Overall Study|Adverse Event|0|||
162731728|NCT00001277|587726687|FG001|Overall Study|Adverse Event|0|||
162731729|NCT00001277|587726688|FG002|Overall Study|Adverse Event|1|||
162731730|NCT00001277|587726686|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
162731731|NCT00001277|587726687|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
162731732|NCT00001277|587726688|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
162731733|NCT00065260|587726689|FG000|Overall Study|Death|0|||
162731734|NCT00065260|587726690|FG001|Overall Study|Death|1|||
162731735|NCT00088413|587726697|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162731736|NCT00088413|587726698|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162731737|NCT00088413|587726699|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
162731738|NCT00088413|587726700|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162731739|NCT00088413|587726697|FG000|Overall Study|Adverse Events/Side Effects|0|||
162731740|NCT00088413|587726698|FG001|Overall Study|Adverse Events/Side Effects|1|||
162731741|NCT00088413|587726699|FG002|Overall Study|Adverse Events/Side Effects|1|||
162731742|NCT00088413|587726700|FG003|Overall Study|Adverse Events/Side Effects|0|||
162731743|NCT00088413|587726697|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
162731744|NCT00088413|587726698|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
162731745|NCT00088413|587726699|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
162731746|NCT00088413|587726700|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
162731747|NCT00088413|587726697|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
162731748|NCT00088413|587726698|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
162731749|NCT00088413|587726699|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
162731750|NCT00088413|587726700|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
162731751|NCT00088413|587726697|FG000|Overall Study|Death|0|||
162731752|NCT00088413|587726698|FG001|Overall Study|Death|1|||
162731753|NCT00088413|587726699|FG002|Overall Study|Death|0|||
162731754|NCT00088413|587726700|FG003|Overall Study|Death|0|||
162731755|NCT00088413|587726697|FG000|Overall Study|Progressive disease|9|||
162731756|NCT00088413|587726698|FG001|Overall Study|Progressive disease|11|||
162731757|NCT00088413|587726699|FG002|Overall Study|Progressive disease|8|||
162731758|NCT00088413|587726700|FG003|Overall Study|Progressive disease|14|||
162731759|NCT00088413|587726697|FG000|Overall Study|Other|0|||
162731760|NCT00088413|587726698|FG001|Overall Study|Other|1|||
162731761|NCT00088413|587726699|FG002|Overall Study|Other|0|||
162731762|NCT00088413|587726700|FG003|Overall Study|Other|0|||
162731763|NCT00088413|587726697|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
162731764|NCT00088413|587726698|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
162731765|NCT00088413|587726699|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
162731766|NCT00088413|587726700|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
162731767|NCT04820686|587726701|FG000|Overall Study|Withdrawal by Subject|5|||
162731768|NCT04820686|587726702|FG001|Overall Study|Withdrawal by Subject|2|||
162731769|NCT04820686|587726703|FG002|Overall Study|Withdrawal by Subject|3|||
162731770|NCT04820686|587726701|FG000|Overall Study|Study Termination|25|||
162731771|NCT04820686|587726702|FG001|Overall Study|Study Termination|13|||
162731772|NCT04820686|587726703|FG002|Overall Study|Study Termination|14|||
162731773|NCT04820686|587726701|FG000|Overall Study|Adverse Event|0|||
162731774|NCT04820686|587726702|FG001|Overall Study|Adverse Event|1|||
162731775|NCT04820686|587726703|FG002|Overall Study|Adverse Event|0|||
162731776|NCT01424670|587726704|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
162731777|NCT01424670|587726705|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
162731778|NCT01424670|587726704|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
162731779|NCT01424670|587726705|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
162731780|NCT01424670|587726704|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
162731781|NCT01424670|587726705|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
162731782|NCT01424670|587726704|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
162731783|NCT01424670|587726705|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
162731784|NCT01424670|587726704|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
162731785|NCT01424670|587726705|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
162731786|NCT01424670|587726704|FG000|Continuation Period|Adverse Event|13|||
162731787|NCT01424670|587726705|FG001|Continuation Period|Adverse Event|5|||
162731788|NCT01424670|587726704|FG000|Continuation Period|Lost to Follow-up|2|||
162731789|NCT01424670|587726705|FG001|Continuation Period|Lost to Follow-up|0|||
162731790|NCT01424670|587726704|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
162731791|NCT01424670|587726705|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
162731792|NCT01424670|587726704|FG000|Continuation Period|Physician Decision|5|||
162731793|NCT01424670|587726705|FG001|Continuation Period|Physician Decision|4|||
162731794|NCT01424670|587726704|FG000|Continuation Period|Withdrawal by Subject|13|||
162731795|NCT01424670|587726705|FG001|Continuation Period|Withdrawal by Subject|4|||
162731796|NCT00761189|587726706|FG000|Overall Study|Adverse Event|42|||
162731797|NCT00761189|587726706|FG000|Overall Study|Lack of Efficacy|45|||
162731798|NCT00761189|587726706|FG000|Overall Study|Lost to Follow-up|36|||
162731799|NCT00761189|587726706|FG000|Overall Study|Withdrawal by Subject|49|||
162731800|NCT00761189|587726706|FG000|Overall Study|Other|13|||
162731801|NCT01494922|587726707|FG000|Overall Study|Adverse Event|1|||
162731802|NCT02891915|587726714|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
162731803|NCT02891915|587726715|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
162731804|NCT02891915|587726714|FG000|Overall Study|Withdrawal by Subject|3|||
162731805|NCT02891915|587726715|FG001|Overall Study|Withdrawal by Subject|3|||
162731806|NCT02891915|587726714|FG000|Overall Study|Became Ineligible After Enrollment|2|||
162731807|NCT02891915|587726715|FG001|Overall Study|Became Ineligible After Enrollment|1|||
162731808|NCT02891915|587726714|FG000|Overall Study|Lost to Follow-up|1|||
162731809|NCT02891915|587726715|FG001|Overall Study|Lost to Follow-up|4|||
162731810|NCT02891915|587726714|FG000|Overall Study|Physician Decision|1|||
162731811|NCT02891915|587726715|FG001|Overall Study|Physician Decision|0|||
162731812|NCT04048382|587726718|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
162731813|NCT04048382|587726719|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
162731814|NCT04048382|587726718|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
162731815|NCT04048382|587726719|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
162731816|NCT04048382|587726718|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
162731817|NCT04048382|587726719|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
162731818|NCT02119650|587726723|FG000|Overall Study|Adverse Event|3|||
162731819|NCT02119650|587726724|FG001|Overall Study|Adverse Event|4|||
162731820|NCT02119650|587726723|FG000|Overall Study|Subject decision|2|||
162731821|NCT02119650|587726724|FG001|Overall Study|Subject decision|3|||
162731822|NCT02119650|587726723|FG000|Overall Study|Disease progression|11|||
162731823|NCT02119650|587726724|FG001|Overall Study|Disease progression|14|||
162731824|NCT02119650|587726723|FG000|Overall Study|Death|5|||
162731825|NCT02119650|587726724|FG001|Overall Study|Death|1|||
162731826|NCT02119650|587726723|FG000|Overall Study|Noncompliance with study treatment|1|||
162731827|NCT02119650|587726724|FG001|Overall Study|Noncompliance with study treatment|1|||
162731828|NCT02119650|587726723|FG000|Overall Study|Study terminated by the sponsor|1|||
162731829|NCT02119650|587726724|FG001|Overall Study|Study terminated by the sponsor|0|||
162731830|NCT02119650|587726723|FG000|Overall Study|Physician Decision|0|||
162731831|NCT02119650|587726724|FG001|Overall Study|Physician Decision|2|||
162731832|NCT02119650|587726723|FG000|Overall Study|Multiple reasons for termination|2|||
162731833|NCT02119650|587726724|FG001|Overall Study|Multiple reasons for termination|1|||
162731834|NCT02269475|587726726|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
162731835|NCT02269475|587726727|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
162731836|NCT02269475|587726726|FG000|Overall Study|Withdrawal by Subject|0|||
162731837|NCT02269475|587726727|FG001|Overall Study|Withdrawal by Subject|1|||
162731838|NCT03481816|587726728|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
162731839|NCT03481816|587726729|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
162731840|NCT03481816|587726728|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
162731841|NCT03481816|587726729|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
162731842|NCT03481816|587726728|FG000|Dose Expansion|Withdrawal by Subject|0|||
162731843|NCT03481816|587726729|FG001|Dose Expansion|Withdrawal by Subject|2|||
162731844|NCT03481816|587726728|FG000|Dose Expansion|Physician Decision|0|||
162731845|NCT03481816|587726729|FG001|Dose Expansion|Physician Decision|5|||
162731846|NCT01037985|587726730|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
162731847|NCT01037985|587726731|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
162731848|NCT01037985|587726730|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
162731849|NCT01037985|587726731|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
162731850|NCT01037985|587726730|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
162731851|NCT01037985|587726731|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
162731852|NCT01037985|587726730|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
162731853|NCT01037985|587726731|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
162731854|NCT02730871|587726734|FG000|Overall Study|Adverse Event|6|||
162731855|NCT02730871|587726735|FG001|Overall Study|Adverse Event|0|||
162731856|NCT05368558|587726737|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
162731857|NCT05368558|587726738|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
162731858|NCT05368558|587726739|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
162731859|NCT05368558|587726740|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731860|NCT05368558|587726741|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731861|NCT05368558|587726742|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731862|NCT05368558|587726743|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731863|NCT05368558|587726744|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731864|NCT05368558|587726745|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731865|NCT05368558|587726746|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731866|NCT05368558|587726747|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731867|NCT05368558|587726748|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162731868|NCT05368558|587726737|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731869|NCT05368558|587726738|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731870|NCT05368558|587726739|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731871|NCT05368558|587726740|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
162731872|NCT05368558|587726741|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731873|NCT05368558|587726742|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
162731874|NCT05368558|587726743|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731875|NCT05368558|587726744|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731876|NCT05368558|587726745|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731877|NCT05368558|587726746|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731878|NCT05368558|587726747|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731879|NCT05368558|587726748|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162731880|NCT05368558|587726737|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731881|NCT05368558|587726738|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731882|NCT05368558|587726739|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731883|NCT05368558|587726740|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
162731884|NCT05368558|587726741|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731885|NCT05368558|587726742|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731886|NCT05368558|587726743|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731887|NCT05368558|587726744|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731888|NCT05368558|587726745|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731889|NCT05368558|587726746|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731890|NCT05368558|587726747|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731891|NCT05368558|587726748|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162731892|NCT05368558|587726737|FG000|Blinded Extension Period (BEP)|other|0|||
162731893|NCT05368558|587726738|FG001|Blinded Extension Period (BEP)|other|0|||
162731894|NCT05368558|587726739|FG002|Blinded Extension Period (BEP)|other|0|||
162731895|NCT05368558|587726740|FG003|Blinded Extension Period (BEP)|other|0|||
162731896|NCT05368558|587726741|FG004|Blinded Extension Period (BEP)|other|0|||
162731897|NCT05368558|587726742|FG005|Blinded Extension Period (BEP)|other|1|||
162731898|NCT05368558|587726743|FG006|Blinded Extension Period (BEP)|other|0|||
162731899|NCT05368558|587726744|FG007|Blinded Extension Period (BEP)|other|0|||
162731900|NCT05368558|587726745|FG008|Blinded Extension Period (BEP)|other|0|||
162731901|NCT05368558|587726746|FG009|Blinded Extension Period (BEP)|other|0|||
162731902|NCT05368558|587726747|FG010|Blinded Extension Period (BEP)|other|0|||
162731903|NCT05368558|587726748|FG011|Blinded Extension Period (BEP)|other|0|||
162731904|NCT04428112|587726749|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
162731905|NCT04428112|587726750|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
162731906|NCT04428112|587726749|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
162731907|NCT04428112|587726750|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
162731908|NCT04428112|587726749|FG000|Overall Study|Withdrawal by Subject|9|||
162731909|NCT04428112|587726750|FG001|Overall Study|Withdrawal by Subject|4|||
162731910|NCT04428112|587726749|FG000|Overall Study|Lost to Follow-up|27|||
162731911|NCT04428112|587726750|FG001|Overall Study|Lost to Follow-up|7|||
162731912|NCT01303445|587726751|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
162731913|NCT01303445|587726752|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
162731914|NCT01303445|587726751|FG000|Second Intervention (7 Days)|Adverse Event|0|||
162731915|NCT01303445|587726752|FG001|Second Intervention (7 Days)|Adverse Event|2|||
162731916|NCT01303445|587726751|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
162731917|NCT01303445|587726752|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
162731918|NCT01303445|587726751|FG000|Washout (14 Days)|Protocol Violation|1|||
162731919|NCT01303445|587726752|FG001|Washout (14 Days)|Protocol Violation|0|||
162731920|NCT01303445|587726751|FG000|Washout (14 Days)|Lost to Follow-up|0|||
162731921|NCT01303445|587726752|FG001|Washout (14 Days)|Lost to Follow-up|2|||
162731922|NCT01303445|587726751|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
162731923|NCT01303445|587726752|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
162731924|NCT01303445|587726751|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
162731925|NCT01303445|587726752|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
162731926|NCT05094141|587726755|FG000|Overall Study|Death|0|||
162731927|NCT05094141|587726756|FG001|Overall Study|Death|0|||
162731928|NCT05094141|587726757|FG002|Overall Study|Death|1|||
162731929|NCT05094141|587726755|FG000|Overall Study|Withdrawal by Subject|0|||
162731930|NCT05094141|587726756|FG001|Overall Study|Withdrawal by Subject|0|||
162731931|NCT05094141|587726757|FG002|Overall Study|Withdrawal by Subject|1|||
162731932|NCT05094141|587726755|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
162731933|NCT05094141|587726756|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
162731934|NCT05094141|587726757|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
162731935|NCT05094141|587726755|FG000|Overall Study|Did not participate in randomization|0|||
162731936|NCT05094141|587726756|FG001|Overall Study|Did not participate in randomization|0|||
162731937|NCT05094141|587726757|FG002|Overall Study|Did not participate in randomization|33|||
162731938|NCT05134337|587728427|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
162731939|NCT05134337|587728428|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
162731940|NCT04923347|587728429|FG000|Overall Study|Withdrawal by Subject|14|||
162731941|NCT01259401|587728430|FG000|4-month Follow-up|Death|0|||
162731942|NCT01259401|587728431|FG001|4-month Follow-up|Death|1|||
162731943|NCT01259401|587728430|FG000|4-month Follow-up|Lost to Follow-up|0|||
162731944|NCT01259401|587728431|FG001|4-month Follow-up|Lost to Follow-up|1|||
162731945|NCT04924062|587728432|FG000|Overall Study|Death|49|||
162731946|NCT04924062|587728433|FG001|Overall Study|Death|63|||
162731947|NCT04924062|587728432|FG000|Overall Study|Participant On-going|26|||
162731948|NCT04924062|587728433|FG001|Overall Study|Participant On-going|20|||
162731949|NCT05478525|587728436|FG000|Overall Study|Withdrawal by Subject|0|||
162731950|NCT05478525|587728437|FG001|Overall Study|Withdrawal by Subject|1|||
162731951|NCT05478525|587728438|FG002|Overall Study|Withdrawal by Subject|2|||
162731952|NCT05478525|587728439|FG003|Overall Study|Withdrawal by Subject|0|||
162731953|NCT05478525|587728436|FG000|Overall Study|COVID-19 Infection|2|||
162731954|NCT05478525|587728437|FG001|Overall Study|COVID-19 Infection|0|||
162731955|NCT05478525|587728438|FG002|Overall Study|COVID-19 Infection|1|||
162731956|NCT05478525|587728439|FG003|Overall Study|COVID-19 Infection|1|||
162731957|NCT01649271|587728440|FG000|Overall Study|Progressive disease|4|||
162731958|NCT01649271|587728441|FG001|Overall Study|Progressive disease|5|||
162731959|NCT01649271|587728440|FG000|Overall Study|Other Adverse Event|0|||
162731960|NCT01649271|587728441|FG001|Overall Study|Other Adverse Event|2|||
162731961|NCT01649271|587728440|FG000|Overall Study|Withdrawal by Subject|1|||
162731962|NCT01649271|587728441|FG001|Overall Study|Withdrawal by Subject|0|||
162731963|NCT01649271|587728440|FG000|Overall Study|Other than stated above|1|||
162731964|NCT01649271|587728441|FG001|Overall Study|Other than stated above|0|||
162731965|NCT05644002|587728444|FG000|Overall Study|Lost to Follow-up|1|||
162731966|NCT05644002|587728445|FG001|Overall Study|Lost to Follow-up|2|||
162731967|NCT05644002|587728444|FG000|Overall Study|Withdrawal by Subject|0|||
162731968|NCT05644002|587728445|FG001|Overall Study|Withdrawal by Subject|1|||
162731969|NCT05756075|587728450|FG000|Overall Study|Withdrawal by Subject|16|||
162731970|NCT05756075|587728451|FG001|Overall Study|Withdrawal by Subject|9|||
162731971|NCT01991977|587728452|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
162731972|NCT01991977|587728452|FG000|Overall Study|Withdrew after start of treatment|5|||
162731973|NCT04038957|587728454|FG000|Overall Study|Withdrawal by Subject|1|||
162731974|NCT04038957|587728454|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
162731975|NCT02605837|587728456|FG000|Overall Study|Adverse Event|3|||
162731976|NCT02605837|587728457|FG001|Overall Study|Adverse Event|1|||
162731977|NCT02605837|587728456|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162731978|NCT02605837|587728457|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162731979|NCT02605837|587728456|FG000|Overall Study|Withdrawal by Subject|8|||
162731980|NCT02605837|587728457|FG001|Overall Study|Withdrawal by Subject|8|||
162731981|NCT02605837|587728456|FG000|Overall Study|Physician Decision|0|||
162731982|NCT02605837|587728457|FG001|Overall Study|Physician Decision|1|||
162731983|NCT03845465|587728458|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
162731984|NCT03845465|587728459|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
162731985|NCT03845465|587728458|FG000|6-month Data Collection|Withdrawal by Subject|0|||
162731986|NCT03845465|587728459|FG001|6-month Data Collection|Withdrawal by Subject|2|||
162731987|NCT03845465|587728458|FG000|12-month Data Collection|Withdrawal by Subject|0|||
162731988|NCT03845465|587728459|FG001|12-month Data Collection|Withdrawal by Subject|2|||
162731989|NCT05656911|587728464|FG000|Treatment Phase|Physician Decision|2|||
162731990|NCT05656911|587728465|FG001|Treatment Phase|Physician Decision|0|||
162731991|NCT05656911|587728464|FG000|Treatment Phase|Lack of Efficacy|6|||
162731992|NCT05656911|587728465|FG001|Treatment Phase|Lack of Efficacy|3|||
162731993|NCT05656911|587728464|FG000|Treatment Phase|Subject Decision|4|||
162731994|NCT05656911|587728465|FG001|Treatment Phase|Subject Decision|2|||
162731995|NCT05656911|587728464|FG000|Treatment Phase|Other Reasons|1|||
162731996|NCT05656911|587728465|FG001|Treatment Phase|Other Reasons|0|||
162731997|NCT05656911|587728464|FG000|Treatment Phase|Adverse Event|3|||
162731998|NCT05656911|587728465|FG001|Treatment Phase|Adverse Event|1|||
162731999|NCT05656911|587728464|FG000|Follow-up Phase|Subject Decision|0|||
162732000|NCT05656911|587728465|FG001|Follow-up Phase|Subject Decision|1|||
162732001|NCT05656911|587728464|FG000|Follow-up Phase|Missing|1|||
162732002|NCT05656911|587728465|FG001|Follow-up Phase|Missing|0|||
162732003|NCT03547908|587728466|FG000|Blinded Phase|Lost to Follow-up|3|||
162732004|NCT03547908|587728467|FG001|Blinded Phase|Lost to Follow-up|3|||
162732005|NCT03547908|587728468|FG002|Blinded Phase|Lost to Follow-up|0|||
162732006|NCT03547908|587728469|FG003|Blinded Phase|Lost to Follow-up|0|||
162732007|NCT03547908|587728466|FG000|Blinded Phase|Withdrew Consent|2|||
162732008|NCT03547908|587728467|FG001|Blinded Phase|Withdrew Consent|3|||
162732009|NCT03547908|587728468|FG002|Blinded Phase|Withdrew Consent|0|||
162732010|NCT03547908|587728469|FG003|Blinded Phase|Withdrew Consent|0|||
162732011|NCT03547908|587728466|FG000|Blinded Phase|Investigator's Discretion|2|||
162732012|NCT03547908|587728467|FG001|Blinded Phase|Investigator's Discretion|1|||
162732013|NCT03547908|587728468|FG002|Blinded Phase|Investigator's Discretion|0|||
162732014|NCT03547908|587728469|FG003|Blinded Phase|Investigator's Discretion|0|||
162732015|NCT03547908|587728466|FG000|Blinded Phase|Death|2|||
162732016|NCT03547908|587728467|FG001|Blinded Phase|Death|0|||
162732017|NCT03547908|587728468|FG002|Blinded Phase|Death|0|||
162732018|NCT03547908|587728469|FG003|Blinded Phase|Death|0|||
162732019|NCT03547908|587728466|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
162732020|NCT03547908|587728467|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
162732021|NCT03547908|587728468|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
162732022|NCT03547908|587728469|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
162732023|NCT03547908|587728466|FG000|Blinded Phase|Adverse Event|1|||
162732024|NCT03547908|587728467|FG001|Blinded Phase|Adverse Event|0|||
162732025|NCT03547908|587728468|FG002|Blinded Phase|Adverse Event|0|||
162732026|NCT03547908|587728469|FG003|Blinded Phase|Adverse Event|0|||
162732027|NCT03547908|587728466|FG000|Blinded Phase|Randomized But Never Treated|1|||
162732028|NCT03547908|587728467|FG001|Blinded Phase|Randomized But Never Treated|0|||
162732029|NCT03547908|587728468|FG002|Blinded Phase|Randomized But Never Treated|0|||
162732030|NCT03547908|587728469|FG003|Blinded Phase|Randomized But Never Treated|0|||
162732031|NCT03547908|587728466|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
162732032|NCT03547908|587728467|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
162732033|NCT03547908|587728468|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
162732034|NCT03547908|587728469|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
162732035|NCT03547908|587728466|FG000|Open-label Extension Phase|Death|0|||
162732036|NCT03547908|587728467|FG001|Open-label Extension Phase|Death|0|||
162732037|NCT03547908|587728468|FG002|Open-label Extension Phase|Death|1|||
162732038|NCT03547908|587728469|FG003|Open-label Extension Phase|Death|0|||
162732039|NCT02349412|587728476|FG000|Overall Study|Withdrawal by Subject|7|||
162732040|NCT02349412|587728477|FG001|Overall Study|Withdrawal by Subject|7|||
162732041|NCT00567398|587728478|FG000|Overall Study|Adverse Event|6|||
162732042|NCT00567398|587728479|FG001|Overall Study|Adverse Event|14|||
162732043|NCT00567398|587728478|FG000|Overall Study|Physician Decision|0|||
162732044|NCT00567398|587728479|FG001|Overall Study|Physician Decision|4|||
162732045|NCT00567398|587728478|FG000|Overall Study|Withdrawal by Subject|0|||
162732046|NCT00567398|587728479|FG001|Overall Study|Withdrawal by Subject|2|||
162732047|NCT00567398|587728478|FG000|Overall Study|Renal Transplantation|0|||
162732048|NCT00567398|587728479|FG001|Overall Study|Renal Transplantation|3|||
162732049|NCT00567398|587728478|FG000|Overall Study|Other|1|||
162732050|NCT00567398|587728479|FG001|Overall Study|Other|0|||
162732051|NCT03517553|587728480|FG000|Overall Study|Withdrawal by Subject|2|||
162732052|NCT03271151|587728481|FG000|Overall Study|Lost to Follow-up|1|||
162732053|NCT03271151|587728482|FG001|Overall Study|Lost to Follow-up|3|||
162732054|NCT03271151|587728481|FG000|Overall Study|Withdrawal by Subject|1|||
162732055|NCT03271151|587728482|FG001|Overall Study|Withdrawal by Subject|0|||
162732056|NCT04093362|587728485|FG000|Overall Study|Study Termination|1|||
162732057|NCT04093362|587728486|FG001|Overall Study|Study Termination|1|||
162732058|NCT04093362|587728485|FG000|Overall Study|Withdrawal of Consent|1|||
162732059|NCT04093362|587728486|FG001|Overall Study|Withdrawal of Consent|0|||
162732060|NCT04093362|587728485|FG000|Overall Study|Death|1|||
162732061|NCT04093362|587728486|FG001|Overall Study|Death|3|||
162732062|NCT04093362|587728485|FG000|Overall Study|Reason not Specified|1|||
162732063|NCT04093362|587728486|FG001|Overall Study|Reason not Specified|2|||
162732064|NCT02201108|587728489|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
162732065|NCT02201108|587728490|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
162732066|NCT02201108|587728491|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
162732067|NCT02201108|587728489|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
162732068|NCT02201108|587728490|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
162732069|NCT02201108|587728491|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
162732070|NCT02201108|587728489|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
162732071|NCT02201108|587728490|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
162732072|NCT02201108|587728491|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
162732073|NCT02201108|587728489|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
162732074|NCT02201108|587728490|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
162732075|NCT02201108|587728491|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
162732076|NCT02201108|587728489|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
162732077|NCT02201108|587728490|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
162732078|NCT02201108|587728491|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
162732079|NCT02201108|587728489|FG000|Open Label Period (up to Week 192)|Other reason|4|||
162732080|NCT02201108|587728490|FG001|Open Label Period (up to Week 192)|Other reason|7|||
162732081|NCT02201108|587728491|FG002|Open Label Period (up to Week 192)|Other reason|0|||
162732082|NCT02201108|587728489|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
162732083|NCT02201108|587728490|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
162732084|NCT02201108|587728491|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
162732085|NCT02201108|587728489|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
162732086|NCT02201108|587728490|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
162732087|NCT02201108|587728491|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
162732088|NCT02201108|587728489|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
162732089|NCT02201108|587728490|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
162732090|NCT02201108|587728491|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
162732091|NCT03055377|587728501|FG000|Treatment Phase|Lost to Follow-up|28|||
162732092|NCT03055377|587728502|FG001|Treatment Phase|Lost to Follow-up|24|||
162732093|NCT03055377|587728501|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
162732094|NCT03055377|587728502|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
162732095|NCT04143061|587728503|FG000|Overall Study|Protocol Deviation|0|||
162732096|NCT04143061|587728504|FG001|Overall Study|Protocol Deviation|0|||
162732097|NCT04143061|587728505|FG002|Overall Study|Protocol Deviation|0|||
162732098|NCT04143061|587728506|FG003|Overall Study|Protocol Deviation|0|||
162732099|NCT04143061|587728507|FG004|Overall Study|Protocol Deviation|0|||
162732100|NCT04143061|587728508|FG005|Overall Study|Protocol Deviation|0|||
162732101|NCT04143061|587728509|FG006|Overall Study|Protocol Deviation|5|||
162732102|NCT04143061|587728510|FG007|Overall Study|Protocol Deviation|5|||
162732103|NCT04143061|587728503|FG000|Overall Study|Withdrawal by Subject|2|||
162732104|NCT04143061|587728504|FG001|Overall Study|Withdrawal by Subject|0|||
162732105|NCT04143061|587728505|FG002|Overall Study|Withdrawal by Subject|0|||
162732106|NCT04143061|587728506|FG003|Overall Study|Withdrawal by Subject|0|||
162732107|NCT04143061|587728507|FG004|Overall Study|Withdrawal by Subject|0|||
162732108|NCT04143061|587728508|FG005|Overall Study|Withdrawal by Subject|1|||
162732109|NCT04143061|587728509|FG006|Overall Study|Withdrawal by Subject|0|||
162732110|NCT04143061|587728510|FG007|Overall Study|Withdrawal by Subject|0|||
162732111|NCT04143061|587728503|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162732112|NCT04143061|587728504|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162732113|NCT04143061|587728505|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162732114|NCT04143061|587728506|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162732115|NCT04143061|587728507|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
162732116|NCT04143061|587728508|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
162732117|NCT04143061|587728509|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
162732118|NCT04143061|587728510|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
162732119|NCT03289039|587728511|FG000|Overall Study|Withdrawal by Subject|0|||
162732120|NCT03289039|587728512|FG001|Overall Study|Withdrawal by Subject|1|||
162732121|NCT03289039|587728511|FG000|Overall Study|Became ineligible prior to treatment start|0|||
162732122|NCT03289039|587728512|FG001|Overall Study|Became ineligible prior to treatment start|1|||
162732123|NCT03289039|587728511|FG000|Overall Study|progressed before treatment start|1|||
162732124|NCT03289039|587728512|FG001|Overall Study|progressed before treatment start|0|||
162732125|NCT04586920|587728513|FG000|Overall Study|Lost to Follow-up|0|||
162732126|NCT04586920|587728514|FG001|Overall Study|Lost to Follow-up|0|||
162732127|NCT04586920|587728515|FG002|Overall Study|Lost to Follow-up|0|||
162732128|NCT04586920|587728516|FG003|Overall Study|Lost to Follow-up|0|||
162732129|NCT04586920|587728517|FG004|Overall Study|Lost to Follow-up|0|||
162732130|NCT04586920|587728518|FG005|Overall Study|Lost to Follow-up|0|||
162732131|NCT04586920|587728519|FG006|Overall Study|Lost to Follow-up|1|||
162732132|NCT04586920|587728520|FG007|Overall Study|Lost to Follow-up|1|||
162732133|NCT04586920|587728521|FG008|Overall Study|Lost to Follow-up|0|||
162732134|NCT04586920|587728522|FG009|Overall Study|Lost to Follow-up|1|||
162732135|NCT04586920|587728523|FG010|Overall Study|Lost to Follow-up|0|||
162732136|NCT04586920|587728524|FG011|Overall Study|Lost to Follow-up|0|||
162732137|NCT04586920|587728525|FG012|Overall Study|Lost to Follow-up|0|||
162732138|NCT04586920|587728526|FG013|Overall Study|Lost to Follow-up|1|||
162732139|NCT04586920|587728527|FG014|Overall Study|Lost to Follow-up|0|||
162732140|NCT04586920|587728528|FG015|Overall Study|Lost to Follow-up|0|||
162732141|NCT04586920|587728529|FG016|Overall Study|Lost to Follow-up|0|||
162732142|NCT04586920|587728530|FG017|Overall Study|Lost to Follow-up|0|||
162732143|NCT04586920|587728513|FG000|Overall Study|Withdrawal by Subject|0|||
162732144|NCT04586920|587728514|FG001|Overall Study|Withdrawal by Subject|0|||
162732145|NCT04586920|587728515|FG002|Overall Study|Withdrawal by Subject|0|||
162732146|NCT04586920|587728516|FG003|Overall Study|Withdrawal by Subject|0|||
162732147|NCT04586920|587728517|FG004|Overall Study|Withdrawal by Subject|0|||
162732148|NCT04586920|587728518|FG005|Overall Study|Withdrawal by Subject|0|||
162732149|NCT04586920|587728519|FG006|Overall Study|Withdrawal by Subject|0|||
162732150|NCT04586920|587728520|FG007|Overall Study|Withdrawal by Subject|1|||
162732151|NCT04586920|587728521|FG008|Overall Study|Withdrawal by Subject|0|||
162732152|NCT04586920|587728522|FG009|Overall Study|Withdrawal by Subject|1|||
162732153|NCT04586920|587728523|FG010|Overall Study|Withdrawal by Subject|0|||
162732154|NCT04586920|587728524|FG011|Overall Study|Withdrawal by Subject|1|||
162732155|NCT04586920|587728525|FG012|Overall Study|Withdrawal by Subject|0|||
162732156|NCT04586920|587728526|FG013|Overall Study|Withdrawal by Subject|0|||
162732157|NCT04586920|587728527|FG014|Overall Study|Withdrawal by Subject|0|||
162732158|NCT04586920|587728528|FG015|Overall Study|Withdrawal by Subject|0|||
162732159|NCT04586920|587728529|FG016|Overall Study|Withdrawal by Subject|0|||
162732160|NCT04586920|587728530|FG017|Overall Study|Withdrawal by Subject|0|||
162732161|NCT02287311|587728535|FG000|Cohort 1: Dose Level 1|Death|2|||
162732162|NCT02287311|587728536|FG001|Cohort 1: Dose Level 1|Death|0|||
162732163|NCT02287311|587728537|FG002|Cohort 1: Dose Level 1|Death|0|||
162732164|NCT02287311|587728538|FG003|Cohort 1: Dose Level 1|Death|3|||
162732165|NCT02287311|587728539|FG004|Cohort 1: Dose Level 1|Death|0|||
162732166|NCT02287311|587728540|FG005|Cohort 1: Dose Level 1|Death|0|||
162732167|NCT02287311|587728541|FG006|Cohort 1: Dose Level 1|Death|1|||
162732168|NCT02287311|587728542|FG007|Cohort 1: Dose Level 1|Death|0|||
162732169|NCT02287311|587728543|FG008|Cohort 1: Dose Level 1|Death|0|||
162732170|NCT02287311|587728535|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732171|NCT02287311|587728536|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732172|NCT02287311|587728537|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732173|NCT02287311|587728538|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
162732174|NCT02287311|587728539|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732175|NCT02287311|587728540|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732176|NCT02287311|587728541|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
162732177|NCT02287311|587728542|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732178|NCT02287311|587728543|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162732179|NCT02287311|587728535|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
162732180|NCT02287311|587728536|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
162732181|NCT02287311|587728537|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
162732182|NCT02287311|587728538|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
162732183|NCT02287311|587728539|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
162732184|NCT02287311|587728540|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
162732185|NCT02287311|587728541|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
162732186|NCT02287311|587728542|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
162732187|NCT02287311|587728543|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
162732188|NCT02287311|587728535|FG000|Cohort 2: Dose Level 2|Death|0|||
162732189|NCT02287311|587728536|FG001|Cohort 2: Dose Level 2|Death|2|||
162732190|NCT02287311|587728537|FG002|Cohort 2: Dose Level 2|Death|0|||
162732191|NCT02287311|587728538|FG003|Cohort 2: Dose Level 2|Death|0|||
162732192|NCT02287311|587728539|FG004|Cohort 2: Dose Level 2|Death|2|||
162732193|NCT02287311|587728540|FG005|Cohort 2: Dose Level 2|Death|0|||
162732194|NCT02287311|587728541|FG006|Cohort 2: Dose Level 2|Death|0|||
162732195|NCT02287311|587728542|FG007|Cohort 2: Dose Level 2|Death|2|||
162732196|NCT02287311|587728543|FG008|Cohort 2: Dose Level 2|Death|0|||
162732197|NCT02287311|587728535|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732198|NCT02287311|587728536|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732199|NCT02287311|587728537|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732200|NCT02287311|587728538|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732201|NCT02287311|587728539|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
162732202|NCT02287311|587728540|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732203|NCT02287311|587728541|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732204|NCT02287311|587728542|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732205|NCT02287311|587728543|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162732206|NCT02287311|587728535|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732207|NCT02287311|587728536|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
162732208|NCT02287311|587728537|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732209|NCT02287311|587728538|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732210|NCT02287311|587728539|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732211|NCT02287311|587728540|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732212|NCT02287311|587728541|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732213|NCT02287311|587728542|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732214|NCT02287311|587728543|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
162732215|NCT02287311|587728535|FG000|Cohort 3: Dose Level 3|Death|0|||
162732216|NCT02287311|587728536|FG001|Cohort 3: Dose Level 3|Death|0|||
162732217|NCT02287311|587728537|FG002|Cohort 3: Dose Level 3|Death|4|||
162732218|NCT02287311|587728538|FG003|Cohort 3: Dose Level 3|Death|0|||
162732219|NCT02287311|587728539|FG004|Cohort 3: Dose Level 3|Death|0|||
162732220|NCT02287311|587728540|FG005|Cohort 3: Dose Level 3|Death|4|||
162732221|NCT02287311|587728541|FG006|Cohort 3: Dose Level 3|Death|0|||
162732222|NCT02287311|587728542|FG007|Cohort 3: Dose Level 3|Death|0|||
162732223|NCT02287311|587728543|FG008|Cohort 3: Dose Level 3|Death|2|||
162732224|NCT02287311|587728535|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732225|NCT02287311|587728536|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732226|NCT02287311|587728537|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
162732227|NCT02287311|587728538|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732228|NCT02287311|587728539|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732229|NCT02287311|587728540|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
162732230|NCT02287311|587728541|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732231|NCT02287311|587728542|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732232|NCT02287311|587728543|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162732233|NCT02287311|587728535|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732234|NCT02287311|587728536|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732235|NCT02287311|587728537|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732236|NCT02287311|587728538|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732237|NCT02287311|587728539|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732238|NCT02287311|587728540|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
162732239|NCT02287311|587728541|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732240|NCT02287311|587728542|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162732241|NCT02287311|587728543|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
162732242|NCT04048681|587728547|FG000|Overall Study|family emergency|0|||
162732243|NCT04048681|587728548|FG001|Overall Study|family emergency|0|||
162732244|NCT04048681|587728549|FG002|Overall Study|family emergency|0|||
162732245|NCT04048681|587728550|FG003|Overall Study|family emergency|1|||
162732246|NCT04048681|587728551|FG004|Overall Study|family emergency|0|||
162732247|NCT04579250|587728552|FG000|Overall Study|Withdrawal by Subject|1|||
162732248|NCT04579250|587728553|FG001|Overall Study|Withdrawal by Subject|1|||
162732249|NCT04579250|587728554|FG002|Overall Study|Withdrawal by Subject|0|||
162732250|NCT04579250|587728552|FG000|Overall Study|Lost to Follow-up|1|||
162732251|NCT04579250|587728553|FG001|Overall Study|Lost to Follow-up|1|||
162732252|NCT04579250|587728554|FG002|Overall Study|Lost to Follow-up|0|||
162732253|NCT04579250|587728552|FG000|Overall Study|Moved from area|0|||
162732254|NCT04579250|587728553|FG001|Overall Study|Moved from area|1|||
162732255|NCT04579250|587728554|FG002|Overall Study|Moved from area|2|||
162732256|NCT02919449|587728555|FG000|Overall Study|Withdrawal by Subject|1|||
162732257|NCT02919449|587728555|FG000|Overall Study|Investigator decision|1|||
162732258|NCT02374307|587728560|FG000|3-months Follow-up|Lost to Follow-up|1|||
162732259|NCT02374307|587728561|FG001|3-months Follow-up|Lost to Follow-up|2|||
162732260|NCT02374307|587728560|FG000|3-months Follow-up|Withdrawal by Subject|1|||
162732261|NCT02374307|587728561|FG001|3-months Follow-up|Withdrawal by Subject|4|||
162732262|NCT02374307|587728560|FG000|3-months Follow-up|Death|1|||
162732263|NCT02374307|587728561|FG001|3-months Follow-up|Death|2|||
162732264|NCT02374307|587728560|FG000|3-months Follow-up|Missed first follow-up|5|||
162732265|NCT02374307|587728561|FG001|3-months Follow-up|Missed first follow-up|1|||
162732266|NCT02374307|587728560|FG000|6-months Follow-up|Lost to Follow-up|1|||
162732267|NCT02374307|587728561|FG001|6-months Follow-up|Lost to Follow-up|2|||
162732268|NCT02374307|587728560|FG000|6-months Follow-up|Death|2|||
162732269|NCT02374307|587728561|FG001|6-months Follow-up|Death|1|||
162732270|NCT02374307|587728560|FG000|6-months Follow-up|Withdrawal by Subject|0|||
162732271|NCT02374307|587728561|FG001|6-months Follow-up|Withdrawal by Subject|3|||
162732272|NCT01989455|587728562|FG000|Overall Study|Adverse Event|0|||
162732273|NCT01989455|587728563|FG001|Overall Study|Adverse Event|1|||
162732274|NCT01989455|587728564|FG002|Overall Study|Adverse Event|0|||
162732275|NCT01989455|587728565|FG003|Overall Study|Adverse Event|0|||
162732276|NCT01989455|587728566|FG004|Overall Study|Adverse Event|0|||
162732277|NCT01989455|587728562|FG000|Overall Study|Withdrawal by Subject|0|||
162732278|NCT01989455|587728563|FG001|Overall Study|Withdrawal by Subject|1|||
162732279|NCT01989455|587728564|FG002|Overall Study|Withdrawal by Subject|0|||
162732280|NCT01989455|587728565|FG003|Overall Study|Withdrawal by Subject|0|||
162732281|NCT01989455|587728566|FG004|Overall Study|Withdrawal by Subject|0|||
162732282|NCT01989455|587728562|FG000|Overall Study|Technical problems with infusion|0|||
162732283|NCT01989455|587728563|FG001|Overall Study|Technical problems with infusion|0|||
162732284|NCT01989455|587728564|FG002|Overall Study|Technical problems with infusion|1|||
162732285|NCT01989455|587728565|FG003|Overall Study|Technical problems with infusion|0|||
162732286|NCT01989455|587728566|FG004|Overall Study|Technical problems with infusion|1|||
162732287|NCT00632203|587728567|FG000|Overall Study|Did not start study treatment|1|||
162732288|NCT00632203|587728568|FG001|Overall Study|Did not start study treatment|0|||
162732289|NCT00448669|587728574|FG000|Overall Study|Lost to Follow-up|52|||
162732290|NCT00448669|587728575|FG001|Overall Study|Lost to Follow-up|63|||
162732291|NCT00448669|587728574|FG000|Overall Study|Withdrawal by Subject|90|||
162732292|NCT00448669|587728575|FG001|Overall Study|Withdrawal by Subject|74|||
162732293|NCT00448669|587728574|FG000|Overall Study|Relocated|49|||
162732294|NCT00448669|587728575|FG001|Overall Study|Relocated|36|||
162732295|NCT00448669|587728574|FG000|Overall Study|Were withdrawn by investigator|10|||
162732296|NCT00448669|587728575|FG001|Overall Study|Were withdrawn by investigator|6|||
162732297|NCT00448669|587728574|FG000|Overall Study|Death|2|||
162732298|NCT00448669|587728575|FG001|Overall Study|Death|4|||
162732299|NCT00448669|587728574|FG000|Overall Study|Had other reasons|5|||
162732300|NCT00448669|587728575|FG001|Overall Study|Had other reasons|6|||
162732301|NCT00448669|587728574|FG000|Overall Study|HIV-infected at enrollment|1|||
162732302|NCT00448669|587728575|FG001|Overall Study|HIV-infected at enrollment|2|||
162732303|NCT00448669|587728574|FG000|Overall Study|Never started drug|9|||
162732304|NCT00448669|587728575|FG001|Overall Study|Never started drug|7|||
162732305|NCT04287985|587728576|FG000|Overall Study|Adverse Event|1|||
162732306|NCT04287985|587728577|FG001|Overall Study|Adverse Event|0|||
162732307|NCT04287985|587728578|FG002|Overall Study|Adverse Event|0|||
162732308|NCT04287985|587728579|FG003|Overall Study|Adverse Event|0|||
162732309|NCT04287985|587728576|FG000|Overall Study|Protocol Violation|0|||
162732310|NCT04287985|587728577|FG001|Overall Study|Protocol Violation|1|||
162732311|NCT04287985|587728578|FG002|Overall Study|Protocol Violation|0|||
162732312|NCT04287985|587728579|FG003|Overall Study|Protocol Violation|0|||
162732313|NCT04287985|587728576|FG000|Overall Study|Physician Decision|0|||
162732314|NCT04287985|587728577|FG001|Overall Study|Physician Decision|0|||
162732315|NCT04287985|587728578|FG002|Overall Study|Physician Decision|0|||
162732316|NCT04287985|587728579|FG003|Overall Study|Physician Decision|1|||
162732317|NCT04287985|587728576|FG000|Overall Study|Withdrawal by Subject|2|||
162732318|NCT04287985|587728577|FG001|Overall Study|Withdrawal by Subject|1|||
162732319|NCT04287985|587728578|FG002|Overall Study|Withdrawal by Subject|1|||
162732320|NCT04287985|587728579|FG003|Overall Study|Withdrawal by Subject|2|||
162732321|NCT02638337|587728580|FG000|Overall Study|Adverse Event|6|||
162732322|NCT02638337|587728581|FG001|Overall Study|Adverse Event|10|||
162732323|NCT02638337|587728580|FG000|Overall Study|Protocol Violation|3|||
162732324|NCT02638337|587728581|FG001|Overall Study|Protocol Violation|0|||
162732325|NCT02638337|587728580|FG000|Overall Study|Withdrawal by Subject|13|||
162732326|NCT02638337|587728581|FG001|Overall Study|Withdrawal by Subject|16|||
162732327|NCT02638337|587728580|FG000|Overall Study|Lost to Follow-up|7|||
162732328|NCT02638337|587728581|FG001|Overall Study|Lost to Follow-up|7|||
162732329|NCT02638337|587728580|FG000|Overall Study|Other - Miscellaneous|4|||
162732330|NCT02638337|587728581|FG001|Overall Study|Other - Miscellaneous|3|||
162732331|NCT03771352|587728582|FG000|Overall Study|Screen failure|2|||
162732332|NCT03771352|587728582|FG000|Overall Study|Withdrawal by Subject|2|||
162732333|NCT04315181|587728587|FG000|Overall Study|Non-responsive to drug conditions.|1|||
162732334|NCT01948661|587728588|FG000|Overall Study|Withdrawal by Subject|2|||
162732335|NCT01948661|587728589|FG001|Overall Study|Withdrawal by Subject|4|||
162732336|NCT02886286|587728590|FG000|Overall Study|pump motor stall|0|||
162732337|NCT02886286|587728591|FG001|Overall Study|pump motor stall|1|||
162732338|NCT01127373|587728592|FG000|Overall Study|Not Treated|3|||
162732339|NCT01127373|587728592|FG000|Overall Study|Lost to Follow-up|7|||
162732340|NCT01127373|587728592|FG000|Overall Study|Withdrawal by Subject|1|||
162732341|NCT01127373|587728592|FG000|Overall Study|Disease progression|1|||
162732342|NCT05494788|587728597|FG000|Initial Treatment Period|Adverse Event|2|||
162732343|NCT05494788|587728597|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
162732344|NCT05494788|587728597|FG000|Extension Period|Adverse Event|1|||
162732345|NCT05494788|587728597|FG000|Extension Period|Withdrawal by Subject|1|||
162732346|NCT00136435|587728598|FG000|Overall Study|Ineligible|8|||
162732347|NCT00136435|587728598|FG000|Overall Study|Induction Death|1|||
162732348|NCT00136435|587728598|FG000|Overall Study|Induction Failure|10|||
162732349|NCT00136435|587728598|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
162732350|NCT00136435|587728598|FG000|Overall Study|Withdrawal by Subject|3|||
162732351|NCT00136435|587728598|FG000|Overall Study|Adverse Event|19|||
162732352|NCT00136435|587728598|FG000|Overall Study|Relapse|4|||
162732353|NCT00136435|587728598|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
162732354|NCT00539734|587728599|FG000|Overall Study|Protocol Violation|1|||
162732355|NCT03101930|587728600|FG000|Overall Study|Withdrawal by Subject|2|||
162732356|NCT03101930|587728601|FG001|Overall Study|Withdrawal by Subject|1|||
162732357|NCT03101930|587728602|FG002|Overall Study|Withdrawal by Subject|2|||
162732358|NCT02814838|587728603|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
162732359|NCT02814838|587728604|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
162732360|NCT02814838|587728603|FG000|Overall Study|Consent withdrawal|1|||
162732361|NCT02814838|587728604|FG001|Overall Study|Consent withdrawal|1|||
162732362|NCT01771731|587728605|FG000|Overall Study|Physician Decision|1|||
162732363|NCT01771731|587728606|FG001|Overall Study|Physician Decision|0|||
162732364|NCT01771731|587728605|FG000|Overall Study|Protocol Violation|0|||
162732365|NCT01771731|587728606|FG001|Overall Study|Protocol Violation|1|||
162732366|NCT01771731|587728605|FG000|Overall Study|Adverse event: Pain Crisis|1|||
162732367|NCT01771731|587728606|FG001|Overall Study|Adverse event: Pain Crisis|1|||
162732368|NCT00087139|587728607|FG000|Overall Study|Adverse Event|18|||
162732369|NCT00087139|587728608|FG001|Overall Study|Adverse Event|17|||
162732370|NCT00087139|587728609|FG002|Overall Study|Adverse Event|13|||
162732371|NCT00087139|587728607|FG000|Overall Study|Death|2|||
162732372|NCT00087139|587728608|FG001|Overall Study|Death|1|||
162732373|NCT00087139|587728609|FG002|Overall Study|Death|0|||
162732374|NCT00087139|587728607|FG000|Overall Study|Withdrawal by Subject|3|||
162732375|NCT00087139|587728608|FG001|Overall Study|Withdrawal by Subject|2|||
162732376|NCT00087139|587728609|FG002|Overall Study|Withdrawal by Subject|2|||
162732377|NCT00087139|587728607|FG000|Overall Study|Physician Decision|1|||
162732378|NCT00087139|587728608|FG001|Overall Study|Physician Decision|1|||
162732379|NCT00087139|587728609|FG002|Overall Study|Physician Decision|1|||
162732380|NCT00087139|587728607|FG000|Overall Study|Disease progression|9|||
162732381|NCT00087139|587728608|FG001|Overall Study|Disease progression|19|||
162732382|NCT00087139|587728609|FG002|Overall Study|Disease progression|12|||
162732383|NCT00087139|587728607|FG000|Overall Study|Ineligible|4|||
162732384|NCT00087139|587728608|FG001|Overall Study|Ineligible|7|||
162732385|NCT00087139|587728609|FG002|Overall Study|Ineligible|4|||
162732386|NCT00087139|587728607|FG000|Overall Study|Symptomatic deterioration|1|||
162732387|NCT00087139|587728608|FG001|Overall Study|Symptomatic deterioration|1|||
162732388|NCT00087139|587728609|FG002|Overall Study|Symptomatic deterioration|3|||
162732389|NCT00087139|587728607|FG000|Overall Study|Use of coumadin|1|||
162732390|NCT00087139|587728608|FG001|Overall Study|Use of coumadin|0|||
162732391|NCT00087139|587728609|FG002|Overall Study|Use of coumadin|0|||
162732392|NCT00087139|587728607|FG000|Overall Study|Response achieved|0|||
162732393|NCT00087139|587728608|FG001|Overall Study|Response achieved|1|||
162732394|NCT00087139|587728609|FG002|Overall Study|Response achieved|0|||
162732395|NCT00087139|587728607|FG000|Overall Study|Extradural disease|0|||
162732396|NCT00087139|587728608|FG001|Overall Study|Extradural disease|0|||
162732397|NCT00087139|587728609|FG002|Overall Study|Extradural disease|1|||
162732398|NCT00073749|587728610|FG000|Overall Study|Disease Progression|2|||
162732399|NCT00073749|587728611|FG001|Overall Study|Disease Progression|0|||
162732400|NCT00073749|587728612|FG002|Overall Study|Disease Progression|3|||
162732401|NCT00073749|587728613|FG003|Overall Study|Disease Progression|2|||
162732402|NCT00073749|587728614|FG004|Overall Study|Disease Progression|3|||
162732403|NCT00073749|587728615|FG005|Overall Study|Disease Progression|1|||
162732404|NCT00073749|587728616|FG006|Overall Study|Disease Progression|3|||
162732405|NCT00073749|587728610|FG000|Overall Study|Death|0|||
162732406|NCT00073749|587728611|FG001|Overall Study|Death|1|||
162732407|NCT00073749|587728612|FG002|Overall Study|Death|1|||
162732408|NCT00073749|587728613|FG003|Overall Study|Death|0|||
162732409|NCT00073749|587728614|FG004|Overall Study|Death|0|||
162732410|NCT00073749|587728615|FG005|Overall Study|Death|0|||
162732411|NCT00073749|587728616|FG006|Overall Study|Death|29|||
162732412|NCT00073749|587728610|FG000|Overall Study|Adverse Event|0|||
162732413|NCT00073749|587728611|FG001|Overall Study|Adverse Event|3|||
162732414|NCT00073749|587728612|FG002|Overall Study|Adverse Event|6|||
162732415|NCT00073749|587728613|FG003|Overall Study|Adverse Event|4|||
162732416|NCT00073749|587728614|FG004|Overall Study|Adverse Event|2|||
162732417|NCT00073749|587728615|FG005|Overall Study|Adverse Event|1|||
162732418|NCT00073749|587728616|FG006|Overall Study|Adverse Event|0|||
162732419|NCT00073749|587728610|FG000|Overall Study|Physician Decision|0|||
162732420|NCT00073749|587728611|FG001|Overall Study|Physician Decision|0|||
162732421|NCT00073749|587728612|FG002|Overall Study|Physician Decision|1|||
162732422|NCT00073749|587728613|FG003|Overall Study|Physician Decision|0|||
162732423|NCT00073749|587728614|FG004|Overall Study|Physician Decision|0|||
162732424|NCT00073749|587728615|FG005|Overall Study|Physician Decision|2|||
162732425|NCT00073749|587728616|FG006|Overall Study|Physician Decision|0|||
162732426|NCT00073749|587728610|FG000|Overall Study|Withdrawal by Subject|0|||
162732427|NCT00073749|587728611|FG001|Overall Study|Withdrawal by Subject|1|||
162732428|NCT00073749|587728612|FG002|Overall Study|Withdrawal by Subject|0|||
162732429|NCT00073749|587728613|FG003|Overall Study|Withdrawal by Subject|0|||
162732430|NCT00073749|587728614|FG004|Overall Study|Withdrawal by Subject|1|||
162732431|NCT00073749|587728615|FG005|Overall Study|Withdrawal by Subject|0|||
162732432|NCT00073749|587728616|FG006|Overall Study|Withdrawal by Subject|2|||
162732433|NCT00073749|587728610|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
162732434|NCT00073749|587728611|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162732435|NCT00073749|587728612|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
162732436|NCT00073749|587728613|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
162732437|NCT00073749|587728614|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
162732438|NCT00073749|587728615|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
162732439|NCT00073749|587728616|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
162732440|NCT00073749|587728610|FG000|Overall Study|Lost to Follow-up|0|||
162732441|NCT00073749|587728611|FG001|Overall Study|Lost to Follow-up|0|||
162732442|NCT00073749|587728612|FG002|Overall Study|Lost to Follow-up|0|||
162732443|NCT00073749|587728613|FG003|Overall Study|Lost to Follow-up|0|||
162732444|NCT00073749|587728614|FG004|Overall Study|Lost to Follow-up|0|||
162732445|NCT00073749|587728615|FG005|Overall Study|Lost to Follow-up|0|||
162732446|NCT00073749|587728616|FG006|Overall Study|Lost to Follow-up|2|||
162732447|NCT00073749|587728610|FG000|Overall Study|Other|0|||
162732448|NCT00073749|587728611|FG001|Overall Study|Other|0|||
162732449|NCT00073749|587728612|FG002|Overall Study|Other|0|||
162732450|NCT00073749|587728613|FG003|Overall Study|Other|0|||
162732451|NCT00073749|587728614|FG004|Overall Study|Other|0|||
162732452|NCT00073749|587728615|FG005|Overall Study|Other|2|||
162732453|NCT00073749|587728616|FG006|Overall Study|Other|0|||
162732454|NCT04377308|587728617|FG000|Overall Study|Withdrawal by Subject|0|||
162732455|NCT04377308|587728618|FG001|Overall Study|Withdrawal by Subject|1|||
162732456|NCT00709098|587728622|FG000|Double-blind Period|Withdrawal of consent|3|||
162732457|NCT00709098|587728623|FG001|Double-blind Period|Withdrawal of consent|3|||
162732458|NCT00709098|587728624|FG002|Double-blind Period|Withdrawal of consent|0|||
162732459|NCT00709098|587728622|FG000|Double-blind Period|Administrative reason|1|||
162732460|NCT00709098|587728623|FG001|Double-blind Period|Administrative reason|3|||
162732461|NCT00709098|587728624|FG002|Double-blind Period|Administrative reason|0|||
162732462|NCT00709098|587728622|FG000|Double-blind Period|Death|1|||
162732463|NCT00709098|587728623|FG001|Double-blind Period|Death|1|||
162732464|NCT00709098|587728624|FG002|Double-blind Period|Death|0|||
162732465|NCT00709098|587728622|FG000|Double-blind Period|Lost to Follow-up|1|||
162732466|NCT00709098|587728623|FG001|Double-blind Period|Lost to Follow-up|1|||
162732467|NCT00709098|587728624|FG002|Double-blind Period|Lost to Follow-up|0|||
162732468|NCT00709098|587728622|FG000|Open-label Period|Withdrawal of consent|0|||
162732469|NCT00709098|587728623|FG001|Open-label Period|Withdrawal of consent|0|||
162732470|NCT00709098|587728624|FG002|Open-label Period|Withdrawal of consent|7|||
162732471|NCT00709098|587728622|FG000|Open-label Period|Administrative reason|0|||
162732472|NCT00709098|587728623|FG001|Open-label Period|Administrative reason|0|||
162732473|NCT00709098|587728624|FG002|Open-label Period|Administrative reason|5|||
162732474|NCT00709098|587728622|FG000|Open-label Period|Death|0|||
162732475|NCT00709098|587728623|FG001|Open-label Period|Death|0|||
162732476|NCT00709098|587728624|FG002|Open-label Period|Death|1|||
162732477|NCT00709098|587728622|FG000|Open-label Period|Lost to Follow-up|0|||
162732478|NCT00709098|587728623|FG001|Open-label Period|Lost to Follow-up|0|||
162732479|NCT00709098|587728624|FG002|Open-label Period|Lost to Follow-up|1|||
162732480|NCT00774852|587728625|FG000|Overall Study|Adverse Event|9|||
162732481|NCT00774852|587728626|FG001|Overall Study|Adverse Event|6|||
162732482|NCT00774852|587728625|FG000|Overall Study|Death|2|||
162732483|NCT00774852|587728626|FG001|Overall Study|Death|1|||
162732484|NCT00774852|587728625|FG000|Overall Study|Lack of Efficacy|3|||
162732485|NCT00774852|587728626|FG001|Overall Study|Lack of Efficacy|7|||
162732486|NCT00774852|587728625|FG000|Overall Study|Lost to Follow-up|9|||
162732487|NCT00774852|587728626|FG001|Overall Study|Lost to Follow-up|5|||
162732488|NCT00774852|587728625|FG000|Overall Study|Physician Decision|2|||
162732489|NCT00774852|587728626|FG001|Overall Study|Physician Decision|6|||
162732490|NCT00774852|587728625|FG000|Overall Study|Pregnancy|1|||
162732491|NCT00774852|587728626|FG001|Overall Study|Pregnancy|2|||
162732492|NCT00774852|587728625|FG000|Overall Study|Withdrawal by Subject|2|||
162732493|NCT00774852|587728626|FG001|Overall Study|Withdrawal by Subject|2|||
162732494|NCT00774852|587728625|FG000|Overall Study|Non-responder|15|||
162732495|NCT00774852|587728626|FG001|Overall Study|Non-responder|11|||
162732496|NCT00774852|587728625|FG000|Overall Study|Subject non-compliance|0|||
162732497|NCT00774852|587728626|FG001|Overall Study|Subject non-compliance|1|||
162732498|NCT00774852|587728625|FG000|Overall Study|Protocol Violation|1|||
162732499|NCT00774852|587728626|FG001|Overall Study|Protocol Violation|0|||
162732500|NCT00774852|587728625|FG000|Overall Study|Subject received prohibited medication|1|||
162732501|NCT00774852|587728626|FG001|Overall Study|Subject received prohibited medication|0|||
162732502|NCT04402294|587728631|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
162732503|NCT04402294|587728632|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
162732504|NCT04402294|587728631|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
162732505|NCT04402294|587728632|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
162732506|NCT04459416|587731046|FG000|Overall Study|Lost to Follow-up|2|||
162732507|NCT04459416|587731047|FG001|Overall Study|Lost to Follow-up|0|||
162732508|NCT04459416|587731046|FG000|Overall Study|Withdrawal by Subject|8|||
162732509|NCT04459416|587731047|FG001|Overall Study|Withdrawal by Subject|10|||
162732510|NCT04459416|587731046|FG000|Overall Study|Disease progression|0|||
162732511|NCT04459416|587731047|FG001|Overall Study|Disease progression|3|||
162732512|NCT03744312|587731048|FG000|Overall Study|Withdrawal by Subject|0|||
162732513|NCT03744312|587731049|FG001|Overall Study|Withdrawal by Subject|1|||
162732514|NCT03744312|587731048|FG000|Overall Study|Screen fail|0|||
162732515|NCT03744312|587731049|FG001|Overall Study|Screen fail|1|||
162732516|NCT04059354|587731052|FG000|Overall Study|COVID-19 pandemic|3|||
162732517|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
162732518|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162732519|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162732520|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162732521|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162732522|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
162732523|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
162732524|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162732525|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162732526|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162732527|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
162732528|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
162732529|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162732530|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162732531|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162732532|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
162732533|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162732534|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162732535|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162732536|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162732537|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
162732538|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
162732539|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162732540|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162732541|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162732542|NCT05338086|587731056|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
162732543|NCT05338086|587731057|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
162732544|NCT05338086|587731058|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
162732545|NCT05338086|587731059|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
162732546|NCT05338086|587731060|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
162732547|NCT05338086|587731056|FG000|Transition Period (M12 to M18)|Death|0|||
162732548|NCT05338086|587731057|FG001|Transition Period (M12 to M18)|Death|0|||
162732549|NCT05338086|587731058|FG002|Transition Period (M12 to M18)|Death|1|||
162732550|NCT05338086|587731059|FG003|Transition Period (M12 to M18)|Death|0|||
162732551|NCT05338086|587731060|FG004|Transition Period (M12 to M18)|Death|0|||
162732552|NCT05338086|587731056|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
162732553|NCT05338086|587731057|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
162732554|NCT05338086|587731058|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
162732555|NCT05338086|587731059|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
162732556|NCT05338086|587731060|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
162732557|NCT05338086|587731056|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
162732558|NCT05338086|587731057|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
162732559|NCT05338086|587731058|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
162732560|NCT05338086|587731059|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
162732561|NCT05338086|587731060|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
162732562|NCT05338086|587731056|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
162732563|NCT05338086|587731057|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
162732564|NCT05338086|587731058|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
162732565|NCT05338086|587731059|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
162732566|NCT05338086|587731060|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
162732567|NCT03424811|587731061|FG000|Overall Study|Lost to Follow-up|9|||
162732568|NCT03424811|587731062|FG001|Overall Study|Lost to Follow-up|0|||
162732569|NCT05387447|587731069|FG000|Overall Study|Participants changed their minds about study participation.|3|||
162732570|NCT05387447|587731070|FG001|Overall Study|Participants changed their minds about study participation.|5|||
162732571|NCT01673984|587731071|FG000|Overall Study|Adverse Event|1|||
162732572|NCT01673984|587731072|FG001|Overall Study|Adverse Event|0|||
162732573|NCT01673984|587731071|FG000|Overall Study|Study termination|9|||
162732574|NCT01673984|587731072|FG001|Overall Study|Study termination|6|||
162732575|NCT04178733|587731073|FG000|Overall Study|Investigator Decision|0|||
162732576|NCT04178733|587731074|FG001|Overall Study|Investigator Decision|0|||
162732577|NCT04178733|587731075|FG002|Overall Study|Investigator Decision|0|||
162732578|NCT04178733|587731076|FG003|Overall Study|Investigator Decision|1|||
162732579|NCT04178733|587731077|FG004|Overall Study|Investigator Decision|2|||
162732580|NCT03655132|587731082|FG000|Overall Study|Lost to Follow-up|2|||
162732581|NCT03655132|587731083|FG001|Overall Study|Lost to Follow-up|1|||
162732582|NCT03655132|587731082|FG000|Overall Study|Withdrawal by Subject|0|||
162732583|NCT03655132|587731083|FG001|Overall Study|Withdrawal by Subject|1|||
162732584|NCT03655132|587731082|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
162732585|NCT03655132|587731083|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
162732586|NCT02651324|587731085|FG000|Overall Study|drug not administered, due dispensing issue|1|||
162732587|NCT02651324|587731086|FG001|Overall Study|drug not administered, due dispensing issue|0|||
162732588|NCT05919082|587731089|FG000|Overall Study|Adverse Event|3|||
162732589|NCT05919082|587731090|FG001|Overall Study|Adverse Event|0|||
162732590|NCT05919082|587731089|FG000|Overall Study|Lost to Follow-up|0|||
162732591|NCT05919082|587731090|FG001|Overall Study|Lost to Follow-up|1|||
162732592|NCT05919082|587731089|FG000|Overall Study|Withdrawal by Subject|8|||
162732593|NCT05919082|587731090|FG001|Overall Study|Withdrawal by Subject|9|||
162732594|NCT05919082|587731089|FG000|Overall Study|Lack of Efficacy|0|||
162732595|NCT05919082|587731090|FG001|Overall Study|Lack of Efficacy|1|||
162732596|NCT05919082|587731089|FG000|Overall Study|Investigator Decision|1|||
162732597|NCT05919082|587731090|FG001|Overall Study|Investigator Decision|0|||
162732598|NCT04437433|587731103|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
162732599|NCT04437433|587731104|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
162732600|NCT04437433|587731103|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
162732601|NCT04437433|587731104|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
162732602|NCT04437433|587731103|FG000|Overall Study|Adverse Event|9|||
162732603|NCT04437433|587731104|FG001|Overall Study|Adverse Event|0|||
162732604|NCT04437433|587731103|FG000|Overall Study|Lack of Efficacy|4|||
162732605|NCT04437433|587731104|FG001|Overall Study|Lack of Efficacy|0|||
162732606|NCT04437433|587731103|FG000|Overall Study|Withdrawal by Subject|4|||
162732607|NCT04437433|587731104|FG001|Overall Study|Withdrawal by Subject|1|||
162732608|NCT04437433|587731103|FG000|Overall Study|Protocol Deviation|0|||
162732609|NCT04437433|587731104|FG001|Overall Study|Protocol Deviation|1|||
162732610|NCT04437433|587731103|FG000|Overall Study|Other, not specified|0|||
162732611|NCT04437433|587731104|FG001|Overall Study|Other, not specified|1|||
162732612|NCT04711135|587731105|FG000|Overall Study|Physician Decision|0|||
162732613|NCT04711135|587731106|FG001|Overall Study|Physician Decision|1|||
162732614|NCT04711135|587731105|FG000|Overall Study|Ongoing treatment|0|||
162732615|NCT04711135|587731106|FG001|Overall Study|Ongoing treatment|1|||
162732616|NCT03578536|587731107|FG000|Overall Study|Lost to Follow-up|1|||
162732617|NCT03732820|587731108|FG000|Overall Study|Death|168|||
162732618|NCT03732820|587731109|FG001|Overall Study|Death|203|||
162732619|NCT03732820|587731108|FG000|Overall Study|Other|2|||
162732620|NCT03732820|587731109|FG001|Overall Study|Other|2|||
162732621|NCT03732820|587731108|FG000|Overall Study|Failure to meet randomisation criteria|1|||
162732622|NCT03732820|587731109|FG001|Overall Study|Failure to meet randomisation criteria|1|||
162732623|NCT03732820|587731108|FG000|Overall Study|Patient decision|14|||
162732624|NCT03732820|587731109|FG001|Overall Study|Patient decision|10|||
162732625|NCT03732820|587731108|FG000|Overall Study|Screen failure|0|||
162732626|NCT03732820|587731109|FG001|Overall Study|Screen failure|1|||
162732627|NCT03732820|587731108|FG000|Overall Study|Patients ongoing study at data cut off|210|||
162732628|NCT03732820|587731109|FG001|Overall Study|Patients ongoing study at data cut off|178|||
162732629|NCT03732820|587731108|FG000|Overall Study|Lost to Follow-up|4|||
162732630|NCT03732820|587731109|FG001|Overall Study|Lost to Follow-up|2|||
162732631|NCT04436107|587731110|FG000|Overall Study|Sponsor Ended Study|2|||
162732632|NCT04436107|587731111|FG001|Overall Study|Sponsor Ended Study|4|||
162732633|NCT04436107|587731112|FG002|Overall Study|Sponsor Ended Study|8|||
162732634|NCT04436107|587731113|FG003|Overall Study|Sponsor Ended Study|20|||
162732635|NCT04436107|587731110|FG000|Overall Study|Death|3|||
162732636|NCT04436107|587731111|FG001|Overall Study|Death|5|||
162732637|NCT04436107|587731112|FG002|Overall Study|Death|3|||
162732638|NCT04436107|587731113|FG003|Overall Study|Death|18|||
162732639|NCT04436107|587731110|FG000|Overall Study|Withdrawal by Subject|1|||
162732640|NCT04436107|587731111|FG001|Overall Study|Withdrawal by Subject|1|||
162732641|NCT04436107|587731112|FG002|Overall Study|Withdrawal by Subject|0|||
162732642|NCT04436107|587731113|FG003|Overall Study|Withdrawal by Subject|1|||
162732643|NCT00999167|587731116|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
162732644|NCT00999167|587731117|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
162732645|NCT00999167|587731118|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
162732646|NCT00999167|587731116|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
162732647|NCT00999167|587731117|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
162732648|NCT00999167|587731118|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
162732649|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
162732650|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
162732651|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
162732652|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
162732653|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
162732654|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
162732655|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
162732656|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
162732657|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
162732658|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
162732659|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
162732660|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
162732661|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
162732662|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
162732663|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
162732664|NCT00999167|587731116|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
162732665|NCT00999167|587731117|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
162732666|NCT00999167|587731118|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
162732667|NCT01340066|587731125|FG000|Placebo Run in Period|Screen Failures|27|||
162732668|NCT01340066|587731126|FG001|Placebo Run in Period|Screen Failures|0|||
162732669|NCT01340066|587731127|FG002|Placebo Run in Period|Screen Failures|0|||
162732670|NCT01340066|587731125|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
162732671|NCT01340066|587731126|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
162732672|NCT01340066|587731127|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
162732673|NCT01340066|587731125|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
162732674|NCT01340066|587731126|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
162732675|NCT01340066|587731127|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
162732676|NCT01340066|587731125|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
162732677|NCT01340066|587731126|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
162732678|NCT01340066|587731127|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
162732679|NCT02789020|587731128|FG000|Overall Study|Withdrawal by Subject|6|||
162732680|NCT02789020|587731129|FG001|Overall Study|Withdrawal by Subject|5|||
162732681|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162732682|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162732683|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
162732684|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162732685|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
162732686|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
162732687|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
162732688|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
162732689|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162732690|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162732691|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
162732692|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162732693|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162732694|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162732695|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
162732696|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162732697|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
162732698|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
162732699|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
162732700|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
162732701|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
162732702|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
162732703|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
162732704|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
162732705|NCT03338816|587731132|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162732706|NCT03338816|587731133|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162732707|NCT03338816|587731134|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162732708|NCT03338816|587731135|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
162732709|NCT04238247|587731136|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
162732710|NCT04238247|587731137|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
162732711|NCT04238247|587731138|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
162732712|NCT04238247|587731139|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
162732713|NCT04238247|587731136|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
162732714|NCT04238247|587731137|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
162732715|NCT04238247|587731138|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
162732716|NCT04238247|587731139|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
162732717|NCT04238247|587731136|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
162732718|NCT04238247|587731137|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
162732719|NCT04238247|587731138|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
162732720|NCT04238247|587731139|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
162732721|NCT04238247|587731136|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
162732722|NCT04238247|587731137|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
162732723|NCT04238247|587731138|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
162732724|NCT04238247|587731139|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
162732725|NCT05512962|587731140|FG000|Overall Study|Withdrawal by Subject|1|||
162732726|NCT05512962|587731141|FG001|Overall Study|Withdrawal by Subject|0|||
162732727|NCT04950127|587731142|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
162732728|NCT04950127|587731143|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
162732729|NCT04950127|587731144|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
162732730|NCT04950127|587731145|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
162732731|NCT04950127|587731146|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
162732732|NCT04950127|587731147|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
162732733|NCT04950127|587731142|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
162732734|NCT04950127|587731143|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
162732735|NCT04950127|587731144|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
162732736|NCT04950127|587731145|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
162732737|NCT04950127|587731146|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
162732738|NCT04950127|587731147|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
162732739|NCT04950127|587731142|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
162732740|NCT04950127|587731143|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
162732741|NCT04950127|587731144|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162732742|NCT04950127|587731145|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162732743|NCT04950127|587731146|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162732744|NCT04950127|587731147|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162732745|NCT04950127|587731142|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162732746|NCT04950127|587731143|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162732747|NCT04950127|587731144|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162732748|NCT04950127|587731145|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162732749|NCT04950127|587731146|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162732750|NCT04950127|587731147|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
162732751|NCT04950127|587731142|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
162732752|NCT04950127|587731143|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
162732753|NCT04950127|587731144|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
162732754|NCT04950127|587731145|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
162732755|NCT04950127|587731146|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
162732756|NCT04950127|587731147|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
162732757|NCT01711632|587731148|FG000|Overall Study|Adverse Event|4|||
162732758|NCT01711632|587731148|FG000|Overall Study|Death|3|||
162732759|NCT01711632|587731148|FG000|Overall Study|Lost to Follow-up|3|||
162732760|NCT01711632|587731148|FG000|Overall Study|Withdrawal by Subject|4|||
162732761|NCT01711632|587731148|FG000|Overall Study|Progressive disease|2|||
162732762|NCT01711632|587731148|FG000|Overall Study|No follow up required in re-treatment|3|||
162732763|NCT01711632|587731148|FG000|Overall Study|No follow up required in re-treatment|3|||
162732764|NCT03517969|587731149|FG000|Overall Study|Never started protocol treatment|3|||
162732765|NCT03517969|587731150|FG001|Overall Study|Never started protocol treatment|5|||
162732766|NCT03517969|587731149|FG000|Overall Study|Disease progression|11|||
162732767|NCT03517969|587731150|FG001|Overall Study|Disease progression|16|||
162732768|NCT03517969|587731149|FG000|Overall Study|PSA progression|8|||
162732769|NCT03517969|587731150|FG001|Overall Study|PSA progression|1|||
162732770|NCT03517969|587731149|FG000|Overall Study|Clinical progression|4|||
162732771|NCT03517969|587731150|FG001|Overall Study|Clinical progression|2|||
162732772|NCT03517969|587731149|FG000|Overall Study|Adverse Event|5|||
162732773|NCT03517969|587731150|FG001|Overall Study|Adverse Event|4|||
162732774|NCT03517969|587731149|FG000|Overall Study|Intercurrent illness|1|||
162732775|NCT03517969|587731150|FG001|Overall Study|Intercurrent illness|2|||
162732776|NCT03517969|587731149|FG000|Overall Study|Death|1|||
162732777|NCT03517969|587731150|FG001|Overall Study|Death|1|||
162732778|NCT03517969|587731149|FG000|Overall Study|Withdrawal by Subject|1|||
162732779|NCT03517969|587731150|FG001|Overall Study|Withdrawal by Subject|2|||
162732780|NCT03517969|587731149|FG000|Overall Study|Physician Decision|1|||
162732781|NCT03517969|587731150|FG001|Overall Study|Physician Decision|1|||
162732782|NCT03517969|587731149|FG000|Overall Study|No clinical benefit|1|||
162732783|NCT03517969|587731150|FG001|Overall Study|No clinical benefit|0|||
162732784|NCT03517969|587731149|FG000|Overall Study|Delayed treatment for dental treatment|1|||
162732785|NCT03517969|587731150|FG001|Overall Study|Delayed treatment for dental treatment|0|||
162732786|NCT03517969|587731149|FG000|Overall Study|Difficult to maintain appointment|0|||
162732787|NCT03517969|587731150|FG001|Overall Study|Difficult to maintain appointment|1|||
162732788|NCT03517969|587731149|FG000|Overall Study|Protocol Violation|0|||
162732789|NCT03517969|587731150|FG001|Overall Study|Protocol Violation|1|||
162732790|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Adverse Event|4|||
162732791|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Adverse Event|1|||
162732792|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
162732793|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
162732794|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
162732795|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
162732796|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
162732797|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
162732798|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
162732799|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
162732800|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Other|6|||
162732801|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Other|1|||
162732802|NCT03271489|587731151|FG000|Double-Blind (DB) Period|Missing|1|||
162732803|NCT03271489|587731152|FG001|Double-Blind (DB) Period|Missing|0|||
162732804|NCT03271489|587731151|FG000|Open-Label (OL) Period|Adverse Event|2|||
162732805|NCT03271489|587731152|FG001|Open-Label (OL) Period|Adverse Event|0|||
162732806|NCT03271489|587731151|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
162732807|NCT03271489|587731152|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
162732808|NCT03271489|587731151|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
162732809|NCT03271489|587731152|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
162732810|NCT03271489|587731151|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
162732811|NCT03271489|587731152|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
162732812|NCT03271489|587731151|FG000|Open-Label (OL) Period|No Specified|2|||
162732813|NCT03271489|587731152|FG001|Open-Label (OL) Period|No Specified|2|||
162732814|NCT03271489|587731151|FG000|Open-Label (OL) Period|Missing|2|||
162732815|NCT03271489|587731152|FG001|Open-Label (OL) Period|Missing|0|||
162732816|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
162732817|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
162732818|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
162732819|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
162732820|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
162732821|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
162732822|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
162732823|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
162732824|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
162732825|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
162732826|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
162732827|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
162732828|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
162732829|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
162732830|NCT03271489|587731151|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
162732831|NCT03271489|587731152|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
162732832|NCT02860130|587731153|FG000|Overall Study|Adverse Event|2|||
162732833|NCT02860130|587731154|FG001|Overall Study|Adverse Event|3|||
162732834|NCT02860130|587731153|FG000|Overall Study|Protocol Violation|1|||
162732835|NCT02860130|587731154|FG001|Overall Study|Protocol Violation|1|||
162732836|NCT02860130|587731153|FG000|Overall Study|Withdrawal by Subject|0|||
162732837|NCT02860130|587731154|FG001|Overall Study|Withdrawal by Subject|2|||
162732838|NCT02860130|587731153|FG000|Overall Study|Physician Decision|2|||
162732839|NCT02860130|587731154|FG001|Overall Study|Physician Decision|2|||
162732840|NCT02860130|587731153|FG000|Overall Study|Other|2|||
162732841|NCT02860130|587731154|FG001|Overall Study|Other|1|||
162732842|NCT00522951|587731157|FG000|Period 1|body motion|0|||
162732843|NCT00522951|587731158|FG001|Period 1|body motion|1|||
162732844|NCT00522951|587731157|FG000|Washout Period|Adverse Event|0|||
162732845|NCT00522951|587731158|FG001|Washout Period|Adverse Event|1|||
162732846|NCT00522951|587731157|FG000|Washout Period|Death|0|||
162732847|NCT00522951|587731158|FG001|Washout Period|Death|1|||
162732848|NCT00522951|587731157|FG000|Period 2|Withdrawal by Subject|1|||
162732849|NCT00522951|587731158|FG001|Period 2|Withdrawal by Subject|0|||
162732850|NCT00522951|587731157|FG000|Period 2|residual contrast medium|1|||
162732851|NCT00522951|587731158|FG001|Period 2|residual contrast medium|1|||
162732852|NCT02140645|587731161|FG000|Overall Study|Not linked|5489|||
162732853|NCT02140645|587731162|FG001|Overall Study|Not linked|61654|||
162732854|NCT02140645|587731163|FG002|Overall Study|Not linked|4236|||
162732855|NCT02140645|587731164|FG003|Overall Study|Not linked|13833|||
162732856|NCT02140645|587731165|FG004|Overall Study|Not linked|3286|||
162732857|NCT02140645|587731166|FG005|Overall Study|Not linked|70896|||
162732858|NCT01101451|587731167|FG000|Overall Study|Eligible and never treated|0|||
162732859|NCT01101451|587731168|FG001|Overall Study|Eligible and never treated|5|||
162732860|NCT01101451|587731167|FG000|Overall Study|Ineligible and treated|12|||
162732861|NCT01101451|587731168|FG001|Overall Study|Ineligible and treated|8|||
162732862|NCT01101451|587731167|FG000|Overall Study|Ineligible and never treated|2|||
162732863|NCT01101451|587731168|FG001|Overall Study|Ineligible and never treated|2|||
162732864|NCT00390299|587731173|FG000|Overall Study|Cancellation|1|||
162732865|NCT00390299|587731174|FG001|Overall Study|Cancellation|0|||
162732866|NCT00390299|587731175|FG002|Overall Study|Cancellation|0|||
162732867|NCT00390299|587731176|FG003|Overall Study|Cancellation|0|||
162732868|NCT00390299|587731177|FG004|Overall Study|Cancellation|0|||
162732869|NCT02965846|587731179|FG000|Overall Study|Lost to Follow-up|1|||
162732870|NCT02965846|587731180|FG001|Overall Study|Lost to Follow-up|0|||
162732871|NCT02965846|587731181|FG002|Overall Study|Lost to Follow-up|0|||
162732872|NCT02965846|587731179|FG000|Overall Study|Withdrawal by Subject|0|||
162732873|NCT02965846|587731180|FG001|Overall Study|Withdrawal by Subject|1|||
162732874|NCT02965846|587731181|FG002|Overall Study|Withdrawal by Subject|0|||
162732875|NCT02965846|587731179|FG000|Overall Study|Study Terminated By Sponsor|4|||
162732876|NCT02965846|587731180|FG001|Overall Study|Study Terminated By Sponsor|4|||
162732877|NCT02965846|587731181|FG002|Overall Study|Study Terminated By Sponsor|0|||
162732878|NCT02965846|587731179|FG000|Overall Study|Participants not randomized|0|||
162732879|NCT02965846|587731180|FG001|Overall Study|Participants not randomized|0|||
162732880|NCT02965846|587731181|FG002|Overall Study|Participants not randomized|33|||
162732881|NCT02794480|587731182|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162732882|NCT02794480|587731183|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162732883|NCT02794480|587731184|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
162732884|NCT02794480|587731185|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162732885|NCT02794480|587731182|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162732886|NCT02794480|587731183|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162732887|NCT02794480|587731184|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
162732888|NCT02794480|587731185|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162732889|NCT02794480|587731182|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162732890|NCT02794480|587731183|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162732891|NCT02794480|587731184|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162732892|NCT02794480|587731185|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
162732893|NCT02794480|587731182|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162732894|NCT02794480|587731183|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
162732895|NCT02794480|587731184|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162732896|NCT02794480|587731185|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162732897|NCT02794480|587731182|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162732898|NCT02794480|587731183|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162732899|NCT02794480|587731184|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162732900|NCT02794480|587731185|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162732901|NCT01070069|587731186|FG000|Overall Study|Death|1|||
162732902|NCT01070069|587731187|FG001|Overall Study|Death|0|||
162732903|NCT01070069|587731188|FG002|Overall Study|Death|2|||
162732904|NCT01070069|587731189|FG003|Overall Study|Death|0|||
162732905|NCT01070069|587731190|FG004|Overall Study|Death|1|||
162732906|NCT01070069|587731186|FG000|Overall Study|Withdrawal by Subject|1|||
162732907|NCT01070069|587731187|FG001|Overall Study|Withdrawal by Subject|1|||
162732908|NCT01070069|587731188|FG002|Overall Study|Withdrawal by Subject|4|||
162732909|NCT01070069|587731189|FG003|Overall Study|Withdrawal by Subject|0|||
162732910|NCT01070069|587731190|FG004|Overall Study|Withdrawal by Subject|0|||
162732911|NCT01070069|587731186|FG000|Overall Study|Lost to Follow-up|4|||
162732912|NCT01070069|587731187|FG001|Overall Study|Lost to Follow-up|1|||
162732913|NCT01070069|587731188|FG002|Overall Study|Lost to Follow-up|0|||
162732914|NCT01070069|587731189|FG003|Overall Study|Lost to Follow-up|0|||
162732915|NCT01070069|587731190|FG004|Overall Study|Lost to Follow-up|3|||
162732916|NCT01747486|587731191|FG000|Stage 1|Physician Decision|3|||
162732917|NCT01747486|587731192|FG001|Stage 1|Physician Decision|0|||
162732918|NCT01747486|587731191|FG000|Stage 1|Withdrawal by Subject|4|||
162732919|NCT01747486|587731192|FG001|Stage 1|Withdrawal by Subject|3|||
162732920|NCT01747486|587731191|FG000|Stage 1|Disease progression|4|||
162732921|NCT01747486|587731192|FG001|Stage 1|Disease progression|9|||
162732922|NCT01747486|587731191|FG000|Stage 1|Death|1|||
162732923|NCT01747486|587731192|FG001|Stage 1|Death|1|||
162732924|NCT01747486|587731191|FG000|Stage 2|Physician Decision|2|||
162732925|NCT01747486|587731192|FG001|Stage 2|Physician Decision|0|||
162732926|NCT01747486|587731191|FG000|Stage 2|Withdrawal by Subject|1|||
162732927|NCT01747486|587731192|FG001|Stage 2|Withdrawal by Subject|0|||
162732928|NCT01747486|587731191|FG000|Stage 2|New Cancer Therapy|3|||
162732929|NCT01747486|587731192|FG001|Stage 2|New Cancer Therapy|0|||
162732930|NCT01747486|587731191|FG000|Stage 2|Disease Progression|3|||
162732931|NCT01747486|587731192|FG001|Stage 2|Disease Progression|0|||
162732932|NCT00632749|587731193|FG000|Overall Study|Progressive disease|3|||
162732933|NCT00632749|587731194|FG001|Overall Study|Progressive disease|2|||
162732934|NCT00632749|587731195|FG002|Overall Study|Progressive disease|2|||
162732935|NCT00632749|587731196|FG003|Overall Study|Progressive disease|2|||
162732936|NCT00632749|587731197|FG004|Overall Study|Progressive disease|4|||
162732937|NCT00632749|587731198|FG005|Overall Study|Progressive disease|4|||
162732938|NCT00632749|587731199|FG006|Overall Study|Progressive disease|3|||
162732939|NCT00632749|587731200|FG007|Overall Study|Progressive disease|2|||
162732940|NCT00632749|587731201|FG008|Overall Study|Progressive disease|3|||
162732941|NCT00632749|587731202|FG009|Overall Study|Progressive disease|2|||
162732942|NCT00632749|587731203|FG010|Overall Study|Progressive disease|4|||
162732943|NCT00632749|587731204|FG011|Overall Study|Progressive disease|3|||
162732944|NCT00632749|587731205|FG012|Overall Study|Progressive disease|2|||
162732945|NCT00632749|587731206|FG013|Overall Study|Progressive disease|4|||
162732946|NCT00632749|587731193|FG000|Overall Study|Other Adverse event|1|||
162732947|NCT00632749|587731194|FG001|Overall Study|Other Adverse event|1|||
162732948|NCT00632749|587731195|FG002|Overall Study|Other Adverse event|1|||
162732949|NCT00632749|587731196|FG003|Overall Study|Other Adverse event|1|||
162732950|NCT00632749|587731197|FG004|Overall Study|Other Adverse event|2|||
162732951|NCT00632749|587731198|FG005|Overall Study|Other Adverse event|4|||
162732952|NCT00632749|587731199|FG006|Overall Study|Other Adverse event|1|||
162732953|NCT00632749|587731200|FG007|Overall Study|Other Adverse event|2|||
162732954|NCT00632749|587731201|FG008|Overall Study|Other Adverse event|2|||
162732955|NCT00632749|587731202|FG009|Overall Study|Other Adverse event|0|||
162732956|NCT00632749|587731203|FG010|Overall Study|Other Adverse event|1|||
162732957|NCT00632749|587731204|FG011|Overall Study|Other Adverse event|0|||
162732958|NCT00632749|587731205|FG012|Overall Study|Other Adverse event|1|||
162732959|NCT00632749|587731206|FG013|Overall Study|Other Adverse event|0|||
162732960|NCT00632749|587731193|FG000|Overall Study|Refuse to continue medication|0|||
162732961|NCT00632749|587731194|FG001|Overall Study|Refuse to continue medication|0|||
162732962|NCT00632749|587731195|FG002|Overall Study|Refuse to continue medication|0|||
162732963|NCT00632749|587731196|FG003|Overall Study|Refuse to continue medication|1|||
162732964|NCT00632749|587731197|FG004|Overall Study|Refuse to continue medication|0|||
162732965|NCT00632749|587731198|FG005|Overall Study|Refuse to continue medication|0|||
162732966|NCT00632749|587731199|FG006|Overall Study|Refuse to continue medication|0|||
162732967|NCT00632749|587731200|FG007|Overall Study|Refuse to continue medication|0|||
162732968|NCT00632749|587731201|FG008|Overall Study|Refuse to continue medication|0|||
162732969|NCT00632749|587731202|FG009|Overall Study|Refuse to continue medication|1|||
162732970|NCT00632749|587731203|FG010|Overall Study|Refuse to continue medication|0|||
162732971|NCT00632749|587731204|FG011|Overall Study|Refuse to continue medication|0|||
162732972|NCT00632749|587731205|FG012|Overall Study|Refuse to continue medication|0|||
162732973|NCT00632749|587731206|FG013|Overall Study|Refuse to continue medication|0|||
162732974|NCT00632749|587731193|FG000|Overall Study|Reason other than those specified above|0|||
162732975|NCT00632749|587731194|FG001|Overall Study|Reason other than those specified above|2|||
162732976|NCT00632749|587731195|FG002|Overall Study|Reason other than those specified above|0|||
162732977|NCT00632749|587731196|FG003|Overall Study|Reason other than those specified above|0|||
162732978|NCT00632749|587731197|FG004|Overall Study|Reason other than those specified above|1|||
162732979|NCT00632749|587731198|FG005|Overall Study|Reason other than those specified above|0|||
162732980|NCT00632749|587731199|FG006|Overall Study|Reason other than those specified above|1|||
162732981|NCT00632749|587731200|FG007|Overall Study|Reason other than those specified above|0|||
162732982|NCT00632749|587731201|FG008|Overall Study|Reason other than those specified above|0|||
162732983|NCT00632749|587731202|FG009|Overall Study|Reason other than those specified above|0|||
162732984|NCT00632749|587731203|FG010|Overall Study|Reason other than those specified above|2|||
162732985|NCT00632749|587731204|FG011|Overall Study|Reason other than those specified above|1|||
162732986|NCT00632749|587731205|FG012|Overall Study|Reason other than those specified above|0|||
162732987|NCT00632749|587731206|FG013|Overall Study|Reason other than those specified above|2|||
162732988|NCT00611559|587731207|FG000|Overall Study|Lost to Follow-up|0|||
162732989|NCT00611559|587731208|FG001|Overall Study|Lost to Follow-up|1|||
162732990|NCT00611559|587731209|FG002|Overall Study|Lost to Follow-up|0|||
162732991|NCT00611559|587731207|FG000|Overall Study|Protocol Violation|1|||
162732992|NCT00611559|587731208|FG001|Overall Study|Protocol Violation|0|||
162732993|NCT00611559|587731209|FG002|Overall Study|Protocol Violation|1|||
162732994|NCT00879333|587731210|FG000|Overall Study|Adverse Event|94|||
162732995|NCT00879333|587731211|FG001|Overall Study|Adverse Event|34|||
162732996|NCT00879333|587731210|FG000|Overall Study|Abnormal Laboratory Value|1|||
162732997|NCT00879333|587731211|FG001|Overall Study|Abnormal Laboratory Value|0|||
162732998|NCT00879333|587731210|FG000|Overall Study|Withdrawal by Subject|20|||
162732999|NCT00879333|587731211|FG001|Overall Study|Withdrawal by Subject|7|||
162733000|NCT00879333|587731210|FG000|Overall Study|Lost to Follow-up|2|||
162733001|NCT00879333|587731211|FG001|Overall Study|Lost to Follow-up|1|||
162733002|NCT00879333|587731210|FG000|Overall Study|Administrative Problems|2|||
162733003|NCT00879333|587731211|FG001|Overall Study|Administrative Problems|0|||
162733004|NCT00879333|587731210|FG000|Overall Study|Death|16|||
162733005|NCT00879333|587731211|FG001|Overall Study|Death|5|||
162733006|NCT00879333|587731210|FG000|Overall Study|Disease Progression|292|||
162733007|NCT00879333|587731211|FG001|Overall Study|Disease Progression|169|||
162733008|NCT00879333|587731210|FG000|Overall Study|Protocol Violation|1|||
162733009|NCT00879333|587731211|FG001|Overall Study|Protocol Violation|1|||
162733010|NCT02671435|587731212|FG000|Overall Study|Death|1|||
162733011|NCT02671435|587731213|FG001|Overall Study|Death|3|||
162733012|NCT02671435|587731214|FG002|Overall Study|Death|0|||
162733013|NCT02671435|587731215|FG003|Overall Study|Death|16|||
162733014|NCT02671435|587731216|FG004|Overall Study|Death|14|||
162733015|NCT02671435|587731217|FG005|Overall Study|Death|29|||
162733016|NCT02671435|587731218|FG006|Overall Study|Death|34|||
162733017|NCT02671435|587731219|FG007|Overall Study|Death|28|||
162733018|NCT02671435|587731220|FG008|Overall Study|Death|19|||
162733019|NCT02671435|587731221|FG009|Overall Study|Death|10|||
162733020|NCT02671435|587731222|FG010|Overall Study|Death|8|||
162733021|NCT02671435|587731223|FG011|Overall Study|Death|29|||
162733022|NCT02671435|587731224|FG012|Overall Study|Death|29|||
162733023|NCT02671435|587731225|FG013|Overall Study|Death|29|||
162733024|NCT02671435|587731226|FG014|Overall Study|Death|27|||
162733025|NCT02671435|587731212|FG000|Overall Study|Lost to Follow-up|0|||
162733026|NCT02671435|587731213|FG001|Overall Study|Lost to Follow-up|0|||
162733027|NCT02671435|587731214|FG002|Overall Study|Lost to Follow-up|1|||
162733028|NCT02671435|587731215|FG003|Overall Study|Lost to Follow-up|0|||
162733029|NCT02671435|587731216|FG004|Overall Study|Lost to Follow-up|1|||
162733030|NCT02671435|587731217|FG005|Overall Study|Lost to Follow-up|1|||
162733031|NCT02671435|587731218|FG006|Overall Study|Lost to Follow-up|2|||
162733032|NCT02671435|587731219|FG007|Overall Study|Lost to Follow-up|2|||
162733033|NCT02671435|587731220|FG008|Overall Study|Lost to Follow-up|0|||
162733034|NCT02671435|587731221|FG009|Overall Study|Lost to Follow-up|2|||
162733035|NCT02671435|587731222|FG010|Overall Study|Lost to Follow-up|0|||
162733036|NCT02671435|587731223|FG011|Overall Study|Lost to Follow-up|3|||
162733037|NCT02671435|587731224|FG012|Overall Study|Lost to Follow-up|3|||
162733038|NCT02671435|587731225|FG013|Overall Study|Lost to Follow-up|2|||
162733039|NCT02671435|587731226|FG014|Overall Study|Lost to Follow-up|0|||
162733040|NCT02671435|587731212|FG000|Overall Study|Withdrawal by Subject|2|||
162733041|NCT02671435|587731213|FG001|Overall Study|Withdrawal by Subject|0|||
162733042|NCT02671435|587731214|FG002|Overall Study|Withdrawal by Subject|2|||
162733043|NCT02671435|587731215|FG003|Overall Study|Withdrawal by Subject|2|||
162733044|NCT02671435|587731216|FG004|Overall Study|Withdrawal by Subject|2|||
162733045|NCT02671435|587731217|FG005|Overall Study|Withdrawal by Subject|7|||
162733046|NCT02671435|587731218|FG006|Overall Study|Withdrawal by Subject|2|||
162733047|NCT02671435|587731219|FG007|Overall Study|Withdrawal by Subject|7|||
162733048|NCT02671435|587731220|FG008|Overall Study|Withdrawal by Subject|1|||
162733049|NCT02671435|587731221|FG009|Overall Study|Withdrawal by Subject|1|||
162733050|NCT02671435|587731222|FG010|Overall Study|Withdrawal by Subject|2|||
162733051|NCT02671435|587731223|FG011|Overall Study|Withdrawal by Subject|4|||
162733052|NCT02671435|587731224|FG012|Overall Study|Withdrawal by Subject|4|||
162733053|NCT02671435|587731225|FG013|Overall Study|Withdrawal by Subject|4|||
162733054|NCT02671435|587731226|FG014|Overall Study|Withdrawal by Subject|2|||
162733055|NCT02671435|587731212|FG000|Overall Study|Un-specified|0|||
162733056|NCT02671435|587731213|FG001|Overall Study|Un-specified|0|||
162733057|NCT02671435|587731214|FG002|Overall Study|Un-specified|0|||
162733058|NCT02671435|587731215|FG003|Overall Study|Un-specified|0|||
162733059|NCT02671435|587731216|FG004|Overall Study|Un-specified|1|||
162733060|NCT02671435|587731217|FG005|Overall Study|Un-specified|3|||
162733061|NCT02671435|587731218|FG006|Overall Study|Un-specified|2|||
162733062|NCT02671435|587731219|FG007|Overall Study|Un-specified|3|||
162733063|NCT02671435|587731220|FG008|Overall Study|Un-specified|0|||
162733064|NCT02671435|587731221|FG009|Overall Study|Un-specified|5|||
162733065|NCT02671435|587731222|FG010|Overall Study|Un-specified|8|||
162733066|NCT02671435|587731223|FG011|Overall Study|Un-specified|4|||
162733067|NCT02671435|587731224|FG012|Overall Study|Un-specified|5|||
162733068|NCT02671435|587731225|FG013|Overall Study|Un-specified|9|||
162733069|NCT02671435|587731226|FG014|Overall Study|Un-specified|8|||
162733070|NCT04128319|587731229|FG000|Overall Study|Death|3|||
162733071|NCT00976937|587731230|FG000|Overall Study|Adverse Event|4|||
162733072|NCT00976937|587731231|FG001|Overall Study|Adverse Event|5|||
162733073|NCT00976937|587731230|FG000|Overall Study|Lost to Follow-up|2|||
162733074|NCT00976937|587731231|FG001|Overall Study|Lost to Follow-up|1|||
162733075|NCT00976937|587731230|FG000|Overall Study|Withdrawal by Subject|5|||
162733076|NCT00976937|587731231|FG001|Overall Study|Withdrawal by Subject|3|||
162733077|NCT00976937|587731230|FG000|Overall Study|Poor compliance to protocol|3|||
162733078|NCT00976937|587731231|FG001|Overall Study|Poor compliance to protocol|0|||
162733079|NCT00976937|587731230|FG000|Overall Study|Personal and Familial Reason|2|||
162733080|NCT00976937|587731231|FG001|Overall Study|Personal and Familial Reason|2|||
162733081|NCT01044303|587731234|FG000|Overall Study|Lost to Follow-up|2|||
162733082|NCT06450405|587731238|FG000|Overall Study|Study funding terminated.|0|||
162733083|NCT06450405|587731239|FG001|Overall Study|Study funding terminated.|2|||
162733084|NCT03767517|587731240|FG000|Overall Study|Lost to Follow-up|16|||
162733085|NCT03767517|587731241|FG001|Overall Study|Lost to Follow-up|10|||
162733086|NCT03767517|587731240|FG000|Overall Study|Death|2|||
162733087|NCT03767517|587731241|FG001|Overall Study|Death|3|||
162733088|NCT04994509|587731242|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
162733089|NCT04994509|587731243|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
162733090|NCT04994509|587731244|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
162733091|NCT04994509|587731242|FG000|Overall Study|Withdrew Consent|73|||
162733092|NCT04994509|587731243|FG001|Overall Study|Withdrew Consent|72|||
162733093|NCT04994509|587731244|FG002|Overall Study|Withdrew Consent|46|||
162733094|NCT04994509|587731242|FG000|Overall Study|Lost to Follow-up|39|||
162733095|NCT04994509|587731243|FG001|Overall Study|Lost to Follow-up|36|||
162733096|NCT04994509|587731244|FG002|Overall Study|Lost to Follow-up|26|||
162733097|NCT04994509|587731242|FG000|Overall Study|HIV-1 Infection|4|||
162733098|NCT04994509|587731243|FG001|Overall Study|HIV-1 Infection|20|||
162733099|NCT04994509|587731244|FG002|Overall Study|HIV-1 Infection|12|||
162733100|NCT04994509|587731242|FG000|Overall Study|Investigator's Discretion|9|||
162733101|NCT04994509|587731243|FG001|Overall Study|Investigator's Discretion|8|||
162733102|NCT04994509|587731244|FG002|Overall Study|Investigator's Discretion|11|||
162733103|NCT04994509|587731242|FG000|Overall Study|Randomized but Never Treated|10|||
162733104|NCT04994509|587731243|FG001|Overall Study|Randomized but Never Treated|10|||
162733105|NCT04994509|587731244|FG002|Overall Study|Randomized but Never Treated|3|||
162733106|NCT04994509|587731242|FG000|Overall Study|Pregnancy|5|||
162733107|NCT04994509|587731243|FG001|Overall Study|Pregnancy|5|||
162733108|NCT04994509|587731244|FG002|Overall Study|Pregnancy|0|||
162733109|NCT04994509|587731242|FG000|Overall Study|Death|0|||
162733110|NCT04994509|587731243|FG001|Overall Study|Death|5|||
162733111|NCT04994509|587731244|FG002|Overall Study|Death|0|||
162733112|NCT04994509|587731242|FG000|Overall Study|Adverse Event|2|||
162733113|NCT04994509|587731243|FG001|Overall Study|Adverse Event|1|||
162733114|NCT04994509|587731244|FG002|Overall Study|Adverse Event|0|||
162733115|NCT04994509|587731242|FG000|Overall Study|Non-compliance With Study Drug|1|||
162733116|NCT04994509|587731243|FG001|Overall Study|Non-compliance With Study Drug|1|||
162733117|NCT04994509|587731244|FG002|Overall Study|Non-compliance With Study Drug|1|||
162733118|NCT04994509|587731242|FG000|Overall Study|Withdrew Assent|3|||
162733119|NCT04994509|587731243|FG001|Overall Study|Withdrew Assent|0|||
162733120|NCT04994509|587731244|FG002|Overall Study|Withdrew Assent|0|||
162733121|NCT04994509|587731242|FG000|Overall Study|Protocol Violation|1|||
162733122|NCT04994509|587731243|FG001|Overall Study|Protocol Violation|0|||
162733123|NCT04994509|587731244|FG002|Overall Study|Protocol Violation|0|||
162733124|NCT03152786|587732865|FG000|Overall Study|Withdrawal by Subject|2|||
162733125|NCT03152786|587732866|FG001|Overall Study|Withdrawal by Subject|1|||
162733126|NCT00979576|587732867|FG000|Combination Treatment Phase|Progressive disease|3|||
162733127|NCT00979576|587732868|FG001|Combination Treatment Phase|Progressive disease|1|||
162733128|NCT00979576|587732869|FG002|Combination Treatment Phase|Progressive disease|5|||
162733129|NCT00979576|587732867|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
162733130|NCT00979576|587732868|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
162733131|NCT00979576|587732869|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
162733132|NCT00979576|587732867|FG000|Combination Treatment Phase|Adverse Event|0|||
162733133|NCT00979576|587732868|FG001|Combination Treatment Phase|Adverse Event|2|||
162733134|NCT00979576|587732869|FG002|Combination Treatment Phase|Adverse Event|2|||
162733135|NCT00979576|587732867|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
162733136|NCT00979576|587732868|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
162733137|NCT00979576|587732869|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
162733138|NCT02163447|587732870|FG000|Overall Study|Withdrawal by Subject|2|||
162733139|NCT02163447|587732871|FG001|Overall Study|Withdrawal by Subject|0|||
162733140|NCT02163447|587732872|FG002|Overall Study|Withdrawal by Subject|1|||
162733141|NCT02163447|587732870|FG000|Overall Study|Lost to Follow-up|1|||
162733142|NCT02163447|587732871|FG001|Overall Study|Lost to Follow-up|3|||
162733143|NCT02163447|587732872|FG002|Overall Study|Lost to Follow-up|0|||
162733144|NCT02163447|587732870|FG000|Overall Study|Moved out of study area|2|||
162733145|NCT02163447|587732871|FG001|Overall Study|Moved out of study area|3|||
162733146|NCT02163447|587732872|FG002|Overall Study|Moved out of study area|2|||
162733147|NCT02163447|587732870|FG000|Overall Study|Became HIV infected at time of delivery|1|||
162733148|NCT02163447|587732871|FG001|Overall Study|Became HIV infected at time of delivery|0|||
162733149|NCT02163447|587732872|FG002|Overall Study|Became HIV infected at time of delivery|0|||
162733150|NCT02597946|587732874|FG000|Overall Study|Withdrawal by Subject|1|||
162733151|NCT02597946|587732874|FG000|Overall Study|Progressive disease|16|||
162733152|NCT02597946|587732874|FG000|Overall Study|Other than above|1|||
162733153|NCT04823611|587732885|FG000|Overall Study|Adverse Event|2|||
162733154|NCT04823611|587732886|FG001|Overall Study|Adverse Event|0|||
162733155|NCT04823611|587732887|FG002|Overall Study|Adverse Event|1|||
162733156|NCT04823611|587732888|FG003|Overall Study|Adverse Event|0|||
162733157|NCT04823611|587732889|FG004|Overall Study|Adverse Event|0|||
162733158|NCT04823611|587732890|FG005|Overall Study|Adverse Event|0|||
162733159|NCT04823611|587732891|FG006|Overall Study|Adverse Event|0|||
162733160|NCT05038566|587732892|FG000|Overall Study|Technical Difficulties with the Device|0|||
162733161|NCT05038566|587732893|FG001|Overall Study|Technical Difficulties with the Device|1|||
162733162|NCT04850807|587732898|FG000|Overall Study|Death|50|||
162733163|NCT04850807|587732899|FG001|Overall Study|Death|55|||
162733164|NCT04850807|587732898|FG000|Overall Study|Discharged|17|||
162733165|NCT04850807|587732899|FG001|Overall Study|Discharged|13|||
162733166|NCT04850807|587732898|FG000|Overall Study|Incomplete baseline data|3|||
162733167|NCT04850807|587732899|FG001|Overall Study|Incomplete baseline data|2|||
162733168|NCT05141903|587732900|FG000|Overall Study|Withdrawal by Subject|0|||
162733169|NCT05141903|587732901|FG001|Overall Study|Withdrawal by Subject|1|||
162733170|NCT05141903|587732902|FG002|Overall Study|Withdrawal by Subject|1|||
162733171|NCT05141903|587732903|FG003|Overall Study|Withdrawal by Subject|0|||
162733172|NCT05141903|587732904|FG004|Overall Study|Withdrawal by Subject|0|||
162733173|NCT05141903|587732900|FG000|Overall Study|Other|1|||
162733174|NCT05141903|587732901|FG001|Overall Study|Other|1|||
162733175|NCT05141903|587732902|FG002|Overall Study|Other|0|||
162733176|NCT05141903|587732903|FG003|Overall Study|Other|0|||
162733177|NCT05141903|587732904|FG004|Overall Study|Other|0|||
162733178|NCT05439603|587732905|FG000|Overall Study|met withdrawal criteria|2|||
162733179|NCT05461131|587732906|FG000|Overall Study|Lost to Follow-up|0|||
162733180|NCT05461131|587732907|FG001|Overall Study|Lost to Follow-up|2|||
162733181|NCT03896516|587732908|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
162733182|NCT03896516|587732909|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
162733183|NCT03896516|587732908|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
162733184|NCT03896516|587732909|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
162733185|NCT03896516|587732908|FG000|Washout Period|Physician Decision|3|||
162733186|NCT03896516|587732909|FG001|Washout Period|Physician Decision|1|||
162733187|NCT03896516|587732908|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
162733188|NCT03896516|587732909|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
162733189|NCT04549168|587732914|FG000|Randomization Phase|Adverse Event|0|||
162733190|NCT04549168|587732915|FG001|Randomization Phase|Adverse Event|0|||
162733191|NCT04549168|587732916|FG002|Randomization Phase|Adverse Event|1|||
162733192|NCT04549168|587732914|FG000|Randomization Phase|Other|0|||
162733193|NCT04549168|587732915|FG001|Randomization Phase|Other|2|||
162733194|NCT04549168|587732916|FG002|Randomization Phase|Other|0|||
162733195|NCT04549168|587732914|FG000|Randomization Phase|Withdrawal by Subject|0|||
162733196|NCT04549168|587732915|FG001|Randomization Phase|Withdrawal by Subject|2|||
162733197|NCT04549168|587732916|FG002|Randomization Phase|Withdrawal by Subject|1|||
162733198|NCT04737772|587732922|FG000|Phase 2 Study|Lost to Follow-up|15|||
162733199|NCT04737772|587732923|FG001|Phase 2 Study|Lost to Follow-up|15|||
162733200|NCT04737772|587732922|FG000|Phase 2 Study|Withdrawal by Subject|0|||
162733201|NCT04737772|587732923|FG001|Phase 2 Study|Withdrawal by Subject|1|||
162733202|NCT04737772|587732922|FG000|Phase 2 Study|Did not take any coaching calls|4|||
162733203|NCT04737772|587732923|FG001|Phase 2 Study|Did not take any coaching calls|0|||
162733204|NCT04737772|587732922|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
162733205|NCT04737772|587732923|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
162733206|NCT04737772|587732922|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
162733207|NCT04737772|587732923|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
162733208|NCT02549339|587732924|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
162733209|NCT02549339|587732925|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
162733210|NCT02549339|587732924|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
162733211|NCT02549339|587732925|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
162733212|NCT02549339|587732924|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
162733213|NCT02549339|587732925|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
162733214|NCT02549339|587732924|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
162733215|NCT02549339|587732925|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
162733216|NCT02549339|587732924|FG000|12-month Follow-up|Lack of Efficacy|0|||
162733217|NCT02549339|587732925|FG001|12-month Follow-up|Lack of Efficacy|2|||
162733218|NCT02549339|587732924|FG000|12-month Follow-up|Withdrawal by Subject|8|||
162733219|NCT02549339|587732925|FG001|12-month Follow-up|Withdrawal by Subject|3|||
162733220|NCT02549339|587732924|FG000|12-month Follow-up|Lost to Follow-up|1|||
162733221|NCT02549339|587732925|FG001|12-month Follow-up|Lost to Follow-up|3|||
162733222|NCT02549339|587732924|FG000|12-month Follow-up|Other|0|||
162733223|NCT02549339|587732925|FG001|12-month Follow-up|Other|3|||
162733224|NCT05415410|587732926|FG000|Overall Study|Death|3|||
162733225|NCT05415410|587732927|FG001|Overall Study|Death|6|||
162733226|NCT05415410|587732928|FG002|Overall Study|Death|1|||
162733227|NCT05415410|587732926|FG000|Overall Study|Trial Terminated by Sponsor|1|||
162733228|NCT05415410|587732927|FG001|Overall Study|Trial Terminated by Sponsor|5|||
162733229|NCT05415410|587732928|FG002|Overall Study|Trial Terminated by Sponsor|0|||
162733230|NCT05415410|587732926|FG000|Overall Study|Adverse Event|2|||
162733231|NCT05415410|587732927|FG001|Overall Study|Adverse Event|1|||
162733232|NCT05415410|587732928|FG002|Overall Study|Adverse Event|0|||
162733233|NCT05415410|587732926|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
162733234|NCT05415410|587732927|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
162733235|NCT05415410|587732928|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
162733236|NCT05415410|587732926|FG000|Overall Study|Withdrawal by Subject|1|||
162733237|NCT05415410|587732927|FG001|Overall Study|Withdrawal by Subject|0|||
162733238|NCT05415410|587732928|FG002|Overall Study|Withdrawal by Subject|0|||
162733239|NCT05415410|587732926|FG000|Overall Study|Pregnancy|5|||
162733240|NCT05415410|587732927|FG001|Overall Study|Pregnancy|2|||
162733241|NCT05415410|587732928|FG002|Overall Study|Pregnancy|0|||
162733242|NCT02365766|587732929|FG000|Overall Study|Withdrawal by Subject|0|||
162733243|NCT02365766|587732930|FG001|Overall Study|Withdrawal by Subject|0|||
162733244|NCT02365766|587732931|FG002|Overall Study|Withdrawal by Subject|1|||
162733245|NCT02365766|587732929|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162733246|NCT02365766|587732930|FG001|Overall Study|Eligibility Criteria Not Met|0|||
162733247|NCT02365766|587732931|FG002|Overall Study|Eligibility Criteria Not Met|1|||
162733248|NCT04791709|587732935|FG000|Overall Study|Withdrawal by Subject|3|||
162733249|NCT02724956|587732936|FG000|Overall Study|Physician Decision|1|||
162733250|NCT02724956|587732937|FG001|Overall Study|Physician Decision|0|||
162733251|NCT02724956|587732936|FG000|Overall Study|Lack of Efficacy|0|||
162733252|NCT02724956|587732937|FG001|Overall Study|Lack of Efficacy|1|||
162733253|NCT02724956|587732936|FG000|Overall Study|Withdrawal by Subject|0|||
162733254|NCT02724956|587732937|FG001|Overall Study|Withdrawal by Subject|1|||
162733255|NCT03385629|587732943|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
162733256|NCT03385629|587732944|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
162733257|NCT03385629|587732943|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
162733258|NCT03385629|587732944|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
162733259|NCT03385629|587732943|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
162733260|NCT03385629|587732944|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
162733261|NCT02538900|587732955|FG000|Overall Study|Death|2|||
162733262|NCT02538900|587732956|FG001|Overall Study|Death|2|||
162733263|NCT02538900|587732957|FG002|Overall Study|Death|2|||
162733264|NCT02538900|587732955|FG000|Overall Study|Withdrawal by Subject|18|||
162733265|NCT02538900|587732956|FG001|Overall Study|Withdrawal by Subject|16|||
162733266|NCT02538900|587732957|FG002|Overall Study|Withdrawal by Subject|15|||
162733267|NCT04600752|587732958|FG000|Overall Study|Physician Decision|0|||
162733268|NCT04600752|587732959|FG001|Overall Study|Physician Decision|0|||
162733269|NCT04600752|587732960|FG002|Overall Study|Physician Decision|1|||
162733270|NCT04600752|587732958|FG000|Overall Study|Adverse Event|0|||
162733271|NCT04600752|587732959|FG001|Overall Study|Adverse Event|1|||
162733272|NCT04600752|587732960|FG002|Overall Study|Adverse Event|0|||
162733273|NCT04600752|587732958|FG000|Overall Study|Withdrawal by Subject|2|||
162733274|NCT04600752|587732959|FG001|Overall Study|Withdrawal by Subject|1|||
162733275|NCT04600752|587732960|FG002|Overall Study|Withdrawal by Subject|0|||
162733276|NCT04600752|587732958|FG000|Overall Study|Lack of Efficacy|1|||
162733277|NCT04600752|587732959|FG001|Overall Study|Lack of Efficacy|0|||
162733278|NCT04600752|587732960|FG002|Overall Study|Lack of Efficacy|0|||
162733279|NCT04431726|587732961|FG000|Overall Study|Ongoing in the Study|55|||
162733280|NCT01095796|587732962|FG000|Overall Study|Randomized but Not Treated|5|||
162733281|NCT01095796|587732963|FG001|Overall Study|Randomized but Not Treated|2|||
162733282|NCT01095796|587732962|FG000|Overall Study|Adverse Event|9|||
162733283|NCT01095796|587732963|FG001|Overall Study|Adverse Event|19|||
162733284|NCT01095796|587732962|FG000|Overall Study|Death|3|||
162733285|NCT01095796|587732963|FG001|Overall Study|Death|2|||
162733286|NCT01095796|587732962|FG000|Overall Study|Pregnancy|2|||
162733287|NCT01095796|587732963|FG001|Overall Study|Pregnancy|0|||
162733288|NCT01095796|587732962|FG000|Overall Study|Lack of Efficacy|5|||
162733289|NCT01095796|587732963|FG001|Overall Study|Lack of Efficacy|3|||
162733290|NCT01095796|587732962|FG000|Overall Study|Investigator's Discretion|7|||
162733291|NCT01095796|587732963|FG001|Overall Study|Investigator's Discretion|2|||
162733292|NCT01095796|587732962|FG000|Overall Study|Withdrew Consent|16|||
162733293|NCT01095796|587732963|FG001|Overall Study|Withdrew Consent|22|||
162733294|NCT01095796|587732962|FG000|Overall Study|Lost to Follow-up|27|||
162733295|NCT01095796|587732963|FG001|Overall Study|Lost to Follow-up|29|||
162733296|NCT01095796|587732962|FG000|Overall Study|Participant Noncompliance|5|||
162733297|NCT01095796|587732963|FG001|Overall Study|Participant Noncompliance|10|||
162733298|NCT01095796|587732962|FG000|Overall Study|Protocol Violation|1|||
162733299|NCT01095796|587732963|FG001|Overall Study|Protocol Violation|0|||
162733300|NCT01095796|587732962|FG000|Overall Study|Participant Transferred to Another Study|215|||
162733301|NCT01095796|587732963|FG001|Overall Study|Participant Transferred to Another Study|200|||
162733302|NCT00604669|587732964|FG000|Overall Study|lack of information in chart|7|||
162733303|NCT00274469|587732972|FG000|Overall Study|Death|63|||
162733304|NCT00274469|587732973|FG001|Overall Study|Death|74|||
162733305|NCT00274469|587732972|FG000|Overall Study|Did not consent to OS follow-up|16|||
162733306|NCT00274469|587732973|FG001|Overall Study|Did not consent to OS follow-up|19|||
162733307|NCT05450458|587732981|FG000|Overall Study|Lost to Follow-up|4|||
162733308|NCT05480943|587732982|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
162733309|NCT05480943|587732982|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
162733310|NCT05480943|587732982|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
162733311|NCT05480943|587732982|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
162733312|NCT04999592|587732983|FG000|Overall Study|Withdrawal by Subject|1|||
162733313|NCT04999592|587732984|FG001|Overall Study|Withdrawal by Subject|0|||
162733314|NCT01227265|587732985|FG000|Overall Study|Did Not Receive Treatment|1|||
162733315|NCT01227265|587732986|FG001|Overall Study|Did Not Receive Treatment|2|||
162733316|NCT01227265|587732987|FG002|Overall Study|Did Not Receive Treatment|0|||
162733317|NCT01227265|587732985|FG000|Overall Study|Administrative|1|||
162733318|NCT01227265|587732986|FG001|Overall Study|Administrative|0|||
162733319|NCT01227265|587732987|FG002|Overall Study|Administrative|2|||
162733320|NCT01227265|587732985|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162733321|NCT01227265|587732986|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
162733322|NCT01227265|587732987|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
162733323|NCT01227265|587732985|FG000|Overall Study|Protocol Violation|2|||
162733324|NCT01227265|587732986|FG001|Overall Study|Protocol Violation|1|||
162733325|NCT01227265|587732987|FG002|Overall Study|Protocol Violation|0|||
162733326|NCT01227265|587732985|FG000|Overall Study|Withdrawal by Subject|7|||
162733327|NCT01227265|587732986|FG001|Overall Study|Withdrawal by Subject|7|||
162733328|NCT01227265|587732987|FG002|Overall Study|Withdrawal by Subject|3|||
162733329|NCT01227265|587732985|FG000|Overall Study|Lost to Follow-up|2|||
162733330|NCT01227265|587732986|FG001|Overall Study|Lost to Follow-up|0|||
162733331|NCT01227265|587732987|FG002|Overall Study|Lost to Follow-up|3|||
162733332|NCT01227265|587732985|FG000|Overall Study|Adverse Event|6|||
162733333|NCT01227265|587732986|FG001|Overall Study|Adverse Event|10|||
162733334|NCT01227265|587732987|FG002|Overall Study|Adverse Event|5|||
162733335|NCT02910713|587732988|FG000|Overall Study|Protocol Violation|2|||
162733336|NCT02910713|587732988|FG000|Overall Study|Subject Choice|4|||
162733337|NCT02910713|587732988|FG000|Overall Study|Received One Application|10|||
162733338|NCT02910713|587732988|FG000|Overall Study|Received Neither Application|18|||
162733339|NCT02910713|587732988|FG000|Overall Study|Enrollment cap|7|||
162733340|NCT02910713|587732988|FG000|Overall Study|Investigator Discretion|1|||
162733341|NCT04442126|587732997|FG000|Overall Study|Withdrawal by Subject|0|||
162733342|NCT04442126|587732998|FG001|Overall Study|Withdrawal by Subject|0|||
162733343|NCT04442126|587732999|FG002|Overall Study|Withdrawal by Subject|0|||
162733344|NCT04442126|587733000|FG003|Overall Study|Withdrawal by Subject|2|||
162733345|NCT04442126|587733001|FG004|Overall Study|Withdrawal by Subject|1|||
162733346|NCT04442126|587733002|FG005|Overall Study|Withdrawal by Subject|0|||
162733347|NCT04442126|587733003|FG006|Overall Study|Withdrawal by Subject|1|||
162733348|NCT04442126|587733004|FG007|Overall Study|Withdrawal by Subject|1|||
162733349|NCT04442126|587733005|FG008|Overall Study|Withdrawal by Subject|3|||
162733350|NCT04442126|587732997|FG000|Overall Study|Death|1|||
162733351|NCT04442126|587732998|FG001|Overall Study|Death|0|||
162733352|NCT04442126|587732999|FG002|Overall Study|Death|0|||
162733353|NCT04442126|587733000|FG003|Overall Study|Death|1|||
162733354|NCT04442126|587733001|FG004|Overall Study|Death|2|||
162733355|NCT04442126|587733002|FG005|Overall Study|Death|2|||
162733356|NCT04442126|587733003|FG006|Overall Study|Death|4|||
162733357|NCT04442126|587733004|FG007|Overall Study|Death|1|||
162733358|NCT04442126|587733005|FG008|Overall Study|Death|5|||
162733359|NCT04442126|587732997|FG000|Overall Study|Study Terminated by Sponsor|0|||
162733360|NCT04442126|587732998|FG001|Overall Study|Study Terminated by Sponsor|0|||
162733361|NCT04442126|587732999|FG002|Overall Study|Study Terminated by Sponsor|0|||
162733362|NCT04442126|587733000|FG003|Overall Study|Study Terminated by Sponsor|0|||
162733363|NCT04442126|587733001|FG004|Overall Study|Study Terminated by Sponsor|0|||
162733364|NCT04442126|587733002|FG005|Overall Study|Study Terminated by Sponsor|1|||
162733365|NCT04442126|587733003|FG006|Overall Study|Study Terminated by Sponsor|4|||
162733366|NCT04442126|587733004|FG007|Overall Study|Study Terminated by Sponsor|2|||
162733367|NCT04442126|587733005|FG008|Overall Study|Study Terminated by Sponsor|10|||
162733368|NCT04442126|587732997|FG000|Overall Study|Lost to Follow-up|0|||
162733369|NCT04442126|587732998|FG001|Overall Study|Lost to Follow-up|0|||
162733370|NCT04442126|587732999|FG002|Overall Study|Lost to Follow-up|0|||
162733371|NCT04442126|587733000|FG003|Overall Study|Lost to Follow-up|0|||
162733372|NCT04442126|587733001|FG004|Overall Study|Lost to Follow-up|0|||
162733373|NCT04442126|587733002|FG005|Overall Study|Lost to Follow-up|0|||
162733374|NCT04442126|587733003|FG006|Overall Study|Lost to Follow-up|0|||
162733375|NCT04442126|587733004|FG007|Overall Study|Lost to Follow-up|1|||
162733376|NCT04442126|587733005|FG008|Overall Study|Lost to Follow-up|2|||
162733377|NCT04442126|587732997|FG000|Overall Study|Progressive Disease|0|||
162733378|NCT04442126|587732998|FG001|Overall Study|Progressive Disease|1|||
162733379|NCT04442126|587732999|FG002|Overall Study|Progressive Disease|3|||
162733380|NCT04442126|587733000|FG003|Overall Study|Progressive Disease|0|||
162733381|NCT04442126|587733001|FG004|Overall Study|Progressive Disease|3|||
162733382|NCT04442126|587733002|FG005|Overall Study|Progressive Disease|0|||
162733383|NCT04442126|587733003|FG006|Overall Study|Progressive Disease|0|||
162733384|NCT04442126|587733004|FG007|Overall Study|Progressive Disease|0|||
162733385|NCT04442126|587733005|FG008|Overall Study|Progressive Disease|0|||
162733386|NCT04442126|587732997|FG000|Overall Study|Other|0|||
162733387|NCT04442126|587732998|FG001|Overall Study|Other|0|||
162733388|NCT04442126|587732999|FG002|Overall Study|Other|0|||
162733389|NCT04442126|587733000|FG003|Overall Study|Other|0|||
162733390|NCT04442126|587733001|FG004|Overall Study|Other|0|||
162733391|NCT04442126|587733002|FG005|Overall Study|Other|0|||
162733392|NCT04442126|587733003|FG006|Overall Study|Other|0|||
162733393|NCT04442126|587733004|FG007|Overall Study|Other|0|||
162733394|NCT04442126|587733005|FG008|Overall Study|Other|1|||
162733395|NCT04623775|587733006|FG000|Randomization|No Longer Meets Study Criteria|2|||
162733396|NCT04623775|587733007|FG001|Randomization|No Longer Meets Study Criteria|1|||
162733397|NCT04623775|587733008|FG002|Randomization|No Longer Meets Study Criteria|0|||
162733398|NCT04623775|587733009|FG003|Randomization|No Longer Meets Study Criteria|0|||
162733399|NCT04623775|587733006|FG000|Randomization|Withdrew Consent|0|||
162733400|NCT04623775|587733007|FG001|Randomization|Withdrew Consent|0|||
162733401|NCT04623775|587733008|FG002|Randomization|Withdrew Consent|0|||
162733402|NCT04623775|587733009|FG003|Randomization|Withdrew Consent|1|||
162733403|NCT04623775|587733006|FG000|Randomization|Other Reasons|0|||
162733404|NCT04623775|587733007|FG001|Randomization|Other Reasons|0|||
162733405|NCT04623775|587733008|FG002|Randomization|Other Reasons|0|||
162733406|NCT04623775|587733009|FG003|Randomization|Other Reasons|1|||
162733407|NCT04623775|587733006|FG000|Treatment Period|participant withdrew consent|4|||
162733408|NCT04623775|587733007|FG001|Treatment Period|participant withdrew consent|0|||
162733409|NCT04623775|587733008|FG002|Treatment Period|participant withdrew consent|1|||
162733410|NCT04623775|587733009|FG003|Treatment Period|participant withdrew consent|2|||
162733411|NCT04623775|587733006|FG000|Treatment Period|Death|3|||
162733412|NCT04623775|587733007|FG001|Treatment Period|Death|1|||
162733413|NCT04623775|587733008|FG002|Treatment Period|Death|4|||
162733414|NCT04623775|587733009|FG003|Treatment Period|Death|2|||
162733415|NCT04623775|587733006|FG000|Treatment Period|Lost to Follow-up|0|||
162733416|NCT04623775|587733007|FG001|Treatment Period|Lost to Follow-up|2|||
162733417|NCT04623775|587733008|FG002|Treatment Period|Lost to Follow-up|0|||
162733418|NCT04623775|587733009|FG003|Treatment Period|Lost to Follow-up|0|||
162733419|NCT04623775|587733006|FG000|Treatment Period|poor/non compliance|0|||
162733420|NCT04623775|587733007|FG001|Treatment Period|poor/non compliance|0|||
162733421|NCT04623775|587733008|FG002|Treatment Period|poor/non compliance|1|||
162733422|NCT04623775|587733009|FG003|Treatment Period|poor/non compliance|0|||
162733423|NCT04623775|587733006|FG000|Treatment Period|participant no longer meets study criteria|0|||
162733424|NCT04623775|587733007|FG001|Treatment Period|participant no longer meets study criteria|1|||
162733425|NCT04623775|587733008|FG002|Treatment Period|participant no longer meets study criteria|0|||
162733426|NCT04623775|587733009|FG003|Treatment Period|participant no longer meets study criteria|0|||
162733427|NCT04623775|587733006|FG000|Treatment Period|administrative reasons by sponsor|3|||
162733428|NCT04623775|587733007|FG001|Treatment Period|administrative reasons by sponsor|2|||
162733429|NCT04623775|587733008|FG002|Treatment Period|administrative reasons by sponsor|0|||
162733430|NCT04623775|587733009|FG003|Treatment Period|administrative reasons by sponsor|0|||
162733431|NCT04623775|587733006|FG000|Treatment Period|other reasons|2|||
162733432|NCT04623775|587733007|FG001|Treatment Period|other reasons|0|||
162733433|NCT04623775|587733008|FG002|Treatment Period|other reasons|1|||
162733434|NCT04623775|587733009|FG003|Treatment Period|other reasons|1|||
162733435|NCT04623775|587733006|FG000|Treatment Period|disease progression|40|||
162733436|NCT04623775|587733007|FG001|Treatment Period|disease progression|35|||
162733437|NCT04623775|587733008|FG002|Treatment Period|disease progression|63|||
162733438|NCT04623775|587733009|FG003|Treatment Period|disease progression|63|||
162733439|NCT04623775|587733006|FG000|Treatment Period|study drug toxicity|12|||
162733440|NCT04623775|587733007|FG001|Treatment Period|study drug toxicity|15|||
162733441|NCT04623775|587733008|FG002|Treatment Period|study drug toxicity|13|||
162733442|NCT04623775|587733009|FG003|Treatment Period|study drug toxicity|12|||
162733443|NCT04623775|587733006|FG000|Treatment Period|AE unrelated to study drug|4|||
162733444|NCT04623775|587733007|FG001|Treatment Period|AE unrelated to study drug|9|||
162733445|NCT04623775|587733008|FG002|Treatment Period|AE unrelated to study drug|12|||
162733446|NCT04623775|587733009|FG003|Treatment Period|AE unrelated to study drug|9|||
162733447|NCT04623775|587733006|FG000|Treatment Period|participant request to discontinue treatment|0|||
162733448|NCT04623775|587733007|FG001|Treatment Period|participant request to discontinue treatment|2|||
162733449|NCT04623775|587733008|FG002|Treatment Period|participant request to discontinue treatment|2|||
162733450|NCT04623775|587733009|FG003|Treatment Period|participant request to discontinue treatment|0|||
162733451|NCT06024174|587733010|FG000|Overall Study|Other Reasons|1|||
162733452|NCT06024174|587733010|FG000|Overall Study|Study terminated by Sponsor|4|||
162733453|NCT02525692|587734127|FG000|Overall Study|Withdrawal by Subject|1|||
162733454|NCT02525692|587734128|FG001|Overall Study|Withdrawal by Subject|1|||
162733455|NCT02525692|587734129|FG002|Overall Study|Withdrawal by Subject|0|||
162733456|NCT02525692|587734130|FG003|Overall Study|Withdrawal by Subject|5|||
162733457|NCT02525692|587734131|FG004|Overall Study|Withdrawal by Subject|0|||
162733458|NCT02525692|587734132|FG005|Overall Study|Withdrawal by Subject|1|||
162733459|NCT02525692|587734127|FG000|Overall Study|Death|16|||
162733460|NCT02525692|587734128|FG001|Overall Study|Death|18|||
162733461|NCT02525692|587734129|FG002|Overall Study|Death|7|||
162733462|NCT02525692|587734130|FG003|Overall Study|Death|20|||
162733463|NCT02525692|587734131|FG004|Overall Study|Death|3|||
162733464|NCT02525692|587734132|FG005|Overall Study|Death|6|||
162733465|NCT02525692|587734127|FG000|Overall Study|Lost to Follow-up|0|||
162733466|NCT02525692|587734128|FG001|Overall Study|Lost to Follow-up|0|||
162733467|NCT02525692|587734129|FG002|Overall Study|Lost to Follow-up|1|||
162733468|NCT02525692|587734130|FG003|Overall Study|Lost to Follow-up|5|||
162733469|NCT02525692|587734131|FG004|Overall Study|Lost to Follow-up|0|||
162733470|NCT02525692|587734132|FG005|Overall Study|Lost to Follow-up|0|||
162733471|NCT02396199|587734133|FG000|Overall Study|Lost to Follow-up|1|||
162733472|NCT02396199|587734133|FG000|Overall Study|Death|4|||
162733473|NCT04112316|587734136|FG000|First Period (8 Weeks)|Protocol Violation|1|||
162733474|NCT04112316|587734137|FG001|First Period (8 Weeks)|Protocol Violation|0|||
162733475|NCT04112316|587734136|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
162733476|NCT04112316|587734137|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
162733477|NCT04247542|587734149|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
162733478|NCT04247542|587734150|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
162733479|NCT04247542|587734151|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
162733480|NCT04247542|587734149|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
162733481|NCT04247542|587734150|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
162733482|NCT04247542|587734151|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
162733483|NCT03438188|587734152|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162733484|NCT03438188|587734153|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162733485|NCT03438188|587734154|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162733486|NCT03438188|587734152|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
162733487|NCT03438188|587734153|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
162733488|NCT03438188|587734154|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
162733489|NCT03438188|587734152|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
162733490|NCT03438188|587734153|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
162733491|NCT03438188|587734154|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
162733492|NCT03438188|587734152|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
162733493|NCT03438188|587734153|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
162733494|NCT03438188|587734154|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
162733495|NCT03438188|587734152|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
162733496|NCT03438188|587734153|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
162733497|NCT03438188|587734154|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
162733498|NCT06066541|587734155|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
162733499|NCT06066541|587734156|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
162733500|NCT06066541|587734157|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
162733501|NCT06066541|587734158|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
162733502|NCT06066541|587734159|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
162733503|NCT06066541|587734160|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
162733504|NCT06066541|587734161|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
162733505|NCT06066541|587734155|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
162733506|NCT06066541|587734156|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
162733507|NCT06066541|587734157|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
162733508|NCT06066541|587734158|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
162733509|NCT06066541|587734159|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
162733510|NCT06066541|587734160|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
162733511|NCT06066541|587734161|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
162733512|NCT04533022|587734162|FG000|Overall Study|Withdrawal by Subject|15|||
162733513|NCT04533022|587734162|FG000|Overall Study|Adverse Event|6|||
162733514|NCT04533022|587734162|FG000|Overall Study|Death|1|||
162733515|NCT04533022|587734162|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
162733516|NCT04533022|587734162|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
162733517|NCT03897686|587734163|FG000|Overall Study|Protocol Violation|1|||
162733518|NCT03897686|587734164|FG001|Overall Study|Protocol Violation|1|||
162733519|NCT03897686|587734163|FG000|Overall Study|Withdrawal by Subject|1|||
162733520|NCT03897686|587734164|FG001|Overall Study|Withdrawal by Subject|1|||
162733521|NCT05415436|587734165|FG000|Overall Study|Surgeon cancelled procedure|1|||
162733522|NCT05415436|587734166|FG001|Overall Study|Surgeon cancelled procedure|0|||
162733523|NCT05415436|587734165|FG000|Overall Study|Death|1|||
162733524|NCT05415436|587734166|FG001|Overall Study|Death|0|||
162733525|NCT05386355|587734177|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162733526|NCT05386355|587734178|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162733527|NCT05386355|587734179|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162733528|NCT05386355|587734180|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162733529|NCT03157167|587734183|FG000|Overall Study|Withdrawal by Subject|1|||
162733530|NCT03157167|587734184|FG001|Overall Study|Withdrawal by Subject|0|||
162733531|NCT03157167|587734185|FG002|Overall Study|Withdrawal by Subject|0|||
162733532|NCT03263026|587734188|FG000|Overall Study|Withdrawal by Subject|1|||
162733533|NCT03263026|587734189|FG001|Overall Study|Withdrawal by Subject|0|||
162733534|NCT03263026|587734188|FG000|Overall Study|Death|1|||
162733535|NCT03263026|587734189|FG001|Overall Study|Death|0|||
162733536|NCT03263026|587734188|FG000|Overall Study|Other/ Various|41|||
162733537|NCT03263026|587734189|FG001|Overall Study|Other/ Various|29|||
162733538|NCT03775109|587734190|FG000|Overall Study|Adverse Event|1|||
162733539|NCT03775109|587734191|FG001|Overall Study|Adverse Event|0|||
162733540|NCT03775109|587734190|FG000|Overall Study|COVID-19 outbreak|2|||
162733541|NCT03775109|587734191|FG001|Overall Study|COVID-19 outbreak|0|||
162733542|NCT03775109|587734190|FG000|Overall Study|Lost to Follow-up|0|||
162733543|NCT03775109|587734191|FG001|Overall Study|Lost to Follow-up|2|||
162733544|NCT03775109|587734190|FG000|Overall Study|Withdrawal by Subject|1|||
162733545|NCT03775109|587734191|FG001|Overall Study|Withdrawal by Subject|1|||
162733546|NCT03775109|587734190|FG000|Overall Study|Death|0|||
162733547|NCT03775109|587734191|FG001|Overall Study|Death|1|||
162733548|NCT03775109|587734190|FG000|Overall Study|Lack of Efficacy|1|||
162733549|NCT03775109|587734191|FG001|Overall Study|Lack of Efficacy|0|||
162733550|NCT05691452|587734192|FG000|Overall Study|Withdrawal by Subject|1|||
162733551|NCT05691452|587734193|FG001|Overall Study|Withdrawal by Subject|1|||
162733552|NCT05691452|587734194|FG002|Overall Study|Withdrawal by Subject|0|||
162733553|NCT05691452|587734192|FG000|Overall Study|Physician Decision|1|||
162733554|NCT05691452|587734193|FG001|Overall Study|Physician Decision|0|||
162733555|NCT05691452|587734194|FG002|Overall Study|Physician Decision|0|||
162733556|NCT05691452|587734192|FG000|Overall Study|Lost to Follow-up|0|||
162733557|NCT05691452|587734193|FG001|Overall Study|Lost to Follow-up|0|||
162733558|NCT05691452|587734194|FG002|Overall Study|Lost to Follow-up|1|||
162733559|NCT05691452|587734192|FG000|Overall Study|Adverse Event|0|||
162733560|NCT05691452|587734193|FG001|Overall Study|Adverse Event|0|||
162733561|NCT05691452|587734194|FG002|Overall Study|Adverse Event|1|||
162733562|NCT01938547|587734197|FG000|Overall Study|Physician Decision|1|||
162733563|NCT05320432|587734202|FG000|Overall Study|Withdrawal by Subject|0|||
162733564|NCT05320432|587734203|FG001|Overall Study|Withdrawal by Subject|2|||
162733565|NCT03739996|587734212|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
162733566|NCT03739996|587734212|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
162733567|NCT03739996|587734212|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
162733568|NCT03739996|587734212|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
162733569|NCT03739996|587734212|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
162733570|NCT03739996|587734212|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
162733571|NCT03739996|587734212|FG000|Step 3 (SOC ART)|Death|1|||
162733572|NCT03739996|587734212|FG000|Step 3 (SOC ART)|Participant moved|1|||
162733573|NCT02728076|587734213|FG000|Overall Study|Physician Decision|4|||
162733574|NCT05054374|587734214|FG000|Overall Study|Withdrawal by Subject|1|||
162733575|NCT05054374|587734215|FG001|Overall Study|Withdrawal by Subject|0|||
162733576|NCT05054374|587734216|FG002|Overall Study|Withdrawal by Subject|0|||
162733577|NCT05054374|587734217|FG003|Overall Study|Withdrawal by Subject|0|||
162733578|NCT05054374|587734214|FG000|Overall Study|Progressive Disease|5|||
162733579|NCT05054374|587734215|FG001|Overall Study|Progressive Disease|0|||
162733580|NCT05054374|587734216|FG002|Overall Study|Progressive Disease|0|||
162733581|NCT05054374|587734217|FG003|Overall Study|Progressive Disease|0|||
162733582|NCT01532388|587734219|FG000|3-month Follow-up|Lost to Follow-up|68|||
162733583|NCT01532388|587734220|FG001|3-month Follow-up|Lost to Follow-up|68|||
162733584|NCT01532388|587734219|FG000|6-month Follow-up|Lost to Follow-up|74|||
162733585|NCT01532388|587734220|FG001|6-month Follow-up|Lost to Follow-up|66|||
162733586|NCT01532388|587734219|FG000|12-month Follow-up|Lost to Follow-up|69|||
162733587|NCT01532388|587734220|FG001|12-month Follow-up|Lost to Follow-up|67|||
162733588|NCT03069313|587734221|FG000|Overall Study|Adverse Event|5|||
162733589|NCT03580369|587734222|FG000|Overall Study|No treatment due to mis-randomization|1|||
162733590|NCT03580369|587734223|FG001|Overall Study|No treatment due to mis-randomization|0|||
162733591|NCT03580369|587734224|FG002|Overall Study|No treatment due to mis-randomization|0|||
162733592|NCT03580369|587734225|FG003|Overall Study|No treatment due to mis-randomization|0|||
162733593|NCT03580369|587734226|FG004|Overall Study|No treatment due to mis-randomization|3|||
162733594|NCT03580369|587734227|FG005|Overall Study|No treatment due to mis-randomization|0|||
162733595|NCT03580369|587734228|FG006|Overall Study|No treatment due to mis-randomization|0|||
162733596|NCT03580369|587734229|FG007|Overall Study|No treatment due to mis-randomization|0|||
162733597|NCT03580369|587734222|FG000|Overall Study|Reason unknown|0|||
162733598|NCT03580369|587734223|FG001|Overall Study|Reason unknown|0|||
162733599|NCT03580369|587734224|FG002|Overall Study|Reason unknown|1|||
162733600|NCT03580369|587734225|FG003|Overall Study|Reason unknown|0|||
162733601|NCT03580369|587734226|FG004|Overall Study|Reason unknown|0|||
162733602|NCT03580369|587734227|FG005|Overall Study|Reason unknown|0|||
162733603|NCT03580369|587734228|FG006|Overall Study|Reason unknown|0|||
162733604|NCT03580369|587734229|FG007|Overall Study|Reason unknown|0|||
162733605|NCT03580369|587734222|FG000|Overall Study|Technical problems|0|||
162733606|NCT03580369|587734223|FG001|Overall Study|Technical problems|0|||
162733607|NCT03580369|587734224|FG002|Overall Study|Technical problems|0|||
162733608|NCT03580369|587734225|FG003|Overall Study|Technical problems|0|||
162733609|NCT03580369|587734226|FG004|Overall Study|Technical problems|1|||
162733610|NCT03580369|587734227|FG005|Overall Study|Technical problems|0|||
162733611|NCT03580369|587734228|FG006|Overall Study|Technical problems|2|||
162733612|NCT03580369|587734229|FG007|Overall Study|Technical problems|0|||
162733613|NCT03580369|587734222|FG000|Overall Study|Pregnancy|2|||
162733614|NCT03580369|587734223|FG001|Overall Study|Pregnancy|0|||
162733615|NCT03580369|587734224|FG002|Overall Study|Pregnancy|3|||
162733616|NCT03580369|587734225|FG003|Overall Study|Pregnancy|0|||
162733617|NCT03580369|587734226|FG004|Overall Study|Pregnancy|2|||
162733618|NCT03580369|587734227|FG005|Overall Study|Pregnancy|0|||
162733619|NCT03580369|587734228|FG006|Overall Study|Pregnancy|0|||
162733620|NCT03580369|587734229|FG007|Overall Study|Pregnancy|0|||
162733621|NCT03580369|587734222|FG000|Overall Study|Lost to Follow-up|2|||
162733622|NCT03580369|587734223|FG001|Overall Study|Lost to Follow-up|0|||
162733623|NCT03580369|587734224|FG002|Overall Study|Lost to Follow-up|2|||
162733624|NCT03580369|587734225|FG003|Overall Study|Lost to Follow-up|0|||
162733625|NCT03580369|587734226|FG004|Overall Study|Lost to Follow-up|3|||
162733626|NCT03580369|587734227|FG005|Overall Study|Lost to Follow-up|0|||
162733627|NCT03580369|587734228|FG006|Overall Study|Lost to Follow-up|1|||
162733628|NCT03580369|587734229|FG007|Overall Study|Lost to Follow-up|0|||
162733629|NCT03580369|587734222|FG000|Overall Study|Physician Decision|4|||
162733630|NCT03580369|587734223|FG001|Overall Study|Physician Decision|0|||
162733631|NCT03580369|587734224|FG002|Overall Study|Physician Decision|4|||
162733632|NCT03580369|587734225|FG003|Overall Study|Physician Decision|1|||
162733633|NCT03580369|587734226|FG004|Overall Study|Physician Decision|1|||
162733634|NCT03580369|587734227|FG005|Overall Study|Physician Decision|0|||
162733635|NCT03580369|587734228|FG006|Overall Study|Physician Decision|0|||
162733636|NCT03580369|587734229|FG007|Overall Study|Physician Decision|0|||
162733637|NCT03580369|587734222|FG000|Overall Study|Lack of Efficacy|3|||
162733638|NCT03580369|587734223|FG001|Overall Study|Lack of Efficacy|0|||
162733639|NCT03580369|587734224|FG002|Overall Study|Lack of Efficacy|7|||
162733640|NCT03580369|587734225|FG003|Overall Study|Lack of Efficacy|0|||
162733641|NCT03580369|587734226|FG004|Overall Study|Lack of Efficacy|2|||
162733642|NCT03580369|587734227|FG005|Overall Study|Lack of Efficacy|0|||
162733643|NCT03580369|587734228|FG006|Overall Study|Lack of Efficacy|3|||
162733644|NCT03580369|587734229|FG007|Overall Study|Lack of Efficacy|0|||
162733645|NCT03580369|587734222|FG000|Overall Study|Protocol Violation|6|||
162733646|NCT03580369|587734223|FG001|Overall Study|Protocol Violation|0|||
162733647|NCT03580369|587734224|FG002|Overall Study|Protocol Violation|6|||
162733648|NCT03580369|587734225|FG003|Overall Study|Protocol Violation|1|||
162733649|NCT03580369|587734226|FG004|Overall Study|Protocol Violation|8|||
162733650|NCT03580369|587734227|FG005|Overall Study|Protocol Violation|2|||
162733651|NCT03580369|587734228|FG006|Overall Study|Protocol Violation|1|||
162733652|NCT03580369|587734229|FG007|Overall Study|Protocol Violation|0|||
162733653|NCT03580369|587734222|FG000|Overall Study|Adverse Event|7|||
162733654|NCT03580369|587734223|FG001|Overall Study|Adverse Event|0|||
162733655|NCT03580369|587734224|FG002|Overall Study|Adverse Event|14|||
162733656|NCT03580369|587734225|FG003|Overall Study|Adverse Event|1|||
162733657|NCT03580369|587734226|FG004|Overall Study|Adverse Event|6|||
162733658|NCT03580369|587734227|FG005|Overall Study|Adverse Event|0|||
162733659|NCT03580369|587734228|FG006|Overall Study|Adverse Event|1|||
162733660|NCT03580369|587734229|FG007|Overall Study|Adverse Event|0|||
162733661|NCT03580369|587734222|FG000|Overall Study|Withdrawal by Subject|19|||
162733662|NCT03580369|587734223|FG001|Overall Study|Withdrawal by Subject|0|||
162733663|NCT03580369|587734224|FG002|Overall Study|Withdrawal by Subject|17|||
162733664|NCT03580369|587734225|FG003|Overall Study|Withdrawal by Subject|0|||
162733665|NCT03580369|587734226|FG004|Overall Study|Withdrawal by Subject|16|||
162733666|NCT03580369|587734227|FG005|Overall Study|Withdrawal by Subject|1|||
162733667|NCT03580369|587734228|FG006|Overall Study|Withdrawal by Subject|7|||
162733668|NCT03580369|587734229|FG007|Overall Study|Withdrawal by Subject|0|||
162733669|NCT03912831|587734230|FG000|Overall Study|Death|1|||
162733670|NCT03912831|587734231|FG001|Overall Study|Death|1|||
162733671|NCT03912831|587734232|FG002|Overall Study|Death|1|||
162733672|NCT03912831|587734233|FG003|Overall Study|Death|1|||
162733673|NCT03912831|587734234|FG004|Overall Study|Death|1|||
162733674|NCT03912831|587734235|FG005|Overall Study|Death|1|||
162733675|NCT03912831|587734230|FG000|Overall Study|Reason not Specified|0|||
162733676|NCT03912831|587734231|FG001|Overall Study|Reason not Specified|0|||
162733677|NCT03912831|587734232|FG002|Overall Study|Reason not Specified|0|||
162733678|NCT03912831|587734233|FG003|Overall Study|Reason not Specified|0|||
162733679|NCT03912831|587734234|FG004|Overall Study|Reason not Specified|1|||
162733680|NCT03912831|587734235|FG005|Overall Study|Reason not Specified|0|||
162733681|NCT03912831|587734230|FG000|Overall Study|Withdrawal by Participant|0|||
162733682|NCT03912831|587734231|FG001|Overall Study|Withdrawal by Participant|0|||
162733683|NCT03912831|587734232|FG002|Overall Study|Withdrawal by Participant|0|||
162733684|NCT03912831|587734233|FG003|Overall Study|Withdrawal by Participant|0|||
162733685|NCT03912831|587734234|FG004|Overall Study|Withdrawal by Participant|1|||
162733686|NCT03912831|587734235|FG005|Overall Study|Withdrawal by Participant|0|||
162733687|NCT03484702|587735543|FG000|Treatment Period|Death|3|||
162733688|NCT03484702|587735544|FG001|Treatment Period|Death|1|||
162733689|NCT03484702|587735545|FG002|Treatment Period|Death|0|||
162733690|NCT03484702|587735546|FG003|Treatment Period|Death|0|||
162733691|NCT03484702|587735547|FG004|Treatment Period|Death|0|||
162733692|NCT03484702|587735548|FG005|Treatment Period|Death|0|||
162733693|NCT03484702|587735543|FG000|Treatment Period|Adverse Event|1|||
162733694|NCT03484702|587735544|FG001|Treatment Period|Adverse Event|0|||
162733695|NCT03484702|587735545|FG002|Treatment Period|Adverse Event|0|||
162733696|NCT03484702|587735546|FG003|Treatment Period|Adverse Event|0|||
162733697|NCT03484702|587735547|FG004|Treatment Period|Adverse Event|0|||
162733698|NCT03484702|587735548|FG005|Treatment Period|Adverse Event|0|||
162733699|NCT03484702|587735543|FG000|Treatment Period|Participant Withdrew from Study|0|||
162733700|NCT03484702|587735544|FG001|Treatment Period|Participant Withdrew from Study|1|||
162733701|NCT03484702|587735545|FG002|Treatment Period|Participant Withdrew from Study|0|||
162733702|NCT03484702|587735546|FG003|Treatment Period|Participant Withdrew from Study|0|||
162733703|NCT03484702|587735547|FG004|Treatment Period|Participant Withdrew from Study|0|||
162733704|NCT03484702|587735548|FG005|Treatment Period|Participant Withdrew from Study|0|||
162733705|NCT03484702|587735543|FG000|Treatment Period|Physician Decision|0|||
162733706|NCT03484702|587735544|FG001|Treatment Period|Physician Decision|1|||
162733707|NCT03484702|587735545|FG002|Treatment Period|Physician Decision|0|||
162733708|NCT03484702|587735546|FG003|Treatment Period|Physician Decision|0|||
162733709|NCT03484702|587735547|FG004|Treatment Period|Physician Decision|0|||
162733710|NCT03484702|587735548|FG005|Treatment Period|Physician Decision|1|||
162733711|NCT01894061|587735550|FG000|Overall Study|Screen failure|1|||
162733712|NCT01894061|587735550|FG000|Overall Study|Withdrawal by Subject|1|||
162733713|NCT02840474|587735551|FG000|Overall Study|Lost to Follow-up|1|||
162733714|NCT02840474|587735552|FG001|Overall Study|Lost to Follow-up|0|||
162733715|NCT04638998|587735557|FG000|Overall Study|Withdrawal by Subject|1|||
162733716|NCT04638998|587735558|FG001|Overall Study|Withdrawal by Subject|3|||
162733717|NCT03713086|587735561|FG000|Overall Study|Withdrawal by Subject|0|||
162733718|NCT03713086|587735562|FG001|Overall Study|Withdrawal by Subject|2|||
162733719|NCT03713086|587735563|FG002|Overall Study|Withdrawal by Subject|1|||
162733720|NCT03713086|587735564|FG003|Overall Study|Withdrawal by Subject|0|||
162733721|NCT03713086|587735561|FG000|Overall Study|Lost to Follow-up|0|||
162733722|NCT03713086|587735562|FG001|Overall Study|Lost to Follow-up|1|||
162733723|NCT03713086|587735563|FG002|Overall Study|Lost to Follow-up|0|||
162733724|NCT03713086|587735564|FG003|Overall Study|Lost to Follow-up|1|||
162733725|NCT05374837|587735566|FG000|Overall Study|Lost to Follow-up|17|||
162733726|NCT05374837|587735567|FG001|Overall Study|Lost to Follow-up|18|||
162733727|NCT05406921|587735570|FG000|Overall Study|Withdrawal by Subject|25|||
162733728|NCT05406921|587735571|FG001|Overall Study|Withdrawal by Subject|0|||
162733729|NCT05406921|587735572|FG002|Overall Study|Withdrawal by Subject|25|||
162733730|NCT05406921|587735570|FG000|Overall Study|Protocol Violation|0|||
162733731|NCT05406921|587735571|FG001|Overall Study|Protocol Violation|12|||
162733732|NCT05406921|587735572|FG002|Overall Study|Protocol Violation|0|||
162733733|NCT04831281|587735575|FG000|Overall Study|Adverse Event|1|||
162733734|NCT04831281|587735576|FG001|Overall Study|Adverse Event|0|||
162733735|NCT04831281|587735577|FG002|Overall Study|Adverse Event|3|||
162733736|NCT04831281|587735575|FG000|Overall Study|Withdrawal by Subject|0|||
162733737|NCT04831281|587735576|FG001|Overall Study|Withdrawal by Subject|1|||
162733738|NCT04831281|587735577|FG002|Overall Study|Withdrawal by Subject|2|||
162733739|NCT04831281|587735575|FG000|Overall Study|Undetermined|1|||
162733740|NCT04831281|587735576|FG001|Overall Study|Undetermined|1|||
162733741|NCT04831281|587735577|FG002|Overall Study|Undetermined|0|||
162733742|NCT02249949|587735578|FG000|Overall Study|Cancelled prior to treatment|2|||
162733743|NCT02097420|587735581|FG000|Overall Study|Death|6|||
162733744|NCT02097420|587735581|FG000|Overall Study|Valve explanted|13|||
162733745|NCT02097420|587735581|FG000|Overall Study|Other Reason|1|||
162733746|NCT05691309|587735598|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
162733747|NCT05691309|587735598|FG000|Overall Study|vancomycin levels not evaluable|2|||
162733748|NCT01707030|587735599|FG000|Overall Study|Death|1|||
162733749|NCT01707030|587735600|FG001|Overall Study|Death|1|||
162733750|NCT01707030|587735599|FG000|Overall Study|Withdrawal by Subject|2|||
162733751|NCT01707030|587735600|FG001|Overall Study|Withdrawal by Subject|3|||
162733752|NCT01707030|587735599|FG000|Overall Study|Lost to Follow-up|8|||
162733753|NCT01707030|587735600|FG001|Overall Study|Lost to Follow-up|13|||
162733754|NCT04263311|587735602|FG000|Overall Study|Lost to Follow-up|1|||
162733755|NCT04263311|587735603|FG001|Overall Study|Lost to Follow-up|2|||
162733756|NCT04263311|587735604|FG002|Overall Study|Lost to Follow-up|0|||
162733757|NCT04263311|587735602|FG000|Overall Study|Health Issues|1|||
162733758|NCT04263311|587735603|FG001|Overall Study|Health Issues|0|||
162733759|NCT04263311|587735604|FG002|Overall Study|Health Issues|0|||
162733760|NCT04263311|587735602|FG000|Overall Study|Left the country|1|||
162733761|NCT04263311|587735603|FG001|Overall Study|Left the country|0|||
162733762|NCT04263311|587735604|FG002|Overall Study|Left the country|0|||
162733763|NCT04263311|587735602|FG000|Overall Study|Unable to maintain time commitment|1|||
162733764|NCT04263311|587735603|FG001|Overall Study|Unable to maintain time commitment|0|||
162733765|NCT04263311|587735604|FG002|Overall Study|Unable to maintain time commitment|0|||
162733766|NCT04263311|587735602|FG000|Overall Study|No longer interested|1|||
162733767|NCT04263311|587735603|FG001|Overall Study|No longer interested|0|||
162733768|NCT04263311|587735604|FG002|Overall Study|No longer interested|0|||
162733769|NCT04263311|587735602|FG000|Overall Study|Ineligible post consent|0|||
162733770|NCT04263311|587735603|FG001|Overall Study|Ineligible post consent|0|||
162733771|NCT04263311|587735604|FG002|Overall Study|Ineligible post consent|5|||
162733772|NCT04820855|587735605|FG000|Overall Study|Lost to Follow-up|6|||
162733773|NCT04820855|587735606|FG001|Overall Study|Lost to Follow-up|9|||
162733774|NCT04838262|587735607|FG000|Overall Study|Withdrawal by Subject|9|||
162733775|NCT04838262|587735608|FG001|Overall Study|Withdrawal by Subject|4|||
162733776|NCT02927769|587735609|FG000|Induction Phase|Study drug toxicity|1|||
162733777|NCT02927769|587735610|FG001|Induction Phase|Study drug toxicity|1|||
162733778|NCT02927769|587735609|FG000|Induction Phase|Disease progression|0|||
162733779|NCT02927769|587735610|FG001|Induction Phase|Disease progression|1|||
162733780|NCT02927769|587735609|FG000|Intensification Phase|Study drug toxicity|1|||
162733781|NCT02927769|587735610|FG001|Intensification Phase|Study drug toxicity|0|||
162733782|NCT05524233|587735615|FG000|Overall Study|Lost to Follow-up|2|||
162733783|NCT05524233|587735615|FG000|Overall Study|Adverse Event|2|||
162733784|NCT05524233|587735615|FG000|Overall Study|Withdrawal by Subject|1|||
162733785|NCT02307565|587735617|FG000|Overall Study|Adverse Event|3|||
162733786|NCT02307565|587735618|FG001|Overall Study|Adverse Event|2|||
162733787|NCT02307565|587735617|FG000|Overall Study|Withdrawal by Subject|2|||
162733788|NCT02307565|587735618|FG001|Overall Study|Withdrawal by Subject|2|||
162733789|NCT00650104|587735619|FG000|Overall Study|Adverse Event|17|||
162733790|NCT00650104|587735619|FG000|Overall Study|Death|2|||
162733791|NCT00650104|587735619|FG000|Overall Study|Withdrawal by Subject|11|||
162733792|NCT00650104|587735619|FG000|Overall Study|Physician Decision|7|||
162733793|NCT00650104|587735619|FG000|Overall Study|Lost to Follow-up|1|||
162733794|NCT00650104|587735619|FG000|Overall Study|Non-compliance|2|||
162733795|NCT00650104|587735619|FG000|Overall Study|Sponsor Terminated Dosing|1|||
162733796|NCT00792636|587735620|FG000|Overall Study|Protocol Violation|17|||
162733797|NCT00792636|587735621|FG001|Overall Study|Protocol Violation|23|||
162733798|NCT00792636|587735622|FG002|Overall Study|Protocol Violation|20|||
162733799|NCT00792636|587735620|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
162733800|NCT00792636|587735621|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
162733801|NCT00792636|587735622|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
162733802|NCT00792636|587735620|FG000|Overall Study|Lost to Follow-up|13|||
162733803|NCT00792636|587735621|FG001|Overall Study|Lost to Follow-up|19|||
162733804|NCT00792636|587735622|FG002|Overall Study|Lost to Follow-up|14|||
162733805|NCT00792636|587735620|FG000|Overall Study|Withdrew Consent|10|||
162733806|NCT00792636|587735621|FG001|Overall Study|Withdrew Consent|13|||
162733807|NCT00792636|587735622|FG002|Overall Study|Withdrew Consent|9|||
162733808|NCT00792636|587735620|FG000|Overall Study|Lack of Efficacy|3|||
162733809|NCT00792636|587735621|FG001|Overall Study|Lack of Efficacy|4|||
162733810|NCT00792636|587735622|FG002|Overall Study|Lack of Efficacy|13|||
162733811|NCT00792636|587735620|FG000|Overall Study|Adverse Event|4|||
162733812|NCT00792636|587735621|FG001|Overall Study|Adverse Event|2|||
162733813|NCT00792636|587735622|FG002|Overall Study|Adverse Event|3|||
162733814|NCT00792636|587735620|FG000|Overall Study|Investigator Discretion|2|||
162733815|NCT00792636|587735621|FG001|Overall Study|Investigator Discretion|0|||
162733816|NCT00792636|587735622|FG002|Overall Study|Investigator Discretion|2|||
162733817|NCT05633407|587735627|FG000|Overall Study|Physician Decision|2|||
162733818|NCT05633407|587735628|FG001|Overall Study|Physician Decision|0|||
162733819|NCT05633407|587735627|FG000|Overall Study|Adverse Event|1|||
162733820|NCT05633407|587735628|FG001|Overall Study|Adverse Event|0|||
162733821|NCT05633407|587735627|FG000|Overall Study|Withdrawal by Subject|1|||
162733822|NCT05633407|587735628|FG001|Overall Study|Withdrawal by Subject|0|||
162733823|NCT05633407|587735627|FG000|Overall Study|Other|1|||
162733824|NCT05633407|587735628|FG001|Overall Study|Other|1|||
162733825|NCT04838613|587735630|FG000|Overall Study|Withdrawal by Subject|3|||
162733826|NCT04838613|587735631|FG001|Overall Study|Withdrawal by Subject|6|||
162733827|NCT04838613|587735630|FG000|Overall Study|Protocol Deviation|3|||
162733828|NCT04838613|587735631|FG001|Overall Study|Protocol Deviation|2|||
162733829|NCT04838613|587735630|FG000|Overall Study|Technical Problems|0|||
162733830|NCT04838613|587735631|FG001|Overall Study|Technical Problems|5|||
162733831|NCT04838613|587735630|FG000|Overall Study|Physician Decision|2|||
162733832|NCT04838613|587735631|FG001|Overall Study|Physician Decision|0|||
162733833|NCT04757610|587735632|FG000|Overall Study|Adverse Event|13|||
162733834|NCT04757610|587735633|FG001|Overall Study|Adverse Event|10|||
162733835|NCT04757610|587735634|FG002|Overall Study|Adverse Event|5|||
162733836|NCT04757610|587735632|FG000|Overall Study|Death|5|||
162733837|NCT04757610|587735633|FG001|Overall Study|Death|13|||
162733838|NCT04757610|587735634|FG002|Overall Study|Death|8|||
162733839|NCT04757610|587735632|FG000|Overall Study|Lack of Efficacy|1|||
162733840|NCT04757610|587735633|FG001|Overall Study|Lack of Efficacy|2|||
162733841|NCT04757610|587735634|FG002|Overall Study|Lack of Efficacy|3|||
162733842|NCT04757610|587735632|FG000|Overall Study|Lost to Follow-up|7|||
162733843|NCT04757610|587735633|FG001|Overall Study|Lost to Follow-up|2|||
162733844|NCT04757610|587735634|FG002|Overall Study|Lost to Follow-up|7|||
162733845|NCT04757610|587735632|FG000|Overall Study|Physician Decision|4|||
162733846|NCT04757610|587735633|FG001|Overall Study|Physician Decision|1|||
162733847|NCT04757610|587735634|FG002|Overall Study|Physician Decision|2|||
162733848|NCT04757610|587735632|FG000|Overall Study|Withdrawal by Subject|26|||
162733849|NCT04757610|587735633|FG001|Overall Study|Withdrawal by Subject|25|||
162733850|NCT04757610|587735634|FG002|Overall Study|Withdrawal by Subject|25|||
162733851|NCT04757610|587735632|FG000|Overall Study|Study Terminated by Sponsor|105|||
162733852|NCT04757610|587735633|FG001|Overall Study|Study Terminated by Sponsor|105|||
162733853|NCT04757610|587735634|FG002|Overall Study|Study Terminated by Sponsor|110|||
162733854|NCT04757610|587735632|FG000|Overall Study|Randomized in Error|1|||
162733855|NCT04757610|587735633|FG001|Overall Study|Randomized in Error|0|||
162733856|NCT04757610|587735634|FG002|Overall Study|Randomized in Error|0|||
162733857|NCT00593489|587735639|FG000|Allocation|did not attend workshop; allocation not|2|||
162733858|NCT00593489|587735640|FG001|Allocation|did not attend workshop; allocation not|1|||
162733859|NCT00951379|587735641|FG000|Overall Study|Adverse Event|4|||
162733860|NCT00951379|587735642|FG001|Overall Study|Adverse Event|1|||
162733861|NCT00951379|587735641|FG000|Overall Study|Withdrawal by Subject|1|||
162733862|NCT00951379|587735642|FG001|Overall Study|Withdrawal by Subject|0|||
162733863|NCT00951379|587735641|FG000|Overall Study|Noncompliance|1|||
162733864|NCT00951379|587735642|FG001|Overall Study|Noncompliance|0|||
162733865|NCT00951379|587735641|FG000|Overall Study|Disease Progression|0|||
162733866|NCT00951379|587735642|FG001|Overall Study|Disease Progression|1|||
162733867|NCT03432858|587735643|FG000|Overall Study|Protocol Violation|2|||
162733868|NCT03432858|587735644|FG001|Overall Study|Protocol Violation|1|||
162733869|NCT03432858|587735645|FG002|Overall Study|Protocol Violation|9|||
162733870|NCT03432858|587735643|FG000|Overall Study|Withdrawal by Subject|0|||
162733871|NCT03432858|587735644|FG001|Overall Study|Withdrawal by Subject|1|||
162733872|NCT03432858|587735645|FG002|Overall Study|Withdrawal by Subject|1|||
162733873|NCT03432858|587735643|FG000|Overall Study|Procedure canceled/rescheduled|0|||
162733874|NCT03432858|587735644|FG001|Overall Study|Procedure canceled/rescheduled|9|||
162733875|NCT03432858|587735645|FG002|Overall Study|Procedure canceled/rescheduled|6|||
162733876|NCT03432858|587735643|FG000|Overall Study|Required postop mobilization with splinting|0|||
162733877|NCT03432858|587735644|FG001|Overall Study|Required postop mobilization with splinting|0|||
162733878|NCT03432858|587735645|FG002|Overall Study|Required postop mobilization with splinting|1|||
162733879|NCT01011946|587735646|FG000|Overall Study|Transferred to another hospital|2|||
162733880|NCT01011946|587735646|FG000|Overall Study|No pathological lab value|1|||
162733881|NCT03527160|587735651|FG000|Overall Study|No urine collected|13|||
162733882|NCT03527160|587735651|FG000|Overall Study|No clinical serum creatinine collected|6|||
162733883|NCT03527160|587735651|FG000|Overall Study|Did not meet inclusion|2|||
162733884|NCT01721291|587735653|FG000|Overall Study|Withdrawal by Subject|1|||
162733885|NCT01721291|587735654|FG001|Overall Study|Withdrawal by Subject|0|||
162733886|NCT01721291|587735653|FG000|Overall Study|did not like the treatment|1|||
162733887|NCT01721291|587735654|FG001|Overall Study|did not like the treatment|0|||
162733888|NCT05239039|587735657|FG000|Overall Study|Withdrawal by Subject|0|||
162733889|NCT05239039|587735658|FG001|Overall Study|Withdrawal by Subject|1|||
162733890|NCT03690206|587735659|FG000|Overall Study|Withdrawal by Subject|2|||
162733891|NCT03690206|587735660|FG001|Overall Study|Withdrawal by Subject|0|||
162733892|NCT03690206|587735661|FG002|Overall Study|Withdrawal by Subject|0|||
162733893|NCT03690206|587735659|FG000|Overall Study|ICF withdrawal|2|||
162733894|NCT03690206|587735660|FG001|Overall Study|ICF withdrawal|0|||
162733895|NCT03690206|587735661|FG002|Overall Study|ICF withdrawal|0|||
162733896|NCT03978637|587735663|FG000|Overall Study|Death|0|||
162733897|NCT03978637|587735664|FG001|Overall Study|Death|2|||
162733898|NCT03978637|587735665|FG002|Overall Study|Death|2|||
162733899|NCT03978637|587735666|FG003|Overall Study|Death|0|||
162733900|NCT03978637|587735663|FG000|Overall Study|Withdrawal by Subject|0|||
162733901|NCT03978637|587735664|FG001|Overall Study|Withdrawal by Subject|0|||
162733902|NCT03978637|587735665|FG002|Overall Study|Withdrawal by Subject|1|||
162733903|NCT03978637|587735666|FG003|Overall Study|Withdrawal by Subject|0|||
162733904|NCT03978637|587735663|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
162733905|NCT03978637|587735664|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
162733906|NCT03978637|587735665|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
162733907|NCT03978637|587735666|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
162733908|NCT01959698|587735667|FG000|Overall Study|Adverse Event|0|||
162733909|NCT01959698|587735668|FG001|Overall Study|Adverse Event|0|||
162733910|NCT01959698|587735669|FG002|Overall Study|Adverse Event|0|||
162733911|NCT01959698|587735670|FG003|Overall Study|Adverse Event|0|||
162733912|NCT01959698|587735671|FG004|Overall Study|Adverse Event|0|||
162733913|NCT01959698|587735672|FG005|Overall Study|Adverse Event|0|||
162733914|NCT01959698|587735673|FG006|Overall Study|Adverse Event|1|||
162733915|NCT01959698|587735667|FG000|Overall Study|Physician Decision|1|||
162733916|NCT01959698|587735668|FG001|Overall Study|Physician Decision|0|||
162733917|NCT01959698|587735669|FG002|Overall Study|Physician Decision|1|||
162733918|NCT01959698|587735670|FG003|Overall Study|Physician Decision|2|||
162733919|NCT01959698|587735671|FG004|Overall Study|Physician Decision|0|||
162733920|NCT01959698|587735672|FG005|Overall Study|Physician Decision|3|||
162733921|NCT01959698|587735673|FG006|Overall Study|Physician Decision|3|||
162733922|NCT03819686|587737083|FG000|Overall Study|Lost to Follow-up|2|||
162733923|NCT03819686|587737084|FG001|Overall Study|Lost to Follow-up|3|||
162733924|NCT06143670|587737085|FG000|Overall Study|Lost to Follow-up|0|||
162733925|NCT06143670|587737086|FG001|Overall Study|Lost to Follow-up|1|||
162733926|NCT06143670|587737085|FG000|Overall Study|Withdrawal by Subject|3|||
162733927|NCT06143670|587737086|FG001|Overall Study|Withdrawal by Subject|0|||
162733928|NCT03625882|587737089|FG000|Overall Study|Protocol Violation|3|||
162733929|NCT05058391|587737090|FG000|Overall Study|Adverse Event|1|||
162733930|NCT03833245|587737095|FG000|Overall Study|Death|0|||
162733931|NCT03833245|587737096|FG001|Overall Study|Death|1|||
162733932|NCT03347383|587737097|FG000|Overall Study|Death|39|||
162733933|NCT03347383|587737097|FG000|Overall Study|Withdrawal by Subject|3|||
162733934|NCT03347383|587737097|FG000|Overall Study|Lost to Follow-up|9|||
162733935|NCT04842643|587737099|FG000|Overall Study|Physician Decision|1|||
162733936|NCT04842643|587737099|FG000|Overall Study|Other|1|||
162733937|NCT00739648|587737103|FG000|Overall Study|Adverse Event|3|||
162733938|NCT00739648|587737104|FG001|Overall Study|Adverse Event|15|||
162733939|NCT00739648|587737103|FG000|Overall Study|Withdrawal by Subject|13|||
162733940|NCT00739648|587737104|FG001|Overall Study|Withdrawal by Subject|25|||
162733941|NCT00739648|587737103|FG000|Overall Study|Lost to Follow-up|4|||
162733942|NCT00739648|587737104|FG001|Overall Study|Lost to Follow-up|7|||
162733943|NCT00739648|587737103|FG000|Overall Study|Death|2|||
162733944|NCT00739648|587737104|FG001|Overall Study|Death|0|||
162733945|NCT00739648|587737103|FG000|Overall Study|Do not know|4|||
162733946|NCT00739648|587737104|FG001|Overall Study|Do not know|6|||
162733947|NCT05110495|587737105|FG000|Overall Study|Lost to Follow-up|1|||
162733948|NCT05110495|587737105|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
162733949|NCT04173663|587737106|FG000|Overall Study|Withdrawal by Subject|1|||
162733950|NCT04173663|587737107|FG001|Overall Study|Withdrawal by Subject|6|||
162733951|NCT04173663|587737106|FG000|Overall Study|Lost to Follow-up|17|||
162733952|NCT04173663|587737107|FG001|Overall Study|Lost to Follow-up|24|||
162733953|NCT04716634|587737112|FG000|Overall Study|Death|24|||
162733954|NCT04716634|587737113|FG001|Overall Study|Death|24|||
162733955|NCT04716634|587737114|FG002|Overall Study|Death|8|||
162733956|NCT04716634|587737112|FG000|Overall Study|Closed by Sponsor|4|||
162733957|NCT04716634|587737113|FG001|Overall Study|Closed by Sponsor|4|||
162733958|NCT04716634|587737114|FG002|Overall Study|Closed by Sponsor|5|||
162733959|NCT04716634|587737112|FG000|Overall Study|Lost to Follow-up|1|||
162733960|NCT04716634|587737113|FG001|Overall Study|Lost to Follow-up|0|||
162733961|NCT04716634|587737114|FG002|Overall Study|Lost to Follow-up|1|||
162733962|NCT04716634|587737112|FG000|Overall Study|Withdrawal by Subject|0|||
162733963|NCT04716634|587737113|FG001|Overall Study|Withdrawal by Subject|0|||
162733964|NCT04716634|587737114|FG002|Overall Study|Withdrawal by Subject|1|||
162733965|NCT04833777|587737115|FG000|Overall Study|Lost to Follow-up|1|||
162733966|NCT04833777|587737116|FG001|Overall Study|Lost to Follow-up|0|||
162733967|NCT03089398|587737124|FG000|Overall Study|Death|4|||
162733968|NCT03089398|587737125|FG001|Overall Study|Death|9|||
162733969|NCT03089398|587737124|FG000|Overall Study|Lost to Follow-up|21|||
162733970|NCT03089398|587737125|FG001|Overall Study|Lost to Follow-up|30|||
162733971|NCT03089398|587737124|FG000|Overall Study|Withdrawal by Subject|2|||
162733972|NCT03089398|587737125|FG001|Overall Study|Withdrawal by Subject|2|||
162733973|NCT05418296|587737130|FG000|Overall Study|Withdrawal by Subject|4|||
162733974|NCT05418296|587737131|FG001|Overall Study|Withdrawal by Subject|1|||
162733975|NCT04703322|587737132|FG000|Overall Study|Ongoing|8|||
162733976|NCT04703322|587737132|FG000|Overall Study|Withdrawal by Subject|1|||
162733977|NCT04419168|587737133|FG000|Overall Study|Protocol Violation|1|||
162733978|NCT04419168|587737134|FG001|Overall Study|Protocol Violation|1|||
162733979|NCT04419168|587737133|FG000|Overall Study|Lost to Follow-up|7|||
162733980|NCT04419168|587737134|FG001|Overall Study|Lost to Follow-up|7|||
162733981|NCT04419168|587737133|FG000|Overall Study|Missed 6-month Visit|48|||
162733982|NCT04419168|587737134|FG001|Overall Study|Missed 6-month Visit|45|||
162733983|NCT05009251|587737138|FG000|Overall Study|Protocol Violation|100|||
162733984|NCT05009251|587737139|FG001|Overall Study|Protocol Violation|105|||
162733985|NCT05009251|587737140|FG002|Overall Study|Protocol Violation|119|||
162733986|NCT05009251|587737141|FG003|Overall Study|Protocol Violation|120|||
162733987|NCT05009251|587737142|FG004|Overall Study|Protocol Violation|119|||
162733988|NCT05009251|587737138|FG000|Overall Study|Death|25|||
162733989|NCT05009251|587737139|FG001|Overall Study|Death|22|||
162733990|NCT05009251|587737140|FG002|Overall Study|Death|24|||
162733991|NCT05009251|587737141|FG003|Overall Study|Death|19|||
162733992|NCT05009251|587737142|FG004|Overall Study|Death|15|||
162733993|NCT00676715|587737147|FG000|Treatment Period (TP)|Adverse Event|0|||
162733994|NCT00676715|587737148|FG001|Treatment Period (TP)|Adverse Event|3|||
162733995|NCT00676715|587737149|FG002|Treatment Period (TP)|Adverse Event|2|||
162733996|NCT00676715|587737150|FG003|Treatment Period (TP)|Adverse Event|2|||
162733997|NCT00676715|587737147|FG000|Treatment Period (TP)|Death|0|||
162733998|NCT00676715|587737148|FG001|Treatment Period (TP)|Death|0|||
162733999|NCT00676715|587737149|FG002|Treatment Period (TP)|Death|1|||
162734000|NCT00676715|587737150|FG003|Treatment Period (TP)|Death|0|||
162734001|NCT00676715|587737147|FG000|Treatment Period (TP)|Failure to return|1|||
162734002|NCT00676715|587737148|FG001|Treatment Period (TP)|Failure to return|0|||
162734003|NCT00676715|587737149|FG002|Treatment Period (TP)|Failure to return|0|||
162734004|NCT00676715|587737150|FG003|Treatment Period (TP)|Failure to return|0|||
162734005|NCT00676715|587737147|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162734006|NCT00676715|587737148|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162734007|NCT00676715|587737149|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
162734008|NCT00676715|587737150|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162734009|NCT00676715|587737147|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
162734010|NCT00676715|587737148|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
162734011|NCT00676715|587737149|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
162734012|NCT00676715|587737150|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
162734013|NCT00676715|587737147|FG000|Treatment Period (TP)|Withdrew consent|3|||
162734014|NCT00676715|587737148|FG001|Treatment Period (TP)|Withdrew consent|3|||
162734015|NCT00676715|587737149|FG002|Treatment Period (TP)|Withdrew consent|3|||
162734016|NCT00676715|587737150|FG003|Treatment Period (TP)|Withdrew consent|3|||
162734017|NCT00676715|587737147|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
162734018|NCT00676715|587737148|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
162734019|NCT00676715|587737149|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
162734020|NCT00676715|587737150|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
162734021|NCT00676715|587737147|FG000|Treatment Period (TP)|Administrative|0|||
162734022|NCT00676715|587737148|FG001|Treatment Period (TP)|Administrative|0|||
162734023|NCT00676715|587737149|FG002|Treatment Period (TP)|Administrative|0|||
162734024|NCT00676715|587737150|FG003|Treatment Period (TP)|Administrative|1|||
162734025|NCT00676715|587737147|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
162734026|NCT00676715|587737148|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
162734027|NCT00676715|587737149|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
162734028|NCT00676715|587737150|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
162734029|NCT00676715|587737147|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
162734030|NCT00676715|587737148|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
162734031|NCT00676715|587737149|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
162734032|NCT00676715|587737150|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
162734033|NCT00676715|587737147|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162734034|NCT00676715|587737148|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162734035|NCT00676715|587737149|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
162734036|NCT00676715|587737150|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162734037|NCT00676715|587737147|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
162734038|NCT00676715|587737148|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
162734039|NCT00676715|587737149|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
162734040|NCT00676715|587737150|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
162734041|NCT00676715|587737147|FG000|Treatment-free Period (TFP)|Death|1|||
162734042|NCT00676715|587737148|FG001|Treatment-free Period (TFP)|Death|1|||
162734043|NCT00676715|587737149|FG002|Treatment-free Period (TFP)|Death|1|||
162734044|NCT00676715|587737150|FG003|Treatment-free Period (TFP)|Death|0|||
162734045|NCT00676715|587737147|FG000|Open Label Extension (OLE)|Reason not provided|3|||
162734046|NCT00676715|587737148|FG001|Open Label Extension (OLE)|Reason not provided|4|||
162734047|NCT00676715|587737149|FG002|Open Label Extension (OLE)|Reason not provided|1|||
162734048|NCT00676715|587737150|FG003|Open Label Extension (OLE)|Reason not provided|4|||
162734049|NCT00676715|587737147|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
162734050|NCT00676715|587737148|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
162734051|NCT00676715|587737149|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
162734052|NCT00676715|587737150|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
162734053|NCT00676715|587737147|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
162734054|NCT00676715|587737148|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
162734055|NCT00676715|587737149|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
162734056|NCT00676715|587737150|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
162734057|NCT00676715|587737147|FG000|Open Label Extension (OLE)|Adverse Event|0|||
162734058|NCT00676715|587737148|FG001|Open Label Extension (OLE)|Adverse Event|3|||
162734059|NCT00676715|587737149|FG002|Open Label Extension (OLE)|Adverse Event|1|||
162734060|NCT00676715|587737150|FG003|Open Label Extension (OLE)|Adverse Event|0|||
162734061|NCT00676715|587737147|FG000|Open Label Extension (OLE)|Death|2|||
162734062|NCT00676715|587737148|FG001|Open Label Extension (OLE)|Death|0|||
162734063|NCT00676715|587737149|FG002|Open Label Extension (OLE)|Death|2|||
162734064|NCT00676715|587737150|FG003|Open Label Extension (OLE)|Death|2|||
162734065|NCT05249439|587737151|FG000|Overall Study|Withdrawal by Subject|2|||
162734066|NCT05249439|587737152|FG001|Overall Study|Withdrawal by Subject|5|||
162734067|NCT05249439|587737151|FG000|Overall Study|Physician Decision|3|||
162734068|NCT05249439|587737152|FG001|Overall Study|Physician Decision|1|||
162734069|NCT00616967|587737153|FG000|Overall Study|Withdrawal by Subject|0|||
162734070|NCT00616967|587737154|FG001|Overall Study|Withdrawal by Subject|0|||
162734071|NCT00616967|587737155|FG002|Overall Study|Withdrawal by Subject|1|||
162734072|NCT05059262|587737157|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
162734073|NCT05059262|587737158|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
162734074|NCT05059262|587737157|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
162734075|NCT05059262|587737158|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
162734076|NCT05059262|587737157|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
162734077|NCT05059262|587737158|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
162734078|NCT05059262|587737157|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
162734079|NCT05059262|587737158|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
162734080|NCT05059262|587737157|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
162734081|NCT05059262|587737158|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
162734082|NCT05059262|587737157|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
162734083|NCT05059262|587737158|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
162734084|NCT05059262|587737157|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
162734085|NCT05059262|587737158|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
162734086|NCT05059262|587737157|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
162734087|NCT05059262|587737158|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
162734088|NCT05059262|587737157|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
162734089|NCT05059262|587737158|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
162734090|NCT02312960|587737160|FG000|Overall Study|Death|24|||
162734091|NCT02312960|587737161|FG001|Overall Study|Death|32|||
162734092|NCT02312960|587737162|FG002|Overall Study|Death|25|||
162734093|NCT02312960|587737163|FG003|Overall Study|Death|11|||
162734094|NCT02312960|587737164|FG004|Overall Study|Death|5|||
162734095|NCT02312960|587737165|FG005|Overall Study|Death|5|||
162734096|NCT02312960|587737166|FG006|Overall Study|Death|8|||
162734097|NCT02312960|587737167|FG007|Overall Study|Death|5|||
162734098|NCT02312960|587737168|FG008|Overall Study|Death|7|||
162734099|NCT02312960|587737169|FG009|Overall Study|Death|3|||
162734100|NCT02312960|587737170|FG010|Overall Study|Death|3|||
162734101|NCT02312960|587737171|FG011|Overall Study|Death|1|||
162734102|NCT02312960|587737172|FG012|Overall Study|Death|25|||
162734103|NCT02312960|587737173|FG013|Overall Study|Death|19|||
162734104|NCT02312960|587737160|FG000|Overall Study|Missing|0|||
162734105|NCT02312960|587737161|FG001|Overall Study|Missing|0|||
162734106|NCT02312960|587737162|FG002|Overall Study|Missing|2|||
162734107|NCT02312960|587737163|FG003|Overall Study|Missing|0|||
162734108|NCT02312960|587737164|FG004|Overall Study|Missing|0|||
162734109|NCT02312960|587737165|FG005|Overall Study|Missing|0|||
162734110|NCT02312960|587737166|FG006|Overall Study|Missing|0|||
162734111|NCT02312960|587737167|FG007|Overall Study|Missing|0|||
162734112|NCT02312960|587737168|FG008|Overall Study|Missing|0|||
162734113|NCT02312960|587737169|FG009|Overall Study|Missing|0|||
162734114|NCT02312960|587737170|FG010|Overall Study|Missing|0|||
162734115|NCT02312960|587737171|FG011|Overall Study|Missing|0|||
162734116|NCT02312960|587737172|FG012|Overall Study|Missing|0|||
162734117|NCT02312960|587737173|FG013|Overall Study|Missing|0|||
162734118|NCT02312960|587737160|FG000|Overall Study|Lost to Follow-up|0|||
162734119|NCT02312960|587737161|FG001|Overall Study|Lost to Follow-up|0|||
162734120|NCT02312960|587737162|FG002|Overall Study|Lost to Follow-up|1|||
162734121|NCT02312960|587737163|FG003|Overall Study|Lost to Follow-up|0|||
162734122|NCT02312960|587737164|FG004|Overall Study|Lost to Follow-up|0|||
162734123|NCT02312960|587737165|FG005|Overall Study|Lost to Follow-up|0|||
162734124|NCT02312960|587737166|FG006|Overall Study|Lost to Follow-up|1|||
162734125|NCT02312960|587737167|FG007|Overall Study|Lost to Follow-up|1|||
162734126|NCT02312960|587737168|FG008|Overall Study|Lost to Follow-up|0|||
162734127|NCT02312960|587737169|FG009|Overall Study|Lost to Follow-up|1|||
162734128|NCT02312960|587737170|FG010|Overall Study|Lost to Follow-up|0|||
162734129|NCT02312960|587737171|FG011|Overall Study|Lost to Follow-up|0|||
162734130|NCT02312960|587737172|FG012|Overall Study|Lost to Follow-up|1|||
162734131|NCT02312960|587737173|FG013|Overall Study|Lost to Follow-up|0|||
162734132|NCT02312960|587737160|FG000|Overall Study|Withdrawal by Subject|1|||
162734133|NCT02312960|587737161|FG001|Overall Study|Withdrawal by Subject|2|||
162734134|NCT02312960|587737162|FG002|Overall Study|Withdrawal by Subject|0|||
162734135|NCT02312960|587737163|FG003|Overall Study|Withdrawal by Subject|0|||
162734136|NCT02312960|587737164|FG004|Overall Study|Withdrawal by Subject|1|||
162734137|NCT02312960|587737165|FG005|Overall Study|Withdrawal by Subject|0|||
162734138|NCT02312960|587737166|FG006|Overall Study|Withdrawal by Subject|1|||
162734139|NCT02312960|587737167|FG007|Overall Study|Withdrawal by Subject|2|||
162734140|NCT02312960|587737168|FG008|Overall Study|Withdrawal by Subject|2|||
162734141|NCT02312960|587737169|FG009|Overall Study|Withdrawal by Subject|3|||
162734142|NCT02312960|587737170|FG010|Overall Study|Withdrawal by Subject|0|||
162734143|NCT02312960|587737171|FG011|Overall Study|Withdrawal by Subject|0|||
162734144|NCT02312960|587737172|FG012|Overall Study|Withdrawal by Subject|2|||
162734145|NCT02312960|587737173|FG013|Overall Study|Withdrawal by Subject|0|||
162734146|NCT03131648|587737174|FG000|Initial Treatment Period|Not dosed|2|||
162734147|NCT03131648|587737175|FG001|Initial Treatment Period|Not dosed|2|||
162734148|NCT03131648|587737176|FG002|Initial Treatment Period|Not dosed|0|||
162734149|NCT03131648|587737177|FG003|Initial Treatment Period|Not dosed|0|||
162734150|NCT03131648|587737178|FG004|Initial Treatment Period|Not dosed|0|||
162734151|NCT03131648|587737179|FG005|Initial Treatment Period|Not dosed|0|||
162734152|NCT03131648|587737180|FG006|Initial Treatment Period|Not dosed|0|||
162734153|NCT03131648|587737181|FG007|Initial Treatment Period|Not dosed|0|||
162734154|NCT03131648|587737174|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
162734155|NCT03131648|587737175|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
162734156|NCT03131648|587737176|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734157|NCT03131648|587737177|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734158|NCT03131648|587737178|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734159|NCT03131648|587737179|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734160|NCT03131648|587737180|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734161|NCT03131648|587737181|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162734162|NCT03131648|587737174|FG000|Open-label Treatment|Discontinued IMP|0|||
162734163|NCT03131648|587737175|FG001|Open-label Treatment|Discontinued IMP|0|||
162734164|NCT03131648|587737176|FG002|Open-label Treatment|Discontinued IMP|0|||
162734165|NCT03131648|587737177|FG003|Open-label Treatment|Discontinued IMP|0|||
162734166|NCT03131648|587737178|FG004|Open-label Treatment|Discontinued IMP|0|||
162734167|NCT03131648|587737179|FG005|Open-label Treatment|Discontinued IMP|0|||
162734168|NCT03131648|587737180|FG006|Open-label Treatment|Discontinued IMP|112|||
162734169|NCT03131648|587737181|FG007|Open-label Treatment|Discontinued IMP|0|||
162734170|NCT03131648|587737174|FG000|Open-label Treatment|Completed Week 50|0|||
162734171|NCT03131648|587737175|FG001|Open-label Treatment|Completed Week 50|0|||
162734172|NCT03131648|587737176|FG002|Open-label Treatment|Completed Week 50|0|||
162734173|NCT03131648|587737177|FG003|Open-label Treatment|Completed Week 50|0|||
162734174|NCT03131648|587737178|FG004|Open-label Treatment|Completed Week 50|0|||
162734175|NCT03131648|587737179|FG005|Open-label Treatment|Completed Week 50|0|||
162734176|NCT03131648|587737180|FG006|Open-label Treatment|Completed Week 50|6|||
162734177|NCT03131648|587737181|FG007|Open-label Treatment|Completed Week 50|0|||
162734178|NCT03131648|587737174|FG000|Maintenance Treatment Period|Not dosed|0|||
162734179|NCT03131648|587737175|FG001|Maintenance Treatment Period|Not dosed|0|||
162734180|NCT03131648|587737176|FG002|Maintenance Treatment Period|Not dosed|3|||
162734181|NCT03131648|587737177|FG003|Maintenance Treatment Period|Not dosed|2|||
162734182|NCT03131648|587737178|FG004|Maintenance Treatment Period|Not dosed|1|||
162734183|NCT03131648|587737179|FG005|Maintenance Treatment Period|Not dosed|0|||
162734184|NCT03131648|587737180|FG006|Maintenance Treatment Period|Not dosed|0|||
162734185|NCT03131648|587737181|FG007|Maintenance Treatment Period|Not dosed|0|||
162734186|NCT03131648|587737174|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
162734187|NCT03131648|587737175|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
162734188|NCT03131648|587737176|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
162734189|NCT03131648|587737177|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
162734190|NCT03131648|587737178|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
162734191|NCT03131648|587737179|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
162734192|NCT03131648|587737180|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
162734193|NCT03131648|587737181|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
162734194|NCT03131648|587737174|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162734195|NCT03131648|587737175|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162734196|NCT03131648|587737176|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
162734197|NCT03131648|587737177|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
162734198|NCT03131648|587737178|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
162734199|NCT03131648|587737179|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
162734200|NCT03131648|587737180|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162734201|NCT03131648|587737181|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162734202|NCT03131648|587737174|FG000|Maintenance Treatment Period|Completed Week 50|0|||
162734203|NCT03131648|587737175|FG001|Maintenance Treatment Period|Completed Week 50|0|||
162734204|NCT03131648|587737176|FG002|Maintenance Treatment Period|Completed Week 50|0|||
162734205|NCT03131648|587737177|FG003|Maintenance Treatment Period|Completed Week 50|0|||
162734206|NCT03131648|587737178|FG004|Maintenance Treatment Period|Completed Week 50|1|||
162734207|NCT03131648|587737179|FG005|Maintenance Treatment Period|Completed Week 50|0|||
162734208|NCT03131648|587737180|FG006|Maintenance Treatment Period|Completed Week 50|0|||
162734209|NCT03131648|587737181|FG007|Maintenance Treatment Period|Completed Week 50|0|||
162734210|NCT03131648|587737174|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734211|NCT03131648|587737175|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734212|NCT03131648|587737176|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734213|NCT03131648|587737177|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734214|NCT03131648|587737178|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734215|NCT03131648|587737179|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734216|NCT03131648|587737180|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
162734217|NCT03131648|587737181|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
162734218|NCT02724878|587737182|FG000|Overall Study|Still on Active Therapy|15|||
162734219|NCT02724878|587737182|FG000|Overall Study|Disease Progression|31|||
162734220|NCT02724878|587737182|FG000|Overall Study|Toxicity|5|||
162734221|NCT02724878|587737182|FG000|Overall Study|Death|1|||
162734222|NCT02724878|587737182|FG000|Overall Study|Withdrawal by Subject|4|||
162734223|NCT02724878|587737182|FG000|Overall Study|Lost to Follow-up|2|||
162734224|NCT02724878|587737182|FG000|Overall Study|Protocol Violation|1|||
162734225|NCT02724878|587737182|FG000|Overall Study|Ineligible for Study Drug|5|||
162734226|NCT02724878|587737182|FG000|Overall Study|not started|1|||
162734227|NCT03436745|587737183|FG000|Overall Study|Ineligible|0|||
162734228|NCT03436745|587737184|FG001|Overall Study|Ineligible|0|||
162734229|NCT03436745|587737185|FG002|Overall Study|Ineligible|1|||
162734230|NCT01772472|587737193|FG000|Overall Study|Death|126|||
162734231|NCT01772472|587737194|FG001|Overall Study|Death|94|||
162734232|NCT01772472|587737193|FG000|Overall Study|Lost to Follow-up|51|||
162734233|NCT01772472|587737194|FG001|Overall Study|Lost to Follow-up|50|||
162734234|NCT01772472|587737193|FG000|Overall Study|Other|9|||
162734235|NCT01772472|587737194|FG001|Overall Study|Other|7|||
162734236|NCT01772472|587737193|FG000|Overall Study|Physician Decision|1|||
162734237|NCT01772472|587737194|FG001|Overall Study|Physician Decision|7|||
162734238|NCT01772472|587737193|FG000|Overall Study|Withdrawal by Subject|115|||
162734239|NCT01772472|587737194|FG001|Overall Study|Withdrawal by Subject|90|||
162734240|NCT01772472|587737193|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
162734241|NCT01772472|587737194|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
162734242|NCT02697136|587737195|FG000|Overall Study|Adverse Event|3|||
162734243|NCT02697136|587737196|FG001|Overall Study|Adverse Event|0|||
162734244|NCT04391894|587737197|FG000|Overall Study|Adverse Event|1|||
162734245|NCT04391894|587737198|FG001|Overall Study|Adverse Event|1|||
162734246|NCT04391894|587737199|FG002|Overall Study|Adverse Event|1|||
162734247|NCT04391894|587737200|FG003|Overall Study|Adverse Event|1|||
162734248|NCT04391894|587737201|FG004|Overall Study|Adverse Event|1|||
162734249|NCT04391894|587737197|FG000|Overall Study|Lost to Follow-up|1|||
162734250|NCT04391894|587737198|FG001|Overall Study|Lost to Follow-up|0|||
162734251|NCT04391894|587737199|FG002|Overall Study|Lost to Follow-up|0|||
162734252|NCT04391894|587737200|FG003|Overall Study|Lost to Follow-up|0|||
162734253|NCT04391894|587737201|FG004|Overall Study|Lost to Follow-up|0|||
162734254|NCT04391894|587737197|FG000|Overall Study|Protocol Violation|0|||
162734255|NCT04391894|587737198|FG001|Overall Study|Protocol Violation|0|||
162734256|NCT04391894|587737199|FG002|Overall Study|Protocol Violation|0|||
162734257|NCT04391894|587737200|FG003|Overall Study|Protocol Violation|1|||
162734258|NCT04391894|587737201|FG004|Overall Study|Protocol Violation|0|||
162734259|NCT04391894|587737197|FG000|Overall Study|Withdrawal by Subject|2|||
162734260|NCT04391894|587737198|FG001|Overall Study|Withdrawal by Subject|0|||
162734261|NCT04391894|587737199|FG002|Overall Study|Withdrawal by Subject|3|||
162734262|NCT04391894|587737200|FG003|Overall Study|Withdrawal by Subject|0|||
162734263|NCT04391894|587737201|FG004|Overall Study|Withdrawal by Subject|1|||
162734264|NCT04391894|587737197|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
162734265|NCT04391894|587737198|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
162734266|NCT04391894|587737199|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
162734267|NCT04391894|587737200|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
162734268|NCT04391894|587737201|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
162734269|NCT02323321|587737205|FG000|Overall Study|Re-Transplant|1|||
162734270|NCT02323321|587737205|FG000|Overall Study|Death|12|||
162734271|NCT00446225|587737206|FG000|Overall Study|Protocol Violation|1|||
162734272|NCT00446225|587737207|FG001|Overall Study|Protocol Violation|0|||
162734273|NCT02500758|587737210|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
162734274|NCT02500758|587737211|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
162734275|NCT02500758|587737210|FG000|Washout (1 Week)|Lost to Follow-up|2|||
162734276|NCT02500758|587737211|FG001|Washout (1 Week)|Lost to Follow-up|2|||
162734277|NCT02500758|587737210|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
162734278|NCT02500758|587737211|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
162734279|NCT02500758|587737210|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
162734280|NCT02500758|587737211|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
162734281|NCT02500758|587737210|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
162734282|NCT02500758|587737211|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
162734283|NCT00220740|587737212|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
162734284|NCT00220740|587737213|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
162734285|NCT00220740|587737212|FG000|Efficacy Period|Adverse Event|1|||
162734286|NCT00220740|587737213|FG001|Efficacy Period|Adverse Event|1|||
162734287|NCT00220740|587737212|FG000|Efficacy Period|Withdrawal by Subject|1|||
162734288|NCT00220740|587737213|FG001|Efficacy Period|Withdrawal by Subject|0|||
162734289|NCT00220740|587737212|FG000|Efficacy Period|Protocol Violation|1|||
162734290|NCT00220740|587737213|FG001|Efficacy Period|Protocol Violation|0|||
162734291|NCT00220740|587737212|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
162734292|NCT00220740|587737213|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
162734293|NCT01057433|587737214|FG000|Overall Study|Adverse Event|1|||
162734294|NCT05792423|587737216|FG000|Overall Study|Withdrawal by Subject|2|||
162734295|NCT02662062|587739070|FG000|Overall Study|Withdrawal by Subject|1|||
162734296|NCT02910583|587739072|FG000|Overall Study|Death|7|||
162734297|NCT02910583|587739073|FG001|Overall Study|Death|3|||
162734298|NCT02910583|587739072|FG000|Overall Study|Lost to Follow-up|1|||
162734299|NCT02910583|587739073|FG001|Overall Study|Lost to Follow-up|0|||
162734300|NCT02910583|587739072|FG000|Overall Study|Withdrawal by Subject|12|||
162734301|NCT02910583|587739073|FG001|Overall Study|Withdrawal by Subject|8|||
162734302|NCT02910583|587739072|FG000|Overall Study|Other, Not Specified|6|||
162734303|NCT02910583|587739073|FG001|Overall Study|Other, Not Specified|3|||
162734304|NCT01331005|587739074|FG000|Overall Study|Lost to Follow-up|2|||
162734305|NCT01331005|587739075|FG001|Overall Study|Lost to Follow-up|1|||
162734306|NCT01331005|587739074|FG000|Overall Study|Withdrawal by Subject|2|||
162734307|NCT01331005|587739075|FG001|Overall Study|Withdrawal by Subject|3|||
162734308|NCT03161379|587739086|FG000|Overall Study|Withdrawal by Subject|4|||
162734309|NCT03161379|587739086|FG000|Overall Study|disease progression during chemotherapy|5|||
162734310|NCT03161379|587739086|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
162734311|NCT03161379|587739086|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
162734312|NCT05021640|587739087|FG000|Overall Study|Lost to Follow-up|0|||
162734313|NCT05021640|587739088|FG001|Overall Study|Lost to Follow-up|0|||
162734314|NCT05021640|587739089|FG002|Overall Study|Lost to Follow-up|0|||
162734315|NCT05021640|587739090|FG003|Overall Study|Lost to Follow-up|0|||
162734316|NCT05021640|587739091|FG004|Overall Study|Lost to Follow-up|1|||
162734317|NCT03779204|587739093|FG000|Overall Study|Lost to Follow-up|2|||
162734318|NCT03779204|587739094|FG001|Overall Study|Lost to Follow-up|0|||
162734319|NCT03315754|587739097|FG000|Overall Study|COVID-19 complications leading to death|1|||
162734320|NCT03315754|587739097|FG000|Overall Study|insurance coverage issue|1|||
162734321|NCT02954341|587739098|FG000|Overall Study|Attempted Implant unsuccessful|5|||
162734322|NCT02954341|587739098|FG000|Overall Study|Death|90|||
162734323|NCT02954341|587739098|FG000|Overall Study|Withdrawal by Subject|4|||
162734324|NCT02954341|587739098|FG000|Overall Study|Physician Decision|13|||
162734325|NCT02954341|587739098|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
162734326|NCT02954341|587739098|FG000|Overall Study|Not implanted due to physician's decision|1|||
162734327|NCT02954341|587739098|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
162734328|NCT05227209|587739099|FG000|Overall Study|Adverse Event|11|||
162734329|NCT05227209|587739099|FG000|Overall Study|Lost to Follow-up|1|||
162734330|NCT05227209|587739099|FG000|Overall Study|Withdrawal by Subject|7|||
162734331|NCT05227209|587739099|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
162734332|NCT05633953|587739100|FG000|Overall Study|Adverse Event|7|||
162734333|NCT05633953|587739100|FG000|Overall Study|Death|30|||
162734334|NCT05633953|587739100|FG000|Overall Study|Lost to Follow-up|1|||
162734335|NCT05633953|587739100|FG000|Overall Study|Osilodrostat discontinued|4|||
162734336|NCT05633953|587739100|FG000|Overall Study|Physician Decision|1|||
162734337|NCT05633953|587739100|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
162734338|NCT05633953|587739100|FG000|Overall Study|Progressive disease|2|||
162734339|NCT04245501|587739116|FG000|Overall Study|Adverse Event|2|||
162734340|NCT04245501|587739117|FG001|Overall Study|Adverse Event|0|||
162734341|NCT04245501|587739116|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
162734342|NCT04245501|587739117|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
162734343|NCT03526861|587739119|FG000|Initial Treatment Period|Not dosed|1|||
162734344|NCT03526861|587739120|FG001|Initial Treatment Period|Not dosed|1|||
162734345|NCT03526861|587739121|FG002|Initial Treatment Period|Not dosed|1|||
162734346|NCT03526861|587739122|FG003|Initial Treatment Period|Not dosed|0|||
162734347|NCT03526861|587739123|FG004|Initial Treatment Period|Not dosed|0|||
162734348|NCT03526861|587739124|FG005|Initial Treatment Period|Not dosed|0|||
162734349|NCT03526861|587739125|FG006|Initial Treatment Period|Not dosed|0|||
162734350|NCT03526861|587739126|FG007|Initial Treatment Period|Not dosed|0|||
162734351|NCT03526861|587739127|FG008|Initial Treatment Period|Not dosed|0|||
162734352|NCT03526861|587739119|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
162734353|NCT03526861|587739120|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
162734354|NCT03526861|587739121|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
162736274|NCT01494662|587744949|FG002|Overall Study|Withdrawal by Subject|1|||
162734355|NCT03526861|587739122|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734356|NCT03526861|587739123|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734357|NCT03526861|587739124|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734358|NCT03526861|587739125|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734359|NCT03526861|587739126|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734360|NCT03526861|587739127|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734361|NCT03526861|587739119|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
162734362|NCT03526861|587739120|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
162734363|NCT03526861|587739121|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
162734364|NCT03526861|587739122|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734365|NCT03526861|587739123|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734366|NCT03526861|587739124|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734367|NCT03526861|587739125|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734368|NCT03526861|587739126|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734369|NCT03526861|587739127|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162734370|NCT03526861|587739119|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734371|NCT03526861|587739120|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734372|NCT03526861|587739121|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734373|NCT03526861|587739122|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162734374|NCT03526861|587739123|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162734375|NCT03526861|587739124|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734376|NCT03526861|587739125|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162734377|NCT03526861|587739126|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734378|NCT03526861|587739127|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734379|NCT03526861|587739119|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162734380|NCT03526861|587739120|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162734381|NCT03526861|587739121|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162734382|NCT03526861|587739122|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
162734383|NCT03526861|587739123|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
162734384|NCT03526861|587739124|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
162734385|NCT03526861|587739125|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
162734386|NCT03526861|587739126|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
162734387|NCT03526861|587739127|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162734388|NCT03526861|587739119|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734389|NCT03526861|587739120|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734390|NCT03526861|587739121|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734391|NCT03526861|587739122|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
162734392|NCT03526861|587739123|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734393|NCT03526861|587739124|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734394|NCT03526861|587739125|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734395|NCT03526861|587739126|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734396|NCT03526861|587739127|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734397|NCT03526861|587739119|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734398|NCT03526861|587739120|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734399|NCT03526861|587739121|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734400|NCT03526861|587739122|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734401|NCT03526861|587739123|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734402|NCT03526861|587739124|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734403|NCT03526861|587739125|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734404|NCT03526861|587739126|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162734405|NCT03526861|587739127|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
162734406|NCT03526861|587739119|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734407|NCT03526861|587739120|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734408|NCT03526861|587739121|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734409|NCT03526861|587739122|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734410|NCT03526861|587739123|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734411|NCT03526861|587739124|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734412|NCT03526861|587739125|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734413|NCT03526861|587739126|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162734414|NCT03526861|587739127|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
162734415|NCT03526861|587739119|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734416|NCT03526861|587739120|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734417|NCT03526861|587739121|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734418|NCT03526861|587739122|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734419|NCT03526861|587739123|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734420|NCT03526861|587739124|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734421|NCT03526861|587739125|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734422|NCT03526861|587739126|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162734423|NCT03526861|587739127|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
162734424|NCT05337748|587739132|FG000|Overall Study|Withdrawal by Subject|1|||
162734425|NCT05337748|587739133|FG001|Overall Study|Withdrawal by Subject|0|||
162734426|NCT05337748|587739132|FG000|Overall Study|Death|1|||
162734427|NCT05337748|587739133|FG001|Overall Study|Death|0|||
162734428|NCT02506959|587739134|FG000|Overall Study|Physician Decision|2|||
162734429|NCT02506959|587739135|FG001|Overall Study|Physician Decision|1|||
162734430|NCT04541706|587739137|FG000|Overall Study|Withdrawal by Subject|3|||
162734431|NCT04541706|587739137|FG000|Overall Study|Progressive disease|33|||
162734432|NCT04541706|587739137|FG000|Overall Study|Physician Decision|1|||
162734433|NCT04541706|587739137|FG000|Overall Study|Lost to Follow-up|2|||
162734434|NCT04541706|587739137|FG000|Overall Study|Death|5|||
162734435|NCT04541706|587739137|FG000|Overall Study|Adverse Event|1|||
162734436|NCT05323084|587739141|FG000|Period 2 - Washout|Lost to Follow-up|0|||
162734437|NCT05323084|587739142|FG001|Period 2 - Washout|Lost to Follow-up|1|||
162734438|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
162734439|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
162734440|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
162734441|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734442|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734443|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734444|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734445|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734446|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734447|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734448|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734449|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734450|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162734451|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
162734452|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
162734453|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734454|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734455|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734456|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734457|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734458|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734459|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734460|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734461|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734462|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734463|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162734464|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
162734465|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
162734466|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734467|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734468|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734469|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734470|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734471|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734472|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734473|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734474|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734475|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734476|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162734477|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
162734478|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
162734479|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734480|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734481|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734482|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734483|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734484|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734485|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734486|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734487|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734488|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734489|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162734490|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
162734491|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
162734492|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
162734493|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734494|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734495|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734496|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734497|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734498|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734499|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734500|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734501|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734502|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162734503|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162734504|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162734505|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162734506|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734507|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734508|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734509|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734510|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734511|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734512|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734513|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734514|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734515|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162734516|NCT01261312|587739143|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
162734517|NCT01261312|587739144|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734518|NCT01261312|587739145|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
162734519|NCT01261312|587739146|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734520|NCT01261312|587739147|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734521|NCT01261312|587739148|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734522|NCT01261312|587739149|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734523|NCT01261312|587739150|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734524|NCT01261312|587739151|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734525|NCT01261312|587739152|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734526|NCT01261312|587739153|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734527|NCT01261312|587739154|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734528|NCT01261312|587739155|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162734529|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734530|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734531|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734532|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
162734533|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
162734534|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
162734535|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734536|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734537|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734538|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734539|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734540|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734541|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162734542|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734543|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734544|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734545|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734546|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
162734547|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
162734548|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734549|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734550|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734551|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734552|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734553|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734554|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162734555|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734556|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734557|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734558|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734559|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
162734560|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
162734561|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734562|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734563|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734564|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734565|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734566|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734567|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162734568|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734569|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734570|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734571|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
162734572|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
162734573|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
162734574|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734575|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734576|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734577|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734578|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734579|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734580|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
162734581|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734582|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734583|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734584|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734585|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734586|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
162734587|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734588|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734589|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734590|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734591|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734592|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734593|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162734594|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734595|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734596|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734597|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
162734598|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
162734599|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
162734600|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734601|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734602|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734603|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734604|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734605|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734606|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162734607|NCT01261312|587739143|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734608|NCT01261312|587739144|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734609|NCT01261312|587739145|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734610|NCT01261312|587739146|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
162734611|NCT01261312|587739147|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
162734612|NCT01261312|587739148|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
162734613|NCT01261312|587739149|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734614|NCT01261312|587739150|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734615|NCT01261312|587739151|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734616|NCT01261312|587739152|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734617|NCT01261312|587739153|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734618|NCT01261312|587739154|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734619|NCT01261312|587739155|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162734620|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734621|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734622|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734623|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734624|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734625|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734626|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
162734627|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
162734628|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
162734629|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734630|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734631|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734632|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162734633|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734634|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734635|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734636|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734637|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734638|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734639|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734640|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
162734641|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
162734642|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734643|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734644|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734645|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162734646|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734647|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734648|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734649|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734650|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734651|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734652|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
162734653|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
162734654|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
162734655|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734656|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734657|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734658|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162734659|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
162734660|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
162734661|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
162734662|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
162734663|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
162734664|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
162734665|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
162734666|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
162734667|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
162734668|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
162734669|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
162734670|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
162734671|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
162734672|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734673|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734674|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734675|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734676|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734677|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734678|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
162734679|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
162734680|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
162734681|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734682|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734683|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734684|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162734685|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734686|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734687|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734688|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734689|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734690|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734691|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
162734692|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
162734693|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
162734694|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734695|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734696|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734697|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162734698|NCT01261312|587739143|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734699|NCT01261312|587739144|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734700|NCT01261312|587739145|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734701|NCT01261312|587739146|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734702|NCT01261312|587739147|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734703|NCT01261312|587739148|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734704|NCT01261312|587739149|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
162734705|NCT01261312|587739150|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
162734706|NCT01261312|587739151|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
162734707|NCT01261312|587739152|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734708|NCT01261312|587739153|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734709|NCT01261312|587739154|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734710|NCT01261312|587739155|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162734711|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734712|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734713|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734714|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734715|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734716|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734717|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734718|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734719|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162734720|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
162734721|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
162734722|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
162734723|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
162734724|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734725|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734726|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734727|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734728|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734729|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734730|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734731|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734732|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734733|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
162734734|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162734735|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
162734736|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
162734737|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734738|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734739|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734740|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734741|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734742|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734743|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734744|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734745|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162734746|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
162734747|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
162734748|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
162734749|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
162734750|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734751|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734752|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734753|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734754|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734755|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734756|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734757|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734758|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162734759|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
162734760|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
162734761|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
162734762|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
162734763|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734764|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734765|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734766|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734767|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734768|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734769|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734770|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734771|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162734772|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
162734773|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
162734774|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
162734775|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
162734776|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734777|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734778|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734779|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734780|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734781|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734782|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734783|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734784|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162734785|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
162734786|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
162734787|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
162734788|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
162734789|NCT01261312|587739143|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734790|NCT01261312|587739144|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734791|NCT01261312|587739145|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734792|NCT01261312|587739146|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734793|NCT01261312|587739147|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734794|NCT01261312|587739148|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734795|NCT01261312|587739149|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734796|NCT01261312|587739150|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734797|NCT01261312|587739151|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162734798|NCT01261312|587739152|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162734799|NCT01261312|587739153|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162734800|NCT01261312|587739154|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162734801|NCT01261312|587739155|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
162734802|NCT04294225|587739156|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
162734803|NCT04294225|587739156|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
162734804|NCT04294225|587739156|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
162734805|NCT04294225|587739156|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
162734806|NCT04294225|587739156|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
162734807|NCT04812535|587739164|FG000|Overall Study|Withdrawal by Subject|0|||
162734808|NCT04812535|587739165|FG001|Overall Study|Withdrawal by Subject|0|||
162734809|NCT04812535|587739166|FG002|Overall Study|Withdrawal by Subject|0|||
162734810|NCT04812535|587739167|FG003|Overall Study|Withdrawal by Subject|1|||
162734811|NCT04812535|587739164|FG000|Overall Study|Death|7|||
162734812|NCT04812535|587739165|FG001|Overall Study|Death|2|||
162734813|NCT04812535|587739166|FG002|Overall Study|Death|4|||
162734814|NCT04812535|587739167|FG003|Overall Study|Death|1|||
162734815|NCT04812535|587739164|FG000|Overall Study|Due to premature study termination by sponsor|2|||
162734816|NCT04812535|587739165|FG001|Overall Study|Due to premature study termination by sponsor|0|||
162734817|NCT04812535|587739166|FG002|Overall Study|Due to premature study termination by sponsor|1|||
162734818|NCT04812535|587739167|FG003|Overall Study|Due to premature study termination by sponsor|3|||
162734819|NCT03336333|587739168|FG000|Overall Study|Remained on study at time of data cut-off|202|||
162734820|NCT03336333|587739169|FG001|Overall Study|Remained on study at time of data cut-off|219|||
162734821|NCT03336333|587739170|FG002|Overall Study|Remained on study at time of data cut-off|102|||
162734822|NCT03336333|587739168|FG000|Overall Study|Death|14|||
162734823|NCT03336333|587739169|FG001|Overall Study|Death|16|||
162734824|NCT03336333|587739170|FG002|Overall Study|Death|8|||
162734825|NCT03336333|587739168|FG000|Overall Study|Withdrawal by Subject|16|||
162734826|NCT03336333|587739169|FG001|Overall Study|Withdrawal by Subject|5|||
162734827|NCT03336333|587739170|FG002|Overall Study|Withdrawal by Subject|1|||
162734828|NCT03336333|587739168|FG000|Overall Study|Physician Decision|5|||
162734829|NCT03336333|587739169|FG001|Overall Study|Physician Decision|1|||
162734830|NCT03336333|587739170|FG002|Overall Study|Physician Decision|0|||
162734831|NCT03336333|587739168|FG000|Overall Study|Lost to Follow-up|1|||
162734832|NCT03336333|587739169|FG001|Overall Study|Lost to Follow-up|0|||
162734833|NCT03336333|587739170|FG002|Overall Study|Lost to Follow-up|0|||
162734834|NCT04401800|587739173|FG000|Overall Study|Death|17|||
162734835|NCT04401800|587739173|FG000|Overall Study|Lost to Follow-up|5|||
162734836|NCT04401800|587739173|FG000|Overall Study|Withdrawal by Subject|4|||
162734837|NCT04927065|587739174|FG000|First Booster|Adverse Event|1|||
162734838|NCT04927065|587739175|FG001|First Booster|Adverse Event|0|||
162734839|NCT04927065|587739176|FG002|First Booster|Adverse Event|0|||
162734840|NCT04927065|587739177|FG003|First Booster|Adverse Event|0|||
162734841|NCT04927065|587739178|FG004|First Booster|Adverse Event|0|||
162734842|NCT04927065|587739179|FG005|First Booster|Adverse Event|0|||
162734843|NCT04927065|587739180|FG006|First Booster|Adverse Event|0|||
162734844|NCT04927065|587739181|FG007|First Booster|Adverse Event|1|||
162734845|NCT04927065|587739182|FG008|First Booster|Adverse Event|0|||
162734846|NCT04927065|587739183|FG009|First Booster|Adverse Event|0|||
162734847|NCT04927065|587739184|FG010|First Booster|Adverse Event|0|||
162734848|NCT04927065|587739185|FG011|First Booster|Adverse Event|0|||
162734849|NCT04927065|587739186|FG012|First Booster|Adverse Event|0|||
162734850|NCT04927065|587739187|FG013|First Booster|Adverse Event|0|||
162734851|NCT04927065|587739188|FG014|First Booster|Adverse Event|0|||
162734852|NCT04927065|587739189|FG015|First Booster|Adverse Event|0|||
162734853|NCT04927065|587739174|FG000|First Booster|Death|1|||
162734854|NCT04927065|587739175|FG001|First Booster|Death|0|||
162734855|NCT04927065|587739176|FG002|First Booster|Death|0|||
162734856|NCT04927065|587739177|FG003|First Booster|Death|1|||
162734857|NCT04927065|587739178|FG004|First Booster|Death|0|||
162734858|NCT04927065|587739179|FG005|First Booster|Death|1|||
162734859|NCT04927065|587739180|FG006|First Booster|Death|0|||
162734860|NCT04927065|587739181|FG007|First Booster|Death|0|||
162734861|NCT04927065|587739182|FG008|First Booster|Death|0|||
162734862|NCT04927065|587739183|FG009|First Booster|Death|0|||
162734863|NCT04927065|587739184|FG010|First Booster|Death|0|||
162734864|NCT04927065|587739185|FG011|First Booster|Death|0|||
162734865|NCT04927065|587739186|FG012|First Booster|Death|0|||
162734866|NCT04927065|587739187|FG013|First Booster|Death|0|||
162734867|NCT04927065|587739188|FG014|First Booster|Death|0|||
162734868|NCT04927065|587739189|FG015|First Booster|Death|0|||
162734869|NCT04927065|587739174|FG000|First Booster|Lost to Follow-up|8|||
162734870|NCT04927065|587739175|FG001|First Booster|Lost to Follow-up|20|||
162734871|NCT04927065|587739176|FG002|First Booster|Lost to Follow-up|0|||
162734872|NCT04927065|587739177|FG003|First Booster|Lost to Follow-up|11|||
162734873|NCT04927065|587739178|FG004|First Booster|Lost to Follow-up|43|||
162734874|NCT04927065|587739179|FG005|First Booster|Lost to Follow-up|30|||
162734875|NCT04927065|587739180|FG006|First Booster|Lost to Follow-up|28|||
162734876|NCT04927065|587739181|FG007|First Booster|Lost to Follow-up|23|||
162734877|NCT04927065|587739182|FG008|First Booster|Lost to Follow-up|4|||
162734878|NCT04927065|587739183|FG009|First Booster|Lost to Follow-up|15|||
162734879|NCT04927065|587739184|FG010|First Booster|Lost to Follow-up|0|||
162734880|NCT04927065|587739185|FG011|First Booster|Lost to Follow-up|0|||
162734881|NCT04927065|587739186|FG012|First Booster|Lost to Follow-up|0|||
162734882|NCT04927065|587739187|FG013|First Booster|Lost to Follow-up|0|||
162734883|NCT04927065|587739188|FG014|First Booster|Lost to Follow-up|0|||
162734884|NCT04927065|587739189|FG015|First Booster|Lost to Follow-up|0|||
162734885|NCT04927065|587739174|FG000|First Booster|Physician Decision|1|||
162734886|NCT04927065|587739175|FG001|First Booster|Physician Decision|0|||
162734887|NCT04927065|587739176|FG002|First Booster|Physician Decision|0|||
162734888|NCT04927065|587739177|FG003|First Booster|Physician Decision|3|||
162734889|NCT04927065|587739178|FG004|First Booster|Physician Decision|1|||
162734890|NCT04927065|587739179|FG005|First Booster|Physician Decision|1|||
162734891|NCT04927065|587739180|FG006|First Booster|Physician Decision|0|||
162734892|NCT04927065|587739181|FG007|First Booster|Physician Decision|3|||
162734893|NCT04927065|587739182|FG008|First Booster|Physician Decision|0|||
162734894|NCT04927065|587739183|FG009|First Booster|Physician Decision|0|||
162734895|NCT04927065|587739184|FG010|First Booster|Physician Decision|0|||
162734896|NCT04927065|587739185|FG011|First Booster|Physician Decision|0|||
162734897|NCT04927065|587739186|FG012|First Booster|Physician Decision|0|||
162734898|NCT04927065|587739187|FG013|First Booster|Physician Decision|0|||
162734899|NCT04927065|587739188|FG014|First Booster|Physician Decision|0|||
162734900|NCT04927065|587739189|FG015|First Booster|Physician Decision|0|||
162734901|NCT04927065|587739174|FG000|First Booster|Protocol Violation|4|||
162734902|NCT04927065|587739175|FG001|First Booster|Protocol Violation|4|||
162734903|NCT04927065|587739176|FG002|First Booster|Protocol Violation|0|||
162734904|NCT04927065|587739177|FG003|First Booster|Protocol Violation|3|||
162734905|NCT04927065|587739178|FG004|First Booster|Protocol Violation|0|||
162734906|NCT04927065|587739179|FG005|First Booster|Protocol Violation|0|||
162734907|NCT04927065|587739180|FG006|First Booster|Protocol Violation|0|||
162734908|NCT04927065|587739181|FG007|First Booster|Protocol Violation|2|||
162734909|NCT04927065|587739182|FG008|First Booster|Protocol Violation|0|||
162734910|NCT04927065|587739183|FG009|First Booster|Protocol Violation|0|||
162734911|NCT04927065|587739184|FG010|First Booster|Protocol Violation|0|||
162734912|NCT04927065|587739185|FG011|First Booster|Protocol Violation|0|||
162734913|NCT04927065|587739186|FG012|First Booster|Protocol Violation|0|||
162734914|NCT04927065|587739187|FG013|First Booster|Protocol Violation|0|||
162734915|NCT04927065|587739188|FG014|First Booster|Protocol Violation|0|||
162734916|NCT04927065|587739189|FG015|First Booster|Protocol Violation|0|||
162734917|NCT04927065|587739174|FG000|First Booster|Withdrawal by Subject|8|||
162734918|NCT04927065|587739175|FG001|First Booster|Withdrawal by Subject|23|||
162734919|NCT04927065|587739176|FG002|First Booster|Withdrawal by Subject|0|||
162734920|NCT04927065|587739177|FG003|First Booster|Withdrawal by Subject|19|||
162734921|NCT04927065|587739178|FG004|First Booster|Withdrawal by Subject|20|||
162734922|NCT04927065|587739179|FG005|First Booster|Withdrawal by Subject|15|||
162734923|NCT04927065|587739180|FG006|First Booster|Withdrawal by Subject|6|||
162734924|NCT04927065|587739181|FG007|First Booster|Withdrawal by Subject|24|||
162734925|NCT04927065|587739182|FG008|First Booster|Withdrawal by Subject|0|||
162734926|NCT04927065|587739183|FG009|First Booster|Withdrawal by Subject|4|||
162734927|NCT04927065|587739184|FG010|First Booster|Withdrawal by Subject|0|||
162734928|NCT04927065|587739185|FG011|First Booster|Withdrawal by Subject|0|||
162734929|NCT04927065|587739186|FG012|First Booster|Withdrawal by Subject|0|||
162734930|NCT04927065|587739187|FG013|First Booster|Withdrawal by Subject|0|||
162734931|NCT04927065|587739188|FG014|First Booster|Withdrawal by Subject|0|||
162734932|NCT04927065|587739189|FG015|First Booster|Withdrawal by Subject|0|||
162734933|NCT04927065|587739174|FG000|First Booster|Other Than Specified|1|||
162734934|NCT04927065|587739175|FG001|First Booster|Other Than Specified|1|||
162734935|NCT04927065|587739176|FG002|First Booster|Other Than Specified|0|||
162734936|NCT04927065|587739177|FG003|First Booster|Other Than Specified|1|||
162734937|NCT04927065|587739178|FG004|First Booster|Other Than Specified|2|||
162734938|NCT04927065|587739179|FG005|First Booster|Other Than Specified|3|||
162734939|NCT04927065|587739180|FG006|First Booster|Other Than Specified|2|||
162734940|NCT04927065|587739181|FG007|First Booster|Other Than Specified|6|||
162734941|NCT04927065|587739182|FG008|First Booster|Other Than Specified|0|||
162734942|NCT04927065|587739183|FG009|First Booster|Other Than Specified|4|||
162734943|NCT04927065|587739184|FG010|First Booster|Other Than Specified|0|||
162734944|NCT04927065|587739185|FG011|First Booster|Other Than Specified|0|||
162734945|NCT04927065|587739186|FG012|First Booster|Other Than Specified|0|||
162734946|NCT04927065|587739187|FG013|First Booster|Other Than Specified|0|||
162734947|NCT04927065|587739188|FG014|First Booster|Other Than Specified|0|||
162734948|NCT04927065|587739189|FG015|First Booster|Other Than Specified|0|||
162734949|NCT04927065|587739174|FG000|Second Booster|Death|0|||
162734950|NCT04927065|587739175|FG001|Second Booster|Death|0|||
162734951|NCT04927065|587739176|FG002|Second Booster|Death|0|||
162734952|NCT04927065|587739177|FG003|Second Booster|Death|0|||
162734953|NCT04927065|587739178|FG004|Second Booster|Death|0|||
162734954|NCT04927065|587739179|FG005|Second Booster|Death|0|||
162734955|NCT04927065|587739180|FG006|Second Booster|Death|0|||
162734956|NCT04927065|587739181|FG007|Second Booster|Death|0|||
162734957|NCT04927065|587739182|FG008|Second Booster|Death|0|||
162734958|NCT04927065|587739183|FG009|Second Booster|Death|0|||
162734959|NCT04927065|587739184|FG010|Second Booster|Death|2|||
162734960|NCT04927065|587739185|FG011|Second Booster|Death|0|||
162734961|NCT04927065|587739186|FG012|Second Booster|Death|2|||
162734962|NCT04927065|587739187|FG013|Second Booster|Death|2|||
162734963|NCT04927065|587739188|FG014|Second Booster|Death|0|||
162734964|NCT04927065|587739189|FG015|Second Booster|Death|0|||
162734965|NCT04927065|587739174|FG000|Second Booster|Lost to Follow-up|0|||
162734966|NCT04927065|587739175|FG001|Second Booster|Lost to Follow-up|0|||
162734967|NCT04927065|587739176|FG002|Second Booster|Lost to Follow-up|3|||
162734968|NCT04927065|587739177|FG003|Second Booster|Lost to Follow-up|0|||
162734969|NCT04927065|587739178|FG004|Second Booster|Lost to Follow-up|0|||
162734970|NCT04927065|587739179|FG005|Second Booster|Lost to Follow-up|0|||
162734971|NCT04927065|587739180|FG006|Second Booster|Lost to Follow-up|0|||
162734972|NCT04927065|587739181|FG007|Second Booster|Lost to Follow-up|0|||
162734973|NCT04927065|587739182|FG008|Second Booster|Lost to Follow-up|0|||
162734974|NCT04927065|587739183|FG009|Second Booster|Lost to Follow-up|0|||
162734975|NCT04927065|587739184|FG010|Second Booster|Lost to Follow-up|14|||
162734976|NCT04927065|587739185|FG011|Second Booster|Lost to Follow-up|10|||
162734977|NCT04927065|587739186|FG012|Second Booster|Lost to Follow-up|13|||
162734978|NCT04927065|587739187|FG013|Second Booster|Lost to Follow-up|16|||
162734979|NCT04927065|587739188|FG014|Second Booster|Lost to Follow-up|0|||
162734980|NCT04927065|587739189|FG015|Second Booster|Lost to Follow-up|0|||
162734981|NCT04927065|587739174|FG000|Second Booster|Physician Decision|0|||
162734982|NCT04927065|587739175|FG001|Second Booster|Physician Decision|0|||
162734983|NCT04927065|587739176|FG002|Second Booster|Physician Decision|0|||
162734984|NCT04927065|587739177|FG003|Second Booster|Physician Decision|0|||
162734985|NCT04927065|587739178|FG004|Second Booster|Physician Decision|0|||
162734986|NCT04927065|587739179|FG005|Second Booster|Physician Decision|0|||
162734987|NCT04927065|587739180|FG006|Second Booster|Physician Decision|0|||
162734988|NCT04927065|587739181|FG007|Second Booster|Physician Decision|0|||
162734989|NCT04927065|587739182|FG008|Second Booster|Physician Decision|0|||
162734990|NCT04927065|587739183|FG009|Second Booster|Physician Decision|0|||
162734991|NCT04927065|587739184|FG010|Second Booster|Physician Decision|0|||
162734992|NCT04927065|587739185|FG011|Second Booster|Physician Decision|3|||
162734993|NCT04927065|587739186|FG012|Second Booster|Physician Decision|0|||
162734994|NCT04927065|587739187|FG013|Second Booster|Physician Decision|1|||
162734995|NCT04927065|587739188|FG014|Second Booster|Physician Decision|0|||
162734996|NCT04927065|587739189|FG015|Second Booster|Physician Decision|0|||
162734997|NCT04927065|587739174|FG000|Second Booster|Withdrawal by Subject|0|||
162734998|NCT04927065|587739175|FG001|Second Booster|Withdrawal by Subject|0|||
162734999|NCT04927065|587739176|FG002|Second Booster|Withdrawal by Subject|4|||
162735000|NCT04927065|587739177|FG003|Second Booster|Withdrawal by Subject|0|||
162735001|NCT04927065|587739178|FG004|Second Booster|Withdrawal by Subject|0|||
162735002|NCT04927065|587739179|FG005|Second Booster|Withdrawal by Subject|0|||
162735003|NCT04927065|587739180|FG006|Second Booster|Withdrawal by Subject|0|||
162735004|NCT04927065|587739181|FG007|Second Booster|Withdrawal by Subject|0|||
162735005|NCT04927065|587739182|FG008|Second Booster|Withdrawal by Subject|0|||
162735006|NCT04927065|587739183|FG009|Second Booster|Withdrawal by Subject|0|||
162735007|NCT04927065|587739184|FG010|Second Booster|Withdrawal by Subject|3|||
162735008|NCT04927065|587739185|FG011|Second Booster|Withdrawal by Subject|16|||
162735009|NCT04927065|587739186|FG012|Second Booster|Withdrawal by Subject|13|||
162735010|NCT04927065|587739187|FG013|Second Booster|Withdrawal by Subject|9|||
162735011|NCT04927065|587739188|FG014|Second Booster|Withdrawal by Subject|0|||
162735012|NCT04927065|587739189|FG015|Second Booster|Withdrawal by Subject|0|||
162735013|NCT04927065|587739174|FG000|Second Booster|Other Than Specified|0|||
162735014|NCT04927065|587739175|FG001|Second Booster|Other Than Specified|0|||
162735015|NCT04927065|587739176|FG002|Second Booster|Other Than Specified|0|||
162735016|NCT04927065|587739177|FG003|Second Booster|Other Than Specified|0|||
162735017|NCT04927065|587739178|FG004|Second Booster|Other Than Specified|0|||
162735018|NCT04927065|587739179|FG005|Second Booster|Other Than Specified|0|||
162735019|NCT04927065|587739180|FG006|Second Booster|Other Than Specified|0|||
162735020|NCT04927065|587739181|FG007|Second Booster|Other Than Specified|0|||
162735021|NCT04927065|587739182|FG008|Second Booster|Other Than Specified|0|||
162735022|NCT04927065|587739183|FG009|Second Booster|Other Than Specified|0|||
162735023|NCT04927065|587739184|FG010|Second Booster|Other Than Specified|1|||
162735024|NCT04927065|587739185|FG011|Second Booster|Other Than Specified|1|||
162735025|NCT04927065|587739186|FG012|Second Booster|Other Than Specified|4|||
162735026|NCT04927065|587739187|FG013|Second Booster|Other Than Specified|0|||
162735027|NCT04927065|587739188|FG014|Second Booster|Other Than Specified|0|||
162735028|NCT04927065|587739189|FG015|Second Booster|Other Than Specified|0|||
162735029|NCT04927065|587739174|FG000|Third Booster|Lost to Follow-up|0|||
162735030|NCT04927065|587739175|FG001|Third Booster|Lost to Follow-up|0|||
162735031|NCT04927065|587739176|FG002|Third Booster|Lost to Follow-up|0|||
162735032|NCT04927065|587739177|FG003|Third Booster|Lost to Follow-up|0|||
162735033|NCT04927065|587739178|FG004|Third Booster|Lost to Follow-up|0|||
162735034|NCT04927065|587739179|FG005|Third Booster|Lost to Follow-up|0|||
162735035|NCT04927065|587739180|FG006|Third Booster|Lost to Follow-up|0|||
162735036|NCT04927065|587739181|FG007|Third Booster|Lost to Follow-up|0|||
162735037|NCT04927065|587739182|FG008|Third Booster|Lost to Follow-up|0|||
162735038|NCT04927065|587739183|FG009|Third Booster|Lost to Follow-up|0|||
162735039|NCT04927065|587739184|FG010|Third Booster|Lost to Follow-up|0|||
162735040|NCT04927065|587739185|FG011|Third Booster|Lost to Follow-up|0|||
162735041|NCT04927065|587739186|FG012|Third Booster|Lost to Follow-up|0|||
162735042|NCT04927065|587739187|FG013|Third Booster|Lost to Follow-up|0|||
162735043|NCT04927065|587739188|FG014|Third Booster|Lost to Follow-up|0|||
162735044|NCT04927065|587739189|FG015|Third Booster|Lost to Follow-up|1|||
162735045|NCT04927065|587739174|FG000|Third Booster|Withdrawal by Subject|0|||
162735046|NCT04927065|587739175|FG001|Third Booster|Withdrawal by Subject|0|||
162735047|NCT04927065|587739176|FG002|Third Booster|Withdrawal by Subject|0|||
162735048|NCT04927065|587739177|FG003|Third Booster|Withdrawal by Subject|0|||
162735049|NCT04927065|587739178|FG004|Third Booster|Withdrawal by Subject|0|||
162735050|NCT04927065|587739179|FG005|Third Booster|Withdrawal by Subject|0|||
162735051|NCT04927065|587739180|FG006|Third Booster|Withdrawal by Subject|0|||
162735052|NCT04927065|587739181|FG007|Third Booster|Withdrawal by Subject|0|||
162735053|NCT04927065|587739182|FG008|Third Booster|Withdrawal by Subject|0|||
162735054|NCT04927065|587739183|FG009|Third Booster|Withdrawal by Subject|0|||
162735055|NCT04927065|587739184|FG010|Third Booster|Withdrawal by Subject|0|||
162735056|NCT04927065|587739185|FG011|Third Booster|Withdrawal by Subject|0|||
162735057|NCT04927065|587739186|FG012|Third Booster|Withdrawal by Subject|0|||
162735058|NCT04927065|587739187|FG013|Third Booster|Withdrawal by Subject|0|||
162735059|NCT04927065|587739188|FG014|Third Booster|Withdrawal by Subject|0|||
162735060|NCT04927065|587739189|FG015|Third Booster|Withdrawal by Subject|1|||
162735061|NCT03846505|587739195|FG000|Treatment Phase|Withdrawal by Subject|9|||
162735062|NCT03846505|587739196|FG001|Treatment Phase|Withdrawal by Subject|11|||
162735063|NCT03846505|587739195|FG000|Treatment Phase|Lost to Follow-up|6|||
162735064|NCT03846505|587739196|FG001|Treatment Phase|Lost to Follow-up|2|||
162735065|NCT03846505|587739195|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
162735066|NCT03846505|587739196|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
162735067|NCT03846505|587739195|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
162735068|NCT03846505|587739196|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
162735069|NCT04021602|587739203|FG000|Overall Study|Lost to Follow-up|3|||
162735070|NCT04021602|587739204|FG001|Overall Study|Lost to Follow-up|3|||
162735071|NCT04021602|587739205|FG002|Overall Study|Lost to Follow-up|1|||
162735072|NCT04021602|587739203|FG000|Overall Study|Adverse Event|1|||
162735073|NCT04021602|587739204|FG001|Overall Study|Adverse Event|0|||
162735074|NCT04021602|587739205|FG002|Overall Study|Adverse Event|1|||
162735075|NCT02689284|587739206|FG000|Overall Study|Adverse Event|1|||
162735076|NCT02689284|587739207|FG001|Overall Study|Adverse Event|8|||
162735077|NCT02689284|587739206|FG000|Overall Study|Death|0|||
162735078|NCT02689284|587739207|FG001|Overall Study|Death|1|||
162735079|NCT02689284|587739206|FG000|Overall Study|Physician Decision|1|||
162735080|NCT02689284|587739207|FG001|Overall Study|Physician Decision|2|||
162735081|NCT02689284|587739206|FG000|Overall Study|Withdrawal by Subject|0|||
162735082|NCT02689284|587739207|FG001|Overall Study|Withdrawal by Subject|1|||
162735083|NCT02689284|587739206|FG000|Overall Study|progression of cancer|1|||
162735084|NCT02689284|587739207|FG001|Overall Study|progression of cancer|72|||
162735085|NCT02689284|587739206|FG000|Overall Study|decreased heart function|0|||
162735086|NCT02689284|587739207|FG001|Overall Study|decreased heart function|1|||
162735087|NCT02689284|587739206|FG000|Overall Study|concern for anemia|0|||
162735088|NCT02689284|587739207|FG001|Overall Study|concern for anemia|1|||
162735089|NCT02689284|587739206|FG000|Overall Study|no measurable cancer for evaluation|0|||
162735090|NCT02689284|587739207|FG001|Overall Study|no measurable cancer for evaluation|1|||
162735091|NCT05592418|587739208|FG000|Overall Study|Adverse Event|1|||
162735092|NCT05592418|587739209|FG001|Overall Study|Adverse Event|0|||
162735093|NCT05592418|587739208|FG000|Overall Study|Lost to Follow-up|1|||
162735094|NCT05592418|587739209|FG001|Overall Study|Lost to Follow-up|3|||
162735095|NCT05592418|587739208|FG000|Overall Study|Withdrawal by Subject|2|||
162735096|NCT05592418|587739209|FG001|Overall Study|Withdrawal by Subject|7|||
162735097|NCT04450342|587739212|FG000|Overall Study|Adverse Event|1|||
162735098|NCT04450342|587739213|FG001|Overall Study|Adverse Event|1|||
162735099|NCT04450342|587739214|FG002|Overall Study|Adverse Event|0|||
162735100|NCT04450342|587739212|FG000|Overall Study|Device not used|1|||
162735101|NCT04450342|587739213|FG001|Overall Study|Device not used|0|||
162735102|NCT04450342|587739214|FG002|Overall Study|Device not used|0|||
162735103|NCT04450342|587739212|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
162735104|NCT04450342|587739213|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
162735105|NCT04450342|587739214|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
162735106|NCT04450342|587739212|FG000|Overall Study|Physician Decision|1|||
162735107|NCT04450342|587739213|FG001|Overall Study|Physician Decision|0|||
162735108|NCT04450342|587739214|FG002|Overall Study|Physician Decision|1|||
162735109|NCT04450342|587739212|FG000|Overall Study|Protocol Deviation|0|||
162735110|NCT04450342|587739213|FG001|Overall Study|Protocol Deviation|1|||
162735111|NCT04450342|587739214|FG002|Overall Study|Protocol Deviation|0|||
162735112|NCT04450342|587739212|FG000|Overall Study|Reoperation|1|||
162735113|NCT04450342|587739213|FG001|Overall Study|Reoperation|1|||
162735114|NCT04450342|587739214|FG002|Overall Study|Reoperation|0|||
162735115|NCT04450342|587739212|FG000|Overall Study|Screen Failures|0|||
162735116|NCT04450342|587739213|FG001|Overall Study|Screen Failures|0|||
162735117|NCT04450342|587739214|FG002|Overall Study|Screen Failures|2|||
162735118|NCT04450342|587739212|FG000|Overall Study|Site Terminated by Sponsor|1|||
162735119|NCT04450342|587739213|FG001|Overall Study|Site Terminated by Sponsor|1|||
162735120|NCT04450342|587739214|FG002|Overall Study|Site Terminated by Sponsor|1|||
162735121|NCT04450342|587739212|FG000|Overall Study|Study Terminated by Sponsor|31|||
162735122|NCT04450342|587739213|FG001|Overall Study|Study Terminated by Sponsor|29|||
162735123|NCT04450342|587739214|FG002|Overall Study|Study Terminated by Sponsor|6|||
162735124|NCT04450342|587739212|FG000|Overall Study|Withdrawal by Subject|0|||
162735125|NCT04450342|587739213|FG001|Overall Study|Withdrawal by Subject|1|||
162735126|NCT04450342|587739214|FG002|Overall Study|Withdrawal by Subject|2|||
162735127|NCT05481320|587739215|FG000|Overall Study|Withdrawal by Subject|1|||
162735128|NCT05481320|587739216|FG001|Overall Study|Withdrawal by Subject|1|||
162735129|NCT05481320|587739215|FG000|Overall Study|Care recipent passed away|0|||
162735130|NCT05481320|587739216|FG001|Overall Study|Care recipent passed away|1|||
162735131|NCT05481320|587739215|FG000|Overall Study|Out-of-window assessment|0|||
162735132|NCT05481320|587739216|FG001|Overall Study|Out-of-window assessment|1|||
162735133|NCT05481320|587739215|FG000|Overall Study|No longer a primary caregiver|3|||
162735134|NCT05481320|587739216|FG001|Overall Study|No longer a primary caregiver|0|||
162735135|NCT05481320|587739215|FG000|Overall Study|Unable to contact|1|||
162735136|NCT05481320|587739216|FG001|Overall Study|Unable to contact|0|||
162735137|NCT02923180|587739217|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
162735138|NCT02923180|587739217|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
162735139|NCT05198310|587739218|FG000|Overall Study|Lost to Follow-up|0|||
162735140|NCT05198310|587739219|FG001|Overall Study|Lost to Follow-up|1|||
162735141|NCT05198310|587739220|FG002|Overall Study|Lost to Follow-up|0|||
162735142|NCT05198310|587739221|FG003|Overall Study|Lost to Follow-up|0|||
162735143|NCT05198310|587739222|FG004|Overall Study|Lost to Follow-up|0|||
162735144|NCT05198310|587739223|FG005|Overall Study|Lost to Follow-up|0|||
162735145|NCT05198310|587739224|FG006|Overall Study|Lost to Follow-up|0|||
162735146|NCT05198310|587739225|FG007|Overall Study|Lost to Follow-up|0|||
162735147|NCT05198310|587739218|FG000|Overall Study|Withdrawal by Subject|0|||
162735148|NCT05198310|587739219|FG001|Overall Study|Withdrawal by Subject|0|||
162735149|NCT05198310|587739220|FG002|Overall Study|Withdrawal by Subject|0|||
162735150|NCT05198310|587739221|FG003|Overall Study|Withdrawal by Subject|2|||
162735151|NCT05198310|587739222|FG004|Overall Study|Withdrawal by Subject|0|||
162735152|NCT05198310|587739223|FG005|Overall Study|Withdrawal by Subject|2|||
162735153|NCT05198310|587739224|FG006|Overall Study|Withdrawal by Subject|1|||
162735154|NCT05198310|587739225|FG007|Overall Study|Withdrawal by Subject|3|||
162735155|NCT04116736|587739226|FG000|Overall Study|Withdrew consent during study|3|||
162735156|NCT04116736|587739227|FG001|Overall Study|Withdrew consent during study|1|||
162735157|NCT04116736|587739226|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
162735158|NCT04116736|587739227|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
162735159|NCT04116736|587739226|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
162735160|NCT04116736|587739227|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
162735161|NCT04116736|587739226|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
162735162|NCT04116736|587739227|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
162735163|NCT04116736|587739226|FG000|Overall Study|Subject was enrolled in error|2|||
162735164|NCT04116736|587739227|FG001|Overall Study|Subject was enrolled in error|0|||
162735165|NCT04116736|587739226|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
162735166|NCT04116736|587739227|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
162735167|NCT04116736|587739226|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
162735168|NCT04116736|587739227|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
162735169|NCT04116736|587739226|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
162735170|NCT04116736|587739227|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
162735171|NCT03941860|587739233|FG000|Overall Study|Withdrawal by Subject|0|||
162735172|NCT03941860|587739234|FG001|Overall Study|Withdrawal by Subject|1|||
162735173|NCT04093752|587739235|FG000|Overall Study|Adverse Event|7|||
162735174|NCT04093752|587739236|FG001|Overall Study|Adverse Event|19|||
162735175|NCT04093752|587739237|FG002|Overall Study|Adverse Event|18|||
162735176|NCT04093752|587739238|FG003|Overall Study|Adverse Event|4|||
162735177|NCT04093752|587739235|FG000|Overall Study|Withdrawal by Subject|6|||
162735178|NCT04093752|587739236|FG001|Overall Study|Withdrawal by Subject|6|||
162735179|NCT04093752|587739237|FG002|Overall Study|Withdrawal by Subject|8|||
162735180|NCT04093752|587739238|FG003|Overall Study|Withdrawal by Subject|20|||
162735181|NCT04093752|587739235|FG000|Overall Study|Lost to Follow-up|2|||
162735182|NCT04093752|587739236|FG001|Overall Study|Lost to Follow-up|1|||
162735183|NCT04093752|587739237|FG002|Overall Study|Lost to Follow-up|1|||
162735184|NCT04093752|587739238|FG003|Overall Study|Lost to Follow-up|1|||
162735185|NCT04093752|587739235|FG000|Overall Study|Death|0|||
162735186|NCT04093752|587739236|FG001|Overall Study|Death|0|||
162735187|NCT04093752|587739237|FG002|Overall Study|Death|1|||
162735188|NCT04093752|587739238|FG003|Overall Study|Death|2|||
162735189|NCT04093752|587739235|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
162735190|NCT04093752|587739236|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
162735191|NCT04093752|587739237|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
162735192|NCT04093752|587739238|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
162735193|NCT04093752|587739235|FG000|Overall Study|Covid 19|0|||
162735194|NCT04093752|587739236|FG001|Overall Study|Covid 19|0|||
162735195|NCT04093752|587739237|FG002|Overall Study|Covid 19|0|||
162735196|NCT04093752|587739238|FG003|Overall Study|Covid 19|1|||
162735197|NCT04093752|587739235|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162735198|NCT04093752|587739236|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162735199|NCT04093752|587739237|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
162735200|NCT04093752|587739238|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162735201|NCT04093752|587739235|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
162735202|NCT04093752|587739236|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
162735203|NCT04093752|587739237|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
162735204|NCT04093752|587739238|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
162735205|NCT04093752|587739235|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
162735206|NCT04093752|587739236|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
162735207|NCT04093752|587739237|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
162735208|NCT04093752|587739238|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
162735209|NCT04854096|587739241|FG000|Overall Study|Adverse Event|1|||
162735210|NCT04854096|587739242|FG001|Overall Study|Adverse Event|0|||
162735211|NCT04854096|587739241|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
162735212|NCT04854096|587739242|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
162735213|NCT04854096|587739241|FG000|Overall Study|Withdrawal by Subject|1|||
162735214|NCT04854096|587739242|FG001|Overall Study|Withdrawal by Subject|0|||
162735215|NCT04854096|587739241|FG000|Overall Study|Other reasons|1|||
162735216|NCT04854096|587739242|FG001|Overall Study|Other reasons|0|||
162735217|NCT03930342|587739245|FG000|Overall Study|Lost to Follow-up|70|||
162735218|NCT03930342|587739246|FG001|Overall Study|Lost to Follow-up|77|||
162735219|NCT02742519|587739249|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
162735220|NCT02742519|587739250|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
162735221|NCT02742519|587739251|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
162735222|NCT02742519|587739249|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
162735223|NCT02742519|587739250|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
162735224|NCT02742519|587739251|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
162735225|NCT02742519|587739249|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
162735226|NCT02742519|587739250|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
162735227|NCT02742519|587739251|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
162735228|NCT01872078|587739253|FG000|Overall Study|Adverse Event|0|||
162735229|NCT01872078|587739254|FG001|Overall Study|Adverse Event|0|||
162735230|NCT01872078|587739255|FG002|Overall Study|Adverse Event|1|||
162735231|NCT01872078|587739256|FG003|Overall Study|Adverse Event|0|||
162735232|NCT01872078|587739253|FG000|Overall Study|Dose administration non-compliance|0|||
162735233|NCT01872078|587739254|FG001|Overall Study|Dose administration non-compliance|0|||
162735234|NCT01872078|587739255|FG002|Overall Study|Dose administration non-compliance|0|||
162735235|NCT01872078|587739256|FG003|Overall Study|Dose administration non-compliance|1|||
162735236|NCT01872078|587739253|FG000|Overall Study|Protocol Violation|0|||
162735237|NCT01872078|587739254|FG001|Overall Study|Protocol Violation|0|||
162735238|NCT01872078|587739255|FG002|Overall Study|Protocol Violation|1|||
162735239|NCT01872078|587739256|FG003|Overall Study|Protocol Violation|0|||
162735240|NCT01872078|587739253|FG000|Overall Study|Withdrawal by Subject|0|||
162735241|NCT01872078|587739254|FG001|Overall Study|Withdrawal by Subject|0|||
162735242|NCT01872078|587739255|FG002|Overall Study|Withdrawal by Subject|1|||
162735243|NCT01872078|587739256|FG003|Overall Study|Withdrawal by Subject|0|||
162735244|NCT01872078|587739253|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
162735245|NCT01872078|587739254|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
162735246|NCT01872078|587739255|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
162735247|NCT01872078|587739256|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
162735248|NCT01091168|587739257|FG000|Overall Study|Progressive disease|250|||
162735249|NCT01091168|587739258|FG001|Overall Study|Progressive disease|234|||
162735250|NCT01091168|587739257|FG000|Overall Study|Adverse Event|21|||
162735251|NCT01091168|587739258|FG001|Overall Study|Adverse Event|24|||
162735252|NCT01091168|587739257|FG000|Overall Study|Lost to Follow-up|0|||
162735253|NCT01091168|587739258|FG001|Overall Study|Lost to Follow-up|1|||
162735254|NCT01091168|587739257|FG000|Overall Study|Physician, patient's decision, other|27|||
162735255|NCT01091168|587739258|FG001|Overall Study|Physician, patient's decision, other|37|||
162735256|NCT04052516|587741193|FG000|Overall Study|Withdrawal by Subject|4|||
162735257|NCT04052516|587741194|FG001|Overall Study|Withdrawal by Subject|5|||
162735258|NCT04052516|587741195|FG002|Overall Study|Withdrawal by Subject|6|||
162735259|NCT04052516|587741193|FG000|Overall Study|Adverse Event|3|||
162735260|NCT04052516|587741194|FG001|Overall Study|Adverse Event|2|||
162735261|NCT04052516|587741195|FG002|Overall Study|Adverse Event|8|||
162735262|NCT04052516|587741193|FG000|Overall Study|Lost to Follow-up|2|||
162735263|NCT04052516|587741194|FG001|Overall Study|Lost to Follow-up|5|||
162735264|NCT04052516|587741195|FG002|Overall Study|Lost to Follow-up|3|||
162735265|NCT04052516|587741193|FG000|Overall Study|Protocol Violation|1|||
162735266|NCT04052516|587741194|FG001|Overall Study|Protocol Violation|1|||
162735267|NCT04052516|587741195|FG002|Overall Study|Protocol Violation|0|||
162735268|NCT04052516|587741193|FG000|Overall Study|Death|1|||
162735269|NCT04052516|587741194|FG001|Overall Study|Death|0|||
162735270|NCT04052516|587741195|FG002|Overall Study|Death|0|||
162735271|NCT04052516|587741193|FG000|Overall Study|Physician Decision|0|||
162735272|NCT04052516|587741194|FG001|Overall Study|Physician Decision|1|||
162735273|NCT04052516|587741195|FG002|Overall Study|Physician Decision|0|||
162735274|NCT04052516|587741193|FG000|Overall Study|Pregnancy|1|||
162735275|NCT04052516|587741194|FG001|Overall Study|Pregnancy|0|||
162735276|NCT04052516|587741195|FG002|Overall Study|Pregnancy|0|||
162735277|NCT04052516|587741193|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
162735278|NCT04052516|587741194|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
162735279|NCT04052516|587741195|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
162735280|NCT04052516|587741193|FG000|Overall Study|Reason not recorded|0|||
162735281|NCT04052516|587741194|FG001|Overall Study|Reason not recorded|1|||
162735282|NCT04052516|587741195|FG002|Overall Study|Reason not recorded|0|||
162735283|NCT03747484|587741196|FG000|Overall Study|Lack of Efficacy|0|||
162735284|NCT03747484|587741197|FG001|Overall Study|Lack of Efficacy|1|||
162735285|NCT03747484|587741198|FG002|Overall Study|Lack of Efficacy|1|||
162735286|NCT03747484|587741199|FG003|Overall Study|Lack of Efficacy|2|||
162735287|NCT03747484|587741200|FG004|Overall Study|Lack of Efficacy|2|||
162735288|NCT05062265|587741204|FG000|Overall Study|Withdrawal by Subject|1|||
162735289|NCT05062265|587741205|FG001|Overall Study|Withdrawal by Subject|0|||
162735290|NCT03101904|587741209|FG000|Wash Out (10 Days)|Adverse Event|1|||
162735291|NCT03101904|587741210|FG001|Wash Out (10 Days)|Adverse Event|0|||
162735292|NCT03101904|587741209|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
162735293|NCT03101904|587741210|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
162735294|NCT04538417|587741211|FG000|Overall Study|Withdrawal by Subject|2|||
162735295|NCT01180634|587741213|FG000|Overall Study|Adverse Event|4|||
162735296|NCT01180634|587741214|FG001|Overall Study|Adverse Event|1|||
162735297|NCT01180634|587741213|FG000|Overall Study|Miscellaneous|2|||
162735298|NCT01180634|587741214|FG001|Overall Study|Miscellaneous|0|||
162735299|NCT01180634|587741213|FG000|Overall Study|Withdrawal by Subject|4|||
162735300|NCT01180634|587741214|FG001|Overall Study|Withdrawal by Subject|0|||
162735301|NCT06311084|587741215|FG000|Overall Study|Lost to Follow-up|14|||
162735302|NCT04725240|587741216|FG000|Overall Study|Adverse Event|2|||
162735303|NCT03393975|587741221|FG000|Urgent Treatment Period|Physician Decision|0|||
162735304|NCT03393975|587741222|FG001|Urgent Treatment Period|Physician Decision|0|||
162735305|NCT03393975|587741223|FG002|Urgent Treatment Period|Physician Decision|0|||
162735306|NCT03393975|587741224|FG003|Urgent Treatment Period|Physician Decision|1|||
162735307|NCT03393975|587741221|FG000|Prophylaxis Period 1|Reason not Specified|0|||
162735308|NCT03393975|587741222|FG001|Prophylaxis Period 1|Reason not Specified|1|||
162735309|NCT03393975|587741223|FG002|Prophylaxis Period 1|Reason not Specified|0|||
162735310|NCT03393975|587741224|FG003|Prophylaxis Period 1|Reason not Specified|0|||
162735311|NCT03393975|587741221|FG000|Prophylaxis Period 2|Reason not Specified|0|||
162735312|NCT03393975|587741222|FG001|Prophylaxis Period 2|Reason not Specified|1|||
162735313|NCT03393975|587741223|FG002|Prophylaxis Period 2|Reason not Specified|0|||
162735314|NCT03393975|587741224|FG003|Prophylaxis Period 2|Reason not Specified|0|||
162735315|NCT04060355|587741227|FG000|Overall Study|Lost to Follow-up|41|||
162735316|NCT01140880|587741228|FG000|Overall Study|Death|0|||
162735317|NCT01140880|587741229|FG001|Overall Study|Death|1|||
162735318|NCT01140880|587741228|FG000|Overall Study|Withdrawal by Subject|6|||
162735319|NCT01140880|587741229|FG001|Overall Study|Withdrawal by Subject|3|||
162735320|NCT01140880|587741228|FG000|Overall Study|Lost to Follow-up|8|||
162735321|NCT01140880|587741229|FG001|Overall Study|Lost to Follow-up|10|||
162735322|NCT01140880|587741228|FG000|Overall Study|Protocol Violation|0|||
162735323|NCT01140880|587741229|FG001|Overall Study|Protocol Violation|30|||
162735324|NCT04421378|587741234|FG000|Overall Study|Adverse Event|2|||
162735325|NCT04421378|587741235|FG001|Overall Study|Adverse Event|7|||
162735326|NCT04421378|587741236|FG002|Overall Study|Adverse Event|0|||
162735327|NCT04421378|587741237|FG003|Overall Study|Adverse Event|1|||
162735328|NCT04421378|587741238|FG004|Overall Study|Adverse Event|0|||
162735329|NCT04421378|587741234|FG000|Overall Study|Physician Decision|1|||
162735330|NCT04421378|587741235|FG001|Overall Study|Physician Decision|2|||
162735331|NCT04421378|587741236|FG002|Overall Study|Physician Decision|0|||
162735332|NCT04421378|587741237|FG003|Overall Study|Physician Decision|0|||
162735333|NCT04421378|587741238|FG004|Overall Study|Physician Decision|0|||
162735334|NCT04421378|587741234|FG000|Overall Study|Progressive Disease|16|||
162735335|NCT04421378|587741235|FG001|Overall Study|Progressive Disease|4|||
162735336|NCT04421378|587741236|FG002|Overall Study|Progressive Disease|18|||
162735337|NCT04421378|587741237|FG003|Overall Study|Progressive Disease|11|||
162735338|NCT04421378|587741238|FG004|Overall Study|Progressive Disease|3|||
162735339|NCT04421378|587741234|FG000|Overall Study|Study Terminated by Sponsor|0|||
162735340|NCT04421378|587741235|FG001|Overall Study|Study Terminated by Sponsor|1|||
162735341|NCT04421378|587741236|FG002|Overall Study|Study Terminated by Sponsor|1|||
162735342|NCT04421378|587741237|FG003|Overall Study|Study Terminated by Sponsor|0|||
162735343|NCT04421378|587741238|FG004|Overall Study|Study Terminated by Sponsor|0|||
162735344|NCT04421378|587741234|FG000|Overall Study|Withdrawal by Subject|3|||
162735345|NCT04421378|587741235|FG001|Overall Study|Withdrawal by Subject|1|||
162735346|NCT04421378|587741236|FG002|Overall Study|Withdrawal by Subject|0|||
162735347|NCT04421378|587741237|FG003|Overall Study|Withdrawal by Subject|2|||
162735348|NCT04421378|587741238|FG004|Overall Study|Withdrawal by Subject|0|||
162735349|NCT04421378|587741234|FG000|Overall Study|Other|1|||
162735350|NCT04421378|587741235|FG001|Overall Study|Other|0|||
162735351|NCT04421378|587741236|FG002|Overall Study|Other|0|||
162735352|NCT04421378|587741237|FG003|Overall Study|Other|0|||
162735353|NCT04421378|587741238|FG004|Overall Study|Other|0|||
162735354|NCT04258709|587741239|FG000|Overall Study|Lost to Follow-up|10|||
162735355|NCT04258709|587741240|FG001|Overall Study|Lost to Follow-up|4|||
162735356|NCT04258709|587741239|FG000|Overall Study|Withdrawal by Subject|1|||
162735357|NCT04258709|587741240|FG001|Overall Study|Withdrawal by Subject|0|||
162735358|NCT04258709|587741239|FG000|Overall Study|Fetal demise|0|||
162735359|NCT04258709|587741240|FG001|Overall Study|Fetal demise|1|||
162735360|NCT04258709|587741239|FG000|Overall Study|Protocol Violation|1|||
162735361|NCT04258709|587741240|FG001|Overall Study|Protocol Violation|1|||
162735362|NCT02592330|587741241|FG000|Overall Study|Withdrawal by Subject|1|||
162735363|NCT02592330|587741242|FG001|Overall Study|Withdrawal by Subject|0|||
162735364|NCT02592330|587741241|FG000|Overall Study|Failed Biopsy|1|||
162735365|NCT02592330|587741242|FG001|Overall Study|Failed Biopsy|0|||
162735366|NCT03090152|587741243|FG000|Overall Study|Withdrawal by Subject|0|||
162735367|NCT03090152|587741244|FG001|Overall Study|Withdrawal by Subject|2|||
162735368|NCT03090152|587741245|FG002|Overall Study|Withdrawal by Subject|1|||
162735369|NCT03090152|587741243|FG000|Overall Study|Surgery Canceled|1|||
162735370|NCT03090152|587741244|FG001|Overall Study|Surgery Canceled|0|||
162735371|NCT03090152|587741245|FG002|Overall Study|Surgery Canceled|0|||
162735372|NCT03090152|587741243|FG000|Overall Study|Epidural catheter could not be placed|0|||
162735373|NCT03090152|587741244|FG001|Overall Study|Epidural catheter could not be placed|2|||
162735374|NCT03090152|587741245|FG002|Overall Study|Epidural catheter could not be placed|0|||
162735375|NCT03958955|587741246|FG000|Overall Study|Adverse Event|1|||
162735376|NCT04673929|587741247|FG000|Overall Study|Death|73|||
162735377|NCT04673929|587741247|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
162735378|NCT02807636|587741251|FG000|Overall Study|Lost to Follow-up|10|||
162735379|NCT02807636|587741252|FG001|Overall Study|Lost to Follow-up|13|||
162735380|NCT02807636|587741253|FG002|Overall Study|Lost to Follow-up|6|||
162735381|NCT02807636|587741251|FG000|Overall Study|Protocol Deviation|1|||
162735382|NCT02807636|587741252|FG001|Overall Study|Protocol Deviation|0|||
162735383|NCT02807636|587741253|FG002|Overall Study|Protocol Deviation|0|||
162735384|NCT02807636|587741251|FG000|Overall Study|Symptomatic Deterioration|0|||
162735385|NCT02807636|587741252|FG001|Overall Study|Symptomatic Deterioration|1|||
162735386|NCT02807636|587741253|FG002|Overall Study|Symptomatic Deterioration|0|||
162735387|NCT02807636|587741251|FG000|Overall Study|Withdrawal by Subject|39|||
162735388|NCT02807636|587741252|FG001|Overall Study|Withdrawal by Subject|28|||
162735389|NCT02807636|587741253|FG002|Overall Study|Withdrawal by Subject|24|||
162735390|NCT02807636|587741251|FG000|Overall Study|Death|303|||
162735391|NCT02807636|587741252|FG001|Overall Study|Death|332|||
162735392|NCT02807636|587741253|FG002|Overall Study|Death|272|||
162735393|NCT02807636|587741251|FG000|Overall Study|Study Terminated By Sponsor|47|||
162735394|NCT02807636|587741252|FG001|Overall Study|Study Terminated By Sponsor|76|||
162735395|NCT02807636|587741253|FG002|Overall Study|Study Terminated By Sponsor|60|||
162735396|NCT02807636|587741251|FG000|Overall Study|Physician Decision|0|||
162735397|NCT02807636|587741252|FG001|Overall Study|Physician Decision|1|||
162735398|NCT02807636|587741253|FG002|Overall Study|Physician Decision|0|||
162735399|NCT03175029|587741256|FG000|Overall Study|Withdrawal by Subject|2|||
162735400|NCT03175029|587741257|FG001|Overall Study|Withdrawal by Subject|1|||
162735401|NCT03175029|587741256|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162735402|NCT03175029|587741257|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
162735403|NCT04089371|587741258|FG000|Overall Study|Withdrawal by Subject|0|||
162735404|NCT04089371|587741259|FG001|Overall Study|Withdrawal by Subject|1|||
162735405|NCT04089371|587741258|FG000|Overall Study|Study terminated early|0|||
162735406|NCT04089371|587741259|FG001|Overall Study|Study terminated early|9|||
162735407|NCT03453619|587741262|FG000|Core Study (Part A)|Physician Decision|0|||
162735408|NCT03453619|587741263|FG001|Core Study (Part A)|Physician Decision|0|||
162735409|NCT03453619|587741264|FG002|Core Study (Part A)|Physician Decision|2|||
162735410|NCT03453619|587741265|FG003|Core Study (Part A)|Physician Decision|0|||
162735411|NCT03453619|587741262|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
162735412|NCT03453619|587741263|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
162735413|NCT03453619|587741264|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
162735414|NCT03453619|587741265|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
162735415|NCT03453619|587741262|FG000|Core Study (Part A)|Other|0|||
162735416|NCT03453619|587741263|FG001|Core Study (Part A)|Other|1|||
162735417|NCT03453619|587741264|FG002|Core Study (Part A)|Other|0|||
162735418|NCT03453619|587741265|FG003|Core Study (Part A)|Other|0|||
162735419|NCT03453619|587741262|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
162735420|NCT03453619|587741263|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
162735421|NCT03453619|587741264|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
162735422|NCT03453619|587741265|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
162735423|NCT03453619|587741262|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
162735424|NCT03453619|587741263|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
162735425|NCT03453619|587741264|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
162735426|NCT03453619|587741265|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
162735427|NCT03453619|587741262|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162735428|NCT03453619|587741263|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162735429|NCT03453619|587741264|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162735430|NCT03453619|587741265|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
162735431|NCT03453619|587741262|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
162735432|NCT03453619|587741263|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
162735433|NCT03453619|587741264|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
162735434|NCT03453619|587741265|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
162735435|NCT04382898|587741266|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
162735436|NCT04382898|587741267|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
162735437|NCT04382898|587741268|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
162735438|NCT04382898|587741269|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
162735439|NCT04382898|587741270|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
162735440|NCT04382898|587741266|FG000|Part 1: Dose Titration|Death|6|||
162735441|NCT04382898|587741267|FG001|Part 1: Dose Titration|Death|0|||
162735442|NCT04382898|587741268|FG002|Part 1: Dose Titration|Death|0|||
162735443|NCT04382898|587741269|FG003|Part 1: Dose Titration|Death|0|||
162735444|NCT04382898|587741270|FG004|Part 1: Dose Titration|Death|0|||
162735445|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162735446|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162735447|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
162735448|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162735449|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162735450|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
162735451|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
162735452|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
162735453|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
162735454|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
162735455|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Death|0|||
162735456|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Death|17|||
162735457|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Death|13|||
162735458|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Death|1|||
162735459|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Death|0|||
162735460|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
162735461|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
162735462|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
162735463|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
162735464|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
162735465|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
162735466|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
162735467|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
162735468|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
162735469|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
162735470|NCT04382898|587741266|FG000|Part 2: Dose Expansion|Other|0|||
162735471|NCT04382898|587741267|FG001|Part 2: Dose Expansion|Other|0|||
162735472|NCT04382898|587741268|FG002|Part 2: Dose Expansion|Other|1|||
162735473|NCT04382898|587741269|FG003|Part 2: Dose Expansion|Other|0|||
162735474|NCT04382898|587741270|FG004|Part 2: Dose Expansion|Other|0|||
162735475|NCT05229120|587741271|FG000|Overall Study|Withdrawal by Subject|8|||
162735476|NCT03932682|587741274|FG000|Overall Study|Death|1|||
162735477|NCT03932682|587741275|FG001|Overall Study|Death|2|||
162735478|NCT03932682|587741274|FG000|Overall Study|Withdrawal by Subject|37|||
162735479|NCT03932682|587741275|FG001|Overall Study|Withdrawal by Subject|45|||
162735480|NCT03932682|587741274|FG000|Overall Study|Lost to Follow-up|19|||
162735481|NCT03932682|587741275|FG001|Overall Study|Lost to Follow-up|25|||
162735482|NCT03932682|587741274|FG000|Overall Study|Protocol Violation|0|||
162735483|NCT03932682|587741275|FG001|Overall Study|Protocol Violation|2|||
162735484|NCT03932682|587741274|FG000|Overall Study|Other|9|||
162735485|NCT03932682|587741275|FG001|Overall Study|Other|23|||
162735486|NCT04321031|587741276|FG000|Overall Study|Adverse Event|0|||
162735487|NCT04321031|587741277|FG001|Overall Study|Adverse Event|2|||
162735488|NCT04321031|587741278|FG002|Overall Study|Adverse Event|2|||
162735489|NCT04321031|587741279|FG003|Overall Study|Adverse Event|2|||
162735490|NCT04321031|587741280|FG004|Overall Study|Adverse Event|2|||
162735491|NCT04321031|587741281|FG005|Overall Study|Adverse Event|2|||
162735492|NCT04321031|587741282|FG006|Overall Study|Adverse Event|0|||
162735493|NCT04321031|587741276|FG000|Overall Study|Lost to Follow-up|0|||
162735494|NCT04321031|587741277|FG001|Overall Study|Lost to Follow-up|0|||
162735495|NCT04321031|587741278|FG002|Overall Study|Lost to Follow-up|0|||
162735496|NCT04321031|587741279|FG003|Overall Study|Lost to Follow-up|1|||
162735497|NCT04321031|587741280|FG004|Overall Study|Lost to Follow-up|0|||
162735498|NCT04321031|587741281|FG005|Overall Study|Lost to Follow-up|2|||
162735499|NCT04321031|587741282|FG006|Overall Study|Lost to Follow-up|1|||
162735500|NCT04321031|587741276|FG000|Overall Study|Withdrawal by Subject|2|||
162735501|NCT04321031|587741277|FG001|Overall Study|Withdrawal by Subject|2|||
162735502|NCT04321031|587741278|FG002|Overall Study|Withdrawal by Subject|1|||
162735503|NCT04321031|587741279|FG003|Overall Study|Withdrawal by Subject|3|||
162735504|NCT04321031|587741280|FG004|Overall Study|Withdrawal by Subject|1|||
162735505|NCT04321031|587741281|FG005|Overall Study|Withdrawal by Subject|0|||
162735506|NCT04321031|587741282|FG006|Overall Study|Withdrawal by Subject|1|||
162735507|NCT04321031|587741276|FG000|Overall Study|Non-compliance with study drug|0|||
162735508|NCT04321031|587741277|FG001|Overall Study|Non-compliance with study drug|0|||
162735509|NCT04321031|587741278|FG002|Overall Study|Non-compliance with study drug|0|||
162735510|NCT04321031|587741279|FG003|Overall Study|Non-compliance with study drug|0|||
162735511|NCT04321031|587741280|FG004|Overall Study|Non-compliance with study drug|0|||
162735512|NCT04321031|587741281|FG005|Overall Study|Non-compliance with study drug|1|||
162735513|NCT04321031|587741282|FG006|Overall Study|Non-compliance with study drug|0|||
162735514|NCT04321031|587741276|FG000|Overall Study|Other|0|||
162735515|NCT04321031|587741277|FG001|Overall Study|Other|0|||
162735516|NCT04321031|587741278|FG002|Overall Study|Other|0|||
162735517|NCT04321031|587741279|FG003|Overall Study|Other|1|||
162735518|NCT04321031|587741280|FG004|Overall Study|Other|0|||
162735519|NCT04321031|587741281|FG005|Overall Study|Other|0|||
162735520|NCT04321031|587741282|FG006|Overall Study|Other|0|||
162735521|NCT04237298|587741283|FG000|Overall Study|Lost to Follow-up|4|||
162735522|NCT04237298|587741284|FG001|Overall Study|Lost to Follow-up|5|||
162735523|NCT04556656|587741288|FG000|Overall Study|Withdrawal by Subject|14|||
162735524|NCT04556656|587741289|FG001|Overall Study|Withdrawal by Subject|12|||
162735525|NCT04556656|587741288|FG000|Overall Study|Physician Decision|1|||
162735526|NCT04556656|587741289|FG001|Overall Study|Physician Decision|0|||
162735527|NCT04556656|587741288|FG000|Overall Study|Adverse Event|4|||
162735528|NCT04556656|587741289|FG001|Overall Study|Adverse Event|7|||
162735529|NCT04556656|587741288|FG000|Overall Study|Death|4|||
162735530|NCT04556656|587741289|FG001|Overall Study|Death|0|||
162735531|NCT04556656|587741288|FG000|Overall Study|Lost to Follow-up|3|||
162735532|NCT04556656|587741289|FG001|Overall Study|Lost to Follow-up|2|||
162735533|NCT04556656|587741288|FG000|Overall Study|Not further specified|2|||
162735534|NCT04556656|587741289|FG001|Overall Study|Not further specified|1|||
162735535|NCT05536440|587741290|FG000|Overall Study|Adverse Event|0|||
162735536|NCT05536440|587741291|FG001|Overall Study|Adverse Event|0|||
162735537|NCT05536440|587741292|FG002|Overall Study|Adverse Event|0|||
162735538|NCT05536440|587741293|FG003|Overall Study|Adverse Event|0|||
162735539|NCT05536440|587741294|FG004|Overall Study|Adverse Event|0|||
162735540|NCT05536440|587741295|FG005|Overall Study|Adverse Event|0|||
162735541|NCT05536440|587741296|FG006|Overall Study|Adverse Event|0|||
162735542|NCT05536440|587741297|FG007|Overall Study|Adverse Event|0|||
162735543|NCT05536440|587741298|FG008|Overall Study|Adverse Event|1|||
162735544|NCT01566695|587741301|FG000|Overall Study|Lack of Efficacy|1|||
162735545|NCT01566695|587741302|FG001|Overall Study|Lack of Efficacy|0|||
162735546|NCT01566695|587741301|FG000|Overall Study|Adverse Event|3|||
162735547|NCT01566695|587741302|FG001|Overall Study|Adverse Event|0|||
162735548|NCT01566695|587741301|FG000|Overall Study|Death|79|||
162735549|NCT01566695|587741302|FG001|Overall Study|Death|86|||
162735550|NCT01566695|587741301|FG000|Overall Study|Withdrawal by Subject|13|||
162735551|NCT01566695|587741302|FG001|Overall Study|Withdrawal by Subject|12|||
162735552|NCT01566695|587741301|FG000|Overall Study|Lost to Follow-up|0|||
162735553|NCT01566695|587741302|FG001|Overall Study|Lost to Follow-up|3|||
162735554|NCT01566695|587741301|FG000|Overall Study|Other reasons|11|||
162735555|NCT01566695|587741302|FG001|Overall Study|Other reasons|8|||
162735556|NCT01416831|587741304|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
162735557|NCT01416831|587741305|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
162735558|NCT05470400|587741306|FG000|Overall Study|Lost to Follow-up|0|||
162735559|NCT05470400|587741307|FG001|Overall Study|Lost to Follow-up|0|||
162735560|NCT05470400|587741308|FG002|Overall Study|Lost to Follow-up|0|||
162735561|NCT05470400|587741309|FG003|Overall Study|Lost to Follow-up|0|||
162735562|NCT05470400|587741310|FG004|Overall Study|Lost to Follow-up|0|||
162735563|NCT05470400|587741311|FG005|Overall Study|Lost to Follow-up|0|||
162735564|NCT05470400|587741312|FG006|Overall Study|Lost to Follow-up|0|||
162735565|NCT05470400|587741313|FG007|Overall Study|Lost to Follow-up|1|||
162735566|NCT05470400|587741306|FG000|Overall Study|Withdrawal by Subject|1|||
162735567|NCT05470400|587741307|FG001|Overall Study|Withdrawal by Subject|0|||
162735568|NCT05470400|587741308|FG002|Overall Study|Withdrawal by Subject|0|||
162735569|NCT05470400|587741309|FG003|Overall Study|Withdrawal by Subject|0|||
162735570|NCT05470400|587741310|FG004|Overall Study|Withdrawal by Subject|0|||
162735571|NCT05470400|587741311|FG005|Overall Study|Withdrawal by Subject|1|||
162735572|NCT05470400|587741312|FG006|Overall Study|Withdrawal by Subject|0|||
162735573|NCT05470400|587741313|FG007|Overall Study|Withdrawal by Subject|2|||
162735574|NCT05956002|587741314|FG000|Treatment Period 3|Adverse Event|0|||
162735575|NCT05956002|587741315|FG001|Treatment Period 3|Adverse Event|0|||
162735576|NCT05956002|587741316|FG002|Treatment Period 3|Adverse Event|1|||
162735577|NCT05956002|587741317|FG003|Treatment Period 3|Adverse Event|0|||
162735578|NCT04784559|587741318|FG000|Overall Study|Withdrawal by Subject|3|||
162735579|NCT04784559|587741319|FG001|Overall Study|Withdrawal by Subject|2|||
162735580|NCT04784559|587741320|FG002|Overall Study|Withdrawal by Subject|1|||
162735581|NCT04784559|587741318|FG000|Overall Study|Death|2|||
162735582|NCT04784559|587741319|FG001|Overall Study|Death|1|||
162735583|NCT04784559|587741320|FG002|Overall Study|Death|2|||
162735584|NCT04784559|587741318|FG000|Overall Study|Lost to Follow-up|0|||
162735585|NCT04784559|587741319|FG001|Overall Study|Lost to Follow-up|0|||
162735586|NCT04784559|587741320|FG002|Overall Study|Lost to Follow-up|2|||
162735587|NCT04784559|587741318|FG000|Overall Study|Participant worsened, PI decision|1|||
162735588|NCT04784559|587741319|FG001|Overall Study|Participant worsened, PI decision|0|||
162735589|NCT04784559|587741320|FG002|Overall Study|Participant worsened, PI decision|0|||
162735590|NCT04784559|587741318|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
162735591|NCT04784559|587741319|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
162735592|NCT04784559|587741320|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
162735593|NCT04784559|587741318|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
162735594|NCT04784559|587741319|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
162735595|NCT04784559|587741320|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
162735596|NCT04784559|587741318|FG000|Overall Study|Did not meet all inclusion criteria|0|||
162735597|NCT04784559|587741319|FG001|Overall Study|Did not meet all inclusion criteria|1|||
162735598|NCT04784559|587741320|FG002|Overall Study|Did not meet all inclusion criteria|0|||
162735599|NCT04784559|587741318|FG000|Overall Study|The participant was transferred to IRCU|0|||
162735600|NCT04784559|587741319|FG001|Overall Study|The participant was transferred to IRCU|1|||
162735601|NCT04784559|587741320|FG002|Overall Study|The participant was transferred to IRCU|0|||
162735602|NCT04784559|587741318|FG000|Overall Study|SAE|0|||
162735603|NCT04784559|587741319|FG001|Overall Study|SAE|1|||
162735604|NCT04784559|587741320|FG002|Overall Study|SAE|0|||
162735605|NCT04784559|587741318|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
162735606|NCT04784559|587741319|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
162735607|NCT04784559|587741320|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
162735608|NCT00931710|587741321|FG000|Overall Study|Adverse Event|16|||
162735609|NCT00931710|587741322|FG001|Overall Study|Adverse Event|10|||
162735610|NCT00931710|587741321|FG000|Overall Study|Abnormal test procedure results|2|||
162735611|NCT00931710|587741322|FG001|Overall Study|Abnormal test procedure results|0|||
162735612|NCT00931710|587741321|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
162735613|NCT00931710|587741322|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
162735614|NCT00931710|587741321|FG000|Overall Study|Patient withdrew consent|4|||
162735615|NCT00931710|587741322|FG001|Overall Study|Patient withdrew consent|9|||
162735616|NCT00931710|587741321|FG000|Overall Study|Lost to Follow-up|6|||
162735617|NCT00931710|587741322|FG001|Overall Study|Lost to Follow-up|5|||
162735618|NCT00931710|587741321|FG000|Overall Study|Protocol deviation|1|||
162735619|NCT00931710|587741322|FG001|Overall Study|Protocol deviation|2|||
162735620|NCT03665597|587741323|FG000|Period 1|Adverse Event|1|||
162735621|NCT03665597|587741324|FG001|Period 1|Adverse Event|0|||
162735622|NCT03665597|587741325|FG002|Period 1|Adverse Event|0|||
162735623|NCT03665597|587741326|FG003|Period 1|Adverse Event|1|||
162735624|NCT03665597|587741327|FG004|Period 1|Adverse Event|0|||
162735625|NCT03665597|587741328|FG005|Period 1|Adverse Event|0|||
162735626|NCT03665597|587741329|FG006|Period 1|Adverse Event|0|||
162735627|NCT03665597|587741323|FG000|Period 1|Screen Failure|0|||
162735628|NCT03665597|587741324|FG001|Period 1|Screen Failure|0|||
162735629|NCT03665597|587741325|FG002|Period 1|Screen Failure|0|||
162735630|NCT03665597|587741326|FG003|Period 1|Screen Failure|1|||
162735631|NCT03665597|587741327|FG004|Period 1|Screen Failure|0|||
162735632|NCT03665597|587741328|FG005|Period 1|Screen Failure|0|||
162735633|NCT03665597|587741329|FG006|Period 1|Screen Failure|0|||
162735634|NCT03665597|587741323|FG000|Period 1|Death|0|||
162735635|NCT03665597|587741324|FG001|Period 1|Death|0|||
162735636|NCT03665597|587741325|FG002|Period 1|Death|0|||
162735637|NCT03665597|587741326|FG003|Period 1|Death|0|||
162735638|NCT03665597|587741327|FG004|Period 1|Death|0|||
162735639|NCT03665597|587741328|FG005|Period 1|Death|0|||
162735640|NCT03665597|587741329|FG006|Period 1|Death|45|||
162735641|NCT03665597|587741323|FG000|Period 1|Withdrawal by Subject|0|||
162735642|NCT03665597|587741324|FG001|Period 1|Withdrawal by Subject|0|||
162735643|NCT03665597|587741325|FG002|Period 1|Withdrawal by Subject|0|||
162735644|NCT03665597|587741326|FG003|Period 1|Withdrawal by Subject|0|||
162735645|NCT03665597|587741327|FG004|Period 1|Withdrawal by Subject|0|||
162735646|NCT03665597|587741328|FG005|Period 1|Withdrawal by Subject|0|||
162735647|NCT03665597|587741329|FG006|Period 1|Withdrawal by Subject|5|||
162735648|NCT03665597|587741323|FG000|Period 2|Adverse Event|0|||
162735649|NCT03665597|587741324|FG001|Period 2|Adverse Event|0|||
162735650|NCT03665597|587741325|FG002|Period 2|Adverse Event|0|||
162735651|NCT03665597|587741326|FG003|Period 2|Adverse Event|0|||
162735652|NCT03665597|587741327|FG004|Period 2|Adverse Event|0|||
162735653|NCT03665597|587741328|FG005|Period 2|Adverse Event|1|||
162735654|NCT03665597|587741329|FG006|Period 2|Adverse Event|0|||
162735655|NCT03665597|587741323|FG000|Period 3|Adverse Event|0|||
162735656|NCT03665597|587741324|FG001|Period 3|Adverse Event|1|||
162735657|NCT03665597|587741325|FG002|Period 3|Adverse Event|0|||
162735658|NCT03665597|587741326|FG003|Period 3|Adverse Event|0|||
162735659|NCT03665597|587741327|FG004|Period 3|Adverse Event|0|||
162735660|NCT03665597|587741328|FG005|Period 3|Adverse Event|0|||
162735661|NCT03665597|587741329|FG006|Period 3|Adverse Event|0|||
162735662|NCT03665597|587741323|FG000|Period 3|Death|0|||
162735663|NCT03665597|587741324|FG001|Period 3|Death|0|||
162735664|NCT03665597|587741325|FG002|Period 3|Death|0|||
162735665|NCT03665597|587741326|FG003|Period 3|Death|0|||
162735666|NCT03665597|587741327|FG004|Period 3|Death|1|||
162735667|NCT03665597|587741328|FG005|Period 3|Death|0|||
162735668|NCT03665597|587741329|FG006|Period 3|Death|0|||
162735669|NCT03665597|587741323|FG000|Period 4|Adverse Event|2|||
162735670|NCT03665597|587741324|FG001|Period 4|Adverse Event|2|||
162735671|NCT03665597|587741325|FG002|Period 4|Adverse Event|2|||
162735672|NCT03665597|587741326|FG003|Period 4|Adverse Event|2|||
162735673|NCT03665597|587741327|FG004|Period 4|Adverse Event|1|||
162735674|NCT03665597|587741328|FG005|Period 4|Adverse Event|0|||
162735675|NCT03665597|587741329|FG006|Period 4|Adverse Event|0|||
162735676|NCT03665597|587741323|FG000|Period 4|Death|0|||
162735677|NCT03665597|587741324|FG001|Period 4|Death|0|||
162735678|NCT03665597|587741325|FG002|Period 4|Death|2|||
162735679|NCT03665597|587741326|FG003|Period 4|Death|0|||
162735680|NCT03665597|587741327|FG004|Period 4|Death|0|||
162735681|NCT03665597|587741328|FG005|Period 4|Death|0|||
162735682|NCT03665597|587741329|FG006|Period 4|Death|0|||
162735683|NCT03665597|587741323|FG000|Period 4|Physician Decision|1|||
162735684|NCT03665597|587741324|FG001|Period 4|Physician Decision|2|||
162735685|NCT03665597|587741325|FG002|Period 4|Physician Decision|0|||
162735686|NCT03665597|587741326|FG003|Period 4|Physician Decision|0|||
162735687|NCT03665597|587741327|FG004|Period 4|Physician Decision|0|||
162735688|NCT03665597|587741328|FG005|Period 4|Physician Decision|0|||
162735689|NCT03665597|587741329|FG006|Period 4|Physician Decision|0|||
162735690|NCT02874534|587741330|FG000|Overall Study|Withdrawal by Subject|5|||
162735691|NCT02874534|587741331|FG001|Overall Study|Withdrawal by Subject|8|||
162735692|NCT02874534|587741330|FG000|Overall Study|Lost to Follow-up|2|||
162735693|NCT02874534|587741331|FG001|Overall Study|Lost to Follow-up|2|||
162735694|NCT02874534|587741330|FG000|Overall Study|Ongoing in study|1|||
162735695|NCT02874534|587741331|FG001|Overall Study|Ongoing in study|1|||
162735696|NCT03361748|587741335|FG000|Overall Study|Death|77|||
162735697|NCT03361748|587741335|FG000|Overall Study|Lost to Follow-up|4|||
162735698|NCT03361748|587741335|FG000|Overall Study|Withdrawal by Subject|20|||
162735699|NCT01084707|587741339|FG000|Overall Study|Withdrawal by Subject|6|||
162735700|NCT00901901|587741340|FG000|Treatment Period|Adverse Event|120|||
162735701|NCT00901901|587741341|FG001|Treatment Period|Adverse Event|128|||
162735702|NCT00901901|587741340|FG000|Treatment Period|Withdrawal by Subject|26|||
162735703|NCT00901901|587741341|FG001|Treatment Period|Withdrawal by Subject|24|||
162735704|NCT00901901|587741340|FG000|Treatment Period|Physician Decision|2|||
162735705|NCT00901901|587741341|FG001|Treatment Period|Physician Decision|2|||
162735706|NCT00901901|587741340|FG000|Treatment Period|Lost to Follow-up|3|||
162735707|NCT00901901|587741341|FG001|Treatment Period|Lost to Follow-up|5|||
162735708|NCT00901901|587741340|FG000|Treatment Period|Noncompliance with study medication|4|||
162735709|NCT00901901|587741341|FG001|Treatment Period|Noncompliance with study medication|1|||
162735710|NCT00901901|587741340|FG000|Treatment Period|Missing|1|||
162735711|NCT00901901|587741341|FG001|Treatment Period|Missing|0|||
162735712|NCT00901901|587741340|FG000|Treatment Period|Never treated|0|||
162735713|NCT00901901|587741341|FG001|Treatment Period|Never treated|3|||
162735714|NCT00901901|587741340|FG000|Treatment Period|Protocol driven decision point|0|||
162735715|NCT00901901|587741341|FG001|Treatment Period|Protocol driven decision point|2|||
162735716|NCT00901901|587741340|FG000|Treatment Period|Study terminated by sponsor|2|||
162735717|NCT00901901|587741341|FG001|Treatment Period|Study terminated by sponsor|0|||
162735718|NCT00901901|587741340|FG000|Treatment Period|Protocol Violation|5|||
162735719|NCT00901901|587741341|FG001|Treatment Period|Protocol Violation|9|||
162735720|NCT00901901|587741340|FG000|Treatment Period|Switch to commercial drug|1|||
162735721|NCT00901901|587741341|FG001|Treatment Period|Switch to commercial drug|1|||
162735722|NCT00901901|587741340|FG000|Treatment Period|Transfer to treatment continuation study|5|||
162735723|NCT00901901|587741341|FG001|Treatment Period|Transfer to treatment continuation study|2|||
162735724|NCT00901901|587741340|FG000|Follow-up Period|Death|181|||
162735725|NCT00901901|587741341|FG001|Follow-up Period|Death|208|||
162735726|NCT00901901|587741340|FG000|Follow-up Period|Protocol driven decision point|47|||
162735727|NCT00901901|587741341|FG001|Follow-up Period|Protocol driven decision point|36|||
162735728|NCT00901901|587741340|FG000|Follow-up Period|Withdrawal by Subject|6|||
162735729|NCT00901901|587741341|FG001|Follow-up Period|Withdrawal by Subject|9|||
162735730|NCT00901901|587741340|FG000|Follow-up Period|Lost to Follow-up|12|||
162735731|NCT00901901|587741341|FG001|Follow-up Period|Lost to Follow-up|8|||
162735732|NCT00901901|587741340|FG000|Follow-up Period|Missing|94|||
162735733|NCT00901901|587741341|FG001|Follow-up Period|Missing|80|||
162735734|NCT04774237|587741345|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
162735735|NCT04774237|587741346|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
162735736|NCT04774237|587741347|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
162735737|NCT04774237|587741348|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
162735738|NCT04774237|587741349|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
162735739|NCT04774237|587741350|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
162735740|NCT00753090|587742789|FG000|Overall Study|Withdrawal by Subject|10|||
162735741|NCT00753090|587742790|FG001|Overall Study|Withdrawal by Subject|10|||
162735742|NCT00753090|587742789|FG000|Overall Study|Death|17|||
162735743|NCT00753090|587742790|FG001|Overall Study|Death|6|||
162735744|NCT00753090|587742789|FG000|Overall Study|Study Prosthesis Removed|12|||
162735745|NCT00753090|587742790|FG001|Overall Study|Study Prosthesis Removed|3|||
162735746|NCT00753090|587742789|FG000|Overall Study|Lost to Follow-up|2|||
162735747|NCT00753090|587742790|FG001|Overall Study|Lost to Follow-up|2|||
162735748|NCT00753090|587742789|FG000|Overall Study|Other|127|||
162735749|NCT00753090|587742790|FG001|Overall Study|Other|75|||
162735750|NCT04521478|587742794|FG000|Overall Study|Protocol Violation|2|||
162735751|NCT04521478|587742795|FG001|Overall Study|Protocol Violation|0|||
162735752|NCT04521478|587742796|FG002|Overall Study|Protocol Violation|1|||
162735753|NCT04521478|587742797|FG003|Overall Study|Protocol Violation|0|||
162735754|NCT04521478|587742798|FG004|Overall Study|Protocol Violation|0|||
162735755|NCT04521478|587742799|FG005|Overall Study|Protocol Violation|0|||
162735756|NCT04521478|587742794|FG000|Overall Study|Technical Problems|0|||
162735757|NCT04521478|587742795|FG001|Overall Study|Technical Problems|0|||
162735758|NCT04521478|587742796|FG002|Overall Study|Technical Problems|0|||
162735759|NCT04521478|587742797|FG003|Overall Study|Technical Problems|1|||
162735760|NCT04521478|587742798|FG004|Overall Study|Technical Problems|0|||
162735761|NCT04521478|587742799|FG005|Overall Study|Technical Problems|0|||
162735762|NCT04521478|587742794|FG000|Overall Study|Burden of Study Procedures|1|||
162735763|NCT04521478|587742795|FG001|Overall Study|Burden of Study Procedures|0|||
162735764|NCT04521478|587742796|FG002|Overall Study|Burden of Study Procedures|0|||
162735765|NCT04521478|587742797|FG003|Overall Study|Burden of Study Procedures|1|||
162735766|NCT04521478|587742798|FG004|Overall Study|Burden of Study Procedures|0|||
162735767|NCT04521478|587742799|FG005|Overall Study|Burden of Study Procedures|1|||
162735768|NCT04521478|587742794|FG000|Overall Study|Lack of Efficacy|0|||
162735769|NCT04521478|587742795|FG001|Overall Study|Lack of Efficacy|0|||
162735770|NCT04521478|587742796|FG002|Overall Study|Lack of Efficacy|0|||
162735771|NCT04521478|587742797|FG003|Overall Study|Lack of Efficacy|0|||
162735772|NCT04521478|587742798|FG004|Overall Study|Lack of Efficacy|1|||
162735773|NCT04521478|587742799|FG005|Overall Study|Lack of Efficacy|1|||
162735774|NCT04521478|587742794|FG000|Overall Study|Adverse Event|7|||
162735775|NCT04521478|587742795|FG001|Overall Study|Adverse Event|0|||
162735776|NCT04521478|587742796|FG002|Overall Study|Adverse Event|2|||
162735777|NCT04521478|587742797|FG003|Overall Study|Adverse Event|1|||
162735778|NCT04521478|587742798|FG004|Overall Study|Adverse Event|2|||
162735779|NCT04521478|587742799|FG005|Overall Study|Adverse Event|7|||
162735780|NCT04521478|587742794|FG000|Overall Study|No Reason Available|0|||
162735781|NCT04521478|587742795|FG001|Overall Study|No Reason Available|2|||
162735782|NCT04521478|587742796|FG002|Overall Study|No Reason Available|0|||
162735783|NCT04521478|587742797|FG003|Overall Study|No Reason Available|0|||
162735784|NCT04521478|587742798|FG004|Overall Study|No Reason Available|1|||
162735785|NCT04521478|587742799|FG005|Overall Study|No Reason Available|0|||
162735786|NCT04521478|587742794|FG000|Overall Study|Other than listed|3|||
162735787|NCT04521478|587742795|FG001|Overall Study|Other than listed|3|||
162735788|NCT04521478|587742796|FG002|Overall Study|Other than listed|3|||
162735789|NCT04521478|587742797|FG003|Overall Study|Other than listed|2|||
162735790|NCT04521478|587742798|FG004|Overall Study|Other than listed|3|||
162735791|NCT04521478|587742799|FG005|Overall Study|Other than listed|3|||
162735792|NCT04521478|587742794|FG000|Overall Study|Not treated|0|||
162735793|NCT04521478|587742795|FG001|Overall Study|Not treated|0|||
162735794|NCT04521478|587742796|FG002|Overall Study|Not treated|0|||
162735795|NCT04521478|587742797|FG003|Overall Study|Not treated|0|||
162735796|NCT04521478|587742798|FG004|Overall Study|Not treated|0|||
162735797|NCT04521478|587742799|FG005|Overall Study|Not treated|1|||
162735798|NCT02630823|587742816|FG000|Overall Study|Withdrawal by Subject|1|||
162735799|NCT02630823|587742816|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
162735800|NCT02682316|587742829|FG000|Overall Study|Benign Final Pathology|27|||
162735801|NCT02682316|587742830|FG001|Overall Study|Benign Final Pathology|26|||
162735802|NCT02682316|587742829|FG000|Overall Study|Reoperation before 30 days|7|||
162735803|NCT02682316|587742830|FG001|Overall Study|Reoperation before 30 days|6|||
162735804|NCT02682316|587742829|FG000|Overall Study|Ineligible|1|||
162735805|NCT02682316|587742830|FG001|Overall Study|Ineligible|0|||
162735806|NCT02682316|587742829|FG000|Overall Study|Death|1|||
162735807|NCT02682316|587742830|FG001|Overall Study|Death|0|||
162735808|NCT02682316|587742829|FG000|Overall Study|Lost to Follow-up|7|||
162735809|NCT02682316|587742830|FG001|Overall Study|Lost to Follow-up|3|||
162735810|NCT04630262|587742832|FG000|Overall Study|Intraoperative Screen Failure|5|||
162735811|NCT04630262|587742832|FG000|Overall Study|Study terminated prematurely|71|||
162735812|NCT04630262|587742832|FG000|Overall Study|Withdrawal by Subject|2|||
162735813|NCT04630262|587742832|FG000|Overall Study|Physician Decision|2|||
162735814|NCT03692676|587742834|FG000|Overall Study|exclude patients with prior use|4424|||
162735815|NCT03692676|587742835|FG001|Overall Study|exclude patients with prior use|24726|||
162735816|NCT03692676|587742836|FG002|Overall Study|exclude patients with prior use|0|||
162735817|NCT03692676|587742837|FG003|Overall Study|exclude patients with prior use|0|||
162735818|NCT03692676|587742834|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
162735819|NCT03692676|587742835|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
162735820|NCT03692676|587742836|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
162735821|NCT03692676|587742837|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
162735822|NCT03692676|587742834|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
162735823|NCT03692676|587742835|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
162735824|NCT03692676|587742836|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
162735825|NCT03692676|587742837|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
162735826|NCT03692676|587742834|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
162735827|NCT03692676|587742835|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
162735828|NCT03692676|587742836|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
162735829|NCT03692676|587742837|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
162735830|NCT03692676|587742834|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
162735831|NCT03692676|587742835|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
162735832|NCT03692676|587742836|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
162735833|NCT03692676|587742837|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
162735834|NCT03692676|587742834|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
162735835|NCT03692676|587742835|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
162735836|NCT03692676|587742836|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
162735837|NCT03692676|587742837|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
162735838|NCT03692676|587742834|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
162735839|NCT03692676|587742835|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
162735840|NCT03692676|587742836|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
162735841|NCT03692676|587742837|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
162735842|NCT03692676|587742834|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
162735843|NCT03692676|587742835|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
162735844|NCT03692676|587742836|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
162735845|NCT03692676|587742837|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
162735846|NCT03692676|587742834|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
162735847|NCT03692676|587742835|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
162735848|NCT03692676|587742836|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
162735849|NCT03692676|587742837|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
162735850|NCT03692676|587742834|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
162735851|NCT03692676|587742835|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
162735852|NCT03692676|587742836|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
162735853|NCT03692676|587742837|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
162735854|NCT03692676|587742834|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162735855|NCT03692676|587742835|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162735856|NCT03692676|587742836|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162735857|NCT03692676|587742837|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
162735858|NCT03692676|587742834|FG000|Overall Study|Other|0|||
162735859|NCT03692676|587742835|FG001|Overall Study|Other|805|||
162735860|NCT03692676|587742836|FG002|Overall Study|Other|758|||
162735861|NCT03692676|587742837|FG003|Overall Study|Other|277|||
162735862|NCT03692676|587742834|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162735863|NCT03692676|587742835|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162735864|NCT03692676|587742836|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162735865|NCT03692676|587742837|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
162735866|NCT03692611|587742838|FG000|Overall Study|Found to be ineligible postrandomization|3|||
162735867|NCT03692611|587742839|FG001|Overall Study|Found to be ineligible postrandomization|0|||
162735868|NCT03988634|587742840|FG000|Double-Blind|Adverse Event|4|||
162735869|NCT03988634|587742841|FG001|Double-Blind|Adverse Event|0|||
162735870|NCT03988634|587742842|FG002|Double-Blind|Adverse Event|0|||
162735871|NCT03988634|587742840|FG000|Double-Blind|Death|18|||
162735872|NCT03988634|587742841|FG001|Double-Blind|Death|26|||
162735873|NCT03988634|587742842|FG002|Double-Blind|Death|0|||
162735874|NCT03988634|587742840|FG000|Double-Blind|Lost to Follow-up|6|||
162735875|NCT03988634|587742841|FG001|Double-Blind|Lost to Follow-up|7|||
162735876|NCT03988634|587742842|FG002|Double-Blind|Lost to Follow-up|0|||
162735877|NCT03988634|587742840|FG000|Double-Blind|Physician Decision|9|||
162735878|NCT03988634|587742841|FG001|Double-Blind|Physician Decision|5|||
162735879|NCT03988634|587742842|FG002|Double-Blind|Physician Decision|0|||
162735880|NCT03988634|587742840|FG000|Double-Blind|Subject decision|24|||
162735881|NCT03988634|587742841|FG001|Double-Blind|Subject decision|13|||
162735882|NCT03988634|587742842|FG002|Double-Blind|Subject decision|0|||
162735883|NCT03988634|587742840|FG000|Open-Label|Adverse Event|0|||
162735884|NCT03988634|587742841|FG001|Open-Label|Adverse Event|0|||
162735885|NCT03988634|587742842|FG002|Open-Label|Adverse Event|7|||
162735886|NCT03988634|587742840|FG000|Open-Label|Physician Decision|0|||
162735887|NCT03988634|587742841|FG001|Open-Label|Physician Decision|0|||
162735888|NCT03988634|587742842|FG002|Open-Label|Physician Decision|1|||
162735889|NCT03988634|587742840|FG000|Open-Label|Technical problems|0|||
162735890|NCT03988634|587742841|FG001|Open-Label|Technical problems|0|||
162735891|NCT03988634|587742842|FG002|Open-Label|Technical problems|1|||
162735892|NCT04083235|587742860|FG000|Overall Study|Death|252|||
162735893|NCT04083235|587742861|FG001|Overall Study|Death|277|||
162735894|NCT04083235|587742860|FG000|Overall Study|Withdrawal by Subject|13|||
162735895|NCT04083235|587742861|FG001|Overall Study|Withdrawal by Subject|17|||
162735896|NCT04083235|587742860|FG000|Overall Study|Lost to Follow-up|1|||
162735897|NCT04083235|587742861|FG001|Overall Study|Lost to Follow-up|1|||
162735898|NCT04083235|587742860|FG000|Overall Study|Does not meet entry criteria|1|||
162735899|NCT04083235|587742861|FG001|Overall Study|Does not meet entry criteria|0|||
162735900|NCT04083235|587742860|FG000|Overall Study|Did not receive treatment|13|||
162735901|NCT04083235|587742861|FG001|Overall Study|Did not receive treatment|8|||
162735902|NCT04083235|587742860|FG000|Overall Study|Ongoing at the time of DCO|44|||
162735903|NCT04083235|587742861|FG001|Overall Study|Ongoing at the time of DCO|7|||
162735904|NCT03016169|587742862|FG000|Overall Study|Lost to Follow-up|4|||
162735905|NCT03016169|587742862|FG000|Overall Study|Death|54|||
162735906|NCT03016169|587742862|FG000|Overall Study|Device Explant|11|||
162735907|NCT03016169|587742862|FG000|Overall Study|Withdrawal by Subject|19|||
162735908|NCT03016169|587742862|FG000|Overall Study|Other Reasons|1|||
162735909|NCT05082909|587742863|FG000|Overall Study|Protocol Violation|0|||
162735910|NCT05082909|587742864|FG001|Overall Study|Protocol Violation|0|||
162735911|NCT05082909|587742865|FG002|Overall Study|Protocol Violation|1|||
162735912|NCT05082909|587742866|FG003|Overall Study|Protocol Violation|0|||
162735913|NCT05082909|587742867|FG004|Overall Study|Protocol Violation|0|||
162735914|NCT05082909|587742868|FG005|Overall Study|Protocol Violation|0|||
162735915|NCT04088630|587742869|FG000|Overall Study|Lost to Follow-up|3|||
162735916|NCT04088630|587742870|FG001|Overall Study|Lost to Follow-up|2|||
162735917|NCT04088630|587742871|FG002|Overall Study|Lost to Follow-up|6|||
162735918|NCT04088630|587742869|FG000|Overall Study|Death|3|||
162735919|NCT04088630|587742870|FG001|Overall Study|Death|1|||
162735920|NCT04088630|587742871|FG002|Overall Study|Death|1|||
162735921|NCT04088630|587742869|FG000|Overall Study|Physician Decision|0|||
162735922|NCT04088630|587742870|FG001|Overall Study|Physician Decision|1|||
162735923|NCT04088630|587742871|FG002|Overall Study|Physician Decision|1|||
162735924|NCT03047928|587742875|FG000|Overall Study|Adverse Event|0|||
162735925|NCT03047928|587742876|FG001|Overall Study|Adverse Event|2|||
162735926|NCT03047928|587742877|FG002|Overall Study|Adverse Event|0|||
162735927|NCT03047928|587742875|FG000|Overall Study|Protocol Violation|0|||
162735928|NCT03047928|587742876|FG001|Overall Study|Protocol Violation|1|||
162735929|NCT03047928|587742877|FG002|Overall Study|Protocol Violation|0|||
162735930|NCT03047928|587742875|FG000|Overall Study|included in another protocol|0|||
162735931|NCT03047928|587742876|FG001|Overall Study|included in another protocol|1|||
162735932|NCT03047928|587742877|FG002|Overall Study|included in another protocol|0|||
162735933|NCT02729311|587742878|FG000|Overall Study|Withdrawal by Subject|8|||
162735934|NCT02729311|587742879|FG001|Overall Study|Withdrawal by Subject|2|||
162735935|NCT05324124|587742880|FG000|Period 1|Withdrawal by Subject|1|||
162735936|NCT05324124|587742881|FG001|Period 1|Withdrawal by Subject|0|||
162735937|NCT05324124|587742880|FG000|Period 1|Physician Decision|0|||
162735938|NCT05324124|587742881|FG001|Period 1|Physician Decision|1|||
162735939|NCT02287610|587742882|FG000|Overall Study|Lost to Follow-up|3|||
162735940|NCT02287610|587742882|FG000|Overall Study|Withdrawal by Subject|8|||
162735941|NCT02287610|587742882|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
162735942|NCT04950660|587742883|FG000|Overall Study|Protocol Violation|4|||
162735943|NCT04950660|587742884|FG001|Overall Study|Protocol Violation|2|||
162735944|NCT04950660|587742883|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
162735945|NCT04950660|587742884|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
162735946|NCT04950660|587742883|FG000|Overall Study|Withdrawal by Subject|0|||
162735947|NCT04950660|587742884|FG001|Overall Study|Withdrawal by Subject|1|||
162735948|NCT04950660|587742883|FG000|Overall Study|Hypotension|1|||
162735949|NCT04950660|587742884|FG001|Overall Study|Hypotension|0|||
162735950|NCT04783935|587742887|FG000|Overall Study|Withdrawal by Subject|6|||
162735951|NCT04783935|587742887|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
162735952|NCT04783935|587742887|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
162735953|NCT04783935|587742887|FG000|Overall Study|Lost to Follow-up|3|||
162735954|NCT04783935|587742887|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
162735955|NCT03338790|587742888|FG000|Overall Study|Disease Progression|65|||
162735956|NCT03338790|587742889|FG001|Overall Study|Disease Progression|43|||
162735957|NCT03338790|587742890|FG002|Overall Study|Disease Progression|50|||
162735958|NCT03338790|587742891|FG003|Overall Study|Disease Progression|37|||
162735959|NCT03338790|587742888|FG000|Overall Study|Study Drug Toxicity|9|||
162735960|NCT03338790|587742889|FG001|Overall Study|Study Drug Toxicity|8|||
162735961|NCT03338790|587742890|FG002|Overall Study|Study Drug Toxicity|15|||
162735962|NCT03338790|587742891|FG003|Overall Study|Study Drug Toxicity|0|||
162735963|NCT03338790|587742888|FG000|Overall Study|Death|1|||
162735964|NCT03338790|587742889|FG001|Overall Study|Death|1|||
162735965|NCT03338790|587742890|FG002|Overall Study|Death|1|||
162735966|NCT03338790|587742891|FG003|Overall Study|Death|0|||
162735967|NCT03338790|587742888|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
162735968|NCT03338790|587742889|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
162735969|NCT03338790|587742890|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
162735970|NCT03338790|587742891|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
162735971|NCT03338790|587742888|FG000|Overall Study|Participant request to discontinue study treatment|3|||
162735972|NCT03338790|587742889|FG001|Overall Study|Participant request to discontinue study treatment|3|||
162735973|NCT03338790|587742890|FG002|Overall Study|Participant request to discontinue study treatment|2|||
162735974|NCT03338790|587742891|FG003|Overall Study|Participant request to discontinue study treatment|1|||
162735975|NCT03338790|587742888|FG000|Overall Study|Poor/non-compliance|0|||
162735976|NCT03338790|587742889|FG001|Overall Study|Poor/non-compliance|1|||
162735977|NCT03338790|587742890|FG002|Overall Study|Poor/non-compliance|0|||
162735978|NCT03338790|587742891|FG003|Overall Study|Poor/non-compliance|0|||
162735979|NCT03338790|587742888|FG000|Overall Study|Participant withdrew consent|1|||
162735980|NCT03338790|587742889|FG001|Overall Study|Participant withdrew consent|0|||
162735981|NCT03338790|587742890|FG002|Overall Study|Participant withdrew consent|1|||
162735982|NCT03338790|587742891|FG003|Overall Study|Participant withdrew consent|1|||
162735983|NCT03338790|587742888|FG000|Overall Study|Other reasons|0|||
162735984|NCT03338790|587742889|FG001|Overall Study|Other reasons|5|||
162735985|NCT03338790|587742890|FG002|Overall Study|Other reasons|0|||
162735986|NCT03338790|587742891|FG003|Overall Study|Other reasons|2|||
162735987|NCT03338790|587742888|FG000|Overall Study|Not reported|0|||
162735988|NCT03338790|587742889|FG001|Overall Study|Not reported|0|||
162735989|NCT03338790|587742890|FG002|Overall Study|Not reported|1|||
162735990|NCT03338790|587742891|FG003|Overall Study|Not reported|0|||
162735991|NCT03338790|587742888|FG000|Overall Study|Completed treatment period|1|||
162735992|NCT03338790|587742889|FG001|Overall Study|Completed treatment period|2|||
162735993|NCT03338790|587742890|FG002|Overall Study|Completed treatment period|0|||
162735994|NCT03338790|587742891|FG003|Overall Study|Completed treatment period|0|||
162735995|NCT04588298|587742892|FG000|Overall Study|Adverse Event|0|||
162735996|NCT04588298|587742893|FG001|Overall Study|Adverse Event|0|||
162735997|NCT04588298|587742894|FG002|Overall Study|Adverse Event|1|||
162735998|NCT04588298|587742895|FG003|Overall Study|Adverse Event|0|||
162735999|NCT04588298|587742896|FG004|Overall Study|Adverse Event|2|||
162736000|NCT04588298|587742892|FG000|Overall Study|Withdrawal by Subject|1|||
162736001|NCT04588298|587742893|FG001|Overall Study|Withdrawal by Subject|0|||
162736002|NCT04588298|587742894|FG002|Overall Study|Withdrawal by Subject|0|||
162736003|NCT04588298|587742895|FG003|Overall Study|Withdrawal by Subject|1|||
162736004|NCT04588298|587742896|FG004|Overall Study|Withdrawal by Subject|0|||
162736005|NCT02281955|587742897|FG000|Overall Study|Death|1|||
162736006|NCT03892616|587742898|FG000|Washout Period 2|Met discontinuation criterion|0|||
162736007|NCT03892616|587742899|FG001|Washout Period 2|Met discontinuation criterion|0|||
162736008|NCT03892616|587742900|FG002|Washout Period 2|Met discontinuation criterion|0|||
162736009|NCT03892616|587742901|FG003|Washout Period 2|Met discontinuation criterion|0|||
162736010|NCT03892616|587742902|FG004|Washout Period 2|Met discontinuation criterion|0|||
162736011|NCT03892616|587742903|FG005|Washout Period 2|Met discontinuation criterion|0|||
162736012|NCT03892616|587742904|FG006|Washout Period 2|Met discontinuation criterion|0|||
162736013|NCT03892616|587742905|FG007|Washout Period 2|Met discontinuation criterion|0|||
162736014|NCT03892616|587742906|FG008|Washout Period 2|Met discontinuation criterion|1|||
162736015|NCT03892616|587742907|FG009|Washout Period 2|Met discontinuation criterion|0|||
162736016|NCT03892616|587742908|FG010|Washout Period 2|Met discontinuation criterion|0|||
162736017|NCT03892616|587742909|FG011|Washout Period 2|Met discontinuation criterion|0|||
162736018|NCT03683719|587742910|FG000|Overall Study|Lack of Efficacy|1|||
162736019|NCT03683719|587742911|FG001|Overall Study|Lack of Efficacy|3|||
162736020|NCT03683719|587742912|FG002|Overall Study|Lack of Efficacy|4|||
162736021|NCT03683719|587742913|FG003|Overall Study|Lack of Efficacy|0|||
162736022|NCT03683719|587742914|FG004|Overall Study|Lack of Efficacy|4|||
162736023|NCT03683719|587742910|FG000|Overall Study|Adverse Event|6|||
162736024|NCT03683719|587742911|FG001|Overall Study|Adverse Event|6|||
162736025|NCT03683719|587742912|FG002|Overall Study|Adverse Event|0|||
162736026|NCT03683719|587742913|FG003|Overall Study|Adverse Event|1|||
162736027|NCT03683719|587742914|FG004|Overall Study|Adverse Event|3|||
162736028|NCT03683719|587742910|FG000|Overall Study|Withdrawal by Subject|4|||
162736029|NCT03683719|587742911|FG001|Overall Study|Withdrawal by Subject|4|||
162736030|NCT03683719|587742912|FG002|Overall Study|Withdrawal by Subject|3|||
162736031|NCT03683719|587742913|FG003|Overall Study|Withdrawal by Subject|5|||
162736032|NCT03683719|587742914|FG004|Overall Study|Withdrawal by Subject|5|||
162736033|NCT03683719|587742910|FG000|Overall Study|Lost to Follow-up|1|||
162736034|NCT03683719|587742911|FG001|Overall Study|Lost to Follow-up|0|||
162736035|NCT03683719|587742912|FG002|Overall Study|Lost to Follow-up|0|||
162736036|NCT03683719|587742913|FG003|Overall Study|Lost to Follow-up|1|||
162736037|NCT03683719|587742914|FG004|Overall Study|Lost to Follow-up|1|||
162736038|NCT03683719|587742910|FG000|Overall Study|Other personal reasons|0|||
162736039|NCT03683719|587742911|FG001|Overall Study|Other personal reasons|0|||
162736040|NCT03683719|587742912|FG002|Overall Study|Other personal reasons|1|||
162736041|NCT03683719|587742913|FG003|Overall Study|Other personal reasons|0|||
162736042|NCT03683719|587742914|FG004|Overall Study|Other personal reasons|1|||
162736043|NCT00601900|587742916|FG000|Overall Study|Withdrawal by Subject|0|||
162736044|NCT00601900|587742917|FG001|Overall Study|Withdrawal by Subject|3|||
162736045|NCT03924986|587742918|FG000|Overall Study|Death|57|||
162736046|NCT03924986|587742919|FG001|Overall Study|Death|66|||
162736047|NCT03924986|587742918|FG000|Overall Study|Study Concluded by Sponsor|51|||
162736048|NCT03924986|587742919|FG001|Overall Study|Study Concluded by Sponsor|41|||
162736049|NCT03924986|587742918|FG000|Overall Study|Withdrawal by Subject|15|||
162736050|NCT03924986|587742919|FG001|Overall Study|Withdrawal by Subject|20|||
162736051|NCT03924986|587742918|FG000|Overall Study|Lost to Follow-up|7|||
162736052|NCT03924986|587742919|FG001|Overall Study|Lost to Follow-up|5|||
162736053|NCT03924986|587742918|FG000|Overall Study|Miscellaneous|1|||
162736054|NCT03924986|587742919|FG001|Overall Study|Miscellaneous|0|||
162736055|NCT05569252|587742925|FG000|Overall Study|Adverse event (central vision loss)|1|||
162736056|NCT05569252|587742926|FG001|Overall Study|Adverse event (central vision loss)|0|||
162736057|NCT05569252|587742927|FG002|Overall Study|Adverse event (central vision loss)|0|||
162736058|NCT05569252|587742928|FG003|Overall Study|Adverse event (central vision loss)|0|||
162736059|NCT05516147|587742929|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
162736060|NCT05113966|587744854|FG000|Overall Study|Death|21|||
162736061|NCT05113966|587744854|FG000|Overall Study|Study Terminated by Sponsor|9|||
162736062|NCT02187003|587744857|FG000|Overall Study|Adverse Event|2|||
162736063|NCT02187003|587744858|FG001|Overall Study|Adverse Event|0|||
162736064|NCT02187003|587744857|FG000|Overall Study|Lost to Follow-up|14|||
162736065|NCT02187003|587744858|FG001|Overall Study|Lost to Follow-up|10|||
162736066|NCT02187003|587744857|FG000|Overall Study|Withdrawal by Subject|3|||
162736067|NCT02187003|587744858|FG001|Overall Study|Withdrawal by Subject|7|||
162736068|NCT02187003|587744857|FG000|Overall Study|Protocol Violation|2|||
162736069|NCT02187003|587744858|FG001|Overall Study|Protocol Violation|4|||
162736070|NCT02187003|587744857|FG000|Overall Study|Other|5|||
162736071|NCT02187003|587744858|FG001|Overall Study|Other|5|||
162736072|NCT02187003|587744857|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162736073|NCT02187003|587744858|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
162736074|NCT05382936|587744860|FG000|Overall Study|Progressive Disease|3|||
162736075|NCT05382936|587744861|FG001|Overall Study|Progressive Disease|5|||
162736076|NCT05382936|587744862|FG002|Overall Study|Progressive Disease|2|||
162736077|NCT05382936|587744863|FG003|Overall Study|Progressive Disease|5|||
162736078|NCT05382936|587744860|FG000|Overall Study|Adverse Event|0|||
162736079|NCT05382936|587744861|FG001|Overall Study|Adverse Event|1|||
162736080|NCT05382936|587744862|FG002|Overall Study|Adverse Event|1|||
162736081|NCT05382936|587744863|FG003|Overall Study|Adverse Event|0|||
162736082|NCT05382936|587744860|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162736083|NCT05382936|587744861|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
162736084|NCT05382936|587744862|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162736085|NCT05382936|587744863|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162736086|NCT05382936|587744860|FG000|Overall Study|Withdrawal by Subject|0|||
162736087|NCT05382936|587744861|FG001|Overall Study|Withdrawal by Subject|0|||
162736088|NCT05382936|587744862|FG002|Overall Study|Withdrawal by Subject|1|||
162736089|NCT05382936|587744863|FG003|Overall Study|Withdrawal by Subject|1|||
162736090|NCT05063994|587744864|FG000|Cortef Run-In|Withdrawal of Consent|1|||
162736091|NCT05063994|587744865|FG001|Cortef Run-In|Withdrawal of Consent|0|||
162736092|NCT05063994|587744866|FG002|Cortef Run-In|Withdrawal of Consent|0|||
162736093|NCT05063994|587744864|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
162736094|NCT05063994|587744865|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
162736095|NCT05063994|587744866|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
162736096|NCT05063994|587744864|FG000|Treatment|Physician Decision|0|||
162736097|NCT05063994|587744865|FG001|Treatment|Physician Decision|0|||
162736098|NCT05063994|587744866|FG002|Treatment|Physician Decision|1|||
162736099|NCT05063994|587744864|FG000|Treatment|Withdrawal by Subject|0|||
162736100|NCT05063994|587744865|FG001|Treatment|Withdrawal by Subject|0|||
162736101|NCT05063994|587744866|FG002|Treatment|Withdrawal by Subject|1|||
162736102|NCT05063994|587744864|FG000|Treatment|Withdrawal of Consent|0|||
162736103|NCT05063994|587744865|FG001|Treatment|Withdrawal of Consent|0|||
162736104|NCT05063994|587744866|FG002|Treatment|Withdrawal of Consent|1|||
162736105|NCT01195831|587744870|FG000|Overall Study|Lost to Follow-up|2|||
162736106|NCT01195831|587744871|FG001|Overall Study|Lost to Follow-up|4|||
162736107|NCT01195831|587744870|FG000|Overall Study|Withdrawal by Subject|2|||
162736108|NCT01195831|587744871|FG001|Overall Study|Withdrawal by Subject|2|||
162736109|NCT01195831|587744870|FG000|Overall Study|Adverse Event|4|||
162736110|NCT01195831|587744871|FG001|Overall Study|Adverse Event|2|||
162736111|NCT01195831|587744870|FG000|Overall Study|Protocol Violation|0|||
162736112|NCT01195831|587744871|FG001|Overall Study|Protocol Violation|2|||
162736113|NCT04490915|587744873|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162736114|NCT04490915|587744874|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162736115|NCT04490915|587744873|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162736116|NCT04490915|587744874|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162736117|NCT04490915|587744873|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162736118|NCT04490915|587744874|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
162736119|NCT04490915|587744873|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
162736120|NCT04490915|587744874|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
162736121|NCT04490915|587744873|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
162736122|NCT04490915|587744874|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
162736123|NCT04490915|587744873|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
162736124|NCT04490915|587744874|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
162736125|NCT04490915|587744873|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
162736126|NCT04490915|587744874|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
162736127|NCT00667251|587744876|FG000|Overall Study|Disease progression|232|||
162736128|NCT00667251|587744877|FG001|Overall Study|Disease progression|203|||
162736129|NCT00667251|587744876|FG000|Overall Study|Toxicity|44|||
162736130|NCT00667251|587744877|FG001|Overall Study|Toxicity|23|||
162736131|NCT00667251|587744876|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
162736132|NCT00667251|587744877|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
162736133|NCT00667251|587744876|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
162736134|NCT00667251|587744877|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
162736135|NCT00667251|587744876|FG000|Overall Study|Symptomatic progression|8|||
162736136|NCT00667251|587744877|FG001|Overall Study|Symptomatic progression|4|||
162736137|NCT00667251|587744876|FG000|Overall Study|Death|6|||
162736138|NCT00667251|587744877|FG001|Overall Study|Death|11|||
162736139|NCT00667251|587744876|FG000|Overall Study|Intercurrent illness|5|||
162736140|NCT00667251|587744877|FG001|Overall Study|Intercurrent illness|6|||
162736141|NCT00667251|587744876|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
162736142|NCT00667251|587744877|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
162736143|NCT00667251|587744876|FG000|Overall Study|Randomized not Treated|4|||
162736144|NCT00667251|587744877|FG001|Overall Study|Randomized not Treated|1|||
162736145|NCT05034952|587744881|FG000|Overall Study|Adverse Event|1|||
162736146|NCT05034952|587744882|FG001|Overall Study|Adverse Event|0|||
162736147|NCT05034952|587744883|FG002|Overall Study|Adverse Event|0|||
162736148|NCT05034952|587744884|FG003|Overall Study|Adverse Event|0|||
162736149|NCT05034952|587744881|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162736150|NCT05034952|587744882|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
162736151|NCT05034952|587744883|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
162736152|NCT05034952|587744884|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
162736153|NCT05034952|587744881|FG000|Overall Study|Lost to Follow-up|1|||
162736154|NCT05034952|587744882|FG001|Overall Study|Lost to Follow-up|4|||
162736155|NCT05034952|587744883|FG002|Overall Study|Lost to Follow-up|3|||
162736156|NCT05034952|587744884|FG003|Overall Study|Lost to Follow-up|3|||
162736157|NCT05034952|587744881|FG000|Overall Study|Other|0|||
162736158|NCT05034952|587744882|FG001|Overall Study|Other|0|||
162736159|NCT05034952|587744883|FG002|Overall Study|Other|0|||
162736160|NCT05034952|587744884|FG003|Overall Study|Other|1|||
162736161|NCT02437318|587744885|FG000|Overall Study|Progressive disease|207|||
162736162|NCT02437318|587744886|FG001|Overall Study|Progressive disease|240|||
162736163|NCT02437318|587744885|FG000|Overall Study|Subject/guardian decision|24|||
162736164|NCT02437318|587744886|FG001|Overall Study|Subject/guardian decision|11|||
162736165|NCT02437318|587744885|FG000|Overall Study|Physician Decision|29|||
162736166|NCT02437318|587744886|FG001|Overall Study|Physician Decision|22|||
162736167|NCT02437318|587744885|FG000|Overall Study|Adverse Event|14|||
162736168|NCT02437318|587744886|FG001|Overall Study|Adverse Event|4|||
162736169|NCT02437318|587744885|FG000|Overall Study|Death|4|||
162736170|NCT02437318|587744886|FG001|Overall Study|Death|4|||
162736171|NCT02437318|587744885|FG000|Overall Study|Protocol deviation|5|||
162736172|NCT02437318|587744886|FG001|Overall Study|Protocol deviation|7|||
162736173|NCT02437318|587744885|FG000|Overall Study|Sponsor decision|1|||
162736174|NCT02437318|587744886|FG001|Overall Study|Sponsor decision|0|||
162736175|NCT06074523|587744890|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
162736176|NCT06074523|587744890|FG000|Overall Study|Withdrawal by Subject|1|||
162736177|NCT05273749|587744891|FG000|Overall Study|Adverse Event|14|||
162736178|NCT05273749|587744892|FG001|Overall Study|Adverse Event|8|||
162736179|NCT05273749|587744891|FG000|Overall Study|Lack of Efficacy|2|||
162736180|NCT05273749|587744892|FG001|Overall Study|Lack of Efficacy|8|||
162736181|NCT05273749|587744891|FG000|Overall Study|Physician Decision|0|||
162736182|NCT05273749|587744892|FG001|Overall Study|Physician Decision|2|||
162736183|NCT05273749|587744891|FG000|Overall Study|Withdrawal by Subject|14|||
162736184|NCT05273749|587744892|FG001|Overall Study|Withdrawal by Subject|16|||
162736185|NCT05273749|587744891|FG000|Overall Study|Lost to Follow-up|10|||
162736186|NCT05273749|587744892|FG001|Overall Study|Lost to Follow-up|10|||
162736187|NCT05273749|587744891|FG000|Overall Study|Pregnancy|1|||
162736188|NCT05273749|587744892|FG001|Overall Study|Pregnancy|0|||
162736189|NCT05273749|587744891|FG000|Overall Study|Non-Compliance|3|||
162736190|NCT05273749|587744892|FG001|Overall Study|Non-Compliance|2|||
162736191|NCT05273749|587744891|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
162736192|NCT05273749|587744892|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
162736193|NCT02900924|587744896|FG000|Overall Study|Death|52|||
162736194|NCT02900924|587744896|FG000|Overall Study|Lost to Follow-up|4|||
162736195|NCT02900924|587744896|FG000|Overall Study|Withdrawal by Subject|20|||
162736196|NCT02900924|587744896|FG000|Overall Study|Missed Visit|33|||
162736197|NCT04382404|587744901|FG000|Overall Study|Adverse Event|1|||
162736198|NCT04382404|587744901|FG000|Overall Study|Lost to Follow-up|2|||
162736199|NCT05687916|587744905|FG000|Overall Study|Adverse Event|1|||
162736200|NCT05687916|587744906|FG001|Overall Study|Adverse Event|2|||
162736201|NCT05687916|587744907|FG002|Overall Study|Adverse Event|0|||
162736202|NCT05687916|587744905|FG000|Overall Study|Withdrawal by Subject|1|||
162736203|NCT05687916|587744906|FG001|Overall Study|Withdrawal by Subject|0|||
162736204|NCT05687916|587744907|FG002|Overall Study|Withdrawal by Subject|1|||
162736205|NCT05687916|587744905|FG000|Overall Study|Protocol Violation|0|||
162736206|NCT05687916|587744906|FG001|Overall Study|Protocol Violation|2|||
162736207|NCT05687916|587744907|FG002|Overall Study|Protocol Violation|1|||
162736208|NCT05687916|587744905|FG000|Overall Study|Reason not Specified|1|||
162736209|NCT05687916|587744906|FG001|Overall Study|Reason not Specified|0|||
162736210|NCT05687916|587744907|FG002|Overall Study|Reason not Specified|0|||
162736211|NCT03406871|587744911|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
162736212|NCT03406871|587744912|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
162736213|NCT03406871|587744913|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
162736214|NCT03406871|587744911|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
162736215|NCT03406871|587744912|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
162736216|NCT03406871|587744913|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
162736217|NCT03406871|587744911|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
162736218|NCT03406871|587744912|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
162736219|NCT03406871|587744913|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
162736220|NCT03406871|587744911|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
162736221|NCT03406871|587744912|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
162736222|NCT03406871|587744913|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
162736223|NCT03406871|587744911|FG000|Expansion Cohort(Final Analysis)|Death|0|||
162736224|NCT03406871|587744912|FG001|Expansion Cohort(Final Analysis)|Death|1|||
162736225|NCT03406871|587744913|FG002|Expansion Cohort(Final Analysis)|Death|0|||
162736226|NCT03406871|587744911|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
162736227|NCT03406871|587744912|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
162736228|NCT03406871|587744913|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
162736229|NCT04177823|587744921|FG000|Overall Study|Physician Decision|1|||
162736230|NCT04177823|587744921|FG000|Overall Study|Withdrawal by Subject|1|||
162736231|NCT03699709|587744922|FG000|Overall Study|Death|1|||
162736232|NCT03699709|587744923|FG001|Overall Study|Death|2|||
162736275|NCT01494662|587744950|FG003|Overall Study|Withdrawal by Subject|0|||
162736276|NCT01494662|587744951|FG004|Overall Study|Withdrawal by Subject|0|||
162736277|NCT01494662|587744952|FG005|Overall Study|Withdrawal by Subject|0|||
162736278|NCT01494662|587744953|FG006|Overall Study|Withdrawal by Subject|0|||
162736279|NCT01494662|587744947|FG000|Overall Study|Physician Decision|0|||
162736280|NCT01494662|587744948|FG001|Overall Study|Physician Decision|0|||
162736281|NCT01494662|587744949|FG002|Overall Study|Physician Decision|1|||
162736282|NCT01494662|587744950|FG003|Overall Study|Physician Decision|0|||
162736283|NCT01494662|587744951|FG004|Overall Study|Physician Decision|0|||
162736284|NCT01494662|587744952|FG005|Overall Study|Physician Decision|0|||
162736285|NCT01494662|587744953|FG006|Overall Study|Physician Decision|0|||
162736286|NCT04322643|587744954|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
162736287|NCT05486078|587744957|FG000|Overall Study|4 drop out and one withdrawn|5|||
162736288|NCT03302494|587744958|FG000|Overall Study|Other|7|||
162736289|NCT03302494|587744959|FG001|Overall Study|Other|4|||
162736290|NCT03302494|587744960|FG002|Overall Study|Other|6|||
162736291|NCT03302494|587744958|FG000|Overall Study|Withdrawal by Subject|10|||
162736292|NCT03302494|587744959|FG001|Overall Study|Withdrawal by Subject|2|||
162736293|NCT03302494|587744960|FG002|Overall Study|Withdrawal by Subject|9|||
162736294|NCT03302494|587744958|FG000|Overall Study|Study Terminated by Sponsor|32|||
162736295|NCT03302494|587744959|FG001|Overall Study|Study Terminated by Sponsor|29|||
162736296|NCT03302494|587744960|FG002|Overall Study|Study Terminated by Sponsor|30|||
162736297|NCT03302494|587744958|FG000|Overall Study|Physician Decision|1|||
162736298|NCT03302494|587744959|FG001|Overall Study|Physician Decision|0|||
162736299|NCT03302494|587744960|FG002|Overall Study|Physician Decision|1|||
162736300|NCT03302494|587744958|FG000|Overall Study|Lost to Follow-up|1|||
162736301|NCT03302494|587744959|FG001|Overall Study|Lost to Follow-up|3|||
162736302|NCT03302494|587744960|FG002|Overall Study|Lost to Follow-up|3|||
162736303|NCT03302494|587744958|FG000|Overall Study|Death|13|||
162736304|NCT03302494|587744959|FG001|Overall Study|Death|11|||
162736305|NCT03302494|587744960|FG002|Overall Study|Death|4|||
162736306|NCT03302494|587744958|FG000|Overall Study|Adverse Event|1|||
162736307|NCT03302494|587744959|FG001|Overall Study|Adverse Event|2|||
162736308|NCT03302494|587744960|FG002|Overall Study|Adverse Event|0|||
162736309|NCT03302494|587744958|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
162736310|NCT03302494|587744959|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
162736311|NCT03302494|587744960|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
162736312|NCT05134233|587744961|FG000|Overall Study|Pregnancy|1|||
162736313|NCT05134233|587744961|FG000|Overall Study|MEP value too low|2|||
162736314|NCT05134233|587744961|FG000|Overall Study|Lost to Follow-up|1|||
162736315|NCT03978871|587744962|FG000|Overall Study|Lost to Follow-up|11|||
162736316|NCT03978871|587744963|FG001|Overall Study|Lost to Follow-up|12|||
162736317|NCT05710107|587744964|FG000|Overall Study|Withdrawal by Subject|1|||
162736318|NCT05710107|587744965|FG001|Overall Study|Withdrawal by Subject|1|||
162736319|NCT05710107|587744964|FG000|Overall Study|Lost to Follow-up|8|||
162736320|NCT05710107|587744965|FG001|Overall Study|Lost to Follow-up|9|||
162736321|NCT05710107|587744964|FG000|Overall Study|Unable to place assigned block|2|||
162736322|NCT05710107|587744965|FG001|Overall Study|Unable to place assigned block|0|||
162736323|NCT05710107|587744964|FG000|Overall Study|Withdrawn by study team|0|||
162736324|NCT05710107|587744965|FG001|Overall Study|Withdrawn by study team|1|||
162736325|NCT04166773|587744966|FG000|Overall Study|Adverse Event|2|||
162736326|NCT04166773|587744967|FG001|Overall Study|Adverse Event|0|||
162736327|NCT04166773|587744968|FG002|Overall Study|Adverse Event|2|||
162736328|NCT04166773|587744969|FG003|Overall Study|Adverse Event|1|||
162736329|NCT04166773|587744966|FG000|Overall Study|Lost to Follow-up|4|||
162736330|NCT04166773|587744967|FG001|Overall Study|Lost to Follow-up|2|||
162736331|NCT04166773|587744968|FG002|Overall Study|Lost to Follow-up|1|||
162736332|NCT04166773|587744969|FG003|Overall Study|Lost to Follow-up|3|||
162736333|NCT04166773|587744966|FG000|Overall Study|Physician Decision|0|||
162736334|NCT04166773|587744967|FG001|Overall Study|Physician Decision|0|||
162736335|NCT04166773|587744968|FG002|Overall Study|Physician Decision|0|||
162736336|NCT04166773|587744969|FG003|Overall Study|Physician Decision|1|||
162736337|NCT04166773|587744966|FG000|Overall Study|Withdrawal by Subject|1|||
162736338|NCT04166773|587744967|FG001|Overall Study|Withdrawal by Subject|1|||
162736339|NCT04166773|587744968|FG002|Overall Study|Withdrawal by Subject|2|||
162736340|NCT04166773|587744969|FG003|Overall Study|Withdrawal by Subject|5|||
162736341|NCT04072822|587744970|FG000|Treatment|Adverse Event|9|||
162736342|NCT04072822|587744971|FG001|Treatment|Adverse Event|5|||
162736343|NCT04072822|587744970|FG000|Treatment|Met Stopping Criteria|13|||
162736344|NCT04072822|587744971|FG001|Treatment|Met Stopping Criteria|24|||
162736345|NCT04072822|587744970|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
162736346|NCT04072822|587744971|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
162736347|NCT04072822|587744970|FG000|Treatment|Withdrawal by Subject|0|||
162736348|NCT04072822|587744971|FG001|Treatment|Withdrawal by Subject|2|||
162736349|NCT04072822|587744970|FG000|Treatment|Death|0|||
162736350|NCT04072822|587744971|FG001|Treatment|Death|2|||
162736351|NCT04072822|587744970|FG000|Treatment|Lost to Follow-up|11|||
162736352|NCT04072822|587744971|FG001|Treatment|Lost to Follow-up|3|||
162736353|NCT04072822|587744970|FG000|Treatment|Physician Decision|1|||
162736354|NCT04072822|587744971|FG001|Treatment|Physician Decision|0|||
162736355|NCT04072822|587744970|FG000|Treatment|Other|7|||
162736356|NCT04072822|587744971|FG001|Treatment|Other|9|||
162736357|NCT04072822|587744970|FG000|Follow-up|Withdrawal by Subject|1|||
162736358|NCT04072822|587744971|FG001|Follow-up|Withdrawal by Subject|0|||
162736359|NCT04072822|587744970|FG000|Follow-up|Lost to Follow-up|5|||
162736360|NCT04072822|587744971|FG001|Follow-up|Lost to Follow-up|4|||
162736361|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Other|0|||
162736362|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Other|0|||
162736363|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Other|0|||
162736364|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Other|0|||
162736365|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Other|0|||
162736366|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Other|0|||
162736367|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Other|0|||
162736368|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Other|0|||
162736369|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Other|0|||
162736370|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Other|0|||
162736371|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Other|1|||
162736372|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Other|1|||
162736373|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Other|1|||
162736374|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Other|0|||
162736375|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Other|3|||
162736376|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Other|1|||
162736377|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Other|1|||
162736378|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Other|0|||
162736379|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736380|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736381|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736382|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736383|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736384|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736385|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
162736386|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736387|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
162736388|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736389|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736390|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736391|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
162736392|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736393|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736394|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736395|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736396|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
162736397|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736398|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736399|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736400|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736401|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736402|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736403|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736404|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
162736405|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736406|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736407|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736408|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736409|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736410|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736411|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736412|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736413|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736414|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162736415|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736416|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736417|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736418|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736419|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736420|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736421|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736422|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736423|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736424|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
162736425|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736426|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736427|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736428|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736429|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736430|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736431|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736432|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
162736433|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Death|0|||
162736434|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Death|0|||
162736435|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Death|0|||
162736436|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Death|0|||
162736437|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Death|0|||
162736438|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Death|0|||
162736439|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Death|0|||
162736440|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Death|0|||
162736441|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Death|0|||
162736442|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Death|1|||
162736443|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Death|0|||
162736444|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Death|1|||
162736445|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Death|0|||
162736446|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Death|1|||
162736447|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Death|0|||
162736448|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Death|0|||
162736449|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Death|2|||
162736450|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Death|0|||
162736451|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
162736452|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
162736453|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
162736454|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
162736455|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
162736456|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
162736457|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
162736458|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
162736459|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
162736460|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
162736461|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
162736462|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
162736463|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
162736464|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
162736465|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
162736466|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
162736467|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
162736468|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
162736469|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Adverse Event|0|||
162736470|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Adverse Event|0|||
162736471|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Adverse Event|0|||
162736472|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Adverse Event|0|||
162736473|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Adverse Event|0|||
162736474|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Adverse Event|0|||
162736475|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Adverse Event|2|||
162736476|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Adverse Event|0|||
162736477|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Adverse Event|0|||
162736478|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Adverse Event|0|||
162736479|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Adverse Event|1|||
162736480|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Adverse Event|2|||
162736481|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Adverse Event|0|||
162736482|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Adverse Event|1|||
162736483|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Adverse Event|0|||
162736484|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Adverse Event|0|||
162736485|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Adverse Event|1|||
162736486|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Adverse Event|0|||
162736487|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
162736488|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
162736489|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
162736490|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
162736491|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
162736492|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
162736493|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
162736494|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
162736495|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
162736496|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
162736497|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
162736498|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
162736499|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
162810469|NCT03435497|588018230|FG001|Overall Study|Death|0|||
162736500|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
162736501|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
162736502|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
162736503|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
162736504|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
162736505|NCT03269136|587744972|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736506|NCT03269136|587744973|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736507|NCT03269136|587744974|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736508|NCT03269136|587744975|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736509|NCT03269136|587744976|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736510|NCT03269136|587744977|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736511|NCT03269136|587744978|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736512|NCT03269136|587744979|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736513|NCT03269136|587744980|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736514|NCT03269136|587744981|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736515|NCT03269136|587744982|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736516|NCT03269136|587744983|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736517|NCT03269136|587744984|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
162736518|NCT03269136|587744985|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162736519|NCT03269136|587744986|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162736520|NCT03269136|587744987|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736521|NCT03269136|587744988|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
162736522|NCT03269136|587744989|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162736523|NCT03269136|587744972|FG000|Part 2A: Dose Expansion|Other|0|||
162736524|NCT03269136|587744973|FG001|Part 2A: Dose Expansion|Other|0|||
162736525|NCT03269136|587744974|FG002|Part 2A: Dose Expansion|Other|0|||
162736526|NCT03269136|587744975|FG003|Part 2A: Dose Expansion|Other|0|||
162736527|NCT03269136|587744976|FG004|Part 2A: Dose Expansion|Other|0|||
162736528|NCT03269136|587744977|FG005|Part 2A: Dose Expansion|Other|0|||
162736529|NCT03269136|587744978|FG006|Part 2A: Dose Expansion|Other|0|||
162736530|NCT03269136|587744979|FG007|Part 2A: Dose Expansion|Other|0|||
162736531|NCT03269136|587744980|FG008|Part 2A: Dose Expansion|Other|0|||
162736532|NCT03269136|587744981|FG009|Part 2A: Dose Expansion|Other|0|||
162736533|NCT03269136|587744982|FG010|Part 2A: Dose Expansion|Other|0|||
162736534|NCT03269136|587744983|FG011|Part 2A: Dose Expansion|Other|0|||
162736535|NCT03269136|587744984|FG012|Part 2A: Dose Expansion|Other|0|||
162736536|NCT03269136|587744985|FG013|Part 2A: Dose Expansion|Other|0|||
162736537|NCT03269136|587744986|FG014|Part 2A: Dose Expansion|Other|0|||
162736538|NCT03269136|587744987|FG015|Part 2A: Dose Expansion|Other|0|||
162736539|NCT03269136|587744988|FG016|Part 2A: Dose Expansion|Other|0|||
162736540|NCT03269136|587744989|FG017|Part 2A: Dose Expansion|Other|1|||
162736541|NCT03269136|587744972|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736542|NCT03269136|587744973|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736543|NCT03269136|587744974|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736544|NCT03269136|587744975|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736545|NCT03269136|587744976|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736546|NCT03269136|587744977|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736547|NCT03269136|587744978|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736548|NCT03269136|587744979|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736549|NCT03269136|587744980|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736550|NCT03269136|587744981|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736551|NCT03269136|587744982|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736552|NCT03269136|587744983|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736553|NCT03269136|587744984|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736554|NCT03269136|587744985|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736555|NCT03269136|587744986|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736556|NCT03269136|587744987|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736557|NCT03269136|587744988|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162736558|NCT03269136|587744989|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
162736559|NCT03269136|587744972|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
162736560|NCT03269136|587744973|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
162736561|NCT03269136|587744974|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
162736562|NCT03269136|587744975|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
162736563|NCT03269136|587744976|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
162736564|NCT03269136|587744977|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
162736565|NCT03269136|587744978|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
162736566|NCT03269136|587744979|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
162736567|NCT03269136|587744980|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
162736568|NCT03269136|587744981|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
162736569|NCT03269136|587744982|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
162736570|NCT03269136|587744983|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
162736571|NCT03269136|587744984|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
162736572|NCT03269136|587744985|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
162736573|NCT03269136|587744986|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
162736574|NCT03269136|587744987|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
162736575|NCT03269136|587744988|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
162736576|NCT03269136|587744989|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
162736577|NCT03269136|587744972|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
162736578|NCT03269136|587744973|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
162736579|NCT03269136|587744974|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
162736580|NCT03269136|587744975|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
162736581|NCT03269136|587744976|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
162736582|NCT03269136|587744977|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
162736583|NCT03269136|587744978|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
162736584|NCT03269136|587744979|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
162736585|NCT03269136|587744980|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
162736586|NCT03269136|587744981|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
162736587|NCT03269136|587744982|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
162736588|NCT03269136|587744983|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
162736589|NCT03269136|587744984|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
162736590|NCT03269136|587744985|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
162736591|NCT03269136|587744986|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
162736592|NCT03269136|587744987|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
162736593|NCT03269136|587744988|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
162736594|NCT03269136|587744989|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
162736595|NCT03269136|587744972|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
162736596|NCT03269136|587744973|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
162736597|NCT03269136|587744974|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
162736598|NCT03269136|587744975|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
162736599|NCT03269136|587744976|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
162736600|NCT03269136|587744977|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
162736601|NCT03269136|587744978|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
162736602|NCT03269136|587744979|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
162736603|NCT03269136|587744980|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
162736604|NCT03269136|587744981|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
162736605|NCT03269136|587744982|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
162736606|NCT03269136|587744983|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
162736607|NCT03269136|587744984|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
162736608|NCT03269136|587744985|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
162736609|NCT03269136|587744986|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
162736610|NCT03269136|587744987|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
162736611|NCT03269136|587744988|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
162736612|NCT03269136|587744989|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
162736613|NCT03033576|587744990|FG000|Overall Study|Ineligible|1|||
162736614|NCT03033576|587744991|FG001|Overall Study|Ineligible|1|||
162736615|NCT03033576|587744990|FG000|Overall Study|Adverse Event|4|||
162736616|NCT03033576|587744991|FG001|Overall Study|Adverse Event|20|||
162736617|NCT03033576|587744990|FG000|Overall Study|Progression/relapse|9|||
162736618|NCT03033576|587744991|FG001|Overall Study|Progression/relapse|36|||
162736619|NCT03033576|587744990|FG000|Overall Study|Death|1|||
162736620|NCT03033576|587744991|FG001|Overall Study|Death|1|||
162736621|NCT03033576|587744990|FG000|Overall Study|Patient refusal|1|||
162736622|NCT03033576|587744991|FG001|Overall Study|Patient refusal|6|||
162736623|NCT03033576|587744990|FG000|Overall Study|Other, unspecified reasons|0|||
162736624|NCT03033576|587744991|FG001|Overall Study|Other, unspecified reasons|4|||
162736625|NCT03033576|587744990|FG000|Overall Study|Currently on protocol therapy|0|||
162736626|NCT03033576|587744991|FG001|Overall Study|Currently on protocol therapy|2|||
162736627|NCT01214616|587744994|FG000|Overall Study|Progressive disease|2|||
162736628|NCT01214616|587744995|FG001|Overall Study|Progressive disease|2|||
162736629|NCT01214616|587744996|FG002|Overall Study|Progressive disease|2|||
162736630|NCT01214616|587744997|FG003|Overall Study|Progressive disease|4|||
162736631|NCT01214616|587744994|FG000|Overall Study|Dose limiting toxicity|0|||
162736632|NCT01214616|587744995|FG001|Overall Study|Dose limiting toxicity|2|||
162736633|NCT01214616|587744996|FG002|Overall Study|Dose limiting toxicity|0|||
162736634|NCT01214616|587744997|FG003|Overall Study|Dose limiting toxicity|0|||
162736635|NCT01214616|587744994|FG000|Overall Study|Other adverse events|0|||
162736636|NCT01214616|587744995|FG001|Overall Study|Other adverse events|1|||
162736637|NCT01214616|587744996|FG002|Overall Study|Other adverse events|1|||
162736638|NCT01214616|587744997|FG003|Overall Study|Other adverse events|1|||
162736639|NCT01214616|587744994|FG000|Overall Study|Withdrawal by Subject|1|||
162736640|NCT01214616|587744995|FG001|Overall Study|Withdrawal by Subject|0|||
162736641|NCT01214616|587744996|FG002|Overall Study|Withdrawal by Subject|0|||
162736642|NCT01214616|587744997|FG003|Overall Study|Withdrawal by Subject|1|||
162736643|NCT02949362|587744998|FG000|Retrospective Period|Inform consent not signed by participant|4|||
162736644|NCT02949362|587744999|FG001|Retrospective Period|Inform consent not signed by participant|1|||
162736645|NCT02949362|587745000|FG002|Retrospective Period|Inform consent not signed by participant|0|||
162736646|NCT02949362|587745001|FG003|Retrospective Period|Inform consent not signed by participant|0|||
162736647|NCT02949362|587744998|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162736648|NCT02949362|587744999|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162736649|NCT02949362|587745000|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
162736650|NCT02949362|587745001|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162736651|NCT02949362|587744998|FG000|Prospective Period|Other|0|||
162736652|NCT02949362|587744999|FG001|Prospective Period|Other|0|||
162736653|NCT02949362|587745000|FG002|Prospective Period|Other|0|||
162736654|NCT02949362|587745001|FG003|Prospective Period|Other|4|||
162736655|NCT05268302|587745002|FG000|Overall Study|Death|0|||
162736656|NCT05268302|587745003|FG001|Overall Study|Death|1|||
162736657|NCT02811679|587745004|FG000|Overall Study|Adverse Event|1|||
162736658|NCT02811679|587745004|FG000|Overall Study|Lack of Efficacy|6|||
162736659|NCT02811679|587745004|FG000|Overall Study|Early study closure due to slow accrual|3|||
162736660|NCT05319860|587745008|FG000|Overall Study|Death|1|||
162736661|NCT05319860|587745009|FG001|Overall Study|Death|1|||
162736662|NCT05319860|587745008|FG000|Overall Study|Lost to Follow-up|3|||
162736663|NCT05319860|587745009|FG001|Overall Study|Lost to Follow-up|1|||
162736664|NCT05319860|587745008|FG000|Overall Study|Withdrawal by Subject|1|||
162736665|NCT05319860|587745009|FG001|Overall Study|Withdrawal by Subject|7|||
162736666|NCT04314895|587745010|FG000|Overall Study|Lost to Follow-up|1|||
162736667|NCT04314895|587745010|FG000|Overall Study|Death|10|||
162736668|NCT04314895|587745010|FG000|Overall Study|Physician Decision|2|||
162736669|NCT01361711|587745014|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
162736670|NCT01361711|587745014|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
162736671|NCT01361711|587745014|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
162736672|NCT01361711|587745014|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
162736673|NCT01361711|587745014|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
162736674|NCT01361711|587745014|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
162736675|NCT01361711|587745014|FG000|Completed Week 18 of Treatment|Other|9|||
162736676|NCT01361711|587745014|FG000|10 Year Follow-up|Still in follow-up|22|||
162736677|NCT01361711|587745014|FG000|10 Year Follow-up|Death|7|||
162736678|NCT01361711|587745014|FG000|10 Year Follow-up|Developed new cancer|1|||
162736679|NCT01361711|587745014|FG000|10 Year Follow-up|Lost to Follow-up|2|||
162736680|NCT01361711|587745014|FG000|10 Year Follow-up|New treatment started|6|||
162736681|NCT01361711|587745014|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
162736682|NCT01361711|587745014|FG000|10 Year Follow-up|Progressive Disease|1|||
162736683|NCT02596126|587745015|FG000|Overall Study|Lost to Follow-up|12|||
162736684|NCT02596126|587745016|FG001|Overall Study|Lost to Follow-up|21|||
162736685|NCT02596126|587745015|FG000|Overall Study|Protocol Violation|7|||
162736686|NCT02596126|587745016|FG001|Overall Study|Protocol Violation|9|||
162736687|NCT03648840|587746837|FG000|First IV Infusion Session|Adverse Event|0|||
162736688|NCT03648840|587746838|FG001|First IV Infusion Session|Adverse Event|2|||
162736689|NCT03648840|587746837|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
162736690|NCT03648840|587746838|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
162736691|NCT03648840|587746837|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
162736692|NCT03648840|587746838|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
162736693|NCT03648840|587746837|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
162736694|NCT03648840|587746838|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
162736695|NCT03376321|587746839|FG000|Overall Study|Other|5|||
162736696|NCT03376321|587746840|FG001|Overall Study|Other|1|||
162736697|NCT03376321|587746839|FG000|Overall Study|Withdrawal by Subject|8|||
162736698|NCT03376321|587746840|FG001|Overall Study|Withdrawal by Subject|14|||
162736699|NCT03376321|587746839|FG000|Overall Study|Lost to Follow-up|1|||
162736700|NCT03376321|587746840|FG001|Overall Study|Lost to Follow-up|7|||
162736701|NCT03376321|587746839|FG000|Overall Study|Death|4|||
162736702|NCT03376321|587746840|FG001|Overall Study|Death|0|||
162736703|NCT03376321|587746839|FG000|Overall Study|Randomized, not treated|5|||
162736704|NCT03376321|587746840|FG001|Overall Study|Randomized, not treated|3|||
162736705|NCT02995434|587746841|FG000|Overall Study|Adverse Event|1|||
162736706|NCT02995434|587746842|FG001|Overall Study|Adverse Event|0|||
162736707|NCT02995434|587746841|FG000|Overall Study|Withdrawal by Subject|6|||
162736708|NCT02995434|587746842|FG001|Overall Study|Withdrawal by Subject|3|||
162736709|NCT04150718|587746845|FG000|Overall Study|Withdrawal by Subject|2|||
162736710|NCT04150718|587746846|FG001|Overall Study|Withdrawal by Subject|7|||
162736711|NCT04150718|587746847|FG002|Overall Study|Withdrawal by Subject|1|||
162736712|NCT04150718|587746845|FG000|Overall Study|Lost to Follow-up|1|||
162736713|NCT04150718|587746846|FG001|Overall Study|Lost to Follow-up|2|||
162736714|NCT04150718|587746847|FG002|Overall Study|Lost to Follow-up|0|||
162736715|NCT04150718|587746845|FG000|Overall Study|Ineligible|1|||
162736716|NCT04150718|587746846|FG001|Overall Study|Ineligible|0|||
162736717|NCT04150718|587746847|FG002|Overall Study|Ineligible|10|||
162736718|NCT04024813|587746848|FG000|Overall Study|Study terminated by Sponsor|1|||
162736719|NCT04034251|587746849|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
162810470|NCT03435497|588018229|FG000|Overall Study|Withdrawal by Subject|0|||
162736720|NCT04034251|587746850|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
162736721|NCT04034251|587746851|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
162736722|NCT00920621|587746854|FG000|Overall Study|Lost to Follow-up|16|||
162736723|NCT00920621|587746855|FG001|Overall Study|Lost to Follow-up|17|||
162736724|NCT00920621|587746856|FG002|Overall Study|Lost to Follow-up|19|||
162736725|NCT00920621|587746857|FG003|Overall Study|Lost to Follow-up|21|||
162736726|NCT00920621|587746854|FG000|Overall Study|Fetal/neonatal deaths|16|||
162736727|NCT00920621|587746855|FG001|Overall Study|Fetal/neonatal deaths|14|||
162736728|NCT00920621|587746856|FG002|Overall Study|Fetal/neonatal deaths|16|||
162736729|NCT00920621|587746857|FG003|Overall Study|Fetal/neonatal deaths|14|||
162736730|NCT00920621|587746854|FG000|Overall Study|Blood sample not collected|22|||
162736731|NCT00920621|587746855|FG001|Overall Study|Blood sample not collected|14|||
162736732|NCT00920621|587746856|FG002|Overall Study|Blood sample not collected|0|||
162736733|NCT00920621|587746857|FG003|Overall Study|Blood sample not collected|0|||
162736734|NCT01426425|587746858|FG000|Overall Study|Exited prior to EP study|22|||
162736735|NCT01426425|587746858|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
162736736|NCT01426425|587746858|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
162736737|NCT03281291|587746864|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
162736738|NCT03281291|587746865|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
162736739|NCT03281291|587746866|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
162736740|NCT03281291|587746867|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
162736741|NCT03281291|587746868|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
162736742|NCT03281291|587746864|FG000|Overall Study|Protocol Deviation|2|||
162736743|NCT03281291|587746865|FG001|Overall Study|Protocol Deviation|0|||
162736744|NCT03281291|587746866|FG002|Overall Study|Protocol Deviation|1|||
162736745|NCT03281291|587746867|FG003|Overall Study|Protocol Deviation|2|||
162736746|NCT03281291|587746868|FG004|Overall Study|Protocol Deviation|1|||
162736747|NCT03281291|587746864|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
162736748|NCT03281291|587746865|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162736749|NCT03281291|587746866|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
162736750|NCT03281291|587746867|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162736751|NCT03281291|587746868|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
162736752|NCT03281291|587746864|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
162736753|NCT03281291|587746865|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
162736754|NCT03281291|587746866|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
162736755|NCT03281291|587746867|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
162736756|NCT03281291|587746868|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
162736757|NCT03281291|587746864|FG000|Overall Study|Lost to Follow-up|10|||
162736758|NCT03281291|587746865|FG001|Overall Study|Lost to Follow-up|10|||
162736759|NCT03281291|587746866|FG002|Overall Study|Lost to Follow-up|4|||
162736760|NCT03281291|587746867|FG003|Overall Study|Lost to Follow-up|6|||
162736761|NCT03281291|587746868|FG004|Overall Study|Lost to Follow-up|10|||
162736762|NCT03281291|587746864|FG000|Overall Study|Other|0|||
162736763|NCT03281291|587746865|FG001|Overall Study|Other|2|||
162736764|NCT03281291|587746866|FG002|Overall Study|Other|0|||
162736765|NCT03281291|587746867|FG003|Overall Study|Other|2|||
162736766|NCT03281291|587746868|FG004|Overall Study|Other|1|||
162736767|NCT00512070|587746869|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
162736768|NCT00512070|587746870|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
162736769|NCT00512070|587746871|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
162736770|NCT00512070|587746869|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
162736771|NCT00512070|587746870|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
162736772|NCT00512070|587746871|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
162736773|NCT04956861|587746872|FG000|Overall Study|Withdrawal by Subject|4|||
162736774|NCT04956861|587746873|FG001|Overall Study|Withdrawal by Subject|4|||
162736775|NCT04956861|587746874|FG002|Overall Study|Withdrawal by Subject|2|||
162736776|NCT04956861|587746872|FG000|Overall Study|Physician Decision|4|||
162736777|NCT04956861|587746873|FG001|Overall Study|Physician Decision|5|||
162736778|NCT04956861|587746874|FG002|Overall Study|Physician Decision|1|||
162736779|NCT00961571|587746875|FG000|Overall Study|Physician Decision|39|||
162736780|NCT05862870|587746878|FG000|Overall Study|Lost to Follow-up|3|||
162736781|NCT02543281|587746881|FG000|Overall Study|Lost to Follow-up|0|||
162736782|NCT02543281|587746882|FG001|Overall Study|Lost to Follow-up|0|||
162736783|NCT02543281|587746883|FG002|Overall Study|Lost to Follow-up|1|||
162736784|NCT03143153|587746884|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
162736785|NCT03143153|587746885|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
162736786|NCT03143153|587746886|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
162736787|NCT03143153|587746884|FG000|Pre-Treatment|Participant withdrew consent|0|||
162736788|NCT03143153|587746885|FG001|Pre-Treatment|Participant withdrew consent|1|||
162736789|NCT03143153|587746886|FG002|Pre-Treatment|Participant withdrew consent|12|||
162736790|NCT03143153|587746884|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
162736791|NCT03143153|587746885|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
162736792|NCT03143153|587746886|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
162736793|NCT03143153|587746884|FG000|Pre-Treatment|Other Reasons|1|||
162736794|NCT03143153|587746885|FG001|Pre-Treatment|Other Reasons|2|||
162736795|NCT03143153|587746886|FG002|Pre-Treatment|Other Reasons|1|||
162736796|NCT03143153|587746884|FG000|Pre-Treatment|Disease Progression|1|||
162736797|NCT03143153|587746885|FG001|Pre-Treatment|Disease Progression|1|||
162736798|NCT03143153|587746886|FG002|Pre-Treatment|Disease Progression|2|||
162736799|NCT03143153|587746884|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
162736800|NCT03143153|587746885|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
162736801|NCT03143153|587746886|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
162736802|NCT03143153|587746884|FG000|Treatment|Disease progression|174|||
162736803|NCT03143153|587746885|FG001|Treatment|Disease progression|184|||
162736804|NCT03143153|587746886|FG002|Treatment|Disease progression|193|||
162736805|NCT03143153|587746884|FG000|Treatment|Study drug toxicity|59|||
162736806|NCT03143153|587746885|FG001|Treatment|Study drug toxicity|33|||
162736807|NCT03143153|587746886|FG002|Treatment|Study drug toxicity|40|||
162736808|NCT03143153|587746884|FG000|Treatment|Death|5|||
162736809|NCT03143153|587746885|FG001|Treatment|Death|3|||
162736810|NCT03143153|587746886|FG002|Treatment|Death|4|||
162736811|NCT03143153|587746884|FG000|Treatment|Adverse event unrelated to study drug|19|||
162736812|NCT03143153|587746885|FG001|Treatment|Adverse event unrelated to study drug|28|||
162736813|NCT03143153|587746886|FG002|Treatment|Adverse event unrelated to study drug|12|||
162736814|NCT03143153|587746884|FG000|Treatment|Participant request to discontinue study treatment|13|||
162736815|NCT03143153|587746885|FG001|Treatment|Participant request to discontinue study treatment|15|||
162736816|NCT03143153|587746886|FG002|Treatment|Participant request to discontinue study treatment|20|||
162736817|NCT03143153|587746884|FG000|Treatment|Participant withdrew consent|3|||
162736818|NCT03143153|587746885|FG001|Treatment|Participant withdrew consent|4|||
162736819|NCT03143153|587746886|FG002|Treatment|Participant withdrew consent|12|||
162736820|NCT03143153|587746884|FG000|Treatment|Pregnancy|1|||
162736821|NCT03143153|587746885|FG001|Treatment|Pregnancy|0|||
162736822|NCT03143153|587746886|FG002|Treatment|Pregnancy|0|||
162736823|NCT03143153|587746884|FG000|Treatment|Maximum clinical benefit|1|||
162736824|NCT03143153|587746885|FG001|Treatment|Maximum clinical benefit|3|||
162736825|NCT03143153|587746886|FG002|Treatment|Maximum clinical benefit|4|||
162736826|NCT03143153|587746884|FG000|Treatment|Completed treatment as per Protocol|13|||
162736827|NCT03143153|587746885|FG001|Treatment|Completed treatment as per Protocol|8|||
162736828|NCT03143153|587746886|FG002|Treatment|Completed treatment as per Protocol|0|||
162736829|NCT03143153|587746884|FG000|Treatment|Other reasons|12|||
162736830|NCT03143153|587746885|FG001|Treatment|Other reasons|7|||
162736831|NCT03143153|587746886|FG002|Treatment|Other reasons|15|||
162736832|NCT03143153|587746884|FG000|Treatment|Not reported|1|||
162736833|NCT03143153|587746885|FG001|Treatment|Not reported|0|||
162736834|NCT03143153|587746886|FG002|Treatment|Not reported|0|||
162736835|NCT02736409|587746892|FG000|Overall Study|Withdrawal by Subject|4|||
162736836|NCT02736409|587746893|FG001|Overall Study|Withdrawal by Subject|2|||
162736837|NCT02736409|587746894|FG002|Overall Study|Withdrawal by Subject|17|||
162736838|NCT02736409|587746895|FG003|Overall Study|Withdrawal by Subject|3|||
162736839|NCT02736409|587746892|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162736840|NCT02736409|587746893|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162736841|NCT02736409|587746894|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162736842|NCT02736409|587746895|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162736843|NCT02736409|587746892|FG000|Overall Study|Adverse Event|0|||
162736844|NCT02736409|587746893|FG001|Overall Study|Adverse Event|1|||
162736845|NCT02736409|587746894|FG002|Overall Study|Adverse Event|5|||
162736846|NCT02736409|587746895|FG003|Overall Study|Adverse Event|4|||
162736847|NCT02736409|587746892|FG000|Overall Study|Other|0|||
162736848|NCT02736409|587746893|FG001|Overall Study|Other|0|||
162736849|NCT02736409|587746894|FG002|Overall Study|Other|1|||
162736850|NCT02736409|587746895|FG003|Overall Study|Other|1|||
162736851|NCT02736409|587746892|FG000|Overall Study|Pregnancy|0|||
162736852|NCT02736409|587746893|FG001|Overall Study|Pregnancy|0|||
162736853|NCT02736409|587746894|FG002|Overall Study|Pregnancy|1|||
162736854|NCT02736409|587746895|FG003|Overall Study|Pregnancy|0|||
162736855|NCT02736409|587746892|FG000|Overall Study|Lost to Follow-up|0|||
162736856|NCT02736409|587746893|FG001|Overall Study|Lost to Follow-up|0|||
162736857|NCT02736409|587746894|FG002|Overall Study|Lost to Follow-up|2|||
162736858|NCT02736409|587746895|FG003|Overall Study|Lost to Follow-up|1|||
162736859|NCT02736409|587746892|FG000|Overall Study|Physician Decision|0|||
162736860|NCT02736409|587746893|FG001|Overall Study|Physician Decision|0|||
162736861|NCT02736409|587746894|FG002|Overall Study|Physician Decision|0|||
162736862|NCT02736409|587746895|FG003|Overall Study|Physician Decision|2|||
162736863|NCT01415154|587746896|FG000|Overall Study|Lack of Efficacy|4|||
162736864|NCT01415154|587746897|FG001|Overall Study|Lack of Efficacy|5|||
162736865|NCT01415154|587746896|FG000|Overall Study|Withdrawal by Subject|7|||
162736866|NCT01415154|587746897|FG001|Overall Study|Withdrawal by Subject|8|||
162736867|NCT01415154|587746896|FG000|Overall Study|Lost to Follow-up|1|||
162736868|NCT01415154|587746897|FG001|Overall Study|Lost to Follow-up|4|||
162736869|NCT01415154|587746896|FG000|Overall Study|Protocol Violation|0|||
162736870|NCT01415154|587746897|FG001|Overall Study|Protocol Violation|1|||
162736871|NCT01415154|587746896|FG000|Overall Study|Satisfactory Response|0|||
162736872|NCT01415154|587746897|FG001|Overall Study|Satisfactory Response|1|||
162736873|NCT01415154|587746896|FG000|Overall Study|Adverse Event|1|||
162736874|NCT01415154|587746897|FG001|Overall Study|Adverse Event|1|||
162736875|NCT00170573|587746900|FG000|Overall Study|Violation of inclusion criteria|13|||
162736876|NCT03763708|587746926|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
162736877|NCT03763708|587746927|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736878|NCT03763708|587746928|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736879|NCT03763708|587746929|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736880|NCT03763708|587746930|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736881|NCT03763708|587746931|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736882|NCT03763708|587746932|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736883|NCT03763708|587746933|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736884|NCT03763708|587746934|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162736885|NCT03763708|587746926|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736886|NCT03763708|587746927|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736887|NCT03763708|587746928|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
162736888|NCT03763708|587746929|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736889|NCT03763708|587746930|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736890|NCT03763708|587746931|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736891|NCT03763708|587746932|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736892|NCT03763708|587746933|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736893|NCT03763708|587746934|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162736894|NCT03763708|587746926|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736895|NCT03763708|587746927|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736896|NCT03763708|587746928|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736897|NCT03763708|587746929|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
162736898|NCT03763708|587746930|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736899|NCT03763708|587746931|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736900|NCT03763708|587746932|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736901|NCT03763708|587746933|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736902|NCT03763708|587746934|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162736903|NCT03763708|587746926|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736904|NCT03763708|587746927|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736905|NCT03763708|587746928|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736906|NCT03763708|587746929|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736907|NCT03763708|587746930|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
162736908|NCT03763708|587746931|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736909|NCT03763708|587746932|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736910|NCT03763708|587746933|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736911|NCT03763708|587746934|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162736912|NCT03763708|587746926|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736913|NCT03763708|587746927|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736914|NCT03763708|587746928|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736915|NCT03763708|587746929|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736916|NCT03763708|587746930|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736917|NCT03763708|587746931|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
162736918|NCT03763708|587746932|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736919|NCT03763708|587746933|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736920|NCT03763708|587746934|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162736921|NCT03763708|587746926|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736922|NCT03763708|587746927|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736923|NCT03763708|587746928|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736924|NCT03763708|587746929|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736925|NCT03763708|587746930|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736926|NCT03763708|587746931|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736927|NCT03763708|587746932|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
162736928|NCT03763708|587746933|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736929|NCT03763708|587746934|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162736930|NCT03763708|587746926|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
162736931|NCT03763708|587746927|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
162736932|NCT03763708|587746928|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
162736933|NCT03763708|587746929|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
162736934|NCT03763708|587746930|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
162736935|NCT03763708|587746931|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
162736936|NCT03763708|587746932|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
162736937|NCT03763708|587746933|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
162736938|NCT03763708|587746934|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
162736939|NCT03763708|587746926|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
162736940|NCT03763708|587746927|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
162736941|NCT03763708|587746928|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
162736942|NCT03763708|587746929|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
162736943|NCT03763708|587746930|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
162736944|NCT03763708|587746931|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
162736945|NCT03763708|587746932|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
162736946|NCT03763708|587746933|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
162736947|NCT03763708|587746934|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
162736948|NCT03763708|587746926|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
162736949|NCT03763708|587746927|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
162736950|NCT03763708|587746928|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
162736951|NCT03763708|587746929|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
162736952|NCT03763708|587746930|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
162736953|NCT03763708|587746931|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
162736954|NCT03763708|587746932|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
162736955|NCT03763708|587746933|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
162736956|NCT03763708|587746934|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
162736957|NCT01580488|587746939|FG000|Overall Study|Withdrawal by Subject|1|||
162736958|NCT02243709|587746944|FG000|Phase 1|Lost to Follow-up|0|||
162736959|NCT02243709|587746945|FG001|Phase 1|Lost to Follow-up|1|||
162736960|NCT02243709|587746944|FG000|Phase 1|Withdrawal by Subject|1|||
162736961|NCT02243709|587746945|FG001|Phase 1|Withdrawal by Subject|0|||
162736962|NCT02243709|587746944|FG000|Phase 1|Protocol Violation|0|||
162736963|NCT02243709|587746945|FG001|Phase 1|Protocol Violation|1|||
162736964|NCT02243709|587746944|FG000|Phase 1|Adverse Event|0|||
162736965|NCT02243709|587746945|FG001|Phase 1|Adverse Event|1|||
162736966|NCT01748448|587746946|FG000|Treatment Period|Consent withdrawn by subject|1|||
162736967|NCT01748448|587746947|FG001|Treatment Period|Consent withdrawn by subject|0|||
162736968|NCT01748448|587746946|FG000|Treatment Period|Adverse Event|1|||
162736969|NCT01748448|587746947|FG001|Treatment Period|Adverse Event|0|||
162736970|NCT01748448|587746946|FG000|Treatment Period|Personal|0|||
162736971|NCT01748448|587746947|FG001|Treatment Period|Personal|1|||
162736972|NCT02913872|587746957|FG000|Overall Study|Withdrawal by Subject|1|||
162736973|NCT03920111|587746960|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
162736974|NCT03920111|587746961|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
162736975|NCT03920111|587746962|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
162736976|NCT05177848|587746963|FG000|Overall Study|Lost to Follow-up|1|||
162736977|NCT05177848|587746964|FG001|Overall Study|Lost to Follow-up|4|||
162736978|NCT05177848|587746963|FG000|Overall Study|Discontinued|2|||
162736979|NCT05177848|587746964|FG001|Overall Study|Discontinued|1|||
162736980|NCT06414213|587746965|FG000|Overall Study|Lost to Follow-up|1|||
162736981|NCT06414213|587746966|FG001|Overall Study|Lost to Follow-up|1|||
162736982|NCT06414213|587746967|FG002|Overall Study|Lost to Follow-up|3|||
162736983|NCT03720795|587746968|FG000|Phase 1|Lost to Follow-up|4|||
162736984|NCT03720795|587746968|FG000|Phase 1|Withdrawal by Subject|6|||
162736985|NCT03720795|587746968|FG000|Phase 1|Protocol Violation|1|||
162736986|NCT03720795|587746968|FG000|Phase 1|Other|1|||
162736987|NCT03720795|587746968|FG000|Phase 2|Lost to Follow-up|5|||
162736988|NCT03720795|587746968|FG000|Phase 2|Withdrawal by Subject|10|||
162736989|NCT03720795|587746968|FG000|Phase 2|Protocol Violation|2|||
162736990|NCT03720795|587746968|FG000|3 Month Follow Up|Lost to Follow-up|2|||
162736991|NCT01573442|587746971|FG000|Overall Study|Cancels|9|||
162736992|NCT01573442|587746972|FG001|Overall Study|Cancels|10|||
162736993|NCT04763265|587746978|FG000|Overall Study|Adverse Event|1|||
162736994|NCT04763265|587746979|FG001|Overall Study|Adverse Event|0|||
162736995|NCT04763265|587746978|FG000|Overall Study|Lost to Follow-up|2|||
162736996|NCT04763265|587746979|FG001|Overall Study|Lost to Follow-up|4|||
162736997|NCT04763265|587746978|FG000|Overall Study|Withdrawal by Subject|0|||
162736998|NCT04763265|587746979|FG001|Overall Study|Withdrawal by Subject|1|||
162736999|NCT05308004|587746986|FG000|Overall Study|Not seen by Palliative Care NP|0|||
162737000|NCT05308004|587746987|FG001|Overall Study|Not seen by Palliative Care NP|1|||
162737001|NCT04552223|587746994|FG000|Overall Study|Withdrawal by Subject|1|||
162737002|NCT04856163|587746995|FG000|Overall Study|Lost to Follow-up|97|||
162737003|NCT04856163|587746996|FG001|Overall Study|Lost to Follow-up|100|||
162737004|NCT02515773|587746999|FG000|Overall Study|Withdrawal by Subject|12|||
162737005|NCT02515773|587747000|FG001|Overall Study|Withdrawal by Subject|2|||
162737006|NCT02515773|587746999|FG000|Overall Study|Lost to Follow-up|119|||
162737007|NCT02515773|587747000|FG001|Overall Study|Lost to Follow-up|126|||
162737008|NCT02515773|587746999|FG000|Overall Study|Discharged from Clinic Services|53|||
162737009|NCT02515773|587747000|FG001|Overall Study|Discharged from Clinic Services|84|||
162737010|NCT02515773|587746999|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
162737011|NCT02515773|587747000|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
162737012|NCT02515773|587746999|FG000|Overall Study|Follow-up at non-study site|8|||
162737013|NCT02515773|587747000|FG001|Overall Study|Follow-up at non-study site|16|||
162737014|NCT02515773|587746999|FG000|Overall Study|Moved from area|9|||
162737015|NCT02515773|587747000|FG001|Overall Study|Moved from area|14|||
162737016|NCT04072380|587747002|FG000|Overall Study|Adverse Event|4|||
162737017|NCT04072380|587747003|FG001|Overall Study|Adverse Event|6|||
162737018|NCT04072380|587747004|FG002|Overall Study|Adverse Event|0|||
162737019|NCT04072380|587747002|FG000|Overall Study|Withdrawal by Subject|3|||
162737020|NCT04072380|587747003|FG001|Overall Study|Withdrawal by Subject|1|||
162737021|NCT04072380|587747004|FG002|Overall Study|Withdrawal by Subject|1|||
162737022|NCT04072380|587747002|FG000|Overall Study|Physician Decision|2|||
162737023|NCT04072380|587747003|FG001|Overall Study|Physician Decision|0|||
162737024|NCT04072380|587747004|FG002|Overall Study|Physician Decision|0|||
162737025|NCT04072380|587747002|FG000|Overall Study|Protocol Violation|0|||
162737026|NCT04072380|587747003|FG001|Overall Study|Protocol Violation|2|||
162737027|NCT04072380|587747004|FG002|Overall Study|Protocol Violation|3|||
162737028|NCT04072380|587747002|FG000|Overall Study|Intercurrent Illness and Others|3|||
162737029|NCT04072380|587747003|FG001|Overall Study|Intercurrent Illness and Others|5|||
162737030|NCT04072380|587747004|FG002|Overall Study|Intercurrent Illness and Others|6|||
162737031|NCT03468218|587747010|FG000|Overall Study|Adverse Event|5|||
162737032|NCT03468218|587747010|FG000|Overall Study|Progressive Disease|16|||
162737033|NCT03468218|587747010|FG000|Overall Study|Death|1|||
162737034|NCT03468218|587747010|FG000|Overall Study|Alternate therapy|1|||
162737035|NCT03468218|587747010|FG000|Overall Study|Withdrawal by Subject|2|||
162737036|NCT03719443|587747011|FG000|Overall Study|Lost to Follow-up|0|||
162737037|NCT03719443|587747012|FG001|Overall Study|Lost to Follow-up|0|||
162737038|NCT03719443|587747013|FG002|Overall Study|Lost to Follow-up|1|||
162737039|NCT03719443|587747014|FG003|Overall Study|Lost to Follow-up|0|||
162737040|NCT03719443|587747015|FG004|Overall Study|Lost to Follow-up|1|||
162737041|NCT03719443|587747016|FG005|Overall Study|Lost to Follow-up|0|||
162737042|NCT03719443|587747017|FG006|Overall Study|Lost to Follow-up|1|||
162737043|NCT03719443|587747011|FG000|Overall Study|Withdrawal by Subject|0|||
162737044|NCT03719443|587747012|FG001|Overall Study|Withdrawal by Subject|0|||
162737045|NCT03719443|587747013|FG002|Overall Study|Withdrawal by Subject|1|||
162737046|NCT03719443|587747014|FG003|Overall Study|Withdrawal by Subject|0|||
162737047|NCT03719443|587747015|FG004|Overall Study|Withdrawal by Subject|0|||
162737048|NCT03719443|587747016|FG005|Overall Study|Withdrawal by Subject|0|||
162737049|NCT03719443|587747017|FG006|Overall Study|Withdrawal by Subject|0|||
162737050|NCT03447470|587747022|FG000|Overall Study|Death|0|||
162737051|NCT03447470|587747023|FG001|Overall Study|Death|1|||
162737052|NCT03447470|587747024|FG002|Overall Study|Death|3|||
162737053|NCT03447470|587747025|FG003|Overall Study|Death|0|||
162737054|NCT03447470|587747026|FG004|Overall Study|Death|1|||
162737055|NCT03447470|587747027|FG005|Overall Study|Death|0|||
162737056|NCT03447470|587747028|FG006|Overall Study|Death|3|||
162737057|NCT03447470|587747029|FG007|Overall Study|Death|3|||
162737058|NCT03447470|587747030|FG008|Overall Study|Death|1|||
162737059|NCT03447470|587747022|FG000|Overall Study|Withdrawal by Subject|1|||
162737060|NCT03447470|587747023|FG001|Overall Study|Withdrawal by Subject|0|||
162737061|NCT03447470|587747024|FG002|Overall Study|Withdrawal by Subject|0|||
162737062|NCT03447470|587747025|FG003|Overall Study|Withdrawal by Subject|0|||
162737063|NCT03447470|587747026|FG004|Overall Study|Withdrawal by Subject|1|||
162737064|NCT03447470|587747027|FG005|Overall Study|Withdrawal by Subject|0|||
162737065|NCT03447470|587747028|FG006|Overall Study|Withdrawal by Subject|1|||
162737066|NCT03447470|587747029|FG007|Overall Study|Withdrawal by Subject|1|||
162737067|NCT03447470|587747030|FG008|Overall Study|Withdrawal by Subject|3|||
162737068|NCT03447470|587747022|FG000|Overall Study|Treatment discontinued|3|||
162737069|NCT03447470|587747023|FG001|Overall Study|Treatment discontinued|2|||
162737070|NCT03447470|587747024|FG002|Overall Study|Treatment discontinued|4|||
162737071|NCT03447470|587747025|FG003|Overall Study|Treatment discontinued|6|||
162737072|NCT03447470|587747026|FG004|Overall Study|Treatment discontinued|2|||
162737073|NCT03447470|587747027|FG005|Overall Study|Treatment discontinued|1|||
162737074|NCT03447470|587747028|FG006|Overall Study|Treatment discontinued|2|||
162737075|NCT03447470|587747029|FG007|Overall Study|Treatment discontinued|4|||
162737076|NCT03447470|587747030|FG008|Overall Study|Treatment discontinued|3|||
162737077|NCT02471638|587747033|FG000|Overall Study|Early Term Withdrawal|10|||
162737078|NCT05816551|587748992|FG000|Overall Study|Withdrawal by Subject|0|||
162737079|NCT05816551|587748993|FG001|Overall Study|Withdrawal by Subject|1|||
162737080|NCT05816551|587748992|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
162737081|NCT05816551|587748993|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
162737082|NCT04353661|587748994|FG000|Overall Study|Protocol Violation|0|||
162737083|NCT04353661|587748995|FG001|Overall Study|Protocol Violation|0|||
162737084|NCT04353661|587748996|FG002|Overall Study|Protocol Violation|1|||
162737085|NCT04353661|587748994|FG000|Overall Study|Study termination by the Sponsor|1|||
162737086|NCT04353661|587748995|FG001|Overall Study|Study termination by the Sponsor|1|||
162737087|NCT04353661|587748996|FG002|Overall Study|Study termination by the Sponsor|1|||
162737088|NCT02530671|587749006|FG000|Overall Study|Lost to Follow-up|2|||
162737089|NCT02530671|587749007|FG001|Overall Study|Lost to Follow-up|0|||
162737090|NCT02530671|587749006|FG000|Overall Study|Withdrawal by Subject|1|||
162737091|NCT02530671|587749007|FG001|Overall Study|Withdrawal by Subject|0|||
162737092|NCT05247489|587749008|FG000|Overall Study|Lost to Follow-up|5|||
162737093|NCT05247489|587749009|FG001|Overall Study|Lost to Follow-up|1|||
162737094|NCT05247489|587749008|FG000|Overall Study|Withdrawal by Subject|6|||
162737095|NCT05247489|587749009|FG001|Overall Study|Withdrawal by Subject|7|||
162737096|NCT05247489|587749008|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
162737097|NCT05247489|587749009|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
162737098|NCT05247489|587749008|FG000|Overall Study|Left Country|1|||
162737099|NCT05247489|587749009|FG001|Overall Study|Left Country|0|||
162737100|NCT05247489|587749008|FG000|Overall Study|Noncompliance with Investigational Product|1|||
162737101|NCT05247489|587749009|FG001|Overall Study|Noncompliance with Investigational Product|0|||
162737102|NCT05247489|587749008|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
162737103|NCT05247489|587749009|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
162737104|NCT03126019|587749010|FG000|Overall Study|Death|5|||
162737105|NCT03126019|587749011|FG001|Overall Study|Death|27|||
162737106|NCT03126019|587749010|FG000|Overall Study|Lost to Follow-up|2|||
162737107|NCT03126019|587749011|FG001|Overall Study|Lost to Follow-up|4|||
162737108|NCT03126019|587749010|FG000|Overall Study|Withdrawal by Subject|1|||
162737109|NCT03126019|587749011|FG001|Overall Study|Withdrawal by Subject|9|||
162737110|NCT03126019|587749010|FG000|Overall Study|Physician Decision|1|||
162737111|NCT03126019|587749011|FG001|Overall Study|Physician Decision|0|||
162737112|NCT03126019|587749010|FG000|Overall Study|Transitioned to Rollover Study|0|||
162737113|NCT03126019|587749011|FG001|Overall Study|Transitioned to Rollover Study|11|||
162737114|NCT03126019|587749010|FG000|Overall Study|Did Not Return to Site for Care|0|||
162737115|NCT03126019|587749011|FG001|Overall Study|Did Not Return to Site for Care|1|||
162737116|NCT03126019|587749010|FG000|Overall Study|Site Closed|0|||
162737117|NCT03126019|587749011|FG001|Overall Study|Site Closed|1|||
162737118|NCT05563246|587749034|FG000|Overall Study|Withdrawal by Subject|1|||
162737119|NCT05563246|587749035|FG001|Overall Study|Withdrawal by Subject|2|||
162737120|NCT05563246|587749036|FG002|Overall Study|Withdrawal by Subject|0|||
162737121|NCT05563246|587749037|FG003|Overall Study|Withdrawal by Subject|0|||
162737122|NCT05563246|587749034|FG000|Overall Study|Protocol Deviation|0|||
162737123|NCT05563246|587749035|FG001|Overall Study|Protocol Deviation|1|||
162737124|NCT05563246|587749036|FG002|Overall Study|Protocol Deviation|0|||
162737125|NCT05563246|587749037|FG003|Overall Study|Protocol Deviation|0|||
162737126|NCT05563246|587749034|FG000|Overall Study|Physician Decision|0|||
162737127|NCT05563246|587749035|FG001|Overall Study|Physician Decision|1|||
162737128|NCT05563246|587749036|FG002|Overall Study|Physician Decision|0|||
162737129|NCT05563246|587749037|FG003|Overall Study|Physician Decision|0|||
162737130|NCT05563246|587749034|FG000|Overall Study|Adverse Event|0|||
162737131|NCT05563246|587749035|FG001|Overall Study|Adverse Event|0|||
162737132|NCT05563246|587749036|FG002|Overall Study|Adverse Event|2|||
162737133|NCT05563246|587749037|FG003|Overall Study|Adverse Event|0|||
162737134|NCT05563246|587749034|FG000|Overall Study|Lost to Follow-up|0|||
162737135|NCT05563246|587749035|FG001|Overall Study|Lost to Follow-up|0|||
162737136|NCT05563246|587749036|FG002|Overall Study|Lost to Follow-up|1|||
162737137|NCT05563246|587749037|FG003|Overall Study|Lost to Follow-up|0|||
162737138|NCT03332017|587749039|FG000|Overall Study|Lost to Follow-up|1|||
162737139|NCT03332017|587749040|FG001|Overall Study|Lost to Follow-up|2|||
162737140|NCT03332017|587749039|FG000|Overall Study|Death|17|||
162737141|NCT03332017|587749040|FG001|Overall Study|Death|16|||
162737142|NCT03332017|587749039|FG000|Overall Study|Withdrawal by Subject|6|||
162737143|NCT03332017|587749040|FG001|Overall Study|Withdrawal by Subject|14|||
162737144|NCT03332017|587749039|FG000|Overall Study|Other|1|||
162737145|NCT03332017|587749040|FG001|Overall Study|Other|3|||
162737146|NCT03332017|587749039|FG000|Overall Study|Remained in Study (Ongoing)|47|||
162737147|NCT03332017|587749040|FG001|Overall Study|Remained in Study (Ongoing)|110|||
162737148|NCT04241068|587749049|FG000|Core Treatment Period|Adverse Event|91|||
162737149|NCT04241068|587749049|FG000|Core Treatment Period|Change of Treatment|4|||
162737150|NCT04241068|587749049|FG000|Core Treatment Period|Consent Withdrawn|143|||
162737151|NCT04241068|587749049|FG000|Core Treatment Period|Death|26|||
162737152|NCT04241068|587749049|FG000|Core Treatment Period|Disease Progression|67|||
162737153|NCT04241068|587749049|FG000|Core Treatment Period|Investigator Decision|40|||
162737154|NCT04241068|587749049|FG000|Core Treatment Period|Loss of Capacity|9|||
162737155|NCT04241068|587749049|FG000|Core Treatment Period|Lost to Follow-up|11|||
162737156|NCT04241068|587749049|FG000|Core Treatment Period|Relocation|4|||
162737157|NCT04241068|587749049|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
162737158|NCT04241068|587749049|FG000|Core Treatment Period|Study Visit Burden|40|||
162737159|NCT04241068|587749049|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
162737160|NCT04241068|587749049|FG000|Core Treatment Period|Missing|2|||
162737161|NCT04241068|587749049|FG000|Core Treatment Period|Reason Not Specified|41|||
162737162|NCT04241068|587749049|FG000|LTE Period|Adverse Event|19|||
162737163|NCT04241068|587749049|FG000|LTE Period|Change of Treatment|1|||
162737164|NCT04241068|587749049|FG000|LTE Period|Consent Withdrawn|71|||
162737165|NCT04241068|587749049|FG000|LTE Period|Death|8|||
162737166|NCT04241068|587749049|FG000|LTE Period|Disease Progression|11|||
162737167|NCT04241068|587749049|FG000|LTE Period|Investigator Decision|12|||
162737168|NCT04241068|587749049|FG000|LTE Period|Loss of Capacity|2|||
162737169|NCT04241068|587749049|FG000|LTE Period|Lost to Follow-up|7|||
162737170|NCT04241068|587749049|FG000|LTE Period|Relocation|6|||
162737171|NCT04241068|587749049|FG000|LTE Period|Site Terminated by Sponsor|26|||
162737172|NCT04241068|587749049|FG000|LTE Period|Study Terminated by Sponsor|276|||
162737173|NCT04241068|587749049|FG000|LTE Period|Study Visit Burden|10|||
162737174|NCT04241068|587749049|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
162737175|NCT04241068|587749049|FG000|LTE Period|Reason Not Specified|65|||
162737176|NCT04229992|587749054|FG000|Overall Study|Withdrawal by Subject|0|||
162737177|NCT04229992|587749055|FG001|Overall Study|Withdrawal by Subject|2|||
162737178|NCT04229992|587749056|FG002|Overall Study|Withdrawal by Subject|1|||
162737179|NCT04229992|587749057|FG003|Overall Study|Withdrawal by Subject|1|||
162737180|NCT04229992|587749054|FG000|Overall Study|Adverse Event|1|||
162737181|NCT04229992|587749055|FG001|Overall Study|Adverse Event|1|||
162737182|NCT04229992|587749056|FG002|Overall Study|Adverse Event|3|||
162737183|NCT04229992|587749057|FG003|Overall Study|Adverse Event|1|||
162737184|NCT04229992|587749054|FG000|Overall Study|Lost to Follow-up|0|||
162737185|NCT04229992|587749055|FG001|Overall Study|Lost to Follow-up|0|||
162737186|NCT04229992|587749056|FG002|Overall Study|Lost to Follow-up|0|||
162737187|NCT04229992|587749057|FG003|Overall Study|Lost to Follow-up|1|||
162737188|NCT05178316|587749058|FG000|Overall Study|Adverse Event|5|||
162737189|NCT05178316|587749059|FG001|Overall Study|Adverse Event|4|||
162737190|NCT05178316|587749060|FG002|Overall Study|Adverse Event|9|||
162737191|NCT05178316|587749058|FG000|Overall Study|Enrolled in Error|1|||
162737192|NCT05178316|587749059|FG001|Overall Study|Enrolled in Error|2|||
162737193|NCT05178316|587749060|FG002|Overall Study|Enrolled in Error|1|||
162737194|NCT05178316|587749058|FG000|Overall Study|Lost to Follow-up|3|||
162737195|NCT05178316|587749059|FG001|Overall Study|Lost to Follow-up|15|||
162737196|NCT05178316|587749060|FG002|Overall Study|Lost to Follow-up|11|||
162737197|NCT05178316|587749058|FG000|Overall Study|Noncompliance|1|||
162737198|NCT05178316|587749059|FG001|Overall Study|Noncompliance|3|||
162737199|NCT05178316|587749060|FG002|Overall Study|Noncompliance|1|||
162737200|NCT05178316|587749058|FG000|Overall Study|Other|0|||
162737201|NCT05178316|587749059|FG001|Overall Study|Other|1|||
162737202|NCT05178316|587749060|FG002|Overall Study|Other|0|||
162737203|NCT05178316|587749058|FG000|Overall Study|Physician Decision|0|||
162737204|NCT05178316|587749059|FG001|Overall Study|Physician Decision|3|||
162737205|NCT05178316|587749060|FG002|Overall Study|Physician Decision|2|||
162737206|NCT05178316|587749058|FG000|Overall Study|Protocol deviation|1|||
162737207|NCT05178316|587749059|FG001|Overall Study|Protocol deviation|0|||
162737208|NCT05178316|587749060|FG002|Overall Study|Protocol deviation|1|||
162737209|NCT05178316|587749058|FG000|Overall Study|Sponsor decision|1|||
162737210|NCT05178316|587749059|FG001|Overall Study|Sponsor decision|0|||
162737211|NCT05178316|587749060|FG002|Overall Study|Sponsor decision|1|||
162737212|NCT05178316|587749058|FG000|Overall Study|Withdrawal by Subject|5|||
162737213|NCT05178316|587749059|FG001|Overall Study|Withdrawal by Subject|11|||
162737214|NCT05178316|587749060|FG002|Overall Study|Withdrawal by Subject|5|||
162737215|NCT04347161|587749061|FG000|Overall Study|Death|0|||
162737216|NCT04347161|587749062|FG001|Overall Study|Death|2|||
162737217|NCT04347161|587749061|FG000|Overall Study|Withdrawal by Subject|1|||
162737218|NCT04347161|587749062|FG001|Overall Study|Withdrawal by Subject|0|||
162737219|NCT04347161|587749061|FG000|Overall Study|Lost to Follow-up|0|||
162737220|NCT04347161|587749062|FG001|Overall Study|Lost to Follow-up|1|||
162737221|NCT04347161|587749061|FG000|Overall Study|No longer on study medication|1|||
162737222|NCT04347161|587749062|FG001|Overall Study|No longer on study medication|1|||
162737223|NCT04169373|587749063|FG000|Week 1 to Week 14|Adverse Event|1|||
162737224|NCT04169373|587749064|FG001|Week 1 to Week 14|Adverse Event|0|||
162737225|NCT04169373|587749065|FG002|Week 1 to Week 14|Adverse Event|1|||
162737226|NCT04169373|587749066|FG003|Week 1 to Week 14|Adverse Event|2|||
162737227|NCT04169373|587749063|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
162737228|NCT04169373|587749064|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
162737229|NCT04169373|587749065|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
162737230|NCT04169373|587749066|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
162737231|NCT04169373|587749063|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
162737232|NCT04169373|587749064|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
162737233|NCT04169373|587749065|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
162737234|NCT04169373|587749066|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
162737235|NCT04169373|587749063|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162737236|NCT04169373|587749064|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
162737237|NCT04169373|587749065|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162737238|NCT04169373|587749066|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162737239|NCT04169373|587749063|FG000|Week 1 to Week 14|Other|1|||
162737240|NCT04169373|587749064|FG001|Week 1 to Week 14|Other|3|||
162737241|NCT04169373|587749065|FG002|Week 1 to Week 14|Other|3|||
162737242|NCT04169373|587749066|FG003|Week 1 to Week 14|Other|5|||
162737243|NCT04169373|587749063|FG000|Week 14 to Week 52|Adverse Event|1|||
162737244|NCT04169373|587749064|FG001|Week 14 to Week 52|Adverse Event|0|||
162737245|NCT04169373|587749065|FG002|Week 14 to Week 52|Adverse Event|0|||
162737246|NCT04169373|587749066|FG003|Week 14 to Week 52|Adverse Event|1|||
162737247|NCT04169373|587749063|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
162737248|NCT04169373|587749064|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
162737249|NCT04169373|587749065|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
162737250|NCT04169373|587749066|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
162737251|NCT04169373|587749063|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
162737252|NCT04169373|587749064|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
162737253|NCT04169373|587749065|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
162737254|NCT04169373|587749066|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
162737255|NCT04169373|587749063|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
162737256|NCT04169373|587749064|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162737257|NCT04169373|587749065|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162737258|NCT04169373|587749066|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162737259|NCT04169373|587749063|FG000|Week 14 to Week 52|Other|4|||
162737260|NCT04169373|587749064|FG001|Week 14 to Week 52|Other|5|||
162737261|NCT04169373|587749065|FG002|Week 14 to Week 52|Other|4|||
162737262|NCT04169373|587749066|FG003|Week 14 to Week 52|Other|5|||
162737263|NCT04169373|587749063|FG000|Week 14 to Week 52|Ongoing|0|||
162737264|NCT04169373|587749064|FG001|Week 14 to Week 52|Ongoing|1|||
162737265|NCT04169373|587749065|FG002|Week 14 to Week 52|Ongoing|0|||
162737266|NCT04169373|587749066|FG003|Week 14 to Week 52|Ongoing|0|||
162737267|NCT04610892|587749067|FG000|Overall Study|Adverse Event|1|||
162737268|NCT04610892|587749068|FG001|Overall Study|Adverse Event|0|||
162737269|NCT04610892|587749069|FG002|Overall Study|Adverse Event|0|||
162737270|NCT04610892|587749070|FG003|Overall Study|Adverse Event|1|||
162737271|NCT04610892|587749071|FG004|Overall Study|Adverse Event|3|||
162737272|NCT04610892|587749067|FG000|Overall Study|Death|0|||
162737273|NCT04610892|587749068|FG001|Overall Study|Death|1|||
162737274|NCT04610892|587749069|FG002|Overall Study|Death|0|||
162737275|NCT04610892|587749070|FG003|Overall Study|Death|1|||
162737276|NCT04610892|587749071|FG004|Overall Study|Death|0|||
162737277|NCT04610892|587749067|FG000|Overall Study|Withdrawal by Subject|3|||
162737278|NCT04610892|587749068|FG001|Overall Study|Withdrawal by Subject|2|||
162737279|NCT04610892|587749069|FG002|Overall Study|Withdrawal by Subject|0|||
162737280|NCT04610892|587749070|FG003|Overall Study|Withdrawal by Subject|6|||
162737281|NCT04610892|587749071|FG004|Overall Study|Withdrawal by Subject|6|||
162737282|NCT04610892|587749067|FG000|Overall Study|Subjects who did not receive treatment|1|||
162737283|NCT04610892|587749068|FG001|Overall Study|Subjects who did not receive treatment|0|||
162737284|NCT04610892|587749069|FG002|Overall Study|Subjects who did not receive treatment|0|||
162737285|NCT04610892|587749070|FG003|Overall Study|Subjects who did not receive treatment|0|||
162737286|NCT04610892|587749071|FG004|Overall Study|Subjects who did not receive treatment|2|||
162737287|NCT01413100|587749072|FG000|Overall Study|Withdrawal by Subject|1|||
162737288|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
162737289|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
162737290|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
162737291|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
162737292|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
162737293|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
162737294|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
162737295|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
162737296|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
162737297|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
162737298|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
162737299|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
162737300|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
162737301|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
162737302|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
162737303|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
162737304|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
162737305|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
162737306|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
162737307|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
162737308|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
162737309|NCT05369403|587749073|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
162737310|NCT05369403|587749074|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
162737311|NCT05369403|587749075|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
162737312|NCT05369403|587749073|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
162737313|NCT05369403|587749074|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
162737314|NCT05369403|587749075|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
162737315|NCT05369403|587749073|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
162737316|NCT05369403|587749074|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
162737317|NCT05369403|587749075|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
162737318|NCT05369403|587749073|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
162737319|NCT05369403|587749074|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
162737320|NCT05369403|587749075|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
162737321|NCT03792256|587749076|FG000|Overall Study|Death|0|||
162737322|NCT03792256|587749077|FG001|Overall Study|Death|1|||
162737323|NCT03792256|587749076|FG000|Overall Study|Lack of Efficacy|0|||
162737324|NCT03792256|587749077|FG001|Overall Study|Lack of Efficacy|1|||
162737325|NCT03792256|587749076|FG000|Overall Study|Withdrawal by Subject|0|||
162737326|NCT03792256|587749077|FG001|Overall Study|Withdrawal by Subject|1|||
162737327|NCT04760678|587749080|FG000|Overall Study|Death|13|||
162737328|NCT04760678|587749080|FG000|Overall Study|Lost to Follow-up|48|||
162737329|NCT04760678|587749080|FG000|Overall Study|Withdrawal by Subject|1|||
162737330|NCT04562649|587749086|FG000|Overall Study|Withdrawal by Subject|11|||
162737331|NCT04562649|587749087|FG001|Overall Study|Withdrawal by Subject|8|||
162737332|NCT04562649|587749086|FG000|Overall Study|Lost to Follow-up|26|||
162737333|NCT04562649|587749087|FG001|Overall Study|Lost to Follow-up|20|||
162737334|NCT05368103|587749088|FG000|Overall Study|Withdrawal by Subject|4|||
162737335|NCT05368103|587749088|FG000|Overall Study|Lost to Follow-up|1|||
162737336|NCT05368103|587749088|FG000|Overall Study|Lack of Efficacy|3|||
162737337|NCT03675282|587749091|FG000|Overall Study|Lost to Follow-up|4|||
162737338|NCT03675282|587749092|FG001|Overall Study|Lost to Follow-up|8|||
162737339|NCT03675282|587749093|FG002|Overall Study|Lost to Follow-up|1|||
162737340|NCT03675282|587749094|FG003|Overall Study|Lost to Follow-up|0|||
162737341|NCT03675282|587749095|FG004|Overall Study|Lost to Follow-up|2|||
162737342|NCT03675282|587749096|FG005|Overall Study|Lost to Follow-up|7|||
162737343|NCT03675282|587749091|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
162737344|NCT03675282|587749092|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
162737345|NCT03675282|587749093|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
162737346|NCT03675282|587749094|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
162737347|NCT03675282|587749095|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
162737348|NCT03675282|587749096|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
162737349|NCT03675282|587749091|FG000|Overall Study|Physician Decision|1|||
162737350|NCT03675282|587749092|FG001|Overall Study|Physician Decision|0|||
162737351|NCT03675282|587749093|FG002|Overall Study|Physician Decision|0|||
162737352|NCT03675282|587749094|FG003|Overall Study|Physician Decision|0|||
162737353|NCT03675282|587749095|FG004|Overall Study|Physician Decision|0|||
162737354|NCT03675282|587749096|FG005|Overall Study|Physician Decision|0|||
162737355|NCT03232138|587749105|FG000|Overall Study|Physician Decision|1|||
162737356|NCT03232138|587749106|FG001|Overall Study|Physician Decision|0|||
162737357|NCT03232138|587749105|FG000|Overall Study|Adverse Event|2|||
162737358|NCT03232138|587749106|FG001|Overall Study|Adverse Event|0|||
162737359|NCT03232138|587749105|FG000|Overall Study|Withdrawal by Subject|1|||
162737360|NCT03232138|587749106|FG001|Overall Study|Withdrawal by Subject|2|||
162737361|NCT03853746|587749108|FG000|Overall Study|Withdrawal by Subject|1|||
162737362|NCT04359108|587749111|FG000|Overall Study|Withdrawal by Subject|1|||
162737363|NCT04359108|587749112|FG001|Overall Study|Withdrawal by Subject|0|||
162737364|NCT04359108|587749111|FG000|Overall Study|Unable or too feeble to walk independently|0|||
162737365|NCT04359108|587749112|FG001|Overall Study|Unable or too feeble to walk independently|2|||
162737366|NCT04359108|587749111|FG000|Overall Study|Argus II system stopped functioning|0|||
162737367|NCT04359108|587749112|FG001|Overall Study|Argus II system stopped functioning|1|||
162737368|NCT04359108|587749111|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
162737369|NCT04359108|587749112|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
162737370|NCT04176965|587749113|FG000|Overall Study|Death|1|||
162737371|NCT04176965|587749114|FG001|Overall Study|Death|2|||
162737372|NCT04176965|587749113|FG000|Overall Study|Lost to Follow-up|10|||
162737373|NCT04176965|587749114|FG001|Overall Study|Lost to Follow-up|2|||
162737374|NCT04176965|587749113|FG000|Overall Study|Withdrawal by Subject|6|||
162737375|NCT04176965|587749114|FG001|Overall Study|Withdrawal by Subject|1|||
162737376|NCT05434078|587749115|FG000|Overall Study|Lost to Follow-up|2|||
162737377|NCT05434078|587749116|FG001|Overall Study|Lost to Follow-up|1|||
162737378|NCT05434078|587749115|FG000|Overall Study|Withdrawal by Subject|1|||
162737379|NCT05434078|587749116|FG001|Overall Study|Withdrawal by Subject|0|||
162737380|NCT03652688|587749117|FG000|Baseline|Withdrawal by Subject|0|||
162737381|NCT03652688|587749118|FG001|Baseline|Withdrawal by Subject|3|||
162737382|NCT03652688|587749117|FG000|Follow-up|Lost to Follow-up|56|||
162737383|NCT03652688|587749118|FG001|Follow-up|Lost to Follow-up|54|||
162737384|NCT00554788|587749119|FG000|Overall Study|Adverse Event|0|||
162737385|NCT00554788|587749120|FG001|Overall Study|Adverse Event|1|||
162737386|NCT00554788|587749121|FG002|Overall Study|Adverse Event|2|||
162737387|NCT00554788|587749119|FG000|Overall Study|Lost to Follow-up|4|||
162737388|NCT00554788|587749120|FG001|Overall Study|Lost to Follow-up|3|||
162737389|NCT00554788|587749121|FG002|Overall Study|Lost to Follow-up|3|||
162737390|NCT00554788|587749119|FG000|Overall Study|Physician Decision|1|||
162737391|NCT00554788|587749120|FG001|Overall Study|Physician Decision|1|||
162737392|NCT00554788|587749121|FG002|Overall Study|Physician Decision|3|||
162737393|NCT00554788|587749119|FG000|Overall Study|Withdrawal by Subject|0|||
162737394|NCT00554788|587749120|FG001|Overall Study|Withdrawal by Subject|0|||
162737395|NCT00554788|587749121|FG002|Overall Study|Withdrawal by Subject|1|||
162737396|NCT00554788|587749119|FG000|Overall Study|Refusal of further protocol therapy|0|||
162737397|NCT00554788|587749120|FG001|Overall Study|Refusal of further protocol therapy|1|||
162737398|NCT00554788|587749121|FG002|Overall Study|Refusal of further protocol therapy|1|||
162737399|NCT00554788|587749119|FG000|Overall Study|Progressive disease|0|||
162737400|NCT00554788|587749120|FG001|Overall Study|Progressive disease|0|||
162737401|NCT00554788|587749121|FG002|Overall Study|Progressive disease|3|||
162737402|NCT00554788|587749119|FG000|Overall Study|Ineligible|2|||
162737403|NCT00554788|587749120|FG001|Overall Study|Ineligible|0|||
162737404|NCT00554788|587749121|FG002|Overall Study|Ineligible|1|||
162737405|NCT03197662|587749127|FG000|Overall Study|Withdrawn by family|0|||
162737406|NCT03197662|587749128|FG001|Overall Study|Withdrawn by family|2|||
162737407|NCT03721952|587749129|FG000|Overall Study|Lost to Follow-up|0|||
162737408|NCT03721952|587749130|FG001|Overall Study|Lost to Follow-up|0|||
162737409|NCT03721952|587749131|FG002|Overall Study|Lost to Follow-up|2|||
162737410|NCT03721952|587749132|FG003|Overall Study|Lost to Follow-up|0|||
162737411|NCT03721952|587749133|FG004|Overall Study|Lost to Follow-up|0|||
162737412|NCT03721952|587749129|FG000|Overall Study|Protocol Violation|0|||
162737413|NCT03721952|587749130|FG001|Overall Study|Protocol Violation|1|||
162737414|NCT03721952|587749131|FG002|Overall Study|Protocol Violation|0|||
162737415|NCT03721952|587749132|FG003|Overall Study|Protocol Violation|0|||
162737416|NCT03721952|587749133|FG004|Overall Study|Protocol Violation|0|||
162737417|NCT03721952|587749129|FG000|Overall Study|Withdrawal by Subject|1|||
162737418|NCT03721952|587749130|FG001|Overall Study|Withdrawal by Subject|0|||
162737419|NCT03721952|587749131|FG002|Overall Study|Withdrawal by Subject|40|||
162737420|NCT03721952|587749132|FG003|Overall Study|Withdrawal by Subject|28|||
162737421|NCT03721952|587749133|FG004|Overall Study|Withdrawal by Subject|0|||
162737422|NCT03364647|587749134|FG000|Overall Study|Withdrawal by Subject|3|||
162737423|NCT03364647|587749135|FG001|Overall Study|Withdrawal by Subject|1|||
162737424|NCT03476460|587749136|FG000|Overall Study|Withdrawal by Subject|3|||
162737425|NCT03476460|587749137|FG001|Overall Study|Withdrawal by Subject|2|||
162737426|NCT03476460|587749136|FG000|Overall Study|Non-compliance with treatment|3|||
162737427|NCT03476460|587749137|FG001|Overall Study|Non-compliance with treatment|0|||
162737428|NCT03476460|587749136|FG000|Overall Study|Missing laboratory tests|5|||
162737429|NCT03476460|587749137|FG001|Overall Study|Missing laboratory tests|5|||
162737430|NCT03476460|587749136|FG000|Overall Study|Adverse Event|0|||
162737431|NCT03476460|587749137|FG001|Overall Study|Adverse Event|1|||
162737432|NCT04624633|587749141|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
162737433|NCT04624633|587749142|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
162737434|NCT04624633|587749141|FG000|Overall Study|Death|1|||
162737435|NCT04624633|587749142|FG001|Overall Study|Death|0|||
162737436|NCT01902173|587749146|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
162737437|NCT01902173|587749147|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162737438|NCT01902173|587749148|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162737439|NCT01902173|587749149|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162737440|NCT01902173|587749150|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162737441|NCT01902173|587749151|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162737442|NCT01902173|587749146|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
162737443|NCT01902173|587749147|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162737444|NCT01902173|587749148|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162737445|NCT01902173|587749149|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162737446|NCT01902173|587749150|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162737447|NCT01902173|587749151|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162737448|NCT01902173|587749146|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162737449|NCT01902173|587749147|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
162737450|NCT01902173|587749148|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162737451|NCT01902173|587749149|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162737452|NCT01902173|587749150|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162737453|NCT01902173|587749151|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162737454|NCT01902173|587749146|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162737455|NCT01902173|587749147|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
162737456|NCT01902173|587749148|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162737457|NCT01902173|587749149|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162737458|NCT01902173|587749150|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162737459|NCT01902173|587749151|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162737460|NCT01902173|587749146|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162737461|NCT01902173|587749147|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
162737462|NCT01902173|587749148|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162737463|NCT01902173|587749149|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162737464|NCT01902173|587749150|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162737465|NCT01902173|587749151|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162737466|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162737467|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162737468|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
162737469|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162737470|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162737471|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162737472|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162737473|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162737474|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
162737475|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162737476|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162737477|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162737478|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162737479|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162737480|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162737481|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
162737482|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162737483|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162737484|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162737485|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162737486|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162737487|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
162737488|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162737489|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162737490|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162737491|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162737492|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162737493|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162737494|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
162737495|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162737496|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162737497|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162737498|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162737499|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162737500|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
162737501|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162737502|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162737503|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162737504|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162737505|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162737506|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162737507|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
162737508|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162737509|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162737510|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162737511|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162737512|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162737513|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
162737514|NCT01902173|587749146|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162737515|NCT01902173|587749147|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162737516|NCT01902173|587749148|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162737517|NCT01902173|587749149|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162737518|NCT01902173|587749150|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162737519|NCT01902173|587749151|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
162737520|NCT03640312|587749156|FG000|Overall Study|Lost to Follow-up|3|||
162737521|NCT03640312|587749157|FG001|Overall Study|Lost to Follow-up|6|||
162737522|NCT03536754|587749158|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
162737523|NCT03536754|587749159|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
162737524|NCT03536754|587749160|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
162737525|NCT03536754|587749161|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
162737526|NCT03536754|587749162|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
162737527|NCT03536754|587749158|FG000|Open Label Extension|Other|0|||
162737528|NCT03536754|587749159|FG001|Open Label Extension|Other|0|||
162737529|NCT03536754|587749160|FG002|Open Label Extension|Other|0|||
162737530|NCT03536754|587749161|FG003|Open Label Extension|Other|0|||
162737531|NCT03536754|587749162|FG004|Open Label Extension|Other|1|||
162737532|NCT03382652|587749165|FG000|Overall Study|Lost to Follow-up|6|||
162737533|NCT03382652|587749165|FG000|Overall Study|Death|4|||
162737534|NCT03382652|587749165|FG000|Overall Study|Revision|5|||
162737535|NCT03382652|587749165|FG000|Overall Study|Patient withdrew|3|||
162737536|NCT03382652|587749165|FG000|Overall Study|Other reasons|21|||
162737537|NCT05008835|587749169|FG000|Overall Study|Adverse Event|5|||
162737538|NCT05008835|587749170|FG001|Overall Study|Adverse Event|2|||
162737539|NCT05008835|587749171|FG002|Overall Study|Adverse Event|1|||
162737540|NCT05008835|587749169|FG000|Overall Study|Lack of Efficacy|0|||
162737541|NCT05008835|587749170|FG001|Overall Study|Lack of Efficacy|0|||
162737542|NCT05008835|587749171|FG002|Overall Study|Lack of Efficacy|1|||
162737543|NCT05008835|587749169|FG000|Overall Study|Study terminated by sponsor|0|||
162737544|NCT05008835|587749170|FG001|Overall Study|Study terminated by sponsor|0|||
162737545|NCT05008835|587749171|FG002|Overall Study|Study terminated by sponsor|1|||
162737546|NCT05008835|587749169|FG000|Overall Study|Not further specified|3|||
162737547|NCT05008835|587749170|FG001|Overall Study|Not further specified|2|||
162737548|NCT05008835|587749171|FG002|Overall Study|Not further specified|1|||
162737549|NCT04876118|587749172|FG000|Overall Study|Pregnancy|1|||
162737550|NCT04876118|587749172|FG000|Overall Study|Withdrawal by Subject|14|||
162737551|NCT04593472|587751490|FG000|Overall Study|Death|31|||
162737552|NCT04593472|587751491|FG001|Overall Study|Death|27|||
162737553|NCT04593472|587751490|FG000|Overall Study|Withdrawal by Subject|12|||
162737554|NCT04593472|587751491|FG001|Overall Study|Withdrawal by Subject|12|||
162737555|NCT04593472|587751490|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
162737556|NCT04593472|587751491|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
162737557|NCT04593472|587751490|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
162737558|NCT04593472|587751491|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
162737559|NCT04593472|587751490|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
162737560|NCT04593472|587751491|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
162737561|NCT04593472|587751490|FG000|Overall Study|Lost to Follow-up|0|||
162737562|NCT04593472|587751491|FG001|Overall Study|Lost to Follow-up|2|||
162737563|NCT04593472|587751490|FG000|Overall Study|Still collecting 24-month assessment|17|||
162737564|NCT04593472|587751491|FG001|Overall Study|Still collecting 24-month assessment|10|||
162737565|NCT02671903|587751499|FG000|Period 0 (Run-In)|Death|0|||
162737566|NCT02671903|587751500|FG001|Period 0 (Run-In)|Death|0|||
162737567|NCT02671903|587751501|FG002|Period 0 (Run-In)|Death|3|||
162737568|NCT02671903|587751499|FG000|Period 0 (Run-In)|Physician Decision|0|||
162737569|NCT02671903|587751500|FG001|Period 0 (Run-In)|Physician Decision|0|||
162737570|NCT02671903|587751501|FG002|Period 0 (Run-In)|Physician Decision|4|||
162737571|NCT02671903|587751499|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
162737572|NCT02671903|587751500|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
162737573|NCT02671903|587751501|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
162737574|NCT02671903|587751499|FG000|Period 0 (Run-In)|Protocol Violation|0|||
162737575|NCT02671903|587751500|FG001|Period 0 (Run-In)|Protocol Violation|0|||
162737576|NCT02671903|587751501|FG002|Period 0 (Run-In)|Protocol Violation|1|||
162737577|NCT02671903|587751499|FG000|Period 0 (Run-In)|Adverse Event|0|||
162737578|NCT02671903|587751500|FG001|Period 0 (Run-In)|Adverse Event|0|||
162737579|NCT02671903|587751501|FG002|Period 0 (Run-In)|Adverse Event|1|||
162737580|NCT02671903|587751499|FG000|Period 0 (Run-In)|Implantation Failure|0|||
162737581|NCT02671903|587751500|FG001|Period 0 (Run-In)|Implantation Failure|0|||
162737582|NCT02671903|587751501|FG002|Period 0 (Run-In)|Implantation Failure|2|||
162737583|NCT02671903|587751499|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
162737584|NCT02671903|587751500|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
162737585|NCT02671903|587751501|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
162737586|NCT04806594|587751502|FG000|Overall Study|Withdrawal by Subject|2|||
162737587|NCT04806594|587751502|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
162737588|NCT04390048|587751503|FG000|Overall Study|Withdrawal by Subject|1|||
162737589|NCT04390048|587751504|FG001|Overall Study|Withdrawal by Subject|3|||
162737590|NCT05215314|587751505|FG000|Overall Study|Lost to Follow-up|2|||
162737591|NCT05215314|587751506|FG001|Overall Study|Lost to Follow-up|2|||
162737592|NCT05215314|587751505|FG000|Overall Study|Withdrawal by Subject|2|||
162737593|NCT05215314|587751506|FG001|Overall Study|Withdrawal by Subject|0|||
162737594|NCT05215314|587751505|FG000|Overall Study|Physician Decision|1|||
162737595|NCT05215314|587751506|FG001|Overall Study|Physician Decision|0|||
162737596|NCT04179500|587751507|FG000|Treatment|Withdrawal by Subject|1|||
162737597|NCT04179500|587751507|FG000|Treatment|Adverse Event|2|||
162737598|NCT04179500|587751507|FG000|Treatment|pyrazinamide resistance|1|||
162737599|NCT03138512|587751508|FG000|Randomization|Participants withdrew consent|0|||
162737600|NCT03138512|587751509|FG001|Randomization|Participants withdrew consent|1|||
162737601|NCT03138512|587751510|FG002|Randomization|Participants withdrew consent|1|||
162737602|NCT03138512|587751511|FG003|Randomization|Participants withdrew consent|0|||
162737603|NCT03138512|587751512|FG004|Randomization|Participants withdrew consent|0|||
162737604|NCT03138512|587751508|FG000|Randomization|Participant no longer meets study criteria|0|||
162737605|NCT03138512|587751509|FG001|Randomization|Participant no longer meets study criteria|3|||
162737606|NCT03138512|587751510|FG002|Randomization|Participant no longer meets study criteria|1|||
162737607|NCT03138512|587751511|FG003|Randomization|Participant no longer meets study criteria|1|||
162737608|NCT03138512|587751512|FG004|Randomization|Participant no longer meets study criteria|3|||
162737609|NCT03138512|587751508|FG000|Randomization|Other reasons|1|||
162737610|NCT03138512|587751509|FG001|Randomization|Other reasons|0|||
162737611|NCT03138512|587751510|FG002|Randomization|Other reasons|0|||
162737612|NCT03138512|587751511|FG003|Randomization|Other reasons|0|||
162737613|NCT03138512|587751512|FG004|Randomization|Other reasons|0|||
162737614|NCT03138512|587751508|FG000|Treatment Part A|Disease recurrence|10|||
162737615|NCT03138512|587751509|FG001|Treatment Part A|Disease recurrence|20|||
162737616|NCT03138512|587751510|FG002|Treatment Part A|Disease recurrence|0|||
162737617|NCT03138512|587751511|FG003|Treatment Part A|Disease recurrence|0|||
162737618|NCT03138512|587751512|FG004|Treatment Part A|Disease recurrence|0|||
162737619|NCT03138512|587751508|FG000|Treatment Part A|Study Drug Toxicity|132|||
162737620|NCT03138512|587751509|FG001|Treatment Part A|Study Drug Toxicity|5|||
162737621|NCT03138512|587751510|FG002|Treatment Part A|Study Drug Toxicity|0|||
162737622|NCT03138512|587751511|FG003|Treatment Part A|Study Drug Toxicity|0|||
162737623|NCT03138512|587751512|FG004|Treatment Part A|Study Drug Toxicity|0|||
162737624|NCT03138512|587751508|FG000|Treatment Part A|Death|1|||
162737625|NCT03138512|587751509|FG001|Treatment Part A|Death|0|||
162737626|NCT03138512|587751510|FG002|Treatment Part A|Death|0|||
162737627|NCT03138512|587751511|FG003|Treatment Part A|Death|0|||
162737628|NCT03138512|587751512|FG004|Treatment Part A|Death|0|||
162737629|NCT03138512|587751508|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
162737630|NCT03138512|587751509|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
162737631|NCT03138512|587751510|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
162737632|NCT03138512|587751511|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
162737633|NCT03138512|587751512|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
162737634|NCT03138512|587751508|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
162737635|NCT03138512|587751509|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
162737636|NCT03138512|587751510|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
162737637|NCT03138512|587751511|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
162737638|NCT03138512|587751512|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
162737639|NCT03138512|587751508|FG000|Treatment Part A|Participant withdrew consent|2|||
162737640|NCT03138512|587751509|FG001|Treatment Part A|Participant withdrew consent|4|||
162737641|NCT03138512|587751510|FG002|Treatment Part A|Participant withdrew consent|0|||
162737642|NCT03138512|587751511|FG003|Treatment Part A|Participant withdrew consent|0|||
162737643|NCT03138512|587751512|FG004|Treatment Part A|Participant withdrew consent|0|||
162737644|NCT03138512|587751508|FG000|Treatment Part A|Lost to Follow-up|0|||
162737645|NCT03138512|587751509|FG001|Treatment Part A|Lost to Follow-up|1|||
162737646|NCT03138512|587751510|FG002|Treatment Part A|Lost to Follow-up|0|||
162737647|NCT03138512|587751511|FG003|Treatment Part A|Lost to Follow-up|0|||
162737648|NCT03138512|587751512|FG004|Treatment Part A|Lost to Follow-up|0|||
162737649|NCT03138512|587751508|FG000|Treatment Part A|Poor/non-compliance|1|||
162737650|NCT03138512|587751509|FG001|Treatment Part A|Poor/non-compliance|0|||
162737651|NCT03138512|587751510|FG002|Treatment Part A|Poor/non-compliance|0|||
162737652|NCT03138512|587751511|FG003|Treatment Part A|Poor/non-compliance|0|||
162737653|NCT03138512|587751512|FG004|Treatment Part A|Poor/non-compliance|0|||
162737654|NCT03138512|587751508|FG000|Treatment Part A|Pregnancy|0|||
162737655|NCT03138512|587751509|FG001|Treatment Part A|Pregnancy|1|||
162737656|NCT03138512|587751510|FG002|Treatment Part A|Pregnancy|0|||
162737657|NCT03138512|587751511|FG003|Treatment Part A|Pregnancy|0|||
162737658|NCT03138512|587751512|FG004|Treatment Part A|Pregnancy|0|||
162737659|NCT03138512|587751508|FG000|Treatment Part A|Other reasons|11|||
162737660|NCT03138512|587751509|FG001|Treatment Part A|Other reasons|8|||
162737661|NCT03138512|587751510|FG002|Treatment Part A|Other reasons|0|||
162737662|NCT03138512|587751511|FG003|Treatment Part A|Other reasons|0|||
162737663|NCT03138512|587751512|FG004|Treatment Part A|Other reasons|0|||
162737664|NCT03138512|587751508|FG000|Treatment Part B|Disease recurrence|0|||
162737665|NCT03138512|587751509|FG001|Treatment Part B|Disease recurrence|0|||
162737666|NCT03138512|587751510|FG002|Treatment Part B|Disease recurrence|6|||
162737667|NCT03138512|587751511|FG003|Treatment Part B|Disease recurrence|12|||
162737668|NCT03138512|587751512|FG004|Treatment Part B|Disease recurrence|10|||
162737669|NCT03138512|587751508|FG000|Treatment Part B|Study drug toxicity|0|||
162737670|NCT03138512|587751509|FG001|Treatment Part B|Study drug toxicity|0|||
162737671|NCT03138512|587751510|FG002|Treatment Part B|Study drug toxicity|63|||
162925342|NCT00602641|588428937|FG001|Overall Study|Other Complicating Disease|2|||
162737672|NCT03138512|587751511|FG003|Treatment Part B|Study drug toxicity|3|||
162737673|NCT03138512|587751512|FG004|Treatment Part B|Study drug toxicity|45|||
162737674|NCT03138512|587751508|FG000|Treatment Part B|Death|0|||
162737675|NCT03138512|587751509|FG001|Treatment Part B|Death|0|||
162737676|NCT03138512|587751510|FG002|Treatment Part B|Death|1|||
162737677|NCT03138512|587751511|FG003|Treatment Part B|Death|0|||
162737678|NCT03138512|587751512|FG004|Treatment Part B|Death|0|||
162737679|NCT03138512|587751508|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
162737680|NCT03138512|587751509|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
162737681|NCT03138512|587751510|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
162737682|NCT03138512|587751511|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
162737683|NCT03138512|587751512|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
162737684|NCT03138512|587751508|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
162737685|NCT03138512|587751509|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
162737686|NCT03138512|587751510|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
162737687|NCT03138512|587751511|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
162737688|NCT03138512|587751512|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
162737689|NCT03138512|587751508|FG000|Treatment Part B|Participant withdrew consent|0|||
162737690|NCT03138512|587751509|FG001|Treatment Part B|Participant withdrew consent|0|||
162737691|NCT03138512|587751510|FG002|Treatment Part B|Participant withdrew consent|1|||
162737692|NCT03138512|587751511|FG003|Treatment Part B|Participant withdrew consent|1|||
162737693|NCT03138512|587751512|FG004|Treatment Part B|Participant withdrew consent|2|||
162737694|NCT03138512|587751508|FG000|Treatment Part B|Lost to Follow-up|0|||
162737695|NCT03138512|587751509|FG001|Treatment Part B|Lost to Follow-up|0|||
162737696|NCT03138512|587751510|FG002|Treatment Part B|Lost to Follow-up|0|||
162737697|NCT03138512|587751511|FG003|Treatment Part B|Lost to Follow-up|1|||
162737698|NCT03138512|587751512|FG004|Treatment Part B|Lost to Follow-up|0|||
162737699|NCT03138512|587751508|FG000|Treatment Part B|Poor/non-compliance|0|||
162737700|NCT03138512|587751509|FG001|Treatment Part B|Poor/non-compliance|0|||
162737701|NCT03138512|587751510|FG002|Treatment Part B|Poor/non-compliance|1|||
162737702|NCT03138512|587751511|FG003|Treatment Part B|Poor/non-compliance|1|||
162737703|NCT03138512|587751512|FG004|Treatment Part B|Poor/non-compliance|1|||
162737704|NCT03138512|587751508|FG000|Treatment Part B|Other reasons|0|||
162737705|NCT03138512|587751509|FG001|Treatment Part B|Other reasons|0|||
162737706|NCT03138512|587751510|FG002|Treatment Part B|Other reasons|3|||
162737707|NCT03138512|587751511|FG003|Treatment Part B|Other reasons|1|||
162737708|NCT03138512|587751512|FG004|Treatment Part B|Other reasons|5|||
162737709|NCT03673111|587751519|FG000|Overall Study|Protocol Violation|0|||
162737710|NCT03673111|587751520|FG001|Overall Study|Protocol Violation|0|||
162737711|NCT03673111|587751521|FG002|Overall Study|Protocol Violation|0|||
162737712|NCT03673111|587751522|FG003|Overall Study|Protocol Violation|0|||
162737713|NCT03673111|587751523|FG004|Overall Study|Protocol Violation|0|||
162737714|NCT03673111|587751524|FG005|Overall Study|Protocol Violation|0|||
162737715|NCT03673111|587751525|FG006|Overall Study|Protocol Violation|0|||
162737716|NCT03673111|587751526|FG007|Overall Study|Protocol Violation|0|||
162737717|NCT03673111|587751527|FG008|Overall Study|Protocol Violation|0|||
162737718|NCT03673111|587751528|FG009|Overall Study|Protocol Violation|0|||
162737719|NCT03673111|587751529|FG010|Overall Study|Protocol Violation|1|||
162737720|NCT03673111|587751530|FG011|Overall Study|Protocol Violation|0|||
162737721|NCT03673111|587751531|FG012|Overall Study|Protocol Violation|0|||
162737722|NCT03673111|587751532|FG013|Overall Study|Protocol Violation|0|||
162737723|NCT03673111|587751519|FG000|Overall Study|Adverse Event|1|||
162737724|NCT03673111|587751520|FG001|Overall Study|Adverse Event|0|||
162737725|NCT03673111|587751521|FG002|Overall Study|Adverse Event|0|||
162737726|NCT03673111|587751522|FG003|Overall Study|Adverse Event|0|||
162737727|NCT03673111|587751523|FG004|Overall Study|Adverse Event|0|||
162737728|NCT03673111|587751524|FG005|Overall Study|Adverse Event|0|||
162737729|NCT03673111|587751525|FG006|Overall Study|Adverse Event|0|||
162737730|NCT03673111|587751526|FG007|Overall Study|Adverse Event|0|||
162737731|NCT03673111|587751527|FG008|Overall Study|Adverse Event|0|||
162737732|NCT03673111|587751528|FG009|Overall Study|Adverse Event|0|||
162737733|NCT03673111|587751529|FG010|Overall Study|Adverse Event|0|||
162737734|NCT03673111|587751530|FG011|Overall Study|Adverse Event|0|||
162737735|NCT03673111|587751531|FG012|Overall Study|Adverse Event|0|||
162737736|NCT03673111|587751532|FG013|Overall Study|Adverse Event|0|||
162737737|NCT03792555|587751538|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
162737738|NCT03792555|587751539|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
162737739|NCT03792555|587751540|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
162737740|NCT03792555|587751538|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
162737741|NCT03792555|587751539|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
162737742|NCT03792555|587751540|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
162737743|NCT03792555|587751538|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
162737744|NCT03792555|587751539|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
162737745|NCT03792555|587751540|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
162737746|NCT04485039|587751544|FG000|TPOXX Only|Adverse Event|2|||
162737747|NCT04485039|587751544|FG000|TPOXX Only|Physician Decision|1|||
162737748|NCT04485039|587751544|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
162737749|NCT04485039|587751544|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
162737750|NCT04005716|587751548|FG000|Overall Study|Death|175|||
162737751|NCT04005716|587751549|FG001|Overall Study|Death|196|||
162737752|NCT04005716|587751548|FG000|Overall Study|Withdrawal by Subject|1|||
162737753|NCT04005716|587751549|FG001|Overall Study|Withdrawal by Subject|6|||
162737754|NCT04005716|587751548|FG000|Overall Study|Lost to Follow-up|2|||
162737755|NCT04005716|587751549|FG001|Overall Study|Lost to Follow-up|2|||
162737756|NCT02783300|587751550|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737757|NCT02783300|587751551|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737758|NCT02783300|587751552|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737759|NCT02783300|587751553|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737760|NCT02783300|587751554|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737761|NCT02783300|587751555|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737762|NCT02783300|587751556|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
162737763|NCT02783300|587751557|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737764|NCT02783300|587751558|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737765|NCT02783300|587751559|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737766|NCT02783300|587751560|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737767|NCT02783300|587751561|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737768|NCT02783300|587751562|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737769|NCT02783300|587751563|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737770|NCT02783300|587751564|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737771|NCT02783300|587751565|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737772|NCT02783300|587751566|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737773|NCT02783300|587751567|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737774|NCT02783300|587751568|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737775|NCT02783300|587751569|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737776|NCT02783300|587751570|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737777|NCT02783300|587751571|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737778|NCT02783300|587751572|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737779|NCT02783300|587751573|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737780|NCT02783300|587751574|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737781|NCT02783300|587751575|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737782|NCT02783300|587751576|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162737783|NCT02783300|587751550|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737784|NCT02783300|587751551|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737785|NCT02783300|587751552|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737786|NCT02783300|587751553|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
162737787|NCT02783300|587751554|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737788|NCT02783300|587751555|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737789|NCT02783300|587751556|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737790|NCT02783300|587751557|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737791|NCT02783300|587751558|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737792|NCT02783300|587751559|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737793|NCT02783300|587751560|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737794|NCT02783300|587751561|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737795|NCT02783300|587751562|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737796|NCT02783300|587751563|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737797|NCT02783300|587751564|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737798|NCT02783300|587751565|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737799|NCT02783300|587751566|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737800|NCT02783300|587751567|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737801|NCT02783300|587751568|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737802|NCT02783300|587751569|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737803|NCT02783300|587751570|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737804|NCT02783300|587751571|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737805|NCT02783300|587751572|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737806|NCT02783300|587751573|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737807|NCT02783300|587751574|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737808|NCT02783300|587751575|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737809|NCT02783300|587751576|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162737810|NCT02783300|587751550|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
162737811|NCT02783300|587751551|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
162737812|NCT02783300|587751552|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
162737813|NCT02783300|587751553|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
162737814|NCT02783300|587751554|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
162737815|NCT02783300|587751555|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
162737816|NCT02783300|587751556|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
162737817|NCT02783300|587751557|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
162737818|NCT02783300|587751558|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
162737819|NCT02783300|587751559|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
162737820|NCT02783300|587751560|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
162737821|NCT02783300|587751561|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
162737822|NCT02783300|587751562|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
162737823|NCT02783300|587751563|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
162737824|NCT02783300|587751564|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
162737825|NCT02783300|587751565|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
162737826|NCT02783300|587751566|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
162737827|NCT02783300|587751567|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
162737828|NCT02783300|587751568|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
162737829|NCT02783300|587751569|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
162737830|NCT02783300|587751570|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
162737831|NCT02783300|587751571|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
162737832|NCT02783300|587751572|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
162737833|NCT02783300|587751573|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
162737834|NCT02783300|587751574|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
162737835|NCT02783300|587751575|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
162737836|NCT02783300|587751576|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
162737837|NCT02783300|587751550|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737838|NCT02783300|587751551|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737839|NCT02783300|587751552|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737840|NCT02783300|587751553|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737841|NCT02783300|587751554|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737842|NCT02783300|587751555|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737843|NCT02783300|587751556|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
162737844|NCT02783300|587751557|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737845|NCT02783300|587751558|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737846|NCT02783300|587751559|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737847|NCT02783300|587751560|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737848|NCT02783300|587751561|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737849|NCT02783300|587751562|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
162737850|NCT02783300|587751563|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737851|NCT02783300|587751564|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737852|NCT02783300|587751565|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737853|NCT02783300|587751566|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737854|NCT02783300|587751567|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737855|NCT02783300|587751568|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737856|NCT02783300|587751569|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737857|NCT02783300|587751570|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737858|NCT02783300|587751571|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737859|NCT02783300|587751572|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737860|NCT02783300|587751573|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737861|NCT02783300|587751574|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737862|NCT02783300|587751575|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737863|NCT02783300|587751576|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162737864|NCT02783300|587751550|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737865|NCT02783300|587751551|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737866|NCT02783300|587751552|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737867|NCT02783300|587751553|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737868|NCT02783300|587751554|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162737869|NCT02783300|587751555|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737870|NCT02783300|587751556|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162737871|NCT02783300|587751557|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737872|NCT02783300|587751558|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737873|NCT02783300|587751559|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162737874|NCT02783300|587751560|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737875|NCT02783300|587751561|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737876|NCT02783300|587751562|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
162737877|NCT02783300|587751563|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737878|NCT02783300|587751564|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737879|NCT02783300|587751565|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737880|NCT02783300|587751566|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737881|NCT02783300|587751567|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737882|NCT02783300|587751568|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737883|NCT02783300|587751569|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737884|NCT02783300|587751570|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737885|NCT02783300|587751571|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737886|NCT02783300|587751572|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737887|NCT02783300|587751573|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737888|NCT02783300|587751574|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737889|NCT02783300|587751575|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737890|NCT02783300|587751576|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162737891|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737892|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737893|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737894|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737895|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737896|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737897|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737898|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737899|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737900|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737901|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737902|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737903|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737904|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737905|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737906|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162737907|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737908|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
162737909|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
162737910|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162737911|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737912|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737913|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737914|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737915|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162737916|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737917|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162737918|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737919|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737920|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737921|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737922|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737923|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737924|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737925|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737926|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737927|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737928|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737929|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737930|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737931|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737932|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737933|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737934|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
162737935|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737936|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
162737937|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
162737938|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737939|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737940|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737941|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737942|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737943|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737944|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162737945|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737946|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737947|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737948|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737949|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737950|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737951|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737952|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737953|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737954|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737955|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737956|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737957|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737958|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737959|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737960|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737961|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162737962|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737963|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162737964|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
162737965|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162737966|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737967|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737968|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737969|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737970|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737971|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162737972|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737973|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737974|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737975|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737976|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737977|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737978|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737979|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737980|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737981|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737982|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737983|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737984|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737985|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737986|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737987|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
162737988|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737989|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737990|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737991|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737992|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737993|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737994|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
162737995|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737996|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737997|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737998|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162737999|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738000|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738001|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738002|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738003|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738004|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738005|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738006|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738007|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738008|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738009|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738010|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738011|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738012|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
162738013|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
162738014|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
162738015|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
162738016|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738017|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
162738018|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
162738019|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738020|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738021|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738022|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738023|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738024|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738025|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162738026|NCT02783300|587751550|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738027|NCT02783300|587751551|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738028|NCT02783300|587751552|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738029|NCT02783300|587751553|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738030|NCT02783300|587751554|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738031|NCT02783300|587751555|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738032|NCT02783300|587751556|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738033|NCT02783300|587751557|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738034|NCT02783300|587751558|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738035|NCT02783300|587751559|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738036|NCT02783300|587751560|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738037|NCT02783300|587751561|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738038|NCT02783300|587751562|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738039|NCT02783300|587751563|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
162738040|NCT02783300|587751564|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162738041|NCT02783300|587751565|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162738042|NCT02783300|587751566|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162738043|NCT02783300|587751567|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162738044|NCT02783300|587751568|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162738045|NCT02783300|587751569|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
162738046|NCT02783300|587751570|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162738047|NCT02783300|587751571|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162738048|NCT02783300|587751572|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
162738049|NCT02783300|587751573|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162738050|NCT02783300|587751574|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162738051|NCT02783300|587751575|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
162738052|NCT02783300|587751576|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162738053|NCT02783300|587751550|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738054|NCT02783300|587751551|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738055|NCT02783300|587751552|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738056|NCT02783300|587751553|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738057|NCT02783300|587751554|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738058|NCT02783300|587751555|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738059|NCT02783300|587751556|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738060|NCT02783300|587751557|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738061|NCT02783300|587751558|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738062|NCT02783300|587751559|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738063|NCT02783300|587751560|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738064|NCT02783300|587751561|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738065|NCT02783300|587751562|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738066|NCT02783300|587751563|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738067|NCT02783300|587751564|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738068|NCT02783300|587751565|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738069|NCT02783300|587751566|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738070|NCT02783300|587751567|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738071|NCT02783300|587751568|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738072|NCT02783300|587751569|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738073|NCT02783300|587751570|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738074|NCT02783300|587751571|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738075|NCT02783300|587751572|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738076|NCT02783300|587751573|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738077|NCT02783300|587751574|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738078|NCT02783300|587751575|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162738079|NCT02783300|587751576|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
162738080|NCT02783300|587751550|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738081|NCT02783300|587751551|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738082|NCT02783300|587751552|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738083|NCT02783300|587751553|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738084|NCT02783300|587751554|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738085|NCT02783300|587751555|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738086|NCT02783300|587751556|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738087|NCT02783300|587751557|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738088|NCT02783300|587751558|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738089|NCT02783300|587751559|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738090|NCT02783300|587751560|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738091|NCT02783300|587751561|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738092|NCT02783300|587751562|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738093|NCT02783300|587751563|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738094|NCT02783300|587751564|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738095|NCT02783300|587751565|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738096|NCT02783300|587751566|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738097|NCT02783300|587751567|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738098|NCT02783300|587751568|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738099|NCT02783300|587751569|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738100|NCT02783300|587751570|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738101|NCT02783300|587751571|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738102|NCT02783300|587751572|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738103|NCT02783300|587751573|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738104|NCT02783300|587751574|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738105|NCT02783300|587751575|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
162738106|NCT02783300|587751576|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
162738107|NCT03535272|587751577|FG000|Overall Study|Lost to Follow-up|71|||
162738108|NCT03535272|587751578|FG001|Overall Study|Lost to Follow-up|73|||
162738109|NCT01744782|587751579|FG000|Overall Study|Death|1|||
162738110|NCT00378105|587751581|FG000|Overall Study|Adverse Event|3|||
162738111|NCT00378105|587751582|FG001|Overall Study|Adverse Event|1|||
162738112|NCT00378105|587751581|FG000|Overall Study|Withdrawal by Subject|3|||
162738113|NCT00378105|587751582|FG001|Overall Study|Withdrawal by Subject|3|||
162738114|NCT00378105|587751581|FG000|Overall Study|Death|1|||
162738115|NCT00378105|587751582|FG001|Overall Study|Death|0|||
162738116|NCT00378105|587751581|FG000|Overall Study|Going to transplant|7|||
162738117|NCT00378105|587751582|FG001|Overall Study|Going to transplant|8|||
162738118|NCT00378105|587751581|FG000|Overall Study|Progressive disease|3|||
162738119|NCT00378105|587751582|FG001|Overall Study|Progressive disease|3|||
162738120|NCT00378105|587751581|FG000|Overall Study|remain on study|3|||
162738121|NCT00378105|587751582|FG001|Overall Study|remain on study|11|||
162738122|NCT00378105|587751581|FG000|Overall Study|Physician Decision|0|||
162738123|NCT00378105|587751582|FG001|Overall Study|Physician Decision|2|||
162738124|NCT00378105|587751581|FG000|Overall Study|Going non-protocol therapy|0|||
162738125|NCT00378105|587751582|FG001|Overall Study|Going non-protocol therapy|1|||
162738126|NCT00378105|587751581|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
162738127|NCT00378105|587751582|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
162738128|NCT02120456|587751583|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738129|NCT02120456|587751584|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738130|NCT02120456|587751585|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738131|NCT02120456|587751586|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738132|NCT02120456|587751587|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738133|NCT02120456|587751588|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738134|NCT02120456|587751589|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
162738135|NCT02120456|587751590|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738136|NCT02120456|587751591|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162738137|NCT02120456|587751583|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738138|NCT02120456|587751584|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738139|NCT02120456|587751585|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738140|NCT02120456|587751586|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738141|NCT02120456|587751587|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738142|NCT02120456|587751588|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738143|NCT02120456|587751589|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
162738144|NCT02120456|587751590|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738145|NCT02120456|587751591|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162738146|NCT02120456|587751583|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738147|NCT02120456|587751584|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738148|NCT02120456|587751585|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738149|NCT02120456|587751586|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738150|NCT02120456|587751587|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738151|NCT02120456|587751588|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738152|NCT02120456|587751589|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738153|NCT02120456|587751590|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162738154|NCT02120456|587751591|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
162738155|NCT05192200|587751592|FG000|Treatment Period|Other|1|||
162738156|NCT05192200|587751592|FG000|Treatment Period|Lack of Efficacy|1|||
162738157|NCT05192200|587751592|FG000|Treatment Period|Withdrawal by Subject|1|||
162738158|NCT05192200|587751592|FG000|Follow-up|Withdrawal by Subject|1|||
162738159|NCT03623321|587751593|FG000|Overall Study|Adverse Event|32|||
162738160|NCT03623321|587751593|FG000|Overall Study|Death|9|||
162738161|NCT03623321|587751593|FG000|Overall Study|Lack of Efficacy|9|||
162738162|NCT03623321|587751593|FG000|Overall Study|Lost to Follow-up|6|||
162738163|NCT03623321|587751593|FG000|Overall Study|Noncompliance with study drug|6|||
162738164|NCT03623321|587751593|FG000|Overall Study|Use of prohibited medication|3|||
162738165|NCT03623321|587751593|FG000|Overall Study|Physician Decision|5|||
162738166|NCT03623321|587751593|FG000|Overall Study|Protocol Violation|1|||
162738167|NCT03623321|587751593|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
162738168|NCT03623321|587751593|FG000|Overall Study|Not further specified|43|||
162738169|NCT03443323|587751598|FG000|Overall Study|Lost to Follow-up|2|||
162738170|NCT03443323|587751599|FG001|Overall Study|Lost to Follow-up|2|||
162738171|NCT03443323|587751598|FG000|Overall Study|PI withdrawal|1|||
162738172|NCT03443323|587751599|FG001|Overall Study|PI withdrawal|0|||
162738173|NCT04492007|587751603|FG000|Overall Study|Lost to Follow-up|1|||
162738174|NCT04492007|587751604|FG001|Overall Study|Lost to Follow-up|1|||
162738175|NCT04492007|587751605|FG002|Overall Study|Lost to Follow-up|2|||
162738176|NCT04492007|587751606|FG003|Overall Study|Lost to Follow-up|2|||
162738177|NCT04492007|587751603|FG000|Overall Study|Protocol Violation|1|||
162738178|NCT04492007|587751604|FG001|Overall Study|Protocol Violation|1|||
162738179|NCT04492007|587751605|FG002|Overall Study|Protocol Violation|1|||
162738180|NCT04492007|587751606|FG003|Overall Study|Protocol Violation|1|||
162738181|NCT04492007|587751603|FG000|Overall Study|Withdrawal by Subject|0|||
162738182|NCT04492007|587751604|FG001|Overall Study|Withdrawal by Subject|0|||
162738183|NCT04492007|587751605|FG002|Overall Study|Withdrawal by Subject|1|||
162738184|NCT04492007|587751606|FG003|Overall Study|Withdrawal by Subject|1|||
162738185|NCT03770273|587751609|FG000|Overall Study|Adverse Event|2|||
162738186|NCT03770273|587751610|FG001|Overall Study|Adverse Event|0|||
162738187|NCT03770273|587751609|FG000|Overall Study|Lost to Follow-up|1|||
162738188|NCT03770273|587751610|FG001|Overall Study|Lost to Follow-up|1|||
162738189|NCT00418886|587751611|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
162738190|NCT00418886|587751612|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
162738191|NCT00418886|587751611|FG000|Randomized Period|Death|122|||
162738192|NCT00418886|587751612|FG001|Randomized Period|Death|147|||
162738193|NCT00418886|587751611|FG000|Randomized Period|Withdrawal by Subject|9|||
162738194|NCT00418886|587751612|FG001|Randomized Period|Withdrawal by Subject|10|||
162738195|NCT00418886|587751611|FG000|Randomized Period|Lost to Follow-up|4|||
162738196|NCT00418886|587751612|FG001|Randomized Period|Lost to Follow-up|6|||
162738197|NCT00418886|587751611|FG000|Randomized Period|withdrawn due to other reason|1|||
162738198|NCT00418886|587751612|FG001|Randomized Period|withdrawn due to other reason|0|||
162738199|NCT00418886|587751611|FG000|Randomized Period|randomised but no treatment received|0|||
162738200|NCT00418886|587751612|FG001|Randomized Period|randomised but no treatment received|1|||
162738201|NCT01999075|587751613|FG000|Overall Study|Lost to Follow-up|0|||
162738202|NCT01999075|587751614|FG001|Overall Study|Lost to Follow-up|2|||
162738203|NCT01999075|587751613|FG000|Overall Study|Withdrawal by Subject|2|||
162738204|NCT01999075|587751614|FG001|Overall Study|Withdrawal by Subject|7|||
162738205|NCT01999075|587751613|FG000|Overall Study|Enrolled in drug trial|3|||
162738206|NCT01999075|587751614|FG001|Overall Study|Enrolled in drug trial|1|||
162738207|NCT01999075|587751613|FG000|Overall Study|Became ineligible|0|||
162738208|NCT01999075|587751614|FG001|Overall Study|Became ineligible|2|||
162738209|NCT03907397|587751617|FG000|Overall Study|Lost to Follow-up|0|||
162738210|NCT03907397|587751618|FG001|Overall Study|Lost to Follow-up|1|||
162738211|NCT03907397|587751617|FG000|Overall Study|Physician Decision|2|||
162738212|NCT03907397|587751618|FG001|Overall Study|Physician Decision|1|||
162738213|NCT03907397|587751617|FG000|Overall Study|Withdrawal by Subject|5|||
162738214|NCT03907397|587751618|FG001|Overall Study|Withdrawal by Subject|4|||
162738215|NCT03907397|587751617|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
162738216|NCT03907397|587751618|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
162738217|NCT05948670|587751626|FG000|Overall Study|Protocol Violation|6|||
162925343|NCT00602641|588428936|FG000|Overall Study|Physician Decision|5|||
162925344|NCT00602641|588428937|FG001|Overall Study|Physician Decision|4|||
162738218|NCT05948670|587751627|FG001|Overall Study|Protocol Violation|8|||
162738219|NCT05948670|587751626|FG000|Overall Study|Withdrawal by Subject|0|||
162738220|NCT05948670|587751627|FG001|Overall Study|Withdrawal by Subject|1|||
162738221|NCT03056040|587751629|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
162738222|NCT03056040|587751630|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
162738223|NCT03056040|587751629|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
162738224|NCT03056040|587751630|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
162738225|NCT03056040|587751629|FG000|Primary Evaluation Period|Pregnancy|0|||
162738226|NCT03056040|587751630|FG001|Primary Evaluation Period|Pregnancy|1|||
162738227|NCT03056040|587751629|FG000|Primary Evaluation Period|Randomized, not treated|1|||
162738228|NCT03056040|587751630|FG001|Primary Evaluation Period|Randomized, not treated|1|||
162738229|NCT03056040|587751629|FG000|Extension Period|Physician Decision|3|||
162738230|NCT03056040|587751630|FG001|Extension Period|Physician Decision|3|||
162738231|NCT03056040|587751629|FG000|Extension Period|Lost to Follow-up|0|||
162738232|NCT03056040|587751630|FG001|Extension Period|Lost to Follow-up|1|||
162738233|NCT03056040|587751629|FG000|Extension Period|Death|0|||
162738234|NCT03056040|587751630|FG001|Extension Period|Death|3|||
162738235|NCT03056040|587751629|FG000|Extension Period|Withdrawal by Subject|1|||
162738236|NCT03056040|587751630|FG001|Extension Period|Withdrawal by Subject|0|||
162738237|NCT04142788|587751631|FG000|Overall Study|Trial terminated prematurely|2|||
162738238|NCT04142788|587751632|FG001|Overall Study|Trial terminated prematurely|2|||
162738239|NCT05028634|587751636|FG000|Overall Study|Withdrawal by Subject|0|||
162738240|NCT05028634|587751637|FG001|Overall Study|Withdrawal by Subject|1|||
162738241|NCT01997840|587751638|FG000|Overall Study|Lost to Follow-up|0|||
162738242|NCT01997840|587751639|FG001|Overall Study|Lost to Follow-up|0|||
162738243|NCT01997840|587751640|FG002|Overall Study|Lost to Follow-up|1|||
162738244|NCT01997840|587751641|FG003|Overall Study|Lost to Follow-up|0|||
162738245|NCT01997840|587751638|FG000|Overall Study|Withdrawal by participant|0|||
162738246|NCT01997840|587751639|FG001|Overall Study|Withdrawal by participant|0|||
162738247|NCT01997840|587751640|FG002|Overall Study|Withdrawal by participant|8|||
162738248|NCT01997840|587751641|FG003|Overall Study|Withdrawal by participant|1|||
162738249|NCT01997840|587751638|FG000|Overall Study|Physician Decision|0|||
162738250|NCT01997840|587751639|FG001|Overall Study|Physician Decision|0|||
162738251|NCT01997840|587751640|FG002|Overall Study|Physician Decision|3|||
162738252|NCT01997840|587751641|FG003|Overall Study|Physician Decision|0|||
162738253|NCT01997840|587751638|FG000|Overall Study|Progressive disease|3|||
162738254|NCT01997840|587751639|FG001|Overall Study|Progressive disease|4|||
162738255|NCT01997840|587751640|FG002|Overall Study|Progressive disease|57|||
162738256|NCT01997840|587751641|FG003|Overall Study|Progressive disease|8|||
162738257|NCT01997840|587751638|FG000|Overall Study|Other reasons|0|||
162738258|NCT01997840|587751639|FG001|Overall Study|Other reasons|0|||
162738259|NCT01997840|587751640|FG002|Overall Study|Other reasons|1|||
162738260|NCT01997840|587751641|FG003|Overall Study|Other reasons|0|||
162738261|NCT01997840|587751638|FG000|Overall Study|Adverse Event|0|||
162738262|NCT01997840|587751639|FG001|Overall Study|Adverse Event|0|||
162738263|NCT01997840|587751640|FG002|Overall Study|Adverse Event|15|||
162738264|NCT01997840|587751641|FG003|Overall Study|Adverse Event|2|||
162738265|NCT03850678|587751642|FG000|Overall Study|Withdrawal by Subject|3|||
162738266|NCT03850678|587751643|FG001|Overall Study|Withdrawal by Subject|0|||
162738267|NCT03850678|587751642|FG000|Overall Study|Experimenter Error|1|||
162738268|NCT03850678|587751643|FG001|Overall Study|Experimenter Error|1|||
162738269|NCT03850678|587751642|FG000|Overall Study|Did Not Condition To Experiment|7|||
162738270|NCT03850678|587751643|FG001|Overall Study|Did Not Condition To Experiment|2|||
162738271|NCT05311384|587751654|FG000|Overall Study|Uncontrolled health conditions|2|||
162738272|NCT05311384|587751654|FG000|Overall Study|Withdrawal by Subject|1|||
162738273|NCT02724631|587751661|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
162738274|NCT05076708|587751662|FG000|Overall Study|Withdrawal by Subject|4|||
162738275|NCT05076708|587751662|FG000|Overall Study|Lost to study during switch phase|8|||
162738276|NCT02908477|587751663|FG000|Overall Study|Withdrawal by Subject|8|||
162738277|NCT02908477|587751664|FG001|Overall Study|Withdrawal by Subject|28|||
162738278|NCT05590403|587751667|FG000|Overall Study|Lost to Follow-up|13|||
162738279|NCT05590403|587751668|FG001|Overall Study|Lost to Follow-up|1|||
162738280|NCT05590403|587751669|FG002|Overall Study|Lost to Follow-up|7|||
162738281|NCT05590403|587751670|FG003|Overall Study|Lost to Follow-up|3|||
162738282|NCT05590403|587751671|FG004|Overall Study|Lost to Follow-up|4|||
162738283|NCT05590403|587751667|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
162738284|NCT05590403|587751668|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
162738285|NCT05590403|587751669|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
162738286|NCT05590403|587751670|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
162738287|NCT05590403|587751671|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
162738288|NCT05590403|587751667|FG000|Overall Study|Other|2|||
162738289|NCT05590403|587751668|FG001|Overall Study|Other|0|||
162738290|NCT05590403|587751669|FG002|Overall Study|Other|2|||
162738291|NCT05590403|587751670|FG003|Overall Study|Other|2|||
162738292|NCT05590403|587751671|FG004|Overall Study|Other|0|||
162738293|NCT05590403|587751667|FG000|Overall Study|Migrated / moved from the study area|1|||
162738294|NCT05590403|587751668|FG001|Overall Study|Migrated / moved from the study area|1|||
162738295|NCT05590403|587751669|FG002|Overall Study|Migrated / moved from the study area|0|||
162738296|NCT05590403|587751670|FG003|Overall Study|Migrated / moved from the study area|3|||
162738297|NCT05590403|587751671|FG004|Overall Study|Migrated / moved from the study area|1|||
162738298|NCT05590403|587751667|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
162738299|NCT05590403|587751668|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
162738300|NCT05590403|587751669|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
162738301|NCT05590403|587751670|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
162738302|NCT05590403|587751671|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
162738303|NCT04717492|587751674|FG000|Overall Study|Withdrawal by Subject|2|||
162738304|NCT04717492|587751675|FG001|Overall Study|Withdrawal by Subject|13|||
162738305|NCT04717492|587751674|FG000|Overall Study|Lost to Follow-up|2|||
162738306|NCT04717492|587751675|FG001|Overall Study|Lost to Follow-up|9|||
162738307|NCT03766009|587751679|FG000|Usual Care|Death|0|||
162738308|NCT03766009|587751680|FG001|Usual Care|Death|0|||
162738309|NCT03766009|587751681|FG002|Usual Care|Death|0|||
162738310|NCT03766009|587751682|FG003|Usual Care|Death|1|||
162738311|NCT03766009|587751683|FG004|Usual Care|Death|0|||
162738312|NCT03766009|587751684|FG005|Usual Care|Death|0|||
162738313|NCT03766009|587751679|FG000|Usual Care|Lost to Follow-up|0|||
162738314|NCT03766009|587751680|FG001|Usual Care|Lost to Follow-up|0|||
162738315|NCT03766009|587751681|FG002|Usual Care|Lost to Follow-up|0|||
162738316|NCT03766009|587751682|FG003|Usual Care|Lost to Follow-up|1|||
162738317|NCT03766009|587751683|FG004|Usual Care|Lost to Follow-up|0|||
162738318|NCT03766009|587751684|FG005|Usual Care|Lost to Follow-up|0|||
162738319|NCT03766009|587751679|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
162738320|NCT03766009|587751680|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
162738321|NCT03766009|587751681|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
162738322|NCT03766009|587751682|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
162738323|NCT03766009|587751683|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
162738324|NCT03766009|587751684|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
162738325|NCT03766009|587751679|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162738326|NCT03766009|587751680|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
162738327|NCT03766009|587751681|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162738328|NCT03766009|587751682|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
162738329|NCT03766009|587751683|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162738330|NCT03766009|587751684|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162738331|NCT03766009|587751679|FG000|Usual Care|No treatment or declined surgery|0|||
162738332|NCT03766009|587751680|FG001|Usual Care|No treatment or declined surgery|0|||
162738333|NCT03766009|587751681|FG002|Usual Care|No treatment or declined surgery|0|||
162738334|NCT03766009|587751682|FG003|Usual Care|No treatment or declined surgery|2|||
162738335|NCT03766009|587751683|FG004|Usual Care|No treatment or declined surgery|0|||
162738336|NCT03766009|587751684|FG005|Usual Care|No treatment or declined surgery|0|||
162738337|NCT03766009|587751679|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
162738338|NCT03766009|587751680|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
162738339|NCT03766009|587751681|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
162738340|NCT03766009|587751682|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
162738341|NCT03766009|587751683|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
162738342|NCT03766009|587751684|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
162738343|NCT03766009|587751679|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162738344|NCT03766009|587751680|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
162738345|NCT03766009|587751681|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162738346|NCT03766009|587751682|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162738347|NCT03766009|587751683|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162738348|NCT03766009|587751684|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162738349|NCT03766009|587751679|FG000|Usual Care|Ineligible|0|||
162738350|NCT03766009|587751680|FG001|Usual Care|Ineligible|1|||
162738351|NCT03766009|587751681|FG002|Usual Care|Ineligible|0|||
162738352|NCT03766009|587751682|FG003|Usual Care|Ineligible|0|||
162738353|NCT03766009|587751683|FG004|Usual Care|Ineligible|0|||
162738354|NCT03766009|587751684|FG005|Usual Care|Ineligible|0|||
162738355|NCT03766009|587751679|FG000|Usual Care|Other: Staff turnover|0|||
162738356|NCT03766009|587751680|FG001|Usual Care|Other: Staff turnover|0|||
162738357|NCT03766009|587751681|FG002|Usual Care|Other: Staff turnover|0|||
162738358|NCT03766009|587751682|FG003|Usual Care|Other: Staff turnover|0|||
162738359|NCT03766009|587751683|FG004|Usual Care|Other: Staff turnover|0|||
162738360|NCT03766009|587751684|FG005|Usual Care|Other: Staff turnover|2|||
162738361|NCT04952909|587751688|FG000|Overall Study|Death|3|||
162738362|NCT00881621|587751690|FG000|Overall Study|Physician Decision|34|||
162738363|NCT06393088|587751691|FG000|Overall Study|Withdrawal by Subject|0|||
162738364|NCT06393088|587751692|FG001|Overall Study|Withdrawal by Subject|2|||
162738365|NCT03903146|587751693|FG000|Overall Study|Lost to Follow-up|6|||
162738366|NCT03903146|587751694|FG001|Overall Study|Lost to Follow-up|4|||
162738367|NCT03903146|587751693|FG000|Overall Study|Withdrawal by Subject|0|||
162738368|NCT03903146|587751694|FG001|Overall Study|Withdrawal by Subject|1|||
162738369|NCT05179837|587751695|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
162738370|NCT05179837|587751695|FG000|Overall Study|Device malfunctioned|1|||
162738371|NCT05179837|587751695|FG000|Overall Study|Image quality too low|2|||
162738372|NCT03557697|587751696|FG000|Overall Study|Withdrawal by Subject|2|||
162738373|NCT03557697|587751697|FG001|Overall Study|Withdrawal by Subject|4|||
162738374|NCT04495894|587751701|FG000|Overall Study|Withdrawal by Subject|2|||
162738375|NCT04495894|587751702|FG001|Overall Study|Withdrawal by Subject|0|||
162738376|NCT04495894|587751703|FG002|Overall Study|Withdrawal by Subject|2|||
162738377|NCT04495894|587751704|FG003|Overall Study|Withdrawal by Subject|3|||
162738378|NCT04495894|587751701|FG000|Overall Study|Early termination|0|||
162738379|NCT04495894|587751702|FG001|Overall Study|Early termination|0|||
162738380|NCT04495894|587751703|FG002|Overall Study|Early termination|3|||
162738381|NCT04495894|587751704|FG003|Overall Study|Early termination|0|||
162738382|NCT01000961|587751705|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
162738383|NCT01000961|587751706|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162738384|NCT01000961|587751705|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
162738385|NCT01000961|587751706|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
162738386|NCT05089734|587751707|FG000|Overall Study|Still on study|122|||
162738387|NCT05089734|587751708|FG001|Overall Study|Still on study|101|||
162738388|NCT05089734|587751707|FG000|Overall Study|Death|161|||
162738389|NCT05089734|587751708|FG001|Overall Study|Death|179|||
162738390|NCT05089734|587751707|FG000|Overall Study|Withdrew consent|11|||
162738391|NCT05089734|587751708|FG001|Overall Study|Withdrew consent|24|||
162738392|NCT05089734|587751707|FG000|Overall Study|Lost to Follow-up|5|||
162738393|NCT05089734|587751708|FG001|Overall Study|Lost to Follow-up|0|||
162738394|NCT06283173|587753298|FG000|Overall Study|Did not show for first visit|10|||
162738395|NCT06283173|587753298|FG000|Overall Study|Lost to Follow-up|12|||
162738396|NCT06283173|587753298|FG000|Overall Study|Physician Decision|7|||
162738397|NCT03457142|587753301|FG000|Overall Study|Death|1|||
162738398|NCT04060654|587753302|FG000|Overall Study|Withdrawal by Subject|1|||
162738399|NCT04060654|587753302|FG000|Overall Study|Lost to Follow-up|5|||
162738400|NCT03707951|587753303|FG000|Overall Study|Lost to Follow-up|8|||
162738401|NCT03707951|587753304|FG001|Overall Study|Lost to Follow-up|17|||
162738402|NCT03707951|587753303|FG000|Overall Study|Withdrawal by Subject|6|||
162738403|NCT03707951|587753304|FG001|Overall Study|Withdrawal by Subject|6|||
162738404|NCT04887129|587753305|FG000|Overall Study|Lost to Follow-up|0|||
162738405|NCT04887129|587753306|FG001|Overall Study|Lost to Follow-up|24|||
162738406|NCT04887129|587753305|FG000|Overall Study|Withdrawal by Subject|9|||
162738407|NCT04887129|587753306|FG001|Overall Study|Withdrawal by Subject|57|||
162738408|NCT04887129|587753305|FG000|Overall Study|Other|2|||
162738409|NCT04887129|587753306|FG001|Overall Study|Other|9|||
162738410|NCT04533347|587753308|FG000|Overall Study|Adverse Event|1|||
162738411|NCT04533347|587753309|FG001|Overall Study|Adverse Event|2|||
162738412|NCT04533347|587753308|FG000|Overall Study|Lost to Follow-up|2|||
162738413|NCT04533347|587753309|FG001|Overall Study|Lost to Follow-up|0|||
162738414|NCT04533347|587753308|FG000|Overall Study|Withdrawal by Subject|1|||
162738415|NCT04533347|587753309|FG001|Overall Study|Withdrawal by Subject|0|||
162738416|NCT05520190|587753310|FG000|Overall Study|Lost to Follow-up|7|||
162738417|NCT05520190|587753310|FG000|Overall Study|Withdrawal by Subject|2|||
162738418|NCT04896476|587753316|FG000|Overall Study|Withdrawal by Subject|1|||
162738419|NCT04896476|587753316|FG000|Overall Study|Lost to Follow-up|2|||
162738420|NCT03476187|587753317|FG000|Overall Study|Protocol Violation|7|||
162738421|NCT03476187|587753317|FG000|Overall Study|Physician Decision|5|||
162738422|NCT02921230|587753318|FG000|Overall Study|Withdrawal by Subject|20|||
162738423|NCT02921230|587753319|FG001|Overall Study|Withdrawal by Subject|8|||
162738424|NCT02921230|587753318|FG000|Overall Study|Death|12|||
162738425|NCT02921230|587753319|FG001|Overall Study|Death|3|||
162738426|NCT02921230|587753318|FG000|Overall Study|Protocol Violation|17|||
162738427|NCT02921230|587753319|FG001|Overall Study|Protocol Violation|6|||
162738428|NCT02921230|587753318|FG000|Overall Study|Early completion|5|||
162738429|NCT02921230|587753319|FG001|Overall Study|Early completion|1|||
162738430|NCT02921230|587753318|FG000|Overall Study|Pending data entry|1|||
162738431|NCT02921230|587753319|FG001|Overall Study|Pending data entry|0|||
162738432|NCT04274764|587753320|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
162738433|NCT04274764|587753321|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
162738434|NCT05268393|587753326|FG000|Overall Study|Withdrawal by Subject|2|||
162738435|NCT05268393|587753327|FG001|Overall Study|Withdrawal by Subject|1|||
162738436|NCT03396926|587753328|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
162738437|NCT03396926|587753329|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
162738438|NCT02035787|587753330|FG000|Overall Study- 12 Months|Adverse Event|3|||
162738439|NCT02035787|587753331|FG001|Overall Study- 12 Months|Adverse Event|0|||
162738440|NCT02035787|587753330|FG000|Overall Study- 12 Months|Complete response|4|||
162738441|NCT02035787|587753331|FG001|Overall Study- 12 Months|Complete response|1|||
162738442|NCT02035787|587753330|FG000|Overall Study- 12 Months|Protocol Violation|1|||
162738443|NCT02035787|587753331|FG001|Overall Study- 12 Months|Protocol Violation|1|||
162738444|NCT01396278|587753333|FG000|Overall Study|Adverse Event|0|||
162738445|NCT01396278|587753334|FG001|Overall Study|Adverse Event|0|||
162738446|NCT01396278|587753335|FG002|Overall Study|Adverse Event|0|||
162738447|NCT01396278|587753336|FG003|Overall Study|Adverse Event|2|||
162738448|NCT01396278|587753337|FG004|Overall Study|Adverse Event|0|||
162738449|NCT01396278|587753333|FG000|Overall Study|Withdraw due to trial termination|2|||
162738450|NCT01396278|587753334|FG001|Overall Study|Withdraw due to trial termination|1|||
162738451|NCT01396278|587753335|FG002|Overall Study|Withdraw due to trial termination|1|||
162738452|NCT01396278|587753336|FG003|Overall Study|Withdraw due to trial termination|0|||
162738453|NCT01396278|587753337|FG004|Overall Study|Withdraw due to trial termination|2|||
162738454|NCT00450658|587753338|FG000|Overall Study|Adverse Event|24|||
162738455|NCT00450658|587753339|FG001|Overall Study|Adverse Event|15|||
162738456|NCT00450658|587753338|FG000|Overall Study|Withdrawal by Subject|43|||
162738457|NCT00450658|587753339|FG001|Overall Study|Withdrawal by Subject|26|||
162738458|NCT00450658|587753338|FG000|Overall Study|Lost to Follow-up|22|||
162738459|NCT00450658|587753339|FG001|Overall Study|Lost to Follow-up|5|||
162738460|NCT00450658|587753338|FG000|Overall Study|UGI ulcer|33|||
162738461|NCT00450658|587753339|FG001|Overall Study|UGI ulcer|34|||
162738462|NCT00450658|587753338|FG000|Overall Study|misc|21|||
162738463|NCT00450658|587753339|FG001|Overall Study|misc|10|||
162738464|NCT04727554|587753341|FG000|Overall Study|Lost to Follow-up|0|||
162738465|NCT04727554|587753342|FG001|Overall Study|Lost to Follow-up|1|||
162738466|NCT04727554|587753341|FG000|Overall Study|Death|2|||
162738467|NCT04727554|587753342|FG001|Overall Study|Death|6|||
162738468|NCT04727554|587753341|FG000|Overall Study|Withdrawal by Subject|1|||
162738469|NCT04727554|587753342|FG001|Overall Study|Withdrawal by Subject|0|||
162738470|NCT05763823|587753343|FG000|Overall Study|Death|6|||
162738471|NCT05763823|587753343|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162738472|NCT05763823|587753343|FG000|Overall Study|Withdrawal by Subject|6|||
162738473|NCT00999804|587753346|FG000|Overall Study|Lack of Efficacy|9|||
162738474|NCT00999804|587753347|FG001|Overall Study|Lack of Efficacy|2|||
162738475|NCT00999804|587753346|FG000|Overall Study|Adverse Event|4|||
162738476|NCT00999804|587753347|FG001|Overall Study|Adverse Event|3|||
162738477|NCT00999804|587753346|FG000|Overall Study|Withdrawal by Subject|4|||
162738478|NCT00999804|587753347|FG001|Overall Study|Withdrawal by Subject|0|||
162738479|NCT00999804|587753346|FG000|Overall Study|Death|1|||
162738480|NCT00999804|587753347|FG001|Overall Study|Death|0|||
162738481|NCT00999804|587753346|FG000|Overall Study|Ineligible|3|||
162738482|NCT00999804|587753347|FG001|Overall Study|Ineligible|0|||
162738483|NCT05071807|587753351|FG000|Overall Study|Withdrawal by Subject|4|||
162738484|NCT05071807|587753352|FG001|Overall Study|Withdrawal by Subject|0|||
162738485|NCT05071807|587753351|FG000|Overall Study|Unrelated medical issues|3|||
162738486|NCT05071807|587753352|FG001|Overall Study|Unrelated medical issues|0|||
162738487|NCT05071807|587753351|FG000|Overall Study|Relocated|0|||
162738488|NCT05071807|587753352|FG001|Overall Study|Relocated|1|||
162738489|NCT03150810|587753358|FG000|Overall Study|Death|4|||
162738490|NCT03150810|587753359|FG001|Overall Study|Death|8|||
162738491|NCT03150810|587753360|FG002|Overall Study|Death|7|||
162738492|NCT03150810|587753361|FG003|Overall Study|Death|2|||
162738493|NCT03150810|587753362|FG004|Overall Study|Death|2|||
162738494|NCT03150810|587753363|FG005|Overall Study|Death|10|||
162738495|NCT03150810|587753364|FG006|Overall Study|Death|8|||
162738496|NCT03150810|587753365|FG007|Overall Study|Death|6|||
162738497|NCT03150810|587753366|FG008|Overall Study|Death|18|||
162738498|NCT03150810|587753367|FG009|Overall Study|Death|3|||
162738499|NCT03150810|587753368|FG010|Overall Study|Death|19|||
162738500|NCT03150810|587753369|FG011|Overall Study|Death|1|||
162738501|NCT03150810|587753370|FG012|Overall Study|Death|19|||
162738502|NCT03150810|587753358|FG000|Overall Study|Withdrawal by Subject|0|||
162738503|NCT03150810|587753359|FG001|Overall Study|Withdrawal by Subject|1|||
162738504|NCT03150810|587753360|FG002|Overall Study|Withdrawal by Subject|1|||
162738505|NCT03150810|587753361|FG003|Overall Study|Withdrawal by Subject|1|||
162738506|NCT03150810|587753362|FG004|Overall Study|Withdrawal by Subject|0|||
162738507|NCT03150810|587753363|FG005|Overall Study|Withdrawal by Subject|0|||
162738508|NCT03150810|587753364|FG006|Overall Study|Withdrawal by Subject|2|||
162738509|NCT03150810|587753365|FG007|Overall Study|Withdrawal by Subject|0|||
162738510|NCT03150810|587753366|FG008|Overall Study|Withdrawal by Subject|2|||
162738511|NCT03150810|587753367|FG009|Overall Study|Withdrawal by Subject|0|||
162738512|NCT03150810|587753368|FG010|Overall Study|Withdrawal by Subject|1|||
162738513|NCT03150810|587753369|FG011|Overall Study|Withdrawal by Subject|0|||
162738514|NCT03150810|587753370|FG012|Overall Study|Withdrawal by Subject|1|||
162738515|NCT03150810|587753358|FG000|Overall Study|Sponsor Decision|0|||
162738516|NCT03150810|587753359|FG001|Overall Study|Sponsor Decision|2|||
162738517|NCT03150810|587753360|FG002|Overall Study|Sponsor Decision|0|||
162738518|NCT03150810|587753361|FG003|Overall Study|Sponsor Decision|0|||
162738519|NCT03150810|587753362|FG004|Overall Study|Sponsor Decision|1|||
162738520|NCT03150810|587753363|FG005|Overall Study|Sponsor Decision|1|||
162738521|NCT03150810|587753364|FG006|Overall Study|Sponsor Decision|0|||
162738522|NCT03150810|587753365|FG007|Overall Study|Sponsor Decision|0|||
162738523|NCT03150810|587753366|FG008|Overall Study|Sponsor Decision|1|||
162738524|NCT03150810|587753367|FG009|Overall Study|Sponsor Decision|0|||
162738525|NCT03150810|587753368|FG010|Overall Study|Sponsor Decision|0|||
162738526|NCT03150810|587753369|FG011|Overall Study|Sponsor Decision|0|||
162738527|NCT03150810|587753370|FG012|Overall Study|Sponsor Decision|5|||
162738528|NCT03150810|587753358|FG000|Overall Study|Lost to Follow-up|0|||
162738529|NCT03150810|587753359|FG001|Overall Study|Lost to Follow-up|1|||
162738530|NCT03150810|587753360|FG002|Overall Study|Lost to Follow-up|1|||
162738531|NCT03150810|587753361|FG003|Overall Study|Lost to Follow-up|0|||
162738532|NCT03150810|587753362|FG004|Overall Study|Lost to Follow-up|0|||
162738533|NCT03150810|587753363|FG005|Overall Study|Lost to Follow-up|0|||
162738534|NCT03150810|587753364|FG006|Overall Study|Lost to Follow-up|1|||
162738535|NCT03150810|587753365|FG007|Overall Study|Lost to Follow-up|0|||
162738536|NCT03150810|587753366|FG008|Overall Study|Lost to Follow-up|0|||
162738537|NCT03150810|587753367|FG009|Overall Study|Lost to Follow-up|0|||
162738538|NCT03150810|587753368|FG010|Overall Study|Lost to Follow-up|1|||
162738539|NCT03150810|587753369|FG011|Overall Study|Lost to Follow-up|0|||
162738540|NCT03150810|587753370|FG012|Overall Study|Lost to Follow-up|0|||
162738541|NCT03150810|587753358|FG000|Overall Study|Physician Decision|0|||
162738542|NCT03150810|587753359|FG001|Overall Study|Physician Decision|0|||
162738543|NCT03150810|587753360|FG002|Overall Study|Physician Decision|0|||
162738544|NCT03150810|587753361|FG003|Overall Study|Physician Decision|0|||
162738545|NCT03150810|587753362|FG004|Overall Study|Physician Decision|0|||
162738546|NCT03150810|587753363|FG005|Overall Study|Physician Decision|1|||
162738547|NCT03150810|587753364|FG006|Overall Study|Physician Decision|1|||
162738548|NCT03150810|587753365|FG007|Overall Study|Physician Decision|0|||
162738549|NCT03150810|587753366|FG008|Overall Study|Physician Decision|0|||
162738550|NCT03150810|587753367|FG009|Overall Study|Physician Decision|0|||
162738551|NCT03150810|587753368|FG010|Overall Study|Physician Decision|0|||
162738552|NCT03150810|587753369|FG011|Overall Study|Physician Decision|0|||
162738553|NCT03150810|587753370|FG012|Overall Study|Physician Decision|0|||
162738554|NCT03150810|587753358|FG000|Overall Study|Site withdrawal from study|0|||
162738555|NCT03150810|587753359|FG001|Overall Study|Site withdrawal from study|1|||
162738556|NCT03150810|587753360|FG002|Overall Study|Site withdrawal from study|0|||
162738557|NCT03150810|587753361|FG003|Overall Study|Site withdrawal from study|0|||
162738558|NCT03150810|587753362|FG004|Overall Study|Site withdrawal from study|0|||
162738559|NCT03150810|587753363|FG005|Overall Study|Site withdrawal from study|0|||
162738560|NCT03150810|587753364|FG006|Overall Study|Site withdrawal from study|0|||
162738561|NCT03150810|587753365|FG007|Overall Study|Site withdrawal from study|0|||
162738562|NCT03150810|587753366|FG008|Overall Study|Site withdrawal from study|0|||
162738563|NCT03150810|587753367|FG009|Overall Study|Site withdrawal from study|1|||
162738564|NCT03150810|587753368|FG010|Overall Study|Site withdrawal from study|1|||
162738565|NCT03150810|587753369|FG011|Overall Study|Site withdrawal from study|0|||
162738566|NCT03150810|587753370|FG012|Overall Study|Site withdrawal from study|0|||
162738567|NCT03150810|587753358|FG000|Overall Study|Hospice|0|||
162738568|NCT03150810|587753359|FG001|Overall Study|Hospice|0|||
162738569|NCT03150810|587753360|FG002|Overall Study|Hospice|0|||
162738570|NCT03150810|587753361|FG003|Overall Study|Hospice|0|||
162738571|NCT03150810|587753362|FG004|Overall Study|Hospice|0|||
162738572|NCT03150810|587753363|FG005|Overall Study|Hospice|1|||
162738573|NCT03150810|587753364|FG006|Overall Study|Hospice|0|||
162738574|NCT03150810|587753365|FG007|Overall Study|Hospice|0|||
162738575|NCT03150810|587753366|FG008|Overall Study|Hospice|0|||
162738576|NCT03150810|587753367|FG009|Overall Study|Hospice|0|||
162738577|NCT03150810|587753368|FG010|Overall Study|Hospice|0|||
162738578|NCT03150810|587753369|FG011|Overall Study|Hospice|0|||
162738579|NCT03150810|587753370|FG012|Overall Study|Hospice|0|||
162738580|NCT03150810|587753358|FG000|Overall Study|Participant relocated abroad.|0|||
162738581|NCT03150810|587753359|FG001|Overall Study|Participant relocated abroad.|0|||
162738582|NCT03150810|587753360|FG002|Overall Study|Participant relocated abroad.|0|||
162738583|NCT03150810|587753361|FG003|Overall Study|Participant relocated abroad.|0|||
162738584|NCT03150810|587753362|FG004|Overall Study|Participant relocated abroad.|0|||
162738585|NCT03150810|587753363|FG005|Overall Study|Participant relocated abroad.|1|||
162738586|NCT03150810|587753364|FG006|Overall Study|Participant relocated abroad.|0|||
162738587|NCT03150810|587753365|FG007|Overall Study|Participant relocated abroad.|0|||
162738588|NCT03150810|587753366|FG008|Overall Study|Participant relocated abroad.|0|||
162738589|NCT03150810|587753367|FG009|Overall Study|Participant relocated abroad.|0|||
162738590|NCT03150810|587753368|FG010|Overall Study|Participant relocated abroad.|0|||
162738591|NCT03150810|587753369|FG011|Overall Study|Participant relocated abroad.|0|||
162738592|NCT03150810|587753370|FG012|Overall Study|Participant relocated abroad.|0|||
162738593|NCT03150810|587753358|FG000|Overall Study|Transferred care to oncologist|0|||
162738594|NCT03150810|587753359|FG001|Overall Study|Transferred care to oncologist|0|||
162738595|NCT03150810|587753360|FG002|Overall Study|Transferred care to oncologist|0|||
162738596|NCT03150810|587753361|FG003|Overall Study|Transferred care to oncologist|0|||
162738597|NCT03150810|587753362|FG004|Overall Study|Transferred care to oncologist|0|||
162738598|NCT03150810|587753363|FG005|Overall Study|Transferred care to oncologist|0|||
162738599|NCT03150810|587753364|FG006|Overall Study|Transferred care to oncologist|2|||
162738600|NCT03150810|587753365|FG007|Overall Study|Transferred care to oncologist|0|||
162738601|NCT03150810|587753366|FG008|Overall Study|Transferred care to oncologist|0|||
162738602|NCT03150810|587753367|FG009|Overall Study|Transferred care to oncologist|0|||
162738603|NCT03150810|587753368|FG010|Overall Study|Transferred care to oncologist|0|||
162738604|NCT03150810|587753369|FG011|Overall Study|Transferred care to oncologist|0|||
162738605|NCT03150810|587753370|FG012|Overall Study|Transferred care to oncologist|0|||
162738606|NCT04526704|587753371|FG000|Overall Study|Adverse Event|1|||
162738607|NCT04526704|587753372|FG001|Overall Study|Adverse Event|0|||
162738608|NCT04526704|587753371|FG000|Overall Study|Physician Decision|1|||
162738609|NCT04526704|587753372|FG001|Overall Study|Physician Decision|0|||
162738610|NCT04526704|587753371|FG000|Overall Study|Withdrawal by Subject|2|||
162738611|NCT04526704|587753372|FG001|Overall Study|Withdrawal by Subject|0|||
162738612|NCT02737436|587753376|FG000|Washout Period|Lost to Follow-up|5|||
162738613|NCT02737436|587753377|FG001|Washout Period|Lost to Follow-up|11|||
162738614|NCT02737436|587753376|FG000|Data Analysis|Scanning data problems|5|||
162738615|NCT02737436|587753377|FG001|Data Analysis|Scanning data problems|8|||
162738616|NCT03936322|587753378|FG000|Overall Study|Lost to Follow-up|1|||
162738617|NCT03936322|587753378|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
162738618|NCT01160211|587753379|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
162738619|NCT01160211|587753380|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
162738620|NCT01160211|587753381|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
162738621|NCT01160211|587753379|FG000|Overall Study|Lost to Follow-up|4|||
162738622|NCT01160211|587753380|FG001|Overall Study|Lost to Follow-up|8|||
162738623|NCT01160211|587753381|FG002|Overall Study|Lost to Follow-up|4|||
162738624|NCT01160211|587753379|FG000|Overall Study|Physician Decision|1|||
162738625|NCT01160211|587753380|FG001|Overall Study|Physician Decision|0|||
162738626|NCT01160211|587753381|FG002|Overall Study|Physician Decision|0|||
162738627|NCT01160211|587753379|FG000|Overall Study|Withdrawal by Subject|4|||
162738628|NCT01160211|587753380|FG001|Overall Study|Withdrawal by Subject|2|||
162738629|NCT01160211|587753381|FG002|Overall Study|Withdrawal by Subject|2|||
162738630|NCT01160211|587753379|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
162738631|NCT01160211|587753380|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
162738632|NCT01160211|587753381|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
162738633|NCT05551637|587753382|FG000|Overall Study|Lack of Efficacy|0|||
162738634|NCT05551637|587753383|FG001|Overall Study|Lack of Efficacy|6|||
162738635|NCT05551637|587753382|FG000|Overall Study|Lost to Follow-up|1|||
162738636|NCT05551637|587753383|FG001|Overall Study|Lost to Follow-up|1|||
162738637|NCT02734290|587753386|FG000|Overall Study|Adverse Event|1|||
162738638|NCT02734290|587753387|FG001|Overall Study|Adverse Event|0|||
162738639|NCT02734290|587753386|FG000|Overall Study|Death|1|||
162738640|NCT02734290|587753387|FG001|Overall Study|Death|0|||
162738641|NCT03829410|587753389|FG000|Overall Study|Adverse Event|1|||
162738642|NCT03829410|587753390|FG001|Overall Study|Adverse Event|0|||
162738643|NCT03829410|587753391|FG002|Overall Study|Adverse Event|1|||
162738644|NCT03829410|587753392|FG003|Overall Study|Adverse Event|4|||
162738645|NCT03829410|587753389|FG000|Overall Study|Physician Decision|0|||
162738646|NCT03829410|587753390|FG001|Overall Study|Physician Decision|0|||
162738647|NCT03829410|587753391|FG002|Overall Study|Physician Decision|0|||
162738648|NCT03829410|587753392|FG003|Overall Study|Physician Decision|2|||
162738649|NCT03829410|587753389|FG000|Overall Study|Disease Progressing|3|||
162738650|NCT03829410|587753390|FG001|Overall Study|Disease Progressing|4|||
162738651|NCT03829410|587753391|FG002|Overall Study|Disease Progressing|2|||
162738652|NCT03829410|587753392|FG003|Overall Study|Disease Progressing|31|||
162738653|NCT03829410|587753389|FG000|Overall Study|Miscellaneous|2|||
162738654|NCT03829410|587753390|FG001|Overall Study|Miscellaneous|4|||
162738655|NCT03829410|587753391|FG002|Overall Study|Miscellaneous|3|||
162738656|NCT03829410|587753392|FG003|Overall Study|Miscellaneous|10|||
162738657|NCT03158129|587753393|FG000|Overall Study|Adverse Event|0|||
162738658|NCT03158129|587753394|FG001|Overall Study|Adverse Event|1|||
162738659|NCT03158129|587753395|FG002|Overall Study|Adverse Event|0|||
162738660|NCT03158129|587753396|FG003|Overall Study|Adverse Event|0|||
162738661|NCT03158129|587753393|FG000|Overall Study|Death|0|||
162738662|NCT03158129|587753394|FG001|Overall Study|Death|0|||
162738663|NCT03158129|587753395|FG002|Overall Study|Death|0|||
162738664|NCT03158129|587753396|FG003|Overall Study|Death|1|||
162738665|NCT03158129|587753393|FG000|Overall Study|High surgical risk|1|||
162738666|NCT03158129|587753394|FG001|Overall Study|High surgical risk|1|||
162738667|NCT03158129|587753395|FG002|Overall Study|High surgical risk|0|||
162738668|NCT03158129|587753396|FG003|Overall Study|High surgical risk|0|||
162738669|NCT03158129|587753393|FG000|Overall Study|Progression|1|||
162738670|NCT03158129|587753394|FG001|Overall Study|Progression|1|||
162738671|NCT03158129|587753395|FG002|Overall Study|Progression|0|||
162738672|NCT03158129|587753396|FG003|Overall Study|Progression|0|||
162738673|NCT03158129|587753393|FG000|Overall Study|Lack of resectability|0|||
162738674|NCT03158129|587753394|FG001|Overall Study|Lack of resectability|1|||
162738675|NCT03158129|587753395|FG002|Overall Study|Lack of resectability|0|||
162738676|NCT03158129|587753396|FG003|Overall Study|Lack of resectability|0|||
162738677|NCT03158129|587753393|FG000|Overall Study|Declined surgery|0|||
162738678|NCT03158129|587753394|FG001|Overall Study|Declined surgery|1|||
162738679|NCT03158129|587753395|FG002|Overall Study|Declined surgery|0|||
162738680|NCT03158129|587753396|FG003|Overall Study|Declined surgery|0|||
162738681|NCT03158129|587753393|FG000|Overall Study|No longer surgical candidate|0|||
162738682|NCT03158129|587753394|FG001|Overall Study|No longer surgical candidate|0|||
162738683|NCT03158129|587753395|FG002|Overall Study|No longer surgical candidate|0|||
162738684|NCT03158129|587753396|FG003|Overall Study|No longer surgical candidate|1|||
162738685|NCT05051124|587753397|FG000|Overall Study|Lost to Follow-up|2|||
162738686|NCT05051124|587753397|FG000|Overall Study|Withdrawal by Subject|1|||
162738687|NCT05051124|587753397|FG000|Overall Study|Residential relocation|2|||
162738688|NCT05051124|587753397|FG000|Overall Study|Death|1|||
162738689|NCT04782973|587753398|FG000|Overall Study|Withdrawal by Subject|5|||
162738690|NCT04782973|587753398|FG000|Overall Study|Protocol Violation|6|||
162738691|NCT04782973|587753398|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
162738692|NCT04924660|587753399|FG000|United States|Death|29|||
162738693|NCT04924660|587753400|FG001|United States|Death|32|||
162738694|NCT04924660|587753401|FG002|United States|Death|34|||
162738695|NCT04924660|587753402|FG003|United States|Death|25|||
162738696|NCT04924660|587753403|FG004|United States|Death|26|||
162738697|NCT04924660|587753404|FG005|United States|Death|23|||
162738698|NCT04924660|587753399|FG000|United States|Lost to Follow-up|15|||
162738699|NCT04924660|587753400|FG001|United States|Lost to Follow-up|10|||
162738700|NCT04924660|587753401|FG002|United States|Lost to Follow-up|13|||
162738701|NCT04924660|587753402|FG003|United States|Lost to Follow-up|5|||
162738702|NCT04924660|587753403|FG004|United States|Lost to Follow-up|19|||
162738703|NCT04924660|587753404|FG005|United States|Lost to Follow-up|20|||
162738704|NCT04924660|587753399|FG000|United States|Withdrawal by Subject|8|||
162738705|NCT04924660|587753400|FG001|United States|Withdrawal by Subject|3|||
162738706|NCT04924660|587753401|FG002|United States|Withdrawal by Subject|3|||
162738707|NCT04924660|587753402|FG003|United States|Withdrawal by Subject|3|||
162738708|NCT04924660|587753403|FG004|United States|Withdrawal by Subject|8|||
162738709|NCT04924660|587753404|FG005|United States|Withdrawal by Subject|4|||
162738710|NCT04924660|587753399|FG000|Spain|Death|0|||
162738711|NCT04924660|587753400|FG001|Spain|Death|0|||
162738712|NCT04924660|587753401|FG002|Spain|Death|0|||
162738713|NCT04924660|587753402|FG003|Spain|Death|0|||
162738714|NCT04924660|587753403|FG004|Spain|Death|0|||
162738715|NCT04924660|587753404|FG005|Spain|Death|2|||
162738716|NCT04924660|587753399|FG000|Spain|Lost to Follow-up|0|||
162738717|NCT04924660|587753400|FG001|Spain|Lost to Follow-up|0|||
162738718|NCT04924660|587753401|FG002|Spain|Lost to Follow-up|0|||
162738719|NCT04924660|587753402|FG003|Spain|Lost to Follow-up|0|||
162738720|NCT04924660|587753403|FG004|Spain|Lost to Follow-up|1|||
162738721|NCT04924660|587753404|FG005|Spain|Lost to Follow-up|0|||
162738722|NCT04924660|587753399|FG000|Brazil|Death|0|||
162738723|NCT04924660|587753400|FG001|Brazil|Death|0|||
162738724|NCT04924660|587753401|FG002|Brazil|Death|0|||
162738725|NCT04924660|587753402|FG003|Brazil|Death|0|||
162738726|NCT04924660|587753403|FG004|Brazil|Death|1|||
162738727|NCT04924660|587753404|FG005|Brazil|Death|0|||
162738728|NCT04924660|587753399|FG000|Italy|Lost to Follow-up|0|||
162738729|NCT04924660|587753400|FG001|Italy|Lost to Follow-up|0|||
162738730|NCT04924660|587753401|FG002|Italy|Lost to Follow-up|0|||
162738731|NCT04924660|587753402|FG003|Italy|Lost to Follow-up|0|||
162738732|NCT04924660|587753403|FG004|Italy|Lost to Follow-up|0|||
162738733|NCT04924660|587753404|FG005|Italy|Lost to Follow-up|1|||
162738734|NCT04924660|587753399|FG000|South Africa|Death|0|||
162738735|NCT04924660|587753400|FG001|South Africa|Death|0|||
162738736|NCT04924660|587753401|FG002|South Africa|Death|0|||
162738737|NCT04924660|587753402|FG003|South Africa|Death|0|||
162738738|NCT04924660|587753403|FG004|South Africa|Death|0|||
162738739|NCT04924660|587753404|FG005|South Africa|Death|1|||
162738740|NCT04924660|587753399|FG000|South Africa|Lost to Follow-up|0|||
162738741|NCT04924660|587753400|FG001|South Africa|Lost to Follow-up|0|||
162738742|NCT04924660|587753401|FG002|South Africa|Lost to Follow-up|0|||
162738743|NCT04924660|587753402|FG003|South Africa|Lost to Follow-up|0|||
162738744|NCT04924660|587753403|FG004|South Africa|Lost to Follow-up|0|||
162738745|NCT04924660|587753404|FG005|South Africa|Lost to Follow-up|1|||
162738746|NCT02105766|587753405|FG000|Overall Study|Physician Decision|1|||
162738747|NCT02105766|587753406|FG001|Overall Study|Physician Decision|1|||
162738748|NCT02105766|587753407|FG002|Overall Study|Physician Decision|0|||
162738749|NCT02105766|587753405|FG000|Overall Study|Lost to Follow-up|2|||
162738750|NCT02105766|587753406|FG001|Overall Study|Lost to Follow-up|0|||
162738751|NCT02105766|587753407|FG002|Overall Study|Lost to Follow-up|0|||
162738752|NCT02105766|587753405|FG000|Overall Study|Death|1|||
162738753|NCT02105766|587753406|FG001|Overall Study|Death|1|||
162738754|NCT02105766|587753407|FG002|Overall Study|Death|0|||
162738755|NCT04676022|587753408|FG000|Overall Study|Screen Failure/|1|||
162738756|NCT04676022|587753409|FG001|Overall Study|Screen Failure/|1|||
162738757|NCT04676022|587753410|FG002|Overall Study|Screen Failure/|85|||
162738758|NCT04676022|587753408|FG000|Overall Study|Lost to Follow-up|1|||
162738759|NCT04676022|587753409|FG001|Overall Study|Lost to Follow-up|1|||
162738760|NCT04676022|587753410|FG002|Overall Study|Lost to Follow-up|0|||
162738761|NCT04676022|587753408|FG000|Overall Study|Adverse Event|2|||
162738762|NCT04676022|587753409|FG001|Overall Study|Adverse Event|0|||
162738763|NCT04676022|587753410|FG002|Overall Study|Adverse Event|1|||
162738764|NCT04676022|587753408|FG000|Overall Study|Physician Decision|2|||
162738765|NCT04676022|587753409|FG001|Overall Study|Physician Decision|0|||
162738766|NCT04676022|587753410|FG002|Overall Study|Physician Decision|1|||
162738767|NCT04676022|587753408|FG000|Overall Study|Withdrawal by Subject|3|||
162738768|NCT04676022|587753409|FG001|Overall Study|Withdrawal by Subject|1|||
162738769|NCT04676022|587753410|FG002|Overall Study|Withdrawal by Subject|6|||
162738770|NCT04676022|587753408|FG000|Overall Study|Will not move forward with permanent implant|6|||
162738771|NCT04676022|587753409|FG001|Overall Study|Will not move forward with permanent implant|0|||
162738772|NCT04676022|587753410|FG002|Overall Study|Will not move forward with permanent implant|0|||
162738773|NCT04676022|587753408|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
162738774|NCT04676022|587753409|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
162738775|NCT04676022|587753410|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
162738776|NCT05409183|587753422|FG000|Complete Study|Adverse Event|1|||
162738777|NCT05409183|587753423|FG001|Complete Study|Adverse Event|2|||
162738778|NCT05409183|587753422|FG000|Complete Study|Withdrawal by Subject|3|||
162738779|NCT05409183|587753423|FG001|Complete Study|Withdrawal by Subject|0|||
162738780|NCT02274662|587753424|FG000|Overall Study|Death|1|||
162738781|NCT02274662|587753424|FG000|Overall Study|Lost to Follow-up|3|||
162738782|NCT02936752|587753425|FG000|Overall Study|Death|2|||
162738783|NCT02936752|587753426|FG001|Overall Study|Death|1|||
162738784|NCT02936752|587753425|FG000|Overall Study|Physician Decision|4|||
162738785|NCT02936752|587753426|FG001|Overall Study|Physician Decision|0|||
162738786|NCT02936752|587753425|FG000|Overall Study|Withdrawal by Subject|0|||
162738787|NCT02936752|587753426|FG001|Overall Study|Withdrawal by Subject|2|||
162738788|NCT05746455|587753436|FG000|Overall Study|Discharged from Clinical Service|1|||
162738789|NCT05746455|587753436|FG000|Overall Study|Lost to Follow-up|1|||
162738790|NCT02023866|587753437|FG000|Overall Study|Non-compliance|2|||
162738791|NCT02023866|587753437|FG000|Overall Study|Adverse Event|3|||
162738792|NCT02023866|587753437|FG000|Overall Study|Withdrawal by Subject|1|||
162738793|NCT03307343|587753438|FG000|Overall Study|Withdrawal by Subject|1|||
162738794|NCT03307343|587753439|FG001|Overall Study|Withdrawal by Subject|2|||
162738795|NCT03307343|587753438|FG000|Overall Study|Pregnancy|0|||
162738796|NCT03307343|587753439|FG001|Overall Study|Pregnancy|2|||
162738797|NCT03307343|587753438|FG000|Overall Study|Physician Decision|1|||
162738798|NCT03307343|587753439|FG001|Overall Study|Physician Decision|0|||
162738799|NCT03307343|587753438|FG000|Overall Study|Lost to Follow-up|0|||
162738800|NCT03307343|587753439|FG001|Overall Study|Lost to Follow-up|2|||
162738801|NCT05184192|587753445|FG000|Overall Study|Lost to Follow-up|4|||
162738802|NCT05184192|587753446|FG001|Overall Study|Lost to Follow-up|7|||
162738803|NCT05184192|587753445|FG000|Overall Study|Adverse Event|1|||
162738804|NCT05184192|587753446|FG001|Overall Study|Adverse Event|4|||
162738805|NCT05184192|587753445|FG000|Overall Study|PI withdrawal|1|||
162738806|NCT05184192|587753446|FG001|Overall Study|PI withdrawal|2|||
162738807|NCT05184192|587753445|FG000|Overall Study|Withdrew due to adverse effect|1|||
162738808|NCT05184192|587753446|FG001|Overall Study|Withdrew due to adverse effect|0|||
162738809|NCT05184192|587753445|FG000|Overall Study|Medication schedule|1|||
162738810|NCT05184192|587753446|FG001|Overall Study|Medication schedule|0|||
162738811|NCT05184192|587753445|FG000|Overall Study|Concern for adverse effects|0|||
162738812|NCT05184192|587753446|FG001|Overall Study|Concern for adverse effects|4|||
162738813|NCT04810650|587753458|FG000|Overall Study|Disenrolled in error|0|||
162738814|NCT04810650|587753459|FG001|Overall Study|Disenrolled in error|0|||
162738815|NCT04810650|587753460|FG002|Overall Study|Disenrolled in error|0|||
162738816|NCT04810650|587753461|FG003|Overall Study|Disenrolled in error|0|||
162738817|NCT04810650|587753462|FG004|Overall Study|Disenrolled in error|0|||
162738818|NCT04810650|587753463|FG005|Overall Study|Disenrolled in error|0|||
162738819|NCT04810650|587753464|FG006|Overall Study|Disenrolled in error|0|||
162738820|NCT04810650|587753465|FG007|Overall Study|Disenrolled in error|0|||
162738821|NCT04810650|587753466|FG008|Overall Study|Disenrolled in error|1|||
162738822|NCT04810650|587753467|FG009|Overall Study|Disenrolled in error|0|||
162738823|NCT04810650|587753468|FG010|Overall Study|Disenrolled in error|0|||
162738824|NCT04810650|587753469|FG011|Overall Study|Disenrolled in error|0|||
162738825|NCT04810650|587753470|FG012|Overall Study|Disenrolled in error|0|||
162738826|NCT04810650|587753471|FG013|Overall Study|Disenrolled in error|0|||
162738827|NCT04810650|587753458|FG000|Overall Study|Death|0|||
162738828|NCT04810650|587753459|FG001|Overall Study|Death|0|||
162738829|NCT04810650|587753460|FG002|Overall Study|Death|0|||
162738830|NCT04810650|587753461|FG003|Overall Study|Death|0|||
162738831|NCT04810650|587753462|FG004|Overall Study|Death|0|||
162738832|NCT04810650|587753463|FG005|Overall Study|Death|0|||
162738833|NCT04810650|587753464|FG006|Overall Study|Death|2|||
162738834|NCT04810650|587753465|FG007|Overall Study|Death|2|||
162738835|NCT04810650|587753466|FG008|Overall Study|Death|0|||
162738836|NCT04810650|587753467|FG009|Overall Study|Death|1|||
162738837|NCT04810650|587753468|FG010|Overall Study|Death|0|||
162738838|NCT04810650|587753469|FG011|Overall Study|Death|0|||
162738839|NCT04810650|587753470|FG012|Overall Study|Death|2|||
162738840|NCT04810650|587753471|FG013|Overall Study|Death|1|||
162738841|NCT04810650|587753458|FG000|Overall Study|Moved/transferred care|0|||
162738842|NCT04810650|587753459|FG001|Overall Study|Moved/transferred care|0|||
162738843|NCT04810650|587753460|FG002|Overall Study|Moved/transferred care|0|||
162738844|NCT04810650|587753461|FG003|Overall Study|Moved/transferred care|0|||
162738845|NCT04810650|587753462|FG004|Overall Study|Moved/transferred care|0|||
162738846|NCT04810650|587753463|FG005|Overall Study|Moved/transferred care|0|||
162738847|NCT04810650|587753464|FG006|Overall Study|Moved/transferred care|0|||
162738848|NCT04810650|587753465|FG007|Overall Study|Moved/transferred care|1|||
162738849|NCT04810650|587753466|FG008|Overall Study|Moved/transferred care|12|||
162738850|NCT04810650|587753467|FG009|Overall Study|Moved/transferred care|10|||
162738851|NCT04810650|587753468|FG010|Overall Study|Moved/transferred care|0|||
162738852|NCT04810650|587753469|FG011|Overall Study|Moved/transferred care|0|||
162738853|NCT04810650|587753470|FG012|Overall Study|Moved/transferred care|0|||
162738854|NCT04810650|587753471|FG013|Overall Study|Moved/transferred care|0|||
162738855|NCT04810650|587753458|FG000|Overall Study|Lost to Follow-up|15|||
162738856|NCT04810650|587753459|FG001|Overall Study|Lost to Follow-up|12|||
162738857|NCT04810650|587753460|FG002|Overall Study|Lost to Follow-up|7|||
162738858|NCT04810650|587753461|FG003|Overall Study|Lost to Follow-up|9|||
162738859|NCT04810650|587753462|FG004|Overall Study|Lost to Follow-up|10|||
162738860|NCT04810650|587753463|FG005|Overall Study|Lost to Follow-up|6|||
162738861|NCT04810650|587753464|FG006|Overall Study|Lost to Follow-up|0|||
162738862|NCT04810650|587753465|FG007|Overall Study|Lost to Follow-up|0|||
162738863|NCT04810650|587753466|FG008|Overall Study|Lost to Follow-up|0|||
162738864|NCT04810650|587753467|FG009|Overall Study|Lost to Follow-up|0|||
162738865|NCT04810650|587753468|FG010|Overall Study|Lost to Follow-up|1|||
162738866|NCT04810650|587753469|FG011|Overall Study|Lost to Follow-up|0|||
162738867|NCT04810650|587753470|FG012|Overall Study|Lost to Follow-up|3|||
162738868|NCT04810650|587753471|FG013|Overall Study|Lost to Follow-up|9|||
162738869|NCT04810650|587753458|FG000|Overall Study|Participant declined|0|||
162738870|NCT04810650|587753459|FG001|Overall Study|Participant declined|0|||
162738871|NCT04810650|587753460|FG002|Overall Study|Participant declined|0|||
162738872|NCT04810650|587753461|FG003|Overall Study|Participant declined|0|||
162738873|NCT04810650|587753462|FG004|Overall Study|Participant declined|0|||
162738874|NCT04810650|587753463|FG005|Overall Study|Participant declined|0|||
162738875|NCT04810650|587753464|FG006|Overall Study|Participant declined|0|||
162738876|NCT04810650|587753465|FG007|Overall Study|Participant declined|0|||
162738877|NCT04810650|587753466|FG008|Overall Study|Participant declined|0|||
162738878|NCT04810650|587753467|FG009|Overall Study|Participant declined|0|||
162738879|NCT04810650|587753468|FG010|Overall Study|Participant declined|2|||
162738880|NCT04810650|587753469|FG011|Overall Study|Participant declined|0|||
162738881|NCT04810650|587753470|FG012|Overall Study|Participant declined|0|||
162738882|NCT04810650|587753471|FG013|Overall Study|Participant declined|0|||
162738883|NCT05609760|587753472|FG000|Overall Study|Lost to Follow-up|0|||
162738884|NCT05609760|587753473|FG001|Overall Study|Lost to Follow-up|1|||
162738885|NCT05609760|587753472|FG000|Overall Study|Withdrawal by Subject|1|||
162738886|NCT05609760|587753473|FG001|Overall Study|Withdrawal by Subject|0|||
162738887|NCT05179395|587753474|FG000|Overall Study|Lack of Efficacy|1|||
162738888|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Physician Decision|1|||
162738889|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Physician Decision|0|||
162738890|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
162738891|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
162738892|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
162738893|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
162738894|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Pregnancy|0|||
162738895|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Pregnancy|2|||
162738896|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
162738897|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
162738898|NCT01785719|587755249|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
162738899|NCT01785719|587755250|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
162738900|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
162738901|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
162738902|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
162738903|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
162738904|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
162738905|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
162738906|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
162738907|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
162738908|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
162738909|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
162738910|NCT01785719|587755249|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
162738911|NCT01785719|587755250|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
162738912|NCT01785719|587755249|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
162738913|NCT01785719|587755250|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
162738914|NCT01785719|587755249|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
162738915|NCT01785719|587755250|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
162738916|NCT01785719|587755249|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
162738917|NCT01785719|587755250|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
162738918|NCT04977947|587755251|FG000|Overall Study|Lost to Follow-up|1|||
162738919|NCT04977947|587755252|FG001|Overall Study|Lost to Follow-up|1|||
162738920|NCT03445988|587755253|FG000|Overall Study|Lost to Follow-up|14|||
162738921|NCT03445988|587755254|FG001|Overall Study|Lost to Follow-up|26|||
162738922|NCT03445988|587755255|FG002|Overall Study|Lost to Follow-up|27|||
162738923|NCT03445988|587755256|FG003|Overall Study|Lost to Follow-up|66|||
162738924|NCT03445988|587755253|FG000|Overall Study|Withdrawal by Subject|7|||
162738925|NCT03445988|587755254|FG001|Overall Study|Withdrawal by Subject|4|||
162738926|NCT03445988|587755255|FG002|Overall Study|Withdrawal by Subject|3|||
162738927|NCT03445988|587755256|FG003|Overall Study|Withdrawal by Subject|5|||
162738928|NCT03445988|587755253|FG000|Overall Study|Death (unrelated to study)|5|||
162738929|NCT03445988|587755254|FG001|Overall Study|Death (unrelated to study)|1|||
162738930|NCT03445988|587755255|FG002|Overall Study|Death (unrelated to study)|2|||
162738931|NCT03445988|587755256|FG003|Overall Study|Death (unrelated to study)|4|||
162738932|NCT05875142|587755257|FG000|Overall Study|Lost to Follow-up|0|||
162738933|NCT05875142|587755258|FG001|Overall Study|Lost to Follow-up|1|||
162738934|NCT05875142|587755259|FG002|Overall Study|Lost to Follow-up|1|||
162738935|NCT03891667|587755262|FG000|Overall Study|Physician Decision|1|||
162738936|NCT03891667|587755263|FG001|Overall Study|Physician Decision|1|||
162738937|NCT03891667|587755262|FG000|Overall Study|COVID related pause|1|||
162738938|NCT03891667|587755263|FG001|Overall Study|COVID related pause|0|||
162738939|NCT03891667|587755262|FG000|Overall Study|Withdrawal by Subject|0|||
162738940|NCT03891667|587755263|FG001|Overall Study|Withdrawal by Subject|1|||
162738941|NCT03891667|587755262|FG000|Overall Study|Adverse Event|0|||
162738942|NCT03891667|587755263|FG001|Overall Study|Adverse Event|1|||
162738943|NCT05659537|587755264|FG000|Overall Study|Adverse Event|5|||
162738944|NCT05659537|587755264|FG000|Overall Study|Lost to Follow-up|4|||
162738945|NCT05659537|587755264|FG000|Overall Study|Withdrawal by Subject|13|||
162738946|NCT05659537|587755264|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
162738947|NCT05659537|587755264|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
162738948|NCT05659537|587755264|FG000|Overall Study|Participant was suffering from anaemia|1|||
162738949|NCT04971395|587755265|FG000|Overall Study|Withdrawal by Subject|0|||
162738950|NCT04971395|587755266|FG001|Overall Study|Withdrawal by Subject|1|||
162738951|NCT04971395|587755267|FG002|Overall Study|Withdrawal by Subject|0|||
162738952|NCT04456517|587755268|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
162738953|NCT04456517|587755269|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
162738954|NCT02924272|587755270|FG000|Overall Study|Site Terminated by Sponsor|4|||
162738955|NCT02924272|587755271|FG001|Overall Study|Site Terminated by Sponsor|1|||
162738956|NCT02924272|587755270|FG000|Overall Study|Withdrawal by Subject|2|||
162738957|NCT02924272|587755271|FG001|Overall Study|Withdrawal by Subject|0|||
162738958|NCT02924272|587755270|FG000|Overall Study|Adverse Event|3|||
162738959|NCT02924272|587755271|FG001|Overall Study|Adverse Event|0|||
162738960|NCT02924272|587755270|FG000|Overall Study|Progressive Disease|11|||
162738961|NCT02924272|587755271|FG001|Overall Study|Progressive Disease|8|||
162738962|NCT02924272|587755270|FG000|Overall Study|Clinical Deterioration|1|||
162738963|NCT02924272|587755271|FG001|Overall Study|Clinical Deterioration|0|||
162738964|NCT02924272|587755270|FG000|Overall Study|Death|1|||
162738965|NCT02924272|587755271|FG001|Overall Study|Death|0|||
162738966|NCT02924272|587755270|FG000|Overall Study|Reason Not Specified|1|||
162738967|NCT02924272|587755271|FG001|Overall Study|Reason Not Specified|0|||
162738968|NCT02100813|587755274|FG000|Overall Study|Adverse Event|0|||
162738969|NCT02100813|587755275|FG001|Overall Study|Adverse Event|0|||
162738970|NCT02100813|587755276|FG002|Overall Study|Adverse Event|0|||
162738971|NCT02100813|587755277|FG003|Overall Study|Adverse Event|0|||
162738972|NCT02100813|587755278|FG004|Overall Study|Adverse Event|0|||
162738973|NCT02100813|587755279|FG005|Overall Study|Adverse Event|0|||
162738974|NCT02100813|587755280|FG006|Overall Study|Adverse Event|0|||
162738975|NCT02100813|587755281|FG007|Overall Study|Adverse Event|1|||
162738976|NCT03575897|587755283|FG000|Overall Study|Lost to Follow-up|12|||
162738977|NCT03575897|587755284|FG001|Overall Study|Lost to Follow-up|13|||
162738978|NCT00506519|587755291|FG000|Overall Study|Death|4|||
162738979|NCT00506519|587755292|FG001|Overall Study|Death|6|||
162738980|NCT00506519|587755293|FG002|Overall Study|Death|0|||
162738981|NCT00506519|587755291|FG000|Overall Study|Adverse Event|1|||
162738982|NCT00506519|587755292|FG001|Overall Study|Adverse Event|0|||
162738983|NCT00506519|587755293|FG002|Overall Study|Adverse Event|0|||
162738984|NCT01186367|587755294|FG000|Overall Study|Lost to Follow-up|7|||
162738985|NCT01186367|587755295|FG001|Overall Study|Lost to Follow-up|4|||
162738986|NCT01186367|587755296|FG002|Overall Study|Lost to Follow-up|7|||
162738987|NCT01186367|587755294|FG000|Overall Study|Did not receive study treatment|0|||
162738988|NCT01186367|587755295|FG001|Overall Study|Did not receive study treatment|1|||
162738989|NCT01186367|587755296|FG002|Overall Study|Did not receive study treatment|0|||
162738990|NCT02975882|587755297|FG000|Overall Study|Adverse Event|1|||
162738991|NCT02975882|587755298|FG001|Overall Study|Adverse Event|2|||
162738992|NCT02975882|587755299|FG002|Overall Study|Adverse Event|1|||
162738993|NCT02975882|587755300|FG003|Overall Study|Adverse Event|1|||
162738994|NCT02975882|587755297|FG000|Overall Study|Death|0|||
162738995|NCT02975882|587755298|FG001|Overall Study|Death|1|||
162738996|NCT02975882|587755299|FG002|Overall Study|Death|0|||
162738997|NCT02975882|587755300|FG003|Overall Study|Death|0|||
162738998|NCT02975882|587755297|FG000|Overall Study|Lack of Efficacy|3|||
162738999|NCT02975882|587755298|FG001|Overall Study|Lack of Efficacy|7|||
162739000|NCT02975882|587755299|FG002|Overall Study|Lack of Efficacy|4|||
162739001|NCT02975882|587755300|FG003|Overall Study|Lack of Efficacy|3|||
162739002|NCT02975882|587755297|FG000|Overall Study|Physician Decision|0|||
162739003|NCT02975882|587755298|FG001|Overall Study|Physician Decision|2|||
162739004|NCT02975882|587755299|FG002|Overall Study|Physician Decision|4|||
162739005|NCT02975882|587755300|FG003|Overall Study|Physician Decision|2|||
162739006|NCT02975882|587755297|FG000|Overall Study|Ineligible|0|||
162739007|NCT02975882|587755298|FG001|Overall Study|Ineligible|1|||
162739008|NCT02975882|587755299|FG002|Overall Study|Ineligible|0|||
162739009|NCT02975882|587755300|FG003|Overall Study|Ineligible|0|||
162739010|NCT05116787|587755301|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
162739011|NCT05116787|587755302|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
162739012|NCT05116787|587755301|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
162739013|NCT05116787|587755302|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
162739014|NCT05116787|587755301|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
162739015|NCT05116787|587755302|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
162739016|NCT05116787|587755301|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
162739017|NCT05116787|587755302|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
162739018|NCT02919683|587755304|FG000|Post-Surgery Follow-Up|Death|2|||
162739019|NCT02919683|587755305|FG001|Post-Surgery Follow-Up|Death|2|||
162739020|NCT02919683|587755304|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
162739021|NCT02919683|587755305|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
162739022|NCT03867500|587755310|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
162739023|NCT06205407|587755311|FG000|Period 2|Withdrawal by Subject|0|||
162739024|NCT06205407|587755312|FG001|Period 2|Withdrawal by Subject|1|||
162739025|NCT06205407|587755311|FG000|Period 2|Adverse Event|2|||
162739026|NCT06205407|587755312|FG001|Period 2|Adverse Event|1|||
162739027|NCT06491433|587755313|FG000|Overall Study|Protocol Violation|51|||
162739028|NCT06491433|587755313|FG000|Overall Study|consent withdrawal|2|||
162739029|NCT06491433|587755313|FG000|Overall Study|screen failure|1|||
162739030|NCT04749615|587755315|FG000|Overall Study|Lost to Follow-up|6|||
162739031|NCT04749615|587755316|FG001|Overall Study|Lost to Follow-up|10|||
162739032|NCT03611491|587755317|FG000|Overall Study|Lost to Follow-up|1|||
162739033|NCT04806451|587755325|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
162739034|NCT04806451|587755326|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
162739035|NCT04806451|587755325|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
162739036|NCT04806451|587755326|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
162739037|NCT04806451|587755325|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
162739038|NCT04806451|587755326|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
162739039|NCT05894577|587755327|FG000|Overall Study|No receipt of study drug|14|||
162739040|NCT05894577|587755328|FG001|Overall Study|No receipt of study drug|13|||
162739041|NCT05894577|587755327|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
162739042|NCT05894577|587755328|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
162739043|NCT05894577|587755327|FG000|Overall Study|Screen Fail|2|||
162739044|NCT05894577|587755328|FG001|Overall Study|Screen Fail|0|||
162739045|NCT05894577|587755327|FG000|Overall Study|Study drug recall|86|||
162739046|NCT05894577|587755328|FG001|Overall Study|Study drug recall|63|||
162739047|NCT05292365|587755333|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
162739048|NCT05292365|587755334|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
162739049|NCT05292365|587755335|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
162739050|NCT05292365|587755336|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
162739051|NCT05282173|587755337|FG000|Overall Study|Missed|3|||
162739052|NCT05282173|587755338|FG001|Overall Study|Missed|2|||
162739053|NCT05282173|587755339|FG002|Overall Study|Missed|4|||
162739054|NCT03134196|587755347|FG000|Overall Study|Death|2|||
162739055|NCT03134196|587755348|FG001|Overall Study|Death|1|||
162739056|NCT03134196|587755347|FG000|Overall Study|Lost to Follow-up|13|||
162739057|NCT03134196|587755348|FG001|Overall Study|Lost to Follow-up|15|||
162739058|NCT03134196|587755347|FG000|Overall Study|Physician Decision|0|||
162739059|NCT03134196|587755348|FG001|Overall Study|Physician Decision|1|||
162739060|NCT03134196|587755347|FG000|Overall Study|Withdrawal by Subject|19|||
162739061|NCT03134196|587755348|FG001|Overall Study|Withdrawal by Subject|12|||
162739062|NCT03134196|587755347|FG000|Overall Study|Site Unable to Contact Participant|2|||
162739063|NCT03134196|587755348|FG001|Overall Study|Site Unable to Contact Participant|0|||
162739064|NCT03134196|587755347|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
162739065|NCT03134196|587755348|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
162739066|NCT03134196|587755347|FG000|Overall Study|Scheduling Conflict|1|||
162739067|NCT03134196|587755348|FG001|Overall Study|Scheduling Conflict|0|||
162739068|NCT04064164|587755355|FG000|Overall Study|Withdrawal by Subject|8|||
162739069|NCT04064164|587755356|FG001|Overall Study|Withdrawal by Subject|8|||
162739070|NCT04683744|587755367|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
162739071|NCT04683744|587755368|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
162739072|NCT04683744|587755369|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
162739073|NCT01798498|587755370|FG000|Overall Study|Lost to Follow-up|1|||
162739074|NCT04592549|587755375|FG000|Overall Study|Withdrawal by Subject|0|||
162739075|NCT04592549|587755376|FG001|Overall Study|Withdrawal by Subject|1|||
162739076|NCT04592549|587755377|FG002|Overall Study|Withdrawal by Subject|0|||
162739077|NCT04592549|587755378|FG003|Overall Study|Withdrawal by Subject|1|||
162739078|NCT04592549|587755379|FG004|Overall Study|Withdrawal by Subject|1|||
162739079|NCT04592549|587755380|FG005|Overall Study|Withdrawal by Subject|0|||
162739080|NCT04592549|587755375|FG000|Overall Study|Lost to Follow-up|2|||
162739081|NCT04592549|587755376|FG001|Overall Study|Lost to Follow-up|0|||
162739082|NCT04592549|587755377|FG002|Overall Study|Lost to Follow-up|0|||
162739083|NCT04592549|587755378|FG003|Overall Study|Lost to Follow-up|1|||
162739084|NCT04592549|587755379|FG004|Overall Study|Lost to Follow-up|1|||
162739085|NCT04592549|587755380|FG005|Overall Study|Lost to Follow-up|1|||
162739086|NCT04295798|587755381|FG000|Overall Study|Lost to Follow-up|1|||
162739087|NCT04091750|587755385|FG000|Overall Study|Adverse Event|4|||
162739088|NCT04091750|587755385|FG000|Overall Study|Withdrawal by Subject|1|||
162739089|NCT04625283|587755386|FG000|Overall Study|post randomization exclusion|28|||
162739090|NCT04625283|587755387|FG001|Overall Study|post randomization exclusion|20|||
162739091|NCT01824394|587755388|FG000|Overall Study|Early Termination|1|||
162739092|NCT01824394|587755389|FG001|Overall Study|Early Termination|1|||
162739093|NCT01824394|587755390|FG002|Overall Study|Early Termination|3|||
162739094|NCT01824394|587755388|FG000|Overall Study|Withdrawn due to Study Termination|91|||
162739095|NCT01824394|587755389|FG001|Overall Study|Withdrawn due to Study Termination|83|||
162739096|NCT01824394|587755390|FG002|Overall Study|Withdrawn due to Study Termination|41|||
162739097|NCT01824394|587755388|FG000|Overall Study|Lost to Follow-up|0|||
162739098|NCT01824394|587755389|FG001|Overall Study|Lost to Follow-up|9|||
162739099|NCT01824394|587755390|FG002|Overall Study|Lost to Follow-up|3|||
162739100|NCT01824394|587755388|FG000|Overall Study|Death|3|||
162739101|NCT01824394|587755389|FG001|Overall Study|Death|2|||
162739102|NCT01824394|587755390|FG002|Overall Study|Death|4|||
162739103|NCT01824394|587755388|FG000|Overall Study|Discontinued Subjects|1|||
162739104|NCT01824394|587755389|FG001|Overall Study|Discontinued Subjects|1|||
162739105|NCT01824394|587755390|FG002|Overall Study|Discontinued Subjects|2|||
162739106|NCT01824394|587755388|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
162739107|NCT01824394|587755389|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
162739108|NCT01824394|587755390|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
162739109|NCT05364671|587755391|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
162739110|NCT05364671|587755392|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
162739111|NCT05364671|587755391|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
162739112|NCT05364671|587755392|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
162739113|NCT05364671|587755391|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
162739114|NCT05364671|587755392|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
162739115|NCT05364671|587755391|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
162739116|NCT05364671|587755392|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
162739117|NCT05364671|587755391|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
162739118|NCT05364671|587755392|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
162739119|NCT04015167|587755393|FG000|Overall Study|Lost to Follow-up|40|||
162739120|NCT04015167|587755393|FG000|Overall Study|Adverse Event|5|||
162739121|NCT04015167|587755393|FG000|Overall Study|Withdrawal by Subject|2|||
162739122|NCT04015167|587755393|FG000|Overall Study|Subject went to jail|1|||
162739123|NCT05794243|587755394|FG000|Overall Study|Withdrawal by Subject|1|||
162739124|NCT05794243|587755395|FG001|Overall Study|Withdrawal by Subject|0|||
162739125|NCT05794243|587755396|FG002|Overall Study|Withdrawal by Subject|1|||
162739126|NCT05794243|587755394|FG000|Overall Study|Physician Decision|0|||
162739127|NCT05794243|587755395|FG001|Overall Study|Physician Decision|3|||
162739128|NCT05794243|587755396|FG002|Overall Study|Physician Decision|1|||
162739129|NCT05093829|587755403|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162739130|NCT05093829|587755404|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162739131|NCT05093829|587755405|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
162739132|NCT05093829|587755406|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162739133|NCT05093829|587755407|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162739134|NCT02727699|587757072|FG000|Overall Study|Adverse Event|2|||
162739135|NCT02727699|587757073|FG001|Overall Study|Adverse Event|0|||
162739136|NCT02727699|587757072|FG000|Overall Study|Withdrawal by Subject|5|||
162739137|NCT02727699|587757073|FG001|Overall Study|Withdrawal by Subject|3|||
162739138|NCT02727699|587757072|FG000|Overall Study|Protocol Violation|0|||
162739139|NCT02727699|587757073|FG001|Overall Study|Protocol Violation|1|||
162739140|NCT02727699|587757072|FG000|Overall Study|Physician Decision|0|||
162739141|NCT02727699|587757073|FG001|Overall Study|Physician Decision|1|||
162739142|NCT02727699|587757072|FG000|Overall Study|Lost to Follow-up|1|||
162739143|NCT02727699|587757073|FG001|Overall Study|Lost to Follow-up|0|||
162739144|NCT02727699|587757072|FG000|Overall Study|Sponsor Decision|1|||
162739145|NCT02727699|587757073|FG001|Overall Study|Sponsor Decision|0|||
162739146|NCT04318548|587757082|FG000|Overall Study|Adverse Event|0|||
162739147|NCT04318548|587757083|FG001|Overall Study|Adverse Event|0|||
162739148|NCT04318548|587757084|FG002|Overall Study|Adverse Event|1|||
162739149|NCT04318548|587757082|FG000|Overall Study|Lost to Follow-up|6|||
162739150|NCT04318548|587757083|FG001|Overall Study|Lost to Follow-up|13|||
162739151|NCT04318548|587757084|FG002|Overall Study|Lost to Follow-up|9|||
162739152|NCT04318548|587757082|FG000|Overall Study|Protocol Violation|1|||
162739153|NCT04318548|587757083|FG001|Overall Study|Protocol Violation|0|||
162739154|NCT04318548|587757084|FG002|Overall Study|Protocol Violation|2|||
162739155|NCT04318548|587757082|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
162739156|NCT04318548|587757083|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
162739157|NCT04318548|587757084|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
162739158|NCT04318548|587757082|FG000|Overall Study|Migrated / moved from the study area|0|||
162739159|NCT04318548|587757083|FG001|Overall Study|Migrated / moved from the study area|0|||
162739160|NCT04318548|587757084|FG002|Overall Study|Migrated / moved from the study area|1|||
162739161|NCT04318548|587757082|FG000|Overall Study|Other|1|||
162739162|NCT04318548|587757083|FG001|Overall Study|Other|2|||
162739163|NCT04318548|587757084|FG002|Overall Study|Other|3|||
162739164|NCT03366649|587757087|FG000|Overall Study|Failed preoperative screening|4|||
162739165|NCT03366649|587757088|FG001|Overall Study|Failed preoperative screening|0|||
162739166|NCT03366649|587757089|FG002|Overall Study|Failed preoperative screening|0|||
162739167|NCT03366649|587757087|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
162739168|NCT03366649|587757088|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
162739169|NCT03366649|587757089|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
162739170|NCT04029688|587757097|FG000|Overall Study|Death|8|||
162739171|NCT04029688|587757098|FG001|Overall Study|Death|3|||
162739172|NCT04029688|587757099|FG002|Overall Study|Death|6|||
162739173|NCT04029688|587757100|FG003|Overall Study|Death|2|||
162739174|NCT04029688|587757101|FG004|Overall Study|Death|5|||
162739175|NCT04029688|587757102|FG005|Overall Study|Death|0|||
162739176|NCT04029688|587757103|FG006|Overall Study|Death|2|||
162739177|NCT04029688|587757104|FG007|Overall Study|Death|3|||
162739178|NCT04029688|587757097|FG000|Overall Study|Study Terminated by Sponsor|0|||
162739179|NCT04029688|587757098|FG001|Overall Study|Study Terminated by Sponsor|0|||
162739180|NCT04029688|587757099|FG002|Overall Study|Study Terminated by Sponsor|0|||
162739181|NCT04029688|587757100|FG003|Overall Study|Study Terminated by Sponsor|0|||
162739182|NCT04029688|587757101|FG004|Overall Study|Study Terminated by Sponsor|1|||
162739183|NCT04029688|587757102|FG005|Overall Study|Study Terminated by Sponsor|3|||
162739184|NCT04029688|587757103|FG006|Overall Study|Study Terminated by Sponsor|1|||
162739185|NCT04029688|587757104|FG007|Overall Study|Study Terminated by Sponsor|3|||
162739186|NCT04029688|587757097|FG000|Overall Study|Withdrawal by Subject|0|||
162739187|NCT04029688|587757098|FG001|Overall Study|Withdrawal by Subject|0|||
162739188|NCT04029688|587757099|FG002|Overall Study|Withdrawal by Subject|0|||
162739189|NCT04029688|587757100|FG003|Overall Study|Withdrawal by Subject|1|||
162739190|NCT04029688|587757101|FG004|Overall Study|Withdrawal by Subject|0|||
162739191|NCT04029688|587757102|FG005|Overall Study|Withdrawal by Subject|0|||
162739192|NCT04029688|587757103|FG006|Overall Study|Withdrawal by Subject|0|||
162739193|NCT04029688|587757104|FG007|Overall Study|Withdrawal by Subject|0|||
162739194|NCT03436290|587757105|FG000|Overall Study|Post-randomization Exclusion|1|||
162739195|NCT03436290|587757106|FG001|Overall Study|Post-randomization Exclusion|0|||
162739196|NCT03436290|587757105|FG000|Overall Study|Death|6|||
162739197|NCT03436290|587757106|FG001|Overall Study|Death|0|||
162739198|NCT03436290|587757105|FG000|Overall Study|Withdrawal by Subject|4|||
162739199|NCT03436290|587757106|FG001|Overall Study|Withdrawal by Subject|0|||
162739200|NCT03436290|587757105|FG000|Overall Study|Protocol Violation|30|||
162739201|NCT03436290|587757106|FG001|Overall Study|Protocol Violation|0|||
162739202|NCT02677298|587757119|FG000|Double Blind Phase|Adverse Event|2|||
162739203|NCT02677298|587757120|FG001|Double Blind Phase|Adverse Event|1|||
162739204|NCT02677298|587757121|FG002|Double Blind Phase|Adverse Event|0|||
162739205|NCT02677298|587757119|FG000|Double Blind Phase|Physician Decision|5|||
162739206|NCT02677298|587757120|FG001|Double Blind Phase|Physician Decision|0|||
162739207|NCT02677298|587757121|FG002|Double Blind Phase|Physician Decision|0|||
162739208|NCT02677298|587757119|FG000|Double Blind Phase|Lost to Follow-up|11|||
162739209|NCT02677298|587757120|FG001|Double Blind Phase|Lost to Follow-up|7|||
162739210|NCT02677298|587757121|FG002|Double Blind Phase|Lost to Follow-up|0|||
162739211|NCT02677298|587757119|FG000|Double Blind Phase|Withdrawal by Subject|11|||
162739212|NCT02677298|587757120|FG001|Double Blind Phase|Withdrawal by Subject|8|||
162739213|NCT02677298|587757121|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162739214|NCT02677298|587757119|FG000|Double Blind Phase|No study drug available at site|0|||
162739215|NCT02677298|587757120|FG001|Double Blind Phase|No study drug available at site|1|||
162739216|NCT02677298|587757121|FG002|Double Blind Phase|No study drug available at site|0|||
162739217|NCT02677298|587757119|FG000|Open Label Phase|Adverse Event|0|||
162739218|NCT02677298|587757120|FG001|Open Label Phase|Adverse Event|0|||
162739219|NCT02677298|587757121|FG002|Open Label Phase|Adverse Event|4|||
162739220|NCT02677298|587757119|FG000|Open Label Phase|Physician Decision|0|||
162739221|NCT02677298|587757120|FG001|Open Label Phase|Physician Decision|0|||
162739222|NCT02677298|587757121|FG002|Open Label Phase|Physician Decision|1|||
162739223|NCT02677298|587757119|FG000|Open Label Phase|Lost to Follow-up|0|||
162739224|NCT02677298|587757120|FG001|Open Label Phase|Lost to Follow-up|0|||
162739225|NCT02677298|587757121|FG002|Open Label Phase|Lost to Follow-up|17|||
162739226|NCT02677298|587757119|FG000|Open Label Phase|Withdrawal by Subject|0|||
162739227|NCT02677298|587757120|FG001|Open Label Phase|Withdrawal by Subject|0|||
162739228|NCT02677298|587757121|FG002|Open Label Phase|Withdrawal by Subject|38|||
162739229|NCT03611621|587757122|FG000|Overall Study|Graft loss|3|||
162739230|NCT03611621|587757122|FG000|Overall Study|Death|3|||
162739231|NCT03611621|587757122|FG000|Overall Study|Lost to Follow-up|1|||
162739232|NCT03812679|587757144|FG000|Overall Study|Adverse Event|2|||
162739233|NCT03812679|587757144|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
162739234|NCT03812679|587757144|FG000|Overall Study|Renal transplant|1|||
162739235|NCT03812679|587757144|FG000|Overall Study|Withdrawal by Subject|1|||
162739236|NCT03812679|587757144|FG000|Overall Study|Termination of study|2|||
162739237|NCT03812679|587757144|FG000|Overall Study|Water device replacement|1|||
162739238|NCT05653427|587757145|FG000|Overall Study|Study Terminated by Sponsor|13|||
162739239|NCT03524118|587757149|FG000|Overall Study|Lost to Follow-up|0|||
162739240|NCT03524118|587757150|FG001|Overall Study|Lost to Follow-up|0|||
162739241|NCT03524118|587757151|FG002|Overall Study|Lost to Follow-up|0|||
162739242|NCT03524118|587757152|FG003|Overall Study|Lost to Follow-up|0|||
162739243|NCT03524118|587757153|FG004|Overall Study|Lost to Follow-up|1|||
162739244|NCT03524118|587757154|FG005|Overall Study|Lost to Follow-up|0|||
162739245|NCT03524118|587757149|FG000|Overall Study|Other|0|||
162739246|NCT03524118|587757150|FG001|Overall Study|Other|1|||
162739247|NCT03524118|587757151|FG002|Overall Study|Other|0|||
162739248|NCT03524118|587757152|FG003|Overall Study|Other|0|||
162739249|NCT03524118|587757153|FG004|Overall Study|Other|1|||
162739250|NCT03524118|587757154|FG005|Overall Study|Other|1|||
162739251|NCT03524118|587757149|FG000|Overall Study|Physician Decision|0|||
162739252|NCT03524118|587757150|FG001|Overall Study|Physician Decision|0|||
162739253|NCT03524118|587757151|FG002|Overall Study|Physician Decision|0|||
162739254|NCT03524118|587757152|FG003|Overall Study|Physician Decision|0|||
162739255|NCT03524118|587757153|FG004|Overall Study|Physician Decision|1|||
162739256|NCT03524118|587757154|FG005|Overall Study|Physician Decision|0|||
162739257|NCT03524118|587757149|FG000|Overall Study|Protocol Violation|0|||
162739258|NCT03524118|587757150|FG001|Overall Study|Protocol Violation|0|||
162739259|NCT03524118|587757151|FG002|Overall Study|Protocol Violation|1|||
162739260|NCT03524118|587757152|FG003|Overall Study|Protocol Violation|0|||
162739261|NCT03524118|587757153|FG004|Overall Study|Protocol Violation|1|||
162739262|NCT03524118|587757154|FG005|Overall Study|Protocol Violation|0|||
162739263|NCT03524118|587757149|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162739264|NCT03524118|587757150|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162739265|NCT03524118|587757151|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162739266|NCT03524118|587757152|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
162739267|NCT03524118|587757153|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
162739268|NCT03524118|587757154|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162739269|NCT04650269|587757157|FG000|Overall Study|Death|3|||
162739270|NCT04650269|587757157|FG000|Overall Study|Lost to Follow-up|6|||
162739271|NCT01437709|587757158|FG000|Overall Study|Adverse Event|0|||
162739272|NCT01437709|587757159|FG001|Overall Study|Adverse Event|1|||
162739273|NCT01437709|587757160|FG002|Overall Study|Adverse Event|0|||
162739274|NCT01437709|587757158|FG000|Overall Study|Pt trasnferred care|0|||
162739275|NCT01437709|587757159|FG001|Overall Study|Pt trasnferred care|1|||
162739276|NCT01437709|587757160|FG002|Overall Study|Pt trasnferred care|0|||
162739277|NCT02919306|587757161|FG000|Overall Study|Withdrawal by Subject|1|||
162739278|NCT02919306|587757162|FG001|Overall Study|Withdrawal by Subject|0|||
162739279|NCT02919306|587757161|FG000|Overall Study|Protocol Violation|1|||
162739280|NCT02919306|587757162|FG001|Overall Study|Protocol Violation|0|||
162739281|NCT04293055|587757163|FG000|Overall Study|Lost to Follow-up|1|||
162739282|NCT04293055|587757164|FG001|Overall Study|Lost to Follow-up|1|||
162739283|NCT04293055|587757163|FG000|Overall Study|Did not trigger randomization|6|||
162739284|NCT04293055|587757164|FG001|Overall Study|Did not trigger randomization|5|||
162739285|NCT02619838|587757166|FG000|Overall Study|Lost to Follow-up|9|||
162739286|NCT02619838|587757166|FG000|Overall Study|Withdrawal by Subject|15|||
162739287|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
162739288|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
162739289|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
162739290|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
162739291|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
162739292|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
162739293|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
162739294|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
162739295|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
162739296|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
162739297|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
162739298|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
162739299|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
162739300|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
162739301|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
162739302|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
162739303|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
162739304|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
162739305|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
162739306|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
162739307|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
162739308|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
162739309|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
162739310|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
162739311|NCT01715285|587757167|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
162739312|NCT01715285|587757168|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
162739313|NCT01715285|587757169|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
162739314|NCT01715285|587757167|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
162739315|NCT01715285|587757168|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
162739316|NCT01715285|587757169|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
162739317|NCT01715285|587757167|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
162739318|NCT01715285|587757168|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
162739319|NCT01715285|587757169|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
162739320|NCT01715285|587757167|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
162739321|NCT01715285|587757168|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
162739322|NCT01715285|587757169|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
162739323|NCT01715285|587757167|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
162739324|NCT01715285|587757168|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
162739325|NCT01715285|587757169|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
162739326|NCT01715285|587757167|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
162739327|NCT01715285|587757168|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
162739328|NCT01715285|587757169|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
162739329|NCT05020249|587757170|FG000|Overall Study|Protocol Violation|1|||
162739330|NCT05020249|587757171|FG001|Overall Study|Protocol Violation|0|||
162739331|NCT02761057|587757185|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
162739332|NCT02761057|587757186|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
162739333|NCT02761057|587757187|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
162739334|NCT02761057|587757188|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
162739335|NCT02761057|587757185|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
162739336|NCT02761057|587757186|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
162739337|NCT02761057|587757187|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
162739338|NCT02761057|587757188|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
162739339|NCT02761057|587757185|FG000|Overall Study|Currently On Study Treatment|0|||
162739340|NCT02761057|587757186|FG001|Overall Study|Currently On Study Treatment|3|||
162739341|NCT02761057|587757187|FG002|Overall Study|Currently On Study Treatment|0|||
162739342|NCT02761057|587757188|FG003|Overall Study|Currently On Study Treatment|0|||
162739343|NCT02761057|587757185|FG000|Overall Study|Adverse Event|11|||
162739344|NCT02761057|587757186|FG001|Overall Study|Adverse Event|9|||
162739345|NCT02761057|587757187|FG002|Overall Study|Adverse Event|5|||
162739346|NCT02761057|587757188|FG003|Overall Study|Adverse Event|3|||
162739347|NCT02761057|587757185|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
162739348|NCT02761057|587757186|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
162739349|NCT02761057|587757187|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
162739350|NCT02761057|587757188|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
162739351|NCT02761057|587757185|FG000|Overall Study|Progression/Relapse|29|||
162739352|NCT02761057|587757186|FG001|Overall Study|Progression/Relapse|27|||
162739353|NCT02761057|587757187|FG002|Overall Study|Progression/Relapse|20|||
162739354|NCT02761057|587757188|FG003|Overall Study|Progression/Relapse|23|||
162739355|NCT02761057|587757185|FG000|Overall Study|Death|2|||
162739356|NCT02761057|587757186|FG001|Overall Study|Death|2|||
162739357|NCT02761057|587757187|FG002|Overall Study|Death|1|||
162739358|NCT02761057|587757188|FG003|Overall Study|Death|1|||
162739359|NCT02761057|587757185|FG000|Overall Study|Other - Not Protocol Specified|2|||
162739360|NCT02761057|587757186|FG001|Overall Study|Other - Not Protocol Specified|1|||
162739361|NCT02761057|587757187|FG002|Overall Study|Other - Not Protocol Specified|2|||
162739362|NCT02761057|587757188|FG003|Overall Study|Other - Not Protocol Specified|0|||
162739363|NCT04971681|587757189|FG000|Followup|Lost to Follow-up|1|||
162739364|NCT04971681|587757190|FG001|Followup|Lost to Follow-up|0|||
162739365|NCT00686335|587757191|FG000|Run-in Period|Adverse Event|1|||
162739366|NCT00686335|587757191|FG000|Run-in Period|asthma exacerbation|1|||
162739367|NCT00686335|587757191|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
162739368|NCT04376502|587757194|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
162739369|NCT05603143|587757195|FG000|Overall Study|Withdrew consent|6|||
162739370|NCT05603143|587757196|FG001|Overall Study|Withdrew consent|2|||
162739371|NCT05603143|587757195|FG000|Overall Study|Randomized but never treated|0|||
162739372|NCT05603143|587757196|FG001|Overall Study|Randomized but never treated|3|||
162739373|NCT05603143|587757195|FG000|Overall Study|Adverse Event|2|||
162739374|NCT05603143|587757196|FG001|Overall Study|Adverse Event|0|||
162739375|NCT05603143|587757195|FG000|Overall Study|Death|0|||
162739376|NCT05603143|587757196|FG001|Overall Study|Death|1|||
162739377|NCT05603143|587757195|FG000|Overall Study|Investigator's discretion|1|||
162739378|NCT05603143|587757196|FG001|Overall Study|Investigator's discretion|0|||
162739379|NCT05603143|587757195|FG000|Overall Study|Lost to Follow-up|0|||
162739380|NCT05603143|587757196|FG001|Overall Study|Lost to Follow-up|1|||
162739381|NCT05603143|587757195|FG000|Overall Study|Protocol Violation|0|||
162739382|NCT05603143|587757196|FG001|Overall Study|Protocol Violation|1|||
162739383|NCT04171999|587757197|FG000|Overall Study|deemed ineligible after randomization|2|||
162739384|NCT04171999|587757198|FG001|Overall Study|deemed ineligible after randomization|1|||
162739385|NCT04277442|587757205|FG000|Overall Study|Death|1|||
162739386|NCT01824537|587757206|FG000|Overall Study|Lost to Follow-up|78|||
162739387|NCT01824537|587757207|FG001|Overall Study|Lost to Follow-up|87|||
162739388|NCT04938492|587757219|FG000|Overall Study|Lost to Follow-up|17|||
162739389|NCT04938492|587757220|FG001|Overall Study|Lost to Follow-up|18|||
162739390|NCT03865498|587757221|FG000|Overall Study|Lack of Efficacy|12|||
162739391|NCT03865498|587757222|FG001|Overall Study|Lack of Efficacy|11|||
162739392|NCT03865498|587757221|FG000|Overall Study|Lost to Follow-up|125|||
162739393|NCT03865498|587757222|FG001|Overall Study|Lost to Follow-up|133|||
162739394|NCT03865498|587757221|FG000|Overall Study|Withdrawal by Subject|2|||
162739395|NCT03865498|587757222|FG001|Overall Study|Withdrawal by Subject|4|||
162739396|NCT05084508|587757223|FG000|Overall Study|Lost to Follow-up|6|||
162739397|NCT05084508|587757224|FG001|Overall Study|Lost to Follow-up|3|||
162739398|NCT05084508|587757225|FG002|Overall Study|Lost to Follow-up|7|||
162739399|NCT05084508|587757226|FG003|Overall Study|Lost to Follow-up|3|||
162739400|NCT05084508|587757223|FG000|Overall Study|Withdrawal by Subject|0|||
162739401|NCT05084508|587757224|FG001|Overall Study|Withdrawal by Subject|2|||
162739402|NCT05084508|587757225|FG002|Overall Study|Withdrawal by Subject|3|||
162739403|NCT05084508|587757226|FG003|Overall Study|Withdrawal by Subject|1|||
162739404|NCT05084508|587757223|FG000|Overall Study|Other|0|||
162739405|NCT05084508|587757224|FG001|Overall Study|Other|0|||
162739406|NCT05084508|587757225|FG002|Overall Study|Other|0|||
162739407|NCT05084508|587757226|FG003|Overall Study|Other|1|||
162739408|NCT04137289|587757227|FG000|Overall Study|Death|0|||
162739409|NCT04137289|587757228|FG001|Overall Study|Death|0|||
162739410|NCT04137289|587757229|FG002|Overall Study|Death|0|||
162739411|NCT04137289|587757230|FG003|Overall Study|Death|0|||
162739412|NCT04137289|587757231|FG004|Overall Study|Death|0|||
162739413|NCT04137289|587757232|FG005|Overall Study|Death|0|||
162739414|NCT04137289|587757233|FG006|Overall Study|Death|1|||
162739415|NCT04137289|587757234|FG007|Overall Study|Death|0|||
162739416|NCT04137289|587757235|FG008|Overall Study|Death|0|||
162739417|NCT04137289|587757227|FG000|Overall Study|Clinical disease progression|0|||
162739418|NCT04137289|587757228|FG001|Overall Study|Clinical disease progression|0|||
162739419|NCT04137289|587757229|FG002|Overall Study|Clinical disease progression|0|||
162739420|NCT04137289|587757230|FG003|Overall Study|Clinical disease progression|4|||
162739421|NCT04137289|587757231|FG004|Overall Study|Clinical disease progression|4|||
162739422|NCT04137289|587757232|FG005|Overall Study|Clinical disease progression|2|||
162739423|NCT04137289|587757233|FG006|Overall Study|Clinical disease progression|5|||
162739424|NCT04137289|587757234|FG007|Overall Study|Clinical disease progression|1|||
162739425|NCT04137289|587757235|FG008|Overall Study|Clinical disease progression|0|||
162739426|NCT04137289|587757227|FG000|Overall Study|Lost to Follow-up|0|||
162739427|NCT04137289|587757228|FG001|Overall Study|Lost to Follow-up|0|||
162739428|NCT04137289|587757229|FG002|Overall Study|Lost to Follow-up|0|||
162739429|NCT04137289|587757230|FG003|Overall Study|Lost to Follow-up|1|||
162739430|NCT04137289|587757231|FG004|Overall Study|Lost to Follow-up|0|||
162739431|NCT04137289|587757232|FG005|Overall Study|Lost to Follow-up|0|||
162739432|NCT04137289|587757233|FG006|Overall Study|Lost to Follow-up|0|||
162739433|NCT04137289|587757234|FG007|Overall Study|Lost to Follow-up|0|||
162739434|NCT04137289|587757235|FG008|Overall Study|Lost to Follow-up|0|||
162739435|NCT04137289|587757227|FG000|Overall Study|Adverse Event|0|||
162739436|NCT04137289|587757228|FG001|Overall Study|Adverse Event|0|||
162739437|NCT04137289|587757229|FG002|Overall Study|Adverse Event|1|||
162739438|NCT04137289|587757230|FG003|Overall Study|Adverse Event|0|||
162739439|NCT04137289|587757231|FG004|Overall Study|Adverse Event|0|||
162739440|NCT04137289|587757232|FG005|Overall Study|Adverse Event|1|||
162739441|NCT04137289|587757233|FG006|Overall Study|Adverse Event|0|||
162739442|NCT04137289|587757234|FG007|Overall Study|Adverse Event|0|||
162739443|NCT04137289|587757235|FG008|Overall Study|Adverse Event|0|||
162739444|NCT04137289|587757227|FG000|Overall Study|Lack of clinical benefit|0|||
162739445|NCT04137289|587757228|FG001|Overall Study|Lack of clinical benefit|0|||
162739446|NCT04137289|587757229|FG002|Overall Study|Lack of clinical benefit|0|||
162739447|NCT04137289|587757230|FG003|Overall Study|Lack of clinical benefit|0|||
162739448|NCT04137289|587757231|FG004|Overall Study|Lack of clinical benefit|0|||
162739449|NCT04137289|587757232|FG005|Overall Study|Lack of clinical benefit|0|||
162739450|NCT04137289|587757233|FG006|Overall Study|Lack of clinical benefit|0|||
162739451|NCT04137289|587757234|FG007|Overall Study|Lack of clinical benefit|0|||
162739452|NCT04137289|587757235|FG008|Overall Study|Lack of clinical benefit|1|||
162739453|NCT04137289|587757227|FG000|Overall Study|Objective disease progression|1|||
162739454|NCT04137289|587757228|FG001|Overall Study|Objective disease progression|1|||
162739455|NCT04137289|587757229|FG002|Overall Study|Objective disease progression|6|||
162739456|NCT04137289|587757230|FG003|Overall Study|Objective disease progression|18|||
162739457|NCT04137289|587757231|FG004|Overall Study|Objective disease progression|12|||
162739458|NCT04137289|587757232|FG005|Overall Study|Objective disease progression|20|||
162739459|NCT04137289|587757233|FG006|Overall Study|Objective disease progression|18|||
162739460|NCT04137289|587757234|FG007|Overall Study|Objective disease progression|7|||
162739461|NCT04137289|587757235|FG008|Overall Study|Objective disease progression|6|||
162739462|NCT03931174|587757240|FG000|Providers|Staff left organization|26|||
162739463|NCT03931174|587757241|FG001|Providers|Staff left organization|25|||
162739464|NCT03931174|587757240|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
162739465|NCT03931174|587757241|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
162739466|NCT03931174|587757240|FG000|Providers|Lost to Follow-up|4|||
162739467|NCT03931174|587757241|FG001|Providers|Lost to Follow-up|4|||
162739468|NCT03931174|587757240|FG000|Patients|Post-consent screening failure|1|||
162739469|NCT03931174|587757241|FG001|Patients|Post-consent screening failure|1|||
162739470|NCT03931174|587757240|FG000|Patients|Death|1|||
162739471|NCT03931174|587757241|FG001|Patients|Death|1|||
162739472|NCT03931174|587757240|FG000|Patients|Lost to Follow-up|60|||
162739473|NCT03931174|587757241|FG001|Patients|Lost to Follow-up|89|||
162739474|NCT05386030|587757242|FG000|Overall Study|Death|1|||
162739475|NCT05386030|587757243|FG001|Overall Study|Death|0|||
162739476|NCT05386030|587757242|FG000|Overall Study|Physician Decision|2|||
162739477|NCT05386030|587757243|FG001|Overall Study|Physician Decision|1|||
162739478|NCT05386030|587757242|FG000|Overall Study|Lost to Follow-up|19|||
162739479|NCT05386030|587757243|FG001|Overall Study|Lost to Follow-up|7|||
162739480|NCT05386030|587757242|FG000|Overall Study|Withdrawal by Subject|20|||
162739481|NCT05386030|587757243|FG001|Overall Study|Withdrawal by Subject|10|||
162739482|NCT05386030|587757242|FG000|Overall Study|Eligibility criteria violation|1|||
162739483|NCT05386030|587757243|FG001|Overall Study|Eligibility criteria violation|1|||
162739484|NCT05386030|587757242|FG000|Overall Study|Personal Reasons|1|||
162739485|NCT05386030|587757243|FG001|Overall Study|Personal Reasons|0|||
162739486|NCT03492216|587757246|FG000|Overall Study|Death|1|||
162739487|NCT03492216|587757247|FG001|Overall Study|Death|0|||
162739488|NCT03492216|587757248|FG002|Overall Study|Death|4|||
162739489|NCT03492216|587757249|FG003|Overall Study|Death|0|||
162739490|NCT03492216|587757246|FG000|Overall Study|Withdrawal by Subject|5|||
162739491|NCT03492216|587757247|FG001|Overall Study|Withdrawal by Subject|3|||
162739492|NCT03492216|587757248|FG002|Overall Study|Withdrawal by Subject|1|||
162739493|NCT03492216|587757249|FG003|Overall Study|Withdrawal by Subject|1|||
162739494|NCT03492216|587757246|FG000|Overall Study|Lost to Follow-up|9|||
162739495|NCT03492216|587757247|FG001|Overall Study|Lost to Follow-up|2|||
162739496|NCT03492216|587757248|FG002|Overall Study|Lost to Follow-up|7|||
162739497|NCT03492216|587757249|FG003|Overall Study|Lost to Follow-up|8|||
162739498|NCT03492216|587757246|FG000|Overall Study|Moved|5|||
162739499|NCT03492216|587757247|FG001|Overall Study|Moved|3|||
162739500|NCT03492216|587757248|FG002|Overall Study|Moved|3|||
162739501|NCT03492216|587757249|FG003|Overall Study|Moved|5|||
162739502|NCT03492216|587757246|FG000|Overall Study|Too ill|0|||
162739503|NCT03492216|587757247|FG001|Overall Study|Too ill|1|||
162739504|NCT03492216|587757248|FG002|Overall Study|Too ill|0|||
162739505|NCT03492216|587757249|FG003|Overall Study|Too ill|0|||
162739506|NCT03492216|587757246|FG000|Overall Study|Incarcerated|0|||
162739507|NCT03492216|587757247|FG001|Overall Study|Incarcerated|0|||
162739508|NCT03492216|587757248|FG002|Overall Study|Incarcerated|2|||
162739509|NCT03492216|587757249|FG003|Overall Study|Incarcerated|0|||
162739510|NCT03396588|587757250|FG000|Overall Study|Physician Decision|2|||
162739511|NCT03396588|587757251|FG001|Overall Study|Physician Decision|3|||
162739512|NCT00812461|587757252|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
162739513|NCT00812461|587757253|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
162739514|NCT00812461|587757252|FG000|All Treated Patients|Adverse Event|8|||
162739515|NCT00812461|587757253|FG001|All Treated Patients|Adverse Event|15|||
162739516|NCT00812461|587757252|FG000|All Treated Patients|Lack of Efficacy|13|||
162739517|NCT00812461|587757253|FG001|All Treated Patients|Lack of Efficacy|7|||
162739518|NCT00812461|587757252|FG000|All Treated Patients|Non-compliance|6|||
162739519|NCT00812461|587757253|FG001|All Treated Patients|Non-compliance|9|||
162739520|NCT00812461|587757252|FG000|All Treated Patients|Protocol Violation|36|||
162739521|NCT00812461|587757253|FG001|All Treated Patients|Protocol Violation|27|||
162739522|NCT00812461|587757252|FG000|All Treated Patients|Withdrawal by Subject|45|||
162739523|NCT00812461|587757253|FG001|All Treated Patients|Withdrawal by Subject|54|||
162739524|NCT00812461|587757252|FG000|All Treated Patients|Lost to Follow-up|11|||
162739525|NCT00812461|587757253|FG001|All Treated Patients|Lost to Follow-up|14|||
162739526|NCT00812461|587757252|FG000|All Treated Patients|Other Reason|13|||
162739527|NCT00812461|587757253|FG001|All Treated Patients|Other Reason|21|||
162739528|NCT05351554|587757255|FG000|Overall Study|Study terminated by sponsor|1|||
162739529|NCT05030233|587757256|FG000|Overall Study|withdrawn for transfer|1|||
162739530|NCT05030233|587757257|FG001|Overall Study|withdrawn for transfer|0|||
162739531|NCT05251909|587759292|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
162739532|NCT05251909|587759293|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
162739533|NCT02140554|587759302|FG000|Overall Study|Withdrawal of consent|1|||
162739534|NCT02140554|587759303|FG001|Overall Study|Withdrawal of consent|0|||
162739535|NCT02140554|587759304|FG002|Overall Study|Withdrawal of consent|4|||
162739536|NCT02140554|587759302|FG000|Overall Study|Physician Decision|1|||
162739537|NCT02140554|587759303|FG001|Overall Study|Physician Decision|0|||
162739538|NCT02140554|587759304|FG002|Overall Study|Physician Decision|2|||
162739539|NCT02140554|587759302|FG000|Overall Study|Death|0|||
162739540|NCT02140554|587759303|FG001|Overall Study|Death|0|||
162739541|NCT02140554|587759304|FG002|Overall Study|Death|1|||
162739542|NCT02140554|587759302|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
162739543|NCT02140554|587759303|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
162739544|NCT02140554|587759304|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
162739545|NCT03953508|587759306|FG000|Baseline|Lost to Follow-up|3|||
162739546|NCT03953508|587759307|FG001|Baseline|Lost to Follow-up|2|||
162739547|NCT03953508|587759306|FG000|6-month Follow-up|Lost to Follow-up|62|||
162739548|NCT03953508|587759307|FG001|6-month Follow-up|Lost to Follow-up|70|||
162739549|NCT03771417|587759308|FG000|Overall Study|Withdrawal by Subject|1|||
162739550|NCT03771417|587759309|FG001|Overall Study|Withdrawal by Subject|0|||
162739551|NCT03771417|587759310|FG002|Overall Study|Withdrawal by Subject|0|||
162739552|NCT03771417|587759308|FG000|Overall Study|Covid-19 Shutdown|0|||
162739553|NCT03771417|587759309|FG001|Overall Study|Covid-19 Shutdown|1|||
162739554|NCT03771417|587759310|FG002|Overall Study|Covid-19 Shutdown|0|||
162739555|NCT04185298|587759312|FG000|Overall Study|Lost to Follow-up|1|||
162739556|NCT04185298|587759313|FG001|Overall Study|Lost to Follow-up|3|||
162739557|NCT04185298|587759312|FG000|Overall Study|Withdrawal by Subject|0|||
162739558|NCT04185298|587759313|FG001|Overall Study|Withdrawal by Subject|3|||
162739559|NCT01606215|587759314|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
162739560|NCT01606215|587759315|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
162739561|NCT04316871|587759316|FG000|Overall Study|Protocol Violation|2|||
162739562|NCT04316871|587759317|FG001|Overall Study|Protocol Violation|2|||
162739563|NCT04316871|587759318|FG002|Overall Study|Protocol Violation|2|||
162739564|NCT04316871|587759319|FG003|Overall Study|Protocol Violation|2|||
162739565|NCT01842542|587759320|FG000|Overall Study|Withdrawal by Subject|2|||
162739566|NCT01842542|587759320|FG000|Overall Study|Lack of Efficacy|1|||
162739567|NCT01842542|587759320|FG000|Overall Study|Protocol Non-compliance|2|||
162739568|NCT01842542|587759320|FG000|Overall Study|Lost to Follow-up|1|||
162739569|NCT02262728|587759321|FG000|Follow-up Phase (3 Years)|Death|0|||
162739570|NCT02262728|587759322|FG001|Follow-up Phase (3 Years)|Death|1|||
162739571|NCT02262728|587759321|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
162739572|NCT02262728|587759322|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
162739573|NCT02262728|587759321|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
162739574|NCT02262728|587759322|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
162739575|NCT04632992|587759344|FG000|Overall Study|Adverse Event|0|||
162739576|NCT04632992|587759345|FG001|Overall Study|Adverse Event|0|||
162739577|NCT04632992|587759346|FG002|Overall Study|Adverse Event|0|||
162739578|NCT04632992|587759347|FG003|Overall Study|Adverse Event|0|||
162739579|NCT04632992|587759348|FG004|Overall Study|Adverse Event|0|||
162739580|NCT04632992|587759349|FG005|Overall Study|Adverse Event|0|||
162739581|NCT04632992|587759350|FG006|Overall Study|Adverse Event|0|||
162739582|NCT04632992|587759351|FG007|Overall Study|Adverse Event|0|||
162739583|NCT04632992|587759352|FG008|Overall Study|Adverse Event|0|||
162739584|NCT04632992|587759353|FG009|Overall Study|Adverse Event|0|||
162739585|NCT04632992|587759354|FG010|Overall Study|Adverse Event|0|||
162739586|NCT04632992|587759355|FG011|Overall Study|Adverse Event|0|||
162739587|NCT04632992|587759356|FG012|Overall Study|Adverse Event|1|||
162739588|NCT04632992|587759357|FG013|Overall Study|Adverse Event|0|||
162739589|NCT04632992|587759344|FG000|Overall Study|Death|17|||
162739590|NCT04632992|587759345|FG001|Overall Study|Death|1|||
162739591|NCT04632992|587759346|FG002|Overall Study|Death|14|||
162739592|NCT04632992|587759347|FG003|Overall Study|Death|14|||
162739593|NCT04632992|587759348|FG004|Overall Study|Death|13|||
162739594|NCT04632992|587759349|FG005|Overall Study|Death|6|||
162739595|NCT04632992|587759350|FG006|Overall Study|Death|7|||
162739596|NCT04632992|587759351|FG007|Overall Study|Death|12|||
162739597|NCT04632992|587759352|FG008|Overall Study|Death|15|||
162739598|NCT04632992|587759353|FG009|Overall Study|Death|20|||
162739599|NCT04632992|587759354|FG010|Overall Study|Death|8|||
162739600|NCT04632992|587759355|FG011|Overall Study|Death|2|||
162739601|NCT04632992|587759356|FG012|Overall Study|Death|10|||
162739602|NCT04632992|587759357|FG013|Overall Study|Death|1|||
162739603|NCT04632992|587759344|FG000|Overall Study|Lost to Follow-up|1|||
162739604|NCT04632992|587759345|FG001|Overall Study|Lost to Follow-up|0|||
162739605|NCT04632992|587759346|FG002|Overall Study|Lost to Follow-up|1|||
162739606|NCT04632992|587759347|FG003|Overall Study|Lost to Follow-up|0|||
162739607|NCT04632992|587759348|FG004|Overall Study|Lost to Follow-up|2|||
162739608|NCT04632992|587759349|FG005|Overall Study|Lost to Follow-up|0|||
162739609|NCT04632992|587759350|FG006|Overall Study|Lost to Follow-up|1|||
162739610|NCT04632992|587759351|FG007|Overall Study|Lost to Follow-up|1|||
162739611|NCT04632992|587759352|FG008|Overall Study|Lost to Follow-up|1|||
162739612|NCT04632992|587759353|FG009|Overall Study|Lost to Follow-up|1|||
162739613|NCT04632992|587759354|FG010|Overall Study|Lost to Follow-up|2|||
162739614|NCT04632992|587759355|FG011|Overall Study|Lost to Follow-up|0|||
162739615|NCT04632992|587759356|FG012|Overall Study|Lost to Follow-up|0|||
162739616|NCT04632992|587759357|FG013|Overall Study|Lost to Follow-up|0|||
162739617|NCT04632992|587759344|FG000|Overall Study|Reason not Specified|2|||
162739618|NCT04632992|587759345|FG001|Overall Study|Reason not Specified|0|||
162739619|NCT04632992|587759346|FG002|Overall Study|Reason not Specified|1|||
162739620|NCT04632992|587759347|FG003|Overall Study|Reason not Specified|1|||
162739621|NCT04632992|587759348|FG004|Overall Study|Reason not Specified|0|||
162739622|NCT04632992|587759349|FG005|Overall Study|Reason not Specified|0|||
162739623|NCT04632992|587759350|FG006|Overall Study|Reason not Specified|0|||
162739624|NCT04632992|587759351|FG007|Overall Study|Reason not Specified|0|||
162739625|NCT04632992|587759352|FG008|Overall Study|Reason not Specified|0|||
162739626|NCT04632992|587759353|FG009|Overall Study|Reason not Specified|0|||
162739627|NCT04632992|587759354|FG010|Overall Study|Reason not Specified|1|||
162739628|NCT04632992|587759355|FG011|Overall Study|Reason not Specified|0|||
162739629|NCT04632992|587759356|FG012|Overall Study|Reason not Specified|0|||
162739630|NCT04632992|587759357|FG013|Overall Study|Reason not Specified|0|||
162739631|NCT04632992|587759344|FG000|Overall Study|Physician Decision|0|||
162739632|NCT04632992|587759345|FG001|Overall Study|Physician Decision|0|||
162739633|NCT04632992|587759346|FG002|Overall Study|Physician Decision|0|||
162739634|NCT04632992|587759347|FG003|Overall Study|Physician Decision|2|||
162739635|NCT04632992|587759348|FG004|Overall Study|Physician Decision|1|||
162739636|NCT04632992|587759349|FG005|Overall Study|Physician Decision|0|||
162739637|NCT04632992|587759350|FG006|Overall Study|Physician Decision|0|||
162739638|NCT04632992|587759351|FG007|Overall Study|Physician Decision|0|||
162739639|NCT04632992|587759352|FG008|Overall Study|Physician Decision|0|||
162739640|NCT04632992|587759353|FG009|Overall Study|Physician Decision|0|||
162739641|NCT04632992|587759354|FG010|Overall Study|Physician Decision|0|||
162739642|NCT04632992|587759355|FG011|Overall Study|Physician Decision|0|||
162739643|NCT04632992|587759356|FG012|Overall Study|Physician Decision|3|||
162739644|NCT04632992|587759357|FG013|Overall Study|Physician Decision|0|||
162739645|NCT04632992|587759344|FG000|Overall Study|Progressive Disease|0|||
162739646|NCT04632992|587759345|FG001|Overall Study|Progressive Disease|0|||
162739647|NCT04632992|587759346|FG002|Overall Study|Progressive Disease|0|||
162739648|NCT04632992|587759347|FG003|Overall Study|Progressive Disease|0|||
162739649|NCT04632992|587759348|FG004|Overall Study|Progressive Disease|1|||
162739650|NCT04632992|587759349|FG005|Overall Study|Progressive Disease|0|||
162739651|NCT04632992|587759350|FG006|Overall Study|Progressive Disease|0|||
162739652|NCT04632992|587759351|FG007|Overall Study|Progressive Disease|0|||
162739653|NCT04632992|587759352|FG008|Overall Study|Progressive Disease|0|||
162739654|NCT04632992|587759353|FG009|Overall Study|Progressive Disease|1|||
162739655|NCT04632992|587759354|FG010|Overall Study|Progressive Disease|1|||
162739656|NCT04632992|587759355|FG011|Overall Study|Progressive Disease|0|||
162739657|NCT04632992|587759356|FG012|Overall Study|Progressive Disease|2|||
162739658|NCT04632992|587759357|FG013|Overall Study|Progressive Disease|0|||
162739659|NCT04632992|587759344|FG000|Overall Study|Withdrawal by Subject|4|||
162739660|NCT04632992|587759345|FG001|Overall Study|Withdrawal by Subject|1|||
162739661|NCT04632992|587759346|FG002|Overall Study|Withdrawal by Subject|5|||
162739662|NCT04632992|587759347|FG003|Overall Study|Withdrawal by Subject|4|||
162739663|NCT04632992|587759348|FG004|Overall Study|Withdrawal by Subject|3|||
162739664|NCT04632992|587759349|FG005|Overall Study|Withdrawal by Subject|3|||
162739665|NCT04632992|587759350|FG006|Overall Study|Withdrawal by Subject|0|||
162739666|NCT04632992|587759351|FG007|Overall Study|Withdrawal by Subject|5|||
162739667|NCT04632992|587759352|FG008|Overall Study|Withdrawal by Subject|0|||
162739668|NCT04632992|587759353|FG009|Overall Study|Withdrawal by Subject|2|||
162739669|NCT04632992|587759354|FG010|Overall Study|Withdrawal by Subject|8|||
162739670|NCT04632992|587759355|FG011|Overall Study|Withdrawal by Subject|0|||
162739671|NCT04632992|587759356|FG012|Overall Study|Withdrawal by Subject|1|||
162739672|NCT04632992|587759357|FG013|Overall Study|Withdrawal by Subject|1|||
162739673|NCT02677805|587759358|FG000|Double Blind Phase|Lost to Follow-up|8|||
162739674|NCT02677805|587759359|FG001|Double Blind Phase|Lost to Follow-up|3|||
162739675|NCT02677805|587759360|FG002|Double Blind Phase|Lost to Follow-up|0|||
162739676|NCT02677805|587759358|FG000|Double Blind Phase|Withdrawal by Subject|5|||
162739677|NCT02677805|587759359|FG001|Double Blind Phase|Withdrawal by Subject|2|||
162739678|NCT02677805|587759360|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162739679|NCT02677805|587759358|FG000|Open Label Phase|Lost to Follow-up|0|||
162739680|NCT02677805|587759359|FG001|Open Label Phase|Lost to Follow-up|0|||
162739681|NCT02677805|587759360|FG002|Open Label Phase|Lost to Follow-up|10|||
162739682|NCT02677805|587759358|FG000|Open Label Phase|Withdrawal by Subject|0|||
162739683|NCT02677805|587759359|FG001|Open Label Phase|Withdrawal by Subject|0|||
162739684|NCT02677805|587759360|FG002|Open Label Phase|Withdrawal by Subject|6|||
162739685|NCT04350463|587759365|FG000|Overall Study|Other reason|0|||
162739686|NCT04350463|587759366|FG001|Overall Study|Other reason|0|||
162739687|NCT04350463|587759367|FG002|Overall Study|Other reason|0|||
162739688|NCT04350463|587759368|FG003|Overall Study|Other reason|1|||
162739689|NCT04350463|587759365|FG000|Overall Study|Lost to Follow-up|0|||
162739690|NCT04350463|587759366|FG001|Overall Study|Lost to Follow-up|0|||
162739691|NCT04350463|587759367|FG002|Overall Study|Lost to Follow-up|0|||
162739692|NCT04350463|587759368|FG003|Overall Study|Lost to Follow-up|2|||
162739693|NCT04350463|587759365|FG000|Overall Study|Withdrawal by Subject|4|||
162739694|NCT04350463|587759366|FG001|Overall Study|Withdrawal by Subject|0|||
162739695|NCT04350463|587759367|FG002|Overall Study|Withdrawal by Subject|1|||
162739696|NCT04350463|587759368|FG003|Overall Study|Withdrawal by Subject|4|||
162739697|NCT04350463|587759365|FG000|Overall Study|Adverse Event|0|||
162739698|NCT04350463|587759366|FG001|Overall Study|Adverse Event|0|||
162739699|NCT04350463|587759367|FG002|Overall Study|Adverse Event|0|||
162739700|NCT04350463|587759368|FG003|Overall Study|Adverse Event|2|||
162739701|NCT04350463|587759365|FG000|Overall Study|Death|27|||
162739702|NCT04350463|587759366|FG001|Overall Study|Death|2|||
162739703|NCT04350463|587759367|FG002|Overall Study|Death|13|||
162739704|NCT04350463|587759368|FG003|Overall Study|Death|26|||
162739705|NCT04111536|587759369|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162739706|NCT04111536|587759370|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162739707|NCT04111536|587759369|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
162739708|NCT04111536|587759370|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
162739709|NCT04111536|587759369|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
162739710|NCT04111536|587759370|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162739711|NCT04111536|587759369|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
162739712|NCT04111536|587759370|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
162739713|NCT04652700|587759371|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
162739714|NCT04652700|587759372|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
162739715|NCT04652700|587759371|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
162739716|NCT04652700|587759372|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
162739717|NCT04652700|587759371|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
162739718|NCT04652700|587759372|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
162739719|NCT04652700|587759371|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
162739720|NCT04652700|587759372|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
162739721|NCT04652700|587759371|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
162739722|NCT04652700|587759372|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
162739723|NCT04652700|587759371|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
162739724|NCT04652700|587759372|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
162739725|NCT04652700|587759371|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
162739726|NCT04652700|587759372|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
162739727|NCT04652700|587759371|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
162739728|NCT04652700|587759372|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
162739729|NCT04652700|587759371|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
162739730|NCT04652700|587759372|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
162739731|NCT04187833|587759373|FG000|Overall Study|Withdrawal by Subject|1|||
162739732|NCT06037369|587759377|FG000|Overall Study|Lost to Follow-up|0|||
162739733|NCT06037369|587759378|FG001|Overall Study|Lost to Follow-up|1|||
162739734|NCT04209465|587759379|FG000|Overall Study|Adverse Event|0|||
162739735|NCT04209465|587759380|FG001|Overall Study|Adverse Event|0|||
162739736|NCT04209465|587759381|FG002|Overall Study|Adverse Event|0|||
162739737|NCT04209465|587759382|FG003|Overall Study|Adverse Event|0|||
162739738|NCT04209465|587759383|FG004|Overall Study|Adverse Event|0|||
162739739|NCT04209465|587759384|FG005|Overall Study|Adverse Event|1|||
162739740|NCT04209465|587759385|FG006|Overall Study|Adverse Event|0|||
162739741|NCT04209465|587759386|FG007|Overall Study|Adverse Event|0|||
162739742|NCT04209465|587759387|FG008|Overall Study|Adverse Event|1|||
162739743|NCT04209465|587759388|FG009|Overall Study|Adverse Event|0|||
162739744|NCT04209465|587759389|FG010|Overall Study|Adverse Event|2|||
162739745|NCT04209465|587759390|FG011|Overall Study|Adverse Event|1|||
162739746|NCT04209465|587759391|FG012|Overall Study|Adverse Event|1|||
162739747|NCT04209465|587759379|FG000|Overall Study|Death|1|||
162739748|NCT04209465|587759380|FG001|Overall Study|Death|0|||
162739749|NCT04209465|587759381|FG002|Overall Study|Death|0|||
162739750|NCT04209465|587759382|FG003|Overall Study|Death|0|||
162739751|NCT04209465|587759383|FG004|Overall Study|Death|2|||
162739752|NCT04209465|587759384|FG005|Overall Study|Death|7|||
162739753|NCT04209465|587759385|FG006|Overall Study|Death|2|||
162739754|NCT04209465|587759386|FG007|Overall Study|Death|2|||
162739755|NCT04209465|587759387|FG008|Overall Study|Death|1|||
162739756|NCT04209465|587759388|FG009|Overall Study|Death|1|||
162739757|NCT04209465|587759389|FG010|Overall Study|Death|1|||
162739758|NCT04209465|587759390|FG011|Overall Study|Death|0|||
162739759|NCT04209465|587759391|FG012|Overall Study|Death|10|||
162739760|NCT04209465|587759379|FG000|Overall Study|Physician Decision|0|||
162739761|NCT04209465|587759380|FG001|Overall Study|Physician Decision|1|||
162739762|NCT04209465|587759381|FG002|Overall Study|Physician Decision|0|||
162739763|NCT04209465|587759382|FG003|Overall Study|Physician Decision|0|||
162739764|NCT04209465|587759383|FG004|Overall Study|Physician Decision|0|||
162739765|NCT04209465|587759384|FG005|Overall Study|Physician Decision|0|||
162739766|NCT04209465|587759385|FG006|Overall Study|Physician Decision|0|||
162739767|NCT04209465|587759386|FG007|Overall Study|Physician Decision|0|||
162739768|NCT04209465|587759387|FG008|Overall Study|Physician Decision|0|||
162739769|NCT04209465|587759388|FG009|Overall Study|Physician Decision|0|||
162739770|NCT04209465|587759389|FG010|Overall Study|Physician Decision|0|||
162739771|NCT04209465|587759390|FG011|Overall Study|Physician Decision|0|||
162739772|NCT04209465|587759391|FG012|Overall Study|Physician Decision|0|||
162739773|NCT04209465|587759379|FG000|Overall Study|Progressive Disease|0|||
162739774|NCT04209465|587759380|FG001|Overall Study|Progressive Disease|0|||
162739775|NCT04209465|587759381|FG002|Overall Study|Progressive Disease|1|||
162739776|NCT04209465|587759382|FG003|Overall Study|Progressive Disease|2|||
162739777|NCT04209465|587759383|FG004|Overall Study|Progressive Disease|8|||
162739778|NCT04209465|587759384|FG005|Overall Study|Progressive Disease|5|||
162739779|NCT04209465|587759385|FG006|Overall Study|Progressive Disease|3|||
162739780|NCT04209465|587759386|FG007|Overall Study|Progressive Disease|4|||
162739781|NCT04209465|587759387|FG008|Overall Study|Progressive Disease|1|||
162739782|NCT04209465|587759388|FG009|Overall Study|Progressive Disease|3|||
162739783|NCT04209465|587759389|FG010|Overall Study|Progressive Disease|2|||
162739784|NCT04209465|587759390|FG011|Overall Study|Progressive Disease|1|||
162739785|NCT04209465|587759391|FG012|Overall Study|Progressive Disease|0|||
162739786|NCT04209465|587759379|FG000|Overall Study|Withdrawal by Subject|0|||
162739787|NCT04209465|587759380|FG001|Overall Study|Withdrawal by Subject|0|||
162739788|NCT04209465|587759381|FG002|Overall Study|Withdrawal by Subject|0|||
162739789|NCT04209465|587759382|FG003|Overall Study|Withdrawal by Subject|0|||
162739790|NCT04209465|587759383|FG004|Overall Study|Withdrawal by Subject|0|||
162739791|NCT04209465|587759384|FG005|Overall Study|Withdrawal by Subject|1|||
162739792|NCT04209465|587759385|FG006|Overall Study|Withdrawal by Subject|2|||
162739793|NCT04209465|587759386|FG007|Overall Study|Withdrawal by Subject|0|||
162739794|NCT04209465|587759387|FG008|Overall Study|Withdrawal by Subject|1|||
162739795|NCT04209465|587759388|FG009|Overall Study|Withdrawal by Subject|0|||
162739796|NCT04209465|587759389|FG010|Overall Study|Withdrawal by Subject|0|||
162739797|NCT04209465|587759390|FG011|Overall Study|Withdrawal by Subject|2|||
162739798|NCT04209465|587759391|FG012|Overall Study|Withdrawal by Subject|2|||
162739799|NCT04209465|587759379|FG000|Overall Study|Lost to Follow-up|0|||
162739800|NCT04209465|587759380|FG001|Overall Study|Lost to Follow-up|0|||
162739801|NCT04209465|587759381|FG002|Overall Study|Lost to Follow-up|0|||
162739802|NCT04209465|587759382|FG003|Overall Study|Lost to Follow-up|0|||
162739803|NCT04209465|587759383|FG004|Overall Study|Lost to Follow-up|0|||
162739804|NCT04209465|587759384|FG005|Overall Study|Lost to Follow-up|1|||
162739805|NCT04209465|587759385|FG006|Overall Study|Lost to Follow-up|0|||
162739806|NCT04209465|587759386|FG007|Overall Study|Lost to Follow-up|0|||
162739807|NCT04209465|587759387|FG008|Overall Study|Lost to Follow-up|1|||
162739808|NCT04209465|587759388|FG009|Overall Study|Lost to Follow-up|0|||
162739809|NCT04209465|587759389|FG010|Overall Study|Lost to Follow-up|0|||
162739810|NCT04209465|587759390|FG011|Overall Study|Lost to Follow-up|1|||
162739811|NCT04209465|587759391|FG012|Overall Study|Lost to Follow-up|0|||
162739812|NCT04209465|587759379|FG000|Overall Study|Started new therapy|0|||
162739813|NCT04209465|587759380|FG001|Overall Study|Started new therapy|0|||
162739814|NCT04209465|587759381|FG002|Overall Study|Started new therapy|0|||
162739815|NCT04209465|587759382|FG003|Overall Study|Started new therapy|0|||
162739816|NCT04209465|587759383|FG004|Overall Study|Started new therapy|0|||
162739817|NCT04209465|587759384|FG005|Overall Study|Started new therapy|1|||
162739818|NCT04209465|587759385|FG006|Overall Study|Started new therapy|0|||
162739819|NCT04209465|587759386|FG007|Overall Study|Started new therapy|0|||
162739820|NCT04209465|587759387|FG008|Overall Study|Started new therapy|0|||
162739821|NCT04209465|587759388|FG009|Overall Study|Started new therapy|0|||
162739822|NCT04209465|587759389|FG010|Overall Study|Started new therapy|0|||
162739823|NCT04209465|587759390|FG011|Overall Study|Started new therapy|0|||
162739824|NCT04209465|587759391|FG012|Overall Study|Started new therapy|0|||
162739825|NCT04209465|587759379|FG000|Overall Study|Study terminated early by sponsor|0|||
162739826|NCT04209465|587759380|FG001|Overall Study|Study terminated early by sponsor|0|||
162739827|NCT04209465|587759381|FG002|Overall Study|Study terminated early by sponsor|0|||
162739828|NCT04209465|587759382|FG003|Overall Study|Study terminated early by sponsor|0|||
162739829|NCT04209465|587759383|FG004|Overall Study|Study terminated early by sponsor|0|||
162739830|NCT04209465|587759384|FG005|Overall Study|Study terminated early by sponsor|0|||
162739831|NCT04209465|587759385|FG006|Overall Study|Study terminated early by sponsor|3|||
162739832|NCT04209465|587759386|FG007|Overall Study|Study terminated early by sponsor|0|||
162739833|NCT04209465|587759387|FG008|Overall Study|Study terminated early by sponsor|0|||
162739834|NCT04209465|587759388|FG009|Overall Study|Study terminated early by sponsor|0|||
162739835|NCT04209465|587759389|FG010|Overall Study|Study terminated early by sponsor|0|||
162739836|NCT04209465|587759390|FG011|Overall Study|Study terminated early by sponsor|0|||
162739837|NCT04209465|587759391|FG012|Overall Study|Study terminated early by sponsor|3|||
162739838|NCT04209465|587759379|FG000|Overall Study|Other|0|||
162739839|NCT04209465|587759380|FG001|Overall Study|Other|0|||
162739840|NCT04209465|587759381|FG002|Overall Study|Other|0|||
162739841|NCT04209465|587759382|FG003|Overall Study|Other|0|||
162739842|NCT04209465|587759383|FG004|Overall Study|Other|0|||
162739843|NCT04209465|587759384|FG005|Overall Study|Other|0|||
162739844|NCT04209465|587759385|FG006|Overall Study|Other|0|||
162739845|NCT04209465|587759386|FG007|Overall Study|Other|0|||
162739846|NCT04209465|587759387|FG008|Overall Study|Other|1|||
162739847|NCT04209465|587759388|FG009|Overall Study|Other|0|||
162739848|NCT04209465|587759389|FG010|Overall Study|Other|0|||
162739849|NCT04209465|587759390|FG011|Overall Study|Other|0|||
162739850|NCT04209465|587759391|FG012|Overall Study|Other|0|||
162739851|NCT05647304|587759392|FG000|Overall Study|Withdrawal by Subject|1|||
162739852|NCT05647304|587759393|FG001|Overall Study|Withdrawal by Subject|0|||
162739853|NCT04505904|587759394|FG000|Overall Study|Withdrawal by Subject|1|||
162739854|NCT04505904|587759395|FG001|Overall Study|Withdrawal by Subject|2|||
162739855|NCT04505904|587759396|FG002|Overall Study|Withdrawal by Subject|0|||
162739856|NCT04505904|587759397|FG003|Overall Study|Withdrawal by Subject|0|||
162739857|NCT04505904|587759394|FG000|Overall Study|Physician Decision|1|||
162739858|NCT04505904|587759395|FG001|Overall Study|Physician Decision|0|||
162739859|NCT04505904|587759396|FG002|Overall Study|Physician Decision|0|||
162739860|NCT04505904|587759397|FG003|Overall Study|Physician Decision|0|||
162739861|NCT04505904|587759394|FG000|Overall Study|Adverse Event|0|||
162739862|NCT04505904|587759395|FG001|Overall Study|Adverse Event|1|||
162739863|NCT04505904|587759396|FG002|Overall Study|Adverse Event|0|||
162739864|NCT04505904|587759397|FG003|Overall Study|Adverse Event|0|||
162739865|NCT03092518|587759398|FG000|Overall Study|Ineligible|2|||
162739866|NCT02547987|587759401|FG000|Overall Study|Withdrawal by Subject|1|||
162739867|NCT02547987|587759401|FG000|Overall Study|Adverse Event|2|||
162739868|NCT04282148|587759402|FG000|Overall Study|Death|7|||
162739869|NCT04282148|587759402|FG000|Overall Study|Withdrawal by Subject|1|||
162739870|NCT04282148|587759402|FG000|Overall Study|Physician Decision|1|||
162739871|NCT02146378|587759403|FG000|Overall Study|No information of administration|2|||
162739872|NCT06215521|587759404|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
162739873|NCT06215521|587759405|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
162739874|NCT06215521|587759406|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
162739875|NCT06215521|587759407|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
162739876|NCT06215521|587759408|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
162739877|NCT06215521|587759409|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
162739878|NCT04096040|587759410|FG000|Overall Study|Protocol Violation|12|||
162739879|NCT04096040|587759410|FG000|Overall Study|Non-compliant site|4|||
162739880|NCT04044768|587759411|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
162739881|NCT04044768|587759412|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
162739882|NCT05089019|587759413|FG000|Period 1|Withdrawal by Subject|0|||
162739883|NCT05089019|587759414|FG001|Period 1|Withdrawal by Subject|1|||
162739884|NCT05089019|587759413|FG000|Washout Period|Adverse Event|3|||
162739885|NCT05089019|587759414|FG001|Washout Period|Adverse Event|4|||
162739886|NCT05089019|587759413|FG000|Washout Period|Lost to Follow-up|1|||
162739887|NCT05089019|587759414|FG001|Washout Period|Lost to Follow-up|0|||
162739888|NCT05089019|587759413|FG000|Washout Period|Physician Decision|2|||
162739889|NCT05089019|587759414|FG001|Washout Period|Physician Decision|0|||
162739890|NCT05089019|587759413|FG000|Washout Period|Withdrawal by Subject|6|||
162739891|NCT05089019|587759414|FG001|Washout Period|Withdrawal by Subject|3|||
162739892|NCT05089019|587759413|FG000|Period 2|Adverse Event|4|||
162739893|NCT05089019|587759414|FG001|Period 2|Adverse Event|2|||
162739894|NCT05089019|587759413|FG000|Period 2|Lost to Follow-up|1|||
162739895|NCT05089019|587759414|FG001|Period 2|Lost to Follow-up|0|||
162739896|NCT05089019|587759413|FG000|Period 2|Withdrawal by Subject|0|||
162739897|NCT05089019|587759414|FG001|Period 2|Withdrawal by Subject|1|||
162739898|NCT04925986|587759415|FG000|Overall Study|Death|0|||
162739899|NCT04925986|587759416|FG001|Overall Study|Death|0|||
162739900|NCT04925986|587759417|FG002|Overall Study|Death|2|||
162739901|NCT04925986|587759418|FG003|Overall Study|Death|0|||
162739902|NCT04925986|587759415|FG000|Overall Study|Lack of Efficacy|1|||
162739903|NCT04925986|587759416|FG001|Overall Study|Lack of Efficacy|2|||
162739904|NCT04925986|587759417|FG002|Overall Study|Lack of Efficacy|0|||
162739905|NCT04925986|587759418|FG003|Overall Study|Lack of Efficacy|1|||
162739906|NCT04925986|587759415|FG000|Overall Study|Withdrawal by Subject|0|||
162739907|NCT04925986|587759416|FG001|Overall Study|Withdrawal by Subject|0|||
162739908|NCT04925986|587759417|FG002|Overall Study|Withdrawal by Subject|1|||
162739909|NCT04925986|587759418|FG003|Overall Study|Withdrawal by Subject|2|||
162739910|NCT03808818|587759419|FG000|Overall Study|Death|6|||
162739911|NCT03808818|587759420|FG001|Overall Study|Death|6|||
162739912|NCT03808818|587759419|FG000|Overall Study|Withdrawal by Subject|7|||
162739913|NCT03808818|587759420|FG001|Overall Study|Withdrawal by Subject|18|||
162739914|NCT03808818|587759419|FG000|Overall Study|Lost to Follow-up|31|||
162739915|NCT03808818|587759420|FG001|Overall Study|Lost to Follow-up|33|||
162739916|NCT03858634|587759421|FG000|Overall Study|Withdrawal by Subject|1|||
162739917|NCT03858634|587759422|FG001|Overall Study|Withdrawal by Subject|0|||
162739918|NCT03858634|587759421|FG000|Overall Study|Adverse Event|1|||
162739919|NCT03858634|587759422|FG001|Overall Study|Adverse Event|0|||
162739920|NCT03858634|587759421|FG000|Overall Study|Lost to Follow-up|0|||
162739921|NCT03858634|587759422|FG001|Overall Study|Lost to Follow-up|1|||
162739922|NCT03858634|587759421|FG000|Overall Study|Other, Not Specified|1|||
162739923|NCT03858634|587759422|FG001|Overall Study|Other, Not Specified|1|||
162739924|NCT06181760|587759423|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
162739925|NCT06181760|587759424|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
162739926|NCT06181760|587759425|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
162739927|NCT06181760|587759426|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
162739928|NCT04537715|587759429|FG000|Overall Study|Death|3|||
162739929|NCT04537715|587759430|FG001|Overall Study|Death|1|||
162739930|NCT04537715|587759429|FG000|Overall Study|Withdrawal by Subject|3|||
162739931|NCT04537715|587759430|FG001|Overall Study|Withdrawal by Subject|1|||
162739932|NCT04537715|587759429|FG000|Overall Study|Other|4|||
162739933|NCT04537715|587759430|FG001|Overall Study|Other|3|||
162739934|NCT04537715|587759429|FG000|Overall Study|Progressive disease|1|||
162739935|NCT04537715|587759430|FG001|Overall Study|Progressive disease|0|||
162739936|NCT05457647|587759432|FG000|Overall Study|Lost to Follow-up|3|||
162739937|NCT03448107|587759433|FG000|Overall Study|Lost to Follow-up|229|||
162739938|NCT03448107|587759434|FG001|Overall Study|Lost to Follow-up|258|||
162739939|NCT03115476|587759435|FG000|LP0084-1369|Death|1|||
162739940|NCT03115476|587759436|FG001|LP0084-1369|Death|0|||
162739941|NCT03115476|587759437|FG002|LP0084-1369|Death|2|||
162739942|NCT03115476|587759435|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
162739943|NCT03115476|587759436|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
162739944|NCT03115476|587759437|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
162739945|NCT01648023|587759438|FG000|Overall Study|Screen Fail Post Randomization|1|||
162739946|NCT01648023|587759439|FG001|Overall Study|Screen Fail Post Randomization|2|||
162739947|NCT05296525|587759443|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162739948|NCT05296525|587759444|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162739949|NCT05296525|587759445|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162739950|NCT05296525|587759446|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
162739951|NCT02465268|587759448|FG000|Overall Study|Withdrawal by Subject|4|||
162739952|NCT02465268|587759449|FG001|Overall Study|Withdrawal by Subject|3|||
162739953|NCT02465268|587759450|FG002|Overall Study|Withdrawal by Subject|1|||
162739954|NCT02465268|587759448|FG000|Overall Study|Not evaluable per protocol criteria|3|||
162739955|NCT02465268|587759449|FG001|Overall Study|Not evaluable per protocol criteria|2|||
162739956|NCT02465268|587759450|FG002|Overall Study|Not evaluable per protocol criteria|1|||
162739957|NCT02465268|587759448|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
162739958|NCT02465268|587759449|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
162739959|NCT02465268|587759450|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
162739960|NCT02465268|587759448|FG000|Overall Study|Study drug did not pass QA/QC|1|||
162739961|NCT02465268|587759449|FG001|Overall Study|Study drug did not pass QA/QC|0|||
162739962|NCT02465268|587759450|FG002|Overall Study|Study drug did not pass QA/QC|0|||
162739963|NCT02465268|587759448|FG000|Overall Study|Adverse Event|0|||
162739964|NCT02465268|587759449|FG001|Overall Study|Adverse Event|1|||
162739965|NCT02465268|587759450|FG002|Overall Study|Adverse Event|0|||
162739966|NCT02465268|587759448|FG000|Overall Study|Physician Decision|0|||
162739967|NCT02465268|587759449|FG001|Overall Study|Physician Decision|1|||
162739968|NCT02465268|587759450|FG002|Overall Study|Physician Decision|0|||
162739969|NCT02547363|587759453|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162739970|NCT02547363|587759454|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162739971|NCT02547363|587759453|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
162739972|NCT02547363|587759454|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
162739973|NCT02547363|587759453|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162739974|NCT02547363|587759454|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162739975|NCT02547363|587759453|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
162739976|NCT02547363|587759454|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
162739977|NCT02547363|587759453|FG000|12-month Follow-up|Withdrawal by Subject|4|||
162739978|NCT02547363|587759454|FG001|12-month Follow-up|Withdrawal by Subject|3|||
162739979|NCT02547363|587759453|FG000|12-month Follow-up|Lost to Follow-up|4|||
162739980|NCT02547363|587759454|FG001|12-month Follow-up|Lost to Follow-up|1|||
162739981|NCT02547363|587759453|FG000|12-month Follow-up|Lack of Efficacy|1|||
162739982|NCT02547363|587759454|FG001|12-month Follow-up|Lack of Efficacy|1|||
162739983|NCT02547363|587759453|FG000|12-month Follow-up|Other|1|||
162739984|NCT02547363|587759454|FG001|12-month Follow-up|Other|0|||
162739985|NCT03322267|587759456|FG000|Overall Study|Lack of Efficacy|11|||
162739986|NCT03322267|587759456|FG000|Overall Study|Adverse Event|1|||
162739987|NCT03322267|587759456|FG000|Overall Study|Withdrawal by Subject|2|||
162739988|NCT05228457|587759459|FG000|Overall Study|Withdrawal by Subject|1|||
162739989|NCT05228457|587759460|FG001|Overall Study|Withdrawal by Subject|1|||
162739990|NCT03213691|587759465|FG000|Overall Study|Adverse Event|2|||
162739991|NCT03213691|587759465|FG000|Overall Study|Death|3|||
162739992|NCT03213691|587759465|FG000|Overall Study|Physician Decision|1|||
162739993|NCT03213691|587759465|FG000|Overall Study|Progressive Disease|14|||
162739994|NCT03213691|587759465|FG000|Overall Study|Ineligible|1|||
162739995|NCT03161028|587759466|FG000|Overall Study|Withdrawal by Subject|6|||
162739996|NCT03161028|587759467|FG001|Overall Study|Withdrawal by Subject|4|||
162739997|NCT03161028|587759466|FG000|Overall Study|Adverse Event|5|||
162739998|NCT03161028|587759467|FG001|Overall Study|Adverse Event|1|||
162739999|NCT03161028|587759466|FG000|Overall Study|Study drug side effects|2|||
162740000|NCT03161028|587759467|FG001|Overall Study|Study drug side effects|2|||
162740001|NCT03161028|587759466|FG000|Overall Study|Administrative PD/UP|4|||
162740002|NCT03161028|587759467|FG001|Overall Study|Administrative PD/UP|2|||
162740003|NCT03161028|587759466|FG000|Overall Study|Lost to Follow-up|2|||
162740004|NCT03161028|587759467|FG001|Overall Study|Lost to Follow-up|0|||
162740005|NCT03161028|587759466|FG000|Overall Study|Unable to comply with procedures|1|||
162740006|NCT03161028|587759467|FG001|Overall Study|Unable to comply with procedures|1|||
162740007|NCT00736723|587759468|FG000|Overall Study|Withdrawal by Subject|4|||
162740008|NCT00736723|587759469|FG001|Overall Study|Withdrawal by Subject|3|||
162740009|NCT01799265|587759472|FG000|Overall Study|Lost to Follow-up|1|||
162740010|NCT01799265|587759473|FG001|Overall Study|Lost to Follow-up|0|||
162740011|NCT01799265|587759472|FG000|Overall Study|Protocol Violation|2|||
162740012|NCT01799265|587759473|FG001|Overall Study|Protocol Violation|1|||
162740013|NCT01799265|587759472|FG000|Overall Study|inadequate sleep study|0|||
162740014|NCT01799265|587759473|FG001|Overall Study|inadequate sleep study|2|||
162740015|NCT03084536|587759477|FG000|Overall Study|Determined to be ineligible|0|||
162740016|NCT03084536|587759478|FG001|Overall Study|Determined to be ineligible|0|||
162740017|NCT03084536|587759479|FG002|Overall Study|Determined to be ineligible|16|||
162740018|NCT03084536|587759477|FG000|Overall Study|Withdrawal by Subject|0|||
162740019|NCT03084536|587759478|FG001|Overall Study|Withdrawal by Subject|0|||
162740020|NCT03084536|587759479|FG002|Overall Study|Withdrawal by Subject|4|||
162740021|NCT03084536|587759477|FG000|Overall Study|Physician Decision|0|||
162740022|NCT03084536|587759478|FG001|Overall Study|Physician Decision|0|||
162740023|NCT03084536|587759479|FG002|Overall Study|Physician Decision|3|||
162740024|NCT03084536|587759477|FG000|Overall Study|Death|0|||
162740025|NCT03084536|587759478|FG001|Overall Study|Death|0|||
162740026|NCT03084536|587759479|FG002|Overall Study|Death|1|||
162740027|NCT03084536|587759477|FG000|Overall Study|Lost to Follow-up|0|||
162740028|NCT03084536|587759478|FG001|Overall Study|Lost to Follow-up|0|||
162740029|NCT03084536|587759479|FG002|Overall Study|Lost to Follow-up|1|||
162740030|NCT03084536|587759477|FG000|Overall Study|Protocol Violation|0|||
162740031|NCT03084536|587759478|FG001|Overall Study|Protocol Violation|0|||
162740032|NCT03084536|587759479|FG002|Overall Study|Protocol Violation|1|||
162740033|NCT03084536|587759477|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
162740034|NCT03084536|587759478|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
162740035|NCT03084536|587759479|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
162740036|NCT05704543|587759480|FG000|Overall Study|Withdrawal by Subject|1|||
162740037|NCT05704543|587759481|FG001|Overall Study|Withdrawal by Subject|1|||
162740038|NCT05704543|587759482|FG002|Overall Study|Withdrawal by Subject|0|||
162740039|NCT05704543|587759483|FG003|Overall Study|Withdrawal by Subject|2|||
162740040|NCT05704543|587759480|FG000|Overall Study|Lost to Follow-up|1|||
162740041|NCT05704543|587759481|FG001|Overall Study|Lost to Follow-up|2|||
162740042|NCT05704543|587759482|FG002|Overall Study|Lost to Follow-up|0|||
162740043|NCT05704543|587759483|FG003|Overall Study|Lost to Follow-up|0|||
162740044|NCT04830800|587759487|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
162740045|NCT04830800|587759488|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
162740046|NCT04830800|587759489|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
162740047|NCT04830800|587759490|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
162740048|NCT04830800|587759491|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
162740049|NCT05302596|587759503|FG000|Overall Study|Withdrawal by Subject|1|||
162740050|NCT05302596|587759504|FG001|Overall Study|Withdrawal by Subject|1|||
162740051|NCT03338933|587761431|FG000|Screening Visit|Lost to Follow-up|1|||
162740052|NCT03338933|587761432|FG001|Screening Visit|Lost to Follow-up|3|||
162740053|NCT03338933|587761433|FG002|Screening Visit|Lost to Follow-up|1|||
162740054|NCT03338933|587761434|FG003|Screening Visit|Lost to Follow-up|4|||
162740055|NCT03338933|587761431|FG000|Screening Visit|Screen fail after consent|2|||
162740056|NCT03338933|587761432|FG001|Screening Visit|Screen fail after consent|7|||
162740057|NCT03338933|587761433|FG002|Screening Visit|Screen fail after consent|1|||
162740058|NCT03338933|587761434|FG003|Screening Visit|Screen fail after consent|4|||
162740059|NCT03338933|587761431|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
162740060|NCT03338933|587761432|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
162740061|NCT03338933|587761433|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
162740062|NCT03338933|587761434|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
162740063|NCT03338933|587761431|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
162740064|NCT03338933|587761432|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
162740065|NCT03338933|587761433|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
162740066|NCT03338933|587761434|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
162740067|NCT03338933|587761431|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
162740068|NCT03338933|587761432|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
162740069|NCT03338933|587761433|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
162740070|NCT03338933|587761434|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
162740071|NCT01084876|587761435|FG000|Main Study Treatment Period|Adverse Event|12|||
162740072|NCT01084876|587761436|FG001|Main Study Treatment Period|Adverse Event|7|||
162740073|NCT01084876|587761435|FG000|Main Study Treatment Period|Disease Progression|41|||
162740074|NCT01084876|587761436|FG001|Main Study Treatment Period|Disease Progression|24|||
162740075|NCT01084876|587761435|FG000|Main Study Treatment Period|Physician Decision|2|||
162740076|NCT01084876|587761436|FG001|Main Study Treatment Period|Physician Decision|0|||
162740077|NCT01084876|587761435|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
162740078|NCT01084876|587761436|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
162740079|NCT01084876|587761435|FG000|Main Study Treatment Period|Other Reason|0|||
162740080|NCT01084876|587761436|FG001|Main Study Treatment Period|Other Reason|1|||
162740081|NCT01084876|587761435|FG000|Main Study Treatment Period|Other|0|||
162740082|NCT01084876|587761436|FG001|Main Study Treatment Period|Other|1|||
162740083|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
162740084|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
162740085|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
162740086|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
162740087|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
162740088|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
162740089|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
162740090|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
162740091|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
162740092|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
162740093|NCT01084876|587761435|FG000|Treatment Period Beyond Cycle 8|Other|6|||
162740094|NCT01084876|587761436|FG001|Treatment Period Beyond Cycle 8|Other|9|||
162740095|NCT04515576|587761437|FG000|Overall Study|Withdrawal by Subject|0|||
162740096|NCT04515576|587761438|FG001|Overall Study|Withdrawal by Subject|0|||
162740097|NCT04515576|587761439|FG002|Overall Study|Withdrawal by Subject|0|||
162740098|NCT04515576|587761440|FG003|Overall Study|Withdrawal by Subject|0|||
162740099|NCT04515576|587761441|FG004|Overall Study|Withdrawal by Subject|0|||
162740100|NCT04515576|587761442|FG005|Overall Study|Withdrawal by Subject|1|||
162740101|NCT03869866|587761443|FG000|Overall Study|Protocol Violation|1|||
162740102|NCT03869866|587761443|FG000|Overall Study|Withdrawal by Subject|3|||
162740103|NCT05543915|587761444|FG000|Overall Study|Lost to Follow-up|0|||
162740104|NCT05543915|587761445|FG001|Overall Study|Lost to Follow-up|1|||
162740105|NCT02577835|587761446|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
162740106|NCT04342494|587761447|FG000|Overall Study|Questionnaire partially completed|1|||
162740107|NCT04342494|587761448|FG001|Overall Study|Questionnaire partially completed|0|||
162740108|NCT04342494|587761449|FG002|Overall Study|Questionnaire partially completed|2|||
162740109|NCT04342494|587761450|FG003|Overall Study|Questionnaire partially completed|0|||
162740110|NCT04342494|587761451|FG004|Overall Study|Questionnaire partially completed|1|||
162740111|NCT04342494|587761447|FG000|Overall Study|Lost to Follow-up|49|||
162740112|NCT04342494|587761448|FG001|Overall Study|Lost to Follow-up|38|||
162740113|NCT04342494|587761449|FG002|Overall Study|Lost to Follow-up|34|||
162740114|NCT04342494|587761450|FG003|Overall Study|Lost to Follow-up|34|||
162740115|NCT04342494|587761451|FG004|Overall Study|Lost to Follow-up|35|||
162740116|NCT05119023|587761453|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
162740117|NCT05119023|587761453|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
162740118|NCT05119023|587761453|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
162740119|NCT03194217|587761454|FG000|Overall Study|Adverse Event|0|||
162740120|NCT03194217|587761455|FG001|Overall Study|Adverse Event|2|||
162740121|NCT03194217|587761456|FG002|Overall Study|Adverse Event|3|||
162740122|NCT03194217|587761457|FG003|Overall Study|Adverse Event|3|||
162740123|NCT03194217|587761454|FG000|Overall Study|Failure to meet randomisation criteria|0|||
162740124|NCT03194217|587761455|FG001|Overall Study|Failure to meet randomisation criteria|0|||
162740125|NCT03194217|587761456|FG002|Overall Study|Failure to meet randomisation criteria|0|||
162740126|NCT03194217|587761457|FG003|Overall Study|Failure to meet randomisation criteria|1|||
162740127|NCT03194217|587761454|FG000|Overall Study|Other|0|||
162740128|NCT03194217|587761455|FG001|Overall Study|Other|1|||
162740129|NCT03194217|587761456|FG002|Overall Study|Other|1|||
162740130|NCT03194217|587761457|FG003|Overall Study|Other|0|||
162740131|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
162740132|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
162740133|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
162740134|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162740135|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162740136|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162740137|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162740138|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740139|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
162740140|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740141|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740142|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740143|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740144|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162740145|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162740146|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
162740147|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
162740148|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162740149|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162740150|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162740151|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162740152|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
162740153|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740154|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740155|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740156|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740157|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740158|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162740159|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740160|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
162740161|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740162|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740163|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740164|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740165|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162740166|NCT02962895|587761458|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740167|NCT02962895|587761459|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740168|NCT02962895|587761460|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740169|NCT02962895|587761461|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
162740170|NCT02962895|587761462|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740171|NCT02962895|587761463|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740172|NCT02962895|587761464|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162740173|NCT02962895|587761458|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740174|NCT02962895|587761459|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740175|NCT02962895|587761460|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740176|NCT02962895|587761461|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740177|NCT02962895|587761462|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740178|NCT02962895|587761463|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162740179|NCT02962895|587761464|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
162740180|NCT02962895|587761458|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162740181|NCT02962895|587761459|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162740182|NCT02962895|587761460|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162740183|NCT02962895|587761461|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162740184|NCT02962895|587761462|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
162740185|NCT02962895|587761463|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162740186|NCT02962895|587761464|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
162740187|NCT02962895|587761458|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740188|NCT02962895|587761459|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740189|NCT02962895|587761460|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740190|NCT02962895|587761461|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740191|NCT02962895|587761462|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740192|NCT02962895|587761463|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162740193|NCT02962895|587761464|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
162740194|NCT02962895|587761458|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740195|NCT02962895|587761459|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
162740196|NCT02962895|587761460|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740197|NCT02962895|587761461|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740198|NCT02962895|587761462|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740199|NCT02962895|587761463|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740200|NCT02962895|587761464|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162740201|NCT02962895|587761458|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740202|NCT02962895|587761459|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740203|NCT02962895|587761460|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740204|NCT02962895|587761461|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740205|NCT02962895|587761462|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
162740206|NCT02962895|587761463|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740207|NCT02962895|587761464|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162740208|NCT02962895|587761458|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740209|NCT02962895|587761459|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740210|NCT02962895|587761460|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740211|NCT02962895|587761461|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740212|NCT02962895|587761462|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
162740213|NCT02962895|587761463|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740214|NCT02962895|587761464|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162740215|NCT02962895|587761458|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162740216|NCT02962895|587761459|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
162740217|NCT02962895|587761460|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
162740218|NCT02962895|587761461|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
162740219|NCT02962895|587761462|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162740220|NCT02962895|587761463|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162740221|NCT02962895|587761464|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162740222|NCT02962895|587761458|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
162740223|NCT02962895|587761459|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162740224|NCT02962895|587761460|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
162740225|NCT02962895|587761461|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
162740226|NCT02962895|587761462|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162740227|NCT02962895|587761463|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162740228|NCT02962895|587761464|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
162740229|NCT04509674|587761467|FG000|Overall Study|Not treated|33|||
162740230|NCT04509674|587761468|FG001|Overall Study|Not treated|26|||
162740231|NCT04509674|587761467|FG000|Overall Study|Protocol Violation|9|||
162740232|NCT04509674|587761468|FG001|Overall Study|Protocol Violation|10|||
162740233|NCT04509674|587761467|FG000|Overall Study|Lost to Follow-up|31|||
162740234|NCT04509674|587761468|FG001|Overall Study|Lost to Follow-up|39|||
162740235|NCT04509674|587761467|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
162740236|NCT04509674|587761468|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
162740237|NCT04509674|587761467|FG000|Overall Study|Adverse event, serious fatal event|11|||
162740238|NCT04509674|587761468|FG001|Overall Study|Adverse event, serious fatal event|4|||
162740239|NCT04509674|587761467|FG000|Overall Study|Adverse event, non-fatal event|107|||
162740240|NCT04509674|587761468|FG001|Overall Study|Adverse event, non-fatal event|118|||
162740241|NCT04509674|587761467|FG000|Overall Study|Other reason than listed|106|||
162740242|NCT04509674|587761468|FG001|Overall Study|Other reason than listed|95|||
162740243|NCT06190691|587761478|FG000|Overall Study|Adverse Event|2|||
162740244|NCT06190691|587761479|FG001|Overall Study|Adverse Event|0|||
162740245|NCT06190691|587761480|FG002|Overall Study|Adverse Event|0|||
162740246|NCT06190691|587761481|FG003|Overall Study|Adverse Event|0|||
162740247|NCT03016754|587761483|FG000|Overall Study|Death|5|||
162740248|NCT03016754|587761484|FG001|Overall Study|Death|4|||
162740249|NCT03016754|587761485|FG002|Overall Study|Death|5|||
162740250|NCT03016754|587761486|FG003|Overall Study|Death|1|||
162740251|NCT03016754|587761483|FG000|Overall Study|Lost to Follow-up|23|||
162740252|NCT03016754|587761484|FG001|Overall Study|Lost to Follow-up|17|||
162740253|NCT03016754|587761485|FG002|Overall Study|Lost to Follow-up|4|||
162740254|NCT03016754|587761486|FG003|Overall Study|Lost to Follow-up|2|||
162740255|NCT03016754|587761483|FG000|Overall Study|Withdrawal by Subject|6|||
162740256|NCT03016754|587761484|FG001|Overall Study|Withdrawal by Subject|6|||
162740257|NCT03016754|587761485|FG002|Overall Study|Withdrawal by Subject|2|||
162740258|NCT03016754|587761486|FG003|Overall Study|Withdrawal by Subject|2|||
162740259|NCT03016754|587761483|FG000|Overall Study|Other/Unknown|2|||
162740260|NCT03016754|587761484|FG001|Overall Study|Other/Unknown|4|||
162740261|NCT03016754|587761485|FG002|Overall Study|Other/Unknown|2|||
162740262|NCT03016754|587761486|FG003|Overall Study|Other/Unknown|1|||
162740263|NCT03016754|587761483|FG000|Overall Study|Protocol Violation|0|||
162740264|NCT03016754|587761484|FG001|Overall Study|Protocol Violation|0|||
162740265|NCT03016754|587761485|FG002|Overall Study|Protocol Violation|0|||
162740266|NCT03016754|587761486|FG003|Overall Study|Protocol Violation|4|||
162740267|NCT04019873|587761487|FG000|Overall Study|Discontinued from the treatment|1|||
162740268|NCT04019873|587761488|FG001|Overall Study|Discontinued from the treatment|39|||
162740269|NCT04019873|587761489|FG002|Overall Study|Discontinued from the treatment|2|||
162740270|NCT03896789|587761497|FG000|Baseline|Lost to Follow-up|1|||
162740271|NCT03896789|587761498|FG001|Baseline|Lost to Follow-up|2|||
162740272|NCT03896789|587761497|FG000|Baseline|Death|3|||
162740273|NCT03896789|587761498|FG001|Baseline|Death|6|||
162740274|NCT03896789|587761497|FG000|Post-Randomization|Lost to Follow-up|12|||
162740275|NCT03896789|587761498|FG001|Post-Randomization|Lost to Follow-up|11|||
162740276|NCT03896789|587761497|FG000|Post-Randomization|Death|12|||
162740277|NCT03896789|587761498|FG001|Post-Randomization|Death|13|||
162740278|NCT05087992|587761504|FG000|Overall Study|Adverse Event|0|||
162740279|NCT05087992|587761505|FG001|Overall Study|Adverse Event|1|||
162740280|NCT05087992|587761506|FG002|Overall Study|Adverse Event|0|||
162740281|NCT05087992|587761504|FG000|Overall Study|Withdrawal by Subject|2|||
162740282|NCT05087992|587761505|FG001|Overall Study|Withdrawal by Subject|0|||
162740283|NCT05087992|587761506|FG002|Overall Study|Withdrawal by Subject|0|||
162740284|NCT05087992|587761504|FG000|Overall Study|clinical disease progression|3|||
162740285|NCT05087992|587761505|FG001|Overall Study|clinical disease progression|1|||
162740286|NCT05087992|587761506|FG002|Overall Study|clinical disease progression|0|||
162740287|NCT05087992|587761504|FG000|Overall Study|objective disease progression|4|||
162740288|NCT05087992|587761505|FG001|Overall Study|objective disease progression|1|||
162740289|NCT05087992|587761506|FG002|Overall Study|objective disease progression|0|||
162740290|NCT04473222|587761507|FG000|Overall Study|Lost to Follow-up|13|||
162740291|NCT04473222|587761508|FG001|Overall Study|Lost to Follow-up|13|||
162740292|NCT04473222|587761507|FG000|Overall Study|Withdrawal by Subject|0|||
162740293|NCT04473222|587761508|FG001|Overall Study|Withdrawal by Subject|1|||
162740294|NCT04473222|587761507|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
162740295|NCT04473222|587761508|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
162740296|NCT01098812|587761517|FG000|Overall Study|Death|2|||
162740297|NCT01098812|587761518|FG001|Overall Study|Death|0|||
162740298|NCT01098812|587761519|FG002|Overall Study|Death|1|||
162740299|NCT01098812|587761517|FG000|Overall Study|Lost to Follow-up|0|||
162740300|NCT01098812|587761518|FG001|Overall Study|Lost to Follow-up|1|||
162740301|NCT01098812|587761519|FG002|Overall Study|Lost to Follow-up|0|||
162740302|NCT02319759|587761520|FG000|Week 0 - 16|Lack of Efficacy|1|||
162740303|NCT02319759|587761521|FG001|Week 0 - 16|Lack of Efficacy|0|||
162740304|NCT02319759|587761522|FG002|Week 0 - 16|Lack of Efficacy|0|||
162740305|NCT02319759|587761523|FG003|Week 0 - 16|Lack of Efficacy|0|||
162740306|NCT02319759|587761524|FG004|Week 0 - 16|Lack of Efficacy|0|||
162740307|NCT02319759|587761520|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
162740308|NCT02319759|587761521|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
162740309|NCT02319759|587761522|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
162740310|NCT02319759|587761523|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
162740311|NCT02319759|587761524|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
162740312|NCT02319759|587761520|FG000|Week 16 - 24|Lack of Efficacy|1|||
162740313|NCT02319759|587761521|FG001|Week 16 - 24|Lack of Efficacy|0|||
162740314|NCT02319759|587761522|FG002|Week 16 - 24|Lack of Efficacy|1|||
162740315|NCT02319759|587761523|FG003|Week 16 - 24|Lack of Efficacy|0|||
162740316|NCT02319759|587761524|FG004|Week 16 - 24|Lack of Efficacy|0|||
162740317|NCT02319759|587761520|FG000|Week 16 - 24|Lost to Follow-up|1|||
162740318|NCT02319759|587761521|FG001|Week 16 - 24|Lost to Follow-up|0|||
162740319|NCT02319759|587761522|FG002|Week 16 - 24|Lost to Follow-up|0|||
162740320|NCT02319759|587761523|FG003|Week 16 - 24|Lost to Follow-up|0|||
162740321|NCT02319759|587761524|FG004|Week 16 - 24|Lost to Follow-up|0|||
162740322|NCT02319759|587761520|FG000|Week 16 - 24|Withdrawal by Subject|0|||
162740323|NCT02319759|587761521|FG001|Week 16 - 24|Withdrawal by Subject|0|||
162740324|NCT02319759|587761522|FG002|Week 16 - 24|Withdrawal by Subject|2|||
162740325|NCT02319759|587761523|FG003|Week 16 - 24|Withdrawal by Subject|0|||
162740326|NCT02319759|587761524|FG004|Week 16 - 24|Withdrawal by Subject|0|||
162740327|NCT02319759|587761520|FG000|Week 24 - 56|Adverse Event|0|||
162740328|NCT02319759|587761521|FG001|Week 24 - 56|Adverse Event|0|||
162740329|NCT02319759|587761522|FG002|Week 24 - 56|Adverse Event|2|||
162740330|NCT02319759|587761523|FG003|Week 24 - 56|Adverse Event|0|||
162740331|NCT02319759|587761524|FG004|Week 24 - 56|Adverse Event|0|||
162740332|NCT02319759|587761520|FG000|Week 24 - 56|Lack of Efficacy|0|||
162740333|NCT02319759|587761521|FG001|Week 24 - 56|Lack of Efficacy|0|||
162740334|NCT02319759|587761522|FG002|Week 24 - 56|Lack of Efficacy|0|||
162740335|NCT02319759|587761523|FG003|Week 24 - 56|Lack of Efficacy|2|||
162740336|NCT02319759|587761524|FG004|Week 24 - 56|Lack of Efficacy|1|||
162740337|NCT02319759|587761520|FG000|Week 24 - 56|Withdrawal by Subject|0|||
162740338|NCT02319759|587761521|FG001|Week 24 - 56|Withdrawal by Subject|1|||
162740339|NCT02319759|587761522|FG002|Week 24 - 56|Withdrawal by Subject|0|||
162740340|NCT02319759|587761523|FG003|Week 24 - 56|Withdrawal by Subject|0|||
162740341|NCT02319759|587761524|FG004|Week 24 - 56|Withdrawal by Subject|0|||
162740342|NCT02319759|587761520|FG000|Week 24 - 56|Lost to Follow-up|0|||
162740343|NCT02319759|587761521|FG001|Week 24 - 56|Lost to Follow-up|0|||
162740344|NCT02319759|587761522|FG002|Week 24 - 56|Lost to Follow-up|0|||
162740345|NCT02319759|587761523|FG003|Week 24 - 56|Lost to Follow-up|0|||
162740346|NCT02319759|587761524|FG004|Week 24 - 56|Lost to Follow-up|1|||
162740347|NCT03474679|587761533|FG000|Overall Study|Death|7|||
162740348|NCT03474679|587761533|FG000|Overall Study|Withdrawal by Subject|1|||
162740349|NCT03452579|587761534|FG000|Overall Study|Death|0|||
162740350|NCT03452579|587761535|FG001|Overall Study|Death|1|||
162740351|NCT03452579|587761534|FG000|Overall Study|Withdrawal by Subject|2|||
162740352|NCT03452579|587761535|FG001|Overall Study|Withdrawal by Subject|0|||
162740353|NCT03452579|587761534|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
162740354|NCT03452579|587761535|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
162740355|NCT03452579|587761534|FG000|Overall Study|Physician Decision|1|||
162740356|NCT03452579|587761535|FG001|Overall Study|Physician Decision|1|||
162740357|NCT03452579|587761534|FG000|Overall Study|Adverse Event|1|||
162740358|NCT03452579|587761535|FG001|Overall Study|Adverse Event|4|||
162740359|NCT04858321|587761539|FG000|Overall Study|Withdrawal by Subject|3|||
162740360|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
162740361|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
162740362|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
162740363|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
162740364|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
162740365|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
162740366|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Death|6|||
162740367|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Death|0|||
162740368|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Death|0|||
162740369|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
162740370|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
162740371|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
162740372|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
162740373|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
162740374|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
162740375|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
162740376|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
162740377|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
162740378|NCT01539083|587761540|FG000|Before Randomization (VCD Induction)|Other|5|||
162740379|NCT01539083|587761541|FG001|Before Randomization (VCD Induction)|Other|0|||
162740380|NCT01539083|587761542|FG002|Before Randomization (VCD Induction)|Other|0|||
162740381|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
162740382|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
162740383|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
162740384|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Other|0|||
162740385|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Other|1|||
162740386|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Other|1|||
162740387|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
162740388|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
162740389|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
162740390|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
162740391|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
162740392|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
162740393|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
162740394|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
162740395|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
162740396|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
162740397|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
162740398|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
162740399|NCT01539083|587761540|FG000|After Randomization (TP and VTP)|Death|0|||
162740400|NCT01539083|587761541|FG001|After Randomization (TP and VTP)|Death|6|||
162740401|NCT01539083|587761542|FG002|After Randomization (TP and VTP)|Death|11|||
162740402|NCT05006872|587761543|FG000|Overall Study|Lost to Follow-up|37|||
162740403|NCT05006872|587761544|FG001|Overall Study|Lost to Follow-up|31|||
162740404|NCT02573493|587761545|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
162740405|NCT02573493|587761546|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
162740406|NCT02573493|587761547|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
162740407|NCT02573493|587761548|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
162740408|NCT04149704|587761549|FG000|Three Month Follow-up|Death|2|||
162740409|NCT04149704|587761550|FG001|Three Month Follow-up|Death|0|||
162740410|NCT04149704|587761551|FG002|Three Month Follow-up|Death|0|||
162740411|NCT04149704|587761552|FG003|Three Month Follow-up|Death|0|||
162740412|NCT04149704|587761549|FG000|Three Month Follow-up|Lost to Follow-up|1|||
162740413|NCT04149704|587761550|FG001|Three Month Follow-up|Lost to Follow-up|4|||
162740414|NCT04149704|587761551|FG002|Three Month Follow-up|Lost to Follow-up|5|||
162740415|NCT04149704|587761552|FG003|Three Month Follow-up|Lost to Follow-up|5|||
162740416|NCT04149704|587761549|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
162740417|NCT04149704|587761550|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
162740418|NCT04149704|587761551|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
162740419|NCT04149704|587761552|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
162740420|NCT04149704|587761549|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
162740421|NCT04149704|587761550|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
162740422|NCT04149704|587761551|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
162740423|NCT04149704|587761552|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
162740424|NCT04332926|587761553|FG000|Overall Study|Withdrawal by Subject|6|||
162740425|NCT04332926|587761553|FG000|Overall Study|Physician Decision|6|||
162740426|NCT03097549|587761554|FG000|Overall Study|Withdrawal by Subject|1|||
162740427|NCT03097549|587761555|FG001|Overall Study|Withdrawal by Subject|0|||
162740428|NCT03097549|587761554|FG000|Overall Study|Lost to Follow-up|1|||
162740429|NCT03097549|587761555|FG001|Overall Study|Lost to Follow-up|0|||
162740430|NCT05783102|587761556|FG000|Overall Study|Lost to Follow-up|1|||
162740431|NCT05783102|587761556|FG000|Overall Study|Withdrawal by Subject|2|||
162740432|NCT04973254|587761557|FG000|Overall Study|Not adherent|0|||
162740433|NCT04973254|587761558|FG001|Overall Study|Not adherent|1|||
162740434|NCT04973254|587761559|FG002|Overall Study|Not adherent|0|||
162740435|NCT05170009|587761560|FG000|Overall Study|Physician Decision|0|||
162740436|NCT05170009|587761561|FG001|Overall Study|Physician Decision|1|||
162740437|NCT05415722|587761562|FG000|Overall Study|Lost to Follow-up|0|||
162740438|NCT05415722|587761563|FG001|Overall Study|Lost to Follow-up|2|||
162740439|NCT05415722|587761564|FG002|Overall Study|Lost to Follow-up|0|||
162740440|NCT05415722|587761565|FG003|Overall Study|Lost to Follow-up|1|||
162740441|NCT05415722|587761566|FG004|Overall Study|Lost to Follow-up|0|||
162740442|NCT05415722|587761567|FG005|Overall Study|Lost to Follow-up|0|||
162740443|NCT05415722|587761568|FG006|Overall Study|Lost to Follow-up|1|||
162740444|NCT05415722|587761562|FG000|Overall Study|Physician Decision|0|||
162740445|NCT05415722|587761563|FG001|Overall Study|Physician Decision|0|||
162740446|NCT05415722|587761564|FG002|Overall Study|Physician Decision|0|||
162740447|NCT05415722|587761565|FG003|Overall Study|Physician Decision|1|||
162740448|NCT05415722|587761566|FG004|Overall Study|Physician Decision|0|||
162740449|NCT05415722|587761567|FG005|Overall Study|Physician Decision|0|||
162740450|NCT05415722|587761568|FG006|Overall Study|Physician Decision|1|||
162740451|NCT05415722|587761562|FG000|Overall Study|Protocol Violation|0|||
162740452|NCT05415722|587761563|FG001|Overall Study|Protocol Violation|0|||
162740453|NCT05415722|587761564|FG002|Overall Study|Protocol Violation|0|||
162740454|NCT05415722|587761565|FG003|Overall Study|Protocol Violation|1|||
162740455|NCT05415722|587761566|FG004|Overall Study|Protocol Violation|0|||
162740456|NCT05415722|587761567|FG005|Overall Study|Protocol Violation|0|||
162740457|NCT05415722|587761568|FG006|Overall Study|Protocol Violation|0|||
162740458|NCT05415722|587761562|FG000|Overall Study|Sponsor Discretion|0|||
162740459|NCT05415722|587761563|FG001|Overall Study|Sponsor Discretion|0|||
162740460|NCT05415722|587761564|FG002|Overall Study|Sponsor Discretion|0|||
162740461|NCT05415722|587761565|FG003|Overall Study|Sponsor Discretion|0|||
162740462|NCT05415722|587761566|FG004|Overall Study|Sponsor Discretion|1|||
162740463|NCT05415722|587761567|FG005|Overall Study|Sponsor Discretion|1|||
162740464|NCT05415722|587761568|FG006|Overall Study|Sponsor Discretion|0|||
162740465|NCT05415722|587761562|FG000|Overall Study|Withdrawal by Subject|0|||
162740466|NCT05415722|587761563|FG001|Overall Study|Withdrawal by Subject|1|||
162740467|NCT05415722|587761564|FG002|Overall Study|Withdrawal by Subject|0|||
162740468|NCT05415722|587761565|FG003|Overall Study|Withdrawal by Subject|1|||
162740469|NCT05415722|587761566|FG004|Overall Study|Withdrawal by Subject|1|||
162740470|NCT05415722|587761567|FG005|Overall Study|Withdrawal by Subject|0|||
162740471|NCT05415722|587761568|FG006|Overall Study|Withdrawal by Subject|1|||
162740472|NCT04629716|587761569|FG000|Overall Study|Lost to Follow-up|7|||
162740473|NCT04629716|587761570|FG001|Overall Study|Lost to Follow-up|3|||
162740474|NCT03524612|587761571|FG000|Overall Study|Lack of Efficacy|10|||
162740475|NCT03524612|587761571|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
162740476|NCT03524612|587761571|FG000|Overall Study|Adverse Event|10|||
162740477|NCT03524612|587761571|FG000|Overall Study|Withdrawal by Subject|7|||
162740478|NCT03524612|587761571|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
162740479|NCT03524612|587761571|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
162740480|NCT03524612|587761571|FG000|Overall Study|New therapy for study indication|6|||
162740481|NCT03524612|587761571|FG000|Overall Study|Death|3|||
162740482|NCT03524612|587761571|FG000|Overall Study|Lost to Follow-up|2|||
162740483|NCT03524612|587761571|FG000|Overall Study|Protocol Violation|1|||
162740484|NCT04623671|587761572|FG000|Overall Study|Adverse Event|0|||
162740485|NCT04623671|587761573|FG001|Overall Study|Adverse Event|1|||
162740486|NCT04623671|587761572|FG000|Overall Study|Lost to Follow-up|2|||
162740487|NCT04623671|587761573|FG001|Overall Study|Lost to Follow-up|1|||
162740488|NCT04623671|587761572|FG000|Overall Study|Death|5|||
162740489|NCT04623671|587761573|FG001|Overall Study|Death|5|||
162740490|NCT04025554|587761574|FG000|Overall Study|Adverse Event|3|||
162740491|NCT01802788|587761578|FG000|Overall Study|Withdrawal by Subject|102|||
162740492|NCT01802788|587761579|FG001|Overall Study|Withdrawal by Subject|5|||
162740493|NCT01802788|587761578|FG000|Overall Study|Death|382|||
162740494|NCT01802788|587761579|FG001|Overall Study|Death|18|||
162740495|NCT01802788|587761578|FG000|Overall Study|Lost to Follow-up|31|||
162740496|NCT01802788|587761579|FG001|Overall Study|Lost to Follow-up|2|||
162740497|NCT01802788|587761578|FG000|Overall Study|Physician Decision|3|||
162740498|NCT01802788|587761579|FG001|Overall Study|Physician Decision|0|||
162740499|NCT01802788|587761578|FG000|Overall Study|Patient Non-Compliance|1|||
162740500|NCT01802788|587761579|FG001|Overall Study|Patient Non-Compliance|0|||
162740501|NCT01802788|587761578|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
162740502|NCT01802788|587761579|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
162740503|NCT01802788|587761578|FG000|Overall Study|Other Reasons|19|||
162740504|NCT01802788|587761579|FG001|Overall Study|Other Reasons|0|||
162740505|NCT05257486|587761580|FG000|Overall Study|Protocol Violation|3|||
162740506|NCT04542317|587761581|FG000|Overall Study|Care recipients passed away|18|||
162740507|NCT04542317|587761582|FG001|Overall Study|Care recipients passed away|13|||
162740508|NCT04542317|587761581|FG000|Overall Study|No longer a primary caregiver|5|||
162740509|NCT04542317|587761582|FG001|Overall Study|No longer a primary caregiver|1|||
162740510|NCT04542317|587761581|FG000|Overall Study|Withdrawal by Subject|4|||
162740511|NCT04542317|587761582|FG001|Overall Study|Withdrawal by Subject|2|||
162740512|NCT04542317|587761581|FG000|Overall Study|Caregivers passed away|0|||
162740513|NCT04542317|587761582|FG001|Overall Study|Caregivers passed away|2|||
162740514|NCT04700163|587761585|FG000|Overall Study|Lost to Follow-up|0|||
162740515|NCT04700163|587761586|FG001|Overall Study|Lost to Follow-up|0|||
162740516|NCT04700163|587761587|FG002|Overall Study|Lost to Follow-up|0|||
162740517|NCT04700163|587761588|FG003|Overall Study|Lost to Follow-up|0|||
162740518|NCT04700163|587761589|FG004|Overall Study|Lost to Follow-up|0|||
162740519|NCT04700163|587761590|FG005|Overall Study|Lost to Follow-up|1|||
162740520|NCT03848065|587761593|FG000|Overall Study|Death|0|||
162740521|NCT03848065|587761594|FG001|Overall Study|Death|1|||
162740522|NCT03848065|587761595|FG002|Overall Study|Death|0|||
162740523|NCT03848065|587761593|FG000|Overall Study|Lost to Follow-up|0|||
162740524|NCT03848065|587761594|FG001|Overall Study|Lost to Follow-up|0|||
162740525|NCT03848065|587761595|FG002|Overall Study|Lost to Follow-up|1|||
162740526|NCT03848065|587761593|FG000|Overall Study|Physician Decision|0|||
162740527|NCT03848065|587761594|FG001|Overall Study|Physician Decision|0|||
162740528|NCT03848065|587761595|FG002|Overall Study|Physician Decision|1|||
162740529|NCT03270501|587761598|FG000|Overall Study|Screen failure|6|||
162740530|NCT03270501|587761598|FG000|Overall Study|Lost to Follow-up|2|||
162740531|NCT03270501|587761598|FG000|Overall Study|Adverse Event|1|||
162740532|NCT00764751|587761603|FG000|Overall Study|Adverse Event|1|||
162740533|NCT00764751|587761604|FG001|Overall Study|Adverse Event|1|||
162740534|NCT00764751|587761603|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
162740535|NCT00764751|587761604|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
162740536|NCT05270408|587761613|FG000|Started Treatment|Withdrawal by Subject|0|||
162740537|NCT05270408|587761614|FG001|Started Treatment|Withdrawal by Subject|0|||
162740538|NCT05270408|587761615|FG002|Started Treatment|Withdrawal by Subject|3|||
162740539|NCT05270408|587761613|FG000|Started Treatment|Adverse Event|0|||
162740540|NCT05270408|587761614|FG001|Started Treatment|Adverse Event|0|||
162740541|NCT05270408|587761615|FG002|Started Treatment|Adverse Event|1|||
162740542|NCT05270408|587761613|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
162740543|NCT05270408|587761614|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
162740544|NCT05270408|587761615|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
162740545|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
162740546|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
162740547|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
162740548|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
162740549|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
162740550|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
162740551|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
162740552|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
162740553|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
162740554|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
162740555|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
162740556|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
162740557|NCT04338061|587761616|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
162740558|NCT04338061|587761617|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
162740559|NCT04338061|587761616|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
162740560|NCT04338061|587761617|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
162740561|NCT04338061|587761616|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
162740562|NCT04338061|587761617|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
162740563|NCT04338061|587761616|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
162740564|NCT04338061|587761617|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
162740565|NCT04338061|587761616|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
162740566|NCT04338061|587761617|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
162740567|NCT04338061|587761616|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
162740568|NCT04338061|587761617|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
162740569|NCT03631784|587761618|FG000|Overall Study|Participants Ongoing|1|||
162740570|NCT03631784|587761619|FG001|Overall Study|Participants Ongoing|0|||
162740571|NCT03631784|587761618|FG000|Overall Study|Withdrawal by Subject|3|||
162740572|NCT03631784|587761619|FG001|Overall Study|Withdrawal by Subject|3|||
162740573|NCT03631784|587761618|FG000|Overall Study|Sponsor's Decision|36|||
162740574|NCT03631784|587761619|FG001|Overall Study|Sponsor's Decision|52|||
162740575|NCT03631784|587761618|FG000|Overall Study|Lost to Follow-up|1|||
162740576|NCT03631784|587761619|FG001|Overall Study|Lost to Follow-up|0|||
162740577|NCT03631784|587761618|FG000|Overall Study|Death|71|||
162740578|NCT03631784|587761619|FG001|Overall Study|Death|49|||
162740579|NCT03287817|587764174|FG000|Overall Study|Progressive disease|4|||
162740580|NCT03287817|587764175|FG001|Overall Study|Progressive disease|2|||
162740581|NCT03287817|587764176|FG002|Overall Study|Progressive disease|3|||
162740582|NCT03287817|587764177|FG003|Overall Study|Progressive disease|10|||
162740583|NCT03287817|587764178|FG004|Overall Study|Progressive disease|8|||
162740584|NCT03287817|587764174|FG000|Overall Study|Death|0|||
162740585|NCT03287817|587764175|FG001|Overall Study|Death|0|||
162740586|NCT03287817|587764176|FG002|Overall Study|Death|2|||
162740587|NCT03287817|587764177|FG003|Overall Study|Death|3|||
162740588|NCT03287817|587764178|FG004|Overall Study|Death|4|||
162740589|NCT03287817|587764174|FG000|Overall Study|Physician Decision|0|||
162740590|NCT03287817|587764175|FG001|Overall Study|Physician Decision|0|||
162740591|NCT03287817|587764176|FG002|Overall Study|Physician Decision|0|||
162740592|NCT03287817|587764177|FG003|Overall Study|Physician Decision|1|||
162740593|NCT03287817|587764178|FG004|Overall Study|Physician Decision|0|||
162740594|NCT03287817|587764174|FG000|Overall Study|Withdrawal by Subject|0|||
162740595|NCT03287817|587764175|FG001|Overall Study|Withdrawal by Subject|0|||
162740596|NCT03287817|587764176|FG002|Overall Study|Withdrawal by Subject|0|||
162740597|NCT03287817|587764177|FG003|Overall Study|Withdrawal by Subject|0|||
162740598|NCT03287817|587764178|FG004|Overall Study|Withdrawal by Subject|4|||
162740599|NCT04130438|587764183|FG000|Overall Study|Lost to Follow-up|0|||
162740600|NCT04130438|587764184|FG001|Overall Study|Lost to Follow-up|0|||
162740601|NCT04130438|587764185|FG002|Overall Study|Lost to Follow-up|1|||
162740602|NCT04764448|587764188|FG000|Overall Study|Study terminated by sponsor|2|||
162740603|NCT04764448|587764189|FG001|Overall Study|Study terminated by sponsor|2|||
162740604|NCT04764448|587764190|FG002|Overall Study|Study terminated by sponsor|5|||
162740605|NCT04764448|587764188|FG000|Overall Study|Withdrawal by Subject|3|||
162740606|NCT04764448|587764189|FG001|Overall Study|Withdrawal by Subject|3|||
162740607|NCT04764448|587764190|FG002|Overall Study|Withdrawal by Subject|1|||
162740608|NCT04256941|587764192|FG000|Overall Study|Withdrawal by Subject|0|||
162740609|NCT04256941|587764193|FG001|Overall Study|Withdrawal by Subject|1|||
162740610|NCT04256941|587764192|FG000|Overall Study|Death|1|||
162740611|NCT04256941|587764193|FG001|Overall Study|Death|0|||
162740612|NCT04256941|587764192|FG000|Overall Study|Disease Progession|0|||
162740613|NCT04256941|587764193|FG001|Overall Study|Disease Progession|2|||
162740614|NCT06181227|587764200|FG000|Overall Study|Study terminated by sponsor|7|||
162740615|NCT06181227|587764201|FG001|Overall Study|Study terminated by sponsor|9|||
162740616|NCT04719390|587764203|FG000|Overall Study|Withdrawal by Subject|1|||
162740617|NCT04633122|587764204|FG000|Overall Study|Remained on treatment|19|||
162740618|NCT04633122|587764205|FG001|Overall Study|Remained on treatment|14|||
162740619|NCT04633122|587764204|FG000|Overall Study|Survival follow-up stopped|22|||
162740620|NCT04633122|587764205|FG001|Overall Study|Survival follow-up stopped|25|||
162740621|NCT03241745|587764206|FG000|Overall Study|Adverse Event|7|||
162740622|NCT03241745|587764206|FG000|Overall Study|Death|1|||
162740623|NCT03241745|587764206|FG000|Overall Study|Withdrawal by Subject|5|||
162740624|NCT03241745|587764206|FG000|Overall Study|Treatment delay >28 days|2|||
162740625|NCT03241745|587764206|FG000|Overall Study|Lack of Efficacy|14|||
162740626|NCT02561247|587764207|FG000|Overall Study|Protocol Violation|1|||
162740627|NCT02561247|587764207|FG000|Overall Study|Withdrawal by Subject|1|||
162740628|NCT02561247|587764207|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
162740629|NCT04908722|587764208|FG000|Overall Study|Protocol deviation|1|||
162740630|NCT04908722|587764209|FG001|Overall Study|Protocol deviation|0|||
162740631|NCT04908722|587764210|FG002|Overall Study|Protocol deviation|0|||
162740632|NCT04908722|587764211|FG003|Overall Study|Protocol deviation|0|||
162740633|NCT04908722|587764212|FG004|Overall Study|Protocol deviation|0|||
162740634|NCT04908722|587764213|FG005|Overall Study|Protocol deviation|1|||
162740635|NCT04908722|587764208|FG000|Overall Study|Lost to Follow-up|33|||
162740636|NCT04908722|587764209|FG001|Overall Study|Lost to Follow-up|33|||
162740637|NCT04908722|587764210|FG002|Overall Study|Lost to Follow-up|36|||
162740638|NCT04908722|587764211|FG003|Overall Study|Lost to Follow-up|30|||
162740639|NCT04908722|587764212|FG004|Overall Study|Lost to Follow-up|32|||
162740640|NCT04908722|587764213|FG005|Overall Study|Lost to Follow-up|34|||
162740641|NCT04908722|587764208|FG000|Overall Study|Physician Decision|1|||
162740642|NCT04908722|587764209|FG001|Overall Study|Physician Decision|1|||
162740643|NCT04908722|587764210|FG002|Overall Study|Physician Decision|1|||
162740644|NCT04908722|587764211|FG003|Overall Study|Physician Decision|2|||
162740645|NCT04908722|587764212|FG004|Overall Study|Physician Decision|0|||
162740646|NCT04908722|587764213|FG005|Overall Study|Physician Decision|0|||
162740647|NCT04908722|587764208|FG000|Overall Study|Death|1|||
162740648|NCT04908722|587764209|FG001|Overall Study|Death|0|||
162740649|NCT04908722|587764210|FG002|Overall Study|Death|0|||
162740650|NCT04908722|587764211|FG003|Overall Study|Death|0|||
162740651|NCT04908722|587764212|FG004|Overall Study|Death|0|||
162740652|NCT04908722|587764213|FG005|Overall Study|Death|1|||
162740653|NCT04908722|587764208|FG000|Overall Study|Withdrawal by Subject|12|||
162740654|NCT04908722|587764209|FG001|Overall Study|Withdrawal by Subject|8|||
162740655|NCT04908722|587764210|FG002|Overall Study|Withdrawal by Subject|7|||
162740656|NCT04908722|587764211|FG003|Overall Study|Withdrawal by Subject|6|||
162740657|NCT04908722|587764212|FG004|Overall Study|Withdrawal by Subject|12|||
162740658|NCT04908722|587764213|FG005|Overall Study|Withdrawal by Subject|14|||
162740659|NCT04908722|587764208|FG000|Overall Study|Other|3|||
162740660|NCT04908722|587764209|FG001|Overall Study|Other|1|||
162740661|NCT04908722|587764210|FG002|Overall Study|Other|3|||
162740662|NCT04908722|587764211|FG003|Overall Study|Other|2|||
162740663|NCT04908722|587764212|FG004|Overall Study|Other|4|||
162740664|NCT04908722|587764213|FG005|Overall Study|Other|1|||
162740665|NCT04908722|587764208|FG000|Overall Study|Initiated prohibited medication|0|||
162740666|NCT04908722|587764209|FG001|Overall Study|Initiated prohibited medication|0|||
162740667|NCT04908722|587764210|FG002|Overall Study|Initiated prohibited medication|0|||
162740668|NCT04908722|587764211|FG003|Overall Study|Initiated prohibited medication|1|||
162740669|NCT04908722|587764212|FG004|Overall Study|Initiated prohibited medication|0|||
162740670|NCT04908722|587764213|FG005|Overall Study|Initiated prohibited medication|1|||
162740671|NCT04908722|587764208|FG000|Overall Study|Randomized but not vaccinated|3|||
162740672|NCT04908722|587764209|FG001|Overall Study|Randomized but not vaccinated|1|||
162740673|NCT04908722|587764210|FG002|Overall Study|Randomized but not vaccinated|2|||
162740674|NCT04908722|587764211|FG003|Overall Study|Randomized but not vaccinated|2|||
162740675|NCT04908722|587764212|FG004|Overall Study|Randomized but not vaccinated|3|||
162740676|NCT04908722|587764213|FG005|Overall Study|Randomized but not vaccinated|4|||
162740677|NCT06424236|587764219|FG000|Overall Study|Adverse Event|0|||
162740678|NCT06424236|587764220|FG001|Overall Study|Adverse Event|1|||
162740679|NCT06424236|587764221|FG002|Overall Study|Adverse Event|0|||
162740680|NCT06424236|587764219|FG000|Overall Study|Withdrawal by Subject|3|||
162740681|NCT06424236|587764220|FG001|Overall Study|Withdrawal by Subject|1|||
162740682|NCT06424236|587764221|FG002|Overall Study|Withdrawal by Subject|2|||
162740683|NCT06424236|587764219|FG000|Overall Study|Physician Decision|0|||
162740684|NCT06424236|587764220|FG001|Overall Study|Physician Decision|1|||
162740685|NCT06424236|587764221|FG002|Overall Study|Physician Decision|0|||
162740686|NCT06424236|587764219|FG000|Overall Study|Study Terminated by Sponsor|11|||
162740687|NCT06424236|587764220|FG001|Overall Study|Study Terminated by Sponsor|20|||
162740688|NCT06424236|587764221|FG002|Overall Study|Study Terminated by Sponsor|16|||
162740689|NCT06424236|587764219|FG000|Overall Study|Lost to Follow-up|0|||
162740690|NCT06424236|587764220|FG001|Overall Study|Lost to Follow-up|1|||
162740691|NCT06424236|587764221|FG002|Overall Study|Lost to Follow-up|0|||
162740692|NCT06424236|587764219|FG000|Overall Study|Disease Progression|0|||
162740693|NCT06424236|587764220|FG001|Overall Study|Disease Progression|1|||
162740694|NCT06424236|587764221|FG002|Overall Study|Disease Progression|2|||
162740695|NCT06424236|587764219|FG000|Overall Study|Other|0|||
162740696|NCT06424236|587764220|FG001|Overall Study|Other|0|||
162740697|NCT06424236|587764221|FG002|Overall Study|Other|1|||
162740698|NCT01959425|587764222|FG000|Overall Study|Withdrawal by Subject|5|||
162740699|NCT01959425|587764223|FG001|Overall Study|Withdrawal by Subject|4|||
162740700|NCT01959425|587764222|FG000|Overall Study|Lost to Follow-up|1|||
162740701|NCT01959425|587764223|FG001|Overall Study|Lost to Follow-up|0|||
162740702|NCT01959425|587764222|FG000|Overall Study|Discontinued Subjects|6|||
162740703|NCT01959425|587764223|FG001|Overall Study|Discontinued Subjects|4|||
162740704|NCT01987895|587764224|FG000|Overall Study|Withdrawal by Subject|12|||
162740705|NCT01987895|587764225|FG001|Overall Study|Withdrawal by Subject|7|||
162740706|NCT01987895|587764224|FG000|Overall Study|Physician Decision|8|||
162740707|NCT01987895|587764225|FG001|Overall Study|Physician Decision|10|||
162740708|NCT01987895|587764224|FG000|Overall Study|Death|7|||
162740709|NCT01987895|587764225|FG001|Overall Study|Death|7|||
162740710|NCT01987895|587764224|FG000|Overall Study|Lost to Follow-up|3|||
162740711|NCT01987895|587764225|FG001|Overall Study|Lost to Follow-up|5|||
162740712|NCT01987895|587764224|FG000|Overall Study|randomized before giving IC|0|||
162740713|NCT01987895|587764225|FG001|Overall Study|randomized before giving IC|1|||
162740714|NCT02979327|587764226|FG000|First Intervention|Protocol Violation|1|||
162740715|NCT02979327|587764227|FG001|First Intervention|Protocol Violation|0|||
162740716|NCT05499377|587764232|FG000|Overall Study|Withdrawal by Subject|2|||
162740717|NCT05499377|587764233|FG001|Overall Study|Withdrawal by Subject|0|||
162740718|NCT05499377|587764232|FG000|Overall Study|Physician Decision|1|||
162740719|NCT05499377|587764233|FG001|Overall Study|Physician Decision|0|||
162740720|NCT03544281|587764236|FG000|Main Study Phase|Death|3|||
162740721|NCT03544281|587764237|FG001|Main Study Phase|Death|2|||
162740722|NCT03544281|587764238|FG002|Main Study Phase|Death|6|||
162740723|NCT03544281|587764239|FG003|Main Study Phase|Death|8|||
162740724|NCT03544281|587764240|FG004|Main Study Phase|Death|4|||
162740725|NCT03544281|587764241|FG005|Main Study Phase|Death|2|||
162740726|NCT03544281|587764242|FG006|Main Study Phase|Death|4|||
162740727|NCT03544281|587764243|FG007|Main Study Phase|Death|5|||
162740728|NCT03544281|587764244|FG008|Main Study Phase|Death|5|||
162740729|NCT03544281|587764245|FG009|Main Study Phase|Death|8|||
162740730|NCT03544281|587764246|FG010|Main Study Phase|Death|6|||
162740731|NCT03544281|587764247|FG011|Main Study Phase|Death|4|||
162740732|NCT03544281|587764248|FG012|Main Study Phase|Death|0|||
162740733|NCT03544281|587764249|FG013|Main Study Phase|Death|0|||
162740734|NCT03544281|587764250|FG014|Main Study Phase|Death|0|||
162740735|NCT03544281|587764251|FG015|Main Study Phase|Death|0|||
162740736|NCT03544281|587764252|FG016|Main Study Phase|Death|0|||
162740737|NCT03544281|587764253|FG017|Main Study Phase|Death|0|||
162740738|NCT03544281|587764254|FG018|Main Study Phase|Death|0|||
162740739|NCT03544281|587764255|FG019|Main Study Phase|Death|0|||
162740740|NCT03544281|587764256|FG020|Main Study Phase|Death|0|||
162740741|NCT03544281|587764257|FG021|Main Study Phase|Death|0|||
162740742|NCT03544281|587764236|FG000|Main Study Phase|Lost to Follow-up|0|||
162740743|NCT03544281|587764237|FG001|Main Study Phase|Lost to Follow-up|0|||
162740744|NCT03544281|587764238|FG002|Main Study Phase|Lost to Follow-up|0|||
162740745|NCT03544281|587764239|FG003|Main Study Phase|Lost to Follow-up|0|||
162740746|NCT03544281|587764240|FG004|Main Study Phase|Lost to Follow-up|0|||
162740747|NCT03544281|587764241|FG005|Main Study Phase|Lost to Follow-up|0|||
162740748|NCT03544281|587764242|FG006|Main Study Phase|Lost to Follow-up|0|||
162740749|NCT03544281|587764243|FG007|Main Study Phase|Lost to Follow-up|0|||
162740750|NCT03544281|587764244|FG008|Main Study Phase|Lost to Follow-up|0|||
162740751|NCT03544281|587764245|FG009|Main Study Phase|Lost to Follow-up|0|||
162740752|NCT03544281|587764246|FG010|Main Study Phase|Lost to Follow-up|1|||
162740753|NCT03544281|587764247|FG011|Main Study Phase|Lost to Follow-up|0|||
162740754|NCT03544281|587764248|FG012|Main Study Phase|Lost to Follow-up|0|||
162740755|NCT03544281|587764249|FG013|Main Study Phase|Lost to Follow-up|0|||
162740756|NCT03544281|587764250|FG014|Main Study Phase|Lost to Follow-up|0|||
162740757|NCT03544281|587764251|FG015|Main Study Phase|Lost to Follow-up|0|||
162740758|NCT03544281|587764252|FG016|Main Study Phase|Lost to Follow-up|0|||
162740759|NCT03544281|587764253|FG017|Main Study Phase|Lost to Follow-up|0|||
162740760|NCT03544281|587764254|FG018|Main Study Phase|Lost to Follow-up|0|||
162740761|NCT03544281|587764255|FG019|Main Study Phase|Lost to Follow-up|0|||
162740762|NCT03544281|587764256|FG020|Main Study Phase|Lost to Follow-up|0|||
162740763|NCT03544281|587764257|FG021|Main Study Phase|Lost to Follow-up|0|||
162740764|NCT03544281|587764236|FG000|Main Study Phase|Physician Decision|0|||
162740765|NCT03544281|587764237|FG001|Main Study Phase|Physician Decision|0|||
162740766|NCT03544281|587764238|FG002|Main Study Phase|Physician Decision|0|||
162740767|NCT03544281|587764239|FG003|Main Study Phase|Physician Decision|0|||
162740768|NCT03544281|587764240|FG004|Main Study Phase|Physician Decision|0|||
162740769|NCT03544281|587764241|FG005|Main Study Phase|Physician Decision|0|||
162740770|NCT03544281|587764242|FG006|Main Study Phase|Physician Decision|0|||
162740771|NCT03544281|587764243|FG007|Main Study Phase|Physician Decision|1|||
162740772|NCT03544281|587764244|FG008|Main Study Phase|Physician Decision|0|||
162740773|NCT03544281|587764245|FG009|Main Study Phase|Physician Decision|0|||
162740774|NCT03544281|587764246|FG010|Main Study Phase|Physician Decision|0|||
162740775|NCT03544281|587764247|FG011|Main Study Phase|Physician Decision|0|||
162740776|NCT03544281|587764248|FG012|Main Study Phase|Physician Decision|0|||
162740777|NCT03544281|587764249|FG013|Main Study Phase|Physician Decision|0|||
162740778|NCT03544281|587764250|FG014|Main Study Phase|Physician Decision|0|||
162740779|NCT03544281|587764251|FG015|Main Study Phase|Physician Decision|0|||
162740780|NCT03544281|587764252|FG016|Main Study Phase|Physician Decision|0|||
162740781|NCT03544281|587764253|FG017|Main Study Phase|Physician Decision|0|||
162740782|NCT03544281|587764254|FG018|Main Study Phase|Physician Decision|0|||
162740783|NCT03544281|587764255|FG019|Main Study Phase|Physician Decision|0|||
162740784|NCT03544281|587764256|FG020|Main Study Phase|Physician Decision|0|||
162740785|NCT03544281|587764257|FG021|Main Study Phase|Physician Decision|0|||
162740786|NCT03544281|587764236|FG000|Main Study Phase|Withdrawal by Subject|2|||
162740787|NCT03544281|587764237|FG001|Main Study Phase|Withdrawal by Subject|0|||
162740788|NCT03544281|587764238|FG002|Main Study Phase|Withdrawal by Subject|1|||
162740789|NCT03544281|587764239|FG003|Main Study Phase|Withdrawal by Subject|2|||
162740790|NCT03544281|587764240|FG004|Main Study Phase|Withdrawal by Subject|0|||
162740791|NCT03544281|587764241|FG005|Main Study Phase|Withdrawal by Subject|0|||
162740792|NCT03544281|587764242|FG006|Main Study Phase|Withdrawal by Subject|0|||
162740793|NCT03544281|587764243|FG007|Main Study Phase|Withdrawal by Subject|0|||
162740794|NCT03544281|587764244|FG008|Main Study Phase|Withdrawal by Subject|2|||
162740795|NCT03544281|587764245|FG009|Main Study Phase|Withdrawal by Subject|3|||
162740796|NCT03544281|587764246|FG010|Main Study Phase|Withdrawal by Subject|0|||
162740797|NCT03544281|587764247|FG011|Main Study Phase|Withdrawal by Subject|4|||
162740798|NCT03544281|587764248|FG012|Main Study Phase|Withdrawal by Subject|0|||
162740799|NCT03544281|587764249|FG013|Main Study Phase|Withdrawal by Subject|0|||
162740800|NCT03544281|587764250|FG014|Main Study Phase|Withdrawal by Subject|0|||
162740801|NCT03544281|587764251|FG015|Main Study Phase|Withdrawal by Subject|0|||
162740802|NCT03544281|587764252|FG016|Main Study Phase|Withdrawal by Subject|0|||
162740803|NCT03544281|587764253|FG017|Main Study Phase|Withdrawal by Subject|0|||
162740804|NCT03544281|587764254|FG018|Main Study Phase|Withdrawal by Subject|0|||
162740805|NCT03544281|587764255|FG019|Main Study Phase|Withdrawal by Subject|0|||
162740806|NCT03544281|587764256|FG020|Main Study Phase|Withdrawal by Subject|0|||
162740807|NCT03544281|587764257|FG021|Main Study Phase|Withdrawal by Subject|0|||
162740808|NCT03544281|587764236|FG000|Main Study Phase|Ongoing|3|||
162740809|NCT03544281|587764237|FG001|Main Study Phase|Ongoing|1|||
162740810|NCT03544281|587764238|FG002|Main Study Phase|Ongoing|2|||
162740811|NCT03544281|587764239|FG003|Main Study Phase|Ongoing|4|||
162740812|NCT03544281|587764240|FG004|Main Study Phase|Ongoing|2|||
162740813|NCT03544281|587764241|FG005|Main Study Phase|Ongoing|4|||
162740814|NCT03544281|587764242|FG006|Main Study Phase|Ongoing|4|||
162740815|NCT03544281|587764243|FG007|Main Study Phase|Ongoing|0|||
162740816|NCT03544281|587764244|FG008|Main Study Phase|Ongoing|2|||
162740817|NCT03544281|587764245|FG009|Main Study Phase|Ongoing|2|||
162740818|NCT03544281|587764246|FG010|Main Study Phase|Ongoing|1|||
162740819|NCT03544281|587764247|FG011|Main Study Phase|Ongoing|0|||
162740820|NCT03544281|587764248|FG012|Main Study Phase|Ongoing|0|||
162740821|NCT03544281|587764249|FG013|Main Study Phase|Ongoing|0|||
162740822|NCT03544281|587764250|FG014|Main Study Phase|Ongoing|0|||
162740823|NCT03544281|587764251|FG015|Main Study Phase|Ongoing|0|||
162740824|NCT03544281|587764252|FG016|Main Study Phase|Ongoing|0|||
162740825|NCT03544281|587764253|FG017|Main Study Phase|Ongoing|0|||
162740826|NCT03544281|587764254|FG018|Main Study Phase|Ongoing|0|||
162740827|NCT03544281|587764255|FG019|Main Study Phase|Ongoing|0|||
162740828|NCT03544281|587764256|FG020|Main Study Phase|Ongoing|0|||
162740829|NCT03544281|587764257|FG021|Main Study Phase|Ongoing|0|||
162740830|NCT03544281|587764236|FG000|Main Study Phase|Investigator Site Closed|0|||
162740831|NCT03544281|587764237|FG001|Main Study Phase|Investigator Site Closed|0|||
162740832|NCT03544281|587764238|FG002|Main Study Phase|Investigator Site Closed|0|||
162740833|NCT03544281|587764239|FG003|Main Study Phase|Investigator Site Closed|0|||
162740834|NCT03544281|587764240|FG004|Main Study Phase|Investigator Site Closed|0|||
162740835|NCT03544281|587764241|FG005|Main Study Phase|Investigator Site Closed|0|||
162740836|NCT03544281|587764242|FG006|Main Study Phase|Investigator Site Closed|0|||
162740837|NCT03544281|587764243|FG007|Main Study Phase|Investigator Site Closed|0|||
162740838|NCT03544281|587764244|FG008|Main Study Phase|Investigator Site Closed|0|||
162740839|NCT03544281|587764245|FG009|Main Study Phase|Investigator Site Closed|1|||
162740840|NCT03544281|587764246|FG010|Main Study Phase|Investigator Site Closed|0|||
162740841|NCT03544281|587764247|FG011|Main Study Phase|Investigator Site Closed|0|||
162740842|NCT03544281|587764248|FG012|Main Study Phase|Investigator Site Closed|0|||
162740843|NCT03544281|587764249|FG013|Main Study Phase|Investigator Site Closed|0|||
162740844|NCT03544281|587764250|FG014|Main Study Phase|Investigator Site Closed|0|||
162740845|NCT03544281|587764251|FG015|Main Study Phase|Investigator Site Closed|0|||
162740846|NCT03544281|587764252|FG016|Main Study Phase|Investigator Site Closed|0|||
162740847|NCT03544281|587764253|FG017|Main Study Phase|Investigator Site Closed|0|||
162740848|NCT03544281|587764254|FG018|Main Study Phase|Investigator Site Closed|0|||
162740849|NCT03544281|587764255|FG019|Main Study Phase|Investigator Site Closed|0|||
162740850|NCT03544281|587764256|FG020|Main Study Phase|Investigator Site Closed|0|||
162740851|NCT03544281|587764257|FG021|Main Study Phase|Investigator Site Closed|0|||
162740852|NCT03544281|587764236|FG000|Main Study Phase|Did not receive study treatment|0|||
162740853|NCT03544281|587764237|FG001|Main Study Phase|Did not receive study treatment|0|||
162740854|NCT03544281|587764238|FG002|Main Study Phase|Did not receive study treatment|0|||
162740855|NCT03544281|587764239|FG003|Main Study Phase|Did not receive study treatment|0|||
162740856|NCT03544281|587764240|FG004|Main Study Phase|Did not receive study treatment|0|||
162740857|NCT03544281|587764241|FG005|Main Study Phase|Did not receive study treatment|0|||
162740858|NCT03544281|587764242|FG006|Main Study Phase|Did not receive study treatment|1|||
162740859|NCT03544281|587764243|FG007|Main Study Phase|Did not receive study treatment|0|||
162740860|NCT03544281|587764244|FG008|Main Study Phase|Did not receive study treatment|0|||
162740861|NCT03544281|587764245|FG009|Main Study Phase|Did not receive study treatment|0|||
162740862|NCT03544281|587764246|FG010|Main Study Phase|Did not receive study treatment|0|||
162740863|NCT03544281|587764247|FG011|Main Study Phase|Did not receive study treatment|0|||
162740864|NCT03544281|587764248|FG012|Main Study Phase|Did not receive study treatment|0|||
162740865|NCT03544281|587764249|FG013|Main Study Phase|Did not receive study treatment|0|||
162740866|NCT03544281|587764250|FG014|Main Study Phase|Did not receive study treatment|0|||
162740867|NCT03544281|587764251|FG015|Main Study Phase|Did not receive study treatment|0|||
162740868|NCT03544281|587764252|FG016|Main Study Phase|Did not receive study treatment|0|||
162740869|NCT03544281|587764253|FG017|Main Study Phase|Did not receive study treatment|0|||
162740870|NCT03544281|587764254|FG018|Main Study Phase|Did not receive study treatment|0|||
162740871|NCT03544281|587764255|FG019|Main Study Phase|Did not receive study treatment|0|||
162740872|NCT03544281|587764256|FG020|Main Study Phase|Did not receive study treatment|0|||
162740873|NCT03544281|587764257|FG021|Main Study Phase|Did not receive study treatment|0|||
162740874|NCT03544281|587764236|FG000|PACT Phase|Adverse Event|0|||
162740875|NCT03544281|587764237|FG001|PACT Phase|Adverse Event|0|||
162740876|NCT03544281|587764238|FG002|PACT Phase|Adverse Event|0|||
162740877|NCT03544281|587764239|FG003|PACT Phase|Adverse Event|0|||
162740878|NCT03544281|587764240|FG004|PACT Phase|Adverse Event|0|||
162740879|NCT03544281|587764241|FG005|PACT Phase|Adverse Event|0|||
162740880|NCT03544281|587764242|FG006|PACT Phase|Adverse Event|0|||
162740881|NCT03544281|587764243|FG007|PACT Phase|Adverse Event|0|||
162740882|NCT03544281|587764244|FG008|PACT Phase|Adverse Event|0|||
162740883|NCT03544281|587764245|FG009|PACT Phase|Adverse Event|0|||
162740884|NCT03544281|587764246|FG010|PACT Phase|Adverse Event|0|||
162740885|NCT03544281|587764247|FG011|PACT Phase|Adverse Event|0|||
162740886|NCT03544281|587764248|FG012|PACT Phase|Adverse Event|1|||
162740887|NCT03544281|587764249|FG013|PACT Phase|Adverse Event|0|||
162740888|NCT03544281|587764250|FG014|PACT Phase|Adverse Event|0|||
162740889|NCT03544281|587764251|FG015|PACT Phase|Adverse Event|0|||
162740890|NCT03544281|587764252|FG016|PACT Phase|Adverse Event|0|||
162740891|NCT03544281|587764253|FG017|PACT Phase|Adverse Event|1|||
162740892|NCT03544281|587764254|FG018|PACT Phase|Adverse Event|1|||
162740893|NCT03544281|587764255|FG019|PACT Phase|Adverse Event|0|||
162740894|NCT03544281|587764256|FG020|PACT Phase|Adverse Event|0|||
162740895|NCT03544281|587764257|FG021|PACT Phase|Adverse Event|0|||
162740896|NCT02547233|587764258|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162740897|NCT02547233|587764259|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162740898|NCT02547233|587764258|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
162740899|NCT02547233|587764259|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
162740900|NCT02547233|587764258|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
162740901|NCT02547233|587764259|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
162740902|NCT02547233|587764258|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
162740903|NCT02547233|587764259|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162740904|NCT02547233|587764258|FG000|12-month Follow-up|Withdrawal by Subject|10|||
162740905|NCT02547233|587764259|FG001|12-month Follow-up|Withdrawal by Subject|10|||
162740906|NCT02547233|587764258|FG000|12-month Follow-up|Lost to Follow-up|3|||
162740907|NCT02547233|587764259|FG001|12-month Follow-up|Lost to Follow-up|3|||
162740908|NCT02547233|587764258|FG000|12-month Follow-up|Lack of Efficacy|1|||
162740909|NCT02547233|587764259|FG001|12-month Follow-up|Lack of Efficacy|2|||
162740910|NCT02547233|587764258|FG000|12-month Follow-up|Protocol Violation|0|||
162740911|NCT02547233|587764259|FG001|12-month Follow-up|Protocol Violation|1|||
162740912|NCT02547233|587764258|FG000|12-month Follow-up|Other|0|||
162740913|NCT02547233|587764259|FG001|12-month Follow-up|Other|1|||
162740914|NCT06019559|587764260|FG000|Overall Study|Withdrawal by Subject|7|||
162740915|NCT06019559|587764261|FG001|Overall Study|Withdrawal by Subject|6|||
162740916|NCT06019559|587764262|FG002|Overall Study|Withdrawal by Subject|5|||
162740917|NCT06019559|587764260|FG000|Overall Study|Lost to Follow-up|2|||
162740918|NCT06019559|587764261|FG001|Overall Study|Lost to Follow-up|0|||
162740919|NCT06019559|587764262|FG002|Overall Study|Lost to Follow-up|3|||
162740920|NCT05362487|587764263|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
162740921|NCT02310646|587764270|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
162740922|NCT02310646|587764271|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
162740923|NCT02310646|587764270|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
162740924|NCT02310646|587764271|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
162740925|NCT00613106|587764272|FG000|Overall Study|Adverse Event|3|||
162740926|NCT00613106|587764273|FG001|Overall Study|Adverse Event|1|||
162740927|NCT00613106|587764272|FG000|Overall Study|Withdrawal by Subject|6|||
162740928|NCT00613106|587764273|FG001|Overall Study|Withdrawal by Subject|3|||
162740929|NCT00613106|587764272|FG000|Overall Study|Lost to Follow-up|7|||
162740930|NCT00613106|587764273|FG001|Overall Study|Lost to Follow-up|2|||
162740931|NCT00613106|587764272|FG000|Overall Study|misc|4|||
162740932|NCT00613106|587764273|FG001|Overall Study|misc|3|||
162740933|NCT03496168|587764280|FG000|Overall Study|Other Reasons|1|||
162740934|NCT03496168|587764280|FG000|Overall Study|Adverse Event|1|||
162740935|NCT05543629|587764283|FG000|Overall Study|Death|1|||
162740936|NCT05543629|587764284|FG001|Overall Study|Death|0|||
162740937|NCT05543629|587764285|FG002|Overall Study|Death|1|||
162740938|NCT05543629|587764286|FG003|Overall Study|Death|0|||
162740939|NCT05543629|587764287|FG004|Overall Study|Death|0|||
162740940|NCT05543629|587764288|FG005|Overall Study|Death|1|||
162740941|NCT05543629|587764289|FG006|Overall Study|Death|2|||
162740942|NCT05543629|587764290|FG007|Overall Study|Death|2|||
162740943|NCT05543629|587764283|FG000|Overall Study|Other Reasons|0|||
162740944|NCT05543629|587764284|FG001|Overall Study|Other Reasons|0|||
162740945|NCT05543629|587764285|FG002|Overall Study|Other Reasons|0|||
162740946|NCT05543629|587764286|FG003|Overall Study|Other Reasons|0|||
162740947|NCT05543629|587764287|FG004|Overall Study|Other Reasons|1|||
162740948|NCT05543629|587764288|FG005|Overall Study|Other Reasons|0|||
162740949|NCT05543629|587764289|FG006|Overall Study|Other Reasons|0|||
162740950|NCT05543629|587764290|FG007|Overall Study|Other Reasons|0|||
162740951|NCT05543629|587764283|FG000|Overall Study|Physician Decision|0|||
162740952|NCT05543629|587764284|FG001|Overall Study|Physician Decision|0|||
162740953|NCT05543629|587764285|FG002|Overall Study|Physician Decision|3|||
162740954|NCT05543629|587764286|FG003|Overall Study|Physician Decision|0|||
162740955|NCT05543629|587764287|FG004|Overall Study|Physician Decision|0|||
162740956|NCT05543629|587764288|FG005|Overall Study|Physician Decision|0|||
162740957|NCT05543629|587764289|FG006|Overall Study|Physician Decision|1|||
162740958|NCT05543629|587764290|FG007|Overall Study|Physician Decision|0|||
162740959|NCT05543629|587764283|FG000|Overall Study|Study terminated by Sponsor|1|||
162740960|NCT05543629|587764284|FG001|Overall Study|Study terminated by Sponsor|0|||
162740961|NCT05543629|587764285|FG002|Overall Study|Study terminated by Sponsor|0|||
162740962|NCT05543629|587764286|FG003|Overall Study|Study terminated by Sponsor|1|||
162740963|NCT05543629|587764287|FG004|Overall Study|Study terminated by Sponsor|0|||
162740964|NCT05543629|587764288|FG005|Overall Study|Study terminated by Sponsor|4|||
162740965|NCT05543629|587764289|FG006|Overall Study|Study terminated by Sponsor|1|||
162740966|NCT05543629|587764290|FG007|Overall Study|Study terminated by Sponsor|0|||
162740967|NCT05543629|587764283|FG000|Overall Study|Withdrawal by Subject|1|||
162740968|NCT05543629|587764284|FG001|Overall Study|Withdrawal by Subject|1|||
162740969|NCT05543629|587764285|FG002|Overall Study|Withdrawal by Subject|0|||
162740970|NCT05543629|587764286|FG003|Overall Study|Withdrawal by Subject|2|||
162740971|NCT05543629|587764287|FG004|Overall Study|Withdrawal by Subject|1|||
162740972|NCT05543629|587764288|FG005|Overall Study|Withdrawal by Subject|1|||
162740973|NCT05543629|587764289|FG006|Overall Study|Withdrawal by Subject|1|||
162740974|NCT05543629|587764290|FG007|Overall Study|Withdrawal by Subject|1|||
162740975|NCT05543629|587764283|FG000|Overall Study|Not Reported|2|||
162740976|NCT05543629|587764284|FG001|Overall Study|Not Reported|2|||
162740977|NCT05543629|587764285|FG002|Overall Study|Not Reported|0|||
162740978|NCT05543629|587764286|FG003|Overall Study|Not Reported|0|||
162740979|NCT05543629|587764287|FG004|Overall Study|Not Reported|1|||
162740980|NCT05543629|587764288|FG005|Overall Study|Not Reported|1|||
162740981|NCT05543629|587764289|FG006|Overall Study|Not Reported|3|||
162740982|NCT05543629|587764290|FG007|Overall Study|Not Reported|0|||
162740983|NCT04568603|587764291|FG000|Overall Study|Physician Decision|1|||
162740984|NCT04564742|587764292|FG000|Overall Study|Lost to Follow-up|1|||
162740985|NCT04564742|587764293|FG001|Overall Study|Lost to Follow-up|0|||
162740986|NCT04564742|587764292|FG000|Overall Study|Consent Withdrawal|4|||
162740987|NCT04564742|587764293|FG001|Overall Study|Consent Withdrawal|4|||
162740988|NCT03313076|587764297|FG000|Overall Study|Withdrawal by Subject|2|||
162740989|NCT03313076|587764298|FG001|Overall Study|Withdrawal by Subject|0|||
162740990|NCT03313076|587764299|FG002|Overall Study|Withdrawal by Subject|0|||
162740991|NCT03313076|587764300|FG003|Overall Study|Withdrawal by Subject|0|||
162740992|NCT03313076|587764297|FG000|Overall Study|Lost to Follow-up|0|||
162740993|NCT03313076|587764298|FG001|Overall Study|Lost to Follow-up|2|||
162740994|NCT03313076|587764299|FG002|Overall Study|Lost to Follow-up|2|||
162740995|NCT03313076|587764300|FG003|Overall Study|Lost to Follow-up|2|||
162740996|NCT05869383|587764301|FG000|Overall Study|Withdrawal by Subject|2|||
162740997|NCT05869383|587764302|FG001|Overall Study|Withdrawal by Subject|0|||
162740998|NCT04137367|587764311|FG000|Overall Study|Lost to Follow-up|8|||
162740999|NCT04137367|587764312|FG001|Overall Study|Lost to Follow-up|6|||
162741000|NCT04137367|587764313|FG002|Overall Study|Lost to Follow-up|4|||
162741001|NCT05144009|587764314|FG000|Overall Study|Lost to Follow-up|0|||
162741002|NCT05144009|587764315|FG001|Overall Study|Lost to Follow-up|1|||
162741003|NCT05144009|587764314|FG000|Overall Study|Study Termination by the Sponsor|11|||
162741004|NCT05144009|587764315|FG001|Overall Study|Study Termination by the Sponsor|11|||
162741005|NCT05144009|587764314|FG000|Overall Study|Disease Progression|1|||
162741006|NCT05144009|587764315|FG001|Overall Study|Disease Progression|0|||
162741007|NCT05144009|587764314|FG000|Overall Study|Participant Decision|0|||
162741008|NCT05144009|587764315|FG001|Overall Study|Participant Decision|2|||
162741009|NCT05144009|587764314|FG000|Overall Study|Death|5|||
162741010|NCT05144009|587764315|FG001|Overall Study|Death|10|||
162741011|NCT02815566|587764320|FG000|Overall Study|Adverse Event|1|||
162741012|NCT02815566|587764321|FG001|Overall Study|Adverse Event|1|||
162741013|NCT02815566|587764320|FG000|Overall Study|Withdrawal by Subject|1|||
162741014|NCT02815566|587764321|FG001|Overall Study|Withdrawal by Subject|0|||
162741015|NCT02815566|587764320|FG000|Overall Study|Lost to Follow-up|0|||
162741016|NCT02815566|587764321|FG001|Overall Study|Lost to Follow-up|1|||
162741017|NCT04492722|587764323|FG000|Overall Study|Adverse Event|7|||
162741018|NCT04492722|587764324|FG001|Overall Study|Adverse Event|2|||
162741019|NCT04492722|587764325|FG002|Overall Study|Adverse Event|3|||
162741020|NCT04492722|587764326|FG003|Overall Study|Adverse Event|0|||
162741021|NCT04492722|587764323|FG000|Overall Study|Death|0|||
162741022|NCT04492722|587764324|FG001|Overall Study|Death|0|||
162741023|NCT04492722|587764325|FG002|Overall Study|Death|0|||
162741024|NCT04492722|587764326|FG003|Overall Study|Death|1|||
162741025|NCT04492722|587764323|FG000|Overall Study|Lost to Follow-up|0|||
162741026|NCT04492722|587764324|FG001|Overall Study|Lost to Follow-up|1|||
162741027|NCT04492722|587764325|FG002|Overall Study|Lost to Follow-up|0|||
162741028|NCT04492722|587764326|FG003|Overall Study|Lost to Follow-up|1|||
162741029|NCT04492722|587764323|FG000|Overall Study|Physician Decision|0|||
162741030|NCT04492722|587764324|FG001|Overall Study|Physician Decision|3|||
162741031|NCT04492722|587764325|FG002|Overall Study|Physician Decision|1|||
162741032|NCT04492722|587764326|FG003|Overall Study|Physician Decision|1|||
162741033|NCT04492722|587764323|FG000|Overall Study|Withdrawal by Subject|6|||
162741034|NCT04492722|587764324|FG001|Overall Study|Withdrawal by Subject|6|||
162741035|NCT04492722|587764325|FG002|Overall Study|Withdrawal by Subject|0|||
162741036|NCT04492722|587764326|FG003|Overall Study|Withdrawal by Subject|3|||
162741037|NCT04492722|587764323|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
162741038|NCT04492722|587764324|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
162741039|NCT04492722|587764325|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
162741040|NCT04492722|587764326|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
162741041|NCT04492722|587764323|FG000|Overall Study|Due to Covid-19 pandemic|7|||
162741042|NCT04492722|587764324|FG001|Overall Study|Due to Covid-19 pandemic|3|||
162741043|NCT04492722|587764325|FG002|Overall Study|Due to Covid-19 pandemic|7|||
162741044|NCT04492722|587764326|FG003|Overall Study|Due to Covid-19 pandemic|6|||
162741045|NCT04492722|587764323|FG000|Overall Study|Failure to meet randomisation criteria|2|||
162741046|NCT04492722|587764324|FG001|Overall Study|Failure to meet randomisation criteria|3|||
162741047|NCT04492722|587764325|FG002|Overall Study|Failure to meet randomisation criteria|4|||
162741048|NCT04492722|587764326|FG003|Overall Study|Failure to meet randomisation criteria|2|||
162741049|NCT04492722|587764323|FG000|Overall Study|Early termination from the study|54|||
162741050|NCT04492722|587764324|FG001|Overall Study|Early termination from the study|51|||
162741051|NCT04492722|587764325|FG002|Overall Study|Early termination from the study|50|||
162741052|NCT04492722|587764326|FG003|Overall Study|Early termination from the study|50|||
162741053|NCT04492722|587764323|FG000|Overall Study|Missing|3|||
162741054|NCT04492722|587764324|FG001|Overall Study|Missing|0|||
162741055|NCT04492722|587764325|FG002|Overall Study|Missing|0|||
162741056|NCT04492722|587764326|FG003|Overall Study|Missing|5|||
162741057|NCT04492722|587764323|FG000|Overall Study|Participants who did not receive treatment|0|||
162741058|NCT04492722|587764324|FG001|Overall Study|Participants who did not receive treatment|1|||
162741059|NCT04492722|587764325|FG002|Overall Study|Participants who did not receive treatment|4|||
162741060|NCT04492722|587764326|FG003|Overall Study|Participants who did not receive treatment|0|||
162741061|NCT04074759|587764327|FG000|Overall Study|Withdrawal by Subject|0|||
162741062|NCT04074759|587764328|FG001|Overall Study|Withdrawal by Subject|0|||
162741063|NCT04074759|587764329|FG002|Overall Study|Withdrawal by Subject|0|||
162741064|NCT04074759|587764330|FG003|Overall Study|Withdrawal by Subject|0|||
162741065|NCT04074759|587764331|FG004|Overall Study|Withdrawal by Subject|0|||
162741066|NCT04074759|587764332|FG005|Overall Study|Withdrawal by Subject|2|||
162741067|NCT04074759|587764333|FG006|Overall Study|Withdrawal by Subject|0|||
162741068|NCT04074759|587764334|FG007|Overall Study|Withdrawal by Subject|2|||
162741069|NCT04074759|587764335|FG008|Overall Study|Withdrawal by Subject|1|||
162741070|NCT04074759|587764336|FG009|Overall Study|Withdrawal by Subject|2|||
162741071|NCT04074759|587764337|FG010|Overall Study|Withdrawal by Subject|9|||
162741072|NCT04074759|587764338|FG011|Overall Study|Withdrawal by Subject|2|||
162741073|NCT04074759|587764339|FG012|Overall Study|Withdrawal by Subject|1|||
162741074|NCT04074759|587764340|FG013|Overall Study|Withdrawal by Subject|3|||
162741075|NCT04074759|587764341|FG014|Overall Study|Withdrawal by Subject|2|||
162741076|NCT04074759|587764342|FG015|Overall Study|Withdrawal by Subject|0|||
162741077|NCT04074759|587764343|FG016|Overall Study|Withdrawal by Subject|0|||
162741078|NCT04074759|587764344|FG017|Overall Study|Withdrawal by Subject|3|||
162741079|NCT04074759|587764345|FG018|Overall Study|Withdrawal by Subject|1|||
162741080|NCT04074759|587764327|FG000|Overall Study|Death|1|||
162741081|NCT04074759|587764328|FG001|Overall Study|Death|0|||
162741082|NCT04074759|587764329|FG002|Overall Study|Death|1|||
162741083|NCT04074759|587764330|FG003|Overall Study|Death|1|||
162741084|NCT04074759|587764331|FG004|Overall Study|Death|2|||
162741085|NCT04074759|587764332|FG005|Overall Study|Death|0|||
162741086|NCT04074759|587764333|FG006|Overall Study|Death|1|||
162741087|NCT04074759|587764334|FG007|Overall Study|Death|0|||
162741088|NCT04074759|587764335|FG008|Overall Study|Death|3|||
162741089|NCT04074759|587764336|FG009|Overall Study|Death|2|||
162741090|NCT04074759|587764337|FG010|Overall Study|Death|4|||
162741091|NCT04074759|587764338|FG011|Overall Study|Death|1|||
162741092|NCT04074759|587764339|FG012|Overall Study|Death|0|||
162741093|NCT04074759|587764340|FG013|Overall Study|Death|2|||
162741094|NCT04074759|587764341|FG014|Overall Study|Death|1|||
162741095|NCT04074759|587764342|FG015|Overall Study|Death|0|||
162741096|NCT04074759|587764343|FG016|Overall Study|Death|1|||
162741097|NCT04074759|587764344|FG017|Overall Study|Death|0|||
162741098|NCT04074759|587764345|FG018|Overall Study|Death|1|||
162741099|NCT04074759|587764327|FG000|Overall Study|Lost to Follow-up|0|||
162741100|NCT04074759|587764328|FG001|Overall Study|Lost to Follow-up|0|||
162741101|NCT04074759|587764329|FG002|Overall Study|Lost to Follow-up|0|||
162741102|NCT04074759|587764330|FG003|Overall Study|Lost to Follow-up|0|||
162741103|NCT04074759|587764331|FG004|Overall Study|Lost to Follow-up|0|||
162741104|NCT04074759|587764332|FG005|Overall Study|Lost to Follow-up|0|||
162741105|NCT04074759|587764333|FG006|Overall Study|Lost to Follow-up|0|||
162741106|NCT04074759|587764334|FG007|Overall Study|Lost to Follow-up|0|||
162741107|NCT04074759|587764335|FG008|Overall Study|Lost to Follow-up|0|||
162741108|NCT04074759|587764336|FG009|Overall Study|Lost to Follow-up|0|||
162741109|NCT04074759|587764337|FG010|Overall Study|Lost to Follow-up|1|||
162741110|NCT04074759|587764338|FG011|Overall Study|Lost to Follow-up|0|||
162741111|NCT04074759|587764339|FG012|Overall Study|Lost to Follow-up|0|||
162741112|NCT04074759|587764340|FG013|Overall Study|Lost to Follow-up|0|||
162741113|NCT04074759|587764341|FG014|Overall Study|Lost to Follow-up|0|||
162741114|NCT04074759|587764342|FG015|Overall Study|Lost to Follow-up|0|||
162741115|NCT04074759|587764343|FG016|Overall Study|Lost to Follow-up|1|||
162741116|NCT04074759|587764344|FG017|Overall Study|Lost to Follow-up|0|||
162741117|NCT04074759|587764345|FG018|Overall Study|Lost to Follow-up|1|||
162741118|NCT04074759|587764327|FG000|Overall Study|Other|0|||
162741119|NCT04074759|587764328|FG001|Overall Study|Other|1|||
162741120|NCT04074759|587764329|FG002|Overall Study|Other|1|||
162741121|NCT04074759|587764330|FG003|Overall Study|Other|0|||
162741122|NCT04074759|587764331|FG004|Overall Study|Other|2|||
162741123|NCT04074759|587764332|FG005|Overall Study|Other|1|||
162741124|NCT04074759|587764333|FG006|Overall Study|Other|2|||
162741125|NCT04074759|587764334|FG007|Overall Study|Other|1|||
162741126|NCT04074759|587764335|FG008|Overall Study|Other|1|||
162741127|NCT04074759|587764336|FG009|Overall Study|Other|4|||
162741128|NCT04074759|587764337|FG010|Overall Study|Other|4|||
162741129|NCT04074759|587764338|FG011|Overall Study|Other|2|||
162741130|NCT04074759|587764339|FG012|Overall Study|Other|0|||
162741131|NCT04074759|587764340|FG013|Overall Study|Other|0|||
162741132|NCT04074759|587764341|FG014|Overall Study|Other|0|||
162741133|NCT04074759|587764342|FG015|Overall Study|Other|1|||
162741134|NCT04074759|587764343|FG016|Overall Study|Other|0|||
162741135|NCT04074759|587764344|FG017|Overall Study|Other|0|||
162741136|NCT04074759|587764345|FG018|Overall Study|Other|0|||
162741137|NCT04074759|587764327|FG000|Overall Study|Missing end of study status|0|||
162741138|NCT04074759|587764328|FG001|Overall Study|Missing end of study status|0|||
162741139|NCT04074759|587764329|FG002|Overall Study|Missing end of study status|0|||
162741140|NCT04074759|587764330|FG003|Overall Study|Missing end of study status|0|||
162741141|NCT04074759|587764331|FG004|Overall Study|Missing end of study status|0|||
162741142|NCT04074759|587764332|FG005|Overall Study|Missing end of study status|0|||
162741143|NCT04074759|587764333|FG006|Overall Study|Missing end of study status|0|||
162741144|NCT04074759|587764334|FG007|Overall Study|Missing end of study status|0|||
162741145|NCT04074759|587764335|FG008|Overall Study|Missing end of study status|0|||
162741146|NCT04074759|587764336|FG009|Overall Study|Missing end of study status|0|||
162741147|NCT04074759|587764337|FG010|Overall Study|Missing end of study status|2|||
162741148|NCT04074759|587764338|FG011|Overall Study|Missing end of study status|0|||
162741149|NCT04074759|587764339|FG012|Overall Study|Missing end of study status|0|||
162741150|NCT04074759|587764340|FG013|Overall Study|Missing end of study status|0|||
162741151|NCT04074759|587764341|FG014|Overall Study|Missing end of study status|0|||
162741152|NCT04074759|587764342|FG015|Overall Study|Missing end of study status|0|||
162741153|NCT04074759|587764343|FG016|Overall Study|Missing end of study status|1|||
162741154|NCT04074759|587764344|FG017|Overall Study|Missing end of study status|0|||
162741155|NCT04074759|587764345|FG018|Overall Study|Missing end of study status|0|||
162741156|NCT05329220|587764349|FG000|Active Trial Period|Adverse Event|0|||
162741157|NCT05329220|587764350|FG001|Active Trial Period|Adverse Event|0|||
162741158|NCT05329220|587764351|FG002|Active Trial Period|Adverse Event|0|||
162741159|NCT05329220|587764352|FG003|Active Trial Period|Adverse Event|0|||
162741160|NCT05329220|587764353|FG004|Active Trial Period|Adverse Event|1|||
162741161|NCT05329220|587764354|FG005|Active Trial Period|Adverse Event|0|||
162741162|NCT05329220|587764349|FG000|Active Trial Period|Lost to Follow-up|0|||
162741163|NCT05329220|587764350|FG001|Active Trial Period|Lost to Follow-up|0|||
162741164|NCT05329220|587764351|FG002|Active Trial Period|Lost to Follow-up|0|||
162741165|NCT05329220|587764352|FG003|Active Trial Period|Lost to Follow-up|0|||
162741166|NCT05329220|587764353|FG004|Active Trial Period|Lost to Follow-up|32|||
162741167|NCT05329220|587764354|FG005|Active Trial Period|Lost to Follow-up|28|||
162741168|NCT05329220|587764349|FG000|Active Trial Period|Physician Decision|0|||
162741169|NCT05329220|587764350|FG001|Active Trial Period|Physician Decision|0|||
162741170|NCT05329220|587764351|FG002|Active Trial Period|Physician Decision|0|||
162741171|NCT05329220|587764352|FG003|Active Trial Period|Physician Decision|0|||
162741172|NCT05329220|587764353|FG004|Active Trial Period|Physician Decision|2|||
162741173|NCT05329220|587764354|FG005|Active Trial Period|Physician Decision|0|||
162741174|NCT05329220|587764349|FG000|Active Trial Period|Protocol Violation|0|||
162741175|NCT05329220|587764350|FG001|Active Trial Period|Protocol Violation|0|||
162741176|NCT05329220|587764351|FG002|Active Trial Period|Protocol Violation|0|||
162741177|NCT05329220|587764352|FG003|Active Trial Period|Protocol Violation|0|||
162741178|NCT05329220|587764353|FG004|Active Trial Period|Protocol Violation|1|||
162741179|NCT05329220|587764354|FG005|Active Trial Period|Protocol Violation|3|||
162741180|NCT05329220|587764349|FG000|Active Trial Period|Withdrawal by Subject|0|||
162741181|NCT05329220|587764350|FG001|Active Trial Period|Withdrawal by Subject|0|||
162741182|NCT05329220|587764351|FG002|Active Trial Period|Withdrawal by Subject|0|||
162741183|NCT05329220|587764352|FG003|Active Trial Period|Withdrawal by Subject|1|||
162741184|NCT05329220|587764353|FG004|Active Trial Period|Withdrawal by Subject|12|||
162741185|NCT05329220|587764354|FG005|Active Trial Period|Withdrawal by Subject|13|||
162741186|NCT05329220|587764349|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162741187|NCT05329220|587764350|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162741188|NCT05329220|587764351|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162741189|NCT05329220|587764352|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162741190|NCT05329220|587764353|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162741191|NCT05329220|587764354|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
162741192|NCT05329220|587764349|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162741193|NCT05329220|587764350|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162741194|NCT05329220|587764351|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162741195|NCT05329220|587764352|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162741196|NCT05329220|587764353|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162741197|NCT05329220|587764354|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
162741198|NCT05329220|587764349|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
162741199|NCT05329220|587764350|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
162741200|NCT05329220|587764351|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
162741201|NCT05329220|587764352|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
162741202|NCT05329220|587764353|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
162741203|NCT05329220|587764354|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
162741204|NCT05329220|587764349|FG000|Follow-up Period|Adverse Event|0|||
162741205|NCT05329220|587764350|FG001|Follow-up Period|Adverse Event|0|||
162741206|NCT05329220|587764351|FG002|Follow-up Period|Adverse Event|0|||
162741207|NCT05329220|587764352|FG003|Follow-up Period|Adverse Event|0|||
162741208|NCT05329220|587764353|FG004|Follow-up Period|Adverse Event|2|||
162741209|NCT05329220|587764354|FG005|Follow-up Period|Adverse Event|1|||
162741210|NCT05329220|587764349|FG000|Follow-up Period|Death|0|||
162741211|NCT05329220|587764350|FG001|Follow-up Period|Death|0|||
162741212|NCT05329220|587764351|FG002|Follow-up Period|Death|1|||
162741213|NCT05329220|587764352|FG003|Follow-up Period|Death|1|||
162741214|NCT05329220|587764353|FG004|Follow-up Period|Death|0|||
162741215|NCT05329220|587764354|FG005|Follow-up Period|Death|1|||
162741216|NCT05329220|587764349|FG000|Follow-up Period|Lost to Follow-up|0|||
162741217|NCT05329220|587764350|FG001|Follow-up Period|Lost to Follow-up|1|||
162741218|NCT05329220|587764351|FG002|Follow-up Period|Lost to Follow-up|2|||
162741219|NCT05329220|587764352|FG003|Follow-up Period|Lost to Follow-up|2|||
162741220|NCT05329220|587764353|FG004|Follow-up Period|Lost to Follow-up|113|||
162741221|NCT05329220|587764354|FG005|Follow-up Period|Lost to Follow-up|89|||
162741222|NCT05329220|587764349|FG000|Follow-up Period|Physician Decision|0|||
162741223|NCT05329220|587764350|FG001|Follow-up Period|Physician Decision|0|||
162741224|NCT05329220|587764351|FG002|Follow-up Period|Physician Decision|0|||
162741225|NCT05329220|587764352|FG003|Follow-up Period|Physician Decision|0|||
162741226|NCT05329220|587764353|FG004|Follow-up Period|Physician Decision|2|||
162741227|NCT05329220|587764354|FG005|Follow-up Period|Physician Decision|2|||
162741228|NCT05329220|587764349|FG000|Follow-up Period|Protocol Violation|0|||
162741229|NCT05329220|587764350|FG001|Follow-up Period|Protocol Violation|0|||
162741230|NCT05329220|587764351|FG002|Follow-up Period|Protocol Violation|0|||
162741231|NCT05329220|587764352|FG003|Follow-up Period|Protocol Violation|0|||
162741232|NCT05329220|587764353|FG004|Follow-up Period|Protocol Violation|0|||
162741233|NCT05329220|587764354|FG005|Follow-up Period|Protocol Violation|1|||
162741234|NCT05329220|587764349|FG000|Follow-up Period|Withdrawal by Subject|0|||
162741235|NCT05329220|587764350|FG001|Follow-up Period|Withdrawal by Subject|0|||
162741236|NCT05329220|587764351|FG002|Follow-up Period|Withdrawal by Subject|1|||
162741237|NCT05329220|587764352|FG003|Follow-up Period|Withdrawal by Subject|1|||
162741238|NCT05329220|587764353|FG004|Follow-up Period|Withdrawal by Subject|34|||
162741239|NCT05329220|587764354|FG005|Follow-up Period|Withdrawal by Subject|35|||
162741240|NCT05329220|587764349|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162741241|NCT05329220|587764350|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162741242|NCT05329220|587764351|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
162741243|NCT05329220|587764352|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162741244|NCT05329220|587764353|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162741245|NCT05329220|587764354|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162741246|NCT05329220|587764349|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162741247|NCT05329220|587764350|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162741248|NCT05329220|587764351|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162741249|NCT05329220|587764352|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162741250|NCT05329220|587764353|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
162741251|NCT05329220|587764354|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162741252|NCT05329220|587764349|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162741253|NCT05329220|587764350|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162741254|NCT05329220|587764351|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162741255|NCT05329220|587764352|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162741256|NCT05329220|587764353|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
162741257|NCT05329220|587764354|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162741258|NCT05329220|587764349|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162741259|NCT05329220|587764350|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162741260|NCT05329220|587764351|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162741261|NCT05329220|587764352|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162741262|NCT05329220|587764353|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162741263|NCT05329220|587764354|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
162741264|NCT05329220|587764349|FG000|Follow-up Period|EARLY TERMINATION|0|||
162741265|NCT05329220|587764350|FG001|Follow-up Period|EARLY TERMINATION|0|||
162741266|NCT05329220|587764351|FG002|Follow-up Period|EARLY TERMINATION|0|||
162741267|NCT05329220|587764352|FG003|Follow-up Period|EARLY TERMINATION|0|||
162741268|NCT05329220|587764353|FG004|Follow-up Period|EARLY TERMINATION|0|||
162741269|NCT05329220|587764354|FG005|Follow-up Period|EARLY TERMINATION|1|||
162741270|NCT05329220|587764349|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162741271|NCT05329220|587764350|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162741272|NCT05329220|587764351|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162741273|NCT05329220|587764352|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162741274|NCT05329220|587764353|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162741275|NCT05329220|587764354|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
162741276|NCT05329220|587764349|FG000|Follow-up Period|DROPPED|0|||
162741277|NCT05329220|587764350|FG001|Follow-up Period|DROPPED|0|||
162741278|NCT05329220|587764351|FG002|Follow-up Period|DROPPED|0|||
162741279|NCT05329220|587764352|FG003|Follow-up Period|DROPPED|0|||
162741280|NCT05329220|587764353|FG004|Follow-up Period|DROPPED|0|||
162741281|NCT05329220|587764354|FG005|Follow-up Period|DROPPED|1|||
162741282|NCT05329220|587764349|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162741283|NCT05329220|587764350|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162741284|NCT05329220|587764351|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162741285|NCT05329220|587764352|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162741286|NCT05329220|587764353|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162741287|NCT05329220|587764354|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
162741288|NCT04313972|587764361|FG000|Overall Study|Withdrawal by Subject|0|||
162741289|NCT04313972|587764362|FG001|Overall Study|Withdrawal by Subject|1|||
162741290|NCT05201079|587764376|FG000|Overall Study|Adverse Event|7|||
162741291|NCT05201079|587764377|FG001|Overall Study|Adverse Event|11|||
162741292|NCT05201079|587764376|FG000|Overall Study|Death|1|||
162741293|NCT05201079|587764377|FG001|Overall Study|Death|1|||
162741294|NCT05201079|587764376|FG000|Overall Study|Lack of Efficacy|0|||
162741295|NCT05201079|587764377|FG001|Overall Study|Lack of Efficacy|2|||
162741296|NCT05201079|587764376|FG000|Overall Study|Lost to Follow-up|0|||
162741297|NCT05201079|587764377|FG001|Overall Study|Lost to Follow-up|1|||
162741298|NCT05201079|587764376|FG000|Overall Study|Physician Decision|1|||
162741299|NCT05201079|587764377|FG001|Overall Study|Physician Decision|1|||
162741300|NCT05201079|587764376|FG000|Overall Study|Protocol Violation|1|||
162741301|NCT05201079|587764377|FG001|Overall Study|Protocol Violation|0|||
162741302|NCT05201079|587764376|FG000|Overall Study|Withdrawal by Subject|1|||
162741303|NCT05201079|587764377|FG001|Overall Study|Withdrawal by Subject|0|||
162741304|NCT05201079|587764376|FG000|Overall Study|Forbidden medication|9|||
162741305|NCT05201079|587764377|FG001|Overall Study|Forbidden medication|5|||
162741306|NCT05201079|587764376|FG000|Overall Study|Transfer to another hospital|0|||
162741307|NCT05201079|587764377|FG001|Overall Study|Transfer to another hospital|1|||
162741308|NCT05201079|587764376|FG000|Overall Study|Clinical condition|1|||
162741309|NCT05201079|587764377|FG001|Overall Study|Clinical condition|0|||
162741310|NCT05201079|587764376|FG000|Overall Study|SAE and sepsis|1|||
162741311|NCT05201079|587764377|FG001|Overall Study|SAE and sepsis|0|||
162741312|NCT04719832|587764381|FG000|Overall Study|Adverse Event|2|||
162741313|NCT04719832|587764382|FG001|Overall Study|Adverse Event|0|||
162741314|NCT04719832|587764381|FG000|Overall Study|Lack of Efficacy|2|||
162741315|NCT04719832|587764382|FG001|Overall Study|Lack of Efficacy|4|||
162741316|NCT04719832|587764381|FG000|Overall Study|Lost to Follow-up|0|||
162741317|NCT04719832|587764382|FG001|Overall Study|Lost to Follow-up|2|||
162741318|NCT04719832|587764381|FG000|Overall Study|Physician Decision|0|||
162741319|NCT04719832|587764382|FG001|Overall Study|Physician Decision|1|||
162741320|NCT04719832|587764381|FG000|Overall Study|Pregnancy|1|||
162741321|NCT04719832|587764382|FG001|Overall Study|Pregnancy|1|||
162741322|NCT04719832|587764381|FG000|Overall Study|Withdrawal by Subject|5|||
162741323|NCT04719832|587764382|FG001|Overall Study|Withdrawal by Subject|5|||
162741324|NCT04719832|587764381|FG000|Overall Study|Randomized, not treated|0|||
162741325|NCT04719832|587764382|FG001|Overall Study|Randomized, not treated|2|||
162741326|NCT04719832|587764381|FG000|Overall Study|GCP violations|4|||
162741327|NCT04719832|587764382|FG001|Overall Study|GCP violations|7|||
162741328|NCT05192109|587764387|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
162741329|NCT05192109|587764388|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
162741330|NCT05192109|587764389|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162741331|NCT05192109|587764390|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162741332|NCT05192109|587764387|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
162741333|NCT05192109|587764388|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
162741334|NCT05192109|587764389|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162741335|NCT05192109|587764390|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162741336|NCT04728347|587766734|FG000|Overall Study|Sponsor decision|0|||
162741337|NCT04728347|587766735|FG001|Overall Study|Sponsor decision|0|||
162741338|NCT04728347|587766736|FG002|Overall Study|Sponsor decision|1|||
162741339|NCT04728347|587766737|FG003|Overall Study|Sponsor decision|0|||
162741340|NCT05835336|587766739|FG000|Overall Study|Withdrawal by Subject|5|||
162741341|NCT05835336|587766739|FG000|Overall Study|Did not complete the personalization process|3|||
162741342|NCT04489771|587766740|FG000|Overall Study|Death|27|||
162741343|NCT04489771|587766741|FG001|Overall Study|Death|25|||
162741344|NCT04489771|587766740|FG000|Overall Study|Withdrawal by Subject|1|||
162741345|NCT04489771|587766741|FG001|Overall Study|Withdrawal by Subject|0|||
162741346|NCT04489771|587766740|FG000|Overall Study|Participants Ongoing in Study|50|||
162741347|NCT04489771|587766741|FG001|Overall Study|Participants Ongoing in Study|51|||
162741348|NCT06516705|587766749|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
162741349|NCT06516705|587766750|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
162741350|NCT06516705|587766749|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
162741351|NCT06516705|587766750|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
162741352|NCT06516705|587766749|FG000|T3 ( 3 Month After Education)|covid-19|1|||
162741353|NCT06516705|587766750|FG001|T3 ( 3 Month After Education)|covid-19|2|||
162741354|NCT06516705|587766749|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
162741355|NCT06516705|587766750|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
162741356|NCT06516705|587766749|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
162741357|NCT06516705|587766750|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
162741358|NCT06516705|587766749|FG000|T4 ( 6 Month After Education)|covid-19|3|||
162741359|NCT06516705|587766750|FG001|T4 ( 6 Month After Education)|covid-19|2|||
162741360|NCT06516705|587766749|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
162741361|NCT06516705|587766750|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
162741362|NCT05579899|587766751|FG000|Overall Study|Lost to Follow-up|3|||
162741363|NCT05579899|587766752|FG001|Overall Study|Lost to Follow-up|1|||
162741364|NCT05579899|587766751|FG000|Overall Study|Adverse Event|0|||
162741365|NCT05579899|587766752|FG001|Overall Study|Adverse Event|3|||
162741366|NCT05579899|587766751|FG000|Overall Study|Pregnancy|0|||
162741367|NCT05579899|587766752|FG001|Overall Study|Pregnancy|1|||
162741368|NCT05579899|587766751|FG000|Overall Study|Withdrawal by Subject|0|||
162741369|NCT05579899|587766752|FG001|Overall Study|Withdrawal by Subject|3|||
162741370|NCT04059484|587766754|FG000|Overall Study|Adverse Event|2|||
162741371|NCT04059484|587766755|FG001|Overall Study|Adverse Event|5|||
162741372|NCT04059484|587766754|FG000|Overall Study|Withdrawal by Subject|5|||
162741373|NCT04059484|587766755|FG001|Overall Study|Withdrawal by Subject|3|||
162741374|NCT04059484|587766754|FG000|Overall Study|Progressive disease|112|||
162741375|NCT04059484|587766755|FG001|Overall Study|Progressive disease|112|||
162741376|NCT04059484|587766754|FG000|Overall Study|Other|8|||
162741377|NCT04059484|587766755|FG001|Overall Study|Other|3|||
162741378|NCT04059484|587766754|FG000|Overall Study|Ongoing|20|||
162741379|NCT04059484|587766755|FG001|Overall Study|Ongoing|20|||
162741380|NCT04292223|587766756|FG000|Overall Study|Adverse Event|1|||
162741381|NCT04292223|587766756|FG000|Overall Study|Lost to Follow-up|1|||
162741382|NCT04292223|587766756|FG000|Overall Study|Noncompliance with study drug|2|||
162741383|NCT04292223|587766756|FG000|Overall Study|Patient moved out of the state|1|||
162741384|NCT00753545|587766757|FG000|Overall Study|Death|98|||
162741385|NCT00753545|587766758|FG001|Overall Study|Death|112|||
162741386|NCT00753545|587766757|FG000|Overall Study|Lost to Follow-up|2|||
162741387|NCT00753545|587766758|FG001|Overall Study|Lost to Follow-up|3|||
162741388|NCT00753545|587766757|FG000|Overall Study|Protocol Violation|1|||
162741389|NCT00753545|587766758|FG001|Overall Study|Protocol Violation|0|||
162741390|NCT00753545|587766757|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
162741391|NCT00753545|587766758|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
162741392|NCT05453773|587766759|FG000|Overall Study|Withdrawal by Subject|3|||
162741393|NCT05453773|587766759|FG000|Overall Study|Lost to Follow-up|3|||
162741394|NCT05453773|587766759|FG000|Overall Study|Difficult Blood Draw|3|||
162741395|NCT02485938|587766762|FG000|Overall Study|Withdrawal of consent|2|||
162741396|NCT02485938|587766763|FG001|Overall Study|Withdrawal of consent|0|||
162741397|NCT03839940|587766764|FG000|Overall Study|Withdrawal by Subject|3|||
162741398|NCT03839940|587766765|FG001|Overall Study|Withdrawal by Subject|0|||
162741399|NCT03839940|587766764|FG000|Overall Study|Protocol Violation|0|||
162741400|NCT03839940|587766765|FG001|Overall Study|Protocol Violation|1|||
162741401|NCT03839940|587766764|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
162741402|NCT03839940|587766765|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
162741403|NCT00470704|587766766|FG000|Overall Study|Withdrawal by Subject|4|||
162741404|NCT00470704|587766767|FG001|Overall Study|Withdrawal by Subject|3|||
162741405|NCT00470704|587766766|FG000|Overall Study|Relapse/Progression|37|||
162741406|NCT00470704|587766767|FG001|Overall Study|Relapse/Progression|42|||
162741407|NCT00470704|587766766|FG000|Overall Study|toxicity|0|||
162741408|NCT00470704|587766767|FG001|Overall Study|toxicity|1|||
162741409|NCT04963270|587766769|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
162741410|NCT04963270|587766770|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
162741411|NCT04963270|587766771|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
162741412|NCT04963270|587766772|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
162741413|NCT04963270|587766769|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
162741414|NCT04963270|587766770|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
162741415|NCT04963270|587766771|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
162741416|NCT04963270|587766772|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
162741417|NCT04963270|587766769|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
162741418|NCT04963270|587766770|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162741419|NCT04963270|587766771|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162741420|NCT04963270|587766772|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162741421|NCT04963270|587766769|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
162741422|NCT04963270|587766770|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162741423|NCT04963270|587766771|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162741424|NCT04963270|587766772|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162741425|NCT04963270|587766769|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162741426|NCT04963270|587766770|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
162741427|NCT04963270|587766771|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162741428|NCT04963270|587766772|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162741429|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162741430|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162741431|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162741432|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
162741433|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162741434|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162741435|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
162741436|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162741437|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
162741438|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
162741439|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
162741440|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
162741441|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
162741442|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
162741443|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
162741444|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
162741445|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162741446|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162741447|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
162741448|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162741449|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
162741450|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
162741451|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
162741452|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
162741453|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162741454|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162741455|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162741456|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
162741457|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162741458|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162741459|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162741460|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
162741461|NCT04963270|587766769|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162741462|NCT04963270|587766770|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162741463|NCT04963270|587766771|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162741464|NCT04963270|587766772|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
162741465|NCT04802967|587766773|FG000|Part B|Withdrawal by Subject|0|||
162741466|NCT04802967|587766774|FG001|Part B|Withdrawal by Subject|0|||
162741467|NCT04802967|587766775|FG002|Part B|Withdrawal by Subject|0|||
162741468|NCT04802967|587766776|FG003|Part B|Withdrawal by Subject|0|||
162741469|NCT04802967|587766777|FG004|Part B|Withdrawal by Subject|0|||
162741470|NCT04802967|587766778|FG005|Part B|Withdrawal by Subject|1|||
162741471|NCT04802967|587766779|FG006|Part B|Withdrawal by Subject|0|||
162741472|NCT04802967|587766780|FG007|Part B|Withdrawal by Subject|0|||
162741473|NCT04802967|587766781|FG008|Part B|Withdrawal by Subject|0|||
162741474|NCT04802967|587766782|FG009|Part B|Withdrawal by Subject|0|||
162741475|NCT03560609|587766787|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
162741476|NCT03560609|587766788|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
162741477|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
162741478|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
162741479|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
162741480|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
162741481|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
162741482|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
162741483|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162741484|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162741485|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162741486|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162741487|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
162741488|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162741489|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162741490|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
162741491|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
162741492|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162741493|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162741494|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162741495|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741496|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
162741497|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
162741498|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741499|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741500|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
162741501|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741502|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741503|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162741504|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
162741505|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162741506|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
162741507|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
162741508|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
162741509|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
162741510|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162741511|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162741512|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162741513|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
162741514|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
162741515|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
162741516|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
162741517|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
162741518|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
162741519|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162741520|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162741521|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162741522|NCT01369355|587766792|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
162741523|NCT01369355|587766793|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
162741524|NCT01369355|587766794|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
162741525|NCT01369355|587766795|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
162741526|NCT01369355|587766796|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
162741527|NCT01369355|587766797|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
162741528|NCT01369355|587766798|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
162741529|NCT01369355|587766799|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
162741530|NCT01369355|587766800|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
162741531|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741532|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741533|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741534|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741535|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741536|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
162741537|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
162741538|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
162741539|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
162741540|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Death|0|||
162741541|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Death|0|||
162741542|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Death|0|||
162741543|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Death|0|||
162741544|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Death|0|||
162741545|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Death|0|||
162741546|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Death|0|||
162741547|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Death|1|||
162741548|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Death|3|||
162741549|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741550|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741551|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741552|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741553|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741554|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162741555|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
162741556|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
162741557|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
162741558|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741559|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741560|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741561|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741562|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741563|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741564|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162741565|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
162741566|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
162741567|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741568|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741569|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741570|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741571|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741572|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
162741573|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
162741574|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
162741575|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
162741576|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741577|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741578|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741579|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741580|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741581|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162741582|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
162741583|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
162741584|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
162741585|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741586|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741587|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741588|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741589|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741590|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162741591|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
162741592|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
162741593|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
162741594|NCT01369355|587766792|FG000|Long-term Extension (Week 44-272)|Other|0|||
162741595|NCT01369355|587766793|FG001|Long-term Extension (Week 44-272)|Other|0|||
162741596|NCT01369355|587766794|FG002|Long-term Extension (Week 44-272)|Other|0|||
162741597|NCT01369355|587766795|FG003|Long-term Extension (Week 44-272)|Other|0|||
162741598|NCT01369355|587766796|FG004|Long-term Extension (Week 44-272)|Other|0|||
162741599|NCT01369355|587766797|FG005|Long-term Extension (Week 44-272)|Other|0|||
162741600|NCT01369355|587766798|FG006|Long-term Extension (Week 44-272)|Other|110|||
162741601|NCT01369355|587766799|FG007|Long-term Extension (Week 44-272)|Other|9|||
162741602|NCT01369355|587766800|FG008|Long-term Extension (Week 44-272)|Other|17|||
162741603|NCT03339713|587766804|FG000|Overall Study|Lost to Follow-up|2|||
162741604|NCT03339713|587766805|FG001|Overall Study|Lost to Follow-up|1|||
162741605|NCT03339713|587766804|FG000|Overall Study|Protocol Violation|1|||
162741606|NCT03339713|587766805|FG001|Overall Study|Protocol Violation|0|||
162741607|NCT03339713|587766804|FG000|Overall Study|Withdrawal by Subject|1|||
162741608|NCT03339713|587766805|FG001|Overall Study|Withdrawal by Subject|1|||
162741609|NCT05540665|587766809|FG000|Overall Study|Study terminated by sponsor|6|||
162741610|NCT05540665|587766810|FG001|Overall Study|Study terminated by sponsor|6|||
162741611|NCT05540665|587766811|FG002|Overall Study|Study terminated by sponsor|7|||
162741612|NCT03462030|587766812|FG000|Overall Study|Withdrawal by Subject|1|||
162741613|NCT03462030|587766813|FG001|Overall Study|Withdrawal by Subject|1|||
162741614|NCT03381196|587766814|FG000|Overall Study|Withdrawal by Subject|7|||
162741615|NCT03381196|587766815|FG001|Overall Study|Withdrawal by Subject|7|||
162741616|NCT03381196|587766814|FG000|Overall Study|Other|0|||
162741617|NCT03381196|587766815|FG001|Overall Study|Other|1|||
162741618|NCT03381196|587766814|FG000|Overall Study|Lost to Follow-up|5|||
162741619|NCT03381196|587766815|FG001|Overall Study|Lost to Follow-up|4|||
162741620|NCT03381196|587766814|FG000|Overall Study|Death|0|||
162741621|NCT03381196|587766815|FG001|Overall Study|Death|1|||
162741622|NCT03381196|587766814|FG000|Overall Study|Adverse Event|1|||
162741623|NCT03381196|587766815|FG001|Overall Study|Adverse Event|0|||
162741624|NCT03381196|587766814|FG000|Overall Study|Randomized, not treated|3|||
162741625|NCT03381196|587766815|FG001|Overall Study|Randomized, not treated|6|||
162741626|NCT00227344|587766816|FG000|Overall Study|study terminated early|12|||
162741627|NCT00227344|587766817|FG001|Overall Study|study terminated early|5|||
162741628|NCT03371381|587766818|FG000|Overall Study|Death|5|||
162741629|NCT03371381|587766818|FG000|Overall Study|Study terminated by sponsor|3|||
162741630|NCT03371381|587766818|FG000|Overall Study|Other|4|||
162741631|NCT03628924|587766825|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
162741632|NCT03628924|587766826|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741633|NCT03628924|587766827|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741634|NCT03628924|587766828|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741635|NCT03628924|587766829|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741636|NCT03628924|587766830|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741637|NCT03628924|587766831|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162741638|NCT03628924|587766825|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741639|NCT03628924|587766826|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741640|NCT03628924|587766827|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
162741641|NCT03628924|587766828|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741642|NCT03628924|587766829|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741643|NCT03628924|587766830|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741644|NCT03628924|587766831|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162741645|NCT03628924|587766825|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
162741646|NCT03628924|587766826|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
162741647|NCT03628924|587766827|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
162741648|NCT03628924|587766828|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162741649|NCT03628924|587766829|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162741650|NCT03628924|587766830|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162741651|NCT03628924|587766831|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162741652|NCT03628924|587766825|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741653|NCT03628924|587766826|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
162741654|NCT03628924|587766827|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741655|NCT03628924|587766828|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741656|NCT03628924|587766829|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741657|NCT03628924|587766830|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741658|NCT03628924|587766831|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162741659|NCT03628924|587766825|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
162741660|NCT03628924|587766826|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162741661|NCT03628924|587766827|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
162741662|NCT03628924|587766828|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162741663|NCT03628924|587766829|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162741664|NCT03628924|587766830|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162741665|NCT03628924|587766831|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162741666|NCT03628924|587766825|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162741667|NCT03628924|587766826|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162741668|NCT03628924|587766827|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162741669|NCT03628924|587766828|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162741670|NCT03628924|587766829|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162741671|NCT03628924|587766830|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
162741672|NCT03628924|587766831|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162741673|NCT03628924|587766825|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162741674|NCT03628924|587766826|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162741675|NCT03628924|587766827|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162741676|NCT03628924|587766828|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
162741677|NCT03628924|587766829|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162741678|NCT03628924|587766830|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
162741679|NCT03628924|587766831|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
162741680|NCT03628924|587766825|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162741681|NCT03628924|587766826|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162741682|NCT03628924|587766827|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162741683|NCT03628924|587766828|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162741684|NCT03628924|587766829|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162741685|NCT03628924|587766830|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162741686|NCT03628924|587766831|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162741687|NCT03628924|587766825|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162741688|NCT03628924|587766826|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162741689|NCT03628924|587766827|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162741690|NCT03628924|587766828|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
162741691|NCT03628924|587766829|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
162741692|NCT03628924|587766830|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
162741693|NCT03628924|587766831|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
162741694|NCT03628924|587766825|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162741695|NCT03628924|587766826|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162741696|NCT03628924|587766827|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162741697|NCT03628924|587766828|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162741698|NCT03628924|587766829|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
162741699|NCT03628924|587766830|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
162741700|NCT03628924|587766831|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
162741701|NCT01073566|587766832|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
162741702|NCT01073566|587766833|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
162741703|NCT05780437|587766836|FG000|Overall Study|Withdrawal by Subject|22|||
162741704|NCT05780437|587766837|FG001|Overall Study|Withdrawal by Subject|16|||
162741705|NCT03603600|587766842|FG000|Overall Study|Withdrawal by Subject|5|||
162741706|NCT03603600|587766843|FG001|Overall Study|Withdrawal by Subject|7|||
162741707|NCT03603600|587766842|FG000|Overall Study|Lost to Follow-up|2|||
162741708|NCT03603600|587766843|FG001|Overall Study|Lost to Follow-up|3|||
162741709|NCT03603600|587766842|FG000|Overall Study|Death|3|||
162741710|NCT03603600|587766843|FG001|Overall Study|Death|1|||
162741711|NCT03603600|587766842|FG000|Overall Study|Physician Decision|2|||
162741712|NCT03603600|587766843|FG001|Overall Study|Physician Decision|1|||
162741713|NCT03603600|587766842|FG000|Overall Study|Other reason|1|||
162741714|NCT03603600|587766843|FG001|Overall Study|Other reason|0|||
162741715|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
162741716|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
162741717|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
162741718|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
162741719|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
162741720|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
162741721|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
162741722|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
162741723|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
162741724|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
162741725|NCT03461276|587766844|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
162741726|NCT03461276|587766845|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
162741727|NCT03461276|587766844|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
162741728|NCT03461276|587766845|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
162741729|NCT03461276|587766844|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
162741730|NCT03461276|587766845|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
162741731|NCT03461276|587766844|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
162741732|NCT03461276|587766845|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
162741733|NCT03461276|587766844|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
162741734|NCT03461276|587766845|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
162741735|NCT02043678|587766850|FG000|Overall Study|Never treated|11|||
162741736|NCT02043678|587766851|FG001|Overall Study|Never treated|9|||
162741737|NCT02043678|587766850|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
162741738|NCT02043678|587766851|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
162741739|NCT02043678|587766850|FG000|Overall Study|AE without clinical PD|54|||
162741740|NCT02043678|587766851|FG001|Overall Study|AE without clinical PD|36|||
162741741|NCT02043678|587766850|FG000|Overall Study|Lost to Follow-up|1|||
162741742|NCT02043678|587766851|FG001|Overall Study|Lost to Follow-up|1|||
162741743|NCT02043678|587766850|FG000|Overall Study|Other|10|||
162741744|NCT02043678|587766851|FG001|Overall Study|Other|14|||
162741745|NCT02043678|587766850|FG000|Overall Study|Clinical PD|114|||
162741746|NCT02043678|587766851|FG001|Overall Study|Clinical PD|148|||
162741747|NCT02043678|587766850|FG000|Overall Study|Radiological PD|100|||
162741748|NCT02043678|587766851|FG001|Overall Study|Radiological PD|90|||
162741749|NCT02043678|587766850|FG000|Overall Study|Protocol-driven decision point|59|||
162741750|NCT02043678|587766851|FG001|Overall Study|Protocol-driven decision point|58|||
162741751|NCT02043678|587766850|FG000|Overall Study|Withdrawal by Subject|16|||
162741752|NCT02043678|587766851|FG001|Overall Study|Withdrawal by Subject|20|||
162741753|NCT02043678|587766850|FG000|Overall Study|Protocol Violation|1|||
162741754|NCT02043678|587766851|FG001|Overall Study|Protocol Violation|0|||
162741755|NCT02043678|587766850|FG000|Overall Study|Deterioration of general conditions|1|||
162741756|NCT02043678|587766851|FG001|Overall Study|Deterioration of general conditions|1|||
162741757|NCT02043678|587766850|FG000|Overall Study|Logistical difficulties|2|||
162741758|NCT02043678|587766851|FG001|Overall Study|Logistical difficulties|0|||
162741759|NCT02043678|587766850|FG000|Overall Study|Non-compliance with study drug|3|||
162741760|NCT02043678|587766851|FG001|Overall Study|Non-compliance with study drug|1|||
162741761|NCT02043678|587766850|FG000|Overall Study|Physician Decision|4|||
162741762|NCT02043678|587766851|FG001|Overall Study|Physician Decision|3|||
162741763|NCT02043678|587766850|FG000|Overall Study|Subject decision|0|||
162741764|NCT02043678|587766851|FG001|Overall Study|Subject decision|1|||
162741765|NCT02043678|587766850|FG000|Overall Study|Switching to other therapy|3|||
162741766|NCT02043678|587766851|FG001|Overall Study|Switching to other therapy|2|||
162741767|NCT02043678|587766850|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
162741768|NCT02043678|587766851|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
162741769|NCT02043678|587766850|FG000|Overall Study|Missing|1|||
162741770|NCT02043678|587766851|FG001|Overall Study|Missing|0|||
162741771|NCT02043678|587766850|FG000|Overall Study|Adverse Event|0|||
162741772|NCT02043678|587766851|FG001|Overall Study|Adverse Event|1|||
162741773|NCT04307355|587766859|FG000|Overall Study|Non-Compliance|3|||
162741774|NCT04307355|587766860|FG001|Overall Study|Non-Compliance|3|||
162741775|NCT04307355|587766861|FG002|Overall Study|Non-Compliance|0|||
162741776|NCT04065841|587766862|FG000|Overall Study|Adverse Event|4|||
162741777|NCT04065841|587766863|FG001|Overall Study|Adverse Event|2|||
162741778|NCT04065841|587766864|FG002|Overall Study|Adverse Event|10|||
162741779|NCT04065841|587766865|FG003|Overall Study|Adverse Event|1|||
162741780|NCT04065841|587766862|FG000|Overall Study|Lost to Follow-up|1|||
162741781|NCT04065841|587766863|FG001|Overall Study|Lost to Follow-up|2|||
162741782|NCT04065841|587766864|FG002|Overall Study|Lost to Follow-up|2|||
162741783|NCT04065841|587766865|FG003|Overall Study|Lost to Follow-up|2|||
162741784|NCT04065841|587766862|FG000|Overall Study|Physician Decision|1|||
162741785|NCT04065841|587766863|FG001|Overall Study|Physician Decision|0|||
162741786|NCT04065841|587766864|FG002|Overall Study|Physician Decision|0|||
162741787|NCT04065841|587766865|FG003|Overall Study|Physician Decision|0|||
162741788|NCT04065841|587766862|FG000|Overall Study|Protocol Violation|0|||
162741789|NCT04065841|587766863|FG001|Overall Study|Protocol Violation|1|||
162741790|NCT04065841|587766864|FG002|Overall Study|Protocol Violation|0|||
162741791|NCT04065841|587766865|FG003|Overall Study|Protocol Violation|0|||
162741792|NCT04065841|587766862|FG000|Overall Study|Study terminated by Sponsor|22|||
162741793|NCT04065841|587766863|FG001|Overall Study|Study terminated by Sponsor|16|||
162741794|NCT04065841|587766864|FG002|Overall Study|Study terminated by Sponsor|28|||
162741795|NCT04065841|587766865|FG003|Overall Study|Study terminated by Sponsor|17|||
162741796|NCT04065841|587766862|FG000|Overall Study|Withdrawal by Subject|1|||
162741797|NCT04065841|587766863|FG001|Overall Study|Withdrawal by Subject|1|||
162741798|NCT04065841|587766864|FG002|Overall Study|Withdrawal by Subject|2|||
162741799|NCT04065841|587766865|FG003|Overall Study|Withdrawal by Subject|0|||
162741800|NCT01420237|587766869|FG000|Overall Study|Death|13|||
162741801|NCT01420237|587766869|FG000|Overall Study|Withdrawal by Subject|41|||
162741802|NCT01420237|587766869|FG000|Overall Study|Lost to Follow-up|32|||
162741803|NCT01420237|587766869|FG000|Overall Study|Adverse Event|10|||
162741804|NCT01420237|587766869|FG000|Overall Study|Investigative Site Termination|43|||
162741805|NCT01420237|587766869|FG000|Overall Study|Censored because study device not implanted|21|||
162741806|NCT01420237|587766869|FG000|Overall Study|Censored because surgery not performed|2|||
162741807|NCT01420237|587766869|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
162741808|NCT01420237|587766869|FG000|Overall Study|Sponsor terminated study early|127|||
162741809|NCT05269667|587766870|FG000|Overall Study|Study Terminated by Sponsor|4|||
162741810|NCT03768505|587766871|FG000|Overall Study|sponsor decision|76|||
162741811|NCT03768505|587766871|FG000|Overall Study|Death|35|||
162741812|NCT03768505|587766871|FG000|Overall Study|Other -Various|30|||
162741813|NCT03768505|587766871|FG000|Overall Study|Withdrawal by Subject|22|||
162741814|NCT03768505|587766871|FG000|Overall Study|Lost to Follow-up|6|||
162741815|NCT02861300|587766875|FG000|Overall Study|Death|0|||
162741816|NCT02861300|587766876|FG001|Overall Study|Death|0|||
162741817|NCT02861300|587766877|FG002|Overall Study|Death|0|||
162741818|NCT02861300|587766878|FG003|Overall Study|Death|0|||
162741819|NCT02861300|587766879|FG004|Overall Study|Death|0|||
162741820|NCT02861300|587766880|FG005|Overall Study|Death|0|||
162741821|NCT02861300|587766881|FG006|Overall Study|Death|24|||
162741822|NCT02861300|587766875|FG000|Overall Study|Delay in treatment|0|||
162741823|NCT02861300|587766876|FG001|Overall Study|Delay in treatment|0|||
162741824|NCT02861300|587766877|FG002|Overall Study|Delay in treatment|0|||
162741825|NCT02861300|587766878|FG003|Overall Study|Delay in treatment|0|||
162741826|NCT02861300|587766879|FG004|Overall Study|Delay in treatment|0|||
162741827|NCT02861300|587766880|FG005|Overall Study|Delay in treatment|1|||
162741828|NCT02861300|587766881|FG006|Overall Study|Delay in treatment|0|||
162741829|NCT02861300|587766875|FG000|Overall Study|Disease Progression|0|||
162741830|NCT02861300|587766876|FG001|Overall Study|Disease Progression|1|||
162741831|NCT02861300|587766877|FG002|Overall Study|Disease Progression|0|||
162741832|NCT02861300|587766878|FG003|Overall Study|Disease Progression|0|||
162741833|NCT02861300|587766879|FG004|Overall Study|Disease Progression|0|||
162741834|NCT02861300|587766880|FG005|Overall Study|Disease Progression|0|||
162741835|NCT02861300|587766881|FG006|Overall Study|Disease Progression|2|||
162741836|NCT02861300|587766875|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
162741837|NCT02861300|587766876|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
162741838|NCT02861300|587766877|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
162741839|NCT02861300|587766878|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
162741840|NCT02861300|587766879|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
162741841|NCT02861300|587766880|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
162741842|NCT02861300|587766881|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
162741843|NCT02861300|587766875|FG000|Overall Study|Clinical Complications|0|||
162741844|NCT02861300|587766876|FG001|Overall Study|Clinical Complications|0|||
162741845|NCT02861300|587766877|FG002|Overall Study|Clinical Complications|0|||
162741846|NCT02861300|587766878|FG003|Overall Study|Clinical Complications|0|||
162741847|NCT02861300|587766879|FG004|Overall Study|Clinical Complications|0|||
162741848|NCT02861300|587766880|FG005|Overall Study|Clinical Complications|0|||
162741849|NCT02861300|587766881|FG006|Overall Study|Clinical Complications|1|||
162741850|NCT03133546|587766887|FG000|Overall Study|Death|46|||
162741851|NCT03133546|587766888|FG001|Overall Study|Death|43|||
162741852|NCT03133546|587766887|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
162741853|NCT03133546|587766888|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
162741854|NCT02993159|587766889|FG000|Overall Study|Withdrawal by Subject|1|||
162741855|NCT02993159|587766890|FG001|Overall Study|Withdrawal by Subject|3|||
162741856|NCT02993159|587766889|FG000|Overall Study|Protocol Violation|1|||
162741857|NCT02993159|587766890|FG001|Overall Study|Protocol Violation|0|||
162741858|NCT02993159|587766889|FG000|Overall Study|Opted out of surgery|2|||
162741859|NCT02993159|587766890|FG001|Overall Study|Opted out of surgery|0|||
162741860|NCT02993159|587766889|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
162741861|NCT02993159|587766890|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
162741862|NCT02993159|587766889|FG000|Overall Study|Physician Decision|0|||
162741863|NCT02993159|587766890|FG001|Overall Study|Physician Decision|1|||
162741864|NCT05034328|587766891|FG000|Overall Study|Protocol Violation|1|||
162741865|NCT05034328|587766892|FG001|Overall Study|Protocol Violation|0|||
162741866|NCT05034328|587766891|FG000|Overall Study|Lost to Follow-up|0|||
162741867|NCT05034328|587766892|FG001|Overall Study|Lost to Follow-up|10|||
162741868|NCT02231164|587766893|FG000|Overall Study|Adverse Event|1|||
162741869|NCT02231164|587766894|FG001|Overall Study|Adverse Event|1|||
162741870|NCT02231164|587766893|FG000|Overall Study|Lack of Efficacy|4|||
162741871|NCT02231164|587766894|FG001|Overall Study|Lack of Efficacy|3|||
162741872|NCT02231164|587766893|FG000|Overall Study|Withdrawal by Subject|1|||
162741873|NCT02231164|587766894|FG001|Overall Study|Withdrawal by Subject|2|||
162741874|NCT05281562|587766897|FG000|Overall Study|Ineligible patient|1|||
162741875|NCT05281562|587766898|FG001|Overall Study|Ineligible patient|0|||
162741876|NCT04524442|587766906|FG000|Overall Study|Subject Decision|1|||
162741877|NCT04898673|587766907|FG000|Overall Study|Screenfail|1|||
162741878|NCT04898673|587766908|FG001|Overall Study|Screenfail|0|||
162741879|NCT05526430|587766909|FG000|Overall Study|Withdrawal by Subject|0|||
162741880|NCT05526430|587766910|FG001|Overall Study|Withdrawal by Subject|2|||
162741881|NCT05526430|587766911|FG002|Overall Study|Withdrawal by Subject|0|||
162741882|NCT05526430|587766912|FG003|Overall Study|Withdrawal by Subject|0|||
162741883|NCT03085810|587766913|FG000|Main Study|Withdrawal by Subject|77|||
162741884|NCT03085810|587766914|FG001|Main Study|Withdrawal by Subject|0|||
162741885|NCT03085810|587766915|FG002|Main Study|Withdrawal by Subject|0|||
162741886|NCT03085810|587766913|FG000|Main Study|Terminated By Sponsor|14|||
162741887|NCT03085810|587766914|FG001|Main Study|Terminated By Sponsor|0|||
162741888|NCT03085810|587766915|FG002|Main Study|Terminated By Sponsor|0|||
162741889|NCT03085810|587766913|FG000|Main Study|Protocol Violation|15|||
162741890|NCT03085810|587766914|FG001|Main Study|Protocol Violation|0|||
162741891|NCT03085810|587766915|FG002|Main Study|Protocol Violation|0|||
162741892|NCT03085810|587766913|FG000|Main Study|Physician Decision|13|||
162741893|NCT03085810|587766914|FG001|Main Study|Physician Decision|0|||
162741894|NCT03085810|587766915|FG002|Main Study|Physician Decision|0|||
162741895|NCT03085810|587766913|FG000|Main Study|Lost to Follow-up|17|||
162741896|NCT03085810|587766914|FG001|Main Study|Lost to Follow-up|0|||
162741897|NCT03085810|587766915|FG002|Main Study|Lost to Follow-up|0|||
162741898|NCT03085810|587766913|FG000|Main Study|Adverse Event|25|||
162741899|NCT03085810|587766914|FG001|Main Study|Adverse Event|0|||
162741900|NCT03085810|587766915|FG002|Main Study|Adverse Event|0|||
162741901|NCT03085810|587766913|FG000|Main Study|Pregnancy|7|||
162741902|NCT03085810|587766914|FG001|Main Study|Pregnancy|0|||
162741903|NCT03085810|587766915|FG002|Main Study|Pregnancy|0|||
162741904|NCT03085810|587766913|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
162741905|NCT03085810|587766914|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
162741906|NCT03085810|587766915|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
162741907|NCT03085810|587766913|FG000|Main Study|Lack of Efficacy|10|||
162741908|NCT03085810|587766914|FG001|Main Study|Lack of Efficacy|0|||
162741909|NCT03085810|587766915|FG002|Main Study|Lack of Efficacy|0|||
162741910|NCT03085810|587766913|FG000|Main Study|Death|12|||
162741911|NCT03085810|587766914|FG001|Main Study|Death|0|||
162741912|NCT03085810|587766915|FG002|Main Study|Death|0|||
162741913|NCT03085810|587766913|FG000|Main Study|Disease progression|1|||
162741914|NCT03085810|587766914|FG001|Main Study|Disease progression|0|||
162741915|NCT03085810|587766915|FG002|Main Study|Disease progression|0|||
162741916|NCT03085810|587766913|FG000|Main Study|Site Closure|3|||
162741917|NCT03085810|587766914|FG001|Main Study|Site Closure|0|||
162741918|NCT03085810|587766915|FG002|Main Study|Site Closure|0|||
162741919|NCT03085810|587766913|FG000|Main Study|Planned pregnancy|17|||
162741920|NCT03085810|587766914|FG001|Main Study|Planned pregnancy|0|||
162741921|NCT03085810|587766915|FG002|Main Study|Planned pregnancy|0|||
162741922|NCT03085810|587766913|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
162741923|NCT03085810|587766914|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
162741924|NCT03085810|587766915|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
162741925|NCT03085810|587766913|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
162741926|NCT03085810|587766914|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
162741927|NCT03085810|587766915|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
162741928|NCT03085810|587766913|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
162741929|NCT03085810|587766914|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
162741930|NCT03085810|587766915|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
162741931|NCT03085810|587766913|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
162741932|NCT03085810|587766914|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
162741933|NCT03085810|587766915|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
162741934|NCT02601313|587766916|FG000|Overall Study|Death|2|||
162741935|NCT02601313|587766917|FG001|Overall Study|Death|41|||
162741936|NCT02601313|587766918|FG002|Overall Study|Death|6|||
162741937|NCT02601313|587766916|FG000|Overall Study|Enrolled but never treated|0|||
162741938|NCT02601313|587766917|FG001|Overall Study|Enrolled but never treated|6|||
162741939|NCT02601313|587766918|FG002|Overall Study|Enrolled but never treated|3|||
162741940|NCT02601313|587766916|FG000|Overall Study|Enrolled, did not initiate AC|4|||
162741941|NCT02601313|587766917|FG001|Overall Study|Enrolled, did not initiate AC|0|||
162741942|NCT02601313|587766918|FG002|Overall Study|Enrolled, did not initiate AC|0|||
162741943|NCT02601313|587766916|FG000|Overall Study|Full consent withdrawal|0|||
162741944|NCT02601313|587766917|FG001|Overall Study|Full consent withdrawal|3|||
162741945|NCT02601313|587766918|FG002|Overall Study|Full consent withdrawal|2|||
162741946|NCT02601313|587766916|FG000|Overall Study|Lost to Follow-up|0|||
162741947|NCT02601313|587766917|FG001|Overall Study|Lost to Follow-up|1|||
162741948|NCT02601313|587766918|FG002|Overall Study|Lost to Follow-up|1|||
162741949|NCT05239455|587766923|FG000|Overall Study|Adverse Event|1|||
162741950|NCT05239455|587766923|FG000|Overall Study|Sponsor Decision|5|||
162741951|NCT05239455|587766923|FG000|Overall Study|Incomplete Blood Collection|1|||
162741952|NCT03701763|587766925|FG000|Placebo-controlled Phase|Adverse Event|1|||
162741953|NCT03701763|587766926|FG001|Placebo-controlled Phase|Adverse Event|5|||
162741954|NCT03701763|587766927|FG002|Placebo-controlled Phase|Adverse Event|0|||
162741955|NCT03701763|587766928|FG003|Placebo-controlled Phase|Adverse Event|0|||
162741956|NCT03701763|587766925|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
162741957|NCT03701763|587766926|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
162741958|NCT03701763|587766927|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
162741959|NCT03701763|587766928|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
162741960|NCT03701763|587766925|FG000|Placebo-controlled Phase|Miscellaneous|2|||
162741961|NCT03701763|587766926|FG001|Placebo-controlled Phase|Miscellaneous|0|||
162741962|NCT03701763|587766927|FG002|Placebo-controlled Phase|Miscellaneous|0|||
162741963|NCT03701763|587766928|FG003|Placebo-controlled Phase|Miscellaneous|0|||
162741964|NCT03701763|587766925|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
162741965|NCT03701763|587766926|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
162741966|NCT03701763|587766927|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
162741967|NCT03701763|587766928|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
162741968|NCT03701763|587766925|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
162741969|NCT03701763|587766926|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
162741970|NCT03701763|587766927|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
162741971|NCT03701763|587766928|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
162741972|NCT03701763|587766925|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
162741973|NCT03701763|587766926|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
162741974|NCT03701763|587766927|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
162741975|NCT03701763|587766928|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
162741976|NCT03701763|587766925|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
162741977|NCT03701763|587766926|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
162741978|NCT03701763|587766927|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
162741979|NCT03701763|587766928|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
162741980|NCT03701763|587766925|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
162741981|NCT03701763|587766926|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
162741982|NCT03701763|587766927|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
162741983|NCT03701763|587766928|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
162741984|NCT03701763|587766925|FG000|Apremilast Extension Phase|Adverse Event|0|||
162741985|NCT03701763|587766926|FG001|Apremilast Extension Phase|Adverse Event|0|||
162741986|NCT03701763|587766927|FG002|Apremilast Extension Phase|Adverse Event|3|||
162741987|NCT03701763|587766928|FG003|Apremilast Extension Phase|Adverse Event|1|||
162741988|NCT03701763|587766925|FG000|Apremilast Extension Phase|Miscellaneous|0|||
162741989|NCT03701763|587766926|FG001|Apremilast Extension Phase|Miscellaneous|0|||
162741990|NCT03701763|587766927|FG002|Apremilast Extension Phase|Miscellaneous|2|||
162741991|NCT03701763|587766928|FG003|Apremilast Extension Phase|Miscellaneous|1|||
162741992|NCT03701763|587766925|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
162741993|NCT03701763|587766926|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
162741994|NCT03701763|587766927|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
162741995|NCT03701763|587766928|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
162741996|NCT03701763|587766925|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
162741997|NCT03701763|587766926|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
162741998|NCT03701763|587766927|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
162741999|NCT03701763|587766928|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
162742000|NCT03701763|587766925|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
162742001|NCT03701763|587766926|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
162742002|NCT03701763|587766927|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
162742003|NCT03701763|587766928|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
162742004|NCT03701763|587766925|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162742005|NCT03701763|587766926|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162742006|NCT03701763|587766927|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
162742007|NCT03701763|587766928|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162742008|NCT03701763|587766925|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
162742009|NCT03701763|587766926|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
162742010|NCT03701763|587766927|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
162742011|NCT03701763|587766928|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
162742012|NCT03701763|587766925|FG000|14-Week Observational Follow-up Phase|Other|0|||
162742013|NCT03701763|587766926|FG001|14-Week Observational Follow-up Phase|Other|0|||
162742014|NCT03701763|587766927|FG002|14-Week Observational Follow-up Phase|Other|1|||
162742015|NCT03701763|587766928|FG003|14-Week Observational Follow-up Phase|Other|0|||
162742016|NCT03701763|587766925|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162742017|NCT03701763|587766926|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162742018|NCT03701763|587766927|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162742019|NCT03701763|587766928|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
162742020|NCT03701763|587766925|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
162742021|NCT03701763|587766926|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
162742022|NCT03701763|587766927|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
162742023|NCT03701763|587766928|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
162742024|NCT02675751|587768484|FG000|Overall Study|Lost to Follow-up|16|||
162742025|NCT02359890|587768485|FG000|Overall Study|Not meeting eligibility|4|||
162742026|NCT02359890|587768485|FG000|Overall Study|Never treated with study catheter|6|||
162742027|NCT02268253|587768489|FG000|Stage 1|Withdrawal by Subject|1|||
162742028|NCT02268253|587768490|FG001|Stage 1|Withdrawal by Subject|0|||
162742029|NCT02268253|587768491|FG002|Stage 1|Withdrawal by Subject|0|||
162742030|NCT02268253|587768492|FG003|Stage 1|Withdrawal by Subject|0|||
162742031|NCT02268253|587768493|FG004|Stage 1|Withdrawal by Subject|0|||
162742032|NCT02268253|587768494|FG005|Stage 1|Withdrawal by Subject|0|||
162742033|NCT02268253|587768495|FG006|Stage 1|Withdrawal by Subject|0|||
162742034|NCT02268253|587768489|FG000|Stage 1|Death|0|||
162742035|NCT02268253|587768490|FG001|Stage 1|Death|2|||
162742036|NCT02268253|587768491|FG002|Stage 1|Death|2|||
162742037|NCT02268253|587768492|FG003|Stage 1|Death|2|||
162742038|NCT02268253|587768493|FG004|Stage 1|Death|1|||
162742039|NCT02268253|587768494|FG005|Stage 1|Death|1|||
162742040|NCT02268253|587768495|FG006|Stage 1|Death|0|||
162742041|NCT02268253|587768489|FG000|Stage 2|Disease Recurrence/ Progression|0|||
162742042|NCT02268253|587768490|FG001|Stage 2|Disease Recurrence/ Progression|0|||
162742043|NCT02268253|587768491|FG002|Stage 2|Disease Recurrence/ Progression|1|||
162742044|NCT02268253|587768492|FG003|Stage 2|Disease Recurrence/ Progression|0|||
162742045|NCT02268253|587768493|FG004|Stage 2|Disease Recurrence/ Progression|0|||
162742046|NCT02268253|587768494|FG005|Stage 2|Disease Recurrence/ Progression|0|||
162742047|NCT02268253|587768495|FG006|Stage 2|Disease Recurrence/ Progression|0|||
162742048|NCT02268253|587768489|FG000|Stage 2|Withdrawal by Subject|0|||
162742049|NCT02268253|587768490|FG001|Stage 2|Withdrawal by Subject|0|||
162742050|NCT02268253|587768491|FG002|Stage 2|Withdrawal by Subject|2|||
162742051|NCT02268253|587768492|FG003|Stage 2|Withdrawal by Subject|0|||
162742052|NCT02268253|587768493|FG004|Stage 2|Withdrawal by Subject|0|||
162742053|NCT02268253|587768494|FG005|Stage 2|Withdrawal by Subject|2|||
162742054|NCT02268253|587768495|FG006|Stage 2|Withdrawal by Subject|0|||
162742055|NCT02268253|587768489|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162742056|NCT02268253|587768490|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162742057|NCT02268253|587768491|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
162742058|NCT02268253|587768492|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162742059|NCT02268253|587768493|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162742060|NCT02268253|587768494|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
162742061|NCT02268253|587768495|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162742062|NCT02268253|587768489|FG000|Stage 2|Death|0|||
162742063|NCT02268253|587768490|FG001|Stage 2|Death|0|||
162742064|NCT02268253|587768491|FG002|Stage 2|Death|19|||
162742065|NCT02268253|587768492|FG003|Stage 2|Death|0|||
162742066|NCT02268253|587768493|FG004|Stage 2|Death|0|||
162742067|NCT02268253|587768494|FG005|Stage 2|Death|20|||
162742068|NCT02268253|587768495|FG006|Stage 2|Death|1|||
162742069|NCT02268253|587768489|FG000|Stage 2|Lost to Follow-up|0|||
162742070|NCT02268253|587768490|FG001|Stage 2|Lost to Follow-up|0|||
162742071|NCT02268253|587768491|FG002|Stage 2|Lost to Follow-up|0|||
162742072|NCT02268253|587768492|FG003|Stage 2|Lost to Follow-up|0|||
162742073|NCT02268253|587768493|FG004|Stage 2|Lost to Follow-up|0|||
162742074|NCT02268253|587768494|FG005|Stage 2|Lost to Follow-up|4|||
162742075|NCT02268253|587768495|FG006|Stage 2|Lost to Follow-up|0|||
162742076|NCT02268253|587768489|FG000|Stage 2|Transferred to Hospice|0|||
162742077|NCT02268253|587768490|FG001|Stage 2|Transferred to Hospice|0|||
162742078|NCT02268253|587768491|FG002|Stage 2|Transferred to Hospice|0|||
162742079|NCT02268253|587768492|FG003|Stage 2|Transferred to Hospice|0|||
162742080|NCT02268253|587768493|FG004|Stage 2|Transferred to Hospice|0|||
162742081|NCT02268253|587768494|FG005|Stage 2|Transferred to Hospice|2|||
162742082|NCT02268253|587768495|FG006|Stage 2|Transferred to Hospice|0|||
162742083|NCT02268253|587768489|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
162742084|NCT02268253|587768490|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
162742085|NCT02268253|587768491|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
162742086|NCT02268253|587768492|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
162742087|NCT02268253|587768493|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
162742088|NCT02268253|587768494|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
162742089|NCT02268253|587768495|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
162742090|NCT02268253|587768489|FG000|Stage 3A|Withdrawal by Subject|0|||
162742091|NCT02268253|587768490|FG001|Stage 3A|Withdrawal by Subject|0|||
162742092|NCT02268253|587768491|FG002|Stage 3A|Withdrawal by Subject|2|||
162742093|NCT02268253|587768492|FG003|Stage 3A|Withdrawal by Subject|0|||
162742094|NCT02268253|587768493|FG004|Stage 3A|Withdrawal by Subject|0|||
162742095|NCT02268253|587768494|FG005|Stage 3A|Withdrawal by Subject|0|||
162742096|NCT02268253|587768495|FG006|Stage 3A|Withdrawal by Subject|0|||
162742097|NCT02268253|587768489|FG000|Stage 3A|Physician Decision|0|||
162742098|NCT02268253|587768490|FG001|Stage 3A|Physician Decision|0|||
162742099|NCT02268253|587768491|FG002|Stage 3A|Physician Decision|2|||
162742100|NCT02268253|587768492|FG003|Stage 3A|Physician Decision|0|||
162742101|NCT02268253|587768493|FG004|Stage 3A|Physician Decision|0|||
162742102|NCT02268253|587768494|FG005|Stage 3A|Physician Decision|0|||
162742103|NCT02268253|587768495|FG006|Stage 3A|Physician Decision|0|||
162742104|NCT02268253|587768489|FG000|Stage 3A|Study Terminated by Sponsor|0|||
162742105|NCT02268253|587768490|FG001|Stage 3A|Study Terminated by Sponsor|0|||
162742106|NCT02268253|587768491|FG002|Stage 3A|Study Terminated by Sponsor|2|||
162742107|NCT02268253|587768492|FG003|Stage 3A|Study Terminated by Sponsor|0|||
162742108|NCT02268253|587768493|FG004|Stage 3A|Study Terminated by Sponsor|0|||
162742109|NCT02268253|587768494|FG005|Stage 3A|Study Terminated by Sponsor|0|||
162742110|NCT02268253|587768495|FG006|Stage 3A|Study Terminated by Sponsor|0|||
162742111|NCT02268253|587768489|FG000|Stage 3A|Lost to Follow-up|0|||
162742112|NCT02268253|587768490|FG001|Stage 3A|Lost to Follow-up|0|||
162742113|NCT02268253|587768491|FG002|Stage 3A|Lost to Follow-up|1|||
162742114|NCT02268253|587768492|FG003|Stage 3A|Lost to Follow-up|0|||
162742115|NCT02268253|587768493|FG004|Stage 3A|Lost to Follow-up|0|||
162742116|NCT02268253|587768494|FG005|Stage 3A|Lost to Follow-up|0|||
162742117|NCT02268253|587768495|FG006|Stage 3A|Lost to Follow-up|0|||
162742118|NCT02268253|587768489|FG000|Stage 3A|Death|0|||
162742119|NCT02268253|587768490|FG001|Stage 3A|Death|0|||
162742120|NCT02268253|587768491|FG002|Stage 3A|Death|5|||
162742121|NCT02268253|587768492|FG003|Stage 3A|Death|0|||
162742122|NCT02268253|587768493|FG004|Stage 3A|Death|0|||
162742123|NCT02268253|587768494|FG005|Stage 3A|Death|0|||
162742124|NCT02268253|587768495|FG006|Stage 3A|Death|0|||
162742125|NCT05714761|587768496|FG000|Overall Study|Lost to Follow-up|3|||
162742126|NCT05714761|587768496|FG000|Overall Study|Withdrawal by Subject|3|||
162742127|NCT05714761|587768496|FG000|Overall Study|unblinding of sensor data|1|||
162742128|NCT05714761|587768496|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
162742129|NCT05714761|587768496|FG000|Overall Study|did not return second CGM sensor|4|||
162742130|NCT05672069|587768497|FG000|Overall Study|Implant removal|1|||
162742131|NCT05672069|587768497|FG000|Overall Study|Lost to Follow-up|2|||
162742132|NCT05213390|587768498|FG000|Overall Study|Withdrawal by Subject|2|||
162742133|NCT05213390|587768498|FG000|Overall Study|Lost to Follow-up|12|||
162742134|NCT05213390|587768498|FG000|Overall Study|Protocol Violation|9|||
162742135|NCT03031470|587768504|FG000|Overall Study|Adverse Event|3|||
162742136|NCT03031470|587768505|FG001|Overall Study|Adverse Event|0|||
162742137|NCT03031470|587768504|FG000|Overall Study|Death|3|||
162742138|NCT03031470|587768505|FG001|Overall Study|Death|1|||
162742139|NCT03031470|587768504|FG000|Overall Study|Lost to Follow-up|1|||
162742140|NCT03031470|587768505|FG001|Overall Study|Lost to Follow-up|1|||
162742141|NCT03031470|587768504|FG000|Overall Study|Withdrawal by Subject|1|||
162742142|NCT03031470|587768505|FG001|Overall Study|Withdrawal by Subject|0|||
162742143|NCT03031470|587768504|FG000|Overall Study|Protocol entry criteria not met|0|||
162742144|NCT03031470|587768505|FG001|Overall Study|Protocol entry criteria not met|1|||
162742145|NCT03031470|587768504|FG000|Overall Study|Cancel the operation|0|||
162742146|NCT03031470|587768505|FG001|Overall Study|Cancel the operation|1|||
162742147|NCT01593917|587768506|FG000|Overall Study|Death|67|||
162742148|NCT01593917|587768506|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
162742149|NCT01593917|587768506|FG000|Overall Study|Withdrawal by Subject|23|||
162742150|NCT01593917|587768506|FG000|Overall Study|Lost to Follow-up|12|||
162742151|NCT01593917|587768506|FG000|Overall Study|Protocol Violation|5|||
162742152|NCT01593917|587768506|FG000|Overall Study|Physician Decision|3|||
162742153|NCT02683447|587768509|FG000|Overall Study|Lost to Follow-up|2|||
162742154|NCT04663737|587768510|FG000|Overall Study|Withdrawal by Subject|2|||
162742155|NCT04663737|587768511|FG001|Overall Study|Withdrawal by Subject|0|||
162742156|NCT04016662|587768512|FG000|Run-In Phase|Death|1|||
162742157|NCT04016662|587768512|FG000|Run-In Phase|Withdrawal by Subject|11|||
162742158|NCT04016662|587768512|FG000|Run-In Phase|Not meeting screening eligibility|9|||
162742159|NCT04016662|587768512|FG000|Run-In Phase|Physician Decision|3|||
162742160|NCT04016662|587768512|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
162742161|NCT04016662|587768512|FG000|PLGS (12 Weeks)|Death|1|||
162742162|NCT04016662|587768512|FG000|SAP (12 Weeks)|Death|1|||
162742163|NCT03021096|587768513|FG000|Overall Study|Lost to Follow-up|4|||
162742164|NCT03021096|587768513|FG000|Overall Study|Protocol Violation|2|||
162742165|NCT03216057|587768514|FG000|Overall Study|Lost to Follow-up|2|||
162742166|NCT03216057|587768515|FG001|Overall Study|Lost to Follow-up|2|||
162742167|NCT03907878|587768516|FG000|Treatment Period|Withdrawal by Subject|5|||
162742168|NCT03907878|587768516|FG000|Treatment Period|Adverse Event|4|||
162742169|NCT03907878|587768516|FG000|Treatment Period|Lack of Efficacy|1|||
162742170|NCT03907878|587768516|FG000|Treatment Period|Protocol Violation|1|||
162742171|NCT03907878|587768516|FG000|Follow-up Period|Adverse Event|3|||
162742172|NCT03907878|587768516|FG000|Follow-up Period|Withdrawal by Subject|3|||
162742173|NCT03904147|587768521|FG000|Overall Study|Death|15|||
162742174|NCT03904147|587768522|FG001|Overall Study|Death|13|||
162742175|NCT03904147|587768523|FG002|Overall Study|Death|15|||
162742176|NCT03904147|587768521|FG000|Overall Study|Withdrawal by Subject|7|||
162742177|NCT03904147|587768522|FG001|Overall Study|Withdrawal by Subject|12|||
162742178|NCT03904147|587768523|FG002|Overall Study|Withdrawal by Subject|1|||
162742179|NCT03904147|587768521|FG000|Overall Study|1Y visit completed after 365 days|1|||
162742180|NCT03904147|587768522|FG001|Overall Study|1Y visit completed after 365 days|1|||
162742181|NCT03904147|587768523|FG002|Overall Study|1Y visit completed after 365 days|0|||
162742182|NCT05399459|587768527|FG000|Overall Study|Randomized but not treated|29|||
162742183|NCT05399459|587768528|FG001|Overall Study|Randomized but not treated|30|||
162742184|NCT05399459|587768529|FG002|Overall Study|Randomized but not treated|38|||
162742185|NCT05399459|587768527|FG000|Overall Study|Lost to Follow-up|1|||
162742186|NCT05399459|587768528|FG001|Overall Study|Lost to Follow-up|0|||
162742187|NCT05399459|587768529|FG002|Overall Study|Lost to Follow-up|0|||
162742188|NCT04992520|587768530|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
162742189|NCT04992520|587768531|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
162742190|NCT04992520|587768532|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
162742191|NCT04992520|587768533|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
162742192|NCT04992520|587768534|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
162742193|NCT04992520|587768535|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
162742194|NCT04992520|587768530|FG000|Part A: First Challenge|Non-compliance|0|||
162742195|NCT04992520|587768531|FG001|Part A: First Challenge|Non-compliance|0|||
162742196|NCT04992520|587768532|FG002|Part A: First Challenge|Non-compliance|0|||
162742197|NCT04992520|587768533|FG003|Part A: First Challenge|Non-compliance|1|||
162742198|NCT04992520|587768534|FG004|Part A: First Challenge|Non-compliance|0|||
162742199|NCT04992520|587768535|FG005|Part A: First Challenge|Non-compliance|0|||
162742200|NCT04992520|587768530|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162742201|NCT04992520|587768531|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162742202|NCT04992520|587768532|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
162742203|NCT04992520|587768533|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162742204|NCT04992520|587768534|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162742205|NCT04992520|587768535|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
162742206|NCT04992520|587768530|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162742207|NCT04992520|587768531|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162742208|NCT04992520|587768532|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
162742209|NCT04992520|587768533|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162742210|NCT04992520|587768534|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162742211|NCT04992520|587768535|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162742212|NCT03625167|587768536|FG000|Overall Study|Protocol Violation|5|||
162742213|NCT01175356|587768537|FG000|Overall Study|Death|1|||
162742214|NCT01175356|587768537|FG000|Overall Study|Lack of Efficacy|12|||
162742215|NCT01175356|587768537|FG000|Overall Study|Lost to Follow-up|1|||
162742216|NCT01175356|587768537|FG000|Overall Study|Physician Decision|23|||
162742217|NCT01175356|587768537|FG000|Overall Study|Ineligible|1|||
162742218|NCT01175356|587768537|FG000|Overall Study|Treatment Slot Not Available|18|||
162742219|NCT01175356|587768537|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
162742220|NCT01175356|587768537|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
162742221|NCT01175356|587768537|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
162742222|NCT01175356|587768537|FG000|Overall Study|Inadequate stem cell for transplant|1|||
162742223|NCT01175356|587768537|FG000|Overall Study|Initiation other tx prior to completion|9|||
162742224|NCT05583578|587768540|FG000|Overall Study|Withdrawal by Subject|2|||
162742225|NCT05583578|587768541|FG001|Overall Study|Withdrawal by Subject|0|||
162742226|NCT05877976|587768544|FG000|Overall Study|Lost to Follow-up|31|||
162742227|NCT00248287|587768545|FG000|Overall Study|Adverse Event|11|||
162742228|NCT00248287|587768546|FG001|Overall Study|Adverse Event|10|||
162742229|NCT00248287|587768545|FG000|Overall Study|Death|1|||
162742230|NCT00248287|587768546|FG001|Overall Study|Death|0|||
162742231|NCT00248287|587768545|FG000|Overall Study|Lost to Follow-up|0|||
162742232|NCT00248287|587768546|FG001|Overall Study|Lost to Follow-up|1|||
162742233|NCT00248287|587768545|FG000|Overall Study|Investigator Request|4|||
162742234|NCT00248287|587768546|FG001|Overall Study|Investigator Request|3|||
162742235|NCT00248287|587768545|FG000|Overall Study|Patient Request|5|||
162742236|NCT00248287|587768546|FG001|Overall Study|Patient Request|3|||
162742237|NCT00248287|587768545|FG000|Overall Study|Other|3|||
162742238|NCT00248287|587768546|FG001|Overall Study|Other|2|||
162742239|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
162742240|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
162742241|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
162742242|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
162742243|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
162742244|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
162742245|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
162742246|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
162742247|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
162742248|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
162742249|NCT04103580|587768549|FG000|Phase 1 Active Caregiving|Other|3|||
162742250|NCT04103580|587768550|FG001|Phase 1 Active Caregiving|Other|3|||
162742251|NCT04103580|587768549|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
162742252|NCT04103580|587768550|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
162742253|NCT04103580|587768549|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
162742254|NCT04103580|587768550|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
162810471|NCT03435497|588018230|FG001|Overall Study|Withdrawal by Subject|4|||
162742255|NCT04103580|587768549|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
162742256|NCT04103580|587768550|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
162742257|NCT04103580|587768549|FG000|Phase 2 Bereavement|Other|8|||
162742258|NCT04103580|587768550|FG001|Phase 2 Bereavement|Other|6|||
162742259|NCT04145440|587768551|FG000|Overall Study|Physician Decision|3|||
162742260|NCT04145440|587768552|FG001|Overall Study|Physician Decision|0|||
162742261|NCT04145440|587768551|FG000|Overall Study|Use of prohibited therapy|2|||
162742262|NCT04145440|587768552|FG001|Overall Study|Use of prohibited therapy|3|||
162742263|NCT05808257|587768555|FG000|Overall Study|Lost to Follow-up|8|||
162742264|NCT05808257|587768556|FG001|Overall Study|Lost to Follow-up|8|||
162742265|NCT04568486|587768557|FG000|Overall Study|Withdrawal by Subject|26|||
162742266|NCT04568486|587768557|FG000|Overall Study|Lost to Follow-up|7|||
162742267|NCT04042233|587768558|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
162742268|NCT04042233|587768559|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
162742269|NCT04042233|587768558|FG000|Overall Study|Protocol Violation|0|||
162742270|NCT04042233|587768559|FG001|Overall Study|Protocol Violation|2|||
162742271|NCT04907851|587768562|FG000|Overall Study|Consent withdrawn|1|||
162742272|NCT04907851|587768563|FG001|Overall Study|Consent withdrawn|2|||
162742273|NCT04907851|587768564|FG002|Overall Study|Consent withdrawn|0|||
162742274|NCT04907851|587768562|FG000|Overall Study|Death|5|||
162742275|NCT04907851|587768563|FG001|Overall Study|Death|15|||
162742276|NCT04907851|587768564|FG002|Overall Study|Death|10|||
162742277|NCT04248725|587768576|FG000|Post-Treatment|Lost to Follow-up|6|||
162742278|NCT04248725|587768577|FG001|Post-Treatment|Lost to Follow-up|5|||
162742279|NCT04248725|587768576|FG000|6-Month Follow Up|Lost to Follow-up|9|||
162742280|NCT04248725|587768577|FG001|6-Month Follow Up|Lost to Follow-up|8|||
162742281|NCT01210807|587768584|FG000|Overall Study|Lost to Follow-up|1|||
162742282|NCT01210807|587768585|FG001|Overall Study|Lost to Follow-up|2|||
162742283|NCT01210807|587768584|FG000|Overall Study|Not implanted bilaterally|2|||
162742284|NCT01210807|587768585|FG001|Overall Study|Not implanted bilaterally|1|||
162742285|NCT00324805|587768590|FG000|Overall Study|Adverse Event|62|||
162742286|NCT00324805|587768591|FG001|Overall Study|Adverse Event|203|||
162742287|NCT00324805|587768590|FG000|Overall Study|Progression|7|||
162742288|NCT00324805|587768591|FG001|Overall Study|Progression|35|||
162742289|NCT00324805|587768590|FG000|Overall Study|Withdrawal by Subject|51|||
162742290|NCT00324805|587768591|FG001|Overall Study|Withdrawal by Subject|174|||
162742291|NCT00324805|587768590|FG000|Overall Study|Death|6|||
162742292|NCT00324805|587768591|FG001|Overall Study|Death|9|||
162742293|NCT00324805|587768590|FG000|Overall Study|Alternative therapy|4|||
162742294|NCT00324805|587768591|FG001|Overall Study|Alternative therapy|8|||
162742295|NCT00324805|587768590|FG000|Overall Study|Other complicating disease|1|||
162742296|NCT00324805|587768591|FG001|Overall Study|Other complicating disease|9|||
162742297|NCT00324805|587768590|FG000|Overall Study|Other reasons|7|||
162742298|NCT00324805|587768591|FG001|Overall Study|Other reasons|26|||
162742299|NCT00324805|587768590|FG000|Overall Study|Other|0|||
162742300|NCT00324805|587768591|FG001|Overall Study|Other|2|||
162742301|NCT00324805|587768590|FG000|Overall Study|Did not start therapy|12|||
162742302|NCT00324805|587768591|FG001|Overall Study|Did not start therapy|17|||
162742303|NCT05792085|587768593|FG000|Overall Study|Death|0|||
162742304|NCT05792085|587768594|FG001|Overall Study|Death|0|||
162742305|NCT05792085|587768595|FG002|Overall Study|Death|0|||
162742306|NCT05792085|587768596|FG003|Overall Study|Death|0|||
162742307|NCT05792085|587768597|FG004|Overall Study|Death|1|||
162742308|NCT05977530|587768599|FG000|Overall Study|Withdrawal by Subject|1|||
162742309|NCT05977530|587768599|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
162742310|NCT05496231|587768600|FG000|Overall Study|Adverse Event|1|||
162742311|NCT05496231|587768601|FG001|Overall Study|Adverse Event|1|||
162742312|NCT05496231|587768602|FG002|Overall Study|Adverse Event|0|||
162742313|NCT05496231|587768603|FG003|Overall Study|Adverse Event|4|||
162742314|NCT05496231|587768600|FG000|Overall Study|Withdrawal by Subject|5|||
162742315|NCT05496231|587768601|FG001|Overall Study|Withdrawal by Subject|5|||
162742316|NCT05496231|587768602|FG002|Overall Study|Withdrawal by Subject|4|||
162742317|NCT05496231|587768603|FG003|Overall Study|Withdrawal by Subject|11|||
162742318|NCT05496231|587768600|FG000|Overall Study|Migrated/moved from the study area|3|||
162742319|NCT05496231|587768601|FG001|Overall Study|Migrated/moved from the study area|5|||
162742320|NCT05496231|587768602|FG002|Overall Study|Migrated/moved from the study area|3|||
162742321|NCT05496231|587768603|FG003|Overall Study|Migrated/moved from the study area|3|||
162742322|NCT05496231|587768600|FG000|Overall Study|Lost to Follow-up|13|||
162742323|NCT05496231|587768601|FG001|Overall Study|Lost to Follow-up|6|||
162742324|NCT05496231|587768602|FG002|Overall Study|Lost to Follow-up|11|||
162742325|NCT05496231|587768603|FG003|Overall Study|Lost to Follow-up|6|||
162742326|NCT05496231|587768600|FG000|Overall Study|Other|9|||
162742327|NCT05496231|587768601|FG001|Overall Study|Other|7|||
162742328|NCT05496231|587768602|FG002|Overall Study|Other|7|||
162742329|NCT05496231|587768603|FG003|Overall Study|Other|8|||
162742330|NCT03819153|587768615|FG000|Overall Study|Withdrawal by Subject|20|||
162742331|NCT03819153|587768616|FG001|Overall Study|Withdrawal by Subject|28|||
162742332|NCT03819153|587768615|FG000|Overall Study|Lost to Follow-up|23|||
162742333|NCT03819153|587768616|FG001|Overall Study|Lost to Follow-up|30|||
162742334|NCT04797897|587768624|FG000|Overall Study|Study Termination by Sponsor|1|||
162742335|NCT04797897|587768625|FG001|Overall Study|Study Termination by Sponsor|1|||
162742336|NCT03058289|587768630|FG000|Overall Study|Radiographic Deterioration|0|||
162742337|NCT03058289|587768631|FG001|Overall Study|Radiographic Deterioration|3|||
162742338|NCT03058289|587768632|FG002|Overall Study|Radiographic Deterioration|1|||
162742339|NCT03058289|587768633|FG003|Overall Study|Radiographic Deterioration|2|||
162742340|NCT03058289|587768634|FG004|Overall Study|Radiographic Deterioration|6|||
162742341|NCT03058289|587768635|FG005|Overall Study|Radiographic Deterioration|3|||
162742342|NCT03058289|587768636|FG006|Overall Study|Radiographic Deterioration|0|||
162742343|NCT03058289|587768637|FG007|Overall Study|Radiographic Deterioration|4|||
162742344|NCT03058289|587768638|FG008|Overall Study|Radiographic Deterioration|2|||
162742345|NCT03058289|587768630|FG000|Overall Study|Adverse Event|2|||
162742346|NCT03058289|587768631|FG001|Overall Study|Adverse Event|0|||
162742347|NCT03058289|587768632|FG002|Overall Study|Adverse Event|1|||
162742348|NCT03058289|587768633|FG003|Overall Study|Adverse Event|3|||
162742349|NCT03058289|587768634|FG004|Overall Study|Adverse Event|1|||
162742350|NCT03058289|587768635|FG005|Overall Study|Adverse Event|0|||
162742351|NCT03058289|587768636|FG006|Overall Study|Adverse Event|1|||
162742352|NCT03058289|587768637|FG007|Overall Study|Adverse Event|3|||
162742353|NCT03058289|587768638|FG008|Overall Study|Adverse Event|0|||
162742354|NCT03058289|587768630|FG000|Overall Study|Withdrawal by Subject|0|||
162742355|NCT03058289|587768631|FG001|Overall Study|Withdrawal by Subject|0|||
162742356|NCT03058289|587768632|FG002|Overall Study|Withdrawal by Subject|0|||
162742357|NCT03058289|587768633|FG003|Overall Study|Withdrawal by Subject|2|||
162742358|NCT03058289|587768634|FG004|Overall Study|Withdrawal by Subject|0|||
162742359|NCT03058289|587768635|FG005|Overall Study|Withdrawal by Subject|2|||
162742360|NCT03058289|587768636|FG006|Overall Study|Withdrawal by Subject|0|||
162742361|NCT03058289|587768637|FG007|Overall Study|Withdrawal by Subject|4|||
162742362|NCT03058289|587768638|FG008|Overall Study|Withdrawal by Subject|1|||
162742363|NCT03058289|587768630|FG000|Overall Study|Physician Decision|1|||
162742364|NCT03058289|587768631|FG001|Overall Study|Physician Decision|0|||
162742365|NCT03058289|587768632|FG002|Overall Study|Physician Decision|0|||
162742366|NCT03058289|587768633|FG003|Overall Study|Physician Decision|2|||
162742367|NCT03058289|587768634|FG004|Overall Study|Physician Decision|1|||
162742368|NCT03058289|587768635|FG005|Overall Study|Physician Decision|0|||
162742369|NCT03058289|587768636|FG006|Overall Study|Physician Decision|2|||
162742370|NCT03058289|587768637|FG007|Overall Study|Physician Decision|3|||
162742371|NCT03058289|587768638|FG008|Overall Study|Physician Decision|0|||
162742372|NCT03058289|587768630|FG000|Overall Study|Clinical Deterioration|2|||
162742373|NCT03058289|587768631|FG001|Overall Study|Clinical Deterioration|0|||
162742374|NCT03058289|587768632|FG002|Overall Study|Clinical Deterioration|0|||
162742375|NCT03058289|587768633|FG003|Overall Study|Clinical Deterioration|2|||
162742376|NCT03058289|587768634|FG004|Overall Study|Clinical Deterioration|1|||
162742377|NCT03058289|587768635|FG005|Overall Study|Clinical Deterioration|1|||
162742378|NCT03058289|587768636|FG006|Overall Study|Clinical Deterioration|0|||
162742379|NCT03058289|587768637|FG007|Overall Study|Clinical Deterioration|3|||
162742380|NCT03058289|587768638|FG008|Overall Study|Clinical Deterioration|2|||
162742381|NCT03058289|587768630|FG000|Overall Study|Lost to Follow-up|0|||
162742382|NCT03058289|587768631|FG001|Overall Study|Lost to Follow-up|0|||
162742383|NCT03058289|587768632|FG002|Overall Study|Lost to Follow-up|0|||
162742384|NCT03058289|587768633|FG003|Overall Study|Lost to Follow-up|0|||
162742385|NCT03058289|587768634|FG004|Overall Study|Lost to Follow-up|1|||
162742386|NCT03058289|587768635|FG005|Overall Study|Lost to Follow-up|0|||
162742387|NCT03058289|587768636|FG006|Overall Study|Lost to Follow-up|0|||
162742388|NCT03058289|587768637|FG007|Overall Study|Lost to Follow-up|0|||
162742389|NCT03058289|587768638|FG008|Overall Study|Lost to Follow-up|0|||
162742390|NCT03058289|587768630|FG000|Overall Study|Refused Further Treatment|0|||
162742391|NCT03058289|587768631|FG001|Overall Study|Refused Further Treatment|0|||
162742392|NCT03058289|587768632|FG002|Overall Study|Refused Further Treatment|1|||
162742393|NCT03058289|587768633|FG003|Overall Study|Refused Further Treatment|0|||
162742394|NCT03058289|587768634|FG004|Overall Study|Refused Further Treatment|1|||
162742395|NCT03058289|587768635|FG005|Overall Study|Refused Further Treatment|0|||
162742396|NCT03058289|587768636|FG006|Overall Study|Refused Further Treatment|0|||
162742397|NCT03058289|587768637|FG007|Overall Study|Refused Further Treatment|0|||
162742398|NCT03058289|587768638|FG008|Overall Study|Refused Further Treatment|0|||
162742399|NCT03058289|587768630|FG000|Overall Study|Rapid Progression of Disease|0|||
162742400|NCT03058289|587768631|FG001|Overall Study|Rapid Progression of Disease|0|||
162742401|NCT03058289|587768632|FG002|Overall Study|Rapid Progression of Disease|0|||
162742402|NCT03058289|587768633|FG003|Overall Study|Rapid Progression of Disease|1|||
162742403|NCT03058289|587768634|FG004|Overall Study|Rapid Progression of Disease|0|||
162742404|NCT03058289|587768635|FG005|Overall Study|Rapid Progression of Disease|0|||
162742405|NCT03058289|587768636|FG006|Overall Study|Rapid Progression of Disease|0|||
162742406|NCT03058289|587768637|FG007|Overall Study|Rapid Progression of Disease|0|||
162742407|NCT03058289|587768638|FG008|Overall Study|Rapid Progression of Disease|0|||
162742408|NCT04049643|587768646|FG000|Overall Study|Lack of Efficacy|1|||
162742409|NCT04049643|587768647|FG001|Overall Study|Lack of Efficacy|1|||
162742410|NCT04049643|587768648|FG002|Overall Study|Lack of Efficacy|0|||
162742411|NCT04049643|587768646|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162742412|NCT04049643|587768647|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162742413|NCT04049643|587768648|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
162742414|NCT05623228|587768649|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
162742415|NCT05623228|587768650|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742416|NCT05623228|587768651|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742417|NCT05623228|587768652|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742418|NCT05623228|587768653|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742419|NCT05623228|587768654|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742420|NCT05623228|587768655|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742421|NCT05623228|587768656|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162742422|NCT05623228|587768649|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162742423|NCT05623228|587768650|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162742424|NCT05623228|587768651|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162742425|NCT05623228|587768652|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162742426|NCT05623228|587768653|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162742427|NCT05623228|587768654|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162742428|NCT05623228|587768655|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162742429|NCT05623228|587768656|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162742430|NCT03365882|587768661|FG000|Randomization|Still Receiving Protocol Treatment|2|||
162742431|NCT03365882|587768662|FG001|Randomization|Still Receiving Protocol Treatment|0|||
162742432|NCT03365882|587768661|FG000|Randomization|Adverse Event|1|||
162742433|NCT03365882|587768662|FG001|Randomization|Adverse Event|2|||
162742434|NCT03365882|587768661|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
162742435|NCT03365882|587768662|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
162742436|NCT03365882|587768661|FG000|Randomization|Progression/Relapse|21|||
162742437|NCT03365882|587768662|FG001|Randomization|Progression/Relapse|3|||
162742438|NCT03365882|587768661|FG000|Randomization|Death|1|||
162742439|NCT03365882|587768662|FG001|Randomization|Death|0|||
162742440|NCT03365882|587768661|FG000|Randomization|Other - Not Protocol Specified|1|||
162742441|NCT03365882|587768662|FG001|Randomization|Other - Not Protocol Specified|1|||
162742442|NCT03365882|587768661|FG000|Randomization|Major Protocol Deviation|0|||
162742443|NCT03365882|587768662|FG001|Randomization|Major Protocol Deviation|1|||
162742444|NCT03365882|587768661|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
162742445|NCT03365882|587768662|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
162742446|NCT03365882|587768661|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
162742447|NCT03365882|587768662|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
162742448|NCT03365882|587768661|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
162742449|NCT03365882|587768662|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
162742450|NCT03365882|587768661|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
162742451|NCT03365882|587768662|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
162742452|NCT04437615|587768663|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
162742453|NCT04828005|587768664|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
162742454|NCT04828005|587768665|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162742455|NCT04828005|587768666|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162742456|NCT04828005|587768667|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162742457|NCT04828005|587768664|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
162742458|NCT04828005|587768665|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
162742459|NCT04828005|587768666|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
162742460|NCT04828005|587768667|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
162742461|NCT04828005|587768664|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162742462|NCT04828005|587768665|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162742463|NCT04828005|587768666|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
162742464|NCT04828005|587768667|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162742465|NCT04828005|587768664|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
162742466|NCT04828005|587768665|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
162742467|NCT04828005|587768666|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
162742468|NCT04828005|587768667|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
162742469|NCT04828005|587768664|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162742470|NCT04828005|587768665|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162742471|NCT04828005|587768666|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162742472|NCT04828005|587768667|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
162742473|NCT04828005|587768664|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162742474|NCT04828005|587768665|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162742475|NCT04828005|587768666|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
162742476|NCT04828005|587768667|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162742477|NCT04828005|587768664|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
162742478|NCT04828005|587768665|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
162742479|NCT04828005|587768666|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
162742480|NCT04828005|587768667|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
162742481|NCT04828005|587768664|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162742482|NCT04828005|587768665|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162742483|NCT04828005|587768666|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162742484|NCT04828005|587768667|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
162742485|NCT04828005|587768664|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162742486|NCT04828005|587768665|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162742487|NCT04828005|587768666|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162742488|NCT04828005|587768667|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
162742489|NCT03023410|587771310|FG000|Overall Study|study termination|0|||
162742490|NCT03023410|587771311|FG001|Overall Study|study termination|1|||
162742491|NCT05459688|587771314|FG000|Overall Study|Lost to Follow-up|6|||
162742492|NCT05459688|587771314|FG000|Overall Study|Physician Decision|1|||
162742493|NCT05459688|587771314|FG000|Overall Study|Withdrawal by Subject|19|||
162742494|NCT05459688|587771314|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
162742495|NCT03379675|587771317|FG000|Overall Study|Lost to Follow-up|0|||
162742496|NCT03379675|587771318|FG001|Overall Study|Lost to Follow-up|1|||
162742497|NCT03379675|587771319|FG002|Overall Study|Lost to Follow-up|0|||
162742498|NCT03379675|587771317|FG000|Overall Study|Adverse Event|2|||
162742499|NCT03379675|587771318|FG001|Overall Study|Adverse Event|0|||
162742500|NCT03379675|587771319|FG002|Overall Study|Adverse Event|0|||
162742501|NCT03379675|587771317|FG000|Overall Study|Withdrawal by Subject|2|||
162742502|NCT03379675|587771318|FG001|Overall Study|Withdrawal by Subject|1|||
162742503|NCT03379675|587771319|FG002|Overall Study|Withdrawal by Subject|2|||
162742504|NCT02817776|587771320|FG000|Overall Study|Excluded|33|||
162742505|NCT02817776|587771320|FG000|Overall Study|Lost to Follow-up|20|||
162742506|NCT02817776|587771320|FG000|Overall Study|Withdrawal by Subject|33|||
162742507|NCT02817776|587771320|FG000|Overall Study|Death|2|||
162742508|NCT05949788|587771323|FG000|Overall Study|severe birth deformity|2|||
162742509|NCT05949788|587771324|FG001|Overall Study|severe birth deformity|7|||
162742510|NCT05949788|587771323|FG000|Overall Study|twin-twin transfusion syndrome|2|||
162742511|NCT05949788|587771324|FG001|Overall Study|twin-twin transfusion syndrome|7|||
162742512|NCT05949788|587771323|FG000|Overall Study|neonatal hemolytic disease|3|||
162742513|NCT05949788|587771324|FG001|Overall Study|neonatal hemolytic disease|8|||
162742514|NCT05949788|587771323|FG000|Overall Study|death within 14 days after birth|2|||
162742515|NCT05949788|587771324|FG001|Overall Study|death within 14 days after birth|6|||
162742516|NCT05949788|587771323|FG000|Overall Study|transfer to another hospital|2|||
162742517|NCT05949788|587771324|FG001|Overall Study|transfer to another hospital|6|||
162742518|NCT02191618|587771328|FG000|Overall Study|Withdrawal by Subject|3|||
162742519|NCT02191618|587771328|FG000|Overall Study|Missed Visit|4|||
162742520|NCT01943409|587771333|FG000|Overall Study|resumed oral/entral|24|||
162742521|NCT01943409|587771334|FG001|Overall Study|resumed oral/entral|20|||
162742522|NCT01943409|587771333|FG000|Overall Study|Protocol Violation|14|||
162742523|NCT01943409|587771334|FG001|Overall Study|Protocol Violation|24|||
162742524|NCT01943409|587771333|FG000|Overall Study|Death|3|||
162742525|NCT01943409|587771334|FG001|Overall Study|Death|1|||
162742526|NCT01943409|587771333|FG000|Overall Study|Withdrawal by Subject|4|||
162742527|NCT01943409|587771334|FG001|Overall Study|Withdrawal by Subject|3|||
162742528|NCT02489903|587771335|FG000|Screening|Screen Failure|24|||
162742529|NCT02489903|587771336|FG001|Screening|Screen Failure|0|||
162742530|NCT02489903|587771337|FG002|Screening|Screen Failure|0|||
162742531|NCT02489903|587771338|FG003|Screening|Screen Failure|8|||
162742532|NCT02489903|587771335|FG000|Randomized and Received Treatment|Protocol Violation|0|||
162742533|NCT02489903|587771336|FG001|Randomized and Received Treatment|Protocol Violation|1|||
162742534|NCT02489903|587771337|FG002|Randomized and Received Treatment|Protocol Violation|0|||
162742535|NCT02489903|587771338|FG003|Randomized and Received Treatment|Protocol Violation|0|||
162742536|NCT02489903|587771335|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
162742537|NCT02489903|587771336|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
162742538|NCT02489903|587771337|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
162742539|NCT02489903|587771338|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
162742540|NCT02489903|587771335|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
162742541|NCT02489903|587771336|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
162742542|NCT02489903|587771337|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
162742543|NCT02489903|587771338|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
162742544|NCT02489903|587771335|FG000|Randomized and Received Treatment|Death|10|||
162742545|NCT02489903|587771336|FG001|Randomized and Received Treatment|Death|1|||
162742546|NCT02489903|587771337|FG002|Randomized and Received Treatment|Death|0|||
162742547|NCT02489903|587771338|FG003|Randomized and Received Treatment|Death|0|||
162742548|NCT05126433|587771339|FG000|Overall Study|Withdrawal by Subject|3|||
162742549|NCT05126433|587771340|FG001|Overall Study|Withdrawal by Subject|0|||
162742550|NCT05126433|587771341|FG002|Overall Study|Withdrawal by Subject|4|||
162742551|NCT05126433|587771339|FG000|Overall Study|Death|9|||
162742552|NCT05126433|587771340|FG001|Overall Study|Death|3|||
162742553|NCT05126433|587771341|FG002|Overall Study|Death|5|||
162742554|NCT05126433|587771339|FG000|Overall Study|Study Terminated by sponsor|0|||
162742555|NCT05126433|587771340|FG001|Overall Study|Study Terminated by sponsor|1|||
162742556|NCT05126433|587771341|FG002|Overall Study|Study Terminated by sponsor|2|||
162742557|NCT05126433|587771339|FG000|Overall Study|Progressive Disease|1|||
162742558|NCT05126433|587771340|FG001|Overall Study|Progressive Disease|4|||
162742559|NCT05126433|587771341|FG002|Overall Study|Progressive Disease|3|||
162742560|NCT05126433|587771339|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
162742561|NCT05126433|587771340|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
162742562|NCT05126433|587771341|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
162742563|NCT04413708|587771342|FG000|Overall Study|Lost to Follow-up|1|||
162742564|NCT04413708|587771343|FG001|Overall Study|Lost to Follow-up|2|||
162742565|NCT04599062|587771344|FG000|Overall Study|Physician Decision|1|||
162742566|NCT04599062|587771345|FG001|Overall Study|Physician Decision|0|||
162742567|NCT06103188|587771350|FG000|Overall Study|Lost to Follow-up|1|||
162742568|NCT06103188|587771351|FG001|Overall Study|Lost to Follow-up|6|||
162742569|NCT06103188|587771352|FG002|Overall Study|Lost to Follow-up|4|||
162742570|NCT02969707|587771353|FG000|Overall Study|Withdrawal by Subject|6|||
162742571|NCT02969707|587771354|FG001|Overall Study|Withdrawal by Subject|5|||
162742572|NCT02969707|587771353|FG000|Overall Study|Severe anxiety|0|||
162742573|NCT02969707|587771354|FG001|Overall Study|Severe anxiety|1|||
162742574|NCT02969707|587771353|FG000|Overall Study|Positive toxicology screen|0|||
162742575|NCT02969707|587771354|FG001|Overall Study|Positive toxicology screen|2|||
162742576|NCT02969707|587771353|FG000|Overall Study|Claustrophobia|2|||
162742577|NCT02969707|587771354|FG001|Overall Study|Claustrophobia|2|||
162742578|NCT02969707|587771353|FG000|Overall Study|Non-compliance|1|||
162742579|NCT02969707|587771354|FG001|Overall Study|Non-compliance|2|||
162742580|NCT04314713|587771359|FG000|Overall Study|Lost to Follow-up|0|||
162742581|NCT04314713|587771360|FG001|Overall Study|Lost to Follow-up|0|||
162742582|NCT04314713|587771361|FG002|Overall Study|Lost to Follow-up|0|||
162742583|NCT04314713|587771362|FG003|Overall Study|Lost to Follow-up|1|||
162742584|NCT04314713|587771363|FG004|Overall Study|Lost to Follow-up|0|||
162742585|NCT04314713|587771364|FG005|Overall Study|Lost to Follow-up|0|||
162742586|NCT02714257|587771365|FG000|Overall Study|Withdrawal by Subject|6|||
162742587|NCT02714257|587771366|FG001|Overall Study|Withdrawal by Subject|11|||
162742588|NCT02714257|587771365|FG000|Overall Study|Death|3|||
162742589|NCT02714257|587771366|FG001|Overall Study|Death|4|||
162742590|NCT02714257|587771365|FG000|Overall Study|Lost to Follow-up|1|||
162742591|NCT02714257|587771366|FG001|Overall Study|Lost to Follow-up|6|||
162742592|NCT04436276|587771374|FG000|Overall Study|Adverse Event|0|||
162742593|NCT04436276|587771375|FG001|Overall Study|Adverse Event|0|||
162742594|NCT04436276|587771376|FG002|Overall Study|Adverse Event|0|||
162742595|NCT04436276|587771377|FG003|Overall Study|Adverse Event|0|||
162742596|NCT04436276|587771378|FG004|Overall Study|Adverse Event|0|||
162742597|NCT04436276|587771379|FG005|Overall Study|Adverse Event|0|||
162742598|NCT04436276|587771380|FG006|Overall Study|Adverse Event|0|||
162742599|NCT04436276|587771381|FG007|Overall Study|Adverse Event|0|||
162742600|NCT04436276|587771382|FG008|Overall Study|Adverse Event|0|||
162742601|NCT04436276|587771383|FG009|Overall Study|Adverse Event|0|||
162742602|NCT04436276|587771384|FG010|Overall Study|Adverse Event|0|||
162742603|NCT04436276|587771385|FG011|Overall Study|Adverse Event|0|||
162742604|NCT04436276|587771386|FG012|Overall Study|Adverse Event|0|||
162742605|NCT04436276|587771387|FG013|Overall Study|Adverse Event|0|||
162742606|NCT04436276|587771388|FG014|Overall Study|Adverse Event|0|||
162742607|NCT04436276|587771389|FG015|Overall Study|Adverse Event|0|||
162742608|NCT04436276|587771390|FG016|Overall Study|Adverse Event|1|||
162742609|NCT04436276|587771391|FG017|Overall Study|Adverse Event|0|||
162742610|NCT04436276|587771392|FG018|Overall Study|Adverse Event|0|||
162742611|NCT04436276|587771393|FG019|Overall Study|Adverse Event|0|||
162742612|NCT04436276|587771394|FG020|Overall Study|Adverse Event|0|||
162742613|NCT04436276|587771395|FG021|Overall Study|Adverse Event|0|||
162742614|NCT04436276|587771396|FG022|Overall Study|Adverse Event|0|||
162742615|NCT04436276|587771374|FG000|Overall Study|Death|0|||
162742616|NCT04436276|587771375|FG001|Overall Study|Death|0|||
162742617|NCT04436276|587771376|FG002|Overall Study|Death|0|||
162742618|NCT04436276|587771377|FG003|Overall Study|Death|0|||
162742619|NCT04436276|587771378|FG004|Overall Study|Death|0|||
162742620|NCT04436276|587771379|FG005|Overall Study|Death|0|||
162742621|NCT04436276|587771380|FG006|Overall Study|Death|0|||
162742622|NCT04436276|587771381|FG007|Overall Study|Death|0|||
162742623|NCT04436276|587771382|FG008|Overall Study|Death|0|||
162742624|NCT04436276|587771383|FG009|Overall Study|Death|0|||
162742625|NCT04436276|587771384|FG010|Overall Study|Death|0|||
162742626|NCT04436276|587771385|FG011|Overall Study|Death|0|||
162742627|NCT04436276|587771386|FG012|Overall Study|Death|1|||
162742628|NCT04436276|587771387|FG013|Overall Study|Death|0|||
162742629|NCT04436276|587771388|FG014|Overall Study|Death|1|||
162742630|NCT04436276|587771389|FG015|Overall Study|Death|0|||
162742631|NCT04436276|587771390|FG016|Overall Study|Death|0|||
162742632|NCT04436276|587771391|FG017|Overall Study|Death|0|||
162742633|NCT04436276|587771392|FG018|Overall Study|Death|0|||
162742634|NCT04436276|587771393|FG019|Overall Study|Death|2|||
162742635|NCT04436276|587771394|FG020|Overall Study|Death|0|||
162742636|NCT04436276|587771395|FG021|Overall Study|Death|1|||
162742637|NCT04436276|587771396|FG022|Overall Study|Death|0|||
162742638|NCT04436276|587771374|FG000|Overall Study|Lost to Follow-up|0|||
162742639|NCT04436276|587771375|FG001|Overall Study|Lost to Follow-up|2|||
162742640|NCT04436276|587771376|FG002|Overall Study|Lost to Follow-up|2|||
162742641|NCT04436276|587771377|FG003|Overall Study|Lost to Follow-up|1|||
162742642|NCT04436276|587771378|FG004|Overall Study|Lost to Follow-up|4|||
162742643|NCT04436276|587771379|FG005|Overall Study|Lost to Follow-up|1|||
162742644|NCT04436276|587771380|FG006|Overall Study|Lost to Follow-up|0|||
162742645|NCT04436276|587771381|FG007|Overall Study|Lost to Follow-up|0|||
162742646|NCT04436276|587771382|FG008|Overall Study|Lost to Follow-up|1|||
162742647|NCT04436276|587771383|FG009|Overall Study|Lost to Follow-up|0|||
162742648|NCT04436276|587771384|FG010|Overall Study|Lost to Follow-up|5|||
162742649|NCT04436276|587771385|FG011|Overall Study|Lost to Follow-up|5|||
162742650|NCT04436276|587771386|FG012|Overall Study|Lost to Follow-up|4|||
162742651|NCT04436276|587771387|FG013|Overall Study|Lost to Follow-up|1|||
162742652|NCT04436276|587771388|FG014|Overall Study|Lost to Follow-up|7|||
162742653|NCT04436276|587771389|FG015|Overall Study|Lost to Follow-up|7|||
162742654|NCT04436276|587771390|FG016|Overall Study|Lost to Follow-up|1|||
162742655|NCT04436276|587771391|FG017|Overall Study|Lost to Follow-up|0|||
162742656|NCT04436276|587771392|FG018|Overall Study|Lost to Follow-up|1|||
162742657|NCT04436276|587771393|FG019|Overall Study|Lost to Follow-up|1|||
162742658|NCT04436276|587771394|FG020|Overall Study|Lost to Follow-up|2|||
162742659|NCT04436276|587771395|FG021|Overall Study|Lost to Follow-up|1|||
162742660|NCT04436276|587771396|FG022|Overall Study|Lost to Follow-up|1|||
162742661|NCT04436276|587771374|FG000|Overall Study|Physician Decision|1|||
162742662|NCT04436276|587771375|FG001|Overall Study|Physician Decision|0|||
162742663|NCT04436276|587771376|FG002|Overall Study|Physician Decision|2|||
162742664|NCT04436276|587771377|FG003|Overall Study|Physician Decision|1|||
162742665|NCT04436276|587771378|FG004|Overall Study|Physician Decision|0|||
162742666|NCT04436276|587771379|FG005|Overall Study|Physician Decision|0|||
162742667|NCT04436276|587771380|FG006|Overall Study|Physician Decision|0|||
162742668|NCT04436276|587771381|FG007|Overall Study|Physician Decision|0|||
162742669|NCT04436276|587771382|FG008|Overall Study|Physician Decision|0|||
162742670|NCT04436276|587771383|FG009|Overall Study|Physician Decision|0|||
162742671|NCT04436276|587771384|FG010|Overall Study|Physician Decision|0|||
162742672|NCT04436276|587771385|FG011|Overall Study|Physician Decision|1|||
162742673|NCT04436276|587771386|FG012|Overall Study|Physician Decision|2|||
162742674|NCT04436276|587771387|FG013|Overall Study|Physician Decision|0|||
162742675|NCT04436276|587771388|FG014|Overall Study|Physician Decision|0|||
162742676|NCT04436276|587771389|FG015|Overall Study|Physician Decision|0|||
162742677|NCT04436276|587771390|FG016|Overall Study|Physician Decision|0|||
162742678|NCT04436276|587771391|FG017|Overall Study|Physician Decision|0|||
162742679|NCT04436276|587771392|FG018|Overall Study|Physician Decision|0|||
162742680|NCT04436276|587771393|FG019|Overall Study|Physician Decision|0|||
162742681|NCT04436276|587771394|FG020|Overall Study|Physician Decision|1|||
162742682|NCT04436276|587771395|FG021|Overall Study|Physician Decision|2|||
162742683|NCT04436276|587771396|FG022|Overall Study|Physician Decision|0|||
162742684|NCT04436276|587771374|FG000|Overall Study|Protocol Violation|0|||
162742685|NCT04436276|587771375|FG001|Overall Study|Protocol Violation|0|||
162742686|NCT04436276|587771376|FG002|Overall Study|Protocol Violation|0|||
162742687|NCT04436276|587771377|FG003|Overall Study|Protocol Violation|0|||
162742688|NCT04436276|587771378|FG004|Overall Study|Protocol Violation|0|||
162742689|NCT04436276|587771379|FG005|Overall Study|Protocol Violation|0|||
162742690|NCT04436276|587771380|FG006|Overall Study|Protocol Violation|0|||
162742691|NCT04436276|587771381|FG007|Overall Study|Protocol Violation|0|||
162742692|NCT04436276|587771382|FG008|Overall Study|Protocol Violation|0|||
162742693|NCT04436276|587771383|FG009|Overall Study|Protocol Violation|0|||
162742694|NCT04436276|587771384|FG010|Overall Study|Protocol Violation|0|||
162742695|NCT04436276|587771385|FG011|Overall Study|Protocol Violation|0|||
162742696|NCT04436276|587771386|FG012|Overall Study|Protocol Violation|0|||
162742697|NCT04436276|587771387|FG013|Overall Study|Protocol Violation|1|||
162742698|NCT04436276|587771388|FG014|Overall Study|Protocol Violation|0|||
162742699|NCT04436276|587771389|FG015|Overall Study|Protocol Violation|1|||
162742700|NCT04436276|587771390|FG016|Overall Study|Protocol Violation|0|||
162742701|NCT04436276|587771391|FG017|Overall Study|Protocol Violation|0|||
162742702|NCT04436276|587771392|FG018|Overall Study|Protocol Violation|0|||
162742703|NCT04436276|587771393|FG019|Overall Study|Protocol Violation|0|||
162742704|NCT04436276|587771394|FG020|Overall Study|Protocol Violation|0|||
162742705|NCT04436276|587771395|FG021|Overall Study|Protocol Violation|0|||
162742706|NCT04436276|587771396|FG022|Overall Study|Protocol Violation|0|||
162742707|NCT04436276|587771374|FG000|Overall Study|Withdrawal by Subject|25|||
162742708|NCT04436276|587771375|FG001|Overall Study|Withdrawal by Subject|22|||
162742709|NCT04436276|587771376|FG002|Overall Study|Withdrawal by Subject|24|||
162742710|NCT04436276|587771377|FG003|Overall Study|Withdrawal by Subject|23|||
162742711|NCT04436276|587771378|FG004|Overall Study|Withdrawal by Subject|14|||
162742712|NCT04436276|587771379|FG005|Overall Study|Withdrawal by Subject|0|||
162742713|NCT04436276|587771380|FG006|Overall Study|Withdrawal by Subject|0|||
162742714|NCT04436276|587771381|FG007|Overall Study|Withdrawal by Subject|1|||
162742715|NCT04436276|587771382|FG008|Overall Study|Withdrawal by Subject|0|||
162742716|NCT04436276|587771383|FG009|Overall Study|Withdrawal by Subject|1|||
162742717|NCT04436276|587771384|FG010|Overall Study|Withdrawal by Subject|17|||
162742718|NCT04436276|587771385|FG011|Overall Study|Withdrawal by Subject|7|||
162742719|NCT04436276|587771386|FG012|Overall Study|Withdrawal by Subject|10|||
162742720|NCT04436276|587771387|FG013|Overall Study|Withdrawal by Subject|6|||
162742721|NCT04436276|587771388|FG014|Overall Study|Withdrawal by Subject|20|||
162742722|NCT04436276|587771389|FG015|Overall Study|Withdrawal by Subject|6|||
162742723|NCT04436276|587771390|FG016|Overall Study|Withdrawal by Subject|11|||
162742724|NCT04436276|587771391|FG017|Overall Study|Withdrawal by Subject|4|||
162742725|NCT04436276|587771392|FG018|Overall Study|Withdrawal by Subject|14|||
162742726|NCT04436276|587771393|FG019|Overall Study|Withdrawal by Subject|24|||
162742727|NCT04436276|587771394|FG020|Overall Study|Withdrawal by Subject|24|||
162742728|NCT04436276|587771395|FG021|Overall Study|Withdrawal by Subject|16|||
162742729|NCT04436276|587771396|FG022|Overall Study|Withdrawal by Subject|14|||
162742730|NCT04436276|587771374|FG000|Overall Study|Other|3|||
162742731|NCT04436276|587771375|FG001|Overall Study|Other|2|||
162742732|NCT04436276|587771376|FG002|Overall Study|Other|5|||
162742733|NCT04436276|587771377|FG003|Overall Study|Other|9|||
162742734|NCT04436276|587771378|FG004|Overall Study|Other|23|||
162742735|NCT04436276|587771379|FG005|Overall Study|Other|1|||
162742736|NCT04436276|587771380|FG006|Overall Study|Other|0|||
162742737|NCT04436276|587771381|FG007|Overall Study|Other|0|||
162742738|NCT04436276|587771382|FG008|Overall Study|Other|0|||
162742739|NCT04436276|587771383|FG009|Overall Study|Other|0|||
162742740|NCT04436276|587771384|FG010|Overall Study|Other|3|||
162742741|NCT04436276|587771385|FG011|Overall Study|Other|1|||
162742742|NCT04436276|587771386|FG012|Overall Study|Other|1|||
162742743|NCT04436276|587771387|FG013|Overall Study|Other|2|||
162742744|NCT04436276|587771388|FG014|Overall Study|Other|3|||
162742745|NCT04436276|587771389|FG015|Overall Study|Other|0|||
162742746|NCT04436276|587771390|FG016|Overall Study|Other|0|||
162742747|NCT04436276|587771391|FG017|Overall Study|Other|6|||
162742748|NCT04436276|587771392|FG018|Overall Study|Other|1|||
162742749|NCT04436276|587771393|FG019|Overall Study|Other|0|||
162742750|NCT04436276|587771394|FG020|Overall Study|Other|2|||
162742751|NCT04436276|587771395|FG021|Overall Study|Other|2|||
162742752|NCT04436276|587771396|FG022|Overall Study|Other|60|||
162742753|NCT03656510|587771398|FG000|Overall Study|Lost to Follow-up|1|||
162742754|NCT03656510|587771399|FG001|Overall Study|Lost to Follow-up|0|||
162742755|NCT03656510|587771400|FG002|Overall Study|Lost to Follow-up|0|||
162742756|NCT03656510|587771401|FG003|Overall Study|Lost to Follow-up|0|||
162742757|NCT03656510|587771402|FG004|Overall Study|Lost to Follow-up|0|||
162742758|NCT03656510|587771403|FG005|Overall Study|Lost to Follow-up|0|||
162742759|NCT03656510|587771398|FG000|Overall Study|Withdrawal by Subject|1|||
162742760|NCT03656510|587771399|FG001|Overall Study|Withdrawal by Subject|1|||
162742761|NCT03656510|587771400|FG002|Overall Study|Withdrawal by Subject|0|||
162742762|NCT03656510|587771401|FG003|Overall Study|Withdrawal by Subject|1|||
162742763|NCT03656510|587771402|FG004|Overall Study|Withdrawal by Subject|0|||
162742764|NCT03656510|587771403|FG005|Overall Study|Withdrawal by Subject|0|||
162742765|NCT06457802|587771410|FG000|Overall Study|Early termination of study prior to participant completion|2|||
162742766|NCT06457802|587771411|FG001|Overall Study|Early termination of study prior to participant completion|2|||
162742767|NCT03974178|587771414|FG000|Overall Study|Death|0|||
162742768|NCT03974178|587771415|FG001|Overall Study|Death|1|||
162742769|NCT03899259|587771416|FG000|Overall Study|Adverse Event|5|||
162742770|NCT03899259|587771417|FG001|Overall Study|Adverse Event|4|||
162742771|NCT03899259|587771418|FG002|Overall Study|Adverse Event|6|||
162742772|NCT03899259|587771416|FG000|Overall Study|Lack of Efficacy|5|||
162742773|NCT03899259|587771417|FG001|Overall Study|Lack of Efficacy|0|||
162742774|NCT03899259|587771418|FG002|Overall Study|Lack of Efficacy|2|||
162742775|NCT03899259|587771416|FG000|Overall Study|Pregnancy|3|||
162742776|NCT03899259|587771417|FG001|Overall Study|Pregnancy|0|||
162742777|NCT03899259|587771418|FG002|Overall Study|Pregnancy|1|||
162742778|NCT03899259|587771416|FG000|Overall Study|Physician Decision|0|||
162742779|NCT03899259|587771417|FG001|Overall Study|Physician Decision|1|||
162742780|NCT03899259|587771418|FG002|Overall Study|Physician Decision|0|||
162742781|NCT03899259|587771416|FG000|Overall Study|Protocol Deviation|1|||
162742782|NCT03899259|587771417|FG001|Overall Study|Protocol Deviation|1|||
162742783|NCT03899259|587771418|FG002|Overall Study|Protocol Deviation|1|||
162742784|NCT03899259|587771416|FG000|Overall Study|Withdrawal by Subject|8|||
162742785|NCT03899259|587771417|FG001|Overall Study|Withdrawal by Subject|10|||
162742786|NCT03899259|587771418|FG002|Overall Study|Withdrawal by Subject|12|||
162742787|NCT03899259|587771416|FG000|Overall Study|Lost to Follow-up|5|||
162742788|NCT03899259|587771417|FG001|Overall Study|Lost to Follow-up|6|||
162742789|NCT03899259|587771418|FG002|Overall Study|Lost to Follow-up|2|||
162742790|NCT03899259|587771416|FG000|Overall Study|Lack of Adherence|1|||
162742791|NCT03899259|587771417|FG001|Overall Study|Lack of Adherence|0|||
162742792|NCT03899259|587771418|FG002|Overall Study|Lack of Adherence|0|||
162742793|NCT03899259|587771416|FG000|Overall Study|Screen Failure|1|||
162742794|NCT03899259|587771417|FG001|Overall Study|Screen Failure|0|||
162742795|NCT03899259|587771418|FG002|Overall Study|Screen Failure|0|||
162742796|NCT03899259|587771416|FG000|Overall Study|Ongoing Study Participation|127|||
162742797|NCT03899259|587771417|FG001|Overall Study|Ongoing Study Participation|134|||
162742798|NCT03899259|587771418|FG002|Overall Study|Ongoing Study Participation|210|||
162742799|NCT01152450|587771419|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
162742800|NCT01152450|587771420|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
162742801|NCT01152450|587771421|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
162742802|NCT01152450|587771422|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
162742803|NCT01152450|587771423|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
162742804|NCT01152450|587771424|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
162742805|NCT01152450|587771419|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
162742806|NCT01152450|587771420|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
162742807|NCT01152450|587771421|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
162742808|NCT01152450|587771422|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
162742809|NCT01152450|587771423|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
162742810|NCT01152450|587771424|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
162742811|NCT01152450|587771419|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162742812|NCT01152450|587771420|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
162742813|NCT01152450|587771421|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
162742814|NCT01152450|587771422|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162742815|NCT01152450|587771423|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162742816|NCT01152450|587771424|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162742817|NCT01544114|587771427|FG000|Overall Study|Withdrawal by Subject|0|||
162742818|NCT01544114|587771428|FG001|Overall Study|Withdrawal by Subject|0|||
162742819|NCT01544114|587771429|FG002|Overall Study|Withdrawal by Subject|3|||
162742820|NCT01544114|587771427|FG000|Overall Study|Lost to Follow-up|0|||
162742821|NCT01544114|587771428|FG001|Overall Study|Lost to Follow-up|2|||
162742822|NCT01544114|587771429|FG002|Overall Study|Lost to Follow-up|0|||
162742823|NCT01544114|587771427|FG000|Overall Study|Adverse Event|1|||
162742824|NCT01544114|587771428|FG001|Overall Study|Adverse Event|1|||
162742825|NCT01544114|587771429|FG002|Overall Study|Adverse Event|2|||
162742826|NCT01544114|587771427|FG000|Overall Study|Protocol Violation|0|||
162742827|NCT01544114|587771428|FG001|Overall Study|Protocol Violation|1|||
162742828|NCT01544114|587771429|FG002|Overall Study|Protocol Violation|0|||
162742829|NCT04508309|587771434|FG000|Overall Study|Death|0|||
162742830|NCT04508309|587771435|FG001|Overall Study|Death|0|||
162742831|NCT04508309|587771436|FG002|Overall Study|Death|0|||
162742832|NCT04508309|587771437|FG003|Overall Study|Death|0|||
162742833|NCT04508309|587771438|FG004|Overall Study|Death|1|||
162742834|NCT04508309|587771434|FG000|Overall Study|Lost to Follow-up|0|||
162742835|NCT04508309|587771435|FG001|Overall Study|Lost to Follow-up|0|||
162742836|NCT04508309|587771436|FG002|Overall Study|Lost to Follow-up|1|||
162742837|NCT04508309|587771437|FG003|Overall Study|Lost to Follow-up|1|||
162742838|NCT04508309|587771438|FG004|Overall Study|Lost to Follow-up|0|||
162742839|NCT04508309|587771434|FG000|Overall Study|Withdrawal by Subject|0|||
162742840|NCT04508309|587771435|FG001|Overall Study|Withdrawal by Subject|0|||
162742841|NCT04508309|587771436|FG002|Overall Study|Withdrawal by Subject|0|||
162742842|NCT04508309|587771437|FG003|Overall Study|Withdrawal by Subject|0|||
162742843|NCT04508309|587771438|FG004|Overall Study|Withdrawal by Subject|1|||
162742844|NCT05940194|587771439|FG000|Overall Study|Adverse Event|0|||
162742845|NCT05940194|587771440|FG001|Overall Study|Adverse Event|1|||
162742846|NCT05940194|587771441|FG002|Overall Study|Adverse Event|0|||
162742847|NCT05940194|587771439|FG000|Overall Study|Migrated/Moved from the study area|2|||
162742848|NCT05940194|587771440|FG001|Overall Study|Migrated/Moved from the study area|2|||
162742849|NCT05940194|587771441|FG002|Overall Study|Migrated/Moved from the study area|4|||
162742850|NCT03800654|587771442|FG000|Overall Study|Time constraints|3|||
162742851|NCT03800654|587771443|FG001|Overall Study|Time constraints|3|||
162742852|NCT03800654|587771444|FG002|Overall Study|Time constraints|3|||
162742853|NCT03800654|587771442|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
162742854|NCT03800654|587771443|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
162742855|NCT03800654|587771444|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
162742856|NCT03800654|587771442|FG000|Overall Study|Lost to Follow-up|2|||
162742857|NCT03800654|587771443|FG001|Overall Study|Lost to Follow-up|1|||
162742858|NCT03800654|587771444|FG002|Overall Study|Lost to Follow-up|6|||
162742859|NCT03800654|587771442|FG000|Overall Study|Medical Health Issue|0|||
162742860|NCT03800654|587771443|FG001|Overall Study|Medical Health Issue|0|||
162742861|NCT03800654|587771444|FG002|Overall Study|Medical Health Issue|1|||
162742862|NCT03800654|587771442|FG000|Overall Study|Personal Issues|0|||
162742863|NCT03800654|587771443|FG001|Overall Study|Personal Issues|2|||
162742864|NCT03800654|587771444|FG002|Overall Study|Personal Issues|0|||
162742865|NCT03800654|587771442|FG000|Overall Study|Protocol Violation|0|||
162742866|NCT03800654|587771443|FG001|Overall Study|Protocol Violation|1|||
162742867|NCT03800654|587771444|FG002|Overall Study|Protocol Violation|0|||
162742868|NCT03459729|587771445|FG000|Overall Study|Physician Decision|2|||
162742869|NCT06182033|587771446|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
162742870|NCT06182033|587771447|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
162742871|NCT06182033|587771446|FG000|Overall Study|Target child relocation|1|||
162742872|NCT06182033|587771447|FG001|Overall Study|Target child relocation|1|||
162742873|NCT06182033|587771446|FG000|Overall Study|Withdrawal by Subject|1|||
162742874|NCT06182033|587771447|FG001|Overall Study|Withdrawal by Subject|0|||
162742875|NCT02626533|587771449|FG000|Overall Study|Protocol Violation|14|||
162742876|NCT02626533|587771449|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
162742877|NCT02626533|587771449|FG000|Overall Study|Withdrawal by Subject|1|||
162742878|NCT02151981|587771450|FG000|Overall Study|Death|184|||
162742879|NCT02151981|587771451|FG001|Overall Study|Death|88|||
162742880|NCT02151981|587771450|FG000|Overall Study|Lost to Follow-up|7|||
162742881|NCT02151981|587771451|FG001|Overall Study|Lost to Follow-up|1|||
162742882|NCT02151981|587771450|FG000|Overall Study|Withdrawal by Subject|27|||
162742883|NCT02151981|587771451|FG001|Overall Study|Withdrawal by Subject|21|||
162742884|NCT02151981|587771450|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162742885|NCT02151981|587771451|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162742886|NCT02151981|587771450|FG000|Overall Study|Other reasons|1|||
162742887|NCT02151981|587771451|FG001|Overall Study|Other reasons|2|||
162742888|NCT05645757|587771471|FG000|Overall Study|Enrolled but treatment not administered|0|||
162742889|NCT05645757|587771472|FG001|Overall Study|Enrolled but treatment not administered|0|||
162742890|NCT05645757|587771473|FG002|Overall Study|Enrolled but treatment not administered|0|||
162742891|NCT05645757|587771474|FG003|Overall Study|Enrolled but treatment not administered|0|||
162742892|NCT05645757|587771475|FG004|Overall Study|Enrolled but treatment not administered|1|||
162742893|NCT05645757|587771476|FG005|Overall Study|Enrolled but treatment not administered|1|||
162742894|NCT05645757|587771477|FG006|Overall Study|Enrolled but treatment not administered|0|||
162742895|NCT05645757|587771478|FG007|Overall Study|Enrolled but treatment not administered|0|||
162742896|NCT04568434|587771483|FG000|Overall Study|Voluntary Withdrawal|0|||
162742897|NCT04568434|587771484|FG001|Overall Study|Voluntary Withdrawal|1|||
162742898|NCT04568434|587771485|FG002|Overall Study|Voluntary Withdrawal|1|||
162742899|NCT04568434|587771483|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
162742900|NCT04568434|587771484|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
162742901|NCT04568434|587771485|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
162742902|NCT04568434|587771483|FG000|Overall Study|Investigator Judgement|1|||
162742903|NCT04568434|587771484|FG001|Overall Study|Investigator Judgement|0|||
162742904|NCT04568434|587771485|FG002|Overall Study|Investigator Judgement|0|||
162742905|NCT03463044|587771486|FG000|Overall Study|Lost to Follow-up|0|||
162742906|NCT03463044|587771487|FG001|Overall Study|Lost to Follow-up|0|||
162742907|NCT03463044|587771488|FG002|Overall Study|Lost to Follow-up|0|||
162742908|NCT03463044|587771489|FG003|Overall Study|Lost to Follow-up|0|||
162742909|NCT03463044|587771490|FG004|Overall Study|Lost to Follow-up|0|||
162742910|NCT03463044|587771491|FG005|Overall Study|Lost to Follow-up|0|||
162742911|NCT03463044|587771492|FG006|Overall Study|Lost to Follow-up|0|||
162742912|NCT03463044|587771493|FG007|Overall Study|Lost to Follow-up|1|||
162742913|NCT03463044|587771494|FG008|Overall Study|Lost to Follow-up|0|||
162742914|NCT05576155|587771495|FG000|Overall Study|Withdrawal by Subject|1|||
162742915|NCT05576155|587771496|FG001|Overall Study|Withdrawal by Subject|1|||
162742916|NCT04515849|587771497|FG000|Overall Study|Adverse Event|0|||
162742917|NCT04515849|587771498|FG001|Overall Study|Adverse Event|0|||
162742918|NCT04515849|587771499|FG002|Overall Study|Adverse Event|0|||
162742919|NCT04515849|587771500|FG003|Overall Study|Adverse Event|1|||
162742920|NCT04515849|587771501|FG004|Overall Study|Adverse Event|2|||
162742921|NCT04515849|587771497|FG000|Overall Study|Death|2|||
162742922|NCT04515849|587771498|FG001|Overall Study|Death|0|||
162742923|NCT04515849|587771499|FG002|Overall Study|Death|0|||
162742924|NCT04515849|587771500|FG003|Overall Study|Death|0|||
162742925|NCT04515849|587771501|FG004|Overall Study|Death|0|||
162742926|NCT04515849|587771497|FG000|Overall Study|Other:family emergency|0|||
162742927|NCT04515849|587771498|FG001|Overall Study|Other:family emergency|0|||
162742928|NCT04515849|587771499|FG002|Overall Study|Other:family emergency|0|||
162742929|NCT04515849|587771500|FG003|Overall Study|Other:family emergency|1|||
162742930|NCT04515849|587771501|FG004|Overall Study|Other:family emergency|0|||
162742931|NCT04515849|587771497|FG000|Overall Study|Other:randomised by error|0|||
162742932|NCT04515849|587771498|FG001|Overall Study|Other:randomised by error|1|||
162742933|NCT04515849|587771499|FG002|Overall Study|Other:randomised by error|0|||
162742934|NCT04515849|587771500|FG003|Overall Study|Other:randomised by error|0|||
162742935|NCT04515849|587771501|FG004|Overall Study|Other:randomised by error|0|||
162742936|NCT04515849|587771497|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162742937|NCT04515849|587771498|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162742938|NCT04515849|587771499|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162742939|NCT04515849|587771500|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
162742940|NCT04515849|587771501|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162742941|NCT04515849|587771497|FG000|Overall Study|Physician Decision|0|||
162742942|NCT04515849|587771498|FG001|Overall Study|Physician Decision|1|||
162742943|NCT04515849|587771499|FG002|Overall Study|Physician Decision|0|||
162742944|NCT04515849|587771500|FG003|Overall Study|Physician Decision|0|||
162742945|NCT04515849|587771501|FG004|Overall Study|Physician Decision|0|||
162742946|NCT04515849|587771497|FG000|Overall Study|Withdrawal by Subject|1|||
162742947|NCT04515849|587771498|FG001|Overall Study|Withdrawal by Subject|2|||
162742948|NCT04515849|587771499|FG002|Overall Study|Withdrawal by Subject|1|||
162742949|NCT04515849|587771500|FG003|Overall Study|Withdrawal by Subject|0|||
162742950|NCT04515849|587771501|FG004|Overall Study|Withdrawal by Subject|0|||
162742951|NCT04081103|587771507|FG000|Overall Study|Adverse Event|1|||
162742952|NCT04081103|587771508|FG001|Overall Study|Adverse Event|1|||
162742953|NCT04081103|587771509|FG002|Overall Study|Adverse Event|1|||
162742954|NCT04081103|587771507|FG000|Overall Study|Physician Decision|0|||
162742955|NCT04081103|587771508|FG001|Overall Study|Physician Decision|0|||
162742956|NCT04081103|587771509|FG002|Overall Study|Physician Decision|1|||
162742957|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
162742958|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
162742959|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
162742960|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
162742961|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
162742962|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
162742963|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
162742964|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
162742965|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
162742966|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
162742967|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
162742968|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162742969|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162742970|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162742971|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
162742972|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
162742973|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
162742974|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
162742975|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162742976|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162742977|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162742978|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
162742979|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
162742980|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162742981|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162742982|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162742983|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162742984|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162742985|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162742986|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
162742987|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162742988|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162742989|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162742990|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162742991|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162742992|NCT05693935|587773028|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
162742993|NCT05693935|587773029|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
162742994|NCT05693935|587773030|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
162742995|NCT05693935|587773031|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
162742996|NCT05693935|587773032|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162742997|NCT05693935|587773033|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162742998|NCT05693935|587773034|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162742999|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
162743000|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
162743001|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
162743002|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
162743003|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
162743004|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
162743005|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
162743006|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
162743007|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
162743008|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
162743009|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
162743010|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
162743011|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
162743012|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
162743013|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
162743014|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
162743015|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
162743016|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
162743017|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
162743018|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
162743019|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
162743020|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
162743021|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
162743022|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
162743023|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
162743024|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
162743025|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
162743026|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
162743027|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
162743028|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162743029|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
162743030|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162743031|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
162743032|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162743033|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
162743034|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743035|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743036|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
162743037|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743038|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743039|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743040|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162743041|NCT05693935|587773028|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
162743042|NCT05693935|587773029|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
162743043|NCT05693935|587773030|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
162743044|NCT05693935|587773031|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
162743045|NCT05693935|587773032|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
162743046|NCT05693935|587773033|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
162743047|NCT05693935|587773034|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
162743048|NCT04799899|587773039|FG000|Overall Study|Lost to Follow-up|2|||
162743049|NCT04799899|587773040|FG001|Overall Study|Lost to Follow-up|4|||
162743050|NCT04987320|587773046|FG000|Overall Study|Withdrawal by Subject|0|||
162743051|NCT04987320|587773047|FG001|Overall Study|Withdrawal by Subject|1|||
162743052|NCT00085735|587773048|FG000|Overall Study|Adverse Event|1|||
162743053|NCT00085735|587773049|FG001|Overall Study|Adverse Event|0|||
162743054|NCT00085735|587773050|FG002|Overall Study|Adverse Event|0|||
162743055|NCT00085735|587773051|FG003|Overall Study|Adverse Event|0|||
162743056|NCT00085735|587773052|FG004|Overall Study|Adverse Event|0|||
162743057|NCT00085735|587773053|FG005|Overall Study|Adverse Event|0|||
162743058|NCT00085735|587773048|FG000|Overall Study|Lack of Efficacy|2|||
162743059|NCT00085735|587773049|FG001|Overall Study|Lack of Efficacy|4|||
162743060|NCT00085735|587773050|FG002|Overall Study|Lack of Efficacy|6|||
162743061|NCT00085735|587773051|FG003|Overall Study|Lack of Efficacy|3|||
162743062|NCT00085735|587773052|FG004|Overall Study|Lack of Efficacy|4|||
162743063|NCT00085735|587773053|FG005|Overall Study|Lack of Efficacy|3|||
162743064|NCT00085735|587773048|FG000|Overall Study|Lost to Follow-up|0|||
162743065|NCT00085735|587773049|FG001|Overall Study|Lost to Follow-up|1|||
162743066|NCT00085735|587773050|FG002|Overall Study|Lost to Follow-up|0|||
162743067|NCT00085735|587773051|FG003|Overall Study|Lost to Follow-up|0|||
162743068|NCT00085735|587773052|FG004|Overall Study|Lost to Follow-up|1|||
162743069|NCT00085735|587773053|FG005|Overall Study|Lost to Follow-up|0|||
162743070|NCT00085735|587773048|FG000|Overall Study|Physician Decision|2|||
162743071|NCT00085735|587773049|FG001|Overall Study|Physician Decision|3|||
162743072|NCT00085735|587773050|FG002|Overall Study|Physician Decision|2|||
162743073|NCT00085735|587773051|FG003|Overall Study|Physician Decision|3|||
162743074|NCT00085735|587773052|FG004|Overall Study|Physician Decision|11|||
162743075|NCT00085735|587773053|FG005|Overall Study|Physician Decision|8|||
162743076|NCT00085735|587773048|FG000|Overall Study|Protocol Violation|1|||
162743077|NCT00085735|587773049|FG001|Overall Study|Protocol Violation|0|||
162743078|NCT00085735|587773050|FG002|Overall Study|Protocol Violation|0|||
162743079|NCT00085735|587773051|FG003|Overall Study|Protocol Violation|0|||
162743080|NCT00085735|587773052|FG004|Overall Study|Protocol Violation|0|||
162743081|NCT00085735|587773053|FG005|Overall Study|Protocol Violation|0|||
162743082|NCT00085735|587773048|FG000|Overall Study|Withdrawal by Subject|1|||
162743083|NCT00085735|587773049|FG001|Overall Study|Withdrawal by Subject|0|||
162743084|NCT00085735|587773050|FG002|Overall Study|Withdrawal by Subject|4|||
162743085|NCT00085735|587773051|FG003|Overall Study|Withdrawal by Subject|5|||
162743086|NCT00085735|587773052|FG004|Overall Study|Withdrawal by Subject|7|||
162743087|NCT00085735|587773053|FG005|Overall Study|Withdrawal by Subject|8|||
162743088|NCT00085735|587773048|FG000|Overall Study|Patient ineligible|1|||
162743089|NCT00085735|587773049|FG001|Overall Study|Patient ineligible|0|||
162743090|NCT00085735|587773050|FG002|Overall Study|Patient ineligible|3|||
162743091|NCT00085735|587773051|FG003|Overall Study|Patient ineligible|7|||
162743092|NCT00085735|587773052|FG004|Overall Study|Patient ineligible|17|||
162743093|NCT00085735|587773053|FG005|Overall Study|Patient ineligible|8|||
162743094|NCT00085735|587773048|FG000|Overall Study|Excess residual disease|2|||
162743095|NCT00085735|587773049|FG001|Overall Study|Excess residual disease|2|||
162743096|NCT00085735|587773050|FG002|Overall Study|Excess residual disease|1|||
162743097|NCT00085735|587773051|FG003|Overall Study|Excess residual disease|1|||
162743098|NCT00085735|587773052|FG004|Overall Study|Excess residual disease|1|||
162743099|NCT00085735|587773053|FG005|Overall Study|Excess residual disease|4|||
162743100|NCT00085735|587773048|FG000|Overall Study|Reason not documented|1|||
162743101|NCT00085735|587773049|FG001|Overall Study|Reason not documented|0|||
162743102|NCT00085735|587773050|FG002|Overall Study|Reason not documented|1|||
162743103|NCT00085735|587773051|FG003|Overall Study|Reason not documented|0|||
162743104|NCT00085735|587773052|FG004|Overall Study|Reason not documented|1|||
162743105|NCT00085735|587773053|FG005|Overall Study|Reason not documented|0|||
162743106|NCT00085735|587773048|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
162743107|NCT00085735|587773049|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
162743108|NCT00085735|587773050|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
162743109|NCT00085735|587773051|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
162743110|NCT00085735|587773052|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
162743111|NCT00085735|587773053|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
162743112|NCT01824875|587773054|FG000|Overall Study|Disease progression|22|||
162743113|NCT01824875|587773055|FG001|Overall Study|Disease progression|15|||
162743114|NCT01824875|587773054|FG000|Overall Study|Withdrawal by Subject|5|||
162743115|NCT01824875|587773055|FG001|Overall Study|Withdrawal by Subject|4|||
162743116|NCT01824875|587773054|FG000|Overall Study|Adverse Event|4|||
162743117|NCT01824875|587773055|FG001|Overall Study|Adverse Event|10|||
162743118|NCT01824875|587773054|FG000|Overall Study|Alternative therapy|3|||
162743119|NCT01824875|587773055|FG001|Overall Study|Alternative therapy|0|||
162743120|NCT01824875|587773054|FG000|Overall Study|Complicating disease|1|||
162743121|NCT01824875|587773055|FG001|Overall Study|Complicating disease|0|||
162743122|NCT01824875|587773054|FG000|Overall Study|Physician Decision|0|||
162743123|NCT01824875|587773055|FG001|Overall Study|Physician Decision|1|||
162743124|NCT01824875|587773054|FG000|Overall Study|Non-compliance|1|||
162743125|NCT01824875|587773055|FG001|Overall Study|Non-compliance|1|||
162743126|NCT01824875|587773054|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
162743127|NCT01824875|587773055|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
162743128|NCT01824875|587773054|FG000|Overall Study|Administrative issues|0|||
162743129|NCT01824875|587773055|FG001|Overall Study|Administrative issues|2|||
162743130|NCT01824875|587773054|FG000|Overall Study|Ineligible or never started treatment|9|||
162743131|NCT01824875|587773055|FG001|Overall Study|Ineligible or never started treatment|5|||
162743132|NCT01824875|587773054|FG000|Overall Study|Other|0|||
162743133|NCT01824875|587773055|FG001|Overall Study|Other|2|||
162743134|NCT00433329|587773056|FG000|Overall Study|Adverse Event|9|||
162743135|NCT00433329|587773056|FG000|Overall Study|Death|4|||
162743136|NCT00433329|587773056|FG000|Overall Study|Withdrew consent|3|||
162743137|NCT00433329|587773056|FG000|Overall Study|Discontinued sildenafil|2|||
162743138|NCT00433329|587773056|FG000|Overall Study|Moved out of state|1|||
162743139|NCT00433329|587773056|FG000|Overall Study|Lost to Follow-up|1|||
162743140|NCT00433329|587773056|FG000|Overall Study|Physician Decision|1|||
162743141|NCT04195698|587773057|FG000|Overall Study|Adverse Event|4|||
162743142|NCT04195698|587773058|FG001|Overall Study|Adverse Event|11|||
162743143|NCT04195698|587773057|FG000|Overall Study|Withdrawal by Subject|9|||
162743144|NCT04195698|587773058|FG001|Overall Study|Withdrawal by Subject|10|||
162743145|NCT04195698|587773057|FG000|Overall Study|Lost to Follow-up|5|||
162743146|NCT04195698|587773058|FG001|Overall Study|Lost to Follow-up|4|||
162743147|NCT04195698|587773057|FG000|Overall Study|Lack of Efficacy|2|||
162743148|NCT04195698|587773058|FG001|Overall Study|Lack of Efficacy|10|||
162743149|NCT04195698|587773057|FG000|Overall Study|Other|5|||
162743150|NCT04195698|587773058|FG001|Overall Study|Other|4|||
162743151|NCT01129102|587773059|FG000|Overall Study|No study drug treatment|2|||
162743152|NCT01129102|587773060|FG001|Overall Study|No study drug treatment|3|||
162743153|NCT01129102|587773061|FG002|Overall Study|No study drug treatment|1|||
162743154|NCT01129102|587773059|FG000|Overall Study|Withdrawal by Subject|2|||
162743155|NCT01129102|587773060|FG001|Overall Study|Withdrawal by Subject|0|||
162743156|NCT01129102|587773061|FG002|Overall Study|Withdrawal by Subject|3|||
162743157|NCT01129102|587773059|FG000|Overall Study|Protocol Violation|0|||
162743158|NCT01129102|587773060|FG001|Overall Study|Protocol Violation|1|||
162743159|NCT01129102|587773061|FG002|Overall Study|Protocol Violation|1|||
162743160|NCT01129102|587773059|FG000|Overall Study|Pregnancy|0|||
162743161|NCT01129102|587773060|FG001|Overall Study|Pregnancy|0|||
162743162|NCT01129102|587773061|FG002|Overall Study|Pregnancy|1|||
162743163|NCT01129102|587773059|FG000|Overall Study|Adverse Event|2|||
162743164|NCT01129102|587773060|FG001|Overall Study|Adverse Event|2|||
162743165|NCT01129102|587773061|FG002|Overall Study|Adverse Event|1|||
162743166|NCT01129102|587773059|FG000|Overall Study|Lost to Follow-up|2|||
162743167|NCT01129102|587773060|FG001|Overall Study|Lost to Follow-up|0|||
162743168|NCT01129102|587773061|FG002|Overall Study|Lost to Follow-up|0|||
162743169|NCT05256017|587773064|FG000|Treatment Period|Withdrawal by Subject|1|||
162743170|NCT05256017|587773065|FG001|Treatment Period|Withdrawal by Subject|1|||
162743171|NCT05256017|587773064|FG000|Follow-up|Lost to Follow-up|7|||
162743172|NCT05256017|587773065|FG001|Follow-up|Lost to Follow-up|1|||
162743173|NCT05256017|587773064|FG000|Follow-up|Withdrawal by Subject|1|||
162743174|NCT05256017|587773065|FG001|Follow-up|Withdrawal by Subject|0|||
162743175|NCT05256017|587773064|FG000|Follow-up|Death|0|||
162743176|NCT05256017|587773065|FG001|Follow-up|Death|1|||
162743177|NCT05082025|587773066|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
162743178|NCT03854227|587773068|FG000|Overall Study|Adverse Event|0|||
162743179|NCT03854227|587773069|FG001|Overall Study|Adverse Event|0|||
162743180|NCT03854227|587773070|FG002|Overall Study|Adverse Event|0|||
162743181|NCT03854227|587773071|FG003|Overall Study|Adverse Event|1|||
162743182|NCT03854227|587773072|FG004|Overall Study|Adverse Event|0|||
162743183|NCT03854227|587773073|FG005|Overall Study|Adverse Event|0|||
162743184|NCT03854227|587773074|FG006|Overall Study|Adverse Event|1|||
162743185|NCT03854227|587773075|FG007|Overall Study|Adverse Event|0|||
162743186|NCT03854227|587773076|FG008|Overall Study|Adverse Event|0|||
162743187|NCT03854227|587773077|FG009|Overall Study|Adverse Event|3|||
162743188|NCT03854227|587773078|FG010|Overall Study|Adverse Event|0|||
162743189|NCT03854227|587773079|FG011|Overall Study|Adverse Event|1|||
162743190|NCT03854227|587773068|FG000|Overall Study|Death|0|||
162743191|NCT03854227|587773069|FG001|Overall Study|Death|0|||
162743192|NCT03854227|587773070|FG002|Overall Study|Death|0|||
162743193|NCT03854227|587773071|FG003|Overall Study|Death|0|||
162743194|NCT03854227|587773072|FG004|Overall Study|Death|0|||
162743195|NCT03854227|587773073|FG005|Overall Study|Death|1|||
162743196|NCT03854227|587773074|FG006|Overall Study|Death|0|||
162743197|NCT03854227|587773075|FG007|Overall Study|Death|0|||
162743198|NCT03854227|587773076|FG008|Overall Study|Death|0|||
162743199|NCT03854227|587773077|FG009|Overall Study|Death|1|||
162743200|NCT03854227|587773078|FG010|Overall Study|Death|0|||
162743201|NCT03854227|587773079|FG011|Overall Study|Death|1|||
162743202|NCT03854227|587773068|FG000|Overall Study|Physician Decision|0|||
162743203|NCT03854227|587773069|FG001|Overall Study|Physician Decision|0|||
162743204|NCT03854227|587773070|FG002|Overall Study|Physician Decision|0|||
162743205|NCT03854227|587773071|FG003|Overall Study|Physician Decision|0|||
162743206|NCT03854227|587773072|FG004|Overall Study|Physician Decision|0|||
162743207|NCT03854227|587773073|FG005|Overall Study|Physician Decision|1|||
162743208|NCT03854227|587773074|FG006|Overall Study|Physician Decision|0|||
162743209|NCT03854227|587773075|FG007|Overall Study|Physician Decision|0|||
162743210|NCT03854227|587773076|FG008|Overall Study|Physician Decision|1|||
162743211|NCT03854227|587773077|FG009|Overall Study|Physician Decision|1|||
162743212|NCT03854227|587773078|FG010|Overall Study|Physician Decision|0|||
162743213|NCT03854227|587773079|FG011|Overall Study|Physician Decision|1|||
162743214|NCT03854227|587773068|FG000|Overall Study|Progressive disease|1|||
162743215|NCT03854227|587773069|FG001|Overall Study|Progressive disease|1|||
162743216|NCT03854227|587773070|FG002|Overall Study|Progressive disease|1|||
162743217|NCT03854227|587773071|FG003|Overall Study|Progressive disease|2|||
162743218|NCT03854227|587773072|FG004|Overall Study|Progressive disease|3|||
162743219|NCT03854227|587773073|FG005|Overall Study|Progressive disease|1|||
162743220|NCT03854227|587773074|FG006|Overall Study|Progressive disease|2|||
162743221|NCT03854227|587773075|FG007|Overall Study|Progressive disease|5|||
162743222|NCT03854227|587773076|FG008|Overall Study|Progressive disease|2|||
162743223|NCT03854227|587773077|FG009|Overall Study|Progressive disease|5|||
162743224|NCT03854227|587773078|FG010|Overall Study|Progressive disease|1|||
162743225|NCT03854227|587773079|FG011|Overall Study|Progressive disease|6|||
162743226|NCT03854227|587773068|FG000|Overall Study|Study terminated by sponsor|0|||
162743227|NCT03854227|587773069|FG001|Overall Study|Study terminated by sponsor|0|||
162743228|NCT03854227|587773070|FG002|Overall Study|Study terminated by sponsor|0|||
162743229|NCT03854227|587773071|FG003|Overall Study|Study terminated by sponsor|0|||
162743230|NCT03854227|587773072|FG004|Overall Study|Study terminated by sponsor|0|||
162743231|NCT03854227|587773073|FG005|Overall Study|Study terminated by sponsor|0|||
162743232|NCT03854227|587773074|FG006|Overall Study|Study terminated by sponsor|0|||
162743233|NCT03854227|587773075|FG007|Overall Study|Study terminated by sponsor|0|||
162743234|NCT03854227|587773076|FG008|Overall Study|Study terminated by sponsor|0|||
162743235|NCT03854227|587773077|FG009|Overall Study|Study terminated by sponsor|1|||
162743236|NCT03854227|587773078|FG010|Overall Study|Study terminated by sponsor|0|||
162743237|NCT03854227|587773079|FG011|Overall Study|Study terminated by sponsor|0|||
162743238|NCT03854227|587773068|FG000|Overall Study|Withdrawal by Subject|0|||
162743239|NCT03854227|587773069|FG001|Overall Study|Withdrawal by Subject|0|||
162743240|NCT03854227|587773070|FG002|Overall Study|Withdrawal by Subject|1|||
162743241|NCT03854227|587773071|FG003|Overall Study|Withdrawal by Subject|0|||
162743242|NCT03854227|587773072|FG004|Overall Study|Withdrawal by Subject|0|||
162743243|NCT03854227|587773073|FG005|Overall Study|Withdrawal by Subject|0|||
162743244|NCT03854227|587773074|FG006|Overall Study|Withdrawal by Subject|0|||
162743245|NCT03854227|587773075|FG007|Overall Study|Withdrawal by Subject|0|||
162743246|NCT03854227|587773076|FG008|Overall Study|Withdrawal by Subject|0|||
162743247|NCT03854227|587773077|FG009|Overall Study|Withdrawal by Subject|1|||
162743248|NCT03854227|587773078|FG010|Overall Study|Withdrawal by Subject|1|||
162743249|NCT03854227|587773079|FG011|Overall Study|Withdrawal by Subject|0|||
162743250|NCT03854227|587773068|FG000|Overall Study|Disease relapse|0|||
162743251|NCT03854227|587773069|FG001|Overall Study|Disease relapse|0|||
162743252|NCT03854227|587773070|FG002|Overall Study|Disease relapse|0|||
162743253|NCT03854227|587773071|FG003|Overall Study|Disease relapse|0|||
162743254|NCT03854227|587773072|FG004|Overall Study|Disease relapse|0|||
162743255|NCT03854227|587773073|FG005|Overall Study|Disease relapse|0|||
162743256|NCT03854227|587773074|FG006|Overall Study|Disease relapse|0|||
162743257|NCT03854227|587773075|FG007|Overall Study|Disease relapse|0|||
162743258|NCT03854227|587773076|FG008|Overall Study|Disease relapse|1|||
162743259|NCT03854227|587773077|FG009|Overall Study|Disease relapse|0|||
162743260|NCT03854227|587773078|FG010|Overall Study|Disease relapse|0|||
162743261|NCT03854227|587773079|FG011|Overall Study|Disease relapse|0|||
162743262|NCT03854227|587773068|FG000|Overall Study|Global deterioration of health status|0|||
162743263|NCT03854227|587773069|FG001|Overall Study|Global deterioration of health status|0|||
162743264|NCT03854227|587773070|FG002|Overall Study|Global deterioration of health status|0|||
162743265|NCT03854227|587773071|FG003|Overall Study|Global deterioration of health status|0|||
162743266|NCT03854227|587773072|FG004|Overall Study|Global deterioration of health status|0|||
162743267|NCT03854227|587773073|FG005|Overall Study|Global deterioration of health status|1|||
162743268|NCT03854227|587773074|FG006|Overall Study|Global deterioration of health status|0|||
162743269|NCT03854227|587773075|FG007|Overall Study|Global deterioration of health status|1|||
162743270|NCT03854227|587773076|FG008|Overall Study|Global deterioration of health status|0|||
162743271|NCT03854227|587773077|FG009|Overall Study|Global deterioration of health status|0|||
162743272|NCT03854227|587773078|FG010|Overall Study|Global deterioration of health status|0|||
162743273|NCT03854227|587773079|FG011|Overall Study|Global deterioration of health status|0|||
162743274|NCT03854227|587773068|FG000|Overall Study|Refused further treatment|0|||
162743275|NCT03854227|587773069|FG001|Overall Study|Refused further treatment|0|||
162743276|NCT03854227|587773070|FG002|Overall Study|Refused further treatment|0|||
162743277|NCT03854227|587773071|FG003|Overall Study|Refused further treatment|0|||
162743278|NCT03854227|587773072|FG004|Overall Study|Refused further treatment|0|||
162743279|NCT03854227|587773073|FG005|Overall Study|Refused further treatment|0|||
162743280|NCT03854227|587773074|FG006|Overall Study|Refused further treatment|0|||
162743281|NCT03854227|587773075|FG007|Overall Study|Refused further treatment|0|||
162743282|NCT03854227|587773076|FG008|Overall Study|Refused further treatment|0|||
162743283|NCT03854227|587773077|FG009|Overall Study|Refused further treatment|1|||
162743284|NCT03854227|587773078|FG010|Overall Study|Refused further treatment|0|||
162743285|NCT03854227|587773079|FG011|Overall Study|Refused further treatment|1|||
162743286|NCT03854227|587773068|FG000|Overall Study|Other|0|||
162743287|NCT03854227|587773069|FG001|Overall Study|Other|0|||
162743288|NCT03854227|587773070|FG002|Overall Study|Other|0|||
162743289|NCT03854227|587773071|FG003|Overall Study|Other|0|||
162743290|NCT03854227|587773072|FG004|Overall Study|Other|0|||
162743291|NCT03854227|587773073|FG005|Overall Study|Other|0|||
162743292|NCT03854227|587773074|FG006|Overall Study|Other|0|||
162743293|NCT03854227|587773075|FG007|Overall Study|Other|0|||
162743294|NCT03854227|587773076|FG008|Overall Study|Other|1|||
162743295|NCT03854227|587773077|FG009|Overall Study|Other|1|||
162743296|NCT03854227|587773078|FG010|Overall Study|Other|0|||
162743297|NCT03854227|587773079|FG011|Overall Study|Other|0|||
162743298|NCT06504862|587773080|FG000|Transition period|Adverse Event|1|||
162743299|NCT06504862|587773081|FG001|Transition period|Adverse Event|0|||
162743300|NCT01574274|587773082|FG000|Overall Study|Ineligible|0|||
162743301|NCT01574274|587773083|FG001|Overall Study|Ineligible|1|||
162743302|NCT01574274|587773082|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
162743303|NCT01574274|587773083|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
162743304|NCT01574274|587773082|FG000|Overall Study|Ph+ B-ALL|3|||
162743305|NCT01574274|587773083|FG001|Overall Study|Ph+ B-ALL|4|||
162743306|NCT01574274|587773082|FG000|Overall Study|Induction Death|2|||
162743307|NCT01574274|587773083|FG001|Overall Study|Induction Death|0|||
162743308|NCT01574274|587773082|FG000|Overall Study|Induction Failure|4|||
162743309|NCT01574274|587773083|FG001|Overall Study|Induction Failure|1|||
162743310|NCT01574274|587773082|FG000|Overall Study|Adverse Event|16|||
162743311|NCT01574274|587773083|FG001|Overall Study|Adverse Event|13|||
162743312|NCT01574274|587773082|FG000|Overall Study|Remission Death|1|||
162743313|NCT01574274|587773083|FG001|Overall Study|Remission Death|0|||
162743314|NCT01574274|587773082|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
162743315|NCT01574274|587773083|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
162743316|NCT01574274|587773082|FG000|Overall Study|Other, unknown|3|||
162743317|NCT01574274|587773083|FG001|Overall Study|Other, unknown|2|||
162743318|NCT04948697|587773090|FG000|Overall Study|Progressive disease|27|||
162743319|NCT04948697|587773091|FG001|Overall Study|Progressive disease|18|||
162743320|NCT04948697|587773090|FG000|Overall Study|Adverse Event|14|||
162743321|NCT04948697|587773091|FG001|Overall Study|Adverse Event|4|||
162743322|NCT04948697|587773090|FG000|Overall Study|Participant moved to long term extension study|7|||
162743323|NCT04948697|587773091|FG001|Overall Study|Participant moved to long term extension study|4|||
162743324|NCT04948697|587773090|FG000|Overall Study|Withdrawal by Subject|10|||
162743325|NCT04948697|587773091|FG001|Overall Study|Withdrawal by Subject|0|||
162743326|NCT04948697|587773090|FG000|Overall Study|Closed by Sponsor|3|||
162743327|NCT04948697|587773091|FG001|Overall Study|Closed by Sponsor|2|||
162743328|NCT04948697|587773090|FG000|Overall Study|Physician Decision|0|||
162743329|NCT04948697|587773091|FG001|Overall Study|Physician Decision|2|||
162743330|NCT04948697|587773090|FG000|Overall Study|Lost to Follow-up|0|||
162743331|NCT04948697|587773091|FG001|Overall Study|Lost to Follow-up|1|||
162743332|NCT04948697|587773090|FG000|Overall Study|Other-Miscellaneous|1|||
162743333|NCT04948697|587773091|FG001|Overall Study|Other-Miscellaneous|0|||
162743334|NCT04948697|587773090|FG000|Overall Study|Randomized but not treated|0|||
162743335|NCT04948697|587773091|FG001|Overall Study|Randomized but not treated|1|||
162743336|NCT04870515|587773092|FG000|Overall Study|Lost to Follow-up|0|||
162743337|NCT04870515|587773093|FG001|Overall Study|Lost to Follow-up|2|||
162743338|NCT04870515|587773092|FG000|Overall Study|Withdrawal by Subject|0|||
162743339|NCT04870515|587773093|FG001|Overall Study|Withdrawal by Subject|1|||
162743340|NCT04870515|587773092|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
162743341|NCT04870515|587773093|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
162743342|NCT04032704|587773094|FG000|Part A|Withdrawal by Subject|0|||
162743343|NCT04032704|587773095|FG001|Part A|Withdrawal by Subject|0|||
162743344|NCT04032704|587773096|FG002|Part A|Withdrawal by Subject|3|||
162743345|NCT04032704|587773097|FG003|Part A|Withdrawal by Subject|0|||
162743346|NCT04032704|587773098|FG004|Part A|Withdrawal by Subject|1|||
162743347|NCT04032704|587773099|FG005|Part A|Withdrawal by Subject|7|||
162743348|NCT04032704|587773100|FG006|Part A|Withdrawal by Subject|0|||
162743349|NCT04032704|587773101|FG007|Part A|Withdrawal by Subject|0|||
162743350|NCT04032704|587773102|FG008|Part A|Withdrawal by Subject|0|||
162743351|NCT04032704|587773103|FG009|Part A|Withdrawal by Subject|0|||
162743352|NCT04032704|587773104|FG010|Part A|Withdrawal by Subject|0|||
162743353|NCT04032704|587773105|FG011|Part A|Withdrawal by Subject|0|||
162743354|NCT04032704|587773106|FG012|Part A|Withdrawal by Subject|0|||
162743355|NCT04032704|587773107|FG013|Part A|Withdrawal by Subject|0|||
162743356|NCT04032704|587773108|FG014|Part A|Withdrawal by Subject|0|||
162743357|NCT04032704|587773109|FG015|Part A|Withdrawal by Subject|0|||
162743358|NCT04032704|587773110|FG016|Part A|Withdrawal by Subject|0|||
162743359|NCT04032704|587773111|FG017|Part A|Withdrawal by Subject|0|||
162743360|NCT04032704|587773094|FG000|Part A|Lost to Follow-up|1|||
162743361|NCT04032704|587773095|FG001|Part A|Lost to Follow-up|0|||
162743362|NCT04032704|587773096|FG002|Part A|Lost to Follow-up|0|||
162743363|NCT04032704|587773097|FG003|Part A|Lost to Follow-up|0|||
162743364|NCT04032704|587773098|FG004|Part A|Lost to Follow-up|0|||
162743365|NCT04032704|587773099|FG005|Part A|Lost to Follow-up|0|||
162743366|NCT04032704|587773100|FG006|Part A|Lost to Follow-up|0|||
162743367|NCT04032704|587773101|FG007|Part A|Lost to Follow-up|0|||
162743368|NCT04032704|587773102|FG008|Part A|Lost to Follow-up|0|||
162743369|NCT04032704|587773103|FG009|Part A|Lost to Follow-up|0|||
162743370|NCT04032704|587773104|FG010|Part A|Lost to Follow-up|0|||
162743371|NCT04032704|587773105|FG011|Part A|Lost to Follow-up|0|||
162743372|NCT04032704|587773106|FG012|Part A|Lost to Follow-up|0|||
162743373|NCT04032704|587773107|FG013|Part A|Lost to Follow-up|0|||
162743374|NCT04032704|587773108|FG014|Part A|Lost to Follow-up|0|||
162743375|NCT04032704|587773109|FG015|Part A|Lost to Follow-up|0|||
162743376|NCT04032704|587773110|FG016|Part A|Lost to Follow-up|0|||
162743377|NCT04032704|587773111|FG017|Part A|Lost to Follow-up|0|||
162743378|NCT04032704|587773094|FG000|Part A|Death|9|||
162743379|NCT04032704|587773095|FG001|Part A|Death|2|||
162743380|NCT04032704|587773096|FG002|Part A|Death|10|||
162743381|NCT04032704|587773097|FG003|Part A|Death|7|||
162743382|NCT04032704|587773098|FG004|Part A|Death|4|||
162743383|NCT04032704|587773099|FG005|Part A|Death|5|||
162743384|NCT04032704|587773100|FG006|Part A|Death|0|||
162743385|NCT04032704|587773101|FG007|Part A|Death|0|||
162743386|NCT04032704|587773102|FG008|Part A|Death|0|||
162743387|NCT04032704|587773103|FG009|Part A|Death|0|||
162743388|NCT04032704|587773104|FG010|Part A|Death|0|||
162743389|NCT04032704|587773105|FG011|Part A|Death|0|||
162743390|NCT04032704|587773106|FG012|Part A|Death|0|||
162743391|NCT04032704|587773107|FG013|Part A|Death|0|||
162743392|NCT04032704|587773108|FG014|Part A|Death|0|||
162743393|NCT04032704|587773109|FG015|Part A|Death|0|||
162743394|NCT04032704|587773110|FG016|Part A|Death|0|||
162743395|NCT04032704|587773111|FG017|Part A|Death|0|||
162743396|NCT04032704|587773094|FG000|Part B|Other|0|||
162743397|NCT04032704|587773095|FG001|Part B|Other|0|||
162743398|NCT04032704|587773096|FG002|Part B|Other|0|||
162743399|NCT04032704|587773097|FG003|Part B|Other|0|||
162743400|NCT04032704|587773098|FG004|Part B|Other|0|||
162743401|NCT04032704|587773099|FG005|Part B|Other|0|||
162743402|NCT04032704|587773100|FG006|Part B|Other|0|||
162743403|NCT04032704|587773101|FG007|Part B|Other|1|||
162743404|NCT04032704|587773102|FG008|Part B|Other|2|||
162743405|NCT04032704|587773103|FG009|Part B|Other|1|||
162743406|NCT04032704|587773104|FG010|Part B|Other|1|||
162743407|NCT04032704|587773105|FG011|Part B|Other|1|||
162743408|NCT04032704|587773106|FG012|Part B|Other|5|||
162743409|NCT04032704|587773107|FG013|Part B|Other|13|||
162743410|NCT04032704|587773108|FG014|Part B|Other|0|||
162743411|NCT04032704|587773109|FG015|Part B|Other|0|||
162743412|NCT04032704|587773110|FG016|Part B|Other|0|||
162743413|NCT04032704|587773111|FG017|Part B|Other|0|||
162743414|NCT04032704|587773094|FG000|Part B|Study termination by Sponsor|0|||
162743415|NCT04032704|587773095|FG001|Part B|Study termination by Sponsor|0|||
162743416|NCT04032704|587773096|FG002|Part B|Study termination by Sponsor|0|||
162743417|NCT04032704|587773097|FG003|Part B|Study termination by Sponsor|0|||
162743418|NCT04032704|587773098|FG004|Part B|Study termination by Sponsor|0|||
162743419|NCT04032704|587773099|FG005|Part B|Study termination by Sponsor|0|||
162743420|NCT04032704|587773100|FG006|Part B|Study termination by Sponsor|0|||
162743421|NCT04032704|587773101|FG007|Part B|Study termination by Sponsor|0|||
162743422|NCT04032704|587773102|FG008|Part B|Study termination by Sponsor|1|||
162743423|NCT04032704|587773103|FG009|Part B|Study termination by Sponsor|0|||
162743424|NCT04032704|587773104|FG010|Part B|Study termination by Sponsor|0|||
162743425|NCT04032704|587773105|FG011|Part B|Study termination by Sponsor|0|||
162743426|NCT04032704|587773106|FG012|Part B|Study termination by Sponsor|0|||
162743427|NCT04032704|587773107|FG013|Part B|Study termination by Sponsor|0|||
162743428|NCT04032704|587773108|FG014|Part B|Study termination by Sponsor|0|||
162743429|NCT04032704|587773109|FG015|Part B|Study termination by Sponsor|0|||
162743430|NCT04032704|587773110|FG016|Part B|Study termination by Sponsor|0|||
162743431|NCT04032704|587773111|FG017|Part B|Study termination by Sponsor|0|||
162743432|NCT04032704|587773094|FG000|Part B|Withdrawal by Subject|0|||
162743433|NCT04032704|587773095|FG001|Part B|Withdrawal by Subject|0|||
162743434|NCT04032704|587773096|FG002|Part B|Withdrawal by Subject|0|||
162743435|NCT04032704|587773097|FG003|Part B|Withdrawal by Subject|0|||
162743436|NCT04032704|587773098|FG004|Part B|Withdrawal by Subject|0|||
162743437|NCT04032704|587773099|FG005|Part B|Withdrawal by Subject|0|||
162743438|NCT04032704|587773100|FG006|Part B|Withdrawal by Subject|3|||
162743439|NCT04032704|587773101|FG007|Part B|Withdrawal by Subject|2|||
162743440|NCT04032704|587773102|FG008|Part B|Withdrawal by Subject|2|||
162743441|NCT04032704|587773103|FG009|Part B|Withdrawal by Subject|1|||
162743442|NCT04032704|587773104|FG010|Part B|Withdrawal by Subject|4|||
162743443|NCT04032704|587773105|FG011|Part B|Withdrawal by Subject|6|||
162743444|NCT04032704|587773106|FG012|Part B|Withdrawal by Subject|2|||
162743445|NCT04032704|587773107|FG013|Part B|Withdrawal by Subject|1|||
162743446|NCT04032704|587773108|FG014|Part B|Withdrawal by Subject|0|||
162743447|NCT04032704|587773109|FG015|Part B|Withdrawal by Subject|1|||
162743448|NCT04032704|587773110|FG016|Part B|Withdrawal by Subject|0|||
162743449|NCT04032704|587773111|FG017|Part B|Withdrawal by Subject|0|||
162743450|NCT04032704|587773094|FG000|Part B|Lost to Follow-up|0|||
162743451|NCT04032704|587773095|FG001|Part B|Lost to Follow-up|0|||
162743452|NCT04032704|587773096|FG002|Part B|Lost to Follow-up|0|||
162743453|NCT04032704|587773097|FG003|Part B|Lost to Follow-up|0|||
162743454|NCT04032704|587773098|FG004|Part B|Lost to Follow-up|0|||
162743455|NCT04032704|587773099|FG005|Part B|Lost to Follow-up|0|||
162743456|NCT04032704|587773100|FG006|Part B|Lost to Follow-up|0|||
162743457|NCT04032704|587773101|FG007|Part B|Lost to Follow-up|0|||
162743458|NCT04032704|587773102|FG008|Part B|Lost to Follow-up|0|||
162743459|NCT04032704|587773103|FG009|Part B|Lost to Follow-up|0|||
162743460|NCT04032704|587773104|FG010|Part B|Lost to Follow-up|0|||
162743461|NCT04032704|587773105|FG011|Part B|Lost to Follow-up|1|||
162743462|NCT04032704|587773106|FG012|Part B|Lost to Follow-up|0|||
162743463|NCT04032704|587773107|FG013|Part B|Lost to Follow-up|0|||
162743464|NCT04032704|587773108|FG014|Part B|Lost to Follow-up|0|||
162743465|NCT04032704|587773109|FG015|Part B|Lost to Follow-up|0|||
162743466|NCT04032704|587773110|FG016|Part B|Lost to Follow-up|0|||
162743467|NCT04032704|587773111|FG017|Part B|Lost to Follow-up|0|||
162743468|NCT04032704|587773094|FG000|Part B|Death|0|||
162743469|NCT04032704|587773095|FG001|Part B|Death|0|||
162743470|NCT04032704|587773096|FG002|Part B|Death|0|||
162743471|NCT04032704|587773097|FG003|Part B|Death|0|||
162743472|NCT04032704|587773098|FG004|Part B|Death|0|||
162743473|NCT04032704|587773099|FG005|Part B|Death|0|||
162743474|NCT04032704|587773100|FG006|Part B|Death|13|||
162743475|NCT04032704|587773101|FG007|Part B|Death|13|||
162743476|NCT04032704|587773102|FG008|Part B|Death|14|||
162743477|NCT04032704|587773103|FG009|Part B|Death|12|||
162743478|NCT04032704|587773104|FG010|Part B|Death|12|||
162743479|NCT04032704|587773105|FG011|Part B|Death|13|||
162743480|NCT04032704|587773106|FG012|Part B|Death|7|||
162743481|NCT04032704|587773107|FG013|Part B|Death|17|||
162743482|NCT04032704|587773108|FG014|Part B|Death|2|||
162743483|NCT04032704|587773109|FG015|Part B|Death|1|||
162743484|NCT04032704|587773110|FG016|Part B|Death|2|||
162743485|NCT04032704|587773111|FG017|Part B|Death|2|||
162743486|NCT03020199|587773114|FG000|Treatment Period|Adverse Event|0|||
162743487|NCT03020199|587773115|FG001|Treatment Period|Adverse Event|2|||
162743488|NCT03020199|587773114|FG000|Treatment Period|Lack of Efficacy|1|||
162743489|NCT03020199|587773115|FG001|Treatment Period|Lack of Efficacy|6|||
162743490|NCT03020199|587773114|FG000|Treatment Period|Lost to Follow-up|1|||
162743491|NCT03020199|587773115|FG001|Treatment Period|Lost to Follow-up|6|||
162743492|NCT03020199|587773114|FG000|Treatment Period|Physician Decision|0|||
162743493|NCT03020199|587773115|FG001|Treatment Period|Physician Decision|1|||
162743494|NCT03020199|587773114|FG000|Treatment Period|Subject/guardian decision|8|||
162743495|NCT03020199|587773115|FG001|Treatment Period|Subject/guardian decision|15|||
162743496|NCT03020199|587773114|FG000|Treatment Period|Subjects not treated|3|||
162743497|NCT03020199|587773115|FG001|Treatment Period|Subjects not treated|4|||
162743498|NCT03020199|587773114|FG000|Follow-up Period|Disease relapse|32|||
162743499|NCT03020199|587773115|FG001|Follow-up Period|Disease relapse|7|||
162743500|NCT03020199|587773114|FG000|Follow-up Period|Lack of Efficacy|1|||
162743501|NCT03020199|587773115|FG001|Follow-up Period|Lack of Efficacy|2|||
162743502|NCT03020199|587773114|FG000|Follow-up Period|Lost to Follow-up|4|||
162743503|NCT03020199|587773115|FG001|Follow-up Period|Lost to Follow-up|6|||
162743504|NCT03020199|587773114|FG000|Follow-up Period|Physician Decision|2|||
162743505|NCT03020199|587773115|FG001|Follow-up Period|Physician Decision|2|||
162743506|NCT03020199|587773114|FG000|Follow-up Period|Protocol Violation|1|||
162743507|NCT03020199|587773115|FG001|Follow-up Period|Protocol Violation|2|||
162743508|NCT03020199|587773114|FG000|Follow-up Period|Study terminated by Sponsor|6|||
162743509|NCT03020199|587773115|FG001|Follow-up Period|Study terminated by Sponsor|3|||
162743510|NCT03020199|587773114|FG000|Follow-up Period|Subject/guardian decision|14|||
162743511|NCT03020199|587773115|FG001|Follow-up Period|Subject/guardian decision|9|||
162743512|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
162743513|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
162743514|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
162743515|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
162743516|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
162743517|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162743518|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
162743519|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
162743520|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162743521|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162743522|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
162743523|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
162743524|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
162743525|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
162743526|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
162743527|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
162743528|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162743529|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
162743530|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162743531|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162743532|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162743533|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
162743534|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162743535|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162743536|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162743537|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
162743538|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
162743539|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
162743540|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
162743541|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
162743542|NCT03852472|587773118|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
162743543|NCT03852472|587773119|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
162743544|NCT03852472|587773120|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
162743545|NCT03852472|587773121|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
162743546|NCT03852472|587773122|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
162743547|NCT03852472|587773118|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
162743548|NCT03852472|587773119|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
162743549|NCT03852472|587773120|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
162743550|NCT03852472|587773121|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
162743551|NCT03852472|587773122|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
162743552|NCT03852472|587773118|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
162743553|NCT03852472|587773119|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
162743554|NCT03852472|587773120|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
162743555|NCT03852472|587773121|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
162743556|NCT03852472|587773122|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
162743557|NCT03852472|587773118|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
162743558|NCT03852472|587773119|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
162743559|NCT03852472|587773120|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
162743560|NCT03852472|587773121|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
162743561|NCT03852472|587773122|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
162743562|NCT03852472|587773118|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
162743563|NCT03852472|587773119|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
162743564|NCT03852472|587773120|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
162743565|NCT03852472|587773121|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
162743566|NCT03852472|587773122|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
162743567|NCT03852472|587773118|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
162743568|NCT03852472|587773119|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
162743569|NCT03852472|587773120|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
162743570|NCT03852472|587773121|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
162743571|NCT03852472|587773122|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
162743572|NCT03852472|587773118|FG000|Period 2 - Week 44|Adverse Event|0|||
162743573|NCT03852472|587773119|FG001|Period 2 - Week 44|Adverse Event|3|||
162743574|NCT03852472|587773120|FG002|Period 2 - Week 44|Adverse Event|1|||
162743575|NCT03852472|587773121|FG003|Period 2 - Week 44|Adverse Event|2|||
162743576|NCT03852472|587773122|FG004|Period 2 - Week 44|Adverse Event|2|||
162743577|NCT03852472|587773118|FG000|Period 2 - Week 44|COVID-19 Related|0|||
162743578|NCT03852472|587773119|FG001|Period 2 - Week 44|COVID-19 Related|0|||
162743579|NCT03852472|587773120|FG002|Period 2 - Week 44|COVID-19 Related|0|||
162743580|NCT03852472|587773121|FG003|Period 2 - Week 44|COVID-19 Related|1|||
162743581|NCT03852472|587773122|FG004|Period 2 - Week 44|COVID-19 Related|0|||
162743582|NCT03852472|587773118|FG000|Period 2 - Week 44|Reason not stated|0|||
162743583|NCT03852472|587773119|FG001|Period 2 - Week 44|Reason not stated|0|||
162743584|NCT03852472|587773120|FG002|Period 2 - Week 44|Reason not stated|0|||
162743585|NCT03852472|587773121|FG003|Period 2 - Week 44|Reason not stated|0|||
162743586|NCT03852472|587773122|FG004|Period 2 - Week 44|Reason not stated|1|||
162743587|NCT04880863|587773125|FG000|Overall Study|Adverse Event|1|||
162743588|NCT04880863|587773125|FG000|Overall Study|Patient decision|2|||
162743589|NCT04880863|587773125|FG000|Overall Study|Confirmed Disease Progression|15|||
162743590|NCT04880863|587773125|FG000|Overall Study|Death|3|||
162743591|NCT04880863|587773125|FG000|Overall Study|Physician Decision|4|||
162743592|NCT04880863|587773125|FG000|Overall Study|Unconfirmed Disease Progression|4|||
162743593|NCT04880863|587773125|FG000|Overall Study|Withdrawal by Subject|2|||
162743594|NCT04880863|587773125|FG000|Overall Study|Study discontinuation by the sponsor|4|||
162743595|NCT04880863|587773125|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
162743596|NCT04880863|587773125|FG000|Overall Study|Not received study drug NAP|2|||
162743597|NCT05670587|587773126|FG000|Overall Study|Withdrawal by Subject|3|||
162743598|NCT02305888|587773136|FG000|Overall Study|Lost to Follow-up|0|||
162743599|NCT02305888|587773137|FG001|Overall Study|Lost to Follow-up|0|||
162743600|NCT02305888|587773138|FG002|Overall Study|Lost to Follow-up|1|||
162743601|NCT02305888|587773136|FG000|Overall Study|Adverse Event|0|||
162743602|NCT02305888|587773137|FG001|Overall Study|Adverse Event|1|||
162743603|NCT02305888|587773138|FG002|Overall Study|Adverse Event|0|||
162743604|NCT05139810|587773139|FG000|Overall Study|Voluntary Withdrawal|2|||
162743605|NCT05139810|587773140|FG001|Overall Study|Voluntary Withdrawal|1|||
162743606|NCT05139810|587773141|FG002|Overall Study|Voluntary Withdrawal|0|||
162743607|NCT05139810|587773139|FG000|Overall Study|Pregnancy|1|||
162743608|NCT05139810|587773140|FG001|Overall Study|Pregnancy|0|||
162743609|NCT05139810|587773141|FG002|Overall Study|Pregnancy|0|||
162743610|NCT05139810|587773139|FG000|Overall Study|Roll Over to CS7|19|||
162743611|NCT05139810|587773140|FG001|Overall Study|Roll Over to CS7|44|||
162743612|NCT05139810|587773141|FG002|Overall Study|Roll Over to CS7|20|||
162743613|NCT04068181|587773145|FG000|Overall Study|Death|17|||
162743614|NCT04068181|587773146|FG001|Overall Study|Death|12|||
162743615|NCT04068181|587773147|FG002|Overall Study|Death|4|||
162743616|NCT04068181|587773148|FG003|Overall Study|Death|7|||
162743617|NCT04068181|587773145|FG000|Overall Study|Lost to Follow-up|1|||
162743618|NCT04068181|587773146|FG001|Overall Study|Lost to Follow-up|0|||
162743619|NCT04068181|587773147|FG002|Overall Study|Lost to Follow-up|0|||
162743620|NCT04068181|587773148|FG003|Overall Study|Lost to Follow-up|0|||
162743621|NCT04068181|587773145|FG000|Overall Study|Withdrawal of consent from study|3|||
162743622|NCT04068181|587773146|FG001|Overall Study|Withdrawal of consent from study|0|||
162743623|NCT04068181|587773147|FG002|Overall Study|Withdrawal of consent from study|0|||
162743624|NCT04068181|587773148|FG003|Overall Study|Withdrawal of consent from study|0|||
162743625|NCT03785964|587773149|FG000|Overall Study|Adverse Event|14|||
162743626|NCT03785964|587773150|FG001|Overall Study|Adverse Event|1|||
162743627|NCT03785964|587773149|FG000|Overall Study|Unqualified Clinical Progression|1|||
162743628|NCT03785964|587773150|FG001|Overall Study|Unqualified Clinical Progression|1|||
162743629|NCT03785964|587773149|FG000|Overall Study|Participant non-compliance|1|||
162743630|NCT03785964|587773150|FG001|Overall Study|Participant non-compliance|1|||
162743631|NCT03785964|587773149|FG000|Overall Study|Not treated|1|||
162743632|NCT03785964|587773150|FG001|Overall Study|Not treated|0|||
162743633|NCT03785964|587773149|FG000|Overall Study|Other reason|5|||
162743634|NCT03785964|587773150|FG001|Overall Study|Other reason|11|||
162743635|NCT03785964|587773149|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
162743636|NCT03785964|587773150|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
162743637|NCT03334630|587773151|FG000|Overall Study|Withdrawal by Subject|7|||
162743638|NCT03334630|587773152|FG001|Overall Study|Withdrawal by Subject|7|||
162743639|NCT03334630|587773151|FG000|Overall Study|Lost to Follow-up|3|||
162743640|NCT03334630|587773152|FG001|Overall Study|Lost to Follow-up|1|||
162743641|NCT03334630|587773151|FG000|Overall Study|Adverse Event|0|||
162743642|NCT03334630|587773152|FG001|Overall Study|Adverse Event|1|||
162743643|NCT03334630|587773151|FG000|Overall Study|Physician Decision|1|||
162743644|NCT03334630|587773152|FG001|Overall Study|Physician Decision|1|||
162743645|NCT03334630|587773151|FG000|Overall Study|Enrollment closed|2|||
162743646|NCT03334630|587773152|FG001|Overall Study|Enrollment closed|1|||
162743647|NCT03334630|587773151|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
162743648|NCT03334630|587773152|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
162743649|NCT03334630|587773151|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
162743650|NCT03334630|587773152|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
162743651|NCT04721977|587773161|FG000|Overall Study|Death|15|||
162743652|NCT04721977|587773161|FG000|Overall Study|Ongoing|51|||
162743653|NCT02670525|587773162|FG000|Overall Study|Death|94|||
162743654|NCT02670525|587773163|FG001|Overall Study|Death|14|||
162743655|NCT02670525|587773162|FG000|Overall Study|Lost to Follow-up|4|||
162743656|NCT02670525|587773163|FG001|Overall Study|Lost to Follow-up|1|||
162743657|NCT02670525|587773162|FG000|Overall Study|Subject withdrew consent|1|||
162743658|NCT02670525|587773163|FG001|Overall Study|Subject withdrew consent|0|||
162743659|NCT02670525|587773162|FG000|Overall Study|Unknown, data entry delayed|123|||
162743660|NCT02670525|587773163|FG001|Overall Study|Unknown, data entry delayed|78|||
162743661|NCT04304820|587774331|FG000|Overall Study|Death|1|||
162743662|NCT04304820|587774331|FG000|Overall Study|Lost to Follow-up|1|||
162743663|NCT04304820|587774331|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
162743664|NCT04304820|587774331|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
162743665|NCT04304820|587774331|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
162743666|NCT03873818|587774332|FG000|Overall Study|Death|9|||
162743667|NCT03873818|587774333|FG001|Overall Study|Death|3|||
162743668|NCT03873818|587774332|FG000|Overall Study|Lost to Follow-up|1|||
162743669|NCT03873818|587774333|FG001|Overall Study|Lost to Follow-up|0|||
162743670|NCT03474107|587774334|FG000|Overall Study|Adverse Event|42|||
162743671|NCT03474107|587774335|FG001|Overall Study|Adverse Event|46|||
162743672|NCT03474107|587774334|FG000|Overall Study|Death|2|||
162743673|NCT03474107|587774335|FG001|Overall Study|Death|2|||
162743674|NCT03474107|587774334|FG000|Overall Study|Lost to Follow-up|0|||
162743675|NCT03474107|587774335|FG001|Overall Study|Lost to Follow-up|1|||
162743676|NCT03474107|587774334|FG000|Overall Study|Progressive Disease|177|||
162743677|NCT03474107|587774335|FG001|Overall Study|Progressive Disease|180|||
162743678|NCT03474107|587774334|FG000|Overall Study|Protocol Violation|1|||
162743679|NCT03474107|587774335|FG001|Overall Study|Protocol Violation|1|||
162743680|NCT03474107|587774334|FG000|Overall Study|Withdrawal by Subject|15|||
162743681|NCT03474107|587774335|FG001|Overall Study|Withdrawal by Subject|27|||
162743682|NCT03474107|587774334|FG000|Overall Study|Physician Decision|7|||
162743683|NCT03474107|587774335|FG001|Overall Study|Physician Decision|22|||
162743684|NCT03474107|587774334|FG000|Overall Study|Miscellaneous|1|||
162743685|NCT03474107|587774335|FG001|Overall Study|Miscellaneous|6|||
162743686|NCT05041257|587774336|FG000|Overall Study|Death|37|||
162743687|NCT05041257|587774336|FG000|Overall Study|Lost to Follow-up|3|||
162743688|NCT05041257|587774336|FG000|Overall Study|Sponsor decision|39|||
162743689|NCT03067480|587774337|FG000|Overall Study|Lost to Follow-up|2|||
162743690|NCT03067480|587774338|FG001|Overall Study|Lost to Follow-up|4|||
162743691|NCT03067480|587774337|FG000|Overall Study|started insulin|1|||
162743692|NCT03067480|587774338|FG001|Overall Study|started insulin|1|||
162743693|NCT05782816|587774341|FG000|Overall Study|Withdrawal by Subject|1|||
162743694|NCT05782816|587774342|FG001|Overall Study|Withdrawal by Subject|0|||
162743695|NCT04221490|587774343|FG000|At 30 Days Follow-up|Death|7|||
162743696|NCT04221490|587774343|FG000|At 30 Days Follow-up|Physician Decision|1|||
162743697|NCT04221490|587774343|FG000|At 30 Days Follow-up|Missed Visit|4|||
162743698|NCT04221490|587774343|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
162743699|NCT04221490|587774343|FG000|At 6 Months Follow-up|Death|9|||
162743700|NCT04221490|587774343|FG000|At 6 Months Follow-up|Missed Visit|8|||
162743701|NCT04221490|587774343|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
162743702|NCT04221490|587774343|FG000|At 1 Year Follow-up|Death|7|||
162743703|NCT04221490|587774343|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
162743704|NCT04221490|587774343|FG000|At 1 Year Follow-up|Missed Visit|9|||
162743705|NCT04221490|587774343|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
162743706|NCT04225273|587774348|FG000|Overall Study|Lost to Follow-up|3|||
162743707|NCT04192266|587774349|FG000|Overall Study|Withdrawal by Subject|3|||
162743708|NCT04192266|587774350|FG001|Overall Study|Withdrawal by Subject|2|||
162743709|NCT03240016|587774358|FG000|Overall Study|Adverse Event|9|||
162743710|NCT03240016|587774358|FG000|Overall Study|Withdrawal by Subject|7|||
162743711|NCT03240016|587774358|FG000|Overall Study|Death|1|||
162743712|NCT03240016|587774358|FG000|Overall Study|Physician Decision|2|||
162743713|NCT05200403|587774359|FG000|Overall Study|Withdrawal by Subject|4|||
162743714|NCT05200403|587774360|FG001|Overall Study|Withdrawal by Subject|2|||
162743715|NCT05200403|587774361|FG002|Overall Study|Withdrawal by Subject|6|||
162743716|NCT05546411|587774362|FG000|Overall Study|Progressive Disease|1|||
162743717|NCT05546411|587774363|FG001|Overall Study|Progressive Disease|0|||
162743718|NCT05546411|587774362|FG000|Overall Study|Adverse Event|0|||
162743719|NCT05546411|587774363|FG001|Overall Study|Adverse Event|1|||
162743720|NCT05546411|587774362|FG000|Overall Study|Metastatic disease|1|||
162743721|NCT05546411|587774363|FG001|Overall Study|Metastatic disease|0|||
162743722|NCT02723591|587774370|FG000|Overall Study|Adverse Event|48|||
162743723|NCT02723591|587774371|FG001|Overall Study|Adverse Event|40|||
162743724|NCT02723591|587774370|FG000|Overall Study|Death|2|||
162743725|NCT02723591|587774371|FG001|Overall Study|Death|2|||
162743726|NCT02723591|587774370|FG000|Overall Study|Lack of Efficacy|4|||
162743727|NCT02723591|587774371|FG001|Overall Study|Lack of Efficacy|3|||
162743728|NCT02723591|587774370|FG000|Overall Study|Lost to Follow-up|1|||
162743729|NCT02723591|587774371|FG001|Overall Study|Lost to Follow-up|7|||
162743730|NCT02723591|587774370|FG000|Overall Study|Protocol Violation|20|||
162743731|NCT02723591|587774371|FG001|Overall Study|Protocol Violation|23|||
162743732|NCT02723591|587774370|FG000|Overall Study|Withdrawal by Subject|4|||
162743733|NCT02723591|587774371|FG001|Overall Study|Withdrawal by Subject|8|||
162743734|NCT02723591|587774370|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
162743735|NCT02723591|587774371|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
162743736|NCT02723591|587774370|FG000|Overall Study|Miscellaneous|5|||
162743737|NCT02723591|587774371|FG001|Overall Study|Miscellaneous|6|||
162743738|NCT05070728|587774372|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
162743739|NCT05070728|587774373|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
162743740|NCT05469464|587774376|FG000|Overall Study|Withdrawal by Subject|8|||
162743741|NCT05469464|587774377|FG001|Overall Study|Withdrawal by Subject|7|||
162743742|NCT05469464|587774378|FG002|Overall Study|Withdrawal by Subject|4|||
162743743|NCT05469464|587774379|FG003|Overall Study|Withdrawal by Subject|5|||
162743744|NCT05469464|587774376|FG000|Overall Study|Adverse Event|8|||
162743745|NCT05469464|587774377|FG001|Overall Study|Adverse Event|14|||
162743746|NCT05469464|587774378|FG002|Overall Study|Adverse Event|13|||
162743747|NCT05469464|587774379|FG003|Overall Study|Adverse Event|2|||
162743748|NCT05469464|587774376|FG000|Overall Study|Lost to Follow-up|2|||
162743749|NCT05469464|587774377|FG001|Overall Study|Lost to Follow-up|5|||
162743750|NCT05469464|587774378|FG002|Overall Study|Lost to Follow-up|3|||
162743751|NCT05469464|587774379|FG003|Overall Study|Lost to Follow-up|3|||
162743752|NCT05469464|587774376|FG000|Overall Study|Lack of Efficacy|4|||
162743753|NCT05469464|587774377|FG001|Overall Study|Lack of Efficacy|1|||
162743754|NCT05469464|587774378|FG002|Overall Study|Lack of Efficacy|2|||
162743755|NCT05469464|587774379|FG003|Overall Study|Lack of Efficacy|2|||
162743756|NCT05469464|587774376|FG000|Overall Study|Physician Decision|0|||
162743757|NCT05469464|587774377|FG001|Overall Study|Physician Decision|0|||
162743758|NCT05469464|587774378|FG002|Overall Study|Physician Decision|0|||
162743759|NCT05469464|587774379|FG003|Overall Study|Physician Decision|1|||
162743760|NCT03905798|587774380|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
162743761|NCT05374798|587774381|FG000|Overall Study|Lost to Follow-up|2|||
162743762|NCT05374798|587774381|FG000|Overall Study|Withdrawal by Subject|2|||
162743763|NCT05374798|587774381|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
162743764|NCT04498390|587774383|FG000|Overall Study|Adverse Event|0|||
162743765|NCT04498390|587774384|FG001|Overall Study|Adverse Event|0|||
162743766|NCT04498390|587774385|FG002|Overall Study|Adverse Event|1|||
162743767|NCT04498390|587774386|FG003|Overall Study|Adverse Event|0|||
162743768|NCT04498390|587774387|FG004|Overall Study|Adverse Event|0|||
162743769|NCT04498390|587774383|FG000|Overall Study|Withdrawal by Subject|0|||
162743770|NCT04498390|587774384|FG001|Overall Study|Withdrawal by Subject|0|||
162743771|NCT04498390|587774385|FG002|Overall Study|Withdrawal by Subject|0|||
162743772|NCT04498390|587774386|FG003|Overall Study|Withdrawal by Subject|1|||
162743773|NCT04498390|587774387|FG004|Overall Study|Withdrawal by Subject|0|||
162743774|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
162743775|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
162743776|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
162743777|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
162743778|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
162743779|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
162743780|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
162743781|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Death|0|||
162743782|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Death|2|||
162743783|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Death|0|||
162743784|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Death|0|||
162743785|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Death|0|||
162743786|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Death|0|||
162743787|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Death|0|||
162743788|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
162743789|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743790|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743791|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743792|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743793|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743794|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162743795|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743796|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
162743797|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743798|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743799|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743800|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743801|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162743802|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
162743803|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
162743804|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
162743805|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
162743806|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
162743807|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
162743808|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
162743809|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
162743810|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
162743811|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162743812|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162743813|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162743814|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162743815|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162743816|NCT04585815|587774388|FG000|Sub-study A- Treatment Phase|Other|1|||
162743817|NCT04585815|587774389|FG001|Sub-study A- Treatment Phase|Other|0|||
162743818|NCT04585815|587774390|FG002|Sub-study A- Treatment Phase|Other|0|||
162743819|NCT04585815|587774391|FG003|Sub-study A- Treatment Phase|Other|0|||
162743820|NCT04585815|587774392|FG004|Sub-study A- Treatment Phase|Other|0|||
162743821|NCT04585815|587774393|FG005|Sub-study A- Treatment Phase|Other|0|||
162743822|NCT04585815|587774394|FG006|Sub-study A- Treatment Phase|Other|0|||
162743823|NCT04585815|587774388|FG000|Sub-study A- Follow-up Phase|Death|0|||
162743824|NCT04585815|587774389|FG001|Sub-study A- Follow-up Phase|Death|1|||
162743825|NCT04585815|587774390|FG002|Sub-study A- Follow-up Phase|Death|0|||
162743826|NCT04585815|587774391|FG003|Sub-study A- Follow-up Phase|Death|0|||
162743827|NCT04585815|587774392|FG004|Sub-study A- Follow-up Phase|Death|0|||
162743828|NCT04585815|587774393|FG005|Sub-study A- Follow-up Phase|Death|0|||
162743829|NCT04585815|587774394|FG006|Sub-study A- Follow-up Phase|Death|0|||
162743830|NCT04585815|587774388|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
162743831|NCT04585815|587774389|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
162743832|NCT04585815|587774390|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162743833|NCT04585815|587774391|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162743834|NCT04585815|587774392|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162743835|NCT04585815|587774393|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162743836|NCT04585815|587774394|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162743837|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
162743838|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
162743839|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
162743840|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
162743841|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
162743842|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
162743843|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
162743844|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Death|0|||
162743845|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Death|0|||
162743846|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Death|0|||
162743847|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Death|1|||
162743848|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Death|0|||
162743849|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Death|0|||
162743850|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Death|0|||
162743851|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
162743852|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
162743853|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
162743854|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
162743855|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
162743856|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
162743857|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
162743858|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162743859|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162743860|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162743861|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
162743862|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162743863|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
162743864|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162743865|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743866|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743867|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743868|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
162743869|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743870|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743871|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162743872|NCT04585815|587774388|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
162743873|NCT04585815|587774389|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
162743874|NCT04585815|587774390|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
162743875|NCT04585815|587774391|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
162743876|NCT04585815|587774392|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
162743877|NCT04585815|587774393|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
162743878|NCT04585815|587774394|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
162743879|NCT04585815|587774388|FG000|Sub-study B- Follow-up Phase|Death|0|||
162743880|NCT04585815|587774389|FG001|Sub-study B- Follow-up Phase|Death|0|||
162743881|NCT04585815|587774390|FG002|Sub-study B- Follow-up Phase|Death|1|||
162743882|NCT04585815|587774391|FG003|Sub-study B- Follow-up Phase|Death|3|||
162743883|NCT04585815|587774392|FG004|Sub-study B- Follow-up Phase|Death|1|||
162743884|NCT04585815|587774393|FG005|Sub-study B- Follow-up Phase|Death|0|||
162743885|NCT04585815|587774394|FG006|Sub-study B- Follow-up Phase|Death|3|||
162743886|NCT04585815|587774388|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743887|NCT04585815|587774389|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743888|NCT04585815|587774390|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743889|NCT04585815|587774391|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743890|NCT04585815|587774392|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743891|NCT04585815|587774393|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
162743892|NCT04585815|587774394|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162743893|NCT01854775|587774395|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
162743894|NCT01854775|587774396|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
162743895|NCT01854775|587774397|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
162743896|NCT01854775|587774395|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
162743897|NCT01854775|587774396|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
162743898|NCT01854775|587774397|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
162743899|NCT01854775|587774395|FG000|Extension Phase|Pregnancy|1|||
162743900|NCT01854775|587774396|FG001|Extension Phase|Pregnancy|0|||
162743901|NCT01854775|587774397|FG002|Extension Phase|Pregnancy|0|||
162743902|NCT01854775|587774395|FG000|Extension Phase|Investigator's Discretion|1|||
162743903|NCT01854775|587774396|FG001|Extension Phase|Investigator's Discretion|0|||
162743904|NCT01854775|587774397|FG002|Extension Phase|Investigator's Discretion|0|||
162743905|NCT01854775|587774395|FG000|Extension Phase|Non-Compliance with study drug|1|||
162743906|NCT01854775|587774396|FG001|Extension Phase|Non-Compliance with study drug|0|||
162743907|NCT01854775|587774397|FG002|Extension Phase|Non-Compliance with study drug|0|||
162743908|NCT01854775|587774395|FG000|Extension Phase|Lost to Follow-up|1|||
162743909|NCT01854775|587774396|FG001|Extension Phase|Lost to Follow-up|0|||
162743910|NCT01854775|587774397|FG002|Extension Phase|Lost to Follow-up|0|||
162743911|NCT01854775|587774395|FG000|Extension Phase|Withdrew consent|0|||
162743912|NCT01854775|587774396|FG001|Extension Phase|Withdrew consent|1|||
162743913|NCT01854775|587774397|FG002|Extension Phase|Withdrew consent|0|||
162743914|NCT04068311|587774398|FG000|Overall Study|Death|3|||
162743915|NCT04068311|587774399|FG001|Overall Study|Death|3|||
162743916|NCT04068311|587774398|FG000|Overall Study|Lost to Follow-up|24|||
162743917|NCT04068311|587774399|FG001|Overall Study|Lost to Follow-up|68|||
162743918|NCT04068311|587774398|FG000|Overall Study|Withdrawal by Subject|5|||
162743919|NCT04068311|587774399|FG001|Overall Study|Withdrawal by Subject|0|||
162743920|NCT02068885|587774400|FG000|Overall Study|Withdrew|3|||
162743921|NCT02068885|587774401|FG001|Overall Study|Withdrew|5|||
162743922|NCT02068885|587774402|FG002|Overall Study|Withdrew|8|||
162743923|NCT03100149|587774405|FG000|Overall Study|Adverse Event|0|||
162743924|NCT03100149|587774406|FG001|Overall Study|Adverse Event|1|||
162743925|NCT03100149|587774407|FG002|Overall Study|Adverse Event|0|||
162743926|NCT03100149|587774405|FG000|Overall Study|Participant Moved out of Country|0|||
162743927|NCT03100149|587774406|FG001|Overall Study|Participant Moved out of Country|0|||
162743928|NCT03100149|587774407|FG002|Overall Study|Participant Moved out of Country|1|||
162743929|NCT03100149|587774405|FG000|Overall Study|Withdrawal by Subject|0|||
162743930|NCT03100149|587774406|FG001|Overall Study|Withdrawal by Subject|3|||
162743931|NCT03100149|587774407|FG002|Overall Study|Withdrawal by Subject|1|||
162743932|NCT03697876|587774408|FG000|Overall Study|Lost to Follow-up|0|||
162743933|NCT03697876|587774409|FG001|Overall Study|Lost to Follow-up|1|||
162743934|NCT03697876|587774408|FG000|Overall Study|Adverse Event|1|||
162743935|NCT03697876|587774409|FG001|Overall Study|Adverse Event|0|||
162743936|NCT05171855|587775875|FG000|Overall Study|Death|1|||
162743937|NCT05171855|587775876|FG001|Overall Study|Death|0|||
162743938|NCT05171855|587775877|FG002|Overall Study|Death|0|||
162743939|NCT05171855|587775875|FG000|Overall Study|Withdrawal by Subject|2|||
162743940|NCT05171855|587775876|FG001|Overall Study|Withdrawal by Subject|0|||
162743941|NCT05171855|587775877|FG002|Overall Study|Withdrawal by Subject|5|||
162743942|NCT05171855|587775875|FG000|Overall Study|Physician Decision|1|||
162743943|NCT05171855|587775876|FG001|Overall Study|Physician Decision|0|||
162743944|NCT05171855|587775877|FG002|Overall Study|Physician Decision|0|||
162743945|NCT05171855|587775875|FG000|Overall Study|Adverse Event|2|||
162743946|NCT05171855|587775876|FG001|Overall Study|Adverse Event|4|||
162743947|NCT05171855|587775877|FG002|Overall Study|Adverse Event|2|||
162743948|NCT05171855|587775875|FG000|Overall Study|Other|0|||
162743949|NCT05171855|587775876|FG001|Overall Study|Other|0|||
162743950|NCT05171855|587775877|FG002|Overall Study|Other|1|||
162743951|NCT02442349|587775880|FG000|Overall Study|Death|95|||
162743952|NCT02442349|587775880|FG000|Overall Study|Withdrawal by Subject|27|||
162743953|NCT02442349|587775880|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
162743954|NCT02442349|587775880|FG000|Overall Study|Lost to Follow-up|1|||
162743955|NCT03748953|587775884|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
162743956|NCT03748953|587775885|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
162743957|NCT03748953|587775884|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
162743958|NCT03748953|587775885|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
162743959|NCT03748953|587775884|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
162743960|NCT03748953|587775885|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
162743961|NCT03748953|587775884|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
162743962|NCT03748953|587775885|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
162743963|NCT03748953|587775884|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
162743964|NCT03748953|587775885|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
162743965|NCT02296125|587775886|FG000|Overall Study|Withdrawal by Subject|18|||
162743966|NCT02296125|587775887|FG001|Overall Study|Withdrawal by Subject|8|||
162743967|NCT02296125|587775888|FG002|Overall Study|Withdrawal by Subject|6|||
162743968|NCT02296125|587775889|FG003|Overall Study|Withdrawal by Subject|2|||
162743969|NCT02296125|587775886|FG000|Overall Study|Adverse Event|41|||
162743970|NCT02296125|587775887|FG001|Overall Study|Adverse Event|52|||
162743971|NCT02296125|587775888|FG002|Overall Study|Adverse Event|9|||
162743972|NCT02296125|587775889|FG003|Overall Study|Adverse Event|4|||
162743973|NCT02296125|587775886|FG000|Overall Study|Severe non-compliance to protocol|0|||
162743974|NCT02296125|587775887|FG001|Overall Study|Severe non-compliance to protocol|1|||
162743975|NCT02296125|587775888|FG002|Overall Study|Severe non-compliance to protocol|0|||
162743976|NCT02296125|587775889|FG003|Overall Study|Severe non-compliance to protocol|0|||
162743977|NCT02296125|587775886|FG000|Overall Study|Condition under investigation worsened|153|||
162743978|NCT02296125|587775887|FG001|Overall Study|Condition under investigation worsened|199|||
162743979|NCT02296125|587775888|FG002|Overall Study|Condition under investigation worsened|39|||
162743980|NCT02296125|587775889|FG003|Overall Study|Condition under investigation worsened|56|||
162743981|NCT02296125|587775886|FG000|Overall Study|Any reason not specifically recorded|6|||
162743982|NCT02296125|587775887|FG001|Overall Study|Any reason not specifically recorded|4|||
162743983|NCT02296125|587775888|FG002|Overall Study|Any reason not specifically recorded|2|||
162743984|NCT02296125|587775889|FG003|Overall Study|Any reason not specifically recorded|0|||
162743985|NCT02998268|587775890|FG000|Overall Study|Adverse Event|0|||
162743986|NCT02998268|587775891|FG001|Overall Study|Adverse Event|2|||
162743987|NCT02998268|587775890|FG000|Overall Study|Withdrawal by Subject|0|||
162743988|NCT02998268|587775891|FG001|Overall Study|Withdrawal by Subject|1|||
162743989|NCT01501955|587775892|FG000|Overall Study|Withdrawal by Subject|1|||
162743990|NCT01501955|587775893|FG001|Overall Study|Withdrawal by Subject|0|||
162743991|NCT01501955|587775892|FG000|Overall Study|Adverse Event|1|||
162743992|NCT01501955|587775893|FG001|Overall Study|Adverse Event|3|||
162743993|NCT04298983|587775894|FG000|Overall Study|Adverse Event|4|||
162743994|NCT04298983|587775894|FG000|Overall Study|Lack of Efficacy|3|||
162743995|NCT02927236|587775895|FG000|Characterization Phase|Physician Decision|0|||
162743996|NCT02927236|587775896|FG001|Characterization Phase|Physician Decision|3|||
162743997|NCT02927236|587775897|FG002|Characterization Phase|Physician Decision|0|||
162743998|NCT02927236|587775898|FG003|Characterization Phase|Physician Decision|2|||
162743999|NCT02927236|587775895|FG000|Characterization Phase|Lost to Follow-up|0|||
162744000|NCT02927236|587775896|FG001|Characterization Phase|Lost to Follow-up|0|||
162744001|NCT02927236|587775897|FG002|Characterization Phase|Lost to Follow-up|0|||
162744002|NCT02927236|587775898|FG003|Characterization Phase|Lost to Follow-up|3|||
162744003|NCT02927236|587775895|FG000|Characterization Phase|Withdrawal by Subject|1|||
162744004|NCT02927236|587775896|FG001|Characterization Phase|Withdrawal by Subject|0|||
162744005|NCT02927236|587775897|FG002|Characterization Phase|Withdrawal by Subject|0|||
162744006|NCT02927236|587775898|FG003|Characterization Phase|Withdrawal by Subject|1|||
162744007|NCT02927236|587775895|FG000|Treatment Phase|Adverse Event|1|||
162744008|NCT02927236|587775896|FG001|Treatment Phase|Adverse Event|0|||
162744009|NCT02927236|587775897|FG002|Treatment Phase|Adverse Event|1|||
162744010|NCT02927236|587775898|FG003|Treatment Phase|Adverse Event|1|||
162744011|NCT02927236|587775895|FG000|Treatment Phase|Protocol Violation|3|||
162744012|NCT02927236|587775896|FG001|Treatment Phase|Protocol Violation|0|||
162744013|NCT02927236|587775897|FG002|Treatment Phase|Protocol Violation|0|||
162744014|NCT02927236|587775898|FG003|Treatment Phase|Protocol Violation|1|||
162744015|NCT02927236|587775895|FG000|Treatment Phase|Lost to Follow-up|1|||
162744016|NCT02927236|587775896|FG001|Treatment Phase|Lost to Follow-up|0|||
162744017|NCT02927236|587775897|FG002|Treatment Phase|Lost to Follow-up|0|||
162744018|NCT02927236|587775898|FG003|Treatment Phase|Lost to Follow-up|0|||
162744019|NCT02927236|587775895|FG000|Follow-up Phase|Lost to Follow-up|1|||
162744020|NCT02927236|587775896|FG001|Follow-up Phase|Lost to Follow-up|0|||
162744021|NCT02927236|587775897|FG002|Follow-up Phase|Lost to Follow-up|1|||
162744022|NCT02927236|587775898|FG003|Follow-up Phase|Lost to Follow-up|0|||
162744023|NCT05477186|587775899|FG000|Overall Study|Vaccine not administered|0|||
162744024|NCT05477186|587775900|FG001|Overall Study|Vaccine not administered|2|||
162744025|NCT05477186|587775901|FG002|Overall Study|Vaccine not administered|1|||
162744026|NCT05477186|587775902|FG003|Overall Study|Vaccine not administered|0|||
162744027|NCT05477186|587775903|FG004|Overall Study|Vaccine not administered|1|||
162744028|NCT05477186|587775904|FG005|Overall Study|Vaccine not administered|0|||
162744029|NCT05477186|587775905|FG006|Overall Study|Vaccine not administered|0|||
162744030|NCT05477186|587775899|FG000|Overall Study|Withdrawal by Subject|1|||
162744031|NCT05477186|587775900|FG001|Overall Study|Withdrawal by Subject|0|||
162744032|NCT05477186|587775901|FG002|Overall Study|Withdrawal by Subject|0|||
162744033|NCT05477186|587775902|FG003|Overall Study|Withdrawal by Subject|0|||
162744034|NCT05477186|587775903|FG004|Overall Study|Withdrawal by Subject|0|||
162744035|NCT05477186|587775904|FG005|Overall Study|Withdrawal by Subject|1|||
162744036|NCT05477186|587775905|FG006|Overall Study|Withdrawal by Subject|0|||
162744037|NCT05477186|587775899|FG000|Overall Study|Lost to Follow-up|1|||
162744038|NCT05477186|587775900|FG001|Overall Study|Lost to Follow-up|0|||
162744039|NCT05477186|587775901|FG002|Overall Study|Lost to Follow-up|2|||
162744040|NCT05477186|587775902|FG003|Overall Study|Lost to Follow-up|1|||
162744041|NCT05477186|587775903|FG004|Overall Study|Lost to Follow-up|1|||
162744042|NCT05477186|587775904|FG005|Overall Study|Lost to Follow-up|0|||
162744043|NCT05477186|587775905|FG006|Overall Study|Lost to Follow-up|2|||
162744044|NCT01919554|587775907|FG000|Overall Study|Withdrawal by Subject|0|||
162744045|NCT01919554|587775908|FG001|Overall Study|Withdrawal by Subject|0|||
162744046|NCT01919554|587775909|FG002|Overall Study|Withdrawal by Subject|1|||
162744047|NCT01919554|587775910|FG003|Overall Study|Withdrawal by Subject|1|||
162744048|NCT01733316|587775911|FG000|RP103 Phase|Non-compliance|1|||
162744049|NCT01733316|587775911|FG000|Long Term Extension Phase|Adverse Event|1|||
162744050|NCT01733316|587775911|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
162744051|NCT01733316|587775911|FG000|Long Term Extension Phase|Sponsor Decision|2|||
162744052|NCT02838420|587775912|FG000|Overall Study|Ongoing in Study|113|||
162744053|NCT02838420|587775913|FG001|Overall Study|Ongoing in Study|45|||
162744054|NCT02838420|587775912|FG000|Overall Study|Lost to Follow-up|1|||
162744055|NCT02838420|587775913|FG001|Overall Study|Lost to Follow-up|0|||
162744056|NCT02838420|587775912|FG000|Overall Study|Withdrawal by Subject|3|||
162744057|NCT02838420|587775913|FG001|Overall Study|Withdrawal by Subject|4|||
162744058|NCT02838420|587775912|FG000|Overall Study|Death|8|||
162744059|NCT02838420|587775913|FG001|Overall Study|Death|13|||
162744060|NCT03024437|587775914|FG000|Overall Study|Adverse Event|0|||
162744061|NCT03024437|587775915|FG001|Overall Study|Adverse Event|1|||
162744062|NCT03024437|587775916|FG002|Overall Study|Adverse Event|3|||
162744063|NCT03024437|587775917|FG003|Overall Study|Adverse Event|5|||
162744064|NCT03024437|587775918|FG004|Overall Study|Adverse Event|0|||
162744065|NCT03024437|587775914|FG000|Overall Study|Physician Decision|1|||
162744066|NCT03024437|587775915|FG001|Overall Study|Physician Decision|0|||
162744067|NCT03024437|587775916|FG002|Overall Study|Physician Decision|0|||
162744068|NCT03024437|587775917|FG003|Overall Study|Physician Decision|1|||
162744069|NCT03024437|587775918|FG004|Overall Study|Physician Decision|0|||
162744070|NCT03024437|587775914|FG000|Overall Study|Disease progression, relapse|1|||
162744071|NCT03024437|587775915|FG001|Overall Study|Disease progression, relapse|0|||
162744072|NCT03024437|587775916|FG002|Overall Study|Disease progression, relapse|0|||
162744073|NCT03024437|587775917|FG003|Overall Study|Disease progression, relapse|3|||
162744074|NCT03024437|587775918|FG004|Overall Study|Disease progression, relapse|0|||
162744075|NCT03024437|587775914|FG000|Overall Study|Disease progression, refractory disease|4|||
162744076|NCT03024437|587775915|FG001|Overall Study|Disease progression, refractory disease|4|||
162744077|NCT03024437|587775916|FG002|Overall Study|Disease progression, refractory disease|2|||
162744078|NCT03024437|587775917|FG003|Overall Study|Disease progression, refractory disease|2|||
162744079|NCT03024437|587775918|FG004|Overall Study|Disease progression, refractory disease|1|||
162744080|NCT03024437|587775914|FG000|Overall Study|Newly diagnosed cancer|0|||
162744081|NCT03024437|587775915|FG001|Overall Study|Newly diagnosed cancer|0|||
162744082|NCT03024437|587775916|FG002|Overall Study|Newly diagnosed cancer|0|||
162744083|NCT03024437|587775917|FG003|Overall Study|Newly diagnosed cancer|1|||
162744084|NCT03024437|587775918|FG004|Overall Study|Newly diagnosed cancer|0|||
162744085|NCT03024437|587775914|FG000|Overall Study|Moved out of state|0|||
162744086|NCT03024437|587775915|FG001|Overall Study|Moved out of state|1|||
162744087|NCT03024437|587775916|FG002|Overall Study|Moved out of state|0|||
162744088|NCT03024437|587775917|FG003|Overall Study|Moved out of state|0|||
162744089|NCT03024437|587775918|FG004|Overall Study|Moved out of state|0|||
162744090|NCT03024437|587775914|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162744091|NCT03024437|587775915|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162744092|NCT03024437|587775916|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
162744093|NCT03024437|587775917|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162744094|NCT03024437|587775918|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162744095|NCT02606422|587775919|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
162744096|NCT02606422|587775920|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
162744097|NCT02606422|587775919|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
162744098|NCT02606422|587775920|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
162744099|NCT02606422|587775919|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
162744100|NCT02606422|587775920|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
162744101|NCT02606422|587775919|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
162744102|NCT02606422|587775920|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
162744103|NCT04625465|587775921|FG000|Overall Study|Lost to Follow-up|2|||
162744104|NCT04625465|587775922|FG001|Overall Study|Lost to Follow-up|2|||
162744105|NCT04625465|587775923|FG002|Overall Study|Lost to Follow-up|1|||
162744106|NCT04625465|587775924|FG003|Overall Study|Lost to Follow-up|0|||
162744107|NCT04625465|587775925|FG004|Overall Study|Lost to Follow-up|0|||
162744108|NCT04625465|587775926|FG005|Overall Study|Lost to Follow-up|2|||
162744109|NCT04625465|587775927|FG006|Overall Study|Lost to Follow-up|0|||
162744110|NCT04625465|587775928|FG007|Overall Study|Lost to Follow-up|0|||
162744111|NCT04625465|587775921|FG000|Overall Study|Death|1|||
162744112|NCT04625465|587775922|FG001|Overall Study|Death|0|||
162744113|NCT04625465|587775923|FG002|Overall Study|Death|0|||
162744114|NCT04625465|587775924|FG003|Overall Study|Death|0|||
162744115|NCT04625465|587775925|FG004|Overall Study|Death|0|||
162744116|NCT04625465|587775926|FG005|Overall Study|Death|0|||
162744117|NCT04625465|587775927|FG006|Overall Study|Death|0|||
162744118|NCT04625465|587775928|FG007|Overall Study|Death|0|||
162744119|NCT04625465|587775921|FG000|Overall Study|Withdrawal by Subject|1|||
162744120|NCT04625465|587775922|FG001|Overall Study|Withdrawal by Subject|0|||
162744121|NCT04625465|587775923|FG002|Overall Study|Withdrawal by Subject|4|||
162744122|NCT04625465|587775924|FG003|Overall Study|Withdrawal by Subject|4|||
162744123|NCT04625465|587775925|FG004|Overall Study|Withdrawal by Subject|4|||
162744124|NCT04625465|587775926|FG005|Overall Study|Withdrawal by Subject|0|||
162744125|NCT04625465|587775927|FG006|Overall Study|Withdrawal by Subject|0|||
162744126|NCT04625465|587775928|FG007|Overall Study|Withdrawal by Subject|0|||
162744127|NCT05566639|587775932|FG000|Overall Study|Adverse Event|1|||
162744128|NCT05566639|587775933|FG001|Overall Study|Adverse Event|1|||
162744129|NCT05566639|587775932|FG000|Overall Study|Serious Adverse Event|1|||
162744130|NCT05566639|587775933|FG001|Overall Study|Serious Adverse Event|3|||
162744131|NCT05566639|587775932|FG000|Overall Study|Death|44|||
162744132|NCT05566639|587775933|FG001|Overall Study|Death|45|||
162744133|NCT05566639|587775932|FG000|Overall Study|Lost to Follow-up|467|||
162744134|NCT05566639|587775933|FG001|Overall Study|Lost to Follow-up|461|||
162744135|NCT05566639|587775932|FG000|Overall Study|Physician Decision|45|||
162744136|NCT05566639|587775933|FG001|Overall Study|Physician Decision|44|||
162744137|NCT05566639|587775932|FG000|Overall Study|Protocol Deviation|4|||
162744138|NCT05566639|587775933|FG001|Overall Study|Protocol Deviation|4|||
162744139|NCT05566639|587775932|FG000|Overall Study|Withdrawal by Subject|277|||
162744140|NCT05566639|587775933|FG001|Overall Study|Withdrawal by Subject|271|||
162744141|NCT05566639|587775932|FG000|Overall Study|Other Than Specified|52|||
162744142|NCT05566639|587775933|FG001|Overall Study|Other Than Specified|64|||
162744143|NCT04054193|587775941|FG000|Cycle 1|Physician Decision|1|||
162744144|NCT04054193|587775941|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
162744145|NCT04054193|587775941|FG000|Cycle 1|Allocated but not treated|3|||
162744146|NCT04054193|587775941|FG000|Cycles 2-3|Physician Decision|2|||
162744147|NCT04054193|587775941|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
162744148|NCT04054193|587775941|FG000|Cycles 2-3|Various reasons|17|||
162744149|NCT02966873|587775942|FG000|Overall Study|Lost to Follow-up|16|||
162744150|NCT02966873|587775943|FG001|Overall Study|Lost to Follow-up|15|||
162744151|NCT03235544|587775945|FG000|Overall Study|Death|11|||
162744152|NCT03235544|587775946|FG001|Overall Study|Death|31|||
162744153|NCT03235544|587775947|FG002|Overall Study|Death|19|||
162744154|NCT03235544|587775948|FG003|Overall Study|Death|34|||
162744155|NCT03235544|587775945|FG000|Overall Study|Lost to Follow-up|0|||
162744156|NCT03235544|587775946|FG001|Overall Study|Lost to Follow-up|1|||
162744157|NCT03235544|587775947|FG002|Overall Study|Lost to Follow-up|1|||
162744158|NCT03235544|587775948|FG003|Overall Study|Lost to Follow-up|1|||
162744159|NCT03235544|587775945|FG000|Overall Study|Withdrawal by Subject|0|||
162744160|NCT03235544|587775946|FG001|Overall Study|Withdrawal by Subject|3|||
162744161|NCT03235544|587775947|FG002|Overall Study|Withdrawal by Subject|1|||
162744162|NCT03235544|587775948|FG003|Overall Study|Withdrawal by Subject|5|||
162744163|NCT03235544|587775945|FG000|Overall Study|Disease Progression|0|||
162744164|NCT03235544|587775946|FG001|Overall Study|Disease Progression|1|||
162744165|NCT03235544|587775947|FG002|Overall Study|Disease Progression|0|||
162744166|NCT03235544|587775948|FG003|Overall Study|Disease Progression|2|||
162744167|NCT03235544|587775945|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
162744168|NCT03235544|587775946|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
162744169|NCT03235544|587775947|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
162744170|NCT03235544|587775948|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
162744171|NCT03235544|587775945|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162744172|NCT03235544|587775946|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162744173|NCT03235544|587775947|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162744174|NCT03235544|587775948|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
162744175|NCT00950742|587775949|FG000|Overall Study|Other Adverse Event|1|||
162744176|NCT00950742|587775950|FG001|Overall Study|Other Adverse Event|0|||
162744177|NCT00950742|587775949|FG000|Overall Study|Withdrawal by Subject|3|||
162744178|NCT00950742|587775950|FG001|Overall Study|Withdrawal by Subject|0|||
162744179|NCT00950742|587775949|FG000|Overall Study|Progressive Disease|6|||
162744180|NCT00950742|587775950|FG001|Overall Study|Progressive Disease|2|||
162744181|NCT00950742|587775949|FG000|Overall Study|Dose limiting toxicity|6|||
162744182|NCT00950742|587775950|FG001|Overall Study|Dose limiting toxicity|0|||
162744183|NCT05436262|587775952|FG000|Pre-Randomization|Withdrawal by Subject|1|||
162744184|NCT05436262|587775953|FG001|Pre-Randomization|Withdrawal by Subject|0|||
162744185|NCT05436262|587775954|FG002|Pre-Randomization|Withdrawal by Subject|0|||
162744186|NCT05436262|587775952|FG000|Randomization|Withdrawal by Subject|0|||
162744187|NCT05436262|587775953|FG001|Randomization|Withdrawal by Subject|1|||
162744188|NCT05436262|587775954|FG002|Randomization|Withdrawal by Subject|0|||
162744189|NCT05299073|587775955|FG000|Overall Study|Withdrawal by Subject|0|||
162744190|NCT05299073|587775956|FG001|Overall Study|Withdrawal by Subject|0|||
162744191|NCT05299073|587775957|FG002|Overall Study|Withdrawal by Subject|1|||
162744192|NCT05299073|587775955|FG000|Overall Study|Adverse Event|0|||
162744193|NCT05299073|587775956|FG001|Overall Study|Adverse Event|1|||
162744194|NCT05299073|587775957|FG002|Overall Study|Adverse Event|0|||
162744195|NCT05299073|587775955|FG000|Overall Study|Lost to Follow-up|0|||
162744196|NCT05299073|587775956|FG001|Overall Study|Lost to Follow-up|1|||
162744197|NCT05299073|587775957|FG002|Overall Study|Lost to Follow-up|0|||
162744198|NCT03952338|587775958|FG000|Overall Study|Lost to Follow-up|11|||
162744199|NCT03952338|587775959|FG001|Overall Study|Lost to Follow-up|17|||
162744200|NCT03952338|587775958|FG000|Overall Study|Withdrawal by Subject|1|||
162744201|NCT03952338|587775959|FG001|Overall Study|Withdrawal by Subject|1|||
162744202|NCT03952338|587775958|FG000|Overall Study|Protocol Violation|1|||
162744203|NCT03952338|587775959|FG001|Overall Study|Protocol Violation|0|||
162744204|NCT01456949|587775960|FG000|Enrollment|PI death- incomplete data|6|||
162744205|NCT01456949|587775960|FG000|Enrollment|Death|1|||
162744206|NCT01456949|587775960|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
162744207|NCT01456949|587775960|FG000|Enrollment|Physician Decision|10|||
162744208|NCT01456949|587775960|FG000|Enrollment|Withdrawal by Subject|7|||
162744209|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
162744210|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
162744211|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
162744212|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
162744213|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
162744214|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
162744215|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
162744216|NCT01456949|587775960|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
162744217|NCT04753697|587775961|FG000|Induction Phase|Withdrawal by Subject|12|||
162744218|NCT04753697|587775962|FG001|Induction Phase|Withdrawal by Subject|5|||
162744219|NCT04753697|587775963|FG002|Induction Phase|Withdrawal by Subject|6|||
162744220|NCT04753697|587775961|FG000|Induction Phase|Physician Decision|1|||
162744221|NCT04753697|587775962|FG001|Induction Phase|Physician Decision|0|||
162744222|NCT04753697|587775963|FG002|Induction Phase|Physician Decision|0|||
162744223|NCT04753697|587775961|FG000|Induction Phase|Lost to Follow-up|2|||
162744224|NCT04753697|587775962|FG001|Induction Phase|Lost to Follow-up|2|||
162744225|NCT04753697|587775963|FG002|Induction Phase|Lost to Follow-up|1|||
162744226|NCT04753697|587775961|FG000|Induction Phase|Lack of Efficacy|1|||
162744227|NCT04753697|587775962|FG001|Induction Phase|Lack of Efficacy|0|||
162744228|NCT04753697|587775963|FG002|Induction Phase|Lack of Efficacy|0|||
162744229|NCT04753697|587775961|FG000|Maintenance Phase|Physician Decision|0|||
162744230|NCT04753697|587775962|FG001|Maintenance Phase|Physician Decision|0|||
162744231|NCT04753697|587775963|FG002|Maintenance Phase|Physician Decision|1|||
162744232|NCT04753697|587775961|FG000|Maintenance Phase|Withdrawal by Subject|3|||
162744233|NCT04753697|587775962|FG001|Maintenance Phase|Withdrawal by Subject|4|||
162744234|NCT04753697|587775963|FG002|Maintenance Phase|Withdrawal by Subject|6|||
162744235|NCT04753697|587775961|FG000|Maintenance Phase|Lost to Follow-up|2|||
162744236|NCT04753697|587775962|FG001|Maintenance Phase|Lost to Follow-up|2|||
162744237|NCT04753697|587775963|FG002|Maintenance Phase|Lost to Follow-up|0|||
162744238|NCT04753697|587775961|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
162744239|NCT04753697|587775962|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
162744240|NCT04753697|587775963|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
162744241|NCT04753697|587775961|FG000|Maintenance Phase|Adverse Event|0|||
162744242|NCT04753697|587775962|FG001|Maintenance Phase|Adverse Event|1|||
162744243|NCT04753697|587775963|FG002|Maintenance Phase|Adverse Event|1|||
162744244|NCT04753697|587775961|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
162744245|NCT04753697|587775962|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162744246|NCT04753697|587775963|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162744247|NCT04200456|587775966|FG000|Overall Study|Physician Decision|0|||
162744248|NCT04200456|587775967|FG001|Overall Study|Physician Decision|1|||
162744249|NCT04200456|587775966|FG000|Overall Study|Withdrawal by Subject|2|||
162744250|NCT04200456|587775967|FG001|Overall Study|Withdrawal by Subject|2|||
162744251|NCT04200456|587775966|FG000|Overall Study|Lack of Efficacy|1|||
162744252|NCT04200456|587775967|FG001|Overall Study|Lack of Efficacy|1|||
162744253|NCT04200456|587775966|FG000|Overall Study|Adverse event, non-fatal|0|||
162744254|NCT04200456|587775967|FG001|Overall Study|Adverse event, non-fatal|1|||
162744255|NCT04200456|587775966|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
162744256|NCT04200456|587775967|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
162744257|NCT00592852|587775968|FG000|Overall Study|Non-compliance|1|||
162744258|NCT00592852|587775968|FG000|Overall Study|Adverse Event|3|||
162744259|NCT00592852|587775968|FG000|Overall Study|Found ineligible|1|||
162744260|NCT00592852|587775968|FG000|Overall Study|Withdrawal by Subject|1|||
162744261|NCT05002088|587775970|FG000|Overall Study|Withdrawal by Subject|9|||
162744262|NCT05002088|587775971|FG001|Overall Study|Withdrawal by Subject|0|||
162744263|NCT05002088|587775970|FG000|Overall Study|Lost to Follow-up|0|||
162744264|NCT05002088|587775971|FG001|Overall Study|Lost to Follow-up|1|||
162744265|NCT05002088|587775970|FG000|Overall Study|Death|16|||
162744266|NCT05002088|587775971|FG001|Overall Study|Death|2|||
162744267|NCT05002088|587775970|FG000|Overall Study|Protocol Violation|25|||
162744268|NCT05002088|587775971|FG001|Overall Study|Protocol Violation|7|||
162744269|NCT04770402|587775972|FG000|Overall Study|Lost to Follow-up|1|||
162744270|NCT04770402|587775973|FG001|Overall Study|Lost to Follow-up|2|||
162744271|NCT04770402|587775972|FG000|Overall Study|Non-compliance|1|||
162744272|NCT04770402|587775973|FG001|Overall Study|Non-compliance|0|||
162744273|NCT04770402|587775972|FG000|Overall Study|Withdrawal by Subject|0|||
162744274|NCT04770402|587775973|FG001|Overall Study|Withdrawal by Subject|1|||
162744275|NCT03599661|587775974|FG000|Overall Study|Lost to Follow-up|9|||
162744276|NCT04811040|587775975|FG000|Overall Study|Lost to Follow-up|2|||
162744277|NCT04811040|587775976|FG001|Overall Study|Lost to Follow-up|0|||
162744278|NCT04811040|587775977|FG002|Overall Study|Lost to Follow-up|0|||
162744279|NCT04811040|587775978|FG003|Overall Study|Lost to Follow-up|0|||
162744280|NCT04811040|587775975|FG000|Overall Study|Withdrew consent|1|||
162744281|NCT04811040|587775976|FG001|Overall Study|Withdrew consent|1|||
162744282|NCT04811040|587775977|FG002|Overall Study|Withdrew consent|0|||
162744283|NCT04811040|587775978|FG003|Overall Study|Withdrew consent|0|||
162744284|NCT05446168|587775979|FG000|Overall Study|Physician Decision|0|||
162744285|NCT05446168|587775980|FG001|Overall Study|Physician Decision|1|||
162744286|NCT01828099|587775981|FG000|Treatment Period|Adverse Event|24|||
162744287|NCT01828099|587775982|FG001|Treatment Period|Adverse Event|23|||
162744288|NCT01828099|587775981|FG000|Treatment Period|Death|10|||
162744289|NCT01828099|587775982|FG001|Treatment Period|Death|12|||
162744290|NCT01828099|587775981|FG000|Treatment Period|Lost to Follow-up|2|||
162744291|NCT01828099|587775982|FG001|Treatment Period|Lost to Follow-up|1|||
162744292|NCT01828099|587775981|FG000|Treatment Period|Non-compliance with study treatment|1|||
162744293|NCT01828099|587775982|FG001|Treatment Period|Non-compliance with study treatment|0|||
162744294|NCT01828099|587775981|FG000|Treatment Period|Physician Decision|17|||
162744295|NCT01828099|587775982|FG001|Treatment Period|Physician Decision|16|||
162744296|NCT01828099|587775981|FG000|Treatment Period|Progressive disease|99|||
162744297|NCT01828099|587775982|FG001|Treatment Period|Progressive disease|107|||
162744298|NCT01828099|587775981|FG000|Treatment Period|Subject/guardian decision|22|||
162744299|NCT01828099|587775982|FG001|Treatment Period|Subject/guardian decision|26|||
162744300|NCT01828099|587775981|FG000|Treatment Period|Study terminated by Sponsor|13|||
162744301|NCT01828099|587775982|FG001|Treatment Period|Study terminated by Sponsor|1|||
162744302|NCT01828099|587775981|FG000|Treatment Period|Protocol deviation|1|||
162744303|NCT01828099|587775982|FG001|Treatment Period|Protocol deviation|0|||
162744304|NCT01828099|587775981|FG000|Treatment Period|No longer requires treatment|0|||
162744305|NCT01828099|587775982|FG001|Treatment Period|No longer requires treatment|1|||
162744306|NCT01828099|587775981|FG000|Extension-treatment Phase|Adverse Event|0|||
162744307|NCT01828099|587775982|FG001|Extension-treatment Phase|Adverse Event|17|||
162744308|NCT01828099|587775981|FG000|Extension-treatment Phase|Death|0|||
162744309|NCT01828099|587775982|FG001|Extension-treatment Phase|Death|11|||
162744310|NCT01828099|587775981|FG000|Extension-treatment Phase|Physician Decision|0|||
162744311|NCT01828099|587775982|FG001|Extension-treatment Phase|Physician Decision|5|||
162744312|NCT01828099|587775981|FG000|Extension-treatment Phase|Progressive disease|0|||
162744313|NCT01828099|587775982|FG001|Extension-treatment Phase|Progressive disease|54|||
162744314|NCT01828099|587775981|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
162744315|NCT01828099|587775982|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
162744316|NCT01828099|587775981|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
162744317|NCT01828099|587775982|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
162744318|NCT05934942|587775985|FG000|Run-in Period|Not treated|1|||
162744319|NCT05934942|587775985|FG000|Run-in Period|Withdrawal by Subject|1|||
162744320|NCT03924635|587775986|FG000|Overall Study|Withdrawal by Subject|2|||
162744321|NCT03924635|587775987|FG001|Overall Study|Withdrawal by Subject|4|||
162744322|NCT06473662|587775990|FG000|Overall Study|Withdrawal by Subject|1|||
162744323|NCT06473662|587775991|FG001|Overall Study|Withdrawal by Subject|6|||
162744324|NCT06473662|587775992|FG002|Overall Study|Withdrawal by Subject|5|||
162744325|NCT06473662|587775990|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
162744326|NCT06473662|587775991|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
162744327|NCT06473662|587775992|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
162744328|NCT06473662|587775990|FG000|Overall Study|Starting HbA1c below 7%|0|||
162744329|NCT06473662|587775991|FG001|Overall Study|Starting HbA1c below 7%|1|||
162744330|NCT06473662|587775992|FG002|Overall Study|Starting HbA1c below 7%|1|||
162744331|NCT06473662|587775990|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
162744332|NCT06473662|587775991|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
162744333|NCT06473662|587775992|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
162744334|NCT06473662|587775990|FG000|Overall Study|Did not take medication|2|||
162744335|NCT06473662|587775991|FG001|Overall Study|Did not take medication|3|||
162744336|NCT06473662|587775992|FG002|Overall Study|Did not take medication|2|||
162744337|NCT04471246|587775997|FG000|Overall Study|Lost to Follow-up|2|||
162744338|NCT04471246|587775998|FG001|Overall Study|Lost to Follow-up|2|||
162744339|NCT04826471|587775999|FG000|Overall Study|Lost to Follow-up|2|||
162744340|NCT04826471|587775999|FG000|Overall Study|Protocol Violation|3|||
162744341|NCT04826471|587775999|FG000|Overall Study|Withdrawal by Subject|1|||
162744342|NCT05321082|587776000|FG000|Overall Study|Other than listed|40|||
162744343|NCT05321082|587776001|FG001|Overall Study|Other than listed|26|||
162744344|NCT05321082|587776002|FG002|Overall Study|Other than listed|27|||
162744345|NCT05321082|587776000|FG000|Overall Study|Lost to Follow-up|0|||
162744346|NCT05321082|587776001|FG001|Overall Study|Lost to Follow-up|1|||
162744347|NCT05321082|587776002|FG002|Overall Study|Lost to Follow-up|0|||
162744348|NCT05321082|587776000|FG000|Overall Study|Withdrawal by Subject|30|||
162744349|NCT05321082|587776001|FG001|Overall Study|Withdrawal by Subject|34|||
162744350|NCT05321082|587776002|FG002|Overall Study|Withdrawal by Subject|42|||
162744351|NCT05321082|587776000|FG000|Overall Study|Protocol Violation|0|||
162744352|NCT05321082|587776001|FG001|Overall Study|Protocol Violation|0|||
162744353|NCT05321082|587776002|FG002|Overall Study|Protocol Violation|1|||
162744354|NCT05321082|587776000|FG000|Overall Study|Adverse Event|49|||
162744355|NCT05321082|587776001|FG001|Overall Study|Adverse Event|49|||
162744356|NCT05321082|587776002|FG002|Overall Study|Adverse Event|48|||
162744357|NCT05321082|587776000|FG000|Overall Study|Lack of Efficacy|2|||
162744358|NCT05321082|587776001|FG001|Overall Study|Lack of Efficacy|0|||
162744359|NCT05321082|587776002|FG002|Overall Study|Lack of Efficacy|1|||
162744360|NCT05321082|587776000|FG000|Overall Study|Not treated|1|||
162744361|NCT05321082|587776001|FG001|Overall Study|Not treated|0|||
162744362|NCT05321082|587776002|FG002|Overall Study|Not treated|1|||
162744363|NCT07147257|587776003|FG000|Overall Study|Pregnancy|1|||
162744364|NCT07147257|587776004|FG001|Overall Study|Pregnancy|0|||
162744365|NCT07147257|587776003|FG000|Overall Study|Physician Decision|0|||
162744366|NCT07147257|587776004|FG001|Overall Study|Physician Decision|1|||
162744367|NCT07147257|587776003|FG000|Overall Study|Withdrawal by Subject|0|||
162744368|NCT07147257|587776004|FG001|Overall Study|Withdrawal by Subject|1|||
162744369|NCT07147257|587776003|FG000|Overall Study|Drug administration failure|0|||
162744370|NCT07147257|587776004|FG001|Overall Study|Drug administration failure|1|||
162744371|NCT04676763|587777659|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
162744372|NCT04676763|587777660|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
162744373|NCT04676763|587777661|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
162744374|NCT04676763|587777659|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
162744375|NCT04676763|587777660|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
162744376|NCT04676763|587777661|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
162744377|NCT04676763|587777659|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
162744378|NCT04676763|587777660|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
162744379|NCT04676763|587777661|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
162744380|NCT04858451|587777662|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
162744381|NCT04858451|587777663|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744382|NCT04858451|587777664|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744383|NCT04858451|587777665|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744384|NCT04858451|587777666|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744385|NCT04858451|587777667|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744386|NCT04858451|587777668|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744387|NCT04858451|587777669|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744388|NCT04858451|587777670|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162744389|NCT04858451|587777662|FG000|Part 2|Discontinued|0|||
162744390|NCT04858451|587777663|FG001|Part 2|Discontinued|0|||
162744391|NCT04858451|587777664|FG002|Part 2|Discontinued|0|||
162744392|NCT04858451|587777665|FG003|Part 2|Discontinued|0|||
162744393|NCT04858451|587777666|FG004|Part 2|Discontinued|0|||
162744394|NCT04858451|587777667|FG005|Part 2|Discontinued|0|||
162744395|NCT04858451|587777668|FG006|Part 2|Discontinued|0|||
162744396|NCT04858451|587777669|FG007|Part 2|Discontinued|0|||
162744397|NCT04858451|587777670|FG008|Part 2|Discontinued|63|||
162744398|NCT03252847|587777671|FG000|Overall Study|Withdrawal by Subject|0|||
162744399|NCT03252847|587777672|FG001|Overall Study|Withdrawal by Subject|0|||
162744400|NCT03252847|587777673|FG002|Overall Study|Withdrawal by Subject|1|||
162744401|NCT03252847|587777674|FG003|Overall Study|Withdrawal by Subject|0|||
162744402|NCT03252847|587777675|FG004|Overall Study|Withdrawal by Subject|0|||
162744403|NCT03252847|587777676|FG005|Overall Study|Withdrawal by Subject|0|||
162744404|NCT03252847|587777677|FG006|Overall Study|Withdrawal by Subject|0|||
162744405|NCT03252847|587777671|FG000|Overall Study|Other: Patient decision|0|||
162744406|NCT03252847|587777672|FG001|Overall Study|Other: Patient decision|0|||
162744407|NCT03252847|587777673|FG002|Overall Study|Other: Patient decision|0|||
162744408|NCT03252847|587777674|FG003|Overall Study|Other: Patient decision|0|||
162744409|NCT03252847|587777675|FG004|Overall Study|Other: Patient decision|1|||
162744410|NCT03252847|587777676|FG005|Overall Study|Other: Patient decision|0|||
162744411|NCT03252847|587777677|FG006|Overall Study|Other: Patient decision|0|||
162744412|NCT02116530|587777680|FG000|Overall Study|Withdrawal by Subject|1|||
162744413|NCT02116530|587777681|FG001|Overall Study|Withdrawal by Subject|2|||
162744414|NCT02116530|587777680|FG000|Overall Study|Adverse Event|4|||
162744415|NCT02116530|587777681|FG001|Overall Study|Adverse Event|0|||
162744416|NCT02116530|587777680|FG000|Overall Study|Physician Decision|1|||
162744417|NCT02116530|587777681|FG001|Overall Study|Physician Decision|0|||
162744418|NCT02116530|587777680|FG000|Overall Study|Lost to Follow-up|1|||
162744419|NCT02116530|587777681|FG001|Overall Study|Lost to Follow-up|0|||
162744420|NCT02116530|587777680|FG000|Overall Study|Other Medical Problems|2|||
162744421|NCT02116530|587777681|FG001|Overall Study|Other Medical Problems|2|||
162744422|NCT04914676|587777682|FG000|Overall Study|Study termination|3|||
162744423|NCT04914676|587777683|FG001|Overall Study|Study termination|0|||
162744424|NCT02433379|587777684|FG000|Overall Study|Screen Failures|55|||
162744425|NCT02433379|587777684|FG000|Overall Study|Death|57|||
162744426|NCT02433379|587777684|FG000|Overall Study|Total Withdrawals|209|||
162744427|NCT02505984|587777685|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
162744428|NCT02505984|587777686|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
162744429|NCT02505984|587777685|FG000|Overall Study|Unreliable self-report data|1|||
162744430|NCT02505984|587777686|FG001|Overall Study|Unreliable self-report data|0|||
162744431|NCT02505984|587777685|FG000|Overall Study|Study blind opened during assessment|0|||
162744432|NCT02505984|587777686|FG001|Overall Study|Study blind opened during assessment|1|||
162744433|NCT02505984|587777685|FG000|Overall Study|Noncompliance with study protocol|0|||
162744434|NCT02505984|587777686|FG001|Overall Study|Noncompliance with study protocol|1|||
162744435|NCT05764525|587777693|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
162744436|NCT05764525|587777694|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
162744437|NCT05764525|587777693|FG000|Overall Study|Withdrawal by Subject|4|||
162744438|NCT05764525|587777694|FG001|Overall Study|Withdrawal by Subject|8|||
162744439|NCT05764525|587777693|FG000|Overall Study|Physician Decision|1|||
162744440|NCT05764525|587777694|FG001|Overall Study|Physician Decision|0|||
162744441|NCT04079218|587777695|FG000|Overall Study|Death|1|||
162744442|NCT04079218|587777696|FG001|Overall Study|Death|0|||
162744443|NCT04079218|587777695|FG000|Overall Study|Withdrawal by Subject|3|||
162744444|NCT04079218|587777696|FG001|Overall Study|Withdrawal by Subject|0|||
162744445|NCT04079218|587777695|FG000|Overall Study|Physician Decision|4|||
162744446|NCT04079218|587777696|FG001|Overall Study|Physician Decision|0|||
162744447|NCT04079218|587777695|FG000|Overall Study|Lost to Follow-up|0|||
162744448|NCT04079218|587777696|FG001|Overall Study|Lost to Follow-up|1|||
162744449|NCT05093842|587777704|FG000|Overall Study|Pregnancy loss|1|||
162744450|NCT05093842|587777705|FG001|Overall Study|Pregnancy loss|1|||
162744451|NCT05093842|587777704|FG000|Overall Study|Lost to Follow-up|6|||
162744452|NCT05093842|587777705|FG001|Overall Study|Lost to Follow-up|0|||
162744453|NCT05093842|587777704|FG000|Overall Study|Physician Decision|0|||
162744454|NCT05093842|587777705|FG001|Overall Study|Physician Decision|1|||
162744455|NCT03910478|587777711|FG000|Overall Study|Death|13|||
162744456|NCT03910478|587777712|FG001|Overall Study|Death|6|||
162744457|NCT03910478|587777711|FG000|Overall Study|Withdrawal by Subject|23|||
162744458|NCT03910478|587777712|FG001|Overall Study|Withdrawal by Subject|2|||
162744459|NCT03910478|587777711|FG000|Overall Study|Physician Decision|5|||
162744460|NCT03910478|587777712|FG001|Overall Study|Physician Decision|0|||
162744461|NCT03910478|587777711|FG000|Overall Study|Protocol Violation|1|||
162744462|NCT03910478|587777712|FG001|Overall Study|Protocol Violation|0|||
162744463|NCT03910478|587777711|FG000|Overall Study|Failure to meet continuation criteria|2|||
162744464|NCT03910478|587777712|FG001|Overall Study|Failure to meet continuation criteria|0|||
162744465|NCT03910478|587777711|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
162744466|NCT03910478|587777712|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
162744467|NCT05293171|587777714|FG000|Washout 5 to 7 Days|Adverse Event|1|||
162744468|NCT05293171|587777715|FG001|Washout 5 to 7 Days|Adverse Event|1|||
162744469|NCT05293171|587777716|FG002|Washout 5 to 7 Days|Adverse Event|0|||
162744470|NCT05293171|587777717|FG003|Washout 5 to 7 Days|Adverse Event|0|||
162744471|NCT05293171|587777718|FG004|Washout 5 to 7 Days|Adverse Event|0|||
162744472|NCT05293171|587777719|FG005|Washout 5 to 7 Days|Adverse Event|0|||
162744473|NCT05293171|587777720|FG006|Washout 5 to 7 Days|Adverse Event|0|||
162744474|NCT05293171|587777721|FG007|Washout 5 to 7 Days|Adverse Event|0|||
162744475|NCT05293171|587777722|FG008|Washout 5 to 7 Days|Adverse Event|0|||
162744476|NCT05293171|587777723|FG009|Washout 5 to 7 Days|Adverse Event|0|||
162744477|NCT05293171|587777724|FG010|Washout 5 to 7 Days|Adverse Event|0|||
162744478|NCT05293171|587777725|FG011|Washout 5 to 7 Days|Adverse Event|0|||
162744479|NCT05293171|587777714|FG000|Washout 5 to 7 Days|Adverse Event|0|||
162744480|NCT05293171|587777715|FG001|Washout 5 to 7 Days|Adverse Event|0|||
162744481|NCT05293171|587777716|FG002|Washout 5 to 7 Days|Adverse Event|0|||
162744482|NCT05293171|587777717|FG003|Washout 5 to 7 Days|Adverse Event|0|||
162744483|NCT05293171|587777718|FG004|Washout 5 to 7 Days|Adverse Event|0|||
162744484|NCT05293171|587777719|FG005|Washout 5 to 7 Days|Adverse Event|1|||
162744485|NCT05293171|587777720|FG006|Washout 5 to 7 Days|Adverse Event|0|||
162744486|NCT05293171|587777721|FG007|Washout 5 to 7 Days|Adverse Event|0|||
162744487|NCT05293171|587777722|FG008|Washout 5 to 7 Days|Adverse Event|0|||
162744488|NCT05293171|587777723|FG009|Washout 5 to 7 Days|Adverse Event|0|||
162744489|NCT05293171|587777724|FG010|Washout 5 to 7 Days|Adverse Event|0|||
162744490|NCT05293171|587777725|FG011|Washout 5 to 7 Days|Adverse Event|0|||
162744491|NCT04066205|587777726|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
162744492|NCT04066205|587777727|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
162744493|NCT04066205|587777726|FG000|T2 Immediate Post-Intervention|did not respond|5|||
162744494|NCT04066205|587777727|FG001|T2 Immediate Post-Intervention|did not respond|3|||
162744495|NCT02052882|587777728|FG000|Overall Study|Not treated|11|||
162744496|NCT02052882|587777728|FG000|Overall Study|Protocol Violation|1|||
162744497|NCT02052882|587777728|FG000|Overall Study|Inadequate testing|1|||
162744498|NCT01275677|587777735|FG000|Overall Study|Not at risk for recurrence.|1|||
162744499|NCT01275677|587777736|FG001|Overall Study|Not at risk for recurrence.|1|||
162744500|NCT01275677|587777735|FG000|Overall Study|No follow-up|26|||
162744501|NCT01275677|587777736|FG001|Overall Study|No follow-up|37|||
162744502|NCT01275677|587777735|FG000|Overall Study|No clinical follow up.|1|||
162744503|NCT01275677|587777736|FG001|Overall Study|No clinical follow up.|4|||
162744504|NCT03478956|587777738|FG000|Randomized Treatment Period|Adverse Event|1|||
162744505|NCT03478956|587777739|FG001|Randomized Treatment Period|Adverse Event|0|||
162744506|NCT03478956|587777740|FG002|Randomized Treatment Period|Adverse Event|0|||
162744507|NCT03478956|587777741|FG003|Randomized Treatment Period|Adverse Event|0|||
162744508|NCT03478956|587777738|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
162744509|NCT03478956|587777739|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
162744510|NCT03478956|587777740|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
162744511|NCT03478956|587777741|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
162744512|NCT03478956|587777738|FG000|Open Label Extension Period|Adverse Event|0|||
162744513|NCT03478956|587777739|FG001|Open Label Extension Period|Adverse Event|0|||
162744514|NCT03478956|587777740|FG002|Open Label Extension Period|Adverse Event|4|||
162744515|NCT03478956|587777741|FG003|Open Label Extension Period|Adverse Event|0|||
162744516|NCT03478956|587777738|FG000|Open Label Extension Period|Lack of Efficacy|0|||
162744517|NCT03478956|587777739|FG001|Open Label Extension Period|Lack of Efficacy|0|||
162744518|NCT03478956|587777740|FG002|Open Label Extension Period|Lack of Efficacy|8|||
162744519|NCT03478956|587777741|FG003|Open Label Extension Period|Lack of Efficacy|0|||
162744520|NCT03478956|587777738|FG000|Open Label Extension Period|Reason Not Provided|0|||
162744521|NCT03478956|587777739|FG001|Open Label Extension Period|Reason Not Provided|0|||
162744522|NCT03478956|587777740|FG002|Open Label Extension Period|Reason Not Provided|1|||
162744523|NCT03478956|587777741|FG003|Open Label Extension Period|Reason Not Provided|0|||
162744524|NCT03478956|587777738|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
162744525|NCT03478956|587777739|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
162744526|NCT03478956|587777740|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
162744527|NCT03478956|587777741|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
162744528|NCT03478956|587777738|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
162744529|NCT03478956|587777739|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
162744530|NCT03478956|587777740|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
162744531|NCT03478956|587777741|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
162744532|NCT03478956|587777738|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162744533|NCT03478956|587777739|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162744534|NCT03478956|587777740|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162744535|NCT03478956|587777741|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
162744536|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
162744537|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
162744538|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
162744539|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
162744540|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
162744541|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
162744542|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
162744543|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
162744544|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
162744545|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
162744546|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
162744547|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
162744548|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
162744549|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
162744550|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
162744551|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
162744552|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
162744553|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
162744554|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
162744555|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
162744556|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
162744557|NCT04800211|587777742|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
162744558|NCT04800211|587777743|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
162744559|NCT04800211|587777744|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
162744560|NCT04800211|587777742|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
162744561|NCT04800211|587777743|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
162744562|NCT04800211|587777744|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
162744563|NCT04800211|587777742|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
162744564|NCT04800211|587777743|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
162744565|NCT04800211|587777744|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
162744566|NCT04800211|587777742|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
162744567|NCT04800211|587777743|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
162744568|NCT04800211|587777744|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
162744569|NCT05170841|587777745|FG000|Single Dose Phase|Adverse Event|1|||
162744570|NCT05170841|587777746|FG001|Single Dose Phase|Adverse Event|2|||
162744571|NCT05170841|587777747|FG002|Single Dose Phase|Adverse Event|0|||
162744572|NCT05170841|587777748|FG003|Single Dose Phase|Adverse Event|2|||
162744573|NCT05170841|587777745|FG000|Multiple Dose Phase|Adverse Event|1|||
162744574|NCT05170841|587777746|FG001|Multiple Dose Phase|Adverse Event|2|||
162744575|NCT05170841|587777747|FG002|Multiple Dose Phase|Adverse Event|1|||
162744576|NCT05170841|587777748|FG003|Multiple Dose Phase|Adverse Event|4|||
162744577|NCT05170841|587777745|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
162744578|NCT05170841|587777746|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
162744579|NCT05170841|587777747|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
162744580|NCT05170841|587777748|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
162744581|NCT03734679|587777765|FG000|Overall Study|Missed Visit|1|||
162744582|NCT02733159|587777776|FG000|Overall Study|Adverse Event|1|||
162744583|NCT02733159|587777776|FG000|Overall Study|Lack of disease progression|1|||
162744584|NCT06122194|587777779|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
162744585|NCT06122194|587777780|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
162744586|NCT06122194|587777781|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
162744587|NCT06122194|587777782|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
162744588|NCT05218096|587777783|FG000|Primary Evaluation|Withdrawal by Subject|0|||
162744589|NCT05218096|587777784|FG001|Primary Evaluation|Withdrawal by Subject|0|||
162744590|NCT05218096|587777785|FG002|Primary Evaluation|Withdrawal by Subject|2|||
162744591|NCT05218096|587777786|FG003|Primary Evaluation|Withdrawal by Subject|0|||
162744592|NCT05218096|587777787|FG004|Primary Evaluation|Withdrawal by Subject|0|||
162744593|NCT05218096|587777783|FG000|Primary Evaluation|Physician Decision|1|||
162744594|NCT05218096|587777784|FG001|Primary Evaluation|Physician Decision|0|||
162744595|NCT05218096|587777785|FG002|Primary Evaluation|Physician Decision|0|||
162744596|NCT05218096|587777786|FG003|Primary Evaluation|Physician Decision|0|||
162744597|NCT05218096|587777787|FG004|Primary Evaluation|Physician Decision|0|||
162744598|NCT05218096|587777783|FG000|Extended Treatment|Clinical Deterioration|1|||
162744599|NCT05218096|587777784|FG001|Extended Treatment|Clinical Deterioration|1|||
162744600|NCT05218096|587777785|FG002|Extended Treatment|Clinical Deterioration|0|||
162744601|NCT05218096|587777786|FG003|Extended Treatment|Clinical Deterioration|0|||
162744602|NCT05218096|587777787|FG004|Extended Treatment|Clinical Deterioration|0|||
162744603|NCT05218096|587777783|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
162744604|NCT05218096|587777784|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
162744605|NCT05218096|587777785|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
162744606|NCT05218096|587777786|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
162744607|NCT05218096|587777787|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
162744608|NCT05218096|587777783|FG000|Extended Treatment|Withdrawal by Subject|1|||
162744609|NCT05218096|587777784|FG001|Extended Treatment|Withdrawal by Subject|3|||
162744610|NCT05218096|587777785|FG002|Extended Treatment|Withdrawal by Subject|0|||
162744611|NCT05218096|587777786|FG003|Extended Treatment|Withdrawal by Subject|2|||
162744612|NCT05218096|587777787|FG004|Extended Treatment|Withdrawal by Subject|2|||
162744613|NCT05218096|587777783|FG000|Extended Treatment|Lack of Efficacy|3|||
162744614|NCT05218096|587777784|FG001|Extended Treatment|Lack of Efficacy|0|||
162744615|NCT05218096|587777785|FG002|Extended Treatment|Lack of Efficacy|0|||
162744616|NCT05218096|587777786|FG003|Extended Treatment|Lack of Efficacy|0|||
162744617|NCT05218096|587777787|FG004|Extended Treatment|Lack of Efficacy|0|||
162744618|NCT05218096|587777783|FG000|Extended Treatment|Physician Decision|0|||
162744619|NCT05218096|587777784|FG001|Extended Treatment|Physician Decision|1|||
162744620|NCT05218096|587777785|FG002|Extended Treatment|Physician Decision|0|||
162744621|NCT05218096|587777786|FG003|Extended Treatment|Physician Decision|0|||
162744622|NCT05218096|587777787|FG004|Extended Treatment|Physician Decision|0|||
162744623|NCT05218096|587777783|FG000|Open-label Extension|Adverse Event|1|||
162744624|NCT05218096|587777784|FG001|Open-label Extension|Adverse Event|0|||
162744625|NCT05218096|587777785|FG002|Open-label Extension|Adverse Event|0|||
162744626|NCT05218096|587777786|FG003|Open-label Extension|Adverse Event|0|||
162744627|NCT05218096|587777787|FG004|Open-label Extension|Adverse Event|1|||
162744628|NCT05218096|587777783|FG000|Open-label Extension|Pregnancy|0|||
162744629|NCT05218096|587777784|FG001|Open-label Extension|Pregnancy|0|||
162744630|NCT05218096|587777785|FG002|Open-label Extension|Pregnancy|0|||
162744631|NCT05218096|587777786|FG003|Open-label Extension|Pregnancy|0|||
162744632|NCT05218096|587777787|FG004|Open-label Extension|Pregnancy|1|||
162744633|NCT05218096|587777783|FG000|Open-label Extension|Lack of Efficacy|1|||
162744634|NCT05218096|587777784|FG001|Open-label Extension|Lack of Efficacy|2|||
162744635|NCT05218096|587777785|FG002|Open-label Extension|Lack of Efficacy|0|||
162744636|NCT05218096|587777786|FG003|Open-label Extension|Lack of Efficacy|0|||
162744637|NCT05218096|587777787|FG004|Open-label Extension|Lack of Efficacy|0|||
162744638|NCT05218096|587777783|FG000|Open-label Extension|Lost to Follow-up|1|||
162744639|NCT05218096|587777784|FG001|Open-label Extension|Lost to Follow-up|0|||
162744640|NCT05218096|587777785|FG002|Open-label Extension|Lost to Follow-up|0|||
162744641|NCT05218096|587777786|FG003|Open-label Extension|Lost to Follow-up|0|||
162744642|NCT05218096|587777787|FG004|Open-label Extension|Lost to Follow-up|0|||
162744643|NCT05218096|587777783|FG000|Open-label Extension|Death|0|||
162744644|NCT05218096|587777784|FG001|Open-label Extension|Death|0|||
162744645|NCT05218096|587777785|FG002|Open-label Extension|Death|0|||
162744646|NCT05218096|587777786|FG003|Open-label Extension|Death|1|||
162744647|NCT05218096|587777787|FG004|Open-label Extension|Death|0|||
162744648|NCT05218096|587777783|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
162744649|NCT05218096|587777784|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
162744650|NCT05218096|587777785|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
162744651|NCT05218096|587777786|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
162744652|NCT05218096|587777787|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
162744653|NCT03088878|587777797|FG000|Overall Study|Adverse Event|0|||
162744654|NCT03088878|587777798|FG001|Overall Study|Adverse Event|0|||
162744655|NCT03088878|587777799|FG002|Overall Study|Adverse Event|0|||
162744656|NCT03088878|587777800|FG003|Overall Study|Adverse Event|0|||
162744657|NCT03088878|587777801|FG004|Overall Study|Adverse Event|4|||
162744658|NCT03088878|587777802|FG005|Overall Study|Adverse Event|2|||
162744659|NCT03088878|587777803|FG006|Overall Study|Adverse Event|1|||
162744660|NCT03088878|587777804|FG007|Overall Study|Adverse Event|0|||
162744661|NCT03088878|587777805|FG008|Overall Study|Adverse Event|0|||
162744662|NCT03088878|587777806|FG009|Overall Study|Adverse Event|0|||
162744663|NCT03088878|587777807|FG010|Overall Study|Adverse Event|0|||
162744664|NCT03088878|587777808|FG011|Overall Study|Adverse Event|0|||
162744665|NCT03088878|587777809|FG012|Overall Study|Adverse Event|5|||
162744666|NCT03088878|587777810|FG013|Overall Study|Adverse Event|3|||
162744667|NCT03088878|587777797|FG000|Overall Study|Clinical Progression|0|||
162744668|NCT03088878|587777798|FG001|Overall Study|Clinical Progression|0|||
162744669|NCT03088878|587777799|FG002|Overall Study|Clinical Progression|0|||
162744670|NCT03088878|587777800|FG003|Overall Study|Clinical Progression|0|||
162744671|NCT03088878|587777801|FG004|Overall Study|Clinical Progression|2|||
162744672|NCT03088878|587777802|FG005|Overall Study|Clinical Progression|0|||
162744673|NCT03088878|587777803|FG006|Overall Study|Clinical Progression|0|||
162744674|NCT03088878|587777804|FG007|Overall Study|Clinical Progression|0|||
162744675|NCT03088878|587777805|FG008|Overall Study|Clinical Progression|0|||
162744676|NCT03088878|587777806|FG009|Overall Study|Clinical Progression|0|||
162744677|NCT03088878|587777807|FG010|Overall Study|Clinical Progression|0|||
162744678|NCT03088878|587777808|FG011|Overall Study|Clinical Progression|0|||
162744679|NCT03088878|587777809|FG012|Overall Study|Clinical Progression|0|||
162744680|NCT03088878|587777810|FG013|Overall Study|Clinical Progression|0|||
162744681|NCT03088878|587777797|FG000|Overall Study|Death|0|||
162744682|NCT03088878|587777798|FG001|Overall Study|Death|0|||
162744683|NCT03088878|587777799|FG002|Overall Study|Death|0|||
162744684|NCT03088878|587777800|FG003|Overall Study|Death|0|||
162744685|NCT03088878|587777801|FG004|Overall Study|Death|2|||
162744686|NCT03088878|587777802|FG005|Overall Study|Death|0|||
162744687|NCT03088878|587777803|FG006|Overall Study|Death|0|||
162744688|NCT03088878|587777804|FG007|Overall Study|Death|0|||
162744689|NCT03088878|587777805|FG008|Overall Study|Death|0|||
162744690|NCT03088878|587777806|FG009|Overall Study|Death|0|||
162744691|NCT03088878|587777807|FG010|Overall Study|Death|0|||
162744692|NCT03088878|587777808|FG011|Overall Study|Death|1|||
162744693|NCT03088878|587777809|FG012|Overall Study|Death|0|||
162744694|NCT03088878|587777810|FG013|Overall Study|Death|0|||
162744695|NCT03088878|587777797|FG000|Overall Study|Disease Progression|1|||
162744696|NCT03088878|587777798|FG001|Overall Study|Disease Progression|2|||
162744697|NCT03088878|587777799|FG002|Overall Study|Disease Progression|3|||
162744698|NCT03088878|587777800|FG003|Overall Study|Disease Progression|0|||
162744699|NCT03088878|587777801|FG004|Overall Study|Disease Progression|3|||
162744700|NCT03088878|587777802|FG005|Overall Study|Disease Progression|0|||
162744701|NCT03088878|587777803|FG006|Overall Study|Disease Progression|0|||
162744702|NCT03088878|587777804|FG007|Overall Study|Disease Progression|0|||
162744703|NCT03088878|587777805|FG008|Overall Study|Disease Progression|0|||
162744704|NCT03088878|587777806|FG009|Overall Study|Disease Progression|0|||
162744705|NCT03088878|587777807|FG010|Overall Study|Disease Progression|0|||
162744706|NCT03088878|587777808|FG011|Overall Study|Disease Progression|0|||
162744707|NCT03088878|587777809|FG012|Overall Study|Disease Progression|1|||
162744708|NCT03088878|587777810|FG013|Overall Study|Disease Progression|1|||
162744709|NCT03088878|587777797|FG000|Overall Study|Initiation of Alternative Treatment|0|||
162744710|NCT03088878|587777798|FG001|Overall Study|Initiation of Alternative Treatment|0|||
162744711|NCT03088878|587777799|FG002|Overall Study|Initiation of Alternative Treatment|0|||
162744712|NCT03088878|587777800|FG003|Overall Study|Initiation of Alternative Treatment|1|||
162744713|NCT03088878|587777801|FG004|Overall Study|Initiation of Alternative Treatment|0|||
162744714|NCT03088878|587777802|FG005|Overall Study|Initiation of Alternative Treatment|0|||
162744715|NCT03088878|587777803|FG006|Overall Study|Initiation of Alternative Treatment|0|||
162744716|NCT03088878|587777804|FG007|Overall Study|Initiation of Alternative Treatment|1|||
162744717|NCT03088878|587777805|FG008|Overall Study|Initiation of Alternative Treatment|1|||
162744718|NCT03088878|587777806|FG009|Overall Study|Initiation of Alternative Treatment|0|||
162744719|NCT03088878|587777807|FG010|Overall Study|Initiation of Alternative Treatment|0|||
162744720|NCT03088878|587777808|FG011|Overall Study|Initiation of Alternative Treatment|0|||
162744721|NCT03088878|587777809|FG012|Overall Study|Initiation of Alternative Treatment|0|||
162744722|NCT03088878|587777810|FG013|Overall Study|Initiation of Alternative Treatment|0|||
162744723|NCT03088878|587777797|FG000|Overall Study|Withdrawal by Subject|0|||
162744724|NCT03088878|587777798|FG001|Overall Study|Withdrawal by Subject|0|||
162744725|NCT03088878|587777799|FG002|Overall Study|Withdrawal by Subject|0|||
162744726|NCT03088878|587777800|FG003|Overall Study|Withdrawal by Subject|1|||
162744727|NCT03088878|587777801|FG004|Overall Study|Withdrawal by Subject|4|||
162744728|NCT03088878|587777802|FG005|Overall Study|Withdrawal by Subject|1|||
162744729|NCT03088878|587777803|FG006|Overall Study|Withdrawal by Subject|1|||
162744730|NCT03088878|587777804|FG007|Overall Study|Withdrawal by Subject|0|||
162744731|NCT03088878|587777805|FG008|Overall Study|Withdrawal by Subject|1|||
162744732|NCT03088878|587777806|FG009|Overall Study|Withdrawal by Subject|2|||
162744733|NCT03088878|587777807|FG010|Overall Study|Withdrawal by Subject|0|||
162744734|NCT03088878|587777808|FG011|Overall Study|Withdrawal by Subject|2|||
162744735|NCT03088878|587777809|FG012|Overall Study|Withdrawal by Subject|1|||
162744736|NCT03088878|587777810|FG013|Overall Study|Withdrawal by Subject|0|||
162744737|NCT03088878|587777797|FG000|Overall Study|Terminated by Sponsor|2|||
162744738|NCT03088878|587777798|FG001|Overall Study|Terminated by Sponsor|1|||
162744739|NCT03088878|587777799|FG002|Overall Study|Terminated by Sponsor|0|||
162744740|NCT03088878|587777800|FG003|Overall Study|Terminated by Sponsor|1|||
162744741|NCT03088878|587777801|FG004|Overall Study|Terminated by Sponsor|6|||
162744742|NCT03088878|587777802|FG005|Overall Study|Terminated by Sponsor|0|||
162744743|NCT03088878|587777803|FG006|Overall Study|Terminated by Sponsor|0|||
162744744|NCT03088878|587777804|FG007|Overall Study|Terminated by Sponsor|0|||
162744745|NCT03088878|587777805|FG008|Overall Study|Terminated by Sponsor|0|||
162744746|NCT03088878|587777806|FG009|Overall Study|Terminated by Sponsor|0|||
162744747|NCT03088878|587777807|FG010|Overall Study|Terminated by Sponsor|3|||
162744748|NCT03088878|587777808|FG011|Overall Study|Terminated by Sponsor|13|||
162744749|NCT03088878|587777809|FG012|Overall Study|Terminated by Sponsor|2|||
162744750|NCT03088878|587777810|FG013|Overall Study|Terminated by Sponsor|1|||
162744751|NCT03088878|587777797|FG000|Overall Study|Completed 2 years of Treatment|0|||
162744752|NCT03088878|587777798|FG001|Overall Study|Completed 2 years of Treatment|0|||
162744753|NCT03088878|587777799|FG002|Overall Study|Completed 2 years of Treatment|0|||
162744754|NCT03088878|587777800|FG003|Overall Study|Completed 2 years of Treatment|0|||
162744755|NCT03088878|587777801|FG004|Overall Study|Completed 2 years of Treatment|0|||
162744756|NCT03088878|587777802|FG005|Overall Study|Completed 2 years of Treatment|0|||
162744757|NCT03088878|587777803|FG006|Overall Study|Completed 2 years of Treatment|1|||
162744758|NCT03088878|587777804|FG007|Overall Study|Completed 2 years of Treatment|0|||
162744759|NCT03088878|587777805|FG008|Overall Study|Completed 2 years of Treatment|0|||
162744760|NCT03088878|587777806|FG009|Overall Study|Completed 2 years of Treatment|1|||
162744761|NCT03088878|587777807|FG010|Overall Study|Completed 2 years of Treatment|0|||
162744762|NCT03088878|587777808|FG011|Overall Study|Completed 2 years of Treatment|0|||
162744763|NCT03088878|587777809|FG012|Overall Study|Completed 2 years of Treatment|8|||
162744764|NCT03088878|587777810|FG013|Overall Study|Completed 2 years of Treatment|3|||
162744765|NCT03088878|587777797|FG000|Overall Study|Physician Decision|0|||
162744766|NCT03088878|587777798|FG001|Overall Study|Physician Decision|0|||
162744767|NCT03088878|587777799|FG002|Overall Study|Physician Decision|0|||
162744768|NCT03088878|587777800|FG003|Overall Study|Physician Decision|0|||
162744769|NCT03088878|587777801|FG004|Overall Study|Physician Decision|0|||
162744770|NCT03088878|587777802|FG005|Overall Study|Physician Decision|0|||
162744771|NCT03088878|587777803|FG006|Overall Study|Physician Decision|0|||
162744772|NCT03088878|587777804|FG007|Overall Study|Physician Decision|2|||
162744773|NCT03088878|587777805|FG008|Overall Study|Physician Decision|1|||
162744774|NCT03088878|587777806|FG009|Overall Study|Physician Decision|0|||
162744775|NCT03088878|587777807|FG010|Overall Study|Physician Decision|0|||
162744776|NCT03088878|587777808|FG011|Overall Study|Physician Decision|0|||
162744777|NCT03088878|587777809|FG012|Overall Study|Physician Decision|0|||
162744778|NCT03088878|587777810|FG013|Overall Study|Physician Decision|1|||
162744779|NCT03088878|587777797|FG000|Overall Study|COVID Related noncompliance|0|||
162744780|NCT03088878|587777798|FG001|Overall Study|COVID Related noncompliance|0|||
162744781|NCT03088878|587777799|FG002|Overall Study|COVID Related noncompliance|0|||
162744782|NCT03088878|587777800|FG003|Overall Study|COVID Related noncompliance|0|||
162744783|NCT03088878|587777801|FG004|Overall Study|COVID Related noncompliance|0|||
162744784|NCT03088878|587777802|FG005|Overall Study|COVID Related noncompliance|0|||
162744785|NCT03088878|587777803|FG006|Overall Study|COVID Related noncompliance|0|||
162744786|NCT03088878|587777804|FG007|Overall Study|COVID Related noncompliance|0|||
162744787|NCT03088878|587777805|FG008|Overall Study|COVID Related noncompliance|0|||
162744788|NCT03088878|587777806|FG009|Overall Study|COVID Related noncompliance|0|||
162744789|NCT03088878|587777807|FG010|Overall Study|COVID Related noncompliance|0|||
162744790|NCT03088878|587777808|FG011|Overall Study|COVID Related noncompliance|0|||
162744791|NCT03088878|587777809|FG012|Overall Study|COVID Related noncompliance|0|||
162744792|NCT03088878|587777810|FG013|Overall Study|COVID Related noncompliance|1|||
162744793|NCT03088878|587777797|FG000|Overall Study|Drug or Study Noncompliance|0|||
162744794|NCT03088878|587777798|FG001|Overall Study|Drug or Study Noncompliance|0|||
162744795|NCT03088878|587777799|FG002|Overall Study|Drug or Study Noncompliance|0|||
162744796|NCT03088878|587777800|FG003|Overall Study|Drug or Study Noncompliance|0|||
162744797|NCT03088878|587777801|FG004|Overall Study|Drug or Study Noncompliance|0|||
162744798|NCT03088878|587777802|FG005|Overall Study|Drug or Study Noncompliance|0|||
162744799|NCT03088878|587777803|FG006|Overall Study|Drug or Study Noncompliance|0|||
162744800|NCT03088878|587777804|FG007|Overall Study|Drug or Study Noncompliance|0|||
162744801|NCT03088878|587777805|FG008|Overall Study|Drug or Study Noncompliance|0|||
162744802|NCT03088878|587777806|FG009|Overall Study|Drug or Study Noncompliance|0|||
162744803|NCT03088878|587777807|FG010|Overall Study|Drug or Study Noncompliance|0|||
162744804|NCT03088878|587777808|FG011|Overall Study|Drug or Study Noncompliance|0|||
162744805|NCT03088878|587777809|FG012|Overall Study|Drug or Study Noncompliance|1|||
162744806|NCT03088878|587777810|FG013|Overall Study|Drug or Study Noncompliance|0|||
162744807|NCT04032847|587777823|FG000|Overall Study|Study termination by sponsor|8|||
162744808|NCT04032847|587777824|FG001|Overall Study|Study termination by sponsor|0|||
162744809|NCT04032847|587777825|FG002|Overall Study|Study termination by sponsor|4|||
162744810|NCT04032847|587777823|FG000|Overall Study|Death|12|||
162744811|NCT04032847|587777824|FG001|Overall Study|Death|0|||
162744812|NCT04032847|587777825|FG002|Overall Study|Death|0|||
162744813|NCT04032847|587777823|FG000|Overall Study|Progressive disease|2|||
162744814|NCT04032847|587777824|FG001|Overall Study|Progressive disease|0|||
162744815|NCT04032847|587777825|FG002|Overall Study|Progressive disease|1|||
162744816|NCT03056573|587777826|FG000|Overall Study|Death|2|||
162744817|NCT03056573|587777827|FG001|Overall Study|Death|4|||
162744818|NCT03056573|587777826|FG000|Overall Study|Withdrawal by Subject|2|||
162744819|NCT03056573|587777827|FG001|Overall Study|Withdrawal by Subject|0|||
162744820|NCT03056573|587777826|FG000|Overall Study|Lost to Follow-up|1|||
162744821|NCT03056573|587777827|FG001|Overall Study|Lost to Follow-up|1|||
162744822|NCT05104463|587777828|FG000|Overall Study|Adverse Event|1|||
162744823|NCT05104463|587777829|FG001|Overall Study|Adverse Event|1|||
162744824|NCT05104463|587777828|FG000|Overall Study|Lost to Follow-up|1|||
162744825|NCT05104463|587777829|FG001|Overall Study|Lost to Follow-up|1|||
162744826|NCT05104463|587777828|FG000|Overall Study|Physician Decision|1|||
162744827|NCT05104463|587777829|FG001|Overall Study|Physician Decision|0|||
162744828|NCT05104463|587777828|FG000|Overall Study|Protocol Violation|0|||
162744829|NCT05104463|587777829|FG001|Overall Study|Protocol Violation|2|||
162744830|NCT05104463|587777828|FG000|Overall Study|Withdrawal by Subject|1|||
162744831|NCT05104463|587777829|FG001|Overall Study|Withdrawal by Subject|1|||
162744832|NCT05267470|587777830|FG000|Overall Study|Decision by sponsor|0|||
162744833|NCT05267470|587777831|FG001|Overall Study|Decision by sponsor|3|||
162744834|NCT05267470|587777832|FG002|Overall Study|Decision by sponsor|19|||
162744835|NCT05267470|587777833|FG003|Overall Study|Decision by sponsor|7|||
162744836|NCT05267470|587777834|FG004|Overall Study|Decision by sponsor|3|||
162744837|NCT05267470|587777830|FG000|Overall Study|Withdrawal by Subject|1|||
162744838|NCT05267470|587777831|FG001|Overall Study|Withdrawal by Subject|1|||
162744839|NCT05267470|587777832|FG002|Overall Study|Withdrawal by Subject|2|||
162744840|NCT05267470|587777833|FG003|Overall Study|Withdrawal by Subject|2|||
162744841|NCT05267470|587777834|FG004|Overall Study|Withdrawal by Subject|0|||
162744842|NCT05267470|587777830|FG000|Overall Study|Death|3|||
162744843|NCT05267470|587777831|FG001|Overall Study|Death|5|||
162744844|NCT05267470|587777832|FG002|Overall Study|Death|8|||
162744845|NCT05267470|587777833|FG003|Overall Study|Death|18|||
162744846|NCT05267470|587777834|FG004|Overall Study|Death|1|||
162744847|NCT05267470|587777830|FG000|Overall Study|Lost to Follow-up|0|||
162744848|NCT05267470|587777831|FG001|Overall Study|Lost to Follow-up|0|||
162744849|NCT05267470|587777832|FG002|Overall Study|Lost to Follow-up|0|||
162744850|NCT05267470|587777833|FG003|Overall Study|Lost to Follow-up|1|||
162744851|NCT05267470|587777834|FG004|Overall Study|Lost to Follow-up|0|||
162744852|NCT04428203|587777835|FG000|Overall Study|Adverse Event|1|||
162744853|NCT04428203|587777836|FG001|Overall Study|Adverse Event|0|||
162744854|NCT04428203|587777837|FG002|Overall Study|Adverse Event|0|||
162744855|NCT04428203|587777835|FG000|Overall Study|Withdrawal by Subject|1|||
162744856|NCT04428203|587777836|FG001|Overall Study|Withdrawal by Subject|0|||
162744857|NCT04428203|587777837|FG002|Overall Study|Withdrawal by Subject|1|||
162744858|NCT02823145|587777838|FG000|Enrollment|Other|1|||
162744859|NCT02823145|587777839|FG001|Enrollment|Other|0|||
162744860|NCT02823145|587777838|FG000|Treatment|Adverse Event|0|||
162744861|NCT02823145|587777839|FG001|Treatment|Adverse Event|11|||
162744862|NCT02823145|587777838|FG000|Treatment|Death|0|||
162744863|NCT02823145|587777839|FG001|Treatment|Death|3|||
162744864|NCT02823145|587777838|FG000|Treatment|Family Decision|0|||
162744865|NCT02823145|587777839|FG001|Treatment|Family Decision|1|||
162744866|NCT02823145|587777838|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
162744867|NCT02823145|587777839|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
162744868|NCT02823145|587777838|FG000|Treatment|Lack of Efficacy|0|||
162744869|NCT02823145|587777839|FG001|Treatment|Lack of Efficacy|48|||
162744870|NCT02823145|587777838|FG000|Treatment|Non-Compliance With E-Diary|0|||
162744871|NCT02823145|587777839|FG001|Treatment|Non-Compliance With E-Diary|1|||
162744872|NCT02823145|587777838|FG000|Treatment|Physician Decision|0|||
162744873|NCT02823145|587777839|FG001|Treatment|Physician Decision|2|||
162744874|NCT02823145|587777838|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
162744875|NCT02823145|587777839|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
162744876|NCT02823145|587777838|FG000|Treatment|Subject needed to take prohibited medication|0|||
162744877|NCT02823145|587777839|FG001|Treatment|Subject needed to take prohibited medication|1|||
162744878|NCT02823145|587777838|FG000|Treatment|Subject transferred to direct access programme|0|||
162744879|NCT02823145|587777839|FG001|Treatment|Subject transferred to direct access programme|1|||
162744880|NCT02823145|587777838|FG000|Treatment|Switching to commercially available drug|0|||
162744881|NCT02823145|587777839|FG001|Treatment|Switching to commercially available drug|11|||
162744882|NCT02823145|587777838|FG000|Treatment|Transitioned to commercial supply of medication|0|||
162744883|NCT02823145|587777839|FG001|Treatment|Transitioned to commercial supply of medication|1|||
162744884|NCT02823145|587777838|FG000|Treatment|Withdrawal By Caregiver|0|||
162744885|NCT02823145|587777839|FG001|Treatment|Withdrawal By Caregiver|1|||
162744886|NCT02823145|587777838|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
162744887|NCT02823145|587777839|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
162744888|NCT02823145|587777838|FG000|Treatment|Withdrawal by Subject|0|||
162744889|NCT02823145|587777839|FG001|Treatment|Withdrawal by Subject|16|||
162744890|NCT02823145|587777838|FG000|Treatment|Reason unknown|0|||
162744891|NCT02823145|587777839|FG001|Treatment|Reason unknown|1|||
162744892|NCT04622046|587777840|FG000|Intervention Period|Adverse Event|1|||
162744893|NCT04622046|587777840|FG000|Intervention Period|Withdrawal by Subject|2|||
162744894|NCT04622046|587777840|FG000|Extension Period|Ongoing in the Extension Period|21|||
162744895|NCT04171141|587779780|FG000|Overall Study|Adverse Event|0|||
162744896|NCT04171141|587779781|FG001|Overall Study|Adverse Event|0|||
162744897|NCT04171141|587779782|FG002|Overall Study|Adverse Event|2|||
162744898|NCT04171141|587779783|FG003|Overall Study|Adverse Event|0|||
162744899|NCT04171141|587779784|FG004|Overall Study|Adverse Event|0|||
162744900|NCT04171141|587779785|FG005|Overall Study|Adverse Event|0|||
162744901|NCT04171141|587779786|FG006|Overall Study|Adverse Event|0|||
162744902|NCT04171141|587779787|FG007|Overall Study|Adverse Event|0|||
162744903|NCT04171141|587779788|FG008|Overall Study|Adverse Event|0|||
162744904|NCT04171141|587779789|FG009|Overall Study|Adverse Event|0|||
162744905|NCT04171141|587779790|FG010|Overall Study|Adverse Event|0|||
162744906|NCT04171141|587779791|FG011|Overall Study|Adverse Event|0|||
162744907|NCT04171141|587779792|FG012|Overall Study|Adverse Event|0|||
162744908|NCT04171141|587779793|FG013|Overall Study|Adverse Event|2|||
162744909|NCT04171141|587779794|FG014|Overall Study|Adverse Event|0|||
162744910|NCT04171141|587779795|FG015|Overall Study|Adverse Event|0|||
162744911|NCT04171141|587779780|FG000|Overall Study|Physician Decision|0|||
162744912|NCT04171141|587779781|FG001|Overall Study|Physician Decision|0|||
162744913|NCT04171141|587779782|FG002|Overall Study|Physician Decision|0|||
162744914|NCT04171141|587779783|FG003|Overall Study|Physician Decision|0|||
162744915|NCT04171141|587779784|FG004|Overall Study|Physician Decision|1|||
162744916|NCT04171141|587779785|FG005|Overall Study|Physician Decision|0|||
162744917|NCT04171141|587779786|FG006|Overall Study|Physician Decision|0|||
162744918|NCT04171141|587779787|FG007|Overall Study|Physician Decision|0|||
162744919|NCT04171141|587779788|FG008|Overall Study|Physician Decision|0|||
162744920|NCT04171141|587779789|FG009|Overall Study|Physician Decision|0|||
162744921|NCT04171141|587779790|FG010|Overall Study|Physician Decision|0|||
162744922|NCT04171141|587779791|FG011|Overall Study|Physician Decision|0|||
162744923|NCT04171141|587779792|FG012|Overall Study|Physician Decision|0|||
162744924|NCT04171141|587779793|FG013|Overall Study|Physician Decision|0|||
162744925|NCT04171141|587779794|FG014|Overall Study|Physician Decision|0|||
162744926|NCT04171141|587779795|FG015|Overall Study|Physician Decision|1|||
162744927|NCT04171141|587779780|FG000|Overall Study|Progressive disease|2|||
162744928|NCT04171141|587779781|FG001|Overall Study|Progressive disease|3|||
162744929|NCT04171141|587779782|FG002|Overall Study|Progressive disease|4|||
162744930|NCT04171141|587779783|FG003|Overall Study|Progressive disease|7|||
162744931|NCT04171141|587779784|FG004|Overall Study|Progressive disease|1|||
162744932|NCT04171141|587779785|FG005|Overall Study|Progressive disease|8|||
162744933|NCT04171141|587779786|FG006|Overall Study|Progressive disease|4|||
162744934|NCT04171141|587779787|FG007|Overall Study|Progressive disease|6|||
162744935|NCT04171141|587779788|FG008|Overall Study|Progressive disease|7|||
162744936|NCT04171141|587779789|FG009|Overall Study|Progressive disease|3|||
162744937|NCT04171141|587779790|FG010|Overall Study|Progressive disease|4|||
162744938|NCT04171141|587779791|FG011|Overall Study|Progressive disease|3|||
162744939|NCT04171141|587779792|FG012|Overall Study|Progressive disease|4|||
162744940|NCT04171141|587779793|FG013|Overall Study|Progressive disease|2|||
162744941|NCT04171141|587779794|FG014|Overall Study|Progressive disease|4|||
162744942|NCT04171141|587779795|FG015|Overall Study|Progressive disease|1|||
162744943|NCT04171141|587779780|FG000|Overall Study|Withdrawal by Subject|0|||
162744944|NCT04171141|587779781|FG001|Overall Study|Withdrawal by Subject|0|||
162744945|NCT04171141|587779782|FG002|Overall Study|Withdrawal by Subject|0|||
162744946|NCT04171141|587779783|FG003|Overall Study|Withdrawal by Subject|1|||
162744947|NCT04171141|587779784|FG004|Overall Study|Withdrawal by Subject|0|||
162744948|NCT04171141|587779785|FG005|Overall Study|Withdrawal by Subject|0|||
162744949|NCT04171141|587779786|FG006|Overall Study|Withdrawal by Subject|1|||
162744950|NCT04171141|587779787|FG007|Overall Study|Withdrawal by Subject|0|||
162744951|NCT04171141|587779788|FG008|Overall Study|Withdrawal by Subject|0|||
162744952|NCT04171141|587779789|FG009|Overall Study|Withdrawal by Subject|1|||
162744953|NCT04171141|587779790|FG010|Overall Study|Withdrawal by Subject|0|||
162744954|NCT04171141|587779791|FG011|Overall Study|Withdrawal by Subject|0|||
162744955|NCT04171141|587779792|FG012|Overall Study|Withdrawal by Subject|0|||
162744956|NCT04171141|587779793|FG013|Overall Study|Withdrawal by Subject|0|||
162744957|NCT04171141|587779794|FG014|Overall Study|Withdrawal by Subject|0|||
162744958|NCT04171141|587779795|FG015|Overall Study|Withdrawal by Subject|0|||
162744959|NCT04171141|587779780|FG000|Overall Study|Global deterioration of health status|0|||
162744960|NCT04171141|587779781|FG001|Overall Study|Global deterioration of health status|0|||
162744961|NCT04171141|587779782|FG002|Overall Study|Global deterioration of health status|0|||
162744962|NCT04171141|587779783|FG003|Overall Study|Global deterioration of health status|1|||
162744963|NCT04171141|587779784|FG004|Overall Study|Global deterioration of health status|0|||
162744964|NCT04171141|587779785|FG005|Overall Study|Global deterioration of health status|2|||
162744965|NCT04171141|587779786|FG006|Overall Study|Global deterioration of health status|1|||
162744966|NCT04171141|587779787|FG007|Overall Study|Global deterioration of health status|0|||
162744967|NCT04171141|587779788|FG008|Overall Study|Global deterioration of health status|1|||
162744968|NCT04171141|587779789|FG009|Overall Study|Global deterioration of health status|0|||
162744969|NCT04171141|587779790|FG010|Overall Study|Global deterioration of health status|0|||
162744970|NCT04171141|587779791|FG011|Overall Study|Global deterioration of health status|0|||
162744971|NCT04171141|587779792|FG012|Overall Study|Global deterioration of health status|0|||
162744972|NCT04171141|587779793|FG013|Overall Study|Global deterioration of health status|0|||
162744973|NCT04171141|587779794|FG014|Overall Study|Global deterioration of health status|1|||
162744974|NCT04171141|587779795|FG015|Overall Study|Global deterioration of health status|1|||
162744975|NCT03314454|587779796|FG000|Overall Study|Protocol Violation|1|||
162744976|NCT04119843|587779797|FG000|Overall Study|Adverse Event|3|||
162744977|NCT04119843|587779797|FG000|Overall Study|Death|1|||
162744978|NCT02841579|587779806|FG000|Overall Study|Death|1|||
162744979|NCT02841579|587779806|FG000|Overall Study|Adverse Event|1|||
162744980|NCT02841579|587779806|FG000|Overall Study|Lack of Efficacy|9|||
162744981|NCT04233216|587779809|FG000|Overall Study|Lost to Follow-up|1|||
162744982|NCT04233216|587779810|FG001|Overall Study|Lost to Follow-up|0|||
162744983|NCT04233216|587779811|FG002|Overall Study|Lost to Follow-up|2|||
162744984|NCT04233216|587779812|FG003|Overall Study|Lost to Follow-up|0|||
162744985|NCT04233216|587779809|FG000|Overall Study|Physician Decision|0|||
162744986|NCT04233216|587779810|FG001|Overall Study|Physician Decision|3|||
162744987|NCT04233216|587779811|FG002|Overall Study|Physician Decision|0|||
162744988|NCT04233216|587779812|FG003|Overall Study|Physician Decision|2|||
162744989|NCT04233216|587779809|FG000|Overall Study|Withdrawal by Subject|0|||
162744990|NCT04233216|587779810|FG001|Overall Study|Withdrawal by Subject|2|||
162744991|NCT04233216|587779811|FG002|Overall Study|Withdrawal by Subject|1|||
162744992|NCT04233216|587779812|FG003|Overall Study|Withdrawal by Subject|0|||
162744993|NCT03652389|587779813|FG000|Overall Study|Lost to Follow-up|1|||
162744994|NCT03652389|587779814|FG001|Overall Study|Lost to Follow-up|5|||
162744995|NCT03652389|587779813|FG000|Overall Study|Withdrawal by Subject|5|||
162744996|NCT03652389|587779814|FG001|Overall Study|Withdrawal by Subject|1|||
162744997|NCT03652389|587779813|FG000|Overall Study|New diagnosis|2|||
162744998|NCT03652389|587779814|FG001|Overall Study|New diagnosis|0|||
162744999|NCT04231149|587779815|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162745000|NCT04231149|587779816|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
162745001|NCT04231149|587779817|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162745002|NCT04231149|587779818|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162745003|NCT04231149|587779819|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162745004|NCT04979442|587779822|FG000|Overall Study|Death|43|||
162745005|NCT04979442|587779823|FG001|Overall Study|Death|30|||
162745006|NCT04979442|587779822|FG000|Overall Study|Withdrawal by Subject|8|||
162745007|NCT04979442|587779823|FG001|Overall Study|Withdrawal by Subject|13|||
162745008|NCT04979442|587779822|FG000|Overall Study|Physician Decision|1|||
162745009|NCT04979442|587779823|FG001|Overall Study|Physician Decision|1|||
162745010|NCT04979442|587779822|FG000|Overall Study|Lost to Follow-up|0|||
162745011|NCT04979442|587779823|FG001|Overall Study|Lost to Follow-up|2|||
162745012|NCT04979442|587779822|FG000|Overall Study|do not want to continue|0|||
162745013|NCT04979442|587779823|FG001|Overall Study|do not want to continue|1|||
162745014|NCT04005794|587779825|FG000|Overall Study|Lost to Follow-up|0|||
162745015|NCT04005794|587779826|FG001|Overall Study|Lost to Follow-up|4|||
162745016|NCT04005794|587779827|FG002|Overall Study|Lost to Follow-up|0|||
162745017|NCT05622812|587779831|FG000|Overall Study|Withdrawal by Subject|1|||
162745018|NCT05622812|587779832|FG001|Overall Study|Withdrawal by Subject|4|||
162745019|NCT05622812|587779831|FG000|Overall Study|Lost to Follow-up|2|||
162745020|NCT05622812|587779832|FG001|Overall Study|Lost to Follow-up|1|||
162745021|NCT03916185|587779833|FG000|Overall Study|Lost to Follow-up|0|||
162745022|NCT03916185|587779834|FG001|Overall Study|Lost to Follow-up|1|||
162745023|NCT03916185|587779835|FG002|Overall Study|Lost to Follow-up|0|||
162745024|NCT03916185|587779836|FG003|Overall Study|Lost to Follow-up|0|||
162745025|NCT03916185|587779833|FG000|Overall Study|Moved|1|||
162745026|NCT03916185|587779834|FG001|Overall Study|Moved|0|||
162745027|NCT03916185|587779835|FG002|Overall Study|Moved|0|||
162745028|NCT03916185|587779836|FG003|Overall Study|Moved|1|||
162745029|NCT03916185|587779833|FG000|Overall Study|Not Able to Get to Clinic|1|||
162745030|NCT03916185|587779834|FG001|Overall Study|Not Able to Get to Clinic|0|||
162745031|NCT03916185|587779835|FG002|Overall Study|Not Able to Get to Clinic|0|||
162745032|NCT03916185|587779836|FG003|Overall Study|Not Able to Get to Clinic|0|||
162745033|NCT03766685|587779837|FG000|Overall Study|Lost to Follow-up|1|||
162745034|NCT03766685|587779838|FG001|Overall Study|Lost to Follow-up|1|||
162745035|NCT03766685|587779839|FG002|Overall Study|Lost to Follow-up|0|||
162745036|NCT03766685|587779840|FG003|Overall Study|Lost to Follow-up|0|||
162745037|NCT03766685|587779837|FG000|Overall Study|Adverse Event, not fatal|0|||
162745038|NCT03766685|587779838|FG001|Overall Study|Adverse Event, not fatal|1|||
162745039|NCT03766685|587779839|FG002|Overall Study|Adverse Event, not fatal|0|||
162745040|NCT03766685|587779840|FG003|Overall Study|Adverse Event, not fatal|1|||
162745041|NCT03766685|587779837|FG000|Overall Study|Withdrawal by Subject|0|||
162745042|NCT03766685|587779838|FG001|Overall Study|Withdrawal by Subject|2|||
162745043|NCT03766685|587779839|FG002|Overall Study|Withdrawal by Subject|0|||
162745044|NCT03766685|587779840|FG003|Overall Study|Withdrawal by Subject|0|||
162745045|NCT03766685|587779837|FG000|Overall Study|Protocol Violation|0|||
162745046|NCT03766685|587779838|FG001|Overall Study|Protocol Violation|1|||
162745047|NCT03766685|587779839|FG002|Overall Study|Protocol Violation|0|||
162745048|NCT03766685|587779840|FG003|Overall Study|Protocol Violation|0|||
162745049|NCT03766685|587779837|FG000|Overall Study|Non-compliance|0|||
162745050|NCT03766685|587779838|FG001|Overall Study|Non-compliance|2|||
162745051|NCT03766685|587779839|FG002|Overall Study|Non-compliance|0|||
162745052|NCT03766685|587779840|FG003|Overall Study|Non-compliance|0|||
162745053|NCT02844465|587779845|FG000|Overall Study|Screen Failure|36|||
162745054|NCT02844465|587779845|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
162745055|NCT02844465|587779845|FG000|Overall Study|Withdrawal by Subject|5|||
162745056|NCT02844465|587779845|FG000|Overall Study|Lost to Follow-up|1|||
162745057|NCT02844465|587779845|FG000|Overall Study|Retreatment|1|||
162745058|NCT05297565|587779846|FG000|Overall Study|Other Reasons|0|||
162745059|NCT05297565|587779847|FG001|Overall Study|Other Reasons|1|||
162745060|NCT05297565|587779846|FG000|Overall Study|Physician Decision|0|||
162745061|NCT05297565|587779847|FG001|Overall Study|Physician Decision|1|||
162745062|NCT05297565|587779846|FG000|Overall Study|Disease recurrence|1|||
162745063|NCT05297565|587779847|FG001|Overall Study|Disease recurrence|0|||
162745064|NCT05029622|587779848|FG000|Overall Study|Lost to Follow-up|1|||
162745065|NCT05671653|587779849|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
162745066|NCT05671653|587779850|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
162745067|NCT05671653|587779851|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
162745068|NCT05671653|587779852|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
162745069|NCT05671653|587779853|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
162745070|NCT05671653|587779854|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
162745071|NCT05671653|587779855|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
162745072|NCT05671653|587779856|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
162745073|NCT05671653|587779857|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
162745074|NCT05671653|587779858|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
162745075|NCT05671653|587779859|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
162745076|NCT05671653|587779860|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
162745077|NCT05671653|587779861|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
162745078|NCT05671653|587779849|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745079|NCT05671653|587779850|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745080|NCT05671653|587779851|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745081|NCT05671653|587779852|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745082|NCT05671653|587779853|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745083|NCT05671653|587779854|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
162745084|NCT05671653|587779855|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745085|NCT05671653|587779856|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745086|NCT05671653|587779857|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745087|NCT05671653|587779858|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745088|NCT05671653|587779859|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745089|NCT05671653|587779860|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745090|NCT05671653|587779861|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162745091|NCT05671653|587779849|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745092|NCT05671653|587779850|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745093|NCT05671653|587779851|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745094|NCT05671653|587779852|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745095|NCT05671653|587779853|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745096|NCT05671653|587779854|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
162745097|NCT05671653|587779855|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745098|NCT05671653|587779856|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745099|NCT05671653|587779857|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745100|NCT05671653|587779858|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745101|NCT05671653|587779859|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745102|NCT05671653|587779860|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745103|NCT05671653|587779861|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162745104|NCT05671653|587779849|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745105|NCT05671653|587779850|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745106|NCT05671653|587779851|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745107|NCT05671653|587779852|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745108|NCT05671653|587779853|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745109|NCT05671653|587779854|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745110|NCT05671653|587779855|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745111|NCT05671653|587779856|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745112|NCT05671653|587779857|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
162745113|NCT05671653|587779858|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745114|NCT05671653|587779859|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745115|NCT05671653|587779860|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745116|NCT05671653|587779861|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162745117|NCT05671653|587779849|FG000|Cohort 2 Period 2|Adverse Event|0|||
162745118|NCT05671653|587779850|FG001|Cohort 2 Period 2|Adverse Event|0|||
162745119|NCT05671653|587779851|FG002|Cohort 2 Period 2|Adverse Event|0|||
162745120|NCT05671653|587779852|FG003|Cohort 2 Period 2|Adverse Event|0|||
162745121|NCT05671653|587779853|FG004|Cohort 2 Period 2|Adverse Event|0|||
162745122|NCT05671653|587779854|FG005|Cohort 2 Period 2|Adverse Event|0|||
162745123|NCT05671653|587779855|FG006|Cohort 2 Period 2|Adverse Event|0|||
162745124|NCT05671653|587779856|FG007|Cohort 2 Period 2|Adverse Event|0|||
162745125|NCT05671653|587779857|FG008|Cohort 2 Period 2|Adverse Event|0|||
162745126|NCT05671653|587779858|FG009|Cohort 2 Period 2|Adverse Event|0|||
162745127|NCT05671653|587779859|FG010|Cohort 2 Period 2|Adverse Event|1|||
162745128|NCT05671653|587779860|FG011|Cohort 2 Period 2|Adverse Event|0|||
162745129|NCT05671653|587779861|FG012|Cohort 2 Period 2|Adverse Event|0|||
162745130|NCT05671653|587779849|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
162745131|NCT05671653|587779850|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
162745132|NCT05671653|587779851|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
162745133|NCT05671653|587779852|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
162745134|NCT05671653|587779853|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
162745135|NCT05671653|587779854|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
162745136|NCT05671653|587779855|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
162745137|NCT05671653|587779856|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
162745138|NCT05671653|587779857|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
162745139|NCT05671653|587779858|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
162745140|NCT05671653|587779859|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
162745141|NCT05671653|587779860|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
162745142|NCT05671653|587779861|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
162745143|NCT05671653|587779849|FG000|Cohort 2 Period 2|Pregnancy|0|||
162745144|NCT05671653|587779850|FG001|Cohort 2 Period 2|Pregnancy|0|||
162745145|NCT05671653|587779851|FG002|Cohort 2 Period 2|Pregnancy|0|||
162745146|NCT05671653|587779852|FG003|Cohort 2 Period 2|Pregnancy|0|||
162745147|NCT05671653|587779853|FG004|Cohort 2 Period 2|Pregnancy|0|||
162745148|NCT05671653|587779854|FG005|Cohort 2 Period 2|Pregnancy|0|||
162745149|NCT05671653|587779855|FG006|Cohort 2 Period 2|Pregnancy|0|||
162745150|NCT05671653|587779856|FG007|Cohort 2 Period 2|Pregnancy|0|||
162745151|NCT05671653|587779857|FG008|Cohort 2 Period 2|Pregnancy|0|||
162745152|NCT05671653|587779858|FG009|Cohort 2 Period 2|Pregnancy|0|||
162745153|NCT05671653|587779859|FG010|Cohort 2 Period 2|Pregnancy|1|||
162745154|NCT05671653|587779860|FG011|Cohort 2 Period 2|Pregnancy|0|||
162745155|NCT05671653|587779861|FG012|Cohort 2 Period 2|Pregnancy|0|||
162745156|NCT05671653|587779849|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745157|NCT05671653|587779850|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745158|NCT05671653|587779851|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745159|NCT05671653|587779852|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745160|NCT05671653|587779853|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745161|NCT05671653|587779854|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745162|NCT05671653|587779855|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745163|NCT05671653|587779856|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745164|NCT05671653|587779857|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745165|NCT05671653|587779858|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745166|NCT05671653|587779859|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
162745167|NCT05671653|587779860|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745168|NCT05671653|587779861|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
162745169|NCT05671653|587779849|FG000|Cohort 2 Period 2|Other|0|||
162745170|NCT05671653|587779850|FG001|Cohort 2 Period 2|Other|0|||
162745171|NCT05671653|587779851|FG002|Cohort 2 Period 2|Other|0|||
162745172|NCT05671653|587779852|FG003|Cohort 2 Period 2|Other|0|||
162745173|NCT05671653|587779853|FG004|Cohort 2 Period 2|Other|0|||
162745174|NCT05671653|587779854|FG005|Cohort 2 Period 2|Other|0|||
162745175|NCT05671653|587779855|FG006|Cohort 2 Period 2|Other|0|||
162745176|NCT05671653|587779856|FG007|Cohort 2 Period 2|Other|0|||
162745177|NCT05671653|587779857|FG008|Cohort 2 Period 2|Other|0|||
162745178|NCT05671653|587779858|FG009|Cohort 2 Period 2|Other|0|||
162745179|NCT05671653|587779859|FG010|Cohort 2 Period 2|Other|1|||
162745180|NCT05671653|587779860|FG011|Cohort 2 Period 2|Other|0|||
162745181|NCT05671653|587779861|FG012|Cohort 2 Period 2|Other|0|||
162745182|NCT05671653|587779849|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745183|NCT05671653|587779850|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745184|NCT05671653|587779851|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745185|NCT05671653|587779852|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745186|NCT05671653|587779853|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745187|NCT05671653|587779854|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745188|NCT05671653|587779855|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745189|NCT05671653|587779856|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745190|NCT05671653|587779857|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745191|NCT05671653|587779858|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745192|NCT05671653|587779859|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745193|NCT05671653|587779860|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
162745194|NCT05671653|587779861|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162745195|NCT01197378|587779865|FG000|Overall Study|Adverse Event|3|||
162745196|NCT01197378|587779865|FG000|Overall Study|Withdrawal by Subject|1|||
162745197|NCT01197378|587779865|FG000|Overall Study|Physician Decision|1|||
162745198|NCT01197378|587779865|FG000|Overall Study|Other|2|||
162745199|NCT06232590|587779866|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
162745200|NCT06232590|587779867|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
162745201|NCT05299723|587779868|FG000|Overall Study|Withdrawal by Subject|0|||
162745202|NCT05299723|587779869|FG001|Overall Study|Withdrawal by Subject|2|||
162745203|NCT05299723|587779870|FG002|Overall Study|Withdrawal by Subject|0|||
162745204|NCT01959607|587779871|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
162745205|NCT01959607|587779872|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
162745206|NCT01959607|587779873|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162745207|NCT01959607|587779874|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
162745208|NCT03913442|587779875|FG000|Overall Study|Adverse Event|0|||
162745209|NCT03913442|587779876|FG001|Overall Study|Adverse Event|3|||
162745210|NCT03913442|587779875|FG000|Overall Study|Withdrawal by Subject|5|||
162745211|NCT03913442|587779876|FG001|Overall Study|Withdrawal by Subject|5|||
162745212|NCT03913442|587779875|FG000|Overall Study|Terminations|2|||
162745213|NCT03913442|587779876|FG001|Overall Study|Terminations|1|||
162745214|NCT03913442|587779875|FG000|Overall Study|Lost to Follow-up|2|||
162745215|NCT03913442|587779876|FG001|Overall Study|Lost to Follow-up|2|||
162745216|NCT02460458|587779877|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
162745217|NCT02460458|587779877|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
162745218|NCT02460458|587779877|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
162745219|NCT02460458|587779877|FG000|First Prospective Phase|Lost to Follow-up|84|||
162745220|NCT02460458|587779877|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
162745221|NCT03710603|587779881|FG000|Overall Study|Adverse Event|1|||
162745222|NCT03710603|587779882|FG001|Overall Study|Adverse Event|0|||
162745223|NCT03710603|587779881|FG000|Overall Study|Death|44|||
162745224|NCT03710603|587779882|FG001|Overall Study|Death|34|||
162745225|NCT03710603|587779881|FG000|Overall Study|Lost to Follow-up|3|||
162745226|NCT03710603|587779882|FG001|Overall Study|Lost to Follow-up|5|||
162745227|NCT03710603|587779881|FG000|Overall Study|Withdrawal by Subject|11|||
162745228|NCT03710603|587779882|FG001|Overall Study|Withdrawal by Subject|10|||
162745229|NCT02589795|587779886|FG000|Overall Study|Lost to Follow-up|1|||
162745230|NCT02589795|587779887|FG001|Overall Study|Lost to Follow-up|0|||
162745231|NCT02589795|587779888|FG002|Overall Study|Lost to Follow-up|0|||
162745232|NCT02589795|587779886|FG000|Overall Study|Withdrawal by Subject|0|||
162745233|NCT02589795|587779887|FG001|Overall Study|Withdrawal by Subject|0|||
162745234|NCT02589795|587779888|FG002|Overall Study|Withdrawal by Subject|2|||
162745235|NCT02589795|587779886|FG000|Overall Study|Protocol Violation|0|||
162745236|NCT02589795|587779887|FG001|Overall Study|Protocol Violation|0|||
162745237|NCT02589795|587779888|FG002|Overall Study|Protocol Violation|1|||
162745238|NCT03691935|587779895|FG000|Overall Study|Physician Decision|2|||
162745239|NCT03691935|587779896|FG001|Overall Study|Physician Decision|1|||
162745240|NCT03691935|587779895|FG000|Overall Study|Adverse Event|3|||
162745241|NCT03691935|587779896|FG001|Overall Study|Adverse Event|0|||
162745242|NCT03511664|587779903|FG000|Overall Study|Death|457|||
162745243|NCT03511664|587779904|FG001|Overall Study|Death|201|||
162745244|NCT03511664|587779905|FG002|Overall Study|Death|21|||
162745245|NCT03511664|587779903|FG000|Overall Study|Withdrew consent|40|||
162745246|NCT03511664|587779904|FG001|Overall Study|Withdrew consent|63|||
162745247|NCT03511664|587779905|FG002|Overall Study|Withdrew consent|3|||
162745248|NCT03511664|587779903|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
162745249|NCT03511664|587779904|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
162745250|NCT03511664|587779905|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
162745251|NCT03511664|587779903|FG000|Overall Study|Lost to Follow-up|8|||
162745252|NCT03511664|587779904|FG001|Overall Study|Lost to Follow-up|5|||
162745253|NCT03511664|587779905|FG002|Overall Study|Lost to Follow-up|0|||
162745254|NCT03511664|587779903|FG000|Overall Study|Physician Decision|2|||
162745255|NCT03511664|587779904|FG001|Overall Study|Physician Decision|1|||
162745256|NCT03511664|587779905|FG002|Overall Study|Physician Decision|0|||
162745257|NCT03511664|587779903|FG000|Overall Study|Patient non-compliance|1|||
162745258|NCT03511664|587779904|FG001|Overall Study|Patient non-compliance|0|||
162745259|NCT03511664|587779905|FG002|Overall Study|Patient non-compliance|0|||
162745260|NCT01946789|587779906|FG000|Overall Study|Death|0|||
162745261|NCT01946789|587779907|FG001|Overall Study|Death|2|||
162745262|NCT01946789|587779908|FG002|Overall Study|Death|1|||
162745263|NCT01946789|587779909|FG003|Overall Study|Death|1|||
162745264|NCT01946789|587779910|FG004|Overall Study|Death|1|||
162745265|NCT01946789|587779911|FG005|Overall Study|Death|1|||
162745266|NCT01946789|587779912|FG006|Overall Study|Death|3|||
162745267|NCT01946789|587779913|FG007|Overall Study|Death|1|||
162745268|NCT01946789|587779914|FG008|Overall Study|Death|2|||
162745269|NCT01946789|587779906|FG000|Overall Study|Progressive Disease|0|||
162745270|NCT01946789|587779907|FG001|Overall Study|Progressive Disease|0|||
162745271|NCT01946789|587779908|FG002|Overall Study|Progressive Disease|1|||
162745272|NCT01946789|587779909|FG003|Overall Study|Progressive Disease|0|||
162745273|NCT01946789|587779910|FG004|Overall Study|Progressive Disease|0|||
162745274|NCT01946789|587779911|FG005|Overall Study|Progressive Disease|2|||
162745275|NCT01946789|587779912|FG006|Overall Study|Progressive Disease|0|||
162745276|NCT01946789|587779913|FG007|Overall Study|Progressive Disease|0|||
162745277|NCT01946789|587779914|FG008|Overall Study|Progressive Disease|0|||
162745278|NCT01946789|587779906|FG000|Overall Study|Withdrawal by Subject|0|||
162745279|NCT01946789|587779907|FG001|Overall Study|Withdrawal by Subject|0|||
162745280|NCT01946789|587779908|FG002|Overall Study|Withdrawal by Subject|0|||
162745281|NCT01946789|587779909|FG003|Overall Study|Withdrawal by Subject|2|||
162745282|NCT01946789|587779910|FG004|Overall Study|Withdrawal by Subject|1|||
162745283|NCT01946789|587779911|FG005|Overall Study|Withdrawal by Subject|0|||
162745284|NCT01946789|587779912|FG006|Overall Study|Withdrawal by Subject|1|||
162745285|NCT01946789|587779913|FG007|Overall Study|Withdrawal by Subject|0|||
162745286|NCT01946789|587779914|FG008|Overall Study|Withdrawal by Subject|0|||
162745287|NCT04076618|587779915|FG000|Overall Study|Lost to Follow-up|2|||
162925345|NCT00602641|588428936|FG000|Overall Study|Administrative Closure|1|||
162745288|NCT04076618|587779916|FG001|Overall Study|Lost to Follow-up|1|||
162745289|NCT04076618|587779917|FG002|Overall Study|Lost to Follow-up|3|||
162745290|NCT04076618|587779915|FG000|Overall Study|Withdrawal by Subject|3|||
162745291|NCT04076618|587779916|FG001|Overall Study|Withdrawal by Subject|1|||
162745292|NCT04076618|587779917|FG002|Overall Study|Withdrawal by Subject|2|||
162745293|NCT04076618|587779915|FG000|Overall Study|Relocated out of state|0|||
162745294|NCT04076618|587779916|FG001|Overall Study|Relocated out of state|2|||
162745295|NCT04076618|587779917|FG002|Overall Study|Relocated out of state|0|||
162745296|NCT04076618|587779915|FG000|Overall Study|COVID concerns|0|||
162745297|NCT04076618|587779916|FG001|Overall Study|COVID concerns|1|||
162745298|NCT04076618|587779917|FG002|Overall Study|COVID concerns|0|||
162745299|NCT04076618|587779915|FG000|Overall Study|Adverse Event|0|||
162745300|NCT04076618|587779916|FG001|Overall Study|Adverse Event|0|||
162745301|NCT04076618|587779917|FG002|Overall Study|Adverse Event|2|||
162745302|NCT01928394|587779918|FG000|Treatment Period|Disease progression|17|||
162745303|NCT01928394|587779919|FG001|Treatment Period|Disease progression|2|||
162745304|NCT01928394|587779920|FG002|Treatment Period|Disease progression|12|||
162745305|NCT01928394|587779921|FG003|Treatment Period|Disease progression|48|||
162745306|NCT01928394|587779922|FG004|Treatment Period|Disease progression|3|||
162745307|NCT01928394|587779923|FG005|Treatment Period|Disease progression|25|||
162745308|NCT01928394|587779924|FG006|Treatment Period|Disease progression|38|||
162745309|NCT01928394|587779925|FG007|Treatment Period|Disease progression|16|||
162745310|NCT01928394|587779926|FG008|Treatment Period|Disease progression|3|||
162745311|NCT01928394|587779927|FG009|Treatment Period|Disease progression|11|||
162745312|NCT01928394|587779928|FG010|Treatment Period|Disease progression|22|||
162745313|NCT01928394|587779929|FG011|Treatment Period|Disease progression|73|||
162745314|NCT01928394|587779930|FG012|Treatment Period|Disease progression|38|||
162745315|NCT01928394|587779931|FG013|Treatment Period|Disease progression|118|||
162745316|NCT01928394|587779932|FG014|Treatment Period|Disease progression|59|||
162745317|NCT01928394|587779933|FG015|Treatment Period|Disease progression|1|||
162745318|NCT01928394|587779934|FG016|Treatment Period|Disease progression|43|||
162745319|NCT01928394|587779935|FG017|Treatment Period|Disease progression|56|||
162745320|NCT01928394|587779936|FG018|Treatment Period|Disease progression|50|||
162745321|NCT01928394|587779937|FG019|Treatment Period|Disease progression|71|||
162745322|NCT01928394|587779938|FG020|Treatment Period|Disease progression|30|||
162745323|NCT01928394|587779939|FG021|Treatment Period|Disease progression|31|||
162745324|NCT01928394|587779940|FG022|Treatment Period|Disease progression|31|||
162745325|NCT01928394|587779918|FG000|Treatment Period|Study drug toxicity|1|||
162745326|NCT01928394|587779919|FG001|Treatment Period|Study drug toxicity|1|||
162745327|NCT01928394|587779920|FG002|Treatment Period|Study drug toxicity|3|||
162745328|NCT01928394|587779921|FG003|Treatment Period|Study drug toxicity|3|||
162745329|NCT01928394|587779922|FG004|Treatment Period|Study drug toxicity|0|||
162745330|NCT01928394|587779923|FG005|Treatment Period|Study drug toxicity|9|||
162745331|NCT01928394|587779924|FG006|Treatment Period|Study drug toxicity|7|||
162745332|NCT01928394|587779925|FG007|Treatment Period|Study drug toxicity|1|||
162745333|NCT01928394|587779926|FG008|Treatment Period|Study drug toxicity|0|||
162745334|NCT01928394|587779927|FG009|Treatment Period|Study drug toxicity|5|||
162745335|NCT01928394|587779928|FG010|Treatment Period|Study drug toxicity|2|||
162745336|NCT01928394|587779929|FG011|Treatment Period|Study drug toxicity|3|||
162745337|NCT01928394|587779930|FG012|Treatment Period|Study drug toxicity|7|||
162745338|NCT01928394|587779931|FG013|Treatment Period|Study drug toxicity|5|||
162745339|NCT01928394|587779932|FG014|Treatment Period|Study drug toxicity|12|||
162745340|NCT01928394|587779933|FG015|Treatment Period|Study drug toxicity|0|||
162745341|NCT01928394|587779934|FG016|Treatment Period|Study drug toxicity|3|||
162745342|NCT01928394|587779935|FG017|Treatment Period|Study drug toxicity|3|||
162745343|NCT01928394|587779936|FG018|Treatment Period|Study drug toxicity|12|||
162745344|NCT01928394|587779937|FG019|Treatment Period|Study drug toxicity|15|||
162745345|NCT01928394|587779938|FG020|Treatment Period|Study drug toxicity|4|||
162745346|NCT01928394|587779939|FG021|Treatment Period|Study drug toxicity|7|||
162745347|NCT01928394|587779940|FG022|Treatment Period|Study drug toxicity|4|||
162745348|NCT01928394|587779918|FG000|Treatment Period|AE unrelated to study drug|0|||
162745349|NCT01928394|587779919|FG001|Treatment Period|AE unrelated to study drug|0|||
162745350|NCT01928394|587779920|FG002|Treatment Period|AE unrelated to study drug|2|||
162745351|NCT01928394|587779921|FG003|Treatment Period|AE unrelated to study drug|3|||
162745352|NCT01928394|587779922|FG004|Treatment Period|AE unrelated to study drug|0|||
162745353|NCT01928394|587779923|FG005|Treatment Period|AE unrelated to study drug|5|||
162745354|NCT01928394|587779924|FG006|Treatment Period|AE unrelated to study drug|1|||
162745355|NCT01928394|587779925|FG007|Treatment Period|AE unrelated to study drug|0|||
162745356|NCT01928394|587779926|FG008|Treatment Period|AE unrelated to study drug|0|||
162745357|NCT01928394|587779927|FG009|Treatment Period|AE unrelated to study drug|2|||
162745358|NCT01928394|587779928|FG010|Treatment Period|AE unrelated to study drug|0|||
162745359|NCT01928394|587779929|FG011|Treatment Period|AE unrelated to study drug|12|||
162745360|NCT01928394|587779930|FG012|Treatment Period|AE unrelated to study drug|6|||
162745361|NCT01928394|587779931|FG013|Treatment Period|AE unrelated to study drug|13|||
162745362|NCT01928394|587779932|FG014|Treatment Period|AE unrelated to study drug|6|||
162745363|NCT01928394|587779933|FG015|Treatment Period|AE unrelated to study drug|1|||
162745364|NCT01928394|587779934|FG016|Treatment Period|AE unrelated to study drug|1|||
162745365|NCT01928394|587779935|FG017|Treatment Period|AE unrelated to study drug|6|||
162745366|NCT01928394|587779936|FG018|Treatment Period|AE unrelated to study drug|3|||
162745367|NCT01928394|587779937|FG019|Treatment Period|AE unrelated to study drug|5|||
162745368|NCT01928394|587779938|FG020|Treatment Period|AE unrelated to study drug|1|||
162745369|NCT01928394|587779939|FG021|Treatment Period|AE unrelated to study drug|1|||
162745370|NCT01928394|587779940|FG022|Treatment Period|AE unrelated to study drug|0|||
162745371|NCT01928394|587779918|FG000|Treatment Period|Participant request to stop therapy|0|||
162745372|NCT01928394|587779919|FG001|Treatment Period|Participant request to stop therapy|0|||
162745373|NCT01928394|587779920|FG002|Treatment Period|Participant request to stop therapy|0|||
162745374|NCT01928394|587779921|FG003|Treatment Period|Participant request to stop therapy|0|||
162745375|NCT01928394|587779922|FG004|Treatment Period|Participant request to stop therapy|0|||
162745376|NCT01928394|587779923|FG005|Treatment Period|Participant request to stop therapy|3|||
162745377|NCT01928394|587779924|FG006|Treatment Period|Participant request to stop therapy|3|||
162745378|NCT01928394|587779925|FG007|Treatment Period|Participant request to stop therapy|0|||
162745379|NCT01928394|587779926|FG008|Treatment Period|Participant request to stop therapy|0|||
162745380|NCT01928394|587779927|FG009|Treatment Period|Participant request to stop therapy|0|||
162745381|NCT01928394|587779928|FG010|Treatment Period|Participant request to stop therapy|3|||
162745382|NCT01928394|587779929|FG011|Treatment Period|Participant request to stop therapy|2|||
162745383|NCT01928394|587779930|FG012|Treatment Period|Participant request to stop therapy|1|||
162745384|NCT01928394|587779931|FG013|Treatment Period|Participant request to stop therapy|2|||
162745385|NCT01928394|587779932|FG014|Treatment Period|Participant request to stop therapy|4|||
162745386|NCT01928394|587779933|FG015|Treatment Period|Participant request to stop therapy|0|||
162745387|NCT01928394|587779934|FG016|Treatment Period|Participant request to stop therapy|1|||
162745388|NCT01928394|587779935|FG017|Treatment Period|Participant request to stop therapy|3|||
162745389|NCT01928394|587779936|FG018|Treatment Period|Participant request to stop therapy|1|||
162745390|NCT01928394|587779937|FG019|Treatment Period|Participant request to stop therapy|1|||
162745391|NCT01928394|587779938|FG020|Treatment Period|Participant request to stop therapy|3|||
162745392|NCT01928394|587779939|FG021|Treatment Period|Participant request to stop therapy|1|||
162745393|NCT01928394|587779940|FG022|Treatment Period|Participant request to stop therapy|3|||
162745394|NCT01928394|587779918|FG000|Treatment Period|Participant withdrew consent|0|||
162745395|NCT01928394|587779919|FG001|Treatment Period|Participant withdrew consent|0|||
162745396|NCT01928394|587779920|FG002|Treatment Period|Participant withdrew consent|1|||
162745397|NCT01928394|587779921|FG003|Treatment Period|Participant withdrew consent|1|||
162745398|NCT01928394|587779922|FG004|Treatment Period|Participant withdrew consent|0|||
162745399|NCT01928394|587779923|FG005|Treatment Period|Participant withdrew consent|1|||
162745400|NCT01928394|587779924|FG006|Treatment Period|Participant withdrew consent|0|||
162745401|NCT01928394|587779925|FG007|Treatment Period|Participant withdrew consent|1|||
162745402|NCT01928394|587779926|FG008|Treatment Period|Participant withdrew consent|0|||
162745403|NCT01928394|587779927|FG009|Treatment Period|Participant withdrew consent|0|||
162745404|NCT01928394|587779928|FG010|Treatment Period|Participant withdrew consent|1|||
162745405|NCT01928394|587779929|FG011|Treatment Period|Participant withdrew consent|1|||
162745406|NCT01928394|587779930|FG012|Treatment Period|Participant withdrew consent|1|||
162745407|NCT01928394|587779931|FG013|Treatment Period|Participant withdrew consent|0|||
162745408|NCT01928394|587779932|FG014|Treatment Period|Participant withdrew consent|2|||
162745409|NCT01928394|587779933|FG015|Treatment Period|Participant withdrew consent|0|||
162745410|NCT01928394|587779934|FG016|Treatment Period|Participant withdrew consent|2|||
162745411|NCT01928394|587779935|FG017|Treatment Period|Participant withdrew consent|1|||
162745412|NCT01928394|587779936|FG018|Treatment Period|Participant withdrew consent|1|||
162745413|NCT01928394|587779937|FG019|Treatment Period|Participant withdrew consent|1|||
162745414|NCT01928394|587779938|FG020|Treatment Period|Participant withdrew consent|0|||
162745415|NCT01928394|587779939|FG021|Treatment Period|Participant withdrew consent|2|||
162745416|NCT01928394|587779940|FG022|Treatment Period|Participant withdrew consent|0|||
162745417|NCT01928394|587779918|FG000|Treatment Period|Poor/non-compliance|0|||
162745418|NCT01928394|587779919|FG001|Treatment Period|Poor/non-compliance|0|||
162745419|NCT01928394|587779920|FG002|Treatment Period|Poor/non-compliance|0|||
162745420|NCT01928394|587779921|FG003|Treatment Period|Poor/non-compliance|1|||
162745421|NCT01928394|587779922|FG004|Treatment Period|Poor/non-compliance|0|||
162745422|NCT01928394|587779923|FG005|Treatment Period|Poor/non-compliance|0|||
162745423|NCT01928394|587779924|FG006|Treatment Period|Poor/non-compliance|0|||
162745424|NCT01928394|587779925|FG007|Treatment Period|Poor/non-compliance|0|||
162745425|NCT01928394|587779926|FG008|Treatment Period|Poor/non-compliance|0|||
162745426|NCT01928394|587779927|FG009|Treatment Period|Poor/non-compliance|0|||
162745427|NCT01928394|587779928|FG010|Treatment Period|Poor/non-compliance|0|||
162745428|NCT01928394|587779929|FG011|Treatment Period|Poor/non-compliance|0|||
162745429|NCT01928394|587779930|FG012|Treatment Period|Poor/non-compliance|1|||
162745430|NCT01928394|587779931|FG013|Treatment Period|Poor/non-compliance|0|||
162745431|NCT01928394|587779932|FG014|Treatment Period|Poor/non-compliance|1|||
162745432|NCT01928394|587779933|FG015|Treatment Period|Poor/non-compliance|0|||
162745433|NCT01928394|587779934|FG016|Treatment Period|Poor/non-compliance|0|||
162745434|NCT01928394|587779935|FG017|Treatment Period|Poor/non-compliance|1|||
162745435|NCT01928394|587779936|FG018|Treatment Period|Poor/non-compliance|0|||
162745436|NCT01928394|587779937|FG019|Treatment Period|Poor/non-compliance|1|||
162745437|NCT01928394|587779938|FG020|Treatment Period|Poor/non-compliance|0|||
162745438|NCT01928394|587779939|FG021|Treatment Period|Poor/non-compliance|0|||
162745439|NCT01928394|587779940|FG022|Treatment Period|Poor/non-compliance|0|||
162745440|NCT01928394|587779918|FG000|Treatment Period|other reason|0|||
162745441|NCT01928394|587779919|FG001|Treatment Period|other reason|0|||
162745442|NCT01928394|587779920|FG002|Treatment Period|other reason|0|||
162745443|NCT01928394|587779921|FG003|Treatment Period|other reason|0|||
162745444|NCT01928394|587779922|FG004|Treatment Period|other reason|0|||
162745445|NCT01928394|587779923|FG005|Treatment Period|other reason|0|||
162745446|NCT01928394|587779924|FG006|Treatment Period|other reason|0|||
162745447|NCT01928394|587779925|FG007|Treatment Period|other reason|0|||
162745448|NCT01928394|587779926|FG008|Treatment Period|other reason|0|||
162745449|NCT01928394|587779927|FG009|Treatment Period|other reason|0|||
162745450|NCT01928394|587779928|FG010|Treatment Period|other reason|1|||
162745451|NCT01928394|587779929|FG011|Treatment Period|other reason|1|||
162745452|NCT01928394|587779930|FG012|Treatment Period|other reason|1|||
162745453|NCT01928394|587779931|FG013|Treatment Period|other reason|0|||
162745454|NCT01928394|587779932|FG014|Treatment Period|other reason|1|||
162745455|NCT01928394|587779933|FG015|Treatment Period|other reason|0|||
162745456|NCT01928394|587779934|FG016|Treatment Period|other reason|0|||
162745457|NCT01928394|587779935|FG017|Treatment Period|other reason|0|||
162745458|NCT01928394|587779936|FG018|Treatment Period|other reason|2|||
162745459|NCT01928394|587779937|FG019|Treatment Period|other reason|2|||
162745460|NCT01928394|587779938|FG020|Treatment Period|other reason|0|||
162745461|NCT01928394|587779939|FG021|Treatment Period|other reason|0|||
162745462|NCT01928394|587779940|FG022|Treatment Period|other reason|0|||
162745463|NCT01928394|587779918|FG000|Treatment Period|Maximum clinical benefit|0|||
162745464|NCT01928394|587779919|FG001|Treatment Period|Maximum clinical benefit|0|||
162745465|NCT01928394|587779920|FG002|Treatment Period|Maximum clinical benefit|0|||
162745466|NCT01928394|587779921|FG003|Treatment Period|Maximum clinical benefit|0|||
162745467|NCT01928394|587779922|FG004|Treatment Period|Maximum clinical benefit|0|||
162745468|NCT01928394|587779923|FG005|Treatment Period|Maximum clinical benefit|0|||
162745469|NCT01928394|587779924|FG006|Treatment Period|Maximum clinical benefit|0|||
162745470|NCT01928394|587779925|FG007|Treatment Period|Maximum clinical benefit|0|||
162745471|NCT01928394|587779926|FG008|Treatment Period|Maximum clinical benefit|0|||
162745472|NCT01928394|587779927|FG009|Treatment Period|Maximum clinical benefit|0|||
162745473|NCT01928394|587779928|FG010|Treatment Period|Maximum clinical benefit|1|||
162745474|NCT01928394|587779929|FG011|Treatment Period|Maximum clinical benefit|1|||
162745475|NCT01928394|587779930|FG012|Treatment Period|Maximum clinical benefit|0|||
162745476|NCT01928394|587779931|FG013|Treatment Period|Maximum clinical benefit|0|||
162745477|NCT01928394|587779932|FG014|Treatment Period|Maximum clinical benefit|1|||
162745478|NCT01928394|587779933|FG015|Treatment Period|Maximum clinical benefit|0|||
162745479|NCT01928394|587779934|FG016|Treatment Period|Maximum clinical benefit|0|||
162745480|NCT01928394|587779935|FG017|Treatment Period|Maximum clinical benefit|1|||
162745481|NCT01928394|587779936|FG018|Treatment Period|Maximum clinical benefit|1|||
162745482|NCT01928394|587779937|FG019|Treatment Period|Maximum clinical benefit|0|||
162745483|NCT01928394|587779938|FG020|Treatment Period|Maximum clinical benefit|2|||
162745484|NCT01928394|587779939|FG021|Treatment Period|Maximum clinical benefit|0|||
162745485|NCT01928394|587779940|FG022|Treatment Period|Maximum clinical benefit|0|||
162745486|NCT01928394|587779918|FG000|Treatment Period|Lost to Follow-up|0|||
162745487|NCT01928394|587779919|FG001|Treatment Period|Lost to Follow-up|0|||
162745488|NCT01928394|587779920|FG002|Treatment Period|Lost to Follow-up|0|||
162745489|NCT01928394|587779921|FG003|Treatment Period|Lost to Follow-up|0|||
162745490|NCT01928394|587779922|FG004|Treatment Period|Lost to Follow-up|0|||
162745491|NCT01928394|587779923|FG005|Treatment Period|Lost to Follow-up|0|||
162745492|NCT01928394|587779924|FG006|Treatment Period|Lost to Follow-up|0|||
162745493|NCT01928394|587779925|FG007|Treatment Period|Lost to Follow-up|0|||
162745494|NCT01928394|587779926|FG008|Treatment Period|Lost to Follow-up|0|||
162745495|NCT01928394|587779927|FG009|Treatment Period|Lost to Follow-up|0|||
162745496|NCT01928394|587779928|FG010|Treatment Period|Lost to Follow-up|0|||
162745497|NCT01928394|587779929|FG011|Treatment Period|Lost to Follow-up|0|||
162745498|NCT01928394|587779930|FG012|Treatment Period|Lost to Follow-up|0|||
162745499|NCT01928394|587779931|FG013|Treatment Period|Lost to Follow-up|0|||
162745500|NCT01928394|587779932|FG014|Treatment Period|Lost to Follow-up|0|||
162745501|NCT01928394|587779933|FG015|Treatment Period|Lost to Follow-up|0|||
162745502|NCT01928394|587779934|FG016|Treatment Period|Lost to Follow-up|0|||
162745503|NCT01928394|587779935|FG017|Treatment Period|Lost to Follow-up|0|||
162745504|NCT01928394|587779936|FG018|Treatment Period|Lost to Follow-up|0|||
162745505|NCT01928394|587779937|FG019|Treatment Period|Lost to Follow-up|0|||
162745506|NCT01928394|587779938|FG020|Treatment Period|Lost to Follow-up|0|||
162745507|NCT01928394|587779939|FG021|Treatment Period|Lost to Follow-up|0|||
162745508|NCT01928394|587779940|FG022|Treatment Period|Lost to Follow-up|1|||
162745509|NCT01928394|587779918|FG000|Treatment Period|Death|0|||
162745510|NCT01928394|587779919|FG001|Treatment Period|Death|0|||
162745511|NCT01928394|587779920|FG002|Treatment Period|Death|0|||
162745512|NCT01928394|587779921|FG003|Treatment Period|Death|0|||
162745513|NCT01928394|587779922|FG004|Treatment Period|Death|0|||
162745514|NCT01928394|587779923|FG005|Treatment Period|Death|0|||
162745515|NCT01928394|587779924|FG006|Treatment Period|Death|0|||
162745516|NCT01928394|587779925|FG007|Treatment Period|Death|0|||
162745517|NCT01928394|587779926|FG008|Treatment Period|Death|0|||
162745518|NCT01928394|587779927|FG009|Treatment Period|Death|0|||
162745519|NCT01928394|587779928|FG010|Treatment Period|Death|0|||
162745520|NCT01928394|587779929|FG011|Treatment Period|Death|0|||
162745521|NCT01928394|587779930|FG012|Treatment Period|Death|0|||
162745522|NCT01928394|587779931|FG013|Treatment Period|Death|1|||
162745523|NCT01928394|587779932|FG014|Treatment Period|Death|2|||
162745524|NCT01928394|587779933|FG015|Treatment Period|Death|0|||
162745525|NCT01928394|587779934|FG016|Treatment Period|Death|0|||
162745526|NCT01928394|587779935|FG017|Treatment Period|Death|0|||
162745527|NCT01928394|587779936|FG018|Treatment Period|Death|0|||
162745528|NCT01928394|587779937|FG019|Treatment Period|Death|0|||
162745529|NCT01928394|587779938|FG020|Treatment Period|Death|0|||
162745530|NCT01928394|587779939|FG021|Treatment Period|Death|0|||
162745531|NCT01928394|587779940|FG022|Treatment Period|Death|0|||
162745532|NCT01928394|587779918|FG000|Follow-up Period|Participant withdrew consent|3|||
162745533|NCT01928394|587779919|FG001|Follow-up Period|Participant withdrew consent|0|||
162745534|NCT01928394|587779920|FG002|Follow-up Period|Participant withdrew consent|1|||
162745535|NCT01928394|587779921|FG003|Follow-up Period|Participant withdrew consent|4|||
162745536|NCT01928394|587779922|FG004|Follow-up Period|Participant withdrew consent|0|||
162745537|NCT01928394|587779923|FG005|Follow-up Period|Participant withdrew consent|2|||
162745538|NCT01928394|587779924|FG006|Follow-up Period|Participant withdrew consent|5|||
162745539|NCT01928394|587779925|FG007|Follow-up Period|Participant withdrew consent|1|||
162745540|NCT01928394|587779926|FG008|Follow-up Period|Participant withdrew consent|0|||
162745541|NCT01928394|587779927|FG009|Follow-up Period|Participant withdrew consent|0|||
162745542|NCT01928394|587779928|FG010|Follow-up Period|Participant withdrew consent|5|||
162745543|NCT01928394|587779929|FG011|Follow-up Period|Participant withdrew consent|8|||
162745544|NCT01928394|587779930|FG012|Follow-up Period|Participant withdrew consent|2|||
162745545|NCT01928394|587779931|FG013|Follow-up Period|Participant withdrew consent|12|||
162745546|NCT01928394|587779932|FG014|Follow-up Period|Participant withdrew consent|7|||
162745547|NCT01928394|587779933|FG015|Follow-up Period|Participant withdrew consent|0|||
162745548|NCT01928394|587779934|FG016|Follow-up Period|Participant withdrew consent|5|||
162745549|NCT01928394|587779935|FG017|Follow-up Period|Participant withdrew consent|3|||
162745550|NCT01928394|587779936|FG018|Follow-up Period|Participant withdrew consent|2|||
162745551|NCT01928394|587779937|FG019|Follow-up Period|Participant withdrew consent|7|||
162745552|NCT01928394|587779938|FG020|Follow-up Period|Participant withdrew consent|4|||
162745553|NCT01928394|587779939|FG021|Follow-up Period|Participant withdrew consent|6|||
162745554|NCT01928394|587779940|FG022|Follow-up Period|Participant withdrew consent|2|||
162745555|NCT01928394|587779918|FG000|Follow-up Period|Death|0|||
162745556|NCT01928394|587779919|FG001|Follow-up Period|Death|0|||
162745557|NCT01928394|587779920|FG002|Follow-up Period|Death|2|||
162745558|NCT01928394|587779921|FG003|Follow-up Period|Death|6|||
162745559|NCT01928394|587779922|FG004|Follow-up Period|Death|0|||
162745560|NCT01928394|587779923|FG005|Follow-up Period|Death|6|||
162745561|NCT01928394|587779924|FG006|Follow-up Period|Death|6|||
162745562|NCT01928394|587779925|FG007|Follow-up Period|Death|2|||
162745563|NCT01928394|587779926|FG008|Follow-up Period|Death|1|||
162745564|NCT01928394|587779927|FG009|Follow-up Period|Death|2|||
162745565|NCT01928394|587779928|FG010|Follow-up Period|Death|4|||
162745566|NCT01928394|587779929|FG011|Follow-up Period|Death|12|||
162745567|NCT01928394|587779930|FG012|Follow-up Period|Death|11|||
162745568|NCT01928394|587779931|FG013|Follow-up Period|Death|25|||
162745569|NCT01928394|587779932|FG014|Follow-up Period|Death|18|||
162745570|NCT01928394|587779933|FG015|Follow-up Period|Death|0|||
162745571|NCT01928394|587779934|FG016|Follow-up Period|Death|6|||
162745572|NCT01928394|587779935|FG017|Follow-up Period|Death|5|||
162745573|NCT01928394|587779936|FG018|Follow-up Period|Death|13|||
162745574|NCT01928394|587779937|FG019|Follow-up Period|Death|13|||
162745575|NCT01928394|587779938|FG020|Follow-up Period|Death|5|||
162745576|NCT01928394|587779939|FG021|Follow-up Period|Death|3|||
162745577|NCT01928394|587779940|FG022|Follow-up Period|Death|2|||
162745578|NCT01928394|587779918|FG000|Follow-up Period|other reason|0|||
162745579|NCT01928394|587779919|FG001|Follow-up Period|other reason|0|||
162745580|NCT01928394|587779920|FG002|Follow-up Period|other reason|0|||
162745581|NCT01928394|587779921|FG003|Follow-up Period|other reason|0|||
162745582|NCT01928394|587779922|FG004|Follow-up Period|other reason|0|||
162745583|NCT01928394|587779923|FG005|Follow-up Period|other reason|0|||
162745584|NCT01928394|587779924|FG006|Follow-up Period|other reason|1|||
162745585|NCT01928394|587779925|FG007|Follow-up Period|other reason|3|||
162745586|NCT01928394|587779926|FG008|Follow-up Period|other reason|0|||
162745587|NCT01928394|587779927|FG009|Follow-up Period|other reason|0|||
162745588|NCT01928394|587779928|FG010|Follow-up Period|other reason|2|||
162745589|NCT01928394|587779929|FG011|Follow-up Period|other reason|1|||
162745590|NCT01928394|587779930|FG012|Follow-up Period|other reason|0|||
162745591|NCT01928394|587779931|FG013|Follow-up Period|other reason|1|||
162745592|NCT01928394|587779932|FG014|Follow-up Period|other reason|4|||
162745593|NCT01928394|587779933|FG015|Follow-up Period|other reason|0|||
162745594|NCT01928394|587779934|FG016|Follow-up Period|other reason|2|||
162745595|NCT01928394|587779935|FG017|Follow-up Period|other reason|0|||
162745596|NCT01928394|587779936|FG018|Follow-up Period|other reason|1|||
162745597|NCT01928394|587779937|FG019|Follow-up Period|other reason|1|||
162745598|NCT01928394|587779938|FG020|Follow-up Period|other reason|0|||
162745599|NCT01928394|587779939|FG021|Follow-up Period|other reason|0|||
162745600|NCT01928394|587779940|FG022|Follow-up Period|other reason|1|||
162745601|NCT01928394|587779918|FG000|Follow-up Period|Lost to Follow-up|0|||
162745602|NCT01928394|587779919|FG001|Follow-up Period|Lost to Follow-up|0|||
162745603|NCT01928394|587779920|FG002|Follow-up Period|Lost to Follow-up|0|||
162745604|NCT01928394|587779921|FG003|Follow-up Period|Lost to Follow-up|0|||
162745605|NCT01928394|587779922|FG004|Follow-up Period|Lost to Follow-up|0|||
162745606|NCT01928394|587779923|FG005|Follow-up Period|Lost to Follow-up|0|||
162745607|NCT01928394|587779924|FG006|Follow-up Period|Lost to Follow-up|0|||
162745608|NCT01928394|587779925|FG007|Follow-up Period|Lost to Follow-up|0|||
162745609|NCT01928394|587779926|FG008|Follow-up Period|Lost to Follow-up|0|||
162745610|NCT01928394|587779927|FG009|Follow-up Period|Lost to Follow-up|0|||
162745611|NCT01928394|587779928|FG010|Follow-up Period|Lost to Follow-up|0|||
162745612|NCT01928394|587779929|FG011|Follow-up Period|Lost to Follow-up|1|||
162745613|NCT01928394|587779930|FG012|Follow-up Period|Lost to Follow-up|1|||
162745614|NCT01928394|587779931|FG013|Follow-up Period|Lost to Follow-up|0|||
162745615|NCT01928394|587779932|FG014|Follow-up Period|Lost to Follow-up|1|||
162745616|NCT01928394|587779933|FG015|Follow-up Period|Lost to Follow-up|0|||
162745617|NCT01928394|587779934|FG016|Follow-up Period|Lost to Follow-up|1|||
162745618|NCT01928394|587779935|FG017|Follow-up Period|Lost to Follow-up|0|||
162745619|NCT01928394|587779936|FG018|Follow-up Period|Lost to Follow-up|0|||
162745620|NCT01928394|587779937|FG019|Follow-up Period|Lost to Follow-up|0|||
162745621|NCT01928394|587779938|FG020|Follow-up Period|Lost to Follow-up|0|||
162745622|NCT01928394|587779939|FG021|Follow-up Period|Lost to Follow-up|0|||
162745623|NCT01928394|587779940|FG022|Follow-up Period|Lost to Follow-up|1|||
162745624|NCT00321048|587779941|FG000|Overall Study|Withdrawal by Subject|6|||
162745625|NCT00321048|587779942|FG001|Overall Study|Withdrawal by Subject|8|||
162745626|NCT04299464|587779943|FG000|Overall Study|Adverse Event|1|||
162745627|NCT04299464|587779944|FG001|Overall Study|Adverse Event|0|||
162745628|NCT04299464|587779945|FG002|Overall Study|Adverse Event|2|||
162745629|NCT04299464|587779943|FG000|Overall Study|Non-compliance with Study Drug|1|||
162745630|NCT04299464|587779944|FG001|Overall Study|Non-compliance with Study Drug|0|||
162745631|NCT04299464|587779945|FG002|Overall Study|Non-compliance with Study Drug|0|||
162745632|NCT04299464|587779943|FG000|Overall Study|Reason not Specified|0|||
162745633|NCT04299464|587779944|FG001|Overall Study|Reason not Specified|1|||
162745634|NCT04299464|587779945|FG002|Overall Study|Reason not Specified|3|||
162745635|NCT04299464|587779943|FG000|Overall Study|Physician Decision|0|||
162745636|NCT04299464|587779944|FG001|Overall Study|Physician Decision|1|||
162745637|NCT04299464|587779945|FG002|Overall Study|Physician Decision|1|||
162745638|NCT04299464|587779943|FG000|Overall Study|Withdrawal by Subject|0|||
162745639|NCT04299464|587779944|FG001|Overall Study|Withdrawal by Subject|2|||
162745640|NCT04299464|587779945|FG002|Overall Study|Withdrawal by Subject|1|||
162745641|NCT05907174|587779948|FG000|3-Month Assessment|Withdrawal by Subject|0|||
162745642|NCT05907174|587779949|FG001|3-Month Assessment|Withdrawal by Subject|0|||
162745643|NCT05907174|587779950|FG002|3-Month Assessment|Withdrawal by Subject|0|||
162745644|NCT05907174|587779951|FG003|3-Month Assessment|Withdrawal by Subject|1|||
162745645|NCT05907174|587779948|FG000|3-Month Assessment|Lost to Follow-up|1|||
162745646|NCT05907174|587779949|FG001|3-Month Assessment|Lost to Follow-up|1|||
162745647|NCT05907174|587779950|FG002|3-Month Assessment|Lost to Follow-up|1|||
162745648|NCT05907174|587779951|FG003|3-Month Assessment|Lost to Follow-up|1|||
162745649|NCT05907174|587779948|FG000|6-Month Assessment|Death|0|||
162745650|NCT05907174|587779949|FG001|6-Month Assessment|Death|0|||
162745651|NCT05907174|587779950|FG002|6-Month Assessment|Death|3|||
162745652|NCT05907174|587779951|FG003|6-Month Assessment|Death|0|||
162745653|NCT05907174|587779948|FG000|6-Month Assessment|Withdrawal by Subject|0|||
162745654|NCT05907174|587779949|FG001|6-Month Assessment|Withdrawal by Subject|0|||
162745655|NCT05907174|587779950|FG002|6-Month Assessment|Withdrawal by Subject|1|||
162745656|NCT05907174|587779951|FG003|6-Month Assessment|Withdrawal by Subject|1|||
162745657|NCT05907174|587779948|FG000|6-Month Assessment|Lost to Follow-up|0|||
162745658|NCT05907174|587779949|FG001|6-Month Assessment|Lost to Follow-up|1|||
162745659|NCT05907174|587779950|FG002|6-Month Assessment|Lost to Follow-up|1|||
162745660|NCT05907174|587779951|FG003|6-Month Assessment|Lost to Follow-up|1|||
162745661|NCT03209973|587779959|FG000|Overall Study|Withdrawal by Subject|7|||
162745662|NCT03209973|587779959|FG000|Overall Study|Lost to Follow-up|2|||
162745663|NCT03209973|587779959|FG000|Overall Study|Death|8|||
162745664|NCT03209973|587779959|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
162745665|NCT03209973|587779959|FG000|Overall Study|Sponsor Decision|18|||
162745666|NCT03209973|587779959|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
162745667|NCT03209973|587779959|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
162745668|NCT05123586|587779964|FG000|Overall Study|Physician Decision|1|||
162745669|NCT05123586|587779965|FG001|Overall Study|Physician Decision|1|||
162745670|NCT05123586|587779964|FG000|Overall Study|Withdrawal by Subject|0|||
162745671|NCT05123586|587779965|FG001|Overall Study|Withdrawal by Subject|3|||
162745672|NCT04690582|587779971|FG000|Overall Study|Withdrawal by Subject|6|||
162745673|NCT04690582|587779972|FG001|Overall Study|Withdrawal by Subject|4|||
162745674|NCT03257410|587781710|FG000|Overall Study|Adverse Event|2|||
162745675|NCT03257410|587781711|FG001|Overall Study|Adverse Event|3|||
162745676|NCT03257410|587781710|FG000|Overall Study|Protocol Violation|1|||
162745677|NCT03257410|587781711|FG001|Overall Study|Protocol Violation|2|||
162745678|NCT03257410|587781710|FG000|Overall Study|Lost to Follow-up|1|||
162745679|NCT03257410|587781711|FG001|Overall Study|Lost to Follow-up|0|||
162745680|NCT03257410|587781710|FG000|Overall Study|Withdrawal by Subject|1|||
162745681|NCT03257410|587781711|FG001|Overall Study|Withdrawal by Subject|2|||
162745682|NCT03257410|587781710|FG000|Overall Study|Physician Decision|1|||
162745683|NCT03257410|587781711|FG001|Overall Study|Physician Decision|1|||
162745684|NCT03257410|587781710|FG000|Overall Study|Renal transplantation|2|||
162745685|NCT03257410|587781711|FG001|Overall Study|Renal transplantation|0|||
162745686|NCT03257410|587781710|FG000|Overall Study|Switch to peritoneal dialysis|1|||
162745687|NCT03257410|587781711|FG001|Overall Study|Switch to peritoneal dialysis|0|||
162745688|NCT03257410|587781710|FG000|Overall Study|Death|3|||
162745689|NCT03257410|587781711|FG001|Overall Study|Death|2|||
162745690|NCT03257410|587781710|FG000|Overall Study|Change to another dialysis center|2|||
162745691|NCT03257410|587781711|FG001|Overall Study|Change to another dialysis center|2|||
162745692|NCT03257410|587781710|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
162745693|NCT03257410|587781711|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
162745694|NCT03257410|587781710|FG000|Overall Study|Miscellaneous|2|||
162745695|NCT03257410|587781711|FG001|Overall Study|Miscellaneous|2|||
162745696|NCT03257410|587781710|FG000|Overall Study|Other|0|||
162745697|NCT03257410|587781711|FG001|Overall Study|Other|1|||
162745698|NCT02598388|587781712|FG000|Overall Study|Lost to Follow-up|1|||
162745699|NCT02598388|587781713|FG001|Overall Study|Lost to Follow-up|0|||
162745700|NCT02598388|587781714|FG002|Overall Study|Lost to Follow-up|1|||
162745701|NCT02598388|587781715|FG003|Overall Study|Lost to Follow-up|0|||
162745702|NCT02598388|587781716|FG004|Overall Study|Lost to Follow-up|5|||
162745703|NCT02598388|587781717|FG005|Overall Study|Lost to Follow-up|1|||
162745704|NCT02598388|587781718|FG006|Overall Study|Lost to Follow-up|2|||
162745705|NCT02598388|587781719|FG007|Overall Study|Lost to Follow-up|1|||
162745706|NCT02598388|587781720|FG008|Overall Study|Lost to Follow-up|0|||
162745707|NCT02598388|587781721|FG009|Overall Study|Lost to Follow-up|0|||
162745708|NCT02598388|587781722|FG010|Overall Study|Lost to Follow-up|1|||
162745709|NCT02598388|587781723|FG011|Overall Study|Lost to Follow-up|0|||
162745710|NCT02598388|587781712|FG000|Overall Study|Withdrawal by Subject|0|||
162745711|NCT02598388|587781713|FG001|Overall Study|Withdrawal by Subject|0|||
162745712|NCT02598388|587781714|FG002|Overall Study|Withdrawal by Subject|0|||
162745713|NCT02598388|587781715|FG003|Overall Study|Withdrawal by Subject|0|||
162745714|NCT02598388|587781716|FG004|Overall Study|Withdrawal by Subject|2|||
162745715|NCT02598388|587781717|FG005|Overall Study|Withdrawal by Subject|0|||
162745716|NCT02598388|587781718|FG006|Overall Study|Withdrawal by Subject|2|||
162745717|NCT02598388|587781719|FG007|Overall Study|Withdrawal by Subject|0|||
162745718|NCT02598388|587781720|FG008|Overall Study|Withdrawal by Subject|0|||
162745719|NCT02598388|587781721|FG009|Overall Study|Withdrawal by Subject|1|||
162745720|NCT02598388|587781722|FG010|Overall Study|Withdrawal by Subject|0|||
162745721|NCT02598388|587781723|FG011|Overall Study|Withdrawal by Subject|0|||
162745722|NCT02598388|587781712|FG000|Overall Study|Other|0|||
162745723|NCT02598388|587781713|FG001|Overall Study|Other|0|||
162745724|NCT02598388|587781714|FG002|Overall Study|Other|1|||
162745725|NCT02598388|587781715|FG003|Overall Study|Other|0|||
162745726|NCT02598388|587781716|FG004|Overall Study|Other|3|||
162745727|NCT02598388|587781717|FG005|Overall Study|Other|0|||
162745728|NCT02598388|587781718|FG006|Overall Study|Other|1|||
162745729|NCT02598388|587781719|FG007|Overall Study|Other|0|||
162745730|NCT02598388|587781720|FG008|Overall Study|Other|0|||
162745731|NCT02598388|587781721|FG009|Overall Study|Other|0|||
162745732|NCT02598388|587781722|FG010|Overall Study|Other|0|||
162745733|NCT02598388|587781723|FG011|Overall Study|Other|0|||
162745734|NCT03668236|587781726|FG000|90-day Follow-up|Withdrawal by Subject|3|||
162745735|NCT03668236|587781727|FG001|90-day Follow-up|Withdrawal by Subject|2|||
162745736|NCT03668236|587781726|FG000|90-day Follow-up|Lost to Follow-up|3|||
162745737|NCT03668236|587781727|FG001|90-day Follow-up|Lost to Follow-up|1|||
162745738|NCT03668236|587781726|FG000|Baseline Characteristics|Lost to Follow-up|9|||
162745739|NCT03668236|587781727|FG001|Baseline Characteristics|Lost to Follow-up|5|||
162745740|NCT03668236|587781726|FG000|1-year Follow-up|Withdrawal by Subject|17|||
162745741|NCT03668236|587781727|FG001|1-year Follow-up|Withdrawal by Subject|15|||
162745742|NCT06132282|587781728|FG000|Overall Study|Lost to Follow-up|31|||
162745743|NCT00104676|587781729|FG000|Overall Study|Death|3|||
162745744|NCT00104676|587781730|FG001|Overall Study|Death|2|||
162745745|NCT00104676|587781729|FG000|Overall Study|Withdrawal by Subject|0|||
162745746|NCT00104676|587781730|FG001|Overall Study|Withdrawal by Subject|2|||
162745747|NCT00104676|587781729|FG000|Overall Study|treatment interruption|4|||
162745748|NCT00104676|587781730|FG001|Overall Study|treatment interruption|10|||
162745749|NCT00696111|587781739|FG000|Overall Study|Withdrawal by Subject|17|||
162745750|NCT03687086|587781746|FG000|Overall Study|Withdrawal by Subject|3|||
162745751|NCT03687086|587781747|FG001|Overall Study|Withdrawal by Subject|4|||
162745752|NCT03687086|587781746|FG000|Overall Study|Lost to Follow-up|1|||
162745753|NCT03687086|587781747|FG001|Overall Study|Lost to Follow-up|1|||
162745754|NCT03687086|587781746|FG000|Overall Study|Death|1|||
162745755|NCT03687086|587781747|FG001|Overall Study|Death|0|||
162745756|NCT03687086|587781746|FG000|Overall Study|Incomplete assessment|0|||
162745757|NCT03687086|587781747|FG001|Overall Study|Incomplete assessment|2|||
162745758|NCT04362254|587781751|FG000|Overall Study|Adverse Event|1|||
162745759|NCT04362254|587781751|FG000|Overall Study|Protocol Violation|1|||
162745760|NCT04362254|587781751|FG000|Overall Study|Due to early termination of the trial|10|||
162745761|NCT04707625|587781752|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
162745762|NCT02038777|587781753|FG000|Overall Study|Death|0|||
162745763|NCT02038777|587781754|FG001|Overall Study|Death|2|||
162745764|NCT02038777|587781755|FG002|Overall Study|Death|0|||
162745765|NCT02038777|587781756|FG003|Overall Study|Death|1|||
162745766|NCT02038777|587781757|FG004|Overall Study|Death|2|||
162745767|NCT02038777|587781758|FG005|Overall Study|Death|4|||
162745768|NCT02038777|587781759|FG006|Overall Study|Death|0|||
162745769|NCT02038777|587781760|FG007|Overall Study|Death|11|||
162745770|NCT02038777|587781753|FG000|Overall Study|Lost to Follow-up|0|||
162745771|NCT02038777|587781754|FG001|Overall Study|Lost to Follow-up|0|||
162745772|NCT02038777|587781755|FG002|Overall Study|Lost to Follow-up|0|||
162745773|NCT02038777|587781756|FG003|Overall Study|Lost to Follow-up|1|||
162745774|NCT02038777|587781757|FG004|Overall Study|Lost to Follow-up|0|||
162745775|NCT02038777|587781758|FG005|Overall Study|Lost to Follow-up|0|||
162745776|NCT02038777|587781759|FG006|Overall Study|Lost to Follow-up|0|||
162745777|NCT02038777|587781760|FG007|Overall Study|Lost to Follow-up|0|||
162745778|NCT02038777|587781753|FG000|Overall Study|Other|0|||
162745779|NCT02038777|587781754|FG001|Overall Study|Other|1|||
162745780|NCT02038777|587781755|FG002|Overall Study|Other|0|||
162745781|NCT02038777|587781756|FG003|Overall Study|Other|2|||
162745782|NCT02038777|587781757|FG004|Overall Study|Other|1|||
162745783|NCT02038777|587781758|FG005|Overall Study|Other|0|||
162745784|NCT02038777|587781759|FG006|Overall Study|Other|0|||
162745785|NCT02038777|587781760|FG007|Overall Study|Other|0|||
162745786|NCT02038777|587781753|FG000|Overall Study|Randomized but not treated|0|||
162745787|NCT02038777|587781754|FG001|Overall Study|Randomized but not treated|1|||
162745788|NCT02038777|587781755|FG002|Overall Study|Randomized but not treated|0|||
162745789|NCT02038777|587781756|FG003|Overall Study|Randomized but not treated|0|||
162745790|NCT02038777|587781757|FG004|Overall Study|Randomized but not treated|0|||
162745791|NCT02038777|587781758|FG005|Overall Study|Randomized but not treated|0|||
162745792|NCT02038777|587781759|FG006|Overall Study|Randomized but not treated|0|||
162745793|NCT02038777|587781760|FG007|Overall Study|Randomized but not treated|0|||
162745794|NCT02038777|587781753|FG000|Overall Study|Started Chemotherapy|1|||
162745795|NCT02038777|587781754|FG001|Overall Study|Started Chemotherapy|0|||
162745796|NCT02038777|587781755|FG002|Overall Study|Started Chemotherapy|3|||
162745797|NCT02038777|587781756|FG003|Overall Study|Started Chemotherapy|0|||
162745798|NCT02038777|587781757|FG004|Overall Study|Started Chemotherapy|0|||
162745799|NCT02038777|587781758|FG005|Overall Study|Started Chemotherapy|0|||
162745800|NCT02038777|587781759|FG006|Overall Study|Started Chemotherapy|0|||
162745801|NCT02038777|587781760|FG007|Overall Study|Started Chemotherapy|0|||
162745802|NCT02038777|587781753|FG000|Overall Study|participation terminated by sponsor|0|||
162745803|NCT02038777|587781754|FG001|Overall Study|participation terminated by sponsor|0|||
162745804|NCT02038777|587781755|FG002|Overall Study|participation terminated by sponsor|0|||
162745805|NCT02038777|587781756|FG003|Overall Study|participation terminated by sponsor|0|||
162745806|NCT02038777|587781757|FG004|Overall Study|participation terminated by sponsor|0|||
162745807|NCT02038777|587781758|FG005|Overall Study|participation terminated by sponsor|0|||
162745808|NCT02038777|587781759|FG006|Overall Study|participation terminated by sponsor|1|||
162745809|NCT02038777|587781760|FG007|Overall Study|participation terminated by sponsor|1|||
162745810|NCT03386578|587781764|FG000|PK Component|Lost to Follow-up|0|||
162745811|NCT03386578|587781765|FG001|PK Component|Lost to Follow-up|1|||
162745812|NCT03386578|587781766|FG002|PK Component|Lost to Follow-up|0|||
162745813|NCT03386578|587781767|FG003|PK Component|Lost to Follow-up|0|||
162745814|NCT03386578|587781768|FG004|PK Component|Lost to Follow-up|0|||
162745815|NCT03386578|587781769|FG005|PK Component|Lost to Follow-up|0|||
162745816|NCT03386578|587781770|FG006|PK Component|Lost to Follow-up|1|||
162745817|NCT03386578|587781771|FG007|PK Component|Lost to Follow-up|0|||
162745818|NCT03386578|587781772|FG008|PK Component|Lost to Follow-up|0|||
162745819|NCT03386578|587781773|FG009|PK Component|Lost to Follow-up|0|||
162745820|NCT03386578|587781764|FG000|PK Component|Stillbirth/Abortion|0|||
162745821|NCT03386578|587781765|FG001|PK Component|Stillbirth/Abortion|0|||
162745822|NCT03386578|587781766|FG002|PK Component|Stillbirth/Abortion|0|||
162745823|NCT03386578|587781767|FG003|PK Component|Stillbirth/Abortion|0|||
162745824|NCT03386578|587781768|FG004|PK Component|Stillbirth/Abortion|0|||
162745825|NCT03386578|587781769|FG005|PK Component|Stillbirth/Abortion|2|||
162745826|NCT03386578|587781770|FG006|PK Component|Stillbirth/Abortion|0|||
162745827|NCT03386578|587781771|FG007|PK Component|Stillbirth/Abortion|0|||
162745828|NCT03386578|587781772|FG008|PK Component|Stillbirth/Abortion|0|||
162745829|NCT03386578|587781773|FG009|PK Component|Stillbirth/Abortion|0|||
162745830|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745831|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745832|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
162745833|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
162745834|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745835|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745836|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745837|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
162745838|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
162745839|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162745840|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745841|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745842|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
162745843|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
162745844|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745845|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745846|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745847|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
162745848|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
162745849|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162745850|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Death|0|||
162745851|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Death|0|||
162745852|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Death|1|||
162745853|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Death|0|||
162745854|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Death|0|||
162745855|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Death|0|||
162745856|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Death|0|||
162745857|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Death|9|||
162745858|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Death|5|||
162745859|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Death|0|||
162745860|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745861|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745862|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745863|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
162745864|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745865|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745866|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745867|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745868|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
162745869|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162745870|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745871|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745872|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745873|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745874|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745875|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745876|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745877|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
162745878|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
162745879|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162745880|NCT03386578|587781764|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745881|NCT03386578|587781765|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745882|NCT03386578|587781766|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745883|NCT03386578|587781767|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745884|NCT03386578|587781768|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745885|NCT03386578|587781769|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745886|NCT03386578|587781770|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745887|NCT03386578|587781771|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
162745888|NCT03386578|587781772|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
162745889|NCT03386578|587781773|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162745890|NCT01868997|587781776|FG000|Overall Study|Adverse Event|2|||
162745891|NCT01868997|587781777|FG001|Overall Study|Adverse Event|5|||
162925346|NCT00602641|588428937|FG001|Overall Study|Administrative Closure|1|||
162745892|NCT01868997|587781776|FG000|Overall Study|Lack of Efficacy|2|||
162745893|NCT01868997|587781777|FG001|Overall Study|Lack of Efficacy|0|||
162745894|NCT01868997|587781776|FG000|Overall Study|Other|3|||
162745895|NCT01868997|587781777|FG001|Overall Study|Other|1|||
162745896|NCT04971109|587781780|FG000|Overall Study|Adverse Event|4|||
162745897|NCT04971109|587781781|FG001|Overall Study|Adverse Event|3|||
162745898|NCT04971109|587781780|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
162745899|NCT04971109|587781781|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
162745900|NCT04971109|587781780|FG000|Overall Study|Lost to Follow-up|8|||
162745901|NCT04971109|587781781|FG001|Overall Study|Lost to Follow-up|2|||
162745902|NCT04971109|587781780|FG000|Overall Study|Physician Decision|5|||
162745903|NCT04971109|587781781|FG001|Overall Study|Physician Decision|0|||
162745904|NCT04971109|587781780|FG000|Overall Study|Protocol Violation|0|||
162745905|NCT04971109|587781781|FG001|Overall Study|Protocol Violation|1|||
162745906|NCT04971109|587781780|FG000|Overall Study|Withdrawal by Subject|18|||
162745907|NCT04971109|587781781|FG001|Overall Study|Withdrawal by Subject|3|||
162745908|NCT04971109|587781780|FG000|Overall Study|Subject was randomized in error|1|||
162745909|NCT04971109|587781781|FG001|Overall Study|Subject was randomized in error|0|||
162745910|NCT03987022|587781783|FG000|Overall Study|Lost to Follow-up|2|||
162745911|NCT03987022|587781784|FG001|Overall Study|Lost to Follow-up|2|||
162745912|NCT03987022|587781783|FG000|Overall Study|Withdrawal by Subject|1|||
162745913|NCT03987022|587781784|FG001|Overall Study|Withdrawal by Subject|0|||
162745914|NCT01627574|587781787|FG000|Overall Study|Withdrawal by Subject|8|||
162745915|NCT01627574|587781788|FG001|Overall Study|Withdrawal by Subject|5|||
162745916|NCT01627574|587781787|FG000|Overall Study|Lost to Follow-up|13|||
162745917|NCT01627574|587781788|FG001|Overall Study|Lost to Follow-up|13|||
162745918|NCT04730739|587781789|FG000|Overall Study|Death|1|||
162745919|NCT05646355|587781799|FG000|Overall Study|Lost to Follow-up|1|||
162745920|NCT05646355|587781800|FG001|Overall Study|Lost to Follow-up|0|||
162745921|NCT05646355|587781799|FG000|Overall Study|translated materials not available for pilot|2|||
162745922|NCT05646355|587781800|FG001|Overall Study|translated materials not available for pilot|0|||
162745923|NCT05646355|587781799|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
162745924|NCT05646355|587781800|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
162745925|NCT01346540|587781801|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
162745926|NCT01346540|587781802|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
162745927|NCT01346540|587781801|FG000|Overall Study|Adverse Event|0|||
162745928|NCT01346540|587781802|FG001|Overall Study|Adverse Event|4|||
162745929|NCT05863156|587781803|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
162745930|NCT05863156|587781804|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
162745931|NCT05863156|587781805|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
162745932|NCT03362476|587781806|FG000|Overall Study|Withdrawal by Subject|0|||
162745933|NCT03362476|587781807|FG001|Overall Study|Withdrawal by Subject|1|||
162745934|NCT05216406|587781808|FG000|Overall Study|Lost to Follow-up|8|||
162745935|NCT05216406|587781809|FG001|Overall Study|Lost to Follow-up|9|||
162745936|NCT04270942|587781812|FG000|Overall Study|Death|1|||
162745937|NCT04797195|587781818|FG000|Overall Study|Death|8|||
162745938|NCT04797195|587781819|FG001|Overall Study|Death|15|||
162745939|NCT04797195|587781818|FG000|Overall Study|Change from PD|15|||
162745940|NCT04797195|587781819|FG001|Overall Study|Change from PD|15|||
162745941|NCT04797195|587781818|FG000|Overall Study|Withdrawal by Subject|3|||
162745942|NCT04797195|587781819|FG001|Overall Study|Withdrawal by Subject|2|||
162745943|NCT01236781|587781820|FG000|Overall Study|Ineligible|2|||
162745944|NCT01236781|587781821|FG001|Overall Study|Ineligible|1|||
162745945|NCT01236781|587781820|FG000|Overall Study|Did not complete study imaging|5|||
162745946|NCT01236781|587781821|FG001|Overall Study|Did not complete study imaging|0|||
162745947|NCT04862416|587781829|FG000|Overall Study|Withdrawal by Subject|0|||
162745948|NCT04862416|587781830|FG001|Overall Study|Withdrawal by Subject|1|||
162745949|NCT04862416|587781831|FG002|Overall Study|Withdrawal by Subject|0|||
162745950|NCT04862416|587781832|FG003|Overall Study|Withdrawal by Subject|1|||
162745951|NCT04862416|587781833|FG004|Overall Study|Withdrawal by Subject|0|||
162745952|NCT04862416|587781834|FG005|Overall Study|Withdrawal by Subject|0|||
162745953|NCT04862416|587781835|FG006|Overall Study|Withdrawal by Subject|0|||
162745954|NCT04862416|587781836|FG007|Overall Study|Withdrawal by Subject|0|||
162745955|NCT04059185|587781839|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
162745956|NCT04059185|587781840|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
162745957|NCT04059185|587781841|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
162745958|NCT04059185|587781839|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
162745959|NCT04059185|587781840|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
162745960|NCT04059185|587781841|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
162745961|NCT04059185|587781839|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
162745962|NCT04059185|587781840|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
162745963|NCT04059185|587781841|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
162745964|NCT04059185|587781839|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
162745965|NCT04059185|587781840|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
162745966|NCT04059185|587781841|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
162745967|NCT04059185|587781839|FG000|Longitudinal Assessment-Adults Only|Death|4|||
162745968|NCT04059185|587781840|FG001|Longitudinal Assessment-Adults Only|Death|4|||
162745969|NCT04059185|587781841|FG002|Longitudinal Assessment-Adults Only|Death|3|||
162745970|NCT01009788|587781855|FG000|Overall Study|Withdrawal by Subject|1|||
162745971|NCT01009788|587781856|FG001|Overall Study|Withdrawal by Subject|0|||
162745972|NCT04587453|587781857|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
162745973|NCT04587453|587781858|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
162745974|NCT03571581|587781859|FG000|Overall Study|Death|2|||
162745975|NCT03571581|587781859|FG000|Overall Study|Withdrawal by Subject|2|||
162745976|NCT01309672|587781860|FG000|Overall Study|Lack of Efficacy|20|||
162745977|NCT01309672|587781860|FG000|Overall Study|Other|9|||
162745978|NCT01309672|587781860|FG000|Overall Study|Adverse Event|5|||
162745979|NCT01309672|587781860|FG000|Overall Study|Withdrawal by Subject|3|||
162745980|NCT04737330|587781864|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
162745981|NCT04737330|587781865|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
162745982|NCT04737330|587781864|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
162745983|NCT04737330|587781865|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
162745984|NCT04737330|587781864|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
162745985|NCT04737330|587781865|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
162745986|NCT04737330|587781864|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
162745987|NCT04737330|587781865|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
162745988|NCT04737330|587781864|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
162745989|NCT04737330|587781865|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
162745990|NCT04737330|587781864|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
162745991|NCT04737330|587781865|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
162745992|NCT04741776|587781871|FG000|Overall Study|Withdrawal by Subject|7|||
162745993|NCT04741776|587781872|FG001|Overall Study|Withdrawal by Subject|10|||
162745994|NCT04741776|587781873|FG002|Overall Study|Withdrawal by Subject|10|||
162745995|NCT04741776|587781874|FG003|Overall Study|Withdrawal by Subject|17|||
162745996|NCT04741776|587781871|FG000|Overall Study|Death|0|||
162745997|NCT04741776|587781872|FG001|Overall Study|Death|0|||
162745998|NCT04741776|587781873|FG002|Overall Study|Death|1|||
162745999|NCT04741776|587781874|FG003|Overall Study|Death|0|||
162746000|NCT02852655|587781890|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
162746001|NCT02852655|587781891|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
162746002|NCT02852655|587781892|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
162746003|NCT02852655|587781890|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
162746004|NCT02852655|587781891|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
162746005|NCT02852655|587781892|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
162746006|NCT02852655|587781890|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
162746007|NCT02852655|587781891|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
162746008|NCT02852655|587781892|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
162746009|NCT02852655|587781890|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
162746010|NCT02852655|587781891|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
162746011|NCT02852655|587781892|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
162746012|NCT02852655|587781890|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
162746013|NCT02852655|587781891|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
162746014|NCT02852655|587781892|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
162746015|NCT02852655|587781890|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
162746016|NCT02852655|587781891|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
162746017|NCT02852655|587781892|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
162746018|NCT02852655|587781890|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
162746019|NCT02852655|587781891|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
162746020|NCT02852655|587781892|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
162746021|NCT02852655|587781890|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
162746022|NCT02852655|587781891|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
162746023|NCT02852655|587781892|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
162746024|NCT02852655|587781890|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
162746025|NCT02852655|587781891|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
162746026|NCT02852655|587781892|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
162746027|NCT05809453|587783344|FG000|Overall Study|Withdrawal by Subject|1|||
162746028|NCT05809453|587783345|FG001|Overall Study|Withdrawal by Subject|0|||
162746029|NCT05809453|587783346|FG002|Overall Study|Withdrawal by Subject|0|||
162746030|NCT05809453|587783347|FG003|Overall Study|Withdrawal by Subject|0|||
162746031|NCT04499924|587783350|FG000|Overall Study|Study termination by sponsor|4|||
162746032|NCT04499924|587783351|FG001|Overall Study|Study termination by sponsor|6|||
162746033|NCT04499924|587783350|FG000|Overall Study|Withdrawal by Subject|1|||
162746034|NCT04499924|587783351|FG001|Overall Study|Withdrawal by Subject|3|||
162746035|NCT03011333|587783352|FG000|Overall Study|Lost to Follow-up|0|||
162746036|NCT03011333|587783353|FG001|Overall Study|Lost to Follow-up|1|||
162746037|NCT03011333|587783354|FG002|Overall Study|Lost to Follow-up|0|||
162746038|NCT03011333|587783355|FG003|Overall Study|Lost to Follow-up|1|||
162746039|NCT03011333|587783356|FG004|Overall Study|Lost to Follow-up|4|||
162746040|NCT03011333|587783357|FG005|Overall Study|Lost to Follow-up|4|||
162746041|NCT03011333|587783358|FG006|Overall Study|Lost to Follow-up|5|||
162746042|NCT03663569|587783359|FG000|Overall Study|Discontinuation of study|11|||
162746043|NCT03663569|587783359|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
162746044|NCT03663569|587783359|FG000|Overall Study|Deceased patient|6|||
162746045|NCT03663569|587783359|FG000|Overall Study|Lost to Follow-up|18|||
162746046|NCT03663569|587783359|FG000|Overall Study|Withdrawal of consent|5|||
162746047|NCT03663569|587783359|FG000|Overall Study|Patient's request|11|||
162746048|NCT03663569|587783359|FG000|Overall Study|Adverse Event|4|||
162746049|NCT03663569|587783359|FG000|Overall Study|Not come to second visit|3|||
162746050|NCT03663569|587783359|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
162746051|NCT03663569|587783359|FG000|Overall Study|Serious adverse event|1|||
162746052|NCT04183283|587783360|FG000|Period 1|Withdrawal by Subject|0|||
162746053|NCT04183283|587783361|FG001|Period 1|Withdrawal by Subject|1|||
162746054|NCT04183283|587783362|FG002|Period 1|Withdrawal by Subject|0|||
162746055|NCT04183283|587783363|FG003|Period 1|Withdrawal by Subject|0|||
162746056|NCT04183283|587783360|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
162746057|NCT04183283|587783361|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
162746058|NCT04183283|587783362|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
162746059|NCT04183283|587783363|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
162746060|NCT04909801|587783371|FG000|Overall Study|Lack of Efficacy|2|||
162746061|NCT04909801|587783372|FG001|Overall Study|Lack of Efficacy|1|||
162746062|NCT04909801|587783371|FG000|Overall Study|Adverse Event|1|||
162746063|NCT04909801|587783372|FG001|Overall Study|Adverse Event|2|||
162746064|NCT04909801|587783371|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162746065|NCT04909801|587783372|FG001|Overall Study|Participant request to discontinue study treatment|2|||
162746066|NCT04909801|587783371|FG000|Overall Study|Withdrawal by Subject|2|||
162746067|NCT04909801|587783372|FG001|Overall Study|Withdrawal by Subject|1|||
162746068|NCT04909801|587783371|FG000|Overall Study|other reasons|1|||
162746069|NCT04909801|587783372|FG001|Overall Study|other reasons|1|||
162746070|NCT05274074|587783373|FG000|Overall Study|Lost to Follow-up|2|||
162746071|NCT05274074|587783374|FG001|Overall Study|Lost to Follow-up|3|||
162746072|NCT05274074|587783373|FG000|Overall Study|Withdrawal by Subject|1|||
162746073|NCT05274074|587783374|FG001|Overall Study|Withdrawal by Subject|2|||
162746074|NCT04117347|587783375|FG000|Overall Study|Adverse Event|0|||
162746075|NCT04117347|587783376|FG001|Overall Study|Adverse Event|0|||
162746076|NCT04117347|587783377|FG002|Overall Study|Adverse Event|1|||
162746077|NCT04117347|587783375|FG000|Overall Study|No time for study|0|||
162746078|NCT04117347|587783376|FG001|Overall Study|No time for study|2|||
162746079|NCT04117347|587783377|FG002|Overall Study|No time for study|0|||
162746080|NCT04117347|587783375|FG000|Overall Study|Family emergency|1|||
162746081|NCT04117347|587783376|FG001|Overall Study|Family emergency|0|||
162746082|NCT04117347|587783377|FG002|Overall Study|Family emergency|0|||
162746083|NCT05194956|587783378|FG000|Washout Period|Withdrawal by Subject|0|||
162746084|NCT05194956|587783379|FG001|Washout Period|Withdrawal by Subject|2|||
162746085|NCT03676192|587783380|FG000|Induction Study Period|Adverse Event|21|||
162746086|NCT03676192|587783381|FG001|Induction Study Period|Adverse Event|20|||
162746087|NCT03676192|587783380|FG000|Induction Study Period|Death|23|||
162746088|NCT03676192|587783381|FG001|Induction Study Period|Death|20|||
162746089|NCT03676192|587783380|FG000|Induction Study Period|Lost to Follow-up|3|||
162746090|NCT03676192|587783381|FG001|Induction Study Period|Lost to Follow-up|3|||
162746091|NCT03676192|587783380|FG000|Induction Study Period|Physician Decision|6|||
162746092|NCT03676192|587783381|FG001|Induction Study Period|Physician Decision|3|||
162746093|NCT03676192|587783380|FG000|Induction Study Period|Progressive Disease|32|||
162746094|NCT03676192|587783381|FG001|Induction Study Period|Progressive Disease|21|||
162746095|NCT03676192|587783380|FG000|Induction Study Period|Protocol Violation|1|||
162746096|NCT03676192|587783381|FG001|Induction Study Period|Protocol Violation|2|||
162746097|NCT03676192|587783380|FG000|Induction Study Period|Withdrawal by Subject|20|||
162746098|NCT03676192|587783381|FG001|Induction Study Period|Withdrawal by Subject|15|||
162746099|NCT02424617|587783382|FG000|Overall Study|Adverse Event|0|||
162746100|NCT02424617|587783383|FG001|Overall Study|Adverse Event|1|||
162746101|NCT02424617|587783384|FG002|Overall Study|Adverse Event|0|||
162746102|NCT02424617|587783385|FG003|Overall Study|Adverse Event|0|||
162746103|NCT02424617|587783382|FG000|Overall Study|Investigator Decision|0|||
162746104|NCT02424617|587783383|FG001|Overall Study|Investigator Decision|0|||
162746105|NCT02424617|587783384|FG002|Overall Study|Investigator Decision|0|||
162746106|NCT02424617|587783385|FG003|Overall Study|Investigator Decision|1|||
162746107|NCT02424617|587783382|FG000|Overall Study|Withdrawal by Subject|1|||
162746108|NCT02424617|587783383|FG001|Overall Study|Withdrawal by Subject|1|||
162746109|NCT02424617|587783384|FG002|Overall Study|Withdrawal by Subject|0|||
162746110|NCT02424617|587783385|FG003|Overall Study|Withdrawal by Subject|1|||
162746111|NCT02424617|587783382|FG000|Overall Study|Progressive Disease|7|||
162746112|NCT02424617|587783383|FG001|Overall Study|Progressive Disease|6|||
162746113|NCT02424617|587783384|FG002|Overall Study|Progressive Disease|11|||
162746114|NCT02424617|587783385|FG003|Overall Study|Progressive Disease|10|||
162746115|NCT02424617|587783382|FG000|Overall Study|Other|0|||
162746116|NCT02424617|587783383|FG001|Overall Study|Other|0|||
162746117|NCT02424617|587783384|FG002|Overall Study|Other|0|||
162746118|NCT02424617|587783385|FG003|Overall Study|Other|1|||
162746119|NCT04778397|587783388|FG000|Overall Study|Death|59|||
162746120|NCT04778397|587783389|FG001|Overall Study|Death|54|||
162746121|NCT04778397|587783390|FG002|Overall Study|Death|11|||
162746122|NCT04778397|587783391|FG003|Overall Study|Death|9|||
162746123|NCT04778397|587783388|FG000|Overall Study|Study Terminated by Sponsor|34|||
162746124|NCT04778397|587783389|FG001|Overall Study|Study Terminated by Sponsor|42|||
162746125|NCT04778397|587783390|FG002|Overall Study|Study Terminated by Sponsor|15|||
162746126|NCT04778397|587783391|FG003|Overall Study|Study Terminated by Sponsor|12|||
162746127|NCT04778397|587783388|FG000|Overall Study|Withdrew Consent|5|||
162746128|NCT04778397|587783389|FG001|Overall Study|Withdrew Consent|4|||
162746129|NCT04778397|587783390|FG002|Overall Study|Withdrew Consent|1|||
162746130|NCT04778397|587783391|FG003|Overall Study|Withdrew Consent|1|||
162746131|NCT04778397|587783388|FG000|Overall Study|Reason Not Specified|1|||
162746132|NCT04778397|587783389|FG001|Overall Study|Reason Not Specified|3|||
162746133|NCT04778397|587783390|FG002|Overall Study|Reason Not Specified|0|||
162746134|NCT04778397|587783391|FG003|Overall Study|Reason Not Specified|2|||
162746135|NCT04778397|587783388|FG000|Overall Study|Lost to Follow-up|2|||
162746136|NCT04778397|587783389|FG001|Overall Study|Lost to Follow-up|1|||
162746137|NCT04778397|587783390|FG002|Overall Study|Lost to Follow-up|0|||
162746138|NCT04778397|587783391|FG003|Overall Study|Lost to Follow-up|1|||
162746139|NCT03308877|587783392|FG000|Overall Study|Lost to Follow-up|32|||
162746140|NCT03308877|587783393|FG001|Overall Study|Lost to Follow-up|28|||
162746141|NCT04314778|587783395|FG000|Overall Study|Lost to Follow-up|5|||
162746142|NCT04314778|587783396|FG001|Overall Study|Lost to Follow-up|3|||
162746143|NCT02240238|587783397|FG000|Phase 1|Adverse Event|0|||
162746144|NCT02240238|587783398|FG001|Phase 1|Adverse Event|0|||
162746145|NCT02240238|587783399|FG002|Phase 1|Adverse Event|0|||
162746146|NCT02240238|587783400|FG003|Phase 1|Adverse Event|0|||
162746147|NCT02240238|587783401|FG004|Phase 1|Adverse Event|0|||
162746148|NCT02240238|587783402|FG005|Phase 1|Adverse Event|0|||
162746149|NCT02240238|587783403|FG006|Phase 1|Adverse Event|3|||
162746150|NCT02240238|587783404|FG007|Phase 1|Adverse Event|1|||
162746151|NCT02240238|587783405|FG008|Phase 1|Adverse Event|0|||
162746152|NCT02240238|587783406|FG009|Phase 1|Adverse Event|0|||
162746153|NCT02240238|587783407|FG010|Phase 1|Adverse Event|0|||
162746154|NCT02240238|587783408|FG011|Phase 1|Adverse Event|0|||
162746155|NCT02240238|587783397|FG000|Phase 1|Death|0|||
162746156|NCT02240238|587783398|FG001|Phase 1|Death|0|||
162746157|NCT02240238|587783399|FG002|Phase 1|Death|0|||
162746158|NCT02240238|587783400|FG003|Phase 1|Death|0|||
162746159|NCT02240238|587783401|FG004|Phase 1|Death|0|||
162746160|NCT02240238|587783402|FG005|Phase 1|Death|1|||
162746161|NCT02240238|587783403|FG006|Phase 1|Death|0|||
162746162|NCT02240238|587783404|FG007|Phase 1|Death|0|||
162746163|NCT02240238|587783405|FG008|Phase 1|Death|0|||
162746164|NCT02240238|587783406|FG009|Phase 1|Death|0|||
162746165|NCT02240238|587783407|FG010|Phase 1|Death|0|||
162746166|NCT02240238|587783408|FG011|Phase 1|Death|0|||
162746167|NCT02240238|587783397|FG000|Phase 1|Sponsor termination|0|||
162746168|NCT02240238|587783398|FG001|Phase 1|Sponsor termination|0|||
162746169|NCT02240238|587783399|FG002|Phase 1|Sponsor termination|0|||
162746170|NCT02240238|587783400|FG003|Phase 1|Sponsor termination|0|||
162746171|NCT02240238|587783401|FG004|Phase 1|Sponsor termination|0|||
162746172|NCT02240238|587783402|FG005|Phase 1|Sponsor termination|1|||
162746173|NCT02240238|587783403|FG006|Phase 1|Sponsor termination|0|||
162746174|NCT02240238|587783404|FG007|Phase 1|Sponsor termination|0|||
162746175|NCT02240238|587783405|FG008|Phase 1|Sponsor termination|0|||
162746176|NCT02240238|587783406|FG009|Phase 1|Sponsor termination|0|||
162746177|NCT02240238|587783407|FG010|Phase 1|Sponsor termination|0|||
162746178|NCT02240238|587783408|FG011|Phase 1|Sponsor termination|0|||
162746179|NCT02240238|587783397|FG000|Phase 1|Withdrawal by Subject|0|||
162746180|NCT02240238|587783398|FG001|Phase 1|Withdrawal by Subject|0|||
162746181|NCT02240238|587783399|FG002|Phase 1|Withdrawal by Subject|0|||
162746182|NCT02240238|587783400|FG003|Phase 1|Withdrawal by Subject|0|||
162746183|NCT02240238|587783401|FG004|Phase 1|Withdrawal by Subject|0|||
162746184|NCT02240238|587783402|FG005|Phase 1|Withdrawal by Subject|2|||
162746185|NCT02240238|587783403|FG006|Phase 1|Withdrawal by Subject|0|||
162746186|NCT02240238|587783404|FG007|Phase 1|Withdrawal by Subject|0|||
162746187|NCT02240238|587783405|FG008|Phase 1|Withdrawal by Subject|0|||
162746188|NCT02240238|587783406|FG009|Phase 1|Withdrawal by Subject|0|||
162746189|NCT02240238|587783407|FG010|Phase 1|Withdrawal by Subject|0|||
162746190|NCT02240238|587783408|FG011|Phase 1|Withdrawal by Subject|0|||
162746191|NCT02240238|587783397|FG000|Phase 1|Physician Decision|0|||
162746192|NCT02240238|587783398|FG001|Phase 1|Physician Decision|0|||
162746193|NCT02240238|587783399|FG002|Phase 1|Physician Decision|0|||
162746194|NCT02240238|587783400|FG003|Phase 1|Physician Decision|0|||
162746195|NCT02240238|587783401|FG004|Phase 1|Physician Decision|0|||
162746196|NCT02240238|587783402|FG005|Phase 1|Physician Decision|2|||
162746197|NCT02240238|587783403|FG006|Phase 1|Physician Decision|0|||
162746198|NCT02240238|587783404|FG007|Phase 1|Physician Decision|0|||
162746199|NCT02240238|587783405|FG008|Phase 1|Physician Decision|0|||
162746200|NCT02240238|587783406|FG009|Phase 1|Physician Decision|0|||
162746201|NCT02240238|587783407|FG010|Phase 1|Physician Decision|0|||
162746202|NCT02240238|587783408|FG011|Phase 1|Physician Decision|0|||
162746203|NCT02240238|587783397|FG000|Phase 2|Adverse Event|0|||
162746204|NCT02240238|587783398|FG001|Phase 2|Adverse Event|0|||
162746205|NCT02240238|587783399|FG002|Phase 2|Adverse Event|0|||
162746206|NCT02240238|587783400|FG003|Phase 2|Adverse Event|0|||
162746207|NCT02240238|587783401|FG004|Phase 2|Adverse Event|0|||
162746208|NCT02240238|587783402|FG005|Phase 2|Adverse Event|0|||
162746209|NCT02240238|587783403|FG006|Phase 2|Adverse Event|0|||
162746210|NCT02240238|587783404|FG007|Phase 2|Adverse Event|0|||
162746211|NCT02240238|587783405|FG008|Phase 2|Adverse Event|0|||
162746212|NCT02240238|587783406|FG009|Phase 2|Adverse Event|7|||
162746213|NCT02240238|587783407|FG010|Phase 2|Adverse Event|14|||
162746214|NCT02240238|587783408|FG011|Phase 2|Adverse Event|2|||
162746215|NCT02240238|587783397|FG000|Phase 2|Death|0|||
162746216|NCT02240238|587783398|FG001|Phase 2|Death|0|||
162746217|NCT02240238|587783399|FG002|Phase 2|Death|0|||
162746218|NCT02240238|587783400|FG003|Phase 2|Death|0|||
162746219|NCT02240238|587783401|FG004|Phase 2|Death|0|||
162746220|NCT02240238|587783402|FG005|Phase 2|Death|0|||
162746221|NCT02240238|587783403|FG006|Phase 2|Death|0|||
162746222|NCT02240238|587783404|FG007|Phase 2|Death|0|||
162746223|NCT02240238|587783405|FG008|Phase 2|Death|0|||
162746224|NCT02240238|587783406|FG009|Phase 2|Death|3|||
162746225|NCT02240238|587783407|FG010|Phase 2|Death|2|||
162746226|NCT02240238|587783408|FG011|Phase 2|Death|1|||
162746227|NCT02240238|587783397|FG000|Phase 2|Disease progression|0|||
162746228|NCT02240238|587783398|FG001|Phase 2|Disease progression|0|||
162746229|NCT02240238|587783399|FG002|Phase 2|Disease progression|0|||
162746230|NCT02240238|587783400|FG003|Phase 2|Disease progression|0|||
162746231|NCT02240238|587783401|FG004|Phase 2|Disease progression|0|||
162746232|NCT02240238|587783402|FG005|Phase 2|Disease progression|0|||
162746233|NCT02240238|587783403|FG006|Phase 2|Disease progression|0|||
162746234|NCT02240238|587783404|FG007|Phase 2|Disease progression|0|||
162746235|NCT02240238|587783405|FG008|Phase 2|Disease progression|0|||
162746236|NCT02240238|587783406|FG009|Phase 2|Disease progression|5|||
162746237|NCT02240238|587783407|FG010|Phase 2|Disease progression|11|||
162746238|NCT02240238|587783408|FG011|Phase 2|Disease progression|1|||
162746239|NCT02240238|587783397|FG000|Phase 2|Withdrawal by Subject|0|||
162746240|NCT02240238|587783398|FG001|Phase 2|Withdrawal by Subject|0|||
162746241|NCT02240238|587783399|FG002|Phase 2|Withdrawal by Subject|0|||
162746242|NCT02240238|587783400|FG003|Phase 2|Withdrawal by Subject|0|||
162746243|NCT02240238|587783401|FG004|Phase 2|Withdrawal by Subject|0|||
162746244|NCT02240238|587783402|FG005|Phase 2|Withdrawal by Subject|0|||
162746245|NCT02240238|587783403|FG006|Phase 2|Withdrawal by Subject|0|||
162746246|NCT02240238|587783404|FG007|Phase 2|Withdrawal by Subject|0|||
162746247|NCT02240238|587783405|FG008|Phase 2|Withdrawal by Subject|0|||
162746248|NCT02240238|587783406|FG009|Phase 2|Withdrawal by Subject|1|||
162746249|NCT02240238|587783407|FG010|Phase 2|Withdrawal by Subject|1|||
162746250|NCT02240238|587783408|FG011|Phase 2|Withdrawal by Subject|0|||
162746251|NCT02240238|587783397|FG000|Phase 2|Physician Decision|0|||
162746252|NCT02240238|587783398|FG001|Phase 2|Physician Decision|0|||
162746253|NCT02240238|587783399|FG002|Phase 2|Physician Decision|0|||
162746254|NCT02240238|587783400|FG003|Phase 2|Physician Decision|0|||
162746255|NCT02240238|587783401|FG004|Phase 2|Physician Decision|0|||
162746256|NCT02240238|587783402|FG005|Phase 2|Physician Decision|0|||
162746257|NCT02240238|587783403|FG006|Phase 2|Physician Decision|0|||
162746258|NCT02240238|587783404|FG007|Phase 2|Physician Decision|0|||
162746259|NCT02240238|587783405|FG008|Phase 2|Physician Decision|0|||
162746260|NCT02240238|587783406|FG009|Phase 2|Physician Decision|1|||
162746261|NCT02240238|587783407|FG010|Phase 2|Physician Decision|3|||
162746262|NCT02240238|587783408|FG011|Phase 2|Physician Decision|0|||
162746263|NCT02240238|587783397|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746264|NCT02240238|587783398|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746265|NCT02240238|587783399|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746266|NCT02240238|587783400|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746267|NCT02240238|587783401|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746268|NCT02240238|587783402|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746269|NCT02240238|587783403|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746270|NCT02240238|587783404|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162810472|NCT03435497|588018229|FG000|Overall Study|Wrong survey administered|0|||
162746271|NCT02240238|587783405|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746272|NCT02240238|587783406|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
162746273|NCT02240238|587783407|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746274|NCT02240238|587783408|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162746275|NCT02240238|587783397|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746276|NCT02240238|587783398|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746277|NCT02240238|587783399|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746278|NCT02240238|587783400|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746279|NCT02240238|587783401|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746280|NCT02240238|587783402|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746281|NCT02240238|587783403|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746282|NCT02240238|587783404|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746283|NCT02240238|587783405|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746284|NCT02240238|587783406|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
162746285|NCT02240238|587783407|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746286|NCT02240238|587783408|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162746287|NCT02240238|587783397|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746288|NCT02240238|587783398|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746289|NCT02240238|587783399|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746290|NCT02240238|587783400|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746291|NCT02240238|587783401|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746292|NCT02240238|587783402|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746293|NCT02240238|587783403|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746294|NCT02240238|587783404|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746295|NCT02240238|587783405|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746296|NCT02240238|587783406|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746297|NCT02240238|587783407|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
162746298|NCT02240238|587783408|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162746299|NCT02240238|587783397|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746300|NCT02240238|587783398|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746301|NCT02240238|587783399|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746302|NCT02240238|587783400|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746303|NCT02240238|587783401|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746304|NCT02240238|587783402|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746305|NCT02240238|587783403|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746306|NCT02240238|587783404|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746307|NCT02240238|587783405|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746308|NCT02240238|587783406|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746309|NCT02240238|587783407|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
162746310|NCT02240238|587783408|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162746311|NCT02240238|587783397|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746312|NCT02240238|587783398|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746313|NCT02240238|587783399|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746314|NCT02240238|587783400|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746315|NCT02240238|587783401|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746316|NCT02240238|587783402|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746317|NCT02240238|587783403|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746318|NCT02240238|587783404|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746319|NCT02240238|587783405|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746320|NCT02240238|587783406|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746321|NCT02240238|587783407|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
162746322|NCT02240238|587783408|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162746323|NCT02240238|587783397|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746324|NCT02240238|587783398|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746325|NCT02240238|587783399|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746326|NCT02240238|587783400|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746327|NCT02240238|587783401|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746328|NCT02240238|587783402|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746329|NCT02240238|587783403|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746330|NCT02240238|587783404|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746331|NCT02240238|587783405|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746332|NCT02240238|587783406|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746333|NCT02240238|587783407|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
162746334|NCT02240238|587783408|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162746335|NCT02240238|587783397|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746336|NCT02240238|587783398|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746337|NCT02240238|587783399|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746338|NCT02240238|587783400|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746339|NCT02240238|587783401|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746340|NCT02240238|587783402|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746341|NCT02240238|587783403|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746342|NCT02240238|587783404|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746343|NCT02240238|587783405|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746344|NCT02240238|587783406|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746345|NCT02240238|587783407|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
162746346|NCT02240238|587783408|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162746347|NCT02240238|587783397|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746348|NCT02240238|587783398|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746349|NCT02240238|587783399|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746350|NCT02240238|587783400|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746351|NCT02240238|587783401|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746352|NCT02240238|587783402|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746353|NCT02240238|587783403|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746354|NCT02240238|587783404|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746355|NCT02240238|587783405|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746356|NCT02240238|587783406|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746357|NCT02240238|587783407|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162746358|NCT02240238|587783408|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
162746359|NCT03625115|587783421|FG000|Overall Study|Withdrawal by Subject|4|||
162746360|NCT03625115|587783422|FG001|Overall Study|Withdrawal by Subject|7|||
162746361|NCT03625115|587783421|FG000|Overall Study|Lost to Follow-up|17|||
162746362|NCT03625115|587783422|FG001|Overall Study|Lost to Follow-up|24|||
162746363|NCT05868382|587783423|FG000|Overall Study|Lost to Follow-up|5|||
162746364|NCT05868382|587783424|FG001|Overall Study|Lost to Follow-up|0|||
162746365|NCT05868382|587783425|FG002|Overall Study|Lost to Follow-up|6|||
162746366|NCT05868382|587783426|FG003|Overall Study|Lost to Follow-up|4|||
162746367|NCT05868382|587783427|FG004|Overall Study|Lost to Follow-up|2|||
162746368|NCT05868382|587783428|FG005|Overall Study|Lost to Follow-up|6|||
162746369|NCT05868382|587783423|FG000|Overall Study|Withdrawal by Subject|1|||
162746370|NCT05868382|587783424|FG001|Overall Study|Withdrawal by Subject|0|||
162746371|NCT05868382|587783425|FG002|Overall Study|Withdrawal by Subject|0|||
162746372|NCT05868382|587783426|FG003|Overall Study|Withdrawal by Subject|0|||
162746373|NCT05868382|587783427|FG004|Overall Study|Withdrawal by Subject|1|||
162746374|NCT05868382|587783428|FG005|Overall Study|Withdrawal by Subject|0|||
162746375|NCT03655028|587783429|FG000|12-weeks Follow up|Death|1|||
162746376|NCT03655028|587783430|FG001|12-weeks Follow up|Death|0|||
162746377|NCT03655028|587783429|FG000|12-weeks Follow up|Physician Decision|3|||
162746378|NCT03655028|587783430|FG001|12-weeks Follow up|Physician Decision|3|||
162746379|NCT03655028|587783429|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
162746380|NCT03655028|587783430|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
162746381|NCT03655028|587783429|FG000|12-weeks Follow up|Lost to Follow-up|4|||
162746382|NCT03655028|587783430|FG001|12-weeks Follow up|Lost to Follow-up|4|||
162746383|NCT03655028|587783429|FG000|24-weeks|Lost to Follow-up|1|||
162746384|NCT03655028|587783430|FG001|24-weeks|Lost to Follow-up|1|||
162746385|NCT03655028|587783429|FG000|24-weeks|Death|0|||
162746386|NCT03655028|587783430|FG001|24-weeks|Death|1|||
162746387|NCT03513302|587783431|FG000|First Intervention (14 Days)|Screen failure|15|||
162746388|NCT03513302|587783432|FG001|First Intervention (14 Days)|Screen failure|16|||
162746389|NCT04577963|587783433|FG000|Part 2|Death|0|||
162746390|NCT04577963|587783434|FG001|Part 2|Death|1|||
162746391|NCT04577963|587783435|FG002|Part 2|Death|8|||
162746392|NCT04577963|587783436|FG003|Part 2|Death|0|||
162746393|NCT04577963|587783437|FG004|Part 2|Death|20|||
162746394|NCT04577963|587783433|FG000|Part 2|Lost to Follow-up|0|||
162746395|NCT04577963|587783434|FG001|Part 2|Lost to Follow-up|0|||
162746396|NCT04577963|587783435|FG002|Part 2|Lost to Follow-up|0|||
162746397|NCT04577963|587783436|FG003|Part 2|Lost to Follow-up|0|||
162746398|NCT04577963|587783437|FG004|Part 2|Lost to Follow-up|2|||
162746399|NCT04577963|587783433|FG000|Part 2|Withdrawal by Subject|0|||
162746400|NCT04577963|587783434|FG001|Part 2|Withdrawal by Subject|0|||
162746401|NCT04577963|587783435|FG002|Part 2|Withdrawal by Subject|0|||
162746402|NCT04577963|587783436|FG003|Part 2|Withdrawal by Subject|0|||
162746403|NCT04577963|587783437|FG004|Part 2|Withdrawal by Subject|10|||
162746404|NCT04577963|587783433|FG000|Part 2|Progressive disease|0|||
162746405|NCT04577963|587783434|FG001|Part 2|Progressive disease|0|||
162746406|NCT04577963|587783435|FG002|Part 2|Progressive disease|0|||
162746407|NCT04577963|587783436|FG003|Part 2|Progressive disease|0|||
162746408|NCT04577963|587783437|FG004|Part 2|Progressive disease|2|||
162746409|NCT04577963|587783433|FG000|Part 2|Investigator decision|0|||
162746410|NCT04577963|587783434|FG001|Part 2|Investigator decision|0|||
162746411|NCT04577963|587783435|FG002|Part 2|Investigator decision|0|||
162746412|NCT04577963|587783436|FG003|Part 2|Investigator decision|0|||
162746413|NCT04577963|587783437|FG004|Part 2|Investigator decision|1|||
162746414|NCT04577963|587783433|FG000|Part 2|Sponsor terminated study|0|||
162746415|NCT04577963|587783434|FG001|Part 2|Sponsor terminated study|0|||
162746416|NCT04577963|587783435|FG002|Part 2|Sponsor terminated study|3|||
162746417|NCT04577963|587783436|FG003|Part 2|Sponsor terminated study|1|||
162746418|NCT04577963|587783437|FG004|Part 2|Sponsor terminated study|4|||
162746419|NCT05256654|587783438|FG000|Overall Study|Adverse Event|0|||
162746420|NCT05256654|587783439|FG001|Overall Study|Adverse Event|0|||
162746421|NCT05256654|587783440|FG002|Overall Study|Adverse Event|1|||
162746422|NCT05256654|587783441|FG003|Overall Study|Adverse Event|0|||
162746423|NCT05256654|587783438|FG000|Overall Study|Lost to Follow-up|0|||
162746424|NCT05256654|587783439|FG001|Overall Study|Lost to Follow-up|0|||
162746425|NCT05256654|587783440|FG002|Overall Study|Lost to Follow-up|0|||
162746426|NCT05256654|587783441|FG003|Overall Study|Lost to Follow-up|1|||
162746427|NCT05256654|587783438|FG000|Overall Study|Withdrawal by Subject|1|||
162746428|NCT05256654|587783439|FG001|Overall Study|Withdrawal by Subject|2|||
162746429|NCT05256654|587783440|FG002|Overall Study|Withdrawal by Subject|1|||
162746430|NCT05256654|587783441|FG003|Overall Study|Withdrawal by Subject|3|||
162746431|NCT05256654|587783438|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
162746432|NCT05256654|587783439|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
162746433|NCT05256654|587783440|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
162746434|NCT05256654|587783441|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
162746435|NCT05256654|587783438|FG000|Overall Study|Other|0|||
162746436|NCT05256654|587783439|FG001|Overall Study|Other|0|||
162746437|NCT05256654|587783440|FG002|Overall Study|Other|0|||
162746438|NCT05256654|587783441|FG003|Overall Study|Other|1|||
162746439|NCT02709161|587783442|FG000|Overall Study|Withdrawal by Subject|1|||
162746440|NCT02709161|587783443|FG001|Overall Study|Withdrawal by Subject|0|||
162746441|NCT01221948|587783446|FG000|Overall Study|Physician Decision|5|||
162746442|NCT01221948|587783446|FG000|Overall Study|Withdrawal by Subject|2|||
162746443|NCT01221948|587783446|FG000|Overall Study|not disclosed|2|||
162746444|NCT01221948|587783446|FG000|Overall Study|Death|1|||
162746445|NCT01221948|587783446|FG000|Overall Study|Protocol Violation|4|||
162746446|NCT00746096|587783447|FG000|Overall Study|Adverse Event|1|||
162746447|NCT00746096|587783448|FG001|Overall Study|Adverse Event|0|||
162746448|NCT00746096|587783447|FG000|Overall Study|Withdrawal by Subject|5|||
162746449|NCT00746096|587783448|FG001|Overall Study|Withdrawal by Subject|1|||
162746450|NCT00746096|587783447|FG000|Overall Study|Lost to Follow-up|2|||
162746451|NCT00746096|587783448|FG001|Overall Study|Lost to Follow-up|1|||
162746452|NCT00746096|587783447|FG000|Overall Study|Protocol Violation|1|||
162746453|NCT00746096|587783448|FG001|Overall Study|Protocol Violation|0|||
162746454|NCT00746096|587783447|FG000|Overall Study|No study drug treatment|1|||
162746455|NCT00746096|587783448|FG001|Overall Study|No study drug treatment|1|||
162746456|NCT03756662|587783449|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
162746457|NCT04295512|587783454|FG000|Overall Study|Lack of family response to schedule assessment|0|||
162746458|NCT04295512|587783455|FG001|Overall Study|Lack of family response to schedule assessment|0|||
162746459|NCT04295512|587783456|FG002|Overall Study|Lack of family response to schedule assessment|0|||
162746460|NCT04295512|587783457|FG003|Overall Study|Lack of family response to schedule assessment|2|||
162746461|NCT04295512|587783454|FG000|Overall Study|Therapist did not refer eligible family|7|||
162746462|NCT04295512|587783455|FG001|Overall Study|Therapist did not refer eligible family|7|||
162746463|NCT04295512|587783456|FG002|Overall Study|Therapist did not refer eligible family|0|||
162746464|NCT04295512|587783457|FG003|Overall Study|Therapist did not refer eligible family|0|||
162746465|NCT05207956|587783461|FG000|Overall Study|Lost to follow up|1|||
162746466|NCT05207956|587783462|FG001|Overall Study|Lost to follow up|2|||
162746467|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
162746468|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
162746469|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
162746470|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
162746471|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
162746472|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
162746473|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
162746474|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
162746475|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
162746476|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
162746477|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
162746478|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
162746479|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
162746480|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
162746481|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
162746482|NCT01254864|587783464|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
162746483|NCT01254864|587783465|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
162746484|NCT01254864|587783466|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
162746485|NCT01254864|587783464|FG000|Randomization Phase|Adverse Event|0|||
162746486|NCT01254864|587783465|FG001|Randomization Phase|Adverse Event|5|||
162746487|NCT01254864|587783466|FG002|Randomization Phase|Adverse Event|17|||
162746488|NCT01254864|587783464|FG000|Randomization Phase|Death|0|||
162746489|NCT01254864|587783465|FG001|Randomization Phase|Death|1|||
162746490|NCT01254864|587783466|FG002|Randomization Phase|Death|0|||
162746491|NCT01254864|587783464|FG000|Randomization Phase|Lost to Follow-up|0|||
162746492|NCT01254864|587783465|FG001|Randomization Phase|Lost to Follow-up|0|||
162746493|NCT01254864|587783466|FG002|Randomization Phase|Lost to Follow-up|1|||
162746494|NCT01254864|587783464|FG000|Randomization Phase|Physician Decision|0|||
162746495|NCT01254864|587783465|FG001|Randomization Phase|Physician Decision|20|||
162746496|NCT01254864|587783466|FG002|Randomization Phase|Physician Decision|25|||
162746497|NCT01254864|587783464|FG000|Randomization Phase|Withdrawal by Subject|0|||
162746498|NCT01254864|587783465|FG001|Randomization Phase|Withdrawal by Subject|4|||
162746499|NCT01254864|587783466|FG002|Randomization Phase|Withdrawal by Subject|2|||
162746500|NCT01254864|587783464|FG000|Randomization Phase|Non-Compliance|0|||
162746501|NCT01254864|587783465|FG001|Randomization Phase|Non-Compliance|1|||
162746502|NCT01254864|587783466|FG002|Randomization Phase|Non-Compliance|0|||
162746503|NCT01254864|587783464|FG000|Randomization Phase|Comorbidities|0|||
162746504|NCT01254864|587783465|FG001|Randomization Phase|Comorbidities|2|||
162746505|NCT01254864|587783466|FG002|Randomization Phase|Comorbidities|1|||
162746506|NCT04141891|587783468|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
162746507|NCT04141891|587783469|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
162746508|NCT04141891|587783468|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
162746509|NCT04141891|587783469|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
162746510|NCT04141891|587783468|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
162746511|NCT04141891|587783469|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
162746512|NCT04141891|587783468|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
162746513|NCT04141891|587783469|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
162746514|NCT04141891|587783468|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
162746515|NCT04141891|587783469|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
162746516|NCT04141891|587783468|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
162746517|NCT04141891|587783469|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
162746518|NCT04141891|587783468|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
162746519|NCT04141891|587783469|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
162746520|NCT04141891|587783468|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
162746521|NCT04141891|587783469|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
162746522|NCT04141891|587783468|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
162746523|NCT04141891|587783469|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
162746524|NCT04141891|587783468|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
162746525|NCT04141891|587783469|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
162746526|NCT04141891|587783468|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
162746527|NCT04141891|587783469|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
162746528|NCT04141891|587783468|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
162746529|NCT04141891|587783469|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
162746530|NCT04141891|587783468|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
162746531|NCT04141891|587783469|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
162746532|NCT04141891|587783468|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
162746533|NCT04141891|587783469|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
162746534|NCT03626220|587783470|FG000|Overall Study|Withdrawal by Subject|2|||
162746535|NCT03626220|587783471|FG001|Overall Study|Withdrawal by Subject|0|||
162746536|NCT03295721|587783472|FG000|Overall Study|Adverse Event|1|||
162746537|NCT03295721|587783473|FG001|Overall Study|Adverse Event|0|||
162746538|NCT03295721|587783474|FG002|Overall Study|Adverse Event|0|||
162746539|NCT03295721|587783472|FG000|Overall Study|Lost to Follow-up|1|||
162746540|NCT03295721|587783473|FG001|Overall Study|Lost to Follow-up|1|||
162746541|NCT03295721|587783474|FG002|Overall Study|Lost to Follow-up|1|||
162746542|NCT03295721|587783472|FG000|Overall Study|Withdrawal by Subject|1|||
162746543|NCT03295721|587783473|FG001|Overall Study|Withdrawal by Subject|0|||
162746544|NCT03295721|587783474|FG002|Overall Study|Withdrawal by Subject|1|||
162746545|NCT03295721|587783472|FG000|Overall Study|Death|0|||
162746546|NCT03295721|587783473|FG001|Overall Study|Death|0|||
162746547|NCT03295721|587783474|FG002|Overall Study|Death|1|||
162746548|NCT01651403|587783480|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
162746549|NCT01651403|587783481|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
162746550|NCT01651403|587783480|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
162746551|NCT01651403|587783481|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
162746552|NCT01651403|587783480|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
162746553|NCT01651403|587783481|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
162746554|NCT01651403|587783480|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
162746555|NCT01651403|587783481|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
162746556|NCT01651403|587783480|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
162746557|NCT01651403|587783481|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
162746558|NCT01651403|587783480|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
162746559|NCT01651403|587783481|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
162746560|NCT05090683|587783482|FG000|Overall Study|Lost to Follow-up|10|||
162746561|NCT05090683|587783483|FG001|Overall Study|Lost to Follow-up|2|||
162746562|NCT05090683|587783482|FG000|Overall Study|Withdrawal by Subject|15|||
162746563|NCT05090683|587783483|FG001|Overall Study|Withdrawal by Subject|0|||
162746564|NCT03325985|587783484|FG000|Overall Study|Lost to Follow-up|122|||
162746565|NCT03325985|587783485|FG001|Overall Study|Lost to Follow-up|26|||
162746566|NCT03325985|587783486|FG002|Overall Study|Lost to Follow-up|141|||
162746567|NCT03325985|587783487|FG003|Overall Study|Lost to Follow-up|28|||
162746568|NCT03325985|587783484|FG000|Overall Study|Death|99|||
162746569|NCT03325985|587783485|FG001|Overall Study|Death|36|||
162746570|NCT03325985|587783486|FG002|Overall Study|Death|94|||
162746571|NCT03325985|587783487|FG003|Overall Study|Death|32|||
162746572|NCT03213665|587783488|FG000|Overall Study|Adverse Event|1|||
162746573|NCT03213665|587783488|FG000|Overall Study|Physician Decision|2|||
162746574|NCT03213665|587783488|FG000|Overall Study|Withdrawal by Subject|3|||
162746575|NCT03213665|587783488|FG000|Overall Study|Progressive Disease|13|||
162746576|NCT03034356|587783489|FG000|Baseline|Lost to Follow-up|2|||
162746577|NCT03034356|587783490|FG001|Baseline|Lost to Follow-up|4|||
162746578|NCT03034356|587783489|FG000|Baseline|Withdrawal by Subject|2|||
162746579|NCT03034356|587783490|FG001|Baseline|Withdrawal by Subject|0|||
162746580|NCT03034356|587783489|FG000|Baseline|Physician Decision|0|||
162746581|NCT03034356|587783490|FG001|Baseline|Physician Decision|1|||
162746582|NCT03034356|587783489|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
162746583|NCT03034356|587783490|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
162746584|NCT03034356|587783489|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
162746585|NCT03034356|587783490|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
162746586|NCT03034356|587783489|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
162746587|NCT03034356|587783490|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
162746588|NCT03034356|587783489|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
162746589|NCT03034356|587783490|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
162746590|NCT02684227|587783491|FG000|Overall Study|Adverse Event|1|||
162746591|NCT02684227|587783492|FG001|Overall Study|Adverse Event|7|||
162746592|NCT02684227|587783491|FG000|Overall Study|Death|0|||
162746593|NCT02684227|587783492|FG001|Overall Study|Death|2|||
162746594|NCT02684227|587783491|FG000|Overall Study|Withdrawal by Subject|0|||
162746595|NCT02684227|587783492|FG001|Overall Study|Withdrawal by Subject|1|||
162746596|NCT02684227|587783491|FG000|Overall Study|Progressive Disease|0|||
162746597|NCT02684227|587783492|FG001|Overall Study|Progressive Disease|2|||
162746598|NCT04571619|587783495|FG000|Phase 1|Death|22|||
162746599|NCT04571619|587783496|FG001|Phase 1|Death|18|||
162746600|NCT04571619|587783495|FG000|Phase 1|Withdrawal by Subject|7|||
162746601|NCT04571619|587783496|FG001|Phase 1|Withdrawal by Subject|2|||
162746602|NCT04571619|587783495|FG000|Phase 2|Death|13|||
162746603|NCT04571619|587783496|FG001|Phase 2|Death|16|||
162746604|NCT04571619|587783495|FG000|Phase 2|Withdrawal by Subject|6|||
162746605|NCT04571619|587783496|FG001|Phase 2|Withdrawal by Subject|4|||
162746606|NCT04479761|587783500|FG000|Overall Study|could not perform the balance tasks|1|||
162746607|NCT04479761|587783501|FG001|Overall Study|could not perform the balance tasks|0|||
162746608|NCT04479761|587783502|FG002|Overall Study|could not perform the balance tasks|0|||
162746609|NCT04479761|587783500|FG000|Overall Study|Adverse Event|1|||
162746610|NCT04479761|587783501|FG001|Overall Study|Adverse Event|0|||
162746611|NCT04479761|587783502|FG002|Overall Study|Adverse Event|0|||
162746612|NCT04479761|587783500|FG000|Overall Study|one control did not meet screening criteria|0|||
162746613|NCT04479761|587783501|FG001|Overall Study|one control did not meet screening criteria|0|||
162746614|NCT04479761|587783502|FG002|Overall Study|one control did not meet screening criteria|1|||
162746615|NCT04479761|587783500|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
162746616|NCT04479761|587783501|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
162746617|NCT04479761|587783502|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
162746618|NCT05309291|587783503|FG000|Overall Study|Adverse Event|0|||
162746619|NCT05309291|587783504|FG001|Overall Study|Adverse Event|1|||
162746620|NCT05209152|587783505|FG000|Overall Study|Sponsor decision|1|||
162746621|NCT05209152|587783506|FG001|Overall Study|Sponsor decision|2|||
162746622|NCT05209152|587783505|FG000|Overall Study|Death|3|||
162746623|NCT05209152|587783506|FG001|Overall Study|Death|1|||
162746624|NCT04850898|587785665|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
162746625|NCT04850898|587785666|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
162746626|NCT04550221|587785673|FG000|Overall Study|Lost to Follow-up|0|||
162746627|NCT04550221|587785674|FG001|Overall Study|Lost to Follow-up|4|||
162746628|NCT04550221|587785673|FG000|Overall Study|Withdrawn|3|||
162746629|NCT04550221|587785674|FG001|Overall Study|Withdrawn|0|||
162746630|NCT04550221|587785673|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
162746631|NCT04550221|587785674|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
162746632|NCT05452460|587785675|FG000|Overall Study|Lost to Follow-up|3|||
162746633|NCT05452460|587785676|FG001|Overall Study|Lost to Follow-up|3|||
162746634|NCT05452460|587785675|FG000|Overall Study|Did not receive intervention|1|||
162746635|NCT05452460|587785676|FG001|Overall Study|Did not receive intervention|0|||
162746636|NCT04447040|587785678|FG000|Overall Study|Lost to Follow-up|2|||
162746637|NCT04447040|587785679|FG001|Overall Study|Lost to Follow-up|1|||
162746638|NCT04447040|587785680|FG002|Overall Study|Lost to Follow-up|3|||
162746639|NCT04447040|587785681|FG003|Overall Study|Lost to Follow-up|3|||
162746640|NCT04447040|587785682|FG004|Overall Study|Lost to Follow-up|1|||
162746641|NCT04447040|587785683|FG005|Overall Study|Lost to Follow-up|3|||
162746642|NCT04447040|587785678|FG000|Overall Study|Withdrawal by Subject|0|||
162746643|NCT04447040|587785679|FG001|Overall Study|Withdrawal by Subject|1|||
162746644|NCT04447040|587785680|FG002|Overall Study|Withdrawal by Subject|1|||
162746645|NCT04447040|587785681|FG003|Overall Study|Withdrawal by Subject|1|||
162746646|NCT04447040|587785682|FG004|Overall Study|Withdrawal by Subject|0|||
162746647|NCT04447040|587785683|FG005|Overall Study|Withdrawal by Subject|0|||
162746648|NCT01208662|587785684|FG000|Induction and Consolidation|Disease Progression|23|||
162746649|NCT01208662|587785685|FG001|Induction and Consolidation|Disease Progression|13|||
162746650|NCT01208662|587785686|FG002|Induction and Consolidation|Disease Progression|0|||
162746651|NCT01208662|587785684|FG000|Induction and Consolidation|Adverse Event|16|||
162746652|NCT01208662|587785685|FG001|Induction and Consolidation|Adverse Event|18|||
162746653|NCT01208662|587785686|FG002|Induction and Consolidation|Adverse Event|2|||
162746654|NCT01208662|587785684|FG000|Induction and Consolidation|MD or Participant Decision|16|||
162746655|NCT01208662|587785685|FG001|Induction and Consolidation|MD or Participant Decision|34|||
162746656|NCT01208662|587785686|FG002|Induction and Consolidation|MD or Participant Decision|4|||
162746657|NCT01208662|587785684|FG000|Induction and Consolidation|Death|1|||
162746658|NCT01208662|587785685|FG001|Induction and Consolidation|Death|3|||
162746659|NCT01208662|587785686|FG002|Induction and Consolidation|Death|1|||
162746660|NCT01208662|587785684|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
162746661|NCT01208662|587785685|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
162746662|NCT01208662|587785686|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
162746663|NCT01208662|587785684|FG000|Maintenance|Disease Progression|156|||
162746664|NCT01208662|587785685|FG001|Maintenance|Disease Progression|102|||
162746665|NCT01208662|587785686|FG002|Maintenance|Disease Progression|0|||
162746666|NCT01208662|587785684|FG000|Maintenance|Adverse Event|12|||
162746667|NCT01208662|587785685|FG001|Maintenance|Adverse Event|28|||
162746668|NCT01208662|587785686|FG002|Maintenance|Adverse Event|0|||
162746669|NCT01208662|587785684|FG000|Maintenance|MD or Participant Decision|24|||
162746670|NCT01208662|587785685|FG001|Maintenance|MD or Participant Decision|36|||
162746671|NCT01208662|587785686|FG002|Maintenance|MD or Participant Decision|0|||
162746672|NCT01208662|587785684|FG000|Maintenance|Death|0|||
162746673|NCT01208662|587785685|FG001|Maintenance|Death|3|||
162746674|NCT01208662|587785686|FG002|Maintenance|Death|0|||
162746675|NCT01208662|587785684|FG000|Maintenance|Discontinued for other reasons|21|||
162746676|NCT01208662|587785685|FG001|Maintenance|Discontinued for other reasons|31|||
162746677|NCT01208662|587785686|FG002|Maintenance|Discontinued for other reasons|0|||
162746678|NCT01208662|587785684|FG000|Maintenance|Still on Treatment|78|||
162746679|NCT01208662|587785685|FG001|Maintenance|Still on Treatment|89|||
162746680|NCT01208662|587785686|FG002|Maintenance|Still on Treatment|0|||
162746681|NCT04433208|587785689|FG000|Overall Study|Withdrawal by Subject|0|||
162746682|NCT04433208|587785690|FG001|Overall Study|Withdrawal by Subject|1|||
162746683|NCT04433208|587785691|FG002|Overall Study|Withdrawal by Subject|1|||
162746684|NCT04433208|587785692|FG003|Overall Study|Withdrawal by Subject|0|||
162746685|NCT04433208|587785693|FG004|Overall Study|Withdrawal by Subject|2|||
162746686|NCT04433208|587785694|FG005|Overall Study|Withdrawal by Subject|1|||
162746687|NCT04433208|587785689|FG000|Overall Study|Lost to Follow-up|0|||
162746688|NCT04433208|587785690|FG001|Overall Study|Lost to Follow-up|0|||
162746689|NCT04433208|587785691|FG002|Overall Study|Lost to Follow-up|0|||
162746690|NCT04433208|587785692|FG003|Overall Study|Lost to Follow-up|0|||
162746691|NCT04433208|587785693|FG004|Overall Study|Lost to Follow-up|0|||
162746692|NCT04433208|587785694|FG005|Overall Study|Lost to Follow-up|1|||
162746693|NCT05485779|587785695|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746694|NCT05485779|587785696|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746695|NCT05485779|587785697|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746696|NCT05485779|587785698|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746697|NCT05485779|587785699|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746698|NCT05485779|587785700|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746699|NCT05485779|587785701|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746700|NCT05485779|587785702|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
162746701|NCT05485779|587785703|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
162746702|NCT05485779|587785704|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746703|NCT05485779|587785705|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
162746704|NCT05485779|587785695|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746705|NCT05485779|587785696|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746706|NCT05485779|587785697|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746707|NCT05485779|587785698|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746708|NCT05485779|587785699|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746709|NCT05485779|587785700|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746710|NCT05485779|587785701|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746711|NCT05485779|587785702|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746712|NCT05485779|587785703|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746713|NCT05485779|587785704|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
162746714|NCT05485779|587785705|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
162746715|NCT05485779|587785695|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746716|NCT05485779|587785696|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746717|NCT05485779|587785697|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746718|NCT05485779|587785698|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
162746719|NCT05485779|587785699|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746720|NCT05485779|587785700|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746721|NCT05485779|587785701|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746722|NCT05485779|587785702|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746723|NCT05485779|587785703|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746724|NCT05485779|587785704|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746725|NCT05485779|587785705|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162746726|NCT02694822|587785708|FG000|Phase 1|Death|2|||
162746727|NCT02694822|587785709|FG001|Phase 1|Death|1|||
162746728|NCT02694822|587785710|FG002|Phase 1|Death|6|||
162746729|NCT02694822|587785711|FG003|Phase 1|Death|6|||
162746730|NCT02694822|587785712|FG004|Phase 1|Death|3|||
162746731|NCT02694822|587785713|FG005|Phase 1|Death|0|||
162746732|NCT02694822|587785708|FG000|Phase 1|Withdrawal by Subject|2|||
162746733|NCT02694822|587785709|FG001|Phase 1|Withdrawal by Subject|2|||
162746734|NCT02694822|587785710|FG002|Phase 1|Withdrawal by Subject|4|||
162746735|NCT02694822|587785711|FG003|Phase 1|Withdrawal by Subject|8|||
162746736|NCT02694822|587785712|FG004|Phase 1|Withdrawal by Subject|1|||
162746737|NCT02694822|587785713|FG005|Phase 1|Withdrawal by Subject|0|||
162746738|NCT02694822|587785708|FG000|Phase 2|Death|0|||
162746739|NCT02694822|587785709|FG001|Phase 2|Death|0|||
162746740|NCT02694822|587785710|FG002|Phase 2|Death|0|||
162746741|NCT02694822|587785711|FG003|Phase 2|Death|0|||
162746742|NCT02694822|587785712|FG004|Phase 2|Death|0|||
162746743|NCT02694822|587785713|FG005|Phase 2|Death|26|||
162746744|NCT02694822|587785708|FG000|Phase 2|Withdrawal by Subject|0|||
162746745|NCT02694822|587785709|FG001|Phase 2|Withdrawal by Subject|0|||
162746746|NCT02694822|587785710|FG002|Phase 2|Withdrawal by Subject|0|||
162746747|NCT02694822|587785711|FG003|Phase 2|Withdrawal by Subject|0|||
162746748|NCT02694822|587785712|FG004|Phase 2|Withdrawal by Subject|0|||
162746749|NCT02694822|587785713|FG005|Phase 2|Withdrawal by Subject|13|||
162746750|NCT02694822|587785708|FG000|Phase 2|Administrative Study Closure|0|||
162746751|NCT02694822|587785709|FG001|Phase 2|Administrative Study Closure|0|||
162746752|NCT02694822|587785710|FG002|Phase 2|Administrative Study Closure|0|||
162746753|NCT02694822|587785711|FG003|Phase 2|Administrative Study Closure|0|||
162746754|NCT02694822|587785712|FG004|Phase 2|Administrative Study Closure|0|||
162746755|NCT02694822|587785713|FG005|Phase 2|Administrative Study Closure|2|||
162746756|NCT02694822|587785708|FG000|Phase 2|Lost to Follow-up|0|||
162746757|NCT02694822|587785709|FG001|Phase 2|Lost to Follow-up|0|||
162746758|NCT02694822|587785710|FG002|Phase 2|Lost to Follow-up|0|||
162746759|NCT02694822|587785711|FG003|Phase 2|Lost to Follow-up|0|||
162746760|NCT02694822|587785712|FG004|Phase 2|Lost to Follow-up|0|||
162746761|NCT02694822|587785713|FG005|Phase 2|Lost to Follow-up|1|||
162746762|NCT02694822|587785708|FG000|Phase 2|Participant Transferred to Another Site|0|||
162746763|NCT02694822|587785709|FG001|Phase 2|Participant Transferred to Another Site|0|||
162746764|NCT02694822|587785710|FG002|Phase 2|Participant Transferred to Another Site|0|||
162746765|NCT02694822|587785711|FG003|Phase 2|Participant Transferred to Another Site|0|||
162746766|NCT02694822|587785712|FG004|Phase 2|Participant Transferred to Another Site|0|||
162746767|NCT02694822|587785713|FG005|Phase 2|Participant Transferred to Another Site|1|||
162746768|NCT05370040|587785714|FG000|Overall Study|Lost to Follow-up|0|||
162746769|NCT05370040|587785715|FG001|Overall Study|Lost to Follow-up|0|||
162746770|NCT05370040|587785716|FG002|Overall Study|Lost to Follow-up|1|||
162746771|NCT05370040|587785717|FG003|Overall Study|Lost to Follow-up|0|||
162746772|NCT05370040|587785718|FG004|Overall Study|Lost to Follow-up|1|||
162746773|NCT05370040|587785719|FG005|Overall Study|Lost to Follow-up|0|||
162746774|NCT04294641|587785720|FG000|Overall Study|Screen failure|4|||
162746775|NCT05906784|587785722|FG000|Overall Study|Lost to Follow-up|2|||
162746776|NCT05906784|587785723|FG001|Overall Study|Lost to Follow-up|1|||
162746777|NCT05906784|587785724|FG002|Overall Study|Lost to Follow-up|1|||
162746778|NCT05906784|587785725|FG003|Overall Study|Lost to Follow-up|1|||
162746779|NCT03249090|587785735|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
162746780|NCT03249090|587785736|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
162746781|NCT03249090|587785735|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
162746782|NCT03249090|587785736|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
162746783|NCT03249090|587785735|FG000|3 Month Time Point|Voluntary withdrawal|6|||
162746784|NCT03249090|587785736|FG001|3 Month Time Point|Voluntary withdrawal|3|||
162746785|NCT03249090|587785735|FG000|3 Month Time Point|Changed oncology practice|4|||
162746786|NCT03249090|587785736|FG001|3 Month Time Point|Changed oncology practice|2|||
162746787|NCT03249090|587785735|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
162746788|NCT03249090|587785736|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
162746789|NCT03249090|587785735|FG000|12 Month Time Point|Voluntary withdrawal|35|||
162746790|NCT03249090|587785736|FG001|12 Month Time Point|Voluntary withdrawal|4|||
162746791|NCT03249090|587785735|FG000|12 Month Time Point|Changed oncology practice|20|||
162746792|NCT03249090|587785736|FG001|12 Month Time Point|Changed oncology practice|9|||
162746793|NCT03523572|587785741|FG000|Dose Escalation|Progressive disease|1|||
162746794|NCT03523572|587785742|FG001|Dose Escalation|Progressive disease|0|||
162746795|NCT03523572|587785743|FG002|Dose Escalation|Progressive disease|0|||
162746796|NCT03523572|587785744|FG003|Dose Escalation|Progressive disease|0|||
162746797|NCT03523572|587785745|FG004|Dose Escalation|Progressive disease|0|||
162746798|NCT03523572|587785746|FG005|Dose Escalation|Progressive disease|0|||
162746799|NCT03523572|587785741|FG000|Dose Escalation|Clinical Progression|0|||
162746800|NCT03523572|587785742|FG001|Dose Escalation|Clinical Progression|1|||
162746801|NCT03523572|587785743|FG002|Dose Escalation|Clinical Progression|0|||
162746802|NCT03523572|587785744|FG003|Dose Escalation|Clinical Progression|0|||
162746803|NCT03523572|587785745|FG004|Dose Escalation|Clinical Progression|0|||
162746804|NCT03523572|587785746|FG005|Dose Escalation|Clinical Progression|0|||
162746805|NCT03523572|587785741|FG000|Dose Escalation|Adverse Event|2|||
162746806|NCT03523572|587785742|FG001|Dose Escalation|Adverse Event|0|||
162746807|NCT03523572|587785743|FG002|Dose Escalation|Adverse Event|0|||
162746808|NCT03523572|587785744|FG003|Dose Escalation|Adverse Event|0|||
162746809|NCT03523572|587785745|FG004|Dose Escalation|Adverse Event|0|||
162746810|NCT03523572|587785746|FG005|Dose Escalation|Adverse Event|0|||
162746811|NCT03523572|587785741|FG000|Dose Escalation|Physician Decision|1|||
162746812|NCT03523572|587785742|FG001|Dose Escalation|Physician Decision|1|||
162746813|NCT03523572|587785743|FG002|Dose Escalation|Physician Decision|0|||
162746814|NCT03523572|587785744|FG003|Dose Escalation|Physician Decision|0|||
162746815|NCT03523572|587785745|FG004|Dose Escalation|Physician Decision|0|||
162746816|NCT03523572|587785746|FG005|Dose Escalation|Physician Decision|0|||
162746817|NCT03523572|587785741|FG000|Dose Expansion|Progressive Disease|0|||
162746818|NCT03523572|587785742|FG001|Dose Expansion|Progressive Disease|0|||
162746819|NCT03523572|587785743|FG002|Dose Expansion|Progressive Disease|9|||
162746820|NCT03523572|587785744|FG003|Dose Expansion|Progressive Disease|11|||
162746821|NCT03523572|587785745|FG004|Dose Expansion|Progressive Disease|15|||
162746822|NCT03523572|587785746|FG005|Dose Expansion|Progressive Disease|2|||
162746823|NCT03523572|587785741|FG000|Dose Expansion|Clinical Progression|0|||
162746824|NCT03523572|587785742|FG001|Dose Expansion|Clinical Progression|0|||
162746825|NCT03523572|587785743|FG002|Dose Expansion|Clinical Progression|2|||
162746826|NCT03523572|587785744|FG003|Dose Expansion|Clinical Progression|2|||
162746827|NCT03523572|587785745|FG004|Dose Expansion|Clinical Progression|2|||
162746828|NCT03523572|587785746|FG005|Dose Expansion|Clinical Progression|0|||
162746829|NCT03523572|587785741|FG000|Dose Expansion|Adverse Event|0|||
162746830|NCT03523572|587785742|FG001|Dose Expansion|Adverse Event|0|||
162746831|NCT03523572|587785743|FG002|Dose Expansion|Adverse Event|10|||
162746832|NCT03523572|587785744|FG003|Dose Expansion|Adverse Event|1|||
162746833|NCT03523572|587785745|FG004|Dose Expansion|Adverse Event|5|||
162746834|NCT03523572|587785746|FG005|Dose Expansion|Adverse Event|2|||
162746835|NCT03523572|587785741|FG000|Dose Expansion|Withdrawal by Subject|0|||
162746836|NCT03523572|587785742|FG001|Dose Expansion|Withdrawal by Subject|0|||
162746837|NCT03523572|587785743|FG002|Dose Expansion|Withdrawal by Subject|1|||
162746838|NCT03523572|587785744|FG003|Dose Expansion|Withdrawal by Subject|1|||
162746839|NCT03523572|587785745|FG004|Dose Expansion|Withdrawal by Subject|0|||
162746840|NCT03523572|587785746|FG005|Dose Expansion|Withdrawal by Subject|0|||
162746841|NCT03523572|587785741|FG000|Dose Expansion|Physician Decision|0|||
162746842|NCT03523572|587785742|FG001|Dose Expansion|Physician Decision|0|||
162746843|NCT03523572|587785743|FG002|Dose Expansion|Physician Decision|1|||
162746844|NCT03523572|587785744|FG003|Dose Expansion|Physician Decision|0|||
162746845|NCT03523572|587785745|FG004|Dose Expansion|Physician Decision|1|||
162746846|NCT03523572|587785746|FG005|Dose Expansion|Physician Decision|0|||
162746847|NCT03523572|587785741|FG000|Dose Expansion|Miscellaneous|0|||
162746848|NCT03523572|587785742|FG001|Dose Expansion|Miscellaneous|0|||
162746849|NCT03523572|587785743|FG002|Dose Expansion|Miscellaneous|0|||
162746850|NCT03523572|587785744|FG003|Dose Expansion|Miscellaneous|0|||
162746851|NCT03523572|587785745|FG004|Dose Expansion|Miscellaneous|3|||
162746852|NCT03523572|587785746|FG005|Dose Expansion|Miscellaneous|0|||
162746853|NCT04685135|587785752|FG000|Overall Study|Death|126|||
162746854|NCT04685135|587785753|FG001|Overall Study|Death|53|||
162746855|NCT04685135|587785752|FG000|Overall Study|Withdrawal by Subject|12|||
162746856|NCT04685135|587785753|FG001|Overall Study|Withdrawal by Subject|16|||
162746857|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162746858|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162746859|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162746860|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162746861|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162746862|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162746863|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162746864|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162746865|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
162746866|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
162746867|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
162746868|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
162746869|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162746870|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
162746871|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162746872|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162746873|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746874|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746875|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746876|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746877|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746878|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
162746879|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
162746880|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162746881|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746882|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746883|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746884|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746885|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746886|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746887|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162746888|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
162746889|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162746890|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
162746891|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
162746892|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
162746893|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
162746894|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162746895|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162746896|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
162746897|NCT02315703|587785756|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
162746898|NCT02315703|587785757|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
162746899|NCT02315703|587785758|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
162746900|NCT02315703|587785759|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
162746901|NCT02315703|587785760|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
162746902|NCT02315703|587785761|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
162746903|NCT02315703|587785762|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
162746904|NCT02315703|587785763|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
162746905|NCT02315703|587785756|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
162746906|NCT02315703|587785757|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
162746907|NCT02315703|587785758|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746908|NCT02315703|587785759|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746909|NCT02315703|587785760|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746910|NCT02315703|587785761|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746911|NCT02315703|587785762|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746912|NCT02315703|587785763|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162746913|NCT02315703|587785756|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746914|NCT02315703|587785757|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
162746915|NCT02315703|587785758|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746916|NCT02315703|587785759|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746917|NCT02315703|587785760|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746918|NCT02315703|587785761|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746919|NCT02315703|587785762|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746920|NCT02315703|587785763|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162746921|NCT02315703|587785756|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
162746922|NCT02315703|587785757|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
162746923|NCT02315703|587785758|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
162746924|NCT02315703|587785759|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
162746925|NCT02315703|587785760|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
162746926|NCT02315703|587785761|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
162746927|NCT02315703|587785762|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
162746928|NCT02315703|587785763|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
162746929|NCT03476343|587785765|FG000|Overall Study|Clinical exam moved to another scanner|7|||
162746930|NCT03476343|587785765|FG000|Overall Study|Clinical order cancelled|4|||
162746931|NCT03476343|587785765|FG000|Overall Study|Neonate did not settle down for the scan|1|||
162746932|NCT02724969|587785766|FG000|Overall Study|Lost to Follow-up|12|||
162746933|NCT02724969|587785767|FG001|Overall Study|Lost to Follow-up|6|||
162746934|NCT02724969|587785766|FG000|Overall Study|Withdrawal by Subject|3|||
162746935|NCT02724969|587785767|FG001|Overall Study|Withdrawal by Subject|3|||
162746936|NCT02724969|587785766|FG000|Overall Study|Infant demise|0|||
162746937|NCT02724969|587785767|FG001|Overall Study|Infant demise|2|||
162746938|NCT05974501|587785768|FG000|Overall Study|Physician Decision|0|||
162746939|NCT05974501|587785769|FG001|Overall Study|Physician Decision|1|||
162746940|NCT05147116|587785771|FG000|Overall Study|Withdrawal by Subject|0|||
162746941|NCT05147116|587785772|FG001|Overall Study|Withdrawal by Subject|1|||
162746942|NCT03672916|587785773|FG000|Overall Study|Death|6|||
162746943|NCT03672916|587785773|FG000|Overall Study|Lost to Follow-up|29|||
162746944|NCT03672916|587785773|FG000|Overall Study|Adverse Event|6|||
162746945|NCT03672916|587785773|FG000|Overall Study|Withdrawal by Subject|11|||
162746946|NCT04197336|587785774|FG000|Overall Study|Withdrawal by Subject|1|||
162746947|NCT02497950|587785778|FG000|Overall Study|Death|209|||
162746948|NCT02497950|587785778|FG000|Overall Study|Transplanted|85|||
162746949|NCT02497950|587785778|FG000|Overall Study|Explanted|8|||
162746950|NCT02497950|587785778|FG000|Overall Study|Device Permanently Deactivated|4|||
162746951|NCT02497950|587785778|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
162746952|NCT02497950|587785778|FG000|Overall Study|Lost to Follow-up|6|||
162746953|NCT02497950|587785778|FG000|Overall Study|Withdrawal by Subject|2|||
162746954|NCT02497950|587785778|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
162746955|NCT02497950|587785778|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
162746956|NCT04625725|587785785|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
162746957|NCT04625725|587785786|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162746958|NCT04625725|587785787|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162746959|NCT04625725|587785788|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162746960|NCT04625725|587785789|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162746961|NCT04625725|587785790|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162746962|NCT04625725|587785785|FG000|Provent Main Study|Withdrawal by Subject|242|||
162746963|NCT04625725|587785786|FG001|Provent Main Study|Withdrawal by Subject|144|||
162746964|NCT04625725|587785787|FG002|Provent Main Study|Withdrawal by Subject|0|||
162746965|NCT04625725|587785788|FG003|Provent Main Study|Withdrawal by Subject|0|||
162746966|NCT04625725|587785789|FG004|Provent Main Study|Withdrawal by Subject|0|||
162746967|NCT04625725|587785790|FG005|Provent Main Study|Withdrawal by Subject|0|||
162746968|NCT04625725|587785785|FG000|Provent Main Study|Physician Decision|5|||
162746969|NCT04625725|587785786|FG001|Provent Main Study|Physician Decision|0|||
162746970|NCT04625725|587785787|FG002|Provent Main Study|Physician Decision|0|||
162746971|NCT04625725|587785788|FG003|Provent Main Study|Physician Decision|0|||
162746972|NCT04625725|587785789|FG004|Provent Main Study|Physician Decision|0|||
162746973|NCT04625725|587785790|FG005|Provent Main Study|Physician Decision|0|||
162746974|NCT04625725|587785785|FG000|Provent Main Study|Protocol Violation|1|||
162746975|NCT04625725|587785786|FG001|Provent Main Study|Protocol Violation|0|||
162746976|NCT04625725|587785787|FG002|Provent Main Study|Protocol Violation|0|||
162746977|NCT04625725|587785788|FG003|Provent Main Study|Protocol Violation|0|||
162746978|NCT04625725|587785789|FG004|Provent Main Study|Protocol Violation|0|||
162746979|NCT04625725|587785790|FG005|Provent Main Study|Protocol Violation|0|||
162746980|NCT04625725|587785785|FG000|Provent Main Study|Lost to Follow-up|357|||
162746981|NCT04625725|587785786|FG001|Provent Main Study|Lost to Follow-up|200|||
162746982|NCT04625725|587785787|FG002|Provent Main Study|Lost to Follow-up|0|||
162746983|NCT04625725|587785788|FG003|Provent Main Study|Lost to Follow-up|0|||
162746984|NCT04625725|587785789|FG004|Provent Main Study|Lost to Follow-up|0|||
162746985|NCT04625725|587785790|FG005|Provent Main Study|Lost to Follow-up|0|||
162746986|NCT04625725|587785785|FG000|Provent Main Study|Death|22|||
162746987|NCT04625725|587785786|FG001|Provent Main Study|Death|10|||
162746988|NCT04625725|587785787|FG002|Provent Main Study|Death|0|||
162746989|NCT04625725|587785788|FG003|Provent Main Study|Death|0|||
162746990|NCT04625725|587785789|FG004|Provent Main Study|Death|0|||
162746991|NCT04625725|587785790|FG005|Provent Main Study|Death|0|||
162746992|NCT04625725|587785785|FG000|Provent Main Study|Adverse Event|2|||
162746993|NCT04625725|587785786|FG001|Provent Main Study|Adverse Event|1|||
162746994|NCT04625725|587785787|FG002|Provent Main Study|Adverse Event|0|||
162746995|NCT04625725|587785788|FG003|Provent Main Study|Adverse Event|0|||
162746996|NCT04625725|587785789|FG004|Provent Main Study|Adverse Event|0|||
162746997|NCT04625725|587785790|FG005|Provent Main Study|Adverse Event|0|||
162746998|NCT04625725|587785785|FG000|Provent Main Study|Participants dosed in sub-study|310|||
162746999|NCT04625725|587785786|FG001|Provent Main Study|Participants dosed in sub-study|193|||
162747000|NCT04625725|587785787|FG002|Provent Main Study|Participants dosed in sub-study|0|||
162747001|NCT04625725|587785788|FG003|Provent Main Study|Participants dosed in sub-study|0|||
162747002|NCT04625725|587785789|FG004|Provent Main Study|Participants dosed in sub-study|0|||
162747003|NCT04625725|587785790|FG005|Provent Main Study|Participants dosed in sub-study|0|||
162747004|NCT04625725|587785785|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
162747005|NCT04625725|587785786|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
162747006|NCT04625725|587785787|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162747007|NCT04625725|587785788|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162747008|NCT04625725|587785789|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162747009|NCT04625725|587785790|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162747010|NCT04625725|587785785|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
162747011|NCT04625725|587785786|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
162747012|NCT04625725|587785787|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162747013|NCT04625725|587785788|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162747014|NCT04625725|587785789|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162747015|NCT04625725|587785790|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162747016|NCT04625725|587785785|FG000|Provent Main Study|INCARCERATION|3|||
162747017|NCT04625725|587785786|FG001|Provent Main Study|INCARCERATION|0|||
162747018|NCT04625725|587785787|FG002|Provent Main Study|INCARCERATION|0|||
162747019|NCT04625725|587785788|FG003|Provent Main Study|INCARCERATION|0|||
162747020|NCT04625725|587785789|FG004|Provent Main Study|INCARCERATION|0|||
162747021|NCT04625725|587785790|FG005|Provent Main Study|INCARCERATION|0|||
162747022|NCT04625725|587785785|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
162747023|NCT04625725|587785786|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
162747024|NCT04625725|587785787|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162747025|NCT04625725|587785788|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162747026|NCT04625725|587785789|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162747027|NCT04625725|587785790|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162747028|NCT04625725|587785785|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
162747029|NCT04625725|587785786|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
162747030|NCT04625725|587785787|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162747031|NCT04625725|587785788|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162747032|NCT04625725|587785789|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162747033|NCT04625725|587785790|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162747034|NCT04625725|587785785|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
162747035|NCT04625725|587785786|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
162747036|NCT04625725|587785787|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162747037|NCT04625725|587785788|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162747038|NCT04625725|587785789|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162747039|NCT04625725|587785790|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162747040|NCT04625725|587785785|FG000|Provent Main Study|MISSING REASON|0|||
162747041|NCT04625725|587785786|FG001|Provent Main Study|MISSING REASON|1|||
162747042|NCT04625725|587785787|FG002|Provent Main Study|MISSING REASON|0|||
162747043|NCT04625725|587785788|FG003|Provent Main Study|MISSING REASON|0|||
162747044|NCT04625725|587785789|FG004|Provent Main Study|MISSING REASON|0|||
162747045|NCT04625725|587785790|FG005|Provent Main Study|MISSING REASON|0|||
162747046|NCT04625725|587785785|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162747047|NCT04625725|587785786|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162747048|NCT04625725|587785787|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162747049|NCT04625725|587785788|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
162747050|NCT04625725|587785789|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162747051|NCT04625725|587785790|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162747052|NCT04625725|587785785|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162747053|NCT04625725|587785786|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162747054|NCT04625725|587785787|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
162747055|NCT04625725|587785788|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162747056|NCT04625725|587785789|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162747057|NCT04625725|587785790|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162747058|NCT04625725|587785785|FG000|Provent Sub Study|Lost to Follow-up|0|||
162747059|NCT04625725|587785786|FG001|Provent Sub Study|Lost to Follow-up|0|||
162747060|NCT04625725|587785787|FG002|Provent Sub Study|Lost to Follow-up|20|||
162747061|NCT04625725|587785788|FG003|Provent Sub Study|Lost to Follow-up|10|||
162747062|NCT04625725|587785789|FG004|Provent Sub Study|Lost to Follow-up|6|||
162747063|NCT04625725|587785790|FG005|Provent Sub Study|Lost to Follow-up|4|||
162747064|NCT04625725|587785785|FG000|Provent Sub Study|Death|0|||
162747065|NCT04625725|587785786|FG001|Provent Sub Study|Death|0|||
162747066|NCT04625725|587785787|FG002|Provent Sub Study|Death|8|||
162747067|NCT04625725|587785788|FG003|Provent Sub Study|Death|5|||
162747068|NCT04625725|587785789|FG004|Provent Sub Study|Death|0|||
162747069|NCT04625725|587785790|FG005|Provent Sub Study|Death|1|||
162747070|NCT04625725|587785785|FG000|Provent Sub Study|Adverse Event|0|||
162747071|NCT04625725|587785786|FG001|Provent Sub Study|Adverse Event|0|||
162747072|NCT04625725|587785787|FG002|Provent Sub Study|Adverse Event|0|||
162747073|NCT04625725|587785788|FG003|Provent Sub Study|Adverse Event|0|||
162747074|NCT04625725|587785789|FG004|Provent Sub Study|Adverse Event|0|||
162747075|NCT04625725|587785790|FG005|Provent Sub Study|Adverse Event|1|||
162747076|NCT04625725|587785785|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162747077|NCT04625725|587785786|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162747078|NCT04625725|587785787|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162747079|NCT04625725|587785788|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162747080|NCT04625725|587785789|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
162747081|NCT04625725|587785790|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162747082|NCT04625725|587785785|FG000|Provent Sub Study|Withdrawal by Subject|0|||
162747083|NCT04625725|587785786|FG001|Provent Sub Study|Withdrawal by Subject|0|||
162747084|NCT04625725|587785787|FG002|Provent Sub Study|Withdrawal by Subject|11|||
162747085|NCT04625725|587785788|FG003|Provent Sub Study|Withdrawal by Subject|13|||
162747086|NCT04625725|587785789|FG004|Provent Sub Study|Withdrawal by Subject|5|||
162747087|NCT04625725|587785790|FG005|Provent Sub Study|Withdrawal by Subject|6|||
162747088|NCT04625725|587785785|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162747089|NCT04625725|587785786|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162747090|NCT04625725|587785787|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162747091|NCT04625725|587785788|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162747092|NCT04625725|587785789|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162747093|NCT04625725|587785790|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
162747094|NCT04308681|587785791|FG000|Pre-Treatment|Not reported|1|||
162747095|NCT04308681|587785792|FG001|Pre-Treatment|Not reported|1|||
162747096|NCT04308681|587785793|FG002|Pre-Treatment|Not reported|0|||
162747097|NCT04308681|587785794|FG003|Pre-Treatment|Not reported|0|||
162747098|NCT04308681|587785795|FG004|Pre-Treatment|Not reported|0|||
162747099|NCT04308681|587785796|FG005|Pre-Treatment|Not reported|2|||
162747100|NCT04308681|587785797|FG006|Pre-Treatment|Not reported|0|||
162747101|NCT04308681|587785798|FG007|Pre-Treatment|Not reported|0|||
162747102|NCT04308681|587785791|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
162747103|NCT04308681|587785792|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
162747104|NCT04308681|587785793|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
162747105|NCT04308681|587785794|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
162747106|NCT04308681|587785795|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
162747107|NCT04308681|587785796|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
162747108|NCT04308681|587785797|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
162747109|NCT04308681|587785798|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
162747110|NCT04308681|587785791|FG000|Treatment up to Week 26|Other reasons|2|||
162747111|NCT04308681|587785792|FG001|Treatment up to Week 26|Other reasons|0|||
162747112|NCT04308681|587785793|FG002|Treatment up to Week 26|Other reasons|0|||
162747113|NCT04308681|587785794|FG003|Treatment up to Week 26|Other reasons|0|||
162747114|NCT04308681|587785795|FG004|Treatment up to Week 26|Other reasons|1|||
162747115|NCT04308681|587785796|FG005|Treatment up to Week 26|Other reasons|1|||
162747116|NCT04308681|587785797|FG006|Treatment up to Week 26|Other reasons|0|||
162747117|NCT04308681|587785798|FG007|Treatment up to Week 26|Other reasons|0|||
162747118|NCT04308681|587785791|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162747119|NCT04308681|587785792|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162747120|NCT04308681|587785793|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
162747121|NCT04308681|587785794|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162747122|NCT04308681|587785795|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162747123|NCT04308681|587785796|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162747124|NCT04308681|587785797|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162747125|NCT04308681|587785798|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162747126|NCT04308681|587785791|FG000|Treatment up to Week 26|Adverse Event|6|||
162747127|NCT04308681|587785792|FG001|Treatment up to Week 26|Adverse Event|5|||
162747128|NCT04308681|587785793|FG002|Treatment up to Week 26|Adverse Event|5|||
162747129|NCT04308681|587785794|FG003|Treatment up to Week 26|Adverse Event|0|||
162747130|NCT04308681|587785795|FG004|Treatment up to Week 26|Adverse Event|6|||
162747131|NCT04308681|587785796|FG005|Treatment up to Week 26|Adverse Event|1|||
162747132|NCT04308681|587785797|FG006|Treatment up to Week 26|Adverse Event|0|||
162747133|NCT04308681|587785798|FG007|Treatment up to Week 26|Adverse Event|0|||
162747134|NCT04308681|587785791|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747135|NCT04308681|587785792|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
162747136|NCT04308681|587785793|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
162747137|NCT04308681|587785794|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747138|NCT04308681|587785795|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747139|NCT04308681|587785796|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747140|NCT04308681|587785797|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747141|NCT04308681|587785798|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162747142|NCT04308681|587785791|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
162747143|NCT04308681|587785792|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
162747144|NCT04308681|587785793|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
162747145|NCT04308681|587785794|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
162747146|NCT04308681|587785795|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
162747147|NCT04308681|587785796|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
162747148|NCT04308681|587785797|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
162747149|NCT04308681|587785798|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
162747150|NCT04308681|587785791|FG000|OTE - 26 Weeks|Death|0|||
162747151|NCT04308681|587785792|FG001|OTE - 26 Weeks|Death|1|||
162747152|NCT04308681|587785793|FG002|OTE - 26 Weeks|Death|0|||
162747153|NCT04308681|587785794|FG003|OTE - 26 Weeks|Death|0|||
162747154|NCT04308681|587785795|FG004|OTE - 26 Weeks|Death|0|||
162747155|NCT04308681|587785796|FG005|OTE - 26 Weeks|Death|0|||
162747156|NCT04308681|587785797|FG006|OTE - 26 Weeks|Death|1|||
162747157|NCT04308681|587785798|FG007|OTE - 26 Weeks|Death|0|||
162747158|NCT04308681|587785791|FG000|OTE - 26 Weeks|Adverse Event|0|||
162747159|NCT04308681|587785792|FG001|OTE - 26 Weeks|Adverse Event|2|||
162747160|NCT04308681|587785793|FG002|OTE - 26 Weeks|Adverse Event|8|||
162747161|NCT04308681|587785794|FG003|OTE - 26 Weeks|Adverse Event|3|||
162747162|NCT04308681|587785795|FG004|OTE - 26 Weeks|Adverse Event|0|||
162747163|NCT04308681|587785796|FG005|OTE - 26 Weeks|Adverse Event|1|||
162747164|NCT04308681|587785797|FG006|OTE - 26 Weeks|Adverse Event|2|||
162747165|NCT04308681|587785798|FG007|OTE - 26 Weeks|Adverse Event|0|||
162747166|NCT04308681|587785791|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162747167|NCT04308681|587785792|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162747168|NCT04308681|587785793|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162747169|NCT04308681|587785794|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162747170|NCT04308681|587785795|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162747171|NCT04308681|587785796|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162747172|NCT04308681|587785797|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162747173|NCT04308681|587785798|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162747174|NCT00429364|587785801|FG000|Overall Study|Withdrawal by Subject|11|||
162747175|NCT00429364|587785802|FG001|Overall Study|Withdrawal by Subject|5|||
162747176|NCT00429364|587785801|FG000|Overall Study|Physician Decision|4|||
162747177|NCT00429364|587785802|FG001|Overall Study|Physician Decision|2|||
162747178|NCT00429364|587785801|FG000|Overall Study|Lost to Follow-up|7|||
162747179|NCT00429364|587785802|FG001|Overall Study|Lost to Follow-up|6|||
162747180|NCT00429364|587785801|FG000|Overall Study|Death|0|||
162747181|NCT00429364|587785802|FG001|Overall Study|Death|1|||
162747182|NCT00429364|587785801|FG000|Overall Study|Underwent aortic root surgery|10|||
162747183|NCT00429364|587785802|FG001|Overall Study|Underwent aortic root surgery|18|||
162747184|NCT00429364|587785801|FG000|Overall Study|Pregnancy|0|||
162747185|NCT00429364|587785802|FG001|Overall Study|Pregnancy|1|||
162747186|NCT05873556|587785803|FG000|Overall Study|Lost to Follow-up|4|||
162747187|NCT05873556|587785804|FG001|Overall Study|Lost to Follow-up|1|||
162747188|NCT03714815|587785813|FG000|Overall Study|Physician Decision|2|||
162747189|NCT03714815|587785813|FG000|Overall Study|Withdrawal by Subject|2|||
162747190|NCT03714815|587785813|FG000|Overall Study|Death|11|||
162747191|NCT04580914|587785814|FG000|Overall Study|Withdrawal by Subject|6|||
162747192|NCT04580914|587785814|FG000|Overall Study|Lost to Follow-up|2|||
162747193|NCT04167553|587785817|FG000|Overall Study|Withdrawal by Subject|1|||
162747194|NCT04167553|587785818|FG001|Overall Study|Withdrawal by Subject|0|||
162747195|NCT04167553|587785819|FG002|Overall Study|Withdrawal by Subject|1|||
162747196|NCT04167553|587785820|FG003|Overall Study|Withdrawal by Subject|2|||
162747197|NCT04167553|587785821|FG004|Overall Study|Withdrawal by Subject|1|||
162747198|NCT04167553|587785822|FG005|Overall Study|Withdrawal by Subject|0|||
162747199|NCT04167553|587785823|FG006|Overall Study|Withdrawal by Subject|0|||
162747200|NCT04167553|587785817|FG000|Overall Study|Physician Decision|0|||
162747201|NCT04167553|587785818|FG001|Overall Study|Physician Decision|0|||
162747202|NCT04167553|587785819|FG002|Overall Study|Physician Decision|0|||
162747203|NCT04167553|587785820|FG003|Overall Study|Physician Decision|0|||
162747204|NCT04167553|587785821|FG004|Overall Study|Physician Decision|2|||
162747205|NCT04167553|587785822|FG005|Overall Study|Physician Decision|2|||
162747206|NCT04167553|587785823|FG006|Overall Study|Physician Decision|0|||
162747207|NCT04167553|587785817|FG000|Overall Study|Lost to Follow-up|0|||
162747208|NCT04167553|587785818|FG001|Overall Study|Lost to Follow-up|0|||
162747209|NCT04167553|587785819|FG002|Overall Study|Lost to Follow-up|2|||
162747210|NCT04167553|587785820|FG003|Overall Study|Lost to Follow-up|0|||
162747211|NCT04167553|587785821|FG004|Overall Study|Lost to Follow-up|0|||
162747212|NCT04167553|587785822|FG005|Overall Study|Lost to Follow-up|0|||
162747213|NCT04167553|587785823|FG006|Overall Study|Lost to Follow-up|0|||
162747214|NCT02828358|587785824|FG000|Overall Study|Physician Decision|7|||
162747215|NCT02828358|587785825|FG001|Overall Study|Physician Decision|1|||
162747216|NCT02828358|587785824|FG000|Overall Study|Treatment Failure|6|||
162747217|NCT02828358|587785825|FG001|Overall Study|Treatment Failure|0|||
162747218|NCT02828358|587785824|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
162747219|NCT02828358|587785825|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
162747220|NCT02828358|587785824|FG000|Overall Study|Refusal of further protocol therapy|2|||
162747221|NCT02828358|587785825|FG001|Overall Study|Refusal of further protocol therapy|0|||
162747222|NCT02828358|587785824|FG000|Overall Study|Relapse|25|||
162747223|NCT02828358|587785825|FG001|Overall Study|Relapse|0|||
162747224|NCT02828358|587785824|FG000|Overall Study|Still on therapy|5|||
162747225|NCT02828358|587785825|FG001|Overall Study|Still on therapy|0|||
162747226|NCT05285137|587785840|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
162747227|NCT05285137|587785841|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
162747228|NCT05285137|587785842|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
162747229|NCT05285137|587785843|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
162747230|NCT05285137|587785844|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
162747231|NCT05285137|587785845|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
162747232|NCT05285137|587785846|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
162747233|NCT05285137|587785847|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
162747234|NCT05285137|587785848|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
162747235|NCT05285137|587785840|FG000|Overall Study|Lost to Follow-up|0|||
162747236|NCT05285137|587785841|FG001|Overall Study|Lost to Follow-up|0|||
162747237|NCT05285137|587785842|FG002|Overall Study|Lost to Follow-up|1|||
162747238|NCT05285137|587785843|FG003|Overall Study|Lost to Follow-up|3|||
162747239|NCT05285137|587785844|FG004|Overall Study|Lost to Follow-up|0|||
162747240|NCT05285137|587785845|FG005|Overall Study|Lost to Follow-up|0|||
162747241|NCT05285137|587785846|FG006|Overall Study|Lost to Follow-up|1|||
162747242|NCT05285137|587785847|FG007|Overall Study|Lost to Follow-up|0|||
162747243|NCT05285137|587785848|FG008|Overall Study|Lost to Follow-up|0|||
162747244|NCT05285137|587785840|FG000|Overall Study|Physician Decision|0|||
162747245|NCT05285137|587785841|FG001|Overall Study|Physician Decision|1|||
162747246|NCT05285137|587785842|FG002|Overall Study|Physician Decision|0|||
162747247|NCT05285137|587785843|FG003|Overall Study|Physician Decision|0|||
162747248|NCT05285137|587785844|FG004|Overall Study|Physician Decision|0|||
162747249|NCT05285137|587785845|FG005|Overall Study|Physician Decision|0|||
162747250|NCT05285137|587785846|FG006|Overall Study|Physician Decision|0|||
162747251|NCT05285137|587785847|FG007|Overall Study|Physician Decision|0|||
162747252|NCT05285137|587785848|FG008|Overall Study|Physician Decision|0|||
162747253|NCT05285137|587785840|FG000|Overall Study|Pregnancy|0|||
162747254|NCT05285137|587785841|FG001|Overall Study|Pregnancy|0|||
162747255|NCT05285137|587785842|FG002|Overall Study|Pregnancy|0|||
162747256|NCT05285137|587785843|FG003|Overall Study|Pregnancy|0|||
162747257|NCT05285137|587785844|FG004|Overall Study|Pregnancy|0|||
162747258|NCT05285137|587785845|FG005|Overall Study|Pregnancy|0|||
162747259|NCT05285137|587785846|FG006|Overall Study|Pregnancy|1|||
162747260|NCT05285137|587785847|FG007|Overall Study|Pregnancy|0|||
162747261|NCT05285137|587785848|FG008|Overall Study|Pregnancy|0|||
162747262|NCT05285137|587785840|FG000|Overall Study|Withdrawal by Subject|0|||
162747263|NCT05285137|587785841|FG001|Overall Study|Withdrawal by Subject|1|||
162747264|NCT05285137|587785842|FG002|Overall Study|Withdrawal by Subject|2|||
162747265|NCT05285137|587785843|FG003|Overall Study|Withdrawal by Subject|1|||
162747266|NCT05285137|587785844|FG004|Overall Study|Withdrawal by Subject|0|||
162747267|NCT05285137|587785845|FG005|Overall Study|Withdrawal by Subject|0|||
162747268|NCT05285137|587785846|FG006|Overall Study|Withdrawal by Subject|0|||
162747269|NCT05285137|587785847|FG007|Overall Study|Withdrawal by Subject|0|||
162747270|NCT05285137|587785848|FG008|Overall Study|Withdrawal by Subject|1|||
162747271|NCT03221426|587785849|FG000|Overall Study|Ongoing in study|212|||
162747272|NCT03221426|587785850|FG001|Overall Study|Ongoing in study|193|||
162747273|NCT03221426|587785851|FG002|Overall Study|Ongoing in study|61|||
162747274|NCT03221426|587785852|FG003|Overall Study|Ongoing in study|55|||
162747275|NCT03221426|587785849|FG000|Overall Study|Withdrawal by Subject|12|||
162747276|NCT03221426|587785850|FG001|Overall Study|Withdrawal by Subject|4|||
162747277|NCT03221426|587785851|FG002|Overall Study|Withdrawal by Subject|2|||
162747278|NCT03221426|587785852|FG003|Overall Study|Withdrawal by Subject|3|||
162747279|NCT03221426|587785849|FG000|Overall Study|Lost to Follow-up|4|||
162747280|NCT03221426|587785850|FG001|Overall Study|Lost to Follow-up|1|||
162747281|NCT03221426|587785851|FG002|Overall Study|Lost to Follow-up|1|||
162747282|NCT03221426|587785852|FG003|Overall Study|Lost to Follow-up|0|||
162747283|NCT03221426|587785849|FG000|Overall Study|Death|174|||
162747284|NCT03221426|587785850|FG001|Overall Study|Death|204|||
162747285|NCT03221426|587785851|FG002|Overall Study|Death|36|||
162747286|NCT03221426|587785852|FG003|Overall Study|Death|45|||
162747287|NCT06262477|587787666|FG000|Overall Study|Withdrawal by Subject|1|||
162747288|NCT06262477|587787667|FG001|Overall Study|Withdrawal by Subject|0|||
162747289|NCT06262477|587787666|FG000|Overall Study|Adverse Event|0|||
162747290|NCT06262477|587787667|FG001|Overall Study|Adverse Event|1|||
162747291|NCT06262477|587787666|FG000|Overall Study|Lost to Follow-up|0|||
162747292|NCT06262477|587787667|FG001|Overall Study|Lost to Follow-up|1|||
162747293|NCT02593773|587787671|FG000|Overall Study|Voluntary Withdrawal|3|||
162747294|NCT02593773|587787671|FG000|Overall Study|Study Terminated by Sponsor|31|||
162747295|NCT02593773|587787671|FG000|Overall Study|Death|1|||
162747296|NCT04024020|587787675|FG000|Overall Study|Withdrawal by Subject|2|||
162747297|NCT04024020|587787676|FG001|Overall Study|Withdrawal by Subject|2|||
162747298|NCT05269966|587787677|FG000|Overall Study|Adverse Event|4|||
162747299|NCT05269966|587787677|FG000|Overall Study|Withdrawal by Subject|1|||
162747300|NCT05269966|587787677|FG000|Overall Study|Lost to Follow-up|4|||
162747301|NCT05269966|587787677|FG000|Overall Study|Physician Decision|1|||
162747302|NCT06262347|587787680|FG000|Overall Study|Lost to Follow-up|4|||
162747303|NCT06262347|587787681|FG001|Overall Study|Lost to Follow-up|3|||
162747304|NCT06262347|587787680|FG000|Overall Study|Withdrawal by Subject|0|||
162747305|NCT06262347|587787681|FG001|Overall Study|Withdrawal by Subject|1|||
162747306|NCT04304144|587787694|FG000|DLT Observation Period|Physician Decision|0|||
162747307|NCT04304144|587787695|FG001|DLT Observation Period|Physician Decision|1|||
162747308|NCT04304144|587787696|FG002|DLT Observation Period|Physician Decision|0|||
162747309|NCT04304144|587787697|FG003|DLT Observation Period|Physician Decision|0|||
162747310|NCT04304144|587787694|FG000|Continued Treatment Period|Adverse Event|0|||
162747311|NCT04304144|587787695|FG001|Continued Treatment Period|Adverse Event|1|||
162747312|NCT04304144|587787696|FG002|Continued Treatment Period|Adverse Event|0|||
162747313|NCT04304144|587787697|FG003|Continued Treatment Period|Adverse Event|0|||
162747314|NCT04304144|587787694|FG000|Continued Treatment Period|Death|0|||
162747315|NCT04304144|587787695|FG001|Continued Treatment Period|Death|0|||
162747316|NCT04304144|587787696|FG002|Continued Treatment Period|Death|1|||
162747317|NCT04304144|587787697|FG003|Continued Treatment Period|Death|2|||
162747318|NCT04304144|587787694|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
162747319|NCT04304144|587787695|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
162747320|NCT04304144|587787696|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
162747321|NCT04304144|587787697|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
162747322|NCT04304144|587787694|FG000|Continued Treatment Period|Other than specified|2|||
162747323|NCT04304144|587787695|FG001|Continued Treatment Period|Other than specified|0|||
162747324|NCT04304144|587787696|FG002|Continued Treatment Period|Other than specified|1|||
162747325|NCT04304144|587787697|FG003|Continued Treatment Period|Other than specified|1|||
162747326|NCT04101357|587787698|FG000|Overall Study|Death|1|||
162747327|NCT04101357|587787699|FG001|Overall Study|Death|1|||
162747328|NCT04101357|587787700|FG002|Overall Study|Death|1|||
162747329|NCT04101357|587787701|FG003|Overall Study|Death|2|||
162747330|NCT04101357|587787702|FG004|Overall Study|Death|4|||
162747331|NCT04101357|587787703|FG005|Overall Study|Death|11|||
162747332|NCT04101357|587787704|FG006|Overall Study|Death|4|||
162747333|NCT04101357|587787705|FG007|Overall Study|Death|4|||
162747334|NCT04101357|587787706|FG008|Overall Study|Death|5|||
162747335|NCT04101357|587787707|FG009|Overall Study|Death|2|||
162747336|NCT04101357|587787708|FG010|Overall Study|Death|3|||
162747337|NCT04101357|587787698|FG000|Overall Study|Trial closure|0|||
162747338|NCT04101357|587787699|FG001|Overall Study|Trial closure|0|||
162747339|NCT04101357|587787700|FG002|Overall Study|Trial closure|0|||
162747340|NCT04101357|587787701|FG003|Overall Study|Trial closure|0|||
162747341|NCT04101357|587787702|FG004|Overall Study|Trial closure|0|||
162747342|NCT04101357|587787703|FG005|Overall Study|Trial closure|2|||
162747343|NCT04101357|587787704|FG006|Overall Study|Trial closure|2|||
162747344|NCT04101357|587787705|FG007|Overall Study|Trial closure|0|||
162747345|NCT04101357|587787706|FG008|Overall Study|Trial closure|0|||
162747346|NCT04101357|587787707|FG009|Overall Study|Trial closure|0|||
162747347|NCT04101357|587787708|FG010|Overall Study|Trial closure|1|||
162747348|NCT04101357|587787698|FG000|Overall Study|Lost to Follow-up|0|||
162747349|NCT04101357|587787699|FG001|Overall Study|Lost to Follow-up|0|||
162747350|NCT04101357|587787700|FG002|Overall Study|Lost to Follow-up|0|||
162747351|NCT04101357|587787701|FG003|Overall Study|Lost to Follow-up|1|||
162747352|NCT04101357|587787702|FG004|Overall Study|Lost to Follow-up|0|||
162747353|NCT04101357|587787703|FG005|Overall Study|Lost to Follow-up|0|||
162747354|NCT04101357|587787704|FG006|Overall Study|Lost to Follow-up|0|||
162747355|NCT04101357|587787705|FG007|Overall Study|Lost to Follow-up|1|||
162747356|NCT04101357|587787706|FG008|Overall Study|Lost to Follow-up|0|||
162747357|NCT04101357|587787707|FG009|Overall Study|Lost to Follow-up|0|||
162747358|NCT04101357|587787708|FG010|Overall Study|Lost to Follow-up|0|||
162747359|NCT04101357|587787698|FG000|Overall Study|Withdrawal by Subject|1|||
162747360|NCT04101357|587787699|FG001|Overall Study|Withdrawal by Subject|0|||
162747361|NCT04101357|587787700|FG002|Overall Study|Withdrawal by Subject|0|||
162747362|NCT04101357|587787701|FG003|Overall Study|Withdrawal by Subject|0|||
162747363|NCT04101357|587787702|FG004|Overall Study|Withdrawal by Subject|0|||
162747364|NCT04101357|587787703|FG005|Overall Study|Withdrawal by Subject|0|||
162747365|NCT04101357|587787704|FG006|Overall Study|Withdrawal by Subject|0|||
162747366|NCT04101357|587787705|FG007|Overall Study|Withdrawal by Subject|0|||
162747367|NCT04101357|587787706|FG008|Overall Study|Withdrawal by Subject|1|||
162747368|NCT04101357|587787707|FG009|Overall Study|Withdrawal by Subject|1|||
162747369|NCT04101357|587787708|FG010|Overall Study|Withdrawal by Subject|0|||
162747370|NCT04101357|587787698|FG000|Overall Study|Other|0|||
162747371|NCT04101357|587787699|FG001|Overall Study|Other|0|||
162747372|NCT04101357|587787700|FG002|Overall Study|Other|0|||
162747373|NCT04101357|587787701|FG003|Overall Study|Other|0|||
162747374|NCT04101357|587787702|FG004|Overall Study|Other|0|||
162747375|NCT04101357|587787703|FG005|Overall Study|Other|1|||
162747376|NCT04101357|587787704|FG006|Overall Study|Other|2|||
162747377|NCT04101357|587787705|FG007|Overall Study|Other|1|||
162747378|NCT04101357|587787706|FG008|Overall Study|Other|0|||
162747379|NCT04101357|587787707|FG009|Overall Study|Other|0|||
162747380|NCT04101357|587787708|FG010|Overall Study|Other|0|||
162747381|NCT04101357|587787698|FG000|Overall Study|Enrolled but not treated|0|||
162747382|NCT04101357|587787699|FG001|Overall Study|Enrolled but not treated|0|||
162747383|NCT04101357|587787700|FG002|Overall Study|Enrolled but not treated|0|||
162747384|NCT04101357|587787701|FG003|Overall Study|Enrolled but not treated|0|||
162747385|NCT04101357|587787702|FG004|Overall Study|Enrolled but not treated|0|||
162747386|NCT04101357|587787703|FG005|Overall Study|Enrolled but not treated|1|||
162747387|NCT04101357|587787704|FG006|Overall Study|Enrolled but not treated|1|||
162747388|NCT04101357|587787705|FG007|Overall Study|Enrolled but not treated|0|||
162747389|NCT04101357|587787706|FG008|Overall Study|Enrolled but not treated|0|||
162747390|NCT04101357|587787707|FG009|Overall Study|Enrolled but not treated|0|||
162747391|NCT04101357|587787708|FG010|Overall Study|Enrolled but not treated|0|||
162747392|NCT04660539|587787711|FG000|Overall Study|Adverse Event|10|||
162747393|NCT04660539|587787711|FG000|Overall Study|Lack of Efficacy|4|||
162747394|NCT04660539|587787711|FG000|Overall Study|Lost to Follow-up|5|||
162747395|NCT04660539|587787711|FG000|Overall Study|Non-Compliance With Study Drug|3|||
162747396|NCT04660539|587787711|FG000|Overall Study|Reason not Specified|12|||
162747397|NCT04660539|587787711|FG000|Overall Study|Pregnancy|2|||
162747398|NCT04660539|587787711|FG000|Overall Study|Protocol Violation|2|||
162747399|NCT04660539|587787711|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
162747400|NCT04660539|587787711|FG000|Overall Study|Withdrawal by Subject|21|||
162747401|NCT05618587|587787712|FG000|Overall Study|Lost to Follow-up|2|||
162747402|NCT05618587|587787713|FG001|Overall Study|Lost to Follow-up|0|||
162747403|NCT05167864|587787714|FG000|Overall Study|Lost to Follow-up|7|||
162747404|NCT05167864|587787715|FG001|Overall Study|Lost to Follow-up|6|||
162747405|NCT05167864|587787716|FG002|Overall Study|Lost to Follow-up|7|||
162747406|NCT05167864|587787717|FG003|Overall Study|Lost to Follow-up|9|||
162747407|NCT03852550|587787720|FG000|Overall Study|Lost to Follow-up|4|||
162747408|NCT03852550|587787721|FG001|Overall Study|Lost to Follow-up|3|||
162747409|NCT03852550|587787720|FG000|Overall Study|Only parent outcomes completed|0|||
162747410|NCT03852550|587787721|FG001|Overall Study|Only parent outcomes completed|1|||
162747411|NCT03852550|587787720|FG000|Overall Study|Withdrawal by Subject|1|||
162747412|NCT03852550|587787721|FG001|Overall Study|Withdrawal by Subject|0|||
162747413|NCT05204654|587787722|FG000|Overall Study|Study terminated due to time restraint|2|||
162747414|NCT05204654|587787723|FG001|Overall Study|Study terminated due to time restraint|2|||
162747415|NCT01828112|587787734|FG000|Treatment Phase|Adverse Event|7|||
162747416|NCT01828112|587787735|FG001|Treatment Phase|Adverse Event|8|||
162747417|NCT01828112|587787736|FG002|Treatment Phase|Adverse Event|0|||
162747418|NCT01828112|587787734|FG000|Treatment Phase|Death|9|||
162747419|NCT01828112|587787735|FG001|Treatment Phase|Death|5|||
162747420|NCT01828112|587787736|FG002|Treatment Phase|Death|0|||
162747421|NCT01828112|587787734|FG000|Treatment Phase|No longer required treatment|0|||
162747422|NCT01828112|587787735|FG001|Treatment Phase|No longer required treatment|1|||
162747423|NCT01828112|587787736|FG002|Treatment Phase|No longer required treatment|0|||
162747424|NCT01828112|587787734|FG000|Treatment Phase|Physician Decision|6|||
162747425|NCT01828112|587787735|FG001|Treatment Phase|Physician Decision|7|||
162747426|NCT01828112|587787736|FG002|Treatment Phase|Physician Decision|0|||
162747427|NCT01828112|587787734|FG000|Treatment Phase|Pregnancy|1|||
162747428|NCT01828112|587787735|FG001|Treatment Phase|Pregnancy|0|||
162747429|NCT01828112|587787736|FG002|Treatment Phase|Pregnancy|0|||
162747430|NCT01828112|587787734|FG000|Treatment Phase|Progressive disease|79|||
162747431|NCT01828112|587787735|FG001|Treatment Phase|Progressive disease|87|||
162747432|NCT01828112|587787736|FG002|Treatment Phase|Progressive disease|0|||
162747433|NCT01828112|587787734|FG000|Treatment Phase|Study terminated by sponsor|1|||
162747434|NCT01828112|587787735|FG001|Treatment Phase|Study terminated by sponsor|0|||
162747435|NCT01828112|587787736|FG002|Treatment Phase|Study terminated by sponsor|0|||
162747436|NCT01828112|587787734|FG000|Treatment Phase|Subject/guardian decision|12|||
162747437|NCT01828112|587787735|FG001|Treatment Phase|Subject/guardian decision|8|||
162747438|NCT01828112|587787736|FG002|Treatment Phase|Subject/guardian decision|0|||
162747439|NCT01828112|587787734|FG000|Extension Treatment Phase|Adverse Event|0|||
162747440|NCT01828112|587787735|FG001|Extension Treatment Phase|Adverse Event|0|||
162747441|NCT01828112|587787736|FG002|Extension Treatment Phase|Adverse Event|6|||
162747442|NCT01828112|587787734|FG000|Extension Treatment Phase|Death|0|||
162747443|NCT01828112|587787735|FG001|Extension Treatment Phase|Death|0|||
162747444|NCT01828112|587787736|FG002|Extension Treatment Phase|Death|17|||
162747445|NCT01828112|587787734|FG000|Extension Treatment Phase|Physician Decision|0|||
162747446|NCT01828112|587787735|FG001|Extension Treatment Phase|Physician Decision|0|||
162747447|NCT01828112|587787736|FG002|Extension Treatment Phase|Physician Decision|5|||
162747448|NCT01828112|587787734|FG000|Extension Treatment Phase|Progressive disease|0|||
162747449|NCT01828112|587787735|FG001|Extension Treatment Phase|Progressive disease|0|||
162747450|NCT01828112|587787736|FG002|Extension Treatment Phase|Progressive disease|46|||
162747451|NCT01828112|587787734|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
162747452|NCT01828112|587787735|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
162747453|NCT01828112|587787736|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
162747454|NCT01828112|587787734|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
162747455|NCT01828112|587787735|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
162747456|NCT01828112|587787736|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
162747457|NCT05565820|587787750|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
162747458|NCT05565820|587787751|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
162747459|NCT05565820|587787750|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
162747460|NCT05565820|587787751|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
162747461|NCT03606408|587787753|FG000|Overall Study|Adverse Event|13|||
162747462|NCT03606408|587787753|FG000|Overall Study|Withdrawal by Subject|7|||
162747463|NCT03606408|587787753|FG000|Overall Study|Physician Decision|4|||
162747464|NCT03606408|587787753|FG000|Overall Study|Lack of Efficacy|2|||
162747465|NCT03606408|587787753|FG000|Overall Study|Death|1|||
162747466|NCT03606408|587787753|FG000|Overall Study|new therapy for study indication|1|||
162747467|NCT04689256|587787754|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
162747468|NCT04689256|587787755|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
162747469|NCT04862234|587787758|FG000|Overall Study|Surgery cancellation|1|||
162747470|NCT04862234|587787759|FG001|Overall Study|Surgery cancellation|2|||
162747471|NCT04862234|587787758|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
162747472|NCT04862234|587787759|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
162747473|NCT04862234|587787758|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
162747474|NCT04862234|587787759|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
162747475|NCT05828017|587787760|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
162747476|NCT05012163|587787764|FG000|Overall Study|Protocol Violation|0|||
162747477|NCT05012163|587787765|FG001|Overall Study|Protocol Violation|0|||
162747478|NCT05012163|587787766|FG002|Overall Study|Protocol Violation|1|||
162747479|NCT05012163|587787767|FG003|Overall Study|Protocol Violation|1|||
162747480|NCT04132518|587787770|FG000|Overall Study|Prematurely withdrawn from the study|0|||
162747481|NCT04132518|587787771|FG001|Overall Study|Prematurely withdrawn from the study|9|||
162747482|NCT04132518|587787772|FG002|Overall Study|Prematurely withdrawn from the study|1|||
162747483|NCT05425420|587787774|FG000|Overall Study|Physician Decision|1|||
162747484|NCT05425420|587787774|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
162747485|NCT03381586|587787775|FG000|Overall Study|Adverse Event|1|||
162747486|NCT03381586|587787776|FG001|Overall Study|Adverse Event|1|||
162747487|NCT03381586|587787775|FG000|Overall Study|Protocol Violation|1|||
162747488|NCT03381586|587787776|FG001|Overall Study|Protocol Violation|0|||
162747489|NCT03381586|587787775|FG000|Overall Study|Withdrawal by Subject|1|||
162747490|NCT03381586|587787776|FG001|Overall Study|Withdrawal by Subject|2|||
162747491|NCT04999111|587787777|FG000|Overall Study|Lost to Follow-up|21|||
162747492|NCT04999111|587787778|FG001|Overall Study|Lost to Follow-up|16|||
162747493|NCT04999111|587787779|FG002|Overall Study|Lost to Follow-up|2|||
162747494|NCT04999111|587787780|FG003|Overall Study|Lost to Follow-up|26|||
162747495|NCT04999111|587787781|FG004|Overall Study|Lost to Follow-up|30|||
162747496|NCT04999111|587787782|FG005|Overall Study|Lost to Follow-up|6|||
162747497|NCT04999111|587787777|FG000|Overall Study|Physician Decision|1|||
162747498|NCT04999111|587787778|FG001|Overall Study|Physician Decision|3|||
162747499|NCT04999111|587787779|FG002|Overall Study|Physician Decision|0|||
162747500|NCT04999111|587787780|FG003|Overall Study|Physician Decision|1|||
162747501|NCT04999111|587787781|FG004|Overall Study|Physician Decision|2|||
162747502|NCT04999111|587787782|FG005|Overall Study|Physician Decision|0|||
162747503|NCT04999111|587787777|FG000|Overall Study|Withdrawal by Subject|23|||
162747504|NCT04999111|587787778|FG001|Overall Study|Withdrawal by Subject|29|||
162747505|NCT04999111|587787779|FG002|Overall Study|Withdrawal by Subject|15|||
162747506|NCT04999111|587787780|FG003|Overall Study|Withdrawal by Subject|30|||
162747507|NCT04999111|587787781|FG004|Overall Study|Withdrawal by Subject|35|||
162747508|NCT04999111|587787782|FG005|Overall Study|Withdrawal by Subject|10|||
162747509|NCT04999111|587787777|FG000|Overall Study|Other|6|||
162747510|NCT04999111|587787778|FG001|Overall Study|Other|6|||
162747511|NCT04999111|587787779|FG002|Overall Study|Other|3|||
162747512|NCT04999111|587787780|FG003|Overall Study|Other|8|||
162747513|NCT04999111|587787781|FG004|Overall Study|Other|8|||
162747514|NCT04999111|587787782|FG005|Overall Study|Other|5|||
162747515|NCT04999111|587787777|FG000|Overall Study|Non-compliance with study schedule|1|||
162747516|NCT04999111|587787778|FG001|Overall Study|Non-compliance with study schedule|0|||
162747517|NCT04999111|587787779|FG002|Overall Study|Non-compliance with study schedule|0|||
162747518|NCT04999111|587787780|FG003|Overall Study|Non-compliance with study schedule|1|||
162747519|NCT04999111|587787781|FG004|Overall Study|Non-compliance with study schedule|1|||
162747520|NCT04999111|587787782|FG005|Overall Study|Non-compliance with study schedule|1|||
162747521|NCT04999111|587787777|FG000|Overall Study|Randomized but not vaccinated|1|||
162747522|NCT04999111|587787778|FG001|Overall Study|Randomized but not vaccinated|2|||
162747523|NCT04999111|587787779|FG002|Overall Study|Randomized but not vaccinated|0|||
162747524|NCT04999111|587787780|FG003|Overall Study|Randomized but not vaccinated|3|||
162747525|NCT04999111|587787781|FG004|Overall Study|Randomized but not vaccinated|3|||
162747526|NCT04999111|587787782|FG005|Overall Study|Randomized but not vaccinated|0|||
162747527|NCT04999111|587787777|FG000|Overall Study|Adverse Event|1|||
162747528|NCT04999111|587787778|FG001|Overall Study|Adverse Event|1|||
162747529|NCT04999111|587787779|FG002|Overall Study|Adverse Event|0|||
162747530|NCT04999111|587787780|FG003|Overall Study|Adverse Event|0|||
162747531|NCT04999111|587787781|FG004|Overall Study|Adverse Event|0|||
162747532|NCT04999111|587787782|FG005|Overall Study|Adverse Event|0|||
162747533|NCT04999111|587787777|FG000|Overall Study|Initiated prohibited medication|0|||
162747534|NCT04999111|587787778|FG001|Overall Study|Initiated prohibited medication|0|||
162747535|NCT04999111|587787779|FG002|Overall Study|Initiated prohibited medication|0|||
162747536|NCT04999111|587787780|FG003|Overall Study|Initiated prohibited medication|0|||
162747537|NCT04999111|587787781|FG004|Overall Study|Initiated prohibited medication|1|||
162747538|NCT04999111|587787782|FG005|Overall Study|Initiated prohibited medication|0|||
162747539|NCT04056611|587787789|FG000|Overall Study|Physician Decision|1|||
162747540|NCT03733925|587787792|FG000|Overall Study|Lost to Follow-up|1|||
162747541|NCT03733925|587787792|FG000|Overall Study|Withdrawal by Subject|2|||
162747542|NCT03733925|587787792|FG000|Overall Study|Adverse Event|2|||
162747543|NCT03733925|587787792|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162747544|NCT03213873|587787793|FG000|Overall Study|Withdrawal by Subject|8|||
162747545|NCT03213873|587787794|FG001|Overall Study|Withdrawal by Subject|9|||
162747546|NCT03213873|587787793|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
162747547|NCT03213873|587787794|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
162747548|NCT03213873|587787793|FG000|Overall Study|Lost to Follow-up|0|||
162747549|NCT03213873|587787794|FG001|Overall Study|Lost to Follow-up|2|||
162747550|NCT02631746|587787800|FG000|Overall Study|Lack of Efficacy|3|||
162747551|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
162747552|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
162747553|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
162747554|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
162747555|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
162747556|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
162747557|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
162747558|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
162747559|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
162747560|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
162747561|NCT02361216|587787801|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
162747562|NCT02361216|587787802|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
162747563|NCT04709419|587787803|FG000|Overall Study|Physician Decision|1|||
162747564|NCT04709419|587787804|FG001|Overall Study|Physician Decision|0|||
162747565|NCT05683340|587787805|FG000|Overall Study|Adverse Event|1|||
162747566|NCT05683340|587787806|FG001|Overall Study|Adverse Event|1|||
162747567|NCT05683340|587787805|FG000|Overall Study|Protocol Violation|1|||
162747568|NCT05683340|587787806|FG001|Overall Study|Protocol Violation|0|||
162747569|NCT05683340|587787805|FG000|Overall Study|Withdrawal by Subject|0|||
162747570|NCT05683340|587787806|FG001|Overall Study|Withdrawal by Subject|2|||
162747571|NCT02224144|587787810|FG000|Overall Study|Lost to Follow-up|3|||
162747572|NCT02224144|587787811|FG001|Overall Study|Lost to Follow-up|1|||
162747573|NCT02224144|587787810|FG000|Overall Study|Death|2|||
162747574|NCT02224144|587787811|FG001|Overall Study|Death|0|||
162747575|NCT02224144|587787810|FG000|Overall Study|Withdrawal by Subject|0|||
162747576|NCT02224144|587787811|FG001|Overall Study|Withdrawal by Subject|1|||
162747577|NCT03505008|587787812|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
162747578|NCT03505008|587787813|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
162747579|NCT03505008|587787814|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
162747580|NCT03505008|587787815|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
162747581|NCT03505008|587787812|FG000|Before Week 24 Randomization|Adverse Event|10|||
162747582|NCT03505008|587787813|FG001|Before Week 24 Randomization|Adverse Event|0|||
162747583|NCT03505008|587787814|FG002|Before Week 24 Randomization|Adverse Event|0|||
162747584|NCT03505008|587787815|FG003|Before Week 24 Randomization|Adverse Event|0|||
162747585|NCT03505008|587787812|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
162747586|NCT03505008|587787813|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
162747587|NCT03505008|587787814|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
162747588|NCT03505008|587787815|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
162747589|NCT03505008|587787812|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
162747590|NCT03505008|587787813|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162747591|NCT03505008|587787814|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162747592|NCT03505008|587787815|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162747593|NCT03505008|587787812|FG000|Before Week 24 Randomization|Physician Decision|2|||
162747594|NCT03505008|587787813|FG001|Before Week 24 Randomization|Physician Decision|0|||
162747595|NCT03505008|587787814|FG002|Before Week 24 Randomization|Physician Decision|0|||
162747596|NCT03505008|587787815|FG003|Before Week 24 Randomization|Physician Decision|0|||
162747597|NCT03505008|587787812|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
162747598|NCT03505008|587787813|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
162747599|NCT03505008|587787814|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
162747600|NCT03505008|587787815|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
162747601|NCT03505008|587787812|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
162747602|NCT03505008|587787813|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162747603|NCT03505008|587787814|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162747604|NCT03505008|587787815|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162747605|NCT03505008|587787812|FG000|Before Week 24 Randomization|Complication|1|||
162747606|NCT03505008|587787813|FG001|Before Week 24 Randomization|Complication|0|||
162747607|NCT03505008|587787814|FG002|Before Week 24 Randomization|Complication|0|||
162747608|NCT03505008|587787815|FG003|Before Week 24 Randomization|Complication|0|||
162747609|NCT03505008|587787812|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
162747610|NCT03505008|587787813|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
162747611|NCT03505008|587787814|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
162747612|NCT03505008|587787815|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
162747613|NCT03505008|587787812|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
162747614|NCT03505008|587787813|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
162747615|NCT03505008|587787814|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
162747616|NCT03505008|587787815|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
162747617|NCT03505008|587787812|FG000|After Week 24 Randomization|Adverse Event|0|||
162747618|NCT03505008|587787813|FG001|After Week 24 Randomization|Adverse Event|1|||
162747619|NCT03505008|587787814|FG002|After Week 24 Randomization|Adverse Event|2|||
162747620|NCT03505008|587787815|FG003|After Week 24 Randomization|Adverse Event|2|||
162747621|NCT03505008|587787812|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
162747622|NCT03505008|587787813|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
162747623|NCT03505008|587787814|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
162747624|NCT03505008|587787815|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
162747625|NCT03505008|587787812|FG000|After Week 24 Randomization|Protocol Violation|0|||
162747626|NCT03505008|587787813|FG001|After Week 24 Randomization|Protocol Violation|0|||
162747627|NCT03505008|587787814|FG002|After Week 24 Randomization|Protocol Violation|1|||
162747628|NCT03505008|587787815|FG003|After Week 24 Randomization|Protocol Violation|0|||
162747629|NCT02437136|587787816|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
162747630|NCT02437136|587787817|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747631|NCT02437136|587787818|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747632|NCT02437136|587787819|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747633|NCT02437136|587787820|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747634|NCT02437136|587787821|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747635|NCT02437136|587787822|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162747636|NCT02437136|587787816|FG000|Expansion (Phase 2)|Death|0|||
162747637|NCT02437136|587787817|FG001|Expansion (Phase 2)|Death|0|||
162747638|NCT02437136|587787818|FG002|Expansion (Phase 2)|Death|0|||
162747639|NCT02437136|587787819|FG003|Expansion (Phase 2)|Death|6|||
162747640|NCT02437136|587787820|FG004|Expansion (Phase 2)|Death|37|||
162747641|NCT02437136|587787821|FG005|Expansion (Phase 2)|Death|29|||
162747642|NCT02437136|587787822|FG006|Expansion (Phase 2)|Death|24|||
162747643|NCT02437136|587787816|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
162747644|NCT02437136|587787817|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
162747645|NCT02437136|587787818|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
162747646|NCT02437136|587787819|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
162747647|NCT02437136|587787820|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
162747648|NCT02437136|587787821|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
162747649|NCT02437136|587787822|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
162747650|NCT02437136|587787816|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
162747651|NCT02437136|587787817|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
162747652|NCT02437136|587787818|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
162747653|NCT02437136|587787819|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
162747654|NCT02437136|587787820|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
162747655|NCT02437136|587787821|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
162747656|NCT02437136|587787822|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
162747657|NCT02056834|587787825|FG000|Overall Study|Lost to Follow-up|7|||
162747658|NCT02780700|587787827|FG000|Overall Study|Progressive disease|1|||
162747659|NCT03824366|587787838|FG000|Overall Study|Death|1|||
162747660|NCT03824366|587787838|FG000|Overall Study|Previously unidentified metal artifact|1|||
162747661|NCT03824366|587787838|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
162747662|NCT03824366|587787838|FG000|Overall Study|Withdrawal by Subject|1|||
162747663|NCT00323856|587787839|FG000|Overall Study|Withdrawal by Subject|1|||
162747664|NCT00323856|587787839|FG000|Overall Study|Was uncooperative and noncompliant|1|||
162747665|NCT00323856|587787839|FG000|Overall Study|Reason not specified|1|||
162747666|NCT00323856|587787839|FG000|Overall Study|Missing|2|||
162747667|NCT04086121|587787840|FG000|Overall Study|Other than listed|8|||
162747668|NCT04086121|587787840|FG000|Overall Study|Withdrawal by Subject|3|||
162747669|NCT04086121|587787840|FG000|Overall Study|Lost to Follow-up|2|||
162747670|NCT04086121|587787840|FG000|Overall Study|Adverse Event|1|||
162747671|NCT03118518|587787845|FG000|Overall Study|Early Exit after treatment|2|||
162747672|NCT03118518|587787846|FG001|Overall Study|Early Exit after treatment|8|||
162747673|NCT03118518|587787845|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
162747674|NCT03118518|587787846|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
162747675|NCT02834390|587787847|FG000|Induction Phase|Progressive disease|0|||
162747676|NCT02834390|587787848|FG001|Induction Phase|Progressive disease|1|||
162747677|NCT02834390|587787847|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
162747678|NCT02834390|587787848|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
162747679|NCT02834390|587787847|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
162747680|NCT02834390|587787848|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
162747681|NCT02834390|587787847|FG000|Consolidation Phase|Physician Decision|1|||
162747682|NCT02834390|587787848|FG001|Consolidation Phase|Physician Decision|1|||
162747683|NCT01064440|587789178|FG000|Overall Study|Lost to Follow-up|1|||
162747684|NCT01064440|587789179|FG001|Overall Study|Lost to Follow-up|1|||
162747685|NCT01064440|587789180|FG002|Overall Study|Lost to Follow-up|1|||
162747686|NCT01064440|587789178|FG000|Overall Study|Non-compliance|0|||
162747687|NCT01064440|587789179|FG001|Overall Study|Non-compliance|1|||
162747688|NCT01064440|587789180|FG002|Overall Study|Non-compliance|0|||
162747689|NCT01064440|587789178|FG000|Overall Study|Death|1|||
162747690|NCT01064440|587789179|FG001|Overall Study|Death|0|||
162747691|NCT01064440|587789180|FG002|Overall Study|Death|1|||
162747692|NCT01064440|587789178|FG000|Overall Study|Withdrawal by Subject|0|||
162747693|NCT01064440|587789179|FG001|Overall Study|Withdrawal by Subject|1|||
162747694|NCT01064440|587789180|FG002|Overall Study|Withdrawal by Subject|1|||
162747695|NCT01064440|587789178|FG000|Overall Study|Other: amputation|1|||
162747696|NCT01064440|587789179|FG001|Overall Study|Other: amputation|0|||
162747697|NCT01064440|587789180|FG002|Overall Study|Other: amputation|0|||
162747698|NCT03220035|587789182|FG000|Overall Study|Adverse Event|1|||
162747699|NCT03220035|587789182|FG000|Overall Study|Protocol Violation|1|||
162747700|NCT03220035|587789182|FG000|Overall Study|Progressive Disease|2|||
162747701|NCT04871529|587789186|FG000|Overall Study|Withdrawal by Subject|0|||
162747702|NCT04871529|587789187|FG001|Overall Study|Withdrawal by Subject|1|||
162747703|NCT04871529|587789186|FG000|Overall Study|Death|0|||
162747704|NCT04871529|587789187|FG001|Overall Study|Death|1|||
162747705|NCT04871529|587789186|FG000|Overall Study|Not protocol specified|0|||
162747706|NCT04871529|587789187|FG001|Overall Study|Not protocol specified|1|||
162747707|NCT05184452|587789188|FG000|Overall Study|Lost to Follow-up|0|||
162747708|NCT05184452|587789189|FG001|Overall Study|Lost to Follow-up|0|||
162747709|NCT05184452|587789190|FG002|Overall Study|Lost to Follow-up|0|||
162747710|NCT05184452|587789191|FG003|Overall Study|Lost to Follow-up|0|||
162747711|NCT05184452|587789192|FG004|Overall Study|Lost to Follow-up|0|||
162747712|NCT05184452|587789193|FG005|Overall Study|Lost to Follow-up|2|||
162747713|NCT05184452|587789194|FG006|Overall Study|Lost to Follow-up|0|||
162747714|NCT05184452|587789195|FG007|Overall Study|Lost to Follow-up|0|||
162747715|NCT05184452|587789196|FG008|Overall Study|Lost to Follow-up|0|||
162747716|NCT05184452|587789197|FG009|Overall Study|Lost to Follow-up|1|||
162747717|NCT05184452|587789188|FG000|Overall Study|Withdrawal by Subject|0|||
162747718|NCT05184452|587789189|FG001|Overall Study|Withdrawal by Subject|0|||
162747719|NCT05184452|587789190|FG002|Overall Study|Withdrawal by Subject|0|||
162747720|NCT05184452|587789191|FG003|Overall Study|Withdrawal by Subject|0|||
162747721|NCT05184452|587789192|FG004|Overall Study|Withdrawal by Subject|0|||
162747722|NCT05184452|587789193|FG005|Overall Study|Withdrawal by Subject|1|||
162747723|NCT05184452|587789194|FG006|Overall Study|Withdrawal by Subject|0|||
162747724|NCT05184452|587789195|FG007|Overall Study|Withdrawal by Subject|0|||
162747725|NCT05184452|587789196|FG008|Overall Study|Withdrawal by Subject|0|||
162747726|NCT05184452|587789197|FG009|Overall Study|Withdrawal by Subject|1|||
162747727|NCT05586490|587789198|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162747728|NCT05586490|587789199|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162747729|NCT05586490|587789200|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
162747730|NCT05586490|587789201|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162747731|NCT05586490|587789202|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162747732|NCT05586490|587789198|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
162747733|NCT05586490|587789199|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162747734|NCT05586490|587789200|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162747735|NCT05586490|587789201|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162747736|NCT05586490|587789202|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162747737|NCT05586490|587789198|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
162747738|NCT05586490|587789199|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162747739|NCT05586490|587789200|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162747740|NCT05586490|587789201|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162747741|NCT05586490|587789202|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162747742|NCT04136912|587789205|FG000|Overall Study|Operational reasons|0|||
162747743|NCT04136912|587789206|FG001|Overall Study|Operational reasons|0|||
162747744|NCT04136912|587789207|FG002|Overall Study|Operational reasons|2|||
162747745|NCT03556293|587789208|FG000|Overall Study|Ineligible for analysis|1904|||
162747746|NCT03556293|587789209|FG001|Overall Study|Ineligible for analysis|1471|||
162747747|NCT03556293|587789210|FG002|Overall Study|Ineligible for analysis|1091|||
162747748|NCT03556293|587789211|FG003|Overall Study|Ineligible for analysis|1269|||
162747749|NCT03292484|587789217|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
162747750|NCT03292484|587789217|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
162747751|NCT03292484|587789217|FG000|Overall Study|Protocol Violation|2|||
162747752|NCT03292484|587789217|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
162747753|NCT03292484|587789217|FG000|Overall Study|Sponsor decision|349|||
162747754|NCT03292484|587789217|FG000|Overall Study|Lost to Follow-up|7|||
162747755|NCT03292484|587789217|FG000|Overall Study|Coronavirus Disease 2019|1|||
162747756|NCT03292484|587789217|FG000|Overall Study|Other|20|||
162747757|NCT05290493|587789218|FG000|Overall Study|Withdrawal by Subject|2|||
162747758|NCT05290493|587789219|FG001|Overall Study|Withdrawal by Subject|2|||
162747759|NCT05290493|587789218|FG000|Overall Study|Adverse Event|1|||
162747760|NCT05290493|587789219|FG001|Overall Study|Adverse Event|0|||
162747761|NCT05524402|587789227|FG000|Overall Study|Withdrawal by Subject|3|||
162747762|NCT05524402|587789228|FG001|Overall Study|Withdrawal by Subject|1|||
162747763|NCT05524402|587789227|FG000|Overall Study|Lost to Follow-up|2|||
162747764|NCT05524402|587789228|FG001|Overall Study|Lost to Follow-up|1|||
162747765|NCT05976334|587789229|FG000|Part B|Death|0|||
162747766|NCT05976334|587789230|FG001|Part B|Death|1|||
162747767|NCT05976334|587789229|FG000|Part B|Study Terminated by Sponsor|0|||
162747768|NCT05976334|587789230|FG001|Part B|Study Terminated by Sponsor|1|||
162747769|NCT05976334|587789229|FG000|Part B|Reason Not Specified|0|||
162747770|NCT05976334|587789230|FG001|Part B|Reason Not Specified|1|||
162747771|NCT05280574|587789236|FG000|Overall Study|Withdrawal by Subject|0|||
162747772|NCT05280574|587789237|FG001|Overall Study|Withdrawal by Subject|2|||
162747773|NCT05280574|587789238|FG002|Overall Study|Withdrawal by Subject|0|||
162747774|NCT05363163|587789239|FG000|Overall Study|Withdrawal by Subject|13|||
162747775|NCT03673501|587789245|FG000|Overall Study|Participants ongoing.|36|||
162747776|NCT03673501|587789246|FG001|Overall Study|Participants ongoing.|24|||
162747777|NCT05838027|587789247|FG000|Overall Study|Lost to Follow-up|5|||
162747778|NCT05838027|587789248|FG001|Overall Study|Lost to Follow-up|1|||
162747779|NCT05838027|587789247|FG000|Overall Study|Withdrawal by Subject|1|||
162747780|NCT05838027|587789248|FG001|Overall Study|Withdrawal by Subject|0|||
162747781|NCT05237284|587789249|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162747782|NCT05237284|587789250|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
162747783|NCT05237284|587789251|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162747784|NCT05237284|587789252|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162747785|NCT05237284|587789249|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
162747786|NCT05237284|587789250|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
162747787|NCT05237284|587789251|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
162747788|NCT05237284|587789252|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
162747789|NCT05237284|587789249|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162747790|NCT05237284|587789250|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
162747791|NCT05237284|587789251|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162747792|NCT05237284|587789252|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162747793|NCT05237284|587789249|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
162747794|NCT05237284|587789250|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
162747795|NCT05237284|587789251|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
162747796|NCT05237284|587789252|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
162747797|NCT05237284|587789249|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
162747798|NCT05237284|587789250|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
162747799|NCT05237284|587789251|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
162747800|NCT05237284|587789252|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
162747801|NCT05237284|587789249|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
162747802|NCT05237284|587789250|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
162747803|NCT05237284|587789251|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
162747804|NCT05237284|587789252|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
162747805|NCT05237284|587789249|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
162747806|NCT05237284|587789250|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
162747807|NCT05237284|587789251|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
162747808|NCT05237284|587789252|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
162747809|NCT05237284|587789249|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162747810|NCT05237284|587789250|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162747811|NCT05237284|587789251|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162747812|NCT05237284|587789252|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
162747813|NCT05237284|587789249|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
162747814|NCT05237284|587789250|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
162747815|NCT05237284|587789251|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
162747816|NCT05237284|587789252|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
162747817|NCT04599634|587789253|FG000|Overall Study|Dose limiting toxicity|0|||
162747818|NCT04599634|587789254|FG001|Overall Study|Dose limiting toxicity|0|||
162747819|NCT04599634|587789255|FG002|Overall Study|Dose limiting toxicity|2|||
162747820|NCT04599634|587789256|FG003|Overall Study|Dose limiting toxicity|0|||
162747821|NCT04068831|587789272|FG000|Overall Study|Disease Progression|10|||
162747822|NCT04068831|587789273|FG001|Overall Study|Disease Progression|8|||
162747823|NCT03485729|587789282|FG000|Overall Study|Withdrawal by Subject|0|||
162747824|NCT03485729|587789283|FG001|Overall Study|Withdrawal by Subject|0|||
162747825|NCT03485729|587789284|FG002|Overall Study|Withdrawal by Subject|1|||
162747826|NCT03485729|587789282|FG000|Overall Study|Disease progression|8|||
162747827|NCT03485729|587789283|FG001|Overall Study|Disease progression|13|||
162747828|NCT03485729|587789284|FG002|Overall Study|Disease progression|1|||
162747829|NCT03485729|587789282|FG000|Overall Study|Hospice care|1|||
162747830|NCT03485729|587789283|FG001|Overall Study|Hospice care|0|||
162747831|NCT03485729|587789284|FG002|Overall Study|Hospice care|0|||
162747832|NCT03485729|587789282|FG000|Overall Study|Poor performance status|1|||
162747833|NCT03485729|587789283|FG001|Overall Study|Poor performance status|0|||
162747834|NCT03485729|587789284|FG002|Overall Study|Poor performance status|0|||
162747835|NCT03485729|587789282|FG000|Overall Study|Illness|0|||
162747836|NCT03485729|587789283|FG001|Overall Study|Illness|1|||
162747837|NCT03485729|587789284|FG002|Overall Study|Illness|0|||
162747838|NCT05533190|587789285|FG000|Overall Study|Lost to Follow-up|19|||
162747839|NCT05533190|587789286|FG001|Overall Study|Lost to Follow-up|7|||
162747840|NCT05533190|587789285|FG000|Overall Study|Failed to download app|1|||
162747841|NCT05533190|587789286|FG001|Overall Study|Failed to download app|0|||
162747842|NCT05533190|587789285|FG000|Overall Study|Thought app was a scam|1|||
162747843|NCT05533190|587789286|FG001|Overall Study|Thought app was a scam|0|||
162747844|NCT05533190|587789285|FG000|Overall Study|Withdrawal by Subject|2|||
162747845|NCT05533190|587789286|FG001|Overall Study|Withdrawal by Subject|0|||
162747846|NCT05552508|587789287|FG000|Overall Study|Adverse Event|3|||
162747847|NCT01199133|587789294|FG000|Year 1|Adverse Event|16|||
162747848|NCT01199133|587789295|FG001|Year 1|Adverse Event|4|||
162747849|NCT01199133|587789294|FG000|Year 1|Withdrawal by Subject|8|||
162747850|NCT01199133|587789295|FG001|Year 1|Withdrawal by Subject|4|||
162747851|NCT01199133|587789294|FG000|Year 1|Any other reason not above-mentioned|6|||
162747852|NCT01199133|587789295|FG001|Year 1|Any other reason not above-mentioned|7|||
162747853|NCT01199133|587789294|FG000|Year 2|Adverse Event|1|||
162747854|NCT01199133|587789295|FG001|Year 2|Adverse Event|0|||
162747855|NCT01199133|587789294|FG000|Year 2|Withdrawal by Subject|1|||
162747856|NCT01199133|587789295|FG001|Year 2|Withdrawal by Subject|1|||
162747857|NCT01199133|587789294|FG000|Year 2|Any other reason not above-mentioned|1|||
162747858|NCT01199133|587789295|FG001|Year 2|Any other reason not above-mentioned|2|||
162747859|NCT02575950|587789296|FG000|Overall Study|Withdrawal by Subject|0|||
162747860|NCT02575950|587789297|FG001|Overall Study|Withdrawal by Subject|0|||
162747861|NCT02575950|587789298|FG002|Overall Study|Withdrawal by Subject|0|||
162747862|NCT02575950|587789299|FG003|Overall Study|Withdrawal by Subject|2|||
162747863|NCT02575950|587789296|FG000|Overall Study|Lost to Follow-up|0|||
162747864|NCT02575950|587789297|FG001|Overall Study|Lost to Follow-up|1|||
162747865|NCT02575950|587789298|FG002|Overall Study|Lost to Follow-up|0|||
162747866|NCT02575950|587789299|FG003|Overall Study|Lost to Follow-up|3|||
162747867|NCT03993392|587789301|FG000|Overall Study|Withdrawal by Subject|3|||
162747868|NCT03993392|587789301|FG000|Overall Study|Lost to Follow-up|2|||
162747869|NCT03993392|587789301|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
162747870|NCT05292391|587789304|FG000|Overall Study|Lost to Follow-up|0|||
162747871|NCT05292391|587789305|FG001|Overall Study|Lost to Follow-up|0|||
162747872|NCT05292391|587789306|FG002|Overall Study|Lost to Follow-up|0|||
162747873|NCT05292391|587789307|FG003|Overall Study|Lost to Follow-up|1|||
162747874|NCT05292391|587789308|FG004|Overall Study|Lost to Follow-up|0|||
162747875|NCT04857723|587789311|FG000|Overall Study|Withdrawal by Subject|2|||
162747876|NCT03106740|587790679|FG000|Overall Study|Lost to Follow-up|2|||
162747877|NCT03106740|587790680|FG001|Overall Study|Lost to Follow-up|2|||
162747878|NCT03106740|587790679|FG000|Overall Study|Withdrawal by Subject|2|||
162747879|NCT03106740|587790680|FG001|Overall Study|Withdrawal by Subject|4|||
162747880|NCT03106740|587790679|FG000|Overall Study|Physician Decision|0|||
162747881|NCT03106740|587790680|FG001|Overall Study|Physician Decision|1|||
162747882|NCT03106740|587790679|FG000|Overall Study|Partial data|1|||
162747883|NCT03106740|587790680|FG001|Overall Study|Partial data|0|||
162747884|NCT04797858|587790681|FG000|Overall Study|Withdrawal by Subject|0|||
162747885|NCT04797858|587790682|FG001|Overall Study|Withdrawal by Subject|1|||
162747886|NCT04797858|587790681|FG000|Overall Study|Excluded due to administrative error|7|||
162747887|NCT04797858|587790682|FG001|Overall Study|Excluded due to administrative error|8|||
162747888|NCT01880515|587790686|FG000|Overall Study|Lost to Follow-up|3|||
162747889|NCT01880515|587790687|FG001|Overall Study|Lost to Follow-up|2|||
162747890|NCT01880515|587790686|FG000|Overall Study|Disease Progression|5|||
162747891|NCT01880515|587790687|FG001|Overall Study|Disease Progression|7|||
162747892|NCT03505710|587790688|FG000|Overall Study|Progressive Disease|24|||
162747893|NCT03505710|587790689|FG001|Overall Study|Progressive Disease|17|||
162747894|NCT03505710|587790690|FG002|Overall Study|Progressive Disease|43|||
162747895|NCT03505710|587790688|FG000|Overall Study|Clinical Progression|6|||
162747896|NCT03505710|587790689|FG001|Overall Study|Clinical Progression|8|||
162747897|NCT03505710|587790690|FG002|Overall Study|Clinical Progression|3|||
162747898|NCT03505710|587790688|FG000|Overall Study|Adverse Event|12|||
162747899|NCT03505710|587790689|FG001|Overall Study|Adverse Event|6|||
162747900|NCT03505710|587790690|FG002|Overall Study|Adverse Event|28|||
162747901|NCT03505710|587790688|FG000|Overall Study|Withdrawal by Subject|1|||
162747902|NCT03505710|587790689|FG001|Overall Study|Withdrawal by Subject|3|||
162747903|NCT03505710|587790690|FG002|Overall Study|Withdrawal by Subject|7|||
162747904|NCT03505710|587790688|FG000|Overall Study|Physician Decision|1|||
162747905|NCT03505710|587790689|FG001|Overall Study|Physician Decision|1|||
162747906|NCT03505710|587790690|FG002|Overall Study|Physician Decision|2|||
162747907|NCT03505710|587790688|FG000|Overall Study|Death|4|||
162747908|NCT03505710|587790689|FG001|Overall Study|Death|5|||
162747909|NCT03505710|587790690|FG002|Overall Study|Death|6|||
162747910|NCT03505710|587790688|FG000|Overall Study|Other Reasons|1|||
162747911|NCT03505710|587790689|FG001|Overall Study|Other Reasons|1|||
162747912|NCT03505710|587790690|FG002|Overall Study|Other Reasons|1|||
162747913|NCT03505710|587790688|FG000|Overall Study|Study Terminated by Sponsor|0|||
162747914|NCT03505710|587790689|FG001|Overall Study|Study Terminated by Sponsor|0|||
162747915|NCT03505710|587790690|FG002|Overall Study|Study Terminated by Sponsor|1|||
162747916|NCT04414722|587790691|FG000|Overall Study|Lost to Follow-up|3|||
162747917|NCT04414722|587790692|FG001|Overall Study|Lost to Follow-up|4|||
162747918|NCT04414722|587790693|FG002|Overall Study|Lost to Follow-up|3|||
162747919|NCT04414722|587790694|FG003|Overall Study|Lost to Follow-up|2|||
162747920|NCT04414722|587790695|FG004|Overall Study|Lost to Follow-up|3|||
162747921|NCT04414722|587790691|FG000|Overall Study|Withdrawal by Subject|6|||
162747922|NCT04414722|587790692|FG001|Overall Study|Withdrawal by Subject|3|||
162747923|NCT04414722|587790693|FG002|Overall Study|Withdrawal by Subject|1|||
162747924|NCT04414722|587790694|FG003|Overall Study|Withdrawal by Subject|5|||
162747925|NCT04414722|587790695|FG004|Overall Study|Withdrawal by Subject|1|||
162747926|NCT04414722|587790691|FG000|Overall Study|Physician Decision|0|||
162747927|NCT04414722|587790692|FG001|Overall Study|Physician Decision|1|||
162747928|NCT04414722|587790693|FG002|Overall Study|Physician Decision|2|||
162747929|NCT04414722|587790694|FG003|Overall Study|Physician Decision|0|||
162747930|NCT04414722|587790695|FG004|Overall Study|Physician Decision|0|||
162747931|NCT04414722|587790691|FG000|Overall Study|Non-participatory|0|||
162747932|NCT04414722|587790692|FG001|Overall Study|Non-participatory|1|||
162747933|NCT04414722|587790693|FG002|Overall Study|Non-participatory|1|||
162747934|NCT04414722|587790694|FG003|Overall Study|Non-participatory|0|||
162747935|NCT04414722|587790695|FG004|Overall Study|Non-participatory|0|||
162747936|NCT04766892|587790696|FG000|Overall Study|Withdrawal by Subject|1|||
162747937|NCT04766892|587790696|FG000|Overall Study|Lost to Follow-up|1|||
162747938|NCT04766892|587790696|FG000|Overall Study|Adverse Event|3|||
162747939|NCT04766892|587790696|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
162747940|NCT04359654|587790697|FG000|Overall Study|Withdrawal by Subject|1|||
162747941|NCT04359654|587790698|FG001|Overall Study|Withdrawal by Subject|0|||
162747942|NCT04359654|587790697|FG000|Overall Study|Adverse Event|0|||
162747943|NCT04359654|587790698|FG001|Overall Study|Adverse Event|1|||
162747944|NCT03711474|587790701|FG000|Overall Study|Physician Decision|2|||
162747945|NCT03711474|587790702|FG001|Overall Study|Physician Decision|0|||
162747946|NCT02446236|587790703|FG000|Overall Study|Screen Failure|1|||
162747947|NCT02446236|587790704|FG001|Overall Study|Screen Failure|0|||
162747948|NCT02446236|587790705|FG002|Overall Study|Screen Failure|1|||
162747949|NCT02446236|587790703|FG000|Overall Study|Actively Receiving Therapy|0|||
162747950|NCT02446236|587790704|FG001|Overall Study|Actively Receiving Therapy|0|||
162747951|NCT02446236|587790705|FG002|Overall Study|Actively Receiving Therapy|1|||
162747952|NCT03677141|587790706|FG000|Overall Study|Death|2|||
162747953|NCT03677141|587790707|FG001|Overall Study|Death|1|||
162747954|NCT03677141|587790708|FG002|Overall Study|Death|6|||
162747955|NCT03677141|587790709|FG003|Overall Study|Death|9|||
162747956|NCT03677141|587790710|FG004|Overall Study|Death|5|||
162747957|NCT03677141|587790711|FG005|Overall Study|Death|3|||
162747958|NCT03677141|587790706|FG000|Overall Study|Lost to Follow-up|0|||
162747959|NCT03677141|587790707|FG001|Overall Study|Lost to Follow-up|0|||
162747960|NCT03677141|587790708|FG002|Overall Study|Lost to Follow-up|0|||
162747961|NCT03677141|587790709|FG003|Overall Study|Lost to Follow-up|2|||
162747962|NCT03677141|587790710|FG004|Overall Study|Lost to Follow-up|0|||
162747963|NCT03677141|587790711|FG005|Overall Study|Lost to Follow-up|0|||
162747964|NCT03677141|587790706|FG000|Overall Study|Screen failure or enrolled in error|0|||
162747965|NCT03677141|587790707|FG001|Overall Study|Screen failure or enrolled in error|0|||
162747966|NCT03677141|587790708|FG002|Overall Study|Screen failure or enrolled in error|0|||
162747967|NCT03677141|587790709|FG003|Overall Study|Screen failure or enrolled in error|0|||
162747968|NCT03677141|587790710|FG004|Overall Study|Screen failure or enrolled in error|2|||
162747969|NCT03677141|587790711|FG005|Overall Study|Screen failure or enrolled in error|0|||
162747970|NCT03677141|587790706|FG000|Overall Study|Physician Decision|0|||
162747971|NCT03677141|587790707|FG001|Overall Study|Physician Decision|0|||
162747972|NCT03677141|587790708|FG002|Overall Study|Physician Decision|0|||
162747973|NCT03677141|587790709|FG003|Overall Study|Physician Decision|0|||
162747974|NCT03677141|587790710|FG004|Overall Study|Physician Decision|1|||
162747975|NCT03677141|587790711|FG005|Overall Study|Physician Decision|0|||
162747976|NCT03677141|587790706|FG000|Overall Study|Withdrawal by Subject|0|||
162747977|NCT03677141|587790707|FG001|Overall Study|Withdrawal by Subject|0|||
162747978|NCT03677141|587790708|FG002|Overall Study|Withdrawal by Subject|1|||
162747979|NCT03677141|587790709|FG003|Overall Study|Withdrawal by Subject|1|||
162747980|NCT03677141|587790710|FG004|Overall Study|Withdrawal by Subject|1|||
162747981|NCT03677141|587790711|FG005|Overall Study|Withdrawal by Subject|0|||
162747982|NCT04003246|587790715|FG000|Overall Study|Death|9|||
162747983|NCT04526886|587790717|FG000|Overall Study|Physician Decision|4|||
162747984|NCT03276676|587790720|FG000|Overall Study|Withdrawal by Subject|2|||
162747985|NCT03276676|587790721|FG001|Overall Study|Withdrawal by Subject|1|||
162747986|NCT02962076|587790723|FG000|Overall Study|MHED tracer not available|5|||
162747987|NCT02962076|587790723|FG000|Overall Study|Protocol Violation|1|||
162747988|NCT02962076|587790723|FG000|Overall Study|Physician Decision|1|||
162747989|NCT03583333|587790727|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
162747990|NCT03583333|587790728|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
162747991|NCT03583333|587790727|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
162747992|NCT03583333|587790728|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
162747993|NCT03583333|587790727|FG000|Overall Study|Withdrawal by Subject|9|||
162747994|NCT03583333|587790728|FG001|Overall Study|Withdrawal by Subject|5|||
162747995|NCT03583333|587790727|FG000|Overall Study|Physician Decision|3|||
162747996|NCT03583333|587790728|FG001|Overall Study|Physician Decision|2|||
162747997|NCT03583333|587790727|FG000|Overall Study|Death|12|||
162747998|NCT03583333|587790728|FG001|Overall Study|Death|7|||
162747999|NCT03926130|587790729|FG000|Overall Study|Adverse Event|9|||
162748000|NCT03926130|587790730|FG001|Overall Study|Adverse Event|11|||
162748001|NCT03926130|587790731|FG002|Overall Study|Adverse Event|2|||
162748002|NCT03926130|587790732|FG003|Overall Study|Adverse Event|0|||
162748003|NCT03926130|587790729|FG000|Overall Study|Death|2|||
162748004|NCT03926130|587790730|FG001|Overall Study|Death|0|||
162748005|NCT03926130|587790731|FG002|Overall Study|Death|1|||
162748006|NCT03926130|587790732|FG003|Overall Study|Death|0|||
162748007|NCT03926130|587790729|FG000|Overall Study|Lack of Efficacy|14|||
162748008|NCT03926130|587790730|FG001|Overall Study|Lack of Efficacy|11|||
162748009|NCT03926130|587790731|FG002|Overall Study|Lack of Efficacy|7|||
162748010|NCT03926130|587790732|FG003|Overall Study|Lack of Efficacy|1|||
162748011|NCT03926130|587790729|FG000|Overall Study|Lost to Follow-up|0|||
162748012|NCT03926130|587790730|FG001|Overall Study|Lost to Follow-up|7|||
162748013|NCT03926130|587790731|FG002|Overall Study|Lost to Follow-up|1|||
162748014|NCT03926130|587790732|FG003|Overall Study|Lost to Follow-up|0|||
162748015|NCT03926130|587790729|FG000|Overall Study|As Reported by Investigator|2|||
162748016|NCT03926130|587790730|FG001|Overall Study|As Reported by Investigator|6|||
162748017|NCT03926130|587790731|FG002|Overall Study|As Reported by Investigator|6|||
162748018|NCT03926130|587790732|FG003|Overall Study|As Reported by Investigator|0|||
162748019|NCT03926130|587790729|FG000|Overall Study|Physician Decision|3|||
162748020|NCT03926130|587790730|FG001|Overall Study|Physician Decision|2|||
162748021|NCT03926130|587790731|FG002|Overall Study|Physician Decision|1|||
162748022|NCT03926130|587790732|FG003|Overall Study|Physician Decision|0|||
162748023|NCT03926130|587790729|FG000|Overall Study|Pregnancy|2|||
162748024|NCT03926130|587790730|FG001|Overall Study|Pregnancy|2|||
162748025|NCT03926130|587790731|FG002|Overall Study|Pregnancy|1|||
162748026|NCT03926130|587790732|FG003|Overall Study|Pregnancy|0|||
162748027|NCT03926130|587790729|FG000|Overall Study|Withdrawal by Subject|20|||
162748028|NCT03926130|587790730|FG001|Overall Study|Withdrawal by Subject|28|||
162748029|NCT03926130|587790731|FG002|Overall Study|Withdrawal by Subject|18|||
162748030|NCT03926130|587790732|FG003|Overall Study|Withdrawal by Subject|1|||
162748031|NCT03926130|587790729|FG000|Overall Study|Non-Compliance|1|||
162748032|NCT03926130|587790730|FG001|Overall Study|Non-Compliance|1|||
162748033|NCT03926130|587790731|FG002|Overall Study|Non-Compliance|0|||
162748034|NCT03926130|587790732|FG003|Overall Study|Non-Compliance|0|||
162748035|NCT03926130|587790729|FG000|Overall Study|Disposition Not Captured|0|||
162748036|NCT03926130|587790730|FG001|Overall Study|Disposition Not Captured|2|||
162748037|NCT03926130|587790731|FG002|Overall Study|Disposition Not Captured|1|||
162748038|NCT03926130|587790732|FG003|Overall Study|Disposition Not Captured|0|||
162748039|NCT05069896|587790739|FG000|Overall Study|Adverse Event|0|||
162748040|NCT05069896|587790740|FG001|Overall Study|Adverse Event|1|||
162748041|NCT05069896|587790741|FG002|Overall Study|Adverse Event|1|||
162748042|NCT05069896|587790742|FG003|Overall Study|Adverse Event|0|||
162748043|NCT05069896|587790743|FG004|Overall Study|Adverse Event|0|||
162748044|NCT05069896|587790744|FG005|Overall Study|Adverse Event|0|||
162748045|NCT05069896|587790739|FG000|Overall Study|Lost to Follow-up|0|||
162748046|NCT05069896|587790740|FG001|Overall Study|Lost to Follow-up|0|||
162748047|NCT05069896|587790741|FG002|Overall Study|Lost to Follow-up|1|||
162748048|NCT05069896|587790742|FG003|Overall Study|Lost to Follow-up|0|||
162748049|NCT05069896|587790743|FG004|Overall Study|Lost to Follow-up|1|||
162748050|NCT05069896|587790744|FG005|Overall Study|Lost to Follow-up|2|||
162748051|NCT03580356|587790748|FG000|Treatment Period|Withdrawal by Subject|13|||
162748052|NCT03580356|587790749|FG001|Treatment Period|Withdrawal by Subject|0|||
162748053|NCT03580356|587790750|FG002|Treatment Period|Withdrawal by Subject|13|||
162748054|NCT03580356|587790751|FG003|Treatment Period|Withdrawal by Subject|1|||
162748055|NCT03580356|587790752|FG004|Treatment Period|Withdrawal by Subject|17|||
162748056|NCT03580356|587790753|FG005|Treatment Period|Withdrawal by Subject|0|||
162748057|NCT03580356|587790754|FG006|Treatment Period|Withdrawal by Subject|5|||
162748058|NCT03580356|587790755|FG007|Treatment Period|Withdrawal by Subject|0|||
162748059|NCT03580356|587790748|FG000|Treatment Period|Adverse Event|10|||
162748060|NCT03580356|587790749|FG001|Treatment Period|Adverse Event|0|||
162748061|NCT03580356|587790750|FG002|Treatment Period|Adverse Event|13|||
162748062|NCT03580356|587790751|FG003|Treatment Period|Adverse Event|0|||
162748063|NCT03580356|587790752|FG004|Treatment Period|Adverse Event|5|||
162748064|NCT03580356|587790753|FG005|Treatment Period|Adverse Event|0|||
162748065|NCT03580356|587790754|FG006|Treatment Period|Adverse Event|8|||
162748066|NCT03580356|587790755|FG007|Treatment Period|Adverse Event|0|||
162748067|NCT03580356|587790748|FG000|Treatment Period|Protocol Violation|5|||
162748068|NCT03580356|587790749|FG001|Treatment Period|Protocol Violation|0|||
162748069|NCT03580356|587790750|FG002|Treatment Period|Protocol Violation|6|||
162748070|NCT03580356|587790751|FG003|Treatment Period|Protocol Violation|1|||
162748071|NCT03580356|587790752|FG004|Treatment Period|Protocol Violation|9|||
162748072|NCT03580356|587790753|FG005|Treatment Period|Protocol Violation|1|||
162748073|NCT03580356|587790754|FG006|Treatment Period|Protocol Violation|1|||
162748074|NCT03580356|587790755|FG007|Treatment Period|Protocol Violation|0|||
162748075|NCT03580356|587790748|FG000|Treatment Period|Lack of Efficacy|6|||
162748076|NCT03580356|587790749|FG001|Treatment Period|Lack of Efficacy|0|||
162748077|NCT03580356|587790750|FG002|Treatment Period|Lack of Efficacy|2|||
162748078|NCT03580356|587790751|FG003|Treatment Period|Lack of Efficacy|0|||
162748079|NCT03580356|587790752|FG004|Treatment Period|Lack of Efficacy|3|||
162748080|NCT03580356|587790753|FG005|Treatment Period|Lack of Efficacy|0|||
162748081|NCT03580356|587790754|FG006|Treatment Period|Lack of Efficacy|3|||
162748082|NCT03580356|587790755|FG007|Treatment Period|Lack of Efficacy|0|||
162748083|NCT03580356|587790748|FG000|Treatment Period|Pregnancy|1|||
162748084|NCT03580356|587790749|FG001|Treatment Period|Pregnancy|0|||
162748085|NCT03580356|587790750|FG002|Treatment Period|Pregnancy|7|||
162748086|NCT03580356|587790751|FG003|Treatment Period|Pregnancy|0|||
162748087|NCT03580356|587790752|FG004|Treatment Period|Pregnancy|2|||
162748088|NCT03580356|587790753|FG005|Treatment Period|Pregnancy|0|||
162748089|NCT03580356|587790754|FG006|Treatment Period|Pregnancy|1|||
162748090|NCT03580356|587790755|FG007|Treatment Period|Pregnancy|0|||
162748091|NCT03580356|587790748|FG000|Treatment Period|Physician Decision|2|||
162748092|NCT03580356|587790749|FG001|Treatment Period|Physician Decision|0|||
162748093|NCT03580356|587790750|FG002|Treatment Period|Physician Decision|1|||
162748094|NCT03580356|587790751|FG003|Treatment Period|Physician Decision|0|||
162748095|NCT03580356|587790752|FG004|Treatment Period|Physician Decision|4|||
162748096|NCT03580356|587790753|FG005|Treatment Period|Physician Decision|0|||
162748097|NCT03580356|587790754|FG006|Treatment Period|Physician Decision|2|||
162748098|NCT03580356|587790755|FG007|Treatment Period|Physician Decision|0|||
162748099|NCT03580356|587790748|FG000|Treatment Period|Lost to Follow-up|1|||
162748100|NCT03580356|587790749|FG001|Treatment Period|Lost to Follow-up|1|||
162748101|NCT03580356|587790750|FG002|Treatment Period|Lost to Follow-up|1|||
162748102|NCT03580356|587790751|FG003|Treatment Period|Lost to Follow-up|0|||
162748103|NCT03580356|587790752|FG004|Treatment Period|Lost to Follow-up|3|||
162748104|NCT03580356|587790753|FG005|Treatment Period|Lost to Follow-up|0|||
162748105|NCT03580356|587790754|FG006|Treatment Period|Lost to Follow-up|1|||
162748106|NCT03580356|587790755|FG007|Treatment Period|Lost to Follow-up|0|||
162748107|NCT03580356|587790748|FG000|Treatment Period|Death|0|||
162748108|NCT03580356|587790749|FG001|Treatment Period|Death|0|||
162748109|NCT03580356|587790750|FG002|Treatment Period|Death|1|||
162748110|NCT03580356|587790751|FG003|Treatment Period|Death|0|||
162748111|NCT03580356|587790752|FG004|Treatment Period|Death|0|||
162748112|NCT03580356|587790753|FG005|Treatment Period|Death|0|||
162748113|NCT03580356|587790754|FG006|Treatment Period|Death|0|||
162748114|NCT03580356|587790755|FG007|Treatment Period|Death|0|||
162748115|NCT03580356|587790748|FG000|Treatment Period|Technical problems|0|||
162748116|NCT03580356|587790749|FG001|Treatment Period|Technical problems|0|||
162748117|NCT03580356|587790750|FG002|Treatment Period|Technical problems|0|||
162748118|NCT03580356|587790751|FG003|Treatment Period|Technical problems|0|||
162748119|NCT03580356|587790752|FG004|Treatment Period|Technical problems|1|||
162748120|NCT03580356|587790753|FG005|Treatment Period|Technical problems|0|||
162748121|NCT03580356|587790754|FG006|Treatment Period|Technical problems|0|||
162748122|NCT03580356|587790755|FG007|Treatment Period|Technical problems|0|||
162748123|NCT03580356|587790748|FG000|Treatment Period|Misrandomized, no treatment|0|||
162748124|NCT03580356|587790749|FG001|Treatment Period|Misrandomized, no treatment|0|||
162748125|NCT03580356|587790750|FG002|Treatment Period|Misrandomized, no treatment|1|||
162748126|NCT03580356|587790751|FG003|Treatment Period|Misrandomized, no treatment|0|||
162748127|NCT03580356|587790752|FG004|Treatment Period|Misrandomized, no treatment|2|||
162748128|NCT03580356|587790753|FG005|Treatment Period|Misrandomized, no treatment|0|||
162748129|NCT03580356|587790754|FG006|Treatment Period|Misrandomized, no treatment|0|||
162748130|NCT03580356|587790755|FG007|Treatment Period|Misrandomized, no treatment|0|||
162748131|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
162748132|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
162748133|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
162748134|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
162748135|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
162748136|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
162748137|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
162748138|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
162748139|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
162748140|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162748141|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
162748142|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162748143|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
162748144|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162748145|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162748146|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162748147|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
162748148|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
162748149|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
162748150|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
162748151|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
162748152|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
162748153|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
162748154|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
162748155|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748156|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748157|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
162748158|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748159|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
162748160|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748161|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748162|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162748163|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
162748164|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
162748165|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
162748166|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
162748167|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
162748168|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
162748169|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
162748170|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
162748171|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
162748172|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
162748173|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
162748174|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
162748175|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
162748176|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
162748177|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
162748178|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
162748179|NCT03580356|587790748|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
162748180|NCT03580356|587790749|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
162748181|NCT03580356|587790750|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
162748182|NCT03580356|587790751|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
162748183|NCT03580356|587790752|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
162748184|NCT03580356|587790753|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
162748185|NCT03580356|587790754|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
162748186|NCT03580356|587790755|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
162748187|NCT05715528|587790756|FG000|Overall Study|Randomized but never treated|11|||
162748188|NCT05715528|587790757|FG001|Overall Study|Randomized but never treated|13|||
162748189|NCT05715528|587790756|FG000|Overall Study|Withdrew consent|7|||
162748190|NCT05715528|587790757|FG001|Overall Study|Withdrew consent|15|||
162748191|NCT05715528|587790756|FG000|Overall Study|Lost to Follow-up|5|||
162748192|NCT05715528|587790757|FG001|Overall Study|Lost to Follow-up|13|||
162748193|NCT05715528|587790756|FG000|Overall Study|Investigator's discretion|3|||
162748194|NCT05715528|587790757|FG001|Overall Study|Investigator's discretion|1|||
162748195|NCT05715528|587790756|FG000|Overall Study|Protocol Violation|2|||
162748196|NCT05715528|587790757|FG001|Overall Study|Protocol Violation|0|||
162748197|NCT05715528|587790756|FG000|Overall Study|Non-compliance with study drug|0|||
162748198|NCT05715528|587790757|FG001|Overall Study|Non-compliance with study drug|1|||
162748199|NCT05035654|587790760|FG000|Overall Study|Physician Decision|0|||
162748200|NCT05035654|587790761|FG001|Overall Study|Physician Decision|1|||
162748201|NCT05035654|587790762|FG002|Overall Study|Physician Decision|0|||
162748202|NCT05035654|587790760|FG000|Overall Study|Adverse Event|0|||
162748203|NCT05035654|587790761|FG001|Overall Study|Adverse Event|1|||
162748204|NCT05035654|587790762|FG002|Overall Study|Adverse Event|0|||
162748205|NCT05035654|587790760|FG000|Overall Study|Withdrawal by Subject|0|||
162748206|NCT05035654|587790761|FG001|Overall Study|Withdrawal by Subject|0|||
162748207|NCT05035654|587790762|FG002|Overall Study|Withdrawal by Subject|4|||
162748208|NCT05035654|587790760|FG000|Overall Study|Bilateral Dislodgement|1|||
162748209|NCT05035654|587790761|FG001|Overall Study|Bilateral Dislodgement|0|||
162748210|NCT05035654|587790762|FG002|Overall Study|Bilateral Dislodgement|0|||
162748211|NCT04451772|587790765|FG000|Overall Study|Adverse Event|1|||
162748212|NCT04451772|587790766|FG001|Overall Study|Adverse Event|0|||
162748213|NCT04451772|587790767|FG002|Overall Study|Adverse Event|1|||
162748214|NCT04451772|587790768|FG003|Overall Study|Adverse Event|1|||
162748215|NCT04451772|587790769|FG004|Overall Study|Adverse Event|0|||
162748216|NCT04451772|587790770|FG005|Overall Study|Adverse Event|3|||
162748217|NCT04451772|587790765|FG000|Overall Study|Withdrawal by Subject|2|||
162748218|NCT04451772|587790766|FG001|Overall Study|Withdrawal by Subject|7|||
162748219|NCT04451772|587790767|FG002|Overall Study|Withdrawal by Subject|2|||
162748220|NCT04451772|587790768|FG003|Overall Study|Withdrawal by Subject|1|||
162748221|NCT04451772|587790769|FG004|Overall Study|Withdrawal by Subject|1|||
162748222|NCT04451772|587790770|FG005|Overall Study|Withdrawal by Subject|0|||
162748223|NCT04451772|587790765|FG000|Overall Study|Other, not specified|1|||
162748224|NCT04451772|587790766|FG001|Overall Study|Other, not specified|2|||
162748225|NCT04451772|587790767|FG002|Overall Study|Other, not specified|1|||
162748226|NCT04451772|587790768|FG003|Overall Study|Other, not specified|0|||
162748227|NCT04451772|587790769|FG004|Overall Study|Other, not specified|0|||
162748228|NCT04451772|587790770|FG005|Overall Study|Other, not specified|1|||
162748229|NCT04451772|587790765|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
162748230|NCT04451772|587790766|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
162748231|NCT04451772|587790767|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
162748232|NCT04451772|587790768|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
162748233|NCT04451772|587790769|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
162748234|NCT04451772|587790770|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
162748235|NCT04311632|587790771|FG000|Overall Study|Withdrawal by Subject|0|||
162748236|NCT04311632|587790772|FG001|Overall Study|Withdrawal by Subject|0|||
162748237|NCT04311632|587790773|FG002|Overall Study|Withdrawal by Subject|1|||
162748238|NCT05856435|587790774|FG000|Overall Study|Lost to Follow-up|6|||
162748239|NCT04632225|587790775|FG000|Overall Study|Withdrawal by Subject|2|||
162748240|NCT04632225|587790776|FG001|Overall Study|Withdrawal by Subject|2|||
162748241|NCT05660434|587790777|FG000|Overall Study|Never obtained study materials|2|||
162748242|NCT05660434|587790778|FG001|Overall Study|Never obtained study materials|1|||
162748243|NCT03213678|587790783|FG000|Overall Study|Death|1|||
162748244|NCT03213678|587790783|FG000|Overall Study|Physician Decision|1|||
162748245|NCT03213678|587790783|FG000|Overall Study|Progressive disease|16|||
162748246|NCT02413489|587790784|FG000|Overall Study|Death|11|||
162748247|NCT02413489|587790785|FG001|Overall Study|Death|3|||
162748248|NCT02413489|587790786|FG002|Overall Study|Death|4|||
162748249|NCT02413489|587790784|FG000|Overall Study|Withdrawal by Subject|2|||
162748250|NCT02413489|587790785|FG001|Overall Study|Withdrawal by Subject|0|||
162748251|NCT02413489|587790786|FG002|Overall Study|Withdrawal by Subject|0|||
162748252|NCT02413489|587790784|FG000|Overall Study|Study Terminated By Sponsor|2|||
162748253|NCT02413489|587790785|FG001|Overall Study|Study Terminated By Sponsor|13|||
162748254|NCT02413489|587790786|FG002|Overall Study|Study Terminated By Sponsor|1|||
162748255|NCT03717935|587790787|FG000|Overall Study|Withdrawal by Subject|0|||
162748256|NCT03717935|587790788|FG001|Overall Study|Withdrawal by Subject|2|||
162748257|NCT04456296|587790789|FG000|Overall Study|Withdrawal by Subject|14|||
162748258|NCT04456296|587790790|FG001|Overall Study|Withdrawal by Subject|21|||
162748259|NCT04456296|587790791|FG002|Overall Study|Withdrawal by Subject|21|||
162748260|NCT04456296|587790789|FG000|Overall Study|Adverse Event|2|||
162748261|NCT04456296|587790790|FG001|Overall Study|Adverse Event|2|||
162748262|NCT04456296|587790791|FG002|Overall Study|Adverse Event|2|||
162748263|NCT04456296|587790789|FG000|Overall Study|Death|1|||
162748264|NCT04456296|587790790|FG001|Overall Study|Death|0|||
162748265|NCT04456296|587790791|FG002|Overall Study|Death|0|||
162748266|NCT04456296|587790789|FG000|Overall Study|Lost to Follow-up|3|||
162748267|NCT04456296|587790790|FG001|Overall Study|Lost to Follow-up|5|||
162748268|NCT04456296|587790791|FG002|Overall Study|Lost to Follow-up|6|||
162748269|NCT04456296|587790789|FG000|Overall Study|Other than specified|0|||
162748270|NCT04456296|587790790|FG001|Overall Study|Other than specified|1|||
162748271|NCT04456296|587790791|FG002|Overall Study|Other than specified|4|||
162748272|NCT04456296|587790789|FG000|Overall Study|Randomized, not treated|2|||
162748273|NCT04456296|587790790|FG001|Overall Study|Randomized, not treated|1|||
162748274|NCT04456296|587790791|FG002|Overall Study|Randomized, not treated|0|||
162748275|NCT05736458|587790792|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
162748276|NCT05736458|587790793|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
162748277|NCT05736458|587790794|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
162748278|NCT05736458|587790792|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
162748279|NCT05736458|587790793|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
162748280|NCT05736458|587790794|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
162748281|NCT05736458|587790792|FG000|TMS/fMRI #1|Physician Decision|0|||
162748282|NCT05736458|587790793|FG001|TMS/fMRI #1|Physician Decision|0|||
162748283|NCT05736458|587790794|FG002|TMS/fMRI #1|Physician Decision|2|||
162748284|NCT05736458|587790792|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
162748285|NCT05736458|587790793|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
162748286|NCT05736458|587790794|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
162748287|NCT05100628|587790800|FG000|Overall Study|Progressive Disease|1|||
162748288|NCT05100628|587790801|FG001|Overall Study|Progressive Disease|0|||
162748289|NCT05100628|587790802|FG002|Overall Study|Progressive Disease|0|||
162748290|NCT05100628|587790803|FG003|Overall Study|Progressive Disease|0|||
162748291|NCT05100628|587790800|FG000|Overall Study|Study Terminated by Sponsor|0|||
162748292|NCT05100628|587790801|FG001|Overall Study|Study Terminated by Sponsor|0|||
162748293|NCT05100628|587790802|FG002|Overall Study|Study Terminated by Sponsor|3|||
162748294|NCT05100628|587790803|FG003|Overall Study|Study Terminated by Sponsor|0|||
162748295|NCT05100628|587790800|FG000|Overall Study|unkown|0|||
162748296|NCT05100628|587790801|FG001|Overall Study|unkown|1|||
162748297|NCT05100628|587790802|FG002|Overall Study|unkown|0|||
162748298|NCT05100628|587790803|FG003|Overall Study|unkown|0|||
162748299|NCT03914469|587790806|FG000|Overall Study|Lost to Follow-up|1|||
162748300|NCT03914469|587790807|FG001|Overall Study|Lost to Follow-up|4|||
162748301|NCT00721149|587790811|FG000|Overall Study|Physician Decision|1|||
162748302|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
162748303|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
162748304|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
162748305|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
162748306|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
162748307|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
162748308|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
162748309|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
162748310|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
162748311|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
162748312|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
162748313|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
162748314|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
162748315|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
162748316|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
162748317|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
162748318|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
162748319|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
162748320|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
162748321|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
162748322|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
162748323|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
162748324|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
162748325|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
162748326|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
162748327|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
162748328|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
162748329|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
162748330|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
162748331|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
162748332|NCT04614948|587790814|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
162748333|NCT04614948|587790815|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
162748334|NCT04614948|587790816|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
162748335|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
162748336|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
162748337|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
162748338|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
162748339|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
162748340|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
162748341|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
162748342|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
162748343|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
162748344|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
162748345|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
162748346|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
162748347|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
162748348|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
162748349|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
162748350|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
162748351|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
162748352|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
162748353|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
162748354|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
162748355|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
162748356|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
162748357|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
162748358|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
162748359|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
162748360|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
162748361|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
162748362|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
162748363|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
162748364|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
162748365|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
162748366|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
162748367|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
162748368|NCT04614948|587790814|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
162748369|NCT04614948|587790815|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
162748370|NCT04614948|587790816|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
162748371|NCT04271046|587790817|FG000|Overall Study|Death|0|||
162748372|NCT04271046|587790818|FG001|Overall Study|Death|2|||
162748373|NCT04271046|587790819|FG002|Overall Study|Death|0|||
162748374|NCT04271046|587790820|FG003|Overall Study|Death|2|||
162748375|NCT04271046|587790817|FG000|Overall Study|Lost to Follow-up|12|||
162748376|NCT04271046|587790818|FG001|Overall Study|Lost to Follow-up|12|||
162748377|NCT04271046|587790819|FG002|Overall Study|Lost to Follow-up|11|||
162748378|NCT04271046|587790820|FG003|Overall Study|Lost to Follow-up|11|||
162748379|NCT04271046|587790817|FG000|Overall Study|Patient with Dementia Died|2|||
162748380|NCT04271046|587790818|FG001|Overall Study|Patient with Dementia Died|0|||
162748381|NCT04271046|587790819|FG002|Overall Study|Patient with Dementia Died|2|||
162748382|NCT04271046|587790820|FG003|Overall Study|Patient with Dementia Died|0|||
162748383|NCT04271046|587790817|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
162748384|NCT04271046|587790818|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
162748385|NCT04271046|587790819|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
162748386|NCT04271046|587790820|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
162748387|NCT04129554|587790821|FG000|Overall Study|Withdrawal by Subject|4|||
162748388|NCT04129554|587790822|FG001|Overall Study|Withdrawal by Subject|3|||
162748389|NCT04129554|587790821|FG000|Overall Study|Other|0|||
162748390|NCT04129554|587790822|FG001|Overall Study|Other|2|||
162748391|NCT01570361|587790823|FG000|Overall Study|Subject discontinued|1|||
162748392|NCT01570361|587790824|FG001|Overall Study|Subject discontinued|2|||
162748393|NCT01570361|587790823|FG000|Overall Study|Sponsor closing the study|51|||
162748394|NCT01570361|587790824|FG001|Overall Study|Sponsor closing the study|50|||
162748395|NCT01570361|587790823|FG000|Overall Study|Subject excluded|5|||
162748396|NCT01570361|587790824|FG001|Overall Study|Subject excluded|3|||
162748397|NCT01570361|587790823|FG000|Overall Study|Subject withdrew consent|14|||
162748398|NCT01570361|587790824|FG001|Overall Study|Subject withdrew consent|9|||
162748399|NCT01570361|587790823|FG000|Overall Study|Adverse Event|2|||
162748400|NCT01570361|587790824|FG001|Overall Study|Adverse Event|1|||
162748401|NCT01570361|587790823|FG000|Overall Study|Lost to Follow-up|4|||
162748402|NCT01570361|587790824|FG001|Overall Study|Lost to Follow-up|4|||
162748403|NCT01570361|587790823|FG000|Overall Study|Death|5|||
162748404|NCT01570361|587790824|FG001|Overall Study|Death|4|||
162748405|NCT01570361|587790823|FG000|Overall Study|Other|0|||
162748406|NCT01570361|587790824|FG001|Overall Study|Other|2|||
162748407|NCT05158504|587790827|FG000|Overall Study|Lost to Follow-up|2|||
162748408|NCT05158504|587790828|FG001|Overall Study|Lost to Follow-up|3|||
162748409|NCT03606512|587790829|FG000|Overall Study|Lost to Follow-up|0|||
162748410|NCT03606512|587790830|FG001|Overall Study|Lost to Follow-up|1|||
162748411|NCT03606512|587790829|FG000|Overall Study|'moved from study area|0|||
162748412|NCT03606512|587790830|FG001|Overall Study|'moved from study area|1|||
162748413|NCT05513937|587790831|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162748414|NCT05513937|587790832|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
162748415|NCT05513937|587790833|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162748416|NCT05513937|587790834|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162748417|NCT05513937|587790831|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
162748418|NCT05513937|587790832|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
162748419|NCT05513937|587790833|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
162748420|NCT05513937|587790834|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
162748421|NCT05513937|587790831|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
162748422|NCT05513937|587790832|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162748423|NCT05513937|587790833|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162748424|NCT05513937|587790834|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162748425|NCT05513937|587790831|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
162748426|NCT05513937|587790832|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162748427|NCT05513937|587790833|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162748428|NCT05513937|587790834|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162748429|NCT05513937|587790831|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162748430|NCT05513937|587790832|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162748431|NCT05513937|587790833|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
162748432|NCT05513937|587790834|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162748433|NCT05513937|587790831|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
162748434|NCT05513937|587790832|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
162748435|NCT05513937|587790833|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
162748436|NCT05513937|587790834|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
162748437|NCT02846545|587790835|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
162748438|NCT02846545|587790836|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
162748439|NCT02846545|587790835|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
162748440|NCT02846545|587790836|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
162748441|NCT02846545|587790835|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
162748442|NCT02846545|587790836|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
162748443|NCT02846545|587790835|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
162748444|NCT02846545|587790836|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
162748445|NCT02846545|587790835|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
162748446|NCT02846545|587790836|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
162748447|NCT04230681|587790840|FG000|Overall Study|Physician Decision|2|||
162748448|NCT04230681|587790841|FG001|Overall Study|Physician Decision|3|||
162748449|NCT04230681|587790840|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
162748450|NCT04230681|587790841|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
162748451|NCT04230681|587790840|FG000|Overall Study|IV inadvertently removed|0|||
162748452|NCT04230681|587790841|FG001|Overall Study|IV inadvertently removed|1|||
162748453|NCT04565990|587792444|FG000|Overall Study|Death|5|||
162748454|NCT04565990|587792444|FG000|Overall Study|Lost to Follow-up|1|||
162748455|NCT04565990|587792444|FG000|Overall Study|Withdrawal by Subject|1|||
162748456|NCT05507333|587792445|FG000|Overall Study|Protocol Violation|1|||
162748457|NCT01960452|587792448|FG000|Overall Study|Withdrawal by Subject|2|||
162748458|NCT01960452|587792449|FG001|Overall Study|Withdrawal by Subject|1|||
162748459|NCT01960452|587792448|FG000|Overall Study|Sleep apnea in Night 1|1|||
162748460|NCT01960452|587792449|FG001|Overall Study|Sleep apnea in Night 1|0|||
162748461|NCT01960452|587792448|FG000|Overall Study|Poor Sleep in Night 1|0|||
162748462|NCT01960452|587792449|FG001|Overall Study|Poor Sleep in Night 1|2|||
162748463|NCT01960452|587792448|FG000|Overall Study|No Sex/Age Match Night 1|1|||
162748464|NCT01960452|587792449|FG001|Overall Study|No Sex/Age Match Night 1|0|||
162748465|NCT01960452|587792448|FG000|Overall Study|No Sex/Age Match Night 2|0|||
162925347|NCT00602641|588428936|FG000|Overall Study|Other|3|||
162748466|NCT01960452|587792449|FG001|Overall Study|No Sex/Age Match Night 2|2|||
162748467|NCT01960452|587792448|FG000|Overall Study|Technical Difficulties Night 2|2|||
162748468|NCT01960452|587792449|FG001|Overall Study|Technical Difficulties Night 2|0|||
162748469|NCT03981926|587792450|FG000|Overall Study|Lost to Follow-up|5|||
162748470|NCT03981926|587792451|FG001|Overall Study|Lost to Follow-up|9|||
162748471|NCT04820322|587792456|FG000|Overall Study|Adverse Event|1|||
162748472|NCT04820322|587792457|FG001|Overall Study|Adverse Event|0|||
162748473|NCT03156465|587792463|FG000|Overall Study|Withdrawal by Subject|2|||
162748474|NCT02839265|587792466|FG000|Overall Study|Screen Failure|2|||
162748475|NCT02839265|587792466|FG000|Overall Study|Death|1|||
162748476|NCT02839265|587792466|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
162748477|NCT04605159|587792478|FG000|Overall Study|Adverse Event|6|||
162748478|NCT04605159|587792479|FG001|Overall Study|Adverse Event|3|||
162748479|NCT04605159|587792480|FG002|Overall Study|Adverse Event|21|||
162748480|NCT04605159|587792481|FG003|Overall Study|Adverse Event|4|||
162748481|NCT04605159|587792478|FG000|Overall Study|Lost to Follow-up|74|||
162748482|NCT04605159|587792479|FG001|Overall Study|Lost to Follow-up|45|||
162748483|NCT04605159|587792480|FG002|Overall Study|Lost to Follow-up|119|||
162748484|NCT04605159|587792481|FG003|Overall Study|Lost to Follow-up|80|||
162748485|NCT04605159|587792478|FG000|Overall Study|Protocol Violation|4|||
162748486|NCT04605159|587792479|FG001|Overall Study|Protocol Violation|5|||
162748487|NCT04605159|587792480|FG002|Overall Study|Protocol Violation|2|||
162748488|NCT04605159|587792481|FG003|Overall Study|Protocol Violation|0|||
162748489|NCT04605159|587792478|FG000|Overall Study|Withdrawal by Subject|66|||
162748490|NCT04605159|587792479|FG001|Overall Study|Withdrawal by Subject|37|||
162748491|NCT04605159|587792480|FG002|Overall Study|Withdrawal by Subject|68|||
162748492|NCT04605159|587792481|FG003|Overall Study|Withdrawal by Subject|50|||
162748493|NCT04605159|587792478|FG000|Overall Study|Migrated / moved from the study area|32|||
162748494|NCT04605159|587792479|FG001|Overall Study|Migrated / moved from the study area|22|||
162748495|NCT04605159|587792480|FG002|Overall Study|Migrated / moved from the study area|41|||
162748496|NCT04605159|587792481|FG003|Overall Study|Migrated / moved from the study area|21|||
162748497|NCT04605159|587792478|FG000|Overall Study|Other|1|||
162748498|NCT04605159|587792479|FG001|Overall Study|Other|2|||
162748499|NCT04605159|587792480|FG002|Overall Study|Other|7|||
162748500|NCT04605159|587792481|FG003|Overall Study|Other|3|||
162748501|NCT02323880|587792482|FG000|Overall Study|Adverse Event|2|||
162748502|NCT02323880|587792483|FG001|Overall Study|Adverse Event|0|||
162748503|NCT02323880|587792484|FG002|Overall Study|Adverse Event|1|||
162748504|NCT02323880|587792485|FG003|Overall Study|Adverse Event|1|||
162748505|NCT02323880|587792486|FG004|Overall Study|Adverse Event|1|||
162748506|NCT02323880|587792487|FG005|Overall Study|Adverse Event|0|||
162748507|NCT02323880|587792488|FG006|Overall Study|Adverse Event|1|||
162748508|NCT02323880|587792489|FG007|Overall Study|Adverse Event|0|||
162748509|NCT02323880|587792482|FG000|Overall Study|Death|0|||
162748510|NCT02323880|587792483|FG001|Overall Study|Death|0|||
162748511|NCT02323880|587792484|FG002|Overall Study|Death|0|||
162748512|NCT02323880|587792485|FG003|Overall Study|Death|0|||
162748513|NCT02323880|587792486|FG004|Overall Study|Death|0|||
162748514|NCT02323880|587792487|FG005|Overall Study|Death|1|||
162748515|NCT02323880|587792488|FG006|Overall Study|Death|0|||
162748516|NCT02323880|587792489|FG007|Overall Study|Death|0|||
162748517|NCT02323880|587792482|FG000|Overall Study|Lack of Efficacy|4|||
162748518|NCT02323880|587792483|FG001|Overall Study|Lack of Efficacy|11|||
162748519|NCT02323880|587792484|FG002|Overall Study|Lack of Efficacy|5|||
162748520|NCT02323880|587792485|FG003|Overall Study|Lack of Efficacy|5|||
162748521|NCT02323880|587792486|FG004|Overall Study|Lack of Efficacy|4|||
162748522|NCT02323880|587792487|FG005|Overall Study|Lack of Efficacy|8|||
162748523|NCT02323880|587792488|FG006|Overall Study|Lack of Efficacy|4|||
162748524|NCT02323880|587792489|FG007|Overall Study|Lack of Efficacy|6|||
162748525|NCT02323880|587792482|FG000|Overall Study|Physician Decision|0|||
162748526|NCT02323880|587792483|FG001|Overall Study|Physician Decision|0|||
162748527|NCT02323880|587792484|FG002|Overall Study|Physician Decision|0|||
162748528|NCT02323880|587792485|FG003|Overall Study|Physician Decision|0|||
162748529|NCT02323880|587792486|FG004|Overall Study|Physician Decision|1|||
162748530|NCT02323880|587792487|FG005|Overall Study|Physician Decision|1|||
162748531|NCT02323880|587792488|FG006|Overall Study|Physician Decision|1|||
162748532|NCT02323880|587792489|FG007|Overall Study|Physician Decision|0|||
162748533|NCT02323880|587792482|FG000|Overall Study|Withdrawal by Subject|0|||
162748534|NCT02323880|587792483|FG001|Overall Study|Withdrawal by Subject|2|||
162748535|NCT02323880|587792484|FG002|Overall Study|Withdrawal by Subject|0|||
162748536|NCT02323880|587792485|FG003|Overall Study|Withdrawal by Subject|0|||
162748537|NCT02323880|587792486|FG004|Overall Study|Withdrawal by Subject|0|||
162748538|NCT02323880|587792487|FG005|Overall Study|Withdrawal by Subject|0|||
162748539|NCT02323880|587792488|FG006|Overall Study|Withdrawal by Subject|0|||
162748540|NCT02323880|587792489|FG007|Overall Study|Withdrawal by Subject|0|||
162748541|NCT04934072|587792491|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
162748542|NCT04934072|587792492|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
162748543|NCT04934072|587792493|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
162748544|NCT04934072|587792494|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
162748545|NCT04934072|587792495|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
162748546|NCT04934072|587792491|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
162748547|NCT04934072|587792492|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
162748548|NCT04934072|587792493|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
162748549|NCT04934072|587792494|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
162748550|NCT04934072|587792495|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
162748551|NCT04934072|587792491|FG000|Day 0 to Week 52|Other|3|||
162748552|NCT04934072|587792492|FG001|Day 0 to Week 52|Other|1|||
162748553|NCT04934072|587792493|FG002|Day 0 to Week 52|Other|0|||
162748554|NCT04934072|587792494|FG003|Day 0 to Week 52|Other|0|||
162748555|NCT04934072|587792495|FG004|Day 0 to Week 52|Other|0|||
162748556|NCT04934072|587792491|FG000|Day 0 to Week 52|Adverse Event|1|||
162748557|NCT04934072|587792492|FG001|Day 0 to Week 52|Adverse Event|3|||
162748558|NCT04934072|587792493|FG002|Day 0 to Week 52|Adverse Event|0|||
162748559|NCT04934072|587792494|FG003|Day 0 to Week 52|Adverse Event|0|||
162748560|NCT04934072|587792495|FG004|Day 0 to Week 52|Adverse Event|0|||
162748561|NCT04934072|587792491|FG000|Week 52 to Week 78|Adverse Event|0|||
162748562|NCT04934072|587792492|FG001|Week 52 to Week 78|Adverse Event|0|||
162748563|NCT04934072|587792493|FG002|Week 52 to Week 78|Adverse Event|0|||
162748564|NCT04934072|587792494|FG003|Week 52 to Week 78|Adverse Event|1|||
162748565|NCT04934072|587792495|FG004|Week 52 to Week 78|Adverse Event|1|||
162748566|NCT04934072|587792491|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
162748567|NCT04934072|587792492|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
162748568|NCT04934072|587792493|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
162748569|NCT04934072|587792494|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
162748570|NCT04934072|587792495|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
162748571|NCT04934072|587792491|FG000|Week 52 to Week 78|Other|0|||
162748572|NCT04934072|587792492|FG001|Week 52 to Week 78|Other|0|||
162748573|NCT04934072|587792493|FG002|Week 52 to Week 78|Other|1|||
162748574|NCT04934072|587792494|FG003|Week 52 to Week 78|Other|0|||
162748575|NCT04934072|587792495|FG004|Week 52 to Week 78|Other|0|||
162748576|NCT05424380|587792500|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
162748577|NCT05424380|587792501|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162748578|NCT05424380|587792502|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162748579|NCT05424380|587792503|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162748580|NCT05424380|587792504|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162748581|NCT05424380|587792505|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162748582|NCT05424380|587792500|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
162748583|NCT05424380|587792501|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162748584|NCT05424380|587792502|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162748585|NCT05424380|587792503|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162748586|NCT05424380|587792504|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162748587|NCT05424380|587792505|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162748588|NCT05424380|587792500|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
162748589|NCT05424380|587792501|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162748590|NCT05424380|587792502|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162748591|NCT05424380|587792503|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162748592|NCT05424380|587792504|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162748593|NCT05424380|587792505|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162748594|NCT05424380|587792500|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162748595|NCT05424380|587792501|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
162748596|NCT05424380|587792502|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162748597|NCT05424380|587792503|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162748598|NCT05424380|587792504|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162748599|NCT05424380|587792505|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162748600|NCT05424380|587792500|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162748601|NCT05424380|587792501|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
162748602|NCT05424380|587792502|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162748603|NCT05424380|587792503|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162748604|NCT05424380|587792504|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162748605|NCT05424380|587792505|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162748606|NCT05424380|587792500|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162748607|NCT05424380|587792501|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162748608|NCT05424380|587792502|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
162748609|NCT05424380|587792503|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162748610|NCT05424380|587792504|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162748611|NCT05424380|587792505|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162748612|NCT05424380|587792500|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162748613|NCT05424380|587792501|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162748614|NCT05424380|587792502|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
162748615|NCT05424380|587792503|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162748616|NCT05424380|587792504|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162748617|NCT05424380|587792505|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162748618|NCT05424380|587792500|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162748619|NCT05424380|587792501|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162748620|NCT05424380|587792502|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
162748621|NCT05424380|587792503|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162748622|NCT05424380|587792504|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162748623|NCT05424380|587792505|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162748624|NCT05424380|587792500|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748625|NCT05424380|587792501|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748626|NCT05424380|587792502|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748627|NCT05424380|587792503|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
162748628|NCT05424380|587792504|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748629|NCT05424380|587792505|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748630|NCT05424380|587792500|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162748631|NCT05424380|587792501|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162748632|NCT05424380|587792502|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162748633|NCT05424380|587792503|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
162748634|NCT05424380|587792504|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162748635|NCT05424380|587792505|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162748636|NCT05424380|587792500|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162748637|NCT05424380|587792501|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162748638|NCT05424380|587792502|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162748639|NCT05424380|587792503|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
162748640|NCT05424380|587792504|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162748641|NCT05424380|587792505|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162748642|NCT05424380|587792500|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162748643|NCT05424380|587792501|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162748644|NCT05424380|587792502|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162748645|NCT05424380|587792503|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162748646|NCT05424380|587792504|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
162748647|NCT05424380|587792505|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162748648|NCT05424380|587792500|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748649|NCT05424380|587792501|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748650|NCT05424380|587792502|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748651|NCT05424380|587792503|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748652|NCT05424380|587792504|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
162748653|NCT05424380|587792505|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162748654|NCT05424380|587792500|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162748655|NCT05424380|587792501|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162748656|NCT05424380|587792502|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162748657|NCT05424380|587792503|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162748658|NCT05424380|587792504|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
162748659|NCT05424380|587792505|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162748660|NCT04218851|587792512|FG000|Overall Study|Death|1|||
162748661|NCT04218851|587792513|FG001|Overall Study|Death|3|||
162748662|NCT00844415|587792514|FG000|Overall Study|Withdrawal by Subject|1|||
162748663|NCT03174275|587792515|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
162748664|NCT03174275|587792515|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
162748665|NCT03174275|587792515|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
162748666|NCT03174275|587792515|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
162748667|NCT03174275|587792515|FG000|Adjuvant Chemotherapy|Progression|1|||
162748668|NCT03174275|587792515|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
162748669|NCT03174275|587792515|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
162748670|NCT03174275|587792515|FG000|Adjuvant Durvalumab|Progression|1|||
162748671|NCT03174275|587792515|FG000|Adjuvant Durvalumab|Adverse Event|3|||
162748672|NCT03174275|587792515|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
162748673|NCT03174275|587792515|FG000|Adjuvant Radiotherapy|Progression|1|||
162748674|NCT03174275|587792515|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
162748675|NCT05970861|587792516|FG000|Overall Study|Physician Decision|4|||
162748676|NCT05970861|587792517|FG001|Overall Study|Physician Decision|4|||
162748677|NCT05970861|587792516|FG000|Overall Study|Lost to Follow-up|4|||
162748678|NCT05970861|587792517|FG001|Overall Study|Lost to Follow-up|3|||
162748679|NCT02990338|587792518|FG000|Overall Study|Randomized and not treated|4|||
162748680|NCT02990338|587792519|FG001|Overall Study|Randomized and not treated|2|||
162748681|NCT02990338|587792518|FG000|Overall Study|Adverse Event|23|||
162748682|NCT02990338|587792519|FG001|Overall Study|Adverse Event|22|||
162748683|NCT02990338|587792518|FG000|Overall Study|Progressive disease|118|||
162748684|NCT02990338|587792519|FG001|Overall Study|Progressive disease|107|||
162748685|NCT02990338|587792518|FG000|Overall Study|Poor compliance to protocol|0|||
162748686|NCT02990338|587792519|FG001|Overall Study|Poor compliance to protocol|1|||
162748687|NCT02990338|587792518|FG000|Overall Study|Withdrawal by Subject|6|||
162748688|NCT02990338|587792519|FG001|Overall Study|Withdrawal by Subject|8|||
162748689|NCT02990338|587792518|FG000|Overall Study|Physician's decision|2|||
162748690|NCT02990338|587792519|FG001|Overall Study|Physician's decision|6|||
162748691|NCT02990338|587792518|FG000|Overall Study|Treatment extension study|0|||
162748692|NCT02990338|587792519|FG001|Overall Study|Treatment extension study|6|||
162748693|NCT02990338|587792518|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
162748694|NCT02990338|587792519|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
162748695|NCT02990338|587792518|FG000|Overall Study|Continue with therapy available commercially|0|||
162748696|NCT02990338|587792519|FG001|Overall Study|Continue with therapy available commercially|1|||
162748697|NCT04186819|587792520|FG000|Overall Study|Adverse Event|1|||
162748698|NCT04186819|587792520|FG000|Overall Study|Lost to Follow-up|1|||
162748699|NCT04186819|587792520|FG000|Overall Study|Opted for EBRT|1|||
162748700|NCT04186819|587792520|FG000|Overall Study|Opted SBRT|1|||
162748701|NCT04186819|587792520|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
162748702|NCT04186819|587792520|FG000|Overall Study|Physician Decision|1|||
162748703|NCT04186819|587792520|FG000|Overall Study|RP Delayed|1|||
162748704|NCT04186819|587792520|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
162748705|NCT04186819|587792520|FG000|Overall Study|Subject declined for financial reasons|1|||
162748706|NCT04186819|587792520|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
162748707|NCT04186819|587792520|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
162748708|NCT04186819|587792520|FG000|Overall Study|The subject opted for other treatment option|2|||
162748709|NCT04186819|587792520|FG000|Overall Study|The subject opted for other treatment options|1|||
162748710|NCT04186819|587792520|FG000|Overall Study|Withdrawal by Subject|3|||
162748711|NCT04186819|587792520|FG000|Overall Study|Reason not specified|1|||
162748712|NCT00677365|587792521|FG000|Overall Study|Adverse Event|2|||
162748713|NCT00677365|587792522|FG001|Overall Study|Adverse Event|1|||
162748714|NCT00677365|587792523|FG002|Overall Study|Adverse Event|1|||
162748715|NCT00677365|587792524|FG003|Overall Study|Adverse Event|2|||
162748716|NCT00677365|587792521|FG000|Overall Study|Withdrawal by Subject|0|||
162748717|NCT00677365|587792522|FG001|Overall Study|Withdrawal by Subject|0|||
162748718|NCT00677365|587792523|FG002|Overall Study|Withdrawal by Subject|1|||
162748719|NCT00677365|587792524|FG003|Overall Study|Withdrawal by Subject|0|||
162748720|NCT00677365|587792521|FG000|Overall Study|Other reason|0|||
162748721|NCT00677365|587792522|FG001|Overall Study|Other reason|0|||
162748722|NCT00677365|587792523|FG002|Overall Study|Other reason|0|||
162748723|NCT00677365|587792524|FG003|Overall Study|Other reason|1|||
162748724|NCT05900154|587792525|FG000|Follow-Up Period|Lost to Follow-up|1|||
162748725|NCT05900154|587792526|FG001|Follow-Up Period|Lost to Follow-up|2|||
162748726|NCT05900154|587792527|FG002|Follow-Up Period|Lost to Follow-up|1|||
162748727|NCT05900154|587792528|FG003|Follow-Up Period|Lost to Follow-up|0|||
162748728|NCT05900154|587792529|FG004|Follow-Up Period|Lost to Follow-up|1|||
162748729|NCT05900154|587792530|FG005|Follow-Up Period|Lost to Follow-up|1|||
162748730|NCT04102111|587792539|FG000|Overall Study|Withdrawal by Subject|2|||
162748731|NCT04102111|587792540|FG001|Overall Study|Withdrawal by Subject|3|||
162748732|NCT04102111|587792539|FG000|Overall Study|Adverse Event|1|||
162748733|NCT04102111|587792540|FG001|Overall Study|Adverse Event|1|||
162748734|NCT04102111|587792539|FG000|Overall Study|Study terminated by sponsor|1|||
162748735|NCT04102111|587792540|FG001|Overall Study|Study terminated by sponsor|3|||
162748736|NCT03334695|587792541|FG000|Overall Study|Lost to Follow-up|3|||
162748737|NCT03334695|587792542|FG001|Overall Study|Lost to Follow-up|3|||
162748738|NCT03334695|587792541|FG000|Overall Study|Physician Decision|1|||
162748739|NCT03334695|587792542|FG001|Overall Study|Physician Decision|2|||
162748740|NCT03334695|587792541|FG000|Overall Study|Protocol Violation|0|||
162748741|NCT03334695|587792542|FG001|Overall Study|Protocol Violation|1|||
162748742|NCT02542631|587792543|FG000|Overall Study|Adverse Event|1|||
162748743|NCT02542631|587792544|FG001|Overall Study|Adverse Event|1|||
162748744|NCT02542631|587792543|FG000|Overall Study|Sponsor Termination|1|||
162748745|NCT02542631|587792544|FG001|Overall Study|Sponsor Termination|0|||
162748746|NCT02542631|587792543|FG000|Overall Study|Withdrawal by Subject|11|||
162748747|NCT02542631|587792544|FG001|Overall Study|Withdrawal by Subject|16|||
162748748|NCT02542631|587792543|FG000|Overall Study|Protocol Violation|1|||
162748749|NCT02542631|587792544|FG001|Overall Study|Protocol Violation|1|||
162748750|NCT02542631|587792543|FG000|Overall Study|Physician Decision|6|||
162748751|NCT02542631|587792544|FG001|Overall Study|Physician Decision|4|||
162748752|NCT02542631|587792543|FG000|Overall Study|Lost to Follow-up|6|||
162748753|NCT02542631|587792544|FG001|Overall Study|Lost to Follow-up|5|||
162748754|NCT02542631|587792543|FG000|Overall Study|Death|1|||
162748755|NCT02542631|587792544|FG001|Overall Study|Death|2|||
162748756|NCT02542631|587792543|FG000|Overall Study|Other|2|||
162748757|NCT02542631|587792544|FG001|Overall Study|Other|1|||
162748758|NCT02542631|587792543|FG000|Overall Study|Used Prohibited Medication|2|||
162748759|NCT02542631|587792544|FG001|Overall Study|Used Prohibited Medication|1|||
162748760|NCT02641730|587792545|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
162748761|NCT02641730|587792546|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162748762|NCT02641730|587792547|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162748763|NCT02641730|587792548|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
162748764|NCT02641730|587792549|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
162748765|NCT02641730|587792545|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162748766|NCT02641730|587792546|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
162748767|NCT02641730|587792547|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
162748768|NCT02641730|587792548|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
162748769|NCT02641730|587792549|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
162748770|NCT02641730|587792545|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162748771|NCT02641730|587792546|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
162748772|NCT02641730|587792547|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162748773|NCT02641730|587792548|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
162748774|NCT02641730|587792549|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162748775|NCT02641730|587792545|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162748776|NCT02641730|587792546|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162748777|NCT02641730|587792547|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162748778|NCT02641730|587792548|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
162748779|NCT02641730|587792549|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
162748780|NCT02641730|587792545|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
162748781|NCT02641730|587792546|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
162748782|NCT02641730|587792547|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
162748783|NCT02641730|587792548|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
162748784|NCT02641730|587792549|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
162748785|NCT02641730|587792545|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
162748786|NCT02641730|587792546|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
162748787|NCT02641730|587792547|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
162748788|NCT02641730|587792548|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
162748789|NCT02641730|587792549|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
162748790|NCT05460871|587792550|FG000|Overall Study|Withdrawal by Subject|1|||
162748791|NCT05460871|587792551|FG001|Overall Study|Withdrawal by Subject|2|||
162748792|NCT02938923|587792552|FG000|Overall Study|Death|1|||
162748793|NCT02938923|587792553|FG001|Overall Study|Death|0|||
162748794|NCT02938923|587792554|FG002|Overall Study|Death|0|||
162748795|NCT02938923|587792552|FG000|Overall Study|Physician Decision|0|||
162748796|NCT02938923|587792553|FG001|Overall Study|Physician Decision|2|||
162748797|NCT02938923|587792554|FG002|Overall Study|Physician Decision|0|||
162748798|NCT02938923|587792552|FG000|Overall Study|Withdrawal by Subject|0|||
162748799|NCT02938923|587792553|FG001|Overall Study|Withdrawal by Subject|1|||
162748800|NCT02938923|587792554|FG002|Overall Study|Withdrawal by Subject|1|||
162748801|NCT03663205|587792555|FG000|Overall Study|Death|144|||
162748802|NCT03663205|587792556|FG001|Overall Study|Death|69|||
162748803|NCT03663205|587792555|FG000|Overall Study|Sponsor decision|53|||
162748804|NCT03663205|587792556|FG001|Overall Study|Sponsor decision|19|||
162748805|NCT03663205|587792555|FG000|Overall Study|Withdrawal by Subject|8|||
162748806|NCT03663205|587792556|FG001|Overall Study|Withdrawal by Subject|11|||
162748807|NCT03663205|587792555|FG000|Overall Study|Lost to Follow-up|7|||
162748808|NCT03663205|587792556|FG001|Overall Study|Lost to Follow-up|9|||
162748809|NCT03663205|587792555|FG000|Overall Study|Transferred to long term extension study|11|||
162748810|NCT03663205|587792556|FG001|Overall Study|Transferred to long term extension study|3|||
162748811|NCT02326974|587792557|FG000|Overall Study|Withdrawal by Subject|2|||
162748812|NCT02326974|587792557|FG000|Overall Study|failed heterogenity evaluation|5|||
162748813|NCT04924400|587792558|FG000|Overall Study|Lost to Follow-up|3|||
162748814|NCT04924400|587792559|FG001|Overall Study|Lost to Follow-up|0|||
162748815|NCT04633538|587792562|FG000|Overall Study|Death|1|||
162748816|NCT04633538|587792562|FG000|Overall Study|Lost to Follow-up|3|||
162748817|NCT04633538|587792562|FG000|Overall Study|Withdrawal by Subject|1|||
162748818|NCT03582033|587792563|FG000|Part A|Other|0|||
162748819|NCT03582033|587792564|FG001|Part A|Other|0|||
162748820|NCT03582033|587792565|FG002|Part A|Other|0|||
162748821|NCT03582033|587792566|FG003|Part A|Other|0|||
162748822|NCT03582033|587792567|FG004|Part A|Other|2|||
162748823|NCT03582033|587792568|FG005|Part A|Other|0|||
162748824|NCT03582033|587792569|FG006|Part A|Other|0|||
162748825|NCT03582033|587792570|FG007|Part A|Other|0|||
162748826|NCT03582033|587792571|FG008|Part A|Other|0|||
162748827|NCT03582033|587792572|FG009|Part A|Other|0|||
162748828|NCT03582033|587792563|FG000|Part A|Death|1|||
162748829|NCT03582033|587792564|FG001|Part A|Death|1|||
162748830|NCT03582033|587792565|FG002|Part A|Death|2|||
162748831|NCT03582033|587792566|FG003|Part A|Death|4|||
162748832|NCT03582033|587792567|FG004|Part A|Death|11|||
162748833|NCT03582033|587792568|FG005|Part A|Death|0|||
162748834|NCT03582033|587792569|FG006|Part A|Death|0|||
162748835|NCT03582033|587792570|FG007|Part A|Death|0|||
162748836|NCT03582033|587792571|FG008|Part A|Death|0|||
162748837|NCT03582033|587792572|FG009|Part A|Death|0|||
162748838|NCT03582033|587792563|FG000|Part A|Lost to Follow-up|0|||
162748839|NCT03582033|587792564|FG001|Part A|Lost to Follow-up|0|||
162748840|NCT03582033|587792565|FG002|Part A|Lost to Follow-up|0|||
162748841|NCT03582033|587792566|FG003|Part A|Lost to Follow-up|0|||
162748842|NCT03582033|587792567|FG004|Part A|Lost to Follow-up|1|||
162748843|NCT03582033|587792568|FG005|Part A|Lost to Follow-up|0|||
162748844|NCT03582033|587792569|FG006|Part A|Lost to Follow-up|0|||
162748845|NCT03582033|587792570|FG007|Part A|Lost to Follow-up|0|||
162748846|NCT03582033|587792571|FG008|Part A|Lost to Follow-up|0|||
162748847|NCT03582033|587792572|FG009|Part A|Lost to Follow-up|0|||
162748848|NCT03582033|587792563|FG000|Part A|Study terminated by sponsor|0|||
162748849|NCT03582033|587792564|FG001|Part A|Study terminated by sponsor|0|||
162748850|NCT03582033|587792565|FG002|Part A|Study terminated by sponsor|0|||
162748851|NCT03582033|587792566|FG003|Part A|Study terminated by sponsor|2|||
162748852|NCT03582033|587792567|FG004|Part A|Study terminated by sponsor|1|||
162748853|NCT03582033|587792568|FG005|Part A|Study terminated by sponsor|0|||
162748854|NCT03582033|587792569|FG006|Part A|Study terminated by sponsor|0|||
162748855|NCT03582033|587792570|FG007|Part A|Study terminated by sponsor|0|||
162748856|NCT03582033|587792571|FG008|Part A|Study terminated by sponsor|0|||
162748857|NCT03582033|587792572|FG009|Part A|Study terminated by sponsor|0|||
162748858|NCT03582033|587792563|FG000|Part A|Withdrawal by Subject|1|||
162748859|NCT03582033|587792564|FG001|Part A|Withdrawal by Subject|1|||
162748860|NCT03582033|587792565|FG002|Part A|Withdrawal by Subject|0|||
162748861|NCT03582033|587792566|FG003|Part A|Withdrawal by Subject|1|||
162748862|NCT03582033|587792567|FG004|Part A|Withdrawal by Subject|7|||
162748863|NCT03582033|587792568|FG005|Part A|Withdrawal by Subject|0|||
162748864|NCT03582033|587792569|FG006|Part A|Withdrawal by Subject|0|||
162748865|NCT03582033|587792570|FG007|Part A|Withdrawal by Subject|0|||
162748866|NCT03582033|587792571|FG008|Part A|Withdrawal by Subject|0|||
162748867|NCT03582033|587792572|FG009|Part A|Withdrawal by Subject|0|||
162748868|NCT03582033|587792563|FG000|Part B|Death|0|||
162748869|NCT03582033|587792564|FG001|Part B|Death|0|||
162748870|NCT03582033|587792565|FG002|Part B|Death|0|||
162748871|NCT03582033|587792566|FG003|Part B|Death|0|||
162748872|NCT03582033|587792567|FG004|Part B|Death|0|||
162748873|NCT03582033|587792568|FG005|Part B|Death|2|||
162748874|NCT03582033|587792569|FG006|Part B|Death|0|||
162748875|NCT03582033|587792570|FG007|Part B|Death|0|||
162748876|NCT03582033|587792571|FG008|Part B|Death|0|||
162748877|NCT03582033|587792572|FG009|Part B|Death|0|||
162748878|NCT03582033|587792563|FG000|Part B|Study terminated by sponsor|0|||
162748879|NCT03582033|587792564|FG001|Part B|Study terminated by sponsor|0|||
162748880|NCT03582033|587792565|FG002|Part B|Study terminated by sponsor|0|||
162748881|NCT03582033|587792566|FG003|Part B|Study terminated by sponsor|0|||
162748882|NCT03582033|587792567|FG004|Part B|Study terminated by sponsor|0|||
162748883|NCT03582033|587792568|FG005|Part B|Study terminated by sponsor|12|||
162748884|NCT03582033|587792569|FG006|Part B|Study terminated by sponsor|0|||
162748885|NCT03582033|587792570|FG007|Part B|Study terminated by sponsor|0|||
162748886|NCT03582033|587792571|FG008|Part B|Study terminated by sponsor|0|||
162748887|NCT03582033|587792572|FG009|Part B|Study terminated by sponsor|0|||
162748888|NCT03582033|587792563|FG000|Part B|Withdrawal by Subject|0|||
162748889|NCT03582033|587792564|FG001|Part B|Withdrawal by Subject|0|||
162748890|NCT03582033|587792565|FG002|Part B|Withdrawal by Subject|0|||
162748891|NCT03582033|587792566|FG003|Part B|Withdrawal by Subject|0|||
162748892|NCT03582033|587792567|FG004|Part B|Withdrawal by Subject|0|||
162748893|NCT03582033|587792568|FG005|Part B|Withdrawal by Subject|6|||
162748894|NCT03582033|587792569|FG006|Part B|Withdrawal by Subject|0|||
162748895|NCT03582033|587792570|FG007|Part B|Withdrawal by Subject|0|||
162748896|NCT03582033|587792571|FG008|Part B|Withdrawal by Subject|0|||
162748897|NCT03582033|587792572|FG009|Part B|Withdrawal by Subject|0|||
162748898|NCT03582033|587792563|FG000|Part C|Other|0|||
162748899|NCT03582033|587792564|FG001|Part C|Other|0|||
162748900|NCT03582033|587792565|FG002|Part C|Other|0|||
162748901|NCT03582033|587792566|FG003|Part C|Other|0|||
162748902|NCT03582033|587792567|FG004|Part C|Other|0|||
162748903|NCT03582033|587792568|FG005|Part C|Other|0|||
162748904|NCT03582033|587792569|FG006|Part C|Other|2|||
162748905|NCT03582033|587792570|FG007|Part C|Other|0|||
162748906|NCT03582033|587792571|FG008|Part C|Other|0|||
162748907|NCT03582033|587792572|FG009|Part C|Other|0|||
162748908|NCT03582033|587792563|FG000|Part C|Death|0|||
162748909|NCT03582033|587792564|FG001|Part C|Death|0|||
162748910|NCT03582033|587792565|FG002|Part C|Death|0|||
162748911|NCT03582033|587792566|FG003|Part C|Death|0|||
162748912|NCT03582033|587792567|FG004|Part C|Death|0|||
162748913|NCT03582033|587792568|FG005|Part C|Death|0|||
162748914|NCT03582033|587792569|FG006|Part C|Death|6|||
162748915|NCT03582033|587792570|FG007|Part C|Death|1|||
162748916|NCT03582033|587792571|FG008|Part C|Death|2|||
162748917|NCT03582033|587792572|FG009|Part C|Death|0|||
162748918|NCT03582033|587792563|FG000|Part C|Study terminated by sponsor|0|||
162748919|NCT03582033|587792564|FG001|Part C|Study terminated by sponsor|0|||
162748920|NCT03582033|587792565|FG002|Part C|Study terminated by sponsor|0|||
162748921|NCT03582033|587792566|FG003|Part C|Study terminated by sponsor|0|||
162748922|NCT03582033|587792567|FG004|Part C|Study terminated by sponsor|0|||
162748923|NCT03582033|587792568|FG005|Part C|Study terminated by sponsor|0|||
162748924|NCT03582033|587792569|FG006|Part C|Study terminated by sponsor|3|||
162748925|NCT03582033|587792570|FG007|Part C|Study terminated by sponsor|3|||
162748926|NCT03582033|587792571|FG008|Part C|Study terminated by sponsor|2|||
162748927|NCT03582033|587792572|FG009|Part C|Study terminated by sponsor|0|||
162748928|NCT03582033|587792563|FG000|Part C|Withdrawal by Subject|0|||
162748929|NCT03582033|587792564|FG001|Part C|Withdrawal by Subject|0|||
162748930|NCT03582033|587792565|FG002|Part C|Withdrawal by Subject|0|||
162748931|NCT03582033|587792566|FG003|Part C|Withdrawal by Subject|0|||
162748932|NCT03582033|587792567|FG004|Part C|Withdrawal by Subject|0|||
162748933|NCT03582033|587792568|FG005|Part C|Withdrawal by Subject|0|||
162748934|NCT03582033|587792569|FG006|Part C|Withdrawal by Subject|1|||
162748935|NCT03582033|587792570|FG007|Part C|Withdrawal by Subject|2|||
162748936|NCT03582033|587792571|FG008|Part C|Withdrawal by Subject|1|||
162748937|NCT03582033|587792572|FG009|Part C|Withdrawal by Subject|0|||
162748938|NCT03582033|587792563|FG000|Part D|Death|0|||
162748939|NCT03582033|587792564|FG001|Part D|Death|0|||
162748940|NCT03582033|587792565|FG002|Part D|Death|0|||
162748941|NCT03582033|587792566|FG003|Part D|Death|0|||
162748942|NCT03582033|587792567|FG004|Part D|Death|0|||
162748943|NCT03582033|587792568|FG005|Part D|Death|0|||
162748944|NCT03582033|587792569|FG006|Part D|Death|0|||
162748945|NCT03582033|587792570|FG007|Part D|Death|0|||
162748946|NCT03582033|587792571|FG008|Part D|Death|0|||
162748947|NCT03582033|587792572|FG009|Part D|Death|1|||
162748948|NCT03582033|587792563|FG000|Part D|Study terminated by sponsor|0|||
162748949|NCT03582033|587792564|FG001|Part D|Study terminated by sponsor|0|||
162748950|NCT03582033|587792565|FG002|Part D|Study terminated by sponsor|0|||
162748951|NCT03582033|587792566|FG003|Part D|Study terminated by sponsor|0|||
162748952|NCT03582033|587792567|FG004|Part D|Study terminated by sponsor|0|||
162748953|NCT03582033|587792568|FG005|Part D|Study terminated by sponsor|0|||
162748954|NCT03582033|587792569|FG006|Part D|Study terminated by sponsor|0|||
162748955|NCT03582033|587792570|FG007|Part D|Study terminated by sponsor|0|||
162748956|NCT03582033|587792571|FG008|Part D|Study terminated by sponsor|0|||
162748957|NCT03582033|587792572|FG009|Part D|Study terminated by sponsor|4|||
162748958|NCT06010836|587792573|FG000|Overall Study|Lost to Follow-up|2|||
162748959|NCT06010836|587792574|FG001|Overall Study|Lost to Follow-up|2|||
162748960|NCT06010836|587792573|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
162748961|NCT06010836|587792574|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
162748962|NCT06010836|587792573|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
162748963|NCT06010836|587792574|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
162748964|NCT06010836|587792573|FG000|Overall Study|Did not receive intervention discussion|0|||
162748965|NCT06010836|587792574|FG001|Overall Study|Did not receive intervention discussion|4|||
162748966|NCT04505410|587792578|FG000|Overall Study|Adverse Event|2|||
162748967|NCT04505410|587792579|FG001|Overall Study|Adverse Event|0|||
162748968|NCT04505410|587792578|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
162748969|NCT04505410|587792579|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
162748970|NCT04505410|587792578|FG000|Overall Study|did not want to follow diet|1|||
162748971|NCT04505410|587792579|FG001|Overall Study|did not want to follow diet|0|||
162748972|NCT04505410|587792578|FG000|Overall Study|flare up of ulcerative colitis|0|||
162748973|NCT04505410|587792579|FG001|Overall Study|flare up of ulcerative colitis|1|||
162748974|NCT04505410|587792578|FG000|Overall Study|Lost to Follow-up|0|||
162748975|NCT04505410|587792579|FG001|Overall Study|Lost to Follow-up|2|||
162748976|NCT04505410|587792578|FG000|Overall Study|Lost to Follow-up|1|||
162748977|NCT04505410|587792579|FG001|Overall Study|Lost to Follow-up|0|||
162748978|NCT04505410|587792578|FG000|Overall Study|initiated another diet on their own|0|||
162748979|NCT04505410|587792579|FG001|Overall Study|initiated another diet on their own|2|||
162748980|NCT05654662|587792580|FG000|Overall Study|Withdrawal by Subject|1|||
162748981|NCT05654662|587792581|FG001|Overall Study|Withdrawal by Subject|0|||
162748982|NCT05654662|587792580|FG000|Overall Study|A death in the family|1|||
162748983|NCT05654662|587792581|FG001|Overall Study|A death in the family|0|||
162748984|NCT05962814|587792582|FG000|Overall Study|failed eligibility|1|||
162748985|NCT03057054|587792583|FG000|Overall Study|Death|4|||
162748986|NCT03057054|587792584|FG001|Overall Study|Death|4|||
162748987|NCT03057054|587792583|FG000|Overall Study|Withdrawal by Subject|6|||
162748988|NCT03057054|587792584|FG001|Overall Study|Withdrawal by Subject|3|||
162748989|NCT03057054|587792583|FG000|Overall Study|Ineligible|1|||
162748990|NCT03057054|587792584|FG001|Overall Study|Ineligible|1|||
162748991|NCT04427007|587793944|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
162748992|NCT04427007|587793945|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
162748993|NCT05311176|587793948|FG000|Overall Study|Death|6|||
162748994|NCT05311176|587793948|FG000|Overall Study|Sponsor discontinued the study|1|||
162748995|NCT05247034|587793949|FG000|Overall Study|Lost to Follow-up|3|||
162748996|NCT05247034|587793950|FG001|Overall Study|Lost to Follow-up|2|||
162748997|NCT05247034|587793949|FG000|Overall Study|Organizational problems when attending appointments|1|||
162748998|NCT05247034|587793950|FG001|Overall Study|Organizational problems when attending appointments|0|||
162748999|NCT03972150|587793953|FG000|Overall Study|Adverse Event|0|||
162749000|NCT03972150|587793954|FG001|Overall Study|Adverse Event|1|||
162749001|NCT03972150|587793955|FG002|Overall Study|Adverse Event|1|||
162749002|NCT03972150|587793956|FG003|Overall Study|Adverse Event|0|||
162749003|NCT03972150|587793957|FG004|Overall Study|Adverse Event|0|||
162749004|NCT03972150|587793953|FG000|Overall Study|Progressive disease|3|||
162749005|NCT03972150|587793954|FG001|Overall Study|Progressive disease|5|||
162749006|NCT03972150|587793955|FG002|Overall Study|Progressive disease|2|||
162749007|NCT03972150|587793956|FG003|Overall Study|Progressive disease|2|||
162749008|NCT03972150|587793957|FG004|Overall Study|Progressive disease|3|||
162749009|NCT02668692|587793958|FG000|Overall Study|Adverse Event|1|||
162749010|NCT02668692|587793959|FG001|Overall Study|Adverse Event|0|||
162749011|NCT03442309|587793961|FG000|Overall Study|Lost to Follow-up|1676|||
162749012|NCT03442309|587793962|FG001|Overall Study|Lost to Follow-up|1642|||
162749013|NCT04615273|587793968|FG000|Overall Study|Withdrawal by Subject|3|||
162749014|NCT04615273|587793969|FG001|Overall Study|Withdrawal by Subject|1|||
162749015|NCT04615273|587793970|FG002|Overall Study|Withdrawal by Subject|2|||
162749016|NCT04615273|587793968|FG000|Overall Study|Adverse Event|1|||
162749017|NCT04615273|587793969|FG001|Overall Study|Adverse Event|0|||
162749018|NCT04615273|587793970|FG002|Overall Study|Adverse Event|1|||
162749019|NCT04615273|587793968|FG000|Overall Study|Lost to Follow-up|0|||
162749020|NCT04615273|587793969|FG001|Overall Study|Lost to Follow-up|1|||
162749021|NCT04615273|587793970|FG002|Overall Study|Lost to Follow-up|0|||
162749022|NCT04615273|587793968|FG000|Overall Study|Physician Decision|0|||
162749023|NCT04615273|587793969|FG001|Overall Study|Physician Decision|0|||
162749024|NCT04615273|587793970|FG002|Overall Study|Physician Decision|1|||
162749025|NCT04615273|587793968|FG000|Overall Study|Other|0|||
162749026|NCT04615273|587793969|FG001|Overall Study|Other|1|||
162749027|NCT04615273|587793970|FG002|Overall Study|Other|0|||
162749028|NCT04615273|587793968|FG000|Overall Study|Randomized but not treated|1|||
162749029|NCT04615273|587793969|FG001|Overall Study|Randomized but not treated|3|||
162749030|NCT04615273|587793970|FG002|Overall Study|Randomized but not treated|1|||
162749031|NCT01314105|587793973|FG000|Overall Study|Progressive Disease|6|||
162749032|NCT01314105|587793974|FG001|Overall Study|Progressive Disease|10|||
162749033|NCT01314105|587793973|FG000|Overall Study|Refused to continue taking medication|0|||
162749034|NCT01314105|587793974|FG001|Overall Study|Refused to continue taking medication|1|||
162749035|NCT01314105|587793973|FG000|Overall Study|Other Adverse Event|1|||
162749036|NCT01314105|587793974|FG001|Overall Study|Other Adverse Event|1|||
162749037|NCT06106022|587793975|FG000|Overall Study|Lost to Follow-up|1|||
162749038|NCT06106022|587793976|FG001|Overall Study|Lost to Follow-up|0|||
162749039|NCT06106022|587793975|FG000|Overall Study|Voluntary Withdrawal|0|||
162749040|NCT06106022|587793976|FG001|Overall Study|Voluntary Withdrawal|2|||
162749041|NCT03640286|587793981|FG000|Overall Study|Adverse Event|6|||
162749042|NCT03640286|587793982|FG001|Overall Study|Adverse Event|6|||
162749043|NCT03640286|587793981|FG000|Overall Study|Lost to Follow-up|3|||
162749044|NCT03640286|587793982|FG001|Overall Study|Lost to Follow-up|6|||
162749045|NCT03640286|587793981|FG000|Overall Study|Pregnancy|1|||
162749046|NCT03640286|587793982|FG001|Overall Study|Pregnancy|0|||
162749047|NCT03640286|587793981|FG000|Overall Study|Withdrawal by Subject|10|||
162749048|NCT03640286|587793982|FG001|Overall Study|Withdrawal by Subject|10|||
162749049|NCT03640286|587793981|FG000|Overall Study|Non-compliance|4|||
162749050|NCT03640286|587793982|FG001|Overall Study|Non-compliance|10|||
162749051|NCT03640286|587793981|FG000|Overall Study|Medication change|1|||
162749052|NCT03640286|587793982|FG001|Overall Study|Medication change|0|||
162749053|NCT03640286|587793981|FG000|Overall Study|Other|1|||
162749054|NCT03640286|587793982|FG001|Overall Study|Other|2|||
162749055|NCT03640286|587793981|FG000|Overall Study|Joined another lifestyle program|0|||
162749056|NCT03640286|587793982|FG001|Overall Study|Joined another lifestyle program|1|||
162749057|NCT05524116|587793983|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
162749058|NCT05524116|587793984|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
162749059|NCT05524116|587793983|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
162749060|NCT05524116|587793984|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
162749061|NCT05524116|587793983|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
162749062|NCT05524116|587793984|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
162749063|NCT05524116|587793983|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
162749064|NCT05524116|587793984|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
162749065|NCT05524116|587793983|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
162749066|NCT05524116|587793984|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
162749067|NCT03181516|587793993|FG000|Overall Study|Withdrawal by Subject|14|||
162749068|NCT03181516|587793994|FG001|Overall Study|Withdrawal by Subject|7|||
162749069|NCT03181516|587793993|FG000|Overall Study|Lost to Follow-up|2|||
162749070|NCT03181516|587793994|FG001|Overall Study|Lost to Follow-up|2|||
162749071|NCT04544007|587794000|FG000|Overall Study|Withdrawal by Subject|1|||
162749072|NCT04544007|587794000|FG000|Overall Study|Confirmed Progressive Disease|1|||
162749073|NCT05405985|587794006|FG000|Overall Study|Withdrawal by Subject|1|||
162749074|NCT05405985|587794007|FG001|Overall Study|Withdrawal by Subject|0|||
162749075|NCT01820611|587794018|FG000|Overall Study|Death|8|||
162749076|NCT01820611|587794018|FG000|Overall Study|Adverse Event|1|||
162749077|NCT01820611|587794018|FG000|Overall Study|Withdrawal by Subject|9|||
162749078|NCT03484819|587794019|FG000|Overall Study|Death|2|||
162749079|NCT03484819|587794019|FG000|Overall Study|Adverse Event|2|||
162749080|NCT03484819|587794019|FG000|Overall Study|Physician Decision|1|||
162749081|NCT03484819|587794019|FG000|Overall Study|Withdrawal by Subject|2|||
162749082|NCT03484819|587794019|FG000|Overall Study|Disease Progression|4|||
162749083|NCT03484819|587794019|FG000|Overall Study|Complicating Condition|1|||
162749084|NCT03015532|587794020|FG000|Overall Study|Adverse Event|0|||
162749085|NCT03015532|587794021|FG001|Overall Study|Adverse Event|0|||
162749086|NCT03015532|587794022|FG002|Overall Study|Adverse Event|0|||
162749087|NCT03015532|587794023|FG003|Overall Study|Adverse Event|0|||
162749088|NCT03015532|587794024|FG004|Overall Study|Adverse Event|0|||
162749089|NCT03015532|587794025|FG005|Overall Study|Adverse Event|2|||
162749090|NCT03015532|587794026|FG006|Overall Study|Adverse Event|1|||
162749091|NCT03015532|587794027|FG007|Overall Study|Adverse Event|0|||
162749092|NCT03015532|587794020|FG000|Overall Study|Withdrawal by Subject|0|||
162749093|NCT03015532|587794021|FG001|Overall Study|Withdrawal by Subject|0|||
162749094|NCT03015532|587794022|FG002|Overall Study|Withdrawal by Subject|0|||
162749095|NCT03015532|587794023|FG003|Overall Study|Withdrawal by Subject|0|||
162749096|NCT03015532|587794024|FG004|Overall Study|Withdrawal by Subject|0|||
162749097|NCT03015532|587794025|FG005|Overall Study|Withdrawal by Subject|0|||
162749098|NCT03015532|587794026|FG006|Overall Study|Withdrawal by Subject|1|||
162749099|NCT03015532|587794027|FG007|Overall Study|Withdrawal by Subject|0|||
162749100|NCT05013385|587794032|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
162749101|NCT01447719|587794033|FG000|Overall Study|Image acquisition failure|2|||
162749102|NCT01447719|587794033|FG000|Overall Study|Invalid image or not imaged|3|||
162749103|NCT01447719|587794033|FG000|Overall Study|Subject still living at end of study|79|||
162749104|NCT01447719|587794033|FG000|Overall Study|Withdrawal by Subject|2|||
162749105|NCT01447719|587794033|FG000|Overall Study|Family withdrew autopsy consent|7|||
162749106|NCT03252288|587794034|FG000|Overall Study|Death|1|||
162749107|NCT03252288|587794035|FG001|Overall Study|Death|0|||
162749108|NCT03252288|587794036|FG002|Overall Study|Death|0|||
162749109|NCT03252288|587794034|FG000|Overall Study|Death|11|||
162749110|NCT03252288|587794035|FG001|Overall Study|Death|0|||
162749111|NCT03252288|587794036|FG002|Overall Study|Death|0|||
162749112|NCT03252288|587794034|FG000|Overall Study|Withdrawal by Subject|2|||
162749113|NCT03252288|587794035|FG001|Overall Study|Withdrawal by Subject|0|||
162749114|NCT03252288|587794036|FG002|Overall Study|Withdrawal by Subject|0|||
162749115|NCT03252288|587794034|FG000|Overall Study|Lost to Follow-up|79|||
162749116|NCT03252288|587794035|FG001|Overall Study|Lost to Follow-up|0|||
162749117|NCT03252288|587794036|FG002|Overall Study|Lost to Follow-up|0|||
162749118|NCT03252288|587794034|FG000|Overall Study|Loss of baseline data on tablets|6|||
162749119|NCT03252288|587794035|FG001|Overall Study|Loss of baseline data on tablets|0|||
162749120|NCT03252288|587794036|FG002|Overall Study|Loss of baseline data on tablets|0|||
162749121|NCT02944968|587794037|FG000|Overall Study|Subject excluded before study procedure|1|||
162749122|NCT02944968|587794037|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
162749123|NCT03812614|587794043|FG000|Intervention|Withdrawal by Subject|7|||
162749124|NCT03812614|587794044|FG001|Intervention|Withdrawal by Subject|2|||
162749125|NCT03812614|587794045|FG002|Intervention|Withdrawal by Subject|7|||
162749126|NCT03812614|587794046|FG003|Intervention|Withdrawal by Subject|2|||
162749127|NCT03812614|587794043|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
162749128|NCT03812614|587794044|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
162749129|NCT03812614|587794045|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
162749130|NCT03812614|587794046|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
162749131|NCT03812614|587794043|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
162749132|NCT03812614|587794044|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
162749133|NCT03812614|587794045|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
162749134|NCT03812614|587794046|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
162749135|NCT03812614|587794043|FG000|6-month Follow-up|Lost to Follow-up|0|||
162749136|NCT03812614|587794044|FG001|6-month Follow-up|Lost to Follow-up|0|||
162749137|NCT03812614|587794045|FG002|6-month Follow-up|Lost to Follow-up|12|||
162749138|NCT03812614|587794046|FG003|6-month Follow-up|Lost to Follow-up|8|||
162749139|NCT03812614|587794043|FG000|12-month Follow-up|Lost to Follow-up|18|||
162749140|NCT03812614|587794044|FG001|12-month Follow-up|Lost to Follow-up|17|||
162749141|NCT03812614|587794045|FG002|12-month Follow-up|Lost to Follow-up|5|||
162749142|NCT03812614|587794046|FG003|12-month Follow-up|Lost to Follow-up|2|||
162749143|NCT05451693|587794048|FG000|Overall Study|Withdrawal by Subject|1|||
162749144|NCT05451693|587794049|FG001|Overall Study|Withdrawal by Subject|1|||
162749145|NCT03372057|587794060|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
162749146|NCT03372057|587794061|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
162749147|NCT03372057|587794062|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
162749148|NCT03372057|587794060|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
162749149|NCT03372057|587794061|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
162749150|NCT03372057|587794062|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
162749151|NCT03372057|587794060|FG000|Dose Optimization Phase|Death|16|||
162749152|NCT03372057|587794061|FG001|Dose Optimization Phase|Death|11|||
162749153|NCT03372057|587794062|FG002|Dose Optimization Phase|Death|0|||
162749154|NCT03372057|587794060|FG000|Expansion Phase|Withdrawal by Subject|0|||
162749155|NCT03372057|587794061|FG001|Expansion Phase|Withdrawal by Subject|0|||
162749156|NCT03372057|587794062|FG002|Expansion Phase|Withdrawal by Subject|4|||
162749157|NCT03372057|587794060|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
162749158|NCT03372057|587794061|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
162749159|NCT03372057|587794062|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
162749160|NCT03372057|587794060|FG000|Expansion Phase|Death|0|||
162749161|NCT03372057|587794061|FG001|Expansion Phase|Death|0|||
162749162|NCT03372057|587794062|FG002|Expansion Phase|Death|78|||
162749163|NCT03372057|587794060|FG000|Expansion Phase|Progressive Disease|0|||
162749164|NCT03372057|587794061|FG001|Expansion Phase|Progressive Disease|0|||
162749165|NCT03372057|587794062|FG002|Expansion Phase|Progressive Disease|1|||
162749166|NCT03372057|587794060|FG000|Expansion Phase|Adverse Event|0|||
162749167|NCT03372057|587794061|FG001|Expansion Phase|Adverse Event|0|||
162749168|NCT03372057|587794062|FG002|Expansion Phase|Adverse Event|1|||
162749169|NCT02518048|587794063|FG000|Overall Study|Withdrawal by Subject|1|||
162749170|NCT05890105|587794064|FG000|Overall Study|Adverse Event|1|||
162749171|NCT05890105|587794065|FG001|Overall Study|Adverse Event|0|||
162749172|NCT05890105|587794066|FG002|Overall Study|Adverse Event|0|||
162749173|NCT05890105|587794064|FG000|Overall Study|Other|1|||
162749174|NCT05890105|587794065|FG001|Overall Study|Other|2|||
162749175|NCT05890105|587794066|FG002|Overall Study|Other|0|||
162749176|NCT05123027|587794068|FG000|Overall Study|Lost to Follow-up|17|||
162749177|NCT05123027|587794069|FG001|Overall Study|Lost to Follow-up|22|||
162749178|NCT05123027|587794068|FG000|Overall Study|Incarceration|3|||
162749179|NCT05123027|587794069|FG001|Overall Study|Incarceration|4|||
162749180|NCT05123027|587794068|FG000|Overall Study|Death|2|||
162749181|NCT05123027|587794069|FG001|Overall Study|Death|2|||
162749182|NCT05123027|587794068|FG000|Overall Study|Other|2|||
162749183|NCT05123027|587794069|FG001|Overall Study|Other|0|||
162749184|NCT04330040|587794070|FG000|Overall Study|Other: Adverse event|5|||
162749185|NCT04330040|587794071|FG001|Overall Study|Other: Adverse event|0|||
162749186|NCT04330040|587794072|FG002|Overall Study|Other: Adverse event|0|||
162749187|NCT04330040|587794070|FG000|Overall Study|Disease progression|38|||
162749188|NCT04330040|587794071|FG001|Overall Study|Disease progression|10|||
162749189|NCT04330040|587794072|FG002|Overall Study|Disease progression|0|||
162749190|NCT04330040|587794070|FG000|Overall Study|Physician Decision|5|||
162749191|NCT04330040|587794071|FG001|Overall Study|Physician Decision|3|||
162749192|NCT04330040|587794072|FG002|Overall Study|Physician Decision|0|||
162749193|NCT04330040|587794070|FG000|Overall Study|Lost to Follow-up|1|||
162749194|NCT04330040|587794071|FG001|Overall Study|Lost to Follow-up|1|||
162749195|NCT04330040|587794072|FG002|Overall Study|Lost to Follow-up|0|||
162749196|NCT04330040|587794070|FG000|Overall Study|Death|2|||
162749197|NCT04330040|587794071|FG001|Overall Study|Death|1|||
162749198|NCT04330040|587794072|FG002|Overall Study|Death|0|||
162749199|NCT04330040|587794070|FG000|Overall Study|Withdrawal by Subject|3|||
162749200|NCT04330040|587794071|FG001|Overall Study|Withdrawal by Subject|3|||
162749201|NCT04330040|587794072|FG002|Overall Study|Withdrawal by Subject|0|||
162749202|NCT04330040|587794070|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
162749203|NCT04330040|587794071|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
162749204|NCT04330040|587794072|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
162749205|NCT04330040|587794070|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
162749206|NCT04330040|587794071|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
162749207|NCT04330040|587794072|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
162749208|NCT04330040|587794070|FG000|Overall Study|Other: Disease progression|1|||
162749209|NCT04330040|587794071|FG001|Overall Study|Other: Disease progression|0|||
162749210|NCT04330040|587794072|FG002|Overall Study|Other: Disease progression|0|||
162749211|NCT04330040|587794070|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
162749212|NCT04330040|587794071|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
162749213|NCT04330040|587794072|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
162749214|NCT04330040|587794070|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
162749215|NCT04330040|587794071|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
162749216|NCT04330040|587794072|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
162749217|NCT04330040|587794070|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
162749218|NCT04330040|587794071|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
162749219|NCT04330040|587794072|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
162749220|NCT05464069|587795303|FG000|Overall Study|Protocol Violation|3|||
162749221|NCT05464069|587795304|FG001|Overall Study|Protocol Violation|2|||
162749222|NCT04389957|587795307|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
162749223|NCT04389957|587795308|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
162749224|NCT04389957|587795309|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
162749225|NCT04389957|587795310|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
162749226|NCT04389957|587795311|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
162749227|NCT02905331|587795313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
162749228|NCT02905331|587795314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
162749229|NCT02905331|587795315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
162749230|NCT02905331|587795313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
162749231|NCT02905331|587795314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
162749232|NCT02905331|587795315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
162749233|NCT02905331|587795313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
162749234|NCT02905331|587795314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
162749235|NCT02905331|587795315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
162749236|NCT02905331|587795313|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
162749237|NCT02905331|587795314|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
162749238|NCT02905331|587795315|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
162749239|NCT02905331|587795313|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
162749240|NCT02905331|587795314|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
162749241|NCT02905331|587795315|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
162749242|NCT02874742|587795317|FG000|Overall Study|Death|0|||
162749243|NCT02874742|587795318|FG001|Overall Study|Death|1|||
162749244|NCT02874742|587795319|FG002|Overall Study|Death|0|||
162749245|NCT02874742|587795317|FG000|Overall Study|Lost to Follow-up|5|||
162749246|NCT02874742|587795318|FG001|Overall Study|Lost to Follow-up|4|||
162749247|NCT02874742|587795319|FG002|Overall Study|Lost to Follow-up|1|||
162749248|NCT02874742|587795317|FG000|Overall Study|Withdrawal by Subject|17|||
162749249|NCT02874742|587795318|FG001|Overall Study|Withdrawal by Subject|8|||
162749250|NCT02874742|587795319|FG002|Overall Study|Withdrawal by Subject|0|||
162749251|NCT02874742|587795317|FG000|Overall Study|Other|4|||
162749252|NCT02874742|587795318|FG001|Overall Study|Other|1|||
162749253|NCT02874742|587795319|FG002|Overall Study|Other|0|||
162749254|NCT02874742|587795317|FG000|Overall Study|Progressive Disease|1|||
162749255|NCT02874742|587795318|FG001|Overall Study|Progressive Disease|0|||
162749256|NCT02874742|587795319|FG002|Overall Study|Progressive Disease|0|||
162749257|NCT02874742|587795317|FG000|Overall Study|Screen Failure|0|||
162749258|NCT02874742|587795318|FG001|Overall Study|Screen Failure|2|||
162749259|NCT02874742|587795319|FG002|Overall Study|Screen Failure|0|||
162749260|NCT03691298|587795322|FG000|Overall Study|Lost to Follow-up|8|||
162749261|NCT03691298|587795322|FG000|Overall Study|Sponsor terminated study|2|||
162749262|NCT04424316|587795325|FG000|Overall Study|Adverse Event|0|||
162749263|NCT04424316|587795326|FG001|Overall Study|Adverse Event|1|||
162749264|NCT04424316|587795327|FG002|Overall Study|Adverse Event|0|||
162749265|NCT04424316|587795328|FG003|Overall Study|Adverse Event|0|||
162749266|NCT04424316|587795325|FG000|Overall Study|Death|1|||
162749267|NCT04424316|587795326|FG001|Overall Study|Death|0|||
162749268|NCT04424316|587795327|FG002|Overall Study|Death|8|||
162749269|NCT04424316|587795328|FG003|Overall Study|Death|14|||
162749270|NCT04424316|587795325|FG000|Overall Study|Lost to Follow-up|93|||
162749271|NCT04424316|587795326|FG001|Overall Study|Lost to Follow-up|88|||
162749272|NCT04424316|587795327|FG002|Overall Study|Lost to Follow-up|224|||
162749273|NCT04424316|587795328|FG003|Overall Study|Lost to Follow-up|211|||
162749274|NCT04424316|587795325|FG000|Overall Study|No longer met eligibility criteria|1|||
162749275|NCT04424316|587795326|FG001|Overall Study|No longer met eligibility criteria|0|||
162749276|NCT04424316|587795327|FG002|Overall Study|No longer met eligibility criteria|0|||
162749277|NCT04424316|587795328|FG003|Overall Study|No longer met eligibility criteria|0|||
162749278|NCT04424316|587795325|FG000|Overall Study|Other|15|||
162749279|NCT04424316|587795326|FG001|Overall Study|Other|11|||
162749280|NCT04424316|587795327|FG002|Overall Study|Other|34|||
162749281|NCT04424316|587795328|FG003|Overall Study|Other|45|||
162749282|NCT04424316|587795325|FG000|Overall Study|Physician Decision|1|||
162749283|NCT04424316|587795326|FG001|Overall Study|Physician Decision|0|||
162749284|NCT04424316|587795327|FG002|Overall Study|Physician Decision|1|||
162749285|NCT04424316|587795328|FG003|Overall Study|Physician Decision|1|||
162749286|NCT04424316|587795325|FG000|Overall Study|Protocol Violation|0|||
162749287|NCT04424316|587795326|FG001|Overall Study|Protocol Violation|1|||
162749288|NCT04424316|587795327|FG002|Overall Study|Protocol Violation|0|||
162749289|NCT04424316|587795328|FG003|Overall Study|Protocol Violation|0|||
162749290|NCT04424316|587795325|FG000|Overall Study|Withdrawal by Subject|71|||
162749291|NCT04424316|587795326|FG001|Overall Study|Withdrawal by Subject|77|||
162749292|NCT04424316|587795327|FG002|Overall Study|Withdrawal by Subject|0|||
162749293|NCT04424316|587795328|FG003|Overall Study|Withdrawal by Subject|0|||
162749294|NCT04424316|587795325|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162749295|NCT04424316|587795326|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162749296|NCT04424316|587795327|FG002|Overall Study|Withdrawal by parent/guardian|74|||
162749297|NCT04424316|587795328|FG003|Overall Study|Withdrawal by parent/guardian|81|||
162749298|NCT04424316|587795325|FG000|Overall Study|Randomized but not vaccinated|13|||
162749299|NCT04424316|587795326|FG001|Overall Study|Randomized but not vaccinated|21|||
162749300|NCT04424316|587795327|FG002|Overall Study|Randomized but not vaccinated|0|||
162749301|NCT04424316|587795328|FG003|Overall Study|Randomized but not vaccinated|0|||
162749302|NCT04424316|587795325|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
162749303|NCT04424316|587795326|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
162749304|NCT04424316|587795327|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
162749305|NCT04424316|587795328|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
162749306|NCT05070741|587795329|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
162749307|NCT03245840|587795330|FG000|Overall Study|Adverse Event|6|||
162749308|NCT03245840|587795331|FG001|Overall Study|Adverse Event|0|||
162749309|NCT03245840|587795330|FG000|Overall Study|Death|2|||
162749310|NCT03245840|587795331|FG001|Overall Study|Death|0|||
162749311|NCT03245840|587795330|FG000|Overall Study|Withdrawal by Subject|31|||
162749312|NCT03245840|587795331|FG001|Overall Study|Withdrawal by Subject|1|||
162749313|NCT03245840|587795330|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
162749314|NCT03245840|587795331|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162749315|NCT03245840|587795330|FG000|Overall Study|Physician Decision|4|||
162749316|NCT03245840|587795331|FG001|Overall Study|Physician Decision|1|||
162749317|NCT03245840|587795330|FG000|Overall Study|Study Terminated by Sponsor|56|||
162749318|NCT03245840|587795331|FG001|Overall Study|Study Terminated by Sponsor|6|||
162749319|NCT03245840|587795330|FG000|Overall Study|Site Terminated by Sponsor|4|||
162749320|NCT03245840|587795331|FG001|Overall Study|Site Terminated by Sponsor|0|||
162749321|NCT03245840|587795330|FG000|Overall Study|Lost to Follow-up|12|||
162749322|NCT03245840|587795331|FG001|Overall Study|Lost to Follow-up|2|||
162749323|NCT03245840|587795330|FG000|Overall Study|Pregnancy|2|||
162749324|NCT03245840|587795331|FG001|Overall Study|Pregnancy|0|||
162749325|NCT03245840|587795330|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162749326|NCT03245840|587795331|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162749327|NCT03245840|587795330|FG000|Overall Study|Not treated|1|||
162749328|NCT03245840|587795331|FG001|Overall Study|Not treated|1|||
162749329|NCT05652010|587795337|FG000|First Intervention|Withdrawal by Subject|0|||
162749330|NCT05652010|587795338|FG001|First Intervention|Withdrawal by Subject|1|||
162749331|NCT05652010|587795337|FG000|Second Intervention|Withdrawal by Subject|1|||
162749332|NCT05652010|587795338|FG001|Second Intervention|Withdrawal by Subject|0|||
162749333|NCT04206787|587795344|FG000|Overall Study|Other than listed|2|||
162749334|NCT04206787|587795344|FG000|Overall Study|Investigator decision|1|||
162749335|NCT04206787|587795344|FG000|Overall Study|Death|25|||
162749336|NCT04206787|587795344|FG000|Overall Study|Lost to Follow-up|9|||
162749337|NCT04206787|587795344|FG000|Overall Study|Withdrawal of consent|9|||
162749338|NCT05008055|587795345|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
162749339|NCT05008055|587795346|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
162749340|NCT05008055|587795347|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
162749341|NCT03011034|587795355|FG000|Overall Study|Adverse Event|1|||
162749342|NCT03011034|587795356|FG001|Overall Study|Adverse Event|0|||
162749343|NCT03735979|587795365|FG000|Overall Study|Lost to Follow-up|1|||
162749344|NCT03735979|587795366|FG001|Overall Study|Lost to Follow-up|12|||
162749345|NCT03735979|587795367|FG002|Overall Study|Lost to Follow-up|14|||
162749346|NCT03735979|587795365|FG000|Overall Study|Withdrawal by Subject|1|||
162749347|NCT03735979|587795366|FG001|Overall Study|Withdrawal by Subject|5|||
162749348|NCT03735979|587795367|FG002|Overall Study|Withdrawal by Subject|2|||
162749349|NCT03735979|587795365|FG000|Overall Study|Not due to the above reasons|1|||
162749350|NCT03735979|587795366|FG001|Overall Study|Not due to the above reasons|0|||
162749351|NCT03735979|587795367|FG002|Overall Study|Not due to the above reasons|0|||
162749352|NCT00319111|587795370|FG000|Overall Study|Adverse Event|20|||
162749353|NCT00319111|587795370|FG000|Overall Study|Withdrawal of consent|11|||
162749354|NCT00319111|587795370|FG000|Overall Study|Death|9|||
162749355|NCT00319111|587795370|FG000|Overall Study|Lack of clinical improvement|4|||
162749356|NCT00319111|587795370|FG000|Overall Study|Administrative|2|||
162749357|NCT00319111|587795370|FG000|Overall Study|Treatment failure|1|||
162749358|NCT01475786|587795371|FG000|Overall Study|Adverse Event|0|||
162749359|NCT01475786|587795372|FG001|Overall Study|Adverse Event|1|||
162749360|NCT01475786|587795373|FG002|Overall Study|Adverse Event|0|||
162749361|NCT01475786|587795371|FG000|Overall Study|Lost to Follow-up|1|||
162749362|NCT01475786|587795372|FG001|Overall Study|Lost to Follow-up|2|||
162749363|NCT01475786|587795373|FG002|Overall Study|Lost to Follow-up|1|||
162749364|NCT01475786|587795371|FG000|Overall Study|Withdrawal by Subject|0|||
162749365|NCT01475786|587795372|FG001|Overall Study|Withdrawal by Subject|1|||
162749366|NCT01475786|587795373|FG002|Overall Study|Withdrawal by Subject|1|||
162749367|NCT01475786|587795371|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
162749368|NCT01475786|587795372|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
162749369|NCT01475786|587795373|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
162749370|NCT03165955|587795375|FG000|Treatment|Withdrawal by Subject|3|||
162749371|NCT03165955|587795375|FG000|Treatment|Death|1|||
162749372|NCT03165955|587795375|FG000|Treatment|Adverse Event|1|||
162749373|NCT03165955|587795375|FG000|Treatment|Progressive disease|3|||
162749374|NCT04761198|587795378|FG000|Overall Study|Progressive Disease|1|||
162749375|NCT04761198|587795379|FG001|Overall Study|Progressive Disease|0|||
162749376|NCT04761198|587795380|FG002|Overall Study|Progressive Disease|0|||
162749377|NCT04761198|587795381|FG003|Overall Study|Progressive Disease|1|||
162749378|NCT04761198|587795382|FG004|Overall Study|Progressive Disease|4|||
162749379|NCT04761198|587795383|FG005|Overall Study|Progressive Disease|1|||
162749380|NCT04761198|587795384|FG006|Overall Study|Progressive Disease|2|||
162749381|NCT04761198|587795378|FG000|Overall Study|Protocol Violation|0|||
162749382|NCT04761198|587795379|FG001|Overall Study|Protocol Violation|0|||
162749383|NCT04761198|587795380|FG002|Overall Study|Protocol Violation|0|||
162749384|NCT04761198|587795381|FG003|Overall Study|Protocol Violation|0|||
162749385|NCT04761198|587795382|FG004|Overall Study|Protocol Violation|1|||
162749386|NCT04761198|587795383|FG005|Overall Study|Protocol Violation|0|||
162749387|NCT04761198|587795384|FG006|Overall Study|Protocol Violation|0|||
162749388|NCT04761198|587795378|FG000|Overall Study|Death|2|||
162749389|NCT04761198|587795379|FG001|Overall Study|Death|1|||
162749390|NCT04761198|587795380|FG002|Overall Study|Death|2|||
162749391|NCT04761198|587795381|FG003|Overall Study|Death|5|||
162749392|NCT04761198|587795382|FG004|Overall Study|Death|14|||
162749393|NCT04761198|587795383|FG005|Overall Study|Death|2|||
162749394|NCT04761198|587795384|FG006|Overall Study|Death|5|||
162749395|NCT04761198|587795378|FG000|Overall Study|Lost to Follow-up|0|||
162749396|NCT04761198|587795379|FG001|Overall Study|Lost to Follow-up|0|||
162749397|NCT04761198|587795380|FG002|Overall Study|Lost to Follow-up|0|||
162749398|NCT04761198|587795381|FG003|Overall Study|Lost to Follow-up|0|||
162749399|NCT04761198|587795382|FG004|Overall Study|Lost to Follow-up|1|||
162749400|NCT04761198|587795383|FG005|Overall Study|Lost to Follow-up|0|||
162749401|NCT04761198|587795384|FG006|Overall Study|Lost to Follow-up|0|||
162749402|NCT04761198|587795378|FG000|Overall Study|Withdrawal by Subject|2|||
162749403|NCT04761198|587795379|FG001|Overall Study|Withdrawal by Subject|0|||
162749404|NCT04761198|587795380|FG002|Overall Study|Withdrawal by Subject|1|||
162749405|NCT04761198|587795381|FG003|Overall Study|Withdrawal by Subject|0|||
162749406|NCT04761198|587795382|FG004|Overall Study|Withdrawal by Subject|2|||
162749407|NCT04761198|587795383|FG005|Overall Study|Withdrawal by Subject|0|||
162749408|NCT04761198|587795384|FG006|Overall Study|Withdrawal by Subject|1|||
162749409|NCT04761198|587795378|FG000|Overall Study|Study Terminated by Sponsor|6|||
162749410|NCT04761198|587795379|FG001|Overall Study|Study Terminated by Sponsor|0|||
162749411|NCT04761198|587795380|FG002|Overall Study|Study Terminated by Sponsor|5|||
162749412|NCT04761198|587795381|FG003|Overall Study|Study Terminated by Sponsor|3|||
162749413|NCT04761198|587795382|FG004|Overall Study|Study Terminated by Sponsor|10|||
162749414|NCT04761198|587795383|FG005|Overall Study|Study Terminated by Sponsor|1|||
162749415|NCT04761198|587795384|FG006|Overall Study|Study Terminated by Sponsor|2|||
162749416|NCT02994927|587795385|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162749417|NCT02994927|587795386|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162749418|NCT02994927|587795385|FG000|Overall Study|Did not meet eligibility criteria|0|||
162749419|NCT02994927|587795386|FG001|Overall Study|Did not meet eligibility criteria|1|||
162749420|NCT02994927|587795385|FG000|Overall Study|Physician Decision|4|||
162749421|NCT02994927|587795386|FG001|Overall Study|Physician Decision|3|||
162749422|NCT02994927|587795385|FG000|Overall Study|Death|4|||
162749423|NCT02994927|587795386|FG001|Overall Study|Death|2|||
162749424|NCT02994927|587795385|FG000|Overall Study|Adverse Event|2|||
162749425|NCT02994927|587795386|FG001|Overall Study|Adverse Event|1|||
162749426|NCT02994927|587795385|FG000|Overall Study|Withdrawal by Subject|3|||
162749427|NCT02994927|587795386|FG001|Overall Study|Withdrawal by Subject|6|||
162749428|NCT02994927|587795385|FG000|Overall Study|Lost to Follow-up|2|||
162749429|NCT02994927|587795386|FG001|Overall Study|Lost to Follow-up|1|||
162749430|NCT03533257|587795394|FG000|Overall Study|Adverse Event|4|||
162749431|NCT03533257|587795395|FG001|Overall Study|Adverse Event|2|||
162749432|NCT03533257|587795394|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
162749433|NCT03533257|587795395|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
162749434|NCT05525104|587795399|FG000|Overall Study|Failed caudal analgesia|1|||
162749435|NCT05525104|587795400|FG001|Overall Study|Failed caudal analgesia|3|||
162749436|NCT05525104|587795399|FG000|Overall Study|Premedication needed|0|||
162749437|NCT05525104|587795400|FG001|Overall Study|Premedication needed|1|||
162749438|NCT05525104|587795399|FG000|Overall Study|Protocol Violation|10|||
162749439|NCT05525104|587795400|FG001|Overall Study|Protocol Violation|0|||
162749440|NCT05525104|587795399|FG000|Overall Study|Cancelled operation|1|||
162749441|NCT05525104|587795400|FG001|Overall Study|Cancelled operation|0|||
162749442|NCT02039401|587795401|FG000|Overall Study|Adverse Event|0|||
162749443|NCT02039401|587795402|FG001|Overall Study|Adverse Event|1|||
162749444|NCT02865538|587795405|FG000|Overall Study|Withdrawal by Subject|0|||
162749445|NCT02865538|587795406|FG001|Overall Study|Withdrawal by Subject|0|||
162749446|NCT02865538|587795407|FG002|Overall Study|Withdrawal by Subject|1|||
162749447|NCT02865538|587795408|FG003|Overall Study|Withdrawal by Subject|0|||
162749448|NCT02865538|587795409|FG004|Overall Study|Withdrawal by Subject|0|||
162749449|NCT02865538|587795405|FG000|Overall Study|Lost to Follow-up|1|||
162749450|NCT02865538|587795406|FG001|Overall Study|Lost to Follow-up|0|||
162749451|NCT02865538|587795407|FG002|Overall Study|Lost to Follow-up|0|||
162749452|NCT02865538|587795408|FG003|Overall Study|Lost to Follow-up|0|||
162749453|NCT02865538|587795409|FG004|Overall Study|Lost to Follow-up|0|||
162749454|NCT03417284|587796695|FG000|Overall Study|Inadequate supply on study drug|1|||
162749455|NCT03417284|587796696|FG001|Overall Study|Inadequate supply on study drug|0|||
162749456|NCT03417284|587796697|FG002|Overall Study|Inadequate supply on study drug|0|||
162749457|NCT03417284|587796698|FG003|Overall Study|Inadequate supply on study drug|0|||
162749458|NCT03417284|587796695|FG000|Overall Study|Disease Progression|0|||
162749459|NCT03417284|587796696|FG001|Overall Study|Disease Progression|0|||
162749460|NCT03417284|587796697|FG002|Overall Study|Disease Progression|1|||
162749461|NCT03417284|587796698|FG003|Overall Study|Disease Progression|0|||
162749462|NCT04089865|587796705|FG000|Overall Study|Withdrawal by Subject|2|||
162749463|NCT04089865|587796706|FG001|Overall Study|Withdrawal by Subject|2|||
162749464|NCT04089865|587796707|FG002|Overall Study|Withdrawal by Subject|7|||
162749465|NCT04089865|587796708|FG003|Overall Study|Withdrawal by Subject|2|||
162749466|NCT04282980|587796713|FG000|Overall Study|Remained on treatment|6|||
162749467|NCT04282980|587796713|FG000|Overall Study|Survival follow-up|11|||
162749468|NCT04282980|587796713|FG000|Overall Study|Withdrawal of informed consent|1|||
162749469|NCT04282980|587796713|FG000|Overall Study|Lost to Follow-up|1|||
162749470|NCT01917084|587796715|FG000|Overall Study|Withdrawal by Subject|1|||
162749471|NCT03571386|587796716|FG000|Overall Study|scheduling conflict|4|||
162749472|NCT03571386|587796717|FG001|Overall Study|scheduling conflict|0|||
162749473|NCT03571386|587796716|FG000|Overall Study|Withdrawal by Subject|15|||
162749474|NCT03571386|587796717|FG001|Overall Study|Withdrawal by Subject|5|||
162749475|NCT06037668|587796724|FG000|Overall Study|Lost to Follow-up|1|||
162749476|NCT06037668|587796725|FG001|Overall Study|Lost to Follow-up|1|||
162749477|NCT06037668|587796724|FG000|Overall Study|Protocol Violation|1|||
162749478|NCT06037668|587796725|FG001|Overall Study|Protocol Violation|0|||
162749479|NCT06037668|587796724|FG000|Overall Study|Withdrawal by Subject|1|||
162749480|NCT06037668|587796725|FG001|Overall Study|Withdrawal by Subject|0|||
162749481|NCT06037668|587796724|FG000|Overall Study|Other Study Discontinuation Reason|1|||
162749482|NCT06037668|587796725|FG001|Overall Study|Other Study Discontinuation Reason|0|||
162749483|NCT02473445|587796726|FG000|Overall Study|Withdrawal by Subject|2|||
162749484|NCT02473445|587796726|FG000|Overall Study|Sponsor Decision|20|||
162749485|NCT04881461|587796727|FG000|Overall Study|Adverse Event|2|||
162749486|NCT04881461|587796728|FG001|Overall Study|Adverse Event|4|||
162749487|NCT04881461|587796727|FG000|Overall Study|Withdrawal by Subject|19|||
162749488|NCT04881461|587796728|FG001|Overall Study|Withdrawal by Subject|19|||
162749489|NCT04881461|587796727|FG000|Overall Study|Lost to Follow-up|4|||
162749490|NCT04881461|587796728|FG001|Overall Study|Lost to Follow-up|4|||
162749491|NCT04881461|587796727|FG000|Overall Study|Lack of Efficacy|1|||
162749492|NCT04881461|587796728|FG001|Overall Study|Lack of Efficacy|0|||
162749493|NCT04881461|587796727|FG000|Overall Study|"Reason stated as other in CRF"|1|||
162749494|NCT04881461|587796728|FG001|Overall Study|"Reason stated as other in CRF"|2|||
162749495|NCT03988621|587796729|FG000|Overall Study|Lost to Follow-up|16|||
162749496|NCT03988621|587796730|FG001|Overall Study|Lost to Follow-up|17|||
162749497|NCT03988621|587796729|FG000|Overall Study|Withdrawal by Subject|14|||
162749498|NCT03988621|587796730|FG001|Overall Study|Withdrawal by Subject|7|||
162749499|NCT03988621|587796729|FG000|Overall Study|Patient Lost to Follow Up|15|||
162749500|NCT03988621|587796730|FG001|Overall Study|Patient Lost to Follow Up|15|||
162749501|NCT03988621|587796729|FG000|Overall Study|Patient death|1|||
162749502|NCT03988621|587796730|FG001|Overall Study|Patient death|5|||
162749503|NCT04247802|587796731|FG000|Overall Study|Withdrawal by Subject|1|||
162749504|NCT04247802|587796732|FG001|Overall Study|Withdrawal by Subject|3|||
162749505|NCT04247802|587796731|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
162749506|NCT04247802|587796732|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
162749507|NCT04629339|587796738|FG000|Overall Study|Death|1|||
162749508|NCT04629339|587796739|FG001|Overall Study|Death|0|||
162749509|NCT04629339|587796740|FG002|Overall Study|Death|2|||
162749510|NCT04629339|587796741|FG003|Overall Study|Death|2|||
162749511|NCT04629339|587796742|FG004|Overall Study|Death|0|||
162749512|NCT04629339|587796738|FG000|Overall Study|Disease Progression|0|||
162749513|NCT04629339|587796739|FG001|Overall Study|Disease Progression|0|||
162749514|NCT04629339|587796740|FG002|Overall Study|Disease Progression|1|||
162749515|NCT04629339|587796741|FG003|Overall Study|Disease Progression|1|||
162749516|NCT04629339|587796742|FG004|Overall Study|Disease Progression|0|||
162749517|NCT04629339|587796738|FG000|Overall Study|Lost to Follow-up|0|||
162749518|NCT04629339|587796739|FG001|Overall Study|Lost to Follow-up|0|||
162749519|NCT04629339|587796740|FG002|Overall Study|Lost to Follow-up|0|||
162749520|NCT04629339|587796741|FG003|Overall Study|Lost to Follow-up|1|||
162749521|NCT04629339|587796742|FG004|Overall Study|Lost to Follow-up|0|||
162749522|NCT04629339|587796738|FG000|Overall Study|Physician Decision|0|||
162749523|NCT04629339|587796739|FG001|Overall Study|Physician Decision|1|||
162749524|NCT04629339|587796740|FG002|Overall Study|Physician Decision|0|||
162749525|NCT04629339|587796741|FG003|Overall Study|Physician Decision|0|||
162749526|NCT04629339|587796742|FG004|Overall Study|Physician Decision|0|||
162749527|NCT04629339|587796738|FG000|Overall Study|Study Terminated by Sponsor|0|||
162749528|NCT04629339|587796739|FG001|Overall Study|Study Terminated by Sponsor|0|||
162749529|NCT04629339|587796740|FG002|Overall Study|Study Terminated by Sponsor|0|||
162749530|NCT04629339|587796741|FG003|Overall Study|Study Terminated by Sponsor|1|||
162749531|NCT04629339|587796742|FG004|Overall Study|Study Terminated by Sponsor|0|||
162749532|NCT04629339|587796738|FG000|Overall Study|Withdrawal by Subject|0|||
162749533|NCT04629339|587796739|FG001|Overall Study|Withdrawal by Subject|0|||
162749534|NCT04629339|587796740|FG002|Overall Study|Withdrawal by Subject|2|||
162749535|NCT04629339|587796741|FG003|Overall Study|Withdrawal by Subject|2|||
162749536|NCT04629339|587796742|FG004|Overall Study|Withdrawal by Subject|0|||
162749537|NCT04158739|587796749|FG000|Overall Study|Adverse Event|1|||
162749538|NCT04158739|587796750|FG001|Overall Study|Adverse Event|0|||
162749539|NCT04158739|587796749|FG000|Overall Study|Death|0|||
162749540|NCT04158739|587796750|FG001|Overall Study|Death|1|||
162749541|NCT04158739|587796749|FG000|Overall Study|Lack of Efficacy|3|||
162749542|NCT04158739|587796750|FG001|Overall Study|Lack of Efficacy|7|||
162749543|NCT04158739|587796749|FG000|Overall Study|Physician Decision|0|||
162749544|NCT04158739|587796750|FG001|Overall Study|Physician Decision|1|||
162749545|NCT04158739|587796749|FG000|Overall Study|Withdrawal by Subject|3|||
162749546|NCT04158739|587796750|FG001|Overall Study|Withdrawal by Subject|0|||
162749547|NCT04778410|587796751|FG000|Safety Run-in Period|Death|5|||
162749548|NCT04778410|587796752|FG001|Safety Run-in Period|Death|6|||
162749549|NCT04778410|587796753|FG002|Safety Run-in Period|Death|0|||
162749550|NCT04778410|587796754|FG003|Safety Run-in Period|Death|0|||
162749551|NCT04778410|587796755|FG004|Safety Run-in Period|Death|0|||
162749552|NCT04778410|587796756|FG005|Safety Run-in Period|Death|0|||
162749553|NCT04778410|587796751|FG000|Phase 2 Period|Death|0|||
162749554|NCT04778410|587796752|FG001|Phase 2 Period|Death|0|||
162749555|NCT04778410|587796753|FG002|Phase 2 Period|Death|0|||
162749556|NCT04778410|587796754|FG003|Phase 2 Period|Death|5|||
162749557|NCT04778410|587796755|FG004|Phase 2 Period|Death|18|||
162749558|NCT04778410|587796756|FG005|Phase 2 Period|Death|0|||
162749559|NCT04778410|587796751|FG000|Phase 2 Period|Lost to Follow-up|0|||
162749560|NCT04778410|587796752|FG001|Phase 2 Period|Lost to Follow-up|0|||
162749561|NCT04778410|587796753|FG002|Phase 2 Period|Lost to Follow-up|0|||
162749562|NCT04778410|587796754|FG003|Phase 2 Period|Lost to Follow-up|1|||
162749563|NCT04778410|587796755|FG004|Phase 2 Period|Lost to Follow-up|1|||
162749564|NCT04778410|587796756|FG005|Phase 2 Period|Lost to Follow-up|0|||
162749565|NCT04778410|587796751|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
162749566|NCT04778410|587796752|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
162749567|NCT04778410|587796753|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
162749568|NCT04778410|587796754|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
162749569|NCT04778410|587796755|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
162749570|NCT04778410|587796756|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
162749571|NCT04778410|587796751|FG000|Phase 2 Period|Withdrew Consent|0|||
162749572|NCT04778410|587796752|FG001|Phase 2 Period|Withdrew Consent|0|||
162749573|NCT04778410|587796753|FG002|Phase 2 Period|Withdrew Consent|0|||
162749574|NCT04778410|587796754|FG003|Phase 2 Period|Withdrew Consent|0|||
162749575|NCT04778410|587796755|FG004|Phase 2 Period|Withdrew Consent|2|||
162749576|NCT04778410|587796756|FG005|Phase 2 Period|Withdrew Consent|0|||
162749577|NCT00942877|587796768|FG000|Overall Study|Refused further treatment|1|||
162749578|NCT00942877|587796769|FG001|Overall Study|Refused further treatment|1|||
162749579|NCT00942877|587796768|FG000|Overall Study|Patient was not treated|1|||
162749580|NCT00942877|587796769|FG001|Overall Study|Patient was not treated|0|||
162749581|NCT00942877|587796768|FG000|Overall Study|Adverse Event|1|||
162749582|NCT00942877|587796769|FG001|Overall Study|Adverse Event|0|||
162749583|NCT00942877|587796768|FG000|Overall Study|Progressive disease|42|||
162749584|NCT00942877|587796769|FG001|Overall Study|Progressive disease|3|||
162749585|NCT01385202|587796770|FG000|Overall Study|Lost to Follow-up|6|||
162749586|NCT01385202|587796770|FG000|Overall Study|Not Eligible|11|||
162749587|NCT01385202|587796770|FG000|Overall Study|Withdrawn|1|||
162749588|NCT02095691|587796771|FG000|Overall Study|Physician Decision|1|||
162749589|NCT05007080|587796773|FG000|Overall Study|Lost to Follow-up|0|||
162749590|NCT05007080|587796774|FG001|Overall Study|Lost to Follow-up|1|||
162749591|NCT05007080|587796775|FG002|Overall Study|Lost to Follow-up|0|||
162749592|NCT05007080|587796776|FG003|Overall Study|Lost to Follow-up|1|||
162749593|NCT05007080|587796777|FG004|Overall Study|Lost to Follow-up|1|||
162749594|NCT05007080|587796778|FG005|Overall Study|Lost to Follow-up|1|||
162749595|NCT05007080|587796773|FG000|Overall Study|Death|0|||
162749596|NCT05007080|587796774|FG001|Overall Study|Death|1|||
162749597|NCT05007080|587796775|FG002|Overall Study|Death|0|||
162749598|NCT05007080|587796776|FG003|Overall Study|Death|0|||
162749599|NCT05007080|587796777|FG004|Overall Study|Death|0|||
162749600|NCT05007080|587796778|FG005|Overall Study|Death|0|||
162749601|NCT05007080|587796773|FG000|Overall Study|Withdrawal by Subject|1|||
162749602|NCT05007080|587796774|FG001|Overall Study|Withdrawal by Subject|2|||
162749603|NCT05007080|587796775|FG002|Overall Study|Withdrawal by Subject|0|||
162749604|NCT05007080|587796776|FG003|Overall Study|Withdrawal by Subject|2|||
162749605|NCT05007080|587796777|FG004|Overall Study|Withdrawal by Subject|1|||
162749606|NCT05007080|587796778|FG005|Overall Study|Withdrawal by Subject|1|||
162749607|NCT05007080|587796773|FG000|Overall Study|Other|1|||
162749608|NCT05007080|587796774|FG001|Overall Study|Other|0|||
162749609|NCT05007080|587796775|FG002|Overall Study|Other|1|||
162749610|NCT05007080|587796776|FG003|Overall Study|Other|1|||
162749611|NCT05007080|587796777|FG004|Overall Study|Other|0|||
162749612|NCT05007080|587796778|FG005|Overall Study|Other|2|||
162749613|NCT05007080|587796773|FG000|Overall Study|Randomized not vaccinated|0|||
162749614|NCT05007080|587796774|FG001|Overall Study|Randomized not vaccinated|0|||
162749615|NCT05007080|587796775|FG002|Overall Study|Randomized not vaccinated|0|||
162749616|NCT05007080|587796776|FG003|Overall Study|Randomized not vaccinated|0|||
162749617|NCT05007080|587796777|FG004|Overall Study|Randomized not vaccinated|0|||
162749618|NCT05007080|587796778|FG005|Overall Study|Randomized not vaccinated|1|||
162749619|NCT04583280|587796782|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
162749620|NCT04583280|587796783|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
162749621|NCT00964392|587796784|FG000|Overall Study|Withdrawal by Subject|4|||
162749622|NCT00964392|587796785|FG001|Overall Study|Withdrawal by Subject|6|||
162749623|NCT00964392|587796784|FG000|Overall Study|Lost to Follow-up|4|||
162749624|NCT00964392|587796785|FG001|Overall Study|Lost to Follow-up|10|||
162749625|NCT00964392|587796784|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
162749626|NCT00964392|587796785|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
162749627|NCT00964392|587796784|FG000|Overall Study|Not completed|44|||
162749628|NCT00964392|587796785|FG001|Overall Study|Not completed|168|||
162749629|NCT00631475|587796788|FG000|Overall Study|Death|18|||
162749630|NCT00631475|587796788|FG000|Overall Study|Adverse Event|14|||
162749631|NCT00631475|587796788|FG000|Overall Study|Withdrew consent|5|||
162749632|NCT00631475|587796788|FG000|Overall Study|Preparation for lung transplant|8|||
162749633|NCT02577354|587796794|FG000|Overall Study|Lack of Efficacy|4|||
162749634|NCT02577354|587796795|FG001|Overall Study|Lack of Efficacy|4|||
162749635|NCT02577354|587796794|FG000|Overall Study|Lost to Follow-up|3|||
162749636|NCT02577354|587796795|FG001|Overall Study|Lost to Follow-up|1|||
162749637|NCT02577354|587796794|FG000|Overall Study|Missed Visit|4|||
162749638|NCT02577354|587796795|FG001|Overall Study|Missed Visit|3|||
162749639|NCT02577354|587796794|FG000|Overall Study|Adverse Event|4|||
162749640|NCT02577354|587796795|FG001|Overall Study|Adverse Event|5|||
162749641|NCT04173247|587796796|FG000|Overall Study|Withdrawal by Subject|0|||
162749642|NCT04173247|587796797|FG001|Overall Study|Withdrawal by Subject|2|||
162749643|NCT04173247|587796796|FG000|Overall Study|Death|1|||
162749644|NCT04173247|587796797|FG001|Overall Study|Death|0|||
162749645|NCT04173247|587796796|FG000|Overall Study|Physician Decision|1|||
162749646|NCT04173247|587796797|FG001|Overall Study|Physician Decision|0|||
162749647|NCT04214834|587796805|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
162749648|NCT04214834|587796806|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
162749649|NCT04109066|587796816|FG000|Pre-treatment|Participant withdrew consent|2|||
162749650|NCT04109066|587796817|FG001|Pre-treatment|Participant withdrew consent|0|||
162749651|NCT04109066|587796816|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
162749652|NCT04109066|587796817|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
162749653|NCT04109066|587796816|FG000|Treatment|Lack of Efficacy|2|||
162749654|NCT04109066|587796817|FG001|Treatment|Lack of Efficacy|4|||
162749655|NCT04109066|587796816|FG000|Treatment|Adverse Event|23|||
162749656|NCT04109066|587796817|FG001|Treatment|Adverse Event|7|||
162749657|NCT04109066|587796816|FG000|Treatment|Participant request to discontinue Study treatment|15|||
162749658|NCT04109066|587796817|FG001|Treatment|Participant request to discontinue Study treatment|14|||
162749659|NCT04109066|587796816|FG000|Treatment|Withdrawal by Subject|8|||
162749660|NCT04109066|587796817|FG001|Treatment|Withdrawal by Subject|8|||
162749661|NCT04109066|587796816|FG000|Treatment|Death|3|||
162749662|NCT04109066|587796817|FG001|Treatment|Death|0|||
162749663|NCT04109066|587796816|FG000|Treatment|Participant no longer meets study criteria|2|||
162749664|NCT04109066|587796817|FG001|Treatment|Participant no longer meets study criteria|2|||
162749665|NCT04109066|587796816|FG000|Treatment|Administrative reasons by sponsor|2|||
162749666|NCT04109066|587796817|FG001|Treatment|Administrative reasons by sponsor|3|||
162749667|NCT04109066|587796816|FG000|Treatment|Other reasons|17|||
162749668|NCT04109066|587796817|FG001|Treatment|Other reasons|23|||
162749669|NCT04109066|587796816|FG000|Treatment|Disease Progression|4|||
162749670|NCT04109066|587796817|FG001|Treatment|Disease Progression|7|||
162749671|NCT04109066|587796816|FG000|Treatment|Study drug toxicity|12|||
162749672|NCT04109066|587796817|FG001|Treatment|Study drug toxicity|5|||
162749673|NCT04109066|587796816|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
162749674|NCT04109066|587796817|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
162749675|NCT04109066|587796816|FG000|Treatment|Disease Recurrence|0|||
162749676|NCT04109066|587796817|FG001|Treatment|Disease Recurrence|2|||
162749677|NCT04109066|587796816|FG000|Treatment|Not reported|4|||
162749678|NCT04109066|587796817|FG001|Treatment|Not reported|8|||
162749679|NCT03744676|587796818|FG000|Pre-Treatment Phase|Disease related complications|2|||
162749680|NCT03744676|587796818|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
162749681|NCT03744676|587796818|FG000|Pre-Treatment Phase|Death|7|||
162749682|NCT03744676|587796818|FG000|Pre-Treatment Phase|Other Reasons|7|||
162749683|NCT03744676|587796818|FG000|Treatment Phase|Participant withdrew consent|8|||
162749684|NCT03744676|587796818|FG000|Treatment Phase|Death|33|||
162749685|NCT03744676|587796818|FG000|Treatment Phase|other reasons|6|||
162749686|NCT04108130|587798171|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
162749687|NCT04108130|587798172|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
162749688|NCT04108130|587798171|FG000|Overall Study|Consent Withdrawn|9|||
162749689|NCT04108130|587798172|FG001|Overall Study|Consent Withdrawn|6|||
162749690|NCT04108130|587798171|FG000|Overall Study|Surgery Cancelled|4|||
162749691|NCT04108130|587798172|FG001|Overall Study|Surgery Cancelled|4|||
162749692|NCT04108130|587798171|FG000|Overall Study|Found Ineligible for Study|4|||
162749693|NCT04108130|587798172|FG001|Overall Study|Found Ineligible for Study|3|||
162749694|NCT04108130|587798171|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
162749695|NCT04108130|587798172|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
162749696|NCT04108130|587798171|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
162749697|NCT04108130|587798172|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
162749698|NCT04244175|587798173|FG000|Overall Study|Adverse Event|3|||
162749699|NCT04244175|587798174|FG001|Overall Study|Adverse Event|2|||
162749700|NCT04244175|587798175|FG002|Overall Study|Adverse Event|5|||
162749701|NCT04244175|587798173|FG000|Overall Study|Lack of Efficacy|1|||
162749702|NCT04244175|587798174|FG001|Overall Study|Lack of Efficacy|0|||
162749703|NCT04244175|587798175|FG002|Overall Study|Lack of Efficacy|1|||
162749704|NCT04244175|587798173|FG000|Overall Study|Lost to Follow-up|1|||
162749705|NCT04244175|587798174|FG001|Overall Study|Lost to Follow-up|0|||
162749706|NCT04244175|587798175|FG002|Overall Study|Lost to Follow-up|0|||
162749707|NCT04244175|587798173|FG000|Overall Study|Non-compliance with study drug|1|||
162749708|NCT04244175|587798174|FG001|Overall Study|Non-compliance with study drug|0|||
162749709|NCT04244175|587798175|FG002|Overall Study|Non-compliance with study drug|1|||
162749710|NCT04244175|587798173|FG000|Overall Study|Protocol deviation|0|||
162749711|NCT04244175|587798174|FG001|Overall Study|Protocol deviation|1|||
162749712|NCT04244175|587798175|FG002|Overall Study|Protocol deviation|0|||
162749713|NCT04244175|587798173|FG000|Overall Study|Withdrawal by Subject|1|||
162749714|NCT04244175|587798174|FG001|Overall Study|Withdrawal by Subject|3|||
162749715|NCT04244175|587798175|FG002|Overall Study|Withdrawal by Subject|1|||
162749716|NCT04244175|587798173|FG000|Overall Study|Other, not specified|0|||
162749717|NCT04244175|587798174|FG001|Overall Study|Other, not specified|1|||
162749718|NCT04244175|587798175|FG002|Overall Study|Other, not specified|2|||
162749719|NCT03636490|587798176|FG000|Overall Study|Dropped out or incomplete data|141|||
162749720|NCT02909686|587798178|FG000|Overall Study|Physician Decision|3|||
162749721|NCT02909686|587798178|FG000|Overall Study|Withdrawal by Subject|2|||
162749722|NCT03858517|587798179|FG000|Overall Study|Adverse Event|1|||
162749723|NCT03858517|587798179|FG000|Overall Study|Lost to Follow-up|1|||
162749724|NCT03858517|587798179|FG000|Overall Study|removed for being incarcerated|1|||
162749725|NCT03858517|587798179|FG000|Overall Study|Sponsor Closure|48|||
162749726|NCT04804540|587798180|FG000|Overall Study|Adverse Event|26|||
162749727|NCT04804540|587798181|FG001|Overall Study|Adverse Event|13|||
162749728|NCT05172232|587798182|FG000|Overall Study|Lost to Follow-up|3|||
162749729|NCT02997202|587798183|FG000|Overall Study|Miscellaneous|2|||
162749730|NCT02997202|587798184|FG001|Overall Study|Miscellaneous|2|||
162749731|NCT02997202|587798183|FG000|Overall Study|Withdrawal by Subject|8|||
162749732|NCT02997202|587798184|FG001|Overall Study|Withdrawal by Subject|12|||
162749733|NCT02997202|587798183|FG000|Overall Study|Lost to Follow-up|5|||
162749734|NCT02997202|587798184|FG001|Overall Study|Lost to Follow-up|3|||
162749735|NCT02997202|587798183|FG000|Overall Study|Death|41|||
162749736|NCT02997202|587798184|FG001|Overall Study|Death|45|||
162749737|NCT05422885|587798185|FG000|Overall Study|Lost to Follow-up|1|||
162749738|NCT05422885|587798185|FG000|Overall Study|Withdrawal by Subject|2|||
162749739|NCT04084574|587798186|FG000|Overall Study|Lost to Follow-up|1|||
162749740|NCT04084574|587798187|FG001|Overall Study|Lost to Follow-up|0|||
162749741|NCT04084574|587798186|FG000|Overall Study|Physician Decision|1|||
162749742|NCT04084574|587798187|FG001|Overall Study|Physician Decision|0|||
162749743|NCT04084574|587798186|FG000|Overall Study|Relocated out of state|1|||
162749744|NCT04084574|587798187|FG001|Overall Study|Relocated out of state|0|||
162749745|NCT01121588|587798188|FG000|Overall Study|Death|5|||
162749746|NCT01121588|587798189|FG001|Overall Study|Death|3|||
162749747|NCT01121588|587798190|FG002|Overall Study|Death|13|||
162749748|NCT01121588|587798188|FG000|Overall Study|Study Terminated by Sponsor|1|||
162749749|NCT01121588|587798189|FG001|Overall Study|Study Terminated by Sponsor|1|||
162749750|NCT01121588|587798190|FG002|Overall Study|Study Terminated by Sponsor|0|||
162749751|NCT01121588|587798188|FG000|Overall Study|Participant Refused Further Followup|2|||
162749752|NCT01121588|587798189|FG001|Overall Study|Participant Refused Further Followup|0|||
162749753|NCT01121588|587798190|FG002|Overall Study|Participant Refused Further Followup|2|||
162749754|NCT01121588|587798188|FG000|Overall Study|Lost to Follow-up|0|||
162749755|NCT01121588|587798189|FG001|Overall Study|Lost to Follow-up|1|||
162749756|NCT01121588|587798190|FG002|Overall Study|Lost to Follow-up|1|||
162749757|NCT01121588|587798188|FG000|Overall Study|Non-Specified Reasons|9|||
162749758|NCT01121588|587798189|FG001|Overall Study|Non-Specified Reasons|4|||
162749759|NCT01121588|587798190|FG002|Overall Study|Non-Specified Reasons|2|||
162749760|NCT03681262|587798191|FG000|Overall Study|Continuing on study|3|||
162749761|NCT03681262|587798192|FG001|Overall Study|Continuing on study|3|||
162749762|NCT03681262|587798191|FG000|Overall Study|Lost to Follow-up|1|||
162749763|NCT03681262|587798192|FG001|Overall Study|Lost to Follow-up|0|||
162749764|NCT04631016|587798195|FG000|Overall Study|Adverse Event|3|||
162749765|NCT04631016|587798196|FG001|Overall Study|Adverse Event|0|||
162749766|NCT04631016|587798195|FG000|Overall Study|Withdrawal by Subject|5|||
162749767|NCT04631016|587798196|FG001|Overall Study|Withdrawal by Subject|4|||
162749768|NCT04631016|587798195|FG000|Overall Study|Reason unspecified|1|||
162749769|NCT04631016|587798196|FG001|Overall Study|Reason unspecified|0|||
162749770|NCT04631016|587798195|FG000|Overall Study|Failure to meet randomization criteria|2|||
162749771|NCT04631016|587798196|FG001|Overall Study|Failure to meet randomization criteria|1|||
162749772|NCT05205161|587798197|FG000|Overall Study|Study terminated by sponsor|3|||
162749773|NCT05205161|587798198|FG001|Overall Study|Study terminated by sponsor|3|||
162749774|NCT05205161|587798199|FG002|Overall Study|Study terminated by sponsor|1|||
162749775|NCT04967599|587798200|FG000|Overall Study|Lost to Follow-up|35|||
162749776|NCT04967599|587798201|FG001|Overall Study|Lost to Follow-up|19|||
162749777|NCT04967599|587798202|FG002|Overall Study|Lost to Follow-up|23|||
162749778|NCT04369911|587798204|FG000|Overall Study|Lost to Follow-up|3|||
162749779|NCT04369911|587798205|FG001|Overall Study|Lost to Follow-up|3|||
162749780|NCT04369911|587798204|FG000|Overall Study|Withdrawal by Subject|1|||
162749781|NCT04369911|587798205|FG001|Overall Study|Withdrawal by Subject|2|||
162749782|NCT05741294|587798206|FG000|Overall Study|Lost to Follow-up|3|||
162749783|NCT05741294|587798206|FG000|Overall Study|Protocol deviation|3|||
162749784|NCT05741294|587798206|FG000|Overall Study|Withdrawal by Subject|1|||
162749785|NCT04707768|587798211|FG000|Overall Study|Adverse Event|9|||
162749786|NCT04707768|587798212|FG001|Overall Study|Adverse Event|18|||
162749787|NCT04707768|587798213|FG002|Overall Study|Adverse Event|3|||
162749788|NCT04707768|587798211|FG000|Overall Study|Investigator's Discretion|8|||
162749789|NCT04707768|587798212|FG001|Overall Study|Investigator's Discretion|4|||
162749790|NCT04707768|587798213|FG002|Overall Study|Investigator's Discretion|3|||
162749791|NCT04707768|587798211|FG000|Overall Study|Withdrawal by Subject|6|||
162749792|NCT04707768|587798212|FG001|Overall Study|Withdrawal by Subject|8|||
162749793|NCT04707768|587798213|FG002|Overall Study|Withdrawal by Subject|2|||
162749794|NCT04707768|587798211|FG000|Overall Study|Lack of Efficacy|1|||
162749795|NCT04707768|587798212|FG001|Overall Study|Lack of Efficacy|3|||
162749796|NCT04707768|587798213|FG002|Overall Study|Lack of Efficacy|0|||
162749797|NCT04707768|587798211|FG000|Overall Study|Lost to Follow-up|0|||
162749798|NCT04707768|587798212|FG001|Overall Study|Lost to Follow-up|0|||
162749799|NCT04707768|587798213|FG002|Overall Study|Lost to Follow-up|3|||
162749800|NCT04707768|587798211|FG000|Overall Study|Death|13|||
162749801|NCT04707768|587798212|FG001|Overall Study|Death|11|||
162749802|NCT04707768|587798213|FG002|Overall Study|Death|13|||
162749803|NCT04707768|587798211|FG000|Overall Study|Protocol Violation|2|||
162749804|NCT04707768|587798212|FG001|Overall Study|Protocol Violation|1|||
162749805|NCT04707768|587798213|FG002|Overall Study|Protocol Violation|0|||
162749806|NCT04707768|587798211|FG000|Overall Study|Non Compliance with Study Drug|1|||
162749807|NCT04707768|587798212|FG001|Overall Study|Non Compliance with Study Drug|0|||
162749808|NCT04707768|587798213|FG002|Overall Study|Non Compliance with Study Drug|0|||
162749809|NCT04707768|587798211|FG000|Overall Study|Transplant|4|||
162749810|NCT04707768|587798212|FG001|Overall Study|Transplant|4|||
162749811|NCT04707768|587798213|FG002|Overall Study|Transplant|8|||
162749812|NCT04707768|587798211|FG000|Overall Study|Other|9|||
162749813|NCT04707768|587798212|FG001|Overall Study|Other|5|||
162749814|NCT04707768|587798213|FG002|Overall Study|Other|2|||
162749815|NCT04490109|587798214|FG000|Overall Study|Lost to Follow-up|3|||
162749816|NCT04490109|587798215|FG001|Overall Study|Lost to Follow-up|10|||
162749817|NCT04490109|587798216|FG002|Overall Study|Lost to Follow-up|4|||
162749818|NCT04490109|587798214|FG000|Overall Study|Withdrawal by Subject|8|||
162749819|NCT04490109|587798215|FG001|Overall Study|Withdrawal by Subject|6|||
162749820|NCT04490109|587798216|FG002|Overall Study|Withdrawal by Subject|9|||
162749821|NCT04490109|587798214|FG000|Overall Study|Physician Decision|0|||
162749822|NCT04490109|587798215|FG001|Overall Study|Physician Decision|2|||
162749823|NCT04490109|587798216|FG002|Overall Study|Physician Decision|3|||
162749824|NCT04490109|587798214|FG000|Overall Study|Adverse Event|2|||
162749825|NCT04490109|587798215|FG001|Overall Study|Adverse Event|1|||
162749826|NCT04490109|587798216|FG002|Overall Study|Adverse Event|0|||
162749827|NCT04490109|587798214|FG000|Overall Study|Significant Non-Compliance|2|||
162749828|NCT04490109|587798215|FG001|Overall Study|Significant Non-Compliance|4|||
162749829|NCT04490109|587798216|FG002|Overall Study|Significant Non-Compliance|4|||
162749830|NCT04490109|587798214|FG000|Overall Study|Significant Clinical Event|0|||
162749831|NCT04490109|587798215|FG001|Overall Study|Significant Clinical Event|1|||
162749832|NCT04490109|587798216|FG002|Overall Study|Significant Clinical Event|0|||
162749833|NCT04490109|587798214|FG000|Overall Study|Other Reason|4|||
162749834|NCT04490109|587798215|FG001|Overall Study|Other Reason|1|||
162749835|NCT04490109|587798216|FG002|Overall Study|Other Reason|1|||
162749836|NCT04163991|587798217|FG000|Overall Study|Adverse Event|0|||
162749837|NCT04163991|587798218|FG001|Overall Study|Adverse Event|0|||
162749838|NCT04163991|587798219|FG002|Overall Study|Adverse Event|0|||
162749839|NCT04163991|587798220|FG003|Overall Study|Adverse Event|1|||
162749840|NCT04163991|587798221|FG004|Overall Study|Adverse Event|0|||
162749841|NCT04163991|587798217|FG000|Overall Study|Death|0|||
162749842|NCT04163991|587798218|FG001|Overall Study|Death|0|||
162749843|NCT04163991|587798219|FG002|Overall Study|Death|1|||
162749844|NCT04163991|587798220|FG003|Overall Study|Death|0|||
162749845|NCT04163991|587798221|FG004|Overall Study|Death|0|||
162749846|NCT04163991|587798217|FG000|Overall Study|Lost to Follow-up|0|||
162749847|NCT04163991|587798218|FG001|Overall Study|Lost to Follow-up|1|||
162749848|NCT04163991|587798219|FG002|Overall Study|Lost to Follow-up|0|||
162749849|NCT04163991|587798220|FG003|Overall Study|Lost to Follow-up|0|||
162749850|NCT04163991|587798221|FG004|Overall Study|Lost to Follow-up|0|||
162749851|NCT04163991|587798217|FG000|Overall Study|Withdrawal by Subject|1|||
162749852|NCT04163991|587798218|FG001|Overall Study|Withdrawal by Subject|1|||
162749853|NCT04163991|587798219|FG002|Overall Study|Withdrawal by Subject|3|||
162749854|NCT04163991|587798220|FG003|Overall Study|Withdrawal by Subject|1|||
162749855|NCT04163991|587798221|FG004|Overall Study|Withdrawal by Subject|1|||
162749856|NCT04163991|587798217|FG000|Overall Study|Other, Not Specified|0|||
162749857|NCT04163991|587798218|FG001|Overall Study|Other, Not Specified|1|||
162749858|NCT04163991|587798219|FG002|Overall Study|Other, Not Specified|1|||
162749859|NCT04163991|587798220|FG003|Overall Study|Other, Not Specified|1|||
162749860|NCT04163991|587798221|FG004|Overall Study|Other, Not Specified|0|||
162749861|NCT05953740|587798222|FG000|Period 1|Physician Decision|0|||
162749862|NCT05953740|587798223|FG001|Period 1|Physician Decision|1|||
162749863|NCT05953740|587798224|FG002|Period 1|Physician Decision|0|||
162749864|NCT05953740|587798225|FG003|Period 1|Physician Decision|0|||
162749865|NCT05953740|587798226|FG004|Period 1|Physician Decision|0|||
162749866|NCT05953740|587798227|FG005|Period 1|Physician Decision|0|||
162749867|NCT05953740|587798228|FG006|Period 1|Physician Decision|0|||
162749868|NCT05953740|587798229|FG007|Period 1|Physician Decision|0|||
162749869|NCT05953740|587798222|FG000|Period 2|Withdrawal by Subject|0|||
162749870|NCT05953740|587798223|FG001|Period 2|Withdrawal by Subject|1|||
162749871|NCT05953740|587798224|FG002|Period 2|Withdrawal by Subject|1|||
162749872|NCT05953740|587798225|FG003|Period 2|Withdrawal by Subject|0|||
162749873|NCT05953740|587798226|FG004|Period 2|Withdrawal by Subject|0|||
162749874|NCT05953740|587798227|FG005|Period 2|Withdrawal by Subject|0|||
162749875|NCT05953740|587798228|FG006|Period 2|Withdrawal by Subject|0|||
162749876|NCT05953740|587798229|FG007|Period 2|Withdrawal by Subject|0|||
162749877|NCT03817983|587798230|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
162749878|NCT03817983|587798231|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
162749879|NCT03817983|587798232|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
162749880|NCT02510235|587798233|FG000|Overall Study|Withdrawal by Subject|1|||
162749881|NCT02510235|587798234|FG001|Overall Study|Withdrawal by Subject|0|||
162749882|NCT00450216|587798235|FG000|Overall Study|Adverse Event|38|||
162749883|NCT00450216|587798236|FG001|Overall Study|Adverse Event|23|||
162749884|NCT00450216|587798235|FG000|Overall Study|Withdrawal by Subject|48|||
162749885|NCT00450216|587798236|FG001|Overall Study|Withdrawal by Subject|26|||
162749886|NCT00450216|587798235|FG000|Overall Study|Lost to Follow-up|16|||
162749887|NCT00450216|587798236|FG001|Overall Study|Lost to Follow-up|9|||
162749888|NCT00450216|587798235|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
162749889|NCT00450216|587798236|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
162749890|NCT00450216|587798235|FG000|Overall Study|misc|21|||
162749891|NCT00450216|587798236|FG001|Overall Study|misc|20|||
162749892|NCT05541484|587798241|FG000|Overall Study|Withdrawal by Subject|1|||
162749893|NCT05541484|587798242|FG001|Overall Study|Withdrawal by Subject|0|||
162749894|NCT03418740|587798247|FG000|Overall Study|Lost to Follow-up|13|||
162749895|NCT03418740|587798247|FG000|Overall Study|Scheduling Issues|7|||
162749896|NCT03418740|587798247|FG000|Overall Study|Withdrawal by Subject|2|||
162749897|NCT03418740|587798247|FG000|Overall Study|Unable to Continue Consent|1|||
162749898|NCT04499521|587798248|FG000|Overall Study|Disease Progression|1|||
162749899|NCT04499521|587798249|FG001|Overall Study|Disease Progression|0|||
162749900|NCT02585323|587799031|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
162749901|NCT02585323|587799032|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
162749902|NCT02585323|587799031|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
162749903|NCT02585323|587799032|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
162749904|NCT02585323|587799031|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
162749905|NCT02585323|587799032|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
162749906|NCT02585323|587799031|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
162749907|NCT02585323|587799032|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
162749908|NCT01130883|587799033|FG000|Overall Study|Patient Noncompliance|6|||
162749909|NCT01130883|587799033|FG000|Overall Study|Reason Unknown|1|||
162749910|NCT01130883|587799033|FG000|Overall Study|Adverse Event|3|||
162749911|NCT04165213|587799043|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
162749912|NCT04165213|587799044|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
162749913|NCT04165213|587799043|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
162749914|NCT04165213|587799044|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
162749915|NCT04165213|587799043|FG000|Clinician Enrollment|Termination from site|0|||
162749916|NCT04165213|587799044|FG001|Clinician Enrollment|Termination from site|1|||
162749917|NCT04165213|587799043|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
162749918|NCT04165213|587799044|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
162749919|NCT04165213|587799043|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
162749920|NCT04165213|587799044|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
162749921|NCT04165213|587799043|FG000|Caregiver Enrollment|Physician Decision|1|||
162749922|NCT04165213|587799044|FG001|Caregiver Enrollment|Physician Decision|0|||
162749923|NCT04165213|587799043|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
162749924|NCT04165213|587799044|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
162749925|NCT04165213|587799043|FG000|Caregiver Enrollment|PLWD death|2|||
162749926|NCT04165213|587799044|FG001|Caregiver Enrollment|PLWD death|0|||
162749927|NCT04165213|587799043|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
162749928|NCT04165213|587799044|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
162749929|NCT04165213|587799043|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
162749930|NCT04165213|587799044|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
162749931|NCT04165213|587799043|FG000|PLWD Enrollment|Lost to Follow-up|1|||
162749932|NCT04165213|587799044|FG001|PLWD Enrollment|Lost to Follow-up|1|||
162749933|NCT04165213|587799043|FG000|PLWD Enrollment|Physician Decision|1|||
162749934|NCT04165213|587799044|FG001|PLWD Enrollment|Physician Decision|0|||
162749935|NCT04165213|587799043|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
162749936|NCT04165213|587799044|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
162749937|NCT04165213|587799043|FG000|PLWD Enrollment|Death|2|||
162749938|NCT04165213|587799044|FG001|PLWD Enrollment|Death|0|||
162749939|NCT04165213|587799043|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
162749940|NCT04165213|587799044|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
162749941|NCT04464564|587799045|FG000|Period A (Placebo lead-in)|Other|5|||
162749942|NCT04464564|587799046|FG001|Period A (Placebo lead-in)|Other|0|||
162749943|NCT04464564|587799047|FG002|Period A (Placebo lead-in)|Other|0|||
162749944|NCT04464564|587799048|FG003|Period A (Placebo lead-in)|Other|0|||
162749945|NCT04464564|587799045|FG000|Period B (Randomization Period)|Adverse Event|0|||
162749946|NCT04464564|587799046|FG001|Period B (Randomization Period)|Adverse Event|1|||
162749947|NCT04464564|587799047|FG002|Period B (Randomization Period)|Adverse Event|2|||
162749948|NCT04464564|587799048|FG003|Period B (Randomization Period)|Adverse Event|8|||
162749949|NCT04464564|587799045|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
162749950|NCT04464564|587799046|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
162749951|NCT04464564|587799047|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
162749952|NCT04464564|587799048|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
162749953|NCT04464564|587799045|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
162749954|NCT04464564|587799046|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
162749955|NCT04464564|587799047|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
162749956|NCT04464564|587799048|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
162749957|NCT04464564|587799045|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
162749958|NCT04464564|587799046|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
162749959|NCT04464564|587799047|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
162749960|NCT04464564|587799048|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
162749961|NCT04464564|587799045|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
162749962|NCT04464564|587799046|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
162749963|NCT04464564|587799047|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
162749964|NCT04464564|587799048|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
162749965|NCT04464564|587799045|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
162749966|NCT04464564|587799046|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
162749967|NCT04464564|587799047|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
162749968|NCT04464564|587799048|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
162749969|NCT04464564|587799045|FG000|Period B (Randomization Period)|Reason not Specified|0|||
162749970|NCT04464564|587799046|FG001|Period B (Randomization Period)|Reason not Specified|3|||
162749971|NCT04464564|587799047|FG002|Period B (Randomization Period)|Reason not Specified|3|||
162749972|NCT04464564|587799048|FG003|Period B (Randomization Period)|Reason not Specified|3|||
162749973|NCT02278211|587799056|FG000|Overall Study|Unable to analyse PET scan|2|||
162749974|NCT01828021|587799059|FG000|Overall Study|Adverse Event|5|||
162749975|NCT01828021|587799059|FG000|Overall Study|Lack of Efficacy|17|||
162749976|NCT01828021|587799059|FG000|Overall Study|Withdrawal by Subject|2|||
162749977|NCT01828021|587799059|FG000|Overall Study|Ileal obstruction, unrelated|1|||
162749978|NCT00887198|587799065|FG000|Randomized Period|Ongoing|42|||
162749979|NCT00887198|587799066|FG001|Randomized Period|Ongoing|0|||
162749980|NCT00887198|587799067|FG002|Randomized Period|Ongoing|0|||
162749981|NCT00887198|587799065|FG000|Randomized Period|Adverse Event|50|||
162749982|NCT00887198|587799066|FG001|Randomized Period|Adverse Event|33|||
162749983|NCT00887198|587799067|FG002|Randomized Period|Adverse Event|0|||
162749984|NCT00887198|587799065|FG000|Randomized Period|Lost to Follow-up|1|||
162749985|NCT00887198|587799066|FG001|Randomized Period|Lost to Follow-up|0|||
162749986|NCT00887198|587799067|FG002|Randomized Period|Lost to Follow-up|0|||
162749987|NCT00887198|587799065|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
162925348|NCT00602641|588428937|FG001|Overall Study|Other|1|||
162749988|NCT00887198|587799066|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
162749989|NCT00887198|587799067|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
162749990|NCT00887198|587799065|FG000|Randomized Period|Withdrawal by Subject|41|||
162749991|NCT00887198|587799066|FG001|Randomized Period|Withdrawal by Subject|56|||
162749992|NCT00887198|587799067|FG002|Randomized Period|Withdrawal by Subject|0|||
162749993|NCT00887198|587799065|FG000|Randomized Period|Progressive disease|366|||
162749994|NCT00887198|587799066|FG001|Randomized Period|Progressive disease|370|||
162749995|NCT00887198|587799067|FG002|Randomized Period|Progressive disease|0|||
162749996|NCT00887198|587799065|FG000|Randomized Period|Other|42|||
162749997|NCT00887198|587799066|FG001|Randomized Period|Other|30|||
162749998|NCT00887198|587799067|FG002|Randomized Period|Other|0|||
162749999|NCT00887198|587799065|FG000|Randomized Period|Randomized, Not treated|4|||
162750000|NCT00887198|587799066|FG001|Randomized Period|Randomized, Not treated|2|||
162750001|NCT00887198|587799067|FG002|Randomized Period|Randomized, Not treated|0|||
162750002|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
162750003|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
162750004|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
162750005|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
162750006|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
162750007|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
162750008|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
162750009|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
162750010|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
162750011|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
162750012|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
162750013|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
162750014|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
162750015|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
162750016|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
162750017|NCT00887198|587799065|FG000|Cross Over (Placebo to AA)|Other|0|||
162750018|NCT00887198|587799066|FG001|Cross Over (Placebo to AA)|Other|0|||
162750019|NCT00887198|587799067|FG002|Cross Over (Placebo to AA)|Other|19|||
162750020|NCT02782676|587799068|FG000|Overall Study|Lost to Follow-up|0|||
162750021|NCT02782676|587799069|FG001|Overall Study|Lost to Follow-up|1|||
162750022|NCT00303459|587799075|FG000|Overall Study|Death|33|||
162750023|NCT00303459|587799076|FG001|Overall Study|Death|44|||
162750024|NCT00303459|587799075|FG000|Overall Study|Withdrawal of consent|32|||
162750025|NCT00303459|587799076|FG001|Overall Study|Withdrawal of consent|26|||
162750026|NCT00303459|587799075|FG000|Overall Study|Lost to Follow-up|5|||
162750027|NCT00303459|587799076|FG001|Overall Study|Lost to Follow-up|4|||
162750028|NCT00303459|587799075|FG000|Overall Study|Administrative reason|7|||
162750029|NCT00303459|587799076|FG001|Overall Study|Administrative reason|7|||
162750030|NCT00303459|587799075|FG000|Overall Study|Decision by the investigator|5|||
162750031|NCT00303459|587799076|FG001|Overall Study|Decision by the investigator|7|||
162750032|NCT00303459|587799075|FG000|Overall Study|Lung transplantation|1|||
162750033|NCT00303459|587799076|FG001|Overall Study|Lung transplantation|1|||
162750034|NCT04055012|587799077|FG000|Overall Study|Withdrawal by Subject|1|||
162750035|NCT04055012|587799078|FG001|Overall Study|Withdrawal by Subject|3|||
162750036|NCT04055012|587799079|FG002|Overall Study|Withdrawal by Subject|1|||
162750037|NCT04055012|587799080|FG003|Overall Study|Withdrawal by Subject|0|||
162750038|NCT04055012|587799077|FG000|Overall Study|Metformin Recall|1|||
162750039|NCT04055012|587799078|FG001|Overall Study|Metformin Recall|1|||
162750040|NCT04055012|587799079|FG002|Overall Study|Metformin Recall|1|||
162750041|NCT04055012|587799080|FG003|Overall Study|Metformin Recall|0|||
162750042|NCT02492711|587799084|FG000|Overall Study|Adverse Event|9|||
162750043|NCT02492711|587799085|FG001|Overall Study|Adverse Event|9|||
162750044|NCT02492711|587799086|FG002|Overall Study|Adverse Event|2|||
162750045|NCT02492711|587799084|FG000|Overall Study|Death|3|||
162750046|NCT02492711|587799085|FG001|Overall Study|Death|3|||
162750047|NCT02492711|587799086|FG002|Overall Study|Death|0|||
162750048|NCT02492711|587799084|FG000|Overall Study|Withdrawal by Subject|10|||
162750049|NCT02492711|587799085|FG001|Overall Study|Withdrawal by Subject|16|||
162750050|NCT02492711|587799086|FG002|Overall Study|Withdrawal by Subject|5|||
162750051|NCT02492711|587799084|FG000|Overall Study|Physician Decision|10|||
162750052|NCT02492711|587799085|FG001|Overall Study|Physician Decision|6|||
162750053|NCT02492711|587799086|FG002|Overall Study|Physician Decision|4|||
162750054|NCT02492711|587799084|FG000|Overall Study|Lost to Follow-up|0|||
162750055|NCT02492711|587799085|FG001|Overall Study|Lost to Follow-up|0|||
162750056|NCT02492711|587799086|FG002|Overall Study|Lost to Follow-up|1|||
162750057|NCT02492711|587799084|FG000|Overall Study|study treatment delay|2|||
162750058|NCT02492711|587799085|FG001|Overall Study|study treatment delay|1|||
162750059|NCT02492711|587799086|FG002|Overall Study|study treatment delay|0|||
162750060|NCT02492711|587799084|FG000|Overall Study|change in chemotherapy|0|||
162750061|NCT02492711|587799085|FG001|Overall Study|change in chemotherapy|1|||
162750062|NCT02492711|587799086|FG002|Overall Study|change in chemotherapy|0|||
162750063|NCT02492711|587799084|FG000|Overall Study|never treated|2|||
162750064|NCT02492711|587799085|FG001|Overall Study|never treated|4|||
162750065|NCT02492711|587799086|FG002|Overall Study|never treated|0|||
162750066|NCT02492711|587799084|FG000|Overall Study|Other|0|||
162750067|NCT02492711|587799085|FG001|Overall Study|Other|0|||
162750068|NCT02492711|587799086|FG002|Overall Study|Other|1|||
162750069|NCT05830799|587799090|FG000|Overall Study|Withdrawal by Subject|1|||
162750070|NCT03652272|587799091|FG000|3 Month|Withdrawal by Subject|1|||
162750071|NCT03652272|587799092|FG001|3 Month|Withdrawal by Subject|1|||
162750072|NCT03652272|587799091|FG000|3 Month|Lost to Follow-up|16|||
162750073|NCT03652272|587799092|FG001|3 Month|Lost to Follow-up|14|||
162750074|NCT02163694|587799093|FG000|Overall Study|Adverse event- related to progression|4|||
162750075|NCT02163694|587799094|FG001|Overall Study|Adverse event- related to progression|10|||
162750076|NCT02163694|587799093|FG000|Overall Study|Adverse event- not related to progression|7|||
162750077|NCT02163694|587799094|FG001|Overall Study|Adverse event- not related to progression|22|||
162750078|NCT02163694|587799093|FG000|Overall Study|Withdrew consent|13|||
162750079|NCT02163694|587799094|FG001|Overall Study|Withdrew consent|28|||
162750080|NCT02163694|587799093|FG000|Overall Study|Lost to Follow-up|2|||
162750081|NCT02163694|587799094|FG001|Overall Study|Lost to Follow-up|2|||
162750082|NCT02163694|587799093|FG000|Overall Study|Sponsor discontinued study|3|||
162750083|NCT02163694|587799094|FG001|Overall Study|Sponsor discontinued study|29|||
162750084|NCT02163694|587799093|FG000|Overall Study|Progressive disease per protocol|125|||
162750085|NCT02163694|587799094|FG001|Overall Study|Progressive disease per protocol|224|||
162750086|NCT02163694|587799093|FG000|Overall Study|Other, not specified|17|||
162750087|NCT02163694|587799094|FG001|Overall Study|Other, not specified|22|||
162750088|NCT02163694|587799093|FG000|Overall Study|Randomized but Not Treated|1|||
162750089|NCT02163694|587799094|FG001|Overall Study|Randomized but Not Treated|0|||
162750090|NCT02163694|587799093|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
162750091|NCT02163694|587799094|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
162750092|NCT03884101|587799095|FG000|Overall Study|Participant Ongoing in Study|202|||
162750093|NCT03884101|587799096|FG001|Overall Study|Participant Ongoing in Study|186|||
162750094|NCT03884101|587799095|FG000|Overall Study|Death|212|||
162750095|NCT03884101|587799096|FG001|Overall Study|Death|224|||
162750096|NCT03884101|587799095|FG000|Overall Study|Lost to Follow-up|0|||
162750097|NCT03884101|587799096|FG001|Overall Study|Lost to Follow-up|1|||
162750098|NCT03884101|587799095|FG000|Overall Study|Withdrawal by Subject|6|||
162750099|NCT03884101|587799096|FG001|Overall Study|Withdrawal by Subject|11|||
162750100|NCT03880955|587799103|FG000|Overall Study|Adverse Event|1|||
162750101|NCT03880955|587799103|FG000|Overall Study|Death|1|||
162750102|NCT03880955|587799103|FG000|Overall Study|Lost to Follow-up|12|||
162750103|NCT03880955|587799103|FG000|Overall Study|Withdrawal by Subject|4|||
162750104|NCT03880955|587799103|FG000|Overall Study|Missing- Study Site Closed|27|||
162750105|NCT05112900|587799104|FG000|Overall Study|Withdrawal by Subject|960|||
162750106|NCT05112900|587799105|FG001|Overall Study|Withdrawal by Subject|921|||
162750107|NCT05112900|587799106|FG002|Overall Study|Withdrawal by Subject|968|||
162750108|NCT02919917|587799107|FG000|Overall Study|Withdrawal by Subject|4|||
162750109|NCT02919917|587799108|FG001|Overall Study|Withdrawal by Subject|8|||
162750110|NCT04743973|587799109|FG000|Overall Study|Withdrawal by Subject|5|||
162750111|NCT02461134|587799114|FG000|Overall Study|Adverse Event|1|||
162750112|NCT00626795|587799115|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
162750113|NCT00626795|587799116|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
162750114|NCT00626795|587799117|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
162750115|NCT00626795|587799115|FG000|Blinded Treatment|Lack of Efficacy|2|||
162750116|NCT00626795|587799116|FG001|Blinded Treatment|Lack of Efficacy|0|||
162750117|NCT00626795|587799117|FG002|Blinded Treatment|Lack of Efficacy|0|||
162750118|NCT00626795|587799115|FG000|Blinded Treatment|Unacceptable adverse event|0|||
162750119|NCT00626795|587799116|FG001|Blinded Treatment|Unacceptable adverse event|0|||
162750120|NCT00626795|587799117|FG002|Blinded Treatment|Unacceptable adverse event|1|||
162750121|NCT00626795|587799115|FG000|Blinded Treatment|Protocol Violation|0|||
162750122|NCT00626795|587799116|FG001|Blinded Treatment|Protocol Violation|1|||
162750123|NCT00626795|587799117|FG002|Blinded Treatment|Protocol Violation|1|||
162750124|NCT00626795|587799115|FG000|Blinded Treatment|Withdrawal by Subject|1|||
162750125|NCT00626795|587799116|FG001|Blinded Treatment|Withdrawal by Subject|1|||
162750126|NCT00626795|587799117|FG002|Blinded Treatment|Withdrawal by Subject|0|||
162750127|NCT00626795|587799115|FG000|Blinded Treatment|Other reasons|2|||
162750128|NCT00626795|587799116|FG001|Blinded Treatment|Other reasons|0|||
162750129|NCT00626795|587799117|FG002|Blinded Treatment|Other reasons|2|||
162750130|NCT00626795|587799115|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
162750131|NCT00626795|587799116|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
162750132|NCT00626795|587799117|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
162750133|NCT05412004|587799858|FG000|Overall Study|Adverse Event|0|||
162750134|NCT05412004|587799859|FG001|Overall Study|Adverse Event|2|||
162750135|NCT05412004|587799860|FG002|Overall Study|Adverse Event|1|||
162750136|NCT05412004|587799861|FG003|Overall Study|Adverse Event|5|||
162750137|NCT05412004|587799858|FG000|Overall Study|Assigned Treatment by Mistake|5|||
162750138|NCT05412004|587799859|FG001|Overall Study|Assigned Treatment by Mistake|10|||
162750139|NCT05412004|587799860|FG002|Overall Study|Assigned Treatment by Mistake|2|||
162750140|NCT05412004|587799861|FG003|Overall Study|Assigned Treatment by Mistake|5|||
162750141|NCT05412004|587799858|FG000|Overall Study|Lost to Follow-up|3|||
162750142|NCT05412004|587799859|FG001|Overall Study|Lost to Follow-up|0|||
162750143|NCT05412004|587799860|FG002|Overall Study|Lost to Follow-up|0|||
162750144|NCT05412004|587799861|FG003|Overall Study|Lost to Follow-up|0|||
162750145|NCT05412004|587799858|FG000|Overall Study|Patient could not travel to site|0|||
162750146|NCT05412004|587799859|FG001|Overall Study|Patient could not travel to site|1|||
162750147|NCT05412004|587799860|FG002|Overall Study|Patient could not travel to site|0|||
162750148|NCT05412004|587799861|FG003|Overall Study|Patient could not travel to site|0|||
162750149|NCT05412004|587799858|FG000|Overall Study|Physician Decision|0|||
162750150|NCT05412004|587799859|FG001|Overall Study|Physician Decision|1|||
162750151|NCT05412004|587799860|FG002|Overall Study|Physician Decision|0|||
162750152|NCT05412004|587799861|FG003|Overall Study|Physician Decision|0|||
162750153|NCT05412004|587799858|FG000|Overall Study|Pregnancy|0|||
162750154|NCT05412004|587799859|FG001|Overall Study|Pregnancy|1|||
162750155|NCT05412004|587799860|FG002|Overall Study|Pregnancy|0|||
162750156|NCT05412004|587799861|FG003|Overall Study|Pregnancy|0|||
162750157|NCT05412004|587799858|FG000|Overall Study|Protocol Violation|1|||
162750158|NCT05412004|587799859|FG001|Overall Study|Protocol Violation|0|||
162750159|NCT05412004|587799860|FG002|Overall Study|Protocol Violation|0|||
162750160|NCT05412004|587799861|FG003|Overall Study|Protocol Violation|0|||
162750161|NCT05412004|587799858|FG000|Overall Study|Withdrawal by Subject|4|||
162750162|NCT05412004|587799859|FG001|Overall Study|Withdrawal by Subject|19|||
162750163|NCT05412004|587799860|FG002|Overall Study|Withdrawal by Subject|4|||
162750164|NCT05412004|587799861|FG003|Overall Study|Withdrawal by Subject|14|||
162750165|NCT05412004|587799858|FG000|Overall Study|Screen Failure|0|||
162750166|NCT05412004|587799859|FG001|Overall Study|Screen Failure|0|||
162750167|NCT05412004|587799860|FG002|Overall Study|Screen Failure|0|||
162750168|NCT05412004|587799861|FG003|Overall Study|Screen Failure|1|||
162750169|NCT05412004|587799858|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162750170|NCT05412004|587799859|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162750171|NCT05412004|587799860|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162750172|NCT05412004|587799861|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
162750173|NCT03781089|587799862|FG000|Overall Study|Constipation|1|||
162750174|NCT03781089|587799863|FG001|Overall Study|Constipation|0|||
162750175|NCT03781089|587799862|FG000|Overall Study|Positive pregnancy test|0|||
162750176|NCT03781089|587799863|FG001|Overall Study|Positive pregnancy test|1|||
162750177|NCT04644029|587799864|FG000|Overall Study|Death|1|||
162750178|NCT04644029|587799865|FG001|Overall Study|Death|0|||
162750179|NCT04644029|587799864|FG000|Overall Study|Physician Decision|1|||
162750180|NCT04644029|587799865|FG001|Overall Study|Physician Decision|2|||
162750181|NCT04644029|587799864|FG000|Overall Study|Withdrawal by Subject|21|||
162750182|NCT04644029|587799865|FG001|Overall Study|Withdrawal by Subject|19|||
162750183|NCT04644029|587799864|FG000|Overall Study|Lost to Follow-up|31|||
162750184|NCT04644029|587799865|FG001|Overall Study|Lost to Follow-up|34|||
162750185|NCT04644029|587799864|FG000|Overall Study|Study Terminated by Sponsor|308|||
162750186|NCT04644029|587799865|FG001|Overall Study|Study Terminated by Sponsor|309|||
162750187|NCT04644029|587799864|FG000|Overall Study|Randomized in Error|2|||
162750188|NCT04644029|587799865|FG001|Overall Study|Randomized in Error|1|||
162750189|NCT04644029|587799864|FG000|Overall Study|Other|0|||
162750190|NCT04644029|587799865|FG001|Overall Study|Other|1|||
162750191|NCT05132400|587799866|FG000|Overall Study|Withdrawal by Subject|14|||
162750192|NCT05132400|587799867|FG001|Overall Study|Withdrawal by Subject|8|||
162750193|NCT05132400|587799866|FG000|Overall Study|Lost to Follow-up|132|||
162750194|NCT05132400|587799867|FG001|Overall Study|Lost to Follow-up|121|||
162750195|NCT02246127|587799870|FG000|First Course Treatment|Adverse Event|9|||
162750196|NCT02246127|587799871|FG001|First Course Treatment|Adverse Event|7|||
162750197|NCT02246127|587799870|FG000|First Course Treatment|Withdrawal by Subject|6|||
162750198|NCT02246127|587799871|FG001|First Course Treatment|Withdrawal by Subject|7|||
162750199|NCT02246127|587799870|FG000|First Course Treatment|Physician Decision|9|||
162750200|NCT02246127|587799871|FG001|First Course Treatment|Physician Decision|9|||
162750201|NCT02246127|587799870|FG000|First Course Treatment|Death|3|||
162750202|NCT02246127|587799871|FG001|First Course Treatment|Death|3|||
162750203|NCT02246127|587799870|FG000|First Course Treatment|Not reported reasons|6|||
162750204|NCT02246127|587799871|FG001|First Course Treatment|Not reported reasons|7|||
162750205|NCT02246127|587799870|FG000|First Course Treatment|Not treated|3|||
162750206|NCT02246127|587799871|FG001|First Course Treatment|Not treated|3|||
162750207|NCT00739908|587799872|FG000|Overall Study|Adverse Event|5|||
162750208|NCT00739908|587799873|FG001|Overall Study|Adverse Event|6|||
162750209|NCT00739908|587799872|FG000|Overall Study|Withdrawal by Subject|4|||
162750210|NCT00739908|587799873|FG001|Overall Study|Withdrawal by Subject|2|||
162750211|NCT00739908|587799872|FG000|Overall Study|Lost to Follow-up|14|||
162750212|NCT00739908|587799873|FG001|Overall Study|Lost to Follow-up|9|||
162750213|NCT00739908|587799872|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
162750214|NCT00739908|587799873|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
162750215|NCT00739908|587799872|FG000|Overall Study|Non-Compliance With Study Medication|0|||
162750216|NCT00739908|587799873|FG001|Overall Study|Non-Compliance With Study Medication|3|||
162750217|NCT00739908|587799872|FG000|Overall Study|Lack of Efficacy|0|||
162750218|NCT00739908|587799873|FG001|Overall Study|Lack of Efficacy|1|||
162750219|NCT00739908|587799872|FG000|Overall Study|Relocation|0|||
162750220|NCT00739908|587799873|FG001|Overall Study|Relocation|1|||
162750221|NCT02076009|587799874|FG000|Overall Study|Death|172|||
162750222|NCT02076009|587799875|FG001|Overall Study|Death|153|||
162750223|NCT02076009|587799874|FG000|Overall Study|Withdrawal by Subject|16|||
162750224|NCT02076009|587799875|FG001|Overall Study|Withdrawal by Subject|12|||
162750225|NCT02076009|587799874|FG000|Overall Study|Lost to Follow-up|4|||
162750226|NCT02076009|587799875|FG001|Overall Study|Lost to Follow-up|2|||
162750227|NCT02076009|587799874|FG000|Overall Study|Progressive Disease|1|||
162750228|NCT02076009|587799875|FG001|Overall Study|Progressive Disease|0|||
162750229|NCT02076009|587799874|FG000|Overall Study|Physician Decision|0|||
162750230|NCT02076009|587799875|FG001|Overall Study|Physician Decision|1|||
162750231|NCT02076009|587799874|FG000|Overall Study|End of data collection|90|||
162750232|NCT02076009|587799875|FG001|Overall Study|End of data collection|118|||
162750233|NCT03786926|587799876|FG000|Overall Study|Adverse Event|0|||
162750234|NCT03786926|587799877|FG001|Overall Study|Adverse Event|0|||
162750235|NCT03786926|587799878|FG002|Overall Study|Adverse Event|0|||
162750236|NCT03786926|587799879|FG003|Overall Study|Adverse Event|0|||
162750237|NCT03786926|587799880|FG004|Overall Study|Adverse Event|0|||
162750238|NCT03786926|587799881|FG005|Overall Study|Adverse Event|0|||
162750239|NCT03786926|587799882|FG006|Overall Study|Adverse Event|0|||
162750240|NCT03786926|587799883|FG007|Overall Study|Adverse Event|1|||
162750241|NCT03786926|587799884|FG008|Overall Study|Adverse Event|1|||
162750242|NCT03786926|587799885|FG009|Overall Study|Adverse Event|0|||
162750243|NCT03786926|587799886|FG010|Overall Study|Adverse Event|1|||
162750244|NCT03786926|587799876|FG000|Overall Study|Progressive disease|3|||
162750245|NCT03786926|587799877|FG001|Overall Study|Progressive disease|0|||
162750246|NCT03786926|587799878|FG002|Overall Study|Progressive disease|3|||
162750247|NCT03786926|587799879|FG003|Overall Study|Progressive disease|1|||
162750248|NCT03786926|587799880|FG004|Overall Study|Progressive disease|2|||
162750249|NCT03786926|587799881|FG005|Overall Study|Progressive disease|2|||
162750250|NCT03786926|587799882|FG006|Overall Study|Progressive disease|1|||
162750251|NCT03786926|587799883|FG007|Overall Study|Progressive disease|6|||
162750252|NCT03786926|587799884|FG008|Overall Study|Progressive disease|1|||
162750253|NCT03786926|587799885|FG009|Overall Study|Progressive disease|1|||
162750254|NCT03786926|587799886|FG010|Overall Study|Progressive disease|1|||
162750255|NCT03786926|587799876|FG000|Overall Study|Death|0|||
162750256|NCT03786926|587799877|FG001|Overall Study|Death|1|||
162750257|NCT03786926|587799878|FG002|Overall Study|Death|1|||
162750258|NCT03786926|587799879|FG003|Overall Study|Death|0|||
162750259|NCT03786926|587799880|FG004|Overall Study|Death|0|||
162750260|NCT03786926|587799881|FG005|Overall Study|Death|0|||
162750261|NCT03786926|587799882|FG006|Overall Study|Death|0|||
162750262|NCT03786926|587799883|FG007|Overall Study|Death|0|||
162750263|NCT03786926|587799884|FG008|Overall Study|Death|0|||
162750264|NCT03786926|587799885|FG009|Overall Study|Death|1|||
162750265|NCT03786926|587799886|FG010|Overall Study|Death|2|||
162750266|NCT03786926|587799876|FG000|Overall Study|Physician Decision|0|||
162750267|NCT03786926|587799877|FG001|Overall Study|Physician Decision|1|||
162750268|NCT03786926|587799878|FG002|Overall Study|Physician Decision|0|||
162750269|NCT03786926|587799879|FG003|Overall Study|Physician Decision|1|||
162750270|NCT03786926|587799880|FG004|Overall Study|Physician Decision|2|||
162750271|NCT03786926|587799881|FG005|Overall Study|Physician Decision|0|||
162750272|NCT03786926|587799882|FG006|Overall Study|Physician Decision|0|||
162750273|NCT03786926|587799883|FG007|Overall Study|Physician Decision|2|||
162750274|NCT03786926|587799884|FG008|Overall Study|Physician Decision|1|||
162750275|NCT03786926|587799885|FG009|Overall Study|Physician Decision|1|||
162750276|NCT03786926|587799886|FG010|Overall Study|Physician Decision|0|||
162750277|NCT03786926|587799876|FG000|Overall Study|Withdrawal by Subject|0|||
162750278|NCT03786926|587799877|FG001|Overall Study|Withdrawal by Subject|1|||
162750279|NCT03786926|587799878|FG002|Overall Study|Withdrawal by Subject|1|||
162750280|NCT03786926|587799879|FG003|Overall Study|Withdrawal by Subject|0|||
162750281|NCT03786926|587799880|FG004|Overall Study|Withdrawal by Subject|0|||
162750282|NCT03786926|587799881|FG005|Overall Study|Withdrawal by Subject|0|||
162750283|NCT03786926|587799882|FG006|Overall Study|Withdrawal by Subject|1|||
162750284|NCT03786926|587799883|FG007|Overall Study|Withdrawal by Subject|0|||
162750285|NCT03786926|587799884|FG008|Overall Study|Withdrawal by Subject|1|||
162750286|NCT03786926|587799885|FG009|Overall Study|Withdrawal by Subject|0|||
162750287|NCT03786926|587799886|FG010|Overall Study|Withdrawal by Subject|1|||
162750288|NCT03786926|587799876|FG000|Overall Study|Study terminated by Sponsor|0|||
162750289|NCT03786926|587799877|FG001|Overall Study|Study terminated by Sponsor|0|||
162750290|NCT03786926|587799878|FG002|Overall Study|Study terminated by Sponsor|0|||
162750291|NCT03786926|587799879|FG003|Overall Study|Study terminated by Sponsor|0|||
162750292|NCT03786926|587799880|FG004|Overall Study|Study terminated by Sponsor|1|||
162750293|NCT03786926|587799881|FG005|Overall Study|Study terminated by Sponsor|0|||
162750294|NCT03786926|587799882|FG006|Overall Study|Study terminated by Sponsor|0|||
162750295|NCT03786926|587799883|FG007|Overall Study|Study terminated by Sponsor|4|||
162750296|NCT03786926|587799884|FG008|Overall Study|Study terminated by Sponsor|0|||
162750297|NCT03786926|587799885|FG009|Overall Study|Study terminated by Sponsor|0|||
162750298|NCT03786926|587799886|FG010|Overall Study|Study terminated by Sponsor|0|||
162750299|NCT03786926|587799876|FG000|Overall Study|Anti-neoplasm treatment|0|||
162750300|NCT03786926|587799877|FG001|Overall Study|Anti-neoplasm treatment|0|||
162750301|NCT03786926|587799878|FG002|Overall Study|Anti-neoplasm treatment|0|||
162750302|NCT03786926|587799879|FG003|Overall Study|Anti-neoplasm treatment|0|||
162750303|NCT03786926|587799880|FG004|Overall Study|Anti-neoplasm treatment|1|||
162750304|NCT03786926|587799881|FG005|Overall Study|Anti-neoplasm treatment|0|||
162750305|NCT03786926|587799882|FG006|Overall Study|Anti-neoplasm treatment|1|||
162750306|NCT03786926|587799883|FG007|Overall Study|Anti-neoplasm treatment|0|||
162750307|NCT03786926|587799884|FG008|Overall Study|Anti-neoplasm treatment|0|||
162750308|NCT03786926|587799885|FG009|Overall Study|Anti-neoplasm treatment|0|||
162750309|NCT03786926|587799886|FG010|Overall Study|Anti-neoplasm treatment|0|||
162750310|NCT03786926|587799876|FG000|Overall Study|Other|0|||
162750311|NCT03786926|587799877|FG001|Overall Study|Other|0|||
162750312|NCT03786926|587799878|FG002|Overall Study|Other|0|||
162750313|NCT03786926|587799879|FG003|Overall Study|Other|1|||
162750314|NCT03786926|587799880|FG004|Overall Study|Other|0|||
162750315|NCT03786926|587799881|FG005|Overall Study|Other|1|||
162750316|NCT03786926|587799882|FG006|Overall Study|Other|0|||
162750317|NCT03786926|587799883|FG007|Overall Study|Other|0|||
162750318|NCT03786926|587799884|FG008|Overall Study|Other|2|||
162750319|NCT03786926|587799885|FG009|Overall Study|Other|0|||
162750320|NCT03786926|587799886|FG010|Overall Study|Other|0|||
162750321|NCT05988398|587799887|FG000|Overall Study|Lack of time|21|||
162750322|NCT05988398|587799888|FG001|Overall Study|Lack of time|0|||
162750323|NCT05988398|587799887|FG000|Overall Study|Absent from school|0|||
162750324|NCT05988398|587799888|FG001|Overall Study|Absent from school|38|||
162750325|NCT05988398|587799887|FG000|Overall Study|Chose not to participate|0|||
162750326|NCT05988398|587799888|FG001|Overall Study|Chose not to participate|42|||
162750327|NCT05988398|587799887|FG000|Overall Study|Other commitments (e.g., sports)|0|||
162750328|NCT05988398|587799888|FG001|Overall Study|Other commitments (e.g., sports)|25|||
162750329|NCT03733626|587799889|FG000|Overall Study|Physician Decision|4|||
162750330|NCT03733626|587799890|FG001|Overall Study|Physician Decision|4|||
162750331|NCT05147584|587799891|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
162750332|NCT05454514|587799896|FG000|Overall Study|Withdrawal by Subject|4|||
162750333|NCT01438853|587799899|FG000|Overall Study|Death|0|||
162750334|NCT01438853|587799900|FG001|Overall Study|Death|0|||
162750335|NCT01438853|587799901|FG002|Overall Study|Death|0|||
162750336|NCT01438853|587799902|FG003|Overall Study|Death|1|||
162750337|NCT01438853|587799899|FG000|Overall Study|Withdrawal by Subject|0|||
162750338|NCT01438853|587799900|FG001|Overall Study|Withdrawal by Subject|0|||
162750339|NCT01438853|587799901|FG002|Overall Study|Withdrawal by Subject|1|||
162750340|NCT01438853|587799902|FG003|Overall Study|Withdrawal by Subject|0|||
162750341|NCT03279978|587799904|FG000|Overall Study|Withdrawal by Subject|0|||
162750342|NCT03279978|587799905|FG001|Overall Study|Withdrawal by Subject|1|||
162750343|NCT03279978|587799906|FG002|Overall Study|Withdrawal by Subject|0|||
162750344|NCT03279978|587799907|FG003|Overall Study|Withdrawal by Subject|0|||
162750345|NCT03279978|587799908|FG004|Overall Study|Withdrawal by Subject|0|||
162750346|NCT03279978|587799909|FG005|Overall Study|Withdrawal by Subject|0|||
162750347|NCT03279978|587799910|FG006|Overall Study|Withdrawal by Subject|0|||
162750348|NCT03279978|587799911|FG007|Overall Study|Withdrawal by Subject|0|||
162750349|NCT03279978|587799912|FG008|Overall Study|Withdrawal by Subject|0|||
162750350|NCT03279978|587799913|FG009|Overall Study|Withdrawal by Subject|1|||
162750351|NCT03279978|587799904|FG000|Overall Study|Lost to Follow-up|1|||
162750352|NCT03279978|587799905|FG001|Overall Study|Lost to Follow-up|0|||
162750353|NCT03279978|587799906|FG002|Overall Study|Lost to Follow-up|1|||
162750354|NCT03279978|587799907|FG003|Overall Study|Lost to Follow-up|0|||
162750355|NCT03279978|587799908|FG004|Overall Study|Lost to Follow-up|0|||
162750356|NCT03279978|587799909|FG005|Overall Study|Lost to Follow-up|0|||
162750357|NCT03279978|587799910|FG006|Overall Study|Lost to Follow-up|0|||
162750358|NCT03279978|587799911|FG007|Overall Study|Lost to Follow-up|0|||
162750359|NCT03279978|587799912|FG008|Overall Study|Lost to Follow-up|0|||
162750360|NCT03279978|587799913|FG009|Overall Study|Lost to Follow-up|0|||
162750361|NCT03279978|587799904|FG000|Overall Study|Other than stated above|0|||
162750362|NCT03279978|587799905|FG001|Overall Study|Other than stated above|0|||
162750363|NCT03279978|587799906|FG002|Overall Study|Other than stated above|0|||
162750364|NCT03279978|587799907|FG003|Overall Study|Other than stated above|0|||
162750365|NCT03279978|587799908|FG004|Overall Study|Other than stated above|0|||
162750366|NCT03279978|587799909|FG005|Overall Study|Other than stated above|0|||
162750367|NCT03279978|587799910|FG006|Overall Study|Other than stated above|1|||
162750368|NCT03279978|587799911|FG007|Overall Study|Other than stated above|0|||
162750369|NCT03279978|587799912|FG008|Overall Study|Other than stated above|0|||
162750370|NCT03279978|587799913|FG009|Overall Study|Other than stated above|0|||
162750371|NCT04159519|587799914|FG000|Overall Study|Adverse Event|1|||
162750372|NCT04159519|587799915|FG001|Overall Study|Adverse Event|1|||
162750373|NCT04159519|587799914|FG000|Overall Study|Lack of Efficacy|1|||
162750374|NCT04159519|587799915|FG001|Overall Study|Lack of Efficacy|0|||
162750375|NCT04159519|587799914|FG000|Overall Study|Discontinued from study|1|||
162750376|NCT04159519|587799915|FG001|Overall Study|Discontinued from study|0|||
162750377|NCT04159519|587799914|FG000|Overall Study|Protocol Violation|1|||
162750378|NCT04159519|587799915|FG001|Overall Study|Protocol Violation|1|||
162750379|NCT04159519|587799914|FG000|Overall Study|Withdrawal by Subject|4|||
162750380|NCT04159519|587799915|FG001|Overall Study|Withdrawal by Subject|4|||
162750381|NCT03493542|587799918|FG000|Base Study|Withdrawal by Subject|0|||
162750382|NCT03493542|587799919|FG001|Base Study|Withdrawal by Subject|4|||
162750383|NCT03493542|587799920|FG002|Base Study|Withdrawal by Subject|0|||
162750384|NCT03493542|587799918|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
162750385|NCT03493542|587799919|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
162750386|NCT03493542|587799920|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
162750387|NCT03493542|587799918|FG000|Extension Study|Withdrawal by Subject|0|||
162750388|NCT03493542|587799919|FG001|Extension Study|Withdrawal by Subject|0|||
162750389|NCT03493542|587799920|FG002|Extension Study|Withdrawal by Subject|25|||
162750390|NCT01651000|587799921|FG000|Overall Study|Adverse Event|2|||
162750391|NCT01651000|587799922|FG001|Overall Study|Adverse Event|8|||
162750392|NCT01651000|587799921|FG000|Overall Study|Lost to Follow-up|3|||
162750393|NCT01651000|587799922|FG001|Overall Study|Lost to Follow-up|2|||
162750394|NCT01651000|587799921|FG000|Overall Study|Protocol Violation|0|||
162750395|NCT01651000|587799922|FG001|Overall Study|Protocol Violation|3|||
162750396|NCT01651000|587799921|FG000|Overall Study|Withdrawal by Subject|2|||
162750397|NCT01651000|587799922|FG001|Overall Study|Withdrawal by Subject|10|||
162750398|NCT01651000|587799921|FG000|Overall Study|Subject noncompliance|0|||
162750399|NCT01651000|587799922|FG001|Overall Study|Subject noncompliance|3|||
162750400|NCT01651000|587799921|FG000|Overall Study|Lack of Efficacy|1|||
162750401|NCT01651000|587799922|FG001|Overall Study|Lack of Efficacy|1|||
162750402|NCT01651000|587799921|FG000|Overall Study|Physician Decision|1|||
162750403|NCT01651000|587799922|FG001|Overall Study|Physician Decision|0|||
162750404|NCT01651000|587799921|FG000|Overall Study|Administrative reason|1|||
162750405|NCT01651000|587799922|FG001|Overall Study|Administrative reason|0|||
162750406|NCT01651000|587799921|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
162750407|NCT01651000|587799922|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
162750408|NCT03734029|587799923|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
162750409|NCT03734029|587799924|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
162750410|NCT03734029|587799923|FG000|Overall Study|Adverse Event|60|||
162750411|NCT03734029|587799924|FG001|Overall Study|Adverse Event|14|||
162750412|NCT03734029|587799923|FG000|Overall Study|Withdrawal by Subject|12|||
162750413|NCT03734029|587799924|FG001|Overall Study|Withdrawal by Subject|11|||
162750414|NCT03734029|587799923|FG000|Overall Study|Clinical progression by investigator|10|||
162750415|NCT03734029|587799924|FG001|Overall Study|Clinical progression by investigator|8|||
162750416|NCT03734029|587799923|FG000|Overall Study|Death|5|||
162750417|NCT03734029|587799924|FG001|Overall Study|Death|2|||
162750418|NCT03734029|587799923|FG000|Overall Study|Physician Decision|4|||
162750419|NCT03734029|587799924|FG001|Overall Study|Physician Decision|3|||
162750420|NCT03734029|587799923|FG000|Overall Study|Other|2|||
162750421|NCT03734029|587799924|FG001|Overall Study|Other|0|||
162750422|NCT03734029|587799923|FG000|Overall Study|Lost to Follow-up|0|||
162750423|NCT03734029|587799924|FG001|Overall Study|Lost to Follow-up|1|||
162750424|NCT03734029|587799923|FG000|Overall Study|Randomized, but not treated|2|||
162750425|NCT03734029|587799924|FG001|Overall Study|Randomized, but not treated|12|||
162750426|NCT02611687|587800561|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
162750427|NCT02611687|587800562|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
162750428|NCT03934931|587800563|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
162750429|NCT03934931|587800564|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
162750430|NCT03934931|587800565|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
162750431|NCT03635567|587800568|FG000|Overall Study|Lost to Follow-up|4|||
162750432|NCT03635567|587800569|FG001|Overall Study|Lost to Follow-up|1|||
162750433|NCT03635567|587800568|FG000|Overall Study|Withdrawal by Subject|11|||
162750434|NCT03635567|587800569|FG001|Overall Study|Withdrawal by Subject|16|||
162750435|NCT03635567|587800568|FG000|Overall Study|Sponsor Decision|99|||
162750436|NCT03635567|587800569|FG001|Overall Study|Sponsor Decision|57|||
162750437|NCT03635567|587800568|FG000|Overall Study|Death|194|||
162750438|NCT03635567|587800569|FG001|Overall Study|Death|235|||
162750439|NCT05157841|587800570|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
162750440|NCT05157841|587800571|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
162750441|NCT05157841|587800572|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
162750442|NCT05157841|587800570|FG000|Part A (14 Days)|Adverse Event|1|||
162750443|NCT05157841|587800571|FG001|Part A (14 Days)|Adverse Event|0|||
162750444|NCT05157841|587800572|FG002|Part A (14 Days)|Adverse Event|0|||
162750445|NCT05157841|587800570|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
162750446|NCT05157841|587800571|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
162750447|NCT05157841|587800572|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
162750448|NCT04757753|587800574|FG000|Overall Study|Lost to Follow-up|7|||
162750449|NCT04757753|587800575|FG001|Overall Study|Lost to Follow-up|7|||
162750450|NCT04757753|587800574|FG000|Overall Study|Withdrawal by Subject|0|||
162750451|NCT04757753|587800575|FG001|Overall Study|Withdrawal by Subject|3|||
162750452|NCT04757753|587800574|FG000|Overall Study|Endodontic treatment failure|1|||
162750453|NCT04757753|587800575|FG001|Overall Study|Endodontic treatment failure|2|||
162750454|NCT04757753|587800574|FG000|Overall Study|Tooth fracture/extraction|3|||
162750455|NCT04757753|587800575|FG001|Overall Study|Tooth fracture/extraction|0|||
162750456|NCT00942734|587800581|FG000|Overall Study|Adverse Event|2|||
162750457|NCT00942734|587800581|FG000|Overall Study|Protocol Violation|3|||
162750458|NCT00942734|587800581|FG000|Overall Study|Disease Progression|2|||
162750459|NCT00942734|587800581|FG000|Overall Study|Physician Decision|1|||
162750460|NCT00319046|587800582|FG000|Overall Study|withdrawal of subject's consent|7|||
162750461|NCT00319046|587800582|FG000|Overall Study|administrative reason|1|||
162750462|NCT03370913|587800586|FG000|Overall Study|Death|1|||
162750463|NCT03370913|587800586|FG000|Overall Study|Lost to Follow-up|1|||
162750464|NCT03816397|587800587|FG000|Overall Study|Censored at interim analysis date.|13|||
162750465|NCT03816397|587800588|FG001|Overall Study|Censored at interim analysis date.|6|||
162750466|NCT03816397|587800587|FG000|Overall Study|Withdrawal by Subject|1|||
162750467|NCT03816397|587800588|FG001|Overall Study|Withdrawal by Subject|1|||
162750468|NCT04560179|587800591|FG000|Overall Study|Physician Decision|1|||
162750469|NCT04560179|587800592|FG001|Overall Study|Physician Decision|0|||
162750470|NCT04560179|587800593|FG002|Overall Study|Physician Decision|0|||
162750471|NCT04560179|587800594|FG003|Overall Study|Physician Decision|0|||
162750472|NCT04560179|587800595|FG004|Overall Study|Physician Decision|0|||
162750473|NCT04560179|587800591|FG000|Overall Study|Adverse Event|0|||
162750474|NCT04560179|587800592|FG001|Overall Study|Adverse Event|0|||
162750475|NCT04560179|587800593|FG002|Overall Study|Adverse Event|0|||
162750476|NCT04560179|587800594|FG003|Overall Study|Adverse Event|1|||
162750477|NCT04560179|587800595|FG004|Overall Study|Adverse Event|0|||
162750478|NCT04496752|587800596|FG000|Second Assessment|Lost to Follow-up|3|||
162750479|NCT04496752|587800597|FG001|Second Assessment|Lost to Follow-up|3|||
162750480|NCT04496752|587800596|FG000|Second Assessment|Adverse Event|2|||
162750481|NCT04496752|587800597|FG001|Second Assessment|Adverse Event|0|||
162750482|NCT04078152|587800598|FG000|Overall Study|Other|83|||
162750483|NCT04078152|587800599|FG001|Overall Study|Other|22|||
162750484|NCT04078152|587800600|FG002|Overall Study|Other|25|||
162750485|NCT04078152|587800598|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
162750486|NCT04078152|587800599|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
162750487|NCT04078152|587800600|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
162750488|NCT04078152|587800598|FG000|Overall Study|Withdrawal by Subject|5|||
162750489|NCT04078152|587800599|FG001|Overall Study|Withdrawal by Subject|0|||
162750490|NCT04078152|587800600|FG002|Overall Study|Withdrawal by Subject|1|||
162750491|NCT04078152|587800598|FG000|Overall Study|Death|10|||
162750492|NCT04078152|587800599|FG001|Overall Study|Death|2|||
162750493|NCT04078152|587800600|FG002|Overall Study|Death|12|||
162750494|NCT04078152|587800598|FG000|Overall Study|Adverse Event|1|||
162750495|NCT04078152|587800599|FG001|Overall Study|Adverse Event|0|||
162750496|NCT04078152|587800600|FG002|Overall Study|Adverse Event|0|||
162750497|NCT04908930|587800606|FG000|Overall Study|Lost to Follow-up|1|||
162750498|NCT04908930|587800607|FG001|Overall Study|Lost to Follow-up|1|||
162750499|NCT04908930|587800608|FG002|Overall Study|Lost to Follow-up|0|||
162750500|NCT04908930|587800609|FG003|Overall Study|Lost to Follow-up|0|||
162750501|NCT04908930|587800610|FG004|Overall Study|Lost to Follow-up|0|||
162750502|NCT04908930|587800606|FG000|Overall Study|hardware in mouth|1|||
162750503|NCT04908930|587800607|FG001|Overall Study|hardware in mouth|1|||
162750504|NCT04908930|587800608|FG002|Overall Study|hardware in mouth|0|||
162750505|NCT04908930|587800609|FG003|Overall Study|hardware in mouth|0|||
162750506|NCT04908930|587800610|FG004|Overall Study|hardware in mouth|0|||
162750507|NCT04908930|587800606|FG000|Overall Study|wrong team|1|||
162750508|NCT04908930|587800607|FG001|Overall Study|wrong team|0|||
162750509|NCT04908930|587800608|FG002|Overall Study|wrong team|0|||
162750510|NCT04908930|587800609|FG003|Overall Study|wrong team|0|||
162750511|NCT04908930|587800610|FG004|Overall Study|wrong team|0|||
162750512|NCT04908930|587800606|FG000|Overall Study|quit team|2|||
162750513|NCT04908930|587800607|FG001|Overall Study|quit team|4|||
162750514|NCT04908930|587800608|FG002|Overall Study|quit team|0|||
162750515|NCT04908930|587800609|FG003|Overall Study|quit team|0|||
162750516|NCT04908930|587800610|FG004|Overall Study|quit team|0|||
162750517|NCT04908930|587800606|FG000|Overall Study|Withdrawal by Subject|1|||
162750518|NCT04908930|587800607|FG001|Overall Study|Withdrawal by Subject|2|||
162750519|NCT04908930|587800608|FG002|Overall Study|Withdrawal by Subject|0|||
162750520|NCT04908930|587800609|FG003|Overall Study|Withdrawal by Subject|0|||
162750521|NCT04908930|587800610|FG004|Overall Study|Withdrawal by Subject|0|||
162750522|NCT04908930|587800606|FG000|Overall Study|parent not liking program|0|||
162750523|NCT04908930|587800607|FG001|Overall Study|parent not liking program|1|||
162750524|NCT04908930|587800608|FG002|Overall Study|parent not liking program|0|||
162750525|NCT04908930|587800609|FG003|Overall Study|parent not liking program|0|||
162750526|NCT04908930|587800610|FG004|Overall Study|parent not liking program|0|||
162750527|NCT04679389|587800611|FG000|Overall Study|Adverse Event|1|||
162750528|NCT04679389|587800612|FG001|Overall Study|Adverse Event|0|||
162750529|NCT04679389|587800611|FG000|Overall Study|Protocol Violation|2|||
162750530|NCT04679389|587800612|FG001|Overall Study|Protocol Violation|0|||
162750531|NCT04679389|587800611|FG000|Overall Study|Physician Decision|3|||
162750532|NCT04679389|587800612|FG001|Overall Study|Physician Decision|5|||
162750533|NCT04679389|587800611|FG000|Overall Study|Withdrawal by Subject|5|||
162750534|NCT04679389|587800612|FG001|Overall Study|Withdrawal by Subject|7|||
162750535|NCT02777593|587800615|FG000|Overall Study|Still in study|1|||
162750536|NCT02777593|587800616|FG001|Overall Study|Still in study|32|||
162750537|NCT02777593|587800617|FG002|Overall Study|Still in study|3|||
162750538|NCT02777593|587800618|FG003|Overall Study|Still in study|6|||
162750539|NCT02777593|587800619|FG004|Overall Study|Still in study|5|||
162750540|NCT02777593|587800615|FG000|Overall Study|Death|21|||
162750541|NCT02777593|587800616|FG001|Overall Study|Death|28|||
162750542|NCT02777593|587800617|FG002|Overall Study|Death|0|||
162750543|NCT02777593|587800618|FG003|Overall Study|Death|5|||
162750544|NCT02777593|587800619|FG004|Overall Study|Death|0|||
162750545|NCT02777593|587800615|FG000|Overall Study|Withdrawal by Subject|8|||
162750546|NCT02777593|587800616|FG001|Overall Study|Withdrawal by Subject|4|||
162750547|NCT02777593|587800617|FG002|Overall Study|Withdrawal by Subject|1|||
162750548|NCT02777593|587800618|FG003|Overall Study|Withdrawal by Subject|1|||
162750549|NCT02777593|587800619|FG004|Overall Study|Withdrawal by Subject|0|||
162750550|NCT02777593|587800615|FG000|Overall Study|Lost to Follow-up|8|||
162750551|NCT02777593|587800616|FG001|Overall Study|Lost to Follow-up|16|||
162750552|NCT02777593|587800617|FG002|Overall Study|Lost to Follow-up|5|||
162750553|NCT02777593|587800618|FG003|Overall Study|Lost to Follow-up|0|||
162750554|NCT02777593|587800619|FG004|Overall Study|Lost to Follow-up|1|||
162750555|NCT02777593|587800615|FG000|Overall Study|Physician Decision|2|||
162750556|NCT02777593|587800616|FG001|Overall Study|Physician Decision|2|||
162750557|NCT02777593|587800617|FG002|Overall Study|Physician Decision|0|||
162750558|NCT02777593|587800618|FG003|Overall Study|Physician Decision|0|||
162750559|NCT02777593|587800619|FG004|Overall Study|Physician Decision|0|||
162750560|NCT02777593|587800615|FG000|Overall Study|Discontinued due to Other|1|||
162750561|NCT02777593|587800616|FG001|Overall Study|Discontinued due to Other|0|||
162750562|NCT02777593|587800617|FG002|Overall Study|Discontinued due to Other|0|||
162750563|NCT02777593|587800618|FG003|Overall Study|Discontinued due to Other|0|||
162750564|NCT02777593|587800619|FG004|Overall Study|Discontinued due to Other|0|||
162750565|NCT04795245|587800626|FG000|Overall Study|Unkown reason|7|||
162750566|NCT04795245|587800626|FG000|Overall Study|Death|17|||
162750567|NCT04795245|587800626|FG000|Overall Study|Other than listed|19|||
162750568|NCT04795245|587800626|FG000|Overall Study|Adverse Event|143|||
162750569|NCT04795245|587800626|FG000|Overall Study|Progressive disease|512|||
162750570|NCT04795245|587800626|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
162750571|NCT04780581|587800627|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
162750572|NCT04780581|587800628|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
162750573|NCT04780581|587800627|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
162750574|NCT04780581|587800628|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
162750575|NCT01756300|587800629|FG000|Overall Study|Death|1|||
162750576|NCT01756300|587800629|FG000|Overall Study|Withdrawal by Subject|1|||
162750577|NCT02765412|587800630|FG000|Overall Study|Death|482|||
162750578|NCT02765412|587800631|FG001|Overall Study|Death|855|||
162750579|NCT03990883|587800632|FG000|Blinded Treatment Phase|Adverse Event|1|||
162750580|NCT03990883|587800633|FG001|Blinded Treatment Phase|Adverse Event|1|||
162750581|NCT03990883|587800634|FG002|Blinded Treatment Phase|Adverse Event|0|||
162750582|NCT03990883|587800632|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
162750583|NCT03990883|587800633|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
162750584|NCT03990883|587800634|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
162750585|NCT03990883|587800632|FG000|Blinded Treatment Phase|Physician Decision|1|||
162750586|NCT03990883|587800633|FG001|Blinded Treatment Phase|Physician Decision|0|||
162750587|NCT03990883|587800634|FG002|Blinded Treatment Phase|Physician Decision|0|||
162750588|NCT03990883|587800632|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
162750589|NCT03990883|587800633|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
162750590|NCT03990883|587800634|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
162750591|NCT03990883|587800632|FG000|Blinded Treatment Phase|COVID-19|3|||
162750592|NCT03990883|587800633|FG001|Blinded Treatment Phase|COVID-19|2|||
162750593|NCT03990883|587800634|FG002|Blinded Treatment Phase|COVID-19|0|||
162750594|NCT03990883|587800632|FG000|Blinded Treatment Phase|Personal Reasons|6|||
162750595|NCT03990883|587800633|FG001|Blinded Treatment Phase|Personal Reasons|3|||
162750596|NCT03990883|587800634|FG002|Blinded Treatment Phase|Personal Reasons|0|||
162750597|NCT03990883|587800632|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
162750598|NCT03990883|587800633|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
162750599|NCT03990883|587800634|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
162750600|NCT03990883|587800632|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
162750601|NCT03990883|587800633|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
162750602|NCT03990883|587800634|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
162925349|NCT03901339|588428938|FG000|Overall Study|Death|220|||
162750603|NCT03990883|587800632|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
162750604|NCT03990883|587800633|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
162750605|NCT03990883|587800634|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
162750606|NCT04595331|587801367|FG000|Overall Study|Withdrawal by Subject|0|||
162750607|NCT04595331|587801368|FG001|Overall Study|Withdrawal by Subject|1|||
162750608|NCT04595331|587801367|FG000|Overall Study|Lost to Follow-up|0|||
162750609|NCT04595331|587801368|FG001|Overall Study|Lost to Follow-up|5|||
162750610|NCT04595331|587801367|FG000|Overall Study|Medical reason|0|||
162750611|NCT04595331|587801368|FG001|Overall Study|Medical reason|1|||
162750612|NCT05020353|587801371|FG000|Overall Study|Protocol Violation|7|||
162750613|NCT05020353|587801371|FG000|Overall Study|Withdrawal by Subject|33|||
162750614|NCT02075554|587801377|FG000|Overall Study|Lost to Follow-up|7|||
162750615|NCT02075554|587801377|FG000|Overall Study|Withdrawal by Subject|5|||
162750616|NCT02075554|587801377|FG000|Overall Study|Physician Decision|3|||
162750617|NCT04933474|587801383|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
162750618|NCT04933474|587801384|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
162750619|NCT04933474|587801383|FG000|Overall Study|Lost to Follow-up|19|||
162750620|NCT04933474|587801384|FG001|Overall Study|Lost to Follow-up|9|||
162750621|NCT04933474|587801383|FG000|Overall Study|Life Burden - unable to participate|6|||
162750622|NCT04933474|587801384|FG001|Overall Study|Life Burden - unable to participate|2|||
162750623|NCT04933474|587801383|FG000|Overall Study|Disease Burden - unable to participate|4|||
162750624|NCT04933474|587801384|FG001|Overall Study|Disease Burden - unable to participate|1|||
162750625|NCT04933474|587801383|FG000|Overall Study|Surgery/Hospitalization|1|||
162750626|NCT04933474|587801384|FG001|Overall Study|Surgery/Hospitalization|2|||
162750627|NCT04933474|587801383|FG000|Overall Study|Dissatisfied with Intervention|1|||
162750628|NCT04933474|587801384|FG001|Overall Study|Dissatisfied with Intervention|1|||
162750629|NCT04933474|587801383|FG000|Overall Study|Withdrew interest in participation|1|||
162750630|NCT04933474|587801384|FG001|Overall Study|Withdrew interest in participation|0|||
162750631|NCT04933474|587801383|FG000|Overall Study|Had previously enrolled in the study|0|||
162750632|NCT04933474|587801384|FG001|Overall Study|Had previously enrolled in the study|1|||
162750633|NCT06655818|587801400|FG000|Overall Study|Withdrawal by Subject|1|||
162750634|NCT04214418|587801407|FG000|Overall Study|Withdrawal by Subject|1|||
162750635|NCT04214418|587801408|FG001|Overall Study|Withdrawal by Subject|0|||
162750636|NCT04214418|587801409|FG002|Overall Study|Withdrawal by Subject|0|||
162750637|NCT04214418|587801410|FG003|Overall Study|Withdrawal by Subject|0|||
162750638|NCT04214418|587801411|FG004|Overall Study|Withdrawal by Subject|0|||
162750639|NCT04214418|587801412|FG005|Overall Study|Withdrawal by Subject|0|||
162750640|NCT04214418|587801407|FG000|Overall Study|Adverse Event|0|||
162750641|NCT04214418|587801408|FG001|Overall Study|Adverse Event|2|||
162750642|NCT04214418|587801409|FG002|Overall Study|Adverse Event|0|||
162750643|NCT04214418|587801410|FG003|Overall Study|Adverse Event|0|||
162750644|NCT04214418|587801411|FG004|Overall Study|Adverse Event|0|||
162750645|NCT04214418|587801412|FG005|Overall Study|Adverse Event|0|||
162750646|NCT04214418|587801407|FG000|Overall Study|Death|1|||
162750647|NCT04214418|587801408|FG001|Overall Study|Death|0|||
162750648|NCT04214418|587801409|FG002|Overall Study|Death|0|||
162750649|NCT04214418|587801410|FG003|Overall Study|Death|0|||
162750650|NCT04214418|587801411|FG004|Overall Study|Death|0|||
162750651|NCT04214418|587801412|FG005|Overall Study|Death|0|||
162750652|NCT05785130|587801417|FG000|Overall Study|Withdrawal by Subject|1|||
162750653|NCT05785130|587801418|FG001|Overall Study|Withdrawal by Subject|0|||
162750654|NCT05785130|587801417|FG000|Overall Study|Lack of Efficacy|0|||
162750655|NCT05785130|587801418|FG001|Overall Study|Lack of Efficacy|1|||
162750656|NCT02624050|587801420|FG000|Overall Study|Physician Decision|4|||
162750657|NCT02624050|587801421|FG001|Overall Study|Physician Decision|0|||
162750658|NCT02624050|587801420|FG000|Overall Study|Protocol Violation|2|||
162750659|NCT02624050|587801421|FG001|Overall Study|Protocol Violation|0|||
162750660|NCT03547271|587801422|FG000|Overall Study|Adverse Event|1|||
162750661|NCT03547271|587801423|FG001|Overall Study|Adverse Event|1|||
162750662|NCT03547271|587801424|FG002|Overall Study|Adverse Event|0|||
162750663|NCT03547271|587801425|FG003|Overall Study|Adverse Event|0|||
162750664|NCT03547271|587801422|FG000|Overall Study|Protocol deviation|5|||
162750665|NCT03547271|587801423|FG001|Overall Study|Protocol deviation|7|||
162750666|NCT03547271|587801424|FG002|Overall Study|Protocol deviation|3|||
162750667|NCT03547271|587801425|FG003|Overall Study|Protocol deviation|0|||
162750668|NCT03547271|587801422|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
162750669|NCT03547271|587801423|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
162750670|NCT03547271|587801424|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
162750671|NCT03547271|587801425|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
162750672|NCT03547271|587801422|FG000|Overall Study|Lost to Follow-up|3|||
162750673|NCT03547271|587801423|FG001|Overall Study|Lost to Follow-up|3|||
162750674|NCT03547271|587801424|FG002|Overall Study|Lost to Follow-up|1|||
162750675|NCT03547271|587801425|FG003|Overall Study|Lost to Follow-up|0|||
162750676|NCT03904576|587801430|FG000|Washout Period|Protocol Violation|1|||
162750677|NCT03904576|587801431|FG001|Washout Period|Protocol Violation|1|||
162750678|NCT05215054|587801436|FG000|Overall Study|Lost to Follow-up|1|||
162750679|NCT05215054|587801437|FG001|Overall Study|Lost to Follow-up|1|||
162750680|NCT05215054|587801436|FG000|Overall Study|Protocol Violation|1|||
162750681|NCT05215054|587801437|FG001|Overall Study|Protocol Violation|1|||
162750682|NCT05215054|587801436|FG000|Overall Study|Withdrawal by Subject|4|||
162750683|NCT05215054|587801437|FG001|Overall Study|Withdrawal by Subject|4|||
162750684|NCT01897441|587801438|FG000|Overall Study|Lost to Follow-up|0|||
162750685|NCT01897441|587801439|FG001|Overall Study|Lost to Follow-up|0|||
162750686|NCT01897441|587801440|FG002|Overall Study|Lost to Follow-up|1|||
162750687|NCT01897441|587801441|FG003|Overall Study|Lost to Follow-up|0|||
162750688|NCT01897441|587801442|FG004|Overall Study|Lost to Follow-up|0|||
162750689|NCT01897441|587801443|FG005|Overall Study|Lost to Follow-up|0|||
162750690|NCT01897441|587801438|FG000|Overall Study|Withdrawal by Subject|0|||
162750691|NCT01897441|587801439|FG001|Overall Study|Withdrawal by Subject|0|||
162750692|NCT01897441|587801440|FG002|Overall Study|Withdrawal by Subject|0|||
162750693|NCT01897441|587801441|FG003|Overall Study|Withdrawal by Subject|0|||
162750694|NCT01897441|587801442|FG004|Overall Study|Withdrawal by Subject|1|||
162750695|NCT01897441|587801443|FG005|Overall Study|Withdrawal by Subject|0|||
162750696|NCT01897441|587801438|FG000|Overall Study|Withdrawn by Provider|0|||
162750697|NCT01897441|587801439|FG001|Overall Study|Withdrawn by Provider|2|||
162750698|NCT01897441|587801440|FG002|Overall Study|Withdrawn by Provider|0|||
162750699|NCT01897441|587801441|FG003|Overall Study|Withdrawn by Provider|0|||
162750700|NCT01897441|587801442|FG004|Overall Study|Withdrawn by Provider|0|||
162750701|NCT01897441|587801443|FG005|Overall Study|Withdrawn by Provider|0|||
162750702|NCT02933489|587801444|FG000|Overall Study|Ineligible|3|||
162750703|NCT02933489|587801445|FG001|Overall Study|Ineligible|3|||
162750704|NCT02933489|587801444|FG000|Overall Study|Withdrawal by Subject|27|||
162750705|NCT02933489|587801445|FG001|Overall Study|Withdrawal by Subject|18|||
162750706|NCT02933489|587801444|FG000|Overall Study|Unable to complete exams (other)|14|||
162750707|NCT02933489|587801445|FG001|Overall Study|Unable to complete exams (other)|7|||
162750708|NCT02325154|587801446|FG000|Overall Study|Physician Decision|1|||
162750709|NCT04678856|587801447|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
162750710|NCT04678856|587801448|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
162750711|NCT04678856|587801447|FG000|Overall Study|Withdrawal by Subject|5|||
162750712|NCT04678856|587801448|FG001|Overall Study|Withdrawal by Subject|1|||
162750713|NCT04633278|587802562|FG000|Overall Study|Adverse Event|1|||
162750714|NCT04633278|587802563|FG001|Overall Study|Adverse Event|0|||
162750715|NCT04633278|587802562|FG000|Overall Study|Withdrawal by Subject|1|||
162750716|NCT04633278|587802563|FG001|Overall Study|Withdrawal by Subject|0|||
162750717|NCT04633278|587802562|FG000|Overall Study|Death|11|||
162750718|NCT04633278|587802563|FG001|Overall Study|Death|7|||
162750719|NCT04633278|587802562|FG000|Overall Study|Sponsor Decision|3|||
162750720|NCT04633278|587802563|FG001|Overall Study|Sponsor Decision|0|||
162750721|NCT04633278|587802562|FG000|Overall Study|Not Listed|1|||
162750722|NCT04633278|587802563|FG001|Overall Study|Not Listed|0|||
162750723|NCT03705793|587802564|FG000|Overall Study|Lost to Follow-up|3|||
162750724|NCT03705793|587802565|FG001|Overall Study|Lost to Follow-up|4|||
162750725|NCT03705793|587802564|FG000|Overall Study|Withdrawal by Subject|2|||
162750726|NCT03705793|587802565|FG001|Overall Study|Withdrawal by Subject|1|||
162750727|NCT00447980|587802566|FG000|Overall Study|Withdrawal by Subject|1|||
162750728|NCT00447980|587802567|FG001|Overall Study|Withdrawal by Subject|1|||
162750729|NCT00447980|587802568|FG002|Overall Study|Withdrawal by Subject|4|||
162750730|NCT00447980|587802569|FG003|Overall Study|Withdrawal by Subject|4|||
162750731|NCT00447980|587802566|FG000|Overall Study|Lost to Follow-up|1|||
162750732|NCT00447980|587802567|FG001|Overall Study|Lost to Follow-up|1|||
162750733|NCT00447980|587802568|FG002|Overall Study|Lost to Follow-up|0|||
162750734|NCT00447980|587802569|FG003|Overall Study|Lost to Follow-up|0|||
162750735|NCT00447980|587802566|FG000|Overall Study|Did not proceed with surgery|3|||
162750736|NCT00447980|587802567|FG001|Overall Study|Did not proceed with surgery|3|||
162750737|NCT00447980|587802568|FG002|Overall Study|Did not proceed with surgery|2|||
162750738|NCT00447980|587802569|FG003|Overall Study|Did not proceed with surgery|2|||
162750739|NCT02720068|587802570|FG000|Overall Study|Adverse Event|0|||
162750740|NCT02720068|587802571|FG001|Overall Study|Adverse Event|0|||
162750741|NCT02720068|587802572|FG002|Overall Study|Adverse Event|0|||
162750742|NCT02720068|587802573|FG003|Overall Study|Adverse Event|0|||
162750743|NCT02720068|587802574|FG004|Overall Study|Adverse Event|0|||
162750744|NCT02720068|587802575|FG005|Overall Study|Adverse Event|0|||
162750745|NCT02720068|587802576|FG006|Overall Study|Adverse Event|0|||
162750746|NCT02720068|587802577|FG007|Overall Study|Adverse Event|0|||
162750747|NCT02720068|587802578|FG008|Overall Study|Adverse Event|0|||
162750748|NCT02720068|587802579|FG009|Overall Study|Adverse Event|0|||
162750749|NCT02720068|587802580|FG010|Overall Study|Adverse Event|0|||
162750750|NCT02720068|587802581|FG011|Overall Study|Adverse Event|1|||
162750751|NCT02720068|587802582|FG012|Overall Study|Adverse Event|0|||
162750752|NCT02720068|587802583|FG013|Overall Study|Adverse Event|0|||
162750753|NCT02720068|587802584|FG014|Overall Study|Adverse Event|0|||
162750754|NCT02720068|587802585|FG015|Overall Study|Adverse Event|0|||
162750755|NCT02720068|587802586|FG016|Overall Study|Adverse Event|0|||
162750756|NCT02720068|587802587|FG017|Overall Study|Adverse Event|0|||
162750757|NCT02720068|587802570|FG000|Overall Study|Death|1|||
162750758|NCT02720068|587802571|FG001|Overall Study|Death|3|||
162750759|NCT02720068|587802572|FG002|Overall Study|Death|2|||
162750760|NCT02720068|587802573|FG003|Overall Study|Death|1|||
162750761|NCT02720068|587802574|FG004|Overall Study|Death|2|||
162750762|NCT02720068|587802575|FG005|Overall Study|Death|1|||
162750763|NCT02720068|587802576|FG006|Overall Study|Death|2|||
162750764|NCT02720068|587802577|FG007|Overall Study|Death|2|||
162750765|NCT02720068|587802578|FG008|Overall Study|Death|3|||
162750766|NCT02720068|587802579|FG009|Overall Study|Death|1|||
162750767|NCT02720068|587802580|FG010|Overall Study|Death|20|||
162750768|NCT02720068|587802581|FG011|Overall Study|Death|166|||
162750769|NCT02720068|587802582|FG012|Overall Study|Death|34|||
162750770|NCT02720068|587802583|FG013|Overall Study|Death|30|||
162750771|NCT02720068|587802584|FG014|Overall Study|Death|45|||
162750772|NCT02720068|587802585|FG015|Overall Study|Death|16|||
162750773|NCT02720068|587802586|FG016|Overall Study|Death|20|||
162750774|NCT02720068|587802587|FG017|Overall Study|Death|28|||
162750775|NCT02720068|587802570|FG000|Overall Study|Lost to Follow-up|0|||
162750776|NCT02720068|587802571|FG001|Overall Study|Lost to Follow-up|0|||
162750777|NCT02720068|587802572|FG002|Overall Study|Lost to Follow-up|0|||
162750778|NCT02720068|587802573|FG003|Overall Study|Lost to Follow-up|0|||
162750779|NCT02720068|587802574|FG004|Overall Study|Lost to Follow-up|0|||
162750780|NCT02720068|587802575|FG005|Overall Study|Lost to Follow-up|0|||
162750781|NCT02720068|587802576|FG006|Overall Study|Lost to Follow-up|0|||
162750782|NCT02720068|587802577|FG007|Overall Study|Lost to Follow-up|0|||
162750783|NCT02720068|587802578|FG008|Overall Study|Lost to Follow-up|0|||
162750784|NCT02720068|587802579|FG009|Overall Study|Lost to Follow-up|0|||
162750785|NCT02720068|587802580|FG010|Overall Study|Lost to Follow-up|0|||
162750786|NCT02720068|587802581|FG011|Overall Study|Lost to Follow-up|1|||
162750787|NCT02720068|587802582|FG012|Overall Study|Lost to Follow-up|0|||
162750788|NCT02720068|587802583|FG013|Overall Study|Lost to Follow-up|1|||
162750789|NCT02720068|587802584|FG014|Overall Study|Lost to Follow-up|2|||
162750790|NCT02720068|587802585|FG015|Overall Study|Lost to Follow-up|0|||
162750791|NCT02720068|587802586|FG016|Overall Study|Lost to Follow-up|0|||
162750792|NCT02720068|587802587|FG017|Overall Study|Lost to Follow-up|1|||
162750793|NCT02720068|587802570|FG000|Overall Study|Physician Decision|0|||
162750794|NCT02720068|587802571|FG001|Overall Study|Physician Decision|0|||
162750795|NCT02720068|587802572|FG002|Overall Study|Physician Decision|0|||
162750796|NCT02720068|587802573|FG003|Overall Study|Physician Decision|1|||
162750797|NCT02720068|587802574|FG004|Overall Study|Physician Decision|0|||
162750798|NCT02720068|587802575|FG005|Overall Study|Physician Decision|0|||
162750799|NCT02720068|587802576|FG006|Overall Study|Physician Decision|0|||
162750800|NCT02720068|587802577|FG007|Overall Study|Physician Decision|0|||
162750801|NCT02720068|587802578|FG008|Overall Study|Physician Decision|0|||
162750802|NCT02720068|587802579|FG009|Overall Study|Physician Decision|0|||
162750803|NCT02720068|587802580|FG010|Overall Study|Physician Decision|0|||
162750804|NCT02720068|587802581|FG011|Overall Study|Physician Decision|1|||
162750805|NCT02720068|587802582|FG012|Overall Study|Physician Decision|0|||
162750806|NCT02720068|587802583|FG013|Overall Study|Physician Decision|0|||
162750807|NCT02720068|587802584|FG014|Overall Study|Physician Decision|0|||
162750808|NCT02720068|587802585|FG015|Overall Study|Physician Decision|0|||
162750809|NCT02720068|587802586|FG016|Overall Study|Physician Decision|0|||
162750810|NCT02720068|587802587|FG017|Overall Study|Physician Decision|1|||
162750811|NCT02720068|587802570|FG000|Overall Study|Progressive Disease|2|||
162750812|NCT02720068|587802571|FG001|Overall Study|Progressive Disease|3|||
162750813|NCT02720068|587802572|FG002|Overall Study|Progressive Disease|1|||
162750814|NCT02720068|587802573|FG003|Overall Study|Progressive Disease|1|||
162750815|NCT02720068|587802574|FG004|Overall Study|Progressive Disease|1|||
162750816|NCT02720068|587802575|FG005|Overall Study|Progressive Disease|2|||
162750817|NCT02720068|587802576|FG006|Overall Study|Progressive Disease|1|||
162750818|NCT02720068|587802577|FG007|Overall Study|Progressive Disease|1|||
162750819|NCT02720068|587802578|FG008|Overall Study|Progressive Disease|0|||
162750820|NCT02720068|587802579|FG009|Overall Study|Progressive Disease|1|||
162750821|NCT02720068|587802580|FG010|Overall Study|Progressive Disease|0|||
162750822|NCT02720068|587802581|FG011|Overall Study|Progressive Disease|4|||
162750823|NCT02720068|587802582|FG012|Overall Study|Progressive Disease|1|||
162750824|NCT02720068|587802583|FG013|Overall Study|Progressive Disease|0|||
162750825|NCT02720068|587802584|FG014|Overall Study|Progressive Disease|0|||
162750826|NCT02720068|587802585|FG015|Overall Study|Progressive Disease|0|||
162750827|NCT02720068|587802586|FG016|Overall Study|Progressive Disease|0|||
162750828|NCT02720068|587802587|FG017|Overall Study|Progressive Disease|0|||
162750829|NCT02720068|587802570|FG000|Overall Study|Sponsor Decision|0|||
162750830|NCT02720068|587802571|FG001|Overall Study|Sponsor Decision|0|||
162750831|NCT02720068|587802572|FG002|Overall Study|Sponsor Decision|0|||
162750832|NCT02720068|587802573|FG003|Overall Study|Sponsor Decision|0|||
162750833|NCT02720068|587802574|FG004|Overall Study|Sponsor Decision|0|||
162750834|NCT02720068|587802575|FG005|Overall Study|Sponsor Decision|0|||
162750835|NCT02720068|587802576|FG006|Overall Study|Sponsor Decision|0|||
162750836|NCT02720068|587802577|FG007|Overall Study|Sponsor Decision|0|||
162750837|NCT02720068|587802578|FG008|Overall Study|Sponsor Decision|0|||
162750838|NCT02720068|587802579|FG009|Overall Study|Sponsor Decision|0|||
162750839|NCT02720068|587802580|FG010|Overall Study|Sponsor Decision|0|||
162750840|NCT02720068|587802581|FG011|Overall Study|Sponsor Decision|6|||
162750841|NCT02720068|587802582|FG012|Overall Study|Sponsor Decision|3|||
162750842|NCT02720068|587802583|FG013|Overall Study|Sponsor Decision|2|||
162750843|NCT02720068|587802584|FG014|Overall Study|Sponsor Decision|4|||
162750844|NCT02720068|587802585|FG015|Overall Study|Sponsor Decision|4|||
162750845|NCT02720068|587802586|FG016|Overall Study|Sponsor Decision|0|||
162750846|NCT02720068|587802587|FG017|Overall Study|Sponsor Decision|8|||
162750847|NCT02720068|587802570|FG000|Overall Study|Withdrawal by Subject|0|||
162750848|NCT02720068|587802571|FG001|Overall Study|Withdrawal by Subject|0|||
162750849|NCT02720068|587802572|FG002|Overall Study|Withdrawal by Subject|0|||
162750850|NCT02720068|587802573|FG003|Overall Study|Withdrawal by Subject|0|||
162750851|NCT02720068|587802574|FG004|Overall Study|Withdrawal by Subject|0|||
162750852|NCT02720068|587802575|FG005|Overall Study|Withdrawal by Subject|0|||
162750853|NCT02720068|587802576|FG006|Overall Study|Withdrawal by Subject|0|||
162750854|NCT02720068|587802577|FG007|Overall Study|Withdrawal by Subject|0|||
162750855|NCT02720068|587802578|FG008|Overall Study|Withdrawal by Subject|0|||
162750856|NCT02720068|587802579|FG009|Overall Study|Withdrawal by Subject|1|||
162750857|NCT02720068|587802580|FG010|Overall Study|Withdrawal by Subject|0|||
162750858|NCT02720068|587802581|FG011|Overall Study|Withdrawal by Subject|27|||
162750859|NCT02720068|587802582|FG012|Overall Study|Withdrawal by Subject|2|||
162750860|NCT02720068|587802583|FG013|Overall Study|Withdrawal by Subject|8|||
162750861|NCT02720068|587802584|FG014|Overall Study|Withdrawal by Subject|7|||
162750862|NCT02720068|587802585|FG015|Overall Study|Withdrawal by Subject|0|||
162750863|NCT02720068|587802586|FG016|Overall Study|Withdrawal by Subject|0|||
162750864|NCT02720068|587802587|FG017|Overall Study|Withdrawal by Subject|2|||
162750865|NCT02720068|587802570|FG000|Overall Study|Protocol Violation|0|||
162750866|NCT02720068|587802571|FG001|Overall Study|Protocol Violation|0|||
162750867|NCT02720068|587802572|FG002|Overall Study|Protocol Violation|0|||
162750868|NCT02720068|587802573|FG003|Overall Study|Protocol Violation|0|||
162750869|NCT02720068|587802574|FG004|Overall Study|Protocol Violation|0|||
162750870|NCT02720068|587802575|FG005|Overall Study|Protocol Violation|0|||
162750871|NCT02720068|587802576|FG006|Overall Study|Protocol Violation|0|||
162750872|NCT02720068|587802577|FG007|Overall Study|Protocol Violation|0|||
162750873|NCT02720068|587802578|FG008|Overall Study|Protocol Violation|0|||
162750874|NCT02720068|587802579|FG009|Overall Study|Protocol Violation|0|||
162750875|NCT02720068|587802580|FG010|Overall Study|Protocol Violation|1|||
162750876|NCT02720068|587802581|FG011|Overall Study|Protocol Violation|0|||
162750877|NCT02720068|587802582|FG012|Overall Study|Protocol Violation|0|||
162750878|NCT02720068|587802583|FG013|Overall Study|Protocol Violation|0|||
162750879|NCT02720068|587802584|FG014|Overall Study|Protocol Violation|1|||
162750880|NCT02720068|587802585|FG015|Overall Study|Protocol Violation|0|||
162750881|NCT02720068|587802586|FG016|Overall Study|Protocol Violation|1|||
162750882|NCT02720068|587802587|FG017|Overall Study|Protocol Violation|0|||
162750883|NCT01773993|587802589|FG000|Overall Study|No Visit After Treatment|35|||
162750884|NCT04664881|587802590|FG000|Overall Study|Withdrawal by Subject|1|||
162750885|NCT04664881|587802591|FG001|Overall Study|Withdrawal by Subject|8|||
162750886|NCT04664881|587802590|FG000|Overall Study|Physician Decision|0|||
162750887|NCT04664881|587802591|FG001|Overall Study|Physician Decision|5|||
162750888|NCT04664881|587802590|FG000|Overall Study|Lost to Follow-up|1|||
162750889|NCT04664881|587802591|FG001|Overall Study|Lost to Follow-up|0|||
162750890|NCT04408755|587802599|FG000|Period A (Placebo lead-in)|Other|11|||
162750891|NCT04408755|587802600|FG001|Period A (Placebo lead-in)|Other|0|||
162750892|NCT04408755|587802601|FG002|Period A (Placebo lead-in)|Other|0|||
162750893|NCT04408755|587802602|FG003|Period A (Placebo lead-in)|Other|0|||
162750894|NCT04408755|587802599|FG000|Period B (Randomization Period)|Adverse Event|0|||
162750895|NCT04408755|587802600|FG001|Period B (Randomization Period)|Adverse Event|3|||
162750896|NCT04408755|587802601|FG002|Period B (Randomization Period)|Adverse Event|0|||
162750897|NCT04408755|587802602|FG003|Period B (Randomization Period)|Adverse Event|1|||
162750898|NCT04408755|587802599|FG000|Period B (Randomization Period)|Death|0|||
162750899|NCT04408755|587802600|FG001|Period B (Randomization Period)|Death|0|||
162750900|NCT04408755|587802601|FG002|Period B (Randomization Period)|Death|1|||
162750901|NCT04408755|587802602|FG003|Period B (Randomization Period)|Death|0|||
162750902|NCT04408755|587802599|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
162750903|NCT04408755|587802600|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
162750904|NCT04408755|587802601|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
162750905|NCT04408755|587802602|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
162750906|NCT04408755|587802599|FG000|Period B (Randomization Period)|Physician Decision|0|||
162750907|NCT04408755|587802600|FG001|Period B (Randomization Period)|Physician Decision|0|||
162750908|NCT04408755|587802601|FG002|Period B (Randomization Period)|Physician Decision|1|||
162750909|NCT04408755|587802602|FG003|Period B (Randomization Period)|Physician Decision|0|||
162750910|NCT04408755|587802599|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
162750911|NCT04408755|587802600|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
162750912|NCT04408755|587802601|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
162750913|NCT04408755|587802602|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
162750914|NCT04408755|587802599|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
162750915|NCT04408755|587802600|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162750916|NCT04408755|587802601|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162750917|NCT04408755|587802602|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162750918|NCT04408755|587802599|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
162750919|NCT04408755|587802600|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
162750920|NCT04408755|587802601|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
162750921|NCT04408755|587802602|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
162750922|NCT04408755|587802599|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
162750923|NCT04408755|587802600|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
162750924|NCT04408755|587802601|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
162750925|NCT04408755|587802602|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
162750926|NCT04408755|587802599|FG000|Period B (Randomization Period)|Reason not Specified|0|||
162750927|NCT04408755|587802600|FG001|Period B (Randomization Period)|Reason not Specified|1|||
162750928|NCT04408755|587802601|FG002|Period B (Randomization Period)|Reason not Specified|0|||
162750929|NCT04408755|587802602|FG003|Period B (Randomization Period)|Reason not Specified|2|||
162750930|NCT00308997|587802603|FG000|Overall Study|Subject feigned clinical data|0|||
162750931|NCT00308997|587802604|FG001|Overall Study|Subject feigned clinical data|1|||
162750932|NCT00308997|587802603|FG000|Overall Study|Unable to tolerate intervention|1|||
162750933|NCT00308997|587802604|FG001|Overall Study|Unable to tolerate intervention|0|||
162750934|NCT05836012|587802612|FG000|Overall Study|Lost to Follow-up|1|||
162750935|NCT05836012|587802613|FG001|Overall Study|Lost to Follow-up|0|||
162750936|NCT05836012|587802612|FG000|Overall Study|Withdrawal by Subject|1|||
162750937|NCT05836012|587802613|FG001|Overall Study|Withdrawal by Subject|3|||
162750938|NCT05836012|587802612|FG000|Overall Study|Reason not included in pre-specified categories|2|||
162750939|NCT05836012|587802613|FG001|Overall Study|Reason not included in pre-specified categories|1|||
162750940|NCT03248479|587802614|FG000|Overall Study|Death|12|||
162750941|NCT03248479|587802615|FG001|Overall Study|Death|44|||
162750942|NCT03248479|587802616|FG002|Overall Study|Death|1|||
162750943|NCT03248479|587802617|FG003|Overall Study|Death|72|||
162750944|NCT03248479|587802618|FG004|Overall Study|Death|17|||
162750945|NCT03248479|587802619|FG005|Overall Study|Death|6|||
162750946|NCT03248479|587802620|FG006|Overall Study|Death|1|||
162750947|NCT03248479|587802621|FG007|Overall Study|Death|14|||
162750948|NCT03248479|587802622|FG008|Overall Study|Death|3|||
162750949|NCT03248479|587802623|FG009|Overall Study|Death|7|||
162750950|NCT03248479|587802624|FG010|Overall Study|Death|3|||
162750951|NCT03248479|587802625|FG011|Overall Study|Death|1|||
162750952|NCT03248479|587802626|FG012|Overall Study|Death|1|||
162750953|NCT03248479|587802614|FG000|Overall Study|Study terminated by sponsor|12|||
162750954|NCT03248479|587802615|FG001|Overall Study|Study terminated by sponsor|15|||
162750955|NCT03248479|587802616|FG002|Overall Study|Study terminated by sponsor|0|||
162750956|NCT03248479|587802617|FG003|Overall Study|Study terminated by sponsor|5|||
162750957|NCT03248479|587802618|FG004|Overall Study|Study terminated by sponsor|0|||
162750958|NCT03248479|587802619|FG005|Overall Study|Study terminated by sponsor|0|||
162750959|NCT03248479|587802620|FG006|Overall Study|Study terminated by sponsor|0|||
162750960|NCT03248479|587802621|FG007|Overall Study|Study terminated by sponsor|1|||
162750961|NCT03248479|587802622|FG008|Overall Study|Study terminated by sponsor|1|||
162750962|NCT03248479|587802623|FG009|Overall Study|Study terminated by sponsor|0|||
162750963|NCT03248479|587802624|FG010|Overall Study|Study terminated by sponsor|5|||
162750964|NCT03248479|587802625|FG011|Overall Study|Study terminated by sponsor|4|||
162750965|NCT03248479|587802626|FG012|Overall Study|Study terminated by sponsor|0|||
162750966|NCT03248479|587802614|FG000|Overall Study|Consent withdrawn|6|||
162750967|NCT03248479|587802615|FG001|Overall Study|Consent withdrawn|3|||
162750968|NCT03248479|587802616|FG002|Overall Study|Consent withdrawn|0|||
162750969|NCT03248479|587802617|FG003|Overall Study|Consent withdrawn|9|||
162750970|NCT03248479|587802618|FG004|Overall Study|Consent withdrawn|1|||
162750971|NCT03248479|587802619|FG005|Overall Study|Consent withdrawn|0|||
162750972|NCT03248479|587802620|FG006|Overall Study|Consent withdrawn|0|||
162750973|NCT03248479|587802621|FG007|Overall Study|Consent withdrawn|1|||
162750974|NCT03248479|587802622|FG008|Overall Study|Consent withdrawn|0|||
162750975|NCT03248479|587802623|FG009|Overall Study|Consent withdrawn|3|||
162750976|NCT03248479|587802624|FG010|Overall Study|Consent withdrawn|1|||
162750977|NCT03248479|587802625|FG011|Overall Study|Consent withdrawn|0|||
162750978|NCT03248479|587802626|FG012|Overall Study|Consent withdrawn|1|||
162750979|NCT03248479|587802614|FG000|Overall Study|Lost to Follow-up|2|||
162750980|NCT03248479|587802615|FG001|Overall Study|Lost to Follow-up|1|||
162750981|NCT03248479|587802616|FG002|Overall Study|Lost to Follow-up|0|||
162750982|NCT03248479|587802617|FG003|Overall Study|Lost to Follow-up|0|||
162750983|NCT03248479|587802618|FG004|Overall Study|Lost to Follow-up|0|||
162750984|NCT03248479|587802619|FG005|Overall Study|Lost to Follow-up|0|||
162750985|NCT03248479|587802620|FG006|Overall Study|Lost to Follow-up|0|||
162750986|NCT03248479|587802621|FG007|Overall Study|Lost to Follow-up|0|||
162750987|NCT03248479|587802622|FG008|Overall Study|Lost to Follow-up|0|||
162750988|NCT03248479|587802623|FG009|Overall Study|Lost to Follow-up|0|||
162750989|NCT03248479|587802624|FG010|Overall Study|Lost to Follow-up|0|||
162750990|NCT03248479|587802625|FG011|Overall Study|Lost to Follow-up|0|||
162750991|NCT03248479|587802626|FG012|Overall Study|Lost to Follow-up|1|||
162750992|NCT03248479|587802614|FG000|Overall Study|Not reported|0|||
162750993|NCT03248479|587802615|FG001|Overall Study|Not reported|0|||
162750994|NCT03248479|587802616|FG002|Overall Study|Not reported|0|||
162750995|NCT03248479|587802617|FG003|Overall Study|Not reported|1|||
162750996|NCT03248479|587802618|FG004|Overall Study|Not reported|1|||
162750997|NCT03248479|587802619|FG005|Overall Study|Not reported|0|||
162750998|NCT03248479|587802620|FG006|Overall Study|Not reported|0|||
162750999|NCT03248479|587802621|FG007|Overall Study|Not reported|1|||
162751000|NCT03248479|587802622|FG008|Overall Study|Not reported|1|||
162751001|NCT03248479|587802623|FG009|Overall Study|Not reported|0|||
162751002|NCT03248479|587802624|FG010|Overall Study|Not reported|0|||
162751003|NCT03248479|587802625|FG011|Overall Study|Not reported|0|||
162751004|NCT03248479|587802626|FG012|Overall Study|Not reported|0|||
162751005|NCT06065735|587802635|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
162751006|NCT06065735|587802636|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
162751007|NCT06065735|587802637|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
162751008|NCT06065735|587802635|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
162751009|NCT06065735|587802636|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
162751010|NCT06065735|587802637|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
162751011|NCT06065735|587802635|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
162751012|NCT06065735|587802636|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
162751013|NCT06065735|587802637|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
162751014|NCT06065735|587802635|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
162751015|NCT06065735|587802636|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
162751016|NCT06065735|587802637|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
162751017|NCT06065735|587802635|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
162751018|NCT06065735|587802636|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
162751019|NCT06065735|587802637|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
162751020|NCT03522298|587802638|FG000|Overall Study|Adverse Event|1|||
162751021|NCT03522298|587802639|FG001|Overall Study|Adverse Event|0|||
162751022|NCT03522298|587802640|FG002|Overall Study|Adverse Event|0|||
162751023|NCT03522298|587802641|FG003|Overall Study|Adverse Event|1|||
162751024|NCT03522298|587802638|FG000|Overall Study|Death|2|||
162751025|NCT03522298|587802639|FG001|Overall Study|Death|4|||
162751026|NCT03522298|587802640|FG002|Overall Study|Death|8|||
162751027|NCT03522298|587802641|FG003|Overall Study|Death|8|||
162751028|NCT03522298|587802638|FG000|Overall Study|Patient decision|0|||
162751029|NCT03522298|587802639|FG001|Overall Study|Patient decision|2|||
162751030|NCT03522298|587802640|FG002|Overall Study|Patient decision|2|||
162751031|NCT03522298|587802641|FG003|Overall Study|Patient decision|2|||
162751032|NCT05718687|587802642|FG000|Overall Study|Withdrawal by Subject|3|||
162751033|NCT05485935|587802645|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
162751034|NCT05485935|587802646|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
162751035|NCT05485935|587802645|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
162751036|NCT05485935|587802646|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
162751037|NCT05485935|587802645|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
162751038|NCT05485935|587802646|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
162751039|NCT05485935|587802645|FG000|Period 2 (T2 and V3)|loss of contact|0|||
162751040|NCT05485935|587802646|FG001|Period 2 (T2 and V3)|loss of contact|1|||
162751041|NCT04093869|587802647|FG000|Overall Study|Death|0|||
162751042|NCT04093869|587802648|FG001|Overall Study|Death|1|||
162751043|NCT04093869|587802647|FG000|Overall Study|Withdrawal by Subject|1|||
162751044|NCT04093869|587802648|FG001|Overall Study|Withdrawal by Subject|0|||
162751045|NCT01499368|587802649|FG000|Overall Study|Did not meet I/E criteria|8|||
162751046|NCT01499368|587802650|FG001|Overall Study|Did not meet I/E criteria|4|||
162751047|NCT01499368|587802651|FG002|Overall Study|Did not meet I/E criteria|4|||
162751048|NCT01499368|587802649|FG000|Overall Study|Prohibited Concomitant medication|1|||
162751049|NCT01499368|587802650|FG001|Overall Study|Prohibited Concomitant medication|1|||
162751050|NCT01499368|587802651|FG002|Overall Study|Prohibited Concomitant medication|0|||
162751051|NCT01499368|587802649|FG000|Overall Study|Withdrawal by Subject|11|||
162751052|NCT01499368|587802650|FG001|Overall Study|Withdrawal by Subject|10|||
162751053|NCT01499368|587802651|FG002|Overall Study|Withdrawal by Subject|8|||
162751054|NCT01499368|587802649|FG000|Overall Study|Lost to Follow-up|3|||
162751055|NCT01499368|587802650|FG001|Overall Study|Lost to Follow-up|2|||
162751056|NCT01499368|587802651|FG002|Overall Study|Lost to Follow-up|5|||
162751057|NCT01499368|587802649|FG000|Overall Study|Adverse Event|4|||
162751058|NCT01499368|587802650|FG001|Overall Study|Adverse Event|0|||
162751059|NCT01499368|587802651|FG002|Overall Study|Adverse Event|2|||
162751060|NCT01499368|587802649|FG000|Overall Study|Physician Decision|0|||
162751061|NCT01499368|587802650|FG001|Overall Study|Physician Decision|1|||
162751062|NCT01499368|587802651|FG002|Overall Study|Physician Decision|0|||
162751063|NCT01499368|587802649|FG000|Overall Study|Deviation from visit window|0|||
162751064|NCT01499368|587802650|FG001|Overall Study|Deviation from visit window|0|||
162751065|NCT01499368|587802651|FG002|Overall Study|Deviation from visit window|1|||
162751066|NCT01499368|587802649|FG000|Overall Study|Error of Prescriptions|0|||
162751067|NCT01499368|587802650|FG001|Overall Study|Error of Prescriptions|0|||
162751068|NCT01499368|587802651|FG002|Overall Study|Error of Prescriptions|1|||
162751069|NCT03092674|587802652|FG000|Overall Study|Adverse Event or Side Effects|1|||
162751070|NCT03092674|587802653|FG001|Overall Study|Adverse Event or Side Effects|4|||
162751071|NCT03092674|587802654|FG002|Overall Study|Adverse Event or Side Effects|4|||
162751072|NCT03092674|587802652|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
162751073|NCT03092674|587802653|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
162751074|NCT03092674|587802654|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
162751075|NCT03092674|587802652|FG000|Overall Study|Progression/Relapse|5|||
162751076|NCT03092674|587802653|FG001|Overall Study|Progression/Relapse|4|||
162751077|NCT03092674|587802654|FG002|Overall Study|Progression/Relapse|8|||
162751078|NCT03092674|587802652|FG000|Overall Study|Death|4|||
162751079|NCT03092674|587802653|FG001|Overall Study|Death|8|||
162751080|NCT03092674|587802654|FG002|Overall Study|Death|2|||
162751081|NCT03092674|587802652|FG000|Overall Study|Other - Not Protocol Specified|11|||
162751082|NCT03092674|587802653|FG001|Overall Study|Other - Not Protocol Specified|8|||
162751083|NCT03092674|587802654|FG002|Overall Study|Other - Not Protocol Specified|8|||
162751084|NCT01527188|587802655|FG000|Overall Study|Adverse Event|5|||
162751085|NCT01527188|587802656|FG001|Overall Study|Adverse Event|5|||
162751086|NCT01527188|587802657|FG002|Overall Study|Adverse Event|11|||
162751087|NCT01527188|587802658|FG003|Overall Study|Adverse Event|0|||
162751088|NCT01527188|587802655|FG000|Overall Study|Withdrawal by Subject|3|||
162751089|NCT01527188|587802656|FG001|Overall Study|Withdrawal by Subject|6|||
162751090|NCT01527188|587802657|FG002|Overall Study|Withdrawal by Subject|4|||
162751091|NCT01527188|587802658|FG003|Overall Study|Withdrawal by Subject|4|||
162751092|NCT01527188|587802655|FG000|Overall Study|Any other reason not above-mentioned|6|||
162751093|NCT01527188|587802656|FG001|Overall Study|Any other reason not above-mentioned|7|||
162751094|NCT01527188|587802657|FG002|Overall Study|Any other reason not above-mentioned|8|||
162751095|NCT01527188|587802658|FG003|Overall Study|Any other reason not above-mentioned|8|||
162751096|NCT04626427|587802659|FG000|Overall Study|Death|1|||
162751097|NCT04626427|587802659|FG000|Overall Study|Withdrawal by Subject|1|||
162751098|NCT04626427|587802659|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
162751099|NCT04626427|587802659|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
162751100|NCT01265537|587802660|FG000|Overall Study|Adverse Event|2|||
162751101|NCT01265537|587802661|FG001|Overall Study|Adverse Event|1|||
162751102|NCT01265537|587802660|FG000|Overall Study|Physician Decision|0|||
162751103|NCT01265537|587802661|FG001|Overall Study|Physician Decision|1|||
162751104|NCT04518943|587803341|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
162751105|NCT04518943|587803342|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
162751106|NCT04518943|587803343|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
162751107|NCT04518943|587803344|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
162751108|NCT04518943|587803345|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
162751109|NCT04518943|587803346|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
162751110|NCT04518943|587803347|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
162751111|NCT04518943|587803348|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
162751112|NCT04518943|587803349|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
162751113|NCT04518943|587803350|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
162751114|NCT04518943|587803351|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
162751115|NCT04518943|587803352|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
162751116|NCT04518943|587803353|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
162751117|NCT04518943|587803354|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
162751118|NCT04518943|587803355|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
162751119|NCT04518943|587803356|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
162751120|NCT06408870|587803360|FG000|Washout period|Withdrawal by Subject|1|||
162751121|NCT06408870|587803361|FG001|Washout period|Withdrawal by Subject|0|||
162751122|NCT06408870|587803360|FG000|Washout period|Adverse Event|2|||
162751123|NCT06408870|587803361|FG001|Washout period|Adverse Event|0|||
162751124|NCT04772534|587803366|FG000|Overall Study|Physician Decision|1|||
162751125|NCT04772534|587803367|FG001|Overall Study|Physician Decision|0|||
162751126|NCT04772534|587803368|FG002|Overall Study|Physician Decision|0|||
162751127|NCT04772534|587803366|FG000|Overall Study|Withdrawal by Subject|3|||
162751128|NCT04772534|587803367|FG001|Overall Study|Withdrawal by Subject|0|||
162751129|NCT04772534|587803368|FG002|Overall Study|Withdrawal by Subject|1|||
162751130|NCT04194450|587803369|FG000|Overall Study|not eligible|1|||
162751131|NCT04194450|587803370|FG001|Overall Study|not eligible|0|||
162751132|NCT05875701|587803379|FG000|Overall Study|Lost to Follow-up|2|||
162751133|NCT05875701|587803380|FG001|Overall Study|Lost to Follow-up|0|||
162751134|NCT05875701|587803379|FG000|Overall Study|Withdrawal by Subject|1|||
162751135|NCT05875701|587803380|FG001|Overall Study|Withdrawal by Subject|1|||
162751136|NCT04490356|587803386|FG000|Overall Study|Lost to Follow-up|1|||
162751137|NCT00412607|587803389|FG000|Overall Study|Withdrawal by Subject|9|||
162751138|NCT00412607|587803389|FG000|Overall Study|Lost to Follow-up|19|||
162751139|NCT00412607|587803389|FG000|Overall Study|Death|61|||
162751140|NCT00412607|587803389|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
162751141|NCT03662022|587803390|FG000|Year 1 2019|prevalent case|83|||
162751142|NCT03662022|587803391|FG001|Year 1 2019|prevalent case|116|||
162751143|NCT03662022|587803392|FG002|Year 1 2019|prevalent case|158|||
162751144|NCT03662022|587803393|FG003|Year 1 2019|prevalent case|99|||
162751145|NCT03662022|587803390|FG000|Year 2 2020|incident case|18|||
162751146|NCT03662022|587803391|FG001|Year 2 2020|incident case|18|||
162751147|NCT03662022|587803392|FG002|Year 2 2020|incident case|16|||
162751148|NCT03662022|587803393|FG003|Year 2 2020|incident case|26|||
162751149|NCT03662022|587803390|FG000|Year 2 2020|other case|18|||
162751150|NCT03662022|587803391|FG001|Year 2 2020|other case|16|||
162751151|NCT03662022|587803392|FG002|Year 2 2020|other case|16|||
162751152|NCT03662022|587803393|FG003|Year 2 2020|other case|24|||
162751153|NCT03662022|587803390|FG000|Year 2 2020|Lost to Follow-up|1633|||
162751154|NCT03662022|587803391|FG001|Year 2 2020|Lost to Follow-up|1183|||
162751155|NCT03662022|587803392|FG002|Year 2 2020|Lost to Follow-up|1381|||
162751156|NCT03662022|587803393|FG003|Year 2 2020|Lost to Follow-up|2858|||
162751157|NCT03662022|587803390|FG000|Year 3 2021|incident case|24|||
162751158|NCT03662022|587803391|FG001|Year 3 2021|incident case|27|||
162751159|NCT03662022|587803392|FG002|Year 3 2021|incident case|24|||
162751160|NCT03662022|587803393|FG003|Year 3 2021|incident case|11|||
162751161|NCT03662022|587803390|FG000|Year 3 2021|other case|4|||
162751162|NCT03662022|587803391|FG001|Year 3 2021|other case|15|||
162751163|NCT03662022|587803392|FG002|Year 3 2021|other case|10|||
162751164|NCT03662022|587803393|FG003|Year 3 2021|other case|14|||
162751165|NCT03662022|587803390|FG000|Year 3 2021|Lost to Follow-up|179|||
162751166|NCT03662022|587803391|FG001|Year 3 2021|Lost to Follow-up|244|||
162751167|NCT03662022|587803392|FG002|Year 3 2021|Lost to Follow-up|480|||
162751168|NCT03662022|587803393|FG003|Year 3 2021|Lost to Follow-up|477|||
162751169|NCT03662022|587803390|FG000|Year 4 2022|incident case|25|||
162751170|NCT03662022|587803391|FG001|Year 4 2022|incident case|41|||
162751171|NCT03662022|587803392|FG002|Year 4 2022|incident case|28|||
162751172|NCT03662022|587803393|FG003|Year 4 2022|incident case|7|||
162751173|NCT03662022|587803390|FG000|Year 4 2022|other case|8|||
162751174|NCT03662022|587803391|FG001|Year 4 2022|other case|19|||
162751175|NCT03662022|587803392|FG002|Year 4 2022|other case|13|||
162751176|NCT03662022|587803393|FG003|Year 4 2022|other case|7|||
162751177|NCT03662022|587803390|FG000|Year 4 2022|Lost to Follow-up|986|||
162751178|NCT03662022|587803391|FG001|Year 4 2022|Lost to Follow-up|1079|||
162751179|NCT03662022|587803392|FG002|Year 4 2022|Lost to Follow-up|1236|||
162751180|NCT03662022|587803393|FG003|Year 4 2022|Lost to Follow-up|1826|||
162751181|NCT02806726|587803399|FG000|Overall Study|Lost to Follow-up|1|||
162751182|NCT03250676|587803400|FG000|Overall Study|Adverse Event|0|||
162751183|NCT03250676|587803401|FG001|Overall Study|Adverse Event|0|||
162751184|NCT03250676|587803402|FG002|Overall Study|Adverse Event|0|||
162751185|NCT03250676|587803403|FG003|Overall Study|Adverse Event|1|||
162751186|NCT03250676|587803404|FG004|Overall Study|Adverse Event|2|||
162751187|NCT03250676|587803405|FG005|Overall Study|Adverse Event|9|||
162751188|NCT03250676|587803400|FG000|Overall Study|Withdrawal by Subject|1|||
162751189|NCT03250676|587803401|FG001|Overall Study|Withdrawal by Subject|0|||
162751190|NCT03250676|587803402|FG002|Overall Study|Withdrawal by Subject|0|||
162751191|NCT03250676|587803403|FG003|Overall Study|Withdrawal by Subject|1|||
162751192|NCT03250676|587803404|FG004|Overall Study|Withdrawal by Subject|1|||
162751193|NCT03250676|587803405|FG005|Overall Study|Withdrawal by Subject|2|||
162751194|NCT03250676|587803400|FG000|Overall Study|Physician Decision|0|||
162751195|NCT03250676|587803401|FG001|Overall Study|Physician Decision|0|||
162751196|NCT03250676|587803402|FG002|Overall Study|Physician Decision|0|||
162751197|NCT03250676|587803403|FG003|Overall Study|Physician Decision|2|||
162751198|NCT03250676|587803404|FG004|Overall Study|Physician Decision|0|||
162751199|NCT03250676|587803405|FG005|Overall Study|Physician Decision|3|||
162751200|NCT03250676|587803400|FG000|Overall Study|Withdrawal of consent|0|||
162751201|NCT03250676|587803401|FG001|Overall Study|Withdrawal of consent|0|||
162751202|NCT03250676|587803402|FG002|Overall Study|Withdrawal of consent|2|||
162751203|NCT03250676|587803403|FG003|Overall Study|Withdrawal of consent|0|||
162751204|NCT03250676|587803404|FG004|Overall Study|Withdrawal of consent|0|||
162751205|NCT03250676|587803405|FG005|Overall Study|Withdrawal of consent|2|||
162751206|NCT03250676|587803400|FG000|Overall Study|Other|1|||
162751207|NCT03250676|587803401|FG001|Overall Study|Other|0|||
162751208|NCT03250676|587803402|FG002|Overall Study|Other|0|||
162751209|NCT03250676|587803403|FG003|Overall Study|Other|0|||
162751210|NCT03250676|587803404|FG004|Overall Study|Other|0|||
162751211|NCT03250676|587803405|FG005|Overall Study|Other|0|||
162751212|NCT03250676|587803400|FG000|Overall Study|Disease progression|4|||
162751213|NCT03250676|587803401|FG001|Overall Study|Disease progression|12|||
162751214|NCT03250676|587803402|FG002|Overall Study|Disease progression|9|||
162751215|NCT03250676|587803403|FG003|Overall Study|Disease progression|7|||
162751216|NCT03250676|587803404|FG004|Overall Study|Disease progression|4|||
162751217|NCT03250676|587803405|FG005|Overall Study|Disease progression|88|||
162751218|NCT05129501|587803408|FG000|Overall Study|Lost to Follow-up|54|||
162751219|NCT05129501|587803409|FG001|Overall Study|Lost to Follow-up|41|||
162751220|NCT01553149|587803410|FG000|Overall Study|Adverse Event|0|||
162751221|NCT01553149|587803411|FG001|Overall Study|Adverse Event|9|||
162751222|NCT01553149|587803410|FG000|Overall Study|Physician Decision|5|||
162751223|NCT01553149|587803411|FG001|Overall Study|Physician Decision|10|||
162751224|NCT01553149|587803410|FG000|Overall Study|Ineligible|0|||
162751225|NCT01553149|587803411|FG001|Overall Study|Ineligible|1|||
162751226|NCT04993677|587804247|FG000|Overall Study|Lost to Follow-up|1|||
162751227|NCT04993677|587804248|FG001|Overall Study|Lost to Follow-up|0|||
162751228|NCT04993677|587804249|FG002|Overall Study|Lost to Follow-up|0|||
162751229|NCT04993677|587804250|FG003|Overall Study|Lost to Follow-up|0|||
162751230|NCT04993677|587804247|FG000|Overall Study|Death|11|||
162751231|NCT04993677|587804248|FG001|Overall Study|Death|8|||
162751232|NCT04993677|587804249|FG002|Overall Study|Death|3|||
162751233|NCT04993677|587804250|FG003|Overall Study|Death|1|||
162751234|NCT04993677|587804247|FG000|Overall Study|Subject withdrawal of consent|4|||
162751235|NCT04993677|587804248|FG001|Overall Study|Subject withdrawal of consent|3|||
162751236|NCT04993677|587804249|FG002|Overall Study|Subject withdrawal of consent|0|||
162751237|NCT04993677|587804250|FG003|Overall Study|Subject withdrawal of consent|2|||
162751238|NCT04993677|587804247|FG000|Overall Study|Study termination by sponsor|3|||
162751239|NCT04993677|587804248|FG001|Overall Study|Study termination by sponsor|25|||
162751240|NCT04993677|587804249|FG002|Overall Study|Study termination by sponsor|3|||
162751241|NCT04993677|587804250|FG003|Overall Study|Study termination by sponsor|3|||
162751242|NCT04993677|587804247|FG000|Overall Study|Other|2|||
162751243|NCT04993677|587804248|FG001|Overall Study|Other|3|||
162751244|NCT04993677|587804249|FG002|Overall Study|Other|3|||
162751245|NCT04993677|587804250|FG003|Overall Study|Other|2|||
162751246|NCT04174170|587804251|FG000|Placebo Run-in Period|Not Randomized|38|||
162751247|NCT04174170|587804252|FG001|Placebo Run-in Period|Not Randomized|0|||
162751248|NCT04174170|587804253|FG002|Placebo Run-in Period|Not Randomized|0|||
162751249|NCT04174170|587804254|FG003|Placebo Run-in Period|Not Randomized|0|||
162751250|NCT04174170|587804251|FG000|Double Blind Treatment Period|Adverse Event|0|||
162751251|NCT04174170|587804252|FG001|Double Blind Treatment Period|Adverse Event|9|||
162751252|NCT04174170|587804253|FG002|Double Blind Treatment Period|Adverse Event|9|||
162751253|NCT04174170|587804254|FG003|Double Blind Treatment Period|Adverse Event|8|||
162751254|NCT04174170|587804251|FG000|Double Blind Treatment Period|Death|0|||
162751255|NCT04174170|587804252|FG001|Double Blind Treatment Period|Death|1|||
162751256|NCT04174170|587804253|FG002|Double Blind Treatment Period|Death|0|||
162751257|NCT04174170|587804254|FG003|Double Blind Treatment Period|Death|0|||
162751258|NCT04174170|587804251|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162751259|NCT04174170|587804252|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
162751260|NCT04174170|587804253|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
162751261|NCT04174170|587804254|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
162751262|NCT04174170|587804251|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
162751263|NCT04174170|587804252|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
162751264|NCT04174170|587804253|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
162751265|NCT04174170|587804254|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
162751266|NCT04174170|587804251|FG000|Double Blind Treatment Period|Physician Decision|0|||
162751267|NCT04174170|587804252|FG001|Double Blind Treatment Period|Physician Decision|1|||
162751268|NCT04174170|587804253|FG002|Double Blind Treatment Period|Physician Decision|0|||
162751269|NCT04174170|587804254|FG003|Double Blind Treatment Period|Physician Decision|1|||
162751270|NCT04174170|587804251|FG000|Double Blind Treatment Period|Pregnancy|0|||
162751271|NCT04174170|587804252|FG001|Double Blind Treatment Period|Pregnancy|1|||
162751272|NCT04174170|587804253|FG002|Double Blind Treatment Period|Pregnancy|0|||
162751273|NCT04174170|587804254|FG003|Double Blind Treatment Period|Pregnancy|1|||
162751274|NCT04174170|587804251|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
162751275|NCT04174170|587804252|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
162751276|NCT04174170|587804253|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
162751277|NCT04174170|587804254|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
162751278|NCT04174170|587804251|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
162751279|NCT04174170|587804252|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
162751280|NCT04174170|587804253|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
162751281|NCT04174170|587804254|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
162751282|NCT04174170|587804251|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
162751283|NCT04174170|587804252|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
162751284|NCT04174170|587804253|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
162751285|NCT04174170|587804254|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
162751286|NCT04675034|587804270|FG000|Overall Study|Lost to Follow-up|1|||
162751287|NCT04675034|587804271|FG001|Overall Study|Lost to Follow-up|1|||
162751288|NCT04675034|587804272|FG002|Overall Study|Lost to Follow-up|0|||
162751289|NCT04675034|587804273|FG003|Overall Study|Lost to Follow-up|2|||
162751290|NCT04675034|587804274|FG004|Overall Study|Lost to Follow-up|0|||
162751291|NCT04675034|587804270|FG000|Overall Study|Protocol Violation|1|||
162751292|NCT04675034|587804271|FG001|Overall Study|Protocol Violation|0|||
162751293|NCT04675034|587804272|FG002|Overall Study|Protocol Violation|0|||
162751294|NCT04675034|587804273|FG003|Overall Study|Protocol Violation|1|||
162751295|NCT04675034|587804274|FG004|Overall Study|Protocol Violation|3|||
162751296|NCT04675034|587804270|FG000|Overall Study|Withdrawal by Subject|9|||
162751297|NCT04675034|587804271|FG001|Overall Study|Withdrawal by Subject|3|||
162751298|NCT04675034|587804272|FG002|Overall Study|Withdrawal by Subject|4|||
162751299|NCT04675034|587804273|FG003|Overall Study|Withdrawal by Subject|8|||
162751300|NCT04675034|587804274|FG004|Overall Study|Withdrawal by Subject|6|||
162751301|NCT03201939|587804279|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
162751302|NCT03201939|587804280|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
162751303|NCT03884439|587804281|FG000|Overall Study|No informed consent for publication of study results|38|||
162751304|NCT03884439|587804281|FG000|Overall Study|Contract violation/deficiency|7|||
162751305|NCT03142009|587804290|FG000|Overall Study|Lost to Follow-up|45|||
162751306|NCT03142009|587804291|FG001|Overall Study|Lost to Follow-up|30|||
162751307|NCT03587805|587804293|FG000|Overall Study|Adverse Event|72|||
162751308|NCT03587805|587804293|FG000|Overall Study|Death|1|||
162751309|NCT03587805|587804293|FG000|Overall Study|Lost to Follow-up|78|||
162751310|NCT03587805|587804293|FG000|Overall Study|Withdrawal by Subject|105|||
162751311|NCT03587805|587804293|FG000|Overall Study|Lack of Efficacy|119|||
162751312|NCT03587805|587804293|FG000|Overall Study|Reason unknown|26|||
162751313|NCT03587805|587804293|FG000|Overall Study|COVID_19 pandemic|4|||
162751314|NCT03587805|587804293|FG000|Overall Study|Various reasons|121|||
162751315|NCT03587805|587804293|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162751316|NCT03982186|587804294|FG000|Overall Study|Lost to Follow-up|0|||
162751317|NCT03982186|587804295|FG001|Overall Study|Lost to Follow-up|1|||
162751318|NCT03982186|587804296|FG002|Overall Study|Lost to Follow-up|2|||
162751319|NCT03982186|587804297|FG003|Overall Study|Lost to Follow-up|1|||
162751320|NCT03982186|587804298|FG004|Overall Study|Lost to Follow-up|1|||
162751321|NCT03982186|587804299|FG005|Overall Study|Lost to Follow-up|0|||
162751322|NCT03982186|587804294|FG000|Overall Study|Physician Decision|0|||
162751323|NCT03982186|587804295|FG001|Overall Study|Physician Decision|1|||
162751324|NCT03982186|587804296|FG002|Overall Study|Physician Decision|0|||
162751325|NCT03982186|587804297|FG003|Overall Study|Physician Decision|0|||
162751326|NCT03982186|587804298|FG004|Overall Study|Physician Decision|0|||
162751327|NCT03982186|587804299|FG005|Overall Study|Physician Decision|0|||
162751328|NCT03982186|587804294|FG000|Overall Study|Withdrawal by Subject|3|||
162751329|NCT03982186|587804295|FG001|Overall Study|Withdrawal by Subject|4|||
162751330|NCT03982186|587804296|FG002|Overall Study|Withdrawal by Subject|1|||
162751331|NCT03982186|587804297|FG003|Overall Study|Withdrawal by Subject|7|||
162751332|NCT03982186|587804298|FG004|Overall Study|Withdrawal by Subject|2|||
162751333|NCT03982186|587804299|FG005|Overall Study|Withdrawal by Subject|0|||
162751334|NCT03982186|587804294|FG000|Overall Study|Randomized and not treated|0|||
162751335|NCT03982186|587804295|FG001|Overall Study|Randomized and not treated|0|||
162751336|NCT03982186|587804296|FG002|Overall Study|Randomized and not treated|0|||
162751337|NCT03982186|587804297|FG003|Overall Study|Randomized and not treated|1|||
162751338|NCT03982186|587804298|FG004|Overall Study|Randomized and not treated|0|||
162751339|NCT03982186|587804299|FG005|Overall Study|Randomized and not treated|0|||
162751340|NCT03008382|587804301|FG000|Overall Study|Withdrawal by Subject|2|||
162751341|NCT03008382|587804302|FG001|Overall Study|Withdrawal by Subject|5|||
162751342|NCT03008382|587804303|FG002|Overall Study|Withdrawal by Subject|2|||
162751343|NCT03008382|587804304|FG003|Overall Study|Withdrawal by Subject|0|||
162751344|NCT03008382|587804301|FG000|Overall Study|Protocol Violation|1|||
162751345|NCT03008382|587804302|FG001|Overall Study|Protocol Violation|0|||
162751346|NCT03008382|587804303|FG002|Overall Study|Protocol Violation|0|||
162751347|NCT03008382|587804304|FG003|Overall Study|Protocol Violation|0|||
162751348|NCT03008382|587804301|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
162751349|NCT03008382|587804302|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
162751350|NCT03008382|587804303|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
162751351|NCT03008382|587804304|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
162751352|NCT03008382|587804301|FG000|Overall Study|Lost to Follow-up|0|||
162751353|NCT03008382|587804302|FG001|Overall Study|Lost to Follow-up|0|||
162751354|NCT03008382|587804303|FG002|Overall Study|Lost to Follow-up|1|||
162751355|NCT03008382|587804304|FG003|Overall Study|Lost to Follow-up|0|||
162751356|NCT03008382|587804301|FG000|Overall Study|Screenfail|0|||
162751357|NCT03008382|587804302|FG001|Overall Study|Screenfail|0|||
162751358|NCT03008382|587804303|FG002|Overall Study|Screenfail|2|||
162751359|NCT03008382|587804304|FG003|Overall Study|Screenfail|0|||
162751360|NCT03512301|587804749|FG000|Overall Study|Protocol Violation|2|||
162751361|NCT03512301|587804749|FG000|Overall Study|Did Not Qualify|3|||
162751362|NCT03512301|587804749|FG000|Overall Study|Age-ineligible|1|||
162751363|NCT03512301|587804749|FG000|Overall Study|Inadequate fluency with the English language|3|||
162751364|NCT02231749|587804756|FG000|Overall Study|Disease progression|229|||
162751365|NCT02231749|587804757|FG001|Overall Study|Disease progression|297|||
162751366|NCT02231749|587804756|FG000|Overall Study|Study Drug Toxicity|134|||
162751367|NCT02231749|587804757|FG001|Overall Study|Study Drug Toxicity|63|||
162751368|NCT02231749|587804756|FG000|Overall Study|Death|1|||
162751369|NCT02231749|587804757|FG001|Overall Study|Death|1|||
162751370|NCT02231749|587804756|FG000|Overall Study|AE unrelated to Study drug|32|||
162751371|NCT02231749|587804757|FG001|Overall Study|AE unrelated to Study drug|31|||
162751372|NCT02231749|587804756|FG000|Overall Study|Participant's request to discontinue|10|||
162751373|NCT02231749|587804757|FG001|Overall Study|Participant's request to discontinue|21|||
162751374|NCT02231749|587804756|FG000|Overall Study|Participant withdrew Consent|8|||
162751375|NCT02231749|587804757|FG001|Overall Study|Participant withdrew Consent|15|||
162751376|NCT02231749|587804756|FG000|Overall Study|Lost to Follow-up|1|||
162751377|NCT02231749|587804757|FG001|Overall Study|Lost to Follow-up|2|||
162751378|NCT02231749|587804756|FG000|Overall Study|Maximum Clinical Benefit|5|||
162751379|NCT02231749|587804757|FG001|Overall Study|Maximum Clinical Benefit|8|||
162751380|NCT02231749|587804756|FG000|Overall Study|Poor/Non-Compliance|0|||
162751381|NCT02231749|587804757|FG001|Overall Study|Poor/Non-Compliance|3|||
162751382|NCT02231749|587804756|FG000|Overall Study|Pregnancy|1|||
162751383|NCT02231749|587804757|FG001|Overall Study|Pregnancy|0|||
162751384|NCT02231749|587804756|FG000|Overall Study|other|0|||
162751385|NCT02231749|587804757|FG001|Overall Study|other|8|||
162751386|NCT02231749|587804756|FG000|Overall Study|No longer meets Study Criteria|1|||
162751387|NCT02231749|587804757|FG001|Overall Study|No longer meets Study Criteria|0|||
162751388|NCT02532621|587804760|FG000|Overall Study|Death|3|||
162751389|NCT02532621|587804760|FG000|Overall Study|Lost to Follow-up|3|||
162751390|NCT02532621|587804760|FG000|Overall Study|Withdrawal by Subject|6|||
162751391|NCT02532621|587804760|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
162751392|NCT02532621|587804760|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
162751393|NCT04281498|587804761|FG000|Overall Study|Progression of disease|1|||
162751394|NCT04281498|587804761|FG000|Overall Study|Planned SCT|1|||
162751395|NCT04281498|587804761|FG000|Overall Study|Alternative Treatment|1|||
162751396|NCT06059443|587804762|FG000|Overall Study|Withdrawal by Subject|2|||
162751397|NCT06059443|587804763|FG001|Overall Study|Withdrawal by Subject|0|||
162751398|NCT06059443|587804762|FG000|Overall Study|Lost to Follow-up|2|||
162751399|NCT06059443|587804763|FG001|Overall Study|Lost to Follow-up|2|||
162751400|NCT00709956|587804766|FG000|Overall Study|Withdrawal by Subject|1|||
162751401|NCT00709956|587804767|FG001|Overall Study|Withdrawal by Subject|1|||
162751402|NCT00709956|587804766|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
162751403|NCT00709956|587804767|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
162751404|NCT04940624|587804770|FG000|Overall Study|Adverse Event|4|||
162751405|NCT04940624|587804771|FG001|Overall Study|Adverse Event|11|||
162751406|NCT04940624|587804770|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162751407|NCT04940624|587804771|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162751408|NCT04940624|587804770|FG000|Overall Study|Physician Decision|1|||
162751409|NCT04940624|587804771|FG001|Overall Study|Physician Decision|0|||
162751410|NCT04940624|587804770|FG000|Overall Study|Lost to Follow-up|1|||
162751411|NCT04940624|587804771|FG001|Overall Study|Lost to Follow-up|0|||
162751412|NCT04940624|587804770|FG000|Overall Study|Reason Not Specified|1|||
162751413|NCT04940624|587804771|FG001|Overall Study|Reason Not Specified|0|||
162751414|NCT04479787|587804772|FG000|Through 6 Months|Withdrawal by Subject|16|||
162751415|NCT04479787|587804773|FG001|Through 6 Months|Withdrawal by Subject|14|||
162751416|NCT04479787|587804772|FG000|Through 6 Months|Unsuccessful Trial|17|||
162751417|NCT04479787|587804773|FG001|Through 6 Months|Unsuccessful Trial|0|||
162751418|NCT04479787|587804772|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
162751419|NCT04479787|587804773|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
162751420|NCT04479787|587804772|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
162751421|NCT04479787|587804773|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
162751422|NCT04479787|587804772|FG000|Through 6 Months|Lost to Follow-up|3|||
162751423|NCT04479787|587804773|FG001|Through 6 Months|Lost to Follow-up|2|||
162751424|NCT04479787|587804772|FG000|Through 6 Months|Death|3|||
162751425|NCT04479787|587804773|FG001|Through 6 Months|Death|0|||
162751426|NCT04479787|587804772|FG000|Through 6 Months|Inclusion/Exclusion|2|||
162751427|NCT04479787|587804773|FG001|Through 6 Months|Inclusion/Exclusion|1|||
162751428|NCT04479787|587804772|FG000|Through 6 Months|Subject Became Pregnant|1|||
162751429|NCT04479787|587804773|FG001|Through 6 Months|Subject Became Pregnant|1|||
162751430|NCT04479787|587804772|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
162751431|NCT04479787|587804773|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
162751432|NCT04479787|587804772|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
162751433|NCT04479787|587804773|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
162751434|NCT04479787|587804772|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
162751435|NCT04479787|587804773|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
162751436|NCT04479787|587804772|FG000|After 6 Months|Withdrawal by Subject|3|||
162751437|NCT04479787|587804773|FG001|After 6 Months|Withdrawal by Subject|13|||
162751438|NCT04479787|587804772|FG000|After 6 Months|Unsuccessful Trial|0|||
162751439|NCT04479787|587804773|FG001|After 6 Months|Unsuccessful Trial|7|||
162751440|NCT04479787|587804772|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
162751441|NCT04479787|587804773|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
162751442|NCT04479787|587804772|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
162751443|NCT04479787|587804773|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
162751444|NCT04479787|587804772|FG000|After 6 Months|Death|2|||
162751445|NCT04479787|587804773|FG001|After 6 Months|Death|0|||
162751446|NCT04479787|587804772|FG000|After 6 Months|Lost to Follow-up|1|||
162751447|NCT04479787|587804773|FG001|After 6 Months|Lost to Follow-up|1|||
162751448|NCT04479787|587804772|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
162751449|NCT04479787|587804773|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
162751450|NCT04479787|587804772|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
162751451|NCT04479787|587804773|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
162751452|NCT04479787|587804772|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
162751453|NCT04479787|587804773|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
162751454|NCT04479787|587804772|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
162751455|NCT04479787|587804773|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
162751456|NCT04039113|587804776|FG000|Overall Study|Withdrawal by Subject|8|||
162751457|NCT04039113|587804777|FG001|Overall Study|Withdrawal by Subject|11|||
162751458|NCT04039113|587804776|FG000|Overall Study|Lost to Follow-up|1|||
162751459|NCT04039113|587804777|FG001|Overall Study|Lost to Follow-up|1|||
162751460|NCT04039113|587804776|FG000|Overall Study|Adverse Event|2|||
162751461|NCT04039113|587804777|FG001|Overall Study|Adverse Event|2|||
162751462|NCT04039113|587804776|FG000|Overall Study|Death|2|||
162751463|NCT04039113|587804777|FG001|Overall Study|Death|4|||
162751464|NCT04039113|587804776|FG000|Overall Study|Site Closure|6|||
162751465|NCT04039113|587804777|FG001|Overall Study|Site Closure|0|||
162751466|NCT04039113|587804776|FG000|Overall Study|Failure to meet randomisation criteria|4|||
162751467|NCT04039113|587804777|FG001|Overall Study|Failure to meet randomisation criteria|0|||
162751468|NCT00353496|587804778|FG000|Overall Study|Adverse Event|1|||
162751469|NCT00353496|587804779|FG001|Overall Study|Adverse Event|0|||
162751470|NCT00353496|587804778|FG000|Overall Study|Protocol Violation|2|||
162751471|NCT00353496|587804779|FG001|Overall Study|Protocol Violation|2|||
162751472|NCT00353496|587804778|FG000|Overall Study|Withdrawal by Subject|3|||
162751473|NCT00353496|587804779|FG001|Overall Study|Withdrawal by Subject|4|||
162751474|NCT00353496|587804778|FG000|Overall Study|Physician Decision|6|||
162751475|NCT00353496|587804779|FG001|Overall Study|Physician Decision|9|||
162751476|NCT00353496|587804778|FG000|Overall Study|Not otherwise specified|4|||
162751477|NCT00353496|587804779|FG001|Overall Study|Not otherwise specified|2|||
162751478|NCT02180867|587804780|FG000|Overall Study|Adverse Event|3|||
162751479|NCT02180867|587804781|FG001|Overall Study|Adverse Event|4|||
162751480|NCT02180867|587804782|FG002|Overall Study|Adverse Event|1|||
162751481|NCT02180867|587804783|FG003|Overall Study|Adverse Event|5|||
162751482|NCT02180867|587804784|FG004|Overall Study|Adverse Event|0|||
162751483|NCT02180867|587804785|FG005|Overall Study|Adverse Event|0|||
162751484|NCT02180867|587804786|FG006|Overall Study|Adverse Event|0|||
162751485|NCT02180867|587804780|FG000|Overall Study|Death|0|||
162751486|NCT02180867|587804781|FG001|Overall Study|Death|0|||
162751487|NCT02180867|587804782|FG002|Overall Study|Death|0|||
162751488|NCT02180867|587804783|FG003|Overall Study|Death|0|||
162751489|NCT02180867|587804784|FG004|Overall Study|Death|1|||
162751490|NCT02180867|587804785|FG005|Overall Study|Death|0|||
162751491|NCT02180867|587804786|FG006|Overall Study|Death|0|||
162751492|NCT02180867|587804780|FG000|Overall Study|Lack of Efficacy|0|||
162751493|NCT02180867|587804781|FG001|Overall Study|Lack of Efficacy|2|||
162751494|NCT02180867|587804782|FG002|Overall Study|Lack of Efficacy|0|||
162751495|NCT02180867|587804783|FG003|Overall Study|Lack of Efficacy|1|||
162751496|NCT02180867|587804784|FG004|Overall Study|Lack of Efficacy|6|||
162751497|NCT02180867|587804785|FG005|Overall Study|Lack of Efficacy|0|||
162751498|NCT02180867|587804786|FG006|Overall Study|Lack of Efficacy|1|||
162751499|NCT02180867|587804780|FG000|Overall Study|Physician Decision|1|||
162751500|NCT02180867|587804781|FG001|Overall Study|Physician Decision|3|||
162751501|NCT02180867|587804782|FG002|Overall Study|Physician Decision|1|||
162751502|NCT02180867|587804783|FG003|Overall Study|Physician Decision|10|||
162751503|NCT02180867|587804784|FG004|Overall Study|Physician Decision|9|||
162751504|NCT02180867|587804785|FG005|Overall Study|Physician Decision|3|||
162751505|NCT02180867|587804786|FG006|Overall Study|Physician Decision|4|||
162751506|NCT02180867|587804780|FG000|Overall Study|Withdrawal by Subject|0|||
162751507|NCT02180867|587804781|FG001|Overall Study|Withdrawal by Subject|0|||
162751508|NCT02180867|587804782|FG002|Overall Study|Withdrawal by Subject|0|||
162751509|NCT02180867|587804783|FG003|Overall Study|Withdrawal by Subject|1|||
162751510|NCT02180867|587804784|FG004|Overall Study|Withdrawal by Subject|1|||
162751511|NCT02180867|587804785|FG005|Overall Study|Withdrawal by Subject|0|||
162751512|NCT02180867|587804786|FG006|Overall Study|Withdrawal by Subject|0|||
162751513|NCT02180867|587804780|FG000|Overall Study|Ineligible|1|||
162751514|NCT02180867|587804781|FG001|Overall Study|Ineligible|2|||
162751515|NCT02180867|587804782|FG002|Overall Study|Ineligible|0|||
162751516|NCT02180867|587804783|FG003|Overall Study|Ineligible|3|||
162751517|NCT02180867|587804784|FG004|Overall Study|Ineligible|5|||
162751518|NCT02180867|587804785|FG005|Overall Study|Ineligible|0|||
162751519|NCT02180867|587804786|FG006|Overall Study|Ineligible|0|||
162751520|NCT02180867|587804780|FG000|Overall Study|Repeat Eligibility Studies|0|||
162751521|NCT02180867|587804781|FG001|Overall Study|Repeat Eligibility Studies|0|||
162751522|NCT02180867|587804782|FG002|Overall Study|Repeat Eligibility Studies|0|||
162751523|NCT02180867|587804783|FG003|Overall Study|Repeat Eligibility Studies|0|||
162751524|NCT02180867|587804784|FG004|Overall Study|Repeat Eligibility Studies|1|||
162751525|NCT02180867|587804785|FG005|Overall Study|Repeat Eligibility Studies|0|||
162751526|NCT02180867|587804786|FG006|Overall Study|Repeat Eligibility Studies|0|||
162751527|NCT02180867|587804780|FG000|Overall Study|Refusal of further protocol therapy|1|||
162751528|NCT02180867|587804781|FG001|Overall Study|Refusal of further protocol therapy|0|||
162751529|NCT02180867|587804782|FG002|Overall Study|Refusal of further protocol therapy|2|||
162751530|NCT02180867|587804783|FG003|Overall Study|Refusal of further protocol therapy|6|||
162751531|NCT02180867|587804784|FG004|Overall Study|Refusal of further protocol therapy|4|||
162751532|NCT02180867|587804785|FG005|Overall Study|Refusal of further protocol therapy|0|||
162751533|NCT02180867|587804786|FG006|Overall Study|Refusal of further protocol therapy|0|||
162751534|NCT05267639|587805686|FG000|Overall Study|Withdrawal by Subject|1|||
162751535|NCT05267639|587805687|FG001|Overall Study|Withdrawal by Subject|0|||
162751536|NCT04732871|587805688|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
162751537|NCT04732871|587805689|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
162751538|NCT04732871|587805690|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
162751539|NCT04732871|587805688|FG000|Overall Study|Lost to Follow-up|7|||
162751540|NCT04732871|587805689|FG001|Overall Study|Lost to Follow-up|4|||
162751541|NCT04732871|587805690|FG002|Overall Study|Lost to Follow-up|3|||
162751542|NCT04732871|587805688|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
162751543|NCT04732871|587805689|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
162751544|NCT04732871|587805690|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
162751545|NCT04732871|587805688|FG000|Overall Study|Migrated / moved from the study area|5|||
162751546|NCT04732871|587805689|FG001|Overall Study|Migrated / moved from the study area|0|||
162751547|NCT04732871|587805690|FG002|Overall Study|Migrated / moved from the study area|0|||
162751548|NCT04732871|587805688|FG000|Overall Study|Other|1|||
162751549|NCT04732871|587805689|FG001|Overall Study|Other|0|||
162751550|NCT04732871|587805690|FG002|Overall Study|Other|1|||
162751551|NCT04732871|587805688|FG000|Overall Study|Ongoing|6|||
162751552|NCT04732871|587805689|FG001|Overall Study|Ongoing|0|||
162751553|NCT04732871|587805690|FG002|Overall Study|Ongoing|1|||
162751554|NCT04732871|587805688|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
162751555|NCT04732871|587805689|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
162751556|NCT04732871|587805690|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
162751557|NCT05180539|587805696|FG000|Overall Study|Lost to Follow-up|27|||
162751558|NCT05180539|587805697|FG001|Overall Study|Lost to Follow-up|30|||
162751559|NCT00968149|587805698|FG000|Overall Study|Adverse Event|5|||
162751560|NCT00968149|587805699|FG001|Overall Study|Adverse Event|1|||
162751561|NCT00968149|587805698|FG000|Overall Study|Lack of Efficacy|0|||
162751562|NCT00968149|587805699|FG001|Overall Study|Lack of Efficacy|4|||
162751563|NCT00968149|587805698|FG000|Overall Study|Lost to Follow-up|0|||
162751564|NCT00968149|587805699|FG001|Overall Study|Lost to Follow-up|1|||
162751565|NCT00968149|587805698|FG000|Overall Study|Protocol Violation|4|||
162751566|NCT00968149|587805699|FG001|Overall Study|Protocol Violation|0|||
162751567|NCT00968149|587805698|FG000|Overall Study|Withdrawal by Subject|2|||
162751568|NCT00968149|587805699|FG001|Overall Study|Withdrawal by Subject|0|||
162751569|NCT02502266|587805700|FG000|Overall Study|Adverse Event|0|||
162751570|NCT02502266|587805701|FG001|Overall Study|Adverse Event|0|||
162751571|NCT02502266|587805702|FG002|Overall Study|Adverse Event|0|||
162751572|NCT02502266|587805703|FG003|Overall Study|Adverse Event|0|||
162751573|NCT02502266|587805704|FG004|Overall Study|Adverse Event|1|||
162751574|NCT02502266|587805705|FG005|Overall Study|Adverse Event|1|||
162751575|NCT02502266|587805706|FG006|Overall Study|Adverse Event|1|||
162751576|NCT02502266|587805700|FG000|Overall Study|Withdrawal by Subject|30|||
162751577|NCT02502266|587805701|FG001|Overall Study|Withdrawal by Subject|15|||
162751578|NCT02502266|587805702|FG002|Overall Study|Withdrawal by Subject|16|||
162751579|NCT02502266|587805703|FG003|Overall Study|Withdrawal by Subject|0|||
162751580|NCT02502266|587805704|FG004|Overall Study|Withdrawal by Subject|0|||
162751581|NCT02502266|587805705|FG005|Overall Study|Withdrawal by Subject|0|||
162751582|NCT02502266|587805706|FG006|Overall Study|Withdrawal by Subject|0|||
162751583|NCT02502266|587805700|FG000|Overall Study|Still on Treatment|0|||
162751584|NCT02502266|587805701|FG001|Overall Study|Still on Treatment|0|||
162751585|NCT02502266|587805702|FG002|Overall Study|Still on Treatment|1|||
162751586|NCT02502266|587805703|FG003|Overall Study|Still on Treatment|0|||
162751587|NCT02502266|587805704|FG004|Overall Study|Still on Treatment|0|||
162751588|NCT02502266|587805705|FG005|Overall Study|Still on Treatment|0|||
162751589|NCT02502266|587805706|FG006|Overall Study|Still on Treatment|0|||
162751590|NCT02502266|587805700|FG000|Overall Study|Other Reasons|19|||
162751591|NCT02502266|587805701|FG001|Overall Study|Other Reasons|6|||
162751592|NCT02502266|587805702|FG002|Overall Study|Other Reasons|14|||
162751593|NCT02502266|587805703|FG003|Overall Study|Other Reasons|0|||
162751594|NCT02502266|587805704|FG004|Overall Study|Other Reasons|1|||
162751595|NCT02502266|587805705|FG005|Overall Study|Other Reasons|1|||
162751596|NCT02502266|587805706|FG006|Overall Study|Other Reasons|0|||
162751597|NCT02502266|587805700|FG000|Overall Study|Arm 4 Discontinued|0|||
162751598|NCT02502266|587805701|FG001|Overall Study|Arm 4 Discontinued|0|||
162751599|NCT02502266|587805702|FG002|Overall Study|Arm 4 Discontinued|0|||
162751600|NCT02502266|587805703|FG003|Overall Study|Arm 4 Discontinued|52|||
162751601|NCT02502266|587805704|FG004|Overall Study|Arm 4 Discontinued|0|||
162751602|NCT02502266|587805705|FG005|Overall Study|Arm 4 Discontinued|0|||
162751603|NCT02502266|587805706|FG006|Overall Study|Arm 4 Discontinued|0|||
162751604|NCT02502266|587805700|FG000|Overall Study|Never treated|0|||
162751605|NCT02502266|587805701|FG001|Overall Study|Never treated|0|||
162751606|NCT02502266|587805702|FG002|Overall Study|Never treated|0|||
162751607|NCT02502266|587805703|FG003|Overall Study|Never treated|0|||
162751608|NCT02502266|587805704|FG004|Overall Study|Never treated|0|||
162751609|NCT02502266|587805705|FG005|Overall Study|Never treated|1|||
162751610|NCT02502266|587805706|FG006|Overall Study|Never treated|0|||
162751611|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Other|0|||
162751612|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Other|2|||
162751613|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Other|1|||
162751614|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Other|2|||
162751615|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Other|2|||
162751616|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Other|0|||
162751617|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Other|0|||
162751618|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Other|0|||
162751619|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Other|0|||
162751620|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Other|0|||
162751621|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Other|0|||
162751622|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Other|0|||
162751623|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Other|0|||
162751624|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Other|0|||
162751625|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Other|0|||
162751626|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Other|0|||
162751627|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Other|0|||
162751628|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
162751629|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
162751630|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
162751631|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
162751632|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
162751633|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
162751634|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751635|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751636|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751637|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751638|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751639|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751640|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751641|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751642|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751643|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751644|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162751645|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751646|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
162751647|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162751648|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751649|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162751650|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162751651|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751652|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751653|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751654|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751655|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751656|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751657|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751658|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751659|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751660|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751661|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162751662|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Death|2|||
162751663|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Death|1|||
162751664|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Death|1|||
162751665|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Death|0|||
162751666|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Death|0|||
162751667|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Death|0|||
162751668|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Death|0|||
162751669|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Death|0|||
162751670|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Death|0|||
162751671|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Death|0|||
162751672|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Death|0|||
162751673|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Death|0|||
162751674|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Death|0|||
162751675|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Death|0|||
162751676|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Death|0|||
162751677|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Death|0|||
162751678|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Death|0|||
162751679|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751680|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
162751681|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751682|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751683|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
162751684|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
162751685|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751686|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751687|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751688|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751689|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751690|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751691|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751692|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751693|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751694|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751695|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
162751696|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751697|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751698|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751699|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751700|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
162751701|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
162751702|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751703|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751704|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751705|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751706|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751707|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751708|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751709|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751710|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751711|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751712|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
162751713|NCT02719574|587805707|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751714|NCT02719574|587805708|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751715|NCT02719574|587805709|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
162751716|NCT02719574|587805710|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751717|NCT02719574|587805711|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751718|NCT02719574|587805712|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751719|NCT02719574|587805713|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751720|NCT02719574|587805714|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751721|NCT02719574|587805715|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751722|NCT02719574|587805716|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751723|NCT02719574|587805717|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751724|NCT02719574|587805718|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751725|NCT02719574|587805719|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751726|NCT02719574|587805720|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751727|NCT02719574|587805721|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751728|NCT02719574|587805722|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751729|NCT02719574|587805723|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162751730|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751731|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751732|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751733|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751734|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751735|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751736|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
162751737|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
162751738|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
162751739|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751740|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751741|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751742|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751743|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751744|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751745|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751746|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162751747|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751748|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751749|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751750|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751751|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751752|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751753|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
162751754|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
162751755|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751756|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751757|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751758|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751759|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751760|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751761|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751762|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751763|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162751764|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|Death|0|||
162751765|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|Death|0|||
162751766|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|Death|0|||
162751767|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|Death|0|||
162751768|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|Death|0|||
162751769|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|Death|0|||
162751770|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|Death|1|||
162751771|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|Death|6|||
162751772|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|Death|0|||
162751773|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|Death|0|||
162751774|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|Death|0|||
162751775|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|Death|0|||
162751776|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|Death|0|||
162751777|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|Death|0|||
162751778|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|Death|0|||
162751779|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|Death|0|||
162751780|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|Death|0|||
162751781|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751782|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751783|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751784|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751785|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751786|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751787|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
162751788|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
162751789|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751790|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751791|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751792|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751793|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751794|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751795|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751796|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751797|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
162751798|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751799|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751800|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751801|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751802|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751803|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751804|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
162751805|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
162751806|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751807|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751808|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751809|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751810|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751811|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751812|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751813|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751814|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
162751815|NCT02719574|587805707|FG000|Phase 1 (Dose Expansion)|Other|0|||
162751816|NCT02719574|587805708|FG001|Phase 1 (Dose Expansion)|Other|0|||
162751817|NCT02719574|587805709|FG002|Phase 1 (Dose Expansion)|Other|0|||
162751818|NCT02719574|587805710|FG003|Phase 1 (Dose Expansion)|Other|0|||
162751819|NCT02719574|587805711|FG004|Phase 1 (Dose Expansion)|Other|0|||
162751820|NCT02719574|587805712|FG005|Phase 1 (Dose Expansion)|Other|0|||
162751821|NCT02719574|587805713|FG006|Phase 1 (Dose Expansion)|Other|1|||
162751822|NCT02719574|587805714|FG007|Phase 1 (Dose Expansion)|Other|7|||
162751823|NCT02719574|587805715|FG008|Phase 1 (Dose Expansion)|Other|0|||
162751824|NCT02719574|587805716|FG009|Phase 1 (Dose Expansion)|Other|0|||
162751825|NCT02719574|587805717|FG010|Phase 1 (Dose Expansion)|Other|0|||
162751826|NCT02719574|587805718|FG011|Phase 1 (Dose Expansion)|Other|0|||
162751827|NCT02719574|587805719|FG012|Phase 1 (Dose Expansion)|Other|0|||
162751828|NCT02719574|587805720|FG013|Phase 1 (Dose Expansion)|Other|0|||
162751829|NCT02719574|587805721|FG014|Phase 1 (Dose Expansion)|Other|0|||
162751830|NCT02719574|587805722|FG015|Phase 1 (Dose Expansion)|Other|0|||
162751831|NCT02719574|587805723|FG016|Phase 1 (Dose Expansion)|Other|0|||
162751832|NCT02719574|587805707|FG000|Phase 2|Protocol Defined Disease Progression|0|||
162751833|NCT02719574|587805708|FG001|Phase 2|Protocol Defined Disease Progression|0|||
162751834|NCT02719574|587805709|FG002|Phase 2|Protocol Defined Disease Progression|0|||
162751835|NCT02719574|587805710|FG003|Phase 2|Protocol Defined Disease Progression|0|||
162751836|NCT02719574|587805711|FG004|Phase 2|Protocol Defined Disease Progression|0|||
162751837|NCT02719574|587805712|FG005|Phase 2|Protocol Defined Disease Progression|0|||
162751838|NCT02719574|587805713|FG006|Phase 2|Protocol Defined Disease Progression|0|||
162751839|NCT02719574|587805714|FG007|Phase 2|Protocol Defined Disease Progression|0|||
162751840|NCT02719574|587805715|FG008|Phase 2|Protocol Defined Disease Progression|0|||
162751841|NCT02719574|587805716|FG009|Phase 2|Protocol Defined Disease Progression|65|||
162751842|NCT02719574|587805717|FG010|Phase 2|Protocol Defined Disease Progression|8|||
162751843|NCT02719574|587805718|FG011|Phase 2|Protocol Defined Disease Progression|2|||
162751844|NCT02719574|587805719|FG012|Phase 2|Protocol Defined Disease Progression|4|||
162751845|NCT02719574|587805720|FG013|Phase 2|Protocol Defined Disease Progression|9|||
162751846|NCT02719574|587805721|FG014|Phase 2|Protocol Defined Disease Progression|11|||
162751847|NCT02719574|587805722|FG015|Phase 2|Protocol Defined Disease Progression|3|||
162751848|NCT02719574|587805723|FG016|Phase 2|Protocol Defined Disease Progression|4|||
162751849|NCT02719574|587805707|FG000|Phase 2|Adverse Event|0|||
162751850|NCT02719574|587805708|FG001|Phase 2|Adverse Event|0|||
162751851|NCT02719574|587805709|FG002|Phase 2|Adverse Event|0|||
162751852|NCT02719574|587805710|FG003|Phase 2|Adverse Event|0|||
162751853|NCT02719574|587805711|FG004|Phase 2|Adverse Event|0|||
162751854|NCT02719574|587805712|FG005|Phase 2|Adverse Event|0|||
162751855|NCT02719574|587805713|FG006|Phase 2|Adverse Event|0|||
162751856|NCT02719574|587805714|FG007|Phase 2|Adverse Event|0|||
162751857|NCT02719574|587805715|FG008|Phase 2|Adverse Event|0|||
162751858|NCT02719574|587805716|FG009|Phase 2|Adverse Event|27|||
162751859|NCT02719574|587805717|FG010|Phase 2|Adverse Event|0|||
162751860|NCT02719574|587805718|FG011|Phase 2|Adverse Event|1|||
162751861|NCT02719574|587805719|FG012|Phase 2|Adverse Event|1|||
162751862|NCT02719574|587805720|FG013|Phase 2|Adverse Event|1|||
162751863|NCT02719574|587805721|FG014|Phase 2|Adverse Event|2|||
162751864|NCT02719574|587805722|FG015|Phase 2|Adverse Event|2|||
162751865|NCT02719574|587805723|FG016|Phase 2|Adverse Event|3|||
162751866|NCT02719574|587805707|FG000|Phase 2|Other|0|||
162751867|NCT02719574|587805708|FG001|Phase 2|Other|0|||
162751868|NCT02719574|587805709|FG002|Phase 2|Other|0|||
162751869|NCT02719574|587805710|FG003|Phase 2|Other|0|||
162751870|NCT02719574|587805711|FG004|Phase 2|Other|0|||
162751871|NCT02719574|587805712|FG005|Phase 2|Other|0|||
162751872|NCT02719574|587805713|FG006|Phase 2|Other|0|||
162751873|NCT02719574|587805714|FG007|Phase 2|Other|0|||
162751874|NCT02719574|587805715|FG008|Phase 2|Other|0|||
162751875|NCT02719574|587805716|FG009|Phase 2|Other|20|||
162751876|NCT02719574|587805717|FG010|Phase 2|Other|7|||
162751877|NCT02719574|587805718|FG011|Phase 2|Other|0|||
162751878|NCT02719574|587805719|FG012|Phase 2|Other|5|||
162751879|NCT02719574|587805720|FG013|Phase 2|Other|7|||
162751880|NCT02719574|587805721|FG014|Phase 2|Other|0|||
162751881|NCT02719574|587805722|FG015|Phase 2|Other|1|||
162751882|NCT02719574|587805723|FG016|Phase 2|Other|4|||
162751883|NCT02719574|587805707|FG000|Phase 2|Transplant|0|||
162751884|NCT02719574|587805708|FG001|Phase 2|Transplant|0|||
162751885|NCT02719574|587805709|FG002|Phase 2|Transplant|0|||
162751886|NCT02719574|587805710|FG003|Phase 2|Transplant|0|||
162751887|NCT02719574|587805711|FG004|Phase 2|Transplant|0|||
162751888|NCT02719574|587805712|FG005|Phase 2|Transplant|0|||
162751889|NCT02719574|587805713|FG006|Phase 2|Transplant|0|||
162751890|NCT02719574|587805714|FG007|Phase 2|Transplant|0|||
162751891|NCT02719574|587805715|FG008|Phase 2|Transplant|0|||
162751892|NCT02719574|587805716|FG009|Phase 2|Transplant|15|||
162751893|NCT02719574|587805717|FG010|Phase 2|Transplant|2|||
162751894|NCT02719574|587805718|FG011|Phase 2|Transplant|0|||
162751895|NCT02719574|587805719|FG012|Phase 2|Transplant|6|||
162751896|NCT02719574|587805720|FG013|Phase 2|Transplant|1|||
162751897|NCT02719574|587805721|FG014|Phase 2|Transplant|1|||
162751898|NCT02719574|587805722|FG015|Phase 2|Transplant|0|||
162751899|NCT02719574|587805723|FG016|Phase 2|Transplant|0|||
162751900|NCT02719574|587805707|FG000|Phase 2|Death|0|||
162751901|NCT02719574|587805708|FG001|Phase 2|Death|0|||
162751902|NCT02719574|587805709|FG002|Phase 2|Death|0|||
162751903|NCT02719574|587805710|FG003|Phase 2|Death|0|||
162751904|NCT02719574|587805711|FG004|Phase 2|Death|0|||
162751905|NCT02719574|587805712|FG005|Phase 2|Death|0|||
162751906|NCT02719574|587805713|FG006|Phase 2|Death|0|||
162751907|NCT02719574|587805714|FG007|Phase 2|Death|0|||
162751908|NCT02719574|587805715|FG008|Phase 2|Death|0|||
162751909|NCT02719574|587805716|FG009|Phase 2|Death|14|||
162751910|NCT02719574|587805717|FG010|Phase 2|Death|0|||
162751911|NCT02719574|587805718|FG011|Phase 2|Death|0|||
162751912|NCT02719574|587805719|FG012|Phase 2|Death|1|||
162751913|NCT02719574|587805720|FG013|Phase 2|Death|1|||
162751914|NCT02719574|587805721|FG014|Phase 2|Death|2|||
162751915|NCT02719574|587805722|FG015|Phase 2|Death|0|||
162751916|NCT02719574|587805723|FG016|Phase 2|Death|0|||
162751917|NCT02719574|587805707|FG000|Phase 2|Investigator Decision|0|||
162751918|NCT02719574|587805708|FG001|Phase 2|Investigator Decision|0|||
162751919|NCT02719574|587805709|FG002|Phase 2|Investigator Decision|0|||
162751920|NCT02719574|587805710|FG003|Phase 2|Investigator Decision|0|||
162751921|NCT02719574|587805711|FG004|Phase 2|Investigator Decision|0|||
162751922|NCT02719574|587805712|FG005|Phase 2|Investigator Decision|0|||
162751923|NCT02719574|587805713|FG006|Phase 2|Investigator Decision|0|||
162751924|NCT02719574|587805714|FG007|Phase 2|Investigator Decision|0|||
162751925|NCT02719574|587805715|FG008|Phase 2|Investigator Decision|0|||
162751926|NCT02719574|587805716|FG009|Phase 2|Investigator Decision|6|||
162751927|NCT02719574|587805717|FG010|Phase 2|Investigator Decision|1|||
162751928|NCT02719574|587805718|FG011|Phase 2|Investigator Decision|2|||
162751929|NCT02719574|587805719|FG012|Phase 2|Investigator Decision|3|||
162751930|NCT02719574|587805720|FG013|Phase 2|Investigator Decision|1|||
162751931|NCT02719574|587805721|FG014|Phase 2|Investigator Decision|3|||
162751932|NCT02719574|587805722|FG015|Phase 2|Investigator Decision|2|||
162751933|NCT02719574|587805723|FG016|Phase 2|Investigator Decision|0|||
162751934|NCT02719574|587805707|FG000|Phase 2|Withdrawal by Subject|0|||
162751935|NCT02719574|587805708|FG001|Phase 2|Withdrawal by Subject|0|||
162751936|NCT02719574|587805709|FG002|Phase 2|Withdrawal by Subject|0|||
162751937|NCT02719574|587805710|FG003|Phase 2|Withdrawal by Subject|0|||
162751938|NCT02719574|587805711|FG004|Phase 2|Withdrawal by Subject|0|||
162751939|NCT02719574|587805712|FG005|Phase 2|Withdrawal by Subject|0|||
162751940|NCT02719574|587805713|FG006|Phase 2|Withdrawal by Subject|0|||
162751941|NCT02719574|587805714|FG007|Phase 2|Withdrawal by Subject|0|||
162751942|NCT02719574|587805715|FG008|Phase 2|Withdrawal by Subject|0|||
162751943|NCT02719574|587805716|FG009|Phase 2|Withdrawal by Subject|5|||
162751944|NCT02719574|587805717|FG010|Phase 2|Withdrawal by Subject|0|||
162751945|NCT02719574|587805718|FG011|Phase 2|Withdrawal by Subject|0|||
162751946|NCT02719574|587805719|FG012|Phase 2|Withdrawal by Subject|0|||
162751947|NCT02719574|587805720|FG013|Phase 2|Withdrawal by Subject|1|||
162751948|NCT02719574|587805721|FG014|Phase 2|Withdrawal by Subject|1|||
162751949|NCT02719574|587805722|FG015|Phase 2|Withdrawal by Subject|2|||
162751950|NCT02719574|587805723|FG016|Phase 2|Withdrawal by Subject|0|||
162751951|NCT02719574|587805707|FG000|Phase 2|Protocol Violation|0|||
162751952|NCT02719574|587805708|FG001|Phase 2|Protocol Violation|0|||
162751953|NCT02719574|587805709|FG002|Phase 2|Protocol Violation|0|||
162751954|NCT02719574|587805710|FG003|Phase 2|Protocol Violation|0|||
162751955|NCT02719574|587805711|FG004|Phase 2|Protocol Violation|0|||
162751956|NCT02719574|587805712|FG005|Phase 2|Protocol Violation|0|||
162751957|NCT02719574|587805713|FG006|Phase 2|Protocol Violation|0|||
162751958|NCT02719574|587805714|FG007|Phase 2|Protocol Violation|0|||
162751959|NCT02719574|587805715|FG008|Phase 2|Protocol Violation|0|||
162751960|NCT02719574|587805716|FG009|Phase 2|Protocol Violation|1|||
162751961|NCT02719574|587805717|FG010|Phase 2|Protocol Violation|0|||
162751962|NCT02719574|587805718|FG011|Phase 2|Protocol Violation|0|||
162751963|NCT02719574|587805719|FG012|Phase 2|Protocol Violation|0|||
162751964|NCT02719574|587805720|FG013|Phase 2|Protocol Violation|0|||
162751965|NCT02719574|587805721|FG014|Phase 2|Protocol Violation|0|||
162751966|NCT02719574|587805722|FG015|Phase 2|Protocol Violation|0|||
162751967|NCT02719574|587805723|FG016|Phase 2|Protocol Violation|0|||
162751968|NCT00113360|587805724|FG000|Overall Study|Adverse Event|3|||
162751969|NCT00113360|587805724|FG000|Overall Study|Subject required surgery|1|||
162751970|NCT00113360|587805724|FG000|Overall Study|Did not meet eligibility criteria|3|||
162751971|NCT01976936|587805735|FG000|Overall Study|Did not receive at least 9 doses|9|||
162751972|NCT01976936|587805736|FG001|Overall Study|Did not receive at least 9 doses|4|||
162751973|NCT02467270|587805737|FG000|Overall Study|Participants Never Treated|0|||
162751974|NCT02467270|587805738|FG001|Overall Study|Participants Never Treated|1|||
162751975|NCT02467270|587805739|FG002|Overall Study|Participants Never Treated|0|||
162751976|NCT02467270|587805737|FG000|Overall Study|Ongoing|50|||
162751977|NCT02467270|587805738|FG001|Overall Study|Ongoing|41|||
162751978|NCT02467270|587805739|FG002|Overall Study|Ongoing|43|||
162751979|NCT02467270|587805737|FG000|Overall Study|Adverse Event|16|||
162751980|NCT02467270|587805738|FG001|Overall Study|Adverse Event|15|||
162751981|NCT02467270|587805739|FG002|Overall Study|Adverse Event|14|||
162751982|NCT02467270|587805737|FG000|Overall Study|Progressive Disease|7|||
162751983|NCT02467270|587805738|FG001|Overall Study|Progressive Disease|7|||
162751984|NCT02467270|587805739|FG002|Overall Study|Progressive Disease|4|||
162751985|NCT02467270|587805737|FG000|Overall Study|Death|2|||
162751986|NCT02467270|587805738|FG001|Overall Study|Death|0|||
162751987|NCT02467270|587805739|FG002|Overall Study|Death|2|||
162751988|NCT02467270|587805737|FG000|Overall Study|Lack of Efficacy|12|||
162751989|NCT02467270|587805738|FG001|Overall Study|Lack of Efficacy|18|||
162751990|NCT02467270|587805739|FG002|Overall Study|Lack of Efficacy|23|||
162751991|NCT02467270|587805737|FG000|Overall Study|Non-compliance With Study Drug|0|||
162751992|NCT02467270|587805738|FG001|Overall Study|Non-compliance With Study Drug|2|||
162751993|NCT02467270|587805739|FG002|Overall Study|Non-compliance With Study Drug|1|||
162751994|NCT02467270|587805737|FG000|Overall Study|Lost to Follow-up|2|||
162751995|NCT02467270|587805738|FG001|Overall Study|Lost to Follow-up|1|||
162751996|NCT02467270|587805739|FG002|Overall Study|Lost to Follow-up|0|||
162751997|NCT02467270|587805737|FG000|Overall Study|Pregnancy|0|||
162751998|NCT02467270|587805738|FG001|Overall Study|Pregnancy|1|||
162751999|NCT02467270|587805739|FG002|Overall Study|Pregnancy|0|||
162752000|NCT02467270|587805737|FG000|Overall Study|Physician Decision|0|||
162752001|NCT02467270|587805738|FG001|Overall Study|Physician Decision|4|||
162752002|NCT02467270|587805739|FG002|Overall Study|Physician Decision|1|||
162752003|NCT02467270|587805737|FG000|Overall Study|Withdrawal by Subject|4|||
162752004|NCT02467270|587805738|FG001|Overall Study|Withdrawal by Subject|3|||
162752005|NCT02467270|587805739|FG002|Overall Study|Withdrawal by Subject|5|||
162752006|NCT02467270|587805737|FG000|Overall Study|Reason not Specified|1|||
162752007|NCT02467270|587805738|FG001|Overall Study|Reason not Specified|2|||
162752008|NCT02467270|587805739|FG002|Overall Study|Reason not Specified|1|||
162752009|NCT00495677|587805741|FG000|Stage 1 (25 Days)|Adverse Event|0|||
162752010|NCT00495677|587805742|FG001|Stage 1 (25 Days)|Adverse Event|0|||
162752011|NCT00495677|587805743|FG002|Stage 1 (25 Days)|Adverse Event|1|||
162752012|NCT00495677|587805744|FG003|Stage 1 (25 Days)|Adverse Event|0|||
162752013|NCT00495677|587805745|FG004|Stage 1 (25 Days)|Adverse Event|0|||
162752014|NCT00495677|587805746|FG005|Stage 1 (25 Days)|Adverse Event|0|||
162752015|NCT00495677|587805747|FG006|Stage 1 (25 Days)|Adverse Event|0|||
162752016|NCT02306161|587805751|FG000|Overall Study|Death|1|||
162752017|NCT02306161|587805752|FG001|Overall Study|Death|3|||
162752018|NCT02306161|587805751|FG000|Overall Study|Lack of Efficacy|20|||
162752019|NCT02306161|587805752|FG001|Overall Study|Lack of Efficacy|43|||
162752020|NCT02306161|587805751|FG000|Overall Study|Physician Decision|30|||
162752021|NCT02306161|587805752|FG001|Overall Study|Physician Decision|18|||
162752022|NCT02306161|587805751|FG000|Overall Study|Withdrawal by Subject|4|||
162752023|NCT02306161|587805752|FG001|Overall Study|Withdrawal by Subject|0|||
162752024|NCT02306161|587805751|FG000|Overall Study|Ineligible|9|||
162752025|NCT02306161|587805752|FG001|Overall Study|Ineligible|5|||
162752026|NCT05162586|587805753|FG000|Overall Study|Other|0|||
162752027|NCT05162586|587805754|FG001|Overall Study|Other|0|||
162752028|NCT05162586|587805755|FG002|Overall Study|Other|0|||
162752029|NCT05162586|587805756|FG003|Overall Study|Other|0|||
162752030|NCT05162586|587805757|FG004|Overall Study|Other|1|||
162752031|NCT05162586|587805758|FG005|Overall Study|Other|0|||
162752032|NCT05162586|587805759|FG006|Overall Study|Other|2|||
162752033|NCT05162586|587805760|FG007|Overall Study|Other|2|||
162752034|NCT05162586|587805753|FG000|Overall Study|Lack of Efficacy|0|||
162752035|NCT05162586|587805754|FG001|Overall Study|Lack of Efficacy|0|||
162752036|NCT05162586|587805755|FG002|Overall Study|Lack of Efficacy|0|||
162752037|NCT05162586|587805756|FG003|Overall Study|Lack of Efficacy|0|||
162752038|NCT05162586|587805757|FG004|Overall Study|Lack of Efficacy|1|||
162752039|NCT05162586|587805758|FG005|Overall Study|Lack of Efficacy|0|||
162752040|NCT05162586|587805759|FG006|Overall Study|Lack of Efficacy|0|||
162752041|NCT05162586|587805760|FG007|Overall Study|Lack of Efficacy|1|||
162752042|NCT05162586|587805753|FG000|Overall Study|Lost to Follow-up|0|||
162752043|NCT05162586|587805754|FG001|Overall Study|Lost to Follow-up|0|||
162752044|NCT05162586|587805755|FG002|Overall Study|Lost to Follow-up|0|||
162752045|NCT05162586|587805756|FG003|Overall Study|Lost to Follow-up|0|||
162752046|NCT05162586|587805757|FG004|Overall Study|Lost to Follow-up|2|||
162752047|NCT05162586|587805758|FG005|Overall Study|Lost to Follow-up|0|||
162752048|NCT05162586|587805759|FG006|Overall Study|Lost to Follow-up|0|||
162752049|NCT05162586|587805760|FG007|Overall Study|Lost to Follow-up|2|||
162752050|NCT05162586|587805753|FG000|Overall Study|Non-Compliance|0|||
162752051|NCT05162586|587805754|FG001|Overall Study|Non-Compliance|1|||
162752052|NCT05162586|587805755|FG002|Overall Study|Non-Compliance|0|||
162752053|NCT05162586|587805756|FG003|Overall Study|Non-Compliance|0|||
162752054|NCT05162586|587805757|FG004|Overall Study|Non-Compliance|1|||
162752055|NCT05162586|587805758|FG005|Overall Study|Non-Compliance|0|||
162752056|NCT05162586|587805759|FG006|Overall Study|Non-Compliance|0|||
162752057|NCT05162586|587805760|FG007|Overall Study|Non-Compliance|1|||
162752058|NCT05162586|587805753|FG000|Overall Study|Withdrawal by Subject|2|||
162752059|NCT05162586|587805754|FG001|Overall Study|Withdrawal by Subject|0|||
162752060|NCT05162586|587805755|FG002|Overall Study|Withdrawal by Subject|0|||
162752061|NCT05162586|587805756|FG003|Overall Study|Withdrawal by Subject|0|||
162752062|NCT05162586|587805757|FG004|Overall Study|Withdrawal by Subject|7|||
162752063|NCT05162586|587805758|FG005|Overall Study|Withdrawal by Subject|6|||
162752064|NCT05162586|587805759|FG006|Overall Study|Withdrawal by Subject|2|||
162752065|NCT05162586|587805760|FG007|Overall Study|Withdrawal by Subject|2|||
162752066|NCT05162586|587805753|FG000|Overall Study|Adverse Event|2|||
162752067|NCT05162586|587805754|FG001|Overall Study|Adverse Event|0|||
162752068|NCT05162586|587805755|FG002|Overall Study|Adverse Event|1|||
162752069|NCT05162586|587805756|FG003|Overall Study|Adverse Event|2|||
162752070|NCT05162586|587805757|FG004|Overall Study|Adverse Event|4|||
162752071|NCT05162586|587805758|FG005|Overall Study|Adverse Event|1|||
162752072|NCT05162586|587805759|FG006|Overall Study|Adverse Event|5|||
162752073|NCT05162586|587805760|FG007|Overall Study|Adverse Event|2|||
162752074|NCT00982644|587805763|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
162752075|NCT00982644|587805764|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
162752076|NCT00982644|587805763|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
162752077|NCT00982644|587805764|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
162752078|NCT00982644|587805763|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
162752079|NCT00982644|587805764|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
162752080|NCT00982644|587805763|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
162752081|NCT00982644|587805764|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
162752082|NCT00982644|587805763|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
162752083|NCT00982644|587805764|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
162752084|NCT00982644|587805763|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
162752085|NCT00982644|587805764|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
162752086|NCT00982644|587805763|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
162752087|NCT00982644|587805764|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
162752088|NCT00982644|587805763|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
162752089|NCT00982644|587805764|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
162752090|NCT00982644|587805763|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
162752091|NCT00982644|587805764|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
162752092|NCT00982644|587805763|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
162752093|NCT00982644|587805764|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
162752094|NCT05030584|587805767|FG000|Overall Study|Adverse Event|17|||
162752095|NCT05030584|587805768|FG001|Overall Study|Adverse Event|2|||
162752096|NCT05030584|587805767|FG000|Overall Study|Lack of Efficacy|0|||
162752097|NCT05030584|587805768|FG001|Overall Study|Lack of Efficacy|6|||
162752098|NCT05030584|587805767|FG000|Overall Study|Lost to Follow-up|5|||
162752099|NCT05030584|587805768|FG001|Overall Study|Lost to Follow-up|2|||
162752100|NCT05030584|587805767|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162752101|NCT05030584|587805768|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162752102|NCT05030584|587805767|FG000|Overall Study|Other reason|4|||
162752103|NCT05030584|587805768|FG001|Overall Study|Other reason|3|||
162752104|NCT05030584|587805767|FG000|Overall Study|Physician Decision|1|||
162752105|NCT05030584|587805768|FG001|Overall Study|Physician Decision|4|||
162752106|NCT05030584|587805767|FG000|Overall Study|Protocol Violation|0|||
162752107|NCT05030584|587805768|FG001|Overall Study|Protocol Violation|2|||
162752108|NCT05030584|587805767|FG000|Overall Study|Randomized by Mistake|0|||
162752109|NCT05030584|587805768|FG001|Overall Study|Randomized by Mistake|2|||
162752110|NCT05030584|587805767|FG000|Overall Study|Withdrawal by Subject|21|||
162752111|NCT05030584|587805768|FG001|Overall Study|Withdrawal by Subject|28|||
162752112|NCT05030584|587805767|FG000|Overall Study|Technical Problems|0|||
162752113|NCT05030584|587805768|FG001|Overall Study|Technical Problems|1|||
162752114|NCT05030584|587805767|FG000|Overall Study|Completed post-treatment/FU visits|41|||
162752115|NCT05030584|587805768|FG001|Overall Study|Completed post-treatment/FU visits|31|||
162752116|NCT00357682|587805773|FG000|Overall Study|Did not receive allocated Treatment|10|||
162752117|NCT00357682|587805774|FG001|Overall Study|Did not receive allocated Treatment|9|||
162752118|NCT00357682|587805775|FG002|Overall Study|Did not receive allocated Treatment|9|||
162752119|NCT00357682|587805776|FG003|Overall Study|Did not receive allocated Treatment|10|||
162752120|NCT00357682|587805773|FG000|Overall Study|Withdrew consent|6|||
162752121|NCT00357682|587805774|FG001|Overall Study|Withdrew consent|6|||
162752122|NCT00357682|587805775|FG002|Overall Study|Withdrew consent|5|||
162752123|NCT00357682|587805776|FG003|Overall Study|Withdrew consent|5|||
162752124|NCT00357682|587805773|FG000|Overall Study|Lost to Follow-up|39|||
162752125|NCT00357682|587805774|FG001|Overall Study|Lost to Follow-up|33|||
162752126|NCT00357682|587805775|FG002|Overall Study|Lost to Follow-up|26|||
162752127|NCT00357682|587805776|FG003|Overall Study|Lost to Follow-up|35|||
162752128|NCT00357682|587805773|FG000|Overall Study|Adverse Event|24|||
162752129|NCT00357682|587805774|FG001|Overall Study|Adverse Event|32|||
162752130|NCT00357682|587805775|FG002|Overall Study|Adverse Event|22|||
162752131|NCT00357682|587805776|FG003|Overall Study|Adverse Event|27|||
162752132|NCT00357682|587805773|FG000|Overall Study|Physician Decision|32|||
162752133|NCT00357682|587805774|FG001|Overall Study|Physician Decision|20|||
162752134|NCT00357682|587805775|FG002|Overall Study|Physician Decision|24|||
162752135|NCT00357682|587805776|FG003|Overall Study|Physician Decision|30|||
162752136|NCT00357682|587805773|FG000|Overall Study|Patient decision|73|||
162752137|NCT00357682|587805774|FG001|Overall Study|Patient decision|80|||
162752138|NCT00357682|587805775|FG002|Overall Study|Patient decision|51|||
162752139|NCT00357682|587805776|FG003|Overall Study|Patient decision|59|||
162752140|NCT00357682|587805773|FG000|Overall Study|Other reason|157|||
162752141|NCT00357682|587805774|FG001|Overall Study|Other reason|130|||
162752142|NCT00357682|587805775|FG002|Overall Study|Other reason|114|||
162752143|NCT00357682|587805776|FG003|Overall Study|Other reason|99|||
162752144|NCT05424718|587805785|FG000|Overall Study|Lost to Follow-up|5|||
162752145|NCT05424718|587805786|FG001|Overall Study|Lost to Follow-up|4|||
162752146|NCT04046549|587805787|FG000|Overall Study|Adverse Event|1|||
162752147|NCT04046549|587805787|FG000|Overall Study|Physician Decision|1|||
162752148|NCT04046549|587805787|FG000|Overall Study|Withdrawal by Subject|3|||
162752149|NCT04046549|587805787|FG000|Overall Study|Other, Not Specified|5|||
162752150|NCT05771467|587805789|FG000|Overall Study|Lost to Follow-up|6|||
162752151|NCT05771467|587805790|FG001|Overall Study|Lost to Follow-up|3|||
162752152|NCT01220531|587805793|FG000|Overall Study|Death|7|||
162752153|NCT01220531|587805793|FG000|Overall Study|Lost to Follow-up|1|||
162752154|NCT05866926|587805796|FG000|Overall Study|Death|16|||
162752155|NCT05866926|587805797|FG001|Overall Study|Death|9|||
162752156|NCT05866926|587805796|FG000|Overall Study|Lost to Follow-up|0|||
162752157|NCT05866926|587805797|FG001|Overall Study|Lost to Follow-up|1|||
162752158|NCT05866926|587805796|FG000|Overall Study|Adverse Event|1|||
162752159|NCT05866926|587805797|FG001|Overall Study|Adverse Event|0|||
162752160|NCT05866926|587805796|FG000|Overall Study|Withdrawal by Subject|5|||
162752161|NCT05866926|587805797|FG001|Overall Study|Withdrawal by Subject|1|||
162752162|NCT05866926|587805796|FG000|Overall Study|Disease progression|1|||
162752163|NCT05866926|587805797|FG001|Overall Study|Disease progression|0|||
162752164|NCT05866926|587805796|FG000|Overall Study|other causes|2|||
162752165|NCT05866926|587805797|FG001|Overall Study|other causes|1|||
162752166|NCT01105091|587805798|FG000|Overall Study|Death|2|||
162752167|NCT01105091|587805799|FG001|Overall Study|Death|0|||
162752168|NCT03699163|587806500|FG000|Overall Study|Physician Decision|12|||
162752169|NCT03699163|587806501|FG001|Overall Study|Physician Decision|0|||
162752170|NCT03699163|587806500|FG000|Overall Study|failed QC measures|205|||
162752171|NCT03699163|587806501|FG001|Overall Study|failed QC measures|206|||
162752172|NCT03983382|587806511|FG000|Overall Study|Death|1|||
162752173|NCT03983382|587806511|FG000|Overall Study|Lost to Follow-up|3|||
162752174|NCT03983382|587806511|FG000|Overall Study|Physician Decision|2|||
162752175|NCT03983382|587806511|FG000|Overall Study|Withdrawal by Subject|10|||
162752176|NCT03983382|587806511|FG000|Overall Study|Change in cancer treatment|2|||
162752177|NCT03767335|587806516|FG000|Overall Study|Physician Decision|1|||
162752178|NCT03767335|587806517|FG001|Overall Study|Physician Decision|1|||
162752179|NCT03767335|587806518|FG002|Overall Study|Physician Decision|0|||
162752180|NCT03767335|587806516|FG000|Overall Study|Withdrawal by Subject|0|||
162752181|NCT03767335|587806517|FG001|Overall Study|Withdrawal by Subject|0|||
162752182|NCT03767335|587806518|FG002|Overall Study|Withdrawal by Subject|6|||
162752183|NCT03767335|587806516|FG000|Overall Study|Participant excluded from efficacy population|0|||
162752184|NCT03767335|587806517|FG001|Overall Study|Participant excluded from efficacy population|0|||
162752185|NCT03767335|587806518|FG002|Overall Study|Participant excluded from efficacy population|1|||
162752186|NCT03767335|587806516|FG000|Overall Study|Death|0|||
162752187|NCT03767335|587806517|FG001|Overall Study|Death|0|||
162752188|NCT03767335|587806518|FG002|Overall Study|Death|2|||
162752189|NCT03767335|587806516|FG000|Overall Study|Progressive Disease|2|||
162752190|NCT03767335|587806517|FG001|Overall Study|Progressive Disease|2|||
162752191|NCT03767335|587806518|FG002|Overall Study|Progressive Disease|2|||
162752192|NCT03767335|587806516|FG000|Overall Study|Disease progression needing additional medication|0|||
162752193|NCT03767335|587806517|FG001|Overall Study|Disease progression needing additional medication|0|||
162752194|NCT03767335|587806518|FG002|Overall Study|Disease progression needing additional medication|17|||
162752195|NCT03767335|587806516|FG000|Overall Study|Sponsor decision|0|||
162752196|NCT03767335|587806517|FG001|Overall Study|Sponsor decision|0|||
162752197|NCT03767335|587806518|FG002|Overall Study|Sponsor decision|2|||
162752198|NCT03767335|587806516|FG000|Overall Study|Other Medical Reasons|0|||
162752199|NCT03767335|587806517|FG001|Overall Study|Other Medical Reasons|0|||
162752200|NCT03767335|587806518|FG002|Overall Study|Other Medical Reasons|3|||
162752201|NCT03705390|587806519|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
162752202|NCT03705390|587806519|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
162752203|NCT03047213|587806520|FG000|Overall Study|Withdrawal by Subject|2|||
162752204|NCT03047213|587806521|FG001|Overall Study|Withdrawal by Subject|0|||
162752205|NCT03047213|587806520|FG000|Overall Study|Adverse Event|2|||
162752206|NCT03047213|587806521|FG001|Overall Study|Adverse Event|0|||
162752207|NCT02989662|587806527|FG000|Overall Study|Lost to Follow-up|0|||
162752208|NCT02989662|587806528|FG001|Overall Study|Lost to Follow-up|0|||
162752209|NCT02989662|587806529|FG002|Overall Study|Lost to Follow-up|0|||
162752210|NCT02989662|587806530|FG003|Overall Study|Lost to Follow-up|2|||
162752211|NCT02989662|587806527|FG000|Overall Study|Physician Decision|3|||
162752212|NCT02989662|587806528|FG001|Overall Study|Physician Decision|0|||
162752213|NCT02989662|587806529|FG002|Overall Study|Physician Decision|0|||
162752214|NCT02989662|587806530|FG003|Overall Study|Physician Decision|0|||
162752215|NCT02989662|587806527|FG000|Overall Study|Withdrawal by Subject|1|||
162752216|NCT02989662|587806528|FG001|Overall Study|Withdrawal by Subject|0|||
162752217|NCT02989662|587806529|FG002|Overall Study|Withdrawal by Subject|0|||
162752218|NCT02989662|587806530|FG003|Overall Study|Withdrawal by Subject|0|||
162752219|NCT06393127|587806531|FG000|Washout period|Withdrawal by Subject|1|||
162752220|NCT06393127|587806532|FG001|Washout period|Withdrawal by Subject|0|||
162752221|NCT06393127|587806531|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
162752222|NCT06393127|587806532|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
162752223|NCT02446600|587806533|FG000|Overall Study|Never treated|20|||
162752224|NCT02446600|587806534|FG001|Overall Study|Never treated|2|||
162752225|NCT02446600|587806535|FG002|Overall Study|Never treated|6|||
162752226|NCT02446600|587806536|FG003|Overall Study|Never treated|0|||
162752227|NCT02446600|587806533|FG000|Overall Study|Withdrawal by Subject|19|||
162752228|NCT02446600|587806534|FG001|Overall Study|Withdrawal by Subject|5|||
162752229|NCT02446600|587806535|FG002|Overall Study|Withdrawal by Subject|17|||
162752230|NCT02446600|587806536|FG003|Overall Study|Withdrawal by Subject|0|||
162752231|NCT02446600|587806533|FG000|Overall Study|Ineligible|1|||
162752232|NCT02446600|587806534|FG001|Overall Study|Ineligible|4|||
162752233|NCT02446600|587806535|FG002|Overall Study|Ineligible|4|||
162752234|NCT02446600|587806536|FG003|Overall Study|Ineligible|1|||
162752235|NCT02446600|587806533|FG000|Overall Study|Duplicate Enrollment|0|||
162752236|NCT02446600|587806534|FG001|Overall Study|Duplicate Enrollment|1|||
162752237|NCT02446600|587806535|FG002|Overall Study|Duplicate Enrollment|0|||
162752238|NCT02446600|587806536|FG003|Overall Study|Duplicate Enrollment|0|||
162752239|NCT00328783|587806537|FG000|Overall Study|Could not tolerate ABC|21|||
162752240|NCT00328783|587806537|FG000|Overall Study|No heart in RT field|4|||
162752241|NCT00328783|587806537|FG000|Overall Study|Withdrawal by Subject|1|||
162752242|NCT03660930|587806538|FG000|Overall Study|Adverse Event|0|||
162752243|NCT03660930|587806539|FG001|Overall Study|Adverse Event|0|||
162752244|NCT03660930|587806540|FG002|Overall Study|Adverse Event|0|||
162752245|NCT03660930|587806541|FG003|Overall Study|Adverse Event|2|||
162752246|NCT03660930|587806542|FG004|Overall Study|Adverse Event|0|||
162752247|NCT03660930|587806543|FG005|Overall Study|Adverse Event|1|||
162752248|NCT03660930|587806544|FG006|Overall Study|Adverse Event|0|||
162752249|NCT03660930|587806545|FG007|Overall Study|Adverse Event|0|||
162752250|NCT03660930|587806538|FG000|Overall Study|Withdrawal by Subject|0|||
162752251|NCT03660930|587806539|FG001|Overall Study|Withdrawal by Subject|0|||
162752252|NCT03660930|587806540|FG002|Overall Study|Withdrawal by Subject|0|||
162752253|NCT03660930|587806541|FG003|Overall Study|Withdrawal by Subject|0|||
162752254|NCT03660930|587806542|FG004|Overall Study|Withdrawal by Subject|0|||
162752255|NCT03660930|587806543|FG005|Overall Study|Withdrawal by Subject|1|||
162752256|NCT03660930|587806544|FG006|Overall Study|Withdrawal by Subject|0|||
162752257|NCT03660930|587806545|FG007|Overall Study|Withdrawal by Subject|0|||
162752258|NCT03725332|587806546|FG000|Overall Study|Adverse Event|5|||
162752259|NCT03725332|587806547|FG001|Overall Study|Adverse Event|10|||
162752260|NCT03725332|587806546|FG000|Overall Study|Death|1|||
162752261|NCT03725332|587806547|FG001|Overall Study|Death|3|||
162752262|NCT03725332|587806546|FG000|Overall Study|Lost to Follow-up|43|||
162752263|NCT03725332|587806547|FG001|Overall Study|Lost to Follow-up|122|||
162752264|NCT03725332|587806546|FG000|Overall Study|Withdrawal by Subject|0|||
162752265|NCT03725332|587806547|FG001|Overall Study|Withdrawal by Subject|1|||
162752266|NCT03725332|587806546|FG000|Overall Study|Duplicate enrollment|0|||
162752267|NCT03725332|587806547|FG001|Overall Study|Duplicate enrollment|1|||
162752268|NCT03725332|587806546|FG000|Overall Study|Did not consent|0|||
162752269|NCT03725332|587806547|FG001|Overall Study|Did not consent|1|||
162752270|NCT03242915|587806554|FG000|Overall Study|Adverse Event|5|||
162752271|NCT03242915|587806555|FG001|Overall Study|Adverse Event|1|||
162752272|NCT03242915|587806554|FG000|Overall Study|Withdrawal by Subject|0|||
162752273|NCT03242915|587806555|FG001|Overall Study|Withdrawal by Subject|2|||
162752274|NCT03242915|587806554|FG000|Overall Study|Physician Decision|4|||
162752275|NCT03242915|587806555|FG001|Overall Study|Physician Decision|1|||
162752276|NCT02726386|587806556|FG000|Overall Study|Adverse Event|17|||
162752277|NCT02726386|587806557|FG001|Overall Study|Adverse Event|20|||
162752278|NCT02726386|587806556|FG000|Overall Study|Withdrawal by Subject|14|||
162752279|NCT02726386|587806557|FG001|Overall Study|Withdrawal by Subject|28|||
162752280|NCT02726386|587806556|FG000|Overall Study|Other reasons|7|||
162752281|NCT02726386|587806557|FG001|Overall Study|Other reasons|8|||
162752282|NCT02101853|587806560|FG000|Block 1 Induction|Adverse Event|11|||
162752283|NCT02101853|587806561|FG001|Block 1 Induction|Adverse Event|0|||
162752284|NCT02101853|587806562|FG002|Block 1 Induction|Adverse Event|0|||
162752285|NCT02101853|587806563|FG003|Block 1 Induction|Adverse Event|0|||
162752286|NCT02101853|587806564|FG004|Block 1 Induction|Adverse Event|0|||
162752287|NCT02101853|587806565|FG005|Block 1 Induction|Adverse Event|0|||
162752288|NCT02101853|587806560|FG000|Block 1 Induction|Death|20|||
162752289|NCT02101853|587806561|FG001|Block 1 Induction|Death|0|||
162752290|NCT02101853|587806562|FG002|Block 1 Induction|Death|0|||
162752291|NCT02101853|587806563|FG003|Block 1 Induction|Death|0|||
162752292|NCT02101853|587806564|FG004|Block 1 Induction|Death|0|||
162752293|NCT02101853|587806565|FG005|Block 1 Induction|Death|0|||
162752294|NCT02101853|587806560|FG000|Block 1 Induction|Lack of Efficacy|6|||
162752295|NCT02101853|587806561|FG001|Block 1 Induction|Lack of Efficacy|0|||
162752296|NCT02101853|587806562|FG002|Block 1 Induction|Lack of Efficacy|0|||
162752297|NCT02101853|587806563|FG003|Block 1 Induction|Lack of Efficacy|0|||
162752298|NCT02101853|587806564|FG004|Block 1 Induction|Lack of Efficacy|0|||
162752299|NCT02101853|587806565|FG005|Block 1 Induction|Lack of Efficacy|0|||
162752300|NCT02101853|587806560|FG000|Block 1 Induction|Physician Decision|61|||
162752301|NCT02101853|587806561|FG001|Block 1 Induction|Physician Decision|0|||
162752302|NCT02101853|587806562|FG002|Block 1 Induction|Physician Decision|0|||
162752303|NCT02101853|587806563|FG003|Block 1 Induction|Physician Decision|0|||
162752304|NCT02101853|587806564|FG004|Block 1 Induction|Physician Decision|0|||
162752305|NCT02101853|587806565|FG005|Block 1 Induction|Physician Decision|0|||
162752306|NCT02101853|587806560|FG000|Block 1 Induction|Protocol Violation|2|||
162752307|NCT02101853|587806561|FG001|Block 1 Induction|Protocol Violation|0|||
162752308|NCT02101853|587806562|FG002|Block 1 Induction|Protocol Violation|0|||
162752309|NCT02101853|587806563|FG003|Block 1 Induction|Protocol Violation|0|||
162752310|NCT02101853|587806564|FG004|Block 1 Induction|Protocol Violation|0|||
162752311|NCT02101853|587806565|FG005|Block 1 Induction|Protocol Violation|0|||
162752312|NCT02101853|587806560|FG000|Block 1 Induction|Withdrawal by Subject|65|||
162752313|NCT02101853|587806561|FG001|Block 1 Induction|Withdrawal by Subject|0|||
162752314|NCT02101853|587806562|FG002|Block 1 Induction|Withdrawal by Subject|0|||
162752315|NCT02101853|587806563|FG003|Block 1 Induction|Withdrawal by Subject|0|||
162752316|NCT02101853|587806564|FG004|Block 1 Induction|Withdrawal by Subject|0|||
162752317|NCT02101853|587806565|FG005|Block 1 Induction|Withdrawal by Subject|0|||
162752318|NCT02101853|587806560|FG000|Block 1 Induction|Ineligible|8|||
162752319|NCT02101853|587806561|FG001|Block 1 Induction|Ineligible|0|||
162752320|NCT02101853|587806562|FG002|Block 1 Induction|Ineligible|0|||
162752321|NCT02101853|587806563|FG003|Block 1 Induction|Ineligible|0|||
162752322|NCT02101853|587806564|FG004|Block 1 Induction|Ineligible|0|||
162752323|NCT02101853|587806565|FG005|Block 1 Induction|Ineligible|0|||
162752324|NCT02101853|587806560|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
162752325|NCT02101853|587806561|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162752326|NCT02101853|587806562|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162752327|NCT02101853|587806563|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162752328|NCT02101853|587806564|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162752329|NCT02101853|587806565|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162752330|NCT02101853|587806560|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
162752331|NCT02101853|587806561|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752332|NCT02101853|587806562|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752333|NCT02101853|587806563|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752334|NCT02101853|587806564|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752335|NCT02101853|587806565|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752336|NCT02101853|587806560|FG000|Post Induction Randomization|Adverse Event|0|||
162752337|NCT02101853|587806561|FG001|Post Induction Randomization|Adverse Event|3|||
162752338|NCT02101853|587806562|FG002|Post Induction Randomization|Adverse Event|8|||
162752339|NCT02101853|587806563|FG003|Post Induction Randomization|Adverse Event|4|||
162752340|NCT02101853|587806564|FG004|Post Induction Randomization|Adverse Event|4|||
162752341|NCT02101853|587806565|FG005|Post Induction Randomization|Adverse Event|0|||
162752342|NCT02101853|587806560|FG000|Post Induction Randomization|Death|0|||
162752343|NCT02101853|587806561|FG001|Post Induction Randomization|Death|9|||
162752344|NCT02101853|587806562|FG002|Post Induction Randomization|Death|2|||
162752345|NCT02101853|587806563|FG003|Post Induction Randomization|Death|2|||
162752346|NCT02101853|587806564|FG004|Post Induction Randomization|Death|0|||
162752347|NCT02101853|587806565|FG005|Post Induction Randomization|Death|0|||
162752348|NCT02101853|587806560|FG000|Post Induction Randomization|Lack of Efficacy|0|||
162752349|NCT02101853|587806561|FG001|Post Induction Randomization|Lack of Efficacy|14|||
162752350|NCT02101853|587806562|FG002|Post Induction Randomization|Lack of Efficacy|23|||
162752351|NCT02101853|587806563|FG003|Post Induction Randomization|Lack of Efficacy|18|||
162752352|NCT02101853|587806564|FG004|Post Induction Randomization|Lack of Efficacy|21|||
162752353|NCT02101853|587806565|FG005|Post Induction Randomization|Lack of Efficacy|0|||
162752354|NCT02101853|587806560|FG000|Post Induction Randomization|Physician Decision|0|||
162752355|NCT02101853|587806561|FG001|Post Induction Randomization|Physician Decision|43|||
162752356|NCT02101853|587806562|FG002|Post Induction Randomization|Physician Decision|23|||
162752357|NCT02101853|587806563|FG003|Post Induction Randomization|Physician Decision|14|||
162752358|NCT02101853|587806564|FG004|Post Induction Randomization|Physician Decision|14|||
162752359|NCT02101853|587806565|FG005|Post Induction Randomization|Physician Decision|0|||
162752360|NCT02101853|587806560|FG000|Post Induction Randomization|Protocol Violation|0|||
162752361|NCT02101853|587806561|FG001|Post Induction Randomization|Protocol Violation|3|||
162752362|NCT02101853|587806562|FG002|Post Induction Randomization|Protocol Violation|0|||
162752363|NCT02101853|587806563|FG003|Post Induction Randomization|Protocol Violation|0|||
162752364|NCT02101853|587806564|FG004|Post Induction Randomization|Protocol Violation|0|||
162752365|NCT02101853|587806565|FG005|Post Induction Randomization|Protocol Violation|0|||
162752366|NCT02101853|587806560|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
162752367|NCT02101853|587806561|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
162752368|NCT02101853|587806562|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
162752369|NCT02101853|587806563|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
162752370|NCT02101853|587806564|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
162752371|NCT02101853|587806565|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
162752372|NCT02101853|587806560|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752373|NCT02101853|587806561|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752374|NCT02101853|587806562|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752375|NCT02101853|587806563|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
162752376|NCT02101853|587806564|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752377|NCT02101853|587806565|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162752378|NCT02101853|587806560|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162752379|NCT02101853|587806561|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
162752380|NCT02101853|587806562|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
162752381|NCT02101853|587806563|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162752382|NCT02101853|587806564|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162752383|NCT02101853|587806565|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162752384|NCT02101853|587806560|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162752385|NCT02101853|587806561|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
162752386|NCT02101853|587806562|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162752387|NCT02101853|587806563|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162752388|NCT02101853|587806564|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162752389|NCT02101853|587806565|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162752390|NCT02101853|587806560|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162752391|NCT02101853|587806561|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162752392|NCT02101853|587806562|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162752393|NCT02101853|587806563|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
162752394|NCT02101853|587806564|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
162752395|NCT02101853|587806565|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162752396|NCT02101853|587806560|FG000|Blinatumomab Salvage Therapy|Death|0|||
162752397|NCT02101853|587806561|FG001|Blinatumomab Salvage Therapy|Death|0|||
162752398|NCT02101853|587806562|FG002|Blinatumomab Salvage Therapy|Death|0|||
162752399|NCT02101853|587806563|FG003|Blinatumomab Salvage Therapy|Death|0|||
162752400|NCT02101853|587806564|FG004|Blinatumomab Salvage Therapy|Death|0|||
162752401|NCT02101853|587806565|FG005|Blinatumomab Salvage Therapy|Death|2|||
162752402|NCT02101853|587806560|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162752403|NCT02101853|587806561|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162752404|NCT02101853|587806562|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162752405|NCT02101853|587806563|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162752406|NCT02101853|587806564|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162752407|NCT02101853|587806565|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
162752408|NCT02101853|587806560|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
162752409|NCT02101853|587806561|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
162752410|NCT02101853|587806562|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
162752411|NCT02101853|587806563|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
162752412|NCT02101853|587806564|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
162752413|NCT02101853|587806565|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
162752414|NCT02101853|587806560|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162752415|NCT02101853|587806561|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162752416|NCT02101853|587806562|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162752417|NCT02101853|587806563|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162752418|NCT02101853|587806564|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162752419|NCT02101853|587806565|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
162752420|NCT02112916|587806569|FG000|Overall Study|Adverse Event|6|||
162752421|NCT02112916|587806570|FG001|Overall Study|Adverse Event|9|||
162752422|NCT02112916|587806571|FG002|Overall Study|Adverse Event|3|||
162752423|NCT02112916|587806572|FG003|Overall Study|Adverse Event|2|||
162752424|NCT02112916|587806569|FG000|Overall Study|Death|9|||
162752425|NCT02112916|587806570|FG001|Overall Study|Death|9|||
162752426|NCT02112916|587806571|FG002|Overall Study|Death|3|||
162752427|NCT02112916|587806572|FG003|Overall Study|Death|4|||
162752428|NCT02112916|587806569|FG000|Overall Study|Lost to Follow-up|1|||
162752429|NCT02112916|587806570|FG001|Overall Study|Lost to Follow-up|0|||
162752430|NCT02112916|587806571|FG002|Overall Study|Lost to Follow-up|0|||
162752431|NCT02112916|587806572|FG003|Overall Study|Lost to Follow-up|0|||
162752432|NCT02112916|587806569|FG000|Overall Study|Physician Decision|94|||
162752433|NCT02112916|587806570|FG001|Overall Study|Physician Decision|72|||
162752434|NCT02112916|587806571|FG002|Overall Study|Physician Decision|24|||
162752435|NCT02112916|587806572|FG003|Overall Study|Physician Decision|15|||
162752436|NCT02112916|587806569|FG000|Overall Study|Withdrawal by Subject|5|||
162752437|NCT02112916|587806570|FG001|Overall Study|Withdrawal by Subject|3|||
162752438|NCT02112916|587806571|FG002|Overall Study|Withdrawal by Subject|1|||
162752439|NCT02112916|587806572|FG003|Overall Study|Withdrawal by Subject|1|||
162752440|NCT02112916|587806569|FG000|Overall Study|Ineligible|4|||
162752441|NCT02112916|587806570|FG001|Overall Study|Ineligible|8|||
162752442|NCT02112916|587806571|FG002|Overall Study|Ineligible|3|||
162752443|NCT02112916|587806572|FG003|Overall Study|Ineligible|8|||
162752444|NCT02112916|587806569|FG000|Overall Study|Inevaluable|6|||
162752445|NCT02112916|587806570|FG001|Overall Study|Inevaluable|4|||
162752446|NCT02112916|587806571|FG002|Overall Study|Inevaluable|5|||
162752447|NCT02112916|587806572|FG003|Overall Study|Inevaluable|5|||
162752448|NCT02112916|587806569|FG000|Overall Study|Refusal of further protocol therapy|19|||
162752449|NCT02112916|587806570|FG001|Overall Study|Refusal of further protocol therapy|16|||
162752450|NCT02112916|587806571|FG002|Overall Study|Refusal of further protocol therapy|1|||
162752451|NCT02112916|587806572|FG003|Overall Study|Refusal of further protocol therapy|7|||
162752452|NCT02112916|587806569|FG000|Overall Study|Development of SMN|1|||
162752453|NCT02112916|587806570|FG001|Overall Study|Development of SMN|0|||
162752454|NCT02112916|587806571|FG002|Overall Study|Development of SMN|0|||
162752455|NCT02112916|587806572|FG003|Overall Study|Development of SMN|1|||
162752456|NCT02112916|587806569|FG000|Overall Study|Relapse/Progression|10|||
162752457|NCT02112916|587806570|FG001|Overall Study|Relapse/Progression|18|||
162752458|NCT02112916|587806571|FG002|Overall Study|Relapse/Progression|15|||
162752459|NCT02112916|587806572|FG003|Overall Study|Relapse/Progression|2|||
162752460|NCT02112916|587806569|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162752461|NCT02112916|587806570|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162752462|NCT02112916|587806571|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
162752463|NCT02112916|587806572|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
162752464|NCT02112916|587806569|FG000|Overall Study|Still on Therapy|44|||
162752465|NCT02112916|587806570|FG001|Overall Study|Still on Therapy|47|||
162752466|NCT02112916|587806571|FG002|Overall Study|Still on Therapy|3|||
162752467|NCT02112916|587806572|FG003|Overall Study|Still on Therapy|2|||
162752468|NCT02112916|587806569|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
162752469|NCT02112916|587806570|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
162752470|NCT02112916|587806571|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
162752471|NCT02112916|587806572|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
162752472|NCT02112916|587806569|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
162752473|NCT02112916|587806570|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
162752474|NCT02112916|587806571|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
162752475|NCT02112916|587806572|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
162752476|NCT03333915|587806574|FG000|Overall Study|Lost to Follow-up|0|||
162752477|NCT03333915|587806575|FG001|Overall Study|Lost to Follow-up|0|||
162752478|NCT03333915|587806576|FG002|Overall Study|Lost to Follow-up|1|||
162752479|NCT03333915|587806577|FG003|Overall Study|Lost to Follow-up|0|||
162752480|NCT03333915|587806578|FG004|Overall Study|Lost to Follow-up|0|||
162752481|NCT03333915|587806574|FG000|Overall Study|Disease Progression|0|||
162752482|NCT03333915|587806575|FG001|Overall Study|Disease Progression|1|||
162752483|NCT03333915|587806576|FG002|Overall Study|Disease Progression|0|||
162752484|NCT03333915|587806577|FG003|Overall Study|Disease Progression|0|||
162752485|NCT03333915|587806578|FG004|Overall Study|Disease Progression|0|||
162752486|NCT03333915|587806574|FG000|Overall Study|Death|0|||
162752487|NCT03333915|587806575|FG001|Overall Study|Death|0|||
162752488|NCT03333915|587806576|FG002|Overall Study|Death|0|||
162752489|NCT03333915|587806577|FG003|Overall Study|Death|37|||
162752490|NCT03333915|587806578|FG004|Overall Study|Death|18|||
162752491|NCT03333915|587806574|FG000|Overall Study|Sponsor's Decision|0|||
162752492|NCT03333915|587806575|FG001|Overall Study|Sponsor's Decision|0|||
162752493|NCT03333915|587806576|FG002|Overall Study|Sponsor's Decision|0|||
162752494|NCT03333915|587806577|FG003|Overall Study|Sponsor's Decision|48|||
162752495|NCT03333915|587806578|FG004|Overall Study|Sponsor's Decision|4|||
162752496|NCT03333915|587806574|FG000|Overall Study|Withdrawal by Subject|0|||
162752497|NCT03333915|587806575|FG001|Overall Study|Withdrawal by Subject|0|||
162752498|NCT03333915|587806576|FG002|Overall Study|Withdrawal by Subject|0|||
162752499|NCT03333915|587806577|FG003|Overall Study|Withdrawal by Subject|5|||
162752500|NCT03333915|587806578|FG004|Overall Study|Withdrawal by Subject|1|||
162752501|NCT00945724|587806586|FG000|Overall Study|Withdrawal by Subject|2|||
162752502|NCT00945724|587806586|FG000|Overall Study|Physician Decision|1|||
162752503|NCT00945724|587806586|FG000|Overall Study|Adverse Event|5|||
162752504|NCT00945724|587806586|FG000|Overall Study|Second malignancy|1|||
162752505|NCT05039021|587807159|FG000|Overall Study|Death|1|||
162752506|NCT05039021|587807159|FG000|Overall Study|Lost to Follow-up|3|||
162752507|NCT00994643|587807160|FG000|Overall Study|Withdrawal by Subject|1|||
162752508|NCT02566889|587807161|FG000|Overall Study|Withdrawal by Subject|3|||
162752509|NCT02566889|587807162|FG001|Overall Study|Withdrawal by Subject|1|||
162752510|NCT02566889|587807161|FG000|Overall Study|Adverse Event|4|||
162752511|NCT02566889|587807162|FG001|Overall Study|Adverse Event|2|||
162752512|NCT02566889|587807161|FG000|Overall Study|Other|6|||
162752513|NCT02566889|587807162|FG001|Overall Study|Other|2|||
162752514|NCT00557492|587807174|FG000|Overall Study|Change in health insurance|1|||
162752515|NCT03653364|587807184|FG000|Overall Study|Withdrawal by Subject|1|||
162752516|NCT03653364|587807184|FG000|Overall Study|Enrolled in Error|1|||
162752517|NCT03653364|587807184|FG000|Overall Study|Death|1|||
162752518|NCT02567435|587807190|FG000|Overall Study|Death|1|||
162752519|NCT02567435|587807191|FG001|Overall Study|Death|1|||
162752520|NCT02567435|587807192|FG002|Overall Study|Death|0|||
162752521|NCT02567435|587807193|FG003|Overall Study|Death|0|||
162752522|NCT02567435|587807190|FG000|Overall Study|Ineligible|1|||
162752523|NCT02567435|587807191|FG001|Overall Study|Ineligible|3|||
162752524|NCT02567435|587807192|FG002|Overall Study|Ineligible|0|||
162752525|NCT02567435|587807193|FG003|Overall Study|Ineligible|0|||
162752526|NCT02567435|587807190|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
162752527|NCT02567435|587807191|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
162752528|NCT02567435|587807192|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
162752529|NCT02567435|587807193|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
162752530|NCT02166463|587807194|FG000|Overall Study|Lost to Follow-up|0|||
162752531|NCT02166463|587807195|FG001|Overall Study|Lost to Follow-up|1|||
162752532|NCT02166463|587807194|FG000|Overall Study|Physician Decision|10|||
162752533|NCT02166463|587807195|FG001|Overall Study|Physician Decision|10|||
162752534|NCT02166463|587807194|FG000|Overall Study|Ineligible|11|||
162752535|NCT02166463|587807195|FG001|Overall Study|Ineligible|2|||
162752536|NCT02166463|587807194|FG000|Overall Study|Progressive Disease|9|||
162752537|NCT02166463|587807195|FG001|Overall Study|Progressive Disease|6|||
162752538|NCT02166463|587807194|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
162752539|NCT02166463|587807195|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
162752540|NCT02166463|587807194|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
162752541|NCT02166463|587807195|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
162752542|NCT02166463|587807194|FG000|Overall Study|Refusal of further protocol therapy|5|||
162752543|NCT02166463|587807195|FG001|Overall Study|Refusal of further protocol therapy|6|||
162752544|NCT03782116|587807219|FG000|Completed Intervetion|Lost to Follow-up|11|||
162752545|NCT03782116|587807220|FG001|Completed Intervetion|Lost to Follow-up|7|||
162752546|NCT03782116|587807219|FG000|Completed Intervetion|Withdrawal by Subject|6|||
162752547|NCT03782116|587807220|FG001|Completed Intervetion|Withdrawal by Subject|5|||
162752548|NCT03782116|587807219|FG000|Included in Analysis|Protocol Violation|5|||
162752549|NCT03782116|587807220|FG001|Included in Analysis|Protocol Violation|5|||
162752550|NCT04908514|587807221|FG000|Overall Study|Lost to Follow-up|2|||
162752551|NCT04908514|587807221|FG000|Overall Study|Withdrawal by Subject|1|||
162752552|NCT02890355|587807222|FG000|Overall Study|Adverse Event|5|||
162752553|NCT02890355|587807223|FG001|Overall Study|Adverse Event|5|||
162752554|NCT02890355|587807222|FG000|Overall Study|Refusal unrelated to adverse event|5|||
162752555|NCT02890355|587807223|FG001|Overall Study|Refusal unrelated to adverse event|10|||
162752556|NCT02890355|587807222|FG000|Overall Study|Progression/relapse|46|||
162752557|NCT02890355|587807223|FG001|Overall Study|Progression/relapse|39|||
162752558|NCT02890355|587807222|FG000|Overall Study|Not protocol specified|3|||
162752559|NCT02890355|587807223|FG001|Overall Study|Not protocol specified|4|||
162752560|NCT02206828|587807224|FG000|Overall Study|Lost to Follow-up|7|||
162752561|NCT03391466|587808000|FG000|Overall Study|Death|84|||
162752562|NCT03391466|587808001|FG001|Overall Study|Death|91|||
162752563|NCT03391466|587808000|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
162752564|NCT03391466|587808001|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
162752565|NCT03391466|587808000|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
162752566|NCT03391466|587808001|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
162752567|NCT03391466|587808000|FG000|Overall Study|Lost to Follow-up|9|||
162752568|NCT03391466|587808001|FG001|Overall Study|Lost to Follow-up|5|||
162752569|NCT03391466|587808000|FG000|Overall Study|Reason Not Specified|2|||
162752570|NCT03391466|587808001|FG001|Overall Study|Reason Not Specified|2|||
162752571|NCT03391466|587808000|FG000|Overall Study|Investigator Decision|0|||
162752572|NCT03391466|587808001|FG001|Overall Study|Investigator Decision|1|||
162752573|NCT03140670|587808002|FG000|Overall Study|Withdrawal by Subject|2|||
162752574|NCT03140670|587808002|FG000|Overall Study|Lost to Follow-up|1|||
162752575|NCT03140670|587808002|FG000|Overall Study|Physician Decision|1|||
162752576|NCT00220805|587808003|FG000|Overall Study|Adverse Event|1|||
162752577|NCT00220805|587808004|FG001|Overall Study|Adverse Event|3|||
162752578|NCT00220805|587808003|FG000|Overall Study|Withdrawal by Subject|3|||
162752579|NCT00220805|587808004|FG001|Overall Study|Withdrawal by Subject|0|||
162752580|NCT00220805|587808003|FG000|Overall Study|Lack of Efficacy|1|||
162752581|NCT00220805|587808004|FG001|Overall Study|Lack of Efficacy|0|||
162752582|NCT00220805|587808003|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
162752583|NCT00220805|587808004|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
162752584|NCT02325466|587808005|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
162752585|NCT02325466|587808006|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
162925350|NCT03901339|588428939|FG001|Overall Study|Death|192|||
162752586|NCT02325466|587808007|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
162752587|NCT02325466|587808005|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
162752588|NCT02325466|587808006|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
162752589|NCT02325466|587808007|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
162752590|NCT02325466|587808005|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
162752591|NCT02325466|587808006|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
162752592|NCT02325466|587808007|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
162752593|NCT02325466|587808005|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
162752594|NCT02325466|587808006|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
162752595|NCT02325466|587808007|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
162752596|NCT02325466|587808005|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
162752597|NCT02325466|587808006|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
162752598|NCT02325466|587808007|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
162752599|NCT02325466|587808005|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
162752600|NCT02325466|587808006|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
162752601|NCT02325466|587808007|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
162752602|NCT02325466|587808005|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
162752603|NCT02325466|587808006|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
162752604|NCT02325466|587808007|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
162752605|NCT02325466|587808005|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
162752606|NCT02325466|587808006|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
162752607|NCT02325466|587808007|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
162752608|NCT02325466|587808005|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
162752609|NCT02325466|587808006|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
162752610|NCT02325466|587808007|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
162752611|NCT01964300|587808012|FG000|Overall Study|Ineligible after enrollment|0|||
162752612|NCT01964300|587808013|FG001|Overall Study|Ineligible after enrollment|1|||
162752613|NCT01964300|587808012|FG000|Overall Study|Adverse Event|1|||
162752614|NCT01964300|587808013|FG001|Overall Study|Adverse Event|1|||
162752615|NCT01964300|587808012|FG000|Overall Study|Lack of Efficacy|3|||
162752616|NCT01964300|587808013|FG001|Overall Study|Lack of Efficacy|5|||
162752617|NCT01964300|587808012|FG000|Overall Study|Withdrawal by Subject|0|||
162752618|NCT01964300|587808013|FG001|Overall Study|Withdrawal by Subject|1|||
162752619|NCT01964300|587808012|FG000|Overall Study|To receive alternative therapy|1|||
162752620|NCT01964300|587808013|FG001|Overall Study|To receive alternative therapy|2|||
162752621|NCT01964300|587808012|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
162752622|NCT01964300|587808013|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
162752623|NCT01964300|587808012|FG000|Overall Study|Weight criteria not met|0|||
162752624|NCT01964300|587808013|FG001|Overall Study|Weight criteria not met|1|||
162752625|NCT02285270|587808014|FG000|Overall Study|Lost to Follow-up|1|||
162752626|NCT02285270|587808014|FG000|Overall Study|Physician Decision|3|||
162752627|NCT02285270|587808014|FG000|Overall Study|Determined to be ineligible|1|||
162752628|NCT04121546|587808015|FG000|Overall Study|Lost to Follow-up|1|||
162752629|NCT04121546|587808016|FG001|Overall Study|Lost to Follow-up|3|||
162752630|NCT04129164|587808017|FG000|Overall Study|Non-compliance with procedures|0|||
162752631|NCT04129164|587808018|FG001|Overall Study|Non-compliance with procedures|0|||
162752632|NCT04129164|587808019|FG002|Overall Study|Non-compliance with procedures|2|||
162752633|NCT04129164|587808020|FG003|Overall Study|Non-compliance with procedures|0|||
162752634|NCT04129164|587808017|FG000|Overall Study|Adverse Event|0|||
162752635|NCT04129164|587808018|FG001|Overall Study|Adverse Event|0|||
162752636|NCT04129164|587808019|FG002|Overall Study|Adverse Event|2|||
162752637|NCT04129164|587808020|FG003|Overall Study|Adverse Event|0|||
162752638|NCT04129164|587808017|FG000|Overall Study|Pregnancy|0|||
162752639|NCT04129164|587808018|FG001|Overall Study|Pregnancy|0|||
162752640|NCT04129164|587808019|FG002|Overall Study|Pregnancy|0|||
162752641|NCT04129164|587808020|FG003|Overall Study|Pregnancy|1|||
162752642|NCT04129164|587808017|FG000|Overall Study|Withdrawal by Subject|3|||
162752643|NCT04129164|587808018|FG001|Overall Study|Withdrawal by Subject|2|||
162752644|NCT04129164|587808019|FG002|Overall Study|Withdrawal by Subject|4|||
162752645|NCT04129164|587808020|FG003|Overall Study|Withdrawal by Subject|6|||
162752646|NCT04129164|587808017|FG000|Overall Study|Death|0|||
162752647|NCT04129164|587808018|FG001|Overall Study|Death|1|||
162752648|NCT04129164|587808019|FG002|Overall Study|Death|0|||
162752649|NCT04129164|587808020|FG003|Overall Study|Death|0|||
162752650|NCT04129164|587808017|FG000|Overall Study|Lost to Follow-up|0|||
162752651|NCT04129164|587808018|FG001|Overall Study|Lost to Follow-up|1|||
162752652|NCT04129164|587808019|FG002|Overall Study|Lost to Follow-up|0|||
162752653|NCT04129164|587808020|FG003|Overall Study|Lost to Follow-up|0|||
162752654|NCT03286114|587808021|FG000|Overall Study|Adverse Event|6|||
162752655|NCT03286114|587808021|FG000|Overall Study|Death|3|||
162752656|NCT01260896|587808025|FG000|First Intervention|Withdrawn Due to Emesis|2|||
162752657|NCT01260896|587808026|FG001|First Intervention|Withdrawn Due to Emesis|0|||
162752658|NCT00943917|587808035|FG000|Stage I|Adverse Event|1|||
162752659|NCT00943917|587808036|FG001|Stage I|Adverse Event|2|||
162752660|NCT00943917|587808037|FG002|Stage I|Adverse Event|2|||
162752661|NCT00943917|587808038|FG003|Stage I|Adverse Event|0|||
162752662|NCT00943917|587808039|FG004|Stage I|Adverse Event|0|||
162752663|NCT00943917|587808040|FG005|Stage I|Adverse Event|0|||
162752664|NCT00943917|587808041|FG006|Stage I|Adverse Event|0|||
162752665|NCT00943917|587808042|FG007|Stage I|Adverse Event|0|||
162752666|NCT00943917|587808043|FG008|Stage I|Adverse Event|0|||
162752667|NCT00943917|587808044|FG009|Stage I|Adverse Event|0|||
162752668|NCT00943917|587808045|FG010|Stage I|Adverse Event|0|||
162752669|NCT00943917|587808046|FG011|Stage I|Adverse Event|0|||
162752670|NCT00943917|587808047|FG012|Stage I|Adverse Event|0|||
162752671|NCT00943917|587808048|FG013|Stage I|Adverse Event|0|||
162752672|NCT00943917|587808049|FG014|Stage I|Adverse Event|0|||
162752673|NCT00943917|587808035|FG000|Stage I|Lost to Follow-up|0|||
162752674|NCT00943917|587808036|FG001|Stage I|Lost to Follow-up|0|||
162752675|NCT00943917|587808037|FG002|Stage I|Lost to Follow-up|1|||
162752676|NCT00943917|587808038|FG003|Stage I|Lost to Follow-up|0|||
162752677|NCT00943917|587808039|FG004|Stage I|Lost to Follow-up|0|||
162752678|NCT00943917|587808040|FG005|Stage I|Lost to Follow-up|0|||
162752679|NCT00943917|587808041|FG006|Stage I|Lost to Follow-up|0|||
162752680|NCT00943917|587808042|FG007|Stage I|Lost to Follow-up|0|||
162752681|NCT00943917|587808043|FG008|Stage I|Lost to Follow-up|0|||
162752682|NCT00943917|587808044|FG009|Stage I|Lost to Follow-up|0|||
162752683|NCT00943917|587808045|FG010|Stage I|Lost to Follow-up|0|||
162752684|NCT00943917|587808046|FG011|Stage I|Lost to Follow-up|0|||
162752685|NCT00943917|587808047|FG012|Stage I|Lost to Follow-up|0|||
162752686|NCT00943917|587808048|FG013|Stage I|Lost to Follow-up|0|||
162752687|NCT00943917|587808049|FG014|Stage I|Lost to Follow-up|0|||
162752688|NCT00943917|587808035|FG000|Stage I|hyperglycemia|0|||
162752689|NCT00943917|587808036|FG001|Stage I|hyperglycemia|0|||
162752690|NCT00943917|587808037|FG002|Stage I|hyperglycemia|1|||
162752691|NCT00943917|587808038|FG003|Stage I|hyperglycemia|0|||
162752692|NCT00943917|587808039|FG004|Stage I|hyperglycemia|0|||
162752693|NCT00943917|587808040|FG005|Stage I|hyperglycemia|0|||
162752694|NCT00943917|587808041|FG006|Stage I|hyperglycemia|0|||
162752695|NCT00943917|587808042|FG007|Stage I|hyperglycemia|0|||
162752696|NCT00943917|587808043|FG008|Stage I|hyperglycemia|0|||
162752697|NCT00943917|587808044|FG009|Stage I|hyperglycemia|0|||
162752698|NCT00943917|587808045|FG010|Stage I|hyperglycemia|0|||
162752699|NCT00943917|587808046|FG011|Stage I|hyperglycemia|0|||
162752700|NCT00943917|587808047|FG012|Stage I|hyperglycemia|0|||
162752701|NCT00943917|587808048|FG013|Stage I|hyperglycemia|0|||
162752702|NCT00943917|587808049|FG014|Stage I|hyperglycemia|0|||
162752703|NCT00943917|587808035|FG000|Stage I|A1C elevation|1|||
162752704|NCT00943917|587808036|FG001|Stage I|A1C elevation|0|||
162752705|NCT00943917|587808037|FG002|Stage I|A1C elevation|0|||
162752706|NCT00943917|587808038|FG003|Stage I|A1C elevation|0|||
162752707|NCT00943917|587808039|FG004|Stage I|A1C elevation|0|||
162752708|NCT00943917|587808040|FG005|Stage I|A1C elevation|0|||
162752709|NCT00943917|587808041|FG006|Stage I|A1C elevation|0|||
162752710|NCT00943917|587808042|FG007|Stage I|A1C elevation|0|||
162752711|NCT00943917|587808043|FG008|Stage I|A1C elevation|0|||
162752712|NCT00943917|587808044|FG009|Stage I|A1C elevation|0|||
162752713|NCT00943917|587808045|FG010|Stage I|A1C elevation|0|||
162752714|NCT00943917|587808046|FG011|Stage I|A1C elevation|0|||
162752715|NCT00943917|587808047|FG012|Stage I|A1C elevation|0|||
162752716|NCT00943917|587808048|FG013|Stage I|A1C elevation|0|||
162752717|NCT00943917|587808049|FG014|Stage I|A1C elevation|0|||
162752718|NCT00943917|587808035|FG000|Stage I|Withdrawal by Subject|2|||
162752719|NCT00943917|587808036|FG001|Stage I|Withdrawal by Subject|1|||
162752720|NCT00943917|587808037|FG002|Stage I|Withdrawal by Subject|2|||
162752721|NCT00943917|587808038|FG003|Stage I|Withdrawal by Subject|0|||
162752722|NCT00943917|587808039|FG004|Stage I|Withdrawal by Subject|0|||
162752723|NCT00943917|587808040|FG005|Stage I|Withdrawal by Subject|0|||
162752724|NCT00943917|587808041|FG006|Stage I|Withdrawal by Subject|0|||
162752725|NCT00943917|587808042|FG007|Stage I|Withdrawal by Subject|0|||
162752726|NCT00943917|587808043|FG008|Stage I|Withdrawal by Subject|0|||
162752727|NCT00943917|587808044|FG009|Stage I|Withdrawal by Subject|0|||
162752728|NCT00943917|587808045|FG010|Stage I|Withdrawal by Subject|0|||
162752729|NCT00943917|587808046|FG011|Stage I|Withdrawal by Subject|0|||
162752730|NCT00943917|587808047|FG012|Stage I|Withdrawal by Subject|0|||
162752731|NCT00943917|587808048|FG013|Stage I|Withdrawal by Subject|0|||
162752732|NCT00943917|587808049|FG014|Stage I|Withdrawal by Subject|0|||
162752733|NCT00943917|587808035|FG000|Stage II|Adverse Event|0|||
162752734|NCT00943917|587808036|FG001|Stage II|Adverse Event|0|||
162752735|NCT00943917|587808037|FG002|Stage II|Adverse Event|0|||
162752736|NCT00943917|587808038|FG003|Stage II|Adverse Event|0|||
162752737|NCT00943917|587808039|FG004|Stage II|Adverse Event|0|||
162752738|NCT00943917|587808040|FG005|Stage II|Adverse Event|1|||
162752739|NCT00943917|587808041|FG006|Stage II|Adverse Event|3|||
162752740|NCT00943917|587808042|FG007|Stage II|Adverse Event|0|||
162752741|NCT00943917|587808043|FG008|Stage II|Adverse Event|1|||
162752742|NCT00943917|587808044|FG009|Stage II|Adverse Event|0|||
162752743|NCT00943917|587808045|FG010|Stage II|Adverse Event|0|||
162752744|NCT00943917|587808046|FG011|Stage II|Adverse Event|0|||
162752745|NCT00943917|587808047|FG012|Stage II|Adverse Event|0|||
162752746|NCT00943917|587808048|FG013|Stage II|Adverse Event|0|||
162752747|NCT00943917|587808049|FG014|Stage II|Adverse Event|0|||
162752748|NCT00943917|587808035|FG000|Stage II|Withdrawal by Subject|0|||
162752749|NCT00943917|587808036|FG001|Stage II|Withdrawal by Subject|0|||
162752750|NCT00943917|587808037|FG002|Stage II|Withdrawal by Subject|0|||
162752751|NCT00943917|587808038|FG003|Stage II|Withdrawal by Subject|0|||
162752752|NCT00943917|587808039|FG004|Stage II|Withdrawal by Subject|0|||
162752753|NCT00943917|587808040|FG005|Stage II|Withdrawal by Subject|1|||
162752754|NCT00943917|587808041|FG006|Stage II|Withdrawal by Subject|0|||
162752755|NCT00943917|587808042|FG007|Stage II|Withdrawal by Subject|0|||
162752756|NCT00943917|587808043|FG008|Stage II|Withdrawal by Subject|0|||
162752757|NCT00943917|587808044|FG009|Stage II|Withdrawal by Subject|0|||
162752758|NCT00943917|587808045|FG010|Stage II|Withdrawal by Subject|0|||
162752759|NCT00943917|587808046|FG011|Stage II|Withdrawal by Subject|0|||
162752760|NCT00943917|587808047|FG012|Stage II|Withdrawal by Subject|0|||
162752761|NCT00943917|587808048|FG013|Stage II|Withdrawal by Subject|0|||
162752762|NCT00943917|587808049|FG014|Stage II|Withdrawal by Subject|0|||
162752763|NCT00943917|587808035|FG000|Stage II|Pregnancy|0|||
162752764|NCT00943917|587808036|FG001|Stage II|Pregnancy|0|||
162752765|NCT00943917|587808037|FG002|Stage II|Pregnancy|0|||
162752766|NCT00943917|587808038|FG003|Stage II|Pregnancy|0|||
162752767|NCT00943917|587808039|FG004|Stage II|Pregnancy|0|||
162752768|NCT00943917|587808040|FG005|Stage II|Pregnancy|1|||
162752769|NCT00943917|587808041|FG006|Stage II|Pregnancy|0|||
162752770|NCT00943917|587808042|FG007|Stage II|Pregnancy|0|||
162752771|NCT00943917|587808043|FG008|Stage II|Pregnancy|0|||
162752772|NCT00943917|587808044|FG009|Stage II|Pregnancy|0|||
162752773|NCT00943917|587808045|FG010|Stage II|Pregnancy|0|||
162752774|NCT00943917|587808046|FG011|Stage II|Pregnancy|0|||
162752775|NCT00943917|587808047|FG012|Stage II|Pregnancy|0|||
162752776|NCT00943917|587808048|FG013|Stage II|Pregnancy|0|||
162752777|NCT00943917|587808049|FG014|Stage II|Pregnancy|0|||
162752778|NCT00943917|587808035|FG000|Stage II Continuation|Adverse Event|0|||
162752779|NCT00943917|587808036|FG001|Stage II Continuation|Adverse Event|0|||
162752780|NCT00943917|587808037|FG002|Stage II Continuation|Adverse Event|0|||
162752781|NCT00943917|587808038|FG003|Stage II Continuation|Adverse Event|0|||
162752782|NCT00943917|587808039|FG004|Stage II Continuation|Adverse Event|0|||
162752783|NCT00943917|587808040|FG005|Stage II Continuation|Adverse Event|0|||
162752784|NCT00943917|587808041|FG006|Stage II Continuation|Adverse Event|0|||
162752785|NCT00943917|587808042|FG007|Stage II Continuation|Adverse Event|0|||
162752786|NCT00943917|587808043|FG008|Stage II Continuation|Adverse Event|0|||
162752787|NCT00943917|587808044|FG009|Stage II Continuation|Adverse Event|0|||
162752788|NCT00943917|587808045|FG010|Stage II Continuation|Adverse Event|0|||
162752789|NCT00943917|587808046|FG011|Stage II Continuation|Adverse Event|1|||
162752790|NCT00943917|587808047|FG012|Stage II Continuation|Adverse Event|2|||
162752791|NCT00943917|587808048|FG013|Stage II Continuation|Adverse Event|1|||
162752792|NCT00943917|587808049|FG014|Stage II Continuation|Adverse Event|1|||
162752793|NCT00943917|587808035|FG000|Stage II Continuation|Withdrawal by Subject|0|||
162752794|NCT00943917|587808036|FG001|Stage II Continuation|Withdrawal by Subject|0|||
162752795|NCT00943917|587808037|FG002|Stage II Continuation|Withdrawal by Subject|0|||
162752796|NCT00943917|587808038|FG003|Stage II Continuation|Withdrawal by Subject|0|||
162752797|NCT00943917|587808039|FG004|Stage II Continuation|Withdrawal by Subject|0|||
162752798|NCT00943917|587808040|FG005|Stage II Continuation|Withdrawal by Subject|0|||
162752799|NCT00943917|587808041|FG006|Stage II Continuation|Withdrawal by Subject|0|||
162752800|NCT00943917|587808042|FG007|Stage II Continuation|Withdrawal by Subject|0|||
162752801|NCT00943917|587808043|FG008|Stage II Continuation|Withdrawal by Subject|0|||
162752802|NCT00943917|587808044|FG009|Stage II Continuation|Withdrawal by Subject|0|||
162752803|NCT00943917|587808045|FG010|Stage II Continuation|Withdrawal by Subject|0|||
162752804|NCT00943917|587808046|FG011|Stage II Continuation|Withdrawal by Subject|0|||
162752805|NCT00943917|587808047|FG012|Stage II Continuation|Withdrawal by Subject|0|||
162752806|NCT00943917|587808048|FG013|Stage II Continuation|Withdrawal by Subject|1|||
162752807|NCT00943917|587808049|FG014|Stage II Continuation|Withdrawal by Subject|3|||
162752808|NCT00943917|587808035|FG000|Stage II Continuation|Protocol Violation|0|||
162752809|NCT00943917|587808036|FG001|Stage II Continuation|Protocol Violation|0|||
162752810|NCT00943917|587808037|FG002|Stage II Continuation|Protocol Violation|0|||
162752811|NCT00943917|587808038|FG003|Stage II Continuation|Protocol Violation|0|||
162752812|NCT00943917|587808039|FG004|Stage II Continuation|Protocol Violation|0|||
162752813|NCT00943917|587808040|FG005|Stage II Continuation|Protocol Violation|0|||
162752814|NCT00943917|587808041|FG006|Stage II Continuation|Protocol Violation|0|||
162752815|NCT00943917|587808042|FG007|Stage II Continuation|Protocol Violation|0|||
162752816|NCT00943917|587808043|FG008|Stage II Continuation|Protocol Violation|0|||
162752817|NCT00943917|587808044|FG009|Stage II Continuation|Protocol Violation|1|||
162752818|NCT00943917|587808045|FG010|Stage II Continuation|Protocol Violation|0|||
162752819|NCT00943917|587808046|FG011|Stage II Continuation|Protocol Violation|1|||
162752820|NCT00943917|587808047|FG012|Stage II Continuation|Protocol Violation|0|||
162752821|NCT00943917|587808048|FG013|Stage II Continuation|Protocol Violation|0|||
162752822|NCT00943917|587808049|FG014|Stage II Continuation|Protocol Violation|0|||
162752823|NCT00943917|587808035|FG000|Stage II Continuation|hypoglycemia|0|||
162752824|NCT00943917|587808036|FG001|Stage II Continuation|hypoglycemia|0|||
162752825|NCT00943917|587808037|FG002|Stage II Continuation|hypoglycemia|0|||
162752826|NCT00943917|587808038|FG003|Stage II Continuation|hypoglycemia|0|||
162752827|NCT00943917|587808039|FG004|Stage II Continuation|hypoglycemia|0|||
162752828|NCT00943917|587808040|FG005|Stage II Continuation|hypoglycemia|0|||
162752829|NCT00943917|587808041|FG006|Stage II Continuation|hypoglycemia|0|||
162752830|NCT00943917|587808042|FG007|Stage II Continuation|hypoglycemia|0|||
162752831|NCT00943917|587808043|FG008|Stage II Continuation|hypoglycemia|0|||
162752832|NCT00943917|587808044|FG009|Stage II Continuation|hypoglycemia|0|||
162752833|NCT00943917|587808045|FG010|Stage II Continuation|hypoglycemia|0|||
162752834|NCT00943917|587808046|FG011|Stage II Continuation|hypoglycemia|0|||
162752835|NCT00943917|587808047|FG012|Stage II Continuation|hypoglycemia|1|||
162752836|NCT00943917|587808048|FG013|Stage II Continuation|hypoglycemia|0|||
162752837|NCT00943917|587808049|FG014|Stage II Continuation|hypoglycemia|0|||
162752838|NCT00943917|587808035|FG000|Stage II Continuation|A1C elevation|0|||
162752839|NCT00943917|587808036|FG001|Stage II Continuation|A1C elevation|0|||
162752840|NCT00943917|587808037|FG002|Stage II Continuation|A1C elevation|0|||
162752841|NCT00943917|587808038|FG003|Stage II Continuation|A1C elevation|0|||
162752842|NCT00943917|587808039|FG004|Stage II Continuation|A1C elevation|0|||
162752843|NCT00943917|587808040|FG005|Stage II Continuation|A1C elevation|0|||
162752844|NCT00943917|587808041|FG006|Stage II Continuation|A1C elevation|0|||
162752845|NCT00943917|587808042|FG007|Stage II Continuation|A1C elevation|0|||
162752846|NCT00943917|587808043|FG008|Stage II Continuation|A1C elevation|0|||
162752847|NCT00943917|587808044|FG009|Stage II Continuation|A1C elevation|0|||
162752848|NCT00943917|587808045|FG010|Stage II Continuation|A1C elevation|0|||
162752849|NCT00943917|587808046|FG011|Stage II Continuation|A1C elevation|0|||
162752850|NCT00943917|587808047|FG012|Stage II Continuation|A1C elevation|0|||
162752851|NCT00943917|587808048|FG013|Stage II Continuation|A1C elevation|1|||
162752852|NCT00943917|587808049|FG014|Stage II Continuation|A1C elevation|0|||
162752853|NCT01171976|587808050|FG000|Overall Study|Protocol Violation|0|||
162752854|NCT01171976|587808051|FG001|Overall Study|Protocol Violation|0|||
162752855|NCT01171976|587808052|FG002|Overall Study|Protocol Violation|1|||
162752856|NCT01171976|587808050|FG000|Overall Study|Death|2|||
162752857|NCT01171976|587808051|FG001|Overall Study|Death|4|||
162752858|NCT01171976|587808052|FG002|Overall Study|Death|1|||
162752859|NCT01171976|587808050|FG000|Overall Study|Lost to Follow-up|4|||
162752860|NCT01171976|587808051|FG001|Overall Study|Lost to Follow-up|0|||
162752861|NCT01171976|587808052|FG002|Overall Study|Lost to Follow-up|2|||
162752862|NCT01171976|587808050|FG000|Overall Study|Withdrawal by Subject|1|||
162752863|NCT01171976|587808051|FG001|Overall Study|Withdrawal by Subject|5|||
162752864|NCT01171976|587808052|FG002|Overall Study|Withdrawal by Subject|6|||
162752865|NCT01171976|587808050|FG000|Overall Study|Abnormal test result|1|||
162752866|NCT01171976|587808051|FG001|Overall Study|Abnormal test result|0|||
162752867|NCT01171976|587808052|FG002|Overall Study|Abnormal test result|0|||
162752868|NCT01171976|587808050|FG000|Overall Study|Adverse Event|6|||
162752869|NCT01171976|587808051|FG001|Overall Study|Adverse Event|2|||
162752870|NCT01171976|587808052|FG002|Overall Study|Adverse Event|5|||
162752871|NCT00003222|587808053|FG000|Overall Study|Physician Decision|0|||
162752872|NCT00003222|587808054|FG001|Overall Study|Physician Decision|1|||
162752873|NCT01313559|587808056|FG000|Overall Study|Withdrawal by Subject|1|||
162752874|NCT01313559|587808057|FG001|Overall Study|Withdrawal by Subject|2|||
162752875|NCT01313559|587808056|FG000|Overall Study|Disease progression|1|||
162752876|NCT01313559|587808057|FG001|Overall Study|Disease progression|0|||
162752877|NCT01313559|587808056|FG000|Overall Study|Rising PSA|2|||
162752878|NCT01313559|587808057|FG001|Overall Study|Rising PSA|0|||
162752879|NCT02754596|587808058|FG000|Overall Study|Withdrawal by Subject|3|||
162752880|NCT02754596|587808059|FG001|Overall Study|Withdrawal by Subject|4|||
162752881|NCT02754596|587808060|FG002|Overall Study|Withdrawal by Subject|0|||
162752882|NCT02754596|587808058|FG000|Overall Study|Physician Decision|1|||
162752883|NCT02754596|587808059|FG001|Overall Study|Physician Decision|1|||
162752884|NCT02754596|587808060|FG002|Overall Study|Physician Decision|1|||
162752885|NCT02754596|587808058|FG000|Overall Study|Lost to Follow-up|1|||
162752886|NCT02754596|587808059|FG001|Overall Study|Lost to Follow-up|1|||
162752887|NCT02754596|587808060|FG002|Overall Study|Lost to Follow-up|2|||
162752888|NCT02754596|587808058|FG000|Overall Study|Death|0|||
162752889|NCT02754596|587808059|FG001|Overall Study|Death|2|||
162752890|NCT02754596|587808060|FG002|Overall Study|Death|0|||
162752891|NCT02754596|587808058|FG000|Overall Study|Adverse Event|1|||
162752892|NCT02754596|587808059|FG001|Overall Study|Adverse Event|0|||
162752893|NCT02754596|587808060|FG002|Overall Study|Adverse Event|1|||
162752894|NCT02754596|587808058|FG000|Overall Study|Other|1|||
162752895|NCT02754596|587808059|FG001|Overall Study|Other|0|||
162752896|NCT02754596|587808060|FG002|Overall Study|Other|0|||
162752897|NCT04174560|587808064|FG000|Overall Study|Lost to Follow-up|1|||
162752898|NCT04174560|587808065|FG001|Overall Study|Lost to Follow-up|0|||
162752899|NCT04174560|587808066|FG002|Overall Study|Lost to Follow-up|0|||
162752900|NCT04174560|587808067|FG003|Overall Study|Lost to Follow-up|0|||
162752901|NCT04174560|587808064|FG000|Overall Study|Withdrawal by Subject|0|||
162752902|NCT04174560|587808065|FG001|Overall Study|Withdrawal by Subject|0|||
162752903|NCT04174560|587808066|FG002|Overall Study|Withdrawal by Subject|2|||
162752904|NCT04174560|587808067|FG003|Overall Study|Withdrawal by Subject|0|||
162752905|NCT03872466|587808068|FG000|Overall Study|Withdrawal by Subject|1|||
162752906|NCT03872466|587808069|FG001|Overall Study|Withdrawal by Subject|0|||
162752907|NCT03872466|587808068|FG000|Overall Study|Physician Decision|2|||
162752908|NCT03872466|587808069|FG001|Overall Study|Physician Decision|0|||
162752909|NCT01778686|587808070|FG000|Overall Study|Adverse Event|0|||
162752910|NCT01778686|587808071|FG001|Overall Study|Adverse Event|0|||
162752911|NCT01778686|587808072|FG002|Overall Study|Adverse Event|1|||
162752912|NCT04012567|587808073|FG000|Overall Study|Lost to Follow-up|0|||
162752913|NCT04012567|587808074|FG001|Overall Study|Lost to Follow-up|1|||
162752914|NCT04012567|587808073|FG000|Overall Study|Withdrawal by Subject|1|||
162752915|NCT04012567|587808074|FG001|Overall Study|Withdrawal by Subject|0|||
162752916|NCT04018495|587808080|FG000|Overall Study|Physician Decision|1|||
162752917|NCT05934292|587808089|FG000|Overall Study|Lost to Follow-up|0|||
162752918|NCT05934292|587808090|FG001|Overall Study|Lost to Follow-up|0|||
162752919|NCT05934292|587808091|FG002|Overall Study|Lost to Follow-up|1|||
162752920|NCT05934292|587808092|FG003|Overall Study|Lost to Follow-up|0|||
162752921|NCT05714059|587808095|FG000|Overall Study|Withdrawal by Subject|2|||
162752922|NCT05714059|587808096|FG001|Overall Study|Withdrawal by Subject|2|||
162752923|NCT05714059|587808095|FG000|Overall Study|Adverse Event|0|||
162752924|NCT05714059|587808096|FG001|Overall Study|Adverse Event|1|||
162752925|NCT05714059|587808095|FG000|Overall Study|Lost to Follow-up|0|||
162752926|NCT05714059|587808096|FG001|Overall Study|Lost to Follow-up|1|||
162752927|NCT05714059|587808095|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
162752928|NCT05714059|587808096|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162752929|NCT05714059|587808095|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
162752930|NCT05714059|587808096|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
162752931|NCT04899674|587808097|FG000|Test|Adverse Event|1|||
162752932|NCT04974047|587808868|FG000|Overall Study|Sponsor Ended Study|20|||
162752933|NCT04974047|587808869|FG001|Overall Study|Sponsor Ended Study|22|||
162752934|NCT04974047|587808868|FG000|Overall Study|Death|8|||
162752935|NCT04974047|587808869|FG001|Overall Study|Death|17|||
162752936|NCT04974047|587808868|FG000|Overall Study|Lost to Follow-up|2|||
162752937|NCT04974047|587808869|FG001|Overall Study|Lost to Follow-up|0|||
162752938|NCT04974047|587808868|FG000|Overall Study|Withdrawal by Subject|0|||
162752939|NCT04974047|587808869|FG001|Overall Study|Withdrawal by Subject|1|||
162752940|NCT00655499|587808870|FG000|Overall Study|not eligible|4|||
162752941|NCT01596972|587808872|FG000|Overall Study|Physician Decision|1|||
162752942|NCT01596972|587808873|FG001|Overall Study|Physician Decision|9|||
162752943|NCT01596972|587808872|FG000|Overall Study|Lost to Follow-up|0|||
162752944|NCT01596972|587808873|FG001|Overall Study|Lost to Follow-up|4|||
162752945|NCT01596972|587808872|FG000|Overall Study|Withdrawal by Subject|0|||
162752946|NCT01596972|587808873|FG001|Overall Study|Withdrawal by Subject|1|||
162752947|NCT01639131|587808874|FG000|Overall Study|Disease Progression|6|||
162752948|NCT00945321|587808878|FG000|Period 1|Adverse Event|0|||
162752949|NCT00945321|587808879|FG001|Period 1|Adverse Event|0|||
162752950|NCT00945321|587808880|FG002|Period 1|Adverse Event|0|||
162752951|NCT00945321|587808881|FG003|Period 1|Adverse Event|0|||
162752952|NCT00945321|587808882|FG004|Period 1|Adverse Event|1|||
162752953|NCT00945321|587808883|FG005|Period 1|Adverse Event|0|||
162752954|NCT00945321|587808878|FG000|Period 4|Lost to Follow-up|0|||
162752955|NCT00945321|587808879|FG001|Period 4|Lost to Follow-up|0|||
162752956|NCT00945321|587808880|FG002|Period 4|Lost to Follow-up|0|||
162752957|NCT00945321|587808881|FG003|Period 4|Lost to Follow-up|0|||
162752958|NCT00945321|587808882|FG004|Period 4|Lost to Follow-up|0|||
162752959|NCT00945321|587808883|FG005|Period 4|Lost to Follow-up|1|||
162752960|NCT02438137|587808884|FG000|Overall Study|Lost to Follow-up|3|||
162752961|NCT02438137|587808885|FG001|Overall Study|Lost to Follow-up|2|||
162752962|NCT02438137|587808884|FG000|Overall Study|Adverse Event|1|||
162752963|NCT02438137|587808885|FG001|Overall Study|Adverse Event|0|||
162752964|NCT02438137|587808884|FG000|Overall Study|Withdrawal by Subject|4|||
162752965|NCT02438137|587808885|FG001|Overall Study|Withdrawal by Subject|3|||
162752966|NCT02438137|587808884|FG000|Overall Study|Physician Decision|0|||
162752967|NCT02438137|587808885|FG001|Overall Study|Physician Decision|1|||
162752968|NCT00692913|587808886|FG000|Overall Study|Adverse Event|8|||
162752969|NCT00692913|587808887|FG001|Overall Study|Adverse Event|4|||
162752970|NCT00692913|587808886|FG000|Overall Study|Lost to Follow-up|3|||
162752971|NCT00692913|587808887|FG001|Overall Study|Lost to Follow-up|5|||
162752972|NCT00692913|587808886|FG000|Overall Study|Physician Decision|2|||
162752973|NCT00692913|587808887|FG001|Overall Study|Physician Decision|0|||
162752974|NCT00692913|587808886|FG000|Overall Study|Protocol Violation|1|||
162752975|NCT00692913|587808887|FG001|Overall Study|Protocol Violation|1|||
162752976|NCT00692913|587808886|FG000|Overall Study|Withdrawal by Subject|15|||
162752977|NCT00692913|587808887|FG001|Overall Study|Withdrawal by Subject|20|||
162752978|NCT01637402|587808888|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
162752979|NCT01637402|587808889|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
162752980|NCT01637402|587808888|FG000|Standard Dose Regimen|Adverse Event|1|||
162752981|NCT01637402|587808889|FG001|Standard Dose Regimen|Adverse Event|0|||
162752982|NCT01637402|587808888|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
162752983|NCT01637402|587808889|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
162752984|NCT01637402|587808888|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
162752985|NCT01637402|587808889|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
162752986|NCT01637402|587808888|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
162752987|NCT01637402|587808889|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
162752988|NCT01637402|587808888|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
162752989|NCT01637402|587808889|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
162752990|NCT02111096|587808892|FG000|Overall Study|Adverse Event|4|||
162752991|NCT02111096|587808893|FG001|Overall Study|Adverse Event|1|||
162752992|NCT02111096|587808894|FG002|Overall Study|Adverse Event|2|||
162752993|NCT02111096|587808892|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162752994|NCT02111096|587808893|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162752995|NCT02111096|587808894|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162752996|NCT02111096|587808892|FG000|Overall Study|Lost to Follow Up|1|||
162752997|NCT02111096|587808893|FG001|Overall Study|Lost to Follow Up|1|||
162752998|NCT02111096|587808894|FG002|Overall Study|Lost to Follow Up|1|||
162752999|NCT02111096|587808892|FG000|Overall Study|Physician Decision|0|||
162753000|NCT02111096|587808893|FG001|Overall Study|Physician Decision|1|||
162753001|NCT02111096|587808894|FG002|Overall Study|Physician Decision|0|||
162753002|NCT02111096|587808892|FG000|Overall Study|Protocol Violation|1|||
162753003|NCT02111096|587808893|FG001|Overall Study|Protocol Violation|0|||
162753004|NCT02111096|587808894|FG002|Overall Study|Protocol Violation|1|||
162753005|NCT02111096|587808892|FG000|Overall Study|Terminated by Sponsor|53|||
162753006|NCT02111096|587808893|FG001|Overall Study|Terminated by Sponsor|35|||
162753007|NCT02111096|587808894|FG002|Overall Study|Terminated by Sponsor|54|||
162753008|NCT02111096|587808892|FG000|Overall Study|Withdrawal by Subject|4|||
162753009|NCT02111096|587808893|FG001|Overall Study|Withdrawal by Subject|2|||
162753010|NCT02111096|587808894|FG002|Overall Study|Withdrawal by Subject|8|||
162753011|NCT00439270|587808897|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
162753012|NCT00439270|587808898|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
162753013|NCT00439270|587808899|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
162753014|NCT00439270|587808900|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
162753015|NCT00439270|587808901|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
162753016|NCT00439270|587808897|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162753017|NCT00439270|587808898|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
162753018|NCT00439270|587808899|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162753019|NCT00439270|587808900|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162753020|NCT00439270|587808901|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162753021|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
162753022|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
162753023|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
162753024|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
162753025|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
162753026|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162753027|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162753028|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162753029|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
162753030|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162753031|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162753032|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162753033|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162753034|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
162753035|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162753036|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162753037|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162753038|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162753039|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
162753040|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162753041|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162753042|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162753043|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162753044|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
162753045|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162753046|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162753047|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162753048|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162753049|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
162753050|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162753051|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162753052|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162753053|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162753054|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
162753055|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162753056|NCT00439270|587808897|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162753057|NCT00439270|587808898|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162753058|NCT00439270|587808899|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162753059|NCT00439270|587808900|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
162753060|NCT00439270|587808901|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162753061|NCT01268306|587808902|FG000|Overall Study|Lost to Follow-up|1|||
162753062|NCT02466971|587808918|FG000|Overall Study|eligible and never treated|14|||
162753063|NCT02466971|587808919|FG001|Overall Study|eligible and never treated|20|||
162753064|NCT02466971|587808918|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
162753065|NCT02466971|587808919|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
162753066|NCT02466971|587808918|FG000|Overall Study|ineligible and treated|1|||
162753067|NCT02466971|587808919|FG001|Overall Study|ineligible and treated|0|||
162753068|NCT02466971|587808918|FG000|Overall Study|ineligible and never treated|0|||
162753069|NCT02466971|587808919|FG001|Overall Study|ineligible and never treated|1|||
162753070|NCT05707351|587808920|FG000|Overall Study|Withdrawal by Subject|2|||
162753071|NCT05707351|587808920|FG000|Overall Study|Reason Not Specified|1|||
162753072|NCT04121741|587808922|FG000|Overall Study|Protocol Violation|1|||
162753073|NCT04121741|587808923|FG001|Overall Study|Protocol Violation|0|||
162753074|NCT04121741|587808924|FG002|Overall Study|Protocol Violation|0|||
162753075|NCT04121741|587808925|FG003|Overall Study|Protocol Violation|0|||
162753076|NCT04121741|587808926|FG004|Overall Study|Protocol Violation|0|||
162753077|NCT04121741|587808927|FG005|Overall Study|Protocol Violation|0|||
162753078|NCT01084863|587808929|FG000|Main Study Treatment Period|Disease progression|11|||
162753079|NCT01084863|587808930|FG001|Main Study Treatment Period|Disease progression|7|||
162753080|NCT01084863|587808929|FG000|Main Study Treatment Period|Adverse Event|5|||
162753081|NCT01084863|587808930|FG001|Main Study Treatment Period|Adverse Event|3|||
162753082|NCT01084863|587808929|FG000|Main Study Treatment Period|Other Reason|0|||
162753083|NCT01084863|587808930|FG001|Main Study Treatment Period|Other Reason|1|||
162753084|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
162753085|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
162753086|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
162753087|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
162753088|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
162753089|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
162753090|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
162753091|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
162753092|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Other|0|||
162753093|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Other|1|||
162753094|NCT01084863|587808929|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
162753095|NCT01084863|587808930|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
162753096|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
162753097|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
162753098|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
162753099|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
162753100|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
162753101|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
162753102|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
162753103|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
162753104|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
162753105|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
162753106|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
162753107|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
162753108|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
162753109|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
162753110|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
162753111|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
162753112|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
162753113|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
162753114|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
162753115|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
162753116|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
162753117|NCT04505722|587808931|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
162753118|NCT04505722|587808932|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
162753119|NCT04505722|587808933|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
162753120|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
162753121|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
162753122|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
162753123|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
162753124|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
162753125|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
162753126|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
162753127|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
162753128|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
162753129|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
162753130|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
162753131|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
162753132|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
162753133|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
162753134|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
162753135|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
162753136|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
162753137|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
162753138|NCT04505722|587808931|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
162753139|NCT04505722|587808932|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
162753140|NCT04505722|587808933|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
162753141|NCT04755595|587808934|FG000|Overall Study|Lost to Follow-up|1|||
162753142|NCT04305327|587808937|FG000|Overall Study|Study early termination|2|||
162753143|NCT04305327|587808938|FG001|Overall Study|Study early termination|5|||
162753144|NCT04305327|587808939|FG002|Overall Study|Study early termination|2|||
162753145|NCT04305327|587808940|FG003|Overall Study|Study early termination|2|||
162753146|NCT04305327|587808937|FG000|Overall Study|Withdrawal by Subject|0|||
162753147|NCT04305327|587808938|FG001|Overall Study|Withdrawal by Subject|1|||
162753148|NCT04305327|587808939|FG002|Overall Study|Withdrawal by Subject|0|||
162753149|NCT04305327|587808940|FG003|Overall Study|Withdrawal by Subject|0|||
162753150|NCT04129450|587808943|FG000|Overall Study|Lost to Follow-up|20|||
162753151|NCT04129450|587808944|FG001|Overall Study|Lost to Follow-up|10|||
162753152|NCT04129450|587808943|FG000|Overall Study|Withdrawal by Subject|9|||
162753153|NCT04129450|587808944|FG001|Overall Study|Withdrawal by Subject|5|||
162753154|NCT04129450|587808943|FG000|Overall Study|Work Family Obligations|2|||
162753155|NCT04129450|587808944|FG001|Overall Study|Work Family Obligations|0|||
162753156|NCT04129450|587808943|FG000|Overall Study|Other|3|||
162753157|NCT04129450|587808944|FG001|Overall Study|Other|0|||
162753158|NCT05864209|587809963|FG000|Overall Study|Lost to Follow-up|2|||
162753159|NCT05864209|587809964|FG001|Overall Study|Lost to Follow-up|3|||
162753160|NCT04530487|587809965|FG000|Overall Study|Death|1|||
162753161|NCT04977583|587809966|FG000|Overall Study|Lost to Follow-up|8|||
162753162|NCT04977583|587809967|FG001|Overall Study|Lost to Follow-up|4|||
162753163|NCT04977583|587809968|FG002|Overall Study|Lost to Follow-up|13|||
162753164|NCT04977583|587809966|FG000|Overall Study|Withdrawal by Subject|3|||
162753165|NCT04977583|587809967|FG001|Overall Study|Withdrawal by Subject|2|||
162925351|NCT03901339|588428938|FG000|Overall Study|Informed consent withdrawn|13|||
162925352|NCT03901339|588428939|FG001|Overall Study|Informed consent withdrawn|40|||
162925353|NCT03901339|588428938|FG000|Overall Study|Sponsor request|30|||
162925354|NCT03901339|588428939|FG001|Overall Study|Sponsor request|23|||
162925355|NCT03901339|588428938|FG000|Overall Study|Reason not specified|5|||
162925356|NCT03901339|588428939|FG001|Overall Study|Reason not specified|7|||
162925357|NCT03901339|588428938|FG000|Overall Study|Lost to Follow-up|4|||
162925358|NCT03901339|588428939|FG001|Overall Study|Lost to Follow-up|7|||
162925359|NCT03901339|588428938|FG000|Overall Study|Covid19|0|||
162925360|NCT03901339|588428939|FG001|Overall Study|Covid19|2|||
162925361|NCT01988337|588428942|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
162925362|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
162925363|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
162925364|NCT00457418|588428943|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
162925365|NCT00457418|588428943|FG000|Post PK Maintenance|Adverse Event|10|||
162925366|NCT00457418|588428943|FG000|Post PK Maintenance|Progression of Disease|6|||
162925367|NCT00457418|588428943|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
162925368|NCT00457418|588428943|FG000|Post PK Maintenance|Lost to Follow-up|1|||
162925369|NCT03387735|588428946|FG000|Overall Study|Lost to Follow-up|4|||
162925370|NCT03387735|588428947|FG001|Overall Study|Lost to Follow-up|8|||
162925371|NCT03387735|588428946|FG000|Overall Study|Death|4|||
162925372|NCT03387735|588428947|FG001|Overall Study|Death|8|||
162925373|NCT03099161|588428948|FG000|Overall Study|Adverse Event|0|||
162925374|NCT03099161|588428949|FG001|Overall Study|Adverse Event|0|||
162925375|NCT03099161|588428950|FG002|Overall Study|Adverse Event|2|||
162925376|NCT03099161|588428948|FG000|Overall Study|Physician Decision|2|||
162925377|NCT03099161|588428949|FG001|Overall Study|Physician Decision|0|||
162925378|NCT03099161|588428950|FG002|Overall Study|Physician Decision|0|||
162925379|NCT03099161|588428948|FG000|Overall Study|Progressive Disease|1|||
162925380|NCT03099161|588428949|FG001|Overall Study|Progressive Disease|4|||
162925381|NCT03099161|588428950|FG002|Overall Study|Progressive Disease|1|||
162925382|NCT00110084|588428953|FG000|Overall Study|Adverse Event|9|||
162925383|NCT00110084|588428953|FG000|Overall Study|Death|1|||
162753166|NCT04977583|587809968|FG002|Overall Study|Withdrawal by Subject|1|||
162753167|NCT00146172|587809973|FG000|Overall Study|Adverse Event|0|||
162753168|NCT00146172|587809974|FG001|Overall Study|Adverse Event|0|||
162753169|NCT00146172|587809975|FG002|Overall Study|Adverse Event|1|||
162753170|NCT00146172|587809976|FG003|Overall Study|Adverse Event|1|||
162753171|NCT00146172|587809977|FG004|Overall Study|Adverse Event|0|||
162753172|NCT00146172|587809978|FG005|Overall Study|Adverse Event|2|||
162753173|NCT00146172|587809979|FG006|Overall Study|Adverse Event|3|||
162753174|NCT00146172|587809980|FG007|Overall Study|Adverse Event|10|||
162753175|NCT00146172|587809973|FG000|Overall Study|Lost to Follow-up|0|||
162753176|NCT00146172|587809974|FG001|Overall Study|Lost to Follow-up|0|||
162753177|NCT00146172|587809975|FG002|Overall Study|Lost to Follow-up|0|||
162753178|NCT00146172|587809976|FG003|Overall Study|Lost to Follow-up|0|||
162753179|NCT00146172|587809977|FG004|Overall Study|Lost to Follow-up|0|||
162753180|NCT00146172|587809978|FG005|Overall Study|Lost to Follow-up|0|||
162753181|NCT00146172|587809979|FG006|Overall Study|Lost to Follow-up|0|||
162753182|NCT00146172|587809980|FG007|Overall Study|Lost to Follow-up|1|||
162753183|NCT00146172|587809973|FG000|Overall Study|Disease Progression|2|||
162753184|NCT00146172|587809974|FG001|Overall Study|Disease Progression|4|||
162753185|NCT00146172|587809975|FG002|Overall Study|Disease Progression|2|||
162753186|NCT00146172|587809976|FG003|Overall Study|Disease Progression|5|||
162753187|NCT00146172|587809977|FG004|Overall Study|Disease Progression|2|||
162753188|NCT00146172|587809978|FG005|Overall Study|Disease Progression|2|||
162753189|NCT00146172|587809979|FG006|Overall Study|Disease Progression|1|||
162753190|NCT00146172|587809980|FG007|Overall Study|Disease Progression|22|||
162753191|NCT00146172|587809973|FG000|Overall Study|Death|0|||
162753192|NCT00146172|587809974|FG001|Overall Study|Death|0|||
162753193|NCT00146172|587809975|FG002|Overall Study|Death|0|||
162753194|NCT00146172|587809976|FG003|Overall Study|Death|0|||
162753195|NCT00146172|587809977|FG004|Overall Study|Death|0|||
162753196|NCT00146172|587809978|FG005|Overall Study|Death|0|||
162753197|NCT00146172|587809979|FG006|Overall Study|Death|1|||
162753198|NCT00146172|587809980|FG007|Overall Study|Death|0|||
162753199|NCT00146172|587809973|FG000|Overall Study|Physician Decision|0|||
162753200|NCT00146172|587809974|FG001|Overall Study|Physician Decision|0|||
162753201|NCT00146172|587809975|FG002|Overall Study|Physician Decision|0|||
162753202|NCT00146172|587809976|FG003|Overall Study|Physician Decision|0|||
162753203|NCT00146172|587809977|FG004|Overall Study|Physician Decision|0|||
162753204|NCT00146172|587809978|FG005|Overall Study|Physician Decision|0|||
162753205|NCT00146172|587809979|FG006|Overall Study|Physician Decision|0|||
162753206|NCT00146172|587809980|FG007|Overall Study|Physician Decision|1|||
162753207|NCT00146172|587809973|FG000|Overall Study|Withdrawal by Subject|0|||
162753208|NCT00146172|587809974|FG001|Overall Study|Withdrawal by Subject|0|||
162753209|NCT00146172|587809975|FG002|Overall Study|Withdrawal by Subject|0|||
162753210|NCT00146172|587809976|FG003|Overall Study|Withdrawal by Subject|0|||
162753211|NCT00146172|587809977|FG004|Overall Study|Withdrawal by Subject|0|||
162753212|NCT00146172|587809978|FG005|Overall Study|Withdrawal by Subject|1|||
162753213|NCT00146172|587809979|FG006|Overall Study|Withdrawal by Subject|1|||
162753214|NCT00146172|587809980|FG007|Overall Study|Withdrawal by Subject|4|||
162753215|NCT00146172|587809973|FG000|Overall Study|Symptomatic Deterioration|1|||
162753216|NCT00146172|587809974|FG001|Overall Study|Symptomatic Deterioration|0|||
162753217|NCT00146172|587809975|FG002|Overall Study|Symptomatic Deterioration|1|||
162753218|NCT00146172|587809976|FG003|Overall Study|Symptomatic Deterioration|0|||
162753219|NCT00146172|587809977|FG004|Overall Study|Symptomatic Deterioration|1|||
162753220|NCT00146172|587809978|FG005|Overall Study|Symptomatic Deterioration|2|||
162753221|NCT00146172|587809979|FG006|Overall Study|Symptomatic Deterioration|0|||
162753222|NCT00146172|587809980|FG007|Overall Study|Symptomatic Deterioration|2|||
162753223|NCT00210106|587809981|FG000|Overall Study|Death|1|||
162753224|NCT00210106|587809981|FG000|Overall Study|Protocol Violation|13|||
162753225|NCT00786864|587809982|FG000|Overall Study|Lost to Follow-up|0|||
162753226|NCT00786864|587809983|FG001|Overall Study|Lost to Follow-up|1|||
162753227|NCT00786864|587809982|FG000|Overall Study|Sustained serious back injury|1|||
162753228|NCT00786864|587809983|FG001|Overall Study|Sustained serious back injury|0|||
162753229|NCT02422615|587809984|FG000|Treatment Period|Progressive disease|314|||
162753230|NCT02422615|587809985|FG001|Treatment Period|Progressive disease|200|||
162753231|NCT02422615|587809984|FG000|Treatment Period|Adverse Event|51|||
162753232|NCT02422615|587809985|FG001|Treatment Period|Adverse Event|9|||
162753233|NCT02422615|587809984|FG000|Treatment Period|Physician Decision|32|||
162753234|NCT02422615|587809985|FG001|Treatment Period|Physician Decision|8|||
162753235|NCT02422615|587809984|FG000|Treatment Period|Subject/guardian decision|38|||
162753236|NCT02422615|587809985|FG001|Treatment Period|Subject/guardian decision|8|||
162753237|NCT02422615|587809984|FG000|Treatment Period|Death|2|||
162753238|NCT02422615|587809985|FG001|Treatment Period|Death|1|||
162753239|NCT02422615|587809984|FG000|Treatment Period|Technical problems|0|||
162753240|NCT02422615|587809985|FG001|Treatment Period|Technical problems|1|||
162753241|NCT02422615|587809984|FG000|Treatment Period|Protocol deviation|1|||
162753242|NCT02422615|587809985|FG001|Treatment Period|Protocol deviation|1|||
162753243|NCT02422615|587809984|FG000|Treatment Period|Study terminated as per protocol|46|||
162753244|NCT02422615|587809985|FG001|Treatment Period|Study terminated as per protocol|14|||
162753245|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162753246|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162753247|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Death|2|||
162753248|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Death|1|||
162753249|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162753250|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162753251|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
162753252|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
162753253|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
162753254|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
162753255|NCT02422615|587809984|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
162753256|NCT02422615|587809985|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
162753257|NCT01288443|587809986|FG000|Overall Study|Adverse Event|0|||
162753258|NCT01288443|587809987|FG001|Overall Study|Adverse Event|0|||
162753259|NCT01288443|587809988|FG002|Overall Study|Adverse Event|1|||
162753260|NCT01288443|587809989|FG003|Overall Study|Adverse Event|1|||
162753261|NCT01288443|587809990|FG004|Overall Study|Adverse Event|3|||
162753262|NCT01288443|587809991|FG005|Overall Study|Adverse Event|1|||
162753263|NCT01288443|587809986|FG000|Overall Study|Poor compliance to protocol|0|||
162753264|NCT01288443|587809987|FG001|Overall Study|Poor compliance to protocol|0|||
162753265|NCT01288443|587809988|FG002|Overall Study|Poor compliance to protocol|0|||
162753266|NCT01288443|587809989|FG003|Overall Study|Poor compliance to protocol|0|||
162753267|NCT01288443|587809990|FG004|Overall Study|Poor compliance to protocol|0|||
162753268|NCT01288443|587809991|FG005|Overall Study|Poor compliance to protocol|1|||
162753269|NCT01288443|587809986|FG000|Overall Study|Participant Moved|0|||
162753270|NCT01288443|587809987|FG001|Overall Study|Participant Moved|0|||
162753271|NCT01288443|587809988|FG002|Overall Study|Participant Moved|0|||
162753272|NCT01288443|587809989|FG003|Overall Study|Participant Moved|1|||
162753273|NCT01288443|587809990|FG004|Overall Study|Participant Moved|2|||
162753274|NCT01288443|587809991|FG005|Overall Study|Participant Moved|1|||
162753275|NCT01288443|587809986|FG000|Overall Study|Consent withdrawn by Participant|0|||
162753276|NCT01288443|587809987|FG001|Overall Study|Consent withdrawn by Participant|0|||
162753277|NCT01288443|587809988|FG002|Overall Study|Consent withdrawn by Participant|0|||
162753278|NCT01288443|587809989|FG003|Overall Study|Consent withdrawn by Participant|0|||
162753279|NCT01288443|587809990|FG004|Overall Study|Consent withdrawn by Participant|0|||
162753280|NCT01288443|587809991|FG005|Overall Study|Consent withdrawn by Participant|1|||
162753281|NCT01288443|587809986|FG000|Overall Study|Lost to Follow-up|0|||
162753282|NCT01288443|587809987|FG001|Overall Study|Lost to Follow-up|1|||
162753283|NCT01288443|587809988|FG002|Overall Study|Lost to Follow-up|0|||
162753284|NCT01288443|587809989|FG003|Overall Study|Lost to Follow-up|0|||
162753285|NCT01288443|587809990|FG004|Overall Study|Lost to Follow-up|0|||
162753286|NCT01288443|587809991|FG005|Overall Study|Lost to Follow-up|0|||
162753287|NCT01288443|587809986|FG000|Overall Study|Study drug auto-injector administration|0|||
162753288|NCT01288443|587809987|FG001|Overall Study|Study drug auto-injector administration|0|||
162753289|NCT01288443|587809988|FG002|Overall Study|Study drug auto-injector administration|0|||
162753290|NCT01288443|587809989|FG003|Overall Study|Study drug auto-injector administration|0|||
162753291|NCT01288443|587809990|FG004|Overall Study|Study drug auto-injector administration|1|||
162753292|NCT01288443|587809991|FG005|Overall Study|Study drug auto-injector administration|1|||
162753293|NCT01288443|587809986|FG000|Overall Study|Other than above|0|||
162753294|NCT01288443|587809987|FG001|Overall Study|Other than above|0|||
162753295|NCT01288443|587809988|FG002|Overall Study|Other than above|0|||
162753296|NCT01288443|587809989|FG003|Overall Study|Other than above|2|||
162753297|NCT01288443|587809990|FG004|Overall Study|Other than above|1|||
162753298|NCT01288443|587809991|FG005|Overall Study|Other than above|0|||
162753299|NCT02291913|587809993|FG000|Overall Study|Progressive Disease|32|||
162753300|NCT02291913|587809993|FG000|Overall Study|Adverse Event|11|||
162753301|NCT02291913|587809993|FG000|Overall Study|Death|2|||
162753302|NCT02291913|587809993|FG000|Overall Study|Physician Decision|1|||
162753303|NCT02291913|587809993|FG000|Overall Study|Withdrawal by Subject|1|||
162753304|NCT02291913|587809993|FG000|Overall Study|Protocol Violation|1|||
162753305|NCT04876417|587809994|FG000|Overall Study|Lost to Follow-up|5|||
162753306|NCT04876417|587809995|FG001|Overall Study|Lost to Follow-up|8|||
162753307|NCT04876417|587809996|FG002|Overall Study|Lost to Follow-up|0|||
162753308|NCT04876417|587809997|FG003|Overall Study|Lost to Follow-up|0|||
162753309|NCT04334317|587809998|FG000|Overall Study|Adverse Event|1|||
162753310|NCT04334317|587809999|FG001|Overall Study|Adverse Event|2|||
162753311|NCT04334317|587810000|FG002|Overall Study|Adverse Event|0|||
162753312|NCT04334317|587810001|FG003|Overall Study|Adverse Event|0|||
162753313|NCT04334317|587809998|FG000|Overall Study|Protocol Deviation|0|||
162753314|NCT04334317|587809999|FG001|Overall Study|Protocol Deviation|1|||
162925384|NCT00110084|588428953|FG000|Overall Study|Patient Refusal|10|||
162753315|NCT04334317|587810000|FG002|Overall Study|Protocol Deviation|0|||
162753316|NCT04334317|587810001|FG003|Overall Study|Protocol Deviation|0|||
162753317|NCT04334317|587809998|FG000|Overall Study|Withdrawal by Subject|2|||
162753318|NCT04334317|587809999|FG001|Overall Study|Withdrawal by Subject|2|||
162753319|NCT04334317|587810000|FG002|Overall Study|Withdrawal by Subject|0|||
162753320|NCT04334317|587810001|FG003|Overall Study|Withdrawal by Subject|0|||
162753321|NCT03621735|587810002|FG000|Overall Study|Withdrawal by Subject|13|||
162753322|NCT03621735|587810003|FG001|Overall Study|Withdrawal by Subject|13|||
162753323|NCT00605306|587810006|FG000|Overall Study|Adverse Event|0|||
162753324|NCT00605306|587810007|FG001|Overall Study|Adverse Event|1|||
162753325|NCT03875313|587810010|FG000|Overall Study|Withdrawal by Subject|1|||
162753326|NCT03875313|587810011|FG001|Overall Study|Withdrawal by Subject|3|||
162753327|NCT03875313|587810012|FG002|Overall Study|Withdrawal by Subject|0|||
162753328|NCT03875313|587810013|FG003|Overall Study|Withdrawal by Subject|0|||
162753329|NCT03875313|587810014|FG004|Overall Study|Withdrawal by Subject|0|||
162753330|NCT03875313|587810010|FG000|Overall Study|Death|0|||
162753331|NCT03875313|587810011|FG001|Overall Study|Death|0|||
162753332|NCT03875313|587810012|FG002|Overall Study|Death|0|||
162753333|NCT03875313|587810013|FG003|Overall Study|Death|0|||
162753334|NCT03875313|587810014|FG004|Overall Study|Death|1|||
162753335|NCT03875313|587810010|FG000|Overall Study|Lost to Follow-up|0|||
162753336|NCT03875313|587810011|FG001|Overall Study|Lost to Follow-up|0|||
162753337|NCT03875313|587810012|FG002|Overall Study|Lost to Follow-up|0|||
162753338|NCT03875313|587810013|FG003|Overall Study|Lost to Follow-up|0|||
162753339|NCT03875313|587810014|FG004|Overall Study|Lost to Follow-up|1|||
162753340|NCT03875313|587810010|FG000|Overall Study|Study Termination by Sponsor|0|||
162753341|NCT03875313|587810011|FG001|Overall Study|Study Termination by Sponsor|1|||
162753342|NCT03875313|587810012|FG002|Overall Study|Study Termination by Sponsor|1|||
162753343|NCT03875313|587810013|FG003|Overall Study|Study Termination by Sponsor|0|||
162753344|NCT03875313|587810014|FG004|Overall Study|Study Termination by Sponsor|1|||
162753345|NCT03875313|587810010|FG000|Overall Study|New Anticancer Treatment|0|||
162753346|NCT03875313|587810011|FG001|Overall Study|New Anticancer Treatment|1|||
162753347|NCT03875313|587810012|FG002|Overall Study|New Anticancer Treatment|2|||
162753348|NCT03875313|587810013|FG003|Overall Study|New Anticancer Treatment|1|||
162753349|NCT03875313|587810014|FG004|Overall Study|New Anticancer Treatment|0|||
162753350|NCT03875313|587810010|FG000|Overall Study|Other, Not Specified|2|||
162753351|NCT03875313|587810011|FG001|Overall Study|Other, Not Specified|11|||
162753352|NCT03875313|587810012|FG002|Overall Study|Other, Not Specified|3|||
162753353|NCT03875313|587810013|FG003|Overall Study|Other, Not Specified|3|||
162753354|NCT03875313|587810014|FG004|Overall Study|Other, Not Specified|1|||
162753355|NCT01092416|587810015|FG000|Enrollment|Atherectomy device not inserted|3|||
162753356|NCT01092416|587810015|FG000|30-Day Follow-up|Death|2|||
162753357|NCT01092416|587810015|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
162753358|NCT01092416|587810015|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
162753359|NCT01092416|587810015|FG000|12-Month Follow-up|Death|16|||
162753360|NCT01092416|587810015|FG000|12-Month Follow-up|Lost to Follow-up|4|||
162753361|NCT01092416|587810015|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
162753362|NCT01092416|587810015|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
162753363|NCT01092416|587810015|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
162753364|NCT03709706|587810016|FG000|Overall Study|Adverse Event|0|||
162753365|NCT03709706|587810017|FG001|Overall Study|Adverse Event|1|||
162753366|NCT03709706|587810016|FG000|Overall Study|Physician Decision|14|||
162753367|NCT03709706|587810017|FG001|Overall Study|Physician Decision|8|||
162753368|NCT03709706|587810016|FG000|Overall Study|Withdrawal by Subject|2|||
162753369|NCT03709706|587810017|FG001|Overall Study|Withdrawal by Subject|1|||
162753370|NCT03709706|587810016|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
162753371|NCT03709706|587810017|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
162753372|NCT01105975|587810018|FG000|Overall Study|Adverse Event|2|||
162753373|NCT01105975|587810019|FG001|Overall Study|Adverse Event|1|||
162753374|NCT01105975|587810020|FG002|Overall Study|Adverse Event|5|||
162753375|NCT01105975|587810021|FG003|Overall Study|Adverse Event|1|||
162753376|NCT01105975|587810022|FG004|Overall Study|Adverse Event|0|||
162753377|NCT01105975|587810023|FG005|Overall Study|Adverse Event|1|||
162753378|NCT01105975|587810024|FG006|Overall Study|Adverse Event|2|||
162753379|NCT01105975|587810025|FG007|Overall Study|Adverse Event|4|||
162753380|NCT01105975|587810026|FG008|Overall Study|Adverse Event|1|||
162753381|NCT01105975|587810027|FG009|Overall Study|Adverse Event|4|||
162753382|NCT01105975|587810018|FG000|Overall Study|Withdrawal by Subject|2|||
162753383|NCT01105975|587810019|FG001|Overall Study|Withdrawal by Subject|2|||
162753384|NCT01105975|587810020|FG002|Overall Study|Withdrawal by Subject|2|||
162753385|NCT01105975|587810021|FG003|Overall Study|Withdrawal by Subject|0|||
162753386|NCT01105975|587810022|FG004|Overall Study|Withdrawal by Subject|4|||
162753387|NCT01105975|587810023|FG005|Overall Study|Withdrawal by Subject|1|||
162753388|NCT01105975|587810024|FG006|Overall Study|Withdrawal by Subject|2|||
162753389|NCT01105975|587810025|FG007|Overall Study|Withdrawal by Subject|1|||
162753390|NCT01105975|587810026|FG008|Overall Study|Withdrawal by Subject|0|||
162753391|NCT01105975|587810027|FG009|Overall Study|Withdrawal by Subject|3|||
162753392|NCT01105975|587810018|FG000|Overall Study|Lost to Follow-up|1|||
162753393|NCT01105975|587810019|FG001|Overall Study|Lost to Follow-up|0|||
162753394|NCT01105975|587810020|FG002|Overall Study|Lost to Follow-up|0|||
162753395|NCT01105975|587810021|FG003|Overall Study|Lost to Follow-up|1|||
162753396|NCT01105975|587810022|FG004|Overall Study|Lost to Follow-up|1|||
162753397|NCT01105975|587810023|FG005|Overall Study|Lost to Follow-up|0|||
162753398|NCT01105975|587810024|FG006|Overall Study|Lost to Follow-up|0|||
162753399|NCT01105975|587810025|FG007|Overall Study|Lost to Follow-up|0|||
162753400|NCT01105975|587810026|FG008|Overall Study|Lost to Follow-up|1|||
162753401|NCT01105975|587810027|FG009|Overall Study|Lost to Follow-up|0|||
162753402|NCT01105975|587810018|FG000|Overall Study|Physician Decision|0|||
162753403|NCT01105975|587810019|FG001|Overall Study|Physician Decision|0|||
162753404|NCT01105975|587810020|FG002|Overall Study|Physician Decision|0|||
162753405|NCT01105975|587810021|FG003|Overall Study|Physician Decision|0|||
162753406|NCT01105975|587810022|FG004|Overall Study|Physician Decision|0|||
162753407|NCT01105975|587810023|FG005|Overall Study|Physician Decision|0|||
162753408|NCT01105975|587810024|FG006|Overall Study|Physician Decision|2|||
162753409|NCT01105975|587810025|FG007|Overall Study|Physician Decision|0|||
162753410|NCT01105975|587810026|FG008|Overall Study|Physician Decision|0|||
162753411|NCT01105975|587810027|FG009|Overall Study|Physician Decision|0|||
162753412|NCT01105975|587810018|FG000|Overall Study|Protocol Violation|0|||
162753413|NCT01105975|587810019|FG001|Overall Study|Protocol Violation|2|||
162753414|NCT01105975|587810020|FG002|Overall Study|Protocol Violation|2|||
162753415|NCT01105975|587810021|FG003|Overall Study|Protocol Violation|0|||
162753416|NCT01105975|587810022|FG004|Overall Study|Protocol Violation|1|||
162753417|NCT01105975|587810023|FG005|Overall Study|Protocol Violation|1|||
162753418|NCT01105975|587810024|FG006|Overall Study|Protocol Violation|1|||
162753419|NCT01105975|587810025|FG007|Overall Study|Protocol Violation|1|||
162753420|NCT01105975|587810026|FG008|Overall Study|Protocol Violation|2|||
162753421|NCT01105975|587810027|FG009|Overall Study|Protocol Violation|2|||
162753422|NCT01105975|587810018|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162753423|NCT01105975|587810019|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162753424|NCT01105975|587810020|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162753425|NCT01105975|587810021|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162753426|NCT01105975|587810022|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162753427|NCT01105975|587810023|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
162753428|NCT01105975|587810024|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162753429|NCT01105975|587810025|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162753430|NCT01105975|587810026|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
162753431|NCT01105975|587810027|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162753432|NCT04868617|587810028|FG000|Overall Study|Death|1|||
162753433|NCT04868617|587810029|FG001|Overall Study|Death|0|||
162753434|NCT04868617|587810028|FG000|Overall Study|Adverse Event|1|||
162753435|NCT04868617|587810029|FG001|Overall Study|Adverse Event|0|||
162753436|NCT04868617|587810028|FG000|Overall Study|Withdrawal by Subject|1|||
162753437|NCT04868617|587810029|FG001|Overall Study|Withdrawal by Subject|0|||
162753438|NCT04868617|587810028|FG000|Overall Study|Device deficiency|1|||
162753439|NCT04868617|587810029|FG001|Overall Study|Device deficiency|0|||
162753440|NCT00686595|587810030|FG000|Overall Study|Adverse Event|3|||
162753441|NCT00686595|587810030|FG000|Overall Study|Protocol Violation|1|||
162753442|NCT00686595|587810030|FG000|Overall Study|Lost to Follow-up|1|||
162753443|NCT00686595|587810030|FG000|Overall Study|Lack of Efficacy|1|||
162753444|NCT00686595|587810030|FG000|Overall Study|Poor Compliance|1|||
162753445|NCT03248492|587810031|FG000|Overall Study|Progressive Disease|24|||
162753446|NCT03248492|587810032|FG001|Overall Study|Progressive Disease|23|||
162753447|NCT03248492|587810033|FG002|Overall Study|Progressive Disease|11|||
162753448|NCT03248492|587810034|FG003|Overall Study|Progressive Disease|66|||
162753449|NCT03248492|587810035|FG004|Overall Study|Progressive Disease|1|||
162753450|NCT03248492|587810031|FG000|Overall Study|Adverse Event|14|||
162753451|NCT03248492|587810032|FG001|Overall Study|Adverse Event|13|||
162753452|NCT03248492|587810033|FG002|Overall Study|Adverse Event|9|||
162753453|NCT03248492|587810034|FG003|Overall Study|Adverse Event|22|||
162753454|NCT03248492|587810035|FG004|Overall Study|Adverse Event|2|||
162753455|NCT03248492|587810031|FG000|Overall Study|Withdrawal by Subject|5|||
162753456|NCT03248492|587810032|FG001|Overall Study|Withdrawal by Subject|4|||
162753457|NCT03248492|587810033|FG002|Overall Study|Withdrawal by Subject|0|||
162753458|NCT03248492|587810034|FG003|Overall Study|Withdrawal by Subject|8|||
162753459|NCT03248492|587810035|FG004|Overall Study|Withdrawal by Subject|1|||
162753460|NCT03248492|587810031|FG000|Overall Study|Physician Decision|1|||
162753461|NCT03248492|587810032|FG001|Overall Study|Physician Decision|1|||
162753462|NCT03248492|587810033|FG002|Overall Study|Physician Decision|1|||
162753463|NCT03248492|587810034|FG003|Overall Study|Physician Decision|7|||
162753464|NCT03248492|587810035|FG004|Overall Study|Physician Decision|0|||
162753465|NCT03248492|587810031|FG000|Overall Study|Death|1|||
162753466|NCT03248492|587810032|FG001|Overall Study|Death|1|||
162753467|NCT03248492|587810033|FG002|Overall Study|Death|0|||
162753468|NCT03248492|587810034|FG003|Overall Study|Death|6|||
162753469|NCT03248492|587810035|FG004|Overall Study|Death|0|||
162753470|NCT03248492|587810031|FG000|Overall Study|Study Terminated by Sponsor|3|||
162753471|NCT03248492|587810032|FG001|Overall Study|Study Terminated by Sponsor|1|||
162753472|NCT03248492|587810033|FG002|Overall Study|Study Terminated by Sponsor|0|||
162753473|NCT03248492|587810034|FG003|Overall Study|Study Terminated by Sponsor|7|||
162753474|NCT03248492|587810035|FG004|Overall Study|Study Terminated by Sponsor|0|||
162753475|NCT03248492|587810031|FG000|Overall Study|Other|2|||
162753476|NCT03248492|587810032|FG001|Overall Study|Other|5|||
162753477|NCT03248492|587810033|FG002|Overall Study|Other|0|||
162753478|NCT03248492|587810034|FG003|Overall Study|Other|14|||
162753479|NCT03248492|587810035|FG004|Overall Study|Other|0|||
162753480|NCT04495621|587810036|FG000|Overall Study|Withdrawal by Subject|0|||
162753481|NCT04495621|587810037|FG001|Overall Study|Withdrawal by Subject|3|||
162753482|NCT04495621|587810036|FG000|Overall Study|Death|7|||
162753483|NCT04495621|587810037|FG001|Overall Study|Death|11|||
162753484|NCT04495621|587810036|FG000|Overall Study|Investigator Decision|0|||
162753485|NCT04495621|587810037|FG001|Overall Study|Investigator Decision|7|||
162753486|NCT04495621|587810036|FG000|Overall Study|Lost to Follow-up|0|||
162753487|NCT04495621|587810037|FG001|Overall Study|Lost to Follow-up|1|||
162753488|NCT03774472|587810038|FG000|Overall Study|Physician Decision|1|||
162753489|NCT03774472|587810039|FG001|Overall Study|Physician Decision|0|||
162753490|NCT03774472|587810040|FG002|Overall Study|Physician Decision|0|||
162753491|NCT03774472|587810038|FG000|Overall Study|Progression prior to 4 weeks|0|||
162753492|NCT03774472|587810039|FG001|Overall Study|Progression prior to 4 weeks|1|||
162753493|NCT03774472|587810040|FG002|Overall Study|Progression prior to 4 weeks|0|||
162753494|NCT03774472|587810038|FG000|Overall Study|Withdrawal by Subject|0|||
162753495|NCT03774472|587810039|FG001|Overall Study|Withdrawal by Subject|1|||
162753496|NCT03774472|587810040|FG002|Overall Study|Withdrawal by Subject|0|||
162753497|NCT04059406|587810041|FG000|Overall Study|Early Treatment Termination|5|||
162753498|NCT04059406|587810042|FG001|Overall Study|Early Treatment Termination|5|||
162753499|NCT04059406|587810043|FG002|Overall Study|Early Treatment Termination|15|||
162753500|NCT05155306|587810048|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
162753501|NCT05155306|587810049|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
162753502|NCT05155306|587810050|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
162753503|NCT05155306|587810051|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
162753504|NCT05155306|587810048|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
162753505|NCT05155306|587810049|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
162753506|NCT05155306|587810050|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
162753507|NCT05155306|587810051|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
162753508|NCT04158141|587810052|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
162753509|NCT04158141|587810053|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
162753510|NCT04158141|587810054|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
162753511|NCT04158141|587810052|FG000|Step 1: Registration|Adverse Event|1|||
162753512|NCT04158141|587810053|FG001|Step 1: Registration|Adverse Event|0|||
162753513|NCT04158141|587810054|FG002|Step 1: Registration|Adverse Event|0|||
162753514|NCT04158141|587810052|FG000|Step 1: Registration|Withdrawal by Subject|1|||
162753515|NCT04158141|587810053|FG001|Step 1: Registration|Withdrawal by Subject|0|||
162753516|NCT04158141|587810054|FG002|Step 1: Registration|Withdrawal by Subject|0|||
162753517|NCT04158141|587810052|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
162753518|NCT04158141|587810053|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
162753519|NCT04158141|587810054|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
162753520|NCT03473223|587810058|FG000|Overall Study|Lost to Follow-up|1|||
162753521|NCT03473223|587810059|FG001|Overall Study|Lost to Follow-up|1|||
162753522|NCT03473223|587810058|FG000|Overall Study|Withdrawal by Subject|47|||
162753523|NCT03473223|587810059|FG001|Overall Study|Withdrawal by Subject|42|||
162753524|NCT03473223|587810058|FG000|Overall Study|Indirect contact|32|||
162753525|NCT03473223|587810059|FG001|Overall Study|Indirect contact|29|||
162753526|NCT03473223|587810058|FG000|Overall Study|Other (Not specified)|32|||
162753527|NCT03473223|587810059|FG001|Overall Study|Other (Not specified)|20|||
162753528|NCT00319696|587810060|FG000|Overall Study|Adverse Event|36|||
162753529|NCT00319696|587810060|FG000|Overall Study|withdrawal of consent|14|||
162753530|NCT00319696|587810060|FG000|Overall Study|administrative|7|||
162753531|NCT00319696|587810060|FG000|Overall Study|Lost to Follow-up|3|||
162753532|NCT03777657|587810062|FG000|Overall Study|Death|397|||
162753533|NCT03777657|587810063|FG001|Overall Study|Death|431|||
162753534|NCT03777657|587810062|FG000|Overall Study|Study Closed by Sponsor|77|||
162753535|NCT03777657|587810063|FG001|Overall Study|Study Closed by Sponsor|38|||
162753536|NCT03777657|587810062|FG000|Overall Study|Withdrawal by Subject|20|||
162753537|NCT03777657|587810063|FG001|Overall Study|Withdrawal by Subject|17|||
162753538|NCT03777657|587810062|FG000|Overall Study|Lost to Follow-up|6|||
162753539|NCT03777657|587810063|FG001|Overall Study|Lost to Follow-up|10|||
162753540|NCT02549352|587810066|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162753541|NCT02549352|587810067|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162753542|NCT02549352|587810066|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
162753543|NCT02549352|587810067|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
162753544|NCT02549352|587810066|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
162753545|NCT02549352|587810067|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
162753546|NCT02549352|587810066|FG000|12-month Follow-up|Withdrawal by Subject|4|||
162753547|NCT02549352|587810067|FG001|12-month Follow-up|Withdrawal by Subject|5|||
162753548|NCT02549352|587810066|FG000|12-month Follow-up|Lost to Follow-up|3|||
162753549|NCT02549352|587810067|FG001|12-month Follow-up|Lost to Follow-up|2|||
162753550|NCT02549352|587810066|FG000|12-month Follow-up|Death|0|||
162753551|NCT02549352|587810067|FG001|12-month Follow-up|Death|1|||
162753552|NCT02549352|587810066|FG000|12-month Follow-up|Protocol Violation|0|||
162753553|NCT02549352|587810067|FG001|12-month Follow-up|Protocol Violation|1|||
162753554|NCT02549352|587810066|FG000|12-month Follow-up|Other|1|||
162753555|NCT02549352|587810067|FG001|12-month Follow-up|Other|3|||
162753556|NCT04559698|587810559|FG000|Overall Study|Lost to Follow-up|14|||
162753557|NCT04559698|587810560|FG001|Overall Study|Lost to Follow-up|15|||
162753558|NCT04559698|587810559|FG000|Overall Study|Withdrawal by Subject|0|||
162753559|NCT04559698|587810560|FG001|Overall Study|Withdrawal by Subject|1|||
162753560|NCT01982682|587810561|FG000|Overall Study|Physician Decision|1|||
162753561|NCT02760654|587810562|FG000|Overall Study|Lost to Follow-up|3|||
162753562|NCT02760654|587810563|FG001|Overall Study|Lost to Follow-up|3|||
162753563|NCT02760654|587810562|FG000|Overall Study|Withdrawal by Subject|4|||
162753564|NCT02760654|587810563|FG001|Overall Study|Withdrawal by Subject|3|||
162753565|NCT01574716|587810564|FG000|Part 1|Death|3|||
162753566|NCT01574716|587810565|FG001|Part 1|Death|1|||
162753567|NCT01574716|587810566|FG002|Part 1|Death|8|||
162753568|NCT01574716|587810567|FG003|Part 1|Death|0|||
162753569|NCT01574716|587810568|FG004|Part 1|Death|0|||
162753570|NCT01574716|587810564|FG000|Part 1|Discontinuation of study by sponsor|0|||
162753571|NCT01574716|587810565|FG001|Part 1|Discontinuation of study by sponsor|0|||
162753572|NCT01574716|587810566|FG002|Part 1|Discontinuation of study by sponsor|1|||
162753573|NCT01574716|587810567|FG003|Part 1|Discontinuation of study by sponsor|0|||
162753574|NCT01574716|587810568|FG004|Part 1|Discontinuation of study by sponsor|0|||
162753575|NCT01574716|587810564|FG000|Part 1|Withdrawal by Subject|0|||
162753576|NCT01574716|587810565|FG001|Part 1|Withdrawal by Subject|2|||
162753577|NCT01574716|587810566|FG002|Part 1|Withdrawal by Subject|0|||
162753578|NCT01574716|587810567|FG003|Part 1|Withdrawal by Subject|0|||
162753579|NCT01574716|587810568|FG004|Part 1|Withdrawal by Subject|0|||
162753580|NCT01574716|587810564|FG000|Part 1|Lost to Follow-up|0|||
162753581|NCT01574716|587810565|FG001|Part 1|Lost to Follow-up|1|||
162753582|NCT01574716|587810566|FG002|Part 1|Lost to Follow-up|0|||
162753583|NCT01574716|587810567|FG003|Part 1|Lost to Follow-up|0|||
162753584|NCT01574716|587810568|FG004|Part 1|Lost to Follow-up|0|||
162753585|NCT01574716|587810564|FG000|Part 2|Progressive disease|0|||
162753586|NCT01574716|587810565|FG001|Part 2|Progressive disease|0|||
162753587|NCT01574716|587810566|FG002|Part 2|Progressive disease|0|||
162753588|NCT01574716|587810567|FG003|Part 2|Progressive disease|1|||
162753589|NCT01574716|587810568|FG004|Part 2|Progressive disease|0|||
162753590|NCT01574716|587810564|FG000|Part 2|Death|0|||
162753591|NCT01574716|587810565|FG001|Part 2|Death|0|||
162753592|NCT01574716|587810566|FG002|Part 2|Death|0|||
162753593|NCT01574716|587810567|FG003|Part 2|Death|76|||
162753594|NCT01574716|587810568|FG004|Part 2|Death|35|||
162753595|NCT01574716|587810564|FG000|Part 2|Discontinuation of study by sponsor|0|||
162753596|NCT01574716|587810565|FG001|Part 2|Discontinuation of study by sponsor|0|||
162753597|NCT01574716|587810566|FG002|Part 2|Discontinuation of study by sponsor|0|||
162753598|NCT01574716|587810567|FG003|Part 2|Discontinuation of study by sponsor|51|||
162753599|NCT01574716|587810568|FG004|Part 2|Discontinuation of study by sponsor|31|||
162753600|NCT01574716|587810564|FG000|Part 2|Withdrawal by Subject|0|||
162753601|NCT01574716|587810565|FG001|Part 2|Withdrawal by Subject|0|||
162753602|NCT01574716|587810566|FG002|Part 2|Withdrawal by Subject|0|||
162753603|NCT01574716|587810567|FG003|Part 2|Withdrawal by Subject|5|||
162753604|NCT01574716|587810568|FG004|Part 2|Withdrawal by Subject|4|||
162753605|NCT01574716|587810564|FG000|Part 2|Brain metastases|0|||
162753606|NCT01574716|587810565|FG001|Part 2|Brain metastases|0|||
162753607|NCT01574716|587810566|FG002|Part 2|Brain metastases|0|||
162753608|NCT01574716|587810567|FG003|Part 2|Brain metastases|1|||
162753609|NCT01574716|587810568|FG004|Part 2|Brain metastases|0|||
162753610|NCT01574716|587810564|FG000|Part 2|Lost to Follow-up|0|||
162753611|NCT01574716|587810565|FG001|Part 2|Lost to Follow-up|0|||
162753612|NCT01574716|587810566|FG002|Part 2|Lost to Follow-up|0|||
162753613|NCT01574716|587810567|FG003|Part 2|Lost to Follow-up|3|||
162753614|NCT01574716|587810568|FG004|Part 2|Lost to Follow-up|0|||
162753615|NCT03183050|587810570|FG000|Overall Study|Lost to Follow-up|23|||
162753616|NCT02797132|587810574|FG000|Part A (15 Days)|Adverse Event|1|||
162753617|NCT02797132|587810574|FG000|Part B (24 Weeks)|Adverse Event|3|||
162753618|NCT02502526|587810575|FG000|Overall Study|Lost to Follow-up|2|||
162753619|NCT02502526|587810576|FG001|Overall Study|Lost to Follow-up|2|||
162753620|NCT02502526|587810577|FG002|Overall Study|Lost to Follow-up|3|||
162753621|NCT02502526|587810575|FG000|Overall Study|Withdrawal by Subject|0|||
162753622|NCT02502526|587810576|FG001|Overall Study|Withdrawal by Subject|1|||
162753623|NCT02502526|587810577|FG002|Overall Study|Withdrawal by Subject|1|||
162753624|NCT02502526|587810575|FG000|Overall Study|Disqualified due to cataract grading|0|||
162753625|NCT02502526|587810576|FG001|Overall Study|Disqualified due to cataract grading|0|||
162753626|NCT02502526|587810577|FG002|Overall Study|Disqualified due to cataract grading|1|||
162753627|NCT02502526|587810575|FG000|Overall Study|Enrollment suspension|4|||
162753628|NCT02502526|587810576|FG001|Overall Study|Enrollment suspension|1|||
162753629|NCT02502526|587810577|FG002|Overall Study|Enrollment suspension|1|||
162753630|NCT02964741|587810578|FG000|Overall Study|Protocol Violation|1|||
162753631|NCT02964741|587810579|FG001|Overall Study|Protocol Violation|0|||
162753632|NCT02964741|587810580|FG002|Overall Study|Protocol Violation|0|||
162753633|NCT02964741|587810578|FG000|Overall Study|Withdrawal by Subject|0|||
162753634|NCT02964741|587810579|FG001|Overall Study|Withdrawal by Subject|1|||
162753635|NCT02964741|587810580|FG002|Overall Study|Withdrawal by Subject|0|||
162753636|NCT02964741|587810578|FG000|Overall Study|claustrophobia|1|||
162753637|NCT02964741|587810579|FG001|Overall Study|claustrophobia|0|||
162753638|NCT02964741|587810580|FG002|Overall Study|claustrophobia|0|||
162753639|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
162753640|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162753641|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162753642|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162753643|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
162753644|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162753645|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162753646|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162753647|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
162753648|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
162753649|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
162753650|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
162753651|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
162753652|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162753653|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162753654|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162753655|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
162753656|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162753657|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162753658|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162753659|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
162753660|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162753661|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162753662|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162753663|NCT01074294|587810584|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
162753664|NCT01074294|587810585|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162753665|NCT01074294|587810586|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162753666|NCT01074294|587810587|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162753667|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
162753668|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
162753669|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
162753670|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
162753671|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
162753672|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
162753673|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
162753674|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
162753675|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162753676|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
162753677|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162753678|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162753679|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
162753680|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
162753681|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
162753682|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
162753683|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
162753684|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
162753685|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
162753686|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
162753687|NCT01074294|587810584|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162753688|NCT01074294|587810585|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
162753689|NCT01074294|587810586|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162753690|NCT01074294|587810587|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162753691|NCT00112359|587810588|FG000|Overall Study|Unrelated adverse event|16|||
162753692|NCT00112359|587810589|FG001|Overall Study|Unrelated adverse event|8|||
162753693|NCT00112359|587810588|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
162753694|NCT00112359|587810589|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
162753695|NCT00112359|587810588|FG000|Overall Study|Related adverse event|5|||
162753696|NCT00112359|587810589|FG001|Overall Study|Related adverse event|3|||
162753697|NCT00112359|587810588|FG000|Overall Study|Lost to Follow-up|0|||
162753698|NCT00112359|587810589|FG001|Overall Study|Lost to Follow-up|1|||
162753699|NCT00112359|587810588|FG000|Overall Study|Personal/administrative|1|||
162753700|NCT00112359|587810589|FG001|Overall Study|Personal/administrative|1|||
162753701|NCT00112359|587810588|FG000|Overall Study|Other|3|||
162753702|NCT00112359|587810589|FG001|Overall Study|Other|0|||
162753703|NCT00312208|587810590|FG000|Overall Study|Adverse Event|97|||
162753704|NCT00312208|587810591|FG001|Overall Study|Adverse Event|61|||
162753705|NCT00312208|587810590|FG000|Overall Study|Protocol Violation|5|||
162753706|NCT00312208|587810591|FG001|Overall Study|Protocol Violation|3|||
162753707|NCT00312208|587810590|FG000|Overall Study|Death|2|||
162753708|NCT00312208|587810591|FG001|Overall Study|Death|1|||
162753709|NCT00312208|587810590|FG000|Overall Study|Lack of Efficacy|7|||
162753710|NCT00312208|587810591|FG001|Overall Study|Lack of Efficacy|4|||
162753711|NCT00312208|587810590|FG000|Overall Study|Lost to Follow-up|3|||
162753712|NCT00312208|587810591|FG001|Overall Study|Lost to Follow-up|5|||
162753713|NCT00312208|587810590|FG000|Overall Study|Withdrawal by Subject|53|||
162753714|NCT00312208|587810591|FG001|Overall Study|Withdrawal by Subject|42|||
162753715|NCT00312208|587810590|FG000|Overall Study|Other|5|||
162753716|NCT00312208|587810591|FG001|Overall Study|Other|7|||
162753717|NCT01315132|587810594|FG000|Overall Study|not treated due to disease progression|1|||
162753718|NCT03437733|587811282|FG000|Overall Study|Eligibility criteria not met|0|||
162753719|NCT03437733|587811283|FG001|Overall Study|Eligibility criteria not met|3|||
162753720|NCT00246805|587811298|FG000|Phase 1|Lost to Follow-up|1|||
162753721|NCT00246805|587811299|FG001|Phase 1|Lost to Follow-up|0|||
162753722|NCT01342367|587811301|FG000|Overall Study|Death|1|||
162753723|NCT01342367|587811302|FG001|Overall Study|Death|0|||
162753724|NCT01342367|587811301|FG000|Overall Study|Withdrawal by Subject|1|||
162753725|NCT01342367|587811302|FG001|Overall Study|Withdrawal by Subject|2|||
162753726|NCT00640159|587811303|FG000|Overall Study|Lost to Follow-up|2|||
162753727|NCT01500200|587811304|FG000|Stage 1|Adverse Event|1|||
162753728|NCT01500200|587811305|FG001|Stage 1|Adverse Event|4|||
162753729|NCT01500200|587811306|FG002|Stage 1|Adverse Event|5|||
162753730|NCT01500200|587811307|FG003|Stage 1|Adverse Event|0|||
162753731|NCT01500200|587811308|FG004|Stage 1|Adverse Event|0|||
162753732|NCT01500200|587811309|FG005|Stage 1|Adverse Event|0|||
162753733|NCT01500200|587811304|FG000|Stage 1|Lost to Follow-up|2|||
162753734|NCT01500200|587811305|FG001|Stage 1|Lost to Follow-up|2|||
162753735|NCT01500200|587811306|FG002|Stage 1|Lost to Follow-up|1|||
162753736|NCT01500200|587811307|FG003|Stage 1|Lost to Follow-up|0|||
162753737|NCT01500200|587811308|FG004|Stage 1|Lost to Follow-up|0|||
162753738|NCT01500200|587811309|FG005|Stage 1|Lost to Follow-up|0|||
162753739|NCT01500200|587811304|FG000|Stage 1|Withdrawal by Subject|3|||
162753740|NCT01500200|587811305|FG001|Stage 1|Withdrawal by Subject|0|||
162753741|NCT01500200|587811306|FG002|Stage 1|Withdrawal by Subject|0|||
162753742|NCT01500200|587811307|FG003|Stage 1|Withdrawal by Subject|0|||
162753743|NCT01500200|587811308|FG004|Stage 1|Withdrawal by Subject|0|||
162753744|NCT01500200|587811309|FG005|Stage 1|Withdrawal by Subject|0|||
162753745|NCT01500200|587811304|FG000|Stage 1|Noncompliance with Study Drug|1|||
162753746|NCT01500200|587811305|FG001|Stage 1|Noncompliance with Study Drug|0|||
162753747|NCT01500200|587811306|FG002|Stage 1|Noncompliance with Study Drug|0|||
162753748|NCT01500200|587811307|FG003|Stage 1|Noncompliance with Study Drug|0|||
162753749|NCT01500200|587811308|FG004|Stage 1|Noncompliance with Study Drug|0|||
162753750|NCT01500200|587811309|FG005|Stage 1|Noncompliance with Study Drug|0|||
162753751|NCT01500200|587811304|FG000|Stage 1|Physician Decision|1|||
162753752|NCT01500200|587811305|FG001|Stage 1|Physician Decision|0|||
162753753|NCT01500200|587811306|FG002|Stage 1|Physician Decision|0|||
162753754|NCT01500200|587811307|FG003|Stage 1|Physician Decision|0|||
162753755|NCT01500200|587811308|FG004|Stage 1|Physician Decision|0|||
162753756|NCT01500200|587811309|FG005|Stage 1|Physician Decision|0|||
162753757|NCT01500200|587811304|FG000|Stage 2|Adverse Event|0|||
162753758|NCT01500200|587811305|FG001|Stage 2|Adverse Event|0|||
162753759|NCT01500200|587811306|FG002|Stage 2|Adverse Event|0|||
162753760|NCT01500200|587811307|FG003|Stage 2|Adverse Event|0|||
162753761|NCT01500200|587811308|FG004|Stage 2|Adverse Event|5|||
162753762|NCT01500200|587811309|FG005|Stage 2|Adverse Event|4|||
162753763|NCT01218659|587811311|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
162753764|NCT01218659|587811312|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
162753765|NCT01218659|587811313|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
162753766|NCT01218659|587811311|FG000|18-Month Randomized Period|Did not receive study drug|0|||
162753767|NCT01218659|587811312|FG001|18-Month Randomized Period|Did not receive study drug|3|||
162753768|NCT01218659|587811313|FG002|18-Month Randomized Period|Did not receive study drug|0|||
162753769|NCT01218659|587811311|FG000|12-Month OLE|Withdrawal by Subject|0|||
162753770|NCT01218659|587811312|FG001|12-Month OLE|Withdrawal by Subject|0|||
162753771|NCT01218659|587811313|FG002|12-Month OLE|Withdrawal by Subject|2|||
162753772|NCT01218659|587811311|FG000|12-Month OLE|Physician Decision|0|||
162753773|NCT01218659|587811312|FG001|12-Month OLE|Physician Decision|0|||
162753774|NCT01218659|587811313|FG002|12-Month OLE|Physician Decision|1|||
162753775|NCT01218659|587811311|FG000|12-Month OLE|Lost to Follow-up|0|||
162753776|NCT01218659|587811312|FG001|12-Month OLE|Lost to Follow-up|0|||
162753777|NCT01218659|587811313|FG002|12-Month OLE|Lost to Follow-up|1|||
162753778|NCT01218659|587811311|FG000|12-Month OLE|Pregnancy|0|||
162753779|NCT01218659|587811312|FG001|12-Month OLE|Pregnancy|0|||
162753780|NCT01218659|587811313|FG002|12-Month OLE|Pregnancy|1|||
162753781|NCT01218659|587811311|FG000|12-Month OLE|Lack of Efficacy|0|||
162753782|NCT01218659|587811312|FG001|12-Month OLE|Lack of Efficacy|0|||
162753783|NCT01218659|587811313|FG002|12-Month OLE|Lack of Efficacy|1|||
162753784|NCT01218659|587811311|FG000|12-Month OLE|Declined to participate in the OLE|0|||
162753785|NCT01218659|587811312|FG001|12-Month OLE|Declined to participate in the OLE|0|||
162753786|NCT01218659|587811313|FG002|12-Month OLE|Declined to participate in the OLE|4|||
162753787|NCT03066609|587811316|FG000|INDUCTION|Pregnancy|0|||
162753788|NCT03066609|587811317|FG001|INDUCTION|Pregnancy|0|||
162753789|NCT03066609|587811318|FG002|INDUCTION|Pregnancy|1|||
162753790|NCT03066609|587811319|FG003|INDUCTION|Pregnancy|0|||
162753791|NCT03066609|587811316|FG000|INDUCTION|Lack of Efficacy|0|||
162753792|NCT03066609|587811317|FG001|INDUCTION|Lack of Efficacy|0|||
162753793|NCT03066609|587811318|FG002|INDUCTION|Lack of Efficacy|1|||
162753794|NCT03066609|587811319|FG003|INDUCTION|Lack of Efficacy|0|||
162753795|NCT03066609|587811316|FG000|INDUCTION|Adverse Event|2|||
162753796|NCT03066609|587811317|FG001|INDUCTION|Adverse Event|2|||
162753797|NCT03066609|587811318|FG002|INDUCTION|Adverse Event|0|||
162753798|NCT03066609|587811319|FG003|INDUCTION|Adverse Event|0|||
162753799|NCT03066609|587811316|FG000|MAINTENANCE|Adverse Event|0|||
162753800|NCT03066609|587811317|FG001|MAINTENANCE|Adverse Event|0|||
162753801|NCT03066609|587811318|FG002|MAINTENANCE|Adverse Event|0|||
162753802|NCT03066609|587811319|FG003|MAINTENANCE|Adverse Event|1|||
162753803|NCT03066609|587811316|FG000|MAINTENANCE|Withdrawal by Subject|4|||
162753804|NCT03066609|587811317|FG001|MAINTENANCE|Withdrawal by Subject|2|||
162753805|NCT03066609|587811318|FG002|MAINTENANCE|Withdrawal by Subject|1|||
162753806|NCT03066609|587811319|FG003|MAINTENANCE|Withdrawal by Subject|1|||
162753807|NCT03066609|587811316|FG000|MAINTENANCE|Lost to Follow-up|0|||
162753808|NCT03066609|587811317|FG001|MAINTENANCE|Lost to Follow-up|1|||
162753809|NCT03066609|587811318|FG002|MAINTENANCE|Lost to Follow-up|1|||
162753810|NCT03066609|587811319|FG003|MAINTENANCE|Lost to Follow-up|0|||
162753811|NCT03066609|587811316|FG000|MAINTENANCE|Pregnancy|1|||
162753812|NCT03066609|587811317|FG001|MAINTENANCE|Pregnancy|0|||
162753813|NCT03066609|587811318|FG002|MAINTENANCE|Pregnancy|0|||
162753814|NCT03066609|587811319|FG003|MAINTENANCE|Pregnancy|0|||
162753815|NCT03066609|587811316|FG000|MAINTENANCE|Lack of Efficacy|2|||
162753816|NCT03066609|587811317|FG001|MAINTENANCE|Lack of Efficacy|1|||
162753817|NCT03066609|587811318|FG002|MAINTENANCE|Lack of Efficacy|0|||
162753818|NCT03066609|587811319|FG003|MAINTENANCE|Lack of Efficacy|1|||
162753819|NCT03066609|587811316|FG000|OVERALL STUDY|Adverse Event|2|||
162753820|NCT03066609|587811317|FG001|OVERALL STUDY|Adverse Event|2|||
162753821|NCT03066609|587811318|FG002|OVERALL STUDY|Adverse Event|0|||
162753822|NCT03066609|587811319|FG003|OVERALL STUDY|Adverse Event|1|||
162753823|NCT03066609|587811316|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
162753824|NCT03066609|587811317|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
162753825|NCT03066609|587811318|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
162753826|NCT03066609|587811319|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
162753827|NCT03066609|587811316|FG000|OVERALL STUDY|Lost to Follow-up|1|||
162753828|NCT03066609|587811317|FG001|OVERALL STUDY|Lost to Follow-up|1|||
162753829|NCT03066609|587811318|FG002|OVERALL STUDY|Lost to Follow-up|1|||
162753830|NCT03066609|587811319|FG003|OVERALL STUDY|Lost to Follow-up|1|||
162753831|NCT03066609|587811316|FG000|OVERALL STUDY|Pregnancy|1|||
162753832|NCT03066609|587811317|FG001|OVERALL STUDY|Pregnancy|0|||
162753833|NCT03066609|587811318|FG002|OVERALL STUDY|Pregnancy|1|||
162753834|NCT03066609|587811319|FG003|OVERALL STUDY|Pregnancy|0|||
162753835|NCT03066609|587811316|FG000|OVERALL STUDY|Lack of Efficacy|2|||
162753836|NCT03066609|587811317|FG001|OVERALL STUDY|Lack of Efficacy|1|||
162753837|NCT03066609|587811318|FG002|OVERALL STUDY|Lack of Efficacy|1|||
162753838|NCT03066609|587811319|FG003|OVERALL STUDY|Lack of Efficacy|1|||
162753839|NCT03066609|587811316|FG000|OVERALL STUDY|discontinued follow up|0|||
162753840|NCT03066609|587811317|FG001|OVERALL STUDY|discontinued follow up|2|||
162753841|NCT03066609|587811318|FG002|OVERALL STUDY|discontinued follow up|0|||
162753842|NCT03066609|587811319|FG003|OVERALL STUDY|discontinued follow up|0|||
162753843|NCT02284113|587811320|FG000|Overall Study|Adverse Event|1|||
162753844|NCT02284113|587811321|FG001|Overall Study|Adverse Event|0|||
162753845|NCT02284113|587811320|FG000|Overall Study|non-compliance|0|||
162753846|NCT02284113|587811321|FG001|Overall Study|non-compliance|1|||
162753847|NCT02284113|587811320|FG000|Overall Study|Withdrawal by Subject|0|||
162753848|NCT02284113|587811321|FG001|Overall Study|Withdrawal by Subject|1|||
162753849|NCT02284113|587811320|FG000|Overall Study|not provided|0|||
162753850|NCT02284113|587811321|FG001|Overall Study|not provided|1|||
162753851|NCT02284113|587811320|FG000|Overall Study|surgery cancelled|2|||
162753852|NCT02284113|587811321|FG001|Overall Study|surgery cancelled|0|||
162753853|NCT04191824|587811322|FG000|Overall Study|Death|13|||
162753854|NCT04191824|587811323|FG001|Overall Study|Death|12|||
162753855|NCT04191824|587811322|FG000|Overall Study|Lost to Follow-up|456|||
162753856|NCT04191824|587811323|FG001|Overall Study|Lost to Follow-up|435|||
162753857|NCT04191824|587811322|FG000|Overall Study|Physician Decision|2|||
162753858|NCT04191824|587811323|FG001|Overall Study|Physician Decision|1|||
162753859|NCT04191824|587811322|FG000|Overall Study|Protocol Violation|0|||
162753860|NCT04191824|587811323|FG001|Overall Study|Protocol Violation|2|||
162753861|NCT04191824|587811322|FG000|Overall Study|Withdrawal by Subject|16|||
162753862|NCT04191824|587811323|FG001|Overall Study|Withdrawal by Subject|18|||
162753863|NCT04191824|587811322|FG000|Overall Study|Early site closure|24|||
162753864|NCT04191824|587811323|FG001|Overall Study|Early site closure|22|||
162753865|NCT01324310|587811326|FG000|Overall Study|Adverse Event|1|||
162753866|NCT01324310|587811326|FG000|Overall Study|Disease Progression|1|||
162753867|NCT03170882|587811327|FG000|Overall Study|Death|17|||
162753868|NCT03170882|587811328|FG001|Overall Study|Death|29|||
162753869|NCT03170882|587811327|FG000|Overall Study|Lost to Follow-up|0|||
162753870|NCT03170882|587811328|FG001|Overall Study|Lost to Follow-up|1|||
162753871|NCT03170882|587811327|FG000|Overall Study|Withdrawal by Subject|4|||
162753872|NCT03170882|587811328|FG001|Overall Study|Withdrawal by Subject|7|||
162753873|NCT03170882|587811327|FG000|Overall Study|Reason not Specified|28|||
162753874|NCT03170882|587811328|FG001|Overall Study|Reason not Specified|36|||
162753875|NCT01371994|587811332|FG000|Overall Study|Adverse Event|3|||
162753876|NCT01371994|587811333|FG001|Overall Study|Adverse Event|6|||
162753877|NCT01371994|587811332|FG000|Overall Study|Lack of Efficacy|3|||
162753878|NCT01371994|587811333|FG001|Overall Study|Lack of Efficacy|0|||
162753879|NCT01371994|587811332|FG000|Overall Study|Withdrawal by Subject|13|||
162753880|NCT01371994|587811333|FG001|Overall Study|Withdrawal by Subject|7|||
162753881|NCT01371994|587811332|FG000|Overall Study|Lost to Follow-up|1|||
162753882|NCT01371994|587811333|FG001|Overall Study|Lost to Follow-up|1|||
162753883|NCT01371994|587811332|FG000|Overall Study|Protocol Violation|24|||
162753884|NCT01371994|587811333|FG001|Overall Study|Protocol Violation|17|||
162753885|NCT01371994|587811332|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
162753886|NCT01371994|587811333|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
162753887|NCT01371994|587811332|FG000|Overall Study|Physician Decision|1|||
162753888|NCT01371994|587811333|FG001|Overall Study|Physician Decision|1|||
162753889|NCT01371994|587811332|FG000|Overall Study|Miscellaneous Reasons|6|||
162753890|NCT01371994|587811333|FG001|Overall Study|Miscellaneous Reasons|4|||
162753891|NCT00087685|587811334|FG000|Overall Study|Adverse Event|5|||
162753892|NCT00087685|587811334|FG000|Overall Study|Non-Compliance|1|||
162753893|NCT00087685|587811334|FG000|Overall Study|Progressive Disease|5|||
162753894|NCT00087685|587811334|FG000|Overall Study|Withdrawal by Subject|3|||
162753895|NCT03213457|587811335|FG000|Screening Period|Withdrawal by Subject|0|||
162753896|NCT03213457|587811336|FG001|Screening Period|Withdrawal by Subject|1|||
162753897|NCT03213457|587811337|FG002|Screening Period|Withdrawal by Subject|0|||
162753898|NCT03213457|587811335|FG000|Screening Period|Other|1|||
162753899|NCT03213457|587811336|FG001|Screening Period|Other|0|||
162753900|NCT03213457|587811337|FG002|Screening Period|Other|0|||
162753901|NCT03213457|587811335|FG000|Double-Blind Period|Adverse Event|3|||
162753902|NCT03213457|587811336|FG001|Double-Blind Period|Adverse Event|2|||
162753903|NCT03213457|587811337|FG002|Double-Blind Period|Adverse Event|7|||
162753904|NCT03213457|587811335|FG000|Double-Blind Period|Withdrawal by Subject|14|||
162753905|NCT03213457|587811336|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162753906|NCT03213457|587811337|FG002|Double-Blind Period|Withdrawal by Subject|14|||
162753907|NCT03213457|587811335|FG000|Double-Blind Period|Lost to Follow-up|2|||
162753908|NCT03213457|587811336|FG001|Double-Blind Period|Lost to Follow-up|3|||
162753909|NCT03213457|587811337|FG002|Double-Blind Period|Lost to Follow-up|9|||
162753910|NCT03213457|587811335|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162753911|NCT03213457|587811336|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162753912|NCT03213457|587811337|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
162753913|NCT03213457|587811335|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
162753914|NCT03213457|587811336|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
162753915|NCT03213457|587811337|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
162753916|NCT03213457|587811335|FG000|Double-Blind Period|Pregnancy|5|||
162753917|NCT03213457|587811336|FG001|Double-Blind Period|Pregnancy|0|||
162753918|NCT03213457|587811337|FG002|Double-Blind Period|Pregnancy|0|||
162753919|NCT03213457|587811335|FG000|Double-Blind Period|Other|10|||
162753920|NCT03213457|587811336|FG001|Double-Blind Period|Other|3|||
162753921|NCT03213457|587811337|FG002|Double-Blind Period|Other|17|||
162753922|NCT03213457|587811335|FG000|Open-Label Period|Adverse Event|1|||
162753923|NCT03213457|587811336|FG001|Open-Label Period|Adverse Event|2|||
162753924|NCT03213457|587811337|FG002|Open-Label Period|Adverse Event|2|||
162753925|NCT03213457|587811335|FG000|Open-Label Period|Withdrawal by Subject|12|||
162753926|NCT03213457|587811336|FG001|Open-Label Period|Withdrawal by Subject|5|||
162753927|NCT03213457|587811337|FG002|Open-Label Period|Withdrawal by Subject|24|||
162753928|NCT03213457|587811335|FG000|Open-Label Period|Lost to Follow-up|1|||
162753929|NCT03213457|587811336|FG001|Open-Label Period|Lost to Follow-up|2|||
162753930|NCT03213457|587811337|FG002|Open-Label Period|Lost to Follow-up|8|||
162753931|NCT03213457|587811335|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162810473|NCT03435497|588018230|FG001|Overall Study|Wrong survey administered|2|||
162753932|NCT03213457|587811336|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162753933|NCT03213457|587811337|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162753934|NCT03213457|587811335|FG000|Open-Label Period|Non-compliance with study procedures|1|||
162753935|NCT03213457|587811336|FG001|Open-Label Period|Non-compliance with study procedures|1|||
162753936|NCT03213457|587811337|FG002|Open-Label Period|Non-compliance with study procedures|2|||
162753937|NCT03213457|587811335|FG000|Open-Label Period|Exclusionary medications|0|||
162753938|NCT03213457|587811336|FG001|Open-Label Period|Exclusionary medications|0|||
162753939|NCT03213457|587811337|FG002|Open-Label Period|Exclusionary medications|1|||
162753940|NCT03213457|587811335|FG000|Open-Label Period|Other|1|||
162753941|NCT03213457|587811336|FG001|Open-Label Period|Other|1|||
162753942|NCT03213457|587811337|FG002|Open-Label Period|Other|6|||
162753943|NCT03213457|587811335|FG000|Follow-Up Period|Adverse Event|16|||
162753944|NCT03213457|587811336|FG001|Follow-Up Period|Adverse Event|8|||
162753945|NCT03213457|587811337|FG002|Follow-Up Period|Adverse Event|37|||
162753946|NCT03213457|587811335|FG000|Follow-Up Period|Withdrawal by Subject|18|||
162753947|NCT03213457|587811336|FG001|Follow-Up Period|Withdrawal by Subject|11|||
162753948|NCT03213457|587811337|FG002|Follow-Up Period|Withdrawal by Subject|55|||
162753949|NCT03213457|587811335|FG000|Follow-Up Period|Lost to Follow-up|28|||
162753950|NCT03213457|587811336|FG001|Follow-Up Period|Lost to Follow-up|15|||
162753951|NCT03213457|587811337|FG002|Follow-Up Period|Lost to Follow-up|50|||
162753952|NCT03213457|587811335|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
162753953|NCT03213457|587811336|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
162753954|NCT03213457|587811337|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162753955|NCT03213457|587811335|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
162753956|NCT03213457|587811336|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
162753957|NCT03213457|587811337|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
162753958|NCT03213457|587811335|FG000|Follow-Up Period|Pregnancy|7|||
162753959|NCT03213457|587811336|FG001|Follow-Up Period|Pregnancy|0|||
162753960|NCT03213457|587811337|FG002|Follow-Up Period|Pregnancy|18|||
162753961|NCT03213457|587811335|FG000|Follow-Up Period|Exclusionary medications|1|||
162753962|NCT03213457|587811336|FG001|Follow-Up Period|Exclusionary medications|1|||
162753963|NCT03213457|587811337|FG002|Follow-Up Period|Exclusionary medications|5|||
162753964|NCT03213457|587811335|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
162753965|NCT03213457|587811336|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
162753966|NCT03213457|587811337|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
162753967|NCT03213457|587811335|FG000|Follow-Up Period|Other|14|||
162753968|NCT03213457|587811336|FG001|Follow-Up Period|Other|10|||
162753969|NCT03213457|587811337|FG002|Follow-Up Period|Other|31|||
162753970|NCT01830595|587811338|FG000|First Period|Withdrawal by Subject|1|||
162753971|NCT01830595|587811339|FG001|First Period|Withdrawal by Subject|3|||
162753972|NCT01830595|587811338|FG000|Washout|Withdrawal by Subject|2|||
162753973|NCT01830595|587811339|FG001|Washout|Withdrawal by Subject|2|||
162753974|NCT05116774|587811344|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
162753975|NCT05116774|587811345|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
162753976|NCT05116774|587811344|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
162753977|NCT05116774|587811345|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
162753978|NCT05116774|587811344|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
162753979|NCT05116774|587811345|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
162753980|NCT05116774|587811344|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
162753981|NCT05116774|587811345|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
162753982|NCT03150862|587811346|FG000|Overall Study|Death|2|||
162753983|NCT03150862|587811347|FG001|Overall Study|Death|7|||
162753984|NCT03150862|587811348|FG002|Overall Study|Death|8|||
162753985|NCT03150862|587811349|FG003|Overall Study|Death|27|||
162753986|NCT03150862|587811350|FG004|Overall Study|Death|4|||
162753987|NCT03150862|587811351|FG005|Overall Study|Death|8|||
162753988|NCT03150862|587811352|FG006|Overall Study|Death|6|||
162753989|NCT03150862|587811353|FG007|Overall Study|Death|21|||
162753990|NCT03150862|587811346|FG000|Overall Study|Withdrawal by Subject|1|||
162753991|NCT03150862|587811347|FG001|Overall Study|Withdrawal by Subject|1|||
162753992|NCT03150862|587811348|FG002|Overall Study|Withdrawal by Subject|0|||
162753993|NCT03150862|587811349|FG003|Overall Study|Withdrawal by Subject|3|||
162753994|NCT03150862|587811350|FG004|Overall Study|Withdrawal by Subject|1|||
162753995|NCT03150862|587811351|FG005|Overall Study|Withdrawal by Subject|1|||
162753996|NCT03150862|587811352|FG006|Overall Study|Withdrawal by Subject|1|||
162753997|NCT03150862|587811353|FG007|Overall Study|Withdrawal by Subject|3|||
162753998|NCT03150862|587811346|FG000|Overall Study|Lost to Follow-up|0|||
162753999|NCT03150862|587811347|FG001|Overall Study|Lost to Follow-up|0|||
162754000|NCT03150862|587811348|FG002|Overall Study|Lost to Follow-up|1|||
162754001|NCT03150862|587811349|FG003|Overall Study|Lost to Follow-up|0|||
162754002|NCT03150862|587811350|FG004|Overall Study|Lost to Follow-up|0|||
162754003|NCT03150862|587811351|FG005|Overall Study|Lost to Follow-up|0|||
162754004|NCT03150862|587811352|FG006|Overall Study|Lost to Follow-up|0|||
162754005|NCT03150862|587811353|FG007|Overall Study|Lost to Follow-up|2|||
162754006|NCT03150862|587811346|FG000|Overall Study|Sponsor's decision|0|||
162754007|NCT03150862|587811347|FG001|Overall Study|Sponsor's decision|0|||
162754008|NCT03150862|587811348|FG002|Overall Study|Sponsor's decision|0|||
162754009|NCT03150862|587811349|FG003|Overall Study|Sponsor's decision|10|||
162754010|NCT03150862|587811350|FG004|Overall Study|Sponsor's decision|3|||
162754011|NCT03150862|587811351|FG005|Overall Study|Sponsor's decision|0|||
162754012|NCT03150862|587811352|FG006|Overall Study|Sponsor's decision|1|||
162754013|NCT03150862|587811353|FG007|Overall Study|Sponsor's decision|1|||
162754014|NCT03150862|587811346|FG000|Overall Study|Change in Methylation status|0|||
162754015|NCT03150862|587811347|FG001|Overall Study|Change in Methylation status|0|||
162754016|NCT03150862|587811348|FG002|Overall Study|Change in Methylation status|0|||
162754017|NCT03150862|587811349|FG003|Overall Study|Change in Methylation status|0|||
162754018|NCT03150862|587811350|FG004|Overall Study|Change in Methylation status|1|||
162754019|NCT03150862|587811351|FG005|Overall Study|Change in Methylation status|0|||
162754020|NCT03150862|587811352|FG006|Overall Study|Change in Methylation status|0|||
162754021|NCT03150862|587811353|FG007|Overall Study|Change in Methylation status|0|||
162754022|NCT03150862|587811346|FG000|Overall Study|Roll over in to Long Term Extension|0|||
162754023|NCT03150862|587811347|FG001|Overall Study|Roll over in to Long Term Extension|0|||
162754024|NCT03150862|587811348|FG002|Overall Study|Roll over in to Long Term Extension|0|||
162754025|NCT03150862|587811349|FG003|Overall Study|Roll over in to Long Term Extension|0|||
162754026|NCT03150862|587811350|FG004|Overall Study|Roll over in to Long Term Extension|0|||
162754027|NCT03150862|587811351|FG005|Overall Study|Roll over in to Long Term Extension|0|||
162754028|NCT03150862|587811352|FG006|Overall Study|Roll over in to Long Term Extension|0|||
162754029|NCT03150862|587811353|FG007|Overall Study|Roll over in to Long Term Extension|1|||
162754030|NCT03150862|587811346|FG000|Overall Study|Progressive Disease|0|||
162754031|NCT03150862|587811347|FG001|Overall Study|Progressive Disease|0|||
162754032|NCT03150862|587811348|FG002|Overall Study|Progressive Disease|0|||
162754033|NCT03150862|587811349|FG003|Overall Study|Progressive Disease|0|||
162754034|NCT03150862|587811350|FG004|Overall Study|Progressive Disease|0|||
162754035|NCT03150862|587811351|FG005|Overall Study|Progressive Disease|0|||
162754036|NCT03150862|587811352|FG006|Overall Study|Progressive Disease|0|||
162754037|NCT03150862|587811353|FG007|Overall Study|Progressive Disease|2|||
162754038|NCT05139992|587811356|FG000|Overall Study|Withdrawal by Subject|12|||
162754039|NCT05139992|587811356|FG000|Overall Study|Lost to Follow-up|6|||
162754040|NCT05521516|587811357|FG000|Overall Study|Withdrawal by Subject|1|||
162754041|NCT05521516|587811358|FG001|Overall Study|Withdrawal by Subject|1|||
162754042|NCT00747565|587811359|FG000|Overall Study|Withdrawal by Subject|10|||
162754043|NCT00747565|587811360|FG001|Overall Study|Withdrawal by Subject|6|||
162754044|NCT00747565|587811359|FG000|Overall Study|Lost to Follow-up|4|||
162754045|NCT00747565|587811360|FG001|Overall Study|Lost to Follow-up|1|||
162754046|NCT01983683|587811363|FG000|Overall Study|Withdrawal by Subject|14|||
162754047|NCT01983683|587811364|FG001|Overall Study|Withdrawal by Subject|18|||
162754048|NCT01983683|587811363|FG000|Overall Study|Death|11|||
162754049|NCT01983683|587811364|FG001|Overall Study|Death|15|||
162754050|NCT01983683|587811363|FG000|Overall Study|Physician Decision|8|||
162754051|NCT01983683|587811364|FG001|Overall Study|Physician Decision|9|||
162754052|NCT01983683|587811363|FG000|Overall Study|Lost to Follow-up|4|||
162754053|NCT01983683|587811364|FG001|Overall Study|Lost to Follow-up|8|||
162754054|NCT01983683|587811363|FG000|Overall Study|Sponsor Decision|1|||
162754055|NCT01983683|587811364|FG001|Overall Study|Sponsor Decision|1|||
162754056|NCT00536120|587812364|FG000|Overall Study|Lost to Follow-up|1|||
162754057|NCT00536120|587812365|FG001|Overall Study|Lost to Follow-up|0|||
162754058|NCT00536120|587812364|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
162754059|NCT00536120|587812365|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
162754060|NCT00536120|587812364|FG000|Overall Study|Non-compliance|1|||
162754061|NCT00536120|587812365|FG001|Overall Study|Non-compliance|0|||
162754062|NCT00536120|587812364|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
162754063|NCT00536120|587812365|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
162754064|NCT00536120|587812364|FG000|Overall Study|Steroid Use|0|||
162754065|NCT00536120|587812365|FG001|Overall Study|Steroid Use|2|||
162754066|NCT00536120|587812364|FG000|Overall Study|Missed Study Visit|0|||
162754067|NCT00536120|587812365|FG001|Overall Study|Missed Study Visit|1|||
162754068|NCT02722434|587812366|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
162754069|NCT02722434|587812367|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
162754070|NCT02722434|587812366|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
162754071|NCT02722434|587812367|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
162754072|NCT03876457|587812372|FG000|Overall Study|Lost to Follow-up|1|||
162754073|NCT03876457|587812373|FG001|Overall Study|Lost to Follow-up|3|||
162754074|NCT01084694|587812374|FG000|Overall Study|Withdrawal by Subject|2|||
162754075|NCT01084694|587812375|FG001|Overall Study|Withdrawal by Subject|1|||
162754076|NCT01084694|587812374|FG000|Overall Study|Death|2|||
162754077|NCT01084694|587812375|FG001|Overall Study|Death|12|||
162754078|NCT01084694|587812374|FG000|Overall Study|eligibility not maintained|2|||
162754079|NCT01084694|587812375|FG001|Overall Study|eligibility not maintained|7|||
162754080|NCT04017611|587812382|FG000|Overall Study|Withdrawn prior to completion|1|||
162754081|NCT01128595|587812383|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162754082|NCT01128595|587812384|FG001|Treatment Period 3|Withdrawal by Subject|1|||
162754083|NCT01128595|587812385|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162754084|NCT01128595|587812386|FG003|Treatment Period 3|Withdrawal by Subject|0|||
162754085|NCT02185794|587812388|FG000|Overall Study|Enrolled but Never Dosed|1|||
162754086|NCT02185794|587812389|FG001|Overall Study|Enrolled but Never Dosed|6|||
162754087|NCT02185794|587812390|FG002|Overall Study|Enrolled but Never Dosed|3|||
162754088|NCT02185794|587812391|FG003|Overall Study|Enrolled but Never Dosed|1|||
162754089|NCT02185794|587812392|FG004|Overall Study|Enrolled but Never Dosed|1|||
162754090|NCT02185794|587812393|FG005|Overall Study|Enrolled but Never Dosed|0|||
162754091|NCT02185794|587812388|FG000|Overall Study|Investigator's Discretion|1|||
162754092|NCT02185794|587812389|FG001|Overall Study|Investigator's Discretion|0|||
162754093|NCT02185794|587812390|FG002|Overall Study|Investigator's Discretion|1|||
162754094|NCT02185794|587812391|FG003|Overall Study|Investigator's Discretion|2|||
162754095|NCT02185794|587812392|FG004|Overall Study|Investigator's Discretion|2|||
162754096|NCT02185794|587812393|FG005|Overall Study|Investigator's Discretion|15|||
162754097|NCT02185794|587812388|FG000|Overall Study|Withdrew Consent|2|||
162754098|NCT02185794|587812389|FG001|Overall Study|Withdrew Consent|5|||
162754099|NCT02185794|587812390|FG002|Overall Study|Withdrew Consent|10|||
162754100|NCT02185794|587812391|FG003|Overall Study|Withdrew Consent|2|||
162754101|NCT02185794|587812392|FG004|Overall Study|Withdrew Consent|0|||
162754102|NCT02185794|587812393|FG005|Overall Study|Withdrew Consent|0|||
162754103|NCT02185794|587812388|FG000|Overall Study|Lost to Follow-up|1|||
162754104|NCT02185794|587812389|FG001|Overall Study|Lost to Follow-up|2|||
162754105|NCT02185794|587812390|FG002|Overall Study|Lost to Follow-up|2|||
162754106|NCT02185794|587812391|FG003|Overall Study|Lost to Follow-up|3|||
162754107|NCT02185794|587812392|FG004|Overall Study|Lost to Follow-up|0|||
162754108|NCT02185794|587812393|FG005|Overall Study|Lost to Follow-up|1|||
162754109|NCT00336505|587812394|FG000|Overall Study|Adverse Event|10|||
162754110|NCT00336505|587812395|FG001|Overall Study|Adverse Event|9|||
162754111|NCT00336505|587812394|FG000|Overall Study|Lack of Efficacy|8|||
162754112|NCT00336505|587812395|FG001|Overall Study|Lack of Efficacy|4|||
162754113|NCT00336505|587812394|FG000|Overall Study|Lost to Follow-up|7|||
162754114|NCT00336505|587812395|FG001|Overall Study|Lost to Follow-up|4|||
162754115|NCT00336505|587812394|FG000|Overall Study|Withdrawal by Subject|5|||
162754116|NCT00336505|587812395|FG001|Overall Study|Withdrawal by Subject|3|||
162754117|NCT00336505|587812394|FG000|Overall Study|Other|7|||
162754118|NCT00336505|587812395|FG001|Overall Study|Other|7|||
162754119|NCT00366249|587812396|FG000|Overall Study|Adverse Event|53|||
162754120|NCT00366249|587812397|FG001|Overall Study|Adverse Event|28|||
162754121|NCT00366249|587812396|FG000|Overall Study|Death|0|||
162754122|NCT00366249|587812397|FG001|Overall Study|Death|1|||
162754123|NCT00366249|587812396|FG000|Overall Study|Physician Decision|5|||
162754124|NCT00366249|587812397|FG001|Overall Study|Physician Decision|2|||
162754125|NCT00366249|587812396|FG000|Overall Study|Lost to Follow-up|2|||
162754126|NCT00366249|587812397|FG001|Overall Study|Lost to Follow-up|0|||
162754127|NCT00366249|587812396|FG000|Overall Study|Protocol Violation|1|||
162754128|NCT00366249|587812397|FG001|Overall Study|Protocol Violation|2|||
162754129|NCT00366249|587812396|FG000|Overall Study|Withdrawal by Subject|18|||
162754130|NCT00366249|587812397|FG001|Overall Study|Withdrawal by Subject|4|||
162754131|NCT00366249|587812396|FG000|Overall Study|Lack of Efficacy|21|||
162754132|NCT00366249|587812397|FG001|Overall Study|Lack of Efficacy|21|||
162754133|NCT00366249|587812396|FG000|Overall Study|Most due to osteomylitis status|31|||
162754134|NCT00366249|587812397|FG001|Overall Study|Most due to osteomylitis status|20|||
162754135|NCT00609869|587812398|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
162754136|NCT00609869|587812398|FG000|Overall Study|Severe hematologic toxicity|1|||
162754137|NCT00609869|587812398|FG000|Overall Study|Withdrawal by Subject|1|||
162754138|NCT00609869|587812398|FG000|Overall Study|Seizures|1|||
162754139|NCT00609869|587812398|FG000|Overall Study|Severe tumor flare reaction|1|||
162754140|NCT00609869|587812398|FG000|Overall Study|Hepatitis B infection|1|||
162754141|NCT00609869|587812398|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
162754142|NCT00609869|587812398|FG000|Overall Study|Mantle cell: not evaluable|4|||
162754143|NCT03478969|587812399|FG000|Overall Study|Withdrawal by Subject|4|||
162754144|NCT03478969|587812400|FG001|Overall Study|Withdrawal by Subject|7|||
162754145|NCT03478969|587812401|FG002|Overall Study|Withdrawal by Subject|6|||
162754146|NCT03478969|587812399|FG000|Overall Study|Adverse Event|2|||
162754147|NCT03478969|587812400|FG001|Overall Study|Adverse Event|0|||
162754148|NCT03478969|587812401|FG002|Overall Study|Adverse Event|1|||
162754149|NCT03478969|587812399|FG000|Overall Study|Pregnancy|1|||
162754150|NCT03478969|587812400|FG001|Overall Study|Pregnancy|0|||
162754151|NCT03478969|587812401|FG002|Overall Study|Pregnancy|0|||
162754152|NCT03478969|587812399|FG000|Overall Study|Personal Reasons|1|||
162754153|NCT03478969|587812400|FG001|Overall Study|Personal Reasons|0|||
162754154|NCT03478969|587812401|FG002|Overall Study|Personal Reasons|1|||
162754155|NCT03478969|587812399|FG000|Overall Study|Covid-19|1|||
162754156|NCT03478969|587812400|FG001|Overall Study|Covid-19|4|||
162754157|NCT03478969|587812401|FG002|Overall Study|Covid-19|3|||
162754158|NCT03478969|587812399|FG000|Overall Study|Multiple Reasons|0|||
162754159|NCT03478969|587812400|FG001|Overall Study|Multiple Reasons|1|||
162754160|NCT03478969|587812401|FG002|Overall Study|Multiple Reasons|1|||
162754161|NCT03478969|587812399|FG000|Overall Study|Eligibility Criteria|0|||
162754162|NCT03478969|587812400|FG001|Overall Study|Eligibility Criteria|0|||
162754163|NCT03478969|587812401|FG002|Overall Study|Eligibility Criteria|5|||
162754164|NCT03478969|587812399|FG000|Overall Study|Lost to Follow-up|0|||
162754165|NCT03478969|587812400|FG001|Overall Study|Lost to Follow-up|0|||
162754166|NCT03478969|587812401|FG002|Overall Study|Lost to Follow-up|1|||
162754167|NCT01185600|587812402|FG000|Overall Study|Adverse Event|1|||
162754168|NCT01185600|587812403|FG001|Overall Study|Adverse Event|1|||
162754169|NCT01185600|587812402|FG000|Overall Study|Death|0|||
162754170|NCT01185600|587812403|FG001|Overall Study|Death|1|||
162754171|NCT01185600|587812402|FG000|Overall Study|Lost to Follow-up|0|||
162754172|NCT01185600|587812403|FG001|Overall Study|Lost to Follow-up|5|||
162754173|NCT01185600|587812402|FG000|Overall Study|Physician Decision|29|||
162754174|NCT01185600|587812403|FG001|Overall Study|Physician Decision|35|||
162754175|NCT01185600|587812402|FG000|Overall Study|Withdrawal by Subject|1|||
162754176|NCT01185600|587812403|FG001|Overall Study|Withdrawal by Subject|1|||
162754177|NCT01185600|587812402|FG000|Overall Study|Hold by DSMB|1|||
162754178|NCT01185600|587812403|FG001|Overall Study|Hold by DSMB|2|||
162754179|NCT05405244|587812404|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
162754180|NCT05405244|587812405|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
162754181|NCT05405244|587812404|FG000|Washout (2 Weeks)|Adverse Event|2|||
162754182|NCT05405244|587812405|FG001|Washout (2 Weeks)|Adverse Event|0|||
162754183|NCT05405244|587812404|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
162754184|NCT05405244|587812405|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
162754185|NCT00739934|587812406|FG000|Voriconazole IV|Adverse Event|6|||
162754186|NCT00739934|587812406|FG000|Voriconazole Oral|Other|3|||
162754187|NCT02167451|587812411|FG000|Overall Study|Withdrawal by Subject|1|||
162754188|NCT03355573|587812416|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
162754189|NCT03355573|587812416|FG000|Overall Study|Sponsor's decision|1|||
162754190|NCT03355573|587812416|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
162754191|NCT03355573|587812416|FG000|Overall Study|PI's decision|2|||
162754192|NCT03355573|587812416|FG000|Overall Study|Withdrawal by Subject|23|||
162754193|NCT03355573|587812416|FG000|Overall Study|Lost to Follow-up|4|||
162754194|NCT03355573|587812416|FG000|Overall Study|Lack of Efficacy|2|||
162754195|NCT03355573|587812416|FG000|Overall Study|Adverse Event, non-fatal|17|||
162754196|NCT03355573|587812416|FG000|Overall Study|Adverse Event, serious fatal|2|||
162754197|NCT01218009|587812417|FG000|Overall Study|Protocol Violation|2|||
162754198|NCT01218009|587812418|FG001|Overall Study|Protocol Violation|1|||
162754199|NCT01218009|587812417|FG000|Overall Study|Withdrawal by Subject|3|||
162754200|NCT01218009|587812418|FG001|Overall Study|Withdrawal by Subject|1|||
162754201|NCT01218009|587812417|FG000|Overall Study|Sponsor terminated study|161|||
162754202|NCT01218009|587812418|FG001|Overall Study|Sponsor terminated study|163|||
162754203|NCT03280030|587812420|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
162754204|NCT03280030|587812421|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
162754205|NCT03280030|587812422|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
162754206|NCT03280030|587812420|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
162754207|NCT03280030|587812421|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
162754208|NCT03280030|587812422|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
162754209|NCT03280030|587812420|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
162754210|NCT03280030|587812421|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
162754211|NCT03280030|587812422|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
162754212|NCT03280030|587812420|FG000|Part 2 - Efficacy|Adverse Event|0|||
162754213|NCT03280030|587812421|FG001|Part 2 - Efficacy|Adverse Event|4|||
162754214|NCT03280030|587812422|FG002|Part 2 - Efficacy|Adverse Event|6|||
162754215|NCT03280030|587812420|FG000|Part 2 - Efficacy|Death|0|||
162754216|NCT03280030|587812421|FG001|Part 2 - Efficacy|Death|3|||
162754217|NCT03280030|587812422|FG002|Part 2 - Efficacy|Death|0|||
162754218|NCT03280030|587812420|FG000|Part 2 - Efficacy|Physician Decision|0|||
162754219|NCT03280030|587812421|FG001|Part 2 - Efficacy|Physician Decision|10|||
162754220|NCT03280030|587812422|FG002|Part 2 - Efficacy|Physician Decision|16|||
162754221|NCT03280030|587812420|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
162754222|NCT03280030|587812421|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
162754223|NCT03280030|587812422|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
162754224|NCT03280030|587812420|FG000|Part 2 - Efficacy|Progressive disease|0|||
162754225|NCT03280030|587812421|FG001|Part 2 - Efficacy|Progressive disease|7|||
162754226|NCT03280030|587812422|FG002|Part 2 - Efficacy|Progressive disease|5|||
162754227|NCT03275285|587812425|FG000|Overall Study|Ongoing|45|||
162754228|NCT03275285|587812426|FG001|Overall Study|Ongoing|69|||
162754229|NCT00115934|587812427|FG000|Overall Study|Lost to Follow-up|1|||
162754230|NCT00115934|587812428|FG001|Overall Study|Lost to Follow-up|0|||
162754231|NCT00115934|587812427|FG000|Overall Study|Did not receive intervention|3|||
162754232|NCT00115934|587812428|FG001|Overall Study|Did not receive intervention|2|||
162754233|NCT03789110|587812429|FG000|Overall Study|Adverse Event|2|||
162754234|NCT03789110|587812429|FG000|Overall Study|Physician Decision|1|||
162754235|NCT03789110|587812429|FG000|Overall Study|Withdrawal by Subject|2|||
162754236|NCT03789110|587812429|FG000|Overall Study|Lack of Efficacy|22|||
162754237|NCT03789110|587812429|FG000|Overall Study|still on treatment|3|||
162754238|NCT04882917|587812436|FG000|Overall Study|Adverse Event|0|||
162754239|NCT04882917|587812437|FG001|Overall Study|Adverse Event|1|||
162754240|NCT04882917|587812438|FG002|Overall Study|Adverse Event|2|||
162754241|NCT04882917|587812439|FG003|Overall Study|Adverse Event|2|||
162754242|NCT04882917|587812436|FG000|Overall Study|Withdrawal by Subject|1|||
162754243|NCT04882917|587812437|FG001|Overall Study|Withdrawal by Subject|0|||
162754244|NCT04882917|587812438|FG002|Overall Study|Withdrawal by Subject|2|||
162754245|NCT04882917|587812439|FG003|Overall Study|Withdrawal by Subject|1|||
162754246|NCT04882917|587812436|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
162754247|NCT04882917|587812437|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162754248|NCT04882917|587812438|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162754249|NCT04882917|587812439|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162754250|NCT00319020|587812440|FG000|Overall Study|Death|2|||
162754251|NCT00319020|587812441|FG001|Overall Study|Death|2|||
162754252|NCT00319020|587812440|FG000|Overall Study|Withdrawal by Subject|4|||
162754253|NCT00319020|587812441|FG001|Overall Study|Withdrawal by Subject|1|||
162754254|NCT00319020|587812440|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
162754255|NCT00319020|587812441|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
162754256|NCT00319020|587812440|FG000|Overall Study|Administrative reason|0|||
162754257|NCT00319020|587812441|FG001|Overall Study|Administrative reason|5|||
162754258|NCT00319020|587812440|FG000|Overall Study|Disease progression|0|||
162754259|NCT00319020|587812441|FG001|Overall Study|Disease progression|2|||
162754260|NCT00319020|587812440|FG000|Overall Study|Transplant|0|||
162754261|NCT00319020|587812441|FG001|Overall Study|Transplant|1|||
162754262|NCT00319020|587812440|FG000|Overall Study|Treatment failure|0|||
162754263|NCT00319020|587812441|FG001|Overall Study|Treatment failure|1|||
162754264|NCT00319020|587812440|FG000|Overall Study|Adverse Event|0|||
162754265|NCT00319020|587812441|FG001|Overall Study|Adverse Event|1|||
162754266|NCT03959423|587812442|FG000|Overall Study|Withdrawal by Subject|2|||
162754267|NCT03959423|587812443|FG001|Overall Study|Withdrawal by Subject|3|||
162754268|NCT03959423|587812442|FG000|Overall Study|Physician Decision|0|||
162754269|NCT03959423|587812443|FG001|Overall Study|Physician Decision|1|||
162754270|NCT03959423|587812442|FG000|Overall Study|Lost to Follow-up|1|||
162754271|NCT03959423|587812443|FG001|Overall Study|Lost to Follow-up|0|||
162754272|NCT03959423|587812442|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
162754273|NCT03959423|587812443|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162754274|NCT04926740|587812446|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
162754275|NCT04926740|587812447|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
162754276|NCT04926740|587812446|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
162754277|NCT04926740|587812447|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
162754278|NCT04980300|587812448|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
162754279|NCT04980300|587812449|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
162754280|NCT04980300|587812448|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
162754281|NCT04980300|587812449|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
162754282|NCT04980300|587812448|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
162754283|NCT04980300|587812449|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
162754284|NCT04980300|587812448|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
162754285|NCT04980300|587812449|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
162754286|NCT00593840|587812454|FG000|Overall Study|Withdrawal by Subject|1|||
162754287|NCT06056310|587813548|FG000|Overall Study|Other Reasons|2|||
162754288|NCT06056310|587813548|FG000|Overall Study|Sponsor Request|16|||
162754289|NCT04989816|587813559|FG000|Overall Study|Death|77|||
162754290|NCT04989816|587813559|FG000|Overall Study|Lost to Follow-up|3|||
162754291|NCT01184326|587813560|FG000|Overall Study|Adverse Event|1|||
162754292|NCT01184326|587813561|FG001|Overall Study|Adverse Event|2|||
162754293|NCT01184326|587813562|FG002|Overall Study|Adverse Event|0|||
162754294|NCT01184326|587813560|FG000|Overall Study|Death|0|||
162754295|NCT01184326|587813561|FG001|Overall Study|Death|0|||
162754296|NCT01184326|587813562|FG002|Overall Study|Death|1|||
162754297|NCT01184326|587813560|FG000|Overall Study|Withdrawal by Subject|0|||
162754298|NCT01184326|587813561|FG001|Overall Study|Withdrawal by Subject|0|||
162754299|NCT01184326|587813562|FG002|Overall Study|Withdrawal by Subject|1|||
162754300|NCT01184326|587813560|FG000|Overall Study|Physician Decision|1|||
162754301|NCT01184326|587813561|FG001|Overall Study|Physician Decision|1|||
162754302|NCT01184326|587813562|FG002|Overall Study|Physician Decision|0|||
162754303|NCT01184326|587813560|FG000|Overall Study|Disease Progression|1|||
162754304|NCT01184326|587813561|FG001|Overall Study|Disease Progression|3|||
162754305|NCT01184326|587813562|FG002|Overall Study|Disease Progression|12|||
162925385|NCT00110084|588428953|FG000|Overall Study|Alternate Therapy|5|||
162754306|NCT01036724|587813563|FG000|Overall Study|Adverse Event|1|||
162754307|NCT01036724|587813564|FG001|Overall Study|Adverse Event|2|||
162754308|NCT01036724|587813563|FG000|Overall Study|Lack of Efficacy|1|||
162754309|NCT01036724|587813564|FG001|Overall Study|Lack of Efficacy|1|||
162754310|NCT01036724|587813563|FG000|Overall Study|Protocol Violation|4|||
162754311|NCT01036724|587813564|FG001|Overall Study|Protocol Violation|5|||
162754312|NCT02866942|587813566|FG000|Overall Study|Invalid consent|1|||
162754313|NCT01750684|587813567|FG000|Overall Study|Death|1|||
162754314|NCT01750684|587813568|FG001|Overall Study|Death|0|||
162754315|NCT01750684|587813567|FG000|Overall Study|Non-compliance with Study Drug|0|||
162754316|NCT01750684|587813568|FG001|Overall Study|Non-compliance with Study Drug|1|||
162754317|NCT01750684|587813567|FG000|Overall Study|Withdrawn by Sponsor|0|||
162754318|NCT01750684|587813568|FG001|Overall Study|Withdrawn by Sponsor|1|||
162754319|NCT01750684|587813567|FG000|Overall Study|Protocol Violation|1|||
162754320|NCT01750684|587813568|FG001|Overall Study|Protocol Violation|0|||
162754321|NCT00372775|587813569|FG000|Overall Study|Adverse Event|8|||
162754322|NCT00372775|587813569|FG000|Overall Study|Death|15|||
162754323|NCT00372775|587813569|FG000|Overall Study|Objective progression or relapse|30|||
162754324|NCT00372775|587813569|FG000|Overall Study|Global deterioration of health status|6|||
162754325|NCT00372775|587813569|FG000|Overall Study|Withdrawal by Subject|1|||
162754326|NCT00372775|587813569|FG000|Overall Study|Other|1|||
162754327|NCT00372775|587813569|FG000|Overall Study|Not Treated|2|||
162754328|NCT01561300|587813570|FG000|Run in on Placebo|Adverse Event|1|||
162754329|NCT01561300|587813571|FG001|Run in on Placebo|Adverse Event|0|||
162754330|NCT00777049|587813572|FG000|Overall Study|Withdrawal by Subject|1|||
162754331|NCT00777049|587813573|FG001|Overall Study|Withdrawal by Subject|0|||
162754332|NCT00777049|587813572|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
162754333|NCT00777049|587813573|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
162754334|NCT01436175|587813574|FG000|Overall Study|Adverse Event|111|||
162754335|NCT01436175|587813574|FG000|Overall Study|Protocol Violation|49|||
162754336|NCT01436175|587813574|FG000|Overall Study|Withdrawal by Subject|108|||
162754337|NCT01436175|587813574|FG000|Overall Study|Lost to Follow-up|89|||
162754338|NCT01436175|587813574|FG000|Overall Study|Lack of Efficacy|24|||
162754339|NCT01436175|587813574|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
162754340|NCT01436175|587813574|FG000|Overall Study|Other|826|||
162754341|NCT00754065|587813579|FG000|Overall Study|Never received treatment|12|||
162754342|NCT00754065|587813580|FG001|Overall Study|Never received treatment|2|||
162754343|NCT00754065|587813579|FG000|Overall Study|Adverse Event|19|||
162754344|NCT00754065|587813580|FG001|Overall Study|Adverse Event|25|||
162754345|NCT00754065|587813579|FG000|Overall Study|Lost to Follow-up|7|||
162754346|NCT00754065|587813580|FG001|Overall Study|Lost to Follow-up|11|||
162754347|NCT00754065|587813579|FG000|Overall Study|Protocol Violation|12|||
162754348|NCT00754065|587813580|FG001|Overall Study|Protocol Violation|10|||
162754349|NCT00754065|587813579|FG000|Overall Study|Withdrawal by Subject|4|||
162754350|NCT00754065|587813580|FG001|Overall Study|Withdrawal by Subject|5|||
162754351|NCT00754065|587813579|FG000|Overall Study|Pregnancy|6|||
162754352|NCT00754065|587813580|FG001|Overall Study|Pregnancy|0|||
162754353|NCT00754065|587813579|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
162754354|NCT00754065|587813580|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
162754355|NCT04353492|587813583|FG000|Overall Study|Subject decision|24|||
162754356|NCT04353492|587813583|FG000|Overall Study|Physician Decision|5|||
162754357|NCT04353492|587813583|FG000|Overall Study|Adverse Event|3|||
162754358|NCT04353492|587813583|FG000|Overall Study|Pregnancy|3|||
162754359|NCT04353492|587813583|FG000|Overall Study|Lost to Follow-up|2|||
162754360|NCT04353492|587813583|FG000|Overall Study|Protocol deviation|1|||
162754361|NCT04353492|587813583|FG000|Overall Study|Technical problems|1|||
162754362|NCT04250194|587813584|FG000|Overall Study|Declined to schedule biopsy|6|||
162754363|NCT04250194|587813585|FG001|Overall Study|Declined to schedule biopsy|10|||
162754364|NCT04250194|587813584|FG000|Overall Study|Medically Unfit for Biopsy|2|||
162754365|NCT04250194|587813585|FG001|Overall Study|Medically Unfit for Biopsy|1|||
162754366|NCT04250194|587813584|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
162754367|NCT04250194|587813585|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
162754368|NCT04250194|587813584|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
162754369|NCT04250194|587813585|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
162754370|NCT04250194|587813584|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
162754371|NCT04250194|587813585|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
162754372|NCT00623194|587813588|FG000|Overall Study|Lack of Efficacy|1|||
162754373|NCT00623194|587813588|FG000|Overall Study|Protocol Violation|3|||
162754374|NCT00623194|587813588|FG000|Overall Study|Unclassified|1|||
162754375|NCT01952366|587813589|FG000|Overall Study|Death|22|||
162754376|NCT01952366|587813589|FG000|Overall Study|Withdrawal by Subject|9|||
162754377|NCT00857766|587813590|FG000|Overall Study|Adverse Event|13|||
162754378|NCT00857766|587813591|FG001|Overall Study|Adverse Event|12|||
162754379|NCT00857766|587813590|FG000|Overall Study|Protocol Violation|11|||
162754380|NCT00857766|587813591|FG001|Overall Study|Protocol Violation|11|||
162754381|NCT00857766|587813590|FG000|Overall Study|Lost to Follow-up|1|||
162754382|NCT00857766|587813591|FG001|Overall Study|Lost to Follow-up|0|||
162754383|NCT00857766|587813590|FG000|Overall Study|Investigator Discretion|2|||
162754384|NCT00857766|587813591|FG001|Overall Study|Investigator Discretion|3|||
162754385|NCT00857766|587813590|FG000|Overall Study|Participant Withdrew Consent|4|||
162754386|NCT00857766|587813591|FG001|Overall Study|Participant Withdrew Consent|4|||
162754387|NCT01961609|587813592|FG000|Initiation|Missing|3|||
162754388|NCT01961609|587813593|FG001|Initiation|Missing|2|||
162754389|NCT01961609|587813594|FG002|Initiation|Missing|0|||
162754390|NCT01961609|587813595|FG003|Initiation|Missing|0|||
162754391|NCT01961609|587813592|FG000|Initiation|Protocol deviation|1|||
162754392|NCT01961609|587813593|FG001|Initiation|Protocol deviation|0|||
162754393|NCT01961609|587813594|FG002|Initiation|Protocol deviation|0|||
162754394|NCT01961609|587813595|FG003|Initiation|Protocol deviation|0|||
162754395|NCT01961609|587813592|FG000|Initiation|Death|0|||
162754396|NCT01961609|587813593|FG001|Initiation|Death|1|||
162754397|NCT01961609|587813594|FG002|Initiation|Death|0|||
162754398|NCT01961609|587813595|FG003|Initiation|Death|0|||
162754399|NCT01961609|587813592|FG000|Initiation|Administrative problems|1|||
162754400|NCT01961609|587813593|FG001|Initiation|Administrative problems|0|||
162754401|NCT01961609|587813594|FG002|Initiation|Administrative problems|0|||
162754402|NCT01961609|587813595|FG003|Initiation|Administrative problems|0|||
162754403|NCT01961609|587813592|FG000|Initiation|Withdrawal by Subject|1|||
162754404|NCT01961609|587813593|FG001|Initiation|Withdrawal by Subject|2|||
162754405|NCT01961609|587813594|FG002|Initiation|Withdrawal by Subject|0|||
162754406|NCT01961609|587813595|FG003|Initiation|Withdrawal by Subject|0|||
162754407|NCT01961609|587813592|FG000|Initiation|Lack of Efficacy|2|||
162754408|NCT01961609|587813593|FG001|Initiation|Lack of Efficacy|1|||
162754409|NCT01961609|587813594|FG002|Initiation|Lack of Efficacy|0|||
162754410|NCT01961609|587813595|FG003|Initiation|Lack of Efficacy|0|||
162754411|NCT01961609|587813592|FG000|Initiation|Abnormal lab values|0|||
162754412|NCT01961609|587813593|FG001|Initiation|Abnormal lab values|1|||
162754413|NCT01961609|587813594|FG002|Initiation|Abnormal lab values|0|||
162754414|NCT01961609|587813595|FG003|Initiation|Abnormal lab values|0|||
162754415|NCT01961609|587813592|FG000|Initiation|Adverse Event|3|||
162754416|NCT01961609|587813593|FG001|Initiation|Adverse Event|5|||
162754417|NCT01961609|587813594|FG002|Initiation|Adverse Event|0|||
162754418|NCT01961609|587813595|FG003|Initiation|Adverse Event|0|||
162754419|NCT01961609|587813592|FG000|Initiation|Randomized but not treated|1|||
162754420|NCT01961609|587813593|FG001|Initiation|Randomized but not treated|1|||
162754421|NCT01961609|587813594|FG002|Initiation|Randomized but not treated|0|||
162754422|NCT01961609|587813595|FG003|Initiation|Randomized but not treated|0|||
162754423|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
162754424|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
162754425|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
162754426|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
162754427|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
162754428|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
162754429|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
162754430|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
162754431|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
162754432|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
162754433|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
162754434|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
162754435|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
162754436|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
162754437|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
162754438|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
162754439|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
162754440|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
162754441|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
162754442|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
162754443|NCT01961609|587813592|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162754444|NCT01961609|587813593|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162754445|NCT01961609|587813594|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
162754446|NCT01961609|587813595|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162754447|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
162754448|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
162754449|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
162754450|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
162754451|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162754452|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162754453|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
162754454|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162754455|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
162754456|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162754457|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162754458|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162754459|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162754460|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
162754461|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162754462|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162754463|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
162754464|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
162754465|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
162754466|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
162754467|NCT01961609|587813592|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
162754468|NCT01961609|587813593|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
162754469|NCT01961609|587813594|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
162754470|NCT01961609|587813595|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
162754471|NCT01988402|587813596|FG000|Overall Study|Adverse Event|1|||
162754472|NCT01988402|587813597|FG001|Overall Study|Adverse Event|2|||
162754473|NCT01988402|587813596|FG000|Overall Study|Withdrawal by Subject|1|||
162754474|NCT01988402|587813597|FG001|Overall Study|Withdrawal by Subject|0|||
162754475|NCT01212744|587813598|FG000|Overall Study|Withdrawal by Subject|1|||
162754476|NCT00571649|587813599|FG000|Treatment Period|Adverse Event|438|||
162754477|NCT00571649|587813600|FG001|Treatment Period|Adverse Event|385|||
162754478|NCT00571649|587813599|FG000|Treatment Period|Clinical endpoint reached|50|||
162754479|NCT00571649|587813600|FG001|Treatment Period|Clinical endpoint reached|56|||
162754480|NCT00571649|587813599|FG000|Treatment Period|Withdrawal by Subject|285|||
162754481|NCT00571649|587813600|FG001|Treatment Period|Withdrawal by Subject|255|||
162754482|NCT00571649|587813599|FG000|Treatment Period|Death|76|||
162754483|NCT00571649|587813600|FG001|Treatment Period|Death|59|||
162754484|NCT00571649|587813599|FG000|Treatment Period|Physician Decision|8|||
162754485|NCT00571649|587813600|FG001|Treatment Period|Physician Decision|9|||
162754486|NCT00571649|587813599|FG000|Treatment Period|Lost to Follow-up|43|||
162754487|NCT00571649|587813600|FG001|Treatment Period|Lost to Follow-up|41|||
162754488|NCT00571649|587813599|FG000|Treatment Period|Non-compliant with study medication|88|||
162754489|NCT00571649|587813600|FG001|Treatment Period|Non-compliant with study medication|89|||
162754490|NCT00571649|587813599|FG000|Treatment Period|Patient convenience|11|||
162754491|NCT00571649|587813600|FG001|Treatment Period|Patient convenience|13|||
162754492|NCT00571649|587813599|FG000|Treatment Period|Protocol Violation|90|||
162754493|NCT00571649|587813600|FG001|Treatment Period|Protocol Violation|92|||
162754494|NCT00571649|587813599|FG000|Treatment Period|Technical problems|3|||
162754495|NCT00571649|587813600|FG001|Treatment Period|Technical problems|5|||
162754496|NCT00571649|587813599|FG000|Follow-up Period|Adverse Event|46|||
162754497|NCT00571649|587813600|FG001|Follow-up Period|Adverse Event|40|||
162754498|NCT00571649|587813599|FG000|Follow-up Period|Clinical endpoint reached|5|||
162754499|NCT00571649|587813600|FG001|Follow-up Period|Clinical endpoint reached|2|||
162754500|NCT00571649|587813599|FG000|Follow-up Period|Withdrawal by Subject|119|||
162754501|NCT00571649|587813600|FG001|Follow-up Period|Withdrawal by Subject|115|||
162754502|NCT00571649|587813599|FG000|Follow-up Period|Death|132|||
162754503|NCT00571649|587813600|FG001|Follow-up Period|Death|133|||
162754504|NCT00571649|587813599|FG000|Follow-up Period|Physician Decision|7|||
162754505|NCT00571649|587813600|FG001|Follow-up Period|Physician Decision|13|||
162754506|NCT00571649|587813599|FG000|Follow-up Period|Lost to Follow-up|95|||
162754507|NCT00571649|587813600|FG001|Follow-up Period|Lost to Follow-up|92|||
162754508|NCT00571649|587813599|FG000|Follow-up Period|Patient convenience|136|||
162754509|NCT00571649|587813600|FG001|Follow-up Period|Patient convenience|121|||
162754510|NCT00571649|587813599|FG000|Follow-up Period|Protocol Violation|5|||
162754511|NCT00571649|587813600|FG001|Follow-up Period|Protocol Violation|12|||
162754512|NCT01566890|587813601|FG000|Overall Study|Adverse Event|1|||
162754513|NCT01566890|587813602|FG001|Overall Study|Adverse Event|0|||
162754514|NCT01566890|587813603|FG002|Overall Study|Adverse Event|0|||
162754515|NCT01566890|587813604|FG003|Overall Study|Adverse Event|0|||
162754516|NCT01566890|587813605|FG004|Overall Study|Adverse Event|0|||
162754517|NCT01566890|587813601|FG000|Overall Study|Withdrawal by Subject|3|||
162754518|NCT01566890|587813602|FG001|Overall Study|Withdrawal by Subject|1|||
162754519|NCT01566890|587813603|FG002|Overall Study|Withdrawal by Subject|1|||
162754520|NCT01566890|587813604|FG003|Overall Study|Withdrawal by Subject|1|||
162754521|NCT01566890|587813605|FG004|Overall Study|Withdrawal by Subject|0|||
162754522|NCT01566890|587813601|FG000|Overall Study|Screen failure|6|||
162754523|NCT01566890|587813602|FG001|Overall Study|Screen failure|0|||
162754524|NCT01566890|587813603|FG002|Overall Study|Screen failure|1|||
162754525|NCT01566890|587813604|FG003|Overall Study|Screen failure|1|||
162754526|NCT01566890|587813605|FG004|Overall Study|Screen failure|0|||
162754527|NCT01566890|587813601|FG000|Overall Study|Incomplete CEU data|1|||
162754528|NCT01566890|587813602|FG001|Overall Study|Incomplete CEU data|3|||
162754529|NCT01566890|587813603|FG002|Overall Study|Incomplete CEU data|5|||
162754530|NCT01566890|587813604|FG003|Overall Study|Incomplete CEU data|8|||
162754531|NCT01566890|587813605|FG004|Overall Study|Incomplete CEU data|0|||
162754532|NCT01566890|587813601|FG000|Overall Study|Lost to Follow-up|0|||
162754533|NCT01566890|587813602|FG001|Overall Study|Lost to Follow-up|0|||
162754534|NCT01566890|587813603|FG002|Overall Study|Lost to Follow-up|4|||
162754535|NCT01566890|587813604|FG003|Overall Study|Lost to Follow-up|4|||
162754536|NCT01566890|587813605|FG004|Overall Study|Lost to Follow-up|0|||
162754537|NCT01566890|587813601|FG000|Overall Study|Other|0|||
162754538|NCT01566890|587813602|FG001|Overall Study|Other|0|||
162754539|NCT01566890|587813603|FG002|Overall Study|Other|0|||
162754540|NCT01566890|587813604|FG003|Overall Study|Other|0|||
162754541|NCT01566890|587813605|FG004|Overall Study|Other|7|||
162754542|NCT02397096|587813608|FG000|Day 1 to Week 24|Adverse Event|7|||
162754543|NCT02397096|587813609|FG001|Day 1 to Week 24|Adverse Event|1|||
162754544|NCT02397096|587813608|FG000|Day 1 to Week 24|Death|1|||
162754545|NCT02397096|587813609|FG001|Day 1 to Week 24|Death|0|||
162754546|NCT02397096|587813608|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
162754547|NCT02397096|587813609|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
162754548|NCT02397096|587813608|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
162754549|NCT02397096|587813609|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
162754550|NCT02397096|587813608|FG000|Day 1 to Week 24|Physician Decision|2|||
162754551|NCT02397096|587813609|FG001|Day 1 to Week 24|Physician Decision|3|||
162754552|NCT02397096|587813608|FG000|Day 1 to Week 24|Protocol Violation|1|||
162754553|NCT02397096|587813609|FG001|Day 1 to Week 24|Protocol Violation|4|||
162754554|NCT02397096|587813608|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
162754555|NCT02397096|587813609|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
162754556|NCT02397096|587813608|FG000|Day 1 to Week 24|Randomized, not treated|3|||
162754557|NCT02397096|587813609|FG001|Day 1 to Week 24|Randomized, not treated|0|||
162754558|NCT02397096|587813608|FG000|Week 24 to Week 48|Adverse Event|6|||
162754559|NCT02397096|587813609|FG001|Week 24 to Week 48|Adverse Event|2|||
162754560|NCT02397096|587813608|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
162754561|NCT02397096|587813609|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
162754562|NCT02397096|587813608|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
162754563|NCT02397096|587813609|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
162754564|NCT02397096|587813608|FG000|Week 24 to Week 48|Physician Decision|2|||
162754565|NCT02397096|587813609|FG001|Week 24 to Week 48|Physician Decision|1|||
162754566|NCT02397096|587813608|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
162754567|NCT02397096|587813609|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
162754568|NCT02397096|587813608|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
162754569|NCT02397096|587813609|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
162754570|NCT02397096|587813608|FG000|Study Extension 1|Adverse Event|7|||
162754571|NCT02397096|587813609|FG001|Study Extension 1|Adverse Event|5|||
162754572|NCT02397096|587813608|FG000|Study Extension 1|Death|1|||
162754573|NCT02397096|587813609|FG001|Study Extension 1|Death|0|||
162754574|NCT02397096|587813608|FG000|Study Extension 1|Lack of Efficacy|2|||
162754575|NCT02397096|587813609|FG001|Study Extension 1|Lack of Efficacy|5|||
162754576|NCT02397096|587813608|FG000|Study Extension 1|Lost to Follow-up|2|||
162754577|NCT02397096|587813609|FG001|Study Extension 1|Lost to Follow-up|3|||
162754578|NCT02397096|587813608|FG000|Study Extension 1|Non-compliance with study drug|3|||
162754579|NCT02397096|587813609|FG001|Study Extension 1|Non-compliance with study drug|0|||
162754580|NCT02397096|587813608|FG000|Study Extension 1|Physician Decision|4|||
162754581|NCT02397096|587813609|FG001|Study Extension 1|Physician Decision|2|||
162754582|NCT02397096|587813608|FG000|Study Extension 1|Pregnancy|1|||
162754583|NCT02397096|587813609|FG001|Study Extension 1|Pregnancy|0|||
162754584|NCT02397096|587813608|FG000|Study Extension 1|Protocol Violation|0|||
162754585|NCT02397096|587813609|FG001|Study Extension 1|Protocol Violation|1|||
162754586|NCT02397096|587813608|FG000|Study Extension 1|Withdrawal by Subject|21|||
162754587|NCT02397096|587813609|FG001|Study Extension 1|Withdrawal by Subject|7|||
162754588|NCT02397096|587813608|FG000|Study Extension 2|Adverse Event|3|||
162754589|NCT02397096|587813609|FG001|Study Extension 2|Adverse Event|3|||
162754590|NCT02397096|587813608|FG000|Study Extension 2|Availability of study medication locally|152|||
162754591|NCT02397096|587813609|FG001|Study Extension 2|Availability of study medication locally|64|||
162754592|NCT02397096|587813608|FG000|Study Extension 2|Death|2|||
162754593|NCT02397096|587813609|FG001|Study Extension 2|Death|0|||
162754594|NCT02397096|587813608|FG000|Study Extension 2|Lack of Efficacy|1|||
162754595|NCT02397096|587813609|FG001|Study Extension 2|Lack of Efficacy|0|||
162754596|NCT02397096|587813608|FG000|Study Extension 2|Lost to Follow-up|2|||
162754597|NCT02397096|587813609|FG001|Study Extension 2|Lost to Follow-up|1|||
162754598|NCT02397096|587813608|FG000|Study Extension 2|Non-compliance with study drug|1|||
162754599|NCT02397096|587813609|FG001|Study Extension 2|Non-compliance with study drug|0|||
162754600|NCT02397096|587813608|FG000|Study Extension 2|Physician Decision|2|||
162754601|NCT02397096|587813609|FG001|Study Extension 2|Physician Decision|5|||
162754602|NCT02397096|587813608|FG000|Study Extension 2|Pregnancy|1|||
162754603|NCT02397096|587813609|FG001|Study Extension 2|Pregnancy|0|||
162754604|NCT02397096|587813608|FG000|Study Extension 2|Withdrawal by Subject|10|||
162754605|NCT02397096|587813609|FG001|Study Extension 2|Withdrawal by Subject|3|||
162754606|NCT02397096|587813608|FG000|Study Extension 3|Adverse Event|1|||
162754607|NCT02397096|587813609|FG001|Study Extension 3|Adverse Event|0|||
162754608|NCT02397096|587813608|FG000|Study Extension 3|Availability of study medication locally|11|||
162754609|NCT02397096|587813609|FG001|Study Extension 3|Availability of study medication locally|3|||
162754610|NCT02397096|587813608|FG000|Study Extension 3|Lost to Follow-up|1|||
162754611|NCT02397096|587813609|FG001|Study Extension 3|Lost to Follow-up|0|||
162754612|NCT02397096|587813608|FG000|Study Extension 3|Withdrawal by Subject|2|||
162754613|NCT02397096|587813609|FG001|Study Extension 3|Withdrawal by Subject|1|||
162754614|NCT00274261|587813610|FG000|Overall Study|Adverse Event|19|||
162754615|NCT00274261|587813611|FG001|Overall Study|Adverse Event|11|||
162754616|NCT00274261|587813610|FG000|Overall Study|Pregnancy|114|||
162754617|NCT00274261|587813611|FG001|Overall Study|Pregnancy|83|||
162754618|NCT00274261|587813610|FG000|Overall Study|Withdrawal by Subject|179|||
162754619|NCT00274261|587813611|FG001|Overall Study|Withdrawal by Subject|126|||
162754620|NCT00274261|587813610|FG000|Overall Study|Protocol Violation|71|||
162754621|NCT00274261|587813611|FG001|Overall Study|Protocol Violation|42|||
162754622|NCT00274261|587813610|FG000|Overall Study|Lost to Follow-up|106|||
162754623|NCT00274261|587813611|FG001|Overall Study|Lost to Follow-up|75|||
162754624|NCT03500549|587813612|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
162754625|NCT03500549|587813613|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
162754626|NCT03500549|587813612|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
162754627|NCT03500549|587813613|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
162754628|NCT02016872|587813614|FG000|Overall Study|Withdrawal by Subject|10|||
162754629|NCT02016872|587813614|FG000|Overall Study|Death Progression|2|||
162754630|NCT02016872|587813614|FG000|Overall Study|No FMISO scan|1|||
162754631|NCT02016872|587813614|FG000|Overall Study|Ineligible|2|||
162754632|NCT05018143|587813615|FG000|Overall Study|Lost to Follow-up|5|||
162754633|NCT05018143|587813616|FG001|Overall Study|Lost to Follow-up|4|||
162754634|NCT05018143|587813615|FG000|Overall Study|Withdrawal by Subject|0|||
162754635|NCT05018143|587813616|FG001|Overall Study|Withdrawal by Subject|1|||
162754636|NCT06688357|587813617|FG000|Overall Study|Adverse Event|0|||
162754637|NCT06688357|587813618|FG001|Overall Study|Adverse Event|1|||
162754654|NCT00545545|587813625|FG000|Overall Study|Progressive Neoplastic Disease|1|||
162754655|NCT00545545|587813626|FG001|Overall Study|Progressive Neoplastic Disease|5|||
162754656|NCT00545545|587813627|FG002|Overall Study|Progressive Neoplastic Disease|0|||
162754657|NCT00545545|587813628|FG003|Overall Study|Progressive Neoplastic Disease|4|||
162754658|NCT00545545|587813629|FG004|Overall Study|Progressive Neoplastic Disease|8|||
162754659|NCT00545545|587813630|FG005|Overall Study|Progressive Neoplastic Disease|7|||
162754660|NCT00545545|587813625|FG000|Overall Study|Withdrawal by Subject|0|||
162754661|NCT00545545|587813626|FG001|Overall Study|Withdrawal by Subject|1|||
162754662|NCT00545545|587813627|FG002|Overall Study|Withdrawal by Subject|0|||
162754663|NCT00545545|587813628|FG003|Overall Study|Withdrawal by Subject|0|||
162754664|NCT00545545|587813629|FG004|Overall Study|Withdrawal by Subject|0|||
162754665|NCT00545545|587813630|FG005|Overall Study|Withdrawal by Subject|0|||
162754666|NCT00545545|587813625|FG000|Overall Study|Physician Decision|1|||
162754667|NCT00545545|587813626|FG001|Overall Study|Physician Decision|0|||
162754668|NCT00545545|587813627|FG002|Overall Study|Physician Decision|0|||
162754669|NCT00545545|587813628|FG003|Overall Study|Physician Decision|0|||
162754670|NCT00545545|587813629|FG004|Overall Study|Physician Decision|0|||
162754671|NCT00545545|587813630|FG005|Overall Study|Physician Decision|1|||
162754672|NCT00545545|587813625|FG000|Overall Study|Irinotecan intolerance|1|||
162754673|NCT00545545|587813626|FG001|Overall Study|Irinotecan intolerance|1|||
162754674|NCT00545545|587813627|FG002|Overall Study|Irinotecan intolerance|0|||
162754675|NCT00545545|587813628|FG003|Overall Study|Irinotecan intolerance|0|||
162754676|NCT00545545|587813629|FG004|Overall Study|Irinotecan intolerance|0|||
162754677|NCT00545545|587813630|FG005|Overall Study|Irinotecan intolerance|0|||
162754678|NCT00545545|587813625|FG000|Overall Study|No target lesions to track post surgery|0|||
162754679|NCT00545545|587813626|FG001|Overall Study|No target lesions to track post surgery|0|||
162754680|NCT00545545|587813627|FG002|Overall Study|No target lesions to track post surgery|0|||
162754681|NCT00545545|587813628|FG003|Overall Study|No target lesions to track post surgery|0|||
162754682|NCT00545545|587813629|FG004|Overall Study|No target lesions to track post surgery|1|||
162754683|NCT00545545|587813630|FG005|Overall Study|No target lesions to track post surgery|1|||
162754684|NCT02761187|587813634|FG000|Overall Study|Too ill to Participate|13|||
162754685|NCT02761187|587813635|FG001|Overall Study|Too ill to Participate|8|||
162754686|NCT02761187|587813634|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
162754687|NCT02761187|587813635|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
162754688|NCT02761187|587813634|FG000|Overall Study|Patient withdrew consent|64|||
162754689|NCT02761187|587813635|FG001|Overall Study|Patient withdrew consent|58|||
162754690|NCT02761187|587813634|FG000|Overall Study|Physician discretion|4|||
162754691|NCT02761187|587813635|FG001|Overall Study|Physician discretion|8|||
162754692|NCT02761187|587813634|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
162754693|NCT02761187|587813635|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
162754694|NCT02761187|587813634|FG000|Overall Study|On Hospice|20|||
162754695|NCT02761187|587813635|FG001|Overall Study|On Hospice|26|||
162754696|NCT02761187|587813634|FG000|Overall Study|Deceased|474|||
162754697|NCT02761187|587813635|FG001|Overall Study|Deceased|642|||
162754698|NCT02761187|587813634|FG000|Overall Study|Lost to Follow-up|73|||
162754699|NCT02761187|587813635|FG001|Overall Study|Lost to Follow-up|63|||
162754700|NCT02761187|587813634|FG000|Overall Study|Due to study discontinued at site|100|||
162754701|NCT02761187|587813635|FG001|Overall Study|Due to study discontinued at site|85|||
162754702|NCT02761187|587813634|FG000|Overall Study|Reason not Specified|1484|||
162754703|NCT02761187|587813635|FG001|Overall Study|Reason not Specified|937|||
162754704|NCT05704725|587813637|FG000|Overall Study|Lost to Follow-up|0|||
162754705|NCT05704725|587813638|FG001|Overall Study|Lost to Follow-up|1|||
162754706|NCT05704725|587813637|FG000|Overall Study|Withdrawal by Subject|1|||
162754707|NCT05704725|587813638|FG001|Overall Study|Withdrawal by Subject|0|||
162754708|NCT01470144|587813639|FG000|Overall Study|Adverse Event|2|||
162754709|NCT01470144|587813639|FG000|Overall Study|Death|1|||
162754710|NCT01470144|587813639|FG000|Overall Study|Lung transplant|6|||
162754711|NCT01470144|587813639|FG000|Overall Study|Patient's and investigator's decision|1|||
162754712|NCT05802173|587814786|FG000|Overall Study|Withdrawal by Subject|2|||
162754713|NCT05802173|587814787|FG001|Overall Study|Withdrawal by Subject|0|||
162754714|NCT05802173|587814788|FG002|Overall Study|Withdrawal by Subject|0|||
162754715|NCT05802173|587814786|FG000|Overall Study|Protocol Violation|1|||
162754716|NCT05802173|587814787|FG001|Overall Study|Protocol Violation|0|||
162754717|NCT05802173|587814788|FG002|Overall Study|Protocol Violation|0|||
162754718|NCT05802173|587814786|FG000|Overall Study|Lost to Follow-up|0|||
162754719|NCT05802173|587814787|FG001|Overall Study|Lost to Follow-up|6|||
162754720|NCT05802173|587814788|FG002|Overall Study|Lost to Follow-up|4|||
162754721|NCT05802173|587814786|FG000|Overall Study|non-compliance|0|||
162754722|NCT05802173|587814787|FG001|Overall Study|non-compliance|1|||
162754723|NCT05802173|587814788|FG002|Overall Study|non-compliance|0|||
162754724|NCT04503681|587814789|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
162754725|NCT04503681|587814790|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
162754726|NCT03352713|587814791|FG000|Overall Study|Lost to Follow-up|8|||
162754727|NCT03352713|587814791|FG000|Overall Study|Withdrawn by investigator|5|||
162754728|NCT03352713|587814791|FG000|Overall Study|Completed 0 EMAs|8|||
162754729|NCT03352713|587814791|FG000|Overall Study|Device incompatible/stolen|5|||
162754730|NCT01812759|587814792|FG000|Overall Study|Physician Decision|0|||
162754731|NCT01812759|587814793|FG001|Overall Study|Physician Decision|0|||
162754732|NCT01812759|587814794|FG002|Overall Study|Physician Decision|1|||
162754733|NCT00360269|587814795|FG000|Overall Study|Lost to Follow-up|7|||
162754734|NCT00360269|587814796|FG001|Overall Study|Lost to Follow-up|9|||
162754735|NCT00360269|587814795|FG000|Overall Study|Physician Decision|1|||
162754736|NCT00360269|587814796|FG001|Overall Study|Physician Decision|2|||
162754737|NCT00360269|587814795|FG000|Overall Study|Adverse Event|1|||
162754738|NCT00360269|587814796|FG001|Overall Study|Adverse Event|0|||
162754739|NCT00360269|587814795|FG000|Overall Study|Withdrawal by Subject|1|||
162754740|NCT00360269|587814796|FG001|Overall Study|Withdrawal by Subject|1|||
162754741|NCT03758638|587814799|FG000|Overall Study|Pregnancy|17|||
162754742|NCT03758638|587814800|FG001|Overall Study|Pregnancy|25|||
162754743|NCT03758638|587814799|FG000|Overall Study|Lost to Follow-up|60|||
162754744|NCT03758638|587814800|FG001|Overall Study|Lost to Follow-up|54|||
162754745|NCT03758638|587814799|FG000|Overall Study|Protocol Violation|2|||
162754746|NCT03758638|587814800|FG001|Overall Study|Protocol Violation|0|||
162754747|NCT03758638|587814799|FG000|Overall Study|Withdrawal by Subject|8|||
162754748|NCT03758638|587814800|FG001|Overall Study|Withdrawal by Subject|2|||
162754749|NCT03758638|587814799|FG000|Overall Study|Providers not included in the primary outcome.|183|||
162754750|NCT03758638|587814800|FG001|Overall Study|Providers not included in the primary outcome.|128|||
162754751|NCT04213807|587814802|FG000|Overall Study|Physician Decision|0|||
162754752|NCT04213807|587814803|FG001|Overall Study|Physician Decision|0|||
162754753|NCT04213807|587814804|FG002|Overall Study|Physician Decision|1|||
162754754|NCT03442777|587814805|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
162754755|NCT03442777|587814806|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
162754756|NCT03442777|587814807|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
162754757|NCT00790569|587814808|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
162754758|NCT00790569|587814809|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
162754759|NCT00790569|587814810|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
162754760|NCT00790569|587814808|FG000|End of Treatment (6 Month Interview)|Death|0|||
162754761|NCT00790569|587814809|FG001|End of Treatment (6 Month Interview)|Death|2|||
162754762|NCT00790569|587814810|FG002|End of Treatment (6 Month Interview)|Death|1|||
162754763|NCT00790569|587814808|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
162754764|NCT00790569|587814809|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
162754765|NCT00790569|587814810|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
162754766|NCT00790569|587814808|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
162754767|NCT00790569|587814809|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
162754768|NCT00790569|587814810|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
162754769|NCT00790569|587814808|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
162754770|NCT00790569|587814809|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
162754771|NCT00790569|587814810|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
162754772|NCT00790569|587814808|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
162754773|NCT00790569|587814809|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
162754774|NCT00790569|587814810|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
162754775|NCT01627561|587814811|FG000|Overall Study|Lost to Follow-up|1|||
162754776|NCT01627561|587814812|FG001|Overall Study|Lost to Follow-up|0|||
162754777|NCT01627561|587814811|FG000|Overall Study|Withdrawal by Subject|0|||
162754778|NCT01627561|587814812|FG001|Overall Study|Withdrawal by Subject|1|||
162754779|NCT01627561|587814811|FG000|Overall Study|Migrated/moved from study area|0|||
162754780|NCT01627561|587814812|FG001|Overall Study|Migrated/moved from study area|2|||
162754781|NCT00724126|587814813|FG000|Overall Study|Adverse Event|2|||
162754782|NCT00724126|587814814|FG001|Overall Study|Adverse Event|0|||
162754783|NCT00724126|587814813|FG000|Overall Study|Withdrawal by Subject|8|||
162754784|NCT00724126|587814814|FG001|Overall Study|Withdrawal by Subject|6|||
162754785|NCT00724126|587814813|FG000|Overall Study|Lost to Follow-up|6|||
162754786|NCT00724126|587814814|FG001|Overall Study|Lost to Follow-up|6|||
162754787|NCT00724126|587814813|FG000|Overall Study|Noncompliance|2|||
162754788|NCT00724126|587814814|FG001|Overall Study|Noncompliance|1|||
162754789|NCT00724126|587814813|FG000|Overall Study|Subject randomized although ineligible|1|||
162754790|NCT00724126|587814814|FG001|Overall Study|Subject randomized although ineligible|1|||
162754791|NCT00724126|587814813|FG000|Overall Study|Subject had to leave vicinity of site|0|||
162754792|NCT00724126|587814814|FG001|Overall Study|Subject had to leave vicinity of site|1|||
162754793|NCT03577106|587814818|FG000|Overall Study|Withdrawal by Subject|3|||
162754794|NCT03451422|587814819|FG000|Overall Study|Lost to Follow-up|0|||
162754795|NCT03451422|587814820|FG001|Overall Study|Lost to Follow-up|0|||
162754796|NCT03451422|587814821|FG002|Overall Study|Lost to Follow-up|0|||
162754797|NCT03451422|587814822|FG003|Overall Study|Lost to Follow-up|0|||
162754798|NCT03451422|587814823|FG004|Overall Study|Lost to Follow-up|0|||
162754799|NCT03451422|587814824|FG005|Overall Study|Lost to Follow-up|1|||
162754800|NCT03451422|587814819|FG000|Overall Study|Decision by sponsor|1|||
162754801|NCT03451422|587814820|FG001|Overall Study|Decision by sponsor|0|||
162754802|NCT03451422|587814821|FG002|Overall Study|Decision by sponsor|1|||
162754803|NCT03451422|587814822|FG003|Overall Study|Decision by sponsor|0|||
162754804|NCT03451422|587814823|FG004|Overall Study|Decision by sponsor|0|||
162754805|NCT03451422|587814824|FG005|Overall Study|Decision by sponsor|0|||
162754806|NCT03451422|587814819|FG000|Overall Study|Withdrawal by Subject|0|||
162754807|NCT03451422|587814820|FG001|Overall Study|Withdrawal by Subject|0|||
162754808|NCT03451422|587814821|FG002|Overall Study|Withdrawal by Subject|2|||
162754809|NCT03451422|587814822|FG003|Overall Study|Withdrawal by Subject|3|||
162754810|NCT03451422|587814823|FG004|Overall Study|Withdrawal by Subject|2|||
162754811|NCT03451422|587814824|FG005|Overall Study|Withdrawal by Subject|1|||
162754812|NCT01579318|587814825|FG000|Overall Study|Disease Progression|1|||
162754813|NCT03601715|587814828|FG000|Second Intervention|Lost to Follow-up|1|||
162754814|NCT03601715|587814829|FG001|Second Intervention|Lost to Follow-up|1|||
162754815|NCT03601715|587814830|FG002|Second Intervention|Lost to Follow-up|0|||
162754816|NCT01478594|587814832|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
162754817|NCT01478594|587814833|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
162754818|NCT01478594|587814832|FG000|Overall Study|Death|45|||
162754819|NCT01478594|587814833|FG001|Overall Study|Death|18|||
162754820|NCT01478594|587814832|FG000|Overall Study|Lost to Follow-up|3|||
162754821|NCT01478594|587814833|FG001|Overall Study|Lost to Follow-up|1|||
162754822|NCT01478594|587814832|FG000|Overall Study|Withdrawal by Subject|9|||
162754823|NCT01478594|587814833|FG001|Overall Study|Withdrawal by Subject|3|||
162754824|NCT01478594|587814832|FG000|Overall Study|Study Closed by Sponsor|8|||
162754825|NCT01478594|587814833|FG001|Overall Study|Study Closed by Sponsor|5|||
162754826|NCT01313884|587814834|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
162754827|NCT01970007|587814835|FG000|Overall Study|Death|5|||
162754828|NCT01970007|587814835|FG000|Overall Study|Withdrawal by Subject|23|||
162754829|NCT01970007|587814835|FG000|Overall Study|Lost to Follow-up|24|||
162754830|NCT01970007|587814835|FG000|Overall Study|"Other endpoint"|3|||
162754831|NCT00523419|587814839|FG000|Overall Study|Adverse Event|1|||
162754832|NCT00523419|587814839|FG000|Overall Study|Withdrawal by Subject|1|||
162754833|NCT00523419|587814839|FG000|Overall Study|Physician Decision|2|||
162754834|NCT00523419|587814839|FG000|Overall Study|Progressive Disease|22|||
162754835|NCT00523419|587814839|FG000|Overall Study|Death due to Study Disease|4|||
162754836|NCT00523419|587814839|FG000|Overall Study|Death due to Adverse Event|2|||
162754837|NCT00822120|587814840|FG000|Initial Registration|Adverse Event|1|||
162754838|NCT00822120|587814841|FG001|Initial Registration|Adverse Event|0|||
162754839|NCT00822120|587814842|FG002|Initial Registration|Adverse Event|0|||
162754840|NCT00822120|587814843|FG003|Initial Registration|Adverse Event|0|||
162754841|NCT00822120|587814844|FG004|Initial Registration|Adverse Event|0|||
162754842|NCT00822120|587814845|FG005|Initial Registration|Adverse Event|0|||
162754843|NCT00822120|587814840|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
162754844|NCT00822120|587814841|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162754845|NCT00822120|587814842|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162754846|NCT00822120|587814843|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162754847|NCT00822120|587814844|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162754848|NCT00822120|587814845|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162754849|NCT00822120|587814840|FG000|Initial Registration|Reasons not Protocol Specified|2|||
162754850|NCT00822120|587814841|FG001|Initial Registration|Reasons not Protocol Specified|0|||
162754851|NCT00822120|587814842|FG002|Initial Registration|Reasons not Protocol Specified|0|||
162754852|NCT00822120|587814843|FG003|Initial Registration|Reasons not Protocol Specified|0|||
162754853|NCT00822120|587814844|FG004|Initial Registration|Reasons not Protocol Specified|0|||
162754854|NCT00822120|587814845|FG005|Initial Registration|Reasons not Protocol Specified|0|||
162754855|NCT00822120|587814840|FG000|Initial Registration|Ineligible|22|||
162754856|NCT00822120|587814841|FG001|Initial Registration|Ineligible|1|||
162754857|NCT00822120|587814842|FG002|Initial Registration|Ineligible|0|||
162754858|NCT00822120|587814843|FG003|Initial Registration|Ineligible|0|||
162754859|NCT00822120|587814844|FG004|Initial Registration|Ineligible|0|||
162754860|NCT00822120|587814845|FG005|Initial Registration|Ineligible|0|||
162754861|NCT00822120|587814840|FG000|PET-directed Therapy|Adverse Event|0|||
162754862|NCT00822120|587814841|FG001|PET-directed Therapy|Adverse Event|0|||
162754863|NCT00822120|587814842|FG002|PET-directed Therapy|Adverse Event|0|||
162754864|NCT00822120|587814843|FG003|PET-directed Therapy|Adverse Event|1|||
162754865|NCT00822120|587814844|FG004|PET-directed Therapy|Adverse Event|0|||
162754866|NCT00822120|587814845|FG005|PET-directed Therapy|Adverse Event|0|||
162754867|NCT00822120|587814840|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162754868|NCT00822120|587814841|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162754869|NCT00822120|587814842|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162754870|NCT00822120|587814843|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
162754871|NCT00822120|587814844|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162754872|NCT00822120|587814845|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162754873|NCT00822120|587814840|FG000|PET-directed Therapy|Death|0|||
162754874|NCT00822120|587814841|FG001|PET-directed Therapy|Death|0|||
162754875|NCT00822120|587814842|FG002|PET-directed Therapy|Death|0|||
162754876|NCT00822120|587814843|FG003|PET-directed Therapy|Death|2|||
162754877|NCT00822120|587814844|FG004|PET-directed Therapy|Death|0|||
162754878|NCT00822120|587814845|FG005|PET-directed Therapy|Death|0|||
162754879|NCT00822120|587814840|FG000|PET-directed Therapy|Protocol Violation|0|||
162754880|NCT00822120|587814841|FG001|PET-directed Therapy|Protocol Violation|0|||
162754881|NCT00822120|587814842|FG002|PET-directed Therapy|Protocol Violation|0|||
162754882|NCT00822120|587814843|FG003|PET-directed Therapy|Protocol Violation|6|||
162754883|NCT00822120|587814844|FG004|PET-directed Therapy|Protocol Violation|0|||
162754884|NCT00822120|587814845|FG005|PET-directed Therapy|Protocol Violation|0|||
162754885|NCT01759862|587814846|FG000|Overall Study|Physician Decision|3|||
162754886|NCT01759862|587814847|FG001|Overall Study|Physician Decision|1|||
162754887|NCT01759862|587814846|FG000|Overall Study|Adverse Event|0|||
162754888|NCT01759862|587814847|FG001|Overall Study|Adverse Event|1|||
162754889|NCT01499849|587814849|FG000|Overall Study|Adverse Event|28|||
162754890|NCT01499849|587814850|FG001|Overall Study|Adverse Event|32|||
162754891|NCT01499849|587814849|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
162754892|NCT01499849|587814850|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
162754893|NCT01499849|587814849|FG000|Overall Study|Withdrawal by Subject|43|||
162754894|NCT01499849|587814850|FG001|Overall Study|Withdrawal by Subject|43|||
162754895|NCT01499849|587814849|FG000|Overall Study|Death|5|||
162754896|NCT01499849|587814850|FG001|Overall Study|Death|7|||
162754897|NCT01499849|587814849|FG000|Overall Study|Disease Progression|11|||
162754898|NCT01499849|587814850|FG001|Overall Study|Disease Progression|10|||
162754899|NCT01499849|587814849|FG000|Overall Study|Protocol Violation|11|||
162754900|NCT01499849|587814850|FG001|Overall Study|Protocol Violation|11|||
162754901|NCT01499849|587814849|FG000|Overall Study|Physician Decision|20|||
162754902|NCT01499849|587814850|FG001|Overall Study|Physician Decision|19|||
162754903|NCT01499849|587814849|FG000|Overall Study|Lack of Efficacy|3|||
162754904|NCT01499849|587814850|FG001|Overall Study|Lack of Efficacy|4|||
162754905|NCT01499849|587814849|FG000|Overall Study|Lost to Follow-up|6|||
162754906|NCT01499849|587814850|FG001|Overall Study|Lost to Follow-up|3|||
162754907|NCT01499849|587814849|FG000|Overall Study|Other Reasons|27|||
162754908|NCT01499849|587814850|FG001|Overall Study|Other Reasons|30|||
162754909|NCT02646618|587814851|FG000|Overall Study|Lost to Follow-up|10|||
162754910|NCT02646618|587814852|FG001|Overall Study|Lost to Follow-up|14|||
162754911|NCT03885232|587814853|FG000|Overall Study|Lost to Follow-up|74|||
162754912|NCT03885232|587814854|FG001|Overall Study|Lost to Follow-up|32|||
162754913|NCT03885232|587814853|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
162754914|NCT03885232|587814854|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
162754915|NCT05601882|587814857|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
162754916|NCT05601882|587814858|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162754917|NCT05601882|587814859|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162754918|NCT05601882|587814860|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162754919|NCT05601882|587814857|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
162754920|NCT05601882|587814858|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
162754921|NCT05601882|587814859|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
162754922|NCT05601882|587814860|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
162754923|NCT05601882|587814857|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
162754924|NCT05601882|587814858|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
162754925|NCT05601882|587814859|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
162754926|NCT05601882|587814860|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
162754927|NCT05601882|587814857|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
162754928|NCT05601882|587814858|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
162754929|NCT05601882|587814859|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
162754930|NCT05601882|587814860|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
162754931|NCT05601882|587814857|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
162754932|NCT05601882|587814858|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
162754933|NCT05601882|587814859|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
162754934|NCT05601882|587814860|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
162754935|NCT05601882|587814857|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
162754936|NCT05601882|587814858|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
162754937|NCT05601882|587814859|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
162754938|NCT05601882|587814860|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
162754939|NCT03834740|587814861|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
162754940|NCT03834740|587814862|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
162754941|NCT03834740|587814863|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
162754942|NCT01208974|587814864|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
162754943|NCT01208974|587814865|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162754944|NCT01208974|587814866|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162754945|NCT01208974|587814867|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162754946|NCT01208974|587814864|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
162754947|NCT01208974|587814865|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162754948|NCT01208974|587814866|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162754949|NCT01208974|587814867|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162754950|NCT01208974|587814864|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
162754951|NCT01208974|587814865|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162754952|NCT01208974|587814866|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162754953|NCT01208974|587814867|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162754954|NCT03593226|587814868|FG000|Overall Study|Disease progression|6|||
162754955|NCT03593226|587814869|FG001|Overall Study|Disease progression|13|||
162754956|NCT03593226|587814870|FG002|Overall Study|Disease progression|5|||
162754957|NCT03593226|587814871|FG003|Overall Study|Disease progression|6|||
162754958|NCT03593226|587814868|FG000|Overall Study|Adverse Event|0|||
162754959|NCT03593226|587814869|FG001|Overall Study|Adverse Event|1|||
162754960|NCT03593226|587814870|FG002|Overall Study|Adverse Event|0|||
162754961|NCT03593226|587814871|FG003|Overall Study|Adverse Event|0|||
162754962|NCT03593226|587814868|FG000|Overall Study|Withdrawal by Subject|0|||
162754963|NCT03593226|587814869|FG001|Overall Study|Withdrawal by Subject|4|||
162754964|NCT03593226|587814870|FG002|Overall Study|Withdrawal by Subject|1|||
162754965|NCT03593226|587814871|FG003|Overall Study|Withdrawal by Subject|0|||
162754966|NCT03593226|587814868|FG000|Overall Study|Physician Decision|0|||
162754967|NCT03593226|587814869|FG001|Overall Study|Physician Decision|1|||
162754968|NCT03593226|587814870|FG002|Overall Study|Physician Decision|0|||
162754969|NCT03593226|587814871|FG003|Overall Study|Physician Decision|0|||
162754970|NCT03593226|587814868|FG000|Overall Study|Clinical disease progression|0|||
162754971|NCT03593226|587814869|FG001|Overall Study|Clinical disease progression|0|||
162754972|NCT03593226|587814870|FG002|Overall Study|Clinical disease progression|1|||
162754973|NCT03593226|587814871|FG003|Overall Study|Clinical disease progression|0|||
162754974|NCT02500576|587814872|FG000|Overall Study|Adverse Event|0|||
162754975|NCT02500576|587814873|FG001|Overall Study|Adverse Event|1|||
162754976|NCT02500576|587814872|FG000|Overall Study|Death|2|||
162754977|NCT02500576|587814873|FG001|Overall Study|Death|1|||
162754978|NCT02500576|587814872|FG000|Overall Study|Lack of Efficacy|5|||
162754979|NCT02500576|587814873|FG001|Overall Study|Lack of Efficacy|5|||
162754980|NCT02500576|587814872|FG000|Overall Study|Withdrawal by Subject|1|||
162754981|NCT02500576|587814873|FG001|Overall Study|Withdrawal by Subject|1|||
162754982|NCT03691493|587814877|FG000|Overall Study|Withdrawal by Subject|1|||
162754983|NCT00227266|587814888|FG000|Overall Study|Withdrawal by Subject|0|||
162754984|NCT00227266|587814889|FG001|Overall Study|Withdrawal by Subject|0|||
162754985|NCT00227266|587814890|FG002|Overall Study|Withdrawal by Subject|1|||
162754986|NCT00227266|587814888|FG000|Overall Study|Protocol Violation|1|||
162754987|NCT00227266|587814889|FG001|Overall Study|Protocol Violation|0|||
162754988|NCT00227266|587814890|FG002|Overall Study|Protocol Violation|1|||
162754989|NCT00227266|587814888|FG000|Overall Study|Excessive weight gain|0|||
162754990|NCT00227266|587814889|FG001|Overall Study|Excessive weight gain|0|||
162754991|NCT00227266|587814890|FG002|Overall Study|Excessive weight gain|2|||
162754992|NCT05786612|587814892|FG000|Overall Study|Adverse Event|1|||
162754993|NCT05786612|587814893|FG001|Overall Study|Adverse Event|2|||
162754994|NCT05786612|587814892|FG000|Overall Study|one screening failure|0|||
162754995|NCT05786612|587814893|FG001|Overall Study|one screening failure|2|||
162754996|NCT02798471|587814900|FG000|Overall Study|Adverse Event|7|||
162754997|NCT02798471|587814901|FG001|Overall Study|Adverse Event|2|||
162754998|NCT02798471|587814900|FG000|Overall Study|Physician Decision|3|||
162754999|NCT02798471|587814901|FG001|Overall Study|Physician Decision|7|||
162755000|NCT02798471|587814900|FG000|Overall Study|Death|2|||
162755001|NCT02798471|587814901|FG001|Overall Study|Death|3|||
162755002|NCT02798471|587814900|FG000|Overall Study|Lost to Follow-up|0|||
162755003|NCT02798471|587814901|FG001|Overall Study|Lost to Follow-up|1|||
162755004|NCT02798471|587814900|FG000|Overall Study|Other|5|||
162755005|NCT02798471|587814901|FG001|Overall Study|Other|3|||
162755006|NCT02798471|587814900|FG000|Overall Study|Subject withdrew consent|0|||
162755007|NCT02798471|587814901|FG001|Overall Study|Subject withdrew consent|6|||
162755008|NCT02798471|587814900|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
162755009|NCT02798471|587814901|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
162755010|NCT02798471|587814900|FG000|Overall Study|Randomized, but not treated|0|||
162755011|NCT02798471|587814901|FG001|Overall Study|Randomized, but not treated|2|||
162810474|NCT04281004|588018233|FG000|Overall Study|Physician Decision|1|||
162810475|NCT04281004|588018234|FG001|Overall Study|Physician Decision|0|||
162810476|NCT00701779|588018235|FG000|Overall Study|Adverse Event|6|||
162810477|NCT00701779|588018235|FG000|Overall Study|Lost to Follow-up|1|||
162810478|NCT00701779|588018235|FG000|Overall Study|Withdrawal by Subject|2|||
162810479|NCT02245672|588018236|FG000|Overall Study|Adverse Event|4|||
162810480|NCT02245672|588018237|FG001|Overall Study|Adverse Event|4|||
162810481|NCT02245672|588018238|FG002|Overall Study|Adverse Event|4|||
162810482|NCT02245672|588018236|FG000|Overall Study|Lost to Follow-up|3|||
162810483|NCT02245672|588018237|FG001|Overall Study|Lost to Follow-up|5|||
162810484|NCT02245672|588018238|FG002|Overall Study|Lost to Follow-up|1|||
162810485|NCT02245672|588018236|FG000|Overall Study|Withdrawal by Subject|6|||
162810486|NCT02245672|588018237|FG001|Overall Study|Withdrawal by Subject|3|||
162810487|NCT02245672|588018238|FG002|Overall Study|Withdrawal by Subject|0|||
162810488|NCT02245672|588018236|FG000|Overall Study|Randomized in error (not treated)|0|||
162810489|NCT02245672|588018237|FG001|Overall Study|Randomized in error (not treated)|1|||
162810490|NCT02245672|588018238|FG002|Overall Study|Randomized in error (not treated)|0|||
162810491|NCT04363801|588018244|FG000|Overall Study|Death|18|||
162810492|NCT04363801|588018245|FG001|Overall Study|Death|14|||
162810493|NCT04363801|588018246|FG002|Overall Study|Death|16|||
162810494|NCT04363801|588018247|FG003|Overall Study|Death|48|||
162810495|NCT04363801|588018248|FG004|Overall Study|Death|38|||
162810496|NCT04363801|588018244|FG000|Overall Study|Withdrawal by Subject|1|||
162810497|NCT04363801|588018245|FG001|Overall Study|Withdrawal by Subject|6|||
162810498|NCT04363801|588018246|FG002|Overall Study|Withdrawal by Subject|1|||
162810499|NCT04363801|588018247|FG003|Overall Study|Withdrawal by Subject|4|||
162810500|NCT04363801|588018248|FG004|Overall Study|Withdrawal by Subject|14|||
162810501|NCT04363801|588018244|FG000|Overall Study|Sponsor Decision|6|||
162810502|NCT04363801|588018245|FG001|Overall Study|Sponsor Decision|4|||
162810503|NCT04363801|588018246|FG002|Overall Study|Sponsor Decision|10|||
162810504|NCT04363801|588018247|FG003|Overall Study|Sponsor Decision|33|||
162810505|NCT04363801|588018248|FG004|Overall Study|Sponsor Decision|32|||
162810506|NCT04363801|588018244|FG000|Overall Study|Lost to Follow-up|0|||
162810507|NCT04363801|588018245|FG001|Overall Study|Lost to Follow-up|0|||
162810508|NCT04363801|588018246|FG002|Overall Study|Lost to Follow-up|1|||
162810509|NCT04363801|588018247|FG003|Overall Study|Lost to Follow-up|0|||
162810510|NCT04363801|588018248|FG004|Overall Study|Lost to Follow-up|1|||
162810511|NCT01146054|588018249|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
162810512|NCT01146054|588018249|FG000|Overall Study|Rapid tumor progression|2|||
162810513|NCT01146054|588018249|FG000|Overall Study|Other illness precluded treatment|2|||
162810514|NCT01146054|588018249|FG000|Overall Study|Lost to Follow-up|1|||
162810515|NCT00762970|588018250|FG000|Overall Study|Withdrawal by Subject|7|||
162810516|NCT00762970|588018251|FG001|Overall Study|Withdrawal by Subject|4|||
162810517|NCT00762970|588018252|FG002|Overall Study|Withdrawal by Subject|0|||
162810518|NCT00762970|588018250|FG000|Overall Study|Protocol Violation|3|||
162810519|NCT00762970|588018251|FG001|Overall Study|Protocol Violation|1|||
162810520|NCT00762970|588018252|FG002|Overall Study|Protocol Violation|1|||
162810521|NCT00762970|588018250|FG000|Overall Study|Lost to Follow-up|1|||
162810522|NCT00762970|588018251|FG001|Overall Study|Lost to Follow-up|2|||
162810523|NCT00762970|588018252|FG002|Overall Study|Lost to Follow-up|0|||
162755012|NCT03459196|587816619|FG000|Overall Study|Subject didn't receive study catheter|2|||
162755013|NCT03367156|587816620|FG000|Overall Study|Lack of interest|3|||
162755014|NCT03367156|587816621|FG001|Overall Study|Lack of interest|1|||
162755015|NCT03367156|587816620|FG000|Overall Study|Death|2|||
162755016|NCT03367156|587816621|FG001|Overall Study|Death|0|||
162755017|NCT03367156|587816620|FG000|Overall Study|Lost to Follow-up|2|||
162755018|NCT03367156|587816621|FG001|Overall Study|Lost to Follow-up|1|||
162755019|NCT03367156|587816620|FG000|Overall Study|Became ineligible|1|||
162755020|NCT03367156|587816621|FG001|Overall Study|Became ineligible|2|||
162755021|NCT03367156|587816620|FG000|Overall Study|Hospitalization|1|||
162755022|NCT03367156|587816621|FG001|Overall Study|Hospitalization|0|||
162755023|NCT03367156|587816620|FG000|Overall Study|Concerned about Treatment|11|||
162755024|NCT03367156|587816621|FG001|Overall Study|Concerned about Treatment|3|||
162755025|NCT03367156|587816620|FG000|Overall Study|Started new treatment|4|||
162755026|NCT03367156|587816621|FG001|Overall Study|Started new treatment|1|||
162755027|NCT03762850|587816622|FG000|Overall Study|Death|0|||
162755028|NCT03762850|587816623|FG001|Overall Study|Death|1|||
162755029|NCT03762850|587816622|FG000|Overall Study|Lost to Follow-up|0|||
162755030|NCT03762850|587816623|FG001|Overall Study|Lost to Follow-up|1|||
162755031|NCT03762850|587816622|FG000|Overall Study|Physician Decision|0|||
162755032|NCT03762850|587816623|FG001|Overall Study|Physician Decision|1|||
162755033|NCT03762850|587816622|FG000|Overall Study|Withdrawal by Subject|4|||
162755034|NCT03762850|587816623|FG001|Overall Study|Withdrawal by Subject|9|||
162755035|NCT00092534|587816626|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
162755036|NCT00092534|587816627|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
162755037|NCT00092534|587816628|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162755038|NCT00092534|587816629|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162755039|NCT00092534|587816630|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162755040|NCT00092534|587816626|FG000|Base Study Vaccination Period|Adverse Event|3|||
162755041|NCT00092534|587816627|FG001|Base Study Vaccination Period|Adverse Event|1|||
162755042|NCT00092534|587816628|FG002|Base Study Vaccination Period|Adverse Event|0|||
162755043|NCT00092534|587816629|FG003|Base Study Vaccination Period|Adverse Event|0|||
162755044|NCT00092534|587816630|FG004|Base Study Vaccination Period|Adverse Event|0|||
162755045|NCT00092534|587816626|FG000|Base Study Vaccination Period|Death|5|||
162755046|NCT00092534|587816627|FG001|Base Study Vaccination Period|Death|4|||
162755047|NCT00092534|587816628|FG002|Base Study Vaccination Period|Death|0|||
162755048|NCT00092534|587816629|FG003|Base Study Vaccination Period|Death|0|||
162755049|NCT00092534|587816630|FG004|Base Study Vaccination Period|Death|0|||
162755050|NCT00092534|587816626|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
162755051|NCT00092534|587816627|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
162755052|NCT00092534|587816628|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
162755053|NCT00092534|587816629|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
162755054|NCT00092534|587816630|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
162755055|NCT00092534|587816626|FG000|Base Study Vaccination Period|Physician Decision|1|||
162755056|NCT00092534|587816627|FG001|Base Study Vaccination Period|Physician Decision|0|||
162755057|NCT00092534|587816628|FG002|Base Study Vaccination Period|Physician Decision|0|||
162755058|NCT00092534|587816629|FG003|Base Study Vaccination Period|Physician Decision|0|||
162755059|NCT00092534|587816630|FG004|Base Study Vaccination Period|Physician Decision|0|||
162755060|NCT00092534|587816626|FG000|Base Study Vaccination Period|Pregnancy|9|||
162755061|NCT00092534|587816627|FG001|Base Study Vaccination Period|Pregnancy|7|||
162755062|NCT00092534|587816628|FG002|Base Study Vaccination Period|Pregnancy|0|||
162755063|NCT00092534|587816629|FG003|Base Study Vaccination Period|Pregnancy|0|||
162755064|NCT00092534|587816630|FG004|Base Study Vaccination Period|Pregnancy|0|||
162755065|NCT00092534|587816626|FG000|Base Study Vaccination Period|Protocol Violation|2|||
162755066|NCT00092534|587816627|FG001|Base Study Vaccination Period|Protocol Violation|1|||
162755067|NCT00092534|587816628|FG002|Base Study Vaccination Period|Protocol Violation|0|||
162755068|NCT00092534|587816629|FG003|Base Study Vaccination Period|Protocol Violation|0|||
162755069|NCT00092534|587816630|FG004|Base Study Vaccination Period|Protocol Violation|0|||
162755070|NCT00092534|587816626|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
162755071|NCT00092534|587816627|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
162755072|NCT00092534|587816628|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
162755073|NCT00092534|587816629|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
162755074|NCT00092534|587816630|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
162755075|NCT00092534|587816626|FG000|Base Study Vaccination Period|Moved|14|||
162755076|NCT00092534|587816627|FG001|Base Study Vaccination Period|Moved|12|||
162755077|NCT00092534|587816628|FG002|Base Study Vaccination Period|Moved|0|||
162755078|NCT00092534|587816629|FG003|Base Study Vaccination Period|Moved|0|||
162755079|NCT00092534|587816630|FG004|Base Study Vaccination Period|Moved|0|||
162755080|NCT00092534|587816626|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
162755081|NCT00092534|587816627|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162755082|NCT00092534|587816628|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162755083|NCT00092534|587816629|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162755084|NCT00092534|587816630|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162755085|NCT00092534|587816626|FG000|Base Study Vaccination Period|Travel|1|||
162755086|NCT00092534|587816627|FG001|Base Study Vaccination Period|Travel|0|||
162755087|NCT00092534|587816628|FG002|Base Study Vaccination Period|Travel|0|||
162755088|NCT00092534|587816629|FG003|Base Study Vaccination Period|Travel|0|||
162755089|NCT00092534|587816630|FG004|Base Study Vaccination Period|Travel|0|||
162755090|NCT00092534|587816626|FG000|Base Study Vaccination Period|Site Closed|0|||
162755091|NCT00092534|587816627|FG001|Base Study Vaccination Period|Site Closed|1|||
162755092|NCT00092534|587816628|FG002|Base Study Vaccination Period|Site Closed|0|||
162755093|NCT00092534|587816629|FG003|Base Study Vaccination Period|Site Closed|0|||
162755094|NCT00092534|587816630|FG004|Base Study Vaccination Period|Site Closed|0|||
162755095|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Adverse Event|2|||
162755096|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Adverse Event|4|||
162755097|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Adverse Event|0|||
162755098|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Adverse Event|0|||
162755099|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Adverse Event|0|||
162755100|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Death|2|||
162755101|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Death|1|||
162755102|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Death|0|||
162755103|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Death|0|||
162755104|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Death|0|||
162755105|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
162755106|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
162755107|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
162755108|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
162755109|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
162755110|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Pregnancy|6|||
162755111|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Pregnancy|10|||
162755112|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Pregnancy|0|||
162755113|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Pregnancy|0|||
162755114|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Pregnancy|0|||
162755115|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
162755116|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
162755117|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
162755118|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
162755119|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
162755120|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
162755121|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
162755122|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162755123|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162755124|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162755125|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Moved|62|||
162755126|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Moved|58|||
162755127|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Moved|0|||
162755128|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Moved|0|||
162755129|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Moved|0|||
162755130|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Travel|10|||
162755131|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Travel|7|||
162755132|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Travel|0|||
162755133|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Travel|0|||
162755134|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Travel|0|||
162755135|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Site Closed|0|||
162755136|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Site Closed|2|||
162755137|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Site Closed|0|||
162755138|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Site Closed|0|||
162755139|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Site Closed|0|||
162755140|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
162755141|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
162755142|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
162755143|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
162755144|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
162755145|NCT00092534|587816626|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
162755146|NCT00092534|587816627|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
162755147|NCT00092534|587816628|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
162755148|NCT00092534|587816629|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
162755149|NCT00092534|587816630|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
162755150|NCT00092534|587816626|FG000|Base Study EXT|Lost to Follow-up|0|||
162755151|NCT00092534|587816627|FG001|Base Study EXT|Lost to Follow-up|0|||
162755152|NCT00092534|587816628|FG002|Base Study EXT|Lost to Follow-up|41|||
162755153|NCT00092534|587816629|FG003|Base Study EXT|Lost to Follow-up|0|||
162755154|NCT00092534|587816630|FG004|Base Study EXT|Lost to Follow-up|0|||
162755155|NCT00092534|587816626|FG000|Base Study EXT|Physician Decision|0|||
162755156|NCT00092534|587816627|FG001|Base Study EXT|Physician Decision|0|||
162755157|NCT00092534|587816628|FG002|Base Study EXT|Physician Decision|1|||
162755158|NCT00092534|587816629|FG003|Base Study EXT|Physician Decision|0|||
162755159|NCT00092534|587816630|FG004|Base Study EXT|Physician Decision|0|||
162755160|NCT00092534|587816626|FG000|Base Study EXT|Pregnancy|0|||
162755161|NCT00092534|587816627|FG001|Base Study EXT|Pregnancy|0|||
162755162|NCT00092534|587816628|FG002|Base Study EXT|Pregnancy|12|||
162755163|NCT00092534|587816629|FG003|Base Study EXT|Pregnancy|0|||
162755164|NCT00092534|587816630|FG004|Base Study EXT|Pregnancy|0|||
162755165|NCT00092534|587816626|FG000|Base Study EXT|Withdrawal by Subject|0|||
162755166|NCT00092534|587816627|FG001|Base Study EXT|Withdrawal by Subject|0|||
162755167|NCT00092534|587816628|FG002|Base Study EXT|Withdrawal by Subject|18|||
162755168|NCT00092534|587816629|FG003|Base Study EXT|Withdrawal by Subject|0|||
162755169|NCT00092534|587816630|FG004|Base Study EXT|Withdrawal by Subject|0|||
162755170|NCT00092534|587816626|FG000|Base Study EXT|Participant moved|0|||
162755171|NCT00092534|587816627|FG001|Base Study EXT|Participant moved|0|||
162755172|NCT00092534|587816628|FG002|Base Study EXT|Participant moved|6|||
162755173|NCT00092534|587816629|FG003|Base Study EXT|Participant moved|0|||
162755174|NCT00092534|587816630|FG004|Base Study EXT|Participant moved|0|||
162755175|NCT00092534|587816626|FG000|Base Study EXT|Travel|0|||
162755176|NCT00092534|587816627|FG001|Base Study EXT|Travel|0|||
162755177|NCT00092534|587816628|FG002|Base Study EXT|Travel|2|||
162755178|NCT00092534|587816629|FG003|Base Study EXT|Travel|0|||
162755179|NCT00092534|587816630|FG004|Base Study EXT|Travel|0|||
162755180|NCT00092534|587816626|FG000|Base Study EXT|Site closed|0|||
162755181|NCT00092534|587816627|FG001|Base Study EXT|Site closed|0|||
162755182|NCT00092534|587816628|FG002|Base Study EXT|Site closed|21|||
162755183|NCT00092534|587816629|FG003|Base Study EXT|Site closed|0|||
162755184|NCT00092534|587816630|FG004|Base Study EXT|Site closed|0|||
162755185|NCT00092534|587816626|FG000|Base Study EXT|Study ended|0|||
162755186|NCT00092534|587816627|FG001|Base Study EXT|Study ended|0|||
162755187|NCT00092534|587816628|FG002|Base Study EXT|Study ended|29|||
162755188|NCT00092534|587816629|FG003|Base Study EXT|Study ended|0|||
162755189|NCT00092534|587816630|FG004|Base Study EXT|Study ended|0|||
162755190|NCT00092534|587816626|FG000|Base Study EXT|Protocol Violation|0|||
162755191|NCT00092534|587816627|FG001|Base Study EXT|Protocol Violation|0|||
162755192|NCT00092534|587816628|FG002|Base Study EXT|Protocol Violation|15|||
162755193|NCT00092534|587816629|FG003|Base Study EXT|Protocol Violation|0|||
162755194|NCT00092534|587816630|FG004|Base Study EXT|Protocol Violation|0|||
162755195|NCT00092534|587816626|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162755196|NCT00092534|587816627|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162755197|NCT00092534|587816628|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162755198|NCT00092534|587816629|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
162755199|NCT00092534|587816630|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162755200|NCT03083366|587816631|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
162755201|NCT03083366|587816632|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
162755202|NCT03083366|587816631|FG000|Enrollment Period|Lack of Efficacy|1|||
162755203|NCT03083366|587816632|FG001|Enrollment Period|Lack of Efficacy|0|||
162755204|NCT03752684|587816639|FG000|Overall Study|Lost to Follow-up|4|||
162755205|NCT00048932|587816642|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
162755206|NCT00048932|587816643|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
162755207|NCT00048932|587816644|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
162755208|NCT00048932|587816642|FG000|Double Blind Period (DB)|Adverse Event|51|||
162755209|NCT00048932|587816643|FG001|Double Blind Period (DB)|Adverse Event|19|||
162755210|NCT00048932|587816644|FG002|Double Blind Period (DB)|Adverse Event|0|||
162755211|NCT00048932|587816642|FG000|Double Blind Period (DB)|Death|5|||
162755212|NCT00048932|587816643|FG001|Double Blind Period (DB)|Death|3|||
162755213|NCT00048932|587816644|FG002|Double Blind Period (DB)|Death|0|||
162755214|NCT00048932|587816642|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
162755215|NCT00048932|587816643|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
162755216|NCT00048932|587816644|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
162755217|NCT00048932|587816642|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
162755218|NCT00048932|587816643|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
162755219|NCT00048932|587816644|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
162755220|NCT00048932|587816642|FG000|Double Blind Period (DB)|Relocation|1|||
162755221|NCT00048932|587816643|FG001|Double Blind Period (DB)|Relocation|0|||
162755222|NCT00048932|587816644|FG002|Double Blind Period (DB)|Relocation|0|||
162755223|NCT00048932|587816642|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
162755224|NCT00048932|587816643|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
162755225|NCT00048932|587816644|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
162755226|NCT00048932|587816642|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
162755227|NCT00048932|587816643|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
162755228|NCT00048932|587816644|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
162755229|NCT00048932|587816642|FG000|Double Blind Period (DB)|Pregnancy|1|||
162755230|NCT00048932|587816643|FG001|Double Blind Period (DB)|Pregnancy|0|||
162755231|NCT00048932|587816644|FG002|Double Blind Period (DB)|Pregnancy|0|||
162755232|NCT00048932|587816642|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
162755233|NCT00048932|587816643|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
162755234|NCT00048932|587816644|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
162755235|NCT00048932|587816642|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
162755236|NCT00048932|587816643|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
162755237|NCT00048932|587816644|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
162755238|NCT00048932|587816642|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
162755239|NCT00048932|587816643|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
162755240|NCT00048932|587816644|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
162755241|NCT00048932|587816642|FG000|Open Label Period (OL)|Death|0|||
162755242|NCT00048932|587816643|FG001|Open Label Period (OL)|Death|0|||
162755243|NCT00048932|587816644|FG002|Open Label Period (OL)|Death|25|||
162755244|NCT00048932|587816642|FG000|Open Label Period (OL)|Adverse Event|0|||
162755245|NCT00048932|587816643|FG001|Open Label Period (OL)|Adverse Event|0|||
162755246|NCT00048932|587816644|FG002|Open Label Period (OL)|Adverse Event|103|||
162755247|NCT00048932|587816642|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
162755248|NCT00048932|587816643|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
162755249|NCT00048932|587816644|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
162755250|NCT00048932|587816642|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
162755251|NCT00048932|587816643|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
162755252|NCT00048932|587816644|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
162755253|NCT00048932|587816642|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
162755254|NCT00048932|587816643|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
162755255|NCT00048932|587816644|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
162755256|NCT00048932|587816642|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
162755257|NCT00048932|587816643|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
162755258|NCT00048932|587816644|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
162755259|NCT00048932|587816642|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
162755260|NCT00048932|587816643|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
162755261|NCT00048932|587816644|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
162755262|NCT00048932|587816642|FG000|Open Label Period (OL)|Pregnancy|0|||
162755263|NCT00048932|587816643|FG001|Open Label Period (OL)|Pregnancy|0|||
162755264|NCT00048932|587816644|FG002|Open Label Period (OL)|Pregnancy|6|||
162755265|NCT00048932|587816642|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
162755266|NCT00048932|587816643|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
162755267|NCT00048932|587816644|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
162755268|NCT00048932|587816642|FG000|Open Label Period (OL)|Investigator Retiring|0|||
162755269|NCT00048932|587816643|FG001|Open Label Period (OL)|Investigator Retiring|0|||
162755270|NCT00048932|587816644|FG002|Open Label Period (OL)|Investigator Retiring|2|||
162755271|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
162755272|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
162755273|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
162755274|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Relocated|0|||
162755275|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Relocated|0|||
162755276|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Relocated|6|||
162755277|NCT00048932|587816642|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
162755278|NCT00048932|587816643|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
162755279|NCT00048932|587816644|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
162755280|NCT00048932|587816642|FG000|Open Label Period (OL)|Site Closure|0|||
162755281|NCT00048932|587816643|FG001|Open Label Period (OL)|Site Closure|0|||
162755282|NCT00048932|587816644|FG002|Open Label Period (OL)|Site Closure|3|||
162755283|NCT00048932|587816642|FG000|Open Label Period (OL)|Trial Terminated|0|||
162755284|NCT00048932|587816643|FG001|Open Label Period (OL)|Trial Terminated|0|||
162755285|NCT00048932|587816644|FG002|Open Label Period (OL)|Trial Terminated|1|||
162755286|NCT00048932|587816642|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
162755287|NCT00048932|587816643|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
162755288|NCT00048932|587816644|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
162755289|NCT00048932|587816642|FG000|Open Label Period (OL)|Patient Decision|0|||
162755290|NCT00048932|587816643|FG001|Open Label Period (OL)|Patient Decision|0|||
162755291|NCT00048932|587816644|FG002|Open Label Period (OL)|Patient Decision|4|||
162755292|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
162755293|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
162755294|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
162755295|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
162755296|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
162755297|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
162755298|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
162755299|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
162755300|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
162755301|NCT00048932|587816642|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
162755302|NCT00048932|587816643|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
162755303|NCT00048932|587816644|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
162755304|NCT00048932|587816642|FG000|Open Label Period (OL)|Investigator Decision|0|||
162755305|NCT00048932|587816643|FG001|Open Label Period (OL)|Investigator Decision|0|||
162755306|NCT00048932|587816644|FG002|Open Label Period (OL)|Investigator Decision|4|||
162755307|NCT00048932|587816642|FG000|Open Label Period (OL)|Site Staff Issues|0|||
162755308|NCT00048932|587816643|FG001|Open Label Period (OL)|Site Staff Issues|0|||
162755309|NCT00048932|587816644|FG002|Open Label Period (OL)|Site Staff Issues|2|||
162755310|NCT00048932|587816642|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
162755311|NCT00048932|587816643|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
162755312|NCT00048932|587816644|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
162755313|NCT00048932|587816642|FG000|Open Label Period (OL)|Participant Surgery|0|||
162755314|NCT00048932|587816643|FG001|Open Label Period (OL)|Participant Surgery|0|||
162755315|NCT00048932|587816644|FG002|Open Label Period (OL)|Participant Surgery|1|||
162755316|NCT03418922|587816647|FG000|Overall Study|Withdrawal by Subject|0|||
162755317|NCT03418922|587816648|FG001|Overall Study|Withdrawal by Subject|2|||
162755318|NCT03418922|587816647|FG000|Overall Study|Adverse Event|2|||
162755319|NCT03418922|587816648|FG001|Overall Study|Adverse Event|2|||
162755320|NCT03418922|587816647|FG000|Overall Study|Death|0|||
162755321|NCT03418922|587816648|FG001|Overall Study|Death|1|||
162755322|NCT03418922|587816647|FG000|Overall Study|Physician Decision|0|||
162755323|NCT03418922|587816648|FG001|Overall Study|Physician Decision|1|||
162755324|NCT02347332|587816649|FG000|Overall Study|Not treated|5|||
162755325|NCT02347332|587816650|FG001|Overall Study|Not treated|2|||
162755326|NCT02347332|587816649|FG000|Overall Study|Progressive disease|141|||
162755327|NCT02347332|587816650|FG001|Overall Study|Progressive disease|159|||
162755328|NCT02347332|587816649|FG000|Overall Study|Adverse Event|50|||
162755329|NCT02347332|587816650|FG001|Overall Study|Adverse Event|41|||
162755330|NCT02347332|587816649|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
162755331|NCT02347332|587816650|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
162755332|NCT02347332|587816649|FG000|Overall Study|Protocol Violation|1|||
162755333|NCT02347332|587816650|FG001|Overall Study|Protocol Violation|1|||
162755334|NCT02347332|587816649|FG000|Overall Study|Lost to Follow-up|2|||
162755335|NCT02347332|587816650|FG001|Overall Study|Lost to Follow-up|1|||
162755336|NCT02347332|587816649|FG000|Overall Study|Physician Decision|4|||
162755337|NCT02347332|587816650|FG001|Overall Study|Physician Decision|3|||
162755338|NCT02347332|587816649|FG000|Overall Study|Withdrawal by Subject|20|||
162755339|NCT02347332|587816650|FG001|Overall Study|Withdrawal by Subject|14|||
162755340|NCT02347332|587816649|FG000|Overall Study|Protocol requirement|1|||
162755341|NCT02347332|587816650|FG001|Overall Study|Protocol requirement|1|||
162755342|NCT02347332|587816649|FG000|Overall Study|Switch Post-Trial program|0|||
162755343|NCT02347332|587816650|FG001|Overall Study|Switch Post-Trial program|1|||
162755344|NCT04384172|587816652|FG000|Overall Study|Lost to Follow-up|0|||
162755345|NCT04384172|587816653|FG001|Overall Study|Lost to Follow-up|2|||
162755346|NCT04384172|587816652|FG000|Overall Study|Pregnancy|1|||
162755347|NCT04384172|587816653|FG001|Overall Study|Pregnancy|0|||
162755348|NCT04384172|587816652|FG000|Overall Study|Withdrawal by Subject|0|||
162755349|NCT04384172|587816653|FG001|Overall Study|Withdrawal by Subject|1|||
162755350|NCT04860505|587816654|FG000|Overall Study|Lost to Follow-up|2|||
162755351|NCT01640951|587816655|FG000|Overall Study|Adverse Event|8|||
162755352|NCT01640951|587816656|FG001|Overall Study|Adverse Event|3|||
162755353|NCT01640951|587816657|FG002|Overall Study|Adverse Event|10|||
162755354|NCT01640951|587816658|FG003|Overall Study|Adverse Event|6|||
162755355|NCT01640951|587816659|FG004|Overall Study|Adverse Event|1|||
162755356|NCT01640951|587816660|FG005|Overall Study|Adverse Event|11|||
162755357|NCT01640951|587816661|FG006|Overall Study|Adverse Event|1|||
162755358|NCT01640951|587816662|FG007|Overall Study|Adverse Event|3|||
162755359|NCT01640951|587816655|FG000|Overall Study|Lack of Efficacy|20|||
162755360|NCT01640951|587816656|FG001|Overall Study|Lack of Efficacy|1|||
162755361|NCT01640951|587816657|FG002|Overall Study|Lack of Efficacy|7|||
162755362|NCT01640951|587816658|FG003|Overall Study|Lack of Efficacy|14|||
162755363|NCT01640951|587816659|FG004|Overall Study|Lack of Efficacy|0|||
162755364|NCT01640951|587816660|FG005|Overall Study|Lack of Efficacy|6|||
162755365|NCT01640951|587816661|FG006|Overall Study|Lack of Efficacy|5|||
162755366|NCT01640951|587816662|FG007|Overall Study|Lack of Efficacy|6|||
162755367|NCT01640951|587816655|FG000|Overall Study|Lost to Follow-up|1|||
162755368|NCT01640951|587816656|FG001|Overall Study|Lost to Follow-up|0|||
162755369|NCT01640951|587816657|FG002|Overall Study|Lost to Follow-up|6|||
162755370|NCT01640951|587816658|FG003|Overall Study|Lost to Follow-up|2|||
162755371|NCT01640951|587816659|FG004|Overall Study|Lost to Follow-up|2|||
162755372|NCT01640951|587816660|FG005|Overall Study|Lost to Follow-up|3|||
162755373|NCT01640951|587816661|FG006|Overall Study|Lost to Follow-up|1|||
162755374|NCT01640951|587816662|FG007|Overall Study|Lost to Follow-up|1|||
162755375|NCT01640951|587816655|FG000|Overall Study|Non-compliance with study treatment|0|||
162755376|NCT01640951|587816656|FG001|Overall Study|Non-compliance with study treatment|0|||
162755377|NCT01640951|587816657|FG002|Overall Study|Non-compliance with study treatment|1|||
162755378|NCT01640951|587816658|FG003|Overall Study|Non-compliance with study treatment|1|||
162755379|NCT01640951|587816659|FG004|Overall Study|Non-compliance with study treatment|1|||
162755380|NCT01640951|587816660|FG005|Overall Study|Non-compliance with study treatment|4|||
162755381|NCT01640951|587816661|FG006|Overall Study|Non-compliance with study treatment|1|||
162755382|NCT01640951|587816662|FG007|Overall Study|Non-compliance with study treatment|0|||
162755383|NCT01640951|587816655|FG000|Overall Study|Physician Decision|2|||
162755384|NCT01640951|587816656|FG001|Overall Study|Physician Decision|5|||
162755385|NCT01640951|587816657|FG002|Overall Study|Physician Decision|2|||
162755386|NCT01640951|587816658|FG003|Overall Study|Physician Decision|2|||
162755387|NCT01640951|587816659|FG004|Overall Study|Physician Decision|2|||
162755388|NCT01640951|587816660|FG005|Overall Study|Physician Decision|3|||
162755389|NCT01640951|587816661|FG006|Overall Study|Physician Decision|3|||
162755390|NCT01640951|587816662|FG007|Overall Study|Physician Decision|0|||
162755391|NCT01640951|587816655|FG000|Overall Study|Pregnancy|3|||
162755392|NCT01640951|587816656|FG001|Overall Study|Pregnancy|0|||
162755393|NCT01640951|587816657|FG002|Overall Study|Pregnancy|0|||
162755394|NCT01640951|587816658|FG003|Overall Study|Pregnancy|4|||
162755395|NCT01640951|587816659|FG004|Overall Study|Pregnancy|0|||
162755396|NCT01640951|587816660|FG005|Overall Study|Pregnancy|0|||
162755397|NCT01640951|587816661|FG006|Overall Study|Pregnancy|2|||
162755398|NCT01640951|587816662|FG007|Overall Study|Pregnancy|0|||
162755399|NCT01640951|587816655|FG000|Overall Study|Protocol Deviation|0|||
162755400|NCT01640951|587816656|FG001|Overall Study|Protocol Deviation|1|||
162755401|NCT01640951|587816657|FG002|Overall Study|Protocol Deviation|2|||
162755402|NCT01640951|587816658|FG003|Overall Study|Protocol Deviation|1|||
162755403|NCT01640951|587816659|FG004|Overall Study|Protocol Deviation|0|||
162755404|NCT01640951|587816660|FG005|Overall Study|Protocol Deviation|1|||
162755405|NCT01640951|587816661|FG006|Overall Study|Protocol Deviation|0|||
162755406|NCT01640951|587816662|FG007|Overall Study|Protocol Deviation|0|||
162755407|NCT01640951|587816655|FG000|Overall Study|Subject/Guardian decision|12|||
162755408|NCT01640951|587816656|FG001|Overall Study|Subject/Guardian decision|4|||
162755409|NCT01640951|587816657|FG002|Overall Study|Subject/Guardian decision|13|||
162755410|NCT01640951|587816658|FG003|Overall Study|Subject/Guardian decision|15|||
162755411|NCT01640951|587816659|FG004|Overall Study|Subject/Guardian decision|7|||
162755412|NCT01640951|587816660|FG005|Overall Study|Subject/Guardian decision|19|||
162755413|NCT01640951|587816661|FG006|Overall Study|Subject/Guardian decision|5|||
162755414|NCT01640951|587816662|FG007|Overall Study|Subject/Guardian decision|4|||
162755415|NCT01640951|587816655|FG000|Overall Study|Death|0|||
162755416|NCT01640951|587816656|FG001|Overall Study|Death|1|||
162755417|NCT01640951|587816657|FG002|Overall Study|Death|1|||
162755418|NCT01640951|587816658|FG003|Overall Study|Death|0|||
162755419|NCT01640951|587816659|FG004|Overall Study|Death|0|||
162755420|NCT01640951|587816660|FG005|Overall Study|Death|0|||
162755421|NCT01640951|587816661|FG006|Overall Study|Death|0|||
162755422|NCT01640951|587816662|FG007|Overall Study|Death|2|||
162755423|NCT00582972|587816663|FG000|Overall Study|Protocol Violation|2|||
162755424|NCT00293397|587816664|FG000|Overall Study|Death|2|||
162755425|NCT04060212|587816665|FG000|Overall Study|Withdrawal by Subject|7|||
162755426|NCT01437319|587816666|FG000|Phase I|Lost to Follow-up|2|||
162755427|NCT01437319|587816667|FG001|Phase I|Lost to Follow-up|0|||
162755428|NCT01437319|587816668|FG002|Phase I|Lost to Follow-up|0|||
162755429|NCT01437319|587816666|FG000|Phase I|Protocol Violation|1|||
162755430|NCT01437319|587816667|FG001|Phase I|Protocol Violation|0|||
162755431|NCT01437319|587816668|FG002|Phase I|Protocol Violation|0|||
162755432|NCT01437319|587816666|FG000|Phase I|Study related symptoms/complaints|27|||
162755433|NCT01437319|587816667|FG001|Phase I|Study related symptoms/complaints|0|||
162755434|NCT01437319|587816668|FG002|Phase I|Study related symptoms/complaints|0|||
162755435|NCT01437319|587816666|FG000|Phase I|Withdrawal by Subject|25|||
162755436|NCT01437319|587816667|FG001|Phase I|Withdrawal by Subject|0|||
162755437|NCT01437319|587816668|FG002|Phase I|Withdrawal by Subject|0|||
162755438|NCT01437319|587816666|FG000|Phase II|Withdrawal by Subject|0|||
162755439|NCT01437319|587816667|FG001|Phase II|Withdrawal by Subject|8|||
162755440|NCT01437319|587816668|FG002|Phase II|Withdrawal by Subject|16|||
162755441|NCT01437319|587816666|FG000|Phase II|Lost to Follow-up|0|||
162755442|NCT01437319|587816667|FG001|Phase II|Lost to Follow-up|7|||
162755443|NCT01437319|587816668|FG002|Phase II|Lost to Follow-up|2|||
162755444|NCT01437319|587816666|FG000|Phase II|Study related symptoms/complaints|0|||
162755445|NCT01437319|587816667|FG001|Phase II|Study related symptoms/complaints|28|||
162755446|NCT01437319|587816668|FG002|Phase II|Study related symptoms/complaints|19|||
162755447|NCT01437319|587816666|FG000|Phase II|Protocol Violation|0|||
162755448|NCT01437319|587816667|FG001|Phase II|Protocol Violation|1|||
162755449|NCT01437319|587816668|FG002|Phase II|Protocol Violation|0|||
162755450|NCT00983294|587816669|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
162755451|NCT00983294|587816669|FG000|Colchicine With Azithromycin|Adverse Event|1|||
162755452|NCT00622700|587816670|FG000|Core Treatment Period|Randomized but Not Treated|0|||
162755453|NCT00622700|587816671|FG001|Core Treatment Period|Randomized but Not Treated|2|||
162755454|NCT00622700|587816672|FG002|Core Treatment Period|Randomized but Not Treated|2|||
162755455|NCT00622700|587816673|FG003|Core Treatment Period|Randomized but Not Treated|0|||
162755456|NCT00622700|587816674|FG004|Core Treatment Period|Randomized but Not Treated|0|||
162755457|NCT00622700|587816675|FG005|Core Treatment Period|Randomized but Not Treated|0|||
162755458|NCT00622700|587816676|FG006|Core Treatment Period|Randomized but Not Treated|0|||
162755459|NCT00622700|587816670|FG000|Core Treatment Period|Adverse Event|18|||
162755460|NCT00622700|587816671|FG001|Core Treatment Period|Adverse Event|25|||
162755461|NCT00622700|587816672|FG002|Core Treatment Period|Adverse Event|18|||
162755462|NCT00622700|587816673|FG003|Core Treatment Period|Adverse Event|0|||
162755463|NCT00622700|587816674|FG004|Core Treatment Period|Adverse Event|0|||
162755464|NCT00622700|587816675|FG005|Core Treatment Period|Adverse Event|0|||
162755465|NCT00622700|587816676|FG006|Core Treatment Period|Adverse Event|0|||
162755466|NCT00622700|587816670|FG000|Core Treatment Period|Lack of Efficacy|19|||
162755467|NCT00622700|587816671|FG001|Core Treatment Period|Lack of Efficacy|6|||
162755468|NCT00622700|587816672|FG002|Core Treatment Period|Lack of Efficacy|12|||
162755469|NCT00622700|587816673|FG003|Core Treatment Period|Lack of Efficacy|0|||
162755470|NCT00622700|587816674|FG004|Core Treatment Period|Lack of Efficacy|0|||
162755471|NCT00622700|587816675|FG005|Core Treatment Period|Lack of Efficacy|0|||
162755472|NCT00622700|587816676|FG006|Core Treatment Period|Lack of Efficacy|0|||
162755473|NCT00622700|587816670|FG000|Core Treatment Period|Lost to Follow-up|1|||
162755474|NCT00622700|587816671|FG001|Core Treatment Period|Lost to Follow-up|1|||
162755475|NCT00622700|587816672|FG002|Core Treatment Period|Lost to Follow-up|1|||
162755476|NCT00622700|587816673|FG003|Core Treatment Period|Lost to Follow-up|0|||
162755477|NCT00622700|587816674|FG004|Core Treatment Period|Lost to Follow-up|0|||
162755478|NCT00622700|587816675|FG005|Core Treatment Period|Lost to Follow-up|0|||
162755479|NCT00622700|587816676|FG006|Core Treatment Period|Lost to Follow-up|0|||
162755480|NCT00622700|587816670|FG000|Core Treatment Period|Death|1|||
162755481|NCT00622700|587816671|FG001|Core Treatment Period|Death|0|||
162755482|NCT00622700|587816672|FG002|Core Treatment Period|Death|0|||
162755483|NCT00622700|587816673|FG003|Core Treatment Period|Death|0|||
162755484|NCT00622700|587816674|FG004|Core Treatment Period|Death|0|||
162755485|NCT00622700|587816675|FG005|Core Treatment Period|Death|0|||
162755486|NCT00622700|587816676|FG006|Core Treatment Period|Death|0|||
162755487|NCT00622700|587816670|FG000|Core Treatment Period|Progressive Disease|3|||
162755488|NCT00622700|587816671|FG001|Core Treatment Period|Progressive Disease|1|||
162755489|NCT00622700|587816672|FG002|Core Treatment Period|Progressive Disease|0|||
162755490|NCT00622700|587816673|FG003|Core Treatment Period|Progressive Disease|0|||
162755491|NCT00622700|587816674|FG004|Core Treatment Period|Progressive Disease|0|||
162755492|NCT00622700|587816675|FG005|Core Treatment Period|Progressive Disease|0|||
162755493|NCT00622700|587816676|FG006|Core Treatment Period|Progressive Disease|0|||
162755494|NCT00622700|587816670|FG000|Core Treatment Period|Withdrawal by Subject|12|||
162755495|NCT00622700|587816671|FG001|Core Treatment Period|Withdrawal by Subject|18|||
162755496|NCT00622700|587816672|FG002|Core Treatment Period|Withdrawal by Subject|15|||
162755497|NCT00622700|587816673|FG003|Core Treatment Period|Withdrawal by Subject|0|||
162755498|NCT00622700|587816674|FG004|Core Treatment Period|Withdrawal by Subject|0|||
162755499|NCT00622700|587816675|FG005|Core Treatment Period|Withdrawal by Subject|0|||
162755500|NCT00622700|587816676|FG006|Core Treatment Period|Withdrawal by Subject|0|||
162755501|NCT00622700|587816670|FG000|Core Treatment Period|Other than specified above|2|||
162755502|NCT00622700|587816671|FG001|Core Treatment Period|Other than specified above|2|||
162755503|NCT00622700|587816672|FG002|Core Treatment Period|Other than specified above|5|||
162755504|NCT00622700|587816673|FG003|Core Treatment Period|Other than specified above|0|||
162755505|NCT00622700|587816674|FG004|Core Treatment Period|Other than specified above|0|||
162755506|NCT00622700|587816675|FG005|Core Treatment Period|Other than specified above|0|||
162755507|NCT00622700|587816676|FG006|Core Treatment Period|Other than specified above|0|||
162755508|NCT00622700|587816670|FG000|Extension Treatment Period|Adverse Event|0|||
162755509|NCT00622700|587816671|FG001|Extension Treatment Period|Adverse Event|0|||
162755510|NCT00622700|587816672|FG002|Extension Treatment Period|Adverse Event|0|||
162755511|NCT00622700|587816673|FG003|Extension Treatment Period|Adverse Event|5|||
162755512|NCT00622700|587816674|FG004|Extension Treatment Period|Adverse Event|9|||
162755513|NCT00622700|587816675|FG005|Extension Treatment Period|Adverse Event|6|||
162755514|NCT00622700|587816676|FG006|Extension Treatment Period|Adverse Event|8|||
162755515|NCT00622700|587816670|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162755516|NCT00622700|587816671|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162755517|NCT00622700|587816672|FG002|Extension Treatment Period|Lack of Efficacy|0|||
162755518|NCT00622700|587816673|FG003|Extension Treatment Period|Lack of Efficacy|2|||
162755519|NCT00622700|587816674|FG004|Extension Treatment Period|Lack of Efficacy|8|||
162755520|NCT00622700|587816675|FG005|Extension Treatment Period|Lack of Efficacy|1|||
162755521|NCT00622700|587816676|FG006|Extension Treatment Period|Lack of Efficacy|9|||
162755522|NCT00622700|587816670|FG000|Extension Treatment Period|Protocol Violation|0|||
162755523|NCT00622700|587816671|FG001|Extension Treatment Period|Protocol Violation|0|||
162755524|NCT00622700|587816672|FG002|Extension Treatment Period|Protocol Violation|0|||
162755525|NCT00622700|587816673|FG003|Extension Treatment Period|Protocol Violation|0|||
162755526|NCT00622700|587816674|FG004|Extension Treatment Period|Protocol Violation|0|||
162755527|NCT00622700|587816675|FG005|Extension Treatment Period|Protocol Violation|2|||
162755528|NCT00622700|587816676|FG006|Extension Treatment Period|Protocol Violation|0|||
162755529|NCT00622700|587816670|FG000|Extension Treatment Period|Lost to Follow-up|0|||
162755530|NCT00622700|587816671|FG001|Extension Treatment Period|Lost to Follow-up|0|||
162755531|NCT00622700|587816672|FG002|Extension Treatment Period|Lost to Follow-up|0|||
162755532|NCT00622700|587816673|FG003|Extension Treatment Period|Lost to Follow-up|0|||
162755533|NCT00622700|587816674|FG004|Extension Treatment Period|Lost to Follow-up|1|||
162755534|NCT00622700|587816675|FG005|Extension Treatment Period|Lost to Follow-up|0|||
162755535|NCT00622700|587816676|FG006|Extension Treatment Period|Lost to Follow-up|0|||
162755536|NCT00622700|587816670|FG000|Extension Treatment Period|Progressive Disease|0|||
162755537|NCT00622700|587816671|FG001|Extension Treatment Period|Progressive Disease|0|||
162755538|NCT00622700|587816672|FG002|Extension Treatment Period|Progressive Disease|0|||
162755539|NCT00622700|587816673|FG003|Extension Treatment Period|Progressive Disease|1|||
162755540|NCT00622700|587816674|FG004|Extension Treatment Period|Progressive Disease|2|||
162755541|NCT00622700|587816675|FG005|Extension Treatment Period|Progressive Disease|0|||
162755542|NCT00622700|587816676|FG006|Extension Treatment Period|Progressive Disease|2|||
162755543|NCT00622700|587816670|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162755544|NCT00622700|587816671|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162755545|NCT00622700|587816672|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
162755546|NCT00622700|587816673|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
162755547|NCT00622700|587816674|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
162755548|NCT00622700|587816675|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
162755549|NCT00622700|587816676|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
162755550|NCT00622700|587816670|FG000|Extension Treatment Period|Missing|0|||
162755551|NCT00622700|587816671|FG001|Extension Treatment Period|Missing|0|||
162755552|NCT00622700|587816672|FG002|Extension Treatment Period|Missing|0|||
162755553|NCT00622700|587816673|FG003|Extension Treatment Period|Missing|2|||
162755554|NCT00622700|587816674|FG004|Extension Treatment Period|Missing|3|||
162755555|NCT00622700|587816675|FG005|Extension Treatment Period|Missing|1|||
162755556|NCT00622700|587816676|FG006|Extension Treatment Period|Missing|0|||
162755557|NCT00622700|587816670|FG000|Extension Treatment Period|Other than specified above|0|||
162755558|NCT00622700|587816671|FG001|Extension Treatment Period|Other than specified above|0|||
162755559|NCT00622700|587816672|FG002|Extension Treatment Period|Other than specified above|0|||
162755560|NCT00622700|587816673|FG003|Extension Treatment Period|Other than specified above|0|||
162755561|NCT00622700|587816674|FG004|Extension Treatment Period|Other than specified above|0|||
162755562|NCT00622700|587816675|FG005|Extension Treatment Period|Other than specified above|1|||
162755563|NCT00622700|587816676|FG006|Extension Treatment Period|Other than specified above|1|||
162755564|NCT03611556|587816677|FG000|Overall Study|Death|7|||
162755565|NCT03611556|587816678|FG001|Overall Study|Death|7|||
162755566|NCT03611556|587816679|FG002|Overall Study|Death|3|||
162755567|NCT03611556|587816680|FG003|Overall Study|Death|8|||
162755568|NCT03611556|587816681|FG004|Overall Study|Death|47|||
162755569|NCT03611556|587816682|FG005|Overall Study|Death|32|||
162755570|NCT03611556|587816683|FG006|Overall Study|Death|53|||
162755571|NCT03611556|587816677|FG000|Overall Study|Withdrawal by Subject|0|||
162755572|NCT03611556|587816678|FG001|Overall Study|Withdrawal by Subject|0|||
162755573|NCT03611556|587816679|FG002|Overall Study|Withdrawal by Subject|0|||
162755574|NCT03611556|587816680|FG003|Overall Study|Withdrawal by Subject|0|||
162755575|NCT03611556|587816681|FG004|Overall Study|Withdrawal by Subject|4|||
162755576|NCT03611556|587816682|FG005|Overall Study|Withdrawal by Subject|2|||
162755577|NCT03611556|587816683|FG006|Overall Study|Withdrawal by Subject|4|||
162755578|NCT03611556|587816677|FG000|Overall Study|Sponsor decision|0|||
162755579|NCT03611556|587816678|FG001|Overall Study|Sponsor decision|0|||
162755580|NCT03611556|587816679|FG002|Overall Study|Sponsor decision|0|||
162755581|NCT03611556|587816680|FG003|Overall Study|Sponsor decision|0|||
162755582|NCT03611556|587816681|FG004|Overall Study|Sponsor decision|9|||
162755583|NCT03611556|587816682|FG005|Overall Study|Sponsor decision|4|||
162755584|NCT03611556|587816683|FG006|Overall Study|Sponsor decision|12|||
162755585|NCT03611556|587816677|FG000|Overall Study|Reasons|0|||
162755586|NCT03611556|587816678|FG001|Overall Study|Reasons|0|||
162755587|NCT03611556|587816679|FG002|Overall Study|Reasons|0|||
162755588|NCT03611556|587816680|FG003|Overall Study|Reasons|0|||
162755589|NCT03611556|587816681|FG004|Overall Study|Reasons|2|||
162755590|NCT03611556|587816682|FG005|Overall Study|Reasons|0|||
162755591|NCT03611556|587816683|FG006|Overall Study|Reasons|1|||
162755592|NCT02844439|587816705|FG000|Overall Study|Withdrawal by Subject|1|||
162755593|NCT02844439|587816705|FG000|Overall Study|Lost to Follow-up|2|||
162755594|NCT02844439|587816705|FG000|Overall Study|Termination by Sponsor|4|||
162755595|NCT02844439|587816705|FG000|Overall Study|Death|28|||
162755596|NCT02844439|587816705|FG000|Overall Study|Other|5|||
162755597|NCT00390884|587816708|FG000|Overall Study|Withdrawal by Subject|2|||
162755598|NCT00390884|587816709|FG001|Overall Study|Withdrawal by Subject|2|||
162755599|NCT00756574|587816710|FG000|Overall Study|Withdrawal by Subject|9|||
162755600|NCT00756574|587816711|FG001|Overall Study|Withdrawal by Subject|7|||
162755601|NCT00756574|587816710|FG000|Overall Study|Lost to Follow-up|4|||
162755602|NCT00756574|587816711|FG001|Overall Study|Lost to Follow-up|4|||
162755603|NCT04035447|587816712|FG000|Treatment Period|Lost to Follow-up|6|||
162755604|NCT04035447|587816713|FG001|Treatment Period|Lost to Follow-up|5|||
162755605|NCT04035447|587816712|FG000|Treatment Period|Physician Decision|0|||
162755606|NCT04035447|587816713|FG001|Treatment Period|Physician Decision|2|||
162755607|NCT04622332|587816714|FG000|Overall Study|Withdrawal by Subject|4|||
162755608|NCT04622332|587816715|FG001|Overall Study|Withdrawal by Subject|2|||
162755609|NCT04622332|587816714|FG000|Overall Study|Physician Decision|1|||
162755610|NCT04622332|587816715|FG001|Overall Study|Physician Decision|1|||
162755611|NCT04622332|587816714|FG000|Overall Study|Adverse Event|0|||
162755612|NCT04622332|587816715|FG001|Overall Study|Adverse Event|2|||
162755613|NCT04622332|587816714|FG000|Overall Study|Protocol Violation|0|||
162755614|NCT04622332|587816715|FG001|Overall Study|Protocol Violation|1|||
162755615|NCT05966155|587816716|FG000|Overall Study|Death|1|||
162755616|NCT05966155|587816717|FG001|Overall Study|Death|2|||
162755617|NCT05966155|587816716|FG000|Overall Study|Lost to Follow-up|63|||
162755618|NCT05966155|587816717|FG001|Overall Study|Lost to Follow-up|67|||
162755619|NCT05966155|587816716|FG000|Overall Study|Protocol Violation|1|||
162755620|NCT05966155|587816717|FG001|Overall Study|Protocol Violation|0|||
162755621|NCT05966155|587816716|FG000|Overall Study|Withdrawal by Subject|8|||
162755622|NCT05966155|587816717|FG001|Overall Study|Withdrawal by Subject|9|||
162755623|NCT05966155|587816716|FG000|Overall Study|Enrolled Erroneously|0|||
162755624|NCT05966155|587816717|FG001|Overall Study|Enrolled Erroneously|1|||
162755625|NCT05966155|587816716|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
162755626|NCT05966155|587816717|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
162755627|NCT03304587|587816721|FG000|Overall Study|Headache after intervention|0|||
162755628|NCT03304587|587816722|FG001|Overall Study|Headache after intervention|1|||
162755629|NCT03304587|587816721|FG000|Overall Study|Withdrawal by Subject|1|||
162755630|NCT03304587|587816722|FG001|Overall Study|Withdrawal by Subject|0|||
162755631|NCT05036278|587816727|FG000|Overall Study|Withdrawal by Subject|1|||
162755632|NCT05036278|587816727|FG000|Overall Study|Adverse Event|1|||
162755633|NCT01458366|587816729|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
162755634|NCT01458366|587816730|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
162755635|NCT01458366|587816731|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
162755636|NCT01458366|587816732|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
162755637|NCT01458366|587816733|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
162755638|NCT01458366|587816729|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162755639|NCT01458366|587816730|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162755640|NCT01458366|587816731|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162755641|NCT01458366|587816732|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162755642|NCT01458366|587816733|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
162755643|NCT04647487|587816736|FG000|Overall Study|Protocol Deviation|0|||
162755644|NCT04647487|587816737|FG001|Overall Study|Protocol Deviation|0|||
162755645|NCT04647487|587816738|FG002|Overall Study|Protocol Deviation|1|||
162755646|NCT04647487|587816736|FG000|Overall Study|Withdrawal by Subject|1|||
162755647|NCT04647487|587816737|FG001|Overall Study|Withdrawal by Subject|0|||
162755648|NCT04647487|587816738|FG002|Overall Study|Withdrawal by Subject|2|||
162755649|NCT02787005|587816739|FG000|Overall Study|Adverse Event|24|||
162755650|NCT02787005|587816740|FG001|Overall Study|Adverse Event|9|||
162755651|NCT02787005|587816741|FG002|Overall Study|Adverse Event|9|||
162755652|NCT02787005|587816742|FG003|Overall Study|Adverse Event|7|||
162755653|NCT02787005|587816743|FG004|Overall Study|Adverse Event|2|||
162755654|NCT02787005|587816739|FG000|Overall Study|Death|100|||
162755655|NCT02787005|587816740|FG001|Overall Study|Death|53|||
162755656|NCT02787005|587816741|FG002|Overall Study|Death|48|||
162755657|NCT02787005|587816742|FG003|Overall Study|Death|69|||
162755658|NCT02787005|587816743|FG004|Overall Study|Death|38|||
162755659|NCT02787005|587816739|FG000|Overall Study|Sponsor Decision|7|||
162755660|NCT02787005|587816740|FG001|Overall Study|Sponsor Decision|4|||
162755661|NCT02787005|587816741|FG002|Overall Study|Sponsor Decision|0|||
162755662|NCT02787005|587816742|FG003|Overall Study|Sponsor Decision|4|||
162755663|NCT02787005|587816743|FG004|Overall Study|Sponsor Decision|5|||
162755664|NCT02787005|587816739|FG000|Overall Study|Withdrawal by Subject|2|||
162755665|NCT02787005|587816740|FG001|Overall Study|Withdrawal by Subject|1|||
162755666|NCT02787005|587816741|FG002|Overall Study|Withdrawal by Subject|1|||
162755667|NCT02787005|587816742|FG003|Overall Study|Withdrawal by Subject|0|||
162755668|NCT02787005|587816743|FG004|Overall Study|Withdrawal by Subject|1|||
162755669|NCT02787005|587816739|FG000|Overall Study|Screen Failure|0|||
162755670|NCT02787005|587816740|FG001|Overall Study|Screen Failure|2|||
162755671|NCT02787005|587816741|FG002|Overall Study|Screen Failure|0|||
162755672|NCT02787005|587816742|FG003|Overall Study|Screen Failure|0|||
162755673|NCT02787005|587816743|FG004|Overall Study|Screen Failure|1|||
162755674|NCT02787005|587816739|FG000|Overall Study|Lost to Follow-up|0|||
162755675|NCT02787005|587816740|FG001|Overall Study|Lost to Follow-up|0|||
162755676|NCT02787005|587816741|FG002|Overall Study|Lost to Follow-up|0|||
162755677|NCT02787005|587816742|FG003|Overall Study|Lost to Follow-up|1|||
162755678|NCT02787005|587816743|FG004|Overall Study|Lost to Follow-up|0|||
162755679|NCT03890289|587816749|FG000|Overall Study|Adverse Event|1|||
162755680|NCT03890289|587816749|FG000|Overall Study|Physician Decision|1|||
162755681|NCT03890289|587816749|FG000|Overall Study|Lack of Efficacy|2|||
162755682|NCT00174252|587816756|FG000|Overall Study|Protocol Violation|2|||
162755683|NCT02744066|587816757|FG000|Overall Study|Withdrawal by parent|0|||
162755684|NCT02744066|587816758|FG001|Overall Study|Withdrawal by parent|1|||
162755685|NCT02744066|587816757|FG000|Overall Study|Discharged from NICU prior to completion|0|||
162755686|NCT02744066|587816758|FG001|Overall Study|Discharged from NICU prior to completion|4|||
162755687|NCT05509816|587816759|FG000|Overall Study|Lost to Follow-up|1|||
162755688|NCT02107261|587816766|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
162755689|NCT02107261|587816767|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
162755690|NCT02107261|587816766|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
162755691|NCT02107261|587816767|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
162755692|NCT04337931|587816769|FG000|Overall Study|Death|4|||
162755693|NCT04337931|587816770|FG001|Overall Study|Death|1|||
162755694|NCT04337931|587816771|FG002|Overall Study|Death|7|||
162755695|NCT04337931|587816769|FG000|Overall Study|Withdrawal by Subject|0|||
162755696|NCT04337931|587816770|FG001|Overall Study|Withdrawal by Subject|1|||
162755697|NCT04337931|587816771|FG002|Overall Study|Withdrawal by Subject|0|||
162755698|NCT04337931|587816769|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
162755699|NCT04337931|587816770|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
162755700|NCT04337931|587816771|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
162755701|NCT04337931|587816769|FG000|Overall Study|Study terminated by sponsor|3|||
162755702|NCT04337931|587816770|FG001|Overall Study|Study terminated by sponsor|6|||
162755703|NCT04337931|587816771|FG002|Overall Study|Study terminated by sponsor|2|||
162755704|NCT04337931|587816769|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
162755705|NCT04337931|587816770|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
162755706|NCT04337931|587816771|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
162755707|NCT04337931|587816769|FG000|Overall Study|Colorectal cancer treatment|1|||
162755708|NCT04337931|587816770|FG001|Overall Study|Colorectal cancer treatment|0|||
162755709|NCT04337931|587816771|FG002|Overall Study|Colorectal cancer treatment|0|||
162755710|NCT04337931|587816769|FG000|Overall Study|Participant decision|0|||
162755711|NCT04337931|587816770|FG001|Overall Study|Participant decision|1|||
162755712|NCT04337931|587816771|FG002|Overall Study|Participant decision|0|||
162755713|NCT01738438|587816773|FG000|Overall Study|Disease Progression|32|||
162755714|NCT01738438|587816773|FG000|Overall Study|Adverse Event|3|||
162755715|NCT02130557|587816775|FG000|Overall Study|Withdrawal by Subject|12|||
162755716|NCT02130557|587816776|FG001|Overall Study|Withdrawal by Subject|12|||
162755717|NCT02130557|587816775|FG000|Overall Study|Investigator Request|0|||
162755718|NCT02130557|587816776|FG001|Overall Study|Investigator Request|2|||
162755719|NCT02130557|587816775|FG000|Overall Study|Deceased|14|||
162755720|NCT02130557|587816776|FG001|Overall Study|Deceased|14|||
162755721|NCT02130557|587816775|FG000|Overall Study|Lost to Follow-up|6|||
162755722|NCT02130557|587816776|FG001|Overall Study|Lost to Follow-up|7|||
162755723|NCT02130557|587816775|FG000|Overall Study|Other|2|||
162755724|NCT02130557|587816776|FG001|Overall Study|Other|1|||
162755725|NCT02130557|587816775|FG000|Overall Study|Missing|2|||
162755726|NCT02130557|587816776|FG001|Overall Study|Missing|1|||
162755727|NCT02928172|587816777|FG000|Overall Study|Device did not record data|1|||
162755728|NCT01532999|587816778|FG000|Overall Study|Lost to Follow-up|14|||
162755729|NCT01532999|587816779|FG001|Overall Study|Lost to Follow-up|8|||
162755730|NCT01532999|587816778|FG000|Overall Study|Physician Decision|1|||
162755731|NCT01532999|587816779|FG001|Overall Study|Physician Decision|2|||
162755732|NCT01532999|587816778|FG000|Overall Study|Withdrawal by Subject|5|||
162755733|NCT01532999|587816779|FG001|Overall Study|Withdrawal by Subject|0|||
162755734|NCT01532999|587816778|FG000|Overall Study|Relocated|2|||
162755735|NCT01532999|587816779|FG001|Overall Study|Relocated|0|||
162755736|NCT01532999|587816778|FG000|Overall Study|should not have been randomized|1|||
162755737|NCT01532999|587816779|FG001|Overall Study|should not have been randomized|0|||
162755738|NCT01532999|587816778|FG000|Overall Study|substantial noncompliance|2|||
162755739|NCT01532999|587816779|FG001|Overall Study|substantial noncompliance|0|||
162755740|NCT01532999|587816778|FG000|Overall Study|no show for week 9 assessments|6|||
162755741|NCT01532999|587816779|FG001|Overall Study|no show for week 9 assessments|4|||
162755742|NCT01532999|587816778|FG000|Overall Study|Adverse Event|0|||
162755743|NCT01532999|587816779|FG001|Overall Study|Adverse Event|1|||
162755744|NCT01532999|587816778|FG000|Overall Study|incarcerated|0|||
162755745|NCT01532999|587816779|FG001|Overall Study|incarcerated|1|||
162755746|NCT01532999|587816778|FG000|Overall Study|New job|0|||
162755747|NCT01532999|587816779|FG001|Overall Study|New job|2|||
162755748|NCT02408887|587816780|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
162755749|NCT02408887|587816781|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
162755750|NCT02408887|587816780|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
162755751|NCT02408887|587816781|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
162755752|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162755753|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162755754|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162755755|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162755756|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162755757|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
162755758|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
162755759|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
162755760|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
162755761|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
162755762|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
162755763|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
162755764|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
162755765|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
162755766|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
162755767|NCT03333109|587816783|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
162755768|NCT03333109|587816784|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
162755769|NCT03333109|587816785|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
162755770|NCT03333109|587816783|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
162755771|NCT03333109|587816784|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
162755772|NCT03333109|587816785|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
162755773|NCT03333109|587816783|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
162755774|NCT03333109|587816784|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
162755775|NCT03333109|587816785|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
162755776|NCT00918203|587816786|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
162755777|NCT00918203|587816787|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
162755778|NCT00918203|587816788|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
162755779|NCT00918203|587816786|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
162755780|NCT00918203|587816787|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
162755781|NCT00918203|587816788|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
162755782|NCT00918203|587816786|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
162755783|NCT00918203|587816787|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
162755784|NCT00918203|587816788|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
162755785|NCT00918203|587816786|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
162755786|NCT00918203|587816787|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
162755787|NCT00918203|587816788|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
162755788|NCT04066075|587816791|FG000|Overall Study|Lost to Follow-up|3|||
162755789|NCT04066075|587816792|FG001|Overall Study|Lost to Follow-up|3|||
162755790|NCT04066075|587816791|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
162755791|NCT04066075|587816792|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
162755792|NCT04066075|587816791|FG000|Overall Study|Withdrawal by Subject|2|||
162755793|NCT04066075|587816792|FG001|Overall Study|Withdrawal by Subject|2|||
162755794|NCT00309166|587816793|FG000|Overall Study|Adverse event, non-fatal|1|||
162755795|NCT00309166|587816794|FG001|Overall Study|Adverse event, non-fatal|0|||
162755796|NCT00309166|587816793|FG000|Overall Study|Withdrawal by Subject|4|||
162755797|NCT00309166|587816794|FG001|Overall Study|Withdrawal by Subject|3|||
162755798|NCT00701701|587816797|FG000|Overall Study|Withdrawal by Subject|0|||
162755799|NCT00701701|587816798|FG001|Overall Study|Withdrawal by Subject|1|||
162755800|NCT00701701|587816797|FG000|Overall Study|Adverse Event|0|||
162755801|NCT00701701|587816798|FG001|Overall Study|Adverse Event|1|||
162755802|NCT02678689|587816801|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
162755803|NCT02678689|587816802|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
162755804|NCT05250115|587818071|FG000|Overall Study|Premature study end|40|||
162755805|NCT05250115|587818071|FG000|Overall Study|Adverse Event|8|||
162755806|NCT05250115|587818071|FG000|Overall Study|Lost to Follow-up|7|||
162755807|NCT05250115|587818071|FG000|Overall Study|Withdrawal by Subject|6|||
162755808|NCT05250115|587818071|FG000|Overall Study|Withdrawal of informed consent|1|||
162755809|NCT05250115|587818071|FG000|Overall Study|Other|7|||
162755810|NCT03244800|587818073|FG000|Overall Study|Adverse Event|0|||
162755811|NCT03244800|587818074|FG001|Overall Study|Adverse Event|1|||
162755812|NCT03244800|587818075|FG002|Overall Study|Adverse Event|0|||
162755813|NCT03244800|587818076|FG003|Overall Study|Adverse Event|1|||
162755814|NCT03244800|587818073|FG000|Overall Study|Withdrew treatment|0|||
162755815|NCT03244800|587818074|FG001|Overall Study|Withdrew treatment|0|||
162755816|NCT03244800|587818075|FG002|Overall Study|Withdrew treatment|0|||
162755817|NCT03244800|587818076|FG003|Overall Study|Withdrew treatment|1|||
162755818|NCT00890591|587818085|FG000|Overall Study|Lack of Efficacy|20|||
162755819|NCT00776009|587818090|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
162755820|NCT00776009|587818091|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
162755821|NCT00776009|587818092|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
162755822|NCT00776009|587818093|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
162755823|NCT00776009|587818094|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
162755824|NCT00776009|587818095|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
162755825|NCT00776009|587818090|FG000|Period 1: First Intervention|Protocol Violation|0|||
162755826|NCT00776009|587818091|FG001|Period 1: First Intervention|Protocol Violation|1|||
162755827|NCT00776009|587818092|FG002|Period 1: First Intervention|Protocol Violation|0|||
162755828|NCT00776009|587818093|FG003|Period 1: First Intervention|Protocol Violation|0|||
162755829|NCT00776009|587818094|FG004|Period 1: First Intervention|Protocol Violation|1|||
162755830|NCT00776009|587818095|FG005|Period 1: First Intervention|Protocol Violation|0|||
162755831|NCT00776009|587818090|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
162755832|NCT00776009|587818091|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
162755833|NCT00776009|587818092|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
162755834|NCT00776009|587818093|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
162755835|NCT00776009|587818094|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
162755836|NCT00776009|587818095|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
162755837|NCT00776009|587818090|FG000|Period 2: Second Intervention|Protocol Violation|1|||
162755838|NCT00776009|587818091|FG001|Period 2: Second Intervention|Protocol Violation|0|||
162755839|NCT00776009|587818092|FG002|Period 2: Second Intervention|Protocol Violation|1|||
162755840|NCT00776009|587818093|FG003|Period 2: Second Intervention|Protocol Violation|0|||
162755841|NCT00776009|587818094|FG004|Period 2: Second Intervention|Protocol Violation|0|||
162755842|NCT00776009|587818095|FG005|Period 2: Second Intervention|Protocol Violation|0|||
162755843|NCT00776009|587818090|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
162755844|NCT00776009|587818091|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
162755845|NCT00776009|587818092|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
162755846|NCT00776009|587818093|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
162755847|NCT00776009|587818094|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
162755848|NCT00776009|587818095|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
162755849|NCT01536093|587818101|FG000|Overall Study|Death|1|||
162755850|NCT01536093|587818102|FG001|Overall Study|Death|2|||
162755851|NCT01536093|587818101|FG000|Overall Study|absence of maternal colostrum|2|||
162755852|NCT01536093|587818102|FG001|Overall Study|absence of maternal colostrum|0|||
162755853|NCT01536093|587818101|FG000|Overall Study|Withdrawal by Subject|0|||
162755854|NCT01536093|587818102|FG001|Overall Study|Withdrawal by Subject|1|||
162755855|NCT02275611|587818105|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
162755856|NCT02275611|587818106|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
162755857|NCT02275611|587818107|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
162755858|NCT02275611|587818108|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
162755859|NCT03631407|587818114|FG000|Overall Study|Withdrawal by Subject|3|||
162755860|NCT03631407|587818115|FG001|Overall Study|Withdrawal by Subject|2|||
162755861|NCT03631407|587818114|FG000|Overall Study|Sponsor Decision|0|||
162755862|NCT03631407|587818115|FG001|Overall Study|Sponsor Decision|2|||
162755863|NCT03631407|587818114|FG000|Overall Study|Death|16|||
162755864|NCT03631407|587818115|FG001|Overall Study|Death|16|||
162755865|NCT03631407|587818114|FG000|Overall Study|Randomized by mistake without study treatment|1|||
162755866|NCT03631407|587818115|FG001|Overall Study|Randomized by mistake without study treatment|0|||
162755867|NCT00811941|587818117|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
162755868|NCT00811941|587818118|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
162755869|NCT00811941|587818117|FG000|All Treated Patients|Adverse Event|2|||
162755870|NCT00811941|587818118|FG001|All Treated Patients|Adverse Event|43|||
162755871|NCT00811941|587818117|FG000|All Treated Patients|Lack of Efficacy|2|||
162755872|NCT00811941|587818118|FG001|All Treated Patients|Lack of Efficacy|3|||
162755873|NCT00811941|587818117|FG000|All Treated Patients|Non-compliance|1|||
162755874|NCT00811941|587818118|FG001|All Treated Patients|Non-compliance|8|||
162755875|NCT00811941|587818117|FG000|All Treated Patients|Protocol Violation|5|||
162755876|NCT00811941|587818118|FG001|All Treated Patients|Protocol Violation|17|||
162755877|NCT00811941|587818117|FG000|All Treated Patients|Withdrawal by Subject|35|||
162755878|NCT00811941|587818118|FG001|All Treated Patients|Withdrawal by Subject|94|||
162755879|NCT00811941|587818117|FG000|All Treated Patients|Lost to Follow-up|3|||
162755880|NCT00811941|587818118|FG001|All Treated Patients|Lost to Follow-up|12|||
162755881|NCT00811941|587818117|FG000|All Treated Patients|Other Reason|4|||
162755882|NCT00811941|587818118|FG001|All Treated Patients|Other Reason|14|||
162755883|NCT03802994|587818121|FG000|Overall Study|Lost to Follow-up|0|||
162755884|NCT03802994|587818122|FG001|Overall Study|Lost to Follow-up|2|||
162755885|NCT03802994|587818123|FG002|Overall Study|Lost to Follow-up|3|||
162755886|NCT03802994|587818124|FG003|Overall Study|Lost to Follow-up|2|||
162755887|NCT03802994|587818125|FG004|Overall Study|Lost to Follow-up|2|||
162755888|NCT00942266|587818131|FG000|Overall Study|Withdrawal by Subject|1|||
162755889|NCT00942266|587818132|FG001|Overall Study|Withdrawal by Subject|0|||
162755890|NCT00942266|587818131|FG000|Overall Study|Adverse Event|2|||
162755891|NCT00942266|587818132|FG001|Overall Study|Adverse Event|1|||
162755892|NCT00942266|587818131|FG000|Overall Study|Disease Progression|38|||
162755893|NCT00942266|587818132|FG001|Overall Study|Disease Progression|11|||
162755894|NCT00942266|587818131|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
162755895|NCT00942266|587818132|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
162755896|NCT00942266|587818131|FG000|Overall Study|Intercurrent illness|0|||
162755897|NCT00942266|587818132|FG001|Overall Study|Intercurrent illness|1|||
162755898|NCT00942266|587818131|FG000|Overall Study|Physician Decision|2|||
162755899|NCT00942266|587818132|FG001|Overall Study|Physician Decision|0|||
162755900|NCT00942266|587818131|FG000|Overall Study|medical deterioration (pneumonia)|0|||
162755901|NCT00942266|587818132|FG001|Overall Study|medical deterioration (pneumonia)|1|||
162755902|NCT04795167|587818135|FG000|Overall Study|Death|1|||
162755903|NCT04795167|587818136|FG001|Overall Study|Death|18|||
162755904|NCT04795167|587818137|FG002|Overall Study|Death|1|||
162755905|NCT04795167|587818135|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
162755906|NCT04795167|587818136|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
162755907|NCT04795167|587818137|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
162755908|NCT01753999|587818138|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
162755909|NCT01753999|587818139|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
162755910|NCT01753999|587818138|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
162755911|NCT01753999|587818139|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
162755912|NCT01753999|587818138|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
162755913|NCT01753999|587818139|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
162755914|NCT01753999|587818138|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
162755915|NCT01753999|587818139|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
162755916|NCT01753999|587818138|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
162755917|NCT01753999|587818139|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
162755918|NCT01753999|587818138|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
162755919|NCT01753999|587818139|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
162755920|NCT02029235|587818141|FG000|Overall Study|Non-compliance with study meds or diary|4|||
162755921|NCT02029235|587818142|FG001|Overall Study|Non-compliance with study meds or diary|1|||
162755922|NCT04436289|587818143|FG000|Overall Study|Death prior to hospital discharge|8|||
162755923|NCT04436289|587818144|FG001|Overall Study|Death prior to hospital discharge|5|||
162755924|NCT04436289|587818145|FG002|Overall Study|Death prior to hospital discharge|0|||
162755925|NCT04436289|587818146|FG003|Overall Study|Death prior to hospital discharge|1|||
162755926|NCT04436289|587818143|FG000|Overall Study|Withdrawal by Subject|0|||
162755927|NCT04436289|587818144|FG001|Overall Study|Withdrawal by Subject|1|||
162755928|NCT04436289|587818145|FG002|Overall Study|Withdrawal by Subject|4|||
162755929|NCT04436289|587818146|FG003|Overall Study|Withdrawal by Subject|0|||
162755930|NCT04436289|587818143|FG000|Overall Study|Extended hospital stay|0|||
162755931|NCT04436289|587818144|FG001|Overall Study|Extended hospital stay|1|||
162755932|NCT04436289|587818145|FG002|Overall Study|Extended hospital stay|0|||
162755933|NCT04436289|587818146|FG003|Overall Study|Extended hospital stay|0|||
162755934|NCT04436289|587818143|FG000|Overall Study|Lost to Follow-up|0|||
162755935|NCT04436289|587818144|FG001|Overall Study|Lost to Follow-up|4|||
162755936|NCT04436289|587818145|FG002|Overall Study|Lost to Follow-up|1|||
162755937|NCT04436289|587818146|FG003|Overall Study|Lost to Follow-up|3|||
162755938|NCT00589875|587818147|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
162755939|NCT00589875|587818147|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
162755940|NCT03357952|587818150|FG000|Overall Study|Withdrawal by Subject|0|||
162755941|NCT03357952|587818151|FG001|Overall Study|Withdrawal by Subject|1|||
162755942|NCT03357952|587818150|FG000|Overall Study|Sponsor Decision|9|||
162755943|NCT03357952|587818151|FG001|Overall Study|Sponsor Decision|0|||
162755944|NCT03598907|587818152|FG000|Overall Study|Physician Decision|14|||
162755945|NCT03598907|587818153|FG001|Overall Study|Physician Decision|19|||
162755946|NCT01675492|587818156|FG000|Overall Study|study completed early - product approval|42|||
162755947|NCT04517435|587818173|FG000|Overall Study|Withdrawal by Subject|0|||
162755948|NCT04517435|587818174|FG001|Overall Study|Withdrawal by Subject|0|||
162755949|NCT04517435|587818175|FG002|Overall Study|Withdrawal by Subject|1|||
162755950|NCT04517435|587818173|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
162755951|NCT04517435|587818174|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
162755952|NCT04517435|587818175|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
162755953|NCT06191679|587818176|FG000|Baseline|Lost to Follow-up|1|||
162755954|NCT06191679|587818177|FG001|Baseline|Lost to Follow-up|0|||
162755955|NCT06191679|587818178|FG002|Baseline|Lost to Follow-up|1|||
162755956|NCT06191679|587818179|FG003|Baseline|Lost to Follow-up|0|||
162755957|NCT06191679|587818176|FG000|Allocation to Group|Withdrawal by Subject|0|||
162755958|NCT06191679|587818177|FG001|Allocation to Group|Withdrawal by Subject|1|||
162755959|NCT06191679|587818178|FG002|Allocation to Group|Withdrawal by Subject|2|||
162755960|NCT06191679|587818179|FG003|Allocation to Group|Withdrawal by Subject|0|||
162755961|NCT06191679|587818176|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
162755962|NCT06191679|587818177|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
162755963|NCT06191679|587818178|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
162755964|NCT06191679|587818179|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
162755965|NCT06191679|587818176|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
162755966|NCT06191679|587818177|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
162755967|NCT06191679|587818178|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
162755968|NCT06191679|587818179|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
162755969|NCT06191679|587818176|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162755970|NCT06191679|587818177|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162755971|NCT06191679|587818178|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162755972|NCT06191679|587818179|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
162755973|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
162755974|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
162755975|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
162755976|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
162755977|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
162755978|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
162755979|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
162755980|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
162755981|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162755982|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162755983|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
162755984|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
162755985|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
162755986|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162755987|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
162755988|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
162755989|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
162755990|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
162755991|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
162755992|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
162755993|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
162755994|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162755995|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162755996|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162755997|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162755998|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162755999|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
162756000|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
162756001|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
162756002|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162756003|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162756004|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162756005|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162756006|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162756007|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
162756008|NCT03656718|587818180|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162756009|NCT03656718|587818181|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162756010|NCT03656718|587818182|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162756011|NCT03656718|587818183|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162756012|NCT03656718|587818184|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162756013|NCT03656718|587818185|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
162756014|NCT03656718|587818186|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
162756015|NCT03656718|587818180|FG000|Treatment Period Part C|Disease progression|0|||
162756016|NCT03656718|587818181|FG001|Treatment Period Part C|Disease progression|0|||
162756017|NCT03656718|587818182|FG002|Treatment Period Part C|Disease progression|0|||
162756018|NCT03656718|587818183|FG003|Treatment Period Part C|Disease progression|0|||
162756019|NCT03656718|587818184|FG004|Treatment Period Part C|Disease progression|12|||
162756020|NCT03656718|587818185|FG005|Treatment Period Part C|Disease progression|0|||
162756021|NCT03656718|587818186|FG006|Treatment Period Part C|Disease progression|0|||
162756022|NCT03656718|587818180|FG000|Treatment Period Part C|Death|0|||
162756023|NCT03656718|587818181|FG001|Treatment Period Part C|Death|0|||
162756024|NCT03656718|587818182|FG002|Treatment Period Part C|Death|0|||
162756025|NCT03656718|587818183|FG003|Treatment Period Part C|Death|0|||
162756026|NCT03656718|587818184|FG004|Treatment Period Part C|Death|1|||
162756027|NCT03656718|587818185|FG005|Treatment Period Part C|Death|0|||
162756028|NCT03656718|587818186|FG006|Treatment Period Part C|Death|0|||
162756029|NCT03656718|587818180|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756030|NCT03656718|587818181|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756031|NCT03656718|587818182|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756032|NCT03656718|587818183|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756033|NCT03656718|587818184|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
162756034|NCT03656718|587818185|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756035|NCT03656718|587818186|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162756036|NCT03656718|587818180|FG000|Treatment Period Part C|Other reasons|0|||
162756037|NCT03656718|587818181|FG001|Treatment Period Part C|Other reasons|0|||
162756038|NCT03656718|587818182|FG002|Treatment Period Part C|Other reasons|0|||
162756039|NCT03656718|587818183|FG003|Treatment Period Part C|Other reasons|0|||
162756040|NCT03656718|587818184|FG004|Treatment Period Part C|Other reasons|1|||
162756041|NCT03656718|587818185|FG005|Treatment Period Part C|Other reasons|0|||
162756042|NCT03656718|587818186|FG006|Treatment Period Part C|Other reasons|0|||
162756043|NCT03656718|587818180|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
162756044|NCT03656718|587818181|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
162756045|NCT03656718|587818182|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
162756046|NCT03656718|587818183|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
162756047|NCT03656718|587818184|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
162756048|NCT03656718|587818185|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
162756049|NCT03656718|587818186|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
162756050|NCT03211247|587818187|FG000|Overall Study|Adverse Event|8|||
162756051|NCT03211247|587818188|FG001|Overall Study|Adverse Event|0|||
162756052|NCT03211247|587818189|FG002|Overall Study|Adverse Event|1|||
162756053|NCT03211247|587818190|FG003|Overall Study|Adverse Event|0|||
162756054|NCT03211247|587818191|FG004|Overall Study|Adverse Event|0|||
162756055|NCT03211247|587818187|FG000|Overall Study|Lost to Follow-up|2|||
162756056|NCT03211247|587818188|FG001|Overall Study|Lost to Follow-up|1|||
162756057|NCT03211247|587818189|FG002|Overall Study|Lost to Follow-up|0|||
162756058|NCT03211247|587818190|FG003|Overall Study|Lost to Follow-up|0|||
162756059|NCT03211247|587818191|FG004|Overall Study|Lost to Follow-up|0|||
162756060|NCT03211247|587818187|FG000|Overall Study|Physician Decision|1|||
162756061|NCT03211247|587818188|FG001|Overall Study|Physician Decision|2|||
162756062|NCT03211247|587818189|FG002|Overall Study|Physician Decision|0|||
162756063|NCT03211247|587818190|FG003|Overall Study|Physician Decision|0|||
162756064|NCT03211247|587818191|FG004|Overall Study|Physician Decision|0|||
162756065|NCT03211247|587818187|FG000|Overall Study|Non-compliance with study drug|2|||
162756066|NCT03211247|587818188|FG001|Overall Study|Non-compliance with study drug|0|||
162756067|NCT03211247|587818189|FG002|Overall Study|Non-compliance with study drug|0|||
162756068|NCT03211247|587818190|FG003|Overall Study|Non-compliance with study drug|0|||
162756069|NCT03211247|587818191|FG004|Overall Study|Non-compliance with study drug|0|||
162756070|NCT03211247|587818187|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
162756071|NCT03211247|587818188|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
162756072|NCT03211247|587818189|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
162756073|NCT03211247|587818190|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
162756074|NCT03211247|587818191|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
162756075|NCT03211247|587818187|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
162756076|NCT03211247|587818188|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
162756077|NCT03211247|587818189|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
162756078|NCT03211247|587818190|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
162756079|NCT03211247|587818191|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
162756080|NCT03211247|587818187|FG000|Overall Study|Protocol Violation|0|||
162756081|NCT03211247|587818188|FG001|Overall Study|Protocol Violation|1|||
162756082|NCT03211247|587818189|FG002|Overall Study|Protocol Violation|0|||
162756083|NCT03211247|587818190|FG003|Overall Study|Protocol Violation|0|||
162756084|NCT03211247|587818191|FG004|Overall Study|Protocol Violation|0|||
162756085|NCT02415127|587818192|FG000|Overall Study|Adverse Event|1|||
162756086|NCT02415127|587818193|FG001|Overall Study|Adverse Event|0|||
162756087|NCT05827068|587818194|FG000|Overall Study|Lost to Follow-up|1|||
162756088|NCT05827068|587818195|FG001|Overall Study|Lost to Follow-up|4|||
162756089|NCT05827068|587818196|FG002|Overall Study|Lost to Follow-up|1|||
162756090|NCT05827068|587818197|FG003|Overall Study|Lost to Follow-up|1|||
162756091|NCT05827068|587818198|FG004|Overall Study|Lost to Follow-up|2|||
162756092|NCT05827068|587818199|FG005|Overall Study|Lost to Follow-up|4|||
162756093|NCT05827068|587818200|FG006|Overall Study|Lost to Follow-up|1|||
162756094|NCT05827068|587818194|FG000|Overall Study|Withdrawal by Subject|4|||
162756095|NCT05827068|587818195|FG001|Overall Study|Withdrawal by Subject|0|||
162756096|NCT05827068|587818196|FG002|Overall Study|Withdrawal by Subject|1|||
162756097|NCT05827068|587818197|FG003|Overall Study|Withdrawal by Subject|2|||
162756098|NCT05827068|587818198|FG004|Overall Study|Withdrawal by Subject|3|||
162756099|NCT05827068|587818199|FG005|Overall Study|Withdrawal by Subject|0|||
162756100|NCT05827068|587818200|FG006|Overall Study|Withdrawal by Subject|1|||
162925386|NCT00110084|588428953|FG000|Overall Study|Intercurrent Illness|1|||
162756101|NCT05827068|587818194|FG000|Overall Study|Physician Decision|0|||
162756102|NCT05827068|587818195|FG001|Overall Study|Physician Decision|0|||
162756103|NCT05827068|587818196|FG002|Overall Study|Physician Decision|0|||
162756104|NCT05827068|587818197|FG003|Overall Study|Physician Decision|0|||
162756105|NCT05827068|587818198|FG004|Overall Study|Physician Decision|1|||
162756106|NCT05827068|587818199|FG005|Overall Study|Physician Decision|0|||
162756107|NCT05827068|587818200|FG006|Overall Study|Physician Decision|1|||
162756108|NCT05827068|587818194|FG000|Overall Study|Other Than Specified|0|||
162756109|NCT05827068|587818195|FG001|Overall Study|Other Than Specified|1|||
162756110|NCT05827068|587818196|FG002|Overall Study|Other Than Specified|0|||
162756111|NCT05827068|587818197|FG003|Overall Study|Other Than Specified|0|||
162756112|NCT05827068|587818198|FG004|Overall Study|Other Than Specified|0|||
162756113|NCT05827068|587818199|FG005|Overall Study|Other Than Specified|0|||
162756114|NCT05827068|587818200|FG006|Overall Study|Other Than Specified|0|||
162756115|NCT05630833|587818203|FG000|Overall Study|Adverse Event|3|||
162756116|NCT05630833|587818204|FG001|Overall Study|Adverse Event|0|||
162756117|NCT05630833|587818203|FG000|Overall Study|Lack of Efficacy|0|||
162756118|NCT05630833|587818204|FG001|Overall Study|Lack of Efficacy|1|||
162756119|NCT05630833|587818203|FG000|Overall Study|Lost to Follow-up|1|||
162756120|NCT05630833|587818204|FG001|Overall Study|Lost to Follow-up|0|||
162756121|NCT05630833|587818203|FG000|Overall Study|Withdrawal by Subject|3|||
162756122|NCT05630833|587818204|FG001|Overall Study|Withdrawal by Subject|1|||
162756123|NCT05071430|587818205|FG000|Overall Study|Adverse Event|1|||
162756124|NCT05071430|587818206|FG001|Overall Study|Adverse Event|2|||
162756125|NCT05071430|587818205|FG000|Overall Study|Lost to Follow-up|4|||
162756126|NCT05071430|587818206|FG001|Overall Study|Lost to Follow-up|4|||
162756127|NCT05071430|587818205|FG000|Overall Study|Protocol Violation|1|||
162756128|NCT05071430|587818206|FG001|Overall Study|Protocol Violation|0|||
162756129|NCT05071430|587818205|FG000|Overall Study|Withdrawal by Subject|3|||
162756130|NCT05071430|587818206|FG001|Overall Study|Withdrawal by Subject|2|||
162756131|NCT05071430|587818205|FG000|Overall Study|Other|1|||
162756132|NCT05071430|587818206|FG001|Overall Study|Other|1|||
162756133|NCT01958021|587818207|FG000|Treatment|Progressive disease|206|||
162756134|NCT01958021|587818208|FG001|Treatment|Progressive disease|265|||
162756135|NCT01958021|587818207|FG000|Treatment|Adverse Event|38|||
162756136|NCT01958021|587818208|FG001|Treatment|Adverse Event|10|||
162756137|NCT01958021|587818207|FG000|Treatment|Subject/guardian decision|29|||
162756138|NCT01958021|587818208|FG001|Treatment|Subject/guardian decision|25|||
162756139|NCT01958021|587818207|FG000|Treatment|Physician Decision|28|||
162756140|NCT01958021|587818208|FG001|Treatment|Physician Decision|21|||
162756141|NCT01958021|587818207|FG000|Treatment|Death|6|||
162756142|NCT01958021|587818208|FG001|Treatment|Death|1|||
162756143|NCT01958021|587818207|FG000|Treatment|Protocol deviation|3|||
162756144|NCT01958021|587818208|FG001|Treatment|Protocol deviation|1|||
162756145|NCT01958021|587818207|FG000|Treatment|Sponsor decision|24|||
162756146|NCT01958021|587818208|FG001|Treatment|Sponsor decision|11|||
162756147|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162756148|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162756149|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Death|1|||
162756150|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Death|0|||
162756151|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
162756152|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162756153|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162756154|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162756155|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
162756156|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
162756157|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
162756158|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
162756159|NCT01958021|587818207|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
162756160|NCT01958021|587818208|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
162756161|NCT00490139|587818209|FG000|Overall Study|Lost to Follow-up|249|||
162756162|NCT00490139|587818210|FG001|Overall Study|Lost to Follow-up|216|||
162756163|NCT00490139|587818211|FG002|Overall Study|Lost to Follow-up|205|||
162756164|NCT00490139|587818212|FG003|Overall Study|Lost to Follow-up|229|||
162756165|NCT00490139|587818209|FG000|Overall Study|Withdrawal by Subject|333|||
162756166|NCT00490139|587818210|FG001|Overall Study|Withdrawal by Subject|322|||
162756167|NCT00490139|587818211|FG002|Overall Study|Withdrawal by Subject|396|||
162756168|NCT00490139|587818212|FG003|Overall Study|Withdrawal by Subject|295|||
162756169|NCT00490139|587818209|FG000|Overall Study|Patient did not sign ICF 12|169|||
162756170|NCT00490139|587818210|FG001|Overall Study|Patient did not sign ICF 12|176|||
162756171|NCT00490139|587818211|FG002|Overall Study|Patient did not sign ICF 12|139|||
162756172|NCT00490139|587818212|FG003|Overall Study|Patient did not sign ICF 12|167|||
162756173|NCT00490139|587818209|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
162756174|NCT00490139|587818210|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
162756175|NCT00490139|587818211|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
162756176|NCT00490139|587818212|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
162756177|NCT00490139|587818209|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162756178|NCT00490139|587818210|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
162756179|NCT00490139|587818211|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162756180|NCT00490139|587818212|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162756181|NCT00490139|587818209|FG000|Overall Study|Other reasons as defined per protocol|98|||
162756182|NCT00490139|587818210|FG001|Overall Study|Other reasons as defined per protocol|84|||
162756183|NCT00490139|587818211|FG002|Overall Study|Other reasons as defined per protocol|82|||
162756184|NCT00490139|587818212|FG003|Overall Study|Other reasons as defined per protocol|105|||
162756185|NCT02036970|587819962|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162756186|NCT02036970|587819963|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162756187|NCT02036970|587819964|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
162756188|NCT02036970|587819965|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
162756189|NCT02036970|587819966|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162756190|NCT02036970|587819967|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
162756191|NCT02036970|587819968|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162756192|NCT02036970|587819969|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
162756193|NCT02036970|587819970|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
162756194|NCT02036970|587819971|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
162756195|NCT02036970|587819962|FG000|Part 1: Day 1 Through Week 16|Death|0|||
162756196|NCT02036970|587819963|FG001|Part 1: Day 1 Through Week 16|Death|0|||
162756197|NCT02036970|587819964|FG002|Part 1: Day 1 Through Week 16|Death|0|||
162756198|NCT02036970|587819965|FG003|Part 1: Day 1 Through Week 16|Death|0|||
162756199|NCT02036970|587819966|FG004|Part 1: Day 1 Through Week 16|Death|0|||
162756200|NCT02036970|587819967|FG005|Part 1: Day 1 Through Week 16|Death|0|||
162756201|NCT02036970|587819968|FG006|Part 1: Day 1 Through Week 16|Death|0|||
162756202|NCT02036970|587819969|FG007|Part 1: Day 1 Through Week 16|Death|0|||
162756203|NCT02036970|587819970|FG008|Part 1: Day 1 Through Week 16|Death|1|||
162756204|NCT02036970|587819971|FG009|Part 1: Day 1 Through Week 16|Death|0|||
162756205|NCT02036970|587819962|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
162756206|NCT02036970|587819963|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756207|NCT02036970|587819964|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
162756208|NCT02036970|587819965|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756209|NCT02036970|587819966|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756210|NCT02036970|587819967|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756211|NCT02036970|587819968|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756212|NCT02036970|587819969|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756213|NCT02036970|587819970|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
162756214|NCT02036970|587819971|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162756215|NCT02036970|587819962|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756216|NCT02036970|587819963|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756217|NCT02036970|587819964|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756218|NCT02036970|587819965|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756219|NCT02036970|587819966|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
162756220|NCT02036970|587819967|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756221|NCT02036970|587819968|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756222|NCT02036970|587819969|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162756223|NCT02036970|587819970|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
162756224|NCT02036970|587819971|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
162756225|NCT02036970|587819962|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756226|NCT02036970|587819963|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756227|NCT02036970|587819964|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756228|NCT02036970|587819965|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
162756229|NCT02036970|587819966|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756230|NCT02036970|587819967|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756231|NCT02036970|587819968|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756232|NCT02036970|587819969|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756233|NCT02036970|587819970|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756234|NCT02036970|587819971|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162756235|NCT02036970|587819962|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
162756236|NCT02036970|587819963|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
162756237|NCT02036970|587819964|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
162756238|NCT02036970|587819965|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
162756239|NCT02036970|587819966|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
162756240|NCT02036970|587819967|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
162756241|NCT02036970|587819968|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
162756242|NCT02036970|587819969|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
162756243|NCT02036970|587819970|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
162756244|NCT02036970|587819971|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
162925387|NCT00110084|588428953|FG000|Overall Study|Other|2|||
162756245|NCT02036970|587819962|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756246|NCT02036970|587819963|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756247|NCT02036970|587819964|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756248|NCT02036970|587819965|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756249|NCT02036970|587819966|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756250|NCT02036970|587819967|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756251|NCT02036970|587819968|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
162925388|NCT04854707|588428955|FG000|Overall Study|Lack of Efficacy|78|||
162756252|NCT02036970|587819969|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
162756253|NCT02036970|587819970|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756254|NCT02036970|587819971|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
162756255|NCT02036970|587819962|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756256|NCT02036970|587819963|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
162756257|NCT02036970|587819964|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
162756258|NCT02036970|587819965|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756259|NCT02036970|587819966|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756260|NCT02036970|587819967|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756261|NCT02036970|587819968|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756262|NCT02036970|587819969|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756263|NCT02036970|587819970|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
162756264|NCT02036970|587819971|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162756265|NCT02036970|587819962|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756266|NCT02036970|587819963|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
162756267|NCT02036970|587819964|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
162756268|NCT02036970|587819965|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
162756269|NCT02036970|587819966|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756270|NCT02036970|587819967|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756271|NCT02036970|587819968|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756272|NCT02036970|587819969|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756273|NCT02036970|587819970|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
162756274|NCT02036970|587819971|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
162756275|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
162756276|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
162756277|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162756278|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162756279|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162756280|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
162756281|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
162756282|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
162756283|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
162756284|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
162756285|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
162756286|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
162756287|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162756288|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162756289|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162756290|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162756291|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
162756292|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162756293|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162756294|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162756295|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
162756296|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
162756297|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162756298|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162756299|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162756300|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Other|1|||
162756301|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Other|0|||
162756302|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Other|0|||
162756303|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Other|0|||
162756304|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Other|0|||
162756305|NCT02386098|587819972|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
162756306|NCT02386098|587819973|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
162756307|NCT02386098|587819974|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162756308|NCT02386098|587819975|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162756309|NCT02386098|587819976|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162756310|NCT02702843|587819979|FG000|Overall Study|Insufficient data to analyze|15|||
162756311|NCT02702843|587819980|FG001|Overall Study|Insufficient data to analyze|23|||
162756312|NCT05029284|587819983|FG000|Overall Study|Lost to Follow-up|1|||
162756313|NCT02200705|587819984|FG000|Overall Study|Excluded|12|||
162756314|NCT02200705|587819984|FG000|Overall Study|Death|21|||
162756315|NCT02200705|587819984|FG000|Overall Study|Withdrawal by Subject|22|||
162756316|NCT02200705|587819984|FG000|Overall Study|Lost to Follow-up|13|||
162756317|NCT02200705|587819984|FG000|Overall Study|Physician Decision|5|||
162756318|NCT02200705|587819984|FG000|Overall Study|Adverse Event|2|||
162756319|NCT00065182|587819988|FG000|Overall Study|Adverse Event|24|||
162756320|NCT00065182|587819989|FG001|Overall Study|Adverse Event|17|||
162756321|NCT00065182|587819988|FG000|Overall Study|Lost to Follow-up|0|||
162756322|NCT00065182|587819989|FG001|Overall Study|Lost to Follow-up|4|||
162756323|NCT00065182|587819988|FG000|Overall Study|Protocol Violation|3|||
162756324|NCT00065182|587819989|FG001|Overall Study|Protocol Violation|4|||
162756325|NCT00065182|587819988|FG000|Overall Study|Serious adverse events (SAE)|1|||
162756326|NCT00065182|587819989|FG001|Overall Study|Serious adverse events (SAE)|0|||
162756327|NCT00065182|587819988|FG000|Overall Study|Sponsor Decision|11|||
162756328|NCT00065182|587819989|FG001|Overall Study|Sponsor Decision|7|||
162756329|NCT00065182|587819988|FG000|Overall Study|Withdrawal by Subject|8|||
162756330|NCT00065182|587819989|FG001|Overall Study|Withdrawal by Subject|3|||
162756331|NCT00065182|587819988|FG000|Overall Study|No clinical benefit|1|||
162756332|NCT00065182|587819989|FG001|Overall Study|No clinical benefit|0|||
162756333|NCT00065182|587819988|FG000|Overall Study|Death|0|||
162756334|NCT00065182|587819989|FG001|Overall Study|Death|1|||
162756335|NCT00065182|587819988|FG000|Overall Study|Decline in Status|0|||
162756336|NCT00065182|587819989|FG001|Overall Study|Decline in Status|1|||
162756337|NCT02633215|587819990|FG000|Overall Study|Lost to Follow-up|2|||
162756338|NCT02633215|587819991|FG001|Overall Study|Lost to Follow-up|3|||
162756339|NCT00754325|587819992|FG000|Initial Treatment|Continuing Active Treatment|4|||
162756340|NCT00754325|587819993|FG001|Initial Treatment|Continuing Active Treatment|5|||
162756341|NCT00754325|587819992|FG000|Initial Treatment|Adverse Event|7|||
162756342|NCT00754325|587819993|FG001|Initial Treatment|Adverse Event|6|||
162756343|NCT00754325|587819992|FG000|Initial Treatment|Withdrawal by Subject|2|||
162756344|NCT00754325|587819993|FG001|Initial Treatment|Withdrawal by Subject|2|||
162756345|NCT00754325|587819992|FG000|Initial Treatment|Physician Decision|2|||
162756346|NCT00754325|587819993|FG001|Initial Treatment|Physician Decision|0|||
162756347|NCT00754325|587819992|FG000|Initial Treatment|Sponsor Request|0|||
162756348|NCT00754325|587819993|FG001|Initial Treatment|Sponsor Request|1|||
162756349|NCT00754325|587819992|FG000|Initial Treatment|Disease Progression|35|||
162756350|NCT00754325|587819993|FG001|Initial Treatment|Disease Progression|35|||
162756351|NCT03738228|587819994|FG000|Overall Study|Never received study treatment|2|||
162756352|NCT03738228|587819995|FG001|Overall Study|Never received study treatment|2|||
162756353|NCT03801148|587819996|FG000|Period 1 (2 Days)|Adverse Event|1|||
162756354|NCT03801148|587819997|FG001|Period 1 (2 Days)|Adverse Event|1|||
162756355|NCT03801148|587819998|FG002|Period 1 (2 Days)|Adverse Event|0|||
162756356|NCT03801148|587819999|FG003|Period 1 (2 Days)|Adverse Event|0|||
162756357|NCT03801148|587819996|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162756358|NCT03801148|587819997|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162756359|NCT03801148|587819998|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162756360|NCT03801148|587819999|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
162756361|NCT03801148|587819996|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162756362|NCT03801148|587819997|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162756363|NCT03801148|587819998|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162756364|NCT03801148|587819999|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162756365|NCT03801148|587819996|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
162756366|NCT03801148|587819997|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
162756367|NCT03801148|587819998|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
162756368|NCT03801148|587819999|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
162756369|NCT06212752|587820000|FG000|Overall Study|Death|5|||
162756370|NCT06212752|587820001|FG001|Overall Study|Death|3|||
162756371|NCT06212752|587820000|FG000|Overall Study|Participants ongoing|23|||
162756372|NCT06212752|587820001|FG001|Overall Study|Participants ongoing|8|||
162756373|NCT04162210|587820002|FG000|Overall Study|Lost to Follow-up|4|||
162756374|NCT04162210|587820003|FG001|Overall Study|Lost to Follow-up|1|||
162756375|NCT04162210|587820002|FG000|Overall Study|Withdrawal by Subject|17|||
162756376|NCT04162210|587820003|FG001|Overall Study|Withdrawal by Subject|9|||
162756377|NCT04162210|587820002|FG000|Overall Study|Ongoing|113|||
162756378|NCT04162210|587820003|FG001|Overall Study|Ongoing|59|||
162756379|NCT02568215|587820004|FG000|Overall Study|Death|1|||
162756380|NCT02568215|587820005|FG001|Overall Study|Death|2|||
162756381|NCT02568215|587820006|FG002|Overall Study|Death|0|||
162756382|NCT02568215|587820004|FG000|Overall Study|Physician Decision|2|||
162756383|NCT02568215|587820005|FG001|Overall Study|Physician Decision|2|||
162756384|NCT02568215|587820006|FG002|Overall Study|Physician Decision|2|||
162756385|NCT02568215|587820004|FG000|Overall Study|Lost to Follow-up|29|||
162756386|NCT02568215|587820005|FG001|Overall Study|Lost to Follow-up|32|||
162756387|NCT02568215|587820006|FG002|Overall Study|Lost to Follow-up|41|||
162756388|NCT02568215|587820004|FG000|Overall Study|Withdrawal by Subject|21|||
162756389|NCT02568215|587820005|FG001|Overall Study|Withdrawal by Subject|19|||
162756390|NCT02568215|587820006|FG002|Overall Study|Withdrawal by Subject|22|||
162756391|NCT02568215|587820004|FG000|Overall Study|Protocol Violation|1|||
162756392|NCT02568215|587820005|FG001|Overall Study|Protocol Violation|1|||
162756393|NCT02568215|587820006|FG002|Overall Study|Protocol Violation|0|||
162756394|NCT02568215|587820004|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
162756395|NCT02568215|587820005|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
162756396|NCT02568215|587820006|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
162756397|NCT02568215|587820004|FG000|Overall Study|Other|0|||
162756398|NCT02568215|587820005|FG001|Overall Study|Other|1|||
162756399|NCT02568215|587820006|FG002|Overall Study|Other|4|||
162756400|NCT01641900|587820007|FG000|Overall Study|Withdrawal by Subject|2|||
162756401|NCT01641900|587820008|FG001|Overall Study|Withdrawal by Subject|2|||
162756402|NCT02941549|587820009|FG000|Overall Study|Adverse Event|1|||
162756403|NCT02941549|587820010|FG001|Overall Study|Adverse Event|0|||
162756404|NCT02941549|587820011|FG002|Overall Study|Adverse Event|0|||
162756405|NCT02941549|587820009|FG000|Overall Study|Withdrawal by Subject|2|||
162756406|NCT02941549|587820010|FG001|Overall Study|Withdrawal by Subject|1|||
162756407|NCT02941549|587820011|FG002|Overall Study|Withdrawal by Subject|2|||
162756408|NCT00263757|587820012|FG000|Overall Study|Withdrawal by Subject|5|||
162756409|NCT00263757|587820013|FG001|Overall Study|Withdrawal by Subject|4|||
162756410|NCT00263757|587820012|FG000|Overall Study|Screen failure|0|||
162756411|NCT00263757|587820013|FG001|Overall Study|Screen failure|1|||
162756412|NCT00263757|587820012|FG000|Overall Study|Adverse Event|3|||
162756413|NCT00263757|587820013|FG001|Overall Study|Adverse Event|3|||
162756414|NCT00713596|587820014|FG000|Overall Study|Study was terminated|2|||
162756415|NCT00713596|587820015|FG001|Overall Study|Study was terminated|3|||
162756416|NCT00713596|587820016|FG002|Overall Study|Study was terminated|2|||
162756417|NCT01211184|587820017|FG000|Overall Study|Withdrawal by Subject|0|||
162756418|NCT01211184|587820018|FG001|Overall Study|Withdrawal by Subject|2|||
162756419|NCT01211184|587820019|FG002|Overall Study|Withdrawal by Subject|1|||
162756420|NCT01421667|587820020|FG000|Overall Study|Withdrawal by Subject|0|||
162756421|NCT01421667|587820021|FG001|Overall Study|Withdrawal by Subject|1|||
162756422|NCT01421667|587820022|FG002|Overall Study|Withdrawal by Subject|2|||
162756423|NCT01421667|587820023|FG003|Overall Study|Withdrawal by Subject|1|||
162756424|NCT01421667|587820020|FG000|Overall Study|Lost to Follow-up|0|||
162756425|NCT01421667|587820021|FG001|Overall Study|Lost to Follow-up|1|||
162756426|NCT01421667|587820022|FG002|Overall Study|Lost to Follow-up|0|||
162756427|NCT01421667|587820023|FG003|Overall Study|Lost to Follow-up|0|||
162756428|NCT00503906|587820024|FG000|Overall Study|Withdrawal by Subject|1|||
162756429|NCT05580003|587820025|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756430|NCT05580003|587820026|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756431|NCT05580003|587820027|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756432|NCT05580003|587820028|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756433|NCT05580003|587820029|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756434|NCT05580003|587820030|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756435|NCT05580003|587820031|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
162756436|NCT05580003|587820032|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756437|NCT05580003|587820033|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756438|NCT05580003|587820034|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756439|NCT05580003|587820035|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756440|NCT05580003|587820036|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756441|NCT05580003|587820037|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756442|NCT05580003|587820038|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756443|NCT05580003|587820039|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756444|NCT05580003|587820040|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756445|NCT05580003|587820041|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756446|NCT05580003|587820042|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756447|NCT05580003|587820043|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756448|NCT05580003|587820044|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756449|NCT05580003|587820045|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756450|NCT05580003|587820046|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756451|NCT05580003|587820047|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756452|NCT05580003|587820048|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756453|NCT05580003|587820049|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756454|NCT05580003|587820050|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756455|NCT05580003|587820051|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756456|NCT05580003|587820052|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162756457|NCT05580003|587820025|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756458|NCT05580003|587820026|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756459|NCT05580003|587820027|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756460|NCT05580003|587820028|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162925389|NCT04854707|588428956|FG001|Overall Study|Lack of Efficacy|59|||
162925390|NCT04854707|588428957|FG002|Overall Study|Lack of Efficacy|30|||
162756461|NCT05580003|587820029|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756462|NCT05580003|587820030|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
162756463|NCT05580003|587820031|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756464|NCT05580003|587820032|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756465|NCT05580003|587820033|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756466|NCT05580003|587820034|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756467|NCT05580003|587820035|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756468|NCT05580003|587820036|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756469|NCT05580003|587820037|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756470|NCT05580003|587820038|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756471|NCT05580003|587820039|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756472|NCT05580003|587820040|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756473|NCT05580003|587820041|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756474|NCT05580003|587820042|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756475|NCT05580003|587820043|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756476|NCT05580003|587820044|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756477|NCT05580003|587820045|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756478|NCT05580003|587820046|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756479|NCT05580003|587820047|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756480|NCT05580003|587820048|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756481|NCT05580003|587820049|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756482|NCT05580003|587820050|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756483|NCT05580003|587820051|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756484|NCT05580003|587820052|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162756485|NCT05580003|587820025|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756486|NCT05580003|587820026|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756487|NCT05580003|587820027|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756488|NCT05580003|587820028|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
162756489|NCT05580003|587820029|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756490|NCT05580003|587820030|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756491|NCT05580003|587820031|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756492|NCT05580003|587820032|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756493|NCT05580003|587820033|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756494|NCT05580003|587820034|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756495|NCT05580003|587820035|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756496|NCT05580003|587820036|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756497|NCT05580003|587820037|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756498|NCT05580003|587820038|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756499|NCT05580003|587820039|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756500|NCT05580003|587820040|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756501|NCT05580003|587820041|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756502|NCT05580003|587820042|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756503|NCT05580003|587820043|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756504|NCT05580003|587820044|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756505|NCT05580003|587820045|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756506|NCT05580003|587820046|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756507|NCT05580003|587820047|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756508|NCT05580003|587820048|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756509|NCT05580003|587820049|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756510|NCT05580003|587820050|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756511|NCT05580003|587820051|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756512|NCT05580003|587820052|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162756513|NCT05580003|587820025|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756514|NCT05580003|587820026|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
162756515|NCT05580003|587820027|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756516|NCT05580003|587820028|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756517|NCT05580003|587820029|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756518|NCT05580003|587820030|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756519|NCT05580003|587820031|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756520|NCT05580003|587820032|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756521|NCT05580003|587820033|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756522|NCT05580003|587820034|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756523|NCT05580003|587820035|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756524|NCT05580003|587820036|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756525|NCT05580003|587820037|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756526|NCT05580003|587820038|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756527|NCT05580003|587820039|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756528|NCT05580003|587820040|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756529|NCT05580003|587820041|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756530|NCT05580003|587820042|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756531|NCT05580003|587820043|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756532|NCT05580003|587820044|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756533|NCT05580003|587820045|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756534|NCT05580003|587820046|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756535|NCT05580003|587820047|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756536|NCT05580003|587820048|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756537|NCT05580003|587820049|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756538|NCT05580003|587820050|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756539|NCT05580003|587820051|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756540|NCT05580003|587820052|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162756541|NCT05580003|587820025|FG000|Part 2 (up to 10 Days)|Other|0|||
162756542|NCT05580003|587820026|FG001|Part 2 (up to 10 Days)|Other|0|||
162756543|NCT05580003|587820027|FG002|Part 2 (up to 10 Days)|Other|0|||
162756544|NCT05580003|587820028|FG003|Part 2 (up to 10 Days)|Other|0|||
162756545|NCT05580003|587820029|FG004|Part 2 (up to 10 Days)|Other|0|||
162756546|NCT05580003|587820030|FG005|Part 2 (up to 10 Days)|Other|0|||
162756547|NCT05580003|587820031|FG006|Part 2 (up to 10 Days)|Other|0|||
162756548|NCT05580003|587820032|FG007|Part 2 (up to 10 Days)|Other|0|||
162756549|NCT05580003|587820033|FG008|Part 2 (up to 10 Days)|Other|0|||
162756550|NCT05580003|587820034|FG009|Part 2 (up to 10 Days)|Other|1|||
162756551|NCT05580003|587820035|FG010|Part 2 (up to 10 Days)|Other|0|||
162756552|NCT05580003|587820036|FG011|Part 2 (up to 10 Days)|Other|0|||
162756553|NCT05580003|587820037|FG012|Part 2 (up to 10 Days)|Other|0|||
162756554|NCT05580003|587820038|FG013|Part 2 (up to 10 Days)|Other|0|||
162756555|NCT05580003|587820039|FG014|Part 2 (up to 10 Days)|Other|0|||
162756556|NCT05580003|587820040|FG015|Part 2 (up to 10 Days)|Other|0|||
162756557|NCT05580003|587820041|FG016|Part 2 (up to 10 Days)|Other|0|||
162756558|NCT05580003|587820042|FG017|Part 2 (up to 10 Days)|Other|0|||
162756559|NCT05580003|587820043|FG018|Part 2 (up to 10 Days)|Other|0|||
162756560|NCT05580003|587820044|FG019|Part 2 (up to 10 Days)|Other|0|||
162756561|NCT05580003|587820045|FG020|Part 2 (up to 10 Days)|Other|0|||
162756562|NCT05580003|587820046|FG021|Part 2 (up to 10 Days)|Other|0|||
162756563|NCT05580003|587820047|FG022|Part 2 (up to 10 Days)|Other|0|||
162756564|NCT05580003|587820048|FG023|Part 2 (up to 10 Days)|Other|0|||
162756565|NCT05580003|587820049|FG024|Part 2 (up to 10 Days)|Other|0|||
162756566|NCT05580003|587820050|FG025|Part 2 (up to 10 Days)|Other|0|||
162756567|NCT05580003|587820051|FG026|Part 2 (up to 10 Days)|Other|0|||
162756568|NCT05580003|587820052|FG027|Part 2 (up to 10 Days)|Other|0|||
162756569|NCT05580003|587820025|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756570|NCT05580003|587820026|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756571|NCT05580003|587820027|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756572|NCT05580003|587820028|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756573|NCT05580003|587820029|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756574|NCT05580003|587820030|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756575|NCT05580003|587820031|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756576|NCT05580003|587820032|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756577|NCT05580003|587820033|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756578|NCT05580003|587820034|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756579|NCT05580003|587820035|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756580|NCT05580003|587820036|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756581|NCT05580003|587820037|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756582|NCT05580003|587820038|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756583|NCT05580003|587820039|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756584|NCT05580003|587820040|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756585|NCT05580003|587820041|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756586|NCT05580003|587820042|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756587|NCT05580003|587820043|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756588|NCT05580003|587820044|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
162756589|NCT05580003|587820045|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756590|NCT05580003|587820046|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756591|NCT05580003|587820047|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756592|NCT05580003|587820048|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756593|NCT05580003|587820049|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756594|NCT05580003|587820050|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756595|NCT05580003|587820051|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756596|NCT05580003|587820052|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162756597|NCT05580003|587820025|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756598|NCT05580003|587820026|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756599|NCT05580003|587820027|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756600|NCT05580003|587820028|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756601|NCT05580003|587820029|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756602|NCT05580003|587820030|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756603|NCT05580003|587820031|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756604|NCT05580003|587820032|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756605|NCT05580003|587820033|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756606|NCT05580003|587820034|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756607|NCT05580003|587820035|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756608|NCT05580003|587820036|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756609|NCT05580003|587820037|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756610|NCT05580003|587820038|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756611|NCT05580003|587820039|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756612|NCT05580003|587820040|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756613|NCT05580003|587820041|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756614|NCT05580003|587820042|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756615|NCT05580003|587820043|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756616|NCT05580003|587820044|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756617|NCT05580003|587820045|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
162756618|NCT05580003|587820046|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756619|NCT05580003|587820047|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756620|NCT05580003|587820048|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756621|NCT05580003|587820049|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756622|NCT05580003|587820050|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756623|NCT05580003|587820051|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756624|NCT05580003|587820052|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162756625|NCT05580003|587820025|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756626|NCT05580003|587820026|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756627|NCT05580003|587820027|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756628|NCT05580003|587820028|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756629|NCT05580003|587820029|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756630|NCT05580003|587820030|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756631|NCT05580003|587820031|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756632|NCT05580003|587820032|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756633|NCT05580003|587820033|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756634|NCT05580003|587820034|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756635|NCT05580003|587820035|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756636|NCT05580003|587820036|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756637|NCT05580003|587820037|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756638|NCT05580003|587820038|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756639|NCT05580003|587820039|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756640|NCT05580003|587820040|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756641|NCT05580003|587820041|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756642|NCT05580003|587820042|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756643|NCT05580003|587820043|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756644|NCT05580003|587820044|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756645|NCT05580003|587820045|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756646|NCT05580003|587820046|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
162756647|NCT05580003|587820047|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756648|NCT05580003|587820048|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756649|NCT05580003|587820049|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756650|NCT05580003|587820050|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756651|NCT05580003|587820051|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756652|NCT05580003|587820052|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162756653|NCT05580003|587820025|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756654|NCT05580003|587820026|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756655|NCT05580003|587820027|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756656|NCT05580003|587820028|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756657|NCT05580003|587820029|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756658|NCT05580003|587820030|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756659|NCT05580003|587820031|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756660|NCT05580003|587820032|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756661|NCT05580003|587820033|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756662|NCT05580003|587820034|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756663|NCT05580003|587820035|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756664|NCT05580003|587820036|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756665|NCT05580003|587820037|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756666|NCT05580003|587820038|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756667|NCT05580003|587820039|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756668|NCT05580003|587820040|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756669|NCT05580003|587820041|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756670|NCT05580003|587820042|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756671|NCT05580003|587820043|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756672|NCT05580003|587820044|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756673|NCT05580003|587820045|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756674|NCT05580003|587820046|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756675|NCT05580003|587820047|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756676|NCT05580003|587820048|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756677|NCT05580003|587820049|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756678|NCT05580003|587820050|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756679|NCT05580003|587820051|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162756680|NCT05580003|587820052|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
162756681|NCT05580003|587820025|FG000|Part 6 Period 2 (Day 1)|Other|0|||
162756682|NCT05580003|587820026|FG001|Part 6 Period 2 (Day 1)|Other|0|||
162756683|NCT05580003|587820027|FG002|Part 6 Period 2 (Day 1)|Other|0|||
162756684|NCT05580003|587820028|FG003|Part 6 Period 2 (Day 1)|Other|0|||
162756685|NCT05580003|587820029|FG004|Part 6 Period 2 (Day 1)|Other|0|||
162756686|NCT05580003|587820030|FG005|Part 6 Period 2 (Day 1)|Other|0|||
162756687|NCT05580003|587820031|FG006|Part 6 Period 2 (Day 1)|Other|0|||
162756688|NCT05580003|587820032|FG007|Part 6 Period 2 (Day 1)|Other|0|||
162756689|NCT05580003|587820033|FG008|Part 6 Period 2 (Day 1)|Other|0|||
162756690|NCT05580003|587820034|FG009|Part 6 Period 2 (Day 1)|Other|0|||
162756691|NCT05580003|587820035|FG010|Part 6 Period 2 (Day 1)|Other|0|||
162756692|NCT05580003|587820036|FG011|Part 6 Period 2 (Day 1)|Other|0|||
162756693|NCT05580003|587820037|FG012|Part 6 Period 2 (Day 1)|Other|0|||
162756694|NCT05580003|587820038|FG013|Part 6 Period 2 (Day 1)|Other|0|||
162756695|NCT05580003|587820039|FG014|Part 6 Period 2 (Day 1)|Other|0|||
162756696|NCT05580003|587820040|FG015|Part 6 Period 2 (Day 1)|Other|0|||
162756697|NCT05580003|587820041|FG016|Part 6 Period 2 (Day 1)|Other|0|||
162756698|NCT05580003|587820042|FG017|Part 6 Period 2 (Day 1)|Other|0|||
162756699|NCT05580003|587820043|FG018|Part 6 Period 2 (Day 1)|Other|0|||
162756700|NCT05580003|587820044|FG019|Part 6 Period 2 (Day 1)|Other|0|||
162756701|NCT05580003|587820045|FG020|Part 6 Period 2 (Day 1)|Other|0|||
162756702|NCT05580003|587820046|FG021|Part 6 Period 2 (Day 1)|Other|0|||
162756703|NCT05580003|587820047|FG022|Part 6 Period 2 (Day 1)|Other|0|||
162756704|NCT05580003|587820048|FG023|Part 6 Period 2 (Day 1)|Other|0|||
162756705|NCT05580003|587820049|FG024|Part 6 Period 2 (Day 1)|Other|1|||
162756706|NCT05580003|587820050|FG025|Part 6 Period 2 (Day 1)|Other|0|||
162756707|NCT05580003|587820051|FG026|Part 6 Period 2 (Day 1)|Other|0|||
162756708|NCT05580003|587820052|FG027|Part 6 Period 2 (Day 1)|Other|0|||
162756709|NCT03516812|587820053|FG000|Overall Study|Adverse Event|4|||
162756710|NCT03516812|587820053|FG000|Overall Study|Lack of Efficacy|2|||
162756711|NCT03840902|587820054|FG000|Overall Study|Randomized but not treated|1|||
162756712|NCT03840902|587820055|FG001|Overall Study|Randomized but not treated|1|||
162756713|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162756714|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
162756715|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162756716|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
162756717|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162756718|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162756719|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162756720|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162756721|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162756722|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162756723|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
162756724|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162756725|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162756726|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162756727|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162756728|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162756729|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162756730|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
162756731|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
162756732|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162756733|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162756734|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
162756735|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162756736|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162756737|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162756738|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162756739|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162756740|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162756741|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162756742|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
162756743|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
162756744|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
162756745|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
162756746|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
162756747|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
162756748|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
162756749|NCT02392234|587820056|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162756750|NCT02392234|587820057|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162756751|NCT02392234|587820058|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
162756752|NCT02392234|587820059|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162756753|NCT02392234|587820060|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
162756754|NCT02392234|587820061|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162756755|NCT02392234|587820056|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
162756756|NCT02392234|587820057|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162756757|NCT02392234|587820058|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162756758|NCT02392234|587820059|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162756759|NCT02392234|587820060|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162756760|NCT02392234|587820061|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162756761|NCT02816398|587820066|FG000|Overall Study|Death|5|||
162756762|NCT02816398|587820066|FG000|Overall Study|Lack of Efficacy|8|||
162756763|NCT02816398|587820066|FG000|Overall Study|Lost to Follow-up|1|||
162756764|NCT03582475|587820067|FG000|Treatment Period|Withdrawal by Subject|0|||
162756765|NCT03582475|587820068|FG001|Treatment Period|Withdrawal by Subject|1|||
162756766|NCT03582475|587820067|FG000|Follow-up Period|Withdrawal by Subject|0|||
162756767|NCT03582475|587820068|FG001|Follow-up Period|Withdrawal by Subject|1|||
162756768|NCT01400958|587820072|FG000|Overall Study|Physician Decision|0|||
162756769|NCT01400958|587820073|FG001|Overall Study|Physician Decision|1|||
162756770|NCT01400958|587820072|FG000|Overall Study|Withdrawal by Subject|0|||
162756771|NCT01400958|587820073|FG001|Overall Study|Withdrawal by Subject|1|||
162756772|NCT01400958|587820072|FG000|Overall Study|Adverse Event|1|||
162756773|NCT01400958|587820073|FG001|Overall Study|Adverse Event|0|||
162756774|NCT05464732|587820080|FG000|Overall Study|Lost to Follow-up|0|||
162756775|NCT05464732|587820081|FG001|Overall Study|Lost to Follow-up|1|||
162756776|NCT05464732|587820080|FG000|Overall Study|Adverse Event|1|||
162756777|NCT05464732|587820081|FG001|Overall Study|Adverse Event|0|||
162756778|NCT04153890|587820082|FG000|Overall Study|Lost to Follow-up|9|||
162756779|NCT04153890|587820083|FG001|Overall Study|Lost to Follow-up|0|||
162756780|NCT04153890|587820084|FG002|Overall Study|Lost to Follow-up|9|||
162756781|NCT04153890|587820085|FG003|Overall Study|Lost to Follow-up|0|||
162756782|NCT04153890|587820082|FG000|Overall Study|Death|0|||
162756783|NCT04153890|587820083|FG001|Overall Study|Death|2|||
162756784|NCT04153890|587820084|FG002|Overall Study|Death|0|||
162756785|NCT04153890|587820085|FG003|Overall Study|Death|0|||
162756786|NCT04153890|587820082|FG000|Overall Study|Withdrawal by Subject|0|||
162756787|NCT04153890|587820083|FG001|Overall Study|Withdrawal by Subject|0|||
162756788|NCT04153890|587820084|FG002|Overall Study|Withdrawal by Subject|0|||
162756789|NCT04153890|587820085|FG003|Overall Study|Withdrawal by Subject|2|||
162756790|NCT03610581|587820086|FG000|Overall Study|Study terminated by sponsor|2|||
162756791|NCT03610581|587820087|FG001|Overall Study|Study terminated by sponsor|0|||
162756792|NCT03610581|587820086|FG000|Overall Study|Other|0|||
162756793|NCT03610581|587820087|FG001|Overall Study|Other|1|||
162756794|NCT03610581|587820086|FG000|Overall Study|Withdrawal by Subject|1|||
162756795|NCT03610581|587820087|FG001|Overall Study|Withdrawal by Subject|0|||
162756796|NCT02307682|587820092|FG000|Overall Study|Adverse Event|9|||
162756797|NCT02307682|587820093|FG001|Overall Study|Adverse Event|8|||
162756798|NCT02307682|587820094|FG002|Overall Study|Adverse Event|12|||
162756799|NCT02307682|587820092|FG000|Overall Study|Lack of Efficacy|1|||
162756800|NCT02307682|587820093|FG001|Overall Study|Lack of Efficacy|0|||
162756801|NCT02307682|587820094|FG002|Overall Study|Lack of Efficacy|1|||
162756802|NCT02307682|587820092|FG000|Overall Study|Physician Decision|2|||
162756803|NCT02307682|587820093|FG001|Overall Study|Physician Decision|2|||
162756804|NCT02307682|587820094|FG002|Overall Study|Physician Decision|8|||
162756805|NCT02307682|587820092|FG000|Overall Study|Progressive Disease|1|||
162756806|NCT02307682|587820093|FG001|Overall Study|Progressive Disease|0|||
162756807|NCT02307682|587820094|FG002|Overall Study|Progressive Disease|0|||
162756808|NCT02307682|587820092|FG000|Overall Study|Withdrawal by Subject|26|||
162756809|NCT02307682|587820093|FG001|Overall Study|Withdrawal by Subject|34|||
162756810|NCT02307682|587820094|FG002|Overall Study|Withdrawal by Subject|23|||
162756811|NCT02307682|587820092|FG000|Overall Study|Death|9|||
162756812|NCT02307682|587820093|FG001|Overall Study|Death|7|||
162756813|NCT02307682|587820094|FG002|Overall Study|Death|12|||
162756814|NCT02307682|587820092|FG000|Overall Study|Lost to Follow-up|1|||
162756815|NCT02307682|587820093|FG001|Overall Study|Lost to Follow-up|5|||
162756816|NCT02307682|587820094|FG002|Overall Study|Lost to Follow-up|6|||
162756817|NCT02307682|587820092|FG000|Overall Study|Protocol Deviation|0|||
162756818|NCT02307682|587820093|FG001|Overall Study|Protocol Deviation|0|||
162756819|NCT02307682|587820094|FG002|Overall Study|Protocol Deviation|2|||
162756820|NCT02307682|587820092|FG000|Overall Study|Other|1|||
162756821|NCT02307682|587820093|FG001|Overall Study|Other|1|||
162756822|NCT02307682|587820094|FG002|Overall Study|Other|0|||
162756823|NCT03997474|587820096|FG000|Overall Study|Death|6|||
162756824|NCT03997474|587820097|FG001|Overall Study|Death|2|||
162756825|NCT03997474|587820098|FG002|Overall Study|Death|1|||
162756826|NCT03997474|587820096|FG000|Overall Study|Physician Decision|2|||
162756827|NCT03997474|587820097|FG001|Overall Study|Physician Decision|0|||
162756828|NCT03997474|587820098|FG002|Overall Study|Physician Decision|0|||
162756829|NCT03997474|587820096|FG000|Overall Study|study terminated by sponsor|1|||
162756830|NCT03997474|587820097|FG001|Overall Study|study terminated by sponsor|0|||
162756831|NCT03997474|587820098|FG002|Overall Study|study terminated by sponsor|1|||
162756832|NCT03277989|587820100|FG000|Overall Study|Lost to Follow-up|6|||
162756833|NCT03277989|587820100|FG000|Overall Study|Adverse Event|6|||
162756834|NCT03277989|587820100|FG000|Overall Study|Withdrawal by Subject|3|||
162756835|NCT03277989|587820100|FG000|Overall Study|Didn't Receive Study Device|7|||
162756836|NCT03277989|587820100|FG000|Overall Study|Site Closure|26|||
162756837|NCT03277989|587820100|FG000|Overall Study|Sponsor Closure|107|||
162756838|NCT04306367|587820101|FG000|Overall Study|Progression of Disease|9|||
162756839|NCT04306367|587820101|FG000|Overall Study|Adverse Event|3|||
162756840|NCT04306367|587820101|FG000|Overall Study|Withdrawal by Subject|1|||
162756841|NCT02751528|587820108|FG000|Overall Study|Withdrawal by Subject|1|||
162756842|NCT02751528|587820108|FG000|Overall Study|Adverse Event|1|||
162756843|NCT05485805|587820109|FG000|Overall Study|Withdrawal by Subject|1|||
162756844|NCT05485805|587820110|FG001|Overall Study|Withdrawal by Subject|2|||
162756845|NCT05485805|587820111|FG002|Overall Study|Withdrawal by Subject|2|||
162756846|NCT05485805|587820112|FG003|Overall Study|Withdrawal by Subject|0|||
162756847|NCT05485805|587820113|FG004|Overall Study|Withdrawal by Subject|2|||
162756848|NCT05485805|587820109|FG000|Overall Study|Adverse Event|0|||
162756849|NCT05485805|587820110|FG001|Overall Study|Adverse Event|1|||
162756850|NCT05485805|587820111|FG002|Overall Study|Adverse Event|0|||
162756851|NCT05485805|587820112|FG003|Overall Study|Adverse Event|0|||
162756852|NCT05485805|587820113|FG004|Overall Study|Adverse Event|0|||
162756853|NCT05485805|587820109|FG000|Overall Study|Lost to Follow-up|1|||
162756854|NCT05485805|587820110|FG001|Overall Study|Lost to Follow-up|1|||
162756855|NCT05485805|587820111|FG002|Overall Study|Lost to Follow-up|3|||
162756856|NCT05485805|587820112|FG003|Overall Study|Lost to Follow-up|1|||
162756857|NCT05485805|587820113|FG004|Overall Study|Lost to Follow-up|0|||
162756858|NCT04218357|587820114|FG000|1st Allocation|Withdrawal by Subject|1|||
162756859|NCT04218357|587820115|FG001|1st Allocation|Withdrawal by Subject|0|||
162756860|NCT05349838|587820116|FG000|Overall Study|Virological Failure|1|||
162756861|NCT05349838|587820117|FG001|Overall Study|Virological Failure|2|||
162756862|NCT05349838|587820116|FG000|Overall Study|Withdrawal by Subject|2|||
162756863|NCT05349838|587820117|FG001|Overall Study|Withdrawal by Subject|3|||
162756864|NCT05349838|587820116|FG000|Overall Study|Adverse Event|3|||
162756865|NCT05349838|587820117|FG001|Overall Study|Adverse Event|1|||
162756866|NCT05349838|587820116|FG000|Overall Study|Lost to Follow-up|1|||
162756867|NCT05349838|587820117|FG001|Overall Study|Lost to Follow-up|2|||
162756868|NCT05349838|587820116|FG000|Overall Study|Other reasons|5|||
162756869|NCT05349838|587820117|FG001|Overall Study|Other reasons|1|||
162756870|NCT05037513|587820122|FG000|Intervention Period|Lost to Follow-up|1|||
162756871|NCT05037513|587820123|FG001|Intervention Period|Lost to Follow-up|2|||
162756872|NCT05037513|587820122|FG000|Follow Up Period|Lost to Follow-up|16|||
162756873|NCT05037513|587820123|FG001|Follow Up Period|Lost to Follow-up|21|||
162756874|NCT05037513|587820122|FG000|Follow Up Period|Death|0|||
162756875|NCT05037513|587820123|FG001|Follow Up Period|Death|1|||
162756876|NCT05037513|587820122|FG000|Follow Up Period|Incarcerated|4|||
162756877|NCT05037513|587820123|FG001|Follow Up Period|Incarcerated|2|||
162756878|NCT03664804|587820125|FG000|Overall Study|Withdrawal by Subject|7|||
162756879|NCT05529992|587820126|FG000|Overall Study|Withdrawal by Subject|1|||
162756880|NCT06140290|587820127|FG000|Period 1|Adverse Event|1|||
162756881|NCT06140290|587820128|FG001|Period 1|Adverse Event|0|||
162756882|NCT06140290|587820127|FG000|Period 2|Assigned but not treated|0|||
162756883|NCT06140290|587820128|FG001|Period 2|Assigned but not treated|1|||
162756884|NCT06140290|587820127|FG000|Period 2|Withdrawal by Subject|0|||
162756885|NCT06140290|587820128|FG001|Period 2|Withdrawal by Subject|1|||
162756886|NCT03002194|587821577|FG000|Overall Study|Lost to Follow-up|6|||
162756887|NCT03002194|587821577|FG000|Overall Study|Adverse Event|1|||
162756888|NCT03002194|587821577|FG000|Overall Study|Lack of Efficacy|1|||
162756889|NCT03002194|587821577|FG000|Overall Study|Withdrawal by Subject|2|||
162756890|NCT02232737|587821578|FG000|Overall Study|Lost to Follow-up|18|||
162756891|NCT02232737|587821579|FG001|Overall Study|Lost to Follow-up|28|||
162756892|NCT02232737|587821580|FG002|Overall Study|Lost to Follow-up|33|||
162756893|NCT02232737|587821578|FG000|Overall Study|Personal reasons|7|||
162756894|NCT02232737|587821579|FG001|Overall Study|Personal reasons|8|||
162756895|NCT02232737|587821580|FG002|Overall Study|Personal reasons|14|||
162756896|NCT02232737|587821578|FG000|Overall Study|Adverse Event|6|||
162756897|NCT02232737|587821579|FG001|Overall Study|Adverse Event|3|||
162756898|NCT02232737|587821580|FG002|Overall Study|Adverse Event|8|||
162756899|NCT02232737|587821578|FG000|Overall Study|Incarcerated|2|||
162756900|NCT02232737|587821579|FG001|Overall Study|Incarcerated|1|||
162756901|NCT02232737|587821580|FG002|Overall Study|Incarcerated|2|||
162756902|NCT02232737|587821578|FG000|Overall Study|Withdrawal by Subject|0|||
162756903|NCT02232737|587821579|FG001|Overall Study|Withdrawal by Subject|1|||
162756904|NCT02232737|587821580|FG002|Overall Study|Withdrawal by Subject|2|||
162756905|NCT02232737|587821578|FG000|Overall Study|Death|0|||
162756906|NCT02232737|587821579|FG001|Overall Study|Death|1|||
162756907|NCT02232737|587821580|FG002|Overall Study|Death|1|||
162756908|NCT02232737|587821578|FG000|Overall Study|Physician Decision|1|||
162756909|NCT02232737|587821579|FG001|Overall Study|Physician Decision|3|||
162756910|NCT02232737|587821580|FG002|Overall Study|Physician Decision|1|||
162756911|NCT02232737|587821578|FG000|Overall Study|Protocol Violation|1|||
162756912|NCT02232737|587821579|FG001|Overall Study|Protocol Violation|0|||
162756913|NCT02232737|587821580|FG002|Overall Study|Protocol Violation|1|||
162756914|NCT02232737|587821578|FG000|Overall Study|Reason unknown|1|||
162756915|NCT02232737|587821579|FG001|Overall Study|Reason unknown|0|||
162756916|NCT02232737|587821580|FG002|Overall Study|Reason unknown|0|||
162756917|NCT03116464|587821587|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
162756918|NCT00371345|587821593|FG000|Overall Study|Disease Progression|21|||
162756919|NCT00371345|587821594|FG001|Overall Study|Disease Progression|35|||
162756920|NCT00371345|587821593|FG000|Overall Study|Study Drug Toxicity|1|||
162756921|NCT00371345|587821594|FG001|Overall Study|Study Drug Toxicity|7|||
162756922|NCT00371345|587821593|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
162756923|NCT00371345|587821594|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
162756924|NCT00371345|587821593|FG000|Overall Study|Participant Request|1|||
162756925|NCT00371345|587821594|FG001|Overall Study|Participant Request|1|||
162756926|NCT00371345|587821593|FG000|Overall Study|Participant Withdrew Consent|0|||
162756927|NCT00371345|587821594|FG001|Overall Study|Participant Withdrew Consent|1|||
162756928|NCT00705406|587821595|FG000|Overall Study|Lost to Follow-up|3|||
162756929|NCT00705406|587821596|FG001|Overall Study|Lost to Follow-up|3|||
162756930|NCT00705406|587821595|FG000|Overall Study|Did not receive study drug|1|||
162756931|NCT00705406|587821596|FG001|Overall Study|Did not receive study drug|2|||
162756932|NCT04545619|587821597|FG000|Overall Study|due to equipment challenges|1|||
162756933|NCT03712371|587821598|FG000|Overall Study|Lack of Efficacy|0|||
162756934|NCT03712371|587821599|FG001|Overall Study|Lack of Efficacy|0|||
162756935|NCT03712371|587821600|FG002|Overall Study|Lack of Efficacy|0|||
162756936|NCT03712371|587821601|FG003|Overall Study|Lack of Efficacy|1|||
162756937|NCT00683800|587821607|FG000|Overall Study|Adverse Event|195|||
162756938|NCT00683800|587821608|FG001|Overall Study|Adverse Event|102|||
162756939|NCT00683800|587821607|FG000|Overall Study|Death|0|||
162756940|NCT00683800|587821608|FG001|Overall Study|Death|1|||
162756941|NCT00683800|587821607|FG000|Overall Study|Lost to Follow-up|57|||
162756942|NCT00683800|587821608|FG001|Overall Study|Lost to Follow-up|44|||
162756943|NCT00683800|587821607|FG000|Overall Study|Other|5|||
162756944|NCT00683800|587821608|FG001|Overall Study|Other|2|||
162756945|NCT00683800|587821607|FG000|Overall Study|Protocol Violation|13|||
162756946|NCT00683800|587821608|FG001|Overall Study|Protocol Violation|16|||
162756947|NCT00683800|587821607|FG000|Overall Study|Withdrawal by Subject|66|||
162756948|NCT00683800|587821608|FG001|Overall Study|Withdrawal by Subject|64|||
162756949|NCT00683800|587821607|FG000|Overall Study|Lack of Efficacy|61|||
162756950|NCT00683800|587821608|FG001|Overall Study|Lack of Efficacy|104|||
162756951|NCT00683800|587821607|FG000|Overall Study|Randomized, not treated|35|||
162756952|NCT00683800|587821608|FG001|Overall Study|Randomized, not treated|33|||
162756953|NCT04949542|587821615|FG000|Overall Study|Lost to Follow-up|4|||
162756954|NCT04949542|587821616|FG001|Overall Study|Lost to Follow-up|1|||
162756955|NCT03021993|587821618|FG000|Overall Study|Withdrawal by Subject|4|||
162756956|NCT03021993|587821618|FG000|Overall Study|Physician Decision|1|||
162756957|NCT03021993|587821618|FG000|Overall Study|enrolled but were not treated|1|||
162756958|NCT03021993|587821618|FG000|Overall Study|Death|3|||
162756959|NCT02101775|587821620|FG000|Overall Study|Adverse Event|4|||
162756960|NCT02101775|587821621|FG001|Overall Study|Adverse Event|0|||
162756961|NCT02101775|587821622|FG002|Overall Study|Adverse Event|0|||
162756962|NCT02101775|587821620|FG000|Overall Study|Admission to Hospital|0|||
162756963|NCT02101775|587821621|FG001|Overall Study|Admission to Hospital|1|||
162756964|NCT02101775|587821622|FG002|Overall Study|Admission to Hospital|0|||
162756965|NCT01387516|587821629|FG000|Overall Study|Lost to Follow-up|4|||
162756966|NCT01387516|587821630|FG001|Overall Study|Lost to Follow-up|4|||
162756967|NCT01387516|587821631|FG002|Overall Study|Lost to Follow-up|2|||
162756968|NCT01387516|587821632|FG003|Overall Study|Lost to Follow-up|3|||
162756969|NCT01387516|587821629|FG000|Overall Study|Withdrawal by Subject|1|||
162756970|NCT01387516|587821630|FG001|Overall Study|Withdrawal by Subject|1|||
162756971|NCT01387516|587821631|FG002|Overall Study|Withdrawal by Subject|2|||
162756972|NCT01387516|587821632|FG003|Overall Study|Withdrawal by Subject|0|||
162756973|NCT01387516|587821629|FG000|Overall Study|Death|0|||
162756974|NCT01387516|587821630|FG001|Overall Study|Death|0|||
162756975|NCT01387516|587821631|FG002|Overall Study|Death|0|||
162756976|NCT01387516|587821632|FG003|Overall Study|Death|1|||
162756977|NCT03509909|587821636|FG000|Overall Study|Withdrawal by Subject|16|||
162756978|NCT03509909|587821637|FG001|Overall Study|Withdrawal by Subject|9|||
162756979|NCT03509909|587821636|FG000|Overall Study|Lost to Follow-up|3|||
162756980|NCT03509909|587821637|FG001|Overall Study|Lost to Follow-up|4|||
162756981|NCT03509909|587821636|FG000|Overall Study|Adverse Event|2|||
162756982|NCT03509909|587821637|FG001|Overall Study|Adverse Event|0|||
162756983|NCT03683576|587821639|FG000|Overall Study|Withdrawal by Subject|2|||
162756984|NCT03683576|587821640|FG001|Overall Study|Withdrawal by Subject|0|||
162756985|NCT03683576|587821641|FG002|Overall Study|Withdrawal by Subject|8|||
162756986|NCT03683576|587821642|FG003|Overall Study|Withdrawal by Subject|3|||
162756987|NCT03683576|587821639|FG000|Overall Study|Adverse Event|3|||
162756988|NCT03683576|587821640|FG001|Overall Study|Adverse Event|0|||
162756989|NCT03683576|587821641|FG002|Overall Study|Adverse Event|0|||
162756990|NCT03683576|587821642|FG003|Overall Study|Adverse Event|4|||
162756991|NCT03683576|587821639|FG000|Overall Study|Lack of Efficacy|1|||
162756992|NCT03683576|587821640|FG001|Overall Study|Lack of Efficacy|0|||
162756993|NCT03683576|587821641|FG002|Overall Study|Lack of Efficacy|1|||
162756994|NCT03683576|587821642|FG003|Overall Study|Lack of Efficacy|1|||
162756995|NCT03683576|587821639|FG000|Overall Study|Lost to Follow-up|0|||
162756996|NCT03683576|587821640|FG001|Overall Study|Lost to Follow-up|1|||
162756997|NCT03683576|587821641|FG002|Overall Study|Lost to Follow-up|2|||
162756998|NCT03683576|587821642|FG003|Overall Study|Lost to Follow-up|0|||
162756999|NCT03683576|587821639|FG000|Overall Study|Other, Not Specified|0|||
162757000|NCT03683576|587821640|FG001|Overall Study|Other, Not Specified|2|||
162757001|NCT03683576|587821641|FG002|Overall Study|Other, Not Specified|0|||
162757002|NCT03683576|587821642|FG003|Overall Study|Other, Not Specified|0|||
162757003|NCT03683576|587821639|FG000|Overall Study|Protocol Violation|0|||
162757004|NCT03683576|587821640|FG001|Overall Study|Protocol Violation|1|||
162757005|NCT03683576|587821641|FG002|Overall Study|Protocol Violation|1|||
162757006|NCT03683576|587821642|FG003|Overall Study|Protocol Violation|0|||
162757007|NCT01588951|587821643|FG000|Overall Study|Ineligible in retrospect|0|||
162757008|NCT01588951|587821644|FG001|Overall Study|Ineligible in retrospect|0|||
162757009|NCT01588951|587821645|FG002|Overall Study|Ineligible in retrospect|1|||
162757010|NCT02454959|587821646|FG000|Overall Study|Protocol-Specified Criteria|3|||
162757011|NCT02454959|587821646|FG000|Overall Study|Physician Decision|1|||
162757012|NCT02454959|587821646|FG000|Overall Study|Withdrawal by Subject|3|||
162757013|NCT02454959|587821646|FG000|Overall Study|Adverse Event|2|||
162757014|NCT02350634|587821647|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
162757015|NCT02499328|587821656|FG000|Overall Study|Withdrawal by Subject|1|||
162757016|NCT02499328|587821657|FG001|Overall Study|Withdrawal by Subject|1|||
162757017|NCT02499328|587821658|FG002|Overall Study|Withdrawal by Subject|5|||
162757018|NCT02499328|587821659|FG003|Overall Study|Withdrawal by Subject|3|||
162757019|NCT02499328|587821660|FG004|Overall Study|Withdrawal by Subject|5|||
162757020|NCT02499328|587821661|FG005|Overall Study|Withdrawal by Subject|0|||
162757021|NCT02499328|587821662|FG006|Overall Study|Withdrawal by Subject|0|||
162757022|NCT02499328|587821663|FG007|Overall Study|Withdrawal by Subject|0|||
162757023|NCT02499328|587821664|FG008|Overall Study|Withdrawal by Subject|2|||
162757024|NCT02499328|587821665|FG009|Overall Study|Withdrawal by Subject|2|||
162757025|NCT02499328|587821666|FG010|Overall Study|Withdrawal by Subject|0|||
162757026|NCT02499328|587821667|FG011|Overall Study|Withdrawal by Subject|3|||
162757027|NCT02499328|587821668|FG012|Overall Study|Withdrawal by Subject|7|||
162757028|NCT02499328|587821669|FG013|Overall Study|Withdrawal by Subject|3|||
162757029|NCT02499328|587821670|FG014|Overall Study|Withdrawal by Subject|1|||
162757030|NCT02499328|587821671|FG015|Overall Study|Withdrawal by Subject|0|||
162757031|NCT02499328|587821672|FG016|Overall Study|Withdrawal by Subject|0|||
162757032|NCT02499328|587821673|FG017|Overall Study|Withdrawal by Subject|3|||
162757033|NCT02499328|587821674|FG018|Overall Study|Withdrawal by Subject|0|||
162757034|NCT02499328|587821656|FG000|Overall Study|Lost to Follow-up|0|||
162757035|NCT02499328|587821657|FG001|Overall Study|Lost to Follow-up|1|||
162757036|NCT02499328|587821658|FG002|Overall Study|Lost to Follow-up|1|||
162757037|NCT02499328|587821659|FG003|Overall Study|Lost to Follow-up|2|||
162757038|NCT02499328|587821660|FG004|Overall Study|Lost to Follow-up|0|||
162757039|NCT02499328|587821661|FG005|Overall Study|Lost to Follow-up|0|||
162757040|NCT02499328|587821662|FG006|Overall Study|Lost to Follow-up|0|||
162757041|NCT02499328|587821663|FG007|Overall Study|Lost to Follow-up|2|||
162757042|NCT02499328|587821664|FG008|Overall Study|Lost to Follow-up|3|||
162757043|NCT02499328|587821665|FG009|Overall Study|Lost to Follow-up|0|||
162757044|NCT02499328|587821666|FG010|Overall Study|Lost to Follow-up|0|||
162757045|NCT02499328|587821667|FG011|Overall Study|Lost to Follow-up|0|||
162757046|NCT02499328|587821668|FG012|Overall Study|Lost to Follow-up|0|||
162757047|NCT02499328|587821669|FG013|Overall Study|Lost to Follow-up|0|||
162757048|NCT02499328|587821670|FG014|Overall Study|Lost to Follow-up|0|||
162757049|NCT02499328|587821671|FG015|Overall Study|Lost to Follow-up|0|||
162757050|NCT02499328|587821672|FG016|Overall Study|Lost to Follow-up|0|||
162757051|NCT02499328|587821673|FG017|Overall Study|Lost to Follow-up|0|||
162757052|NCT02499328|587821674|FG018|Overall Study|Lost to Follow-up|1|||
162757053|NCT02499328|587821656|FG000|Overall Study|Death|0|||
162757054|NCT02499328|587821657|FG001|Overall Study|Death|3|||
162757055|NCT02499328|587821658|FG002|Overall Study|Death|3|||
162757056|NCT02499328|587821659|FG003|Overall Study|Death|2|||
162757057|NCT02499328|587821660|FG004|Overall Study|Death|4|||
162757058|NCT02499328|587821661|FG005|Overall Study|Death|7|||
162757059|NCT02499328|587821662|FG006|Overall Study|Death|3|||
162757060|NCT02499328|587821663|FG007|Overall Study|Death|0|||
162757061|NCT02499328|587821664|FG008|Overall Study|Death|2|||
162757062|NCT02499328|587821665|FG009|Overall Study|Death|6|||
162757063|NCT02499328|587821666|FG010|Overall Study|Death|6|||
162757064|NCT02499328|587821667|FG011|Overall Study|Death|20|||
162757065|NCT02499328|587821668|FG012|Overall Study|Death|9|||
162757066|NCT02499328|587821669|FG013|Overall Study|Death|7|||
162757067|NCT02499328|587821670|FG014|Overall Study|Death|3|||
162757068|NCT02499328|587821671|FG015|Overall Study|Death|1|||
162757069|NCT02499328|587821672|FG016|Overall Study|Death|1|||
162757070|NCT02499328|587821673|FG017|Overall Study|Death|16|||
162757071|NCT02499328|587821674|FG018|Overall Study|Death|5|||
162757072|NCT02499328|587821656|FG000|Overall Study|"Other"|2|||
162757073|NCT02499328|587821657|FG001|Overall Study|"Other"|2|||
162757074|NCT02499328|587821658|FG002|Overall Study|"Other"|1|||
162757075|NCT02499328|587821659|FG003|Overall Study|"Other"|3|||
162757076|NCT02499328|587821660|FG004|Overall Study|"Other"|6|||
162757077|NCT02499328|587821661|FG005|Overall Study|"Other"|2|||
162757078|NCT02499328|587821662|FG006|Overall Study|"Other"|3|||
162757079|NCT02499328|587821663|FG007|Overall Study|"Other"|4|||
162757080|NCT02499328|587821664|FG008|Overall Study|"Other"|6|||
162757081|NCT02499328|587821665|FG009|Overall Study|"Other"|16|||
162757082|NCT02499328|587821666|FG010|Overall Study|"Other"|13|||
162757083|NCT02499328|587821667|FG011|Overall Study|"Other"|31|||
162757084|NCT02499328|587821668|FG012|Overall Study|"Other"|8|||
162757085|NCT02499328|587821669|FG013|Overall Study|"Other"|7|||
162757086|NCT02499328|587821670|FG014|Overall Study|"Other"|6|||
162757087|NCT02499328|587821671|FG015|Overall Study|"Other"|0|||
162757088|NCT02499328|587821672|FG016|Overall Study|"Other"|0|||
162757089|NCT02499328|587821673|FG017|Overall Study|"Other"|34|||
162757090|NCT02499328|587821674|FG018|Overall Study|"Other"|43|||
162757091|NCT02499328|587821656|FG000|Overall Study|Disease Progression|0|||
162757092|NCT02499328|587821657|FG001|Overall Study|Disease Progression|0|||
162757093|NCT02499328|587821658|FG002|Overall Study|Disease Progression|0|||
162757094|NCT02499328|587821659|FG003|Overall Study|Disease Progression|0|||
162757095|NCT02499328|587821660|FG004|Overall Study|Disease Progression|0|||
162757096|NCT02499328|587821661|FG005|Overall Study|Disease Progression|0|||
162757097|NCT02499328|587821662|FG006|Overall Study|Disease Progression|1|||
162757098|NCT02499328|587821663|FG007|Overall Study|Disease Progression|0|||
162757099|NCT02499328|587821664|FG008|Overall Study|Disease Progression|1|||
162757100|NCT02499328|587821665|FG009|Overall Study|Disease Progression|0|||
162757101|NCT02499328|587821666|FG010|Overall Study|Disease Progression|1|||
162757102|NCT02499328|587821667|FG011|Overall Study|Disease Progression|0|||
162757103|NCT02499328|587821668|FG012|Overall Study|Disease Progression|0|||
162757104|NCT02499328|587821669|FG013|Overall Study|Disease Progression|0|||
162757105|NCT02499328|587821670|FG014|Overall Study|Disease Progression|0|||
162757106|NCT02499328|587821671|FG015|Overall Study|Disease Progression|0|||
162757107|NCT02499328|587821672|FG016|Overall Study|Disease Progression|0|||
162757108|NCT02499328|587821673|FG017|Overall Study|Disease Progression|2|||
162757109|NCT02499328|587821674|FG018|Overall Study|Disease Progression|0|||
162757110|NCT02499328|587821656|FG000|Overall Study|Adverse Event|1|||
162757111|NCT02499328|587821657|FG001|Overall Study|Adverse Event|0|||
162757112|NCT02499328|587821658|FG002|Overall Study|Adverse Event|0|||
162757113|NCT02499328|587821659|FG003|Overall Study|Adverse Event|1|||
162757114|NCT02499328|587821660|FG004|Overall Study|Adverse Event|0|||
162757115|NCT02499328|587821661|FG005|Overall Study|Adverse Event|0|||
162757116|NCT02499328|587821662|FG006|Overall Study|Adverse Event|0|||
162757117|NCT02499328|587821663|FG007|Overall Study|Adverse Event|0|||
162757118|NCT02499328|587821664|FG008|Overall Study|Adverse Event|0|||
162757119|NCT02499328|587821665|FG009|Overall Study|Adverse Event|0|||
162757120|NCT02499328|587821666|FG010|Overall Study|Adverse Event|0|||
162757121|NCT02499328|587821667|FG011|Overall Study|Adverse Event|0|||
162757122|NCT02499328|587821668|FG012|Overall Study|Adverse Event|1|||
162757123|NCT02499328|587821669|FG013|Overall Study|Adverse Event|0|||
162757124|NCT02499328|587821670|FG014|Overall Study|Adverse Event|0|||
162757125|NCT02499328|587821671|FG015|Overall Study|Adverse Event|0|||
162757126|NCT02499328|587821672|FG016|Overall Study|Adverse Event|0|||
162757127|NCT02499328|587821673|FG017|Overall Study|Adverse Event|0|||
162757128|NCT02499328|587821674|FG018|Overall Study|Adverse Event|0|||
162757129|NCT03488719|587821675|FG000|Overall Study|Adverse Event|0|||
162757130|NCT03488719|587821676|FG001|Overall Study|Adverse Event|4|||
162757131|NCT03488719|587821677|FG002|Overall Study|Adverse Event|2|||
162757132|NCT03488719|587821675|FG000|Overall Study|Other|0|||
162757133|NCT03488719|587821676|FG001|Overall Study|Other|0|||
162757134|NCT03488719|587821677|FG002|Overall Study|Other|5|||
162757135|NCT04801420|587821685|FG000|Overall Study|Other|1|||
162757136|NCT04801420|587821686|FG001|Overall Study|Other|2|||
162757137|NCT04801420|587821687|FG002|Overall Study|Other|1|||
162757138|NCT04801420|587821685|FG000|Overall Study|Lost to Follow-up|7|||
162757139|NCT04801420|587821686|FG001|Overall Study|Lost to Follow-up|9|||
162757140|NCT04801420|587821687|FG002|Overall Study|Lost to Follow-up|10|||
162757141|NCT04801420|587821685|FG000|Overall Study|Moved from study area|0|||
162757142|NCT04801420|587821686|FG001|Overall Study|Moved from study area|1|||
162757143|NCT04801420|587821687|FG002|Overall Study|Moved from study area|1|||
162757144|NCT04801420|587821685|FG000|Overall Study|Withdrawal by Subject|5|||
162757145|NCT04801420|587821686|FG001|Overall Study|Withdrawal by Subject|1|||
162757146|NCT04801420|587821687|FG002|Overall Study|Withdrawal by Subject|4|||
162757147|NCT04801420|587821685|FG000|Overall Study|Individual stopping criteria reached|0|||
162757148|NCT04801420|587821686|FG001|Overall Study|Individual stopping criteria reached|1|||
162757149|NCT04801420|587821687|FG002|Overall Study|Individual stopping criteria reached|0|||
162757150|NCT04801420|587821685|FG000|Overall Study|Ongoing in the study|195|||
162757151|NCT04801420|587821686|FG001|Overall Study|Ongoing in the study|195|||
162757152|NCT04801420|587821687|FG002|Overall Study|Ongoing in the study|192|||
162757153|NCT03414684|587821688|FG000|First-course Treatment|Complete response|0|||
162757154|NCT03414684|587821689|FG001|First-course Treatment|Complete response|1|||
162757155|NCT03414684|587821688|FG000|First-course Treatment|Intercurrent illness|1|||
162757156|NCT03414684|587821689|FG001|First-course Treatment|Intercurrent illness|0|||
162757157|NCT03414684|587821688|FG000|First-course Treatment|Progressive Disease|31|||
162757158|NCT03414684|587821689|FG001|First-course Treatment|Progressive Disease|32|||
162757159|NCT03414684|587821688|FG000|First-course Treatment|Adverse Event|1|||
162757160|NCT03414684|587821689|FG001|First-course Treatment|Adverse Event|2|||
162757161|NCT03414684|587821688|FG000|First-course Treatment|Physician Decision|0|||
162757162|NCT03414684|587821689|FG001|First-course Treatment|Physician Decision|1|||
162757163|NCT03414684|587821688|FG000|First-course Treatment|Withdrawal by Subject|0|||
162757164|NCT03414684|587821689|FG001|First-course Treatment|Withdrawal by Subject|1|||
162757165|NCT03414684|587821688|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
162757166|NCT03414684|587821689|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
162757167|NCT03414684|587821688|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
162757168|NCT03414684|587821689|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
162757169|NCT03414684|587821688|FG000|First-course Treatment|Still on treatment|3|||
162757170|NCT03414684|587821689|FG001|First-course Treatment|Still on treatment|0|||
162757171|NCT03414684|587821688|FG000|First-course Treatment|Never started protocol therapy|2|||
162757172|NCT03414684|587821689|FG001|First-course Treatment|Never started protocol therapy|1|||
162757173|NCT03414684|587821688|FG000|Crossover Treatment|Progressive disease|0|||
162757174|NCT03414684|587821689|FG001|Crossover Treatment|Progressive disease|12|||
162757175|NCT03414684|587821688|FG000|Crossover Treatment|Adverse Event|0|||
162757176|NCT03414684|587821689|FG001|Crossover Treatment|Adverse Event|3|||
162757177|NCT03414684|587821688|FG000|Crossover Treatment|Physician Decision|0|||
162757178|NCT03414684|587821689|FG001|Crossover Treatment|Physician Decision|1|||
162757179|NCT03414684|587821688|FG000|Crossover Treatment|Still on treatment|0|||
162757180|NCT03414684|587821689|FG001|Crossover Treatment|Still on treatment|2|||
162757181|NCT04038580|587821690|FG000|Washout 1|Death|0|||
162757182|NCT04038580|587821691|FG001|Washout 1|Death|0|||
162757183|NCT04038580|587821692|FG002|Washout 1|Death|0|||
162757184|NCT04038580|587821693|FG003|Washout 1|Death|1|||
162757185|NCT04038580|587821694|FG004|Washout 1|Death|0|||
162757186|NCT04038580|587821695|FG005|Washout 1|Death|0|||
162757187|NCT04038580|587821690|FG000|Washout 1|Withdrawal by Subject|0|||
162757188|NCT04038580|587821691|FG001|Washout 1|Withdrawal by Subject|0|||
162757189|NCT04038580|587821692|FG002|Washout 1|Withdrawal by Subject|0|||
162757190|NCT04038580|587821693|FG003|Washout 1|Withdrawal by Subject|0|||
162757191|NCT04038580|587821694|FG004|Washout 1|Withdrawal by Subject|1|||
162757192|NCT04038580|587821695|FG005|Washout 1|Withdrawal by Subject|0|||
162757193|NCT04038580|587821690|FG000|Wash-out 2|Withdrawal by Subject|1|||
162757194|NCT04038580|587821691|FG001|Wash-out 2|Withdrawal by Subject|0|||
162757195|NCT04038580|587821692|FG002|Wash-out 2|Withdrawal by Subject|0|||
162757196|NCT04038580|587821693|FG003|Wash-out 2|Withdrawal by Subject|2|||
162757197|NCT04038580|587821694|FG004|Wash-out 2|Withdrawal by Subject|0|||
162757198|NCT04038580|587821695|FG005|Wash-out 2|Withdrawal by Subject|1|||
162757199|NCT04038580|587821690|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
162757200|NCT04038580|587821691|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
162757201|NCT04038580|587821692|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
162757202|NCT04038580|587821693|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
162757203|NCT04038580|587821694|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
162757204|NCT04038580|587821695|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
162757205|NCT04038580|587821690|FG000|Wash-out 3|Withdrawal by Subject|1|||
162757206|NCT04038580|587821691|FG001|Wash-out 3|Withdrawal by Subject|0|||
162757207|NCT04038580|587821692|FG002|Wash-out 3|Withdrawal by Subject|2|||
162757208|NCT04038580|587821693|FG003|Wash-out 3|Withdrawal by Subject|0|||
162757209|NCT04038580|587821694|FG004|Wash-out 3|Withdrawal by Subject|0|||
162757210|NCT04038580|587821695|FG005|Wash-out 3|Withdrawal by Subject|0|||
162757211|NCT03477175|587821696|FG000|Overall Study|Unable to travel due to COVID-19|0|||
162757212|NCT03477175|587821697|FG001|Overall Study|Unable to travel due to COVID-19|1|||
162757213|NCT03477175|587821696|FG000|Overall Study|Physician Decision|1|||
162757214|NCT03477175|587821697|FG001|Overall Study|Physician Decision|0|||
162757215|NCT03477175|587821696|FG000|Overall Study|Transitioned to commercial drug|6|||
162757216|NCT03477175|587821697|FG001|Overall Study|Transitioned to commercial drug|6|||
162757217|NCT03477175|587821696|FG000|Overall Study|Lost to Follow-up|1|||
162757218|NCT03477175|587821697|FG001|Overall Study|Lost to Follow-up|1|||
162757219|NCT03477175|587821696|FG000|Overall Study|Withdrawal by Subject|3|||
162757220|NCT03477175|587821697|FG001|Overall Study|Withdrawal by Subject|1|||
162757221|NCT03477175|587821696|FG000|Overall Study|Adverse Event|1|||
162757222|NCT03477175|587821697|FG001|Overall Study|Adverse Event|5|||
162757223|NCT03477175|587821696|FG000|Overall Study|Disease Progression|7|||
162757224|NCT03477175|587821697|FG001|Overall Study|Disease Progression|7|||
162757225|NCT02078648|587821698|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
162757226|NCT02078648|587821699|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
162757227|NCT02078648|587821698|FG000|Overall Study|Adverse Event|0|||
162757228|NCT02078648|587821699|FG001|Overall Study|Adverse Event|1|||
162757229|NCT02078648|587821698|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
162757230|NCT02078648|587821699|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
162757231|NCT02078648|587821698|FG000|Overall Study|Withdrawal by Subject|3|||
162757232|NCT02078648|587821699|FG001|Overall Study|Withdrawal by Subject|1|||
162757233|NCT02078648|587821698|FG000|Overall Study|Investigator Decision|5|||
162757234|NCT02078648|587821699|FG001|Overall Study|Investigator Decision|7|||
162757235|NCT02078648|587821698|FG000|Overall Study|Death|1|||
162757236|NCT02078648|587821699|FG001|Overall Study|Death|1|||
162757237|NCT02078648|587821698|FG000|Overall Study|Undefined|0|||
162757238|NCT02078648|587821699|FG001|Overall Study|Undefined|1|||
162757239|NCT04088227|587821700|FG000|Overall Study|Withdrawal by Subject|1|||
162757240|NCT04088227|587821701|FG001|Overall Study|Withdrawal by Subject|0|||
162757241|NCT04088227|587821700|FG000|Overall Study|Surgery postponed >5weeks|1|||
162757242|NCT04088227|587821701|FG001|Overall Study|Surgery postponed >5weeks|0|||
162757243|NCT04021862|587821702|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162757244|NCT04021862|587821703|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
162757245|NCT04021862|587821704|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162757246|NCT04021862|587821705|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162757247|NCT04021862|587821706|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162757248|NCT04021862|587821707|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162757249|NCT04021862|587821702|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
162757250|NCT04021862|587821703|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162757251|NCT04021862|587821704|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162757252|NCT04021862|587821705|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162757253|NCT04021862|587821706|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162757254|NCT04021862|587821707|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162757255|NCT04021862|587821702|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162757256|NCT04021862|587821703|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162757257|NCT04021862|587821704|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
162757258|NCT04021862|587821705|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162757259|NCT04021862|587821706|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162757260|NCT04021862|587821707|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162757261|NCT04021862|587821702|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
162757262|NCT04021862|587821703|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
162757263|NCT04021862|587821704|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
162757264|NCT04021862|587821705|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
162757265|NCT04021862|587821706|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
162757266|NCT04021862|587821707|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
162757267|NCT04021862|587821702|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162757268|NCT04021862|587821703|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162757269|NCT04021862|587821704|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162757270|NCT04021862|587821705|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
162757271|NCT04021862|587821706|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162757272|NCT04021862|587821707|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162757273|NCT00442104|587822737|FG000|Overall Study|Adverse Event|5|||
162757274|NCT00442104|587822737|FG000|Overall Study|Death|2|||
162757275|NCT00442104|587822737|FG000|Overall Study|Lost to Follow-up|3|||
162757276|NCT00442104|587822737|FG000|Overall Study|Withdrawal by Subject|5|||
162757277|NCT00442104|587822737|FG000|Overall Study|Insufficient Clinical Response|10|||
162757278|NCT00442104|587822737|FG000|Overall Study|Other|21|||
162757279|NCT00442104|587822737|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
162757280|NCT04497415|587822744|FG000|Overall Study|Lost to Follow-up|43|||
162757281|NCT04497415|587822745|FG001|Overall Study|Lost to Follow-up|27|||
162757282|NCT00975585|587822746|FG000|Overall Study|Adverse Event|0|||
162757283|NCT00975585|587822747|FG001|Overall Study|Adverse Event|4|||
162757284|NCT00975585|587822746|FG000|Overall Study|Lost to Follow-up|3|||
162757285|NCT00975585|587822747|FG001|Overall Study|Lost to Follow-up|5|||
162757286|NCT00975585|587822746|FG000|Overall Study|Withdrawal by Subject|2|||
162757287|NCT00975585|587822747|FG001|Overall Study|Withdrawal by Subject|1|||
162757288|NCT00975585|587822746|FG000|Overall Study|Lens issue|2|||
162757289|NCT00975585|587822747|FG001|Overall Study|Lens issue|2|||
162757290|NCT00205179|587822748|FG000|Overall Study|Death|0|||
162757291|NCT00205179|587822749|FG001|Overall Study|Death|2|||
162757292|NCT00205179|587822748|FG000|Overall Study|Physician Decision|1|||
162757293|NCT00205179|587822749|FG001|Overall Study|Physician Decision|1|||
162757294|NCT00205179|587822748|FG000|Overall Study|Adverse Event|1|||
162757295|NCT00205179|587822749|FG001|Overall Study|Adverse Event|1|||
162757296|NCT01619059|587822754|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
162757297|NCT01619059|587822755|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
162757298|NCT01619059|587822754|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
162757299|NCT01619059|587822755|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
162757300|NCT01619059|587822754|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
162757301|NCT01619059|587822755|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
162757302|NCT01619059|587822754|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
162757303|NCT01619059|587822755|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
162757304|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
162757305|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
162757306|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
162757307|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
162757308|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
162757309|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
162757310|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Death|1|||
162757311|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Death|0|||
162757312|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
162757313|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
162757314|NCT01619059|587822754|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
162757315|NCT01619059|587822755|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
162757316|NCT03041233|587822756|FG000|Overall Study|Death|5|||
162757317|NCT03041233|587822756|FG000|Overall Study|Physician Decision|1|||
162757318|NCT03041233|587822756|FG000|Overall Study|Lost to Follow-up|16|||
162757319|NCT03041233|587822756|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
162757320|NCT03041233|587822756|FG000|Overall Study|Sponsor Request|1|||
162757321|NCT03041233|587822756|FG000|Overall Study|Duplicate subject|1|||
162757322|NCT03041233|587822756|FG000|Overall Study|Re-ablation|1|||
162757323|NCT00853593|587822760|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
162757324|NCT00853593|587822760|FG000|Overall Study|Model 4396 lead not attempted|29|||
162757325|NCT00853593|587822760|FG000|Overall Study|Implant not attempted|4|||
162757326|NCT03170648|587822766|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
162757327|NCT03170648|587822766|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
162757328|NCT02052440|587822767|FG000|Overall Study|Withdrawal by Subject|0|||
162757329|NCT02052440|587822768|FG001|Overall Study|Withdrawal by Subject|1|||
162757330|NCT01367236|587822772|FG000|Overall Study|Withdrawal by Subject|3|||
162757331|NCT01367236|587822773|FG001|Overall Study|Withdrawal by Subject|1|||
162757332|NCT02628626|587822778|FG000|Overall Study|Withdrawal by Subject|2|||
162757333|NCT02628626|587822779|FG001|Overall Study|Withdrawal by Subject|2|||
162757334|NCT01593020|587822780|FG000|Overall Study|Adverse Event|1|||
162757335|NCT01593020|587822781|FG001|Overall Study|Adverse Event|1|||
162757336|NCT01593020|587822780|FG000|Overall Study|Death|0|||
162757337|NCT01593020|587822781|FG001|Overall Study|Death|1|||
162757338|NCT01593020|587822780|FG000|Overall Study|Ineligible|1|||
162757339|NCT01593020|587822781|FG001|Overall Study|Ineligible|0|||
162757340|NCT03611075|587822786|FG000|Overall Study|Physician Decision|0|||
162757341|NCT03611075|587822787|FG001|Overall Study|Physician Decision|1|||
162757342|NCT03611075|587822788|FG002|Overall Study|Physician Decision|1|||
162757343|NCT03611075|587822789|FG003|Overall Study|Physician Decision|0|||
162757344|NCT03611075|587822790|FG004|Overall Study|Physician Decision|0|||
162757345|NCT03611075|587822791|FG005|Overall Study|Physician Decision|0|||
162757346|NCT03611075|587822792|FG006|Overall Study|Physician Decision|0|||
162757347|NCT03611075|587822793|FG007|Overall Study|Physician Decision|0|||
162757348|NCT03611075|587822794|FG008|Overall Study|Physician Decision|0|||
162757349|NCT03611075|587822786|FG000|Overall Study|Lost to Follow-up|1|||
162757350|NCT03611075|587822787|FG001|Overall Study|Lost to Follow-up|0|||
162757351|NCT03611075|587822788|FG002|Overall Study|Lost to Follow-up|0|||
162757352|NCT03611075|587822789|FG003|Overall Study|Lost to Follow-up|2|||
162757353|NCT03611075|587822790|FG004|Overall Study|Lost to Follow-up|0|||
162757354|NCT03611075|587822791|FG005|Overall Study|Lost to Follow-up|0|||
162757355|NCT03611075|587822792|FG006|Overall Study|Lost to Follow-up|0|||
162757356|NCT03611075|587822793|FG007|Overall Study|Lost to Follow-up|0|||
162757357|NCT03611075|587822794|FG008|Overall Study|Lost to Follow-up|0|||
162757358|NCT03611075|587822786|FG000|Overall Study|Withdrawal by Subject|0|||
162757359|NCT03611075|587822787|FG001|Overall Study|Withdrawal by Subject|1|||
162757360|NCT03611075|587822788|FG002|Overall Study|Withdrawal by Subject|1|||
162757361|NCT03611075|587822789|FG003|Overall Study|Withdrawal by Subject|1|||
162757362|NCT03611075|587822790|FG004|Overall Study|Withdrawal by Subject|0|||
162757363|NCT03611075|587822791|FG005|Overall Study|Withdrawal by Subject|0|||
162757364|NCT03611075|587822792|FG006|Overall Study|Withdrawal by Subject|1|||
162757365|NCT03611075|587822793|FG007|Overall Study|Withdrawal by Subject|0|||
162757366|NCT03611075|587822794|FG008|Overall Study|Withdrawal by Subject|0|||
162757367|NCT03611075|587822786|FG000|Overall Study|Reason unknown|0|||
162757368|NCT03611075|587822787|FG001|Overall Study|Reason unknown|0|||
162757369|NCT03611075|587822788|FG002|Overall Study|Reason unknown|0|||
162757370|NCT03611075|587822789|FG003|Overall Study|Reason unknown|1|||
162757371|NCT03611075|587822790|FG004|Overall Study|Reason unknown|0|||
162757372|NCT03611075|587822791|FG005|Overall Study|Reason unknown|0|||
162757373|NCT03611075|587822792|FG006|Overall Study|Reason unknown|1|||
162757374|NCT03611075|587822793|FG007|Overall Study|Reason unknown|0|||
162757375|NCT03611075|587822794|FG008|Overall Study|Reason unknown|0|||
162757376|NCT02972359|587822795|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
162757377|NCT02972359|587822795|FG000|Overall Study|Lack of Efficacy|1|||
162757378|NCT02972359|587822795|FG000|Overall Study|Adverse Event|4|||
162757379|NCT02972359|587822795|FG000|Overall Study|Death|1|||
162757380|NCT02972359|587822795|FG000|Overall Study|Withdrawal by Subject|30|||
162757381|NCT02972359|587822795|FG000|Overall Study|Protocol Violation|1|||
162757382|NCT02972359|587822795|FG000|Overall Study|Lost to Follow-up|26|||
162757383|NCT02972359|587822795|FG000|Overall Study|Other reasons|5|||
162757384|NCT02972359|587822795|FG000|Overall Study|Missing|1|||
162757385|NCT01855750|587822799|FG000|Overall Study|Death|78|||
162757386|NCT01855750|587822800|FG001|Overall Study|Death|78|||
162757387|NCT01855750|587822799|FG000|Overall Study|Lost to Follow-up|9|||
162757388|NCT01855750|587822800|FG001|Overall Study|Lost to Follow-up|23|||
162757389|NCT01855750|587822799|FG000|Overall Study|Withdrawal by Subject|35|||
162757390|NCT01855750|587822800|FG001|Overall Study|Withdrawal by Subject|28|||
162757391|NCT01855750|587822799|FG000|Overall Study|Sponsor ends the study|297|||
162757392|NCT01855750|587822800|FG001|Overall Study|Sponsor ends the study|290|||
162757393|NCT05379270|587822801|FG000|Overall Study|Withdrawal by Subject|1|||
162757394|NCT05379270|587822802|FG001|Overall Study|Withdrawal by Subject|1|||
162757395|NCT05025384|587822803|FG000|Overall Study|Physician Decision|5|||
162757396|NCT05025384|587822804|FG001|Overall Study|Physician Decision|6|||
162757397|NCT03160885|587822805|FG000|Initial Treatment Period|Not dosed|2|||
162757398|NCT03160885|587822806|FG001|Initial Treatment Period|Not dosed|0|||
162757399|NCT03160885|587822807|FG002|Initial Treatment Period|Not dosed|0|||
162757400|NCT03160885|587822808|FG003|Initial Treatment Period|Not dosed|0|||
162757401|NCT03160885|587822809|FG004|Initial Treatment Period|Not dosed|0|||
162757402|NCT03160885|587822810|FG005|Initial Treatment Period|Not dosed|0|||
162757403|NCT03160885|587822811|FG006|Initial Treatment Period|Not dosed|0|||
162757404|NCT03160885|587822805|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
162757405|NCT03160885|587822806|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
162757406|NCT03160885|587822807|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162757407|NCT03160885|587822808|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162757408|NCT03160885|587822809|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162757409|NCT03160885|587822810|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162757410|NCT03160885|587822811|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162757411|NCT03160885|587822805|FG000|Open-label Treatment|Not dosed|0|||
162757412|NCT03160885|587822806|FG001|Open-label Treatment|Not dosed|0|||
162757413|NCT03160885|587822807|FG002|Open-label Treatment|Not dosed|0|||
162757414|NCT03160885|587822808|FG003|Open-label Treatment|Not dosed|0|||
162757415|NCT03160885|587822809|FG004|Open-label Treatment|Not dosed|0|||
162757416|NCT03160885|587822810|FG005|Open-label Treatment|Not dosed|0|||
162757417|NCT03160885|587822811|FG006|Open-label Treatment|Not dosed|2|||
162757418|NCT03160885|587822805|FG000|Open-label Treatment|Discontinued IMP|0|||
162757419|NCT03160885|587822806|FG001|Open-label Treatment|Discontinued IMP|0|||
162757420|NCT03160885|587822807|FG002|Open-label Treatment|Discontinued IMP|0|||
162757421|NCT03160885|587822808|FG003|Open-label Treatment|Discontinued IMP|0|||
162757422|NCT03160885|587822809|FG004|Open-label Treatment|Discontinued IMP|0|||
162757423|NCT03160885|587822810|FG005|Open-label Treatment|Discontinued IMP|0|||
162757424|NCT03160885|587822811|FG006|Open-label Treatment|Discontinued IMP|131|||
162757425|NCT03160885|587822805|FG000|Open-label Treatment|Completed Week 50|0|||
162757426|NCT03160885|587822806|FG001|Open-label Treatment|Completed Week 50|0|||
162757427|NCT03160885|587822807|FG002|Open-label Treatment|Completed Week 50|0|||
162757428|NCT03160885|587822808|FG003|Open-label Treatment|Completed Week 50|0|||
162757429|NCT03160885|587822809|FG004|Open-label Treatment|Completed Week 50|0|||
162757430|NCT03160885|587822810|FG005|Open-label Treatment|Completed Week 50|0|||
162757431|NCT03160885|587822811|FG006|Open-label Treatment|Completed Week 50|4|||
162757432|NCT03160885|587822805|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757433|NCT03160885|587822806|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757434|NCT03160885|587822807|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757435|NCT03160885|587822808|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
162757436|NCT03160885|587822809|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757437|NCT03160885|587822810|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757438|NCT03160885|587822811|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162757439|NCT03160885|587822805|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
162757440|NCT03160885|587822806|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
162757441|NCT03160885|587822807|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
162757442|NCT03160885|587822808|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
162757443|NCT03160885|587822809|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
162757444|NCT03160885|587822810|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
162757445|NCT03160885|587822811|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
162757446|NCT03160885|587822805|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162757447|NCT03160885|587822806|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162757448|NCT03160885|587822807|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
162757449|NCT03160885|587822808|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
162757450|NCT03160885|587822809|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
162757451|NCT03160885|587822810|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
162757452|NCT03160885|587822811|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162757453|NCT03160885|587822805|FG000|Maintenance Treatment Period|Completed Week 50|0|||
162757454|NCT03160885|587822806|FG001|Maintenance Treatment Period|Completed Week 50|0|||
162757455|NCT03160885|587822807|FG002|Maintenance Treatment Period|Completed Week 50|1|||
162757456|NCT03160885|587822808|FG003|Maintenance Treatment Period|Completed Week 50|0|||
162757457|NCT03160885|587822809|FG004|Maintenance Treatment Period|Completed Week 50|0|||
162757458|NCT03160885|587822810|FG005|Maintenance Treatment Period|Completed Week 50|0|||
162757459|NCT03160885|587822811|FG006|Maintenance Treatment Period|Completed Week 50|0|||
162757460|NCT03425682|587822812|FG000|Overall Study|Lost to Follow-up|2|||
162757461|NCT03425682|587822813|FG001|Overall Study|Lost to Follow-up|4|||
162757462|NCT03425682|587822812|FG000|Overall Study|Withdrawal by Subject|0|||
162757463|NCT03425682|587822813|FG001|Overall Study|Withdrawal by Subject|3|||
162757464|NCT03425682|587822812|FG000|Overall Study|Subject did not meet I/E|4|||
162757465|NCT03425682|587822813|FG001|Overall Study|Subject did not meet I/E|10|||
162757466|NCT03835754|587822814|FG000|Overall Study|Death|4|||
162757467|NCT03227861|587822817|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
162757468|NCT03227861|587822817|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
162757469|NCT03227861|587822817|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
162757470|NCT03227861|587822817|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
162757471|NCT03227861|587822817|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
162757472|NCT03227861|587822817|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
162757473|NCT03227861|587822817|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
162757474|NCT03227861|587822817|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
162757475|NCT03227861|587822817|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
162757476|NCT03227861|587822817|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
162757477|NCT05810285|587822818|FG000|Overall Study|Death|4|||
162757478|NCT05810285|587822819|FG001|Overall Study|Death|21|||
162757479|NCT05810285|587822818|FG000|Overall Study|Adverse Event|18|||
162757480|NCT05810285|587822819|FG001|Overall Study|Adverse Event|16|||
162757481|NCT05886777|587822820|FG000|Overall Study|Lost to Follow-up|1|||
162757482|NCT05886777|587822821|FG001|Overall Study|Lost to Follow-up|0|||
162757483|NCT05886777|587822822|FG002|Overall Study|Lost to Follow-up|2|||
162757484|NCT05886777|587822823|FG003|Overall Study|Lost to Follow-up|1|||
162757485|NCT05886777|587822824|FG004|Overall Study|Lost to Follow-up|0|||
162757486|NCT05886777|587822825|FG005|Overall Study|Lost to Follow-up|2|||
162757487|NCT05886777|587822826|FG006|Overall Study|Lost to Follow-up|0|||
162757488|NCT05886777|587822820|FG000|Overall Study|Other|0|||
162757489|NCT05886777|587822821|FG001|Overall Study|Other|2|||
162757490|NCT05886777|587822822|FG002|Overall Study|Other|1|||
162757491|NCT05886777|587822823|FG003|Overall Study|Other|0|||
162757492|NCT05886777|587822824|FG004|Overall Study|Other|0|||
162757493|NCT05886777|587822825|FG005|Overall Study|Other|0|||
162757494|NCT05886777|587822826|FG006|Overall Study|Other|0|||
162757495|NCT05886777|587822820|FG000|Overall Study|Withdrawal by Subject|1|||
162757496|NCT05886777|587822821|FG001|Overall Study|Withdrawal by Subject|0|||
162757497|NCT05886777|587822822|FG002|Overall Study|Withdrawal by Subject|1|||
162757498|NCT05886777|587822823|FG003|Overall Study|Withdrawal by Subject|4|||
162757499|NCT05886777|587822824|FG004|Overall Study|Withdrawal by Subject|3|||
162757500|NCT05886777|587822825|FG005|Overall Study|Withdrawal by Subject|1|||
162757501|NCT05886777|587822826|FG006|Overall Study|Withdrawal by Subject|1|||
162757502|NCT05886777|587822820|FG000|Overall Study|Protocol Violation|0|||
162757503|NCT05886777|587822821|FG001|Overall Study|Protocol Violation|0|||
162757504|NCT05886777|587822822|FG002|Overall Study|Protocol Violation|1|||
162757505|NCT05886777|587822823|FG003|Overall Study|Protocol Violation|0|||
162757506|NCT05886777|587822824|FG004|Overall Study|Protocol Violation|0|||
162757507|NCT05886777|587822825|FG005|Overall Study|Protocol Violation|0|||
162757508|NCT05886777|587822826|FG006|Overall Study|Protocol Violation|0|||
162757509|NCT05886777|587822820|FG000|Overall Study|No longer met eligibility criteria|0|||
162757510|NCT05886777|587822821|FG001|Overall Study|No longer met eligibility criteria|1|||
162757511|NCT05886777|587822822|FG002|Overall Study|No longer met eligibility criteria|0|||
162757512|NCT05886777|587822823|FG003|Overall Study|No longer met eligibility criteria|0|||
162757513|NCT05886777|587822824|FG004|Overall Study|No longer met eligibility criteria|0|||
162757514|NCT05886777|587822825|FG005|Overall Study|No longer met eligibility criteria|0|||
162757515|NCT05886777|587822826|FG006|Overall Study|No longer met eligibility criteria|0|||
162757516|NCT03773107|587822827|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
162757517|NCT03773107|587822828|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
162757518|NCT03773107|587822829|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
162757519|NCT03773107|587822830|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
162757520|NCT07204444|587822832|FG000|Overall Study|Medical/Hospitalization|6|||
162757521|NCT07204444|587822833|FG001|Overall Study|Medical/Hospitalization|9|||
162757522|NCT07204444|587822834|FG002|Overall Study|Medical/Hospitalization|6|||
162757523|NCT07204444|587822832|FG000|Overall Study|Treatment Provider Issue|1|||
162757524|NCT07204444|587822833|FG001|Overall Study|Treatment Provider Issue|3|||
162757525|NCT07204444|587822834|FG002|Overall Study|Treatment Provider Issue|0|||
162757526|NCT07204444|587822832|FG000|Overall Study|Withdrawal by Subject|11|||
162757527|NCT07204444|587822833|FG001|Overall Study|Withdrawal by Subject|5|||
162757528|NCT07204444|587822834|FG002|Overall Study|Withdrawal by Subject|5|||
162757529|NCT07204444|587822832|FG000|Overall Study|Death|3|||
162757530|NCT07204444|587822833|FG001|Overall Study|Death|6|||
162757531|NCT07204444|587822834|FG002|Overall Study|Death|1|||
162757532|NCT07204444|587822832|FG000|Overall Study|Unable To Reach|29|||
162757533|NCT07204444|587822833|FG001|Overall Study|Unable To Reach|26|||
162757534|NCT07204444|587822834|FG002|Overall Study|Unable To Reach|17|||
162757535|NCT07204444|587822832|FG000|Overall Study|Protocol Deviation|3|||
162757536|NCT07204444|587822833|FG001|Overall Study|Protocol Deviation|2|||
162757537|NCT07204444|587822834|FG002|Overall Study|Protocol Deviation|0|||
162757538|NCT00345046|587824061|FG000|Overall Study|Protocol Violation|1|||
162757539|NCT00345046|587824062|FG001|Overall Study|Protocol Violation|1|||
162757540|NCT00345046|587824063|FG002|Overall Study|Protocol Violation|2|||
162757541|NCT01779700|587824064|FG000|Overall Study|Adverse Event|4|||
162757542|NCT01779700|587824065|FG001|Overall Study|Adverse Event|3|||
162757543|NCT01779700|587824064|FG000|Overall Study|Withdrawal by Subject|0|||
162757544|NCT01779700|587824065|FG001|Overall Study|Withdrawal by Subject|2|||
162757545|NCT00918333|587824066|FG000|Overall Study|Drug not taken per protocol|1|||
162757546|NCT00918333|587824067|FG001|Overall Study|Drug not taken per protocol|0|||
162757547|NCT00918333|587824066|FG000|Overall Study|Inadequate amount of drugs provided|1|||
162757548|NCT00918333|587824067|FG001|Overall Study|Inadequate amount of drugs provided|4|||
162757549|NCT00918333|587824066|FG000|Overall Study|Ineligible|1|||
162757550|NCT00918333|587824067|FG001|Overall Study|Ineligible|0|||
162757551|NCT00918333|587824066|FG000|Overall Study|Withdrawal by Subject|0|||
162757552|NCT00918333|587824067|FG001|Overall Study|Withdrawal by Subject|1|||
162757553|NCT02157116|587824074|FG000|Overall Study|Withdrawal by Subject|4|||
162757554|NCT02157116|587824074|FG000|Overall Study|Physician Decision|3|||
162757555|NCT02157116|587824074|FG000|Overall Study|Failed Screening|2|||
162757556|NCT02463448|587824075|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
162757557|NCT02463448|587824075|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
162757558|NCT02463448|587824075|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
162757559|NCT02463448|587824075|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
162757560|NCT00463229|587824076|FG000|Overall Study|Lost to Follow-up|5|||
162757561|NCT00463229|587824077|FG001|Overall Study|Lost to Follow-up|7|||
162757562|NCT00463229|587824076|FG000|Overall Study|Death|4|||
162757563|NCT00463229|587824077|FG001|Overall Study|Death|3|||
162757564|NCT01359150|587824084|FG000|Overall Study|Lack of Efficacy|1|||
162757565|NCT01359150|587824085|FG001|Overall Study|Lack of Efficacy|1|||
162757566|NCT01359150|587824084|FG000|Overall Study|Withdrawal by Subject|1|||
162757567|NCT01359150|587824085|FG001|Overall Study|Withdrawal by Subject|1|||
162757568|NCT01359150|587824084|FG000|Overall Study|Adverse Event|4|||
162757569|NCT01359150|587824085|FG001|Overall Study|Adverse Event|3|||
162757570|NCT01359150|587824084|FG000|Overall Study|Other|1|||
162757571|NCT01359150|587824085|FG001|Overall Study|Other|0|||
162757572|NCT01728324|587824086|FG000|Termination of DBV|Adverse Event|14|||
162757573|NCT01728324|587824087|FG001|Termination of DBV|Adverse Event|13|||
162757574|NCT01728324|587824088|FG002|Termination of DBV|Adverse Event|4|||
162757575|NCT01728324|587824086|FG000|Termination of DBV|Lack of Efficacy|14|||
162757576|NCT01728324|587824087|FG001|Termination of DBV|Lack of Efficacy|12|||
162757577|NCT01728324|587824088|FG002|Termination of DBV|Lack of Efficacy|8|||
162757578|NCT01728324|587824086|FG000|Termination of DBV|Withdrawal by Subject|9|||
162757579|NCT01728324|587824087|FG001|Termination of DBV|Withdrawal by Subject|6|||
162757580|NCT01728324|587824088|FG002|Termination of DBV|Withdrawal by Subject|2|||
162757581|NCT01728324|587824086|FG000|Termination of DBV|Other than stated|1|||
162757582|NCT01728324|587824087|FG001|Termination of DBV|Other than stated|3|||
162757583|NCT01728324|587824088|FG002|Termination of DBV|Other than stated|0|||
162757584|NCT01728324|587824086|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
162757585|NCT01728324|587824087|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
162757586|NCT01728324|587824088|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
162757587|NCT01728324|587824086|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
162757588|NCT01728324|587824087|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
162757589|NCT01728324|587824088|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
162757590|NCT01728324|587824086|FG000|Termination of FDV|Adverse Event|14|||
162757591|NCT01728324|587824087|FG001|Termination of FDV|Adverse Event|13|||
162757592|NCT01728324|587824088|FG002|Termination of FDV|Adverse Event|4|||
162757593|NCT01728324|587824086|FG000|Termination of FDV|Lack of Efficacy|14|||
162757594|NCT01728324|587824087|FG001|Termination of FDV|Lack of Efficacy|12|||
162757595|NCT01728324|587824088|FG002|Termination of FDV|Lack of Efficacy|8|||
162757596|NCT01728324|587824086|FG000|Termination of FDV|Withdrawal by Subject|9|||
162757597|NCT01728324|587824087|FG001|Termination of FDV|Withdrawal by Subject|6|||
162757598|NCT01728324|587824088|FG002|Termination of FDV|Withdrawal by Subject|2|||
162757599|NCT01728324|587824086|FG000|Termination of FDV|Other than stated|1|||
162757600|NCT01728324|587824087|FG001|Termination of FDV|Other than stated|3|||
162757601|NCT01728324|587824088|FG002|Termination of FDV|Other than stated|0|||
162757602|NCT01728324|587824086|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
162757603|NCT01728324|587824087|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
162757604|NCT01728324|587824088|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
162757605|NCT01728324|587824086|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
162757606|NCT01728324|587824087|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
162757607|NCT01728324|587824088|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
162757608|NCT01728324|587824086|FG000|Termination of RBV|Adverse Event|15|||
162757609|NCT01728324|587824087|FG001|Termination of RBV|Adverse Event|16|||
162757610|NCT01728324|587824088|FG002|Termination of RBV|Adverse Event|5|||
162757611|NCT01728324|587824086|FG000|Termination of RBV|Lack of Efficacy|14|||
162757612|NCT01728324|587824087|FG001|Termination of RBV|Lack of Efficacy|11|||
162757613|NCT01728324|587824088|FG002|Termination of RBV|Lack of Efficacy|7|||
162757614|NCT01728324|587824086|FG000|Termination of RBV|Withdrawal by Subject|9|||
162757615|NCT01728324|587824087|FG001|Termination of RBV|Withdrawal by Subject|5|||
162757616|NCT01728324|587824088|FG002|Termination of RBV|Withdrawal by Subject|2|||
162757617|NCT01728324|587824086|FG000|Termination of RBV|Other than stated|1|||
162757618|NCT01728324|587824087|FG001|Termination of RBV|Other than stated|3|||
162757619|NCT01728324|587824088|FG002|Termination of RBV|Other than stated|1|||
162757620|NCT01728324|587824086|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
162757621|NCT01728324|587824087|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
162757622|NCT01728324|587824088|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
162757623|NCT01728324|587824086|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
162757624|NCT01728324|587824087|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
162757625|NCT01728324|587824088|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
162757626|NCT01787032|587824091|FG000|Overall Study|Protocol Violation|0|||
162757627|NCT01787032|587824092|FG001|Overall Study|Protocol Violation|0|||
162757628|NCT01787032|587824093|FG002|Overall Study|Protocol Violation|0|||
162757629|NCT01787032|587824094|FG003|Overall Study|Protocol Violation|0|||
162757630|NCT01787032|587824095|FG004|Overall Study|Protocol Violation|1|||
162757631|NCT01787032|587824096|FG005|Overall Study|Protocol Violation|1|||
162757632|NCT02040870|587824097|FG000|Overall Study|Completed treatment phase|6|||
162757633|NCT02040870|587824097|FG000|Overall Study|Adverse Event|7|||
162757634|NCT02040870|587824097|FG000|Overall Study|Progressive disease|58|||
162757635|NCT02040870|587824097|FG000|Overall Study|Physician Decision|6|||
162757636|NCT02040870|587824097|FG000|Overall Study|Subject/guardian decision|10|||
162757637|NCT02040870|587824097|FG000|Overall Study|Lost to Follow-up|3|||
162757638|NCT02040870|587824097|FG000|Overall Study|Death|13|||
162757639|NCT00388726|587824100|FG000|Overall Study|Adverse Event|50|||
162757640|NCT00388726|587824101|FG001|Overall Study|Adverse Event|24|||
162757641|NCT00388726|587824100|FG000|Overall Study|Progressive Disease|336|||
162757642|NCT00388726|587824101|FG001|Overall Study|Progressive Disease|153|||
162757643|NCT00388726|587824100|FG000|Overall Study|Clinical Progression|61|||
162757644|NCT00388726|587824101|FG001|Overall Study|Clinical Progression|36|||
162757645|NCT00388726|587824100|FG000|Overall Study|Withdrawal by Subject|10|||
162757646|NCT00388726|587824101|FG001|Overall Study|Withdrawal by Subject|7|||
162757647|NCT00388726|587824100|FG000|Overall Study|Administrative|6|||
162757648|NCT00388726|587824101|FG001|Overall Study|Administrative|9|||
162757649|NCT00388726|587824100|FG000|Overall Study|Physician Decision|18|||
162757650|NCT00388726|587824101|FG001|Overall Study|Physician Decision|13|||
162757651|NCT00388726|587824100|FG000|Overall Study|Death|3|||
162757652|NCT00388726|587824101|FG001|Overall Study|Death|2|||
162757653|NCT02406092|587824107|FG000|Overall Study|Screen failure|10|||
162757654|NCT02406092|587824108|FG001|Overall Study|Screen failure|7|||
162757655|NCT02406092|587824107|FG000|Overall Study|Death|22|||
162757656|NCT02406092|587824108|FG001|Overall Study|Death|5|||
162757657|NCT02406092|587824107|FG000|Overall Study|Lost to Follow-up|4|||
162757658|NCT02406092|587824108|FG001|Overall Study|Lost to Follow-up|1|||
162757659|NCT02406092|587824107|FG000|Overall Study|Adverse Event|1|||
162757660|NCT02406092|587824108|FG001|Overall Study|Adverse Event|0|||
162757661|NCT02406092|587824107|FG000|Overall Study|Withdrawal by Subject|1|||
162757662|NCT02406092|587824108|FG001|Overall Study|Withdrawal by Subject|0|||
162757663|NCT00641537|587824109|FG000|96-week Period|Adverse Event|0|||
162757664|NCT00641537|587824110|FG001|96-week Period|Adverse Event|1|||
162757665|NCT00641537|587824111|FG002|96-week Period|Adverse Event|3|||
162757666|NCT00641537|587824112|FG003|96-week Period|Adverse Event|0|||
162757667|NCT00641537|587824113|FG004|96-week Period|Adverse Event|2|||
162757668|NCT00641537|587824114|FG005|96-week Period|Adverse Event|0|||
162757669|NCT00641537|587824115|FG006|96-week Period|Adverse Event|0|||
162757670|NCT00641537|587824116|FG007|96-week Period|Adverse Event|0|||
162757671|NCT00641537|587824109|FG000|96-week Period|Lost to Follow-up|3|||
162757672|NCT00641537|587824110|FG001|96-week Period|Lost to Follow-up|1|||
162757673|NCT00641537|587824111|FG002|96-week Period|Lost to Follow-up|2|||
162757674|NCT00641537|587824112|FG003|96-week Period|Lost to Follow-up|2|||
162757675|NCT00641537|587824113|FG004|96-week Period|Lost to Follow-up|4|||
162757676|NCT00641537|587824114|FG005|96-week Period|Lost to Follow-up|0|||
162757677|NCT00641537|587824115|FG006|96-week Period|Lost to Follow-up|1|||
162757678|NCT00641537|587824116|FG007|96-week Period|Lost to Follow-up|0|||
162757679|NCT00641537|587824109|FG000|96-week Period|Protocol Violation|0|||
162757680|NCT00641537|587824110|FG001|96-week Period|Protocol Violation|1|||
162757681|NCT00641537|587824111|FG002|96-week Period|Protocol Violation|0|||
162757682|NCT00641537|587824112|FG003|96-week Period|Protocol Violation|1|||
162757683|NCT00641537|587824113|FG004|96-week Period|Protocol Violation|0|||
162757684|NCT00641537|587824114|FG005|96-week Period|Protocol Violation|1|||
162757685|NCT00641537|587824115|FG006|96-week Period|Protocol Violation|0|||
162757686|NCT00641537|587824116|FG007|96-week Period|Protocol Violation|0|||
162757687|NCT00641537|587824109|FG000|96-week Period|Death|2|||
162757688|NCT00641537|587824110|FG001|96-week Period|Death|0|||
162757689|NCT00641537|587824111|FG002|96-week Period|Death|1|||
162757690|NCT00641537|587824112|FG003|96-week Period|Death|0|||
162757691|NCT00641537|587824113|FG004|96-week Period|Death|0|||
162757692|NCT00641537|587824114|FG005|96-week Period|Death|0|||
162757693|NCT00641537|587824115|FG006|96-week Period|Death|0|||
162757694|NCT00641537|587824116|FG007|96-week Period|Death|0|||
162757695|NCT00641537|587824109|FG000|96-week Period|Other|4|||
162757696|NCT00641537|587824110|FG001|96-week Period|Other|7|||
162757697|NCT00641537|587824111|FG002|96-week Period|Other|14|||
162757698|NCT00641537|587824112|FG003|96-week Period|Other|9|||
162757699|NCT00641537|587824113|FG004|96-week Period|Other|11|||
162757700|NCT00641537|587824114|FG005|96-week Period|Other|6|||
162757701|NCT00641537|587824115|FG006|96-week Period|Other|4|||
162757702|NCT00641537|587824116|FG007|96-week Period|Other|6|||
162757703|NCT00641537|587824109|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162757704|NCT00641537|587824110|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162757705|NCT00641537|587824111|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162757706|NCT00641537|587824112|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
162757707|NCT00641537|587824113|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
162757708|NCT00641537|587824114|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162757709|NCT00641537|587824115|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162757710|NCT00641537|587824116|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162757711|NCT00641537|587824109|FG000|24-Week Supplemental Follow-up Period|Other|0|||
162757712|NCT00641537|587824110|FG001|24-Week Supplemental Follow-up Period|Other|2|||
162757713|NCT00641537|587824111|FG002|24-Week Supplemental Follow-up Period|Other|2|||
162757714|NCT00641537|587824112|FG003|24-Week Supplemental Follow-up Period|Other|1|||
162757715|NCT00641537|587824113|FG004|24-Week Supplemental Follow-up Period|Other|3|||
162757716|NCT00641537|587824114|FG005|24-Week Supplemental Follow-up Period|Other|0|||
162757717|NCT00641537|587824115|FG006|24-Week Supplemental Follow-up Period|Other|1|||
162757718|NCT00641537|587824116|FG007|24-Week Supplemental Follow-up Period|Other|1|||
162757719|NCT03229408|587824117|FG000|Overall Study|Withdrawal by Subject|4|||
162757720|NCT03229408|587824118|FG001|Overall Study|Withdrawal by Subject|1|||
162757721|NCT03229408|587824117|FG000|Overall Study|Adverse Event|2|||
162757722|NCT03229408|587824118|FG001|Overall Study|Adverse Event|0|||
162757723|NCT03229408|587824117|FG000|Overall Study|Pregnancy|0|||
162757724|NCT03229408|587824118|FG001|Overall Study|Pregnancy|1|||
162757725|NCT03229408|587824117|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
162757726|NCT03229408|587824118|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
162757727|NCT03745313|587824123|FG000|At 30 Days Follow-up|Death|2|||
162757728|NCT03745313|587824123|FG000|At 6 Months Follow-up|Death|1|||
162757729|NCT03745313|587824123|FG000|At 6 Months Follow-up|Missed Visit|1|||
162757730|NCT03745313|587824123|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
162757731|NCT03745313|587824123|FG000|At 1 Year Follow-up|Death|2|||
162757732|NCT03745313|587824123|FG000|At 1 Year Follow-up|Missed Visit|2|||
162757733|NCT03745313|587824123|FG000|At 2 Year Follow-up|Missed Visit|1|||
162757734|NCT01706159|587824124|FG000|Overall Study|Withdrawal Criteria|2|||
162757735|NCT01706159|587824125|FG001|Overall Study|Withdrawal Criteria|1|||
162757736|NCT01706159|587824124|FG000|Overall Study|Unclassified|6|||
162757737|NCT01706159|587824125|FG001|Overall Study|Unclassified|1|||
162757738|NCT02235298|587824126|FG000|Overall Study|Lost to Follow-up|6|||
162925391|NCT05302414|588428961|FG000|Pretest to Posttest|Lost to Follow-up|12|||
162757739|NCT02235298|587824127|FG001|Overall Study|Lost to Follow-up|5|||
162757740|NCT02235298|587824126|FG000|Overall Study|Adverse Event|2|||
162757741|NCT02235298|587824127|FG001|Overall Study|Adverse Event|2|||
162757742|NCT02235298|587824126|FG000|Overall Study|Withdrawal by Subject|0|||
162757743|NCT02235298|587824127|FG001|Overall Study|Withdrawal by Subject|1|||
162757744|NCT05525572|587824129|FG000|Overall Study|Lost to Follow-up|2|||
162757745|NCT00489307|587824136|FG000|Overall Study|Death|1|||
162757746|NCT00489307|587824137|FG001|Overall Study|Death|1|||
162757747|NCT00489307|587824136|FG000|Overall Study|Lost to Follow-up|2|||
162757748|NCT00489307|587824137|FG001|Overall Study|Lost to Follow-up|2|||
162757749|NCT00489307|587824136|FG000|Overall Study|Physician Decision|1|||
162757750|NCT00489307|587824137|FG001|Overall Study|Physician Decision|0|||
162757751|NCT00489307|587824136|FG000|Overall Study|Withdrawal by Subject|2|||
162757752|NCT00489307|587824137|FG001|Overall Study|Withdrawal by Subject|4|||
162757753|NCT00489307|587824136|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
162757754|NCT00489307|587824137|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
162757755|NCT00489307|587824136|FG000|Overall Study|Surgery after assignment|1|||
162757756|NCT00489307|587824137|FG001|Overall Study|Surgery after assignment|0|||
162757757|NCT00489307|587824136|FG000|Overall Study|Did not fill up the forms|2|||
162757758|NCT00489307|587824137|FG001|Overall Study|Did not fill up the forms|1|||
162757759|NCT00489307|587824136|FG000|Overall Study|Patient or family refusal|5|||
162757760|NCT00489307|587824137|FG001|Overall Study|Patient or family refusal|9|||
162757761|NCT02517268|587824140|FG000|Overall Study|Withdrawal by Subject|1|||
162757762|NCT02517268|587824141|FG001|Overall Study|Withdrawal by Subject|0|||
162757763|NCT02401815|587824142|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757764|NCT02401815|587824143|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757765|NCT02401815|587824144|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757766|NCT02401815|587824145|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
162757767|NCT02401815|587824146|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757768|NCT02401815|587824147|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757769|NCT02401815|587824148|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757770|NCT02401815|587824149|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757771|NCT02401815|587824150|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757772|NCT02401815|587824151|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162757773|NCT02401815|587824142|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
162757774|NCT02401815|587824143|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757775|NCT02401815|587824144|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757776|NCT02401815|587824145|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
162757777|NCT02401815|587824146|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757778|NCT02401815|587824147|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757779|NCT02401815|587824148|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757780|NCT02401815|587824149|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757781|NCT02401815|587824150|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757782|NCT02401815|587824151|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162757783|NCT02401815|587824142|FG000|Dose Escalation (up to 670 Days)|Death|1|||
162757784|NCT02401815|587824143|FG001|Dose Escalation (up to 670 Days)|Death|2|||
162757785|NCT02401815|587824144|FG002|Dose Escalation (up to 670 Days)|Death|3|||
162757786|NCT02401815|587824145|FG003|Dose Escalation (up to 670 Days)|Death|5|||
162757787|NCT02401815|587824146|FG004|Dose Escalation (up to 670 Days)|Death|4|||
162757788|NCT02401815|587824147|FG005|Dose Escalation (up to 670 Days)|Death|0|||
162757789|NCT02401815|587824148|FG006|Dose Escalation (up to 670 Days)|Death|0|||
162757790|NCT02401815|587824149|FG007|Dose Escalation (up to 670 Days)|Death|0|||
162757791|NCT02401815|587824150|FG008|Dose Escalation (up to 670 Days)|Death|0|||
162757792|NCT02401815|587824151|FG009|Dose Escalation (up to 670 Days)|Death|0|||
162757793|NCT02401815|587824142|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757794|NCT02401815|587824143|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
162757795|NCT02401815|587824144|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757796|NCT02401815|587824145|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757797|NCT02401815|587824146|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
162757798|NCT02401815|587824147|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757799|NCT02401815|587824148|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757800|NCT02401815|587824149|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757801|NCT02401815|587824150|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757802|NCT02401815|587824151|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162757803|NCT02401815|587824142|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
162757804|NCT02401815|587824143|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757805|NCT02401815|587824144|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757806|NCT02401815|587824145|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757807|NCT02401815|587824146|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
162757808|NCT02401815|587824147|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757809|NCT02401815|587824148|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757810|NCT02401815|587824149|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757811|NCT02401815|587824150|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757812|NCT02401815|587824151|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162757813|NCT02401815|587824142|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757814|NCT02401815|587824143|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757815|NCT02401815|587824144|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757816|NCT02401815|587824145|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757817|NCT02401815|587824146|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757818|NCT02401815|587824147|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
162757819|NCT02401815|587824148|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757820|NCT02401815|587824149|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757821|NCT02401815|587824150|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757822|NCT02401815|587824151|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162757823|NCT02401815|587824142|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757824|NCT02401815|587824143|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757825|NCT02401815|587824144|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757826|NCT02401815|587824145|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757827|NCT02401815|587824146|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757828|NCT02401815|587824147|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757829|NCT02401815|587824148|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
162757830|NCT02401815|587824149|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757831|NCT02401815|587824150|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757832|NCT02401815|587824151|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757833|NCT02401815|587824142|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757834|NCT02401815|587824143|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757835|NCT02401815|587824144|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757836|NCT02401815|587824145|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757837|NCT02401815|587824146|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757838|NCT02401815|587824147|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
162757839|NCT02401815|587824148|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
162757840|NCT02401815|587824149|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757841|NCT02401815|587824150|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757842|NCT02401815|587824151|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162757843|NCT02401815|587824142|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757844|NCT02401815|587824143|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757845|NCT02401815|587824144|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757846|NCT02401815|587824145|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757847|NCT02401815|587824146|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757848|NCT02401815|587824147|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
162757849|NCT02401815|587824148|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757850|NCT02401815|587824149|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757851|NCT02401815|587824150|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757852|NCT02401815|587824151|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162757853|NCT02401815|587824142|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757854|NCT02401815|587824143|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757855|NCT02401815|587824144|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757856|NCT02401815|587824145|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757857|NCT02401815|587824146|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757858|NCT02401815|587824147|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757859|NCT02401815|587824148|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162757860|NCT02401815|587824149|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
162757861|NCT02401815|587824150|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
162757862|NCT02401815|587824151|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
162757863|NCT02401815|587824142|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757864|NCT02401815|587824143|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757865|NCT02401815|587824144|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757866|NCT02401815|587824145|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757867|NCT02401815|587824146|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757868|NCT02401815|587824147|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757869|NCT02401815|587824148|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757870|NCT02401815|587824149|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162757871|NCT02401815|587824150|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
162757872|NCT02401815|587824151|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
162757873|NCT02401815|587824142|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757874|NCT02401815|587824143|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757875|NCT02401815|587824144|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757876|NCT02401815|587824145|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757877|NCT02401815|587824146|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757878|NCT02401815|587824147|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757879|NCT02401815|587824148|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757880|NCT02401815|587824149|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757881|NCT02401815|587824150|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162757882|NCT02401815|587824151|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
162757883|NCT02401815|587824142|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757884|NCT02401815|587824143|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757885|NCT02401815|587824144|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757886|NCT02401815|587824145|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757887|NCT02401815|587824146|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757888|NCT02401815|587824147|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757889|NCT02401815|587824148|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757890|NCT02401815|587824149|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757891|NCT02401815|587824150|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
162757892|NCT02401815|587824151|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162757893|NCT02401815|587824142|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757894|NCT02401815|587824143|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757895|NCT02401815|587824144|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757896|NCT02401815|587824145|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757897|NCT02401815|587824146|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757898|NCT02401815|587824147|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757899|NCT02401815|587824148|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757900|NCT02401815|587824149|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
162757901|NCT02401815|587824150|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162757902|NCT02401815|587824151|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
162757903|NCT05613907|587824152|FG000|Overall Study|Lost to Follow-up|5|||
162757904|NCT05613907|587824152|FG000|Overall Study|Death|3|||
162757905|NCT05613907|587824152|FG000|Overall Study|Withdrawal by Subject|2|||
162757906|NCT00748709|587824162|FG000|Overall Study|Progressive disease|15|||
162757907|NCT00748709|587824162|FG000|Overall Study|Drug reducing Toxity|2|||
162757908|NCT00748709|587824162|FG000|Overall Study|Other Adverse Event|1|||
162757909|NCT00748709|587824162|FG000|Overall Study|Withdrawal by Subject|1|||
162757910|NCT00748709|587824162|FG000|Overall Study|Other Reasons|1|||
162757911|NCT03789656|587824163|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
162757912|NCT03789656|587824164|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162757913|NCT03789656|587824165|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162757914|NCT03789656|587824166|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
162757915|NCT03789656|587824167|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162757916|NCT03789656|587824163|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162757917|NCT03789656|587824164|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162757918|NCT03789656|587824165|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
162757919|NCT03789656|587824166|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162757920|NCT03789656|587824167|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162757921|NCT03789656|587824163|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
162757922|NCT03789656|587824164|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162757923|NCT03789656|587824165|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162757924|NCT03789656|587824166|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162757925|NCT03789656|587824167|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162757926|NCT03789656|587824163|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
162757927|NCT03789656|587824164|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162757928|NCT03789656|587824165|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162757929|NCT03789656|587824166|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162757930|NCT03789656|587824167|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162757931|NCT04484623|587824175|FG000|Overall Study|Lost to Follow-up|0|||
162757932|NCT04484623|587824176|FG001|Overall Study|Lost to Follow-up|1|||
162757933|NCT04484623|587824175|FG000|Overall Study|Protocol Deviation|1|||
162757934|NCT04484623|587824176|FG001|Overall Study|Protocol Deviation|0|||
162757935|NCT04484623|587824175|FG000|Overall Study|Physician Decision|1|||
162757936|NCT04484623|587824176|FG001|Overall Study|Physician Decision|0|||
162757937|NCT04484623|587824175|FG000|Overall Study|Withdrawal by Subject|11|||
162757938|NCT04484623|587824176|FG001|Overall Study|Withdrawal by Subject|8|||
162757939|NCT04484623|587824175|FG000|Overall Study|Ongoing|94|||
162757940|NCT04484623|587824176|FG001|Overall Study|Ongoing|84|||
162757941|NCT05470114|587824177|FG000|Overall Study|Withdrawal by Subject|1|||
162757942|NCT05470114|587824178|FG001|Overall Study|Withdrawal by Subject|0|||
162757943|NCT05470114|587824177|FG000|Overall Study|Lost to Follow-up|1|||
162757944|NCT05470114|587824178|FG001|Overall Study|Lost to Follow-up|0|||
162757945|NCT05325294|587824183|FG000|Overall Study|Adverse Event|3|||
162757946|NCT05325294|587824184|FG001|Overall Study|Adverse Event|3|||
162757947|NCT05325294|587824183|FG000|Overall Study|Physician Decision|0|||
162757948|NCT05325294|587824184|FG001|Overall Study|Physician Decision|1|||
162757949|NCT05325294|587824183|FG000|Overall Study|Withdrawal by Subject|0|||
162757950|NCT05325294|587824184|FG001|Overall Study|Withdrawal by Subject|3|||
162757951|NCT05325294|587824183|FG000|Overall Study|Lost to Follow-up|1|||
162757952|NCT05325294|587824184|FG001|Overall Study|Lost to Follow-up|0|||
162757953|NCT05325294|587824183|FG000|Overall Study|Sponsor Request|0|||
162757954|NCT05325294|587824184|FG001|Overall Study|Sponsor Request|2|||
162757955|NCT04649047|587824185|FG000|Overall Study|Withdrawal by Subject|3|||
162757956|NCT02488408|587824186|FG000|Part A|Adverse Event|2|||
162757957|NCT02488408|587824187|FG001|Part A|Adverse Event|0|||
162757958|NCT02488408|587824188|FG002|Part A|Adverse Event|0|||
162757959|NCT02488408|587824189|FG003|Part A|Adverse Event|0|||
162757960|NCT02488408|587824190|FG004|Part A|Adverse Event|0|||
162757961|NCT02488408|587824191|FG005|Part A|Adverse Event|0|||
162757962|NCT02488408|587824192|FG006|Part A|Adverse Event|0|||
162757963|NCT02488408|587824193|FG007|Part A|Adverse Event|0|||
162757964|NCT02488408|587824194|FG008|Part A|Adverse Event|0|||
162757965|NCT02488408|587824195|FG009|Part A|Adverse Event|0|||
162757966|NCT02488408|587824186|FG000|Part A|Death|1|||
162757967|NCT02488408|587824187|FG001|Part A|Death|5|||
162757968|NCT02488408|587824188|FG002|Part A|Death|0|||
162757969|NCT02488408|587824189|FG003|Part A|Death|0|||
162757970|NCT02488408|587824190|FG004|Part A|Death|3|||
162757971|NCT02488408|587824191|FG005|Part A|Death|0|||
162757972|NCT02488408|587824192|FG006|Part A|Death|0|||
162757973|NCT02488408|587824193|FG007|Part A|Death|0|||
162757974|NCT02488408|587824194|FG008|Part A|Death|0|||
162757975|NCT02488408|587824195|FG009|Part A|Death|0|||
162757976|NCT02488408|587824186|FG000|Part A|Disease Progression|2|||
162757977|NCT02488408|587824187|FG001|Part A|Disease Progression|8|||
162757978|NCT02488408|587824188|FG002|Part A|Disease Progression|2|||
162757979|NCT02488408|587824189|FG003|Part A|Disease Progression|3|||
162757980|NCT02488408|587824190|FG004|Part A|Disease Progression|4|||
162757981|NCT02488408|587824191|FG005|Part A|Disease Progression|0|||
162757982|NCT02488408|587824192|FG006|Part A|Disease Progression|0|||
162757983|NCT02488408|587824193|FG007|Part A|Disease Progression|0|||
162757984|NCT02488408|587824194|FG008|Part A|Disease Progression|0|||
162757985|NCT02488408|587824195|FG009|Part A|Disease Progression|0|||
162757986|NCT02488408|587824186|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
162757987|NCT02488408|587824187|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
162757988|NCT02488408|587824188|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
162757989|NCT02488408|587824189|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
162757990|NCT02488408|587824190|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
162757991|NCT02488408|587824191|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
162757992|NCT02488408|587824192|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
162757993|NCT02488408|587824193|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
162757994|NCT02488408|587824194|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
162757995|NCT02488408|587824195|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
162757996|NCT02488408|587824186|FG000|Part A|Investigator Decision|0|||
162757997|NCT02488408|587824187|FG001|Part A|Investigator Decision|1|||
162757998|NCT02488408|587824188|FG002|Part A|Investigator Decision|1|||
162757999|NCT02488408|587824189|FG003|Part A|Investigator Decision|0|||
162758000|NCT02488408|587824190|FG004|Part A|Investigator Decision|0|||
162758001|NCT02488408|587824191|FG005|Part A|Investigator Decision|0|||
162758002|NCT02488408|587824192|FG006|Part A|Investigator Decision|0|||
162758003|NCT02488408|587824193|FG007|Part A|Investigator Decision|0|||
162758004|NCT02488408|587824194|FG008|Part A|Investigator Decision|0|||
162758005|NCT02488408|587824195|FG009|Part A|Investigator Decision|0|||
162758006|NCT02488408|587824186|FG000|Part A|Withdrawal by Subject|0|||
162758007|NCT02488408|587824187|FG001|Part A|Withdrawal by Subject|0|||
162758008|NCT02488408|587824188|FG002|Part A|Withdrawal by Subject|2|||
162758009|NCT02488408|587824189|FG003|Part A|Withdrawal by Subject|0|||
162758010|NCT02488408|587824190|FG004|Part A|Withdrawal by Subject|0|||
162758011|NCT02488408|587824191|FG005|Part A|Withdrawal by Subject|0|||
162758012|NCT02488408|587824192|FG006|Part A|Withdrawal by Subject|0|||
162758013|NCT02488408|587824193|FG007|Part A|Withdrawal by Subject|0|||
162758014|NCT02488408|587824194|FG008|Part A|Withdrawal by Subject|0|||
162758015|NCT02488408|587824195|FG009|Part A|Withdrawal by Subject|0|||
162758016|NCT02488408|587824186|FG000|Part A|Other|1|||
162758017|NCT02488408|587824187|FG001|Part A|Other|0|||
162758018|NCT02488408|587824188|FG002|Part A|Other|0|||
162758019|NCT02488408|587824189|FG003|Part A|Other|0|||
162758020|NCT02488408|587824190|FG004|Part A|Other|0|||
162758021|NCT02488408|587824191|FG005|Part A|Other|0|||
162758022|NCT02488408|587824192|FG006|Part A|Other|0|||
162758023|NCT02488408|587824193|FG007|Part A|Other|0|||
162758024|NCT02488408|587824194|FG008|Part A|Other|0|||
162758025|NCT02488408|587824195|FG009|Part A|Other|0|||
162758026|NCT02488408|587824186|FG000|Part B|Adverse Event|0|||
162758027|NCT02488408|587824187|FG001|Part B|Adverse Event|0|||
162758028|NCT02488408|587824188|FG002|Part B|Adverse Event|0|||
162758029|NCT02488408|587824189|FG003|Part B|Adverse Event|0|||
162758030|NCT02488408|587824190|FG004|Part B|Adverse Event|0|||
162758031|NCT02488408|587824191|FG005|Part B|Adverse Event|2|||
162758032|NCT02488408|587824192|FG006|Part B|Adverse Event|2|||
162758033|NCT02488408|587824193|FG007|Part B|Adverse Event|7|||
162758034|NCT02488408|587824194|FG008|Part B|Adverse Event|2|||
162758035|NCT02488408|587824195|FG009|Part B|Adverse Event|2|||
162758036|NCT02488408|587824186|FG000|Part B|Death|0|||
162758037|NCT02488408|587824187|FG001|Part B|Death|0|||
162758038|NCT02488408|587824188|FG002|Part B|Death|0|||
162758039|NCT02488408|587824189|FG003|Part B|Death|0|||
162758040|NCT02488408|587824190|FG004|Part B|Death|0|||
162758041|NCT02488408|587824191|FG005|Part B|Death|3|||
162758042|NCT02488408|587824192|FG006|Part B|Death|1|||
162758043|NCT02488408|587824193|FG007|Part B|Death|2|||
162758044|NCT02488408|587824194|FG008|Part B|Death|2|||
162758045|NCT02488408|587824195|FG009|Part B|Death|2|||
162758046|NCT02488408|587824186|FG000|Part B|Death due to Disease Progression|0|||
162758047|NCT02488408|587824187|FG001|Part B|Death due to Disease Progression|0|||
162758048|NCT02488408|587824188|FG002|Part B|Death due to Disease Progression|0|||
162758049|NCT02488408|587824189|FG003|Part B|Death due to Disease Progression|0|||
162758050|NCT02488408|587824190|FG004|Part B|Death due to Disease Progression|0|||
162758051|NCT02488408|587824191|FG005|Part B|Death due to Disease Progression|2|||
162758052|NCT02488408|587824192|FG006|Part B|Death due to Disease Progression|2|||
162758053|NCT02488408|587824193|FG007|Part B|Death due to Disease Progression|1|||
162758054|NCT02488408|587824194|FG008|Part B|Death due to Disease Progression|1|||
162758055|NCT02488408|587824195|FG009|Part B|Death due to Disease Progression|1|||
162758056|NCT02488408|587824186|FG000|Part B|Disease Progression|0|||
162758057|NCT02488408|587824187|FG001|Part B|Disease Progression|0|||
162758058|NCT02488408|587824188|FG002|Part B|Disease Progression|0|||
162758059|NCT02488408|587824189|FG003|Part B|Disease Progression|0|||
162758060|NCT02488408|587824190|FG004|Part B|Disease Progression|0|||
162758061|NCT02488408|587824191|FG005|Part B|Disease Progression|6|||
162758062|NCT02488408|587824192|FG006|Part B|Disease Progression|9|||
162758063|NCT02488408|587824193|FG007|Part B|Disease Progression|7|||
162758064|NCT02488408|587824194|FG008|Part B|Disease Progression|9|||
162758065|NCT02488408|587824195|FG009|Part B|Disease Progression|11|||
162758066|NCT02488408|587824186|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
162758067|NCT02488408|587824187|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
162758068|NCT02488408|587824188|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
162758069|NCT02488408|587824189|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
162758070|NCT02488408|587824190|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
162758071|NCT02488408|587824191|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
162758072|NCT02488408|587824192|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
162758073|NCT02488408|587824193|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
162758074|NCT02488408|587824194|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
162758075|NCT02488408|587824195|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
162758076|NCT02488408|587824186|FG000|Part B|Investigator Decision|0|||
162758077|NCT02488408|587824187|FG001|Part B|Investigator Decision|0|||
162758078|NCT02488408|587824188|FG002|Part B|Investigator Decision|0|||
162758079|NCT02488408|587824189|FG003|Part B|Investigator Decision|0|||
162758080|NCT02488408|587824190|FG004|Part B|Investigator Decision|0|||
162758081|NCT02488408|587824191|FG005|Part B|Investigator Decision|0|||
162758082|NCT02488408|587824192|FG006|Part B|Investigator Decision|1|||
162758083|NCT02488408|587824193|FG007|Part B|Investigator Decision|0|||
162758084|NCT02488408|587824194|FG008|Part B|Investigator Decision|2|||
162758085|NCT02488408|587824195|FG009|Part B|Investigator Decision|1|||
162758086|NCT00719888|587824196|FG000|Overall Study|Death|24|||
162758087|NCT00719888|587824197|FG001|Overall Study|Death|9|||
162758088|NCT00719888|587824196|FG000|Overall Study|Relapse|8|||
162758089|NCT00719888|587824197|FG001|Overall Study|Relapse|3|||
162758090|NCT00719888|587824196|FG000|Overall Study|Physician Decision|1|||
162758091|NCT00719888|587824197|FG001|Overall Study|Physician Decision|0|||
162758092|NCT00719888|587824196|FG000|Overall Study|Withdrawal by Subject|1|||
162758093|NCT00719888|587824197|FG001|Overall Study|Withdrawal by Subject|0|||
162758094|NCT00491894|587824198|FG000|Overall Study|Adverse Event|14|||
162758095|NCT00491894|587824198|FG000|Overall Study|Withdrawal by Subject|5|||
162758096|NCT00491894|587824198|FG000|Overall Study|Death|3|||
162758097|NCT00491894|587824198|FG000|Overall Study|Lost to Follow-up|3|||
162758098|NCT00491894|587824198|FG000|Overall Study|Lack of Efficacy|2|||
162758099|NCT00491894|587824198|FG000|Overall Study|Other-Failed to meet any criteria|2|||
162758100|NCT00491894|587824198|FG000|Overall Study|Physician Decision|2|||
162758101|NCT00491894|587824198|FG000|Overall Study|Protocol Violation|2|||
162758102|NCT00491894|587824198|FG000|Overall Study|Other-Intake of prohibited medication|1|||
162758103|NCT04172675|587825367|FG000|Overall Study|Withdrawal by Subject|7|||
162758104|NCT04172675|587825368|FG001|Overall Study|Withdrawal by Subject|5|||
162758105|NCT04172675|587825369|FG002|Overall Study|Withdrawal by Subject|1|||
162758106|NCT04172675|587825370|FG003|Overall Study|Withdrawal by Subject|4|||
162758107|NCT00378898|587825371|FG000|Overall Study|Withdrawal by Subject|10|||
162758108|NCT00378898|587825372|FG001|Overall Study|Withdrawal by Subject|5|||
162758109|NCT00378898|587825371|FG000|Overall Study|Protocol Violation|1|||
162758110|NCT00378898|587825372|FG001|Overall Study|Protocol Violation|1|||
162758111|NCT00551421|587825373|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
162758112|NCT01278030|587825374|FG000|Overall Study|Withdrawal by Subject|8|||
162758113|NCT01278030|587825375|FG001|Overall Study|Withdrawal by Subject|4|||
162758114|NCT05815342|587825380|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
162758115|NCT05815342|587825380|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
162758116|NCT05815342|587825380|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
162758117|NCT05815342|587825380|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
162758118|NCT05815342|587825380|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
162758119|NCT01555138|587825381|FG000|Overall Study|Death|0|||
162758120|NCT01555138|587825382|FG001|Overall Study|Death|1|||
162758121|NCT01555138|587825381|FG000|Overall Study|Lost to Follow-up|1|||
162758122|NCT01555138|587825382|FG001|Overall Study|Lost to Follow-up|0|||
162758123|NCT01555138|587825381|FG000|Overall Study|Abnormal Lab reults|1|||
162758124|NCT01555138|587825382|FG001|Overall Study|Abnormal Lab reults|3|||
162758125|NCT01555138|587825381|FG000|Overall Study|Lack of Efficacy|2|||
162758126|NCT01555138|587825382|FG001|Overall Study|Lack of Efficacy|2|||
162758127|NCT01555138|587825381|FG000|Overall Study|Protocol Violation|5|||
162758128|NCT01555138|587825382|FG001|Overall Study|Protocol Violation|3|||
162758129|NCT01555138|587825381|FG000|Overall Study|Administrative problems|8|||
162758130|NCT01555138|587825382|FG001|Overall Study|Administrative problems|0|||
162758131|NCT01555138|587825381|FG000|Overall Study|Withdrawal by Subject|16|||
162758132|NCT01555138|587825382|FG001|Overall Study|Withdrawal by Subject|15|||
162758133|NCT01555138|587825381|FG000|Overall Study|Adverse Event|14|||
162758134|NCT01555138|587825382|FG001|Overall Study|Adverse Event|14|||
162758135|NCT03220724|587825386|FG000|Overall Study|Lost to Follow-up|2|||
162758136|NCT03220724|587825387|FG001|Overall Study|Lost to Follow-up|2|||
162758137|NCT03220724|587825388|FG002|Overall Study|Lost to Follow-up|0|||
162758138|NCT03220724|587825389|FG003|Overall Study|Lost to Follow-up|3|||
162758139|NCT03220724|587825390|FG004|Overall Study|Lost to Follow-up|1|||
162758140|NCT03220724|587825391|FG005|Overall Study|Lost to Follow-up|0|||
162758141|NCT03220724|587825392|FG006|Overall Study|Lost to Follow-up|2|||
162758142|NCT03220724|587825393|FG007|Overall Study|Lost to Follow-up|1|||
162758143|NCT03220724|587825394|FG008|Overall Study|Lost to Follow-up|0|||
162758144|NCT03220724|587825386|FG000|Overall Study|Withdrawal by Subject|1|||
162758145|NCT03220724|587825387|FG001|Overall Study|Withdrawal by Subject|0|||
162758146|NCT03220724|587825388|FG002|Overall Study|Withdrawal by Subject|1|||
162758147|NCT03220724|587825389|FG003|Overall Study|Withdrawal by Subject|0|||
162758148|NCT03220724|587825390|FG004|Overall Study|Withdrawal by Subject|0|||
162758149|NCT03220724|587825391|FG005|Overall Study|Withdrawal by Subject|0|||
162758150|NCT03220724|587825392|FG006|Overall Study|Withdrawal by Subject|0|||
162758151|NCT03220724|587825393|FG007|Overall Study|Withdrawal by Subject|0|||
162758152|NCT03220724|587825394|FG008|Overall Study|Withdrawal by Subject|0|||
162758153|NCT01613417|587825395|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
162758154|NCT01613417|587825396|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
162758155|NCT02000752|587825399|FG000|Overall Study|Dystocic delivery|19|||
162758156|NCT02000752|587825400|FG001|Overall Study|Dystocic delivery|8|||
162758157|NCT02000752|587825399|FG000|Overall Study|Shift Changes|12|||
162758158|NCT02000752|587825400|FG001|Overall Study|Shift Changes|5|||
162758159|NCT00512252|587825402|FG000|Overall Study|Lost to Follow-up|0|||
162758160|NCT00512252|587825403|FG001|Overall Study|Lost to Follow-up|0|||
162758161|NCT00512252|587825404|FG002|Overall Study|Lost to Follow-up|1|||
162758162|NCT00512252|587825402|FG000|Overall Study|Protocol Violation|0|||
162758163|NCT00512252|587825403|FG001|Overall Study|Protocol Violation|0|||
162758164|NCT00512252|587825404|FG002|Overall Study|Protocol Violation|1|||
162758165|NCT00512252|587825402|FG000|Overall Study|Death|0|||
162758166|NCT00512252|587825403|FG001|Overall Study|Death|0|||
162758167|NCT00512252|587825404|FG002|Overall Study|Death|1|||
162758168|NCT02357966|587825405|FG000|Overall Study|Death|0|||
162758169|NCT02357966|587825406|FG001|Overall Study|Death|0|||
162758170|NCT02357966|587825407|FG002|Overall Study|Death|1|||
162758171|NCT02357966|587825408|FG003|Overall Study|Death|0|||
162758172|NCT02357966|587825409|FG004|Overall Study|Death|2|||
162758173|NCT02357966|587825410|FG005|Overall Study|Death|0|||
162758174|NCT02357966|587825405|FG000|Overall Study|Physician Decision|1|||
162758175|NCT02357966|587825406|FG001|Overall Study|Physician Decision|0|||
162758176|NCT02357966|587825407|FG002|Overall Study|Physician Decision|0|||
162758177|NCT02357966|587825408|FG003|Overall Study|Physician Decision|0|||
162758178|NCT02357966|587825409|FG004|Overall Study|Physician Decision|1|||
162758179|NCT02357966|587825410|FG005|Overall Study|Physician Decision|0|||
162758180|NCT00019604|587825411|FG000|Overall Study|Death|1|||
162758181|NCT00019604|587825411|FG000|Overall Study|Progressive disease|23|||
162758182|NCT00019604|587825411|FG000|Overall Study|Refused treatment|1|||
162758183|NCT00019604|587825411|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
162758184|NCT00019604|587825411|FG000|Overall Study|Going to have liver transplant|1|||
162758185|NCT00019604|587825411|FG000|Overall Study|Move to a different study|1|||
162758186|NCT00019604|587825411|FG000|Overall Study|Non compliant on systemic CH|1|||
162758187|NCT00019604|587825411|FG000|Overall Study|Non compliant|1|||
162758188|NCT00019604|587825411|FG000|Overall Study|Resectable disease|1|||
162758189|NCT00019604|587825411|FG000|Overall Study|Started new chemo regimen|1|||
162758190|NCT00019604|587825411|FG000|Overall Study|Pt going to immunotherapy study|1|||
162758191|NCT00019604|587825411|FG000|Overall Study|Too much disease|1|||
162758192|NCT00019604|587825411|FG000|Overall Study|Unable to evaluate|1|||
162758193|NCT00019604|587825411|FG000|Overall Study|Details for other not available|4|||
162758194|NCT04608409|587825415|FG000|Overall Study|Physician Decision|1|||
162758195|NCT04608409|587825416|FG001|Overall Study|Physician Decision|1|||
162758196|NCT04608409|587825417|FG002|Overall Study|Physician Decision|2|||
162758197|NCT03392194|587825419|FG000|Overall Study|Withdrawal by Subject|1|||
162758198|NCT03392194|587825420|FG001|Overall Study|Withdrawal by Subject|2|||
162758199|NCT03392194|587825419|FG000|Overall Study|Conflicts with personal schedule|1|||
162758200|NCT03392194|587825420|FG001|Overall Study|Conflicts with personal schedule|0|||
162758201|NCT00620854|587825423|FG000|Washout 1|Withdrawal by Subject|0|||
162758202|NCT00620854|587825424|FG001|Washout 1|Withdrawal by Subject|0|||
162758203|NCT00620854|587825425|FG002|Washout 1|Withdrawal by Subject|1|||
162758204|NCT00620854|587825426|FG003|Washout 1|Withdrawal by Subject|1|||
162758205|NCT00620854|587825427|FG004|Washout 1|Withdrawal by Subject|0|||
162758206|NCT00620854|587825428|FG005|Washout 1|Withdrawal by Subject|0|||
162758207|NCT00229658|587825442|FG000|Overall Study|Administrative|2|||
162758208|NCT00229658|587825443|FG001|Overall Study|Administrative|1|||
162758209|NCT00229658|587825442|FG000|Overall Study|Investigator decision|13|||
162758210|NCT00229658|587825443|FG001|Overall Study|Investigator decision|10|||
162758211|NCT00229658|587825442|FG000|Overall Study|Other|80|||
162758212|NCT00229658|587825443|FG001|Overall Study|Other|60|||
162758213|NCT00229658|587825442|FG000|Overall Study|Lost to Follow-up|82|||
162758214|NCT00229658|587825443|FG001|Overall Study|Lost to Follow-up|55|||
162758215|NCT00229658|587825442|FG000|Overall Study|Serious Adverse Event|2|||
162758216|NCT00229658|587825443|FG001|Overall Study|Serious Adverse Event|2|||
162758217|NCT00229658|587825442|FG000|Overall Study|Withdrawal of consent|46|||
162758218|NCT00229658|587825443|FG001|Overall Study|Withdrawal of consent|39|||
162758219|NCT00093496|587825444|FG000|Overall Study|Protocol Violation|1|||
162758220|NCT00093496|587825445|FG001|Overall Study|Protocol Violation|3|||
162758221|NCT01953224|587825446|FG000|Overall Study|Lost to Follow-up|1|||
162758222|NCT01953224|587825447|FG001|Overall Study|Lost to Follow-up|1|||
162758223|NCT01953224|587825446|FG000|Overall Study|Withdrawal by Subject|1|||
162758224|NCT01953224|587825447|FG001|Overall Study|Withdrawal by Subject|2|||
162758225|NCT00586313|587825448|FG000|Overall Study|Lack of Efficacy|2|||
162758226|NCT03205566|587825453|FG000|Phase 1|Protocol Violation|1|||
162758227|NCT03205566|587825454|FG001|Phase 1|Protocol Violation|1|||
162758228|NCT01700205|587825455|FG000|Overall Study|Withdrawal by Subject|13|||
162758229|NCT01700205|587825456|FG001|Overall Study|Withdrawal by Subject|13|||
162758230|NCT01700205|587825455|FG000|Overall Study|Protocol Violation|2|||
162758231|NCT01700205|587825456|FG001|Overall Study|Protocol Violation|2|||
162758232|NCT01170208|587825459|FG000|Overall Study|Withdrawal by Subject|5|||
162758233|NCT01170208|587825460|FG001|Overall Study|Withdrawal by Subject|0|||
162758234|NCT01170208|587825461|FG002|Overall Study|Withdrawal by Subject|1|||
162758235|NCT01170208|587825459|FG000|Overall Study|Protocol Violation|1|||
162758236|NCT01170208|587825460|FG001|Overall Study|Protocol Violation|0|||
162758237|NCT01170208|587825461|FG002|Overall Study|Protocol Violation|1|||
162758238|NCT03113409|587825462|FG000|Overall Study|Withdrawal by Subject|5|||
162758239|NCT03113409|587825463|FG001|Overall Study|Withdrawal by Subject|0|||
162758240|NCT03113409|587825464|FG002|Overall Study|Withdrawal by Subject|0|||
162758241|NCT03335488|587825465|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
162758242|NCT03335488|587825466|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
162758243|NCT03335488|587825465|FG000|Safety Extension Period|Adverse Event|1|||
162758244|NCT03335488|587825466|FG001|Safety Extension Period|Adverse Event|0|||
162758245|NCT03335488|587825465|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
162758246|NCT03335488|587825466|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
162758247|NCT04971733|587825467|FG000|Overall Study|Adverse Event|1|||
162758248|NCT04971733|587825468|FG001|Overall Study|Adverse Event|1|||
162758249|NCT04971733|587825467|FG000|Overall Study|Subject choice|2|||
162758250|NCT04971733|587825468|FG001|Overall Study|Subject choice|0|||
162758251|NCT04971733|587825467|FG000|Overall Study|Withdrawal by Subject|1|||
162758252|NCT04971733|587825468|FG001|Overall Study|Withdrawal by Subject|0|||
162758253|NCT04971733|587825467|FG000|Overall Study|Other|1|||
162758254|NCT04971733|587825468|FG001|Overall Study|Other|0|||
162758255|NCT01160354|587825469|FG000|Overall Study|Death|0|||
162758256|NCT01160354|587825470|FG001|Overall Study|Death|1|||
162758257|NCT01160354|587825471|FG002|Overall Study|Death|1|||
162758258|NCT00600353|587825475|FG000|Overall Study|history of malignancy within 5 years|1|||
162758259|NCT00600353|587825476|FG001|Overall Study|history of malignancy within 5 years|0|||
162758260|NCT00600353|587825475|FG000|Overall Study|History of prepartive regimen|0|||
162758261|NCT00600353|587825476|FG001|Overall Study|History of prepartive regimen|1|||
162758262|NCT04941482|587825477|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
162758263|NCT04941482|587825478|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
162758264|NCT02743819|587825479|FG000|Overall Study|Lack of Efficacy|5|||
162758265|NCT02743819|587825479|FG000|Overall Study|Death|2|||
162758266|NCT02743819|587825479|FG000|Overall Study|Adverse Event|1|||
162758267|NCT04200664|587825480|FG000|Overall Study|Withdrawal by Subject|1|||
162758268|NCT04200664|587825481|FG001|Overall Study|Withdrawal by Subject|0|||
162758269|NCT04200664|587825482|FG002|Overall Study|Withdrawal by Subject|0|||
162758270|NCT03362190|587825485|FG000|Overall Study|Adverse Event|0|||
162758271|NCT03362190|587825486|FG001|Overall Study|Adverse Event|0|||
162758272|NCT03362190|587825487|FG002|Overall Study|Adverse Event|0|||
162758273|NCT03362190|587825488|FG003|Overall Study|Adverse Event|1|||
162758274|NCT03362190|587825485|FG000|Overall Study|Withdrawal by Subject|0|||
162758275|NCT03362190|587825486|FG001|Overall Study|Withdrawal by Subject|0|||
162758276|NCT03362190|587825487|FG002|Overall Study|Withdrawal by Subject|0|||
162758277|NCT03362190|587825488|FG003|Overall Study|Withdrawal by Subject|1|||
162758278|NCT00687219|587825489|FG000|Overall Study|Adverse Event|8|||
162758279|NCT00687219|587825489|FG000|Overall Study|Discontinuance criteria met|7|||
162758280|NCT00687219|587825489|FG000|Overall Study|HCV-RNA positive conversion|34|||
162758281|NCT00687219|587825489|FG000|Overall Study|Withdrawal by Subject|1|||
162758282|NCT00687219|587825489|FG000|Overall Study|Lack of Efficacy|1|||
162758283|NCT03371017|587825490|FG000|Overall Study|Physician Decision|0|||
162758284|NCT03371017|587825491|FG001|Overall Study|Physician Decision|1|||
162758285|NCT03371017|587825490|FG000|Overall Study|Reason not Specified|0|||
162758286|NCT03371017|587825491|FG001|Overall Study|Reason not Specified|1|||
162758287|NCT03371017|587825490|FG000|Overall Study|Lost to Follow-up|13|||
162758288|NCT03371017|587825491|FG001|Overall Study|Lost to Follow-up|16|||
162758289|NCT03371017|587825490|FG000|Overall Study|Death|228|||
162758290|NCT03371017|587825491|FG001|Overall Study|Death|215|||
162758291|NCT03371017|587825490|FG000|Overall Study|Withdrawal by Subject|20|||
162758292|NCT03371017|587825491|FG001|Overall Study|Withdrawal by Subject|25|||
162758293|NCT03371017|587825490|FG000|Overall Study|Study Ended by Sponsor|37|||
162758294|NCT03371017|587825491|FG001|Overall Study|Study Ended by Sponsor|38|||
162758295|NCT03371017|587825490|FG000|Overall Study|Protocol Deviation|0|||
162758296|NCT03371017|587825491|FG001|Overall Study|Protocol Deviation|1|||
162758297|NCT04300023|587825492|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
162758298|NCT04300023|587825493|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
162758299|NCT04057131|587825494|FG000|Overall Study|Protocol Violation|24|||
162758300|NCT05251363|587825495|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
162758301|NCT05251363|587825495|FG000|Overall Study After Implant Period|Death|9|||
162758302|NCT05251363|587825495|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
162758303|NCT05251363|587825495|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
162758304|NCT05251363|587825495|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
162758305|NCT05251363|587825495|FG000|Overall Study After Implant Period|Physician Decision|1|||
162758306|NCT05251363|587825495|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
162758307|NCT02830204|587825496|FG000|Overall Study|Death|9|||
162758308|NCT02830204|587825496|FG000|Overall Study|Withdrawal by Subject|1|||
162758309|NCT04686266|587825499|FG000|Overall Study|Withdrawal by Subject|0|||
162758310|NCT04686266|587825500|FG001|Overall Study|Withdrawal by Subject|1|||
162758311|NCT05422339|587827391|FG000|Overall Study|Withdrawal by Subject|17|||
162758312|NCT05422339|587827392|FG001|Overall Study|Withdrawal by Subject|15|||
162758313|NCT03070392|587827399|FG000|Overall Study|Not Treated|7|||
162758314|NCT03070392|587827400|FG001|Overall Study|Not Treated|0|||
162758315|NCT03070392|587827401|FG002|Overall Study|Not Treated|3|||
162758316|NCT03070392|587827402|FG003|Overall Study|Not Treated|12|||
162758317|NCT03070392|587827399|FG000|Overall Study|Death|3|||
162758318|NCT03070392|587827400|FG001|Overall Study|Death|0|||
162758319|NCT03070392|587827401|FG002|Overall Study|Death|0|||
162758320|NCT03070392|587827402|FG003|Overall Study|Death|1|||
162758321|NCT03070392|587827399|FG000|Overall Study|Withdrawal by Subject|7|||
162758322|NCT03070392|587827400|FG001|Overall Study|Withdrawal by Subject|0|||
162758323|NCT03070392|587827401|FG002|Overall Study|Withdrawal by Subject|0|||
162758324|NCT03070392|587827402|FG003|Overall Study|Withdrawal by Subject|3|||
162758325|NCT03070392|587827399|FG000|Overall Study|Physician Decision|1|||
162758326|NCT03070392|587827400|FG001|Overall Study|Physician Decision|0|||
162758327|NCT03070392|587827401|FG002|Overall Study|Physician Decision|0|||
162758328|NCT03070392|587827402|FG003|Overall Study|Physician Decision|2|||
162758329|NCT03070392|587827399|FG000|Overall Study|Progressive Disease|154|||
162758330|NCT03070392|587827400|FG001|Overall Study|Progressive Disease|6|||
162758331|NCT03070392|587827401|FG002|Overall Study|Progressive Disease|2|||
162758332|NCT03070392|587827402|FG003|Overall Study|Progressive Disease|70|||
162758333|NCT03070392|587827399|FG000|Overall Study|Adverse Event|6|||
162758334|NCT03070392|587827400|FG001|Overall Study|Adverse Event|1|||
162758335|NCT03070392|587827401|FG002|Overall Study|Adverse Event|1|||
162758336|NCT03070392|587827402|FG003|Overall Study|Adverse Event|3|||
162758337|NCT03070392|587827399|FG000|Overall Study|Alternate anticancer treatment|1|||
162758338|NCT03070392|587827400|FG001|Overall Study|Alternate anticancer treatment|0|||
162758339|NCT03070392|587827401|FG002|Overall Study|Alternate anticancer treatment|0|||
162758340|NCT03070392|587827402|FG003|Overall Study|Alternate anticancer treatment|1|||
162758341|NCT03070392|587827399|FG000|Overall Study|Ongoing|73|||
162758342|NCT03070392|587827400|FG001|Overall Study|Ongoing|0|||
162758343|NCT03070392|587827401|FG002|Overall Study|Ongoing|0|||
162758344|NCT03070392|587827402|FG003|Overall Study|Ongoing|11|||
162758345|NCT02972034|587827403|FG000|Overall Study|Death|11|||
162758346|NCT02972034|587827404|FG001|Overall Study|Death|1|||
162758347|NCT02972034|587827405|FG002|Overall Study|Death|3|||
162758348|NCT02972034|587827406|FG003|Overall Study|Death|3|||
162758349|NCT02972034|587827407|FG004|Overall Study|Death|2|||
162758350|NCT02972034|587827408|FG005|Overall Study|Death|2|||
162758351|NCT02972034|587827409|FG006|Overall Study|Death|3|||
162758352|NCT02972034|587827410|FG007|Overall Study|Death|4|||
162758353|NCT02972034|587827411|FG008|Overall Study|Death|8|||
162758354|NCT02972034|587827412|FG009|Overall Study|Death|11|||
162758355|NCT02972034|587827413|FG010|Overall Study|Death|3|||
162758356|NCT02972034|587827414|FG011|Overall Study|Death|2|||
162758357|NCT02972034|587827415|FG012|Overall Study|Death|11|||
162758358|NCT02972034|587827416|FG013|Overall Study|Death|10|||
162758359|NCT02972034|587827417|FG014|Overall Study|Death|9|||
162758360|NCT02972034|587827403|FG000|Overall Study|Lost to Follow-up|0|||
162758361|NCT02972034|587827404|FG001|Overall Study|Lost to Follow-up|0|||
162758362|NCT02972034|587827405|FG002|Overall Study|Lost to Follow-up|0|||
162758363|NCT02972034|587827406|FG003|Overall Study|Lost to Follow-up|0|||
162758364|NCT02972034|587827407|FG004|Overall Study|Lost to Follow-up|1|||
162758365|NCT02972034|587827408|FG005|Overall Study|Lost to Follow-up|0|||
162758366|NCT02972034|587827409|FG006|Overall Study|Lost to Follow-up|0|||
162758367|NCT02972034|587827410|FG007|Overall Study|Lost to Follow-up|1|||
162758368|NCT02972034|587827411|FG008|Overall Study|Lost to Follow-up|0|||
162758369|NCT02972034|587827412|FG009|Overall Study|Lost to Follow-up|0|||
162758370|NCT02972034|587827413|FG010|Overall Study|Lost to Follow-up|0|||
162758371|NCT02972034|587827414|FG011|Overall Study|Lost to Follow-up|0|||
162758372|NCT02972034|587827415|FG012|Overall Study|Lost to Follow-up|0|||
162758373|NCT02972034|587827416|FG013|Overall Study|Lost to Follow-up|0|||
162758374|NCT02972034|587827417|FG014|Overall Study|Lost to Follow-up|1|||
162758375|NCT02972034|587827403|FG000|Overall Study|Physician Decision|0|||
162758376|NCT02972034|587827404|FG001|Overall Study|Physician Decision|0|||
162758377|NCT02972034|587827405|FG002|Overall Study|Physician Decision|0|||
162758378|NCT02972034|587827406|FG003|Overall Study|Physician Decision|0|||
162758379|NCT02972034|587827407|FG004|Overall Study|Physician Decision|0|||
162758380|NCT02972034|587827408|FG005|Overall Study|Physician Decision|0|||
162758381|NCT02972034|587827409|FG006|Overall Study|Physician Decision|0|||
162758382|NCT02972034|587827410|FG007|Overall Study|Physician Decision|1|||
162758383|NCT02972034|587827411|FG008|Overall Study|Physician Decision|0|||
162758384|NCT02972034|587827412|FG009|Overall Study|Physician Decision|0|||
162758385|NCT02972034|587827413|FG010|Overall Study|Physician Decision|1|||
162758386|NCT02972034|587827414|FG011|Overall Study|Physician Decision|0|||
162758387|NCT02972034|587827415|FG012|Overall Study|Physician Decision|0|||
162758388|NCT02972034|587827416|FG013|Overall Study|Physician Decision|0|||
162758389|NCT02972034|587827417|FG014|Overall Study|Physician Decision|0|||
162758390|NCT02972034|587827403|FG000|Overall Study|Sponsor Decision|0|||
162758391|NCT02972034|587827404|FG001|Overall Study|Sponsor Decision|0|||
162758392|NCT02972034|587827405|FG002|Overall Study|Sponsor Decision|0|||
162758393|NCT02972034|587827406|FG003|Overall Study|Sponsor Decision|1|||
162758394|NCT02972034|587827407|FG004|Overall Study|Sponsor Decision|0|||
162758395|NCT02972034|587827408|FG005|Overall Study|Sponsor Decision|0|||
162758396|NCT02972034|587827409|FG006|Overall Study|Sponsor Decision|1|||
162758397|NCT02972034|587827410|FG007|Overall Study|Sponsor Decision|1|||
162758398|NCT02972034|587827411|FG008|Overall Study|Sponsor Decision|1|||
162758399|NCT02972034|587827412|FG009|Overall Study|Sponsor Decision|2|||
162758400|NCT02972034|587827413|FG010|Overall Study|Sponsor Decision|2|||
162758401|NCT02972034|587827414|FG011|Overall Study|Sponsor Decision|0|||
162758402|NCT02972034|587827415|FG012|Overall Study|Sponsor Decision|1|||
162758403|NCT02972034|587827416|FG013|Overall Study|Sponsor Decision|0|||
162758404|NCT02972034|587827417|FG014|Overall Study|Sponsor Decision|1|||
162758405|NCT02972034|587827403|FG000|Overall Study|Withdrawal by Subject|3|||
162758406|NCT02972034|587827404|FG001|Overall Study|Withdrawal by Subject|0|||
162758407|NCT02972034|587827405|FG002|Overall Study|Withdrawal by Subject|0|||
162758408|NCT02972034|587827406|FG003|Overall Study|Withdrawal by Subject|0|||
162758409|NCT02972034|587827407|FG004|Overall Study|Withdrawal by Subject|1|||
162758410|NCT02972034|587827408|FG005|Overall Study|Withdrawal by Subject|1|||
162758411|NCT02972034|587827409|FG006|Overall Study|Withdrawal by Subject|0|||
162758412|NCT02972034|587827410|FG007|Overall Study|Withdrawal by Subject|0|||
162758413|NCT02972034|587827411|FG008|Overall Study|Withdrawal by Subject|1|||
162758414|NCT02972034|587827412|FG009|Overall Study|Withdrawal by Subject|1|||
162758415|NCT02972034|587827413|FG010|Overall Study|Withdrawal by Subject|2|||
162758416|NCT02972034|587827414|FG011|Overall Study|Withdrawal by Subject|1|||
162758417|NCT02972034|587827415|FG012|Overall Study|Withdrawal by Subject|1|||
162758418|NCT02972034|587827416|FG013|Overall Study|Withdrawal by Subject|1|||
162758419|NCT02972034|587827417|FG014|Overall Study|Withdrawal by Subject|0|||
162758420|NCT02972034|587827403|FG000|Overall Study|Screen Failure|0|||
162758421|NCT02972034|587827404|FG001|Overall Study|Screen Failure|0|||
162758422|NCT02972034|587827405|FG002|Overall Study|Screen Failure|0|||
162758423|NCT02972034|587827406|FG003|Overall Study|Screen Failure|0|||
162758424|NCT02972034|587827407|FG004|Overall Study|Screen Failure|0|||
162758425|NCT02972034|587827408|FG005|Overall Study|Screen Failure|0|||
162758426|NCT02972034|587827409|FG006|Overall Study|Screen Failure|0|||
162758427|NCT02972034|587827410|FG007|Overall Study|Screen Failure|0|||
162758428|NCT02972034|587827411|FG008|Overall Study|Screen Failure|0|||
162758429|NCT02972034|587827412|FG009|Overall Study|Screen Failure|0|||
162758430|NCT02972034|587827413|FG010|Overall Study|Screen Failure|0|||
162758431|NCT02972034|587827414|FG011|Overall Study|Screen Failure|0|||
162758432|NCT02972034|587827415|FG012|Overall Study|Screen Failure|1|||
162758433|NCT02972034|587827416|FG013|Overall Study|Screen Failure|0|||
162758434|NCT02972034|587827417|FG014|Overall Study|Screen Failure|0|||
162758435|NCT03861052|587827418|FG000|Overall Study|Adverse Event|1|||
162758436|NCT03861052|587827419|FG001|Overall Study|Adverse Event|1|||
162758437|NCT03861052|587827420|FG002|Overall Study|Adverse Event|2|||
162758438|NCT03861052|587827421|FG003|Overall Study|Adverse Event|4|||
162758439|NCT03861052|587827418|FG000|Overall Study|Lost to Follow-up|0|||
162758440|NCT03861052|587827419|FG001|Overall Study|Lost to Follow-up|0|||
162758441|NCT03861052|587827420|FG002|Overall Study|Lost to Follow-up|0|||
162758442|NCT03861052|587827421|FG003|Overall Study|Lost to Follow-up|1|||
162758443|NCT03861052|587827418|FG000|Overall Study|Physician Decision|0|||
162758444|NCT03861052|587827419|FG001|Overall Study|Physician Decision|1|||
162758445|NCT03861052|587827420|FG002|Overall Study|Physician Decision|0|||
162758446|NCT03861052|587827421|FG003|Overall Study|Physician Decision|0|||
162758447|NCT03861052|587827418|FG000|Overall Study|Withdrawal by Subject|2|||
162758448|NCT03861052|587827419|FG001|Overall Study|Withdrawal by Subject|5|||
162758449|NCT03861052|587827420|FG002|Overall Study|Withdrawal by Subject|3|||
162758450|NCT03861052|587827421|FG003|Overall Study|Withdrawal by Subject|0|||
162758451|NCT03861052|587827418|FG000|Overall Study|Relocation to other city|1|||
162758452|NCT03861052|587827419|FG001|Overall Study|Relocation to other city|0|||
162758453|NCT03861052|587827420|FG002|Overall Study|Relocation to other city|0|||
162758454|NCT03861052|587827421|FG003|Overall Study|Relocation to other city|0|||
162758455|NCT03009344|587827422|FG000|Overall Study|Lack of Efficacy|5|||
162758456|NCT03009344|587827422|FG000|Overall Study|Withdrawal by Subject|1|||
162758457|NCT03009344|587827422|FG000|Overall Study|Adverse Event|1|||
162758458|NCT03678688|587827423|FG000|Overall Study|Reason not Specified|0|||
162758459|NCT03678688|587827424|FG001|Overall Study|Reason not Specified|0|||
162758460|NCT03678688|587827425|FG002|Overall Study|Reason not Specified|3|||
162758461|NCT03678688|587827426|FG003|Overall Study|Reason not Specified|0|||
162758462|NCT03678688|587827427|FG004|Overall Study|Reason not Specified|1|||
162758463|NCT03678688|587827428|FG005|Overall Study|Reason not Specified|0|||
162758464|NCT03678688|587827429|FG006|Overall Study|Reason not Specified|0|||
162758465|NCT03678688|587827430|FG007|Overall Study|Reason not Specified|0|||
162758466|NCT03678688|587827431|FG008|Overall Study|Reason not Specified|0|||
162758467|NCT03678688|587827423|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
162758468|NCT03678688|587827424|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
162758469|NCT03678688|587827425|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
162758470|NCT03678688|587827426|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
162758471|NCT03678688|587827427|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
162758472|NCT03678688|587827428|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
162758473|NCT03678688|587827429|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
162758474|NCT03678688|587827430|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
162758475|NCT03678688|587827431|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
162758476|NCT03678688|587827423|FG000|Overall Study|Covid Related Adverse Event|0|||
162758477|NCT03678688|587827424|FG001|Overall Study|Covid Related Adverse Event|0|||
162758478|NCT03678688|587827425|FG002|Overall Study|Covid Related Adverse Event|0|||
162758479|NCT03678688|587827426|FG003|Overall Study|Covid Related Adverse Event|0|||
162758480|NCT03678688|587827427|FG004|Overall Study|Covid Related Adverse Event|0|||
162758481|NCT03678688|587827428|FG005|Overall Study|Covid Related Adverse Event|3|||
162758482|NCT03678688|587827429|FG006|Overall Study|Covid Related Adverse Event|1|||
162758483|NCT03678688|587827430|FG007|Overall Study|Covid Related Adverse Event|1|||
162758484|NCT03678688|587827431|FG008|Overall Study|Covid Related Adverse Event|0|||
162758485|NCT03678688|587827423|FG000|Overall Study|Physician Decision|0|||
162758486|NCT03678688|587827424|FG001|Overall Study|Physician Decision|0|||
162758487|NCT03678688|587827425|FG002|Overall Study|Physician Decision|0|||
162758488|NCT03678688|587827426|FG003|Overall Study|Physician Decision|0|||
162758489|NCT03678688|587827427|FG004|Overall Study|Physician Decision|0|||
162758490|NCT03678688|587827428|FG005|Overall Study|Physician Decision|1|||
162758491|NCT03678688|587827429|FG006|Overall Study|Physician Decision|0|||
162758492|NCT03678688|587827430|FG007|Overall Study|Physician Decision|0|||
162758493|NCT03678688|587827431|FG008|Overall Study|Physician Decision|0|||
162758494|NCT03678688|587827423|FG000|Overall Study|Withdrawal by Subject|0|||
162758495|NCT03678688|587827424|FG001|Overall Study|Withdrawal by Subject|0|||
162758496|NCT03678688|587827425|FG002|Overall Study|Withdrawal by Subject|0|||
162758497|NCT03678688|587827426|FG003|Overall Study|Withdrawal by Subject|0|||
162758498|NCT03678688|587827427|FG004|Overall Study|Withdrawal by Subject|0|||
162758499|NCT03678688|587827428|FG005|Overall Study|Withdrawal by Subject|0|||
162758500|NCT03678688|587827429|FG006|Overall Study|Withdrawal by Subject|2|||
162758501|NCT03678688|587827430|FG007|Overall Study|Withdrawal by Subject|1|||
162758502|NCT03678688|587827431|FG008|Overall Study|Withdrawal by Subject|0|||
162758503|NCT02534233|587827434|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
162758504|NCT03136159|587827438|FG000|Overall Study|chorioamnionitis|2|||
162758505|NCT03136159|587827439|FG001|Overall Study|chorioamnionitis|0|||
162758506|NCT03136159|587827438|FG000|Overall Study|vertical skin incision|1|||
162758507|NCT03136159|587827439|FG001|Overall Study|vertical skin incision|0|||
162758508|NCT03136159|587827438|FG000|Overall Study|additional dressing|1|||
162758509|NCT03136159|587827439|FG001|Overall Study|additional dressing|0|||
162758510|NCT03136159|587827438|FG000|Overall Study|never got dressing placed|1|||
162758511|NCT03136159|587827439|FG001|Overall Study|never got dressing placed|0|||
162758512|NCT03823703|587827440|FG000|Overall Study|Sponsor request|0|||
162758513|NCT03823703|587827441|FG001|Overall Study|Sponsor request|3|||
162758514|NCT03823703|587827442|FG002|Overall Study|Sponsor request|4|||
162758515|NCT03823703|587827440|FG000|Overall Study|Adverse Event|3|||
162758516|NCT03823703|587827441|FG001|Overall Study|Adverse Event|1|||
162758517|NCT03823703|587827442|FG002|Overall Study|Adverse Event|0|||
162758518|NCT03823703|587827440|FG000|Overall Study|Withdrawal by Subject|0|||
162758519|NCT03823703|587827441|FG001|Overall Study|Withdrawal by Subject|1|||
162758520|NCT03823703|587827442|FG002|Overall Study|Withdrawal by Subject|0|||
162758521|NCT00925548|587827443|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
162758522|NCT00925548|587827444|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
162758523|NCT00458783|587827446|FG000|Overall Study|Protocol Violation|1228|||
162758524|NCT00458783|587827447|FG001|Overall Study|Protocol Violation|1220|||
162758525|NCT01737398|587827448|FG000|Overall Study|Adverse event or SAE|16|||
162758526|NCT01737398|587827449|FG001|Overall Study|Adverse event or SAE|1|||
162758527|NCT01737398|587827448|FG000|Overall Study|Stopping rule met|2|||
162758528|NCT01737398|587827449|FG001|Overall Study|Stopping rule met|1|||
162758529|NCT01737398|587827448|FG000|Overall Study|Voluntary withdrawal|2|||
162758530|NCT01737398|587827449|FG001|Overall Study|Voluntary withdrawal|3|||
162758531|NCT01737398|587827448|FG000|Overall Study|Ineligibility|1|||
162758532|NCT01737398|587827449|FG001|Overall Study|Ineligibility|0|||
162758533|NCT01737398|587827448|FG000|Overall Study|Liver transplant|1|||
162758534|NCT01737398|587827449|FG001|Overall Study|Liver transplant|0|||
162758535|NCT01737398|587827448|FG000|Overall Study|Disease progression|2|||
162758536|NCT01737398|587827449|FG001|Overall Study|Disease progression|3|||
162758537|NCT01737398|587827448|FG000|Overall Study|Sponsor's decision|2|||
162758538|NCT01737398|587827449|FG001|Overall Study|Sponsor's decision|0|||
162758539|NCT00089609|587827450|FG000|Overall Study|Withdrawal by Subject|3|||
162758540|NCT00089609|587827451|FG001|Overall Study|Withdrawal by Subject|1|||
162758541|NCT00357994|587827452|FG000|Overall Study|Adverse Event|1|||
162758542|NCT00357994|587827453|FG001|Overall Study|Adverse Event|2|||
162758543|NCT00357994|587827452|FG000|Overall Study|Lack of Efficacy|0|||
162758544|NCT00357994|587827453|FG001|Overall Study|Lack of Efficacy|1|||
162758545|NCT00357994|587827452|FG000|Overall Study|Protocol Violation|1|||
162758546|NCT00357994|587827453|FG001|Overall Study|Protocol Violation|0|||
162758547|NCT00745875|587827458|FG000|Overall Study|Continuing study treatment|4|||
162758548|NCT00745875|587827459|FG001|Overall Study|Continuing study treatment|4|||
162758549|NCT01833455|587827462|FG000|Overall Study|Withdrawal by Subject|1|||
162758550|NCT01833455|587827463|FG001|Overall Study|Withdrawal by Subject|0|||
162758551|NCT03689946|587827466|FG000|Overall Study|Withdrawal by Subject|3|||
162758552|NCT03689946|587827466|FG000|Overall Study|Lost to Follow-up|3|||
162758553|NCT03689946|587827466|FG000|Overall Study|Data corruption|2|||
162758554|NCT00047385|587827467|FG000|Overall Study|Death before any screening|2|||
162758555|NCT00047385|587827468|FG001|Overall Study|Death before any screening|5|||
162758556|NCT00047385|587827467|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
162758557|NCT00047385|587827468|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
162758558|NCT00047385|587827467|FG000|Overall Study|Eligible for screening but had no screen|260|||
162758559|NCT00047385|587827468|FG001|Overall Study|Eligible for screening but had no screen|492|||
162758560|NCT03865732|587827469|FG000|Overall Study|Adverse Event|0|||
162758561|NCT03865732|587827470|FG001|Overall Study|Adverse Event|1|||
162758562|NCT00454194|587827471|FG000|Overall Study|Adverse Event|7|||
162758563|NCT00454194|587827472|FG001|Overall Study|Adverse Event|2|||
162758564|NCT00454194|587827471|FG000|Overall Study|Withdrawal by Subject|12|||
162758565|NCT00454194|587827472|FG001|Overall Study|Withdrawal by Subject|8|||
162758566|NCT00454194|587827471|FG000|Overall Study|Other Medical Problems|1|||
162758567|NCT00454194|587827472|FG001|Overall Study|Other Medical Problems|2|||
162758568|NCT00454194|587827471|FG000|Overall Study|Other Unspecified Reason|2|||
162758569|NCT00454194|587827472|FG001|Overall Study|Other Unspecified Reason|2|||
162758570|NCT02095145|587827475|FG000|Overall Study|Withdrawal by Subject|1|||
162758571|NCT02095145|587827476|FG001|Overall Study|Withdrawal by Subject|0|||
162758572|NCT02085941|587827479|FG000|Overall Study|Lack of Efficacy|1|||
162758573|NCT02085941|587827480|FG001|Overall Study|Lack of Efficacy|0|||
162758574|NCT02085941|587827479|FG000|Overall Study|Death|6|||
162758575|NCT02085941|587827480|FG001|Overall Study|Death|1|||
162758576|NCT02085941|587827479|FG000|Overall Study|Lost to Follow-up|1|||
162758577|NCT02085941|587827480|FG001|Overall Study|Lost to Follow-up|0|||
162758578|NCT02085941|587827479|FG000|Overall Study|Physician Decision|0|||
162758579|NCT02085941|587827480|FG001|Overall Study|Physician Decision|2|||
162758580|NCT03184987|587827483|FG000|Overall Study|Withdrawal by Subject|0|||
162758581|NCT03184987|587827484|FG001|Overall Study|Withdrawal by Subject|1|||
162758582|NCT03184987|587827485|FG002|Overall Study|Withdrawal by Subject|2|||
162758583|NCT03184987|587827483|FG000|Overall Study|Physician Decision|0|||
162758584|NCT03184987|587827484|FG001|Overall Study|Physician Decision|0|||
162758585|NCT03184987|587827485|FG002|Overall Study|Physician Decision|1|||
162758586|NCT03184987|587827483|FG000|Overall Study|Adverse Event|1|||
162758587|NCT03184987|587827484|FG001|Overall Study|Adverse Event|0|||
162758588|NCT03184987|587827485|FG002|Overall Study|Adverse Event|1|||
162758589|NCT00853580|587827486|FG000|Overall Study|Lost to Follow-up|3|||
162758590|NCT00853580|587827487|FG001|Overall Study|Lost to Follow-up|5|||
162758591|NCT00853580|587827486|FG000|Overall Study|Protocol Violation|2|||
162758592|NCT00853580|587827487|FG001|Overall Study|Protocol Violation|1|||
162758593|NCT00853580|587827486|FG000|Overall Study|Withdrawal by Subject|2|||
162758594|NCT00853580|587827487|FG001|Overall Study|Withdrawal by Subject|8|||
162758595|NCT00853580|587827486|FG000|Overall Study|Commenced contraindicated therapy|0|||
162758596|NCT00853580|587827487|FG001|Overall Study|Commenced contraindicated therapy|2|||
162758597|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
162758598|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
162758599|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
162758600|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
162758601|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
162758602|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
162758603|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
162758604|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
162758605|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
162758606|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
162758607|NCT01767467|587827488|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
162758608|NCT01767467|587827489|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
162758609|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
162758610|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
162758611|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
162758612|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
162758613|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
162758614|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
162758615|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
162758616|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
162758617|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
162758618|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
162758619|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
162758620|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
162758621|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
162758622|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
162758623|NCT01767467|587827488|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
162758624|NCT01767467|587827489|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
162758625|NCT02203799|587827496|FG000|Overall Study|Withdrawal by Subject|3|||
162758626|NCT01065779|587827501|FG000|Overall Study|Duplicate Investigation|1|||
162758627|NCT01065779|587827501|FG000|Overall Study|Investigation Before Contract Date|37|||
162758628|NCT01065779|587827501|FG000|Overall Study|Non-enrollment Period Administration|10|||
162758629|NCT01065779|587827501|FG000|Overall Study|Not Administered With Study Drug|17|||
162758630|NCT01065779|587827501|FG000|Overall Study|Failed to Follow-up|10|||
162758631|NCT01065779|587827501|FG000|Overall Study|Inclusion Criteria Violation|7|||
162758632|NCT01801007|587827502|FG000|Overall Study|Adverse Event|2|||
162758633|NCT01801007|587827502|FG000|Overall Study|Lost to Follow-up|4|||
162758634|NCT01801007|587827502|FG000|Overall Study|Withdrawal by Subject|5|||
162758635|NCT01683409|587827503|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162758636|NCT01683409|587827504|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162758637|NCT01683409|587827505|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
162758638|NCT01683409|587827506|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162758639|NCT01683409|587827507|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162758640|NCT01683409|587827503|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
162758641|NCT01683409|587827504|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
162758642|NCT01683409|587827505|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
162758643|NCT01683409|587827506|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
162758644|NCT01683409|587827507|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
162758645|NCT01683409|587827503|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162758646|NCT01683409|587827504|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
162758647|NCT01683409|587827505|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162758648|NCT01683409|587827506|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162758649|NCT01683409|587827507|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162758650|NCT01683409|587827503|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162758651|NCT01683409|587827504|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162758652|NCT01683409|587827505|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162758653|NCT01683409|587827506|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
162758654|NCT01683409|587827507|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
162758655|NCT01683409|587827503|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162758656|NCT01683409|587827504|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162758657|NCT01683409|587827505|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
162758658|NCT01683409|587827506|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162758659|NCT01683409|587827507|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162758660|NCT01683409|587827503|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
162758661|NCT01683409|587827504|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
162758662|NCT01683409|587827505|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
162758663|NCT01683409|587827506|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
162758664|NCT01683409|587827507|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
162758665|NCT01683409|587827503|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
162758666|NCT01683409|587827504|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162758667|NCT01683409|587827505|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162758668|NCT01683409|587827506|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162758669|NCT01683409|587827507|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
162758670|NCT01683409|587827503|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
162758671|NCT01683409|587827504|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162758672|NCT01683409|587827505|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162758673|NCT01683409|587827506|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162758674|NCT01683409|587827507|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162758675|NCT01683409|587827503|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
162758676|NCT01683409|587827504|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
162758677|NCT01683409|587827505|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
162758678|NCT01683409|587827506|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
162758679|NCT01683409|587827507|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
162758680|NCT01683409|587827503|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162758681|NCT01683409|587827504|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162758682|NCT01683409|587827505|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162758683|NCT01683409|587827506|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162758684|NCT01683409|587827507|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
162758685|NCT01683409|587827503|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162758686|NCT01683409|587827504|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162758687|NCT01683409|587827505|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
162758688|NCT01683409|587827506|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162758689|NCT01683409|587827507|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162758690|NCT00553332|587827512|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
162758691|NCT04745676|587827522|FG000|Overall Study|Death|1|||
162758692|NCT04745676|587827523|FG001|Overall Study|Death|0|||
162758693|NCT04745676|587827524|FG002|Overall Study|Death|0|||
162758694|NCT03102034|587827527|FG000|Overall Study|Withdrawal by Subject|1|||
162758695|NCT03102034|587827528|FG001|Overall Study|Withdrawal by Subject|0|||
162758696|NCT00145470|587827529|FG000|Overall Study|Adverse Event|19|||
162758697|NCT00145470|587827530|FG001|Overall Study|Adverse Event|25|||
162758698|NCT00145470|587827529|FG000|Overall Study|Lack of Efficacy|27|||
162758699|NCT00145470|587827530|FG001|Overall Study|Lack of Efficacy|13|||
162758700|NCT00145470|587827529|FG000|Overall Study|Withdrawal by Subject|36|||
162758701|NCT00145470|587827530|FG001|Overall Study|Withdrawal by Subject|34|||
162758702|NCT00145470|587827529|FG000|Overall Study|Lost to Follow-up|21|||
162758703|NCT00145470|587827530|FG001|Overall Study|Lost to Follow-up|17|||
162758704|NCT00145470|587827529|FG000|Overall Study|Reason Not Reported|9|||
162758705|NCT00145470|587827530|FG001|Overall Study|Reason Not Reported|9|||
162758706|NCT00676091|587827532|FG000|Infant Series|Parent or legal guardian request|10|||
162758707|NCT00676091|587827533|FG001|Infant Series|Parent or legal guardian request|8|||
162758708|NCT00676091|587827532|FG000|Infant Series|Protocol Violation|6|||
162758709|NCT00676091|587827533|FG001|Infant Series|Protocol Violation|3|||
162758710|NCT00676091|587827532|FG000|Infant Series|Adverse Event|2|||
162758711|NCT00676091|587827533|FG001|Infant Series|Adverse Event|3|||
162758712|NCT00676091|587827532|FG000|Infant Series|Failed to return|1|||
162758713|NCT00676091|587827533|FG001|Infant Series|Failed to return|3|||
162758714|NCT00676091|587827532|FG000|Infant Series|Lost to Follow-up|1|||
162758715|NCT00676091|587827533|FG001|Infant Series|Lost to Follow-up|0|||
162758716|NCT00676091|587827532|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
162758717|NCT00676091|587827533|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
162758718|NCT00676091|587827532|FG000|After Infant Series|Adverse Event|0|||
162758719|NCT00676091|587827533|FG001|After Infant Series|Adverse Event|1|||
162758720|NCT00676091|587827532|FG000|After Infant Series|Protocol Violation|0|||
162758721|NCT00676091|587827533|FG001|After Infant Series|Protocol Violation|1|||
162758722|NCT00676091|587827532|FG000|After Infant Series|Failed to return|1|||
162758723|NCT00676091|587827533|FG001|After Infant Series|Failed to return|1|||
162758724|NCT00676091|587827532|FG000|Toddler Dose|Failed to return|2|||
162758725|NCT00676091|587827533|FG001|Toddler Dose|Failed to return|0|||
162758726|NCT00676091|587827532|FG000|Toddler Dose|Parent or legal guardian request|1|||
162758727|NCT00676091|587827533|FG001|Toddler Dose|Parent or legal guardian request|0|||
162758728|NCT02063659|587827539|FG000|Double-Blind Treatment Period|Adverse Event|1|||
162758729|NCT02063659|587827540|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162758730|NCT02063659|587827541|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162758731|NCT02063659|587827542|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162758732|NCT02063659|587827539|FG000|Double-Blind Treatment Period|Physician Decision|1|||
162758733|NCT02063659|587827540|FG001|Double-Blind Treatment Period|Physician Decision|0|||
162758734|NCT02063659|587827541|FG002|Double-Blind Treatment Period|Physician Decision|0|||
162758735|NCT02063659|587827542|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162758736|NCT02063659|587827539|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
162758737|NCT02063659|587827540|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
162758738|NCT02063659|587827541|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
162758739|NCT02063659|587827542|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
162758740|NCT02063659|587827539|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
162758741|NCT02063659|587827540|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
162758742|NCT02063659|587827541|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
162758743|NCT02063659|587827542|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
162758744|NCT02063659|587827539|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162758745|NCT02063659|587827540|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162758746|NCT02063659|587827541|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162758747|NCT02063659|587827542|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
162758748|NCT02063659|587827539|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162758749|NCT02063659|587827540|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162758750|NCT02063659|587827541|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162758751|NCT02063659|587827542|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
162758752|NCT02063659|587827539|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
162758753|NCT02063659|587827540|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
162758754|NCT02063659|587827541|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
162758755|NCT02063659|587827542|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
162758756|NCT02063659|587827539|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162758757|NCT02063659|587827540|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162758758|NCT02063659|587827541|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162758759|NCT02063659|587827542|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
162758760|NCT00989196|587827543|FG000|Treatment Period|Lost to Follow-up|1|||
162758761|NCT00989196|587827544|FG001|Treatment Period|Lost to Follow-up|0|||
162758762|NCT04762277|587827547|FG000|Overall Study|Withdrawal by Subject|0|||
162758763|NCT04762277|587827548|FG001|Overall Study|Withdrawal by Subject|2|||
162758764|NCT04762277|587827547|FG000|Overall Study|Protocol Violation|0|||
162758765|NCT04762277|587827548|FG001|Overall Study|Protocol Violation|1|||
162758766|NCT04762277|587827547|FG000|Overall Study|Adverse Event|1|||
162758767|NCT04762277|587827548|FG001|Overall Study|Adverse Event|0|||
162758768|NCT02556918|587829003|FG000|Overall Study|Protocol Violation|5|||
162758769|NCT02556918|587829004|FG001|Overall Study|Protocol Violation|6|||
162758770|NCT02556918|587829003|FG000|Overall Study|Withdrawal by Subject|4|||
162758771|NCT02556918|587829004|FG001|Overall Study|Withdrawal by Subject|4|||
162758772|NCT04511702|587829014|FG000|Overall Study|Lost to Follow-up|3|||
162758773|NCT04511702|587829015|FG001|Overall Study|Lost to Follow-up|0|||
162758774|NCT04511702|587829016|FG002|Overall Study|Lost to Follow-up|4|||
162758775|NCT04511702|587829014|FG000|Overall Study|Withdrawal by Subject|17|||
162758776|NCT04511702|587829015|FG001|Overall Study|Withdrawal by Subject|1|||
162758777|NCT04511702|587829016|FG002|Overall Study|Withdrawal by Subject|8|||
162758778|NCT05349721|587829017|FG000|Part A (24 Weeks)|Adverse Event|9|||
162758779|NCT05349721|587829018|FG001|Part A (24 Weeks)|Adverse Event|2|||
162758780|NCT05349721|587829017|FG000|Part A (24 Weeks)|Death|8|||
162758781|NCT05349721|587829018|FG001|Part A (24 Weeks)|Death|3|||
162758782|NCT05349721|587829017|FG000|Part A (24 Weeks)|Disease Progression|1|||
162758783|NCT05349721|587829018|FG001|Part A (24 Weeks)|Disease Progression|1|||
162758784|NCT05349721|587829017|FG000|Part A (24 Weeks)|Screen Failure|2|||
162758785|NCT05349721|587829018|FG001|Part A (24 Weeks)|Screen Failure|0|||
162758786|NCT05349721|587829017|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
162758787|NCT05349721|587829018|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
162758788|NCT05349721|587829017|FG000|Part A (24 Weeks)|Other Than Specified|5|||
162758789|NCT05349721|587829018|FG001|Part A (24 Weeks)|Other Than Specified|1|||
162758790|NCT05349721|587829017|FG000|Part B (28 Weeks)|Adverse Event|3|||
162758791|NCT05349721|587829018|FG001|Part B (28 Weeks)|Adverse Event|0|||
162758792|NCT05349721|587829017|FG000|Part B (28 Weeks)|Death|21|||
162758793|NCT05349721|587829018|FG001|Part B (28 Weeks)|Death|11|||
162758794|NCT05349721|587829017|FG000|Part B (28 Weeks)|Disease Progression|2|||
162758795|NCT05349721|587829018|FG001|Part B (28 Weeks)|Disease Progression|1|||
162758796|NCT05349721|587829017|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
162758797|NCT05349721|587829018|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
162758798|NCT05349721|587829017|FG000|Part B (28 Weeks)|Physician Decision|1|||
162758799|NCT05349721|587829018|FG001|Part B (28 Weeks)|Physician Decision|0|||
162758800|NCT05349721|587829017|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
162758801|NCT05349721|587829018|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
162758802|NCT05349721|587829017|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
162758803|NCT05349721|587829018|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
162758804|NCT05349721|587829017|FG000|Part B (28 Weeks)|Other Than Specified|4|||
162758805|NCT05349721|587829018|FG001|Part B (28 Weeks)|Other Than Specified|2|||
162758806|NCT05349721|587829017|FG000|Part C (108 Weeks)|Death|0|||
162758807|NCT05349721|587829018|FG001|Part C (108 Weeks)|Death|1|||
162758808|NCT05349721|587829017|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
162758809|NCT05349721|587829018|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
162758810|NCT05349721|587829017|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
162758811|NCT05349721|587829018|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
162758812|NCT05349721|587829017|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
162758813|NCT05349721|587829018|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
162758814|NCT00799409|587829021|FG000|Overall Study|Withdrawal by Subject|1|||
162758815|NCT00799409|587829022|FG001|Overall Study|Withdrawal by Subject|0|||
162758816|NCT00799409|587829023|FG002|Overall Study|Withdrawal by Subject|0|||
162758817|NCT00799409|587829021|FG000|Overall Study|Lost to Follow-up|1|||
162758818|NCT00799409|587829022|FG001|Overall Study|Lost to Follow-up|0|||
162758819|NCT00799409|587829023|FG002|Overall Study|Lost to Follow-up|0|||
162758820|NCT00799409|587829021|FG000|Overall Study|Optimal Dose Not Achieved|2|||
162758821|NCT00799409|587829022|FG001|Overall Study|Optimal Dose Not Achieved|0|||
162758822|NCT00799409|587829023|FG002|Overall Study|Optimal Dose Not Achieved|0|||
162758823|NCT00799409|587829021|FG000|Overall Study|Failure to follow study protocol)|1|||
162758824|NCT00799409|587829022|FG001|Overall Study|Failure to follow study protocol)|0|||
162758825|NCT00799409|587829023|FG002|Overall Study|Failure to follow study protocol)|0|||
162758826|NCT00799409|587829021|FG000|Overall Study|Did not attend lab school day 1|1|||
162758827|NCT00799409|587829022|FG001|Overall Study|Did not attend lab school day 1|0|||
162758828|NCT00799409|587829023|FG002|Overall Study|Did not attend lab school day 1|0|||
162758829|NCT00799409|587829021|FG000|Overall Study|medication compliance|1|||
162758830|NCT00799409|587829022|FG001|Overall Study|medication compliance|0|||
162758831|NCT00799409|587829023|FG002|Overall Study|medication compliance|0|||
162758832|NCT04323800|587829024|FG000|Overall Study|Withdrawal by Subject|4|||
162758833|NCT04323800|587829025|FG001|Overall Study|Withdrawal by Subject|4|||
162758834|NCT04323800|587829024|FG000|Overall Study|Incomplete transfusion|1|||
162758835|NCT04323800|587829025|FG001|Overall Study|Incomplete transfusion|0|||
162758836|NCT04323800|587829024|FG000|Overall Study|Other|0|||
162758837|NCT04323800|587829025|FG001|Overall Study|Other|1|||
162758838|NCT04323800|587829024|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
162758839|NCT04323800|587829025|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
162758840|NCT00489554|587829026|FG000|Overall Study|Adverse Event|2|||
162758841|NCT00489554|587829026|FG000|Overall Study|Withdrawal by Subject|1|||
162758842|NCT00489554|587829026|FG000|Overall Study|Lost to Follow-up|1|||
162758843|NCT01732757|587829027|FG000|Overall Study|Lost to Follow-up|1|||
162758844|NCT01732757|587829028|FG001|Overall Study|Lost to Follow-up|0|||
162758845|NCT01732757|587829029|FG002|Overall Study|Lost to Follow-up|0|||
162758846|NCT00731692|587829030|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
162758847|NCT00731692|587829031|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
162758848|NCT00731692|587829032|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
162758849|NCT00731692|587829030|FG000|Core Study (36 Months)|Physician Decision|1|||
162758850|NCT00731692|587829031|FG001|Core Study (36 Months)|Physician Decision|0|||
162758851|NCT00731692|587829032|FG002|Core Study (36 Months)|Physician Decision|2|||
162758852|NCT00731692|587829030|FG000|Core Study (36 Months)|Death|2|||
162758853|NCT00731692|587829031|FG001|Core Study (36 Months)|Death|1|||
162758854|NCT00731692|587829032|FG002|Core Study (36 Months)|Death|2|||
162758855|NCT00731692|587829030|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
162758856|NCT00731692|587829031|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
162758857|NCT00731692|587829032|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
162758858|NCT00731692|587829030|FG000|Core Study (36 Months)|Administrative|2|||
162758859|NCT00731692|587829031|FG001|Core Study (36 Months)|Administrative|2|||
162758860|NCT00731692|587829032|FG002|Core Study (36 Months)|Administrative|6|||
162758861|NCT00731692|587829030|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
162758862|NCT00731692|587829031|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
162758863|NCT00731692|587829032|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
162758864|NCT00731692|587829030|FG000|Core Study (36 Months)|Protocol Violation|4|||
162758865|NCT00731692|587829031|FG001|Core Study (36 Months)|Protocol Violation|5|||
162758866|NCT00731692|587829032|FG002|Core Study (36 Months)|Protocol Violation|8|||
162758867|NCT00731692|587829030|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
162758868|NCT00731692|587829031|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
162758869|NCT00731692|587829032|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
162758870|NCT00731692|587829030|FG000|Core Study (36 Months)|Adverse Event|25|||
162758871|NCT00731692|587829031|FG001|Core Study (36 Months)|Adverse Event|28|||
162758872|NCT00731692|587829032|FG002|Core Study (36 Months)|Adverse Event|29|||
162758873|NCT00731692|587829030|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
162758874|NCT00731692|587829031|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
162758875|NCT00731692|587829032|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
162758876|NCT00731692|587829030|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
162758877|NCT00731692|587829031|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
162758878|NCT00731692|587829032|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
162758879|NCT00731692|587829030|FG000|Extension Phase|Abnormal test procedure|0|||
162758880|NCT00731692|587829031|FG001|Extension Phase|Abnormal test procedure|0|||
162758881|NCT00731692|587829032|FG002|Extension Phase|Abnormal test procedure|1|||
162758882|NCT00731692|587829030|FG000|Extension Phase|Abnormal lab values|0|||
162758883|NCT00731692|587829031|FG001|Extension Phase|Abnormal lab values|0|||
162758884|NCT00731692|587829032|FG002|Extension Phase|Abnormal lab values|1|||
162758885|NCT00731692|587829030|FG000|Extension Phase|Lost to Follow-up|0|||
162758886|NCT00731692|587829031|FG001|Extension Phase|Lost to Follow-up|1|||
162758887|NCT00731692|587829032|FG002|Extension Phase|Lost to Follow-up|4|||
162758888|NCT00731692|587829030|FG000|Extension Phase|Withdrawal by Subject|4|||
162758889|NCT00731692|587829031|FG001|Extension Phase|Withdrawal by Subject|5|||
162758890|NCT00731692|587829032|FG002|Extension Phase|Withdrawal by Subject|3|||
162758891|NCT00731692|587829030|FG000|Extension Phase|Adverse Event|1|||
162758892|NCT00731692|587829031|FG001|Extension Phase|Adverse Event|1|||
162758893|NCT00731692|587829032|FG002|Extension Phase|Adverse Event|15|||
162758894|NCT02372799|587829033|FG000|Treatment Period|Adverse Event|3|||
162758895|NCT02372799|587829034|FG001|Treatment Period|Adverse Event|10|||
162758896|NCT02372799|587829035|FG002|Treatment Period|Adverse Event|6|||
162758897|NCT02372799|587829033|FG000|Treatment Period|Insufficient therapeutic response|2|||
162758898|NCT02372799|587829034|FG001|Treatment Period|Insufficient therapeutic response|2|||
162758899|NCT02372799|587829035|FG002|Treatment Period|Insufficient therapeutic response|0|||
162758900|NCT02372799|587829033|FG000|Treatment Period|Withdrawal by Subject|10|||
162758901|NCT02372799|587829034|FG001|Treatment Period|Withdrawal by Subject|10|||
162758902|NCT02372799|587829035|FG002|Treatment Period|Withdrawal by Subject|2|||
162758903|NCT02372799|587829033|FG000|Treatment Period|Lost to Follow-up|11|||
162758904|NCT02372799|587829034|FG001|Treatment Period|Lost to Follow-up|5|||
162758905|NCT02372799|587829035|FG002|Treatment Period|Lost to Follow-up|3|||
162758906|NCT02372799|587829033|FG000|Treatment Period|Protocol Violation|3|||
162758907|NCT02372799|587829034|FG001|Treatment Period|Protocol Violation|0|||
162758908|NCT02372799|587829035|FG002|Treatment Period|Protocol Violation|0|||
162758909|NCT02372799|587829033|FG000|Treatment Period|Non-compliance with study drug|4|||
162758910|NCT02372799|587829034|FG001|Treatment Period|Non-compliance with study drug|4|||
162758911|NCT02372799|587829035|FG002|Treatment Period|Non-compliance with study drug|4|||
162758912|NCT02372799|587829033|FG000|Treatment Period|Miscellaneous Reasons|1|||
162758913|NCT02372799|587829034|FG001|Treatment Period|Miscellaneous Reasons|1|||
162758914|NCT02372799|587829035|FG002|Treatment Period|Miscellaneous Reasons|0|||
162758915|NCT02372799|587829033|FG000|Down-taper Period|Lost to Follow-up|1|||
162758916|NCT02372799|587829034|FG001|Down-taper Period|Lost to Follow-up|2|||
162758917|NCT02372799|587829035|FG002|Down-taper Period|Lost to Follow-up|2|||
162758918|NCT00747006|587829036|FG000|Overall Study|Adverse Event|1|||
162758919|NCT00747006|587829037|FG001|Overall Study|Adverse Event|0|||
162758920|NCT00747006|587829038|FG002|Overall Study|Adverse Event|0|||
162758921|NCT00747006|587829036|FG000|Overall Study|Lost to Follow-up|0|||
162758922|NCT00747006|587829037|FG001|Overall Study|Lost to Follow-up|1|||
162758923|NCT00747006|587829038|FG002|Overall Study|Lost to Follow-up|0|||
162758924|NCT00747006|587829036|FG000|Overall Study|Physician Decision|2|||
162758925|NCT00747006|587829037|FG001|Overall Study|Physician Decision|0|||
162758926|NCT00747006|587829038|FG002|Overall Study|Physician Decision|1|||
162758927|NCT02132949|587829043|FG000|Overall Study|Death|7|||
162758928|NCT02132949|587829044|FG001|Overall Study|Death|13|||
162758929|NCT02132949|587829043|FG000|Overall Study|Lost to Follow-up|14|||
162758930|NCT02132949|587829044|FG001|Overall Study|Lost to Follow-up|4|||
162758931|NCT02132949|587829043|FG000|Overall Study|Withdrawal by Subject|6|||
162758932|NCT02132949|587829044|FG001|Overall Study|Withdrawal by Subject|5|||
162758933|NCT02132949|587829043|FG000|Overall Study|Noncompliance|5|||
162758934|NCT02132949|587829044|FG001|Overall Study|Noncompliance|1|||
162758935|NCT02132949|587829043|FG000|Overall Study|Physician Decision|3|||
162758936|NCT02132949|587829044|FG001|Overall Study|Physician Decision|1|||
162758937|NCT02132949|587829043|FG000|Overall Study|Disease Progression|3|||
162758938|NCT02132949|587829044|FG001|Overall Study|Disease Progression|0|||
162758939|NCT02132949|587829043|FG000|Overall Study|Adverse Event|2|||
162758940|NCT02132949|587829044|FG001|Overall Study|Adverse Event|1|||
162758941|NCT02132949|587829043|FG000|Overall Study|Withdrew Prior to Treatment|1|||
162758942|NCT02132949|587829044|FG001|Overall Study|Withdrew Prior to Treatment|2|||
162758943|NCT02132949|587829043|FG000|Overall Study|Reason Unspecified|0|||
162758944|NCT02132949|587829044|FG001|Overall Study|Reason Unspecified|1|||
162758945|NCT01583166|587829047|FG000|Overall Study|Withdrawal by Subject|4|||
162758946|NCT01583166|587829048|FG001|Overall Study|Withdrawal by Subject|6|||
162758947|NCT04652869|587829051|FG000|Overall Study|Withdrawal by Subject|0|||
162758948|NCT04652869|587829052|FG001|Overall Study|Withdrawal by Subject|2|||
162758949|NCT04652869|587829053|FG002|Overall Study|Withdrawal by Subject|0|||
162758950|NCT01372085|587829054|FG000|Washout Period 2|Physician Decision|0|||
162758951|NCT01372085|587829055|FG001|Washout Period 2|Physician Decision|0|||
162758952|NCT01372085|587829056|FG002|Washout Period 2|Physician Decision|0|||
162758953|NCT01372085|587829057|FG003|Washout Period 2|Physician Decision|0|||
162758954|NCT01372085|587829058|FG004|Washout Period 2|Physician Decision|1|||
162758955|NCT01372085|587829059|FG005|Washout Period 2|Physician Decision|0|||
162758956|NCT01372085|587829060|FG006|Washout Period 2|Physician Decision|0|||
162758957|NCT01372085|587829061|FG007|Washout Period 2|Physician Decision|0|||
162758958|NCT01372085|587829062|FG008|Washout Period 2|Physician Decision|0|||
162758959|NCT01372085|587829063|FG009|Washout Period 2|Physician Decision|0|||
162758960|NCT01372085|587829054|FG000|Washout Period 3|Withdrawal by Subject|0|||
162758961|NCT01372085|587829055|FG001|Washout Period 3|Withdrawal by Subject|0|||
162758962|NCT01372085|587829056|FG002|Washout Period 3|Withdrawal by Subject|0|||
162758963|NCT01372085|587829057|FG003|Washout Period 3|Withdrawal by Subject|0|||
162758964|NCT01372085|587829058|FG004|Washout Period 3|Withdrawal by Subject|0|||
162758965|NCT01372085|587829059|FG005|Washout Period 3|Withdrawal by Subject|2|||
162758966|NCT01372085|587829060|FG006|Washout Period 3|Withdrawal by Subject|0|||
162758967|NCT01372085|587829061|FG007|Washout Period 3|Withdrawal by Subject|0|||
162758968|NCT01372085|587829062|FG008|Washout Period 3|Withdrawal by Subject|0|||
162758969|NCT01372085|587829063|FG009|Washout Period 3|Withdrawal by Subject|0|||
162758970|NCT00562094|587829064|FG000|Overall Study|Lost to Follow-up|62|||
162758971|NCT03960645|587829065|FG000|Overall Study|Protocol Violation|1|||
162758972|NCT03960645|587829066|FG001|Overall Study|Protocol Violation|0|||
162758973|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
162758974|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
162758975|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
162758976|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
162758977|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
162758978|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
162758979|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
162758980|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162758981|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162758982|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162758983|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
162758984|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162758985|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162758986|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162758987|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
162758988|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
162758989|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
162758990|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
162758991|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
162758992|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
162758993|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
162758994|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
162758995|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
162758996|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
162758997|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
162758998|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
162758999|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
162759000|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
162759001|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
162759002|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
162759003|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
162759004|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
162759005|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
162759006|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
162759007|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
162759008|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162759009|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162759010|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162759011|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162759012|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162759013|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162759014|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
162759015|NCT03732807|587829071|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759016|NCT03732807|587829072|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759017|NCT03732807|587829073|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759018|NCT03732807|587829074|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759019|NCT03732807|587829075|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759020|NCT03732807|587829076|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
162759021|NCT03732807|587829077|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162759022|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162759023|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162759024|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162759025|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
162759026|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162759027|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162759028|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162759029|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
162759030|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
162759031|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
162759032|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
162759033|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
162759034|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
162759035|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
162759036|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162759037|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162759038|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
162759039|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
162759040|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
162759041|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
162759042|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162759043|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759044|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
162759045|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759046|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759047|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759048|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759049|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162759050|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162759051|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162759052|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162759053|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162759054|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162759055|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162759056|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162759057|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
162759058|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
162759059|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162759060|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162759061|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
162759062|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162759063|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162759064|NCT03732807|587829071|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
162759065|NCT03732807|587829072|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
162759066|NCT03732807|587829073|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
162759067|NCT03732807|587829074|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
162759068|NCT03732807|587829075|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
162759069|NCT03732807|587829076|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
162759070|NCT03732807|587829077|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
162759071|NCT03345979|587829078|FG000|Overall Study|Withdrawal by Subject|20|||
162759072|NCT03345979|587829079|FG001|Overall Study|Withdrawal by Subject|31|||
162759073|NCT03345979|587829078|FG000|Overall Study|Adverse Event|10|||
162759074|NCT03345979|587829079|FG001|Overall Study|Adverse Event|11|||
162759075|NCT03345979|587829078|FG000|Overall Study|Lost to Follow-up|8|||
162759076|NCT03345979|587829079|FG001|Overall Study|Lost to Follow-up|9|||
162759077|NCT03345979|587829078|FG000|Overall Study|Lack of Efficacy|4|||
162759078|NCT03345979|587829079|FG001|Overall Study|Lack of Efficacy|2|||
162759079|NCT03345979|587829078|FG000|Overall Study|Protocol Violation|1|||
162759080|NCT03345979|587829079|FG001|Overall Study|Protocol Violation|3|||
162759081|NCT03345979|587829078|FG000|Overall Study|Physician Decision|0|||
162759082|NCT03345979|587829079|FG001|Overall Study|Physician Decision|2|||
162759083|NCT00734578|587829081|FG000|Overall Study|Adverse Event|4|||
162759084|NCT00734578|587829082|FG001|Overall Study|Adverse Event|6|||
162759085|NCT00734578|587829083|FG002|Overall Study|Adverse Event|1|||
162759086|NCT00734578|587829081|FG000|Overall Study|Protocol Violation|8|||
162759087|NCT00734578|587829082|FG001|Overall Study|Protocol Violation|6|||
162759088|NCT00734578|587829083|FG002|Overall Study|Protocol Violation|3|||
162759089|NCT00734578|587829081|FG000|Overall Study|Withdrawal by Subject|7|||
162759090|NCT00734578|587829082|FG001|Overall Study|Withdrawal by Subject|8|||
162759091|NCT00734578|587829083|FG002|Overall Study|Withdrawal by Subject|11|||
162759092|NCT00734578|587829081|FG000|Overall Study|Lost to Follow-up|9|||
162759093|NCT00734578|587829082|FG001|Overall Study|Lost to Follow-up|3|||
162759094|NCT00734578|587829083|FG002|Overall Study|Lost to Follow-up|5|||
162759095|NCT00734578|587829081|FG000|Overall Study|Lack of Efficacy|3|||
162759096|NCT00734578|587829082|FG001|Overall Study|Lack of Efficacy|2|||
162759097|NCT00734578|587829083|FG002|Overall Study|Lack of Efficacy|5|||
162759098|NCT00734578|587829081|FG000|Overall Study|Randomized in error|1|||
162759099|NCT00734578|587829082|FG001|Overall Study|Randomized in error|0|||
162759100|NCT00734578|587829083|FG002|Overall Study|Randomized in error|0|||
162759101|NCT00734578|587829081|FG000|Overall Study|Exclusion criteria|1|||
162759102|NCT00734578|587829082|FG001|Overall Study|Exclusion criteria|0|||
162759103|NCT00734578|587829083|FG002|Overall Study|Exclusion criteria|0|||
162759104|NCT00999596|587829084|FG000|Overall Study|Statistical population not required|101|||
162759105|NCT02384382|587829085|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
162759106|NCT02384382|587829085|FG000|Overall Study|Death|1|||
162759107|NCT02384382|587829085|FG000|Overall Study|Adverse Event|1|||
162759108|NCT02384382|587829085|FG000|Overall Study|Disease progression|16|||
162759109|NCT01953692|587829086|FG000|Overall Study|Adverse Event|5|||
162759110|NCT01953692|587829087|FG001|Overall Study|Adverse Event|2|||
162759111|NCT01953692|587829088|FG002|Overall Study|Adverse Event|4|||
162759112|NCT01953692|587829089|FG003|Overall Study|Adverse Event|2|||
162759113|NCT01953692|587829090|FG004|Overall Study|Adverse Event|1|||
162759114|NCT01953692|587829091|FG005|Overall Study|Adverse Event|2|||
162759115|NCT01953692|587829092|FG006|Overall Study|Adverse Event|0|||
162759116|NCT01953692|587829093|FG007|Overall Study|Adverse Event|0|||
162759117|NCT01953692|587829094|FG008|Overall Study|Adverse Event|0|||
162759118|NCT01953692|587829086|FG000|Overall Study|Clinical Progression|0|||
162759119|NCT01953692|587829087|FG001|Overall Study|Clinical Progression|15|||
162759120|NCT01953692|587829088|FG002|Overall Study|Clinical Progression|7|||
162759121|NCT01953692|587829089|FG003|Overall Study|Clinical Progression|5|||
162759122|NCT01953692|587829090|FG004|Overall Study|Clinical Progression|0|||
162759123|NCT01953692|587829091|FG005|Overall Study|Clinical Progression|7|||
162759124|NCT01953692|587829092|FG006|Overall Study|Clinical Progression|20|||
162759125|NCT01953692|587829093|FG007|Overall Study|Clinical Progression|3|||
162759126|NCT01953692|587829094|FG008|Overall Study|Clinical Progression|3|||
162759127|NCT01953692|587829086|FG000|Overall Study|Death|5|||
162759128|NCT01953692|587829087|FG001|Overall Study|Death|0|||
162759129|NCT01953692|587829088|FG002|Overall Study|Death|2|||
162759130|NCT01953692|587829089|FG003|Overall Study|Death|2|||
162759131|NCT01953692|587829090|FG004|Overall Study|Death|1|||
162759132|NCT01953692|587829091|FG005|Overall Study|Death|3|||
162759133|NCT01953692|587829092|FG006|Overall Study|Death|6|||
162759134|NCT01953692|587829093|FG007|Overall Study|Death|2|||
162759135|NCT01953692|587829094|FG008|Overall Study|Death|1|||
162759136|NCT01953692|587829086|FG000|Overall Study|Excluded Medication|1|||
162759137|NCT01953692|587829087|FG001|Overall Study|Excluded Medication|0|||
162759138|NCT01953692|587829088|FG002|Overall Study|Excluded Medication|0|||
162759139|NCT01953692|587829089|FG003|Overall Study|Excluded Medication|0|||
162759140|NCT01953692|587829090|FG004|Overall Study|Excluded Medication|0|||
162759141|NCT01953692|587829091|FG005|Overall Study|Excluded Medication|0|||
162759142|NCT01953692|587829092|FG006|Overall Study|Excluded Medication|0|||
162759143|NCT01953692|587829093|FG007|Overall Study|Excluded Medication|0|||
162759144|NCT01953692|587829094|FG008|Overall Study|Excluded Medication|0|||
162759145|NCT01953692|587829086|FG000|Overall Study|Lost to Follow-up|1|||
162759146|NCT01953692|587829087|FG001|Overall Study|Lost to Follow-up|0|||
162759147|NCT01953692|587829088|FG002|Overall Study|Lost to Follow-up|3|||
162759148|NCT01953692|587829089|FG003|Overall Study|Lost to Follow-up|1|||
162759149|NCT01953692|587829090|FG004|Overall Study|Lost to Follow-up|0|||
162759150|NCT01953692|587829091|FG005|Overall Study|Lost to Follow-up|1|||
162759151|NCT01953692|587829092|FG006|Overall Study|Lost to Follow-up|0|||
162759152|NCT01953692|587829093|FG007|Overall Study|Lost to Follow-up|0|||
162759153|NCT01953692|587829094|FG008|Overall Study|Lost to Follow-up|0|||
162759154|NCT01953692|587829086|FG000|Overall Study|Physician Decision|11|||
162759155|NCT01953692|587829087|FG001|Overall Study|Physician Decision|4|||
162759156|NCT01953692|587829088|FG002|Overall Study|Physician Decision|2|||
162759157|NCT01953692|587829089|FG003|Overall Study|Physician Decision|2|||
162759158|NCT01953692|587829090|FG004|Overall Study|Physician Decision|1|||
162759159|NCT01953692|587829091|FG005|Overall Study|Physician Decision|2|||
162759160|NCT01953692|587829092|FG006|Overall Study|Physician Decision|4|||
162759161|NCT01953692|587829093|FG007|Overall Study|Physician Decision|1|||
162759162|NCT01953692|587829094|FG008|Overall Study|Physician Decision|0|||
162759163|NCT01953692|587829086|FG000|Overall Study|Protocol Violation|0|||
162759164|NCT01953692|587829087|FG001|Overall Study|Protocol Violation|2|||
162759165|NCT01953692|587829088|FG002|Overall Study|Protocol Violation|1|||
162759166|NCT01953692|587829089|FG003|Overall Study|Protocol Violation|0|||
162759167|NCT01953692|587829090|FG004|Overall Study|Protocol Violation|0|||
162759168|NCT01953692|587829091|FG005|Overall Study|Protocol Violation|0|||
162759169|NCT01953692|587829092|FG006|Overall Study|Protocol Violation|0|||
162759170|NCT01953692|587829093|FG007|Overall Study|Protocol Violation|1|||
162759171|NCT01953692|587829094|FG008|Overall Study|Protocol Violation|0|||
162759172|NCT01953692|587829086|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759173|NCT01953692|587829087|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759174|NCT01953692|587829088|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759175|NCT01953692|587829089|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759176|NCT01953692|587829090|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759177|NCT01953692|587829091|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759178|NCT01953692|587829092|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759179|NCT01953692|587829093|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
162759180|NCT01953692|587829094|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162759181|NCT01953692|587829086|FG000|Overall Study|Withdrawal by Subject|4|||
162759182|NCT01953692|587829087|FG001|Overall Study|Withdrawal by Subject|2|||
162759183|NCT01953692|587829088|FG002|Overall Study|Withdrawal by Subject|1|||
162759184|NCT01953692|587829089|FG003|Overall Study|Withdrawal by Subject|2|||
162759185|NCT01953692|587829090|FG004|Overall Study|Withdrawal by Subject|0|||
162759186|NCT01953692|587829091|FG005|Overall Study|Withdrawal by Subject|3|||
162759187|NCT01953692|587829092|FG006|Overall Study|Withdrawal by Subject|2|||
162759188|NCT01953692|587829093|FG007|Overall Study|Withdrawal by Subject|1|||
162759189|NCT01953692|587829094|FG008|Overall Study|Withdrawal by Subject|1|||
162759190|NCT01822756|587829097|FG000|Overall Study|Adverse Event|0|||
162759191|NCT01822756|587829098|FG001|Overall Study|Adverse Event|0|||
162759192|NCT01822756|587829099|FG002|Overall Study|Adverse Event|0|||
162759193|NCT01822756|587829100|FG003|Overall Study|Adverse Event|2|||
162759194|NCT01822756|587829101|FG004|Overall Study|Adverse Event|0|||
162759195|NCT01822756|587829097|FG000|Overall Study|Disease progression|11|||
162759196|NCT01822756|587829098|FG001|Overall Study|Disease progression|1|||
162759197|NCT01822756|587829099|FG002|Overall Study|Disease progression|7|||
162759198|NCT01822756|587829100|FG003|Overall Study|Disease progression|2|||
162759199|NCT01822756|587829101|FG004|Overall Study|Disease progression|6|||
162759200|NCT01822756|587829097|FG000|Overall Study|Death|2|||
162759201|NCT01822756|587829098|FG001|Overall Study|Death|2|||
162759202|NCT01822756|587829099|FG002|Overall Study|Death|1|||
162759203|NCT01822756|587829100|FG003|Overall Study|Death|0|||
162759204|NCT01822756|587829101|FG004|Overall Study|Death|0|||
162759205|NCT01822756|587829097|FG000|Overall Study|Lost to Follow-up|1|||
162759206|NCT01822756|587829098|FG001|Overall Study|Lost to Follow-up|0|||
162759207|NCT01822756|587829099|FG002|Overall Study|Lost to Follow-up|1|||
162759208|NCT01822756|587829100|FG003|Overall Study|Lost to Follow-up|0|||
162759209|NCT01822756|587829101|FG004|Overall Study|Lost to Follow-up|1|||
162759210|NCT01822756|587829097|FG000|Overall Study|Physician Decision|0|||
162759211|NCT01822756|587829098|FG001|Overall Study|Physician Decision|1|||
162759212|NCT01822756|587829099|FG002|Overall Study|Physician Decision|0|||
162759213|NCT01822756|587829100|FG003|Overall Study|Physician Decision|0|||
162759214|NCT01822756|587829101|FG004|Overall Study|Physician Decision|0|||
162759215|NCT01822756|587829097|FG000|Overall Study|disease progression & patient preference|2|||
162759216|NCT01822756|587829098|FG001|Overall Study|disease progression & patient preference|0|||
162759217|NCT01822756|587829099|FG002|Overall Study|disease progression & patient preference|1|||
162759218|NCT01822756|587829100|FG003|Overall Study|disease progression & patient preference|0|||
162759219|NCT01822756|587829101|FG004|Overall Study|disease progression & patient preference|0|||
162759220|NCT02157948|587829102|FG000|Overall Study|Withdrawal by Subject|4|||
162759221|NCT02157948|587829103|FG001|Overall Study|Withdrawal by Subject|5|||
162759222|NCT02157948|587829102|FG000|Overall Study|Lost to Follow-up|3|||
162759223|NCT02157948|587829103|FG001|Overall Study|Lost to Follow-up|2|||
162759224|NCT02157948|587829102|FG000|Overall Study|Protocol Specified Criteria|2|||
162759225|NCT02157948|587829103|FG001|Overall Study|Protocol Specified Criteria|1|||
162759226|NCT02157948|587829102|FG000|Overall Study|Decision by Sponsor|0|||
162759227|NCT02157948|587829103|FG001|Overall Study|Decision by Sponsor|1|||
162759228|NCT00467272|587829107|FG000|Overall Study|Pneumonia|2|||
162759229|NCT00467272|587829107|FG000|Overall Study|Thrombophlebitis|1|||
162759230|NCT01701401|587829108|FG000|Overall Study|Randomized But Not Treated|3|||
162759231|NCT01701401|587829109|FG001|Overall Study|Randomized But Not Treated|1|||
162759232|NCT01701401|587829110|FG002|Overall Study|Randomized But Not Treated|0|||
162759233|NCT01701401|587829111|FG003|Overall Study|Randomized But Not Treated|1|||
162759234|NCT01701401|587829108|FG000|Overall Study|Lost to Follow-up|5|||
162759235|NCT01701401|587829109|FG001|Overall Study|Lost to Follow-up|5|||
162759236|NCT01701401|587829110|FG002|Overall Study|Lost to Follow-up|1|||
162759237|NCT01701401|587829111|FG003|Overall Study|Lost to Follow-up|3|||
162759238|NCT01701401|587829108|FG000|Overall Study|Withdrew Consent|0|||
162759239|NCT01701401|587829109|FG001|Overall Study|Withdrew Consent|3|||
162759240|NCT01701401|587829110|FG002|Overall Study|Withdrew Consent|1|||
162759241|NCT01701401|587829111|FG003|Overall Study|Withdrew Consent|2|||
162759242|NCT01701401|587829108|FG000|Overall Study|Lack of Efficacy|1|||
162759243|NCT01701401|587829109|FG001|Overall Study|Lack of Efficacy|0|||
162759244|NCT01701401|587829110|FG002|Overall Study|Lack of Efficacy|2|||
162759245|NCT01701401|587829111|FG003|Overall Study|Lack of Efficacy|0|||
162759246|NCT01701401|587829108|FG000|Overall Study|Adverse Event|1|||
162759247|NCT01701401|587829109|FG001|Overall Study|Adverse Event|0|||
162759248|NCT01701401|587829110|FG002|Overall Study|Adverse Event|0|||
162759249|NCT01701401|587829111|FG003|Overall Study|Adverse Event|0|||
162759250|NCT01701401|587829108|FG000|Overall Study|Protocol Violation|0|||
162759251|NCT01701401|587829109|FG001|Overall Study|Protocol Violation|0|||
162759252|NCT01701401|587829110|FG002|Overall Study|Protocol Violation|1|||
162759253|NCT01701401|587829111|FG003|Overall Study|Protocol Violation|0|||
162759254|NCT00914966|587829112|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
162759255|NCT00914966|587829112|FG000|Step 1: 1500 Units|Physician Decision|1|||
162759256|NCT00914966|587829112|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
162759257|NCT04827732|587829116|FG000|Overall Study|Did not start treatment|0|||
162759258|NCT04827732|587829117|FG001|Overall Study|Did not start treatment|1|||
162759259|NCT04827732|587829118|FG002|Overall Study|Did not start treatment|0|||
162759260|NCT04827732|587829119|FG003|Overall Study|Did not start treatment|1|||
162759261|NCT00108355|587830211|FG000|Overall Study|Peritonitis at index paracentesis|1|||
162759262|NCT00108355|587830212|FG001|Overall Study|Peritonitis at index paracentesis|1|||
162759263|NCT00108355|587830211|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
162759264|NCT00108355|587830212|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
162759265|NCT03739866|587830218|FG000|Overall Study|Lost to Follow-up|0|||
162759266|NCT03739866|587830219|FG001|Overall Study|Lost to Follow-up|0|||
162759267|NCT03739866|587830220|FG002|Overall Study|Lost to Follow-up|0|||
162759268|NCT03739866|587830221|FG003|Overall Study|Lost to Follow-up|1|||
162759269|NCT03739866|587830222|FG004|Overall Study|Lost to Follow-up|0|||
162759270|NCT03739866|587830223|FG005|Overall Study|Lost to Follow-up|0|||
162759271|NCT03739866|587830224|FG006|Overall Study|Lost to Follow-up|0|||
162759272|NCT03739866|587830225|FG007|Overall Study|Lost to Follow-up|0|||
162759273|NCT03739866|587830218|FG000|Overall Study|Enrolled but not treated|0|||
162759274|NCT03739866|587830219|FG001|Overall Study|Enrolled but not treated|0|||
162759275|NCT03739866|587830220|FG002|Overall Study|Enrolled but not treated|1|||
162759276|NCT03739866|587830221|FG003|Overall Study|Enrolled but not treated|0|||
162759277|NCT03739866|587830222|FG004|Overall Study|Enrolled but not treated|1|||
162759278|NCT03739866|587830223|FG005|Overall Study|Enrolled but not treated|0|||
162759279|NCT03739866|587830224|FG006|Overall Study|Enrolled but not treated|0|||
162759280|NCT03739866|587830225|FG007|Overall Study|Enrolled but not treated|0|||
162759281|NCT00836498|587830226|FG000|Overall Study|Adverse Event|1|||
162759282|NCT00836498|587830227|FG001|Overall Study|Adverse Event|0|||
162759283|NCT00836498|587830226|FG000|Overall Study|Lost to Follow-up|1|||
162759284|NCT00836498|587830227|FG001|Overall Study|Lost to Follow-up|0|||
162759285|NCT00836498|587830226|FG000|Overall Study|Withdrawal by Subject|2|||
162759286|NCT00836498|587830227|FG001|Overall Study|Withdrawal by Subject|1|||
162759287|NCT01034306|587830228|FG000|Overall Study|Adverse Event|1|||
162759288|NCT01034306|587830229|FG001|Overall Study|Adverse Event|0|||
162759289|NCT01034306|587830228|FG000|Overall Study|Lost to Follow-up|0|||
162759290|NCT01034306|587830229|FG001|Overall Study|Lost to Follow-up|1|||
162759291|NCT01034306|587830228|FG000|Overall Study|Withdrawal by Subject|2|||
162759292|NCT01034306|587830229|FG001|Overall Study|Withdrawal by Subject|2|||
162759293|NCT01034306|587830228|FG000|Overall Study|hospitalized and decided to stop|1|||
162759294|NCT01034306|587830229|FG001|Overall Study|hospitalized and decided to stop|0|||
162759295|NCT01034306|587830228|FG000|Overall Study|Noncomplience|1|||
162759296|NCT01034306|587830229|FG001|Overall Study|Noncomplience|0|||
162759297|NCT03057600|587830230|FG000|Overall Study|Adverse Event|0|||
162759298|NCT03057600|587830231|FG001|Overall Study|Adverse Event|0|||
162759299|NCT03057600|587830232|FG002|Overall Study|Adverse Event|4|||
162759300|NCT03057600|587830233|FG003|Overall Study|Adverse Event|0|||
162759301|NCT03057600|587830230|FG000|Overall Study|Radiologic Disease Progression|8|||
162759302|NCT03057600|587830231|FG001|Overall Study|Radiologic Disease Progression|7|||
162759303|NCT03057600|587830232|FG002|Overall Study|Radiologic Disease Progression|13|||
162759304|NCT03057600|587830233|FG003|Overall Study|Radiologic Disease Progression|10|||
162759305|NCT03057600|587830230|FG000|Overall Study|Symptomatic Deterioration|0|||
162759306|NCT03057600|587830231|FG001|Overall Study|Symptomatic Deterioration|1|||
162759307|NCT03057600|587830232|FG002|Overall Study|Symptomatic Deterioration|1|||
162759308|NCT03057600|587830233|FG003|Overall Study|Symptomatic Deterioration|0|||
162759309|NCT03057600|587830230|FG000|Overall Study|Investigator Decision|0|||
162759310|NCT03057600|587830231|FG001|Overall Study|Investigator Decision|0|||
162759311|NCT03057600|587830232|FG002|Overall Study|Investigator Decision|1|||
162759312|NCT03057600|587830233|FG003|Overall Study|Investigator Decision|0|||
162759313|NCT03057600|587830230|FG000|Overall Study|Study Termination by Sponsor|0|||
162759314|NCT03057600|587830231|FG001|Overall Study|Study Termination by Sponsor|0|||
162759315|NCT03057600|587830232|FG002|Overall Study|Study Termination by Sponsor|0|||
162759316|NCT03057600|587830233|FG003|Overall Study|Study Termination by Sponsor|2|||
162759317|NCT03057600|587830230|FG000|Overall Study|Withdrawal by Subject|0|||
162759318|NCT03057600|587830231|FG001|Overall Study|Withdrawal by Subject|1|||
162759319|NCT03057600|587830232|FG002|Overall Study|Withdrawal by Subject|0|||
162759320|NCT03057600|587830233|FG003|Overall Study|Withdrawal by Subject|0|||
162759321|NCT03057600|587830230|FG000|Overall Study|Other, Not Specified|1|||
162759322|NCT03057600|587830231|FG001|Overall Study|Other, Not Specified|1|||
162759323|NCT03057600|587830232|FG002|Overall Study|Other, Not Specified|1|||
162759324|NCT03057600|587830233|FG003|Overall Study|Other, Not Specified|1|||
162759325|NCT01604824|587830240|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162759326|NCT01604824|587830241|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162759327|NCT01604824|587830242|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162759328|NCT01604824|587830243|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162759329|NCT01604824|587830244|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
162759330|NCT01604824|587830245|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162759331|NCT01604824|587830240|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
162759332|NCT01604824|587830241|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
162759333|NCT01604824|587830242|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
162759334|NCT01604824|587830243|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
162759335|NCT01604824|587830244|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
162759336|NCT01604824|587830245|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
162759337|NCT02630966|587830246|FG000|Overall Study|Adverse Event|1|||
162759338|NCT02630966|587830247|FG001|Overall Study|Adverse Event|3|||
162759339|NCT02630966|587830246|FG000|Overall Study|Significant Protocol Deviation|0|||
162759340|NCT02630966|587830247|FG001|Overall Study|Significant Protocol Deviation|2|||
162759341|NCT02630966|587830246|FG000|Overall Study|Voluntary Withdrawal|1|||
162759342|NCT02630966|587830247|FG001|Overall Study|Voluntary Withdrawal|1|||
162759343|NCT02630966|587830246|FG000|Overall Study|Lack of Efficacy|0|||
162759344|NCT02630966|587830247|FG001|Overall Study|Lack of Efficacy|2|||
162759345|NCT03389802|587830271|FG000|Overall Study|Lack of Efficacy|3|||
162759346|NCT03389802|587830272|FG001|Overall Study|Lack of Efficacy|3|||
162759347|NCT03389802|587830273|FG002|Overall Study|Lack of Efficacy|13|||
162759348|NCT03389802|587830274|FG003|Overall Study|Lack of Efficacy|6|||
162759349|NCT03389802|587830275|FG004|Overall Study|Lack of Efficacy|1|||
162759350|NCT03389802|587830271|FG000|Overall Study|Adverse Event|0|||
162759351|NCT03389802|587830272|FG001|Overall Study|Adverse Event|0|||
162759352|NCT03389802|587830273|FG002|Overall Study|Adverse Event|1|||
162759353|NCT03389802|587830274|FG003|Overall Study|Adverse Event|0|||
162759354|NCT03389802|587830275|FG004|Overall Study|Adverse Event|4|||
162759355|NCT03389802|587830271|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
162759356|NCT03389802|587830272|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
162759357|NCT03389802|587830273|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
162759358|NCT03389802|587830274|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
162759359|NCT03389802|587830275|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
162759360|NCT02426138|587830276|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162759361|NCT02426138|587830277|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162759362|NCT04677738|587830278|FG000|Overall Study|Withdrawal by Subject|4|||
162759363|NCT04677738|587830279|FG001|Overall Study|Withdrawal by Subject|2|||
162759364|NCT02409680|587830287|FG000|Overall Study|Lost to Follow-up|15|||
162759365|NCT02409680|587830288|FG001|Overall Study|Lost to Follow-up|30|||
162759366|NCT05366751|587830289|FG000|Overall Study|Adverse Event|25|||
162759367|NCT05366751|587830289|FG000|Overall Study|Physician Decision|3|||
162759368|NCT05366751|587830289|FG000|Overall Study|Lost to Follow-up|2|||
162759369|NCT05366751|587830289|FG000|Overall Study|Withdrawal by Subject|14|||
162759370|NCT05366751|587830289|FG000|Overall Study|Study Terminated by Sponsor|50|||
162759371|NCT05366751|587830289|FG000|Overall Study|Site Terminated by Sponsor|3|||
162759372|NCT01690624|587830292|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
162759373|NCT01690624|587830293|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
162759374|NCT01690624|587830294|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
162759375|NCT01690624|587830295|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
162759376|NCT01690624|587830292|FG000|Overall Study|Adverse event (other than DLT)|3|||
162759377|NCT01690624|587830293|FG001|Overall Study|Adverse event (other than DLT)|1|||
162759378|NCT01690624|587830294|FG002|Overall Study|Adverse event (other than DLT)|1|||
162759379|NCT01690624|587830295|FG003|Overall Study|Adverse event (other than DLT)|1|||
162759380|NCT01690624|587830292|FG000|Overall Study|Withdrawal by Subject|0|||
162759381|NCT01690624|587830293|FG001|Overall Study|Withdrawal by Subject|0|||
162759382|NCT01690624|587830294|FG002|Overall Study|Withdrawal by Subject|1|||
162759383|NCT01690624|587830295|FG003|Overall Study|Withdrawal by Subject|0|||
162759384|NCT01690624|587830292|FG000|Overall Study|Sponsor is ending trial|0|||
162759385|NCT01690624|587830293|FG001|Overall Study|Sponsor is ending trial|0|||
162759386|NCT01690624|587830294|FG002|Overall Study|Sponsor is ending trial|0|||
162759387|NCT01690624|587830295|FG003|Overall Study|Sponsor is ending trial|1|||
162759388|NCT01690624|587830292|FG000|Overall Study|Physician Decision|0|||
162759389|NCT01690624|587830293|FG001|Overall Study|Physician Decision|0|||
162759390|NCT01690624|587830294|FG002|Overall Study|Physician Decision|0|||
162759391|NCT01690624|587830295|FG003|Overall Study|Physician Decision|1|||
162759392|NCT01690624|587830292|FG000|Overall Study|Withdrawal by Subject|0|||
162759393|NCT01690624|587830293|FG001|Overall Study|Withdrawal by Subject|1|||
162759394|NCT01690624|587830294|FG002|Overall Study|Withdrawal by Subject|0|||
162759395|NCT01690624|587830295|FG003|Overall Study|Withdrawal by Subject|0|||
162759396|NCT01690624|587830292|FG000|Overall Study|Lack of Efficacy|1|||
162759397|NCT01690624|587830293|FG001|Overall Study|Lack of Efficacy|1|||
162759398|NCT01690624|587830294|FG002|Overall Study|Lack of Efficacy|3|||
162759399|NCT01690624|587830295|FG003|Overall Study|Lack of Efficacy|0|||
162759400|NCT04701203|587830303|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
162759401|NCT04701203|587830304|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
162759402|NCT04701203|587830305|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
162759403|NCT04701203|587830303|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
162759404|NCT04701203|587830304|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
162759405|NCT04701203|587830305|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
162759406|NCT04701203|587830303|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
162759407|NCT04701203|587830304|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
162759408|NCT04701203|587830305|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
162759409|NCT04701203|587830303|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
162759410|NCT04701203|587830304|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
162759411|NCT04701203|587830305|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
162759412|NCT01563185|587830308|FG000|Overall Study|Withdrawal by Subject|1|||
162759413|NCT01563185|587830308|FG000|Overall Study|Non-Compliance with study drug|1|||
162759414|NCT04577651|587830309|FG000|Overall Study|Screen Failure|7|||
162759415|NCT04577651|587830309|FG000|Overall Study|Adverse Event|1|||
162759416|NCT04577651|587830309|FG000|Overall Study|Death|1|||
162759417|NCT04577651|587830309|FG000|Overall Study|Physician Decision|1|||
162759418|NCT04577651|587830309|FG000|Overall Study|Withdrawal by Subject|3|||
162759419|NCT00647387|587830312|FG000|Overall Study|Lost to Follow-up|6|||
162759420|NCT00647387|587830312|FG000|Overall Study|Unsuccessful implant|5|||
162759421|NCT00647387|587830312|FG000|Overall Study|Device explanted|3|||
162759422|NCT00647387|587830312|FG000|Overall Study|Other Reason|3|||
162759423|NCT00647387|587830312|FG000|Overall Study|Death|2|||
162759424|NCT05293717|587830314|FG000|Overall Study|Physician Decision|1|||
162759425|NCT03147287|587830315|FG000|Overall Study|Randomized Not Treated|2|||
162759426|NCT03147287|587830316|FG001|Overall Study|Randomized Not Treated|1|||
162759427|NCT03147287|587830317|FG002|Overall Study|Randomized Not Treated|1|||
162759428|NCT03147287|587830315|FG000|Overall Study|Progressive Disease RECIST|31|||
162759429|NCT03147287|587830316|FG001|Overall Study|Progressive Disease RECIST|72|||
162759430|NCT03147287|587830317|FG002|Overall Study|Progressive Disease RECIST|32|||
162759431|NCT03147287|587830315|FG000|Overall Study|Progressive Disease not RECIST|13|||
162759432|NCT03147287|587830316|FG001|Overall Study|Progressive Disease not RECIST|21|||
162759433|NCT03147287|587830317|FG002|Overall Study|Progressive Disease not RECIST|13|||
162759434|NCT03147287|587830315|FG000|Overall Study|Physician Decision|1|||
162759435|NCT03147287|587830316|FG001|Overall Study|Physician Decision|2|||
162759436|NCT03147287|587830317|FG002|Overall Study|Physician Decision|1|||
162759437|NCT03147287|587830315|FG000|Overall Study|Intercurrent illness|0|||
162759438|NCT03147287|587830316|FG001|Overall Study|Intercurrent illness|1|||
162759439|NCT03147287|587830317|FG002|Overall Study|Intercurrent illness|0|||
162759440|NCT03147287|587830315|FG000|Overall Study|Withdrawal by Subject|2|||
162759441|NCT03147287|587830316|FG001|Overall Study|Withdrawal by Subject|3|||
162759442|NCT03147287|587830317|FG002|Overall Study|Withdrawal by Subject|2|||
162759443|NCT03147287|587830315|FG000|Overall Study|Patient Non-Compliance|0|||
162759444|NCT03147287|587830316|FG001|Overall Study|Patient Non-Compliance|2|||
162759445|NCT03147287|587830317|FG002|Overall Study|Patient Non-Compliance|0|||
162759446|NCT03147287|587830315|FG000|Overall Study|Patient moved|0|||
162759447|NCT03147287|587830316|FG001|Overall Study|Patient moved|1|||
162759448|NCT03147287|587830317|FG002|Overall Study|Patient moved|0|||
162759449|NCT03147287|587830315|FG000|Overall Study|Arm A crossover without PD|1|||
162759450|NCT03147287|587830316|FG001|Overall Study|Arm A crossover without PD|0|||
162759451|NCT03147287|587830317|FG002|Overall Study|Arm A crossover without PD|0|||
162759452|NCT03147287|587830315|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
162759453|NCT03147287|587830316|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
162759454|NCT03147287|587830317|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
162759455|NCT00302211|587830318|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
162759456|NCT00302211|587830319|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
162759457|NCT00302211|587830320|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162759458|NCT00302211|587830321|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162759459|NCT00302211|587830322|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162759460|NCT00302211|587830318|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
162759461|NCT00302211|587830319|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
162759462|NCT00302211|587830320|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
162759463|NCT00302211|587830321|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
162759464|NCT00302211|587830322|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
162759465|NCT00302211|587830318|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
162759466|NCT00302211|587830319|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
162759467|NCT00302211|587830320|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
162759468|NCT00302211|587830321|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
162759469|NCT00302211|587830322|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
162759470|NCT00302211|587830318|FG000|Double Blind Period (New Patients)|Disease progression|0|||
162759471|NCT00302211|587830319|FG001|Double Blind Period (New Patients)|Disease progression|1|||
162759472|NCT00302211|587830320|FG002|Double Blind Period (New Patients)|Disease progression|1|||
162759473|NCT00302211|587830321|FG003|Double Blind Period (New Patients)|Disease progression|0|||
162759474|NCT00302211|587830322|FG004|Double Blind Period (New Patients)|Disease progression|0|||
162759475|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162759476|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162759477|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162759478|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
162759479|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
162759480|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
162759481|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
162759482|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
162759483|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
162759484|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
162759485|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162759486|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162759487|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162759488|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
162759489|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162759490|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
162759491|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
162759492|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
162759493|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
162759494|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
162759495|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Death|0|||
162759496|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Death|0|||
162759497|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Death|0|||
162759498|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Death|1|||
162759499|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Death|1|||
162759500|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162759501|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162759502|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162759503|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162759504|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
162759505|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162759506|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162759507|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162759508|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162759509|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
162759510|NCT00302211|587830318|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162759511|NCT00302211|587830319|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162759512|NCT00302211|587830320|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162759513|NCT00302211|587830321|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
162759514|NCT00302211|587830322|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162759515|NCT06571695|587832667|FG000|Overall Study|Lost to Follow-up|1|||
162759516|NCT06571695|587832668|FG001|Overall Study|Lost to Follow-up|6|||
162759517|NCT04921358|587832669|FG000|Overall Study|Withdrawal by Subject|6|||
162759518|NCT04921358|587832670|FG001|Overall Study|Withdrawal by Subject|13|||
162759519|NCT04921358|587832669|FG000|Overall Study|Lost to Follow-up|3|||
162759520|NCT04921358|587832670|FG001|Overall Study|Lost to Follow-up|6|||
162759521|NCT04921358|587832669|FG000|Overall Study|Study Terminated by Sponsor|86|||
162759522|NCT04921358|587832670|FG001|Overall Study|Study Terminated by Sponsor|89|||
162759523|NCT04921358|587832669|FG000|Overall Study|Death|92|||
162759524|NCT04921358|587832670|FG001|Overall Study|Death|82|||
162759525|NCT02278796|587832671|FG000|Overall Study|Death|2|||
162759526|NCT02278796|587832672|FG001|Overall Study|Death|3|||
162759527|NCT04926857|587832673|FG000|Overall Study|Withdrawal by Subject|40|||
162759528|NCT04926857|587832673|FG000|Overall Study|Death|9|||
162759529|NCT04926857|587832673|FG000|Overall Study|Study product no longer in use|44|||
162759530|NCT04926857|587832673|FG000|Overall Study|Inadequate data to address primary objective|16|||
162759531|NCT01256359|587832677|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
162810524|NCT00762970|588018250|FG000|Overall Study|Difficulty of handling lens|1|||
162759532|NCT01256359|587832678|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
162759533|NCT01256359|587832677|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
162759534|NCT01256359|587832678|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
162759535|NCT03737110|587832681|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
162759536|NCT03737110|587832682|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
162759537|NCT03737110|587832683|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
162759538|NCT03737110|587832684|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
162759539|NCT03737110|587832685|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
162759540|NCT03737110|587832686|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
162759541|NCT03737110|587832681|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
162759542|NCT03737110|587832682|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162759543|NCT03737110|587832683|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162759544|NCT03737110|587832684|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162759545|NCT03737110|587832685|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162759546|NCT03737110|587832686|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162759547|NCT03737110|587832681|FG000|Run-in (RI) Period|Adverse Event|4|||
162759548|NCT03737110|587832682|FG001|Run-in (RI) Period|Adverse Event|0|||
162759549|NCT03737110|587832683|FG002|Run-in (RI) Period|Adverse Event|0|||
162759550|NCT03737110|587832684|FG003|Run-in (RI) Period|Adverse Event|0|||
162759551|NCT03737110|587832685|FG004|Run-in (RI) Period|Adverse Event|0|||
162759552|NCT03737110|587832686|FG005|Run-in (RI) Period|Adverse Event|0|||
162759553|NCT03737110|587832681|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162759554|NCT03737110|587832682|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
162759555|NCT03737110|587832683|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162759556|NCT03737110|587832684|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162759557|NCT03737110|587832685|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162759558|NCT03737110|587832686|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162759559|NCT03737110|587832681|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162759560|NCT03737110|587832682|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162759561|NCT03737110|587832683|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
162759562|NCT03737110|587832684|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162759563|NCT03737110|587832685|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162759564|NCT03737110|587832686|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162759565|NCT03737110|587832681|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162759566|NCT03737110|587832682|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162759567|NCT03737110|587832683|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162759568|NCT03737110|587832684|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
162759569|NCT03737110|587832685|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162759570|NCT03737110|587832686|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162759571|NCT03737110|587832681|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162759572|NCT03737110|587832682|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162759573|NCT03737110|587832683|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162759574|NCT03737110|587832684|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
162759575|NCT03737110|587832685|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162759576|NCT03737110|587832686|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
162759577|NCT03737110|587832681|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162759578|NCT03737110|587832682|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162759579|NCT03737110|587832683|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162759580|NCT03737110|587832684|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162759581|NCT03737110|587832685|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
162759582|NCT03737110|587832686|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162759583|NCT04237792|587832697|FG000|Treatment (Day 1)|Adverse Event|1|||
162759584|NCT04237792|587832698|FG001|Treatment (Day 1)|Adverse Event|0|||
162759585|NCT04237792|587832699|FG002|Treatment (Day 1)|Adverse Event|0|||
162759586|NCT04237792|587832700|FG003|Treatment (Day 1)|Adverse Event|0|||
162759587|NCT04237792|587832701|FG004|Treatment (Day 1)|Adverse Event|1|||
162759588|NCT04237792|587832702|FG005|Treatment (Day 1)|Adverse Event|1|||
162759589|NCT04237792|587832697|FG000|Treatment (Day 1)|Other|0|||
162759590|NCT04237792|587832698|FG001|Treatment (Day 1)|Other|0|||
162759591|NCT04237792|587832699|FG002|Treatment (Day 1)|Other|1|||
162759592|NCT04237792|587832700|FG003|Treatment (Day 1)|Other|0|||
162759593|NCT04237792|587832701|FG004|Treatment (Day 1)|Other|0|||
162759594|NCT04237792|587832702|FG005|Treatment (Day 1)|Other|1|||
162759595|NCT04237792|587832697|FG000|Treatment (Day 1)|Not treated|1|||
162759596|NCT04237792|587832698|FG001|Treatment (Day 1)|Not treated|1|||
162759597|NCT04237792|587832699|FG002|Treatment (Day 1)|Not treated|2|||
162759598|NCT04237792|587832700|FG003|Treatment (Day 1)|Not treated|1|||
162759599|NCT04237792|587832701|FG004|Treatment (Day 1)|Not treated|0|||
162759600|NCT04237792|587832702|FG005|Treatment (Day 1)|Not treated|1|||
162759601|NCT04693637|587832703|FG000|Overall Study|Death|4|||
162759602|NCT04693637|587832703|FG000|Overall Study|Withdrawal by Subject|3|||
162759603|NCT04693637|587832703|FG000|Overall Study|Physician Decision|2|||
162759604|NCT04693637|587832703|FG000|Overall Study|Lost to Follow-up|1|||
162759605|NCT03052517|587832705|FG000|Overall Study|Study Terminated By Sponsor|928|||
162759606|NCT03052517|587832706|FG001|Overall Study|Study Terminated By Sponsor|938|||
162759607|NCT03052517|587832707|FG002|Overall Study|Study Terminated By Sponsor|296|||
162759608|NCT03052517|587832705|FG000|Overall Study|Subject/Guardian Decision|50|||
162759609|NCT03052517|587832706|FG001|Overall Study|Subject/Guardian Decision|45|||
162759610|NCT03052517|587832707|FG002|Overall Study|Subject/Guardian Decision|22|||
162759611|NCT03052517|587832705|FG000|Overall Study|Lack of Efficacy|23|||
162759612|NCT03052517|587832706|FG001|Overall Study|Lack of Efficacy|14|||
162759613|NCT03052517|587832707|FG002|Overall Study|Lack of Efficacy|7|||
162759614|NCT03052517|587832705|FG000|Overall Study|Adverse Event|6|||
162759615|NCT03052517|587832706|FG001|Overall Study|Adverse Event|5|||
162759616|NCT03052517|587832707|FG002|Overall Study|Adverse Event|0|||
162759617|NCT03052517|587832705|FG000|Overall Study|Physician Decision|4|||
162759618|NCT03052517|587832706|FG001|Overall Study|Physician Decision|5|||
162759619|NCT03052517|587832707|FG002|Overall Study|Physician Decision|1|||
162759620|NCT03052517|587832705|FG000|Overall Study|Death|3|||
162759621|NCT03052517|587832706|FG001|Overall Study|Death|0|||
162759622|NCT03052517|587832707|FG002|Overall Study|Death|1|||
162759623|NCT03052517|587832705|FG000|Overall Study|Lost to Follow-up|2|||
162759624|NCT03052517|587832706|FG001|Overall Study|Lost to Follow-up|4|||
162759625|NCT03052517|587832707|FG002|Overall Study|Lost to Follow-up|0|||
162759626|NCT03052517|587832705|FG000|Overall Study|Pregnancy|1|||
162759627|NCT03052517|587832706|FG001|Overall Study|Pregnancy|0|||
162759628|NCT03052517|587832707|FG002|Overall Study|Pregnancy|1|||
162759629|NCT03052517|587832705|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
162759630|NCT03052517|587832706|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
162759631|NCT03052517|587832707|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
162759632|NCT03052517|587832705|FG000|Overall Study|Technical Problems|0|||
162759633|NCT03052517|587832706|FG001|Overall Study|Technical Problems|1|||
162759634|NCT03052517|587832707|FG002|Overall Study|Technical Problems|0|||
162759635|NCT04885998|587832710|FG000|Overall Study|Withdrawal by Subject|0|||
162759636|NCT04885998|587832711|FG001|Overall Study|Withdrawal by Subject|2|||
162759637|NCT04885998|587832712|FG002|Overall Study|Withdrawal by Subject|0|||
162759638|NCT04885998|587832713|FG003|Overall Study|Withdrawal by Subject|3|||
162759639|NCT04885998|587832710|FG000|Overall Study|Lost to Follow-up|1|||
162759640|NCT04885998|587832711|FG001|Overall Study|Lost to Follow-up|1|||
162759641|NCT04885998|587832712|FG002|Overall Study|Lost to Follow-up|0|||
162759642|NCT04885998|587832713|FG003|Overall Study|Lost to Follow-up|0|||
162759643|NCT04885998|587832710|FG000|Overall Study|Death|2|||
162759644|NCT04885998|587832711|FG001|Overall Study|Death|1|||
162759645|NCT04885998|587832712|FG002|Overall Study|Death|2|||
162759646|NCT04885998|587832713|FG003|Overall Study|Death|2|||
162759647|NCT04885998|587832710|FG000|Overall Study|Decision by sponsor|1|||
162759648|NCT04885998|587832711|FG001|Overall Study|Decision by sponsor|1|||
162759649|NCT04885998|587832712|FG002|Overall Study|Decision by sponsor|0|||
162759650|NCT04885998|587832713|FG003|Overall Study|Decision by sponsor|0|||
162759651|NCT05260437|587832715|FG000|Overall Study|Lost to Follow-up|5|||
162759652|NCT05260437|587832716|FG001|Overall Study|Lost to Follow-up|2|||
162759653|NCT05260437|587832717|FG002|Overall Study|Lost to Follow-up|1|||
162759654|NCT05260437|587832718|FG003|Overall Study|Lost to Follow-up|2|||
162759655|NCT05260437|587832719|FG004|Overall Study|Lost to Follow-up|2|||
162759656|NCT05260437|587832715|FG000|Overall Study|Withdrawal by Subject|3|||
162759657|NCT05260437|587832716|FG001|Overall Study|Withdrawal by Subject|0|||
162759658|NCT05260437|587832717|FG002|Overall Study|Withdrawal by Subject|4|||
162759659|NCT05260437|587832718|FG003|Overall Study|Withdrawal by Subject|5|||
162759660|NCT05260437|587832719|FG004|Overall Study|Withdrawal by Subject|0|||
162759661|NCT05260437|587832715|FG000|Overall Study|Vaccine Not Administered|0|||
162759662|NCT05260437|587832716|FG001|Overall Study|Vaccine Not Administered|1|||
162759663|NCT05260437|587832717|FG002|Overall Study|Vaccine Not Administered|0|||
162759664|NCT05260437|587832718|FG003|Overall Study|Vaccine Not Administered|0|||
162759665|NCT05260437|587832719|FG004|Overall Study|Vaccine Not Administered|0|||
162759666|NCT00910962|587832720|FG000|Overall Study|Adverse Event|5|||
162759667|NCT00910962|587832721|FG001|Overall Study|Adverse Event|20|||
162759668|NCT00910962|587832722|FG002|Overall Study|Adverse Event|17|||
162759669|NCT00910962|587832720|FG000|Overall Study|Protocol Violation|1|||
162759670|NCT00910962|587832721|FG001|Overall Study|Protocol Violation|3|||
162759671|NCT00910962|587832722|FG002|Overall Study|Protocol Violation|3|||
162759672|NCT00910962|587832720|FG000|Overall Study|Lost to Follow-up|0|||
162759673|NCT00910962|587832721|FG001|Overall Study|Lost to Follow-up|3|||
162759674|NCT00910962|587832722|FG002|Overall Study|Lost to Follow-up|1|||
162759675|NCT00910962|587832720|FG000|Overall Study|Physician Decision|0|||
162759676|NCT00910962|587832721|FG001|Overall Study|Physician Decision|6|||
162759677|NCT00910962|587832722|FG002|Overall Study|Physician Decision|6|||
162759678|NCT00910962|587832720|FG000|Overall Study|Withdrawal by Subject|25|||
162759679|NCT00910962|587832721|FG001|Overall Study|Withdrawal by Subject|32|||
162759680|NCT00910962|587832722|FG002|Overall Study|Withdrawal by Subject|32|||
162759681|NCT00910962|587832720|FG000|Overall Study|Reached defined stopping criteria|12|||
162759682|NCT00910962|587832721|FG001|Overall Study|Reached defined stopping criteria|14|||
162759683|NCT00910962|587832722|FG002|Overall Study|Reached defined stopping criteria|17|||
162759684|NCT00195819|587832723|FG000|Double-Blind|Withdrawal by Subject|1|||
162759685|NCT00195819|587832724|FG001|Double-Blind|Withdrawal by Subject|0|||
162759686|NCT00195819|587832723|FG000|Double-Blind|Moved|1|||
162759687|NCT00195819|587832724|FG001|Double-Blind|Moved|0|||
162759688|NCT00195819|587832723|FG000|Open-label|Adverse Event|0|||
162759689|NCT00195819|587832724|FG001|Open-label|Adverse Event|9|||
162759690|NCT00195819|587832723|FG000|Open-label|Lack of Efficacy|0|||
162759691|NCT00195819|587832724|FG001|Open-label|Lack of Efficacy|2|||
162759692|NCT00195819|587832723|FG000|Open-label|Pregnancy|0|||
162759693|NCT00195819|587832724|FG001|Open-label|Pregnancy|1|||
162759694|NCT00195819|587832723|FG000|Open-label|Protocol Violation|0|||
162759695|NCT00195819|587832724|FG001|Open-label|Protocol Violation|2|||
162759696|NCT00195819|587832723|FG000|Open-label|Moved|0|||
162759697|NCT00195819|587832724|FG001|Open-label|Moved|1|||
162759698|NCT00195819|587832723|FG000|Open-label|Withdrawal by Subject|0|||
162759699|NCT00195819|587832724|FG001|Open-label|Withdrawal by Subject|5|||
162759700|NCT00787176|587832725|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
162759701|NCT00787176|587832726|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
162759702|NCT00787176|587832727|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
162759703|NCT00787176|587832728|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
162759704|NCT01124045|587832729|FG000|Overall Study|Lost to Follow-up|0|||
162759705|NCT01124045|587832730|FG001|Overall Study|Lost to Follow-up|1|||
162759706|NCT01124045|587832729|FG000|Overall Study|Physician Decision|0|||
162759707|NCT01124045|587832730|FG001|Overall Study|Physician Decision|2|||
162759708|NCT03298087|587832736|FG000|Overall Study|Withdrawal by Subject|4|||
162759709|NCT01079806|587832737|FG000|Day 1 to Week 96|Adverse Event|0|||
162759710|NCT01079806|587832738|FG001|Day 1 to Week 96|Adverse Event|3|||
162759711|NCT01079806|587832737|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
162759712|NCT01079806|587832738|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
162759713|NCT01079806|587832737|FG000|Day 1 to Week 96|Pregnancy|0|||
162759714|NCT01079806|587832738|FG001|Day 1 to Week 96|Pregnancy|1|||
162759715|NCT01079806|587832737|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
162759716|NCT01079806|587832738|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
162759717|NCT01079806|587832737|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
162759718|NCT01079806|587832738|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
162759719|NCT01079806|587832737|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
162759720|NCT01079806|587832738|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
162759721|NCT01079806|587832737|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
162759722|NCT01079806|587832738|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
162759723|NCT01079806|587832737|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
162759724|NCT01079806|587832738|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
162759725|NCT01079806|587832737|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
162759726|NCT01079806|587832738|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
162759727|NCT01079806|587832737|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
162759728|NCT01079806|587832738|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
162759729|NCT00249769|587832743|FG000|Overall Study|Withdrawal by Subject|1|||
162759730|NCT00249769|587832744|FG001|Overall Study|Withdrawal by Subject|10|||
162759731|NCT00249769|587832745|FG002|Overall Study|Withdrawal by Subject|6|||
162759732|NCT00249769|587832743|FG000|Overall Study|Migration from Study Area|1|||
162759733|NCT00249769|587832744|FG001|Overall Study|Migration from Study Area|3|||
162759734|NCT00249769|587832745|FG002|Overall Study|Migration from Study Area|14|||
162759735|NCT00249769|587832743|FG000|Overall Study|Miscellaneous|0|||
162759736|NCT00249769|587832744|FG001|Overall Study|Miscellaneous|2|||
162759737|NCT00249769|587832745|FG002|Overall Study|Miscellaneous|2|||
162759738|NCT00249769|587832743|FG000|Overall Study|Adverse Event|0|||
162759739|NCT00249769|587832744|FG001|Overall Study|Adverse Event|0|||
162759740|NCT00249769|587832745|FG002|Overall Study|Adverse Event|1|||
162759741|NCT00249769|587832743|FG000|Overall Study|Physician Decision|0|||
162759742|NCT00249769|587832744|FG001|Overall Study|Physician Decision|0|||
162759743|NCT00249769|587832745|FG002|Overall Study|Physician Decision|2|||
162759744|NCT00249769|587832743|FG000|Overall Study|Lost to Follow-up|0|||
162759745|NCT00249769|587832744|FG001|Overall Study|Lost to Follow-up|0|||
162759746|NCT00249769|587832745|FG002|Overall Study|Lost to Follow-up|3|||
162759747|NCT03274076|587832750|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
162759748|NCT03274076|587832751|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
162759749|NCT03274076|587832752|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
162759750|NCT03274076|587832753|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
162759751|NCT03274076|587832750|FG000|24 Weeks Open Label|Adverse Event|0|||
162759752|NCT03274076|587832751|FG001|24 Weeks Open Label|Adverse Event|0|||
162759753|NCT03274076|587832752|FG002|24 Weeks Open Label|Adverse Event|2|||
162759754|NCT03274076|587832753|FG003|24 Weeks Open Label|Adverse Event|0|||
162759755|NCT03274076|587832750|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
162759756|NCT03274076|587832751|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
162759757|NCT03274076|587832752|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
162759758|NCT03274076|587832753|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
162759759|NCT03781375|587832754|FG000|Double-blind Phase|Adverse Event|0|||
162759760|NCT03781375|587832755|FG001|Double-blind Phase|Adverse Event|1|||
162759761|NCT03781375|587832754|FG000|Double-blind Phase|Lack of Response|6|||
162759762|NCT03781375|587832755|FG001|Double-blind Phase|Lack of Response|2|||
162759763|NCT03781375|587832754|FG000|Double-blind Phase|Other|1|||
162759764|NCT03781375|587832755|FG001|Double-blind Phase|Other|3|||
162759765|NCT03781375|587832754|FG000|Open-label Phase|Protocol Issues|0|||
162759766|NCT03781375|587832755|FG001|Open-label Phase|Protocol Issues|1|||
162759767|NCT03781375|587832754|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
162759768|NCT03781375|587832755|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
162759769|NCT03781375|587832754|FG000|Open-label Phase|Other|2|||
162759770|NCT03781375|587832755|FG001|Open-label Phase|Other|2|||
162759771|NCT01530334|587832756|FG000|Overall Study|Adverse Event|3|||
162759772|NCT01530334|587832756|FG000|Overall Study|unknown reason|1|||
162759773|NCT01530334|587832756|FG000|Overall Study|Progressive disease|47|||
162759774|NCT01629589|587832757|FG000|Overall Study|Protocol Violation|4|||
162759775|NCT01629589|587832758|FG001|Overall Study|Protocol Violation|2|||
162759776|NCT01629589|587832757|FG000|Overall Study|Lost to Follow-up|2|||
162759777|NCT01629589|587832758|FG001|Overall Study|Lost to Follow-up|1|||
162759778|NCT01629589|587832757|FG000|Overall Study|Withdrawal by Subject|2|||
162759779|NCT01629589|587832758|FG001|Overall Study|Withdrawal by Subject|3|||
162759780|NCT01629589|587832757|FG000|Overall Study|Did not receive study vaccine|0|||
162759781|NCT01629589|587832758|FG001|Overall Study|Did not receive study vaccine|1|||
162759782|NCT02079649|587832759|FG000|Overall Study|Lost to Follow-up|0|||
162759783|NCT02079649|587832760|FG001|Overall Study|Lost to Follow-up|0|||
162759784|NCT02079649|587832761|FG002|Overall Study|Lost to Follow-up|0|||
162759785|NCT02079649|587832762|FG003|Overall Study|Lost to Follow-up|1|||
162759786|NCT02079649|587832759|FG000|Overall Study|Withdrawal by Subject|0|||
162759787|NCT02079649|587832760|FG001|Overall Study|Withdrawal by Subject|0|||
162759788|NCT02079649|587832761|FG002|Overall Study|Withdrawal by Subject|0|||
162759789|NCT02079649|587832762|FG003|Overall Study|Withdrawal by Subject|1|||
162759790|NCT02079649|587832759|FG000|Overall Study|Randomization error (prior to treatment)|1|||
162759791|NCT02079649|587832760|FG001|Overall Study|Randomization error (prior to treatment)|0|||
162759792|NCT02079649|587832761|FG002|Overall Study|Randomization error (prior to treatment)|1|||
162759793|NCT02079649|587832762|FG003|Overall Study|Randomization error (prior to treatment)|0|||
162759794|NCT01932970|587832785|FG000|Overall Study|Withdrawal by Subject|5|||
162759795|NCT01932970|587832785|FG000|Overall Study|Death|1|||
162759796|NCT01932970|587832785|FG000|Overall Study|Lost to Follow-up|2|||
162759797|NCT01932970|587832785|FG000|Overall Study|Protocol Specified Criteria|10|||
162759798|NCT00822900|587832786|FG000|Overall Study|Withdrawal by Subject|14|||
162759799|NCT00822900|587832787|FG001|Overall Study|Withdrawal by Subject|14|||
162759800|NCT00822900|587832786|FG000|Overall Study|Lost to Follow-up|9|||
162759801|NCT00822900|587832787|FG001|Overall Study|Lost to Follow-up|9|||
162759802|NCT00822900|587832786|FG000|Overall Study|Death|83|||
162759803|NCT00822900|587832787|FG001|Overall Study|Death|69|||
162759804|NCT00822900|587832786|FG000|Overall Study|Became a ward of the state|2|||
162759805|NCT00822900|587832787|FG001|Overall Study|Became a ward of the state|1|||
162759806|NCT03489369|587832788|FG000|Overall Study|Documented Progressive Disease|3|||
162759807|NCT03489369|587832789|FG001|Overall Study|Documented Progressive Disease|2|||
162759808|NCT03489369|587832790|FG002|Overall Study|Documented Progressive Disease|3|||
162759809|NCT03489369|587832791|FG003|Overall Study|Documented Progressive Disease|6|||
162759810|NCT03489369|587832788|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
162759811|NCT03489369|587832789|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
162759812|NCT03489369|587832790|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
162759813|NCT03489369|587832791|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
162759814|NCT01968967|587832792|FG000|Treatment Period|Other|22|||
162759815|NCT01968967|587832793|FG001|Treatment Period|Other|22|||
162759816|NCT01968967|587832794|FG002|Treatment Period|Other|0|||
162759817|NCT01968967|587832795|FG003|Treatment Period|Other|0|||
162759818|NCT01968967|587832796|FG004|Treatment Period|Other|0|||
162759819|NCT01968967|587832792|FG000|Treatment Period|Withdrawal by Subject|71|||
162759820|NCT01968967|587832793|FG001|Treatment Period|Withdrawal by Subject|61|||
162759821|NCT01968967|587832794|FG002|Treatment Period|Withdrawal by Subject|0|||
162759822|NCT01968967|587832795|FG003|Treatment Period|Withdrawal by Subject|0|||
162759823|NCT01968967|587832796|FG004|Treatment Period|Withdrawal by Subject|0|||
162759824|NCT01968967|587832792|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
162759825|NCT01968967|587832793|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
162759826|NCT01968967|587832794|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
162759827|NCT01968967|587832795|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
162759828|NCT01968967|587832796|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
162759829|NCT01968967|587832792|FG000|Treatment Period|Lost to Follow-up|26|||
162759830|NCT01968967|587832793|FG001|Treatment Period|Lost to Follow-up|31|||
162759831|NCT01968967|587832794|FG002|Treatment Period|Lost to Follow-up|0|||
162759832|NCT01968967|587832795|FG003|Treatment Period|Lost to Follow-up|0|||
162759833|NCT01968967|587832796|FG004|Treatment Period|Lost to Follow-up|0|||
162759834|NCT01968967|587832792|FG000|Treatment Period|Protocol Violation|1|||
162759835|NCT01968967|587832793|FG001|Treatment Period|Protocol Violation|2|||
162759836|NCT01968967|587832794|FG002|Treatment Period|Protocol Violation|0|||
162759837|NCT01968967|587832795|FG003|Treatment Period|Protocol Violation|0|||
162759838|NCT01968967|587832796|FG004|Treatment Period|Protocol Violation|0|||
162759839|NCT01968967|587832792|FG000|Treatment Period|Adverse Event|9|||
162759840|NCT01968967|587832793|FG001|Treatment Period|Adverse Event|8|||
162759841|NCT01968967|587832794|FG002|Treatment Period|Adverse Event|0|||
162759842|NCT01968967|587832795|FG003|Treatment Period|Adverse Event|0|||
162759843|NCT01968967|587832796|FG004|Treatment Period|Adverse Event|0|||
162759844|NCT01968967|587832792|FG000|Treatment Period|Death|9|||
162759845|NCT01968967|587832793|FG001|Treatment Period|Death|2|||
162759846|NCT01968967|587832794|FG002|Treatment Period|Death|0|||
162759847|NCT01968967|587832795|FG003|Treatment Period|Death|0|||
162759848|NCT01968967|587832796|FG004|Treatment Period|Death|0|||
162759849|NCT01968967|587832792|FG000|Treatment Period|Randomized Not Treated|6|||
162759850|NCT01968967|587832793|FG001|Treatment Period|Randomized Not Treated|5|||
162759851|NCT01968967|587832794|FG002|Treatment Period|Randomized Not Treated|0|||
162759852|NCT01968967|587832795|FG003|Treatment Period|Randomized Not Treated|0|||
162759853|NCT01968967|587832796|FG004|Treatment Period|Randomized Not Treated|0|||
162759854|NCT01968967|587832792|FG000|Extension Period|Withdrew Consent|0|||
162759855|NCT01968967|587832793|FG001|Extension Period|Withdrew Consent|0|||
162759856|NCT01968967|587832794|FG002|Extension Period|Withdrew Consent|2|||
162759857|NCT01968967|587832795|FG003|Extension Period|Withdrew Consent|0|||
162759858|NCT01968967|587832796|FG004|Extension Period|Withdrew Consent|5|||
162759859|NCT02022670|587832799|FG000|Overall Study|Adverse Event|1|||
162759860|NCT02022670|587832800|FG001|Overall Study|Adverse Event|0|||
162759861|NCT02022670|587832801|FG002|Overall Study|Adverse Event|1|||
162759862|NCT00109031|587832802|FG000|Overall Study|Adverse Event|0|||
162759863|NCT00109031|587832803|FG001|Overall Study|Adverse Event|0|||
162759864|NCT00109031|587832804|FG002|Overall Study|Adverse Event|1|||
162759865|NCT00109031|587832805|FG003|Overall Study|Adverse Event|0|||
162759866|NCT00109031|587832802|FG000|Overall Study|Withdrawal by Subject|0|||
162759867|NCT00109031|587832803|FG001|Overall Study|Withdrawal by Subject|1|||
162759868|NCT00109031|587832804|FG002|Overall Study|Withdrawal by Subject|0|||
162759869|NCT00109031|587832805|FG003|Overall Study|Withdrawal by Subject|0|||
162759870|NCT00109031|587832802|FG000|Overall Study|Physician Decision|0|||
162759871|NCT00109031|587832803|FG001|Overall Study|Physician Decision|1|||
162759872|NCT00109031|587832804|FG002|Overall Study|Physician Decision|0|||
162759873|NCT00109031|587832805|FG003|Overall Study|Physician Decision|0|||
162759874|NCT00109031|587832802|FG000|Overall Study|Protocol Violation|0|||
162759875|NCT00109031|587832803|FG001|Overall Study|Protocol Violation|0|||
162759876|NCT00109031|587832804|FG002|Overall Study|Protocol Violation|1|||
162759877|NCT00109031|587832805|FG003|Overall Study|Protocol Violation|0|||
162759878|NCT02091752|587832806|FG000|Overall Study|Study terminated by Sponsor|2|||
162759879|NCT02091752|587832806|FG000|Overall Study|Adverse Event|1|||
162759880|NCT00665392|587832807|FG000|Overall Study|not treated|1|||
162759881|NCT00243867|587832813|FG000|Overall Study|Adverse Event|24|||
162759882|NCT00243867|587832814|FG001|Overall Study|Adverse Event|34|||
162759883|NCT00243867|587832813|FG000|Overall Study|Lack of Efficacy|115|||
162759884|NCT00243867|587832814|FG001|Overall Study|Lack of Efficacy|78|||
162759885|NCT00243867|587832813|FG000|Overall Study|Withdrawal by Subject|11|||
162759886|NCT00243867|587832814|FG001|Overall Study|Withdrawal by Subject|23|||
162759887|NCT00243867|587832813|FG000|Overall Study|Lost to Follow-up|2|||
162759888|NCT00243867|587832814|FG001|Overall Study|Lost to Follow-up|1|||
162759889|NCT00243867|587832813|FG000|Overall Study|Physician Decision|2|||
162759890|NCT00243867|587832814|FG001|Overall Study|Physician Decision|7|||
162759891|NCT00243867|587832813|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
162759892|NCT00243867|587832814|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
162759893|NCT02060487|587832815|FG000|Overall Study|Other|1|||
162759894|NCT02060487|587832816|FG001|Overall Study|Other|2|||
162759895|NCT02060487|587832817|FG002|Overall Study|Other|1|||
162759896|NCT02060487|587832815|FG000|Overall Study|Lack of Efficacy|0|||
162759897|NCT02060487|587832816|FG001|Overall Study|Lack of Efficacy|1|||
162759898|NCT02060487|587832817|FG002|Overall Study|Lack of Efficacy|0|||
162759899|NCT02060487|587832815|FG000|Overall Study|Withdrawal by Subject|3|||
162759900|NCT02060487|587832816|FG001|Overall Study|Withdrawal by Subject|10|||
162759901|NCT02060487|587832817|FG002|Overall Study|Withdrawal by Subject|4|||
162759902|NCT02060487|587832815|FG000|Overall Study|Study Terminated By Sponsor|87|||
162759903|NCT02060487|587832816|FG001|Overall Study|Study Terminated By Sponsor|89|||
162759904|NCT02060487|587832817|FG002|Overall Study|Study Terminated By Sponsor|100|||
162759905|NCT02060487|587832815|FG000|Overall Study|Randomized in error|1|||
162759906|NCT02060487|587832816|FG001|Overall Study|Randomized in error|0|||
162759907|NCT02060487|587832817|FG002|Overall Study|Randomized in error|0|||
162759908|NCT02060487|587832815|FG000|Overall Study|Protocol Violation|0|||
162759909|NCT02060487|587832816|FG001|Overall Study|Protocol Violation|1|||
162759910|NCT02060487|587832817|FG002|Overall Study|Protocol Violation|1|||
162759911|NCT02060487|587832815|FG000|Overall Study|Lost to Follow-up|3|||
162759912|NCT02060487|587832816|FG001|Overall Study|Lost to Follow-up|0|||
162759913|NCT02060487|587832817|FG002|Overall Study|Lost to Follow-up|2|||
162759914|NCT02060487|587832815|FG000|Overall Study|Death|34|||
162759915|NCT02060487|587832816|FG001|Overall Study|Death|25|||
162759916|NCT02060487|587832817|FG002|Overall Study|Death|19|||
162759917|NCT02060487|587832815|FG000|Overall Study|Adverse Event|0|||
162759918|NCT02060487|587832816|FG001|Overall Study|Adverse Event|0|||
162759919|NCT02060487|587832817|FG002|Overall Study|Adverse Event|1|||
162759920|NCT03697603|587832822|FG000|Overall Study|Adverse Event|3|||
162759921|NCT03697603|587832823|FG001|Overall Study|Adverse Event|18|||
162759922|NCT03697603|587832824|FG002|Overall Study|Adverse Event|3|||
162759923|NCT03697603|587832822|FG000|Overall Study|Physician Decision|1|||
162759924|NCT03697603|587832823|FG001|Overall Study|Physician Decision|0|||
162759925|NCT03697603|587832824|FG002|Overall Study|Physician Decision|2|||
162759926|NCT03697603|587832822|FG000|Overall Study|Protocol Violation|3|||
162759927|NCT03697603|587832823|FG001|Overall Study|Protocol Violation|8|||
162759928|NCT03697603|587832824|FG002|Overall Study|Protocol Violation|5|||
162759929|NCT03697603|587832822|FG000|Overall Study|Withdrawal by Subject|5|||
162759930|NCT03697603|587832823|FG001|Overall Study|Withdrawal by Subject|1|||
162759931|NCT03697603|587832824|FG002|Overall Study|Withdrawal by Subject|1|||
162759932|NCT03697603|587832822|FG000|Overall Study|Protocol Violation|0|||
162759933|NCT03697603|587832823|FG001|Overall Study|Protocol Violation|0|||
162759934|NCT03697603|587832824|FG002|Overall Study|Protocol Violation|1|||
162759935|NCT04218864|587832825|FG000|Overall Study|Lost to Follow-up|8|||
162759936|NCT04218864|587832826|FG001|Overall Study|Lost to Follow-up|4|||
162759937|NCT04218864|587832825|FG000|Overall Study|Withdrawal by Subject|1|||
162759938|NCT04218864|587832826|FG001|Overall Study|Withdrawal by Subject|3|||
162759939|NCT03683030|587832827|FG000|Overall Study|Enrolled but screen failures|12|||
162759940|NCT03683030|587832828|FG001|Overall Study|Enrolled but screen failures|7|||
162759941|NCT03683030|587832827|FG000|Overall Study|Enrolled but no catheter inserted|11|||
162759942|NCT03683030|587832828|FG001|Overall Study|Enrolled but no catheter inserted|13|||
162759943|NCT03683030|587832827|FG000|Overall Study|Withdrawal by Subject|0|||
162759944|NCT03683030|587832828|FG001|Overall Study|Withdrawal by Subject|2|||
162759945|NCT03683030|587832827|FG000|Overall Study|Early termination by subject|1|||
162759946|NCT03683030|587832828|FG001|Overall Study|Early termination by subject|0|||
162759947|NCT03683030|587832827|FG000|Overall Study|Lost to Follow-up|0|||
162759948|NCT03683030|587832828|FG001|Overall Study|Lost to Follow-up|6|||
162759949|NCT03683030|587832827|FG000|Overall Study|Death|0|||
162759950|NCT03683030|587832828|FG001|Overall Study|Death|2|||
162759951|NCT03683030|587832827|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
162759952|NCT03683030|587832828|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
162759953|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
162759954|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
162759955|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
162759956|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
162759957|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
162759958|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
162759959|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
162759960|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
162759961|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
162759962|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
162759963|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
162759964|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
162759965|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
162759966|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
162759967|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
162759968|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
162759969|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
162759970|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
162759971|NCT02222493|587832829|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
162759972|NCT02222493|587832830|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
162759973|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
162759974|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
162759975|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
162759976|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
162759977|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
162759978|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
162759979|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
162759980|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
162759981|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
162759982|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
162759983|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
162759984|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
162759985|NCT02222493|587832829|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
162759986|NCT02222493|587832830|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
162759987|NCT02222493|587832829|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
162759988|NCT02222493|587832830|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
162759989|NCT02222493|587832829|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
162759990|NCT02222493|587832830|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
162759991|NCT02222493|587832829|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
162759992|NCT02222493|587832830|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
162759993|NCT02222493|587832829|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
162759994|NCT02222493|587832830|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
162759995|NCT02222493|587832829|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
162759996|NCT02222493|587832830|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
162759997|NCT00933270|587832833|FG000|Overall Study|Withdrawal by Subject|26|||
162759998|NCT00933270|587832833|FG000|Overall Study|Insufficient Follow-up|10|||
162759999|NCT00933270|587832833|FG000|Overall Study|Lost to Follow-up|14|||
162760000|NCT00933270|587832833|FG000|Overall Study|Adverse Event|1|||
162760001|NCT00933270|587832833|FG000|Overall Study|Missed Visit|2|||
162760002|NCT00933270|587832833|FG000|Overall Study|Death|24|||
162760003|NCT00933270|587832833|FG000|Overall Study|Moved or would not return|10|||
162760004|NCT02542943|587832834|FG000|Overall Study|Lost to Follow-up|1|||
162760005|NCT02542943|587832835|FG001|Overall Study|Lost to Follow-up|0|||
162760006|NCT02542943|587832836|FG002|Overall Study|Lost to Follow-up|0|||
162760007|NCT02542943|587832834|FG000|Overall Study|Withdrawal by Subject|0|||
162760008|NCT02542943|587832835|FG001|Overall Study|Withdrawal by Subject|1|||
162760009|NCT02542943|587832836|FG002|Overall Study|Withdrawal by Subject|0|||
162760010|NCT05824559|587832839|FG000|Overall Study|Adverse Event|2|||
162760011|NCT05824559|587832839|FG000|Overall Study|Physician Decision|2|||
162760012|NCT05824559|587832839|FG000|Overall Study|Progressive Disease|16|||
162760013|NCT05824559|587832839|FG000|Overall Study|Study Terminated by Sponsor|1|||
162760014|NCT05824559|587832839|FG000|Overall Study|Withdrawal by Subject|2|||
162760015|NCT04445831|587832842|FG000|Overall Study|Withdrawal by Subject|2|||
162760016|NCT04445831|587832843|FG001|Overall Study|Withdrawal by Subject|1|||
162760017|NCT04445831|587832844|FG002|Overall Study|Withdrawal by Subject|1|||
162760018|NCT04445831|587832845|FG003|Overall Study|Withdrawal by Subject|0|||
162760019|NCT04445831|587832846|FG004|Overall Study|Withdrawal by Subject|0|||
162760020|NCT04445831|587832847|FG005|Overall Study|Withdrawal by Subject|0|||
162760021|NCT04445831|587832848|FG006|Overall Study|Withdrawal by Subject|0|||
162760022|NCT04445831|587832842|FG000|Overall Study|Subject withdrawal by caregiver|0|||
162760023|NCT04445831|587832843|FG001|Overall Study|Subject withdrawal by caregiver|1|||
162760024|NCT04445831|587832844|FG002|Overall Study|Subject withdrawal by caregiver|0|||
162760025|NCT04445831|587832845|FG003|Overall Study|Subject withdrawal by caregiver|0|||
162760026|NCT04445831|587832846|FG004|Overall Study|Subject withdrawal by caregiver|0|||
162760027|NCT04445831|587832847|FG005|Overall Study|Subject withdrawal by caregiver|0|||
162760028|NCT04445831|587832848|FG006|Overall Study|Subject withdrawal by caregiver|0|||
162760029|NCT04912856|587832852|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
162760030|NCT04912856|587832853|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
162760031|NCT04912856|587832852|FG000|Overall Study|Not reported in synoptic CSR.|0|||
162760032|NCT04912856|587832853|FG001|Overall Study|Not reported in synoptic CSR.|1|||
162760033|NCT02434328|587832854|FG000|Overall Study|Adverse Event|9|||
162760034|NCT02434328|587832855|FG001|Overall Study|Adverse Event|4|||
162760035|NCT02434328|587832854|FG000|Overall Study|Lack of Efficacy|0|||
162760036|NCT02434328|587832855|FG001|Overall Study|Lack of Efficacy|2|||
162760037|NCT02434328|587832854|FG000|Overall Study|Physician Decision|0|||
162760038|NCT02434328|587832855|FG001|Overall Study|Physician Decision|1|||
162760039|NCT02434328|587832854|FG000|Overall Study|Withdrawal by Subject|12|||
162760040|NCT02434328|587832855|FG001|Overall Study|Withdrawal by Subject|21|||
162760041|NCT02434328|587832854|FG000|Overall Study|Death|4|||
162760042|NCT02434328|587832855|FG001|Overall Study|Death|7|||
162760043|NCT02434328|587832854|FG000|Overall Study|Lost to Follow-up|1|||
162760044|NCT02434328|587832855|FG001|Overall Study|Lost to Follow-up|6|||
162760045|NCT02434328|587832854|FG000|Overall Study|Other|4|||
162760046|NCT02434328|587832855|FG001|Overall Study|Other|1|||
162760047|NCT03137459|587834225|FG000|2-month Assessment|Withdrawal by Subject|13|||
162760048|NCT03137459|587834226|FG001|2-month Assessment|Withdrawal by Subject|3|||
162760049|NCT03137459|587834225|FG000|2-month Assessment|Unable to reach|42|||
162760050|NCT03137459|587834226|FG001|2-month Assessment|Unable to reach|32|||
162760051|NCT03137459|587834225|FG000|2-month Assessment|Refused assessment|7|||
162760052|NCT03137459|587834226|FG001|2-month Assessment|Refused assessment|5|||
162760053|NCT03137459|587834225|FG000|2-month Assessment|Acutely ill|6|||
162760054|NCT03137459|587834226|FG001|2-month Assessment|Acutely ill|2|||
162760055|NCT03137459|587834225|FG000|4-month Assessment|Death|4|||
162760056|NCT03137459|587834226|FG001|4-month Assessment|Death|2|||
162760057|NCT03137459|587834225|FG000|4-month Assessment|Withdrawal by Subject|4|||
162760058|NCT03137459|587834226|FG001|4-month Assessment|Withdrawal by Subject|2|||
162760059|NCT03137459|587834225|FG000|4-month Assessment|Unable to reach|44|||
162760060|NCT03137459|587834226|FG001|4-month Assessment|Unable to reach|29|||
162760061|NCT03137459|587834225|FG000|4-month Assessment|Refused assessment|24|||
162760062|NCT03137459|587834226|FG001|4-month Assessment|Refused assessment|10|||
162760063|NCT03137459|587834225|FG000|4-month Assessment|Acutely ill|2|||
162760064|NCT03137459|587834226|FG001|4-month Assessment|Acutely ill|3|||
162760065|NCT03137459|587834225|FG000|6-months|Lost to Follow-up|14|||
162760066|NCT03137459|587834226|FG001|6-months|Lost to Follow-up|11|||
162760067|NCT03137459|587834225|FG000|6-months|Death|0|||
162760068|NCT03137459|587834226|FG001|6-months|Death|2|||
162760069|NCT03137459|587834225|FG000|6-months|Refused assessment|6|||
162760070|NCT03137459|587834226|FG001|6-months|Refused assessment|3|||
162760071|NCT03137459|587834225|FG000|6-months|Acutely ill|1|||
162760072|NCT03137459|587834226|FG001|6-months|Acutely ill|1|||
162760073|NCT00985088|587834227|FG000|Overall Study|Serious Adverse Event|1|||
162760074|NCT00985088|587834228|FG001|Overall Study|Serious Adverse Event|1|||
162760075|NCT00985088|587834229|FG002|Overall Study|Serious Adverse Event|0|||
162760076|NCT00985088|587834230|FG003|Overall Study|Serious Adverse Event|0|||
162760077|NCT00985088|587834231|FG004|Overall Study|Serious Adverse Event|0|||
162760078|NCT00985088|587834232|FG005|Overall Study|Serious Adverse Event|0|||
162760079|NCT00985088|587834233|FG006|Overall Study|Serious Adverse Event|0|||
162760080|NCT00985088|587834234|FG007|Overall Study|Serious Adverse Event|1|||
162760081|NCT00985088|587834227|FG000|Overall Study|Adverse Event|0|||
162760082|NCT00985088|587834228|FG001|Overall Study|Adverse Event|0|||
162760083|NCT00985088|587834229|FG002|Overall Study|Adverse Event|1|||
162760084|NCT00985088|587834230|FG003|Overall Study|Adverse Event|0|||
162760085|NCT00985088|587834231|FG004|Overall Study|Adverse Event|0|||
162760086|NCT00985088|587834232|FG005|Overall Study|Adverse Event|0|||
162760087|NCT00985088|587834233|FG006|Overall Study|Adverse Event|0|||
162760088|NCT00985088|587834234|FG007|Overall Study|Adverse Event|0|||
162760089|NCT00985088|587834227|FG000|Overall Study|Withdrawal by Subject|4|||
162760090|NCT00985088|587834228|FG001|Overall Study|Withdrawal by Subject|0|||
162760091|NCT00985088|587834229|FG002|Overall Study|Withdrawal by Subject|0|||
162760092|NCT00985088|587834230|FG003|Overall Study|Withdrawal by Subject|1|||
162760093|NCT00985088|587834231|FG004|Overall Study|Withdrawal by Subject|3|||
162760094|NCT00985088|587834232|FG005|Overall Study|Withdrawal by Subject|2|||
162760095|NCT00985088|587834233|FG006|Overall Study|Withdrawal by Subject|1|||
162760096|NCT00985088|587834234|FG007|Overall Study|Withdrawal by Subject|2|||
162760097|NCT00985088|587834227|FG000|Overall Study|Migrated/moved from study area|0|||
162760098|NCT00985088|587834228|FG001|Overall Study|Migrated/moved from study area|0|||
162760099|NCT00985088|587834229|FG002|Overall Study|Migrated/moved from study area|1|||
162760100|NCT00985088|587834230|FG003|Overall Study|Migrated/moved from study area|0|||
162760101|NCT00985088|587834231|FG004|Overall Study|Migrated/moved from study area|0|||
162760102|NCT00985088|587834232|FG005|Overall Study|Migrated/moved from study area|0|||
162760103|NCT00985088|587834233|FG006|Overall Study|Migrated/moved from study area|0|||
162760104|NCT00985088|587834234|FG007|Overall Study|Migrated/moved from study area|1|||
162760105|NCT00985088|587834227|FG000|Overall Study|Lost to Follow-up|6|||
162760106|NCT00985088|587834228|FG001|Overall Study|Lost to Follow-up|1|||
162760107|NCT00985088|587834229|FG002|Overall Study|Lost to Follow-up|2|||
162760108|NCT00985088|587834230|FG003|Overall Study|Lost to Follow-up|6|||
162760109|NCT00985088|587834231|FG004|Overall Study|Lost to Follow-up|6|||
162760110|NCT00985088|587834232|FG005|Overall Study|Lost to Follow-up|5|||
162760111|NCT00985088|587834233|FG006|Overall Study|Lost to Follow-up|3|||
162760112|NCT00985088|587834234|FG007|Overall Study|Lost to Follow-up|2|||
162760113|NCT01970878|587834235|FG000|Overall Study|Withdrawal by Subject|11|||
162760114|NCT01970878|587834236|FG001|Overall Study|Withdrawal by Subject|10|||
162760115|NCT01970878|587834237|FG002|Overall Study|Withdrawal by Subject|14|||
162760116|NCT01970878|587834238|FG003|Overall Study|Withdrawal by Subject|7|||
162760117|NCT01970878|587834235|FG000|Overall Study|Lost to Follow-up|1|||
162760118|NCT01970878|587834236|FG001|Overall Study|Lost to Follow-up|3|||
162760119|NCT01970878|587834237|FG002|Overall Study|Lost to Follow-up|2|||
162760120|NCT01970878|587834238|FG003|Overall Study|Lost to Follow-up|4|||
162760121|NCT01970878|587834235|FG000|Overall Study|Administrative Reasons|1|||
162760122|NCT01970878|587834236|FG001|Overall Study|Administrative Reasons|0|||
162760123|NCT01970878|587834237|FG002|Overall Study|Administrative Reasons|0|||
162760124|NCT01970878|587834238|FG003|Overall Study|Administrative Reasons|4|||
162760125|NCT01970878|587834235|FG000|Overall Study|Lack of Efficacy|2|||
162760126|NCT01970878|587834236|FG001|Overall Study|Lack of Efficacy|1|||
162760127|NCT01970878|587834237|FG002|Overall Study|Lack of Efficacy|2|||
162760128|NCT01970878|587834238|FG003|Overall Study|Lack of Efficacy|0|||
162760129|NCT01970878|587834235|FG000|Overall Study|Adverse Event|12|||
162760130|NCT01970878|587834236|FG001|Overall Study|Adverse Event|7|||
162760131|NCT01970878|587834237|FG002|Overall Study|Adverse Event|4|||
162760132|NCT01970878|587834238|FG003|Overall Study|Adverse Event|3|||
162760133|NCT01970878|587834235|FG000|Overall Study|Protocol Specified Criteria|10|||
162760134|NCT01970878|587834236|FG001|Overall Study|Protocol Specified Criteria|4|||
162760135|NCT01970878|587834237|FG002|Overall Study|Protocol Specified Criteria|3|||
162760136|NCT01970878|587834238|FG003|Overall Study|Protocol Specified Criteria|6|||
162760137|NCT01970878|587834235|FG000|Overall Study|Physician Decision|0|||
162760138|NCT01970878|587834236|FG001|Overall Study|Physician Decision|1|||
162760139|NCT01970878|587834237|FG002|Overall Study|Physician Decision|1|||
162760140|NCT01970878|587834238|FG003|Overall Study|Physician Decision|0|||
162760141|NCT01970878|587834235|FG000|Overall Study|No Completion Status|0|||
162760142|NCT01970878|587834236|FG001|Overall Study|No Completion Status|1|||
162760143|NCT01970878|587834237|FG002|Overall Study|No Completion Status|0|||
162760144|NCT01970878|587834238|FG003|Overall Study|No Completion Status|0|||
162760145|NCT04992273|587834243|FG000|Overall Study|Lost to Follow-up|0|||
162760146|NCT04992273|587834244|FG001|Overall Study|Lost to Follow-up|1|||
162760147|NCT01364597|587834245|FG000|Overall Study|Adverse Event|4|||
162760148|NCT01364597|587834246|FG001|Overall Study|Adverse Event|5|||
162760149|NCT01364597|587834247|FG002|Overall Study|Adverse Event|16|||
162760150|NCT01364597|587834248|FG003|Overall Study|Adverse Event|7|||
162760151|NCT01364597|587834245|FG000|Overall Study|Lack of Efficacy|4|||
162760152|NCT01364597|587834246|FG001|Overall Study|Lack of Efficacy|4|||
162760153|NCT01364597|587834247|FG002|Overall Study|Lack of Efficacy|23|||
162760154|NCT01364597|587834248|FG003|Overall Study|Lack of Efficacy|8|||
162760155|NCT01364597|587834245|FG000|Overall Study|Protocol Violation|0|||
162760156|NCT01364597|587834246|FG001|Overall Study|Protocol Violation|0|||
162760157|NCT01364597|587834247|FG002|Overall Study|Protocol Violation|2|||
162760158|NCT01364597|587834248|FG003|Overall Study|Protocol Violation|0|||
162760159|NCT01364597|587834245|FG000|Overall Study|Lost to Follow-up|0|||
162760160|NCT01364597|587834246|FG001|Overall Study|Lost to Follow-up|0|||
162760161|NCT01364597|587834247|FG002|Overall Study|Lost to Follow-up|5|||
162760162|NCT01364597|587834248|FG003|Overall Study|Lost to Follow-up|3|||
162760163|NCT01364597|587834245|FG000|Overall Study|Withdrawal by Subject|4|||
162760164|NCT01364597|587834246|FG001|Overall Study|Withdrawal by Subject|1|||
162760165|NCT01364597|587834247|FG002|Overall Study|Withdrawal by Subject|18|||
162760166|NCT01364597|587834248|FG003|Overall Study|Withdrawal by Subject|6|||
162760167|NCT01364597|587834245|FG000|Overall Study|Non compliance|1|||
162760168|NCT01364597|587834246|FG001|Overall Study|Non compliance|0|||
162760169|NCT01364597|587834247|FG002|Overall Study|Non compliance|1|||
162760170|NCT01364597|587834248|FG003|Overall Study|Non compliance|0|||
162760171|NCT01364597|587834245|FG000|Overall Study|Lack of compliance|1|||
162760172|NCT01364597|587834246|FG001|Overall Study|Lack of compliance|0|||
162760173|NCT01364597|587834247|FG002|Overall Study|Lack of compliance|0|||
162760174|NCT01364597|587834248|FG003|Overall Study|Lack of compliance|0|||
162760175|NCT01364597|587834245|FG000|Overall Study|End of treatment epilepsy|1|||
162760176|NCT01364597|587834246|FG001|Overall Study|End of treatment epilepsy|0|||
162760177|NCT01364597|587834247|FG002|Overall Study|End of treatment epilepsy|0|||
162760178|NCT01364597|587834248|FG003|Overall Study|End of treatment epilepsy|0|||
162760179|NCT01364597|587834245|FG000|Overall Study|No Seizures|1|||
162760180|NCT01364597|587834246|FG001|Overall Study|No Seizures|0|||
162760181|NCT01364597|587834247|FG002|Overall Study|No Seizures|0|||
162760182|NCT01364597|587834248|FG003|Overall Study|No Seizures|0|||
162760183|NCT01364597|587834245|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
162760184|NCT01364597|587834246|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
162760185|NCT01364597|587834247|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
162760186|NCT01364597|587834248|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
162760187|NCT01364597|587834245|FG000|Overall Study|Cure|1|||
162760188|NCT01364597|587834246|FG001|Overall Study|Cure|0|||
162760189|NCT01364597|587834247|FG002|Overall Study|Cure|0|||
162760190|NCT01364597|587834248|FG003|Overall Study|Cure|0|||
162760191|NCT01364597|587834245|FG000|Overall Study|Patient was moving|0|||
162760192|NCT01364597|587834246|FG001|Overall Study|Patient was moving|1|||
162760193|NCT01364597|587834247|FG002|Overall Study|Patient was moving|0|||
162760194|NCT01364597|587834248|FG003|Overall Study|Patient was moving|0|||
162760195|NCT01364597|587834245|FG000|Overall Study|Seizures resolved|0|||
162760196|NCT01364597|587834246|FG001|Overall Study|Seizures resolved|0|||
162760197|NCT01364597|587834247|FG002|Overall Study|Seizures resolved|1|||
162760198|NCT01364597|587834248|FG003|Overall Study|Seizures resolved|0|||
162760199|NCT01364597|587834245|FG000|Overall Study|Patient became seizure-free after surgery|0|||
162760200|NCT01364597|587834246|FG001|Overall Study|Patient became seizure-free after surgery|0|||
162760201|NCT01364597|587834247|FG002|Overall Study|Patient became seizure-free after surgery|1|||
162760202|NCT01364597|587834248|FG003|Overall Study|Patient became seizure-free after surgery|0|||
162760203|NCT01364597|587834245|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
162760204|NCT01364597|587834246|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
162760205|NCT01364597|587834247|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
162760206|NCT01364597|587834248|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
162760207|NCT01364597|587834245|FG000|Overall Study|Patient cured from Epilepsy|0|||
162760208|NCT01364597|587834246|FG001|Overall Study|Patient cured from Epilepsy|0|||
162760209|NCT01364597|587834247|FG002|Overall Study|Patient cured from Epilepsy|1|||
162760210|NCT01364597|587834248|FG003|Overall Study|Patient cured from Epilepsy|0|||
162760211|NCT01364597|587834245|FG000|Overall Study|Investigator decision|0|||
162760212|NCT01364597|587834246|FG001|Overall Study|Investigator decision|0|||
162760213|NCT01364597|587834247|FG002|Overall Study|Investigator decision|1|||
162760214|NCT01364597|587834248|FG003|Overall Study|Investigator decision|0|||
162760215|NCT01364597|587834245|FG000|Overall Study|Sponsor recommended discontinuation|0|||
162760216|NCT01364597|587834246|FG001|Overall Study|Sponsor recommended discontinuation|0|||
162760217|NCT01364597|587834247|FG002|Overall Study|Sponsor recommended discontinuation|0|||
162760218|NCT01364597|587834248|FG003|Overall Study|Sponsor recommended discontinuation|1|||
162760219|NCT01364597|587834245|FG000|Overall Study|Parents went abroad with the patient|0|||
162760220|NCT01364597|587834246|FG001|Overall Study|Parents went abroad with the patient|0|||
162760221|NCT01364597|587834247|FG002|Overall Study|Parents went abroad with the patient|1|||
162760222|NCT01364597|587834248|FG003|Overall Study|Parents went abroad with the patient|0|||
162760223|NCT01364597|587834245|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162760224|NCT01364597|587834246|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162760225|NCT01364597|587834247|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
162760226|NCT01364597|587834248|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162760227|NCT01364597|587834245|FG000|Overall Study|BRV administration dropout|0|||
162760228|NCT01364597|587834246|FG001|Overall Study|BRV administration dropout|0|||
162760229|NCT01364597|587834247|FG002|Overall Study|BRV administration dropout|1|||
162760230|NCT01364597|587834248|FG003|Overall Study|BRV administration dropout|0|||
162760231|NCT01364597|587834245|FG000|Overall Study|Dropout|0|||
162760232|NCT01364597|587834246|FG001|Overall Study|Dropout|0|||
162760233|NCT01364597|587834247|FG002|Overall Study|Dropout|3|||
162760234|NCT01364597|587834248|FG003|Overall Study|Dropout|1|||
162760235|NCT01364597|587834245|FG000|Overall Study|Unreliable subject|0|||
162760236|NCT01364597|587834246|FG001|Overall Study|Unreliable subject|0|||
162760237|NCT01364597|587834247|FG002|Overall Study|Unreliable subject|0|||
162760238|NCT01364597|587834248|FG003|Overall Study|Unreliable subject|1|||
162760239|NCT01364597|587834245|FG000|Overall Study|Other|0|||
162760240|NCT01364597|587834246|FG001|Overall Study|Other|0|||
162760241|NCT01364597|587834247|FG002|Overall Study|Other|0|||
162760242|NCT01364597|587834248|FG003|Overall Study|Other|1|||
162760243|NCT03214081|587834249|FG000|Overall Study|Case Report Forms Uncollected|9|||
162760244|NCT03214081|587834249|FG000|Overall Study|Protocol Deviation|54|||
162760245|NCT02962284|587834250|FG000|Overall Study|Death|2|||
162760246|NCT02962284|587834251|FG001|Overall Study|Death|0|||
162760247|NCT02962284|587834250|FG000|Overall Study|Progressive disease|2|||
162760248|NCT02962284|587834251|FG001|Overall Study|Progressive disease|3|||
162760249|NCT02962284|587834250|FG000|Overall Study|Withdrawal by Subject|1|||
162760250|NCT02962284|587834251|FG001|Overall Study|Withdrawal by Subject|0|||
162760251|NCT03493282|587834255|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
162760252|NCT03493282|587834256|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
162760253|NCT03493282|587834257|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
162760254|NCT03493282|587834255|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
162760255|NCT03493282|587834256|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
162760256|NCT03493282|587834257|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
162760257|NCT02637063|587834258|FG000|Overall Study|Lost to Follow-up|3|||
162760258|NCT02637063|587834259|FG001|Overall Study|Lost to Follow-up|2|||
162760259|NCT02637063|587834260|FG002|Overall Study|Lost to Follow-up|3|||
162760260|NCT02637063|587834258|FG000|Overall Study|Withdrawal by Subject|2|||
162760261|NCT02637063|587834259|FG001|Overall Study|Withdrawal by Subject|2|||
162760262|NCT02637063|587834260|FG002|Overall Study|Withdrawal by Subject|3|||
162760263|NCT00491400|587834261|FG000|Overall Study|Withdrawal by Subject|5|||
162760264|NCT00491400|587834262|FG001|Overall Study|Withdrawal by Subject|4|||
162760265|NCT00597376|587834263|FG000|Overall Study|Withdrawal by Subject|4|||
162760266|NCT00597376|587834264|FG001|Overall Study|Withdrawal by Subject|3|||
162760267|NCT00597376|587834263|FG000|Overall Study|Adverse Event|4|||
162760268|NCT00597376|587834264|FG001|Overall Study|Adverse Event|1|||
162760269|NCT01380145|587834265|FG000|Overall Study|Progressive disease|4|||
162760270|NCT00599196|587834268|FG000|Overall Study|Lack of Efficacy|22|||
162760271|NCT00599196|587834268|FG000|Overall Study|Adverse Event|93|||
162760272|NCT00599196|587834268|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
162760273|NCT00599196|587834268|FG000|Overall Study|Subject withdrew consent|43|||
162760274|NCT00599196|587834268|FG000|Overall Study|Study ended per sponsor|197|||
162760275|NCT00599196|587834268|FG000|Overall Study|Lost to Follow-up|17|||
162760276|NCT00599196|587834268|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
162760277|NCT00599196|587834268|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
162760278|NCT00599196|587834268|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
162760279|NCT00599196|587834268|FG000|Overall Study|Other: Pt Moved To Australia|1|||
162760280|NCT00599196|587834268|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
162760281|NCT00599196|587834268|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
162760282|NCT01009645|587834279|FG000|Overall Study|Lost to Follow-up|2|||
162760283|NCT01009645|587834280|FG001|Overall Study|Lost to Follow-up|8|||
162760284|NCT01009645|587834281|FG002|Overall Study|Lost to Follow-up|4|||
162760285|NCT01009645|587834282|FG003|Overall Study|Lost to Follow-up|5|||
162760286|NCT02788981|587834283|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
162760287|NCT02788981|587834284|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
162760288|NCT05553366|587834285|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
162760289|NCT05553366|587834286|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
162760290|NCT05553366|587834287|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
162760291|NCT05553366|587834285|FG000|Overall Study|Lost to Follow-up|3|||
162760292|NCT05553366|587834286|FG001|Overall Study|Lost to Follow-up|3|||
162760293|NCT05553366|587834287|FG002|Overall Study|Lost to Follow-up|3|||
162760294|NCT05553366|587834285|FG000|Overall Study|Other non-compliance|1|||
162760295|NCT05553366|587834286|FG001|Overall Study|Other non-compliance|1|||
162760296|NCT05553366|587834287|FG002|Overall Study|Other non-compliance|0|||
162760297|NCT05553366|587834285|FG000|Overall Study|Randomized but not dosed|0|||
162760298|NCT05553366|587834286|FG001|Overall Study|Randomized but not dosed|0|||
162760299|NCT05553366|587834287|FG002|Overall Study|Randomized but not dosed|2|||
162760300|NCT02022657|587834288|FG000|Overall Study|Withdrawal by Subject|2|||
162760301|NCT02022657|587834289|FG001|Overall Study|Withdrawal by Subject|0|||
162760302|NCT02022657|587834290|FG002|Overall Study|Withdrawal by Subject|1|||
162760303|NCT02022657|587834291|FG003|Overall Study|Withdrawal by Subject|0|||
162760304|NCT02022657|587834292|FG004|Overall Study|Withdrawal by Subject|0|||
162760305|NCT02022657|587834293|FG005|Overall Study|Withdrawal by Subject|0|||
162760306|NCT02022657|587834288|FG000|Overall Study|Physician Decision|0|||
162760307|NCT02022657|587834289|FG001|Overall Study|Physician Decision|0|||
162760308|NCT02022657|587834290|FG002|Overall Study|Physician Decision|0|||
162760309|NCT02022657|587834291|FG003|Overall Study|Physician Decision|0|||
162760310|NCT02022657|587834292|FG004|Overall Study|Physician Decision|0|||
162760311|NCT02022657|587834293|FG005|Overall Study|Physician Decision|1|||
162760312|NCT00795184|587834295|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
162760313|NCT00795184|587834296|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
162760314|NCT01303510|587834298|FG000|Overall Study|Lost to Follow-up|1|||
162760315|NCT01303510|587834299|FG001|Overall Study|Lost to Follow-up|0|||
162760316|NCT00701415|587834308|FG000|Overall Study|Adverse Event|0|||
162760317|NCT00701415|587834309|FG001|Overall Study|Adverse Event|1|||
162760318|NCT00701415|587834308|FG000|Overall Study|Social/family issues and needle phobia|1|||
162760319|NCT00701415|587834309|FG001|Overall Study|Social/family issues and needle phobia|0|||
162760320|NCT02106884|587834320|FG000|Overall Study|Change of diagnosis/exclusion|0|||
162760321|NCT02106884|587834321|FG001|Overall Study|Change of diagnosis/exclusion|1|||
162760322|NCT02113449|587834323|FG000|Overall Study|Adverse Event|4|||
162760323|NCT00659373|587834324|FG000|Overall Study|Withdrawal by Subject|3|||
162760324|NCT00659373|587834325|FG001|Overall Study|Withdrawal by Subject|5|||
162760325|NCT00659373|587834324|FG000|Overall Study|Assessment Missed|2|||
162760326|NCT00659373|587834325|FG001|Overall Study|Assessment Missed|2|||
162760327|NCT03042767|587834328|FG000|Overall Study|Lost to Follow-up|1|||
162760328|NCT03042767|587834329|FG001|Overall Study|Lost to Follow-up|2|||
162760329|NCT04638816|587834331|FG000|Overall Study|Withdrawal by Subject|0|||
162760330|NCT04638816|587834332|FG001|Overall Study|Withdrawal by Subject|1|||
162760331|NCT04638816|587834331|FG000|Overall Study|Lost to Follow-up|0|||
162760332|NCT04638816|587834332|FG001|Overall Study|Lost to Follow-up|1|||
162760333|NCT01328496|587834335|FG000|Overall Study|Significant Change in Health Status|1|||
162760334|NCT01328496|587834336|FG001|Overall Study|Significant Change in Health Status|0|||
162760335|NCT02208843|587834339|FG000|Overall Study|Clinical symptoms of progression|2|||
162760336|NCT02208843|587834339|FG000|Overall Study|Progression disease according to RECIST|24|||
162760337|NCT02208843|587834339|FG000|Overall Study|Adverse Event|12|||
162760338|NCT02208843|587834339|FG000|Overall Study|Protocol Violation|1|||
162760339|NCT02208843|587834339|FG000|Overall Study|Withdrawal by Subject|1|||
162760340|NCT02208843|587834339|FG000|Overall Study|Switched to commercial afatinib|20|||
162760341|NCT04399837|587834341|FG000|Overall Study|Other than listed|0|||
162760342|NCT04399837|587834342|FG001|Overall Study|Other than listed|2|||
162760343|NCT04399837|587834343|FG002|Overall Study|Other than listed|2|||
162760344|NCT04399837|587834344|FG003|Overall Study|Other than listed|3|||
162760345|NCT04399837|587834341|FG000|Overall Study|Withdrawal by Subject|1|||
162760346|NCT04399837|587834342|FG001|Overall Study|Withdrawal by Subject|2|||
162760347|NCT04399837|587834343|FG002|Overall Study|Withdrawal by Subject|1|||
162760348|NCT04399837|587834344|FG003|Overall Study|Withdrawal by Subject|1|||
162760349|NCT02686658|587834349|FG000|Overall Study|Adverse Event|0|||
162760350|NCT02686658|587834350|FG001|Overall Study|Adverse Event|0|||
162760351|NCT02686658|587834351|FG002|Overall Study|Adverse Event|1|||
162760352|NCT02686658|587834352|FG003|Overall Study|Adverse Event|1|||
162760353|NCT02686658|587834353|FG004|Overall Study|Adverse Event|2|||
162760354|NCT02686658|587834354|FG005|Overall Study|Adverse Event|1|||
162760355|NCT02686658|587834349|FG000|Overall Study|Investigator decision|0|||
162760356|NCT02686658|587834350|FG001|Overall Study|Investigator decision|0|||
162760357|NCT02686658|587834351|FG002|Overall Study|Investigator decision|0|||
162760358|NCT02686658|587834352|FG003|Overall Study|Investigator decision|1|||
162760359|NCT02686658|587834353|FG004|Overall Study|Investigator decision|2|||
162760360|NCT02686658|587834354|FG005|Overall Study|Investigator decision|1|||
162760361|NCT02686658|587834349|FG000|Overall Study|Sponsor decision|1|||
162760362|NCT02686658|587834350|FG001|Overall Study|Sponsor decision|2|||
162760363|NCT02686658|587834351|FG002|Overall Study|Sponsor decision|1|||
162760364|NCT02686658|587834352|FG003|Overall Study|Sponsor decision|5|||
162760365|NCT02686658|587834353|FG004|Overall Study|Sponsor decision|13|||
162760366|NCT02686658|587834354|FG005|Overall Study|Sponsor decision|2|||
162760367|NCT02686658|587834349|FG000|Overall Study|Lost to Follow-up|0|||
162760368|NCT02686658|587834350|FG001|Overall Study|Lost to Follow-up|0|||
162760369|NCT02686658|587834351|FG002|Overall Study|Lost to Follow-up|2|||
162760370|NCT02686658|587834352|FG003|Overall Study|Lost to Follow-up|0|||
162760371|NCT02686658|587834353|FG004|Overall Study|Lost to Follow-up|0|||
162760372|NCT02686658|587834354|FG005|Overall Study|Lost to Follow-up|1|||
162760373|NCT02686658|587834349|FG000|Overall Study|Death|1|||
162760374|NCT02686658|587834350|FG001|Overall Study|Death|0|||
162760375|NCT02686658|587834351|FG002|Overall Study|Death|0|||
162760376|NCT02686658|587834352|FG003|Overall Study|Death|1|||
162760377|NCT02686658|587834353|FG004|Overall Study|Death|1|||
162760378|NCT02686658|587834354|FG005|Overall Study|Death|1|||
162760379|NCT02686658|587834349|FG000|Overall Study|Withdrawal by Subject|2|||
162760380|NCT02686658|587834350|FG001|Overall Study|Withdrawal by Subject|5|||
162760381|NCT02686658|587834351|FG002|Overall Study|Withdrawal by Subject|4|||
162760382|NCT02686658|587834352|FG003|Overall Study|Withdrawal by Subject|4|||
162760383|NCT02686658|587834353|FG004|Overall Study|Withdrawal by Subject|17|||
162760384|NCT02686658|587834354|FG005|Overall Study|Withdrawal by Subject|8|||
162760385|NCT02686658|587834349|FG000|Overall Study|Placed in hospice care|0|||
162760386|NCT02686658|587834350|FG001|Overall Study|Placed in hospice care|0|||
162760387|NCT02686658|587834351|FG002|Overall Study|Placed in hospice care|1|||
162760388|NCT02686658|587834352|FG003|Overall Study|Placed in hospice care|0|||
162760389|NCT02686658|587834353|FG004|Overall Study|Placed in hospice care|0|||
162760390|NCT02686658|587834354|FG005|Overall Study|Placed in hospice care|0|||
162760391|NCT02686658|587834349|FG000|Overall Study|Participant non-compliance|0|||
162760392|NCT02686658|587834350|FG001|Overall Study|Participant non-compliance|0|||
162760393|NCT02686658|587834351|FG002|Overall Study|Participant non-compliance|0|||
162760394|NCT02686658|587834352|FG003|Overall Study|Participant non-compliance|0|||
162760395|NCT02686658|587834353|FG004|Overall Study|Participant non-compliance|0|||
162760396|NCT02686658|587834354|FG005|Overall Study|Participant non-compliance|1|||
162760397|NCT02686658|587834349|FG000|Overall Study|Concern over coronavirus disease care|0|||
162760398|NCT02686658|587834350|FG001|Overall Study|Concern over coronavirus disease care|0|||
162760399|NCT02686658|587834351|FG002|Overall Study|Concern over coronavirus disease care|0|||
162760400|NCT02686658|587834352|FG003|Overall Study|Concern over coronavirus disease care|0|||
162760401|NCT02686658|587834353|FG004|Overall Study|Concern over coronavirus disease care|2|||
162760402|NCT02686658|587834354|FG005|Overall Study|Concern over coronavirus disease care|1|||
162760403|NCT03476798|587834358|FG000|Overall Study|Death|1|||
162760404|NCT03476798|587834358|FG000|Overall Study|Withdrawal by Subject|2|||
162760405|NCT03476798|587834358|FG000|Overall Study|Protocol Violation|2|||
162760406|NCT06269003|587834359|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162760407|NCT06269003|587834360|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162760408|NCT06269003|587834361|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
162760409|NCT06269003|587834362|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162760410|NCT04224272|587834366|FG000|Part 1 - Dose Finding|Death|4|||
162760411|NCT04224272|587834366|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
162760412|NCT04224272|587834366|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
162760413|NCT04224272|587834366|FG000|Part 2 - Dose Expansion|Death|10|||
162760414|NCT04224272|587834366|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
162760415|NCT02609048|587834367|FG000|Overall Study|Adverse Event|3|||
162760416|NCT02609048|587834368|FG001|Overall Study|Adverse Event|0|||
162760417|NCT02609048|587834369|FG002|Overall Study|Adverse Event|0|||
162760418|NCT02609048|587834367|FG000|Overall Study|Randomized but never treated|1|||
162760419|NCT02609048|587834368|FG001|Overall Study|Randomized but never treated|1|||
162760420|NCT02609048|587834369|FG002|Overall Study|Randomized but never treated|1|||
162760421|NCT02609048|587834367|FG000|Overall Study|Withdrawal of informed consent|1|||
162760422|NCT02609048|587834368|FG001|Overall Study|Withdrawal of informed consent|0|||
162760423|NCT02609048|587834369|FG002|Overall Study|Withdrawal of informed consent|0|||
162760424|NCT02609048|587834367|FG000|Overall Study|Reason not specified|6|||
162760425|NCT02609048|587834368|FG001|Overall Study|Reason not specified|9|||
162760426|NCT02609048|587834369|FG002|Overall Study|Reason not specified|9|||
162760427|NCT01276509|587836152|FG000|Overall Study|Adverse Event|9|||
162760428|NCT01276509|587836153|FG001|Overall Study|Adverse Event|8|||
162760429|NCT01276509|587836154|FG002|Overall Study|Adverse Event|4|||
162760430|NCT01276509|587836155|FG003|Overall Study|Adverse Event|3|||
162760431|NCT01276509|587836152|FG000|Overall Study|Lack of Efficacy|2|||
162760432|NCT01276509|587836153|FG001|Overall Study|Lack of Efficacy|1|||
162760433|NCT01276509|587836154|FG002|Overall Study|Lack of Efficacy|1|||
162760434|NCT01276509|587836155|FG003|Overall Study|Lack of Efficacy|2|||
162760435|NCT01276509|587836152|FG000|Overall Study|Pregnancy|1|||
162760436|NCT01276509|587836153|FG001|Overall Study|Pregnancy|0|||
162760437|NCT01276509|587836154|FG002|Overall Study|Pregnancy|0|||
162760438|NCT01276509|587836155|FG003|Overall Study|Pregnancy|0|||
162760439|NCT01276509|587836152|FG000|Overall Study|Withdrawal by Subject|1|||
162760440|NCT01276509|587836153|FG001|Overall Study|Withdrawal by Subject|2|||
162760441|NCT01276509|587836154|FG002|Overall Study|Withdrawal by Subject|0|||
162760442|NCT01276509|587836155|FG003|Overall Study|Withdrawal by Subject|0|||
162760443|NCT01276509|587836152|FG000|Overall Study|Other|0|||
162760444|NCT01276509|587836153|FG001|Overall Study|Other|1|||
162760445|NCT01276509|587836154|FG002|Overall Study|Other|0|||
162760446|NCT01276509|587836155|FG003|Overall Study|Other|0|||
162760447|NCT00949117|587836157|FG000|Overall Study|Lack of Efficacy|2|||
162760448|NCT00949117|587836158|FG001|Overall Study|Lack of Efficacy|3|||
162760449|NCT00949117|587836157|FG000|Overall Study|Protocol Violation|1|||
162760450|NCT00949117|587836158|FG001|Overall Study|Protocol Violation|1|||
162760451|NCT00949117|587836157|FG000|Overall Study|Adverse Event|0|||
162760452|NCT00949117|587836158|FG001|Overall Study|Adverse Event|1|||
162760453|NCT03964974|587836159|FG000|Overall Study|Lost to Follow-up|3|||
162760454|NCT03964974|587836160|FG001|Overall Study|Lost to Follow-up|2|||
162760455|NCT03964974|587836159|FG000|Overall Study|Withdrawal by Subject|0|||
162760456|NCT03964974|587836160|FG001|Overall Study|Withdrawal by Subject|3|||
162760457|NCT02014402|587836164|FG000|Overall Study|Adverse Event|1|||
162760458|NCT02014402|587836165|FG001|Overall Study|Adverse Event|0|||
162760459|NCT02014402|587836166|FG002|Overall Study|Adverse Event|0|||
162760460|NCT02014402|587836167|FG003|Overall Study|Adverse Event|0|||
162760461|NCT02014402|587836164|FG000|Overall Study|Withdrawal by Subject|1|||
162760462|NCT02014402|587836165|FG001|Overall Study|Withdrawal by Subject|2|||
162760463|NCT02014402|587836166|FG002|Overall Study|Withdrawal by Subject|2|||
162760464|NCT02014402|587836167|FG003|Overall Study|Withdrawal by Subject|1|||
162760465|NCT02014402|587836164|FG000|Overall Study|Subject did not have transportation|0|||
162760466|NCT02014402|587836165|FG001|Overall Study|Subject did not have transportation|1|||
162760467|NCT02014402|587836166|FG002|Overall Study|Subject did not have transportation|0|||
162760468|NCT02014402|587836167|FG003|Overall Study|Subject did not have transportation|0|||
162760469|NCT02014402|587836164|FG000|Overall Study|Lost to Follow-up|0|||
162760470|NCT02014402|587836165|FG001|Overall Study|Lost to Follow-up|0|||
162760471|NCT02014402|587836166|FG002|Overall Study|Lost to Follow-up|1|||
162760472|NCT02014402|587836167|FG003|Overall Study|Lost to Follow-up|2|||
162760473|NCT00670449|587836168|FG000|Overall Study|Adverse Event|6|||
162760474|NCT00670449|587836169|FG001|Overall Study|Adverse Event|2|||
162760475|NCT00670449|587836170|FG002|Overall Study|Adverse Event|8|||
162760476|NCT00670449|587836171|FG003|Overall Study|Adverse Event|5|||
162760477|NCT00670449|587836168|FG000|Overall Study|Protocol Deviation|1|||
162760478|NCT00670449|587836169|FG001|Overall Study|Protocol Deviation|2|||
162760479|NCT00670449|587836170|FG002|Overall Study|Protocol Deviation|0|||
162760480|NCT00670449|587836171|FG003|Overall Study|Protocol Deviation|1|||
162760481|NCT00670449|587836168|FG000|Overall Study|Administrative Problems|0|||
162760482|NCT00670449|587836169|FG001|Overall Study|Administrative Problems|2|||
162760483|NCT00670449|587836170|FG002|Overall Study|Administrative Problems|0|||
162760484|NCT00670449|587836171|FG003|Overall Study|Administrative Problems|1|||
162760485|NCT00670449|587836168|FG000|Overall Study|Subject Withdrew Consent|0|||
162760486|NCT00670449|587836169|FG001|Overall Study|Subject Withdrew Consent|2|||
162760487|NCT00670449|587836170|FG002|Overall Study|Subject Withdrew Consent|0|||
162760488|NCT00670449|587836171|FG003|Overall Study|Subject Withdrew Consent|1|||
162760489|NCT00670449|587836168|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
162760490|NCT00670449|587836169|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162760491|NCT00670449|587836170|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
162760492|NCT00670449|587836171|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162760493|NCT00670449|587836168|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162760494|NCT00670449|587836169|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
162760495|NCT00670449|587836170|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162760496|NCT00670449|587836171|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
162760497|NCT02634307|587836172|FG000|Overall Study|Adverse Event|50|||
162760498|NCT02634307|587836173|FG001|Overall Study|Adverse Event|24|||
162760499|NCT02634307|587836174|FG002|Overall Study|Adverse Event|14|||
162760500|NCT02634307|587836172|FG000|Overall Study|Lost to Follow-up|21|||
162760501|NCT02634307|587836173|FG001|Overall Study|Lost to Follow-up|5|||
162760502|NCT02634307|587836174|FG002|Overall Study|Lost to Follow-up|6|||
162760503|NCT02634307|587836172|FG000|Overall Study|Pregnancy|5|||
162760504|NCT02634307|587836173|FG001|Overall Study|Pregnancy|1|||
162760505|NCT02634307|587836174|FG002|Overall Study|Pregnancy|3|||
162760506|NCT02634307|587836172|FG000|Overall Study|Withdrawal by Subject|38|||
162760507|NCT02634307|587836173|FG001|Overall Study|Withdrawal by Subject|24|||
162760508|NCT02634307|587836174|FG002|Overall Study|Withdrawal by Subject|18|||
162760509|NCT02634307|587836172|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162760510|NCT02634307|587836173|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162760511|NCT02634307|587836174|FG002|Overall Study|Non-Compliance with Study Drug|2|||
162760512|NCT02634307|587836172|FG000|Overall Study|Lack of Efficacy|1|||
162760513|NCT02634307|587836173|FG001|Overall Study|Lack of Efficacy|5|||
162760514|NCT02634307|587836174|FG002|Overall Study|Lack of Efficacy|3|||
162760515|NCT02634307|587836172|FG000|Overall Study|Physician Decision|7|||
162760516|NCT02634307|587836173|FG001|Overall Study|Physician Decision|5|||
162760517|NCT02634307|587836174|FG002|Overall Study|Physician Decision|5|||
162760518|NCT02634307|587836172|FG000|Overall Study|Reason not Specified|3|||
162760519|NCT02634307|587836173|FG001|Overall Study|Reason not Specified|5|||
162760520|NCT02634307|587836174|FG002|Overall Study|Reason not Specified|10|||
162760521|NCT02698475|587836175|FG000|Main Study Period|Lack of Efficacy|1|||
162760522|NCT02698475|587836175|FG000|Main Study Period|Protocol Violation|2|||
162760523|NCT02698475|587836175|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
162760524|NCT02698475|587836175|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
162760525|NCT02698475|587836175|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
162760526|NCT02698475|587836175|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
162760527|NCT02698475|587836175|FG000|Long-Term Extension Period|Other|1|||
162760528|NCT02038049|587836176|FG000|Overall Study|Lost to Follow-up|1|||
162760529|NCT02038049|587836177|FG001|Overall Study|Lost to Follow-up|0|||
162760530|NCT00413283|587836182|FG000|Overall Study|Withdrawal by Subject|1|||
162760531|NCT00413283|587836183|FG001|Overall Study|Withdrawal by Subject|0|||
162760532|NCT00413283|587836184|FG002|Overall Study|Withdrawal by Subject|0|||
162760533|NCT00413283|587836185|FG003|Overall Study|Withdrawal by Subject|1|||
162760534|NCT00413283|587836182|FG000|Overall Study|Death|0|||
162760535|NCT00413283|587836183|FG001|Overall Study|Death|0|||
162760536|NCT00413283|587836184|FG002|Overall Study|Death|1|||
162760537|NCT00413283|587836185|FG003|Overall Study|Death|1|||
162760538|NCT00413283|587836182|FG000|Overall Study|Adverse Event|0|||
162760539|NCT00413283|587836183|FG001|Overall Study|Adverse Event|0|||
162760540|NCT00413283|587836184|FG002|Overall Study|Adverse Event|0|||
162760541|NCT00413283|587836185|FG003|Overall Study|Adverse Event|1|||
162760542|NCT00413283|587836182|FG000|Overall Study|Ineligibility determined|0|||
162760543|NCT00413283|587836183|FG001|Overall Study|Ineligibility determined|0|||
162760544|NCT00413283|587836184|FG002|Overall Study|Ineligibility determined|0|||
162760545|NCT00413283|587836185|FG003|Overall Study|Ineligibility determined|1|||
162760546|NCT00413283|587836182|FG000|Overall Study|Protocol deviation|0|||
162760547|NCT00413283|587836183|FG001|Overall Study|Protocol deviation|1|||
162760548|NCT00413283|587836184|FG002|Overall Study|Protocol deviation|0|||
162760549|NCT00413283|587836185|FG003|Overall Study|Protocol deviation|0|||
162760550|NCT00413283|587836182|FG000|Overall Study|Requirement for alternative therapy|0|||
162760551|NCT00413283|587836183|FG001|Overall Study|Requirement for alternative therapy|2|||
162760552|NCT00413283|587836184|FG002|Overall Study|Requirement for alternative therapy|0|||
162760553|NCT00413283|587836185|FG003|Overall Study|Requirement for alternative therapy|0|||
162760554|NCT00413283|587836182|FG000|Overall Study|Other|0|||
162760555|NCT00413283|587836183|FG001|Overall Study|Other|0|||
162760556|NCT00413283|587836184|FG002|Overall Study|Other|1|||
162760557|NCT00413283|587836185|FG003|Overall Study|Other|0|||
162760558|NCT02660086|587836187|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
162760559|NCT02660086|587836188|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
162760560|NCT02660086|587836187|FG000|Overall Study- 12-month|Left full-time employment|12|||
162760561|NCT02660086|587836188|FG001|Overall Study- 12-month|Left full-time employment|20|||
162760562|NCT02660086|587836187|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
162760563|NCT02660086|587836188|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
162760564|NCT02660086|587836187|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
162760565|NCT02660086|587836188|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
162760566|NCT02660086|587836187|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
162760567|NCT02660086|587836188|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
162760568|NCT02660086|587836187|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
162760569|NCT02660086|587836188|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
162760570|NCT01377844|587836189|FG000|Overall Study|Withdrawal by Subject|25|||
162760571|NCT01377844|587836190|FG001|Overall Study|Withdrawal by Subject|28|||
162760572|NCT01377844|587836189|FG000|Overall Study|Protocol Violation|2|||
162760573|NCT01377844|587836190|FG001|Overall Study|Protocol Violation|3|||
162760574|NCT01377844|587836189|FG000|Overall Study|Adverse Event|3|||
162760575|NCT01377844|587836190|FG001|Overall Study|Adverse Event|0|||
162760576|NCT01377844|587836189|FG000|Overall Study|Physician Decision|6|||
162760577|NCT01377844|587836190|FG001|Overall Study|Physician Decision|3|||
162760578|NCT01377844|587836189|FG000|Overall Study|Study terminated by Sponsor|0|||
162760579|NCT01377844|587836190|FG001|Overall Study|Study terminated by Sponsor|1|||
162760580|NCT01214200|587836194|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
162760581|NCT01214200|587836194|FG000|Overall Study|Withdrawal by Subject|2|||
162760582|NCT00667017|587836195|FG000|Overall Study|Withdrawal by Subject|1|||
162760583|NCT01823224|587836196|FG000|Overall Study|Lost to Follow-up|5|||
162760584|NCT01823224|587836197|FG001|Overall Study|Lost to Follow-up|6|||
162760585|NCT01823224|587836196|FG000|Overall Study|didn't qualify|1|||
162760586|NCT01823224|587836197|FG001|Overall Study|didn't qualify|2|||
162760587|NCT01823224|587836196|FG000|Overall Study|pharmacy error|0|||
162760588|NCT01823224|587836197|FG001|Overall Study|pharmacy error|1|||
162760589|NCT01823224|587836196|FG000|Overall Study|missed med dose|0|||
162760590|NCT01823224|587836197|FG001|Overall Study|missed med dose|1|||
162760591|NCT01823224|587836196|FG000|Overall Study|Withdrawal by Subject|0|||
162760592|NCT01823224|587836197|FG001|Overall Study|Withdrawal by Subject|1|||
162760593|NCT00587171|587836198|FG000|Overall Study|Lost to Follow-up|1|||
162760594|NCT00587171|587836199|FG001|Overall Study|Lost to Follow-up|1|||
162760595|NCT01532648|587836208|FG000|Overall Study|Lost to Follow-up|3|||
162760596|NCT01532648|587836209|FG001|Overall Study|Lost to Follow-up|4|||
162760597|NCT01532648|587836208|FG000|Overall Study|Lack of Efficacy|4|||
162760598|NCT01532648|587836209|FG001|Overall Study|Lack of Efficacy|1|||
162760599|NCT01532648|587836208|FG000|Overall Study|Protocol Violation|1|||
162760600|NCT01532648|587836209|FG001|Overall Study|Protocol Violation|1|||
162760601|NCT01532648|587836208|FG000|Overall Study|Adverse Event|12|||
162760602|NCT01532648|587836209|FG001|Overall Study|Adverse Event|9|||
162760603|NCT01532648|587836208|FG000|Overall Study|Withdrawal by Subject|16|||
162760604|NCT01532648|587836209|FG001|Overall Study|Withdrawal by Subject|2|||
162760605|NCT02148705|587836210|FG000|Overall Study|Death|2|||
162760606|NCT02148705|587836211|FG001|Overall Study|Death|0|||
162760607|NCT02148705|587836212|FG002|Overall Study|Death|0|||
162760608|NCT02148705|587836210|FG000|Overall Study|Lost to Follow-up|13|||
162760609|NCT02148705|587836211|FG001|Overall Study|Lost to Follow-up|4|||
162760610|NCT02148705|587836212|FG002|Overall Study|Lost to Follow-up|10|||
162760611|NCT02148705|587836210|FG000|Overall Study|Withdrawal by Subject|3|||
162760612|NCT02148705|587836211|FG001|Overall Study|Withdrawal by Subject|0|||
162760613|NCT02148705|587836212|FG002|Overall Study|Withdrawal by Subject|2|||
162760614|NCT02148705|587836210|FG000|Overall Study|Not Treated|0|||
162760615|NCT02148705|587836211|FG001|Overall Study|Not Treated|1|||
162760616|NCT02148705|587836212|FG002|Overall Study|Not Treated|5|||
162760617|NCT01737021|587836215|FG000|Overall Study|Lost to Follow-up|5|||
162760618|NCT01737021|587836216|FG001|Overall Study|Lost to Follow-up|3|||
162760619|NCT02310581|587836217|FG000|Overall Study|Adverse Event|1|||
162760620|NCT02310581|587836218|FG001|Overall Study|Adverse Event|1|||
162760621|NCT02310581|587836219|FG002|Overall Study|Adverse Event|1|||
162760622|NCT02310581|587836220|FG003|Overall Study|Adverse Event|0|||
162760623|NCT02310581|587836217|FG000|Overall Study|Withdrawal by Subject|2|||
162760624|NCT02310581|587836218|FG001|Overall Study|Withdrawal by Subject|1|||
162760625|NCT02310581|587836219|FG002|Overall Study|Withdrawal by Subject|0|||
162760626|NCT02310581|587836220|FG003|Overall Study|Withdrawal by Subject|1|||
162760627|NCT01673594|587836221|FG000|Overall Study|Adverse Event|3|||
162760628|NCT01673594|587836222|FG001|Overall Study|Adverse Event|1|||
162760629|NCT01673594|587836221|FG000|Overall Study|Lost to Follow-up|1|||
162760630|NCT01673594|587836222|FG001|Overall Study|Lost to Follow-up|0|||
162760631|NCT01673594|587836221|FG000|Overall Study|Physician Decision|2|||
162760632|NCT01673594|587836222|FG001|Overall Study|Physician Decision|4|||
162760633|NCT01673594|587836221|FG000|Overall Study|Withdrawal by Subject|0|||
162760634|NCT01673594|587836222|FG001|Overall Study|Withdrawal by Subject|1|||
162760635|NCT02824198|587836223|FG000|Overall Study|Non-compliance with the protocol|5|||
162760636|NCT02824198|587836224|FG001|Overall Study|Non-compliance with the protocol|1|||
162760637|NCT02824198|587836223|FG000|Overall Study|Lost to Follow-up|5|||
162760638|NCT02824198|587836224|FG001|Overall Study|Lost to Follow-up|2|||
162760639|NCT02824198|587836223|FG000|Overall Study|Withdrawal by Subject|5|||
162760640|NCT02824198|587836224|FG001|Overall Study|Withdrawal by Subject|0|||
162760641|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
162760642|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
162760643|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
162760644|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
162760645|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
162760646|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
162760647|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
162760648|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
162760649|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
162760650|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
162760651|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
162760652|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
162760653|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Other|1|||
162760654|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Other|0|||
162760655|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Other|0|||
162760656|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
162760657|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
162760658|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
162760659|NCT00887224|587836225|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
162760660|NCT00887224|587836226|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
162760661|NCT00887224|587836227|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
162760662|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
162760663|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
162760664|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
162760665|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
162760666|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
162760667|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
162760668|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
162760669|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
162760670|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
162760671|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
162760672|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
162760673|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
162760674|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Other|1|||
162760675|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Other|0|||
162760676|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Other|0|||
162760677|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
162760678|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
162760679|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
162760680|NCT00887224|587836225|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
162760681|NCT00887224|587836226|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
162760682|NCT00887224|587836227|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
162760683|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
162760684|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
162760685|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
162760686|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
162760687|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
162760688|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
162760689|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
162760690|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
162760691|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
162760692|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
162760693|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
162760694|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
162760695|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Other|30|||
162760696|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Other|0|||
162760697|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Other|0|||
162760698|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
162760699|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
162760700|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
162760701|NCT00887224|587836225|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
162760702|NCT00887224|587836226|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
162760703|NCT00887224|587836227|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
162760704|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Adverse Event|0|||
162760705|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Adverse Event|7|||
162760706|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Adverse Event|2|||
162760707|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Failed to return|0|||
162760708|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Failed to return|2|||
162760709|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Failed to return|2|||
162760710|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
162760711|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
162760712|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
162760713|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
162760714|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
162760715|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
162760716|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Other|0|||
162760717|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Other|2|||
162760718|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Other|0|||
162760719|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
162760720|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
162760721|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
162760722|NCT00887224|587836225|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
162760723|NCT00887224|587836226|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
162760724|NCT00887224|587836227|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
162760725|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
162760726|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
162760727|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
162760728|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
162760729|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
162760730|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
162760731|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
162760732|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
162760733|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
162760734|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
162760735|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
162760736|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
162760737|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
162760738|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
162760739|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
162760740|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
162760741|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
162760742|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
162760743|NCT00887224|587836225|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
162760744|NCT00887224|587836226|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
162760745|NCT00887224|587836227|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
162760746|NCT03883828|587836228|FG000|Overall Study|Did not start radiotherapy|1|||
162760747|NCT03883828|587836229|FG001|Overall Study|Did not start radiotherapy|2|||
162760748|NCT01353274|587836230|FG000|Overall Study|No case report form (CRF) collected|28|||
162760749|NCT00403494|587836231|FG000|Overall Study|Adverse Event|10|||
162760750|NCT00403494|587836232|FG001|Overall Study|Adverse Event|8|||
162760751|NCT00403494|587836231|FG000|Overall Study|Withdrew Consent|3|||
162760752|NCT00403494|587836232|FG001|Overall Study|Withdrew Consent|2|||
162760753|NCT00403494|587836231|FG000|Overall Study|Inappropriately enrolled|0|||
162760754|NCT00403494|587836232|FG001|Overall Study|Inappropriately enrolled|1|||
162760755|NCT00403494|587836231|FG000|Overall Study|Lost to Follow-up|0|||
162760756|NCT00403494|587836232|FG001|Overall Study|Lost to Follow-up|2|||
162760757|NCT00403494|587836231|FG000|Overall Study|Protocol noncompliance|0|||
162760758|NCT00403494|587836232|FG001|Overall Study|Protocol noncompliance|1|||
162760759|NCT00403494|587836231|FG000|Overall Study|Death|1|||
162760760|NCT00403494|587836232|FG001|Overall Study|Death|0|||
162760761|NCT00403494|587836231|FG000|Overall Study|Sponsor Request|1|||
162760762|NCT00403494|587836232|FG001|Overall Study|Sponsor Request|0|||
162760763|NCT05005247|587836233|FG000|Overall Study|Withdrawal by Subject|0|||
162760764|NCT05005247|587836234|FG001|Overall Study|Withdrawal by Subject|1|||
162760765|NCT05005247|587836235|FG002|Overall Study|Withdrawal by Subject|0|||
162760766|NCT02575365|587836236|FG000|Overall Study|Lost to Follow-up|4|||
162760767|NCT00487240|587836244|FG000|Overall Study|Withdrawal by Subject|12|||
162760768|NCT00487240|587836245|FG001|Overall Study|Withdrawal by Subject|6|||
162760769|NCT00487240|587836244|FG000|Overall Study|Lost to Follow-up|7|||
162760770|NCT00487240|587836245|FG001|Overall Study|Lost to Follow-up|6|||
162760771|NCT00487240|587836244|FG000|Overall Study|Adverse Event|0|||
162760772|NCT00487240|587836245|FG001|Overall Study|Adverse Event|4|||
162760773|NCT00487240|587836244|FG000|Overall Study|Protocol Violation|5|||
162760774|NCT00487240|587836245|FG001|Overall Study|Protocol Violation|5|||
162760775|NCT00487240|587836244|FG000|Overall Study|Entry Criteria Not Met|3|||
162760776|NCT00487240|587836245|FG001|Overall Study|Entry Criteria Not Met|4|||
162760777|NCT00487240|587836244|FG000|Overall Study|Sponsor Decision|2|||
162760778|NCT00487240|587836245|FG001|Overall Study|Sponsor Decision|1|||
162760779|NCT00487240|587836244|FG000|Overall Study|Physician Decision|2|||
162760780|NCT00487240|587836245|FG001|Overall Study|Physician Decision|0|||
162760781|NCT02736188|587836246|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
162760782|NCT02736188|587836246|FG000|Overall Study|Adverse Event|1|||
162760783|NCT02736188|587836246|FG000|Overall Study|Withdrawal by Subject|1|||
162760784|NCT02736188|587836246|FG000|Overall Study|Other|6|||
162760785|NCT01698918|587836247|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
162760786|NCT01698918|587836247|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
162760787|NCT01698918|587836247|FG000|First Line Treatment (Core+Extension)|Death|2|||
162760788|NCT01698918|587836247|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
162760789|NCT01698918|587836247|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
162760790|NCT01698918|587836247|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
162760791|NCT01698918|587836247|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
162760792|NCT01698918|587836247|FG000|Second Line Treatment (Core+Extension)|Death|1|||
162760793|NCT01698918|587836247|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
162760794|NCT01698918|587836247|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
162760795|NCT03176407|587836248|FG000|Overall Study|Protocol Violation|1|||
162760796|NCT03176407|587836248|FG000|Overall Study|human failure|1|||
162760797|NCT03176407|587836248|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
162760798|NCT01428583|587836250|FG000|Overall Study|Adverse Event|75|||
162760799|NCT01428583|587836250|FG000|Overall Study|Withdrawal by Subject|51|||
162760800|NCT01428583|587836250|FG000|Overall Study|Lack of Efficacy|37|||
162760801|NCT01428583|587836250|FG000|Overall Study|Lost to Follow-up|17|||
162760802|NCT01428583|587836250|FG000|Overall Study|Death|1|||
162760803|NCT01428583|587836250|FG000|Overall Study|Pregnancy|1|||
162760804|NCT01428583|587836250|FG000|Overall Study|Protocol Violation|1|||
162760805|NCT01428583|587836250|FG000|Overall Study|Physician Decision|12|||
162760806|NCT01428583|587836250|FG000|Overall Study|Non-compliant|25|||
162760807|NCT01428583|587836250|FG000|Overall Study|Confirmed positive urine drug test|8|||
162760808|NCT01428583|587836250|FG000|Overall Study|Sponsor's request|3|||
162760809|NCT01428583|587836250|FG000|Overall Study|Other|6|||
162760810|NCT00768755|587836254|FG000|Phase 1|Death|6|||
162760811|NCT00768755|587836255|FG001|Phase 1|Death|0|||
162760812|NCT00768755|587836256|FG002|Phase 1|Death|0|||
162760813|NCT00768755|587836257|FG003|Phase 1|Death|0|||
162760814|NCT00768755|587836254|FG000|Phase 1|Other|4|||
162760815|NCT00768755|587836255|FG001|Phase 1|Other|0|||
162760816|NCT00768755|587836256|FG002|Phase 1|Other|0|||
162760817|NCT00768755|587836257|FG003|Phase 1|Other|0|||
162760818|NCT00768755|587836254|FG000|Phase 2|Death|0|||
162760819|NCT00768755|587836255|FG001|Phase 2|Death|37|||
162760820|NCT00768755|587836256|FG002|Phase 2|Death|48|||
162760821|NCT00768755|587836257|FG003|Phase 2|Death|31|||
162760822|NCT00768755|587836254|FG000|Phase 2|Protocol Violation|0|||
162760823|NCT00768755|587836255|FG001|Phase 2|Protocol Violation|2|||
162760824|NCT00768755|587836256|FG002|Phase 2|Protocol Violation|0|||
162760825|NCT00768755|587836257|FG003|Phase 2|Protocol Violation|1|||
162760826|NCT00768755|587836254|FG000|Phase 2|Lost to Follow-up|0|||
162760827|NCT00768755|587836255|FG001|Phase 2|Lost to Follow-up|1|||
162760828|NCT00768755|587836256|FG002|Phase 2|Lost to Follow-up|1|||
162760829|NCT00768755|587836257|FG003|Phase 2|Lost to Follow-up|4|||
162760830|NCT00768755|587836254|FG000|Phase 2|Withdrawal by Subject|0|||
162760831|NCT00768755|587836255|FG001|Phase 2|Withdrawal by Subject|1|||
162760832|NCT00768755|587836256|FG002|Phase 2|Withdrawal by Subject|0|||
162760833|NCT00768755|587836257|FG003|Phase 2|Withdrawal by Subject|1|||
162760834|NCT00768755|587836254|FG000|Phase 2|Other|0|||
162760835|NCT00768755|587836255|FG001|Phase 2|Other|1|||
162760836|NCT00768755|587836256|FG002|Phase 2|Other|2|||
162760837|NCT00768755|587836257|FG003|Phase 2|Other|4|||
162760838|NCT00768755|587836254|FG000|Phase 2|Study Terminated by Sponsor|0|||
162760839|NCT00768755|587836255|FG001|Phase 2|Study Terminated by Sponsor|13|||
162760840|NCT00768755|587836256|FG002|Phase 2|Study Terminated by Sponsor|7|||
162760841|NCT00768755|587836257|FG003|Phase 2|Study Terminated by Sponsor|14|||
162760842|NCT00768755|587836254|FG000|Phase 2|Randomized but not treated|0|||
162760843|NCT00768755|587836255|FG001|Phase 2|Randomized but not treated|0|||
162760844|NCT00768755|587836256|FG002|Phase 2|Randomized but not treated|0|||
162760845|NCT00768755|587836257|FG003|Phase 2|Randomized but not treated|2|||
162760846|NCT00670488|587836258|FG000|Overall Study|Adverse Event|0|||
162760847|NCT00670488|587836259|FG001|Overall Study|Adverse Event|7|||
162760848|NCT00670488|587836260|FG002|Overall Study|Adverse Event|0|||
162760849|NCT00670488|587836261|FG003|Overall Study|Adverse Event|3|||
162760850|NCT00670488|587836262|FG004|Overall Study|Adverse Event|1|||
162760851|NCT00670488|587836263|FG005|Overall Study|Adverse Event|1|||
162760852|NCT00670488|587836264|FG006|Overall Study|Adverse Event|5|||
162760853|NCT00670488|587836265|FG007|Overall Study|Adverse Event|1|||
162760854|NCT00670488|587836266|FG008|Overall Study|Adverse Event|0|||
162760855|NCT00670488|587836267|FG009|Overall Study|Adverse Event|1|||
162760856|NCT00670488|587836258|FG000|Overall Study|Physician Decision|1|||
162760857|NCT00670488|587836259|FG001|Overall Study|Physician Decision|9|||
162760858|NCT00670488|587836260|FG002|Overall Study|Physician Decision|0|||
162760859|NCT00670488|587836261|FG003|Overall Study|Physician Decision|1|||
162760860|NCT00670488|587836262|FG004|Overall Study|Physician Decision|0|||
162760861|NCT00670488|587836263|FG005|Overall Study|Physician Decision|0|||
162760862|NCT00670488|587836264|FG006|Overall Study|Physician Decision|0|||
162760863|NCT00670488|587836265|FG007|Overall Study|Physician Decision|0|||
162760864|NCT00670488|587836266|FG008|Overall Study|Physician Decision|0|||
162760865|NCT00670488|587836267|FG009|Overall Study|Physician Decision|0|||
162760866|NCT00670488|587836258|FG000|Overall Study|Progressive Disease|2|||
162760867|NCT00670488|587836259|FG001|Overall Study|Progressive Disease|41|||
162760868|NCT00670488|587836260|FG002|Overall Study|Progressive Disease|3|||
162760869|NCT00670488|587836261|FG003|Overall Study|Progressive Disease|2|||
162760870|NCT00670488|587836262|FG004|Overall Study|Progressive Disease|2|||
162760871|NCT00670488|587836263|FG005|Overall Study|Progressive Disease|4|||
162760872|NCT00670488|587836264|FG006|Overall Study|Progressive Disease|11|||
162760873|NCT00670488|587836265|FG007|Overall Study|Progressive Disease|2|||
162760874|NCT00670488|587836266|FG008|Overall Study|Progressive Disease|2|||
162760875|NCT00670488|587836267|FG009|Overall Study|Progressive Disease|1|||
162760876|NCT00670488|587836258|FG000|Overall Study|Withdrawal by Subject|0|||
162760877|NCT00670488|587836259|FG001|Overall Study|Withdrawal by Subject|1|||
162760878|NCT00670488|587836260|FG002|Overall Study|Withdrawal by Subject|0|||
162760879|NCT00670488|587836261|FG003|Overall Study|Withdrawal by Subject|1|||
162760880|NCT00670488|587836262|FG004|Overall Study|Withdrawal by Subject|0|||
162760881|NCT00670488|587836263|FG005|Overall Study|Withdrawal by Subject|0|||
162760882|NCT00670488|587836264|FG006|Overall Study|Withdrawal by Subject|1|||
162760883|NCT00670488|587836265|FG007|Overall Study|Withdrawal by Subject|0|||
162760884|NCT00670488|587836266|FG008|Overall Study|Withdrawal by Subject|1|||
162760885|NCT00670488|587836267|FG009|Overall Study|Withdrawal by Subject|0|||
162760886|NCT00878189|587836268|FG000|Overall Study|Death|0|||
162760887|NCT00878189|587836269|FG001|Overall Study|Death|1|||
162760888|NCT00878189|587836270|FG002|Overall Study|Death|0|||
162760889|NCT00878189|587836271|FG003|Overall Study|Death|1|||
162760890|NCT00878189|587836272|FG004|Overall Study|Death|0|||
162760891|NCT00878189|587836273|FG005|Overall Study|Death|0|||
162760892|NCT00878189|587836274|FG006|Overall Study|Death|0|||
162760893|NCT00878189|587836275|FG007|Overall Study|Death|0|||
162760894|NCT00878189|587836276|FG008|Overall Study|Death|1|||
162760895|NCT00878189|587836268|FG000|Overall Study|Participant Refused to Follow-up|0|||
162760896|NCT00878189|587836269|FG001|Overall Study|Participant Refused to Follow-up|0|||
162760897|NCT00878189|587836270|FG002|Overall Study|Participant Refused to Follow-up|0|||
162760898|NCT00878189|587836271|FG003|Overall Study|Participant Refused to Follow-up|0|||
162760899|NCT00878189|587836272|FG004|Overall Study|Participant Refused to Follow-up|0|||
162760900|NCT00878189|587836273|FG005|Overall Study|Participant Refused to Follow-up|4|||
162760901|NCT00878189|587836274|FG006|Overall Study|Participant Refused to Follow-up|0|||
162760902|NCT00878189|587836275|FG007|Overall Study|Participant Refused to Follow-up|0|||
162760903|NCT00878189|587836276|FG008|Overall Study|Participant Refused to Follow-up|0|||
162760904|NCT00878189|587836268|FG000|Overall Study|Other|3|||
162760905|NCT00878189|587836269|FG001|Overall Study|Other|2|||
162760906|NCT00878189|587836270|FG002|Overall Study|Other|4|||
162760907|NCT00878189|587836271|FG003|Overall Study|Other|7|||
162760908|NCT00878189|587836272|FG004|Overall Study|Other|4|||
162760909|NCT00878189|587836273|FG005|Overall Study|Other|18|||
162760910|NCT00878189|587836274|FG006|Overall Study|Other|15|||
162760911|NCT00878189|587836275|FG007|Overall Study|Other|3|||
162760912|NCT00878189|587836276|FG008|Overall Study|Other|4|||
162760913|NCT00878189|587836268|FG000|Overall Study|Lost to Follow-up|0|||
162760914|NCT00878189|587836269|FG001|Overall Study|Lost to Follow-up|0|||
162760915|NCT00878189|587836270|FG002|Overall Study|Lost to Follow-up|0|||
162760916|NCT00878189|587836271|FG003|Overall Study|Lost to Follow-up|0|||
162760917|NCT00878189|587836272|FG004|Overall Study|Lost to Follow-up|0|||
162760918|NCT00878189|587836273|FG005|Overall Study|Lost to Follow-up|1|||
162760919|NCT00878189|587836274|FG006|Overall Study|Lost to Follow-up|1|||
162760920|NCT00878189|587836275|FG007|Overall Study|Lost to Follow-up|0|||
162760921|NCT00878189|587836276|FG008|Overall Study|Lost to Follow-up|0|||
162760922|NCT00878189|587836268|FG000|Overall Study|Objection Progression or Relapse|0|||
162760923|NCT00878189|587836269|FG001|Overall Study|Objection Progression or Relapse|0|||
162760924|NCT00878189|587836270|FG002|Overall Study|Objection Progression or Relapse|0|||
162760925|NCT00878189|587836271|FG003|Overall Study|Objection Progression or Relapse|0|||
162760926|NCT00878189|587836272|FG004|Overall Study|Objection Progression or Relapse|0|||
162760927|NCT00878189|587836273|FG005|Overall Study|Objection Progression or Relapse|0|||
162760928|NCT00878189|587836274|FG006|Overall Study|Objection Progression or Relapse|0|||
162760929|NCT00878189|587836275|FG007|Overall Study|Objection Progression or Relapse|0|||
162760930|NCT00878189|587836276|FG008|Overall Study|Objection Progression or Relapse|3|||
162760931|NCT02708498|587836277|FG000|Overall Study|Death|20|||
162760932|NCT02708498|587836278|FG001|Overall Study|Death|19|||
162760933|NCT02708498|587836279|FG002|Overall Study|Death|0|||
162760934|NCT02708498|587836280|FG003|Overall Study|Death|0|||
162760935|NCT02708498|587836281|FG004|Overall Study|Death|1|||
162760936|NCT02708498|587836282|FG005|Overall Study|Death|0|||
162760937|NCT02708498|587836283|FG006|Overall Study|Death|0|||
162760938|NCT02708498|587836284|FG007|Overall Study|Death|0|||
162760939|NCT02708498|587836277|FG000|Overall Study|Unknown reason, missing data|0|||
162760940|NCT02708498|587836278|FG001|Overall Study|Unknown reason, missing data|0|||
162760941|NCT02708498|587836279|FG002|Overall Study|Unknown reason, missing data|62|||
162760942|NCT02708498|587836280|FG003|Overall Study|Unknown reason, missing data|51|||
162760943|NCT02708498|587836281|FG004|Overall Study|Unknown reason, missing data|195|||
162760944|NCT02708498|587836282|FG005|Overall Study|Unknown reason, missing data|132|||
162760945|NCT02708498|587836283|FG006|Overall Study|Unknown reason, missing data|0|||
162760946|NCT02708498|587836284|FG007|Overall Study|Unknown reason, missing data|0|||
162760947|NCT01829711|587836285|FG000|Overall Study|Lost to Follow-up|2|||
162760948|NCT01829711|587836285|FG000|Overall Study|Withdrawal by Subject|3|||
162760949|NCT01829711|587836285|FG000|Overall Study|Death|4|||
162760950|NCT01829711|587836285|FG000|Overall Study|Started new therapies|17|||
162760951|NCT01829711|587836285|FG000|Overall Study|Adverse Event|3|||
162760952|NCT01829711|587836285|FG000|Overall Study|Due to progression of disease|13|||
162760953|NCT01829711|587836285|FG000|Overall Study|Due to lack of response|1|||
162760954|NCT01480258|587836286|FG000|Infant Series|Protocol Violation|2|||
162760955|NCT01480258|587836287|FG001|Infant Series|Protocol Violation|0|||
162760956|NCT01480258|587836286|FG000|Infant Series|Physician Decision|0|||
162760957|NCT01480258|587836287|FG001|Infant Series|Physician Decision|1|||
162760958|NCT01480258|587836286|FG000|Infant Series|Not Vaccinated|3|||
162760959|NCT01480258|587836287|FG001|Infant Series|Not Vaccinated|0|||
162760960|NCT01480258|587836286|FG000|Infant Series|Adverse Event|1|||
162760961|NCT01480258|587836287|FG001|Infant Series|Adverse Event|1|||
162760962|NCT01480258|587836286|FG000|Infant Series|Withdrawal by Subject|1|||
162760963|NCT01480258|587836287|FG001|Infant Series|Withdrawal by Subject|6|||
162760964|NCT01480258|587836286|FG000|Interim Period|Lost to Follow-up|0|||
162760965|NCT01480258|587836287|FG001|Interim Period|Lost to Follow-up|2|||
162760966|NCT01480258|587836286|FG000|Interim Period|Physician Decision|1|||
162760967|NCT01480258|587836287|FG001|Interim Period|Physician Decision|0|||
162760968|NCT01480258|587836286|FG000|Interim Period|Protocol Violation|0|||
162760969|NCT01480258|587836287|FG001|Interim Period|Protocol Violation|1|||
162760970|NCT01480258|587836286|FG000|Interim Period|Withdrawal by Subject|9|||
162760971|NCT01480258|587836287|FG001|Interim Period|Withdrawal by Subject|6|||
162760972|NCT01858688|587836288|FG000|Overall Study|Withdrawal by Subject|8|||
162760973|NCT01858688|587836288|FG000|Overall Study|Participant began another therapy|3|||
162760974|NCT01858688|587836288|FG000|Overall Study|Physician Decision|2|||
162760975|NCT01858688|587836288|FG000|Overall Study|Progressive Disease|2|||
162760976|NCT01858688|587836288|FG000|Overall Study|Reason not reproted|5|||
162760977|NCT04248868|587836289|FG000|Overall Study|Death|1|||
162760978|NCT04248868|587836289|FG000|Overall Study|Lost to Follow-up|3|||
162760979|NCT04248868|587836289|FG000|Overall Study|Protocol Violation|2|||
162760980|NCT01543204|587836292|FG000|Overall Study|Non-compliance|1|||
162760981|NCT01543204|587836292|FG000|Overall Study|Adverse Event|1|||
162760982|NCT01543204|587836292|FG000|Overall Study|Withdrawal by Subject|4|||
162760983|NCT01543204|587836292|FG000|Overall Study|Requirement for Alternative Therapy|1|||
162760984|NCT01543204|587836292|FG000|Overall Study|Lost to Follow-up|1|||
162760985|NCT02309294|587836298|FG000|Overall Study|Withdrawal by Subject|2|||
162760986|NCT01227421|587836299|FG000|Overall Study|Lost to Follow-up|6|||
162760987|NCT01227421|587836300|FG001|Overall Study|Lost to Follow-up|7|||
162760988|NCT01227421|587836301|FG002|Overall Study|Lost to Follow-up|5|||
162760989|NCT01227421|587836299|FG000|Overall Study|Adverse Event|2|||
162760990|NCT01227421|587836300|FG001|Overall Study|Adverse Event|7|||
162760991|NCT01227421|587836301|FG002|Overall Study|Adverse Event|2|||
162760992|NCT01227421|587836299|FG000|Overall Study|Withdrawal by Subject|1|||
162760993|NCT01227421|587836300|FG001|Overall Study|Withdrawal by Subject|2|||
162760994|NCT01227421|587836301|FG002|Overall Study|Withdrawal by Subject|1|||
162760995|NCT01227421|587836299|FG000|Overall Study|Protocol Violation|1|||
162760996|NCT01227421|587836300|FG001|Overall Study|Protocol Violation|1|||
162760997|NCT01227421|587836301|FG002|Overall Study|Protocol Violation|2|||
162760998|NCT01227421|587836299|FG000|Overall Study|Randomized in error|1|||
162760999|NCT01227421|587836300|FG001|Overall Study|Randomized in error|1|||
162761000|NCT01227421|587836301|FG002|Overall Study|Randomized in error|0|||
162761001|NCT02969356|587836308|FG000|Overall Study|Adverse Event|7|||
162761002|NCT02969356|587836308|FG000|Overall Study|Consent withdrawn|2|||
162761003|NCT02969356|587836308|FG000|Overall Study|Lost to Follow-up|3|||
162761004|NCT02969356|587836308|FG000|Overall Study|Did not need to be reinjected|6|||
162761005|NCT02969356|587836308|FG000|Overall Study|Personal reasons|5|||
162761006|NCT05432986|587836321|FG000|Overall Study|Withdrawal by Subject|2|||
162761007|NCT05432986|587836321|FG000|Overall Study|incomplete measurement|7|||
162761008|NCT01128959|587837704|FG000|Lead in Period|Adverse Event|3|||
162761009|NCT01128959|587837704|FG000|Treatment Period|Adverse Event|3|||
162761010|NCT01128959|587837704|FG000|Treatment Period|Withdrawal by Subject|1|||
162761011|NCT01409837|587837707|FG000|Overall Study|Withdrawal by Subject|2|||
162761012|NCT01409837|587837708|FG001|Overall Study|Withdrawal by Subject|1|||
162761013|NCT01409837|587837707|FG000|Overall Study|Lost to Follow-up|1|||
162761014|NCT01409837|587837708|FG001|Overall Study|Lost to Follow-up|0|||
162761015|NCT01409837|587837707|FG000|Overall Study|Physician Decision|0|||
162761016|NCT01409837|587837708|FG001|Overall Study|Physician Decision|1|||
162761017|NCT04938453|587837709|FG000|Washout Period 1|Adverse Event|1|||
162761018|NCT04938453|587837710|FG001|Washout Period 1|Adverse Event|0|||
162761019|NCT04938453|587837709|FG000|Washout Period 1|Physician Decision|0|||
162761020|NCT04938453|587837710|FG001|Washout Period 1|Physician Decision|1|||
162761021|NCT03292406|587837712|FG000|Overall Study|Progressive Disease|6|||
162761022|NCT03292406|587837713|FG001|Overall Study|Progressive Disease|3|||
162761023|NCT03292406|587837714|FG002|Overall Study|Progressive Disease|4|||
162761024|NCT03292406|587837712|FG000|Overall Study|Adverse Event|7|||
162761025|NCT03292406|587837713|FG001|Overall Study|Adverse Event|1|||
162761026|NCT03292406|587837714|FG002|Overall Study|Adverse Event|4|||
162761027|NCT03292406|587837712|FG000|Overall Study|Withdrawal by Subject|0|||
162761028|NCT03292406|587837713|FG001|Overall Study|Withdrawal by Subject|7|||
162761029|NCT03292406|587837714|FG002|Overall Study|Withdrawal by Subject|2|||
162761030|NCT03292406|587837712|FG000|Overall Study|Protocol Violation|0|||
162761031|NCT03292406|587837713|FG001|Overall Study|Protocol Violation|1|||
162761032|NCT03292406|587837714|FG002|Overall Study|Protocol Violation|1|||
162761033|NCT03292406|587837712|FG000|Overall Study|Other|0|||
162761034|NCT03292406|587837713|FG001|Overall Study|Other|1|||
162761035|NCT03292406|587837714|FG002|Overall Study|Other|2|||
162761036|NCT00022672|587837716|FG000|Main Phase: 24 Months|Adverse Event|6|||
162761037|NCT00022672|587837717|FG001|Main Phase: 24 Months|Adverse Event|0|||
162761038|NCT00022672|587837716|FG000|Main Phase: 24 Months|Death|0|||
162761039|NCT00022672|587837717|FG001|Main Phase: 24 Months|Death|3|||
162761040|NCT00022672|587837716|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
162761041|NCT00022672|587837717|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
162761042|NCT00022672|587837716|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
162761043|NCT00022672|587837717|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
162761044|NCT00022672|587837716|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
162761045|NCT00022672|587837717|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
162761046|NCT00022672|587837716|FG000|Main Phase: 24 Months|Refused Treatment|3|||
162761047|NCT00022672|587837717|FG001|Main Phase: 24 Months|Refused Treatment|4|||
162761048|NCT00022672|587837716|FG000|Main Phase: 24 Months|Failure to Return|1|||
162761049|NCT00022672|587837717|FG001|Main Phase: 24 Months|Failure to Return|1|||
162761050|NCT00022672|587837716|FG000|Main Phase: 24 Months|Other|1|||
162761051|NCT00022672|587837717|FG001|Main Phase: 24 Months|Other|0|||
162761052|NCT00022672|587837716|FG000|Extension Phase|Adverse Event|1|||
162761053|NCT00022672|587837717|FG001|Extension Phase|Adverse Event|3|||
162761054|NCT00022672|587837716|FG000|Extension Phase|Death|0|||
162761055|NCT00022672|587837717|FG001|Extension Phase|Death|1|||
162761056|NCT00022672|587837716|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
162761057|NCT00022672|587837717|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
162761058|NCT00022672|587837716|FG000|Extension Phase|Refused Treatment|0|||
162761059|NCT00022672|587837717|FG001|Extension Phase|Refused Treatment|2|||
162761060|NCT00022672|587837716|FG000|Extension Phase|Other|1|||
162761061|NCT00022672|587837717|FG001|Extension Phase|Other|1|||
162761062|NCT03648541|587837720|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
162761063|NCT03648541|587837721|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
162761064|NCT03648541|587837720|FG000|Re-induction Period Only|Lack of Efficacy|7|||
162761065|NCT03648541|587837721|FG001|Re-induction Period Only|Lack of Efficacy|0|||
162761066|NCT03648541|587837720|FG000|Maintenance Period Only|Missing|0|||
162761067|NCT03648541|587837721|FG001|Maintenance Period Only|Missing|1|||
162761068|NCT03648541|587837720|FG000|Maintenance Period Only|Other not listed below|0|||
162761069|NCT03648541|587837721|FG001|Maintenance Period Only|Other not listed below|4|||
162761070|NCT03648541|587837720|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
162761071|NCT03648541|587837721|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
162761072|NCT03648541|587837720|FG000|Maintenance Period Only|Protocol Violation|0|||
162761073|NCT03648541|587837721|FG001|Maintenance Period Only|Protocol Violation|1|||
162761074|NCT03648541|587837720|FG000|Maintenance Period Only|Lack of Efficacy|0|||
162761075|NCT03648541|587837721|FG001|Maintenance Period Only|Lack of Efficacy|18|||
162761076|NCT03648541|587837720|FG000|Maintenance Period Only|Adverse Event|0|||
162761077|NCT03648541|587837721|FG001|Maintenance Period Only|Adverse Event|4|||
162761078|NCT03648541|587837720|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
162761079|NCT03648541|587837721|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
162761080|NCT03490032|587837722|FG000|Overall Study|family issue (child custody)|1|||
162761081|NCT03490032|587837723|FG001|Overall Study|family issue (child custody)|0|||
162761082|NCT03490032|587837724|FG002|Overall Study|family issue (child custody)|0|||
162761083|NCT00308308|587837725|FG000|Overall Study|Adverse Event|17|||
162761084|NCT00308308|587837726|FG001|Overall Study|Adverse Event|2|||
162761085|NCT00308308|587837725|FG000|Overall Study|Lost to Follow-up|5|||
162761086|NCT00308308|587837726|FG001|Overall Study|Lost to Follow-up|5|||
162761087|NCT00308308|587837725|FG000|Overall Study|Physician Decision|15|||
162761088|NCT00308308|587837726|FG001|Overall Study|Physician Decision|7|||
162761089|NCT00308308|587837725|FG000|Overall Study|Protocol Violation|3|||
162761090|NCT00308308|587837726|FG001|Overall Study|Protocol Violation|14|||
162761091|NCT00308308|587837725|FG000|Overall Study|Withdrawal by Subject|47|||
162761092|NCT00308308|587837726|FG001|Overall Study|Withdrawal by Subject|19|||
162761093|NCT00308308|587837725|FG000|Overall Study|Various|7|||
162761094|NCT00308308|587837726|FG001|Overall Study|Various|5|||
162761095|NCT00308308|587837725|FG000|Overall Study|Randomized but not dosed|8|||
162761096|NCT00308308|587837726|FG001|Overall Study|Randomized but not dosed|16|||
162761097|NCT00308308|587837725|FG000|Overall Study|Other|1|||
162761098|NCT00308308|587837726|FG001|Overall Study|Other|0|||
162761099|NCT01951703|587837729|FG000|First Intervention|Withdrawal by Subject|1|||
162761100|NCT01951703|587837730|FG001|First Intervention|Withdrawal by Subject|0|||
162761101|NCT01951703|587837729|FG000|First Intervention|Subject was not compliant|1|||
162761102|NCT01951703|587837730|FG001|First Intervention|Subject was not compliant|1|||
162761103|NCT01951703|587837729|FG000|First Intervention|Physician Decision|1|||
162761104|NCT01951703|587837730|FG001|First Intervention|Physician Decision|0|||
162761105|NCT01951703|587837729|FG000|Second Intervention|Protocol Violation|0|||
162761106|NCT01951703|587837730|FG001|Second Intervention|Protocol Violation|1|||
162761107|NCT01951703|587837729|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
162761108|NCT01951703|587837730|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
162761109|NCT01852045|587837731|FG000|Overall Study|Adverse Event|1|||
162761110|NCT01852045|587837732|FG001|Overall Study|Adverse Event|0|||
162761111|NCT01852045|587837733|FG002|Overall Study|Adverse Event|0|||
162761112|NCT01852045|587837731|FG000|Overall Study|Lack of Efficacy|3|||
162761113|NCT01852045|587837732|FG001|Overall Study|Lack of Efficacy|0|||
162761114|NCT01852045|587837733|FG002|Overall Study|Lack of Efficacy|0|||
162761115|NCT01852045|587837731|FG000|Overall Study|Lost to Follow-up|0|||
162761116|NCT01852045|587837732|FG001|Overall Study|Lost to Follow-up|1|||
162761117|NCT01852045|587837733|FG002|Overall Study|Lost to Follow-up|1|||
162761118|NCT01852045|587837731|FG000|Overall Study|Withdrawal by Subject|1|||
162761119|NCT01852045|587837732|FG001|Overall Study|Withdrawal by Subject|0|||
162761120|NCT01852045|587837733|FG002|Overall Study|Withdrawal by Subject|1|||
162761121|NCT01852045|587837731|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162761122|NCT01852045|587837732|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162761123|NCT01852045|587837733|FG002|Overall Study|Other Miscellaneous Reasons|2|||
162761124|NCT02827201|587837734|FG000|Overall Study|Death|1|||
162761125|NCT02827201|587837735|FG001|Overall Study|Death|2|||
162761126|NCT02827201|587837734|FG000|Overall Study|Patients not treated|1|||
162761127|NCT02827201|587837735|FG001|Overall Study|Patients not treated|1|||
162761128|NCT02128269|587837736|FG000|Treatment Period|Adverse Event|1|||
162761129|NCT02128269|587837736|FG000|Treatment Period|Physician Decision|1|||
162761130|NCT01640288|587837737|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
162761131|NCT01640288|587837738|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
162761132|NCT01640288|587837737|FG000|Overall Study|Screen Failure|20|||
162761133|NCT01640288|587837738|FG001|Overall Study|Screen Failure|18|||
162761134|NCT01640288|587837737|FG000|Overall Study|Withdrawn by PI|5|||
162761135|NCT01640288|587837738|FG001|Overall Study|Withdrawn by PI|0|||
162761136|NCT01640288|587837737|FG000|Overall Study|Withdrawal by Subject|1|||
162761137|NCT01640288|587837738|FG001|Overall Study|Withdrawal by Subject|0|||
162761138|NCT01972776|587837739|FG000|Part 1|Withdrawal by Subject|0|||
162761139|NCT01972776|587837740|FG001|Part 1|Withdrawal by Subject|0|||
162761140|NCT01972776|587837741|FG002|Part 1|Withdrawal by Subject|1|||
162761141|NCT01972776|587837742|FG003|Part 1|Withdrawal by Subject|0|||
162761142|NCT01972776|587837743|FG004|Part 1|Withdrawal by Subject|0|||
162761143|NCT01972776|587837744|FG005|Part 1|Withdrawal by Subject|0|||
162761144|NCT01972776|587837739|FG000|Part 1|Adverse Event|0|||
162761145|NCT01972776|587837740|FG001|Part 1|Adverse Event|0|||
162761146|NCT01972776|587837741|FG002|Part 1|Adverse Event|1|||
162761147|NCT01972776|587837742|FG003|Part 1|Adverse Event|1|||
162761148|NCT01972776|587837743|FG004|Part 1|Adverse Event|0|||
162761149|NCT01972776|587837744|FG005|Part 1|Adverse Event|0|||
162761150|NCT01972776|587837739|FG000|Part 2|Adverse Event|0|||
162761151|NCT01972776|587837740|FG001|Part 2|Adverse Event|0|||
162761152|NCT01972776|587837741|FG002|Part 2|Adverse Event|0|||
162761153|NCT01972776|587837742|FG003|Part 2|Adverse Event|0|||
162761154|NCT01972776|587837743|FG004|Part 2|Adverse Event|3|||
162761155|NCT01972776|587837744|FG005|Part 2|Adverse Event|0|||
162761156|NCT01972776|587837739|FG000|Part 2|Administrative problems|0|||
162761157|NCT01972776|587837740|FG001|Part 2|Administrative problems|0|||
162761158|NCT01972776|587837741|FG002|Part 2|Administrative problems|0|||
162761159|NCT01972776|587837742|FG003|Part 2|Administrative problems|0|||
162761160|NCT01972776|587837743|FG004|Part 2|Administrative problems|10|||
162761161|NCT01972776|587837744|FG005|Part 2|Administrative problems|7|||
162761162|NCT01228734|587837745|FG000|Overall Study|Randomized, but not treated|0|||
162761163|NCT01228734|587837746|FG001|Overall Study|Randomized, but not treated|4|||
162761164|NCT02449902|587837747|FG000|Overall Study|Adverse Event|0|||
162761165|NCT02449902|587837748|FG001|Overall Study|Adverse Event|1|||
162761166|NCT02449902|587837747|FG000|Overall Study|Withdrawal by Subject|0|||
162761167|NCT02449902|587837748|FG001|Overall Study|Withdrawal by Subject|1|||
162761168|NCT01365546|587837749|FG000|Overall Study|Withdrawal by Subject|1|||
162761169|NCT01365546|587837749|FG000|Overall Study|Screen failure|9|||
162761170|NCT01365546|587837749|FG000|Overall Study|Study termination|1|||
162761171|NCT03326856|587837750|FG000|Overall Study|Lost to Follow-up|1|||
162761172|NCT03326856|587837751|FG001|Overall Study|Lost to Follow-up|1|||
162761173|NCT03326856|587837752|FG002|Overall Study|Lost to Follow-up|0|||
162761174|NCT03326856|587837753|FG003|Overall Study|Lost to Follow-up|0|||
162761175|NCT03326856|587837754|FG004|Overall Study|Lost to Follow-up|0|||
162761176|NCT03162614|587837755|FG000|Overall Study|Lost to Follow-up|2|||
162761177|NCT03162614|587837756|FG001|Overall Study|Lost to Follow-up|1|||
162761178|NCT03162614|587837757|FG002|Overall Study|Lost to Follow-up|1|||
162761179|NCT03162614|587837758|FG003|Overall Study|Lost to Follow-up|1|||
162761180|NCT03162614|587837759|FG004|Overall Study|Lost to Follow-up|2|||
162761181|NCT03162614|587837760|FG005|Overall Study|Lost to Follow-up|0|||
162761182|NCT03162614|587837755|FG000|Overall Study|Protocol Violation|0|||
162761183|NCT03162614|587837756|FG001|Overall Study|Protocol Violation|1|||
162761184|NCT03162614|587837757|FG002|Overall Study|Protocol Violation|0|||
162761185|NCT03162614|587837758|FG003|Overall Study|Protocol Violation|1|||
162761186|NCT03162614|587837759|FG004|Overall Study|Protocol Violation|0|||
162761187|NCT03162614|587837760|FG005|Overall Study|Protocol Violation|0|||
162761188|NCT03162614|587837755|FG000|Overall Study|Withdrawal by Subject|2|||
162761189|NCT03162614|587837756|FG001|Overall Study|Withdrawal by Subject|1|||
162761190|NCT03162614|587837757|FG002|Overall Study|Withdrawal by Subject|1|||
162761191|NCT03162614|587837758|FG003|Overall Study|Withdrawal by Subject|1|||
162761192|NCT03162614|587837759|FG004|Overall Study|Withdrawal by Subject|0|||
162761193|NCT03162614|587837760|FG005|Overall Study|Withdrawal by Subject|0|||
162761194|NCT03162614|587837755|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
162761195|NCT03162614|587837756|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
162761196|NCT03162614|587837757|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
162761197|NCT03162614|587837758|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
162761198|NCT03162614|587837759|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
162761199|NCT03162614|587837760|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
162761200|NCT00621842|587837761|FG000|Overall Study|Adverse Event|6|||
162761201|NCT00621842|587837761|FG000|Overall Study|Withdrawal by Subject|7|||
162761202|NCT00621842|587837761|FG000|Overall Study|Protocol Violation|4|||
162761203|NCT00621842|587837761|FG000|Overall Study|Lack of Efficacy|2|||
162761204|NCT01074242|587837764|FG000|Overall Study|Case report before date of contract|40|||
162761205|NCT01074242|587837764|FG000|Overall Study|Lost to Follow-up|1|||
162761206|NCT01074242|587837764|FG000|Overall Study|Case report unclear|6|||
162761207|NCT01074242|587837764|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
162761208|NCT01074242|587837764|FG000|Overall Study|Duplicate Case Report Form|5|||
162761209|NCT01957163|587837765|FG000|Overall Study|Adverse Event|5|||
162761210|NCT01957163|587837766|FG001|Overall Study|Adverse Event|2|||
162761211|NCT01957163|587837767|FG002|Overall Study|Adverse Event|4|||
162761212|NCT01957163|587837765|FG000|Overall Study|Lack of Efficacy|5|||
162761213|NCT01957163|587837766|FG001|Overall Study|Lack of Efficacy|4|||
162761214|NCT01957163|587837767|FG002|Overall Study|Lack of Efficacy|9|||
162761215|NCT01957163|587837765|FG000|Overall Study|Protocol Violation|1|||
162761216|NCT01957163|587837766|FG001|Overall Study|Protocol Violation|2|||
162761217|NCT01957163|587837767|FG002|Overall Study|Protocol Violation|0|||
162761218|NCT01957163|587837765|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
162761219|NCT01957163|587837766|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
162761220|NCT01957163|587837767|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
162761221|NCT01957163|587837765|FG000|Overall Study|Lost to Follow-up|0|||
162761222|NCT01957163|587837766|FG001|Overall Study|Lost to Follow-up|1|||
162761223|NCT01957163|587837767|FG002|Overall Study|Lost to Follow-up|0|||
162761224|NCT01957163|587837765|FG000|Overall Study|Withdrawal by Subject|4|||
162761225|NCT01957163|587837766|FG001|Overall Study|Withdrawal by Subject|2|||
162761226|NCT01957163|587837767|FG002|Overall Study|Withdrawal by Subject|4|||
162761227|NCT03822832|587837772|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
162761228|NCT03822832|587837773|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
162761229|NCT03822832|587837772|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
162761230|NCT03822832|587837773|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
162761231|NCT03822832|587837772|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
162761232|NCT03822832|587837773|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
162761233|NCT03822832|587837772|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
162761234|NCT03822832|587837773|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
162761235|NCT03822832|587837772|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
162761236|NCT03822832|587837773|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
162761237|NCT03822832|587837772|FG000|Re-allocation|Not re-allocated to open label period|2|||
162761238|NCT03822832|587837773|FG001|Re-allocation|Not re-allocated to open label period|6|||
162761239|NCT03822832|587837772|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
162761240|NCT03822832|587837773|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
162761241|NCT03822832|587837772|FG000|Period 2 - Open Label Period|Adverse Event|0|||
162761242|NCT03822832|587837773|FG001|Period 2 - Open Label Period|Adverse Event|3|||
162761243|NCT01668719|587837774|FG000|Phase I|On treatment|1|||
162761244|NCT01668719|587837775|FG001|Phase I|On treatment|0|||
162761245|NCT01668719|587837776|FG002|Phase I|On treatment|0|||
162761246|NCT01668719|587837774|FG000|Phase I|Adverse Event|2|||
162761247|NCT01668719|587837775|FG001|Phase I|Adverse Event|0|||
162761248|NCT01668719|587837776|FG002|Phase I|Adverse Event|0|||
162761249|NCT01668719|587837774|FG000|Phase I|Progression/relapse|1|||
162761250|NCT01668719|587837775|FG001|Phase I|Progression/relapse|0|||
162761251|NCT01668719|587837776|FG002|Phase I|Progression/relapse|0|||
162761252|NCT01668719|587837774|FG000|Phase I|not protocol specified|2|||
162761253|NCT01668719|587837775|FG001|Phase I|not protocol specified|0|||
162761254|NCT01668719|587837776|FG002|Phase I|not protocol specified|0|||
162761255|NCT01668719|587837774|FG000|Phase II|On treatment|0|||
162761256|NCT01668719|587837775|FG001|Phase II|On treatment|4|||
162761257|NCT01668719|587837776|FG002|Phase II|On treatment|3|||
162761258|NCT01668719|587837774|FG000|Phase II|Adverse Event|0|||
162761259|NCT01668719|587837775|FG001|Phase II|Adverse Event|18|||
162761260|NCT01668719|587837776|FG002|Phase II|Adverse Event|18|||
162761261|NCT01668719|587837774|FG000|Phase II|Refusal unrelated to adverse event|0|||
162761262|NCT01668719|587837775|FG001|Phase II|Refusal unrelated to adverse event|4|||
162761263|NCT01668719|587837776|FG002|Phase II|Refusal unrelated to adverse event|1|||
162761264|NCT01668719|587837774|FG000|Phase II|Progression/relapse|0|||
162761265|NCT01668719|587837775|FG001|Phase II|Progression/relapse|13|||
162761266|NCT01668719|587837776|FG002|Phase II|Progression/relapse|17|||
162761267|NCT01668719|587837774|FG000|Phase II|Death|0|||
162761268|NCT01668719|587837775|FG001|Phase II|Death|0|||
162761269|NCT01668719|587837776|FG002|Phase II|Death|2|||
162761270|NCT01668719|587837774|FG000|Phase II|not protocol specified|0|||
162761271|NCT01668719|587837775|FG001|Phase II|not protocol specified|13|||
162761272|NCT01668719|587837776|FG002|Phase II|not protocol specified|7|||
162761273|NCT03539055|587837777|FG000|Overall Study|Death|4|||
162761274|NCT03539055|587837777|FG000|Overall Study|Lost to Follow-up|1|||
162761275|NCT03539055|587837777|FG000|Overall Study|Withdrawal by Subject|2|||
162761276|NCT03539055|587837777|FG000|Overall Study|Screen Fail|7|||
162761277|NCT03539055|587837777|FG000|Overall Study|Drug Intolerance|2|||
162761278|NCT01321073|587837779|FG000|Overall Study|Did not attempt implant|4|||
162761279|NCT01321073|587837779|FG000|Overall Study|Death|3|||
162761280|NCT01638000|587837780|FG000|Overall Study|Randomized but Never Received Drug|7|||
162761281|NCT01638000|587837781|FG001|Overall Study|Randomized but Never Received Drug|10|||
162761282|NCT01638000|587837780|FG000|Overall Study|Adverse Event|14|||
162761283|NCT01638000|587837781|FG001|Overall Study|Adverse Event|16|||
162761284|NCT01638000|587837780|FG000|Overall Study|Lack of Efficacy|5|||
162761285|NCT01638000|587837781|FG001|Overall Study|Lack of Efficacy|6|||
162761286|NCT01638000|587837780|FG000|Overall Study|Protocol Violation|11|||
162761287|NCT01638000|587837781|FG001|Overall Study|Protocol Violation|13|||
162761288|NCT01638000|587837780|FG000|Overall Study|Withdrawal by Subject|21|||
162761289|NCT01638000|587837781|FG001|Overall Study|Withdrawal by Subject|24|||
162761290|NCT01638000|587837780|FG000|Overall Study|Miscellaneous|2|||
162761291|NCT01638000|587837781|FG001|Overall Study|Miscellaneous|2|||
162761292|NCT04248803|587837782|FG000|Overall Study|Lost to Follow-up|7|||
162761293|NCT04248803|587837783|FG001|Overall Study|Lost to Follow-up|7|||
162761294|NCT04248803|587837784|FG002|Overall Study|Lost to Follow-up|7|||
162761295|NCT04248803|587837785|FG003|Overall Study|Lost to Follow-up|7|||
162761296|NCT04248803|587837786|FG004|Overall Study|Lost to Follow-up|7|||
162761297|NCT04248803|587837787|FG005|Overall Study|Lost to Follow-up|7|||
162761298|NCT05352230|587837788|FG000|First Intervention (3 Months)|study terminated|2|||
162761299|NCT05352230|587837789|FG001|First Intervention (3 Months)|study terminated|2|||
162761300|NCT00875706|587837791|FG000|Overall Study|Withdrawal by Subject|1|||
162761301|NCT00875706|587837792|FG001|Overall Study|Withdrawal by Subject|0|||
162761302|NCT00875706|587837793|FG002|Overall Study|Withdrawal by Subject|0|||
162761303|NCT03775213|587837794|FG000|Overall Study|Withdrawal by Subject|51|||
162761304|NCT03775213|587837795|FG001|Overall Study|Withdrawal by Subject|53|||
162761305|NCT03775213|587837794|FG000|Overall Study|Incomplete Survey|7|||
162761306|NCT03775213|587837795|FG001|Overall Study|Incomplete Survey|7|||
162761307|NCT00786188|587837796|FG000|Overall Study|Adverse Event|3|||
162761308|NCT00786188|587837797|FG001|Overall Study|Adverse Event|1|||
162761309|NCT00786188|587837796|FG000|Overall Study|Withdrawal by Subject|2|||
162761310|NCT00786188|587837797|FG001|Overall Study|Withdrawal by Subject|0|||
162761311|NCT01827839|587837799|FG000|Overall Study|Adverse Event|1|||
162761312|NCT01827839|587837799|FG000|Overall Study|Consent Withdrawal|2|||
162761313|NCT00570505|587837800|FG000|Overall Study|Adverse Event|7|||
162761314|NCT00570505|587837800|FG000|Overall Study|Withdrawal by Subject|7|||
162761315|NCT00570505|587837800|FG000|Overall Study|Lost to Follow-up|23|||
162761316|NCT00570505|587837800|FG000|Overall Study|Other loss to follow-up|4|||
162761317|NCT00614614|587837801|FG000|Primary Vaccination Phase|Adverse Event|6|||
162761318|NCT00614614|587837802|FG001|Primary Vaccination Phase|Adverse Event|0|||
162761319|NCT00614614|587837803|FG002|Primary Vaccination Phase|Adverse Event|0|||
162761320|NCT00614614|587837804|FG003|Primary Vaccination Phase|Adverse Event|0|||
162761321|NCT00614614|587837805|FG004|Primary Vaccination Phase|Adverse Event|0|||
162761322|NCT00614614|587837801|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
162761323|NCT00614614|587837802|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
162761324|NCT00614614|587837803|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
162761325|NCT00614614|587837804|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
162761326|NCT00614614|587837805|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
162761327|NCT00614614|587837801|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
162761328|NCT00614614|587837802|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
162761329|NCT00614614|587837803|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
162761330|NCT00614614|587837804|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
162761331|NCT00614614|587837805|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
162761332|NCT00614614|587837801|FG000|Primary Vaccination Phase|Protocol Violation|9|||
162761333|NCT00614614|587837802|FG001|Primary Vaccination Phase|Protocol Violation|3|||
162761334|NCT00614614|587837803|FG002|Primary Vaccination Phase|Protocol Violation|0|||
162761335|NCT00614614|587837804|FG003|Primary Vaccination Phase|Protocol Violation|0|||
162761336|NCT00614614|587837805|FG004|Primary Vaccination Phase|Protocol Violation|0|||
162761337|NCT00614614|587837801|FG000|Primary Vaccination Phase|Other|4|||
162761338|NCT00614614|587837802|FG001|Primary Vaccination Phase|Other|0|||
162761339|NCT00614614|587837803|FG002|Primary Vaccination Phase|Other|0|||
162761340|NCT00614614|587837804|FG003|Primary Vaccination Phase|Other|0|||
162761341|NCT00614614|587837805|FG004|Primary Vaccination Phase|Other|0|||
162761342|NCT00614614|587837801|FG000|Booster Vaccination Phase|Adverse Event|0|||
162761343|NCT00614614|587837802|FG001|Booster Vaccination Phase|Adverse Event|0|||
162761344|NCT00614614|587837803|FG002|Booster Vaccination Phase|Adverse Event|1|||
162761345|NCT00614614|587837804|FG003|Booster Vaccination Phase|Adverse Event|1|||
162761346|NCT00614614|587837805|FG004|Booster Vaccination Phase|Adverse Event|0|||
162761347|NCT00614614|587837801|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
162761348|NCT00614614|587837802|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162761349|NCT00614614|587837803|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
162761350|NCT00614614|587837804|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
162761351|NCT00614614|587837805|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
162761352|NCT00614614|587837801|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
162761353|NCT00614614|587837802|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
162761354|NCT00614614|587837803|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
162761355|NCT00614614|587837804|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
162761356|NCT00614614|587837805|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
162761357|NCT00614614|587837801|FG000|Booster Vaccination Phase|Protocol Violation|0|||
162761358|NCT00614614|587837802|FG001|Booster Vaccination Phase|Protocol Violation|0|||
162761359|NCT00614614|587837803|FG002|Booster Vaccination Phase|Protocol Violation|2|||
162761360|NCT00614614|587837804|FG003|Booster Vaccination Phase|Protocol Violation|3|||
162761361|NCT00614614|587837805|FG004|Booster Vaccination Phase|Protocol Violation|0|||
162761362|NCT00614614|587837801|FG000|Booster Vaccination Phase|Other|0|||
162761363|NCT00614614|587837802|FG001|Booster Vaccination Phase|Other|1|||
162761364|NCT00614614|587837803|FG002|Booster Vaccination Phase|Other|3|||
162761365|NCT00614614|587837804|FG003|Booster Vaccination Phase|Other|2|||
162761366|NCT00614614|587837805|FG004|Booster Vaccination Phase|Other|1|||
162761367|NCT05426109|587837806|FG000|Overall Study|Withdrawal by Subject|0|||
162761368|NCT05426109|587837807|FG001|Overall Study|Withdrawal by Subject|1|||
162761369|NCT05212285|587837808|FG000|Overall Study|Lack of Efficacy|12|||
162761370|NCT05212285|587837809|FG001|Overall Study|Lack of Efficacy|8|||
162761371|NCT05212285|587837808|FG000|Overall Study|Withdrawal by Subject|8|||
162761372|NCT05212285|587837809|FG001|Overall Study|Withdrawal by Subject|1|||
162761373|NCT05212285|587837808|FG000|Overall Study|Lost to Follow-up|13|||
162761374|NCT05212285|587837809|FG001|Overall Study|Lost to Follow-up|1|||
162761375|NCT05212285|587837808|FG000|Overall Study|miss data|21|||
162761376|NCT05212285|587837809|FG001|Overall Study|miss data|2|||
162761377|NCT01000805|587837810|FG000|Overall Study|Adverse Event|21|||
162761378|NCT01000805|587837811|FG001|Overall Study|Adverse Event|9|||
162761379|NCT01000805|587837810|FG000|Overall Study|Lack of Efficacy|5|||
162761380|NCT01000805|587837811|FG001|Overall Study|Lack of Efficacy|16|||
162761381|NCT01000805|587837810|FG000|Overall Study|Lost to Follow-up|16|||
162761382|NCT01000805|587837811|FG001|Overall Study|Lost to Follow-up|21|||
162761383|NCT01000805|587837810|FG000|Overall Study|Physician Decision|0|||
162761384|NCT01000805|587837811|FG001|Overall Study|Physician Decision|1|||
162761385|NCT01000805|587837810|FG000|Overall Study|Protocol Violation|12|||
162761386|NCT01000805|587837811|FG001|Overall Study|Protocol Violation|8|||
162761387|NCT01000805|587837810|FG000|Overall Study|Withdrawal by Subject|16|||
162761388|NCT01000805|587837811|FG001|Overall Study|Withdrawal by Subject|6|||
162761389|NCT01000805|587837810|FG000|Overall Study|Sponsor Decision|0|||
162761390|NCT01000805|587837811|FG001|Overall Study|Sponsor Decision|1|||
162761391|NCT03343704|587837812|FG000|Overall Study|Refused to complete follow up|0|||
162761392|NCT03343704|587837813|FG001|Overall Study|Refused to complete follow up|1|||
162761393|NCT03343704|587837812|FG000|Overall Study|Death|0|||
162761394|NCT03343704|587837813|FG001|Overall Study|Death|1|||
162761395|NCT03343704|587837812|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
162761396|NCT03343704|587837813|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
162761397|NCT04118894|587837817|FG000|Overall Study|Lost to Follow-up|21|||
162761398|NCT04118894|587837817|FG000|Overall Study|Withdrawal by Subject|10|||
162761399|NCT04118894|587837817|FG000|Overall Study|Adverse Event|4|||
162761400|NCT04493424|587839289|FG000|Overall Study|Termination of the trial by the sponsor|89|||
162761401|NCT04493424|587839289|FG000|Overall Study|Withdrawal by Subject|9|||
162761402|NCT04493424|587839289|FG000|Overall Study|Lost to Follow-up|2|||
162761403|NCT04493424|587839289|FG000|Overall Study|Lack of Efficacy|3|||
162761404|NCT04493424|587839289|FG000|Overall Study|Adverse Event|5|||
162761405|NCT03769090|587839291|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
162761406|NCT03769090|587839292|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
162761407|NCT03769090|587839293|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
162761408|NCT03769090|587839291|FG000|Overall Study|Withdrawal by Subject|52|||
162761409|NCT03769090|587839292|FG001|Overall Study|Withdrawal by Subject|62|||
162761410|NCT03769090|587839293|FG002|Overall Study|Withdrawal by Subject|74|||
162761411|NCT03769090|587839291|FG000|Overall Study|Death|4|||
162761412|NCT03769090|587839292|FG001|Overall Study|Death|2|||
162761413|NCT03769090|587839293|FG002|Overall Study|Death|2|||
162761414|NCT03769090|587839291|FG000|Overall Study|Adverse Event|7|||
162761415|NCT03769090|587839292|FG001|Overall Study|Adverse Event|7|||
162761416|NCT03769090|587839293|FG002|Overall Study|Adverse Event|8|||
162761417|NCT03769090|587839291|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
162761418|NCT03769090|587839292|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
162761419|NCT03769090|587839293|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
162761420|NCT03769090|587839291|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
162761421|NCT03769090|587839292|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
162761422|NCT03769090|587839293|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
162761423|NCT03769090|587839291|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
162761424|NCT03769090|587839292|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
162761425|NCT03769090|587839293|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
162761426|NCT03769090|587839291|FG000|Overall Study|Protocol Violation|5|||
162761427|NCT03769090|587839292|FG001|Overall Study|Protocol Violation|6|||
162761428|NCT03769090|587839293|FG002|Overall Study|Protocol Violation|8|||
162761429|NCT03769090|587839291|FG000|Overall Study|Pregnancy|1|||
162761430|NCT03769090|587839292|FG001|Overall Study|Pregnancy|0|||
162761431|NCT03769090|587839293|FG002|Overall Study|Pregnancy|3|||
162761432|NCT03769090|587839291|FG000|Overall Study|Lost to Follow-up|19|||
162761433|NCT03769090|587839292|FG001|Overall Study|Lost to Follow-up|25|||
162761434|NCT03769090|587839293|FG002|Overall Study|Lost to Follow-up|21|||
162761435|NCT03769090|587839291|FG000|Overall Study|Condition under investigation worsened|2|||
162761436|NCT03769090|587839292|FG001|Overall Study|Condition under investigation worsened|0|||
162761437|NCT03769090|587839293|FG002|Overall Study|Condition under investigation worsened|1|||
162761438|NCT03769090|587839291|FG000|Overall Study|Lack of Efficacy|1|||
162761439|NCT03769090|587839292|FG001|Overall Study|Lack of Efficacy|2|||
162761440|NCT03769090|587839293|FG002|Overall Study|Lack of Efficacy|2|||
162761441|NCT03769090|587839291|FG000|Overall Study|Other reasons|8|||
162761442|NCT03769090|587839292|FG001|Overall Study|Other reasons|12|||
162761443|NCT03769090|587839293|FG002|Overall Study|Other reasons|15|||
162761444|NCT02830893|587839299|FG000|Overall Study|Relocation to out of the country|1|||
162761445|NCT02830893|587839300|FG001|Overall Study|Relocation to out of the country|0|||
162761446|NCT02830893|587839299|FG000|Overall Study|Lost to Follow-up|0|||
162761447|NCT02830893|587839300|FG001|Overall Study|Lost to Follow-up|2|||
162761448|NCT02830893|587839299|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
162761449|NCT02830893|587839300|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
162761450|NCT01277302|587839301|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
162761451|NCT01277302|587839302|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
162761452|NCT01277302|587839303|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
162761453|NCT01277302|587839301|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
162761454|NCT01277302|587839302|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
162761455|NCT01277302|587839303|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
162761456|NCT01277302|587839301|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
162761457|NCT01277302|587839302|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
162761458|NCT01277302|587839303|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
162761459|NCT01277302|587839301|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
162761460|NCT01277302|587839302|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
162761461|NCT01277302|587839303|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
162761462|NCT01277302|587839301|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
162761463|NCT01277302|587839302|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
162761464|NCT01277302|587839303|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
162761465|NCT01277302|587839301|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
162761466|NCT01277302|587839302|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
162761467|NCT01277302|587839303|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
162761468|NCT01277302|587839301|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
162761469|NCT01277302|587839302|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
162761470|NCT01277302|587839303|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
162761471|NCT01277302|587839301|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
162761472|NCT01277302|587839302|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
162761473|NCT01277302|587839303|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
162761474|NCT01277302|587839301|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
162761475|NCT01277302|587839302|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
162761476|NCT01277302|587839303|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
162761477|NCT02710669|587839304|FG000|Overall Study|Physician Decision|2|||
162761478|NCT02710669|587839305|FG001|Overall Study|Physician Decision|1|||
162761479|NCT02710669|587839306|FG002|Overall Study|Physician Decision|0|||
162761480|NCT02710669|587839304|FG000|Overall Study|Institutional delays (including COVID)|2|||
162761481|NCT02710669|587839305|FG001|Overall Study|Institutional delays (including COVID)|2|||
162761482|NCT02710669|587839306|FG002|Overall Study|Institutional delays (including COVID)|0|||
162761483|NCT02710669|587839304|FG000|Overall Study|arrived in afib/aflutter|10|||
162761484|NCT02710669|587839305|FG001|Overall Study|arrived in afib/aflutter|8|||
162761485|NCT02710669|587839306|FG002|Overall Study|arrived in afib/aflutter|2|||
162761486|NCT01567852|587839309|FG000|Overall Study|Withdrawal by Subject|3|||
162761487|NCT01567852|587839310|FG001|Overall Study|Withdrawal by Subject|6|||
162761488|NCT01567852|587839309|FG000|Overall Study|ECT discontinued|1|||
162761489|NCT01567852|587839310|FG001|Overall Study|ECT discontinued|1|||
162761490|NCT03332589|587839311|FG000|Overall Study|Lack of Efficacy|2|||
162761491|NCT03332589|587839312|FG001|Overall Study|Lack of Efficacy|0|||
162761492|NCT03332589|587839313|FG002|Overall Study|Lack of Efficacy|0|||
162761493|NCT03332589|587839311|FG000|Overall Study|Adverse Event|1|||
162761494|NCT03332589|587839312|FG001|Overall Study|Adverse Event|0|||
162761495|NCT03332589|587839313|FG002|Overall Study|Adverse Event|0|||
162761496|NCT03332589|587839311|FG000|Overall Study|Death|1|||
162761497|NCT03332589|587839312|FG001|Overall Study|Death|0|||
162761498|NCT03332589|587839313|FG002|Overall Study|Death|0|||
162761499|NCT01190124|587839315|FG000|Overall Study|Death|3|||
162761500|NCT01190124|587839316|FG001|Overall Study|Death|0|||
162761501|NCT01190124|587839317|FG002|Overall Study|Death|0|||
162761502|NCT01190124|587839315|FG000|Overall Study|Therapeutic Failure|12|||
162761503|NCT01190124|587839316|FG001|Overall Study|Therapeutic Failure|0|||
162761504|NCT01190124|587839317|FG002|Overall Study|Therapeutic Failure|1|||
162761505|NCT01190124|587839315|FG000|Overall Study|Lost to Follow-up|2|||
162761506|NCT01190124|587839316|FG001|Overall Study|Lost to Follow-up|0|||
162761507|NCT01190124|587839317|FG002|Overall Study|Lost to Follow-up|0|||
162761508|NCT02713594|587839318|FG000|Overall Study|Withdrawal by Subject|32|||
162761509|NCT02713594|587839319|FG001|Overall Study|Withdrawal by Subject|22|||
162761510|NCT02713594|587839318|FG000|Overall Study|Lost to Follow-up|358|||
162761511|NCT02713594|587839319|FG001|Overall Study|Lost to Follow-up|374|||
162761512|NCT03690219|587839320|FG000|Overall Study|no injuries|9|||
162761513|NCT03690219|587839321|FG001|Overall Study|no injuries|20|||
162761514|NCT03690219|587839320|FG000|Overall Study|missing information|7|||
162761515|NCT03690219|587839321|FG001|Overall Study|missing information|7|||
162761516|NCT01523392|587839322|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162761517|NCT01523392|587839323|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162761518|NCT01523392|587839322|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
162761519|NCT01523392|587839323|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
162761520|NCT01523392|587839322|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
162761521|NCT01523392|587839323|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
162761522|NCT02771366|587839324|FG000|Period 1|Withdrawal by Subject|0|||
162761523|NCT02771366|587839325|FG001|Period 1|Withdrawal by Subject|2|||
162761524|NCT02771366|587839324|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
162761525|NCT02771366|587839325|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
162761526|NCT02092285|587839327|FG000|Induction Phase|Adverse Event|7|||
162761527|NCT02092285|587839327|FG000|Induction Phase|Physician Decision|4|||
162761528|NCT02092285|587839327|FG000|Induction Phase|Pregnancy|1|||
162761529|NCT02092285|587839327|FG000|Induction Phase|Relapse/Recurrence|7|||
162761530|NCT02092285|587839327|FG000|Induction Phase|Withdrawal by Subject|2|||
162761531|NCT02092285|587839327|FG000|Induction Phase|Lack of Efficacy|14|||
162761532|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
162761533|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
162761534|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
162761535|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
162761536|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
162761537|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
162761538|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
162761539|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
162761540|NCT02092285|587839327|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
162761541|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
162761542|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162761543|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162761544|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162761545|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
162761546|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162761547|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162761548|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162761549|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
162761550|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162761551|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162761552|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162761553|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
162761554|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162761555|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162761556|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162761557|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
162761558|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162761559|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162761560|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162761561|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
162761562|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162761563|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162761564|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162761565|NCT01185340|587839330|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
162761566|NCT01185340|587839331|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162761567|NCT01185340|587839332|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162761568|NCT01185340|587839333|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162761569|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
162761570|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162761571|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
162761572|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162761573|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
162761574|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
162761575|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
162761576|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
162761577|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
162761578|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
162761579|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
162761580|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
162761581|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162761582|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162761583|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162761584|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162761585|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
162761586|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162761587|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
162761588|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162761589|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
162761590|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
162761591|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
162761592|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
162761593|NCT01185340|587839330|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162761594|NCT01185340|587839331|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162761595|NCT01185340|587839332|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
162761596|NCT01185340|587839333|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
162761597|NCT01719172|587839334|FG000|Overall Study|Lost to Follow-up|1|||
162761598|NCT01719172|587839334|FG000|Overall Study|Death|1|||
162761599|NCT00087516|587839335|FG000|Overall Study|Adverse Event|10|||
162761600|NCT00087516|587839336|FG001|Overall Study|Adverse Event|10|||
162761601|NCT00087516|587839337|FG002|Overall Study|Adverse Event|3|||
162761602|NCT00087516|587839338|FG003|Overall Study|Adverse Event|6|||
162761603|NCT00087516|587839335|FG000|Overall Study|Lack of Efficacy|82|||
162761604|NCT00087516|587839336|FG001|Overall Study|Lack of Efficacy|80|||
162761605|NCT00087516|587839337|FG002|Overall Study|Lack of Efficacy|39|||
162761606|NCT00087516|587839338|FG003|Overall Study|Lack of Efficacy|29|||
162761607|NCT00087516|587839335|FG000|Overall Study|Lost to Follow-up|8|||
162761608|NCT00087516|587839336|FG001|Overall Study|Lost to Follow-up|6|||
162761609|NCT00087516|587839337|FG002|Overall Study|Lost to Follow-up|5|||
162761610|NCT00087516|587839338|FG003|Overall Study|Lost to Follow-up|5|||
162761611|NCT00087516|587839335|FG000|Overall Study|Protocol Violation|4|||
162761612|NCT00087516|587839336|FG001|Overall Study|Protocol Violation|8|||
162761613|NCT00087516|587839337|FG002|Overall Study|Protocol Violation|3|||
162761614|NCT00087516|587839338|FG003|Overall Study|Protocol Violation|6|||
162761615|NCT00087516|587839335|FG000|Overall Study|Withdrawal by Subject|16|||
162761616|NCT00087516|587839336|FG001|Overall Study|Withdrawal by Subject|27|||
162761617|NCT00087516|587839337|FG002|Overall Study|Withdrawal by Subject|11|||
162761618|NCT00087516|587839338|FG003|Overall Study|Withdrawal by Subject|12|||
162761619|NCT00087516|587839335|FG000|Overall Study|Site terminated|0|||
162761620|NCT00087516|587839336|FG001|Overall Study|Site terminated|2|||
162761621|NCT00087516|587839337|FG002|Overall Study|Site terminated|1|||
162761622|NCT00087516|587839338|FG003|Overall Study|Site terminated|0|||
162761623|NCT00087516|587839335|FG000|Overall Study|Protocol specified discontinuation|35|||
162761624|NCT00087516|587839336|FG001|Overall Study|Protocol specified discontinuation|33|||
162761625|NCT00087516|587839337|FG002|Overall Study|Protocol specified discontinuation|33|||
162761626|NCT00087516|587839338|FG003|Overall Study|Protocol specified discontinuation|26|||
162761627|NCT00087516|587839335|FG000|Overall Study|Patient moved|3|||
162761628|NCT00087516|587839336|FG001|Overall Study|Patient moved|2|||
162761629|NCT00087516|587839337|FG002|Overall Study|Patient moved|1|||
162761630|NCT00087516|587839338|FG003|Overall Study|Patient moved|0|||
162761631|NCT00087516|587839335|FG000|Overall Study|Patient was non-compliant|3|||
162761632|NCT00087516|587839336|FG001|Overall Study|Patient was non-compliant|1|||
162761633|NCT00087516|587839337|FG002|Overall Study|Patient was non-compliant|0|||
162761634|NCT00087516|587839338|FG003|Overall Study|Patient was non-compliant|0|||
162761635|NCT00087516|587839335|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
162761636|NCT00087516|587839336|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
162761637|NCT00087516|587839337|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
162761638|NCT00087516|587839338|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
162761639|NCT00087516|587839335|FG000|Overall Study|Other|0|||
162761640|NCT00087516|587839336|FG001|Overall Study|Other|0|||
162761641|NCT00087516|587839337|FG002|Overall Study|Other|1|||
162761642|NCT00087516|587839338|FG003|Overall Study|Other|0|||
162761643|NCT00246129|587839339|FG000|Overall Study|Lost to Follow-up|1|||
162761644|NCT00246129|587839340|FG001|Overall Study|Lost to Follow-up|0|||
162761645|NCT00246129|587839339|FG000|Overall Study|Death|2|||
162761646|NCT00246129|587839340|FG001|Overall Study|Death|1|||
162761647|NCT00246129|587839339|FG000|Overall Study|suffered primary non-function|1|||
162761648|NCT00246129|587839340|FG001|Overall Study|suffered primary non-function|0|||
162761649|NCT00246129|587839339|FG000|Overall Study|grafts failed|3|||
162761650|NCT00246129|587839340|FG001|Overall Study|grafts failed|1|||
162761651|NCT03469258|587839341|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
162761652|NCT02605174|587839348|FG000|Overall Study|Adverse Event|0|||
162761653|NCT02605174|587839349|FG001|Overall Study|Adverse Event|0|||
162761654|NCT02605174|587839350|FG002|Overall Study|Adverse Event|1|||
162761655|NCT02605174|587839351|FG003|Overall Study|Adverse Event|0|||
162761656|NCT02605174|587839352|FG004|Overall Study|Adverse Event|4|||
162761657|NCT02605174|587839353|FG005|Overall Study|Adverse Event|0|||
162761658|NCT02605174|587839354|FG006|Overall Study|Adverse Event|0|||
162761659|NCT02605174|587839348|FG000|Overall Study|Lost to Follow-up|20|||
162761660|NCT02605174|587839349|FG001|Overall Study|Lost to Follow-up|7|||
162761661|NCT02605174|587839350|FG002|Overall Study|Lost to Follow-up|27|||
162761662|NCT02605174|587839351|FG003|Overall Study|Lost to Follow-up|10|||
162761663|NCT02605174|587839352|FG004|Overall Study|Lost to Follow-up|20|||
162761664|NCT02605174|587839353|FG005|Overall Study|Lost to Follow-up|10|||
162761665|NCT02605174|587839354|FG006|Overall Study|Lost to Follow-up|29|||
162761666|NCT02605174|587839348|FG000|Overall Study|Protocol Violation|10|||
162761667|NCT02605174|587839349|FG001|Overall Study|Protocol Violation|4|||
162761668|NCT02605174|587839350|FG002|Overall Study|Protocol Violation|14|||
162761669|NCT02605174|587839351|FG003|Overall Study|Protocol Violation|6|||
162761670|NCT02605174|587839352|FG004|Overall Study|Protocol Violation|7|||
162761671|NCT02605174|587839353|FG005|Overall Study|Protocol Violation|7|||
162761672|NCT02605174|587839354|FG006|Overall Study|Protocol Violation|12|||
162761673|NCT02605174|587839348|FG000|Overall Study|Pregnancy|1|||
162761674|NCT02605174|587839349|FG001|Overall Study|Pregnancy|0|||
162761675|NCT02605174|587839350|FG002|Overall Study|Pregnancy|0|||
162761676|NCT02605174|587839351|FG003|Overall Study|Pregnancy|2|||
162761677|NCT02605174|587839352|FG004|Overall Study|Pregnancy|0|||
162761678|NCT02605174|587839353|FG005|Overall Study|Pregnancy|0|||
162761679|NCT02605174|587839354|FG006|Overall Study|Pregnancy|0|||
162761680|NCT02605174|587839348|FG000|Overall Study|Withdrawal by Subject|9|||
162761681|NCT02605174|587839349|FG001|Overall Study|Withdrawal by Subject|6|||
162761682|NCT02605174|587839350|FG002|Overall Study|Withdrawal by Subject|14|||
162761683|NCT02605174|587839351|FG003|Overall Study|Withdrawal by Subject|11|||
162761684|NCT02605174|587839352|FG004|Overall Study|Withdrawal by Subject|6|||
162761685|NCT02605174|587839353|FG005|Overall Study|Withdrawal by Subject|4|||
162761686|NCT02605174|587839354|FG006|Overall Study|Withdrawal by Subject|15|||
162761687|NCT02605174|587839348|FG000|Overall Study|Physician Decision|2|||
162761688|NCT02605174|587839349|FG001|Overall Study|Physician Decision|0|||
162761689|NCT02605174|587839350|FG002|Overall Study|Physician Decision|0|||
162761690|NCT02605174|587839351|FG003|Overall Study|Physician Decision|0|||
162761691|NCT02605174|587839352|FG004|Overall Study|Physician Decision|0|||
162761692|NCT02605174|587839353|FG005|Overall Study|Physician Decision|0|||
162761693|NCT02605174|587839354|FG006|Overall Study|Physician Decision|3|||
162761694|NCT02605174|587839348|FG000|Overall Study|Randomization Failure|22|||
162761695|NCT02605174|587839349|FG001|Overall Study|Randomization Failure|6|||
162761696|NCT02605174|587839350|FG002|Overall Study|Randomization Failure|20|||
162761697|NCT02605174|587839351|FG003|Overall Study|Randomization Failure|7|||
162761698|NCT02605174|587839352|FG004|Overall Study|Randomization Failure|16|||
162761699|NCT02605174|587839353|FG005|Overall Study|Randomization Failure|11|||
162761700|NCT02605174|587839354|FG006|Overall Study|Randomization Failure|30|||
162761701|NCT04250636|587839357|FG000|Overall Study|Lost to Follow-up|2|||
162761702|NCT01779050|587839358|FG000|Overall Study|Withdrawal by Subject|1|||
162761703|NCT01779050|587839359|FG001|Overall Study|Withdrawal by Subject|0|||
162761704|NCT03403036|587839360|FG000|Overall Study|Lack of Efficacy|5|||
162761705|NCT02392507|587839362|FG000|Induction Regimen|Death|3|||
162761706|NCT02392507|587839362|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
162761707|NCT02392507|587839362|FG000|Induction Regimen|Physician Decision|1|||
162761708|NCT02392507|587839362|FG000|Induction Regimen|Withdrawal by Subject|2|||
162761709|NCT02392507|587839362|FG000|Maintenance Regimen|Death|1|||
162761710|NCT02392507|587839362|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
162761711|NCT00273052|587839363|FG000|Overall Study|Withdrawal by Subject|16|||
162761712|NCT00273052|587839364|FG001|Overall Study|Withdrawal by Subject|19|||
162761713|NCT00273052|587839363|FG000|Overall Study|Adverse Event|21|||
162761714|NCT00273052|587839364|FG001|Overall Study|Adverse Event|19|||
162761715|NCT00273052|587839363|FG000|Overall Study|Protocol Violation|14|||
162761716|NCT00273052|587839364|FG001|Overall Study|Protocol Violation|18|||
162761717|NCT00273052|587839363|FG000|Overall Study|Lost to Follow-up|7|||
162761718|NCT00273052|587839364|FG001|Overall Study|Lost to Follow-up|25|||
162761719|NCT00273052|587839363|FG000|Overall Study|Lack of Efficacy|6|||
162761720|NCT00273052|587839364|FG001|Overall Study|Lack of Efficacy|4|||
162761721|NCT00273052|587839363|FG000|Overall Study|Non-Compliance|3|||
162761722|NCT00273052|587839364|FG001|Overall Study|Non-Compliance|1|||
162761723|NCT00273052|587839363|FG000|Overall Study|Other|2|||
162761724|NCT00273052|587839364|FG001|Overall Study|Other|0|||
162761725|NCT00273052|587839363|FG000|Overall Study|Worsening serum lipid levels|0|||
162761726|NCT00273052|587839364|FG001|Overall Study|Worsening serum lipid levels|2|||
162761727|NCT00240994|587839365|FG000|Overall Study|Lost to Follow-up|1|||
162761728|NCT00240994|587839365|FG000|Overall Study|Protocol Violation|1|||
162761729|NCT00240994|587839365|FG000|Overall Study|Graft failure|1|||
162761730|NCT02630186|587839367|FG000|Overall Study|Withdrawal by Subject|1|||
162761731|NCT00439218|587839368|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
162761732|NCT03142932|587839371|FG000|Overall Study|Lost to Follow-up|2|||
162761733|NCT03142932|587839372|FG001|Overall Study|Lost to Follow-up|11|||
162761734|NCT01021748|587839373|FG000|Overall Study|Adverse Event|2|||
162761735|NCT01021748|587839374|FG001|Overall Study|Adverse Event|1|||
162761736|NCT01021748|587839375|FG002|Overall Study|Adverse Event|2|||
162761737|NCT01021748|587839376|FG003|Overall Study|Adverse Event|0|||
162761738|NCT01021748|587839377|FG004|Overall Study|Adverse Event|2|||
162761739|NCT01021748|587839378|FG005|Overall Study|Adverse Event|0|||
162761740|NCT01021748|587839379|FG006|Overall Study|Adverse Event|1|||
162761741|NCT01021748|587839380|FG007|Overall Study|Adverse Event|0|||
162761742|NCT01021748|587839381|FG008|Overall Study|Adverse Event|7|||
162761743|NCT01021748|587839373|FG000|Overall Study|Physician Decision|1|||
162761744|NCT01021748|587839374|FG001|Overall Study|Physician Decision|0|||
162761745|NCT01021748|587839375|FG002|Overall Study|Physician Decision|1|||
162761746|NCT01021748|587839376|FG003|Overall Study|Physician Decision|1|||
162761747|NCT01021748|587839377|FG004|Overall Study|Physician Decision|0|||
162761748|NCT01021748|587839378|FG005|Overall Study|Physician Decision|0|||
162761749|NCT01021748|587839379|FG006|Overall Study|Physician Decision|1|||
162761750|NCT01021748|587839380|FG007|Overall Study|Physician Decision|1|||
162761751|NCT01021748|587839381|FG008|Overall Study|Physician Decision|2|||
162761752|NCT01021748|587839373|FG000|Overall Study|Progressive Disease|3|||
162761753|NCT01021748|587839374|FG001|Overall Study|Progressive Disease|3|||
162761754|NCT01021748|587839375|FG002|Overall Study|Progressive Disease|4|||
162761755|NCT01021748|587839376|FG003|Overall Study|Progressive Disease|6|||
162761756|NCT01021748|587839377|FG004|Overall Study|Progressive Disease|7|||
162761757|NCT01021748|587839378|FG005|Overall Study|Progressive Disease|3|||
162761758|NCT01021748|587839379|FG006|Overall Study|Progressive Disease|0|||
162761759|NCT01021748|587839380|FG007|Overall Study|Progressive Disease|5|||
162761760|NCT01021748|587839381|FG008|Overall Study|Progressive Disease|6|||
162761761|NCT01021748|587839373|FG000|Overall Study|Withdrawal by Subject|0|||
162761762|NCT01021748|587839374|FG001|Overall Study|Withdrawal by Subject|0|||
162761763|NCT01021748|587839375|FG002|Overall Study|Withdrawal by Subject|0|||
162761764|NCT01021748|587839376|FG003|Overall Study|Withdrawal by Subject|0|||
162761765|NCT01021748|587839377|FG004|Overall Study|Withdrawal by Subject|0|||
162761766|NCT01021748|587839378|FG005|Overall Study|Withdrawal by Subject|0|||
162761767|NCT01021748|587839379|FG006|Overall Study|Withdrawal by Subject|1|||
162761768|NCT01021748|587839380|FG007|Overall Study|Withdrawal by Subject|0|||
162761769|NCT01021748|587839381|FG008|Overall Study|Withdrawal by Subject|1|||
162761770|NCT01021748|587839373|FG000|Overall Study|Not Treated|0|||
162761771|NCT01021748|587839374|FG001|Overall Study|Not Treated|1|||
162761772|NCT01021748|587839375|FG002|Overall Study|Not Treated|0|||
162761773|NCT01021748|587839376|FG003|Overall Study|Not Treated|0|||
162761774|NCT01021748|587839377|FG004|Overall Study|Not Treated|0|||
162761775|NCT01021748|587839378|FG005|Overall Study|Not Treated|0|||
162761776|NCT01021748|587839379|FG006|Overall Study|Not Treated|0|||
162761777|NCT01021748|587839380|FG007|Overall Study|Not Treated|0|||
162761778|NCT01021748|587839381|FG008|Overall Study|Not Treated|0|||
162761779|NCT01485887|587839386|FG000|Overall Study|Withdrawal by Subject|2|||
162761780|NCT01485887|587839386|FG000|Overall Study|Adverse Event|8|||
162761781|NCT01485887|587839386|FG000|Overall Study|Deterioration of primary disease|1|||
162761782|NCT01485887|587839386|FG000|Overall Study|Primary disease markedly improved|1|||
162761783|NCT02234141|587839387|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761784|NCT02234141|587839388|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761785|NCT02234141|587839389|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761786|NCT02234141|587839390|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
162761787|NCT02234141|587839391|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761788|NCT02234141|587839392|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761789|NCT02234141|587839393|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
162761790|NCT02234141|587839387|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761791|NCT02234141|587839388|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
162761792|NCT02234141|587839389|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761793|NCT02234141|587839390|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761794|NCT02234141|587839391|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761795|NCT02234141|587839392|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761796|NCT02234141|587839393|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162761797|NCT02234141|587839387|FG000|Treatment Period (24 Weeks)|Death|1|||
162761798|NCT02234141|587839388|FG001|Treatment Period (24 Weeks)|Death|2|||
162761799|NCT02234141|587839389|FG002|Treatment Period (24 Weeks)|Death|0|||
162761800|NCT02234141|587839390|FG003|Treatment Period (24 Weeks)|Death|1|||
162761801|NCT02234141|587839391|FG004|Treatment Period (24 Weeks)|Death|0|||
162761802|NCT02234141|587839392|FG005|Treatment Period (24 Weeks)|Death|0|||
162761803|NCT02234141|587839393|FG006|Treatment Period (24 Weeks)|Death|0|||
162761804|NCT02234141|587839387|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
162761805|NCT02234141|587839388|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
162761806|NCT02234141|587839389|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
162761807|NCT02234141|587839390|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
162761808|NCT02234141|587839391|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
162761809|NCT02234141|587839392|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
162761810|NCT02234141|587839393|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
162761811|NCT02234141|587839387|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761812|NCT02234141|587839388|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
162761813|NCT02234141|587839389|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761814|NCT02234141|587839390|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761815|NCT02234141|587839391|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761816|NCT02234141|587839392|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761817|NCT02234141|587839393|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162761818|NCT02234141|587839387|FG000|Long-Term Treatment Period|Death|0|||
162761819|NCT02234141|587839388|FG001|Long-Term Treatment Period|Death|0|||
162761820|NCT02234141|587839389|FG002|Long-Term Treatment Period|Death|0|||
162761821|NCT02234141|587839390|FG003|Long-Term Treatment Period|Death|0|||
162761822|NCT02234141|587839391|FG004|Long-Term Treatment Period|Death|0|||
162761823|NCT02234141|587839392|FG005|Long-Term Treatment Period|Death|1|||
162761824|NCT02234141|587839393|FG006|Long-Term Treatment Period|Death|0|||
162761825|NCT02234141|587839387|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
162761826|NCT02234141|587839388|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
162761827|NCT02234141|587839389|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
162761828|NCT02234141|587839390|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
162761829|NCT02234141|587839391|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
162761830|NCT02234141|587839392|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
162761831|NCT02234141|587839393|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
162761832|NCT02234141|587839387|FG000|Long-Term Treatment Period|Adverse Event|4|||
162761833|NCT02234141|587839388|FG001|Long-Term Treatment Period|Adverse Event|0|||
162761834|NCT02234141|587839389|FG002|Long-Term Treatment Period|Adverse Event|5|||
162761835|NCT02234141|587839390|FG003|Long-Term Treatment Period|Adverse Event|0|||
162761836|NCT02234141|587839391|FG004|Long-Term Treatment Period|Adverse Event|1|||
162761837|NCT02234141|587839392|FG005|Long-Term Treatment Period|Adverse Event|1|||
162761838|NCT02234141|587839393|FG006|Long-Term Treatment Period|Adverse Event|1|||
162761839|NCT02234141|587839387|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
162761840|NCT02234141|587839388|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
162761841|NCT02234141|587839389|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
162761842|NCT02234141|587839390|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
162761843|NCT02234141|587839391|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
162761844|NCT02234141|587839392|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
162761845|NCT02234141|587839393|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
162761846|NCT02234141|587839387|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
162761847|NCT02234141|587839388|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
162761848|NCT02234141|587839389|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
162761849|NCT02234141|587839390|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
162761850|NCT02234141|587839391|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
162761851|NCT02234141|587839392|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
162761852|NCT02234141|587839393|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
162761853|NCT00895245|587839394|FG000|Overall Study|Lack of Efficacy|6|||
162761854|NCT02095678|587839395|FG000|Overall Study|Withdrawal by Subject|0|||
162761855|NCT02095678|587839396|FG001|Overall Study|Withdrawal by Subject|1|||
162761856|NCT02095678|587839395|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
162761857|NCT02095678|587839396|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
162761858|NCT02095678|587839395|FG000|Overall Study|lesion impacted by previous treatment|1|||
162761859|NCT02095678|587839396|FG001|Overall Study|lesion impacted by previous treatment|1|||
162761860|NCT02095678|587839395|FG000|Overall Study|No Confirmed Diagnosis|0|||
162761861|NCT02095678|587839396|FG001|Overall Study|No Confirmed Diagnosis|3|||
162761862|NCT02095678|587839395|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
162761863|NCT02095678|587839396|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
162761864|NCT02095678|587839395|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
162761865|NCT02095678|587839396|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
162761866|NCT03418545|587839397|FG000|Overall Study|Withdrawal by Participant|2|||
162761867|NCT03418545|587839398|FG001|Overall Study|Withdrawal by Participant|4|||
162761868|NCT03418545|587839397|FG000|Overall Study|Lost to Follow-up|3|||
162761869|NCT03418545|587839398|FG001|Overall Study|Lost to Follow-up|5|||
162761870|NCT03418545|587839397|FG000|Overall Study|Reason Not Specified|0|||
162761871|NCT03418545|587839398|FG001|Overall Study|Reason Not Specified|1|||
162761872|NCT03418545|587839397|FG000|Overall Study|Missing Completion Status|0|||
162761873|NCT03418545|587839398|FG001|Overall Study|Missing Completion Status|1|||
162761874|NCT04660799|587839399|FG000|Overall Study|Progressive Disease|1|||
162761875|NCT04660799|587839400|FG001|Overall Study|Progressive Disease|1|||
162761876|NCT04660799|587839399|FG000|Overall Study|Death|2|||
162761877|NCT04660799|587839400|FG001|Overall Study|Death|1|||
162761878|NCT04660799|587839399|FG000|Overall Study|Adverse Event|2|||
162761879|NCT04660799|587839400|FG001|Overall Study|Adverse Event|1|||
162761880|NCT04660799|587839399|FG000|Overall Study|Withdrawal by Subject|2|||
162761881|NCT04660799|587839400|FG001|Overall Study|Withdrawal by Subject|5|||
162761882|NCT02706483|587839401|FG000|Overall Study|Adverse Event|97|||
162761883|NCT02706483|587839401|FG000|Overall Study|Death|1|||
162761884|NCT02706483|587839401|FG000|Overall Study|Lack of Efficacy|39|||
162761885|NCT02706483|587839401|FG000|Overall Study|Lost to Follow-up|101|||
162761886|NCT02706483|587839401|FG000|Overall Study|Non-compliance with study drug|15|||
162761887|NCT02706483|587839401|FG000|Overall Study|Physician Decision|6|||
162761888|NCT02706483|587839401|FG000|Overall Study|Pregnancy|6|||
162761889|NCT02706483|587839401|FG000|Overall Study|Protocol Violation|18|||
162761890|NCT02706483|587839401|FG000|Overall Study|Withdrawal by Subject|136|||
162761891|NCT02706483|587839401|FG000|Overall Study|Non-compliance with visits|6|||
162761892|NCT02706483|587839401|FG000|Overall Study|Site closure|4|||
162761893|NCT02706483|587839401|FG000|Overall Study|Subject moved|1|||
162761894|NCT03131713|587839402|FG000|Overall Study|Lost to Follow-up|5|||
162761895|NCT03131713|587839403|FG001|Overall Study|Lost to Follow-up|0|||
162761896|NCT02382640|587839412|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
162761897|NCT02382640|587839413|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162761898|NCT02382640|587839414|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162761899|NCT02382640|587839415|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162761900|NCT01220999|587839416|FG000|Overall Study|Progressive disease|0|||
162761901|NCT01220999|587839417|FG001|Overall Study|Progressive disease|0|||
162761902|NCT01220999|587839418|FG002|Overall Study|Progressive disease|1|||
162761903|NCT01220999|587839419|FG003|Overall Study|Progressive disease|0|||
162761904|NCT01220999|587839420|FG004|Overall Study|Progressive disease|0|||
162761905|NCT01560429|587839423|FG000|Overall Study|Protocol Violation|3|||
162761906|NCT01560429|587839424|FG001|Overall Study|Protocol Violation|6|||
162761907|NCT03861234|587839425|FG000|Overall Study|Not treated|0|||
162761908|NCT03861234|587839426|FG001|Overall Study|Not treated|0|||
162761909|NCT03861234|587839427|FG002|Overall Study|Not treated|0|||
162761910|NCT03861234|587839428|FG003|Overall Study|Not treated|0|||
162761911|NCT03861234|587839429|FG004|Overall Study|Not treated|0|||
162761912|NCT03861234|587839430|FG005|Overall Study|Not treated|1|||
162761913|NCT03861234|587839431|FG006|Overall Study|Not treated|0|||
162761914|NCT03861234|587839432|FG007|Overall Study|Not treated|0|||
162761915|NCT03861234|587839425|FG000|Overall Study|Adverse Event|0|||
162761916|NCT03861234|587839426|FG001|Overall Study|Adverse Event|0|||
162761917|NCT03861234|587839427|FG002|Overall Study|Adverse Event|0|||
162761918|NCT03861234|587839428|FG003|Overall Study|Adverse Event|0|||
162761919|NCT03861234|587839429|FG004|Overall Study|Adverse Event|0|||
162761920|NCT03861234|587839430|FG005|Overall Study|Adverse Event|1|||
162761921|NCT03861234|587839431|FG006|Overall Study|Adverse Event|0|||
162761922|NCT03861234|587839432|FG007|Overall Study|Adverse Event|0|||
162761923|NCT03861234|587839425|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
162761924|NCT03861234|587839426|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
162761925|NCT03861234|587839427|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
162761926|NCT03861234|587839428|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
162761927|NCT03861234|587839429|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
162761928|NCT03861234|587839430|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
162761929|NCT03861234|587839431|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
162761930|NCT03861234|587839432|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
162761931|NCT03861234|587839425|FG000|Overall Study|As per sponsor decision|0|||
162761932|NCT03861234|587839426|FG001|Overall Study|As per sponsor decision|0|||
162761933|NCT03861234|587839427|FG002|Overall Study|As per sponsor decision|0|||
162761934|NCT03861234|587839428|FG003|Overall Study|As per sponsor decision|0|||
162761935|NCT03861234|587839429|FG004|Overall Study|As per sponsor decision|0|||
162761936|NCT03861234|587839430|FG005|Overall Study|As per sponsor decision|0|||
162761937|NCT03861234|587839431|FG006|Overall Study|As per sponsor decision|1|||
162761938|NCT03861234|587839432|FG007|Overall Study|As per sponsor decision|0|||
162761939|NCT03861234|587839425|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
162761940|NCT03861234|587839426|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
162761941|NCT03861234|587839427|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
162761942|NCT03861234|587839428|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
162761943|NCT03861234|587839429|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
162761944|NCT03861234|587839430|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
162761945|NCT03861234|587839431|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
162761946|NCT03861234|587839432|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
162761947|NCT05169684|587839438|FG000|Overall Study|Adverse Event|1|||
162761948|NCT05169684|587839439|FG001|Overall Study|Adverse Event|3|||
162761949|NCT05169684|587839438|FG000|Overall Study|Physician Decision|0|||
162761950|NCT05169684|587839439|FG001|Overall Study|Physician Decision|1|||
162761951|NCT05169684|587839438|FG000|Overall Study|Progressive Disease|1|||
162761952|NCT05169684|587839439|FG001|Overall Study|Progressive Disease|1|||
162761953|NCT05169684|587839438|FG000|Overall Study|Participant request to discontinue treatment|0|||
162761954|NCT05169684|587839439|FG001|Overall Study|Participant request to discontinue treatment|1|||
162761955|NCT05169684|587839438|FG000|Overall Study|Other Reason|0|||
162761956|NCT05169684|587839439|FG001|Overall Study|Other Reason|1|||
162761957|NCT00326183|587839445|FG000|Overall Study|Lost to Follow-up|104|||
162761958|NCT00326183|587839446|FG001|Overall Study|Lost to Follow-up|56|||
162761959|NCT00326183|587839445|FG000|Overall Study|Protocol Violation|6|||
162761960|NCT00326183|587839446|FG001|Overall Study|Protocol Violation|3|||
162761961|NCT00326183|587839445|FG000|Overall Study|Withdrawal by Subject|35|||
162761962|NCT00326183|587839446|FG001|Overall Study|Withdrawal by Subject|7|||
162761963|NCT00326183|587839445|FG000|Overall Study|Subject Moved|7|||
162761964|NCT00326183|587839446|FG001|Overall Study|Subject Moved|4|||
162761965|NCT00326183|587839445|FG000|Overall Study|Other|47|||
162761966|NCT00326183|587839446|FG001|Overall Study|Other|13|||
162761967|NCT00326183|587839445|FG000|Overall Study|Adverse Event|1|||
162761968|NCT00326183|587839446|FG001|Overall Study|Adverse Event|0|||
162761969|NCT04748341|587839449|FG000|Overall Study|Lost to Follow-up|1|||
162761970|NCT04748341|587839450|FG001|Overall Study|Lost to Follow-up|1|||
162761971|NCT02334215|587839451|FG000|Overall Study|Death|1|||
162761972|NCT02334215|587839452|FG001|Overall Study|Death|1|||
162761973|NCT02334215|587839453|FG002|Overall Study|Death|0|||
162761974|NCT02334215|587839451|FG000|Overall Study|Lost to Follow-up|1|||
162761975|NCT02334215|587839452|FG001|Overall Study|Lost to Follow-up|0|||
162761976|NCT02334215|587839453|FG002|Overall Study|Lost to Follow-up|4|||
162761977|NCT02334215|587839451|FG000|Overall Study|Withdrawal by Subject|2|||
162761978|NCT02334215|587839452|FG001|Overall Study|Withdrawal by Subject|2|||
162761979|NCT02334215|587839453|FG002|Overall Study|Withdrawal by Subject|1|||
162761980|NCT02334215|587839451|FG000|Overall Study|Not released from incarceration on time|3|||
162761981|NCT02334215|587839452|FG001|Overall Study|Not released from incarceration on time|3|||
162761982|NCT02334215|587839453|FG002|Overall Study|Not released from incarceration on time|3|||
162761983|NCT02334215|587839451|FG000|Overall Study|Incarcerated|0|||
162761984|NCT02334215|587839452|FG001|Overall Study|Incarcerated|0|||
162761985|NCT02334215|587839453|FG002|Overall Study|Incarcerated|7|||
162761986|NCT05865392|587839456|FG000|Overall Study|Withdrawal by Subject|4|||
162761987|NCT05865392|587839457|FG001|Overall Study|Withdrawal by Subject|0|||
162761988|NCT05865392|587839456|FG000|Overall Study|Didn't meet inclusion criteria|4|||
162761989|NCT05865392|587839457|FG001|Overall Study|Didn't meet inclusion criteria|0|||
162761990|NCT02159989|587839458|FG000|Overall Study|Adverse Event|1|||
162761991|NCT02159989|587839459|FG001|Overall Study|Adverse Event|0|||
162761992|NCT02159989|587839460|FG002|Overall Study|Adverse Event|0|||
162761993|NCT02159989|587839461|FG003|Overall Study|Adverse Event|0|||
162761994|NCT02159989|587839462|FG004|Overall Study|Adverse Event|1|||
162761995|NCT02159989|587839463|FG005|Overall Study|Adverse Event|0|||
162761996|NCT02159989|587839464|FG006|Overall Study|Adverse Event|1|||
162761997|NCT02159989|587839465|FG007|Overall Study|Adverse Event|2|||
162761998|NCT02159989|587839466|FG008|Overall Study|Adverse Event|0|||
162761999|NCT02159989|587839467|FG009|Overall Study|Adverse Event|2|||
162762000|NCT02159989|587839468|FG010|Overall Study|Adverse Event|1|||
162762001|NCT02159989|587839458|FG000|Overall Study|Death|0|||
162762002|NCT02159989|587839459|FG001|Overall Study|Death|0|||
162762003|NCT02159989|587839460|FG002|Overall Study|Death|0|||
162762004|NCT02159989|587839461|FG003|Overall Study|Death|0|||
162762005|NCT02159989|587839462|FG004|Overall Study|Death|0|||
162762006|NCT02159989|587839463|FG005|Overall Study|Death|0|||
162762007|NCT02159989|587839464|FG006|Overall Study|Death|0|||
162762008|NCT02159989|587839465|FG007|Overall Study|Death|0|||
162762009|NCT02159989|587839466|FG008|Overall Study|Death|0|||
162762010|NCT02159989|587839467|FG009|Overall Study|Death|0|||
162762011|NCT02159989|587839468|FG010|Overall Study|Death|1|||
162762012|NCT02159989|587839458|FG000|Overall Study|Lack of Efficacy|2|||
162762013|NCT02159989|587839459|FG001|Overall Study|Lack of Efficacy|3|||
162762014|NCT02159989|587839460|FG002|Overall Study|Lack of Efficacy|3|||
162762015|NCT02159989|587839461|FG003|Overall Study|Lack of Efficacy|0|||
162762016|NCT02159989|587839462|FG004|Overall Study|Lack of Efficacy|2|||
162762017|NCT02159989|587839463|FG005|Overall Study|Lack of Efficacy|3|||
162762018|NCT02159989|587839464|FG006|Overall Study|Lack of Efficacy|3|||
162762019|NCT02159989|587839465|FG007|Overall Study|Lack of Efficacy|1|||
162762020|NCT02159989|587839466|FG008|Overall Study|Lack of Efficacy|3|||
162762021|NCT02159989|587839467|FG009|Overall Study|Lack of Efficacy|6|||
162762022|NCT02159989|587839468|FG010|Overall Study|Lack of Efficacy|7|||
162762023|NCT02159989|587839458|FG000|Overall Study|Lost to Follow-up|0|||
162762024|NCT02159989|587839459|FG001|Overall Study|Lost to Follow-up|0|||
162762025|NCT02159989|587839460|FG002|Overall Study|Lost to Follow-up|0|||
162762026|NCT02159989|587839461|FG003|Overall Study|Lost to Follow-up|1|||
162762027|NCT02159989|587839462|FG004|Overall Study|Lost to Follow-up|0|||
162762028|NCT02159989|587839463|FG005|Overall Study|Lost to Follow-up|0|||
162762029|NCT02159989|587839464|FG006|Overall Study|Lost to Follow-up|0|||
162762030|NCT02159989|587839465|FG007|Overall Study|Lost to Follow-up|0|||
162762031|NCT02159989|587839466|FG008|Overall Study|Lost to Follow-up|0|||
162762032|NCT02159989|587839467|FG009|Overall Study|Lost to Follow-up|0|||
162762033|NCT02159989|587839468|FG010|Overall Study|Lost to Follow-up|1|||
162762034|NCT02159989|587839458|FG000|Overall Study|Withdrawal by Subject|2|||
162762035|NCT02159989|587839459|FG001|Overall Study|Withdrawal by Subject|0|||
162762036|NCT02159989|587839460|FG002|Overall Study|Withdrawal by Subject|0|||
162762037|NCT02159989|587839461|FG003|Overall Study|Withdrawal by Subject|2|||
162762038|NCT02159989|587839462|FG004|Overall Study|Withdrawal by Subject|1|||
162762039|NCT02159989|587839463|FG005|Overall Study|Withdrawal by Subject|0|||
162762040|NCT02159989|587839464|FG006|Overall Study|Withdrawal by Subject|3|||
162762041|NCT02159989|587839465|FG007|Overall Study|Withdrawal by Subject|1|||
162762042|NCT02159989|587839466|FG008|Overall Study|Withdrawal by Subject|0|||
162762043|NCT02159989|587839467|FG009|Overall Study|Withdrawal by Subject|0|||
162762044|NCT02159989|587839468|FG010|Overall Study|Withdrawal by Subject|0|||
162762045|NCT02159989|587839458|FG000|Overall Study|New treatment|0|||
162762046|NCT02159989|587839459|FG001|Overall Study|New treatment|1|||
162762047|NCT02159989|587839460|FG002|Overall Study|New treatment|0|||
162762048|NCT02159989|587839461|FG003|Overall Study|New treatment|0|||
162762049|NCT02159989|587839462|FG004|Overall Study|New treatment|0|||
162762050|NCT02159989|587839463|FG005|Overall Study|New treatment|0|||
162762051|NCT02159989|587839464|FG006|Overall Study|New treatment|0|||
162762052|NCT02159989|587839465|FG007|Overall Study|New treatment|0|||
162762053|NCT02159989|587839466|FG008|Overall Study|New treatment|0|||
162762054|NCT02159989|587839467|FG009|Overall Study|New treatment|0|||
162762055|NCT02159989|587839468|FG010|Overall Study|New treatment|0|||
162762056|NCT02159989|587839458|FG000|Overall Study|Insurance Issues|0|||
162762057|NCT02159989|587839459|FG001|Overall Study|Insurance Issues|0|||
162762058|NCT02159989|587839460|FG002|Overall Study|Insurance Issues|0|||
162762059|NCT02159989|587839461|FG003|Overall Study|Insurance Issues|0|||
162762060|NCT02159989|587839462|FG004|Overall Study|Insurance Issues|0|||
162762061|NCT02159989|587839463|FG005|Overall Study|Insurance Issues|0|||
162762062|NCT02159989|587839464|FG006|Overall Study|Insurance Issues|0|||
162762063|NCT02159989|587839465|FG007|Overall Study|Insurance Issues|0|||
162762064|NCT02159989|587839466|FG008|Overall Study|Insurance Issues|0|||
162762065|NCT02159989|587839467|FG009|Overall Study|Insurance Issues|1|||
162762066|NCT02159989|587839468|FG010|Overall Study|Insurance Issues|0|||
162762067|NCT04369664|587840730|FG000|Overall Study|Physician Decision|1|||
162762068|NCT04369664|587840731|FG001|Overall Study|Physician Decision|0|||
162762069|NCT03840200|587840732|FG000|Overall Study|Death|6|||
162762070|NCT03840200|587840733|FG001|Overall Study|Death|3|||
162762071|NCT03840200|587840734|FG002|Overall Study|Death|6|||
162762072|NCT03840200|587840735|FG003|Overall Study|Death|10|||
162762073|NCT03840200|587840732|FG000|Overall Study|Reason Not Specified|2|||
162762074|NCT03840200|587840733|FG001|Overall Study|Reason Not Specified|2|||
162762075|NCT03840200|587840734|FG002|Overall Study|Reason Not Specified|1|||
162762076|NCT03840200|587840735|FG003|Overall Study|Reason Not Specified|15|||
162762077|NCT03840200|587840732|FG000|Overall Study|Physician Decision|0|||
162762078|NCT03840200|587840733|FG001|Overall Study|Physician Decision|0|||
162762079|NCT03840200|587840734|FG002|Overall Study|Physician Decision|0|||
162762080|NCT03840200|587840735|FG003|Overall Study|Physician Decision|2|||
162762081|NCT03840200|587840732|FG000|Overall Study|Progressive Disease|0|||
162762082|NCT03840200|587840733|FG001|Overall Study|Progressive Disease|0|||
162762083|NCT03840200|587840734|FG002|Overall Study|Progressive Disease|0|||
162762084|NCT03840200|587840735|FG003|Overall Study|Progressive Disease|1|||
162762085|NCT03840200|587840732|FG000|Overall Study|Withdrawal by Subject|0|||
162762086|NCT03840200|587840733|FG001|Overall Study|Withdrawal by Subject|1|||
162762087|NCT03840200|587840734|FG002|Overall Study|Withdrawal by Subject|0|||
162762088|NCT03840200|587840735|FG003|Overall Study|Withdrawal by Subject|2|||
162762089|NCT01450007|587840737|FG000|Overall Study|Late exclusion before treatment|2|||
162762090|NCT01450007|587840738|FG001|Overall Study|Late exclusion before treatment|3|||
162762091|NCT01450007|587840739|FG002|Overall Study|Late exclusion before treatment|2|||
162762092|NCT01450007|587840737|FG000|Overall Study|Protocol Violation|0|||
162762093|NCT01450007|587840738|FG001|Overall Study|Protocol Violation|1|||
162762094|NCT01450007|587840739|FG002|Overall Study|Protocol Violation|1|||
162762095|NCT01450007|587840737|FG000|Overall Study|Adverse Event|0|||
162762096|NCT01450007|587840738|FG001|Overall Study|Adverse Event|1|||
162762097|NCT01450007|587840739|FG002|Overall Study|Adverse Event|0|||
162762098|NCT03851094|587840740|FG000|Overall Study|Withdrawal by Subject|0|||
162762099|NCT03851094|587840741|FG001|Overall Study|Withdrawal by Subject|1|||
162762100|NCT03851094|587840740|FG000|Overall Study|Participant lost device|0|||
162762101|NCT03851094|587840741|FG001|Overall Study|Participant lost device|1|||
162762102|NCT03851094|587840740|FG000|Overall Study|Participant returned device|0|||
162762103|NCT03851094|587840741|FG001|Overall Study|Participant returned device|2|||
162762104|NCT00484198|587840742|FG000|Overall Study|Participant Withdrew Consent|12|||
162762105|NCT00484198|587840743|FG001|Overall Study|Participant Withdrew Consent|21|||
162762106|NCT00484198|587840744|FG002|Overall Study|Participant Withdrew Consent|47|||
162762107|NCT00484198|587840745|FG003|Overall Study|Participant Withdrew Consent|59|||
162762108|NCT00484198|587840742|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
162762109|NCT00484198|587840743|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
162762110|NCT00484198|587840744|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
162762111|NCT00484198|587840745|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
162762112|NCT00484198|587840742|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
162762113|NCT00484198|587840743|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
162762114|NCT00484198|587840744|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
162762115|NCT00484198|587840745|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
162762116|NCT00484198|587840742|FG000|Overall Study|Adverse Event|3|||
162762117|NCT00484198|587840743|FG001|Overall Study|Adverse Event|11|||
162762118|NCT00484198|587840744|FG002|Overall Study|Adverse Event|32|||
162762119|NCT00484198|587840745|FG003|Overall Study|Adverse Event|31|||
162762120|NCT00484198|587840742|FG000|Overall Study|Protocol Violation|0|||
162762121|NCT00484198|587840743|FG001|Overall Study|Protocol Violation|5|||
162762122|NCT00484198|587840744|FG002|Overall Study|Protocol Violation|6|||
162762123|NCT00484198|587840745|FG003|Overall Study|Protocol Violation|8|||
162762124|NCT00484198|587840742|FG000|Overall Study|Other|7|||
162762125|NCT00484198|587840743|FG001|Overall Study|Other|10|||
162762126|NCT00484198|587840744|FG002|Overall Study|Other|31|||
162762127|NCT00484198|587840745|FG003|Overall Study|Other|28|||
162762128|NCT01536704|587840746|FG000|Washout Period 1|Withdrawal by Subject|1|||
162762129|NCT01536704|587840747|FG001|Washout Period 1|Withdrawal by Subject|2|||
162762130|NCT01536704|587840748|FG002|Washout Period 1|Withdrawal by Subject|0|||
162762131|NCT01536704|587840749|FG003|Washout Period 1|Withdrawal by Subject|0|||
162762132|NCT01536704|587840746|FG000|Washout Period 2|Adverse Event|1|||
162762133|NCT01536704|587840747|FG001|Washout Period 2|Adverse Event|0|||
162762134|NCT01536704|587840748|FG002|Washout Period 2|Adverse Event|0|||
162762135|NCT01536704|587840749|FG003|Washout Period 2|Adverse Event|0|||
162762136|NCT01536704|587840746|FG000|Washout Period 2|Withdrawal by Subject|0|||
162762137|NCT01536704|587840747|FG001|Washout Period 2|Withdrawal by Subject|0|||
162762138|NCT01536704|587840748|FG002|Washout Period 2|Withdrawal by Subject|0|||
162762139|NCT01536704|587840749|FG003|Washout Period 2|Withdrawal by Subject|1|||
162762140|NCT01536704|587840746|FG000|Period 3|Adverse Event|0|||
162762141|NCT01536704|587840747|FG001|Period 3|Adverse Event|0|||
162762142|NCT01536704|587840748|FG002|Period 3|Adverse Event|0|||
162762143|NCT01536704|587840749|FG003|Period 3|Adverse Event|1|||
162762144|NCT01536704|587840746|FG000|Washout Period 3|Adverse Event|0|||
162762145|NCT01536704|587840747|FG001|Washout Period 3|Adverse Event|0|||
162762146|NCT01536704|587840748|FG002|Washout Period 3|Adverse Event|1|||
162762147|NCT01536704|587840749|FG003|Washout Period 3|Adverse Event|0|||
162762148|NCT04658784|587840750|FG000|6-month Follow-up|Lost to Follow-up|2|||
162762149|NCT04658784|587840751|FG001|6-month Follow-up|Lost to Follow-up|5|||
162762150|NCT02958553|587840752|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
162762151|NCT02958553|587840752|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
162762152|NCT00704340|587840760|FG000|Overall Study|Lost to Follow-up|2|||
162762153|NCT00704340|587840761|FG001|Overall Study|Lost to Follow-up|1|||
162762154|NCT00704340|587840760|FG000|Overall Study|Death|0|||
162762155|NCT00704340|587840761|FG001|Overall Study|Death|1|||
162762156|NCT00703092|587840765|FG000|Overall Study|Withdrawal by Subject|2|||
162762157|NCT02007070|587840766|FG000|Overall Study|Adverse Event|4|||
162762158|NCT02007070|587840766|FG000|Overall Study|Clinical Progression|4|||
162762159|NCT02007070|587840766|FG000|Overall Study|Death|1|||
162762160|NCT02007070|587840766|FG000|Overall Study|Protocol Violation|2|||
162762161|NCT02007070|587840766|FG000|Overall Study|Physician Decision|1|||
162762162|NCT02007070|587840766|FG000|Overall Study|Progressive Disease|21|||
162762163|NCT00403845|587840770|FG000|Treatment Period 1|Subject withdrew consent|1|||
162762164|NCT00403845|587840771|FG001|Treatment Period 1|Subject withdrew consent|0|||
162762165|NCT00403845|587840772|FG002|Treatment Period 1|Subject withdrew consent|0|||
162762166|NCT00403845|587840773|FG003|Treatment Period 1|Subject withdrew consent|0|||
162762167|NCT00403845|587840770|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
162762168|NCT00403845|587840771|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
162762169|NCT00403845|587840772|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
162762170|NCT00403845|587840773|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
162762171|NCT00403845|587840770|FG000|Treatment Period 2|Subject withdrew consent|1|||
162762172|NCT00403845|587840771|FG001|Treatment Period 2|Subject withdrew consent|0|||
162762173|NCT00403845|587840772|FG002|Treatment Period 2|Subject withdrew consent|0|||
162762174|NCT00403845|587840773|FG003|Treatment Period 2|Subject withdrew consent|0|||
162762175|NCT00403845|587840770|FG000|Treatment Period 3|Subject withdrew consent|0|||
162762176|NCT00403845|587840771|FG001|Treatment Period 3|Subject withdrew consent|0|||
162762177|NCT00403845|587840772|FG002|Treatment Period 3|Subject withdrew consent|0|||
162762178|NCT00403845|587840773|FG003|Treatment Period 3|Subject withdrew consent|1|||
162762179|NCT00403845|587840770|FG000|Treatment Period 3|Adverse Event|0|||
162762180|NCT00403845|587840771|FG001|Treatment Period 3|Adverse Event|0|||
162762181|NCT00403845|587840772|FG002|Treatment Period 3|Adverse Event|0|||
162762182|NCT00403845|587840773|FG003|Treatment Period 3|Adverse Event|1|||
162762183|NCT03316170|587840774|FG000|Overall Study|Death|1|||
162762184|NCT03316170|587840775|FG001|Overall Study|Death|0|||
162762185|NCT03316170|587840774|FG000|Overall Study|Lost to Follow-up|6|||
162762186|NCT03316170|587840775|FG001|Overall Study|Lost to Follow-up|7|||
162762187|NCT02935673|587840776|FG000|Overall Study|Adverse Event|0|||
162762188|NCT02935673|587840777|FG001|Overall Study|Adverse Event|1|||
162762189|NCT02935673|587840778|FG002|Overall Study|Adverse Event|0|||
162762190|NCT02935673|587840776|FG000|Overall Study|Withdrawal by Subject|1|||
162762191|NCT02935673|587840777|FG001|Overall Study|Withdrawal by Subject|2|||
162762192|NCT02935673|587840778|FG002|Overall Study|Withdrawal by Subject|0|||
162762193|NCT01836523|587840779|FG000|Overall Study|Adverse Event|15|||
162762194|NCT01836523|587840780|FG001|Overall Study|Adverse Event|41|||
162762195|NCT01836523|587840781|FG002|Overall Study|Adverse Event|49|||
162762196|NCT01836523|587840782|FG003|Overall Study|Adverse Event|14|||
162762197|NCT01836523|587840779|FG000|Overall Study|Protocol Violation|6|||
162762198|NCT01836523|587840780|FG001|Overall Study|Protocol Violation|3|||
162762199|NCT01836523|587840781|FG002|Overall Study|Protocol Violation|2|||
162762200|NCT01836523|587840782|FG003|Overall Study|Protocol Violation|4|||
162762201|NCT01836523|587840779|FG000|Overall Study|Met Withdrawal Criteria|13|||
162762202|NCT01836523|587840780|FG001|Overall Study|Met Withdrawal Criteria|13|||
162762203|NCT01836523|587840781|FG002|Overall Study|Met Withdrawal Criteria|21|||
162762204|NCT01836523|587840782|FG003|Overall Study|Met Withdrawal Criteria|27|||
162762205|NCT01836523|587840779|FG000|Overall Study|Unclassified|17|||
162762206|NCT01836523|587840780|FG001|Overall Study|Unclassified|28|||
162762207|NCT01836523|587840781|FG002|Overall Study|Unclassified|19|||
162762208|NCT01836523|587840782|FG003|Overall Study|Unclassified|29|||
162762209|NCT02037568|587840783|FG000|Overall Study|Withdrawal by Subject|17|||
162762210|NCT02037568|587840784|FG001|Overall Study|Withdrawal by Subject|24|||
162762211|NCT02037568|587840783|FG000|Overall Study|Lost to Follow-up|16|||
162762212|NCT02037568|587840784|FG001|Overall Study|Lost to Follow-up|13|||
162762213|NCT02037568|587840783|FG000|Overall Study|Screen Failure|3|||
162762214|NCT02037568|587840784|FG001|Overall Study|Screen Failure|1|||
162762215|NCT02037568|587840783|FG000|Overall Study|Patient did not receive transplant|0|||
162762216|NCT02037568|587840784|FG001|Overall Study|Patient did not receive transplant|1|||
162762217|NCT00380250|587840785|FG000|Overall Study|Withdrawal by Subject|39|||
162762218|NCT00380250|587840786|FG001|Overall Study|Withdrawal by Subject|28|||
162762219|NCT00380250|587840785|FG000|Overall Study|Adverse Event|20|||
162762220|NCT00380250|587840786|FG001|Overall Study|Adverse Event|9|||
162762221|NCT00380250|587840785|FG000|Overall Study|Lack of Efficacy|10|||
162762222|NCT00380250|587840786|FG001|Overall Study|Lack of Efficacy|8|||
162762223|NCT00380250|587840785|FG000|Overall Study|Protocol Violation|15|||
162762224|NCT00380250|587840786|FG001|Overall Study|Protocol Violation|5|||
162762225|NCT00380250|587840785|FG000|Overall Study|Lost to Follow-up|14|||
162762226|NCT00380250|587840786|FG001|Overall Study|Lost to Follow-up|5|||
162762227|NCT00380250|587840785|FG000|Overall Study|Physician Decision|1|||
162762228|NCT00380250|587840786|FG001|Overall Study|Physician Decision|0|||
162762229|NCT03652610|587840792|FG000|Overall Study|Lost to Follow-up|1|||
162762230|NCT03652610|587840793|FG001|Overall Study|Lost to Follow-up|0|||
162762231|NCT03652610|587840792|FG000|Overall Study|Withdrawal by Subject|3|||
162762232|NCT03652610|587840793|FG001|Overall Study|Withdrawal by Subject|5|||
162762233|NCT05615363|587840797|FG000|Overall Study|Adverse Event|0|||
162762234|NCT05615363|587840798|FG001|Overall Study|Adverse Event|4|||
162762235|NCT05615363|587840799|FG002|Overall Study|Adverse Event|4|||
162762236|NCT05615363|587840800|FG003|Overall Study|Adverse Event|3|||
162762237|NCT05615363|587840801|FG004|Overall Study|Adverse Event|1|||
162762238|NCT05615363|587840797|FG000|Overall Study|Physician Decision|2|||
162762239|NCT05615363|587840798|FG001|Overall Study|Physician Decision|0|||
162762240|NCT05615363|587840799|FG002|Overall Study|Physician Decision|4|||
162762241|NCT05615363|587840800|FG003|Overall Study|Physician Decision|1|||
162762242|NCT05615363|587840801|FG004|Overall Study|Physician Decision|3|||
162762243|NCT05615363|587840797|FG000|Overall Study|Protocol Violation|2|||
162762244|NCT05615363|587840798|FG001|Overall Study|Protocol Violation|0|||
162762245|NCT05615363|587840799|FG002|Overall Study|Protocol Violation|0|||
162762246|NCT05615363|587840800|FG003|Overall Study|Protocol Violation|0|||
162762247|NCT05615363|587840801|FG004|Overall Study|Protocol Violation|1|||
162762248|NCT05615363|587840797|FG000|Overall Study|Withdrawal by Subject|0|||
162762249|NCT05615363|587840798|FG001|Overall Study|Withdrawal by Subject|0|||
162762250|NCT05615363|587840799|FG002|Overall Study|Withdrawal by Subject|1|||
162762251|NCT05615363|587840800|FG003|Overall Study|Withdrawal by Subject|0|||
162762252|NCT05615363|587840801|FG004|Overall Study|Withdrawal by Subject|0|||
162762253|NCT03905642|587840802|FG000|Overall Study|Withdrawal by Subject|3|||
162762254|NCT03905642|587840802|FG000|Overall Study|Pregnancy|1|||
162762255|NCT03905642|587840802|FG000|Overall Study|Adverse Event|1|||
162762256|NCT03905642|587840802|FG000|Overall Study|Lack of Efficacy|1|||
162762257|NCT03905642|587840802|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
162762258|NCT04447027|587840807|FG000|Dose Escalation|Withdrawal by Subject|1|||
162762259|NCT04447027|587840808|FG001|Dose Escalation|Withdrawal by Subject|4|||
162762260|NCT04447027|587840809|FG002|Dose Escalation|Withdrawal by Subject|3|||
162762261|NCT04447027|587840810|FG003|Dose Escalation|Withdrawal by Subject|3|||
162762262|NCT04447027|587840811|FG004|Dose Escalation|Withdrawal by Subject|1|||
162762263|NCT04447027|587840812|FG005|Dose Escalation|Withdrawal by Subject|0|||
162762264|NCT04447027|587840813|FG006|Dose Escalation|Withdrawal by Subject|0|||
162762265|NCT04447027|587840814|FG007|Dose Escalation|Withdrawal by Subject|0|||
162762266|NCT04447027|587840815|FG008|Dose Escalation|Withdrawal by Subject|0|||
162762267|NCT04447027|587840807|FG000|Dose Escalation|Refused further treatment|0|||
162762268|NCT04447027|587840808|FG001|Dose Escalation|Refused further treatment|1|||
162762269|NCT04447027|587840809|FG002|Dose Escalation|Refused further treatment|1|||
162762270|NCT04447027|587840810|FG003|Dose Escalation|Refused further treatment|0|||
162762271|NCT04447027|587840811|FG004|Dose Escalation|Refused further treatment|0|||
162762272|NCT04447027|587840812|FG005|Dose Escalation|Refused further treatment|0|||
162762273|NCT04447027|587840813|FG006|Dose Escalation|Refused further treatment|0|||
162762274|NCT04447027|587840814|FG007|Dose Escalation|Refused further treatment|0|||
162762275|NCT04447027|587840815|FG008|Dose Escalation|Refused further treatment|0|||
162762276|NCT04447027|587840807|FG000|Dose Expansion|Withdrawal by Subject|0|||
162762277|NCT04447027|587840808|FG001|Dose Expansion|Withdrawal by Subject|0|||
162762278|NCT04447027|587840809|FG002|Dose Expansion|Withdrawal by Subject|0|||
162762279|NCT04447027|587840810|FG003|Dose Expansion|Withdrawal by Subject|0|||
162762280|NCT04447027|587840811|FG004|Dose Expansion|Withdrawal by Subject|0|||
162762281|NCT04447027|587840812|FG005|Dose Expansion|Withdrawal by Subject|2|||
162762282|NCT04447027|587840813|FG006|Dose Expansion|Withdrawal by Subject|0|||
162762283|NCT04447027|587840814|FG007|Dose Expansion|Withdrawal by Subject|2|||
162762284|NCT04447027|587840815|FG008|Dose Expansion|Withdrawal by Subject|0|||
162762285|NCT02485925|587840818|FG000|Overall Study|Withdrawal by Subject|3|||
162762286|NCT02485925|587840818|FG000|Overall Study|Death|1|||
162762287|NCT02485925|587840818|FG000|Overall Study|Lost to Follow-up|11|||
162762288|NCT05995977|587840819|FG000|Overall Study|Withdrawal by Subject|1|||
162762289|NCT05995977|587840820|FG001|Overall Study|Withdrawal by Subject|4|||
162762290|NCT05995977|587840819|FG000|Overall Study|Lost to Follow-up|2|||
162762291|NCT05995977|587840820|FG001|Overall Study|Lost to Follow-up|0|||
162762292|NCT04181788|587840821|FG000|TREATMENT|Adverse Event|0|||
162762293|NCT04181788|587840822|FG001|TREATMENT|Adverse Event|2|||
162762294|NCT04181788|587840823|FG002|TREATMENT|Adverse Event|1|||
162762295|NCT04181788|587840824|FG003|TREATMENT|Adverse Event|0|||
162762296|NCT04181788|587840825|FG004|TREATMENT|Adverse Event|1|||
162762297|NCT04181788|587840826|FG005|TREATMENT|Adverse Event|3|||
162762298|NCT04181788|587840821|FG000|TREATMENT|Death|0|||
162762299|NCT04181788|587840822|FG001|TREATMENT|Death|0|||
162762300|NCT04181788|587840823|FG002|TREATMENT|Death|0|||
162762301|NCT04181788|587840824|FG003|TREATMENT|Death|0|||
162762302|NCT04181788|587840825|FG004|TREATMENT|Death|8|||
162762303|NCT04181788|587840826|FG005|TREATMENT|Death|8|||
162762304|NCT04181788|587840821|FG000|TREATMENT|Physician Decision|0|||
162762305|NCT04181788|587840822|FG001|TREATMENT|Physician Decision|0|||
162762306|NCT04181788|587840823|FG002|TREATMENT|Physician Decision|0|||
162762307|NCT04181788|587840824|FG003|TREATMENT|Physician Decision|0|||
162762308|NCT04181788|587840825|FG004|TREATMENT|Physician Decision|0|||
162762309|NCT04181788|587840826|FG005|TREATMENT|Physician Decision|1|||
162762310|NCT04181788|587840821|FG000|TREATMENT|Progressive disease|3|||
162762311|NCT04181788|587840822|FG001|TREATMENT|Progressive disease|3|||
162762312|NCT04181788|587840823|FG002|TREATMENT|Progressive disease|5|||
162762313|NCT04181788|587840824|FG003|TREATMENT|Progressive disease|7|||
162762314|NCT04181788|587840825|FG004|TREATMENT|Progressive disease|20|||
162762315|NCT04181788|587840826|FG005|TREATMENT|Progressive disease|38|||
162762316|NCT04181788|587840821|FG000|TREATMENT|Global deterioration of health status|0|||
162762317|NCT04181788|587840822|FG001|TREATMENT|Global deterioration of health status|2|||
162762318|NCT04181788|587840823|FG002|TREATMENT|Global deterioration of health status|0|||
162762319|NCT04181788|587840824|FG003|TREATMENT|Global deterioration of health status|0|||
162762320|NCT04181788|587840825|FG004|TREATMENT|Global deterioration of health status|2|||
162762321|NCT04181788|587840826|FG005|TREATMENT|Global deterioration of health status|8|||
162762322|NCT04181788|587840821|FG000|TREATMENT|Withdrawal by Subject|1|||
162762323|NCT04181788|587840822|FG001|TREATMENT|Withdrawal by Subject|2|||
162762324|NCT04181788|587840823|FG002|TREATMENT|Withdrawal by Subject|0|||
162762325|NCT04181788|587840824|FG003|TREATMENT|Withdrawal by Subject|0|||
162762326|NCT04181788|587840825|FG004|TREATMENT|Withdrawal by Subject|3|||
162762327|NCT04181788|587840826|FG005|TREATMENT|Withdrawal by Subject|5|||
162762328|NCT04181788|587840821|FG000|TREATMENT|Other unspecified|0|||
162762329|NCT04181788|587840822|FG001|TREATMENT|Other unspecified|0|||
162762330|NCT04181788|587840823|FG002|TREATMENT|Other unspecified|0|||
162762331|NCT04181788|587840824|FG003|TREATMENT|Other unspecified|0|||
162762332|NCT04181788|587840825|FG004|TREATMENT|Other unspecified|0|||
162762333|NCT04181788|587840826|FG005|TREATMENT|Other unspecified|2|||
162762334|NCT04181788|587840821|FG000|TREATMENT|Ongoing|0|||
162762335|NCT04181788|587840822|FG001|TREATMENT|Ongoing|3|||
162762336|NCT04181788|587840823|FG002|TREATMENT|Ongoing|0|||
162762337|NCT04181788|587840824|FG003|TREATMENT|Ongoing|5|||
162762338|NCT04181788|587840825|FG004|TREATMENT|Ongoing|7|||
162762339|NCT04181788|587840826|FG005|TREATMENT|Ongoing|15|||
162762340|NCT04181788|587840821|FG000|FOLLOW-UP|Death|0|||
162762341|NCT04181788|587840822|FG001|FOLLOW-UP|Death|0|||
162762342|NCT04181788|587840823|FG002|FOLLOW-UP|Death|1|||
162762343|NCT04181788|587840824|FG003|FOLLOW-UP|Death|2|||
162762344|NCT04181788|587840825|FG004|FOLLOW-UP|Death|8|||
162762345|NCT04181788|587840826|FG005|FOLLOW-UP|Death|20|||
162762346|NCT04181788|587840821|FG000|FOLLOW-UP|Lost to Follow-up|0|||
162762347|NCT04181788|587840822|FG001|FOLLOW-UP|Lost to Follow-up|0|||
162762348|NCT04181788|587840823|FG002|FOLLOW-UP|Lost to Follow-up|0|||
162762349|NCT04181788|587840824|FG003|FOLLOW-UP|Lost to Follow-up|0|||
162762350|NCT04181788|587840825|FG004|FOLLOW-UP|Lost to Follow-up|0|||
162762351|NCT04181788|587840826|FG005|FOLLOW-UP|Lost to Follow-up|2|||
162762352|NCT04181788|587840821|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
162762353|NCT04181788|587840822|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
162762354|NCT04181788|587840823|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
162762355|NCT04181788|587840824|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
162762356|NCT04181788|587840825|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
162762357|NCT04181788|587840826|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
162762358|NCT04181788|587840821|FG000|FOLLOW-UP|Other unspecified|0|||
162762359|NCT04181788|587840822|FG001|FOLLOW-UP|Other unspecified|1|||
162762360|NCT04181788|587840823|FG002|FOLLOW-UP|Other unspecified|0|||
162762361|NCT04181788|587840824|FG003|FOLLOW-UP|Other unspecified|0|||
162762362|NCT04181788|587840825|FG004|FOLLOW-UP|Other unspecified|0|||
162762363|NCT04181788|587840826|FG005|FOLLOW-UP|Other unspecified|3|||
162762364|NCT04181788|587840821|FG000|FOLLOW-UP|Ongoing|0|||
162762365|NCT04181788|587840822|FG001|FOLLOW-UP|Ongoing|0|||
162762366|NCT04181788|587840823|FG002|FOLLOW-UP|Ongoing|1|||
162762367|NCT04181788|587840824|FG003|FOLLOW-UP|Ongoing|3|||
162762368|NCT04181788|587840825|FG004|FOLLOW-UP|Ongoing|2|||
162762369|NCT04181788|587840826|FG005|FOLLOW-UP|Ongoing|2|||
162762370|NCT04937504|587840827|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
162762371|NCT04937504|587840828|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
162762372|NCT04937504|587840827|FG000|9 Months Assessment|Lost to Follow-up|3|||
162762373|NCT04937504|587840828|FG001|9 Months Assessment|Lost to Follow-up|2|||
162762374|NCT04535414|587840829|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
162762375|NCT04535414|587840830|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
162762376|NCT04535414|587840829|FG000|Overall Study|Cancelled appointment|1|||
162762377|NCT04535414|587840830|FG001|Overall Study|Cancelled appointment|0|||
162762378|NCT04535414|587840829|FG000|Overall Study|cancelled - food in stomach|2|||
162762379|NCT04535414|587840830|FG001|Overall Study|cancelled - food in stomach|0|||
162762380|NCT04535414|587840829|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
162762381|NCT04535414|587840830|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
162762382|NCT04535414|587840829|FG000|Overall Study|Withdrawal by Subject|0|||
162762383|NCT04535414|587840830|FG001|Overall Study|Withdrawal by Subject|1|||
162762384|NCT03662659|587840831|FG000|Pre-treatment|Participant no longer met study criteria|1|||
162762385|NCT03662659|587840832|FG001|Pre-treatment|Participant no longer met study criteria|1|||
162762386|NCT03662659|587840831|FG000|Pre-treatment|Other reasons|1|||
162762387|NCT03662659|587840832|FG001|Pre-treatment|Other reasons|0|||
162762388|NCT03662659|587840831|FG000|Treatment|Completed Treatment|0|||
162762389|NCT03662659|587840832|FG001|Treatment|Completed Treatment|2|||
162762390|NCT03662659|587840831|FG000|Treatment|Disease Progression|85|||
162762391|NCT03662659|587840832|FG001|Treatment|Disease Progression|97|||
162762392|NCT03662659|587840831|FG000|Treatment|Study Drug Toxicity|19|||
162762393|NCT03662659|587840832|FG001|Treatment|Study Drug Toxicity|9|||
162762394|NCT03662659|587840831|FG000|Treatment|Death|11|||
162762395|NCT03662659|587840832|FG001|Treatment|Death|9|||
162762396|NCT03662659|587840831|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
162762397|NCT03662659|587840832|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
162762398|NCT03662659|587840831|FG000|Treatment|Withdrawal by Subject|1|||
162762399|NCT03662659|587840832|FG001|Treatment|Withdrawal by Subject|1|||
162762400|NCT03662659|587840831|FG000|Treatment|Poor/Non-compliance|1|||
162762401|NCT03662659|587840832|FG001|Treatment|Poor/Non-compliance|0|||
162762402|NCT03662659|587840831|FG000|Treatment|Participant no longer meets study criteria|1|||
162762403|NCT03662659|587840832|FG001|Treatment|Participant no longer meets study criteria|0|||
162762404|NCT03662659|587840831|FG000|Treatment|Other reasons|10|||
162762405|NCT03662659|587840832|FG001|Treatment|Other reasons|8|||
162762406|NCT03662659|587840831|FG000|Treatment|Administrative reasons by sponsor|1|||
162762407|NCT03662659|587840832|FG001|Treatment|Administrative reasons by sponsor|0|||
162762408|NCT03662659|587840831|FG000|Treatment|maximum clinical benefit|0|||
162762409|NCT03662659|587840832|FG001|Treatment|maximum clinical benefit|2|||
162762410|NCT04311983|587843103|FG000|Overall Study|Lost to Follow-up|421|||
162762411|NCT04311983|587843104|FG001|Overall Study|Lost to Follow-up|456|||
162762412|NCT04311983|587843103|FG000|Overall Study|Incomplete survey|7|||
162762413|NCT04311983|587843104|FG001|Overall Study|Incomplete survey|9|||
162762414|NCT04311983|587843103|FG000|Overall Study|Death|1|||
162762415|NCT04311983|587843104|FG001|Overall Study|Death|0|||
162762416|NCT04070105|587843107|FG000|Overall Study|Lost to Follow-up|0|||
162762417|NCT04070105|587843108|FG001|Overall Study|Lost to Follow-up|0|||
162762418|NCT04070105|587843109|FG002|Overall Study|Lost to Follow-up|0|||
162762419|NCT04070105|587843110|FG003|Overall Study|Lost to Follow-up|0|||
162762420|NCT04070105|587843111|FG004|Overall Study|Lost to Follow-up|0|||
162762421|NCT04070105|587843112|FG005|Overall Study|Lost to Follow-up|1|||
162762422|NCT00749944|587843113|FG000|Overall Study|Lost to Follow-up|2|||
162762423|NCT00749944|587843114|FG001|Overall Study|Lost to Follow-up|1|||
162762424|NCT00749944|587843113|FG000|Overall Study|Other|1|||
162762425|NCT00749944|587843114|FG001|Overall Study|Other|0|||
162762426|NCT00749944|587843113|FG000|Overall Study|Withdrawal by Subject|2|||
162762427|NCT00749944|587843114|FG001|Overall Study|Withdrawal by Subject|0|||
162762428|NCT00624377|587843115|FG000|Overall Study|Lost to Follow-up|355|||
162762429|NCT00624377|587843115|FG000|Overall Study|Withdrawal by Subject|100|||
162762430|NCT00624377|587843115|FG000|Overall Study|Adverse Event|14|||
162762431|NCT00624377|587843115|FG000|Overall Study|Other|91|||
162762432|NCT00624377|587843115|FG000|Overall Study|Non-evaluable population|84|||
162762433|NCT01768572|587843116|FG000|Overall Study|Adverse Event|7|||
162762434|NCT01768572|587843117|FG001|Overall Study|Adverse Event|8|||
162762435|NCT01768572|587843118|FG002|Overall Study|Adverse Event|4|||
162762436|NCT01768572|587843116|FG000|Overall Study|Lack of Efficacy|1|||
162762437|NCT01768572|587843117|FG001|Overall Study|Lack of Efficacy|3|||
162762438|NCT01768572|587843118|FG002|Overall Study|Lack of Efficacy|1|||
162762439|NCT01768572|587843116|FG000|Overall Study|Other, Not due to an adverse event|1|||
162762440|NCT01768572|587843117|FG001|Overall Study|Other, Not due to an adverse event|1|||
162762441|NCT01768572|587843118|FG002|Overall Study|Other, Not due to an adverse event|1|||
162762442|NCT03265132|587843129|FG000|Overall Study|Adverse Event|0|||
162762443|NCT03265132|587843130|FG001|Overall Study|Adverse Event|1|||
162762444|NCT03265132|587843129|FG000|Overall Study|Lack of Efficacy|0|||
162762445|NCT03265132|587843130|FG001|Overall Study|Lack of Efficacy|2|||
162762446|NCT03265132|587843129|FG000|Overall Study|Progressive disease|0|||
162762447|NCT03265132|587843130|FG001|Overall Study|Progressive disease|2|||
162762448|NCT03265132|587843129|FG000|Overall Study|Withdrawal by Subject|0|||
162762449|NCT03265132|587843130|FG001|Overall Study|Withdrawal by Subject|1|||
162762450|NCT03259568|587843136|FG000|Overall Study|Participant performance was low|3|||
162762451|NCT00681109|587843137|FG000|Overall Study|Lost to Follow-up|2|||
162762452|NCT00681109|587843138|FG001|Overall Study|Lost to Follow-up|6|||
162762453|NCT00681109|587843139|FG002|Overall Study|Lost to Follow-up|0|||
162762454|NCT03128099|587843143|FG000|Overall Study|High dose task was too long|0|||
162762455|NCT03128099|587843144|FG001|Overall Study|High dose task was too long|4|||
162762456|NCT03128099|587843145|FG002|Overall Study|High dose task was too long|0|||
162762457|NCT03128099|587843143|FG000|Overall Study|Participant got a full time job.|1|||
162762458|NCT03128099|587843144|FG001|Overall Study|Participant got a full time job.|0|||
162762459|NCT03128099|587843145|FG002|Overall Study|Participant got a full time job.|0|||
162762460|NCT03128099|587843143|FG000|Overall Study|Became homeless and lost contact|1|||
162762461|NCT03128099|587843144|FG001|Overall Study|Became homeless and lost contact|0|||
162762462|NCT03128099|587843145|FG002|Overall Study|Became homeless and lost contact|0|||
162762463|NCT03128099|587843143|FG000|Overall Study|Did not complete all the assessments|0|||
162762464|NCT03128099|587843144|FG001|Overall Study|Did not complete all the assessments|0|||
162762465|NCT03128099|587843145|FG002|Overall Study|Did not complete all the assessments|1|||
162762466|NCT00089791|587843146|FG000|Overall Study|Physician Decision|6|||
162762467|NCT00089791|587843147|FG001|Overall Study|Physician Decision|3|||
162762468|NCT00089791|587843146|FG000|Overall Study|Adverse Event|81|||
162762469|NCT00089791|587843147|FG001|Overall Study|Adverse Event|93|||
162762470|NCT00089791|587843146|FG000|Overall Study|Withdrawal by Subject|403|||
162762471|NCT00089791|587843147|FG001|Overall Study|Withdrawal by Subject|344|||
162762472|NCT00089791|587843146|FG000|Overall Study|Death|78|||
162762473|NCT00089791|587843147|FG001|Overall Study|Death|62|||
162762474|NCT00089791|587843146|FG000|Overall Study|Disease progression|7|||
162762475|NCT00089791|587843147|FG001|Overall Study|Disease progression|3|||
162762476|NCT00089791|587843146|FG000|Overall Study|Ineligibility determined|12|||
162762477|NCT00089791|587843147|FG001|Overall Study|Ineligibility determined|9|||
162762478|NCT00089791|587843146|FG000|Overall Study|Lost to Follow-up|57|||
162762479|NCT00089791|587843147|FG001|Overall Study|Lost to Follow-up|57|||
162762480|NCT00089791|587843146|FG000|Overall Study|Noncompliance|17|||
162762481|NCT00089791|587843147|FG001|Overall Study|Noncompliance|13|||
162762482|NCT00089791|587843146|FG000|Overall Study|Other|20|||
162762483|NCT00089791|587843147|FG001|Overall Study|Other|32|||
162762484|NCT00089791|587843146|FG000|Overall Study|Protocol deviation|12|||
162762485|NCT00089791|587843147|FG001|Overall Study|Protocol deviation|10|||
162762486|NCT00089791|587843146|FG000|Overall Study|Requirement for alternative therapy|7|||
162762487|NCT00089791|587843147|FG001|Overall Study|Requirement for alternative therapy|4|||
162762488|NCT02161458|587843148|FG000|Overall Study|Withdrawal by Subject|0|||
162762489|NCT02161458|587843149|FG001|Overall Study|Withdrawal by Subject|4|||
162762490|NCT02161458|587843150|FG002|Overall Study|Withdrawal by Subject|4|||
162762491|NCT02161458|587843151|FG003|Overall Study|Withdrawal by Subject|0|||
162762492|NCT02161458|587843148|FG000|Overall Study|Lost to Follow-up|0|||
162762493|NCT02161458|587843149|FG001|Overall Study|Lost to Follow-up|2|||
162762494|NCT02161458|587843150|FG002|Overall Study|Lost to Follow-up|1|||
162762495|NCT02161458|587843151|FG003|Overall Study|Lost to Follow-up|0|||
162762496|NCT00148122|587843152|FG000|Overall Study|Withdrawal by Subject|2|||
162762497|NCT02362789|587843160|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
162762498|NCT02362789|587843161|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
162762499|NCT02362789|587843162|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
162762500|NCT02362789|587843160|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
162762501|NCT02362789|587843161|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
162762502|NCT02362789|587843162|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
162762503|NCT02362789|587843160|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
162762504|NCT02362789|587843161|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
162762505|NCT02362789|587843162|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
162762506|NCT02362789|587843160|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
162762507|NCT02362789|587843161|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
162762508|NCT02362789|587843162|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
162762509|NCT02362789|587843160|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
162762510|NCT02362789|587843161|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
162762511|NCT02362789|587843162|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
162762512|NCT00721734|587843164|FG000|Overall Study|Progressive Disease|3|||
162762513|NCT00721734|587843165|FG001|Overall Study|Progressive Disease|10|||
162762514|NCT00721734|587843166|FG002|Overall Study|Progressive Disease|4|||
162762515|NCT00721734|587843167|FG003|Overall Study|Progressive Disease|5|||
162762516|NCT00721734|587843168|FG004|Overall Study|Progressive Disease|2|||
162762517|NCT00721734|587843164|FG000|Overall Study|Adverse Event|3|||
162762518|NCT00721734|587843165|FG001|Overall Study|Adverse Event|1|||
162762519|NCT00721734|587843166|FG002|Overall Study|Adverse Event|4|||
162762520|NCT00721734|587843167|FG003|Overall Study|Adverse Event|0|||
162762521|NCT00721734|587843168|FG004|Overall Study|Adverse Event|3|||
162762522|NCT00721734|587843164|FG000|Overall Study|Withdrawal by Subject|2|||
162762523|NCT00721734|587843165|FG001|Overall Study|Withdrawal by Subject|1|||
162762524|NCT00721734|587843166|FG002|Overall Study|Withdrawal by Subject|0|||
162762525|NCT00721734|587843167|FG003|Overall Study|Withdrawal by Subject|0|||
162762526|NCT00721734|587843168|FG004|Overall Study|Withdrawal by Subject|1|||
162762527|NCT00721734|587843164|FG000|Overall Study|Other|0|||
162762528|NCT00721734|587843165|FG001|Overall Study|Other|0|||
162762529|NCT00721734|587843166|FG002|Overall Study|Other|0|||
162762530|NCT00721734|587843167|FG003|Overall Study|Other|1|||
162762531|NCT00721734|587843168|FG004|Overall Study|Other|0|||
162762532|NCT05074433|587843172|FG000|Overall Study|Adverse Event|0|||
162762533|NCT05074433|587843173|FG001|Overall Study|Adverse Event|2|||
162762534|NCT05074433|587843174|FG002|Overall Study|Adverse Event|0|||
162762535|NCT05074433|587843175|FG003|Overall Study|Adverse Event|1|||
162762536|NCT05074433|587843172|FG000|Overall Study|Sponsor Request|0|||
162762537|NCT05074433|587843173|FG001|Overall Study|Sponsor Request|1|||
162762538|NCT05074433|587843174|FG002|Overall Study|Sponsor Request|1|||
162762539|NCT05074433|587843175|FG003|Overall Study|Sponsor Request|0|||
162762540|NCT05074433|587843172|FG000|Overall Study|Death|1|||
162762541|NCT05074433|587843173|FG001|Overall Study|Death|0|||
162762542|NCT05074433|587843174|FG002|Overall Study|Death|0|||
162762543|NCT05074433|587843175|FG003|Overall Study|Death|0|||
162762544|NCT05074433|587843172|FG000|Overall Study|Lost to Follow-up|0|||
162762545|NCT05074433|587843173|FG001|Overall Study|Lost to Follow-up|0|||
162762546|NCT05074433|587843174|FG002|Overall Study|Lost to Follow-up|2|||
162762547|NCT05074433|587843175|FG003|Overall Study|Lost to Follow-up|0|||
162762548|NCT05074433|587843172|FG000|Overall Study|Subject Decision|8|||
162762549|NCT05074433|587843173|FG001|Overall Study|Subject Decision|6|||
162762550|NCT05074433|587843174|FG002|Overall Study|Subject Decision|4|||
162762551|NCT05074433|587843175|FG003|Overall Study|Subject Decision|5|||
162762552|NCT04397263|587843176|FG000|Overall Study|Withdrawal by Subject|2|||
162762553|NCT02251652|587843177|FG000|Overall Study|Withdrawal by Subject|1|||
162762554|NCT01989689|587843178|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
162762555|NCT01989689|587843179|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
162762556|NCT01989689|587843178|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
162762557|NCT01989689|587843179|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
162762558|NCT04492475|587843180|FG000|Overall Study|Enrolled but not treated|8|||
162762559|NCT04492475|587843181|FG001|Overall Study|Enrolled but not treated|8|||
162762560|NCT04492475|587843180|FG000|Overall Study|Withdrawal by Subject|4|||
162762561|NCT04492475|587843181|FG001|Overall Study|Withdrawal by Subject|0|||
162762562|NCT04492475|587843180|FG000|Overall Study|Became ineligible after enrollment|2|||
162762563|NCT04492475|587843181|FG001|Overall Study|Became ineligible after enrollment|0|||
162762564|NCT02066636|587843182|FG000|Overall Study|Disease progression|51|||
162762565|NCT02066636|587843183|FG001|Overall Study|Disease progression|60|||
162762566|NCT02066636|587843184|FG002|Overall Study|Disease progression|700|||
162762567|NCT02066636|587843182|FG000|Overall Study|Study drug toxicity|13|||
162762568|NCT02066636|587843183|FG001|Overall Study|Study drug toxicity|2|||
162762569|NCT02066636|587843184|FG002|Overall Study|Study drug toxicity|58|||
162762570|NCT02066636|587843182|FG000|Overall Study|Death|4|||
162762571|NCT02066636|587843183|FG001|Overall Study|Death|2|||
162762572|NCT02066636|587843184|FG002|Overall Study|Death|158|||
162762573|NCT02066636|587843182|FG000|Overall Study|Adverse event unrelated to study drug|6|||
162762574|NCT02066636|587843183|FG001|Overall Study|Adverse event unrelated to study drug|4|||
162762575|NCT02066636|587843184|FG002|Overall Study|Adverse event unrelated to study drug|45|||
162762576|NCT02066636|587843182|FG000|Overall Study|Participant request to discontinue treatment|12|||
162762577|NCT02066636|587843183|FG001|Overall Study|Participant request to discontinue treatment|12|||
162762578|NCT02066636|587843184|FG002|Overall Study|Participant request to discontinue treatment|70|||
162762579|NCT02066636|587843182|FG000|Overall Study|Participant withdrew consent|10|||
162762580|NCT02066636|587843183|FG001|Overall Study|Participant withdrew consent|18|||
162762581|NCT02066636|587843184|FG002|Overall Study|Participant withdrew consent|61|||
162762582|NCT02066636|587843182|FG000|Overall Study|Lost to Follow-up|0|||
162762583|NCT02066636|587843183|FG001|Overall Study|Lost to Follow-up|2|||
162762584|NCT02066636|587843184|FG002|Overall Study|Lost to Follow-up|2|||
162762585|NCT02066636|587843182|FG000|Overall Study|Maximum clinical benefit|2|||
162762586|NCT02066636|587843183|FG001|Overall Study|Maximum clinical benefit|2|||
162762587|NCT02066636|587843184|FG002|Overall Study|Maximum clinical benefit|3|||
162762588|NCT02066636|587843182|FG000|Overall Study|Poor/non-compliance|2|||
162762589|NCT02066636|587843183|FG001|Overall Study|Poor/non-compliance|1|||
162762590|NCT02066636|587843184|FG002|Overall Study|Poor/non-compliance|1|||
162762591|NCT02066636|587843182|FG000|Overall Study|Participant no loner meets study criteria|3|||
162762592|NCT02066636|587843183|FG001|Overall Study|Participant no loner meets study criteria|2|||
162762593|NCT02066636|587843184|FG002|Overall Study|Participant no loner meets study criteria|28|||
162762594|NCT02066636|587843182|FG000|Overall Study|Administrative reasons by sponsor|8|||
162762595|NCT02066636|587843183|FG001|Overall Study|Administrative reasons by sponsor|5|||
162762596|NCT02066636|587843184|FG002|Overall Study|Administrative reasons by sponsor|0|||
162762597|NCT02066636|587843182|FG000|Overall Study|Other reasons|16|||
162762598|NCT02066636|587843183|FG001|Overall Study|Other reasons|15|||
162762599|NCT02066636|587843184|FG002|Overall Study|Other reasons|50|||
162762600|NCT00391170|587843191|FG000|Overall Study|Withdrawal by Subject|1|||
162762601|NCT00391170|587843192|FG001|Overall Study|Withdrawal by Subject|0|||
162762602|NCT00391170|587843191|FG000|Overall Study|Adverse Event|3|||
162762603|NCT00391170|587843192|FG001|Overall Study|Adverse Event|2|||
162762604|NCT00391170|587843191|FG000|Overall Study|Physician Decision|2|||
162762605|NCT00391170|587843192|FG001|Overall Study|Physician Decision|2|||
162762606|NCT03567616|587843197|FG000|Overall Study|Disease progression|4|||
162762607|NCT03567616|587843197|FG000|Overall Study|Withdrawal by Subject|1|||
162762608|NCT03567616|587843197|FG000|Overall Study|Physician Decision|1|||
162762609|NCT03567616|587843197|FG000|Overall Study|Death|1|||
162762610|NCT03567616|587843197|FG000|Overall Study|Adverse Event|1|||
162762611|NCT03035942|587843199|FG000|Overall Study|Adverse Event|8|||
162762612|NCT03035942|587843200|FG001|Overall Study|Adverse Event|4|||
162762613|NCT03035942|587843201|FG002|Overall Study|Adverse Event|5|||
162762614|NCT05270460|587843202|FG000|Overall Study|Adverse Event|0|||
162762615|NCT05270460|587843203|FG001|Overall Study|Adverse Event|1|||
162762616|NCT05270460|587843204|FG002|Overall Study|Adverse Event|0|||
162762617|NCT05270460|587843202|FG000|Overall Study|Early Termination|0|||
162762618|NCT05270460|587843203|FG001|Overall Study|Early Termination|1|||
162762619|NCT05270460|587843204|FG002|Overall Study|Early Termination|0|||
162762620|NCT01989104|587843205|FG000|Overall Study|Withdrawal by Subject|3|||
162762621|NCT01989104|587843206|FG001|Overall Study|Withdrawal by Subject|0|||
162762622|NCT01989104|587843207|FG002|Overall Study|Withdrawal by Subject|0|||
162762623|NCT01989104|587843208|FG003|Overall Study|Withdrawal by Subject|0|||
162762624|NCT01989104|587843209|FG004|Overall Study|Withdrawal by Subject|0|||
162762625|NCT02833948|587843210|FG000|Overall Study|Death|2|||
162762626|NCT02833948|587843211|FG001|Overall Study|Death|3|||
162762627|NCT02833948|587843210|FG000|Overall Study|were not scanned|8|||
162762628|NCT02833948|587843211|FG001|Overall Study|were not scanned|13|||
162762629|NCT02833948|587843210|FG000|Overall Study|scans could not be evaluated|5|||
162762630|NCT02833948|587843211|FG001|Overall Study|scans could not be evaluated|2|||
162762631|NCT00680771|587843214|FG000|Overall Study|Withdrawal by Subject|1|||
162762632|NCT00680771|587843215|FG001|Overall Study|Withdrawal by Subject|0|||
162762633|NCT00680771|587843214|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
162762634|NCT00680771|587843215|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
162762635|NCT00680771|587843214|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
162762636|NCT00680771|587843215|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
162762637|NCT02691702|587843216|FG000|Overall Study|Adverse Event|1|||
162762638|NCT02691702|587843217|FG001|Overall Study|Adverse Event|0|||
162762639|NCT02691702|587843218|FG002|Overall Study|Adverse Event|0|||
162762640|NCT02691702|587843219|FG003|Overall Study|Adverse Event|0|||
162762641|NCT02691702|587843220|FG004|Overall Study|Adverse Event|0|||
162762642|NCT02691702|587843221|FG005|Overall Study|Adverse Event|0|||
162762643|NCT02691702|587843222|FG006|Overall Study|Adverse Event|0|||
162762644|NCT02691702|587843223|FG007|Overall Study|Adverse Event|0|||
162762645|NCT02691702|587843224|FG008|Overall Study|Adverse Event|1|||
162762646|NCT02691702|587843225|FG009|Overall Study|Adverse Event|0|||
162762647|NCT02691702|587843226|FG010|Overall Study|Adverse Event|1|||
162762648|NCT02691702|587843216|FG000|Overall Study|Lost to Follow-up|0|||
162762649|NCT02691702|587843217|FG001|Overall Study|Lost to Follow-up|0|||
162762650|NCT02691702|587843218|FG002|Overall Study|Lost to Follow-up|1|||
162762651|NCT02691702|587843219|FG003|Overall Study|Lost to Follow-up|0|||
162762652|NCT02691702|587843220|FG004|Overall Study|Lost to Follow-up|0|||
162762653|NCT02691702|587843221|FG005|Overall Study|Lost to Follow-up|2|||
162762654|NCT02691702|587843222|FG006|Overall Study|Lost to Follow-up|0|||
162762655|NCT02691702|587843223|FG007|Overall Study|Lost to Follow-up|0|||
162762656|NCT02691702|587843224|FG008|Overall Study|Lost to Follow-up|0|||
162762657|NCT02691702|587843225|FG009|Overall Study|Lost to Follow-up|0|||
162762658|NCT02691702|587843226|FG010|Overall Study|Lost to Follow-up|1|||
162762659|NCT02691702|587843216|FG000|Overall Study|Withdrawal by Subject|1|||
162762660|NCT02691702|587843217|FG001|Overall Study|Withdrawal by Subject|1|||
162762661|NCT02691702|587843218|FG002|Overall Study|Withdrawal by Subject|0|||
162762662|NCT02691702|587843219|FG003|Overall Study|Withdrawal by Subject|0|||
162762663|NCT02691702|587843220|FG004|Overall Study|Withdrawal by Subject|0|||
162762664|NCT02691702|587843221|FG005|Overall Study|Withdrawal by Subject|1|||
162762665|NCT02691702|587843222|FG006|Overall Study|Withdrawal by Subject|2|||
162762666|NCT02691702|587843223|FG007|Overall Study|Withdrawal by Subject|0|||
162762667|NCT02691702|587843224|FG008|Overall Study|Withdrawal by Subject|0|||
162762668|NCT02691702|587843225|FG009|Overall Study|Withdrawal by Subject|0|||
162762669|NCT02691702|587843226|FG010|Overall Study|Withdrawal by Subject|0|||
162762670|NCT02691702|587843216|FG000|Overall Study|Other|0|||
162762671|NCT02691702|587843217|FG001|Overall Study|Other|0|||
162762672|NCT02691702|587843218|FG002|Overall Study|Other|0|||
162762673|NCT02691702|587843219|FG003|Overall Study|Other|0|||
162762674|NCT02691702|587843220|FG004|Overall Study|Other|0|||
162762675|NCT02691702|587843221|FG005|Overall Study|Other|0|||
162762676|NCT02691702|587843222|FG006|Overall Study|Other|1|||
162762677|NCT02691702|587843223|FG007|Overall Study|Other|0|||
162762678|NCT02691702|587843224|FG008|Overall Study|Other|1|||
162762679|NCT02691702|587843225|FG009|Overall Study|Other|0|||
162762680|NCT02691702|587843226|FG010|Overall Study|Other|0|||
162762681|NCT02691702|587843216|FG000|Overall Study|Protocol Violation|0|||
162762682|NCT02691702|587843217|FG001|Overall Study|Protocol Violation|0|||
162762683|NCT02691702|587843218|FG002|Overall Study|Protocol Violation|0|||
162762684|NCT02691702|587843219|FG003|Overall Study|Protocol Violation|0|||
162762685|NCT02691702|587843220|FG004|Overall Study|Protocol Violation|0|||
162762686|NCT02691702|587843221|FG005|Overall Study|Protocol Violation|0|||
162762687|NCT02691702|587843222|FG006|Overall Study|Protocol Violation|0|||
162762688|NCT02691702|587843223|FG007|Overall Study|Protocol Violation|0|||
162762689|NCT02691702|587843224|FG008|Overall Study|Protocol Violation|0|||
162762690|NCT02691702|587843225|FG009|Overall Study|Protocol Violation|2|||
162762691|NCT02691702|587843226|FG010|Overall Study|Protocol Violation|0|||
162762692|NCT05613088|587843227|FG000|Treatment|Ongoing Study Treatment|9|||
162762693|NCT05613088|587843228|FG001|Treatment|Ongoing Study Treatment|2|||
162762694|NCT05613088|587843227|FG000|Treatment|Adverse Event|3|||
162762695|NCT05613088|587843228|FG001|Treatment|Adverse Event|1|||
162762696|NCT05613088|587843227|FG000|Treatment|Other Reasons|0|||
162762697|NCT05613088|587843228|FG001|Treatment|Other Reasons|1|||
162762698|NCT05613088|587843227|FG000|Treatment|Progressive Disease|58|||
162762699|NCT05613088|587843228|FG001|Treatment|Progressive Disease|26|||
162762700|NCT05613088|587843227|FG000|Treatment|Withdrawal by Subject|0|||
162762701|NCT05613088|587843228|FG001|Treatment|Withdrawal by Subject|4|||
162762702|NCT05484661|587843231|FG000|Overall Study|Withdrawal by Subject|1|||
162762703|NCT05484661|587843232|FG001|Overall Study|Withdrawal by Subject|0|||
162762704|NCT03205488|587843233|FG000|Overall Study|Adverse Event|1|||
162762705|NCT03205488|587843234|FG001|Overall Study|Adverse Event|2|||
162762706|NCT03205488|587843235|FG002|Overall Study|Adverse Event|4|||
162762707|NCT03205488|587843233|FG000|Overall Study|Protocol Violation|0|||
162762708|NCT03205488|587843234|FG001|Overall Study|Protocol Violation|0|||
162762709|NCT03205488|587843235|FG002|Overall Study|Protocol Violation|1|||
162762710|NCT05163353|587843238|FG000|Overall Study|Adverse Event|1|||
162762711|NCT05163353|587843239|FG001|Overall Study|Adverse Event|0|||
162762712|NCT05163353|587843238|FG000|Overall Study|Withdrawal by Subject|21|||
162762713|NCT05163353|587843239|FG001|Overall Study|Withdrawal by Subject|6|||
162762714|NCT05163353|587843238|FG000|Overall Study|Protocol Violation|0|||
162762715|NCT05163353|587843239|FG001|Overall Study|Protocol Violation|1|||
162762716|NCT05163353|587843238|FG000|Overall Study|Lost to Follow-up|13|||
162762717|NCT05163353|587843239|FG001|Overall Study|Lost to Follow-up|2|||
162762718|NCT06086028|587843241|FG000|Overall Study|Withdrawal by Subject|1|||
162762719|NCT06086028|587843242|FG001|Overall Study|Withdrawal by Subject|1|||
162762720|NCT06086028|587843241|FG000|Overall Study|Lost to Follow-up|2|||
162762721|NCT06086028|587843242|FG001|Overall Study|Lost to Follow-up|3|||
162762722|NCT00824408|587843243|FG000|Run-in Phase|Progressive disease|4|||
162762723|NCT00824408|587843244|FG001|Run-in Phase|Progressive disease|4|||
162762724|NCT00824408|587843245|FG002|Run-in Phase|Progressive disease|0|||
162762725|NCT00824408|587843246|FG003|Run-in Phase|Progressive disease|0|||
162762726|NCT00824408|587843247|FG004|Run-in Phase|Progressive disease|0|||
162762727|NCT00824408|587843243|FG000|Run-in Phase|Adverse Event|1|||
162762728|NCT00824408|587843244|FG001|Run-in Phase|Adverse Event|1|||
162762729|NCT00824408|587843245|FG002|Run-in Phase|Adverse Event|0|||
162762730|NCT00824408|587843246|FG003|Run-in Phase|Adverse Event|0|||
162762731|NCT00824408|587843247|FG004|Run-in Phase|Adverse Event|0|||
162762732|NCT00824408|587843243|FG000|Run-in Phase|Refused to continue medication|1|||
162762733|NCT00824408|587843244|FG001|Run-in Phase|Refused to continue medication|0|||
162762734|NCT00824408|587843245|FG002|Run-in Phase|Refused to continue medication|0|||
162762735|NCT00824408|587843246|FG003|Run-in Phase|Refused to continue medication|0|||
162762736|NCT00824408|587843247|FG004|Run-in Phase|Refused to continue medication|0|||
162762737|NCT00824408|587843243|FG000|Run-in Phase|Other reason not defined above|0|||
162762738|NCT00824408|587843244|FG001|Run-in Phase|Other reason not defined above|1|||
162762739|NCT00824408|587843245|FG002|Run-in Phase|Other reason not defined above|0|||
162762740|NCT00824408|587843246|FG003|Run-in Phase|Other reason not defined above|0|||
162762741|NCT00824408|587843247|FG004|Run-in Phase|Other reason not defined above|0|||
162762742|NCT00824408|587843243|FG000|Randomized Phase|Not treated|0|||
162762743|NCT00824408|587843244|FG001|Randomized Phase|Not treated|0|||
162762744|NCT00824408|587843245|FG002|Randomized Phase|Not treated|1|||
162762745|NCT00824408|587843246|FG003|Randomized Phase|Not treated|1|||
162762746|NCT00824408|587843247|FG004|Randomized Phase|Not treated|1|||
162762747|NCT00824408|587843243|FG000|Randomized Phase|Progressive disease|0|||
162762748|NCT00824408|587843244|FG001|Randomized Phase|Progressive disease|0|||
162762749|NCT00824408|587843245|FG002|Randomized Phase|Progressive disease|25|||
162762750|NCT00824408|587843246|FG003|Randomized Phase|Progressive disease|36|||
162762751|NCT00824408|587843247|FG004|Randomized Phase|Progressive disease|34|||
162762752|NCT00824408|587843243|FG000|Randomized Phase|Adverse Event|0|||
162762753|NCT00824408|587843244|FG001|Randomized Phase|Adverse Event|0|||
162762754|NCT00824408|587843245|FG002|Randomized Phase|Adverse Event|4|||
162762755|NCT00824408|587843246|FG003|Randomized Phase|Adverse Event|5|||
162762756|NCT00824408|587843247|FG004|Randomized Phase|Adverse Event|5|||
162762757|NCT00824408|587843243|FG000|Randomized Phase|Refused to continue medication|0|||
162762758|NCT00824408|587843244|FG001|Randomized Phase|Refused to continue medication|0|||
162762759|NCT00824408|587843245|FG002|Randomized Phase|Refused to continue medication|2|||
162762760|NCT00824408|587843246|FG003|Randomized Phase|Refused to continue medication|2|||
162762761|NCT00824408|587843247|FG004|Randomized Phase|Refused to continue medication|2|||
162762762|NCT00824408|587843243|FG000|Randomized Phase|Other reason not defined above|0|||
162762763|NCT00824408|587843244|FG001|Randomized Phase|Other reason not defined above|0|||
162762764|NCT00824408|587843245|FG002|Randomized Phase|Other reason not defined above|4|||
162762765|NCT00824408|587843246|FG003|Randomized Phase|Other reason not defined above|2|||
162762766|NCT00824408|587843247|FG004|Randomized Phase|Other reason not defined above|4|||
162762767|NCT01263496|587843253|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
162762768|NCT01263496|587843254|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762769|NCT01263496|587843255|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762770|NCT01263496|587843256|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762771|NCT01263496|587843257|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762772|NCT01263496|587843258|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762773|NCT01263496|587843259|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762774|NCT01263496|587843260|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762775|NCT01263496|587843261|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162762776|NCT01263496|587843253|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762777|NCT01263496|587843254|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762778|NCT01263496|587843255|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762779|NCT01263496|587843256|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
162762780|NCT01263496|587843257|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
162762781|NCT01263496|587843258|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762782|NCT01263496|587843259|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762783|NCT01263496|587843260|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762784|NCT01263496|587843261|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162762785|NCT01263496|587843253|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
162762786|NCT01263496|587843254|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
162762787|NCT01263496|587843255|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
162762788|NCT01263496|587843256|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
162762789|NCT01263496|587843257|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
162762790|NCT01263496|587843258|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
162762791|NCT01263496|587843259|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
162762792|NCT01263496|587843260|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
162762793|NCT01263496|587843261|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
162762794|NCT01263496|587843253|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762795|NCT01263496|587843254|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
162762796|NCT01263496|587843255|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762797|NCT01263496|587843256|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762798|NCT01263496|587843257|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762799|NCT01263496|587843258|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762800|NCT01263496|587843259|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762801|NCT01263496|587843260|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762802|NCT01263496|587843261|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162762803|NCT01263496|587843253|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162762804|NCT01263496|587843254|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162762805|NCT01263496|587843255|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162762806|NCT01263496|587843256|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162762807|NCT01263496|587843257|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
162762808|NCT01263496|587843258|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162762809|NCT01263496|587843259|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162762810|NCT01263496|587843260|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162762811|NCT01263496|587843261|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162762812|NCT01263496|587843253|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
162762813|NCT01263496|587843254|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162762814|NCT01263496|587843255|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162762815|NCT01263496|587843256|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162762816|NCT01263496|587843257|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
162762817|NCT01263496|587843258|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162762818|NCT01263496|587843259|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162762819|NCT01263496|587843260|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162762820|NCT01263496|587843261|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162762821|NCT01263496|587843253|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762822|NCT01263496|587843254|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762823|NCT01263496|587843255|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762824|NCT01263496|587843256|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762825|NCT01263496|587843257|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762826|NCT01263496|587843258|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762827|NCT01263496|587843259|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762828|NCT01263496|587843260|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162762829|NCT01263496|587843261|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162762830|NCT01218594|587843262|FG000|Overall Study|Death|1|||
162762831|NCT01218594|587843262|FG000|Overall Study|Withdrawal by Subject|3|||
162762832|NCT01218594|587843262|FG000|Overall Study|Adverse Event|2|||
162762833|NCT01218594|587843262|FG000|Overall Study|Physician Decision|6|||
162762834|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
162762835|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162762836|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162762837|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162762838|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
162762839|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162762840|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162762841|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162762842|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
162762843|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162762844|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162762845|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162762846|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
162762847|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162762848|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162762849|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162762850|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
162762851|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162762852|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162762853|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162762854|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
162762855|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162762856|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162762857|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162762858|NCT02203032|587843263|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
162762859|NCT02203032|587843264|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162762860|NCT02203032|587843265|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162762861|NCT02203032|587843266|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162762862|NCT02203032|587843263|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
162762863|NCT02203032|587843264|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
162762864|NCT02203032|587843265|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
162762865|NCT02203032|587843266|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
162762866|NCT02203032|587843263|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
162762867|NCT02203032|587843264|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
162762868|NCT02203032|587843265|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
162762869|NCT02203032|587843266|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
162762870|NCT02203032|587843263|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
162762871|NCT02203032|587843264|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
162762872|NCT02203032|587843265|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
162762873|NCT02203032|587843266|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
162762874|NCT02203032|587843263|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
162762875|NCT02203032|587843264|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
162762876|NCT02203032|587843265|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
162762877|NCT02203032|587843266|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
162762878|NCT02203032|587843263|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
162762879|NCT02203032|587843264|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
162762880|NCT02203032|587843265|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
162762881|NCT02203032|587843266|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
162762882|NCT02241785|587843269|FG000|Overall Study|Sponsor Termination|43|||
162762883|NCT02241785|587843269|FG000|Overall Study|Withdrawal by Subject|1|||
162762884|NCT02241785|587843269|FG000|Overall Study|Lost to Follow-up|2|||
162762885|NCT02241785|587843269|FG000|Overall Study|Adverse Event|1|||
162762886|NCT04852978|587843272|FG000|Overall Study|Physician Decision|0|||
162762887|NCT04852978|587843273|FG001|Overall Study|Physician Decision|1|||
162762888|NCT04852978|587843274|FG002|Overall Study|Physician Decision|0|||
162762889|NCT04852978|587843275|FG003|Overall Study|Physician Decision|0|||
162762890|NCT04852978|587843276|FG004|Overall Study|Physician Decision|0|||
162762891|NCT04852978|587843277|FG005|Overall Study|Physician Decision|0|||
162762892|NCT04852978|587843278|FG006|Overall Study|Physician Decision|0|||
162762893|NCT04852978|587843279|FG007|Overall Study|Physician Decision|2|||
162762894|NCT04852978|587843280|FG008|Overall Study|Physician Decision|0|||
162762895|NCT04852978|587843272|FG000|Overall Study|Sponsor request|0|||
162762896|NCT04852978|587843273|FG001|Overall Study|Sponsor request|0|||
162762897|NCT04852978|587843274|FG002|Overall Study|Sponsor request|1|||
162762898|NCT04852978|587843275|FG003|Overall Study|Sponsor request|0|||
162762899|NCT04852978|587843276|FG004|Overall Study|Sponsor request|0|||
162762900|NCT04852978|587843277|FG005|Overall Study|Sponsor request|0|||
162762901|NCT04852978|587843278|FG006|Overall Study|Sponsor request|0|||
162762902|NCT04852978|587843279|FG007|Overall Study|Sponsor request|0|||
162762903|NCT04852978|587843280|FG008|Overall Study|Sponsor request|0|||
162762904|NCT04852978|587843272|FG000|Overall Study|Death|0|||
162762905|NCT04852978|587843273|FG001|Overall Study|Death|0|||
162762906|NCT04852978|587843274|FG002|Overall Study|Death|0|||
162762907|NCT04852978|587843275|FG003|Overall Study|Death|0|||
162762908|NCT04852978|587843276|FG004|Overall Study|Death|0|||
162762909|NCT04852978|587843277|FG005|Overall Study|Death|0|||
162762910|NCT04852978|587843278|FG006|Overall Study|Death|1|||
162762911|NCT04852978|587843279|FG007|Overall Study|Death|0|||
162762912|NCT04852978|587843280|FG008|Overall Study|Death|0|||
162762913|NCT04852978|587843272|FG000|Overall Study|Lost to Follow-up|3|||
162762914|NCT04852978|587843273|FG001|Overall Study|Lost to Follow-up|2|||
162762915|NCT04852978|587843274|FG002|Overall Study|Lost to Follow-up|2|||
162762916|NCT04852978|587843275|FG003|Overall Study|Lost to Follow-up|0|||
162762917|NCT04852978|587843276|FG004|Overall Study|Lost to Follow-up|2|||
162762918|NCT04852978|587843277|FG005|Overall Study|Lost to Follow-up|4|||
162762919|NCT04852978|587843278|FG006|Overall Study|Lost to Follow-up|1|||
162762920|NCT04852978|587843279|FG007|Overall Study|Lost to Follow-up|2|||
162762921|NCT04852978|587843280|FG008|Overall Study|Lost to Follow-up|2|||
162762922|NCT04852978|587843272|FG000|Overall Study|Withdrawal by Subject|4|||
162762923|NCT04852978|587843273|FG001|Overall Study|Withdrawal by Subject|2|||
162762924|NCT04852978|587843274|FG002|Overall Study|Withdrawal by Subject|2|||
162762925|NCT04852978|587843275|FG003|Overall Study|Withdrawal by Subject|1|||
162762926|NCT04852978|587843276|FG004|Overall Study|Withdrawal by Subject|5|||
162762927|NCT04852978|587843277|FG005|Overall Study|Withdrawal by Subject|3|||
162762928|NCT04852978|587843278|FG006|Overall Study|Withdrawal by Subject|2|||
162762929|NCT04852978|587843279|FG007|Overall Study|Withdrawal by Subject|2|||
162762930|NCT04852978|587843280|FG008|Overall Study|Withdrawal by Subject|1|||
162762931|NCT00535626|587845130|FG000|Overall Study|Death|15|||
162762932|NCT00535626|587845130|FG000|Overall Study|Lost to Follow-up|29|||
162762933|NCT00535626|587845130|FG000|Overall Study|Withdrawal by Subject|20|||
162762934|NCT00535626|587845130|FG000|Overall Study|Removal/revision of study component|8|||
162762935|NCT00535626|587845130|FG000|Overall Study|Subject terminated|31|||
162762936|NCT00535626|587845130|FG000|Overall Study|Unable to return|2|||
162762937|NCT04633200|587845131|FG000|Overall Study|Lost to Follow-up|3|||
162762938|NCT04633200|587845132|FG001|Overall Study|Lost to Follow-up|5|||
162762939|NCT04809623|587845133|FG000|Overall Study|Study Terminated by Sponsor|1|||
162762940|NCT04809623|587845134|FG001|Overall Study|Study Terminated by Sponsor|0|||
162762941|NCT00671853|587845135|FG000|Overall Study|Lack of Efficacy|3|||
162762942|NCT00671853|587845136|FG001|Overall Study|Lack of Efficacy|7|||
162762943|NCT00671853|587845135|FG000|Overall Study|Adverse Event|7|||
162762944|NCT00671853|587845136|FG001|Overall Study|Adverse Event|1|||
162762945|NCT00671853|587845135|FG000|Overall Study|Withdrawal by Subject|1|||
162762946|NCT00671853|587845136|FG001|Overall Study|Withdrawal by Subject|5|||
162762947|NCT00671853|587845135|FG000|Overall Study|Lost to Follow-up|8|||
162762948|NCT00671853|587845136|FG001|Overall Study|Lost to Follow-up|8|||
162762949|NCT00671853|587845135|FG000|Overall Study|Physician Decision|0|||
162762950|NCT00671853|587845136|FG001|Overall Study|Physician Decision|2|||
162762951|NCT00671853|587845135|FG000|Overall Study|Non-adherence with study procedures|1|||
162762952|NCT00671853|587845136|FG001|Overall Study|Non-adherence with study procedures|4|||
162762953|NCT02354417|587845137|FG000|Overall Study|Physician Decision|1|||
162762954|NCT01848483|587845138|FG000|Overall Study|Death|2|||
162762955|NCT01848483|587845139|FG001|Overall Study|Death|1|||
162762956|NCT01848483|587845138|FG000|Overall Study|Lost to Follow-up|6|||
162762957|NCT01848483|587845139|FG001|Overall Study|Lost to Follow-up|8|||
162762958|NCT01848483|587845138|FG000|Overall Study|Withdrawal by Subject|1|||
162762959|NCT01848483|587845139|FG001|Overall Study|Withdrawal by Subject|0|||
162762960|NCT01848483|587845138|FG000|Overall Study|Incarceration|2|||
162762961|NCT01848483|587845139|FG001|Overall Study|Incarceration|2|||
162762962|NCT02236611|587845142|FG000|Overall Study|Adverse Event|10|||
162762963|NCT02236611|587845143|FG001|Overall Study|Adverse Event|16|||
162762964|NCT02236611|587845142|FG000|Overall Study|Lack of Efficacy|4|||
162762965|NCT02236611|587845143|FG001|Overall Study|Lack of Efficacy|7|||
162762966|NCT02236611|587845142|FG000|Overall Study|Lost to Follow-up|0|||
162762967|NCT02236611|587845143|FG001|Overall Study|Lost to Follow-up|2|||
162762968|NCT02236611|587845142|FG000|Overall Study|Protocol deviation|3|||
162762969|NCT02236611|587845143|FG001|Overall Study|Protocol deviation|5|||
162762970|NCT02236611|587845142|FG000|Overall Study|Withdrew consent|9|||
162762971|NCT02236611|587845143|FG001|Overall Study|Withdrew consent|4|||
162762972|NCT03041090|587845144|FG000|Overall Study|technical error|0|||
162762973|NCT03041090|587845145|FG001|Overall Study|technical error|3|||
162762974|NCT02202317|587845146|FG000|Overall Study|Lost to Follow-up|1|||
162762975|NCT02338999|587845147|FG000|First Intervention|Withdrawal by Subject|3|||
162762976|NCT02338999|587845148|FG001|First Intervention|Withdrawal by Subject|1|||
162762977|NCT02338999|587845147|FG000|Washout Period|Withdrawal by Subject|0|||
162762978|NCT02338999|587845148|FG001|Washout Period|Withdrawal by Subject|2|||
162762979|NCT02338999|587845147|FG000|Second Intervention|Withdrawal by Subject|0|||
162762980|NCT02338999|587845148|FG001|Second Intervention|Withdrawal by Subject|2|||
162762981|NCT02701296|587845149|FG000|Overall Study|Incomplete Data|0|||
162762982|NCT02701296|587845150|FG001|Overall Study|Incomplete Data|2|||
162762983|NCT01332266|587845151|FG000|Phase 1b|Death|3|||
162762984|NCT01332266|587845152|FG001|Phase 1b|Death|3|||
162762985|NCT01332266|587845153|FG002|Phase 1b|Death|2|||
162762986|NCT01332266|587845154|FG003|Phase 1b|Death|0|||
162762987|NCT01332266|587845155|FG004|Phase 1b|Death|0|||
162762988|NCT01332266|587845151|FG000|Phase 1b|Lost to Follow-up|0|||
162762989|NCT01332266|587845152|FG001|Phase 1b|Lost to Follow-up|1|||
162762990|NCT01332266|587845153|FG002|Phase 1b|Lost to Follow-up|0|||
162762991|NCT01332266|587845154|FG003|Phase 1b|Lost to Follow-up|0|||
162762992|NCT01332266|587845155|FG004|Phase 1b|Lost to Follow-up|0|||
162762993|NCT01332266|587845151|FG000|Phase 1b|Withdrawal by Subject|1|||
162762994|NCT01332266|587845152|FG001|Phase 1b|Withdrawal by Subject|1|||
162762995|NCT01332266|587845153|FG002|Phase 1b|Withdrawal by Subject|1|||
162762996|NCT01332266|587845154|FG003|Phase 1b|Withdrawal by Subject|0|||
162762997|NCT01332266|587845155|FG004|Phase 1b|Withdrawal by Subject|0|||
162762998|NCT01332266|587845151|FG000|Phase 2|Death|0|||
162762999|NCT01332266|587845152|FG001|Phase 2|Death|0|||
162763000|NCT01332266|587845153|FG002|Phase 2|Death|0|||
162763001|NCT01332266|587845154|FG003|Phase 2|Death|33|||
162763002|NCT01332266|587845155|FG004|Phase 2|Death|36|||
162763003|NCT01332266|587845151|FG000|Phase 2|Lost to Follow-up|0|||
162763004|NCT01332266|587845152|FG001|Phase 2|Lost to Follow-up|0|||
162763005|NCT01332266|587845153|FG002|Phase 2|Lost to Follow-up|0|||
162763006|NCT01332266|587845154|FG003|Phase 2|Lost to Follow-up|2|||
162763007|NCT01332266|587845155|FG004|Phase 2|Lost to Follow-up|0|||
162763008|NCT01332266|587845151|FG000|Phase 2|Physician Decision|0|||
162763009|NCT01332266|587845152|FG001|Phase 2|Physician Decision|0|||
162763010|NCT01332266|587845153|FG002|Phase 2|Physician Decision|0|||
162763011|NCT01332266|587845154|FG003|Phase 2|Physician Decision|3|||
162763012|NCT01332266|587845155|FG004|Phase 2|Physician Decision|1|||
162763013|NCT01332266|587845151|FG000|Phase 2|Symptomatic deterioration|0|||
162763014|NCT01332266|587845152|FG001|Phase 2|Symptomatic deterioration|0|||
162763015|NCT01332266|587845153|FG002|Phase 2|Symptomatic deterioration|0|||
162763016|NCT01332266|587845154|FG003|Phase 2|Symptomatic deterioration|0|||
162763017|NCT01332266|587845155|FG004|Phase 2|Symptomatic deterioration|1|||
162763018|NCT01332266|587845151|FG000|Phase 2|Progression Disease|0|||
162763019|NCT01332266|587845152|FG001|Phase 2|Progression Disease|0|||
162763020|NCT01332266|587845153|FG002|Phase 2|Progression Disease|0|||
162763021|NCT01332266|587845154|FG003|Phase 2|Progression Disease|2|||
162763022|NCT01332266|587845155|FG004|Phase 2|Progression Disease|1|||
162763023|NCT01332266|587845151|FG000|Phase 2|Withdrawal by Subject|0|||
162763024|NCT01332266|587845152|FG001|Phase 2|Withdrawal by Subject|0|||
162763025|NCT01332266|587845153|FG002|Phase 2|Withdrawal by Subject|0|||
162763026|NCT01332266|587845154|FG003|Phase 2|Withdrawal by Subject|2|||
162763027|NCT01332266|587845155|FG004|Phase 2|Withdrawal by Subject|2|||
162763028|NCT01686152|587845158|FG000|Overall Study|Withdrawal by Subject|11|||
162763029|NCT01686152|587845159|FG001|Overall Study|Withdrawal by Subject|11|||
162763030|NCT01686152|587845160|FG002|Overall Study|Withdrawal by Subject|3|||
162763031|NCT01686152|587845158|FG000|Overall Study|Drug Code Unblinded|0|||
162763032|NCT01686152|587845159|FG001|Overall Study|Drug Code Unblinded|1|||
162763033|NCT01686152|587845160|FG002|Overall Study|Drug Code Unblinded|0|||
162763034|NCT01686152|587845158|FG000|Overall Study|Protocol Violation|6|||
162763035|NCT01686152|587845159|FG001|Overall Study|Protocol Violation|1|||
162763036|NCT01686152|587845160|FG002|Overall Study|Protocol Violation|0|||
162763037|NCT01686152|587845158|FG000|Overall Study|Adverse Event|12|||
162763038|NCT01686152|587845159|FG001|Overall Study|Adverse Event|11|||
162763039|NCT01686152|587845160|FG002|Overall Study|Adverse Event|0|||
162763040|NCT01686152|587845158|FG000|Overall Study|Lack of Efficacy|0|||
162763041|NCT01686152|587845159|FG001|Overall Study|Lack of Efficacy|0|||
162763042|NCT01686152|587845160|FG002|Overall Study|Lack of Efficacy|1|||
162763043|NCT01686152|587845158|FG000|Overall Study|IP Non-compliance|5|||
162763044|NCT01686152|587845159|FG001|Overall Study|IP Non-compliance|5|||
162763045|NCT01686152|587845160|FG002|Overall Study|IP Non-compliance|0|||
162763046|NCT01686152|587845158|FG000|Overall Study|Lost to Follow-up|7|||
162763047|NCT01686152|587845159|FG001|Overall Study|Lost to Follow-up|6|||
162763048|NCT01686152|587845160|FG002|Overall Study|Lost to Follow-up|5|||
162763049|NCT01802333|587845161|FG000|Overall Study|Ineligible|2|||
162763050|NCT01802333|587845162|FG001|Overall Study|Ineligible|6|||
162763051|NCT01802333|587845163|FG002|Overall Study|Ineligible|8|||
162763052|NCT01802333|587845161|FG000|Overall Study|Adverse Event|1|||
162763053|NCT01802333|587845162|FG001|Overall Study|Adverse Event|8|||
162763054|NCT01802333|587845163|FG002|Overall Study|Adverse Event|8|||
162763055|NCT01802333|587845161|FG000|Overall Study|Withdrawal by Subject|6|||
162763056|NCT01802333|587845162|FG001|Overall Study|Withdrawal by Subject|6|||
162763057|NCT01802333|587845163|FG002|Overall Study|Withdrawal by Subject|5|||
162763058|NCT01802333|587845161|FG000|Overall Study|Progression/relapse|1|||
162763059|NCT01802333|587845162|FG001|Overall Study|Progression/relapse|3|||
162763060|NCT01802333|587845163|FG002|Overall Study|Progression/relapse|0|||
162763061|NCT01802333|587845161|FG000|Overall Study|Death|7|||
162763062|NCT01802333|587845162|FG001|Overall Study|Death|14|||
162763063|NCT01802333|587845163|FG002|Overall Study|Death|13|||
162763064|NCT01802333|587845161|FG000|Overall Study|Other - not protocol specified|32|||
162763065|NCT01802333|587845162|FG001|Overall Study|Other - not protocol specified|22|||
162763066|NCT01802333|587845163|FG002|Overall Study|Other - not protocol specified|24|||
162763067|NCT01802333|587845161|FG000|Overall Study|Did not start treatment|0|||
162763068|NCT01802333|587845162|FG001|Overall Study|Did not start treatment|2|||
162763069|NCT01802333|587845163|FG002|Overall Study|Did not start treatment|5|||
162763070|NCT01947491|587845166|FG000|Overall Study|Lost to Follow-up|5|||
162763071|NCT01947491|587845167|FG001|Overall Study|Lost to Follow-up|3|||
162763072|NCT01947491|587845168|FG002|Overall Study|Lost to Follow-up|1|||
162763073|NCT01947491|587845169|FG003|Overall Study|Lost to Follow-up|2|||
162763074|NCT01947491|587845166|FG000|Overall Study|Lack of Efficacy|1|||
162763075|NCT01947491|587845167|FG001|Overall Study|Lack of Efficacy|0|||
162763076|NCT01947491|587845168|FG002|Overall Study|Lack of Efficacy|0|||
162763077|NCT01947491|587845169|FG003|Overall Study|Lack of Efficacy|1|||
162763078|NCT01947491|587845166|FG000|Overall Study|Protocol Violation|1|||
162763079|NCT01947491|587845167|FG001|Overall Study|Protocol Violation|0|||
162763080|NCT01947491|587845168|FG002|Overall Study|Protocol Violation|0|||
162763081|NCT01947491|587845169|FG003|Overall Study|Protocol Violation|0|||
162763082|NCT01947491|587845166|FG000|Overall Study|Withdrawal by Subject|1|||
162763083|NCT01947491|587845167|FG001|Overall Study|Withdrawal by Subject|1|||
162763084|NCT01947491|587845168|FG002|Overall Study|Withdrawal by Subject|1|||
162763085|NCT01947491|587845169|FG003|Overall Study|Withdrawal by Subject|0|||
162763086|NCT01947491|587845166|FG000|Overall Study|Worsening of condition|0|||
162763087|NCT01947491|587845167|FG001|Overall Study|Worsening of condition|1|||
162763088|NCT01947491|587845168|FG002|Overall Study|Worsening of condition|0|||
162763089|NCT01947491|587845169|FG003|Overall Study|Worsening of condition|0|||
162763090|NCT01947491|587845166|FG000|Overall Study|Adverse Event|0|||
162763091|NCT01947491|587845167|FG001|Overall Study|Adverse Event|1|||
162763092|NCT01947491|587845168|FG002|Overall Study|Adverse Event|0|||
162763093|NCT01947491|587845169|FG003|Overall Study|Adverse Event|2|||
162763094|NCT02224755|587845171|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
162763095|NCT02224755|587845172|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
162763096|NCT02224755|587845171|FG000|Two Year Follow up Post-implant|Death|103|||
162763097|NCT02224755|587845172|FG001|Two Year Follow up Post-implant|Death|98|||
162763098|NCT02224755|587845171|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
162763099|NCT02224755|587845172|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
162763100|NCT02224755|587845171|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
162763101|NCT02224755|587845172|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
162763102|NCT02224755|587845171|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
162763103|NCT02224755|587845172|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
162763104|NCT02067663|587845173|FG000|Overall Study|Lost to Follow-up|13|||
162763105|NCT02067663|587845174|FG001|Overall Study|Lost to Follow-up|14|||
162763106|NCT01205126|587845175|FG000|Titration Phase|Adverse Event|5|||
162763107|NCT01205126|587845176|FG001|Titration Phase|Adverse Event|3|||
162763108|NCT01205126|587845175|FG000|Titration Phase|Withdrawal by Subject|5|||
162763109|NCT01205126|587845176|FG001|Titration Phase|Withdrawal by Subject|5|||
162763110|NCT01205126|587845175|FG000|Titration Phase|Lost to Follow-up|2|||
162763111|NCT01205126|587845176|FG001|Titration Phase|Lost to Follow-up|2|||
162763112|NCT01205126|587845175|FG000|Titration Phase|No stable titration dose|1|||
162763113|NCT01205126|587845176|FG001|Titration Phase|No stable titration dose|0|||
162763114|NCT01205126|587845175|FG000|Titration Phase|More than maximum dosage required|2|||
162763115|NCT01205126|587845176|FG001|Titration Phase|More than maximum dosage required|3|||
162763116|NCT01205126|587845175|FG000|Titration Phase|Other|8|||
162763117|NCT01205126|587845176|FG001|Titration Phase|Other|6|||
162763118|NCT01205126|587845175|FG000|Between Titration & Maintenance Phase|Other|0|||
162763119|NCT01205126|587845176|FG001|Between Titration & Maintenance Phase|Other|4|||
162763120|NCT01205126|587845175|FG000|Maintenance Phase|Adverse Event|3|||
162763121|NCT01205126|587845176|FG001|Maintenance Phase|Adverse Event|7|||
162763122|NCT01205126|587845175|FG000|Maintenance Phase|Death|4|||
162763123|NCT01205126|587845176|FG001|Maintenance Phase|Death|4|||
162763124|NCT01205126|587845175|FG000|Maintenance Phase|More than the maximum dosage required|5|||
162763125|NCT01205126|587845176|FG001|Maintenance Phase|More than the maximum dosage required|5|||
162763126|NCT01205126|587845175|FG000|Maintenance Phase|Prohibited drugs used|1|||
162763127|NCT01205126|587845176|FG001|Maintenance Phase|Prohibited drugs used|0|||
162763128|NCT01205126|587845175|FG000|Maintenance Phase|Other|11|||
162763129|NCT01205126|587845176|FG001|Maintenance Phase|Other|8|||
162763130|NCT01205126|587845175|FG000|Maintenance Phase|Lost to Follow-up|5|||
162763131|NCT01205126|587845176|FG001|Maintenance Phase|Lost to Follow-up|5|||
162763132|NCT01205126|587845175|FG000|Maintenance Phase|Withdrawal by Subject|8|||
162763133|NCT01205126|587845176|FG001|Maintenance Phase|Withdrawal by Subject|11|||
162763134|NCT03236779|587845179|FG000|Overall Study|Lost to Follow-up|13|||
162763135|NCT03236779|587845180|FG001|Overall Study|Lost to Follow-up|21|||
162763136|NCT00929526|587845182|FG000|Overall Study|Withdrawal by Subject|1|||
162763137|NCT00929526|587845183|FG001|Overall Study|Withdrawal by Subject|11|||
162763138|NCT00929526|587845182|FG000|Overall Study|Lost to Follow-up|8|||
162763139|NCT00929526|587845183|FG001|Overall Study|Lost to Follow-up|12|||
162763140|NCT00929526|587845182|FG000|Overall Study|Other|8|||
162763141|NCT00929526|587845183|FG001|Overall Study|Other|6|||
162763142|NCT00578344|587845184|FG000|Overall Study|Insurance problems|1|||
162763143|NCT00578344|587845184|FG000|Overall Study|Graft failure|1|||
162763144|NCT02169414|587845185|FG000|Overall Study|Withdrawal by Subject|1|||
162763145|NCT02169414|587845186|FG001|Overall Study|Withdrawal by Subject|0|||
162763146|NCT02169414|587845187|FG002|Overall Study|Withdrawal by Subject|0|||
162763147|NCT02169414|587845188|FG003|Overall Study|Withdrawal by Subject|0|||
162763148|NCT02169414|587845185|FG000|Overall Study|Adverse Event|0|||
162763149|NCT02169414|587845186|FG001|Overall Study|Adverse Event|1|||
162763150|NCT02169414|587845187|FG002|Overall Study|Adverse Event|0|||
162763151|NCT02169414|587845188|FG003|Overall Study|Adverse Event|0|||
162763152|NCT02309515|587845192|FG000|Overall Study|Withdrawal by Subject|0|||
162763153|NCT02309515|587845193|FG001|Overall Study|Withdrawal by Subject|1|||
162763154|NCT02547974|587845196|FG000|Overall Study|Withdrawal by Subject|1|||
162763155|NCT02547974|587845197|FG001|Overall Study|Withdrawal by Subject|0|||
162763156|NCT02547974|587845198|FG002|Overall Study|Withdrawal by Subject|0|||
162763157|NCT02547974|587845199|FG003|Overall Study|Withdrawal by Subject|0|||
162763158|NCT00923078|587845203|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
162763159|NCT00923078|587845204|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
162763160|NCT00923078|587845205|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
162763161|NCT00923078|587845203|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
162763162|NCT00923078|587845204|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
162763163|NCT00923078|587845205|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
162763164|NCT01072149|587845209|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763165|NCT01072149|587845210|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763166|NCT01072149|587845211|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162763167|NCT01072149|587845212|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763168|NCT01072149|587845213|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763169|NCT01072149|587845214|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763170|NCT01072149|587845215|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763171|NCT01072149|587845216|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763172|NCT01072149|587845217|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763173|NCT01072149|587845218|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763174|NCT01072149|587845219|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763175|NCT01072149|587845220|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763176|NCT01072149|587845221|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763177|NCT01072149|587845222|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763178|NCT01072149|587845223|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763179|NCT01072149|587845224|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763180|NCT01072149|587845225|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763181|NCT01072149|587845226|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162763182|NCT01072149|587845209|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763183|NCT01072149|587845210|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763184|NCT01072149|587845211|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763185|NCT01072149|587845212|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763186|NCT01072149|587845213|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763187|NCT01072149|587845214|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763188|NCT01072149|587845215|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763189|NCT01072149|587845216|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763190|NCT01072149|587845217|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763191|NCT01072149|587845218|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763192|NCT01072149|587845219|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763193|NCT01072149|587845220|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763194|NCT01072149|587845221|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763195|NCT01072149|587845222|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763196|NCT01072149|587845223|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763197|NCT01072149|587845224|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763198|NCT01072149|587845225|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162763199|NCT01072149|587845226|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
162763200|NCT01072149|587845209|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763201|NCT01072149|587845210|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763202|NCT01072149|587845211|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763203|NCT01072149|587845212|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763204|NCT01072149|587845213|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763205|NCT01072149|587845214|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763206|NCT01072149|587845215|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763207|NCT01072149|587845216|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763208|NCT01072149|587845217|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763209|NCT01072149|587845218|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763210|NCT01072149|587845219|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
162763211|NCT01072149|587845220|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763212|NCT01072149|587845221|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763213|NCT01072149|587845222|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763214|NCT01072149|587845223|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763215|NCT01072149|587845224|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763216|NCT01072149|587845225|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763217|NCT01072149|587845226|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162763218|NCT01072149|587845209|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763219|NCT01072149|587845210|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
162763220|NCT01072149|587845211|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763221|NCT01072149|587845212|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763222|NCT01072149|587845213|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763223|NCT01072149|587845214|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763224|NCT01072149|587845215|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763225|NCT01072149|587845216|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763226|NCT01072149|587845217|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763227|NCT01072149|587845218|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763228|NCT01072149|587845219|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763229|NCT01072149|587845220|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763230|NCT01072149|587845221|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763231|NCT01072149|587845222|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763232|NCT01072149|587845223|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763233|NCT01072149|587845224|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763234|NCT01072149|587845225|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763235|NCT01072149|587845226|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162763236|NCT01072149|587845209|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763237|NCT01072149|587845210|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763238|NCT01072149|587845211|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162763239|NCT01072149|587845212|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763240|NCT01072149|587845213|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763241|NCT01072149|587845214|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763242|NCT01072149|587845215|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763243|NCT01072149|587845216|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763244|NCT01072149|587845217|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763245|NCT01072149|587845218|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763246|NCT01072149|587845219|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763247|NCT01072149|587845220|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763248|NCT01072149|587845221|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763249|NCT01072149|587845222|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763250|NCT01072149|587845223|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763251|NCT01072149|587845224|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763252|NCT01072149|587845225|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763253|NCT01072149|587845226|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162763254|NCT01072149|587845209|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763255|NCT01072149|587845210|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763256|NCT01072149|587845211|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763257|NCT01072149|587845212|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763258|NCT01072149|587845213|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763259|NCT01072149|587845214|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763260|NCT01072149|587845215|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763261|NCT01072149|587845216|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
162763262|NCT01072149|587845217|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763263|NCT01072149|587845218|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763264|NCT01072149|587845219|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763265|NCT01072149|587845220|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763266|NCT01072149|587845221|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763267|NCT01072149|587845222|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763268|NCT01072149|587845223|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763269|NCT01072149|587845224|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763270|NCT01072149|587845225|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763271|NCT01072149|587845226|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
162763272|NCT01072149|587845209|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
162763273|NCT01072149|587845210|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
162763274|NCT01072149|587845211|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
162763275|NCT01072149|587845212|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
162763276|NCT01072149|587845213|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
162763277|NCT01072149|587845214|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
162763278|NCT01072149|587845215|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
162763279|NCT01072149|587845216|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
162763280|NCT01072149|587845217|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
162763281|NCT01072149|587845218|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
162763282|NCT01072149|587845219|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
162763283|NCT01072149|587845220|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
162763284|NCT01072149|587845221|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
162763285|NCT01072149|587845222|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
162763286|NCT01072149|587845223|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
162763287|NCT01072149|587845224|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
162763288|NCT01072149|587845225|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
162763289|NCT01072149|587845226|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
162763290|NCT01072149|587845209|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763291|NCT01072149|587845210|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763292|NCT01072149|587845211|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763293|NCT01072149|587845212|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763294|NCT01072149|587845213|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763295|NCT01072149|587845214|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763296|NCT01072149|587845215|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763297|NCT01072149|587845216|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763298|NCT01072149|587845217|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763299|NCT01072149|587845218|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763300|NCT01072149|587845219|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763301|NCT01072149|587845220|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763302|NCT01072149|587845221|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763303|NCT01072149|587845222|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763304|NCT01072149|587845223|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763305|NCT01072149|587845224|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
162763306|NCT01072149|587845225|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763307|NCT01072149|587845226|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162763308|NCT01072149|587845209|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
162763309|NCT01072149|587845210|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
162763310|NCT01072149|587845211|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
162763311|NCT01072149|587845212|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
162763312|NCT01072149|587845213|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
162763313|NCT01072149|587845214|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
162763314|NCT01072149|587845215|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
162763315|NCT01072149|587845216|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
162763316|NCT01072149|587845217|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
162763317|NCT01072149|587845218|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
162763318|NCT01072149|587845219|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
162763319|NCT01072149|587845220|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
162763320|NCT01072149|587845221|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
162763321|NCT01072149|587845222|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
162763322|NCT01072149|587845223|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
162763323|NCT01072149|587845224|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
162763324|NCT01072149|587845225|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
162763325|NCT01072149|587845226|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
162763326|NCT01072149|587845209|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763327|NCT01072149|587845210|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763328|NCT01072149|587845211|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763329|NCT01072149|587845212|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763330|NCT01072149|587845213|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763331|NCT01072149|587845214|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763332|NCT01072149|587845215|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763333|NCT01072149|587845216|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763334|NCT01072149|587845217|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763335|NCT01072149|587845218|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763336|NCT01072149|587845219|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763337|NCT01072149|587845220|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763338|NCT01072149|587845221|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
162763339|NCT01072149|587845222|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763340|NCT01072149|587845223|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763341|NCT01072149|587845224|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763342|NCT01072149|587845225|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763343|NCT01072149|587845226|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162763344|NCT01072149|587845209|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763345|NCT01072149|587845210|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763346|NCT01072149|587845211|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
162763347|NCT01072149|587845212|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763348|NCT01072149|587845213|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763349|NCT01072149|587845214|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763350|NCT01072149|587845215|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763351|NCT01072149|587845216|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763352|NCT01072149|587845217|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763353|NCT01072149|587845218|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763354|NCT01072149|587845219|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763355|NCT01072149|587845220|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763356|NCT01072149|587845221|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763357|NCT01072149|587845222|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
162763358|NCT01072149|587845223|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763359|NCT01072149|587845224|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763360|NCT01072149|587845225|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763361|NCT01072149|587845226|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162763362|NCT04766996|587845229|FG000|Overall Study|Withdrawal by Subject|1|||
162763363|NCT04766996|587845230|FG001|Overall Study|Withdrawal by Subject|0|||
162763364|NCT04766996|587845231|FG002|Overall Study|Withdrawal by Subject|13|||
162763365|NCT01322386|587845232|FG000|Overall Study|Protocol Violation|0|||
162763366|NCT01322386|587845233|FG001|Overall Study|Protocol Violation|1|||
162763367|NCT01322386|587845232|FG000|Overall Study|Physician Decision|0|||
162763368|NCT01322386|587845233|FG001|Overall Study|Physician Decision|1|||
162763369|NCT01102426|587845234|FG000|Overall Study|Randomized but not treated|4|||
162763370|NCT01102426|587845235|FG001|Overall Study|Randomized but not treated|1|||
162763371|NCT01102426|587845234|FG000|Overall Study|Adverse Events (treatment-related)|15|||
162763372|NCT01102426|587845235|FG001|Overall Study|Adverse Events (treatment-related)|8|||
162763373|NCT01102426|587845234|FG000|Overall Study|Physician Decision|9|||
162763374|NCT01102426|587845235|FG001|Overall Study|Physician Decision|6|||
162763375|NCT01102426|587845234|FG000|Overall Study|Progressive Disease|85|||
162763376|NCT01102426|587845235|FG001|Overall Study|Progressive Disease|44|||
162763377|NCT01102426|587845234|FG000|Overall Study|Adverse Events (unrelated to|9|||
162763378|NCT01102426|587845235|FG001|Overall Study|Adverse Events (unrelated to|1|||
162763379|NCT01102426|587845234|FG000|Overall Study|Patient Refusal|24|||
162763380|NCT01102426|587845235|FG001|Overall Study|Patient Refusal|12|||
162763381|NCT01102426|587845234|FG000|Overall Study|Death (due to adverse events|0|||
162763382|NCT01102426|587845235|FG001|Overall Study|Death (due to adverse events|1|||
162763383|NCT01102426|587845234|FG000|Overall Study|Death (non-related to the study|19|||
162763384|NCT01102426|587845235|FG001|Overall Study|Death (non-related to the study|8|||
162763385|NCT00871494|587845236|FG000|Overall Study|Protocol Violation|5|||
162763386|NCT00871494|587845236|FG000|Overall Study|Lack of Efficacy|4|||
162763387|NCT00871494|587845236|FG000|Overall Study|Adverse Event|4|||
162763388|NCT00871494|587845236|FG000|Overall Study|Lost to Follow-up|1|||
162763389|NCT02988713|587845242|FG000|Overall Study|Withdrawal by Subject|1|||
162763390|NCT02988713|587845242|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
162763391|NCT00088166|587845243|FG000|Overall Study|Adverse Event|11|||
162763392|NCT00088166|587845244|FG001|Overall Study|Adverse Event|9|||
162763393|NCT00088166|587845243|FG000|Overall Study|Death|3|||
162763394|NCT00088166|587845244|FG001|Overall Study|Death|1|||
162763395|NCT00088166|587845243|FG000|Overall Study|Lost to Follow-up|0|||
162763396|NCT00088166|587845244|FG001|Overall Study|Lost to Follow-up|1|||
162763397|NCT00088166|587845243|FG000|Overall Study|Physician Decision|4|||
162763398|NCT00088166|587845244|FG001|Overall Study|Physician Decision|1|||
162763399|NCT00088166|587845243|FG000|Overall Study|Protocol Violation|1|||
162763400|NCT00088166|587845244|FG001|Overall Study|Protocol Violation|5|||
162763401|NCT00088166|587845243|FG000|Overall Study|Patient deterioration|29|||
162763402|NCT00088166|587845244|FG001|Overall Study|Patient deterioration|39|||
162763403|NCT00088166|587845243|FG000|Overall Study|Withdrawal by Subject|5|||
162763404|NCT00088166|587845244|FG001|Overall Study|Withdrawal by Subject|5|||
162763405|NCT00666705|587845245|FG000|Overall Study|Withdrawal by Subject|1|||
162763406|NCT01976507|587845246|FG000|Overall Study|Adverse Event|6|||
162763407|NCT01976507|587845246|FG000|Overall Study|ablation not done, drug not given|1|||
162763408|NCT01029704|587845248|FG000|Overall Study|Adverse Event|0|||
162763409|NCT01029704|587845249|FG001|Overall Study|Adverse Event|0|||
162763410|NCT01029704|587845250|FG002|Overall Study|Adverse Event|0|||
162763411|NCT01029704|587845251|FG003|Overall Study|Adverse Event|0|||
162763412|NCT01029704|587845252|FG004|Overall Study|Adverse Event|0|||
162763413|NCT01029704|587845253|FG005|Overall Study|Adverse Event|0|||
162763414|NCT01029704|587845254|FG006|Overall Study|Adverse Event|1|||
162763415|NCT01029704|587845255|FG007|Overall Study|Adverse Event|1|||
162763416|NCT01029704|587845256|FG008|Overall Study|Adverse Event|0|||
162763417|NCT01029704|587845248|FG000|Overall Study|Withdrawal by Subject|0|||
162763418|NCT01029704|587845249|FG001|Overall Study|Withdrawal by Subject|0|||
162763419|NCT01029704|587845250|FG002|Overall Study|Withdrawal by Subject|0|||
162763420|NCT01029704|587845251|FG003|Overall Study|Withdrawal by Subject|0|||
162763421|NCT01029704|587845252|FG004|Overall Study|Withdrawal by Subject|2|||
162763422|NCT01029704|587845253|FG005|Overall Study|Withdrawal by Subject|1|||
162763423|NCT01029704|587845254|FG006|Overall Study|Withdrawal by Subject|1|||
162763424|NCT01029704|587845255|FG007|Overall Study|Withdrawal by Subject|1|||
162763425|NCT01029704|587845256|FG008|Overall Study|Withdrawal by Subject|0|||
162763426|NCT01029704|587845248|FG000|Overall Study|Lost to Follow-up|0|||
162763427|NCT01029704|587845249|FG001|Overall Study|Lost to Follow-up|0|||
162763428|NCT01029704|587845250|FG002|Overall Study|Lost to Follow-up|0|||
162763429|NCT01029704|587845251|FG003|Overall Study|Lost to Follow-up|0|||
162763430|NCT01029704|587845252|FG004|Overall Study|Lost to Follow-up|0|||
162763431|NCT01029704|587845253|FG005|Overall Study|Lost to Follow-up|0|||
162763432|NCT01029704|587845254|FG006|Overall Study|Lost to Follow-up|1|||
162763433|NCT01029704|587845255|FG007|Overall Study|Lost to Follow-up|1|||
162763434|NCT01029704|587845256|FG008|Overall Study|Lost to Follow-up|1|||
162763435|NCT01029704|587845248|FG000|Overall Study|Lack of Efficacy|0|||
162763436|NCT01029704|587845249|FG001|Overall Study|Lack of Efficacy|0|||
162763437|NCT01029704|587845250|FG002|Overall Study|Lack of Efficacy|0|||
162763438|NCT01029704|587845251|FG003|Overall Study|Lack of Efficacy|0|||
162763439|NCT01029704|587845252|FG004|Overall Study|Lack of Efficacy|2|||
162763440|NCT01029704|587845253|FG005|Overall Study|Lack of Efficacy|3|||
162763441|NCT01029704|587845254|FG006|Overall Study|Lack of Efficacy|1|||
162763442|NCT01029704|587845255|FG007|Overall Study|Lack of Efficacy|2|||
162763443|NCT01029704|587845256|FG008|Overall Study|Lack of Efficacy|0|||
162763444|NCT01029704|587845248|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
162763445|NCT01029704|587845249|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
162763446|NCT01029704|587845250|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
162763447|NCT01029704|587845251|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
162763448|NCT01029704|587845252|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
162763449|NCT01029704|587845253|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
162763450|NCT01029704|587845254|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
162763451|NCT01029704|587845255|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
162763452|NCT01029704|587845256|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
162763453|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
162763454|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
162763455|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
162763456|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
162763457|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Death|0|||
162763458|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Death|0|||
162763459|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Death|1|||
162763460|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Death|0|||
162763461|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
162763462|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
162763463|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
162763464|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
162763465|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162763466|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162763467|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162763468|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162763469|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
162763470|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162763471|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162763472|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162763473|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
162763474|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
162763475|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
162763476|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
162763477|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
162763478|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162763479|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162763480|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162763481|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Other|2|||
162763482|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Other|0|||
162763483|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Other|0|||
162763484|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Other|0|||
162763485|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
162763486|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
162763487|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
162763488|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
162763489|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
162763490|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
162763491|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
162763492|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
162763493|NCT03845517|587845257|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
162763494|NCT03845517|587845258|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
162763495|NCT03845517|587845259|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
162763496|NCT03845517|587845260|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162763497|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
162763498|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
162763499|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
162763500|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
162763501|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Death|0|||
162763502|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Death|0|||
162763503|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Death|1|||
162763504|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Death|1|||
162763505|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
162763506|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
162763507|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
162763508|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
162763509|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
162763510|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
162763511|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
162763512|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
162763513|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162763514|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162763515|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162763516|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
162763517|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Other|1|||
162763518|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Other|0|||
162763519|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Other|1|||
162763520|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Other|0|||
162763521|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
162763522|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
162763523|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
162763524|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
162763525|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162763526|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162763527|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162763528|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
162763529|NCT03845517|587845257|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
162763530|NCT03845517|587845258|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
162763531|NCT03845517|587845259|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
162763532|NCT03845517|587845260|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
162763533|NCT01109979|587845261|FG000|Overall Study|Physician Decision|2|||
162763534|NCT01109979|587845262|FG001|Overall Study|Physician Decision|0|||
162763535|NCT01109979|587845261|FG000|Overall Study|Withdrawal by Subject|0|||
162763536|NCT01109979|587845262|FG001|Overall Study|Withdrawal by Subject|1|||
162763537|NCT03136861|587845265|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
162763538|NCT03136861|587845266|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
162763539|NCT03136861|587845267|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162763540|NCT03136861|587845268|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162763541|NCT03136861|587845269|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162763542|NCT03136861|587845270|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162763543|NCT03136861|587845271|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162763544|NCT03136861|587845265|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
162763545|NCT03136861|587845266|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
162763546|NCT03136861|587845267|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162763547|NCT03136861|587845268|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162763548|NCT03136861|587845269|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162763549|NCT03136861|587845270|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162763550|NCT03136861|587845271|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162763551|NCT03136861|587845265|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
162763552|NCT03136861|587845266|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
162763553|NCT03136861|587845267|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162763554|NCT03136861|587845268|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162763555|NCT03136861|587845269|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162763556|NCT03136861|587845270|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162763557|NCT03136861|587845271|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162763558|NCT03136861|587845265|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763559|NCT03136861|587845266|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
162763560|NCT03136861|587845267|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763561|NCT03136861|587845268|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763562|NCT03136861|587845269|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763563|NCT03136861|587845270|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763564|NCT03136861|587845271|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162763565|NCT03136861|587845265|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
162763566|NCT03136861|587845266|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
162763567|NCT03136861|587845267|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162763568|NCT03136861|587845268|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162763569|NCT03136861|587845269|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162763570|NCT03136861|587845270|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162763571|NCT03136861|587845271|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162763572|NCT03136861|587845265|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162763573|NCT03136861|587845266|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162763574|NCT03136861|587845267|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162763575|NCT03136861|587845268|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
162763576|NCT03136861|587845269|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
162763577|NCT03136861|587845270|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162763578|NCT03136861|587845271|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
162763579|NCT03136861|587845265|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763580|NCT03136861|587845266|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763581|NCT03136861|587845267|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
162763582|NCT03136861|587845268|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763583|NCT03136861|587845269|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763584|NCT03136861|587845270|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763585|NCT03136861|587845271|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162763586|NCT03136861|587845265|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763587|NCT03136861|587845266|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763588|NCT03136861|587845267|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
162763589|NCT03136861|587845268|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763590|NCT03136861|587845269|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763591|NCT03136861|587845270|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763592|NCT03136861|587845271|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162763593|NCT03026166|587845274|FG000|Overall Study|Death|22|||
162763594|NCT03026166|587845275|FG001|Overall Study|Death|7|||
162763595|NCT03026166|587845274|FG000|Overall Study|Physician Decision|2|||
162763596|NCT03026166|587845275|FG001|Overall Study|Physician Decision|0|||
162763597|NCT03026166|587845274|FG000|Overall Study|Withdrawal by Subject|1|||
162763598|NCT03026166|587845275|FG001|Overall Study|Withdrawal by Subject|2|||
162763599|NCT03026166|587845274|FG000|Overall Study|Lost to Follow-up|1|||
162763600|NCT03026166|587845275|FG001|Overall Study|Lost to Follow-up|0|||
162763601|NCT03026166|587845274|FG000|Overall Study|Study Terminated by Sponsor|3|||
162763602|NCT03026166|587845275|FG001|Overall Study|Study Terminated by Sponsor|3|||
162763603|NCT03026166|587845274|FG000|Overall Study|Other|1|||
162763604|NCT03026166|587845275|FG001|Overall Study|Other|0|||
162763605|NCT00266656|587845279|FG000|Overall Study|Death|1|||
162763606|NCT00266656|587845280|FG001|Overall Study|Death|0|||
162763607|NCT00266656|587845279|FG000|Overall Study|Lost to Follow-up|4|||
162763608|NCT00266656|587845280|FG001|Overall Study|Lost to Follow-up|1|||
162763609|NCT00266656|587845279|FG000|Overall Study|Withdrawal by Subject|4|||
162763610|NCT00266656|587845280|FG001|Overall Study|Withdrawal by Subject|2|||
162763611|NCT00266656|587845279|FG000|Overall Study|Did Not Reach Final Height|4|||
162763612|NCT00266656|587845280|FG001|Overall Study|Did Not Reach Final Height|8|||
162763613|NCT00266656|587845279|FG000|Overall Study|Parent/Caregiver Decision|1|||
162763614|NCT00266656|587845280|FG001|Overall Study|Parent/Caregiver Decision|2|||
162763615|NCT00667732|587845282|FG000|Run -In (8 Weeks)|Adverse Event|4|||
162763616|NCT00667732|587845283|FG001|Run -In (8 Weeks)|Adverse Event|0|||
162763617|NCT00667732|587845284|FG002|Run -In (8 Weeks)|Adverse Event|0|||
162763618|NCT00667732|587845282|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
162763619|NCT00667732|587845283|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
162763620|NCT00667732|587845284|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
162763621|NCT00667732|587845282|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
162763622|NCT00667732|587845283|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
162763623|NCT00667732|587845284|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
162763624|NCT05289037|587845288|FG000|Overall Study|Withdrawal by Subject|7|||
162763625|NCT05289037|587845289|FG001|Overall Study|Withdrawal by Subject|0|||
162763626|NCT05289037|587845290|FG002|Overall Study|Withdrawal by Subject|3|||
162763627|NCT05289037|587845291|FG003|Overall Study|Withdrawal by Subject|3|||
162763628|NCT05289037|587845292|FG004|Overall Study|Withdrawal by Subject|1|||
162763629|NCT05289037|587845293|FG005|Overall Study|Withdrawal by Subject|5|||
162763630|NCT05289037|587845294|FG006|Overall Study|Withdrawal by Subject|2|||
162763631|NCT05289037|587845295|FG007|Overall Study|Withdrawal by Subject|1|||
162763632|NCT05289037|587845296|FG008|Overall Study|Withdrawal by Subject|2|||
162763633|NCT05289037|587845297|FG009|Overall Study|Withdrawal by Subject|2|||
162763634|NCT05289037|587845298|FG010|Overall Study|Withdrawal by Subject|1|||
162763635|NCT05289037|587845299|FG011|Overall Study|Withdrawal by Subject|0|||
162763636|NCT05289037|587845300|FG012|Overall Study|Withdrawal by Subject|1|||
162763637|NCT05289037|587845301|FG013|Overall Study|Withdrawal by Subject|2|||
162763638|NCT05289037|587845302|FG014|Overall Study|Withdrawal by Subject|0|||
162763639|NCT05289037|587845303|FG015|Overall Study|Withdrawal by Subject|3|||
162763640|NCT05289037|587845304|FG016|Overall Study|Withdrawal by Subject|3|||
162763641|NCT05289037|587845288|FG000|Overall Study|Lost to Follow-up|1|||
162763642|NCT05289037|587845289|FG001|Overall Study|Lost to Follow-up|4|||
162763643|NCT05289037|587845290|FG002|Overall Study|Lost to Follow-up|3|||
162763644|NCT05289037|587845291|FG003|Overall Study|Lost to Follow-up|3|||
162763645|NCT05289037|587845292|FG004|Overall Study|Lost to Follow-up|3|||
162763646|NCT05289037|587845293|FG005|Overall Study|Lost to Follow-up|2|||
162763647|NCT05289037|587845294|FG006|Overall Study|Lost to Follow-up|3|||
162763648|NCT05289037|587845295|FG007|Overall Study|Lost to Follow-up|2|||
162763649|NCT05289037|587845296|FG008|Overall Study|Lost to Follow-up|2|||
162763650|NCT05289037|587845297|FG009|Overall Study|Lost to Follow-up|1|||
162763651|NCT05289037|587845298|FG010|Overall Study|Lost to Follow-up|3|||
162763652|NCT05289037|587845299|FG011|Overall Study|Lost to Follow-up|4|||
162763653|NCT05289037|587845300|FG012|Overall Study|Lost to Follow-up|2|||
162763654|NCT05289037|587845301|FG013|Overall Study|Lost to Follow-up|7|||
162763655|NCT05289037|587845302|FG014|Overall Study|Lost to Follow-up|4|||
162763656|NCT05289037|587845303|FG015|Overall Study|Lost to Follow-up|6|||
162763657|NCT05289037|587845304|FG016|Overall Study|Lost to Follow-up|4|||
162763658|NCT05289037|587845288|FG000|Overall Study|Death|0|||
162763659|NCT05289037|587845289|FG001|Overall Study|Death|0|||
162763660|NCT05289037|587845290|FG002|Overall Study|Death|0|||
162763661|NCT05289037|587845291|FG003|Overall Study|Death|0|||
162763662|NCT05289037|587845292|FG004|Overall Study|Death|0|||
162763663|NCT05289037|587845293|FG005|Overall Study|Death|1|||
162763664|NCT05289037|587845294|FG006|Overall Study|Death|0|||
162763665|NCT05289037|587845295|FG007|Overall Study|Death|0|||
162763666|NCT05289037|587845296|FG008|Overall Study|Death|0|||
162763667|NCT05289037|587845297|FG009|Overall Study|Death|0|||
162763668|NCT05289037|587845298|FG010|Overall Study|Death|0|||
162763669|NCT05289037|587845299|FG011|Overall Study|Death|0|||
162763670|NCT05289037|587845300|FG012|Overall Study|Death|0|||
162763671|NCT05289037|587845301|FG013|Overall Study|Death|0|||
162763672|NCT05289037|587845302|FG014|Overall Study|Death|1|||
162763673|NCT05289037|587845303|FG015|Overall Study|Death|0|||
162763674|NCT05289037|587845304|FG016|Overall Study|Death|0|||
162763675|NCT05289037|587845288|FG000|Overall Study|Did not receive vaccine|0|||
162763676|NCT05289037|587845289|FG001|Overall Study|Did not receive vaccine|3|||
162763677|NCT05289037|587845290|FG002|Overall Study|Did not receive vaccine|0|||
162763678|NCT05289037|587845291|FG003|Overall Study|Did not receive vaccine|0|||
162763679|NCT05289037|587845292|FG004|Overall Study|Did not receive vaccine|1|||
162763680|NCT05289037|587845293|FG005|Overall Study|Did not receive vaccine|1|||
162763681|NCT05289037|587845294|FG006|Overall Study|Did not receive vaccine|1|||
162763682|NCT05289037|587845295|FG007|Overall Study|Did not receive vaccine|0|||
162763683|NCT05289037|587845296|FG008|Overall Study|Did not receive vaccine|0|||
162763684|NCT05289037|587845297|FG009|Overall Study|Did not receive vaccine|0|||
162763685|NCT05289037|587845298|FG010|Overall Study|Did not receive vaccine|0|||
162763686|NCT05289037|587845299|FG011|Overall Study|Did not receive vaccine|0|||
162763687|NCT05289037|587845300|FG012|Overall Study|Did not receive vaccine|0|||
162763688|NCT05289037|587845301|FG013|Overall Study|Did not receive vaccine|0|||
162763689|NCT05289037|587845302|FG014|Overall Study|Did not receive vaccine|1|||
162763690|NCT05289037|587845303|FG015|Overall Study|Did not receive vaccine|0|||
162763691|NCT05289037|587845304|FG016|Overall Study|Did not receive vaccine|0|||
162763692|NCT05289037|587845288|FG000|Overall Study|Unable to make last visit|0|||
162763693|NCT05289037|587845289|FG001|Overall Study|Unable to make last visit|0|||
162763694|NCT05289037|587845290|FG002|Overall Study|Unable to make last visit|1|||
162763695|NCT05289037|587845291|FG003|Overall Study|Unable to make last visit|0|||
162763696|NCT05289037|587845292|FG004|Overall Study|Unable to make last visit|0|||
162763697|NCT05289037|587845293|FG005|Overall Study|Unable to make last visit|0|||
162763698|NCT05289037|587845294|FG006|Overall Study|Unable to make last visit|0|||
162763699|NCT05289037|587845295|FG007|Overall Study|Unable to make last visit|0|||
162763700|NCT05289037|587845296|FG008|Overall Study|Unable to make last visit|0|||
162763701|NCT05289037|587845297|FG009|Overall Study|Unable to make last visit|0|||
162763702|NCT05289037|587845298|FG010|Overall Study|Unable to make last visit|0|||
162763703|NCT05289037|587845299|FG011|Overall Study|Unable to make last visit|0|||
162763704|NCT05289037|587845300|FG012|Overall Study|Unable to make last visit|0|||
162763705|NCT05289037|587845301|FG013|Overall Study|Unable to make last visit|0|||
162763706|NCT05289037|587845302|FG014|Overall Study|Unable to make last visit|0|||
162763707|NCT05289037|587845303|FG015|Overall Study|Unable to make last visit|0|||
162763708|NCT05289037|587845304|FG016|Overall Study|Unable to make last visit|0|||
162763709|NCT05289037|587845288|FG000|Overall Study|Protocol deviation|0|||
162763710|NCT05289037|587845289|FG001|Overall Study|Protocol deviation|0|||
162763711|NCT05289037|587845290|FG002|Overall Study|Protocol deviation|0|||
162763712|NCT05289037|587845291|FG003|Overall Study|Protocol deviation|0|||
162763713|NCT05289037|587845292|FG004|Overall Study|Protocol deviation|0|||
162763714|NCT05289037|587845293|FG005|Overall Study|Protocol deviation|0|||
162763715|NCT05289037|587845294|FG006|Overall Study|Protocol deviation|0|||
162763716|NCT05289037|587845295|FG007|Overall Study|Protocol deviation|0|||
162763717|NCT05289037|587845296|FG008|Overall Study|Protocol deviation|0|||
162763718|NCT05289037|587845297|FG009|Overall Study|Protocol deviation|0|||
162763719|NCT05289037|587845298|FG010|Overall Study|Protocol deviation|0|||
162763720|NCT05289037|587845299|FG011|Overall Study|Protocol deviation|0|||
162763721|NCT05289037|587845300|FG012|Overall Study|Protocol deviation|0|||
162763722|NCT05289037|587845301|FG013|Overall Study|Protocol deviation|0|||
162763723|NCT05289037|587845302|FG014|Overall Study|Protocol deviation|0|||
162763724|NCT05289037|587845303|FG015|Overall Study|Protocol deviation|1|||
162763725|NCT05289037|587845304|FG016|Overall Study|Protocol deviation|0|||
162763726|NCT04186247|587845305|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
162763727|NCT04186247|587845306|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162763728|NCT04186247|587845307|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162763729|NCT04186247|587845308|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162763730|NCT04186247|587845309|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162763731|NCT05006703|587846862|FG000|Overall Study|Withdrawal by Subject|1|||
162763732|NCT05006703|587846863|FG001|Overall Study|Withdrawal by Subject|0|||
162763733|NCT05006703|587846862|FG000|Overall Study|Lost to Follow-up|13|||
162763734|NCT05006703|587846863|FG001|Overall Study|Lost to Follow-up|5|||
162763735|NCT02196259|587846868|FG000|Overall Study|Researcher choice|0|||
162763736|NCT02196259|587846869|FG001|Overall Study|Researcher choice|0|||
162763737|NCT02196259|587846870|FG002|Overall Study|Researcher choice|1|||
162763738|NCT02196259|587846868|FG000|Overall Study|Partial data analysis|0|||
162763739|NCT02196259|587846869|FG001|Overall Study|Partial data analysis|3|||
162763740|NCT02196259|587846870|FG002|Overall Study|Partial data analysis|0|||
162763741|NCT00264576|587846871|FG000|Overall Study|Lost to Follow-up|1|||
162763742|NCT00264576|587846872|FG001|Overall Study|Lost to Follow-up|1|||
162763743|NCT01668355|587846874|FG000|Overall Study|Death|3|||
162763744|NCT01668355|587846875|FG001|Overall Study|Death|1|||
162763745|NCT01668355|587846874|FG000|Overall Study|Withdrawal by Subject|6|||
162763746|NCT01668355|587846875|FG001|Overall Study|Withdrawal by Subject|1|||
162763747|NCT02659059|587846876|FG000|Overall Study|Other reasons|6|||
162763748|NCT02659059|587846877|FG001|Overall Study|Other reasons|1|||
162763749|NCT02659059|587846876|FG000|Overall Study|Disease Progression|143|||
162763750|NCT02659059|587846877|FG001|Overall Study|Disease Progression|16|||
162763751|NCT02659059|587846876|FG000|Overall Study|Study Drug toxicity|56|||
162763752|NCT02659059|587846877|FG001|Overall Study|Study Drug toxicity|9|||
162763753|NCT02659059|587846876|FG000|Overall Study|Death|3|||
162763754|NCT02659059|587846877|FG001|Overall Study|Death|1|||
162763755|NCT02659059|587846876|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
162763756|NCT02659059|587846877|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
162763757|NCT02659059|587846876|FG000|Overall Study|Participant request to discontinue study treatment|5|||
162763758|NCT02659059|587846877|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162763759|NCT02659059|587846876|FG000|Overall Study|Participant withdrew consent|6|||
162763760|NCT02659059|587846877|FG001|Overall Study|Participant withdrew consent|1|||
162763761|NCT02002689|587846878|FG000|Overall Study|Disease Progression|7|||
162763762|NCT02002689|587846878|FG000|Overall Study|Adverse Event|3|||
162763763|NCT01808534|587846879|FG000|Overall Study|Disease progression|3|||
162763764|NCT01808534|587846879|FG000|Overall Study|Physician Decision|1|||
162763765|NCT00278395|587846882|FG000|Overall Study|Adverse Event|2|||
162763766|NCT00278395|587846882|FG000|Overall Study|Nonevaluable|1|||
162763767|NCT01148017|587846883|FG000|Overall Study|Withdrawal by Subject|31|||
162763768|NCT01148017|587846884|FG001|Overall Study|Withdrawal by Subject|14|||
162763769|NCT01148017|587846885|FG002|Overall Study|Withdrawal by Subject|0|||
162763770|NCT01148017|587846886|FG003|Overall Study|Withdrawal by Subject|0|||
162763771|NCT01148017|587846883|FG000|Overall Study|Lost to Follow-up|23|||
162763772|NCT01148017|587846884|FG001|Overall Study|Lost to Follow-up|10|||
162763773|NCT01148017|587846885|FG002|Overall Study|Lost to Follow-up|0|||
162763774|NCT01148017|587846886|FG003|Overall Study|Lost to Follow-up|0|||
162763775|NCT01148017|587846883|FG000|Overall Study|Inappropriate enrollment|1|||
162763776|NCT01148017|587846884|FG001|Overall Study|Inappropriate enrollment|0|||
162763777|NCT01148017|587846885|FG002|Overall Study|Inappropriate enrollment|0|||
162763778|NCT01148017|587846886|FG003|Overall Study|Inappropriate enrollment|0|||
162763779|NCT01148017|587846883|FG000|Overall Study|Administrative reason|22|||
162763780|NCT01148017|587846884|FG001|Overall Study|Administrative reason|9|||
162763781|NCT01148017|587846885|FG002|Overall Study|Administrative reason|0|||
162763782|NCT01148017|587846886|FG003|Overall Study|Administrative reason|0|||
162763783|NCT01148017|587846883|FG000|Overall Study|Unable to classify|3|||
162763784|NCT01148017|587846884|FG001|Overall Study|Unable to classify|1|||
162763785|NCT01148017|587846885|FG002|Overall Study|Unable to classify|0|||
162763786|NCT01148017|587846886|FG003|Overall Study|Unable to classify|0|||
162763787|NCT00569166|587846888|FG000|Overall Study|Withdrawal by Subject|7|||
162763788|NCT00569166|587846889|FG001|Overall Study|Withdrawal by Subject|5|||
162763789|NCT00569166|587846890|FG002|Overall Study|Withdrawal by Subject|3|||
162763790|NCT00569166|587846888|FG000|Overall Study|Lost to Follow-up|2|||
162763791|NCT00569166|587846889|FG001|Overall Study|Lost to Follow-up|1|||
162763792|NCT00569166|587846890|FG002|Overall Study|Lost to Follow-up|1|||
162763793|NCT01853384|587846891|FG000|Randomized|Adverse Event|5|||
162763794|NCT01853384|587846892|FG001|Randomized|Adverse Event|3|||
162763795|NCT01853384|587846891|FG000|Randomized|Death|1|||
162763796|NCT01853384|587846892|FG001|Randomized|Death|2|||
162763797|NCT01853384|587846891|FG000|Randomized|Lost to Follow-up|1|||
162763798|NCT01853384|587846892|FG001|Randomized|Lost to Follow-up|1|||
162763799|NCT01853384|587846891|FG000|Randomized|Withdrawal by Subject|5|||
162763800|NCT01853384|587846892|FG001|Randomized|Withdrawal by Subject|3|||
162763801|NCT01853384|587846891|FG000|Randomized|Sponsor Decision|47|||
162763802|NCT01853384|587846892|FG001|Randomized|Sponsor Decision|34|||
162763803|NCT01853384|587846891|FG000|Randomized|Other|3|||
162763804|NCT01853384|587846892|FG001|Randomized|Other|3|||
162763805|NCT01853384|587846891|FG000|Completed Follow up Visit 1|Early Termination|13|||
162763806|NCT01853384|587846892|FG001|Completed Follow up Visit 1|Early Termination|9|||
162763807|NCT01853384|587846891|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
162763808|NCT01853384|587846892|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
162763809|NCT01853384|587846891|FG000|Completed Follow up Visit 2|Adverse Event|1|||
162763810|NCT01853384|587846892|FG001|Completed Follow up Visit 2|Adverse Event|0|||
162763811|NCT01853384|587846891|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
162763812|NCT01853384|587846892|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
162763813|NCT01853384|587846891|FG000|Completed Follow up Visit 2|Death|1|||
162763814|NCT01853384|587846892|FG001|Completed Follow up Visit 2|Death|0|||
162763815|NCT01853384|587846891|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
162763816|NCT01853384|587846892|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
162763817|NCT01019135|587846896|FG000|Overall Study|Did not receive allocated intervention|12|||
162763818|NCT01019135|587846897|FG001|Overall Study|Did not receive allocated intervention|6|||
162763819|NCT01019135|587846898|FG002|Overall Study|Did not receive allocated intervention|25|||
162763820|NCT01019135|587846896|FG000|Overall Study|Did not attend CR|8|||
162763821|NCT01019135|587846897|FG001|Overall Study|Did not attend CR|13|||
162763822|NCT01019135|587846898|FG002|Overall Study|Did not attend CR|6|||
162763823|NCT00486954|587846899|FG000|Pilot Part|Adverse Event|4|||
162763824|NCT00486954|587846900|FG001|Pilot Part|Adverse Event|0|||
162763825|NCT00486954|587846901|FG002|Pilot Part|Adverse Event|5|||
162763826|NCT00486954|587846902|FG003|Pilot Part|Adverse Event|0|||
162763827|NCT00486954|587846903|FG004|Pilot Part|Adverse Event|0|||
162763828|NCT00486954|587846899|FG000|Pilot Part|Disease Progression|2|||
162763829|NCT00486954|587846900|FG001|Pilot Part|Disease Progression|0|||
162763830|NCT00486954|587846901|FG002|Pilot Part|Disease Progression|1|||
162763831|NCT00486954|587846902|FG003|Pilot Part|Disease Progression|0|||
162763832|NCT00486954|587846903|FG004|Pilot Part|Disease Progression|0|||
162763833|NCT00486954|587846899|FG000|Randomized Part|Lost to Follow-up|0|||
162763834|NCT00486954|587846900|FG001|Randomized Part|Lost to Follow-up|0|||
162763835|NCT00486954|587846901|FG002|Randomized Part|Lost to Follow-up|0|||
162763836|NCT00486954|587846902|FG003|Randomized Part|Lost to Follow-up|0|||
162763837|NCT00486954|587846903|FG004|Randomized Part|Lost to Follow-up|1|||
162763838|NCT00486954|587846899|FG000|Randomized Part|Withdrawal by Subject|0|||
162763839|NCT00486954|587846900|FG001|Randomized Part|Withdrawal by Subject|0|||
162763840|NCT00486954|587846901|FG002|Randomized Part|Withdrawal by Subject|0|||
162763841|NCT00486954|587846902|FG003|Randomized Part|Withdrawal by Subject|1|||
162763842|NCT00486954|587846903|FG004|Randomized Part|Withdrawal by Subject|0|||
162763843|NCT00486954|587846899|FG000|Randomized Part|Sponsor Terminated Study|0|||
162763844|NCT00486954|587846900|FG001|Randomized Part|Sponsor Terminated Study|0|||
162763845|NCT00486954|587846901|FG002|Randomized Part|Sponsor Terminated Study|0|||
162763846|NCT00486954|587846902|FG003|Randomized Part|Sponsor Terminated Study|19|||
162763847|NCT00486954|587846903|FG004|Randomized Part|Sponsor Terminated Study|13|||
162763848|NCT05124210|587846904|FG000|Overall Study|Lost to Follow-up|1|||
162763849|NCT05124210|587846905|FG001|Overall Study|Lost to Follow-up|0|||
162763850|NCT05124210|587846904|FG000|Overall Study|Withdrawal by Subject|1|||
162763851|NCT05124210|587846905|FG001|Overall Study|Withdrawal by Subject|0|||
162763852|NCT00638456|587846906|FG000|Overall Study|Withdrawal by Subject|6|||
162763853|NCT00638456|587846907|FG001|Overall Study|Withdrawal by Subject|2|||
162763854|NCT03374254|587846908|FG000|Overall Study|Death|5|||
162763855|NCT03374254|587846909|FG001|Overall Study|Death|16|||
162763856|NCT03374254|587846910|FG002|Overall Study|Death|13|||
162763857|NCT03374254|587846911|FG003|Overall Study|Death|11|||
162763858|NCT03374254|587846912|FG004|Overall Study|Death|9|||
162763859|NCT03374254|587846913|FG005|Overall Study|Death|12|||
162763860|NCT03374254|587846914|FG006|Overall Study|Death|11|||
162763861|NCT03374254|587846915|FG007|Overall Study|Death|6|||
162763862|NCT03374254|587846916|FG008|Overall Study|Death|7|||
162763863|NCT03374254|587846908|FG000|Overall Study|Lost to Follow-up|0|||
162763864|NCT03374254|587846909|FG001|Overall Study|Lost to Follow-up|0|||
162763865|NCT03374254|587846910|FG002|Overall Study|Lost to Follow-up|0|||
162763866|NCT03374254|587846911|FG003|Overall Study|Lost to Follow-up|0|||
162763867|NCT03374254|587846912|FG004|Overall Study|Lost to Follow-up|0|||
162763868|NCT03374254|587846913|FG005|Overall Study|Lost to Follow-up|0|||
162763869|NCT03374254|587846914|FG006|Overall Study|Lost to Follow-up|2|||
162763870|NCT03374254|587846915|FG007|Overall Study|Lost to Follow-up|0|||
162763871|NCT03374254|587846916|FG008|Overall Study|Lost to Follow-up|0|||
162763872|NCT03374254|587846908|FG000|Overall Study|Sponsor Decision|1|||
162763873|NCT03374254|587846909|FG001|Overall Study|Sponsor Decision|0|||
162763874|NCT03374254|587846910|FG002|Overall Study|Sponsor Decision|2|||
162763875|NCT03374254|587846911|FG003|Overall Study|Sponsor Decision|3|||
162763876|NCT03374254|587846912|FG004|Overall Study|Sponsor Decision|2|||
162763877|NCT03374254|587846913|FG005|Overall Study|Sponsor Decision|3|||
162763878|NCT03374254|587846914|FG006|Overall Study|Sponsor Decision|3|||
162763879|NCT03374254|587846915|FG007|Overall Study|Sponsor Decision|3|||
162763880|NCT03374254|587846916|FG008|Overall Study|Sponsor Decision|4|||
162763881|NCT03374254|587846908|FG000|Overall Study|Withdrawal by Subject|0|||
162763882|NCT03374254|587846909|FG001|Overall Study|Withdrawal by Subject|0|||
162763883|NCT03374254|587846910|FG002|Overall Study|Withdrawal by Subject|0|||
162763884|NCT03374254|587846911|FG003|Overall Study|Withdrawal by Subject|2|||
162763885|NCT03374254|587846912|FG004|Overall Study|Withdrawal by Subject|0|||
162763886|NCT03374254|587846913|FG005|Overall Study|Withdrawal by Subject|1|||
162763887|NCT03374254|587846914|FG006|Overall Study|Withdrawal by Subject|0|||
162763888|NCT03374254|587846915|FG007|Overall Study|Withdrawal by Subject|0|||
162763889|NCT03374254|587846916|FG008|Overall Study|Withdrawal by Subject|0|||
162763890|NCT02784834|587846918|FG000|Overall Study|Lack of Efficacy|1|||
162763891|NCT02245620|587846919|FG000|Overall Study|Physician Decision|1|||
162763892|NCT02245620|587846920|FG001|Overall Study|Physician Decision|1|||
162763893|NCT01090739|587846929|FG000|Enrollment|Withdrawal by Subject|24|||
162763894|NCT01090739|587846929|FG000|Enrollment|Protocol Violation|14|||
162763895|NCT01090739|587846929|FG000|Enrollment|Lost to Follow-up|5|||
162763896|NCT01090739|587846929|FG000|Enrollment|Physician Decision|5|||
162763897|NCT01090739|587846929|FG000|Enrollment|Sponsor termination of site|4|||
162763898|NCT01090739|587846929|FG000|Enrollment|Study implant limit reached|2|||
162763899|NCT01090739|587846929|FG000|Enrollment|Adverse Event|1|||
162763900|NCT01090739|587846929|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
162763901|NCT01090739|587846929|FG000|12 Month Follow-up|Lost to Follow-up|1|||
162763902|NCT01090739|587846929|FG000|12 Month Follow-up|Physician Decision|1|||
162763903|NCT01090739|587846929|FG000|12 Month Follow-up|Death|1|||
162763904|NCT01090739|587846929|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
162763905|NCT01090739|587846929|FG000|24 Month Follow-up|Lost to Follow-up|1|||
162763906|NCT01090739|587846929|FG000|24 Month Follow-up|Death|1|||
162763907|NCT01090739|587846929|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
162763908|NCT01090739|587846929|FG000|36 Month Follow-up|Visit still pending|17|||
162763909|NCT00441168|587846930|FG000|Treatment Period|Death|3|||
162763910|NCT00441168|587846931|FG001|Treatment Period|Death|0|||
162763911|NCT00441168|587846930|FG000|Treatment Period|Adverse Event|1|||
162763912|NCT00441168|587846931|FG001|Treatment Period|Adverse Event|2|||
162763913|NCT00441168|587846930|FG000|Treatment Period|Progressive Disease|0|||
162763914|NCT00441168|587846931|FG001|Treatment Period|Progressive Disease|2|||
162763915|NCT00441168|587846930|FG000|Treatment Period|Protocol Violation|0|||
162763916|NCT00441168|587846931|FG001|Treatment Period|Protocol Violation|1|||
162763917|NCT00441168|587846930|FG000|Treatment Period|Lost to Follow-up|0|||
162763918|NCT00441168|587846931|FG001|Treatment Period|Lost to Follow-up|1|||
162763919|NCT00441168|587846930|FG000|Treatment Period|Withdrawal by Subject|3|||
162763920|NCT00441168|587846931|FG001|Treatment Period|Withdrawal by Subject|0|||
162763921|NCT00441168|587846930|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
162763922|NCT00441168|587846931|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
162763923|NCT00441168|587846930|FG000|Treatment Period|refractory disease|1|||
162763924|NCT00441168|587846931|FG001|Treatment Period|refractory disease|0|||
162763925|NCT00441168|587846930|FG000|Follow-up Period|Death|3|||
162763926|NCT00441168|587846931|FG001|Follow-up Period|Death|0|||
162763927|NCT00441168|587846930|FG000|Follow-up Period|Lost to Follow-up|5|||
162763928|NCT00441168|587846931|FG001|Follow-up Period|Lost to Follow-up|6|||
162763929|NCT00441168|587846930|FG000|Follow-up Period|Withdrawal by Subject|3|||
162763930|NCT00441168|587846931|FG001|Follow-up Period|Withdrawal by Subject|0|||
162763931|NCT00441168|587846930|FG000|Follow-up Period|Other|1|||
162763932|NCT00441168|587846931|FG001|Follow-up Period|Other|3|||
162763933|NCT02291861|587846933|FG000|Overall Study|Adverse Event|2|||
162763934|NCT02291861|587846934|FG001|Overall Study|Adverse Event|4|||
162763935|NCT02291861|587846935|FG002|Overall Study|Adverse Event|1|||
162763936|NCT02291861|587846936|FG003|Overall Study|Adverse Event|2|||
162763937|NCT02291861|587846933|FG000|Overall Study|Death|0|||
162763938|NCT02291861|587846934|FG001|Overall Study|Death|0|||
162763939|NCT02291861|587846935|FG002|Overall Study|Death|1|||
162763940|NCT02291861|587846936|FG003|Overall Study|Death|1|||
162763941|NCT02291861|587846933|FG000|Overall Study|Protocol Violation|1|||
162763942|NCT02291861|587846934|FG001|Overall Study|Protocol Violation|0|||
162763943|NCT02291861|587846935|FG002|Overall Study|Protocol Violation|0|||
162763944|NCT02291861|587846936|FG003|Overall Study|Protocol Violation|1|||
162763945|NCT02291861|587846933|FG000|Overall Study|Withdrawal by Subject|1|||
162763946|NCT02291861|587846934|FG001|Overall Study|Withdrawal by Subject|2|||
162763947|NCT02291861|587846935|FG002|Overall Study|Withdrawal by Subject|1|||
162763948|NCT02291861|587846936|FG003|Overall Study|Withdrawal by Subject|4|||
162763949|NCT02291861|587846933|FG000|Overall Study|Noncompliance|1|||
162763950|NCT02291861|587846934|FG001|Overall Study|Noncompliance|1|||
162763951|NCT02291861|587846935|FG002|Overall Study|Noncompliance|2|||
162763952|NCT02291861|587846936|FG003|Overall Study|Noncompliance|1|||
162763953|NCT02291861|587846933|FG000|Overall Study|Lost to Follow-up|2|||
162763954|NCT02291861|587846934|FG001|Overall Study|Lost to Follow-up|1|||
162763955|NCT02291861|587846935|FG002|Overall Study|Lost to Follow-up|4|||
162763956|NCT02291861|587846936|FG003|Overall Study|Lost to Follow-up|0|||
162763957|NCT02291861|587846933|FG000|Overall Study|Other|0|||
162763958|NCT02291861|587846934|FG001|Overall Study|Other|0|||
162763959|NCT02291861|587846935|FG002|Overall Study|Other|0|||
162763960|NCT02291861|587846936|FG003|Overall Study|Other|1|||
162763961|NCT03547154|587846940|FG000|Overall Study|Disease Progression/Recurrence|6|||
162763962|NCT03547154|587846941|FG001|Overall Study|Disease Progression/Recurrence|14|||
162763963|NCT03547154|587846940|FG000|Overall Study|Adverse Event|26|||
162763964|NCT03547154|587846941|FG001|Overall Study|Adverse Event|31|||
162763965|NCT03547154|587846940|FG000|Overall Study|Protocol Violation|6|||
162763966|NCT03547154|587846941|FG001|Overall Study|Protocol Violation|1|||
162763967|NCT03547154|587846940|FG000|Overall Study|Physician Decision|4|||
162763968|NCT03547154|587846941|FG001|Overall Study|Physician Decision|3|||
162763969|NCT03547154|587846940|FG000|Overall Study|Insufficient Therapeutic Response|13|||
162763970|NCT03547154|587846941|FG001|Overall Study|Insufficient Therapeutic Response|10|||
162763971|NCT03547154|587846940|FG000|Overall Study|Withdrawal by Subject|10|||
162763972|NCT03547154|587846941|FG001|Overall Study|Withdrawal by Subject|6|||
162763973|NCT03547154|587846940|FG000|Overall Study|Not Selected|0|||
162763974|NCT03547154|587846941|FG001|Overall Study|Not Selected|1|||
162763975|NCT03547154|587846940|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
162763976|NCT03547154|587846941|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
162763977|NCT02404441|587846942|FG000|Phase 1 Part|Adverse Event|1|||
162763978|NCT02404441|587846943|FG001|Phase 1 Part|Adverse Event|0|||
162763979|NCT02404441|587846944|FG002|Phase 1 Part|Adverse Event|0|||
162763980|NCT02404441|587846945|FG003|Phase 1 Part|Adverse Event|0|||
162763981|NCT02404441|587846946|FG004|Phase 1 Part|Adverse Event|0|||
162763982|NCT02404441|587846947|FG005|Phase 1 Part|Adverse Event|0|||
162763983|NCT02404441|587846948|FG006|Phase 1 Part|Adverse Event|0|||
162763984|NCT02404441|587846949|FG007|Phase 1 Part|Adverse Event|0|||
162763985|NCT02404441|587846950|FG008|Phase 1 Part|Adverse Event|0|||
162763986|NCT02404441|587846951|FG009|Phase 1 Part|Adverse Event|0|||
162763987|NCT02404441|587846942|FG000|Phase 1 Part|Physician Decision|0|||
162763988|NCT02404441|587846943|FG001|Phase 1 Part|Physician Decision|1|||
162763989|NCT02404441|587846944|FG002|Phase 1 Part|Physician Decision|0|||
162763990|NCT02404441|587846945|FG003|Phase 1 Part|Physician Decision|0|||
162763991|NCT02404441|587846946|FG004|Phase 1 Part|Physician Decision|0|||
162763992|NCT02404441|587846947|FG005|Phase 1 Part|Physician Decision|0|||
162763993|NCT02404441|587846948|FG006|Phase 1 Part|Physician Decision|0|||
162763994|NCT02404441|587846949|FG007|Phase 1 Part|Physician Decision|0|||
162763995|NCT02404441|587846950|FG008|Phase 1 Part|Physician Decision|0|||
162763996|NCT02404441|587846951|FG009|Phase 1 Part|Physician Decision|0|||
162763997|NCT02404441|587846942|FG000|Phase 1 Part|Progressive Disease|14|||
162763998|NCT02404441|587846943|FG001|Phase 1 Part|Progressive Disease|11|||
162763999|NCT02404441|587846944|FG002|Phase 1 Part|Progressive Disease|7|||
162764000|NCT02404441|587846945|FG003|Phase 1 Part|Progressive Disease|6|||
162764001|NCT02404441|587846946|FG004|Phase 1 Part|Progressive Disease|9|||
162764002|NCT02404441|587846947|FG005|Phase 1 Part|Progressive Disease|0|||
162764003|NCT02404441|587846948|FG006|Phase 1 Part|Progressive Disease|0|||
162764004|NCT02404441|587846949|FG007|Phase 1 Part|Progressive Disease|0|||
162764005|NCT02404441|587846950|FG008|Phase 1 Part|Progressive Disease|0|||
162764006|NCT02404441|587846951|FG009|Phase 1 Part|Progressive Disease|0|||
162764007|NCT02404441|587846942|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
162764008|NCT02404441|587846943|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
162764009|NCT02404441|587846944|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
162764010|NCT02404441|587846945|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
162764011|NCT02404441|587846946|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
162764012|NCT02404441|587846947|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
162764013|NCT02404441|587846948|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
162764014|NCT02404441|587846949|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
162764015|NCT02404441|587846950|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
162764016|NCT02404441|587846951|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
162764017|NCT02404441|587846942|FG000|Phase 1 Part|Death|1|||
162764018|NCT02404441|587846943|FG001|Phase 1 Part|Death|1|||
162764019|NCT02404441|587846944|FG002|Phase 1 Part|Death|1|||
162764020|NCT02404441|587846945|FG003|Phase 1 Part|Death|0|||
162764021|NCT02404441|587846946|FG004|Phase 1 Part|Death|1|||
162764022|NCT02404441|587846947|FG005|Phase 1 Part|Death|0|||
162764023|NCT02404441|587846948|FG006|Phase 1 Part|Death|0|||
162764024|NCT02404441|587846949|FG007|Phase 1 Part|Death|0|||
162764025|NCT02404441|587846950|FG008|Phase 1 Part|Death|0|||
162764026|NCT02404441|587846951|FG009|Phase 1 Part|Death|0|||
162764027|NCT02404441|587846942|FG000|Phase 2 Part|Adverse Event|0|||
162764028|NCT02404441|587846943|FG001|Phase 2 Part|Adverse Event|0|||
162764029|NCT02404441|587846944|FG002|Phase 2 Part|Adverse Event|0|||
162764030|NCT02404441|587846945|FG003|Phase 2 Part|Adverse Event|0|||
162764031|NCT02404441|587846946|FG004|Phase 2 Part|Adverse Event|0|||
162764032|NCT02404441|587846947|FG005|Phase 2 Part|Adverse Event|2|||
162764033|NCT02404441|587846948|FG006|Phase 2 Part|Adverse Event|3|||
162764034|NCT02404441|587846949|FG007|Phase 2 Part|Adverse Event|3|||
162764035|NCT02404441|587846950|FG008|Phase 2 Part|Adverse Event|6|||
162764036|NCT02404441|587846951|FG009|Phase 2 Part|Adverse Event|1|||
162764037|NCT02404441|587846942|FG000|Phase 2 Part|Physician Decision|0|||
162764038|NCT02404441|587846943|FG001|Phase 2 Part|Physician Decision|0|||
162764039|NCT02404441|587846944|FG002|Phase 2 Part|Physician Decision|0|||
162764040|NCT02404441|587846945|FG003|Phase 2 Part|Physician Decision|0|||
162764041|NCT02404441|587846946|FG004|Phase 2 Part|Physician Decision|0|||
162764042|NCT02404441|587846947|FG005|Phase 2 Part|Physician Decision|7|||
162764043|NCT02404441|587846948|FG006|Phase 2 Part|Physician Decision|9|||
162764044|NCT02404441|587846949|FG007|Phase 2 Part|Physician Decision|2|||
162764045|NCT02404441|587846950|FG008|Phase 2 Part|Physician Decision|1|||
162764046|NCT02404441|587846951|FG009|Phase 2 Part|Physician Decision|3|||
162764047|NCT02404441|587846942|FG000|Phase 2 Part|Progressive disease|0|||
162764048|NCT02404441|587846943|FG001|Phase 2 Part|Progressive disease|0|||
162764049|NCT02404441|587846944|FG002|Phase 2 Part|Progressive disease|0|||
162764050|NCT02404441|587846945|FG003|Phase 2 Part|Progressive disease|0|||
162764051|NCT02404441|587846946|FG004|Phase 2 Part|Progressive disease|0|||
162764052|NCT02404441|587846947|FG005|Phase 2 Part|Progressive disease|43|||
162764053|NCT02404441|587846948|FG006|Phase 2 Part|Progressive disease|32|||
162764054|NCT02404441|587846949|FG007|Phase 2 Part|Progressive disease|31|||
162764055|NCT02404441|587846950|FG008|Phase 2 Part|Progressive disease|39|||
162764056|NCT02404441|587846951|FG009|Phase 2 Part|Progressive disease|27|||
162764057|NCT02404441|587846942|FG000|Phase 2 Part|Subject/guardian decision|0|||
162764058|NCT02404441|587846943|FG001|Phase 2 Part|Subject/guardian decision|0|||
162764059|NCT02404441|587846944|FG002|Phase 2 Part|Subject/guardian decision|0|||
162764060|NCT02404441|587846945|FG003|Phase 2 Part|Subject/guardian decision|0|||
162764061|NCT02404441|587846946|FG004|Phase 2 Part|Subject/guardian decision|0|||
162764062|NCT02404441|587846947|FG005|Phase 2 Part|Subject/guardian decision|3|||
162764063|NCT02404441|587846948|FG006|Phase 2 Part|Subject/guardian decision|9|||
162764064|NCT02404441|587846949|FG007|Phase 2 Part|Subject/guardian decision|0|||
162764065|NCT02404441|587846950|FG008|Phase 2 Part|Subject/guardian decision|3|||
162764066|NCT02404441|587846951|FG009|Phase 2 Part|Subject/guardian decision|2|||
162764067|NCT02404441|587846942|FG000|Phase 2 Part|Death|0|||
162764068|NCT02404441|587846943|FG001|Phase 2 Part|Death|0|||
162764069|NCT02404441|587846944|FG002|Phase 2 Part|Death|0|||
162764070|NCT02404441|587846945|FG003|Phase 2 Part|Death|0|||
162764071|NCT02404441|587846946|FG004|Phase 2 Part|Death|0|||
162764072|NCT02404441|587846947|FG005|Phase 2 Part|Death|4|||
162764073|NCT02404441|587846948|FG006|Phase 2 Part|Death|8|||
162764074|NCT02404441|587846949|FG007|Phase 2 Part|Death|4|||
162764075|NCT02404441|587846950|FG008|Phase 2 Part|Death|10|||
162764076|NCT02404441|587846951|FG009|Phase 2 Part|Death|9|||
162764077|NCT02671266|587846952|FG000|Overall Study|Withdrawal by Subject|1|||
162764078|NCT02671266|587846953|FG001|Overall Study|Withdrawal by Subject|1|||
162764079|NCT03390166|587846956|FG000|Overall Study|Death|0|||
162764080|NCT03390166|587846957|FG001|Overall Study|Death|1|||
162764081|NCT03390166|587846956|FG000|Overall Study|Lost to Follow-up|6|||
162764082|NCT03390166|587846957|FG001|Overall Study|Lost to Follow-up|4|||
162764083|NCT03390166|587846956|FG000|Overall Study|Physician Decision|2|||
162764084|NCT03390166|587846957|FG001|Overall Study|Physician Decision|1|||
162764085|NCT03390166|587846956|FG000|Overall Study|Move from study area|3|||
162764086|NCT03390166|587846957|FG001|Overall Study|Move from study area|2|||
162764087|NCT03390166|587846956|FG000|Overall Study|To militarycamp for conscript|1|||
162764088|NCT03390166|587846957|FG001|Overall Study|To militarycamp for conscript|0|||
162764089|NCT03390166|587846956|FG000|Overall Study|To drug therapy course|0|||
162764090|NCT03390166|587846957|FG001|Overall Study|To drug therapy course|1|||
162764091|NCT03390166|587846956|FG000|Overall Study|Move to work oversea|0|||
162764092|NCT03390166|587846957|FG001|Overall Study|Move to work oversea|1|||
162764093|NCT01328756|587846961|FG000|Overall Study|Protocol Violation|4|||
162764094|NCT01328756|587846961|FG000|Overall Study|Adverse Event|39|||
162764095|NCT01328756|587846961|FG000|Overall Study|Lack of Efficacy|5|||
162764096|NCT01328756|587846961|FG000|Overall Study|Withdrawal by Subject|41|||
162764097|NCT01328756|587846961|FG000|Overall Study|Lost to Follow-up|5|||
162764098|NCT01328756|587846961|FG000|Overall Study|Other|29|||
162764099|NCT03200574|587846976|FG000|Overall Study|Death|4|||
162764100|NCT03200574|587846976|FG000|Overall Study|Withdrawal by Subject|8|||
162764101|NCT03200574|587846976|FG000|Overall Study|Long-Term need for anticoagulation|1|||
162764102|NCT03200574|587846976|FG000|Overall Study|Relocation|2|||
162764103|NCT03200574|587846976|FG000|Overall Study|Lost to Follow-up|2|||
162764104|NCT00705159|587846980|FG000|Overall Study|Withdrawal by Subject|0|||
162764105|NCT00705159|587846981|FG001|Overall Study|Withdrawal by Subject|1|||
162764106|NCT00705159|587846982|FG002|Overall Study|Withdrawal by Subject|1|||
162764107|NCT00705159|587846983|FG003|Overall Study|Withdrawal by Subject|1|||
162764108|NCT00705159|587846980|FG000|Overall Study|Protocol Violation|0|||
162764109|NCT00705159|587846981|FG001|Overall Study|Protocol Violation|1|||
162764110|NCT00705159|587846982|FG002|Overall Study|Protocol Violation|0|||
162764111|NCT00705159|587846983|FG003|Overall Study|Protocol Violation|0|||
162764112|NCT00705159|587846980|FG000|Overall Study|Adverse Event|0|||
162764113|NCT00705159|587846981|FG001|Overall Study|Adverse Event|0|||
162764114|NCT00705159|587846982|FG002|Overall Study|Adverse Event|1|||
162764115|NCT00705159|587846983|FG003|Overall Study|Adverse Event|0|||
162764116|NCT00705159|587846980|FG000|Overall Study|Lost to Follow-up|0|||
162764117|NCT00705159|587846981|FG001|Overall Study|Lost to Follow-up|0|||
162764118|NCT00705159|587846982|FG002|Overall Study|Lost to Follow-up|3|||
162764119|NCT00705159|587846983|FG003|Overall Study|Lost to Follow-up|2|||
162764120|NCT00705159|587846980|FG000|Overall Study|Screen Failure|0|||
162764121|NCT00705159|587846981|FG001|Overall Study|Screen Failure|0|||
162764122|NCT00705159|587846982|FG002|Overall Study|Screen Failure|0|||
162764123|NCT00705159|587846983|FG003|Overall Study|Screen Failure|1|||
162764124|NCT00526994|587846984|FG000|Overall Study|Lost to Follow-up|98|||
162764125|NCT00526994|587846985|FG001|Overall Study|Lost to Follow-up|108|||
162764126|NCT00526994|587846986|FG002|Overall Study|Lost to Follow-up|96|||
162764127|NCT00526994|587846984|FG000|Overall Study|Death|4|||
162764128|NCT00526994|587846985|FG001|Overall Study|Death|3|||
162764129|NCT00526994|587846986|FG002|Overall Study|Death|3|||
162764130|NCT00526994|587846984|FG000|Overall Study|Withdrawal by Subject|2|||
162764131|NCT00526994|587846985|FG001|Overall Study|Withdrawal by Subject|7|||
162764132|NCT00526994|587846986|FG002|Overall Study|Withdrawal by Subject|5|||
162764133|NCT00526994|587846984|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
162764134|NCT00526994|587846985|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
162764135|NCT00526994|587846986|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
162764136|NCT01262456|587846987|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
162764137|NCT01262456|587846988|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
162764138|NCT01262456|587846989|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
162764139|NCT01262456|587846987|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
162764140|NCT01262456|587846988|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
162764141|NCT01262456|587846989|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
162764142|NCT01262456|587846987|FG000|3-Month Double-Blind Period|Adverse Event|6|||
162764143|NCT01262456|587846988|FG001|3-Month Double-Blind Period|Adverse Event|4|||
162764144|NCT01262456|587846989|FG002|3-Month Double-Blind Period|Adverse Event|8|||
162764145|NCT01262456|587846987|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
162764146|NCT01262456|587846988|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
162764147|NCT01262456|587846989|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
162764148|NCT01262456|587846987|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162764149|NCT01262456|587846988|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162764150|NCT01262456|587846989|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162764151|NCT01262456|587846987|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
162764152|NCT01262456|587846988|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
162764153|NCT01262456|587846989|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
162764154|NCT01262456|587846987|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
162764155|NCT01262456|587846988|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
162764156|NCT01262456|587846989|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
162764157|NCT01262456|587846987|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
162764158|NCT01262456|587846988|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
162764159|NCT01262456|587846989|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
162764160|NCT01262456|587846987|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
162764161|NCT01262456|587846988|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
162764162|NCT01262456|587846989|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
162764163|NCT03938272|587846990|FG000|Overall Study|Withdrawal by Subject|1|||
162764164|NCT03938272|587846991|FG001|Overall Study|Withdrawal by Subject|0|||
162764165|NCT03938272|587846990|FG000|Overall Study|Physician Decision|0|||
162764166|NCT03938272|587846991|FG001|Overall Study|Physician Decision|2|||
162764167|NCT03938272|587846990|FG000|Overall Study|Study termination by sponsor|10|||
162764168|NCT03938272|587846991|FG001|Overall Study|Study termination by sponsor|8|||
162764169|NCT01880736|587846999|FG000|Overall Study|Adverse Event|0|||
162764170|NCT01880736|587847000|FG001|Overall Study|Adverse Event|0|||
162764171|NCT01880736|587847001|FG002|Overall Study|Adverse Event|0|||
162764172|NCT01880736|587847002|FG003|Overall Study|Adverse Event|1|||
162764173|NCT01880736|587846999|FG000|Overall Study|Withdrawal Criteria|1|||
162764174|NCT01880736|587847000|FG001|Overall Study|Withdrawal Criteria|2|||
162764175|NCT01880736|587847001|FG002|Overall Study|Withdrawal Criteria|1|||
162764176|NCT01880736|587847002|FG003|Overall Study|Withdrawal Criteria|5|||
162764177|NCT00428714|587847005|FG000|Overall Study|Progressive Disease|28|||
162764178|NCT00428714|587847006|FG001|Overall Study|Progressive Disease|36|||
162764179|NCT00428714|587847005|FG000|Overall Study|Withdrawal by Subject|0|||
162764180|NCT00428714|587847006|FG001|Overall Study|Withdrawal by Subject|3|||
162764181|NCT00428714|587847005|FG000|Overall Study|Adverse Event|0|||
162764182|NCT00428714|587847006|FG001|Overall Study|Adverse Event|2|||
162764183|NCT00428714|587847005|FG000|Overall Study|Physician Decision|1|||
162764184|NCT00428714|587847006|FG001|Overall Study|Physician Decision|1|||
162764185|NCT00428714|587847005|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
162764186|NCT00428714|587847006|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
162764187|NCT00428714|587847005|FG000|Overall Study|Death due to other then PD|1|||
162764188|NCT00428714|587847006|FG001|Overall Study|Death due to other then PD|0|||
162764189|NCT00513071|587847008|FG000|Overall Study|Adverse Event|1|||
162764190|NCT00513071|587847008|FG000|Overall Study|Withdrawal by Subject|1|||
162764191|NCT00513071|587847008|FG000|Overall Study|Physician Decision|3|||
162764192|NCT02106325|587847011|FG000|Phase 1|Lost to Follow-up|2|||
162764193|NCT02106325|587847012|FG001|Phase 1|Lost to Follow-up|2|||
162764194|NCT02106325|587847011|FG000|Phase 2|Lost to Follow-up|2|||
162764195|NCT02106325|587847012|FG001|Phase 2|Lost to Follow-up|3|||
162764196|NCT02106325|587847011|FG000|Phase 3|Lost to Follow-up|2|||
162764197|NCT02106325|587847012|FG001|Phase 3|Lost to Follow-up|1|||
162764198|NCT00452114|587847014|FG000|Overall Study|Physician Decision|3|||
162764199|NCT00452114|587847015|FG001|Overall Study|Physician Decision|3|||
162764200|NCT03242863|587847016|FG000|Study Week 1|Withdrawal by Subject|0|||
162764201|NCT03242863|587847017|FG001|Study Week 1|Withdrawal by Subject|1|||
162764202|NCT03242863|587847018|FG002|Study Week 1|Withdrawal by Subject|0|||
162764203|NCT03242863|587847019|FG003|Study Week 1|Withdrawal by Subject|0|||
162764204|NCT03242863|587847020|FG004|Study Week 1|Withdrawal by Subject|3|||
162764205|NCT03242863|587847021|FG005|Study Week 1|Withdrawal by Subject|0|||
162764206|NCT02831049|587847024|FG000|Overall Study|Lost to Follow-up|0|||
162764207|NCT02831049|587847025|FG001|Overall Study|Lost to Follow-up|0|||
162764208|NCT02831049|587847026|FG002|Overall Study|Lost to Follow-up|1|||
162764209|NCT02831049|587847024|FG000|Overall Study|Withdrawal by Subject|0|||
162764210|NCT02831049|587847025|FG001|Overall Study|Withdrawal by Subject|1|||
162764211|NCT02831049|587847026|FG002|Overall Study|Withdrawal by Subject|1|||
162764212|NCT02831049|587847024|FG000|Overall Study|Pandemic shutdown|1|||
162764213|NCT02831049|587847025|FG001|Overall Study|Pandemic shutdown|0|||
162764214|NCT02831049|587847026|FG002|Overall Study|Pandemic shutdown|0|||
162764215|NCT03786471|587847028|FG000|Overall Study|Death|254|||
162764216|NCT03786471|587847029|FG001|Overall Study|Death|223|||
162764217|NCT03786471|587847030|FG002|Overall Study|Death|37|||
162764218|NCT03786471|587847028|FG000|Overall Study|Lost to Follow-up|63|||
162764219|NCT03786471|587847029|FG001|Overall Study|Lost to Follow-up|50|||
162764220|NCT03786471|587847030|FG002|Overall Study|Lost to Follow-up|15|||
162764221|NCT03786471|587847028|FG000|Overall Study|Withdrawal by Subject|99|||
162764222|NCT03786471|587847029|FG001|Overall Study|Withdrawal by Subject|81|||
162764223|NCT03786471|587847030|FG002|Overall Study|Withdrawal by Subject|11|||
162764224|NCT00747149|587848381|FG000|Overall Study|Adverse Event|0|||
162764225|NCT00747149|587848382|FG001|Overall Study|Adverse Event|15|||
162764226|NCT00747149|587848381|FG000|Overall Study|Lost to Follow-up|0|||
162764227|NCT00747149|587848382|FG001|Overall Study|Lost to Follow-up|10|||
162764228|NCT00747149|587848381|FG000|Overall Study|Withdrawal by Subject|0|||
162764229|NCT00747149|587848382|FG001|Overall Study|Withdrawal by Subject|6|||
162764230|NCT00747149|587848381|FG000|Overall Study|Did not receive treatment|0|||
162764231|NCT00747149|587848382|FG001|Overall Study|Did not receive treatment|1|||
162764232|NCT00747149|587848381|FG000|Overall Study|Incorrect enrollment|0|||
162764233|NCT00747149|587848382|FG001|Overall Study|Incorrect enrollment|6|||
162764234|NCT00747149|587848381|FG000|Overall Study|Severe non-compliance to protocol|0|||
162764235|NCT00747149|587848382|FG001|Overall Study|Severe non-compliance to protocol|1|||
162764236|NCT00747149|587848381|FG000|Overall Study|Not reported|1|||
162764237|NCT00747149|587848382|FG001|Overall Study|Not reported|4|||
162764238|NCT03141177|587848385|FG000|Overall Study|Death|62|||
162764239|NCT03141177|587848386|FG001|Overall Study|Death|13|||
162764240|NCT03141177|587848387|FG002|Overall Study|Death|84|||
162764241|NCT03141177|587848385|FG000|Overall Study|Participant withdrew consent|9|||
162764242|NCT03141177|587848386|FG001|Overall Study|Participant withdrew consent|2|||
162764243|NCT03141177|587848387|FG002|Overall Study|Participant withdrew consent|13|||
162764244|NCT03141177|587848385|FG000|Overall Study|Not reported|1|||
162764245|NCT03141177|587848386|FG001|Overall Study|Not reported|0|||
162764246|NCT03141177|587848387|FG002|Overall Study|Not reported|1|||
162764247|NCT03141177|587848385|FG000|Overall Study|Lost to Follow-up|2|||
162764248|NCT03141177|587848386|FG001|Overall Study|Lost to Follow-up|1|||
162764249|NCT03141177|587848387|FG002|Overall Study|Lost to Follow-up|1|||
162764250|NCT03141177|587848385|FG000|Overall Study|Other reasons|4|||
162764251|NCT03141177|587848386|FG001|Overall Study|Other reasons|0|||
162764252|NCT03141177|587848387|FG002|Overall Study|Other reasons|11|||
162764253|NCT03141177|587848385|FG000|Overall Study|Participants did not start treatment period|3|||
162764254|NCT03141177|587848386|FG001|Overall Study|Participants did not start treatment period|0|||
162764255|NCT03141177|587848387|FG002|Overall Study|Participants did not start treatment period|8|||
162764256|NCT00092456|587848390|FG000|Overall Study|Adverse Event|0|||
162764257|NCT00092456|587848391|FG001|Overall Study|Adverse Event|0|||
162764258|NCT00092456|587848392|FG002|Overall Study|Adverse Event|1|||
162764259|NCT00092456|587848393|FG003|Overall Study|Adverse Event|1|||
162764260|NCT00092456|587848390|FG000|Overall Study|Lost to Follow-up|2|||
162764261|NCT00092456|587848391|FG001|Overall Study|Lost to Follow-up|2|||
162764262|NCT00092456|587848392|FG002|Overall Study|Lost to Follow-up|1|||
162764263|NCT00092456|587848393|FG003|Overall Study|Lost to Follow-up|2|||
162764264|NCT00092456|587848390|FG000|Overall Study|Protocol Violation|5|||
162764265|NCT00092456|587848391|FG001|Overall Study|Protocol Violation|7|||
162764266|NCT00092456|587848392|FG002|Overall Study|Protocol Violation|8|||
162764267|NCT00092456|587848393|FG003|Overall Study|Protocol Violation|6|||
162764268|NCT00092456|587848390|FG000|Overall Study|Withdrawal by Subject|13|||
162764269|NCT00092456|587848391|FG001|Overall Study|Withdrawal by Subject|5|||
162764270|NCT00092456|587848392|FG002|Overall Study|Withdrawal by Subject|16|||
162764271|NCT00092456|587848393|FG003|Overall Study|Withdrawal by Subject|6|||
162764272|NCT00092456|587848390|FG000|Overall Study|Moved|1|||
162764273|NCT00092456|587848391|FG001|Overall Study|Moved|1|||
162764274|NCT00092456|587848392|FG002|Overall Study|Moved|0|||
162764275|NCT00092456|587848393|FG003|Overall Study|Moved|1|||
162764276|NCT00092456|587848390|FG000|Overall Study|Other|4|||
162764277|NCT00092456|587848391|FG001|Overall Study|Other|2|||
162764278|NCT00092456|587848392|FG002|Overall Study|Other|3|||
162764279|NCT00092456|587848393|FG003|Overall Study|Other|0|||
162764280|NCT00215943|587848394|FG000|Overall Study|Disease Progression|3|||
162764281|NCT00215943|587848395|FG001|Overall Study|Disease Progression|5|||
162764282|NCT00215943|587848394|FG000|Overall Study|Alternate therapy|0|||
162764283|NCT00215943|587848395|FG001|Overall Study|Alternate therapy|1|||
162764284|NCT00215943|587848394|FG000|Overall Study|Adverse Event|3|||
162764285|NCT00215943|587848395|FG001|Overall Study|Adverse Event|6|||
162764286|NCT00215943|587848394|FG000|Overall Study|Other disease|0|||
162764287|NCT00215943|587848395|FG001|Overall Study|Other disease|1|||
162764288|NCT00215943|587848394|FG000|Overall Study|Other complications|3|||
162764289|NCT00215943|587848395|FG001|Overall Study|Other complications|1|||
162764290|NCT00443820|587848396|FG000|Overall Study|Adverse Event|1|||
162764291|NCT00443820|587848397|FG001|Overall Study|Adverse Event|1|||
162764292|NCT00443820|587848398|FG002|Overall Study|Adverse Event|0|||
162764293|NCT00443820|587848399|FG003|Overall Study|Adverse Event|0|||
162764294|NCT00443820|587848396|FG000|Overall Study|Lack of Efficacy|3|||
162764295|NCT00443820|587848397|FG001|Overall Study|Lack of Efficacy|2|||
162764296|NCT00443820|587848398|FG002|Overall Study|Lack of Efficacy|1|||
162764297|NCT00443820|587848399|FG003|Overall Study|Lack of Efficacy|1|||
162764298|NCT00443820|587848396|FG000|Overall Study|Protocol Violation|2|||
162764299|NCT00443820|587848397|FG001|Overall Study|Protocol Violation|1|||
162764300|NCT00443820|587848398|FG002|Overall Study|Protocol Violation|2|||
162764301|NCT00443820|587848399|FG003|Overall Study|Protocol Violation|1|||
162764302|NCT00443820|587848396|FG000|Overall Study|Withdrawal by Subject|6|||
162764303|NCT00443820|587848397|FG001|Overall Study|Withdrawal by Subject|7|||
162764304|NCT00443820|587848398|FG002|Overall Study|Withdrawal by Subject|8|||
162764305|NCT00443820|587848399|FG003|Overall Study|Withdrawal by Subject|9|||
162764306|NCT00443820|587848396|FG000|Overall Study|Lost to Follow-up|9|||
162764307|NCT00443820|587848397|FG001|Overall Study|Lost to Follow-up|8|||
162764308|NCT00443820|587848398|FG002|Overall Study|Lost to Follow-up|6|||
162764309|NCT00443820|587848399|FG003|Overall Study|Lost to Follow-up|5|||
162764310|NCT00443820|587848396|FG000|Overall Study|Administrative problems|0|||
162764311|NCT00443820|587848397|FG001|Overall Study|Administrative problems|0|||
162764312|NCT00443820|587848398|FG002|Overall Study|Administrative problems|0|||
162764313|NCT00443820|587848399|FG003|Overall Study|Administrative problems|1|||
162764314|NCT00443820|587848396|FG000|Overall Study|Death|0|||
162764315|NCT00443820|587848397|FG001|Overall Study|Death|0|||
162764316|NCT00443820|587848398|FG002|Overall Study|Death|1|||
162764317|NCT00443820|587848399|FG003|Overall Study|Death|0|||
162764318|NCT02121808|587848400|FG000|Overall Study|Technical problem|3|||
162764319|NCT03924193|587848401|FG000|Overall Study|Adverse Event|10|||
162764320|NCT03924193|587848402|FG001|Overall Study|Adverse Event|0|||
162764321|NCT03924193|587848403|FG002|Overall Study|Adverse Event|10|||
162764322|NCT03924193|587848401|FG000|Overall Study|Withdrawal by Subject|5|||
162764323|NCT03924193|587848402|FG001|Overall Study|Withdrawal by Subject|10|||
162764324|NCT03924193|587848403|FG002|Overall Study|Withdrawal by Subject|2|||
162764325|NCT02489799|587848404|FG000|Overall Study|Lost to Follow-up|4|||
162764326|NCT02489799|587848405|FG001|Overall Study|Lost to Follow-up|1|||
162764327|NCT02489799|587848404|FG000|Overall Study|Failure to Maintain Eligibility|4|||
162764328|NCT02489799|587848405|FG001|Overall Study|Failure to Maintain Eligibility|6|||
162764329|NCT02489799|587848404|FG000|Overall Study|Withdrawal by Subject|1|||
162764330|NCT02489799|587848405|FG001|Overall Study|Withdrawal by Subject|1|||
162764331|NCT02489799|587848404|FG000|Overall Study|Death|0|||
162764332|NCT02489799|587848405|FG001|Overall Study|Death|1|||
162764333|NCT00515112|587848407|FG000|Overall Study|Death|0|||
162764334|NCT00515112|587848408|FG001|Overall Study|Death|1|||
162764335|NCT00515112|587848407|FG000|Overall Study|The study was terminated|3|||
162764336|NCT00515112|587848408|FG001|Overall Study|The study was terminated|2|||
162764337|NCT02753075|587848415|FG000|Overall Study|Adverse Event|2|||
162764338|NCT02753075|587848416|FG001|Overall Study|Adverse Event|1|||
162764339|NCT02753075|587848417|FG002|Overall Study|Adverse Event|0|||
162764340|NCT02753075|587848415|FG000|Overall Study|Lost to Follow-up|2|||
162764341|NCT02753075|587848416|FG001|Overall Study|Lost to Follow-up|0|||
162764342|NCT02753075|587848417|FG002|Overall Study|Lost to Follow-up|0|||
162764343|NCT02753075|587848415|FG000|Overall Study|Withdrawal of Consent|1|||
162764344|NCT02753075|587848416|FG001|Overall Study|Withdrawal of Consent|1|||
162764345|NCT02753075|587848417|FG002|Overall Study|Withdrawal of Consent|3|||
162764346|NCT02753075|587848415|FG000|Overall Study|Physician Decision|3|||
162764347|NCT02753075|587848416|FG001|Overall Study|Physician Decision|1|||
162764348|NCT02753075|587848417|FG002|Overall Study|Physician Decision|0|||
162764349|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
162764350|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
162764351|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
162764352|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
162764353|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Adverse Event|7|||
162764354|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Adverse Event|8|||
162764355|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Adverse Event|8|||
162764356|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Adverse Event|9|||
162764357|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
162764358|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
162764359|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
162764360|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
162764361|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
162764362|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
162764363|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
162764364|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
162764365|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Pregnancy|0|||
162764366|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Pregnancy|2|||
162764367|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Pregnancy|2|||
162764368|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Pregnancy|0|||
162764369|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Non-compliance|1|||
162764370|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Non-compliance|0|||
162764371|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Non-compliance|0|||
162764372|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Non-compliance|3|||
162764373|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Other|3|||
162764374|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Other|0|||
162764375|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Other|3|||
162764376|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Other|2|||
162764377|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162764378|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162764379|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162764380|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
162764381|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
162764382|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
162764383|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
162764384|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
162764385|NCT02143713|587848418|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
162764386|NCT02143713|587848419|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
162764387|NCT02143713|587848420|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
162764388|NCT02143713|587848421|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
162764389|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
162764390|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
162764391|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162764392|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
162764393|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162764394|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162764395|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
162764396|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162764397|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
162764398|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
162764399|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
162764400|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
162764401|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
162764402|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
162764403|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
162764404|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
162764405|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
162764406|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
162764407|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
162764408|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
162764409|NCT02143713|587848418|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
162764410|NCT02143713|587848419|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
162764411|NCT02143713|587848420|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
162764412|NCT02143713|587848421|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
162764413|NCT01999335|587848422|FG000|Overall Study|Discontinued before receiving treatment|0|||
162764414|NCT01999335|587848423|FG001|Overall Study|Discontinued before receiving treatment|0|||
162764415|NCT01999335|587848424|FG002|Overall Study|Discontinued before receiving treatment|0|||
162764416|NCT01999335|587848425|FG003|Overall Study|Discontinued before receiving treatment|0|||
162764417|NCT01999335|587848426|FG004|Overall Study|Discontinued before receiving treatment|2|||
162764418|NCT01215253|587848427|FG000|Overall Study|Withdrawal by Subject|57|||
162764419|NCT01215253|587848428|FG001|Overall Study|Withdrawal by Subject|35|||
162764420|NCT01215253|587848427|FG000|Overall Study|Physician Decision|9|||
162764421|NCT01215253|587848428|FG001|Overall Study|Physician Decision|12|||
162764422|NCT01215253|587848427|FG000|Overall Study|Lost to Follow-up|6|||
162764423|NCT01215253|587848428|FG001|Overall Study|Lost to Follow-up|4|||
162764424|NCT01215253|587848427|FG000|Overall Study|Other|14|||
162764425|NCT01215253|587848428|FG001|Overall Study|Other|12|||
162764426|NCT00080119|587848429|FG000|Overall Study|Discontinued because of study closure|0|||
162764427|NCT00080119|587848430|FG001|Overall Study|Discontinued because of study closure|0|||
162764428|NCT00080119|587848431|FG002|Overall Study|Discontinued because of study closure|130|||
162764429|NCT00080119|587848432|FG003|Overall Study|Discontinued because of study closure|141|||
162764430|NCT00080119|587848429|FG000|Overall Study|Unable to get to clinic|24|||
162764431|NCT00080119|587848430|FG001|Overall Study|Unable to get to clinic|24|||
162764432|NCT00080119|587848431|FG002|Overall Study|Unable to get to clinic|7|||
162764433|NCT00080119|587848432|FG003|Overall Study|Unable to get to clinic|1|||
162764434|NCT00080119|587848429|FG000|Overall Study|Consent withdrawn|13|||
162764435|NCT00080119|587848430|FG001|Overall Study|Consent withdrawn|17|||
162764436|NCT00080119|587848431|FG002|Overall Study|Consent withdrawn|4|||
162764437|NCT00080119|587848432|FG003|Overall Study|Consent withdrawn|6|||
162764438|NCT00080119|587848429|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
162764439|NCT00080119|587848430|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
162764440|NCT00080119|587848431|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
162764441|NCT00080119|587848432|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
162764442|NCT00080119|587848429|FG000|Overall Study|Lost to Follow-up|16|||
162764443|NCT00080119|587848430|FG001|Overall Study|Lost to Follow-up|19|||
162764444|NCT00080119|587848431|FG002|Overall Study|Lost to Follow-up|19|||
162764445|NCT00080119|587848432|FG003|Overall Study|Lost to Follow-up|14|||
162764446|NCT00889863|587848434|FG000|Part I: Open Label|Death|1|||
162764447|NCT00889863|587848435|FG001|Part I: Open Label|Death|0|||
162764448|NCT00889863|587848434|FG000|Part I: Open Label|Adverse Event|4|||
162764449|NCT00889863|587848435|FG001|Part I: Open Label|Adverse Event|0|||
162764450|NCT00889863|587848434|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
162764451|NCT00889863|587848435|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
162764452|NCT00889863|587848434|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
162764453|NCT00889863|587848435|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
162764454|NCT00889863|587848434|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
162764455|NCT00889863|587848435|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
162764456|NCT00889863|587848434|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
162764457|NCT00889863|587848435|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
162764458|NCT00889863|587848434|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
162764459|NCT00889863|587848435|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
162764460|NCT04410445|587848436|FG000|Overall Study|Lost to Follow-up|3|||
162764461|NCT04410445|587848437|FG001|Overall Study|Lost to Follow-up|9|||
162764462|NCT04410445|587848436|FG000|Overall Study|Withdrawal by Subject|27|||
162764463|NCT04410445|587848437|FG001|Overall Study|Withdrawal by Subject|15|||
162764464|NCT02005484|587848440|FG000|Overall Study|Death|1|||
162764465|NCT02005484|587848440|FG000|Overall Study|Disease progression|1|||
162764466|NCT02005484|587848440|FG000|Overall Study|Changed to a Different Study|1|||
162764467|NCT02005484|587848440|FG000|Overall Study|Sponsor decision|1|||
162764468|NCT03909100|587848442|FG000|Overall Study|Protocol Deviation|2|||
162764469|NCT03909100|587848442|FG000|Overall Study|Technical Problems|4|||
162764470|NCT03909100|587848442|FG000|Overall Study|Withdrawal by Subject|4|||
162764471|NCT03909100|587848442|FG000|Overall Study|Lost to Follow-up|1|||
162764472|NCT03909100|587848442|FG000|Overall Study|Reason not Specified|4|||
162764473|NCT01794299|587848444|FG000|Overall Study|ATIR manufacturing not possible|1|||
162764474|NCT01794299|587848444|FG000|Overall Study|Death|14|||
162764475|NCT01794299|587848444|FG000|Overall Study|Graft failure|1|||
162764476|NCT01794299|587848444|FG000|Overall Study|ATIR batch rejected|2|||
162764477|NCT01794299|587848444|FG000|Overall Study|Relapse|2|||
162764478|NCT01794299|587848444|FG000|Overall Study|Discontinued from active follow-up|1|||
162764479|NCT01794299|587848444|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
162764480|NCT03006393|587848445|FG000|Overall Study|Withdrawal by Subject|1|||
162764481|NCT03006393|587848446|FG001|Overall Study|Withdrawal by Subject|1|||
162764482|NCT03006393|587848445|FG000|Overall Study|Pregnancy|0|||
162764483|NCT03006393|587848446|FG001|Overall Study|Pregnancy|1|||
162764484|NCT03006393|587848445|FG000|Overall Study|Lost to Follow-up|0|||
162764485|NCT03006393|587848446|FG001|Overall Study|Lost to Follow-up|1|||
162764486|NCT00807599|587848449|FG000|Overall Study|Not treated on protocol study|0|||
162764487|NCT00807599|587848450|FG001|Overall Study|Not treated on protocol study|0|||
162764488|NCT00807599|587848451|FG002|Overall Study|Not treated on protocol study|2|||
162764489|NCT00807599|587848449|FG000|Overall Study|Adverse Event|0|||
162764490|NCT00807599|587848450|FG001|Overall Study|Adverse Event|0|||
162764491|NCT00807599|587848451|FG002|Overall Study|Adverse Event|5|||
162764492|NCT00807599|587848449|FG000|Overall Study|Inadequate response to induction|0|||
162764493|NCT00807599|587848450|FG001|Overall Study|Inadequate response to induction|0|||
162764494|NCT00807599|587848451|FG002|Overall Study|Inadequate response to induction|9|||
162764495|NCT00807599|587848449|FG000|Overall Study|Withdrawal by Subject|0|||
162764496|NCT00807599|587848450|FG001|Overall Study|Withdrawal by Subject|0|||
162764497|NCT00807599|587848451|FG002|Overall Study|Withdrawal by Subject|1|||
162764498|NCT03695185|587848452|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
162764499|NCT03695185|587848452|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
162764500|NCT03695185|587848452|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
162764501|NCT03695185|587848452|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
162764502|NCT03695185|587848452|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
162764503|NCT03695185|587848452|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
162764504|NCT04183491|587848455|FG000|Overall Study|Withdrawal by Subject|0|||
162764505|NCT04183491|587848456|FG001|Overall Study|Withdrawal by Subject|0|||
162764506|NCT04183491|587848457|FG002|Overall Study|Withdrawal by Subject|1|||
162764507|NCT04183491|587848458|FG003|Overall Study|Withdrawal by Subject|0|||
162764508|NCT04183491|587848459|FG004|Overall Study|Withdrawal by Subject|0|||
162764509|NCT04183491|587848460|FG005|Overall Study|Withdrawal by Subject|1|||
162764510|NCT04183491|587848461|FG006|Overall Study|Withdrawal by Subject|0|||
162764511|NCT02538094|587848462|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
162764512|NCT02538094|587848463|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
162764513|NCT02538094|587848462|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
162764514|NCT02538094|587848463|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
162764515|NCT03288506|587848464|FG000|Overall Study|Withdrawal by Subject|52|||
162764516|NCT03692871|587848465|FG000|Overall Study|Death|1|||
162764517|NCT03692871|587848466|FG001|Overall Study|Death|1|||
162764518|NCT03692871|587848465|FG000|Overall Study|Lost to Follow-up|24|||
162764519|NCT03692871|587848466|FG001|Overall Study|Lost to Follow-up|9|||
162764520|NCT03692871|587848465|FG000|Overall Study|Physician Decision|22|||
162764521|NCT03692871|587848466|FG001|Overall Study|Physician Decision|7|||
162764522|NCT03692871|587848465|FG000|Overall Study|Protocol Deviation|1|||
162764523|NCT03692871|587848466|FG001|Overall Study|Protocol Deviation|0|||
162764524|NCT03692871|587848465|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
162764525|NCT03692871|587848466|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
162764526|NCT02852824|587848470|FG000|Overall Study|Withdrawal by Subject|1|||
162764527|NCT02852824|587848471|FG001|Overall Study|Withdrawal by Subject|0|||
162764528|NCT02852824|587848472|FG002|Overall Study|Withdrawal by Subject|0|||
162764529|NCT02852824|587848473|FG003|Overall Study|Withdrawal by Subject|0|||
162764530|NCT02852824|587848474|FG004|Overall Study|Withdrawal by Subject|0|||
162764531|NCT02852824|587848475|FG005|Overall Study|Withdrawal by Subject|0|||
162764532|NCT02852824|587848476|FG006|Overall Study|Withdrawal by Subject|0|||
162764533|NCT02852824|587848470|FG000|Overall Study|Adverse Event|0|||
162764534|NCT02852824|587848471|FG001|Overall Study|Adverse Event|0|||
162764535|NCT02852824|587848472|FG002|Overall Study|Adverse Event|0|||
162764536|NCT02852824|587848473|FG003|Overall Study|Adverse Event|0|||
162764537|NCT02852824|587848474|FG004|Overall Study|Adverse Event|2|||
162764538|NCT02852824|587848475|FG005|Overall Study|Adverse Event|0|||
162764539|NCT02852824|587848476|FG006|Overall Study|Adverse Event|0|||
162764540|NCT01316913|587848477|FG000|Overall Study|Adverse Event|17|||
162764541|NCT01316913|587848478|FG001|Overall Study|Adverse Event|20|||
162764542|NCT01316913|587848479|FG002|Overall Study|Adverse Event|15|||
162764543|NCT01316913|587848480|FG003|Overall Study|Adverse Event|11|||
162764544|NCT01316913|587848477|FG000|Overall Study|Lack of Efficacy|22|||
162764545|NCT01316913|587848478|FG001|Overall Study|Lack of Efficacy|12|||
162764546|NCT01316913|587848479|FG002|Overall Study|Lack of Efficacy|9|||
162764547|NCT01316913|587848480|FG003|Overall Study|Lack of Efficacy|13|||
162764548|NCT01316913|587848477|FG000|Overall Study|Protocol Violation|1|||
162764549|NCT01316913|587848478|FG001|Overall Study|Protocol Violation|4|||
162764550|NCT01316913|587848479|FG002|Overall Study|Protocol Violation|4|||
162764551|NCT01316913|587848480|FG003|Overall Study|Protocol Violation|1|||
162764552|NCT01316913|587848477|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
162764553|NCT01316913|587848478|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
162764554|NCT01316913|587848479|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
162764555|NCT01316913|587848480|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
162764556|NCT01316913|587848477|FG000|Overall Study|Lost to Follow-up|0|||
162764557|NCT01316913|587848478|FG001|Overall Study|Lost to Follow-up|1|||
162764558|NCT01316913|587848479|FG002|Overall Study|Lost to Follow-up|0|||
162764559|NCT01316913|587848480|FG003|Overall Study|Lost to Follow-up|2|||
162764560|NCT01316913|587848477|FG000|Overall Study|Withdrawal by Subject|10|||
162764561|NCT01316913|587848478|FG001|Overall Study|Withdrawal by Subject|9|||
162764562|NCT01316913|587848479|FG002|Overall Study|Withdrawal by Subject|10|||
162764563|NCT01316913|587848480|FG003|Overall Study|Withdrawal by Subject|6|||
162764564|NCT01860079|587848481|FG000|Overall Study|Physician Decision|14|||
162764565|NCT01860079|587848482|FG001|Overall Study|Physician Decision|22|||
162764566|NCT02102724|587848483|FG000|Overall Study|Lost to Follow-up|1|||
162764567|NCT02102724|587848484|FG001|Overall Study|Lost to Follow-up|0|||
162764568|NCT02102724|587848483|FG000|Overall Study|surgery for brain aneurysm|1|||
162764569|NCT02102724|587848484|FG001|Overall Study|surgery for brain aneurysm|1|||
162764570|NCT04821271|587848485|FG000|Period 1|Withdrawal by Subject|2|||
162764571|NCT04821271|587848486|FG001|Period 1|Withdrawal by Subject|0|||
162764572|NCT02521493|587848487|FG000|Overall Study|Death|3|||
162764573|NCT02521493|587848488|FG001|Overall Study|Death|4|||
162764574|NCT02521493|587848489|FG002|Overall Study|Death|1|||
162764575|NCT02521493|587848487|FG000|Overall Study|Physician Decision|19|||
162764576|NCT02521493|587848488|FG001|Overall Study|Physician Decision|1|||
162764577|NCT02521493|587848489|FG002|Overall Study|Physician Decision|2|||
162764578|NCT02521493|587848487|FG000|Overall Study|Withdrawal by Subject|3|||
162764579|NCT02521493|587848488|FG001|Overall Study|Withdrawal by Subject|0|||
162764580|NCT02521493|587848489|FG002|Overall Study|Withdrawal by Subject|0|||
162764581|NCT02521493|587848487|FG000|Overall Study|Ineligible|0|||
162764582|NCT02521493|587848488|FG001|Overall Study|Ineligible|1|||
162764583|NCT02521493|587848489|FG002|Overall Study|Ineligible|0|||
162764584|NCT02521493|587848487|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
162764585|NCT02521493|587848488|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
162764586|NCT02521493|587848489|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
162764587|NCT02521493|587848487|FG000|Overall Study|No MRD result|0|||
162764588|NCT02521493|587848488|FG001|Overall Study|No MRD result|0|||
162764589|NCT02521493|587848489|FG002|Overall Study|No MRD result|4|||
162764590|NCT02008916|587848490|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
162764591|NCT02008916|587848491|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
162764592|NCT02008916|587848492|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
162764593|NCT02008916|587848490|FG000|Week 16 - 156|Adverse Event|4|||
162764594|NCT02008916|587848491|FG001|Week 16 - 156|Adverse Event|2|||
162764595|NCT02008916|587848492|FG002|Week 16 - 156|Adverse Event|3|||
162764596|NCT02008916|587848490|FG000|Week 16 - 156|Withdrawal by Subject|7|||
162764597|NCT02008916|587848491|FG001|Week 16 - 156|Withdrawal by Subject|3|||
162764598|NCT02008916|587848492|FG002|Week 16 - 156|Withdrawal by Subject|5|||
162764599|NCT02008916|587848490|FG000|Week 16 - 156|No longer requires treatment|0|||
162764600|NCT02008916|587848491|FG001|Week 16 - 156|No longer requires treatment|1|||
162764601|NCT02008916|587848492|FG002|Week 16 - 156|No longer requires treatment|0|||
162764602|NCT02008916|587848490|FG000|Week 16 - 156|Lost to Follow-up|5|||
162764603|NCT02008916|587848491|FG001|Week 16 - 156|Lost to Follow-up|0|||
162764604|NCT02008916|587848492|FG002|Week 16 - 156|Lost to Follow-up|0|||
162764605|NCT02008916|587848490|FG000|Week 16 - 156|Lack of Efficacy|3|||
162764606|NCT02008916|587848491|FG001|Week 16 - 156|Lack of Efficacy|5|||
162764607|NCT02008916|587848492|FG002|Week 16 - 156|Lack of Efficacy|2|||
162764608|NCT02008916|587848490|FG000|Week 16 - 156|Pregnancy|0|||
162764609|NCT02008916|587848491|FG001|Week 16 - 156|Pregnancy|1|||
162764610|NCT02008916|587848492|FG002|Week 16 - 156|Pregnancy|0|||
162764611|NCT02008916|587848490|FG000|Week 16 - 156|Physician Decision|0|||
162764612|NCT02008916|587848491|FG001|Week 16 - 156|Physician Decision|1|||
162764613|NCT02008916|587848492|FG002|Week 16 - 156|Physician Decision|0|||
162764614|NCT01915914|587848494|FG000|Acute Phase|Withdrawal by Subject|4|||
162764615|NCT01915914|587848495|FG001|Acute Phase|Withdrawal by Subject|0|||
162764616|NCT01915914|587848496|FG002|Acute Phase|Withdrawal by Subject|0|||
162764617|NCT01915914|587848497|FG003|Acute Phase|Withdrawal by Subject|0|||
162764618|NCT01915914|587848494|FG000|Acute Phase|Lost to Follow-up|4|||
162764619|NCT01915914|587848495|FG001|Acute Phase|Lost to Follow-up|0|||
162764620|NCT01915914|587848496|FG002|Acute Phase|Lost to Follow-up|0|||
162764621|NCT01915914|587848497|FG003|Acute Phase|Lost to Follow-up|0|||
162764622|NCT01915914|587848494|FG000|Acute Phase|Physician Decision|1|||
162764623|NCT01915914|587848495|FG001|Acute Phase|Physician Decision|0|||
162764624|NCT01915914|587848496|FG002|Acute Phase|Physician Decision|0|||
162764625|NCT01915914|587848497|FG003|Acute Phase|Physician Decision|0|||
162764626|NCT01915914|587848494|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
162764627|NCT01915914|587848495|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
162764628|NCT01915914|587848496|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
162764629|NCT01915914|587848497|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
162764630|NCT01915914|587848494|FG000|Acute Phase|"Not Achieved treatment success"|1|||
162764631|NCT01915914|587848495|FG001|Acute Phase|"Not Achieved treatment success"|0|||
162764632|NCT01915914|587848496|FG002|Acute Phase|"Not Achieved treatment success"|0|||
162764633|NCT01915914|587848497|FG003|Acute Phase|"Not Achieved treatment success"|0|||
162764634|NCT01915914|587848494|FG000|Acute Phase|Missing|1|||
162764635|NCT01915914|587848495|FG001|Acute Phase|Missing|0|||
162764636|NCT01915914|587848496|FG002|Acute Phase|Missing|0|||
162764637|NCT01915914|587848497|FG003|Acute Phase|Missing|0|||
162764638|NCT01915914|587848494|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162764639|NCT01915914|587848495|FG001|Maintenance Phase|Withdrawal by Subject|1|||
162764640|NCT01915914|587848496|FG002|Maintenance Phase|Withdrawal by Subject|1|||
162764641|NCT01915914|587848497|FG003|Maintenance Phase|Withdrawal by Subject|0|||
162764642|NCT01915914|587848494|FG000|Maintenance Phase|Lost to Follow-up|0|||
162764643|NCT01915914|587848495|FG001|Maintenance Phase|Lost to Follow-up|4|||
162764644|NCT01915914|587848496|FG002|Maintenance Phase|Lost to Follow-up|1|||
162764645|NCT01915914|587848497|FG003|Maintenance Phase|Lost to Follow-up|0|||
162764646|NCT01915914|587848494|FG000|Maintenance Phase|Missing|0|||
162764647|NCT01915914|587848495|FG001|Maintenance Phase|Missing|1|||
162764648|NCT01915914|587848496|FG002|Maintenance Phase|Missing|0|||
162764649|NCT01915914|587848497|FG003|Maintenance Phase|Missing|0|||
162764650|NCT01915914|587848494|FG000|Follow-up Phase|Withdrawal by Subject|0|||
162764651|NCT01915914|587848495|FG001|Follow-up Phase|Withdrawal by Subject|0|||
162764652|NCT01915914|587848496|FG002|Follow-up Phase|Withdrawal by Subject|0|||
162764653|NCT01915914|587848497|FG003|Follow-up Phase|Withdrawal by Subject|1|||
162764654|NCT01915914|587848494|FG000|Follow-up Phase|Physician Decision|0|||
162764655|NCT01915914|587848495|FG001|Follow-up Phase|Physician Decision|0|||
162764656|NCT01915914|587848496|FG002|Follow-up Phase|Physician Decision|0|||
162764657|NCT01915914|587848497|FG003|Follow-up Phase|Physician Decision|1|||
162764658|NCT04602728|587848503|FG000|Overall Study|Lost to Follow-up|4|||
162764659|NCT04602728|587848504|FG001|Overall Study|Lost to Follow-up|4|||
162764660|NCT05338476|587848507|FG000|Period 2|Adverse Event|0|||
162764661|NCT05338476|587848508|FG001|Period 2|Adverse Event|1|||
162764662|NCT05522777|587850022|FG000|Overall Study|Lack of Efficacy|1|||
162764663|NCT05522777|587850022|FG000|Overall Study|Withdrawal by Subject|1|||
162764664|NCT05487300|587850023|FG000|Overall Study|Withdrawal by Subject|1|||
162764665|NCT05487300|587850024|FG001|Overall Study|Withdrawal by Subject|0|||
162764666|NCT01241448|587850029|FG000|Overall Study|Adverse Event|1|||
162764667|NCT01241448|587850030|FG001|Overall Study|Adverse Event|0|||
162764668|NCT01241448|587850031|FG002|Overall Study|Adverse Event|2|||
162764669|NCT01241448|587850032|FG003|Overall Study|Adverse Event|2|||
162764670|NCT01241448|587850029|FG000|Overall Study|Lost to Follow-up|2|||
162764671|NCT01241448|587850030|FG001|Overall Study|Lost to Follow-up|1|||
162764672|NCT01241448|587850031|FG002|Overall Study|Lost to Follow-up|1|||
162764673|NCT01241448|587850032|FG003|Overall Study|Lost to Follow-up|1|||
162764674|NCT01241448|587850029|FG000|Overall Study|Physician Decision|0|||
162764675|NCT01241448|587850030|FG001|Overall Study|Physician Decision|2|||
162764676|NCT01241448|587850031|FG002|Overall Study|Physician Decision|0|||
162764677|NCT01241448|587850032|FG003|Overall Study|Physician Decision|0|||
162764678|NCT01241448|587850029|FG000|Overall Study|Protocol Violation|10|||
162764679|NCT01241448|587850030|FG001|Overall Study|Protocol Violation|5|||
162764680|NCT01241448|587850031|FG002|Overall Study|Protocol Violation|3|||
162764681|NCT01241448|587850032|FG003|Overall Study|Protocol Violation|6|||
162764682|NCT01241448|587850029|FG000|Overall Study|Sponsor Decision|17|||
162764683|NCT01241448|587850030|FG001|Overall Study|Sponsor Decision|14|||
162764684|NCT01241448|587850031|FG002|Overall Study|Sponsor Decision|12|||
162764685|NCT01241448|587850032|FG003|Overall Study|Sponsor Decision|6|||
162764686|NCT01241448|587850029|FG000|Overall Study|Withdrawal by Subject|4|||
162764687|NCT01241448|587850030|FG001|Overall Study|Withdrawal by Subject|5|||
162764688|NCT01241448|587850031|FG002|Overall Study|Withdrawal by Subject|3|||
162764689|NCT01241448|587850032|FG003|Overall Study|Withdrawal by Subject|6|||
162764690|NCT01241448|587850029|FG000|Overall Study|Excluded due to data integrity issues|3|||
162764691|NCT01241448|587850030|FG001|Overall Study|Excluded due to data integrity issues|2|||
162764692|NCT01241448|587850031|FG002|Overall Study|Excluded due to data integrity issues|2|||
162764693|NCT01241448|587850032|FG003|Overall Study|Excluded due to data integrity issues|2|||
162764694|NCT00304278|587850034|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
162764695|NCT00304278|587850034|FG000|Overall Study|PT had medical condition preventing TX|1|||
162764696|NCT01304940|587850035|FG000|Overall Study|not meet symptom severity requirement|3|||
162764697|NCT01304940|587850036|FG001|Overall Study|not meet symptom severity requirement|0|||
162764698|NCT02065895|587850039|FG000|Overall Study|Protocol Violation|1|||
162764699|NCT02065895|587850040|FG001|Overall Study|Protocol Violation|0|||
162764700|NCT02065895|587850041|FG002|Overall Study|Protocol Violation|0|||
162764701|NCT02065895|587850042|FG003|Overall Study|Protocol Violation|1|||
162764702|NCT02065895|587850043|FG004|Overall Study|Protocol Violation|0|||
162764703|NCT02065895|587850044|FG005|Overall Study|Protocol Violation|0|||
162764704|NCT02065895|587850039|FG000|Overall Study|Scheduling conflicts|0|||
162764705|NCT02065895|587850040|FG001|Overall Study|Scheduling conflicts|1|||
162764706|NCT02065895|587850041|FG002|Overall Study|Scheduling conflicts|0|||
162764707|NCT02065895|587850042|FG003|Overall Study|Scheduling conflicts|0|||
162764708|NCT02065895|587850043|FG004|Overall Study|Scheduling conflicts|0|||
162764709|NCT02065895|587850044|FG005|Overall Study|Scheduling conflicts|0|||
162764710|NCT03740737|587850045|FG000|Overall Study|Protocol deviation|13|||
162764711|NCT03740737|587850046|FG001|Overall Study|Protocol deviation|0|||
162764712|NCT03740737|587850045|FG000|Overall Study|Adverse Event|2|||
162764713|NCT03740737|587850046|FG001|Overall Study|Adverse Event|0|||
162764714|NCT03740737|587850045|FG000|Overall Study|Lost to Follow-up|1|||
162764715|NCT03740737|587850046|FG001|Overall Study|Lost to Follow-up|0|||
162764716|NCT03740737|587850045|FG000|Overall Study|Randomization failure|1|||
162764717|NCT03740737|587850046|FG001|Overall Study|Randomization failure|0|||
162764718|NCT03740737|587850045|FG000|Overall Study|Participant withdrew consent|1|||
162764719|NCT03740737|587850046|FG001|Overall Study|Participant withdrew consent|0|||
162764720|NCT03740737|587850045|FG000|Overall Study|Participant withdrew from trial|2|||
162764721|NCT03740737|587850046|FG001|Overall Study|Participant withdrew from trial|1|||
162764722|NCT00507429|587850047|FG000|Treatment Phase|Disease Progression|12|||
162764723|NCT00507429|587850048|FG001|Treatment Phase|Disease Progression|5|||
162764724|NCT00507429|587850047|FG000|Treatment Phase|Adverse Event|12|||
162764725|NCT00507429|587850048|FG001|Treatment Phase|Adverse Event|5|||
162764726|NCT00507429|587850047|FG000|Treatment Phase|Withdrawal by Subject|3|||
162764727|NCT00507429|587850048|FG001|Treatment Phase|Withdrawal by Subject|3|||
162764728|NCT00507429|587850047|FG000|Treatment Phase|Physician Decision|4|||
162764729|NCT00507429|587850048|FG001|Treatment Phase|Physician Decision|2|||
162764730|NCT00507429|587850047|FG000|Treatment Phase|Other|6|||
162764731|NCT00507429|587850048|FG001|Treatment Phase|Other|3|||
162764732|NCT00507429|587850047|FG000|Maintenance Phase|Progressive Disease|14|||
162764733|NCT00507429|587850048|FG001|Maintenance Phase|Progressive Disease|0|||
162764734|NCT04025762|587850051|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
162764735|NCT04025762|587850052|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
162764736|NCT03340961|587850057|FG000|Overall Study|Adverse Event|1|||
162764737|NCT03340961|587850058|FG001|Overall Study|Adverse Event|3|||
162764738|NCT03340961|587850059|FG002|Overall Study|Adverse Event|2|||
162764739|NCT03340961|587850060|FG003|Overall Study|Adverse Event|4|||
162764740|NCT03340961|587850057|FG000|Overall Study|Lost to Follow-up|0|||
162764741|NCT03340961|587850058|FG001|Overall Study|Lost to Follow-up|1|||
162764742|NCT03340961|587850059|FG002|Overall Study|Lost to Follow-up|0|||
162764743|NCT03340961|587850060|FG003|Overall Study|Lost to Follow-up|1|||
162764744|NCT03340961|587850057|FG000|Overall Study|Withdrawal by Subject|3|||
162764745|NCT03340961|587850058|FG001|Overall Study|Withdrawal by Subject|2|||
162764746|NCT03340961|587850059|FG002|Overall Study|Withdrawal by Subject|4|||
162764747|NCT03340961|587850060|FG003|Overall Study|Withdrawal by Subject|7|||
162764748|NCT03340961|587850057|FG000|Overall Study|Use of prohibited treatment|0|||
162764749|NCT03340961|587850058|FG001|Overall Study|Use of prohibited treatment|3|||
162764750|NCT03340961|587850059|FG002|Overall Study|Use of prohibited treatment|2|||
162764751|NCT03340961|587850060|FG003|Overall Study|Use of prohibited treatment|4|||
162764752|NCT03340961|587850057|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
162764753|NCT03340961|587850058|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
162764754|NCT03340961|587850059|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
162764755|NCT03340961|587850060|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
162764756|NCT03340961|587850057|FG000|Overall Study|Subject developed an exclusion criterion|0|||
162764757|NCT03340961|587850058|FG001|Overall Study|Subject developed an exclusion criterion|1|||
162764758|NCT03340961|587850059|FG002|Overall Study|Subject developed an exclusion criterion|0|||
162764759|NCT03340961|587850060|FG003|Overall Study|Subject developed an exclusion criterion|0|||
162764760|NCT03340961|587850057|FG000|Overall Study|Protocol Violation|1|||
162764761|NCT03340961|587850058|FG001|Overall Study|Protocol Violation|0|||
162764762|NCT03340961|587850059|FG002|Overall Study|Protocol Violation|1|||
162764763|NCT03340961|587850060|FG003|Overall Study|Protocol Violation|0|||
162764764|NCT03340961|587850057|FG000|Overall Study|Adverse Event|1|||
162764765|NCT03340961|587850058|FG001|Overall Study|Adverse Event|1|||
162764766|NCT03340961|587850059|FG002|Overall Study|Adverse Event|0|||
162764767|NCT03340961|587850060|FG003|Overall Study|Adverse Event|0|||
162764768|NCT03340961|587850057|FG000|Overall Study|Lack of Efficacy|0|||
162764769|NCT03340961|587850058|FG001|Overall Study|Lack of Efficacy|0|||
162764770|NCT03340961|587850059|FG002|Overall Study|Lack of Efficacy|0|||
162764771|NCT03340961|587850060|FG003|Overall Study|Lack of Efficacy|1|||
162764772|NCT03137784|587850063|FG000|Overall Study|Adverse Event|1|||
162764773|NCT03137784|587850064|FG001|Overall Study|Adverse Event|1|||
162764774|NCT03137784|587850065|FG002|Overall Study|Adverse Event|0|||
162764775|NCT03137784|587850066|FG003|Overall Study|Adverse Event|0|||
162764776|NCT03137784|587850067|FG004|Overall Study|Adverse Event|0|||
162764777|NCT03137784|587850068|FG005|Overall Study|Adverse Event|0|||
162764778|NCT03137784|587850063|FG000|Overall Study|Subject/guardian decision|1|||
162764779|NCT03137784|587850064|FG001|Overall Study|Subject/guardian decision|0|||
162764780|NCT03137784|587850065|FG002|Overall Study|Subject/guardian decision|0|||
162764781|NCT03137784|587850066|FG003|Overall Study|Subject/guardian decision|0|||
162764782|NCT03137784|587850067|FG004|Overall Study|Subject/guardian decision|0|||
162764783|NCT03137784|587850068|FG005|Overall Study|Subject/guardian decision|0|||
162764784|NCT03137784|587850063|FG000|Overall Study|Non-compliance with study treatment|0|||
162764785|NCT03137784|587850064|FG001|Overall Study|Non-compliance with study treatment|0|||
162764786|NCT03137784|587850065|FG002|Overall Study|Non-compliance with study treatment|0|||
162764787|NCT03137784|587850066|FG003|Overall Study|Non-compliance with study treatment|0|||
162764788|NCT03137784|587850067|FG004|Overall Study|Non-compliance with study treatment|1|||
162764789|NCT03137784|587850068|FG005|Overall Study|Non-compliance with study treatment|0|||
162764790|NCT04803734|587850074|FG000|Overall Study|Withdrawal by Subject|0|||
162764791|NCT04803734|587850075|FG001|Overall Study|Withdrawal by Subject|1|||
162764792|NCT04803734|587850074|FG000|Overall Study|Protocol Violation|0|||
162764793|NCT04803734|587850075|FG001|Overall Study|Protocol Violation|1|||
162764794|NCT02152384|587850089|FG000|Period 1|Withdrawal by Subject|0|||
162764795|NCT02152384|587850090|FG001|Period 1|Withdrawal by Subject|1|||
162764796|NCT02152384|587850089|FG000|Period 1|Adverse Event|1|||
162764797|NCT02152384|587850090|FG001|Period 1|Adverse Event|1|||
162764798|NCT01393600|587850092|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162764799|NCT01393600|587850093|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
162764800|NCT01393600|587850094|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162764801|NCT01393600|587850095|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162764802|NCT01393600|587850092|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162764803|NCT01393600|587850093|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162764804|NCT01393600|587850094|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
162764805|NCT01393600|587850095|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162764806|NCT01393600|587850092|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
162764807|NCT01393600|587850093|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
162764808|NCT01393600|587850094|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
162764809|NCT01393600|587850095|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
162764810|NCT01393600|587850092|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162764811|NCT01393600|587850093|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162764812|NCT01393600|587850094|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162764813|NCT01393600|587850095|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
162764814|NCT01393600|587850092|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162764815|NCT01393600|587850093|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162764816|NCT01393600|587850094|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
162764817|NCT01393600|587850095|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162764818|NCT01393600|587850092|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162764819|NCT01393600|587850093|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162764820|NCT01393600|587850094|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
162764821|NCT01393600|587850095|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162764822|NCT01393600|587850092|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162764823|NCT01393600|587850093|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162764824|NCT01393600|587850094|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
162764825|NCT01393600|587850095|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162764826|NCT00603798|587850096|FG000|Overall Study|Adverse Event|4|||
162764827|NCT00603798|587850097|FG001|Overall Study|Adverse Event|2|||
162764828|NCT00603798|587850098|FG002|Overall Study|Adverse Event|1|||
162764829|NCT00603798|587850096|FG000|Overall Study|Withdrawal by Subject|4|||
162764830|NCT00603798|587850097|FG001|Overall Study|Withdrawal by Subject|3|||
162764831|NCT00603798|587850098|FG002|Overall Study|Withdrawal by Subject|4|||
162764832|NCT00603798|587850096|FG000|Overall Study|Lost to Follow-up|1|||
162764833|NCT00603798|587850097|FG001|Overall Study|Lost to Follow-up|0|||
162764834|NCT00603798|587850098|FG002|Overall Study|Lost to Follow-up|1|||
162764835|NCT00603798|587850096|FG000|Overall Study|Non-compliance with study procedures|0|||
162764836|NCT00603798|587850097|FG001|Overall Study|Non-compliance with study procedures|1|||
162764837|NCT00603798|587850098|FG002|Overall Study|Non-compliance with study procedures|0|||
162764838|NCT00603798|587850096|FG000|Overall Study|Not due to AE|1|||
162764839|NCT00603798|587850097|FG001|Overall Study|Not due to AE|1|||
162764840|NCT00603798|587850098|FG002|Overall Study|Not due to AE|4|||
162764841|NCT02964234|587850104|FG000|Overall Study|Lost to Follow-up|22|||
162764842|NCT02964234|587850105|FG001|Overall Study|Lost to Follow-up|13|||
162764843|NCT01799993|587850106|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
162764844|NCT01799993|587850107|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
162764845|NCT01799993|587850106|FG000|Overall Study|Death|61|||
162764846|NCT01799993|587850107|FG001|Overall Study|Death|45|||
162764847|NCT01799993|587850106|FG000|Overall Study|Withdrawal by Subject|23|||
162764848|NCT01799993|587850107|FG001|Overall Study|Withdrawal by Subject|24|||
162764849|NCT01799993|587850106|FG000|Overall Study|Lost to Follow-up|5|||
162764850|NCT01799993|587850107|FG001|Overall Study|Lost to Follow-up|8|||
162764851|NCT01799993|587850106|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
162764852|NCT01799993|587850107|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
162764853|NCT01799993|587850106|FG000|Overall Study|Protocol driven decision point|0|||
162764854|NCT01799993|587850107|FG001|Overall Study|Protocol driven decision point|3|||
162764855|NCT01799993|587850106|FG000|Overall Study|Protocol Violation|1|||
162764856|NCT01799993|587850107|FG001|Overall Study|Protocol Violation|1|||
162764857|NCT01799993|587850106|FG000|Overall Study|Deterioration of general conditions|2|||
162764858|NCT01799993|587850107|FG001|Overall Study|Deterioration of general conditions|0|||
162764859|NCT01799993|587850106|FG000|Overall Study|Screen failure|0|||
162764860|NCT01799993|587850107|FG001|Overall Study|Screen failure|1|||
162764861|NCT01799993|587850106|FG000|Overall Study|Adverse Event|1|||
162764862|NCT01799993|587850107|FG001|Overall Study|Adverse Event|0|||
162764863|NCT01799993|587850106|FG000|Overall Study|Lack of Efficacy|1|||
162764864|NCT01799993|587850107|FG001|Overall Study|Lack of Efficacy|0|||
162764865|NCT01799993|587850106|FG000|Overall Study|Recovery|0|||
162764866|NCT01799993|587850107|FG001|Overall Study|Recovery|1|||
162764867|NCT01799993|587850106|FG000|Overall Study|Logistical difficulties|1|||
162764868|NCT01799993|587850107|FG001|Overall Study|Logistical difficulties|0|||
162764869|NCT01799993|587850106|FG000|Overall Study|Protocol deviation|1|||
162764870|NCT01799993|587850107|FG001|Overall Study|Protocol deviation|0|||
162764871|NCT01799993|587850106|FG000|Overall Study|Non-compliance with medical device|1|||
162764872|NCT01799993|587850107|FG001|Overall Study|Non-compliance with medical device|0|||
162764873|NCT01799993|587850106|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162764874|NCT01799993|587850107|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162764875|NCT01799993|587850106|FG000|Overall Study|Other|1|||
162764876|NCT01799993|587850107|FG001|Overall Study|Other|0|||
162764877|NCT01799993|587850106|FG000|Overall Study|Subject didn't return for follow-up|0|||
162764878|NCT01799993|587850107|FG001|Overall Study|Subject didn't return for follow-up|1|||
162764879|NCT01320683|587850108|FG000|Overall Study|Positive antibody response|1|||
162764880|NCT04361617|587850109|FG000|Overall Study|Withdrawal by Subject|0|||
162764881|NCT04361617|587850110|FG001|Overall Study|Withdrawal by Subject|1|||
162764882|NCT01263223|587850111|FG000|Period 2|Withdrawal by Subject|0|||
162764883|NCT01263223|587850112|FG001|Period 2|Withdrawal by Subject|1|||
162764884|NCT01263223|587850111|FG000|7-day Follow-up|Withdrawal by Subject|0|||
162764885|NCT01263223|587850112|FG001|7-day Follow-up|Withdrawal by Subject|1|||
162764886|NCT01263223|587850111|FG000|7-day Follow-up|Lost to Follow-up|1|||
162764887|NCT01263223|587850112|FG001|7-day Follow-up|Lost to Follow-up|0|||
162764888|NCT02246647|587850113|FG000|Overall Study|Withdrawal by Subject|1|||
162764889|NCT02246647|587850114|FG001|Overall Study|Withdrawal by Subject|1|||
162764890|NCT01113541|587850116|FG000|Overall Study|Withdrawal by Subject|1|||
162764891|NCT01113541|587850116|FG000|Overall Study|Protocol Violation|1|||
162764892|NCT01113541|587850116|FG000|Overall Study|Study Terminated by Sponsor|7|||
162764893|NCT01113541|587850116|FG000|Overall Study|Adverse Event|4|||
162764894|NCT00274287|587850119|FG000|Overall Study|Withdrawal by Subject|1|||
162764895|NCT00274287|587850119|FG000|Overall Study|subject non-compliance|1|||
162764896|NCT03031782|587850126|FG000|Treatment Period 1|Lack of Efficacy|3|||
162764897|NCT03031782|587850127|FG001|Treatment Period 1|Lack of Efficacy|0|||
162764898|NCT03031782|587850128|FG002|Treatment Period 1|Lack of Efficacy|0|||
162764899|NCT03031782|587850129|FG003|Treatment Period 1|Lack of Efficacy|0|||
162764900|NCT03031782|587850130|FG004|Treatment Period 1|Lack of Efficacy|0|||
162764901|NCT03031782|587850126|FG000|Treatment Period 2|Physician Decision|0|||
162764902|NCT03031782|587850127|FG001|Treatment Period 2|Physician Decision|1|||
162764903|NCT03031782|587850128|FG002|Treatment Period 2|Physician Decision|0|||
162764904|NCT03031782|587850129|FG003|Treatment Period 2|Physician Decision|0|||
162764905|NCT03031782|587850130|FG004|Treatment Period 2|Physician Decision|3|||
162764906|NCT03031782|587850126|FG000|Treatment Period 2|Lack of Efficacy|0|||
162764907|NCT03031782|587850127|FG001|Treatment Period 2|Lack of Efficacy|1|||
162764908|NCT03031782|587850128|FG002|Treatment Period 2|Lack of Efficacy|0|||
162764909|NCT03031782|587850129|FG003|Treatment Period 2|Lack of Efficacy|0|||
162764910|NCT03031782|587850130|FG004|Treatment Period 2|Lack of Efficacy|1|||
162764911|NCT03031782|587850126|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162764912|NCT03031782|587850127|FG001|Treatment Period 2|Withdrawal by Subject|3|||
162764913|NCT03031782|587850128|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162764914|NCT03031782|587850129|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162764915|NCT03031782|587850130|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162764916|NCT03031782|587850126|FG000|Treatment Period 2|Adverse Event|0|||
162764917|NCT03031782|587850127|FG001|Treatment Period 2|Adverse Event|1|||
162764918|NCT03031782|587850128|FG002|Treatment Period 2|Adverse Event|2|||
162764919|NCT03031782|587850129|FG003|Treatment Period 2|Adverse Event|0|||
162764920|NCT03031782|587850130|FG004|Treatment Period 2|Adverse Event|0|||
162764921|NCT03031782|587850126|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162764922|NCT03031782|587850127|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162764923|NCT03031782|587850128|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162764924|NCT03031782|587850129|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162764925|NCT03031782|587850130|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162764926|NCT04867382|587850131|FG000|Overall Study|Did not complete the survey|2|||
162764927|NCT04867382|587850132|FG001|Overall Study|Did not complete the survey|1|||
162764928|NCT05445557|587850133|FG000|Double Blind Part|Lost to Follow-up|1|||
162764929|NCT03803475|587850134|FG000|Overall Study|Physician Decision|1|||
162764930|NCT01323790|587850135|FG000|Overall Study|Other|3|||
162764931|NCT01323790|587850136|FG001|Overall Study|Other|2|||
162764932|NCT01323790|587850137|FG002|Overall Study|Other|1|||
162764933|NCT01323790|587850135|FG000|Overall Study|Lost to Follow-up|11|||
162764934|NCT01323790|587850136|FG001|Overall Study|Lost to Follow-up|9|||
162764935|NCT01323790|587850137|FG002|Overall Study|Lost to Follow-up|9|||
162764936|NCT01323790|587850135|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
162764937|NCT01323790|587850136|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
162764938|NCT01323790|587850137|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
162764939|NCT01323790|587850135|FG000|Overall Study|Lack of Efficacy|3|||
162764940|NCT01323790|587850136|FG001|Overall Study|Lack of Efficacy|0|||
162764941|NCT01323790|587850137|FG002|Overall Study|Lack of Efficacy|3|||
162764942|NCT01323790|587850135|FG000|Overall Study|Adverse Event|11|||
162764943|NCT01323790|587850136|FG001|Overall Study|Adverse Event|24|||
162764944|NCT01323790|587850137|FG002|Overall Study|Adverse Event|12|||
162764945|NCT01323790|587850135|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162764946|NCT01323790|587850136|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162764947|NCT01323790|587850137|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
162764948|NCT01323790|587850135|FG000|Overall Study|Withdrawal by Subject|23|||
162764949|NCT01323790|587850136|FG001|Overall Study|Withdrawal by Subject|20|||
162764950|NCT01323790|587850137|FG002|Overall Study|Withdrawal by Subject|13|||
162764951|NCT01323790|587850135|FG000|Overall Study|Did Not Receive Treatment|2|||
162764952|NCT01323790|587850136|FG001|Overall Study|Did Not Receive Treatment|0|||
162764953|NCT01323790|587850137|FG002|Overall Study|Did Not Receive Treatment|1|||
162764954|NCT01323790|587850135|FG000|Overall Study|Severe non-compliance with protocol|2|||
162764955|NCT01323790|587850136|FG001|Overall Study|Severe non-compliance with protocol|2|||
162764956|NCT01323790|587850137|FG002|Overall Study|Severe non-compliance with protocol|2|||
162764957|NCT02915783|587850144|FG000|Overall Study|Death|21|||
162764958|NCT02915783|587850144|FG000|Overall Study|Lost to Follow-up|1|||
162764959|NCT02915783|587850144|FG000|Overall Study|Withdrawal by Subject|2|||
162764960|NCT02950961|587850145|FG000|Overall Study|Study had to stop due to COVID.|7|||
162764961|NCT02432274|587850146|FG000|Overall Study|Death|2|||
162764962|NCT02432274|587850147|FG001|Overall Study|Death|6|||
162764963|NCT02432274|587850148|FG002|Overall Study|Death|7|||
162764964|NCT02432274|587850149|FG003|Overall Study|Death|0|||
162764965|NCT02432274|587850150|FG004|Overall Study|Death|27|||
162764966|NCT02432274|587850151|FG005|Overall Study|Death|7|||
162764967|NCT02432274|587850152|FG006|Overall Study|Death|9|||
162764968|NCT02432274|587850153|FG007|Overall Study|Death|14|||
162764969|NCT02432274|587850146|FG000|Overall Study|Withdrawal of Consent|0|||
162764970|NCT02432274|587850147|FG001|Overall Study|Withdrawal of Consent|0|||
162764971|NCT02432274|587850148|FG002|Overall Study|Withdrawal of Consent|0|||
162764972|NCT02432274|587850149|FG003|Overall Study|Withdrawal of Consent|0|||
162764973|NCT02432274|587850150|FG004|Overall Study|Withdrawal of Consent|2|||
162764974|NCT02432274|587850151|FG005|Overall Study|Withdrawal of Consent|0|||
162764975|NCT02432274|587850152|FG006|Overall Study|Withdrawal of Consent|1|||
162764976|NCT02432274|587850153|FG007|Overall Study|Withdrawal of Consent|2|||
162764977|NCT01736475|587850156|FG000|Overall Study|Adverse Event|4|||
162764978|NCT01736475|587850157|FG001|Overall Study|Adverse Event|0|||
162764979|NCT01736475|587850156|FG000|Overall Study|Withdrawal by Subject|2|||
162764980|NCT01736475|587850157|FG001|Overall Study|Withdrawal by Subject|0|||
162764981|NCT01736475|587850156|FG000|Overall Study|Protocol Violation|4|||
162764982|NCT01736475|587850157|FG001|Overall Study|Protocol Violation|0|||
162764983|NCT01736475|587850156|FG000|Overall Study|Other - Screen failure|1|||
162764984|NCT01736475|587850157|FG001|Overall Study|Other - Screen failure|0|||
162764985|NCT01736475|587850156|FG000|Overall Study|Other - Surgical procedure|1|||
162764986|NCT01736475|587850157|FG001|Overall Study|Other - Surgical procedure|0|||
162764987|NCT02807857|587850158|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
162764988|NCT02807857|587850158|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
162764989|NCT02807857|587850158|FG000|Follow-Up Set|Withdrawal by Subject|8|||
162764990|NCT02807857|587850158|FG000|Follow-Up Set|Lost to Follow-up|7|||
162764991|NCT02807857|587850158|FG000|Follow-Up Set|Physician Decision|6|||
162764992|NCT02807857|587850158|FG000|Follow-Up Set|Adverse Event|3|||
162764993|NCT02807857|587850158|FG000|Follow-Up Set|Death|27|||
162764994|NCT02807857|587850158|FG000|Follow-Up Set|Relocation|2|||
162764995|NCT02114515|587850160|FG000|Overall Study|Lost to Follow-up|52|||
162764996|NCT02114515|587850161|FG001|Overall Study|Lost to Follow-up|55|||
162764997|NCT02114515|587850160|FG000|Overall Study|Death|12|||
162764998|NCT02114515|587850161|FG001|Overall Study|Death|12|||
162764999|NCT02114515|587850160|FG000|Overall Study|Withdrawal by Subject|4|||
162765000|NCT02114515|587850161|FG001|Overall Study|Withdrawal by Subject|22|||
162765001|NCT02114515|587850160|FG000|Overall Study|Other|65|||
162765002|NCT02114515|587850161|FG001|Overall Study|Other|61|||
162765003|NCT04197713|587850162|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
162765004|NCT04197713|587850163|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
162765005|NCT02144285|587850164|FG000|Overall Study|Withdrawal by Subject|0|||
162765006|NCT02144285|587850165|FG001|Overall Study|Withdrawal by Subject|0|||
162765007|NCT02144285|587850166|FG002|Overall Study|Withdrawal by Subject|0|||
162765008|NCT02144285|587850167|FG003|Overall Study|Withdrawal by Subject|0|||
162765009|NCT02144285|587850168|FG004|Overall Study|Withdrawal by Subject|1|||
162765010|NCT02144285|587850169|FG005|Overall Study|Withdrawal by Subject|0|||
162765011|NCT02144285|587850170|FG006|Overall Study|Withdrawal by Subject|0|||
162765012|NCT02144285|587850171|FG007|Overall Study|Withdrawal by Subject|0|||
162765013|NCT02144285|587850172|FG008|Overall Study|Withdrawal by Subject|0|||
162765014|NCT02144285|587850173|FG009|Overall Study|Withdrawal by Subject|0|||
162765015|NCT01529632|587850174|FG000|Overall Study|Administrative problem|2|||
162765016|NCT01529632|587850175|FG001|Overall Study|Administrative problem|1|||
162765017|NCT01529632|587850174|FG000|Overall Study|Protocol Violation|0|||
162765018|NCT01529632|587850175|FG001|Overall Study|Protocol Violation|1|||
162765019|NCT01529632|587850174|FG000|Overall Study|Adverse Event|1|||
162765020|NCT01529632|587850175|FG001|Overall Study|Adverse Event|1|||
162765021|NCT05184062|587850177|FG000|Overall Study|Lost to Follow-up|5|||
162765022|NCT05184062|587850178|FG001|Overall Study|Lost to Follow-up|1|||
162765023|NCT05184062|587850177|FG000|Overall Study|Withdrawal by Subject|1|||
162765024|NCT05184062|587850178|FG001|Overall Study|Withdrawal by Subject|0|||
162765025|NCT00711555|587851870|FG000|Overall Study|Adverse Event|3|||
162765026|NCT04914897|587851875|FG000|Overall Study|Withdrawal by Subject|3|||
162765027|NCT04914897|587851876|FG001|Overall Study|Withdrawal by Subject|1|||
162765028|NCT04914897|587851877|FG002|Overall Study|Withdrawal by Subject|1|||
162765029|NCT04914897|587851878|FG003|Overall Study|Withdrawal by Subject|1|||
162765030|NCT04914897|587851875|FG000|Overall Study|Poor compliance to protocol|0|||
162765031|NCT04914897|587851876|FG001|Overall Study|Poor compliance to protocol|0|||
162765032|NCT04914897|587851877|FG002|Overall Study|Poor compliance to protocol|1|||
162765033|NCT04914897|587851878|FG003|Overall Study|Poor compliance to protocol|0|||
162765034|NCT04914897|587851875|FG000|Overall Study|Progressive disease|5|||
162765035|NCT04914897|587851876|FG001|Overall Study|Progressive disease|14|||
162765036|NCT04914897|587851877|FG002|Overall Study|Progressive disease|30|||
162765037|NCT04914897|587851878|FG003|Overall Study|Progressive disease|21|||
162765038|NCT04914897|587851875|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162765039|NCT04914897|587851876|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
162765040|NCT04914897|587851877|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
162765041|NCT04914897|587851878|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
162765042|NCT04914897|587851875|FG000|Overall Study|Other|1|||
162765043|NCT04914897|587851876|FG001|Overall Study|Other|0|||
162765044|NCT04914897|587851877|FG002|Overall Study|Other|0|||
162765045|NCT04914897|587851878|FG003|Overall Study|Other|1|||
162765046|NCT04783389|587851888|FG000|Overall Study|Withdrawal by Subject|2|||
162765047|NCT04783389|587851889|FG001|Overall Study|Withdrawal by Subject|0|||
162765048|NCT04783389|587851890|FG002|Overall Study|Withdrawal by Subject|0|||
162765049|NCT04783389|587851888|FG000|Overall Study|Termination of Study by Sponsor|10|||
162765050|NCT04783389|587851889|FG001|Overall Study|Termination of Study by Sponsor|12|||
162765051|NCT04783389|587851890|FG002|Overall Study|Termination of Study by Sponsor|14|||
162765052|NCT02164578|587851892|FG000|Treatment Period|Withdrawal by Subject|3|||
162765053|NCT02164578|587851893|FG001|Treatment Period|Withdrawal by Subject|3|||
162765054|NCT02164578|587851892|FG000|Treatment Period|Adverse Event|13|||
162765055|NCT02164578|587851893|FG001|Treatment Period|Adverse Event|6|||
162765056|NCT02164578|587851892|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
162765057|NCT02164578|587851893|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
162765058|NCT02164578|587851892|FG000|Treatment Period|Protocol Violation|0|||
162765059|NCT02164578|587851893|FG001|Treatment Period|Protocol Violation|2|||
162765060|NCT02164578|587851892|FG000|Extension Period|Withdrawal by Subject|2|||
162765061|NCT02164578|587851893|FG001|Extension Period|Withdrawal by Subject|0|||
162765062|NCT02164578|587851892|FG000|Extension Period|Adverse Event|4|||
162765063|NCT02164578|587851893|FG001|Extension Period|Adverse Event|0|||
162765064|NCT02164578|587851892|FG000|Extension Period|Expiry of study medication|1|||
162765065|NCT02164578|587851893|FG001|Extension Period|Expiry of study medication|0|||
162765066|NCT02164578|587851892|FG000|Extension Period|Protocol Violation|0|||
162765067|NCT02164578|587851893|FG001|Extension Period|Protocol Violation|1|||
162765068|NCT02507297|587851899|FG000|Overall Study|Withdrawal by Subject|1|||
162765069|NCT02507297|587851900|FG001|Overall Study|Withdrawal by Subject|0|||
162765070|NCT02507297|587851899|FG000|Overall Study|Lost to Follow-up|0|||
162765071|NCT02507297|587851900|FG001|Overall Study|Lost to Follow-up|1|||
162765072|NCT01562275|587851901|FG000|Stage 1|Adverse Event|0|||
162765073|NCT01562275|587851902|FG001|Stage 1|Adverse Event|0|||
162765074|NCT01562275|587851903|FG002|Stage 1|Adverse Event|0|||
162765075|NCT01562275|587851904|FG003|Stage 1|Adverse Event|1|||
162765076|NCT01562275|587851905|FG004|Stage 1|Adverse Event|1|||
162765077|NCT01562275|587851906|FG005|Stage 1|Adverse Event|0|||
162765078|NCT01562275|587851907|FG006|Stage 1|Adverse Event|0|||
162765079|NCT01562275|587851908|FG007|Stage 1|Adverse Event|0|||
162765080|NCT01562275|587851909|FG008|Stage 1|Adverse Event|0|||
162765081|NCT01562275|587851910|FG009|Stage 1|Adverse Event|1|||
162765082|NCT01562275|587851911|FG010|Stage 1|Adverse Event|0|||
162765083|NCT01562275|587851912|FG011|Stage 1|Adverse Event|0|||
162765084|NCT01562275|587851913|FG012|Stage 1|Adverse Event|0|||
162765085|NCT01562275|587851901|FG000|Stage 1|Death|1|||
162765086|NCT01562275|587851902|FG001|Stage 1|Death|0|||
162765087|NCT01562275|587851903|FG002|Stage 1|Death|0|||
162765088|NCT01562275|587851904|FG003|Stage 1|Death|0|||
162765089|NCT01562275|587851905|FG004|Stage 1|Death|0|||
162765090|NCT01562275|587851906|FG005|Stage 1|Death|0|||
162765091|NCT01562275|587851907|FG006|Stage 1|Death|0|||
162765092|NCT01562275|587851908|FG007|Stage 1|Death|0|||
162765093|NCT01562275|587851909|FG008|Stage 1|Death|0|||
162765094|NCT01562275|587851910|FG009|Stage 1|Death|0|||
162765095|NCT01562275|587851911|FG010|Stage 1|Death|0|||
162765096|NCT01562275|587851912|FG011|Stage 1|Death|0|||
162765097|NCT01562275|587851913|FG012|Stage 1|Death|0|||
162765098|NCT01562275|587851901|FG000|Stage 1|Non Compliance|0|||
162765099|NCT01562275|587851902|FG001|Stage 1|Non Compliance|0|||
162765100|NCT01562275|587851903|FG002|Stage 1|Non Compliance|1|||
162765101|NCT01562275|587851904|FG003|Stage 1|Non Compliance|0|||
162765102|NCT01562275|587851905|FG004|Stage 1|Non Compliance|0|||
162765103|NCT01562275|587851906|FG005|Stage 1|Non Compliance|0|||
162765104|NCT01562275|587851907|FG006|Stage 1|Non Compliance|0|||
162765105|NCT01562275|587851908|FG007|Stage 1|Non Compliance|0|||
162765106|NCT01562275|587851909|FG008|Stage 1|Non Compliance|0|||
162765107|NCT01562275|587851910|FG009|Stage 1|Non Compliance|0|||
162765108|NCT01562275|587851911|FG010|Stage 1|Non Compliance|0|||
162765109|NCT01562275|587851912|FG011|Stage 1|Non Compliance|0|||
162765110|NCT01562275|587851913|FG012|Stage 1|Non Compliance|0|||
162765111|NCT01562275|587851901|FG000|Stage 1|Physician Decision|0|||
162765112|NCT01562275|587851902|FG001|Stage 1|Physician Decision|0|||
162765113|NCT01562275|587851903|FG002|Stage 1|Physician Decision|0|||
162765114|NCT01562275|587851904|FG003|Stage 1|Physician Decision|0|||
162765115|NCT01562275|587851905|FG004|Stage 1|Physician Decision|1|||
162765116|NCT01562275|587851906|FG005|Stage 1|Physician Decision|0|||
162765117|NCT01562275|587851907|FG006|Stage 1|Physician Decision|1|||
162765118|NCT01562275|587851908|FG007|Stage 1|Physician Decision|0|||
162765119|NCT01562275|587851909|FG008|Stage 1|Physician Decision|1|||
162765120|NCT01562275|587851910|FG009|Stage 1|Physician Decision|0|||
162765121|NCT01562275|587851911|FG010|Stage 1|Physician Decision|0|||
162765122|NCT01562275|587851912|FG011|Stage 1|Physician Decision|0|||
162765123|NCT01562275|587851913|FG012|Stage 1|Physician Decision|0|||
162765124|NCT01562275|587851901|FG000|Stage 1|Progression of Disease|2|||
162765125|NCT01562275|587851902|FG001|Stage 1|Progression of Disease|6|||
162765126|NCT01562275|587851903|FG002|Stage 1|Progression of Disease|2|||
162765127|NCT01562275|587851904|FG003|Stage 1|Progression of Disease|1|||
162765128|NCT01562275|587851905|FG004|Stage 1|Progression of Disease|2|||
162765129|NCT01562275|587851906|FG005|Stage 1|Progression of Disease|4|||
162765130|NCT01562275|587851907|FG006|Stage 1|Progression of Disease|1|||
162765131|NCT01562275|587851908|FG007|Stage 1|Progression of Disease|7|||
162765132|NCT01562275|587851909|FG008|Stage 1|Progression of Disease|2|||
162765133|NCT01562275|587851910|FG009|Stage 1|Progression of Disease|5|||
162765134|NCT01562275|587851911|FG010|Stage 1|Progression of Disease|3|||
162765135|NCT01562275|587851912|FG011|Stage 1|Progression of Disease|0|||
162765136|NCT01562275|587851913|FG012|Stage 1|Progression of Disease|0|||
162765137|NCT01562275|587851901|FG000|Stage 1|Withdrawal by Subject|0|||
162765138|NCT01562275|587851902|FG001|Stage 1|Withdrawal by Subject|1|||
162765139|NCT01562275|587851903|FG002|Stage 1|Withdrawal by Subject|0|||
162765140|NCT01562275|587851904|FG003|Stage 1|Withdrawal by Subject|2|||
162765141|NCT01562275|587851905|FG004|Stage 1|Withdrawal by Subject|0|||
162765142|NCT01562275|587851906|FG005|Stage 1|Withdrawal by Subject|0|||
162765143|NCT01562275|587851907|FG006|Stage 1|Withdrawal by Subject|1|||
162765144|NCT01562275|587851908|FG007|Stage 1|Withdrawal by Subject|0|||
162765145|NCT01562275|587851909|FG008|Stage 1|Withdrawal by Subject|0|||
162765146|NCT01562275|587851910|FG009|Stage 1|Withdrawal by Subject|1|||
162765147|NCT01562275|587851911|FG010|Stage 1|Withdrawal by Subject|0|||
162765148|NCT01562275|587851912|FG011|Stage 1|Withdrawal by Subject|0|||
162765149|NCT01562275|587851913|FG012|Stage 1|Withdrawal by Subject|0|||
162765150|NCT01562275|587851901|FG000|Stage 2|Death|0|||
162765151|NCT01562275|587851902|FG001|Stage 2|Death|0|||
162765152|NCT01562275|587851903|FG002|Stage 2|Death|0|||
162765153|NCT01562275|587851904|FG003|Stage 2|Death|0|||
162765154|NCT01562275|587851905|FG004|Stage 2|Death|0|||
162765155|NCT01562275|587851906|FG005|Stage 2|Death|0|||
162765156|NCT01562275|587851907|FG006|Stage 2|Death|0|||
162765157|NCT01562275|587851908|FG007|Stage 2|Death|0|||
162765158|NCT01562275|587851909|FG008|Stage 2|Death|0|||
162765159|NCT01562275|587851910|FG009|Stage 2|Death|0|||
162765160|NCT01562275|587851911|FG010|Stage 2|Death|0|||
162765161|NCT01562275|587851912|FG011|Stage 2|Death|2|||
162765162|NCT01562275|587851913|FG012|Stage 2|Death|1|||
162765163|NCT01562275|587851901|FG000|Stage 2|Progression of Disease|0|||
162765164|NCT01562275|587851902|FG001|Stage 2|Progression of Disease|0|||
162765165|NCT01562275|587851903|FG002|Stage 2|Progression of Disease|0|||
162765166|NCT01562275|587851904|FG003|Stage 2|Progression of Disease|0|||
162765167|NCT01562275|587851905|FG004|Stage 2|Progression of Disease|0|||
162765168|NCT01562275|587851906|FG005|Stage 2|Progression of Disease|0|||
162765169|NCT01562275|587851907|FG006|Stage 2|Progression of Disease|0|||
162765170|NCT01562275|587851908|FG007|Stage 2|Progression of Disease|0|||
162765171|NCT01562275|587851909|FG008|Stage 2|Progression of Disease|0|||
162765172|NCT01562275|587851910|FG009|Stage 2|Progression of Disease|0|||
162765173|NCT01562275|587851911|FG010|Stage 2|Progression of Disease|0|||
162765174|NCT01562275|587851912|FG011|Stage 2|Progression of Disease|12|||
162765175|NCT01562275|587851913|FG012|Stage 2|Progression of Disease|4|||
162765176|NCT01863368|587851914|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
162765177|NCT01863368|587851915|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
162765178|NCT01863368|587851914|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
162765179|NCT01863368|587851915|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
162765180|NCT01863368|587851914|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
162765181|NCT01863368|587851915|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
162765182|NCT01863368|587851914|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
162765183|NCT01863368|587851915|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
162765184|NCT01863368|587851914|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
162765185|NCT01863368|587851915|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
162765186|NCT01863368|587851914|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
162765187|NCT01863368|587851915|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
162765188|NCT00070707|587851916|FG000|Overall Study|Adverse Event|1|||
162765189|NCT00070707|587851917|FG001|Overall Study|Adverse Event|2|||
162765190|NCT00070707|587851916|FG000|Overall Study|Lack of Efficacy|4|||
162765191|NCT00070707|587851917|FG001|Overall Study|Lack of Efficacy|1|||
162765192|NCT00070707|587851916|FG000|Overall Study|Protocol Violation|8|||
162765193|NCT00070707|587851917|FG001|Overall Study|Protocol Violation|4|||
162765194|NCT00070707|587851916|FG000|Overall Study|Unrelated to Study Medication|1|||
162765195|NCT00070707|587851917|FG001|Overall Study|Unrelated to Study Medication|0|||
162765196|NCT00647699|587851918|FG000|Overall Study|Lost to Follow-up|5|||
162765197|NCT00647699|587851919|FG001|Overall Study|Lost to Follow-up|4|||
162765198|NCT00647699|587851918|FG000|Overall Study|Withdrawal by Subject|3|||
162765199|NCT00647699|587851919|FG001|Overall Study|Withdrawal by Subject|8|||
162765200|NCT04909593|587851920|FG000|Overall Study|Withdrawal by Subject|1|||
162765201|NCT01018992|587851921|FG000|Overall Study|Adverse Event|8|||
162765202|NCT01018992|587851922|FG001|Overall Study|Adverse Event|3|||
162765203|NCT01018992|587851921|FG000|Overall Study|Withdrawal by Subject|3|||
162765204|NCT01018992|587851922|FG001|Overall Study|Withdrawal by Subject|8|||
162765205|NCT01018992|587851921|FG000|Overall Study|Protocol Violation|0|||
162765206|NCT01018992|587851922|FG001|Overall Study|Protocol Violation|4|||
162765207|NCT01018992|587851921|FG000|Overall Study|Lost to Follow-up|5|||
162765208|NCT01018992|587851922|FG001|Overall Study|Lost to Follow-up|1|||
162765209|NCT03029585|587851925|FG000|Overall Study|Death|1|||
162765210|NCT03029585|587851926|FG001|Overall Study|Death|1|||
162765211|NCT03029585|587851925|FG000|Overall Study|Withdrawal by Subject|1|||
162765212|NCT03029585|587851926|FG001|Overall Study|Withdrawal by Subject|0|||
162765213|NCT02400749|587851927|FG000|Week 0 -16|Withdrawal by Subject|5|||
162765214|NCT02400749|587851928|FG001|Week 0 -16|Withdrawal by Subject|5|||
162765215|NCT02400749|587851927|FG000|Week 0 -16|Adverse Event|3|||
162765216|NCT02400749|587851928|FG001|Week 0 -16|Adverse Event|1|||
162765217|NCT02400749|587851927|FG000|Week 0 -16|Lost to Follow-up|2|||
162765218|NCT02400749|587851928|FG001|Week 0 -16|Lost to Follow-up|0|||
162765219|NCT02400749|587851927|FG000|Week 0 -16|Protocol Violation|1|||
162765220|NCT02400749|587851928|FG001|Week 0 -16|Protocol Violation|0|||
162765221|NCT02400749|587851927|FG000|Week 17 - 32|Withdrawal by Subject|3|||
162765222|NCT02400749|587851928|FG001|Week 17 - 32|Withdrawal by Subject|2|||
162765223|NCT02400749|587851927|FG000|Week 17 - 32|Adverse Event|2|||
162765224|NCT02400749|587851928|FG001|Week 17 - 32|Adverse Event|1|||
162765225|NCT01825785|587851929|FG000|Overall Study|Adverse Event|0|||
162765226|NCT01825785|587851930|FG001|Overall Study|Adverse Event|0|||
162765227|NCT01825785|587851931|FG002|Overall Study|Adverse Event|0|||
162765228|NCT01825785|587851932|FG003|Overall Study|Adverse Event|0|||
162765229|NCT01825785|587851933|FG004|Overall Study|Adverse Event|1|||
162765230|NCT01825785|587851934|FG005|Overall Study|Adverse Event|0|||
162765231|NCT01825785|587851935|FG006|Overall Study|Adverse Event|0|||
162765232|NCT01825785|587851929|FG000|Overall Study|Withdrawal by Subject|0|||
162765233|NCT01825785|587851930|FG001|Overall Study|Withdrawal by Subject|0|||
162765234|NCT01825785|587851931|FG002|Overall Study|Withdrawal by Subject|0|||
162765235|NCT01825785|587851932|FG003|Overall Study|Withdrawal by Subject|0|||
162765236|NCT01825785|587851933|FG004|Overall Study|Withdrawal by Subject|1|||
162765237|NCT01825785|587851934|FG005|Overall Study|Withdrawal by Subject|1|||
162765238|NCT01825785|587851935|FG006|Overall Study|Withdrawal by Subject|0|||
162765239|NCT01286311|587851937|FG000|Overall Study|Physician did not want outreach sent|14|||
162765240|NCT01286311|587851938|FG001|Overall Study|Physician did not want outreach sent|0|||
162765241|NCT01437540|587851939|FG000|Overall Study|Not listed below|7|||
162765242|NCT01437540|587851940|FG001|Overall Study|Not listed below|6|||
162765243|NCT01437540|587851939|FG000|Overall Study|COPD exacerbation|13|||
162765244|NCT01437540|587851940|FG001|Overall Study|COPD exacerbation|3|||
162765245|NCT01437540|587851939|FG000|Overall Study|Lost to Follow-up|3|||
162765246|NCT01437540|587851940|FG001|Overall Study|Lost to Follow-up|5|||
162765247|NCT01437540|587851939|FG000|Overall Study|Lack of Efficacy|23|||
162765248|NCT01437540|587851940|FG001|Overall Study|Lack of Efficacy|11|||
162765249|NCT01437540|587851939|FG000|Overall Study|Protocol Violation|24|||
162765250|NCT01437540|587851940|FG001|Overall Study|Protocol Violation|12|||
162765251|NCT01437540|587851939|FG000|Overall Study|Adverse Event|26|||
162765252|NCT01437540|587851940|FG001|Overall Study|Adverse Event|13|||
162765253|NCT01437540|587851939|FG000|Overall Study|Withdrawal by Subject|31|||
162765254|NCT01437540|587851940|FG001|Overall Study|Withdrawal by Subject|15|||
162765255|NCT01381549|587851941|FG000|Overall Study|Ineligible: No organisms isolated|0|||
162765256|NCT01381549|587851942|FG001|Overall Study|Ineligible: No organisms isolated|0|||
162765257|NCT01381549|587851943|FG002|Overall Study|Ineligible: No organisms isolated|1|||
162765258|NCT02446015|587851944|FG000|Overall Study|Adverse Event|0|||
162765259|NCT02446015|587851945|FG001|Overall Study|Adverse Event|1|||
162765260|NCT02446015|587851944|FG000|Overall Study|Withdrawal by Subject|1|||
162765261|NCT02446015|587851945|FG001|Overall Study|Withdrawal by Subject|0|||
162765262|NCT00988429|587851946|FG000|Overall Study|Adverse Event|9|||
162765263|NCT00988429|587851947|FG001|Overall Study|Adverse Event|21|||
162765264|NCT00988429|587851948|FG002|Overall Study|Adverse Event|45|||
162765265|NCT00988429|587851946|FG000|Overall Study|Lack of Efficacy|0|||
162765266|NCT00988429|587851947|FG001|Overall Study|Lack of Efficacy|0|||
162765267|NCT00988429|587851948|FG002|Overall Study|Lack of Efficacy|1|||
162765268|NCT00988429|587851946|FG000|Overall Study|Non-Compliance with Study Drug|5|||
162765269|NCT00988429|587851947|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162765270|NCT00988429|587851948|FG002|Overall Study|Non-Compliance with Study Drug|3|||
162765271|NCT00988429|587851946|FG000|Overall Study|Physician Decision|1|||
162765272|NCT00988429|587851947|FG001|Overall Study|Physician Decision|0|||
162765273|NCT00988429|587851948|FG002|Overall Study|Physician Decision|3|||
162765274|NCT00988429|587851946|FG000|Overall Study|Pregnancy|2|||
162765275|NCT00988429|587851947|FG001|Overall Study|Pregnancy|1|||
162765276|NCT00988429|587851948|FG002|Overall Study|Pregnancy|0|||
162765277|NCT00988429|587851946|FG000|Overall Study|Protocol Violation|4|||
162765278|NCT00988429|587851947|FG001|Overall Study|Protocol Violation|3|||
162765279|NCT00988429|587851948|FG002|Overall Study|Protocol Violation|3|||
162765280|NCT00988429|587851946|FG000|Overall Study|Withdrawal by Subject|7|||
162765281|NCT00988429|587851947|FG001|Overall Study|Withdrawal by Subject|7|||
162765282|NCT00988429|587851948|FG002|Overall Study|Withdrawal by Subject|12|||
162765283|NCT00988429|587851946|FG000|Overall Study|Administrative Reasons|1|||
162765284|NCT00988429|587851947|FG001|Overall Study|Administrative Reasons|2|||
162765285|NCT00988429|587851948|FG002|Overall Study|Administrative Reasons|1|||
162765286|NCT00988429|587851946|FG000|Overall Study|other reasons|8|||
162765287|NCT00988429|587851947|FG001|Overall Study|other reasons|8|||
162765288|NCT00988429|587851948|FG002|Overall Study|other reasons|1|||
162765289|NCT01123356|587851949|FG000|Overall Study|Adverse Event|2|||
162765290|NCT01123356|587851949|FG000|Overall Study|Lack of Efficacy|4|||
162765291|NCT01123356|587851949|FG000|Overall Study|Withdrawal by Subject|1|||
162765292|NCT00376259|587851952|FG000|Overall Study|Sponsor request - study termination|21|||
162765293|NCT00376259|587851953|FG001|Overall Study|Sponsor request - study termination|21|||
162765294|NCT00376259|587851952|FG000|Overall Study|Patient request|1|||
162765295|NCT00376259|587851953|FG001|Overall Study|Patient request|0|||
162765296|NCT01877720|587851955|FG000|Overall Study|Adverse Event|1|||
162765297|NCT01877720|587851956|FG001|Overall Study|Adverse Event|0|||
162765298|NCT00267956|587851959|FG000|Controlled Period|Adverse Event|4|||
162765299|NCT00267956|587851960|FG001|Controlled Period|Adverse Event|1|||
162765300|NCT00267956|587851961|FG002|Controlled Period|Adverse Event|0|||
162765301|NCT00267956|587851962|FG003|Controlled Period|Adverse Event|0|||
162765302|NCT00267956|587851959|FG000|Controlled Period|Lack of Efficacy|4|||
162765303|NCT00267956|587851960|FG001|Controlled Period|Lack of Efficacy|2|||
162765304|NCT00267956|587851961|FG002|Controlled Period|Lack of Efficacy|0|||
162765305|NCT00267956|587851962|FG003|Controlled Period|Lack of Efficacy|0|||
162765306|NCT00267956|587851959|FG000|Controlled Period|Lost to Follow-up|2|||
162765307|NCT00267956|587851960|FG001|Controlled Period|Lost to Follow-up|0|||
162765308|NCT00267956|587851961|FG002|Controlled Period|Lost to Follow-up|0|||
162765309|NCT00267956|587851962|FG003|Controlled Period|Lost to Follow-up|0|||
162765310|NCT00267956|587851959|FG000|Controlled Period|Withdrew consent|3|||
162765311|NCT00267956|587851960|FG001|Controlled Period|Withdrew consent|1|||
162765312|NCT00267956|587851961|FG002|Controlled Period|Withdrew consent|0|||
162765313|NCT00267956|587851962|FG003|Controlled Period|Withdrew consent|0|||
162765314|NCT00267956|587851959|FG000|After Controlled Period|Adverse Event|0|||
162765315|NCT00267956|587851960|FG001|After Controlled Period|Adverse Event|0|||
162765316|NCT00267956|587851961|FG002|After Controlled Period|Adverse Event|2|||
162765317|NCT00267956|587851962|FG003|After Controlled Period|Adverse Event|1|||
162765318|NCT00267956|587851959|FG000|After Controlled Period|Lack of Efficacy|0|||
162765319|NCT00267956|587851960|FG001|After Controlled Period|Lack of Efficacy|0|||
162765320|NCT00267956|587851961|FG002|After Controlled Period|Lack of Efficacy|1|||
162765321|NCT00267956|587851962|FG003|After Controlled Period|Lack of Efficacy|1|||
162765322|NCT00267956|587851959|FG000|After Controlled Period|Lost to Follow-up|0|||
162765323|NCT00267956|587851960|FG001|After Controlled Period|Lost to Follow-up|0|||
162765324|NCT00267956|587851961|FG002|After Controlled Period|Lost to Follow-up|1|||
162765325|NCT00267956|587851962|FG003|After Controlled Period|Lost to Follow-up|0|||
162765326|NCT00267956|587851959|FG000|After Controlled Period|Withdrew consent|0|||
162765327|NCT00267956|587851960|FG001|After Controlled Period|Withdrew consent|0|||
162765328|NCT00267956|587851961|FG002|After Controlled Period|Withdrew consent|1|||
162765329|NCT00267956|587851962|FG003|After Controlled Period|Withdrew consent|0|||
162765330|NCT01393964|587851967|FG000|Overall Study|Disease Progression|4|||
162765331|NCT01393964|587851968|FG001|Overall Study|Disease Progression|3|||
162765332|NCT01393964|587851969|FG002|Overall Study|Disease Progression|5|||
162765333|NCT01393964|587851967|FG000|Overall Study|Study drug toxicity|1|||
162765334|NCT01393964|587851968|FG001|Overall Study|Study drug toxicity|0|||
162765335|NCT01393964|587851969|FG002|Overall Study|Study drug toxicity|0|||
162765336|NCT01393964|587851967|FG000|Overall Study|Withdrawal by Subject|0|||
162765337|NCT01393964|587851968|FG001|Overall Study|Withdrawal by Subject|0|||
162765338|NCT01393964|587851969|FG002|Overall Study|Withdrawal by Subject|1|||
162765339|NCT01393964|587851967|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162765340|NCT01393964|587851968|FG001|Overall Study|Adverse event unrelated to study drug|3|||
162765341|NCT01393964|587851969|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162765342|NCT01393964|587851967|FG000|Overall Study|Subject request stop study treatment|0|||
162765343|NCT01393964|587851968|FG001|Overall Study|Subject request stop study treatment|1|||
162765344|NCT01393964|587851969|FG002|Overall Study|Subject request stop study treatment|0|||
162765345|NCT01393964|587851967|FG000|Overall Study|Subject decided to move to transplant|1|||
162765346|NCT01393964|587851968|FG001|Overall Study|Subject decided to move to transplant|0|||
162765347|NCT01393964|587851969|FG002|Overall Study|Subject decided to move to transplant|0|||
162765348|NCT01393964|587851967|FG000|Overall Study|Subject switched to commercial supply|1|||
162765349|NCT01393964|587851968|FG001|Overall Study|Subject switched to commercial supply|0|||
162765350|NCT01393964|587851969|FG002|Overall Study|Subject switched to commercial supply|2|||
162765351|NCT01393964|587851967|FG000|Overall Study|Subject plateaued in terms of effect|1|||
162765352|NCT01393964|587851968|FG001|Overall Study|Subject plateaued in terms of effect|0|||
162765353|NCT01393964|587851969|FG002|Overall Study|Subject plateaued in terms of effect|0|||
162765354|NCT01393964|587851967|FG000|Overall Study|Investigator removed subject from study|0|||
162765355|NCT01393964|587851968|FG001|Overall Study|Investigator removed subject from study|1|||
162765356|NCT01393964|587851969|FG002|Overall Study|Investigator removed subject from study|0|||
162765357|NCT01393964|587851967|FG000|Overall Study|Subject converted to roll-over study|0|||
162765358|NCT01393964|587851968|FG001|Overall Study|Subject converted to roll-over study|1|||
162765359|NCT01393964|587851969|FG002|Overall Study|Subject converted to roll-over study|0|||
162765360|NCT01393964|587851967|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
162765361|NCT01393964|587851968|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
162765362|NCT01393964|587851969|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
162765363|NCT01918033|587851975|FG000|Overall Study|Adverse Event|1|||
162765364|NCT01918033|587851976|FG001|Overall Study|Adverse Event|0|||
162765365|NCT01918033|587851977|FG002|Overall Study|Adverse Event|2|||
162765366|NCT01918033|587851975|FG000|Overall Study|Lost to Follow-up|0|||
162765367|NCT01918033|587851976|FG001|Overall Study|Lost to Follow-up|1|||
162765368|NCT01918033|587851977|FG002|Overall Study|Lost to Follow-up|0|||
162765369|NCT01918033|587851975|FG000|Overall Study|Protocol Violation|2|||
162765370|NCT01918033|587851976|FG001|Overall Study|Protocol Violation|0|||
162765371|NCT01918033|587851977|FG002|Overall Study|Protocol Violation|1|||
162765372|NCT01918033|587851975|FG000|Overall Study|Withdrawal by Subject|2|||
162765373|NCT01918033|587851976|FG001|Overall Study|Withdrawal by Subject|1|||
162765374|NCT01918033|587851977|FG002|Overall Study|Withdrawal by Subject|0|||
162765375|NCT04679675|587851978|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
162765376|NCT04679675|587851979|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
162765377|NCT04679675|587851980|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
162765378|NCT04679675|587851981|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
162765379|NCT04679675|587851978|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
162765380|NCT04679675|587851979|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
162765381|NCT04679675|587851980|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
162765382|NCT04679675|587851981|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
162765383|NCT00687297|587851989|FG000|Randomization|Withdrawal by Subject|2|||
162765384|NCT00687297|587851990|FG001|Randomization|Withdrawal by Subject|0|||
162765385|NCT00687297|587851989|FG000|Randomization|Withdrew before treatment, ineligible|1|||
162765386|NCT00687297|587851990|FG001|Randomization|Withdrew before treatment, ineligible|1|||
162765387|NCT00687297|587851989|FG000|Induction|Withdrawal by Subject|4|||
162765388|NCT00687297|587851990|FG001|Induction|Withdrawal by Subject|4|||
162765389|NCT00687297|587851989|FG000|Induction|Adverse Event|16|||
162765390|NCT00687297|587851990|FG001|Induction|Adverse Event|15|||
162765391|NCT00687297|587851989|FG000|Induction|Death|7|||
162765392|NCT00687297|587851990|FG001|Induction|Death|11|||
162765393|NCT00687297|587851989|FG000|Induction|Lack of Efficacy|17|||
162765394|NCT00687297|587851990|FG001|Induction|Lack of Efficacy|21|||
162765395|NCT00687297|587851989|FG000|Induction|Ineligible|0|||
162765396|NCT00687297|587851990|FG001|Induction|Ineligible|1|||
162765397|NCT00687297|587851989|FG000|Induction|Patient Noncompliance|1|||
162765398|NCT00687297|587851990|FG001|Induction|Patient Noncompliance|0|||
162765399|NCT00687297|587851989|FG000|Induction|Physician Decision|0|||
162765400|NCT00687297|587851990|FG001|Induction|Physician Decision|2|||
162765401|NCT00687297|587851989|FG000|Induction|Other|0|||
162765402|NCT00687297|587851990|FG001|Induction|Other|1|||
162765403|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
162765404|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
162765405|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
162765406|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
162765407|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
162765408|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
162765409|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
162765410|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
162765411|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162765412|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162765413|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
162765414|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
162765415|NCT01494467|587851993|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
162765416|NCT01494467|587851994|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
162765417|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
162765418|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
162765419|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
162765420|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
162765421|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
162765422|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
162765423|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
162765424|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
162765425|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
162765426|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
162765427|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
162765428|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
162765429|NCT01494467|587851993|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
162765430|NCT01494467|587851994|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
162765431|NCT02525744|587851999|FG000|Period 1|Physician Decision|0|||
162765432|NCT02525744|587852000|FG001|Period 1|Physician Decision|0|||
162765433|NCT02525744|587852001|FG002|Period 1|Physician Decision|1|||
162765434|NCT02525744|587852002|FG003|Period 1|Physician Decision|0|||
162765435|NCT02525744|587851999|FG000|Period 3|Adverse Event|0|||
162765436|NCT02525744|587852000|FG001|Period 3|Adverse Event|1|||
162765437|NCT02525744|587852001|FG002|Period 3|Adverse Event|0|||
162765438|NCT02525744|587852002|FG003|Period 3|Adverse Event|0|||
162765439|NCT02525744|587851999|FG000|Period 4|Withdrawal by Subject|1|||
162765440|NCT02525744|587852000|FG001|Period 4|Withdrawal by Subject|0|||
162765441|NCT02525744|587852001|FG002|Period 4|Withdrawal by Subject|0|||
162765442|NCT02525744|587852002|FG003|Period 4|Withdrawal by Subject|0|||
162765443|NCT02525744|587851999|FG000|Period 5|Physician Decision|1|||
162765444|NCT02525744|587852000|FG001|Period 5|Physician Decision|0|||
162765445|NCT02525744|587852001|FG002|Period 5|Physician Decision|0|||
162765446|NCT02525744|587852002|FG003|Period 5|Physician Decision|0|||
162765447|NCT01182285|587852003|FG000|First Intervention Week 1-10|Disease progression|1|||
162765448|NCT01182285|587852004|FG001|First Intervention Week 1-10|Disease progression|0|||
162765449|NCT01182285|587852005|FG002|First Intervention Week 1-10|Disease progression|0|||
162765450|NCT01182285|587852003|FG000|First Intervention Week 1-10|Adverse Event|1|||
162765451|NCT01182285|587852004|FG001|First Intervention Week 1-10|Adverse Event|0|||
162765452|NCT01182285|587852005|FG002|First Intervention Week 1-10|Adverse Event|0|||
162765453|NCT01182285|587852003|FG000|First Intervention Week 1-10|Non-compliance|1|||
162765454|NCT01182285|587852004|FG001|First Intervention Week 1-10|Non-compliance|0|||
162765455|NCT01182285|587852005|FG002|First Intervention Week 1-10|Non-compliance|0|||
162765456|NCT01182285|587852003|FG000|Third Intervention Week 11-52|Disease Progression|0|||
162765457|NCT01182285|587852004|FG001|Third Intervention Week 11-52|Disease Progression|0|||
162765458|NCT01182285|587852005|FG002|Third Intervention Week 11-52|Disease Progression|6|||
162765459|NCT01182285|587852003|FG000|Third Intervention Week 11-52|Other|0|||
162765460|NCT01182285|587852004|FG001|Third Intervention Week 11-52|Other|0|||
162765461|NCT01182285|587852005|FG002|Third Intervention Week 11-52|Other|2|||
162765462|NCT00472082|587852006|FG000|Overall Study|Study prematurely terminated|5|||
162765463|NCT02069379|587852007|FG000|Baseline Measurements|Lost to Follow-up|1|||
162765464|NCT02069379|587852008|FG001|Baseline Measurements|Lost to Follow-up|0|||
162765465|NCT02069379|587852009|FG002|Baseline Measurements|Lost to Follow-up|0|||
162765466|NCT02069379|587852010|FG003|Baseline Measurements|Lost to Follow-up|0|||
162765467|NCT02069379|587852007|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
162765468|NCT02069379|587852008|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
162765469|NCT02069379|587852009|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
162765470|NCT02069379|587852010|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
162765471|NCT02069379|587852007|FG000|First Treatment Arm|Lost to Follow-up|0|||
162765472|NCT02069379|587852008|FG001|First Treatment Arm|Lost to Follow-up|1|||
162765473|NCT02069379|587852009|FG002|First Treatment Arm|Lost to Follow-up|1|||
162765474|NCT02069379|587852010|FG003|First Treatment Arm|Lost to Follow-up|0|||
162765475|NCT02069379|587852007|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162765476|NCT02069379|587852008|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162765477|NCT02069379|587852009|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162765478|NCT02069379|587852010|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162765479|NCT02069379|587852007|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
162765480|NCT02069379|587852008|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
162765481|NCT02069379|587852009|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
162765482|NCT02069379|587852010|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
162765483|NCT02069379|587852007|FG000|Second Treatment Arm|Lost to Follow-up|0|||
162765484|NCT02069379|587852008|FG001|Second Treatment Arm|Lost to Follow-up|0|||
162765485|NCT02069379|587852009|FG002|Second Treatment Arm|Lost to Follow-up|1|||
162765486|NCT02069379|587852010|FG003|Second Treatment Arm|Lost to Follow-up|0|||
162765487|NCT04617847|587852013|FG000|Overall Study|Withdrawal by Subject|1|||
162765488|NCT04617847|587852014|FG001|Overall Study|Withdrawal by Subject|0|||
162765489|NCT04617847|587852013|FG000|Overall Study|Adverse Event|0|||
162765490|NCT04617847|587852014|FG001|Overall Study|Adverse Event|2|||
162765491|NCT04617847|587852013|FG000|Overall Study|Death|0|||
162765492|NCT04617847|587852014|FG001|Overall Study|Death|1|||
162765493|NCT04617847|587852013|FG000|Overall Study|Termination of Study by Sponsor|2|||
162765494|NCT04617847|587852014|FG001|Overall Study|Termination of Study by Sponsor|21|||
162765495|NCT01525875|587852015|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
162765496|NCT01525875|587852016|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
162765497|NCT01525875|587852015|FG000|Open-label Period|Lost to Follow-up|0|||
162765498|NCT01525875|587852016|FG001|Open-label Period|Lost to Follow-up|2|||
162765499|NCT00700999|587852017|FG000|Overall Study|Lost to Follow-up|7|||
162765500|NCT00700999|587852018|FG001|Overall Study|Lost to Follow-up|7|||
162765501|NCT00700999|587852017|FG000|Overall Study|Excluded - did not meet study criteria|0|||
162765502|NCT00700999|587852018|FG001|Overall Study|Excluded - did not meet study criteria|1|||
162765503|NCT00700999|587852017|FG000|Overall Study|Withdrawal by Subject|8|||
162765504|NCT00700999|587852018|FG001|Overall Study|Withdrawal by Subject|1|||
162765505|NCT00244751|587852019|FG000|Overall Study|Adverse Event|7|||
162765506|NCT00244751|587852020|FG001|Overall Study|Adverse Event|7|||
162765507|NCT00244751|587852021|FG002|Overall Study|Adverse Event|5|||
162765508|NCT00244751|587852019|FG000|Overall Study|Lost to Follow-up|0|||
162765509|NCT00244751|587852020|FG001|Overall Study|Lost to Follow-up|1|||
162765510|NCT00244751|587852021|FG002|Overall Study|Lost to Follow-up|0|||
162765511|NCT00244751|587852019|FG000|Overall Study|Protocol Violation|1|||
162765512|NCT00244751|587852020|FG001|Overall Study|Protocol Violation|0|||
162765513|NCT00244751|587852021|FG002|Overall Study|Protocol Violation|1|||
162765514|NCT00244751|587852019|FG000|Overall Study|Withdrawal by Subject|7|||
162765515|NCT00244751|587852020|FG001|Overall Study|Withdrawal by Subject|5|||
162765516|NCT00244751|587852021|FG002|Overall Study|Withdrawal by Subject|3|||
162765517|NCT00244751|587852019|FG000|Overall Study|Elevated liver enzymes|1|||
162765518|NCT00244751|587852020|FG001|Overall Study|Elevated liver enzymes|0|||
162765519|NCT00244751|587852021|FG002|Overall Study|Elevated liver enzymes|0|||
162765520|NCT00244751|587852019|FG000|Overall Study|Lack of compliance with protocol|0|||
162765521|NCT00244751|587852020|FG001|Overall Study|Lack of compliance with protocol|1|||
162765522|NCT00244751|587852021|FG002|Overall Study|Lack of compliance with protocol|0|||
162765523|NCT00244751|587852019|FG000|Overall Study|Safety reasons|0|||
162765524|NCT00244751|587852020|FG001|Overall Study|Safety reasons|1|||
162765525|NCT00244751|587852021|FG002|Overall Study|Safety reasons|0|||
162765526|NCT00244751|587852019|FG000|Overall Study|Participant randomized by mistake|0|||
162765527|NCT00244751|587852020|FG001|Overall Study|Participant randomized by mistake|0|||
162765528|NCT00244751|587852021|FG002|Overall Study|Participant randomized by mistake|1|||
162765529|NCT02077374|587852022|FG000|Overall Study|Withdrawal by Subject|0|||
162765530|NCT02077374|587852023|FG001|Overall Study|Withdrawal by Subject|1|||
162765531|NCT02077374|587852022|FG000|Overall Study|Protocol Violation|0|||
162765532|NCT02077374|587852023|FG001|Overall Study|Protocol Violation|1|||
162765533|NCT01777932|587852024|FG000|Overall Study|Disease progression|136|||
162765534|NCT01777932|587852024|FG000|Overall Study|Death|3|||
162765535|NCT01777932|587852024|FG000|Overall Study|Adverse Event|34|||
162765536|NCT01777932|587852024|FG000|Overall Study|Lost to Follow-up|3|||
162765537|NCT01777932|587852024|FG000|Overall Study|Investigator decision|10|||
162765538|NCT01777932|587852024|FG000|Overall Study|Reimbursement limit|9|||
162765539|NCT01777932|587852024|FG000|Overall Study|Patient refused further treatment|10|||
162765540|NCT00068107|587852028|FG000|Overall Study|end-stage renal disease|6|||
162765541|NCT00068107|587852028|FG000|Overall Study|Death|2|||
162765542|NCT00068107|587852028|FG000|Overall Study|Withdrawal by Subject|1|||
162765543|NCT03989232|587852029|FG000|Overall Study|Lost to Follow-up|3|||
162765544|NCT03989232|587852030|FG001|Overall Study|Lost to Follow-up|10|||
162765545|NCT03989232|587852029|FG000|Overall Study|Withdrawal by Subject|6|||
162765546|NCT03989232|587852030|FG001|Overall Study|Withdrawal by Subject|6|||
162765547|NCT03989232|587852029|FG000|Overall Study|Death|1|||
162765548|NCT03989232|587852030|FG001|Overall Study|Death|2|||
162765549|NCT01930188|587852031|FG000|Overall Study|unclassified|4|||
162765550|NCT01930188|587852032|FG001|Overall Study|unclassified|5|||
162765551|NCT01930188|587852033|FG002|Overall Study|unclassified|3|||
162765552|NCT01930188|587852031|FG000|Overall Study|Missing follow-up information|2|||
162765553|NCT01930188|587852032|FG001|Overall Study|Missing follow-up information|2|||
162765554|NCT01930188|587852033|FG002|Overall Study|Missing follow-up information|3|||
162765555|NCT01930188|587852031|FG000|Overall Study|Lost to Follow-up|5|||
162765556|NCT01930188|587852032|FG001|Overall Study|Lost to Follow-up|2|||
162765557|NCT01930188|587852033|FG002|Overall Study|Lost to Follow-up|2|||
162765558|NCT01930188|587852031|FG000|Overall Study|Death|2|||
162765559|NCT01930188|587852032|FG001|Overall Study|Death|1|||
162765560|NCT01930188|587852033|FG002|Overall Study|Death|3|||
162765561|NCT01930188|587852031|FG000|Overall Study|Withdrawal by Subject|9|||
162765562|NCT01930188|587852032|FG001|Overall Study|Withdrawal by Subject|11|||
162765563|NCT01930188|587852033|FG002|Overall Study|Withdrawal by Subject|8|||
162765564|NCT02399449|587852036|FG000|Overall Study|Withdrawal by Subject|3|||
162765565|NCT02399449|587852037|FG001|Overall Study|Withdrawal by Subject|9|||
162765566|NCT02399449|587852036|FG000|Overall Study|Physician Decision|0|||
162765567|NCT02399449|587852037|FG001|Overall Study|Physician Decision|1|||
162765568|NCT01020435|587852038|FG000|Overall Study|Lost to Follow-up|0|||
162765569|NCT01020435|587852039|FG001|Overall Study|Lost to Follow-up|1|||
162765570|NCT00346398|587852040|FG000|Overall Study|Lost to Follow-up|3|||
162765571|NCT00346398|587852041|FG001|Overall Study|Lost to Follow-up|0|||
162765572|NCT00346398|587852040|FG000|Overall Study|Withdrawal by Subject|0|||
162765573|NCT00346398|587852041|FG001|Overall Study|Withdrawal by Subject|2|||
162765574|NCT02607956|587852042|FG000|Double-Blinded Phase|Withdrew Consent|17|||
162765575|NCT02607956|587852043|FG001|Double-Blinded Phase|Withdrew Consent|19|||
162765576|NCT02607956|587852044|FG002|Double-Blinded Phase|Withdrew Consent|0|||
162765577|NCT02607956|587852045|FG003|Double-Blinded Phase|Withdrew Consent|0|||
162765578|NCT02607956|587852042|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
162765579|NCT02607956|587852043|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
162765580|NCT02607956|587852044|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
162765581|NCT02607956|587852045|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
162765582|NCT02607956|587852042|FG000|Double-Blinded Phase|Randomized but never treated|7|||
162765583|NCT02607956|587852043|FG001|Double-Blinded Phase|Randomized but never treated|5|||
162765584|NCT02607956|587852044|FG002|Double-Blinded Phase|Randomized but never treated|0|||
162765585|NCT02607956|587852045|FG003|Double-Blinded Phase|Randomized but never treated|0|||
162765586|NCT02607956|587852042|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
162765587|NCT02607956|587852043|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
162765588|NCT02607956|587852044|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
162765589|NCT02607956|587852045|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
162765590|NCT02607956|587852042|FG000|Double-Blinded Phase|Death|4|||
162765591|NCT02607956|587852043|FG001|Double-Blinded Phase|Death|4|||
162765592|NCT02607956|587852044|FG002|Double-Blinded Phase|Death|0|||
162765593|NCT02607956|587852045|FG003|Double-Blinded Phase|Death|0|||
162765594|NCT02607956|587852042|FG000|Double-Blinded Phase|Adverse Event|4|||
162765595|NCT02607956|587852043|FG001|Double-Blinded Phase|Adverse Event|3|||
162765596|NCT02607956|587852044|FG002|Double-Blinded Phase|Adverse Event|0|||
162765597|NCT02607956|587852045|FG003|Double-Blinded Phase|Adverse Event|0|||
162765598|NCT02607956|587852042|FG000|Double-Blinded Phase|Protocol Violation|3|||
162765599|NCT02607956|587852043|FG001|Double-Blinded Phase|Protocol Violation|1|||
162765600|NCT02607956|587852044|FG002|Double-Blinded Phase|Protocol Violation|0|||
162765601|NCT02607956|587852045|FG003|Double-Blinded Phase|Protocol Violation|0|||
162765602|NCT02607956|587852042|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162765603|NCT02607956|587852043|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
162765604|NCT02607956|587852044|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162765605|NCT02607956|587852045|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162765606|NCT02607956|587852042|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
162765607|NCT02607956|587852043|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
162765608|NCT02607956|587852044|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
162765609|NCT02607956|587852045|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
162765610|NCT02607956|587852042|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162765611|NCT02607956|587852043|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162765612|NCT02607956|587852044|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
162765613|NCT02607956|587852045|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
162765614|NCT02607956|587852042|FG000|Open-Label Extension Phase|Death|0|||
162765615|NCT02607956|587852043|FG001|Open-Label Extension Phase|Death|0|||
162765616|NCT02607956|587852044|FG002|Open-Label Extension Phase|Death|1|||
162765617|NCT02607956|587852045|FG003|Open-Label Extension Phase|Death|3|||
162765618|NCT02607956|587852042|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
162765619|NCT02607956|587852043|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
162765620|NCT02607956|587852044|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
162765621|NCT02607956|587852045|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
162765622|NCT02607956|587852042|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162765623|NCT02607956|587852043|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162765624|NCT02607956|587852044|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
162765625|NCT02607956|587852045|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162765626|NCT02607956|587852042|FG000|Open-Label Extension Phase|Protocol Violation|0|||
162765627|NCT02607956|587852043|FG001|Open-Label Extension Phase|Protocol Violation|0|||
162765628|NCT02607956|587852044|FG002|Open-Label Extension Phase|Protocol Violation|0|||
162765629|NCT02607956|587852045|FG003|Open-Label Extension Phase|Protocol Violation|2|||
162765630|NCT02607956|587852042|FG000|Open-Label Extension Phase|Pregnancy|0|||
162765631|NCT02607956|587852043|FG001|Open-Label Extension Phase|Pregnancy|0|||
162765632|NCT02607956|587852044|FG002|Open-Label Extension Phase|Pregnancy|0|||
162765633|NCT02607956|587852045|FG003|Open-Label Extension Phase|Pregnancy|1|||
162765634|NCT00960206|587852052|FG000|Overall Study|Death|7|||
162765635|NCT00960206|587852053|FG001|Overall Study|Death|4|||
162765636|NCT00960206|587852054|FG002|Overall Study|Death|1|||
162765637|NCT00960206|587852052|FG000|Overall Study|Unwilling/Unable to return|1|||
162765638|NCT00960206|587852053|FG001|Overall Study|Unwilling/Unable to return|2|||
162765639|NCT00960206|587852054|FG002|Overall Study|Unwilling/Unable to return|0|||
162765640|NCT00960206|587852052|FG000|Overall Study|Lost to Follow-up|8|||
162765641|NCT00960206|587852053|FG001|Overall Study|Lost to Follow-up|14|||
162765642|NCT00960206|587852054|FG002|Overall Study|Lost to Follow-up|8|||
162765643|NCT00960206|587852052|FG000|Overall Study|Withdrawal by Subject|2|||
162765644|NCT00960206|587852053|FG001|Overall Study|Withdrawal by Subject|4|||
162765645|NCT00960206|587852054|FG002|Overall Study|Withdrawal by Subject|0|||
162765646|NCT00960206|587852052|FG000|Overall Study|Revision of study component|2|||
162765647|NCT00960206|587852053|FG001|Overall Study|Revision of study component|2|||
162765648|NCT00960206|587852054|FG002|Overall Study|Revision of study component|2|||
162765649|NCT00960206|587852052|FG000|Overall Study|Missing 10 year data|20|||
162765650|NCT00960206|587852053|FG001|Overall Study|Missing 10 year data|1|||
162765651|NCT00960206|587852054|FG002|Overall Study|Missing 10 year data|1|||
162765652|NCT01075152|587852055|FG000|Overall Study|Withdrawal by Subject|1|||
162765653|NCT01075152|587852056|FG001|Overall Study|Withdrawal by Subject|0|||
162765654|NCT01079949|587852059|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
162765655|NCT01079949|587852060|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
162765656|NCT01079949|587852059|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
162765657|NCT01079949|587852060|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
162765658|NCT01079949|587852059|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
162765659|NCT01079949|587852060|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
162765660|NCT01079949|587852059|FG000|Overall Study|Randomized but not treated|1|||
162765661|NCT01079949|587852060|FG001|Overall Study|Randomized but not treated|0|||
162765662|NCT05066230|587853798|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
162765663|NCT05066230|587853799|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
162765664|NCT05066230|587853798|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
162765665|NCT05066230|587853799|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
162765666|NCT05066230|587853798|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
162765667|NCT05066230|587853799|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
162765668|NCT05066230|587853798|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
162765669|NCT05066230|587853799|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
162765670|NCT05066230|587853798|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
162765671|NCT05066230|587853799|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
162765672|NCT05066230|587853798|FG000|After Week 48|Adverse Event|1|||
162765673|NCT05066230|587853799|FG001|After Week 48|Adverse Event|0|||
162765674|NCT05066230|587853798|FG000|After Week 48|Non-compliance with study schedule|1|||
162765675|NCT05066230|587853799|FG001|After Week 48|Non-compliance with study schedule|0|||
162765676|NCT05066230|587853798|FG000|After Week 48|Withdrawal by Subject|0|||
162765677|NCT05066230|587853799|FG001|After Week 48|Withdrawal by Subject|1|||
162765678|NCT05066230|587853798|FG000|After Week 48|Lost to Follow-up|3|||
162765679|NCT05066230|587853799|FG001|After Week 48|Lost to Follow-up|3|||
162765680|NCT05066230|587853798|FG000|After Week 48|Sponsor Request|115|||
162765681|NCT05066230|587853799|FG001|After Week 48|Sponsor Request|111|||
162765682|NCT00307489|587853800|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
162765683|NCT00307489|587853801|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
162765684|NCT00307489|587853800|FG000|Baseline Through Week 48|Physician Decision|1|||
162765685|NCT00307489|587853801|FG001|Baseline Through Week 48|Physician Decision|0|||
162765686|NCT00307489|587853800|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
162765687|NCT00307489|587853801|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
162765688|NCT00307489|587853800|FG000|Week 48 Through Week 168|Adverse Event|1|||
162765689|NCT00307489|587853801|FG001|Week 48 Through Week 168|Adverse Event|0|||
162765690|NCT00307489|587853800|FG000|Week 48 Through Week 168|Physician Decision|1|||
162765691|NCT00307489|587853801|FG001|Week 48 Through Week 168|Physician Decision|0|||
162765692|NCT00307489|587853800|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
162765693|NCT00307489|587853801|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
162765694|NCT00307489|587853800|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
162765695|NCT00307489|587853801|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
162765696|NCT00307489|587853800|FG000|Week 48 Through Week 168|Death|0|||
162765697|NCT00307489|587853801|FG001|Week 48 Through Week 168|Death|1|||
162765698|NCT00307489|587853800|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
162765699|NCT00307489|587853801|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
162765700|NCT00307489|587853800|FG000|Week 48 Through Week 168|Seroconversion|1|||
162765701|NCT00307489|587853801|FG001|Week 48 Through Week 168|Seroconversion|0|||
162765702|NCT04425252|587853802|FG000|Overall Study|Withdrawal by Subject|2|||
162765703|NCT04425252|587853803|FG001|Overall Study|Withdrawal by Subject|1|||
162765704|NCT04425252|587853802|FG000|Overall Study|Lost to Follow-up|1|||
162765705|NCT04425252|587853803|FG001|Overall Study|Lost to Follow-up|0|||
162765706|NCT04425252|587853802|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
162765707|NCT04425252|587853803|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
162765708|NCT02981953|587853804|FG000|Overall Study|Death|9|||
162765709|NCT02981953|587853804|FG000|Overall Study|Withdrawal by Subject|1|||
162765710|NCT02981953|587853804|FG000|Overall Study|Withdrawal to non-compliance|1|||
162765711|NCT02165202|587853809|FG000|Oral Phase|Refused further participation|5|||
162765712|NCT02165202|587853810|FG001|Oral Phase|Refused further participation|1|||
162765713|NCT02165202|587853809|FG000|Oral Phase|Study product Related Toxicity|1|||
162765714|NCT02165202|587853810|FG001|Oral Phase|Study product Related Toxicity|0|||
162765715|NCT02165202|587853809|FG000|Oral Phase|Unable to contact Participant|1|||
162765716|NCT02165202|587853810|FG001|Oral Phase|Unable to contact Participant|1|||
162765717|NCT02165202|587853809|FG000|Oral Phase|Clinical reasons|1|||
162765718|NCT02165202|587853810|FG001|Oral Phase|Clinical reasons|0|||
162765719|NCT02165202|587853809|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
162765720|NCT02165202|587853810|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
162765721|NCT02165202|587853809|FG000|Oral Phase|CMC advised termination|1|||
162765722|NCT02165202|587853810|FG001|Oral Phase|CMC advised termination|0|||
162765723|NCT02165202|587853809|FG000|Oral Phase|Relocated, no follow-up planned|1|||
162765724|NCT02165202|587853810|FG001|Oral Phase|Relocated, no follow-up planned|0|||
162765725|NCT02165202|587853809|FG000|Oral Phase|Abnormal EKG|0|||
162765726|NCT02165202|587853810|FG001|Oral Phase|Abnormal EKG|1|||
162765727|NCT02165202|587853809|FG000|Injection Phase|Abnormal Lab Value|5|||
162765728|NCT02165202|587853810|FG001|Injection Phase|Abnormal Lab Value|1|||
162765729|NCT02165202|587853809|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
162765730|NCT02165202|587853810|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
162765731|NCT02165202|587853809|FG000|Injection Phase|Unable to attend within Visit Window|1|||
162765732|NCT02165202|587853810|FG001|Injection Phase|Unable to attend within Visit Window|0|||
162765733|NCT02165202|587853809|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
162765734|NCT02165202|587853810|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
162765735|NCT02165202|587853809|FG000|Injection Phase|End of Study|2|||
162765736|NCT02165202|587853810|FG001|Injection Phase|End of Study|1|||
162765737|NCT02165202|587853809|FG000|Injection Phase|Study Product related Toxicity|1|||
162765738|NCT02165202|587853810|FG001|Injection Phase|Study Product related Toxicity|0|||
162765739|NCT02165202|587853809|FG000|Injection Phase|No longer interested|0|||
162765740|NCT02165202|587853810|FG001|Injection Phase|No longer interested|1|||
162765741|NCT02165202|587853809|FG000|Injection Phase|Participant unwilling to comply|1|||
162765742|NCT02165202|587853810|FG001|Injection Phase|Participant unwilling to comply|0|||
162765743|NCT04328467|587853816|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
162765744|NCT04328467|587853817|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
162765745|NCT04328467|587853818|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
162765746|NCT00990184|587853819|FG000|Overall Study|Physician Decision|1|||
162765747|NCT01975701|587853820|FG000|Overall Study|Lost to Follow-up|1|||
162765748|NCT01975701|587853820|FG000|Overall Study|Death|23|||
162765749|NCT01975701|587853820|FG000|Overall Study|Physician Decision|1|||
162765750|NCT01655498|587853821|FG000|Overall Study|Unrelated health issue|2|||
162765751|NCT01655498|587853821|FG000|Overall Study|Protocol Violation|2|||
162765752|NCT01655498|587853821|FG000|Overall Study|Withdrawal by Subject|1|||
162765753|NCT01714947|587853824|FG000|Part B|Progressive Disease|3|||
162765754|NCT00759681|587853825|FG000|Overall Study|Death|2|||
162765755|NCT00759681|587853826|FG001|Overall Study|Death|5|||
162765756|NCT00759681|587853825|FG000|Overall Study|Lost to Follow-up|8|||
162765757|NCT00759681|587853826|FG001|Overall Study|Lost to Follow-up|5|||
162765758|NCT01012999|587853827|FG000|Overall Study|Protocol Violation|1|||
162765759|NCT02410278|587853828|FG000|Run-in Period|Adverse Event|5|||
162765760|NCT02410278|587853829|FG001|Run-in Period|Adverse Event|0|||
162765761|NCT02410278|587853830|FG002|Run-in Period|Adverse Event|0|||
162765762|NCT02410278|587853828|FG000|Run-in Period|GSRS Threshold Not Met|30|||
162765763|NCT02410278|587853829|FG001|Run-in Period|GSRS Threshold Not Met|0|||
162765764|NCT02410278|587853830|FG002|Run-in Period|GSRS Threshold Not Met|0|||
162765765|NCT02410278|587853828|FG000|Run-in Period|Lost to Follow-up|1|||
162765766|NCT02410278|587853829|FG001|Run-in Period|Lost to Follow-up|0|||
162765767|NCT02410278|587853830|FG002|Run-in Period|Lost to Follow-up|0|||
162765768|NCT02410278|587853828|FG000|Run-in Period|Withdrawal by Subject|1|||
162765769|NCT02410278|587853829|FG001|Run-in Period|Withdrawal by Subject|0|||
162765770|NCT02410278|587853830|FG002|Run-in Period|Withdrawal by Subject|0|||
162765771|NCT02410278|587853828|FG000|Run-in Period|Pregnancy|1|||
162765772|NCT02410278|587853829|FG001|Run-in Period|Pregnancy|0|||
162765773|NCT02410278|587853830|FG002|Run-in Period|Pregnancy|0|||
162765774|NCT02410278|587853828|FG000|Study Treatment Period|Adverse Event|0|||
162765775|NCT02410278|587853829|FG001|Study Treatment Period|Adverse Event|6|||
162765776|NCT02410278|587853830|FG002|Study Treatment Period|Adverse Event|3|||
162765777|NCT02410278|587853828|FG000|Study Treatment Period|Physician Decision|0|||
162765778|NCT02410278|587853829|FG001|Study Treatment Period|Physician Decision|0|||
162765779|NCT02410278|587853830|FG002|Study Treatment Period|Physician Decision|1|||
162765780|NCT02410278|587853828|FG000|Study Treatment Period|Withdrawal by Subject|0|||
162765781|NCT02410278|587853829|FG001|Study Treatment Period|Withdrawal by Subject|1|||
162765782|NCT02410278|587853830|FG002|Study Treatment Period|Withdrawal by Subject|0|||
162765783|NCT02410278|587853828|FG000|Study Treatment Period|Other|0|||
162765784|NCT02410278|587853829|FG001|Study Treatment Period|Other|3|||
162765785|NCT02410278|587853830|FG002|Study Treatment Period|Other|0|||
162765786|NCT02410278|587853828|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
162765787|NCT02410278|587853829|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
162765788|NCT02410278|587853830|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
162765789|NCT02584257|587853831|FG000|Period 1|Withdrawal by Subject|0|||
162765790|NCT02584257|587853832|FG001|Period 1|Withdrawal by Subject|0|||
162765791|NCT02584257|587853833|FG002|Period 1|Withdrawal by Subject|0|||
162765792|NCT02584257|587853834|FG003|Period 1|Withdrawal by Subject|0|||
162765793|NCT02584257|587853835|FG004|Period 1|Withdrawal by Subject|0|||
162765794|NCT02584257|587853836|FG005|Period 1|Withdrawal by Subject|0|||
162765795|NCT02584257|587853837|FG006|Period 1|Withdrawal by Subject|1|||
162765796|NCT02584257|587853838|FG007|Period 1|Withdrawal by Subject|0|||
162765797|NCT02584257|587853839|FG008|Period 1|Withdrawal by Subject|0|||
162765798|NCT02584257|587853831|FG000|Period 2|Physician Decision|1|||
162765799|NCT02584257|587853832|FG001|Period 2|Physician Decision|0|||
162765800|NCT02584257|587853833|FG002|Period 2|Physician Decision|0|||
162765801|NCT02584257|587853834|FG003|Period 2|Physician Decision|0|||
162765802|NCT02584257|587853835|FG004|Period 2|Physician Decision|0|||
162765803|NCT02584257|587853836|FG005|Period 2|Physician Decision|0|||
162765804|NCT02584257|587853837|FG006|Period 2|Physician Decision|0|||
162765805|NCT02584257|587853838|FG007|Period 2|Physician Decision|0|||
162765806|NCT02584257|587853839|FG008|Period 2|Physician Decision|0|||
162765807|NCT02584257|587853831|FG000|Period 2|Adverse Event|0|||
162765808|NCT02584257|587853832|FG001|Period 2|Adverse Event|1|||
162765809|NCT02584257|587853833|FG002|Period 2|Adverse Event|0|||
162765810|NCT02584257|587853834|FG003|Period 2|Adverse Event|0|||
162765811|NCT02584257|587853835|FG004|Period 2|Adverse Event|0|||
162765812|NCT02584257|587853836|FG005|Period 2|Adverse Event|0|||
162765813|NCT02584257|587853837|FG006|Period 2|Adverse Event|0|||
162765814|NCT02584257|587853838|FG007|Period 2|Adverse Event|0|||
162765815|NCT02584257|587853839|FG008|Period 2|Adverse Event|0|||
162765816|NCT01670877|587853840|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162765817|NCT01670877|587853841|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
162765818|NCT01670877|587853842|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162765819|NCT01670877|587853843|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162765820|NCT01670877|587853844|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162765821|NCT01670877|587853845|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162765822|NCT01670877|587853840|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162765823|NCT01670877|587853841|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162765824|NCT01670877|587853842|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
162765825|NCT01670877|587853843|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162765826|NCT01670877|587853844|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162765827|NCT01670877|587853845|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162765828|NCT01670877|587853840|FG000|Part I and Part 2|Grade 2 vomiting|0|||
162765829|NCT01670877|587853841|FG001|Part I and Part 2|Grade 2 vomiting|0|||
162765830|NCT01670877|587853842|FG002|Part I and Part 2|Grade 2 vomiting|0|||
162765831|NCT01670877|587853843|FG003|Part I and Part 2|Grade 2 vomiting|1|||
162765832|NCT01670877|587853844|FG004|Part I and Part 2|Grade 2 vomiting|0|||
162765833|NCT01670877|587853845|FG005|Part I and Part 2|Grade 2 vomiting|0|||
162765834|NCT01670877|587853840|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162765835|NCT01670877|587853841|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162765836|NCT01670877|587853842|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162765837|NCT01670877|587853843|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
162765838|NCT01670877|587853844|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162765839|NCT01670877|587853845|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162765840|NCT01670877|587853840|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162765841|NCT01670877|587853841|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162765842|NCT01670877|587853842|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162765843|NCT01670877|587853843|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
162765844|NCT01670877|587853844|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162765845|NCT01670877|587853845|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162765846|NCT02309892|587853846|FG000|Overall Study|Physician Decision|1|||
162765847|NCT02309892|587853847|FG001|Overall Study|Physician Decision|0|||
162765848|NCT02309892|587853848|FG002|Overall Study|Physician Decision|0|||
162765849|NCT02309892|587853849|FG003|Overall Study|Physician Decision|0|||
162765850|NCT02309892|587853850|FG004|Overall Study|Physician Decision|0|||
162765851|NCT02309892|587853851|FG005|Overall Study|Physician Decision|0|||
162765852|NCT02309892|587853852|FG006|Overall Study|Physician Decision|0|||
162765853|NCT02309892|587853846|FG000|Overall Study|Adverse Event|1|||
162765854|NCT02309892|587853847|FG001|Overall Study|Adverse Event|0|||
162765855|NCT02309892|587853848|FG002|Overall Study|Adverse Event|1|||
162765856|NCT02309892|587853849|FG003|Overall Study|Adverse Event|0|||
162765857|NCT02309892|587853850|FG004|Overall Study|Adverse Event|0|||
162765858|NCT02309892|587853851|FG005|Overall Study|Adverse Event|0|||
162765859|NCT02309892|587853852|FG006|Overall Study|Adverse Event|0|||
162765860|NCT02309892|587853846|FG000|Overall Study|Progressive Disease|0|||
162765861|NCT02309892|587853847|FG001|Overall Study|Progressive Disease|1|||
162765862|NCT02309892|587853848|FG002|Overall Study|Progressive Disease|0|||
162765863|NCT02309892|587853849|FG003|Overall Study|Progressive Disease|0|||
162765864|NCT02309892|587853850|FG004|Overall Study|Progressive Disease|1|||
162765865|NCT02309892|587853851|FG005|Overall Study|Progressive Disease|0|||
162765866|NCT02309892|587853852|FG006|Overall Study|Progressive Disease|0|||
162765867|NCT02309892|587853846|FG000|Overall Study|Death|0|||
162765868|NCT02309892|587853847|FG001|Overall Study|Death|0|||
162765869|NCT02309892|587853848|FG002|Overall Study|Death|0|||
162765870|NCT02309892|587853849|FG003|Overall Study|Death|0|||
162765871|NCT02309892|587853850|FG004|Overall Study|Death|0|||
162765872|NCT02309892|587853851|FG005|Overall Study|Death|1|||
162765873|NCT02309892|587853852|FG006|Overall Study|Death|0|||
162765874|NCT05376397|587853855|FG000|Overall Study|Lost to Follow-up|1|||
162765875|NCT02721147|587853856|FG000|Overall Study|Lost to Follow-up|2|||
162765876|NCT02721147|587853857|FG001|Overall Study|Lost to Follow-up|0|||
162765877|NCT02721147|587853858|FG002|Overall Study|Lost to Follow-up|0|||
162765878|NCT01722097|587853859|FG000|Overall Study|Patient sheets not returned|6|||
162765879|NCT01722097|587853860|FG001|Overall Study|Patient sheets not returned|5|||
162765880|NCT01535261|587853861|FG000|Overall Study|Physician Decision|8|||
162765881|NCT01535261|587853861|FG000|Overall Study|Protocol Violation|3|||
162765882|NCT01535261|587853861|FG000|Overall Study|Death|5|||
162765883|NCT01535261|587853861|FG000|Overall Study|Lost to Follow-up|8|||
162765884|NCT01535261|587853861|FG000|Overall Study|Withdrawal by Subject|14|||
162765885|NCT01535261|587853861|FG000|Overall Study|Adverse Event|12|||
162765886|NCT01137682|587853862|FG000|Overall Study|Adverse Event-CORE|2|||
162765887|NCT01137682|587853863|FG001|Overall Study|Adverse Event-CORE|4|||
162765888|NCT01137682|587853864|FG002|Overall Study|Adverse Event-CORE|0|||
162765889|NCT01137682|587853862|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
162765890|NCT01137682|587853863|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
162765891|NCT01137682|587853864|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
162765892|NCT01137682|587853862|FG000|Overall Study|Administrative problems-CORE|2|||
162765893|NCT01137682|587853863|FG001|Overall Study|Administrative problems-CORE|1|||
162765894|NCT01137682|587853864|FG002|Overall Study|Administrative problems-CORE|0|||
162765895|NCT01137682|587853862|FG000|Overall Study|Protocol Violation-CORE|0|||
162765896|NCT01137682|587853863|FG001|Overall Study|Protocol Violation-CORE|1|||
162765897|NCT01137682|587853864|FG002|Overall Study|Protocol Violation-CORE|1|||
162765898|NCT01137682|587853862|FG000|Overall Study|Adverse Event-Extension|4|||
162765899|NCT01137682|587853863|FG001|Overall Study|Adverse Event-Extension|8|||
162765900|NCT01137682|587853864|FG002|Overall Study|Adverse Event-Extension|7|||
162765901|NCT01137682|587853862|FG000|Overall Study|Lack of Efficacy-Extension|15|||
162765902|NCT01137682|587853863|FG001|Overall Study|Lack of Efficacy-Extension|9|||
162765903|NCT01137682|587853864|FG002|Overall Study|Lack of Efficacy-Extension|13|||
162765904|NCT01137682|587853862|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
162765905|NCT01137682|587853863|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
162765906|NCT01137682|587853864|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
162765907|NCT01137682|587853862|FG000|Overall Study|Lost to Follow Up-Extension|0|||
162765908|NCT01137682|587853863|FG001|Overall Study|Lost to Follow Up-Extension|1|||
162765909|NCT01137682|587853864|FG002|Overall Study|Lost to Follow Up-Extension|0|||
162765910|NCT01137682|587853862|FG000|Overall Study|Administrative problems-Extension|0|||
162765911|NCT01137682|587853863|FG001|Overall Study|Administrative problems-Extension|2|||
162765912|NCT01137682|587853864|FG002|Overall Study|Administrative problems-Extension|0|||
162765913|NCT01137682|587853862|FG000|Overall Study|Death-Extension|2|||
162765914|NCT01137682|587853863|FG001|Overall Study|Death-Extension|0|||
162765915|NCT01137682|587853864|FG002|Overall Study|Death-Extension|0|||
162765916|NCT01137682|587853862|FG000|Overall Study|Protocol Violation-Extension|2|||
162765917|NCT01137682|587853863|FG001|Overall Study|Protocol Violation-Extension|1|||
162765918|NCT01137682|587853864|FG002|Overall Study|Protocol Violation-Extension|0|||
162765919|NCT01137682|587853862|FG000|Overall Study|Did not enter extension|2|||
162765920|NCT01137682|587853863|FG001|Overall Study|Did not enter extension|3|||
162765921|NCT01137682|587853864|FG002|Overall Study|Did not enter extension|2|||
162765922|NCT01137682|587853862|FG000|Overall Study|Did not receive treatment in extension|0|||
162765923|NCT01137682|587853863|FG001|Overall Study|Did not receive treatment in extension|0|||
162765924|NCT01137682|587853864|FG002|Overall Study|Did not receive treatment in extension|1|||
162765925|NCT02009332|587853865|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162765926|NCT02009332|587853866|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
162765927|NCT02009332|587853867|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162765928|NCT02009332|587853868|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162765929|NCT02009332|587853869|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162765930|NCT02009332|587853870|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162765931|NCT02009332|587853865|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162765932|NCT02009332|587853866|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162765933|NCT02009332|587853867|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162765934|NCT02009332|587853868|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162765935|NCT02009332|587853869|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
162765936|NCT02009332|587853870|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162765937|NCT02009332|587853865|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162765938|NCT02009332|587853866|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162765939|NCT02009332|587853867|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162765940|NCT02009332|587853868|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162765941|NCT02009332|587853869|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162765942|NCT02009332|587853870|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
162765943|NCT01912599|587853872|FG000|Overall Study|Withdrawal by Subject|0|||
162765944|NCT01912599|587853873|FG001|Overall Study|Withdrawal by Subject|1|||
162765945|NCT01757288|587853874|FG000|Overall Study|Consent withdrawal|0|||
162765946|NCT01757288|587853875|FG001|Overall Study|Consent withdrawal|4|||
162765947|NCT01757288|587853876|FG002|Overall Study|Consent withdrawal|4|||
162765948|NCT01757288|587853874|FG000|Overall Study|Patient off study, IRB hold.|0|||
162765949|NCT01757288|587853875|FG001|Overall Study|Patient off study, IRB hold.|0|||
162765950|NCT01757288|587853876|FG002|Overall Study|Patient off study, IRB hold.|1|||
162765951|NCT01757288|587853874|FG000|Overall Study|Patient death prior to starting treatment|0|||
162765952|NCT01757288|587853875|FG001|Overall Study|Patient death prior to starting treatment|0|||
162765953|NCT01757288|587853876|FG002|Overall Study|Patient death prior to starting treatment|1|||
162765954|NCT01757288|587853874|FG000|Overall Study|Wrong medication administered|0|||
162765955|NCT01757288|587853875|FG001|Overall Study|Wrong medication administered|1|||
162765956|NCT01757288|587853876|FG002|Overall Study|Wrong medication administered|0|||
162765957|NCT01757288|587853874|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
162765958|NCT01757288|587853875|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
162765959|NCT01757288|587853876|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
162765960|NCT01757288|587853874|FG000|Overall Study|Not meeting protocol constraints|0|||
162765961|NCT01757288|587853875|FG001|Overall Study|Not meeting protocol constraints|1|||
162765962|NCT01757288|587853876|FG002|Overall Study|Not meeting protocol constraints|1|||
162765963|NCT01757288|587853874|FG000|Overall Study|Multiple missed appointments|0|||
162765964|NCT01757288|587853875|FG001|Overall Study|Multiple missed appointments|1|||
162765965|NCT01757288|587853876|FG002|Overall Study|Multiple missed appointments|0|||
162765966|NCT01757288|587853874|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
162765967|NCT01757288|587853875|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
162765968|NCT01757288|587853876|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
162765969|NCT01757288|587853874|FG000|Overall Study|>2 weeks treatment break|0|||
162765970|NCT01757288|587853875|FG001|Overall Study|>2 weeks treatment break|0|||
162765971|NCT01757288|587853876|FG002|Overall Study|>2 weeks treatment break|1|||
162765972|NCT02825550|587853877|FG000|Overall Study|Physician Decision|1|||
162765973|NCT03386344|587853878|FG000|Overall Study|Adverse Event|6|||
162765974|NCT03386344|587853879|FG001|Overall Study|Adverse Event|3|||
162765975|NCT03386344|587853880|FG002|Overall Study|Adverse Event|1|||
162765976|NCT03386344|587853878|FG000|Overall Study|Poor Compliance to Protocol|0|||
162765977|NCT03386344|587853879|FG001|Overall Study|Poor Compliance to Protocol|1|||
162765978|NCT03386344|587853880|FG002|Overall Study|Poor Compliance to Protocol|0|||
162765979|NCT03386344|587853878|FG000|Overall Study|Study Terminated by Sponsor|101|||
162765980|NCT03386344|587853879|FG001|Overall Study|Study Terminated by Sponsor|102|||
162765981|NCT03386344|587853880|FG002|Overall Study|Study Terminated by Sponsor|106|||
162765982|NCT03386344|587853878|FG000|Overall Study|Lost to Follow-up|3|||
162765983|NCT03386344|587853879|FG001|Overall Study|Lost to Follow-up|2|||
162765984|NCT03386344|587853880|FG002|Overall Study|Lost to Follow-up|1|||
162765985|NCT03386344|587853878|FG000|Overall Study|At the Participant's own Request|7|||
162765986|NCT03386344|587853879|FG001|Overall Study|At the Participant's own Request|7|||
162765987|NCT03386344|587853880|FG002|Overall Study|At the Participant's own Request|8|||
162765988|NCT03386344|587853878|FG000|Overall Study|Reason not Specified|0|||
162765989|NCT03386344|587853879|FG001|Overall Study|Reason not Specified|1|||
162765990|NCT03386344|587853880|FG002|Overall Study|Reason not Specified|0|||
162765991|NCT01077284|587853881|FG000|Overall Study|Adverse Event|2|||
162765992|NCT01077284|587853882|FG001|Overall Study|Adverse Event|0|||
162765993|NCT01077284|587853883|FG002|Overall Study|Adverse Event|1|||
162765994|NCT01077284|587853881|FG000|Overall Study|Lost to Follow-up|1|||
162765995|NCT01077284|587853882|FG001|Overall Study|Lost to Follow-up|2|||
162765996|NCT01077284|587853883|FG002|Overall Study|Lost to Follow-up|0|||
162765997|NCT01077284|587853881|FG000|Overall Study|Withdrawal by Subject|2|||
162765998|NCT01077284|587853882|FG001|Overall Study|Withdrawal by Subject|3|||
162765999|NCT01077284|587853883|FG002|Overall Study|Withdrawal by Subject|1|||
162766000|NCT01077284|587853881|FG000|Overall Study|Other|0|||
162766001|NCT01077284|587853882|FG001|Overall Study|Other|0|||
162766002|NCT01077284|587853883|FG002|Overall Study|Other|1|||
162766003|NCT00042939|587853888|FG000|Overall Study|Adverse Event|6|||
162766004|NCT00042939|587853889|FG001|Overall Study|Adverse Event|7|||
162766005|NCT00042939|587853888|FG000|Overall Study|Death|3|||
162766006|NCT00042939|587853889|FG001|Overall Study|Death|2|||
162766007|NCT00042939|587853888|FG000|Overall Study|Withdrawal by Subject|3|||
162766008|NCT00042939|587853889|FG001|Overall Study|Withdrawal by Subject|4|||
162766009|NCT00042939|587853888|FG000|Overall Study|Other disease|1|||
162766010|NCT00042939|587853889|FG001|Overall Study|Other disease|0|||
162766011|NCT00042939|587853888|FG000|Overall Study|Ineligible|2|||
162766012|NCT00042939|587853889|FG001|Overall Study|Ineligible|2|||
162766013|NCT00042939|587853888|FG000|Overall Study|Deterioration of health|3|||
162766014|NCT00042939|587853889|FG001|Overall Study|Deterioration of health|4|||
162766015|NCT00042939|587853888|FG000|Overall Study|QOL diminished|1|||
162766016|NCT00042939|587853889|FG001|Overall Study|QOL diminished|0|||
162766017|NCT00042939|587853888|FG000|Overall Study|Rising ca 19-9|1|||
162766018|NCT00042939|587853889|FG001|Overall Study|Rising ca 19-9|0|||
162766019|NCT00042939|587853888|FG000|Overall Study|Patient non-compliance|1|||
162766020|NCT00042939|587853889|FG001|Overall Study|Patient non-compliance|0|||
162766021|NCT00042939|587853888|FG000|Overall Study|Still on treatment|1|||
162766022|NCT00042939|587853889|FG001|Overall Study|Still on treatment|0|||
162766023|NCT00042939|587853888|FG000|Overall Study|Treatment break > 4 weeks|0|||
162766024|NCT00042939|587853889|FG001|Overall Study|Treatment break > 4 weeks|1|||
162766025|NCT00042939|587853888|FG000|Overall Study|Did not start treatment|2|||
162766026|NCT00042939|587853889|FG001|Overall Study|Did not start treatment|1|||
162766027|NCT03349476|587853890|FG000|Overall Study|Physician Decision|3|||
162766028|NCT01762345|587853893|FG000|Overall Study|Adverse Event|5|||
162766029|NCT01762345|587853893|FG000|Overall Study|Protocol Violation|2|||
162766030|NCT02379078|587853894|FG000|Overall Study|Lost to Follow-up|33|||
162766031|NCT02379078|587853895|FG001|Overall Study|Lost to Follow-up|30|||
162766032|NCT02379078|587853894|FG000|Overall Study|Withdrawal by Subject|6|||
162766033|NCT02379078|587853895|FG001|Overall Study|Withdrawal by Subject|5|||
162766034|NCT03481725|587853896|FG000|Overall Study|Withdrawal by Subject|1|||
162766035|NCT03481725|587853897|FG001|Overall Study|Withdrawal by Subject|0|||
162766036|NCT03444155|587853900|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
162766037|NCT03444155|587853901|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
162766038|NCT02877680|587853902|FG000|Overall Study|Lost to Follow-up|1|||
162766039|NCT02877680|587853903|FG001|Overall Study|Lost to Follow-up|1|||
162766040|NCT01133678|587853904|FG000|Overall Study|Death|1|||
162766041|NCT01133678|587853905|FG001|Overall Study|Death|1|||
162766042|NCT01864200|587853912|FG000|Overall Study|Lost to Follow-up|1|||
162766043|NCT01864200|587853913|FG001|Overall Study|Lost to Follow-up|3|||
162766044|NCT01864200|587853912|FG000|Overall Study|Protocol Violation|1|||
162766045|NCT01864200|587853913|FG001|Overall Study|Protocol Violation|0|||
162766046|NCT01419184|587853920|FG000|Overall Study|Site data not available|3|||
162766047|NCT01419184|587853921|FG001|Overall Study|Site data not available|2|||
162766048|NCT01419184|587853920|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
162766049|NCT01419184|587853921|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
162766050|NCT01419184|587853920|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
162766051|NCT01419184|587853921|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
162766052|NCT01419184|587853920|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
162766053|NCT01419184|587853921|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
162766054|NCT01419184|587853920|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
162766055|NCT01419184|587853921|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
162766056|NCT01419184|587853920|FG000|Overall Study|Participant randomized, not treated|1|||
162766057|NCT01419184|587853921|FG001|Overall Study|Participant randomized, not treated|0|||
162766058|NCT02644122|587853930|FG000|Overall Study|Withdrawal by Subject|1|||
162766059|NCT00424476|587853931|FG000|Overall Study|Withdrawal by Subject|7|||
162766060|NCT00424476|587853932|FG001|Overall Study|Withdrawal by Subject|6|||
162766061|NCT00424476|587853933|FG002|Overall Study|Withdrawal by Subject|3|||
162766062|NCT00424476|587853931|FG000|Overall Study|Adverse Event|19|||
162766063|NCT00424476|587853932|FG001|Overall Study|Adverse Event|16|||
162766064|NCT00424476|587853933|FG002|Overall Study|Adverse Event|15|||
162766065|NCT00424476|587853931|FG000|Overall Study|Lack of Efficacy|16|||
162766066|NCT00424476|587853932|FG001|Overall Study|Lack of Efficacy|12|||
162766067|NCT00424476|587853933|FG002|Overall Study|Lack of Efficacy|12|||
162766068|NCT00424476|587853931|FG000|Overall Study|Lack of Compliance|1|||
162766069|NCT00424476|587853932|FG001|Overall Study|Lack of Compliance|1|||
162766070|NCT00424476|587853933|FG002|Overall Study|Lack of Compliance|1|||
162766071|NCT00424476|587853931|FG000|Overall Study|Lost to Follow-up|4|||
162766072|NCT00424476|587853932|FG001|Overall Study|Lost to Follow-up|6|||
162766073|NCT00424476|587853933|FG002|Overall Study|Lost to Follow-up|3|||
162766074|NCT00424476|587853931|FG000|Overall Study|Protocol Violation|7|||
162766075|NCT00424476|587853932|FG001|Overall Study|Protocol Violation|2|||
162766076|NCT00424476|587853933|FG002|Overall Study|Protocol Violation|3|||
162766077|NCT00424476|587853931|FG000|Overall Study|Physician Decision|3|||
162766078|NCT00424476|587853932|FG001|Overall Study|Physician Decision|2|||
162766079|NCT00424476|587853933|FG002|Overall Study|Physician Decision|3|||
162766080|NCT00424476|587853931|FG000|Overall Study|Other|4|||
162766081|NCT00424476|587853932|FG001|Overall Study|Other|3|||
162766082|NCT00424476|587853933|FG002|Overall Study|Other|9|||
162766083|NCT02514824|587853934|FG000|Overall Study|Withdrawal by Subject|1|||
162766084|NCT02514824|587853935|FG001|Overall Study|Withdrawal by Subject|0|||
162766085|NCT02514824|587853936|FG002|Overall Study|Withdrawal by Subject|0|||
162766086|NCT02514824|587853937|FG003|Overall Study|Withdrawal by Subject|0|||
162766087|NCT02514824|587853934|FG000|Overall Study|Dose-Limiting Toxicity|0|||
162766088|NCT02514824|587853935|FG001|Overall Study|Dose-Limiting Toxicity|1|||
162766089|NCT02514824|587853936|FG002|Overall Study|Dose-Limiting Toxicity|0|||
162766090|NCT02514824|587853937|FG003|Overall Study|Dose-Limiting Toxicity|0|||
162766091|NCT02170207|587853940|FG000|Overall Study|Case report forms unavailable|5|||
162766092|NCT00657709|587853941|FG000|Overall Study|AE or Death|7|||
162766093|NCT00657709|587853942|FG001|Overall Study|AE or Death|7|||
162766094|NCT00657709|587853943|FG002|Overall Study|AE or Death|6|||
162766095|NCT00657709|587853944|FG003|Overall Study|AE or Death|7|||
162766096|NCT00657709|587853945|FG004|Overall Study|AE or Death|1|||
162766097|NCT00657709|587853941|FG000|Overall Study|Withdrawal by Subject|7|||
162766098|NCT00657709|587853942|FG001|Overall Study|Withdrawal by Subject|15|||
162766099|NCT00657709|587853943|FG002|Overall Study|Withdrawal by Subject|15|||
162766100|NCT00657709|587853944|FG003|Overall Study|Withdrawal by Subject|5|||
162766101|NCT00657709|587853945|FG004|Overall Study|Withdrawal by Subject|9|||
162766102|NCT00657709|587853941|FG000|Overall Study|Lost to Follow-up|9|||
162766103|NCT00657709|587853942|FG001|Overall Study|Lost to Follow-up|9|||
162766104|NCT00657709|587853943|FG002|Overall Study|Lost to Follow-up|7|||
162766105|NCT00657709|587853944|FG003|Overall Study|Lost to Follow-up|1|||
162766106|NCT00657709|587853945|FG004|Overall Study|Lost to Follow-up|21|||
162766107|NCT00657709|587853941|FG000|Overall Study|Protocol Violation|0|||
162766108|NCT00657709|587853942|FG001|Overall Study|Protocol Violation|2|||
162766109|NCT00657709|587853943|FG002|Overall Study|Protocol Violation|0|||
162766110|NCT00657709|587853944|FG003|Overall Study|Protocol Violation|1|||
162766111|NCT00657709|587853945|FG004|Overall Study|Protocol Violation|2|||
162766112|NCT03122860|587853946|FG000|Overall Study|Discontinued Before Treatment|1|||
162766113|NCT03122860|587853947|FG001|Overall Study|Discontinued Before Treatment|1|||
162766114|NCT03122860|587853948|FG002|Overall Study|Discontinued Before Treatment|2|||
162766115|NCT03122860|587853949|FG003|Overall Study|Discontinued Before Treatment|0|||
162766116|NCT03122860|587853950|FG004|Overall Study|Discontinued Before Treatment|1|||
162766117|NCT03122860|587853951|FG005|Overall Study|Discontinued Before Treatment|0|||
162766118|NCT03122860|587853946|FG000|Overall Study|Adverse Event|1|||
162766119|NCT03122860|587853947|FG001|Overall Study|Adverse Event|0|||
162766120|NCT03122860|587853948|FG002|Overall Study|Adverse Event|1|||
162766121|NCT03122860|587853949|FG003|Overall Study|Adverse Event|1|||
162766122|NCT03122860|587853950|FG004|Overall Study|Adverse Event|0|||
162766123|NCT03122860|587853951|FG005|Overall Study|Adverse Event|0|||
162766124|NCT03122860|587853946|FG000|Overall Study|Lost to Follow-up|5|||
162766125|NCT03122860|587853947|FG001|Overall Study|Lost to Follow-up|2|||
162766126|NCT03122860|587853948|FG002|Overall Study|Lost to Follow-up|3|||
162766127|NCT03122860|587853949|FG003|Overall Study|Lost to Follow-up|3|||
162766128|NCT03122860|587853950|FG004|Overall Study|Lost to Follow-up|5|||
162766129|NCT03122860|587853951|FG005|Overall Study|Lost to Follow-up|4|||
162766130|NCT03122860|587853946|FG000|Overall Study|Subject Non-Compliance|0|||
162766131|NCT03122860|587853947|FG001|Overall Study|Subject Non-Compliance|0|||
162766132|NCT03122860|587853948|FG002|Overall Study|Subject Non-Compliance|1|||
162766133|NCT03122860|587853949|FG003|Overall Study|Subject Non-Compliance|0|||
162766134|NCT03122860|587853950|FG004|Overall Study|Subject Non-Compliance|0|||
162766135|NCT03122860|587853951|FG005|Overall Study|Subject Non-Compliance|0|||
162766136|NCT03122860|587853946|FG000|Overall Study|Withdrawal by Subject|3|||
162766137|NCT03122860|587853947|FG001|Overall Study|Withdrawal by Subject|2|||
162766138|NCT03122860|587853948|FG002|Overall Study|Withdrawal by Subject|5|||
162766139|NCT03122860|587853949|FG003|Overall Study|Withdrawal by Subject|7|||
162766140|NCT03122860|587853950|FG004|Overall Study|Withdrawal by Subject|9|||
162766141|NCT03122860|587853951|FG005|Overall Study|Withdrawal by Subject|8|||
162766142|NCT01138657|587853952|FG000|Overall Study|Adverse Event|3|||
162766143|NCT01138657|587853953|FG001|Overall Study|Adverse Event|10|||
162766144|NCT01138657|587853952|FG000|Overall Study|Lack of Efficacy|2|||
162766145|NCT01138657|587853953|FG001|Overall Study|Lack of Efficacy|1|||
162766146|NCT01138657|587853952|FG000|Overall Study|Lost to Follow-up|0|||
162766147|NCT01138657|587853953|FG001|Overall Study|Lost to Follow-up|3|||
162766148|NCT01138657|587853952|FG000|Overall Study|Miscellaneous Reasons|3|||
162766149|NCT01138657|587853953|FG001|Overall Study|Miscellaneous Reasons|4|||
162766150|NCT02574286|587853954|FG000|Overall Study|Adverse Event|3|||
162766151|NCT02574286|587853954|FG000|Overall Study|Withdrawal by Subject|2|||
162766152|NCT00090519|587853955|FG000|Overall Study|Adverse Event|5|||
162766153|NCT00090519|587853956|FG001|Overall Study|Adverse Event|4|||
162766154|NCT00090519|587853955|FG000|Overall Study|Death|9|||
162766155|NCT00090519|587853956|FG001|Overall Study|Death|9|||
162766156|NCT00090519|587853955|FG000|Overall Study|Lost to Follow-up|26|||
162766157|NCT00090519|587853956|FG001|Overall Study|Lost to Follow-up|29|||
162766158|NCT00090519|587853955|FG000|Overall Study|Withdrawal by Subject|28|||
162766159|NCT00090519|587853956|FG001|Overall Study|Withdrawal by Subject|29|||
162766160|NCT00090519|587853955|FG000|Overall Study|Physician Decision|2|||
162766161|NCT00090519|587853956|FG001|Overall Study|Physician Decision|3|||
162766162|NCT00090519|587853955|FG000|Overall Study|Sponsor Decision|3|||
162766163|NCT00090519|587853956|FG001|Overall Study|Sponsor Decision|1|||
162766164|NCT01240590|587853959|FG000|Phase I|Refused further treatment|0|||
162766165|NCT01240590|587853960|FG001|Phase I|Refused further treatment|0|||
162766166|NCT01240590|587853961|FG002|Phase I|Refused further treatment|3|||
162766167|NCT01240590|587853962|FG003|Phase I|Refused further treatment|0|||
162766168|NCT01240590|587853963|FG004|Phase I|Refused further treatment|0|||
162766169|NCT01240590|587853959|FG000|Phase II|Refused further treatment|0|||
162766170|NCT01240590|587853960|FG001|Phase II|Refused further treatment|0|||
162766171|NCT01240590|587853961|FG002|Phase II|Refused further treatment|0|||
162766172|NCT01240590|587853962|FG003|Phase II|Refused further treatment|2|||
162766173|NCT01240590|587853963|FG004|Phase II|Refused further treatment|1|||
162766174|NCT02548585|587853966|FG000|Overall Study|Withdrawal by Subject|0|||
162766175|NCT02548585|587853967|FG001|Overall Study|Withdrawal by Subject|0|||
162766176|NCT02548585|587853968|FG002|Overall Study|Withdrawal by Subject|0|||
162766177|NCT02548585|587853969|FG003|Overall Study|Withdrawal by Subject|0|||
162766178|NCT02548585|587853970|FG004|Overall Study|Withdrawal by Subject|0|||
162766179|NCT02548585|587853971|FG005|Overall Study|Withdrawal by Subject|1|||
162766180|NCT02548585|587853972|FG006|Overall Study|Withdrawal by Subject|0|||
162766181|NCT02548585|587853966|FG000|Overall Study|Lost to Follow-up|1|||
162766182|NCT02548585|587853967|FG001|Overall Study|Lost to Follow-up|0|||
162766183|NCT02548585|587853968|FG002|Overall Study|Lost to Follow-up|0|||
162766184|NCT02548585|587853969|FG003|Overall Study|Lost to Follow-up|0|||
162766185|NCT02548585|587853970|FG004|Overall Study|Lost to Follow-up|0|||
162766186|NCT02548585|587853971|FG005|Overall Study|Lost to Follow-up|0|||
162766187|NCT02548585|587853972|FG006|Overall Study|Lost to Follow-up|0|||
162766188|NCT02548585|587853966|FG000|Overall Study|Other|1|||
162766189|NCT02548585|587853967|FG001|Overall Study|Other|0|||
162766190|NCT02548585|587853968|FG002|Overall Study|Other|0|||
162766191|NCT02548585|587853969|FG003|Overall Study|Other|2|||
162766192|NCT02548585|587853970|FG004|Overall Study|Other|3|||
162766193|NCT02548585|587853971|FG005|Overall Study|Other|0|||
162766194|NCT02548585|587853972|FG006|Overall Study|Other|1|||
162766195|NCT02548585|587853966|FG000|Overall Study|Randomized but not treated|0|||
162766196|NCT02548585|587853967|FG001|Overall Study|Randomized but not treated|0|||
162766197|NCT02548585|587853968|FG002|Overall Study|Randomized but not treated|0|||
162766198|NCT02548585|587853969|FG003|Overall Study|Randomized but not treated|0|||
162766199|NCT02548585|587853970|FG004|Overall Study|Randomized but not treated|0|||
162766200|NCT02548585|587853971|FG005|Overall Study|Randomized but not treated|1|||
162766201|NCT02548585|587853972|FG006|Overall Study|Randomized but not treated|0|||
162766202|NCT03659136|587853977|FG000|Overall Study|Not treated|2|||
162766203|NCT03659136|587853978|FG001|Overall Study|Not treated|0|||
162766204|NCT03659136|587853977|FG000|Overall Study|Covid-19 related|1|||
162766205|NCT03659136|587853978|FG001|Overall Study|Covid-19 related|1|||
162766206|NCT03659136|587853977|FG000|Overall Study|Withdrawal by Subject|1|||
162766207|NCT03659136|587853978|FG001|Overall Study|Withdrawal by Subject|6|||
162766208|NCT03659136|587853977|FG000|Overall Study|Adverse Event|4|||
162766209|NCT03659136|587853978|FG001|Overall Study|Adverse Event|6|||
162766210|NCT03659136|587853977|FG000|Overall Study|Progressive disease|37|||
162766211|NCT03659136|587853978|FG001|Overall Study|Progressive disease|31|||
162766212|NCT03659136|587853977|FG000|Overall Study|Study closure|2|||
162766213|NCT03659136|587853978|FG001|Overall Study|Study closure|2|||
162766214|NCT03659136|587853977|FG000|Overall Study|Sponsor decision/recommendation|3|||
162766215|NCT03659136|587853978|FG001|Overall Study|Sponsor decision/recommendation|2|||
162766216|NCT03659136|587853977|FG000|Overall Study|Switched to other drug/therapy|2|||
162766217|NCT03659136|587853978|FG001|Overall Study|Switched to other drug/therapy|2|||
162766218|NCT03659136|587853977|FG000|Overall Study|Lack of clinical benefit|0|||
162766219|NCT03659136|587853978|FG001|Overall Study|Lack of clinical benefit|1|||
162766220|NCT03020914|587855582|FG000|Overall Study|Surgery Cancelled|1|||
162766221|NCT03020914|587855583|FG001|Overall Study|Surgery Cancelled|0|||
162766222|NCT04620733|587855584|FG000|Overall Study|Adverse Event|4|||
162766223|NCT04620733|587855585|FG001|Overall Study|Adverse Event|3|||
162766224|NCT04620733|587855584|FG000|Overall Study|Withdrawal by Subject|2|||
162766225|NCT04620733|587855585|FG001|Overall Study|Withdrawal by Subject|5|||
162766226|NCT04620733|587855584|FG000|Overall Study|Lost to Follow-up|1|||
162766227|NCT04620733|587855585|FG001|Overall Study|Lost to Follow-up|1|||
162766228|NCT04620733|587855584|FG000|Overall Study|Protocol Deviation|1|||
162766229|NCT04620733|587855585|FG001|Overall Study|Protocol Deviation|1|||
162766230|NCT04620733|587855584|FG000|Overall Study|Reason Not Specified|0|||
162766231|NCT04620733|587855585|FG001|Overall Study|Reason Not Specified|1|||
162766232|NCT03976102|587855589|FG000|Overall Study|Withdrawal by Subject|4|||
162766233|NCT03976102|587855590|FG001|Overall Study|Withdrawal by Subject|4|||
162766234|NCT03976102|587855589|FG000|Overall Study|Adverse Event|2|||
162766235|NCT03976102|587855590|FG001|Overall Study|Adverse Event|4|||
162766236|NCT03976102|587855589|FG000|Overall Study|Not related to Covid-19|9|||
162766237|NCT03976102|587855590|FG001|Overall Study|Not related to Covid-19|13|||
162766238|NCT03976102|587855589|FG000|Overall Study|Lost to Follow-up|0|||
162766239|NCT03976102|587855590|FG001|Overall Study|Lost to Follow-up|2|||
162766240|NCT03976102|587855589|FG000|Overall Study|Death|3|||
162766241|NCT03976102|587855590|FG001|Overall Study|Death|2|||
162766242|NCT03976102|587855589|FG000|Overall Study|Physician Decision|1|||
162766243|NCT03976102|587855590|FG001|Overall Study|Physician Decision|1|||
162766244|NCT00451906|587855592|FG000|Overall Study|Adverse Event|515|||
162766245|NCT00451906|587855592|FG000|Overall Study|Lost to Follow-up|31|||
162766246|NCT00451906|587855592|FG000|Overall Study|Withdrawal by Subject|111|||
162766247|NCT00451906|587855592|FG000|Overall Study|Protocol Violation|21|||
162766248|NCT00451906|587855592|FG000|Overall Study|Progressive disease|1328|||
162766249|NCT00451906|587855592|FG000|Overall Study|Termination of the study|108|||
162766250|NCT00451906|587855592|FG000|Overall Study|Other Reasons|121|||
162766251|NCT00451906|587855592|FG000|Overall Study|Did not complete final visit|4|||
162766252|NCT02889900|587855597|FG000|Overall Study|Adverse Event|11|||
162766253|NCT02889900|587855597|FG000|Overall Study|Condition under investigation worsened|32|||
162766254|NCT02889900|587855597|FG000|Overall Study|Other|5|||
162766255|NCT02889900|587855597|FG000|Overall Study|Withdrawal by Subject|7|||
162766256|NCT02889900|587855597|FG000|Overall Study|Not treated|2|||
162766257|NCT00805792|587855598|FG000|Overall Study|Death|3|||
162766258|NCT00805792|587855598|FG000|Overall Study|Lost to Follow-up|2|||
162766259|NCT01416285|587855599|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
162766260|NCT01416285|587855600|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
162766261|NCT01248715|587855609|FG000|Overall Study|Not influenza positive|501|||
162766262|NCT01248715|587855610|FG001|Overall Study|Not influenza positive|510|||
162766263|NCT00813709|587855611|FG000|Double Blind Period|Adverse Event|4|||
162766264|NCT00813709|587855612|FG001|Double Blind Period|Adverse Event|1|||
162766265|NCT00813709|587855613|FG002|Double Blind Period|Adverse Event|4|||
162766266|NCT00813709|587855614|FG003|Double Blind Period|Adverse Event|0|||
162766267|NCT00813709|587855615|FG004|Double Blind Period|Adverse Event|0|||
162766268|NCT00813709|587855616|FG005|Double Blind Period|Adverse Event|0|||
162766269|NCT00813709|587855611|FG000|Double Blind Period|Lost to Follow-up|3|||
162766270|NCT00813709|587855612|FG001|Double Blind Period|Lost to Follow-up|2|||
162766271|NCT00813709|587855613|FG002|Double Blind Period|Lost to Follow-up|2|||
162766272|NCT00813709|587855614|FG003|Double Blind Period|Lost to Follow-up|0|||
162766273|NCT00813709|587855615|FG004|Double Blind Period|Lost to Follow-up|0|||
162766274|NCT00813709|587855616|FG005|Double Blind Period|Lost to Follow-up|0|||
162766275|NCT00813709|587855611|FG000|Double Blind Period|Switched to open label phase|9|||
162766276|NCT00813709|587855612|FG001|Double Blind Period|Switched to open label phase|26|||
162766277|NCT00813709|587855613|FG002|Double Blind Period|Switched to open label phase|18|||
162766278|NCT00813709|587855614|FG003|Double Blind Period|Switched to open label phase|0|||
162766279|NCT00813709|587855615|FG004|Double Blind Period|Switched to open label phase|0|||
162766280|NCT00813709|587855616|FG005|Double Blind Period|Switched to open label phase|0|||
162766281|NCT00813709|587855611|FG000|Double Blind Period|Randomized but not treated|1|||
162766282|NCT00813709|587855612|FG001|Double Blind Period|Randomized but not treated|3|||
162766283|NCT00813709|587855613|FG002|Double Blind Period|Randomized but not treated|1|||
162766284|NCT00813709|587855614|FG003|Double Blind Period|Randomized but not treated|0|||
162766285|NCT00813709|587855615|FG004|Double Blind Period|Randomized but not treated|0|||
162766286|NCT00813709|587855616|FG005|Double Blind Period|Randomized but not treated|0|||
162766287|NCT00813709|587855611|FG000|Double Blind Period|Other|14|||
162766288|NCT00813709|587855612|FG001|Double Blind Period|Other|9|||
162766289|NCT00813709|587855613|FG002|Double Blind Period|Other|6|||
162766290|NCT00813709|587855614|FG003|Double Blind Period|Other|0|||
162766291|NCT00813709|587855615|FG004|Double Blind Period|Other|0|||
162766292|NCT00813709|587855616|FG005|Double Blind Period|Other|0|||
162766293|NCT00813709|587855611|FG000|Open Label Period|Adverse Event|0|||
162766294|NCT00813709|587855612|FG001|Open Label Period|Adverse Event|0|||
162766295|NCT00813709|587855613|FG002|Open Label Period|Adverse Event|0|||
162766296|NCT00813709|587855614|FG003|Open Label Period|Adverse Event|5|||
162766297|NCT00813709|587855615|FG004|Open Label Period|Adverse Event|4|||
162766298|NCT00813709|587855616|FG005|Open Label Period|Adverse Event|3|||
162766299|NCT00813709|587855611|FG000|Open Label Period|Lack of Efficacy|0|||
162766300|NCT00813709|587855612|FG001|Open Label Period|Lack of Efficacy|0|||
162766301|NCT00813709|587855613|FG002|Open Label Period|Lack of Efficacy|0|||
162766302|NCT00813709|587855614|FG003|Open Label Period|Lack of Efficacy|3|||
162766303|NCT00813709|587855615|FG004|Open Label Period|Lack of Efficacy|1|||
162766304|NCT00813709|587855616|FG005|Open Label Period|Lack of Efficacy|1|||
162766305|NCT00813709|587855611|FG000|Open Label Period|Randomized but not treated|0|||
162766306|NCT00813709|587855612|FG001|Open Label Period|Randomized but not treated|0|||
162766307|NCT00813709|587855613|FG002|Open Label Period|Randomized but not treated|0|||
162766308|NCT00813709|587855614|FG003|Open Label Period|Randomized but not treated|1|||
162766309|NCT00813709|587855615|FG004|Open Label Period|Randomized but not treated|0|||
162766310|NCT00813709|587855616|FG005|Open Label Period|Randomized but not treated|1|||
162766311|NCT00813709|587855611|FG000|Open Label Period|Other|0|||
162766312|NCT00813709|587855612|FG001|Open Label Period|Other|0|||
162766313|NCT00813709|587855613|FG002|Open Label Period|Other|0|||
162766314|NCT00813709|587855614|FG003|Open Label Period|Other|11|||
162766315|NCT00813709|587855615|FG004|Open Label Period|Other|5|||
162766316|NCT00813709|587855616|FG005|Open Label Period|Other|6|||
162766317|NCT01807234|587855617|FG000|Overall Study|Lost to Follow-up|2|||
162766318|NCT01807234|587855618|FG001|Overall Study|Lost to Follow-up|5|||
162766319|NCT01807234|587855619|FG002|Overall Study|Lost to Follow-up|1|||
162766320|NCT01807234|587855620|FG003|Overall Study|Lost to Follow-up|1|||
162766321|NCT01807234|587855621|FG004|Overall Study|Lost to Follow-up|1|||
162766322|NCT01807234|587855622|FG005|Overall Study|Lost to Follow-up|2|||
162766323|NCT01807234|587855617|FG000|Overall Study|Withdrawal by Subject|3|||
162766324|NCT01807234|587855618|FG001|Overall Study|Withdrawal by Subject|1|||
162766325|NCT01807234|587855619|FG002|Overall Study|Withdrawal by Subject|1|||
162766326|NCT01807234|587855620|FG003|Overall Study|Withdrawal by Subject|1|||
162766327|NCT01807234|587855621|FG004|Overall Study|Withdrawal by Subject|2|||
162766328|NCT01807234|587855622|FG005|Overall Study|Withdrawal by Subject|1|||
162766329|NCT01807234|587855617|FG000|Overall Study|Lack of Efficacy|0|||
162766330|NCT01807234|587855618|FG001|Overall Study|Lack of Efficacy|0|||
162766331|NCT01807234|587855619|FG002|Overall Study|Lack of Efficacy|0|||
162766332|NCT01807234|587855620|FG003|Overall Study|Lack of Efficacy|0|||
162766333|NCT01807234|587855621|FG004|Overall Study|Lack of Efficacy|1|||
162766334|NCT01807234|587855622|FG005|Overall Study|Lack of Efficacy|1|||
162766335|NCT01540474|587855623|FG000|Vaccination Period|Lost to Follow-up|0|||
162766336|NCT01540474|587855624|FG001|Vaccination Period|Lost to Follow-up|1|||
162766337|NCT01540474|587855625|FG002|Vaccination Period|Lost to Follow-up|0|||
162766338|NCT01540474|587855626|FG003|Vaccination Period|Lost to Follow-up|0|||
162766339|NCT00857311|587855627|FG000|Overall Study|Lost to Follow-up|1|||
162766340|NCT00857311|587855628|FG001|Overall Study|Lost to Follow-up|0|||
162766341|NCT00857311|587855629|FG002|Overall Study|Lost to Follow-up|0|||
162766342|NCT00857311|587855630|FG003|Overall Study|Lost to Follow-up|0|||
162766343|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
162766344|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
162766345|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
162766346|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
162766347|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
162766348|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
162766349|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
162766350|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
162766351|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
162766352|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
162766353|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
162766354|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
162766355|NCT01345253|587855634|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
162766356|NCT01345253|587855635|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
162766357|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
162766358|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
162766359|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
162766360|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
162766361|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
162766362|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
162766363|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
162766364|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
162766365|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
162766366|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
162766367|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
162766368|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
162766369|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
162766370|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
162766371|NCT01345253|587855634|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
162766372|NCT01345253|587855635|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
162766373|NCT00930644|587855636|FG000|Overall Study|Withdrawal by Subject|4|||
162766374|NCT00930644|587855636|FG000|Overall Study|Physician Decision|2|||
162766375|NCT00930644|587855636|FG000|Overall Study|Death|1|||
162766376|NCT00930644|587855636|FG000|Overall Study|Adverse Event|16|||
162766377|NCT00417885|587855637|FG000|Overall Study|Adverse Event|1|||
162766378|NCT00417885|587855637|FG000|Overall Study|Objective Progression or Relapse|3|||
162766379|NCT00417885|587855637|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
162766380|NCT01280721|587855646|FG000|Overall Study|Adverse Event|4|||
162766381|NCT01280721|587855646|FG000|Overall Study|Physician Decision|3|||
162766382|NCT01280721|587855646|FG000|Overall Study|Withdrawal by Subject|6|||
162766383|NCT01280721|587855646|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
162766384|NCT01280721|587855646|FG000|Overall Study|No tolerability for the lowest dose|2|||
162766385|NCT01180400|587855647|FG000|Overall Study|Withdrawal by Subject|5|||
162766386|NCT01180400|587855648|FG001|Overall Study|Withdrawal by Subject|6|||
162766387|NCT01180400|587855647|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162766388|NCT01180400|587855648|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
162766389|NCT01180400|587855647|FG000|Overall Study|Adverse Event|12|||
162766390|NCT01180400|587855648|FG001|Overall Study|Adverse Event|10|||
162766391|NCT01180400|587855647|FG000|Overall Study|Severe non-compliance to protocol|1|||
162766392|NCT01180400|587855648|FG001|Overall Study|Severe non-compliance to protocol|2|||
162766393|NCT01180400|587855647|FG000|Overall Study|Condition under investigation worsened|2|||
162766394|NCT01180400|587855648|FG001|Overall Study|Condition under investigation worsened|1|||
162766395|NCT01180400|587855647|FG000|Overall Study|Lack of Efficacy|2|||
162766396|NCT01180400|587855648|FG001|Overall Study|Lack of Efficacy|0|||
162766397|NCT01180400|587855647|FG000|Overall Study|Study-specific withdrawal criteria|1|||
162766398|NCT01180400|587855648|FG001|Overall Study|Study-specific withdrawal criteria|2|||
162766399|NCT01180400|587855647|FG000|Overall Study|Lost to Follow-up|2|||
162766400|NCT01180400|587855648|FG001|Overall Study|Lost to Follow-up|3|||
162766401|NCT01180400|587855647|FG000|Overall Study|Other|0|||
162766402|NCT01180400|587855648|FG001|Overall Study|Other|1|||
162766403|NCT00795639|587855649|FG000|Overall Study|Death|1|||
162766404|NCT00795639|587855650|FG001|Overall Study|Death|6|||
162766405|NCT00795639|587855649|FG000|Overall Study|Withdrawal by Subject|1|||
162766406|NCT00795639|587855650|FG001|Overall Study|Withdrawal by Subject|3|||
162766407|NCT00795639|587855649|FG000|Overall Study|Pregnancy|1|||
162766408|NCT00795639|587855650|FG001|Overall Study|Pregnancy|0|||
162766409|NCT00795639|587855649|FG000|Overall Study|Adverse Event|5|||
162766410|NCT00795639|587855650|FG001|Overall Study|Adverse Event|2|||
162766411|NCT00795639|587855649|FG000|Overall Study|Other|0|||
162766412|NCT00795639|587855650|FG001|Overall Study|Other|2|||
162766413|NCT00795639|587855649|FG000|Overall Study|Terminated by sponsor|13|||
162766414|NCT00795639|587855650|FG001|Overall Study|Terminated by sponsor|12|||
162766415|NCT00795639|587855649|FG000|Overall Study|Randomized and not treated|0|||
162766416|NCT00795639|587855650|FG001|Overall Study|Randomized and not treated|1|||
162766417|NCT04626128|587855651|FG000|Overall Study|Withdrawal by Subject|0|||
162766418|NCT04626128|587855652|FG001|Overall Study|Withdrawal by Subject|1|||
162766419|NCT04626128|587855653|FG002|Overall Study|Withdrawal by Subject|0|||
162766420|NCT04626128|587855654|FG003|Overall Study|Withdrawal by Subject|0|||
162766421|NCT00248794|587855655|FG000|Overall Study|Lost to Follow-up|6|||
162766422|NCT00248794|587855656|FG001|Overall Study|Lost to Follow-up|8|||
162766423|NCT00248794|587855657|FG002|Overall Study|Lost to Follow-up|3|||
162766424|NCT03449979|587855658|FG000|Overall Study|Technical difficulty|0|||
162766425|NCT03449979|587855659|FG001|Overall Study|Technical difficulty|0|||
162766426|NCT03449979|587855660|FG002|Overall Study|Technical difficulty|0|||
162766427|NCT03449979|587855661|FG003|Overall Study|Technical difficulty|1|||
162766428|NCT01894620|587855664|FG000|Overall Study|Withdrawal by Subject|0|||
162766429|NCT01894620|587855665|FG001|Overall Study|Withdrawal by Subject|1|||
162766430|NCT01124916|587855666|FG000|Overall Study|Lost to Follow-up|3|||
162766431|NCT01124916|587855667|FG001|Overall Study|Lost to Follow-up|2|||
162766432|NCT02206607|587855668|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
162766433|NCT02206607|587855669|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
162766434|NCT02206607|587855670|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
162766435|NCT02206607|587855671|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
162766436|NCT02206607|587855672|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
162766437|NCT02206607|587855668|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
162766438|NCT02206607|587855669|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
162766439|NCT02206607|587855670|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
162766440|NCT02206607|587855671|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
162766441|NCT02206607|587855672|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
162766442|NCT00761267|587855673|FG000|Overall Study|Death|1|||
162766443|NCT00761267|587855674|FG001|Overall Study|Death|2|||
162766444|NCT00761267|587855675|FG002|Overall Study|Death|5|||
162766445|NCT00761267|587855673|FG000|Overall Study|Lost to Follow-up|0|||
162766446|NCT00761267|587855674|FG001|Overall Study|Lost to Follow-up|0|||
162766447|NCT00761267|587855675|FG002|Overall Study|Lost to Follow-up|1|||
162766448|NCT00761267|587855673|FG000|Overall Study|Randomized but not treated|1|||
162766449|NCT00761267|587855674|FG001|Overall Study|Randomized but not treated|1|||
162766450|NCT00761267|587855675|FG002|Overall Study|Randomized but not treated|0|||
162766451|NCT00761267|587855673|FG000|Overall Study|Withdrawal by Subject|0|||
162766452|NCT00761267|587855674|FG001|Overall Study|Withdrawal by Subject|1|||
162766453|NCT00761267|587855675|FG002|Overall Study|Withdrawal by Subject|0|||
162766454|NCT00963924|587855678|FG000|Overall Study|Adverse Event|1|||
162766455|NCT00963924|587855679|FG001|Overall Study|Adverse Event|0|||
162766456|NCT00963924|587855678|FG000|Overall Study|Withdrawal by Subject|0|||
162766457|NCT00963924|587855679|FG001|Overall Study|Withdrawal by Subject|1|||
162766458|NCT00963924|587855678|FG000|Overall Study|Changed antipsychotic|0|||
162766459|NCT00963924|587855679|FG001|Overall Study|Changed antipsychotic|1|||
162766460|NCT00963924|587855678|FG000|Overall Study|Lost to Follow-up|0|||
162766461|NCT00963924|587855679|FG001|Overall Study|Lost to Follow-up|1|||
162766462|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
162766463|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
162766464|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
162766465|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
162766466|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
162766467|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Adverse Event|0|||
162766468|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Adverse Event|1|||
162766469|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Adverse Event|1|||
162766470|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Adverse Event|0|||
162766471|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Adverse Event|0|||
162766472|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
162766473|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162766474|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162766475|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162766476|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162766477|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Physician Decision|1|||
162766478|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Physician Decision|0|||
162766479|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Physician Decision|0|||
162766480|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Physician Decision|0|||
162766481|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Physician Decision|0|||
162766482|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
162766483|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
162766484|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
162766485|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
162766486|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
162766487|NCT00446095|587855681|FG000|Phase II (8 Weeks)|Ongoing|0|||
162766488|NCT00446095|587855682|FG001|Phase II (8 Weeks)|Ongoing|0|||
162766489|NCT00446095|587855683|FG002|Phase II (8 Weeks)|Ongoing|1|||
162766490|NCT00446095|587855684|FG003|Phase II (8 Weeks)|Ongoing|0|||
162766491|NCT00446095|587855685|FG004|Phase II (8 Weeks)|Ongoing|0|||
162766492|NCT00446095|587855681|FG000|Phase I (28 Days)|Adverse Event|0|||
162766493|NCT00446095|587855682|FG001|Phase I (28 Days)|Adverse Event|0|||
162766494|NCT00446095|587855683|FG002|Phase I (28 Days)|Adverse Event|0|||
162766495|NCT00446095|587855684|FG003|Phase I (28 Days)|Adverse Event|1|||
162766496|NCT00446095|587855685|FG004|Phase I (28 Days)|Adverse Event|0|||
162766497|NCT00446095|587855681|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
162766498|NCT00446095|587855682|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
162766499|NCT00446095|587855683|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
162766500|NCT00446095|587855684|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
162766501|NCT00446095|587855685|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
162766502|NCT02159352|587855688|FG000|Overall Study|Adverse Event|3|||
162766503|NCT02159352|587855689|FG001|Overall Study|Adverse Event|1|||
162766504|NCT02159352|587855688|FG000|Overall Study|Withdrawal by Subject|0|||
162766505|NCT02159352|587855689|FG001|Overall Study|Withdrawal by Subject|1|||
162766506|NCT00529529|587855690|FG000|Overall Study|Adverse Event|12|||
162766507|NCT00529529|587855691|FG001|Overall Study|Adverse Event|17|||
162766508|NCT00529529|587855692|FG002|Overall Study|Adverse Event|8|||
162766509|NCT00529529|587855690|FG000|Overall Study|Subject withdrew consent|12|||
162766510|NCT00529529|587855691|FG001|Overall Study|Subject withdrew consent|9|||
162766511|NCT00529529|587855692|FG002|Overall Study|Subject withdrew consent|12|||
162766512|NCT00529529|587855690|FG000|Overall Study|Protocol deviation|8|||
162766513|NCT00529529|587855691|FG001|Overall Study|Protocol deviation|12|||
162766514|NCT00529529|587855692|FG002|Overall Study|Protocol deviation|5|||
162766515|NCT00529529|587855690|FG000|Overall Study|Lost to Follow-up|5|||
162766516|NCT00529529|587855691|FG001|Overall Study|Lost to Follow-up|3|||
162766517|NCT00529529|587855692|FG002|Overall Study|Lost to Follow-up|1|||
162766518|NCT00529529|587855690|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162766519|NCT00529529|587855691|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162766520|NCT00529529|587855692|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162766521|NCT00529529|587855690|FG000|Overall Study|Death|2|||
162766522|NCT00529529|587855691|FG001|Overall Study|Death|0|||
162766523|NCT00529529|587855692|FG002|Overall Study|Death|0|||
162766524|NCT00529529|587855690|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162766525|NCT00529529|587855691|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162766526|NCT00529529|587855692|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162766527|NCT00529529|587855690|FG000|Overall Study|Administrative problems|1|||
162766528|NCT00529529|587855691|FG001|Overall Study|Administrative problems|0|||
162766529|NCT00529529|587855692|FG002|Overall Study|Administrative problems|3|||
162766530|NCT00337610|587855693|FG000|Overall Study|Adverse Event|2|||
162766531|NCT00337610|587855694|FG001|Overall Study|Adverse Event|2|||
162766532|NCT00337610|587855693|FG000|Overall Study|Death|0|||
162766533|NCT00337610|587855694|FG001|Overall Study|Death|1|||
162766534|NCT00337610|587855693|FG000|Overall Study|Lack of Efficacy|6|||
162766535|NCT00337610|587855694|FG001|Overall Study|Lack of Efficacy|3|||
162766536|NCT00337610|587855693|FG000|Overall Study|Lost to Follow-up|3|||
162766537|NCT00337610|587855694|FG001|Overall Study|Lost to Follow-up|3|||
162766538|NCT00337610|587855693|FG000|Overall Study|Withdrawal by Subject|6|||
162766539|NCT00337610|587855694|FG001|Overall Study|Withdrawal by Subject|5|||
162766540|NCT03979040|587855695|FG000|Overall Study|Withdrawal by Subject|24|||
162766541|NCT03979040|587855696|FG001|Overall Study|Withdrawal by Subject|32|||
162766542|NCT03979040|587855695|FG000|Overall Study|randomized but never started treatment|32|||
162766543|NCT03979040|587855696|FG001|Overall Study|randomized but never started treatment|39|||
162766544|NCT03979040|587855695|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
162766545|NCT03979040|587855696|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
162766546|NCT02279732|587855703|FG000|Overall Study|Death|23|||
162766547|NCT02279732|587855704|FG001|Overall Study|Death|20|||
162766548|NCT02279732|587855703|FG000|Overall Study|Disease Progression|13|||
162766549|NCT02279732|587855704|FG001|Overall Study|Disease Progression|3|||
162766550|NCT02279732|587855703|FG000|Overall Study|Withdrawal by Subject|2|||
162766551|NCT02279732|587855704|FG001|Overall Study|Withdrawal by Subject|7|||
162766552|NCT02279732|587855703|FG000|Overall Study|Adverse Event|1|||
162766553|NCT02279732|587855704|FG001|Overall Study|Adverse Event|2|||
162766554|NCT02279732|587855703|FG000|Overall Study|Administrative Reason By Sponsor|0|||
162766555|NCT02279732|587855704|FG001|Overall Study|Administrative Reason By Sponsor|2|||
162766556|NCT02279732|587855703|FG000|Overall Study|Study Drug Toxicity|2|||
162766557|NCT02279732|587855704|FG001|Overall Study|Study Drug Toxicity|0|||
162766558|NCT02279732|587855703|FG000|Overall Study|Lost to Follow-up|0|||
162766559|NCT02279732|587855704|FG001|Overall Study|Lost to Follow-up|1|||
162766560|NCT02279732|587855703|FG000|Overall Study|Maximum Clinical Benefit|1|||
162766561|NCT02279732|587855704|FG001|Overall Study|Maximum Clinical Benefit|0|||
162766562|NCT02279732|587855703|FG000|Overall Study|Subject Requested to Discontinue|0|||
162766563|NCT02279732|587855704|FG001|Overall Study|Subject Requested to Discontinue|1|||
162766564|NCT02279732|587855703|FG000|Overall Study|Other|53|||
162766565|NCT02279732|587855704|FG001|Overall Study|Other|67|||
162766566|NCT02279732|587855703|FG000|Overall Study|Other|3|||
162766567|NCT02279732|587855704|FG001|Overall Study|Other|3|||
162766568|NCT02203513|587855708|FG000|Overall Study|Refused further treatment|2|||
162766569|NCT02203513|587855709|FG001|Overall Study|Refused further treatment|0|||
162766570|NCT02203513|587855710|FG002|Overall Study|Refused further treatment|1|||
162766571|NCT02203513|587855711|FG003|Overall Study|Refused further treatment|0|||
162766572|NCT02203513|587855712|FG004|Overall Study|Refused further treatment|0|||
162766573|NCT02203513|587855708|FG000|Overall Study|Switched to alternative treatment|3|||
162766574|NCT02203513|587855709|FG001|Overall Study|Switched to alternative treatment|4|||
162766575|NCT02203513|587855710|FG002|Overall Study|Switched to alternative treatment|0|||
162766576|NCT02203513|587855711|FG003|Overall Study|Switched to alternative treatment|0|||
162766577|NCT02203513|587855712|FG004|Overall Study|Switched to alternative treatment|4|||
162766578|NCT02203513|587855708|FG000|Overall Study|Did not receive investigational product (IP)|0|||
162766579|NCT02203513|587855709|FG001|Overall Study|Did not receive investigational product (IP)|1|||
162766580|NCT02203513|587855710|FG002|Overall Study|Did not receive investigational product (IP)|0|||
162766581|NCT02203513|587855711|FG003|Overall Study|Did not receive investigational product (IP)|0|||
162766582|NCT02203513|587855712|FG004|Overall Study|Did not receive investigational product (IP)|0|||
162766583|NCT02203513|587855708|FG000|Overall Study|Death (unrelated to study therapy)|1|||
162766584|NCT02203513|587855709|FG001|Overall Study|Death (unrelated to study therapy)|3|||
162766585|NCT02203513|587855710|FG002|Overall Study|Death (unrelated to study therapy)|1|||
162766586|NCT02203513|587855711|FG003|Overall Study|Death (unrelated to study therapy)|0|||
162766587|NCT02203513|587855712|FG004|Overall Study|Death (unrelated to study therapy)|2|||
162766588|NCT02203513|587855708|FG000|Overall Study|Lost to Follow-up|0|||
162766589|NCT02203513|587855709|FG001|Overall Study|Lost to Follow-up|0|||
162766590|NCT02203513|587855710|FG002|Overall Study|Lost to Follow-up|1|||
162766591|NCT02203513|587855711|FG003|Overall Study|Lost to Follow-up|1|||
162766592|NCT02203513|587855712|FG004|Overall Study|Lost to Follow-up|0|||
162766593|NCT01441596|587855713|FG000|Overall Study|Other reason not defined below|0|||
162766594|NCT01441596|587855714|FG001|Overall Study|Other reason not defined below|2|||
162766595|NCT01441596|587855715|FG002|Overall Study|Other reason not defined below|1|||
162766596|NCT01441596|587855713|FG000|Overall Study|Withdrawal by Subject|4|||
162766597|NCT01441596|587855714|FG001|Overall Study|Withdrawal by Subject|0|||
162766598|NCT01441596|587855715|FG002|Overall Study|Withdrawal by Subject|2|||
162766599|NCT01441596|587855713|FG000|Overall Study|Not treated|0|||
162766600|NCT01441596|587855714|FG001|Overall Study|Not treated|1|||
162766601|NCT01441596|587855715|FG002|Overall Study|Not treated|1|||
162766602|NCT03055988|587855716|FG000|Period 1|Adverse Event|0|||
162766603|NCT03055988|587855717|FG001|Period 1|Adverse Event|1|||
162766604|NCT03055988|587855716|FG000|Period 1|Lost to Follow-up|1|||
162766605|NCT03055988|587855717|FG001|Period 1|Lost to Follow-up|0|||
162766606|NCT03055988|587855716|FG000|Period 1|Withdrawal by Subject|0|||
162766607|NCT03055988|587855717|FG001|Period 1|Withdrawal by Subject|4|||
162766608|NCT03055988|587855716|FG000|Period 2|Adverse Event|0|||
162766609|NCT03055988|587855717|FG001|Period 2|Adverse Event|1|||
162766610|NCT03055988|587855716|FG000|Period 2|Other than listed|1|||
162766611|NCT03055988|587855717|FG001|Period 2|Other than listed|1|||
162766612|NCT01681511|587855718|FG000|Overall Study|No Treatment Received|1|||
162766613|NCT01681511|587855719|FG001|Overall Study|No Treatment Received|3|||
162766614|NCT01681511|587855718|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
162766615|NCT01681511|587855719|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
162766616|NCT01681511|587855718|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
162766617|NCT01681511|587855719|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
162766618|NCT01681511|587855718|FG000|Overall Study|No Daily Urine Sample Collected|0|||
162766619|NCT01681511|587855719|FG001|Overall Study|No Daily Urine Sample Collected|1|||
162766620|NCT01681511|587855718|FG000|Overall Study|No post-catheter sample collected|11|||
162766621|NCT01681511|587855719|FG001|Overall Study|No post-catheter sample collected|4|||
162766622|NCT01156675|587855720|FG000|Overall Study|Death|5|||
162766623|NCT01156675|587855721|FG001|Overall Study|Death|3|||
162766624|NCT01156675|587855722|FG002|Overall Study|Death|0|||
162766625|NCT01156675|587855720|FG000|Overall Study|No data|29|||
162766626|NCT01156675|587855721|FG001|Overall Study|No data|22|||
162766627|NCT01156675|587855722|FG002|Overall Study|No data|2|||
162766628|NCT00116649|587855736|FG000|Overall Study|Adverse Event|20|||
162766629|NCT00116649|587855736|FG000|Overall Study|Lack of Efficacy|1|||
162766630|NCT00116649|587855736|FG000|Overall Study|Lost to Follow-up|32|||
162766631|NCT00116649|587855736|FG000|Overall Study|Withdrawal by Subject|68|||
162766632|NCT00116649|587855736|FG000|Overall Study|Local Skin Reaction|9|||
162766633|NCT00116649|587855736|FG000|Overall Study|Various Reasons|18|||
162766634|NCT00116649|587855736|FG000|Overall Study|Protocol Specified|7|||
162766635|NCT02161146|587855737|FG000|Overall Study|Adverse Event|1|||
162766636|NCT02161146|587855738|FG001|Overall Study|Adverse Event|1|||
162766637|NCT02161146|587855739|FG002|Overall Study|Adverse Event|0|||
162766638|NCT02161146|587855740|FG003|Overall Study|Adverse Event|1|||
162766639|NCT02161146|587855741|FG004|Overall Study|Adverse Event|0|||
162766640|NCT02161146|587855737|FG000|Overall Study|Lost to Follow-up|0|||
162766641|NCT02161146|587855738|FG001|Overall Study|Lost to Follow-up|1|||
162766642|NCT02161146|587855739|FG002|Overall Study|Lost to Follow-up|0|||
162766643|NCT02161146|587855740|FG003|Overall Study|Lost to Follow-up|0|||
162766644|NCT02161146|587855741|FG004|Overall Study|Lost to Follow-up|0|||
162766645|NCT02161146|587855737|FG000|Overall Study|Personal Reasons|0|||
162766646|NCT02161146|587855738|FG001|Overall Study|Personal Reasons|1|||
162766647|NCT02161146|587855739|FG002|Overall Study|Personal Reasons|0|||
162766648|NCT02161146|587855740|FG003|Overall Study|Personal Reasons|2|||
162766649|NCT02161146|587855741|FG004|Overall Study|Personal Reasons|1|||
162766650|NCT02161146|587855737|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162766651|NCT02161146|587855738|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162766652|NCT02161146|587855739|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162766653|NCT02161146|587855740|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162766654|NCT02161146|587855741|FG004|Overall Study|Other Miscellaneous Reasons|0|||
162766655|NCT00845520|587855742|FG000|Overall Study|Death|1|||
162766656|NCT00845520|587855743|FG001|Overall Study|Death|2|||
162766657|NCT00845520|587855744|FG002|Overall Study|Death|0|||
162766658|NCT00845520|587855742|FG000|Overall Study|Lost to Follow-up|1|||
162766659|NCT00845520|587855743|FG001|Overall Study|Lost to Follow-up|0|||
162766660|NCT00845520|587855744|FG002|Overall Study|Lost to Follow-up|0|||
162766661|NCT00845520|587855742|FG000|Overall Study|Adverse Event|0|||
162766662|NCT00845520|587855743|FG001|Overall Study|Adverse Event|0|||
162766663|NCT00845520|587855744|FG002|Overall Study|Adverse Event|1|||
162766664|NCT02613403|587855745|FG000|Overall Study|Lost to Follow-up|0|||
162766665|NCT02613403|587855746|FG001|Overall Study|Lost to Follow-up|1|||
162766666|NCT02613403|587855747|FG002|Overall Study|Lost to Follow-up|0|||
162766667|NCT02613403|587855748|FG003|Overall Study|Lost to Follow-up|0|||
162766668|NCT02613403|587855749|FG004|Overall Study|Lost to Follow-up|0|||
162766669|NCT02613403|587855745|FG000|Overall Study|Withdrawal by Subject|2|||
162766670|NCT02613403|587855746|FG001|Overall Study|Withdrawal by Subject|0|||
162766671|NCT02613403|587855747|FG002|Overall Study|Withdrawal by Subject|0|||
162766672|NCT02613403|587855748|FG003|Overall Study|Withdrawal by Subject|0|||
162766673|NCT02613403|587855749|FG004|Overall Study|Withdrawal by Subject|0|||
162766674|NCT00800176|587855750|FG000|Overall Study|Adverse Event|2|||
162766675|NCT00800176|587855751|FG001|Overall Study|Adverse Event|1|||
162766676|NCT00800176|587855752|FG002|Overall Study|Adverse Event|0|||
162766677|NCT00800176|587855753|FG003|Overall Study|Adverse Event|2|||
162766678|NCT00800176|587855754|FG004|Overall Study|Adverse Event|1|||
162766679|NCT00800176|587855755|FG005|Overall Study|Adverse Event|1|||
162766680|NCT00800176|587855750|FG000|Overall Study|Refused treatment|3|||
162766681|NCT00800176|587855751|FG001|Overall Study|Refused treatment|2|||
162766682|NCT00800176|587855752|FG002|Overall Study|Refused treatment|0|||
162766683|NCT00800176|587855753|FG003|Overall Study|Refused treatment|0|||
162766684|NCT00800176|587855754|FG004|Overall Study|Refused treatment|1|||
162766685|NCT00800176|587855755|FG005|Overall Study|Refused treatment|4|||
162766686|NCT00800176|587855750|FG000|Overall Study|Failure to return|3|||
162766687|NCT00800176|587855751|FG001|Overall Study|Failure to return|3|||
162766688|NCT00800176|587855752|FG002|Overall Study|Failure to return|0|||
162766689|NCT00800176|587855753|FG003|Overall Study|Failure to return|2|||
162766690|NCT00800176|587855754|FG004|Overall Study|Failure to return|0|||
162766691|NCT00800176|587855755|FG005|Overall Study|Failure to return|0|||
162766692|NCT00800176|587855750|FG000|Overall Study|Other|1|||
162766693|NCT00800176|587855751|FG001|Overall Study|Other|0|||
162766694|NCT00800176|587855752|FG002|Overall Study|Other|0|||
162766695|NCT00800176|587855753|FG003|Overall Study|Other|0|||
162766696|NCT00800176|587855754|FG004|Overall Study|Other|2|||
162766697|NCT00800176|587855755|FG005|Overall Study|Other|0|||
162766698|NCT02326220|587855758|FG000|Double-blind Treatment Period|Adverse Event|1|||
162766699|NCT02326220|587855759|FG001|Double-blind Treatment Period|Adverse Event|2|||
162766700|NCT02326220|587855760|FG002|Double-blind Treatment Period|Adverse Event|0|||
162766701|NCT02326220|587855758|FG000|Double-blind Treatment Period|Protocol Violation|0|||
162766702|NCT02326220|587855759|FG001|Double-blind Treatment Period|Protocol Violation|1|||
162766703|NCT02326220|587855760|FG002|Double-blind Treatment Period|Protocol Violation|0|||
162766704|NCT02326220|587855758|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
162766705|NCT02326220|587855759|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
162766706|NCT02326220|587855760|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162766707|NCT02326220|587855758|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
162766708|NCT02326220|587855759|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162766709|NCT02326220|587855760|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
162766710|NCT02326220|587855758|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
162766711|NCT02326220|587855759|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
162766712|NCT02326220|587855760|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
162766713|NCT02699099|587855761|FG000|Overall Study|Adverse Event|1|||
162766714|NCT02699099|587855762|FG001|Overall Study|Adverse Event|0|||
162766715|NCT02699099|587855763|FG002|Overall Study|Adverse Event|2|||
162766716|NCT02699099|587855761|FG000|Overall Study|Lost to Follow-up|0|||
162766717|NCT02699099|587855762|FG001|Overall Study|Lost to Follow-up|1|||
162766718|NCT02699099|587855763|FG002|Overall Study|Lost to Follow-up|0|||
162766719|NCT02699099|587855761|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
162766720|NCT02699099|587855762|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
162766721|NCT02699099|587855763|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
162766722|NCT02659540|587855766|FG000|Overall Study|Adverse Event|3|||
162766723|NCT02659540|587855767|FG001|Overall Study|Adverse Event|2|||
162766724|NCT02659540|587855766|FG000|Overall Study|Death|1|||
162766725|NCT02659540|587855767|FG001|Overall Study|Death|0|||
162766726|NCT02659540|587855766|FG000|Overall Study|Progressive disease|2|||
162766727|NCT02659540|587855767|FG001|Overall Study|Progressive disease|6|||
162766728|NCT00824850|587855768|FG000|Overall Study|Withdrawal by Subject|0|||
162766729|NCT00824850|587855769|FG001|Overall Study|Withdrawal by Subject|1|||
162766730|NCT03072238|587857629|FG000|Overall Study|Withdrawal by Subject|44|||
162766731|NCT03072238|587857630|FG001|Overall Study|Withdrawal by Subject|64|||
162766732|NCT03072238|587857629|FG000|Overall Study|Lost to Follow-up|14|||
162766733|NCT03072238|587857630|FG001|Overall Study|Lost to Follow-up|5|||
162766734|NCT03072238|587857629|FG000|Overall Study|Physician Decision|4|||
162766735|NCT03072238|587857630|FG001|Overall Study|Physician Decision|6|||
162766736|NCT03072238|587857629|FG000|Overall Study|Death|351|||
162766737|NCT03072238|587857630|FG001|Overall Study|Death|318|||
162766738|NCT03072238|587857629|FG000|Overall Study|Progressive Disease|3|||
162766739|NCT03072238|587857630|FG001|Overall Study|Progressive Disease|4|||
162766740|NCT03072238|587857629|FG000|Overall Study|Reason Not Specified|138|||
162766741|NCT03072238|587857630|FG001|Overall Study|Reason Not Specified|150|||
162766742|NCT00608959|587857636|FG000|Part 1|Did not meet eligibility criteria|1|||
162766743|NCT01005602|587857637|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
162766744|NCT01005602|587857638|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
162766745|NCT01919489|587857644|FG000|Overall Study|Rejected the need of injections|4|||
162766746|NCT01919489|587857645|FG001|Overall Study|Rejected the need of injections|7|||
162766747|NCT01919489|587857644|FG000|Overall Study|Adverse Event|10|||
162766748|NCT01919489|587857645|FG001|Overall Study|Adverse Event|0|||
162766749|NCT01919489|587857644|FG000|Overall Study|Hospital readmission|2|||
162766750|NCT01919489|587857645|FG001|Overall Study|Hospital readmission|9|||
162766751|NCT01919489|587857644|FG000|Overall Study|Death|2|||
162766752|NCT01919489|587857645|FG001|Overall Study|Death|1|||
162766753|NCT01919489|587857644|FG000|Overall Study|Lost to Follow-up|38|||
162766754|NCT01919489|587857645|FG001|Overall Study|Lost to Follow-up|27|||
162766755|NCT03884478|587857646|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
162766756|NCT03884478|587857647|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
162766757|NCT03884478|587857648|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
162766758|NCT03884478|587857646|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
162766759|NCT03884478|587857647|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
162766760|NCT03884478|587857648|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
162766761|NCT03884478|587857646|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
162766762|NCT03884478|587857647|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
162766763|NCT03884478|587857648|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
162766764|NCT03884478|587857646|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
162766765|NCT03884478|587857647|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
162766766|NCT03884478|587857648|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
162766767|NCT01587703|587857649|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
162766768|NCT01587703|587857650|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766769|NCT01587703|587857651|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766770|NCT01587703|587857652|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766771|NCT01587703|587857653|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766772|NCT01587703|587857654|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766773|NCT01587703|587857655|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766774|NCT01587703|587857656|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766775|NCT01587703|587857657|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766776|NCT01587703|587857658|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766777|NCT01587703|587857659|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766778|NCT01587703|587857660|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766779|NCT01587703|587857661|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766780|NCT01587703|587857662|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766781|NCT01587703|587857663|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766782|NCT01587703|587857664|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766783|NCT01587703|587857665|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766784|NCT01587703|587857666|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766785|NCT01587703|587857667|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162766786|NCT01587703|587857649|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766787|NCT01587703|587857650|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766788|NCT01587703|587857651|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766789|NCT01587703|587857652|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766790|NCT01587703|587857653|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766791|NCT01587703|587857654|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
162766792|NCT01587703|587857655|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766793|NCT01587703|587857656|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
162766794|NCT01587703|587857657|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766795|NCT01587703|587857658|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766796|NCT01587703|587857659|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766797|NCT01587703|587857660|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766798|NCT01587703|587857661|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766799|NCT01587703|587857662|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766800|NCT01587703|587857663|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766801|NCT01587703|587857664|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766802|NCT01587703|587857665|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766803|NCT01587703|587857666|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766804|NCT01587703|587857667|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162766805|NCT01587703|587857649|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766806|NCT01587703|587857650|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766807|NCT01587703|587857651|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766808|NCT01587703|587857652|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766809|NCT01587703|587857653|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766810|NCT01587703|587857654|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766811|NCT01587703|587857655|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
162766812|NCT01587703|587857656|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766813|NCT01587703|587857657|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766814|NCT01587703|587857658|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766815|NCT01587703|587857659|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766816|NCT01587703|587857660|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766817|NCT01587703|587857661|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766818|NCT01587703|587857662|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766819|NCT01587703|587857663|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766820|NCT01587703|587857664|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766821|NCT01587703|587857665|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766822|NCT01587703|587857666|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766823|NCT01587703|587857667|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162766824|NCT01587703|587857649|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
162766825|NCT01587703|587857650|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
162766826|NCT01587703|587857651|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
162766827|NCT01587703|587857652|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
162766828|NCT01587703|587857653|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
162766829|NCT01587703|587857654|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
162766830|NCT01587703|587857655|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
162766831|NCT01587703|587857656|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
162766832|NCT01587703|587857657|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766833|NCT01587703|587857658|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766834|NCT01587703|587857659|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766835|NCT01587703|587857660|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766836|NCT01587703|587857661|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766837|NCT01587703|587857662|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766838|NCT01587703|587857663|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766839|NCT01587703|587857664|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766840|NCT01587703|587857665|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766841|NCT01587703|587857666|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766842|NCT01587703|587857667|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162766843|NCT01587703|587857649|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766844|NCT01587703|587857650|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766845|NCT01587703|587857651|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766846|NCT01587703|587857652|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766847|NCT01587703|587857653|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766848|NCT01587703|587857654|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766849|NCT01587703|587857655|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766850|NCT01587703|587857656|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766851|NCT01587703|587857657|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
162766852|NCT01587703|587857658|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
162766853|NCT01587703|587857659|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
162766854|NCT01587703|587857660|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766855|NCT01587703|587857661|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766856|NCT01587703|587857662|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766857|NCT01587703|587857663|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766858|NCT01587703|587857664|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766859|NCT01587703|587857665|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766860|NCT01587703|587857666|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766861|NCT01587703|587857667|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162766862|NCT01587703|587857649|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766863|NCT01587703|587857650|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766864|NCT01587703|587857651|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766865|NCT01587703|587857652|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766866|NCT01587703|587857653|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766867|NCT01587703|587857654|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766868|NCT01587703|587857655|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766869|NCT01587703|587857656|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766870|NCT01587703|587857657|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
162766871|NCT01587703|587857658|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766872|NCT01587703|587857659|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
162766873|NCT01587703|587857660|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766874|NCT01587703|587857661|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766875|NCT01587703|587857662|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766876|NCT01587703|587857663|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766877|NCT01587703|587857664|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766878|NCT01587703|587857665|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766879|NCT01587703|587857666|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766880|NCT01587703|587857667|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162766881|NCT01587703|587857649|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766882|NCT01587703|587857650|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766883|NCT01587703|587857651|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766884|NCT01587703|587857652|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766885|NCT01587703|587857653|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766886|NCT01587703|587857654|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766887|NCT01587703|587857655|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766888|NCT01587703|587857656|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766889|NCT01587703|587857657|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766890|NCT01587703|587857658|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
162766891|NCT01587703|587857659|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
162766892|NCT01587703|587857660|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766893|NCT01587703|587857661|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766894|NCT01587703|587857662|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766895|NCT01587703|587857663|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766896|NCT01587703|587857664|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766897|NCT01587703|587857665|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766898|NCT01587703|587857666|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766899|NCT01587703|587857667|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162766900|NCT01587703|587857649|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766901|NCT01587703|587857650|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766902|NCT01587703|587857651|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766903|NCT01587703|587857652|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766904|NCT01587703|587857653|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766905|NCT01587703|587857654|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766906|NCT01587703|587857655|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766907|NCT01587703|587857656|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766908|NCT01587703|587857657|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
162766909|NCT01587703|587857658|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766910|NCT01587703|587857659|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766911|NCT01587703|587857660|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766912|NCT01587703|587857661|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766913|NCT01587703|587857662|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766914|NCT01587703|587857663|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766915|NCT01587703|587857664|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766916|NCT01587703|587857665|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766917|NCT01587703|587857666|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766918|NCT01587703|587857667|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162766919|NCT01587703|587857649|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766920|NCT01587703|587857650|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766921|NCT01587703|587857651|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766922|NCT01587703|587857652|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766923|NCT01587703|587857653|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766924|NCT01587703|587857654|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766925|NCT01587703|587857655|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766926|NCT01587703|587857656|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766927|NCT01587703|587857657|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162925392|NCT05302414|588428962|FG001|Pretest to Posttest|Lost to Follow-up|8|||
162925393|NCT05302414|588428963|FG002|Pretest to Posttest|Lost to Follow-up|8|||
162766928|NCT01587703|587857658|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766929|NCT01587703|587857659|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766930|NCT01587703|587857660|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766931|NCT01587703|587857661|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766932|NCT01587703|587857662|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766933|NCT01587703|587857663|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766934|NCT01587703|587857664|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766935|NCT01587703|587857665|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766936|NCT01587703|587857666|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162766937|NCT01587703|587857667|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
162766938|NCT01587703|587857649|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766939|NCT01587703|587857650|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766940|NCT01587703|587857651|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766941|NCT01587703|587857652|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766942|NCT01587703|587857653|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766943|NCT01587703|587857654|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766944|NCT01587703|587857655|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766945|NCT01587703|587857656|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766946|NCT01587703|587857657|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766947|NCT01587703|587857658|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766948|NCT01587703|587857659|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766949|NCT01587703|587857660|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766950|NCT01587703|587857661|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766951|NCT01587703|587857662|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766952|NCT01587703|587857663|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766953|NCT01587703|587857664|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766954|NCT01587703|587857665|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162766955|NCT01587703|587857666|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
162766956|NCT01587703|587857667|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
162766957|NCT01587703|587857649|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766958|NCT01587703|587857650|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766959|NCT01587703|587857651|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766960|NCT01587703|587857652|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766961|NCT01587703|587857653|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766962|NCT01587703|587857654|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766963|NCT01587703|587857655|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766964|NCT01587703|587857656|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766965|NCT01587703|587857657|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766966|NCT01587703|587857658|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766967|NCT01587703|587857659|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766968|NCT01587703|587857660|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766969|NCT01587703|587857661|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766970|NCT01587703|587857662|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766971|NCT01587703|587857663|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766972|NCT01587703|587857664|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
162766973|NCT01587703|587857665|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766974|NCT01587703|587857666|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766975|NCT01587703|587857667|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162766976|NCT01587703|587857649|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766977|NCT01587703|587857650|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766978|NCT01587703|587857651|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766979|NCT01587703|587857652|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766980|NCT01587703|587857653|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766981|NCT01587703|587857654|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766982|NCT01587703|587857655|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766983|NCT01587703|587857656|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766984|NCT01587703|587857657|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766985|NCT01587703|587857658|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766986|NCT01587703|587857659|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766987|NCT01587703|587857660|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
162766988|NCT01587703|587857661|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766989|NCT01587703|587857662|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766990|NCT01587703|587857663|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
162766991|NCT01587703|587857664|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766992|NCT01587703|587857665|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766993|NCT01587703|587857666|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766994|NCT01587703|587857667|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162766995|NCT01587703|587857649|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162766996|NCT01587703|587857650|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162766997|NCT01587703|587857651|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162766998|NCT01587703|587857652|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162766999|NCT01587703|587857653|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767000|NCT01587703|587857654|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767001|NCT01587703|587857655|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767002|NCT01587703|587857656|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767003|NCT01587703|587857657|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767004|NCT01587703|587857658|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767005|NCT01587703|587857659|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767006|NCT01587703|587857660|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
162767007|NCT01587703|587857661|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
162767008|NCT01587703|587857662|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
162767009|NCT01587703|587857663|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
162767010|NCT01587703|587857664|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
162767011|NCT01587703|587857665|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
162767012|NCT01587703|587857666|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767013|NCT01587703|587857667|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162767014|NCT01587703|587857649|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767015|NCT01587703|587857650|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767016|NCT01587703|587857651|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767017|NCT01587703|587857652|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767018|NCT01587703|587857653|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767019|NCT01587703|587857654|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767020|NCT01587703|587857655|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767021|NCT01587703|587857656|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767022|NCT01587703|587857657|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767023|NCT01587703|587857658|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767024|NCT01587703|587857659|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767025|NCT01587703|587857660|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
162767026|NCT01587703|587857661|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
162767027|NCT01587703|587857662|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
162767028|NCT01587703|587857663|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
162767029|NCT01587703|587857664|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
162767030|NCT01587703|587857665|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
162767031|NCT01587703|587857666|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767032|NCT01587703|587857667|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
162767033|NCT01587703|587857649|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767034|NCT01587703|587857650|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767035|NCT01587703|587857651|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767036|NCT01587703|587857652|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767037|NCT01587703|587857653|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767038|NCT01587703|587857654|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767039|NCT01587703|587857655|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767040|NCT01587703|587857656|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767041|NCT01587703|587857657|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767042|NCT01587703|587857658|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767043|NCT01587703|587857659|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767044|NCT01587703|587857660|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
162767045|NCT01587703|587857661|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767046|NCT01587703|587857662|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767047|NCT01587703|587857663|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767048|NCT01587703|587857664|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767049|NCT01587703|587857665|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767050|NCT01587703|587857666|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767051|NCT01587703|587857667|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162767052|NCT00828139|587857668|FG000|Overall Study|Adverse Event|8|||
162767053|NCT00828139|587857669|FG001|Overall Study|Adverse Event|1|||
162767054|NCT00828139|587857670|FG002|Overall Study|Adverse Event|10|||
162767055|NCT00828139|587857671|FG003|Overall Study|Adverse Event|5|||
162767056|NCT00828139|587857668|FG000|Overall Study|Death|2|||
162767057|NCT00828139|587857669|FG001|Overall Study|Death|1|||
162767058|NCT00828139|587857670|FG002|Overall Study|Death|0|||
162767059|NCT00828139|587857671|FG003|Overall Study|Death|2|||
162767060|NCT00828139|587857668|FG000|Overall Study|Refusal unrelated to toxicity|3|||
162767061|NCT00828139|587857669|FG001|Overall Study|Refusal unrelated to toxicity|4|||
162767062|NCT00828139|587857670|FG002|Overall Study|Refusal unrelated to toxicity|5|||
162767063|NCT00828139|587857671|FG003|Overall Study|Refusal unrelated to toxicity|3|||
162767064|NCT00828139|587857668|FG000|Overall Study|Disease Progression|24|||
162767065|NCT00828139|587857669|FG001|Overall Study|Disease Progression|33|||
162767066|NCT00828139|587857670|FG002|Overall Study|Disease Progression|35|||
162767067|NCT00828139|587857671|FG003|Overall Study|Disease Progression|39|||
162767068|NCT00828139|587857668|FG000|Overall Study|Other|4|||
162767069|NCT00828139|587857669|FG001|Overall Study|Other|2|||
162767070|NCT00828139|587857670|FG002|Overall Study|Other|5|||
162767071|NCT00828139|587857671|FG003|Overall Study|Other|2|||
162767072|NCT04271254|587857672|FG000|Overall Study|Withdrawal by Subject|3|||
162767073|NCT04751929|587857673|FG000|Overall Study|Withdrawal by Subject|2|||
162767074|NCT04751929|587857674|FG001|Overall Study|Withdrawal by Subject|0|||
162767075|NCT04751929|587857675|FG002|Overall Study|Withdrawal by Subject|0|||
162767076|NCT04751929|587857676|FG003|Overall Study|Withdrawal by Subject|0|||
162767077|NCT04751929|587857673|FG000|Overall Study|Rising PSA|0|||
162767078|NCT04751929|587857674|FG001|Overall Study|Rising PSA|1|||
162767079|NCT04751929|587857675|FG002|Overall Study|Rising PSA|0|||
162767080|NCT04751929|587857676|FG003|Overall Study|Rising PSA|0|||
162767081|NCT04751929|587857673|FG000|Overall Study|Adverse Event|1|||
162767082|NCT04751929|587857674|FG001|Overall Study|Adverse Event|2|||
162767083|NCT04751929|587857675|FG002|Overall Study|Adverse Event|0|||
162767084|NCT04751929|587857676|FG003|Overall Study|Adverse Event|0|||
162767085|NCT04751929|587857673|FG000|Overall Study|Progressive Disease|3|||
162767086|NCT04751929|587857674|FG001|Overall Study|Progressive Disease|4|||
162767087|NCT04751929|587857675|FG002|Overall Study|Progressive Disease|4|||
162767088|NCT04751929|587857676|FG003|Overall Study|Progressive Disease|0|||
162767089|NCT04751929|587857673|FG000|Overall Study|Death|1|||
162767090|NCT04751929|587857674|FG001|Overall Study|Death|1|||
162767091|NCT04751929|587857675|FG002|Overall Study|Death|0|||
162767092|NCT04751929|587857676|FG003|Overall Study|Death|0|||
162767093|NCT00473512|587857681|FG000|Period 1 (Phase 1)|Adverse Event|0|||
162767094|NCT00473512|587857682|FG001|Period 1 (Phase 1)|Adverse Event|0|||
162767095|NCT00473512|587857683|FG002|Period 1 (Phase 1)|Adverse Event|0|||
162767096|NCT00473512|587857684|FG003|Period 1 (Phase 1)|Adverse Event|5|||
162767097|NCT00473512|587857685|FG004|Period 1 (Phase 1)|Adverse Event|0|||
162767098|NCT00473512|587857681|FG000|Period 1 (Phase 1)|Death|0|||
162767099|NCT00473512|587857682|FG001|Period 1 (Phase 1)|Death|0|||
162767100|NCT00473512|587857683|FG002|Period 1 (Phase 1)|Death|0|||
162767101|NCT00473512|587857684|FG003|Period 1 (Phase 1)|Death|1|||
162767102|NCT00473512|587857685|FG004|Period 1 (Phase 1)|Death|0|||
162767103|NCT00473512|587857681|FG000|Period 1 (Phase 1)|Disease Progression|1|||
162767104|NCT00473512|587857682|FG001|Period 1 (Phase 1)|Disease Progression|1|||
162767105|NCT00473512|587857683|FG002|Period 1 (Phase 1)|Disease Progression|0|||
162767106|NCT00473512|587857684|FG003|Period 1 (Phase 1)|Disease Progression|10|||
162767107|NCT00473512|587857685|FG004|Period 1 (Phase 1)|Disease Progression|1|||
162767108|NCT00473512|587857681|FG000|Period 1 (Phase 1)|Other|0|||
162767109|NCT00473512|587857682|FG001|Period 1 (Phase 1)|Other|0|||
162767110|NCT00473512|587857683|FG002|Period 1 (Phase 1)|Other|0|||
162767111|NCT00473512|587857684|FG003|Period 1 (Phase 1)|Other|1|||
162767112|NCT00473512|587857685|FG004|Period 1 (Phase 1)|Other|0|||
162767113|NCT00473512|587857681|FG000|Period 2 (Phase 2)|Adverse Event|0|||
162767114|NCT00473512|587857682|FG001|Period 2 (Phase 2)|Adverse Event|0|||
162767115|NCT00473512|587857683|FG002|Period 2 (Phase 2)|Adverse Event|0|||
162767116|NCT00473512|587857684|FG003|Period 2 (Phase 2)|Adverse Event|1|||
162767117|NCT00473512|587857685|FG004|Period 2 (Phase 2)|Adverse Event|0|||
162767118|NCT00473512|587857681|FG000|Period 2 (Phase 2)|Death|0|||
162767119|NCT00473512|587857682|FG001|Period 2 (Phase 2)|Death|0|||
162767120|NCT00473512|587857683|FG002|Period 2 (Phase 2)|Death|0|||
162767121|NCT00473512|587857684|FG003|Period 2 (Phase 2)|Death|1|||
162767122|NCT00473512|587857685|FG004|Period 2 (Phase 2)|Death|1|||
162767123|NCT00473512|587857681|FG000|Period 2 (Phase 2)|Disease Progression|0|||
162767124|NCT00473512|587857682|FG001|Period 2 (Phase 2)|Disease Progression|2|||
162767125|NCT00473512|587857683|FG002|Period 2 (Phase 2)|Disease Progression|2|||
162767126|NCT00473512|587857684|FG003|Period 2 (Phase 2)|Disease Progression|17|||
162767127|NCT00473512|587857685|FG004|Period 2 (Phase 2)|Disease Progression|1|||
162767128|NCT00473512|587857681|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162767129|NCT00473512|587857682|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162767130|NCT00473512|587857683|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162767131|NCT00473512|587857684|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
162767132|NCT00473512|587857685|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162767133|NCT00473512|587857681|FG000|Period 2 (Phase 2)|Other|1|||
162767134|NCT00473512|587857682|FG001|Period 2 (Phase 2)|Other|0|||
162767135|NCT00473512|587857683|FG002|Period 2 (Phase 2)|Other|0|||
162767136|NCT00473512|587857684|FG003|Period 2 (Phase 2)|Other|3|||
162767137|NCT00473512|587857685|FG004|Period 2 (Phase 2)|Other|0|||
162767138|NCT01129011|587857688|FG000|Overall Study|Adverse Event|20|||
162767139|NCT01129011|587857689|FG001|Overall Study|Adverse Event|30|||
162767140|NCT01129011|587857688|FG000|Overall Study|Withdrawal by Subject|24|||
162767141|NCT01129011|587857689|FG001|Overall Study|Withdrawal by Subject|8|||
162767142|NCT01129011|587857688|FG000|Overall Study|Lost to Follow-up|6|||
162767143|NCT01129011|587857689|FG001|Overall Study|Lost to Follow-up|7|||
162767144|NCT01129011|587857688|FG000|Overall Study|Duodenal Ulcer|2|||
162767145|NCT01129011|587857689|FG001|Overall Study|Duodenal Ulcer|8|||
162767146|NCT01129011|587857688|FG000|Overall Study|misc|7|||
162767147|NCT01129011|587857689|FG001|Overall Study|misc|4|||
162767148|NCT01052272|587857690|FG000|Overall Study|Death|0|||
162767149|NCT01052272|587857691|FG001|Overall Study|Death|0|||
162767150|NCT01052272|587857692|FG002|Overall Study|Death|1|||
162767151|NCT01052272|587857693|FG003|Overall Study|Death|1|||
162767152|NCT01052272|587857690|FG000|Overall Study|Physician Decision|0|||
162767153|NCT01052272|587857691|FG001|Overall Study|Physician Decision|1|||
162767154|NCT01052272|587857692|FG002|Overall Study|Physician Decision|0|||
162767155|NCT01052272|587857693|FG003|Overall Study|Physician Decision|0|||
162767156|NCT01052272|587857690|FG000|Overall Study|patient refuses follow-up|5|||
162767157|NCT01052272|587857691|FG001|Overall Study|patient refuses follow-up|4|||
162767158|NCT01052272|587857692|FG002|Overall Study|patient refuses follow-up|2|||
162767159|NCT01052272|587857693|FG003|Overall Study|patient refuses follow-up|4|||
162767160|NCT01052272|587857690|FG000|Overall Study|Withdrawal by Subject|0|||
162767161|NCT01052272|587857691|FG001|Overall Study|Withdrawal by Subject|2|||
162767162|NCT01052272|587857692|FG002|Overall Study|Withdrawal by Subject|3|||
162767163|NCT01052272|587857693|FG003|Overall Study|Withdrawal by Subject|2|||
162767164|NCT01052272|587857690|FG000|Overall Study|placed in long-term care|0|||
162767165|NCT01052272|587857691|FG001|Overall Study|placed in long-term care|0|||
162767166|NCT01052272|587857692|FG002|Overall Study|placed in long-term care|1|||
162767167|NCT01052272|587857693|FG003|Overall Study|placed in long-term care|0|||
162767168|NCT01052272|587857690|FG000|Overall Study|decline in health|0|||
162767169|NCT01052272|587857691|FG001|Overall Study|decline in health|0|||
162767170|NCT01052272|587857692|FG002|Overall Study|decline in health|1|||
162767171|NCT01052272|587857693|FG003|Overall Study|decline in health|0|||
162767172|NCT00648895|587857694|FG000|Overall Study|Lack of Efficacy|0|||
162767173|NCT00648895|587857695|FG001|Overall Study|Lack of Efficacy|1|||
162767174|NCT00841321|587857696|FG000|Overall Study|Lost to Follow-up|1|||
162767175|NCT00841321|587857697|FG001|Overall Study|Lost to Follow-up|1|||
162767176|NCT00841321|587857696|FG000|Overall Study|Adverse Event|0|||
162767177|NCT00841321|587857697|FG001|Overall Study|Adverse Event|2|||
162767178|NCT02632747|587857698|FG000|Wash-out Period|Adverse Event|1|||
162767179|NCT02632747|587857699|FG001|Wash-out Period|Adverse Event|0|||
162767180|NCT03209492|587857700|FG000|Overall Study|Case Report Forms Uncollected|5|||
162767181|NCT01358175|587857701|FG000|Overall Study|Death|1|||
162767182|NCT01358175|587857702|FG001|Overall Study|Death|0|||
162767183|NCT01358175|587857703|FG002|Overall Study|Death|1|||
162767184|NCT01358175|587857701|FG000|Overall Study|Withdrawal by Subject|9|||
162767185|NCT01358175|587857702|FG001|Overall Study|Withdrawal by Subject|5|||
162767186|NCT01358175|587857703|FG002|Overall Study|Withdrawal by Subject|10|||
162767187|NCT01358175|587857701|FG000|Overall Study|Technical issues|0|||
162767188|NCT01358175|587857702|FG001|Overall Study|Technical issues|1|||
162767189|NCT01358175|587857703|FG002|Overall Study|Technical issues|0|||
162767190|NCT01358175|587857701|FG000|Overall Study|Pregnancy|0|||
162767191|NCT01358175|587857702|FG001|Overall Study|Pregnancy|1|||
162767192|NCT01358175|587857703|FG002|Overall Study|Pregnancy|0|||
162767193|NCT01358175|587857701|FG000|Overall Study|Physician Decision|1|||
162767194|NCT01358175|587857702|FG001|Overall Study|Physician Decision|0|||
162767195|NCT01358175|587857703|FG002|Overall Study|Physician Decision|0|||
162767196|NCT01358175|587857701|FG000|Overall Study|Non Compliance with Study Treatment|0|||
162767197|NCT01358175|587857702|FG001|Overall Study|Non Compliance with Study Treatment|1|||
162767198|NCT01358175|587857703|FG002|Overall Study|Non Compliance with Study Treatment|1|||
162767199|NCT01358175|587857701|FG000|Overall Study|Lost to Follow-up|1|||
162767200|NCT01358175|587857702|FG001|Overall Study|Lost to Follow-up|1|||
162767201|NCT01358175|587857703|FG002|Overall Study|Lost to Follow-up|3|||
162767202|NCT01358175|587857701|FG000|Overall Study|Lack of Efficacy|3|||
162767203|NCT01358175|587857702|FG001|Overall Study|Lack of Efficacy|8|||
162767204|NCT01358175|587857703|FG002|Overall Study|Lack of Efficacy|6|||
162767205|NCT01358175|587857701|FG000|Overall Study|Adverse Event|6|||
162767206|NCT01358175|587857702|FG001|Overall Study|Adverse Event|11|||
162767207|NCT01358175|587857703|FG002|Overall Study|Adverse Event|11|||
162767208|NCT04908488|587857704|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
162767209|NCT04908488|587857705|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
162767210|NCT04908488|587857704|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
162767211|NCT04908488|587857705|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
162767212|NCT01107912|587857706|FG000|Period 1|Adverse Event|0|||
162767213|NCT01107912|587857707|FG001|Period 1|Adverse Event|0|||
162767214|NCT01107912|587857708|FG002|Period 1|Adverse Event|0|||
162767215|NCT01107912|587857709|FG003|Period 1|Adverse Event|0|||
162767216|NCT01107912|587857710|FG004|Period 1|Adverse Event|2|||
162767217|NCT01107912|587857711|FG005|Period 1|Adverse Event|0|||
162767218|NCT01107912|587857706|FG000|Period 1|Physician Decision|0|||
162767219|NCT01107912|587857707|FG001|Period 1|Physician Decision|0|||
162767220|NCT01107912|587857708|FG002|Period 1|Physician Decision|0|||
162767221|NCT01107912|587857709|FG003|Period 1|Physician Decision|0|||
162767222|NCT01107912|587857710|FG004|Period 1|Physician Decision|1|||
162767223|NCT01107912|587857711|FG005|Period 1|Physician Decision|0|||
162767224|NCT01107912|587857706|FG000|Period 1|Withdrawal by Subject|1|||
162767225|NCT01107912|587857707|FG001|Period 1|Withdrawal by Subject|0|||
162767226|NCT01107912|587857708|FG002|Period 1|Withdrawal by Subject|0|||
162767227|NCT01107912|587857709|FG003|Period 1|Withdrawal by Subject|0|||
162767228|NCT01107912|587857710|FG004|Period 1|Withdrawal by Subject|0|||
162767229|NCT01107912|587857711|FG005|Period 1|Withdrawal by Subject|0|||
162767230|NCT01107912|587857706|FG000|Period 2|Physician Decision|0|||
162767231|NCT01107912|587857707|FG001|Period 2|Physician Decision|0|||
162767232|NCT01107912|587857708|FG002|Period 2|Physician Decision|1|||
162767233|NCT01107912|587857709|FG003|Period 2|Physician Decision|0|||
162767234|NCT01107912|587857710|FG004|Period 2|Physician Decision|0|||
162767235|NCT01107912|587857711|FG005|Period 2|Physician Decision|0|||
162767236|NCT01107912|587857706|FG000|Period 3|Adverse Event|0|||
162767237|NCT01107912|587857707|FG001|Period 3|Adverse Event|1|||
162767238|NCT01107912|587857708|FG002|Period 3|Adverse Event|1|||
162767239|NCT01107912|587857709|FG003|Period 3|Adverse Event|0|||
162767240|NCT01107912|587857710|FG004|Period 3|Adverse Event|0|||
162767241|NCT01107912|587857711|FG005|Period 3|Adverse Event|0|||
162767242|NCT01107912|587857706|FG000|Period 3|Withdrawal by Subject|0|||
162767243|NCT01107912|587857707|FG001|Period 3|Withdrawal by Subject|0|||
162767244|NCT01107912|587857708|FG002|Period 3|Withdrawal by Subject|0|||
162767245|NCT01107912|587857709|FG003|Period 3|Withdrawal by Subject|1|||
162767246|NCT01107912|587857710|FG004|Period 3|Withdrawal by Subject|0|||
162767247|NCT01107912|587857711|FG005|Period 3|Withdrawal by Subject|0|||
162767248|NCT00879710|587857716|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
162767249|NCT00879710|587857717|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
162767250|NCT00879710|587857718|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
162767251|NCT00879710|587857719|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
162767252|NCT00879710|587857716|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
162767253|NCT00879710|587857717|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
162767254|NCT00879710|587857718|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
162767255|NCT00879710|587857719|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
162767256|NCT03875729|587857720|FG000|Overall Study|Adverse Event|0|||
162767257|NCT03875729|587857721|FG001|Overall Study|Adverse Event|5|||
162767258|NCT03875729|587857720|FG000|Overall Study|Withdrawal by Subject|8|||
162767259|NCT03875729|587857721|FG001|Overall Study|Withdrawal by Subject|11|||
162767260|NCT03875729|587857720|FG000|Overall Study|Pregnancy|0|||
162767261|NCT03875729|587857721|FG001|Overall Study|Pregnancy|1|||
162767262|NCT03875729|587857720|FG000|Overall Study|Lost to Follow-up|0|||
162767263|NCT03875729|587857721|FG001|Overall Study|Lost to Follow-up|5|||
162767264|NCT03875729|587857720|FG000|Overall Study|Personal reasons|2|||
162767265|NCT03875729|587857721|FG001|Overall Study|Personal reasons|0|||
162767266|NCT00753896|587857722|FG000|Overall Study|Adverse Event|4|||
162767267|NCT00753896|587857722|FG000|Overall Study|Death|1|||
162767268|NCT00753896|587857722|FG000|Overall Study|Lost to Follow-up|2|||
162767269|NCT00753896|587857722|FG000|Overall Study|Protocol Violation|1|||
162767270|NCT00753896|587857722|FG000|Overall Study|Withdrawal by Subject|4|||
162767271|NCT00753896|587857722|FG000|Overall Study|Entry Criteria Not Met|4|||
162767272|NCT01280656|587857723|FG000|Overall Study|Adverse Event|1|||
162767273|NCT01280656|587857724|FG001|Overall Study|Adverse Event|14|||
162767274|NCT01280656|587857725|FG002|Overall Study|Adverse Event|13|||
162767275|NCT01280656|587857723|FG000|Overall Study|Lack of Efficacy|1|||
162767276|NCT01280656|587857724|FG001|Overall Study|Lack of Efficacy|22|||
162767277|NCT01280656|587857725|FG002|Overall Study|Lack of Efficacy|38|||
162767278|NCT01280656|587857723|FG000|Overall Study|Treatment shortening (RGT)|0|||
162767279|NCT01280656|587857724|FG001|Overall Study|Treatment shortening (RGT)|4|||
162767280|NCT01280656|587857725|FG002|Overall Study|Treatment shortening (RGT)|5|||
162767281|NCT01280656|587857723|FG000|Overall Study|Other|1|||
162767282|NCT01280656|587857724|FG001|Overall Study|Other|7|||
162767283|NCT01280656|587857725|FG002|Overall Study|Other|7|||
162767284|NCT00952523|587857726|FG000|Overall Study|Withdrawal by Subject|7|||
162767285|NCT01029925|587857727|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
162767286|NCT01029925|587857727|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
162767287|NCT01029925|587857727|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
162767288|NCT05265247|587857728|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
162767289|NCT05265247|587857729|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
162767290|NCT05265247|587857728|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
162767291|NCT05265247|587857729|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
162767292|NCT05265247|587857728|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
162767293|NCT05265247|587857729|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
162767294|NCT00476957|587857730|FG000|Overall Study|Lost to Follow-up|176|||
162767295|NCT00476957|587857731|FG001|Overall Study|Lost to Follow-up|193|||
162767296|NCT02516202|587857732|FG000|Overall Study|Withdrawal by Subject|1|||
162767297|NCT02516202|587857733|FG001|Overall Study|Withdrawal by Subject|0|||
162767298|NCT02516202|587857734|FG002|Overall Study|Withdrawal by Subject|1|||
162767299|NCT02516202|587857732|FG000|Overall Study|Lost to Follow-up|1|||
162767300|NCT02516202|587857733|FG001|Overall Study|Lost to Follow-up|1|||
162767301|NCT02516202|587857734|FG002|Overall Study|Lost to Follow-up|1|||
162767302|NCT02516202|587857732|FG000|Overall Study|Stopped Follow-up|0|||
162767303|NCT02516202|587857733|FG001|Overall Study|Stopped Follow-up|0|||
162767304|NCT02516202|587857734|FG002|Overall Study|Stopped Follow-up|1|||
162767305|NCT01000649|587857737|FG000|Overall Study|Adverse Event|5|||
162767306|NCT01000649|587857738|FG001|Overall Study|Adverse Event|1|||
162767307|NCT01000649|587857739|FG002|Overall Study|Adverse Event|2|||
162767308|NCT01000649|587857740|FG003|Overall Study|Adverse Event|4|||
162767309|NCT01000649|587857737|FG000|Overall Study|Lost to Follow-up|0|||
162767310|NCT01000649|587857738|FG001|Overall Study|Lost to Follow-up|2|||
162767311|NCT01000649|587857739|FG002|Overall Study|Lost to Follow-up|0|||
162767312|NCT01000649|587857740|FG003|Overall Study|Lost to Follow-up|2|||
162767313|NCT01916109|587857741|FG000|Overall Study|Withdrawal by Subject|1|||
162767314|NCT00103857|587857742|FG000|54-Week Base Study|Adverse Event|12|||
162767315|NCT00103857|587857743|FG001|54-Week Base Study|Adverse Event|9|||
162767316|NCT00103857|587857744|FG002|54-Week Base Study|Adverse Event|11|||
162767317|NCT00103857|587857745|FG003|54-Week Base Study|Adverse Event|6|||
162767318|NCT00103857|587857746|FG004|54-Week Base Study|Adverse Event|5|||
162767319|NCT00103857|587857747|FG005|54-Week Base Study|Adverse Event|11|||
162767320|NCT00103857|587857748|FG006|54-Week Base Study|Adverse Event|3|||
162767321|NCT00103857|587857742|FG000|54-Week Base Study|Death|0|||
162767322|NCT00103857|587857743|FG001|54-Week Base Study|Death|0|||
162767323|NCT00103857|587857744|FG002|54-Week Base Study|Death|0|||
162767324|NCT00103857|587857745|FG003|54-Week Base Study|Death|0|||
162767325|NCT00103857|587857746|FG004|54-Week Base Study|Death|1|||
162767326|NCT00103857|587857747|FG005|54-Week Base Study|Death|1|||
162767327|NCT00103857|587857748|FG006|54-Week Base Study|Death|0|||
162767328|NCT00103857|587857742|FG000|54-Week Base Study|Lack of Efficacy|11|||
162767329|NCT00103857|587857743|FG001|54-Week Base Study|Lack of Efficacy|14|||
162767330|NCT00103857|587857744|FG002|54-Week Base Study|Lack of Efficacy|8|||
162767331|NCT00103857|587857745|FG003|54-Week Base Study|Lack of Efficacy|4|||
162767332|NCT00103857|587857746|FG004|54-Week Base Study|Lack of Efficacy|3|||
162767333|NCT00103857|587857747|FG005|54-Week Base Study|Lack of Efficacy|14|||
162767334|NCT00103857|587857748|FG006|54-Week Base Study|Lack of Efficacy|19|||
162767335|NCT00103857|587857742|FG000|54-Week Base Study|Lost to Follow-up|5|||
162767336|NCT00103857|587857743|FG001|54-Week Base Study|Lost to Follow-up|4|||
162767337|NCT00103857|587857744|FG002|54-Week Base Study|Lost to Follow-up|7|||
162767338|NCT00103857|587857745|FG003|54-Week Base Study|Lost to Follow-up|5|||
162767339|NCT00103857|587857746|FG004|54-Week Base Study|Lost to Follow-up|10|||
162767340|NCT00103857|587857747|FG005|54-Week Base Study|Lost to Follow-up|9|||
162767341|NCT00103857|587857748|FG006|54-Week Base Study|Lost to Follow-up|3|||
162767342|NCT00103857|587857742|FG000|54-Week Base Study|Physician Decision|1|||
162767343|NCT00103857|587857743|FG001|54-Week Base Study|Physician Decision|1|||
162767344|NCT00103857|587857744|FG002|54-Week Base Study|Physician Decision|0|||
162767345|NCT00103857|587857745|FG003|54-Week Base Study|Physician Decision|0|||
162767346|NCT00103857|587857746|FG004|54-Week Base Study|Physician Decision|1|||
162767347|NCT00103857|587857747|FG005|54-Week Base Study|Physician Decision|0|||
162767348|NCT00103857|587857748|FG006|54-Week Base Study|Physician Decision|0|||
162767349|NCT00103857|587857742|FG000|54-Week Base Study|Pregnancy|1|||
162767350|NCT00103857|587857743|FG001|54-Week Base Study|Pregnancy|0|||
162767351|NCT00103857|587857744|FG002|54-Week Base Study|Pregnancy|0|||
162767352|NCT00103857|587857745|FG003|54-Week Base Study|Pregnancy|0|||
162767353|NCT00103857|587857746|FG004|54-Week Base Study|Pregnancy|1|||
162767354|NCT00103857|587857747|FG005|54-Week Base Study|Pregnancy|0|||
162767355|NCT00103857|587857748|FG006|54-Week Base Study|Pregnancy|1|||
162767356|NCT00103857|587857742|FG000|54-Week Base Study|Protocol Violation|6|||
162767357|NCT00103857|587857743|FG001|54-Week Base Study|Protocol Violation|4|||
162767358|NCT00103857|587857744|FG002|54-Week Base Study|Protocol Violation|2|||
162767359|NCT00103857|587857745|FG003|54-Week Base Study|Protocol Violation|4|||
162767360|NCT00103857|587857746|FG004|54-Week Base Study|Protocol Violation|0|||
162767361|NCT00103857|587857747|FG005|54-Week Base Study|Protocol Violation|3|||
162767362|NCT00103857|587857748|FG006|54-Week Base Study|Protocol Violation|3|||
162767363|NCT00103857|587857742|FG000|54-Week Base Study|Withdrawal by Subject|17|||
162767364|NCT00103857|587857743|FG001|54-Week Base Study|Withdrawal by Subject|16|||
162767365|NCT00103857|587857744|FG002|54-Week Base Study|Withdrawal by Subject|16|||
162767366|NCT00103857|587857745|FG003|54-Week Base Study|Withdrawal by Subject|15|||
162767367|NCT00103857|587857746|FG004|54-Week Base Study|Withdrawal by Subject|10|||
162767368|NCT00103857|587857747|FG005|54-Week Base Study|Withdrawal by Subject|15|||
162767369|NCT00103857|587857748|FG006|54-Week Base Study|Withdrawal by Subject|4|||
162767370|NCT00103857|587857742|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
162767371|NCT00103857|587857743|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
162767372|NCT00103857|587857744|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
162767373|NCT00103857|587857745|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
162767374|NCT00103857|587857746|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
162767375|NCT00103857|587857747|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
162767376|NCT00103857|587857748|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
162767377|NCT00103857|587857742|FG000|54-Week Base Study|patient moved|0|||
162767378|NCT00103857|587857743|FG001|54-Week Base Study|patient moved|1|||
162767379|NCT00103857|587857744|FG002|54-Week Base Study|patient moved|1|||
162767380|NCT00103857|587857745|FG003|54-Week Base Study|patient moved|2|||
162767381|NCT00103857|587857746|FG004|54-Week Base Study|patient moved|3|||
162767382|NCT00103857|587857747|FG005|54-Week Base Study|patient moved|1|||
162767383|NCT00103857|587857748|FG006|54-Week Base Study|patient moved|0|||
162767384|NCT00103857|587857742|FG000|54-Week Base Study|non-compliance with study procedures|1|||
162767385|NCT00103857|587857743|FG001|54-Week Base Study|non-compliance with study procedures|2|||
162767386|NCT00103857|587857744|FG002|54-Week Base Study|non-compliance with study procedures|0|||
162767387|NCT00103857|587857745|FG003|54-Week Base Study|non-compliance with study procedures|0|||
162767388|NCT00103857|587857746|FG004|54-Week Base Study|non-compliance with study procedures|0|||
162767389|NCT00103857|587857747|FG005|54-Week Base Study|non-compliance with study procedures|2|||
162767390|NCT00103857|587857748|FG006|54-Week Base Study|non-compliance with study procedures|0|||
162767391|NCT00103857|587857742|FG000|54-Week Base Study|patient incarcerated|0|||
162767392|NCT00103857|587857743|FG001|54-Week Base Study|patient incarcerated|0|||
162767393|NCT00103857|587857744|FG002|54-Week Base Study|patient incarcerated|0|||
162767394|NCT00103857|587857745|FG003|54-Week Base Study|patient incarcerated|0|||
162767395|NCT00103857|587857746|FG004|54-Week Base Study|patient incarcerated|1|||
162767396|NCT00103857|587857747|FG005|54-Week Base Study|patient incarcerated|1|||
162767397|NCT00103857|587857748|FG006|54-Week Base Study|patient incarcerated|0|||
162767398|NCT00103857|587857742|FG000|54-Week Base Study|laboratory reporting error|0|||
162767399|NCT00103857|587857743|FG001|54-Week Base Study|laboratory reporting error|0|||
162767400|NCT00103857|587857744|FG002|54-Week Base Study|laboratory reporting error|0|||
162767401|NCT00103857|587857745|FG003|54-Week Base Study|laboratory reporting error|0|||
162767402|NCT00103857|587857746|FG004|54-Week Base Study|laboratory reporting error|1|||
162767403|NCT00103857|587857747|FG005|54-Week Base Study|laboratory reporting error|0|||
162767404|NCT00103857|587857748|FG006|54-Week Base Study|laboratory reporting error|0|||
162767405|NCT00103857|587857742|FG000|54-Week Base Study|site error|0|||
162767406|NCT00103857|587857743|FG001|54-Week Base Study|site error|0|||
162767407|NCT00103857|587857744|FG002|54-Week Base Study|site error|0|||
162767408|NCT00103857|587857745|FG003|54-Week Base Study|site error|0|||
162767409|NCT00103857|587857746|FG004|54-Week Base Study|site error|0|||
162767410|NCT00103857|587857747|FG005|54-Week Base Study|site error|1|||
162767411|NCT00103857|587857748|FG006|54-Week Base Study|site error|0|||
162767412|NCT00103857|587857742|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
162767413|NCT00103857|587857743|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767414|NCT00103857|587857744|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767415|NCT00103857|587857745|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767416|NCT00103857|587857746|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767417|NCT00103857|587857747|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767418|NCT00103857|587857748|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
162767419|NCT00103857|587857742|FG000|50-Week Extension Study|Adverse Event|2|||
162767420|NCT00103857|587857743|FG001|50-Week Extension Study|Adverse Event|3|||
162767421|NCT00103857|587857744|FG002|50-Week Extension Study|Adverse Event|2|||
162767422|NCT00103857|587857745|FG003|50-Week Extension Study|Adverse Event|0|||
162767423|NCT00103857|587857746|FG004|50-Week Extension Study|Adverse Event|1|||
162767424|NCT00103857|587857747|FG005|50-Week Extension Study|Adverse Event|1|||
162767425|NCT00103857|587857748|FG006|50-Week Extension Study|Adverse Event|0|||
162767426|NCT00103857|587857742|FG000|50-Week Extension Study|Death|0|||
162767427|NCT00103857|587857743|FG001|50-Week Extension Study|Death|0|||
162767428|NCT00103857|587857744|FG002|50-Week Extension Study|Death|0|||
162767429|NCT00103857|587857745|FG003|50-Week Extension Study|Death|1|||
162767430|NCT00103857|587857746|FG004|50-Week Extension Study|Death|0|||
162767431|NCT00103857|587857747|FG005|50-Week Extension Study|Death|1|||
162767432|NCT00103857|587857748|FG006|50-Week Extension Study|Death|0|||
162767433|NCT00103857|587857742|FG000|50-Week Extension Study|Lack of Efficacy|26|||
162767434|NCT00103857|587857743|FG001|50-Week Extension Study|Lack of Efficacy|15|||
162767435|NCT00103857|587857744|FG002|50-Week Extension Study|Lack of Efficacy|13|||
162767436|NCT00103857|587857745|FG003|50-Week Extension Study|Lack of Efficacy|16|||
162767437|NCT00103857|587857746|FG004|50-Week Extension Study|Lack of Efficacy|8|||
162767438|NCT00103857|587857747|FG005|50-Week Extension Study|Lack of Efficacy|8|||
162767439|NCT00103857|587857748|FG006|50-Week Extension Study|Lack of Efficacy|0|||
162767440|NCT00103857|587857742|FG000|50-Week Extension Study|Lost to Follow-up|4|||
162767441|NCT00103857|587857743|FG001|50-Week Extension Study|Lost to Follow-up|0|||
162767442|NCT00103857|587857744|FG002|50-Week Extension Study|Lost to Follow-up|1|||
162767443|NCT00103857|587857745|FG003|50-Week Extension Study|Lost to Follow-up|4|||
162767444|NCT00103857|587857746|FG004|50-Week Extension Study|Lost to Follow-up|3|||
162767445|NCT00103857|587857747|FG005|50-Week Extension Study|Lost to Follow-up|3|||
162767446|NCT00103857|587857748|FG006|50-Week Extension Study|Lost to Follow-up|0|||
162767447|NCT00103857|587857742|FG000|50-Week Extension Study|Physician Decision|0|||
162767448|NCT00103857|587857743|FG001|50-Week Extension Study|Physician Decision|1|||
162767449|NCT00103857|587857744|FG002|50-Week Extension Study|Physician Decision|1|||
162767450|NCT00103857|587857745|FG003|50-Week Extension Study|Physician Decision|0|||
162767451|NCT00103857|587857746|FG004|50-Week Extension Study|Physician Decision|0|||
162767452|NCT00103857|587857747|FG005|50-Week Extension Study|Physician Decision|0|||
162767453|NCT00103857|587857748|FG006|50-Week Extension Study|Physician Decision|0|||
162767454|NCT00103857|587857742|FG000|50-Week Extension Study|Pregnancy|0|||
162767455|NCT00103857|587857743|FG001|50-Week Extension Study|Pregnancy|0|||
162767456|NCT00103857|587857744|FG002|50-Week Extension Study|Pregnancy|1|||
162767457|NCT00103857|587857745|FG003|50-Week Extension Study|Pregnancy|0|||
162767458|NCT00103857|587857746|FG004|50-Week Extension Study|Pregnancy|1|||
162767459|NCT00103857|587857747|FG005|50-Week Extension Study|Pregnancy|0|||
162767460|NCT00103857|587857748|FG006|50-Week Extension Study|Pregnancy|0|||
162767461|NCT00103857|587857742|FG000|50-Week Extension Study|Protocol Violation|1|||
162767462|NCT00103857|587857743|FG001|50-Week Extension Study|Protocol Violation|1|||
162767463|NCT00103857|587857744|FG002|50-Week Extension Study|Protocol Violation|1|||
162767464|NCT00103857|587857745|FG003|50-Week Extension Study|Protocol Violation|2|||
162767465|NCT00103857|587857746|FG004|50-Week Extension Study|Protocol Violation|0|||
162767466|NCT00103857|587857747|FG005|50-Week Extension Study|Protocol Violation|1|||
162767467|NCT00103857|587857748|FG006|50-Week Extension Study|Protocol Violation|0|||
162767468|NCT00103857|587857742|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
162767469|NCT00103857|587857743|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
162767470|NCT00103857|587857744|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
162767471|NCT00103857|587857745|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
162767472|NCT00103857|587857746|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
162767473|NCT00103857|587857747|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
162767474|NCT00103857|587857748|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
162767475|NCT00103857|587857742|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
162767476|NCT00103857|587857743|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
162767477|NCT00103857|587857744|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
162767478|NCT00103857|587857745|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
162767479|NCT00103857|587857746|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
162767480|NCT00103857|587857747|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
162767481|NCT00103857|587857748|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
162767482|NCT00103857|587857742|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
162767483|NCT00103857|587857743|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
162767484|NCT00103857|587857744|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
162767485|NCT00103857|587857745|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
162767486|NCT00103857|587857746|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
162767487|NCT00103857|587857747|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
162767488|NCT00103857|587857748|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
162767489|NCT00103857|587857742|FG000|50-Week Extension Study|patient moved|0|||
162767490|NCT00103857|587857743|FG001|50-Week Extension Study|patient moved|0|||
162767491|NCT00103857|587857744|FG002|50-Week Extension Study|patient moved|1|||
162767492|NCT00103857|587857745|FG003|50-Week Extension Study|patient moved|2|||
162767493|NCT00103857|587857746|FG004|50-Week Extension Study|patient moved|0|||
162767494|NCT00103857|587857747|FG005|50-Week Extension Study|patient moved|0|||
162767495|NCT00103857|587857748|FG006|50-Week Extension Study|patient moved|0|||
162767496|NCT00103857|587857742|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767497|NCT00103857|587857743|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767498|NCT00103857|587857744|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
162767499|NCT00103857|587857745|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767500|NCT00103857|587857746|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767501|NCT00103857|587857747|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767502|NCT00103857|587857748|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
162767503|NCT00103857|587857742|FG000|50-Week Extension Study|reason unspecified|0|||
162767504|NCT00103857|587857743|FG001|50-Week Extension Study|reason unspecified|0|||
162767505|NCT00103857|587857744|FG002|50-Week Extension Study|reason unspecified|0|||
162767506|NCT00103857|587857745|FG003|50-Week Extension Study|reason unspecified|0|||
162767507|NCT00103857|587857746|FG004|50-Week Extension Study|reason unspecified|1|||
162767508|NCT00103857|587857747|FG005|50-Week Extension Study|reason unspecified|0|||
162767509|NCT00103857|587857748|FG006|50-Week Extension Study|reason unspecified|0|||
162767510|NCT02707952|587857751|FG000|Overall Study|Adverse Event|1|||
162767511|NCT02707952|587857752|FG001|Overall Study|Adverse Event|0|||
162767512|NCT02707952|587857753|FG002|Overall Study|Adverse Event|0|||
162767513|NCT02707952|587857754|FG003|Overall Study|Adverse Event|0|||
162767514|NCT02707952|587857751|FG000|Overall Study|Lost to Follow-up|1|||
162767515|NCT02707952|587857752|FG001|Overall Study|Lost to Follow-up|0|||
162767516|NCT02707952|587857753|FG002|Overall Study|Lost to Follow-up|0|||
162767517|NCT02707952|587857754|FG003|Overall Study|Lost to Follow-up|0|||
162767518|NCT02707952|587857751|FG000|Overall Study|Withdrawal by Subject|0|||
162767519|NCT02707952|587857752|FG001|Overall Study|Withdrawal by Subject|1|||
162767520|NCT02707952|587857753|FG002|Overall Study|Withdrawal by Subject|2|||
162767521|NCT02707952|587857754|FG003|Overall Study|Withdrawal by Subject|0|||
162767522|NCT01287832|587857756|FG000|Overall Study|Adverse Event|1|||
162767523|NCT01287832|587857757|FG001|Overall Study|Adverse Event|0|||
162767524|NCT01287832|587857756|FG000|Overall Study|Death|0|||
162767525|NCT01287832|587857757|FG001|Overall Study|Death|1|||
162767526|NCT03065400|587857760|FG000|Overall Study|Adverse Event|1|||
162767527|NCT03065400|587857760|FG000|Overall Study|Physician Decision|3|||
162767528|NCT03065400|587857760|FG000|Overall Study|Withdrawal by Subject|1|||
162767529|NCT03065400|587857760|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
162767530|NCT03072862|587857761|FG000|Overall Study|Withdrawal by Subject|4|||
162767531|NCT03072862|587857761|FG000|Overall Study|Lost to Follow-up|6|||
162767532|NCT03072862|587857761|FG000|Overall Study|Protocol Violation|4|||
162767533|NCT03072862|587857761|FG000|Overall Study|Physician Decision|2|||
162767534|NCT03072862|587857761|FG000|Overall Study|Death|1|||
162767535|NCT03072862|587857761|FG000|Overall Study|Adverse Event|1|||
162767536|NCT00632736|587857762|FG000|Overall Study|Adverse Event|104|||
162767537|NCT00632736|587857762|FG000|Overall Study|Lost to Follow-up|15|||
162767538|NCT00632736|587857762|FG000|Overall Study|Protocol Violation|14|||
162767539|NCT00632736|587857762|FG000|Overall Study|Withdrawal by Subject|99|||
162767540|NCT00632736|587857762|FG000|Overall Study|Lack of Efficacy|5|||
162767541|NCT00632736|587857762|FG000|Overall Study|Sponsor terminated study|5|||
162767542|NCT00632736|587857762|FG000|Overall Study|Non-compliance|10|||
162767543|NCT00632736|587857762|FG000|Overall Study|Other|16|||
162767544|NCT03347396|587857763|FG000|Part A (26 Weeks)|Adverse Event|1|||
162767545|NCT03347396|587857764|FG001|Part A (26 Weeks)|Adverse Event|0|||
162767546|NCT03347396|587857763|FG000|Part A (26 Weeks)|Death|0|||
162767547|NCT03347396|587857764|FG001|Part A (26 Weeks)|Death|1|||
162767548|NCT03347396|587857763|FG000|Part B (149 Weeks)|Adverse Event|1|||
162767549|NCT03347396|587857764|FG001|Part B (149 Weeks)|Adverse Event|1|||
162767550|NCT03347396|587857763|FG000|Part B (149 Weeks)|Death|1|||
162767551|NCT03347396|587857764|FG001|Part B (149 Weeks)|Death|0|||
162767552|NCT03015220|587857766|FG000|Overall Study|Withdrawal by Subject|3|||
162767553|NCT03015220|587857767|FG001|Overall Study|Withdrawal by Subject|2|||
162767554|NCT03015220|587857768|FG002|Overall Study|Withdrawal by Subject|2|||
162767555|NCT03015220|587857769|FG003|Overall Study|Withdrawal by Subject|2|||
162767556|NCT03015220|587857766|FG000|Overall Study|Lost to Follow-up|0|||
162767557|NCT03015220|587857767|FG001|Overall Study|Lost to Follow-up|0|||
162767558|NCT03015220|587857768|FG002|Overall Study|Lost to Follow-up|1|||
162767559|NCT03015220|587857769|FG003|Overall Study|Lost to Follow-up|0|||
162767560|NCT01670526|587857771|FG000|Overall Study|Withdrawal by Subject|3|||
162767561|NCT01670526|587857772|FG001|Overall Study|Withdrawal by Subject|1|||
162767562|NCT01670526|587857771|FG000|Overall Study|Lost to Follow-up|9|||
162767563|NCT01670526|587857772|FG001|Overall Study|Lost to Follow-up|5|||
162767564|NCT00392197|587857773|FG000|Overall Study|Adverse Event|4|||
162767565|NCT00392197|587857774|FG001|Overall Study|Adverse Event|12|||
162767566|NCT00392197|587857773|FG000|Overall Study|Lack of Efficacy|3|||
162767567|NCT00392197|587857774|FG001|Overall Study|Lack of Efficacy|4|||
162767568|NCT00392197|587857773|FG000|Overall Study|Lost to Follow-up|0|||
162767569|NCT00392197|587857774|FG001|Overall Study|Lost to Follow-up|1|||
162767570|NCT00392197|587857773|FG000|Overall Study|Physician Decision|3|||
162767571|NCT00392197|587857774|FG001|Overall Study|Physician Decision|2|||
162767572|NCT00392197|587857773|FG000|Overall Study|Protocol Violation|7|||
162767573|NCT00392197|587857774|FG001|Overall Study|Protocol Violation|5|||
162767574|NCT00392197|587857773|FG000|Overall Study|Withdrawal by Subject|4|||
162767575|NCT00392197|587857774|FG001|Overall Study|Withdrawal by Subject|6|||
162767576|NCT02312258|587857775|FG000|Overall Study|Lost to Follow-up|8|||
162767577|NCT02312258|587857776|FG001|Overall Study|Lost to Follow-up|8|||
162767578|NCT02312258|587857775|FG000|Overall Study|Withdrawal by Patient|49|||
162767579|NCT02312258|587857776|FG001|Overall Study|Withdrawal by Patient|76|||
162767580|NCT02312258|587857775|FG000|Overall Study|Reason not Specified|107|||
162767581|NCT02312258|587857776|FG001|Overall Study|Reason not Specified|159|||
162767582|NCT02312258|587857775|FG000|Overall Study|Missing|2|||
162767583|NCT02312258|587857776|FG001|Overall Study|Missing|1|||
162767584|NCT02312258|587857775|FG000|Overall Study|Death|115|||
162767585|NCT02312258|587857776|FG001|Overall Study|Death|181|||
162767586|NCT01528605|587857778|FG000|Overall Study|Lost to Follow-up|1|||
162767587|NCT01528605|587857779|FG001|Overall Study|Lost to Follow-up|0|||
162767588|NCT01528605|587857780|FG002|Overall Study|Lost to Follow-up|1|||
162767589|NCT01528605|587857781|FG003|Overall Study|Lost to Follow-up|1|||
162767590|NCT01528605|587857782|FG004|Overall Study|Lost to Follow-up|0|||
162767591|NCT01528605|587857783|FG005|Overall Study|Lost to Follow-up|0|||
162767592|NCT01528605|587857778|FG000|Overall Study|Death|1|||
162767593|NCT01528605|587857779|FG001|Overall Study|Death|0|||
162767594|NCT01528605|587857780|FG002|Overall Study|Death|0|||
162767595|NCT01528605|587857781|FG003|Overall Study|Death|0|||
162767596|NCT01528605|587857782|FG004|Overall Study|Death|0|||
162767597|NCT01528605|587857783|FG005|Overall Study|Death|0|||
162767598|NCT01970527|587857784|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
162767599|NCT01970527|587857785|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
162767600|NCT01970527|587857784|FG000|Treatment|Disease progression|0|||
162767601|NCT01970527|587857785|FG001|Treatment|Disease progression|1|||
162767602|NCT01970527|587857784|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
162767603|NCT01970527|587857785|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
162767604|NCT01970527|587857784|FG000|Treatment|Death|0|||
162767605|NCT01970527|587857785|FG001|Treatment|Death|1|||
162767606|NCT01970527|587857784|FG000|Follow-up Clinic Visit|Disease progression|1|||
162767607|NCT01970527|587857785|FG001|Follow-up Clinic Visit|Disease progression|1|||
162767608|NCT01970527|587857784|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
162767609|NCT01970527|587857785|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
162767610|NCT01970527|587857784|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
162767611|NCT01970527|587857785|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
162767612|NCT00882050|587857791|FG000|Overall Study|Physician Decision|1|||
162767613|NCT00882050|587857792|FG001|Overall Study|Physician Decision|0|||
162767614|NCT00882050|587857793|FG002|Overall Study|Physician Decision|0|||
162767615|NCT04820491|587857798|FG000|Overall Study|Withdrawal by Subject|1|||
162767616|NCT04820491|587857799|FG001|Overall Study|Withdrawal by Subject|0|||
162767617|NCT00452452|587857800|FG000|Overall Study|Protocol Violation|0|||
162767618|NCT00452452|587857801|FG001|Overall Study|Protocol Violation|0|||
162767619|NCT00452452|587857802|FG002|Overall Study|Protocol Violation|1|||
162767620|NCT00452452|587857800|FG000|Overall Study|Withdrawal by Subject|1|||
162767621|NCT00452452|587857801|FG001|Overall Study|Withdrawal by Subject|0|||
162767622|NCT00452452|587857802|FG002|Overall Study|Withdrawal by Subject|0|||
162767623|NCT00452452|587857800|FG000|Overall Study|Lost to Follow-up|1|||
162767624|NCT00452452|587857801|FG001|Overall Study|Lost to Follow-up|0|||
162767625|NCT00452452|587857802|FG002|Overall Study|Lost to Follow-up|0|||
162767626|NCT01131325|587859690|FG000|Overall Study|Adverse Event|1|||
162767627|NCT01131325|587859690|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
162767628|NCT03761849|587859691|FG000|Overall Study|transferred to OpenLabelExtension|35|||
162767629|NCT03761849|587859692|FG001|Overall Study|transferred to OpenLabelExtension|34|||
162767630|NCT03761849|587859693|FG002|Overall Study|transferred to OpenLabelExtension|36|||
162767631|NCT03761849|587859694|FG003|Overall Study|transferred to OpenLabelExtension|0|||
162767632|NCT03761849|587859695|FG004|Overall Study|transferred to OpenLabelExtension|0|||
162767633|NCT03761849|587859696|FG005|Overall Study|transferred to OpenLabelExtension|0|||
162767634|NCT03761849|587859691|FG000|Overall Study|Adverse Event|1|||
162767635|NCT03761849|587859692|FG001|Overall Study|Adverse Event|0|||
162767636|NCT03761849|587859693|FG002|Overall Study|Adverse Event|0|||
162767637|NCT03761849|587859694|FG003|Overall Study|Adverse Event|0|||
162767638|NCT03761849|587859695|FG004|Overall Study|Adverse Event|2|||
162767639|NCT03761849|587859696|FG005|Overall Study|Adverse Event|3|||
162767640|NCT03761849|587859691|FG000|Overall Study|Withdrawal by Subject|0|||
162767641|NCT03761849|587859692|FG001|Overall Study|Withdrawal by Subject|0|||
162767642|NCT03761849|587859693|FG002|Overall Study|Withdrawal by Subject|0|||
162767643|NCT03761849|587859694|FG003|Overall Study|Withdrawal by Subject|41|||
162767644|NCT03761849|587859695|FG004|Overall Study|Withdrawal by Subject|43|||
162767645|NCT03761849|587859696|FG005|Overall Study|Withdrawal by Subject|35|||
162767646|NCT03761849|587859691|FG000|Overall Study|Lost to Follow-up|0|||
162767647|NCT03761849|587859692|FG001|Overall Study|Lost to Follow-up|1|||
162767648|NCT03761849|587859693|FG002|Overall Study|Lost to Follow-up|0|||
162767649|NCT03761849|587859694|FG003|Overall Study|Lost to Follow-up|2|||
162767650|NCT03761849|587859695|FG004|Overall Study|Lost to Follow-up|4|||
162767651|NCT03761849|587859696|FG005|Overall Study|Lost to Follow-up|5|||
162767652|NCT03761849|587859691|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
162767653|NCT03761849|587859692|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
162767654|NCT03761849|587859693|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
162767655|NCT03761849|587859694|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
162767656|NCT03761849|587859695|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
162767657|NCT03761849|587859696|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
162767658|NCT03761849|587859691|FG000|Overall Study|Physician Decision|0|||
162767659|NCT03761849|587859692|FG001|Overall Study|Physician Decision|0|||
162767660|NCT03761849|587859693|FG002|Overall Study|Physician Decision|0|||
162767661|NCT03761849|587859694|FG003|Overall Study|Physician Decision|1|||
162767662|NCT03761849|587859695|FG004|Overall Study|Physician Decision|4|||
162767663|NCT03761849|587859696|FG005|Overall Study|Physician Decision|4|||
162767664|NCT03761849|587859691|FG000|Overall Study|Death|0|||
162767665|NCT03761849|587859692|FG001|Overall Study|Death|0|||
162767666|NCT03761849|587859693|FG002|Overall Study|Death|0|||
162767667|NCT03761849|587859694|FG003|Overall Study|Death|1|||
162767668|NCT03761849|587859695|FG004|Overall Study|Death|1|||
162767669|NCT03761849|587859696|FG005|Overall Study|Death|3|||
162767670|NCT03761849|587859691|FG000|Overall Study|Protocol Violation|0|||
162767671|NCT03761849|587859692|FG001|Overall Study|Protocol Violation|0|||
162767672|NCT03761849|587859693|FG002|Overall Study|Protocol Violation|0|||
162767673|NCT03761849|587859694|FG003|Overall Study|Protocol Violation|2|||
162767674|NCT03761849|587859695|FG004|Overall Study|Protocol Violation|2|||
162767675|NCT03761849|587859696|FG005|Overall Study|Protocol Violation|1|||
162767676|NCT03761849|587859691|FG000|Overall Study|Participant could not come to site|0|||
162767677|NCT03761849|587859692|FG001|Overall Study|Participant could not come to site|0|||
162767678|NCT03761849|587859693|FG002|Overall Study|Participant could not come to site|0|||
162767679|NCT03761849|587859694|FG003|Overall Study|Participant could not come to site|0|||
162767680|NCT03761849|587859695|FG004|Overall Study|Participant could not come to site|1|||
162767681|NCT03761849|587859696|FG005|Overall Study|Participant could not come to site|0|||
162767682|NCT03761849|587859691|FG000|Overall Study|SF- safety Finding|0|||
162767683|NCT03761849|587859692|FG001|Overall Study|SF- safety Finding|0|||
162767684|NCT03761849|587859693|FG002|Overall Study|SF- safety Finding|0|||
162767685|NCT03761849|587859694|FG003|Overall Study|SF- safety Finding|0|||
162767686|NCT03761849|587859695|FG004|Overall Study|SF- safety Finding|0|||
162767687|NCT03761849|587859696|FG005|Overall Study|SF- safety Finding|1|||
162767688|NCT03761849|587859691|FG000|Overall Study|Patient did not attend visit|0|||
162767689|NCT03761849|587859692|FG001|Overall Study|Patient did not attend visit|0|||
162767690|NCT03761849|587859693|FG002|Overall Study|Patient did not attend visit|0|||
162767691|NCT03761849|587859694|FG003|Overall Study|Patient did not attend visit|0|||
162767692|NCT03761849|587859695|FG004|Overall Study|Patient did not attend visit|0|||
162767693|NCT03761849|587859696|FG005|Overall Study|Patient did not attend visit|1|||
162767694|NCT02213094|587859699|FG000|Overall Study|Adverse Event|1|||
162767695|NCT02213094|587859700|FG001|Overall Study|Adverse Event|0|||
162767696|NCT02163499|587859701|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
162767697|NCT02163499|587859701|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
162767698|NCT02163499|587859701|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
162767699|NCT02163499|587859701|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
162767700|NCT02163499|587859701|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
162767701|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
162767702|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
162767703|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
162767704|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
162767705|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
162767706|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
162767707|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
162767708|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
162767709|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
162767710|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Death|8|||
162767711|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
162767712|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
162767713|NCT02163499|587859701|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
162767714|NCT00555620|587859705|FG000|Overall Study|Death|0|||
162767715|NCT00555620|587859706|FG001|Overall Study|Death|1|||
162767716|NCT00555620|587859707|FG002|Overall Study|Death|0|||
162767717|NCT00555620|587859708|FG003|Overall Study|Death|0|||
162767718|NCT00555620|587859709|FG004|Overall Study|Death|0|||
162767719|NCT00555620|587859710|FG005|Overall Study|Death|1|||
162767720|NCT00555620|587859705|FG000|Overall Study|Study terminated by sponsor|0|||
162767721|NCT00555620|587859706|FG001|Overall Study|Study terminated by sponsor|0|||
162767722|NCT00555620|587859707|FG002|Overall Study|Study terminated by sponsor|1|||
162767723|NCT00555620|587859708|FG003|Overall Study|Study terminated by sponsor|0|||
162767724|NCT00555620|587859709|FG004|Overall Study|Study terminated by sponsor|0|||
162767725|NCT00555620|587859710|FG005|Overall Study|Study terminated by sponsor|0|||
162767726|NCT00555620|587859705|FG000|Overall Study|Adverse Event|0|||
162767727|NCT00555620|587859706|FG001|Overall Study|Adverse Event|0|||
162767728|NCT00555620|587859707|FG002|Overall Study|Adverse Event|1|||
162767729|NCT00555620|587859708|FG003|Overall Study|Adverse Event|5|||
162767730|NCT00555620|587859709|FG004|Overall Study|Adverse Event|0|||
162767731|NCT00555620|587859710|FG005|Overall Study|Adverse Event|1|||
162767732|NCT00555620|587859705|FG000|Overall Study|Objective progression or relapse|6|||
162767733|NCT00555620|587859706|FG001|Overall Study|Objective progression or relapse|5|||
162767734|NCT00555620|587859707|FG002|Overall Study|Objective progression or relapse|12|||
162767735|NCT00555620|587859708|FG003|Overall Study|Objective progression or relapse|17|||
162767736|NCT00555620|587859709|FG004|Overall Study|Objective progression or relapse|3|||
162767737|NCT00555620|587859710|FG005|Overall Study|Objective progression or relapse|16|||
162767738|NCT00555620|587859705|FG000|Overall Study|Participant refused treatment|0|||
162767739|NCT00555620|587859706|FG001|Overall Study|Participant refused treatment|1|||
162767740|NCT00555620|587859707|FG002|Overall Study|Participant refused treatment|1|||
162767741|NCT00555620|587859708|FG003|Overall Study|Participant refused treatment|0|||
162767742|NCT00555620|587859709|FG004|Overall Study|Participant refused treatment|0|||
162767743|NCT00555620|587859710|FG005|Overall Study|Participant refused treatment|1|||
162767744|NCT00555620|587859705|FG000|Overall Study|Other|0|||
162767745|NCT00555620|587859706|FG001|Overall Study|Other|0|||
162767746|NCT00555620|587859707|FG002|Overall Study|Other|0|||
162767747|NCT00555620|587859708|FG003|Overall Study|Other|1|||
162767748|NCT00555620|587859709|FG004|Overall Study|Other|0|||
162767749|NCT00555620|587859710|FG005|Overall Study|Other|3|||
162767750|NCT00476151|587859711|FG000|Overall Study|Adverse Event|0|||
162767751|NCT00476151|587859712|FG001|Overall Study|Adverse Event|2|||
162767752|NCT00476151|587859711|FG000|Overall Study|Protocol Violation|1|||
162767753|NCT00476151|587859712|FG001|Overall Study|Protocol Violation|3|||
162767754|NCT00476151|587859711|FG000|Overall Study|Withdrawal by Subject|2|||
162767755|NCT00476151|587859712|FG001|Overall Study|Withdrawal by Subject|0|||
162767756|NCT00476151|587859711|FG000|Overall Study|Physician Decision|0|||
162767757|NCT00476151|587859712|FG001|Overall Study|Physician Decision|2|||
162767758|NCT02068352|587859714|FG000|Overall Study|Lost to Follow-up|0|||
162767759|NCT02068352|587859715|FG001|Overall Study|Lost to Follow-up|2|||
162767760|NCT02068352|587859716|FG002|Overall Study|Lost to Follow-up|0|||
162767761|NCT02068352|587859714|FG000|Overall Study|Adverse Event|4|||
162767762|NCT02068352|587859715|FG001|Overall Study|Adverse Event|2|||
162767763|NCT02068352|587859716|FG002|Overall Study|Adverse Event|7|||
162767764|NCT02068352|587859714|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
162767765|NCT02068352|587859715|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
162767766|NCT02068352|587859716|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
162767767|NCT02068352|587859714|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
162767768|NCT02068352|587859715|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
162767769|NCT02068352|587859716|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
162767770|NCT02068352|587859714|FG000|Overall Study|Protocol Deviation|0|||
162767771|NCT02068352|587859715|FG001|Overall Study|Protocol Deviation|0|||
162767772|NCT02068352|587859716|FG002|Overall Study|Protocol Deviation|1|||
162767773|NCT01767376|587859720|FG000|Overall Study|Lost to Follow-up|3|||
162767774|NCT01767376|587859721|FG001|Overall Study|Lost to Follow-up|2|||
162767775|NCT01767376|587859722|FG002|Overall Study|Lost to Follow-up|0|||
162767776|NCT01767376|587859720|FG000|Overall Study|Withdrawal by Subject|1|||
162767777|NCT01767376|587859721|FG001|Overall Study|Withdrawal by Subject|1|||
162767778|NCT01767376|587859722|FG002|Overall Study|Withdrawal by Subject|0|||
162767779|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
162767780|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
162767781|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
162767782|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
162767783|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
162767784|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
162767785|NCT03557307|587859725|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
162767786|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
162767787|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Death|3|||
162767788|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
162767789|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
162767790|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
162767791|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
162767792|NCT03557307|587859725|FG000|Period 2: Maintenance Phase|other|3|||
162767793|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
162767794|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
162767795|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162767796|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162767797|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162767798|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162767799|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162767800|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
162767801|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
162767802|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
162767803|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162767804|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162767805|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162767806|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162767807|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
162767808|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162767809|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
162767810|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162767811|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162767812|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162767813|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162767814|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767815|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
162767816|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767817|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767818|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767819|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767820|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162767821|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
162767822|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
162767823|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
162767824|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162767825|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162767826|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162767827|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162767828|NCT03745651|587859726|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
162767829|NCT03745651|587859727|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
162767830|NCT03745651|587859728|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
162767831|NCT03745651|587859729|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162767832|NCT03745651|587859730|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162767833|NCT03745651|587859731|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162767834|NCT03745651|587859732|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162767835|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767836|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767837|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767838|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767839|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767840|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
162767841|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162767842|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162767843|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162767844|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162767845|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
162767846|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162767847|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
162767848|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
162767849|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162767850|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162767851|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162767852|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
162767853|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
162767854|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
162767855|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
162767856|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162767857|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162767858|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162767859|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
162767860|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162767861|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
162767862|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
162767863|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162767864|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162767865|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162767866|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
162767867|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162767868|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162767869|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
162767870|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767871|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767872|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767873|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767874|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767875|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
162767876|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162767877|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162767878|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162767879|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162767880|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
162767881|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
162767882|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
162767883|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
162767884|NCT03745651|587859726|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162767885|NCT03745651|587859727|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162767886|NCT03745651|587859728|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162767887|NCT03745651|587859729|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162767888|NCT03745651|587859730|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162767889|NCT03745651|587859731|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162767890|NCT03745651|587859732|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162767891|NCT04175834|587859733|FG000|Overall Study|Withdrawal by Subject|1|||
162767892|NCT04175834|587859734|FG001|Overall Study|Withdrawal by Subject|0|||
162767893|NCT00946088|587859735|FG000|Overall Study|Withdrawal by Subject|0|||
162767894|NCT00946088|587859736|FG001|Overall Study|Withdrawal by Subject|1|||
162767895|NCT01322347|587859740|FG000|Overall Study|Adverse Event|7|||
162767896|NCT01322347|587859741|FG001|Overall Study|Adverse Event|2|||
162767897|NCT01322347|587859740|FG000|Overall Study|Death|5|||
162767898|NCT01322347|587859741|FG001|Overall Study|Death|3|||
162767899|NCT01322347|587859740|FG000|Overall Study|Physician Decision|2|||
162767900|NCT01322347|587859741|FG001|Overall Study|Physician Decision|1|||
162767901|NCT01322347|587859740|FG000|Overall Study|Protocol Violation|5|||
162767902|NCT01322347|587859741|FG001|Overall Study|Protocol Violation|2|||
162767903|NCT01322347|587859740|FG000|Overall Study|Withdrawal by Subject|1|||
162767904|NCT01322347|587859741|FG001|Overall Study|Withdrawal by Subject|4|||
162767905|NCT01322347|587859740|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
162767906|NCT01322347|587859741|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
162767907|NCT01322347|587859740|FG000|Overall Study|blood transfusion|5|||
162767908|NCT01322347|587859741|FG001|Overall Study|blood transfusion|5|||
162767909|NCT01322347|587859740|FG000|Overall Study|sponsor decision|1|||
162767910|NCT01322347|587859741|FG001|Overall Study|sponsor decision|3|||
162767911|NCT01322347|587859740|FG000|Overall Study|ineligible|6|||
162767912|NCT01322347|587859741|FG001|Overall Study|ineligible|3|||
162767913|NCT01322347|587859740|FG000|Overall Study|kidney transplant|3|||
162767914|NCT01322347|587859741|FG001|Overall Study|kidney transplant|1|||
162767915|NCT01322347|587859740|FG000|Overall Study|study drug withheld > 12 wks|0|||
162767916|NCT01322347|587859741|FG001|Overall Study|study drug withheld > 12 wks|1|||
162767917|NCT01322347|587859740|FG000|Overall Study|moved/changed dialysis|2|||
162767918|NCT01322347|587859741|FG001|Overall Study|moved/changed dialysis|4|||
162767919|NCT01193283|587859742|FG000|Overall Study|Death|1|||
162767920|NCT04883541|587859743|FG000|Overall Study|Not attending regular yoga class|16|||
162767921|NCT04883541|587859744|FG001|Overall Study|Not attending regular yoga class|0|||
162767922|NCT04883541|587859743|FG000|Overall Study|Not attending the pregnancy school|0|||
162767923|NCT04883541|587859744|FG001|Overall Study|Not attending the pregnancy school|9|||
162767924|NCT01369147|587859745|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
162767925|NCT01369147|587859746|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
162767926|NCT01369147|587859747|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
162767927|NCT04239911|587859748|FG000|Overall Study|Lost to Follow-up|2|||
162767928|NCT04239911|587859749|FG001|Overall Study|Lost to Follow-up|1|||
162767929|NCT02137785|587859750|FG000|Overall Study|Lost to Follow-up|1|||
162767930|NCT02137785|587859751|FG001|Overall Study|Lost to Follow-up|0|||
162767931|NCT02137785|587859750|FG000|Overall Study|Withdrawal by Subject|1|||
162767932|NCT02137785|587859751|FG001|Overall Study|Withdrawal by Subject|4|||
162767933|NCT02137785|587859750|FG000|Overall Study|subject moved out of state|1|||
162767934|NCT02137785|587859751|FG001|Overall Study|subject moved out of state|0|||
162767935|NCT03345407|587859753|FG000|Overall Study|Withdrawal by Subject|11|||
162767936|NCT03345407|587859754|FG001|Overall Study|Withdrawal by Subject|1|||
162767937|NCT03345407|587859755|FG002|Overall Study|Withdrawal by Subject|5|||
162767938|NCT03345407|587859756|FG003|Overall Study|Withdrawal by Subject|6|||
162767939|NCT03345407|587859757|FG004|Overall Study|Withdrawal by Subject|3|||
162767940|NCT03345407|587859758|FG005|Overall Study|Withdrawal by Subject|6|||
162767941|NCT03345407|587859759|FG006|Overall Study|Withdrawal by Subject|16|||
162767942|NCT03345407|587859753|FG000|Overall Study|Physician Decision|3|||
162767943|NCT03345407|587859754|FG001|Overall Study|Physician Decision|1|||
162767944|NCT03345407|587859755|FG002|Overall Study|Physician Decision|0|||
162767945|NCT03345407|587859756|FG003|Overall Study|Physician Decision|0|||
162767946|NCT03345407|587859757|FG004|Overall Study|Physician Decision|1|||
162767947|NCT03345407|587859758|FG005|Overall Study|Physician Decision|2|||
162767948|NCT03345407|587859759|FG006|Overall Study|Physician Decision|3|||
162767949|NCT03345407|587859753|FG000|Overall Study|Lost to Follow-up|2|||
162767950|NCT03345407|587859754|FG001|Overall Study|Lost to Follow-up|0|||
162767951|NCT03345407|587859755|FG002|Overall Study|Lost to Follow-up|1|||
162767952|NCT03345407|587859756|FG003|Overall Study|Lost to Follow-up|0|||
162767953|NCT03345407|587859757|FG004|Overall Study|Lost to Follow-up|1|||
162767954|NCT03345407|587859758|FG005|Overall Study|Lost to Follow-up|2|||
162767955|NCT03345407|587859759|FG006|Overall Study|Lost to Follow-up|3|||
162767956|NCT03345407|587859753|FG000|Overall Study|Protocol-defined stopping criteria|9|||
162767957|NCT03345407|587859754|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162767958|NCT03345407|587859755|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162767959|NCT03345407|587859756|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162767960|NCT03345407|587859757|FG004|Overall Study|Protocol-defined stopping criteria|2|||
162767961|NCT03345407|587859758|FG005|Overall Study|Protocol-defined stopping criteria|1|||
162767962|NCT03345407|587859759|FG006|Overall Study|Protocol-defined stopping criteria|1|||
162767963|NCT03345407|587859753|FG000|Overall Study|Protocol Violation|2|||
162767964|NCT03345407|587859754|FG001|Overall Study|Protocol Violation|0|||
162767965|NCT03345407|587859755|FG002|Overall Study|Protocol Violation|0|||
162767966|NCT03345407|587859756|FG003|Overall Study|Protocol Violation|0|||
162767967|NCT03345407|587859757|FG004|Overall Study|Protocol Violation|1|||
162767968|NCT03345407|587859758|FG005|Overall Study|Protocol Violation|0|||
162767969|NCT03345407|587859759|FG006|Overall Study|Protocol Violation|3|||
162767970|NCT03345407|587859753|FG000|Overall Study|Lack of Efficacy|1|||
162767971|NCT03345407|587859754|FG001|Overall Study|Lack of Efficacy|1|||
162767972|NCT03345407|587859755|FG002|Overall Study|Lack of Efficacy|1|||
162767973|NCT03345407|587859756|FG003|Overall Study|Lack of Efficacy|1|||
162767974|NCT03345407|587859757|FG004|Overall Study|Lack of Efficacy|1|||
162767975|NCT03345407|587859758|FG005|Overall Study|Lack of Efficacy|0|||
162767976|NCT03345407|587859759|FG006|Overall Study|Lack of Efficacy|3|||
162767977|NCT03345407|587859753|FG000|Overall Study|Adverse Event|4|||
162767978|NCT03345407|587859754|FG001|Overall Study|Adverse Event|0|||
162767979|NCT03345407|587859755|FG002|Overall Study|Adverse Event|5|||
162767980|NCT03345407|587859756|FG003|Overall Study|Adverse Event|4|||
162767981|NCT03345407|587859757|FG004|Overall Study|Adverse Event|6|||
162767982|NCT03345407|587859758|FG005|Overall Study|Adverse Event|5|||
162767983|NCT03345407|587859759|FG006|Overall Study|Adverse Event|16|||
162767984|NCT01584648|587859760|FG000|Overall Study|Death|136|||
162767985|NCT01584648|587859761|FG001|Overall Study|Death|146|||
162767986|NCT01584648|587859760|FG000|Overall Study|Lost to Follow-up|9|||
162767987|NCT01584648|587859761|FG001|Overall Study|Lost to Follow-up|9|||
162767988|NCT01584648|587859760|FG000|Overall Study|Investigator discretion|3|||
162767989|NCT01584648|587859761|FG001|Overall Study|Investigator discretion|2|||
162767990|NCT01584648|587859760|FG000|Overall Study|Withdrew consent|13|||
162767991|NCT01584648|587859761|FG001|Overall Study|Withdrew consent|4|||
162767992|NCT01584648|587859760|FG000|Overall Study|Study closed/terminated|50|||
162767993|NCT01584648|587859761|FG001|Overall Study|Study closed/terminated|23|||
162767994|NCT01584648|587859760|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
162767995|NCT01584648|587859761|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
162767996|NCT03693989|587859764|FG000|Overall Study|Protocol Violation|3|||
162767997|NCT03693989|587859765|FG001|Overall Study|Protocol Violation|4|||
162767998|NCT01190436|587859766|FG000|Overall Study|Lost to Follow-up|35|||
162767999|NCT01190436|587859766|FG000|Overall Study|Other|4|||
162768000|NCT03146845|587859767|FG000|Overall Study|Reference ulcer healed|1|||
162768001|NCT03146845|587859768|FG001|Overall Study|Reference ulcer healed|0|||
162768002|NCT03146845|587859767|FG000|Overall Study|Physician Decision|1|||
162768003|NCT03146845|587859768|FG001|Overall Study|Physician Decision|0|||
162768004|NCT03146845|587859767|FG000|Overall Study|Adverse Event|1|||
162768005|NCT03146845|587859768|FG001|Overall Study|Adverse Event|0|||
162768006|NCT03146845|587859767|FG000|Overall Study|Withdrawal by Subject|2|||
162768007|NCT03146845|587859768|FG001|Overall Study|Withdrawal by Subject|0|||
162768008|NCT03146845|587859767|FG000|Overall Study|Noncompliance|0|||
162768009|NCT03146845|587859768|FG001|Overall Study|Noncompliance|1|||
162768010|NCT03146845|587859767|FG000|Overall Study|Protocol Violation|0|||
162768011|NCT03146845|587859768|FG001|Overall Study|Protocol Violation|2|||
162768012|NCT03146845|587859767|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
162768013|NCT03146845|587859768|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
162768014|NCT00113529|587859772|FG000|Overall Study|Adverse Event|4|||
162768015|NCT00113529|587859772|FG000|Overall Study|Lack of Efficacy|20|||
162768016|NCT00113529|587859772|FG000|Overall Study|Decision of sponsor|6|||
162768017|NCT00113529|587859772|FG000|Overall Study|Withdrawal by Subject|4|||
162768018|NCT04421456|587859783|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
162768019|NCT04421456|587859784|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
162768020|NCT04421456|587859785|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
162768021|NCT04421456|587859783|FG000|Randomized Treatment Period|Adverse Event|0|||
162768022|NCT04421456|587859784|FG001|Randomized Treatment Period|Adverse Event|1|||
162768023|NCT04421456|587859785|FG002|Randomized Treatment Period|Adverse Event|0|||
162768024|NCT04421456|587859783|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
162768025|NCT04421456|587859784|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
162768026|NCT04421456|587859785|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
162768027|NCT04421456|587859783|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
162768028|NCT04421456|587859784|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
162768029|NCT04421456|587859785|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
162768030|NCT04421456|587859783|FG000|Randomized Treatment Period|Participant non-compliance|1|||
162768031|NCT04421456|587859784|FG001|Randomized Treatment Period|Participant non-compliance|1|||
162768032|NCT04421456|587859785|FG002|Randomized Treatment Period|Participant non-compliance|2|||
162768033|NCT04421456|587859783|FG000|Randomized Treatment Period|Other|0|||
162768034|NCT04421456|587859784|FG001|Randomized Treatment Period|Other|1|||
162768035|NCT04421456|587859785|FG002|Randomized Treatment Period|Other|3|||
162768036|NCT00379210|587859786|FG000|Overall Study|Withdrawal by Subject|10|||
162768037|NCT00379210|587859787|FG001|Overall Study|Withdrawal by Subject|7|||
162768038|NCT00595959|587859788|FG000|Overall Study|Withdrawal by Subject|1|||
162768039|NCT00595959|587859788|FG000|Overall Study|Lost to Follow-up|1|||
162768040|NCT00886834|587859789|FG000|Overall Study|Protocol Violation|0|||
162768041|NCT00886834|587859790|FG001|Overall Study|Protocol Violation|3|||
162768042|NCT04085614|587859791|FG000|Overall Study|Protocol Violation|9|||
162768043|NCT04085614|587859792|FG001|Overall Study|Protocol Violation|6|||
162768044|NCT01405508|587859793|FG000|Overall Study|AE, non-serious non-fatal|1|||
162768045|NCT01405508|587859794|FG001|Overall Study|AE, non-serious non-fatal|1|||
162768046|NCT01405508|587859795|FG002|Overall Study|AE, non-serious non-fatal|0|||
162768047|NCT01405508|587859796|FG003|Overall Study|AE, non-serious non-fatal|0|||
162768048|NCT00409747|587859797|FG000|Overall Study|Withdrawal by Subject|1|||
162768049|NCT01794689|587859800|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
162768050|NCT01794689|587859801|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
162768051|NCT01794689|587859802|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
162768052|NCT01794689|587859803|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
162768053|NCT01794689|587859800|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
162768054|NCT01794689|587859801|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
162768055|NCT01794689|587859802|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
162768056|NCT01794689|587859803|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
162768057|NCT01794689|587859800|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
162768058|NCT01794689|587859801|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
162768059|NCT01794689|587859802|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
162768060|NCT01794689|587859803|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
162768061|NCT01794689|587859800|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
162768062|NCT01794689|587859801|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
162768063|NCT01794689|587859802|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
162768064|NCT01794689|587859803|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
162768065|NCT01697956|587859804|FG000|Overall Study|Protocol Violation|1|||
162768066|NCT01697956|587859805|FG001|Overall Study|Protocol Violation|1|||
162768067|NCT03060525|587859806|FG000|Overall Study|moved out of state|1|||
162768068|NCT03060525|587859807|FG001|Overall Study|moved out of state|1|||
162768069|NCT03060525|587859808|FG002|Overall Study|moved out of state|1|||
162768070|NCT03060525|587859809|FG003|Overall Study|moved out of state|1|||
162768071|NCT03060525|587859806|FG000|Overall Study|unable to meet time commitment required of study|2|||
162768072|NCT03060525|587859807|FG001|Overall Study|unable to meet time commitment required of study|3|||
162768073|NCT03060525|587859808|FG002|Overall Study|unable to meet time commitment required of study|3|||
162768074|NCT03060525|587859809|FG003|Overall Study|unable to meet time commitment required of study|1|||
162768075|NCT03060525|587859806|FG000|Overall Study|no longer interested in doing intervention|0|||
162768076|NCT03060525|587859807|FG001|Overall Study|no longer interested in doing intervention|0|||
162768077|NCT03060525|587859808|FG002|Overall Study|no longer interested in doing intervention|0|||
162768078|NCT03060525|587859809|FG003|Overall Study|no longer interested in doing intervention|1|||
162768079|NCT01964547|587859810|FG000|Overall Study|Adverse Event|8|||
162768080|NCT01964547|587859811|FG001|Overall Study|Adverse Event|2|||
162768081|NCT01964547|587859810|FG000|Overall Study|Withdrawal by Subject|4|||
162768082|NCT01964547|587859811|FG001|Overall Study|Withdrawal by Subject|7|||
162768083|NCT01964547|587859810|FG000|Overall Study|Lost to Follow-up|0|||
162768084|NCT01964547|587859811|FG001|Overall Study|Lost to Follow-up|1|||
162768085|NCT01964547|587859810|FG000|Overall Study|Withdrawal by Investigator|0|||
162768086|NCT01964547|587859811|FG001|Overall Study|Withdrawal by Investigator|1|||
162768087|NCT01115309|587859812|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
162768088|NCT01115309|587859812|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
162768089|NCT01115309|587859812|FG000|Long-term Follow-up|Lost to Follow-up|6|||
162768090|NCT04447287|587859813|FG000|Period 1: Run-in Period|Adverse Event|3|||
162768091|NCT04447287|587859814|FG001|Period 1: Run-in Period|Adverse Event|0|||
162768092|NCT04447287|587859815|FG002|Period 1: Run-in Period|Adverse Event|0|||
162768093|NCT04447287|587859813|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
162768094|NCT04447287|587859814|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
162768095|NCT04447287|587859815|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
162768096|NCT04447287|587859813|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
162768097|NCT04447287|587859814|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
162768098|NCT04447287|587859815|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
162768099|NCT05700851|587859816|FG000|Overall Study|Received a kidney transplant|1|||
162768100|NCT05700851|587859816|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
162768101|NCT05700851|587859816|FG000|Overall Study|Withdrawal by Subject|1|||
162768102|NCT02147093|587859817|FG000|Period 1|Lost to Follow-up|0|||
162768103|NCT02147093|587859818|FG001|Period 1|Lost to Follow-up|1|||
162768104|NCT02147093|587859817|FG000|Period 2|Protocol Violation|2|||
162768105|NCT02147093|587859818|FG001|Period 2|Protocol Violation|0|||
162768106|NCT03246724|587859819|FG000|Overall Study|Withdrawal by Subject|5|||
162768107|NCT03246724|587859820|FG001|Overall Study|Withdrawal by Subject|2|||
162768108|NCT03246724|587859821|FG002|Overall Study|Withdrawal by Subject|4|||
162768109|NCT03246724|587859822|FG003|Overall Study|Withdrawal by Subject|2|||
162768110|NCT03246724|587859819|FG000|Overall Study|Ineligible on day of surgery|7|||
162768111|NCT03246724|587859820|FG001|Overall Study|Ineligible on day of surgery|2|||
162768112|NCT03246724|587859821|FG002|Overall Study|Ineligible on day of surgery|0|||
162768113|NCT03246724|587859822|FG003|Overall Study|Ineligible on day of surgery|3|||
162768114|NCT03246724|587859819|FG000|Overall Study|Study completed before surgical date|2|||
162768115|NCT03246724|587859820|FG001|Overall Study|Study completed before surgical date|1|||
162768116|NCT03246724|587859821|FG002|Overall Study|Study completed before surgical date|8|||
162768117|NCT03246724|587859822|FG003|Overall Study|Study completed before surgical date|1|||
162768118|NCT03246724|587859819|FG000|Overall Study|Transferred to other arm|0|||
162768119|NCT03246724|587859820|FG001|Overall Study|Transferred to other arm|0|||
162768120|NCT03246724|587859821|FG002|Overall Study|Transferred to other arm|1|||
162768121|NCT03246724|587859822|FG003|Overall Study|Transferred to other arm|0|||
162768122|NCT03246724|587859819|FG000|Overall Study|Unable to obtain medication timely|0|||
162768123|NCT03246724|587859820|FG001|Overall Study|Unable to obtain medication timely|2|||
162768124|NCT03246724|587859821|FG002|Overall Study|Unable to obtain medication timely|2|||
162768125|NCT03246724|587859822|FG003|Overall Study|Unable to obtain medication timely|1|||
162768126|NCT03246724|587859819|FG000|Overall Study|Re-consented to participate|0|||
162768127|NCT03246724|587859820|FG001|Overall Study|Re-consented to participate|0|||
162768128|NCT03246724|587859821|FG002|Overall Study|Re-consented to participate|0|||
162768129|NCT03246724|587859822|FG003|Overall Study|Re-consented to participate|1|||
162768130|NCT00655824|587859823|FG000|Overall Study|Adverse Event|3|||
162768131|NCT00655824|587859823|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
162768132|NCT00655824|587859823|FG000|Overall Study|Protocol Violation|1|||
162768133|NCT00655824|587859823|FG000|Overall Study|Withdrawal by Subject|4|||
162768134|NCT00655824|587859823|FG000|Overall Study|Deterioration of Trial Disease|2|||
162768135|NCT02978716|587859824|FG000|Overall Study|Death|25|||
162768136|NCT02978716|587859825|FG001|Overall Study|Death|13|||
162768137|NCT02978716|587859826|FG002|Overall Study|Death|20|||
162768138|NCT02978716|587859824|FG000|Overall Study|Lost to Follow-up|0|||
162768139|NCT02978716|587859825|FG001|Overall Study|Lost to Follow-up|0|||
162768140|NCT02978716|587859826|FG002|Overall Study|Lost to Follow-up|1|||
162768141|NCT02978716|587859824|FG000|Overall Study|Withdrawal by Subject|6|||
162768142|NCT02978716|587859825|FG001|Overall Study|Withdrawal by Subject|4|||
162768143|NCT02978716|587859826|FG002|Overall Study|Withdrawal by Subject|5|||
162768144|NCT02978716|587859824|FG000|Overall Study|Sponsor terminated|2|||
162768145|NCT02978716|587859825|FG001|Overall Study|Sponsor terminated|13|||
162768146|NCT02978716|587859826|FG002|Overall Study|Sponsor terminated|9|||
162768147|NCT02978716|587859824|FG000|Overall Study|Other|1|||
162768148|NCT02978716|587859825|FG001|Overall Study|Other|3|||
162768149|NCT02978716|587859826|FG002|Overall Study|Other|0|||
162768150|NCT00589628|587859827|FG000|Overall Study|Lost to Follow-up|0|||
162768151|NCT00589628|587859828|FG001|Overall Study|Lost to Follow-up|1|||
162768152|NCT00946998|587861682|FG000|Overall Study|Exited prior to first outcome assessment|5|||
162768153|NCT00946998|587861683|FG001|Overall Study|Exited prior to first outcome assessment|3|||
162768154|NCT01945593|587861684|FG000|Overall Study|Adverse Event|0|||
162768155|NCT01945593|587861685|FG001|Overall Study|Adverse Event|0|||
162768156|NCT01945593|587861686|FG002|Overall Study|Adverse Event|0|||
162768157|NCT01945593|587861687|FG003|Overall Study|Adverse Event|5|||
162768158|NCT01945593|587861684|FG000|Overall Study|Physician Decision|0|||
162768159|NCT01945593|587861685|FG001|Overall Study|Physician Decision|0|||
162768160|NCT01945593|587861686|FG002|Overall Study|Physician Decision|1|||
162768161|NCT01945593|587861687|FG003|Overall Study|Physician Decision|1|||
162768162|NCT01945593|587861684|FG000|Overall Study|Withdrawal by Subject|0|||
162768163|NCT01945593|587861685|FG001|Overall Study|Withdrawal by Subject|2|||
162768164|NCT01945593|587861686|FG002|Overall Study|Withdrawal by Subject|0|||
162768165|NCT01945593|587861687|FG003|Overall Study|Withdrawal by Subject|4|||
162768166|NCT01945593|587861684|FG000|Overall Study|Protocol Violation|0|||
162768167|NCT01945593|587861685|FG001|Overall Study|Protocol Violation|2|||
162768168|NCT01945593|587861686|FG002|Overall Study|Protocol Violation|1|||
162768169|NCT01945593|587861687|FG003|Overall Study|Protocol Violation|3|||
162768170|NCT01945593|587861684|FG000|Overall Study|Death|0|||
162768171|NCT01945593|587861685|FG001|Overall Study|Death|0|||
162768172|NCT01945593|587861686|FG002|Overall Study|Death|1|||
162768173|NCT01945593|587861687|FG003|Overall Study|Death|0|||
162768174|NCT01945593|587861684|FG000|Overall Study|Other: Terminated|0|||
162768175|NCT01945593|587861685|FG001|Overall Study|Other: Terminated|0|||
162768176|NCT01945593|587861686|FG002|Overall Study|Other: Terminated|0|||
162768177|NCT01945593|587861687|FG003|Overall Study|Other: Terminated|1|||
162768178|NCT01945593|587861684|FG000|Overall Study|Other: Surgical Procedure|0|||
162768179|NCT01945593|587861685|FG001|Overall Study|Other: Surgical Procedure|2|||
162768180|NCT01945593|587861686|FG002|Overall Study|Other: Surgical Procedure|0|||
162768181|NCT01945593|587861687|FG003|Overall Study|Other: Surgical Procedure|6|||
162768182|NCT01945593|587861684|FG000|Overall Study|Other: Screen Failure|0|||
162768183|NCT01945593|587861685|FG001|Overall Study|Other: Screen Failure|2|||
162768184|NCT01945593|587861686|FG002|Overall Study|Other: Screen Failure|0|||
162768185|NCT01945593|587861687|FG003|Overall Study|Other: Screen Failure|0|||
162768186|NCT00228813|587861688|FG000|Overall Study|Death|4|||
162768187|NCT03456856|587861689|FG000|Overall Study|Lost to Follow-up|2|||
162768188|NCT03456856|587861689|FG000|Overall Study|Withdrawal by Subject|1|||
162768189|NCT02542696|587861691|FG000|Overall Study|Adverse Event|167|||
162768190|NCT02542696|587861691|FG000|Overall Study|Lack of Efficacy|26|||
162768191|NCT02542696|587861691|FG000|Overall Study|Lost to Follow-up|6|||
162768192|NCT02542696|587861691|FG000|Overall Study|Withdrawal by Subject|104|||
162768193|NCT02542696|587861691|FG000|Overall Study|Protocol Violation|5|||
162768194|NCT02542696|587861691|FG000|Overall Study|Death|8|||
162768195|NCT02542696|587861691|FG000|Overall Study|DECREASED OFF TIME|1|||
162768196|NCT02542696|587861691|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
162768197|NCT02542696|587861691|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
162768198|NCT02542696|587861691|FG000|Overall Study|MEDICAL HISTORY|1|||
162768199|NCT02542696|587861691|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
162768200|NCT02542696|587861691|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
162768201|NCT02542696|587861691|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
162768202|NCT02542696|587861691|FG000|Overall Study|SPONSOR DECISION|3|||
162768203|NCT02542696|587861691|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
162768204|NCT02542696|587861691|FG000|Overall Study|SUBJECT DECISION|2|||
162768205|NCT03262389|587861692|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
162768206|NCT03262389|587861692|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
162768207|NCT03262389|587861692|FG000|Overall Study|opted out of PET/MR|1|||
162768208|NCT02256553|587861694|FG000|Period I|Adverse Event|5|||
162768209|NCT02256553|587861694|FG000|Period I|Protocol Violation|1|||
162768210|NCT02256553|587861694|FG000|Period II|Adverse Event|1|||
162768211|NCT02256553|587861694|FG000|Period II|Subject Moved|1|||
162768212|NCT02256553|587861694|FG000|Period III|Adverse Event|3|||
162768213|NCT03651271|587861695|FG000|Overall Study|Death|4|||
162768214|NCT03651271|587861696|FG001|Overall Study|Death|37|||
162768215|NCT03651271|587861697|FG002|Overall Study|Death|0|||
162768216|NCT03651271|587861698|FG003|Overall Study|Death|2|||
162768217|NCT03651271|587861699|FG004|Overall Study|Death|6|||
162768218|NCT03651271|587861695|FG000|Overall Study|Lost to Follow-up|1|||
162768219|NCT03651271|587861696|FG001|Overall Study|Lost to Follow-up|5|||
162768220|NCT03651271|587861697|FG002|Overall Study|Lost to Follow-up|0|||
162768221|NCT03651271|587861698|FG003|Overall Study|Lost to Follow-up|1|||
162768222|NCT03651271|587861699|FG004|Overall Study|Lost to Follow-up|0|||
162768223|NCT03651271|587861695|FG000|Overall Study|Physician Decision|0|||
162768224|NCT03651271|587861696|FG001|Overall Study|Physician Decision|2|||
162768225|NCT03651271|587861697|FG002|Overall Study|Physician Decision|0|||
162768226|NCT03651271|587861698|FG003|Overall Study|Physician Decision|0|||
162768227|NCT03651271|587861699|FG004|Overall Study|Physician Decision|0|||
162768228|NCT03651271|587861695|FG000|Overall Study|Withdrawal by Subject|1|||
162768229|NCT03651271|587861696|FG001|Overall Study|Withdrawal by Subject|15|||
162768230|NCT03651271|587861697|FG002|Overall Study|Withdrawal by Subject|0|||
162768231|NCT03651271|587861698|FG003|Overall Study|Withdrawal by Subject|0|||
162768232|NCT03651271|587861699|FG004|Overall Study|Withdrawal by Subject|1|||
162768233|NCT03651271|587861695|FG000|Overall Study|Patient medically unable to continue|0|||
162768234|NCT03651271|587861696|FG001|Overall Study|Patient medically unable to continue|0|||
162768235|NCT03651271|587861697|FG002|Overall Study|Patient medically unable to continue|0|||
162768236|NCT03651271|587861698|FG003|Overall Study|Patient medically unable to continue|1|||
162768237|NCT03651271|587861699|FG004|Overall Study|Patient medically unable to continue|0|||
162768238|NCT00821093|587861700|FG000|Overall Study|Adverse Event|20|||
162768239|NCT00821093|587861701|FG001|Overall Study|Adverse Event|12|||
162768240|NCT00821093|587861700|FG000|Overall Study|Withdrawal by Subject|9|||
162768241|NCT00821093|587861701|FG001|Overall Study|Withdrawal by Subject|13|||
162768242|NCT00821093|587861700|FG000|Overall Study|Lost to Follow-up|9|||
162768243|NCT00821093|587861701|FG001|Overall Study|Lost to Follow-up|3|||
162768244|NCT00821093|587861700|FG000|Overall Study|Protocol deviation|3|||
162768245|NCT00821093|587861701|FG001|Overall Study|Protocol deviation|6|||
162768246|NCT00821093|587861700|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162768247|NCT00821093|587861701|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162768248|NCT00821093|587861700|FG000|Overall Study|Lack of Efficacy|2|||
162768249|NCT00821093|587861701|FG001|Overall Study|Lack of Efficacy|2|||
162768250|NCT00821093|587861700|FG000|Overall Study|Death|2|||
162768251|NCT00821093|587861701|FG001|Overall Study|Death|1|||
162768252|NCT00821093|587861700|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162768253|NCT00821093|587861701|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162768254|NCT00821093|587861700|FG000|Overall Study|Administrative problems|1|||
162768255|NCT00821093|587861701|FG001|Overall Study|Administrative problems|2|||
162768256|NCT05104242|587861702|FG000|Overall Study|Withdrawal by Subject|1|||
162768257|NCT05104242|587861703|FG001|Overall Study|Withdrawal by Subject|5|||
162768258|NCT05104242|587861702|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
162768259|NCT05104242|587861703|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
162768260|NCT02469155|587861708|FG000|Overall Study|Adverse Event|6|||
162768261|NCT02469155|587861709|FG001|Overall Study|Adverse Event|0|||
162768262|NCT02469155|587861710|FG002|Overall Study|Adverse Event|1|||
162768263|NCT02469155|587861711|FG003|Overall Study|Adverse Event|10|||
162768264|NCT02469155|587861708|FG000|Overall Study|Lack of Efficacy|13|||
162768265|NCT02469155|587861709|FG001|Overall Study|Lack of Efficacy|10|||
162768266|NCT02469155|587861710|FG002|Overall Study|Lack of Efficacy|10|||
162768267|NCT02469155|587861711|FG003|Overall Study|Lack of Efficacy|8|||
162768268|NCT02469155|587861708|FG000|Overall Study|Death|0|||
162768269|NCT02469155|587861709|FG001|Overall Study|Death|0|||
162768270|NCT02469155|587861710|FG002|Overall Study|Death|0|||
162768271|NCT02469155|587861711|FG003|Overall Study|Death|1|||
162768272|NCT02469155|587861708|FG000|Overall Study|Lost to Follow-up|5|||
162768273|NCT02469155|587861709|FG001|Overall Study|Lost to Follow-up|2|||
162768274|NCT02469155|587861710|FG002|Overall Study|Lost to Follow-up|7|||
162768275|NCT02469155|587861711|FG003|Overall Study|Lost to Follow-up|2|||
162768276|NCT02469155|587861708|FG000|Overall Study|Physician Decision|0|||
162768277|NCT02469155|587861709|FG001|Overall Study|Physician Decision|0|||
162768278|NCT02469155|587861710|FG002|Overall Study|Physician Decision|1|||
162768279|NCT02469155|587861711|FG003|Overall Study|Physician Decision|0|||
162768280|NCT02469155|587861708|FG000|Overall Study|Withdrawal by Subject|34|||
162768281|NCT02469155|587861709|FG001|Overall Study|Withdrawal by Subject|30|||
162768282|NCT02469155|587861710|FG002|Overall Study|Withdrawal by Subject|20|||
162768283|NCT02469155|587861711|FG003|Overall Study|Withdrawal by Subject|37|||
162768284|NCT02469155|587861708|FG000|Overall Study|Other|3|||
162768285|NCT02469155|587861709|FG001|Overall Study|Other|3|||
162768286|NCT02469155|587861710|FG002|Overall Study|Other|2|||
162768287|NCT02469155|587861711|FG003|Overall Study|Other|10|||
162768288|NCT02469155|587861708|FG000|Overall Study|Protocol Violation|0|||
162768289|NCT02469155|587861709|FG001|Overall Study|Protocol Violation|1|||
162768290|NCT02469155|587861710|FG002|Overall Study|Protocol Violation|0|||
162768291|NCT02469155|587861711|FG003|Overall Study|Protocol Violation|1|||
162768292|NCT02991118|587861712|FG000|Overall Study|Death|3|||
162768293|NCT02991118|587861713|FG001|Overall Study|Death|8|||
162768294|NCT02991118|587861712|FG000|Overall Study|Protocol Violation|0|||
162768295|NCT02991118|587861713|FG001|Overall Study|Protocol Violation|3|||
162768296|NCT02991118|587861712|FG000|Overall Study|Physician Decision|0|||
162768297|NCT02991118|587861713|FG001|Overall Study|Physician Decision|1|||
162768298|NCT02991118|587861712|FG000|Overall Study|Moved out of the country|0|||
162768299|NCT02991118|587861713|FG001|Overall Study|Moved out of the country|1|||
162768300|NCT02991118|587861712|FG000|Overall Study|Adverse Event|2|||
162768301|NCT02991118|587861713|FG001|Overall Study|Adverse Event|2|||
162768302|NCT02991118|587861712|FG000|Overall Study|Withdrawal by Subject|1|||
162768303|NCT02991118|587861713|FG001|Overall Study|Withdrawal by Subject|7|||
162768304|NCT02991118|587861712|FG000|Overall Study|Could not attend study visits|0|||
162768305|NCT02991118|587861713|FG001|Overall Study|Could not attend study visits|1|||
162768306|NCT02991118|587861712|FG000|Overall Study|Lost to Follow-up|1|||
162768307|NCT02991118|587861713|FG001|Overall Study|Lost to Follow-up|9|||
162768308|NCT02764320|587861721|FG000|Overall Study|Withdrawal by Subject|35|||
162768309|NCT02764320|587861722|FG001|Overall Study|Withdrawal by Subject|38|||
162768310|NCT02764320|587861721|FG000|Overall Study|Protocol Violation|11|||
162768311|NCT02764320|587861722|FG001|Overall Study|Protocol Violation|6|||
162768312|NCT02764320|587861721|FG000|Overall Study|Adverse Event|2|||
162768313|NCT02764320|587861722|FG001|Overall Study|Adverse Event|0|||
162768314|NCT02764320|587861721|FG000|Overall Study|Health Issues unable to continue|2|||
162768315|NCT02764320|587861722|FG001|Overall Study|Health Issues unable to continue|0|||
162768316|NCT02764320|587861721|FG000|Overall Study|Did not meet inclusion criteria|1|||
162768317|NCT02764320|587861722|FG001|Overall Study|Did not meet inclusion criteria|0|||
162768318|NCT02764320|587861721|FG000|Overall Study|Subject moved|0|||
162768319|NCT02764320|587861722|FG001|Overall Study|Subject moved|2|||
162768320|NCT02764320|587861721|FG000|Overall Study|Overused medication unavailable|0|||
162768321|NCT02764320|587861722|FG001|Overall Study|Overused medication unavailable|1|||
162768322|NCT02764320|587861721|FG000|Overall Study|Seeking care outside site|0|||
162768323|NCT02764320|587861722|FG001|Overall Study|Seeking care outside site|1|||
162768324|NCT02764320|587861721|FG000|Overall Study|Technology barriers|0|||
162768325|NCT02764320|587861722|FG001|Overall Study|Technology barriers|1|||
162768326|NCT04765046|587861723|FG000|Overall Study|Screen Failure|2|||
162768327|NCT04765046|587861723|FG000|Overall Study|Withdrawal by Subject|4|||
162768328|NCT04765046|587861723|FG000|Overall Study|Physician Decision|4|||
162768329|NCT04765046|587861723|FG000|Overall Study|Surgery Cancelled|8|||
162768330|NCT03150589|587861725|FG000|Overall Study|Withdrawal by Subject|16|||
162768331|NCT03150589|587861726|FG001|Overall Study|Withdrawal by Subject|9|||
162768332|NCT03150589|587861725|FG000|Overall Study|Adverse Event|7|||
162768333|NCT03150589|587861726|FG001|Overall Study|Adverse Event|6|||
162768334|NCT03150589|587861725|FG000|Overall Study|Protocol Violation|4|||
162768335|NCT03150589|587861726|FG001|Overall Study|Protocol Violation|3|||
162768336|NCT03150589|587861725|FG000|Overall Study|Lost to Follow-up|3|||
162768337|NCT03150589|587861726|FG001|Overall Study|Lost to Follow-up|3|||
162768338|NCT03150589|587861725|FG000|Overall Study|Death|2|||
162768339|NCT03150589|587861726|FG001|Overall Study|Death|3|||
162768340|NCT03150589|587861725|FG000|Overall Study|IP non-compliance and other reasons|12|||
162768341|NCT03150589|587861726|FG001|Overall Study|IP non-compliance and other reasons|3|||
162768342|NCT03529942|587861727|FG000|Overall Study|Withdrawal by Subject|13|||
162768343|NCT03529942|587861727|FG000|Overall Study|Physician Decision|1|||
162768344|NCT03529942|587861727|FG000|Overall Study|Lost to Follow-up|7|||
162768345|NCT03529942|587861727|FG000|Overall Study|Needle inserted but no drug administered|1|||
162768346|NCT03529942|587861727|FG000|Overall Study|Personal reasons|1|||
162768347|NCT01989156|587861740|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
162768348|NCT01989156|587861741|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
162768349|NCT01989156|587861742|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
162768350|NCT01989156|587861740|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
162768351|NCT01989156|587861741|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
162768352|NCT01989156|587861742|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
162768353|NCT01989156|587861740|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
162768354|NCT01989156|587861741|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
162768355|NCT01989156|587861742|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
162768356|NCT01989156|587861740|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
162768357|NCT01989156|587861741|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
162768358|NCT01989156|587861742|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
162768359|NCT01989156|587861740|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
162768360|NCT01989156|587861741|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
162768361|NCT01989156|587861742|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
162768362|NCT01989156|587861740|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
162768363|NCT01989156|587861741|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
162768364|NCT01989156|587861742|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
162768365|NCT01989156|587861740|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
162768366|NCT01989156|587861741|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
162768367|NCT01989156|587861742|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
162768368|NCT01989156|587861740|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
162768369|NCT01989156|587861741|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
162768370|NCT01989156|587861742|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
162768371|NCT03839355|587861743|FG000|Overall Study|Withdrawal by Subject|1|||
162768372|NCT03839355|587861744|FG001|Overall Study|Withdrawal by Subject|0|||
162768373|NCT03541369|587861746|FG000|Overall Study|Death|0|||
162768374|NCT03541369|587861747|FG001|Overall Study|Death|0|||
162768375|NCT03541369|587861748|FG002|Overall Study|Death|0|||
162768376|NCT03541369|587861749|FG003|Overall Study|Death|0|||
162768377|NCT03541369|587861750|FG004|Overall Study|Death|1|||
162768378|NCT03541369|587861751|FG005|Overall Study|Death|1|||
162768379|NCT03541369|587861752|FG006|Overall Study|Death|0|||
162768380|NCT03541369|587861753|FG007|Overall Study|Death|2|||
162768381|NCT03541369|587861754|FG008|Overall Study|Death|1|||
162768382|NCT03541369|587861755|FG009|Overall Study|Death|2|||
162768383|NCT03541369|587861756|FG010|Overall Study|Death|1|||
162768384|NCT03541369|587861757|FG011|Overall Study|Death|0|||
162768385|NCT03541369|587861758|FG012|Overall Study|Death|2|||
162768386|NCT03541369|587861759|FG013|Overall Study|Death|1|||
162768387|NCT03541369|587861760|FG014|Overall Study|Death|1|||
162768388|NCT03541369|587861761|FG015|Overall Study|Death|1|||
162768389|NCT03541369|587861762|FG016|Overall Study|Death|0|||
162768390|NCT03541369|587861763|FG017|Overall Study|Death|1|||
162768391|NCT03541369|587861746|FG000|Overall Study|Decision by sponsor|0|||
162768392|NCT03541369|587861747|FG001|Overall Study|Decision by sponsor|0|||
162768393|NCT03541369|587861748|FG002|Overall Study|Decision by sponsor|0|||
162768394|NCT03541369|587861749|FG003|Overall Study|Decision by sponsor|1|||
162768395|NCT03541369|587861750|FG004|Overall Study|Decision by sponsor|0|||
162768396|NCT03541369|587861751|FG005|Overall Study|Decision by sponsor|2|||
162768397|NCT03541369|587861752|FG006|Overall Study|Decision by sponsor|0|||
162768398|NCT03541369|587861753|FG007|Overall Study|Decision by sponsor|1|||
162768399|NCT03541369|587861754|FG008|Overall Study|Decision by sponsor|2|||
162768400|NCT03541369|587861755|FG009|Overall Study|Decision by sponsor|0|||
162768401|NCT03541369|587861756|FG010|Overall Study|Decision by sponsor|0|||
162768402|NCT03541369|587861757|FG011|Overall Study|Decision by sponsor|0|||
162768403|NCT03541369|587861758|FG012|Overall Study|Decision by sponsor|2|||
162768404|NCT03541369|587861759|FG013|Overall Study|Decision by sponsor|2|||
162768405|NCT03541369|587861760|FG014|Overall Study|Decision by sponsor|0|||
162768406|NCT03541369|587861761|FG015|Overall Study|Decision by sponsor|1|||
162768407|NCT03541369|587861762|FG016|Overall Study|Decision by sponsor|1|||
162768408|NCT03541369|587861763|FG017|Overall Study|Decision by sponsor|1|||
162768409|NCT03541369|587861746|FG000|Overall Study|Withdrawal by Subject|0|||
162768410|NCT03541369|587861747|FG001|Overall Study|Withdrawal by Subject|0|||
162768411|NCT03541369|587861748|FG002|Overall Study|Withdrawal by Subject|0|||
162768412|NCT03541369|587861749|FG003|Overall Study|Withdrawal by Subject|0|||
162768413|NCT03541369|587861750|FG004|Overall Study|Withdrawal by Subject|0|||
162768414|NCT03541369|587861751|FG005|Overall Study|Withdrawal by Subject|0|||
162768415|NCT03541369|587861752|FG006|Overall Study|Withdrawal by Subject|1|||
162768416|NCT03541369|587861753|FG007|Overall Study|Withdrawal by Subject|0|||
162768417|NCT03541369|587861754|FG008|Overall Study|Withdrawal by Subject|0|||
162768418|NCT03541369|587861755|FG009|Overall Study|Withdrawal by Subject|0|||
162768419|NCT03541369|587861756|FG010|Overall Study|Withdrawal by Subject|0|||
162768420|NCT03541369|587861757|FG011|Overall Study|Withdrawal by Subject|1|||
162768421|NCT03541369|587861758|FG012|Overall Study|Withdrawal by Subject|0|||
162768422|NCT03541369|587861759|FG013|Overall Study|Withdrawal by Subject|0|||
162768423|NCT03541369|587861760|FG014|Overall Study|Withdrawal by Subject|3|||
162768424|NCT03541369|587861761|FG015|Overall Study|Withdrawal by Subject|0|||
162768425|NCT03541369|587861762|FG016|Overall Study|Withdrawal by Subject|4|||
162768426|NCT03541369|587861763|FG017|Overall Study|Withdrawal by Subject|2|||
162768427|NCT03541369|587861746|FG000|Overall Study|Lost to Follow-up|0|||
162768428|NCT03541369|587861747|FG001|Overall Study|Lost to Follow-up|0|||
162768429|NCT03541369|587861748|FG002|Overall Study|Lost to Follow-up|0|||
162768430|NCT03541369|587861749|FG003|Overall Study|Lost to Follow-up|0|||
162768431|NCT03541369|587861750|FG004|Overall Study|Lost to Follow-up|1|||
162768432|NCT03541369|587861751|FG005|Overall Study|Lost to Follow-up|0|||
162768433|NCT03541369|587861752|FG006|Overall Study|Lost to Follow-up|0|||
162768434|NCT03541369|587861753|FG007|Overall Study|Lost to Follow-up|0|||
162768435|NCT03541369|587861754|FG008|Overall Study|Lost to Follow-up|1|||
162768436|NCT03541369|587861755|FG009|Overall Study|Lost to Follow-up|0|||
162768437|NCT03541369|587861756|FG010|Overall Study|Lost to Follow-up|0|||
162768438|NCT03541369|587861757|FG011|Overall Study|Lost to Follow-up|0|||
162768439|NCT03541369|587861758|FG012|Overall Study|Lost to Follow-up|1|||
162768440|NCT03541369|587861759|FG013|Overall Study|Lost to Follow-up|0|||
162768441|NCT03541369|587861760|FG014|Overall Study|Lost to Follow-up|0|||
162768442|NCT03541369|587861761|FG015|Overall Study|Lost to Follow-up|0|||
162768443|NCT03541369|587861762|FG016|Overall Study|Lost to Follow-up|0|||
162768444|NCT03541369|587861763|FG017|Overall Study|Lost to Follow-up|0|||
162768445|NCT01856569|587861764|FG000|Overall Study|Other|1|||
162768446|NCT01856569|587861764|FG000|Overall Study|Changed Site/Structure|1|||
162768447|NCT01856569|587861764|FG000|Overall Study|Lost to Follow-up|3|||
162768448|NCT01856569|587861764|FG000|Overall Study|Did not met inclusion criteria|8|||
162768449|NCT00696241|587861765|FG000|Overall Study|Adverse Event|11|||
162768450|NCT00696241|587861766|FG001|Overall Study|Adverse Event|3|||
162768451|NCT00696241|587861767|FG002|Overall Study|Adverse Event|6|||
162768452|NCT00696241|587861768|FG003|Overall Study|Adverse Event|4|||
162768453|NCT00696241|587861769|FG004|Overall Study|Adverse Event|5|||
162768454|NCT00696241|587861765|FG000|Overall Study|Protocol Violation|1|||
162768455|NCT00696241|587861766|FG001|Overall Study|Protocol Violation|1|||
162768456|NCT00696241|587861767|FG002|Overall Study|Protocol Violation|2|||
162768457|NCT00696241|587861768|FG003|Overall Study|Protocol Violation|0|||
162768458|NCT00696241|587861769|FG004|Overall Study|Protocol Violation|3|||
162768459|NCT00696241|587861765|FG000|Overall Study|Lost to Follow-up|1|||
162768460|NCT00696241|587861766|FG001|Overall Study|Lost to Follow-up|4|||
162768461|NCT00696241|587861767|FG002|Overall Study|Lost to Follow-up|1|||
162768462|NCT00696241|587861768|FG003|Overall Study|Lost to Follow-up|2|||
162768463|NCT00696241|587861769|FG004|Overall Study|Lost to Follow-up|0|||
162768464|NCT00696241|587861765|FG000|Overall Study|Withdrawal by Subject|4|||
162768465|NCT00696241|587861766|FG001|Overall Study|Withdrawal by Subject|8|||
162768466|NCT00696241|587861767|FG002|Overall Study|Withdrawal by Subject|6|||
162768467|NCT00696241|587861768|FG003|Overall Study|Withdrawal by Subject|1|||
162768468|NCT00696241|587861769|FG004|Overall Study|Withdrawal by Subject|0|||
162768469|NCT00696241|587861765|FG000|Overall Study|Lack of Efficacy|1|||
162768470|NCT00696241|587861766|FG001|Overall Study|Lack of Efficacy|5|||
162768471|NCT00696241|587861767|FG002|Overall Study|Lack of Efficacy|4|||
162768472|NCT00696241|587861768|FG003|Overall Study|Lack of Efficacy|5|||
162768473|NCT00696241|587861769|FG004|Overall Study|Lack of Efficacy|3|||
162768474|NCT00696241|587861765|FG000|Overall Study|Other|6|||
162768475|NCT00696241|587861766|FG001|Overall Study|Other|1|||
162768476|NCT00696241|587861767|FG002|Overall Study|Other|5|||
162768477|NCT00696241|587861768|FG003|Overall Study|Other|2|||
162768478|NCT00696241|587861769|FG004|Overall Study|Other|1|||
162768479|NCT01613599|587861770|FG000|Overall Study|Death|9|||
162768480|NCT01613599|587861770|FG000|Overall Study|Lost to Follow-up|5|||
162768481|NCT01613599|587861770|FG000|Overall Study|Withdrawal by Subject|8|||
162768482|NCT01613599|587861770|FG000|Overall Study|Reason not specified|3|||
162768483|NCT04749797|587861775|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
162768484|NCT04749797|587861776|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
162768485|NCT04749797|587861777|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
162768486|NCT02513667|587861778|FG000|Overall Study|Withdrawal by Subject|0|||
162768487|NCT02513667|587861779|FG001|Overall Study|Withdrawal by Subject|1|||
162768488|NCT00871715|587861788|FG000|Overall Study|Withdrawal by Subject|6|||
162768489|NCT00871715|587861789|FG001|Overall Study|Withdrawal by Subject|10|||
162768490|NCT00871715|587861790|FG002|Overall Study|Withdrawal by Subject|15|||
162768491|NCT00871715|587861788|FG000|Overall Study|Physician Decision|6|||
162768492|NCT00871715|587861789|FG001|Overall Study|Physician Decision|0|||
162768493|NCT00871715|587861790|FG002|Overall Study|Physician Decision|2|||
162768494|NCT00871715|587861788|FG000|Overall Study|Lost to Follow-up|3|||
162768495|NCT00871715|587861789|FG001|Overall Study|Lost to Follow-up|6|||
162768496|NCT00871715|587861790|FG002|Overall Study|Lost to Follow-up|9|||
162768497|NCT02291549|587861793|FG000|Overall Study|Lost to Follow-up|1|||
162768498|NCT02291549|587861794|FG001|Overall Study|Lost to Follow-up|0|||
162768499|NCT02291549|587861793|FG000|Overall Study|Withdrawal by Subject|0|||
162768500|NCT02291549|587861794|FG001|Overall Study|Withdrawal by Subject|1|||
162768501|NCT00537914|587861795|FG000|Overall Study|Death|1|||
162768502|NCT00537914|587861795|FG000|Overall Study|Adverse Event|7|||
162768503|NCT00537914|587861795|FG000|Overall Study|Treatment failure|10|||
162768504|NCT00537914|587861795|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
162768505|NCT00537914|587861795|FG000|Overall Study|Lost to Follow-up|19|||
162768506|NCT00537914|587861795|FG000|Overall Study|Withdrawal of informed consent|59|||
162768507|NCT02189759|587861811|FG000|Overall Study|Lost to Follow-up|0|||
162768508|NCT02189759|587861812|FG001|Overall Study|Lost to Follow-up|0|||
162768509|NCT02189759|587861813|FG002|Overall Study|Lost to Follow-up|2|||
162768510|NCT02189759|587861814|FG003|Overall Study|Lost to Follow-up|5|||
162768511|NCT03032198|587861815|FG000|Overall Study|Screen Fail|1|||
162768512|NCT02470806|587861816|FG000|Overall Study|Lost to Follow-up|1|||
162768513|NCT02470806|587861817|FG001|Overall Study|Lost to Follow-up|1|||
162768514|NCT02470806|587861816|FG000|Overall Study|Adverse Event|5|||
162768515|NCT02470806|587861817|FG001|Overall Study|Adverse Event|2|||
162768516|NCT02470806|587861816|FG000|Overall Study|Protocol Violation|4|||
162768517|NCT02470806|587861817|FG001|Overall Study|Protocol Violation|11|||
162768518|NCT02470806|587861816|FG000|Overall Study|Physician Decision|0|||
162768519|NCT02470806|587861817|FG001|Overall Study|Physician Decision|3|||
162768520|NCT02470806|587861816|FG000|Overall Study|Withdrawal by Subject|3|||
162768521|NCT02470806|587861817|FG001|Overall Study|Withdrawal by Subject|10|||
162768522|NCT02470806|587861816|FG000|Overall Study|Lack of Efficacy|5|||
162768523|NCT02470806|587861817|FG001|Overall Study|Lack of Efficacy|15|||
162768524|NCT00866619|587861818|FG000|Overall Study|Adverse Event|112|||
162768525|NCT00866619|587861819|FG001|Overall Study|Adverse Event|106|||
162768526|NCT00866619|587861820|FG002|Overall Study|Adverse Event|47|||
162768527|NCT00866619|587861821|FG003|Overall Study|Adverse Event|44|||
162768528|NCT00866619|587861818|FG000|Overall Study|Protocol Violation|2|||
162768529|NCT00866619|587861819|FG001|Overall Study|Protocol Violation|39|||
162768530|NCT00866619|587861820|FG002|Overall Study|Protocol Violation|2|||
162768531|NCT00866619|587861821|FG003|Overall Study|Protocol Violation|17|||
162768532|NCT00866619|587861818|FG000|Overall Study|Withdrawal by Subject|587|||
162768533|NCT00866619|587861819|FG001|Overall Study|Withdrawal by Subject|295|||
162768534|NCT00866619|587861820|FG002|Overall Study|Withdrawal by Subject|272|||
162768535|NCT00866619|587861821|FG003|Overall Study|Withdrawal by Subject|144|||
162768536|NCT00866619|587861818|FG000|Overall Study|Lost to Follow-up|1145|||
162768537|NCT00866619|587861819|FG001|Overall Study|Lost to Follow-up|830|||
162768538|NCT00866619|587861820|FG002|Overall Study|Lost to Follow-up|568|||
162768539|NCT00866619|587861821|FG003|Overall Study|Lost to Follow-up|425|||
162768540|NCT01147471|587861822|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
162768541|NCT01147471|587861823|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
162768542|NCT01147471|587861822|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
162768543|NCT01147471|587861823|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
162768544|NCT01147471|587861822|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
162768545|NCT01147471|587861823|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
162768546|NCT01147471|587861822|FG000|3 Month Follow Up|Lost to Follow-up|1|||
162768547|NCT01147471|587861823|FG001|3 Month Follow Up|Lost to Follow-up|1|||
162768548|NCT01147471|587861822|FG000|3 Month Follow Up|Physician Decision|0|||
162768549|NCT01147471|587861823|FG001|3 Month Follow Up|Physician Decision|1|||
162768550|NCT01147471|587861822|FG000|6 Month Follow Up|Lost to Follow-up|4|||
162768551|NCT01147471|587861823|FG001|6 Month Follow Up|Lost to Follow-up|2|||
162768552|NCT01307800|587861828|FG000|Overall Study|Adverse Event|9|||
162768553|NCT01307800|587861829|FG001|Overall Study|Adverse Event|8|||
162768554|NCT01307800|587861830|FG002|Overall Study|Adverse Event|10|||
162768555|NCT01307800|587861831|FG003|Overall Study|Adverse Event|14|||
162768556|NCT01307800|587861828|FG000|Overall Study|Entry Criteria Not Met|0|||
162768557|NCT01307800|587861829|FG001|Overall Study|Entry Criteria Not Met|0|||
162768558|NCT01307800|587861830|FG002|Overall Study|Entry Criteria Not Met|0|||
162768559|NCT01307800|587861831|FG003|Overall Study|Entry Criteria Not Met|2|||
162768560|NCT01307800|587861828|FG000|Overall Study|Lost to Follow-up|5|||
162768561|NCT01307800|587861829|FG001|Overall Study|Lost to Follow-up|6|||
162768562|NCT01307800|587861830|FG002|Overall Study|Lost to Follow-up|2|||
162768563|NCT01307800|587861831|FG003|Overall Study|Lost to Follow-up|8|||
162768564|NCT01307800|587861828|FG000|Overall Study|Perceived Lack of Efficacy|24|||
162768565|NCT01307800|587861829|FG001|Overall Study|Perceived Lack of Efficacy|23|||
162768566|NCT01307800|587861830|FG002|Overall Study|Perceived Lack of Efficacy|20|||
162768567|NCT01307800|587861831|FG003|Overall Study|Perceived Lack of Efficacy|33|||
162768568|NCT01307800|587861828|FG000|Overall Study|Protocol Violation|0|||
162768569|NCT01307800|587861829|FG001|Overall Study|Protocol Violation|3|||
162768570|NCT01307800|587861830|FG002|Overall Study|Protocol Violation|4|||
162768571|NCT01307800|587861831|FG003|Overall Study|Protocol Violation|5|||
162768572|NCT01307800|587861828|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
162768573|NCT01307800|587861829|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
162768574|NCT01307800|587861830|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
162768575|NCT01307800|587861831|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
162768576|NCT01307800|587861828|FG000|Overall Study|Sponsor Decision|6|||
162768577|NCT01307800|587861829|FG001|Overall Study|Sponsor Decision|9|||
162768578|NCT01307800|587861830|FG002|Overall Study|Sponsor Decision|12|||
162768579|NCT01307800|587861831|FG003|Overall Study|Sponsor Decision|28|||
162768580|NCT01307800|587861828|FG000|Overall Study|Withdrawal by Subject|10|||
162768581|NCT01307800|587861829|FG001|Overall Study|Withdrawal by Subject|11|||
162768582|NCT01307800|587861830|FG002|Overall Study|Withdrawal by Subject|8|||
162768583|NCT01307800|587861831|FG003|Overall Study|Withdrawal by Subject|15|||
162768584|NCT01307800|587861828|FG000|Overall Study|Participant Moved|0|||
162768585|NCT01307800|587861829|FG001|Overall Study|Participant Moved|2|||
162768586|NCT01307800|587861830|FG002|Overall Study|Participant Moved|1|||
162768587|NCT01307800|587861831|FG003|Overall Study|Participant Moved|3|||
162768588|NCT02892019|587861834|FG000|Overall Study|randomized but not treated|0|||
162768589|NCT02892019|587861835|FG001|Overall Study|randomized but not treated|1|||
162768590|NCT02892019|587861834|FG000|Overall Study|Withdrawal by Subject|0|||
162768591|NCT02892019|587861835|FG001|Overall Study|Withdrawal by Subject|1|||
162768592|NCT02892019|587861834|FG000|Overall Study|Adverse Event|1|||
162768593|NCT02892019|587861835|FG001|Overall Study|Adverse Event|1|||
162768594|NCT00689351|587861836|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
162768595|NCT00689351|587861837|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
162768596|NCT00689351|587861836|FG000|Infant Series of Dosing|Adverse Event|1|||
162768597|NCT00689351|587861837|FG001|Infant Series of Dosing|Adverse Event|0|||
162768598|NCT00689351|587861836|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
162768599|NCT00689351|587861837|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
162768600|NCT00689351|587861836|FG000|After Infant Series|Parent/legal guardian request|1|||
162768601|NCT00689351|587861837|FG001|After Infant Series|Parent/legal guardian request|0|||
162768602|NCT01766206|587861838|FG000|Overall Study|Withdrawal by Subject|22|||
162768603|NCT01766206|587861838|FG000|Overall Study|Lost to Follow-up|10|||
162768604|NCT01766206|587861838|FG000|Overall Study|Inappropriate enrollment|18|||
162768605|NCT01766206|587861838|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
162768606|NCT01662505|587861839|FG000|Overall Study|Progressive disease|6|||
162768607|NCT01662505|587861840|FG001|Overall Study|Progressive disease|1|||
162768608|NCT01662505|587861841|FG002|Overall Study|Progressive disease|5|||
162768609|NCT01662505|587861839|FG000|Overall Study|Refused cont. medication|0|||
162768610|NCT01662505|587861840|FG001|Overall Study|Refused cont. medication|0|||
162768611|NCT01662505|587861841|FG002|Overall Study|Refused cont. medication|1|||
162768612|NCT01662505|587861839|FG000|Overall Study|Not specified above|1|||
162768613|NCT01662505|587861840|FG001|Overall Study|Not specified above|3|||
162768614|NCT01662505|587861841|FG002|Overall Study|Not specified above|2|||
162768615|NCT01313663|587861842|FG000|Overall Study|Study Closed/Terminated|2|||
162768616|NCT01313663|587861843|FG001|Overall Study|Study Closed/Terminated|4|||
162768617|NCT01313663|587861842|FG000|Overall Study|Lost to Follow-up|0|||
162768618|NCT01313663|587861843|FG001|Overall Study|Lost to Follow-up|1|||
162768619|NCT01313663|587861842|FG000|Overall Study|Physician Decision|0|||
162768620|NCT01313663|587861843|FG001|Overall Study|Physician Decision|2|||
162768621|NCT01313663|587861842|FG000|Overall Study|Withdrawal by Subject|2|||
162768622|NCT01313663|587861843|FG001|Overall Study|Withdrawal by Subject|1|||
162768623|NCT03890484|587861844|FG000|Overall Study|Lost to Follow-up|1|||
162768624|NCT03890484|587861845|FG001|Overall Study|Lost to Follow-up|1|||
162768625|NCT00518206|587861846|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
162768626|NCT00518206|587861847|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
162768627|NCT00518206|587861846|FG000|Overall Study|Withdrawal by Subject|2|||
162768628|NCT00518206|587861847|FG001|Overall Study|Withdrawal by Subject|0|||
162768629|NCT00518206|587861846|FG000|Overall Study|Drug Supply Issue|1|||
162768630|NCT00518206|587861847|FG001|Overall Study|Drug Supply Issue|0|||
162768631|NCT00518206|587861846|FG000|Overall Study|Reason Unknown|1|||
162768632|NCT00518206|587861847|FG001|Overall Study|Reason Unknown|0|||
162768633|NCT00518206|587861846|FG000|Overall Study|Completion Status Unknown|1|||
162768634|NCT00518206|587861847|FG001|Overall Study|Completion Status Unknown|0|||
162768635|NCT03075878|587861848|FG000|Overall Study|Physician Decision|1|||
162768636|NCT00805441|587861849|FG000|Overall Study|Adverse Event|5|||
162768637|NCT00805441|587861850|FG001|Overall Study|Adverse Event|2|||
162768638|NCT00805441|587861849|FG000|Overall Study|Lack of Efficacy|0|||
162768639|NCT00805441|587861850|FG001|Overall Study|Lack of Efficacy|2|||
162768640|NCT00805441|587861849|FG000|Overall Study|Protocol Violation|4|||
162768641|NCT00805441|587861850|FG001|Overall Study|Protocol Violation|8|||
162768642|NCT00805441|587861849|FG000|Overall Study|Lost to Follow-up|10|||
162768643|NCT00805441|587861850|FG001|Overall Study|Lost to Follow-up|13|||
162768644|NCT00805441|587861849|FG000|Overall Study|Withdrawal by Subject|15|||
162768645|NCT00805441|587861850|FG001|Overall Study|Withdrawal by Subject|9|||
162768646|NCT00805441|587861849|FG000|Overall Study|Physician Decision|0|||
162768647|NCT00805441|587861850|FG001|Overall Study|Physician Decision|1|||
162768648|NCT00805441|587861849|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
162768649|NCT00805441|587861850|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
162768650|NCT05356130|587863179|FG000|Overall Study|Withdrawal by Subject|0|||
162768651|NCT05356130|587863180|FG001|Overall Study|Withdrawal by Subject|0|||
162768652|NCT05356130|587863181|FG002|Overall Study|Withdrawal by Subject|3|||
162768653|NCT04820023|587863184|FG000|Overall Study|Death|0|||
162768654|NCT04820023|587863185|FG001|Overall Study|Death|0|||
162768655|NCT04820023|587863186|FG002|Overall Study|Death|0|||
162768656|NCT04820023|587863187|FG003|Overall Study|Death|0|||
162768657|NCT04820023|587863188|FG004|Overall Study|Death|0|||
162768658|NCT04820023|587863189|FG005|Overall Study|Death|0|||
162768659|NCT04820023|587863190|FG006|Overall Study|Death|1|||
162768660|NCT04820023|587863191|FG007|Overall Study|Death|0|||
162768661|NCT04820023|587863192|FG008|Overall Study|Death|1|||
162768662|NCT04820023|587863184|FG000|Overall Study|Withdrawal by Subject|1|||
162768663|NCT04820023|587863185|FG001|Overall Study|Withdrawal by Subject|2|||
162768664|NCT04820023|587863186|FG002|Overall Study|Withdrawal by Subject|2|||
162768665|NCT04820023|587863187|FG003|Overall Study|Withdrawal by Subject|1|||
162768666|NCT04820023|587863188|FG004|Overall Study|Withdrawal by Subject|4|||
162768667|NCT04820023|587863189|FG005|Overall Study|Withdrawal by Subject|3|||
162768668|NCT04820023|587863190|FG006|Overall Study|Withdrawal by Subject|3|||
162768669|NCT04820023|587863191|FG007|Overall Study|Withdrawal by Subject|6|||
162768670|NCT04820023|587863192|FG008|Overall Study|Withdrawal by Subject|5|||
162768671|NCT04820023|587863184|FG000|Overall Study|Progressive Disease|3|||
162768672|NCT04820023|587863185|FG001|Overall Study|Progressive Disease|0|||
162768673|NCT04820023|587863186|FG002|Overall Study|Progressive Disease|2|||
162768674|NCT04820023|587863187|FG003|Overall Study|Progressive Disease|2|||
162768675|NCT04820023|587863188|FG004|Overall Study|Progressive Disease|2|||
162768676|NCT04820023|587863189|FG005|Overall Study|Progressive Disease|0|||
162768677|NCT04820023|587863190|FG006|Overall Study|Progressive Disease|1|||
162768678|NCT04820023|587863191|FG007|Overall Study|Progressive Disease|1|||
162768679|NCT04820023|587863192|FG008|Overall Study|Progressive Disease|0|||
162768680|NCT04820023|587863184|FG000|Overall Study|New anti-cancer therapy|0|||
162768681|NCT04820023|587863185|FG001|Overall Study|New anti-cancer therapy|0|||
162768682|NCT04820023|587863186|FG002|Overall Study|New anti-cancer therapy|0|||
162768683|NCT04820023|587863187|FG003|Overall Study|New anti-cancer therapy|0|||
162768684|NCT04820023|587863188|FG004|Overall Study|New anti-cancer therapy|2|||
162768685|NCT04820023|587863189|FG005|Overall Study|New anti-cancer therapy|0|||
162768686|NCT04820023|587863190|FG006|Overall Study|New anti-cancer therapy|0|||
162768687|NCT04820023|587863191|FG007|Overall Study|New anti-cancer therapy|0|||
162768688|NCT04820023|587863192|FG008|Overall Study|New anti-cancer therapy|0|||
162768689|NCT04820023|587863184|FG000|Overall Study|Other|0|||
162768690|NCT04820023|587863185|FG001|Overall Study|Other|1|||
162768691|NCT04820023|587863186|FG002|Overall Study|Other|0|||
162768692|NCT04820023|587863187|FG003|Overall Study|Other|0|||
162768693|NCT04820023|587863188|FG004|Overall Study|Other|0|||
162768694|NCT04820023|587863189|FG005|Overall Study|Other|0|||
162768695|NCT04820023|587863190|FG006|Overall Study|Other|0|||
162768696|NCT04820023|587863191|FG007|Overall Study|Other|2|||
162768697|NCT04820023|587863192|FG008|Overall Study|Other|0|||
162768698|NCT02109172|587863203|FG000|Overall Study|Withdrawal by Subject|1|||
162768699|NCT02109172|587863204|FG001|Overall Study|Withdrawal by Subject|0|||
162768700|NCT02109172|587863205|FG002|Overall Study|Withdrawal by Subject|0|||
162768701|NCT02109172|587863206|FG003|Overall Study|Withdrawal by Subject|1|||
162768702|NCT02109172|587863207|FG004|Overall Study|Withdrawal by Subject|0|||
162768703|NCT02109172|587863208|FG005|Overall Study|Withdrawal by Subject|0|||
162768704|NCT02109172|587863203|FG000|Overall Study|Adverse Event|0|||
162768705|NCT02109172|587863204|FG001|Overall Study|Adverse Event|0|||
162768706|NCT02109172|587863205|FG002|Overall Study|Adverse Event|1|||
162768707|NCT02109172|587863206|FG003|Overall Study|Adverse Event|0|||
162768708|NCT02109172|587863207|FG004|Overall Study|Adverse Event|0|||
162768709|NCT02109172|587863208|FG005|Overall Study|Adverse Event|1|||
162768710|NCT02109172|587863203|FG000|Overall Study|Death|0|||
162768711|NCT02109172|587863204|FG001|Overall Study|Death|0|||
162768712|NCT02109172|587863205|FG002|Overall Study|Death|0|||
162768713|NCT02109172|587863206|FG003|Overall Study|Death|0|||
162768714|NCT02109172|587863207|FG004|Overall Study|Death|1|||
162768715|NCT02109172|587863208|FG005|Overall Study|Death|0|||
162768716|NCT00538629|587863211|FG000|Overall Study|At subject's request|1|||
162768717|NCT00538629|587863211|FG000|Overall Study|Adverse Event|2|||
162768718|NCT00538629|587863211|FG000|Overall Study|Lack of Efficacy|12|||
162768719|NCT00538629|587863211|FG000|Overall Study|Lost to Follow-up|6|||
162768720|NCT00538629|587863211|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
162768721|NCT04454125|587863212|FG000|Overall Study|Lost to Follow-up|0|||
162768722|NCT04454125|587863213|FG001|Overall Study|Lost to Follow-up|1|||
162768723|NCT01922102|587863214|FG000|Overall Study|Withdrawal by Subject|7|||
162768724|NCT01922102|587863215|FG001|Overall Study|Withdrawal by Subject|3|||
162768725|NCT01922102|587863216|FG002|Overall Study|Withdrawal by Subject|7|||
162768726|NCT01922102|587863214|FG000|Overall Study|Physician Decision|0|||
162768727|NCT01922102|587863215|FG001|Overall Study|Physician Decision|2|||
162768728|NCT01922102|587863216|FG002|Overall Study|Physician Decision|1|||
162768729|NCT01922102|587863214|FG000|Overall Study|Adverse Event|1|||
162768730|NCT01922102|587863215|FG001|Overall Study|Adverse Event|2|||
162768731|NCT01922102|587863216|FG002|Overall Study|Adverse Event|0|||
162768732|NCT01922102|587863214|FG000|Overall Study|Lost to Follow-up|1|||
162768733|NCT01922102|587863215|FG001|Overall Study|Lost to Follow-up|0|||
162768734|NCT01922102|587863216|FG002|Overall Study|Lost to Follow-up|0|||
162768735|NCT01922102|587863214|FG000|Overall Study|Administrative problems|0|||
162768736|NCT01922102|587863215|FG001|Overall Study|Administrative problems|2|||
162768737|NCT01922102|587863216|FG002|Overall Study|Administrative problems|0|||
162768738|NCT05203822|587863217|FG000|Overall Study|Adverse Event|1|||
162768739|NCT05203822|587863217|FG000|Overall Study|Withdrawal by Subject|1|||
162768740|NCT01816165|587863224|FG000|Overall Study|Adverse Event|1|||
162768741|NCT01816165|587863225|FG001|Overall Study|Adverse Event|0|||
162768742|NCT01816165|587863226|FG002|Overall Study|Adverse Event|0|||
162768743|NCT01816165|587863227|FG003|Overall Study|Adverse Event|0|||
162768744|NCT00447499|587863228|FG000|Overall Study|Adverse Event|1|||
162768745|NCT00447499|587863228|FG000|Overall Study|Patient Decision|4|||
162768746|NCT00447499|587863228|FG000|Overall Study|Sponsor Decision|1|||
162768747|NCT00447499|587863228|FG000|Overall Study|Physician Decision|1|||
162768748|NCT03360071|587863230|FG000|Overall Study|Lost to Follow-up|1|||
162768749|NCT03360071|587863231|FG001|Overall Study|Lost to Follow-up|0|||
162768750|NCT03184519|587863240|FG000|Overall Study|Lost to Follow-up|6|||
162768751|NCT03184519|587863240|FG000|Overall Study|Physician Decision|21|||
162768752|NCT02823574|587863244|FG000|Randomization|Disease Progression|0|||
162768753|NCT02823574|587863245|FG001|Randomization|Disease Progression|0|||
162768754|NCT02823574|587863246|FG002|Randomization|Disease Progression|1|||
162768755|NCT02823574|587863247|FG003|Randomization|Disease Progression|0|||
162768756|NCT02823574|587863244|FG000|Randomization|AE unrelated to Study Drug|1|||
162768757|NCT02823574|587863245|FG001|Randomization|AE unrelated to Study Drug|0|||
162768758|NCT02823574|587863246|FG002|Randomization|AE unrelated to Study Drug|0|||
162768759|NCT02823574|587863247|FG003|Randomization|AE unrelated to Study Drug|0|||
162768760|NCT02823574|587863244|FG000|Treatment Period|Poor/Non Compliance|1|||
162768761|NCT02823574|587863245|FG001|Treatment Period|Poor/Non Compliance|0|||
162768762|NCT02823574|587863246|FG002|Treatment Period|Poor/Non Compliance|0|||
162768763|NCT02823574|587863247|FG003|Treatment Period|Poor/Non Compliance|1|||
162768764|NCT02823574|587863244|FG000|Treatment Period|Maximum Clinical Benefit|8|||
162768765|NCT02823574|587863245|FG001|Treatment Period|Maximum Clinical Benefit|4|||
162768766|NCT02823574|587863246|FG002|Treatment Period|Maximum Clinical Benefit|7|||
162768767|NCT02823574|587863247|FG003|Treatment Period|Maximum Clinical Benefit|1|||
162768768|NCT02823574|587863244|FG000|Treatment Period|Lost to Follow-up|1|||
162768769|NCT02823574|587863245|FG001|Treatment Period|Lost to Follow-up|1|||
162768770|NCT02823574|587863246|FG002|Treatment Period|Lost to Follow-up|0|||
162768771|NCT02823574|587863247|FG003|Treatment Period|Lost to Follow-up|0|||
162768772|NCT02823574|587863244|FG000|Treatment Period|Participant withdrew consent|4|||
162768773|NCT02823574|587863245|FG001|Treatment Period|Participant withdrew consent|0|||
162768774|NCT02823574|587863246|FG002|Treatment Period|Participant withdrew consent|0|||
162768775|NCT02823574|587863247|FG003|Treatment Period|Participant withdrew consent|1|||
162768776|NCT02823574|587863244|FG000|Treatment Period|Participant request to discontinue|5|||
162768777|NCT02823574|587863245|FG001|Treatment Period|Participant request to discontinue|0|||
162768778|NCT02823574|587863246|FG002|Treatment Period|Participant request to discontinue|3|||
162768779|NCT02823574|587863247|FG003|Treatment Period|Participant request to discontinue|2|||
162768780|NCT02823574|587863244|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
162768781|NCT02823574|587863245|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
162768782|NCT02823574|587863246|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
162768783|NCT02823574|587863247|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
162768784|NCT02823574|587863244|FG000|Treatment Period|Study Drug Toxicity|11|||
162768785|NCT02823574|587863245|FG001|Treatment Period|Study Drug Toxicity|2|||
162768786|NCT02823574|587863246|FG002|Treatment Period|Study Drug Toxicity|14|||
162768787|NCT02823574|587863247|FG003|Treatment Period|Study Drug Toxicity|4|||
162768788|NCT02823574|587863244|FG000|Treatment Period|Disease Progression|113|||
162768789|NCT02823574|587863245|FG001|Treatment Period|Disease Progression|64|||
162768790|NCT02823574|587863246|FG002|Treatment Period|Disease Progression|82|||
162768791|NCT02823574|587863247|FG003|Treatment Period|Disease Progression|43|||
162768792|NCT02823574|587863244|FG000|Treatment Period|Other reasons|5|||
162768793|NCT02823574|587863245|FG001|Treatment Period|Other reasons|9|||
162768794|NCT02823574|587863246|FG002|Treatment Period|Other reasons|3|||
162768795|NCT02823574|587863247|FG003|Treatment Period|Other reasons|6|||
162768796|NCT02823574|587863244|FG000|Treatment Period|Participant no longer meets study criteria|0|||
162768797|NCT02823574|587863245|FG001|Treatment Period|Participant no longer meets study criteria|0|||
162768798|NCT02823574|587863246|FG002|Treatment Period|Participant no longer meets study criteria|1|||
162768799|NCT02823574|587863247|FG003|Treatment Period|Participant no longer meets study criteria|0|||
162768800|NCT02823574|587863244|FG000|Treatment Period|Death|0|||
162768801|NCT02823574|587863245|FG001|Treatment Period|Death|0|||
162768802|NCT02823574|587863246|FG002|Treatment Period|Death|3|||
162768803|NCT02823574|587863247|FG003|Treatment Period|Death|1|||
162768804|NCT00590759|587863248|FG000|Overall Study|Death|52|||
162768805|NCT00590759|587863248|FG000|Overall Study|Lost to Follow-up|28|||
162768806|NCT02092909|587863253|FG000|Overall Study|Adverse Event|0|||
162768807|NCT02092909|587863254|FG001|Overall Study|Adverse Event|0|||
162768808|NCT02092909|587863255|FG002|Overall Study|Adverse Event|4|||
162768809|NCT02092909|587863256|FG003|Overall Study|Adverse Event|2|||
162768810|NCT02092909|587863253|FG000|Overall Study|Lack of Efficacy|0|||
162768811|NCT02092909|587863254|FG001|Overall Study|Lack of Efficacy|2|||
162768812|NCT02092909|587863255|FG002|Overall Study|Lack of Efficacy|1|||
162768813|NCT02092909|587863256|FG003|Overall Study|Lack of Efficacy|0|||
162768814|NCT02092909|587863253|FG000|Overall Study|Withdrawal by Subject|0|||
162768815|NCT02092909|587863254|FG001|Overall Study|Withdrawal by Subject|0|||
162768816|NCT02092909|587863255|FG002|Overall Study|Withdrawal by Subject|2|||
162768817|NCT02092909|587863256|FG003|Overall Study|Withdrawal by Subject|1|||
162768818|NCT02092909|587863253|FG000|Overall Study|Study terminated by Sponsor|0|||
162768819|NCT02092909|587863254|FG001|Overall Study|Study terminated by Sponsor|0|||
162768820|NCT02092909|587863255|FG002|Overall Study|Study terminated by Sponsor|0|||
162768821|NCT02092909|587863256|FG003|Overall Study|Study terminated by Sponsor|2|||
162768822|NCT02092909|587863253|FG000|Overall Study|Miscellaneous|1|||
162768823|NCT02092909|587863254|FG001|Overall Study|Miscellaneous|1|||
162768824|NCT02092909|587863255|FG002|Overall Study|Miscellaneous|2|||
162768825|NCT02092909|587863256|FG003|Overall Study|Miscellaneous|1|||
162768826|NCT00096278|587863257|FG000|Overall Study|No follow-up data|15|||
162768827|NCT00096278|587863258|FG001|Overall Study|No follow-up data|18|||
162768828|NCT00096278|587863257|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
162768829|NCT00096278|587863258|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
162768830|NCT02865083|587863259|FG000|Overall Study|Early Termination|3|||
162768831|NCT02865083|587863260|FG001|Overall Study|Early Termination|1|||
162768832|NCT02105688|587863261|FG000|Part A: Double-Blind|Adverse Event|1|||
162768833|NCT02105688|587863262|FG001|Part A: Double-Blind|Adverse Event|0|||
162768834|NCT02105688|587863261|FG000|Part A: Double-Blind|Death|0|||
162768835|NCT02105688|587863262|FG001|Part A: Double-Blind|Death|1|||
162768836|NCT02105688|587863261|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
162768837|NCT02105688|587863262|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
162768838|NCT02105688|587863261|FG000|Part A: Double-Blind|Physician Decision|0|||
162768839|NCT02105688|587863262|FG001|Part A: Double-Blind|Physician Decision|1|||
162768840|NCT02105688|587863261|FG000|Part A: Double-Blind|Status Unknown|0|||
162768841|NCT02105688|587863262|FG001|Part A: Double-Blind|Status Unknown|2|||
162768842|NCT02105688|587863261|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
162768843|NCT02105688|587863262|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
162768844|NCT02105688|587863261|FG000|Part B: Observational Follow-up|Death|2|||
162768845|NCT02105688|587863262|FG001|Part B: Observational Follow-up|Death|1|||
162768846|NCT02105688|587863261|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
162768847|NCT02105688|587863262|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
162768848|NCT02105688|587863261|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
162768849|NCT02105688|587863262|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
162768850|NCT02105688|587863261|FG000|Part B: Observational Follow-up|Physician Decision|3|||
162768851|NCT02105688|587863262|FG001|Part B: Observational Follow-up|Physician Decision|1|||
162768852|NCT02959866|587863268|FG000|Overall Study|Withdrawal by Subject|1|||
162768853|NCT00636168|587863269|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
162768854|NCT00636168|587863270|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
162768855|NCT00636168|587863269|FG000|Randomized to Study Drug|Adverse Event|1|||
162768856|NCT00636168|587863270|FG001|Randomized to Study Drug|Adverse Event|0|||
162768857|NCT00636168|587863269|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
162768858|NCT00636168|587863270|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
162768859|NCT00636168|587863269|FG000|Treated With Study Drug|Recurrence of disease|135|||
162768860|NCT00636168|587863270|FG001|Treated With Study Drug|Recurrence of disease|282|||
162768861|NCT00636168|587863269|FG000|Treated With Study Drug|Adverse Event|250|||
162768862|NCT00636168|587863270|FG001|Treated With Study Drug|Adverse Event|22|||
162768863|NCT00636168|587863269|FG000|Treated With Study Drug|Participant withdrew consent|16|||
162768864|NCT00636168|587863270|FG001|Treated With Study Drug|Participant withdrew consent|21|||
162768865|NCT00636168|587863269|FG000|Treated With Study Drug|Poor/non-compliance|1|||
162768866|NCT00636168|587863270|FG001|Treated With Study Drug|Poor/non-compliance|3|||
162768867|NCT00636168|587863269|FG000|Treated With Study Drug|Death|3|||
162768868|NCT00636168|587863270|FG001|Treated With Study Drug|Death|0|||
162768869|NCT00636168|587863269|FG000|Treated With Study Drug|Pregnancy|1|||
162768870|NCT00636168|587863270|FG001|Treated With Study Drug|Pregnancy|0|||
162768871|NCT00636168|587863269|FG000|Treated With Study Drug|No longer meets study criteria|1|||
162768872|NCT00636168|587863270|FG001|Treated With Study Drug|No longer meets study criteria|0|||
162768873|NCT00636168|587863269|FG000|Treated With Study Drug|Other reason|1|||
162768874|NCT00636168|587863270|FG001|Treated With Study Drug|Other reason|3|||
162768875|NCT00636168|587863269|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
162768876|NCT00636168|587863270|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
162768877|NCT00636168|587863269|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
162768878|NCT00636168|587863270|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
162768879|NCT00636168|587863269|FG000|Long Term Follow-Up|Death|8|||
162768880|NCT00636168|587863270|FG001|Long Term Follow-Up|Death|9|||
162768881|NCT04529941|587863274|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
162768882|NCT04529941|587863275|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
162768883|NCT01005914|587863276|FG000|Overall Study|Adverse Event|4|||
162768884|NCT01005914|587863276|FG000|Overall Study|Death|4|||
162768885|NCT01005914|587863276|FG000|Overall Study|Lack of Efficacy|1|||
162768886|NCT01005914|587863276|FG000|Overall Study|Withdrawal by Subject|1|||
162768887|NCT01229176|587863277|FG000|Overall Study|Withdrawal by Subject|0|||
162768888|NCT01229176|587863278|FG001|Overall Study|Withdrawal by Subject|0|||
162768889|NCT01229176|587863279|FG002|Overall Study|Withdrawal by Subject|0|||
162768890|NCT01229176|587863280|FG003|Overall Study|Withdrawal by Subject|1|||
162768891|NCT01229176|587863281|FG004|Overall Study|Withdrawal by Subject|1|||
162768892|NCT01229176|587863282|FG005|Overall Study|Withdrawal by Subject|1|||
162768893|NCT01229176|587863283|FG006|Overall Study|Withdrawal by Subject|0|||
162768894|NCT01229176|587863284|FG007|Overall Study|Withdrawal by Subject|1|||
162768895|NCT01229176|587863277|FG000|Overall Study|Lost to Follow-up|0|||
162768896|NCT01229176|587863278|FG001|Overall Study|Lost to Follow-up|3|||
162768897|NCT01229176|587863279|FG002|Overall Study|Lost to Follow-up|0|||
162768898|NCT01229176|587863280|FG003|Overall Study|Lost to Follow-up|0|||
162768899|NCT01229176|587863281|FG004|Overall Study|Lost to Follow-up|1|||
162768900|NCT01229176|587863282|FG005|Overall Study|Lost to Follow-up|1|||
162768901|NCT01229176|587863283|FG006|Overall Study|Lost to Follow-up|0|||
162768902|NCT01229176|587863284|FG007|Overall Study|Lost to Follow-up|2|||
162768903|NCT02188459|587863290|FG000|Overall Study|Lost to Follow-up|3|||
162768904|NCT02188459|587863291|FG001|Overall Study|Lost to Follow-up|4|||
162768905|NCT02188459|587863290|FG000|Overall Study|Early Termination|0|||
162768906|NCT02188459|587863291|FG001|Overall Study|Early Termination|3|||
162768907|NCT02367794|587863296|FG000|Overall Study|Death|252|||
162768908|NCT02367794|587863297|FG001|Overall Study|Death|245|||
162768909|NCT02367794|587863298|FG002|Overall Study|Death|243|||
162768910|NCT02367794|587863296|FG000|Overall Study|Lost to Follow-up|1|||
162768911|NCT02367794|587863297|FG001|Overall Study|Lost to Follow-up|2|||
162768912|NCT02367794|587863298|FG002|Overall Study|Lost to Follow-up|2|||
162768913|NCT02367794|587863296|FG000|Overall Study|Physician Decision|0|||
162768914|NCT02367794|587863297|FG001|Overall Study|Physician Decision|5|||
162768915|NCT02367794|587863298|FG002|Overall Study|Physician Decision|3|||
162768916|NCT02367794|587863296|FG000|Overall Study|Protocol Violation|1|||
162768917|NCT02367794|587863297|FG001|Overall Study|Protocol Violation|0|||
162768918|NCT02367794|587863298|FG002|Overall Study|Protocol Violation|1|||
162768919|NCT02367794|587863296|FG000|Overall Study|Withdrawal by Subject|25|||
162768920|NCT02367794|587863297|FG001|Overall Study|Withdrawal by Subject|12|||
162768921|NCT02367794|587863298|FG002|Overall Study|Withdrawal by Subject|20|||
162768922|NCT02367794|587863296|FG000|Overall Study|Brain metastasis|1|||
162768923|NCT02367794|587863297|FG001|Overall Study|Brain metastasis|0|||
162768924|NCT02367794|587863298|FG002|Overall Study|Brain metastasis|0|||
162768925|NCT02367794|587863296|FG000|Overall Study|Randomized in error|0|||
162768926|NCT02367794|587863297|FG001|Overall Study|Randomized in error|0|||
162768927|NCT02367794|587863298|FG002|Overall Study|Randomized in error|1|||
162768928|NCT02367794|587863296|FG000|Overall Study|Patient unable to receive carboplatin|0|||
162768929|NCT02367794|587863297|FG001|Overall Study|Patient unable to receive carboplatin|0|||
162768930|NCT02367794|587863298|FG002|Overall Study|Patient unable to receive carboplatin|1|||
162768931|NCT02367794|587863296|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
162768932|NCT02367794|587863297|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
162768933|NCT02367794|587863298|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
162768934|NCT02367794|587863296|FG000|Overall Study|Adverse Event|0|||
162768935|NCT02367794|587863297|FG001|Overall Study|Adverse Event|0|||
162768936|NCT02367794|587863298|FG002|Overall Study|Adverse Event|2|||
162768937|NCT02367794|587863296|FG000|Overall Study|Study Terminated By Sponsor|0|||
162768938|NCT02367794|587863297|FG001|Overall Study|Study Terminated By Sponsor|1|||
162768939|NCT02367794|587863298|FG002|Overall Study|Study Terminated By Sponsor|1|||
162768940|NCT02367794|587863296|FG000|Overall Study|Moved to Roll-Over Study|0|||
162768941|NCT02367794|587863297|FG001|Overall Study|Moved to Roll-Over Study|15|||
162768942|NCT02367794|587863298|FG002|Overall Study|Moved to Roll-Over Study|13|||
162768943|NCT02367794|587863296|FG000|Overall Study|Sponsor Request|60|||
162768944|NCT02367794|587863297|FG001|Overall Study|Sponsor Request|57|||
162768945|NCT02367794|587863298|FG002|Overall Study|Sponsor Request|45|||
162768946|NCT02367794|587863296|FG000|Overall Study|Moved into PTAP Study|0|||
162768947|NCT02367794|587863297|FG001|Overall Study|Moved into PTAP Study|2|||
162768948|NCT02367794|587863298|FG002|Overall Study|Moved into PTAP Study|3|||
162768949|NCT02367794|587863296|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
162768950|NCT02367794|587863297|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
162768951|NCT02367794|587863298|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
162768952|NCT02367794|587863296|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
162768953|NCT02367794|587863297|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
162768954|NCT02367794|587863298|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
162768955|NCT02367794|587863296|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
162768956|NCT02367794|587863297|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
162768957|NCT02367794|587863298|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
162768958|NCT02367794|587863296|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
162768959|NCT02367794|587863297|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
162768960|NCT02367794|587863298|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
162768961|NCT02612285|587863299|FG000|Overall Study|Withdrawal by Subject|1|||
162768962|NCT02010684|587863300|FG000|Overall Study|Lost to Follow-up|8|||
162768963|NCT02010684|587863301|FG001|Overall Study|Lost to Follow-up|18|||
162768964|NCT02010684|587863300|FG000|Overall Study|Withdrawal by Subject|4|||
162768965|NCT02010684|587863301|FG001|Overall Study|Withdrawal by Subject|5|||
162768966|NCT01986348|587863302|FG000|Overall Study|Death|8|||
162768967|NCT01986348|587863303|FG001|Overall Study|Death|22|||
162768968|NCT01986348|587863304|FG002|Overall Study|Death|10|||
162768969|NCT01986348|587863305|FG003|Overall Study|Death|21|||
162768970|NCT01986348|587863302|FG000|Overall Study|Lost to Follow-up|0|||
162768971|NCT01986348|587863303|FG001|Overall Study|Lost to Follow-up|0|||
162768972|NCT01986348|587863304|FG002|Overall Study|Lost to Follow-up|0|||
162768973|NCT01986348|587863305|FG003|Overall Study|Lost to Follow-up|2|||
162768974|NCT01986348|587863302|FG000|Overall Study|Physician Decision|0|||
162768975|NCT01986348|587863303|FG001|Overall Study|Physician Decision|0|||
162768976|NCT01986348|587863304|FG002|Overall Study|Physician Decision|0|||
162768977|NCT01986348|587863305|FG003|Overall Study|Physician Decision|1|||
162768978|NCT01986348|587863302|FG000|Overall Study|Progressive Disease|0|||
162768979|NCT01986348|587863303|FG001|Overall Study|Progressive Disease|0|||
162768980|NCT01986348|587863304|FG002|Overall Study|Progressive Disease|2|||
162768981|NCT01986348|587863305|FG003|Overall Study|Progressive Disease|0|||
162768982|NCT01986348|587863302|FG000|Overall Study|Withdrawal by Participant|0|||
162768983|NCT01986348|587863303|FG001|Overall Study|Withdrawal by Participant|1|||
162768984|NCT01986348|587863304|FG002|Overall Study|Withdrawal by Participant|2|||
162768985|NCT01986348|587863305|FG003|Overall Study|Withdrawal by Participant|1|||
162768986|NCT01986348|587863302|FG000|Overall Study|Study Terminated by Sponsor|0|||
162768987|NCT01986348|587863303|FG001|Overall Study|Study Terminated by Sponsor|0|||
162768988|NCT01986348|587863304|FG002|Overall Study|Study Terminated by Sponsor|0|||
162768989|NCT01986348|587863305|FG003|Overall Study|Study Terminated by Sponsor|3|||
162768990|NCT01986348|587863302|FG000|Overall Study|Other-unspecified|0|||
162768991|NCT01986348|587863303|FG001|Overall Study|Other-unspecified|1|||
162768992|NCT01986348|587863304|FG002|Overall Study|Other-unspecified|0|||
162768993|NCT01986348|587863305|FG003|Overall Study|Other-unspecified|2|||
162768994|NCT02935894|587863310|FG000|Overall Study|Subject dismissed|1|||
162768995|NCT01884571|587863313|FG000|Overall Study|Adverse Event|1|||
162768996|NCT01884571|587863313|FG000|Overall Study|Death|2|||
162768997|NCT01884571|587863313|FG000|Overall Study|Withdrawal by Subject|2|||
162768998|NCT01884571|587863313|FG000|Overall Study|Disease progression|3|||
162768999|NCT00853957|587863314|FG000|Overall Study|Adverse Event|9|||
162769000|NCT00853957|587863315|FG001|Overall Study|Adverse Event|3|||
162769001|NCT00853957|587863314|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162769002|NCT00853957|587863315|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162769003|NCT00853957|587863314|FG000|Overall Study|Subject withdrew consent|4|||
162769004|NCT00853957|587863315|FG001|Overall Study|Subject withdrew consent|5|||
162769005|NCT00853957|587863314|FG000|Overall Study|Lost to Follow-up|1|||
162769006|NCT00853957|587863315|FG001|Overall Study|Lost to Follow-up|6|||
162769007|NCT00853957|587863314|FG000|Overall Study|Protocol deviation|0|||
162769008|NCT00853957|587863315|FG001|Overall Study|Protocol deviation|3|||
162769009|NCT04895085|587863318|FG000|Overall Study|Death|1|||
162769010|NCT04895085|587863318|FG000|Overall Study|Withdrawal by Subject|1|||
162769011|NCT04895085|587863318|FG000|Overall Study|No longer eligible: Moved from area|1|||
162769012|NCT04919499|587863323|FG000|Overall Study|Adverse Event|0|||
162769013|NCT04919499|587863324|FG001|Overall Study|Adverse Event|0|||
162769014|NCT04919499|587863325|FG002|Overall Study|Adverse Event|0|||
162769015|NCT04919499|587863326|FG003|Overall Study|Adverse Event|0|||
162769016|NCT04919499|587863327|FG004|Overall Study|Adverse Event|2|||
162769017|NCT04919499|587863323|FG000|Overall Study|Not treated|0|||
162769018|NCT04919499|587863324|FG001|Overall Study|Not treated|0|||
162769019|NCT04919499|587863325|FG002|Overall Study|Not treated|0|||
162769020|NCT04919499|587863326|FG003|Overall Study|Not treated|1|||
162769021|NCT04919499|587863327|FG004|Overall Study|Not treated|0|||
162769022|NCT05379400|587864526|FG000|Overall Study|Lost to Follow-up|1|||
162769023|NCT05379400|587864527|FG001|Overall Study|Lost to Follow-up|1|||
162769024|NCT04851587|587864528|FG000|Overall Study|Lost to Follow-up|18|||
162769025|NCT01020487|587864529|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
162769026|NCT01020487|587864530|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
162769027|NCT01020487|587864531|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
162769028|NCT01020487|587864529|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
162769029|NCT01020487|587864530|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
162769030|NCT01020487|587864531|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
162769031|NCT01020487|587864529|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
162769032|NCT01020487|587864530|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
162769033|NCT01020487|587864531|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
162769034|NCT01020487|587864529|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
162769035|NCT01020487|587864530|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
162769036|NCT01020487|587864531|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
162769037|NCT01020487|587864529|FG000|Part 2 Open-label Period|Adverse Event|0|||
162769038|NCT01020487|587864530|FG001|Part 2 Open-label Period|Adverse Event|4|||
162769039|NCT01020487|587864531|FG002|Part 2 Open-label Period|Adverse Event|1|||
162769040|NCT05878990|587864532|FG000|Overall Study|Lost to Follow-up|7|||
162769041|NCT05878990|587864532|FG000|Overall Study|Withdrawal by Subject|1|||
162769042|NCT03605745|587864533|FG000|Overall Study|Study was terminated for business reasons|47|||
162769043|NCT01279447|587864534|FG000|Overall Study|Lost to Follow-up|3|||
162769044|NCT01279447|587864535|FG001|Overall Study|Lost to Follow-up|1|||
162769045|NCT01074229|587864536|FG000|Overall Study|Lost to Follow-up|1|||
162769046|NCT01074229|587864537|FG001|Overall Study|Lost to Follow-up|0|||
162769047|NCT01074229|587864538|FG002|Overall Study|Lost to Follow-up|0|||
162769048|NCT01074229|587864536|FG000|Overall Study|Change to open surgical procedure|1|||
162769049|NCT01074229|587864537|FG001|Overall Study|Change to open surgical procedure|3|||
162769050|NCT01074229|587864538|FG002|Overall Study|Change to open surgical procedure|4|||
162769051|NCT00901459|587864543|FG000|Overall Study|Withdrawal by Subject|6|||
162769052|NCT00910871|587864555|FG000|Overall Study|Adverse Event|5|||
162769053|NCT00910871|587864555|FG000|Overall Study|Death|12|||
162769054|NCT00910871|587864555|FG000|Overall Study|Lost to Follow-up|8|||
162769055|NCT00910871|587864555|FG000|Overall Study|Protocol Violation|11|||
162769056|NCT00910871|587864555|FG000|Overall Study|Withdrawal by Subject|12|||
162769057|NCT00910871|587864555|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
162769058|NCT00910871|587864555|FG000|Overall Study|Undefined|1|||
162769059|NCT00850993|587864556|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
162769060|NCT00850993|587864557|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
162769061|NCT00850993|587864558|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
162769062|NCT00850993|587864559|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
162769063|NCT04501614|587864565|FG000|Overall Study|Study Terminated by Sponsor|6|||
162769064|NCT04501614|587864566|FG001|Overall Study|Study Terminated by Sponsor|3|||
162769065|NCT04501614|587864565|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
162769066|NCT04501614|587864566|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
162769067|NCT02555397|587864570|FG000|Overall Study|Withdrawal by Subject|1|||
162769068|NCT02555397|587864571|FG001|Overall Study|Withdrawal by Subject|0|||
162769069|NCT02555397|587864572|FG002|Overall Study|Withdrawal by Subject|0|||
162769070|NCT02555397|587864573|FG003|Overall Study|Withdrawal by Subject|0|||
162769071|NCT02555397|587864574|FG004|Overall Study|Withdrawal by Subject|0|||
162769072|NCT01240785|587864580|FG000|Overall Study|Lost to Follow-up|1|||
162769073|NCT01240785|587864581|FG001|Overall Study|Lost to Follow-up|0|||
162769074|NCT01240785|587864580|FG000|Overall Study|Protocol Violation|0|||
162769075|NCT01240785|587864581|FG001|Overall Study|Protocol Violation|3|||
162769076|NCT00237809|587864582|FG000|Overall Study|Lost to Follow-up|11|||
162769077|NCT00237809|587864583|FG001|Overall Study|Lost to Follow-up|10|||
162769078|NCT00237809|587864584|FG002|Overall Study|Lost to Follow-up|9|||
162769079|NCT00237809|587864585|FG003|Overall Study|Lost to Follow-up|9|||
162769080|NCT02006641|587864586|FG000|Overall Study|Withdrawal before treatment|2|||
162769081|NCT02006641|587864587|FG001|Overall Study|Withdrawal before treatment|5|||
162769082|NCT02006641|587864588|FG002|Overall Study|Withdrawal before treatment|3|||
162769083|NCT02006641|587864586|FG000|Overall Study|Adverse Event|15|||
162769084|NCT02006641|587864587|FG001|Overall Study|Adverse Event|11|||
162769085|NCT02006641|587864588|FG002|Overall Study|Adverse Event|15|||
162769086|NCT02006641|587864586|FG000|Overall Study|Protocol Violation|0|||
162769087|NCT02006641|587864587|FG001|Overall Study|Protocol Violation|2|||
162769088|NCT02006641|587864588|FG002|Overall Study|Protocol Violation|2|||
162769089|NCT02006641|587864586|FG000|Overall Study|Lost to Follow-up|0|||
162769090|NCT02006641|587864587|FG001|Overall Study|Lost to Follow-up|1|||
162769091|NCT02006641|587864588|FG002|Overall Study|Lost to Follow-up|0|||
162769092|NCT02006641|587864586|FG000|Overall Study|Withdrawal by Subject|7|||
162769093|NCT02006641|587864587|FG001|Overall Study|Withdrawal by Subject|12|||
162769094|NCT02006641|587864588|FG002|Overall Study|Withdrawal by Subject|11|||
162769095|NCT02006641|587864586|FG000|Overall Study|Other reason: patient didn't show up|1|||
162769096|NCT02006641|587864587|FG001|Overall Study|Other reason: patient didn't show up|0|||
162769097|NCT02006641|587864588|FG002|Overall Study|Other reason: patient didn't show up|0|||
162769098|NCT02006641|587864586|FG000|Overall Study|Other reason:patient didn't want to come|0|||
162769099|NCT02006641|587864587|FG001|Overall Study|Other reason:patient didn't want to come|0|||
162769100|NCT02006641|587864588|FG002|Overall Study|Other reason:patient didn't want to come|1|||
162769101|NCT02006641|587864586|FG000|Overall Study|Other reason: patient has moved|1|||
162769102|NCT02006641|587864587|FG001|Overall Study|Other reason: patient has moved|0|||
162769103|NCT02006641|587864588|FG002|Overall Study|Other reason: patient has moved|1|||
162769104|NCT02006641|587864586|FG000|Overall Study|Other reason: caregiver in hospital|0|||
162769105|NCT02006641|587864587|FG001|Overall Study|Other reason: caregiver in hospital|1|||
162769106|NCT02006641|587864588|FG002|Overall Study|Other reason: caregiver in hospital|0|||
162769107|NCT02006641|587864586|FG000|Overall Study|Other reason: patient's wife has died|0|||
162769108|NCT02006641|587864587|FG001|Overall Study|Other reason: patient's wife has died|0|||
162769109|NCT02006641|587864588|FG002|Overall Study|Other reason: patient's wife has died|1|||
162769110|NCT02006641|587864586|FG000|Overall Study|Other reason: hospitalisation|0|||
162769111|NCT02006641|587864587|FG001|Overall Study|Other reason: hospitalisation|1|||
162769112|NCT02006641|587864588|FG002|Overall Study|Other reason: hospitalisation|0|||
162769113|NCT02006641|587864586|FG000|Overall Study|Other reason: caregiver impossibility|0|||
162769114|NCT02006641|587864587|FG001|Overall Study|Other reason: caregiver impossibility|0|||
162769115|NCT02006641|587864588|FG002|Overall Study|Other reason: caregiver impossibility|1|||
162769116|NCT02006641|587864586|FG000|Overall Study|Other reason: protocol non-compliance|0|||
162769117|NCT02006641|587864587|FG001|Overall Study|Other reason: protocol non-compliance|0|||
162769118|NCT02006641|587864588|FG002|Overall Study|Other reason: protocol non-compliance|1|||
162769119|NCT02132195|587864594|FG000|Initial Assignment|Relapsed|14|||
162769120|NCT02132195|587864595|FG001|Initial Assignment|Relapsed|0|||
162769121|NCT02132195|587864596|FG002|Initial Assignment|Relapsed|0|||
162769122|NCT02132195|587864594|FG000|Rescue Therapy|Relapsed|0|||
162769123|NCT02132195|587864595|FG001|Rescue Therapy|Relapsed|0|||
162769124|NCT02132195|587864596|FG002|Rescue Therapy|Relapsed|7|||
162769125|NCT02132195|587864594|FG000|Rescue Therapy|Physician Decision|0|||
162769126|NCT02132195|587864595|FG001|Rescue Therapy|Physician Decision|0|||
162769127|NCT02132195|587864596|FG002|Rescue Therapy|Physician Decision|1|||
162769128|NCT02132195|587864594|FG000|Rescue Therapy|Withdrawal by Subject|0|||
162769129|NCT02132195|587864595|FG001|Rescue Therapy|Withdrawal by Subject|0|||
162769130|NCT02132195|587864596|FG002|Rescue Therapy|Withdrawal by Subject|1|||
162769131|NCT02132195|587864594|FG000|Rescue Therapy|Adverse Event|0|||
162769132|NCT02132195|587864595|FG001|Rescue Therapy|Adverse Event|0|||
162769133|NCT02132195|587864596|FG002|Rescue Therapy|Adverse Event|2|||
162769134|NCT00321555|587864597|FG000|Overall Study|Developed antibodies|1|||
162769135|NCT00321555|587864597|FG000|Overall Study|Switched to alternative treatment|3|||
162769136|NCT00321555|587864597|FG000|Overall Study|Physician Decision|1|||
162769137|NCT00321555|587864597|FG000|Overall Study|Disease progression on study|1|||
162769138|NCT02066389|587864598|FG000|Overall Study|Adverse Event|1|||
162769139|NCT02066389|587864599|FG001|Overall Study|Adverse Event|1|||
162769140|NCT02066389|587864600|FG002|Overall Study|Adverse Event|1|||
162769141|NCT02066389|587864601|FG003|Overall Study|Adverse Event|1|||
162769142|NCT02066389|587864602|FG004|Overall Study|Adverse Event|5|||
162769143|NCT02066389|587864603|FG005|Overall Study|Adverse Event|1|||
162769144|NCT02066389|587864598|FG000|Overall Study|Withdrawal by Subject|4|||
162769145|NCT02066389|587864599|FG001|Overall Study|Withdrawal by Subject|0|||
162769146|NCT02066389|587864600|FG002|Overall Study|Withdrawal by Subject|5|||
162769147|NCT02066389|587864601|FG003|Overall Study|Withdrawal by Subject|1|||
162769148|NCT02066389|587864602|FG004|Overall Study|Withdrawal by Subject|1|||
162769149|NCT02066389|587864603|FG005|Overall Study|Withdrawal by Subject|2|||
162769150|NCT02066389|587864598|FG000|Overall Study|Lost to Follow-up|0|||
162769151|NCT02066389|587864599|FG001|Overall Study|Lost to Follow-up|0|||
162769152|NCT02066389|587864600|FG002|Overall Study|Lost to Follow-up|0|||
162769153|NCT02066389|587864601|FG003|Overall Study|Lost to Follow-up|1|||
162769154|NCT02066389|587864602|FG004|Overall Study|Lost to Follow-up|1|||
162769155|NCT02066389|587864603|FG005|Overall Study|Lost to Follow-up|1|||
162769156|NCT02066389|587864598|FG000|Overall Study|Randomized in Error|0|||
162769157|NCT02066389|587864599|FG001|Overall Study|Randomized in Error|0|||
162769158|NCT02066389|587864600|FG002|Overall Study|Randomized in Error|0|||
162769159|NCT02066389|587864601|FG003|Overall Study|Randomized in Error|0|||
162769160|NCT02066389|587864602|FG004|Overall Study|Randomized in Error|0|||
162769161|NCT02066389|587864603|FG005|Overall Study|Randomized in Error|1|||
162769162|NCT02561195|587864604|FG000|Vaccination 1 to 3|Adverse Event|4|||
162769163|NCT02561195|587864605|FG001|Vaccination 1 to 3|Adverse Event|5|||
162769164|NCT02561195|587864606|FG002|Vaccination 1 to 3|Adverse Event|0|||
162769165|NCT02561195|587864607|FG003|Vaccination 1 to 3|Adverse Event|3|||
162769166|NCT02561195|587864608|FG004|Vaccination 1 to 3|Adverse Event|4|||
162769167|NCT02561195|587864609|FG005|Vaccination 1 to 3|Adverse Event|0|||
162769168|NCT02561195|587864610|FG006|Vaccination 1 to 3|Adverse Event|0|||
162769169|NCT02561195|587864611|FG007|Vaccination 1 to 3|Adverse Event|0|||
162769170|NCT02561195|587864612|FG008|Vaccination 1 to 3|Adverse Event|0|||
162769171|NCT02561195|587864613|FG009|Vaccination 1 to 3|Adverse Event|0|||
162769172|NCT02561195|587864614|FG010|Vaccination 1 to 3|Adverse Event|0|||
162769173|NCT02561195|587864615|FG011|Vaccination 1 to 3|Adverse Event|0|||
162769174|NCT02561195|587864616|FG012|Vaccination 1 to 3|Adverse Event|0|||
162769175|NCT02561195|587864617|FG013|Vaccination 1 to 3|Adverse Event|0|||
162769176|NCT02561195|587864604|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
162769177|NCT02561195|587864605|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
162769178|NCT02561195|587864606|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
162769179|NCT02561195|587864607|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
162769180|NCT02561195|587864608|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
162769181|NCT02561195|587864609|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
162769182|NCT02561195|587864610|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
162769183|NCT02561195|587864611|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
162769184|NCT02561195|587864612|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
162769185|NCT02561195|587864613|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
162769186|NCT02561195|587864614|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
162769187|NCT02561195|587864615|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
162769188|NCT02561195|587864616|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
162769189|NCT02561195|587864617|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
162769190|NCT02561195|587864604|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769191|NCT02561195|587864605|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
162769192|NCT02561195|587864606|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769193|NCT02561195|587864607|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
162769194|NCT02561195|587864608|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
162769195|NCT02561195|587864609|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
162769196|NCT02561195|587864610|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769197|NCT02561195|587864611|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769198|NCT02561195|587864612|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769199|NCT02561195|587864613|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769200|NCT02561195|587864614|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769201|NCT02561195|587864615|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769202|NCT02561195|587864616|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769203|NCT02561195|587864617|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162769204|NCT02561195|587864604|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
162769205|NCT02561195|587864605|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
162769206|NCT02561195|587864606|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
162769207|NCT02561195|587864607|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
162769208|NCT02561195|587864608|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
162769209|NCT02561195|587864609|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
162769210|NCT02561195|587864610|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
162769211|NCT02561195|587864611|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
162769212|NCT02561195|587864612|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
162769213|NCT02561195|587864613|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
162769214|NCT02561195|587864614|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
162769215|NCT02561195|587864615|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
162769216|NCT02561195|587864616|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
162769217|NCT02561195|587864617|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
162769218|NCT02561195|587864604|FG000|Vaccination 1 to 3|Other|7|||
162769219|NCT02561195|587864605|FG001|Vaccination 1 to 3|Other|3|||
162769220|NCT02561195|587864606|FG002|Vaccination 1 to 3|Other|1|||
162769221|NCT02561195|587864607|FG003|Vaccination 1 to 3|Other|7|||
162769222|NCT02561195|587864608|FG004|Vaccination 1 to 3|Other|5|||
162769223|NCT02561195|587864609|FG005|Vaccination 1 to 3|Other|1|||
162769224|NCT02561195|587864610|FG006|Vaccination 1 to 3|Other|0|||
162769225|NCT02561195|587864611|FG007|Vaccination 1 to 3|Other|0|||
162769226|NCT02561195|587864612|FG008|Vaccination 1 to 3|Other|0|||
162769227|NCT02561195|587864613|FG009|Vaccination 1 to 3|Other|0|||
162769228|NCT02561195|587864614|FG010|Vaccination 1 to 3|Other|0|||
162769229|NCT02561195|587864615|FG011|Vaccination 1 to 3|Other|0|||
162769230|NCT02561195|587864616|FG012|Vaccination 1 to 3|Other|0|||
162769231|NCT02561195|587864617|FG013|Vaccination 1 to 3|Other|0|||
162769232|NCT02561195|587864604|FG000|Vaccination 1 to 3|Protocol Violation|1|||
162769233|NCT02561195|587864605|FG001|Vaccination 1 to 3|Protocol Violation|0|||
162769234|NCT02561195|587864606|FG002|Vaccination 1 to 3|Protocol Violation|1|||
162769235|NCT02561195|587864607|FG003|Vaccination 1 to 3|Protocol Violation|2|||
162769236|NCT02561195|587864608|FG004|Vaccination 1 to 3|Protocol Violation|5|||
162769237|NCT02561195|587864609|FG005|Vaccination 1 to 3|Protocol Violation|2|||
162769238|NCT02561195|587864610|FG006|Vaccination 1 to 3|Protocol Violation|0|||
162769239|NCT02561195|587864611|FG007|Vaccination 1 to 3|Protocol Violation|0|||
162769240|NCT02561195|587864612|FG008|Vaccination 1 to 3|Protocol Violation|0|||
162769241|NCT02561195|587864613|FG009|Vaccination 1 to 3|Protocol Violation|0|||
162769242|NCT02561195|587864614|FG010|Vaccination 1 to 3|Protocol Violation|0|||
162769243|NCT02561195|587864615|FG011|Vaccination 1 to 3|Protocol Violation|0|||
162769244|NCT02561195|587864616|FG012|Vaccination 1 to 3|Protocol Violation|0|||
162769245|NCT02561195|587864617|FG013|Vaccination 1 to 3|Protocol Violation|0|||
162769246|NCT02561195|587864604|FG000|Vaccination 1 to 3|Death|2|||
162769247|NCT02561195|587864605|FG001|Vaccination 1 to 3|Death|1|||
162769248|NCT02561195|587864606|FG002|Vaccination 1 to 3|Death|0|||
162769249|NCT02561195|587864607|FG003|Vaccination 1 to 3|Death|2|||
162769250|NCT02561195|587864608|FG004|Vaccination 1 to 3|Death|0|||
162769251|NCT02561195|587864609|FG005|Vaccination 1 to 3|Death|0|||
162769252|NCT02561195|587864610|FG006|Vaccination 1 to 3|Death|0|||
162769253|NCT02561195|587864611|FG007|Vaccination 1 to 3|Death|0|||
162769254|NCT02561195|587864612|FG008|Vaccination 1 to 3|Death|0|||
162769255|NCT02561195|587864613|FG009|Vaccination 1 to 3|Death|0|||
162769256|NCT02561195|587864614|FG010|Vaccination 1 to 3|Death|0|||
162769257|NCT02561195|587864615|FG011|Vaccination 1 to 3|Death|0|||
162769258|NCT02561195|587864616|FG012|Vaccination 1 to 3|Death|0|||
162769259|NCT02561195|587864617|FG013|Vaccination 1 to 3|Death|0|||
162769260|NCT02561195|587864604|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
162769261|NCT02561195|587864605|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
162769262|NCT02561195|587864606|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
162769263|NCT02561195|587864607|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
162769264|NCT02561195|587864608|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
162769265|NCT02561195|587864609|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769266|NCT02561195|587864610|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769267|NCT02561195|587864611|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769268|NCT02561195|587864612|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769269|NCT02561195|587864613|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769270|NCT02561195|587864614|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769271|NCT02561195|587864615|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769272|NCT02561195|587864616|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769273|NCT02561195|587864617|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
162769274|NCT02561195|587864604|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
162769275|NCT02561195|587864605|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
162769276|NCT02561195|587864606|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
162769277|NCT02561195|587864607|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
162769278|NCT02561195|587864608|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
162769279|NCT02561195|587864609|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
162769280|NCT02561195|587864610|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
162769281|NCT02561195|587864611|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
162769282|NCT02561195|587864612|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
162769283|NCT02561195|587864613|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
162769284|NCT02561195|587864614|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
162769285|NCT02561195|587864615|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
162769286|NCT02561195|587864616|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
162769287|NCT02561195|587864617|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
162769288|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769289|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769290|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769291|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769292|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769293|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769294|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769295|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769296|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
162769297|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
162769298|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
162769299|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
162769300|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
162769301|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162769302|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769303|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769304|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769305|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769306|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769307|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769308|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769309|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769310|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769311|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769312|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769313|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769314|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
162769315|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
162769316|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Death|0|||
162769317|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Death|0|||
162769318|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Death|0|||
162769319|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Death|0|||
162769320|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Death|0|||
162769321|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Death|0|||
162769322|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Death|0|||
162769323|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Death|0|||
162769324|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Death|0|||
162769325|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Death|1|||
162769326|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Death|0|||
162769327|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Death|0|||
162769328|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Death|0|||
162769329|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Death|0|||
162769330|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769331|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769332|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769333|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769334|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769335|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769336|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162769337|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162769338|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769339|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162769340|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
162769341|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162769342|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
162769343|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162769344|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769345|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769346|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769347|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769348|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769349|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769350|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769351|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769352|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769353|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769354|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162769355|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
162769356|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
162769357|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
162769358|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Other|0|||
162769359|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Other|0|||
162769360|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Other|0|||
162769361|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Other|0|||
162769362|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Other|0|||
162769363|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Other|0|||
162769364|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Other|0|||
162769365|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Other|0|||
162769366|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Other|0|||
162769367|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Other|0|||
162769368|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Other|2|||
162769369|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Other|2|||
162769370|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Other|1|||
162769371|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Other|0|||
162769372|NCT02561195|587864604|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769373|NCT02561195|587864605|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769374|NCT02561195|587864606|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769375|NCT02561195|587864607|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769376|NCT02561195|587864608|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769377|NCT02561195|587864609|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769378|NCT02561195|587864610|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162769379|NCT02561195|587864611|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769380|NCT02561195|587864612|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769381|NCT02561195|587864613|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769382|NCT02561195|587864614|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
162769383|NCT02561195|587864615|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162769384|NCT02561195|587864616|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162769385|NCT02561195|587864617|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162769386|NCT00736502|587864618|FG000|Overall Study|Adverse Event|22|||
162769387|NCT00736502|587864618|FG000|Overall Study|Lack of Efficacy|16|||
162769388|NCT00736502|587864618|FG000|Overall Study|Lost to Follow-up|27|||
162769389|NCT00508144|587864620|FG000|Overall Study|Not eligible|6|||
162769390|NCT00508144|587864620|FG000|Overall Study|Death|5|||
162769391|NCT01661972|587864621|FG000|Overall Study|Adverse Event|1|||
162769392|NCT01661972|587864622|FG001|Overall Study|Adverse Event|2|||
162769393|NCT01661972|587864621|FG000|Overall Study|Death during Treatment period|1|||
162769394|NCT01661972|587864622|FG001|Overall Study|Death during Treatment period|1|||
162769395|NCT01661972|587864621|FG000|Overall Study|Withdrawal by Subject|0|||
162769396|NCT01661972|587864622|FG001|Overall Study|Withdrawal by Subject|1|||
162769397|NCT01084772|587864623|FG000|Baseline|Withdrawal by Subject|7|||
162769398|NCT01084772|587864624|FG001|Baseline|Withdrawal by Subject|6|||
162769399|NCT01084772|587864623|FG000|3 Months|Death|1|||
162769400|NCT01084772|587864624|FG001|3 Months|Death|0|||
162769401|NCT01084772|587864623|FG000|3 Months|Study Termination|2|||
162769402|NCT01084772|587864624|FG001|3 Months|Study Termination|2|||
162769403|NCT01084772|587864623|FG000|1 Year|Withdrawal by Subject|0|||
162769404|NCT01084772|587864624|FG001|1 Year|Withdrawal by Subject|1|||
162769405|NCT01084772|587864623|FG000|1 Year|Lost to Follow-up|3|||
162769406|NCT01084772|587864624|FG001|1 Year|Lost to Follow-up|0|||
162769407|NCT01084772|587864623|FG000|1 Year|Study Termination|0|||
162769408|NCT01084772|587864624|FG001|1 Year|Study Termination|7|||
162769409|NCT01084772|587864623|FG000|2 Years|Withdrawal by Subject|1|||
162769410|NCT01084772|587864624|FG001|2 Years|Withdrawal by Subject|0|||
162769411|NCT01084772|587864623|FG000|2 Years|Lost to Follow-up|5|||
162769412|NCT01084772|587864624|FG001|2 Years|Lost to Follow-up|2|||
162769413|NCT01084772|587864623|FG000|2 Years|Study Termination|3|||
162769414|NCT01084772|587864624|FG001|2 Years|Study Termination|2|||
162769415|NCT01517282|587864625|FG000|Overall Study|Consent withdrawn|0|||
162769416|NCT01517282|587864626|FG001|Overall Study|Consent withdrawn|1|||
162769417|NCT01517282|587864627|FG002|Overall Study|Consent withdrawn|1|||
162769418|NCT01517282|587864628|FG003|Overall Study|Consent withdrawn|1|||
162769419|NCT01517282|587864625|FG000|Overall Study|Physician Decision|1|||
162769420|NCT01517282|587864626|FG001|Overall Study|Physician Decision|0|||
162769421|NCT01517282|587864627|FG002|Overall Study|Physician Decision|0|||
162769422|NCT01517282|587864628|FG003|Overall Study|Physician Decision|0|||
162769423|NCT02942771|587864631|FG000|Overall Study|Adverse Event|1|||
162769424|NCT02942771|587864632|FG001|Overall Study|Adverse Event|0|||
162769425|NCT02942771|587864633|FG002|Overall Study|Adverse Event|0|||
162769426|NCT02942771|587864634|FG003|Overall Study|Adverse Event|0|||
162769427|NCT02942771|587864635|FG004|Overall Study|Adverse Event|2|||
162769428|NCT02942771|587864631|FG000|Overall Study|Lost to Follow-up|1|||
162769429|NCT02942771|587864632|FG001|Overall Study|Lost to Follow-up|0|||
162769430|NCT02942771|587864633|FG002|Overall Study|Lost to Follow-up|0|||
162769431|NCT02942771|587864634|FG003|Overall Study|Lost to Follow-up|0|||
162769432|NCT02942771|587864635|FG004|Overall Study|Lost to Follow-up|0|||
162769433|NCT02942771|587864631|FG000|Overall Study|Withdrawal by Subject|1|||
162769434|NCT02942771|587864632|FG001|Overall Study|Withdrawal by Subject|0|||
162769435|NCT02942771|587864633|FG002|Overall Study|Withdrawal by Subject|0|||
162769436|NCT02942771|587864634|FG003|Overall Study|Withdrawal by Subject|0|||
162769437|NCT02942771|587864635|FG004|Overall Study|Withdrawal by Subject|2|||
162769438|NCT02158806|587864636|FG000|Overall Study|Death|2|||
162769439|NCT02158806|587864637|FG001|Overall Study|Death|0|||
162769440|NCT02158806|587864636|FG000|Overall Study|Withdrawal by Subject|2|||
162769441|NCT02158806|587864637|FG001|Overall Study|Withdrawal by Subject|0|||
162769442|NCT02158806|587864636|FG000|Overall Study|Lost to Follow-up|0|||
162769443|NCT02158806|587864637|FG001|Overall Study|Lost to Follow-up|3|||
162769444|NCT02158806|587864636|FG000|Overall Study|Moved out of area|0|||
162769445|NCT02158806|587864637|FG001|Overall Study|Moved out of area|1|||
162769446|NCT02158806|587864636|FG000|Overall Study|Transferred to palliative care|0|||
162769447|NCT02158806|587864637|FG001|Overall Study|Transferred to palliative care|1|||
162769448|NCT01898299|587864641|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
162769449|NCT01898299|587864642|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
162769450|NCT02340806|587864643|FG000|Overall Study|Protocol Violation|2|||
162769451|NCT02340806|587864644|FG001|Overall Study|Protocol Violation|0|||
162769452|NCT02340806|587864643|FG000|Overall Study|epidural catheter replaced|2|||
162769453|NCT02340806|587864644|FG001|Overall Study|epidural catheter replaced|1|||
162769454|NCT02340806|587864643|FG000|Overall Study|history of chronic pain medication|1|||
162769455|NCT02340806|587864644|FG001|Overall Study|history of chronic pain medication|0|||
162769456|NCT02340806|587864643|FG000|Overall Study|re-dose < 90 min of CSE|1|||
162769457|NCT02340806|587864644|FG001|Overall Study|re-dose < 90 min of CSE|3|||
162769458|NCT01186809|587864645|FG000|Overall Study|Death|30|||
162769459|NCT01159600|587864647|FG000|Overall Study|Not treated|0|||
162769460|NCT01159600|587864648|FG001|Overall Study|Not treated|0|||
162769461|NCT01159600|587864649|FG002|Overall Study|Not treated|1|||
162769462|NCT01159600|587864650|FG003|Overall Study|Not treated|0|||
162769463|NCT01159600|587864651|FG004|Overall Study|Not treated|0|||
162769464|NCT01159600|587864652|FG005|Overall Study|Not treated|1|||
162769465|NCT01159600|587864653|FG006|Overall Study|Not treated|2|||
162769466|NCT01159600|587864654|FG007|Overall Study|Not treated|2|||
162769467|NCT01159600|587864647|FG000|Overall Study|Adverse Event|7|||
162769468|NCT01159600|587864648|FG001|Overall Study|Adverse Event|2|||
162769469|NCT01159600|587864649|FG002|Overall Study|Adverse Event|5|||
162769470|NCT01159600|587864650|FG003|Overall Study|Adverse Event|1|||
162769471|NCT01159600|587864651|FG004|Overall Study|Adverse Event|8|||
162769472|NCT01159600|587864652|FG005|Overall Study|Adverse Event|6|||
162769473|NCT01159600|587864653|FG006|Overall Study|Adverse Event|7|||
162769474|NCT01159600|587864654|FG007|Overall Study|Adverse Event|5|||
162769475|NCT01159600|587864647|FG000|Overall Study|Lack of Efficacy|0|||
162769476|NCT01159600|587864648|FG001|Overall Study|Lack of Efficacy|0|||
162769477|NCT01159600|587864649|FG002|Overall Study|Lack of Efficacy|0|||
162769478|NCT01159600|587864650|FG003|Overall Study|Lack of Efficacy|0|||
162769479|NCT01159600|587864651|FG004|Overall Study|Lack of Efficacy|2|||
162769480|NCT01159600|587864652|FG005|Overall Study|Lack of Efficacy|0|||
162769481|NCT01159600|587864653|FG006|Overall Study|Lack of Efficacy|0|||
162769482|NCT01159600|587864654|FG007|Overall Study|Lack of Efficacy|1|||
162769483|NCT01159600|587864647|FG000|Overall Study|Non compliant with protocol|2|||
162769484|NCT01159600|587864648|FG001|Overall Study|Non compliant with protocol|1|||
162769485|NCT01159600|587864649|FG002|Overall Study|Non compliant with protocol|0|||
162769486|NCT01159600|587864650|FG003|Overall Study|Non compliant with protocol|0|||
162769487|NCT01159600|587864651|FG004|Overall Study|Non compliant with protocol|2|||
162769488|NCT01159600|587864652|FG005|Overall Study|Non compliant with protocol|0|||
162769489|NCT01159600|587864653|FG006|Overall Study|Non compliant with protocol|2|||
162769490|NCT01159600|587864654|FG007|Overall Study|Non compliant with protocol|0|||
162769491|NCT01159600|587864647|FG000|Overall Study|Lost to Follow-up|2|||
162769492|NCT01159600|587864648|FG001|Overall Study|Lost to Follow-up|3|||
162769493|NCT01159600|587864649|FG002|Overall Study|Lost to Follow-up|4|||
162769494|NCT01159600|587864650|FG003|Overall Study|Lost to Follow-up|3|||
162769495|NCT01159600|587864651|FG004|Overall Study|Lost to Follow-up|3|||
162769496|NCT01159600|587864652|FG005|Overall Study|Lost to Follow-up|0|||
162769497|NCT01159600|587864653|FG006|Overall Study|Lost to Follow-up|3|||
162769498|NCT01159600|587864654|FG007|Overall Study|Lost to Follow-up|2|||
162769499|NCT01159600|587864647|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
162769500|NCT01159600|587864648|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
162769501|NCT01159600|587864649|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
162769502|NCT01159600|587864650|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
162769503|NCT01159600|587864651|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
162769504|NCT01159600|587864652|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
162769505|NCT01159600|587864653|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
162769506|NCT01159600|587864654|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
162769507|NCT01159600|587864647|FG000|Overall Study|Other reason not defined above|3|||
162769508|NCT01159600|587864648|FG001|Overall Study|Other reason not defined above|0|||
162769509|NCT01159600|587864649|FG002|Overall Study|Other reason not defined above|4|||
162769510|NCT01159600|587864650|FG003|Overall Study|Other reason not defined above|2|||
162769511|NCT01159600|587864651|FG004|Overall Study|Other reason not defined above|5|||
162769512|NCT01159600|587864652|FG005|Overall Study|Other reason not defined above|7|||
162769513|NCT01159600|587864653|FG006|Overall Study|Other reason not defined above|3|||
162769514|NCT01159600|587864654|FG007|Overall Study|Other reason not defined above|3|||
162769515|NCT00760877|587865946|FG000|Overall Study|Protocol Violation|1|||
162769516|NCT00760877|587865947|FG001|Overall Study|Protocol Violation|0|||
162769517|NCT00760877|587865946|FG000|Overall Study|Non-compliance with protocol treatment|2|||
162769518|NCT00760877|587865947|FG001|Overall Study|Non-compliance with protocol treatment|1|||
162769519|NCT00760877|587865946|FG000|Overall Study|Pregnancy|1|||
162769520|NCT00760877|587865947|FG001|Overall Study|Pregnancy|4|||
162769521|NCT00760877|587865946|FG000|Overall Study|Death|2|||
162769522|NCT00760877|587865947|FG001|Overall Study|Death|1|||
162769523|NCT00760877|587865946|FG000|Overall Study|Withdrawal by Subject|7|||
162769524|NCT00760877|587865947|FG001|Overall Study|Withdrawal by Subject|3|||
162769525|NCT00760877|587865946|FG000|Overall Study|Adverse Event|19|||
162769526|NCT00760877|587865947|FG001|Overall Study|Adverse Event|12|||
162769527|NCT00760877|587865946|FG000|Overall Study|Participant diagnosed with AML|0|||
162769528|NCT00760877|587865947|FG001|Overall Study|Participant diagnosed with AML|1|||
162769529|NCT00760877|587865946|FG000|Overall Study|Participant not eligible to cross-over|0|||
162769530|NCT00760877|587865947|FG001|Overall Study|Participant not eligible to cross-over|1|||
162769531|NCT00760877|587865946|FG000|Overall Study|Physician Decision|1|||
162769532|NCT00760877|587865947|FG001|Overall Study|Physician Decision|2|||
162769533|NCT00760877|587865946|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
162769534|NCT00760877|587865947|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
162769535|NCT00760877|587865946|FG000|Overall Study|Treatment failure|1|||
162769536|NCT00760877|587865947|FG001|Overall Study|Treatment failure|0|||
162769537|NCT04413149|587865948|FG000|Overall Study|Death|10|||
162769538|NCT04413149|587865949|FG001|Overall Study|Death|5|||
162769539|NCT04413149|587865948|FG000|Overall Study|Lung transplantation|1|||
162769540|NCT04413149|587865949|FG001|Overall Study|Lung transplantation|0|||
162769541|NCT02878590|587865950|FG000|Overall Study|Withdrawal by Subject|2|||
162769542|NCT01730118|587865951|FG000|Dose Escalation|Death on study|5|||
162769543|NCT01730118|587865952|FG001|Dose Escalation|Death on study|7|||
162769544|NCT01730118|587865953|FG002|Dose Escalation|Death on study|2|||
162769545|NCT01730118|587865954|FG003|Dose Escalation|Death on study|6|||
162769546|NCT01730118|587865955|FG004|Dose Escalation|Death on study|0|||
162769547|NCT01730118|587865956|FG005|Dose Escalation|Death on study|0|||
162769548|NCT01730118|587865957|FG006|Dose Escalation|Death on study|0|||
162769549|NCT01730118|587865951|FG000|Dose Escalation|Died before treatment|0|||
162769550|NCT01730118|587865952|FG001|Dose Escalation|Died before treatment|0|||
162769551|NCT01730118|587865953|FG002|Dose Escalation|Died before treatment|0|||
162769552|NCT01730118|587865954|FG003|Dose Escalation|Died before treatment|0|||
162769553|NCT01730118|587865955|FG004|Dose Escalation|Died before treatment|0|||
162769554|NCT01730118|587865956|FG005|Dose Escalation|Died before treatment|0|||
162769555|NCT01730118|587865957|FG006|Dose Escalation|Died before treatment|1|||
162769556|NCT01730118|587865951|FG000|Dose Escalation|Chose to start a different treatment|1|||
162769557|NCT01730118|587865952|FG001|Dose Escalation|Chose to start a different treatment|0|||
162769558|NCT01730118|587865953|FG002|Dose Escalation|Chose to start a different treatment|0|||
162769559|NCT01730118|587865954|FG003|Dose Escalation|Chose to start a different treatment|0|||
162769560|NCT01730118|587865955|FG004|Dose Escalation|Chose to start a different treatment|0|||
162769561|NCT01730118|587865956|FG005|Dose Escalation|Chose to start a different treatment|0|||
162769562|NCT01730118|587865957|FG006|Dose Escalation|Chose to start a different treatment|0|||
162769563|NCT01730118|587865951|FG000|Dose Escalation|Withdrawal by Subject|0|||
162769564|NCT01730118|587865952|FG001|Dose Escalation|Withdrawal by Subject|0|||
162769565|NCT01730118|587865953|FG002|Dose Escalation|Withdrawal by Subject|1|||
162769566|NCT01730118|587865954|FG003|Dose Escalation|Withdrawal by Subject|0|||
162769567|NCT01730118|587865955|FG004|Dose Escalation|Withdrawal by Subject|0|||
162769568|NCT01730118|587865956|FG005|Dose Escalation|Withdrawal by Subject|0|||
162769569|NCT01730118|587865957|FG006|Dose Escalation|Withdrawal by Subject|0|||
162769570|NCT01730118|587865951|FG000|Dose Escalation|Disease progression prior to treatment|0|||
162769571|NCT01730118|587865952|FG001|Dose Escalation|Disease progression prior to treatment|0|||
162769572|NCT01730118|587865953|FG002|Dose Escalation|Disease progression prior to treatment|0|||
162769573|NCT01730118|587865954|FG003|Dose Escalation|Disease progression prior to treatment|0|||
162769574|NCT01730118|587865955|FG004|Dose Escalation|Disease progression prior to treatment|0|||
162769575|NCT01730118|587865956|FG005|Dose Escalation|Disease progression prior to treatment|0|||
162769576|NCT01730118|587865957|FG006|Dose Escalation|Disease progression prior to treatment|1|||
162769577|NCT01730118|587865951|FG000|Dose Expansion|Death|0|||
162769578|NCT01730118|587865952|FG001|Dose Expansion|Death|0|||
162769579|NCT01730118|587865953|FG002|Dose Expansion|Death|0|||
162769580|NCT01730118|587865954|FG003|Dose Expansion|Death|0|||
162769581|NCT01730118|587865955|FG004|Dose Expansion|Death|1|||
162769582|NCT01730118|587865956|FG005|Dose Expansion|Death|0|||
162769583|NCT01730118|587865957|FG006|Dose Expansion|Death|0|||
162769584|NCT01730118|587865951|FG000|Dose Expansion|Other medical condition|0|||
162769585|NCT01730118|587865952|FG001|Dose Expansion|Other medical condition|0|||
162769586|NCT01730118|587865953|FG002|Dose Expansion|Other medical condition|0|||
162769587|NCT01730118|587865954|FG003|Dose Expansion|Other medical condition|0|||
162769588|NCT01730118|587865955|FG004|Dose Expansion|Other medical condition|1|||
162769589|NCT01730118|587865956|FG005|Dose Expansion|Other medical condition|0|||
162769590|NCT01730118|587865957|FG006|Dose Expansion|Other medical condition|0|||
162769591|NCT01730118|587865951|FG000|Dose Expansion|Withdrawal by Subject|0|||
162769592|NCT01730118|587865952|FG001|Dose Expansion|Withdrawal by Subject|0|||
162769593|NCT01730118|587865953|FG002|Dose Expansion|Withdrawal by Subject|0|||
162769594|NCT01730118|587865954|FG003|Dose Expansion|Withdrawal by Subject|0|||
162769595|NCT01730118|587865955|FG004|Dose Expansion|Withdrawal by Subject|1|||
162769596|NCT01730118|587865956|FG005|Dose Expansion|Withdrawal by Subject|0|||
162769597|NCT01730118|587865957|FG006|Dose Expansion|Withdrawal by Subject|0|||
162769598|NCT01730118|587865951|FG000|Dose Expansion|Disease progression|0|||
162769599|NCT01730118|587865952|FG001|Dose Expansion|Disease progression|0|||
162769600|NCT01730118|587865953|FG002|Dose Expansion|Disease progression|0|||
162769601|NCT01730118|587865954|FG003|Dose Expansion|Disease progression|0|||
162769602|NCT01730118|587865955|FG004|Dose Expansion|Disease progression|0|||
162769603|NCT01730118|587865956|FG005|Dose Expansion|Disease progression|1|||
162769604|NCT01730118|587865957|FG006|Dose Expansion|Disease progression|0|||
162769605|NCT01730118|587865951|FG000|Dose Expansion|Inability to return|0|||
162769606|NCT01730118|587865952|FG001|Dose Expansion|Inability to return|0|||
162769607|NCT01730118|587865953|FG002|Dose Expansion|Inability to return|0|||
162769608|NCT01730118|587865954|FG003|Dose Expansion|Inability to return|0|||
162769609|NCT01730118|587865955|FG004|Dose Expansion|Inability to return|0|||
162769610|NCT01730118|587865956|FG005|Dose Expansion|Inability to return|1|||
162769611|NCT01730118|587865957|FG006|Dose Expansion|Inability to return|0|||
162769612|NCT01730118|587865951|FG000|Dose Expansion|Physician Decision|0|||
162769613|NCT01730118|587865952|FG001|Dose Expansion|Physician Decision|0|||
162769614|NCT01730118|587865953|FG002|Dose Expansion|Physician Decision|0|||
162769615|NCT01730118|587865954|FG003|Dose Expansion|Physician Decision|0|||
162769616|NCT01730118|587865955|FG004|Dose Expansion|Physician Decision|0|||
162769617|NCT01730118|587865956|FG005|Dose Expansion|Physician Decision|1|||
162769618|NCT01730118|587865957|FG006|Dose Expansion|Physician Decision|0|||
162769619|NCT04049578|587865960|FG000|Overall Study|Physician Decision|1|||
162769620|NCT00668746|587865961|FG000|Overall Study|Lost to Follow-up|2|||
162769621|NCT00668746|587865962|FG001|Overall Study|Lost to Follow-up|1|||
162769622|NCT03409276|587865963|FG000|Overall Study|Withdrawal by Subject|0|||
162769623|NCT03409276|587865964|FG001|Overall Study|Withdrawal by Subject|0|||
162769624|NCT03409276|587865965|FG002|Overall Study|Withdrawal by Subject|0|||
162769625|NCT03409276|587865966|FG003|Overall Study|Withdrawal by Subject|0|||
162769626|NCT03409276|587865967|FG004|Overall Study|Withdrawal by Subject|1|||
162769627|NCT03409276|587865963|FG000|Overall Study|Lost to Follow-up|0|||
162769628|NCT03409276|587865964|FG001|Overall Study|Lost to Follow-up|0|||
162769629|NCT03409276|587865965|FG002|Overall Study|Lost to Follow-up|0|||
162769630|NCT03409276|587865966|FG003|Overall Study|Lost to Follow-up|2|||
162769631|NCT03409276|587865967|FG004|Overall Study|Lost to Follow-up|2|||
162769632|NCT05361304|587865977|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
162769633|NCT05361304|587865978|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
162769634|NCT05361304|587865977|FG000|Overall Study|COVID-19 Related|1|||
162769635|NCT05361304|587865978|FG001|Overall Study|COVID-19 Related|2|||
162769636|NCT05361304|587865977|FG000|Overall Study|Withdrawal by Subject|1|||
162769637|NCT05361304|587865978|FG001|Overall Study|Withdrawal by Subject|0|||
162769638|NCT03320941|587865979|FG000|Overall Study|subject/guardian decision|0|||
162769639|NCT03320941|587865980|FG001|Overall Study|subject/guardian decision|0|||
162769640|NCT03320941|587865981|FG002|Overall Study|subject/guardian decision|0|||
162769641|NCT03320941|587865982|FG003|Overall Study|subject/guardian decision|1|||
162769642|NCT03320941|587865983|FG004|Overall Study|subject/guardian decision|0|||
162769643|NCT02368691|587865985|FG000|Overall Study|Death|13|||
162769644|NCT02368691|587865985|FG000|Overall Study|Lack of Efficacy|15|||
162769645|NCT02368691|587865985|FG000|Overall Study|Physician Decision|4|||
162769646|NCT03314233|587865986|FG000|Overall Study|No longer eligible at time of delivery|1|||
162769647|NCT01797705|587865987|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
162769648|NCT01797705|587865987|FG000|Overall Study|Withdrawal by Subject|1|||
162769649|NCT01838447|587865988|FG000|Overall Study|Change in surgical plan|1|||
162769650|NCT01838447|587865989|FG001|Overall Study|Change in surgical plan|2|||
162769651|NCT01838447|587865988|FG000|Overall Study|Withdrawal by Subject|1|||
162769652|NCT01838447|587865989|FG001|Overall Study|Withdrawal by Subject|1|||
162769653|NCT01114217|587865991|FG000|Overall Study|Adverse Event|5|||
162769654|NCT01114217|587865992|FG001|Overall Study|Adverse Event|3|||
162769655|NCT01114217|587865991|FG000|Overall Study|Lost to Follow-up|17|||
162769656|NCT01114217|587865992|FG001|Overall Study|Lost to Follow-up|33|||
162769657|NCT01114217|587865991|FG000|Overall Study|Withdrawal by Subject|21|||
162769658|NCT01114217|587865992|FG001|Overall Study|Withdrawal by Subject|28|||
162769659|NCT01114217|587865991|FG000|Overall Study|Other-Clerical Error|3|||
162769660|NCT01114217|587865992|FG001|Overall Study|Other-Clerical Error|0|||
162769661|NCT01114217|587865991|FG000|Overall Study|Other-Early termination|6|||
162769662|NCT01114217|587865992|FG001|Overall Study|Other-Early termination|10|||
162769663|NCT01114217|587865991|FG000|Overall Study|Other-Procedure|1|||
162769664|NCT01114217|587865992|FG001|Overall Study|Other-Procedure|1|||
162769665|NCT01114217|587865991|FG000|Overall Study|Other-Pregnancy|2|||
162769666|NCT01114217|587865992|FG001|Overall Study|Other-Pregnancy|4|||
162769667|NCT01114217|587865991|FG000|Overall Study|Other-Protocol Violation|1|||
162769668|NCT01114217|587865992|FG001|Overall Study|Other-Protocol Violation|3|||
162769669|NCT01114217|587865991|FG000|Overall Study|Other-Lack of Efficacy|1|||
162769670|NCT01114217|587865992|FG001|Overall Study|Other-Lack of Efficacy|0|||
162769671|NCT01114217|587865991|FG000|Overall Study|Other-Non Compliance|2|||
162769672|NCT01114217|587865992|FG001|Overall Study|Other-Non Compliance|0|||
162769673|NCT01114217|587865991|FG000|Overall Study|Other-Physician Decision|1|||
162769674|NCT01114217|587865992|FG001|Overall Study|Other-Physician Decision|1|||
162769675|NCT01114217|587865991|FG000|Overall Study|Other-Sponsor Decision|10|||
162769676|NCT01114217|587865992|FG001|Overall Study|Other-Sponsor Decision|12|||
162769677|NCT01114217|587865991|FG000|Overall Study|Other-Study Termination|0|||
162769678|NCT01114217|587865992|FG001|Overall Study|Other-Study Termination|1|||
162769679|NCT01114217|587865991|FG000|Overall Study|Other-Study Withdrawn|1|||
162769680|NCT01114217|587865992|FG001|Overall Study|Other-Study Withdrawn|1|||
162769681|NCT01114217|587865991|FG000|Overall Study|Other-Site Stopped Communicating|2|||
162769682|NCT01114217|587865992|FG001|Overall Study|Other-Site Stopped Communicating|0|||
162769683|NCT01114217|587865991|FG000|Overall Study|Other-Lost to Follow-up|1|||
162769684|NCT01114217|587865992|FG001|Overall Study|Other-Lost to Follow-up|0|||
162769685|NCT01114217|587865991|FG000|Overall Study|Other-Withdrawal by Subject|1|||
162769686|NCT01114217|587865992|FG001|Overall Study|Other-Withdrawal by Subject|1|||
162769687|NCT01837719|587865993|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
162769688|NCT01837719|587865993|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
162769689|NCT01703988|587865994|FG000|Overall Study|Investigator Judgment|0|||
162769690|NCT01703988|587865995|FG001|Overall Study|Investigator Judgment|0|||
162769691|NCT01703988|587865996|FG002|Overall Study|Investigator Judgment|0|||
162769692|NCT01703988|587865997|FG003|Overall Study|Investigator Judgment|1|||
162769693|NCT06247488|587865998|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
162769694|NCT06247488|587865999|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162769695|NCT06247488|587866000|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162769696|NCT06247488|587866001|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162769697|NCT06247488|587866002|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162769698|NCT06247488|587866003|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162769699|NCT06247488|587865998|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162769700|NCT06247488|587865999|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162769701|NCT06247488|587866000|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162769702|NCT06247488|587866001|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
162769703|NCT06247488|587866002|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162769704|NCT06247488|587866003|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162769705|NCT06247488|587865998|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
162769706|NCT06247488|587865999|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162769707|NCT06247488|587866000|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162769708|NCT06247488|587866001|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162769709|NCT06247488|587866002|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162769710|NCT06247488|587866003|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162769711|NCT06247488|587865998|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162769712|NCT06247488|587865999|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162769713|NCT06247488|587866000|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162769714|NCT06247488|587866001|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
162769715|NCT06247488|587866002|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162769716|NCT06247488|587866003|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162769717|NCT06247488|587865998|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162769718|NCT06247488|587865999|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162769719|NCT06247488|587866000|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162769720|NCT06247488|587866001|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162769721|NCT06247488|587866002|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162769722|NCT06247488|587866003|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
162769723|NCT06247488|587865998|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162769724|NCT06247488|587865999|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
162769725|NCT06247488|587866000|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
162769726|NCT06247488|587866001|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162769727|NCT06247488|587866002|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162769728|NCT06247488|587866003|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
162769729|NCT06247488|587865998|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162769730|NCT06247488|587865999|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162769731|NCT06247488|587866000|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162769732|NCT06247488|587866001|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162769733|NCT06247488|587866002|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162769734|NCT06247488|587866003|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
162769735|NCT01183013|587866006|FG000|Overall Study|Adverse Event|6|||
162769736|NCT01183013|587866007|FG001|Overall Study|Adverse Event|8|||
162769737|NCT01183013|587866008|FG002|Overall Study|Adverse Event|5|||
162769738|NCT01183013|587866009|FG003|Overall Study|Adverse Event|5|||
162769739|NCT01183013|587866010|FG004|Overall Study|Adverse Event|10|||
162769740|NCT01183013|587866011|FG005|Overall Study|Adverse Event|10|||
162769741|NCT01183013|587866012|FG006|Overall Study|Adverse Event|6|||
162769742|NCT01183013|587866006|FG000|Overall Study|Lack of Efficacy|3|||
162769743|NCT01183013|587866007|FG001|Overall Study|Lack of Efficacy|2|||
162769744|NCT01183013|587866008|FG002|Overall Study|Lack of Efficacy|1|||
162769745|NCT01183013|587866009|FG003|Overall Study|Lack of Efficacy|2|||
162769746|NCT01183013|587866010|FG004|Overall Study|Lack of Efficacy|1|||
162769747|NCT01183013|587866011|FG005|Overall Study|Lack of Efficacy|2|||
162769748|NCT01183013|587866012|FG006|Overall Study|Lack of Efficacy|0|||
162769749|NCT01183013|587866006|FG000|Overall Study|Protocol Violation|5|||
162769750|NCT01183013|587866007|FG001|Overall Study|Protocol Violation|2|||
162769751|NCT01183013|587866008|FG002|Overall Study|Protocol Violation|4|||
162769752|NCT01183013|587866009|FG003|Overall Study|Protocol Violation|0|||
162769753|NCT01183013|587866010|FG004|Overall Study|Protocol Violation|4|||
162769754|NCT01183013|587866011|FG005|Overall Study|Protocol Violation|3|||
162769755|NCT01183013|587866012|FG006|Overall Study|Protocol Violation|3|||
162769756|NCT01183013|587866006|FG000|Overall Study|Lost to Follow-up|7|||
162769757|NCT01183013|587866007|FG001|Overall Study|Lost to Follow-up|3|||
162769758|NCT01183013|587866008|FG002|Overall Study|Lost to Follow-up|4|||
162769759|NCT01183013|587866009|FG003|Overall Study|Lost to Follow-up|3|||
162769760|NCT01183013|587866010|FG004|Overall Study|Lost to Follow-up|2|||
162769761|NCT01183013|587866011|FG005|Overall Study|Lost to Follow-up|6|||
162769762|NCT01183013|587866012|FG006|Overall Study|Lost to Follow-up|5|||
162769763|NCT01183013|587866006|FG000|Overall Study|Withdrawal by Subject|9|||
162769764|NCT01183013|587866007|FG001|Overall Study|Withdrawal by Subject|13|||
162769765|NCT01183013|587866008|FG002|Overall Study|Withdrawal by Subject|10|||
162769766|NCT01183013|587866009|FG003|Overall Study|Withdrawal by Subject|8|||
162769767|NCT01183013|587866010|FG004|Overall Study|Withdrawal by Subject|7|||
162769768|NCT01183013|587866011|FG005|Overall Study|Withdrawal by Subject|9|||
162769769|NCT01183013|587866012|FG006|Overall Study|Withdrawal by Subject|10|||
162769770|NCT01183013|587866006|FG000|Overall Study|Reasons other than stated above|15|||
162769771|NCT01183013|587866007|FG001|Overall Study|Reasons other than stated above|11|||
162769772|NCT01183013|587866008|FG002|Overall Study|Reasons other than stated above|17|||
162769773|NCT01183013|587866009|FG003|Overall Study|Reasons other than stated above|12|||
162769774|NCT01183013|587866010|FG004|Overall Study|Reasons other than stated above|12|||
162769775|NCT01183013|587866011|FG005|Overall Study|Reasons other than stated above|15|||
162769776|NCT01183013|587866012|FG006|Overall Study|Reasons other than stated above|13|||
162769777|NCT00584909|587866016|FG000|Overall Study|Adverse Event|4|||
162769778|NCT03436797|587866017|FG000|Main Study|Withdrawal by Subject|2|||
162769779|NCT03436797|587866017|FG000|Main Study|Adverse Event|4|||
162769780|NCT03436797|587866017|FG000|Main Study|Lost to Follow-up|1|||
162769781|NCT03436797|587866017|FG000|Main Study|Death|1|||
162769782|NCT03436797|587866017|FG000|Main Study|Non-Specific|2|||
162769783|NCT03436797|587866017|FG000|Extended Dosing|Patient decision|1|||
162769784|NCT01951105|587866020|FG000|Overall Study|Adverse Event|0|||
162769785|NCT01951105|587866021|FG001|Overall Study|Adverse Event|5|||
162769786|NCT01951105|587866022|FG002|Overall Study|Adverse Event|0|||
162769787|NCT01951105|587866020|FG000|Overall Study|Lost to Follow-up|0|||
162769788|NCT01951105|587866021|FG001|Overall Study|Lost to Follow-up|1|||
162769789|NCT01951105|587866022|FG002|Overall Study|Lost to Follow-up|0|||
162769790|NCT01951105|587866020|FG000|Overall Study|Protocol Violation|1|||
162769791|NCT01951105|587866021|FG001|Overall Study|Protocol Violation|1|||
162769792|NCT01951105|587866022|FG002|Overall Study|Protocol Violation|1|||
162769793|NCT01951105|587866020|FG000|Overall Study|Withdrawal by Subject|0|||
162769794|NCT01951105|587866021|FG001|Overall Study|Withdrawal by Subject|3|||
162769795|NCT01951105|587866022|FG002|Overall Study|Withdrawal by Subject|1|||
162769796|NCT02727998|587866023|FG000|Overall Study|Lost to Follow-up|3|||
162769797|NCT02727998|587866024|FG001|Overall Study|Lost to Follow-up|3|||
162769798|NCT02727998|587866023|FG000|Overall Study|Withdrawal by Subject|0|||
162769799|NCT02727998|587866024|FG001|Overall Study|Withdrawal by Subject|1|||
162769800|NCT05072795|587866025|FG000|Overall Study|Lost to Follow-up|5|||
162769801|NCT00422162|587866026|FG000|Overall Study|Adverse Event|11|||
162769802|NCT00422162|587866027|FG001|Overall Study|Adverse Event|9|||
162769803|NCT00422162|587866026|FG000|Overall Study|Lack of Efficacy|4|||
162769804|NCT00422162|587866027|FG001|Overall Study|Lack of Efficacy|10|||
162769805|NCT00422162|587866026|FG000|Overall Study|Withdrawal by Subject|7|||
162769806|NCT00422162|587866027|FG001|Overall Study|Withdrawal by Subject|6|||
162769807|NCT00422162|587866026|FG000|Overall Study|Lost to Follow-up|1|||
162769808|NCT00422162|587866027|FG001|Overall Study|Lost to Follow-up|2|||
162769809|NCT00422162|587866026|FG000|Overall Study|Non-Compliant with Protocol|1|||
162769810|NCT00422162|587866027|FG001|Overall Study|Non-Compliant with Protocol|1|||
162769811|NCT00422162|587866026|FG000|Overall Study|Other|0|||
162769812|NCT00422162|587866027|FG001|Overall Study|Other|1|||
162769813|NCT00422162|587866026|FG000|Overall Study|Didn't Receive Treatment|0|||
162769814|NCT00422162|587866027|FG001|Overall Study|Didn't Receive Treatment|1|||
162769815|NCT05274906|587866028|FG000|Overall Study|Withdrawal by Subject|2|||
162769816|NCT05274906|587866029|FG001|Overall Study|Withdrawal by Subject|1|||
162769817|NCT01622088|587866033|FG000|Overall Study|Adverse Event|20|||
162769818|NCT01622088|587866033|FG000|Overall Study|Lost to Follow-up|1|||
162769819|NCT01622088|587866033|FG000|Overall Study|Withdrawal by Subject|20|||
162769820|NCT01622088|587866033|FG000|Overall Study|Investigator Decision|1|||
162769821|NCT01622088|587866033|FG000|Overall Study|Death|53|||
162769822|NCT01622088|587866033|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
162769823|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
162769824|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
162769825|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
162769826|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
162769827|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
162769828|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
162769829|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
162769830|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
162769831|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
162769832|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
162769833|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
162769834|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
162769835|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
162769836|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
162769837|NCT02971683|587866034|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
162769838|NCT02971683|587866035|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
162769839|NCT02971683|587866034|FG000|Open-Label|Lost to Follow-up|1|||
162769840|NCT02971683|587866035|FG001|Open-Label|Lost to Follow-up|0|||
162769841|NCT02971683|587866034|FG000|Open-Label|Participants withdrew consent|0|||
162769842|NCT02971683|587866035|FG001|Open-Label|Participants withdrew consent|2|||
162769843|NCT02971683|587866034|FG000|Open-Label|Participant request to discontinue study treatment|1|||
162769844|NCT02971683|587866035|FG001|Open-Label|Participant request to discontinue study treatment|0|||
162769845|NCT02971683|587866034|FG000|Open-Label|Lack of Efficacy|2|||
162769846|NCT02971683|587866035|FG001|Open-Label|Lack of Efficacy|0|||
162769847|NCT02971683|587866034|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
162769848|NCT02971683|587866035|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
162769849|NCT02971683|587866034|FG000|Long-Term Open Label|Participant withdrew consent|1|||
162769850|NCT02971683|587866035|FG001|Long-Term Open Label|Participant withdrew consent|0|||
162769851|NCT02971683|587866034|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
162769852|NCT02971683|587866035|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
162769853|NCT02971683|587866034|FG000|Long-Term Open Label|Adverse Event|1|||
162769854|NCT02971683|587866035|FG001|Long-Term Open Label|Adverse Event|2|||
162769855|NCT02971683|587866034|FG000|Long-Term Open Label|Lack of Efficacy|1|||
162769856|NCT02971683|587866035|FG001|Long-Term Open Label|Lack of Efficacy|1|||
162769857|NCT01468597|587866038|FG000|Overall Study|Found ineligible|17|||
162769858|NCT01468597|587866038|FG000|Overall Study|concomitant valves|12|||
162769859|NCT01468597|587866038|FG000|Overall Study|off-pump CABG|1|||
162769860|NCT01468597|587866038|FG000|Overall Study|no platelet function data|5|||
162769861|NCT00912964|587866039|FG000|Overall Study|Eligibility criterion not met|1|||
162769862|NCT00912964|587866040|FG001|Overall Study|Eligibility criterion not met|1|||
162769863|NCT00912964|587866041|FG002|Overall Study|Eligibility criterion not met|0|||
162769864|NCT00912964|587866039|FG000|Overall Study|Adverse Event|15|||
162769865|NCT00912964|587866040|FG001|Overall Study|Adverse Event|18|||
162769866|NCT00912964|587866041|FG002|Overall Study|Adverse Event|12|||
162769867|NCT00912964|587866039|FG000|Overall Study|Lack of Efficacy|11|||
162769868|NCT00912964|587866040|FG001|Overall Study|Lack of Efficacy|4|||
162769869|NCT00912964|587866041|FG002|Overall Study|Lack of Efficacy|3|||
162769870|NCT00912964|587866039|FG000|Overall Study|Withdrawal by Subject|20|||
162769871|NCT00912964|587866040|FG001|Overall Study|Withdrawal by Subject|12|||
162769872|NCT00912964|587866041|FG002|Overall Study|Withdrawal by Subject|18|||
162769873|NCT00912964|587866039|FG000|Overall Study|Lost to Follow-up|4|||
162769874|NCT00912964|587866040|FG001|Overall Study|Lost to Follow-up|3|||
162769875|NCT00912964|587866041|FG002|Overall Study|Lost to Follow-up|3|||
162769876|NCT00912964|587866039|FG000|Overall Study|Protocol Violation|5|||
162769877|NCT00912964|587866040|FG001|Overall Study|Protocol Violation|3|||
162769878|NCT00912964|587866041|FG002|Overall Study|Protocol Violation|8|||
162769879|NCT00912964|587866039|FG000|Overall Study|Taking exclusionary medications|7|||
162769880|NCT00912964|587866040|FG001|Overall Study|Taking exclusionary medications|4|||
162769881|NCT00912964|587866041|FG002|Overall Study|Taking exclusionary medications|8|||
162769882|NCT00912964|587866039|FG000|Overall Study|Medical History|1|||
162769883|NCT00912964|587866040|FG001|Overall Study|Medical History|0|||
162769884|NCT00912964|587866041|FG002|Overall Study|Medical History|0|||
162769885|NCT00912964|587866039|FG000|Overall Study|Non-compliance with study procedures|2|||
162769886|NCT00912964|587866040|FG001|Overall Study|Non-compliance with study procedures|0|||
162769887|NCT00912964|587866041|FG002|Overall Study|Non-compliance with study procedures|0|||
162769888|NCT00912964|587866039|FG000|Overall Study|Violation of exclusion criterion|0|||
162769889|NCT00912964|587866040|FG001|Overall Study|Violation of exclusion criterion|0|||
162769890|NCT00912964|587866041|FG002|Overall Study|Violation of exclusion criterion|2|||
162769891|NCT00912964|587866039|FG000|Overall Study|Randomized but never received study drug|0|||
162769892|NCT00912964|587866040|FG001|Overall Study|Randomized but never received study drug|1|||
162769893|NCT00912964|587866041|FG002|Overall Study|Randomized but never received study drug|0|||
162769894|NCT03905512|587866043|FG000|Overall Study|Withdrawal by Subject|9|||
162769895|NCT03905512|587866044|FG001|Overall Study|Withdrawal by Subject|8|||
162769896|NCT03905512|587866043|FG000|Overall Study|Adverse Event|1|||
162769897|NCT03905512|587866044|FG001|Overall Study|Adverse Event|2|||
162769898|NCT03905512|587866043|FG000|Overall Study|Lost to Follow-up|4|||
162769899|NCT03905512|587866044|FG001|Overall Study|Lost to Follow-up|3|||
162769900|NCT03905512|587866043|FG000|Overall Study|Other than Specified|7|||
162769901|NCT03905512|587866044|FG001|Overall Study|Other than Specified|4|||
162769902|NCT00070317|587866051|FG000|Overall Study|Inevaluable (Never Treated)|1|||
162769903|NCT00070317|587866051|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
162769904|NCT00070317|587866051|FG000|Overall Study|Ineligible required test not done|1|||
162769905|NCT00070317|587866051|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
162769906|NCT00070317|587866051|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
162769907|NCT03987074|587866052|FG000|Overall Study|Withdrew Consent|1|||
162769908|NCT03987074|587866053|FG001|Overall Study|Withdrew Consent|1|||
162769909|NCT03987074|587866054|FG002|Overall Study|Withdrew Consent|0|||
162769910|NCT03987074|587866055|FG003|Overall Study|Withdrew Consent|2|||
162769911|NCT03987074|587866056|FG004|Overall Study|Withdrew Consent|1|||
162769912|NCT03987074|587866052|FG000|Overall Study|Adverse Event|2|||
162769913|NCT03987074|587866053|FG001|Overall Study|Adverse Event|1|||
162769914|NCT03987074|587866054|FG002|Overall Study|Adverse Event|0|||
162769915|NCT03987074|587866055|FG003|Overall Study|Adverse Event|0|||
162769916|NCT03987074|587866056|FG004|Overall Study|Adverse Event|1|||
162769917|NCT03987074|587866052|FG000|Overall Study|Lost to Follow-up|0|||
162769918|NCT03987074|587866053|FG001|Overall Study|Lost to Follow-up|0|||
162769919|NCT03987074|587866054|FG002|Overall Study|Lost to Follow-up|1|||
162769920|NCT03987074|587866055|FG003|Overall Study|Lost to Follow-up|1|||
162769921|NCT03987074|587866056|FG004|Overall Study|Lost to Follow-up|0|||
162769922|NCT03987074|587866052|FG000|Overall Study|Investigator's Discretion|0|||
162769923|NCT03987074|587866053|FG001|Overall Study|Investigator's Discretion|0|||
162769924|NCT03987074|587866054|FG002|Overall Study|Investigator's Discretion|0|||
162769925|NCT03987074|587866055|FG003|Overall Study|Investigator's Discretion|1|||
162769926|NCT03987074|587866056|FG004|Overall Study|Investigator's Discretion|0|||
162769927|NCT02138838|587866059|FG000|Overall Study|Study Closure|7|||
162769928|NCT02138838|587866060|FG001|Overall Study|Study Closure|6|||
162769929|NCT02138838|587866059|FG000|Overall Study|Withdrawal by Subject|1|||
162769930|NCT02138838|587866060|FG001|Overall Study|Withdrawal by Subject|5|||
162769931|NCT01294644|587866063|FG000|Overall Study|Adverse Event|2|||
162769932|NCT01294644|587866064|FG001|Overall Study|Adverse Event|0|||
162769933|NCT01294644|587866065|FG002|Overall Study|Adverse Event|1|||
162769934|NCT01294644|587866063|FG000|Overall Study|Withdrawal by Subject|3|||
162769935|NCT01294644|587866064|FG001|Overall Study|Withdrawal by Subject|7|||
162769936|NCT01294644|587866065|FG002|Overall Study|Withdrawal by Subject|4|||
162769937|NCT01294644|587866063|FG000|Overall Study|Lost to Follow-up|3|||
162769938|NCT01294644|587866064|FG001|Overall Study|Lost to Follow-up|2|||
162769939|NCT01294644|587866065|FG002|Overall Study|Lost to Follow-up|5|||
162769940|NCT01294644|587866063|FG000|Overall Study|Miscellaneous Reason|2|||
162769941|NCT01294644|587866064|FG001|Overall Study|Miscellaneous Reason|1|||
162769942|NCT01294644|587866065|FG002|Overall Study|Miscellaneous Reason|4|||
162769943|NCT04433091|587866067|FG000|Overall Study|Lost to Follow-up|1|||
162769944|NCT04433091|587866068|FG001|Overall Study|Lost to Follow-up|0|||
162769945|NCT04433091|587866067|FG000|Overall Study|Withdrawn .|2|||
162769946|NCT04433091|587866068|FG001|Overall Study|Withdrawn .|4|||
162769947|NCT04520256|587866069|FG000|Overall Study|Lost to Follow-up|6|||
162769948|NCT04520256|587866070|FG001|Overall Study|Lost to Follow-up|4|||
162769949|NCT04520256|587866071|FG002|Overall Study|Lost to Follow-up|2|||
162769950|NCT04520256|587866072|FG003|Overall Study|Lost to Follow-up|3|||
162769951|NCT04520256|587866073|FG004|Overall Study|Lost to Follow-up|6|||
162769952|NCT04520256|587866074|FG005|Overall Study|Lost to Follow-up|6|||
162769953|NCT04520256|587866075|FG006|Overall Study|Lost to Follow-up|4|||
162769954|NCT04520256|587866076|FG007|Overall Study|Lost to Follow-up|6|||
162769955|NCT04520256|587866077|FG008|Overall Study|Lost to Follow-up|1|||
162769956|NCT04520256|587866078|FG009|Overall Study|Lost to Follow-up|3|||
162769957|NCT04520256|587866079|FG010|Overall Study|Lost to Follow-up|3|||
162769958|NCT04520256|587866080|FG011|Overall Study|Lost to Follow-up|2|||
162769959|NCT04520256|587866081|FG012|Overall Study|Lost to Follow-up|5|||
162769960|NCT04520256|587866082|FG013|Overall Study|Lost to Follow-up|3|||
162769961|NCT04520256|587866083|FG014|Overall Study|Lost to Follow-up|3|||
162769962|NCT04520256|587866084|FG015|Overall Study|Lost to Follow-up|6|||
162769963|NCT04520256|587866085|FG016|Overall Study|Lost to Follow-up|6|||
162769964|NCT04520256|587866086|FG017|Overall Study|Lost to Follow-up|4|||
162769965|NCT04520256|587866087|FG018|Overall Study|Lost to Follow-up|3|||
162769966|NCT04520256|587866088|FG019|Overall Study|Lost to Follow-up|3|||
162769967|NCT04520256|587866089|FG020|Overall Study|Lost to Follow-up|7|||
162769968|NCT04520256|587866090|FG021|Overall Study|Lost to Follow-up|3|||
162769969|NCT04520256|587866091|FG022|Overall Study|Lost to Follow-up|3|||
162769970|NCT04520256|587866092|FG023|Overall Study|Lost to Follow-up|8|||
162769971|NCT04520256|587866093|FG024|Overall Study|Lost to Follow-up|5|||
162769972|NCT04520256|587866094|FG025|Overall Study|Lost to Follow-up|4|||
162769973|NCT04520256|587866095|FG026|Overall Study|Lost to Follow-up|3|||
162769974|NCT04520256|587866096|FG027|Overall Study|Lost to Follow-up|4|||
162769975|NCT04520256|587866097|FG028|Overall Study|Lost to Follow-up|3|||
162769976|NCT04520256|587866098|FG029|Overall Study|Lost to Follow-up|4|||
162769977|NCT04520256|587866099|FG030|Overall Study|Lost to Follow-up|4|||
162769978|NCT04520256|587866100|FG031|Overall Study|Lost to Follow-up|4|||
162769979|NCT00676195|587867544|FG000|Overall Study|Lost to Follow-up|1|||
162769980|NCT00676195|587867544|FG000|Overall Study|Adverse Event|1|||
162769981|NCT00676195|587867544|FG000|Overall Study|Physician Decision|1|||
162769982|NCT03978130|587867548|FG000|Overall Study|Lost to Follow-up|13|||
162769983|NCT03978130|587867549|FG001|Overall Study|Lost to Follow-up|14|||
162769984|NCT03978130|587867548|FG000|Overall Study|Withdrawal by Subject|12|||
162769985|NCT03978130|587867549|FG001|Overall Study|Withdrawal by Subject|2|||
162769986|NCT03978130|587867548|FG000|Overall Study|Adverse Event|2|||
162769987|NCT03978130|587867549|FG001|Overall Study|Adverse Event|1|||
162769988|NCT02880293|587867552|FG000|Overall Study|Inevaluable|5|||
162769989|NCT02101554|587867555|FG000|Overall Study|Protocol Violation|0|||
162769990|NCT02101554|587867556|FG001|Overall Study|Protocol Violation|1|||
162769991|NCT02101554|587867557|FG002|Overall Study|Protocol Violation|0|||
162769992|NCT02101554|587867555|FG000|Overall Study|Insufficient Clinical Response|0|||
162769993|NCT02101554|587867556|FG001|Overall Study|Insufficient Clinical Response|2|||
162769994|NCT02101554|587867557|FG002|Overall Study|Insufficient Clinical Response|0|||
162769995|NCT02101554|587867555|FG000|Overall Study|Adverse Event|2|||
162769996|NCT02101554|587867556|FG001|Overall Study|Adverse Event|1|||
162769997|NCT02101554|587867557|FG002|Overall Study|Adverse Event|1|||
162769998|NCT02101554|587867555|FG000|Overall Study|Lost to Follow-up|0|||
162769999|NCT02101554|587867556|FG001|Overall Study|Lost to Follow-up|1|||
162770000|NCT02101554|587867557|FG002|Overall Study|Lost to Follow-up|0|||
162770001|NCT02101554|587867555|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
162770002|NCT02101554|587867556|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
162770003|NCT02101554|587867557|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
162770004|NCT02069366|587867562|FG000|Overall Study|Lost to Follow-up|0|||
162770005|NCT02069366|587867563|FG001|Overall Study|Lost to Follow-up|0|||
162770006|NCT02069366|587867564|FG002|Overall Study|Lost to Follow-up|1|||
162770007|NCT02069366|587867565|FG003|Overall Study|Lost to Follow-up|0|||
162770008|NCT02069366|587867566|FG004|Overall Study|Lost to Follow-up|0|||
162770009|NCT02069366|587867567|FG005|Overall Study|Lost to Follow-up|2|||
162770010|NCT02069366|587867562|FG000|Overall Study|Protocol Violation|0|||
162770011|NCT02069366|587867563|FG001|Overall Study|Protocol Violation|0|||
162770012|NCT02069366|587867564|FG002|Overall Study|Protocol Violation|1|||
162770013|NCT02069366|587867565|FG003|Overall Study|Protocol Violation|0|||
162770014|NCT02069366|587867566|FG004|Overall Study|Protocol Violation|0|||
162770015|NCT02069366|587867567|FG005|Overall Study|Protocol Violation|0|||
162770016|NCT02069366|587867562|FG000|Overall Study|Withdrawal by Subject|1|||
162770017|NCT02069366|587867563|FG001|Overall Study|Withdrawal by Subject|0|||
162770018|NCT02069366|587867564|FG002|Overall Study|Withdrawal by Subject|1|||
162770019|NCT02069366|587867565|FG003|Overall Study|Withdrawal by Subject|2|||
162770020|NCT02069366|587867566|FG004|Overall Study|Withdrawal by Subject|0|||
162770021|NCT02069366|587867567|FG005|Overall Study|Withdrawal by Subject|0|||
162770022|NCT02030847|587867569|FG000|Overall Study|Death|10|||
162770023|NCT02030847|587867569|FG000|Overall Study|Disease Progression|15|||
162770024|NCT02030847|587867569|FG000|Overall Study|New Cancer Therapy|8|||
162770025|NCT02030847|587867569|FG000|Overall Study|Physician Decision|3|||
162770026|NCT02030847|587867569|FG000|Overall Study|Withdrawal by Subject|1|||
162770027|NCT00168805|587867570|FG000|Overall Study|Adverse Event|7|||
162770028|NCT00168805|587867571|FG001|Overall Study|Adverse Event|11|||
162770029|NCT00168805|587867572|FG002|Overall Study|Adverse Event|16|||
162770030|NCT00168805|587867570|FG000|Overall Study|Protocol Violation|12|||
162770031|NCT00168805|587867571|FG001|Overall Study|Protocol Violation|11|||
162770032|NCT00168805|587867572|FG002|Overall Study|Protocol Violation|8|||
162770033|NCT00168805|587867570|FG000|Overall Study|Lost to Follow-up|12|||
162770034|NCT00168805|587867571|FG001|Overall Study|Lost to Follow-up|17|||
162770035|NCT00168805|587867572|FG002|Overall Study|Lost to Follow-up|11|||
162770036|NCT00168805|587867570|FG000|Overall Study|Withdrawal by Subject|16|||
162770037|NCT00168805|587867571|FG001|Overall Study|Withdrawal by Subject|18|||
162770038|NCT00168805|587867572|FG002|Overall Study|Withdrawal by Subject|21|||
162770039|NCT00168805|587867570|FG000|Overall Study|Other|24|||
162770040|NCT00168805|587867571|FG001|Overall Study|Other|21|||
162770041|NCT00168805|587867572|FG002|Overall Study|Other|22|||
162770042|NCT00168805|587867570|FG000|Treatment|Adverse Event|25|||
162770043|NCT00168805|587867571|FG001|Treatment|Adverse Event|26|||
162770044|NCT00168805|587867572|FG002|Treatment|Adverse Event|32|||
162770045|NCT00168805|587867570|FG000|Treatment|Protocol Violation|3|||
162770046|NCT00168805|587867571|FG001|Treatment|Protocol Violation|5|||
162770047|NCT00168805|587867572|FG002|Treatment|Protocol Violation|5|||
162770048|NCT00168805|587867570|FG000|Treatment|Withdrawal by Subject|3|||
162770049|NCT00168805|587867571|FG001|Treatment|Withdrawal by Subject|7|||
162770050|NCT00168805|587867572|FG002|Treatment|Withdrawal by Subject|8|||
162770051|NCT00168805|587867570|FG000|Treatment|Other|18|||
162770052|NCT00168805|587867571|FG001|Treatment|Other|18|||
162770053|NCT00168805|587867572|FG002|Treatment|Other|17|||
162770054|NCT02995733|587867573|FG000|Overall Study|Study site closed|9|||
162770055|NCT02995733|587867574|FG001|Overall Study|Study site closed|10|||
162770056|NCT02995733|587867573|FG000|Overall Study|Death|3|||
162770057|NCT02995733|587867574|FG001|Overall Study|Death|4|||
162770058|NCT02995733|587867573|FG000|Overall Study|Withdrawal by Subject|6|||
162770059|NCT02995733|587867574|FG001|Overall Study|Withdrawal by Subject|2|||
162770060|NCT02995733|587867573|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
162770061|NCT02995733|587867574|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
162770062|NCT02995733|587867573|FG000|Overall Study|Lost to Follow-up|48|||
162770063|NCT02995733|587867574|FG001|Overall Study|Lost to Follow-up|37|||
162770064|NCT02995733|587867573|FG000|Overall Study|Other|0|||
162770065|NCT02995733|587867574|FG001|Overall Study|Other|1|||
162770066|NCT03785210|587867575|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
162770067|NCT03785210|587867576|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
162770068|NCT04468633|587867577|FG000|Overall Study|Withdrawal by Subject|4|||
162770069|NCT04468633|587867578|FG001|Overall Study|Withdrawal by Subject|0|||
162770070|NCT00460434|587867581|FG000|Overall Study|Lost to Follow-up|3|||
162770071|NCT00460434|587867582|FG001|Overall Study|Lost to Follow-up|7|||
162770072|NCT01498445|587867583|FG000|Overall Study|Lack of Efficacy|0|||
162770073|NCT01498445|587867584|FG001|Overall Study|Lack of Efficacy|0|||
162770074|NCT01498445|587867585|FG002|Overall Study|Lack of Efficacy|1|||
162770075|NCT01498445|587867586|FG003|Overall Study|Lack of Efficacy|2|||
162770076|NCT01498445|587867587|FG004|Overall Study|Lack of Efficacy|0|||
162770077|NCT01498445|587867588|FG005|Overall Study|Lack of Efficacy|0|||
162770078|NCT01498445|587867583|FG000|Overall Study|Screen Failure|0|||
162770079|NCT01498445|587867584|FG001|Overall Study|Screen Failure|0|||
162770080|NCT01498445|587867585|FG002|Overall Study|Screen Failure|0|||
162770081|NCT01498445|587867586|FG003|Overall Study|Screen Failure|0|||
162770082|NCT01498445|587867587|FG004|Overall Study|Screen Failure|1|||
162770083|NCT01498445|587867588|FG005|Overall Study|Screen Failure|1|||
162770084|NCT04739306|587867589|FG000|Main Study Period|Adverse Event|6|||
162770085|NCT04739306|587867590|FG001|Main Study Period|Adverse Event|7|||
162770086|NCT04739306|587867589|FG000|Main Study Period|Lost to Follow-up|4|||
162770087|NCT04739306|587867590|FG001|Main Study Period|Lost to Follow-up|6|||
162770088|NCT04739306|587867589|FG000|Main Study Period|Physician Decision|1|||
162770089|NCT04739306|587867590|FG001|Main Study Period|Physician Decision|1|||
162770090|NCT04739306|587867589|FG000|Main Study Period|Withdrawal by Subject|8|||
162770091|NCT04739306|587867590|FG001|Main Study Period|Withdrawal by Subject|6|||
162770092|NCT04739306|587867589|FG000|Main Study Period|Protocol Violation|0|||
162770093|NCT04739306|587867590|FG001|Main Study Period|Protocol Violation|1|||
162770094|NCT04739306|587867589|FG000|Main Study Period|War in Ukraine|1|||
162770095|NCT04739306|587867590|FG001|Main Study Period|War in Ukraine|1|||
162770096|NCT02722278|587867593|FG000|Overall Study|Withdrawal by Subject|5|||
162770097|NCT02722278|587867594|FG001|Overall Study|Withdrawal by Subject|3|||
162770098|NCT02722278|587867593|FG000|Overall Study|Adverse Event|4|||
162770099|NCT02722278|587867594|FG001|Overall Study|Adverse Event|1|||
162770100|NCT02722278|587867593|FG000|Overall Study|Lost to Follow-up|2|||
162770101|NCT02722278|587867594|FG001|Overall Study|Lost to Follow-up|0|||
162770102|NCT02722278|587867593|FG000|Overall Study|Protocol Violation|1|||
162770103|NCT02722278|587867594|FG001|Overall Study|Protocol Violation|0|||
162770104|NCT02722278|587867593|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
162770105|NCT02722278|587867594|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
162770106|NCT02722278|587867593|FG000|Overall Study|Subject declined after tx assignment|0|||
162770107|NCT02722278|587867594|FG001|Overall Study|Subject declined after tx assignment|1|||
162770108|NCT02722278|587867593|FG000|Overall Study|Site closure not study related|0|||
162770109|NCT02722278|587867594|FG001|Overall Study|Site closure not study related|1|||
162770110|NCT02465866|587867595|FG000|Period 3|Withdrawal by Subject|0|||
162770111|NCT02465866|587867596|FG001|Period 3|Withdrawal by Subject|1|||
162770112|NCT02465866|587867597|FG002|Period 3|Withdrawal by Subject|0|||
162770113|NCT02465866|587867598|FG003|Period 3|Withdrawal by Subject|0|||
162770114|NCT00203502|587867599|FG000|Overall Study|Death|1|||
162770115|NCT02023099|587867600|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
162770116|NCT02023099|587867601|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
162770117|NCT02023099|587867602|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
162770118|NCT02023099|587867600|FG000|Overall Study|Withdrawn Consent|3|||
162770119|NCT02023099|587867601|FG001|Overall Study|Withdrawn Consent|0|||
162770120|NCT02023099|587867602|FG002|Overall Study|Withdrawn Consent|1|||
162770121|NCT02023099|587867600|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
162770122|NCT02023099|587867601|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
162770123|NCT02023099|587867602|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
162770124|NCT04175392|587867603|FG000|Overall Study|Withdrawal by Subject|3|||
162770125|NCT04175392|587867604|FG001|Overall Study|Withdrawal by Subject|2|||
162770126|NCT01469819|587867605|FG000|Overall Study|Withdrawal by Subject|1|||
162770127|NCT01469819|587867605|FG000|Overall Study|Did not meet inclusionary criteria|2|||
162770128|NCT01469819|587867605|FG000|Overall Study|Could not swallow SmartPill|2|||
162770129|NCT01469819|587867605|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
162770130|NCT00561678|587867606|FG000|Overall Study|Withdrawal by Subject|4|||
162770131|NCT00561678|587867607|FG001|Overall Study|Withdrawal by Subject|3|||
162770132|NCT00561678|587867606|FG000|Overall Study|surgery cancelled|1|||
162770133|NCT00561678|587867607|FG001|Overall Study|surgery cancelled|1|||
162770134|NCT00561678|587867606|FG000|Overall Study|surgery rescheduled to different site|2|||
162770135|NCT00561678|587867607|FG001|Overall Study|surgery rescheduled to different site|2|||
162770136|NCT00561678|587867606|FG000|Overall Study|anesthesia provider refusal|1|||
162770137|NCT00561678|587867607|FG001|Overall Study|anesthesia provider refusal|0|||
162770138|NCT01403805|587867608|FG000|Overall Study|Withdrawal by Subject|0|||
162770139|NCT01403805|587867609|FG001|Overall Study|Withdrawal by Subject|4|||
162770140|NCT01403805|587867608|FG000|Overall Study|Lost to Follow-up|0|||
162770141|NCT01403805|587867609|FG001|Overall Study|Lost to Follow-up|2|||
162770142|NCT01403805|587867608|FG000|Overall Study|Death|0|||
162770143|NCT01403805|587867609|FG001|Overall Study|Death|1|||
162770144|NCT01103141|587867610|FG000|Overall Study|Death|0|||
162770145|NCT01103141|587867611|FG001|Overall Study|Death|1|||
162770146|NCT01103141|587867610|FG000|Overall Study|Lost to Follow-up|2|||
162770147|NCT01103141|587867611|FG001|Overall Study|Lost to Follow-up|1|||
162770148|NCT01695993|587867614|FG000|Overall Study|Lost to Follow-up|2|||
162770149|NCT01695993|587867615|FG001|Overall Study|Lost to Follow-up|1|||
162770150|NCT01695993|587867616|FG002|Overall Study|Lost to Follow-up|3|||
162770151|NCT01695993|587867614|FG000|Overall Study|Withdrawal by Subject|2|||
162770152|NCT01695993|587867615|FG001|Overall Study|Withdrawal by Subject|2|||
162770153|NCT01695993|587867616|FG002|Overall Study|Withdrawal by Subject|2|||
162770154|NCT01695993|587867614|FG000|Overall Study|To ill to continue|1|||
162770155|NCT01695993|587867615|FG001|Overall Study|To ill to continue|2|||
162770156|NCT01695993|587867616|FG002|Overall Study|To ill to continue|0|||
162770157|NCT01695993|587867614|FG000|Overall Study|Changed Medical Facility|0|||
162770158|NCT01695993|587867615|FG001|Overall Study|Changed Medical Facility|0|||
162770159|NCT01695993|587867616|FG002|Overall Study|Changed Medical Facility|1|||
162770160|NCT00472199|587867617|FG000|Overall Study|Adverse Event|19|||
162770161|NCT00472199|587867618|FG001|Overall Study|Adverse Event|23|||
162770162|NCT00472199|587867617|FG000|Overall Study|Lack of Efficacy|4|||
162770163|NCT00472199|587867618|FG001|Overall Study|Lack of Efficacy|25|||
162770164|NCT00472199|587867617|FG000|Overall Study|Lost to Follow-up|2|||
162770165|NCT00472199|587867618|FG001|Overall Study|Lost to Follow-up|4|||
162770166|NCT00472199|587867617|FG000|Overall Study|Protocol Violation|3|||
162770167|NCT00472199|587867618|FG001|Overall Study|Protocol Violation|2|||
162770168|NCT00472199|587867617|FG000|Overall Study|Withdrawal by Subject|6|||
162770169|NCT00472199|587867618|FG001|Overall Study|Withdrawal by Subject|5|||
162770170|NCT00472199|587867617|FG000|Overall Study|personal reason|0|||
162770171|NCT00472199|587867618|FG001|Overall Study|personal reason|1|||
162770172|NCT00472199|587867617|FG000|Overall Study|patient was asymptomatic|1|||
162770173|NCT00472199|587867618|FG001|Overall Study|patient was asymptomatic|0|||
162770174|NCT01601821|587867622|FG000|Overall Study|Death|2|||
162770175|NCT01601821|587867623|FG001|Overall Study|Death|5|||
162770176|NCT01601821|587867622|FG000|Overall Study|Protocol Violation|2|||
162770177|NCT01601821|587867623|FG001|Overall Study|Protocol Violation|2|||
162770178|NCT01601821|587867622|FG000|Overall Study|Lost to Follow-up|6|||
162770179|NCT01601821|587867623|FG001|Overall Study|Lost to Follow-up|14|||
162770180|NCT01601821|587867622|FG000|Overall Study|Withdrawal by Subject|1|||
162770181|NCT01601821|587867623|FG001|Overall Study|Withdrawal by Subject|0|||
162770182|NCT01601821|587867622|FG000|Overall Study|Graft Loss|6|||
162770183|NCT01601821|587867623|FG001|Overall Study|Graft Loss|6|||
162770184|NCT01601821|587867622|FG000|Overall Study|Study Events|7|||
162770185|NCT01601821|587867623|FG001|Overall Study|Study Events|1|||
162770186|NCT01601821|587867622|FG000|Overall Study|Other|5|||
162770187|NCT01601821|587867623|FG001|Overall Study|Other|1|||
162770188|NCT01901302|587867627|FG000|Overall Study|Adverse Event|2|||
162770189|NCT01901302|587867628|FG001|Overall Study|Adverse Event|1|||
162770190|NCT01901302|587867627|FG000|Overall Study|Lack of Efficacy|0|||
162770191|NCT01901302|587867628|FG001|Overall Study|Lack of Efficacy|2|||
162770192|NCT01901302|587867627|FG000|Overall Study|Study Terminated by Sponsor|23|||
162770193|NCT01901302|587867628|FG001|Overall Study|Study Terminated by Sponsor|20|||
162770194|NCT01901302|587867627|FG000|Overall Study|Withdrawal by Subject|2|||
162770195|NCT01901302|587867628|FG001|Overall Study|Withdrawal by Subject|0|||
162770196|NCT00848198|587867630|FG000|Overall Study|Incomplete Case Report Forms|15|||
162770197|NCT03708744|587867631|FG000|Overall Study|Withdrawal by Subject|0|||
162770198|NCT03708744|587867632|FG001|Overall Study|Withdrawal by Subject|0|||
162770199|NCT03708744|587867633|FG002|Overall Study|Withdrawal by Subject|1|||
162770200|NCT03708744|587867634|FG003|Overall Study|Withdrawal by Subject|0|||
162770201|NCT02062827|587867635|FG000|Overall Study|Death|1|||
162770202|NCT02062827|587867636|FG001|Overall Study|Death|0|||
162770203|NCT02062827|587867637|FG002|Overall Study|Death|0|||
162770204|NCT02062827|587867638|FG003|Overall Study|Death|0|||
162770205|NCT02062827|587867639|FG004|Overall Study|Death|0|||
162770206|NCT02062827|587867640|FG005|Overall Study|Death|0|||
162770207|NCT02062827|587867641|FG006|Overall Study|Death|0|||
162770208|NCT02062827|587867642|FG007|Overall Study|Death|0|||
162770209|NCT02062827|587867635|FG000|Overall Study|Withdrawal by Subject|3|||
162770210|NCT02062827|587867636|FG001|Overall Study|Withdrawal by Subject|1|||
162770211|NCT02062827|587867637|FG002|Overall Study|Withdrawal by Subject|1|||
162770212|NCT02062827|587867638|FG003|Overall Study|Withdrawal by Subject|2|||
162770213|NCT02062827|587867639|FG004|Overall Study|Withdrawal by Subject|6|||
162770214|NCT02062827|587867640|FG005|Overall Study|Withdrawal by Subject|0|||
162770215|NCT02062827|587867641|FG006|Overall Study|Withdrawal by Subject|5|||
162770216|NCT02062827|587867642|FG007|Overall Study|Withdrawal by Subject|0|||
162770217|NCT02062827|587867635|FG000|Overall Study|Screen Fail|0|||
162770218|NCT02062827|587867636|FG001|Overall Study|Screen Fail|0|||
162770219|NCT02062827|587867637|FG002|Overall Study|Screen Fail|0|||
162770220|NCT02062827|587867638|FG003|Overall Study|Screen Fail|0|||
162770221|NCT02062827|587867639|FG004|Overall Study|Screen Fail|0|||
162770222|NCT02062827|587867640|FG005|Overall Study|Screen Fail|0|||
162770223|NCT02062827|587867641|FG006|Overall Study|Screen Fail|0|||
162770224|NCT02062827|587867642|FG007|Overall Study|Screen Fail|8|||
162770225|NCT04930263|587867643|FG000|Overall Study|Withdrawal by Subject|3|||
162770226|NCT04930263|587867644|FG001|Overall Study|Withdrawal by Subject|5|||
162770227|NCT02812706|587867646|FG000|Phase 1|Adverse Event|0|||
162770228|NCT02812706|587867647|FG001|Phase 1|Adverse Event|2|||
162770229|NCT02812706|587867648|FG002|Phase 1|Adverse Event|0|||
162770230|NCT02812706|587867646|FG000|Phase 1|Progressive disease|3|||
162770231|NCT02812706|587867647|FG001|Phase 1|Progressive disease|3|||
162770232|NCT02812706|587867648|FG002|Phase 1|Progressive disease|0|||
162770233|NCT02812706|587867646|FG000|Phase 2|Adverse Event|0|||
162770234|NCT02812706|587867647|FG001|Phase 2|Adverse Event|0|||
162770235|NCT02812706|587867648|FG002|Phase 2|Adverse Event|2|||
162770236|NCT02812706|587867646|FG000|Phase 2|Progressive disease|0|||
162770237|NCT02812706|587867647|FG001|Phase 2|Progressive disease|0|||
162770238|NCT02812706|587867648|FG002|Phase 2|Progressive disease|22|||
162770239|NCT02812706|587867646|FG000|Phase 2|Other-Unspecified|0|||
162770240|NCT02812706|587867647|FG001|Phase 2|Other-Unspecified|0|||
162770241|NCT02812706|587867648|FG002|Phase 2|Other-Unspecified|4|||
162770242|NCT02213458|587867651|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
162770243|NCT02213458|587867652|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
162770244|NCT02213458|587867651|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
162770245|NCT02213458|587867652|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
162770246|NCT02213458|587867651|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
162770247|NCT02213458|587867652|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
162770248|NCT02213458|587867651|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
162770249|NCT02213458|587867652|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
162770250|NCT02213458|587867651|FG000|Overall Study|Refused re-consent|6|||
162770251|NCT02213458|587867652|FG001|Overall Study|Refused re-consent|0|||
162770252|NCT02213458|587867651|FG000|Overall Study|Lost to Follow-up|2|||
162770253|NCT02213458|587867652|FG001|Overall Study|Lost to Follow-up|2|||
162770254|NCT02213458|587867651|FG000|Overall Study|Withdrawal by Subject|26|||
162770255|NCT02213458|587867652|FG001|Overall Study|Withdrawal by Subject|8|||
162770256|NCT03166215|587867653|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
162770257|NCT03166215|587867654|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
162770258|NCT03166215|587867655|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
162770259|NCT03166215|587867653|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
162770260|NCT03166215|587867654|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
162770261|NCT03166215|587867655|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
162770262|NCT04985604|587867658|FG000|Overall Study|Death|4|||
162770263|NCT04985604|587867659|FG001|Overall Study|Death|6|||
162770264|NCT04985604|587867658|FG000|Overall Study|Withdrawal by Subject|0|||
162770265|NCT04985604|587867659|FG001|Overall Study|Withdrawal by Subject|1|||
162770266|NCT02282761|587867660|FG000|Overall Study|Death|0|||
162770267|NCT02282761|587867661|FG001|Overall Study|Death|0|||
162770268|NCT02282761|587867662|FG002|Overall Study|Death|1|||
162770269|NCT02282761|587867660|FG000|Overall Study|Adverse Event|6|||
162770270|NCT02282761|587867661|FG001|Overall Study|Adverse Event|2|||
162770271|NCT02282761|587867662|FG002|Overall Study|Adverse Event|0|||
162770272|NCT02282761|587867660|FG000|Overall Study|Lack of Efficacy|11|||
162770273|NCT02282761|587867661|FG001|Overall Study|Lack of Efficacy|6|||
162770274|NCT02282761|587867662|FG002|Overall Study|Lack of Efficacy|17|||
162770275|NCT02282761|587867660|FG000|Overall Study|Lost to Follow-up|2|||
162770276|NCT02282761|587867661|FG001|Overall Study|Lost to Follow-up|2|||
162770277|NCT02282761|587867662|FG002|Overall Study|Lost to Follow-up|1|||
162770278|NCT02282761|587867660|FG000|Overall Study|Physician Decision|0|||
162770279|NCT02282761|587867661|FG001|Overall Study|Physician Decision|0|||
162770280|NCT02282761|587867662|FG002|Overall Study|Physician Decision|2|||
162770281|NCT02282761|587867660|FG000|Overall Study|Withdrawal by Subject|8|||
162770282|NCT02282761|587867661|FG001|Overall Study|Withdrawal by Subject|10|||
162770283|NCT02282761|587867662|FG002|Overall Study|Withdrawal by Subject|16|||
162770284|NCT02282761|587867660|FG000|Overall Study|Other|3|||
162770285|NCT02282761|587867661|FG001|Overall Study|Other|2|||
162770286|NCT02282761|587867662|FG002|Overall Study|Other|1|||
162770287|NCT06312566|587867663|FG000|Overall Study|Protocol Violation|0|||
162770288|NCT06312566|587867664|FG001|Overall Study|Protocol Violation|1|||
162770289|NCT04551053|587867665|FG000|Overall Study|Death|10|||
162770290|NCT04551053|587867666|FG001|Overall Study|Death|9|||
162770291|NCT04551053|587867665|FG000|Overall Study|Lost to Follow-up|0|||
162770292|NCT04551053|587867666|FG001|Overall Study|Lost to Follow-up|2|||
162770293|NCT04551053|587867665|FG000|Overall Study|Study Terminated by Sponsor|57|||
162770294|NCT04551053|587867666|FG001|Overall Study|Study Terminated by Sponsor|65|||
162770295|NCT04551053|587867665|FG000|Overall Study|Withdrawal by Subject|12|||
162770296|NCT04551053|587867666|FG001|Overall Study|Withdrawal by Subject|5|||
162770297|NCT04551053|587867665|FG000|Overall Study|Adverse Event|2|||
162770298|NCT04551053|587867666|FG001|Overall Study|Adverse Event|0|||
162770299|NCT04551053|587867665|FG000|Overall Study|Lack of Efficacy|2|||
162770300|NCT04551053|587867666|FG001|Overall Study|Lack of Efficacy|1|||
162770301|NCT04551053|587867665|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
162770302|NCT04551053|587867666|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
162770303|NCT04551053|587867665|FG000|Overall Study|Splenapendectomi|1|||
162770304|NCT04551053|587867666|FG001|Overall Study|Splenapendectomi|0|||
162770305|NCT04551053|587867665|FG000|Overall Study|Medical Decision|1|||
162770306|NCT04551053|587867666|FG001|Overall Study|Medical Decision|1|||
162770307|NCT03861078|587867667|FG000|Overall Study|COVID-19 shut down|4|||
162770308|NCT03861078|587867667|FG000|Overall Study|Lost to Follow-up|1|||
162770309|NCT03861078|587867667|FG000|Overall Study|Protocol Violation|2|||
162770310|NCT03861078|587867667|FG000|Overall Study|lack of venous access|1|||
162770311|NCT01699178|587867668|FG000|Overall Study|Adverse Event|1|||
162770312|NCT01699178|587867669|FG001|Overall Study|Adverse Event|5|||
162770313|NCT01699178|587867668|FG000|Overall Study|Lost to Follow-up|1|||
162770314|NCT01699178|587867669|FG001|Overall Study|Lost to Follow-up|6|||
162770315|NCT01699178|587867668|FG000|Overall Study|Non-compliance with Study Drug|3|||
162770316|NCT01699178|587867669|FG001|Overall Study|Non-compliance with Study Drug|1|||
162770317|NCT01699178|587867668|FG000|Overall Study|Physician Decision|1|||
162770318|NCT01699178|587867669|FG001|Overall Study|Physician Decision|0|||
162770319|NCT01699178|587867668|FG000|Overall Study|Withdrawal by Subject|4|||
162770320|NCT01699178|587867669|FG001|Overall Study|Withdrawal by Subject|12|||
162770321|NCT01699178|587867668|FG000|Overall Study|Hematocrit >54%|1|||
162770322|NCT01699178|587867669|FG001|Overall Study|Hematocrit >54%|1|||
162770323|NCT01699178|587867668|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
162770324|NCT01699178|587867669|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
162770325|NCT01699178|587867668|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
162770326|NCT01699178|587867669|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
162770327|NCT03547167|587867673|FG000|Overall Study|Withdrawal by Subject|34|||
162770328|NCT03547167|587867674|FG001|Overall Study|Withdrawal by Subject|12|||
162770329|NCT03547167|587867673|FG000|Overall Study|Screen Failure|0|||
162770330|NCT03547167|587867674|FG001|Overall Study|Screen Failure|1|||
162770331|NCT03547167|587867673|FG000|Overall Study|Lost to Follow-up|59|||
162770332|NCT03547167|587867674|FG001|Overall Study|Lost to Follow-up|15|||
162770333|NCT03547167|587867673|FG000|Overall Study|Death|4|||
162770334|NCT03547167|587867674|FG001|Overall Study|Death|2|||
162770335|NCT00645411|587867675|FG000|Overall Study|Adverse Event|0|||
162770336|NCT00645411|587867676|FG001|Overall Study|Adverse Event|0|||
162770337|NCT00645411|587867677|FG002|Overall Study|Adverse Event|0|||
162770338|NCT00645411|587867678|FG003|Overall Study|Adverse Event|2|||
162770339|NCT00645411|587867675|FG000|Overall Study|Withdrawal by Subject|2|||
162770340|NCT00645411|587867676|FG001|Overall Study|Withdrawal by Subject|1|||
162770341|NCT00645411|587867677|FG002|Overall Study|Withdrawal by Subject|19|||
162770342|NCT00645411|587867678|FG003|Overall Study|Withdrawal by Subject|21|||
162770343|NCT00645411|587867675|FG000|Overall Study|Lost to Follow-up|10|||
162770344|NCT00645411|587867676|FG001|Overall Study|Lost to Follow-up|5|||
162770345|NCT00645411|587867677|FG002|Overall Study|Lost to Follow-up|124|||
162770346|NCT00645411|587867678|FG003|Overall Study|Lost to Follow-up|75|||
162770347|NCT00645411|587867675|FG000|Overall Study|Protocol Violation|1|||
162770348|NCT00645411|587867676|FG001|Overall Study|Protocol Violation|0|||
162770349|NCT00645411|587867677|FG002|Overall Study|Protocol Violation|1|||
162770350|NCT00645411|587867678|FG003|Overall Study|Protocol Violation|0|||
162770351|NCT00645411|587867675|FG000|Overall Study|Inappropriate enrollment|0|||
162770352|NCT00645411|587867676|FG001|Overall Study|Inappropriate enrollment|0|||
162770353|NCT00645411|587867677|FG002|Overall Study|Inappropriate enrollment|4|||
162770354|NCT00645411|587867678|FG003|Overall Study|Inappropriate enrollment|1|||
162770355|NCT00645411|587867675|FG000|Overall Study|Unable to classify|0|||
162770356|NCT00645411|587867676|FG001|Overall Study|Unable to classify|0|||
162770357|NCT00645411|587867677|FG002|Overall Study|Unable to classify|3|||
162770358|NCT00645411|587867678|FG003|Overall Study|Unable to classify|4|||
162770359|NCT03100370|587867682|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162770360|NCT03100370|587867683|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162770361|NCT03100370|587867684|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162770362|NCT03100370|587867685|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162770363|NCT03100370|587867686|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162770364|NCT03100370|587867687|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162770365|NCT02674399|587867688|FG000|Overall Study|Lost to Follow-up|2|||
162770366|NCT02674399|587867689|FG001|Overall Study|Lost to Follow-up|0|||
162770367|NCT01867307|587867690|FG000|Overall Study|Protocol Violation|2|||
162770368|NCT01867307|587867691|FG001|Overall Study|Protocol Violation|0|||
162770369|NCT01867307|587867690|FG000|Overall Study|Other Adverse Event|1|||
162770370|NCT01867307|587867691|FG001|Overall Study|Other Adverse Event|3|||
162770371|NCT00091572|587867696|FG000|Overall Study|Lost to Follow-up|1|||
162770372|NCT00091572|587867697|FG001|Overall Study|Lost to Follow-up|1|||
162770373|NCT00091572|587867696|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
162770374|NCT00091572|587867697|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
162770375|NCT00091572|587867696|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
162770376|NCT00091572|587867697|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
162770377|NCT00091572|587867696|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
162770378|NCT00091572|587867697|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
162770379|NCT00091572|587867696|FG000|Overall Study|Other Reason|6|||
162770380|NCT00091572|587867697|FG001|Overall Study|Other Reason|13|||
162770381|NCT00091572|587867696|FG000|Overall Study|Ongoing (still on treatment)|8|||
162770382|NCT00091572|587867697|FG001|Overall Study|Ongoing (still on treatment)|12|||
162770383|NCT00091572|587867696|FG000|Overall Study|Major Protocol Violation|2|||
162770384|NCT00091572|587867697|FG001|Overall Study|Major Protocol Violation|0|||
162770385|NCT00091572|587867696|FG000|Overall Study|Toxicity (Related AE)|53|||
162770386|NCT00091572|587867697|FG001|Overall Study|Toxicity (Related AE)|9|||
162770387|NCT01199302|587867703|FG000|Overall Study|Adverse Event|1|||
162770388|NCT01199302|587867704|FG001|Overall Study|Adverse Event|1|||
162770389|NCT01199302|587867705|FG002|Overall Study|Adverse Event|2|||
162770390|NCT01199302|587867706|FG003|Overall Study|Adverse Event|0|||
162770391|NCT01199302|587867703|FG000|Overall Study|Withdrawal by Subject|2|||
162770392|NCT01199302|587867704|FG001|Overall Study|Withdrawal by Subject|2|||
162770393|NCT01199302|587867705|FG002|Overall Study|Withdrawal by Subject|3|||
162770394|NCT01199302|587867706|FG003|Overall Study|Withdrawal by Subject|0|||
162770395|NCT01199302|587867703|FG000|Overall Study|Disease Progression|3|||
162770396|NCT01199302|587867704|FG001|Overall Study|Disease Progression|4|||
162770397|NCT01199302|587867705|FG002|Overall Study|Disease Progression|4|||
162770398|NCT01199302|587867706|FG003|Overall Study|Disease Progression|2|||
162770399|NCT01199302|587867703|FG000|Overall Study|Study Termination|13|||
162770400|NCT01199302|587867704|FG001|Overall Study|Study Termination|8|||
162770401|NCT01199302|587867705|FG002|Overall Study|Study Termination|11|||
162770402|NCT01199302|587867706|FG003|Overall Study|Study Termination|9|||
162770403|NCT01199302|587867703|FG000|Overall Study|Lost to Follow-up|0|||
162770404|NCT01199302|587867704|FG001|Overall Study|Lost to Follow-up|1|||
162770405|NCT01199302|587867705|FG002|Overall Study|Lost to Follow-up|0|||
162770406|NCT01199302|587867706|FG003|Overall Study|Lost to Follow-up|0|||
162770407|NCT01199302|587867703|FG000|Overall Study|Other|1|||
162770408|NCT01199302|587867704|FG001|Overall Study|Other|0|||
162770409|NCT01199302|587867705|FG002|Overall Study|Other|0|||
162770410|NCT01199302|587867706|FG003|Overall Study|Other|0|||
162770411|NCT04097535|587867707|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
162770412|NCT03070301|587867708|FG000|Overall Study|Progression of disease|16|||
162770413|NCT03070301|587867708|FG000|Overall Study|Physician Decision|3|||
162770414|NCT03070301|587867708|FG000|Overall Study|Withdrawal by Subject|1|||
162770415|NCT03322514|587869024|FG000|Overall Study|Withdrawal by Subject|1|||
162770416|NCT03322514|587869025|FG001|Overall Study|Withdrawal by Subject|1|||
162770417|NCT00088452|587869026|FG000|Overall Study|Did not receive intervention|1|||
162770418|NCT00088452|587869027|FG001|Overall Study|Did not receive intervention|0|||
162770419|NCT00088452|587869028|FG002|Overall Study|Did not receive intervention|1|||
162770420|NCT02081196|587869030|FG000|Overall Study|Lost to Follow-up|1|||
162770421|NCT02514577|587869038|FG000|Overall Study|Lost to Follow-up|6|||
162770422|NCT02514577|587869039|FG001|Overall Study|Lost to Follow-up|6|||
162770423|NCT02514577|587869038|FG000|Overall Study|Protocol Violation|1|||
162770424|NCT02514577|587869039|FG001|Overall Study|Protocol Violation|0|||
162770425|NCT02514577|587869038|FG000|Overall Study|Withdrawal by Subject|6|||
162770426|NCT02514577|587869039|FG001|Overall Study|Withdrawal by Subject|6|||
162770427|NCT02514577|587869038|FG000|Overall Study|Adverse Event|1|||
162770428|NCT02514577|587869039|FG001|Overall Study|Adverse Event|1|||
162770429|NCT00489489|587869040|FG000|Overall Study|Not treated due to protocol violation|0|||
162770430|NCT00489489|587869041|FG001|Overall Study|Not treated due to protocol violation|1|||
162770431|NCT00489489|587869042|FG002|Overall Study|Not treated due to protocol violation|1|||
162770432|NCT00489489|587869040|FG000|Overall Study|Adverse Event|1|||
162770433|NCT00489489|587869041|FG001|Overall Study|Adverse Event|1|||
162770434|NCT00489489|587869042|FG002|Overall Study|Adverse Event|1|||
162770435|NCT00489489|587869040|FG000|Overall Study|Protocol Violation|1|||
162770436|NCT00489489|587869041|FG001|Overall Study|Protocol Violation|0|||
162770437|NCT00489489|587869042|FG002|Overall Study|Protocol Violation|1|||
162770438|NCT00489489|587869040|FG000|Overall Study|Progressive disease|0|||
162770439|NCT00489489|587869041|FG001|Overall Study|Progressive disease|1|||
162770440|NCT00489489|587869042|FG002|Overall Study|Progressive disease|0|||
162770441|NCT00489489|587869040|FG000|Overall Study|Participant did not wish to continue|1|||
162770442|NCT00489489|587869041|FG001|Overall Study|Participant did not wish to continue|1|||
162770443|NCT00489489|587869042|FG002|Overall Study|Participant did not wish to continue|0|||
162770444|NCT00489489|587869040|FG000|Overall Study|Other than above|0|||
162770445|NCT00489489|587869041|FG001|Overall Study|Other than above|1|||
162770446|NCT00489489|587869042|FG002|Overall Study|Other than above|0|||
162770447|NCT02136797|587869045|FG000|Overall Study|Not Treated|8|||
162770448|NCT04523571|587869046|FG000|Received 2 Doses|Withdrawal by Subject|0|||
162770449|NCT04523571|587869047|FG001|Received 2 Doses|Withdrawal by Subject|0|||
162770450|NCT04523571|587869048|FG002|Received 2 Doses|Withdrawal by Subject|0|||
162770451|NCT04523571|587869049|FG003|Received 2 Doses|Withdrawal by Subject|1|||
162770452|NCT04523571|587869050|FG004|Received 2 Doses|Withdrawal by Subject|1|||
162770453|NCT04523571|587869051|FG005|Received 2 Doses|Withdrawal by Subject|0|||
162770454|NCT04523571|587869046|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
162770455|NCT04523571|587869047|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162770456|NCT04523571|587869048|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
162770457|NCT04523571|587869049|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162770458|NCT04523571|587869050|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162770459|NCT04523571|587869051|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162770460|NCT04523571|587869046|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162770461|NCT04523571|587869047|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162770462|NCT04523571|587869048|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162770463|NCT04523571|587869049|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162770464|NCT04523571|587869050|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162770465|NCT04523571|587869051|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
162770466|NCT04523571|587869046|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162770467|NCT04523571|587869047|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162770468|NCT04523571|587869048|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162770469|NCT04523571|587869049|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
162770470|NCT04523571|587869050|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
162770471|NCT04523571|587869051|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162770472|NCT04198428|587869052|FG000|Overall Study|Withdrawal by Subject|150|||
162770473|NCT04198428|587869053|FG001|Overall Study|Withdrawal by Subject|156|||
162770474|NCT00627523|587869055|FG000|Overall Study|Lack of Efficacy|1|||
162770475|NCT00627523|587869056|FG001|Overall Study|Lack of Efficacy|0|||
162770476|NCT00627523|587869055|FG000|Overall Study|Withdrawal by Subject|0|||
162770477|NCT00627523|587869056|FG001|Overall Study|Withdrawal by Subject|2|||
162770478|NCT00627523|587869055|FG000|Overall Study|Other|1|||
162770479|NCT00627523|587869056|FG001|Overall Study|Other|0|||
162770480|NCT04385849|587869059|FG000|Overall Study|Lost to Follow-up|1|||
162770481|NCT04385849|587869060|FG001|Overall Study|Lost to Follow-up|0|||
162770482|NCT02011568|587869063|FG000|Overall Study|Withdrawal by Subject|8|||
162770483|NCT02011568|587869064|FG001|Overall Study|Withdrawal by Subject|10|||
162770484|NCT02011568|587869063|FG000|Overall Study|Physician Decision|1|||
162770485|NCT02011568|587869064|FG001|Overall Study|Physician Decision|3|||
162770486|NCT01038128|587869066|FG000|Overall Study|Lack of Efficacy|1|||
162770487|NCT01038128|587869066|FG000|Overall Study|Lost to Follow-up|1|||
162770488|NCT01038128|587869066|FG000|Overall Study|Withdrawal by Subject|2|||
162770489|NCT03344458|587869071|FG000|Overall Study|Physician Decision|1|||
162770490|NCT03344458|587869071|FG000|Overall Study|Withdrawal by Subject|16|||
162770491|NCT03344458|587869071|FG000|Overall Study|Other reasons|10|||
162770492|NCT03344458|587869071|FG000|Overall Study|Lost to Follow-up|9|||
162770493|NCT03344458|587869071|FG000|Overall Study|Protocol Violation|3|||
162770494|NCT00396409|587869072|FG000|Period 1 - 2007|Adverse Event|0|||
162770495|NCT00396409|587869073|FG001|Period 1 - 2007|Adverse Event|1|||
162770496|NCT00396409|587869072|FG000|Period 1 - 2007|Lack of Efficacy|0|||
162770497|NCT00396409|587869073|FG001|Period 1 - 2007|Lack of Efficacy|1|||
162770498|NCT00396409|587869072|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
162770499|NCT00396409|587869073|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
162770500|NCT00396409|587869072|FG000|Period 1 - 2007|Lost to Follow-up|2|||
162770501|NCT00396409|587869073|FG001|Period 1 - 2007|Lost to Follow-up|3|||
162770502|NCT00396409|587869072|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
162770503|NCT00396409|587869073|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
162770504|NCT00396409|587869072|FG000|Period 2 - 2008|Protocol Violation|1|||
162770505|NCT00396409|587869073|FG001|Period 2 - 2008|Protocol Violation|0|||
162770506|NCT00396409|587869072|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
162770507|NCT00396409|587869073|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
162770508|NCT00396409|587869072|FG000|Period 2 - 2008|Lost to Follow-up|3|||
162770509|NCT00396409|587869073|FG001|Period 2 - 2008|Lost to Follow-up|1|||
162770510|NCT00331799|587869074|FG000|Overall Study|Withdrawal by Subject|2|||
162770511|NCT00331799|587869074|FG000|Overall Study|Sedation|1|||
162770512|NCT02889809|587869075|FG000|Overall Study|Withdrawal by Subject|30|||
162770513|NCT02889809|587869076|FG001|Overall Study|Withdrawal by Subject|21|||
162770514|NCT02889809|587869075|FG000|Overall Study|Lost to Follow-up|1|||
162770515|NCT02889809|587869076|FG001|Overall Study|Lost to Follow-up|1|||
162770516|NCT02889809|587869075|FG000|Overall Study|Site Closed|12|||
162770517|NCT02889809|587869076|FG001|Overall Study|Site Closed|11|||
162770518|NCT04203199|587869079|FG000|First Intervention Period|Lost to Follow-up|0|||
162770519|NCT04203199|587869080|FG001|First Intervention Period|Lost to Follow-up|1|||
162770520|NCT04203199|587869079|FG000|Second Intervention Period|Medication change|1|||
162770521|NCT04203199|587869080|FG001|Second Intervention Period|Medication change|0|||
162770522|NCT03960437|587869081|FG000|Overall Study|Removed by PI|4|||
162770523|NCT03960437|587869081|FG000|Overall Study|Lost to Follow-up|2|||
162770524|NCT03960437|587869081|FG000|Overall Study|Withdrawal by Subject|1|||
162770525|NCT03960437|587869081|FG000|Overall Study|Death|2|||
162770526|NCT02592434|587869087|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
162770527|NCT02592434|587869088|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
162770528|NCT02592434|587869089|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
162770529|NCT02592434|587869087|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
162770530|NCT02592434|587869088|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
162770531|NCT02592434|587869089|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
162770532|NCT02592434|587869087|FG000|Open-Label Phase (18 Weeks)|Other|3|||
162770533|NCT02592434|587869088|FG001|Open-Label Phase (18 Weeks)|Other|0|||
162770534|NCT02592434|587869089|FG002|Open-Label Phase (18 Weeks)|Other|0|||
162770535|NCT02592434|587869087|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
162770536|NCT02592434|587869088|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
162770537|NCT02592434|587869089|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
162770538|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
162770539|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
162770540|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
162770541|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
162770542|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
162770543|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
162770544|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Other|0|||
162770545|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Other|1|||
162770546|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Other|0|||
162770547|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
162770548|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
162770549|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
162770550|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
162770551|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
162770552|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
162770553|NCT02592434|587869087|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
162770554|NCT02592434|587869088|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
162770555|NCT02592434|587869089|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
162770556|NCT00147745|587869090|FG000|Overall Study|Withdrawal by Subject|1|||
162770557|NCT00147745|587869091|FG001|Overall Study|Withdrawal by Subject|0|||
162770558|NCT00147745|587869092|FG002|Overall Study|Withdrawal by Subject|0|||
162770559|NCT01757171|587869093|FG000|Overall Study|Adverse Event|5|||
162770560|NCT01757171|587869094|FG001|Overall Study|Adverse Event|1|||
162770561|NCT01757171|587869093|FG000|Overall Study|Disease Progression|1|||
162770562|NCT01757171|587869094|FG001|Overall Study|Disease Progression|0|||
162770563|NCT01757171|587869093|FG000|Overall Study|Hospitalization|1|||
162770564|NCT01757171|587869094|FG001|Overall Study|Hospitalization|0|||
162770565|NCT01757171|587869093|FG000|Overall Study|ECOG decline|1|||
162770566|NCT01757171|587869094|FG001|Overall Study|ECOG decline|0|||
162770567|NCT00510783|587869097|FG000|Overall Study|Lost to Follow-up|29|||
162770568|NCT00510783|587869098|FG001|Overall Study|Lost to Follow-up|25|||
162770569|NCT00510783|587869097|FG000|Overall Study|Withdrawal by Subject|2|||
162770570|NCT00510783|587869098|FG001|Overall Study|Withdrawal by Subject|3|||
162770571|NCT00510783|587869097|FG000|Overall Study|Protocol Violation|0|||
162770572|NCT00510783|587869098|FG001|Overall Study|Protocol Violation|1|||
162770573|NCT00316121|587869099|FG000|Overall Study|Death|1|||
162770574|NCT00316121|587869100|FG001|Overall Study|Death|0|||
162770575|NCT00316121|587869099|FG000|Overall Study|Lost to Follow-up|14|||
162770576|NCT00316121|587869100|FG001|Overall Study|Lost to Follow-up|8|||
162770577|NCT00316121|587869099|FG000|Overall Study|Withdrawal by Subject|2|||
162770578|NCT00316121|587869100|FG001|Overall Study|Withdrawal by Subject|0|||
162770579|NCT00316121|587869099|FG000|Overall Study|Reason is missing|1|||
162770580|NCT00316121|587869100|FG001|Overall Study|Reason is missing|0|||
162770581|NCT00316121|587869099|FG000|Overall Study|Subject relocated|1|||
162770582|NCT00316121|587869100|FG001|Overall Study|Subject relocated|1|||
162770583|NCT00316121|587869099|FG000|Overall Study|Subject refused to return|1|||
162770584|NCT00316121|587869100|FG001|Overall Study|Subject refused to return|0|||
162770585|NCT00316121|587869099|FG000|Overall Study|Subject no show for visit x 3|1|||
162770586|NCT00316121|587869100|FG001|Overall Study|Subject no show for visit x 3|0|||
162770587|NCT00316121|587869099|FG000|Overall Study|Subject did not have 24 month visit|1|||
162770588|NCT00316121|587869100|FG001|Overall Study|Subject did not have 24 month visit|0|||
162770589|NCT00460577|587869102|FG000|Overall Study|Protocol Violation|2|||
162770590|NCT00460577|587869103|FG001|Overall Study|Protocol Violation|6|||
162770591|NCT04043806|587869104|FG000|Overall Study|Commercial drug is available for participants|13|||
162770592|NCT04043806|587869104|FG000|Overall Study|Physician Decision|2|||
162770593|NCT04043806|587869104|FG000|Overall Study|Other|12|||
162770594|NCT04043806|587869104|FG000|Overall Study|Adverse Event|2|||
162770595|NCT04043806|587869104|FG000|Overall Study|Lost to Follow-up|6|||
162770596|NCT04043806|587869104|FG000|Overall Study|Other non-compliance|2|||
162770597|NCT04043806|587869104|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
162770598|NCT04043806|587869104|FG000|Overall Study|Never Dosed|1|||
162770599|NCT04362176|587869109|FG000|Overall Study|Lost to Follow-up|5|||
162770600|NCT04362176|587869110|FG001|Overall Study|Lost to Follow-up|8|||
162770601|NCT04362176|587869109|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
162770602|NCT04362176|587869110|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
162770603|NCT04598776|587869112|FG000|Overall Study|Protocol Violation|5|||
162770604|NCT04598776|587869112|FG000|Overall Study|Physician Decision|4|||
162770605|NCT00658632|587869115|FG000|Overall Study|Adverse Event|13|||
162770606|NCT00658632|587869116|FG001|Overall Study|Adverse Event|11|||
162770607|NCT00658632|587869115|FG000|Overall Study|Lost to Follow-up|25|||
162770608|NCT00658632|587869116|FG001|Overall Study|Lost to Follow-up|23|||
162770609|NCT00658632|587869115|FG000|Overall Study|Withdrawal by Subject|10|||
162770610|NCT00658632|587869116|FG001|Overall Study|Withdrawal by Subject|7|||
162770611|NCT00658632|587869115|FG000|Overall Study|Lack of Efficacy|0|||
162770612|NCT00658632|587869116|FG001|Overall Study|Lack of Efficacy|1|||
162770613|NCT00658632|587869115|FG000|Overall Study|Withdrawal of consent|8|||
162770614|NCT00658632|587869116|FG001|Overall Study|Withdrawal of consent|14|||
162770615|NCT00658632|587869115|FG000|Overall Study|Pregnancy|1|||
162770616|NCT00658632|587869116|FG001|Overall Study|Pregnancy|1|||
162770617|NCT00658632|587869115|FG000|Overall Study|Other|7|||
162770618|NCT00658632|587869116|FG001|Overall Study|Other|8|||
162770619|NCT02632045|587869117|FG000|Overall Study|Withdrawal by Subject|1|||
162770620|NCT02632045|587869118|FG001|Overall Study|Withdrawal by Subject|2|||
162770621|NCT00596960|587869121|FG000|Overall Study|Death|1|||
162770622|NCT00596960|587869122|FG001|Overall Study|Death|2|||
162770623|NCT00596960|587869121|FG000|Overall Study|Lost to Follow-up|6|||
162770624|NCT00596960|587869122|FG001|Overall Study|Lost to Follow-up|5|||
162770625|NCT00596960|587869121|FG000|Overall Study|Withdrawal by Subject|1|||
162770626|NCT00596960|587869122|FG001|Overall Study|Withdrawal by Subject|0|||
162770627|NCT00596960|587869121|FG000|Overall Study|Incarcerated|2|||
162770628|NCT00596960|587869122|FG001|Overall Study|Incarcerated|0|||
162770629|NCT00596960|587869121|FG000|Overall Study|Physician Decision|1|||
162770630|NCT00596960|587869122|FG001|Overall Study|Physician Decision|0|||
162770631|NCT00596960|587869121|FG000|Overall Study|Protocol Violation|0|||
162770632|NCT00596960|587869122|FG001|Overall Study|Protocol Violation|1|||
162770633|NCT00596960|587869121|FG000|Overall Study|No alcohol use data|0|||
162770634|NCT00596960|587869122|FG001|Overall Study|No alcohol use data|1|||
162770635|NCT03503188|587869123|FG000|Overall Study|Non eligible in the sub study|0|||
162770636|NCT03503188|587869124|FG001|Overall Study|Non eligible in the sub study|1|||
162770637|NCT04016415|587869125|FG000|Overall Study|Adverse Event|2|||
162770638|NCT04016415|587869126|FG001|Overall Study|Adverse Event|1|||
162770639|NCT04016415|587869125|FG000|Overall Study|Lost to Follow-up|6|||
162770640|NCT04016415|587869126|FG001|Overall Study|Lost to Follow-up|2|||
162770641|NCT04016415|587869125|FG000|Overall Study|Physician Decision|5|||
162770642|NCT04016415|587869126|FG001|Overall Study|Physician Decision|1|||
162770643|NCT04016415|587869125|FG000|Overall Study|Pregnancy|0|||
162770644|NCT04016415|587869126|FG001|Overall Study|Pregnancy|1|||
162770645|NCT04016415|587869125|FG000|Overall Study|Withdrawal by Subject|24|||
162770646|NCT04016415|587869126|FG001|Overall Study|Withdrawal by Subject|27|||
162770647|NCT04016415|587869125|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
162770648|NCT04016415|587869126|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
162770649|NCT01885559|587869129|FG000|Overall Study|Lost to Follow-up|15|||
162770650|NCT01885559|587869130|FG001|Overall Study|Lost to Follow-up|16|||
162770651|NCT01885559|587869129|FG000|Overall Study|Less than full participation|9|||
162770652|NCT01885559|587869130|FG001|Overall Study|Less than full participation|19|||
162770653|NCT01885559|587869129|FG000|Overall Study|Protocol Violation|0|||
162770654|NCT01885559|587869130|FG001|Overall Study|Protocol Violation|1|||
162770655|NCT03122548|587869142|FG000|Overall Study|Death|2|||
162770656|NCT03122548|587869142|FG000|Overall Study|Progression - subject went into hospice|1|||
162770657|NCT03122548|587869142|FG000|Overall Study|Study Terminated by Sponsor|2|||
162770658|NCT01634165|587869146|FG000|Period 2|Adverse Event|0|||
162770659|NCT01634165|587869147|FG001|Period 2|Adverse Event|1|||
162770660|NCT01634165|587869148|FG002|Period 2|Adverse Event|0|||
162770661|NCT01634165|587869149|FG003|Period 2|Adverse Event|0|||
162770662|NCT03820024|587869152|FG000|Overall Study|Physician Decision|1|||
162770663|NCT03820024|587869153|FG001|Overall Study|Physician Decision|2|||
162770664|NCT00705614|587870824|FG000|Initial Intervention|Adverse Event|40|||
162770665|NCT00705614|587870825|FG001|Initial Intervention|Adverse Event|21|||
162770666|NCT00705614|587870824|FG000|Initial Intervention|Lost to Follow-up|310|||
162770667|NCT00705614|587870825|FG001|Initial Intervention|Lost to Follow-up|191|||
162770668|NCT00705614|587870824|FG000|Initial Intervention|Withdrawal by Subject|114|||
162770669|NCT00705614|587870825|FG001|Initial Intervention|Withdrawal by Subject|71|||
162770670|NCT00705614|587870824|FG000|Initial Intervention|Administrative Reason|51|||
162770671|NCT00705614|587870825|FG001|Initial Intervention|Administrative Reason|38|||
162770672|NCT00705614|587870824|FG000|Initial Intervention|Status completion unknown|3|||
162770673|NCT00705614|587870825|FG001|Initial Intervention|Status completion unknown|0|||
162770674|NCT00705614|587870824|FG000|Switch to Remicade|Adverse Event|0|||
162770675|NCT00705614|587870825|FG001|Switch to Remicade|Adverse Event|5|||
162770676|NCT00705614|587870824|FG000|Switch to Remicade|Lost to Follow-up|0|||
162770677|NCT00705614|587870825|FG001|Switch to Remicade|Lost to Follow-up|23|||
162770678|NCT00705614|587870824|FG000|Switch to Remicade|Withdrawal by Subject|0|||
162770679|NCT00705614|587870825|FG001|Switch to Remicade|Withdrawal by Subject|12|||
162770680|NCT00705614|587870824|FG000|Switch to Remicade|Administrative Reason|0|||
162770681|NCT00705614|587870825|FG001|Switch to Remicade|Administrative Reason|9|||
162770682|NCT02661490|587870826|FG000|Overall Study|Lost to Follow-up|0|||
162770683|NCT02661490|587870827|FG001|Overall Study|Lost to Follow-up|1|||
162770684|NCT02661490|587870828|FG002|Overall Study|Lost to Follow-up|0|||
162770685|NCT02661490|587870829|FG003|Overall Study|Lost to Follow-up|0|||
162770686|NCT02661490|587870830|FG004|Overall Study|Lost to Follow-up|2|||
162770687|NCT02661490|587870826|FG000|Overall Study|Withdrawal by Subject|2|||
162770688|NCT02661490|587870827|FG001|Overall Study|Withdrawal by Subject|0|||
162770689|NCT02661490|587870828|FG002|Overall Study|Withdrawal by Subject|2|||
162770690|NCT02661490|587870829|FG003|Overall Study|Withdrawal by Subject|0|||
162770691|NCT02661490|587870830|FG004|Overall Study|Withdrawal by Subject|0|||
162770692|NCT02661490|587870826|FG000|Overall Study|Death|1|||
162770693|NCT02661490|587870827|FG001|Overall Study|Death|1|||
162770694|NCT02661490|587870828|FG002|Overall Study|Death|0|||
162770695|NCT02661490|587870829|FG003|Overall Study|Death|1|||
162770696|NCT02661490|587870830|FG004|Overall Study|Death|0|||
162770697|NCT02661490|587870826|FG000|Overall Study|Reason not Specified|0|||
162770698|NCT02661490|587870827|FG001|Overall Study|Reason not Specified|0|||
162770699|NCT02661490|587870828|FG002|Overall Study|Reason not Specified|0|||
162770700|NCT02661490|587870829|FG003|Overall Study|Reason not Specified|0|||
162770701|NCT02661490|587870830|FG004|Overall Study|Reason not Specified|1|||
162770702|NCT00961298|587870831|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
162770703|NCT00961298|587870831|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
162770704|NCT00961298|587870831|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
162770705|NCT01232569|587870834|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
162770706|NCT01232569|587870835|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162770707|NCT01232569|587870836|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162770708|NCT01232569|587870837|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
162770709|NCT01232569|587870834|FG000|Double-blind Treatment Period|Escape|2|||
162770710|NCT01232569|587870835|FG001|Double-blind Treatment Period|Escape|2|||
162770711|NCT01232569|587870836|FG002|Double-blind Treatment Period|Escape|0|||
162770712|NCT01232569|587870837|FG003|Double-blind Treatment Period|Escape|0|||
162770713|NCT01232569|587870834|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
162770714|NCT01232569|587870835|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162770715|NCT01232569|587870836|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
162770716|NCT01232569|587870837|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162770717|NCT01232569|587870834|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
162770718|NCT01232569|587870835|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
162770719|NCT01232569|587870836|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162770720|NCT01232569|587870837|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
162770721|NCT01232569|587870834|FG000|Double-blind Treatment Period|Physician Decision|1|||
162770722|NCT01232569|587870835|FG001|Double-blind Treatment Period|Physician Decision|0|||
162770723|NCT01232569|587870836|FG002|Double-blind Treatment Period|Physician Decision|0|||
162770724|NCT01232569|587870837|FG003|Double-blind Treatment Period|Physician Decision|0|||
162770725|NCT01232569|587870834|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
162770726|NCT01232569|587870835|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
162770727|NCT01232569|587870836|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
162770728|NCT01232569|587870837|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
162770729|NCT01232569|587870834|FG000|Double-blind Treatment Period|Death|2|||
162770730|NCT01232569|587870835|FG001|Double-blind Treatment Period|Death|0|||
162770731|NCT01232569|587870836|FG002|Double-blind Treatment Period|Death|0|||
162770732|NCT01232569|587870837|FG003|Double-blind Treatment Period|Death|0|||
162770733|NCT04044352|587870838|FG000|Overall Study|Lost to Follow-up|9|||
162770734|NCT04044352|587870838|FG000|Overall Study|Withdrawal by Subject|2|||
162770735|NCT00814632|587870839|FG000|Overall Study|Lack of Efficacy|2|||
162770736|NCT02388932|587870844|FG000|Overall Study|Death|1|||
162770737|NCT05335005|587870847|FG000|Overall Study|Lost to Follow-up|1|||
162770738|NCT05927753|587870848|FG000|Overall Study|Withdrawal by Subject|0|||
162770739|NCT05927753|587870849|FG001|Overall Study|Withdrawal by Subject|2|||
162770740|NCT05927753|587870848|FG000|Overall Study|Physician Decision|0|||
162770741|NCT05927753|587870849|FG001|Overall Study|Physician Decision|1|||
162770742|NCT02123797|587870850|FG000|Baseline Intervention|Death|9|||
162770743|NCT02123797|587870851|FG001|Baseline Intervention|Death|16|||
162770744|NCT02123797|587870852|FG002|Baseline Intervention|Death|0|||
162770745|NCT02123797|587870853|FG003|Baseline Intervention|Death|0|||
162770746|NCT02123797|587870854|FG004|Baseline Intervention|Death|0|||
162770747|NCT02123797|587870850|FG000|Baseline Intervention|Withdrawal by Subject|2|||
162770748|NCT02123797|587870851|FG001|Baseline Intervention|Withdrawal by Subject|8|||
162770749|NCT02123797|587870852|FG002|Baseline Intervention|Withdrawal by Subject|0|||
162770750|NCT02123797|587870853|FG003|Baseline Intervention|Withdrawal by Subject|0|||
162770751|NCT02123797|587870854|FG004|Baseline Intervention|Withdrawal by Subject|0|||
162770752|NCT02123797|587870850|FG000|Baseline Intervention|Relocation|2|||
162770753|NCT02123797|587870851|FG001|Baseline Intervention|Relocation|0|||
162770754|NCT02123797|587870852|FG002|Baseline Intervention|Relocation|0|||
162770755|NCT02123797|587870853|FG003|Baseline Intervention|Relocation|0|||
162770756|NCT02123797|587870854|FG004|Baseline Intervention|Relocation|0|||
162770757|NCT02123797|587870850|FG000|Baseline Intervention|Out of window for initial survey|6|||
162770758|NCT02123797|587870851|FG001|Baseline Intervention|Out of window for initial survey|13|||
162770759|NCT02123797|587870852|FG002|Baseline Intervention|Out of window for initial survey|0|||
162770760|NCT02123797|587870853|FG003|Baseline Intervention|Out of window for initial survey|0|||
162770761|NCT02123797|587870854|FG004|Baseline Intervention|Out of window for initial survey|0|||
162770762|NCT02123797|587870850|FG000|Baseline Intervention|Lost to Follow-up|0|||
162770763|NCT02123797|587870851|FG001|Baseline Intervention|Lost to Follow-up|5|||
162770764|NCT02123797|587870852|FG002|Baseline Intervention|Lost to Follow-up|0|||
162770765|NCT02123797|587870853|FG003|Baseline Intervention|Lost to Follow-up|0|||
162770766|NCT02123797|587870854|FG004|Baseline Intervention|Lost to Follow-up|0|||
162770767|NCT02123797|587870850|FG000|Baseline Intervention|Other Disease|3|||
162770768|NCT02123797|587870851|FG001|Baseline Intervention|Other Disease|0|||
162770769|NCT02123797|587870852|FG002|Baseline Intervention|Other Disease|0|||
162770770|NCT02123797|587870853|FG003|Baseline Intervention|Other Disease|0|||
162770771|NCT02123797|587870854|FG004|Baseline Intervention|Other Disease|0|||
162770772|NCT02123797|587870850|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
162770773|NCT02123797|587870851|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
162770774|NCT02123797|587870852|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
162770775|NCT02123797|587870853|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
162770776|NCT02123797|587870854|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
162770777|NCT02123797|587870850|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
162770778|NCT02123797|587870851|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
162770779|NCT02123797|587870852|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
162770780|NCT02123797|587870853|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
162770781|NCT02123797|587870854|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162770782|NCT02123797|587870850|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
162770783|NCT02123797|587870851|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
162770784|NCT02123797|587870852|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770785|NCT02123797|587870853|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770786|NCT02123797|587870854|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770787|NCT02123797|587870850|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
162770788|NCT02123797|587870851|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
162770789|NCT02123797|587870852|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
162770790|NCT02123797|587870853|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
162770791|NCT02123797|587870854|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
162770792|NCT02123797|587870850|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
162770793|NCT02123797|587870851|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
162770794|NCT02123797|587870852|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162770795|NCT02123797|587870853|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162770796|NCT02123797|587870854|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162770797|NCT02123797|587870850|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
162770798|NCT02123797|587870851|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
162770799|NCT02123797|587870852|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
162770800|NCT02123797|587870853|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
162770801|NCT02123797|587870854|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
162770802|NCT02123797|587870850|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162770803|NCT02123797|587870851|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
162770804|NCT02123797|587870852|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
162770805|NCT02123797|587870853|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
162770806|NCT02123797|587870854|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162770807|NCT02123797|587870850|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
162770808|NCT02123797|587870851|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
162770809|NCT02123797|587870852|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770810|NCT02123797|587870853|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770811|NCT02123797|587870854|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162770812|NCT02123797|587870850|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
162770813|NCT02123797|587870851|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
162770814|NCT02123797|587870852|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
162770815|NCT02123797|587870853|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
162770816|NCT02123797|587870854|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
162770817|NCT01375777|587870856|FG000|Overall Study|Withdrawal by Subject|0|||
162770818|NCT01375777|587870857|FG001|Overall Study|Withdrawal by Subject|2|||
162770819|NCT01375777|587870858|FG002|Overall Study|Withdrawal by Subject|1|||
162770820|NCT01375777|587870859|FG003|Overall Study|Withdrawal by Subject|0|||
162770821|NCT01375777|587870860|FG004|Overall Study|Withdrawal by Subject|1|||
162770822|NCT01375777|587870861|FG005|Overall Study|Withdrawal by Subject|1|||
162770823|NCT01375777|587870862|FG006|Overall Study|Withdrawal by Subject|1|||
162770824|NCT01375777|587870863|FG007|Overall Study|Withdrawal by Subject|2|||
162770825|NCT01375777|587870864|FG008|Overall Study|Withdrawal by Subject|1|||
162770826|NCT01375777|587870856|FG000|Overall Study|Lost to Follow-up|1|||
162770827|NCT01375777|587870857|FG001|Overall Study|Lost to Follow-up|0|||
162770828|NCT01375777|587870858|FG002|Overall Study|Lost to Follow-up|0|||
162770829|NCT01375777|587870859|FG003|Overall Study|Lost to Follow-up|0|||
162770830|NCT01375777|587870860|FG004|Overall Study|Lost to Follow-up|0|||
162770831|NCT01375777|587870861|FG005|Overall Study|Lost to Follow-up|0|||
162770832|NCT01375777|587870862|FG006|Overall Study|Lost to Follow-up|1|||
162770833|NCT01375777|587870863|FG007|Overall Study|Lost to Follow-up|0|||
162770834|NCT01375777|587870864|FG008|Overall Study|Lost to Follow-up|0|||
162770835|NCT01375777|587870856|FG000|Overall Study|Other|1|||
162770836|NCT01375777|587870857|FG001|Overall Study|Other|1|||
162770837|NCT01375777|587870858|FG002|Overall Study|Other|0|||
162770838|NCT01375777|587870859|FG003|Overall Study|Other|0|||
162770839|NCT01375777|587870860|FG004|Overall Study|Other|0|||
162770840|NCT01375777|587870861|FG005|Overall Study|Other|0|||
162770841|NCT01375777|587870862|FG006|Overall Study|Other|0|||
162770842|NCT01375777|587870863|FG007|Overall Study|Other|0|||
162770843|NCT01375777|587870864|FG008|Overall Study|Other|1|||
162770844|NCT00355784|587870865|FG000|Overall Study|Withdrawal by Subject|0|||
162770845|NCT00355784|587870866|FG001|Overall Study|Withdrawal by Subject|0|||
162770846|NCT00355784|587870867|FG002|Overall Study|Withdrawal by Subject|2|||
162770847|NCT03602053|587870874|FG000|Overall Study|Withdrawal by Subject|7|||
162770848|NCT03602053|587870875|FG001|Overall Study|Withdrawal by Subject|9|||
162770849|NCT03602053|587870876|FG002|Overall Study|Withdrawal by Subject|7|||
162770850|NCT03602053|587870874|FG000|Overall Study|Lost to Follow-up|5|||
162770851|NCT03602053|587870875|FG001|Overall Study|Lost to Follow-up|6|||
162770852|NCT03602053|587870876|FG002|Overall Study|Lost to Follow-up|0|||
162770853|NCT03602053|587870874|FG000|Overall Study|Protocol Violation|3|||
162770854|NCT03602053|587870875|FG001|Overall Study|Protocol Violation|0|||
162770855|NCT03602053|587870876|FG002|Overall Study|Protocol Violation|4|||
162770856|NCT03602053|587870874|FG000|Overall Study|Physician Decision|1|||
162770857|NCT03602053|587870875|FG001|Overall Study|Physician Decision|0|||
162770858|NCT03602053|587870876|FG002|Overall Study|Physician Decision|0|||
162770859|NCT03602053|587870874|FG000|Overall Study|migration|2|||
162770860|NCT03602053|587870875|FG001|Overall Study|migration|3|||
162770861|NCT03602053|587870876|FG002|Overall Study|migration|0|||
162770862|NCT03602053|587870874|FG000|Overall Study|Other|1|||
162770863|NCT03602053|587870875|FG001|Overall Study|Other|0|||
162770864|NCT03602053|587870876|FG002|Overall Study|Other|0|||
162770865|NCT01234675|587870883|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
162770866|NCT01234675|587870884|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162770867|NCT01234675|587870883|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162770868|NCT01234675|587870884|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162770869|NCT02409732|587870885|FG000|Overall Study|Withdrawal by Subject|4|||
162770870|NCT02409732|587870885|FG000|Overall Study|Lost to Follow-up|2|||
162770871|NCT01838499|587870886|FG000|Overall Study|Protocol Violation|0|||
162770872|NCT01838499|587870887|FG001|Overall Study|Protocol Violation|1|||
162770873|NCT01838499|587870886|FG000|Overall Study|Lost to Follow-up|2|||
162770874|NCT01838499|587870887|FG001|Overall Study|Lost to Follow-up|4|||
162770875|NCT01838499|587870886|FG000|Overall Study|Lack of Efficacy|1|||
162770876|NCT01838499|587870887|FG001|Overall Study|Lack of Efficacy|2|||
162770877|NCT01838499|587870886|FG000|Overall Study|Adverse Event|2|||
162770878|NCT01838499|587870887|FG001|Overall Study|Adverse Event|1|||
162770879|NCT01838499|587870886|FG000|Overall Study|Withdrawal by Subject|19|||
162770880|NCT01838499|587870887|FG001|Overall Study|Withdrawal by Subject|9|||
162770881|NCT03614923|587870888|FG000|Overall Study|Withdrawal by Subject|2|||
162770882|NCT03614923|587870889|FG001|Overall Study|Withdrawal by Subject|1|||
162770883|NCT03614923|587870890|FG002|Overall Study|Withdrawal by Subject|1|||
162770884|NCT03614923|587870888|FG000|Overall Study|Adverse Event|0|||
162770885|NCT03614923|587870889|FG001|Overall Study|Adverse Event|2|||
162770886|NCT03614923|587870890|FG002|Overall Study|Adverse Event|1|||
162770887|NCT03614923|587870888|FG000|Overall Study|Lost to Follow-up|1|||
162770888|NCT03614923|587870889|FG001|Overall Study|Lost to Follow-up|0|||
162770889|NCT03614923|587870890|FG002|Overall Study|Lost to Follow-up|1|||
162770890|NCT03614923|587870888|FG000|Overall Study|Lack of Efficacy|2|||
162770891|NCT03614923|587870889|FG001|Overall Study|Lack of Efficacy|0|||
162770892|NCT03614923|587870890|FG002|Overall Study|Lack of Efficacy|1|||
162770893|NCT03614923|587870888|FG000|Overall Study|Non-compliance|0|||
162770894|NCT03614923|587870889|FG001|Overall Study|Non-compliance|1|||
162770895|NCT03614923|587870890|FG002|Overall Study|Non-compliance|0|||
162770896|NCT03614923|587870888|FG000|Overall Study|Other|0|||
162770897|NCT03614923|587870889|FG001|Overall Study|Other|1|||
162770898|NCT03614923|587870890|FG002|Overall Study|Other|1|||
162770899|NCT01136733|587870891|FG000|Phase 1b|Adverse Event|0|||
162770900|NCT01136733|587870892|FG001|Phase 1b|Adverse Event|3|||
162770901|NCT01136733|587870893|FG002|Phase 1b|Adverse Event|1|||
162770902|NCT01136733|587870894|FG003|Phase 1b|Adverse Event|0|||
162770903|NCT01136733|587870895|FG004|Phase 1b|Adverse Event|0|||
162770904|NCT01136733|587870896|FG005|Phase 1b|Adverse Event|0|||
162770905|NCT01136733|587870897|FG006|Phase 1b|Adverse Event|0|||
162770906|NCT01136733|587870891|FG000|Phase 1b|Participant Choice|0|||
162770907|NCT01136733|587870892|FG001|Phase 1b|Participant Choice|0|||
162770908|NCT01136733|587870893|FG002|Phase 1b|Participant Choice|1|||
162770909|NCT01136733|587870894|FG003|Phase 1b|Participant Choice|0|||
162770910|NCT01136733|587870895|FG004|Phase 1b|Participant Choice|0|||
162770911|NCT01136733|587870896|FG005|Phase 1b|Participant Choice|0|||
162770912|NCT01136733|587870897|FG006|Phase 1b|Participant Choice|0|||
162770913|NCT01136733|587870891|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
162770914|NCT01136733|587870892|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
162770915|NCT01136733|587870893|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
162770916|NCT01136733|587870894|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
162770917|NCT01136733|587870895|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
162770918|NCT01136733|587870896|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
162770919|NCT01136733|587870897|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
162770920|NCT01136733|587870891|FG000|Phase 1b|Clinical Progression|1|||
162770921|NCT01136733|587870892|FG001|Phase 1b|Clinical Progression|1|||
162770922|NCT01136733|587870893|FG002|Phase 1b|Clinical Progression|0|||
162770923|NCT01136733|587870894|FG003|Phase 1b|Clinical Progression|0|||
162770924|NCT01136733|587870895|FG004|Phase 1b|Clinical Progression|0|||
162770925|NCT01136733|587870896|FG005|Phase 1b|Clinical Progression|0|||
162770926|NCT01136733|587870897|FG006|Phase 1b|Clinical Progression|0|||
162770927|NCT01136733|587870891|FG000|Phase 2|Disease Progression|0|||
162770928|NCT01136733|587870892|FG001|Phase 2|Disease Progression|0|||
162770929|NCT01136733|587870893|FG002|Phase 2|Disease Progression|0|||
162770930|NCT01136733|587870894|FG003|Phase 2|Disease Progression|0|||
162770931|NCT01136733|587870895|FG004|Phase 2|Disease Progression|30|||
162770932|NCT01136733|587870896|FG005|Phase 2|Disease Progression|32|||
162770933|NCT01136733|587870897|FG006|Phase 2|Disease Progression|38|||
162770934|NCT01136733|587870891|FG000|Phase 2|Adverse Event|0|||
162770935|NCT01136733|587870892|FG001|Phase 2|Adverse Event|0|||
162770936|NCT01136733|587870893|FG002|Phase 2|Adverse Event|0|||
162770937|NCT01136733|587870894|FG003|Phase 2|Adverse Event|0|||
162770938|NCT01136733|587870895|FG004|Phase 2|Adverse Event|11|||
162770939|NCT01136733|587870896|FG005|Phase 2|Adverse Event|13|||
162770940|NCT01136733|587870897|FG006|Phase 2|Adverse Event|5|||
162770941|NCT01136733|587870891|FG000|Phase 2|Participant Choice|0|||
162770942|NCT01136733|587870892|FG001|Phase 2|Participant Choice|0|||
162770943|NCT01136733|587870893|FG002|Phase 2|Participant Choice|0|||
162770944|NCT01136733|587870894|FG003|Phase 2|Participant Choice|0|||
162770945|NCT01136733|587870895|FG004|Phase 2|Participant Choice|3|||
162770946|NCT01136733|587870896|FG005|Phase 2|Participant Choice|0|||
162770947|NCT01136733|587870897|FG006|Phase 2|Participant Choice|1|||
162770948|NCT01136733|587870891|FG000|Phase 2|Administrative-Withdrew Consent|0|||
162770949|NCT01136733|587870892|FG001|Phase 2|Administrative-Withdrew Consent|0|||
162770950|NCT01136733|587870893|FG002|Phase 2|Administrative-Withdrew Consent|0|||
162770951|NCT01136733|587870894|FG003|Phase 2|Administrative-Withdrew Consent|0|||
162770952|NCT01136733|587870895|FG004|Phase 2|Administrative-Withdrew Consent|1|||
162770953|NCT01136733|587870896|FG005|Phase 2|Administrative-Withdrew Consent|0|||
162770954|NCT01136733|587870897|FG006|Phase 2|Administrative-Withdrew Consent|0|||
162770955|NCT01136733|587870891|FG000|Phase 2|Other|0|||
162770956|NCT01136733|587870892|FG001|Phase 2|Other|0|||
162770957|NCT01136733|587870893|FG002|Phase 2|Other|0|||
162770958|NCT01136733|587870894|FG003|Phase 2|Other|0|||
162770959|NCT01136733|587870895|FG004|Phase 2|Other|6|||
162770960|NCT01136733|587870896|FG005|Phase 2|Other|7|||
162770961|NCT01136733|587870897|FG006|Phase 2|Other|6|||
162770962|NCT01882088|587870899|FG000|Overall Study|Intolerance of esophageal manometry|1|||
162770963|NCT01882088|587870899|FG000|Overall Study|no possibility to place the catheter|1|||
162770964|NCT01882088|587870899|FG000|Overall Study|Protocol Violation|1|||
162770965|NCT01882088|587870899|FG000|Overall Study|inadequate pH-impedance tracings|2|||
162770966|NCT02186015|587870900|FG000|Overall Study|Physician Decision|1|||
162770967|NCT02186015|587870901|FG001|Overall Study|Physician Decision|0|||
162770968|NCT01533181|587870904|FG000|Overall Study|Disease progression pre-active treatment|0|||
162770969|NCT01533181|587870905|FG001|Overall Study|Disease progression pre-active treatment|1|||
162770970|NCT01533181|587870904|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
162770971|NCT01533181|587870905|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
162770972|NCT02720198|587870906|FG000|Overall Study|Withdrawal by Subject|0|||
162770973|NCT02720198|587870907|FG001|Overall Study|Withdrawal by Subject|1|||
162770974|NCT00105521|587870911|FG000|Overall Study|Other|1|||
162770975|NCT00105521|587870912|FG001|Overall Study|Other|1|||
162770976|NCT00105521|587870913|FG002|Overall Study|Other|2|||
162770977|NCT00105521|587870914|FG003|Overall Study|Other|0|||
162770978|NCT00105521|587870911|FG000|Overall Study|Adverse Event|10|||
162770979|NCT00105521|587870912|FG001|Overall Study|Adverse Event|4|||
162770980|NCT00105521|587870913|FG002|Overall Study|Adverse Event|10|||
162770981|NCT00105521|587870914|FG003|Overall Study|Adverse Event|8|||
162770982|NCT00105521|587870911|FG000|Overall Study|Withdrawal by Subject|1|||
162770983|NCT00105521|587870912|FG001|Overall Study|Withdrawal by Subject|0|||
162770984|NCT00105521|587870913|FG002|Overall Study|Withdrawal by Subject|1|||
162770985|NCT00105521|587870914|FG003|Overall Study|Withdrawal by Subject|4|||
162770986|NCT00105521|587870911|FG000|Overall Study|Lack of Efficacy|0|||
162770987|NCT00105521|587870912|FG001|Overall Study|Lack of Efficacy|0|||
162770988|NCT00105521|587870913|FG002|Overall Study|Lack of Efficacy|0|||
162770989|NCT00105521|587870914|FG003|Overall Study|Lack of Efficacy|1|||
162770990|NCT00105521|587870911|FG000|Overall Study|Protocol Violation|3|||
162770991|NCT00105521|587870912|FG001|Overall Study|Protocol Violation|5|||
162770992|NCT00105521|587870913|FG002|Overall Study|Protocol Violation|4|||
162770993|NCT00105521|587870914|FG003|Overall Study|Protocol Violation|4|||
162770994|NCT00105521|587870911|FG000|Overall Study|Lost to Follow-up|0|||
162770995|NCT00105521|587870912|FG001|Overall Study|Lost to Follow-up|1|||
162770996|NCT00105521|587870913|FG002|Overall Study|Lost to Follow-up|0|||
162770997|NCT00105521|587870914|FG003|Overall Study|Lost to Follow-up|0|||
162770998|NCT00385697|587870917|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
162770999|NCT00385697|587870918|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
162771000|NCT00385697|587870919|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
162771001|NCT00385697|587870920|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
162771002|NCT00385697|587870921|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
162771003|NCT00385697|587870917|FG000|Open-label Segment 1|Lost to Follow-up|1|||
162771004|NCT00385697|587870918|FG001|Open-label Segment 1|Lost to Follow-up|0|||
162771005|NCT00385697|587870919|FG002|Open-label Segment 1|Lost to Follow-up|0|||
162771006|NCT00385697|587870920|FG003|Open-label Segment 1|Lost to Follow-up|0|||
162771007|NCT00385697|587870921|FG004|Open-label Segment 1|Lost to Follow-up|0|||
162771008|NCT00385697|587870917|FG000|Double-blind Segment 2|Adverse Event|0|||
162771009|NCT00385697|587870918|FG001|Double-blind Segment 2|Adverse Event|3|||
162771010|NCT00385697|587870919|FG002|Double-blind Segment 2|Adverse Event|1|||
162771011|NCT00385697|587870920|FG003|Double-blind Segment 2|Adverse Event|0|||
162771012|NCT00385697|587870921|FG004|Double-blind Segment 2|Adverse Event|0|||
162771013|NCT00385697|587870917|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
162771014|NCT00385697|587870918|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
162771015|NCT00385697|587870919|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
162771016|NCT00385697|587870920|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
162771017|NCT00385697|587870921|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
162771018|NCT00385697|587870917|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
162771019|NCT00385697|587870918|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
162771020|NCT00385697|587870919|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
162771021|NCT00385697|587870920|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
162771022|NCT00385697|587870921|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
162771023|NCT00385697|587870917|FG000|Double-blind Segment 2|Other|0|||
162771024|NCT00385697|587870918|FG001|Double-blind Segment 2|Other|2|||
162771025|NCT00385697|587870919|FG002|Double-blind Segment 2|Other|0|||
162771026|NCT00385697|587870920|FG003|Double-blind Segment 2|Other|0|||
162771027|NCT00385697|587870921|FG004|Double-blind Segment 2|Other|0|||
162771028|NCT01721109|587870937|FG000|Overall Study|Lack of Efficacy|1|||
162771029|NCT01721109|587870937|FG000|Overall Study|Non- Compliance with Study Drug|3|||
162771030|NCT01721109|587870937|FG000|Overall Study|Withdrew Consent|1|||
162771031|NCT01721109|587870937|FG000|Overall Study|Lost to Follow-up|2|||
162771032|NCT03045302|587870938|FG000|Overall Study|Pre-treatment adverse event|1|||
162771033|NCT00134056|587870939|FG000|Randomization|Not eligible for assigned treatment|22|||
162771034|NCT00134056|587870940|FG001|Randomization|Not eligible for assigned treatment|20|||
162771035|NCT00134056|587870939|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
162771036|NCT00134056|587870940|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
162771037|NCT00134056|587870939|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
162771038|NCT00134056|587870940|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
162771039|NCT00134056|587870939|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
162771040|NCT00134056|587870940|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
162771041|NCT00134056|587870939|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
162771042|NCT00134056|587870940|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
162771043|NCT00742560|587870942|FG000|Overall Study|Adverse Event|0|||
162771044|NCT00742560|587870943|FG001|Overall Study|Adverse Event|0|||
162771045|NCT00742560|587870944|FG002|Overall Study|Adverse Event|1|||
162771046|NCT00742560|587870945|FG003|Overall Study|Adverse Event|1|||
162771047|NCT00742560|587870946|FG004|Overall Study|Adverse Event|1|||
162771048|NCT00742560|587870942|FG000|Overall Study|Death|0|||
162771049|NCT00742560|587870943|FG001|Overall Study|Death|2|||
162771050|NCT00742560|587870944|FG002|Overall Study|Death|0|||
162771051|NCT00742560|587870945|FG003|Overall Study|Death|2|||
162771052|NCT00742560|587870946|FG004|Overall Study|Death|3|||
162771053|NCT00742560|587870942|FG000|Overall Study|Subject's Decision|1|||
162771054|NCT00742560|587870943|FG001|Overall Study|Subject's Decision|0|||
162771055|NCT00742560|587870944|FG002|Overall Study|Subject's Decision|2|||
162771056|NCT00742560|587870945|FG003|Overall Study|Subject's Decision|3|||
162771057|NCT00742560|587870946|FG004|Overall Study|Subject's Decision|3|||
162771058|NCT00742560|587870942|FG000|Overall Study|Investigator's Decision|0|||
162771059|NCT00742560|587870943|FG001|Overall Study|Investigator's Decision|0|||
162771060|NCT00742560|587870944|FG002|Overall Study|Investigator's Decision|4|||
162771061|NCT00742560|587870945|FG003|Overall Study|Investigator's Decision|1|||
162771062|NCT00742560|587870946|FG004|Overall Study|Investigator's Decision|0|||
162771063|NCT00742560|587870942|FG000|Overall Study|Disease Progression|1|||
162771064|NCT00742560|587870943|FG001|Overall Study|Disease Progression|0|||
162771065|NCT00742560|587870944|FG002|Overall Study|Disease Progression|5|||
162771066|NCT00742560|587870945|FG003|Overall Study|Disease Progression|17|||
162771067|NCT00742560|587870946|FG004|Overall Study|Disease Progression|16|||
162771068|NCT00742560|587870942|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
162771069|NCT00742560|587870943|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
162771070|NCT00742560|587870944|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
162771071|NCT00742560|587870945|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
162771072|NCT00742560|587870946|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
162771073|NCT00742560|587870942|FG000|Overall Study|Other|0|||
162771074|NCT00742560|587870943|FG001|Overall Study|Other|1|||
162771075|NCT00742560|587870944|FG002|Overall Study|Other|8|||
162771076|NCT00742560|587870945|FG003|Overall Study|Other|9|||
162771077|NCT00742560|587870946|FG004|Overall Study|Other|9|||
162771078|NCT00742560|587870942|FG000|Overall Study|MIssing|0|||
162771079|NCT00742560|587870943|FG001|Overall Study|MIssing|0|||
162771080|NCT00742560|587870944|FG002|Overall Study|MIssing|0|||
162771081|NCT00742560|587870945|FG003|Overall Study|MIssing|0|||
162771082|NCT00742560|587870946|FG004|Overall Study|MIssing|1|||
162771083|NCT01536795|587870947|FG000|Overall Study|Lost to Follow-up|0|||
162771084|NCT01536795|587870948|FG001|Overall Study|Lost to Follow-up|2|||
162771085|NCT01536795|587870947|FG000|Overall Study|Lack of Efficacy|1|||
162771086|NCT01536795|587870948|FG001|Overall Study|Lack of Efficacy|0|||
162771087|NCT02267746|587870949|FG000|Overall Study|Adverse Event|0|||
162771088|NCT02267746|587870950|FG001|Overall Study|Adverse Event|2|||
162771089|NCT02267746|587870951|FG002|Overall Study|Adverse Event|1|||
162771090|NCT02267746|587870949|FG000|Overall Study|Protocol Violation|8|||
162771091|NCT02267746|587870950|FG001|Overall Study|Protocol Violation|7|||
162771092|NCT02267746|587870951|FG002|Overall Study|Protocol Violation|3|||
162771093|NCT02267746|587870949|FG000|Overall Study|Lack of Efficacy|11|||
162771094|NCT02267746|587870950|FG001|Overall Study|Lack of Efficacy|11|||
162771095|NCT02267746|587870951|FG002|Overall Study|Lack of Efficacy|15|||
162771096|NCT02267746|587870949|FG000|Overall Study|Protocol Violation|1|||
162771097|NCT02267746|587870950|FG001|Overall Study|Protocol Violation|2|||
162771098|NCT02267746|587870951|FG002|Overall Study|Protocol Violation|1|||
162771099|NCT02267746|587870949|FG000|Overall Study|Miscellaneous|1|||
162771100|NCT02267746|587870950|FG001|Overall Study|Miscellaneous|0|||
162771101|NCT02267746|587870951|FG002|Overall Study|Miscellaneous|1|||
162771102|NCT05008224|587870952|FG000|Overall Study|Death|3|||
162771103|NCT05008224|587870952|FG000|Overall Study|Lost to Follow-up|2|||
162771104|NCT05008224|587870952|FG000|Overall Study|Did Not Continue on Extension Study|39|||
162771105|NCT05008224|587870952|FG000|Overall Study|Transferred to Extension Study|100|||
162771106|NCT05008224|587870952|FG000|Overall Study|Withdrawal by Subject|2|||
162771107|NCT00348283|587870953|FG000|Induction|Adverse Event|0|||
162771108|NCT00348283|587870954|FG001|Induction|Adverse Event|2|||
162771109|NCT00348283|587870953|FG000|Induction|Protocol Violation|0|||
162771110|NCT00348283|587870954|FG001|Induction|Protocol Violation|4|||
162771111|NCT00348283|587870953|FG000|Double Blind|Adverse Event|2|||
162771112|NCT00348283|587870954|FG001|Double Blind|Adverse Event|5|||
162771113|NCT00348283|587870953|FG000|Double Blind|Withdrawal by Subject|1|||
162771114|NCT00348283|587870954|FG001|Double Blind|Withdrawal by Subject|1|||
162771115|NCT00348283|587870953|FG000|Double Blind|Protocol Violation|0|||
162771116|NCT00348283|587870954|FG001|Double Blind|Protocol Violation|1|||
162771117|NCT00348283|587870953|FG000|Double Blind|Lack of Efficacy|2|||
162771118|NCT00348283|587870954|FG001|Double Blind|Lack of Efficacy|2|||
162771119|NCT00348283|587870953|FG000|Double Blind|Pregnancy|0|||
162771120|NCT00348283|587870954|FG001|Double Blind|Pregnancy|1|||
162771121|NCT00348283|587870953|FG000|Open Label|Adverse Event|0|||
162771122|NCT00348283|587870954|FG001|Open Label|Adverse Event|8|||
162771123|NCT00348283|587870953|FG000|Open Label|Withdrawal by Subject|0|||
162771124|NCT00348283|587870954|FG001|Open Label|Withdrawal by Subject|4|||
162771125|NCT00348283|587870953|FG000|Open Label|Lost to Follow-up|0|||
162771126|NCT00348283|587870954|FG001|Open Label|Lost to Follow-up|1|||
162771127|NCT00348283|587870953|FG000|Open Label|Lack of Efficacy|0|||
162771128|NCT00348283|587870954|FG001|Open Label|Lack of Efficacy|13|||
162771129|NCT00348283|587870953|FG000|Open Label|Administrative reasons|0|||
162771130|NCT00348283|587870954|FG001|Open Label|Administrative reasons|5|||
162771131|NCT00348283|587870953|FG000|Open Label|Subject moved to the United States|0|||
162771132|NCT00348283|587870954|FG001|Open Label|Subject moved to the United States|1|||
162771133|NCT00348283|587870953|FG000|Open Label|Pregnancy|0|||
162771134|NCT00348283|587870954|FG001|Open Label|Pregnancy|1|||
162771135|NCT00348283|587870953|FG000|Open Label|Sponsor decision|0|||
162771136|NCT00348283|587870954|FG001|Open Label|Sponsor decision|1|||
162771137|NCT05878522|587870958|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771138|NCT05878522|587870959|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771139|NCT05878522|587870960|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771140|NCT05878522|587870961|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771141|NCT05878522|587870962|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771142|NCT05878522|587870963|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771143|NCT05878522|587870964|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771144|NCT05878522|587870965|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771145|NCT05878522|587870966|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
162771146|NCT05878522|587870967|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771147|NCT05878522|587870968|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771148|NCT05878522|587870969|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162771149|NCT05878522|587870958|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
162771150|NCT05878522|587870959|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771151|NCT05878522|587870960|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771152|NCT05878522|587870961|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771153|NCT05878522|587870962|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771154|NCT05878522|587870963|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771155|NCT05878522|587870964|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771156|NCT05878522|587870965|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771157|NCT05878522|587870966|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771158|NCT05878522|587870967|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
162771159|NCT05878522|587870968|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771160|NCT05878522|587870969|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162771161|NCT05878522|587870958|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771162|NCT05878522|587870959|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
162771163|NCT05878522|587870960|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771164|NCT05878522|587870961|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
162771165|NCT05878522|587870962|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771166|NCT05878522|587870963|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771167|NCT05878522|587870964|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771168|NCT05878522|587870965|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771169|NCT05878522|587870966|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771170|NCT05878522|587870967|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771171|NCT05878522|587870968|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771172|NCT05878522|587870969|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162771173|NCT05878522|587870958|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771174|NCT05878522|587870959|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771175|NCT05878522|587870960|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771176|NCT05878522|587870961|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771177|NCT05878522|587870962|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
162771178|NCT05878522|587870963|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771179|NCT05878522|587870964|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771180|NCT05878522|587870965|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771181|NCT05878522|587870966|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771182|NCT05878522|587870967|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771183|NCT05878522|587870968|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771184|NCT05878522|587870969|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162771185|NCT05263492|587870970|FG000|Overall Study|Adverse Event|1|||
162771186|NCT05263492|587870970|FG000|Overall Study|Disease progression during active treatment|3|||
162771187|NCT03747575|587870971|FG000|Overall Study|Withdrawal by Subject|6|||
162771188|NCT03747575|587870972|FG001|Overall Study|Withdrawal by Subject|3|||
162771189|NCT03747575|587870971|FG000|Overall Study|Lost to Follow-up|3|||
162771190|NCT03747575|587870972|FG001|Overall Study|Lost to Follow-up|3|||
162771191|NCT03747575|587870971|FG000|Overall Study|Adverse Event|0|||
162771192|NCT03747575|587870972|FG001|Overall Study|Adverse Event|1|||
162771193|NCT02260154|587870974|FG000|Overall Study|Screening failure|2|||
162771194|NCT03560206|587870975|FG000|Overall Study|Lost to Follow-up|19|||
162771195|NCT03560206|587870976|FG001|Overall Study|Lost to Follow-up|11|||
162771196|NCT03560206|587870975|FG000|Overall Study|Withdrawal by Subject|2|||
162771197|NCT03560206|587870976|FG001|Overall Study|Withdrawal by Subject|4|||
162771198|NCT03560206|587870975|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
162771199|NCT03560206|587870976|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
162771200|NCT03560206|587870975|FG000|Overall Study|Busy schedule|14|||
162771201|NCT03560206|587870976|FG001|Overall Study|Busy schedule|2|||
162771202|NCT03560206|587870975|FG000|Overall Study|patients' new health condition such as cancer|10|||
162771203|NCT03560206|587870976|FG001|Overall Study|patients' new health condition such as cancer|1|||
162771204|NCT02009865|587870978|FG000|Overall Study|Adverse Event|0|||
162771205|NCT02009865|587870979|FG001|Overall Study|Adverse Event|2|||
162771206|NCT02009865|587870978|FG000|Overall Study|Protocol Violation|0|||
162771207|NCT02009865|587870979|FG001|Overall Study|Protocol Violation|2|||
162771208|NCT02009865|587870978|FG000|Overall Study|Withdrawal by Subject|1|||
162771209|NCT02009865|587870979|FG001|Overall Study|Withdrawal by Subject|1|||
162771210|NCT01760876|587870980|FG000|Overall Study|Non-cardiac death (head injury)|1|||
162771211|NCT01760876|587870980|FG000|Overall Study|Carcinoma of prostate|1|||
162771212|NCT01760876|587870980|FG000|Overall Study|Impaired renal function|1|||
162771213|NCT01760876|587870980|FG000|Overall Study|Major depression|1|||
162771214|NCT01760876|587870980|FG000|Overall Study|Very poor baseline OCT quality|2|||
162771215|NCT00732498|587870983|FG000|Overall Study|Ineligible|1|||
162771216|NCT00732498|587870983|FG000|Overall Study|Adverse Event|2|||
162771217|NCT00732498|587870983|FG000|Overall Study|Physician Decision|3|||
162771218|NCT04295499|587870984|FG000|Overall Study|moving out of state|1|||
162771219|NCT04295499|587870985|FG001|Overall Study|moving out of state|0|||
162771220|NCT04295499|587870984|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
162771221|NCT04295499|587870985|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
162771222|NCT00308113|587870986|FG000|Overall Study|Protocol closure|0|||
162771223|NCT00308113|587870987|FG001|Overall Study|Protocol closure|0|||
162771224|NCT00308113|587870988|FG002|Overall Study|Protocol closure|0|||
162771225|NCT00308113|587870989|FG003|Overall Study|Protocol closure|1|||
162771226|NCT03556891|587870992|FG000|Initial Pivotal Study|Adverse Event|4|||
162771227|NCT03556891|587870992|FG000|Initial Pivotal Study|MRI Need|3|||
162771228|NCT03556891|587870992|FG000|Initial Pivotal Study|Device Failure|1|||
162771229|NCT03556891|587870992|FG000|Initial Pivotal Study|Death|1|||
162771230|NCT03556891|587870992|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
162771231|NCT03556891|587870992|FG000|Initial Pivotal Study|Missing at random|1|||
162771232|NCT03556891|587870992|FG000|Initial Pivotal Study|Missing due to COVID|1|||
162771233|NCT03556891|587870992|FG000|Initial Pivotal Study|Protocol Violation|1|||
162771234|NCT03722485|587872729|FG000|Overall Study|Withdrawal by Subject|1|||
162771235|NCT03722485|587872730|FG001|Overall Study|Withdrawal by Subject|0|||
162771236|NCT03722485|587872729|FG000|Overall Study|Adverse Event|0|||
162771237|NCT03722485|587872730|FG001|Overall Study|Adverse Event|2|||
162771238|NCT03722485|587872729|FG000|Overall Study|subject discharged prior to study completion|1|||
162771239|NCT03722485|587872730|FG001|Overall Study|subject discharged prior to study completion|5|||
162771240|NCT03722485|587872729|FG000|Overall Study|eligibility criteria not met|2|||
162771241|NCT03722485|587872730|FG001|Overall Study|eligibility criteria not met|0|||
162771242|NCT03672188|587872731|FG000|Overall Study|Withdrawal by Subject|0|||
162771243|NCT03672188|587872732|FG001|Overall Study|Withdrawal by Subject|0|||
162771244|NCT03672188|587872733|FG002|Overall Study|Withdrawal by Subject|0|||
162771245|NCT03672188|587872734|FG003|Overall Study|Withdrawal by Subject|3|||
162771246|NCT03672188|587872735|FG004|Overall Study|Withdrawal by Subject|0|||
162771247|NCT03672188|587872736|FG005|Overall Study|Withdrawal by Subject|0|||
162771248|NCT03672188|587872737|FG006|Overall Study|Withdrawal by Subject|0|||
162771249|NCT03672188|587872738|FG007|Overall Study|Withdrawal by Subject|0|||
162771250|NCT03672188|587872739|FG008|Overall Study|Withdrawal by Subject|0|||
162771251|NCT03672188|587872740|FG009|Overall Study|Withdrawal by Subject|0|||
162771252|NCT03672188|587872741|FG010|Overall Study|Withdrawal by Subject|0|||
162771253|NCT03672188|587872742|FG011|Overall Study|Withdrawal by Subject|0|||
162771254|NCT03672188|587872743|FG012|Overall Study|Withdrawal by Subject|0|||
162771255|NCT03672188|587872744|FG013|Overall Study|Withdrawal by Subject|0|||
162771256|NCT03672188|587872745|FG014|Overall Study|Withdrawal by Subject|0|||
162771257|NCT03672188|587872731|FG000|Overall Study|Death|0|||
162771258|NCT03672188|587872732|FG001|Overall Study|Death|0|||
162771259|NCT03672188|587872733|FG002|Overall Study|Death|0|||
162771260|NCT03672188|587872734|FG003|Overall Study|Death|0|||
162771261|NCT03672188|587872735|FG004|Overall Study|Death|0|||
162771262|NCT03672188|587872736|FG005|Overall Study|Death|0|||
162771263|NCT03672188|587872737|FG006|Overall Study|Death|0|||
162771264|NCT03672188|587872738|FG007|Overall Study|Death|0|||
162771265|NCT03672188|587872739|FG008|Overall Study|Death|0|||
162771266|NCT03672188|587872740|FG009|Overall Study|Death|0|||
162771267|NCT03672188|587872741|FG010|Overall Study|Death|0|||
162771268|NCT03672188|587872742|FG011|Overall Study|Death|0|||
162771269|NCT03672188|587872743|FG012|Overall Study|Death|1|||
162771270|NCT03672188|587872744|FG013|Overall Study|Death|0|||
162771271|NCT03672188|587872745|FG014|Overall Study|Death|0|||
162771272|NCT03672188|587872731|FG000|Overall Study|Lost to Follow-up|0|||
162771273|NCT03672188|587872732|FG001|Overall Study|Lost to Follow-up|0|||
162771274|NCT03672188|587872733|FG002|Overall Study|Lost to Follow-up|1|||
162771275|NCT03672188|587872734|FG003|Overall Study|Lost to Follow-up|0|||
162771276|NCT03672188|587872735|FG004|Overall Study|Lost to Follow-up|0|||
162771277|NCT03672188|587872736|FG005|Overall Study|Lost to Follow-up|0|||
162771278|NCT03672188|587872737|FG006|Overall Study|Lost to Follow-up|0|||
162771279|NCT03672188|587872738|FG007|Overall Study|Lost to Follow-up|0|||
162771280|NCT03672188|587872739|FG008|Overall Study|Lost to Follow-up|0|||
162771281|NCT03672188|587872740|FG009|Overall Study|Lost to Follow-up|0|||
162771282|NCT03672188|587872741|FG010|Overall Study|Lost to Follow-up|0|||
162771283|NCT03672188|587872742|FG011|Overall Study|Lost to Follow-up|0|||
162771284|NCT03672188|587872743|FG012|Overall Study|Lost to Follow-up|0|||
162771285|NCT03672188|587872744|FG013|Overall Study|Lost to Follow-up|0|||
162771286|NCT03672188|587872745|FG014|Overall Study|Lost to Follow-up|0|||
162771287|NCT03997409|587872746|FG000|Overall Study|Protocol Violation|1|||
162771288|NCT03997409|587872747|FG001|Overall Study|Protocol Violation|1|||
162771289|NCT03997409|587872748|FG002|Overall Study|Protocol Violation|0|||
162771290|NCT03997409|587872746|FG000|Overall Study|Withdrawal by Subject|3|||
162771291|NCT03997409|587872747|FG001|Overall Study|Withdrawal by Subject|0|||
162771292|NCT03997409|587872748|FG002|Overall Study|Withdrawal by Subject|0|||
162771293|NCT03997409|587872746|FG000|Overall Study|Lost to Follow-up|0|||
162771294|NCT03997409|587872747|FG001|Overall Study|Lost to Follow-up|0|||
162771295|NCT03997409|587872748|FG002|Overall Study|Lost to Follow-up|1|||
162771296|NCT03696342|587872749|FG000|Overall Study|Lost to Follow-up|1|||
162771297|NCT03696342|587872750|FG001|Overall Study|Lost to Follow-up|0|||
162771298|NCT01753323|587872752|FG000|Overall Study|Lack of Efficacy|0|||
162771299|NCT01753323|587872753|FG001|Overall Study|Lack of Efficacy|0|||
162771300|NCT01753323|587872754|FG002|Overall Study|Lack of Efficacy|8|||
162771301|NCT01753323|587872752|FG000|Overall Study|Protocol deviation|1|||
162771302|NCT01753323|587872753|FG001|Overall Study|Protocol deviation|0|||
162771303|NCT01753323|587872754|FG002|Overall Study|Protocol deviation|0|||
162771304|NCT01753323|587872752|FG000|Overall Study|Adverse Event|0|||
162771305|NCT01753323|587872753|FG001|Overall Study|Adverse Event|0|||
162771306|NCT01753323|587872754|FG002|Overall Study|Adverse Event|1|||
162771307|NCT01870999|587872755|FG000|Overall Study|Adverse Event|0|||
162771308|NCT01870999|587872756|FG001|Overall Study|Adverse Event|4|||
162771309|NCT01870999|587872757|FG002|Overall Study|Adverse Event|1|||
162771310|NCT01870999|587872755|FG000|Overall Study|Subject met withdrawal criteria|3|||
162771311|NCT01870999|587872756|FG001|Overall Study|Subject met withdrawal criteria|2|||
162771312|NCT01870999|587872757|FG002|Overall Study|Subject met withdrawal criteria|0|||
162771313|NCT01870999|587872755|FG000|Overall Study|Subject withdrawn by Investigator|1|||
162771314|NCT01870999|587872756|FG001|Overall Study|Subject withdrawn by Investigator|0|||
162771315|NCT01870999|587872757|FG002|Overall Study|Subject withdrawn by Investigator|0|||
162771316|NCT01870999|587872755|FG000|Overall Study|Withdrawal by Subject|0|||
162771317|NCT01870999|587872756|FG001|Overall Study|Withdrawal by Subject|2|||
162771318|NCT01870999|587872757|FG002|Overall Study|Withdrawal by Subject|5|||
162771319|NCT01870999|587872755|FG000|Overall Study|Protocol Violation|0|||
162771320|NCT01870999|587872756|FG001|Overall Study|Protocol Violation|0|||
162771321|NCT01870999|587872757|FG002|Overall Study|Protocol Violation|1|||
162771322|NCT01636258|587872758|FG000|Overall Study|Lost to Follow-up|1|||
162771323|NCT01636258|587872759|FG001|Overall Study|Lost to Follow-up|0|||
162771324|NCT03034772|587872770|FG000|Overall Study|Adverse Event|0|||
162771325|NCT03034772|587872771|FG001|Overall Study|Adverse Event|1|||
162771326|NCT03034772|587872770|FG000|Overall Study|Withdrawal by Subject|0|||
162771327|NCT03034772|587872771|FG001|Overall Study|Withdrawal by Subject|1|||
162771328|NCT00116584|587872772|FG000|Overall Study|Withdrawal by Subject|1|||
162771329|NCT00116584|587872773|FG001|Overall Study|Withdrawal by Subject|0|||
162771330|NCT00116584|587872772|FG000|Overall Study|Protocol Violation|1|||
162771331|NCT00116584|587872773|FG001|Overall Study|Protocol Violation|1|||
162771332|NCT01745380|587872774|FG000|Overall Study|Lost to Follow-up|1|||
162771333|NCT01745380|587872775|FG001|Overall Study|Lost to Follow-up|0|||
162771334|NCT01745380|587872774|FG000|Overall Study|Lack of Efficacy|0|||
162771335|NCT01745380|587872775|FG001|Overall Study|Lack of Efficacy|1|||
162771336|NCT02660034|587872776|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
162771337|NCT02660034|587872777|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
162771338|NCT02660034|587872778|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
162771339|NCT02660034|587872779|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
162771340|NCT02660034|587872780|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
162771341|NCT02660034|587872781|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
162771342|NCT02660034|587872782|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
162771343|NCT02660034|587872783|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
162771344|NCT02660034|587872784|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
162771345|NCT02660034|587872785|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
162771346|NCT02660034|587872786|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
162771347|NCT02660034|587872787|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
162771348|NCT02660034|587872788|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
162771349|NCT02660034|587872789|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
162771350|NCT02660034|587872776|FG000|Overall Study|Progressive Disease (Clinical)|7|||
162771351|NCT02660034|587872777|FG001|Overall Study|Progressive Disease (Clinical)|8|||
162771352|NCT02660034|587872778|FG002|Overall Study|Progressive Disease (Clinical)|3|||
162771353|NCT02660034|587872779|FG003|Overall Study|Progressive Disease (Clinical)|9|||
162771354|NCT02660034|587872780|FG004|Overall Study|Progressive Disease (Clinical)|3|||
162771355|NCT02660034|587872781|FG005|Overall Study|Progressive Disease (Clinical)|0|||
162771356|NCT02660034|587872782|FG006|Overall Study|Progressive Disease (Clinical)|0|||
162771357|NCT02660034|587872783|FG007|Overall Study|Progressive Disease (Clinical)|0|||
162771358|NCT02660034|587872784|FG008|Overall Study|Progressive Disease (Clinical)|0|||
162771359|NCT02660034|587872785|FG009|Overall Study|Progressive Disease (Clinical)|0|||
162771360|NCT02660034|587872786|FG010|Overall Study|Progressive Disease (Clinical)|0|||
162771361|NCT02660034|587872787|FG011|Overall Study|Progressive Disease (Clinical)|0|||
162771362|NCT02660034|587872788|FG012|Overall Study|Progressive Disease (Clinical)|0|||
162771363|NCT02660034|587872789|FG013|Overall Study|Progressive Disease (Clinical)|0|||
162771364|NCT02660034|587872776|FG000|Overall Study|Lost to Follow-up|0|||
162771365|NCT02660034|587872777|FG001|Overall Study|Lost to Follow-up|0|||
162771366|NCT02660034|587872778|FG002|Overall Study|Lost to Follow-up|1|||
162771367|NCT02660034|587872779|FG003|Overall Study|Lost to Follow-up|1|||
162771368|NCT02660034|587872780|FG004|Overall Study|Lost to Follow-up|0|||
162771369|NCT02660034|587872781|FG005|Overall Study|Lost to Follow-up|0|||
162771370|NCT02660034|587872782|FG006|Overall Study|Lost to Follow-up|0|||
162771371|NCT02660034|587872783|FG007|Overall Study|Lost to Follow-up|0|||
162771372|NCT02660034|587872784|FG008|Overall Study|Lost to Follow-up|0|||
162771373|NCT02660034|587872785|FG009|Overall Study|Lost to Follow-up|1|||
162771374|NCT02660034|587872786|FG010|Overall Study|Lost to Follow-up|1|||
162771375|NCT02660034|587872787|FG011|Overall Study|Lost to Follow-up|1|||
162771376|NCT02660034|587872788|FG012|Overall Study|Lost to Follow-up|0|||
162771377|NCT02660034|587872789|FG013|Overall Study|Lost to Follow-up|0|||
162771378|NCT02660034|587872776|FG000|Overall Study|Participant moved into special access scheme|1|||
162771379|NCT02660034|587872777|FG001|Overall Study|Participant moved into special access scheme|2|||
162771380|NCT02660034|587872778|FG002|Overall Study|Participant moved into special access scheme|0|||
162771381|NCT02660034|587872779|FG003|Overall Study|Participant moved into special access scheme|0|||
162771382|NCT02660034|587872780|FG004|Overall Study|Participant moved into special access scheme|0|||
162771383|NCT02660034|587872781|FG005|Overall Study|Participant moved into special access scheme|0|||
162771384|NCT02660034|587872782|FG006|Overall Study|Participant moved into special access scheme|0|||
162771385|NCT02660034|587872783|FG007|Overall Study|Participant moved into special access scheme|0|||
162771386|NCT02660034|587872784|FG008|Overall Study|Participant moved into special access scheme|0|||
162771387|NCT02660034|587872785|FG009|Overall Study|Participant moved into special access scheme|0|||
162771388|NCT02660034|587872786|FG010|Overall Study|Participant moved into special access scheme|0|||
162771389|NCT02660034|587872787|FG011|Overall Study|Participant moved into special access scheme|0|||
162771390|NCT02660034|587872788|FG012|Overall Study|Participant moved into special access scheme|0|||
162771391|NCT02660034|587872789|FG013|Overall Study|Participant moved into special access scheme|0|||
162771392|NCT02660034|587872776|FG000|Overall Study|Adverse Event|1|||
162771393|NCT02660034|587872777|FG001|Overall Study|Adverse Event|0|||
162771394|NCT02660034|587872778|FG002|Overall Study|Adverse Event|0|||
162771395|NCT02660034|587872779|FG003|Overall Study|Adverse Event|0|||
162771396|NCT02660034|587872780|FG004|Overall Study|Adverse Event|0|||
162771397|NCT02660034|587872781|FG005|Overall Study|Adverse Event|0|||
162771398|NCT02660034|587872782|FG006|Overall Study|Adverse Event|0|||
162771399|NCT02660034|587872783|FG007|Overall Study|Adverse Event|0|||
162771400|NCT02660034|587872784|FG008|Overall Study|Adverse Event|0|||
162771401|NCT02660034|587872785|FG009|Overall Study|Adverse Event|0|||
162771402|NCT02660034|587872786|FG010|Overall Study|Adverse Event|0|||
162771403|NCT02660034|587872787|FG011|Overall Study|Adverse Event|0|||
162771404|NCT02660034|587872788|FG012|Overall Study|Adverse Event|0|||
162771405|NCT02660034|587872789|FG013|Overall Study|Adverse Event|0|||
162771406|NCT02660034|587872776|FG000|Overall Study|Sponsor Decision|0|||
162771407|NCT02660034|587872777|FG001|Overall Study|Sponsor Decision|1|||
162771408|NCT02660034|587872778|FG002|Overall Study|Sponsor Decision|2|||
162771409|NCT02660034|587872779|FG003|Overall Study|Sponsor Decision|2|||
162771410|NCT02660034|587872780|FG004|Overall Study|Sponsor Decision|3|||
162771411|NCT02660034|587872781|FG005|Overall Study|Sponsor Decision|0|||
162771412|NCT02660034|587872782|FG006|Overall Study|Sponsor Decision|0|||
162771413|NCT02660034|587872783|FG007|Overall Study|Sponsor Decision|0|||
162771414|NCT02660034|587872784|FG008|Overall Study|Sponsor Decision|0|||
162771415|NCT02660034|587872785|FG009|Overall Study|Sponsor Decision|0|||
162771416|NCT02660034|587872786|FG010|Overall Study|Sponsor Decision|0|||
162771417|NCT02660034|587872787|FG011|Overall Study|Sponsor Decision|0|||
162771418|NCT02660034|587872788|FG012|Overall Study|Sponsor Decision|0|||
162771419|NCT02660034|587872789|FG013|Overall Study|Sponsor Decision|1|||
162771420|NCT02660034|587872776|FG000|Overall Study|Withdrawal by Subject|0|||
162771421|NCT02660034|587872777|FG001|Overall Study|Withdrawal by Subject|0|||
162771422|NCT02660034|587872778|FG002|Overall Study|Withdrawal by Subject|0|||
162771423|NCT02660034|587872779|FG003|Overall Study|Withdrawal by Subject|0|||
162771424|NCT02660034|587872780|FG004|Overall Study|Withdrawal by Subject|0|||
162771425|NCT02660034|587872781|FG005|Overall Study|Withdrawal by Subject|0|||
162771426|NCT02660034|587872782|FG006|Overall Study|Withdrawal by Subject|1|||
162771427|NCT02660034|587872783|FG007|Overall Study|Withdrawal by Subject|1|||
162771428|NCT02660034|587872784|FG008|Overall Study|Withdrawal by Subject|1|||
162771429|NCT02660034|587872785|FG009|Overall Study|Withdrawal by Subject|0|||
162771430|NCT02660034|587872786|FG010|Overall Study|Withdrawal by Subject|0|||
162771431|NCT02660034|587872787|FG011|Overall Study|Withdrawal by Subject|1|||
162771432|NCT02660034|587872788|FG012|Overall Study|Withdrawal by Subject|2|||
162771433|NCT02660034|587872789|FG013|Overall Study|Withdrawal by Subject|0|||
162771434|NCT02660034|587872776|FG000|Overall Study|Death|0|||
162771435|NCT02660034|587872777|FG001|Overall Study|Death|0|||
162771436|NCT02660034|587872778|FG002|Overall Study|Death|0|||
162771437|NCT02660034|587872779|FG003|Overall Study|Death|0|||
162771438|NCT02660034|587872780|FG004|Overall Study|Death|0|||
162771439|NCT02660034|587872781|FG005|Overall Study|Death|13|||
162771440|NCT02660034|587872782|FG006|Overall Study|Death|14|||
162771441|NCT02660034|587872783|FG007|Overall Study|Death|10|||
162771442|NCT02660034|587872784|FG008|Overall Study|Death|9|||
162771443|NCT02660034|587872785|FG009|Overall Study|Death|21|||
162771444|NCT02660034|587872786|FG010|Overall Study|Death|17|||
162771445|NCT02660034|587872787|FG011|Overall Study|Death|15|||
162771446|NCT02660034|587872788|FG012|Overall Study|Death|18|||
162771447|NCT02660034|587872789|FG013|Overall Study|Death|7|||
162771448|NCT02660034|587872776|FG000|Overall Study|Physician Decision|0|||
162771449|NCT02660034|587872777|FG001|Overall Study|Physician Decision|0|||
162771450|NCT02660034|587872778|FG002|Overall Study|Physician Decision|0|||
162771451|NCT02660034|587872779|FG003|Overall Study|Physician Decision|0|||
162771452|NCT02660034|587872780|FG004|Overall Study|Physician Decision|0|||
162771453|NCT02660034|587872781|FG005|Overall Study|Physician Decision|0|||
162771454|NCT02660034|587872782|FG006|Overall Study|Physician Decision|0|||
162771455|NCT02660034|587872783|FG007|Overall Study|Physician Decision|0|||
162771456|NCT02660034|587872784|FG008|Overall Study|Physician Decision|0|||
162771457|NCT02660034|587872785|FG009|Overall Study|Physician Decision|0|||
162771458|NCT02660034|587872786|FG010|Overall Study|Physician Decision|0|||
162771459|NCT02660034|587872787|FG011|Overall Study|Physician Decision|0|||
162771460|NCT02660034|587872788|FG012|Overall Study|Physician Decision|0|||
162771461|NCT02660034|587872789|FG013|Overall Study|Physician Decision|1|||
162771462|NCT02660034|587872776|FG000|Overall Study|Participants transferred to LTE|0|||
162771463|NCT02660034|587872777|FG001|Overall Study|Participants transferred to LTE|0|||
162771464|NCT02660034|587872778|FG002|Overall Study|Participants transferred to LTE|0|||
162771465|NCT02660034|587872779|FG003|Overall Study|Participants transferred to LTE|0|||
162771466|NCT02660034|587872780|FG004|Overall Study|Participants transferred to LTE|0|||
162771467|NCT02660034|587872781|FG005|Overall Study|Participants transferred to LTE|10|||
162771468|NCT02660034|587872782|FG006|Overall Study|Participants transferred to LTE|8|||
162771469|NCT02660034|587872783|FG007|Overall Study|Participants transferred to LTE|8|||
162771470|NCT02660034|587872784|FG008|Overall Study|Participants transferred to LTE|10|||
162771471|NCT02660034|587872785|FG009|Overall Study|Participants transferred to LTE|1|||
162771472|NCT02660034|587872786|FG010|Overall Study|Participants transferred to LTE|2|||
162771473|NCT02660034|587872787|FG011|Overall Study|Participants transferred to LTE|4|||
162771474|NCT02660034|587872788|FG012|Overall Study|Participants transferred to LTE|1|||
162771475|NCT02660034|587872789|FG013|Overall Study|Participants transferred to LTE|1|||
162771476|NCT04879823|587872801|FG000|Overall Study|Physician Decision|3|||
162771477|NCT04879823|587872802|FG001|Overall Study|Physician Decision|1|||
162771478|NCT04879823|587872801|FG000|Overall Study|Protocol Violation|2|||
162771479|NCT04879823|587872802|FG001|Overall Study|Protocol Violation|3|||
162771480|NCT04879823|587872801|FG000|Overall Study|Lost to Follow-up|43|||
162771481|NCT04879823|587872802|FG001|Overall Study|Lost to Follow-up|35|||
162771482|NCT00730925|587872803|FG000|Overall Study|Progressive Disease|21|||
162771483|NCT00730925|587872803|FG000|Overall Study|Dose reducing Event|2|||
162771484|NCT00730925|587872803|FG000|Overall Study|Other Averse Event|7|||
162771485|NCT00730925|587872803|FG000|Overall Study|Protocol Violation|1|||
162771486|NCT00730925|587872803|FG000|Overall Study|Withdrawal by Subject|1|||
162771487|NCT00730925|587872803|FG000|Overall Study|Switch to combination therapy|8|||
162771488|NCT00730925|587872803|FG000|Overall Study|Other|1|||
162771489|NCT02137239|587872804|FG000|Overall Study|Discontinued Study Treatment|0|||
162771490|NCT02137239|587872805|FG001|Overall Study|Discontinued Study Treatment|3|||
162771491|NCT02137239|587872804|FG000|Overall Study|Withdrew Consent|1|||
162771492|NCT02137239|587872805|FG001|Overall Study|Withdrew Consent|1|||
162771493|NCT02137239|587872804|FG000|Overall Study|Adverse Event|2|||
162771494|NCT02137239|587872805|FG001|Overall Study|Adverse Event|2|||
162771495|NCT04057937|587872806|FG000|Placebo-controlled Phase|Adverse Event|3|||
162771496|NCT04057937|587872807|FG001|Placebo-controlled Phase|Adverse Event|0|||
162771497|NCT04057937|587872806|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
162771498|NCT04057937|587872807|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
162771499|NCT04057937|587872806|FG000|Active-treatment Phase|Pregnancy|0|||
162771500|NCT04057937|587872807|FG001|Active-treatment Phase|Pregnancy|1|||
162771501|NCT04057937|587872806|FG000|Active-treatment Phase|Physician Decision|0|||
162771502|NCT04057937|587872807|FG001|Active-treatment Phase|Physician Decision|1|||
162771503|NCT02029521|587872808|FG000|Overall Study|Protocol Violation|1|||
162771504|NCT02029521|587872809|FG001|Overall Study|Protocol Violation|0|||
162771505|NCT02029521|587872808|FG000|Overall Study|Withdrawal by Subject|1|||
162771506|NCT02029521|587872809|FG001|Overall Study|Withdrawal by Subject|1|||
162771507|NCT01072396|587872810|FG000|Period One|Adverse Event|1|||
162771508|NCT01072396|587872811|FG001|Period One|Adverse Event|1|||
162771509|NCT01072396|587872810|FG000|Period One|Protocol Violation|2|||
162771510|NCT01072396|587872811|FG001|Period One|Protocol Violation|1|||
162771511|NCT01072396|587872810|FG000|Period One|Withdrawal by Subject|2|||
162771512|NCT01072396|587872811|FG001|Period One|Withdrawal by Subject|0|||
162771513|NCT01072396|587872810|FG000|Washout Period|Missing termination information|0|||
162771514|NCT01072396|587872811|FG001|Washout Period|Missing termination information|1|||
162771515|NCT01072396|587872810|FG000|Period Two|Adverse Event|0|||
162771516|NCT01072396|587872811|FG001|Period Two|Adverse Event|3|||
162771517|NCT01072396|587872810|FG000|Period Two|Lost to Follow-up|1|||
162771518|NCT01072396|587872811|FG001|Period Two|Lost to Follow-up|0|||
162771519|NCT02446912|587872812|FG000|Overall Study|Adverse Event|3|||
162771520|NCT02446912|587872813|FG001|Overall Study|Adverse Event|13|||
162771521|NCT02446912|587872814|FG002|Overall Study|Adverse Event|5|||
162771522|NCT02446912|587872812|FG000|Overall Study|Condition under investigation worsened|0|||
162771523|NCT02446912|587872813|FG001|Overall Study|Condition under investigation worsened|1|||
162771524|NCT02446912|587872814|FG002|Overall Study|Condition under investigation worsened|1|||
162771525|NCT02446912|587872812|FG000|Overall Study|Study-specific withdrawal criteria|1|||
162771526|NCT02446912|587872813|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162771527|NCT02446912|587872814|FG002|Overall Study|Study-specific withdrawal criteria|0|||
162771528|NCT02446912|587872812|FG000|Overall Study|Lack of Efficacy|1|||
162771529|NCT02446912|587872813|FG001|Overall Study|Lack of Efficacy|4|||
162771530|NCT02446912|587872814|FG002|Overall Study|Lack of Efficacy|7|||
162771531|NCT02446912|587872812|FG000|Overall Study|Lost to Follow-up|0|||
162771532|NCT02446912|587872813|FG001|Overall Study|Lost to Follow-up|0|||
162771533|NCT02446912|587872814|FG002|Overall Study|Lost to Follow-up|2|||
162771534|NCT02446912|587872812|FG000|Overall Study|Severe non-compliance to protocol|1|||
162771535|NCT02446912|587872813|FG001|Overall Study|Severe non-compliance to protocol|0|||
162771536|NCT02446912|587872814|FG002|Overall Study|Severe non-compliance to protocol|1|||
162771537|NCT02446912|587872812|FG000|Overall Study|Withdrawal by Subject|10|||
162771538|NCT02446912|587872813|FG001|Overall Study|Withdrawal by Subject|15|||
162771539|NCT02446912|587872814|FG002|Overall Study|Withdrawal by Subject|15|||
162771540|NCT02446912|587872812|FG000|Overall Study|Miscellaneous|2|||
162771541|NCT02446912|587872813|FG001|Overall Study|Miscellaneous|2|||
162771542|NCT02446912|587872814|FG002|Overall Study|Miscellaneous|4|||
162771543|NCT01268488|587872815|FG000|Overall Study|Adverse Event|3|||
162771544|NCT01268488|587872815|FG000|Overall Study|Physician Decision|2|||
162771545|NCT01106586|587872818|FG000|Overall Study|Adverse Event|9|||
162771546|NCT01106586|587872819|FG001|Overall Study|Adverse Event|15|||
162771547|NCT01106586|587872818|FG000|Overall Study|Death|1|||
162771548|NCT01106586|587872819|FG001|Overall Study|Death|3|||
162771549|NCT01106586|587872818|FG000|Overall Study|Pregnancy|2|||
162771550|NCT01106586|587872819|FG001|Overall Study|Pregnancy|2|||
162771551|NCT01106586|587872818|FG000|Overall Study|Lack of Efficacy|1|||
162771552|NCT01106586|587872819|FG001|Overall Study|Lack of Efficacy|0|||
162771553|NCT01106586|587872818|FG000|Overall Study|Investigator's Discretion|5|||
162771554|NCT01106586|587872819|FG001|Overall Study|Investigator's Discretion|8|||
162771555|NCT01106586|587872818|FG000|Overall Study|Withdrew Consent|18|||
162771556|NCT01106586|587872819|FG001|Overall Study|Withdrew Consent|30|||
162771557|NCT01106586|587872818|FG000|Overall Study|Lost to Follow-up|24|||
162771558|NCT01106586|587872819|FG001|Overall Study|Lost to Follow-up|20|||
162771559|NCT01106586|587872818|FG000|Overall Study|Participant Noncompliance|12|||
162771560|NCT01106586|587872819|FG001|Overall Study|Participant Noncompliance|10|||
162771561|NCT01106586|587872818|FG000|Overall Study|Protocol Violation|1|||
162771562|NCT01106586|587872819|FG001|Overall Study|Protocol Violation|0|||
162771563|NCT01106586|587872818|FG000|Overall Study|Participant Transferred to Another Study|212|||
162771564|NCT01106586|587872819|FG001|Overall Study|Participant Transferred to Another Study|197|||
162771565|NCT02991456|587872825|FG000|Overall Study|Adverse Event|2|||
162771566|NCT02991456|587872826|FG001|Overall Study|Adverse Event|0|||
162771567|NCT02991456|587872825|FG000|Overall Study|Lost to Follow-up|0|||
162771568|NCT02991456|587872826|FG001|Overall Study|Lost to Follow-up|2|||
162771569|NCT02991456|587872825|FG000|Overall Study|Withdrawal by Subject|1|||
162771570|NCT02991456|587872826|FG001|Overall Study|Withdrawal by Subject|0|||
162771571|NCT02058992|587872827|FG000|Overall Study|Lost to Follow-up|4|||
162771572|NCT02058992|587872827|FG000|Overall Study|Protocol Violation|92|||
162771573|NCT02058992|587872827|FG000|Overall Study|CRF Uncollected|20|||
162771574|NCT03953079|587872828|FG000|Core Study|Withdrawal by Subject|1|||
162771575|NCT03953079|587872829|FG001|Core Study|Withdrawal by Subject|2|||
162771576|NCT03953079|587872830|FG002|Core Study|Withdrawal by Subject|1|||
162771577|NCT03953079|587872828|FG000|Core Study|COVID-19|0|||
162771578|NCT03953079|587872829|FG001|Core Study|COVID-19|1|||
162771579|NCT03953079|587872830|FG002|Core Study|COVID-19|0|||
162771580|NCT03953079|587872828|FG000|Core Study|Difficulties leaving the house|0|||
162771581|NCT03953079|587872829|FG001|Core Study|Difficulties leaving the house|1|||
162771582|NCT03953079|587872830|FG002|Core Study|Difficulties leaving the house|0|||
162771583|NCT03953079|587872828|FG000|Extension Study|Withdrawal by Subject|1|||
162771584|NCT03953079|587872829|FG001|Extension Study|Withdrawal by Subject|0|||
162771585|NCT03953079|587872830|FG002|Extension Study|Withdrawal by Subject|0|||
162771586|NCT03953079|587872828|FG000|Extension Study|Received Rescue Treatment|5|||
162771587|NCT03953079|587872829|FG001|Extension Study|Received Rescue Treatment|6|||
162771588|NCT03953079|587872830|FG002|Extension Study|Received Rescue Treatment|5|||
162771589|NCT00936065|587872831|FG000|Overall Study|Adverse Event|1|||
162771590|NCT00936065|587872832|FG001|Overall Study|Adverse Event|0|||
162771591|NCT00936065|587872833|FG002|Overall Study|Adverse Event|1|||
162771592|NCT00936065|587872831|FG000|Overall Study|Lack of Efficacy|1|||
162771593|NCT00936065|587872832|FG001|Overall Study|Lack of Efficacy|0|||
162771594|NCT00936065|587872833|FG002|Overall Study|Lack of Efficacy|1|||
162771595|NCT00936065|587872831|FG000|Overall Study|Lost to Follow-up|1|||
162771596|NCT00936065|587872832|FG001|Overall Study|Lost to Follow-up|0|||
162771597|NCT00936065|587872833|FG002|Overall Study|Lost to Follow-up|0|||
162771598|NCT00936065|587872831|FG000|Overall Study|Protocol Violation|1|||
162771599|NCT00936065|587872832|FG001|Overall Study|Protocol Violation|2|||
162771600|NCT00936065|587872833|FG002|Overall Study|Protocol Violation|1|||
162771601|NCT00936065|587872831|FG000|Overall Study|Withdrawal by Subject|0|||
162771602|NCT00936065|587872832|FG001|Overall Study|Withdrawal by Subject|2|||
162771603|NCT00936065|587872833|FG002|Overall Study|Withdrawal by Subject|4|||
162771604|NCT01549951|587872837|FG000|Overall Study|Adverse Event|15|||
162771605|NCT01549951|587872837|FG000|Overall Study|Withdrawal by Subject|2|||
162771606|NCT01549951|587872837|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
162771607|NCT01549951|587872837|FG000|Overall Study|Progressive disease|29|||
162771608|NCT01549951|587872837|FG000|Overall Study|Symptomatic deterioration|1|||
162771609|NCT01549951|587872837|FG000|Overall Study|Other|2|||
162771610|NCT00738400|587872840|FG000|Overall Study|Adverse Event|3|||
162771611|NCT00738400|587872841|FG001|Overall Study|Adverse Event|1|||
162771612|NCT00738400|587872840|FG000|Overall Study|Withdrawal by Subject|0|||
162771613|NCT00738400|587872841|FG001|Overall Study|Withdrawal by Subject|1|||
162771614|NCT00738400|587872840|FG000|Overall Study|Lack of Efficacy|0|||
162771615|NCT00738400|587872841|FG001|Overall Study|Lack of Efficacy|1|||
162771616|NCT00738400|587872840|FG000|Overall Study|Lost to Follow-up|0|||
162771617|NCT00738400|587872841|FG001|Overall Study|Lost to Follow-up|3|||
162771618|NCT00738400|587872840|FG000|Overall Study|Protocol Violation|1|||
162771619|NCT00738400|587872841|FG001|Overall Study|Protocol Violation|0|||
162771620|NCT00738400|587872840|FG000|Overall Study|Non-compliant with study medication|0|||
162771621|NCT00738400|587872841|FG001|Overall Study|Non-compliant with study medication|1|||
162771622|NCT02255474|587872842|FG000|Overall Study|Lost to Follow-up|1|||
162771623|NCT02255474|587872843|FG001|Overall Study|Lost to Follow-up|1|||
162771624|NCT02255474|587872844|FG002|Overall Study|Lost to Follow-up|3|||
162771625|NCT02255474|587872842|FG000|Overall Study|Withdrawal by Subject|1|||
162771626|NCT02255474|587872843|FG001|Overall Study|Withdrawal by Subject|1|||
162771627|NCT02255474|587872844|FG002|Overall Study|Withdrawal by Subject|0|||
162771628|NCT02993926|587872847|FG000|Enantone Treatment Phase|Adverse Event|1|||
162771629|NCT02993926|587872848|FG001|Enantone Treatment Phase|Adverse Event|0|||
162771630|NCT02993926|587872849|FG002|Enantone Treatment Phase|Adverse Event|0|||
162771631|NCT02993926|587872847|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
162771632|NCT02993926|587872848|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
162771633|NCT02993926|587872849|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
162771634|NCT02993926|587872847|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
162771635|NCT02993926|587872848|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
162771636|NCT02993926|587872849|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
162771637|NCT02993926|587872847|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
162771638|NCT02993926|587872848|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
162771639|NCT02993926|587872849|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
162771640|NCT03689452|587872854|FG000|Overall Study|Lost to Follow-up|1|||
162771641|NCT03689452|587872855|FG001|Overall Study|Lost to Follow-up|1|||
162771642|NCT00525915|587872856|FG000|Overall Study|Non-Compliance|0|||
162771643|NCT00525915|587872857|FG001|Overall Study|Non-Compliance|1|||
162771644|NCT00525915|587872856|FG000|Overall Study|Disease Progression|5|||
162771645|NCT00525915|587872857|FG001|Overall Study|Disease Progression|6|||
162771646|NCT00525915|587872856|FG000|Overall Study|Withdrawal by Subject|1|||
162771647|NCT00525915|587872857|FG001|Overall Study|Withdrawal by Subject|0|||
162771648|NCT00525915|587872856|FG000|Overall Study|Refused Surgery|1|||
162771649|NCT00525915|587872857|FG001|Overall Study|Refused Surgery|2|||
162771650|NCT00525915|587872856|FG000|Overall Study|Unrelated illness|1|||
162771651|NCT00525915|587872857|FG001|Overall Study|Unrelated illness|0|||
162771652|NCT03394508|587872860|FG000|Overall Study|Protocol Violation|0|||
162771653|NCT03394508|587872861|FG001|Overall Study|Protocol Violation|3|||
162771654|NCT03394508|587872860|FG000|Overall Study|Lost to Follow-up|1|||
162771655|NCT03394508|587872861|FG001|Overall Study|Lost to Follow-up|0|||
162771656|NCT00267865|587872862|FG000|Induction Treatment|Died before completing.|2|||
162771657|NCT00267865|587872862|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
162771658|NCT01755598|587872866|FG000|Overall Study|Other|109|||
162771659|NCT01755598|587872867|FG001|Overall Study|Other|109|||
162771660|NCT01755598|587872866|FG000|Overall Study|Lost to Follow-up|32|||
162771661|NCT01755598|587872867|FG001|Overall Study|Lost to Follow-up|43|||
162771662|NCT01755598|587872866|FG000|Overall Study|Migrated/moved from study area|76|||
162771663|NCT01755598|587872867|FG001|Overall Study|Migrated/moved from study area|65|||
162771664|NCT01755598|587872866|FG000|Overall Study|Withdrawal by Subject|22|||
162771665|NCT01755598|587872867|FG001|Overall Study|Withdrawal by Subject|31|||
162771666|NCT01755598|587872866|FG000|Overall Study|Protocol Violation|7|||
162771667|NCT01755598|587872867|FG001|Overall Study|Protocol Violation|7|||
162771668|NCT01755598|587872866|FG000|Overall Study|Adverse Event|19|||
162771669|NCT01755598|587872867|FG001|Overall Study|Adverse Event|28|||
162771670|NCT02332889|587872868|FG000|Overall Study|Physician Decision|1|||
162771671|NCT02135445|587872869|FG000|Overall Study|Lost to Follow-up|1|||
162771672|NCT02135445|587872870|FG001|Overall Study|Lost to Follow-up|0|||
162771673|NCT02135445|587872869|FG000|Overall Study|Withdrawal by Subject|1|||
162771674|NCT02135445|587872870|FG001|Overall Study|Withdrawal by Subject|0|||
162771675|NCT02819141|587872871|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
162771676|NCT02819141|587872872|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
162771677|NCT01002547|587874769|FG000|Overall Study|Withdrawal by Subject|4|||
162771678|NCT01002547|587874770|FG001|Overall Study|Withdrawal by Subject|0|||
162771679|NCT01002547|587874771|FG002|Overall Study|Withdrawal by Subject|5|||
162771680|NCT01002547|587874769|FG000|Overall Study|Lost to Follow-up|2|||
162771681|NCT01002547|587874770|FG001|Overall Study|Lost to Follow-up|1|||
162771682|NCT01002547|587874771|FG002|Overall Study|Lost to Follow-up|1|||
162771683|NCT01002547|587874769|FG000|Overall Study|Physician Decision|1|||
162771684|NCT01002547|587874770|FG001|Overall Study|Physician Decision|0|||
162771685|NCT01002547|587874771|FG002|Overall Study|Physician Decision|0|||
162771686|NCT01002547|587874769|FG000|Overall Study|Death|0|||
162771687|NCT01002547|587874770|FG001|Overall Study|Death|2|||
162771688|NCT01002547|587874771|FG002|Overall Study|Death|2|||
162771689|NCT01002547|587874769|FG000|Overall Study|Adverse Event|1|||
162771690|NCT01002547|587874770|FG001|Overall Study|Adverse Event|0|||
162771691|NCT01002547|587874771|FG002|Overall Study|Adverse Event|0|||
162771692|NCT01184859|587874776|FG000|Period 1: Single Dose|Insufficient urine production|0|||
162771693|NCT01184859|587874777|FG001|Period 1: Single Dose|Insufficient urine production|1|||
162771694|NCT01184859|587874778|FG002|Period 1: Single Dose|Insufficient urine production|0|||
162771695|NCT01184859|587874779|FG003|Period 1: Single Dose|Insufficient urine production|0|||
162771696|NCT01184859|587874780|FG004|Period 1: Single Dose|Insufficient urine production|0|||
162771697|NCT01184859|587874776|FG000|Period 1: Single Dose|Protocol Violation|0|||
162771698|NCT01184859|587874777|FG001|Period 1: Single Dose|Protocol Violation|1|||
162771699|NCT01184859|587874778|FG002|Period 1: Single Dose|Protocol Violation|0|||
162771700|NCT01184859|587874779|FG003|Period 1: Single Dose|Protocol Violation|0|||
162771701|NCT01184859|587874780|FG004|Period 1: Single Dose|Protocol Violation|0|||
162771702|NCT01184859|587874776|FG000|Period 1: Single Dose|Adverse Event|0|||
162771703|NCT01184859|587874777|FG001|Period 1: Single Dose|Adverse Event|0|||
162771704|NCT01184859|587874778|FG002|Period 1: Single Dose|Adverse Event|0|||
162771705|NCT01184859|587874779|FG003|Period 1: Single Dose|Adverse Event|0|||
162771706|NCT01184859|587874780|FG004|Period 1: Single Dose|Adverse Event|1|||
162771707|NCT01184859|587874776|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162771708|NCT01184859|587874777|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162771709|NCT01184859|587874778|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162771710|NCT01184859|587874779|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162771711|NCT01184859|587874780|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
162771712|NCT01184859|587874776|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
162771713|NCT01184859|587874777|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162771714|NCT01184859|587874778|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162771715|NCT01184859|587874779|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162771716|NCT01184859|587874780|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162771717|NCT00434577|587874783|FG000|Months 0-3|Serious Adverse Event|0|||
162771718|NCT00434577|587874784|FG001|Months 0-3|Serious Adverse Event|0|||
162771719|NCT00434577|587874785|FG002|Months 0-3|Serious Adverse Event|1|||
162771720|NCT00434577|587874786|FG003|Months 0-3|Serious Adverse Event|0|||
162771721|NCT00434577|587874787|FG004|Months 0-3|Serious Adverse Event|0|||
162771722|NCT00434577|587874783|FG000|Months 0-3|Adverse Event|0|||
162771723|NCT00434577|587874784|FG001|Months 0-3|Adverse Event|1|||
162771724|NCT00434577|587874785|FG002|Months 0-3|Adverse Event|1|||
162771725|NCT00434577|587874786|FG003|Months 0-3|Adverse Event|0|||
162771726|NCT00434577|587874787|FG004|Months 0-3|Adverse Event|0|||
162771727|NCT00434577|587874783|FG000|Months 0-3|Lost to Follow-up|0|||
162771728|NCT00434577|587874784|FG001|Months 0-3|Lost to Follow-up|0|||
162771729|NCT00434577|587874785|FG002|Months 0-3|Lost to Follow-up|0|||
162771730|NCT00434577|587874786|FG003|Months 0-3|Lost to Follow-up|0|||
162771731|NCT00434577|587874787|FG004|Months 0-3|Lost to Follow-up|2|||
162771732|NCT00434577|587874783|FG000|Months 0-3|Protocol Violation|1|||
162771733|NCT00434577|587874784|FG001|Months 0-3|Protocol Violation|0|||
162771734|NCT00434577|587874785|FG002|Months 0-3|Protocol Violation|1|||
162771735|NCT00434577|587874786|FG003|Months 0-3|Protocol Violation|0|||
162771736|NCT00434577|587874787|FG004|Months 0-3|Protocol Violation|0|||
162771737|NCT00434577|587874783|FG000|Months 0-3|Withdrawal by Subject|2|||
162771738|NCT00434577|587874784|FG001|Months 0-3|Withdrawal by Subject|1|||
162771739|NCT00434577|587874785|FG002|Months 0-3|Withdrawal by Subject|1|||
162771740|NCT00434577|587874786|FG003|Months 0-3|Withdrawal by Subject|1|||
162771741|NCT00434577|587874787|FG004|Months 0-3|Withdrawal by Subject|1|||
162771742|NCT01537120|587874795|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
162771743|NCT01537120|587874795|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
162771744|NCT00958711|587874799|FG000|Overall Study|Withdrawal by Subject|0|||
162771745|NCT00958711|587874800|FG001|Overall Study|Withdrawal by Subject|4|||
162771746|NCT00958711|587874799|FG000|Overall Study|Physician Decision|5|||
162771747|NCT00958711|587874800|FG001|Overall Study|Physician Decision|7|||
162771748|NCT00958711|587874799|FG000|Overall Study|Lost to Follow-up|4|||
162771749|NCT00958711|587874800|FG001|Overall Study|Lost to Follow-up|1|||
162771750|NCT00958711|587874799|FG000|Overall Study|Other|2|||
162771751|NCT00958711|587874800|FG001|Overall Study|Other|5|||
162771752|NCT00958711|587874799|FG000|Overall Study|Death|1|||
162771753|NCT00958711|587874800|FG001|Overall Study|Death|2|||
162771754|NCT00958711|587874799|FG000|Overall Study|Adverse Event|1|||
162771755|NCT00958711|587874800|FG001|Overall Study|Adverse Event|2|||
162771756|NCT03087851|587874805|FG000|Overall Study|Withdraw on medical grounds|0|||
162771757|NCT03087851|587874806|FG001|Overall Study|Withdraw on medical grounds|1|||
162771758|NCT03087851|587874807|FG002|Overall Study|Withdraw on medical grounds|2|||
162771759|NCT00644332|587874808|FG000|Overall Study|Adverse Event|11|||
162771760|NCT00644332|587874808|FG000|Overall Study|Withdrawal by Subject|6|||
162771761|NCT00644332|587874808|FG000|Overall Study|Completion Status Unknown|2|||
162771762|NCT00644332|587874808|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
162771763|NCT00644332|587874808|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
162771764|NCT00409006|587874810|FG000|Overall Study|Death|15|||
162771765|NCT00409006|587874811|FG001|Overall Study|Death|6|||
162771766|NCT00409006|587874810|FG000|Overall Study|Lost to Follow-up|1|||
162771767|NCT00409006|587874811|FG001|Overall Study|Lost to Follow-up|2|||
162771768|NCT00409006|587874810|FG000|Overall Study|Withdrawal by Subject|3|||
162771769|NCT00409006|587874811|FG001|Overall Study|Withdrawal by Subject|2|||
162771770|NCT00409006|587874810|FG000|Overall Study|Physician Decision|1|||
162771771|NCT00409006|587874811|FG001|Overall Study|Physician Decision|2|||
162771772|NCT03050372|587874812|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
162771773|NCT03050372|587874813|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
162771774|NCT03050372|587874812|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
162771775|NCT03050372|587874813|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
162771776|NCT00443755|587874816|FG000|Overall Study|Withdrawal by Subject|2|||
162771777|NCT00443755|587874817|FG001|Overall Study|Withdrawal by Subject|1|||
162771778|NCT02775214|587874818|FG000|Overall Study|Withdrawal by Subject|2|||
162771779|NCT02775214|587874819|FG001|Overall Study|Withdrawal by Subject|0|||
162771780|NCT02706834|587874820|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162771781|NCT02706834|587874821|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162771782|NCT02706834|587874822|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162771783|NCT02706834|587874823|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
162771784|NCT02706834|587874824|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162771785|NCT02706834|587874825|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162771786|NCT02706834|587874826|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
162771787|NCT02706834|587874827|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
162771788|NCT02706834|587874828|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
162771789|NCT02706834|587874829|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
162771790|NCT02706834|587874830|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
162771791|NCT02706834|587874820|FG000|Overall Study|Lost to Follow-up|0|||
162771792|NCT02706834|587874821|FG001|Overall Study|Lost to Follow-up|0|||
162771793|NCT02706834|587874822|FG002|Overall Study|Lost to Follow-up|1|||
162771794|NCT02706834|587874823|FG003|Overall Study|Lost to Follow-up|0|||
162771795|NCT02706834|587874824|FG004|Overall Study|Lost to Follow-up|0|||
162771796|NCT02706834|587874825|FG005|Overall Study|Lost to Follow-up|0|||
162771797|NCT02706834|587874826|FG006|Overall Study|Lost to Follow-up|0|||
162771798|NCT02706834|587874827|FG007|Overall Study|Lost to Follow-up|0|||
162771799|NCT02706834|587874828|FG008|Overall Study|Lost to Follow-up|0|||
162771800|NCT02706834|587874829|FG009|Overall Study|Lost to Follow-up|0|||
162771801|NCT02706834|587874830|FG010|Overall Study|Lost to Follow-up|0|||
162771802|NCT02706834|587874820|FG000|Overall Study|Voluntary Withdrawal|1|||
162771803|NCT02706834|587874821|FG001|Overall Study|Voluntary Withdrawal|0|||
162771804|NCT02706834|587874822|FG002|Overall Study|Voluntary Withdrawal|0|||
162771805|NCT02706834|587874823|FG003|Overall Study|Voluntary Withdrawal|0|||
162771806|NCT02706834|587874824|FG004|Overall Study|Voluntary Withdrawal|0|||
162771807|NCT02706834|587874825|FG005|Overall Study|Voluntary Withdrawal|0|||
162771808|NCT02706834|587874826|FG006|Overall Study|Voluntary Withdrawal|0|||
162771809|NCT02706834|587874827|FG007|Overall Study|Voluntary Withdrawal|0|||
162771810|NCT02706834|587874828|FG008|Overall Study|Voluntary Withdrawal|0|||
162771811|NCT02706834|587874829|FG009|Overall Study|Voluntary Withdrawal|1|||
162771812|NCT02706834|587874830|FG010|Overall Study|Voluntary Withdrawal|0|||
162771813|NCT02706834|587874820|FG000|Overall Study|Other Reason Not Specified|1|||
162771814|NCT02706834|587874821|FG001|Overall Study|Other Reason Not Specified|0|||
162771815|NCT02706834|587874822|FG002|Overall Study|Other Reason Not Specified|0|||
162771816|NCT02706834|587874823|FG003|Overall Study|Other Reason Not Specified|0|||
162771817|NCT02706834|587874824|FG004|Overall Study|Other Reason Not Specified|1|||
162771818|NCT02706834|587874825|FG005|Overall Study|Other Reason Not Specified|0|||
162771819|NCT02706834|587874826|FG006|Overall Study|Other Reason Not Specified|0|||
162771820|NCT02706834|587874827|FG007|Overall Study|Other Reason Not Specified|0|||
162771821|NCT02706834|587874828|FG008|Overall Study|Other Reason Not Specified|0|||
162771822|NCT02706834|587874829|FG009|Overall Study|Other Reason Not Specified|0|||
162771823|NCT02706834|587874830|FG010|Overall Study|Other Reason Not Specified|0|||
162771824|NCT00678899|587874836|FG000|Overall Study|Adverse Event|1|||
162771825|NCT02543294|587874837|FG000|Overall Study|Lost to Follow-up|3|||
162771826|NCT02543294|587874837|FG000|Overall Study|Physician Decision|2|||
162771827|NCT02543294|587874837|FG000|Overall Study|Withdrawal by Subject|7|||
162771828|NCT01107353|587874843|FG000|Overall Study|Positive Drug Screen|1|||
162771829|NCT01107353|587874844|FG001|Overall Study|Positive Drug Screen|0|||
162771830|NCT02798861|587874847|FG000|Overall Study|Lost to Follow-up|22|||
162771831|NCT02798861|587874847|FG000|Overall Study|Withdrawal by Subject|1|||
162771832|NCT02475733|587874870|FG000|Overall Study|Withdrawal by Subject|1|||
162771833|NCT02475733|587874871|FG001|Overall Study|Withdrawal by Subject|0|||
162771834|NCT02475733|587874870|FG000|Overall Study|Physician Decision|1|||
162771835|NCT02475733|587874871|FG001|Overall Study|Physician Decision|0|||
162771836|NCT02131155|587874872|FG000|Overall Study|Adverse Event|1|||
162771837|NCT02131155|587874873|FG001|Overall Study|Adverse Event|0|||
162771838|NCT02131155|587874872|FG000|Overall Study|Treatment completed|1|||
162771839|NCT02131155|587874873|FG001|Overall Study|Treatment completed|0|||
162771840|NCT02131155|587874872|FG000|Overall Study|Primary tumour recurrence|2|||
162771841|NCT02131155|587874873|FG001|Overall Study|Primary tumour recurrence|1|||
162771842|NCT02131155|587874872|FG000|Overall Study|Refused to continue study medication|1|||
162771843|NCT02131155|587874873|FG001|Overall Study|Refused to continue study medication|0|||
162771844|NCT02131155|587874872|FG000|Overall Study|Study early termination|20|||
162771845|NCT02131155|587874873|FG001|Overall Study|Study early termination|10|||
162771846|NCT01887418|587874874|FG000|Overall Study|Travelling difficulties|0|||
162771847|NCT01887418|587874875|FG001|Overall Study|Travelling difficulties|0|||
162771848|NCT01887418|587874876|FG002|Overall Study|Travelling difficulties|1|||
162771849|NCT01014013|587874879|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
162771850|NCT01014013|587874880|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
162771851|NCT01014013|587874879|FG000|Overall Study|Clinical adverse experience|4|||
162771852|NCT01014013|587874880|FG001|Overall Study|Clinical adverse experience|2|||
162771853|NCT01014013|587874879|FG000|Overall Study|Laboratory adverse experience|1|||
162771854|NCT01014013|587874880|FG001|Overall Study|Laboratory adverse experience|1|||
162771855|NCT01014013|587874879|FG000|Overall Study|Protocol Violation|1|||
162771856|NCT01014013|587874880|FG001|Overall Study|Protocol Violation|3|||
162771857|NCT01014013|587874879|FG000|Overall Study|Withdrawal by Subject|7|||
162771858|NCT01014013|587874880|FG001|Overall Study|Withdrawal by Subject|4|||
162771859|NCT01014013|587874879|FG000|Overall Study|Clinical/microbiologic failure|1|||
162771860|NCT01014013|587874880|FG001|Overall Study|Clinical/microbiologic failure|2|||
162771861|NCT01014013|587874879|FG000|Overall Study|Pathogen culture = no growth|26|||
162771862|NCT01014013|587874880|FG001|Overall Study|Pathogen culture = no growth|34|||
162771863|NCT01014013|587874879|FG000|Overall Study|Negative urine culture|2|||
162771864|NCT01014013|587874880|FG001|Overall Study|Negative urine culture|0|||
162771865|NCT01014013|587874879|FG000|Overall Study|Pathogen resistant|7|||
162771866|NCT01014013|587874880|FG001|Overall Study|Pathogen resistant|4|||
162771867|NCT01014013|587874879|FG000|Overall Study|Physician Decision|0|||
162771868|NCT01014013|587874880|FG001|Overall Study|Physician Decision|1|||
162771869|NCT01014013|587874879|FG000|Overall Study|Another antibiotic therapy required|0|||
162771870|NCT01014013|587874880|FG001|Overall Study|Another antibiotic therapy required|1|||
162771871|NCT01014013|587874879|FG000|Overall Study|Appendectomy|1|||
162771872|NCT01014013|587874880|FG001|Overall Study|Appendectomy|0|||
162771873|NCT01014013|587874879|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
162771874|NCT01014013|587874880|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
162771875|NCT00442559|587874887|FG000|Overall Study|Lost to Follow-up|32|||
162771876|NCT00442559|587874888|FG001|Overall Study|Lost to Follow-up|34|||
162771877|NCT00442559|587874887|FG000|Overall Study|Protocol Violation|1|||
162771878|NCT00442559|587874888|FG001|Overall Study|Protocol Violation|1|||
162771879|NCT00442559|587874887|FG000|Overall Study|Withdrawal by Subject|1|||
162771880|NCT00442559|587874888|FG001|Overall Study|Withdrawal by Subject|0|||
162771881|NCT03906240|587874889|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
162771882|NCT03906240|587874890|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
162771883|NCT03906240|587874889|FG000|Overall Study|Lost to Follow-up|1|||
162771884|NCT03906240|587874890|FG001|Overall Study|Lost to Follow-up|0|||
162771885|NCT03906240|587874889|FG000|Overall Study|Withdrawal by Subject|0|||
162771886|NCT03906240|587874890|FG001|Overall Study|Withdrawal by Subject|1|||
162771887|NCT03575572|587874891|FG000|Overall Study|Withdrawal by Subject|2|||
162771888|NCT03575572|587874891|FG000|Overall Study|Physician Decision|2|||
162771889|NCT03647709|587874893|FG000|Overall Study|Lost to Follow-up|5|||
162771890|NCT03647709|587874893|FG000|Overall Study|Physician Decision|6|||
162771891|NCT03647709|587874893|FG000|Overall Study|Withdrawal by Subject|3|||
162771892|NCT05287178|587874894|FG000|Overall Study|Lost to Follow-up|2|||
162771893|NCT01426217|587874895|FG000|Overall Study|lost sample|8|||
162771894|NCT01426217|587874896|FG001|Overall Study|lost sample|14|||
162771895|NCT01920178|587874897|FG000|Overall Study|Lost to Follow-up|2|||
162771896|NCT01920178|587874898|FG001|Overall Study|Lost to Follow-up|1|||
162771897|NCT03023878|587874899|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
162771898|NCT03023878|587874899|FG000|Pre-Study Run-In Period|Death|1|||
162771899|NCT03023878|587874899|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
162771900|NCT03023878|587874899|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
162771901|NCT03023878|587874899|FG000|Treatment Period|Disease Progression|1|||
162771902|NCT03023878|587874899|FG000|Treatment Period|Withdrawal by Subject|1|||
162771903|NCT03023878|587874899|FG000|Treatment Period|Adverse Event|1|||
162771904|NCT03023878|587874899|FG000|Long Term Follow-Up Period|Death|2|||
162771905|NCT01812837|587874900|FG000|Overall Study|Lost to Follow-up|1|||
162771906|NCT01812837|587874901|FG001|Overall Study|Lost to Follow-up|1|||
162771907|NCT01812837|587874902|FG002|Overall Study|Lost to Follow-up|0|||
162771908|NCT01812837|587874900|FG000|Overall Study|Protocol Violation|1|||
162771909|NCT01812837|587874901|FG001|Overall Study|Protocol Violation|0|||
162771910|NCT01812837|587874902|FG002|Overall Study|Protocol Violation|0|||
162771911|NCT00288353|587874903|FG000|Overall Study|Lack of Efficacy|2|||
162771912|NCT00288353|587874904|FG001|Overall Study|Lack of Efficacy|2|||
162771913|NCT00288353|587874903|FG000|Overall Study|Withdrawal by Subject|5|||
162771914|NCT00288353|587874904|FG001|Overall Study|Withdrawal by Subject|5|||
162771915|NCT05234632|587874905|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
162771916|NCT05234632|587874906|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
162771917|NCT05234632|587874905|FG000|Overall Study|Withdrawal by Subject|2|||
162771918|NCT05234632|587874906|FG001|Overall Study|Withdrawal by Subject|0|||
162771919|NCT05234632|587874905|FG000|Overall Study|Adverse Event|0|||
162771920|NCT05234632|587874906|FG001|Overall Study|Adverse Event|4|||
162771921|NCT05234632|587874905|FG000|Overall Study|Physician Decision|1|||
162771922|NCT05234632|587874906|FG001|Overall Study|Physician Decision|1|||
162771923|NCT05234632|587874905|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
162771924|NCT05234632|587874906|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
162771925|NCT05234632|587874905|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
162771926|NCT05234632|587874906|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
162771927|NCT04799587|587874907|FG000|Overall Study|Withdrawal by Subject|0|||
162771928|NCT04799587|587874908|FG001|Overall Study|Withdrawal by Subject|1|||
162771929|NCT00728884|587874909|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
162771930|NCT00728884|587874909|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
162771931|NCT05216835|587874910|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162771932|NCT05216835|587874911|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162771933|NCT05216835|587874912|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162771934|NCT05216835|587874913|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162771935|NCT05216835|587874914|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
162771936|NCT05216835|587874915|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
162771937|NCT05216835|587874916|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
162771938|NCT05216835|587874917|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
162771939|NCT05216835|587874910|FG000|Overall Study|Death|0|||
162771940|NCT05216835|587874911|FG001|Overall Study|Death|0|||
162771941|NCT05216835|587874912|FG002|Overall Study|Death|0|||
162771942|NCT05216835|587874913|FG003|Overall Study|Death|1|||
162771943|NCT05216835|587874914|FG004|Overall Study|Death|1|||
162771944|NCT05216835|587874915|FG005|Overall Study|Death|1|||
162771945|NCT05216835|587874916|FG006|Overall Study|Death|1|||
162771946|NCT05216835|587874917|FG007|Overall Study|Death|1|||
162771947|NCT05216835|587874910|FG000|Overall Study|Physician Decision|0|||
162771948|NCT05216835|587874911|FG001|Overall Study|Physician Decision|0|||
162771949|NCT05216835|587874912|FG002|Overall Study|Physician Decision|0|||
162771950|NCT05216835|587874913|FG003|Overall Study|Physician Decision|0|||
162771951|NCT05216835|587874914|FG004|Overall Study|Physician Decision|0|||
162771952|NCT05216835|587874915|FG005|Overall Study|Physician Decision|1|||
162771953|NCT05216835|587874916|FG006|Overall Study|Physician Decision|1|||
162771954|NCT05216835|587874917|FG007|Overall Study|Physician Decision|0|||
162771955|NCT05216835|587874910|FG000|Overall Study|Study terminated by Sponsor|0|||
162771956|NCT05216835|587874911|FG001|Overall Study|Study terminated by Sponsor|0|||
162771957|NCT05216835|587874912|FG002|Overall Study|Study terminated by Sponsor|0|||
162771958|NCT05216835|587874913|FG003|Overall Study|Study terminated by Sponsor|0|||
162771959|NCT05216835|587874914|FG004|Overall Study|Study terminated by Sponsor|0|||
162771960|NCT05216835|587874915|FG005|Overall Study|Study terminated by Sponsor|0|||
162771961|NCT05216835|587874916|FG006|Overall Study|Study terminated by Sponsor|0|||
162771962|NCT05216835|587874917|FG007|Overall Study|Study terminated by Sponsor|1|||
162771963|NCT05216835|587874910|FG000|Overall Study|Withdrawal by Subject|1|||
162771964|NCT05216835|587874911|FG001|Overall Study|Withdrawal by Subject|0|||
162771965|NCT05216835|587874912|FG002|Overall Study|Withdrawal by Subject|1|||
162771966|NCT05216835|587874913|FG003|Overall Study|Withdrawal by Subject|0|||
162771967|NCT05216835|587874914|FG004|Overall Study|Withdrawal by Subject|1|||
162771968|NCT05216835|587874915|FG005|Overall Study|Withdrawal by Subject|0|||
162771969|NCT05216835|587874916|FG006|Overall Study|Withdrawal by Subject|0|||
162771970|NCT05216835|587874917|FG007|Overall Study|Withdrawal by Subject|1|||
162771971|NCT05216835|587874910|FG000|Overall Study|Other|0|||
162771972|NCT05216835|587874911|FG001|Overall Study|Other|1|||
162771973|NCT05216835|587874912|FG002|Overall Study|Other|0|||
162771974|NCT05216835|587874913|FG003|Overall Study|Other|0|||
162771975|NCT05216835|587874914|FG004|Overall Study|Other|0|||
162771976|NCT05216835|587874915|FG005|Overall Study|Other|0|||
162771977|NCT05216835|587874916|FG006|Overall Study|Other|0|||
162771978|NCT05216835|587874917|FG007|Overall Study|Other|0|||
162771979|NCT00617708|587874918|FG000|Overall Study|Adverse Event|0|||
162771980|NCT00617708|587874919|FG001|Overall Study|Adverse Event|6|||
162771981|NCT00617708|587874920|FG002|Overall Study|Adverse Event|9|||
162771982|NCT00617708|587874918|FG000|Overall Study|Withdrawal by Subject|1|||
162771983|NCT00617708|587874919|FG001|Overall Study|Withdrawal by Subject|1|||
162771984|NCT00617708|587874920|FG002|Overall Study|Withdrawal by Subject|7|||
162771985|NCT00617708|587874918|FG000|Overall Study|Death|0|||
162771986|NCT00617708|587874919|FG001|Overall Study|Death|6|||
162771987|NCT00617708|587874920|FG002|Overall Study|Death|5|||
162771988|NCT00617708|587874918|FG000|Overall Study|Progression/Relapse|7|||
162771989|NCT00617708|587874919|FG001|Overall Study|Progression/Relapse|40|||
162771990|NCT00617708|587874920|FG002|Overall Study|Progression/Relapse|36|||
162771991|NCT00617708|587874918|FG000|Overall Study|Not protocol specified|1|||
162771992|NCT00617708|587874919|FG001|Overall Study|Not protocol specified|4|||
162771993|NCT00617708|587874920|FG002|Overall Study|Not protocol specified|2|||
162771994|NCT00617708|587874918|FG000|Overall Study|Not eligible|1|||
162771995|NCT00617708|587874919|FG001|Overall Study|Not eligible|3|||
162771996|NCT00617708|587874920|FG002|Overall Study|Not eligible|5|||
162771997|NCT01075815|587874921|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
162771998|NCT01075815|587874922|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
162771999|NCT01075815|587874921|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
162772000|NCT01075815|587874922|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
162772001|NCT01075815|587874921|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
162772002|NCT01075815|587874922|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
162772003|NCT00925288|587876568|FG000|Overall Study|Lost to Follow-up|9|||
162772004|NCT00925288|587876569|FG001|Overall Study|Lost to Follow-up|7|||
162772005|NCT00635570|587876570|FG000|Overall Study|Lost to Follow-up|8|||
162772006|NCT00635570|587876571|FG001|Overall Study|Lost to Follow-up|8|||
162772007|NCT00635570|587876570|FG000|Overall Study|Withdrawal by Subject|1|||
162772008|NCT00635570|587876571|FG001|Overall Study|Withdrawal by Subject|1|||
162772009|NCT00635570|587876570|FG000|Overall Study|Adverse Event|2|||
162772010|NCT00635570|587876571|FG001|Overall Study|Adverse Event|0|||
162772011|NCT00635570|587876570|FG000|Overall Study|Physician Decision|1|||
162772012|NCT00635570|587876571|FG001|Overall Study|Physician Decision|0|||
162772013|NCT00635570|587876570|FG000|Overall Study|Did not complete survey|2|||
162772014|NCT00635570|587876571|FG001|Overall Study|Did not complete survey|1|||
162772015|NCT00635570|587876570|FG000|Overall Study|Early termination(No sexual activity)|1|||
162772016|NCT00635570|587876571|FG001|Overall Study|Early termination(No sexual activity)|1|||
162772017|NCT02176356|587876572|FG000|Overall Study|Screen Failure|14|||
162772018|NCT02176356|587876572|FG000|Overall Study|Lost to Follow-up|4|||
162772019|NCT02176356|587876572|FG000|Overall Study|Personal Reasons|3|||
162772020|NCT02176356|587876572|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162772021|NCT00381888|587876573|FG000|Overall Study|Death|1|||
162772022|NCT00381888|587876573|FG000|Overall Study|Withdrawal by Subject|1|||
162772023|NCT00381888|587876573|FG000|Overall Study|Physician Decision|1|||
162772024|NCT00381888|587876573|FG000|Overall Study|Protocol Violation|9|||
162772025|NCT00381888|587876573|FG000|Overall Study|Had laparoscopic surgery|2|||
162772026|NCT00381888|587876573|FG000|Overall Study|Surgery was cancelled|2|||
162772027|NCT00381888|587876573|FG000|Overall Study|Adverse Event|1|||
162772028|NCT02255435|587876577|FG000|Overall Study|Patient's Limited Time Availability|0|||
162772029|NCT02255435|587876578|FG001|Overall Study|Patient's Limited Time Availability|0|||
162772030|NCT02255435|587876579|FG002|Overall Study|Patient's Limited Time Availability|0|||
162772031|NCT02255435|587876580|FG003|Overall Study|Patient's Limited Time Availability|0|||
162772032|NCT02255435|587876581|FG004|Overall Study|Patient's Limited Time Availability|0|||
162772033|NCT02255435|587876582|FG005|Overall Study|Patient's Limited Time Availability|0|||
162772034|NCT02255435|587876583|FG006|Overall Study|Patient's Limited Time Availability|0|||
162772035|NCT02255435|587876584|FG007|Overall Study|Patient's Limited Time Availability|1|||
162772036|NCT02255435|587876585|FG008|Overall Study|Patient's Limited Time Availability|0|||
162772037|NCT02255435|587876586|FG009|Overall Study|Patient's Limited Time Availability|0|||
162772038|NCT02255435|587876577|FG000|Overall Study|Withdrawal by Subject|0|||
162772039|NCT02255435|587876578|FG001|Overall Study|Withdrawal by Subject|0|||
162772040|NCT02255435|587876579|FG002|Overall Study|Withdrawal by Subject|0|||
162772041|NCT02255435|587876580|FG003|Overall Study|Withdrawal by Subject|0|||
162772042|NCT02255435|587876581|FG004|Overall Study|Withdrawal by Subject|0|||
162772043|NCT02255435|587876582|FG005|Overall Study|Withdrawal by Subject|0|||
162772044|NCT02255435|587876583|FG006|Overall Study|Withdrawal by Subject|0|||
162772045|NCT02255435|587876584|FG007|Overall Study|Withdrawal by Subject|0|||
162772046|NCT02255435|587876585|FG008|Overall Study|Withdrawal by Subject|1|||
162772047|NCT02255435|587876586|FG009|Overall Study|Withdrawal by Subject|4|||
162772048|NCT02255435|587876577|FG000|Overall Study|Administrative reasons|0|||
162772049|NCT02255435|587876578|FG001|Overall Study|Administrative reasons|0|||
162772050|NCT02255435|587876579|FG002|Overall Study|Administrative reasons|0|||
162772051|NCT02255435|587876580|FG003|Overall Study|Administrative reasons|0|||
162772052|NCT02255435|587876581|FG004|Overall Study|Administrative reasons|0|||
162772053|NCT02255435|587876582|FG005|Overall Study|Administrative reasons|0|||
162772054|NCT02255435|587876583|FG006|Overall Study|Administrative reasons|0|||
162772055|NCT02255435|587876584|FG007|Overall Study|Administrative reasons|0|||
162772056|NCT02255435|587876585|FG008|Overall Study|Administrative reasons|0|||
162772057|NCT02255435|587876586|FG009|Overall Study|Administrative reasons|2|||
162772058|NCT02151643|587876587|FG000|Overall Study|Adverse Event|2|||
162772059|NCT02151643|587876588|FG001|Overall Study|Adverse Event|0|||
162772060|NCT02151643|587876589|FG002|Overall Study|Adverse Event|1|||
162772061|NCT02151643|587876590|FG003|Overall Study|Adverse Event|4|||
162772062|NCT02151643|587876591|FG004|Overall Study|Adverse Event|0|||
162772063|NCT02151643|587876587|FG000|Overall Study|Withdrawal by Subject|0|||
162772064|NCT02151643|587876588|FG001|Overall Study|Withdrawal by Subject|1|||
162772065|NCT02151643|587876589|FG002|Overall Study|Withdrawal by Subject|1|||
162772066|NCT02151643|587876590|FG003|Overall Study|Withdrawal by Subject|1|||
162772067|NCT02151643|587876591|FG004|Overall Study|Withdrawal by Subject|1|||
162772068|NCT02151643|587876587|FG000|Overall Study|Hyperphosphataemia|1|||
162772069|NCT02151643|587876588|FG001|Overall Study|Hyperphosphataemia|0|||
162772070|NCT02151643|587876589|FG002|Overall Study|Hyperphosphataemia|0|||
162772071|NCT02151643|587876590|FG003|Overall Study|Hyperphosphataemia|0|||
162772072|NCT02151643|587876591|FG004|Overall Study|Hyperphosphataemia|1|||
162772073|NCT02151643|587876587|FG000|Overall Study|High Ferritin levels|3|||
162772074|NCT02151643|587876588|FG001|Overall Study|High Ferritin levels|3|||
162772075|NCT02151643|587876589|FG002|Overall Study|High Ferritin levels|2|||
162772076|NCT02151643|587876590|FG003|Overall Study|High Ferritin levels|2|||
162772077|NCT02151643|587876591|FG004|Overall Study|High Ferritin levels|1|||
162772078|NCT04307134|587876592|FG000|Overall Study|Lost to Follow-up|2|||
162772079|NCT04307134|587876592|FG000|Overall Study|Withdrawal by Subject|3|||
162772080|NCT04307134|587876592|FG000|Overall Study|Other|3|||
162772081|NCT04307134|587876592|FG000|Overall Study|Death|21|||
162772082|NCT04307134|587876592|FG000|Overall Study|Enrolled but not Treated|1|||
162772083|NCT01809691|587876593|FG000|Overall Study|Currently on Treatment|192|||
162772084|NCT01809691|587876594|FG001|Overall Study|Currently on Treatment|100|||
162772085|NCT01809691|587876593|FG000|Overall Study|No Protocol Treatment|10|||
162772086|NCT01809691|587876594|FG001|Overall Study|No Protocol Treatment|11|||
162772087|NCT01809691|587876593|FG000|Overall Study|Adverse Event|80|||
162772088|NCT01809691|587876594|FG001|Overall Study|Adverse Event|21|||
162772089|NCT01809691|587876593|FG000|Overall Study|Disease Progression|226|||
162772090|NCT01809691|587876594|FG001|Overall Study|Disease Progression|372|||
162772091|NCT01809691|587876593|FG000|Overall Study|Death|26|||
162772092|NCT01809691|587876594|FG001|Overall Study|Death|13|||
162772093|NCT01809691|587876593|FG000|Overall Study|Participant Refusal|70|||
162772094|NCT01809691|587876594|FG001|Overall Study|Participant Refusal|72|||
162772095|NCT01809691|587876593|FG000|Overall Study|Other, Not Specified|34|||
162772096|NCT01809691|587876594|FG001|Overall Study|Other, Not Specified|52|||
162772097|NCT03694210|587876595|FG000|Overall Study|Death|1|||
162772098|NCT03694210|587876595|FG000|Overall Study|Screen Failure|7|||
162772099|NCT00907517|587876600|FG000|Overall Study|Progressive Disease|3|||
162772100|NCT00907517|587876601|FG001|Overall Study|Progressive Disease|3|||
162772101|NCT00907517|587876602|FG002|Overall Study|Progressive Disease|4|||
162772102|NCT00907517|587876603|FG003|Overall Study|Progressive Disease|4|||
162772103|NCT00907517|587876604|FG004|Overall Study|Progressive Disease|4|||
162772104|NCT00907517|587876600|FG000|Overall Study|Symptomatic Deterioration|0|||
162772105|NCT00907517|587876601|FG001|Overall Study|Symptomatic Deterioration|0|||
162772106|NCT00907517|587876602|FG002|Overall Study|Symptomatic Deterioration|0|||
162772107|NCT00907517|587876603|FG003|Overall Study|Symptomatic Deterioration|0|||
162772108|NCT00907517|587876604|FG004|Overall Study|Symptomatic Deterioration|1|||
162772109|NCT03508830|587876608|FG000|Overall Study|Withdrawal by Subject|3|||
162772110|NCT03508830|587876609|FG001|Overall Study|Withdrawal by Subject|4|||
162772111|NCT03508830|587876608|FG000|Overall Study|Physician Decision|2|||
162772112|NCT03508830|587876609|FG001|Overall Study|Physician Decision|2|||
162772113|NCT02522299|587876610|FG000|Overall Study|Adverse Event|2|||
162772114|NCT02522299|587876611|FG001|Overall Study|Adverse Event|0|||
162772115|NCT02522299|587876610|FG000|Overall Study|Physician Decision|0|||
162772116|NCT02522299|587876611|FG001|Overall Study|Physician Decision|1|||
162772117|NCT02522299|587876610|FG000|Overall Study|Withdrawal by Subject|2|||
162772118|NCT02522299|587876611|FG001|Overall Study|Withdrawal by Subject|0|||
162772119|NCT02097056|587876612|FG000|Overall Study|Protocol Violation|2|||
162772120|NCT02097056|587876612|FG000|Overall Study|Withdrawal by Subject|15|||
162772121|NCT02097056|587876612|FG000|Overall Study|Lost to Follow-up|2|||
162772122|NCT02097056|587876612|FG000|Overall Study|Adverse Event|37|||
162772123|NCT02097056|587876612|FG000|Overall Study|Other|2|||
162772124|NCT04908800|587876615|FG000|Overall Study|Adverse Event|0|||
162772125|NCT04908800|587876616|FG001|Overall Study|Adverse Event|0|||
162772126|NCT04908800|587876617|FG002|Overall Study|Adverse Event|0|||
162772127|NCT04908800|587876618|FG003|Overall Study|Adverse Event|0|||
162772128|NCT04908800|587876619|FG004|Overall Study|Adverse Event|0|||
162772129|NCT04908800|587876620|FG005|Overall Study|Adverse Event|0|||
162772130|NCT04908800|587876621|FG006|Overall Study|Adverse Event|0|||
162772131|NCT04908800|587876622|FG007|Overall Study|Adverse Event|0|||
162772132|NCT04908800|587876623|FG008|Overall Study|Adverse Event|0|||
162772133|NCT04908800|587876624|FG009|Overall Study|Adverse Event|0|||
162772134|NCT04908800|587876625|FG010|Overall Study|Adverse Event|1|||
162772135|NCT04908800|587876626|FG011|Overall Study|Adverse Event|0|||
162772136|NCT04908800|587876627|FG012|Overall Study|Adverse Event|0|||
162772137|NCT03751280|587876628|FG000|Overall Study|Adverse Event|0|||
162772138|NCT03751280|587876629|FG001|Overall Study|Adverse Event|1|||
162772139|NCT03751280|587876628|FG000|Overall Study|Lost to Follow-up|3|||
162772140|NCT03751280|587876629|FG001|Overall Study|Lost to Follow-up|5|||
162772141|NCT03751280|587876628|FG000|Overall Study|Physician Decision|0|||
162772142|NCT03751280|587876629|FG001|Overall Study|Physician Decision|2|||
162772143|NCT03751280|587876628|FG000|Overall Study|Protocol Violation|0|||
162772144|NCT03751280|587876629|FG001|Overall Study|Protocol Violation|2|||
162772145|NCT03751280|587876628|FG000|Overall Study|Withdrawal by Subject|5|||
162772146|NCT03751280|587876629|FG001|Overall Study|Withdrawal by Subject|2|||
162772147|NCT00296504|587876630|FG000|Interim Analysis|Withdrawal by Subject|8|||
162772148|NCT00296504|587876631|FG001|Interim Analysis|Withdrawal by Subject|0|||
162772149|NCT00296504|587876632|FG002|Interim Analysis|Withdrawal by Subject|12|||
162772150|NCT00296504|587876633|FG003|Interim Analysis|Withdrawal by Subject|0|||
162772151|NCT00296504|587876634|FG004|Interim Analysis|Withdrawal by Subject|5|||
162772152|NCT00296504|587876635|FG005|Interim Analysis|Withdrawal by Subject|5|||
162772153|NCT00296504|587876636|FG006|Interim Analysis|Withdrawal by Subject|9|||
162772154|NCT00296504|587876637|FG007|Interim Analysis|Withdrawal by Subject|3|||
162772155|NCT00296504|587876638|FG008|Interim Analysis|Withdrawal by Subject|0|||
162772156|NCT00296504|587876630|FG000|Interim Analysis|Lost to Follow-up|13|||
162772157|NCT00296504|587876631|FG001|Interim Analysis|Lost to Follow-up|3|||
162772158|NCT00296504|587876632|FG002|Interim Analysis|Lost to Follow-up|26|||
162772159|NCT00296504|587876633|FG003|Interim Analysis|Lost to Follow-up|8|||
162772160|NCT00296504|587876634|FG004|Interim Analysis|Lost to Follow-up|14|||
162772161|NCT00296504|587876635|FG005|Interim Analysis|Lost to Follow-up|4|||
162772162|NCT00296504|587876636|FG006|Interim Analysis|Lost to Follow-up|11|||
162772163|NCT00296504|587876637|FG007|Interim Analysis|Lost to Follow-up|4|||
162772164|NCT00296504|587876638|FG008|Interim Analysis|Lost to Follow-up|0|||
162772165|NCT00296504|587876630|FG000|Interim Analysis|Clinical Progression|1|||
162772166|NCT00296504|587876631|FG001|Interim Analysis|Clinical Progression|0|||
162772167|NCT00296504|587876632|FG002|Interim Analysis|Clinical Progression|1|||
162772168|NCT00296504|587876633|FG003|Interim Analysis|Clinical Progression|1|||
162772169|NCT00296504|587876634|FG004|Interim Analysis|Clinical Progression|0|||
162772170|NCT00296504|587876635|FG005|Interim Analysis|Clinical Progression|2|||
162772171|NCT00296504|587876636|FG006|Interim Analysis|Clinical Progression|1|||
162772172|NCT00296504|587876637|FG007|Interim Analysis|Clinical Progression|2|||
162772173|NCT00296504|587876638|FG008|Interim Analysis|Clinical Progression|0|||
162772174|NCT00296504|587876630|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
162772175|NCT00296504|587876631|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
162772176|NCT00296504|587876632|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
162772177|NCT00296504|587876633|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
162772178|NCT00296504|587876634|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
162772179|NCT00296504|587876635|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
162772180|NCT00296504|587876636|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
162772181|NCT00296504|587876637|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
162772182|NCT00296504|587876638|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
162772183|NCT00296504|587876630|FG000|Interim Analysis|Adverse Event|0|||
162772184|NCT00296504|587876631|FG001|Interim Analysis|Adverse Event|0|||
162772185|NCT00296504|587876632|FG002|Interim Analysis|Adverse Event|13|||
162772186|NCT00296504|587876633|FG003|Interim Analysis|Adverse Event|4|||
162772187|NCT00296504|587876634|FG004|Interim Analysis|Adverse Event|6|||
162772188|NCT00296504|587876635|FG005|Interim Analysis|Adverse Event|3|||
162772189|NCT00296504|587876636|FG006|Interim Analysis|Adverse Event|4|||
162772190|NCT00296504|587876637|FG007|Interim Analysis|Adverse Event|5|||
162772191|NCT00296504|587876638|FG008|Interim Analysis|Adverse Event|0|||
162772192|NCT00296504|587876630|FG000|Interim Analysis|Protocol Violation|0|||
162772193|NCT00296504|587876631|FG001|Interim Analysis|Protocol Violation|0|||
162772194|NCT00296504|587876632|FG002|Interim Analysis|Protocol Violation|2|||
162772195|NCT00296504|587876633|FG003|Interim Analysis|Protocol Violation|0|||
162772196|NCT00296504|587876634|FG004|Interim Analysis|Protocol Violation|1|||
162772197|NCT00296504|587876635|FG005|Interim Analysis|Protocol Violation|0|||
162772198|NCT00296504|587876636|FG006|Interim Analysis|Protocol Violation|0|||
162772199|NCT00296504|587876637|FG007|Interim Analysis|Protocol Violation|1|||
162772200|NCT00296504|587876638|FG008|Interim Analysis|Protocol Violation|0|||
162772201|NCT00296504|587876630|FG000|Interim Analysis|Insufficient CD4 Response|0|||
162772202|NCT00296504|587876631|FG001|Interim Analysis|Insufficient CD4 Response|0|||
162772203|NCT00296504|587876632|FG002|Interim Analysis|Insufficient CD4 Response|0|||
162772204|NCT00296504|587876633|FG003|Interim Analysis|Insufficient CD4 Response|0|||
162772205|NCT00296504|587876634|FG004|Interim Analysis|Insufficient CD4 Response|1|||
162772206|NCT00296504|587876635|FG005|Interim Analysis|Insufficient CD4 Response|1|||
162772207|NCT00296504|587876636|FG006|Interim Analysis|Insufficient CD4 Response|0|||
162772208|NCT00296504|587876637|FG007|Interim Analysis|Insufficient CD4 Response|0|||
162772209|NCT00296504|587876638|FG008|Interim Analysis|Insufficient CD4 Response|0|||
162772210|NCT00296504|587876630|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
162772211|NCT00296504|587876631|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
162772212|NCT00296504|587876632|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
162772213|NCT00296504|587876633|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
162772214|NCT00296504|587876634|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
162772215|NCT00296504|587876635|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
162772216|NCT00296504|587876636|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
162772217|NCT00296504|587876637|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
162772218|NCT00296504|587876638|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
162772219|NCT00296504|587876630|FG000|Interim Analysis|Pregnancy|4|||
162772220|NCT00296504|587876631|FG001|Interim Analysis|Pregnancy|1|||
162772221|NCT00296504|587876632|FG002|Interim Analysis|Pregnancy|4|||
162772222|NCT00296504|587876633|FG003|Interim Analysis|Pregnancy|2|||
162772223|NCT00296504|587876634|FG004|Interim Analysis|Pregnancy|0|||
162772224|NCT00296504|587876635|FG005|Interim Analysis|Pregnancy|1|||
162772225|NCT00296504|587876636|FG006|Interim Analysis|Pregnancy|1|||
162772226|NCT00296504|587876637|FG007|Interim Analysis|Pregnancy|1|||
162772227|NCT00296504|587876638|FG008|Interim Analysis|Pregnancy|0|||
162772228|NCT00296504|587876630|FG000|Interim Analysis|Death|1|||
162772229|NCT00296504|587876631|FG001|Interim Analysis|Death|0|||
162772230|NCT00296504|587876632|FG002|Interim Analysis|Death|3|||
162772231|NCT00296504|587876633|FG003|Interim Analysis|Death|0|||
162772232|NCT00296504|587876634|FG004|Interim Analysis|Death|0|||
162772233|NCT00296504|587876635|FG005|Interim Analysis|Death|0|||
162772234|NCT00296504|587876636|FG006|Interim Analysis|Death|0|||
162772235|NCT00296504|587876637|FG007|Interim Analysis|Death|0|||
162772236|NCT00296504|587876638|FG008|Interim Analysis|Death|0|||
162772237|NCT00296504|587876630|FG000|Interim Analysis|Participant Non-compliant|0|||
162772238|NCT00296504|587876631|FG001|Interim Analysis|Participant Non-compliant|1|||
162772239|NCT00296504|587876632|FG002|Interim Analysis|Participant Non-compliant|2|||
162772240|NCT00296504|587876633|FG003|Interim Analysis|Participant Non-compliant|1|||
162772241|NCT00296504|587876634|FG004|Interim Analysis|Participant Non-compliant|1|||
162772242|NCT00296504|587876635|FG005|Interim Analysis|Participant Non-compliant|3|||
162772243|NCT00296504|587876636|FG006|Interim Analysis|Participant Non-compliant|6|||
162772244|NCT00296504|587876637|FG007|Interim Analysis|Participant Non-compliant|2|||
162772245|NCT00296504|587876638|FG008|Interim Analysis|Participant Non-compliant|0|||
162772246|NCT00296504|587876630|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772247|NCT00296504|587876631|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772248|NCT00296504|587876632|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
162772249|NCT00296504|587876633|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772250|NCT00296504|587876634|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772251|NCT00296504|587876635|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
162772252|NCT00296504|587876636|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772253|NCT00296504|587876637|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772254|NCT00296504|587876638|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162772255|NCT00296504|587876630|FG000|Interim Analysis|To Simplify Treatment|0|||
162772256|NCT00296504|587876631|FG001|Interim Analysis|To Simplify Treatment|0|||
162772257|NCT00296504|587876632|FG002|Interim Analysis|To Simplify Treatment|1|||
162772258|NCT00296504|587876633|FG003|Interim Analysis|To Simplify Treatment|0|||
162772259|NCT00296504|587876634|FG004|Interim Analysis|To Simplify Treatment|0|||
162772260|NCT00296504|587876635|FG005|Interim Analysis|To Simplify Treatment|0|||
162772261|NCT00296504|587876636|FG006|Interim Analysis|To Simplify Treatment|2|||
162772262|NCT00296504|587876637|FG007|Interim Analysis|To Simplify Treatment|0|||
162772263|NCT00296504|587876638|FG008|Interim Analysis|To Simplify Treatment|0|||
162772264|NCT00296504|587876630|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772265|NCT00296504|587876631|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772266|NCT00296504|587876632|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
162772267|NCT00296504|587876633|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772268|NCT00296504|587876634|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772269|NCT00296504|587876635|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772270|NCT00296504|587876636|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772271|NCT00296504|587876637|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772272|NCT00296504|587876638|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
162772273|NCT00296504|587876630|FG000|Interim Analysis|Participant Moved|1|||
162772274|NCT00296504|587876631|FG001|Interim Analysis|Participant Moved|0|||
162772275|NCT00296504|587876632|FG002|Interim Analysis|Participant Moved|1|||
162772276|NCT00296504|587876633|FG003|Interim Analysis|Participant Moved|0|||
162772277|NCT00296504|587876634|FG004|Interim Analysis|Participant Moved|0|||
162772278|NCT00296504|587876635|FG005|Interim Analysis|Participant Moved|1|||
162772279|NCT00296504|587876636|FG006|Interim Analysis|Participant Moved|1|||
162772280|NCT00296504|587876637|FG007|Interim Analysis|Participant Moved|0|||
162772281|NCT00296504|587876638|FG008|Interim Analysis|Participant Moved|0|||
162772282|NCT00296504|587876630|FG000|Interim Analysis|Participant Was Incarcerated|2|||
162772283|NCT00296504|587876631|FG001|Interim Analysis|Participant Was Incarcerated|0|||
162772284|NCT00296504|587876632|FG002|Interim Analysis|Participant Was Incarcerated|1|||
162772285|NCT00296504|587876633|FG003|Interim Analysis|Participant Was Incarcerated|0|||
162772286|NCT00296504|587876634|FG004|Interim Analysis|Participant Was Incarcerated|0|||
162772287|NCT00296504|587876635|FG005|Interim Analysis|Participant Was Incarcerated|0|||
162772288|NCT00296504|587876636|FG006|Interim Analysis|Participant Was Incarcerated|0|||
162772289|NCT00296504|587876637|FG007|Interim Analysis|Participant Was Incarcerated|0|||
162772290|NCT00296504|587876638|FG008|Interim Analysis|Participant Was Incarcerated|0|||
162772291|NCT00296504|587876630|FG000|Interim Analysis|Resistance to FPV|0|||
162772292|NCT00296504|587876631|FG001|Interim Analysis|Resistance to FPV|0|||
162772293|NCT00296504|587876632|FG002|Interim Analysis|Resistance to FPV|1|||
162772294|NCT00296504|587876633|FG003|Interim Analysis|Resistance to FPV|0|||
162772295|NCT00296504|587876634|FG004|Interim Analysis|Resistance to FPV|0|||
162772296|NCT00296504|587876635|FG005|Interim Analysis|Resistance to FPV|0|||
162772297|NCT00296504|587876636|FG006|Interim Analysis|Resistance to FPV|0|||
162772298|NCT00296504|587876637|FG007|Interim Analysis|Resistance to FPV|0|||
162772299|NCT00296504|587876638|FG008|Interim Analysis|Resistance to FPV|0|||
162772300|NCT00296504|587876630|FG000|Interim Analysis|Physician Decision|0|||
162772301|NCT00296504|587876631|FG001|Interim Analysis|Physician Decision|0|||
162772302|NCT00296504|587876632|FG002|Interim Analysis|Physician Decision|1|||
162772303|NCT00296504|587876633|FG003|Interim Analysis|Physician Decision|0|||
162772304|NCT00296504|587876634|FG004|Interim Analysis|Physician Decision|0|||
162772305|NCT00296504|587876635|FG005|Interim Analysis|Physician Decision|0|||
162772306|NCT00296504|587876636|FG006|Interim Analysis|Physician Decision|0|||
162772307|NCT00296504|587876637|FG007|Interim Analysis|Physician Decision|0|||
162772308|NCT00296504|587876638|FG008|Interim Analysis|Physician Decision|0|||
162772309|NCT00296504|587876630|FG000|Interim Analysis|Principle Investigator Discretion|2|||
162772310|NCT00296504|587876631|FG001|Interim Analysis|Principle Investigator Discretion|0|||
162772311|NCT00296504|587876632|FG002|Interim Analysis|Principle Investigator Discretion|1|||
162772312|NCT00296504|587876633|FG003|Interim Analysis|Principle Investigator Discretion|1|||
162772313|NCT00296504|587876634|FG004|Interim Analysis|Principle Investigator Discretion|0|||
162772314|NCT00296504|587876635|FG005|Interim Analysis|Principle Investigator Discretion|0|||
162772315|NCT00296504|587876636|FG006|Interim Analysis|Principle Investigator Discretion|0|||
162772316|NCT00296504|587876637|FG007|Interim Analysis|Principle Investigator Discretion|0|||
162772317|NCT00296504|587876638|FG008|Interim Analysis|Principle Investigator Discretion|0|||
162772318|NCT00296504|587876630|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
162772319|NCT00296504|587876631|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
162772320|NCT00296504|587876632|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
162772321|NCT00296504|587876633|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
162772322|NCT00296504|587876634|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
162772323|NCT00296504|587876635|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
162772324|NCT00296504|587876636|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
162772325|NCT00296504|587876637|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
162772326|NCT00296504|587876638|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
162772327|NCT00296504|587876630|FG000|Interim Analysis|Non-adherence|2|||
162772328|NCT00296504|587876631|FG001|Interim Analysis|Non-adherence|0|||
162772329|NCT00296504|587876632|FG002|Interim Analysis|Non-adherence|0|||
162772330|NCT00296504|587876633|FG003|Interim Analysis|Non-adherence|0|||
162772331|NCT00296504|587876634|FG004|Interim Analysis|Non-adherence|1|||
162772332|NCT00296504|587876635|FG005|Interim Analysis|Non-adherence|0|||
162772333|NCT00296504|587876636|FG006|Interim Analysis|Non-adherence|0|||
162772334|NCT00296504|587876637|FG007|Interim Analysis|Non-adherence|1|||
162772335|NCT00296504|587876638|FG008|Interim Analysis|Non-adherence|0|||
162772336|NCT00296504|587876630|FG000|Interim Analysis|Site Closing|1|||
162772337|NCT00296504|587876631|FG001|Interim Analysis|Site Closing|0|||
162772338|NCT00296504|587876632|FG002|Interim Analysis|Site Closing|0|||
162772339|NCT00296504|587876633|FG003|Interim Analysis|Site Closing|0|||
162772340|NCT00296504|587876634|FG004|Interim Analysis|Site Closing|0|||
162772341|NCT00296504|587876635|FG005|Interim Analysis|Site Closing|1|||
162772342|NCT00296504|587876636|FG006|Interim Analysis|Site Closing|2|||
162772343|NCT00296504|587876637|FG007|Interim Analysis|Site Closing|0|||
162772344|NCT00296504|587876638|FG008|Interim Analysis|Site Closing|0|||
162772345|NCT00296504|587876630|FG000|Interim Analysis|Lack of Personnel at Site|1|||
162772346|NCT00296504|587876631|FG001|Interim Analysis|Lack of Personnel at Site|0|||
162772347|NCT00296504|587876632|FG002|Interim Analysis|Lack of Personnel at Site|0|||
162772348|NCT00296504|587876633|FG003|Interim Analysis|Lack of Personnel at Site|0|||
162772349|NCT00296504|587876634|FG004|Interim Analysis|Lack of Personnel at Site|0|||
162772350|NCT00296504|587876635|FG005|Interim Analysis|Lack of Personnel at Site|0|||
162772351|NCT00296504|587876636|FG006|Interim Analysis|Lack of Personnel at Site|0|||
162772352|NCT00296504|587876637|FG007|Interim Analysis|Lack of Personnel at Site|0|||
162772353|NCT00296504|587876638|FG008|Interim Analysis|Lack of Personnel at Site|0|||
162772354|NCT00296504|587876630|FG000|Interim Analysis|Missed Schedule Date|1|||
162772355|NCT00296504|587876631|FG001|Interim Analysis|Missed Schedule Date|0|||
162772356|NCT00296504|587876632|FG002|Interim Analysis|Missed Schedule Date|0|||
162772357|NCT00296504|587876633|FG003|Interim Analysis|Missed Schedule Date|0|||
162772358|NCT00296504|587876634|FG004|Interim Analysis|Missed Schedule Date|0|||
162772359|NCT00296504|587876635|FG005|Interim Analysis|Missed Schedule Date|0|||
162772360|NCT00296504|587876636|FG006|Interim Analysis|Missed Schedule Date|0|||
162772361|NCT00296504|587876637|FG007|Interim Analysis|Missed Schedule Date|0|||
162772362|NCT00296504|587876638|FG008|Interim Analysis|Missed Schedule Date|0|||
162772363|NCT00296504|587876630|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
162772364|NCT00296504|587876631|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
162772365|NCT00296504|587876632|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
162772366|NCT00296504|587876633|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
162772367|NCT00296504|587876634|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
162772368|NCT00296504|587876635|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
162772369|NCT00296504|587876636|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
162772370|NCT00296504|587876637|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
162772371|NCT00296504|587876638|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
162772372|NCT00296504|587876630|FG000|Interim Analysis|Participant Stopped|0|||
162772373|NCT00296504|587876631|FG001|Interim Analysis|Participant Stopped|0|||
162772374|NCT00296504|587876632|FG002|Interim Analysis|Participant Stopped|0|||
162772375|NCT00296504|587876633|FG003|Interim Analysis|Participant Stopped|0|||
162772376|NCT00296504|587876634|FG004|Interim Analysis|Participant Stopped|1|||
162772377|NCT00296504|587876635|FG005|Interim Analysis|Participant Stopped|0|||
162772378|NCT00296504|587876636|FG006|Interim Analysis|Participant Stopped|0|||
162772379|NCT00296504|587876637|FG007|Interim Analysis|Participant Stopped|0|||
162772380|NCT00296504|587876638|FG008|Interim Analysis|Participant Stopped|0|||
162772381|NCT00296504|587876630|FG000|Interim Analysis|Physician and Participant Decision|0|||
162772382|NCT00296504|587876631|FG001|Interim Analysis|Physician and Participant Decision|0|||
162772383|NCT00296504|587876632|FG002|Interim Analysis|Physician and Participant Decision|0|||
162772384|NCT00296504|587876633|FG003|Interim Analysis|Physician and Participant Decision|0|||
162772385|NCT00296504|587876634|FG004|Interim Analysis|Physician and Participant Decision|0|||
162772386|NCT00296504|587876635|FG005|Interim Analysis|Physician and Participant Decision|1|||
162772387|NCT00296504|587876636|FG006|Interim Analysis|Physician and Participant Decision|0|||
162772388|NCT00296504|587876637|FG007|Interim Analysis|Physician and Participant Decision|0|||
162772389|NCT00296504|587876638|FG008|Interim Analysis|Physician and Participant Decision|0|||
162772390|NCT00296504|587876630|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
162772391|NCT00296504|587876631|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
162772392|NCT00296504|587876632|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
162772393|NCT00296504|587876633|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
162772394|NCT00296504|587876634|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
162772395|NCT00296504|587876635|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
162772396|NCT00296504|587876636|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
162772397|NCT00296504|587876637|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
162772398|NCT00296504|587876638|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
162772399|NCT00296504|587876630|FG000|Interim Analysis|Study Ended|0|||
162772400|NCT00296504|587876631|FG001|Interim Analysis|Study Ended|0|||
162772401|NCT00296504|587876632|FG002|Interim Analysis|Study Ended|0|||
162772402|NCT00296504|587876633|FG003|Interim Analysis|Study Ended|0|||
162772403|NCT00296504|587876634|FG004|Interim Analysis|Study Ended|0|||
162772404|NCT00296504|587876635|FG005|Interim Analysis|Study Ended|0|||
162772405|NCT00296504|587876636|FG006|Interim Analysis|Study Ended|1|||
162772406|NCT00296504|587876637|FG007|Interim Analysis|Study Ended|0|||
162772407|NCT00296504|587876638|FG008|Interim Analysis|Study Ended|0|||
162772408|NCT00296504|587876630|FG000|Interim Analysis|Participant Needed Interferon|0|||
162772409|NCT00296504|587876631|FG001|Interim Analysis|Participant Needed Interferon|0|||
162772410|NCT00296504|587876632|FG002|Interim Analysis|Participant Needed Interferon|0|||
162772411|NCT00296504|587876633|FG003|Interim Analysis|Participant Needed Interferon|0|||
162772412|NCT00296504|587876634|FG004|Interim Analysis|Participant Needed Interferon|0|||
162772413|NCT00296504|587876635|FG005|Interim Analysis|Participant Needed Interferon|0|||
162772414|NCT00296504|587876636|FG006|Interim Analysis|Participant Needed Interferon|0|||
162772415|NCT00296504|587876637|FG007|Interim Analysis|Participant Needed Interferon|1|||
162772416|NCT00296504|587876638|FG008|Interim Analysis|Participant Needed Interferon|0|||
162772417|NCT00296504|587876630|FG000|Interim Analysis|Ongoing|32|||
162772418|NCT00296504|587876631|FG001|Interim Analysis|Ongoing|12|||
162772419|NCT00296504|587876632|FG002|Interim Analysis|Ongoing|16|||
162772420|NCT00296504|587876633|FG003|Interim Analysis|Ongoing|22|||
162772421|NCT00296504|587876634|FG004|Interim Analysis|Ongoing|0|||
162772422|NCT00296504|587876635|FG005|Interim Analysis|Ongoing|0|||
162772423|NCT00296504|587876636|FG006|Interim Analysis|Ongoing|30|||
162772424|NCT00296504|587876637|FG007|Interim Analysis|Ongoing|1|||
162772425|NCT00296504|587876638|FG008|Interim Analysis|Ongoing|0|||
162772426|NCT00296504|587876630|FG000|Final Analysis|Withdrawal by Subject|0|||
162772427|NCT00296504|587876631|FG001|Final Analysis|Withdrawal by Subject|0|||
162772428|NCT00296504|587876632|FG002|Final Analysis|Withdrawal by Subject|0|||
162772429|NCT00296504|587876633|FG003|Final Analysis|Withdrawal by Subject|0|||
162772430|NCT00296504|587876634|FG004|Final Analysis|Withdrawal by Subject|0|||
162772431|NCT00296504|587876635|FG005|Final Analysis|Withdrawal by Subject|0|||
162772432|NCT00296504|587876636|FG006|Final Analysis|Withdrawal by Subject|0|||
162772433|NCT00296504|587876637|FG007|Final Analysis|Withdrawal by Subject|0|||
162772434|NCT00296504|587876638|FG008|Final Analysis|Withdrawal by Subject|1|||
162772435|NCT00296504|587876630|FG000|Final Analysis|Lost to Follow-up|0|||
162772436|NCT00296504|587876631|FG001|Final Analysis|Lost to Follow-up|0|||
162772437|NCT00296504|587876632|FG002|Final Analysis|Lost to Follow-up|0|||
162772438|NCT00296504|587876633|FG003|Final Analysis|Lost to Follow-up|0|||
162772439|NCT00296504|587876634|FG004|Final Analysis|Lost to Follow-up|0|||
162772440|NCT00296504|587876635|FG005|Final Analysis|Lost to Follow-up|0|||
162772441|NCT00296504|587876636|FG006|Final Analysis|Lost to Follow-up|0|||
162772442|NCT00296504|587876637|FG007|Final Analysis|Lost to Follow-up|0|||
162772443|NCT00296504|587876638|FG008|Final Analysis|Lost to Follow-up|5|||
162772444|NCT00296504|587876630|FG000|Final Analysis|Insufficient Viral Load Response|0|||
162772445|NCT00296504|587876631|FG001|Final Analysis|Insufficient Viral Load Response|0|||
162772446|NCT00296504|587876632|FG002|Final Analysis|Insufficient Viral Load Response|0|||
162772447|NCT00296504|587876633|FG003|Final Analysis|Insufficient Viral Load Response|0|||
162772448|NCT00296504|587876634|FG004|Final Analysis|Insufficient Viral Load Response|0|||
162772449|NCT00296504|587876635|FG005|Final Analysis|Insufficient Viral Load Response|0|||
162772450|NCT00296504|587876636|FG006|Final Analysis|Insufficient Viral Load Response|0|||
162772451|NCT00296504|587876637|FG007|Final Analysis|Insufficient Viral Load Response|0|||
162772452|NCT00296504|587876638|FG008|Final Analysis|Insufficient Viral Load Response|6|||
162772453|NCT00296504|587876630|FG000|Final Analysis|Adverse Event|0|||
162772454|NCT00296504|587876631|FG001|Final Analysis|Adverse Event|0|||
162772455|NCT00296504|587876632|FG002|Final Analysis|Adverse Event|0|||
162772456|NCT00296504|587876633|FG003|Final Analysis|Adverse Event|0|||
162772457|NCT00296504|587876634|FG004|Final Analysis|Adverse Event|0|||
162772458|NCT00296504|587876635|FG005|Final Analysis|Adverse Event|0|||
162772459|NCT00296504|587876636|FG006|Final Analysis|Adverse Event|0|||
162772460|NCT00296504|587876637|FG007|Final Analysis|Adverse Event|0|||
162772461|NCT00296504|587876638|FG008|Final Analysis|Adverse Event|2|||
162772462|NCT00296504|587876630|FG000|Final Analysis|Pregnancy|0|||
162772463|NCT00296504|587876631|FG001|Final Analysis|Pregnancy|0|||
162772464|NCT00296504|587876632|FG002|Final Analysis|Pregnancy|0|||
162772465|NCT00296504|587876633|FG003|Final Analysis|Pregnancy|0|||
162772466|NCT00296504|587876634|FG004|Final Analysis|Pregnancy|0|||
162772467|NCT00296504|587876635|FG005|Final Analysis|Pregnancy|0|||
162772468|NCT00296504|587876636|FG006|Final Analysis|Pregnancy|0|||
162772469|NCT00296504|587876637|FG007|Final Analysis|Pregnancy|0|||
162772470|NCT00296504|587876638|FG008|Final Analysis|Pregnancy|4|||
162772471|NCT00296504|587876630|FG000|Final Analysis|Tuberculosis|0|||
162772472|NCT00296504|587876631|FG001|Final Analysis|Tuberculosis|0|||
162772473|NCT00296504|587876632|FG002|Final Analysis|Tuberculosis|0|||
162772474|NCT00296504|587876633|FG003|Final Analysis|Tuberculosis|0|||
162772475|NCT00296504|587876634|FG004|Final Analysis|Tuberculosis|0|||
162772476|NCT00296504|587876635|FG005|Final Analysis|Tuberculosis|0|||
162772477|NCT00296504|587876636|FG006|Final Analysis|Tuberculosis|0|||
162772478|NCT00296504|587876637|FG007|Final Analysis|Tuberculosis|0|||
162772479|NCT00296504|587876638|FG008|Final Analysis|Tuberculosis|1|||
162772480|NCT00296504|587876630|FG000|Final Analysis|Participant Moved to Another Country|0|||
162772481|NCT00296504|587876631|FG001|Final Analysis|Participant Moved to Another Country|0|||
162772482|NCT00296504|587876632|FG002|Final Analysis|Participant Moved to Another Country|0|||
162772483|NCT00296504|587876633|FG003|Final Analysis|Participant Moved to Another Country|0|||
162772484|NCT00296504|587876634|FG004|Final Analysis|Participant Moved to Another Country|0|||
162772485|NCT00296504|587876635|FG005|Final Analysis|Participant Moved to Another Country|0|||
162772486|NCT00296504|587876636|FG006|Final Analysis|Participant Moved to Another Country|0|||
162772487|NCT00296504|587876637|FG007|Final Analysis|Participant Moved to Another Country|0|||
162772488|NCT00296504|587876638|FG008|Final Analysis|Participant Moved to Another Country|1|||
162772489|NCT00296504|587876630|FG000|Final Analysis|Poor Adherence|0|||
162772490|NCT00296504|587876631|FG001|Final Analysis|Poor Adherence|0|||
162772491|NCT00296504|587876632|FG002|Final Analysis|Poor Adherence|0|||
162772492|NCT00296504|587876633|FG003|Final Analysis|Poor Adherence|0|||
162772493|NCT00296504|587876634|FG004|Final Analysis|Poor Adherence|0|||
162772494|NCT00296504|587876635|FG005|Final Analysis|Poor Adherence|0|||
162772495|NCT00296504|587876636|FG006|Final Analysis|Poor Adherence|0|||
162772496|NCT00296504|587876637|FG007|Final Analysis|Poor Adherence|0|||
162772497|NCT00296504|587876638|FG008|Final Analysis|Poor Adherence|1|||
162772498|NCT02162771|587876642|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
162772499|NCT02162771|587876643|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
162772500|NCT02162771|587876642|FG000|Core Study Period (Part 2)|Adverse Event|4|||
162772501|NCT02162771|587876643|FG001|Core Study Period (Part 2)|Adverse Event|1|||
162772502|NCT02162771|587876642|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
162772503|NCT02162771|587876643|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
162772504|NCT02162771|587876642|FG000|Core Study Period (Part 2)|Physician Decision|0|||
162772505|NCT02162771|587876643|FG001|Core Study Period (Part 2)|Physician Decision|2|||
162772506|NCT02162771|587876642|FG000|Core Study Period (Part 2)|Death|1|||
162772507|NCT02162771|587876643|FG001|Core Study Period (Part 2)|Death|0|||
162772508|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
162772509|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
162772510|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
162772511|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
162772512|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Death|2|||
162772513|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Death|1|||
162772514|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
162772515|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
162772516|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
162772517|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
162772518|NCT02162771|587876642|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
162772519|NCT02162771|587876643|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
162772520|NCT01078571|587876644|FG000|Overall Study|Adverse Event|36|||
162772521|NCT01078571|587876644|FG000|Overall Study|Lack of effectiveness|36|||
162772522|NCT01078571|587876644|FG000|Overall Study|Reason not reported|21|||
162772523|NCT01078571|587876644|FG000|Overall Study|Withdrawal by Subject|12|||
162772524|NCT01078571|587876644|FG000|Overall Study|Lost to Follow-up|8|||
162772525|NCT01078571|587876644|FG000|Overall Study|Protocol Violation|2|||
162772526|NCT01047306|587876646|FG000|Overall Study|Withdrawal by Subject|2|||
162772527|NCT01047306|587876647|FG001|Overall Study|Withdrawal by Subject|0|||
162772528|NCT01047306|587876646|FG000|Overall Study|Lost to Follow-up|1|||
162772529|NCT01047306|587876647|FG001|Overall Study|Lost to Follow-up|0|||
162772530|NCT04393779|587876650|FG000|Overall Study|Death|1|||
162772531|NCT04393779|587876650|FG000|Overall Study|Device reintervention or explant|4|||
162772532|NCT02849509|587876659|FG000|Overall Study|Worsening of disease under study|1|||
162772533|NCT02849509|587876660|FG001|Overall Study|Worsening of disease under study|1|||
162772534|NCT02849509|587876661|FG002|Overall Study|Worsening of disease under study|1|||
162772535|NCT02849509|587876659|FG000|Overall Study|Worsening of other pre-existing disease|0|||
162772536|NCT02849509|587876660|FG001|Overall Study|Worsening of other pre-existing disease|1|||
162772537|NCT02849509|587876661|FG002|Overall Study|Worsening of other pre-existing disease|2|||
162772538|NCT02849509|587876659|FG000|Overall Study|Other adverse event|36|||
162772539|NCT02849509|587876660|FG001|Overall Study|Other adverse event|41|||
162772540|NCT02849509|587876661|FG002|Overall Study|Other adverse event|8|||
162772541|NCT02849509|587876659|FG000|Overall Study|Withdrawal by Subject|6|||
162772542|NCT02849509|587876660|FG001|Overall Study|Withdrawal by Subject|17|||
162772543|NCT02849509|587876661|FG002|Overall Study|Withdrawal by Subject|12|||
162772544|NCT02849509|587876659|FG000|Overall Study|Lost to Follow-up|27|||
162772545|NCT02849509|587876660|FG001|Overall Study|Lost to Follow-up|67|||
162772546|NCT02849509|587876661|FG002|Overall Study|Lost to Follow-up|36|||
162772547|NCT02849509|587876659|FG000|Overall Study|Other, reason not specified|14|||
162772548|NCT02849509|587876660|FG001|Overall Study|Other, reason not specified|29|||
162772549|NCT02849509|587876661|FG002|Overall Study|Other, reason not specified|25|||
162772550|NCT02849509|587876659|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
162772551|NCT02849509|587876660|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
162772552|NCT02849509|587876661|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
162772553|NCT02374476|587876670|FG000|VT Induced Ablation|Screening Failures|36|||
162772554|NCT02374476|587876671|FG001|VT Induced Ablation|Screening Failures|0|||
162772555|NCT02374476|587876672|FG002|VT Induced Ablation|Screening Failures|0|||
162772556|NCT02374476|587876670|FG000|Arm Assignment|Withdrawal by Subject|0|||
162772557|NCT02374476|587876671|FG001|Arm Assignment|Withdrawal by Subject|0|||
162772558|NCT02374476|587876672|FG002|Arm Assignment|Withdrawal by Subject|1|||
162772559|NCT05431543|587876677|FG000|Overall Study|Medical History|1|||
162772560|NCT05431543|587876678|FG001|Overall Study|Medical History|0|||
162772561|NCT05431543|587876679|FG002|Overall Study|Medical History|0|||
162772562|NCT02924051|587876680|FG000|Overall Study|Withdrawal by Subject|1|||
162772563|NCT02924051|587876681|FG001|Overall Study|Withdrawal by Subject|9|||
162772564|NCT02784535|587876682|FG000|Overall Study|Adverse Event|1|||
162772565|NCT02784535|587876683|FG001|Overall Study|Adverse Event|0|||
162772566|NCT02784535|587876682|FG000|Overall Study|Withdrawal by Subject|0|||
162772567|NCT02784535|587876683|FG001|Overall Study|Withdrawal by Subject|1|||
162772568|NCT02784535|587876682|FG000|Overall Study|Physician Decision|0|||
162772569|NCT02784535|587876683|FG001|Overall Study|Physician Decision|1|||
162772570|NCT00914732|587876684|FG000|Overall Study|Lost to Follow-up|6|||
162772571|NCT00914732|587876685|FG001|Overall Study|Lost to Follow-up|7|||
162772572|NCT00914732|587876686|FG002|Overall Study|Lost to Follow-up|9|||
162772573|NCT00914732|587876684|FG000|Overall Study|Withdrawal by Subject|3|||
162772574|NCT00914732|587876685|FG001|Overall Study|Withdrawal by Subject|0|||
162772575|NCT00914732|587876686|FG002|Overall Study|Withdrawal by Subject|2|||
162772576|NCT00914732|587876684|FG000|Overall Study|Adverse Event|1|||
162772577|NCT00914732|587876685|FG001|Overall Study|Adverse Event|0|||
162772578|NCT00914732|587876686|FG002|Overall Study|Adverse Event|0|||
162772579|NCT02130401|587876687|FG000|Overall Study|Poor enrollment|6|||
162772580|NCT03005106|587876688|FG000|Overall Study|Lost to Follow-up|16|||
162772581|NCT03005106|587876688|FG000|Overall Study|Adverse Event|1|||
162772582|NCT03005106|587876688|FG000|Overall Study|Physician Decision|1|||
162772583|NCT03005106|587876688|FG000|Overall Study|Death|2|||
162772584|NCT00321672|587876691|FG000|Overall Study|Withdrawal by Subject|5|||
162772585|NCT00321672|587876692|FG001|Overall Study|Withdrawal by Subject|1|||
162772586|NCT00321672|587876693|FG002|Overall Study|Withdrawal by Subject|2|||
162772587|NCT00321672|587876694|FG003|Overall Study|Withdrawal by Subject|0|||
162772588|NCT00321672|587876691|FG000|Overall Study|Noncompliance|1|||
162772589|NCT00321672|587876692|FG001|Overall Study|Noncompliance|2|||
162772590|NCT00321672|587876693|FG002|Overall Study|Noncompliance|1|||
162772591|NCT00321672|587876694|FG003|Overall Study|Noncompliance|0|||
162772592|NCT00321672|587876691|FG000|Overall Study|Adverse Event|1|||
162772593|NCT00321672|587876692|FG001|Overall Study|Adverse Event|1|||
162772594|NCT00321672|587876693|FG002|Overall Study|Adverse Event|0|||
162772595|NCT00321672|587876694|FG003|Overall Study|Adverse Event|0|||
162772596|NCT00321672|587876691|FG000|Overall Study|Lack of Efficacy|1|||
162772597|NCT00321672|587876692|FG001|Overall Study|Lack of Efficacy|1|||
162772598|NCT00321672|587876693|FG002|Overall Study|Lack of Efficacy|0|||
162772599|NCT00321672|587876694|FG003|Overall Study|Lack of Efficacy|0|||
162772600|NCT00321672|587876691|FG000|Overall Study|Lost to Follow-up|2|||
162772601|NCT00321672|587876692|FG001|Overall Study|Lost to Follow-up|0|||
162772602|NCT00321672|587876693|FG002|Overall Study|Lost to Follow-up|4|||
162772603|NCT00321672|587876694|FG003|Overall Study|Lost to Follow-up|2|||
162772604|NCT00321672|587876691|FG000|Overall Study|Death|1|||
162772605|NCT00321672|587876692|FG001|Overall Study|Death|0|||
162772606|NCT00321672|587876693|FG002|Overall Study|Death|0|||
162772607|NCT00321672|587876694|FG003|Overall Study|Death|0|||
162772608|NCT00321672|587876691|FG000|Overall Study|Too far to travel for visits|1|||
162772609|NCT00321672|587876692|FG001|Overall Study|Too far to travel for visits|0|||
162772610|NCT00321672|587876693|FG002|Overall Study|Too far to travel for visits|0|||
162772611|NCT00321672|587876694|FG003|Overall Study|Too far to travel for visits|0|||
162772612|NCT00321672|587876691|FG000|Overall Study|Incarcerated|0|||
162772613|NCT00321672|587876692|FG001|Overall Study|Incarcerated|0|||
162772614|NCT00321672|587876693|FG002|Overall Study|Incarcerated|2|||
162772615|NCT00321672|587876694|FG003|Overall Study|Incarcerated|0|||
162772616|NCT00321672|587876691|FG000|Overall Study|Moved out of state|0|||
162772617|NCT00321672|587876692|FG001|Overall Study|Moved out of state|1|||
162772618|NCT00321672|587876693|FG002|Overall Study|Moved out of state|1|||
162772619|NCT00321672|587876694|FG003|Overall Study|Moved out of state|0|||
162772620|NCT00321672|587876691|FG000|Overall Study|Protocol Violation|0|||
162772621|NCT00321672|587876692|FG001|Overall Study|Protocol Violation|0|||
162772622|NCT00321672|587876693|FG002|Overall Study|Protocol Violation|1|||
162772623|NCT00321672|587876694|FG003|Overall Study|Protocol Violation|0|||
162772624|NCT00321672|587876691|FG000|Overall Study|Diagnosis of testicular cancer|0|||
162772625|NCT00321672|587876692|FG001|Overall Study|Diagnosis of testicular cancer|1|||
162772626|NCT00321672|587876693|FG002|Overall Study|Diagnosis of testicular cancer|0|||
162772627|NCT00321672|587876694|FG003|Overall Study|Diagnosis of testicular cancer|0|||
162772628|NCT00321672|587876691|FG000|Overall Study|Extensive travel required for new job|0|||
162772629|NCT00321672|587876692|FG001|Overall Study|Extensive travel required for new job|1|||
162772630|NCT00321672|587876693|FG002|Overall Study|Extensive travel required for new job|0|||
162772631|NCT00321672|587876694|FG003|Overall Study|Extensive travel required for new job|0|||
162772632|NCT00512902|587876695|FG000|Overall Study|Adverse Event|7|||
162772633|NCT00512902|587876695|FG000|Overall Study|Lost to Follow-up|1|||
162772634|NCT03019289|587876696|FG000|Overall Study|Adverse Event|1|||
162772635|NCT03019289|587876697|FG001|Overall Study|Adverse Event|0|||
162772636|NCT03019289|587876698|FG002|Overall Study|Adverse Event|0|||
162772637|NCT03019289|587876699|FG003|Overall Study|Adverse Event|0|||
162772638|NCT03019289|587876700|FG004|Overall Study|Adverse Event|0|||
162772639|NCT03019289|587876701|FG005|Overall Study|Adverse Event|0|||
162772640|NCT03019289|587876702|FG006|Overall Study|Adverse Event|0|||
162772641|NCT03019289|587876703|FG007|Overall Study|Adverse Event|0|||
162772642|NCT03019289|587876704|FG008|Overall Study|Adverse Event|1|||
162772643|NCT03019289|587876696|FG000|Overall Study|Other|1|||
162772644|NCT03019289|587876697|FG001|Overall Study|Other|0|||
162772645|NCT03019289|587876698|FG002|Overall Study|Other|0|||
162772646|NCT03019289|587876699|FG003|Overall Study|Other|0|||
162772647|NCT03019289|587876700|FG004|Overall Study|Other|0|||
162772648|NCT03019289|587876701|FG005|Overall Study|Other|0|||
162772649|NCT03019289|587876702|FG006|Overall Study|Other|0|||
162772650|NCT03019289|587876703|FG007|Overall Study|Other|0|||
162772651|NCT03019289|587876704|FG008|Overall Study|Other|0|||
162772652|NCT02389894|587876705|FG000|Overall Study|Death|4|||
162772653|NCT02389894|587876706|FG001|Overall Study|Death|5|||
162772654|NCT02389894|587876707|FG002|Overall Study|Death|3|||
162772655|NCT02389894|587876705|FG000|Overall Study|Withdrawal by Subject|2|||
162772656|NCT02389894|587876706|FG001|Overall Study|Withdrawal by Subject|4|||
162772657|NCT02389894|587876707|FG002|Overall Study|Withdrawal by Subject|5|||
162772658|NCT02389894|587876705|FG000|Overall Study|Lost to Follow-up|2|||
162772659|NCT02389894|587876706|FG001|Overall Study|Lost to Follow-up|1|||
162772660|NCT02389894|587876707|FG002|Overall Study|Lost to Follow-up|1|||
162772661|NCT00145496|587876708|FG000|Overall Study|Adverse Event|42|||
162772662|NCT00145496|587876709|FG001|Overall Study|Adverse Event|30|||
162772663|NCT00145496|587876708|FG000|Overall Study|Lack of Efficacy|12|||
162772664|NCT00145496|587876709|FG001|Overall Study|Lack of Efficacy|7|||
162772665|NCT00145496|587876708|FG000|Overall Study|Withdrawal by Subject|32|||
162772666|NCT00145496|587876709|FG001|Overall Study|Withdrawal by Subject|26|||
162772667|NCT00145496|587876708|FG000|Overall Study|Lost to Follow-up|12|||
162772668|NCT00145496|587876709|FG001|Overall Study|Lost to Follow-up|5|||
162772669|NCT00145496|587876708|FG000|Overall Study|Other|25|||
162772670|NCT00145496|587876709|FG001|Overall Study|Other|13|||
162772671|NCT01429285|587876714|FG000|Overall Study|Protocol Violation|9|||
162772672|NCT01429285|587876715|FG001|Overall Study|Protocol Violation|4|||
162772673|NCT01429285|587876714|FG000|Overall Study|Missing Data|5|||
162772674|NCT01429285|587876715|FG001|Overall Study|Missing Data|3|||
162772675|NCT01429285|587876714|FG000|Overall Study|Erroneously Enrolled Twice|8|||
162772676|NCT01429285|587876715|FG001|Overall Study|Erroneously Enrolled Twice|2|||
162772677|NCT01334606|587876716|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
162772678|NCT02312245|587876717|FG000|Overall Study|Death|0|||
162772679|NCT02312245|587876718|FG001|Overall Study|Death|0|||
162772680|NCT02312245|587876719|FG002|Overall Study|Death|0|||
162772681|NCT02312245|587876720|FG003|Overall Study|Death|1|||
162772682|NCT02312245|587876717|FG000|Overall Study|Withdrawal by Subject|1|||
162772683|NCT02312245|587876718|FG001|Overall Study|Withdrawal by Subject|1|||
162772684|NCT02312245|587876719|FG002|Overall Study|Withdrawal by Subject|0|||
162772685|NCT02312245|587876720|FG003|Overall Study|Withdrawal by Subject|2|||
162772686|NCT02312245|587876717|FG000|Overall Study|Alternative Therapy|1|||
162772687|NCT02312245|587876718|FG001|Overall Study|Alternative Therapy|0|||
162772688|NCT02312245|587876719|FG002|Overall Study|Alternative Therapy|0|||
162772689|NCT02312245|587876720|FG003|Overall Study|Alternative Therapy|0|||
162772690|NCT02312245|587876717|FG000|Overall Study|Progression|0|||
162772691|NCT02312245|587876718|FG001|Overall Study|Progression|0|||
162772692|NCT02312245|587876719|FG002|Overall Study|Progression|0|||
162772693|NCT02312245|587876720|FG003|Overall Study|Progression|5|||
162772694|NCT02312245|587876717|FG000|Overall Study|Patient went to hospice|0|||
162772695|NCT02312245|587876718|FG001|Overall Study|Patient went to hospice|0|||
162772696|NCT02312245|587876719|FG002|Overall Study|Patient went to hospice|0|||
162772697|NCT02312245|587876720|FG003|Overall Study|Patient went to hospice|1|||
162772698|NCT02312245|587876717|FG000|Overall Study|Ineligible|1|||
162772699|NCT02312245|587876718|FG001|Overall Study|Ineligible|0|||
162772700|NCT02312245|587876719|FG002|Overall Study|Ineligible|0|||
162772701|NCT02312245|587876720|FG003|Overall Study|Ineligible|0|||
162772702|NCT00990314|587876723|FG000|Overall Study|Death|2|||
162772703|NCT00990314|587876723|FG000|Overall Study|Adverse Event|2|||
162772704|NCT00990314|587876723|FG000|Overall Study|Withdrawal by Subject|3|||
162772705|NCT00990314|587876723|FG000|Overall Study|Non-Compliance|1|||
162772706|NCT00990314|587876723|FG000|Overall Study|Physician Decision|3|||
162772707|NCT00990314|587876723|FG000|Overall Study|Lack of Efficacy|1|||
162772708|NCT02676778|587876730|FG000|Overall Study|Disease Progression|7|||
162772709|NCT02676778|587876731|FG001|Overall Study|Disease Progression|3|||
162772710|NCT02676778|587876732|FG002|Overall Study|Disease Progression|1|||
162772711|NCT02676778|587876730|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
162772712|NCT02676778|587876731|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
162772713|NCT02676778|587876732|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
162772714|NCT02676778|587876730|FG000|Overall Study|Withdrawal by Subject|3|||
162772715|NCT02676778|587876731|FG001|Overall Study|Withdrawal by Subject|2|||
162772716|NCT02676778|587876732|FG002|Overall Study|Withdrawal by Subject|0|||
162772717|NCT02676778|587876730|FG000|Overall Study|Other|4|||
162772718|NCT02676778|587876731|FG001|Overall Study|Other|3|||
162772719|NCT02676778|587876732|FG002|Overall Study|Other|0|||
162772720|NCT02676778|587876730|FG000|Overall Study|Adverse Event|2|||
162772721|NCT02676778|587876731|FG001|Overall Study|Adverse Event|3|||
162772722|NCT02676778|587876732|FG002|Overall Study|Adverse Event|0|||
162772723|NCT01288729|587876737|FG000|Overall Study|Withdrawal by Subject|1|||
162772724|NCT01288729|587876738|FG001|Overall Study|Withdrawal by Subject|0|||
162772725|NCT03214198|587876739|FG000|Overall Study|Case Report Forms Uncollected|18|||
162772726|NCT03214198|587876739|FG000|Overall Study|Protocol Deviation|18|||
162772727|NCT03686176|587876740|FG000|Overall Study|Procedure cancelled|1|||
162772728|NCT03686176|587876741|FG001|Overall Study|Procedure cancelled|0|||
162772729|NCT03686176|587876742|FG002|Overall Study|Procedure cancelled|0|||
162772730|NCT03686176|587876740|FG000|Overall Study|VR Malfunction|1|||
162772731|NCT03686176|587876741|FG001|Overall Study|VR Malfunction|0|||
162772732|NCT03686176|587876742|FG002|Overall Study|VR Malfunction|0|||
162772733|NCT02442622|587876745|FG000|Overall Study|Withdrawal by Subject|3|||
162772734|NCT02442622|587876746|FG001|Overall Study|Withdrawal by Subject|1|||
162772735|NCT01732627|587878156|FG000|Overall Study|Withdrawal by Subject|1|||
162772736|NCT01732627|587878157|FG001|Overall Study|Withdrawal by Subject|0|||
162772737|NCT03541200|587878158|FG000|Overall Study|Adverse Event|19|||
162772738|NCT03541200|587878158|FG000|Overall Study|Death|1|||
162772739|NCT03541200|587878158|FG000|Overall Study|Lost to Follow-up|10|||
162772740|NCT03541200|587878158|FG000|Overall Study|Physician Decision|1|||
162772741|NCT03541200|587878158|FG000|Overall Study|Protocol Violation|51|||
162772742|NCT03541200|587878158|FG000|Overall Study|Withdrawal by Subject|23|||
162772743|NCT03541200|587878158|FG000|Overall Study|other|8|||
162772744|NCT02305797|587878159|FG000|Overall Study|Adverse Event|11|||
162772745|NCT02305797|587878160|FG001|Overall Study|Adverse Event|2|||
162772746|NCT02305797|587878159|FG000|Overall Study|Withdrawal by Subject|9|||
162772747|NCT02305797|587878160|FG001|Overall Study|Withdrawal by Subject|10|||
162772748|NCT02305797|587878159|FG000|Overall Study|Lack of Efficacy|6|||
162772749|NCT02305797|587878160|FG001|Overall Study|Lack of Efficacy|0|||
162772750|NCT02305797|587878159|FG000|Overall Study|Lost to Follow-up|5|||
162772751|NCT02305797|587878160|FG001|Overall Study|Lost to Follow-up|11|||
162772752|NCT02305797|587878159|FG000|Overall Study|Pregnancy|0|||
162772753|NCT02305797|587878160|FG001|Overall Study|Pregnancy|2|||
162772754|NCT02305797|587878159|FG000|Overall Study|Noncompliance|14|||
162772755|NCT02305797|587878160|FG001|Overall Study|Noncompliance|12|||
162772756|NCT02305797|587878159|FG000|Overall Study|Reason not collected|0|||
162772757|NCT02305797|587878160|FG001|Overall Study|Reason not collected|1|||
162772758|NCT01878253|587878166|FG000|Overall Study|Death|1|||
162772759|NCT01878253|587878166|FG000|Overall Study|SIdus System Removal|3|||
162772760|NCT01878253|587878166|FG000|Overall Study|Withdrawal by Subject|1|||
162772761|NCT01878253|587878166|FG000|Overall Study|Lost to Follow-up|2|||
162772762|NCT01878253|587878166|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
162772763|NCT00449033|587878171|FG000|Treatment Period|Adverse Event|117|||
162772764|NCT00449033|587878172|FG001|Treatment Period|Adverse Event|83|||
162772765|NCT00449033|587878171|FG000|Treatment Period|Death|21|||
162772766|NCT00449033|587878172|FG001|Treatment Period|Death|12|||
162772767|NCT00449033|587878171|FG000|Treatment Period|Lost to Follow-up|0|||
162772768|NCT00449033|587878172|FG001|Treatment Period|Lost to Follow-up|2|||
162772769|NCT00449033|587878171|FG000|Treatment Period|Physician Decision|4|||
162772770|NCT00449033|587878172|FG001|Treatment Period|Physician Decision|5|||
162772771|NCT00449033|587878171|FG000|Treatment Period|Protocol Violation|8|||
162772772|NCT00449033|587878172|FG001|Treatment Period|Protocol Violation|7|||
162772773|NCT00449033|587878171|FG000|Treatment Period|Disease Progression|231|||
162772774|NCT00449033|587878172|FG001|Treatment Period|Disease Progression|288|||
162772775|NCT00449033|587878171|FG000|Treatment Period|Consent Withdrawn|36|||
162772776|NCT00449033|587878172|FG001|Treatment Period|Consent Withdrawn|20|||
162772777|NCT00449033|587878171|FG000|Treatment Period|Amended Protocol Criteria|22|||
162772778|NCT00449033|587878172|FG001|Treatment Period|Amended Protocol Criteria|18|||
162772779|NCT00449033|587878171|FG000|Treatment Period|Non-compliance|7|||
162772780|NCT00449033|587878172|FG001|Treatment Period|Non-compliance|8|||
162772781|NCT00449033|587878171|FG000|Treatment Period|Second Malignancy|0|||
162772782|NCT00449033|587878172|FG001|Treatment Period|Second Malignancy|1|||
162772783|NCT00449033|587878171|FG000|Treatment Period|Reason Missing|0|||
162772784|NCT00449033|587878172|FG001|Treatment Period|Reason Missing|4|||
162772785|NCT00449033|587878171|FG000|Treatment Period|Treatment Ongoing|6|||
162772786|NCT00449033|587878172|FG001|Treatment Period|Treatment Ongoing|4|||
162772787|NCT00449033|587878171|FG000|Follow-up Period|Death|299|||
162772788|NCT00449033|587878172|FG001|Follow-up Period|Death|311|||
162772789|NCT00449033|587878171|FG000|Follow-up Period|Lost to Follow-up|6|||
162772790|NCT00449033|587878172|FG001|Follow-up Period|Lost to Follow-up|10|||
162772791|NCT00449033|587878171|FG000|Follow-up Period|Reason Missing|120|||
162772792|NCT00449033|587878172|FG001|Follow-up Period|Reason Missing|113|||
162772793|NCT03802513|587878173|FG000|Overall Study|Lost to Follow-up|1|||
162772794|NCT01190228|587878174|FG000|Overall Study|Protocol Violation|4|||
162772795|NCT01190228|587878175|FG001|Overall Study|Protocol Violation|0|||
162772796|NCT01190228|587878176|FG002|Overall Study|Protocol Violation|0|||
162772797|NCT01190228|587878174|FG000|Overall Study|Withdrawal by Subject|1|||
162772798|NCT01190228|587878175|FG001|Overall Study|Withdrawal by Subject|0|||
162772799|NCT01190228|587878176|FG002|Overall Study|Withdrawal by Subject|0|||
162772800|NCT01395914|587878182|FG000|Overall Study|Unrelated to study drug AE|6|||
162772801|NCT01395914|587878183|FG001|Overall Study|Unrelated to study drug AE|1|||
162772802|NCT01395914|587878182|FG000|Overall Study|Death|23|||
162772803|NCT01395914|587878183|FG001|Overall Study|Death|17|||
162772804|NCT01395914|587878182|FG000|Overall Study|Other|9|||
162772805|NCT01395914|587878183|FG001|Overall Study|Other|3|||
162772806|NCT01395914|587878182|FG000|Overall Study|Withdrawal by patient|27|||
162772807|NCT01395914|587878183|FG001|Overall Study|Withdrawal by patient|14|||
162772808|NCT01395914|587878182|FG000|Overall Study|Study drug-related AE|1|||
162772809|NCT01395914|587878183|FG001|Overall Study|Study drug-related AE|0|||
162772810|NCT01395914|587878182|FG000|Overall Study|Lost to Follow-up|6|||
162772811|NCT01395914|587878183|FG001|Overall Study|Lost to Follow-up|2|||
162772812|NCT01648699|587878184|FG000|Overall Study|Death|1|||
162772813|NCT01648699|587878184|FG000|Overall Study|Lost to Follow-up|2|||
162772814|NCT01648699|587878184|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
162772815|NCT04930445|587878186|FG000|Overall Study|Adverse Event|7|||
162772816|NCT04930445|587878186|FG000|Overall Study|Lost to Follow-up|1|||
162772817|NCT04930445|587878186|FG000|Overall Study|Physician Decision|1|||
162772818|NCT04930445|587878186|FG000|Overall Study|Lack of Efficacy|1|||
162772819|NCT04930445|587878186|FG000|Overall Study|Study Terminated by Sponsor|245|||
162772820|NCT04930445|587878186|FG000|Overall Study|Screen Failure|8|||
162772821|NCT04930445|587878186|FG000|Overall Study|Other|2|||
162772822|NCT00975130|587878187|FG000|Study Part 1|Adverse Event|150|||
162772823|NCT00975130|587878188|FG001|Study Part 1|Adverse Event|0|||
162772824|NCT00975130|587878189|FG002|Study Part 1|Adverse Event|0|||
162772825|NCT00975130|587878187|FG000|Study Part 1|Lost to Follow-up|19|||
162772826|NCT00975130|587878188|FG001|Study Part 1|Lost to Follow-up|0|||
162772827|NCT00975130|587878189|FG002|Study Part 1|Lost to Follow-up|0|||
162772828|NCT00975130|587878187|FG000|Study Part 1|Withdrawal by Subject|61|||
162772829|NCT00975130|587878188|FG001|Study Part 1|Withdrawal by Subject|0|||
162772830|NCT00975130|587878189|FG002|Study Part 1|Withdrawal by Subject|0|||
162772831|NCT00975130|587878187|FG000|Study Part 1|Protocol Violation|13|||
162772832|NCT00975130|587878188|FG001|Study Part 1|Protocol Violation|0|||
162772833|NCT00975130|587878189|FG002|Study Part 1|Protocol Violation|0|||
162772834|NCT00975130|587878187|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
162772835|NCT00975130|587878188|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
162772836|NCT00975130|587878189|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
162772837|NCT00975130|587878187|FG000|Study Part 1|Administrative|4|||
162772838|NCT00975130|587878188|FG001|Study Part 1|Administrative|0|||
162772839|NCT00975130|587878189|FG002|Study Part 1|Administrative|0|||
162772840|NCT00975130|587878187|FG000|Study Part 1|Withdrew Consent|24|||
162772841|NCT00975130|587878188|FG001|Study Part 1|Withdrew Consent|0|||
162772842|NCT00975130|587878189|FG002|Study Part 1|Withdrew Consent|0|||
162772843|NCT00975130|587878187|FG000|Study Part 2|Adverse Event|0|||
162772844|NCT00975130|587878188|FG001|Study Part 2|Adverse Event|14|||
162772845|NCT00975130|587878189|FG002|Study Part 2|Adverse Event|7|||
162772846|NCT00975130|587878187|FG000|Study Part 2|Lost to Follow-up|0|||
162772847|NCT00975130|587878188|FG001|Study Part 2|Lost to Follow-up|0|||
162772848|NCT00975130|587878189|FG002|Study Part 2|Lost to Follow-up|1|||
162772849|NCT00975130|587878187|FG000|Study Part 2|Withdrawal by Subject|0|||
162772850|NCT00975130|587878188|FG001|Study Part 2|Withdrawal by Subject|13|||
162772851|NCT00975130|587878189|FG002|Study Part 2|Withdrawal by Subject|5|||
162772852|NCT00975130|587878187|FG000|Study Part 2|Withdrew Consent|0|||
162772853|NCT00975130|587878188|FG001|Study Part 2|Withdrew Consent|6|||
162772854|NCT00975130|587878189|FG002|Study Part 2|Withdrew Consent|2|||
162772855|NCT00975130|587878187|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
162772856|NCT00975130|587878188|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
162772857|NCT00975130|587878189|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
162772858|NCT00975130|587878187|FG000|Study Part 2|Administrative|0|||
162772859|NCT00975130|587878188|FG001|Study Part 2|Administrative|1|||
162772860|NCT00975130|587878189|FG002|Study Part 2|Administrative|0|||
162772861|NCT00975130|587878187|FG000|Study Part 2|Protocol Violation|0|||
162772862|NCT00975130|587878188|FG001|Study Part 2|Protocol Violation|0|||
162772863|NCT00975130|587878189|FG002|Study Part 2|Protocol Violation|1|||
162772864|NCT01261793|587878190|FG000|Overall Study|Lack of Efficacy|44|||
162772865|NCT01261793|587878191|FG001|Overall Study|Lack of Efficacy|37|||
162772866|NCT01261793|587878192|FG002|Overall Study|Lack of Efficacy|32|||
162772867|NCT01261793|587878190|FG000|Overall Study|Protocol Violation|3|||
162772868|NCT01261793|587878191|FG001|Overall Study|Protocol Violation|5|||
162772869|NCT01261793|587878192|FG002|Overall Study|Protocol Violation|6|||
162772870|NCT01261793|587878190|FG000|Overall Study|Lost to Follow-up|10|||
162772871|NCT01261793|587878191|FG001|Overall Study|Lost to Follow-up|3|||
162772872|NCT01261793|587878192|FG002|Overall Study|Lost to Follow-up|7|||
162772873|NCT01261793|587878190|FG000|Overall Study|Withdrawal by Subject|12|||
162772874|NCT01261793|587878191|FG001|Overall Study|Withdrawal by Subject|14|||
162772875|NCT01261793|587878192|FG002|Overall Study|Withdrawal by Subject|14|||
162772876|NCT01261793|587878190|FG000|Overall Study|Death|3|||
162772877|NCT01261793|587878191|FG001|Overall Study|Death|1|||
162772878|NCT01261793|587878192|FG002|Overall Study|Death|0|||
162772879|NCT01261793|587878190|FG000|Overall Study|Adverse Event|9|||
162772880|NCT01261793|587878191|FG001|Overall Study|Adverse Event|24|||
162772881|NCT01261793|587878192|FG002|Overall Study|Adverse Event|19|||
162772882|NCT01261793|587878190|FG000|Overall Study|Patient non-availability|1|||
162772883|NCT01261793|587878191|FG001|Overall Study|Patient non-availability|1|||
162772884|NCT01261793|587878192|FG002|Overall Study|Patient non-availability|1|||
162772885|NCT01261793|587878190|FG000|Overall Study|Suspected pregnancy|1|||
162772886|NCT01261793|587878191|FG001|Overall Study|Suspected pregnancy|1|||
162772887|NCT01261793|587878192|FG002|Overall Study|Suspected pregnancy|0|||
162772888|NCT01261793|587878190|FG000|Overall Study|Patient non-compliance|1|||
162772889|NCT01261793|587878191|FG001|Overall Study|Patient non-compliance|0|||
162772890|NCT01261793|587878192|FG002|Overall Study|Patient non-compliance|1|||
162772891|NCT01261793|587878190|FG000|Overall Study|Patient pregnant|1|||
162772892|NCT01261793|587878191|FG001|Overall Study|Patient pregnant|0|||
162772893|NCT01261793|587878192|FG002|Overall Study|Patient pregnant|0|||
162772894|NCT01261793|587878190|FG000|Overall Study|Outside the study area|0|||
162772895|NCT01261793|587878191|FG001|Overall Study|Outside the study area|2|||
162772896|NCT01261793|587878192|FG002|Overall Study|Outside the study area|1|||
162772897|NCT01261793|587878190|FG000|Overall Study|Lack of efficacy & patient not available|0|||
162772898|NCT01261793|587878191|FG001|Overall Study|Lack of efficacy & patient not available|1|||
162772899|NCT01261793|587878192|FG002|Overall Study|Lack of efficacy & patient not available|0|||
162772900|NCT01261793|587878190|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
162772901|NCT01261793|587878191|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
162772902|NCT01261793|587878192|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
162772903|NCT01261793|587878190|FG000|Overall Study|Randomization error|0|||
162772904|NCT01261793|587878191|FG001|Overall Study|Randomization error|1|||
162772905|NCT01261793|587878192|FG002|Overall Study|Randomization error|0|||
162772906|NCT01261793|587878190|FG000|Overall Study|Patient unable to start IV line|0|||
162772907|NCT01261793|587878191|FG001|Overall Study|Patient unable to start IV line|0|||
162772908|NCT01261793|587878192|FG002|Overall Study|Patient unable to start IV line|1|||
162772909|NCT03219216|587878193|FG000|Overall Study|Lost to Follow-up|0|||
162772910|NCT03219216|587878194|FG001|Overall Study|Lost to Follow-up|1|||
162772911|NCT03305458|587878195|FG000|Overall Study|Withdrawal by Subject|50|||
162772912|NCT03305458|587878196|FG001|Overall Study|Withdrawal by Subject|46|||
162772913|NCT03305458|587878197|FG002|Overall Study|Withdrawal by Subject|93|||
162772914|NCT03305458|587878195|FG000|Overall Study|Lost to Follow-up|85|||
162772915|NCT03305458|587878196|FG001|Overall Study|Lost to Follow-up|85|||
162772916|NCT03305458|587878197|FG002|Overall Study|Lost to Follow-up|35|||
162772917|NCT05615870|587878202|FG000|Overall Study|Lost to Follow-up|10|||
162772918|NCT05615870|587878203|FG001|Overall Study|Lost to Follow-up|13|||
162772919|NCT05615870|587878202|FG000|Overall Study|Physician Decision|2|||
162772920|NCT05615870|587878203|FG001|Overall Study|Physician Decision|0|||
162772921|NCT05615870|587878202|FG000|Overall Study|Withdrawal by Subject|0|||
162772922|NCT05615870|587878203|FG001|Overall Study|Withdrawal by Subject|2|||
162772923|NCT05615870|587878202|FG000|Overall Study|Protocol Violation|0|||
162772924|NCT05615870|587878203|FG001|Overall Study|Protocol Violation|3|||
162772925|NCT05615870|587878202|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
162772926|NCT05615870|587878203|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
162772927|NCT05615870|587878202|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
162772928|NCT05615870|587878203|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
162772929|NCT05615870|587878202|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
162772930|NCT05615870|587878203|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
162772931|NCT03520036|587878206|FG000|Overall Study|Adverse Event|1|||
162772932|NCT03520036|587878207|FG001|Overall Study|Adverse Event|2|||
162772933|NCT03520036|587878208|FG002|Overall Study|Adverse Event|0|||
162772934|NCT03520036|587878206|FG000|Overall Study|Protocol Violation|1|||
162772935|NCT03520036|587878207|FG001|Overall Study|Protocol Violation|0|||
162772936|NCT03520036|587878208|FG002|Overall Study|Protocol Violation|0|||
162772937|NCT03520036|587878206|FG000|Overall Study|Withdrawal by Subject|0|||
162772938|NCT03520036|587878207|FG001|Overall Study|Withdrawal by Subject|1|||
162772939|NCT03520036|587878208|FG002|Overall Study|Withdrawal by Subject|4|||
162772940|NCT03520036|587878206|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
162772941|NCT03520036|587878207|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
162772942|NCT03520036|587878208|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
162772943|NCT01855399|587878209|FG000|6 Month|Lost to Follow-up|12|||
162772944|NCT01855399|587878210|FG001|6 Month|Lost to Follow-up|9|||
162772945|NCT01855399|587878209|FG000|6 Month|Withdrawal by Subject|8|||
162772946|NCT01855399|587878210|FG001|6 Month|Withdrawal by Subject|6|||
162772947|NCT01855399|587878209|FG000|12 Month|Lost to Follow-up|7|||
162772948|NCT01855399|587878210|FG001|12 Month|Lost to Follow-up|11|||
162772949|NCT04743999|587878211|FG000|3-month Questionnaire|Death|1|||
162772950|NCT04743999|587878211|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
162772951|NCT04743999|587878211|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
162772952|NCT04743999|587878211|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
162772953|NCT01721759|587878212|FG000|Treatment Period|Disease Progression|85|||
162772954|NCT01721759|587878212|FG000|Treatment Period|Study drug toxicity|14|||
162772955|NCT01721759|587878212|FG000|Treatment Period|Death|1|||
162772956|NCT01721759|587878212|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
162772957|NCT01721759|587878212|FG000|Treatment Period|Participant request to withdraw|3|||
162772958|NCT01721759|587878212|FG000|Treatment Period|Other Reasons|3|||
162772959|NCT01721759|587878212|FG000|End of Study Period|Participant Withdrew Consent|5|||
162772960|NCT01721759|587878212|FG000|End of Study Period|Death|101|||
162772961|NCT01721759|587878212|FG000|End of Study Period|Lost to Follow-up|1|||
162772962|NCT01721759|587878212|FG000|End of Study Period|Other Reasons|10|||
162772963|NCT03926117|587878213|FG000|Overall Study|Unclassified|1|||
162772964|NCT03926117|587878214|FG001|Overall Study|Unclassified|4|||
162772965|NCT03926117|587878215|FG002|Overall Study|Unclassified|1|||
162772966|NCT03926117|587878216|FG003|Overall Study|Unclassified|4|||
162772967|NCT03926117|587878213|FG000|Overall Study|Withdrawal by Subject|3|||
162772968|NCT03926117|587878214|FG001|Overall Study|Withdrawal by Subject|0|||
162772969|NCT03926117|587878215|FG002|Overall Study|Withdrawal by Subject|1|||
162772970|NCT03926117|587878216|FG003|Overall Study|Withdrawal by Subject|1|||
162772971|NCT03926117|587878213|FG000|Overall Study|Lost to Follow-up|0|||
162772972|NCT03926117|587878214|FG001|Overall Study|Lost to Follow-up|2|||
162772973|NCT03926117|587878215|FG002|Overall Study|Lost to Follow-up|1|||
162772974|NCT03926117|587878216|FG003|Overall Study|Lost to Follow-up|0|||
162772975|NCT03926117|587878213|FG000|Overall Study|Adverse Event|1|||
162772976|NCT03926117|587878214|FG001|Overall Study|Adverse Event|2|||
162772977|NCT03926117|587878215|FG002|Overall Study|Adverse Event|3|||
162772978|NCT03926117|587878216|FG003|Overall Study|Adverse Event|1|||
162772979|NCT03926117|587878213|FG000|Overall Study|Randomized but not treated|1|||
162772980|NCT03926117|587878214|FG001|Overall Study|Randomized but not treated|1|||
162772981|NCT03926117|587878215|FG002|Overall Study|Randomized but not treated|0|||
162772982|NCT03926117|587878216|FG003|Overall Study|Randomized but not treated|1|||
162772983|NCT03138499|587878217|FG000|Overall Study|Lost to Follow-up|1|||
162772984|NCT03138499|587878218|FG001|Overall Study|Lost to Follow-up|0|||
162772985|NCT03138499|587878217|FG000|Overall Study|Participants withdrew consent|1|||
162772986|NCT03138499|587878218|FG001|Overall Study|Participants withdrew consent|0|||
162772987|NCT03138499|587878217|FG000|Overall Study|Participant discontinued study before treatment|0|||
162772988|NCT03138499|587878218|FG001|Overall Study|Participant discontinued study before treatment|1|||
162772989|NCT03138499|587878217|FG000|Overall Study|Disease Progression|2|||
162772990|NCT03138499|587878218|FG001|Overall Study|Disease Progression|6|||
162772991|NCT03138499|587878217|FG000|Overall Study|Study drug toxicity|2|||
162772992|NCT03138499|587878218|FG001|Overall Study|Study drug toxicity|2|||
162772993|NCT03138499|587878217|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162772994|NCT03138499|587878218|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162772995|NCT03138499|587878217|FG000|Overall Study|Other reasons|2|||
162772996|NCT03138499|587878218|FG001|Overall Study|Other reasons|0|||
162772997|NCT01123200|587878219|FG000|Overall Study|Withdrawal by Subject|1|||
162772998|NCT02577315|587878222|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162772999|NCT02577315|587878223|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
162773000|NCT01636778|587878226|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
162773001|NCT01636778|587878227|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
162773002|NCT01636778|587878228|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
162773003|NCT01636778|587878226|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
162773004|NCT01636778|587878227|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
162773005|NCT01636778|587878228|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
162773006|NCT01636778|587878226|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
162773007|NCT01636778|587878227|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
162773008|NCT01636778|587878228|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
162773009|NCT01636778|587878226|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
162773010|NCT01636778|587878227|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
162773011|NCT01636778|587878228|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
162773012|NCT01636778|587878226|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
162773013|NCT01636778|587878227|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
162773014|NCT01636778|587878228|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
162773015|NCT01636778|587878226|FG000|Follow-up Period After Part 2|Other|0|||
162773016|NCT01636778|587878227|FG001|Follow-up Period After Part 2|Other|0|||
162773017|NCT01636778|587878228|FG002|Follow-up Period After Part 2|Other|1|||
162773018|NCT01636778|587878226|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
162773019|NCT01636778|587878227|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
162773020|NCT01636778|587878228|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
162773021|NCT01636778|587878226|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
162773022|NCT01636778|587878227|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
162773023|NCT01636778|587878228|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
162773024|NCT00990821|587878232|FG000|Overall Study|Withdrawal by Subject|0|||
162773025|NCT00990821|587878233|FG001|Overall Study|Withdrawal by Subject|2|||
162773026|NCT00990821|587878234|FG002|Overall Study|Withdrawal by Subject|0|||
162773027|NCT00990821|587878235|FG003|Overall Study|Withdrawal by Subject|0|||
162773028|NCT00990821|587878236|FG004|Overall Study|Withdrawal by Subject|3|||
162773029|NCT00990821|587878237|FG005|Overall Study|Withdrawal by Subject|3|||
162773030|NCT00990821|587878238|FG006|Overall Study|Withdrawal by Subject|1|||
162773031|NCT00990821|587878239|FG007|Overall Study|Withdrawal by Subject|0|||
162773032|NCT00990821|587878240|FG008|Overall Study|Withdrawal by Subject|0|||
162773033|NCT00990821|587878241|FG009|Overall Study|Withdrawal by Subject|1|||
162773034|NCT00990821|587878242|FG010|Overall Study|Withdrawal by Subject|3|||
162773035|NCT00990821|587878243|FG011|Overall Study|Withdrawal by Subject|5|||
162773036|NCT00990821|587878244|FG012|Overall Study|Withdrawal by Subject|2|||
162773037|NCT00990821|587878245|FG013|Overall Study|Withdrawal by Subject|1|||
162773038|NCT03530345|587878246|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162773039|NCT03530345|587878247|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
162773040|NCT03530345|587878246|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
162773041|NCT03530345|587878247|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
162773042|NCT03530345|587878246|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
162773043|NCT03530345|587878247|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
162773044|NCT03530345|587878246|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
162773045|NCT03530345|587878247|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
162773046|NCT00170950|587878250|FG000|Overall Study|Death|236|||
162773047|NCT00170950|587878251|FG001|Overall Study|Death|274|||
162773048|NCT00170950|587878250|FG000|Overall Study|Withdrawal by Subject|496|||
162773049|NCT00170950|587878251|FG001|Overall Study|Withdrawal by Subject|498|||
162773050|NCT00170950|587878250|FG000|Overall Study|Lost to Follow-up|134|||
162773051|NCT00170950|587878251|FG001|Overall Study|Lost to Follow-up|115|||
162773052|NCT00170950|587878250|FG000|Overall Study|Missing|2|||
162773053|NCT00170950|587878251|FG001|Overall Study|Missing|1|||
162773054|NCT00170950|587878250|FG000|Overall Study|Termination Data Not Recorded|17|||
162773055|NCT00170950|587878251|FG001|Overall Study|Termination Data Not Recorded|22|||
162773056|NCT00748098|587878252|FG000|First Treatment Intervention Period|Adverse Event|1|||
162773057|NCT00748098|587878253|FG001|First Treatment Intervention Period|Adverse Event|1|||
162773058|NCT00748098|587878252|FG000|First Treatment Intervention Period|Protocol Violation|1|||
162773059|NCT00748098|587878253|FG001|First Treatment Intervention Period|Protocol Violation|0|||
162773060|NCT00748098|587878252|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
162773061|NCT00748098|587878253|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
162773062|NCT00748098|587878252|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
162773063|NCT00748098|587878253|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
162773064|NCT00748098|587878252|FG000|First Taper Period|Protocol Violation|1|||
162773065|NCT00748098|587878253|FG001|First Taper Period|Protocol Violation|0|||
162773066|NCT00748098|587878252|FG000|First Taper Period|Withdrawal by Subject|2|||
162773067|NCT00748098|587878253|FG001|First Taper Period|Withdrawal by Subject|0|||
162773068|NCT00748098|587878252|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
162773069|NCT00748098|587878253|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
162773070|NCT00748098|587878252|FG000|1-Week Washout Period|Adverse Event|0|||
162773071|NCT00748098|587878253|FG001|1-Week Washout Period|Adverse Event|1|||
162773072|NCT00748098|587878252|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
162773073|NCT00748098|587878253|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
162773074|NCT00748098|587878252|FG000|Second Treatment Intervention Period|Adverse Event|4|||
162773075|NCT00748098|587878253|FG001|Second Treatment Intervention Period|Adverse Event|1|||
162773076|NCT00748098|587878252|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
162773077|NCT00748098|587878253|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
162773078|NCT00748098|587878252|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
162773079|NCT00748098|587878253|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
162773080|NCT02938520|587878256|FG000|Overall Study|On-going at the time of analysis|258|||
162773081|NCT02938520|587878257|FG001|Overall Study|On-going at the time of analysis|261|||
162773082|NCT02938520|587878256|FG000|Overall Study|Physician Decision|2|||
162773083|NCT02938520|587878257|FG001|Overall Study|Physician Decision|5|||
162773084|NCT02938520|587878256|FG000|Overall Study|Lost to Follow-up|2|||
162773085|NCT02938520|587878257|FG001|Overall Study|Lost to Follow-up|2|||
162773086|NCT02938520|587878256|FG000|Overall Study|Withdrawal by Subject|7|||
162773087|NCT02938520|587878257|FG001|Overall Study|Withdrawal by Subject|7|||
162773088|NCT02938520|587878256|FG000|Overall Study|Protocol Violation|0|||
162773089|NCT02938520|587878257|FG001|Overall Study|Protocol Violation|1|||
162773090|NCT02938520|587878256|FG000|Overall Study|Lack of Efficacy|5|||
162773091|NCT02938520|587878257|FG001|Overall Study|Lack of Efficacy|3|||
162773092|NCT02938520|587878256|FG000|Overall Study|Adverse Event|9|||
162773093|NCT02938520|587878257|FG001|Overall Study|Adverse Event|4|||
162773094|NCT04448561|587878261|FG000|Overall Study|Noncompliance|1|||
162773095|NCT04448561|587878262|FG001|Overall Study|Noncompliance|0|||
162773096|NCT04816708|587879413|FG000|Overall Study|Lost to Follow-up|10|||
162773097|NCT04816708|587879414|FG001|Overall Study|Lost to Follow-up|4|||
162773098|NCT03596905|587879415|FG000|Overall Study|Protocol Violation|0|||
162773099|NCT03596905|587879416|FG001|Overall Study|Protocol Violation|0|||
162773100|NCT03596905|587879417|FG002|Overall Study|Protocol Violation|0|||
162773101|NCT03596905|587879418|FG003|Overall Study|Protocol Violation|0|||
162773102|NCT03596905|587879419|FG004|Overall Study|Protocol Violation|1|||
162773103|NCT03596905|587879420|FG005|Overall Study|Protocol Violation|0|||
162773104|NCT03596905|587879421|FG006|Overall Study|Protocol Violation|0|||
162773105|NCT03596905|587879415|FG000|Overall Study|Withdrawal by Subject|0|||
162773106|NCT03596905|587879416|FG001|Overall Study|Withdrawal by Subject|2|||
162773107|NCT03596905|587879417|FG002|Overall Study|Withdrawal by Subject|1|||
162773108|NCT03596905|587879418|FG003|Overall Study|Withdrawal by Subject|0|||
162773109|NCT03596905|587879419|FG004|Overall Study|Withdrawal by Subject|2|||
162773110|NCT03596905|587879420|FG005|Overall Study|Withdrawal by Subject|0|||
162773111|NCT03596905|587879421|FG006|Overall Study|Withdrawal by Subject|0|||
162773112|NCT03596905|587879415|FG000|Overall Study|Participant moved and was unable to complete study|0|||
162773113|NCT03596905|587879416|FG001|Overall Study|Participant moved and was unable to complete study|1|||
162773114|NCT03596905|587879417|FG002|Overall Study|Participant moved and was unable to complete study|0|||
162773115|NCT03596905|587879418|FG003|Overall Study|Participant moved and was unable to complete study|0|||
162773116|NCT03596905|587879419|FG004|Overall Study|Participant moved and was unable to complete study|0|||
162773117|NCT03596905|587879420|FG005|Overall Study|Participant moved and was unable to complete study|0|||
162773118|NCT03596905|587879421|FG006|Overall Study|Participant moved and was unable to complete study|0|||
162773119|NCT03596905|587879415|FG000|Overall Study|Adverse Event|0|||
162773120|NCT03596905|587879416|FG001|Overall Study|Adverse Event|0|||
162773121|NCT03596905|587879417|FG002|Overall Study|Adverse Event|0|||
162773122|NCT03596905|587879418|FG003|Overall Study|Adverse Event|0|||
162773123|NCT03596905|587879419|FG004|Overall Study|Adverse Event|0|||
162773124|NCT03596905|587879420|FG005|Overall Study|Adverse Event|0|||
162773125|NCT03596905|587879421|FG006|Overall Study|Adverse Event|1|||
162773126|NCT03596905|587879415|FG000|Overall Study|Non-Compliance with eDiary|1|||
162773127|NCT03596905|587879416|FG001|Overall Study|Non-Compliance with eDiary|0|||
162773128|NCT03596905|587879417|FG002|Overall Study|Non-Compliance with eDiary|0|||
162773129|NCT03596905|587879418|FG003|Overall Study|Non-Compliance with eDiary|0|||
162773130|NCT03596905|587879419|FG004|Overall Study|Non-Compliance with eDiary|1|||
162773131|NCT03596905|587879420|FG005|Overall Study|Non-Compliance with eDiary|0|||
162773132|NCT03596905|587879421|FG006|Overall Study|Non-Compliance with eDiary|2|||
162773133|NCT03596905|587879415|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162773134|NCT03596905|587879416|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162773135|NCT03596905|587879417|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162773136|NCT03596905|587879418|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162773137|NCT03596905|587879419|FG004|Overall Study|Non-Compliance with Study Drug|1|||
162773138|NCT03596905|587879420|FG005|Overall Study|Non-Compliance with Study Drug|0|||
162773139|NCT03596905|587879421|FG006|Overall Study|Non-Compliance with Study Drug|0|||
162773140|NCT03596905|587879415|FG000|Overall Study|Lost to Follow-up|0|||
162773141|NCT03596905|587879416|FG001|Overall Study|Lost to Follow-up|0|||
162773142|NCT03596905|587879417|FG002|Overall Study|Lost to Follow-up|0|||
162773143|NCT03596905|587879418|FG003|Overall Study|Lost to Follow-up|0|||
162773144|NCT03596905|587879419|FG004|Overall Study|Lost to Follow-up|0|||
162773145|NCT03596905|587879420|FG005|Overall Study|Lost to Follow-up|1|||
162773146|NCT03596905|587879421|FG006|Overall Study|Lost to Follow-up|0|||
162773147|NCT00508274|587879422|FG000|Overall Study|Adverse Event|5|||
162773148|NCT00508274|587879422|FG000|Overall Study|Death|7|||
162773149|NCT00508274|587879422|FG000|Overall Study|Disease progression|32|||
162773150|NCT00508274|587879422|FG000|Overall Study|Withdrawal by Subject|1|||
162773151|NCT00508274|587879422|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
162773152|NCT00508274|587879422|FG000|Overall Study|Missing|3|||
162773153|NCT00197106|587879423|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
162773154|NCT00197106|587879424|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
162773155|NCT00197106|587879425|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
162773156|NCT00197106|587879423|FG000|Overall Treatment Period|Lack of Efficacy|0|||
162773157|NCT00197106|587879424|FG001|Overall Treatment Period|Lack of Efficacy|1|||
162773158|NCT00197106|587879425|FG002|Overall Treatment Period|Lack of Efficacy|0|||
162773159|NCT00197106|587879423|FG000|Overall Treatment Period|Lost to Follow-up|0|||
162773160|NCT00197106|587879424|FG001|Overall Treatment Period|Lost to Follow-up|0|||
162773161|NCT00197106|587879425|FG002|Overall Treatment Period|Lost to Follow-up|2|||
162773162|NCT00197106|587879423|FG000|Overall Treatment Period|Protocol Violation|0|||
162773163|NCT00197106|587879424|FG001|Overall Treatment Period|Protocol Violation|0|||
162773164|NCT00197106|587879425|FG002|Overall Treatment Period|Protocol Violation|2|||
162773165|NCT00197106|587879423|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
162773166|NCT00197106|587879424|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
162773167|NCT00197106|587879425|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
162773168|NCT02531126|587879426|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
162773169|NCT02531126|587879427|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
162773170|NCT02531126|587879428|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
162773171|NCT02531126|587879429|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
162773172|NCT02531126|587879426|FG000|Overall Study|Adverse Event|16|||
162773173|NCT02531126|587879427|FG001|Overall Study|Adverse Event|13|||
162773174|NCT02531126|587879428|FG002|Overall Study|Adverse Event|27|||
162773175|NCT02531126|587879429|FG003|Overall Study|Adverse Event|4|||
162773176|NCT02531126|587879426|FG000|Overall Study|Lack of Efficacy|50|||
162773177|NCT02531126|587879427|FG001|Overall Study|Lack of Efficacy|32|||
162773178|NCT02531126|587879428|FG002|Overall Study|Lack of Efficacy|121|||
162773179|NCT02531126|587879429|FG003|Overall Study|Lack of Efficacy|0|||
162773180|NCT02531126|587879426|FG000|Overall Study|Withdrawal by Subject|38|||
162773181|NCT02531126|587879427|FG001|Overall Study|Withdrawal by Subject|31|||
162773182|NCT02531126|587879428|FG002|Overall Study|Withdrawal by Subject|96|||
162773183|NCT02531126|587879429|FG003|Overall Study|Withdrawal by Subject|6|||
162773184|NCT02531126|587879426|FG000|Overall Study|Pregnancy|2|||
162773185|NCT02531126|587879427|FG001|Overall Study|Pregnancy|3|||
162773186|NCT02531126|587879428|FG002|Overall Study|Pregnancy|2|||
162773187|NCT02531126|587879429|FG003|Overall Study|Pregnancy|0|||
162773188|NCT02531126|587879426|FG000|Overall Study|Switched to commercial drug|2|||
162773189|NCT02531126|587879427|FG001|Overall Study|Switched to commercial drug|4|||
162773190|NCT02531126|587879428|FG002|Overall Study|Switched to commercial drug|4|||
162773191|NCT02531126|587879429|FG003|Overall Study|Switched to commercial drug|0|||
162773192|NCT02531126|587879426|FG000|Overall Study|Other reasons|23|||
162773193|NCT02531126|587879427|FG001|Overall Study|Other reasons|29|||
162773194|NCT02531126|587879428|FG002|Overall Study|Other reasons|27|||
162773195|NCT02531126|587879429|FG003|Overall Study|Other reasons|15|||
162773196|NCT02531126|587879426|FG000|Overall Study|Physician Decision|6|||
162773197|NCT02531126|587879427|FG001|Overall Study|Physician Decision|6|||
162773198|NCT02531126|587879428|FG002|Overall Study|Physician Decision|28|||
162773199|NCT02531126|587879429|FG003|Overall Study|Physician Decision|0|||
162773200|NCT02531126|587879426|FG000|Overall Study|Non-compliance with investigational drug|1|||
162773201|NCT02531126|587879427|FG001|Overall Study|Non-compliance with investigational drug|0|||
162773202|NCT02531126|587879428|FG002|Overall Study|Non-compliance with investigational drug|0|||
162773203|NCT02531126|587879429|FG003|Overall Study|Non-compliance with investigational drug|0|||
162773204|NCT00762723|587879430|FG000|Overall Study|Study Terminated slow enrollement|5|||
162773205|NCT00762723|587879431|FG001|Overall Study|Study Terminated slow enrollement|5|||
162773206|NCT00762723|587879432|FG002|Overall Study|Study Terminated slow enrollement|3|||
162773207|NCT01572493|587879435|FG000|Overall Study|Physician Decision|1|||
162773208|NCT01572493|587879436|FG001|Overall Study|Physician Decision|0|||
162773209|NCT01572493|587879437|FG002|Overall Study|Physician Decision|0|||
162773210|NCT01572493|587879438|FG003|Overall Study|Physician Decision|0|||
162773211|NCT01572493|587879439|FG004|Overall Study|Physician Decision|0|||
162773212|NCT01572493|587879440|FG005|Overall Study|Physician Decision|0|||
162773213|NCT01572493|587879441|FG006|Overall Study|Physician Decision|0|||
162773214|NCT01572493|587879442|FG007|Overall Study|Physician Decision|0|||
162773215|NCT01572493|587879443|FG008|Overall Study|Physician Decision|0|||
162773216|NCT01572493|587879435|FG000|Overall Study|Switched to alternative treatment|0|||
162773217|NCT01572493|587879436|FG001|Overall Study|Switched to alternative treatment|1|||
162773218|NCT01572493|587879437|FG002|Overall Study|Switched to alternative treatment|2|||
162773219|NCT01572493|587879438|FG003|Overall Study|Switched to alternative treatment|1|||
162773220|NCT01572493|587879439|FG004|Overall Study|Switched to alternative treatment|2|||
162773221|NCT01572493|587879440|FG005|Overall Study|Switched to alternative treatment|0|||
162773222|NCT01572493|587879441|FG006|Overall Study|Switched to alternative treatment|2|||
162773223|NCT01572493|587879442|FG007|Overall Study|Switched to alternative treatment|0|||
162773224|NCT01572493|587879443|FG008|Overall Study|Switched to alternative treatment|2|||
162773225|NCT01572493|587879435|FG000|Overall Study|Death|0|||
162773226|NCT01572493|587879436|FG001|Overall Study|Death|0|||
162773227|NCT01572493|587879437|FG002|Overall Study|Death|0|||
162773228|NCT01572493|587879438|FG003|Overall Study|Death|1|||
162773229|NCT01572493|587879439|FG004|Overall Study|Death|0|||
162773230|NCT01572493|587879440|FG005|Overall Study|Death|1|||
162773231|NCT01572493|587879441|FG006|Overall Study|Death|0|||
162773232|NCT01572493|587879442|FG007|Overall Study|Death|0|||
162773233|NCT01572493|587879443|FG008|Overall Study|Death|0|||
162773234|NCT01572493|587879435|FG000|Overall Study|Adverse Event|0|||
162773235|NCT01572493|587879436|FG001|Overall Study|Adverse Event|0|||
162773236|NCT01572493|587879437|FG002|Overall Study|Adverse Event|0|||
162773237|NCT01572493|587879438|FG003|Overall Study|Adverse Event|0|||
162773238|NCT01572493|587879439|FG004|Overall Study|Adverse Event|0|||
162773239|NCT01572493|587879440|FG005|Overall Study|Adverse Event|0|||
162773240|NCT01572493|587879441|FG006|Overall Study|Adverse Event|1|||
162773241|NCT01572493|587879442|FG007|Overall Study|Adverse Event|0|||
162773242|NCT01572493|587879443|FG008|Overall Study|Adverse Event|0|||
162773243|NCT00609245|587879444|FG000|Overall Study|Adverse Event|1|||
162773244|NCT02236598|587879445|FG000|Overall Study|Adverse Event|0|||
162773245|NCT02236598|587879446|FG001|Overall Study|Adverse Event|1|||
162773246|NCT02236598|587879445|FG000|Overall Study|Withdrawal by Subject|0|||
162773247|NCT02236598|587879446|FG001|Overall Study|Withdrawal by Subject|1|||
162773248|NCT03132753|587879449|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
162773249|NCT03132753|587879450|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
162773250|NCT03132753|587879449|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
162773251|NCT03132753|587879450|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
162773252|NCT00084747|587879451|FG000|Overall Study|Relapsed|8|||
162773253|NCT00084747|587879451|FG000|Overall Study|Death|3|||
162773254|NCT00084747|587879451|FG000|Overall Study|Withdrawal by Subject|2|||
162773255|NCT01446042|587879455|FG000|Overall Study|Withdrawal by Subject|12|||
162773256|NCT01446042|587879456|FG001|Overall Study|Withdrawal by Subject|2|||
162773257|NCT01446042|587879457|FG002|Overall Study|Withdrawal by Subject|4|||
162773258|NCT01446042|587879455|FG000|Overall Study|Adverse Event|1|||
162773259|NCT01446042|587879456|FG001|Overall Study|Adverse Event|0|||
162773260|NCT01446042|587879457|FG002|Overall Study|Adverse Event|4|||
162773261|NCT01446042|587879455|FG000|Overall Study|Lost to Follow-up|5|||
162773262|NCT01446042|587879456|FG001|Overall Study|Lost to Follow-up|0|||
162773263|NCT01446042|587879457|FG002|Overall Study|Lost to Follow-up|0|||
162773264|NCT01446042|587879455|FG000|Overall Study|Other reasons|2|||
162773265|NCT01446042|587879456|FG001|Overall Study|Other reasons|1|||
162773266|NCT01446042|587879457|FG002|Overall Study|Other reasons|1|||
162773267|NCT05714345|587879465|FG000|Overall Study|Death|1|||
162773268|NCT05714345|587879466|FG001|Overall Study|Death|1|||
162773269|NCT01323309|587879467|FG000|Overall Study|Death|9|||
162773270|NCT01323309|587879468|FG001|Overall Study|Death|15|||
162773271|NCT01323309|587879469|FG002|Overall Study|Death|5|||
162773272|NCT01323309|587879467|FG000|Overall Study|Lost to Follow-up|11|||
162773273|NCT01323309|587879468|FG001|Overall Study|Lost to Follow-up|14|||
162773274|NCT01323309|587879469|FG002|Overall Study|Lost to Follow-up|24|||
162773275|NCT01323309|587879467|FG000|Overall Study|Withdrawal by Subject|14|||
162773276|NCT01323309|587879468|FG001|Overall Study|Withdrawal by Subject|14|||
162773277|NCT01323309|587879469|FG002|Overall Study|Withdrawal by Subject|18|||
162773278|NCT01323309|587879467|FG000|Overall Study|Disease progression|5|||
162773279|NCT01323309|587879468|FG001|Overall Study|Disease progression|11|||
162773280|NCT01323309|587879469|FG002|Overall Study|Disease progression|4|||
162773281|NCT01257698|587879484|FG000|Overall Study|Protocol Violation|4|||
162773282|NCT01257698|587879485|FG001|Overall Study|Protocol Violation|0|||
162773283|NCT00274846|587879488|FG000|Overall Study|Did not receive adequate NK cells|1|||
162773284|NCT04601857|587879492|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
162773285|NCT04601857|587879493|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
162773286|NCT04601857|587879492|FG000|Overall Study|Disease Progression|2|||
162773287|NCT04601857|587879493|FG001|Overall Study|Disease Progression|4|||
162773288|NCT04601857|587879492|FG000|Overall Study|Clinical Disease Progression|2|||
162773289|NCT04601857|587879493|FG001|Overall Study|Clinical Disease Progression|1|||
162773290|NCT04601857|587879492|FG000|Overall Study|Radiological Progression|4|||
162773291|NCT04601857|587879493|FG001|Overall Study|Radiological Progression|11|||
162773292|NCT04601857|587879492|FG000|Overall Study|Death|1|||
162773293|NCT04601857|587879493|FG001|Overall Study|Death|0|||
162773294|NCT04601857|587879492|FG000|Overall Study|Reason Not Specified|0|||
162773295|NCT04601857|587879493|FG001|Overall Study|Reason Not Specified|1|||
162773296|NCT04601857|587879492|FG000|Overall Study|At the Participant's Request|0|||
162773297|NCT04601857|587879493|FG001|Overall Study|At the Participant's Request|1|||
162773298|NCT00980954|587879494|FG000|Overall Study|Protocol Violation|9|||
162773299|NCT00980954|587879495|FG001|Overall Study|Protocol Violation|15|||
162773300|NCT04115319|587879496|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
162773301|NCT04115319|587879497|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
162773302|NCT04115319|587879496|FG000|Overall Study|Withdrawal by participant|17|||
162773303|NCT04115319|587879497|FG001|Overall Study|Withdrawal by participant|9|||
162773304|NCT04115319|587879496|FG000|Overall Study|Geopolitical Conflict Related|2|||
162773305|NCT04115319|587879497|FG001|Overall Study|Geopolitical Conflict Related|1|||
162773306|NCT04115319|587879496|FG000|Overall Study|COVID-19 Related|1|||
162773307|NCT04115319|587879497|FG001|Overall Study|COVID-19 Related|0|||
162773308|NCT04115319|587879496|FG000|Overall Study|Adverse Event|48|||
162773309|NCT04115319|587879497|FG001|Overall Study|Adverse Event|21|||
162773310|NCT04115319|587879496|FG000|Overall Study|Noncompliance with Study Drug|5|||
162773311|NCT04115319|587879497|FG001|Overall Study|Noncompliance with Study Drug|1|||
162773312|NCT04115319|587879496|FG000|Overall Study|Lack of Efficacy|6|||
162773313|NCT04115319|587879497|FG001|Overall Study|Lack of Efficacy|2|||
162773314|NCT04115319|587879496|FG000|Overall Study|Lost to Follow-up|6|||
162773315|NCT04115319|587879497|FG001|Overall Study|Lost to Follow-up|7|||
162773316|NCT04115319|587879496|FG000|Overall Study|Protocol Deviation|5|||
162773317|NCT04115319|587879497|FG001|Overall Study|Protocol Deviation|1|||
162773318|NCT04115319|587879496|FG000|Overall Study|Participant relocated|5|||
162773319|NCT04115319|587879497|FG001|Overall Study|Participant relocated|2|||
162773320|NCT04115319|587879496|FG000|Overall Study|Personal Reasons|0|||
162773321|NCT04115319|587879497|FG001|Overall Study|Personal Reasons|1|||
162773322|NCT04115319|587879496|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
162773323|NCT04115319|587879497|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
162773324|NCT04803214|587879500|FG000|Overall Study|Adverse Event|1|||
162773325|NCT04803214|587879501|FG001|Overall Study|Adverse Event|0|||
162773326|NCT04803214|587879500|FG000|Overall Study|Withdrawal by Subject|1|||
162773327|NCT04803214|587879501|FG001|Overall Study|Withdrawal by Subject|2|||
162773328|NCT04803214|587879500|FG000|Overall Study|Lost to Follow-up|2|||
162773329|NCT04803214|587879501|FG001|Overall Study|Lost to Follow-up|4|||
162773330|NCT04803214|587879500|FG000|Overall Study|Physician Decision|1|||
162773331|NCT04803214|587879501|FG001|Overall Study|Physician Decision|1|||
162773332|NCT04803214|587879500|FG000|Overall Study|Missed 12 month visit|0|||
162773333|NCT04803214|587879501|FG001|Overall Study|Missed 12 month visit|3|||
162773334|NCT02256488|587879504|FG000|Overall Study|Lost to Follow-up|6|||
162773335|NCT02256488|587879505|FG001|Overall Study|Lost to Follow-up|6|||
162773336|NCT02256488|587879506|FG002|Overall Study|Lost to Follow-up|9|||
162773337|NCT02256488|587879507|FG003|Overall Study|Lost to Follow-up|3|||
162773338|NCT02256488|587879504|FG000|Overall Study|OTHER|1|||
162773339|NCT02256488|587879505|FG001|Overall Study|OTHER|0|||
162773340|NCT02256488|587879506|FG002|Overall Study|OTHER|1|||
162773341|NCT02256488|587879507|FG003|Overall Study|OTHER|1|||
162773342|NCT02256488|587879504|FG000|Overall Study|Withdrawal by Subject|1|||
162773343|NCT02256488|587879505|FG001|Overall Study|Withdrawal by Subject|0|||
162773344|NCT02256488|587879506|FG002|Overall Study|Withdrawal by Subject|0|||
162773345|NCT02256488|587879507|FG003|Overall Study|Withdrawal by Subject|2|||
162773346|NCT03562117|587879508|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
162773347|NCT03562117|587879509|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
162773348|NCT03562117|587879510|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
162773349|NCT03928821|587879511|FG000|Overall Study|Death|0|||
162773350|NCT03928821|587879512|FG001|Overall Study|Death|1|||
162773351|NCT03928821|587879513|FG002|Overall Study|Death|0|||
162773352|NCT03928821|587879514|FG003|Overall Study|Death|0|||
162773353|NCT03928821|587879511|FG000|Overall Study|Lost to Follow-up|0|||
162773354|NCT03928821|587879512|FG001|Overall Study|Lost to Follow-up|2|||
162773355|NCT03928821|587879513|FG002|Overall Study|Lost to Follow-up|3|||
162773356|NCT03928821|587879514|FG003|Overall Study|Lost to Follow-up|0|||
162773357|NCT03928821|587879511|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162773358|NCT03928821|587879512|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162773359|NCT03928821|587879513|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162773360|NCT03928821|587879514|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
162773361|NCT04150250|587879521|FG000|Overall Study|Lost to Follow-up|0|||
162773362|NCT04150250|587879522|FG001|Overall Study|Lost to Follow-up|2|||
162773363|NCT05379023|587879526|FG000|Overall Study|Lost to Follow-up|1|||
162773364|NCT05379023|587879527|FG001|Overall Study|Lost to Follow-up|0|||
162773365|NCT05379023|587879528|FG002|Overall Study|Lost to Follow-up|0|||
162773366|NCT05379023|587879526|FG000|Overall Study|Withdrawal by Subject|2|||
162773367|NCT05379023|587879527|FG001|Overall Study|Withdrawal by Subject|0|||
162773368|NCT05379023|587879528|FG002|Overall Study|Withdrawal by Subject|0|||
162773369|NCT05147662|587879529|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162773370|NCT05147662|587879529|FG000|Overall Study|Assigned to treatment but never treated|1|||
162773371|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
162773372|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162773373|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162773374|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162773375|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
162773376|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
162773377|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
162773378|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
162773379|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
162773380|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162773381|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162773382|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162773383|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
162773384|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162773385|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162773386|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162773387|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
162773388|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162773389|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162773390|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162773391|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
162773392|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162773393|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162773394|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162773395|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
162773396|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162773397|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162773398|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162773399|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
162773400|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162773401|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162773402|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162773403|NCT03602859|587879531|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
162773404|NCT03602859|587879532|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162773405|NCT03602859|587879533|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162773406|NCT03602859|587879534|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162773407|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
162773408|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
162773409|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
162773410|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
162773411|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
162773412|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
162773413|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
162773414|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
162773415|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
162773416|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
162773417|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
162773418|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
162773419|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
162773420|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
162773421|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
162773422|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
162773423|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
162773424|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
162773425|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
162773426|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
162773427|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
162773428|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
162773429|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
162773430|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
162773431|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162773432|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162773433|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162773434|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
162773435|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
162773436|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
162773437|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
162773438|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
162773439|NCT03602859|587879531|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
162773440|NCT03602859|587879532|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
162773441|NCT03602859|587879533|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
162773442|NCT03602859|587879534|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
162773443|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
162773444|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
162773445|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
162773446|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
162773447|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
162773448|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
162773449|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
162773450|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
162773451|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
162773452|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
162773453|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
162773454|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
162773455|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
162773456|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
162773457|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
162773458|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
162773459|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
162773460|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
162773461|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
162773462|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
162773463|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
162773464|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
162773465|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
162773466|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
162773467|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
162773468|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
162773469|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
162773470|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
162773471|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
162773472|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
162773473|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
162773474|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
162773475|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
162773476|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
162773477|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
162773478|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
162773479|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162773480|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
162773481|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162773482|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162773483|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
162773484|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
162773485|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
162773486|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
162773487|NCT03602859|587879531|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
162773488|NCT03602859|587879532|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
162773489|NCT03602859|587879533|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
162773490|NCT03602859|587879534|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
162773491|NCT00506922|587880852|FG000|Overall Study|Physician Decision|0|||
162773492|NCT00506922|587880853|FG001|Overall Study|Physician Decision|0|||
162773493|NCT00506922|587880854|FG002|Overall Study|Physician Decision|0|||
162773494|NCT00506922|587880855|FG003|Overall Study|Physician Decision|2|||
162773495|NCT00506922|587880856|FG004|Overall Study|Physician Decision|0|||
162773496|NCT00506922|587880852|FG000|Overall Study|Withdrawal by Subject|0|||
162773497|NCT00506922|587880853|FG001|Overall Study|Withdrawal by Subject|0|||
162773498|NCT00506922|587880854|FG002|Overall Study|Withdrawal by Subject|0|||
162773499|NCT00506922|587880855|FG003|Overall Study|Withdrawal by Subject|0|||
162773500|NCT00506922|587880856|FG004|Overall Study|Withdrawal by Subject|1|||
162773501|NCT00111839|587880860|FG000|Overall Study|Disease Progression|30|||
162773502|NCT00111839|587880861|FG001|Overall Study|Disease Progression|33|||
162773503|NCT00111839|587880862|FG002|Overall Study|Disease Progression|33|||
162773504|NCT00111839|587880860|FG000|Overall Study|Adverse Event|5|||
162773505|NCT00111839|587880861|FG001|Overall Study|Adverse Event|3|||
162773506|NCT00111839|587880862|FG002|Overall Study|Adverse Event|1|||
162773507|NCT00111839|587880860|FG000|Overall Study|Protocol Violation|2|||
162773508|NCT00111839|587880861|FG001|Overall Study|Protocol Violation|4|||
162773509|NCT00111839|587880862|FG002|Overall Study|Protocol Violation|2|||
162773510|NCT00111839|587880860|FG000|Overall Study|Death|1|||
162773511|NCT00111839|587880861|FG001|Overall Study|Death|1|||
162773512|NCT00111839|587880862|FG002|Overall Study|Death|6|||
162773513|NCT00111839|587880860|FG000|Overall Study|Withdrawal by Subject|2|||
162773514|NCT00111839|587880861|FG001|Overall Study|Withdrawal by Subject|2|||
162773515|NCT00111839|587880862|FG002|Overall Study|Withdrawal by Subject|2|||
162773516|NCT00111839|587880860|FG000|Overall Study|Lost to Follow-up|1|||
162773517|NCT00111839|587880861|FG001|Overall Study|Lost to Follow-up|0|||
162773518|NCT00111839|587880862|FG002|Overall Study|Lost to Follow-up|0|||
162773519|NCT00111839|587880860|FG000|Overall Study|Logistical Constraint|1|||
162773520|NCT00111839|587880861|FG001|Overall Study|Logistical Constraint|0|||
162773521|NCT00111839|587880862|FG002|Overall Study|Logistical Constraint|0|||
162773522|NCT00111839|587880860|FG000|Overall Study|Other|6|||
162773523|NCT00111839|587880861|FG001|Overall Study|Other|3|||
162773524|NCT00111839|587880862|FG002|Overall Study|Other|3|||
162773525|NCT00111839|587880860|FG000|Overall Study|Randomized but Not Treated|0|||
162773526|NCT00111839|587880861|FG001|Overall Study|Randomized but Not Treated|0|||
162773527|NCT00111839|587880862|FG002|Overall Study|Randomized but Not Treated|2|||
162773528|NCT00377312|587880863|FG000|Overall Study|Adverse Event|1|||
162773529|NCT00377312|587880864|FG001|Overall Study|Adverse Event|1|||
162773530|NCT00382408|587880867|FG000|Overall Study|Did not meet protocol requirement|3|||
162773531|NCT00382408|587880868|FG001|Overall Study|Did not meet protocol requirement|3|||
162773532|NCT00382408|587880867|FG000|Overall Study|Protocol Violation|2|||
162773533|NCT00382408|587880868|FG001|Overall Study|Protocol Violation|2|||
162773534|NCT00382408|587880867|FG000|Overall Study|Physician Decision|1|||
162773535|NCT00382408|587880868|FG001|Overall Study|Physician Decision|0|||
162773536|NCT00382408|587880867|FG000|Overall Study|Withdrawal by Subject|17|||
162773537|NCT00382408|587880868|FG001|Overall Study|Withdrawal by Subject|6|||
162773538|NCT00382408|587880867|FG000|Overall Study|Pregnancy|2|||
162773539|NCT00382408|587880868|FG001|Overall Study|Pregnancy|0|||
162773540|NCT00382408|587880867|FG000|Overall Study|Lost to Follow-up|19|||
162773541|NCT00382408|587880868|FG001|Overall Study|Lost to Follow-up|8|||
162773542|NCT00382408|587880867|FG000|Overall Study|Other|100|||
162773543|NCT00382408|587880868|FG001|Overall Study|Other|35|||
162773544|NCT03924947|587880869|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162773545|NCT03924947|587880870|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162773546|NCT03924947|587880871|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
162773547|NCT03924947|587880872|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162773548|NCT03924947|587880873|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162773549|NCT03924947|587880874|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162773550|NCT03085433|587880875|FG000|Overall Study|Withdrawal by Subject|2|||
162773551|NCT03085433|587880876|FG001|Overall Study|Withdrawal by Subject|4|||
162773552|NCT03085433|587880875|FG000|Overall Study|Physician Decision|33|||
162773553|NCT03085433|587880876|FG001|Overall Study|Physician Decision|50|||
162773554|NCT03809039|587880877|FG000|Part 1|Withdrawal by Subject|1|||
162773555|NCT03809039|587880878|FG001|Part 1|Withdrawal by Subject|0|||
162773556|NCT03809039|587880879|FG002|Part 1|Withdrawal by Subject|0|||
162773557|NCT03809039|587880880|FG003|Part 1|Withdrawal by Subject|1|||
162773558|NCT03809039|587880881|FG004|Part 1|Withdrawal by Subject|0|||
162773559|NCT03809039|587880882|FG005|Part 1|Withdrawal by Subject|0|||
162773560|NCT03809039|587880883|FG006|Part 1|Withdrawal by Subject|0|||
162773561|NCT03809039|587880884|FG007|Part 1|Withdrawal by Subject|0|||
162773562|NCT03809039|587880885|FG008|Part 1|Withdrawal by Subject|0|||
162773563|NCT03809039|587880877|FG000|Part 3|Withdrawn by study termination|0|||
162773564|NCT03809039|587880878|FG001|Part 3|Withdrawn by study termination|0|||
162773565|NCT03809039|587880879|FG002|Part 3|Withdrawn by study termination|0|||
162773566|NCT03809039|587880880|FG003|Part 3|Withdrawn by study termination|0|||
162773567|NCT03809039|587880881|FG004|Part 3|Withdrawn by study termination|0|||
162773568|NCT03809039|587880882|FG005|Part 3|Withdrawn by study termination|0|||
162773569|NCT03809039|587880883|FG006|Part 3|Withdrawn by study termination|0|||
162773570|NCT03809039|587880884|FG007|Part 3|Withdrawn by study termination|2|||
162773571|NCT03809039|587880885|FG008|Part 3|Withdrawn by study termination|6|||
162773572|NCT03451292|587880886|FG000|Overall Study|Death|44|||
162773573|NCT03451292|587880887|FG001|Overall Study|Death|59|||
162773574|NCT03451292|587880886|FG000|Overall Study|Withdrawal by Subject|18|||
162773575|NCT03451292|587880887|FG001|Overall Study|Withdrawal by Subject|13|||
162773576|NCT03451292|587880886|FG000|Overall Study|Transplantation|18|||
162773577|NCT03451292|587880887|FG001|Overall Study|Transplantation|12|||
162773578|NCT03451292|587880886|FG000|Overall Study|Lost to Follow-up|4|||
162773579|NCT03451292|587880887|FG001|Overall Study|Lost to Follow-up|12|||
162773580|NCT03451292|587880886|FG000|Overall Study|Physician Decision|4|||
162773581|NCT03451292|587880887|FG001|Overall Study|Physician Decision|3|||
162773582|NCT03451292|587880886|FG000|Overall Study|Adverse Event|3|||
162773583|NCT03451292|587880887|FG001|Overall Study|Adverse Event|3|||
162773584|NCT03451292|587880886|FG000|Overall Study|Non-compliance with Study Drug|2|||
162773585|NCT03451292|587880887|FG001|Overall Study|Non-compliance with Study Drug|0|||
162773586|NCT05271552|587880888|FG000|Overall Study|Adverse Event|4|||
162773587|NCT05271552|587880889|FG001|Overall Study|Adverse Event|6|||
162773588|NCT05271552|587880890|FG002|Overall Study|Adverse Event|3|||
162773589|NCT05271552|587880888|FG000|Overall Study|Death|1|||
162773590|NCT05271552|587880889|FG001|Overall Study|Death|1|||
162773591|NCT05271552|587880890|FG002|Overall Study|Death|1|||
162773592|NCT05271552|587880888|FG000|Overall Study|Lost to Follow-up|1|||
162773593|NCT05271552|587880889|FG001|Overall Study|Lost to Follow-up|5|||
162773594|NCT05271552|587880890|FG002|Overall Study|Lost to Follow-up|4|||
162773595|NCT05271552|587880888|FG000|Overall Study|Withdrawal by Subject|0|||
162773596|NCT05271552|587880889|FG001|Overall Study|Withdrawal by Subject|4|||
162773597|NCT05271552|587880890|FG002|Overall Study|Withdrawal by Subject|7|||
162773598|NCT05271552|587880888|FG000|Overall Study|Other medical reason.|1|||
162773599|NCT05271552|587880889|FG001|Overall Study|Other medical reason.|2|||
162773600|NCT05271552|587880890|FG002|Overall Study|Other medical reason.|0|||
162773601|NCT05271552|587880888|FG000|Overall Study|Other|3|||
162773602|NCT05271552|587880889|FG001|Overall Study|Other|3|||
162773603|NCT05271552|587880890|FG002|Overall Study|Other|6|||
162773604|NCT03840993|587880896|FG000|Overall Study|Adverse Event|1|||
162773605|NCT03840993|587880897|FG001|Overall Study|Adverse Event|0|||
162773606|NCT03840993|587880896|FG000|Overall Study|Lost to Follow-up|4|||
162773607|NCT03840993|587880897|FG001|Overall Study|Lost to Follow-up|0|||
162773608|NCT03840993|587880896|FG000|Overall Study|Physician Decision|0|||
162773609|NCT03840993|587880897|FG001|Overall Study|Physician Decision|1|||
162773610|NCT03840993|587880896|FG000|Overall Study|Pregnancy|0|||
162773611|NCT03840993|587880897|FG001|Overall Study|Pregnancy|1|||
162773612|NCT03840993|587880896|FG000|Overall Study|Withdrawal by Subject|1|||
162773613|NCT03840993|587880897|FG001|Overall Study|Withdrawal by Subject|3|||
162773614|NCT03840993|587880896|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
162773615|NCT03840993|587880897|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
162773616|NCT01090076|587880898|FG000|Overall Study|Death|1|||
162773617|NCT01090076|587880899|FG001|Overall Study|Death|1|||
162773618|NCT01090076|587880898|FG000|Overall Study|Withdrawal by Subject|0|||
162773619|NCT01090076|587880899|FG001|Overall Study|Withdrawal by Subject|1|||
162773620|NCT02176018|587880900|FG000|Overall Study|Adverse Event|0|||
162773621|NCT02176018|587880901|FG001|Overall Study|Adverse Event|2|||
162773622|NCT02176018|587880900|FG000|Overall Study|Lost to Follow-up|3|||
162773623|NCT02176018|587880901|FG001|Overall Study|Lost to Follow-up|1|||
162773624|NCT02176018|587880900|FG000|Overall Study|Protocol Violation|1|||
162773625|NCT02176018|587880901|FG001|Overall Study|Protocol Violation|1|||
162773626|NCT02176018|587880900|FG000|Overall Study|Withdrawal by Subject|1|||
162773627|NCT02176018|587880901|FG001|Overall Study|Withdrawal by Subject|2|||
162773628|NCT03022045|587880903|FG000|Overall Study|Adverse Event|0|||
162773629|NCT03022045|587880904|FG001|Overall Study|Adverse Event|1|||
162773630|NCT03022045|587880903|FG000|Overall Study|Withdrawal by Subject|1|||
162773631|NCT03022045|587880904|FG001|Overall Study|Withdrawal by Subject|1|||
162773632|NCT02253147|587880905|FG000|Overall Study|Protocol Violation|30|||
162773633|NCT02253147|587880905|FG000|Overall Study|Did not consent to study extension|9|||
162773634|NCT02253147|587880905|FG000|Overall Study|Conditional re-treatment at W52|5|||
162773635|NCT02253147|587880905|FG000|Overall Study|Lost to Follow-up|2|||
162773636|NCT02253147|587880905|FG000|Overall Study|Withdrawal by Subject|1|||
162773637|NCT02986659|587880906|FG000|First Intervention Period|Adverse Event|3|||
162773638|NCT02986659|587880907|FG001|First Intervention Period|Adverse Event|1|||
162773639|NCT02986659|587880906|FG000|First Intervention Period|Lost to Follow-up|1|||
162773640|NCT02986659|587880907|FG001|First Intervention Period|Lost to Follow-up|0|||
162773641|NCT02986659|587880906|FG000|First Intervention Period|Withdrawal by Subject|0|||
162773642|NCT02986659|587880907|FG001|First Intervention Period|Withdrawal by Subject|1|||
162773643|NCT02986659|587880906|FG000|Second Intervention Period|Adverse Event|0|||
162773644|NCT02986659|587880907|FG001|Second Intervention Period|Adverse Event|6|||
162773645|NCT02402465|587880910|FG000|Overall Study|Withdrawal by Subject|0|||
162773646|NCT02402465|587880911|FG001|Overall Study|Withdrawal by Subject|0|||
162773647|NCT02402465|587880912|FG002|Overall Study|Withdrawal by Subject|0|||
162773648|NCT02402465|587880913|FG003|Overall Study|Withdrawal by Subject|0|||
162773649|NCT02402465|587880914|FG004|Overall Study|Withdrawal by Subject|0|||
162773650|NCT02402465|587880915|FG005|Overall Study|Withdrawal by Subject|1|||
162773651|NCT02402465|587880910|FG000|Overall Study|Lost to Follow-up|0|||
162773652|NCT02402465|587880911|FG001|Overall Study|Lost to Follow-up|1|||
162773653|NCT02402465|587880912|FG002|Overall Study|Lost to Follow-up|0|||
162773654|NCT02402465|587880913|FG003|Overall Study|Lost to Follow-up|0|||
162773655|NCT02402465|587880914|FG004|Overall Study|Lost to Follow-up|1|||
162773656|NCT02402465|587880915|FG005|Overall Study|Lost to Follow-up|0|||
162773657|NCT01284634|587880916|FG000|Overall Study|Adverse Event|1|||
162773658|NCT01284634|587880917|FG001|Overall Study|Adverse Event|0|||
162773659|NCT01284634|587880918|FG002|Overall Study|Adverse Event|2|||
162773660|NCT01284634|587880919|FG003|Overall Study|Adverse Event|1|||
162773661|NCT03807700|587880920|FG000|Overall Study|Withdrawal by Subject|2|||
162773662|NCT03807700|587880921|FG001|Overall Study|Withdrawal by Subject|1|||
162773663|NCT01059526|587880922|FG000|Overall Study|Patient enrolled but not treated|20|||
162773664|NCT01059526|587880923|FG001|Overall Study|Patient enrolled but not treated|17|||
162773665|NCT01059526|587880922|FG000|Overall Study|Adverse Event|2|||
162773666|NCT01059526|587880923|FG001|Overall Study|Adverse Event|2|||
162773667|NCT01059526|587880922|FG000|Overall Study|Protocol Violation|0|||
162773668|NCT01059526|587880923|FG001|Overall Study|Protocol Violation|1|||
162773669|NCT01059526|587880922|FG000|Overall Study|Withdrawal by Subject|3|||
162773670|NCT01059526|587880923|FG001|Overall Study|Withdrawal by Subject|1|||
162773671|NCT01059526|587880922|FG000|Overall Study|Lost to Follow-up|4|||
162773672|NCT01059526|587880923|FG001|Overall Study|Lost to Follow-up|1|||
162773673|NCT01059526|587880922|FG000|Overall Study|Patient found to be dermatographic|1|||
162773674|NCT01059526|587880923|FG001|Overall Study|Patient found to be dermatographic|0|||
162773675|NCT01732588|587880924|FG000|First Intervention (7 Days)|Adverse Event|0|||
162773676|NCT01732588|587880925|FG001|First Intervention (7 Days)|Adverse Event|1|||
162773677|NCT01732588|587880926|FG002|First Intervention (7 Days)|Adverse Event|0|||
162773678|NCT02504502|587880937|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
162773679|NCT02504502|587880938|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
162773680|NCT02504502|587880937|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
162773681|NCT02504502|587880938|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
162773682|NCT01475370|587880942|FG000|Overall Study|Exacerbation of primary disease|2|||
162773683|NCT01475370|587880943|FG001|Overall Study|Exacerbation of primary disease|2|||
162773684|NCT01475370|587880944|FG002|Overall Study|Exacerbation of primary disease|2|||
162773685|NCT01475370|587880942|FG000|Overall Study|Study drug administration difficult|0|||
162773686|NCT01475370|587880943|FG001|Overall Study|Study drug administration difficult|1|||
162773687|NCT01475370|587880944|FG002|Overall Study|Study drug administration difficult|1|||
162773688|NCT01475370|587880942|FG000|Overall Study|Other than specified|1|||
162773689|NCT01475370|587880943|FG001|Overall Study|Other than specified|0|||
162773690|NCT01475370|587880944|FG002|Overall Study|Other than specified|0|||
162773691|NCT04203160|587880945|FG000|Overall Study|Alternative Therapy|3|||
162773692|NCT04203160|587880946|FG001|Overall Study|Alternative Therapy|0|||
162773693|NCT04203160|587880947|FG002|Overall Study|Alternative Therapy|1|||
162773694|NCT04203160|587880948|FG003|Overall Study|Alternative Therapy|0|||
162773695|NCT04203160|587880949|FG004|Overall Study|Alternative Therapy|0|||
162773696|NCT04203160|587880950|FG005|Overall Study|Alternative Therapy|2|||
162773697|NCT04203160|587880945|FG000|Overall Study|Withdrawal by Subject|4|||
162773698|NCT04203160|587880946|FG001|Overall Study|Withdrawal by Subject|5|||
162773699|NCT04203160|587880947|FG002|Overall Study|Withdrawal by Subject|0|||
162773700|NCT04203160|587880948|FG003|Overall Study|Withdrawal by Subject|0|||
162773701|NCT04203160|587880949|FG004|Overall Study|Withdrawal by Subject|0|||
162773702|NCT04203160|587880950|FG005|Overall Study|Withdrawal by Subject|4|||
162773703|NCT04203160|587880945|FG000|Overall Study|Adverse Event|7|||
162773704|NCT04203160|587880946|FG001|Overall Study|Adverse Event|5|||
162773705|NCT04203160|587880947|FG002|Overall Study|Adverse Event|0|||
162773706|NCT04203160|587880948|FG003|Overall Study|Adverse Event|0|||
162773707|NCT04203160|587880949|FG004|Overall Study|Adverse Event|0|||
162773708|NCT04203160|587880950|FG005|Overall Study|Adverse Event|0|||
162773709|NCT04203160|587880945|FG000|Overall Study|Sponsor Termination|1|||
162773710|NCT04203160|587880946|FG001|Overall Study|Sponsor Termination|0|||
162773711|NCT04203160|587880947|FG002|Overall Study|Sponsor Termination|0|||
162773712|NCT04203160|587880948|FG003|Overall Study|Sponsor Termination|0|||
162773713|NCT04203160|587880949|FG004|Overall Study|Sponsor Termination|0|||
162773714|NCT04203160|587880950|FG005|Overall Study|Sponsor Termination|0|||
162773715|NCT04203160|587880945|FG000|Overall Study|Physician Decision|3|||
162773716|NCT04203160|587880946|FG001|Overall Study|Physician Decision|2|||
162773717|NCT04203160|587880947|FG002|Overall Study|Physician Decision|0|||
162773718|NCT04203160|587880948|FG003|Overall Study|Physician Decision|0|||
162773719|NCT04203160|587880949|FG004|Overall Study|Physician Decision|0|||
162773720|NCT04203160|587880950|FG005|Overall Study|Physician Decision|0|||
162773721|NCT00679549|587880951|FG000|Overall Study|dropout|2|||
162773722|NCT00679549|587880952|FG001|Overall Study|dropout|4|||
162773723|NCT00679549|587880951|FG000|Overall Study|missing outcome echocardiograms|4|||
162773724|NCT00679549|587880952|FG001|Overall Study|missing outcome echocardiograms|5|||
162773725|NCT02744898|587880955|FG000|Overall Study|Progressive Disease|2|||
162773726|NCT02744898|587880955|FG000|Overall Study|Physician Decision|1|||
162773727|NCT02744898|587880955|FG000|Overall Study|Toxicity|1|||
162773728|NCT03048058|587880956|FG000|Overall Study|Lost to Follow-up|4|||
162773729|NCT03048058|587880957|FG001|Overall Study|Lost to Follow-up|0|||
162773730|NCT03048058|587880956|FG000|Overall Study|Withdrawal by Subject|0|||
162773731|NCT03048058|587880957|FG001|Overall Study|Withdrawal by Subject|4|||
162773732|NCT04736472|587880958|FG000|Overall Study|Lost to Follow-up|1|||
162773733|NCT04736472|587880959|FG001|Overall Study|Lost to Follow-up|0|||
162773734|NCT04736472|587880960|FG002|Overall Study|Lost to Follow-up|0|||
162773735|NCT04736472|587880958|FG000|Overall Study|Withdrawal by Subject|2|||
162773736|NCT04736472|587880959|FG001|Overall Study|Withdrawal by Subject|0|||
162773737|NCT04736472|587880960|FG002|Overall Study|Withdrawal by Subject|0|||
162773738|NCT04736472|587880958|FG000|Overall Study|Protocol Violation|48|||
162773739|NCT04736472|587880959|FG001|Overall Study|Protocol Violation|0|||
162773740|NCT04736472|587880960|FG002|Overall Study|Protocol Violation|6|||
162773741|NCT02268526|587880961|FG000|Overall Study|Adverse Event|0|||
162773742|NCT02268526|587880962|FG001|Overall Study|Adverse Event|2|||
162773743|NCT02268526|587880963|FG002|Overall Study|Adverse Event|1|||
162773744|NCT02268526|587880961|FG000|Overall Study|Death|1|||
162773745|NCT02268526|587880962|FG001|Overall Study|Death|11|||
162773746|NCT02268526|587880963|FG002|Overall Study|Death|0|||
162773747|NCT02268526|587880961|FG000|Overall Study|protocol deviation|0|||
162773748|NCT02268526|587880962|FG001|Overall Study|protocol deviation|1|||
162773749|NCT02268526|587880963|FG002|Overall Study|protocol deviation|0|||
162773750|NCT02268526|587880961|FG000|Overall Study|Physician Decision|0|||
162773751|NCT02268526|587880962|FG001|Overall Study|Physician Decision|0|||
162773752|NCT02268526|587880963|FG002|Overall Study|Physician Decision|1|||
162773753|NCT02268526|587880961|FG000|Overall Study|Subject/guardian decision|0|||
162773754|NCT02268526|587880962|FG001|Overall Study|Subject/guardian decision|7|||
162773755|NCT02268526|587880963|FG002|Overall Study|Subject/guardian decision|3|||
162773756|NCT02332824|587880966|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
162773757|NCT02332824|587880967|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162773758|NCT02332824|587880968|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
162773759|NCT02332824|587880969|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162773760|NCT02332824|587880970|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
162773761|NCT02332824|587880971|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
162773762|NCT02332824|587880966|FG000|Overall Study|Voluntary Withdrawal|1|||
162773763|NCT02332824|587880967|FG001|Overall Study|Voluntary Withdrawal|0|||
162773764|NCT02332824|587880968|FG002|Overall Study|Voluntary Withdrawal|0|||
162773765|NCT02332824|587880969|FG003|Overall Study|Voluntary Withdrawal|0|||
162773766|NCT02332824|587880970|FG004|Overall Study|Voluntary Withdrawal|0|||
162773767|NCT02332824|587880971|FG005|Overall Study|Voluntary Withdrawal|0|||
162773768|NCT02332824|587880966|FG000|Overall Study|Inconvenient schedule|1|||
162773769|NCT02332824|587880967|FG001|Overall Study|Inconvenient schedule|1|||
162773770|NCT02332824|587880968|FG002|Overall Study|Inconvenient schedule|0|||
162773771|NCT02332824|587880969|FG003|Overall Study|Inconvenient schedule|0|||
162773772|NCT02332824|587880970|FG004|Overall Study|Inconvenient schedule|0|||
162773773|NCT02332824|587880971|FG005|Overall Study|Inconvenient schedule|0|||
162773774|NCT02332824|587880966|FG000|Overall Study|Transfer|0|||
162773775|NCT02332824|587880967|FG001|Overall Study|Transfer|0|||
162773776|NCT02332824|587880968|FG002|Overall Study|Transfer|1|||
162773777|NCT02332824|587880969|FG003|Overall Study|Transfer|1|||
162773778|NCT02332824|587880970|FG004|Overall Study|Transfer|0|||
162773779|NCT02332824|587880971|FG005|Overall Study|Transfer|0|||
162773780|NCT00498797|587880972|FG000|Overall Study|Withdrawal by Subject|4|||
162773781|NCT00498797|587880973|FG001|Overall Study|Withdrawal by Subject|2|||
162773782|NCT00498797|587880972|FG000|Overall Study|Adverse Event|12|||
162773783|NCT00498797|587880973|FG001|Overall Study|Adverse Event|5|||
162773784|NCT00498797|587880972|FG000|Overall Study|Condition under investigation worsened|19|||
162773785|NCT00498797|587880973|FG001|Overall Study|Condition under investigation worsened|21|||
162773786|NCT00498797|587880972|FG000|Overall Study|Other|3|||
162773787|NCT00498797|587880973|FG001|Overall Study|Other|1|||
162773788|NCT01052714|587880976|FG000|Overall Study|Adverse Event|6|||
162773789|NCT01052714|587880977|FG001|Overall Study|Adverse Event|3|||
162773790|NCT01052714|587880978|FG002|Overall Study|Adverse Event|0|||
162773791|NCT01052714|587880976|FG000|Overall Study|Death|1|||
162773792|NCT01052714|587880977|FG001|Overall Study|Death|2|||
162773793|NCT01052714|587880978|FG002|Overall Study|Death|0|||
162773794|NCT01052714|587880976|FG000|Overall Study|Lost to Follow-up|2|||
162773795|NCT01052714|587880977|FG001|Overall Study|Lost to Follow-up|3|||
162773796|NCT01052714|587880978|FG002|Overall Study|Lost to Follow-up|0|||
162773797|NCT01052714|587880976|FG000|Overall Study|Physician Decision|9|||
162773798|NCT01052714|587880977|FG001|Overall Study|Physician Decision|9|||
162773799|NCT01052714|587880978|FG002|Overall Study|Physician Decision|1|||
162773800|NCT01052714|587880976|FG000|Overall Study|Withdrawal by Subject|7|||
162773801|NCT01052714|587880977|FG001|Overall Study|Withdrawal by Subject|12|||
162773802|NCT01052714|587880978|FG002|Overall Study|Withdrawal by Subject|1|||
162773803|NCT00417989|587880982|FG000|Overall Study|Withdrawal by Subject|13|||
162773804|NCT00417989|587880983|FG001|Overall Study|Withdrawal by Subject|13|||
162773805|NCT00417989|587880982|FG000|Overall Study|Lost to Follow-up|1|||
162773806|NCT00417989|587880983|FG001|Overall Study|Lost to Follow-up|6|||
162773807|NCT00417989|587880982|FG000|Overall Study|Protocol Violation|1|||
162773808|NCT00417989|587880983|FG001|Overall Study|Protocol Violation|0|||
162773809|NCT00417989|587880982|FG000|Overall Study|Death|0|||
162773810|NCT00417989|587880983|FG001|Overall Study|Death|1|||
162773811|NCT00417989|587880982|FG000|Overall Study|Physician Decision|5|||
162773812|NCT00417989|587880983|FG001|Overall Study|Physician Decision|2|||
162773813|NCT04212299|587880987|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
162773814|NCT02951052|587880988|FG000|Overall Study|Adverse Event|13|||
162773815|NCT02951052|587880989|FG001|Overall Study|Adverse Event|5|||
162773816|NCT02951052|587880988|FG000|Overall Study|Withdrawal by Subject|1|||
162773817|NCT02951052|587880989|FG001|Overall Study|Withdrawal by Subject|5|||
162773818|NCT02951052|587880988|FG000|Overall Study|Physician Decision|2|||
162773819|NCT02951052|587880989|FG001|Overall Study|Physician Decision|0|||
162773820|NCT02951052|587880988|FG000|Overall Study|Lost to Follow-up|1|||
162773821|NCT02951052|587880989|FG001|Overall Study|Lost to Follow-up|1|||
162773822|NCT02951052|587880988|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
162773823|NCT02951052|587880989|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
162773824|NCT02951052|587880988|FG000|Overall Study|Protocol Violation|5|||
162773825|NCT02951052|587880989|FG001|Overall Study|Protocol Violation|3|||
162773826|NCT02951052|587880988|FG000|Overall Study|Lack of Efficacy|3|||
162773827|NCT02951052|587880989|FG001|Overall Study|Lack of Efficacy|4|||
162773828|NCT02951052|587880988|FG000|Overall Study|Ongoing|1|||
162773829|NCT02951052|587880989|FG001|Overall Study|Ongoing|0|||
162773830|NCT01904019|587882512|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
162773831|NCT01904019|587882512|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
162773832|NCT01904019|587882512|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
162773833|NCT01904019|587882512|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
162773834|NCT01904019|587882512|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
162773835|NCT01904019|587882512|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
162773836|NCT00509821|587882513|FG000|Study Period 1 (Induction)|Death|0|||
162773837|NCT00509821|587882514|FG001|Study Period 1 (Induction)|Death|1|||
162773838|NCT00509821|587882513|FG000|Study Period 1 (Induction)|Adverse Event|0|||
162773839|NCT00509821|587882514|FG001|Study Period 1 (Induction)|Adverse Event|2|||
162773840|NCT00509821|587882513|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
162773841|NCT00509821|587882514|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
162773842|NCT01816685|587882515|FG000|Overall Study|Lost to Follow-up|7|||
162773843|NCT01816685|587882516|FG001|Overall Study|Lost to Follow-up|9|||
162773844|NCT01816685|587882515|FG000|Overall Study|Surgery Cancelled|3|||
162773845|NCT01816685|587882516|FG001|Overall Study|Surgery Cancelled|2|||
162773846|NCT01157351|587882517|FG000|Overall Study|Adverse Event|5|||
162773847|NCT01157351|587882518|FG001|Overall Study|Adverse Event|4|||
162773848|NCT01157351|587882517|FG000|Overall Study|Death|1|||
162773849|NCT01157351|587882518|FG001|Overall Study|Death|0|||
162773850|NCT01157351|587882517|FG000|Overall Study|Lost to Follow-up|53|||
162773851|NCT01157351|587882518|FG001|Overall Study|Lost to Follow-up|55|||
162773852|NCT01157351|587882517|FG000|Overall Study|Withdrawal by Subject|37|||
162773853|NCT01157351|587882518|FG001|Overall Study|Withdrawal by Subject|27|||
162773854|NCT01157351|587882517|FG000|Overall Study|Physician Decision|5|||
162773855|NCT01157351|587882518|FG001|Overall Study|Physician Decision|4|||
162773856|NCT01157351|587882517|FG000|Overall Study|Protocol Violation|0|||
162773857|NCT01157351|587882518|FG001|Overall Study|Protocol Violation|1|||
162773858|NCT01157351|587882517|FG000|Overall Study|Other|32|||
162773859|NCT01157351|587882518|FG001|Overall Study|Other|36|||
162773860|NCT01157351|587882517|FG000|Overall Study|Noncompliance with Study Drug|0|||
162773861|NCT01157351|587882518|FG001|Overall Study|Noncompliance with Study Drug|3|||
162773862|NCT01157351|587882517|FG000|Overall Study|Randomized but not Treated|4|||
162773863|NCT01157351|587882518|FG001|Overall Study|Randomized but not Treated|2|||
162773864|NCT01589523|587882519|FG000|Overall Study|Withdrawal by Subject|1|||
162773865|NCT00792259|587882520|FG000|Overall Study|Poor Quality Scans|1|||
162773866|NCT00792259|587882521|FG001|Overall Study|Poor Quality Scans|0|||
162773867|NCT00792259|587882522|FG002|Overall Study|Poor Quality Scans|0|||
162773868|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
162773869|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
162773870|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
162773871|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
162773872|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
162773873|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
162773874|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
162773875|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
162773876|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
162773877|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
162773878|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
162773879|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
162773880|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
162773881|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
162773882|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
162773883|NCT00332488|587882523|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
162773884|NCT00332488|587882524|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
162773885|NCT00332488|587882525|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
162773886|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
162773887|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
162773888|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
162773889|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
162773890|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
162773891|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
162773892|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
162773893|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
162773894|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
162773895|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
162773896|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
162773897|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
162773898|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
162773899|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
162773900|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
162773901|NCT00332488|587882523|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
162773902|NCT00332488|587882524|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
162773903|NCT00332488|587882525|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
162773904|NCT00371462|587882526|FG000|Overall Study|Withdrawal by Subject|1|||
162773905|NCT00371462|587882527|FG001|Overall Study|Withdrawal by Subject|0|||
162773906|NCT00371462|587882526|FG000|Overall Study|Other|7|||
162773907|NCT00371462|587882527|FG001|Overall Study|Other|8|||
162773908|NCT03721978|587882528|FG000|Overall Study|Withdrawal by Subject|6|||
162773909|NCT03721978|587882529|FG001|Overall Study|Withdrawal by Subject|1|||
162773910|NCT03721978|587882528|FG000|Overall Study|Adverse Event|1|||
162773911|NCT03721978|587882529|FG001|Overall Study|Adverse Event|1|||
162773912|NCT03721978|587882528|FG000|Overall Study|Progressive Disease|1|||
162773913|NCT03721978|587882529|FG001|Overall Study|Progressive Disease|0|||
162773914|NCT03721978|587882528|FG000|Overall Study|Lost to Follow-up|5|||
162773915|NCT03721978|587882529|FG001|Overall Study|Lost to Follow-up|1|||
162773916|NCT03721978|587882528|FG000|Overall Study|Reason not Specified|0|||
162773917|NCT03721978|587882529|FG001|Overall Study|Reason not Specified|2|||
162773918|NCT05244226|587882530|FG000|Overall Study|Adverse Event|1|||
162773919|NCT05244226|587882531|FG001|Overall Study|Adverse Event|0|||
162773920|NCT05244226|587882532|FG002|Overall Study|Adverse Event|0|||
162773921|NCT05244226|587882530|FG000|Overall Study|Lost to Follow-up|0|||
162773922|NCT05244226|587882531|FG001|Overall Study|Lost to Follow-up|0|||
162773923|NCT05244226|587882532|FG002|Overall Study|Lost to Follow-up|1|||
162773924|NCT05244226|587882530|FG000|Overall Study|Protocol Violation|0|||
162773925|NCT05244226|587882531|FG001|Overall Study|Protocol Violation|2|||
162773926|NCT05244226|587882532|FG002|Overall Study|Protocol Violation|2|||
162773927|NCT02675998|587882533|FG000|8-Week Treatment Period|Adverse Event|6|||
162773928|NCT02675998|587882534|FG001|8-Week Treatment Period|Adverse Event|5|||
162773929|NCT02675998|587882535|FG002|8-Week Treatment Period|Adverse Event|6|||
162773930|NCT02675998|587882536|FG003|8-Week Treatment Period|Adverse Event|0|||
162773931|NCT02675998|587882533|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
162773932|NCT02675998|587882534|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
162773933|NCT02675998|587882535|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
162773934|NCT02675998|587882536|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
162773935|NCT02675998|587882533|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
162773936|NCT02675998|587882534|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
162773937|NCT02675998|587882535|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
162773938|NCT02675998|587882536|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
162773939|NCT02675998|587882533|FG000|8-Week Treatment Period|Physician Decision|1|||
162773940|NCT02675998|587882534|FG001|8-Week Treatment Period|Physician Decision|0|||
162773941|NCT02675998|587882535|FG002|8-Week Treatment Period|Physician Decision|2|||
162773942|NCT02675998|587882536|FG003|8-Week Treatment Period|Physician Decision|0|||
162773943|NCT02675998|587882533|FG000|8-Week Treatment Period|GI side Effects|1|||
162773944|NCT02675998|587882534|FG001|8-Week Treatment Period|GI side Effects|4|||
162773945|NCT02675998|587882535|FG002|8-Week Treatment Period|GI side Effects|2|||
162773946|NCT02675998|587882536|FG003|8-Week Treatment Period|GI side Effects|0|||
162773947|NCT02675998|587882533|FG000|8-Week Treatment Period|Protocol Violation|1|||
162773948|NCT02675998|587882534|FG001|8-Week Treatment Period|Protocol Violation|1|||
162773949|NCT02675998|587882535|FG002|8-Week Treatment Period|Protocol Violation|1|||
162773950|NCT02675998|587882536|FG003|8-Week Treatment Period|Protocol Violation|0|||
162773951|NCT02675998|587882533|FG000|8-Week Treatment Period|Other|3|||
162773952|NCT02675998|587882534|FG001|8-Week Treatment Period|Other|1|||
162773953|NCT02675998|587882535|FG002|8-Week Treatment Period|Other|2|||
162773954|NCT02675998|587882536|FG003|8-Week Treatment Period|Other|0|||
162773955|NCT02675998|587882533|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
162773956|NCT02675998|587882534|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
162773957|NCT02675998|587882535|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
162773958|NCT02675998|587882536|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
162773959|NCT02675998|587882533|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
162773960|NCT02675998|587882534|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
162773961|NCT02675998|587882535|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
162773962|NCT02675998|587882536|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
162773963|NCT02675998|587882533|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
162773964|NCT02675998|587882534|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
162773965|NCT02675998|587882535|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
162773966|NCT02675998|587882536|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
162773967|NCT02675998|587882533|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
162773968|NCT02675998|587882534|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162773969|NCT02675998|587882535|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162773970|NCT02675998|587882536|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162773971|NCT02675998|587882533|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162773972|NCT02675998|587882534|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162773973|NCT02675998|587882535|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162773974|NCT02675998|587882536|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
162773975|NCT02561078|587882545|FG000|Overall Study|Adverse Event|5|||
162773976|NCT02561078|587882546|FG001|Overall Study|Adverse Event|2|||
162773977|NCT02561078|587882545|FG000|Overall Study|Death|2|||
162773978|NCT02561078|587882546|FG001|Overall Study|Death|1|||
162773979|NCT02561078|587882545|FG000|Overall Study|Lost to Follow-up|2|||
162773980|NCT02561078|587882546|FG001|Overall Study|Lost to Follow-up|6|||
162773981|NCT02561078|587882545|FG000|Overall Study|Non-Compliance with Study Drug|6|||
162773982|NCT02561078|587882546|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162773983|NCT02561078|587882545|FG000|Overall Study|Physician Decision|2|||
162773984|NCT02561078|587882546|FG001|Overall Study|Physician Decision|3|||
162773985|NCT02561078|587882545|FG000|Overall Study|Withdrawal by Subject|13|||
162773986|NCT02561078|587882546|FG001|Overall Study|Withdrawal by Subject|10|||
162773987|NCT00598871|587882547|FG000|Overall Study|Adverse Event|0|||
162773988|NCT00598871|587882548|FG001|Overall Study|Adverse Event|1|||
162773989|NCT01194271|587882549|FG000|Overall Study|Withdrawal by Subject|1|||
162773990|NCT01194271|587882549|FG000|Overall Study|Ineligible, Screen Failure|1|||
162773991|NCT01194271|587882549|FG000|Overall Study|Death|1|||
162773992|NCT00443898|587882550|FG000|Overall Study|Adverse Event|0|||
162773993|NCT00443898|587882551|FG001|Overall Study|Adverse Event|0|||
162773994|NCT00443898|587882552|FG002|Overall Study|Adverse Event|1|||
162773995|NCT00443898|587882553|FG003|Overall Study|Adverse Event|1|||
162773996|NCT00443898|587882550|FG000|Overall Study|Lack of Efficacy|2|||
162773997|NCT00443898|587882551|FG001|Overall Study|Lack of Efficacy|3|||
162773998|NCT00443898|587882552|FG002|Overall Study|Lack of Efficacy|3|||
162773999|NCT00443898|587882553|FG003|Overall Study|Lack of Efficacy|1|||
162774000|NCT00443898|587882550|FG000|Overall Study|Protocol Violation|1|||
162774001|NCT00443898|587882551|FG001|Overall Study|Protocol Violation|1|||
162774002|NCT00443898|587882552|FG002|Overall Study|Protocol Violation|1|||
162774003|NCT00443898|587882553|FG003|Overall Study|Protocol Violation|0|||
162774004|NCT00443898|587882550|FG000|Overall Study|Withdrawal by Subject|11|||
162774005|NCT00443898|587882551|FG001|Overall Study|Withdrawal by Subject|10|||
162774006|NCT00443898|587882552|FG002|Overall Study|Withdrawal by Subject|10|||
162774007|NCT00443898|587882553|FG003|Overall Study|Withdrawal by Subject|6|||
162774008|NCT00443898|587882550|FG000|Overall Study|Lost to Follow-up|10|||
162774009|NCT00443898|587882551|FG001|Overall Study|Lost to Follow-up|10|||
162774010|NCT00443898|587882552|FG002|Overall Study|Lost to Follow-up|14|||
162774011|NCT00443898|587882553|FG003|Overall Study|Lost to Follow-up|10|||
162774012|NCT00443898|587882550|FG000|Overall Study|Death|0|||
162774013|NCT00443898|587882551|FG001|Overall Study|Death|1|||
162774014|NCT00443898|587882552|FG002|Overall Study|Death|0|||
162774015|NCT00443898|587882553|FG003|Overall Study|Death|0|||
162774016|NCT00043186|587882554|FG000|Overall Study|Physician Decision|0|||
162774017|NCT00043186|587882555|FG001|Overall Study|Physician Decision|0|||
162774018|NCT00043186|587882556|FG002|Overall Study|Physician Decision|3|||
162774019|NCT00043186|587882557|FG003|Overall Study|Physician Decision|0|||
162774020|NCT00043186|587882558|FG004|Overall Study|Physician Decision|1|||
162774021|NCT00043186|587882559|FG005|Overall Study|Physician Decision|0|||
162774022|NCT00043186|587882560|FG006|Overall Study|Physician Decision|0|||
162774023|NCT00043186|587882561|FG007|Overall Study|Physician Decision|1|||
162774024|NCT00043186|587882562|FG008|Overall Study|Physician Decision|1|||
162774025|NCT00043186|587882554|FG000|Overall Study|Adverse Event|2|||
162774026|NCT00043186|587882555|FG001|Overall Study|Adverse Event|2|||
162774027|NCT00043186|587882556|FG002|Overall Study|Adverse Event|2|||
162774028|NCT00043186|587882557|FG003|Overall Study|Adverse Event|3|||
162774029|NCT00043186|587882558|FG004|Overall Study|Adverse Event|2|||
162774030|NCT00043186|587882559|FG005|Overall Study|Adverse Event|1|||
162774031|NCT00043186|587882560|FG006|Overall Study|Adverse Event|2|||
162774032|NCT00043186|587882561|FG007|Overall Study|Adverse Event|1|||
162774033|NCT00043186|587882562|FG008|Overall Study|Adverse Event|3|||
162774034|NCT00043186|587882554|FG000|Overall Study|Withdrawal by Subject|11|||
162774035|NCT00043186|587882555|FG001|Overall Study|Withdrawal by Subject|8|||
162774036|NCT00043186|587882556|FG002|Overall Study|Withdrawal by Subject|11|||
162774037|NCT00043186|587882557|FG003|Overall Study|Withdrawal by Subject|13|||
162774038|NCT00043186|587882558|FG004|Overall Study|Withdrawal by Subject|14|||
162774039|NCT00043186|587882559|FG005|Overall Study|Withdrawal by Subject|6|||
162774040|NCT00043186|587882560|FG006|Overall Study|Withdrawal by Subject|12|||
162774041|NCT00043186|587882561|FG007|Overall Study|Withdrawal by Subject|9|||
162774042|NCT00043186|587882562|FG008|Overall Study|Withdrawal by Subject|10|||
162774043|NCT00043186|587882554|FG000|Overall Study|Death|0|||
162774044|NCT00043186|587882555|FG001|Overall Study|Death|0|||
162774045|NCT00043186|587882556|FG002|Overall Study|Death|1|||
162774046|NCT00043186|587882557|FG003|Overall Study|Death|0|||
162774047|NCT00043186|587882558|FG004|Overall Study|Death|0|||
162774048|NCT00043186|587882559|FG005|Overall Study|Death|0|||
162774049|NCT00043186|587882560|FG006|Overall Study|Death|2|||
162774050|NCT00043186|587882561|FG007|Overall Study|Death|0|||
162774051|NCT00043186|587882562|FG008|Overall Study|Death|0|||
162774052|NCT00043186|587882554|FG000|Overall Study|Disease progression|1|||
162774053|NCT00043186|587882555|FG001|Overall Study|Disease progression|0|||
162774054|NCT00043186|587882556|FG002|Overall Study|Disease progression|0|||
162774055|NCT00043186|587882557|FG003|Overall Study|Disease progression|3|||
162774056|NCT00043186|587882558|FG004|Overall Study|Disease progression|0|||
162774057|NCT00043186|587882559|FG005|Overall Study|Disease progression|0|||
162774058|NCT00043186|587882560|FG006|Overall Study|Disease progression|0|||
162774059|NCT00043186|587882561|FG007|Overall Study|Disease progression|4|||
162774060|NCT00043186|587882562|FG008|Overall Study|Disease progression|0|||
162774061|NCT00043186|587882554|FG000|Overall Study|Ineligibility determined|0|||
162774062|NCT00043186|587882555|FG001|Overall Study|Ineligibility determined|0|||
162774063|NCT00043186|587882556|FG002|Overall Study|Ineligibility determined|0|||
162774064|NCT00043186|587882557|FG003|Overall Study|Ineligibility determined|0|||
162774065|NCT00043186|587882558|FG004|Overall Study|Ineligibility determined|0|||
162774066|NCT00043186|587882559|FG005|Overall Study|Ineligibility determined|0|||
162774067|NCT00043186|587882560|FG006|Overall Study|Ineligibility determined|0|||
162774068|NCT00043186|587882561|FG007|Overall Study|Ineligibility determined|0|||
162774069|NCT00043186|587882562|FG008|Overall Study|Ineligibility determined|1|||
162774070|NCT00043186|587882554|FG000|Overall Study|Lost to Follow-up|3|||
162774071|NCT00043186|587882555|FG001|Overall Study|Lost to Follow-up|5|||
162774072|NCT00043186|587882556|FG002|Overall Study|Lost to Follow-up|1|||
162774073|NCT00043186|587882557|FG003|Overall Study|Lost to Follow-up|1|||
162774074|NCT00043186|587882558|FG004|Overall Study|Lost to Follow-up|1|||
162774075|NCT00043186|587882559|FG005|Overall Study|Lost to Follow-up|1|||
162774076|NCT00043186|587882560|FG006|Overall Study|Lost to Follow-up|1|||
162774077|NCT00043186|587882561|FG007|Overall Study|Lost to Follow-up|1|||
162774078|NCT00043186|587882562|FG008|Overall Study|Lost to Follow-up|2|||
162774079|NCT00043186|587882554|FG000|Overall Study|Noncompliance|0|||
162774080|NCT00043186|587882555|FG001|Overall Study|Noncompliance|0|||
162774081|NCT00043186|587882556|FG002|Overall Study|Noncompliance|1|||
162774082|NCT00043186|587882557|FG003|Overall Study|Noncompliance|1|||
162774083|NCT00043186|587882558|FG004|Overall Study|Noncompliance|0|||
162774084|NCT00043186|587882559|FG005|Overall Study|Noncompliance|0|||
162774085|NCT00043186|587882560|FG006|Overall Study|Noncompliance|0|||
162774086|NCT00043186|587882561|FG007|Overall Study|Noncompliance|0|||
162774087|NCT00043186|587882562|FG008|Overall Study|Noncompliance|0|||
162774088|NCT00043186|587882554|FG000|Overall Study|Other|0|||
162774089|NCT00043186|587882555|FG001|Overall Study|Other|0|||
162774090|NCT00043186|587882556|FG002|Overall Study|Other|1|||
162774091|NCT00043186|587882557|FG003|Overall Study|Other|1|||
162774092|NCT00043186|587882558|FG004|Overall Study|Other|0|||
162774093|NCT00043186|587882559|FG005|Overall Study|Other|0|||
162774094|NCT00043186|587882560|FG006|Overall Study|Other|0|||
162774095|NCT00043186|587882561|FG007|Overall Study|Other|0|||
162774096|NCT00043186|587882562|FG008|Overall Study|Other|0|||
162774097|NCT04050722|587882566|FG000|Overall Study|Withdrawal by Subject|1|||
162774098|NCT04050722|587882567|FG001|Overall Study|Withdrawal by Subject|0|||
162774099|NCT01145417|587882568|FG000|Overall Study|Death|1|||
162774100|NCT01145417|587882569|FG001|Overall Study|Death|0|||
162774101|NCT01145417|587882568|FG000|Overall Study|Lost to Follow-up|2|||
162774102|NCT01145417|587882569|FG001|Overall Study|Lost to Follow-up|1|||
162774103|NCT01145417|587882568|FG000|Overall Study|Withdrawal by Subject|1|||
162774104|NCT01145417|587882569|FG001|Overall Study|Withdrawal by Subject|2|||
162774105|NCT01145417|587882568|FG000|Overall Study|Pregnancy|1|||
162774106|NCT01145417|587882569|FG001|Overall Study|Pregnancy|0|||
162774107|NCT01145417|587882568|FG000|Overall Study|Adverse Event|0|||
162774108|NCT01145417|587882569|FG001|Overall Study|Adverse Event|1|||
162774109|NCT01145417|587882568|FG000|Overall Study|Study terminated by sponsor|35|||
162774110|NCT01145417|587882569|FG001|Overall Study|Study terminated by sponsor|43|||
162774111|NCT01145417|587882568|FG000|Overall Study|Other|1|||
162774112|NCT01145417|587882569|FG001|Overall Study|Other|0|||
162774113|NCT03275402|587882570|FG000|Overall Study|Death|17|||
162774114|NCT03275402|587882570|FG000|Overall Study|Study terminated by sponsor|21|||
162774115|NCT03275402|587882570|FG000|Overall Study|Withdrawal by Subject|1|||
162774116|NCT02469077|587882572|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
162774117|NCT02469077|587882573|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
162774118|NCT02469077|587882572|FG000|Post Randomization/Intervention Period|Relocated|1|||
162774119|NCT02469077|587882573|FG001|Post Randomization/Intervention Period|Relocated|1|||
162774120|NCT02469077|587882572|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
162774121|NCT02469077|587882573|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
162774122|NCT02469077|587882572|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
162774123|NCT02469077|587882573|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
162774124|NCT02973477|587882574|FG000|First Intervention|Lost to Follow-up|0|||
162774125|NCT02973477|587882575|FG001|First Intervention|Lost to Follow-up|2|||
162774126|NCT02973477|587882574|FG000|Washout|Withdrawal by Subject|1|||
162774127|NCT02973477|587882575|FG001|Washout|Withdrawal by Subject|0|||
162774128|NCT02973477|587882574|FG000|Second Intervention|Lost to Follow-up|1|||
162774129|NCT02973477|587882575|FG001|Second Intervention|Lost to Follow-up|0|||
162774130|NCT02720081|587882576|FG000|Overall Study|Adverse Event|0|||
162774131|NCT02720081|587882577|FG001|Overall Study|Adverse Event|3|||
162774132|NCT02720081|587882576|FG000|Overall Study|Protocol Violation|4|||
162774133|NCT02720081|587882577|FG001|Overall Study|Protocol Violation|1|||
162774134|NCT05012397|587882578|FG000|Overall Study|Death|10|||
162774135|NCT05012397|587882578|FG000|Overall Study|Physician Decision|9|||
162774136|NCT05012397|587882578|FG000|Overall Study|Withdrawal by Subject|5|||
162774137|NCT05012397|587882578|FG000|Overall Study|Lost to Follow-up|2|||
162774138|NCT03334747|587882579|FG000|Treatment Phase|Technical problems|0|||
162774139|NCT03334747|587882580|FG001|Treatment Phase|Technical problems|0|||
162774140|NCT03334747|587882581|FG002|Treatment Phase|Technical problems|0|||
162774141|NCT03334747|587882582|FG003|Treatment Phase|Technical problems|0|||
162774142|NCT03334747|587882583|FG004|Treatment Phase|Technical problems|1|||
162774143|NCT03334747|587882584|FG005|Treatment Phase|Technical problems|0|||
162774144|NCT03334747|587882585|FG006|Treatment Phase|Technical problems|0|||
162774145|NCT03334747|587882586|FG007|Treatment Phase|Technical problems|0|||
162774146|NCT03334747|587882587|FG008|Treatment Phase|Technical problems|0|||
162774147|NCT03334747|587882579|FG000|Treatment Phase|Subject/guardian decision|1|||
162774148|NCT03334747|587882580|FG001|Treatment Phase|Subject/guardian decision|0|||
162774149|NCT03334747|587882581|FG002|Treatment Phase|Subject/guardian decision|0|||
162774150|NCT03334747|587882582|FG003|Treatment Phase|Subject/guardian decision|0|||
162774151|NCT03334747|587882583|FG004|Treatment Phase|Subject/guardian decision|0|||
162774152|NCT03334747|587882584|FG005|Treatment Phase|Subject/guardian decision|1|||
162774153|NCT03334747|587882585|FG006|Treatment Phase|Subject/guardian decision|0|||
162774154|NCT03334747|587882586|FG007|Treatment Phase|Subject/guardian decision|0|||
162774155|NCT03334747|587882587|FG008|Treatment Phase|Subject/guardian decision|0|||
162774156|NCT03334747|587882579|FG000|Follow-Up Phase|Subject/guardian decision|0|||
162774157|NCT03334747|587882580|FG001|Follow-Up Phase|Subject/guardian decision|0|||
162774158|NCT03334747|587882581|FG002|Follow-Up Phase|Subject/guardian decision|0|||
162774159|NCT03334747|587882582|FG003|Follow-Up Phase|Subject/guardian decision|0|||
162774160|NCT03334747|587882583|FG004|Follow-Up Phase|Subject/guardian decision|0|||
162774161|NCT03334747|587882584|FG005|Follow-Up Phase|Subject/guardian decision|0|||
162774162|NCT03334747|587882585|FG006|Follow-Up Phase|Subject/guardian decision|1|||
162774163|NCT03334747|587882586|FG007|Follow-Up Phase|Subject/guardian decision|0|||
162774164|NCT03334747|587882587|FG008|Follow-Up Phase|Subject/guardian decision|1|||
162774165|NCT00191984|587882588|FG000|Overall Study|Disease Progression|21|||
162774166|NCT00191984|587882588|FG000|Overall Study|Adverse Event|4|||
162774167|NCT00191984|587882588|FG000|Overall Study|Death|2|||
162774168|NCT00191984|587882588|FG000|Overall Study|Entry Criteria Exclusion|1|||
162774169|NCT00191984|587882588|FG000|Overall Study|Withdrawal by Subject|7|||
162774170|NCT00191984|587882588|FG000|Overall Study|Physician Decision|4|||
162774171|NCT03303521|587882589|FG000|Overall Study|Withdrawal by Subject|2|||
162774172|NCT03303521|587882590|FG001|Overall Study|Withdrawal by Subject|0|||
162774173|NCT03303521|587882589|FG000|Overall Study|Death|1|||
162774174|NCT03303521|587882590|FG001|Overall Study|Death|0|||
162774175|NCT03303521|587882589|FG000|Overall Study|Kidney transplantation|0|||
162774176|NCT03303521|587882590|FG001|Overall Study|Kidney transplantation|1|||
162774177|NCT03303521|587882589|FG000|Overall Study|Investigational product discontinuation|0|||
162774178|NCT03303521|587882590|FG001|Overall Study|Investigational product discontinuation|1|||
162774179|NCT03303521|587882589|FG000|Overall Study|Transferred to non-study dialysis center|1|||
162774180|NCT03303521|587882590|FG001|Overall Study|Transferred to non-study dialysis center|0|||
162774181|NCT03303521|587882589|FG000|Overall Study|Non-comliance to study protocol|0|||
162774182|NCT03303521|587882590|FG001|Overall Study|Non-comliance to study protocol|1|||
162774183|NCT03303521|587882589|FG000|Overall Study|Adverse Event|1|||
162774184|NCT03303521|587882590|FG001|Overall Study|Adverse Event|0|||
162774185|NCT01654289|587882591|FG000|Overall Study|Withdrawal by Subject|10|||
162774186|NCT01654289|587882592|FG001|Overall Study|Withdrawal by Subject|8|||
162774187|NCT01654289|587882593|FG002|Overall Study|Withdrawal by Subject|5|||
162774188|NCT01654289|587882591|FG000|Overall Study|Withdrew from intervention only|17|||
162774189|NCT01654289|587882592|FG001|Overall Study|Withdrew from intervention only|20|||
162774190|NCT01654289|587882593|FG002|Overall Study|Withdrew from intervention only|0|||
162774191|NCT00005908|587882597|FG000|Overall Study|Withdrawal by Subject|1|||
162774192|NCT00005908|587882598|FG001|Overall Study|Withdrawal by Subject|0|||
162774193|NCT04748445|587882599|FG000|Overall Study|No longer met eligibility criteria|12|||
162774194|NCT04748445|587882599|FG000|Overall Study|Other|36|||
162774195|NCT04748445|587882599|FG000|Overall Study|Withdrawal by Subject|553|||
162774196|NCT04748445|587882599|FG000|Overall Study|Lost to Follow-up|30|||
162774197|NCT04736602|587882600|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
162774198|NCT04736602|587882600|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
162774199|NCT00938041|587882607|FG000|Overall Study|Lost to Follow-up|6|||
162774200|NCT00938041|587882607|FG000|Overall Study|Received Alternative Therapy|1|||
162774201|NCT00938041|587882607|FG000|Overall Study|Progressive Disease|5|||
162774202|NCT00938041|587882607|FG000|Overall Study|Death|12|||
162774203|NCT00938041|587882607|FG000|Overall Study|Adrenal Insufficiency|3|||
162774204|NCT03042559|587882611|FG000|Overall Study|drop out|1|||
162774205|NCT03042559|587882612|FG001|Overall Study|drop out|1|||
162774206|NCT01536535|587882613|FG000|Overall Study|Withdrawal by Subject|10|||
162774207|NCT01536535|587882614|FG001|Overall Study|Withdrawal by Subject|5|||
162774208|NCT01536535|587882613|FG000|Overall Study|Lost to Follow-up|4|||
162774209|NCT01536535|587882614|FG001|Overall Study|Lost to Follow-up|6|||
162774210|NCT01536535|587882613|FG000|Overall Study|Physician Decision|1|||
162774211|NCT01536535|587882614|FG001|Overall Study|Physician Decision|1|||
162774212|NCT01536535|587882613|FG000|Overall Study|Participant moved|0|||
162774213|NCT01536535|587882614|FG001|Overall Study|Participant moved|1|||
162774214|NCT00428441|587882615|FG000|Overall Study|Lost to Follow-up|1|||
162774215|NCT01485991|587882616|FG000|Overall Study|Adverse Event|0|||
162774216|NCT01485991|587882617|FG001|Overall Study|Adverse Event|4|||
162774217|NCT01485991|587882616|FG000|Overall Study|Lost to Follow-up|13|||
162774218|NCT01485991|587882617|FG001|Overall Study|Lost to Follow-up|10|||
162774219|NCT01485991|587882616|FG000|Overall Study|Withdrawal by Subject|13|||
162774220|NCT01485991|587882617|FG001|Overall Study|Withdrawal by Subject|20|||
162774221|NCT01485991|587882616|FG000|Overall Study|randomized but not treated|6|||
162774222|NCT01485991|587882617|FG001|Overall Study|randomized but not treated|2|||
162774223|NCT04474691|587882619|FG000|Overall Study|Withdrawal by Subject|9|||
162774224|NCT04372186|587882620|FG000|Overall Study|Death|24|||
162774225|NCT04372186|587882621|FG001|Overall Study|Death|11|||
162774226|NCT04372186|587882620|FG000|Overall Study|Transferred to a different facility for care|0|||
162774227|NCT04372186|587882621|FG001|Overall Study|Transferred to a different facility for care|2|||
162774228|NCT03740919|587882625|FG000|Lead-in Period|Lost to Follow-up|1|||
162774229|NCT03740919|587882626|FG001|Lead-in Period|Lost to Follow-up|0|||
162774230|NCT03740919|587882627|FG002|Lead-in Period|Lost to Follow-up|0|||
162774231|NCT03740919|587882628|FG003|Lead-in Period|Lost to Follow-up|0|||
162774232|NCT03740919|587882625|FG000|Lead-in Period|Physician Decision|2|||
162774233|NCT03740919|587882626|FG001|Lead-in Period|Physician Decision|0|||
162774234|NCT03740919|587882627|FG002|Lead-in Period|Physician Decision|0|||
162774235|NCT03740919|587882628|FG003|Lead-in Period|Physician Decision|0|||
162774236|NCT03740919|587882625|FG000|Lead-in Period|Protocol Violation|1|||
162774237|NCT03740919|587882626|FG001|Lead-in Period|Protocol Violation|0|||
162774238|NCT03740919|587882627|FG002|Lead-in Period|Protocol Violation|0|||
162774239|NCT03740919|587882628|FG003|Lead-in Period|Protocol Violation|0|||
162774240|NCT03740919|587882625|FG000|Lead-in Period|Withdrawal by Subject|10|||
162774241|NCT03740919|587882626|FG001|Lead-in Period|Withdrawal by Subject|0|||
162774242|NCT03740919|587882627|FG002|Lead-in Period|Withdrawal by Subject|0|||
162774243|NCT03740919|587882628|FG003|Lead-in Period|Withdrawal by Subject|0|||
162774244|NCT03740919|587882625|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
162774245|NCT03740919|587882626|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162774246|NCT03740919|587882627|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162774247|NCT03740919|587882628|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162774248|NCT03740919|587882625|FG000|Lead-in Period|Study Task Too Burdensome|1|||
162774249|NCT03740919|587882626|FG001|Lead-in Period|Study Task Too Burdensome|0|||
162774250|NCT03740919|587882627|FG002|Lead-in Period|Study Task Too Burdensome|0|||
162774251|NCT03740919|587882628|FG003|Lead-in Period|Study Task Too Burdensome|0|||
162774252|NCT03740919|587882625|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
162774253|NCT03740919|587882626|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162774254|NCT03740919|587882627|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162774255|NCT03740919|587882628|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162774256|NCT03740919|587882625|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
162774257|NCT03740919|587882626|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162774258|NCT03740919|587882627|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162774259|NCT03740919|587882628|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162774260|NCT03740919|587882625|FG000|Treatment Period|Adverse Event|0|||
162774261|NCT03740919|587882626|FG001|Treatment Period|Adverse Event|0|||
162774262|NCT03740919|587882627|FG002|Treatment Period|Adverse Event|2|||
162774263|NCT03740919|587882628|FG003|Treatment Period|Adverse Event|0|||
162774264|NCT03740919|587882625|FG000|Treatment Period|Protocol Violation|0|||
162774265|NCT03740919|587882626|FG001|Treatment Period|Protocol Violation|1|||
162774266|NCT03740919|587882627|FG002|Treatment Period|Protocol Violation|0|||
162774267|NCT03740919|587882628|FG003|Treatment Period|Protocol Violation|0|||
162774268|NCT03740919|587882625|FG000|Treatment Period|Withdrawal by Subject|0|||
162774269|NCT03740919|587882626|FG001|Treatment Period|Withdrawal by Subject|7|||
162774270|NCT03740919|587882627|FG002|Treatment Period|Withdrawal by Subject|6|||
162774271|NCT03740919|587882628|FG003|Treatment Period|Withdrawal by Subject|2|||
162774272|NCT03740919|587882625|FG000|Treatment Period|Terminated by Sponsor|0|||
162774273|NCT03740919|587882626|FG001|Treatment Period|Terminated by Sponsor|1|||
162774274|NCT03740919|587882627|FG002|Treatment Period|Terminated by Sponsor|0|||
162774275|NCT03740919|587882628|FG003|Treatment Period|Terminated by Sponsor|0|||
162774276|NCT03740919|587882625|FG000|Treatment Period|Issue with Insulin Pump|0|||
162774277|NCT03740919|587882626|FG001|Treatment Period|Issue with Insulin Pump|1|||
162774278|NCT03740919|587882627|FG002|Treatment Period|Issue with Insulin Pump|0|||
162774279|NCT03740919|587882628|FG003|Treatment Period|Issue with Insulin Pump|0|||
162774280|NCT03740919|587882625|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
162774281|NCT03740919|587882626|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
162774282|NCT03740919|587882627|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
162774283|NCT03740919|587882628|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
162774284|NCT03740919|587882625|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
162774285|NCT03740919|587882626|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
162774286|NCT03740919|587882627|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
162774287|NCT03740919|587882628|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
162774288|NCT03740919|587882625|FG000|Treatment Period|Not Completing Diary|0|||
162774289|NCT03740919|587882626|FG001|Treatment Period|Not Completing Diary|0|||
162774290|NCT03740919|587882627|FG002|Treatment Period|Not Completing Diary|1|||
162774291|NCT03740919|587882628|FG003|Treatment Period|Not Completing Diary|0|||
162774292|NCT03740919|587882625|FG000|Treatment Period|Insulin Painful to Participant|0|||
162774293|NCT03740919|587882626|FG001|Treatment Period|Insulin Painful to Participant|0|||
162774294|NCT03740919|587882627|FG002|Treatment Period|Insulin Painful to Participant|1|||
162774295|NCT03740919|587882628|FG003|Treatment Period|Insulin Painful to Participant|0|||
162774296|NCT01911819|587882631|FG000|Overall Study|Adverse Event|0|||
162774297|NCT01911819|587882632|FG001|Overall Study|Adverse Event|1|||
162774298|NCT01911819|587882633|FG002|Overall Study|Adverse Event|0|||
162774299|NCT01911819|587882631|FG000|Overall Study|Withdrawal by Subject|1|||
162774300|NCT01911819|587882632|FG001|Overall Study|Withdrawal by Subject|1|||
162774301|NCT01911819|587882633|FG002|Overall Study|Withdrawal by Subject|0|||
162774302|NCT01207453|587882636|FG000|First Intervention|Adverse Event|2|||
162774303|NCT01207453|587882637|FG001|First Intervention|Adverse Event|1|||
162774304|NCT01207453|587882636|FG000|Washout|Adverse Event|1|||
162774305|NCT01207453|587882637|FG001|Washout|Adverse Event|0|||
162774306|NCT01207453|587882636|FG000|Washout|Lost to Follow-up|1|||
162774307|NCT01207453|587882637|FG001|Washout|Lost to Follow-up|0|||
162774308|NCT01207453|587882636|FG000|2nd Intervention|Adverse Event|1|||
162774309|NCT01207453|587882637|FG001|2nd Intervention|Adverse Event|2|||
162774310|NCT01207453|587882636|FG000|2nd Intervention|Lost to Follow-up|1|||
162774311|NCT01207453|587882637|FG001|2nd Intervention|Lost to Follow-up|0|||
162774312|NCT04374253|587882640|FG000|Overall Study|Adverse Event|0|||
162774313|NCT04374253|587882641|FG001|Overall Study|Adverse Event|26|||
162774314|NCT04374253|587882642|FG002|Overall Study|Adverse Event|2|||
162774315|NCT04374253|587882643|FG003|Overall Study|Adverse Event|12|||
162774316|NCT04374253|587882640|FG000|Overall Study|Study terminated by sponsor|13|||
162774317|NCT04374253|587882641|FG001|Overall Study|Study terminated by sponsor|593|||
162774318|NCT04374253|587882642|FG002|Overall Study|Study terminated by sponsor|21|||
162774319|NCT04374253|587882643|FG003|Overall Study|Study terminated by sponsor|567|||
162774320|NCT04374253|587882640|FG000|Overall Study|Withdrawal by Subject|0|||
162774321|NCT04374253|587882641|FG001|Overall Study|Withdrawal by Subject|55|||
162774322|NCT04374253|587882642|FG002|Overall Study|Withdrawal by Subject|3|||
162774323|NCT04374253|587882643|FG003|Overall Study|Withdrawal by Subject|40|||
162774324|NCT04374253|587882640|FG000|Overall Study|Physician Decision|1|||
162774325|NCT04374253|587882641|FG001|Overall Study|Physician Decision|10|||
162774326|NCT04374253|587882642|FG002|Overall Study|Physician Decision|1|||
162774327|NCT04374253|587882643|FG003|Overall Study|Physician Decision|10|||
162774328|NCT04374253|587882640|FG000|Overall Study|Protocol Violation|0|||
162774329|NCT04374253|587882641|FG001|Overall Study|Protocol Violation|0|||
162774330|NCT04374253|587882642|FG002|Overall Study|Protocol Violation|0|||
162774331|NCT04374253|587882643|FG003|Overall Study|Protocol Violation|2|||
162774332|NCT04374253|587882640|FG000|Overall Study|Death|0|||
162774333|NCT04374253|587882641|FG001|Overall Study|Death|3|||
162774334|NCT04374253|587882642|FG002|Overall Study|Death|1|||
162774335|NCT04374253|587882643|FG003|Overall Study|Death|1|||
162774336|NCT04374253|587882640|FG000|Overall Study|Lack of Efficacy|0|||
162774337|NCT04374253|587882641|FG001|Overall Study|Lack of Efficacy|0|||
162774338|NCT04374253|587882642|FG002|Overall Study|Lack of Efficacy|0|||
162774339|NCT04374253|587882643|FG003|Overall Study|Lack of Efficacy|1|||
162774340|NCT04374253|587882640|FG000|Overall Study|Lost to Follow-up|1|||
162774341|NCT04374253|587882641|FG001|Overall Study|Lost to Follow-up|1|||
162774342|NCT04374253|587882642|FG002|Overall Study|Lost to Follow-up|0|||
162774343|NCT04374253|587882643|FG003|Overall Study|Lost to Follow-up|2|||
162774344|NCT04374253|587882640|FG000|Overall Study|Reason Not Specified|0|||
162774345|NCT04374253|587882641|FG001|Overall Study|Reason Not Specified|8|||
162774346|NCT04374253|587882642|FG002|Overall Study|Reason Not Specified|0|||
162774347|NCT04374253|587882643|FG003|Overall Study|Reason Not Specified|8|||
162774348|NCT00448344|587882647|FG000|Overall Study|Lost to Follow-up|20|||
162774349|NCT00448344|587882648|FG001|Overall Study|Lost to Follow-up|22|||
162774350|NCT00448344|587882647|FG000|Overall Study|Withdrawal by Subject|6|||
162774351|NCT00448344|587882648|FG001|Overall Study|Withdrawal by Subject|8|||
162774352|NCT00448344|587882647|FG000|Overall Study|Death|3|||
162774353|NCT00448344|587882648|FG001|Overall Study|Death|4|||
162774354|NCT00448344|587882647|FG000|Overall Study|Physician Decision|1|||
162774355|NCT00448344|587882648|FG001|Overall Study|Physician Decision|2|||
162774356|NCT02329223|587884101|FG000|Overall Study|Withdrawal by Subject|1|||
162774357|NCT02329223|587884102|FG001|Overall Study|Withdrawal by Subject|2|||
162774358|NCT02329223|587884103|FG002|Overall Study|Withdrawal by Subject|5|||
162774359|NCT02329223|587884101|FG000|Overall Study|Physician Decision|0|||
162774360|NCT02329223|587884102|FG001|Overall Study|Physician Decision|0|||
162774361|NCT02329223|587884103|FG002|Overall Study|Physician Decision|1|||
162774362|NCT02329223|587884101|FG000|Overall Study|Adverse Event|0|||
162774363|NCT02329223|587884102|FG001|Overall Study|Adverse Event|1|||
162774364|NCT02329223|587884103|FG002|Overall Study|Adverse Event|0|||
162774365|NCT00651937|587884104|FG000|Overall Study|Withdrawal by Subject|4|||
162774366|NCT00651937|587884105|FG001|Overall Study|Withdrawal by Subject|1|||
162774367|NCT00552513|587884108|FG000|Overall Study|Lost to Follow-up|5|||
162774368|NCT00552513|587884109|FG001|Overall Study|Lost to Follow-up|1|||
162774369|NCT02507687|587884112|FG000|Overall Study|Adverse Event|3|||
162774370|NCT02507687|587884113|FG001|Overall Study|Adverse Event|2|||
162774371|NCT02507687|587884114|FG002|Overall Study|Adverse Event|2|||
162774372|NCT02507687|587884115|FG003|Overall Study|Adverse Event|2|||
162774373|NCT02507687|587884112|FG000|Overall Study|Withdrawal by Subject|1|||
162774374|NCT02507687|587884113|FG001|Overall Study|Withdrawal by Subject|4|||
162774375|NCT02507687|587884114|FG002|Overall Study|Withdrawal by Subject|6|||
162774376|NCT02507687|587884115|FG003|Overall Study|Withdrawal by Subject|6|||
162774377|NCT02507687|587884112|FG000|Overall Study|Protocol Violation|1|||
162774378|NCT02507687|587884113|FG001|Overall Study|Protocol Violation|0|||
162774379|NCT02507687|587884114|FG002|Overall Study|Protocol Violation|2|||
162774380|NCT02507687|587884115|FG003|Overall Study|Protocol Violation|0|||
162774381|NCT02507687|587884112|FG000|Overall Study|Lost to Follow-up|0|||
162774382|NCT02507687|587884113|FG001|Overall Study|Lost to Follow-up|0|||
162774383|NCT02507687|587884114|FG002|Overall Study|Lost to Follow-up|2|||
162774384|NCT02507687|587884115|FG003|Overall Study|Lost to Follow-up|1|||
162774385|NCT02507687|587884112|FG000|Overall Study|Screen Failure|0|||
162774386|NCT02507687|587884113|FG001|Overall Study|Screen Failure|0|||
162774387|NCT02507687|587884114|FG002|Overall Study|Screen Failure|1|||
162774388|NCT02507687|587884115|FG003|Overall Study|Screen Failure|0|||
162774389|NCT02507687|587884112|FG000|Overall Study|Other, Not Specified|0|||
162774390|NCT02507687|587884113|FG001|Overall Study|Other, Not Specified|0|||
162774391|NCT02507687|587884114|FG002|Overall Study|Other, Not Specified|2|||
162774392|NCT02507687|587884115|FG003|Overall Study|Other, Not Specified|4|||
162774393|NCT01503515|587884120|FG000|Overall Study|Adverse Event|4|||
162774394|NCT01503515|587884121|FG001|Overall Study|Adverse Event|5|||
162774395|NCT01503515|587884120|FG000|Overall Study|Death|0|||
162774396|NCT01503515|587884121|FG001|Overall Study|Death|1|||
162774397|NCT01503515|587884120|FG000|Overall Study|Physician Decision|14|||
162774398|NCT01503515|587884121|FG001|Overall Study|Physician Decision|23|||
162774399|NCT01503515|587884120|FG000|Overall Study|Withdrawal by Subject|0|||
162774400|NCT01503515|587884121|FG001|Overall Study|Withdrawal by Subject|1|||
162774401|NCT01503515|587884120|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
162774402|NCT01503515|587884121|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
162774403|NCT01503515|587884120|FG000|Overall Study|Ineligible|1|||
162774404|NCT01503515|587884121|FG001|Overall Study|Ineligible|1|||
162774405|NCT01350102|587884122|FG000|Overall Study|Adverse Event|0|||
162774406|NCT01350102|587884123|FG001|Overall Study|Adverse Event|0|||
162774407|NCT01350102|587884124|FG002|Overall Study|Adverse Event|1|||
162774408|NCT01350102|587884125|FG003|Overall Study|Adverse Event|0|||
162774409|NCT00550771|587884126|FG000|Overall Study|Adverse Event|11|||
162774410|NCT00550771|587884127|FG001|Overall Study|Adverse Event|3|||
162774411|NCT00550771|587884126|FG000|Overall Study|Discontinued for study-related reasons|0|||
162774412|NCT00550771|587884127|FG001|Overall Study|Discontinued for study-related reasons|1|||
162774413|NCT00550771|587884126|FG000|Overall Study|Physician Decision|2|||
162774414|NCT00550771|587884127|FG001|Overall Study|Physician Decision|0|||
162774415|NCT00550771|587884126|FG000|Overall Study|Withdrawal by Subject|0|||
162774416|NCT00550771|587884127|FG001|Overall Study|Withdrawal by Subject|1|||
162774417|NCT00550771|587884126|FG000|Overall Study|Protocol Violation|4|||
162774418|NCT00550771|587884127|FG001|Overall Study|Protocol Violation|5|||
162774419|NCT03681353|587884130|FG000|Overall Study|Lost to Follow-up|2|||
162774420|NCT03681353|587884130|FG000|Overall Study|Withdrawal by Subject|3|||
162774421|NCT03681353|587884130|FG000|Overall Study|withdrawn by PI|2|||
162774422|NCT00726388|587884133|FG000|Overall Study|Withdrawal by Subject|5|||
162774423|NCT00726388|587884133|FG000|Overall Study|Adverse Event|3|||
162774424|NCT00726388|587884133|FG000|Overall Study|Lost to Follow-up|10|||
162774425|NCT00726388|587884133|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
162774426|NCT00726388|587884133|FG000|Overall Study|Other|5|||
162774427|NCT00726388|587884133|FG000|Overall Study|Enrolled, Not Treated|79|||
162774428|NCT01797562|587884139|FG000|Overall Study|Protocol Violation|5|||
162774429|NCT00917462|587884142|FG000|Overall Study|Clinical Deterioration|1|||
162774430|NCT01441583|587884143|FG000|Overall Study|Withdrawal by Subject|1|||
162774431|NCT01441583|587884144|FG001|Overall Study|Withdrawal by Subject|1|||
162774432|NCT01441583|587884145|FG002|Overall Study|Withdrawal by Subject|1|||
162774433|NCT01441583|587884143|FG000|Overall Study|Death|1|||
162774434|NCT01441583|587884144|FG001|Overall Study|Death|0|||
162774435|NCT01441583|587884145|FG002|Overall Study|Death|4|||
162774436|NCT01441583|587884143|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
162774437|NCT01441583|587884144|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
162774438|NCT01441583|587884145|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
162774439|NCT03341312|587884146|FG000|Period 1|Withdrawal by Subject|0|||
162774440|NCT03341312|587884147|FG001|Period 1|Withdrawal by Subject|1|||
162774441|NCT03341312|587884148|FG002|Period 1|Withdrawal by Subject|0|||
162774442|NCT03341312|587884149|FG003|Period 1|Withdrawal by Subject|0|||
162774443|NCT00744796|587884150|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
162774444|NCT05372913|587884154|FG000|Overall Study|Withdrawal by Subject|0|||
162774445|NCT05372913|587884155|FG001|Overall Study|Withdrawal by Subject|2|||
162774446|NCT05372913|587884154|FG000|Overall Study|Protocol Violation|2|||
162774447|NCT05372913|587884155|FG001|Overall Study|Protocol Violation|2|||
162774448|NCT05372913|587884154|FG000|Overall Study|Adverse Event|0|||
162774449|NCT05372913|587884155|FG001|Overall Study|Adverse Event|1|||
162774450|NCT05135156|587884156|FG000|Overall Study|Lost to Follow-up|0|||
162774451|NCT05135156|587884157|FG001|Overall Study|Lost to Follow-up|0|||
162774452|NCT05135156|587884158|FG002|Overall Study|Lost to Follow-up|2|||
162774453|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Adverse Event|3|||
162774454|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Adverse Event|0|||
162774455|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
162774456|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
162774457|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Disease Progression|23|||
162774458|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Disease Progression|22|||
162774459|NCT01379521|587884162|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
162774460|NCT01379521|587884163|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
162774461|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
162774462|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
162774463|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
162774464|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
162774465|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
162774466|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
162774467|NCT01379521|587884162|FG000|Overall Study -Treatment Period|Death|2|||
162774468|NCT01379521|587884163|FG001|Overall Study -Treatment Period|Death|1|||
162774469|NCT01379521|587884162|FG000|Post-Treatment Evaluations|Disease Progression|22|||
162774470|NCT01379521|587884163|FG001|Post-Treatment Evaluations|Disease Progression|20|||
162774471|NCT01379521|587884162|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
162774472|NCT01379521|587884163|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
162774473|NCT01379521|587884162|FG000|Post-Treatment Evaluations|Death|1|||
162774474|NCT01379521|587884163|FG001|Post-Treatment Evaluations|Death|0|||
162774475|NCT00404547|587884166|FG000|Overall Study|Adverse Event|39|||
162774476|NCT00404547|587884167|FG001|Overall Study|Adverse Event|6|||
162774477|NCT00404547|587884166|FG000|Overall Study|Withdrawal by Subject|19|||
162774478|NCT00404547|587884167|FG001|Overall Study|Withdrawal by Subject|2|||
162774479|NCT00404547|587884166|FG000|Overall Study|Protocol Violation|0|||
162774480|NCT00404547|587884167|FG001|Overall Study|Protocol Violation|1|||
162774481|NCT00404547|587884166|FG000|Overall Study|Lost to Follow-up|20|||
162774482|NCT00404547|587884167|FG001|Overall Study|Lost to Follow-up|9|||
162774483|NCT00404547|587884166|FG000|Overall Study|Lack of compliance|5|||
162774484|NCT00404547|587884167|FG001|Overall Study|Lack of compliance|1|||
162774485|NCT00404547|587884166|FG000|Overall Study|Other|4|||
162774486|NCT00404547|587884167|FG001|Overall Study|Other|0|||
162774487|NCT00404547|587884166|FG000|Overall Study|Reason not stated|3|||
162774488|NCT00404547|587884167|FG001|Overall Study|Reason not stated|6|||
162774489|NCT02538471|587884168|FG000|Overall Study|Progression of disease|2|||
162774490|NCT00475735|587884169|FG000|Treatment Period 1|Adverse Event|2|||
162774491|NCT00475735|587884170|FG001|Treatment Period 1|Adverse Event|0|||
162774492|NCT00475735|587884171|FG002|Treatment Period 1|Adverse Event|0|||
162774493|NCT00475735|587884172|FG003|Treatment Period 1|Adverse Event|0|||
162774494|NCT00475735|587884173|FG004|Treatment Period 1|Adverse Event|0|||
162774495|NCT00475735|587884174|FG005|Treatment Period 1|Adverse Event|0|||
162774496|NCT00475735|587884169|FG000|Treatment Period 1|Lack of Efficacy|1|||
162774497|NCT00475735|587884170|FG001|Treatment Period 1|Lack of Efficacy|0|||
162774498|NCT00475735|587884171|FG002|Treatment Period 1|Lack of Efficacy|0|||
162774499|NCT00475735|587884172|FG003|Treatment Period 1|Lack of Efficacy|0|||
162774500|NCT00475735|587884173|FG004|Treatment Period 1|Lack of Efficacy|0|||
162774501|NCT00475735|587884174|FG005|Treatment Period 1|Lack of Efficacy|0|||
162774502|NCT00475735|587884169|FG000|Treatment Period 1|Lost to Follow-up|0|||
162774503|NCT00475735|587884170|FG001|Treatment Period 1|Lost to Follow-up|0|||
162774504|NCT00475735|587884171|FG002|Treatment Period 1|Lost to Follow-up|0|||
162774505|NCT00475735|587884172|FG003|Treatment Period 1|Lost to Follow-up|0|||
162774506|NCT00475735|587884173|FG004|Treatment Period 1|Lost to Follow-up|0|||
162774507|NCT00475735|587884174|FG005|Treatment Period 1|Lost to Follow-up|1|||
162774508|NCT00475735|587884169|FG000|Treatment Period 1|Protocol Violation|0|||
162774509|NCT00475735|587884170|FG001|Treatment Period 1|Protocol Violation|0|||
162774510|NCT00475735|587884171|FG002|Treatment Period 1|Protocol Violation|0|||
162774511|NCT00475735|587884172|FG003|Treatment Period 1|Protocol Violation|1|||
162774512|NCT00475735|587884173|FG004|Treatment Period 1|Protocol Violation|0|||
162774513|NCT00475735|587884174|FG005|Treatment Period 1|Protocol Violation|0|||
162774514|NCT00475735|587884169|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162774515|NCT00475735|587884170|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162774516|NCT00475735|587884171|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162774517|NCT00475735|587884172|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162774518|NCT00475735|587884173|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162774519|NCT00475735|587884174|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162774520|NCT00475735|587884169|FG000|Treatment Period 1|DC due to AE but continuing|0|||
162774521|NCT00475735|587884170|FG001|Treatment Period 1|DC due to AE but continuing|0|||
162774522|NCT00475735|587884171|FG002|Treatment Period 1|DC due to AE but continuing|0|||
162774523|NCT00475735|587884172|FG003|Treatment Period 1|DC due to AE but continuing|1|||
162774524|NCT00475735|587884173|FG004|Treatment Period 1|DC due to AE but continuing|2|||
162774525|NCT00475735|587884174|FG005|Treatment Period 1|DC due to AE but continuing|2|||
162774526|NCT00475735|587884169|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162774527|NCT00475735|587884170|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
162774528|NCT00475735|587884171|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162774529|NCT00475735|587884172|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162774530|NCT00475735|587884173|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162774531|NCT00475735|587884174|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162774532|NCT00475735|587884169|FG000|Treatment Washout|Lost to Follow-up|0|||
162774533|NCT00475735|587884170|FG001|Treatment Washout|Lost to Follow-up|1|||
162774534|NCT00475735|587884171|FG002|Treatment Washout|Lost to Follow-up|0|||
162774535|NCT00475735|587884172|FG003|Treatment Washout|Lost to Follow-up|0|||
162774536|NCT00475735|587884173|FG004|Treatment Washout|Lost to Follow-up|0|||
162774537|NCT00475735|587884174|FG005|Treatment Washout|Lost to Follow-up|0|||
162774538|NCT00475735|587884169|FG000|Treatment Washout|Protocol Violation|0|||
162774539|NCT00475735|587884170|FG001|Treatment Washout|Protocol Violation|1|||
162774540|NCT00475735|587884171|FG002|Treatment Washout|Protocol Violation|0|||
162774541|NCT00475735|587884172|FG003|Treatment Washout|Protocol Violation|0|||
162774542|NCT00475735|587884173|FG004|Treatment Washout|Protocol Violation|0|||
162774543|NCT00475735|587884174|FG005|Treatment Washout|Protocol Violation|0|||
162774544|NCT00475735|587884169|FG000|Treatment Period 2|Adverse Event|0|||
162774545|NCT00475735|587884170|FG001|Treatment Period 2|Adverse Event|1|||
162774546|NCT00475735|587884171|FG002|Treatment Period 2|Adverse Event|0|||
162774547|NCT00475735|587884172|FG003|Treatment Period 2|Adverse Event|2|||
162774548|NCT00475735|587884173|FG004|Treatment Period 2|Adverse Event|0|||
162774549|NCT00475735|587884174|FG005|Treatment Period 2|Adverse Event|0|||
162774550|NCT00475735|587884169|FG000|Treatment Period 2|Lack of Efficacy|0|||
162774551|NCT00475735|587884170|FG001|Treatment Period 2|Lack of Efficacy|0|||
162774552|NCT00475735|587884171|FG002|Treatment Period 2|Lack of Efficacy|0|||
162774553|NCT00475735|587884172|FG003|Treatment Period 2|Lack of Efficacy|0|||
162774554|NCT00475735|587884173|FG004|Treatment Period 2|Lack of Efficacy|0|||
162774555|NCT00475735|587884174|FG005|Treatment Period 2|Lack of Efficacy|1|||
162774556|NCT00475735|587884169|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162774557|NCT00475735|587884170|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162774558|NCT00475735|587884171|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162774559|NCT00475735|587884172|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162774560|NCT00475735|587884173|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162774561|NCT00475735|587884174|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162774562|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
162774563|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162774564|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162774565|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162774566|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162774567|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
162774568|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162774569|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162774570|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162774571|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162774572|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
162774573|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162774574|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162774575|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162774576|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162774577|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
162774578|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162774579|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162774580|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162774581|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162774582|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
162774583|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162774584|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162774585|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162774586|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162774587|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
162774588|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162774589|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162774590|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162774591|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162774592|NCT01187407|587884175|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
162774593|NCT01187407|587884176|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162774594|NCT01187407|587884177|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162774595|NCT01187407|587884178|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162774596|NCT01187407|587884179|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162774597|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
162774598|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162774599|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
162774600|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
162774601|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
162774602|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
162774603|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
162774604|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
162774605|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
162774606|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
162774607|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
162774608|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
162774609|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
162774610|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
162774611|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
162774612|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162774613|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162774614|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162774615|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162774616|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
162774617|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
162774618|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
162774619|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162774620|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
162774621|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
162774622|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
162774623|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
162774624|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
162774625|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
162774626|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
162774627|NCT01187407|587884175|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162774628|NCT01187407|587884176|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162774629|NCT01187407|587884177|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162774630|NCT01187407|587884178|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162774631|NCT01187407|587884179|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
162774632|NCT02382406|587884182|FG000|Study Treatment|Disease Progression|8|||
162774633|NCT02382406|587884183|FG001|Study Treatment|Disease Progression|0|||
162774634|NCT02382406|587884184|FG002|Study Treatment|Disease Progression|20|||
162774635|NCT02382406|587884182|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
162774636|NCT02382406|587884183|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
162774637|NCT02382406|587884184|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
162774638|NCT02382406|587884182|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
162774639|NCT02382406|587884183|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
162774640|NCT02382406|587884184|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
162774641|NCT02382406|587884182|FG000|Study Treatment|symptomatic deterioration|1|||
162774642|NCT02382406|587884183|FG001|Study Treatment|symptomatic deterioration|0|||
162774643|NCT02382406|587884184|FG002|Study Treatment|symptomatic deterioration|1|||
162774644|NCT02382406|587884182|FG000|Study Treatment|Death|0|||
162774645|NCT02382406|587884183|FG001|Study Treatment|Death|0|||
162774646|NCT02382406|587884184|FG002|Study Treatment|Death|2|||
162774647|NCT02382406|587884182|FG000|Follow up|Death|11|||
162774648|NCT02382406|587884183|FG001|Follow up|Death|0|||
162774649|NCT02382406|587884184|FG002|Follow up|Death|19|||
162774650|NCT02382406|587884182|FG000|Follow up|Symptomatic deterioration|1|||
162774651|NCT02382406|587884183|FG001|Follow up|Symptomatic deterioration|0|||
162774652|NCT02382406|587884184|FG002|Follow up|Symptomatic deterioration|1|||
162774653|NCT02382406|587884182|FG000|Follow up|Patient Refused Follow-up|1|||
162774654|NCT02382406|587884183|FG001|Follow up|Patient Refused Follow-up|0|||
162774655|NCT02382406|587884184|FG002|Follow up|Patient Refused Follow-up|0|||
162774656|NCT02382406|587884182|FG000|Follow up|Study Terminated|1|||
162774657|NCT02382406|587884183|FG001|Follow up|Study Terminated|0|||
162774658|NCT02382406|587884184|FG002|Follow up|Study Terminated|8|||
162774659|NCT02382406|587884182|FG000|Follow up|Withdrawal by Subject|0|||
162774660|NCT02382406|587884183|FG001|Follow up|Withdrawal by Subject|0|||
162774661|NCT02382406|587884184|FG002|Follow up|Withdrawal by Subject|2|||
162774662|NCT01713998|587884185|FG000|Overall Study|Lost to Follow-up|2|||
162774663|NCT01713998|587884186|FG001|Overall Study|Lost to Follow-up|0|||
162774664|NCT01713998|587884187|FG002|Overall Study|Lost to Follow-up|2|||
162774665|NCT01713998|587884185|FG000|Overall Study|Withdrawal by Subject|1|||
162774666|NCT01713998|587884186|FG001|Overall Study|Withdrawal by Subject|0|||
162774667|NCT01713998|587884187|FG002|Overall Study|Withdrawal by Subject|0|||
162774668|NCT00125853|587884188|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
162774669|NCT00125853|587884189|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
162774670|NCT02350127|587884190|FG000|4-Month Assessment|Withdrawal by Subject|10|||
162774671|NCT02350127|587884191|FG001|4-Month Assessment|Withdrawal by Subject|9|||
162774672|NCT02350127|587884190|FG000|4-Month Assessment|Death|1|||
162774673|NCT02350127|587884191|FG001|4-Month Assessment|Death|0|||
162774674|NCT02350127|587884190|FG000|8-Month Assessment|Death|1|||
162774675|NCT02350127|587884191|FG001|8-Month Assessment|Death|1|||
162774676|NCT02350127|587884190|FG000|8-Month Assessment|Withdrawal by Subject|5|||
162774677|NCT02350127|587884191|FG001|8-Month Assessment|Withdrawal by Subject|8|||
162774678|NCT00157209|587884192|FG000|Overall Study|Ongoing at data cut-off|10|||
162774679|NCT00157209|587884193|FG001|Overall Study|Ongoing at data cut-off|0|||
162774680|NCT01348763|587884194|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
162774681|NCT01348763|587884194|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
162774682|NCT00050167|587884206|FG000|Overall Study|not eligible not invasive|1|||
162774683|NCT00050167|587884207|FG001|Overall Study|not eligible not invasive|1|||
162774684|NCT01363297|587884208|FG000|Overall Study|Other|0|||
162774685|NCT01363297|587884209|FG001|Overall Study|Other|0|||
162774686|NCT01363297|587884210|FG002|Overall Study|Other|0|||
162774687|NCT01363297|587884211|FG003|Overall Study|Other|0|||
162774688|NCT01363297|587884212|FG004|Overall Study|Other|1|||
162774689|NCT01363297|587884208|FG000|Overall Study|Death|3|||
162774690|NCT01363297|587884209|FG001|Overall Study|Death|6|||
162774691|NCT01363297|587884210|FG002|Overall Study|Death|6|||
162774692|NCT01363297|587884211|FG003|Overall Study|Death|10|||
162774693|NCT01363297|587884212|FG004|Overall Study|Death|30|||
162774694|NCT02038803|587884216|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
162774695|NCT02038803|587884216|FG000|Overall Study|Lost to Follow-up|1|||
162774696|NCT04754594|587884217|FG000|Blinded Period|Withdrawal by Subject|4|||
162774697|NCT04754594|587884218|FG001|Blinded Period|Withdrawal by Subject|9|||
162774698|NCT04754594|587884219|FG002|Blinded Period|Withdrawal by Subject|0|||
162774699|NCT04754594|587884220|FG003|Blinded Period|Withdrawal by Subject|0|||
162774700|NCT04754594|587884217|FG000|Blinded Period|Protocol Violation|2|||
162774701|NCT04754594|587884218|FG001|Blinded Period|Protocol Violation|2|||
162774702|NCT04754594|587884219|FG002|Blinded Period|Protocol Violation|0|||
162774703|NCT04754594|587884220|FG003|Blinded Period|Protocol Violation|0|||
162774704|NCT04754594|587884217|FG000|Blinded Period|Lost to Follow-up|1|||
162774705|NCT04754594|587884218|FG001|Blinded Period|Lost to Follow-up|1|||
162774706|NCT04754594|587884219|FG002|Blinded Period|Lost to Follow-up|0|||
162774707|NCT04754594|587884220|FG003|Blinded Period|Lost to Follow-up|0|||
162774708|NCT04754594|587884217|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
162774709|NCT04754594|587884218|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
162774710|NCT04754594|587884219|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
162774711|NCT04754594|587884220|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
162774712|NCT04754594|587884217|FG000|Unblinded Period|Withdrawal by Subject|6|||
162774713|NCT04754594|587884218|FG001|Unblinded Period|Withdrawal by Subject|8|||
162774714|NCT04754594|587884219|FG002|Unblinded Period|Withdrawal by Subject|0|||
162774715|NCT04754594|587884220|FG003|Unblinded Period|Withdrawal by Subject|0|||
162774716|NCT04754594|587884217|FG000|Unblinded Period|Lost to Follow-up|5|||
162774717|NCT04754594|587884218|FG001|Unblinded Period|Lost to Follow-up|3|||
162774718|NCT04754594|587884219|FG002|Unblinded Period|Lost to Follow-up|0|||
162774719|NCT04754594|587884220|FG003|Unblinded Period|Lost to Follow-up|0|||
162774720|NCT04754594|587884217|FG000|Unblinded Period|Protocol Violation|2|||
162774721|NCT04754594|587884218|FG001|Unblinded Period|Protocol Violation|4|||
162774722|NCT04754594|587884219|FG002|Unblinded Period|Protocol Violation|0|||
162774723|NCT04754594|587884220|FG003|Unblinded Period|Protocol Violation|0|||
162774724|NCT04754594|587884217|FG000|Unblinded Period|Other|3|||
162774725|NCT04754594|587884218|FG001|Unblinded Period|Other|0|||
162774726|NCT04754594|587884219|FG002|Unblinded Period|Other|0|||
162774727|NCT04754594|587884220|FG003|Unblinded Period|Other|0|||
162774728|NCT04754594|587884217|FG000|Infant Participants|Withdrawal by Subject|0|||
162774729|NCT04754594|587884218|FG001|Infant Participants|Withdrawal by Subject|0|||
162774730|NCT04754594|587884219|FG002|Infant Participants|Withdrawal by Subject|9|||
162774731|NCT04754594|587884220|FG003|Infant Participants|Withdrawal by Subject|17|||
162774732|NCT04754594|587884217|FG000|Infant Participants|Lost to Follow-up|0|||
162774733|NCT04754594|587884218|FG001|Infant Participants|Lost to Follow-up|0|||
162774734|NCT04754594|587884219|FG002|Infant Participants|Lost to Follow-up|4|||
162774735|NCT04754594|587884220|FG003|Infant Participants|Lost to Follow-up|10|||
162774736|NCT04754594|587884217|FG000|Infant Participants|Death|0|||
162774737|NCT04754594|587884218|FG001|Infant Participants|Death|0|||
162774738|NCT04754594|587884219|FG002|Infant Participants|Death|1|||
162774739|NCT04754594|587884220|FG003|Infant Participants|Death|1|||
162774740|NCT04754594|587884217|FG000|Infant Participants|Other|0|||
162774741|NCT04754594|587884218|FG001|Infant Participants|Other|0|||
162774742|NCT04754594|587884219|FG002|Infant Participants|Other|1|||
162774743|NCT04754594|587884220|FG003|Infant Participants|Other|1|||
162774744|NCT01247922|587884221|FG000|Overall Study|Disease progression|4|||
162774745|NCT02116582|587884222|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
162774746|NCT02116582|587884222|FG000|Overall Study|Adverse Event|22|||
162774747|NCT02116582|587884222|FG000|Overall Study|Death|9|||
162774748|NCT02116582|587884222|FG000|Overall Study|Progressive Disease|148|||
162774749|NCT02116582|587884222|FG000|Overall Study|Protocol Violation|3|||
162774750|NCT02116582|587884222|FG000|Overall Study|Withdrawal by Subject|8|||
162774751|NCT02116582|587884222|FG000|Overall Study|Other: Miscellaneous|11|||
162774752|NCT02116582|587884222|FG000|Overall Study|Lost to Follow-up|1|||
162774753|NCT02116582|587884222|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
162774754|NCT01876823|587884223|FG000|Overall Study|Withdrawal by Subject|5|||
162774755|NCT01876823|587884223|FG000|Overall Study|Physician Decision|2|||
162774756|NCT01876823|587884223|FG000|Overall Study|Patients moved|2|||
162774757|NCT00577096|587884224|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
162774758|NCT00577096|587884225|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
162774759|NCT00577096|587884224|FG000|Short Term Participation|Withdrawal by Subject|3|||
162774760|NCT00577096|587884225|FG001|Short Term Participation|Withdrawal by Subject|5|||
162774761|NCT00577096|587884224|FG000|Short Term Participation|Death|1|||
162774762|NCT00577096|587884225|FG001|Short Term Participation|Death|1|||
162774763|NCT00832650|587884226|FG000|Overall Study|Randomized but not treated|0|||
162774764|NCT00832650|587884227|FG001|Overall Study|Randomized but not treated|0|||
162774765|NCT00832650|587884228|FG002|Overall Study|Randomized but not treated|1|||
162774766|NCT00440037|587884233|FG000|Overall Study|Withdrawal by Subject|6|||
162774767|NCT00440037|587884233|FG000|Overall Study|Administrative decision|3|||
162774768|NCT00794573|587884234|FG000|Overall Study|Death|3|||
162774769|NCT00794573|587884235|FG001|Overall Study|Death|0|||
162774770|NCT00794573|587884234|FG000|Overall Study|Withdrawal by Subject|9|||
162774771|NCT00794573|587884235|FG001|Overall Study|Withdrawal by Subject|12|||
162774772|NCT00794573|587884234|FG000|Overall Study|Lost to Follow-up|26|||
162774773|NCT00794573|587884235|FG001|Overall Study|Lost to Follow-up|33|||
162774774|NCT03356145|587884236|FG000|Overall Study|Withdrawal by Subject|2|||
162774775|NCT03356145|587884237|FG001|Overall Study|Withdrawal by Subject|1|||
162774776|NCT03356145|587884236|FG000|Overall Study|Did not meet inclusion criteria|1|||
162774777|NCT03356145|587884237|FG001|Overall Study|Did not meet inclusion criteria|0|||
162774778|NCT04382053|587884245|FG000|Overall Study|Death|6|||
162774779|NCT04382053|587884246|FG001|Overall Study|Death|8|||
162774780|NCT04382053|587884245|FG000|Overall Study|Lost to Follow-up|0|||
162774781|NCT04382053|587884246|FG001|Overall Study|Lost to Follow-up|2|||
162774782|NCT04382053|587884245|FG000|Overall Study|Protocol Deviation|1|||
162774783|NCT04382053|587884246|FG001|Overall Study|Protocol Deviation|2|||
162774784|NCT04382053|587884245|FG000|Overall Study|Withdrawal by Subject|2|||
162774785|NCT04382053|587884246|FG001|Overall Study|Withdrawal by Subject|1|||
162774786|NCT01399905|587884249|FG000|Overall Study|Withdrawal by Subject|1|||
162774787|NCT01399905|587884250|FG001|Overall Study|Withdrawal by Subject|1|||
162774788|NCT01945086|587884251|FG000|Overall Study|Withdrawal by Subject|1|||
162774789|NCT01945086|587884252|FG001|Overall Study|Withdrawal by Subject|0|||
162774790|NCT01945086|587884253|FG002|Overall Study|Withdrawal by Subject|1|||
162774791|NCT01945086|587884251|FG000|Overall Study|Adverse Event|0|||
162774792|NCT01945086|587884252|FG001|Overall Study|Adverse Event|0|||
162774793|NCT01945086|587884253|FG002|Overall Study|Adverse Event|1|||
162774794|NCT01808144|587884254|FG000|Overall Study|Death|1|||
162774795|NCT01808144|587884255|FG001|Overall Study|Death|0|||
162774796|NCT01808144|587884254|FG000|Overall Study|Withdrawal by Subject|16|||
162774797|NCT01808144|587884255|FG001|Overall Study|Withdrawal by Subject|23|||
162774798|NCT01808144|587884254|FG000|Overall Study|Lost to Follow-up|6|||
162774799|NCT01808144|587884255|FG001|Overall Study|Lost to Follow-up|3|||
162774800|NCT01808144|587884254|FG000|Overall Study|Protocol Violation|6|||
162774801|NCT01808144|587884255|FG001|Overall Study|Protocol Violation|6|||
162774802|NCT01808144|587884254|FG000|Overall Study|Gout flare|0|||
162774803|NCT01808144|587884255|FG001|Overall Study|Gout flare|1|||
162774804|NCT01808144|587884254|FG000|Overall Study|Adverse Event|11|||
162774805|NCT01808144|587884255|FG001|Overall Study|Adverse Event|15|||
162774806|NCT03993054|587884256|FG000|Overall Study|PI Decision|1|||
162774807|NCT00383500|587884257|FG000|Overall Study|Withdrawal by Subject|8|||
162774808|NCT00383500|587884258|FG001|Overall Study|Withdrawal by Subject|3|||
162774809|NCT00383500|587884259|FG002|Overall Study|Withdrawal by Subject|0|||
162774810|NCT00383500|587884257|FG000|Overall Study|Lost to Follow-up|0|||
162774811|NCT00383500|587884258|FG001|Overall Study|Lost to Follow-up|0|||
162774812|NCT00383500|587884259|FG002|Overall Study|Lost to Follow-up|2|||
162774813|NCT02093897|587886202|FG000|Overall Study|Physician Decision|1|||
162774814|NCT02093897|587886202|FG000|Overall Study|Planned age group closure - no's reached|17|||
162774815|NCT02093897|587886202|FG000|Overall Study|Adverse event, non-fatal|1|||
162774816|NCT02972242|587886203|FG000|Overall Study|Withdrawal by Subject|1|||
162774817|NCT02972242|587886204|FG001|Overall Study|Withdrawal by Subject|0|||
162774818|NCT04572997|587886208|FG000|Overall Study|Adverse Event|1|||
162774819|NCT03098797|587886209|FG000|Part 2 Open Label Extension|Adverse Event|2|||
162774820|NCT03098797|587886210|FG001|Part 2 Open Label Extension|Adverse Event|0|||
162774821|NCT02720185|587886214|FG000|Overall Study|Lost to Follow-up|1|||
162774822|NCT00275301|587886217|FG000|Overall Study|Adverse Event|5|||
162774823|NCT04357964|587886218|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
162774824|NCT04357964|587886219|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
162774825|NCT04357964|587886218|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
162774826|NCT04357964|587886219|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
162774827|NCT04357964|587886218|FG000|Overall Study|Adipose sample was insufficient quality|0|||
162774828|NCT04357964|587886219|FG001|Overall Study|Adipose sample was insufficient quality|1|||
162774829|NCT00733226|587886220|FG000|Overall Study|Withdrawal by Subject|1|||
162774830|NCT00733226|587886221|FG001|Overall Study|Withdrawal by Subject|0|||
162774831|NCT00733226|587886220|FG000|Overall Study|Lost to Follow-up|2|||
162774832|NCT00733226|587886221|FG001|Overall Study|Lost to Follow-up|0|||
162774833|NCT00733226|587886220|FG000|Overall Study|moved to another place|2|||
162774834|NCT00733226|587886221|FG001|Overall Study|moved to another place|0|||
162774835|NCT00349622|587886228|FG000|Overall Study|Death|168|||
162774836|NCT00349622|587886229|FG001|Overall Study|Death|86|||
162774837|NCT00349622|587886228|FG000|Overall Study|Lost to Follow-up|5|||
162774838|NCT00349622|587886229|FG001|Overall Study|Lost to Follow-up|1|||
162774839|NCT00349622|587886228|FG000|Overall Study|Withdrawal by Subject|5|||
162774840|NCT00349622|587886229|FG001|Overall Study|Withdrawal by Subject|9|||
162774841|NCT03296566|587886230|FG000|Overall Study|Lost to Follow-up|19|||
162774842|NCT03296566|587886231|FG001|Overall Study|Lost to Follow-up|46|||
162774843|NCT03296566|587886230|FG000|Overall Study|Withdrawal by Subject|0|||
162774844|NCT03296566|587886231|FG001|Overall Study|Withdrawal by Subject|3|||
162774845|NCT03511378|587886235|FG000|Overall Study|Withdrawal by Subject|2|||
162774846|NCT03511378|587886236|FG001|Overall Study|Withdrawal by Subject|2|||
162774847|NCT03511378|587886235|FG000|Overall Study|Patient not coming or schedule visit|1|||
162774848|NCT03511378|587886236|FG001|Overall Study|Patient not coming or schedule visit|0|||
162774849|NCT03022578|587886238|FG000|Overall Study|Adverse Event|1|||
162774850|NCT03022578|587886238|FG000|Overall Study|Lack of Efficacy|2|||
162774851|NCT03022578|587886238|FG000|Overall Study|Withdrawal by Subject|1|||
162774852|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
162774853|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
162774854|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
162774855|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
162774856|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
162774857|NCT00520403|587886239|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
162774858|NCT00520403|587886239|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
162774859|NCT00520403|587886239|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
162774860|NCT00805285|587886242|FG000|Overall Study|Lack of Efficacy|1|||
162774861|NCT01812707|587886243|FG000|Overall Study|Adverse Event|0|||
162774862|NCT01812707|587886244|FG001|Overall Study|Adverse Event|0|||
162774863|NCT01812707|587886245|FG002|Overall Study|Adverse Event|0|||
162774864|NCT01812707|587886246|FG003|Overall Study|Adverse Event|2|||
162774865|NCT01812707|587886243|FG000|Overall Study|Poor compliance to protocol|1|||
162774866|NCT01812707|587886244|FG001|Overall Study|Poor compliance to protocol|0|||
162774867|NCT01812707|587886245|FG002|Overall Study|Poor compliance to protocol|0|||
162774868|NCT01812707|587886246|FG003|Overall Study|Poor compliance to protocol|0|||
162774869|NCT01812707|587886243|FG000|Overall Study|Consent withdrawn by participant|1|||
162774870|NCT01812707|587886244|FG001|Overall Study|Consent withdrawn by participant|0|||
162774871|NCT01812707|587886245|FG002|Overall Study|Consent withdrawn by participant|0|||
162774872|NCT01812707|587886246|FG003|Overall Study|Consent withdrawn by participant|0|||
162774873|NCT01697592|587886248|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
162774874|NCT01697592|587886249|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774875|NCT01697592|587886250|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774876|NCT01697592|587886251|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774877|NCT01697592|587886252|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774878|NCT01697592|587886253|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774879|NCT01697592|587886254|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774880|NCT01697592|587886255|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774881|NCT01697592|587886256|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774882|NCT01697592|587886257|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162774883|NCT01697592|587886248|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774884|NCT01697592|587886249|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774885|NCT01697592|587886250|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774886|NCT01697592|587886251|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774887|NCT01697592|587886252|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774888|NCT01697592|587886253|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
162774889|NCT01697592|587886254|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774890|NCT01697592|587886255|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774891|NCT01697592|587886256|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774892|NCT01697592|587886257|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162774893|NCT01697592|587886248|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
162774894|NCT01697592|587886249|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774895|NCT01697592|587886250|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774896|NCT01697592|587886251|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774897|NCT01697592|587886252|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774898|NCT01697592|587886253|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774899|NCT01697592|587886254|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774900|NCT01697592|587886255|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774901|NCT01697592|587886256|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774902|NCT01697592|587886257|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162774903|NCT01697592|587886248|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162774904|NCT01697592|587886249|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162774905|NCT01697592|587886250|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774906|NCT01697592|587886251|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774907|NCT01697592|587886252|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774908|NCT01697592|587886253|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774909|NCT01697592|587886254|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162774910|NCT01697592|587886255|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774911|NCT01697592|587886256|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162774912|NCT01697592|587886257|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162774913|NCT01697592|587886248|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162774914|NCT01697592|587886249|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
162774915|NCT01697592|587886250|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162774916|NCT01697592|587886251|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
162774917|NCT01697592|587886252|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162774918|NCT01697592|587886253|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162774919|NCT01697592|587886254|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162774920|NCT01697592|587886255|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162774921|NCT01697592|587886256|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162774922|NCT01697592|587886257|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162774923|NCT01697592|587886248|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
162774924|NCT01697592|587886249|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774925|NCT01697592|587886250|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774926|NCT01697592|587886251|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
162774927|NCT01697592|587886252|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774928|NCT01697592|587886253|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774929|NCT01697592|587886254|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774930|NCT01697592|587886255|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774931|NCT01697592|587886256|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774932|NCT01697592|587886257|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162774933|NCT01697592|587886248|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
162774934|NCT01697592|587886249|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774935|NCT01697592|587886250|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774936|NCT01697592|587886251|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774937|NCT01697592|587886252|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774938|NCT01697592|587886253|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
162774939|NCT01697592|587886254|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774940|NCT01697592|587886255|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
162774941|NCT01697592|587886256|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774942|NCT01697592|587886257|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162774943|NCT01697592|587886248|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162774944|NCT01697592|587886249|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162774945|NCT01697592|587886250|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162774946|NCT01697592|587886251|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162774947|NCT01697592|587886252|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162774948|NCT01697592|587886253|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162774949|NCT01697592|587886254|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162774950|NCT01697592|587886255|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162774951|NCT01697592|587886256|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162774952|NCT01697592|587886257|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162774953|NCT02396758|587886258|FG000|Overall Study|Withdrawal by Subject|2|||
162774954|NCT02396758|587886259|FG001|Overall Study|Withdrawal by Subject|0|||
162774955|NCT02396758|587886260|FG002|Overall Study|Withdrawal by Subject|0|||
162774956|NCT02396758|587886261|FG003|Overall Study|Withdrawal by Subject|1|||
162774957|NCT02396758|587886258|FG000|Overall Study|Lost to Follow-up|8|||
162774958|NCT02396758|587886259|FG001|Overall Study|Lost to Follow-up|5|||
162774959|NCT02396758|587886260|FG002|Overall Study|Lost to Follow-up|3|||
162774960|NCT02396758|587886261|FG003|Overall Study|Lost to Follow-up|3|||
162774961|NCT02396758|587886258|FG000|Overall Study|Death|1|||
162774962|NCT02396758|587886259|FG001|Overall Study|Death|1|||
162774963|NCT02396758|587886260|FG002|Overall Study|Death|0|||
162774964|NCT02396758|587886261|FG003|Overall Study|Death|1|||
162774965|NCT02396758|587886258|FG000|Overall Study|Randomized but not treated|1|||
162774966|NCT02396758|587886259|FG001|Overall Study|Randomized but not treated|0|||
162774967|NCT02396758|587886260|FG002|Overall Study|Randomized but not treated|1|||
162774968|NCT02396758|587886261|FG003|Overall Study|Randomized but not treated|0|||
162774969|NCT01631825|587886262|FG000|Overall Study|Adverse Event|42|||
162774970|NCT01631825|587886262|FG000|Overall Study|Lack of Efficacy|7|||
162774971|NCT01631825|587886262|FG000|Overall Study|Withdrawal by Subject|9|||
162774972|NCT01631825|587886262|FG000|Overall Study|Protocol Violation|4|||
162774973|NCT01631825|587886262|FG000|Overall Study|Discontinuation criteria|1|||
162774974|NCT01631825|587886262|FG000|Overall Study|Physician Decision|2|||
162774975|NCT02110225|587886263|FG000|Overall Study|Lost to Follow-up|0|||
162774976|NCT02110225|587886264|FG001|Overall Study|Lost to Follow-up|1|||
162774977|NCT02110225|587886265|FG002|Overall Study|Lost to Follow-up|0|||
162774978|NCT01116440|587886266|FG000|Treatment|Withdrawal by Subject|2|||
162774979|NCT01116440|587886267|FG001|Treatment|Withdrawal by Subject|2|||
162774980|NCT01116440|587886266|FG000|Treatment|Lost to Follow-up|1|||
162774981|NCT01116440|587886267|FG001|Treatment|Lost to Follow-up|1|||
162774982|NCT01116440|587886266|FG000|Treatment|Protocol Violation|0|||
162774983|NCT01116440|587886267|FG001|Treatment|Protocol Violation|2|||
162774984|NCT01116440|587886266|FG000|Treatment|Lack of Efficacy|0|||
162774985|NCT01116440|587886267|FG001|Treatment|Lack of Efficacy|1|||
162774986|NCT01116440|587886266|FG000|Treatment|Adverse Event|0|||
162774987|NCT01116440|587886267|FG001|Treatment|Adverse Event|1|||
162774988|NCT01116440|587886266|FG000|Withdrawal|Withdrawal by Subject|0|||
162774989|NCT01116440|587886267|FG001|Withdrawal|Withdrawal by Subject|1|||
162774990|NCT01116440|587886266|FG000|Withdrawal|Lost to Follow-up|0|||
162774991|NCT01116440|587886267|FG001|Withdrawal|Lost to Follow-up|1|||
162774992|NCT01116440|587886266|FG000|Follow-up|Lost to Follow-up|0|||
162774993|NCT01116440|587886267|FG001|Follow-up|Lost to Follow-up|1|||
162774994|NCT01116440|587886266|FG000|Follow-up|Withdrawal by Subject|0|||
162774995|NCT01116440|587886267|FG001|Follow-up|Withdrawal by Subject|1|||
162774996|NCT00774306|587886268|FG000|Overall Study|Adverse Event|3|||
162774997|NCT00774306|587886269|FG001|Overall Study|Adverse Event|0|||
162774998|NCT00774306|587886270|FG002|Overall Study|Adverse Event|0|||
162774999|NCT00774306|587886271|FG003|Overall Study|Adverse Event|0|||
162775000|NCT00774306|587886268|FG000|Overall Study|Protocol Violation|2|||
162775001|NCT00774306|587886269|FG001|Overall Study|Protocol Violation|0|||
162775002|NCT00774306|587886270|FG002|Overall Study|Protocol Violation|3|||
162775003|NCT00774306|587886271|FG003|Overall Study|Protocol Violation|0|||
162775004|NCT00774306|587886268|FG000|Overall Study|Withdrawal by Subject|6|||
162775005|NCT00774306|587886269|FG001|Overall Study|Withdrawal by Subject|1|||
162775006|NCT00774306|587886270|FG002|Overall Study|Withdrawal by Subject|1|||
162775007|NCT00774306|587886271|FG003|Overall Study|Withdrawal by Subject|0|||
162775008|NCT00774306|587886268|FG000|Overall Study|Lost to Follow-up|6|||
162775009|NCT00774306|587886269|FG001|Overall Study|Lost to Follow-up|0|||
162775010|NCT00774306|587886270|FG002|Overall Study|Lost to Follow-up|4|||
162775011|NCT00774306|587886271|FG003|Overall Study|Lost to Follow-up|5|||
162775012|NCT00774306|587886268|FG000|Overall Study|Death|1|||
162775013|NCT00774306|587886269|FG001|Overall Study|Death|1|||
162775014|NCT00774306|587886270|FG002|Overall Study|Death|0|||
162775015|NCT00774306|587886271|FG003|Overall Study|Death|0|||
162775016|NCT01126879|587886277|FG000|Overall Study|Progressive Disease|3|||
162775017|NCT01126879|587886278|FG001|Overall Study|Progressive Disease|1|||
162775018|NCT01126879|587886277|FG000|Overall Study|Withdrawal by Subject|1|||
162775019|NCT01126879|587886278|FG001|Overall Study|Withdrawal by Subject|0|||
162775020|NCT01126879|587886277|FG000|Overall Study|Adverse Event|0|||
162775021|NCT01126879|587886278|FG001|Overall Study|Adverse Event|1|||
162775022|NCT01126879|587886277|FG000|Overall Study|Physician Decision|1|||
162775023|NCT01126879|587886278|FG001|Overall Study|Physician Decision|0|||
162775024|NCT00899379|587886281|FG000|Overall Study|Adverse Event|2|||
162775025|NCT00899379|587886282|FG001|Overall Study|Adverse Event|2|||
162775026|NCT00899379|587886283|FG002|Overall Study|Adverse Event|1|||
162775027|NCT00899379|587886284|FG003|Overall Study|Adverse Event|1|||
162775028|NCT00899379|587886285|FG004|Overall Study|Adverse Event|2|||
162775029|NCT00899379|587886281|FG000|Overall Study|Lack of Efficacy|0|||
162775030|NCT00899379|587886282|FG001|Overall Study|Lack of Efficacy|4|||
162775031|NCT00899379|587886283|FG002|Overall Study|Lack of Efficacy|3|||
162775032|NCT00899379|587886284|FG003|Overall Study|Lack of Efficacy|0|||
162775033|NCT00899379|587886285|FG004|Overall Study|Lack of Efficacy|1|||
162775034|NCT00899379|587886281|FG000|Overall Study|Lost to Follow-up|9|||
162775035|NCT00899379|587886282|FG001|Overall Study|Lost to Follow-up|3|||
162775036|NCT00899379|587886283|FG002|Overall Study|Lost to Follow-up|0|||
162775037|NCT00899379|587886284|FG003|Overall Study|Lost to Follow-up|6|||
162775038|NCT00899379|587886285|FG004|Overall Study|Lost to Follow-up|2|||
162775039|NCT00899379|587886281|FG000|Overall Study|Protocol Violation|0|||
162775040|NCT00899379|587886282|FG001|Overall Study|Protocol Violation|0|||
162775041|NCT00899379|587886283|FG002|Overall Study|Protocol Violation|1|||
162775042|NCT00899379|587886284|FG003|Overall Study|Protocol Violation|1|||
162775043|NCT00899379|587886285|FG004|Overall Study|Protocol Violation|0|||
162775044|NCT00899379|587886281|FG000|Overall Study|Withdrawal by Subject|2|||
162775045|NCT00899379|587886282|FG001|Overall Study|Withdrawal by Subject|4|||
162775046|NCT00899379|587886283|FG002|Overall Study|Withdrawal by Subject|2|||
162775047|NCT00899379|587886284|FG003|Overall Study|Withdrawal by Subject|3|||
162775048|NCT00899379|587886285|FG004|Overall Study|Withdrawal by Subject|6|||
162775049|NCT00899379|587886281|FG000|Overall Study|Pregnancy|0|||
162775050|NCT00899379|587886282|FG001|Overall Study|Pregnancy|0|||
162775051|NCT00899379|587886283|FG002|Overall Study|Pregnancy|1|||
162775052|NCT00899379|587886284|FG003|Overall Study|Pregnancy|0|||
162775053|NCT00899379|587886285|FG004|Overall Study|Pregnancy|1|||
162775054|NCT00899379|587886281|FG000|Overall Study|Patient Uncooperative|0|||
162775055|NCT00899379|587886282|FG001|Overall Study|Patient Uncooperative|1|||
162775056|NCT00899379|587886283|FG002|Overall Study|Patient Uncooperative|0|||
162775057|NCT00899379|587886284|FG003|Overall Study|Patient Uncooperative|1|||
162775058|NCT00899379|587886285|FG004|Overall Study|Patient Uncooperative|2|||
162775059|NCT00899379|587886281|FG000|Overall Study|Abnormal Baseline ECG|0|||
162775060|NCT00899379|587886282|FG001|Overall Study|Abnormal Baseline ECG|0|||
162775061|NCT00899379|587886283|FG002|Overall Study|Abnormal Baseline ECG|0|||
162775062|NCT00899379|587886284|FG003|Overall Study|Abnormal Baseline ECG|1|||
162775063|NCT00899379|587886285|FG004|Overall Study|Abnormal Baseline ECG|0|||
162775064|NCT00899379|587886281|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162775065|NCT00899379|587886282|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162775066|NCT00899379|587886283|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162775067|NCT00899379|587886284|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775068|NCT00899379|587886285|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775069|NCT00899379|587886281|FG000|Overall Study|Not Completed/Entered Extn|5|||
162775070|NCT00899379|587886282|FG001|Overall Study|Not Completed/Entered Extn|1|||
162775071|NCT00899379|587886283|FG002|Overall Study|Not Completed/Entered Extn|6|||
162775072|NCT00899379|587886284|FG003|Overall Study|Not Completed/Entered Extn|4|||
162775073|NCT00899379|587886285|FG004|Overall Study|Not Completed/Entered Extn|3|||
162775074|NCT00899379|587886281|FG000|Overall Study|Study Terminated|3|||
162775075|NCT00899379|587886282|FG001|Overall Study|Study Terminated|0|||
162775076|NCT00899379|587886283|FG002|Overall Study|Study Terminated|3|||
162775077|NCT00899379|587886284|FG003|Overall Study|Study Terminated|3|||
162775078|NCT00899379|587886285|FG004|Overall Study|Study Terminated|1|||
162775079|NCT00899379|587886281|FG000|Overall Study|Lost to Follow-up|3|||
162775080|NCT00899379|587886282|FG001|Overall Study|Lost to Follow-up|1|||
162775081|NCT00899379|587886283|FG002|Overall Study|Lost to Follow-up|0|||
162775082|NCT00899379|587886284|FG003|Overall Study|Lost to Follow-up|2|||
162775083|NCT00899379|587886285|FG004|Overall Study|Lost to Follow-up|5|||
162775084|NCT00899379|587886281|FG000|Overall Study|Withdrawal by Subject|4|||
162775085|NCT00899379|587886282|FG001|Overall Study|Withdrawal by Subject|7|||
162775086|NCT00899379|587886283|FG002|Overall Study|Withdrawal by Subject|4|||
162775087|NCT00899379|587886284|FG003|Overall Study|Withdrawal by Subject|7|||
162775088|NCT00899379|587886285|FG004|Overall Study|Withdrawal by Subject|2|||
162775089|NCT00899379|587886281|FG000|Overall Study|Pregnancy|1|||
162775090|NCT00899379|587886282|FG001|Overall Study|Pregnancy|0|||
162775091|NCT00899379|587886283|FG002|Overall Study|Pregnancy|0|||
162775092|NCT00899379|587886284|FG003|Overall Study|Pregnancy|0|||
162775093|NCT00899379|587886285|FG004|Overall Study|Pregnancy|0|||
162775094|NCT00899379|587886281|FG000|Overall Study|Patient Uncooperative|0|||
162775095|NCT00899379|587886282|FG001|Overall Study|Patient Uncooperative|0|||
162775096|NCT00899379|587886283|FG002|Overall Study|Patient Uncooperative|0|||
162775097|NCT00899379|587886284|FG003|Overall Study|Patient Uncooperative|1|||
162775098|NCT00899379|587886285|FG004|Overall Study|Patient Uncooperative|0|||
162775099|NCT00899379|587886281|FG000|Overall Study|Abnormal Prestudy Labs|0|||
162775100|NCT00899379|587886282|FG001|Overall Study|Abnormal Prestudy Labs|0|||
162775101|NCT00899379|587886283|FG002|Overall Study|Abnormal Prestudy Labs|0|||
162775102|NCT00899379|587886284|FG003|Overall Study|Abnormal Prestudy Labs|0|||
162775103|NCT00899379|587886285|FG004|Overall Study|Abnormal Prestudy Labs|2|||
162775104|NCT00899379|587886281|FG000|Overall Study|Abnormal Baseline ECG|0|||
162775105|NCT00899379|587886282|FG001|Overall Study|Abnormal Baseline ECG|0|||
162775106|NCT00899379|587886283|FG002|Overall Study|Abnormal Baseline ECG|1|||
162775107|NCT00899379|587886284|FG003|Overall Study|Abnormal Baseline ECG|1|||
162775108|NCT00899379|587886285|FG004|Overall Study|Abnormal Baseline ECG|0|||
162775109|NCT00899379|587886281|FG000|Overall Study|No Attack Pretreatment|3|||
162775110|NCT00899379|587886282|FG001|Overall Study|No Attack Pretreatment|5|||
162775111|NCT00899379|587886283|FG002|Overall Study|No Attack Pretreatment|5|||
162775112|NCT00899379|587886284|FG003|Overall Study|No Attack Pretreatment|6|||
162775113|NCT00899379|587886285|FG004|Overall Study|No Attack Pretreatment|4|||
162775114|NCT00899379|587886281|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162775115|NCT00899379|587886282|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775116|NCT00899379|587886283|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775117|NCT00899379|587886284|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775118|NCT00899379|587886285|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162775119|NCT00899379|587886281|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
162775120|NCT00899379|587886282|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
162775121|NCT00899379|587886283|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
162775122|NCT00899379|587886284|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
162775123|NCT00899379|587886285|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
162775124|NCT03441789|587886294|FG000|Overall Study|Withdrawal by Subject|1|||
162775125|NCT03441789|587886295|FG001|Overall Study|Withdrawal by Subject|1|||
162775126|NCT03441789|587886294|FG000|Overall Study|Adverse Event|0|||
162775127|NCT03441789|587886295|FG001|Overall Study|Adverse Event|1|||
162775128|NCT03441789|587886294|FG000|Overall Study|Protocol Violation|0|||
162775129|NCT03441789|587886295|FG001|Overall Study|Protocol Violation|1|||
162775130|NCT03441789|587886294|FG000|Overall Study|Lost to Follow-up|0|||
162775131|NCT03441789|587886295|FG001|Overall Study|Lost to Follow-up|1|||
162775132|NCT01780545|587886296|FG000|Overall Study|Withdrawal by Subject|3|||
162775133|NCT01780545|587886297|FG001|Overall Study|Withdrawal by Subject|1|||
162775134|NCT01780545|587886296|FG000|Overall Study|Lost to Follow-up|1|||
162775135|NCT01780545|587886297|FG001|Overall Study|Lost to Follow-up|1|||
162775136|NCT02581189|587886299|FG000|Overall Study|Failure to return|36|||
162775137|NCT02581189|587886299|FG000|Overall Study|Withdrew consent|5|||
162775138|NCT02581189|587886299|FG000|Overall Study|Death|3|||
162775139|NCT02581189|587886299|FG000|Overall Study|Insufficient virological response|2|||
162775140|NCT02581189|587886299|FG000|Overall Study|Other, not specified|7|||
162775141|NCT01514864|587886300|FG000|Overall Study|Disease progression|7|||
162775142|NCT01514864|587886301|FG001|Overall Study|Disease progression|5|||
162775143|NCT01514864|587886300|FG000|Overall Study|Study drug toxicity|2|||
162775144|NCT01514864|587886301|FG001|Overall Study|Study drug toxicity|0|||
162775145|NCT02254681|587886309|FG000|Overall Study|Lack of Efficacy|6|||
162775146|NCT00396097|587886310|FG000|Overall Study|Withdrawal by Subject|17|||
162775147|NCT00396097|587886311|FG001|Overall Study|Withdrawal by Subject|17|||
162775148|NCT00396097|587886310|FG000|Overall Study|Lost to Follow-up|4|||
162775149|NCT00396097|587886311|FG001|Overall Study|Lost to Follow-up|9|||
162775150|NCT00396097|587886310|FG000|Overall Study|Other|3|||
162775151|NCT00396097|587886311|FG001|Overall Study|Other|5|||
162775152|NCT00396097|587886310|FG000|Overall Study|Protocol Violation|0|||
162775153|NCT00396097|587886311|FG001|Overall Study|Protocol Violation|6|||
162775154|NCT00396097|587886310|FG000|Overall Study|Adverse Event|1|||
162775155|NCT00396097|587886311|FG001|Overall Study|Adverse Event|5|||
162775156|NCT00396097|587886310|FG000|Overall Study|Insufficient Clinical Response|1|||
162775157|NCT00396097|587886311|FG001|Overall Study|Insufficient Clinical Response|4|||
162775158|NCT02316847|587886313|FG000|Overall Study|Adverse Event|0|||
162775159|NCT02316847|587886314|FG001|Overall Study|Adverse Event|3|||
162775160|NCT02316847|587886313|FG000|Overall Study|Lost to Follow-up|0|||
162775161|NCT02316847|587886314|FG001|Overall Study|Lost to Follow-up|2|||
162775162|NCT02316847|587886313|FG000|Overall Study|Physician Decision|0|||
162775163|NCT02316847|587886314|FG001|Overall Study|Physician Decision|1|||
162775164|NCT02316847|587886313|FG000|Overall Study|Pregnancy|0|||
162775165|NCT02316847|587886314|FG001|Overall Study|Pregnancy|1|||
162775166|NCT02316847|587886313|FG000|Overall Study|Withdrawal by Subject|2|||
162775167|NCT02316847|587886314|FG001|Overall Study|Withdrawal by Subject|9|||
162775168|NCT02316847|587886313|FG000|Overall Study|Noncompliance with study drug|0|||
162775169|NCT02316847|587886314|FG001|Overall Study|Noncompliance with study drug|3|||
162775170|NCT02316847|587886313|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
162775171|NCT02316847|587886314|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
162775172|NCT01370018|587886315|FG000|Overall Study|Did not meet criteria for analysis|1|||
162775173|NCT02204319|587886316|FG000|Overall Study|Pregnancy|1|||
162775174|NCT02204319|587886316|FG000|Overall Study|Withdrawal by Subject|2|||
162775175|NCT00588341|587886318|FG000|Overall Study|Withdrawal by Subject|3|||
162775176|NCT00588341|587886318|FG000|Overall Study|Not treated due to metastatic disease|1|||
162775177|NCT00588341|587886318|FG000|Overall Study|Patient ineligible|1|||
162775178|NCT02642159|587886319|FG000|Overall Study|Randomized but not treated|1|||
162775179|NCT02642159|587886320|FG001|Overall Study|Randomized but not treated|0|||
162775180|NCT02642159|587886319|FG000|Overall Study|Adverse Event|10|||
162775181|NCT02642159|587886320|FG001|Overall Study|Adverse Event|4|||
162775182|NCT02642159|587886319|FG000|Overall Study|Withdrawal by Subject|9|||
162775183|NCT02642159|587886320|FG001|Overall Study|Withdrawal by Subject|1|||
162775184|NCT02642159|587886319|FG000|Overall Study|Poor compliance to study protocol|1|||
162775185|NCT02642159|587886320|FG001|Overall Study|Poor compliance to study protocol|0|||
162775186|NCT02642159|587886319|FG000|Overall Study|Other than specified above|10|||
162775187|NCT02642159|587886320|FG001|Overall Study|Other than specified above|3|||
162775188|NCT00853021|587886321|FG000|Overall Study|Adverse Event|2|||
162775189|NCT00853021|587886321|FG000|Overall Study|Withdrawal by Subject|2|||
162775190|NCT00853021|587886321|FG000|Overall Study|Death|1|||
162775191|NCT02864147|587886322|FG000|Overall Study|Withdrawal by Subject|3|||
162775192|NCT02864147|587886323|FG001|Overall Study|Withdrawal by Subject|2|||
162775193|NCT02864147|587886324|FG002|Overall Study|Withdrawal by Subject|1|||
162775194|NCT02864147|587886322|FG000|Overall Study|Lost to Follow-up|0|||
162775195|NCT02864147|587886323|FG001|Overall Study|Lost to Follow-up|4|||
162775196|NCT02864147|587886324|FG002|Overall Study|Lost to Follow-up|0|||
162775197|NCT02864147|587886322|FG000|Overall Study|Adverse Event|0|||
162775198|NCT02864147|587886323|FG001|Overall Study|Adverse Event|1|||
162775199|NCT02864147|587886324|FG002|Overall Study|Adverse Event|0|||
162775200|NCT02864147|587886322|FG000|Overall Study|Pregnancy|4|||
162775201|NCT02864147|587886323|FG001|Overall Study|Pregnancy|0|||
162775202|NCT02864147|587886324|FG002|Overall Study|Pregnancy|0|||
162775203|NCT02864147|587886322|FG000|Overall Study|Physician Decision|0|||
162775204|NCT02864147|587886323|FG001|Overall Study|Physician Decision|0|||
162775205|NCT02864147|587886324|FG002|Overall Study|Physician Decision|1|||
162775206|NCT02864147|587886322|FG000|Overall Study|Opted for excisional procedures|0|||
162775207|NCT02864147|587886323|FG001|Overall Study|Opted for excisional procedures|0|||
162775208|NCT02864147|587886324|FG002|Overall Study|Opted for excisional procedures|3|||
162775209|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
162775210|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
162775211|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
162775212|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
162775213|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
162775214|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
162775215|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
162775216|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
162775217|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
162775218|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
162775219|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
162775220|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
162775221|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
162775222|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
162775223|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
162775224|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
162775225|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
162775226|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
162775227|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
162775228|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
162775229|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
162775230|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
162775231|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
162775232|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
162775233|NCT02269917|587886325|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
162775234|NCT02269917|587886326|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
162775235|NCT02269917|587886327|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
162775236|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162775237|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162775238|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
162775239|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162775240|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162775241|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
162775242|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162775243|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162775244|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
162775245|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162775246|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162775247|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
162775248|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
162775249|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
162775250|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
162775251|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162775252|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162775253|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
162775254|NCT02269917|587886325|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162775255|NCT02269917|587886326|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162775256|NCT02269917|587886327|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
162775257|NCT01770509|587886328|FG000|Overall Study|Injury|0|||
162775258|NCT01770509|587886329|FG001|Overall Study|Injury|1|||
162775259|NCT01770509|587886328|FG000|Overall Study|Lost to Follow-up|1|||
162775260|NCT01770509|587886329|FG001|Overall Study|Lost to Follow-up|2|||
162775261|NCT02865135|587886333|FG000|Overall Study|Death|0|||
162775262|NCT02865135|587886334|FG001|Overall Study|Death|1|||
162775263|NCT02865135|587886335|FG002|Overall Study|Death|0|||
162775264|NCT02865135|587886333|FG000|Overall Study|Progression|6|||
162775265|NCT02865135|587886334|FG001|Overall Study|Progression|2|||
162775266|NCT02865135|587886335|FG002|Overall Study|Progression|2|||
162775267|NCT00985621|587886336|FG000|Overall Study|Adverse Event|2|||
162775268|NCT00985621|587886337|FG001|Overall Study|Adverse Event|3|||
162775269|NCT00985621|587886338|FG002|Overall Study|Adverse Event|4|||
162775270|NCT00985621|587886339|FG003|Overall Study|Adverse Event|16|||
162775271|NCT00985621|587886336|FG000|Overall Study|Lack of Efficacy|10|||
162775272|NCT00985621|587886337|FG001|Overall Study|Lack of Efficacy|6|||
162775273|NCT00985621|587886338|FG002|Overall Study|Lack of Efficacy|5|||
162775274|NCT00985621|587886339|FG003|Overall Study|Lack of Efficacy|12|||
162775275|NCT00985621|587886336|FG000|Overall Study|Lost to Follow-up|2|||
162775276|NCT00985621|587886337|FG001|Overall Study|Lost to Follow-up|3|||
162775277|NCT00985621|587886338|FG002|Overall Study|Lost to Follow-up|4|||
162775278|NCT00985621|587886339|FG003|Overall Study|Lost to Follow-up|4|||
162775279|NCT00985621|587886336|FG000|Overall Study|Study Terminated by Sponsor|89|||
162775280|NCT00985621|587886337|FG001|Overall Study|Study Terminated by Sponsor|108|||
162775281|NCT00985621|587886338|FG002|Overall Study|Study Terminated by Sponsor|99|||
162775282|NCT00985621|587886339|FG003|Overall Study|Study Terminated by Sponsor|92|||
162775283|NCT00985621|587886336|FG000|Overall Study|Protocol Violation|1|||
162775284|NCT00985621|587886337|FG001|Overall Study|Protocol Violation|1|||
162775285|NCT00985621|587886338|FG002|Overall Study|Protocol Violation|1|||
162775286|NCT00985621|587886339|FG003|Overall Study|Protocol Violation|0|||
162775287|NCT00985621|587886336|FG000|Overall Study|Withdrawal by Subject|8|||
162925394|NCT05302414|588428961|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
162775288|NCT00985621|587886337|FG001|Overall Study|Withdrawal by Subject|10|||
162775289|NCT00985621|587886338|FG002|Overall Study|Withdrawal by Subject|8|||
162775290|NCT00985621|587886339|FG003|Overall Study|Withdrawal by Subject|12|||
162775291|NCT00985621|587886336|FG000|Overall Study|Other|1|||
162775292|NCT00985621|587886337|FG001|Overall Study|Other|0|||
162775293|NCT00985621|587886338|FG002|Overall Study|Other|0|||
162775294|NCT00985621|587886339|FG003|Overall Study|Other|0|||
162775295|NCT00985621|587886336|FG000|Overall Study|Randomized but not Treated|1|||
162775296|NCT00985621|587886337|FG001|Overall Study|Randomized but not Treated|0|||
162775297|NCT00985621|587886338|FG002|Overall Study|Randomized but not Treated|2|||
162775298|NCT00985621|587886339|FG003|Overall Study|Randomized but not Treated|1|||
162775299|NCT04394624|587886343|FG000|Overall Study|Adverse Event|6|||
162775300|NCT04394624|587886344|FG001|Overall Study|Adverse Event|0|||
162775301|NCT04394624|587886343|FG000|Overall Study|Progressive disease|24|||
162775302|NCT04394624|587886344|FG001|Overall Study|Progressive disease|0|||
162775303|NCT04394624|587886343|FG000|Overall Study|Not related to COVID-19|1|||
162775304|NCT04394624|587886344|FG001|Overall Study|Not related to COVID-19|0|||
162775305|NCT00905255|587886345|FG000|Overall Study|Adverse Event|7|||
162775306|NCT00905255|587886346|FG001|Overall Study|Adverse Event|5|||
162775307|NCT00905255|587886345|FG000|Overall Study|Withdrawal by Subject|5|||
162775308|NCT00905255|587886346|FG001|Overall Study|Withdrawal by Subject|4|||
162775309|NCT00905255|587886345|FG000|Overall Study|Familial and Personal Reasons|1|||
162775310|NCT00905255|587886346|FG001|Overall Study|Familial and Personal Reasons|0|||
162775311|NCT01774929|587886347|FG000|Overall Study|Adverse Event|3|||
162775312|NCT02418819|587886349|FG000|Overall Study|Adverse Event|0|||
162775313|NCT02418819|587886350|FG001|Overall Study|Adverse Event|0|||
162775314|NCT02418819|587886351|FG002|Overall Study|Adverse Event|1|||
162775315|NCT02418819|587886352|FG003|Overall Study|Adverse Event|0|||
162775316|NCT02418819|587886349|FG000|Overall Study|Lost to Follow-up|1|||
162775317|NCT02418819|587886350|FG001|Overall Study|Lost to Follow-up|0|||
162775318|NCT02418819|587886351|FG002|Overall Study|Lost to Follow-up|0|||
162775319|NCT02418819|587886352|FG003|Overall Study|Lost to Follow-up|0|||
162775320|NCT02418819|587886349|FG000|Overall Study|No longer meets eligibility criteria|0|||
162775321|NCT02418819|587886350|FG001|Overall Study|No longer meets eligibility criteria|0|||
162775322|NCT02418819|587886351|FG002|Overall Study|No longer meets eligibility criteria|1|||
162775323|NCT02418819|587886352|FG003|Overall Study|No longer meets eligibility criteria|0|||
162775324|NCT02418819|587886349|FG000|Overall Study|No longer willing to participate|0|||
162775325|NCT02418819|587886350|FG001|Overall Study|No longer willing to participate|0|||
162775326|NCT02418819|587886351|FG002|Overall Study|No longer willing to participate|2|||
162775327|NCT02418819|587886352|FG003|Overall Study|No longer willing to participate|1|||
162775328|NCT01332318|587886353|FG000|Overall Study|Adverse Event|0|||
162775329|NCT01332318|587886354|FG001|Overall Study|Adverse Event|3|||
162775330|NCT01332318|587886355|FG002|Overall Study|Adverse Event|0|||
162775331|NCT01332318|587886356|FG003|Overall Study|Adverse Event|0|||
162775332|NCT01332318|587886353|FG000|Overall Study|Withdrawal by Subject|1|||
162775333|NCT01332318|587886354|FG001|Overall Study|Withdrawal by Subject|1|||
162775334|NCT01332318|587886355|FG002|Overall Study|Withdrawal by Subject|0|||
162775335|NCT01332318|587886356|FG003|Overall Study|Withdrawal by Subject|1|||
162775336|NCT01332318|587886353|FG000|Overall Study|Protocol Violation|1|||
162775337|NCT01332318|587886354|FG001|Overall Study|Protocol Violation|0|||
162775338|NCT01332318|587886355|FG002|Overall Study|Protocol Violation|1|||
162775339|NCT01332318|587886356|FG003|Overall Study|Protocol Violation|1|||
162775340|NCT02040532|587886357|FG000|Overall Study|Lost to Follow-up|1|||
162775341|NCT02040532|587886357|FG000|Overall Study|Physician Decision|4|||
162775342|NCT02040532|587886357|FG000|Overall Study|Adverse Event|4|||
162775343|NCT02040532|587886357|FG000|Overall Study|Withdrawal by Subject|3|||
162775344|NCT00676663|587886358|FG000|Overall Study|Death|43|||
162775345|NCT00676663|587886359|FG001|Overall Study|Death|27|||
162775346|NCT00676663|587886358|FG000|Overall Study|Withdrew Consent|1|||
162775347|NCT00676663|587886359|FG001|Overall Study|Withdrew Consent|8|||
162775348|NCT00676663|587886358|FG000|Overall Study|Lost to Follow-up|1|||
162775349|NCT00676663|587886359|FG001|Overall Study|Lost to Follow-up|3|||
162775350|NCT00714688|587886370|FG000|Overall Study|Lack of Efficacy|14|||
162775351|NCT00714688|587886371|FG001|Overall Study|Lack of Efficacy|1|||
162775352|NCT00714688|587886372|FG002|Overall Study|Lack of Efficacy|4|||
162775353|NCT00714688|587886370|FG000|Overall Study|Withdrawal by Subject|4|||
162775354|NCT00714688|587886371|FG001|Overall Study|Withdrawal by Subject|3|||
162775355|NCT00714688|587886372|FG002|Overall Study|Withdrawal by Subject|3|||
162775356|NCT00714688|587886370|FG000|Overall Study|Lost to Follow-up|5|||
162775357|NCT00714688|587886371|FG001|Overall Study|Lost to Follow-up|2|||
162775358|NCT00714688|587886372|FG002|Overall Study|Lost to Follow-up|0|||
162775359|NCT00714688|587886370|FG000|Overall Study|Adverse Event|2|||
162775360|NCT00714688|587886371|FG001|Overall Study|Adverse Event|15|||
162775361|NCT00714688|587886372|FG002|Overall Study|Adverse Event|19|||
162775362|NCT00714688|587886370|FG000|Overall Study|Subject Non-compliant|3|||
162775363|NCT00714688|587886371|FG001|Overall Study|Subject Non-compliant|5|||
162775364|NCT00714688|587886372|FG002|Overall Study|Subject Non-compliant|5|||
162775365|NCT00714688|587886370|FG000|Overall Study|Ineligible to Continue the Study|0|||
162775366|NCT00714688|587886371|FG001|Overall Study|Ineligible to Continue the Study|1|||
162775367|NCT00714688|587886372|FG002|Overall Study|Ineligible to Continue the Study|1|||
162775368|NCT00714688|587886370|FG000|Overall Study|Sponsor's Decision|0|||
162775369|NCT00714688|587886371|FG001|Overall Study|Sponsor's Decision|2|||
162775370|NCT00714688|587886372|FG002|Overall Study|Sponsor's Decision|0|||
162775371|NCT00714688|587886370|FG000|Overall Study|Other|1|||
162775372|NCT00714688|587886371|FG001|Overall Study|Other|6|||
162775373|NCT00714688|587886372|FG002|Overall Study|Other|5|||
162775374|NCT01786551|587886373|FG000|Overall Study|Participant withdrew consent|2|||
162775375|NCT01524887|587886376|FG000|Overall Study|Withdrawal by Subject|6|||
162775376|NCT01524887|587886377|FG001|Overall Study|Withdrawal by Subject|2|||
162775377|NCT01524887|587886378|FG002|Overall Study|Withdrawal by Subject|3|||
162775378|NCT01524887|587886376|FG000|Overall Study|Adverse Event|5|||
162775379|NCT01524887|587886377|FG001|Overall Study|Adverse Event|1|||
162775380|NCT01524887|587886378|FG002|Overall Study|Adverse Event|1|||
162775381|NCT01524887|587886376|FG000|Overall Study|Protocol Violation|0|||
162775382|NCT01524887|587886377|FG001|Overall Study|Protocol Violation|0|||
162775383|NCT01524887|587886378|FG002|Overall Study|Protocol Violation|1|||
162775384|NCT01524887|587886376|FG000|Overall Study|Study termination|73|||
162775385|NCT01524887|587886377|FG001|Overall Study|Study termination|87|||
162775386|NCT01524887|587886378|FG002|Overall Study|Study termination|79|||
162775387|NCT01524887|587886376|FG000|Overall Study|Withdrawal by Caregiver|0|||
162775388|NCT01524887|587886377|FG001|Overall Study|Withdrawal by Caregiver|0|||
162775389|NCT01524887|587886378|FG002|Overall Study|Withdrawal by Caregiver|2|||
162775390|NCT01524887|587886376|FG000|Overall Study|Use of prohibited medication|1|||
162775391|NCT01524887|587886377|FG001|Overall Study|Use of prohibited medication|0|||
162775392|NCT01524887|587886378|FG002|Overall Study|Use of prohibited medication|0|||
162775393|NCT02956278|587887977|FG000|Overall Study|Withdrawal by Subject|6|||
162775394|NCT02956278|587887978|FG001|Overall Study|Withdrawal by Subject|2|||
162775395|NCT02956278|587887979|FG002|Overall Study|Withdrawal by Subject|0|||
162775396|NCT01967719|587887980|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
162775397|NCT01967719|587887981|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
162775398|NCT01967719|587887982|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162775399|NCT01967719|587887983|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
162775400|NCT01967719|587887980|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
162775401|NCT01967719|587887981|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
162775402|NCT01967719|587887982|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
162775403|NCT01967719|587887983|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
162775404|NCT00961896|587887992|FG000|Overall Study|Abnormal laboratory value|0|||
162775405|NCT00961896|587887993|FG001|Overall Study|Abnormal laboratory value|0|||
162775406|NCT00961896|587887994|FG002|Overall Study|Abnormal laboratory value|1|||
162775407|NCT00848393|587887995|FG000|Overall Study|Protocol Violation|0|||
162775408|NCT00848393|587887996|FG001|Overall Study|Protocol Violation|0|||
162775409|NCT00848393|587887997|FG002|Overall Study|Protocol Violation|1|||
162775410|NCT00848393|587887995|FG000|Overall Study|surgical complications unrelated to stud|0|||
162775411|NCT00848393|587887996|FG001|Overall Study|surgical complications unrelated to stud|0|||
162775412|NCT00848393|587887997|FG002|Overall Study|surgical complications unrelated to stud|2|||
162775413|NCT00755716|587888000|FG000|Overall Study|Adverse Event|1|||
162775414|NCT00755716|587888001|FG001|Overall Study|Adverse Event|4|||
162775415|NCT00755716|587888002|FG002|Overall Study|Adverse Event|1|||
162775416|NCT00755716|587888000|FG000|Overall Study|Lack of Efficacy|2|||
162775417|NCT00755716|587888001|FG001|Overall Study|Lack of Efficacy|0|||
162775418|NCT00755716|587888002|FG002|Overall Study|Lack of Efficacy|0|||
162775419|NCT00755716|587888000|FG000|Overall Study|Lost to Follow-up|5|||
162775420|NCT00755716|587888001|FG001|Overall Study|Lost to Follow-up|3|||
162775421|NCT00755716|587888002|FG002|Overall Study|Lost to Follow-up|1|||
162775422|NCT00755716|587888000|FG000|Overall Study|work schedule issues|0|||
162775423|NCT00755716|587888001|FG001|Overall Study|work schedule issues|1|||
162775424|NCT00755716|587888002|FG002|Overall Study|work schedule issues|1|||
162775425|NCT02229396|587888003|FG000|Overall Study|Adverse Event|6|||
162775426|NCT02229396|587888004|FG001|Overall Study|Adverse Event|12|||
162775427|NCT02229396|587888005|FG002|Overall Study|Adverse Event|12|||
162775428|NCT02229396|587888003|FG000|Overall Study|Death|2|||
162775429|NCT02229396|587888004|FG001|Overall Study|Death|3|||
162775430|NCT02229396|587888005|FG002|Overall Study|Death|1|||
162775431|NCT02229396|587888003|FG000|Overall Study|Lost to Follow-up|14|||
162775432|NCT02229396|587888004|FG001|Overall Study|Lost to Follow-up|14|||
162775433|NCT02229396|587888005|FG002|Overall Study|Lost to Follow-up|21|||
162775434|NCT02229396|587888003|FG000|Overall Study|Protocol Violation|2|||
162775435|NCT02229396|587888004|FG001|Overall Study|Protocol Violation|1|||
162775436|NCT02229396|587888005|FG002|Overall Study|Protocol Violation|0|||
162775437|NCT02229396|587888003|FG000|Overall Study|Patient Incorrectly Randomized|0|||
162775438|NCT02229396|587888004|FG001|Overall Study|Patient Incorrectly Randomized|0|||
162775439|NCT02229396|587888005|FG002|Overall Study|Patient Incorrectly Randomized|1|||
162775440|NCT02229396|587888003|FG000|Overall Study|Other|10|||
162775441|NCT02229396|587888004|FG001|Overall Study|Other|18|||
162775442|NCT02229396|587888005|FG002|Overall Study|Other|15|||
162775443|NCT02229396|587888003|FG000|Overall Study|Withdrawal by Subject|42|||
162775444|NCT02229396|587888004|FG001|Overall Study|Withdrawal by Subject|28|||
162775445|NCT02229396|587888005|FG002|Overall Study|Withdrawal by Subject|41|||
162775446|NCT02229396|587888003|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
162775447|NCT02229396|587888004|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
162775448|NCT02229396|587888005|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
162775449|NCT02229396|587888003|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
162775450|NCT02229396|587888004|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
162775451|NCT02229396|587888005|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
162775452|NCT02679079|587888009|FG000|Overall Study|Adverse Event|2|||
162775453|NCT02679079|587888010|FG001|Overall Study|Adverse Event|0|||
162775454|NCT02679079|587888011|FG002|Overall Study|Adverse Event|2|||
162775455|NCT02679079|587888009|FG000|Overall Study|Protocol Violation|0|||
162775456|NCT02679079|587888010|FG001|Overall Study|Protocol Violation|1|||
162775457|NCT02679079|587888011|FG002|Overall Study|Protocol Violation|0|||
162775458|NCT02679079|587888009|FG000|Overall Study|Withdrawal by Subject|2|||
162775459|NCT02679079|587888010|FG001|Overall Study|Withdrawal by Subject|1|||
162775460|NCT02679079|587888011|FG002|Overall Study|Withdrawal by Subject|0|||
162775461|NCT00839306|587888015|FG000|Overall Study|Adverse Event|3|||
162775462|NCT00839306|587888016|FG001|Overall Study|Adverse Event|5|||
162775463|NCT00839306|587888015|FG000|Overall Study|Lost to Follow-up|6|||
162775464|NCT00839306|587888016|FG001|Overall Study|Lost to Follow-up|9|||
162775465|NCT00839306|587888015|FG000|Overall Study|Withdrawal by Subject|5|||
162775466|NCT00839306|587888016|FG001|Overall Study|Withdrawal by Subject|7|||
162775467|NCT00839306|587888015|FG000|Overall Study|Lack of Efficacy|5|||
162775468|NCT00839306|587888016|FG001|Overall Study|Lack of Efficacy|4|||
162775469|NCT00839306|587888015|FG000|Overall Study|Other|6|||
162775470|NCT00839306|587888016|FG001|Overall Study|Other|18|||
162775471|NCT05060237|587888017|FG000|Overall Study|Withdrawal by Subject|4|||
162775472|NCT05060237|587888017|FG000|Overall Study|Screening failure|8|||
162775473|NCT01066897|587888018|FG000|Overall Study|Withdrawal by Subject|1|||
162775474|NCT01066897|587888019|FG001|Overall Study|Withdrawal by Subject|0|||
162775475|NCT01066897|587888018|FG000|Overall Study|stopped study after developing the flu.|1|||
162775476|NCT01066897|587888019|FG001|Overall Study|stopped study after developing the flu.|0|||
162775477|NCT00265096|587888022|FG000|Overall Study|Adverse Event|14|||
162775478|NCT00265096|587888023|FG001|Overall Study|Adverse Event|18|||
162775479|NCT00265096|587888024|FG002|Overall Study|Adverse Event|18|||
162775480|NCT00265096|587888022|FG000|Overall Study|Lost to Follow-up|2|||
162775481|NCT00265096|587888023|FG001|Overall Study|Lost to Follow-up|5|||
162775482|NCT00265096|587888024|FG002|Overall Study|Lost to Follow-up|3|||
162775483|NCT00265096|587888022|FG000|Overall Study|Death|0|||
162775484|NCT00265096|587888023|FG001|Overall Study|Death|1|||
162775485|NCT00265096|587888024|FG002|Overall Study|Death|2|||
162775486|NCT00265096|587888022|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
162775487|NCT00265096|587888023|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162775488|NCT00265096|587888024|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
162775489|NCT00265096|587888022|FG000|Overall Study|Other|11|||
162775490|NCT00265096|587888023|FG001|Overall Study|Other|19|||
162775491|NCT00265096|587888024|FG002|Overall Study|Other|10|||
162775492|NCT03568708|587888025|FG000|Overall Study|Withdrawal by Subject|1|||
162775493|NCT03568708|587888026|FG001|Overall Study|Withdrawal by Subject|1|||
162775494|NCT03568708|587888025|FG000|Overall Study|Lost to Follow-up|0|||
162775495|NCT03568708|587888026|FG001|Overall Study|Lost to Follow-up|1|||
162775496|NCT00666835|587888027|FG000|Overall Study|Withdrawal by Subject|5|||
162775497|NCT00666835|587888028|FG001|Overall Study|Withdrawal by Subject|2|||
162775498|NCT00666835|587888027|FG000|Overall Study|Lack of Efficacy|0|||
162775499|NCT00666835|587888028|FG001|Overall Study|Lack of Efficacy|1|||
162775500|NCT00666835|587888027|FG000|Overall Study|Incl./excl. not fulfilled|7|||
162775501|NCT00666835|587888028|FG001|Overall Study|Incl./excl. not fulfilled|2|||
162775502|NCT00666835|587888027|FG000|Overall Study|Adverse Event|7|||
162775503|NCT00666835|587888028|FG001|Overall Study|Adverse Event|6|||
162775504|NCT00666835|587888027|FG000|Overall Study|Protocol Violation|2|||
162775505|NCT00666835|587888028|FG001|Overall Study|Protocol Violation|0|||
162775506|NCT00666835|587888027|FG000|Overall Study|Death|15|||
162775507|NCT00666835|587888028|FG001|Overall Study|Death|4|||
162775508|NCT00666835|587888027|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
162775509|NCT00666835|587888028|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
162775510|NCT00666835|587888027|FG000|Overall Study|Hemoglobulin concentration|4|||
162775511|NCT00666835|587888028|FG001|Overall Study|Hemoglobulin concentration|3|||
162775512|NCT00666835|587888027|FG000|Overall Study|Planned operation|2|||
162775513|NCT00666835|587888028|FG001|Overall Study|Planned operation|0|||
162775514|NCT00666835|587888027|FG000|Overall Study|Physician Decision|1|||
162775515|NCT00666835|587888028|FG001|Overall Study|Physician Decision|2|||
162775516|NCT00511147|587888029|FG000|Overall Study|Withdrawal by Subject|1|||
162775517|NCT00511147|587888029|FG000|Overall Study|Disease progression|5|||
162775518|NCT00511147|587888029|FG000|Overall Study|Required platelet transfusion|1|||
162775519|NCT00809783|587888030|FG000|Overall Study|Death|1|||
162775520|NCT00809783|587888031|FG001|Overall Study|Death|0|||
162775521|NCT00809783|587888032|FG002|Overall Study|Death|0|||
162775522|NCT00809783|587888030|FG000|Overall Study|Adverse Event|34|||
162775523|NCT00809783|587888031|FG001|Overall Study|Adverse Event|52|||
162775524|NCT00809783|587888032|FG002|Overall Study|Adverse Event|71|||
162775525|NCT00809783|587888030|FG000|Overall Study|Lack of Efficacy|39|||
162775526|NCT00809783|587888031|FG001|Overall Study|Lack of Efficacy|52|||
162775527|NCT00809783|587888032|FG002|Overall Study|Lack of Efficacy|63|||
162775528|NCT00809783|587888030|FG000|Overall Study|Lost to Follow-up|0|||
162775529|NCT00809783|587888031|FG001|Overall Study|Lost to Follow-up|3|||
162775530|NCT00809783|587888032|FG002|Overall Study|Lost to Follow-up|4|||
162775531|NCT00809783|587888030|FG000|Overall Study|Withdrawal by Subject|47|||
162775532|NCT00809783|587888031|FG001|Overall Study|Withdrawal by Subject|72|||
162775533|NCT00809783|587888032|FG002|Overall Study|Withdrawal by Subject|64|||
162775534|NCT00809783|587888030|FG000|Overall Study|Protocol Violation|2|||
162775535|NCT00809783|587888031|FG001|Overall Study|Protocol Violation|6|||
162775536|NCT00809783|587888032|FG002|Overall Study|Protocol Violation|5|||
162775537|NCT00809783|587888030|FG000|Overall Study|Randomized, but not treated|3|||
162775538|NCT00809783|587888031|FG001|Overall Study|Randomized, but not treated|0|||
162775539|NCT00809783|587888032|FG002|Overall Study|Randomized, but not treated|2|||
162775540|NCT00809783|587888030|FG000|Overall Study|Study Terminated by Sponsor|378|||
162775541|NCT00809783|587888031|FG001|Overall Study|Study Terminated by Sponsor|626|||
162775542|NCT00809783|587888032|FG002|Overall Study|Study Terminated by Sponsor|565|||
162775543|NCT00809783|587888030|FG000|Overall Study|Other|21|||
162775544|NCT00809783|587888031|FG001|Overall Study|Other|21|||
162775545|NCT00809783|587888032|FG002|Overall Study|Other|16|||
162775546|NCT00126555|587888033|FG000|Overall Study|Withdrawal by Subject|1|||
162775547|NCT00126555|587888033|FG000|Overall Study|Adverse Event|2|||
162775548|NCT00126555|587888033|FG000|Overall Study|Progressive Disease|3|||
162775549|NCT03461211|587888041|FG000|Overall Study|Adverse Event|1|||
162775550|NCT03461211|587888042|FG001|Overall Study|Adverse Event|1|||
162775551|NCT03461211|587888041|FG000|Overall Study|Lack of Efficacy|0|||
162775552|NCT03461211|587888042|FG001|Overall Study|Lack of Efficacy|1|||
162775553|NCT01525641|587888043|FG000|Overall Study|Case report form not collected|25|||
162775554|NCT01525641|587888043|FG000|Overall Study|No visit since the first visit|16|||
162775555|NCT01525641|587888043|FG000|Overall Study|Adverse Event|73|||
162775556|NCT01525641|587888043|FG000|Overall Study|Lack of Efficacy|24|||
162775557|NCT01525641|587888043|FG000|Overall Study|Improvement|5|||
162775558|NCT01525641|587888043|FG000|Overall Study|Lost to follow-up (relocation)|1|||
162775559|NCT01525641|587888043|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
162775560|NCT01525641|587888043|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
162775561|NCT01525641|587888043|FG000|Overall Study|Other than stated above|7|||
162775562|NCT02959177|587888048|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
162775563|NCT02959177|587888049|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
162775564|NCT02959177|587888050|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
162775565|NCT02959177|587888048|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
162775566|NCT02959177|587888049|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
162775567|NCT02959177|587888050|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
162775568|NCT02959177|587888048|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
162775569|NCT02959177|587888049|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
162775570|NCT02959177|587888050|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
162775571|NCT02959177|587888048|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
162775572|NCT02959177|587888049|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
162775573|NCT02959177|587888050|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
162775574|NCT02959177|587888048|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
162775575|NCT02959177|587888049|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
162775576|NCT02959177|587888050|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
162775577|NCT02959177|587888048|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
162775578|NCT02959177|587888049|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
162775579|NCT02959177|587888050|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
162775580|NCT02959177|587888048|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
162775581|NCT02959177|587888049|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
162775582|NCT02959177|587888050|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
162775583|NCT03544229|587888051|FG000|Overall Study|Adverse Event|1|||
162775584|NCT03544229|587888052|FG001|Overall Study|Adverse Event|0|||
162775585|NCT03544229|587888053|FG002|Overall Study|Adverse Event|1|||
162775586|NCT03544229|587888054|FG003|Overall Study|Adverse Event|0|||
162775587|NCT03544229|587888051|FG000|Overall Study|Protocol Deviation|0|||
162775588|NCT03544229|587888052|FG001|Overall Study|Protocol Deviation|0|||
162775589|NCT03544229|587888053|FG002|Overall Study|Protocol Deviation|1|||
162775590|NCT03544229|587888054|FG003|Overall Study|Protocol Deviation|0|||
162775591|NCT03544229|587888051|FG000|Overall Study|Lost to Follow-up|3|||
162775592|NCT03544229|587888052|FG001|Overall Study|Lost to Follow-up|0|||
162775593|NCT03544229|587888053|FG002|Overall Study|Lost to Follow-up|0|||
162775594|NCT03544229|587888054|FG003|Overall Study|Lost to Follow-up|2|||
162775595|NCT03544229|587888051|FG000|Overall Study|Voluntary Withdrawal|2|||
162775596|NCT03544229|587888052|FG001|Overall Study|Voluntary Withdrawal|1|||
162775597|NCT03544229|587888053|FG002|Overall Study|Voluntary Withdrawal|3|||
162775598|NCT03544229|587888054|FG003|Overall Study|Voluntary Withdrawal|0|||
162775599|NCT03544229|587888051|FG000|Overall Study|Lack of Efficacy|0|||
162775600|NCT03544229|587888052|FG001|Overall Study|Lack of Efficacy|1|||
162775601|NCT03544229|587888053|FG002|Overall Study|Lack of Efficacy|0|||
162775602|NCT03544229|587888054|FG003|Overall Study|Lack of Efficacy|0|||
162775603|NCT02460562|587888055|FG000|Overall Study|Lost to Follow-up|15|||
162775604|NCT02460562|587888056|FG001|Overall Study|Lost to Follow-up|16|||
162775605|NCT01061775|587888057|FG000|Overall Study|Physician Decision|2|||
162775606|NCT01061775|587888057|FG000|Overall Study|Lost to Follow-up|1|||
162775607|NCT03746483|587888060|FG000|Overall Study|Adverse Event|0|||
162775608|NCT03746483|587888061|FG001|Overall Study|Adverse Event|1|||
162775609|NCT03746483|587888060|FG000|Overall Study|Lack of Efficacy|3|||
162775610|NCT03746483|587888061|FG001|Overall Study|Lack of Efficacy|2|||
162775611|NCT03746483|587888060|FG000|Overall Study|Lost to Follow-up|1|||
162775612|NCT03746483|587888061|FG001|Overall Study|Lost to Follow-up|0|||
162775613|NCT03746483|587888060|FG000|Overall Study|Protocol Violation|2|||
162775614|NCT03746483|587888061|FG001|Overall Study|Protocol Violation|0|||
162775615|NCT01924806|587888064|FG000|Overall Study|Physician Decision|2|||
162775616|NCT01924806|587888065|FG001|Overall Study|Physician Decision|1|||
162775617|NCT01954771|587888066|FG000|Overall Study|Missing HbA1c of end-point|1|||
162775618|NCT01954771|587888067|FG001|Overall Study|Missing HbA1c of end-point|1|||
162775619|NCT01954771|587888068|FG002|Overall Study|Missing HbA1c of end-point|0|||
162775620|NCT01954771|587888066|FG000|Overall Study|Missing CGMS of end-point|1|||
162775621|NCT01954771|587888067|FG001|Overall Study|Missing CGMS of end-point|1|||
162775622|NCT01954771|587888068|FG002|Overall Study|Missing CGMS of end-point|0|||
162775623|NCT01954771|587888066|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
162775624|NCT01954771|587888067|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
162775625|NCT01954771|587888068|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
162775626|NCT03635775|587888072|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162775627|NCT03635775|587888073|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162775628|NCT03635775|587888074|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162775629|NCT03635775|587888075|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
162775630|NCT01026103|587888076|FG000|Overall Study|Physician Decision|1|||
162775631|NCT01026103|587888076|FG000|Overall Study|did not receive study device bc of error|1|||
162775632|NCT02498418|587888077|FG000|Overall Study|Lack of Efficacy|0|||
162775633|NCT02498418|587888078|FG001|Overall Study|Lack of Efficacy|0|||
162775634|NCT02498418|587888079|FG002|Overall Study|Lack of Efficacy|1|||
162775635|NCT02498418|587888077|FG000|Overall Study|Withdrawal by Subject|2|||
162775636|NCT02498418|587888078|FG001|Overall Study|Withdrawal by Subject|0|||
162775637|NCT02498418|587888079|FG002|Overall Study|Withdrawal by Subject|3|||
162775638|NCT02498418|587888077|FG000|Overall Study|Lost to Follow-up|0|||
162775639|NCT02498418|587888078|FG001|Overall Study|Lost to Follow-up|1|||
162775640|NCT02498418|587888079|FG002|Overall Study|Lost to Follow-up|1|||
162775641|NCT02498418|587888077|FG000|Overall Study|Participant taken prohibited medication|0|||
162775642|NCT02498418|587888078|FG001|Overall Study|Participant taken prohibited medication|1|||
162775643|NCT02498418|587888079|FG002|Overall Study|Participant taken prohibited medication|1|||
162775644|NCT00762502|587888081|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
162775645|NCT00762502|587888082|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
162775646|NCT00762502|587888083|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
162775647|NCT00762502|587888081|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
162775648|NCT00762502|587888082|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
162775649|NCT00762502|587888083|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
162775650|NCT00762502|587888081|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
162775651|NCT00762502|587888082|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
162775652|NCT00762502|587888083|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
162775653|NCT02996097|587888087|FG000|Overall Study|Lost to Follow-up|11|||
162775654|NCT02996097|587888088|FG001|Overall Study|Lost to Follow-up|11|||
162775655|NCT03638258|587888089|FG000|Overall Study|Adverse Event|1|||
162775656|NCT03638258|587888090|FG001|Overall Study|Adverse Event|0|||
162775657|NCT03638258|587888091|FG002|Overall Study|Adverse Event|2|||
162775658|NCT03638258|587888089|FG000|Overall Study|Lost to Follow-up|2|||
162775659|NCT03638258|587888090|FG001|Overall Study|Lost to Follow-up|4|||
162775660|NCT03638258|587888091|FG002|Overall Study|Lost to Follow-up|5|||
162775661|NCT03638258|587888089|FG000|Overall Study|Pregnancy|0|||
162775662|NCT03638258|587888090|FG001|Overall Study|Pregnancy|0|||
162775663|NCT03638258|587888091|FG002|Overall Study|Pregnancy|1|||
162775664|NCT03638258|587888089|FG000|Overall Study|Protocol Violation|0|||
162775665|NCT03638258|587888090|FG001|Overall Study|Protocol Violation|0|||
162775666|NCT03638258|587888091|FG002|Overall Study|Protocol Violation|1|||
162775667|NCT03638258|587888089|FG000|Overall Study|Withdrawal by Subject|4|||
162775668|NCT03638258|587888090|FG001|Overall Study|Withdrawal by Subject|5|||
162775669|NCT03638258|587888091|FG002|Overall Study|Withdrawal by Subject|12|||
162775670|NCT03638258|587888089|FG000|Overall Study|Lack of Efficacy|0|||
162775671|NCT03638258|587888090|FG001|Overall Study|Lack of Efficacy|0|||
162775672|NCT03638258|587888091|FG002|Overall Study|Lack of Efficacy|2|||
162775673|NCT02205476|587888092|FG000|Overall Study|Study termination by Sponsor|7|||
162775674|NCT02205476|587888093|FG001|Overall Study|Study termination by Sponsor|3|||
162775675|NCT02016690|587888106|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
162775676|NCT02016690|587888106|FG000|Overall Study|Excluded from SAS: Duplication|2|||
162775677|NCT02016690|587888106|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
162775678|NCT02016690|587888106|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
162775679|NCT02016690|587888106|FG000|Overall Study|Did not meet inclusion criteria|13|||
162775680|NCT02016690|587888106|FG000|Overall Study|Hospitalized for RSV at study start|3|||
162775681|NCT00603278|587888110|FG000|Overall Study|Lack of Efficacy|35|||
162775682|NCT00603278|587888111|FG001|Overall Study|Lack of Efficacy|10|||
162775683|NCT00603278|587888112|FG002|Overall Study|Lack of Efficacy|11|||
162775684|NCT00603278|587888113|FG003|Overall Study|Lack of Efficacy|8|||
162775685|NCT00603278|587888114|FG004|Overall Study|Lack of Efficacy|7|||
162775686|NCT00603278|587888115|FG005|Overall Study|Lack of Efficacy|14|||
162775687|NCT00603278|587888110|FG000|Overall Study|Adverse Event|0|||
162775688|NCT00603278|587888111|FG001|Overall Study|Adverse Event|3|||
162775689|NCT00603278|587888112|FG002|Overall Study|Adverse Event|1|||
162775690|NCT00603278|587888113|FG003|Overall Study|Adverse Event|0|||
162775691|NCT00603278|587888114|FG004|Overall Study|Adverse Event|2|||
162775692|NCT00603278|587888115|FG005|Overall Study|Adverse Event|1|||
162775693|NCT00603278|587888110|FG000|Overall Study|Withdrawal by Subject|2|||
162775694|NCT00603278|587888111|FG001|Overall Study|Withdrawal by Subject|3|||
162775695|NCT00603278|587888112|FG002|Overall Study|Withdrawal by Subject|1|||
162775696|NCT00603278|587888113|FG003|Overall Study|Withdrawal by Subject|2|||
162775697|NCT00603278|587888114|FG004|Overall Study|Withdrawal by Subject|1|||
162775698|NCT00603278|587888115|FG005|Overall Study|Withdrawal by Subject|2|||
162775699|NCT00603278|587888110|FG000|Overall Study|Protocol Violation|3|||
162775700|NCT00603278|587888111|FG001|Overall Study|Protocol Violation|0|||
162775701|NCT00603278|587888112|FG002|Overall Study|Protocol Violation|1|||
162775702|NCT00603278|587888113|FG003|Overall Study|Protocol Violation|1|||
162775703|NCT00603278|587888114|FG004|Overall Study|Protocol Violation|0|||
162775704|NCT00603278|587888115|FG005|Overall Study|Protocol Violation|1|||
162775705|NCT00603278|587888110|FG000|Overall Study|Physician Decision|0|||
162775706|NCT00603278|587888111|FG001|Overall Study|Physician Decision|1|||
162775707|NCT00603278|587888112|FG002|Overall Study|Physician Decision|0|||
162775708|NCT00603278|587888113|FG003|Overall Study|Physician Decision|0|||
162775709|NCT00603278|587888114|FG004|Overall Study|Physician Decision|2|||
162775710|NCT00603278|587888115|FG005|Overall Study|Physician Decision|1|||
162775711|NCT00603278|587888110|FG000|Overall Study|Lost to Follow-up|1|||
162775712|NCT00603278|587888111|FG001|Overall Study|Lost to Follow-up|0|||
162775713|NCT00603278|587888112|FG002|Overall Study|Lost to Follow-up|0|||
162775714|NCT00603278|587888113|FG003|Overall Study|Lost to Follow-up|0|||
162775715|NCT00603278|587888114|FG004|Overall Study|Lost to Follow-up|1|||
162775716|NCT00603278|587888115|FG005|Overall Study|Lost to Follow-up|0|||
162775717|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
162775718|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
162775719|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
162775720|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
162775721|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
162775722|NCT00500539|587888116|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
162775723|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
162775724|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
162775725|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
162775726|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
162775727|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Death|1|||
162775728|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
162775729|NCT00500539|587888116|FG000|Follow-up Period (16 Weeks)|Missing|3|||
162775730|NCT04853394|587888117|FG000|Follow-up Interviews|Lost to Follow-up|22|||
162775731|NCT04853394|587888118|FG001|Follow-up Interviews|Lost to Follow-up|15|||
162775732|NCT01123642|587888121|FG000|Overall Study|Lost to Follow-up|23|||
162775733|NCT01123642|587888121|FG000|Overall Study|Withdrawal by Subject|9|||
162775734|NCT01123642|587888121|FG000|Overall Study|ineligible at baseline assessment|36|||
162775735|NCT04853238|587888122|FG000|Overall Study|Death|4|||
162775736|NCT04853238|587888123|FG001|Overall Study|Death|0|||
162775737|NCT04853238|587888124|FG002|Overall Study|Death|2|||
162775738|NCT04853238|587888122|FG000|Overall Study|Lost to Follow-up|16|||
162775739|NCT04853238|587888123|FG001|Overall Study|Lost to Follow-up|2|||
162775740|NCT04853238|587888124|FG002|Overall Study|Lost to Follow-up|37|||
162775741|NCT04853238|587888122|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
162775742|NCT04853238|587888123|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
162775743|NCT04853238|587888124|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
162775744|NCT04853238|587888122|FG000|Overall Study|Withdrawal by Subject|6|||
162775745|NCT04853238|587888123|FG001|Overall Study|Withdrawal by Subject|0|||
162775746|NCT04853238|587888124|FG002|Overall Study|Withdrawal by Subject|21|||
162775747|NCT04853238|587888122|FG000|Overall Study|Physician Decision|0|||
162775748|NCT04853238|587888123|FG001|Overall Study|Physician Decision|0|||
162775749|NCT04853238|587888124|FG002|Overall Study|Physician Decision|2|||
162775750|NCT04853238|587888122|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
162775751|NCT04853238|587888123|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
162775752|NCT04853238|587888124|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
162775753|NCT01772147|587889708|FG000|Overall Study|Adverse Event|13|||
162775754|NCT01772147|587889709|FG001|Overall Study|Adverse Event|10|||
162775755|NCT01772147|587889710|FG002|Overall Study|Adverse Event|6|||
162775756|NCT01772147|587889708|FG000|Overall Study|Withdrew Consent|7|||
162775757|NCT01772147|587889709|FG001|Overall Study|Withdrew Consent|8|||
162775758|NCT01772147|587889710|FG002|Overall Study|Withdrew Consent|4|||
162775759|NCT01772147|587889708|FG000|Overall Study|Lost to Follow-up|1|||
162775760|NCT01772147|587889709|FG001|Overall Study|Lost to Follow-up|0|||
162775761|NCT01772147|587889710|FG002|Overall Study|Lost to Follow-up|1|||
162775762|NCT01772147|587889708|FG000|Overall Study|Protocol Deviation|2|||
162775763|NCT01772147|587889709|FG001|Overall Study|Protocol Deviation|1|||
162775764|NCT01772147|587889710|FG002|Overall Study|Protocol Deviation|1|||
162775765|NCT01772147|587889708|FG000|Overall Study|Lack of Efficacy|8|||
162775766|NCT01772147|587889709|FG001|Overall Study|Lack of Efficacy|6|||
162775767|NCT01772147|587889710|FG002|Overall Study|Lack of Efficacy|6|||
162775768|NCT00796614|587889711|FG000|Overall Study|Adverse Event|1|||
162775769|NCT00796614|587889712|FG001|Overall Study|Adverse Event|2|||
162775770|NCT00796614|587889713|FG002|Overall Study|Adverse Event|0|||
162775771|NCT00796614|587889714|FG003|Overall Study|Adverse Event|0|||
162775772|NCT00796614|587889711|FG000|Overall Study|Protocol Violation|0|||
162775773|NCT00796614|587889712|FG001|Overall Study|Protocol Violation|0|||
162775774|NCT00796614|587889713|FG002|Overall Study|Protocol Violation|2|||
162775775|NCT00796614|587889714|FG003|Overall Study|Protocol Violation|0|||
162775776|NCT00796614|587889711|FG000|Overall Study|Lost to Follow-up|2|||
162775777|NCT00796614|587889712|FG001|Overall Study|Lost to Follow-up|2|||
162775778|NCT00796614|587889713|FG002|Overall Study|Lost to Follow-up|1|||
162775779|NCT00796614|587889714|FG003|Overall Study|Lost to Follow-up|0|||
162775780|NCT00796614|587889711|FG000|Overall Study|Withdrawal by Subject|1|||
162775781|NCT00796614|587889712|FG001|Overall Study|Withdrawal by Subject|0|||
162775782|NCT00796614|587889713|FG002|Overall Study|Withdrawal by Subject|0|||
162775783|NCT00796614|587889714|FG003|Overall Study|Withdrawal by Subject|1|||
162775784|NCT00796614|587889711|FG000|Overall Study|Other than stated|1|||
162775785|NCT00796614|587889712|FG001|Overall Study|Other than stated|0|||
162775786|NCT00796614|587889713|FG002|Overall Study|Other than stated|0|||
162775787|NCT00796614|587889714|FG003|Overall Study|Other than stated|0|||
162775788|NCT00740597|587889715|FG000|Overall Study|insurance would not cover treatment|1|||
162775789|NCT01983462|587889722|FG000|Overall Study|Adverse Event|1|||
162775790|NCT01983462|587889723|FG001|Overall Study|Adverse Event|0|||
162775791|NCT01983462|587889724|FG002|Overall Study|Adverse Event|0|||
162775792|NCT01902381|587889725|FG000|Overall Study|Withdrawal by Subject|1|||
162775793|NCT02762500|587889726|FG000|Overall Study|Lack of Efficacy|1|||
162775794|NCT02762500|587889727|FG001|Overall Study|Lack of Efficacy|0|||
162775795|NCT02762500|587889726|FG000|Overall Study|Withdrawal by Subject|1|||
162775796|NCT02762500|587889727|FG001|Overall Study|Withdrawal by Subject|1|||
162775797|NCT02762500|587889726|FG000|Overall Study|Adverse Event|0|||
162775798|NCT02762500|587889727|FG001|Overall Study|Adverse Event|2|||
162775799|NCT00488319|587889728|FG000|Overall Study|Adverse Event|1|||
162775800|NCT00488319|587889729|FG001|Overall Study|Adverse Event|2|||
162775801|NCT00488319|587889730|FG002|Overall Study|Adverse Event|23|||
162775802|NCT00488319|587889728|FG000|Overall Study|Lack of Efficacy|6|||
162775803|NCT00488319|587889729|FG001|Overall Study|Lack of Efficacy|12|||
162775804|NCT00488319|587889730|FG002|Overall Study|Lack of Efficacy|27|||
162775805|NCT00488319|587889728|FG000|Overall Study|Lost to Follow-up|3|||
162775806|NCT00488319|587889729|FG001|Overall Study|Lost to Follow-up|5|||
162775807|NCT00488319|587889730|FG002|Overall Study|Lost to Follow-up|16|||
162775808|NCT00488319|587889728|FG000|Overall Study|Withdrawal by Subject|5|||
162775809|NCT00488319|587889729|FG001|Overall Study|Withdrawal by Subject|20|||
162775810|NCT00488319|587889730|FG002|Overall Study|Withdrawal by Subject|44|||
162775811|NCT00488319|587889728|FG000|Overall Study|Other reasons for withdrawal|0|||
162775812|NCT00488319|587889729|FG001|Overall Study|Other reasons for withdrawal|4|||
162775813|NCT00488319|587889730|FG002|Overall Study|Other reasons for withdrawal|12|||
162775814|NCT00632931|587889736|FG000|Part 1, Period 1|Protocol Violation|1|||
162775815|NCT00632931|587889737|FG001|Part 1, Period 1|Protocol Violation|0|||
162775816|NCT00632931|587889738|FG002|Part 1, Period 1|Protocol Violation|0|||
162775817|NCT00632931|587889736|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
162775818|NCT00632931|587889737|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
162775819|NCT00632931|587889738|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
162775820|NCT00632931|587889736|FG000|Part 2|Adverse Event|0|||
162775821|NCT00632931|587889737|FG001|Part 2|Adverse Event|0|||
162775822|NCT00632931|587889738|FG002|Part 2|Adverse Event|3|||
162775823|NCT00632931|587889736|FG000|Part 2|Death|0|||
162775824|NCT00632931|587889737|FG001|Part 2|Death|0|||
162775825|NCT00632931|587889738|FG002|Part 2|Death|1|||
162775826|NCT00632931|587889736|FG000|Part 2|Lack of Efficacy|0|||
162775827|NCT00632931|587889737|FG001|Part 2|Lack of Efficacy|0|||
162775828|NCT00632931|587889738|FG002|Part 2|Lack of Efficacy|17|||
162775829|NCT00632931|587889736|FG000|Part 2|Withdrawal by Subject|0|||
162775830|NCT00632931|587889737|FG001|Part 2|Withdrawal by Subject|0|||
162775831|NCT00632931|587889738|FG002|Part 2|Withdrawal by Subject|3|||
162775832|NCT02499835|587889742|FG000|Overall Study|Withdrawal by Subject|1|||
162775833|NCT02499835|587889743|FG001|Overall Study|Withdrawal by Subject|0|||
162775834|NCT02499835|587889744|FG002|Overall Study|Withdrawal by Subject|0|||
162775835|NCT02499835|587889745|FG003|Overall Study|Withdrawal by Subject|1|||
162775836|NCT02499835|587889742|FG000|Overall Study|Physician Decision|0|||
162775837|NCT02499835|587889743|FG001|Overall Study|Physician Decision|3|||
162775838|NCT02499835|587889744|FG002|Overall Study|Physician Decision|18|||
162775839|NCT02499835|587889745|FG003|Overall Study|Physician Decision|7|||
162775840|NCT02499835|587889742|FG000|Overall Study|Adverse Event|0|||
162775841|NCT02499835|587889743|FG001|Overall Study|Adverse Event|0|||
162775842|NCT02499835|587889744|FG002|Overall Study|Adverse Event|0|||
162775843|NCT02499835|587889745|FG003|Overall Study|Adverse Event|1|||
162775844|NCT02499835|587889742|FG000|Overall Study|Disease progression|2|||
162775845|NCT02499835|587889743|FG001|Overall Study|Disease progression|1|||
162775846|NCT02499835|587889744|FG002|Overall Study|Disease progression|0|||
162775847|NCT02499835|587889745|FG003|Overall Study|Disease progression|7|||
162775848|NCT03319719|587889750|FG000|Overall Study|Lost to Follow-up|1|||
162775849|NCT02490878|587889751|FG000|Overall Study|deemed ineligible|0|||
162775850|NCT02490878|587889752|FG001|Overall Study|deemed ineligible|1|||
162775851|NCT02490878|587889751|FG000|Overall Study|progression prior to treatment|0|||
162775852|NCT02490878|587889752|FG001|Overall Study|progression prior to treatment|1|||
162775853|NCT02490878|587889751|FG000|Overall Study|only submitted baseline QOL|0|||
162775854|NCT02490878|587889752|FG001|Overall Study|only submitted baseline QOL|1|||
162775855|NCT00523549|587889755|FG000|Overall Study|Adverse Event|6|||
162775856|NCT00523549|587889756|FG001|Overall Study|Adverse Event|3|||
162775857|NCT00523549|587889755|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162775858|NCT00523549|587889756|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162775859|NCT00523549|587889755|FG000|Overall Study|Protocol Deviation|3|||
162775860|NCT00523549|587889756|FG001|Overall Study|Protocol Deviation|1|||
162775861|NCT00523549|587889755|FG000|Overall Study|Patient withdrew consent|7|||
162775862|NCT00523549|587889756|FG001|Overall Study|Patient withdrew consent|6|||
162775863|NCT00523549|587889755|FG000|Overall Study|Lost to Follow-up|3|||
162775864|NCT00523549|587889756|FG001|Overall Study|Lost to Follow-up|5|||
162775865|NCT01264887|587889757|FG000|Overall Study|Adverse Event|5|||
162775866|NCT01264887|587889757|FG000|Overall Study|Death|7|||
162775867|NCT01264887|587889757|FG000|Overall Study|Lack of Efficacy|5|||
162775868|NCT01264887|587889757|FG000|Overall Study|Physician Decision|4|||
162775869|NCT01264887|587889757|FG000|Overall Study|Withdrawal by Subject|6|||
162775870|NCT01264887|587889757|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
162775871|NCT01264887|587889757|FG000|Overall Study|Other|2|||
162775872|NCT02853305|587889763|FG000|Overall Study|Death|287|||
162775873|NCT02853305|587889764|FG001|Overall Study|Death|249|||
162775874|NCT02853305|587889765|FG002|Overall Study|Death|300|||
162775875|NCT02853305|587889763|FG000|Overall Study|Withdrawal by Subject|2|||
162775876|NCT02853305|587889764|FG001|Overall Study|Withdrawal by Subject|8|||
162775877|NCT02853305|587889765|FG002|Overall Study|Withdrawal by Subject|3|||
162775878|NCT02853305|587889763|FG000|Overall Study|Transferred to Extension Study|46|||
162775879|NCT02853305|587889764|FG001|Overall Study|Transferred to Extension Study|30|||
162775880|NCT02853305|587889765|FG002|Overall Study|Transferred to Extension Study|25|||
162775881|NCT02853305|587889763|FG000|Overall Study|Did Not Continue on Extension Study|16|||
162775882|NCT02853305|587889764|FG001|Overall Study|Did Not Continue on Extension Study|20|||
162775883|NCT02853305|587889765|FG002|Overall Study|Did Not Continue on Extension Study|24|||
162775884|NCT00677092|587889768|FG000|Overall Study|Adverse Event|1|||
162775885|NCT00677092|587889768|FG000|Overall Study|Lost to Follow-up|1|||
162775886|NCT00677092|587889768|FG000|Overall Study|Withdrawal by Subject|3|||
162775887|NCT00677092|587889768|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
162775888|NCT02381652|587889771|FG000|Overall Study|Withdrawal by Subject|0|||
162775889|NCT02381652|587889772|FG001|Overall Study|Withdrawal by Subject|0|||
162775890|NCT02381652|587889773|FG002|Overall Study|Withdrawal by Subject|1|||
162775891|NCT04772313|587889774|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
162775892|NCT04772313|587889774|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
162775893|NCT01836198|587889775|FG000|Part A, Period 2|Protocol Violation|0|||
162775894|NCT01836198|587889776|FG001|Part A, Period 2|Protocol Violation|1|||
162775895|NCT01836198|587889777|FG002|Part A, Period 2|Protocol Violation|0|||
162775896|NCT03187353|587889778|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
162775897|NCT03187353|587889779|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
162775898|NCT03187353|587889778|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162775899|NCT03187353|587889779|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162775900|NCT03187353|587889778|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
162775901|NCT03187353|587889779|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
162775902|NCT03187353|587889778|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162775903|NCT03187353|587889779|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
162775904|NCT03187353|587889778|FG000|Washout (2 Weeks)|Adverse Event|2|||
162775905|NCT03187353|587889779|FG001|Washout (2 Weeks)|Adverse Event|0|||
162775906|NCT03187353|587889778|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
162775907|NCT03187353|587889779|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
162775908|NCT02215954|587889780|FG000|Overall Study|Adverse Event|0|||
162775909|NCT02215954|587889781|FG001|Overall Study|Adverse Event|0|||
162775910|NCT02215954|587889782|FG002|Overall Study|Adverse Event|1|||
162775911|NCT02215954|587889780|FG000|Overall Study|Withdrawal by Subject|0|||
162775912|NCT02215954|587889781|FG001|Overall Study|Withdrawal by Subject|0|||
162775913|NCT02215954|587889782|FG002|Overall Study|Withdrawal by Subject|2|||
162775914|NCT02215954|587889780|FG000|Overall Study|Not exposed|1|||
162775915|NCT02215954|587889781|FG001|Overall Study|Not exposed|1|||
162775916|NCT02215954|587889782|FG002|Overall Study|Not exposed|3|||
162775917|NCT00784277|587889787|FG000|IR Treatment|Adverse Event|4|||
162775918|NCT00784277|587889788|FG001|IR Treatment|Adverse Event|8|||
162775919|NCT00784277|587889789|FG002|IR Treatment|Adverse Event|19|||
162775920|NCT00784277|587889790|FG003|IR Treatment|Adverse Event|35|||
162775921|NCT00784277|587889791|FG004|IR Treatment|Adverse Event|0|||
162775922|NCT00784277|587889792|FG005|IR Treatment|Adverse Event|0|||
162775923|NCT00784277|587889793|FG006|IR Treatment|Adverse Event|0|||
162775924|NCT00784277|587889787|FG000|IR Treatment|Lack of Efficacy|4|||
162775925|NCT00784277|587889788|FG001|IR Treatment|Lack of Efficacy|4|||
162775926|NCT00784277|587889789|FG002|IR Treatment|Lack of Efficacy|1|||
162775927|NCT00784277|587889790|FG003|IR Treatment|Lack of Efficacy|0|||
162775928|NCT00784277|587889791|FG004|IR Treatment|Lack of Efficacy|0|||
162775929|NCT00784277|587889792|FG005|IR Treatment|Lack of Efficacy|0|||
162775930|NCT00784277|587889793|FG006|IR Treatment|Lack of Efficacy|0|||
162775931|NCT00784277|587889787|FG000|IR Treatment|Lost to Follow-up|1|||
162775932|NCT00784277|587889788|FG001|IR Treatment|Lost to Follow-up|0|||
162775933|NCT00784277|587889789|FG002|IR Treatment|Lost to Follow-up|1|||
162775934|NCT00784277|587889790|FG003|IR Treatment|Lost to Follow-up|0|||
162775935|NCT00784277|587889791|FG004|IR Treatment|Lost to Follow-up|0|||
162775936|NCT00784277|587889792|FG005|IR Treatment|Lost to Follow-up|0|||
162775937|NCT00784277|587889793|FG006|IR Treatment|Lost to Follow-up|0|||
162775938|NCT00784277|587889787|FG000|IR Treatment|Withdrawal by Subject|5|||
162775939|NCT00784277|587889788|FG001|IR Treatment|Withdrawal by Subject|1|||
162775940|NCT00784277|587889789|FG002|IR Treatment|Withdrawal by Subject|4|||
162775941|NCT00784277|587889790|FG003|IR Treatment|Withdrawal by Subject|6|||
162775942|NCT00784277|587889791|FG004|IR Treatment|Withdrawal by Subject|0|||
162775943|NCT00784277|587889792|FG005|IR Treatment|Withdrawal by Subject|0|||
162775944|NCT00784277|587889793|FG006|IR Treatment|Withdrawal by Subject|0|||
162775945|NCT00784277|587889787|FG000|IR Treatment|Resolution Of Pain|0|||
162775946|NCT00784277|587889788|FG001|IR Treatment|Resolution Of Pain|1|||
162775947|NCT00784277|587889789|FG002|IR Treatment|Resolution Of Pain|0|||
162775948|NCT00784277|587889790|FG003|IR Treatment|Resolution Of Pain|0|||
162775949|NCT00784277|587889791|FG004|IR Treatment|Resolution Of Pain|0|||
162775950|NCT00784277|587889792|FG005|IR Treatment|Resolution Of Pain|0|||
162775951|NCT00784277|587889793|FG006|IR Treatment|Resolution Of Pain|0|||
162775952|NCT00784277|587889787|FG000|IR Treatment|Other|2|||
162775953|NCT00784277|587889788|FG001|IR Treatment|Other|3|||
162775954|NCT00784277|587889789|FG002|IR Treatment|Other|3|||
162775955|NCT00784277|587889790|FG003|IR Treatment|Other|2|||
162775956|NCT00784277|587889791|FG004|IR Treatment|Other|0|||
162775957|NCT00784277|587889792|FG005|IR Treatment|Other|0|||
162775958|NCT00784277|587889793|FG006|IR Treatment|Other|0|||
162775959|NCT00784277|587889787|FG000|ER Treatment|Adverse Event|0|||
162775960|NCT00784277|587889788|FG001|ER Treatment|Adverse Event|0|||
162775961|NCT00784277|587889789|FG002|ER Treatment|Adverse Event|0|||
162775962|NCT00784277|587889790|FG003|ER Treatment|Adverse Event|0|||
162775963|NCT00784277|587889791|FG004|ER Treatment|Adverse Event|1|||
162775964|NCT00784277|587889792|FG005|ER Treatment|Adverse Event|7|||
162775965|NCT00784277|587889793|FG006|ER Treatment|Adverse Event|7|||
162775966|NCT00784277|587889787|FG000|ER Treatment|Lack of Efficacy|0|||
162775967|NCT00784277|587889788|FG001|ER Treatment|Lack of Efficacy|0|||
162775968|NCT00784277|587889789|FG002|ER Treatment|Lack of Efficacy|0|||
162775969|NCT00784277|587889790|FG003|ER Treatment|Lack of Efficacy|0|||
162775970|NCT00784277|587889791|FG004|ER Treatment|Lack of Efficacy|3|||
162775971|NCT00784277|587889792|FG005|ER Treatment|Lack of Efficacy|4|||
162775972|NCT00784277|587889793|FG006|ER Treatment|Lack of Efficacy|0|||
162775973|NCT00784277|587889787|FG000|ER Treatment|Lost to Follow-up|0|||
162775974|NCT00784277|587889788|FG001|ER Treatment|Lost to Follow-up|0|||
162775975|NCT00784277|587889789|FG002|ER Treatment|Lost to Follow-up|0|||
162775976|NCT00784277|587889790|FG003|ER Treatment|Lost to Follow-up|0|||
162775977|NCT00784277|587889791|FG004|ER Treatment|Lost to Follow-up|0|||
162775978|NCT00784277|587889792|FG005|ER Treatment|Lost to Follow-up|2|||
162775979|NCT00784277|587889793|FG006|ER Treatment|Lost to Follow-up|0|||
162775980|NCT00784277|587889787|FG000|ER Treatment|Withdrawal by Subject|0|||
162775981|NCT00784277|587889788|FG001|ER Treatment|Withdrawal by Subject|0|||
162775982|NCT00784277|587889789|FG002|ER Treatment|Withdrawal by Subject|0|||
162775983|NCT00784277|587889790|FG003|ER Treatment|Withdrawal by Subject|0|||
162775984|NCT00784277|587889791|FG004|ER Treatment|Withdrawal by Subject|2|||
162775985|NCT00784277|587889792|FG005|ER Treatment|Withdrawal by Subject|5|||
162775986|NCT00784277|587889793|FG006|ER Treatment|Withdrawal by Subject|3|||
162775987|NCT00784277|587889787|FG000|ER Treatment|Study Medication Non-Compliant|0|||
162775988|NCT00784277|587889788|FG001|ER Treatment|Study Medication Non-Compliant|0|||
162775989|NCT00784277|587889789|FG002|ER Treatment|Study Medication Non-Compliant|0|||
162775990|NCT00784277|587889790|FG003|ER Treatment|Study Medication Non-Compliant|0|||
162775991|NCT00784277|587889791|FG004|ER Treatment|Study Medication Non-Compliant|2|||
162775992|NCT00784277|587889792|FG005|ER Treatment|Study Medication Non-Compliant|3|||
162775993|NCT00784277|587889793|FG006|ER Treatment|Study Medication Non-Compliant|3|||
162775994|NCT00784277|587889787|FG000|ER Treatment|Other|0|||
162775995|NCT00784277|587889788|FG001|ER Treatment|Other|0|||
162775996|NCT00784277|587889789|FG002|ER Treatment|Other|0|||
162775997|NCT00784277|587889790|FG003|ER Treatment|Other|0|||
162775998|NCT00784277|587889791|FG004|ER Treatment|Other|1|||
162775999|NCT00784277|587889792|FG005|ER Treatment|Other|3|||
162776000|NCT00784277|587889793|FG006|ER Treatment|Other|2|||
162776001|NCT01093222|587889794|FG000|Overall Study|Ineligible|6|||
162776002|NCT01093222|587889794|FG000|Overall Study|Adverse Event|7|||
162776003|NCT01093222|587889794|FG000|Overall Study|Progression/relapse|24|||
162776004|NCT01093222|587889794|FG000|Overall Study|Death|2|||
162776005|NCT01093222|587889794|FG000|Overall Study|Not protocol specified|1|||
162776006|NCT04194541|587889795|FG000|Day 1 Through 13|Lost to Follow-up|3|||
162776007|NCT04194541|587889795|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
162776008|NCT04194541|587889795|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
162776009|NCT02567227|587889796|FG000|9 Weeks|Adverse Event|5|||
162776010|NCT02567227|587889797|FG001|9 Weeks|Adverse Event|5|||
162776011|NCT02567227|587889796|FG000|9 Weeks|Withdrawal by Subject|18|||
162776012|NCT02567227|587889797|FG001|9 Weeks|Withdrawal by Subject|8|||
162776013|NCT02567227|587889796|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
162776014|NCT02567227|587889797|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
162776015|NCT02567227|587889796|FG000|6 Month|Death|2|||
162776016|NCT02567227|587889797|FG001|6 Month|Death|0|||
162776017|NCT02567227|587889796|FG000|6 Month|Lost to Follow-up|43|||
162776018|NCT02567227|587889797|FG001|6 Month|Lost to Follow-up|40|||
162776019|NCT02567227|587889796|FG000|12 Months|Lost to Follow-up|31|||
162776020|NCT02567227|587889797|FG001|12 Months|Lost to Follow-up|32|||
162776021|NCT02567227|587889796|FG000|12 Months|Death|0|||
162776022|NCT02567227|587889797|FG001|12 Months|Death|2|||
162776023|NCT00187135|587889798|FG000|Visit One|Withdrawal by Subject|1|||
162776024|NCT00187135|587889799|FG001|Visit One|Withdrawal by Subject|0|||
162776025|NCT00187135|587889800|FG002|Visit One|Withdrawal by Subject|0|||
162776026|NCT00187135|587889801|FG003|Visit One|Withdrawal by Subject|0|||
162776027|NCT00187135|587889802|FG004|Visit One|Withdrawal by Subject|0|||
162776028|NCT00187135|587889803|FG005|Visit One|Withdrawal by Subject|1|||
162776029|NCT00187135|587889798|FG000|Visit One|Physician Decision|3|||
162776030|NCT00187135|587889799|FG001|Visit One|Physician Decision|1|||
162776031|NCT00187135|587889800|FG002|Visit One|Physician Decision|0|||
162776032|NCT00187135|587889801|FG003|Visit One|Physician Decision|0|||
162776033|NCT00187135|587889802|FG004|Visit One|Physician Decision|0|||
162776034|NCT00187135|587889803|FG005|Visit One|Physician Decision|1|||
162776035|NCT00187135|587889798|FG000|Visit Two|Death|0|||
162776036|NCT00187135|587889799|FG001|Visit Two|Death|0|||
162776037|NCT00187135|587889800|FG002|Visit Two|Death|0|||
162776038|NCT00187135|587889801|FG003|Visit Two|Death|1|||
162776039|NCT00187135|587889802|FG004|Visit Two|Death|0|||
162776040|NCT00187135|587889803|FG005|Visit Two|Death|1|||
162776041|NCT00187135|587889798|FG000|Visit Two|Physician Decision|1|||
162776042|NCT00187135|587889799|FG001|Visit Two|Physician Decision|0|||
162776043|NCT00187135|587889800|FG002|Visit Two|Physician Decision|0|||
162776044|NCT00187135|587889801|FG003|Visit Two|Physician Decision|0|||
162776045|NCT00187135|587889802|FG004|Visit Two|Physician Decision|0|||
162776046|NCT00187135|587889803|FG005|Visit Two|Physician Decision|0|||
162776047|NCT00187135|587889798|FG000|Visit Two|Withdrawal by Subject|1|||
162776048|NCT00187135|587889799|FG001|Visit Two|Withdrawal by Subject|1|||
162776049|NCT00187135|587889800|FG002|Visit Two|Withdrawal by Subject|1|||
162776050|NCT00187135|587889801|FG003|Visit Two|Withdrawal by Subject|0|||
162776051|NCT00187135|587889802|FG004|Visit Two|Withdrawal by Subject|1|||
162776052|NCT00187135|587889803|FG005|Visit Two|Withdrawal by Subject|1|||
162776053|NCT00187135|587889798|FG000|Visit Two|Study Discontinued|3|||
162776054|NCT00187135|587889799|FG001|Visit Two|Study Discontinued|2|||
162776055|NCT00187135|587889800|FG002|Visit Two|Study Discontinued|1|||
162776056|NCT00187135|587889801|FG003|Visit Two|Study Discontinued|7|||
162776057|NCT00187135|587889802|FG004|Visit Two|Study Discontinued|5|||
162776058|NCT00187135|587889803|FG005|Visit Two|Study Discontinued|6|||
162776059|NCT00187135|587889798|FG000|Visit Three|Death|0|||
162776060|NCT00187135|587889799|FG001|Visit Three|Death|0|||
162776061|NCT00187135|587889800|FG002|Visit Three|Death|1|||
162776062|NCT00187135|587889801|FG003|Visit Three|Death|0|||
162776063|NCT00187135|587889802|FG004|Visit Three|Death|1|||
162776064|NCT00187135|587889803|FG005|Visit Three|Death|0|||
162776065|NCT00187135|587889798|FG000|Visit Three|Withdrawal by Subject|0|||
162776066|NCT00187135|587889799|FG001|Visit Three|Withdrawal by Subject|1|||
162776067|NCT00187135|587889800|FG002|Visit Three|Withdrawal by Subject|1|||
162776068|NCT00187135|587889801|FG003|Visit Three|Withdrawal by Subject|2|||
162776069|NCT00187135|587889802|FG004|Visit Three|Withdrawal by Subject|0|||
162776070|NCT00187135|587889803|FG005|Visit Three|Withdrawal by Subject|0|||
162776071|NCT00187135|587889798|FG000|Visit Three|Study Discontinued|7|||
162776072|NCT00187135|587889799|FG001|Visit Three|Study Discontinued|6|||
162776073|NCT00187135|587889800|FG002|Visit Three|Study Discontinued|7|||
162776074|NCT00187135|587889801|FG003|Visit Three|Study Discontinued|7|||
162776075|NCT00187135|587889802|FG004|Visit Three|Study Discontinued|7|||
162776076|NCT00187135|587889803|FG005|Visit Three|Study Discontinued|6|||
162776077|NCT01675050|587889809|FG000|Period One Treatment|Withdrawal by Subject|1|||
162776078|NCT01675050|587889810|FG001|Period One Treatment|Withdrawal by Subject|0|||
162776079|NCT00745121|587889811|FG000|Overall Study|Death|3|||
162776080|NCT00745121|587889812|FG001|Overall Study|Death|0|||
162776081|NCT00745121|587889811|FG000|Overall Study|Adverse Event|1|||
162776082|NCT00745121|587889812|FG001|Overall Study|Adverse Event|0|||
162776083|NCT00745121|587889811|FG000|Overall Study|Lost to Follow-up|1|||
162776084|NCT00745121|587889812|FG001|Overall Study|Lost to Follow-up|0|||
162776085|NCT00745121|587889811|FG000|Overall Study|Withdrawal by Subject|4|||
162776086|NCT00745121|587889812|FG001|Overall Study|Withdrawal by Subject|2|||
162776087|NCT03280108|587889814|FG000|Overall Study|Lost to Follow-up|2|||
162776088|NCT03280108|587889815|FG001|Overall Study|Lost to Follow-up|0|||
162776089|NCT01820637|587889816|FG000|Overall Study|Death|2|||
162776090|NCT01820637|587889816|FG000|Overall Study|Withdrawal by Subject|1|||
162776091|NCT00264498|587889817|FG000|Randomized Treatment|Death|0|||
162776092|NCT00264498|587889818|FG001|Randomized Treatment|Death|3|||
162776093|NCT00264498|587889817|FG000|Randomized Treatment|Withdrawal by Subject|0|||
162776094|NCT00264498|587889818|FG001|Randomized Treatment|Withdrawal by Subject|1|||
162776095|NCT00264498|587889817|FG000|Randomized Treatment|Objective disease Progression|13|||
162776096|NCT00264498|587889818|FG001|Randomized Treatment|Objective disease Progression|14|||
162776097|NCT00264498|587889817|FG000|Randomized Treatment|Physician Decision|1|||
162776098|NCT00264498|587889818|FG001|Randomized Treatment|Physician Decision|0|||
162776099|NCT00264498|587889817|FG000|Randomized Treatment|Incorrectly randomized|1|||
162776100|NCT00264498|587889818|FG001|Randomized Treatment|Incorrectly randomized|0|||
162776101|NCT00264498|587889817|FG000|Randomized Treatment|Study Closure|1|||
162776102|NCT00264498|587889818|FG001|Randomized Treatment|Study Closure|0|||
162776103|NCT00264498|587889817|FG000|Randomized Treatment|Protocol Violation|1|||
162776104|NCT00264498|587889818|FG001|Randomized Treatment|Protocol Violation|0|||
162776105|NCT00264498|587889817|FG000|Crossover Treatment|Death|1|||
162776106|NCT00264498|587889818|FG001|Crossover Treatment|Death|3|||
162776107|NCT00264498|587889817|FG000|Crossover Treatment|Objective disease progression|4|||
162776108|NCT00264498|587889818|FG001|Crossover Treatment|Objective disease progression|5|||
162776109|NCT00264498|587889817|FG000|Crossover Treatment|Study closure|0|||
162776110|NCT00264498|587889818|FG001|Crossover Treatment|Study closure|1|||
162776111|NCT00264498|587889817|FG000|Crossover Treatment|Withdrawal by Subject|1|||
162776112|NCT00264498|587889818|FG001|Crossover Treatment|Withdrawal by Subject|0|||
162776113|NCT03794609|587889819|FG000|Overall Study|Other|10|||
162776114|NCT03794609|587889819|FG000|Overall Study|Withdrawal by Subject|66|||
162776115|NCT03794609|587889819|FG000|Overall Study|The child is enrolled in an interventional study|70|||
162776116|NCT03794609|587889819|FG000|Overall Study|Inclusion/exclusion criteria|8|||
162776117|NCT03794609|587889819|FG000|Overall Study|At sponsor's request|151|||
162776118|NCT03794609|587889819|FG000|Overall Study|Physician Decision|1|||
162776119|NCT03794609|587889819|FG000|Overall Study|Lost to Follow-up|5|||
162776120|NCT04543942|587889820|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
162776121|NCT04543942|587889821|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
162776122|NCT04543942|587889820|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
162776123|NCT04543942|587889821|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
162776124|NCT00139659|587889824|FG000|Overall Study|Adverse Event|12|||
162776125|NCT00139659|587889825|FG001|Overall Study|Adverse Event|1|||
162776126|NCT00139659|587889824|FG000|Overall Study|Lack of Efficacy|1|||
162776127|NCT00139659|587889825|FG001|Overall Study|Lack of Efficacy|1|||
162776128|NCT00139659|587889824|FG000|Overall Study|Lost to Follow-up|7|||
162776129|NCT00139659|587889825|FG001|Overall Study|Lost to Follow-up|3|||
162776130|NCT00139659|587889824|FG000|Overall Study|Reason not Specified|6|||
162776131|NCT00139659|587889825|FG001|Overall Study|Reason not Specified|3|||
162776132|NCT00139659|587889824|FG000|Overall Study|Withdrawal by Subject|14|||
162776133|NCT00139659|587889825|FG001|Overall Study|Withdrawal by Subject|10|||
162776134|NCT02625922|587889831|FG000|Overall Study|Non-availability of IMP|1|||
162776135|NCT02625922|587889832|FG001|Overall Study|Non-availability of IMP|1|||
162776136|NCT02625922|587889831|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
162776137|NCT02625922|587889832|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
162776138|NCT00640042|587889833|FG000|Enrollment|Did not receive study drug|83|||
162776139|NCT02359552|587889834|FG000|Overall Study|Lost to Follow-up|3|||
162776140|NCT02359552|587889835|FG001|Overall Study|Lost to Follow-up|4|||
162776141|NCT02391116|587889848|FG000|Treatment|Withdrawal by Subject|1|||
162776142|NCT02391116|587889848|FG000|Treatment|Protocol Violation|1|||
162776143|NCT02391116|587889848|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
162776144|NCT02391116|587889848|FG000|Treatment|AE with Clinical PD|3|||
162776145|NCT02391116|587889848|FG000|Safety Follow-up|Adverse Event|1|||
162776146|NCT02391116|587889848|FG000|Safety Follow-up|Withdrawal by Subject|4|||
162776147|NCT02391116|587889848|FG000|Safety Follow-up|Switching to Other Therapy|4|||
162776148|NCT02391116|587889848|FG000|Safety Follow-up|No Follow Up|1|||
162776149|NCT02391116|587889848|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
162776150|NCT02391116|587889848|FG000|Active Follow-up|Withdrawal by Subject|1|||
162776151|NCT02391116|587889848|FG000|Active Follow-up|Switching to Other Therapy|2|||
162776152|NCT02391116|587889848|FG000|Survival Follow-up|Withdrawal by Subject|3|||
162776153|NCT02391116|587889848|FG000|Survival Follow-up|Switching to Other Therapy|1|||
162776154|NCT01747629|587889850|FG000|Overall Study|Adverse Event|1|||
162776155|NCT01747629|587889851|FG001|Overall Study|Adverse Event|2|||
162776156|NCT01747629|587889850|FG000|Overall Study|Withdrawal by Subject|2|||
162776157|NCT01747629|587889851|FG001|Overall Study|Withdrawal by Subject|2|||
162776158|NCT01747629|587889850|FG000|Overall Study|Noncompliance|1|||
162776159|NCT01747629|587889851|FG001|Overall Study|Noncompliance|1|||
162776160|NCT01747629|587889850|FG000|Overall Study|Inclusion criteria not met|1|||
162776161|NCT01747629|587889851|FG001|Overall Study|Inclusion criteria not met|0|||
162776162|NCT01747629|587889850|FG000|Overall Study|Not treated|1|||
162776163|NCT01747629|587889851|FG001|Overall Study|Not treated|0|||
162776164|NCT01747629|587889850|FG000|Overall Study|Other|2|||
162776165|NCT01747629|587889851|FG001|Overall Study|Other|1|||
162776166|NCT00607789|587889852|FG000|Overall Study|Adverse Event|3|||
162776167|NCT00607789|587889853|FG001|Overall Study|Adverse Event|0|||
162776168|NCT00607789|587889852|FG000|Overall Study|Lack of Efficacy|0|||
162776169|NCT00607789|587889853|FG001|Overall Study|Lack of Efficacy|1|||
162776170|NCT00607789|587889852|FG000|Overall Study|Inadequate adherence|3|||
162776171|NCT00607789|587889853|FG001|Overall Study|Inadequate adherence|0|||
162776172|NCT00607789|587889852|FG000|Overall Study|Lost to Follow-up|0|||
162776173|NCT00607789|587889853|FG001|Overall Study|Lost to Follow-up|5|||
162776174|NCT00607789|587889852|FG000|Overall Study|Withdrawal by Subject|1|||
162776175|NCT00607789|587889853|FG001|Overall Study|Withdrawal by Subject|0|||
162776176|NCT01313299|587889854|FG000|Overall Study|Adverse Event|3|||
162776177|NCT01313299|587889855|FG001|Overall Study|Adverse Event|1|||
162776178|NCT01313299|587889856|FG002|Overall Study|Adverse Event|1|||
162776179|NCT01313299|587889854|FG000|Overall Study|Lost to Follow-up|1|||
162776180|NCT01313299|587889855|FG001|Overall Study|Lost to Follow-up|0|||
162776181|NCT01313299|587889856|FG002|Overall Study|Lost to Follow-up|0|||
162776182|NCT01313299|587889854|FG000|Overall Study|Protocol Violation|2|||
162776183|NCT01313299|587889855|FG001|Overall Study|Protocol Violation|0|||
162776184|NCT01313299|587889856|FG002|Overall Study|Protocol Violation|0|||
162776185|NCT01313299|587889854|FG000|Overall Study|Withdrawal by Subject|1|||
162776186|NCT01313299|587889855|FG001|Overall Study|Withdrawal by Subject|0|||
162776187|NCT01313299|587889856|FG002|Overall Study|Withdrawal by Subject|2|||
162776188|NCT01313299|587889854|FG000|Overall Study|Family reason and moved out of state|0|||
162776189|NCT01313299|587889855|FG001|Overall Study|Family reason and moved out of state|2|||
162776190|NCT01313299|587889856|FG002|Overall Study|Family reason and moved out of state|0|||
162776191|NCT01313299|587889854|FG000|Overall Study|Lack of subject compliance|0|||
162776192|NCT01313299|587889855|FG001|Overall Study|Lack of subject compliance|0|||
162776193|NCT01313299|587889856|FG002|Overall Study|Lack of subject compliance|1|||
162776194|NCT02506881|587889857|FG000|First Intervention (Day 1)|Protocol Violation|0|||
162776195|NCT02506881|587889858|FG001|First Intervention (Day 1)|Protocol Violation|0|||
162776196|NCT02506881|587889859|FG002|First Intervention (Day 1)|Protocol Violation|1|||
162776197|NCT02506881|587889860|FG003|First Intervention (Day 1)|Protocol Violation|0|||
162776198|NCT02506881|587889857|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
162776199|NCT02506881|587889858|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
162776200|NCT02506881|587889859|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162776201|NCT02506881|587889860|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
162776202|NCT02506881|587889857|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
162776203|NCT02506881|587889858|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
162776204|NCT02506881|587889859|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
162776205|NCT02506881|587889860|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
162776206|NCT01919398|587889861|FG000|Overall Study|Progressive Disease|0|||
162776207|NCT01919398|587889862|FG001|Overall Study|Progressive Disease|0|||
162776208|NCT01919398|587889863|FG002|Overall Study|Progressive Disease|4|||
162776209|NCT02391545|587889865|FG000|Overall Study|Death|0|||
162776210|NCT02391545|587889866|FG001|Overall Study|Death|2|||
162776211|NCT02391545|587889865|FG000|Overall Study|Lost to Follow-up|0|||
162776212|NCT02391545|587889866|FG001|Overall Study|Lost to Follow-up|1|||
162776213|NCT02391545|587889865|FG000|Overall Study|Termination of study by sponsor|20|||
162776214|NCT02391545|587889866|FG001|Overall Study|Termination of study by sponsor|20|||
162776215|NCT02391545|587889865|FG000|Overall Study|Withdrawal by Subject|0|||
162776216|NCT02391545|587889866|FG001|Overall Study|Withdrawal by Subject|1|||
162776217|NCT02391545|587889865|FG000|Overall Study|Other Reasons|6|||
162776218|NCT02391545|587889866|FG001|Overall Study|Other Reasons|4|||
162776219|NCT01222078|587889867|FG000|Overall Study|Early termination of the study|1|||
162776220|NCT04089332|587889868|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
162776221|NCT04089332|587889868|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
162776222|NCT04089332|587889868|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
162776223|NCT02588027|587889877|FG000|Overall Study|Withdrawal by Subject|1|||
162776224|NCT02588027|587889878|FG001|Overall Study|Withdrawal by Subject|3|||
162776225|NCT02588027|587889877|FG000|Overall Study|Protocol Violation|4|||
162776226|NCT02588027|587889878|FG001|Overall Study|Protocol Violation|1|||
162776227|NCT00746785|587891753|FG000|Overall Study|Lost to Follow-up|29|||
162776228|NCT00746785|587891754|FG001|Overall Study|Lost to Follow-up|25|||
162776229|NCT00746785|587891755|FG002|Overall Study|Lost to Follow-up|27|||
162776230|NCT01231464|587891756|FG000|Overall Study|Adverse Event|0|||
162776231|NCT01231464|587891757|FG001|Overall Study|Adverse Event|1|||
162776232|NCT01231464|587891756|FG000|Overall Study|Protocol Violation|1|||
162776233|NCT01231464|587891757|FG001|Overall Study|Protocol Violation|2|||
162776234|NCT01231464|587891756|FG000|Overall Study|Lost to Follow-up|1|||
162776235|NCT01231464|587891757|FG001|Overall Study|Lost to Follow-up|2|||
162776236|NCT01231464|587891756|FG000|Overall Study|Withdrawal by Subject|3|||
162776237|NCT01231464|587891757|FG001|Overall Study|Withdrawal by Subject|2|||
162776238|NCT00957996|587891758|FG000|Overall Study|Death|4|||
162776239|NCT00957996|587891759|FG001|Overall Study|Death|10|||
162776240|NCT00957996|587891758|FG000|Overall Study|Lost to Follow-up|4|||
162776241|NCT00957996|587891759|FG001|Overall Study|Lost to Follow-up|7|||
162776242|NCT00957996|587891758|FG000|Overall Study|Withdrawal by Subject|9|||
162776243|NCT00957996|587891759|FG001|Overall Study|Withdrawal by Subject|2|||
162776244|NCT00957996|587891758|FG000|Overall Study|Adverse Event|2|||
162776245|NCT00957996|587891759|FG001|Overall Study|Adverse Event|1|||
162776246|NCT00957996|587891758|FG000|Overall Study|Physician Decision|1|||
162776247|NCT00957996|587891759|FG001|Overall Study|Physician Decision|1|||
162776248|NCT00957996|587891758|FG000|Overall Study|Influenza-related complication|0|||
162776249|NCT00957996|587891759|FG001|Overall Study|Influenza-related complication|1|||
162776250|NCT00957996|587891758|FG000|Overall Study|Missing|1|||
162776251|NCT00957996|587891759|FG001|Overall Study|Missing|0|||
162776252|NCT00957996|587891758|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
162776253|NCT00957996|587891759|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
162776254|NCT00684203|587891766|FG000|Overall Study|Adverse Event|6|||
162776255|NCT00684203|587891767|FG001|Overall Study|Adverse Event|4|||
162776256|NCT00684203|587891768|FG002|Overall Study|Adverse Event|8|||
162776257|NCT00684203|587891769|FG003|Overall Study|Adverse Event|0|||
162776258|NCT00684203|587891770|FG004|Overall Study|Adverse Event|0|||
162776259|NCT00684203|587891771|FG005|Overall Study|Adverse Event|0|||
162776260|NCT00684203|587891766|FG000|Overall Study|Protocol-defined clinical event|3|||
162776261|NCT00684203|587891767|FG001|Overall Study|Protocol-defined clinical event|1|||
162776262|NCT00684203|587891768|FG002|Overall Study|Protocol-defined clinical event|0|||
162776263|NCT00684203|587891769|FG003|Overall Study|Protocol-defined clinical event|0|||
162776264|NCT00684203|587891770|FG004|Overall Study|Protocol-defined clinical event|0|||
162776265|NCT00684203|587891771|FG005|Overall Study|Protocol-defined clinical event|0|||
162776266|NCT00684203|587891766|FG000|Overall Study|Withdrawal by Subject|0|||
162776267|NCT00684203|587891767|FG001|Overall Study|Withdrawal by Subject|2|||
162776268|NCT00684203|587891768|FG002|Overall Study|Withdrawal by Subject|1|||
162776269|NCT00684203|587891769|FG003|Overall Study|Withdrawal by Subject|0|||
162776270|NCT00684203|587891770|FG004|Overall Study|Withdrawal by Subject|0|||
162776271|NCT00684203|587891771|FG005|Overall Study|Withdrawal by Subject|0|||
162776272|NCT00684203|587891766|FG000|Overall Study|Did not meet protocol eligibility|0|||
162776273|NCT00684203|587891767|FG001|Overall Study|Did not meet protocol eligibility|1|||
162776274|NCT00684203|587891768|FG002|Overall Study|Did not meet protocol eligibility|0|||
162776275|NCT00684203|587891769|FG003|Overall Study|Did not meet protocol eligibility|0|||
162776276|NCT00684203|587891770|FG004|Overall Study|Did not meet protocol eligibility|0|||
162776277|NCT00684203|587891771|FG005|Overall Study|Did not meet protocol eligibility|0|||
162776278|NCT00730847|587891776|FG000|Overall Study|Adverse Event|1|||
162776279|NCT00730847|587891776|FG000|Overall Study|Protocol Violation|2|||
162776280|NCT00730847|587891776|FG000|Overall Study|Withdrawal by Subject|16|||
162776281|NCT00730847|587891776|FG000|Overall Study|Lost to Follow-up|67|||
162776282|NCT00730847|587891776|FG000|Overall Study|Unknown completion status|21|||
162776283|NCT00730847|587891776|FG000|Overall Study|Other|24|||
162776284|NCT00280683|587891777|FG000|Overall Study|Withdrawal by Subject|1|||
162776285|NCT00280683|587891778|FG001|Overall Study|Withdrawal by Subject|2|||
162776286|NCT00280683|587891777|FG000|Overall Study|Adverse Event|1|||
162776287|NCT00280683|587891778|FG001|Overall Study|Adverse Event|1|||
162776288|NCT01243411|587891779|FG000|Overall Study|Withdrawal by Subject|18|||
162776289|NCT01243411|587891779|FG000|Overall Study|Lost to Follow-up|10|||
162776290|NCT01243411|587891779|FG000|Overall Study|Adverse Event|5|||
162776291|NCT01243411|587891779|FG000|Overall Study|Other|8|||
162776292|NCT03193216|587891797|FG000|Overall Study|Lost to Follow-up|1|||
162776293|NCT03193216|587891798|FG001|Overall Study|Lost to Follow-up|0|||
162776294|NCT03193216|587891797|FG000|Overall Study|Withdrawal by Subject|5|||
162776295|NCT03193216|587891798|FG001|Overall Study|Withdrawal by Subject|0|||
162776296|NCT03193216|587891797|FG000|Overall Study|Physician Decision|4|||
162776297|NCT03193216|587891798|FG001|Overall Study|Physician Decision|0|||
162776298|NCT00922441|587891799|FG000|Overall Study|Protocol Violation|0|||
162776299|NCT00922441|587891800|FG001|Overall Study|Protocol Violation|0|||
162776300|NCT00922441|587891801|FG002|Overall Study|Protocol Violation|2|||
162776301|NCT00922441|587891799|FG000|Overall Study|Withdrawal by Subject|0|||
162776302|NCT00922441|587891800|FG001|Overall Study|Withdrawal by Subject|0|||
162776303|NCT00922441|587891801|FG002|Overall Study|Withdrawal by Subject|1|||
162776304|NCT00468858|587891807|FG000|Overall Study|Adverse Event|0|||
162776305|NCT00468858|587891808|FG001|Overall Study|Adverse Event|1|||
162776306|NCT00468858|587891809|FG002|Overall Study|Adverse Event|0|||
162776307|NCT00468858|587891807|FG000|Overall Study|Withdrawal by Subject|7|||
162776308|NCT00468858|587891808|FG001|Overall Study|Withdrawal by Subject|4|||
162776309|NCT00468858|587891809|FG002|Overall Study|Withdrawal by Subject|5|||
162776310|NCT00468858|587891807|FG000|Overall Study|Relocation|1|||
162776311|NCT00468858|587891808|FG001|Overall Study|Relocation|3|||
162776312|NCT00468858|587891809|FG002|Overall Study|Relocation|3|||
162776313|NCT00468858|587891807|FG000|Overall Study|Lost to Follow-up|1|||
162776314|NCT00468858|587891808|FG001|Overall Study|Lost to Follow-up|2|||
162776315|NCT00468858|587891809|FG002|Overall Study|Lost to Follow-up|5|||
162776316|NCT00468858|587891807|FG000|Overall Study|Other|0|||
162776317|NCT00468858|587891808|FG001|Overall Study|Other|0|||
162776318|NCT00468858|587891809|FG002|Overall Study|Other|1|||
162776319|NCT00797511|587891812|FG000|Overall Study|Withdrawal by Subject|1|||
162776320|NCT00317603|587891813|FG000|Overall Study|Progressive Disease|3|||
162776321|NCT00439647|587891814|FG000|Overall Study|Withdrawal by Subject|25|||
162776322|NCT00439647|587891815|FG001|Overall Study|Withdrawal by Subject|22|||
162776323|NCT00439647|587891814|FG000|Overall Study|Death|15|||
162776324|NCT00439647|587891815|FG001|Overall Study|Death|18|||
162776325|NCT00439647|587891814|FG000|Overall Study|Adverse Event|11|||
162776326|NCT00439647|587891815|FG001|Overall Study|Adverse Event|11|||
162776327|NCT00439647|587891814|FG000|Overall Study|Lost to Follow-up|4|||
162776328|NCT00439647|587891815|FG001|Overall Study|Lost to Follow-up|12|||
162776329|NCT00439647|587891814|FG000|Overall Study|Protocol Violation|3|||
162776330|NCT00439647|587891815|FG001|Overall Study|Protocol Violation|4|||
162776331|NCT00439647|587891814|FG000|Overall Study|Lack of Efficacy|0|||
162776332|NCT00439647|587891815|FG001|Overall Study|Lack of Efficacy|4|||
162776333|NCT00843115|587891816|FG000|Overall Study|Death|4|||
162776334|NCT00843115|587891816|FG000|Overall Study|Adverse Event|30|||
162776335|NCT00843115|587891816|FG000|Overall Study|Lost to Follow-up|4|||
162776336|NCT00843115|587891816|FG000|Overall Study|Withdrawal by Subject|17|||
162776337|NCT00843115|587891816|FG000|Overall Study|Family wanted meds stopped|1|||
162776338|NCT00843115|587891816|FG000|Overall Study|Family does not want continuation|1|||
162776339|NCT00843115|587891816|FG000|Overall Study|Patient forgot to take meds|1|||
162776340|NCT00843115|587891816|FG000|Overall Study|Does not meet entrance criteria|1|||
162776341|NCT00843115|587891816|FG000|Overall Study|Physician Decision|1|||
162776342|NCT00843115|587891816|FG000|Overall Study|Family discontinued meds|1|||
162776343|NCT00843115|587891816|FG000|Overall Study|patient took for 2 days then stopped|1|||
162776344|NCT00843115|587891816|FG000|Overall Study|patient never took the medication|1|||
162776345|NCT00843115|587891816|FG000|Overall Study|hospitalized due to deterioration|1|||
162776346|NCT00843115|587891816|FG000|Overall Study|week 12 not done|1|||
162776347|NCT00843115|587891816|FG000|Overall Study|Syndrome De Glissement|1|||
162776348|NCT02005029|587891817|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
162776349|NCT02005029|587891818|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
162776350|NCT02621047|587891819|FG000|Overall Study|Adverse Event|0|||
162776351|NCT02621047|587891820|FG001|Overall Study|Adverse Event|0|||
162776352|NCT02621047|587891821|FG002|Overall Study|Adverse Event|1|||
162776353|NCT03772041|587891824|FG000|Overall Study|Adverse Event|8|||
162776354|NCT03772041|587891825|FG001|Overall Study|Adverse Event|3|||
162776355|NCT03772041|587891824|FG000|Overall Study|Withdrawal by Subject|0|||
162776356|NCT03772041|587891825|FG001|Overall Study|Withdrawal by Subject|2|||
162776357|NCT03772041|587891824|FG000|Overall Study|Protocol Violation|4|||
162776358|NCT03772041|587891825|FG001|Overall Study|Protocol Violation|2|||
162776359|NCT03772041|587891824|FG000|Overall Study|Physician Decision|2|||
162776360|NCT03772041|587891825|FG001|Overall Study|Physician Decision|3|||
162776361|NCT03371485|587891828|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
162776362|NCT03371485|587891828|FG000|2-year Follow-up|Death|5|||
162776363|NCT02109107|587891830|FG000|Overall Study|Lost to Follow-up|2|||
162776364|NCT06016127|587891833|FG000|Overall Study|Withdrawal by Subject|4|||
162776365|NCT06016127|587891834|FG001|Overall Study|Withdrawal by Subject|3|||
162776366|NCT03340766|587891839|FG000|Overall Study|Withdrawal by Subject|2|||
162776367|NCT03340766|587891840|FG001|Overall Study|Withdrawal by Subject|1|||
162776368|NCT03340766|587891841|FG002|Overall Study|Withdrawal by Subject|3|||
162776369|NCT03340766|587891839|FG000|Overall Study|Lost to Follow-up|0|||
162776370|NCT03340766|587891840|FG001|Overall Study|Lost to Follow-up|0|||
162776371|NCT03340766|587891841|FG002|Overall Study|Lost to Follow-up|1|||
162776372|NCT03340766|587891839|FG000|Overall Study|Death|6|||
162776373|NCT03340766|587891840|FG001|Overall Study|Death|7|||
162776374|NCT03340766|587891841|FG002|Overall Study|Death|4|||
162776375|NCT00240097|587891842|FG000|Part I|Adverse Event|1|||
162776376|NCT00240097|587891842|FG000|Part I|Death|1|||
162776377|NCT00240097|587891842|FG000|Part I|histology|1|||
162776378|NCT00240097|587891842|FG000|Part I|unevaluable|1|||
162776379|NCT00240097|587891842|FG000|Part II|did not continue from Part I|23|||
162776380|NCT02383927|587891843|FG000|Overall Study|Disease Progression|8|||
162776381|NCT02383927|587891844|FG001|Overall Study|Disease Progression|8|||
162776382|NCT02383927|587891845|FG002|Overall Study|Disease Progression|15|||
162776383|NCT02383927|587891846|FG003|Overall Study|Disease Progression|4|||
162776384|NCT02383927|587891843|FG000|Overall Study|Physician Decision|0|||
162776385|NCT02383927|587891844|FG001|Overall Study|Physician Decision|0|||
162776386|NCT02383927|587891845|FG002|Overall Study|Physician Decision|2|||
162776387|NCT02383927|587891846|FG003|Overall Study|Physician Decision|0|||
162776388|NCT02383927|587891843|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
162776389|NCT02383927|587891844|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
162776390|NCT02383927|587891845|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
162776391|NCT02383927|587891846|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
162776392|NCT02383927|587891843|FG000|Overall Study|Adverse Event|4|||
162776393|NCT02383927|587891844|FG001|Overall Study|Adverse Event|1|||
162776394|NCT02383927|587891845|FG002|Overall Study|Adverse Event|3|||
162776395|NCT02383927|587891846|FG003|Overall Study|Adverse Event|5|||
162776396|NCT02383927|587891843|FG000|Overall Study|Miscellaneous|1|||
162776397|NCT02383927|587891844|FG001|Overall Study|Miscellaneous|0|||
162776398|NCT02383927|587891845|FG002|Overall Study|Miscellaneous|0|||
162776399|NCT02383927|587891846|FG003|Overall Study|Miscellaneous|1|||
162776400|NCT02383927|587891843|FG000|Overall Study|Withdrawal by Subject|0|||
162776401|NCT02383927|587891844|FG001|Overall Study|Withdrawal by Subject|1|||
162776402|NCT02383927|587891845|FG002|Overall Study|Withdrawal by Subject|4|||
162776403|NCT02383927|587891846|FG003|Overall Study|Withdrawal by Subject|0|||
162776404|NCT00734851|587891847|FG000|Overall Study|Withdrawal by Subject|2|||
162776405|NCT00734851|587891847|FG000|Overall Study|Lost to Follow-up|1|||
162776406|NCT00734851|587891847|FG000|Overall Study|Physician Decision|18|||
162776407|NCT00818519|587891848|FG000|Overall Study|Adverse Event|2|||
162776408|NCT00818519|587891849|FG001|Overall Study|Adverse Event|2|||
162776409|NCT00818519|587891848|FG000|Overall Study|Lost to Follow-up|4|||
162776410|NCT00818519|587891849|FG001|Overall Study|Lost to Follow-up|6|||
162776411|NCT00818519|587891848|FG000|Overall Study|Protocol Violation|2|||
162776412|NCT00818519|587891849|FG001|Overall Study|Protocol Violation|1|||
162776413|NCT00818519|587891848|FG000|Overall Study|Pregnancy|0|||
162776414|NCT00818519|587891849|FG001|Overall Study|Pregnancy|1|||
162776415|NCT00818519|587891848|FG000|Overall Study|Withdrawal by Subject|4|||
162776416|NCT00818519|587891849|FG001|Overall Study|Withdrawal by Subject|9|||
162776417|NCT00818519|587891848|FG000|Overall Study|participant recovered completely|1|||
162776418|NCT00818519|587891849|FG001|Overall Study|participant recovered completely|0|||
162776419|NCT00818519|587891848|FG000|Overall Study|participant will leave for long tme|1|||
162776420|NCT00818519|587891849|FG001|Overall Study|participant will leave for long tme|0|||
162776421|NCT00981578|587891853|FG000|Overall Study|Death|1|||
162776422|NCT00981578|587891853|FG000|Overall Study|Withdrawal by Subject|2|||
162776423|NCT01294358|587891856|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162776424|NCT01294358|587891857|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
162776425|NCT01294358|587891858|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162776426|NCT01294358|587891859|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162776427|NCT01294358|587891860|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162776428|NCT01294358|587891856|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162776429|NCT01294358|587891857|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162776430|NCT01294358|587891858|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
162776431|NCT01294358|587891859|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162776432|NCT01294358|587891860|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162776433|NCT01294358|587891856|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162776434|NCT01294358|587891857|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162776435|NCT01294358|587891858|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162776436|NCT01294358|587891859|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
162776437|NCT01294358|587891860|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162776438|NCT01294358|587891856|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162776439|NCT01294358|587891857|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162776440|NCT01294358|587891858|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162776441|NCT01294358|587891859|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162776442|NCT01294358|587891860|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
162776443|NCT03613454|587891861|FG000|Overall Study|Protocol Violation|1|||
162776444|NCT03613454|587891862|FG001|Overall Study|Protocol Violation|0|||
162776445|NCT03613454|587891861|FG000|Overall Study|Protocol Violation|0|||
162776446|NCT03613454|587891862|FG001|Overall Study|Protocol Violation|1|||
162776447|NCT02963922|587891863|FG000|Overall Study|Adverse Event|15|||
162776448|NCT02963922|587891864|FG001|Overall Study|Adverse Event|6|||
162776449|NCT02963922|587891863|FG000|Overall Study|Protocol deviation|6|||
162776450|NCT02963922|587891864|FG001|Overall Study|Protocol deviation|6|||
162776451|NCT02963922|587891863|FG000|Overall Study|Lack of Efficacy|1|||
162776452|NCT02963922|587891864|FG001|Overall Study|Lack of Efficacy|1|||
162776453|NCT02963922|587891863|FG000|Overall Study|Lost to Follow-up|2|||
162776454|NCT02963922|587891864|FG001|Overall Study|Lost to Follow-up|3|||
162776455|NCT02963922|587891863|FG000|Overall Study|Other|8|||
162776456|NCT02963922|587891864|FG001|Overall Study|Other|14|||
162776457|NCT02335242|587891874|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
162776458|NCT02335242|587891875|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
162776459|NCT02335242|587891874|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
162776460|NCT02335242|587891875|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162776461|NCT02335242|587891874|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
162776462|NCT02335242|587891875|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
162776463|NCT03873038|587891876|FG000|Part 2|Withdrawal by Subject|0|||
162776464|NCT03873038|587891877|FG001|Part 2|Withdrawal by Subject|0|||
162776465|NCT03873038|587891878|FG002|Part 2|Withdrawal by Subject|0|||
162776466|NCT03873038|587891879|FG003|Part 2|Withdrawal by Subject|0|||
162776467|NCT03873038|587891880|FG004|Part 2|Withdrawal by Subject|0|||
162776468|NCT03873038|587891881|FG005|Part 2|Withdrawal by Subject|1|||
162776469|NCT03873038|587891876|FG000|Part 2|Unknon|0|||
162776470|NCT03873038|587891877|FG001|Part 2|Unknon|0|||
162776471|NCT03873038|587891878|FG002|Part 2|Unknon|0|||
162776472|NCT03873038|587891879|FG003|Part 2|Unknon|0|||
162776473|NCT03873038|587891880|FG004|Part 2|Unknon|1|||
162776474|NCT03873038|587891881|FG005|Part 2|Unknon|0|||
162776475|NCT04222088|587891882|FG000|Overall Study|Lost to Follow-up|5|||
162776476|NCT04222088|587891883|FG001|Overall Study|Lost to Follow-up|1|||
162776477|NCT04222088|587891882|FG000|Overall Study|Withdrawal by Subject|4|||
162776478|NCT04222088|587891883|FG001|Overall Study|Withdrawal by Subject|0|||
162776479|NCT00595764|587891884|FG000|Overall Study|Protocol Violation|24|||
162776480|NCT00595764|587891885|FG001|Overall Study|Protocol Violation|19|||
162776481|NCT00595764|587891884|FG000|Overall Study|Missed Medication >1 week|10|||
162776482|NCT00595764|587891885|FG001|Overall Study|Missed Medication >1 week|17|||
162776483|NCT00595764|587891884|FG000|Overall Study|Missed 3 PM visits|1|||
162776484|NCT00595764|587891885|FG001|Overall Study|Missed 3 PM visits|7|||
162776485|NCT00595764|587891884|FG000|Overall Study|Withdrawal by Subject|4|||
162776486|NCT00595764|587891885|FG001|Overall Study|Withdrawal by Subject|0|||
162776487|NCT00141271|587891889|FG000|Overall Study|Adverse Event|31|||
162776488|NCT00141271|587891890|FG001|Overall Study|Adverse Event|19|||
162776489|NCT00141271|587891891|FG002|Overall Study|Adverse Event|17|||
162776490|NCT00141271|587891889|FG000|Overall Study|Laboratory Abnormality|2|||
162776491|NCT00141271|587891890|FG001|Overall Study|Laboratory Abnormality|1|||
162776492|NCT00141271|587891891|FG002|Overall Study|Laboratory Abnormality|1|||
162776493|NCT00141271|587891889|FG000|Overall Study|Lack of Efficacy|7|||
162776494|NCT00141271|587891890|FG001|Overall Study|Lack of Efficacy|7|||
162776495|NCT00141271|587891891|FG002|Overall Study|Lack of Efficacy|3|||
162776496|NCT00141271|587891889|FG000|Overall Study|Lost to Follow-up|15|||
162776497|NCT00141271|587891890|FG001|Overall Study|Lost to Follow-up|15|||
162776498|NCT00141271|587891891|FG002|Overall Study|Lost to Follow-up|21|||
162776499|NCT00141271|587891889|FG000|Overall Study|Withdrawal by Subject|14|||
162776500|NCT00141271|587891890|FG001|Overall Study|Withdrawal by Subject|9|||
162776501|NCT00141271|587891891|FG002|Overall Study|Withdrawal by Subject|10|||
162776502|NCT00141271|587891889|FG000|Overall Study|Other|11|||
162776503|NCT00141271|587891890|FG001|Overall Study|Other|12|||
162776504|NCT00141271|587891891|FG002|Overall Study|Other|5|||
162776505|NCT01544153|587891892|FG000|Overall Study|Under 18|0|||
162776506|NCT01544153|587891893|FG001|Overall Study|Under 18|1|||
162776507|NCT01544153|587891894|FG002|Overall Study|Under 18|0|||
162776508|NCT01544153|587891895|FG003|Overall Study|Under 18|0|||
162776509|NCT01544153|587891892|FG000|Overall Study|Non-smoker|0|||
162776510|NCT01544153|587891893|FG001|Overall Study|Non-smoker|0|||
162776511|NCT01544153|587891894|FG002|Overall Study|Non-smoker|1|||
162776512|NCT01544153|587891895|FG003|Overall Study|Non-smoker|0|||
162776513|NCT00390806|587891900|FG000|Overall Study|Lost to Follow-up|7|||
162776514|NCT00390806|587891901|FG001|Overall Study|Lost to Follow-up|6|||
162776515|NCT00390806|587891900|FG000|Overall Study|Protocol Violation|2|||
162776516|NCT00390806|587891901|FG001|Overall Study|Protocol Violation|2|||
162776517|NCT00390806|587891900|FG000|Overall Study|Withdrawal by Subject|12|||
162776518|NCT00390806|587891901|FG001|Overall Study|Withdrawal by Subject|15|||
162776519|NCT00390806|587891900|FG000|Overall Study|Investigator Decision|4|||
162776520|NCT00390806|587891901|FG001|Overall Study|Investigator Decision|6|||
162776521|NCT00390806|587891900|FG000|Overall Study|Death|1|||
162776522|NCT00390806|587891901|FG001|Overall Study|Death|0|||
162776523|NCT00390806|587891900|FG000|Overall Study|Physician Decision|0|||
162776524|NCT00390806|587891901|FG001|Overall Study|Physician Decision|1|||
162776525|NCT00390806|587891900|FG000|Overall Study|Ongoing|4|||
162776526|NCT00390806|587891901|FG001|Overall Study|Ongoing|2|||
162776527|NCT00884793|587891904|FG000|Overall Study|Withdrawal by Subject|1|||
162776528|NCT03169530|587891905|FG000|Overall Study|Study ended by NIH|15|||
162776529|NCT03169530|587891906|FG001|Overall Study|Study ended by NIH|17|||
162776530|NCT04783519|587891907|FG000|Overall Study|Withdrawal by Subject|2|||
162776531|NCT04783519|587891908|FG001|Overall Study|Withdrawal by Subject|7|||
162776532|NCT04783519|587891909|FG002|Overall Study|Withdrawal by Subject|3|||
162776533|NCT04783519|587891907|FG000|Overall Study|Lost to Follow-up|9|||
162776534|NCT04783519|587891908|FG001|Overall Study|Lost to Follow-up|7|||
162776535|NCT04783519|587891909|FG002|Overall Study|Lost to Follow-up|6|||
162776536|NCT01032200|587891910|FG000|Overall Study|Death|1|||
162776537|NCT01032200|587891911|FG001|Overall Study|Death|1|||
162776538|NCT01032200|587891910|FG000|Overall Study|Withdrawal by Subject|1|||
162776539|NCT01032200|587891911|FG001|Overall Study|Withdrawal by Subject|3|||
162776540|NCT01032200|587891910|FG000|Overall Study|Toxicity|0|||
162776541|NCT01032200|587891911|FG001|Overall Study|Toxicity|2|||
162776542|NCT01032200|587891910|FG000|Overall Study|Progression|1|||
162776543|NCT01032200|587891911|FG001|Overall Study|Progression|0|||
162776544|NCT01032200|587891910|FG000|Overall Study|Multiple|1|||
162776545|NCT01032200|587891911|FG001|Overall Study|Multiple|1|||
162776546|NCT04531813|587891915|FG000|Overall Study|Protocol Violation|1|||
162776547|NCT04531813|587891915|FG000|Overall Study|Withdrawal by Subject|1|||
162776548|NCT04341584|587891916|FG000|Overall Study|Withdrew consent|0|||
162776549|NCT04341584|587891917|FG001|Overall Study|Withdrew consent|2|||
162776550|NCT04341584|587891918|FG002|Overall Study|Withdrew consent|2|||
162776551|NCT04341584|587891919|FG003|Overall Study|Withdrew consent|1|||
162776552|NCT00381797|587893332|FG000|Overall Study|Withdrawal by Subject|1|||
162776553|NCT00381797|587893333|FG001|Overall Study|Withdrawal by Subject|1|||
162776554|NCT00381797|587893334|FG002|Overall Study|Withdrawal by Subject|0|||
162776555|NCT00381797|587893335|FG003|Overall Study|Withdrawal by Subject|0|||
162776556|NCT00381797|587893336|FG004|Overall Study|Withdrawal by Subject|2|||
162776557|NCT00381797|587893332|FG000|Overall Study|Ineligible|0|||
162776558|NCT00381797|587893333|FG001|Overall Study|Ineligible|0|||
162776559|NCT00381797|587893334|FG002|Overall Study|Ineligible|0|||
162776560|NCT00381797|587893335|FG003|Overall Study|Ineligible|1|||
162776561|NCT00381797|587893336|FG004|Overall Study|Ineligible|0|||
162776562|NCT01990313|587893340|FG000|Overall Study|Lost to Follow-up|1|||
162776563|NCT00837096|587893342|FG000|Overall Study|Physician Decision|1|||
162776564|NCT00837096|587893343|FG001|Overall Study|Physician Decision|1|||
162776565|NCT00837096|587893342|FG000|Overall Study|Not reported|9|||
162776566|NCT00837096|587893343|FG001|Overall Study|Not reported|8|||
162776567|NCT00721214|587893344|FG000|Overall Study|Chose another center for transplant|1|||
162776568|NCT00721214|587893344|FG000|Overall Study|Death|3|||
162776569|NCT00983905|587893345|FG000|Theophylline Alone|Adverse Event|1|||
162776570|NCT00983905|587893345|FG000|Colchicine Alone|Adverse Event|2|||
162776571|NCT01169636|587893346|FG000|Overall Study|Adverse Event|0|||
162776572|NCT01169636|587893347|FG001|Overall Study|Adverse Event|0|||
162776573|NCT01169636|587893348|FG002|Overall Study|Adverse Event|1|||
162776574|NCT01169636|587893349|FG003|Overall Study|Adverse Event|1|||
162776575|NCT01169636|587893350|FG004|Overall Study|Adverse Event|0|||
162776576|NCT01169636|587893346|FG000|Overall Study|Screen failure|0|||
162776577|NCT01169636|587893347|FG001|Overall Study|Screen failure|0|||
162776578|NCT01169636|587893348|FG002|Overall Study|Screen failure|2|||
162776579|NCT01169636|587893349|FG003|Overall Study|Screen failure|0|||
162776580|NCT01169636|587893350|FG004|Overall Study|Screen failure|0|||
162776581|NCT01169636|587893346|FG000|Overall Study|Withdrawal by Subject|0|||
162776582|NCT01169636|587893347|FG001|Overall Study|Withdrawal by Subject|0|||
162776583|NCT01169636|587893348|FG002|Overall Study|Withdrawal by Subject|0|||
162776584|NCT01169636|587893349|FG003|Overall Study|Withdrawal by Subject|0|||
162776585|NCT01169636|587893350|FG004|Overall Study|Withdrawal by Subject|3|||
162776586|NCT02396953|587893351|FG000|Overall Study|Withdrawal by Subject|0|||
162776587|NCT02396953|587893352|FG001|Overall Study|Withdrawal by Subject|0|||
162776588|NCT02396953|587893353|FG002|Overall Study|Withdrawal by Subject|1|||
162776589|NCT02396953|587893351|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
162776590|NCT02396953|587893352|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
162776591|NCT02396953|587893353|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
162776592|NCT02396953|587893351|FG000|Overall Study|Personal Reasons|1|||
162776593|NCT02396953|587893352|FG001|Overall Study|Personal Reasons|1|||
162776594|NCT02396953|587893353|FG002|Overall Study|Personal Reasons|0|||
162776595|NCT00510198|587893354|FG000|Overall Study|Withdrawal by Subject|5|||
162776596|NCT00510198|587893355|FG001|Overall Study|Withdrawal by Subject|4|||
162776597|NCT00494026|587893357|FG000|Overall Study|Sponsor Decision|4|||
162776598|NCT02466243|587893358|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
162776599|NCT02466243|587893359|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
162776600|NCT02466243|587893358|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
162776601|NCT02466243|587893359|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
162776602|NCT02466243|587893358|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
162776603|NCT02466243|587893359|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
162776604|NCT02466243|587893358|FG000|Part B Open-label Treatment Period|Missing|2|||
162776605|NCT02466243|587893359|FG001|Part B Open-label Treatment Period|Missing|2|||
162776606|NCT00307164|587893362|FG000|Overall Study|Death|1|||
162776607|NCT00307164|587893363|FG001|Overall Study|Death|0|||
162776608|NCT00307164|587893362|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162776609|NCT00307164|587893363|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162776610|NCT00307164|587893362|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
162776611|NCT00307164|587893363|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
162776612|NCT00307164|587893362|FG000|Overall Study|Withdrawal by Subject|1|||
162776613|NCT00307164|587893363|FG001|Overall Study|Withdrawal by Subject|8|||
162776614|NCT00307164|587893362|FG000|Overall Study|Not compliant with requirements|4|||
162776615|NCT00307164|587893363|FG001|Overall Study|Not compliant with requirements|4|||
162776616|NCT00307164|587893362|FG000|Overall Study|Lost to Follow-up|6|||
162776617|NCT00307164|587893363|FG001|Overall Study|Lost to Follow-up|1|||
162776618|NCT03972137|587893368|FG000|Overall Study|Lost to Follow-up|2|||
162776619|NCT03972137|587893368|FG000|Overall Study|Withdrawal by Subject|4|||
162776620|NCT03226353|587893369|FG000|Overall Study|Withdrawal by Subject|1|||
162776621|NCT03226353|587893369|FG000|Overall Study|Screen Failure|5|||
162776622|NCT03168425|587893370|FG000|Overall Study|Lost to Follow-up|5|||
162776623|NCT03168425|587893371|FG001|Overall Study|Lost to Follow-up|8|||
162776624|NCT03168425|587893370|FG000|Overall Study|unable to confirm post op opioids|2|||
162776625|NCT03168425|587893371|FG001|Overall Study|unable to confirm post op opioids|3|||
162776626|NCT03029234|587893374|FG000|Overall Study|Sponsor Decision|1|||
162776627|NCT03029234|587893374|FG000|Overall Study|Withdrawal by Subject|5|||
162776628|NCT03029234|587893374|FG000|Overall Study|Death|91|||
162776629|NCT03029234|587893374|FG000|Overall Study|Lost to Follow-up|2|||
162776630|NCT00498433|587893375|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
162776631|NCT00498433|587893376|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
162776632|NCT00498433|587893377|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
162776633|NCT00498433|587893375|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
162776634|NCT00498433|587893376|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
162776635|NCT00498433|587893377|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
162776636|NCT00498433|587893375|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
162776637|NCT00498433|587893376|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
162776638|NCT00498433|587893377|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
162776639|NCT00498433|587893375|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
162776640|NCT00498433|587893376|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
162776641|NCT00498433|587893377|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
162776642|NCT01885936|587893384|FG000|Overall Study|Withdrawal by Subject|1|||
162776643|NCT01885936|587893385|FG001|Overall Study|Withdrawal by Subject|0|||
162776644|NCT03214250|587893386|FG000|Overall Study|Death|5|||
162776645|NCT03214250|587893387|FG001|Overall Study|Death|5|||
162776646|NCT03214250|587893388|FG002|Overall Study|Death|7|||
162776647|NCT03214250|587893389|FG003|Overall Study|Death|4|||
162776648|NCT03214250|587893390|FG004|Overall Study|Death|23|||
162776649|NCT03214250|587893391|FG005|Overall Study|Death|23|||
162776650|NCT03214250|587893392|FG006|Overall Study|Death|24|||
162776651|NCT03214250|587893386|FG000|Overall Study|Lost to Follow-up|0|||
162776652|NCT03214250|587893387|FG001|Overall Study|Lost to Follow-up|0|||
162776653|NCT03214250|587893388|FG002|Overall Study|Lost to Follow-up|0|||
162776654|NCT03214250|587893389|FG003|Overall Study|Lost to Follow-up|1|||
162776655|NCT03214250|587893390|FG004|Overall Study|Lost to Follow-up|1|||
162776656|NCT03214250|587893391|FG005|Overall Study|Lost to Follow-up|2|||
162776657|NCT03214250|587893392|FG006|Overall Study|Lost to Follow-up|0|||
162776658|NCT03214250|587893386|FG000|Overall Study|Other|0|||
162776659|NCT03214250|587893387|FG001|Overall Study|Other|0|||
162776660|NCT03214250|587893388|FG002|Overall Study|Other|0|||
162776661|NCT03214250|587893389|FG003|Overall Study|Other|0|||
162776662|NCT03214250|587893390|FG004|Overall Study|Other|1|||
162776663|NCT03214250|587893391|FG005|Overall Study|Other|1|||
162776664|NCT03214250|587893392|FG006|Overall Study|Other|2|||
162776665|NCT03214250|587893386|FG000|Overall Study|Remains on Study|2|||
162776666|NCT03214250|587893387|FG001|Overall Study|Remains on Study|2|||
162776667|NCT03214250|587893388|FG002|Overall Study|Remains on Study|0|||
162776668|NCT03214250|587893389|FG003|Overall Study|Remains on Study|1|||
162776669|NCT03214250|587893390|FG004|Overall Study|Remains on Study|7|||
162776670|NCT03214250|587893391|FG005|Overall Study|Remains on Study|5|||
162776671|NCT03214250|587893392|FG006|Overall Study|Remains on Study|3|||
162776672|NCT03214250|587893386|FG000|Overall Study|Withdrawal by Subject|0|||
162776673|NCT03214250|587893387|FG001|Overall Study|Withdrawal by Subject|0|||
162776674|NCT03214250|587893388|FG002|Overall Study|Withdrawal by Subject|1|||
162776675|NCT03214250|587893389|FG003|Overall Study|Withdrawal by Subject|2|||
162776676|NCT03214250|587893390|FG004|Overall Study|Withdrawal by Subject|5|||
162776677|NCT03214250|587893391|FG005|Overall Study|Withdrawal by Subject|0|||
162776678|NCT03214250|587893392|FG006|Overall Study|Withdrawal by Subject|2|||
162776679|NCT02845375|587893398|FG000|Overall Study|upper airway obstruction|1|||
162776680|NCT02845375|587893399|FG001|Overall Study|upper airway obstruction|2|||
162776681|NCT02845375|587893400|FG002|Overall Study|upper airway obstruction|1|||
162776682|NCT02171130|587893403|FG000|Overall Study|Death|1|||
162776683|NCT02171130|587893403|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
162776684|NCT02171130|587893403|FG000|Overall Study|Discontinued; Site Termination|5|||
162776685|NCT02171130|587893403|FG000|Overall Study|Withdrawal by Subject|3|||
162776686|NCT02171130|587893403|FG000|Overall Study|Physician Decision|1|||
162776687|NCT02171130|587893403|FG000|Overall Study|Lost to Follow-up|1|||
162776688|NCT02171130|587893403|FG000|Overall Study|Met Exclusion Criteria|1|||
162776689|NCT01951261|587893404|FG000|Overall Study|Death|1|||
162776690|NCT01951261|587893405|FG001|Overall Study|Death|0|||
162776691|NCT01951261|587893404|FG000|Overall Study|Lost to Follow-up|4|||
162776692|NCT01951261|587893405|FG001|Overall Study|Lost to Follow-up|3|||
162776693|NCT01951261|587893404|FG000|Overall Study|Protocol Violation|4|||
162776694|NCT01951261|587893405|FG001|Overall Study|Protocol Violation|3|||
162776695|NCT03927222|587893406|FG000|Overall Study|Progression|3|||
162776696|NCT03927222|587893406|FG000|Overall Study|CMV testing results inconclusive|1|||
162776697|NCT03927222|587893406|FG000|Overall Study|Unable to generate enough vaccines|1|||
162776698|NCT03927222|587893406|FG000|Overall Study|Early study termination|1|||
162776699|NCT02201771|587893409|FG000|Overall Study|Death|3|||
162776700|NCT02201771|587893410|FG001|Overall Study|Death|2|||
162776701|NCT02201771|587893411|FG002|Overall Study|Death|0|||
162776702|NCT02201771|587893409|FG000|Overall Study|Protocol Violation|10|||
162776703|NCT02201771|587893410|FG001|Overall Study|Protocol Violation|8|||
162776704|NCT02201771|587893411|FG002|Overall Study|Protocol Violation|10|||
162776705|NCT01287416|587893414|FG000|Pre-post Training|Withdrawal by Subject|17|||
162776706|NCT01287416|587893415|FG001|Pre-post Training|Withdrawal by Subject|24|||
162776707|NCT01287416|587893414|FG000|Pre-post Training|Lost to Follow-up|5|||
162776708|NCT01287416|587893415|FG001|Pre-post Training|Lost to Follow-up|1|||
162776709|NCT01287416|587893414|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162776710|NCT01287416|587893415|FG001|6 Month Follow-up|Lost to Follow-up|2|||
162776711|NCT00495612|587893424|FG000|Overall Study|Lost to Follow-up|1|||
162776712|NCT00495612|587893425|FG001|Overall Study|Lost to Follow-up|0|||
162776713|NCT00495612|587893424|FG000|Overall Study|Subject's Decision to Withdraw|3|||
162776714|NCT00495612|587893425|FG001|Overall Study|Subject's Decision to Withdraw|0|||
162776715|NCT01180790|587893428|FG000|Overall Study|Adverse Event|1|||
162776716|NCT01180790|587893429|FG001|Overall Study|Adverse Event|1|||
162776717|NCT01180790|587893430|FG002|Overall Study|Adverse Event|2|||
162776718|NCT01180790|587893431|FG003|Overall Study|Adverse Event|0|||
162776719|NCT01180790|587893432|FG004|Overall Study|Adverse Event|1|||
162776720|NCT01180790|587893433|FG005|Overall Study|Adverse Event|3|||
162776721|NCT01180790|587893434|FG006|Overall Study|Adverse Event|0|||
162776722|NCT01180790|587893428|FG000|Overall Study|Withdrawal by Subject|3|||
162776723|NCT01180790|587893429|FG001|Overall Study|Withdrawal by Subject|0|||
162776724|NCT01180790|587893430|FG002|Overall Study|Withdrawal by Subject|5|||
162776725|NCT01180790|587893431|FG003|Overall Study|Withdrawal by Subject|0|||
162776726|NCT01180790|587893432|FG004|Overall Study|Withdrawal by Subject|2|||
162776727|NCT01180790|587893433|FG005|Overall Study|Withdrawal by Subject|1|||
162776728|NCT01180790|587893434|FG006|Overall Study|Withdrawal by Subject|0|||
162776729|NCT01180790|587893428|FG000|Overall Study|Lost to Follow-up|3|||
162776730|NCT01180790|587893429|FG001|Overall Study|Lost to Follow-up|1|||
162776731|NCT01180790|587893430|FG002|Overall Study|Lost to Follow-up|0|||
162776732|NCT01180790|587893431|FG003|Overall Study|Lost to Follow-up|2|||
162776733|NCT01180790|587893432|FG004|Overall Study|Lost to Follow-up|1|||
162776734|NCT01180790|587893433|FG005|Overall Study|Lost to Follow-up|0|||
162776735|NCT01180790|587893434|FG006|Overall Study|Lost to Follow-up|1|||
162776736|NCT01180790|587893428|FG000|Overall Study|Physician Decision|1|||
162776737|NCT01180790|587893429|FG001|Overall Study|Physician Decision|0|||
162776738|NCT01180790|587893430|FG002|Overall Study|Physician Decision|0|||
162776739|NCT01180790|587893431|FG003|Overall Study|Physician Decision|1|||
162776740|NCT01180790|587893432|FG004|Overall Study|Physician Decision|0|||
162776741|NCT01180790|587893433|FG005|Overall Study|Physician Decision|0|||
162776742|NCT01180790|587893434|FG006|Overall Study|Physician Decision|0|||
162776743|NCT01180790|587893428|FG000|Overall Study|Lack of Efficacy|1|||
162776744|NCT01180790|587893429|FG001|Overall Study|Lack of Efficacy|2|||
162776745|NCT01180790|587893430|FG002|Overall Study|Lack of Efficacy|5|||
162776746|NCT01180790|587893431|FG003|Overall Study|Lack of Efficacy|6|||
162776747|NCT01180790|587893432|FG004|Overall Study|Lack of Efficacy|1|||
162776748|NCT01180790|587893433|FG005|Overall Study|Lack of Efficacy|3|||
162776749|NCT01180790|587893434|FG006|Overall Study|Lack of Efficacy|0|||
162776750|NCT01180790|587893428|FG000|Overall Study|compliance|0|||
162776751|NCT01180790|587893429|FG001|Overall Study|compliance|1|||
162776752|NCT01180790|587893430|FG002|Overall Study|compliance|0|||
162776753|NCT01180790|587893431|FG003|Overall Study|compliance|0|||
162776754|NCT01180790|587893432|FG004|Overall Study|compliance|0|||
162776755|NCT01180790|587893433|FG005|Overall Study|compliance|0|||
162776756|NCT01180790|587893434|FG006|Overall Study|compliance|0|||
162776757|NCT01180790|587893428|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776758|NCT01180790|587893429|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776759|NCT01180790|587893430|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
162776760|NCT01180790|587893431|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776761|NCT01180790|587893432|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776762|NCT01180790|587893433|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776763|NCT01180790|587893434|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
162776764|NCT00655668|587893435|FG000|Overall Study|Adverse Event|6|||
162776765|NCT00655668|587893435|FG000|Overall Study|Death|5|||
162776766|NCT00655668|587893435|FG000|Overall Study|Disease Progression|27|||
162776767|NCT00655668|587893435|FG000|Overall Study|Study Terminated|9|||
162776768|NCT00655668|587893435|FG000|Overall Study|Other|1|||
162776769|NCT00655668|587893435|FG000|Overall Study|New Lymphoma Treatment Started|4|||
162776770|NCT00655668|587893435|FG000|Overall Study|Withdrawal by Subject|2|||
162776771|NCT04167085|587893436|FG000|Baseline|Withdrawal by Subject|2|||
162776772|NCT04167085|587893437|FG001|Baseline|Withdrawal by Subject|1|||
162776773|NCT04167085|587893436|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
162776774|NCT04167085|587893437|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
162776775|NCT03840148|587893438|FG000|Study Drug Disposition|Adverse Event|13|||
162776776|NCT03840148|587893439|FG001|Study Drug Disposition|Adverse Event|2|||
162776777|NCT03840148|587893438|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
162776778|NCT03840148|587893439|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
162776779|NCT03840148|587893438|FG000|Study Drug Disposition|Lack of Efficacy|3|||
162776780|NCT03840148|587893439|FG001|Study Drug Disposition|Lack of Efficacy|0|||
162776781|NCT03840148|587893438|FG000|Study Drug Disposition|Physician Decision|2|||
162776782|NCT03840148|587893439|FG001|Study Drug Disposition|Physician Decision|0|||
162776783|NCT03840148|587893438|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
162776784|NCT03840148|587893439|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
162776785|NCT03840148|587893438|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
162776786|NCT03840148|587893439|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
162776787|NCT03840148|587893438|FG000|Study Completion Disposition|Physician Decision|2|||
162776788|NCT03840148|587893439|FG001|Study Completion Disposition|Physician Decision|0|||
162776789|NCT03840148|587893438|FG000|Study Completion Disposition|Covid-19 related|2|||
162776790|NCT03840148|587893439|FG001|Study Completion Disposition|Covid-19 related|0|||
162776791|NCT03840148|587893438|FG000|Study Completion Disposition|Lost to Follow-up|1|||
162776792|NCT03840148|587893439|FG001|Study Completion Disposition|Lost to Follow-up|1|||
162776793|NCT03840148|587893438|FG000|Study Completion Disposition|Death|1|||
162776794|NCT03840148|587893439|FG001|Study Completion Disposition|Death|0|||
162776795|NCT03840148|587893438|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
162776796|NCT03840148|587893439|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
162776797|NCT03615404|587893440|FG000|Overall Study|Death|1|||
162776798|NCT03615404|587893440|FG000|Overall Study|vaccine did not pass quality assurance|1|||
162776799|NCT00257556|587893441|FG000|Overall Study|Adverse Event|1|||
162776800|NCT00257556|587893442|FG001|Overall Study|Adverse Event|4|||
162776801|NCT00257556|587893441|FG000|Overall Study|Physician Decision|6|||
162776802|NCT00257556|587893442|FG001|Overall Study|Physician Decision|0|||
162776803|NCT00257556|587893441|FG000|Overall Study|Did not meet hCG criterion|3|||
162776804|NCT00257556|587893442|FG001|Overall Study|Did not meet hCG criterion|0|||
162776805|NCT00257556|587893441|FG000|Overall Study|other reason|4|||
162776806|NCT00257556|587893442|FG001|Overall Study|other reason|6|||
162776807|NCT03849300|587893444|FG000|Overall Study|move out to different area|1|||
162776808|NCT03849300|587893445|FG001|Overall Study|move out to different area|3|||
162776809|NCT03849300|587893446|FG002|Overall Study|move out to different area|1|||
162776810|NCT03849300|587893447|FG003|Overall Study|move out to different area|4|||
162776811|NCT03849300|587893444|FG000|Overall Study|scheduling/transportation conflict|4|||
162776812|NCT03849300|587893445|FG001|Overall Study|scheduling/transportation conflict|4|||
162776813|NCT03849300|587893446|FG002|Overall Study|scheduling/transportation conflict|3|||
162776814|NCT03849300|587893447|FG003|Overall Study|scheduling/transportation conflict|2|||
162776815|NCT04839289|587893448|FG000|Overall Study|Withdrawal by Subject|1|||
162776816|NCT04839289|587893449|FG001|Overall Study|Withdrawal by Subject|0|||
162776817|NCT00464737|587893450|FG000|Overall Study|Adverse Event|12|||
162776818|NCT00464737|587893451|FG001|Overall Study|Adverse Event|17|||
162776819|NCT00464737|587893452|FG002|Overall Study|Adverse Event|33|||
162776820|NCT00464737|587893450|FG000|Overall Study|Lack of Efficacy|7|||
162776821|NCT00464737|587893451|FG001|Overall Study|Lack of Efficacy|7|||
162776822|NCT00464737|587893452|FG002|Overall Study|Lack of Efficacy|4|||
162776823|NCT00464737|587893450|FG000|Overall Study|Withdrawal by Subject|5|||
162776824|NCT00464737|587893451|FG001|Overall Study|Withdrawal by Subject|3|||
162776825|NCT00464737|587893452|FG002|Overall Study|Withdrawal by Subject|5|||
162776826|NCT00464737|587893450|FG000|Overall Study|Protocol Violation|1|||
162776827|NCT00464737|587893451|FG001|Overall Study|Protocol Violation|1|||
162776828|NCT00464737|587893452|FG002|Overall Study|Protocol Violation|5|||
162776829|NCT00464737|587893450|FG000|Overall Study|Non-compliance|0|||
162776830|NCT00464737|587893451|FG001|Overall Study|Non-compliance|1|||
162776831|NCT00464737|587893452|FG002|Overall Study|Non-compliance|1|||
162776832|NCT00464737|587893450|FG000|Overall Study|Lost to Follow-up|5|||
162776833|NCT00464737|587893451|FG001|Overall Study|Lost to Follow-up|2|||
162776834|NCT00464737|587893452|FG002|Overall Study|Lost to Follow-up|5|||
162776835|NCT00464737|587893450|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
162776836|NCT00464737|587893451|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
162776837|NCT00464737|587893452|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
162776838|NCT00464737|587893450|FG000|Overall Study|Other: Subject left town; family illness|1|||
162776839|NCT00464737|587893451|FG001|Overall Study|Other: Subject left town; family illness|0|||
162776840|NCT00464737|587893452|FG002|Overall Study|Other: Subject left town; family illness|0|||
162776841|NCT00464737|587893450|FG000|Overall Study|Other: Study demands too great|0|||
162776842|NCT00464737|587893451|FG001|Overall Study|Other: Study demands too great|1|||
162776843|NCT00464737|587893452|FG002|Overall Study|Other: Study demands too great|0|||
162776844|NCT00464737|587893450|FG000|Overall Study|Other: Personal family reasons|0|||
162776845|NCT00464737|587893451|FG001|Overall Study|Other: Personal family reasons|0|||
162776846|NCT00464737|587893452|FG002|Overall Study|Other: Personal family reasons|1|||
162776847|NCT00464737|587893450|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
162776848|NCT00464737|587893451|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
162776849|NCT00464737|587893452|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
162776850|NCT00580047|587893455|FG000|Overall Study|Lost to Follow-up|1|||
162776851|NCT00580047|587893456|FG001|Overall Study|Lost to Follow-up|1|||
162776852|NCT00580047|587893457|FG002|Overall Study|Lost to Follow-up|0|||
162776853|NCT00580047|587893455|FG000|Overall Study|Withdrawal by Subject|1|||
162776854|NCT00580047|587893456|FG001|Overall Study|Withdrawal by Subject|1|||
162776855|NCT00580047|587893457|FG002|Overall Study|Withdrawal by Subject|2|||
162776856|NCT00580047|587893455|FG000|Overall Study|Withdrawal by Subject|1|||
162776857|NCT00580047|587893456|FG001|Overall Study|Withdrawal by Subject|0|||
162776858|NCT00580047|587893457|FG002|Overall Study|Withdrawal by Subject|0|||
162776859|NCT02820298|587893458|FG000|Overall Study|Withdrawal by Subject|0|||
162776860|NCT02820298|587893459|FG001|Overall Study|Withdrawal by Subject|1|||
162776861|NCT02820298|587893458|FG000|Overall Study|Physician Decision|1|||
162776862|NCT02820298|587893459|FG001|Overall Study|Physician Decision|0|||
162776863|NCT02820298|587893458|FG000|Overall Study|Protocol Violation|0|||
162776864|NCT02820298|587893459|FG001|Overall Study|Protocol Violation|1|||
162776865|NCT01780584|587893460|FG000|Overall Study|Death|1|||
162776866|NCT01780584|587893461|FG001|Overall Study|Death|0|||
162776867|NCT01780584|587893462|FG002|Overall Study|Death|1|||
162776868|NCT01780584|587893460|FG000|Overall Study|Adverse Event|0|||
162776869|NCT01780584|587893461|FG001|Overall Study|Adverse Event|1|||
162776870|NCT01780584|587893462|FG002|Overall Study|Adverse Event|0|||
162776871|NCT01780584|587893460|FG000|Overall Study|Protocol Violation|0|||
162776872|NCT01780584|587893461|FG001|Overall Study|Protocol Violation|0|||
162776873|NCT01780584|587893462|FG002|Overall Study|Protocol Violation|1|||
162776874|NCT00727259|587893467|FG000|Overall Study|Not all questionnaires completed|1055|||
162776875|NCT01021683|587893468|FG000|Overall Study|Lack of Efficacy|12|||
162776876|NCT01021683|587893468|FG000|Overall Study|Recovery of neutrophil count|51|||
162776877|NCT01021683|587893468|FG000|Overall Study|Other|8|||
162776878|NCT01374971|587893469|FG000|Overall Study|Withdrawal by Subject|1|||
162776879|NCT02273180|587893470|FG000|Overall Study|Adverse Event|2|||
162776880|NCT02273180|587893471|FG001|Overall Study|Adverse Event|2|||
162776881|NCT02273180|587893470|FG000|Overall Study|Lack of Efficacy|1|||
162776882|NCT02273180|587893471|FG001|Overall Study|Lack of Efficacy|0|||
162776883|NCT02273180|587893470|FG000|Overall Study|Protocol Violation|1|||
162776884|NCT02273180|587893471|FG001|Overall Study|Protocol Violation|7|||
162776885|NCT02273180|587893470|FG000|Overall Study|Randomized but not treated|1|||
162776886|NCT02273180|587893471|FG001|Overall Study|Randomized but not treated|0|||
162776887|NCT02273180|587893470|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
162776888|NCT02273180|587893471|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
162776889|NCT02273180|587893470|FG000|Overall Study|Other than specified above|21|||
162776890|NCT02273180|587893471|FG001|Overall Study|Other than specified above|10|||
162776891|NCT01878383|587895411|FG000|Overall Study|Lost to Follow-up|0|||
162776892|NCT01878383|587895412|FG001|Overall Study|Lost to Follow-up|1499|||
162776893|NCT03464383|587895413|FG000|Overall Study|Lost to Follow-up|1|||
162776894|NCT03464383|587895414|FG001|Overall Study|Lost to Follow-up|0|||
162776895|NCT03464383|587895415|FG002|Overall Study|Lost to Follow-up|0|||
162776896|NCT03464383|587895413|FG000|Overall Study|Withdrawal by Subject|0|||
162776897|NCT03464383|587895414|FG001|Overall Study|Withdrawal by Subject|1|||
162776898|NCT03464383|587895415|FG002|Overall Study|Withdrawal by Subject|0|||
162776899|NCT03449134|587895416|FG000|52-Week Treatment Period|Death|2|||
162776900|NCT03449134|587895417|FG001|52-Week Treatment Period|Death|1|||
162776901|NCT03449134|587895418|FG002|52-Week Treatment Period|Death|0|||
162776902|NCT03449134|587895416|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
162776903|NCT03449134|587895417|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
162776904|NCT03449134|587895418|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
162776905|NCT03449134|587895416|FG000|52-Week Treatment Period|Physician Decision|2|||
162776906|NCT03449134|587895417|FG001|52-Week Treatment Period|Physician Decision|3|||
162776907|NCT03449134|587895418|FG002|52-Week Treatment Period|Physician Decision|3|||
162776908|NCT03449134|587895416|FG000|52-Week Treatment Period|Screen Failure|1|||
162776909|NCT03449134|587895417|FG001|52-Week Treatment Period|Screen Failure|0|||
162776910|NCT03449134|587895418|FG002|52-Week Treatment Period|Screen Failure|1|||
162776911|NCT03449134|587895416|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
162776912|NCT03449134|587895417|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
162776913|NCT03449134|587895418|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
162776914|NCT03449134|587895416|FG000|52-Week Treatment Period|Site Closure|1|||
162776915|NCT03449134|587895417|FG001|52-Week Treatment Period|Site Closure|0|||
162776916|NCT03449134|587895418|FG002|52-Week Treatment Period|Site Closure|0|||
162776917|NCT01960348|587895426|FG000|Overall Study|Adverse event, not serious|2|||
162776918|NCT01960348|587895427|FG001|Overall Study|Adverse event, not serious|2|||
162776919|NCT01960348|587895426|FG000|Overall Study|Adverse event, serious fatal|6|||
162776920|NCT01960348|587895427|FG001|Overall Study|Adverse event, serious fatal|5|||
162776921|NCT01960348|587895426|FG000|Overall Study|Adverse event, serious non-fatal|0|||
162776922|NCT01960348|587895427|FG001|Overall Study|Adverse event, serious non-fatal|3|||
162776923|NCT01960348|587895426|FG000|Overall Study|Withdrawal by Subject|1|||
162776924|NCT01960348|587895427|FG001|Overall Study|Withdrawal by Subject|11|||
162776925|NCT01960348|587895426|FG000|Overall Study|Physician Decision|0|||
162776926|NCT01960348|587895427|FG001|Overall Study|Physician Decision|1|||
162776927|NCT01960348|587895426|FG000|Overall Study|Protocol Violation|1|||
162776928|NCT01960348|587895427|FG001|Overall Study|Protocol Violation|0|||
162776929|NCT01821729|587895428|FG000|Overall Study|Withdrawal by Subject|1|||
162776930|NCT02412111|587895432|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
162776931|NCT02412111|587895433|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
162776932|NCT02412111|587895434|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
162776933|NCT02412111|587895432|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
162776934|NCT02412111|587895433|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
162776935|NCT02412111|587895434|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
162776936|NCT02412111|587895432|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
162776937|NCT02412111|587895433|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
162776938|NCT02412111|587895434|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
162776939|NCT02412111|587895432|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
162776940|NCT02412111|587895433|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
162776941|NCT02412111|587895434|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
162776942|NCT02412111|587895432|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
162776943|NCT02412111|587895433|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
162776944|NCT02412111|587895434|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
162776945|NCT02412111|587895432|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
162776946|NCT02412111|587895433|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
162776947|NCT02412111|587895434|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
162776948|NCT02412111|587895432|FG000|Active Comparator Period (8 Weeks)|Other|0|||
162776949|NCT02412111|587895433|FG001|Active Comparator Period (8 Weeks)|Other|0|||
162776950|NCT02412111|587895434|FG002|Active Comparator Period (8 Weeks)|Other|2|||
162776951|NCT02624869|587895435|FG000|Overall Study|Lost to Follow-up|0|||
162776952|NCT02624869|587895436|FG001|Overall Study|Lost to Follow-up|0|||
162776953|NCT02624869|587895437|FG002|Overall Study|Lost to Follow-up|1|||
162776954|NCT02624869|587895435|FG000|Overall Study|Withdrawal by Subject|1|||
162776955|NCT02624869|587895436|FG001|Overall Study|Withdrawal by Subject|3|||
162776956|NCT02624869|587895437|FG002|Overall Study|Withdrawal by Subject|1|||
162776957|NCT00329550|587895438|FG000|Overall Study|Adverse Event|3|||
162776958|NCT00329550|587895439|FG001|Overall Study|Adverse Event|4|||
162776959|NCT00329550|587895440|FG002|Overall Study|Adverse Event|2|||
162776960|NCT00329550|587895438|FG000|Overall Study|Withdrawal of Consent|1|||
162776961|NCT00329550|587895439|FG001|Overall Study|Withdrawal of Consent|0|||
162776962|NCT00329550|587895440|FG002|Overall Study|Withdrawal of Consent|1|||
162776963|NCT00329550|587895438|FG000|Overall Study|Due to Relocation|0|||
162776964|NCT00329550|587895439|FG001|Overall Study|Due to Relocation|0|||
162776965|NCT00329550|587895440|FG002|Overall Study|Due to Relocation|1|||
162776966|NCT02994784|587895441|FG000|6 Months Follow-up|Lost to Follow-up|3|||
162776967|NCT01649557|587895445|FG000|Overall Study|Lost to Follow-up|5|||
162776968|NCT01649557|587895446|FG001|Overall Study|Lost to Follow-up|0|||
162776969|NCT01649557|587895447|FG002|Overall Study|Lost to Follow-up|3|||
162776970|NCT01649557|587895445|FG000|Overall Study|Adverse Event|7|||
162776971|NCT01649557|587895446|FG001|Overall Study|Adverse Event|5|||
162776972|NCT01649557|587895447|FG002|Overall Study|Adverse Event|1|||
162776973|NCT01649557|587895445|FG000|Overall Study|Met withdrawal criteria|4|||
162776974|NCT01649557|587895446|FG001|Overall Study|Met withdrawal criteria|0|||
162776975|NCT01649557|587895447|FG002|Overall Study|Met withdrawal criteria|0|||
162776976|NCT01649557|587895445|FG000|Overall Study|Physician Decision|8|||
162776977|NCT01649557|587895446|FG001|Overall Study|Physician Decision|2|||
162776978|NCT01649557|587895447|FG002|Overall Study|Physician Decision|1|||
162776979|NCT01649557|587895445|FG000|Overall Study|Withdrawal by Subject|15|||
162776980|NCT01649557|587895446|FG001|Overall Study|Withdrawal by Subject|5|||
162776981|NCT01649557|587895447|FG002|Overall Study|Withdrawal by Subject|4|||
162776982|NCT01649557|587895445|FG000|Overall Study|Protocol deviation|0|||
162776983|NCT01649557|587895446|FG001|Overall Study|Protocol deviation|2|||
162776984|NCT01649557|587895447|FG002|Overall Study|Protocol deviation|0|||
162776985|NCT01649557|587895445|FG000|Overall Study|Lack of Efficacy|5|||
162776986|NCT01649557|587895446|FG001|Overall Study|Lack of Efficacy|0|||
162776987|NCT01649557|587895447|FG002|Overall Study|Lack of Efficacy|0|||
162776988|NCT01011049|587895448|FG000|Overall Study|Protocol Violation|0|||
162776989|NCT01011049|587895449|FG001|Overall Study|Protocol Violation|0|||
162776990|NCT01011049|587895450|FG002|Overall Study|Protocol Violation|2|||
162776991|NCT01011049|587895451|FG003|Overall Study|Protocol Violation|0|||
162776992|NCT01011049|587895448|FG000|Overall Study|Lost to Follow-up|1|||
162776993|NCT01011049|587895449|FG001|Overall Study|Lost to Follow-up|2|||
162776994|NCT01011049|587895450|FG002|Overall Study|Lost to Follow-up|1|||
162776995|NCT01011049|587895451|FG003|Overall Study|Lost to Follow-up|0|||
162776996|NCT01011049|587895448|FG000|Overall Study|Withdrawal by Subject|0|||
162776997|NCT01011049|587895449|FG001|Overall Study|Withdrawal by Subject|0|||
162776998|NCT01011049|587895450|FG002|Overall Study|Withdrawal by Subject|1|||
162776999|NCT01011049|587895451|FG003|Overall Study|Withdrawal by Subject|0|||
162777000|NCT02815735|587895452|FG000|First Intervention (4 Weeks)|Discomfort|1|||
162777001|NCT02815735|587895453|FG001|First Intervention (4 Weeks)|Discomfort|0|||
162777002|NCT02815735|587895452|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
162777003|NCT02815735|587895453|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162777004|NCT02815735|587895452|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
162777005|NCT02815735|587895453|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
162777006|NCT02815735|587895452|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
162777007|NCT02815735|587895453|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
162777008|NCT00352053|587895454|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
162777009|NCT00352053|587895455|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
162777010|NCT00352053|587895454|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
162777011|NCT00352053|587895455|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
162777012|NCT00352053|587895454|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
162777013|NCT00352053|587895455|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
162777014|NCT00352053|587895454|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
162777015|NCT00352053|587895455|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
162777016|NCT00352053|587895454|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
162777017|NCT00352053|587895455|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
162777018|NCT00352053|587895454|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
162777019|NCT00352053|587895455|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
162777020|NCT00352053|587895454|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
162777021|NCT00352053|587895455|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
162777022|NCT00352053|587895454|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
162777023|NCT00352053|587895455|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
162777024|NCT00352053|587895454|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
162777025|NCT00352053|587895455|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
162777026|NCT00352053|587895454|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
162777027|NCT00352053|587895455|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
162777028|NCT00352053|587895454|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
162777029|NCT00352053|587895455|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
162777030|NCT00352053|587895454|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
162777031|NCT00352053|587895455|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
162777032|NCT00352053|587895454|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
162777033|NCT00352053|587895455|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
162777034|NCT02435381|587895456|FG000|Overall Study|Lost to Follow-up|2|||
162777035|NCT02435381|587895457|FG001|Overall Study|Lost to Follow-up|1|||
162777036|NCT04150341|587895460|FG000|Overall Study|Physician Decision|0|||
162777037|NCT04150341|587895461|FG001|Overall Study|Physician Decision|0|||
162777038|NCT04150341|587895462|FG002|Overall Study|Physician Decision|1|||
162777039|NCT04150341|587895463|FG003|Overall Study|Physician Decision|0|||
162777040|NCT04150341|587895464|FG004|Overall Study|Physician Decision|0|||
162777041|NCT04150341|587895465|FG005|Overall Study|Physician Decision|0|||
162777042|NCT04150341|587895460|FG000|Overall Study|Adverse Event|0|||
162777043|NCT04150341|587895461|FG001|Overall Study|Adverse Event|0|||
162777044|NCT04150341|587895462|FG002|Overall Study|Adverse Event|0|||
162777045|NCT04150341|587895463|FG003|Overall Study|Adverse Event|0|||
162777046|NCT04150341|587895464|FG004|Overall Study|Adverse Event|1|||
162777047|NCT04150341|587895465|FG005|Overall Study|Adverse Event|0|||
162777048|NCT00875615|587895466|FG000|Overall Study|Withdrawal by Subject|1|||
162777049|NCT00405912|587895468|FG000|Overall Study|Withdrawal by Subject|12|||
162777050|NCT00405912|587895469|FG001|Overall Study|Withdrawal by Subject|11|||
162777051|NCT00405912|587895470|FG002|Overall Study|Withdrawal by Subject|12|||
162777052|NCT00405912|587895468|FG000|Overall Study|Lost to Follow-up|4|||
162777053|NCT00405912|587895469|FG001|Overall Study|Lost to Follow-up|8|||
162777054|NCT00405912|587895470|FG002|Overall Study|Lost to Follow-up|4|||
162777055|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
162777056|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
162777057|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
162777058|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
162777059|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
162777060|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
162777061|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
162777062|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
162777063|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Death|6|||
162777064|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Death|2|||
162777065|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Death|2|||
162777066|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Death|9|||
162777067|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
162777068|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162777069|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162777070|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
162777071|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
162777072|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
162777073|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
162777074|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
162777075|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
162777076|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
162777077|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
162777078|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
162777079|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162777080|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162777081|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162777082|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
162777083|NCT03730662|587895471|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
162777084|NCT03730662|587895472|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
162777085|NCT03730662|587895473|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
162777086|NCT03730662|587895474|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
162777087|NCT03730662|587895471|FG000|Variable Treatment Period|Adverse Event|1|||
162777088|NCT03730662|587895472|FG001|Variable Treatment Period|Adverse Event|2|||
162777089|NCT03730662|587895473|FG002|Variable Treatment Period|Adverse Event|0|||
162777090|NCT03730662|587895474|FG003|Variable Treatment Period|Adverse Event|7|||
162777091|NCT03730662|587895471|FG000|Variable Treatment Period|Death|9|||
162777092|NCT03730662|587895472|FG001|Variable Treatment Period|Death|0|||
162777093|NCT03730662|587895473|FG002|Variable Treatment Period|Death|6|||
162777094|NCT03730662|587895474|FG003|Variable Treatment Period|Death|26|||
162777095|NCT03730662|587895471|FG000|Variable Treatment Period|Lost to Follow-up|2|||
162777096|NCT03730662|587895472|FG001|Variable Treatment Period|Lost to Follow-up|1|||
162777097|NCT03730662|587895473|FG002|Variable Treatment Period|Lost to Follow-up|4|||
162777098|NCT03730662|587895474|FG003|Variable Treatment Period|Lost to Follow-up|11|||
162777099|NCT03730662|587895471|FG000|Variable Treatment Period|Personal Reason|0|||
162777100|NCT03730662|587895472|FG001|Variable Treatment Period|Personal Reason|2|||
162777101|NCT03730662|587895473|FG002|Variable Treatment Period|Personal Reason|1|||
162777102|NCT03730662|587895474|FG003|Variable Treatment Period|Personal Reason|6|||
162777103|NCT03730662|587895471|FG000|Variable Treatment Period|Physician Decision|0|||
162777104|NCT03730662|587895472|FG001|Variable Treatment Period|Physician Decision|0|||
162777105|NCT03730662|587895473|FG002|Variable Treatment Period|Physician Decision|0|||
162777106|NCT03730662|587895474|FG003|Variable Treatment Period|Physician Decision|3|||
162777107|NCT03730662|587895471|FG000|Variable Treatment Period|Protocol Violation|0|||
162777108|NCT03730662|587895472|FG001|Variable Treatment Period|Protocol Violation|1|||
162777109|NCT03730662|587895473|FG002|Variable Treatment Period|Protocol Violation|1|||
162777110|NCT03730662|587895474|FG003|Variable Treatment Period|Protocol Violation|1|||
162777111|NCT03730662|587895471|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
162777112|NCT03730662|587895472|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
162777113|NCT03730662|587895473|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
162777114|NCT03730662|587895474|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
162777115|NCT00833898|587895475|FG000|Overall Study|Withdrawal by Subject|33|||
162777116|NCT00833898|587895476|FG001|Overall Study|Withdrawal by Subject|27|||
162777117|NCT00833898|587895475|FG000|Overall Study|Lost to Follow-up|7|||
162777118|NCT00833898|587895476|FG001|Overall Study|Lost to Follow-up|7|||
162777119|NCT00833898|587895475|FG000|Overall Study|Patient did not receive transplant|0|||
162777120|NCT00833898|587895476|FG001|Overall Study|Patient did not receive transplant|2|||
162777121|NCT02895360|587895485|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
162777122|NCT02895360|587895486|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162777123|NCT02895360|587895487|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162777124|NCT02895360|587895488|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162777125|NCT02895360|587895489|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162777126|NCT02895360|587895490|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162777127|NCT02895360|587895485|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162777128|NCT02895360|587895486|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
162777129|NCT02895360|587895487|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162777130|NCT02895360|587895488|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162777131|NCT02895360|587895489|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162777132|NCT02895360|587895490|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162777133|NCT02895360|587895485|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162777134|NCT02895360|587895486|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162777135|NCT02895360|587895487|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
162777136|NCT02895360|587895488|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162777137|NCT02895360|587895489|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162777138|NCT02895360|587895490|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162777139|NCT02895360|587895485|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162777140|NCT02895360|587895486|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162777141|NCT02895360|587895487|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
162777142|NCT02895360|587895488|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162777143|NCT02895360|587895489|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162777144|NCT02895360|587895490|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162777145|NCT02895360|587895485|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162777146|NCT02895360|587895486|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162777147|NCT02895360|587895487|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162777148|NCT02895360|587895488|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
162777149|NCT02895360|587895489|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162777150|NCT02895360|587895490|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162777151|NCT02895360|587895485|FG000|Phase 2a|Adverse Event|0|||
162777152|NCT02895360|587895486|FG001|Phase 2a|Adverse Event|0|||
162777153|NCT02895360|587895487|FG002|Phase 2a|Adverse Event|0|||
162777154|NCT02895360|587895488|FG003|Phase 2a|Adverse Event|0|||
162777155|NCT02895360|587895489|FG004|Phase 2a|Adverse Event|0|||
162777156|NCT02895360|587895490|FG005|Phase 2a|Adverse Event|1|||
162777157|NCT02895360|587895485|FG000|Phase 2a|Progressive disease|0|||
162777158|NCT02895360|587895486|FG001|Phase 2a|Progressive disease|0|||
162777159|NCT02895360|587895487|FG002|Phase 2a|Progressive disease|0|||
162777160|NCT02895360|587895488|FG003|Phase 2a|Progressive disease|0|||
162777161|NCT02895360|587895489|FG004|Phase 2a|Progressive disease|11|||
162777162|NCT02895360|587895490|FG005|Phase 2a|Progressive disease|11|||
162777163|NCT03712449|587895491|FG000|Overall Study|Withdraw Consent|0|||
162777164|NCT03712449|587895492|FG001|Overall Study|Withdraw Consent|1|||
162777165|NCT00666198|587895493|FG000|Overall Study|Protocol Violation|10|||
162777166|NCT00666198|587895493|FG000|Overall Study|No Visit After First Day of Treatment|13|||
162777167|NCT00666198|587895493|FG000|Overall Study|Safety Not Assessable|6|||
162777168|NCT00666198|587895493|FG000|Overall Study|No Drug Administration|4|||
162777169|NCT05153499|587895494|FG000|Overall Study|Withdrawal by Subject|1|||
162777170|NCT05153499|587895495|FG001|Overall Study|Withdrawal by Subject|0|||
162777171|NCT05153499|587895494|FG000|Overall Study|Clinical Hold|1|||
162777172|NCT05153499|587895495|FG001|Overall Study|Clinical Hold|0|||
162777173|NCT05153499|587895494|FG000|Overall Study|Study Termination|6|||
162777174|NCT05153499|587895495|FG001|Overall Study|Study Termination|5|||
162777175|NCT01960114|587895497|FG000|Overall Study|Adverse Event|1|||
162777176|NCT01960114|587895498|FG001|Overall Study|Adverse Event|0|||
162777177|NCT01960114|587895497|FG000|Overall Study|Could not swallow study medication|0|||
162777178|NCT01960114|587895498|FG001|Overall Study|Could not swallow study medication|1|||
162777179|NCT00427778|587895499|FG000|First Intervention (4 Weeks)|no longer interested|1|||
162777180|NCT00427778|587895500|FG001|First Intervention (4 Weeks)|no longer interested|0|||
162777181|NCT00427778|587895499|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
162777182|NCT00427778|587895500|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
162777183|NCT00427778|587895499|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
162777184|NCT00427778|587895500|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
162777185|NCT00427778|587895499|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
162777186|NCT00427778|587895500|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
162777187|NCT00225277|587895501|FG000|Overall Study|Adverse Event|30|||
162777188|NCT00225277|587895502|FG001|Overall Study|Adverse Event|34|||
162777189|NCT00225277|587895501|FG000|Overall Study|Lack of Efficacy|4|||
162777190|NCT00225277|587895502|FG001|Overall Study|Lack of Efficacy|1|||
162777191|NCT00225277|587895501|FG000|Overall Study|Lost to Follow-up|4|||
162777192|NCT00225277|587895502|FG001|Overall Study|Lost to Follow-up|6|||
162777193|NCT00225277|587895501|FG000|Overall Study|Physician Decision|6|||
162777194|NCT00225277|587895502|FG001|Overall Study|Physician Decision|8|||
162777195|NCT00225277|587895501|FG000|Overall Study|Protocol Violation|6|||
162777196|NCT00225277|587895502|FG001|Overall Study|Protocol Violation|3|||
162777197|NCT00225277|587895501|FG000|Overall Study|Withdrawal by Subject|40|||
162777198|NCT00225277|587895502|FG001|Overall Study|Withdrawal by Subject|34|||
162777199|NCT00225277|587895501|FG000|Overall Study|Other|7|||
162777200|NCT00225277|587895502|FG001|Overall Study|Other|9|||
162777201|NCT00591409|587895508|FG000|Overall Study|Not Treated|0|||
162777202|NCT00591409|587895509|FG001|Overall Study|Not Treated|0|||
162777203|NCT00591409|587895510|FG002|Overall Study|Not Treated|0|||
162777204|NCT00591409|587895511|FG003|Overall Study|Not Treated|0|||
162777205|NCT00591409|587895512|FG004|Overall Study|Not Treated|1|||
162777206|NCT00591409|587895513|FG005|Overall Study|Not Treated|0|||
162777207|NCT00591409|587895514|FG006|Overall Study|Not Treated|0|||
162777208|NCT00591409|587895515|FG007|Overall Study|Not Treated|0|||
162777209|NCT00591409|587895516|FG008|Overall Study|Not Treated|0|||
162777210|NCT00591409|587895517|FG009|Overall Study|Not Treated|1|||
162777211|NCT01340300|587895518|FG000|Overall Study|Lost to Follow-up|3|||
162777212|NCT01340300|587895519|FG001|Overall Study|Lost to Follow-up|0|||
162777213|NCT01340300|587895520|FG002|Overall Study|Lost to Follow-up|5|||
162777214|NCT01340300|587895521|FG003|Overall Study|Lost to Follow-up|10|||
162777215|NCT01340300|587895518|FG000|Overall Study|Withdrawal by Subject|5|||
162777216|NCT01340300|587895519|FG001|Overall Study|Withdrawal by Subject|6|||
162777217|NCT01340300|587895520|FG002|Overall Study|Withdrawal by Subject|6|||
162777218|NCT01340300|587895521|FG003|Overall Study|Withdrawal by Subject|3|||
162777219|NCT01340300|587895518|FG000|Overall Study|Adverse Event|1|||
162777220|NCT01340300|587895519|FG001|Overall Study|Adverse Event|0|||
162777221|NCT01340300|587895520|FG002|Overall Study|Adverse Event|4|||
162777222|NCT01340300|587895521|FG003|Overall Study|Adverse Event|0|||
162777223|NCT01340300|587895518|FG000|Overall Study|Physician Decision|0|||
162777224|NCT01340300|587895519|FG001|Overall Study|Physician Decision|1|||
162777225|NCT01340300|587895520|FG002|Overall Study|Physician Decision|0|||
162777226|NCT01340300|587895521|FG003|Overall Study|Physician Decision|0|||
162777227|NCT01340300|587895518|FG000|Overall Study|Unrelated sickness|0|||
162777228|NCT01340300|587895519|FG001|Overall Study|Unrelated sickness|2|||
162777229|NCT01340300|587895520|FG002|Overall Study|Unrelated sickness|0|||
162777230|NCT01340300|587895521|FG003|Overall Study|Unrelated sickness|1|||
162777231|NCT03723915|587895528|FG000|Screening|Failed to meet screening requirements.|2|||
162777232|NCT03723915|587895528|FG000|On Treatment|Failed to meet treatment requirements|2|||
162777233|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
162777234|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
162777235|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
162777236|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
162777237|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
162777238|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
162777239|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
162777240|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
162777241|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
162777242|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
162777243|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
162777244|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
162777245|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
162777246|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
162777247|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
162777248|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162777249|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162777250|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162777251|NCT03569475|587895529|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
162777252|NCT03569475|587895530|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
162777253|NCT03569475|587895531|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
162777254|NCT03569475|587895529|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
162777255|NCT03569475|587895530|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
162777256|NCT03569475|587895531|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
162777257|NCT03569475|587895529|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
162777258|NCT03569475|587895530|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
162777259|NCT03569475|587895531|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
162777260|NCT02630706|587895532|FG000|Overall Study|Adverse Event|2|||
162777261|NCT02630706|587895533|FG001|Overall Study|Adverse Event|1|||
162777262|NCT02630706|587895534|FG002|Overall Study|Adverse Event|1|||
162777263|NCT02630706|587895532|FG000|Overall Study|Lost to Follow-up|0|||
162777264|NCT02630706|587895533|FG001|Overall Study|Lost to Follow-up|1|||
162777265|NCT02630706|587895534|FG002|Overall Study|Lost to Follow-up|2|||
162777266|NCT02630706|587895532|FG000|Overall Study|Physician Decision|1|||
162777267|NCT02630706|587895533|FG001|Overall Study|Physician Decision|1|||
162777268|NCT02630706|587895534|FG002|Overall Study|Physician Decision|0|||
162777269|NCT02630706|587895532|FG000|Overall Study|Pregnancy|0|||
162777270|NCT02630706|587895533|FG001|Overall Study|Pregnancy|1|||
162777271|NCT02630706|587895534|FG002|Overall Study|Pregnancy|0|||
162777272|NCT02630706|587895532|FG000|Overall Study|Withdrawal by Subject|4|||
162777273|NCT02630706|587895533|FG001|Overall Study|Withdrawal by Subject|5|||
162777274|NCT02630706|587895534|FG002|Overall Study|Withdrawal by Subject|7|||
162777275|NCT01894256|587895540|FG000|Part A|Adverse Event|0|||
162777276|NCT01894256|587895541|FG001|Part A|Adverse Event|1|||
162777277|NCT01894256|587895542|FG002|Part A|Adverse Event|0|||
162777278|NCT01894256|587895540|FG000|Part B|Death|0|||
162777279|NCT01894256|587895541|FG001|Part B|Death|1|||
162777280|NCT01894256|587895542|FG002|Part B|Death|1|||
162777281|NCT01894256|587895540|FG000|Part B|Withdrawal by Subject|0|||
162777282|NCT01894256|587895541|FG001|Part B|Withdrawal by Subject|1|||
162777283|NCT01894256|587895542|FG002|Part B|Withdrawal by Subject|0|||
162777284|NCT01894256|587895540|FG000|Part B|Lack of Efficacy|15|||
162777285|NCT01894256|587895541|FG001|Part B|Lack of Efficacy|12|||
162777286|NCT01894256|587895542|FG002|Part B|Lack of Efficacy|13|||
162777287|NCT00645099|587895548|FG000|Overall Study|Lack of Efficacy|15|||
162777288|NCT00645099|587895549|FG001|Overall Study|Lack of Efficacy|6|||
162777289|NCT00645099|587895548|FG000|Overall Study|Withdrawal by Subject|30|||
162777290|NCT00645099|587895549|FG001|Overall Study|Withdrawal by Subject|22|||
162777291|NCT00645099|587895548|FG000|Overall Study|Lost to Follow-up|6|||
162777292|NCT00645099|587895549|FG001|Overall Study|Lost to Follow-up|4|||
162777293|NCT00645099|587895548|FG000|Overall Study|Adverse Event|11|||
162777294|NCT00645099|587895549|FG001|Overall Study|Adverse Event|5|||
162777295|NCT00645099|587895548|FG000|Overall Study|Other|9|||
162777296|NCT00645099|587895549|FG001|Overall Study|Other|5|||
162777297|NCT01201915|587895550|FG000|Overall Study|Adverse Event|2|||
162777298|NCT01201915|587895551|FG001|Overall Study|Adverse Event|1|||
162777299|NCT01201915|587895552|FG002|Overall Study|Adverse Event|1|||
162777300|NCT01201915|587895550|FG000|Overall Study|Lost to Follow-up|0|||
162777301|NCT01201915|587895551|FG001|Overall Study|Lost to Follow-up|4|||
162777302|NCT01201915|587895552|FG002|Overall Study|Lost to Follow-up|0|||
162777303|NCT01201915|587895550|FG000|Overall Study|Physician Decision|3|||
162777304|NCT01201915|587895551|FG001|Overall Study|Physician Decision|0|||
162777305|NCT01201915|587895552|FG002|Overall Study|Physician Decision|0|||
162777306|NCT01201915|587895550|FG000|Overall Study|Subject Decision|3|||
162777307|NCT01201915|587895551|FG001|Overall Study|Subject Decision|3|||
162777308|NCT01201915|587895552|FG002|Overall Study|Subject Decision|5|||
162777309|NCT01201915|587895550|FG000|Overall Study|Target Lesion Progression|0|||
162777310|NCT01201915|587895551|FG001|Overall Study|Target Lesion Progression|3|||
162777311|NCT01201915|587895552|FG002|Overall Study|Target Lesion Progression|0|||
162777312|NCT02154516|587895553|FG000|Overall Study|Withdrawal by Subject|0|||
162777313|NCT02154516|587895554|FG001|Overall Study|Withdrawal by Subject|1|||
162777314|NCT02154516|587895553|FG000|Overall Study|Lost to Follow-up|1|||
162777315|NCT02154516|587895554|FG001|Overall Study|Lost to Follow-up|0|||
162777316|NCT02154516|587895553|FG000|Overall Study|Removal/revision of device|1|||
162777317|NCT02154516|587895554|FG001|Overall Study|Removal/revision of device|0|||
162777318|NCT02154516|587895553|FG000|Overall Study|Death|2|||
162777319|NCT02154516|587895554|FG001|Overall Study|Death|1|||
162777320|NCT03406507|587895555|FG000|Extension Period|Lack of Efficacy|0|||
162777321|NCT03406507|587895556|FG001|Extension Period|Lack of Efficacy|1|||
162777322|NCT00663923|587895557|FG000|Overall Study|Lost to Follow-up|2|||
162777323|NCT02316171|587895561|FG000|Overall Study|difficulties with urinary catheter|1|||
162777324|NCT02316171|587895562|FG001|Overall Study|difficulties with urinary catheter|0|||
162777325|NCT02316171|587895563|FG002|Overall Study|difficulties with urinary catheter|0|||
162777326|NCT02316171|587895564|FG003|Overall Study|difficulties with urinary catheter|0|||
162777327|NCT01804140|587895566|FG000|Overall Study|No sampling or biopsy procedures done|114|||
162777328|NCT00547300|587895567|FG000|Overall Study|Study was Administratively Terminated|25|||
162777329|NCT00547300|587895568|FG001|Overall Study|Study was Administratively Terminated|24|||
162777330|NCT00547300|587895567|FG000|Overall Study|Did not Meet Entry Criteria|0|||
162777331|NCT00547300|587895568|FG001|Overall Study|Did not Meet Entry Criteria|2|||
162777332|NCT02785900|587895569|FG000|Overall Study|Study Termination by Sponsor|64|||
162777333|NCT02785900|587895570|FG001|Overall Study|Study Termination by Sponsor|81|||
162777334|NCT02785900|587895569|FG000|Overall Study|Death|46|||
162777335|NCT02785900|587895570|FG001|Overall Study|Death|32|||
162777336|NCT02785900|587895569|FG000|Overall Study|Withdrawal by Subject|4|||
162777337|NCT02785900|587895570|FG001|Overall Study|Withdrawal by Subject|8|||
162777338|NCT02785900|587895569|FG000|Overall Study|Physician Decision|3|||
162777339|NCT02785900|587895570|FG001|Overall Study|Physician Decision|2|||
162777340|NCT04435522|587895573|FG000|Overall Study|Withdrawal by Subject|2|||
162777341|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
162777342|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
162777343|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
162777344|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
162777345|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
162777346|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
162777347|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
162777348|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
162777349|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
162777350|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
162777351|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
162777352|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
162777353|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
162777354|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
162777355|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
162777356|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
162777357|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
162777358|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
162777359|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
162777360|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
162777361|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
162777362|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
162777363|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
162777364|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
162777365|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
162777366|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
162777367|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
162777368|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
162777369|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
162777370|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162777371|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162777372|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162777373|NCT00092521|587897244|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
162777374|NCT00092521|587897245|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162777375|NCT00092521|587897246|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162777376|NCT00092521|587897247|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162777377|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
162777378|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
162777379|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
162777380|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
162777381|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
162777382|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
162777383|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
162777384|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
162777385|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
162777386|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
162777387|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
162777388|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
162777389|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Death|2|||
162777390|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Death|0|||
162777391|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Death|1|||
162777392|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Death|0|||
162777393|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
162777394|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
162777395|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
162777396|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
162777397|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
162777398|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
162777399|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
162777400|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
162777401|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
162777402|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
162777403|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
162777404|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
162777405|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Moved|32|||
162777406|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Moved|2|||
162777407|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Moved|28|||
162777408|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Moved|0|||
162777409|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
162777410|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
162777411|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
162777412|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
162777413|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Travel|2|||
162777414|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Travel|0|||
162777415|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Travel|0|||
162777416|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Travel|0|||
162777417|NCT00092521|587897244|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
162777418|NCT00092521|587897245|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
162777419|NCT00092521|587897246|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
162777420|NCT00092521|587897247|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
162777421|NCT00092521|587897244|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162777422|NCT00092521|587897245|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162777423|NCT00092521|587897246|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162777424|NCT00092521|587897247|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
162777425|NCT00092521|587897244|FG000|Extension Study (Group 4)|Adverse Event|0|||
162777426|NCT00092521|587897245|FG001|Extension Study (Group 4)|Adverse Event|0|||
162777427|NCT00092521|587897246|FG002|Extension Study (Group 4)|Adverse Event|0|||
162777428|NCT00092521|587897247|FG003|Extension Study (Group 4)|Adverse Event|2|||
162777429|NCT00092521|587897244|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
162777430|NCT00092521|587897245|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
162777431|NCT00092521|587897246|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
162777432|NCT00092521|587897247|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
162777433|NCT00092521|587897244|FG000|Extension Study (Group 4)|Pregnancy|0|||
162777434|NCT00092521|587897245|FG001|Extension Study (Group 4)|Pregnancy|0|||
162777435|NCT00092521|587897246|FG002|Extension Study (Group 4)|Pregnancy|0|||
162777436|NCT00092521|587897247|FG003|Extension Study (Group 4)|Pregnancy|4|||
162777437|NCT00092521|587897244|FG000|Extension Study (Group 4)|Protocol Violation|0|||
162777438|NCT00092521|587897245|FG001|Extension Study (Group 4)|Protocol Violation|0|||
162777439|NCT00092521|587897246|FG002|Extension Study (Group 4)|Protocol Violation|0|||
162777440|NCT00092521|587897247|FG003|Extension Study (Group 4)|Protocol Violation|2|||
162777441|NCT00092521|587897244|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
162777442|NCT00092521|587897245|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
162777443|NCT00092521|587897246|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
162777444|NCT00092521|587897247|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
162777445|NCT00092521|587897244|FG000|Extension Study (Group 4)|Moved|0|||
162777446|NCT00092521|587897245|FG001|Extension Study (Group 4)|Moved|0|||
162777447|NCT00092521|587897246|FG002|Extension Study (Group 4)|Moved|0|||
162777448|NCT00092521|587897247|FG003|Extension Study (Group 4)|Moved|16|||
162777449|NCT00092521|587897244|FG000|Extension Study (Group 4)|Site Terminated|0|||
162777450|NCT00092521|587897245|FG001|Extension Study (Group 4)|Site Terminated|0|||
162777451|NCT00092521|587897246|FG002|Extension Study (Group 4)|Site Terminated|0|||
162777452|NCT00092521|587897247|FG003|Extension Study (Group 4)|Site Terminated|4|||
162777453|NCT00092521|587897244|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
162777454|NCT00092521|587897245|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
162777455|NCT00092521|587897246|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
162777456|NCT00092521|587897247|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
162777457|NCT00560313|587897248|FG000|Overall Study|Adverse Events or Death|2|||
162777458|NCT00560313|587897248|FG000|Overall Study|Withdrawal by Subject|2|||
162777459|NCT00560313|587897248|FG000|Overall Study|Lost to Follow-up|1|||
162777460|NCT00560313|587897248|FG000|Overall Study|Protocol Violation|1|||
162777461|NCT00605566|587897249|FG000|Overall Study|Adverse Event|1|||
162777462|NCT00605566|587897249|FG000|Overall Study|Clinical deterioration|1|||
162777463|NCT00605566|587897249|FG000|Overall Study|Poor compliance in run-in period|1|||
162777464|NCT03475056|587897250|FG000|Overall Study|Lost to Follow-up|0|||
162777465|NCT03475056|587897251|FG001|Overall Study|Lost to Follow-up|1|||
162777466|NCT03475056|587897250|FG000|Overall Study|Moved from Area|0|||
162777467|NCT03475056|587897251|FG001|Overall Study|Moved from Area|2|||
162777468|NCT00113269|587897254|FG000|Overall Study|Not transplanted, donor issues|4|||
162777469|NCT00113269|587897255|FG001|Overall Study|Not transplanted, donor issues|0|||
162777470|NCT00113269|587897256|FG002|Overall Study|Not transplanted, donor issues|2|||
162777471|NCT00113269|587897257|FG003|Overall Study|Not transplanted, donor issues|2|||
162777472|NCT00113269|587897254|FG000|Overall Study|Not transplanted, recipient issues|2|||
162777473|NCT00113269|587897255|FG001|Overall Study|Not transplanted, recipient issues|1|||
162777474|NCT00113269|587897256|FG002|Overall Study|Not transplanted, recipient issues|7|||
162777475|NCT00113269|587897257|FG003|Overall Study|Not transplanted, recipient issues|4|||
162777476|NCT00113269|587897254|FG000|Overall Study|Early graft loss, technical|0|||
162777477|NCT00113269|587897255|FG001|Overall Study|Early graft loss, technical|0|||
162777478|NCT00113269|587897256|FG002|Overall Study|Early graft loss, technical|2|||
162777479|NCT00113269|587897257|FG003|Overall Study|Early graft loss, technical|0|||
162777480|NCT00113269|587897254|FG000|Overall Study|Death in operating room|0|||
162777481|NCT00113269|587897255|FG001|Overall Study|Death in operating room|0|||
162777482|NCT00113269|587897256|FG002|Overall Study|Death in operating room|0|||
162777483|NCT00113269|587897257|FG003|Overall Study|Death in operating room|1|||
162777484|NCT00113269|587897254|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
162777485|NCT00113269|587897255|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
162777486|NCT00113269|587897256|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
162777487|NCT00113269|587897257|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
162777488|NCT00113269|587897254|FG000|Overall Study|Adverse Event|2|||
162777489|NCT00113269|587897255|FG001|Overall Study|Adverse Event|7|||
162777490|NCT00113269|587897256|FG002|Overall Study|Adverse Event|11|||
162777491|NCT00113269|587897257|FG003|Overall Study|Adverse Event|7|||
162777492|NCT00113269|587897254|FG000|Overall Study|Withdrawal by Subject|4|||
162777493|NCT00113269|587897255|FG001|Overall Study|Withdrawal by Subject|3|||
162777494|NCT00113269|587897256|FG002|Overall Study|Withdrawal by Subject|4|||
162777495|NCT00113269|587897257|FG003|Overall Study|Withdrawal by Subject|2|||
162777496|NCT00113269|587897254|FG000|Overall Study|Graft loss|6|||
162777497|NCT00113269|587897255|FG001|Overall Study|Graft loss|6|||
162777498|NCT00113269|587897256|FG002|Overall Study|Graft loss|4|||
162777499|NCT00113269|587897257|FG003|Overall Study|Graft loss|9|||
162777500|NCT00113269|587897254|FG000|Overall Study|Protocol Violation|1|||
162777501|NCT00113269|587897255|FG001|Overall Study|Protocol Violation|0|||
162777502|NCT00113269|587897256|FG002|Overall Study|Protocol Violation|4|||
162777503|NCT00113269|587897257|FG003|Overall Study|Protocol Violation|2|||
162777504|NCT00113269|587897254|FG000|Overall Study|Lost to Follow-up|2|||
162777505|NCT00113269|587897255|FG001|Overall Study|Lost to Follow-up|3|||
162777506|NCT00113269|587897256|FG002|Overall Study|Lost to Follow-up|6|||
162777507|NCT00113269|587897257|FG003|Overall Study|Lost to Follow-up|3|||
162777508|NCT00113269|587897254|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
162777509|NCT00113269|587897255|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
162777510|NCT00113269|587897256|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
162777511|NCT00113269|587897257|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
162777512|NCT00113269|587897254|FG000|Overall Study|Discontinued due to rejection|0|||
162777513|NCT00113269|587897255|FG001|Overall Study|Discontinued due to rejection|0|||
162777514|NCT00113269|587897256|FG002|Overall Study|Discontinued due to rejection|1|||
162777515|NCT00113269|587897257|FG003|Overall Study|Discontinued due to rejection|0|||
162777516|NCT00113269|587897254|FG000|Overall Study|Moved|0|||
162777517|NCT00113269|587897255|FG001|Overall Study|Moved|1|||
162777518|NCT00113269|587897256|FG002|Overall Study|Moved|0|||
162777519|NCT00113269|587897257|FG003|Overall Study|Moved|3|||
162777520|NCT00113269|587897254|FG000|Overall Study|Received pancreas transplant|0|||
162777521|NCT00113269|587897255|FG001|Overall Study|Received pancreas transplant|0|||
162777522|NCT00113269|587897256|FG002|Overall Study|Received pancreas transplant|0|||
162777523|NCT00113269|587897257|FG003|Overall Study|Received pancreas transplant|2|||
162777524|NCT00113269|587897254|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
162777525|NCT00113269|587897255|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
162777526|NCT00113269|587897256|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
162777527|NCT00113269|587897257|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
162777528|NCT00113269|587897254|FG000|Overall Study|Did not meet eligibility criteria|1|||
162777529|NCT00113269|587897255|FG001|Overall Study|Did not meet eligibility criteria|0|||
162777530|NCT00113269|587897256|FG002|Overall Study|Did not meet eligibility criteria|0|||
162777531|NCT00113269|587897257|FG003|Overall Study|Did not meet eligibility criteria|1|||
162777532|NCT00113269|587897254|FG000|Overall Study|Unable to return for follow up|2|||
162777533|NCT00113269|587897255|FG001|Overall Study|Unable to return for follow up|1|||
162777534|NCT00113269|587897256|FG002|Overall Study|Unable to return for follow up|0|||
162777535|NCT00113269|587897257|FG003|Overall Study|Unable to return for follow up|0|||
162777536|NCT03864341|587897261|FG000|Overall Study|Withdrawal by Subject|1|||
162777537|NCT01066936|587897262|FG000|Overall Study|Death|2|||
162777538|NCT01066936|587897262|FG000|Overall Study|Device revised/removed|1|||
162777539|NCT01066936|587897262|FG000|Overall Study|Lost to Follow-up|3|||
162777540|NCT01066936|587897262|FG000|Overall Study|Withdrawal by Subject|4|||
162777541|NCT01904136|587897263|FG000|Overall Study|Physician Decision|0|||
162777542|NCT01904136|587897264|FG001|Overall Study|Physician Decision|0|||
162777543|NCT01904136|587897265|FG002|Overall Study|Physician Decision|0|||
162777544|NCT01904136|587897266|FG003|Overall Study|Physician Decision|0|||
162777545|NCT01904136|587897267|FG004|Overall Study|Physician Decision|0|||
162777546|NCT01904136|587897268|FG005|Overall Study|Physician Decision|1|||
162777547|NCT01904136|587897269|FG006|Overall Study|Physician Decision|0|||
162777548|NCT01904136|587897270|FG007|Overall Study|Physician Decision|0|||
162777549|NCT01904136|587897271|FG008|Overall Study|Physician Decision|0|||
162777550|NCT00853372|587897272|FG000|Overall Study|Death|30|||
162777551|NCT00853372|587897273|FG001|Overall Study|Death|26|||
162777552|NCT00853372|587897272|FG000|Overall Study|Lost to Follow-up|1|||
162777553|NCT00853372|587897273|FG001|Overall Study|Lost to Follow-up|2|||
162777554|NCT00853372|587897272|FG000|Overall Study|Full Consent Withdrawn|1|||
162777555|NCT00853372|587897273|FG001|Overall Study|Full Consent Withdrawn|1|||
162777556|NCT01580995|587897274|FG000|Overall Study|Lost to Follow-up|2|||
162777557|NCT01580995|587897275|FG001|Overall Study|Lost to Follow-up|2|||
162777558|NCT02517528|587897277|FG000|Overall Study|Withdrawal by Subject|1|||
162777559|NCT02202109|587897281|FG000|Overall Study|Lost to Follow-up|88|||
162777560|NCT02202109|587897282|FG001|Overall Study|Lost to Follow-up|87|||
162777561|NCT02202109|587897281|FG000|Overall Study|Withdrawal by Subject|2|||
162777562|NCT02202109|587897282|FG001|Overall Study|Withdrawal by Subject|0|||
162777563|NCT01268098|587897285|FG000|Overall Study|Adverse Event|1|||
162777564|NCT01268098|587897286|FG001|Overall Study|Adverse Event|0|||
162777565|NCT04156399|587897293|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
162777566|NCT04156399|587897293|FG000|Overall Study|study suspension due to COVID pandemic|3|||
162777567|NCT01093599|587897294|FG000|Overall Study|Lost to Follow-up|32|||
162777568|NCT01093599|587897295|FG001|Overall Study|Lost to Follow-up|46|||
162777569|NCT01703845|587897296|FG000|Overall Study|Adverse Event|1|||
162777570|NCT01703845|587897297|FG001|Overall Study|Adverse Event|0|||
162777571|NCT01703845|587897296|FG000|Overall Study|Protocol Violation|1|||
162777572|NCT01703845|587897297|FG001|Overall Study|Protocol Violation|0|||
162777573|NCT01703845|587897296|FG000|Overall Study|other than stated above|1|||
162777574|NCT01703845|587897297|FG001|Overall Study|other than stated above|0|||
162777575|NCT01644188|587897298|FG000|Overall Study|Adverse Event|44|||
162777576|NCT01644188|587897299|FG001|Overall Study|Adverse Event|20|||
162777577|NCT01644188|587897298|FG000|Overall Study|Poor compliance to protocol|26|||
162777578|NCT01644188|587897299|FG001|Overall Study|Poor compliance to protocol|14|||
162777579|NCT01644188|587897298|FG000|Overall Study|Physician Decision|1|||
162777580|NCT01644188|587897299|FG001|Overall Study|Physician Decision|3|||
162777581|NCT01644188|587897298|FG000|Overall Study|Participant moved|7|||
162777582|NCT01644188|587897299|FG001|Overall Study|Participant moved|2|||
162777583|NCT01644188|587897298|FG000|Overall Study|Related to auto-injector administration|2|||
162777584|NCT01644188|587897299|FG001|Overall Study|Related to auto-injector administration|2|||
162777585|NCT01644188|587897298|FG000|Overall Study|Consent withdrawn by participant|14|||
162777586|NCT01644188|587897299|FG001|Overall Study|Consent withdrawn by participant|7|||
162777587|NCT01644188|587897298|FG000|Overall Study|Selection criteria finally not met|2|||
162777588|NCT01644188|587897299|FG001|Overall Study|Selection criteria finally not met|0|||
162777589|NCT01644188|587897298|FG000|Overall Study|Lost to Follow-up|1|||
162777590|NCT01644188|587897299|FG001|Overall Study|Lost to Follow-up|0|||
162777591|NCT01644188|587897298|FG000|Overall Study|Death|4|||
162777592|NCT01644188|587897299|FG001|Overall Study|Death|3|||
162777593|NCT01644188|587897298|FG000|Overall Study|Last visit outside protocol visit window|14|||
162777594|NCT01644188|587897299|FG001|Overall Study|Last visit outside protocol visit window|16|||
162777595|NCT01644188|587897298|FG000|Overall Study|Site closure|1|||
162777596|NCT01644188|587897299|FG001|Overall Study|Site closure|1|||
162777597|NCT01644188|587897298|FG000|Overall Study|Other than specified above|6|||
162777598|NCT01644188|587897299|FG001|Overall Study|Other than specified above|7|||
162777599|NCT01845649|587897303|FG000|Overall Study|Adverse Event|7|||
162777600|NCT01845649|587897304|FG001|Overall Study|Adverse Event|10|||
162777601|NCT01845649|587897303|FG000|Overall Study|Lack of Efficacy|1|||
162777602|NCT01845649|587897304|FG001|Overall Study|Lack of Efficacy|1|||
162777603|NCT01845649|587897303|FG000|Overall Study|Lost to Follow-up|2|||
162777604|NCT01845649|587897304|FG001|Overall Study|Lost to Follow-up|2|||
162777605|NCT01845649|587897303|FG000|Overall Study|Withdrew Consent|12|||
162777606|NCT01845649|587897304|FG001|Overall Study|Withdrew Consent|4|||
162777607|NCT01845649|587897303|FG000|Overall Study|Protocol Deviation|7|||
162777608|NCT01845649|587897304|FG001|Overall Study|Protocol Deviation|4|||
162777609|NCT01845649|587897303|FG000|Overall Study|Reason not Specified|2|||
162777610|NCT01845649|587897304|FG001|Overall Study|Reason not Specified|1|||
162777611|NCT03418493|587897307|FG000|Overall Study|Adverse Event|1|||
162777612|NCT03418493|587897308|FG001|Overall Study|Adverse Event|0|||
162777613|NCT03418493|587897309|FG002|Overall Study|Adverse Event|0|||
162777614|NCT03418493|587897310|FG003|Overall Study|Adverse Event|0|||
162777615|NCT03418493|587897311|FG004|Overall Study|Adverse Event|0|||
162777616|NCT03418493|587897312|FG005|Overall Study|Adverse Event|0|||
162777617|NCT03418493|587897313|FG006|Overall Study|Adverse Event|0|||
162777618|NCT03418493|587897314|FG007|Overall Study|Adverse Event|0|||
162777619|NCT03418493|587897315|FG008|Overall Study|Adverse Event|0|||
162777620|NCT03418493|587897316|FG009|Overall Study|Adverse Event|0|||
162777621|NCT03418493|587897317|FG010|Overall Study|Adverse Event|0|||
162777622|NCT03418493|587897307|FG000|Overall Study|Protocol Violation|0|||
162777623|NCT03418493|587897308|FG001|Overall Study|Protocol Violation|0|||
162777624|NCT03418493|587897309|FG002|Overall Study|Protocol Violation|0|||
162777625|NCT03418493|587897310|FG003|Overall Study|Protocol Violation|0|||
162777626|NCT03418493|587897311|FG004|Overall Study|Protocol Violation|0|||
162777627|NCT03418493|587897312|FG005|Overall Study|Protocol Violation|0|||
162777628|NCT03418493|587897313|FG006|Overall Study|Protocol Violation|0|||
162777629|NCT03418493|587897314|FG007|Overall Study|Protocol Violation|0|||
162777630|NCT03418493|587897315|FG008|Overall Study|Protocol Violation|0|||
162777631|NCT03418493|587897316|FG009|Overall Study|Protocol Violation|1|||
162777632|NCT03418493|587897317|FG010|Overall Study|Protocol Violation|0|||
162777633|NCT00719212|587897318|FG000|Overall Study|Death|41|||
162777634|NCT00719212|587897318|FG000|Overall Study|Lost to Follow-up|2|||
162777635|NCT00719212|587897318|FG000|Overall Study|Withdrawal by Subject|1|||
162777636|NCT00526097|587897323|FG000|Overall Study|Adverse Event|6|||
162777637|NCT00526097|587897324|FG001|Overall Study|Adverse Event|44|||
162777638|NCT00526097|587897323|FG000|Overall Study|Protocol Violation|4|||
162777639|NCT00526097|587897324|FG001|Overall Study|Protocol Violation|10|||
162777640|NCT00526097|587897323|FG000|Overall Study|Withdrawal by Subject|3|||
162777641|NCT00526097|587897324|FG001|Overall Study|Withdrawal by Subject|1|||
162777642|NCT00526097|587897323|FG000|Overall Study|Other|2|||
162777643|NCT00526097|587897324|FG001|Overall Study|Other|1|||
162777644|NCT00966979|587897325|FG000|Overall Study|Death|1|||
162777645|NCT00966979|587897325|FG000|Overall Study|Lost to Follow-up|6|||
162777646|NCT00966979|587897325|FG000|Overall Study|Withdrawal by Subject|14|||
162777647|NCT00966979|587897325|FG000|Overall Study|Adverse Event|5|||
162777648|NCT00966979|587897325|FG000|Overall Study|Sponsor terminated early|49|||
162777649|NCT00966979|587897325|FG000|Overall Study|Censored because surgery not done|2|||
162777650|NCT00966979|587897325|FG000|Overall Study|Censored because study device was not implanted|14|||
162777651|NCT00966979|587897325|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
162777652|NCT04140266|587897326|FG000|Overall Study|Physician Decision|2|||
162777653|NCT04140266|587897327|FG001|Overall Study|Physician Decision|0|||
162777654|NCT04140266|587897326|FG000|Overall Study|Withdrawal by Subject|4|||
162777655|NCT04140266|587897327|FG001|Overall Study|Withdrawal by Subject|2|||
162777656|NCT00943618|587897328|FG000|Overall Study|Lost to Follow-up|38|||
162777657|NCT00943618|587897329|FG001|Overall Study|Lost to Follow-up|48|||
162777658|NCT00943618|587897330|FG002|Overall Study|Lost to Follow-up|20|||
162777659|NCT00943618|587897328|FG000|Overall Study|Discontinued Medication|17|||
162777660|NCT00943618|587897329|FG001|Overall Study|Discontinued Medication|29|||
162777661|NCT00943618|587897330|FG002|Overall Study|Discontinued Medication|11|||
162777662|NCT03713281|587897335|FG000|Overall Study|Lens handling difficuluties|2|||
162777663|NCT03713281|587897335|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
162777664|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
162777665|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
162777666|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
162777667|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
162777668|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
162777669|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
162777670|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
162777671|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
162777672|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
162777673|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
162777674|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
162777675|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
162777676|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
162777677|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
162777678|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
162777679|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
162777680|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
162777681|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
162777682|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
162777683|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
162777684|NCT02637856|587897336|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
162777685|NCT02637856|587897337|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
162777686|NCT02637856|587897336|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
162777687|NCT02637856|587897337|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
162777688|NCT02637856|587897336|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
162777689|NCT02637856|587897337|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
162777690|NCT01402063|587897338|FG000|Overall Study|Withdrawal by Subject|3|||
162777691|NCT01402063|587897339|FG001|Overall Study|Withdrawal by Subject|3|||
162777692|NCT05109117|587897340|FG000|Overall Study|Lost to Follow-up|1|||
162777693|NCT05109117|587897340|FG000|Overall Study|Discontinued for non-compliance|1|||
162777694|NCT03220776|587897343|FG000|Overall Study|Claustrophobia|0|||
162777695|NCT03220776|587897344|FG001|Overall Study|Claustrophobia|1|||
162777696|NCT03220776|587897345|FG002|Overall Study|Claustrophobia|1|||
162777697|NCT03220776|587897346|FG003|Overall Study|Claustrophobia|0|||
162777698|NCT03220776|587897347|FG004|Overall Study|Claustrophobia|1|||
162777699|NCT03220776|587897348|FG005|Overall Study|Claustrophobia|0|||
162777700|NCT03220776|587897343|FG000|Overall Study|MRI Equipment Failure|1|||
162777701|NCT03220776|587897344|FG001|Overall Study|MRI Equipment Failure|0|||
162777702|NCT03220776|587897345|FG002|Overall Study|MRI Equipment Failure|0|||
162777703|NCT03220776|587897346|FG003|Overall Study|MRI Equipment Failure|0|||
162777704|NCT03220776|587897347|FG004|Overall Study|MRI Equipment Failure|0|||
162777705|NCT03220776|587897348|FG005|Overall Study|MRI Equipment Failure|0|||
162777706|NCT03220776|587897343|FG000|Overall Study|Inclimate Weather|0|||
162777707|NCT03220776|587897344|FG001|Overall Study|Inclimate Weather|0|||
162777708|NCT03220776|587897345|FG002|Overall Study|Inclimate Weather|0|||
162777709|NCT03220776|587897346|FG003|Overall Study|Inclimate Weather|0|||
162777710|NCT03220776|587897347|FG004|Overall Study|Inclimate Weather|0|||
162777711|NCT03220776|587897348|FG005|Overall Study|Inclimate Weather|1|||
162777712|NCT03220776|587897343|FG000|Overall Study|Physician Decision|0|||
162777713|NCT03220776|587897344|FG001|Overall Study|Physician Decision|0|||
162777714|NCT03220776|587897345|FG002|Overall Study|Physician Decision|0|||
162777715|NCT03220776|587897346|FG003|Overall Study|Physician Decision|1|||
162777716|NCT03220776|587897347|FG004|Overall Study|Physician Decision|0|||
162777717|NCT03220776|587897348|FG005|Overall Study|Physician Decision|0|||
162777718|NCT03220776|587897343|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162777719|NCT03220776|587897344|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162777720|NCT03220776|587897345|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162777721|NCT03220776|587897346|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
162777722|NCT03220776|587897347|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162777723|NCT03220776|587897348|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162777724|NCT03220776|587897343|FG000|Overall Study|Protocol Violation|0|||
162777725|NCT03220776|587897344|FG001|Overall Study|Protocol Violation|0|||
162777726|NCT03220776|587897345|FG002|Overall Study|Protocol Violation|0|||
162777727|NCT03220776|587897346|FG003|Overall Study|Protocol Violation|2|||
162777728|NCT03220776|587897347|FG004|Overall Study|Protocol Violation|0|||
162777729|NCT03220776|587897348|FG005|Overall Study|Protocol Violation|1|||
162777730|NCT03220776|587897343|FG000|Overall Study|Withdrawal by Subject|1|||
162777731|NCT03220776|587897344|FG001|Overall Study|Withdrawal by Subject|0|||
162777732|NCT03220776|587897345|FG002|Overall Study|Withdrawal by Subject|0|||
162777733|NCT03220776|587897346|FG003|Overall Study|Withdrawal by Subject|0|||
162777734|NCT03220776|587897347|FG004|Overall Study|Withdrawal by Subject|0|||
162777735|NCT03220776|587897348|FG005|Overall Study|Withdrawal by Subject|0|||
162777736|NCT04491006|587897349|FG000|Overall Study|Adverse Event|0|||
162777737|NCT04491006|587897350|FG001|Overall Study|Adverse Event|3|||
162777738|NCT04491006|587897351|FG002|Overall Study|Adverse Event|5|||
162777739|NCT04491006|587897349|FG000|Overall Study|Withdrawal by Subject|1|||
162777740|NCT04491006|587897350|FG001|Overall Study|Withdrawal by Subject|0|||
162777741|NCT04491006|587897351|FG002|Overall Study|Withdrawal by Subject|2|||
162777742|NCT02166047|587897352|FG000|Overall Study|Withdrawal by Participant|0|||
162777743|NCT02166047|587897353|FG001|Overall Study|Withdrawal by Participant|1|||
162777744|NCT02166047|587897354|FG002|Overall Study|Withdrawal by Participant|2|||
162777745|NCT02166047|587897355|FG003|Overall Study|Withdrawal by Participant|0|||
162777746|NCT02166047|587897356|FG004|Overall Study|Withdrawal by Participant|0|||
162777747|NCT02166047|587897357|FG005|Overall Study|Withdrawal by Participant|0|||
162777748|NCT02166047|587897358|FG006|Overall Study|Withdrawal by Participant|1|||
162777749|NCT02166047|587897359|FG007|Overall Study|Withdrawal by Participant|0|||
162777750|NCT02166047|587897360|FG008|Overall Study|Withdrawal by Participant|0|||
162777751|NCT02166047|587897361|FG009|Overall Study|Withdrawal by Participant|0|||
162777752|NCT02166047|587897362|FG010|Overall Study|Withdrawal by Participant|0|||
162777753|NCT02166047|587897363|FG011|Overall Study|Withdrawal by Participant|0|||
162777754|NCT02166047|587897352|FG000|Overall Study|Adverse Event|0|||
162777755|NCT02166047|587897353|FG001|Overall Study|Adverse Event|0|||
162777756|NCT02166047|587897354|FG002|Overall Study|Adverse Event|0|||
162777757|NCT02166047|587897355|FG003|Overall Study|Adverse Event|0|||
162777758|NCT02166047|587897356|FG004|Overall Study|Adverse Event|1|||
162777759|NCT02166047|587897357|FG005|Overall Study|Adverse Event|0|||
162777760|NCT02166047|587897358|FG006|Overall Study|Adverse Event|1|||
162777761|NCT02166047|587897359|FG007|Overall Study|Adverse Event|0|||
162777762|NCT02166047|587897360|FG008|Overall Study|Adverse Event|0|||
162777763|NCT02166047|587897361|FG009|Overall Study|Adverse Event|0|||
162777764|NCT02166047|587897362|FG010|Overall Study|Adverse Event|2|||
162777765|NCT02166047|587897363|FG011|Overall Study|Adverse Event|0|||
162777766|NCT00451555|587897369|FG000|Overall Study|Protocol Violation|2|||
162777767|NCT00451555|587897370|FG001|Overall Study|Protocol Violation|2|||
162777768|NCT00451555|587897369|FG000|Overall Study|Adverse Event|3|||
162777769|NCT00451555|587897370|FG001|Overall Study|Adverse Event|1|||
162777770|NCT00451555|587897369|FG000|Overall Study|Withdrawal by Subject|6|||
162777771|NCT00451555|587897370|FG001|Overall Study|Withdrawal by Subject|0|||
162777772|NCT00451555|587897369|FG000|Overall Study|Physician Decision|2|||
162777773|NCT00451555|587897370|FG001|Overall Study|Physician Decision|1|||
162777774|NCT01388478|587897377|FG000|Overall Study|Adverse Event|4|||
162777775|NCT01388478|587897377|FG000|Overall Study|Withdrawal by Subject|1|||
162777776|NCT01990664|587897378|FG000|Overall Study|Lost to Follow-up|2|||
162777777|NCT01990664|587897379|FG001|Overall Study|Lost to Follow-up|6|||
162777778|NCT01990664|587897378|FG000|Overall Study|Withdrawal by Subject|2|||
162777779|NCT01990664|587897379|FG001|Overall Study|Withdrawal by Subject|3|||
162777780|NCT01990664|587897378|FG000|Overall Study|Protocol Violation|1|||
162777781|NCT01990664|587897379|FG001|Overall Study|Protocol Violation|0|||
162777782|NCT01990664|587897378|FG000|Overall Study|Lens Discomfort|1|||
162777783|NCT01990664|587897379|FG001|Overall Study|Lens Discomfort|1|||
162777784|NCT01990664|587897378|FG000|Overall Study|Lens Handling Difficulties|1|||
162777785|NCT01990664|587897379|FG001|Overall Study|Lens Handling Difficulties|0|||
162777786|NCT01990664|587897378|FG000|Overall Study|Unsatisfactory Visual Response|0|||
162777787|NCT01990664|587897379|FG001|Overall Study|Unsatisfactory Visual Response|1|||
162777788|NCT00619983|587897380|FG000|Test Drug Alone|Withdrawal by Subject|1|||
162777789|NCT00619983|587897381|FG001|Test Drug Alone|Withdrawal by Subject|0|||
162777790|NCT00619983|587897382|FG002|Test Drug Alone|Withdrawal by Subject|0|||
162777791|NCT00619983|587897383|FG003|Test Drug Alone|Withdrawal by Subject|1|||
162777792|NCT00619983|587897380|FG000|Test Drug Alone|Failure of daily diary device|1|||
162777793|NCT00619983|587897381|FG001|Test Drug Alone|Failure of daily diary device|1|||
162777794|NCT00619983|587897382|FG002|Test Drug Alone|Failure of daily diary device|2|||
162777795|NCT00619983|587897383|FG003|Test Drug Alone|Failure of daily diary device|2|||
162777796|NCT01177137|587897385|FG000|Overall Study|Withdrawal by Subject|10|||
162777797|NCT01177137|587897386|FG001|Overall Study|Withdrawal by Subject|10|||
162777798|NCT01177137|587897387|FG002|Overall Study|Withdrawal by Subject|2|||
162777799|NCT00297778|587897388|FG000|Overall Study|Adverse Event|16|||
162777800|NCT00297778|587897389|FG001|Overall Study|Adverse Event|10|||
162777801|NCT00297778|587897388|FG000|Overall Study|Withdrawal by Subject|1|||
162777802|NCT00297778|587897389|FG001|Overall Study|Withdrawal by Subject|5|||
162777803|NCT00297778|587897388|FG000|Overall Study|Lack of Efficacy|2|||
162777804|NCT00297778|587897389|FG001|Overall Study|Lack of Efficacy|1|||
162777805|NCT00297778|587897388|FG000|Overall Study|Non-compliant with trial protocol|0|||
162777806|NCT00297778|587897389|FG001|Overall Study|Non-compliant with trial protocol|3|||
162777807|NCT00297778|587897388|FG000|Overall Study|Other|0|||
162777808|NCT00297778|587897389|FG001|Overall Study|Other|1|||
162777809|NCT00583115|587897390|FG000|Overall Study|Death|1|||
162777810|NCT01678898|587897394|FG000|PB-102-F01|Adverse Event|0|||
162777811|NCT01678898|587897395|FG001|PB-102-F01|Adverse Event|1|||
162777812|NCT01678898|587897396|FG002|PB-102-F01|Adverse Event|0|||
162777813|NCT01678898|587897394|FG000|PB-102-F01|Physician Decision|0|||
162777814|NCT01678898|587897395|FG001|PB-102-F01|Physician Decision|1|||
162777815|NCT01678898|587897396|FG002|PB-102-F01|Physician Decision|0|||
162777816|NCT02551692|587897401|FG000|Overall Study|Lost to Follow-up|0|||
162777817|NCT02551692|587897402|FG001|Overall Study|Lost to Follow-up|1|||
162777818|NCT02551692|587897403|FG002|Overall Study|Lost to Follow-up|4|||
162777819|NCT02551692|587897401|FG000|Overall Study|Withdrawal by Subject|1|||
162777820|NCT02551692|587897402|FG001|Overall Study|Withdrawal by Subject|0|||
162777821|NCT02551692|587897403|FG002|Overall Study|Withdrawal by Subject|1|||
162777822|NCT02965599|587897404|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
162777823|NCT02965599|587897405|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
162777824|NCT00230971|587897406|FG000|Randomization|No study drug administered|3|||
162777825|NCT00230971|587897407|FG001|Randomization|No study drug administered|3|||
162777826|NCT00230971|587897406|FG000|Baseline Participants|Lost to Follow-up|5|||
162777827|NCT00230971|587897407|FG001|Baseline Participants|Lost to Follow-up|12|||
162777828|NCT00230971|587897406|FG000|Baseline Participants|Death|6|||
162777829|NCT00230971|587897407|FG001|Baseline Participants|Death|5|||
162777830|NCT00230971|587897406|FG000|Baseline Participants|Withdrawal by Subject|7|||
162777831|NCT00230971|587897407|FG001|Baseline Participants|Withdrawal by Subject|1|||
162777832|NCT00230971|587897406|FG000|Baseline Participants|Adverse Event|1|||
162777833|NCT00230971|587897407|FG001|Baseline Participants|Adverse Event|0|||
162777834|NCT00230971|587897406|FG000|Baseline Participants|No bacteria observed|1|||
162777835|NCT00230971|587897407|FG001|Baseline Participants|No bacteria observed|0|||
162777836|NCT00230971|587897406|FG000|Baseline Participants|Failure to return|1|||
162777837|NCT00230971|587897407|FG001|Baseline Participants|Failure to return|1|||
162777838|NCT00230971|587897406|FG000|Baseline Participants|Reintervention|1|||
162777839|NCT00230971|587897407|FG001|Baseline Participants|Reintervention|0|||
162777840|NCT04130061|587897410|FG000|Overall Study|OR team forgot to request membrane|1|||
162777841|NCT04130061|587897411|FG001|Overall Study|OR team forgot to request membrane|0|||
162777842|NCT04267393|587897414|FG000|Randomization|Adverse Event|1|||
162777843|NCT04267393|587897415|FG001|Randomization|Adverse Event|0|||
162777844|NCT04267393|587897416|FG002|Randomization|Adverse Event|0|||
162777845|NCT04267393|587897414|FG000|Randomization|Administrative Reasons by Sponsor|0|||
162777846|NCT04267393|587897415|FG001|Randomization|Administrative Reasons by Sponsor|1|||
162777847|NCT04267393|587897416|FG002|Randomization|Administrative Reasons by Sponsor|0|||
162777848|NCT04267393|587897414|FG000|Treatment Period|Adverse Event|0|||
162777849|NCT04267393|587897415|FG001|Treatment Period|Adverse Event|2|||
162777850|NCT04267393|587897416|FG002|Treatment Period|Adverse Event|3|||
162777851|NCT04267393|587897414|FG000|Treatment Period|Participant Withdrew Consent|0|||
162777852|NCT04267393|587897415|FG001|Treatment Period|Participant Withdrew Consent|0|||
162777853|NCT04267393|587897416|FG002|Treatment Period|Participant Withdrew Consent|1|||
162777854|NCT04267393|587897414|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
162777855|NCT04267393|587897415|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
162777856|NCT04267393|587897416|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
162777857|NCT01222533|587899058|FG000|Overall Study|Adverse Event|5|||
162777858|NCT01222533|587899058|FG000|Overall Study|Withdrawal by Subject|5|||
162777859|NCT01222533|587899058|FG000|Overall Study|Other|4|||
162777860|NCT03834623|587899059|FG000|Overall Study|Progression|0|||
162777861|NCT03834623|587899060|FG001|Overall Study|Progression|1|||
162777862|NCT01947517|587899061|FG000|Overall Study|Withdrawal by Subject|1|||
162777863|NCT01947517|587899062|FG001|Overall Study|Withdrawal by Subject|1|||
162777864|NCT00460564|587899063|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
162777865|NCT00460564|587899064|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
162777866|NCT00460564|587899065|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777867|NCT00460564|587899066|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777868|NCT00460564|587899067|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777869|NCT00460564|587899068|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777870|NCT00460564|587899069|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777871|NCT00460564|587899070|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162777872|NCT00460564|587899063|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
162777873|NCT00460564|587899064|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777874|NCT00460564|587899065|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777875|NCT00460564|587899066|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777876|NCT00460564|587899067|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777877|NCT00460564|587899068|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777878|NCT00460564|587899069|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777879|NCT00460564|587899070|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162777880|NCT00460564|587899063|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162777881|NCT00460564|587899064|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162777882|NCT00460564|587899065|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162777883|NCT00460564|587899066|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162777884|NCT00460564|587899067|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
162777885|NCT00460564|587899068|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
162777886|NCT00460564|587899069|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
162777887|NCT00460564|587899070|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162777888|NCT00460564|587899063|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777889|NCT00460564|587899064|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777890|NCT00460564|587899065|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777891|NCT00460564|587899066|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777892|NCT00460564|587899067|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
162777893|NCT00460564|587899068|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
162777894|NCT00460564|587899069|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777895|NCT00460564|587899070|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162777896|NCT00460564|587899063|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777897|NCT00460564|587899064|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777898|NCT00460564|587899065|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777899|NCT00460564|587899066|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777900|NCT00460564|587899067|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
162777901|NCT00460564|587899068|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777902|NCT00460564|587899069|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777903|NCT00460564|587899070|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162777904|NCT03226106|587899077|FG000|Overall Study|Withdrawal by Subject|2|||
162777905|NCT03226106|587899078|FG001|Overall Study|Withdrawal by Subject|0|||
162777906|NCT03226106|587899077|FG000|Overall Study|Adverse Event|1|||
162777907|NCT03226106|587899078|FG001|Overall Study|Adverse Event|0|||
162777908|NCT03226106|587899077|FG000|Overall Study|Lost to Follow-up|2|||
162777909|NCT03226106|587899078|FG001|Overall Study|Lost to Follow-up|0|||
162777910|NCT04349644|587899079|FG000|Allocation/Pretest|Lost to pretest|0|||
162777911|NCT04349644|587899080|FG001|Allocation/Pretest|Lost to pretest|3|||
162777912|NCT04349644|587899079|FG000|Posttest|Lost to posttest|0|||
162777913|NCT04349644|587899080|FG001|Posttest|Lost to posttest|8|||
162777914|NCT04349644|587899079|FG000|Posttest|Discontinued intervention|6|||
162777915|NCT04349644|587899080|FG001|Posttest|Discontinued intervention|0|||
162777916|NCT04349644|587899079|FG000|Follow-up|Lost to Follow-up|0|||
162777917|NCT04349644|587899080|FG001|Follow-up|Lost to Follow-up|2|||
162777918|NCT00702650|587899081|FG000|Overall Study|Withdrawal by Subject|9|||
162777919|NCT00702650|587899081|FG000|Overall Study|Non-Compliance of Study Drug|3|||
162777920|NCT00702650|587899081|FG000|Overall Study|Lost to Follow-up|2|||
162777921|NCT00702650|587899081|FG000|Overall Study|Non-Compliance with Site Directives|1|||
162777922|NCT00702650|587899081|FG000|Overall Study|Sponsor Request|1|||
162777923|NCT00702650|587899081|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
162777924|NCT00702650|587899081|FG000|Overall Study|Adverse Event|3|||
162777925|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
162777926|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
162777927|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
162777928|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
162777929|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Death|0|||
162777930|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Death|1|||
162777931|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
162777932|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
162777933|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
162777934|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
162777935|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
162777936|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
162777937|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
162777938|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
162777939|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
162777940|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
162777941|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
162777942|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
162777943|NCT01309243|587899082|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
162777944|NCT01309243|587899083|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
162777945|NCT01309243|587899082|FG000|Extension Phase|Lost to Follow-up|6|||
162777946|NCT01309243|587899083|FG001|Extension Phase|Lost to Follow-up|0|||
162777947|NCT00943722|587899085|FG000|Base Study|Adverse Event|0|||
162777948|NCT00943722|587899086|FG001|Base Study|Adverse Event|0|||
162777949|NCT00943722|587899087|FG002|Base Study|Adverse Event|0|||
162777950|NCT00943722|587899088|FG003|Base Study|Adverse Event|1|||
162777951|NCT00943722|587899089|FG004|Base Study|Adverse Event|0|||
162777952|NCT00943722|587899090|FG005|Base Study|Adverse Event|0|||
162777953|NCT00943722|587899091|FG006|Base Study|Adverse Event|0|||
162777954|NCT00943722|587899085|FG000|Base Study|Lost to Follow-up|12|||
162777955|NCT00943722|587899086|FG001|Base Study|Lost to Follow-up|8|||
162777956|NCT00943722|587899087|FG002|Base Study|Lost to Follow-up|10|||
162777957|NCT00943722|587899088|FG003|Base Study|Lost to Follow-up|8|||
162777958|NCT00943722|587899089|FG004|Base Study|Lost to Follow-up|11|||
162777959|NCT00943722|587899090|FG005|Base Study|Lost to Follow-up|0|||
162777960|NCT00943722|587899091|FG006|Base Study|Lost to Follow-up|0|||
162777961|NCT00943722|587899085|FG000|Base Study|Physician Decision|1|||
162777962|NCT00943722|587899086|FG001|Base Study|Physician Decision|0|||
162777963|NCT00943722|587899087|FG002|Base Study|Physician Decision|0|||
162777964|NCT00943722|587899088|FG003|Base Study|Physician Decision|0|||
162777965|NCT00943722|587899089|FG004|Base Study|Physician Decision|1|||
162777966|NCT00943722|587899090|FG005|Base Study|Physician Decision|0|||
162777967|NCT00943722|587899091|FG006|Base Study|Physician Decision|0|||
162777968|NCT00943722|587899085|FG000|Base Study|Pregnancy|0|||
162777969|NCT00943722|587899086|FG001|Base Study|Pregnancy|0|||
162777970|NCT00943722|587899087|FG002|Base Study|Pregnancy|1|||
162777971|NCT00943722|587899088|FG003|Base Study|Pregnancy|0|||
162777972|NCT00943722|587899089|FG004|Base Study|Pregnancy|2|||
162777973|NCT00943722|587899090|FG005|Base Study|Pregnancy|0|||
162777974|NCT00943722|587899091|FG006|Base Study|Pregnancy|0|||
162777975|NCT00943722|587899085|FG000|Base Study|Protocol Violation|0|||
162777976|NCT00943722|587899086|FG001|Base Study|Protocol Violation|1|||
162777977|NCT00943722|587899087|FG002|Base Study|Protocol Violation|0|||
162777978|NCT00943722|587899088|FG003|Base Study|Protocol Violation|0|||
162777979|NCT00943722|587899089|FG004|Base Study|Protocol Violation|2|||
162777980|NCT00943722|587899090|FG005|Base Study|Protocol Violation|0|||
162777981|NCT00943722|587899091|FG006|Base Study|Protocol Violation|0|||
162777982|NCT00943722|587899085|FG000|Base Study|Withdrawal by Subject|12|||
162777983|NCT00943722|587899086|FG001|Base Study|Withdrawal by Subject|13|||
162777984|NCT00943722|587899087|FG002|Base Study|Withdrawal by Subject|2|||
162777985|NCT00943722|587899088|FG003|Base Study|Withdrawal by Subject|13|||
162777986|NCT00943722|587899089|FG004|Base Study|Withdrawal by Subject|8|||
162777987|NCT00943722|587899090|FG005|Base Study|Withdrawal by Subject|0|||
162777988|NCT00943722|587899091|FG006|Base Study|Withdrawal by Subject|0|||
162777989|NCT00943722|587899085|FG000|Base Study|Month 12 visit not completed|0|||
162777990|NCT00943722|587899086|FG001|Base Study|Month 12 visit not completed|0|||
162777991|NCT00943722|587899087|FG002|Base Study|Month 12 visit not completed|0|||
162777992|NCT00943722|587899088|FG003|Base Study|Month 12 visit not completed|0|||
162777993|NCT00943722|587899089|FG004|Base Study|Month 12 visit not completed|2|||
162777994|NCT00943722|587899090|FG005|Base Study|Month 12 visit not completed|0|||
162777995|NCT00943722|587899091|FG006|Base Study|Month 12 visit not completed|0|||
162777996|NCT00943722|587899085|FG000|First Extension Study: EXT 1|Adverse Event|0|||
162777997|NCT00943722|587899086|FG001|First Extension Study: EXT 1|Adverse Event|0|||
162777998|NCT00943722|587899087|FG002|First Extension Study: EXT 1|Adverse Event|0|||
162777999|NCT00943722|587899088|FG003|First Extension Study: EXT 1|Adverse Event|0|||
162778000|NCT00943722|587899089|FG004|First Extension Study: EXT 1|Adverse Event|0|||
162778001|NCT00943722|587899090|FG005|First Extension Study: EXT 1|Adverse Event|1|||
162778002|NCT00943722|587899091|FG006|First Extension Study: EXT 1|Adverse Event|0|||
162778003|NCT00943722|587899085|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
162778004|NCT00943722|587899086|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
162778005|NCT00943722|587899087|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
162778006|NCT00943722|587899088|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
162778007|NCT00943722|587899089|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
162778008|NCT00943722|587899090|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
162778009|NCT00943722|587899091|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
162778010|NCT00943722|587899085|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162778011|NCT00943722|587899086|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162778012|NCT00943722|587899087|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162778013|NCT00943722|587899088|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162778014|NCT00943722|587899089|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162778015|NCT00943722|587899090|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
162778016|NCT00943722|587899091|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
162778017|NCT00943722|587899085|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
162778018|NCT00943722|587899086|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
162778019|NCT00943722|587899087|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
162778020|NCT00943722|587899088|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
162778021|NCT00943722|587899089|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
162778022|NCT00943722|587899090|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
162778023|NCT00943722|587899091|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
162778024|NCT00943722|587899085|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
162778025|NCT00943722|587899086|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
162778026|NCT00943722|587899087|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
162778027|NCT00943722|587899088|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
162778028|NCT00943722|587899089|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
162778029|NCT00943722|587899090|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
162778030|NCT00943722|587899091|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
162778031|NCT00943722|587899085|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162778032|NCT00943722|587899086|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162778033|NCT00943722|587899087|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162778034|NCT00943722|587899088|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162778035|NCT00943722|587899089|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162778036|NCT00943722|587899090|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
162778037|NCT00943722|587899091|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
162778038|NCT00943722|587899085|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
162778039|NCT00943722|587899086|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
162778040|NCT00943722|587899087|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
162778041|NCT00943722|587899088|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
162778042|NCT00943722|587899089|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
162778043|NCT00943722|587899090|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
162778044|NCT00943722|587899091|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
162778045|NCT00943722|587899085|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
162778046|NCT00943722|587899086|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
162778047|NCT00943722|587899087|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
162778048|NCT00943722|587899088|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
162778049|NCT00943722|587899089|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
162778050|NCT00943722|587899090|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
162778051|NCT00943722|587899091|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
162778052|NCT00943722|587899085|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162778053|NCT00943722|587899086|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162778054|NCT00943722|587899087|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162778055|NCT00943722|587899088|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162778056|NCT00943722|587899089|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162778057|NCT00943722|587899090|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
162778058|NCT00943722|587899091|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
162778059|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
162778060|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
162778061|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
162778062|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
162778063|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
162778064|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
162778065|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
162778066|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
162778067|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
162778068|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
162778069|NCT01772823|587899092|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
162778070|NCT01772823|587899093|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
162778071|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
162778072|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
162778073|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
162778074|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
162778075|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
162778076|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
162778077|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
162778078|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
162778079|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
162778080|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
162778081|NCT01772823|587899092|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
162778082|NCT01772823|587899093|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
162778083|NCT01772823|587899092|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
162778084|NCT01772823|587899093|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
162778085|NCT01772823|587899092|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
162778086|NCT01772823|587899093|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
162778087|NCT01772823|587899092|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
162778088|NCT01772823|587899093|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
162778089|NCT01772823|587899092|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
162778090|NCT01772823|587899093|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
162778091|NCT01004185|587899096|FG000|Overall Study|Adverse Event|1|||
162778092|NCT01004185|587899097|FG001|Overall Study|Adverse Event|1|||
162778093|NCT01004185|587899096|FG000|Overall Study|Lost to Follow-up|0|||
162778094|NCT01004185|587899097|FG001|Overall Study|Lost to Follow-up|1|||
162778095|NCT01004185|587899096|FG000|Overall Study|Lack of Efficacy|2|||
162778096|NCT01004185|587899097|FG001|Overall Study|Lack of Efficacy|1|||
162778097|NCT01004185|587899096|FG000|Overall Study|Sponsor Terminated Study|4|||
162778098|NCT01004185|587899097|FG001|Overall Study|Sponsor Terminated Study|5|||
162778099|NCT01004185|587899096|FG000|Overall Study|Withdrawal by Subject|2|||
162778100|NCT01004185|587899097|FG001|Overall Study|Withdrawal by Subject|1|||
162778101|NCT01037413|587899098|FG000|Part A: Skin Testing|Adverse Event|1|||
162778102|NCT01037413|587899099|FG001|Part A: Skin Testing|Adverse Event|0|||
162778103|NCT01037413|587899098|FG000|Part A: Skin Testing|Protocol Violation|1|||
162778104|NCT01037413|587899099|FG001|Part A: Skin Testing|Protocol Violation|0|||
162778105|NCT01037413|587899098|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
162778106|NCT01037413|587899099|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
162778107|NCT01037413|587899098|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
162778108|NCT01037413|587899099|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
162778109|NCT02560389|587899104|FG000|Overall Study|Lost to Follow-up|1|||
162778110|NCT02560389|587899105|FG001|Overall Study|Lost to Follow-up|2|||
162778111|NCT02560389|587899106|FG002|Overall Study|Lost to Follow-up|2|||
162778112|NCT02560389|587899104|FG000|Overall Study|Tested positive for illicit substance|0|||
162778113|NCT02560389|587899105|FG001|Overall Study|Tested positive for illicit substance|1|||
162778114|NCT02560389|587899106|FG002|Overall Study|Tested positive for illicit substance|0|||
162778115|NCT02716298|587899107|FG000|First Intervention (1 Month)|Lens discomfort|1|||
162778116|NCT02716298|587899108|FG001|First Intervention (1 Month)|Lens discomfort|1|||
162778117|NCT00713206|587899109|FG000|Overall Study|Lost to Follow-up|4|||
162778118|NCT00713206|587899110|FG001|Overall Study|Lost to Follow-up|4|||
162778119|NCT00713206|587899109|FG000|Overall Study|Death|1|||
162778120|NCT00713206|587899110|FG001|Overall Study|Death|0|||
162778121|NCT01114672|587899113|FG000|Overall Study|Death|0|||
162778122|NCT01114672|587899114|FG001|Overall Study|Death|1|||
162778123|NCT01114672|587899113|FG000|Overall Study|Withdrawal by Subject|2|||
162778124|NCT01114672|587899114|FG001|Overall Study|Withdrawal by Subject|1|||
162778125|NCT01114672|587899113|FG000|Overall Study|Lost to Follow-up|1|||
162778126|NCT01114672|587899114|FG001|Overall Study|Lost to Follow-up|0|||
162778127|NCT01114672|587899113|FG000|Overall Study|transplanted|1|||
162778128|NCT01114672|587899114|FG001|Overall Study|transplanted|0|||
162778129|NCT00827775|587899115|FG000|Overall Study|Withdrawal by Subject|0|||
162778130|NCT00827775|587899116|FG001|Overall Study|Withdrawal by Subject|5|||
162778131|NCT03041701|587899117|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
162778132|NCT03041701|587899118|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
162778133|NCT03041701|587899119|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
162778134|NCT03041701|587899117|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
162778135|NCT03041701|587899118|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
162778136|NCT03041701|587899119|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
162778137|NCT01281917|587899135|FG000|Overall Study|Withdrawal by Subject|1|||
162778138|NCT00802438|587899136|FG000|Overall Study|Screen Failure|20|||
162778139|NCT00802438|587899136|FG000|Overall Study|Withdrawal by Subject|7|||
162778140|NCT00802438|587899136|FG000|Overall Study|Physician Decision|1|||
162778141|NCT04016805|587899138|FG000|Overall Study|Sponsor's Discretion|30|||
162778142|NCT04016805|587899139|FG001|Overall Study|Sponsor's Discretion|6|||
162778143|NCT04016805|587899140|FG002|Overall Study|Sponsor's Discretion|5|||
162778144|NCT02101268|587899143|FG000|Randomized Treatment Phase|Subject Decision|8|||
162778145|NCT02101268|587899144|FG001|Randomized Treatment Phase|Subject Decision|4|||
162778146|NCT02101268|587899145|FG002|Randomized Treatment Phase|Subject Decision|0|||
162778147|NCT02101268|587899146|FG003|Randomized Treatment Phase|Subject Decision|0|||
162778148|NCT02101268|587899143|FG000|Randomized Treatment Phase|Physician Decision|4|||
162778149|NCT02101268|587899144|FG001|Randomized Treatment Phase|Physician Decision|1|||
162778150|NCT02101268|587899145|FG002|Randomized Treatment Phase|Physician Decision|0|||
162778151|NCT02101268|587899146|FG003|Randomized Treatment Phase|Physician Decision|0|||
162778152|NCT02101268|587899143|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162778153|NCT02101268|587899144|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
162778154|NCT02101268|587899145|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162778155|NCT02101268|587899146|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162778156|NCT02101268|587899143|FG000|Randomized Treatment Phase|Adverse Event|6|||
162778157|NCT02101268|587899144|FG001|Randomized Treatment Phase|Adverse Event|0|||
162778158|NCT02101268|587899145|FG002|Randomized Treatment Phase|Adverse Event|0|||
162778159|NCT02101268|587899146|FG003|Randomized Treatment Phase|Adverse Event|0|||
162778160|NCT02101268|587899143|FG000|Randomized Treatment Phase|Death|5|||
162778161|NCT02101268|587899144|FG001|Randomized Treatment Phase|Death|4|||
162778162|NCT02101268|587899145|FG002|Randomized Treatment Phase|Death|0|||
162778163|NCT02101268|587899146|FG003|Randomized Treatment Phase|Death|0|||
162778164|NCT02101268|587899143|FG000|Randomized Treatment Phase|Disease Progression|4|||
162778165|NCT02101268|587899144|FG001|Randomized Treatment Phase|Disease Progression|1|||
162778166|NCT02101268|587899145|FG002|Randomized Treatment Phase|Disease Progression|0|||
162778167|NCT02101268|587899146|FG003|Randomized Treatment Phase|Disease Progression|0|||
162778168|NCT02101268|587899143|FG000|Extended Treatment Phase|Subject Decision|0|||
162778169|NCT02101268|587899144|FG001|Extended Treatment Phase|Subject Decision|0|||
162778170|NCT02101268|587899145|FG002|Extended Treatment Phase|Subject Decision|3|||
162778171|NCT02101268|587899146|FG003|Extended Treatment Phase|Subject Decision|2|||
162778172|NCT02101268|587899143|FG000|Extended Treatment Phase|Physician Decision|0|||
162778173|NCT02101268|587899144|FG001|Extended Treatment Phase|Physician Decision|0|||
162778174|NCT02101268|587899145|FG002|Extended Treatment Phase|Physician Decision|5|||
162778175|NCT02101268|587899146|FG003|Extended Treatment Phase|Physician Decision|2|||
162778176|NCT02101268|587899143|FG000|Extended Treatment Phase|Adverse Event|0|||
162778177|NCT02101268|587899144|FG001|Extended Treatment Phase|Adverse Event|0|||
162778178|NCT02101268|587899145|FG002|Extended Treatment Phase|Adverse Event|14|||
162778179|NCT02101268|587899146|FG003|Extended Treatment Phase|Adverse Event|18|||
162778180|NCT02101268|587899143|FG000|Extended Treatment Phase|Death|0|||
162778181|NCT02101268|587899144|FG001|Extended Treatment Phase|Death|0|||
162778182|NCT02101268|587899145|FG002|Extended Treatment Phase|Death|5|||
162778183|NCT02101268|587899146|FG003|Extended Treatment Phase|Death|1|||
162778184|NCT02101268|587899143|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
162778185|NCT02101268|587899144|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
162778186|NCT02101268|587899145|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
162778187|NCT02101268|587899146|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
162778188|NCT02101268|587899143|FG000|Extended Treatment Phase|Disease Progression|0|||
162778189|NCT02101268|587899144|FG001|Extended Treatment Phase|Disease Progression|0|||
162778190|NCT02101268|587899145|FG002|Extended Treatment Phase|Disease Progression|13|||
162778191|NCT02101268|587899146|FG003|Extended Treatment Phase|Disease Progression|6|||
162778192|NCT02101268|587899143|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
162778193|NCT02101268|587899144|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
162778194|NCT02101268|587899145|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
162778195|NCT02101268|587899146|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
162778196|NCT00740870|587899147|FG000|Overall Study|Not Catheterized|4|||
162778197|NCT00740870|587899147|FG000|Overall Study|Further testing contraindicated implant|17|||
162778198|NCT00819013|587899148|FG000|Overall Study|Not meeting continuing study eligibility|2|||
162778199|NCT00819013|587899149|FG001|Overall Study|Not meeting continuing study eligibility|1|||
162778200|NCT00819013|587899150|FG002|Overall Study|Not meeting continuing study eligibility|2|||
162778201|NCT00819013|587899151|FG003|Overall Study|Not meeting continuing study eligibility|1|||
162778202|NCT00819013|587899148|FG000|Overall Study|Adverse Event|0|||
162778203|NCT00819013|587899149|FG001|Overall Study|Adverse Event|0|||
162778204|NCT00819013|587899150|FG002|Overall Study|Adverse Event|1|||
162778205|NCT00819013|587899151|FG003|Overall Study|Adverse Event|0|||
162778206|NCT00819013|587899148|FG000|Overall Study|Withdrawal by Subject|1|||
162778207|NCT00819013|587899149|FG001|Overall Study|Withdrawal by Subject|0|||
162778208|NCT00819013|587899150|FG002|Overall Study|Withdrawal by Subject|1|||
162778209|NCT00819013|587899151|FG003|Overall Study|Withdrawal by Subject|0|||
162778210|NCT00819013|587899148|FG000|Overall Study|Lost to Follow-up|0|||
162778211|NCT00819013|587899149|FG001|Overall Study|Lost to Follow-up|0|||
162778212|NCT00819013|587899150|FG002|Overall Study|Lost to Follow-up|1|||
162778213|NCT00819013|587899151|FG003|Overall Study|Lost to Follow-up|2|||
162778214|NCT00819013|587899148|FG000|Overall Study|Death|0|||
162778215|NCT00819013|587899149|FG001|Overall Study|Death|0|||
162778216|NCT00819013|587899150|FG002|Overall Study|Death|0|||
162778217|NCT00819013|587899151|FG003|Overall Study|Death|1|||
162778218|NCT00576823|587899153|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
162778219|NCT00576823|587899154|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
162778220|NCT00576823|587899155|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
162778221|NCT00576823|587899153|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
162778222|NCT00576823|587899154|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
162778223|NCT00576823|587899155|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
162778224|NCT00839332|587899156|FG000|Phase 1|Disease Progression|38|||
162778225|NCT00839332|587899157|FG001|Phase 1|Disease Progression|0|||
162778226|NCT00839332|587899158|FG002|Phase 1|Disease Progression|0|||
162778227|NCT00839332|587899156|FG000|Phase 1|Adverse Event|6|||
162778228|NCT00839332|587899157|FG001|Phase 1|Adverse Event|0|||
162778229|NCT00839332|587899158|FG002|Phase 1|Adverse Event|0|||
162778230|NCT00839332|587899156|FG000|Phase 1|Withdrawal by Subject|4|||
162778231|NCT00839332|587899157|FG001|Phase 1|Withdrawal by Subject|0|||
162778232|NCT00839332|587899158|FG002|Phase 1|Withdrawal by Subject|0|||
162778233|NCT00839332|587899156|FG000|Phase 1|Physician Decision|2|||
162778234|NCT00839332|587899157|FG001|Phase 1|Physician Decision|0|||
162778235|NCT00839332|587899158|FG002|Phase 1|Physician Decision|0|||
162778236|NCT00839332|587899156|FG000|Phase 2|Protocol Violation|0|||
162778237|NCT00839332|587899157|FG001|Phase 2|Protocol Violation|1|||
162778238|NCT00839332|587899158|FG002|Phase 2|Protocol Violation|0|||
162778239|NCT00839332|587899156|FG000|Phase 2|Disease Progression|0|||
162778240|NCT00839332|587899157|FG001|Phase 2|Disease Progression|46|||
162778241|NCT00839332|587899158|FG002|Phase 2|Disease Progression|21|||
162778242|NCT00839332|587899156|FG000|Phase 2|Adverse Event|0|||
162778243|NCT00839332|587899157|FG001|Phase 2|Adverse Event|8|||
162778244|NCT00839332|587899158|FG002|Phase 2|Adverse Event|6|||
162778245|NCT00839332|587899156|FG000|Phase 2|Death|0|||
162778246|NCT00839332|587899157|FG001|Phase 2|Death|4|||
162778247|NCT00839332|587899158|FG002|Phase 2|Death|2|||
162778248|NCT00839332|587899156|FG000|Phase 2|Withdrawal by Subject|0|||
162778249|NCT00839332|587899157|FG001|Phase 2|Withdrawal by Subject|5|||
162778250|NCT00839332|587899158|FG002|Phase 2|Withdrawal by Subject|8|||
162778251|NCT00839332|587899156|FG000|Phase 2|Physician Decision|0|||
162778252|NCT00839332|587899157|FG001|Phase 2|Physician Decision|4|||
162778253|NCT00839332|587899158|FG002|Phase 2|Physician Decision|1|||
162778254|NCT00839332|587899156|FG000|Phase 2|Lost to Follow-up|0|||
162778255|NCT00839332|587899157|FG001|Phase 2|Lost to Follow-up|0|||
162778256|NCT00839332|587899158|FG002|Phase 2|Lost to Follow-up|1|||
162778257|NCT01200485|587899159|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
162778258|NCT01200485|587899160|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
162778259|NCT01200485|587899161|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
162778260|NCT01200485|587899159|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
162778261|NCT01200485|587899160|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
162778262|NCT01200485|587899161|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
162778263|NCT02132117|587899163|FG000|Overall Study|Adverse Event|6|||
162778264|NCT02132117|587899164|FG001|Overall Study|Adverse Event|1|||
162778265|NCT02132117|587899163|FG000|Overall Study|Lost to Follow-up|2|||
162778266|NCT02132117|587899164|FG001|Overall Study|Lost to Follow-up|2|||
162778267|NCT02132117|587899163|FG000|Overall Study|Personal Reasons|1|||
162778268|NCT02132117|587899164|FG001|Overall Study|Personal Reasons|2|||
162778269|NCT02132117|587899163|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162778270|NCT02132117|587899164|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162778271|NCT04947436|587899166|FG000|Overall Study|Lost to Follow-up|3|||
162778272|NCT04947436|587899167|FG001|Overall Study|Lost to Follow-up|7|||
162778273|NCT04947436|587899168|FG002|Overall Study|Lost to Follow-up|5|||
162778274|NCT04947436|587899166|FG000|Overall Study|Death|1|||
162778275|NCT04947436|587899167|FG001|Overall Study|Death|1|||
162778276|NCT04947436|587899168|FG002|Overall Study|Death|1|||
162778277|NCT01544309|587899172|FG000|Overall Study|Withdrawal by Subject|12|||
162778278|NCT01544309|587899173|FG001|Overall Study|Withdrawal by Subject|7|||
162778279|NCT01544309|587899172|FG000|Overall Study|Protocol Violation|2|||
162778280|NCT01544309|587899173|FG001|Overall Study|Protocol Violation|1|||
162778281|NCT01544309|587899172|FG000|Overall Study|Physician Decision|4|||
162778282|NCT01544309|587899173|FG001|Overall Study|Physician Decision|1|||
162778283|NCT01544309|587899172|FG000|Overall Study|Not performed pre-dose examination|1|||
162778284|NCT01544309|587899173|FG001|Overall Study|Not performed pre-dose examination|2|||
162778285|NCT01544309|587899172|FG000|Overall Study|Administered prohibit prior medication|1|||
162778286|NCT01544309|587899173|FG001|Overall Study|Administered prohibit prior medication|0|||
162778287|NCT03078751|587899174|FG000|Overall Study|Adverse Event|4|||
162778288|NCT03078751|587899175|FG001|Overall Study|Adverse Event|0|||
162778289|NCT03078751|587899174|FG000|Overall Study|Physician Decision|1|||
162778290|NCT03078751|587899175|FG001|Overall Study|Physician Decision|0|||
162778291|NCT03078751|587899174|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
162778292|NCT03078751|587899175|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
162778293|NCT03078751|587899174|FG000|Overall Study|Subject/guardian decision|8|||
162778294|NCT03078751|587899175|FG001|Overall Study|Subject/guardian decision|1|||
162778295|NCT03078751|587899174|FG000|Overall Study|Untreated|0|||
162778296|NCT03078751|587899175|FG001|Overall Study|Untreated|4|||
162778297|NCT02515097|587899181|FG000|Overall Study|Lost to Follow-up|4|||
162778298|NCT02515097|587899182|FG001|Overall Study|Lost to Follow-up|2|||
162778299|NCT02515097|587899181|FG000|Overall Study|Withdrawal by Subject|1|||
162778300|NCT02515097|587899182|FG001|Overall Study|Withdrawal by Subject|3|||
162778301|NCT02515097|587899181|FG000|Overall Study|Adverse Event|2|||
162778302|NCT02515097|587899182|FG001|Overall Study|Adverse Event|1|||
162778303|NCT01196741|587899183|FG000|Overall Study|Disease progression|34|||
162778304|NCT01196741|587899184|FG001|Overall Study|Disease progression|14|||
162778305|NCT01196741|587899183|FG000|Overall Study|Adverse Event|10|||
162778306|NCT01196741|587899184|FG001|Overall Study|Adverse Event|6|||
162778307|NCT01196741|587899183|FG000|Overall Study|Serious Adverse Event|3|||
162778308|NCT01196741|587899184|FG001|Overall Study|Serious Adverse Event|1|||
162778309|NCT01196741|587899183|FG000|Overall Study|Dose limiting Adverse Event|2|||
162778310|NCT01196741|587899184|FG001|Overall Study|Dose limiting Adverse Event|1|||
162778311|NCT01196741|587899183|FG000|Overall Study|Withdrawal by Subject|3|||
162778312|NCT01196741|587899184|FG001|Overall Study|Withdrawal by Subject|0|||
162778313|NCT01196741|587899183|FG000|Overall Study|Other reason|3|||
162778314|NCT01196741|587899184|FG001|Overall Study|Other reason|3|||
162778315|NCT01196741|587899183|FG000|Overall Study|Other|3|||
162778316|NCT01196741|587899184|FG001|Overall Study|Other|2|||
162778317|NCT01196741|587899183|FG000|Overall Study|Protocol Violation|2|||
162778318|NCT01196741|587899184|FG001|Overall Study|Protocol Violation|1|||
162778319|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
162778320|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
162778321|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
162778322|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Other|1|||
162778323|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Other|0|||
162778324|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Other|0|||
162778325|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Physician Decision|3|||
162778326|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Physician Decision|0|||
162778327|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Physician Decision|0|||
162778328|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
162778329|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
162778330|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
162778331|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
162778332|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
162778333|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
162778334|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Adverse Event|18|||
162778335|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Adverse Event|0|||
162778336|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Adverse Event|0|||
162778337|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
162778338|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
162778339|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
162778340|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
162778341|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
162778342|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
162778343|NCT03030599|587899185|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
162778344|NCT03030599|587899186|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
162778345|NCT03030599|587899187|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
162778346|NCT03030599|587899185|FG000|Stable Dose|Protocol deviation|3|||
162778347|NCT03030599|587899186|FG001|Stable Dose|Protocol deviation|0|||
162778348|NCT03030599|587899187|FG002|Stable Dose|Protocol deviation|0|||
162778349|NCT03030599|587899185|FG000|Stable Dose|Adverse Event|1|||
162778350|NCT03030599|587899186|FG001|Stable Dose|Adverse Event|0|||
162778351|NCT03030599|587899187|FG002|Stable Dose|Adverse Event|0|||
162778352|NCT03030599|587899185|FG000|Stable Dose|Lost to Follow-up|1|||
162778353|NCT03030599|587899186|FG001|Stable Dose|Lost to Follow-up|0|||
162778354|NCT03030599|587899187|FG002|Stable Dose|Lost to Follow-up|0|||
162778355|NCT03030599|587899185|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
162778356|NCT03030599|587899186|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
162778357|NCT03030599|587899187|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
162778358|NCT03030599|587899185|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
162778359|NCT03030599|587899186|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
162778360|NCT03030599|587899187|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
162778361|NCT03030599|587899185|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
162778362|NCT03030599|587899186|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
162778363|NCT03030599|587899187|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
162778364|NCT03030599|587899185|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
162778365|NCT03030599|587899186|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
162778366|NCT03030599|587899187|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
162778367|NCT03030599|587899185|FG000|Open-label Extension|Adverse Event|3|||
162778368|NCT03030599|587899186|FG001|Open-label Extension|Adverse Event|0|||
162778369|NCT03030599|587899187|FG002|Open-label Extension|Adverse Event|0|||
162778370|NCT03030599|587899185|FG000|Open-label Extension|Lost to Follow-up|2|||
162778371|NCT03030599|587899186|FG001|Open-label Extension|Lost to Follow-up|0|||
162778372|NCT03030599|587899187|FG002|Open-label Extension|Lost to Follow-up|0|||
162778373|NCT03030599|587899185|FG000|Open-label Extension|Lack of Efficacy|1|||
162778374|NCT03030599|587899186|FG001|Open-label Extension|Lack of Efficacy|0|||
162778375|NCT03030599|587899187|FG002|Open-label Extension|Lack of Efficacy|0|||
162778376|NCT03030599|587899185|FG000|Open-label Extension|Other Reason|1|||
162778377|NCT03030599|587899186|FG001|Open-label Extension|Other Reason|0|||
162778378|NCT03030599|587899187|FG002|Open-label Extension|Other Reason|0|||
162778379|NCT01592383|587899188|FG000|Overall Study|Adverse Event|1|||
162778380|NCT04582864|587899189|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
162778381|NCT04582864|587899189|FG000|Overall Study|Death|1|||
162778382|NCT01064856|587899190|FG000|Double-blind (DB) Period|Adverse Event|1|||
162778383|NCT01064856|587899191|FG001|Double-blind (DB) Period|Adverse Event|0|||
162778384|NCT01064856|587899192|FG002|Double-blind (DB) Period|Adverse Event|0|||
162778385|NCT01064856|587899193|FG003|Double-blind (DB) Period|Adverse Event|0|||
162778386|NCT01064856|587899190|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
162778387|NCT01064856|587899191|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162778388|NCT01064856|587899192|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162778389|NCT01064856|587899193|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162778390|NCT01064856|587899190|FG000|Open-label (OL) Period|Adverse Event|0|||
162778391|NCT01064856|587899191|FG001|Open-label (OL) Period|Adverse Event|0|||
162778392|NCT01064856|587899192|FG002|Open-label (OL) Period|Adverse Event|12|||
162778393|NCT01064856|587899193|FG003|Open-label (OL) Period|Adverse Event|6|||
162778394|NCT01064856|587899190|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
162778395|NCT01064856|587899191|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
162778396|NCT01064856|587899192|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
162778397|NCT01064856|587899193|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
162778398|NCT01064856|587899190|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
162778399|NCT01064856|587899191|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
162778400|NCT01064856|587899192|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
162778401|NCT01064856|587899193|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
162778402|NCT01064856|587899190|FG000|Open-label (OL) Period|Other|0|||
162778403|NCT01064856|587899191|FG001|Open-label (OL) Period|Other|0|||
162778404|NCT01064856|587899192|FG002|Open-label (OL) Period|Other|7|||
162778405|NCT01064856|587899193|FG003|Open-label (OL) Period|Other|7|||
162778406|NCT02133131|587899194|FG000|Overall Study|Adverse Event|0|||
162778407|NCT02133131|587899195|FG001|Overall Study|Adverse Event|0|||
162778408|NCT02133131|587899196|FG002|Overall Study|Adverse Event|0|||
162778409|NCT02133131|587899197|FG003|Overall Study|Adverse Event|1|||
162778410|NCT02133131|587899198|FG004|Overall Study|Adverse Event|0|||
162778411|NCT02133131|587899199|FG005|Overall Study|Adverse Event|0|||
162778412|NCT02133131|587899200|FG006|Overall Study|Adverse Event|0|||
162778413|NCT02133131|587899194|FG000|Overall Study|Lost to Follow-up|1|||
162778414|NCT02133131|587899195|FG001|Overall Study|Lost to Follow-up|0|||
162778415|NCT02133131|587899196|FG002|Overall Study|Lost to Follow-up|0|||
162778416|NCT02133131|587899197|FG003|Overall Study|Lost to Follow-up|1|||
162778417|NCT02133131|587899198|FG004|Overall Study|Lost to Follow-up|0|||
162778418|NCT02133131|587899199|FG005|Overall Study|Lost to Follow-up|0|||
162778419|NCT02133131|587899200|FG006|Overall Study|Lost to Follow-up|0|||
162778420|NCT02133131|587899194|FG000|Overall Study|Status not recorded|4|||
162778421|NCT02133131|587899195|FG001|Overall Study|Status not recorded|5|||
162778422|NCT02133131|587899196|FG002|Overall Study|Status not recorded|1|||
162778423|NCT02133131|587899197|FG003|Overall Study|Status not recorded|4|||
162778424|NCT02133131|587899198|FG004|Overall Study|Status not recorded|0|||
162778425|NCT02133131|587899199|FG005|Overall Study|Status not recorded|0|||
162778426|NCT02133131|587899200|FG006|Overall Study|Status not recorded|0|||
162778427|NCT02133131|587899194|FG000|Overall Study|Ongoing in study|0|||
162778428|NCT02133131|587899195|FG001|Overall Study|Ongoing in study|0|||
162778429|NCT02133131|587899196|FG002|Overall Study|Ongoing in study|0|||
162778430|NCT02133131|587899197|FG003|Overall Study|Ongoing in study|0|||
162778431|NCT02133131|587899198|FG004|Overall Study|Ongoing in study|15|||
162778432|NCT02133131|587899199|FG005|Overall Study|Ongoing in study|14|||
162778433|NCT02133131|587899200|FG006|Overall Study|Ongoing in study|11|||
162778434|NCT02133131|587899194|FG000|Overall Study|Protocol Violation|0|||
162778435|NCT02133131|587899195|FG001|Overall Study|Protocol Violation|0|||
162778436|NCT02133131|587899196|FG002|Overall Study|Protocol Violation|0|||
162778437|NCT02133131|587899197|FG003|Overall Study|Protocol Violation|0|||
162778438|NCT02133131|587899198|FG004|Overall Study|Protocol Violation|0|||
162778439|NCT02133131|587899199|FG005|Overall Study|Protocol Violation|0|||
162778440|NCT02133131|587899200|FG006|Overall Study|Protocol Violation|1|||
162778441|NCT01679613|587899203|FG000|Overall Study|other than stated above|0|||
162778442|NCT01679613|587899204|FG001|Overall Study|other than stated above|1|||
162778443|NCT01679613|587899205|FG002|Overall Study|other than stated above|2|||
162778444|NCT01679613|587899206|FG003|Overall Study|other than stated above|2|||
162778445|NCT00509925|587899208|FG000|Overall Study|Personal reasons|0|||
162778446|NCT00509925|587899209|FG001|Overall Study|Personal reasons|1|||
162778447|NCT00951171|587899210|FG000|Overall Study|Adverse Event|2|||
162778448|NCT00951171|587899211|FG001|Overall Study|Adverse Event|0|||
162778449|NCT02799745|587899214|FG000|Overall Study|Participant moved out of state|1|||
162778450|NCT02799745|587899215|FG001|Overall Study|Participant moved out of state|0|||
162778451|NCT02799745|587899214|FG000|Overall Study|Discontinued due to planned surgery|1|||
162778452|NCT02799745|587899215|FG001|Overall Study|Discontinued due to planned surgery|0|||
162778453|NCT02799745|587899214|FG000|Overall Study|Withdrawal by Subject|16|||
162778454|NCT02799745|587899215|FG001|Overall Study|Withdrawal by Subject|25|||
162778455|NCT02799745|587899214|FG000|Overall Study|Protocol Deviation|4|||
162778456|NCT02799745|587899215|FG001|Overall Study|Protocol Deviation|5|||
162778457|NCT02799745|587899214|FG000|Overall Study|Progressive Disease|28|||
162778458|NCT02799745|587899215|FG001|Overall Study|Progressive Disease|38|||
162778459|NCT02799745|587899214|FG000|Overall Study|Lost to Follow-up|3|||
162778460|NCT02799745|587899215|FG001|Overall Study|Lost to Follow-up|2|||
162778461|NCT02799745|587899214|FG000|Overall Study|Death|3|||
162778462|NCT02799745|587899215|FG001|Overall Study|Death|0|||
162778463|NCT02799745|587899214|FG000|Overall Study|Adverse Event|0|||
162778464|NCT02799745|587899215|FG001|Overall Study|Adverse Event|1|||
162778465|NCT01932762|587900719|FG000|Overall Study|Withdrawal by Subject|1|||
162778466|NCT01932762|587900720|FG001|Overall Study|Withdrawal by Subject|2|||
162778467|NCT01932762|587900721|FG002|Overall Study|Withdrawal by Subject|0|||
162778468|NCT01932762|587900722|FG003|Overall Study|Withdrawal by Subject|0|||
162778469|NCT01932762|587900719|FG000|Overall Study|Lost to Follow-up|4|||
162778470|NCT01932762|587900720|FG001|Overall Study|Lost to Follow-up|0|||
162778471|NCT01932762|587900721|FG002|Overall Study|Lost to Follow-up|0|||
162778472|NCT01932762|587900722|FG003|Overall Study|Lost to Follow-up|1|||
162778473|NCT01932762|587900719|FG000|Overall Study|Physician Decision|1|||
162778474|NCT01932762|587900720|FG001|Overall Study|Physician Decision|0|||
162778475|NCT01932762|587900721|FG002|Overall Study|Physician Decision|0|||
162778476|NCT01932762|587900722|FG003|Overall Study|Physician Decision|0|||
162778477|NCT02210208|587900723|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
162778478|NCT02210208|587900723|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
162778479|NCT02210208|587900723|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
162778480|NCT00695136|587900724|FG000|Overall Study|Withdrawal by Subject|1|||
162778481|NCT00695136|587900724|FG000|Overall Study|unrelated adverse event|1|||
162778482|NCT01726049|587900726|FG000|Overall Study|Death|1|||
162778483|NCT01726049|587900727|FG001|Overall Study|Death|1|||
162778484|NCT01726049|587900726|FG000|Overall Study|Adverse Event|4|||
162778485|NCT01726049|587900727|FG001|Overall Study|Adverse Event|1|||
162778486|NCT01726049|587900726|FG000|Overall Study|refused second HC|0|||
162778487|NCT01726049|587900727|FG001|Overall Study|refused second HC|2|||
162778488|NCT01333111|587900728|FG000|Overall Study|patient undergoing major surgery|0|||
162778489|NCT01333111|587900729|FG001|Overall Study|patient undergoing major surgery|2|||
162778490|NCT01333111|587900730|FG002|Overall Study|patient undergoing major surgery|0|||
162778491|NCT01333111|587900728|FG000|Overall Study|personal reasons|0|||
162778492|NCT01333111|587900729|FG001|Overall Study|personal reasons|0|||
162778493|NCT01333111|587900730|FG002|Overall Study|personal reasons|1|||
162778494|NCT01333111|587900728|FG000|Overall Study|unclassified|1|||
162778495|NCT01333111|587900729|FG001|Overall Study|unclassified|0|||
162778496|NCT01333111|587900730|FG002|Overall Study|unclassified|0|||
162778497|NCT01333111|587900728|FG000|Overall Study|withdrawal criteria|0|||
162778498|NCT01333111|587900729|FG001|Overall Study|withdrawal criteria|1|||
162778499|NCT01333111|587900730|FG002|Overall Study|withdrawal criteria|0|||
162778500|NCT01333111|587900728|FG000|Overall Study|Non-compliance|1|||
162778501|NCT01333111|587900729|FG001|Overall Study|Non-compliance|0|||
162778502|NCT01333111|587900730|FG002|Overall Study|Non-compliance|0|||
162778503|NCT01333111|587900728|FG000|Overall Study|Ineffective therapy|0|||
162778504|NCT01333111|587900729|FG001|Overall Study|Ineffective therapy|0|||
162778505|NCT01333111|587900730|FG002|Overall Study|Ineffective therapy|1|||
162778506|NCT02161406|587900731|FG000|Overall Study|Death|2|||
162778507|NCT02161406|587900732|FG001|Overall Study|Death|1|||
162778508|NCT02161406|587900731|FG000|Overall Study|Lost to Follow-up|2|||
162778509|NCT02161406|587900732|FG001|Overall Study|Lost to Follow-up|1|||
162778510|NCT02161406|587900731|FG000|Overall Study|Withdrawal by Subject|2|||
162778511|NCT02161406|587900732|FG001|Overall Study|Withdrawal by Subject|4|||
162778512|NCT02161406|587900731|FG000|Overall Study|investigator withdrew subject|3|||
162778513|NCT02161406|587900732|FG001|Overall Study|investigator withdrew subject|1|||
162778514|NCT02161406|587900731|FG000|Overall Study|Lack of Efficacy|1|||
162778515|NCT02161406|587900732|FG001|Overall Study|Lack of Efficacy|1|||
162778516|NCT02161406|587900731|FG000|Overall Study|relocation|0|||
162778517|NCT02161406|587900732|FG001|Overall Study|relocation|1|||
162778518|NCT01929876|587900733|FG000|Period 2|Non-Compliance|1|||
162778519|NCT01468077|587900736|FG000|Overall Study|Adverse Event|2|||
162778520|NCT01468077|587900737|FG001|Overall Study|Adverse Event|2|||
162778521|NCT01468077|587900736|FG000|Overall Study|Lack of Efficacy|1|||
162778522|NCT01468077|587900737|FG001|Overall Study|Lack of Efficacy|1|||
162778523|NCT01468077|587900736|FG000|Overall Study|Physician Decision|1|||
162778524|NCT01468077|587900737|FG001|Overall Study|Physician Decision|0|||
162778525|NCT05446714|587900738|FG000|Overall Study|Lost to Follow-up|1|||
162778526|NCT05446714|587900739|FG001|Overall Study|Lost to Follow-up|3|||
162778527|NCT05446714|587900740|FG002|Overall Study|Lost to Follow-up|2|||
162778528|NCT05446714|587900738|FG000|Overall Study|Protocol Violation|2|||
162778529|NCT05446714|587900739|FG001|Overall Study|Protocol Violation|0|||
162778530|NCT05446714|587900740|FG002|Overall Study|Protocol Violation|0|||
162778531|NCT03024996|587900741|FG000|Overall Study|Death|57|||
162778532|NCT03024996|587900742|FG001|Overall Study|Death|55|||
162778533|NCT03024996|587900741|FG000|Overall Study|Disease relapse|1|||
162778534|NCT03024996|587900742|FG001|Overall Study|Disease relapse|0|||
162778535|NCT03024996|587900741|FG000|Overall Study|Lost to Follow-up|5|||
162778536|NCT03024996|587900742|FG001|Overall Study|Lost to Follow-up|10|||
162778537|NCT03024996|587900741|FG000|Overall Study|Other|3|||
162778538|NCT03024996|587900742|FG001|Overall Study|Other|3|||
162778539|NCT03024996|587900741|FG000|Overall Study|Physician Decision|0|||
162778540|NCT03024996|587900742|FG001|Overall Study|Physician Decision|1|||
162778541|NCT03024996|587900741|FG000|Overall Study|Study terminated by sponsor|303|||
162778542|NCT03024996|587900742|FG001|Overall Study|Study terminated by sponsor|283|||
162778543|NCT03024996|587900741|FG000|Overall Study|Withdrawal by Subject|21|||
162778544|NCT03024996|587900742|FG001|Overall Study|Withdrawal by Subject|36|||
162778545|NCT02418845|587900745|FG000|Overall Study|Lost to Follow-up|7|||
162778546|NCT02418845|587900746|FG001|Overall Study|Lost to Follow-up|2|||
162778547|NCT02418845|587900745|FG000|Overall Study|Lack of Efficacy|0|||
162778548|NCT02418845|587900746|FG001|Overall Study|Lack of Efficacy|3|||
162778549|NCT02418845|587900745|FG000|Overall Study|Physician Decision|5|||
162778550|NCT02418845|587900746|FG001|Overall Study|Physician Decision|5|||
162778551|NCT02418845|587900745|FG000|Overall Study|Protocol Violation|1|||
162778552|NCT02418845|587900746|FG001|Overall Study|Protocol Violation|0|||
162778553|NCT02418845|587900745|FG000|Overall Study|Withdrawal by Subject|3|||
162778554|NCT02418845|587900746|FG001|Overall Study|Withdrawal by Subject|2|||
162778555|NCT00478647|587900747|FG000|Overall Study|Adverse Event|1|||
162778556|NCT00478647|587900747|FG000|Overall Study|Withdrawal by Subject|1|||
162778557|NCT04333147|587900748|FG000|Overall Study|Adverse Event|43|||
162778558|NCT04333147|587900749|FG001|Overall Study|Adverse Event|40|||
162778559|NCT04333147|587900748|FG000|Overall Study|Lack of Efficacy|49|||
162778560|NCT04333147|587900749|FG001|Overall Study|Lack of Efficacy|48|||
162778561|NCT04333147|587900748|FG000|Overall Study|Lost to Follow-up|19|||
162778562|NCT04333147|587900749|FG001|Overall Study|Lost to Follow-up|16|||
162778563|NCT04333147|587900748|FG000|Overall Study|Physician Decision|17|||
162778564|NCT04333147|587900749|FG001|Overall Study|Physician Decision|20|||
162778565|NCT04333147|587900748|FG000|Overall Study|Withdrawal by Subject|65|||
162778566|NCT04333147|587900749|FG001|Overall Study|Withdrawal by Subject|68|||
162778567|NCT04333147|587900748|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
162778568|NCT04333147|587900749|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
162778569|NCT04333147|587900748|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
162778570|NCT04333147|587900749|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
162778571|NCT04333147|587900748|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
162778572|NCT04333147|587900749|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
162778573|NCT00487552|587900759|FG000|Overall Study|Unsuccessful magnet placements|3|||
162778574|NCT00487552|587900759|FG000|Overall Study|Death due to progressive malignancy|2|||
162778575|NCT00487552|587900759|FG000|Overall Study|Stent not placed|1|||
162778576|NCT03119688|587900760|FG000|Overall Study|Adverse Event|4|||
162778577|NCT00320398|587900761|FG000|Overall Study|Adverse Event|1|||
162778578|NCT00320398|587900762|FG001|Overall Study|Adverse Event|4|||
162778579|NCT00320398|587900761|FG000|Overall Study|Other|1|||
162778580|NCT00320398|587900762|FG001|Overall Study|Other|0|||
162778581|NCT00630552|587900763|FG000|Overall Study|Adverse Event|0|||
162778582|NCT00630552|587900764|FG001|Overall Study|Adverse Event|1|||
162778583|NCT00630552|587900765|FG002|Overall Study|Adverse Event|5|||
162778584|NCT00630552|587900766|FG003|Overall Study|Adverse Event|4|||
162778585|NCT00630552|587900767|FG004|Overall Study|Adverse Event|2|||
162778586|NCT00630552|587900763|FG000|Overall Study|Disease progression|5|||
162778587|NCT00630552|587900764|FG001|Overall Study|Disease progression|6|||
162778588|NCT00630552|587900765|FG002|Overall Study|Disease progression|27|||
162778589|NCT00630552|587900766|FG003|Overall Study|Disease progression|22|||
162778590|NCT00630552|587900767|FG004|Overall Study|Disease progression|31|||
162778591|NCT00630552|587900763|FG000|Overall Study|Never received IP|0|||
162778592|NCT00630552|587900764|FG001|Overall Study|Never received IP|0|||
162778593|NCT00630552|587900765|FG002|Overall Study|Never received IP|0|||
162778594|NCT00630552|587900766|FG003|Overall Study|Never received IP|2|||
162778595|NCT00630552|587900767|FG004|Overall Study|Never received IP|2|||
162778596|NCT00630552|587900763|FG000|Overall Study|Ineligibility determined|0|||
162778597|NCT00630552|587900764|FG001|Overall Study|Ineligibility determined|0|||
162778598|NCT00630552|587900765|FG002|Overall Study|Ineligibility determined|0|||
162778599|NCT00630552|587900766|FG003|Overall Study|Ineligibility determined|0|||
162778600|NCT00630552|587900767|FG004|Overall Study|Ineligibility determined|1|||
162778601|NCT00630552|587900763|FG000|Overall Study|Protocol Violation|0|||
162778602|NCT00630552|587900764|FG001|Overall Study|Protocol Violation|0|||
162778603|NCT00630552|587900765|FG002|Overall Study|Protocol Violation|0|||
162778604|NCT00630552|587900766|FG003|Overall Study|Protocol Violation|1|||
162778605|NCT00630552|587900767|FG004|Overall Study|Protocol Violation|0|||
162778606|NCT00630552|587900763|FG000|Overall Study|Physician Decision|0|||
162778607|NCT00630552|587900764|FG001|Overall Study|Physician Decision|0|||
162778608|NCT00630552|587900765|FG002|Overall Study|Physician Decision|0|||
162778609|NCT00630552|587900766|FG003|Overall Study|Physician Decision|0|||
162778610|NCT00630552|587900767|FG004|Overall Study|Physician Decision|1|||
162778611|NCT00630552|587900763|FG000|Overall Study|Death|0|||
162778612|NCT00630552|587900764|FG001|Overall Study|Death|0|||
162778613|NCT00630552|587900765|FG002|Overall Study|Death|1|||
162778614|NCT00630552|587900766|FG003|Overall Study|Death|2|||
162778615|NCT00630552|587900767|FG004|Overall Study|Death|2|||
162778616|NCT00630552|587900763|FG000|Overall Study|Withdrawal by Subject|0|||
162778617|NCT00630552|587900764|FG001|Overall Study|Withdrawal by Subject|0|||
162778618|NCT00630552|587900765|FG002|Overall Study|Withdrawal by Subject|0|||
162778619|NCT00630552|587900766|FG003|Overall Study|Withdrawal by Subject|1|||
162778620|NCT00630552|587900767|FG004|Overall Study|Withdrawal by Subject|0|||
162778621|NCT00630552|587900763|FG000|Overall Study|Other|0|||
162778622|NCT00630552|587900764|FG001|Overall Study|Other|0|||
162778623|NCT00630552|587900765|FG002|Overall Study|Other|4|||
162778624|NCT00630552|587900766|FG003|Overall Study|Other|2|||
162778625|NCT00630552|587900767|FG004|Overall Study|Other|0|||
162778626|NCT01084239|587900768|FG000|28-Day Follow-up|Lost to Follow-up|4|||
162778627|NCT01084239|587900769|FG001|28-Day Follow-up|Lost to Follow-up|9|||
162778628|NCT05006417|587900770|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
162778629|NCT02705625|587900771|FG000|Overall Study|Protocol Violation|1|||
162778630|NCT02705625|587900772|FG001|Overall Study|Protocol Violation|0|||
162778631|NCT02705625|587900773|FG002|Overall Study|Protocol Violation|0|||
162778632|NCT02705625|587900771|FG000|Overall Study|Adverse Event|6|||
162778633|NCT02705625|587900772|FG001|Overall Study|Adverse Event|5|||
162778634|NCT02705625|587900773|FG002|Overall Study|Adverse Event|2|||
162778635|NCT02705625|587900771|FG000|Overall Study|Death|0|||
162778636|NCT02705625|587900772|FG001|Overall Study|Death|0|||
162778637|NCT02705625|587900773|FG002|Overall Study|Death|1|||
162778638|NCT02705625|587900771|FG000|Overall Study|Withdrawal by Subject|1|||
162778639|NCT02705625|587900772|FG001|Overall Study|Withdrawal by Subject|4|||
162778640|NCT02705625|587900773|FG002|Overall Study|Withdrawal by Subject|5|||
162778641|NCT02705625|587900771|FG000|Overall Study|Lost to Follow-up|0|||
162778642|NCT02705625|587900772|FG001|Overall Study|Lost to Follow-up|0|||
162778643|NCT02705625|587900773|FG002|Overall Study|Lost to Follow-up|1|||
162778644|NCT02705625|587900771|FG000|Overall Study|Non-compliance|0|||
162778645|NCT02705625|587900772|FG001|Overall Study|Non-compliance|1|||
162778646|NCT02705625|587900773|FG002|Overall Study|Non-compliance|1|||
162778647|NCT02705625|587900771|FG000|Overall Study|Overdosing|0|||
162778648|NCT02705625|587900772|FG001|Overall Study|Overdosing|0|||
162778649|NCT02705625|587900773|FG002|Overall Study|Overdosing|1|||
162778650|NCT00863798|587900774|FG000|Overall Study|Adverse Event|5|||
162778651|NCT00863798|587900775|FG001|Overall Study|Adverse Event|2|||
162778652|NCT00863798|587900776|FG002|Overall Study|Adverse Event|4|||
162778653|NCT00863798|587900774|FG000|Overall Study|Participant failed to return|2|||
162778654|NCT00863798|587900775|FG001|Overall Study|Participant failed to return|1|||
162778655|NCT00863798|587900776|FG002|Overall Study|Participant failed to return|0|||
162778656|NCT00863798|587900774|FG000|Overall Study|Investigator request|1|||
162778657|NCT00863798|587900775|FG001|Overall Study|Investigator request|2|||
162778658|NCT00863798|587900776|FG002|Overall Study|Investigator request|1|||
162778659|NCT00863798|587900774|FG000|Overall Study|Lack of Efficacy|4|||
162778660|NCT00863798|587900775|FG001|Overall Study|Lack of Efficacy|3|||
162778661|NCT00863798|587900776|FG002|Overall Study|Lack of Efficacy|6|||
162778662|NCT00863798|587900774|FG000|Overall Study|Lost to Follow-up|6|||
162778663|NCT00863798|587900775|FG001|Overall Study|Lost to Follow-up|9|||
162778664|NCT00863798|587900776|FG002|Overall Study|Lost to Follow-up|5|||
162778665|NCT00863798|587900774|FG000|Overall Study|Other|2|||
162778666|NCT00863798|587900775|FG001|Overall Study|Other|3|||
162778667|NCT00863798|587900776|FG002|Overall Study|Other|1|||
162778668|NCT00863798|587900774|FG000|Overall Study|Protocol Violation|0|||
162778669|NCT00863798|587900775|FG001|Overall Study|Protocol Violation|1|||
162778670|NCT00863798|587900776|FG002|Overall Study|Protocol Violation|1|||
162778671|NCT00863798|587900774|FG000|Overall Study|Withdrawal by Subject|8|||
162778672|NCT00863798|587900775|FG001|Overall Study|Withdrawal by Subject|7|||
162778673|NCT00863798|587900776|FG002|Overall Study|Withdrawal by Subject|4|||
162778674|NCT00863798|587900774|FG000|Overall Study|Randomized not treated|4|||
162778675|NCT00863798|587900775|FG001|Overall Study|Randomized not treated|2|||
162778676|NCT00863798|587900776|FG002|Overall Study|Randomized not treated|3|||
162778677|NCT04238520|587900777|FG000|Overall Study|Withdrawal by Subject|1|||
162778678|NCT04238520|587900778|FG001|Overall Study|Withdrawal by Subject|1|||
162778679|NCT04238520|587900777|FG000|Overall Study|Lost to Follow-up|1|||
162778680|NCT04238520|587900778|FG001|Overall Study|Lost to Follow-up|2|||
162778681|NCT04238520|587900777|FG000|Overall Study|Death|0|||
162778682|NCT04238520|587900778|FG001|Overall Study|Death|2|||
162778683|NCT04238520|587900777|FG000|Overall Study|Unsafe home environment for research staff|0|||
162778684|NCT04238520|587900778|FG001|Overall Study|Unsafe home environment for research staff|1|||
162778685|NCT01470599|587900779|FG000|Overall Study|Did not meet entrance criteria|1|||
162778686|NCT01470599|587900780|FG001|Overall Study|Did not meet entrance criteria|0|||
162778687|NCT01470599|587900779|FG000|Overall Study|Lost to Follow-up|2|||
162778688|NCT01470599|587900780|FG001|Overall Study|Lost to Follow-up|1|||
162778689|NCT01470599|587900779|FG000|Overall Study|Withdrawal by Subject|3|||
162778690|NCT01470599|587900780|FG001|Overall Study|Withdrawal by Subject|4|||
162778691|NCT01470599|587900779|FG000|Overall Study|Other|1|||
162778692|NCT01470599|587900780|FG001|Overall Study|Other|0|||
162778693|NCT01470599|587900779|FG000|Overall Study|Protocol Violation|3|||
162778694|NCT01470599|587900780|FG001|Overall Study|Protocol Violation|1|||
162778695|NCT01470599|587900779|FG000|Overall Study|Adverse event related to study drug|2|||
162778696|NCT01470599|587900780|FG001|Overall Study|Adverse event related to study drug|5|||
162778697|NCT01470599|587900779|FG000|Overall Study|Insufficient clinical response|6|||
162778698|NCT01470599|587900780|FG001|Overall Study|Insufficient clinical response|27|||
162778699|NCT01470599|587900779|FG000|Overall Study|Adverse event not related to study drug|1|||
162778700|NCT01470599|587900780|FG001|Overall Study|Adverse event not related to study drug|5|||
162778701|NCT00195442|587900781|FG000|Overall Study|Less than expected therapeutic effect|38|||
162778702|NCT00195442|587900781|FG000|Overall Study|Lost to Follow-up|27|||
162778703|NCT00195442|587900781|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
162778704|NCT00195442|587900781|FG000|Overall Study|Intermittent product shortage|21|||
162778705|NCT00195442|587900781|FG000|Overall Study|Death|7|||
162778706|NCT00195442|587900781|FG000|Overall Study|No reason specified|4|||
162778707|NCT00195442|587900781|FG000|Overall Study|Poor cooperation|2|||
162778708|NCT00195442|587900781|FG000|Overall Study|Other|14|||
162778709|NCT01917006|587900782|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
162778710|NCT01917006|587900783|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
162778711|NCT01917006|587900784|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
162778712|NCT01917006|587900785|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
162778713|NCT01917006|587900786|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
162778714|NCT01917006|587900787|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
162778715|NCT01917006|587900788|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
162778716|NCT01917006|587900789|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
162778717|NCT01917006|587900782|FG000|Randomized-treatment Period|Personal Reasons|0|||
162778718|NCT01917006|587900783|FG001|Randomized-treatment Period|Personal Reasons|0|||
162778719|NCT01917006|587900784|FG002|Randomized-treatment Period|Personal Reasons|0|||
162778720|NCT01917006|587900785|FG003|Randomized-treatment Period|Personal Reasons|0|||
162778721|NCT01917006|587900786|FG004|Randomized-treatment Period|Personal Reasons|0|||
162778722|NCT01917006|587900787|FG005|Randomized-treatment Period|Personal Reasons|1|||
162778723|NCT01917006|587900788|FG006|Randomized-treatment Period|Personal Reasons|0|||
162778724|NCT01917006|587900789|FG007|Randomized-treatment Period|Personal Reasons|0|||
162778725|NCT01917006|587900782|FG000|Randomized-treatment Period|Protocol Violation|1|||
162778726|NCT01917006|587900783|FG001|Randomized-treatment Period|Protocol Violation|0|||
162778727|NCT01917006|587900784|FG002|Randomized-treatment Period|Protocol Violation|0|||
162778728|NCT01917006|587900785|FG003|Randomized-treatment Period|Protocol Violation|0|||
162778729|NCT01917006|587900786|FG004|Randomized-treatment Period|Protocol Violation|0|||
162778730|NCT01917006|587900787|FG005|Randomized-treatment Period|Protocol Violation|0|||
162778731|NCT01917006|587900788|FG006|Randomized-treatment Period|Protocol Violation|0|||
162778732|NCT01917006|587900789|FG007|Randomized-treatment Period|Protocol Violation|0|||
162778733|NCT01917006|587900782|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778734|NCT01917006|587900783|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778735|NCT01917006|587900784|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778736|NCT01917006|587900785|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778737|NCT01917006|587900786|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778738|NCT01917006|587900787|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778739|NCT01917006|587900788|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
162778740|NCT01917006|587900789|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162778741|NCT01917006|587900782|FG000|Open-label Period|Adverse Event|0|||
162778742|NCT01917006|587900783|FG001|Open-label Period|Adverse Event|0|||
162778743|NCT01917006|587900784|FG002|Open-label Period|Adverse Event|0|||
162778744|NCT01917006|587900785|FG003|Open-label Period|Adverse Event|0|||
162778745|NCT01917006|587900786|FG004|Open-label Period|Adverse Event|0|||
162778746|NCT01917006|587900787|FG005|Open-label Period|Adverse Event|0|||
162778747|NCT01917006|587900788|FG006|Open-label Period|Adverse Event|0|||
162778748|NCT01917006|587900789|FG007|Open-label Period|Adverse Event|1|||
162778749|NCT01917006|587900782|FG000|Open-label Period|Lost to Follow-up|0|||
162778750|NCT01917006|587900783|FG001|Open-label Period|Lost to Follow-up|0|||
162778751|NCT01917006|587900784|FG002|Open-label Period|Lost to Follow-up|0|||
162778752|NCT01917006|587900785|FG003|Open-label Period|Lost to Follow-up|0|||
162778753|NCT01917006|587900786|FG004|Open-label Period|Lost to Follow-up|0|||
162778754|NCT01917006|587900787|FG005|Open-label Period|Lost to Follow-up|0|||
162778755|NCT01917006|587900788|FG006|Open-label Period|Lost to Follow-up|0|||
162778756|NCT01917006|587900789|FG007|Open-label Period|Lost to Follow-up|1|||
162778757|NCT02158247|587900795|FG000|Overall Study|Invisible vocal cords|5|||
162778758|NCT01057251|587900803|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
162778759|NCT01057251|587900804|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
162778760|NCT01057251|587900803|FG000|Overall Study|Adverse Event|4|||
162778761|NCT01057251|587900804|FG001|Overall Study|Adverse Event|2|||
162778762|NCT01057251|587900803|FG000|Overall Study|Lack of Efficacy|2|||
162778763|NCT01057251|587900804|FG001|Overall Study|Lack of Efficacy|11|||
162778764|NCT01057251|587900803|FG000|Overall Study|Protocol Violation|6|||
162778765|NCT01057251|587900804|FG001|Overall Study|Protocol Violation|2|||
162778766|NCT01057251|587900803|FG000|Overall Study|Withdrawal by Subject|4|||
162778767|NCT01057251|587900804|FG001|Overall Study|Withdrawal by Subject|5|||
162778768|NCT01057251|587900803|FG000|Overall Study|Lost to Follow-up|7|||
162778769|NCT01057251|587900804|FG001|Overall Study|Lost to Follow-up|6|||
162778770|NCT01057251|587900803|FG000|Overall Study|Other Reason|1|||
162778771|NCT01057251|587900804|FG001|Overall Study|Other Reason|1|||
162778772|NCT00784147|587900805|FG000|Overall Study|Lost to Follow-up|2|||
162778773|NCT00784147|587900806|FG001|Overall Study|Lost to Follow-up|4|||
162778774|NCT00784147|587900805|FG000|Overall Study|Withdrawal by Subject|1|||
162778775|NCT00784147|587900806|FG001|Overall Study|Withdrawal by Subject|3|||
162778776|NCT00784147|587900805|FG000|Overall Study|Physician Decision|2|||
162778777|NCT00784147|587900806|FG001|Overall Study|Physician Decision|1|||
162778778|NCT00784147|587900805|FG000|Overall Study|Protocol Violation|1|||
162778779|NCT00784147|587900806|FG001|Overall Study|Protocol Violation|1|||
162778780|NCT00784147|587900805|FG000|Overall Study|Death|2|||
162778781|NCT00784147|587900806|FG001|Overall Study|Death|0|||
162778782|NCT03596242|587900808|FG000|Overall Study|Lost to Follow-up|2|||
162778783|NCT03596242|587900809|FG001|Overall Study|Lost to Follow-up|2|||
162778784|NCT02509312|587900810|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
162778785|NCT02509312|587900811|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
162778786|NCT02509312|587900810|FG000|Overall Study|Obstetrician refusal|0|||
162778787|NCT02509312|587900811|FG001|Overall Study|Obstetrician refusal|1|||
162778788|NCT02509312|587900810|FG000|Overall Study|Patient elected for TOLAC|1|||
162778789|NCT02509312|587900811|FG001|Overall Study|Patient elected for TOLAC|0|||
162778790|NCT02509312|587900810|FG000|Overall Study|Cesarean deemed stat|1|||
162778791|NCT02509312|587900811|FG001|Overall Study|Cesarean deemed stat|0|||
162778792|NCT02509312|587900810|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
162778793|NCT02509312|587900811|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
162778794|NCT04544865|587900812|FG000|Overall Study|Death|0|||
162778795|NCT04544865|587900813|FG001|Overall Study|Death|2|||
162778796|NCT04544865|587900812|FG000|Overall Study|Lost to Follow-up|11|||
162778797|NCT04544865|587900813|FG001|Overall Study|Lost to Follow-up|7|||
162778798|NCT04544865|587900812|FG000|Overall Study|Withdrawal by Subject|0|||
162778799|NCT04544865|587900813|FG001|Overall Study|Withdrawal by Subject|1|||
162778800|NCT04544865|587900812|FG000|Overall Study|Other|0|||
162778801|NCT04544865|587900813|FG001|Overall Study|Other|1|||
162778802|NCT03357471|587900819|FG000|Overall Study|Adverse Event|1|||
162778803|NCT03357471|587900820|FG001|Overall Study|Adverse Event|0|||
162778804|NCT03357471|587900819|FG000|Overall Study|Lost to Follow-up|1|||
162778805|NCT03357471|587900820|FG001|Overall Study|Lost to Follow-up|0|||
162778806|NCT02973802|587900821|FG000|Overall Study|Lost to Follow-up|1|||
162778807|NCT02973802|587900821|FG000|Overall Study|Withdrawal by Subject|1|||
162778808|NCT00706914|587900822|FG000|Overall Study|Lack of Efficacy|0|||
162778809|NCT00706914|587900823|FG001|Overall Study|Lack of Efficacy|1|||
162778810|NCT00706914|587900824|FG002|Overall Study|Lack of Efficacy|0|||
162778811|NCT00706914|587900822|FG000|Overall Study|Lost to Follow-up|1|||
162778812|NCT00706914|587900823|FG001|Overall Study|Lost to Follow-up|0|||
162778813|NCT00706914|587900824|FG002|Overall Study|Lost to Follow-up|0|||
162778814|NCT00706914|587900822|FG000|Overall Study|Adverse Event|2|||
162778815|NCT00706914|587900823|FG001|Overall Study|Adverse Event|2|||
162778816|NCT00706914|587900824|FG002|Overall Study|Adverse Event|0|||
162778817|NCT00706914|587900822|FG000|Overall Study|Protocol Violation|3|||
162778818|NCT00706914|587900823|FG001|Overall Study|Protocol Violation|1|||
162778819|NCT00706914|587900824|FG002|Overall Study|Protocol Violation|1|||
162778820|NCT01850823|587900825|FG000|Overall Study|Early Visit Window|0|||
162778821|NCT01850823|587900826|FG001|Overall Study|Early Visit Window|1|||
162778822|NCT01850823|587900827|FG002|Overall Study|Early Visit Window|4|||
162778823|NCT01850823|587900825|FG000|Overall Study|Enrolled in Error|0|||
162778824|NCT01850823|587900826|FG001|Overall Study|Enrolled in Error|1|||
162778825|NCT01850823|587900827|FG002|Overall Study|Enrolled in Error|2|||
162778826|NCT01850823|587900825|FG000|Overall Study|Lack of Efficacy|1|||
162778827|NCT01850823|587900826|FG001|Overall Study|Lack of Efficacy|0|||
162778828|NCT01850823|587900827|FG002|Overall Study|Lack of Efficacy|0|||
162778829|NCT01850823|587900825|FG000|Overall Study|Lost to Follow-up|0|||
162778830|NCT01850823|587900826|FG001|Overall Study|Lost to Follow-up|0|||
162778831|NCT01850823|587900827|FG002|Overall Study|Lost to Follow-up|1|||
162778832|NCT01850823|587900825|FG000|Overall Study|Restricted Medication|0|||
162778833|NCT01850823|587900826|FG001|Overall Study|Restricted Medication|0|||
162778834|NCT01850823|587900827|FG002|Overall Study|Restricted Medication|2|||
162778835|NCT01850823|587900825|FG000|Overall Study|Significant worstening of SAR|0|||
162778836|NCT01850823|587900826|FG001|Overall Study|Significant worstening of SAR|1|||
162778837|NCT01850823|587900827|FG002|Overall Study|Significant worstening of SAR|0|||
162778838|NCT01850823|587900825|FG000|Overall Study|Withdrawal by Subject|2|||
162778839|NCT01850823|587900826|FG001|Overall Study|Withdrawal by Subject|0|||
162778840|NCT01850823|587900827|FG002|Overall Study|Withdrawal by Subject|1|||
162778841|NCT01202409|587900829|FG000|Overall Study|Adverse Event|1|||
162778842|NCT01202409|587900829|FG000|Overall Study|Ineligible - KRAS mutants|7|||
162778843|NCT01732926|587900832|FG000|Overall Study|Study Terminated by Sponsor|168|||
162778844|NCT01732926|587900833|FG001|Overall Study|Study Terminated by Sponsor|80|||
162778845|NCT01732926|587900832|FG000|Overall Study|Withdrawal by Subject|46|||
162778846|NCT01732926|587900833|FG001|Overall Study|Withdrawal by Subject|8|||
162778847|NCT01732926|587900832|FG000|Overall Study|Physician Decision|24|||
162778848|NCT01732926|587900833|FG001|Overall Study|Physician Decision|11|||
162778849|NCT01732926|587900832|FG000|Overall Study|Other Reason|21|||
162778850|NCT01732926|587900833|FG001|Overall Study|Other Reason|4|||
162778851|NCT01732926|587900832|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
162778852|NCT01732926|587900833|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
162778853|NCT01732926|587900832|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
162778854|NCT01732926|587900833|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
162778855|NCT00053352|587900838|FG000|Overall Study|Lost to Follow-up|0|||
162778856|NCT00053352|587900839|FG001|Overall Study|Lost to Follow-up|1|||
162778857|NCT00053352|587900838|FG000|Overall Study|Physician Decision|11|||
162778858|NCT00053352|587900839|FG001|Overall Study|Physician Decision|1|||
162778859|NCT00053352|587900838|FG000|Overall Study|Withdrawal by Subject|1|||
162778860|NCT00053352|587900839|FG001|Overall Study|Withdrawal by Subject|0|||
162778861|NCT00053352|587900838|FG000|Overall Study|Ineligible|8|||
162778862|NCT00053352|587900839|FG001|Overall Study|Ineligible|8|||
162778863|NCT00053352|587900838|FG000|Overall Study|Disease at new site|1|||
162778864|NCT00053352|587900839|FG001|Overall Study|Disease at new site|0|||
162778865|NCT00931918|587900842|FG000|Overall Study|Adverse Event|4|||
162778866|NCT00931918|587900843|FG001|Overall Study|Adverse Event|6|||
162778867|NCT00931918|587900842|FG000|Overall Study|Progressive Disease|2|||
162778868|NCT00931918|587900843|FG001|Overall Study|Progressive Disease|1|||
162778869|NCT00931918|587900842|FG000|Overall Study|Symptomatic Deterioration|1|||
162778870|NCT00931918|587900843|FG001|Overall Study|Symptomatic Deterioration|0|||
162778871|NCT00931918|587900842|FG000|Overall Study|Withdrawal by Patient|3|||
162778872|NCT00931918|587900843|FG001|Overall Study|Withdrawal by Patient|4|||
162778873|NCT00931918|587900842|FG000|Overall Study|Other Reason not Specified|4|||
162778874|NCT00931918|587900843|FG001|Overall Study|Other Reason not Specified|4|||
162778875|NCT00931918|587900842|FG000|Overall Study|Did not receive study drug|3|||
162778876|NCT00931918|587900843|FG001|Overall Study|Did not receive study drug|2|||
162778877|NCT00809341|587900844|FG000|Overall Study|Physician Decision|0|||
162778878|NCT00809341|587900845|FG001|Overall Study|Physician Decision|1|||
162778879|NCT00025506|587900850|FG000|Overall Study|Ineligible: clerical error|1|||
162778880|NCT00025506|587900850|FG000|Overall Study|Ineligible: wrong cell type|5|||
162778881|NCT00025506|587900850|FG000|Overall Study|Ineligible: inadequate pathology|2|||
162778882|NCT00025506|587900850|FG000|Overall Study|Never Treated|2|||
162778883|NCT04081389|587900855|FG000|Overall Study|Withdrawal by Subject|0|||
162778884|NCT04081389|587900856|FG001|Overall Study|Withdrawal by Subject|0|||
162778885|NCT04081389|587900857|FG002|Overall Study|Withdrawal by Subject|1|||
162778886|NCT04081389|587900858|FG003|Overall Study|Withdrawal by Subject|0|||
162778887|NCT02212301|587900859|FG000|Period 1|Lost to Follow-up|0|||
162778888|NCT02212301|587900860|FG001|Period 1|Lost to Follow-up|1|||
162778889|NCT00866918|587900863|FG000|Overall Study|Death|1|||
162778890|NCT00866918|587900864|FG001|Overall Study|Death|5|||
162778891|NCT00866918|587900863|FG000|Overall Study|Lack of Efficacy|1|||
162778892|NCT00866918|587900864|FG001|Overall Study|Lack of Efficacy|1|||
162778893|NCT00866918|587900863|FG000|Overall Study|Physician Decision|10|||
162778894|NCT00866918|587900864|FG001|Overall Study|Physician Decision|2|||
162778895|NCT00866918|587900863|FG000|Overall Study|Ineligible|2|||
162778896|NCT00866918|587900864|FG001|Overall Study|Ineligible|4|||
162778897|NCT00866918|587900863|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
162778898|NCT00866918|587900864|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
162778899|NCT00866918|587900863|FG000|Overall Study|Secondary malignancy|1|||
162778900|NCT00866918|587900864|FG001|Overall Study|Secondary malignancy|0|||
162778901|NCT00527514|587900866|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
162778902|NCT00527514|587900866|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
162778903|NCT00527514|587900866|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
162778904|NCT00527514|587900866|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
162778905|NCT00527514|587900866|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
162778906|NCT00527514|587900866|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
162778907|NCT00527514|587900866|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
162778908|NCT00920699|587900871|FG000|Overall Study|Withdrawal by Subject|2|||
162778909|NCT00920699|587900872|FG001|Overall Study|Withdrawal by Subject|0|||
162778910|NCT00920699|587900873|FG002|Overall Study|Withdrawal by Subject|2|||
162778911|NCT00920699|587900871|FG000|Overall Study|no longer met eligibility|0|||
162778912|NCT00920699|587900872|FG001|Overall Study|no longer met eligibility|1|||
162778913|NCT00920699|587900873|FG002|Overall Study|no longer met eligibility|0|||
162778914|NCT00920699|587900871|FG000|Overall Study|Lost to Follow-up|0|||
162778915|NCT00920699|587900872|FG001|Overall Study|Lost to Follow-up|0|||
162778916|NCT00920699|587900873|FG002|Overall Study|Lost to Follow-up|2|||
162778917|NCT02287883|587900874|FG000|Overall Study|Death|8|||
162778918|NCT02287883|587900875|FG001|Overall Study|Death|7|||
162778919|NCT02287883|587900874|FG000|Overall Study|No longer eligible|222|||
162778920|NCT02287883|587900875|FG001|Overall Study|No longer eligible|182|||
162778921|NCT02287883|587900874|FG000|Overall Study|Non-response to survey|229|||
162778922|NCT02287883|587900875|FG001|Overall Study|Non-response to survey|237|||
162778923|NCT04414397|587900876|FG000|Control Period|Withdrawal by Subject|2|||
162778924|NCT04414397|587900877|FG001|Control Period|Withdrawal by Subject|2|||
162778925|NCT04414397|587900876|FG000|Control Period|Lost to Follow-up|0|||
162778926|NCT04414397|587900877|FG001|Control Period|Lost to Follow-up|4|||
162778927|NCT04414397|587900876|FG000|Control Period|Protocol deviation|0|||
162778928|NCT04414397|587900877|FG001|Control Period|Protocol deviation|1|||
162778929|NCT04414397|587900876|FG000|Post-Control Period|Withdrawal by Subject|3|||
162778930|NCT04414397|587900877|FG001|Post-Control Period|Withdrawal by Subject|6|||
162778931|NCT04414397|587900876|FG000|Post-Control Period|Lost to Follow-up|4|||
162778932|NCT04414397|587900877|FG001|Post-Control Period|Lost to Follow-up|9|||
162778933|NCT04414397|587900876|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
162778934|NCT04414397|587900877|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
162778935|NCT04414397|587900876|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
162778936|NCT04414397|587900877|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
162778937|NCT00664105|587902785|FG000|Overall Study|Death|3|||
162778938|NCT00664105|587902785|FG000|Overall Study|Withdrawal by Subject|5|||
162778939|NCT00664105|587902785|FG000|Overall Study|Adverse Event|9|||
162778940|NCT00664105|587902785|FG000|Overall Study|Disease progression|7|||
162778941|NCT00847132|587902789|FG000|Overall Study|Death|1|||
162778942|NCT00847132|587902790|FG001|Overall Study|Death|1|||
162778943|NCT00988533|587902792|FG000|Overall Study|Lost to Follow-up|3|||
162778944|NCT00913523|587902795|FG000|Overall Study|Withdrawal by Subject|3|||
162778945|NCT00913523|587902796|FG001|Overall Study|Withdrawal by Subject|2|||
162778946|NCT00913523|587902797|FG002|Overall Study|Withdrawal by Subject|2|||
162778947|NCT00913523|587902795|FG000|Overall Study|Lost to Follow-up|1|||
162778948|NCT00913523|587902796|FG001|Overall Study|Lost to Follow-up|1|||
162778949|NCT00913523|587902797|FG002|Overall Study|Lost to Follow-up|1|||
162778950|NCT00913523|587902795|FG000|Overall Study|Adverse Event|1|||
162778951|NCT00913523|587902796|FG001|Overall Study|Adverse Event|0|||
162778952|NCT00913523|587902797|FG002|Overall Study|Adverse Event|0|||
162778953|NCT00913523|587902795|FG000|Overall Study|Protocol Violation|5|||
162778954|NCT00913523|587902796|FG001|Overall Study|Protocol Violation|8|||
162778955|NCT00913523|587902797|FG002|Overall Study|Protocol Violation|8|||
162778956|NCT00913523|587902795|FG000|Overall Study|Pregnancy|1|||
162778957|NCT00913523|587902796|FG001|Overall Study|Pregnancy|3|||
162778958|NCT00913523|587902797|FG002|Overall Study|Pregnancy|0|||
162778959|NCT00913523|587902795|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
162778960|NCT00913523|587902796|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
162778961|NCT00913523|587902797|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
162778962|NCT01649297|587902799|FG000|Overall Study|Adverse Event|5|||
162778963|NCT01649297|587902800|FG001|Overall Study|Adverse Event|5|||
162778964|NCT01649297|587902801|FG002|Overall Study|Adverse Event|4|||
162778965|NCT01649297|587902802|FG003|Overall Study|Adverse Event|13|||
162778966|NCT01649297|587902803|FG004|Overall Study|Adverse Event|1|||
162778967|NCT01649297|587902799|FG000|Overall Study|Lack of Efficacy|0|||
162778968|NCT01649297|587902800|FG001|Overall Study|Lack of Efficacy|0|||
162778969|NCT01649297|587902801|FG002|Overall Study|Lack of Efficacy|0|||
162778970|NCT01649297|587902802|FG003|Overall Study|Lack of Efficacy|0|||
162778971|NCT01649297|587902803|FG004|Overall Study|Lack of Efficacy|1|||
162778972|NCT01649297|587902799|FG000|Overall Study|Non compliant with Protocol|1|||
162778973|NCT01649297|587902800|FG001|Overall Study|Non compliant with Protocol|0|||
162778974|NCT01649297|587902801|FG002|Overall Study|Non compliant with Protocol|3|||
162778975|NCT01649297|587902802|FG003|Overall Study|Non compliant with Protocol|2|||
162778976|NCT01649297|587902803|FG004|Overall Study|Non compliant with Protocol|1|||
162778977|NCT01649297|587902799|FG000|Overall Study|Lost to Follow-up|1|||
162778978|NCT01649297|587902800|FG001|Overall Study|Lost to Follow-up|1|||
162778979|NCT01649297|587902801|FG002|Overall Study|Lost to Follow-up|4|||
162778980|NCT01649297|587902802|FG003|Overall Study|Lost to Follow-up|3|||
162778981|NCT01649297|587902803|FG004|Overall Study|Lost to Follow-up|0|||
162778982|NCT01649297|587902799|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
162778983|NCT01649297|587902800|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
162778984|NCT01649297|587902801|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
162778985|NCT01649297|587902802|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
162778986|NCT01649297|587902803|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
162778987|NCT01649297|587902799|FG000|Overall Study|For other reason|4|||
162778988|NCT01649297|587902800|FG001|Overall Study|For other reason|1|||
162778989|NCT01649297|587902801|FG002|Overall Study|For other reason|2|||
162778990|NCT01649297|587902802|FG003|Overall Study|For other reason|0|||
162778991|NCT01649297|587902803|FG004|Overall Study|For other reason|0|||
162778992|NCT01685047|587902804|FG000|Overall Study|Withdrawal by Subject|20|||
162778993|NCT01685047|587902804|FG000|Overall Study|Death|26|||
162778994|NCT01685047|587902804|FG000|Overall Study|Lost to Follow-up|8|||
162778995|NCT01685047|587902804|FG000|Overall Study|Physician Decision|25|||
162778996|NCT01685047|587902804|FG000|Overall Study|Adverse Event|5|||
162778997|NCT01685047|587902804|FG000|Overall Study|patient withdrawn by sponsor|1|||
162778998|NCT02544113|587902805|FG000|Overall Study|Death|3|||
162778999|NCT02544113|587902806|FG001|Overall Study|Death|4|||
162779000|NCT02847637|587902810|FG000|Overall Study|Withdrawal by Subject|0|||
162779001|NCT02847637|587902811|FG001|Overall Study|Withdrawal by Subject|1|||
162779002|NCT02847637|587902812|FG002|Overall Study|Withdrawal by Subject|1|||
162779003|NCT02847637|587902813|FG003|Overall Study|Withdrawal by Subject|0|||
162779004|NCT02847637|587902810|FG000|Overall Study|Lost to Follow-up|1|||
162779005|NCT02847637|587902811|FG001|Overall Study|Lost to Follow-up|1|||
162779006|NCT02847637|587902812|FG002|Overall Study|Lost to Follow-up|0|||
162779007|NCT02847637|587902813|FG003|Overall Study|Lost to Follow-up|0|||
162779008|NCT01746108|587902814|FG000|Overall Study|Migrated /moved from study area|0|||
162779009|NCT01746108|587902815|FG001|Overall Study|Migrated /moved from study area|1|||
162779010|NCT01746108|587902816|FG002|Overall Study|Migrated /moved from study area|0|||
162779011|NCT01746108|587902814|FG000|Overall Study|Adverse event, non-fatal|0|||
162779012|NCT01746108|587902815|FG001|Overall Study|Adverse event, non-fatal|1|||
162779013|NCT01746108|587902816|FG002|Overall Study|Adverse event, non-fatal|0|||
162779014|NCT01746108|587902814|FG000|Overall Study|Withdrawal by Subject|0|||
162779015|NCT01746108|587902815|FG001|Overall Study|Withdrawal by Subject|1|||
162779016|NCT01746108|587902816|FG002|Overall Study|Withdrawal by Subject|0|||
162779017|NCT01746108|587902814|FG000|Overall Study|Lost to Follow-up|0|||
162779018|NCT01746108|587902815|FG001|Overall Study|Lost to Follow-up|1|||
162779019|NCT01746108|587902816|FG002|Overall Study|Lost to Follow-up|0|||
162779020|NCT03036150|587902817|FG000|Overall Study|Withdrawal by Subject|8|||
162779021|NCT03036150|587902818|FG001|Overall Study|Withdrawal by Subject|3|||
162779022|NCT03036150|587902817|FG000|Overall Study|Lost to Follow-up|2|||
162779023|NCT03036150|587902818|FG001|Overall Study|Lost to Follow-up|2|||
162779024|NCT02741713|587902825|FG000|Overall Study|Surgery type changed intra-operatively|2|||
162779025|NCT02741713|587902826|FG001|Overall Study|Surgery type changed intra-operatively|1|||
162779026|NCT00496626|587902827|FG000|Overall Study|Lost to Follow-up|0|||
162779027|NCT00496626|587902828|FG001|Overall Study|Lost to Follow-up|1|||
162779028|NCT00496626|587902827|FG000|Overall Study|Protocol Violation|1|||
162779029|NCT00496626|587902828|FG001|Overall Study|Protocol Violation|0|||
162779030|NCT00496626|587902827|FG000|Overall Study|Withdrawal by Subject|5|||
162779031|NCT00496626|587902828|FG001|Overall Study|Withdrawal by Subject|4|||
162779032|NCT00496626|587902827|FG000|Overall Study|Relocated|0|||
162779033|NCT00496626|587902828|FG001|Overall Study|Relocated|1|||
162779034|NCT00570921|587902829|FG000|Overall Study|Protocol Violation|1|||
162779035|NCT00570921|587902829|FG000|Overall Study|Physician Decision|1|||
162779036|NCT04191148|587902830|FG000|Overall Study|Withdrawal by Subject|1|||
162779037|NCT04191148|587902831|FG001|Overall Study|Withdrawal by Subject|0|||
162779038|NCT04191148|587902830|FG000|Overall Study|Adverse Event|1|||
162779039|NCT04191148|587902831|FG001|Overall Study|Adverse Event|0|||
162779040|NCT02647788|587902832|FG000|Overall Study|Lost to Follow-up|13|||
162779041|NCT02647788|587902833|FG001|Overall Study|Lost to Follow-up|11|||
162779042|NCT02647788|587902832|FG000|Overall Study|Did not want opiate|0|||
162779043|NCT02647788|587902833|FG001|Overall Study|Did not want opiate|1|||
162779044|NCT02647788|587902832|FG000|Overall Study|Withdrawal by Subject|1|||
162779045|NCT02647788|587902833|FG001|Overall Study|Withdrawal by Subject|0|||
162779046|NCT02647788|587902832|FG000|Overall Study|Felt itchy with assigned medication|1|||
162779047|NCT02647788|587902833|FG001|Overall Study|Felt itchy with assigned medication|0|||
162779048|NCT02647788|587902832|FG000|Overall Study|Felt nauseous with assigned medication|1|||
162779049|NCT02647788|587902833|FG001|Overall Study|Felt nauseous with assigned medication|1|||
162779050|NCT01274559|587902834|FG000|Overall Study|Adverse Event|57|||
162779051|NCT01274559|587902835|FG001|Overall Study|Adverse Event|13|||
162779052|NCT01274559|587902834|FG000|Overall Study|Death|1|||
162779053|NCT01274559|587902835|FG001|Overall Study|Death|1|||
162779054|NCT01274559|587902834|FG000|Overall Study|Lost to Follow-up|3|||
162779055|NCT01274559|587902835|FG001|Overall Study|Lost to Follow-up|3|||
162779056|NCT01274559|587902834|FG000|Overall Study|Non-compliance with Study Drug|2|||
162779057|NCT01274559|587902835|FG001|Overall Study|Non-compliance with Study Drug|4|||
162779058|NCT01274559|587902834|FG000|Overall Study|Physician Decision|2|||
162779059|NCT01274559|587902835|FG001|Overall Study|Physician Decision|1|||
162779060|NCT01274559|587902834|FG000|Overall Study|Protocol Violation|28|||
162779061|NCT01274559|587902835|FG001|Overall Study|Protocol Violation|23|||
162779062|NCT01274559|587902834|FG000|Overall Study|Study Terminated by Sponsor|79|||
162779063|NCT01274559|587902835|FG001|Overall Study|Study Terminated by Sponsor|87|||
162779064|NCT01274559|587902834|FG000|Overall Study|Withdrawal by Subject|25|||
162779065|NCT01274559|587902835|FG001|Overall Study|Withdrawal by Subject|13|||
162779066|NCT02482935|587902849|FG000|Period 1|Withdrawal by Subject|1|||
162779067|NCT02482935|587902850|FG001|Period 1|Withdrawal by Subject|0|||
162779068|NCT03503162|587902851|FG000|Overall Study|did not meet eligibility|1|||
162779069|NCT02835092|587902852|FG000|Overall Study|Withdrawal by Subject|3|||
162779070|NCT02835092|587902853|FG001|Overall Study|Withdrawal by Subject|6|||
162779071|NCT02835092|587902854|FG002|Overall Study|Withdrawal by Subject|3|||
162779072|NCT02835092|587902852|FG000|Overall Study|Lost to Follow-up|0|||
162779073|NCT02835092|587902853|FG001|Overall Study|Lost to Follow-up|2|||
162779074|NCT02835092|587902854|FG002|Overall Study|Lost to Follow-up|0|||
162779075|NCT00394589|587902855|FG000|Overall Study|Adverse Event|2|||
162779076|NCT00394589|587902856|FG001|Overall Study|Adverse Event|1|||
162779077|NCT00394589|587902857|FG002|Overall Study|Adverse Event|2|||
162779078|NCT00394589|587902855|FG000|Overall Study|Lack of Efficacy|2|||
162779079|NCT00394589|587902856|FG001|Overall Study|Lack of Efficacy|2|||
162779080|NCT00394589|587902857|FG002|Overall Study|Lack of Efficacy|3|||
162779081|NCT00394589|587902855|FG000|Overall Study|Protocol Violation|4|||
162779082|NCT00394589|587902856|FG001|Overall Study|Protocol Violation|0|||
162779083|NCT00394589|587902857|FG002|Overall Study|Protocol Violation|2|||
162779084|NCT01710800|587902865|FG000|Overall Study|Withdrawal by Subject|21|||
162779085|NCT01710800|587902865|FG000|Overall Study|Protocol Violation|1|||
162779086|NCT03891641|587902866|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
162779087|NCT03891641|587902867|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
162779088|NCT01585298|587902871|FG000|Overall Study|Study completion was not documented.|1|||
162779089|NCT01585298|587902871|FG000|Overall Study|Protocol deviation|1|||
162779090|NCT01585298|587902871|FG000|Overall Study|Administrative problems|4|||
162779091|NCT01585298|587902871|FG000|Overall Study|Lost to Follow-up|2|||
162779092|NCT01585298|587902871|FG000|Overall Study|Withdrawal by Subject|4|||
162779093|NCT01585298|587902871|FG000|Overall Study|Abnormal test procedure results|1|||
162779094|NCT01585298|587902871|FG000|Overall Study|Adverse Event|24|||
162779095|NCT01670188|587902872|FG000|Overall Study|Death|0|||
162779096|NCT01670188|587902873|FG001|Overall Study|Death|1|||
162779097|NCT02427958|587902876|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
162779098|NCT02427958|587902876|FG000|Overall Study|Lost to Follow-up|6|||
162779099|NCT02427958|587902876|FG000|Overall Study|Withdrawal by Subject|14|||
162779100|NCT02427958|587902876|FG000|Overall Study|Lack of Efficacy|1|||
162779101|NCT00578318|587902877|FG000|Overall Study|Lost to Follow-up|2|||
162779102|NCT00578318|587902878|FG001|Overall Study|Lost to Follow-up|0|||
162779103|NCT00578318|587902877|FG000|Overall Study|Physician Decision|1|||
162779104|NCT00578318|587902878|FG001|Overall Study|Physician Decision|0|||
162779105|NCT02025985|587902879|FG000|Overall Study|Consent withdrawn|0|||
162779106|NCT02025985|587902880|FG001|Overall Study|Consent withdrawn|0|||
162779107|NCT02025985|587902881|FG002|Overall Study|Consent withdrawn|1|||
162779108|NCT02025985|587902882|FG003|Overall Study|Consent withdrawn|0|||
162779109|NCT02025985|587902883|FG004|Overall Study|Consent withdrawn|0|||
162779110|NCT02025985|587902879|FG000|Overall Study|Termination of study by Sponsor|4|||
162779111|NCT02025985|587902880|FG001|Overall Study|Termination of study by Sponsor|3|||
162779112|NCT02025985|587902881|FG002|Overall Study|Termination of study by Sponsor|1|||
162779113|NCT02025985|587902882|FG003|Overall Study|Termination of study by Sponsor|1|||
162779114|NCT02025985|587902883|FG004|Overall Study|Termination of study by Sponsor|3|||
162779115|NCT02025985|587902879|FG000|Overall Study|Death|21|||
162779116|NCT02025985|587902880|FG001|Overall Study|Death|20|||
162779117|NCT02025985|587902881|FG002|Overall Study|Death|23|||
162779118|NCT02025985|587902882|FG003|Overall Study|Death|20|||
162779119|NCT02025985|587902883|FG004|Overall Study|Death|17|||
162779120|NCT00001941|587902885|FG000|Overall Study|not treated- rapidly progressing disease|0|||
162779121|NCT00001941|587902886|FG001|Overall Study|not treated- rapidly progressing disease|0|||
162779122|NCT00001941|587902887|FG002|Overall Study|not treated- rapidly progressing disease|0|||
162779123|NCT00001941|587902888|FG003|Overall Study|not treated- rapidly progressing disease|0|||
162779124|NCT00001941|587902889|FG004|Overall Study|not treated- rapidly progressing disease|1|||
162779125|NCT03175198|587902891|FG000|Overall Study|Adverse Event|480|||
162779126|NCT03175198|587902891|FG000|Overall Study|No actual visit|120|||
162779127|NCT03175198|587902891|FG000|Overall Study|Registration rule not followed|4|||
162779128|NCT03175198|587902891|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
162779129|NCT03175198|587902891|FG000|Overall Study|Other personal reason|509|||
162779130|NCT03175198|587902891|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
162779131|NCT03175198|587902891|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
162779132|NCT03175198|587902891|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
162779133|NCT03175198|587902891|FG000|Overall Study|To conduct invasive treatment of operation|53|||
162779134|NCT03175198|587902891|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
162779135|NCT00545571|587902892|FG000|Overall Study|Administrative Reasons|1|||
162779136|NCT00545571|587902892|FG000|Overall Study|Adverse Event|2|||
162779137|NCT00545571|587902892|FG000|Overall Study|Death|5|||
162779138|NCT00545571|587902892|FG000|Overall Study|Lack of Efficacy|1|||
162779139|NCT00545571|587902892|FG000|Overall Study|Protocol Violation|2|||
162779140|NCT00545571|587902892|FG000|Overall Study|Refused Treatment|1|||
162779141|NCT00545571|587902892|FG000|Overall Study|Screen Failure|16|||
162779142|NCT00545571|587902892|FG000|Overall Study|Transfusion|12|||
162779143|NCT00545571|587902892|FG000|Overall Study|Early Termination of Study|24|||
162779144|NCT00545571|587902892|FG000|Overall Study|Kidney Transplantation|3|||
162779145|NCT00874497|587902893|FG000|Overall Study|Lost to Follow-up|2|||
162779146|NCT00874497|587902894|FG001|Overall Study|Lost to Follow-up|4|||
162779147|NCT00874497|587902893|FG000|Overall Study|Adverse Event|9|||
162779148|NCT00874497|587902894|FG001|Overall Study|Adverse Event|4|||
162779149|NCT00874497|587902893|FG000|Overall Study|Sponsor Discontinued Trial|7|||
162779150|NCT00874497|587902894|FG001|Overall Study|Sponsor Discontinued Trial|3|||
162779151|NCT00874497|587902893|FG000|Overall Study|Met Withdrawal Criteria|4|||
162779152|NCT00874497|587902894|FG001|Overall Study|Met Withdrawal Criteria|2|||
162779153|NCT00874497|587902893|FG000|Overall Study|Physician Decision|1|||
162779154|NCT00874497|587902894|FG001|Overall Study|Physician Decision|1|||
162779155|NCT00874497|587902893|FG000|Overall Study|Withdrawal by Subject|5|||
162779156|NCT00874497|587902894|FG001|Overall Study|Withdrawal by Subject|4|||
162779157|NCT00591591|587902895|FG000|Overall Study|Withdrawal by Subject|1|||
162779158|NCT00591591|587902896|FG001|Overall Study|Withdrawal by Subject|37|||
162779159|NCT00591591|587902895|FG000|Overall Study|Lack of Efficacy|10|||
162779160|NCT00591591|587902896|FG001|Overall Study|Lack of Efficacy|2|||
162779161|NCT01013740|587902897|FG000|Overall Study|Lost to Follow-up|3|||
162779162|NCT01013740|587902898|FG001|Overall Study|Lost to Follow-up|5|||
162779163|NCT01013740|587902897|FG000|Overall Study|Physician Decision|2|||
162779164|NCT01013740|587902898|FG001|Overall Study|Physician Decision|0|||
162779165|NCT01013740|587902897|FG000|Overall Study|Withdrawal by Subject|2|||
162779166|NCT01013740|587902898|FG001|Overall Study|Withdrawal by Subject|10|||
162779167|NCT01013740|587902897|FG000|Overall Study|study close / terminated : done in error|2|||
162779168|NCT01013740|587902898|FG001|Overall Study|study close / terminated : done in error|1|||
162779169|NCT01013740|587902897|FG000|Overall Study|Missing|2|||
162779170|NCT01013740|587902898|FG001|Overall Study|Missing|1|||
162779171|NCT01013740|587902897|FG000|Overall Study|Ongoing: Study records not completed|0|||
162779172|NCT01013740|587902898|FG001|Overall Study|Ongoing: Study records not completed|2|||
162779173|NCT00607997|587902899|FG000|Overall Study|Lack of Efficacy|6|||
162779174|NCT00607997|587902900|FG001|Overall Study|Lack of Efficacy|20|||
162779175|NCT00607997|587902901|FG002|Overall Study|Lack of Efficacy|14|||
162779176|NCT00607997|587902902|FG003|Overall Study|Lack of Efficacy|10|||
162779177|NCT00607997|587902899|FG000|Overall Study|Death|8|||
162779178|NCT00607997|587902900|FG001|Overall Study|Death|5|||
162779179|NCT00607997|587902901|FG002|Overall Study|Death|2|||
162779180|NCT00607997|587902902|FG003|Overall Study|Death|5|||
162779181|NCT00607997|587902899|FG000|Overall Study|Adverse Event|3|||
162779182|NCT00607997|587902900|FG001|Overall Study|Adverse Event|1|||
162779183|NCT00607997|587902901|FG002|Overall Study|Adverse Event|2|||
162779184|NCT00607997|587902902|FG003|Overall Study|Adverse Event|0|||
162779185|NCT00607997|587902899|FG000|Overall Study|Physician Decision|4|||
162779186|NCT00607997|587902900|FG001|Overall Study|Physician Decision|1|||
162779187|NCT00607997|587902901|FG002|Overall Study|Physician Decision|0|||
162779188|NCT00607997|587902902|FG003|Overall Study|Physician Decision|0|||
162779189|NCT00607997|587902899|FG000|Overall Study|Relapse, recurrent illness|4|||
162779190|NCT00607997|587902900|FG001|Overall Study|Relapse, recurrent illness|0|||
162779191|NCT00607997|587902901|FG002|Overall Study|Relapse, recurrent illness|2|||
162779192|NCT00607997|587902902|FG003|Overall Study|Relapse, recurrent illness|0|||
162779193|NCT00607997|587902899|FG000|Overall Study|Other without explanation|2|||
162779194|NCT00607997|587902900|FG001|Overall Study|Other without explanation|0|||
162779195|NCT00607997|587902901|FG002|Overall Study|Other without explanation|4|||
162779196|NCT00607997|587902902|FG003|Overall Study|Other without explanation|1|||
162779197|NCT03811834|587902903|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
162779198|NCT01242371|587902904|FG000|Overall Study|Withdrawal by Subject|2|||
162779199|NCT01242371|587902905|FG001|Overall Study|Withdrawal by Subject|2|||
162779200|NCT01242371|587902904|FG000|Overall Study|Protocol Violation|0|||
162779201|NCT01242371|587902905|FG001|Overall Study|Protocol Violation|3|||
162779202|NCT00510146|587902906|FG000|Double-Blind Treatment|Adverse Event|30|||
162779203|NCT00510146|587902907|FG001|Double-Blind Treatment|Adverse Event|13|||
162779204|NCT00510146|587902906|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
162779205|NCT00510146|587902907|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
162779206|NCT00510146|587902906|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
162779207|NCT00510146|587902907|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
162779208|NCT00510146|587902906|FG000|Double-Blind Treatment|Physician Decision|6|||
162779209|NCT00510146|587902907|FG001|Double-Blind Treatment|Physician Decision|0|||
162779210|NCT00510146|587902906|FG000|Double-Blind Treatment|Protocol Violation|1|||
162779211|NCT00510146|587902907|FG001|Double-Blind Treatment|Protocol Violation|2|||
162779212|NCT00510146|587902906|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
162779213|NCT00510146|587902907|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
162779214|NCT00510146|587902906|FG000|Double-Blind Treatment|Clinical Relapse|0|||
162779215|NCT00510146|587902907|FG001|Double-Blind Treatment|Clinical Relapse|1|||
162779216|NCT00510146|587902906|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
162779217|NCT00510146|587902907|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
162779218|NCT00510146|587902906|FG000|Open-Label Treatment|Adverse Event|22|||
162779219|NCT00510146|587902907|FG001|Open-Label Treatment|Adverse Event|8|||
162779220|NCT00510146|587902906|FG000|Open-Label Treatment|Death|1|||
162779221|NCT00510146|587902907|FG001|Open-Label Treatment|Death|1|||
162779222|NCT00510146|587902906|FG000|Open-Label Treatment|Lack of Efficacy|4|||
162779223|NCT00510146|587902907|FG001|Open-Label Treatment|Lack of Efficacy|0|||
162779224|NCT00510146|587902906|FG000|Open-Label Treatment|Lost to Follow-up|10|||
162779225|NCT00510146|587902907|FG001|Open-Label Treatment|Lost to Follow-up|1|||
162779226|NCT00510146|587902906|FG000|Open-Label Treatment|Physician Decision|3|||
162779227|NCT00510146|587902907|FG001|Open-Label Treatment|Physician Decision|1|||
162779228|NCT00510146|587902906|FG000|Open-Label Treatment|Protocol Violation|4|||
162779229|NCT00510146|587902907|FG001|Open-Label Treatment|Protocol Violation|2|||
162779230|NCT00510146|587902906|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
162779231|NCT00510146|587902907|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
162779232|NCT00510146|587902906|FG000|Open-Label Treatment|Clinical Relapse|1|||
162779233|NCT00510146|587902907|FG001|Open-Label Treatment|Clinical Relapse|1|||
162779234|NCT00510146|587902906|FG000|Open-Label Treatment|Sponsor Decision|2|||
162779235|NCT00510146|587902907|FG001|Open-Label Treatment|Sponsor Decision|0|||
162779236|NCT06080438|587902910|FG000|Overall Study|Lost to Follow-up|2|||
162779237|NCT03589300|587902911|FG000|Overall Study|Adverse Event|2|||
162779238|NCT03589300|587902911|FG000|Overall Study|Death|4|||
162779239|NCT03589300|587902911|FG000|Overall Study|Lost to Follow-up|12|||
162779240|NCT03589300|587902911|FG000|Overall Study|Withdrawal by Subject|5|||
162779241|NCT00372255|587902912|FG000|Overall Study|Withdrawn for other reasons|2|||
162779242|NCT00372255|587902913|FG001|Overall Study|Withdrawn for other reasons|1|||
162779243|NCT00776984|587902914|FG000|Overall Study|Adverse Event|8|||
162779244|NCT00776984|587902915|FG001|Overall Study|Adverse Event|2|||
162779245|NCT00776984|587902914|FG000|Overall Study|Protocol Violation|4|||
162779246|NCT00776984|587902915|FG001|Overall Study|Protocol Violation|2|||
162779247|NCT00776984|587902914|FG000|Overall Study|Lost to Follow-up|2|||
162779248|NCT00776984|587902915|FG001|Overall Study|Lost to Follow-up|0|||
162779249|NCT00776984|587902914|FG000|Overall Study|Withdrawal by Subject|12|||
162779250|NCT00776984|587902915|FG001|Overall Study|Withdrawal by Subject|7|||
162779251|NCT00776984|587902914|FG000|Overall Study|Lack of Efficacy|0|||
162779252|NCT00776984|587902915|FG001|Overall Study|Lack of Efficacy|1|||
162779253|NCT00776984|587902914|FG000|Overall Study|Other|5|||
162779254|NCT00776984|587902915|FG001|Overall Study|Other|9|||
162779255|NCT00356759|587902921|FG000|Overall Study|Death|5|||
162779256|NCT00356759|587902922|FG001|Overall Study|Death|2|||
162779257|NCT00356759|587902921|FG000|Overall Study|Withdrawal by Subject|2|||
162779258|NCT00356759|587902922|FG001|Overall Study|Withdrawal by Subject|2|||
162779259|NCT00356759|587902921|FG000|Overall Study|Adverse Event|1|||
162779260|NCT00356759|587902922|FG001|Overall Study|Adverse Event|3|||
162779261|NCT00356759|587902921|FG000|Overall Study|Lost to Follow-up|1|||
162779262|NCT00356759|587902922|FG001|Overall Study|Lost to Follow-up|1|||
162779263|NCT00356759|587902921|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
162779264|NCT00356759|587902922|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
162779265|NCT03640754|587902923|FG000|Overall Study|Withdrawal by Subject|1|||
162779266|NCT03640754|587902924|FG001|Overall Study|Withdrawal by Subject|0|||
162779267|NCT03640754|587902923|FG000|Overall Study|Lost to Follow-up|0|||
162779268|NCT03640754|587902924|FG001|Overall Study|Lost to Follow-up|1|||
162779269|NCT01204775|587902925|FG000|Overall Study|Poor/non-compliance|0|||
162779270|NCT01204775|587902926|FG001|Overall Study|Poor/non-compliance|1|||
162779271|NCT01204775|587902925|FG000|Overall Study|Withdrawal by Subject|1|||
162779272|NCT01204775|587902926|FG001|Overall Study|Withdrawal by Subject|0|||
162779273|NCT00276016|587902927|FG000|Intervention 1|Withdrawal by Subject|0|||
162779274|NCT00276016|587902928|FG001|Intervention 1|Withdrawal by Subject|1|||
162779275|NCT00276016|587902929|FG002|Intervention 1|Withdrawal by Subject|0|||
162779276|NCT00276016|587902930|FG003|Intervention 1|Withdrawal by Subject|0|||
162779277|NCT00276016|587902931|FG004|Intervention 1|Withdrawal by Subject|0|||
162779278|NCT00276016|587902932|FG005|Intervention 1|Withdrawal by Subject|0|||
162779279|NCT04380688|587902933|FG000|Overall Study|Death|2|||
162779280|NCT04380688|587902934|FG001|Overall Study|Death|2|||
162779281|NCT04380688|587902933|FG000|Overall Study|Lost to Follow-up|2|||
162779282|NCT04380688|587902934|FG001|Overall Study|Lost to Follow-up|4|||
162779283|NCT04380688|587902933|FG000|Overall Study|Withdrawal by Subject|3|||
162779284|NCT04380688|587902934|FG001|Overall Study|Withdrawal by Subject|3|||
162779285|NCT00919061|587902939|FG000|Overall Study|Adverse Event|1|||
162779286|NCT00919061|587902939|FG000|Overall Study|Withdrawal by Subject|1|||
162779287|NCT05294328|587902940|FG000|Overall Study|Adverse Event|1|||
162779288|NCT05294328|587902941|FG001|Overall Study|Adverse Event|0|||
162779289|NCT05294328|587902942|FG002|Overall Study|Adverse Event|0|||
162779290|NCT05294328|587902940|FG000|Overall Study|Physician Decision|1|||
162779291|NCT05294328|587902941|FG001|Overall Study|Physician Decision|1|||
162779292|NCT05294328|587902942|FG002|Overall Study|Physician Decision|0|||
162779293|NCT05294328|587902940|FG000|Overall Study|Withdrawal by Subject|0|||
162779294|NCT05294328|587902941|FG001|Overall Study|Withdrawal by Subject|2|||
162779295|NCT05294328|587902942|FG002|Overall Study|Withdrawal by Subject|1|||
162779296|NCT05294328|587902940|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
162779297|NCT05294328|587902941|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
162779298|NCT05294328|587902942|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
162779299|NCT02056873|587902943|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
162779300|NCT01181609|587905112|FG000|Overall Study|Adverse Event|1|||
162779301|NCT01181609|587905112|FG000|Overall Study|Withdrawal by Subject|1|||
162779302|NCT01181609|587905112|FG000|Overall Study|Lost to Follow-up|1|||
162779303|NCT01181609|587905112|FG000|Overall Study|Death|50|||
162779304|NCT03991988|587905116|FG000|Overall Study|Withdrawal by Subject|2|||
162779305|NCT03991988|587905117|FG001|Overall Study|Withdrawal by Subject|2|||
162779306|NCT01751165|587905121|FG000|Overall Study|Adverse event, serious fatal|1|||
162779307|NCT01751165|587905122|FG001|Overall Study|Adverse event, serious fatal|0|||
162779308|NCT01751165|587905123|FG002|Overall Study|Adverse event, serious fatal|1|||
162779309|NCT01751165|587905121|FG000|Overall Study|Withdrawal by Subject|0|||
162779310|NCT01751165|587905122|FG001|Overall Study|Withdrawal by Subject|0|||
162779311|NCT01751165|587905123|FG002|Overall Study|Withdrawal by Subject|1|||
162779312|NCT01751165|587905121|FG000|Overall Study|Serious adverse event|0|||
162779313|NCT01751165|587905122|FG001|Overall Study|Serious adverse event|2|||
162779314|NCT01751165|587905123|FG002|Overall Study|Serious adverse event|0|||
162779315|NCT01751165|587905121|FG000|Overall Study|Lost to Follow-up|1|||
162779316|NCT01751165|587905122|FG001|Overall Study|Lost to Follow-up|1|||
162779317|NCT01751165|587905123|FG002|Overall Study|Lost to Follow-up|1|||
162779318|NCT01036165|587905124|FG000|Overall Study|Adverse Event|6|||
162779319|NCT01036165|587905124|FG000|Overall Study|Lost to Follow-up|2|||
162779320|NCT01036165|587905124|FG000|Overall Study|Withdrawal by Subject|3|||
162779321|NCT01036165|587905124|FG000|Overall Study|Device Related Issues|3|||
162779322|NCT01036165|587905124|FG000|Overall Study|Problems finding proper area to inject|1|||
162779323|NCT01475461|587905125|FG000|Run-in Period|Not meet eligibility criteria|16|||
162779324|NCT01475461|587905126|FG001|Run-in Period|Not meet eligibility criteria|0|||
162779325|NCT01475461|587905127|FG002|Run-in Period|Not meet eligibility criteria|0|||
162779326|NCT01475461|587905128|FG003|Run-in Period|Not meet eligibility criteria|0|||
162779327|NCT01475461|587905129|FG004|Run-in Period|Not meet eligibility criteria|0|||
162779328|NCT01475461|587905130|FG005|Run-in Period|Not meet eligibility criteria|0|||
162779329|NCT01475461|587905131|FG006|Run-in Period|Not meet eligibility criteria|0|||
162779330|NCT01475461|587905125|FG000|Run-in Period|Lost to Follow-up|7|||
162779331|NCT01475461|587905126|FG001|Run-in Period|Lost to Follow-up|0|||
162779332|NCT01475461|587905127|FG002|Run-in Period|Lost to Follow-up|0|||
162779333|NCT01475461|587905128|FG003|Run-in Period|Lost to Follow-up|0|||
162779334|NCT01475461|587905129|FG004|Run-in Period|Lost to Follow-up|0|||
162779335|NCT01475461|587905130|FG005|Run-in Period|Lost to Follow-up|0|||
162779336|NCT01475461|587905131|FG006|Run-in Period|Lost to Follow-up|0|||
162779337|NCT01475461|587905125|FG000|Run-in Period|Withdrawal by Subject|11|||
162779338|NCT01475461|587905126|FG001|Run-in Period|Withdrawal by Subject|0|||
162779339|NCT01475461|587905127|FG002|Run-in Period|Withdrawal by Subject|0|||
162779340|NCT01475461|587905128|FG003|Run-in Period|Withdrawal by Subject|0|||
162779341|NCT01475461|587905129|FG004|Run-in Period|Withdrawal by Subject|0|||
162779342|NCT01475461|587905130|FG005|Run-in Period|Withdrawal by Subject|0|||
162779343|NCT01475461|587905131|FG006|Run-in Period|Withdrawal by Subject|0|||
162779344|NCT01475461|587905125|FG000|Run-in Period|Other|3|||
162779345|NCT01475461|587905126|FG001|Run-in Period|Other|0|||
162779346|NCT01475461|587905127|FG002|Run-in Period|Other|0|||
162779347|NCT01475461|587905128|FG003|Run-in Period|Other|0|||
162779348|NCT01475461|587905129|FG004|Run-in Period|Other|0|||
162779349|NCT01475461|587905130|FG005|Run-in Period|Other|0|||
162779350|NCT01475461|587905131|FG006|Run-in Period|Other|0|||
162779351|NCT01475461|587905125|FG000|Run-in Period|Protocol Violation|4|||
162779352|NCT01475461|587905126|FG001|Run-in Period|Protocol Violation|0|||
162779353|NCT01475461|587905127|FG002|Run-in Period|Protocol Violation|0|||
162779354|NCT01475461|587905128|FG003|Run-in Period|Protocol Violation|0|||
162779355|NCT01475461|587905129|FG004|Run-in Period|Protocol Violation|0|||
162779356|NCT01475461|587905130|FG005|Run-in Period|Protocol Violation|0|||
162779357|NCT01475461|587905131|FG006|Run-in Period|Protocol Violation|0|||
162779358|NCT01475461|587905125|FG000|Treatment Period|Death|0|||
162779359|NCT01475461|587905126|FG001|Treatment Period|Death|0|||
162779360|NCT01475461|587905127|FG002|Treatment Period|Death|0|||
162779361|NCT01475461|587905128|FG003|Treatment Period|Death|1|||
162779362|NCT01475461|587905129|FG004|Treatment Period|Death|0|||
162779363|NCT01475461|587905130|FG005|Treatment Period|Death|0|||
162779364|NCT01475461|587905131|FG006|Treatment Period|Death|0|||
162779365|NCT01475461|587905125|FG000|Treatment Period|Lost to Follow-up|0|||
162779366|NCT01475461|587905126|FG001|Treatment Period|Lost to Follow-up|3|||
162779367|NCT01475461|587905127|FG002|Treatment Period|Lost to Follow-up|2|||
162779368|NCT01475461|587905128|FG003|Treatment Period|Lost to Follow-up|3|||
162779369|NCT01475461|587905129|FG004|Treatment Period|Lost to Follow-up|1|||
162779370|NCT01475461|587905130|FG005|Treatment Period|Lost to Follow-up|2|||
162779371|NCT01475461|587905131|FG006|Treatment Period|Lost to Follow-up|1|||
162779372|NCT01475461|587905125|FG000|Treatment Period|Withdrawal by Subject|0|||
162779373|NCT01475461|587905126|FG001|Treatment Period|Withdrawal by Subject|2|||
162779374|NCT01475461|587905127|FG002|Treatment Period|Withdrawal by Subject|2|||
162779375|NCT01475461|587905128|FG003|Treatment Period|Withdrawal by Subject|0|||
162779376|NCT01475461|587905129|FG004|Treatment Period|Withdrawal by Subject|2|||
162779377|NCT01475461|587905130|FG005|Treatment Period|Withdrawal by Subject|2|||
162779378|NCT01475461|587905131|FG006|Treatment Period|Withdrawal by Subject|0|||
162779379|NCT01475461|587905125|FG000|Treatment Period|Other|0|||
162779380|NCT01475461|587905126|FG001|Treatment Period|Other|1|||
162779381|NCT01475461|587905127|FG002|Treatment Period|Other|0|||
162779382|NCT01475461|587905128|FG003|Treatment Period|Other|0|||
162779383|NCT01475461|587905129|FG004|Treatment Period|Other|0|||
162779384|NCT01475461|587905130|FG005|Treatment Period|Other|0|||
162779385|NCT01475461|587905131|FG006|Treatment Period|Other|0|||
162779386|NCT01475461|587905125|FG000|Treatment Period|Protocol Violation|0|||
162779387|NCT01475461|587905126|FG001|Treatment Period|Protocol Violation|1|||
162779388|NCT01475461|587905127|FG002|Treatment Period|Protocol Violation|0|||
162779389|NCT01475461|587905128|FG003|Treatment Period|Protocol Violation|0|||
162779390|NCT01475461|587905129|FG004|Treatment Period|Protocol Violation|0|||
162779391|NCT01475461|587905130|FG005|Treatment Period|Protocol Violation|0|||
162779392|NCT01475461|587905131|FG006|Treatment Period|Protocol Violation|1|||
162779393|NCT01475461|587905125|FG000|Treatment Period|Lack of Efficacy|0|||
162779394|NCT01475461|587905126|FG001|Treatment Period|Lack of Efficacy|2|||
162779395|NCT01475461|587905127|FG002|Treatment Period|Lack of Efficacy|0|||
162779396|NCT01475461|587905128|FG003|Treatment Period|Lack of Efficacy|2|||
162779397|NCT01475461|587905129|FG004|Treatment Period|Lack of Efficacy|1|||
162779398|NCT01475461|587905130|FG005|Treatment Period|Lack of Efficacy|1|||
162779399|NCT01475461|587905131|FG006|Treatment Period|Lack of Efficacy|0|||
162779400|NCT01475461|587905125|FG000|Treatment Period|Medication Error|0|||
162779401|NCT01475461|587905126|FG001|Treatment Period|Medication Error|0|||
162779402|NCT01475461|587905127|FG002|Treatment Period|Medication Error|0|||
162779403|NCT01475461|587905128|FG003|Treatment Period|Medication Error|1|||
162779404|NCT01475461|587905129|FG004|Treatment Period|Medication Error|0|||
162779405|NCT01475461|587905130|FG005|Treatment Period|Medication Error|0|||
162779406|NCT01475461|587905131|FG006|Treatment Period|Medication Error|0|||
162779407|NCT01475461|587905125|FG000|Treatment Period|Adverse Event|0|||
162779408|NCT01475461|587905126|FG001|Treatment Period|Adverse Event|0|||
162779409|NCT01475461|587905127|FG002|Treatment Period|Adverse Event|0|||
162779410|NCT01475461|587905128|FG003|Treatment Period|Adverse Event|1|||
162779411|NCT01475461|587905129|FG004|Treatment Period|Adverse Event|0|||
162779412|NCT01475461|587905130|FG005|Treatment Period|Adverse Event|0|||
162779413|NCT01475461|587905131|FG006|Treatment Period|Adverse Event|0|||
162779414|NCT04051242|587905132|FG000|Overall Study|Withdrawal by Subject|1|||
162779415|NCT04051242|587905132|FG000|Overall Study|Physician Decision|1|||
162779416|NCT02262364|587905135|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
162779417|NCT01049984|587905136|FG000|Overall Study|Withdrawal by Subject|1|||
162779418|NCT01049984|587905137|FG001|Overall Study|Withdrawal by Subject|5|||
162779419|NCT01049984|587905136|FG000|Overall Study|Protocol Violation|3|||
162779420|NCT01049984|587905137|FG001|Overall Study|Protocol Violation|4|||
162779421|NCT01049984|587905136|FG000|Overall Study|Lost to Follow-up|2|||
162779422|NCT01049984|587905137|FG001|Overall Study|Lost to Follow-up|1|||
162779423|NCT01049984|587905136|FG000|Overall Study|Adverse Event|13|||
162779424|NCT01049984|587905137|FG001|Overall Study|Adverse Event|7|||
162779425|NCT01049984|587905136|FG000|Overall Study|Treatment failure|0|||
162779426|NCT01049984|587905137|FG001|Overall Study|Treatment failure|2|||
162779427|NCT00553605|587905138|FG000|Overall Study|Did not meet entrance criteria|1|||
162779428|NCT00553605|587905139|FG001|Overall Study|Did not meet entrance criteria|3|||
162779429|NCT00553605|587905138|FG000|Overall Study|Did not receive full dose|1|||
162779430|NCT00553605|587905139|FG001|Overall Study|Did not receive full dose|0|||
162779431|NCT00553605|587905138|FG000|Overall Study|Randomized but not treated|2|||
162779432|NCT00553605|587905139|FG001|Overall Study|Randomized but not treated|0|||
162779433|NCT01040403|587905143|FG000|Overall Study|Adverse Event|10|||
162779434|NCT01040403|587905143|FG000|Overall Study|Protocol Violation|2|||
162779435|NCT01040403|587905143|FG000|Overall Study|Lost to Follow-up|1|||
162779436|NCT01040403|587905143|FG000|Overall Study|Not treated|1|||
162779437|NCT01040403|587905143|FG000|Overall Study|Other reason not defined above|6|||
162779438|NCT01085812|587905145|FG000|Open-Label Period|Adverse Event|0|||
162779439|NCT01085812|587905146|FG001|Open-Label Period|Adverse Event|80|||
162779440|NCT01085812|587905145|FG000|Open-Label Period|Lack of Efficacy|0|||
162779441|NCT01085812|587905146|FG001|Open-Label Period|Lack of Efficacy|26|||
162779442|NCT01085812|587905145|FG000|Open-Label Period|Protocol Violation|0|||
162779443|NCT01085812|587905146|FG001|Open-Label Period|Protocol Violation|39|||
162779444|NCT01085812|587905145|FG000|Open-Label Period|Withdrawal by Subject|0|||
162779445|NCT01085812|587905146|FG001|Open-Label Period|Withdrawal by Subject|53|||
162779446|NCT01085812|587905145|FG000|Open-Label Period|Lost to Follow-up|0|||
162779447|NCT01085812|587905146|FG001|Open-Label Period|Lost to Follow-up|42|||
162779448|NCT01085812|587905145|FG000|Double-Blind Period|Adverse Event|3|||
162779449|NCT01085812|587905146|FG001|Double-Blind Period|Adverse Event|8|||
162779450|NCT01085812|587905145|FG000|Double-Blind Period|Protocol Violation|2|||
162779451|NCT01085812|587905146|FG001|Double-Blind Period|Protocol Violation|7|||
162779452|NCT01085812|587905145|FG000|Double-Blind Period|Withdrawal by Subject|11|||
162779453|NCT01085812|587905146|FG001|Double-Blind Period|Withdrawal by Subject|24|||
162779454|NCT01085812|587905145|FG000|Double-Blind Period|Lost to Follow-up|5|||
162779455|NCT01085812|587905146|FG001|Double-Blind Period|Lost to Follow-up|17|||
162779456|NCT01085812|587905145|FG000|Double-Blind Period|Other Reasons|0|||
162779457|NCT01085812|587905146|FG001|Double-Blind Period|Other Reasons|2|||
162779458|NCT01085812|587905145|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
162779459|NCT01085812|587905146|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
162779460|NCT01085812|587905145|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
162779461|NCT01085812|587905146|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
162779462|NCT01085812|587905145|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
162779463|NCT01085812|587905146|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
162779464|NCT01085812|587905145|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
162779465|NCT01085812|587905146|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
162779466|NCT01085812|587905145|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
162779467|NCT01085812|587905146|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
162779468|NCT04582669|587905150|FG000|Overall Study|Subject missed appointment(s).|1|||
162779469|NCT04582669|587905151|FG001|Overall Study|Subject missed appointment(s).|0|||
162779470|NCT04582669|587905152|FG002|Overall Study|Subject missed appointment(s).|1|||
162779471|NCT04582669|587905153|FG003|Overall Study|Subject missed appointment(s).|2|||
162779472|NCT04582669|587905150|FG000|Overall Study|Protocol Violation|0|||
162779473|NCT04582669|587905151|FG001|Overall Study|Protocol Violation|1|||
162779474|NCT04582669|587905152|FG002|Overall Study|Protocol Violation|1|||
162779475|NCT04582669|587905153|FG003|Overall Study|Protocol Violation|0|||
162779476|NCT01874665|587905154|FG000|Overall Study|Adverse Event|6|||
162779477|NCT01874665|587905155|FG001|Overall Study|Adverse Event|2|||
162779478|NCT01874665|587905154|FG000|Overall Study|Withdrawal by Subject|4|||
162779479|NCT01874665|587905155|FG001|Overall Study|Withdrawal by Subject|1|||
162779480|NCT01874665|587905154|FG000|Overall Study|Physician Decision|3|||
162779481|NCT01874665|587905155|FG001|Overall Study|Physician Decision|0|||
162779482|NCT01874665|587905154|FG000|Overall Study|Clinical Progressive Disease|4|||
162779483|NCT01874665|587905155|FG001|Overall Study|Clinical Progressive Disease|3|||
162779484|NCT01874665|587905154|FG000|Overall Study|Study Terminated by Sponsor|0|||
162779485|NCT01874665|587905155|FG001|Overall Study|Study Terminated by Sponsor|2|||
162779486|NCT01874665|587905154|FG000|Overall Study|Documented Progressive Disease|11|||
162779487|NCT01874665|587905155|FG001|Overall Study|Documented Progressive Disease|7|||
162779488|NCT01874665|587905154|FG000|Overall Study|Other|2|||
162779489|NCT01874665|587905155|FG001|Overall Study|Other|0|||
162779490|NCT02447432|587905156|FG000|Epoch 001|Adverse Event|1|||
162779491|NCT02447432|587905157|FG001|Epoch 001|Adverse Event|1|||
162779492|NCT02447432|587905156|FG000|Epoch 001|Withdrawal by Subject|0|||
162779493|NCT02447432|587905157|FG001|Epoch 001|Withdrawal by Subject|4|||
162779494|NCT02447432|587905156|FG000|Epoch 001|Migrated/moved from study area|3|||
162779495|NCT02447432|587905157|FG001|Epoch 001|Migrated/moved from study area|5|||
162779496|NCT02447432|587905156|FG000|Epoch 001|Lost to Follow-up|1|||
162779497|NCT02447432|587905157|FG001|Epoch 001|Lost to Follow-up|3|||
162779498|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
162779499|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
162779500|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
162779501|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
162779502|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
162779503|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
162779504|NCT03201900|587905160|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
162779505|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
162779506|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
162779507|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
162779508|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
162779509|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
162779510|NCT03201900|587905160|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
162779511|NCT01233999|587905161|FG000|Overall Study|Withdrawal by Subject|1|||
162779512|NCT01233999|587905161|FG000|Overall Study|Lost to Follow-up|1|||
162779513|NCT00550446|587905162|FG000|Up To Week 12|Adverse Event|2|||
162779514|NCT00550446|587905163|FG001|Up To Week 12|Adverse Event|2|||
162779515|NCT00550446|587905164|FG002|Up To Week 12|Adverse Event|0|||
162779516|NCT00550446|587905165|FG003|Up To Week 12|Adverse Event|0|||
162779517|NCT00550446|587905166|FG004|Up To Week 12|Adverse Event|2|||
162779518|NCT00550446|587905167|FG005|Up To Week 12|Adverse Event|2|||
162779519|NCT00550446|587905168|FG006|Up To Week 12|Adverse Event|1|||
162779520|NCT00550446|587905169|FG007|Up To Week 12|Adverse Event|0|||
162779521|NCT00550446|587905170|FG008|Up To Week 12|Adverse Event|0|||
162779522|NCT00550446|587905171|FG009|Up To Week 12|Adverse Event|0|||
162779523|NCT00550446|587905172|FG010|Up To Week 12|Adverse Event|0|||
162779524|NCT00550446|587905162|FG000|Up To Week 12|Lack of Efficacy|3|||
162779525|NCT00550446|587905163|FG001|Up To Week 12|Lack of Efficacy|1|||
162779526|NCT00550446|587905164|FG002|Up To Week 12|Lack of Efficacy|0|||
162779527|NCT00550446|587905165|FG003|Up To Week 12|Lack of Efficacy|1|||
162779528|NCT00550446|587905166|FG004|Up To Week 12|Lack of Efficacy|0|||
162779529|NCT00550446|587905167|FG005|Up To Week 12|Lack of Efficacy|3|||
162779530|NCT00550446|587905168|FG006|Up To Week 12|Lack of Efficacy|3|||
162779531|NCT00550446|587905169|FG007|Up To Week 12|Lack of Efficacy|0|||
162779532|NCT00550446|587905170|FG008|Up To Week 12|Lack of Efficacy|0|||
162779533|NCT00550446|587905171|FG009|Up To Week 12|Lack of Efficacy|0|||
162779534|NCT00550446|587905172|FG010|Up To Week 12|Lack of Efficacy|0|||
162779535|NCT00550446|587905162|FG000|Up To Week 12|Lost to Follow-up|0|||
162779536|NCT00550446|587905163|FG001|Up To Week 12|Lost to Follow-up|1|||
162779537|NCT00550446|587905164|FG002|Up To Week 12|Lost to Follow-up|0|||
162779538|NCT00550446|587905165|FG003|Up To Week 12|Lost to Follow-up|0|||
162779539|NCT00550446|587905166|FG004|Up To Week 12|Lost to Follow-up|1|||
162779540|NCT00550446|587905167|FG005|Up To Week 12|Lost to Follow-up|1|||
162779541|NCT00550446|587905168|FG006|Up To Week 12|Lost to Follow-up|2|||
162779542|NCT00550446|587905169|FG007|Up To Week 12|Lost to Follow-up|0|||
162779543|NCT00550446|587905170|FG008|Up To Week 12|Lost to Follow-up|0|||
162779544|NCT00550446|587905171|FG009|Up To Week 12|Lost to Follow-up|0|||
162779545|NCT00550446|587905172|FG010|Up To Week 12|Lost to Follow-up|0|||
162779546|NCT00550446|587905162|FG000|Up To Week 12|Withdrawal by Subject|2|||
162779547|NCT00550446|587905163|FG001|Up To Week 12|Withdrawal by Subject|0|||
162779548|NCT00550446|587905164|FG002|Up To Week 12|Withdrawal by Subject|3|||
162779549|NCT00550446|587905165|FG003|Up To Week 12|Withdrawal by Subject|2|||
162779550|NCT00550446|587905166|FG004|Up To Week 12|Withdrawal by Subject|0|||
162779551|NCT00550446|587905167|FG005|Up To Week 12|Withdrawal by Subject|1|||
162779552|NCT00550446|587905168|FG006|Up To Week 12|Withdrawal by Subject|3|||
162779553|NCT00550446|587905169|FG007|Up To Week 12|Withdrawal by Subject|0|||
162779554|NCT00550446|587905170|FG008|Up To Week 12|Withdrawal by Subject|0|||
162779555|NCT00550446|587905171|FG009|Up To Week 12|Withdrawal by Subject|0|||
162779556|NCT00550446|587905172|FG010|Up To Week 12|Withdrawal by Subject|0|||
162779557|NCT00550446|587905162|FG000|Up To Week 12|Other|3|||
162779558|NCT00550446|587905163|FG001|Up To Week 12|Other|0|||
162779559|NCT00550446|587905164|FG002|Up To Week 12|Other|0|||
162779560|NCT00550446|587905165|FG003|Up To Week 12|Other|0|||
162779561|NCT00550446|587905166|FG004|Up To Week 12|Other|0|||
162779562|NCT00550446|587905167|FG005|Up To Week 12|Other|1|||
162779563|NCT00550446|587905168|FG006|Up To Week 12|Other|4|||
162779564|NCT00550446|587905169|FG007|Up To Week 12|Other|0|||
162779565|NCT00550446|587905170|FG008|Up To Week 12|Other|0|||
162779566|NCT00550446|587905171|FG009|Up To Week 12|Other|0|||
162779567|NCT00550446|587905172|FG010|Up To Week 12|Other|0|||
162779568|NCT00550446|587905162|FG000|Up To Week 12|Randomized not treated|0|||
162779569|NCT00550446|587905163|FG001|Up To Week 12|Randomized not treated|1|||
162779570|NCT00550446|587905164|FG002|Up To Week 12|Randomized not treated|1|||
162779571|NCT00550446|587905165|FG003|Up To Week 12|Randomized not treated|0|||
162779572|NCT00550446|587905166|FG004|Up To Week 12|Randomized not treated|0|||
162779573|NCT00550446|587905167|FG005|Up To Week 12|Randomized not treated|0|||
162779574|NCT00550446|587905168|FG006|Up To Week 12|Randomized not treated|0|||
162779575|NCT00550446|587905169|FG007|Up To Week 12|Randomized not treated|0|||
162779576|NCT00550446|587905170|FG008|Up To Week 12|Randomized not treated|0|||
162779577|NCT00550446|587905171|FG009|Up To Week 12|Randomized not treated|0|||
162779578|NCT00550446|587905172|FG010|Up To Week 12|Randomized not treated|0|||
162779579|NCT00550446|587905162|FG000|Post Week 12|Adverse Event|2|||
162779580|NCT00550446|587905163|FG001|Post Week 12|Adverse Event|1|||
162779581|NCT00550446|587905164|FG002|Post Week 12|Adverse Event|1|||
162779582|NCT00550446|587905165|FG003|Post Week 12|Adverse Event|1|||
162779583|NCT00550446|587905166|FG004|Post Week 12|Adverse Event|1|||
162779584|NCT00550446|587905167|FG005|Post Week 12|Adverse Event|1|||
162779585|NCT00550446|587905168|FG006|Post Week 12|Adverse Event|0|||
162779586|NCT00550446|587905169|FG007|Post Week 12|Adverse Event|0|||
162779587|NCT00550446|587905170|FG008|Post Week 12|Adverse Event|0|||
162779588|NCT00550446|587905171|FG009|Post Week 12|Adverse Event|4|||
162779589|NCT00550446|587905172|FG010|Post Week 12|Adverse Event|0|||
162779590|NCT00550446|587905162|FG000|Post Week 12|Lack of Efficacy|0|||
162779591|NCT00550446|587905163|FG001|Post Week 12|Lack of Efficacy|0|||
162779592|NCT00550446|587905164|FG002|Post Week 12|Lack of Efficacy|1|||
162779593|NCT00550446|587905165|FG003|Post Week 12|Lack of Efficacy|0|||
162779594|NCT00550446|587905166|FG004|Post Week 12|Lack of Efficacy|0|||
162779595|NCT00550446|587905167|FG005|Post Week 12|Lack of Efficacy|0|||
162779596|NCT00550446|587905168|FG006|Post Week 12|Lack of Efficacy|0|||
162779597|NCT00550446|587905169|FG007|Post Week 12|Lack of Efficacy|1|||
162779598|NCT00550446|587905170|FG008|Post Week 12|Lack of Efficacy|1|||
162779599|NCT00550446|587905171|FG009|Post Week 12|Lack of Efficacy|2|||
162779600|NCT00550446|587905172|FG010|Post Week 12|Lack of Efficacy|1|||
162779601|NCT00550446|587905162|FG000|Post Week 12|Lost to Follow-up|0|||
162779602|NCT00550446|587905163|FG001|Post Week 12|Lost to Follow-up|0|||
162779603|NCT00550446|587905164|FG002|Post Week 12|Lost to Follow-up|1|||
162779604|NCT00550446|587905165|FG003|Post Week 12|Lost to Follow-up|1|||
162779605|NCT00550446|587905166|FG004|Post Week 12|Lost to Follow-up|0|||
162779606|NCT00550446|587905167|FG005|Post Week 12|Lost to Follow-up|0|||
162779607|NCT00550446|587905168|FG006|Post Week 12|Lost to Follow-up|1|||
162779608|NCT00550446|587905169|FG007|Post Week 12|Lost to Follow-up|0|||
162779609|NCT00550446|587905170|FG008|Post Week 12|Lost to Follow-up|0|||
162779610|NCT00550446|587905171|FG009|Post Week 12|Lost to Follow-up|0|||
162779611|NCT00550446|587905172|FG010|Post Week 12|Lost to Follow-up|0|||
162779612|NCT00550446|587905162|FG000|Post Week 12|Withdrawal by Subject|0|||
162779613|NCT00550446|587905163|FG001|Post Week 12|Withdrawal by Subject|0|||
162779614|NCT00550446|587905164|FG002|Post Week 12|Withdrawal by Subject|0|||
162779615|NCT00550446|587905165|FG003|Post Week 12|Withdrawal by Subject|0|||
162779616|NCT00550446|587905166|FG004|Post Week 12|Withdrawal by Subject|1|||
162779617|NCT00550446|587905167|FG005|Post Week 12|Withdrawal by Subject|0|||
162779618|NCT00550446|587905168|FG006|Post Week 12|Withdrawal by Subject|0|||
162779619|NCT00550446|587905169|FG007|Post Week 12|Withdrawal by Subject|0|||
162779620|NCT00550446|587905170|FG008|Post Week 12|Withdrawal by Subject|0|||
162779621|NCT00550446|587905171|FG009|Post Week 12|Withdrawal by Subject|0|||
162779622|NCT00550446|587905172|FG010|Post Week 12|Withdrawal by Subject|0|||
162779623|NCT00550446|587905162|FG000|Post Week 12|Other|1|||
162779624|NCT00550446|587905163|FG001|Post Week 12|Other|1|||
162779625|NCT00550446|587905164|FG002|Post Week 12|Other|0|||
162779626|NCT00550446|587905165|FG003|Post Week 12|Other|1|||
162779627|NCT00550446|587905166|FG004|Post Week 12|Other|0|||
162779628|NCT00550446|587905167|FG005|Post Week 12|Other|0|||
162779629|NCT00550446|587905168|FG006|Post Week 12|Other|1|||
162779630|NCT00550446|587905169|FG007|Post Week 12|Other|0|||
162779631|NCT00550446|587905170|FG008|Post Week 12|Other|1|||
162779632|NCT00550446|587905171|FG009|Post Week 12|Other|1|||
162779633|NCT00550446|587905172|FG010|Post Week 12|Other|0|||
162779634|NCT02246218|587905173|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162779635|NCT02246218|587905174|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162779636|NCT02246218|587905173|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
162779637|NCT02246218|587905174|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
162779638|NCT02246218|587905173|FG000|Overall Study|Adverse Event|1|||
162779639|NCT02246218|587905174|FG001|Overall Study|Adverse Event|1|||
162779640|NCT02246218|587905173|FG000|Overall Study|Lost to Follow-up|1|||
162779641|NCT02246218|587905174|FG001|Overall Study|Lost to Follow-up|0|||
162779642|NCT01321723|587905175|FG000|Overall Study|Adverse Event|3|||
162779643|NCT01321723|587905176|FG001|Overall Study|Adverse Event|5|||
162779644|NCT01321723|587905177|FG002|Overall Study|Adverse Event|2|||
162779645|NCT01321723|587905175|FG000|Overall Study|Withdrawal by Subject|2|||
162779646|NCT01321723|587905176|FG001|Overall Study|Withdrawal by Subject|0|||
162779647|NCT01321723|587905177|FG002|Overall Study|Withdrawal by Subject|2|||
162779648|NCT02561806|587905178|FG000|Induction Period|Adverse Event|0|||
162779649|NCT02561806|587905179|FG001|Induction Period|Adverse Event|2|||
162779650|NCT02561806|587905178|FG000|Induction Period|Lack of Efficacy|1|||
162779651|NCT02561806|587905179|FG001|Induction Period|Lack of Efficacy|0|||
162779652|NCT02561806|587905178|FG000|Induction Period|Withdrawal by Subject|0|||
162779653|NCT02561806|587905179|FG001|Induction Period|Withdrawal by Subject|2|||
162779654|NCT02561806|587905178|FG000|Induction Period|Site staff became unblinded|1|||
162779655|NCT02561806|587905179|FG001|Induction Period|Site staff became unblinded|0|||
162779656|NCT02561806|587905178|FG000|Induction Period|Randomized but not treated|0|||
162779657|NCT02561806|587905179|FG001|Induction Period|Randomized but not treated|1|||
162779658|NCT02561806|587905178|FG000|Maintenance Period|Adverse Event|2|||
162779659|NCT02561806|587905179|FG001|Maintenance Period|Adverse Event|1|||
162779660|NCT02561806|587905178|FG000|Maintenance Period|Lack of Efficacy|3|||
162779661|NCT02561806|587905179|FG001|Maintenance Period|Lack of Efficacy|1|||
162779662|NCT02561806|587905178|FG000|Maintenance Period|Lost to Follow-up|2|||
162779663|NCT02561806|587905179|FG001|Maintenance Period|Lost to Follow-up|2|||
162779664|NCT02561806|587905178|FG000|Maintenance Period|Protocol Violation|1|||
162779665|NCT02561806|587905179|FG001|Maintenance Period|Protocol Violation|0|||
162779666|NCT02561806|587905178|FG000|Maintenance Period|Withdrawal by Subject|5|||
162779667|NCT02561806|587905179|FG001|Maintenance Period|Withdrawal by Subject|3|||
162779668|NCT02561806|587905178|FG000|Maintenance Period|Site staff became unblinded|0|||
162779669|NCT02561806|587905179|FG001|Maintenance Period|Site staff became unblinded|1|||
162779670|NCT02561806|587905178|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
162779671|NCT02561806|587905179|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
162779672|NCT02561806|587905178|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
162779673|NCT02561806|587905179|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
162779674|NCT00905034|587905181|FG000|Overall Study|Withdrawal by Subject|1|||
162779675|NCT03409731|587905183|FG000|Overall Study|Withdrawal by Subject|17|||
162779676|NCT03409731|587905183|FG000|Overall Study|Death|4|||
162779677|NCT00505414|587905189|FG000|Titration Phase|Adverse Event|0|||
162779678|NCT00505414|587905190|FG001|Titration Phase|Adverse Event|0|||
162779679|NCT00505414|587905191|FG002|Titration Phase|Adverse Event|0|||
162779680|NCT00505414|587905192|FG003|Titration Phase|Adverse Event|8|||
162779681|NCT00505414|587905193|FG004|Titration Phase|Adverse Event|3|||
162779682|NCT00505414|587905189|FG000|Titration Phase|Death|0|||
162779683|NCT00505414|587905190|FG001|Titration Phase|Death|0|||
162779684|NCT00505414|587905191|FG002|Titration Phase|Death|0|||
162779685|NCT00505414|587905192|FG003|Titration Phase|Death|2|||
162779686|NCT00505414|587905193|FG004|Titration Phase|Death|0|||
162779687|NCT00505414|587905189|FG000|Titration Phase|Lack of Efficacy|0|||
162779688|NCT00505414|587905190|FG001|Titration Phase|Lack of Efficacy|0|||
162779689|NCT00505414|587905191|FG002|Titration Phase|Lack of Efficacy|0|||
162779690|NCT00505414|587905192|FG003|Titration Phase|Lack of Efficacy|10|||
162779691|NCT00505414|587905193|FG004|Titration Phase|Lack of Efficacy|1|||
162779692|NCT00505414|587905189|FG000|Titration Phase|Protocol Violation|0|||
162779693|NCT00505414|587905190|FG001|Titration Phase|Protocol Violation|0|||
162779694|NCT00505414|587905191|FG002|Titration Phase|Protocol Violation|0|||
162779695|NCT00505414|587905192|FG003|Titration Phase|Protocol Violation|0|||
162779696|NCT00505414|587905193|FG004|Titration Phase|Protocol Violation|1|||
162779697|NCT00505414|587905189|FG000|Titration Phase|Withdrawal by Subject|0|||
162779698|NCT00505414|587905190|FG001|Titration Phase|Withdrawal by Subject|0|||
162779699|NCT00505414|587905191|FG002|Titration Phase|Withdrawal by Subject|0|||
162779700|NCT00505414|587905192|FG003|Titration Phase|Withdrawal by Subject|3|||
162779701|NCT00505414|587905193|FG004|Titration Phase|Withdrawal by Subject|4|||
162779702|NCT00505414|587905189|FG000|Titration Phase|Underlying disease and therapy required|0|||
162779703|NCT00505414|587905190|FG001|Titration Phase|Underlying disease and therapy required|0|||
162779704|NCT00505414|587905191|FG002|Titration Phase|Underlying disease and therapy required|0|||
162779705|NCT00505414|587905192|FG003|Titration Phase|Underlying disease and therapy required|7|||
162779706|NCT00505414|587905193|FG004|Titration Phase|Underlying disease and therapy required|3|||
162779707|NCT00505414|587905189|FG000|Maintenance Phase|Adverse Event|2|||
162779708|NCT00505414|587905190|FG001|Maintenance Phase|Adverse Event|2|||
162779709|NCT00505414|587905191|FG002|Maintenance Phase|Adverse Event|3|||
162779710|NCT00505414|587905192|FG003|Maintenance Phase|Adverse Event|0|||
162779711|NCT00505414|587905193|FG004|Maintenance Phase|Adverse Event|0|||
162779712|NCT00505414|587905189|FG000|Maintenance Phase|Death|2|||
162779713|NCT00505414|587905190|FG001|Maintenance Phase|Death|0|||
162779714|NCT00505414|587905191|FG002|Maintenance Phase|Death|1|||
162779715|NCT00505414|587905192|FG003|Maintenance Phase|Death|0|||
162779716|NCT00505414|587905193|FG004|Maintenance Phase|Death|0|||
162779717|NCT00505414|587905189|FG000|Maintenance Phase|Lack of Efficacy|2|||
162779718|NCT00505414|587905190|FG001|Maintenance Phase|Lack of Efficacy|1|||
162779719|NCT00505414|587905191|FG002|Maintenance Phase|Lack of Efficacy|1|||
162779720|NCT00505414|587905192|FG003|Maintenance Phase|Lack of Efficacy|0|||
162779721|NCT00505414|587905193|FG004|Maintenance Phase|Lack of Efficacy|0|||
162779722|NCT00505414|587905189|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162779723|NCT00505414|587905190|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162779724|NCT00505414|587905191|FG002|Maintenance Phase|Withdrawal by Subject|1|||
162779725|NCT00505414|587905192|FG003|Maintenance Phase|Withdrawal by Subject|0|||
162779726|NCT00505414|587905193|FG004|Maintenance Phase|Withdrawal by Subject|0|||
162779727|NCT00505414|587905189|FG000|Maintenance Phase|underlying disease and therapy required|0|||
162779728|NCT00505414|587905190|FG001|Maintenance Phase|underlying disease and therapy required|2|||
162779729|NCT00505414|587905191|FG002|Maintenance Phase|underlying disease and therapy required|2|||
162779730|NCT00505414|587905192|FG003|Maintenance Phase|underlying disease and therapy required|0|||
162779731|NCT00505414|587905193|FG004|Maintenance Phase|underlying disease and therapy required|0|||
162779732|NCT04358068|587905194|FG000|Overall Study|Did not initiate study treatment|2|||
162779733|NCT04358068|587905195|FG001|Overall Study|Did not initiate study treatment|2|||
162779734|NCT01193218|587905196|FG000|0-12 Weeks|Adverse Event|6|||
162779735|NCT01193218|587905197|FG001|0-12 Weeks|Adverse Event|0|||
162779736|NCT01193218|587905198|FG002|0-12 Weeks|Adverse Event|1|||
162779737|NCT01193218|587905199|FG003|0-12 Weeks|Adverse Event|0|||
162779738|NCT01193218|587905200|FG004|0-12 Weeks|Adverse Event|0|||
162779739|NCT01193218|587905201|FG005|0-12 Weeks|Adverse Event|2|||
162779740|NCT01193218|587905202|FG006|0-12 Weeks|Adverse Event|2|||
162779741|NCT01193218|587905203|FG007|0-12 Weeks|Adverse Event|0|||
162779742|NCT01193218|587905196|FG000|0-12 Weeks|Protocol Violation|0|||
162779743|NCT01193218|587905197|FG001|0-12 Weeks|Protocol Violation|0|||
162779744|NCT01193218|587905198|FG002|0-12 Weeks|Protocol Violation|0|||
162779745|NCT01193218|587905199|FG003|0-12 Weeks|Protocol Violation|0|||
162779746|NCT01193218|587905200|FG004|0-12 Weeks|Protocol Violation|1|||
162779747|NCT01193218|587905201|FG005|0-12 Weeks|Protocol Violation|1|||
162779748|NCT01193218|587905202|FG006|0-12 Weeks|Protocol Violation|0|||
162779749|NCT01193218|587905203|FG007|0-12 Weeks|Protocol Violation|0|||
162779750|NCT01193218|587905196|FG000|0-12 Weeks|Withdrawal by Subject|3|||
162779751|NCT01193218|587905197|FG001|0-12 Weeks|Withdrawal by Subject|0|||
162779752|NCT01193218|587905198|FG002|0-12 Weeks|Withdrawal by Subject|2|||
162779753|NCT01193218|587905199|FG003|0-12 Weeks|Withdrawal by Subject|0|||
162779754|NCT01193218|587905200|FG004|0-12 Weeks|Withdrawal by Subject|0|||
162779755|NCT01193218|587905201|FG005|0-12 Weeks|Withdrawal by Subject|0|||
162779756|NCT01193218|587905202|FG006|0-12 Weeks|Withdrawal by Subject|1|||
162779757|NCT01193218|587905203|FG007|0-12 Weeks|Withdrawal by Subject|0|||
162779758|NCT01193218|587905196|FG000|12-52 Weeks|Adverse Event|1|||
162779759|NCT01193218|587905197|FG001|12-52 Weeks|Adverse Event|0|||
162779760|NCT01193218|587905198|FG002|12-52 Weeks|Adverse Event|1|||
162779761|NCT01193218|587905199|FG003|12-52 Weeks|Adverse Event|2|||
162779762|NCT01193218|587905200|FG004|12-52 Weeks|Adverse Event|3|||
162779763|NCT01193218|587905201|FG005|12-52 Weeks|Adverse Event|3|||
162779764|NCT01193218|587905202|FG006|12-52 Weeks|Adverse Event|1|||
162779765|NCT01193218|587905203|FG007|12-52 Weeks|Adverse Event|2|||
162779766|NCT01193218|587905196|FG000|12-52 Weeks|Lack of Efficacy|0|||
162779767|NCT01193218|587905197|FG001|12-52 Weeks|Lack of Efficacy|0|||
162779768|NCT01193218|587905198|FG002|12-52 Weeks|Lack of Efficacy|0|||
162779769|NCT01193218|587905199|FG003|12-52 Weeks|Lack of Efficacy|0|||
162779770|NCT01193218|587905200|FG004|12-52 Weeks|Lack of Efficacy|0|||
162779771|NCT01193218|587905201|FG005|12-52 Weeks|Lack of Efficacy|0|||
162779772|NCT01193218|587905202|FG006|12-52 Weeks|Lack of Efficacy|1|||
162779773|NCT01193218|587905203|FG007|12-52 Weeks|Lack of Efficacy|0|||
162779774|NCT01193218|587905196|FG000|12-52 Weeks|Withdrawal by Subject|3|||
162779775|NCT01193218|587905197|FG001|12-52 Weeks|Withdrawal by Subject|0|||
162779776|NCT01193218|587905198|FG002|12-52 Weeks|Withdrawal by Subject|3|||
162779777|NCT01193218|587905199|FG003|12-52 Weeks|Withdrawal by Subject|0|||
162779778|NCT01193218|587905200|FG004|12-52 Weeks|Withdrawal by Subject|0|||
162779779|NCT01193218|587905201|FG005|12-52 Weeks|Withdrawal by Subject|2|||
162779780|NCT01193218|587905202|FG006|12-52 Weeks|Withdrawal by Subject|1|||
162779781|NCT01193218|587905203|FG007|12-52 Weeks|Withdrawal by Subject|2|||
162779782|NCT01193218|587905196|FG000|12-52 Weeks|Other reason than above|1|||
162779783|NCT01193218|587905197|FG001|12-52 Weeks|Other reason than above|0|||
162779784|NCT01193218|587905198|FG002|12-52 Weeks|Other reason than above|0|||
162779785|NCT01193218|587905199|FG003|12-52 Weeks|Other reason than above|1|||
162779786|NCT01193218|587905200|FG004|12-52 Weeks|Other reason than above|1|||
162779787|NCT01193218|587905201|FG005|12-52 Weeks|Other reason than above|0|||
162779788|NCT01193218|587905202|FG006|12-52 Weeks|Other reason than above|0|||
162779789|NCT01193218|587905203|FG007|12-52 Weeks|Other reason than above|0|||
162779790|NCT00665223|587905206|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
162779791|NCT00665223|587905207|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
162779792|NCT00665223|587905208|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
162779793|NCT00665223|587905206|FG000|Randomized Phase (26 Weeks)|Death|0|||
162779794|NCT00665223|587905207|FG001|Randomized Phase (26 Weeks)|Death|0|||
162779795|NCT00665223|587905208|FG002|Randomized Phase (26 Weeks)|Death|1|||
162779796|NCT00665223|587905206|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
162779797|NCT00665223|587905207|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
162779798|NCT00665223|587905208|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
162779799|NCT00665223|587905206|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
162779800|NCT00665223|587905207|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
162779801|NCT00665223|587905208|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
162779802|NCT00665223|587905206|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
162779803|NCT00665223|587905207|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
162779804|NCT00665223|587905208|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
162779805|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
162779806|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
162779807|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
162779808|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Death|0|||
162779809|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Death|1|||
162779810|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Death|0|||
162779811|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
162779812|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
162779813|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
162779814|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
162779815|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
162779816|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
162779817|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
162779818|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
162779819|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
162779820|NCT00665223|587905206|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
162779821|NCT00665223|587905207|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
162779822|NCT00665223|587905208|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
162779823|NCT00363649|587905209|FG000|Overall Study|Withdrawal by Subject|1|||
162779824|NCT00363649|587905210|FG001|Overall Study|Withdrawal by Subject|1|||
162779825|NCT00363649|587905209|FG000|Overall Study|Adverse Event|6|||
162779826|NCT00363649|587905210|FG001|Overall Study|Adverse Event|0|||
162779827|NCT00002597|587905211|FG000|Overall Study|Protocol Violation|19|||
162779828|NCT00002597|587905212|FG001|Overall Study|Protocol Violation|17|||
162779829|NCT00002597|587905211|FG000|Overall Study|Withdrawal by Subject|7|||
162779830|NCT00002597|587905212|FG001|Overall Study|Withdrawal by Subject|6|||
162779831|NCT00912223|587905213|FG000|Overall Study|Withdrawal by Subject|1|||
162779832|NCT00912223|587905213|FG000|Overall Study|Not transplanted|1|||
162779833|NCT00912223|587905213|FG000|Overall Study|Transformed disease|1|||
162779834|NCT00025662|587905217|FG000|Overall Study|Withdrawal by Subject|2|||
162779835|NCT00025662|587905217|FG000|Overall Study|Technical failure of manipulation|1|||
162779836|NCT02161185|587905218|FG000|Treatment Phase|Administrative/Other|7|||
162779837|NCT01527500|587905220|FG000|Part A|Administrative|11|||
162779838|NCT01527500|587905221|FG001|Part A|Administrative|7|||
162779839|NCT01527500|587905220|FG000|Part A|Adverse Event|4|||
162779840|NCT01527500|587905221|FG001|Part A|Adverse Event|2|||
162779841|NCT01527500|587905220|FG000|Part A|Death|4|||
162779842|NCT01527500|587905221|FG001|Part A|Death|1|||
162779843|NCT01527500|587905220|FG000|Part A|Lost to Follow-up|0|||
162779844|NCT01527500|587905221|FG001|Part A|Lost to Follow-up|1|||
162779845|NCT01527500|587905220|FG000|Part A|Protocol Deviation|9|||
162779846|NCT01527500|587905221|FG001|Part A|Protocol Deviation|2|||
162779847|NCT01527500|587905220|FG000|Part A|Withdrawal by Subject|2|||
162779848|NCT01527500|587905221|FG001|Part A|Withdrawal by Subject|0|||
162779849|NCT01527500|587905220|FG000|Part B|Adverse Event|1|||
162779850|NCT01527500|587905221|FG001|Part B|Adverse Event|0|||
162779851|NCT02573883|587905222|FG000|Six Month Follow Up|Lost to Follow-up|1|||
162779852|NCT02573883|587905223|FG001|Six Month Follow Up|Lost to Follow-up|0|||
162779853|NCT02573883|587905224|FG002|Six Month Follow Up|Lost to Follow-up|0|||
162779854|NCT02573883|587905225|FG003|Six Month Follow Up|Lost to Follow-up|0|||
162779855|NCT02573883|587905222|FG000|One Year Follow Up|Lost to Follow-up|2|||
162779856|NCT02573883|587905223|FG001|One Year Follow Up|Lost to Follow-up|1|||
162779857|NCT02573883|587905224|FG002|One Year Follow Up|Lost to Follow-up|0|||
162779858|NCT02573883|587905225|FG003|One Year Follow Up|Lost to Follow-up|0|||
162779859|NCT00582114|587905226|FG000|Overall Study|Death|4|||
162779860|NCT00582114|587905227|FG001|Overall Study|Death|4|||
162779861|NCT00582114|587905226|FG000|Overall Study|Kidney Transplant|3|||
162779862|NCT00582114|587905227|FG001|Overall Study|Kidney Transplant|1|||
162779863|NCT00582114|587905226|FG000|Overall Study|Lost to Follow-up|7|||
162779864|NCT00582114|587905227|FG001|Overall Study|Lost to Follow-up|6|||
162779865|NCT00582114|587905226|FG000|Overall Study|Withdrawal by Subject|8|||
162779866|NCT00582114|587905227|FG001|Overall Study|Withdrawal by Subject|16|||
162779867|NCT00582114|587905226|FG000|Overall Study|Adverse Event|1|||
162779868|NCT00582114|587905227|FG001|Overall Study|Adverse Event|1|||
162779869|NCT00582114|587905226|FG000|Overall Study|Physician Decision|0|||
162779870|NCT00582114|587905227|FG001|Overall Study|Physician Decision|6|||
162779871|NCT00582114|587905226|FG000|Overall Study|Stopped by data safety monitoring board|19|||
162779872|NCT00582114|587905227|FG001|Overall Study|Stopped by data safety monitoring board|20|||
162779873|NCT00130728|587905235|FG000|Overall Study|Death|258|||
162779874|NCT00130728|587905236|FG001|Overall Study|Death|258|||
162779875|NCT00130728|587905235|FG000|Overall Study|Lost to Follow-up|4|||
162779876|NCT00130728|587905236|FG001|Overall Study|Lost to Follow-up|0|||
162779877|NCT00130728|587905235|FG000|Overall Study|Withdrawal by Subject|0|||
162779878|NCT00130728|587905236|FG001|Overall Study|Withdrawal by Subject|2|||
162779879|NCT00519285|587905243|FG000|Overall Study|Adverse Event|127|||
162779880|NCT00519285|587905244|FG001|Overall Study|Adverse Event|266|||
162779881|NCT00519285|587905243|FG000|Overall Study|Disease progression|334|||
162779882|NCT00519285|587905244|FG001|Overall Study|Disease progression|186|||
162779883|NCT00519285|587905243|FG000|Overall Study|Physician Decision|75|||
162779884|NCT00519285|587905244|FG001|Overall Study|Physician Decision|47|||
162779885|NCT00519285|587905243|FG000|Overall Study|Participant's request|53|||
162779886|NCT00519285|587905244|FG001|Overall Study|Participant's request|84|||
162779887|NCT00519285|587905243|FG000|Overall Study|Consent withdrawn|4|||
162779888|NCT00519285|587905244|FG001|Overall Study|Consent withdrawn|5|||
162779889|NCT00519285|587905243|FG000|Overall Study|Poor compliance to protocol|5|||
162779890|NCT00519285|587905244|FG001|Overall Study|Poor compliance to protocol|7|||
162779891|NCT00519285|587905243|FG000|Overall Study|Reason unspecified|5|||
162779892|NCT00519285|587905244|FG001|Overall Study|Reason unspecified|8|||
162779893|NCT00519285|587905243|FG000|Overall Study|Not treated|8|||
162779894|NCT00519285|587905244|FG001|Overall Study|Not treated|7|||
162779895|NCT00519285|587905243|FG000|Overall Study|Treatment ongoing|1|||
162779896|NCT00519285|587905244|FG001|Overall Study|Treatment ongoing|2|||
162779897|NCT02970305|587905245|FG000|Overall Study|Adverse Event|10|||
162779898|NCT02970305|587905246|FG001|Overall Study|Adverse Event|6|||
162779899|NCT02970305|587905245|FG000|Overall Study|Lack of Efficacy|1|||
162779900|NCT02970305|587905246|FG001|Overall Study|Lack of Efficacy|1|||
162779901|NCT02970305|587905245|FG000|Overall Study|Noncompliance with study drug|2|||
162779902|NCT02970305|587905246|FG001|Overall Study|Noncompliance with study drug|4|||
162779903|NCT02970305|587905245|FG000|Overall Study|Protocol Violation|2|||
162779904|NCT02970305|587905246|FG001|Overall Study|Protocol Violation|2|||
162779905|NCT02970305|587905245|FG000|Overall Study|Withdrawal by Subject|12|||
162779906|NCT02970305|587905246|FG001|Overall Study|Withdrawal by Subject|11|||
162779907|NCT02970305|587905245|FG000|Overall Study|Not further specified|1|||
162779908|NCT02970305|587905246|FG001|Overall Study|Not further specified|2|||
162779909|NCT02970305|587905245|FG000|Overall Study|Lost to Follow-up|1|||
162779910|NCT02970305|587905246|FG001|Overall Study|Lost to Follow-up|2|||
162779911|NCT02175745|587905247|FG000|Overall Study|Not Eligible|1|||
162779912|NCT00808899|587905249|FG000|Overall Study|Death|1|||
162779913|NCT00808899|587905249|FG000|Overall Study|Physician Decision|3|||
162779914|NCT04088500|587905250|FG000|Overall Study|Reason unknown|1|||
162779915|NCT04088500|587905250|FG000|Overall Study|Participant withdrew consent|1|||
162779916|NCT04088500|587905250|FG000|Overall Study|Disease progression|3|||
162779917|NCT02212197|587905251|FG000|Overall Study|Need for radiotherapy|1|||
162779918|NCT02212197|587905252|FG001|Overall Study|Need for radiotherapy|0|||
162779919|NCT02212197|587905253|FG002|Overall Study|Need for radiotherapy|0|||
162779920|NCT01078584|587905254|FG000|Overall Study|Final Status Unknown|1073|||
162779921|NCT01078584|587905254|FG000|Overall Study|Lost to Follow-up|670|||
162779922|NCT01078584|587905254|FG000|Overall Study|Non-serious Adverse Event|577|||
162779923|NCT01078584|587905254|FG000|Overall Study|Withdrawal of Consent|244|||
162779924|NCT01078584|587905254|FG000|Overall Study|Physician Withdrew from Study|90|||
162779925|NCT01078584|587905254|FG000|Overall Study|Non-compliance|67|||
162779926|NCT01078584|587905254|FG000|Overall Study|Blood Pressure Controlled|49|||
162779927|NCT01078584|587905254|FG000|Overall Study|Physician Switched Medication|26|||
162779928|NCT01078584|587905254|FG000|Overall Study|Physician Discontinued Patient|12|||
162779929|NCT01078584|587905254|FG000|Overall Study|Lack of Efficacy|98|||
162779930|NCT01078584|587905254|FG000|Overall Study|Protocol Violation|75|||
162779931|NCT01078584|587905254|FG000|Overall Study|Serious Adverse Event|27|||
162779932|NCT01078584|587905254|FG000|Overall Study|Multiple Reasons|2|||
162779933|NCT01208870|587905257|FG000|Overall Study|Lost to Follow-up|2|||
162779934|NCT01208870|587905258|FG001|Overall Study|Lost to Follow-up|8|||
162779935|NCT02979613|587905259|FG000|Double-Blind Phase|Withdrew Consent|2|||
162779936|NCT02979613|587905260|FG001|Double-Blind Phase|Withdrew Consent|4|||
162779937|NCT02979613|587905259|FG000|Double-Blind Phase|Pregnancy|2|||
162779938|NCT02979613|587905260|FG001|Double-Blind Phase|Pregnancy|2|||
162779939|NCT02979613|587905259|FG000|Double-Blind Phase|Adverse Event|2|||
162779940|NCT02979613|587905260|FG001|Double-Blind Phase|Adverse Event|0|||
162779941|NCT02979613|587905259|FG000|Double-Blind Phase|Lost to Follow-up|1|||
162779942|NCT02979613|587905260|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162779943|NCT02979613|587905259|FG000|Double-Blind Phase|Protocol Violation|1|||
162779944|NCT02979613|587905260|FG001|Double-Blind Phase|Protocol Violation|1|||
162779945|NCT02979613|587905259|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
162779946|NCT02979613|587905260|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
162779947|NCT02979613|587905259|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
162779948|NCT02979613|587905260|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
162779949|NCT02979613|587905259|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
162779950|NCT02979613|587905260|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
162779951|NCT02979613|587905259|FG000|Open-Label Extension (OLE) Phase|Death|0|||
162779952|NCT02979613|587905260|FG001|Open-Label Extension (OLE) Phase|Death|1|||
162779953|NCT02979613|587905259|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
162779954|NCT02979613|587905260|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
162779955|NCT00612352|587907255|FG000|Overall Study|Adverse Event|1|||
162779956|NCT00612352|587907256|FG001|Overall Study|Adverse Event|0|||
162779957|NCT00612352|587907255|FG000|Overall Study|Withdrawal by Subject|3|||
162779958|NCT00612352|587907256|FG001|Overall Study|Withdrawal by Subject|5|||
162779959|NCT00612352|587907255|FG000|Overall Study|moved out of state|1|||
162779960|NCT00612352|587907256|FG001|Overall Study|moved out of state|0|||
162779961|NCT00612352|587907255|FG000|Overall Study|didn't return calls/show up on test date|4|||
162779962|NCT00612352|587907256|FG001|Overall Study|didn't return calls/show up on test date|1|||
162779963|NCT00263211|587907257|FG000|Overall Study|Death|1|||
162779964|NCT00263211|587907258|FG001|Overall Study|Death|0|||
162779965|NCT00263211|587907257|FG000|Overall Study|Withdrawal by Subject|3|||
162779966|NCT00263211|587907258|FG001|Overall Study|Withdrawal by Subject|0|||
162779967|NCT00263211|587907257|FG000|Overall Study|Protocol Violation|1|||
162779968|NCT00263211|587907258|FG001|Overall Study|Protocol Violation|0|||
162779969|NCT00263211|587907257|FG000|Overall Study|Disease Progression|0|||
162779970|NCT00263211|587907258|FG001|Overall Study|Disease Progression|1|||
162779971|NCT02820597|587907259|FG000|Overall Study|Lost to Follow-up|12|||
162779972|NCT04606199|587907260|FG000|Overall Study|Withdrawal by Subject|2|||
162779973|NCT00408928|587907261|FG000|Overall Study|Withdrawal by Subject|1|||
162779974|NCT00408928|587907261|FG000|Overall Study|Death|1|||
162779975|NCT00408928|587907261|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
162779976|NCT02512861|587907267|FG000|Overall Study|Protocol Violation|3|||
162779977|NCT02512861|587907268|FG001|Overall Study|Protocol Violation|7|||
162779978|NCT02512861|587907267|FG000|Overall Study|Physician Decision|3|||
162779979|NCT02512861|587907268|FG001|Overall Study|Physician Decision|1|||
162779980|NCT02512861|587907267|FG000|Overall Study|Withdrawal by Subject|0|||
162779981|NCT02512861|587907268|FG001|Overall Study|Withdrawal by Subject|1|||
162779982|NCT00337285|587907269|FG000|Overall Study|Withdrawal by Subject|42|||
162779983|NCT00337285|587907269|FG000|Overall Study|Lost to Follow-up|41|||
162779984|NCT00337285|587907269|FG000|Overall Study|Adverse Event|28|||
162779985|NCT00337285|587907269|FG000|Overall Study|Protocol Violation|27|||
162779986|NCT00337285|587907269|FG000|Overall Study|Lack of Efficacy|11|||
162779987|NCT00337285|587907269|FG000|Overall Study|Death|1|||
162779988|NCT00337285|587907269|FG000|Overall Study|Physician Decision|1|||
162779989|NCT00337285|587907269|FG000|Overall Study|Lack of protocol compliance|7|||
162779990|NCT00292981|587907270|FG000|Overall Study|Adverse Event|1|||
162779991|NCT00292981|587907270|FG000|Overall Study|Lost to Follow-up|13|||
162779992|NCT00292981|587907270|FG000|Overall Study|Withdrawal by Subject|22|||
162779993|NCT00292981|587907270|FG000|Overall Study|Other|3|||
162779994|NCT00594178|587907273|FG000|Overall Study|Physician Decision|5|||
162779995|NCT03245619|587907284|FG000|Part A (Up to Day 22)|Physician Decision|4|||
162779996|NCT03245619|587907285|FG001|Part A (Up to Day 22)|Physician Decision|6|||
162779997|NCT03245619|587907286|FG002|Part A (Up to Day 22)|Physician Decision|6|||
162779998|NCT03245619|587907287|FG003|Part A (Up to Day 22)|Physician Decision|0|||
162779999|NCT03245619|587907288|FG004|Part A (Up to Day 22)|Physician Decision|0|||
162780000|NCT03245619|587907289|FG005|Part A (Up to Day 22)|Physician Decision|0|||
162780001|NCT03245619|587907290|FG006|Part A (Up to Day 22)|Physician Decision|0|||
162780002|NCT03245619|587907291|FG007|Part A (Up to Day 22)|Physician Decision|0|||
162780003|NCT03245619|587907292|FG008|Part A (Up to Day 22)|Physician Decision|0|||
162780004|NCT03245619|587907293|FG009|Part A (Up to Day 22)|Physician Decision|0|||
162780005|NCT03245619|587907294|FG010|Part A (Up to Day 22)|Physician Decision|0|||
162780006|NCT03245619|587907295|FG011|Part A (Up to Day 22)|Physician Decision|0|||
162780007|NCT03245619|587907296|FG012|Part A (Up to Day 22)|Physician Decision|0|||
162780008|NCT03245619|587907297|FG013|Part A (Up to Day 22)|Physician Decision|0|||
162780009|NCT03245619|587907298|FG014|Part A (Up to Day 22)|Physician Decision|0|||
162780010|NCT03245619|587907299|FG015|Part A (Up to Day 22)|Physician Decision|0|||
162780011|NCT03245619|587907300|FG016|Part A (Up to Day 22)|Physician Decision|0|||
162780012|NCT00776659|587907316|FG000|Overall Study|Lost to Follow-up|15|||
162780013|NCT00776659|587907316|FG000|Overall Study|Withdrawal by Subject|10|||
162780014|NCT00776659|587907316|FG000|Overall Study|Study Terminated by Sponsor|1|||
162780015|NCT02971228|587907317|FG000|Overall Study|Withdrawal by Subject|1|||
162780016|NCT02971228|587907318|FG001|Overall Study|Withdrawal by Subject|1|||
162780017|NCT02971228|587907319|FG002|Overall Study|Withdrawal by Subject|0|||
162780018|NCT02971228|587907320|FG003|Overall Study|Withdrawal by Subject|0|||
162780019|NCT02971228|587907321|FG004|Overall Study|Withdrawal by Subject|0|||
162780020|NCT02971228|587907317|FG000|Overall Study|Logistical challenges|0|||
162780021|NCT02971228|587907318|FG001|Overall Study|Logistical challenges|1|||
162780022|NCT02971228|587907319|FG002|Overall Study|Logistical challenges|0|||
162780023|NCT02971228|587907320|FG003|Overall Study|Logistical challenges|0|||
162780024|NCT02971228|587907321|FG004|Overall Study|Logistical challenges|0|||
162780025|NCT01167192|587907324|FG000|Overall Study|Adverse Event|1|||
162780026|NCT01167192|587907324|FG000|Overall Study|Death|1|||
162780027|NCT01167192|587907324|FG000|Overall Study|Withdrawal by Subject|1|||
162780028|NCT01167192|587907324|FG000|Overall Study|Insurance denial|1|||
162780029|NCT01336205|587907325|FG000|Overall Study|Other|22|||
162780030|NCT01336205|587907326|FG001|Overall Study|Other|9|||
162780031|NCT01336205|587907325|FG000|Overall Study|Lost to Follow-up|40|||
162780032|NCT01336205|587907326|FG001|Overall Study|Lost to Follow-up|20|||
162780033|NCT01336205|587907325|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
162780034|NCT01336205|587907326|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
162780035|NCT01336205|587907325|FG000|Overall Study|Lack of Efficacy|4|||
162780036|NCT01336205|587907326|FG001|Overall Study|Lack of Efficacy|0|||
162780037|NCT01336205|587907325|FG000|Overall Study|Severe noncompliance with protocol|9|||
162780038|NCT01336205|587907326|FG001|Overall Study|Severe noncompliance with protocol|2|||
162780039|NCT01336205|587907325|FG000|Overall Study|Adverse Event|56|||
162780040|NCT01336205|587907326|FG001|Overall Study|Adverse Event|6|||
162780041|NCT01336205|587907325|FG000|Overall Study|Death|1|||
162780042|NCT01336205|587907326|FG001|Overall Study|Death|1|||
162780043|NCT01336205|587907325|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
162780044|NCT01336205|587907326|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
162780045|NCT01336205|587907325|FG000|Overall Study|Withdrawal by Subject|72|||
162780046|NCT01336205|587907326|FG001|Overall Study|Withdrawal by Subject|38|||
162780047|NCT01336205|587907325|FG000|Overall Study|Did not receive treatment|4|||
162780048|NCT01336205|587907326|FG001|Overall Study|Did not receive treatment|0|||
162780049|NCT00129649|587907327|FG000|Overall Study|Withdrawal by Subject|76|||
162780050|NCT00129649|587907328|FG001|Overall Study|Withdrawal by Subject|65|||
162780051|NCT04952701|587907329|FG000|Control Lens|Physician Decision|4|||
162780052|NCT04952701|587907329|FG000|Test Lens|Physician Decision|1|||
162780053|NCT02547441|587907330|FG000|Double-Blind Study Period|Adverse Event|4|||
162780054|NCT02547441|587907331|FG001|Double-Blind Study Period|Adverse Event|9|||
162780055|NCT02547441|587907330|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
162780056|NCT02547441|587907331|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
162780057|NCT02547441|587907330|FG000|Double-Blind Study Period|Physician Decision|1|||
162780058|NCT02547441|587907331|FG001|Double-Blind Study Period|Physician Decision|0|||
162780059|NCT02547441|587907330|FG000|Double-Blind Study Period|Protocol Violation|1|||
162780060|NCT02547441|587907331|FG001|Double-Blind Study Period|Protocol Violation|2|||
162780061|NCT02547441|587907330|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
162780062|NCT02547441|587907331|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
162780063|NCT02547441|587907330|FG000|Double-Blind Study Period|Sponsor Decision|1|||
162780064|NCT02547441|587907331|FG001|Double-Blind Study Period|Sponsor Decision|0|||
162780065|NCT02547441|587907330|FG000|Open-Label Study Period|Adverse Event|10|||
162780066|NCT02547441|587907331|FG001|Open-Label Study Period|Adverse Event|11|||
162780067|NCT02547441|587907330|FG000|Open-Label Study Period|Lack of Efficacy|3|||
162780068|NCT02547441|587907331|FG001|Open-Label Study Period|Lack of Efficacy|2|||
162780069|NCT02547441|587907330|FG000|Open-Label Study Period|Lost to Follow-up|7|||
162780070|NCT02547441|587907331|FG001|Open-Label Study Period|Lost to Follow-up|8|||
162780071|NCT02547441|587907330|FG000|Open-Label Study Period|Physician Decision|1|||
162780072|NCT02547441|587907331|FG001|Open-Label Study Period|Physician Decision|0|||
162780073|NCT02547441|587907330|FG000|Open-Label Study Period|Protocol Violation|2|||
162780074|NCT02547441|587907331|FG001|Open-Label Study Period|Protocol Violation|0|||
162780075|NCT02547441|587907330|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
162780076|NCT02547441|587907331|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
162780077|NCT02547441|587907330|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
162780078|NCT02547441|587907331|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
162780079|NCT01322009|587907332|FG000|Overall Study|Death|0|||
162780080|NCT01322009|587907333|FG001|Overall Study|Death|1|||
162780081|NCT01322009|587907332|FG000|Overall Study|Adverse Event|0|||
162780082|NCT01322009|587907333|FG001|Overall Study|Adverse Event|1|||
162780083|NCT01322009|587907332|FG000|Overall Study|ng tube discontinued|0|||
162780084|NCT01322009|587907333|FG001|Overall Study|ng tube discontinued|1|||
162780085|NCT01657877|587907334|FG000|Overall Study|Withdrawal by Subject|4|||
162780086|NCT01657877|587907334|FG000|Overall Study|Protocol Violation|6|||
162780087|NCT01657877|587907334|FG000|Overall Study|Adverse Event|2|||
162780088|NCT01657877|587907334|FG000|Overall Study|Other Reason|2|||
162780089|NCT04545476|587907335|FG000|Overall Study|Lost to Follow-up|1|||
162780090|NCT04545476|587907336|FG001|Overall Study|Lost to Follow-up|1|||
162780091|NCT04545476|587907337|FG002|Overall Study|Lost to Follow-up|0|||
162780092|NCT04545476|587907338|FG003|Overall Study|Lost to Follow-up|0|||
162780093|NCT01978236|587907343|FG000|Overall Study|Discontinued due to study close|2|||
162780094|NCT00846768|587907345|FG000|Overall Study|Adverse Event|0|||
162780095|NCT00846768|587907346|FG001|Overall Study|Adverse Event|1|||
162780096|NCT00846768|587907347|FG002|Overall Study|Adverse Event|0|||
162780097|NCT00846768|587907348|FG003|Overall Study|Adverse Event|0|||
162780098|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
162780099|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
162780100|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
162780101|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
162780102|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
162780103|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
162780104|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Rejections|0|||
162780105|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Rejections|0|||
162780106|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Rejections|55|||
162780107|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
162780108|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
162780109|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
162780110|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
162780111|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
162780112|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
162780113|NCT00634920|587907350|FG000|Period 1 - Pre-Randomization|Other issues|0|||
162780114|NCT00634920|587907351|FG001|Period 1 - Pre-Randomization|Other issues|0|||
162780115|NCT00634920|587907352|FG002|Period 1 - Pre-Randomization|Other issues|6|||
162780116|NCT00634920|587907350|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
162780117|NCT00634920|587907351|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
162780118|NCT00634920|587907352|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
162780119|NCT00634920|587907350|FG000|Period 2 - Post-Randomization|Rejection|11|||
162780120|NCT00634920|587907351|FG001|Period 2 - Post-Randomization|Rejection|5|||
162780121|NCT00634920|587907352|FG002|Period 2 - Post-Randomization|Rejection|0|||
162780122|NCT00634920|587907350|FG000|Period 2 - Post-Randomization|Death|2|||
162780123|NCT00634920|587907351|FG001|Period 2 - Post-Randomization|Death|5|||
162780124|NCT00634920|587907352|FG002|Period 2 - Post-Randomization|Death|0|||
162780125|NCT00634920|587907350|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
162780126|NCT00634920|587907351|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
162780127|NCT00634920|587907352|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
162780128|NCT00634920|587907350|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
162780129|NCT00634920|587907351|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
162780130|NCT00634920|587907352|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
162780131|NCT00644878|587907353|FG000|Overall Study|Adverse Event|2|||
162780132|NCT00644878|587907353|FG000|Overall Study|Abnormal laboratory value|3|||
162780133|NCT00644878|587907353|FG000|Overall Study|Protocol deviation|2|||
162780134|NCT00644878|587907353|FG000|Overall Study|Treatment duration completed as per protocol|11|||
162780135|NCT04353817|587907354|FG000|Overall Study|Adverse Event|0|||
162780136|NCT04353817|587907355|FG001|Overall Study|Adverse Event|1|||
162780137|NCT02143063|587907358|FG000|Overall Study|Lost to Follow-up|16|||
162780138|NCT02143063|587907359|FG001|Overall Study|Lost to Follow-up|28|||
162780139|NCT02143063|587907360|FG002|Overall Study|Lost to Follow-up|29|||
162780140|NCT02143063|587907358|FG000|Overall Study|Withdrawal by Subject|0|||
162780141|NCT02143063|587907359|FG001|Overall Study|Withdrawal by Subject|1|||
162780142|NCT02143063|587907360|FG002|Overall Study|Withdrawal by Subject|0|||
162780143|NCT02143063|587907358|FG000|Overall Study|Death|0|||
162780144|NCT02143063|587907359|FG001|Overall Study|Death|1|||
162780145|NCT02143063|587907360|FG002|Overall Study|Death|1|||
162780146|NCT03517111|587907361|FG000|Enrolled|Withdrawal by Subject|0|||
162780147|NCT03517111|587907362|FG001|Enrolled|Withdrawal by Subject|1|||
162780148|NCT03517111|587907363|FG002|Enrolled|Withdrawal by Subject|0|||
162780149|NCT03517111|587907361|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
162780150|NCT03517111|587907362|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
162780151|NCT03517111|587907363|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
162780152|NCT03517111|587907361|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
162780153|NCT03517111|587907362|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
162780154|NCT03517111|587907363|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
162780155|NCT03517111|587907361|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
162780156|NCT03517111|587907362|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
162780157|NCT03517111|587907363|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
162780158|NCT03517111|587907361|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
162780159|NCT03517111|587907362|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
162780160|NCT03517111|587907363|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
162780161|NCT02062645|587907366|FG000|Overall Study|Adverse Event|2|||
162780162|NCT02062645|587907366|FG000|Overall Study|Protocol Violation|8|||
162780163|NCT02062645|587907366|FG000|Overall Study|Lost to Follow-up|5|||
162780164|NCT02864342|587907368|FG000|Overall Study|Eligibility Criteria Deviation|2|||
162780165|NCT02864342|587907369|FG001|Overall Study|Eligibility Criteria Deviation|3|||
162780166|NCT02864342|587907368|FG000|Overall Study|Withdrawal by Subject|4|||
162780167|NCT02864342|587907369|FG001|Overall Study|Withdrawal by Subject|2|||
162780168|NCT02864342|587907368|FG000|Overall Study|Device Technology Issue|6|||
162780169|NCT02864342|587907369|FG001|Overall Study|Device Technology Issue|7|||
162780170|NCT02864342|587907368|FG000|Overall Study|Death|0|||
162780171|NCT02864342|587907369|FG001|Overall Study|Death|1|||
162780172|NCT02864342|587907368|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
162780173|NCT02864342|587907369|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
162780174|NCT02864342|587907368|FG000|Overall Study|Lost to Follow-up|1|||
162780175|NCT02864342|587907369|FG001|Overall Study|Lost to Follow-up|5|||
162780176|NCT02864342|587907368|FG000|Overall Study|Lost Device|1|||
162780177|NCT02864342|587907369|FG001|Overall Study|Lost Device|0|||
162780178|NCT02864342|587907368|FG000|Overall Study|Adverse Event|1|||
162780179|NCT02864342|587907369|FG001|Overall Study|Adverse Event|0|||
162780180|NCT00927901|587907370|FG000|Treatment Period 1|Subject withdrew consent|0|||
162780181|NCT00927901|587907371|FG001|Treatment Period 1|Subject withdrew consent|0|||
162780182|NCT00927901|587907372|FG002|Treatment Period 1|Subject withdrew consent|1|||
162780183|NCT00927901|587907373|FG003|Treatment Period 1|Subject withdrew consent|0|||
162780184|NCT00927901|587907370|FG000|Treatment Period 4|Adverse Event|0|||
162780185|NCT00927901|587907371|FG001|Treatment Period 4|Adverse Event|0|||
162780186|NCT00927901|587907372|FG002|Treatment Period 4|Adverse Event|0|||
162780187|NCT00927901|587907373|FG003|Treatment Period 4|Adverse Event|1|||
162780188|NCT00927901|587907370|FG000|Treatment Period 4|Subject withdrew consent|0|||
162780189|NCT00927901|587907371|FG001|Treatment Period 4|Subject withdrew consent|0|||
162780190|NCT00927901|587907372|FG002|Treatment Period 4|Subject withdrew consent|1|||
162780191|NCT00927901|587907373|FG003|Treatment Period 4|Subject withdrew consent|0|||
162780192|NCT01349036|587907374|FG000|Overall Study|Disease progression|13|||
162780193|NCT01349036|587907375|FG001|Overall Study|Disease progression|22|||
162780194|NCT01349036|587907374|FG000|Overall Study|Other|1|||
162780195|NCT01349036|587907375|FG001|Overall Study|Other|0|||
162780196|NCT01349036|587907374|FG000|Overall Study|Withdrawal by Subject|0|||
162780197|NCT01349036|587907375|FG001|Overall Study|Withdrawal by Subject|2|||
162780198|NCT03796208|587907376|FG000|Overall Study|Withdrawal by Subject|3|||
162780199|NCT03796208|587907377|FG001|Overall Study|Withdrawal by Subject|0|||
162780200|NCT03796208|587907376|FG000|Overall Study|Loss of pregnancy|1|||
162780201|NCT03796208|587907377|FG001|Overall Study|Loss of pregnancy|1|||
162780202|NCT03796208|587907376|FG000|Overall Study|Changed prenatal clinics|0|||
162780203|NCT03796208|587907377|FG001|Overall Study|Changed prenatal clinics|5|||
162780204|NCT03796208|587907376|FG000|Overall Study|Lost to Follow-up|20|||
162780205|NCT03796208|587907377|FG001|Overall Study|Lost to Follow-up|16|||
162780206|NCT01161628|587907378|FG000|Overall Study|Death|6|||
162780207|NCT01161628|587907378|FG000|Overall Study|Lack of Efficacy|2|||
162780208|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
162780209|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
162780210|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
162780211|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
162780212|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
162780213|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
162780214|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
162780215|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
162780216|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
162780217|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
162780218|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
162780219|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
162780220|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
162780221|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
162780222|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
162780223|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
162780224|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
162780225|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
162780226|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
162780227|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
162780228|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
162780229|NCT01125566|587907380|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
162780230|NCT01125566|587907381|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
162780231|NCT01125566|587907382|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
162780232|NCT01125566|587907380|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
162780233|NCT01125566|587907381|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
162780234|NCT01125566|587907382|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
162780235|NCT01125566|587907380|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
162780236|NCT01125566|587907381|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
162780237|NCT01125566|587907382|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
162780238|NCT01125566|587907380|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
162780239|NCT01125566|587907381|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
162780240|NCT01125566|587907382|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
162780241|NCT01125566|587907380|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
162780242|NCT01125566|587907381|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
162780243|NCT01125566|587907382|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
162780244|NCT01726517|587907383|FG000|Overall Study|Withdrawal by Subject|0|||
162780245|NCT01726517|587907384|FG001|Overall Study|Withdrawal by Subject|0|||
162780246|NCT01726517|587907385|FG002|Overall Study|Withdrawal by Subject|1|||
162780247|NCT01726517|587907386|FG003|Overall Study|Withdrawal by Subject|0|||
162780248|NCT01726517|587907387|FG004|Overall Study|Withdrawal by Subject|0|||
162780249|NCT01424189|587907392|FG000|Overall Study|Adverse Event|1|||
162780250|NCT01424189|587907393|FG001|Overall Study|Adverse Event|0|||
162780251|NCT01424189|587907392|FG000|Overall Study|Lost to Follow-up|4|||
162780252|NCT01424189|587907393|FG001|Overall Study|Lost to Follow-up|1|||
162780253|NCT01424189|587907392|FG000|Overall Study|Withdrawal by Subject|4|||
162780254|NCT01424189|587907393|FG001|Overall Study|Withdrawal by Subject|4|||
162780255|NCT01424189|587907392|FG000|Overall Study|Subject moved|1|||
162780256|NCT01424189|587907393|FG001|Overall Study|Subject moved|0|||
162780257|NCT01424189|587907392|FG000|Overall Study|Death|3|||
162780258|NCT01424189|587907393|FG001|Overall Study|Death|1|||
162780259|NCT01203956|587907394|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
162780260|NCT01203956|587907395|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
162780261|NCT02230306|587907398|FG000|Overall Study|Did not receive study treatment|1|||
162780262|NCT00312845|587907399|FG000|Overall Study|Adverse Event|19|||
162780263|NCT00312845|587907400|FG001|Overall Study|Adverse Event|5|||
162780264|NCT00312845|587907399|FG000|Overall Study|Death|2|||
162780265|NCT00312845|587907400|FG001|Overall Study|Death|2|||
162780266|NCT00312845|587907399|FG000|Overall Study|Withdrawal by Subject|14|||
162780267|NCT00312845|587907400|FG001|Overall Study|Withdrawal by Subject|6|||
162780268|NCT00312845|587907399|FG000|Overall Study|Disease Progression|56|||
162780269|NCT00312845|587907400|FG001|Overall Study|Disease Progression|77|||
162780270|NCT00312845|587907399|FG000|Overall Study|Lost to Follow-up|2|||
162780271|NCT00312845|587907400|FG001|Overall Study|Lost to Follow-up|0|||
162780272|NCT00312845|587907399|FG000|Overall Study|Other|6|||
162780273|NCT00312845|587907400|FG001|Overall Study|Other|5|||
162780274|NCT04206384|587907402|FG000|Overall Study|Withdrawal by Subject|8|||
162780275|NCT04206384|587907402|FG000|Overall Study|Adverse Event|2|||
162780276|NCT01121185|587907404|FG000|Overall Study|Not infused|0|||
162780277|NCT01121185|587907405|FG001|Overall Study|Not infused|1|||
162780278|NCT01121185|587907404|FG000|Overall Study|Not transplanted|1|||
162780279|NCT01121185|587907405|FG001|Overall Study|Not transplanted|0|||
162780280|NCT01260142|587907406|FG000|Treatment Period 1|Study on hold|1|||
162780281|NCT01260142|587907407|FG001|Treatment Period 1|Study on hold|1|||
162780282|NCT01260142|587907408|FG002|Treatment Period 1|Study on hold|0|||
162780283|NCT01260142|587907409|FG003|Treatment Period 1|Study on hold|0|||
162780284|NCT01260142|587907410|FG004|Treatment Period 1|Study on hold|1|||
162780285|NCT01260142|587907411|FG005|Treatment Period 1|Study on hold|2|||
162780286|NCT01260142|587907406|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
162780287|NCT01260142|587907407|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
162780288|NCT01260142|587907408|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
162780289|NCT01260142|587907409|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
162780290|NCT01260142|587907410|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
162780291|NCT01260142|587907411|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
162780292|NCT01260142|587907406|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162780293|NCT01260142|587907407|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162780294|NCT01260142|587907408|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162780295|NCT01260142|587907409|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162780296|NCT01260142|587907410|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162780297|NCT01260142|587907411|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162780298|NCT00496834|587907419|FG000|Overall Study|Withdrawal by Subject|4|||
162780299|NCT00496834|587907420|FG001|Overall Study|Withdrawal by Subject|6|||
162780300|NCT00496834|587907419|FG000|Overall Study|Contraindicated medication administered|0|||
162780301|NCT00496834|587907420|FG001|Overall Study|Contraindicated medication administered|1|||
162780302|NCT00496834|587907419|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
162780303|NCT00496834|587907420|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
162780304|NCT00496834|587907419|FG000|Overall Study|Adverse Event|5|||
162780305|NCT00496834|587907420|FG001|Overall Study|Adverse Event|3|||
162780306|NCT00496834|587907419|FG000|Overall Study|IP administration violation|2|||
162780307|NCT00496834|587907420|FG001|Overall Study|IP administration violation|0|||
162780308|NCT00496834|587907419|FG000|Overall Study|Lost to Follow-up|2|||
162780309|NCT00496834|587907420|FG001|Overall Study|Lost to Follow-up|0|||
162780310|NCT00496834|587907419|FG000|Overall Study|Blood Pressure control failure|2|||
162780311|NCT00496834|587907420|FG001|Overall Study|Blood Pressure control failure|1|||
162780312|NCT01503164|587907421|FG000|Overall Study|Withdrawal by Subject|2|||
162780313|NCT01503164|587907422|FG001|Overall Study|Withdrawal by Subject|1|||
162780314|NCT01227928|587907423|FG000|Overall Study|Lost to Follow-up|4|||
162780315|NCT01227928|587907424|FG001|Overall Study|Lost to Follow-up|2|||
162780316|NCT01227928|587907423|FG000|Overall Study|Withdrawal by Subject|4|||
162780317|NCT01227928|587907424|FG001|Overall Study|Withdrawal by Subject|3|||
162780318|NCT01227928|587907423|FG000|Overall Study|Death|14|||
162780319|NCT01227928|587907424|FG001|Overall Study|Death|12|||
162780320|NCT04088136|587907427|FG000|Overall Study|Withdrawal by Subject|5|||
162780321|NCT04088136|587907428|FG001|Overall Study|Withdrawal by Subject|0|||
162780322|NCT04088136|587907427|FG000|Overall Study|Lack of Efficacy|0|||
162780323|NCT04088136|587907428|FG001|Overall Study|Lack of Efficacy|1|||
162780324|NCT01494298|587907429|FG000|Overall Study|Protocol Violation|2|||
162780325|NCT01494298|587907430|FG001|Overall Study|Protocol Violation|8|||
162780326|NCT04159805|587907431|FG000|Overall Study|Withdrawal by Subject|0|||
162780327|NCT04159805|587907432|FG001|Overall Study|Withdrawal by Subject|2|||
162780328|NCT04159805|587907433|FG002|Overall Study|Withdrawal by Subject|2|||
162780329|NCT02930837|587907434|FG000|Overall Study|Adverse Event|6|||
162780330|NCT02930837|587907434|FG000|Overall Study|Lost to Follow-up|5|||
162780331|NCT02930837|587907434|FG000|Overall Study|Withdrawal by Subject|1|||
162780332|NCT01393613|587907435|FG000|Overall Study|Adverse Event|11|||
162780333|NCT01393613|587907436|FG001|Overall Study|Adverse Event|11|||
162780334|NCT01393613|587907437|FG002|Overall Study|Adverse Event|13|||
162780335|NCT01393613|587907438|FG003|Overall Study|Adverse Event|22|||
162780336|NCT01393613|587907435|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
162780337|NCT01393613|587907436|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
162780338|NCT01393613|587907437|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
162780339|NCT01393613|587907438|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
162780340|NCT01393613|587907435|FG000|Overall Study|Physician Decision|2|||
162780341|NCT01393613|587907436|FG001|Overall Study|Physician Decision|0|||
162780342|NCT01393613|587907437|FG002|Overall Study|Physician Decision|0|||
162780343|NCT01393613|587907438|FG003|Overall Study|Physician Decision|1|||
162780344|NCT01393613|587907435|FG000|Overall Study|Withdrawal by Subject|15|||
162780345|NCT01393613|587907436|FG001|Overall Study|Withdrawal by Subject|25|||
162780346|NCT01393613|587907437|FG002|Overall Study|Withdrawal by Subject|23|||
162780347|NCT01393613|587907438|FG003|Overall Study|Withdrawal by Subject|21|||
162780348|NCT01393613|587907435|FG000|Overall Study|Protocol Deviation|2|||
162780349|NCT01393613|587907436|FG001|Overall Study|Protocol Deviation|1|||
162780350|NCT01393613|587907437|FG002|Overall Study|Protocol Deviation|0|||
162780351|NCT01393613|587907438|FG003|Overall Study|Protocol Deviation|0|||
162780352|NCT01393613|587907435|FG000|Overall Study|Lack of Efficacy|9|||
162780353|NCT01393613|587907436|FG001|Overall Study|Lack of Efficacy|20|||
162780354|NCT01393613|587907437|FG002|Overall Study|Lack of Efficacy|16|||
162780355|NCT01393613|587907438|FG003|Overall Study|Lack of Efficacy|21|||
162780356|NCT02998918|587907442|FG000|Overall Study|Withdrawal by Subject|1|||
162780357|NCT02998918|587907443|FG001|Overall Study|Withdrawal by Subject|0|||
162780358|NCT01071317|587907444|FG000|Overall Study|Lost to Follow-up|2|||
162780359|NCT01071317|587907445|FG001|Overall Study|Lost to Follow-up|2|||
162780360|NCT05041439|587907448|FG000|Overall Study|Withdrawal by Subject|1|||
162780361|NCT05041439|587907449|FG001|Overall Study|Withdrawal by Subject|1|||
162780362|NCT05041439|587907448|FG000|Overall Study|Death|1|||
162780363|NCT05041439|587907449|FG001|Overall Study|Death|0|||
162780364|NCT02388347|587908848|FG000|Overall Study|Withdrawal by Subject|0|||
162780365|NCT02388347|587908849|FG001|Overall Study|Withdrawal by Subject|0|||
162780366|NCT02388347|587908850|FG002|Overall Study|Withdrawal by Subject|1|||
162780367|NCT02388347|587908851|FG003|Overall Study|Withdrawal by Subject|0|||
162780368|NCT02388347|587908852|FG004|Overall Study|Withdrawal by Subject|0|||
162780369|NCT00497874|587908853|FG000|Overall Study|Withdrawal by Subject|48|||
162780370|NCT00497874|587908854|FG001|Overall Study|Withdrawal by Subject|17|||
162780371|NCT00497874|587908853|FG000|Overall Study|Illness|8|||
162780372|NCT00497874|587908854|FG001|Overall Study|Illness|4|||
162780373|NCT00497874|587908853|FG000|Overall Study|Death|2|||
162780374|NCT00497874|587908854|FG001|Overall Study|Death|4|||
162780375|NCT00497874|587908853|FG000|Overall Study|Unable to contact|52|||
162780376|NCT00497874|587908854|FG001|Overall Study|Unable to contact|67|||
162780377|NCT00497874|587908853|FG000|Overall Study|Unable to schedule|37|||
162780378|NCT00497874|587908854|FG001|Overall Study|Unable to schedule|24|||
162780379|NCT01101334|587908855|FG000|Overall Study|Adverse Event|9|||
162780380|NCT01101334|587908856|FG001|Overall Study|Adverse Event|4|||
162780381|NCT01101334|587908855|FG000|Overall Study|Death|7|||
162780382|NCT01101334|587908856|FG001|Overall Study|Death|1|||
162780383|NCT01101334|587908855|FG000|Overall Study|Withdrawal by Subject|4|||
162780384|NCT01101334|587908856|FG001|Overall Study|Withdrawal by Subject|3|||
162780385|NCT01101334|587908855|FG000|Overall Study|Withdrawal by Sponsor|1|||
162780386|NCT01101334|587908856|FG001|Overall Study|Withdrawal by Sponsor|1|||
162780387|NCT01101334|587908855|FG000|Overall Study|Progressive Disease|22|||
162780388|NCT01101334|587908856|FG001|Overall Study|Progressive Disease|35|||
162780389|NCT01101334|587908855|FG000|Overall Study|Other|2|||
162780390|NCT01101334|587908856|FG001|Overall Study|Other|1|||
162780391|NCT01774019|587908858|FG000|Overall Study|No longer meets protocol criteria|2|||
162780392|NCT01774019|587908859|FG001|Overall Study|No longer meets protocol criteria|0|||
162780393|NCT01774019|587908858|FG000|Overall Study|Withdrawal by Subject|1|||
162780394|NCT01774019|587908859|FG001|Overall Study|Withdrawal by Subject|0|||
162780395|NCT01774019|587908858|FG000|Overall Study|Surgery delayed > 120 days|1|||
162780396|NCT01774019|587908859|FG001|Overall Study|Surgery delayed > 120 days|0|||
162780397|NCT01774019|587908858|FG000|Overall Study|Patient refused surgery|1|||
162780398|NCT01774019|587908859|FG001|Overall Study|Patient refused surgery|1|||
162780399|NCT01774019|587908858|FG000|Overall Study|Unable to implant study device|1|||
162780400|NCT01774019|587908859|FG001|Overall Study|Unable to implant study device|0|||
162780401|NCT01774019|587908858|FG000|Overall Study|Lost to Follow-up|0|||
162780402|NCT01774019|587908859|FG001|Overall Study|Lost to Follow-up|3|||
162780403|NCT03470545|587908862|FG000|Overall Study|Death|0|||
162780404|NCT03470545|587908863|FG001|Overall Study|Death|1|||
162780405|NCT03470545|587908862|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
162780406|NCT03470545|587908863|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
162780407|NCT03470545|587908862|FG000|Overall Study|Adverse Event|2|||
162780408|NCT03470545|587908863|FG001|Overall Study|Adverse Event|0|||
162780409|NCT03470545|587908862|FG000|Overall Study|Withdrawal by Subject|1|||
162780410|NCT03470545|587908863|FG001|Overall Study|Withdrawal by Subject|1|||
162780411|NCT03470545|587908862|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
162780412|NCT03470545|587908863|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
162780413|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
162780414|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
162780415|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
162780416|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
162780417|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
162780418|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
162780419|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
162780420|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
162780421|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
162780422|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
162780423|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
162780424|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
162780425|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
162780426|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
162780427|NCT01664923|587908864|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
162780428|NCT01664923|587908865|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
162780429|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
162780430|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
162780431|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
162780432|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
162780433|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
162780434|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
162780435|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
162780436|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
162780437|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
162780438|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
162780439|NCT01664923|587908864|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
162780440|NCT01664923|587908865|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
162780441|NCT00937521|587908868|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780442|NCT00937521|587908869|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780443|NCT00937521|587908870|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
162780444|NCT00937521|587908871|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780445|NCT00937521|587908872|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780446|NCT00937521|587908873|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780447|NCT00937521|587908874|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
162780448|NCT00937521|587908875|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162780449|NCT00937521|587908868|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
162780450|NCT00937521|587908869|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
162780451|NCT00937521|587908870|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
162780452|NCT00937521|587908871|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
162780453|NCT00937521|587908872|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
162780454|NCT00937521|587908873|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
162780455|NCT00937521|587908874|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
162780456|NCT00937521|587908875|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
162780457|NCT00937521|587908868|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780458|NCT00937521|587908869|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780459|NCT00937521|587908870|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
162780460|NCT00937521|587908871|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
162780461|NCT00937521|587908872|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780462|NCT00937521|587908873|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780463|NCT00937521|587908874|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780464|NCT00937521|587908875|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162780465|NCT00937521|587908868|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162780466|NCT00937521|587908869|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
162780467|NCT00937521|587908870|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162780468|NCT00937521|587908871|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162780469|NCT00937521|587908872|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
162780470|NCT00937521|587908873|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
162780471|NCT00937521|587908874|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
162780472|NCT00937521|587908875|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162780473|NCT00937521|587908868|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
162780474|NCT00937521|587908869|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780475|NCT00937521|587908870|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780476|NCT00937521|587908871|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780477|NCT00937521|587908872|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780478|NCT00937521|587908873|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780479|NCT00937521|587908874|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
162780480|NCT00937521|587908875|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162780481|NCT00937521|587908868|FG000|Booster Phase|Adverse Event|0|||
162780482|NCT00937521|587908869|FG001|Booster Phase|Adverse Event|0|||
162780483|NCT00937521|587908870|FG002|Booster Phase|Adverse Event|0|||
162780484|NCT00937521|587908871|FG003|Booster Phase|Adverse Event|0|||
162780485|NCT00937521|587908872|FG004|Booster Phase|Adverse Event|0|||
162780486|NCT00937521|587908873|FG005|Booster Phase|Adverse Event|0|||
162780487|NCT00937521|587908874|FG006|Booster Phase|Adverse Event|1|||
162780488|NCT00937521|587908875|FG007|Booster Phase|Adverse Event|0|||
162780489|NCT00937521|587908868|FG000|Booster Phase|Withdrawal by Subject|1|||
162780490|NCT00937521|587908869|FG001|Booster Phase|Withdrawal by Subject|0|||
162780491|NCT00937521|587908870|FG002|Booster Phase|Withdrawal by Subject|0|||
162780492|NCT00937521|587908871|FG003|Booster Phase|Withdrawal by Subject|1|||
162780493|NCT00937521|587908872|FG004|Booster Phase|Withdrawal by Subject|0|||
162780494|NCT00937521|587908873|FG005|Booster Phase|Withdrawal by Subject|0|||
162780495|NCT00937521|587908874|FG006|Booster Phase|Withdrawal by Subject|0|||
162780496|NCT00937521|587908875|FG007|Booster Phase|Withdrawal by Subject|2|||
162780497|NCT00937521|587908868|FG000|Booster Phase|Lost to Follow-up|2|||
162780498|NCT00937521|587908869|FG001|Booster Phase|Lost to Follow-up|2|||
162780499|NCT00937521|587908870|FG002|Booster Phase|Lost to Follow-up|4|||
162780500|NCT00937521|587908871|FG003|Booster Phase|Lost to Follow-up|2|||
162780501|NCT00937521|587908872|FG004|Booster Phase|Lost to Follow-up|4|||
162780502|NCT00937521|587908873|FG005|Booster Phase|Lost to Follow-up|4|||
162780503|NCT00937521|587908874|FG006|Booster Phase|Lost to Follow-up|3|||
162780504|NCT00937521|587908875|FG007|Booster Phase|Lost to Follow-up|0|||
162780505|NCT00937521|587908868|FG000|Booster Phase|Administrative Reason|0|||
162780506|NCT00937521|587908869|FG001|Booster Phase|Administrative Reason|0|||
162780507|NCT00937521|587908870|FG002|Booster Phase|Administrative Reason|1|||
162780508|NCT00937521|587908871|FG003|Booster Phase|Administrative Reason|0|||
162780509|NCT00937521|587908872|FG004|Booster Phase|Administrative Reason|1|||
162780510|NCT00937521|587908873|FG005|Booster Phase|Administrative Reason|1|||
162780511|NCT00937521|587908874|FG006|Booster Phase|Administrative Reason|0|||
162780512|NCT00937521|587908875|FG007|Booster Phase|Administrative Reason|0|||
162780513|NCT00937521|587908868|FG000|Booster Phase|Protocol Deviation|0|||
162780514|NCT00937521|587908869|FG001|Booster Phase|Protocol Deviation|0|||
162780515|NCT00937521|587908870|FG002|Booster Phase|Protocol Deviation|0|||
162780516|NCT00937521|587908871|FG003|Booster Phase|Protocol Deviation|0|||
162780517|NCT00937521|587908872|FG004|Booster Phase|Protocol Deviation|0|||
162780518|NCT00937521|587908873|FG005|Booster Phase|Protocol Deviation|0|||
162780519|NCT00937521|587908874|FG006|Booster Phase|Protocol Deviation|1|||
162780520|NCT00937521|587908875|FG007|Booster Phase|Protocol Deviation|0|||
162780521|NCT04035577|587908876|FG000|Overall Study|Lost to Follow-up|1|||
162780522|NCT04035577|587908876|FG000|Overall Study|Withdrawal by Subject|1|||
162780523|NCT01426113|587908879|FG000|Overall Study|Study Discontinued|1|||
162780524|NCT01426113|587908880|FG001|Overall Study|Study Discontinued|1|||
162780525|NCT01426113|587908879|FG000|Overall Study|Adverse Event|0|||
162780526|NCT01426113|587908880|FG001|Overall Study|Adverse Event|1|||
162780527|NCT00878553|587908881|FG000|Sleep Study|Withdrawal by Subject|2|||
162780528|NCT00878553|587908882|FG001|Sleep Study|Withdrawal by Subject|0|||
162780529|NCT00878553|587908883|FG002|Sleep Study|Withdrawal by Subject|0|||
162780530|NCT00878553|587908884|FG003|Sleep Study|Withdrawal by Subject|0|||
162780531|NCT00878553|587908885|FG004|Sleep Study|Withdrawal by Subject|0|||
162780532|NCT00878553|587908881|FG000|Sleep Study|Lost to Follow-up|1|||
162780533|NCT00878553|587908882|FG001|Sleep Study|Lost to Follow-up|0|||
162780534|NCT00878553|587908883|FG002|Sleep Study|Lost to Follow-up|0|||
162780535|NCT00878553|587908884|FG003|Sleep Study|Lost to Follow-up|0|||
162780536|NCT00878553|587908885|FG004|Sleep Study|Lost to Follow-up|0|||
162780537|NCT00878553|587908881|FG000|Sleep Study|car accident|1|||
162780538|NCT00878553|587908882|FG001|Sleep Study|car accident|0|||
162780539|NCT00878553|587908883|FG002|Sleep Study|car accident|0|||
162780540|NCT00878553|587908884|FG003|Sleep Study|car accident|0|||
162780541|NCT00878553|587908885|FG004|Sleep Study|car accident|0|||
162780542|NCT00878553|587908881|FG000|Sleep Study|family emergency|1|||
162780543|NCT00878553|587908882|FG001|Sleep Study|family emergency|0|||
162780544|NCT00878553|587908883|FG002|Sleep Study|family emergency|0|||
162780545|NCT00878553|587908884|FG003|Sleep Study|family emergency|0|||
162780546|NCT00878553|587908885|FG004|Sleep Study|family emergency|0|||
162780547|NCT00878553|587908881|FG000|PK Study|Withdrawal by Subject|0|||
162780548|NCT00878553|587908882|FG001|PK Study|Withdrawal by Subject|0|||
162780549|NCT00878553|587908883|FG002|PK Study|Withdrawal by Subject|0|||
162780550|NCT00878553|587908884|FG003|PK Study|Withdrawal by Subject|1|||
162780551|NCT00878553|587908885|FG004|PK Study|Withdrawal by Subject|0|||
162780552|NCT00909532|587908888|FG000|Overall Study|Adverse Event|4|||
162780553|NCT00909532|587908889|FG001|Overall Study|Adverse Event|1|||
162780554|NCT00909532|587908888|FG000|Overall Study|Pregnancy|0|||
162780555|NCT00909532|587908889|FG001|Overall Study|Pregnancy|1|||
162780556|NCT00909532|587908888|FG000|Overall Study|Prohibited Medication|2|||
162780557|NCT00909532|587908889|FG001|Overall Study|Prohibited Medication|1|||
162780558|NCT00909532|587908888|FG000|Overall Study|Withdrawal of Consent|1|||
162780559|NCT00909532|587908889|FG001|Overall Study|Withdrawal of Consent|1|||
162780560|NCT00909532|587908888|FG000|Overall Study|Noncompliance with Study Requirements|0|||
162780561|NCT00909532|587908889|FG001|Overall Study|Noncompliance with Study Requirements|2|||
162780562|NCT00909532|587908888|FG000|Overall Study|Physician Decision|1|||
162780563|NCT00909532|587908889|FG001|Overall Study|Physician Decision|0|||
162780564|NCT00909532|587908888|FG000|Overall Study|Wrong Genotype|1|||
162780565|NCT00909532|587908889|FG001|Overall Study|Wrong Genotype|0|||
162780566|NCT00909532|587908888|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
162780567|NCT00909532|587908889|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
162780568|NCT03188536|587908891|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
162780569|NCT03188536|587908891|FG000|Overall Study|Not participated/met inclusion criteria|1|||
162780570|NCT00118703|587908894|FG000|Overall Study|Protocol Violation|1|||
162780571|NCT00118703|587908895|FG001|Overall Study|Protocol Violation|0|||
162780572|NCT00118703|587908894|FG000|Overall Study|Adverse Event|1|||
162780573|NCT00118703|587908895|FG001|Overall Study|Adverse Event|1|||
162780574|NCT00118703|587908894|FG000|Overall Study|Participant took two different treatment|0|||
162780575|NCT00118703|587908895|FG001|Overall Study|Participant took two different treatment|1|||
162780576|NCT00118703|587908894|FG000|Overall Study|Withdrawal by Subject|2|||
162780577|NCT00118703|587908895|FG001|Overall Study|Withdrawal by Subject|5|||
162780578|NCT00118703|587908894|FG000|Overall Study|Lost to Follow-up|1|||
162780579|NCT00118703|587908895|FG001|Overall Study|Lost to Follow-up|2|||
162780580|NCT00461123|587908896|FG000|Overall Study|Adverse Event|1|||
162780581|NCT00461123|587908897|FG001|Overall Study|Adverse Event|0|||
162780582|NCT00461123|587908896|FG000|Overall Study|Lost to Follow-up|1|||
162780583|NCT00461123|587908897|FG001|Overall Study|Lost to Follow-up|1|||
162780584|NCT00461123|587908896|FG000|Overall Study|Protocol Violation|3|||
162780585|NCT00461123|587908897|FG001|Overall Study|Protocol Violation|2|||
162780586|NCT00461123|587908896|FG000|Overall Study|Withdrawal by Subject|1|||
162780587|NCT00461123|587908897|FG001|Overall Study|Withdrawal by Subject|3|||
162780588|NCT02344173|587908898|FG000|Procedure|Ablation Procedure Not Performed|7|||
162780589|NCT02344173|587908898|FG000|12-month Visit|Death|8|||
162780590|NCT02344173|587908898|FG000|12-month Visit|Withdrawal by Subject|30|||
162780591|NCT02344173|587908898|FG000|12-month Visit|Lost to Follow-up|58|||
162780592|NCT00746356|587908903|FG000|Overall Study|Withdrawal by Subject|2|||
162780593|NCT00746356|587908904|FG001|Overall Study|Withdrawal by Subject|3|||
162780594|NCT00746356|587908903|FG000|Overall Study|Death|7|||
162780595|NCT00746356|587908904|FG001|Overall Study|Death|3|||
162780596|NCT00746356|587908903|FG000|Overall Study|Lost to Follow-up|1|||
162780597|NCT00746356|587908904|FG001|Overall Study|Lost to Follow-up|0|||
162780598|NCT00746356|587908903|FG000|Overall Study|Removal of Device|0|||
162780599|NCT00746356|587908904|FG001|Overall Study|Removal of Device|1|||
162780600|NCT00746356|587908903|FG000|Overall Study|Patient relocated|1|||
162780601|NCT00746356|587908904|FG001|Overall Study|Patient relocated|0|||
162780602|NCT01263925|587908905|FG000|Overall Study|Protocol Violation|1|||
162780603|NCT01263925|587908906|FG001|Overall Study|Protocol Violation|0|||
162780604|NCT01263925|587908905|FG000|Overall Study|Lack of Efficacy|0|||
162780605|NCT01263925|587908906|FG001|Overall Study|Lack of Efficacy|1|||
162780606|NCT01263925|587908905|FG000|Overall Study|Adverse Event|23|||
162780607|NCT01263925|587908906|FG001|Overall Study|Adverse Event|22|||
162780608|NCT01263925|587908905|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
162780609|NCT01263925|587908906|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
162780610|NCT01263925|587908905|FG000|Overall Study|Withdrawal by Subject|6|||
162780611|NCT01263925|587908906|FG001|Overall Study|Withdrawal by Subject|8|||
162780612|NCT01263925|587908905|FG000|Overall Study|Other|4|||
162780613|NCT01263925|587908906|FG001|Overall Study|Other|4|||
162780614|NCT01263925|587908905|FG000|Overall Study|Lost to Follow-up|3|||
162780615|NCT01263925|587908906|FG001|Overall Study|Lost to Follow-up|1|||
162780616|NCT01263925|587908905|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
162780617|NCT01263925|587908906|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
162780618|NCT01263925|587908905|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
162780619|NCT01263925|587908906|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
162780620|NCT01263925|587908905|FG000|Overall Study|AE/ Withdrawal|1|||
162780621|NCT01263925|587908906|FG001|Overall Study|AE/ Withdrawal|4|||
162780622|NCT01263925|587908905|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
162780623|NCT01263925|587908906|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
162780624|NCT01263925|587908905|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
162780625|NCT01263925|587908906|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
162780626|NCT01263925|587908905|FG000|Overall Study|Withdrawal/ Not specified|0|||
162780627|NCT01263925|587908906|FG001|Overall Study|Withdrawal/ Not specified|1|||
162780628|NCT01215032|587908911|FG000|Overall Study|Adverse Event|3|||
162780629|NCT01215032|587908911|FG000|Overall Study|Lack of Efficacy|17|||
162780630|NCT01560585|587908912|FG000|Overall Study|Physician Decision|3|||
162780631|NCT00983892|587908913|FG000|Overall Study|Withdrawal by Subject|10|||
162780632|NCT00983892|587908914|FG001|Overall Study|Withdrawal by Subject|12|||
162780633|NCT03028012|587908915|FG000|Overall Study|Lost to Follow-up|2|||
162780634|NCT03028012|587908916|FG001|Overall Study|Lost to Follow-up|3|||
162780635|NCT03028012|587908917|FG002|Overall Study|Lost to Follow-up|3|||
162780636|NCT02484547|587908922|FG000|Placebo-Controlled Period|Adverse Event|10|||
162780637|NCT02484547|587908923|FG001|Placebo-Controlled Period|Adverse Event|13|||
162780638|NCT02484547|587908924|FG002|Placebo-Controlled Period|Adverse Event|20|||
162780639|NCT02484547|587908925|FG003|Placebo-Controlled Period|Adverse Event|0|||
162780640|NCT02484547|587908926|FG004|Placebo-Controlled Period|Adverse Event|0|||
162780641|NCT02484547|587908927|FG005|Placebo-Controlled Period|Adverse Event|0|||
162780642|NCT02484547|587908928|FG006|Placebo-Controlled Period|Adverse Event|0|||
162780643|NCT02484547|587908922|FG000|Placebo-Controlled Period|Change of Treatment|0|||
162780644|NCT02484547|587908923|FG001|Placebo-Controlled Period|Change of Treatment|0|||
162780645|NCT02484547|587908924|FG002|Placebo-Controlled Period|Change of Treatment|1|||
162780646|NCT02484547|587908925|FG003|Placebo-Controlled Period|Change of Treatment|0|||
162780647|NCT02484547|587908926|FG004|Placebo-Controlled Period|Change of Treatment|0|||
162780648|NCT02484547|587908927|FG005|Placebo-Controlled Period|Change of Treatment|0|||
162780649|NCT02484547|587908928|FG006|Placebo-Controlled Period|Change of Treatment|0|||
162780650|NCT02484547|587908922|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
162780651|NCT02484547|587908923|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
162780652|NCT02484547|587908924|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
162780653|NCT02484547|587908925|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
162780654|NCT02484547|587908926|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
162780655|NCT02484547|587908927|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
162780656|NCT02484547|587908928|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
162780657|NCT02484547|587908922|FG000|Placebo-Controlled Period|Death|5|||
162780658|NCT02484547|587908923|FG001|Placebo-Controlled Period|Death|0|||
162780659|NCT02484547|587908924|FG002|Placebo-Controlled Period|Death|6|||
162780660|NCT02484547|587908925|FG003|Placebo-Controlled Period|Death|0|||
162780661|NCT02484547|587908926|FG004|Placebo-Controlled Period|Death|0|||
162780662|NCT02484547|587908927|FG005|Placebo-Controlled Period|Death|0|||
162780663|NCT02484547|587908928|FG006|Placebo-Controlled Period|Death|0|||
162780664|NCT02484547|587908922|FG000|Placebo-Controlled Period|Disease Progression|2|||
162780665|NCT02484547|587908923|FG001|Placebo-Controlled Period|Disease Progression|0|||
162780666|NCT02484547|587908924|FG002|Placebo-Controlled Period|Disease Progression|1|||
162780667|NCT02484547|587908925|FG003|Placebo-Controlled Period|Disease Progression|0|||
162780668|NCT02484547|587908926|FG004|Placebo-Controlled Period|Disease Progression|0|||
162780669|NCT02484547|587908927|FG005|Placebo-Controlled Period|Disease Progression|0|||
162780670|NCT02484547|587908928|FG006|Placebo-Controlled Period|Disease Progression|0|||
162780671|NCT02484547|587908922|FG000|Placebo-Controlled Period|Investigator Decision|2|||
162780672|NCT02484547|587908923|FG001|Placebo-Controlled Period|Investigator Decision|2|||
162780673|NCT02484547|587908924|FG002|Placebo-Controlled Period|Investigator Decision|5|||
162780674|NCT02484547|587908925|FG003|Placebo-Controlled Period|Investigator Decision|0|||
162780675|NCT02484547|587908926|FG004|Placebo-Controlled Period|Investigator Decision|0|||
162780676|NCT02484547|587908927|FG005|Placebo-Controlled Period|Investigator Decision|0|||
162780677|NCT02484547|587908928|FG006|Placebo-Controlled Period|Investigator Decision|0|||
162780678|NCT02484547|587908922|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
162780679|NCT02484547|587908923|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
162780680|NCT02484547|587908924|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
162780681|NCT02484547|587908925|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
162780682|NCT02484547|587908926|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
162780683|NCT02484547|587908927|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
162780684|NCT02484547|587908928|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
162780685|NCT02484547|587908922|FG000|Placebo-Controlled Period|Relocation|1|||
162780686|NCT02484547|587908923|FG001|Placebo-Controlled Period|Relocation|1|||
162780687|NCT02484547|587908924|FG002|Placebo-Controlled Period|Relocation|1|||
162780688|NCT02484547|587908925|FG003|Placebo-Controlled Period|Relocation|0|||
162780689|NCT02484547|587908926|FG004|Placebo-Controlled Period|Relocation|0|||
162780690|NCT02484547|587908927|FG005|Placebo-Controlled Period|Relocation|0|||
162780691|NCT02484547|587908928|FG006|Placebo-Controlled Period|Relocation|0|||
162780692|NCT02484547|587908922|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
162780693|NCT02484547|587908923|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
162780694|NCT02484547|587908924|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
162780695|NCT02484547|587908925|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
162780696|NCT02484547|587908926|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
162780697|NCT02484547|587908927|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
162780698|NCT02484547|587908928|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
162780699|NCT02484547|587908922|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
162780700|NCT02484547|587908923|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162780701|NCT02484547|587908924|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162780702|NCT02484547|587908925|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162780703|NCT02484547|587908926|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162780704|NCT02484547|587908927|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162780705|NCT02484547|587908928|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162780706|NCT02484547|587908922|FG000|Placebo-Controlled Period|Reason not Specified|216|||
162780707|NCT02484547|587908923|FG001|Placebo-Controlled Period|Reason not Specified|194|||
162780708|NCT02484547|587908924|FG002|Placebo-Controlled Period|Reason not Specified|183|||
162780709|NCT02484547|587908925|FG003|Placebo-Controlled Period|Reason not Specified|0|||
162780710|NCT02484547|587908926|FG004|Placebo-Controlled Period|Reason not Specified|0|||
162780711|NCT02484547|587908927|FG005|Placebo-Controlled Period|Reason not Specified|0|||
162780712|NCT02484547|587908928|FG006|Placebo-Controlled Period|Reason not Specified|0|||
162780713|NCT02484547|587908922|FG000|Long-Term Extension Period|Adverse Event|0|||
162780714|NCT02484547|587908923|FG001|Long-Term Extension Period|Adverse Event|0|||
162780715|NCT02484547|587908924|FG002|Long-Term Extension Period|Adverse Event|0|||
162780716|NCT02484547|587908925|FG003|Long-Term Extension Period|Adverse Event|0|||
162780717|NCT02484547|587908926|FG004|Long-Term Extension Period|Adverse Event|1|||
162780718|NCT02484547|587908927|FG005|Long-Term Extension Period|Adverse Event|3|||
162780719|NCT02484547|587908928|FG006|Long-Term Extension Period|Adverse Event|2|||
162780720|NCT02484547|587908922|FG000|Long-Term Extension Period|Death|0|||
162780721|NCT02484547|587908923|FG001|Long-Term Extension Period|Death|0|||
162780722|NCT02484547|587908924|FG002|Long-Term Extension Period|Death|0|||
162780723|NCT02484547|587908925|FG003|Long-Term Extension Period|Death|0|||
162780724|NCT02484547|587908926|FG004|Long-Term Extension Period|Death|0|||
162780725|NCT02484547|587908927|FG005|Long-Term Extension Period|Death|3|||
162780726|NCT02484547|587908928|FG006|Long-Term Extension Period|Death|0|||
162780727|NCT02484547|587908922|FG000|Long-Term Extension Period|Disease Progression|0|||
162780728|NCT02484547|587908923|FG001|Long-Term Extension Period|Disease Progression|0|||
162780729|NCT02484547|587908924|FG002|Long-Term Extension Period|Disease Progression|0|||
162780730|NCT02484547|587908925|FG003|Long-Term Extension Period|Disease Progression|0|||
162780731|NCT02484547|587908926|FG004|Long-Term Extension Period|Disease Progression|2|||
162780732|NCT02484547|587908927|FG005|Long-Term Extension Period|Disease Progression|4|||
162780733|NCT02484547|587908928|FG006|Long-Term Extension Period|Disease Progression|0|||
162780734|NCT02484547|587908922|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
162780735|NCT02484547|587908923|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
162780736|NCT02484547|587908924|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
162780737|NCT02484547|587908925|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
162780738|NCT02484547|587908926|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
162780739|NCT02484547|587908927|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
162780740|NCT02484547|587908928|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
162780741|NCT02484547|587908922|FG000|Long-Term Extension Period|Loss of Capacity|0|||
162780742|NCT02484547|587908923|FG001|Long-Term Extension Period|Loss of Capacity|0|||
162780743|NCT02484547|587908924|FG002|Long-Term Extension Period|Loss of Capacity|0|||
162780744|NCT02484547|587908925|FG003|Long-Term Extension Period|Loss of Capacity|0|||
162780745|NCT02484547|587908926|FG004|Long-Term Extension Period|Loss of Capacity|1|||
162780746|NCT02484547|587908927|FG005|Long-Term Extension Period|Loss of Capacity|0|||
162780747|NCT02484547|587908928|FG006|Long-Term Extension Period|Loss of Capacity|0|||
162780748|NCT02484547|587908922|FG000|Long-Term Extension Period|Change of Treatment|0|||
162780749|NCT02484547|587908923|FG001|Long-Term Extension Period|Change of Treatment|0|||
162780750|NCT02484547|587908924|FG002|Long-Term Extension Period|Change of Treatment|0|||
162780751|NCT02484547|587908925|FG003|Long-Term Extension Period|Change of Treatment|0|||
162780752|NCT02484547|587908926|FG004|Long-Term Extension Period|Change of Treatment|0|||
162780753|NCT02484547|587908927|FG005|Long-Term Extension Period|Change of Treatment|0|||
162780754|NCT02484547|587908928|FG006|Long-Term Extension Period|Change of Treatment|1|||
162780755|NCT02484547|587908922|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
162780756|NCT02484547|587908923|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
162780757|NCT02484547|587908924|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
162780758|NCT02484547|587908925|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
162780759|NCT02484547|587908926|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
162780760|NCT02484547|587908927|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
162780761|NCT02484547|587908928|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
162780762|NCT02484547|587908922|FG000|Long-Term Extension Period|Investigator Decision|0|||
162780763|NCT02484547|587908923|FG001|Long-Term Extension Period|Investigator Decision|0|||
162780764|NCT02484547|587908924|FG002|Long-Term Extension Period|Investigator Decision|0|||
162780765|NCT02484547|587908925|FG003|Long-Term Extension Period|Investigator Decision|2|||
162780766|NCT02484547|587908926|FG004|Long-Term Extension Period|Investigator Decision|1|||
162780767|NCT02484547|587908927|FG005|Long-Term Extension Period|Investigator Decision|0|||
162780768|NCT02484547|587908928|FG006|Long-Term Extension Period|Investigator Decision|1|||
162780769|NCT02484547|587908922|FG000|Long-Term Extension Period|Relocation|0|||
162780770|NCT02484547|587908923|FG001|Long-Term Extension Period|Relocation|0|||
162780771|NCT02484547|587908924|FG002|Long-Term Extension Period|Relocation|0|||
162780772|NCT02484547|587908925|FG003|Long-Term Extension Period|Relocation|1|||
162780773|NCT02484547|587908926|FG004|Long-Term Extension Period|Relocation|1|||
162780774|NCT02484547|587908927|FG005|Long-Term Extension Period|Relocation|0|||
162780775|NCT02484547|587908928|FG006|Long-Term Extension Period|Relocation|0|||
162780776|NCT02484547|587908922|FG000|Long-Term Extension Period|Study Visit Burden|0|||
162780777|NCT02484547|587908923|FG001|Long-Term Extension Period|Study Visit Burden|0|||
162780778|NCT02484547|587908924|FG002|Long-Term Extension Period|Study Visit Burden|0|||
162780779|NCT02484547|587908925|FG003|Long-Term Extension Period|Study Visit Burden|2|||
162780780|NCT02484547|587908926|FG004|Long-Term Extension Period|Study Visit Burden|0|||
162780781|NCT02484547|587908927|FG005|Long-Term Extension Period|Study Visit Burden|0|||
162780782|NCT02484547|587908928|FG006|Long-Term Extension Period|Study Visit Burden|3|||
162780783|NCT02484547|587908922|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162780784|NCT02484547|587908923|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162780785|NCT02484547|587908924|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162780786|NCT02484547|587908925|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162780787|NCT02484547|587908926|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
162780788|NCT02484547|587908927|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
162780789|NCT02484547|587908928|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
162780790|NCT02484547|587908922|FG000|Long-Term Extension Period|Reason not Specified|0|||
162780791|NCT02484547|587908923|FG001|Long-Term Extension Period|Reason not Specified|0|||
162780792|NCT02484547|587908924|FG002|Long-Term Extension Period|Reason not Specified|0|||
162780793|NCT02484547|587908925|FG003|Long-Term Extension Period|Reason not Specified|119|||
162780794|NCT02484547|587908926|FG004|Long-Term Extension Period|Reason not Specified|117|||
162780795|NCT02484547|587908927|FG005|Long-Term Extension Period|Reason not Specified|223|||
162780796|NCT02484547|587908928|FG006|Long-Term Extension Period|Reason not Specified|231|||
162780797|NCT03765164|587908929|FG000|Pre-intervention|Withdrawal by Subject|5|||
162780798|NCT03765164|587908930|FG001|Pre-intervention|Withdrawal by Subject|6|||
162780799|NCT01813305|587908931|FG000|Overall Study|Withdrawal by Subject|12|||
162780800|NCT01813305|587908932|FG001|Overall Study|Withdrawal by Subject|5|||
162780801|NCT01813305|587908931|FG000|Overall Study|Safety Concern|4|||
162780802|NCT01813305|587908932|FG001|Overall Study|Safety Concern|0|||
162780803|NCT01813305|587908931|FG000|Overall Study|Ulcer became worse|4|||
162780804|NCT01813305|587908932|FG001|Overall Study|Ulcer became worse|0|||
162780805|NCT01813305|587908931|FG000|Overall Study|Physician Decision|4|||
162780806|NCT01813305|587908932|FG001|Overall Study|Physician Decision|0|||
162780807|NCT01813305|587908931|FG000|Overall Study|Lost to Follow-up|3|||
162780808|NCT01813305|587908932|FG001|Overall Study|Lost to Follow-up|1|||
162780809|NCT01813305|587908931|FG000|Overall Study|Protocol Violation|1|||
162780810|NCT01813305|587908932|FG001|Overall Study|Protocol Violation|0|||
162780811|NCT01813305|587908931|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
162780812|NCT01813305|587908932|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
162780813|NCT03448536|587908933|FG000|Overall Study|Protocol Violation|2|||
162780814|NCT03448536|587908934|FG001|Overall Study|Protocol Violation|0|||
162780815|NCT03448536|587908933|FG000|Overall Study|Pregnancy|1|||
162780816|NCT03448536|587908934|FG001|Overall Study|Pregnancy|0|||
162780817|NCT03448536|587908933|FG000|Overall Study|Withdrawal by Subject|1|||
162780818|NCT03448536|587908934|FG001|Overall Study|Withdrawal by Subject|2|||
162780819|NCT03448536|587908933|FG000|Overall Study|Lost to Follow-up|3|||
162780820|NCT03448536|587908934|FG001|Overall Study|Lost to Follow-up|2|||
162780821|NCT03448536|587908933|FG000|Overall Study|Inadequate pain reporter|1|||
162780822|NCT03448536|587908934|FG001|Overall Study|Inadequate pain reporter|0|||
162780823|NCT03448536|587908933|FG000|Overall Study|Other|3|||
162780824|NCT03448536|587908934|FG001|Overall Study|Other|0|||
162780825|NCT03448536|587908933|FG000|Overall Study|Physician Decision|1|||
162780826|NCT03448536|587908934|FG001|Overall Study|Physician Decision|0|||
162780827|NCT01665599|587908935|FG000|Overall Study|Adverse Event|1|||
162780828|NCT01665599|587908935|FG000|Overall Study|Consent Withdrawn|1|||
162780829|NCT01665599|587908935|FG000|Overall Study|Investigator/Sponsor decision|1|||
162780830|NCT01665599|587908935|FG000|Overall Study|Death|1|||
162780831|NCT01665599|587908935|FG000|Overall Study|Lost to Follow-up|2|||
162780832|NCT01665599|587908935|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
162780833|NCT01665599|587908935|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
162780834|NCT00770588|587908936|FG000|Overall Study|Adverse Event|9|||
162780835|NCT00770588|587908937|FG001|Overall Study|Adverse Event|2|||
162780836|NCT00770588|587908936|FG000|Overall Study|Death caused by progression of disease|70|||
162780837|NCT00770588|587908937|FG001|Overall Study|Death caused by progression of disease|91|||
162780838|NCT00770588|587908936|FG000|Overall Study|Lost to Follow-up|1|||
162780839|NCT00770588|587908937|FG001|Overall Study|Lost to Follow-up|1|||
162780840|NCT00770588|587908936|FG000|Overall Study|Withdrawal by Subject|1|||
162780841|NCT00770588|587908937|FG001|Overall Study|Withdrawal by Subject|1|||
162780842|NCT03120949|587908938|FG000|Overall Study|randomized in error|1|||
162780843|NCT03120949|587908939|FG001|Overall Study|randomized in error|0|||
162780844|NCT03120949|587908938|FG000|Overall Study|Death|13|||
162780845|NCT03120949|587908939|FG001|Overall Study|Death|13|||
162780846|NCT03120949|587908938|FG000|Overall Study|Lost to Follow-up|23|||
162780847|NCT03120949|587908939|FG001|Overall Study|Lost to Follow-up|13|||
162780848|NCT03120949|587908938|FG000|Overall Study|Withdrawal by Subject|139|||
162780849|NCT03120949|587908939|FG001|Overall Study|Withdrawal by Subject|124|||
162780850|NCT03120949|587908938|FG000|Overall Study|Covid-19|43|||
162780851|NCT03120949|587908939|FG001|Overall Study|Covid-19|34|||
162780852|NCT03120949|587908938|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
162780853|NCT03120949|587908939|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
162780854|NCT03120949|587908938|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
162780855|NCT03120949|587908939|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
162780856|NCT03120949|587908938|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
162780857|NCT03120949|587908939|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
162780858|NCT03120949|587908938|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
162780859|NCT03120949|587908939|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
162780860|NCT03120949|587908938|FG000|Overall Study|Site was closed|2|||
162780861|NCT03120949|587908939|FG001|Overall Study|Site was closed|3|||
162780862|NCT03120949|587908938|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
162780863|NCT03120949|587908939|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
162780864|NCT03120949|587908938|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
162780865|NCT03120949|587908939|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
162780866|NCT03120949|587908938|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
162780867|NCT03120949|587908939|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
162780868|NCT03120949|587908938|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
162780869|NCT03120949|587908939|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
162780870|NCT03120949|587908938|FG000|Overall Study|Other: Adverse Event|0|||
162780871|NCT03120949|587908939|FG001|Overall Study|Other: Adverse Event|1|||
162780872|NCT03120949|587908938|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
162780873|NCT03120949|587908939|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
162780874|NCT03120949|587908938|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
162780875|NCT03120949|587908939|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
162780876|NCT03120949|587908938|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
162780877|NCT03120949|587908939|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
162780878|NCT03120949|587908938|FG000|Overall Study|Personal Reasons|0|||
162780879|NCT03120949|587908939|FG001|Overall Study|Personal Reasons|1|||
162780880|NCT03120949|587908938|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
162780881|NCT03120949|587908939|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
162780882|NCT03120949|587908938|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
162780883|NCT03120949|587908939|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
162780884|NCT03120949|587908938|FG000|Overall Study|Compliance With Medication|0|||
162780885|NCT03120949|587908939|FG001|Overall Study|Compliance With Medication|1|||
162780886|NCT03120949|587908938|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
162780887|NCT03120949|587908939|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
162780888|NCT03120949|587908938|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
162780889|NCT03120949|587908939|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
162780890|NCT03120949|587908938|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
162780891|NCT03120949|587908939|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
162780892|NCT01705145|587908940|FG000|Part B|Adverse Event|1|||
162780893|NCT00988117|587908941|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
162780894|NCT00988117|587908941|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
162780895|NCT01077622|587908943|FG000|Overall Study|Physician Decision|2|||
162780896|NCT01077622|587908943|FG000|Overall Study|Withdrawal by Subject|1|||
162780897|NCT00424177|587908944|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
162780898|NCT00424177|587908944|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
162780899|NCT00424177|587908944|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
162780900|NCT00424177|587908944|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
162780901|NCT00424177|587908944|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
162780902|NCT00424177|587908944|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
162780903|NCT00424177|587908944|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
162780904|NCT00424177|587908944|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
162780905|NCT00424177|587908944|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
162780906|NCT00424177|587908944|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
162780907|NCT01091519|587908945|FG000|Overall Study|Adverse Event|12|||
162780908|NCT01091519|587908946|FG001|Overall Study|Adverse Event|16|||
162780909|NCT01091519|587908945|FG000|Overall Study|Death|1|||
162780910|NCT01091519|587908946|FG001|Overall Study|Death|0|||
162780911|NCT01091519|587908945|FG000|Overall Study|Lack of Efficacy|16|||
162780912|NCT01091519|587908946|FG001|Overall Study|Lack of Efficacy|19|||
162780913|NCT01091519|587908945|FG000|Overall Study|Lost to Follow-up|14|||
162780914|NCT01091519|587908946|FG001|Overall Study|Lost to Follow-up|24|||
162780915|NCT01091519|587908945|FG000|Overall Study|Withdrawal by Subject|2|||
162780916|NCT01091519|587908946|FG001|Overall Study|Withdrawal by Subject|2|||
162780917|NCT01091519|587908945|FG000|Overall Study|Other|6|||
162780918|NCT01091519|587908946|FG001|Overall Study|Other|8|||
162780919|NCT01091519|587908945|FG000|Overall Study|Randomized not treated|4|||
162780920|NCT01091519|587908946|FG001|Overall Study|Randomized not treated|4|||
162780921|NCT00316589|587908949|FG000|Overall Study|Withdrawal by Subject|0|||
162780922|NCT00316589|587908950|FG001|Overall Study|Withdrawal by Subject|5|||
162780923|NCT00316589|587908951|FG002|Overall Study|Withdrawal by Subject|0|||
162780924|NCT00316589|587908952|FG003|Overall Study|Withdrawal by Subject|1|||
162780925|NCT00316589|587908949|FG000|Overall Study|Subject unwilling/unable to comply|0|||
162780926|NCT00316589|587908950|FG001|Overall Study|Subject unwilling/unable to comply|6|||
162780927|NCT00316589|587908951|FG002|Overall Study|Subject unwilling/unable to comply|0|||
162780928|NCT00316589|587908952|FG003|Overall Study|Subject unwilling/unable to comply|2|||
162780929|NCT00316589|587908949|FG000|Overall Study|Adverse Event|1|||
162780930|NCT00316589|587908950|FG001|Overall Study|Adverse Event|0|||
162780931|NCT00316589|587908951|FG002|Overall Study|Adverse Event|0|||
162780932|NCT00316589|587908952|FG003|Overall Study|Adverse Event|1|||
162780933|NCT00316589|587908949|FG000|Overall Study|Physician Decision|0|||
162780934|NCT00316589|587908950|FG001|Overall Study|Physician Decision|1|||
162780935|NCT00316589|587908951|FG002|Overall Study|Physician Decision|0|||
162780936|NCT00316589|587908952|FG003|Overall Study|Physician Decision|0|||
162780937|NCT00316589|587908949|FG000|Overall Study|Other reason|0|||
162780938|NCT00316589|587908950|FG001|Overall Study|Other reason|12|||
162780939|NCT00316589|587908951|FG002|Overall Study|Other reason|1|||
162780940|NCT00316589|587908952|FG003|Overall Study|Other reason|1|||
162780941|NCT00562484|587908953|FG000|Overall Study|Adverse Event|6|||
162780942|NCT00562484|587908954|FG001|Overall Study|Adverse Event|1|||
162780943|NCT00562484|587908953|FG000|Overall Study|Protocol Violation|11|||
162780944|NCT00562484|587908954|FG001|Overall Study|Protocol Violation|2|||
162780945|NCT00562484|587908953|FG000|Overall Study|Withdrawal by Subject|12|||
162780946|NCT00562484|587908954|FG001|Overall Study|Withdrawal by Subject|9|||
162780947|NCT00562484|587908953|FG000|Overall Study|Moved away from the study area|20|||
162780948|NCT00562484|587908954|FG001|Overall Study|Moved away from the study area|9|||
162780949|NCT00562484|587908953|FG000|Overall Study|Lost to Follow-up|132|||
162780950|NCT00562484|587908954|FG001|Overall Study|Lost to Follow-up|71|||
162780951|NCT00562484|587908953|FG000|Overall Study|Reason not provided or not specified|25|||
162780952|NCT00562484|587908954|FG001|Overall Study|Reason not provided or not specified|12|||
162780953|NCT02598934|587908959|FG000|Overall Study|Adverse Event|11|||
162780954|NCT02598934|587908960|FG001|Overall Study|Adverse Event|13|||
162780955|NCT02598934|587908959|FG000|Overall Study|Failure to Return|3|||
162780956|NCT02598934|587908960|FG001|Overall Study|Failure to Return|3|||
162780957|NCT02598934|587908959|FG000|Overall Study|Withdrawal by Subject|2|||
162780958|NCT02598934|587908960|FG001|Overall Study|Withdrawal by Subject|3|||
162780959|NCT02598934|587908959|FG000|Overall Study|Administrative|2|||
162780960|NCT02598934|587908960|FG001|Overall Study|Administrative|1|||
162780961|NCT02598934|587908959|FG000|Overall Study|Protocol Violation|1|||
162780962|NCT02598934|587908960|FG001|Overall Study|Protocol Violation|2|||
162780963|NCT00702520|587908961|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162780964|NCT00702520|587908962|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
162780965|NCT00702520|587908963|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162780966|NCT00702520|587908964|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162780967|NCT00702520|587908961|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
162780968|NCT00702520|587908962|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
162780969|NCT00702520|587908963|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
162780970|NCT00702520|587908964|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
162780971|NCT00702520|587908961|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
162780972|NCT00702520|587908962|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
162780973|NCT00702520|587908963|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
162780974|NCT00702520|587908964|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
162780975|NCT02154347|587908965|FG000|Double-blind Period|Adverse Event|1|||
162780976|NCT02154347|587908966|FG001|Double-blind Period|Adverse Event|2|||
162780977|NCT02154347|587908965|FG000|Double-blind Period|Lack of Efficacy|1|||
162780978|NCT02154347|587908966|FG001|Double-blind Period|Lack of Efficacy|0|||
162780979|NCT02154347|587908965|FG000|Double-blind Period|Physician Decision|0|||
162780980|NCT02154347|587908966|FG001|Double-blind Period|Physician Decision|1|||
162780981|NCT02154347|587908965|FG000|Double-blind Period|Withdrawal by Subject|1|||
162780982|NCT02154347|587908966|FG001|Double-blind Period|Withdrawal by Subject|1|||
162780983|NCT02154347|587908965|FG000|Open-label Period|Adverse Event|3|||
162780984|NCT02154347|587908966|FG001|Open-label Period|Adverse Event|4|||
162780985|NCT02154347|587908965|FG000|Open-label Period|Lack of Efficacy|4|||
162780986|NCT02154347|587908966|FG001|Open-label Period|Lack of Efficacy|19|||
162780987|NCT02154347|587908965|FG000|Open-label Period|Protocol Violation|0|||
162780988|NCT02154347|587908966|FG001|Open-label Period|Protocol Violation|1|||
162780989|NCT02154347|587908965|FG000|Open-label Period|Withdrawal by Subject|0|||
162780990|NCT02154347|587908966|FG001|Open-label Period|Withdrawal by Subject|1|||
162780991|NCT02481934|587908967|FG000|Overall Study|Death|2|||
162780992|NCT02473913|587908968|FG000|Overall Study|Lost to Follow-up|3|||
162780993|NCT02473913|587908969|FG001|Overall Study|Lost to Follow-up|3|||
162780994|NCT02250183|587908975|FG000|Overall Study|Withdrawal by Subject|2|||
162780995|NCT02250183|587908975|FG000|Overall Study|Adverse Event|5|||
162780996|NCT02250183|587908975|FG000|Overall Study|Lost to Follow-up|1|||
162780997|NCT03282799|587908976|FG000|Overall Study|Pregnancy|1|||
162780998|NCT03282799|587908977|FG001|Overall Study|Pregnancy|0|||
162780999|NCT03282799|587908976|FG000|Overall Study|Physician Decision|1|||
162781000|NCT03282799|587908977|FG001|Overall Study|Physician Decision|0|||
162781001|NCT03749616|587908978|FG000|Overall Study|Lost to Follow-up|4|||
162781002|NCT03749616|587908979|FG001|Overall Study|Lost to Follow-up|7|||
162781003|NCT03749616|587908978|FG000|Overall Study|Screen Failure|1|||
162781004|NCT03749616|587908979|FG001|Overall Study|Screen Failure|1|||
162781005|NCT03749616|587908978|FG000|Overall Study|Withdrawal by Subject|2|||
162781006|NCT03749616|587908979|FG001|Overall Study|Withdrawal by Subject|0|||
162781007|NCT03440047|587910795|FG000|Overall Study|Withdrawal by Subject|2|||
162781008|NCT01053247|587910800|FG000|Overall Study|Withdrawal by Subject|9|||
162781009|NCT01053247|587910801|FG001|Overall Study|Withdrawal by Subject|4|||
162781010|NCT01053247|587910802|FG002|Overall Study|Withdrawal by Subject|15|||
162781011|NCT01053247|587910800|FG000|Overall Study|Lack of Efficacy|1|||
162781012|NCT01053247|587910801|FG001|Overall Study|Lack of Efficacy|0|||
162781013|NCT01053247|587910802|FG002|Overall Study|Lack of Efficacy|1|||
162781014|NCT01053247|587910800|FG000|Overall Study|Protocol Violation|2|||
162781015|NCT01053247|587910801|FG001|Overall Study|Protocol Violation|1|||
162781016|NCT01053247|587910802|FG002|Overall Study|Protocol Violation|2|||
162781017|NCT01053247|587910800|FG000|Overall Study|Lost to Follow-up|8|||
162781018|NCT01053247|587910801|FG001|Overall Study|Lost to Follow-up|5|||
162781019|NCT01053247|587910802|FG002|Overall Study|Lost to Follow-up|7|||
162781020|NCT01053247|587910800|FG000|Overall Study|Adverse Event|0|||
162781021|NCT01053247|587910801|FG001|Overall Study|Adverse Event|9|||
162781022|NCT01053247|587910802|FG002|Overall Study|Adverse Event|3|||
162781023|NCT03458728|587910803|FG000|Overall Study|Adverse Event|1|||
162781024|NCT03458728|587910804|FG001|Overall Study|Adverse Event|0|||
162781025|NCT03458728|587910803|FG000|Overall Study|Physician Decision|1|||
162781026|NCT03458728|587910804|FG001|Overall Study|Physician Decision|0|||
162781027|NCT03458728|587910803|FG000|Overall Study|Progressive disease - clinical assessment|1|||
162781028|NCT03458728|587910804|FG001|Overall Study|Progressive disease - clinical assessment|0|||
162781029|NCT03458728|587910803|FG000|Overall Study|Progressive disease - radiological progression|21|||
162781030|NCT03458728|587910804|FG001|Overall Study|Progressive disease - radiological progression|6|||
162781031|NCT03458728|587910803|FG000|Overall Study|Withdrawal by Subject|0|||
162781032|NCT03458728|587910804|FG001|Overall Study|Withdrawal by Subject|1|||
162781033|NCT00908349|587910807|FG000|Overall Study|Adverse Event|10|||
162781034|NCT00908349|587910807|FG000|Overall Study|Withdrawal by Subject|9|||
162781035|NCT00908349|587910807|FG000|Overall Study|Physician Decision|5|||
162781036|NCT00908349|587910807|FG000|Overall Study|Lost to Follow-up|5|||
162781037|NCT00908349|587910807|FG000|Overall Study|Various|6|||
162781038|NCT00971997|587910810|FG000|Overall Study|Adverse Event|2|||
162781039|NCT00971997|587910810|FG000|Overall Study|Death|1|||
162781040|NCT00971997|587910810|FG000|Overall Study|Protocol Violation|4|||
162781041|NCT00971997|587910810|FG000|Overall Study|Withdrawal by Subject|5|||
162781042|NCT00971997|587910810|FG000|Overall Study|Physician Decision|7|||
162781043|NCT04843579|587910814|FG000|Overall Study|Adverse Event|1|||
162781044|NCT04843579|587910814|FG000|Overall Study|Disease Progression|1|||
162781045|NCT04009629|587910815|FG000|Overall Study|Withdrawal by Subject|2|||
162781046|NCT04009629|587910816|FG001|Overall Study|Withdrawal by Subject|0|||
162781047|NCT00761956|587910817|FG000|Overall Study|Lost to Follow-up|6|||
162781048|NCT00761956|587910818|FG001|Overall Study|Lost to Follow-up|11|||
162781049|NCT00761956|587910817|FG000|Overall Study|Withdrawal by Subject|3|||
162781050|NCT00761956|587910818|FG001|Overall Study|Withdrawal by Subject|8|||
162781051|NCT00761956|587910817|FG000|Overall Study|Death|0|||
162781052|NCT00761956|587910818|FG001|Overall Study|Death|1|||
162781053|NCT00761956|587910817|FG000|Overall Study|Adverse Event|26|||
162781054|NCT00761956|587910818|FG001|Overall Study|Adverse Event|34|||
162781055|NCT04398368|587910824|FG000|Overall Study|Withdrawal by Subject|2|||
162781056|NCT03602586|587910825|FG000|Overall Study|Withdrawal by Subject|3|||
162781057|NCT01755546|587910828|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
162781058|NCT01755546|587910828|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
162781059|NCT01755546|587910828|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
162781060|NCT01755546|587910828|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
162781061|NCT01755546|587910828|FG000|Titration Phase|Adverse Event|11|||
162781062|NCT01755546|587910828|FG000|Titration Phase|Lack of Efficacy|18|||
162781063|NCT01755546|587910828|FG000|Titration Phase|Protocol Violation|9|||
162781064|NCT01755546|587910828|FG000|Titration Phase|Lost to Follow-up|2|||
162781065|NCT01755546|587910828|FG000|Titration Phase|Other and Continuing|22|||
162781066|NCT01755546|587910828|FG000|Titration Phase|Withdrawal by Subject|8|||
162781067|NCT01755546|587910828|FG000|Long Term Treatment|Adverse Event|12|||
162781068|NCT01755546|587910828|FG000|Long Term Treatment|Lack of Efficacy|6|||
162781069|NCT01755546|587910828|FG000|Long Term Treatment|Protocol Violation|10|||
162781070|NCT01755546|587910828|FG000|Long Term Treatment|Withdrawal by Subject|35|||
162781071|NCT01755546|587910828|FG000|Long Term Treatment|Lost to Follow-up|17|||
162781072|NCT01755546|587910828|FG000|Long Term Treatment|other and ongoing|41|||
162781073|NCT04702893|587910829|FG000|Overall Study|Other reasons than listed|11|||
162781074|NCT04702893|587910829|FG000|Overall Study|Withdrawal by Subject|3|||
162781075|NCT04702893|587910829|FG000|Overall Study|Lost to Follow-up|7|||
162781076|NCT04702893|587910829|FG000|Overall Study|Death|10|||
162781077|NCT04702893|587910829|FG000|Overall Study|Not treated|6|||
162781078|NCT01114139|587910831|FG000|Overall Study|Adverse Event|3|||
162781079|NCT01114139|587910832|FG001|Overall Study|Adverse Event|2|||
162781080|NCT01114139|587910831|FG000|Overall Study|Lost to Follow-up|15|||
162781081|NCT01114139|587910832|FG001|Overall Study|Lost to Follow-up|3|||
162781082|NCT01114139|587910831|FG000|Overall Study|Withdrawal by Subject|17|||
162781083|NCT01114139|587910832|FG001|Overall Study|Withdrawal by Subject|6|||
162781084|NCT01114139|587910831|FG000|Overall Study|Other-Missed 1 visit|1|||
162781085|NCT01114139|587910832|FG001|Overall Study|Other-Missed 1 visit|0|||
162781086|NCT01114139|587910831|FG000|Overall Study|Other-Protocol Violation|1|||
162781087|NCT01114139|587910832|FG001|Overall Study|Other-Protocol Violation|0|||
162781088|NCT01114139|587910831|FG000|Overall Study|Other-Out of window for study drug dose|1|||
162781089|NCT01114139|587910832|FG001|Overall Study|Other-Out of window for study drug dose|0|||
162781090|NCT01114139|587910831|FG000|Overall Study|Other-Participant falsified records|0|||
162781091|NCT01114139|587910832|FG001|Overall Study|Other-Participant falsified records|1|||
162781092|NCT01114139|587910831|FG000|Overall Study|Other-Participant went on hospice|0|||
162781093|NCT01114139|587910832|FG001|Overall Study|Other-Participant went on hospice|1|||
162781094|NCT01114139|587910831|FG000|Overall Study|Other-Physician changed treatment|1|||
162781095|NCT01114139|587910832|FG001|Overall Study|Other-Physician changed treatment|0|||
162781096|NCT01114139|587910831|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
162781097|NCT01114139|587910832|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
162781098|NCT01951378|587910833|FG000|Overall Study|Study Terminated-Not completed|23|||
162781099|NCT01951378|587910834|FG001|Overall Study|Study Terminated-Not completed|17|||
162781100|NCT00477464|587910836|FG000|Overall Study|Lost to Follow-up|1|||
162781101|NCT00477464|587910836|FG000|Overall Study|Death|36|||
162781102|NCT00477464|587910836|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
162781103|NCT03568812|587910837|FG000|Overall Study|Physician Decision|0|||
162781104|NCT03568812|587910838|FG001|Overall Study|Physician Decision|1|||
162781105|NCT00639769|587910840|FG000|Overall Study|Death|2|||
162781106|NCT00639769|587910840|FG000|Overall Study|Adverse Event|7|||
162781107|NCT00639769|587910840|FG000|Overall Study|Lack of Efficacy|1|||
162781108|NCT00639769|587910840|FG000|Overall Study|Disease progression|26|||
162781109|NCT00639769|587910840|FG000|Overall Study|Withdrawal by Subject|4|||
162781110|NCT00634842|587910841|FG000|Overall Study|Adverse Event|2|||
162781111|NCT00634842|587910842|FG001|Overall Study|Adverse Event|3|||
162781112|NCT00634842|587910841|FG000|Overall Study|Protocol Violation|8|||
162781113|NCT00634842|587910842|FG001|Overall Study|Protocol Violation|4|||
162781114|NCT00634842|587910841|FG000|Overall Study|Move to another state|1|||
162781115|NCT00634842|587910842|FG001|Overall Study|Move to another state|0|||
162781116|NCT00634842|587910841|FG000|Overall Study|Inclusion criteria were not met|1|||
162781117|NCT00634842|587910842|FG001|Overall Study|Inclusion criteria were not met|0|||
162781118|NCT00634842|587910841|FG000|Overall Study|Lost to Follow-up|1|||
162781119|NCT00634842|587910842|FG001|Overall Study|Lost to Follow-up|2|||
162781120|NCT00634842|587910841|FG000|Overall Study|Physician Decision|1|||
162781121|NCT00634842|587910842|FG001|Overall Study|Physician Decision|0|||
162781122|NCT00634842|587910841|FG000|Overall Study|Withdrawal by Subject|1|||
162781123|NCT00634842|587910842|FG001|Overall Study|Withdrawal by Subject|3|||
162781124|NCT00634842|587910841|FG000|Overall Study|Lack of time and intolerance to drug|0|||
162781125|NCT00634842|587910842|FG001|Overall Study|Lack of time and intolerance to drug|1|||
162781126|NCT00634842|587910841|FG000|Overall Study|Discontinued due to injection|0|||
162781127|NCT00634842|587910842|FG001|Overall Study|Discontinued due to injection|2|||
162781128|NCT00634842|587910841|FG000|Overall Study|No need of study drug to treat diabetes|0|||
162781129|NCT00634842|587910842|FG001|Overall Study|No need of study drug to treat diabetes|1|||
162781130|NCT00634842|587910841|FG000|Overall Study|No wish to keep taking Avandia|0|||
162781131|NCT00634842|587910842|FG001|Overall Study|No wish to keep taking Avandia|1|||
162781132|NCT00634842|587910841|FG000|Overall Study|Subject off study drug for too long|0|||
162781133|NCT00634842|587910842|FG001|Overall Study|Subject off study drug for too long|1|||
162781134|NCT03294941|587910843|FG000|Overall Study|Withdrawal by Subject|0|||
162781135|NCT03294941|587910844|FG001|Overall Study|Withdrawal by Subject|2|||
162781136|NCT04629443|587910845|FG000|Overall Study|Adverse Event|2|||
162781137|NCT04629443|587910846|FG001|Overall Study|Adverse Event|1|||
162781138|NCT04629443|587910847|FG002|Overall Study|Adverse Event|2|||
162781139|NCT04629443|587910845|FG000|Overall Study|Progressive Disease|2|||
162781140|NCT04629443|587910846|FG001|Overall Study|Progressive Disease|3|||
162781141|NCT04629443|587910847|FG002|Overall Study|Progressive Disease|3|||
162781142|NCT04629443|587910845|FG000|Overall Study|Physician Decision|1|||
162781143|NCT04629443|587910846|FG001|Overall Study|Physician Decision|3|||
162781144|NCT04629443|587910847|FG002|Overall Study|Physician Decision|0|||
162781145|NCT01172639|587910853|FG000|Overall Study|Death|1|||
162781146|NCT01172639|587910854|FG001|Overall Study|Death|1|||
162781147|NCT01172639|587910855|FG002|Overall Study|Death|0|||
162781148|NCT01172639|587910856|FG003|Overall Study|Death|0|||
162781149|NCT01172639|587910857|FG004|Overall Study|Death|0|||
162781150|NCT01172639|587910853|FG000|Overall Study|Lost to Follow-up|9|||
162781151|NCT01172639|587910854|FG001|Overall Study|Lost to Follow-up|7|||
162781152|NCT01172639|587910855|FG002|Overall Study|Lost to Follow-up|11|||
162781153|NCT01172639|587910856|FG003|Overall Study|Lost to Follow-up|6|||
162781154|NCT01172639|587910857|FG004|Overall Study|Lost to Follow-up|6|||
162781155|NCT01172639|587910853|FG000|Overall Study|Withdrawal by Subject|3|||
162781156|NCT01172639|587910854|FG001|Overall Study|Withdrawal by Subject|3|||
162781157|NCT01172639|587910855|FG002|Overall Study|Withdrawal by Subject|5|||
162781158|NCT01172639|587910856|FG003|Overall Study|Withdrawal by Subject|5|||
162781159|NCT01172639|587910857|FG004|Overall Study|Withdrawal by Subject|0|||
162781160|NCT02172950|587910858|FG000|Overall Study|Physician Decision|3|||
162781161|NCT02172950|587910859|FG001|Overall Study|Physician Decision|3|||
162781162|NCT02172950|587910858|FG000|Overall Study|Lack of Efficacy|1|||
162781163|NCT02172950|587910859|FG001|Overall Study|Lack of Efficacy|0|||
162781164|NCT02172950|587910858|FG000|Overall Study|Adverse Event|4|||
162781165|NCT02172950|587910859|FG001|Overall Study|Adverse Event|1|||
162781166|NCT02172950|587910858|FG000|Overall Study|Withdrawal by Subject|10|||
162781167|NCT02172950|587910859|FG001|Overall Study|Withdrawal by Subject|0|||
162781168|NCT02172950|587910858|FG000|Overall Study|Protocol Violation|1|||
162781169|NCT02172950|587910859|FG001|Overall Study|Protocol Violation|0|||
162781170|NCT02172950|587910858|FG000|Overall Study|Lost to Follow-up|1|||
162781171|NCT02172950|587910859|FG001|Overall Study|Lost to Follow-up|0|||
162781172|NCT02172950|587910858|FG000|Overall Study|Death|1|||
162781173|NCT02172950|587910859|FG001|Overall Study|Death|0|||
162781174|NCT02172950|587910858|FG000|Overall Study|Patient traveling|1|||
162781175|NCT02172950|587910859|FG001|Overall Study|Patient traveling|0|||
162781176|NCT02172950|587910858|FG000|Overall Study|Patient went to other country|1|||
162781177|NCT02172950|587910859|FG001|Overall Study|Patient went to other country|0|||
162781178|NCT02172950|587910858|FG000|Overall Study|Patient relocated overseas|1|||
162781179|NCT02172950|587910859|FG001|Overall Study|Patient relocated overseas|1|||
162781180|NCT02172950|587910858|FG000|Overall Study|Patient moving|1|||
162781181|NCT02172950|587910859|FG001|Overall Study|Patient moving|0|||
162781182|NCT01086384|587910862|FG000|2-week Run-in Period|Adverse Event|1|||
162781183|NCT01086384|587910863|FG001|2-week Run-in Period|Adverse Event|0|||
162781184|NCT01086384|587910864|FG002|2-week Run-in Period|Adverse Event|0|||
162781185|NCT01086384|587910862|FG000|2-week Run-in Period|Protocol Violation|1|||
162781186|NCT01086384|587910863|FG001|2-week Run-in Period|Protocol Violation|0|||
162781187|NCT01086384|587910864|FG002|2-week Run-in Period|Protocol Violation|0|||
162781188|NCT01086384|587910862|FG000|2-week Run-in Period|Lost to Follow-up|1|||
162781189|NCT01086384|587910863|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162781190|NCT01086384|587910864|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162781191|NCT01086384|587910862|FG000|2-week Run-in Period|Physician Decision|6|||
162781192|NCT01086384|587910863|FG001|2-week Run-in Period|Physician Decision|0|||
162781193|NCT01086384|587910864|FG002|2-week Run-in Period|Physician Decision|0|||
162781194|NCT01086384|587910862|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
162781195|NCT01086384|587910863|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162781196|NCT01086384|587910864|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162781197|NCT01086384|587910862|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
162781198|NCT01086384|587910863|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
162781199|NCT01086384|587910864|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
162781200|NCT01086384|587910862|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
162781201|NCT01086384|587910863|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
162781202|NCT01086384|587910864|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
162781203|NCT01086384|587910862|FG000|2-week Run-in Period|Randomized in Error|1|||
162781204|NCT01086384|587910863|FG001|2-week Run-in Period|Randomized in Error|0|||
162781205|NCT01086384|587910864|FG002|2-week Run-in Period|Randomized in Error|0|||
162781206|NCT01086384|587910862|FG000|Treatment Period|Withdrawal by Subject|0|||
162781207|NCT01086384|587910863|FG001|Treatment Period|Withdrawal by Subject|53|||
162781208|NCT01086384|587910864|FG002|Treatment Period|Withdrawal by Subject|55|||
162781209|NCT01086384|587910862|FG000|Treatment Period|Protocol Violation|0|||
162781210|NCT01086384|587910863|FG001|Treatment Period|Protocol Violation|26|||
162781211|NCT01086384|587910864|FG002|Treatment Period|Protocol Violation|17|||
162781212|NCT01086384|587910862|FG000|Treatment Period|Lack of Efficacy|0|||
162781213|NCT01086384|587910863|FG001|Treatment Period|Lack of Efficacy|22|||
162781214|NCT01086384|587910864|FG002|Treatment Period|Lack of Efficacy|13|||
162781215|NCT01086384|587910862|FG000|Treatment Period|Adverse Event|0|||
162781216|NCT01086384|587910863|FG001|Treatment Period|Adverse Event|19|||
162781217|NCT01086384|587910864|FG002|Treatment Period|Adverse Event|15|||
162781218|NCT01086384|587910862|FG000|Treatment Period|Lost to Follow-up|0|||
162781219|NCT01086384|587910863|FG001|Treatment Period|Lost to Follow-up|11|||
162781220|NCT01086384|587910864|FG002|Treatment Period|Lost to Follow-up|9|||
162781221|NCT01086384|587910862|FG000|Treatment Period|Physician Decision|0|||
162781222|NCT01086384|587910863|FG001|Treatment Period|Physician Decision|9|||
162781223|NCT01086384|587910864|FG002|Treatment Period|Physician Decision|6|||
162781224|NCT01086384|587910862|FG000|Treatment Period|Study Closed/Terminated|0|||
162781225|NCT01086384|587910863|FG001|Treatment Period|Study Closed/Terminated|7|||
162781226|NCT01086384|587910864|FG002|Treatment Period|Study Closed/Terminated|8|||
162781227|NCT01086384|587910862|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
162781228|NCT01086384|587910863|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
162781229|NCT01086384|587910864|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
162781230|NCT01086384|587910862|FG000|Treatment Period|Received Treatment in Error|0|||
162781231|NCT01086384|587910863|FG001|Treatment Period|Received Treatment in Error|1|||
162781232|NCT01086384|587910864|FG002|Treatment Period|Received Treatment in Error|0|||
162781233|NCT02586415|587910865|FG000|Overall Study|Death|13|||
162781234|NCT02586415|587910866|FG001|Overall Study|Death|23|||
162781235|NCT02586415|587910865|FG000|Overall Study|Lost to Follow-up|1|||
162781236|NCT02586415|587910866|FG001|Overall Study|Lost to Follow-up|2|||
162781237|NCT00832000|587910867|FG000|Overall Study|Adverse Event|2|||
162781238|NCT00832000|587910868|FG001|Overall Study|Adverse Event|0|||
162781239|NCT00832000|587910867|FG000|Overall Study|Withdrawal by Subject|1|||
162781240|NCT00832000|587910868|FG001|Overall Study|Withdrawal by Subject|0|||
162781241|NCT00832000|587910867|FG000|Overall Study|No calls to IVR in either period|1|||
162781242|NCT00832000|587910868|FG001|Overall Study|No calls to IVR in either period|1|||
162781243|NCT00832000|587910867|FG000|Overall Study|No calls to IVR in period 2|2|||
162781244|NCT00832000|587910868|FG001|Overall Study|No calls to IVR in period 2|0|||
162781245|NCT03974100|587910869|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
162781246|NCT03974100|587910870|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
162781247|NCT03974100|587910871|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
162781248|NCT03974100|587910872|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
162781249|NCT03974100|587910873|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
162781250|NCT03974100|587910869|FG000|TP1 - Day 1 to Week 52|Death|1|||
162781251|NCT03974100|587910870|FG001|TP1 - Day 1 to Week 52|Death|0|||
162781252|NCT03974100|587910871|FG002|TP1 - Day 1 to Week 52|Death|0|||
162781253|NCT03974100|587910872|FG003|TP1 - Day 1 to Week 52|Death|0|||
162781254|NCT03974100|587910873|FG004|TP1 - Day 1 to Week 52|Death|0|||
162781255|NCT03974100|587910869|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162781256|NCT03974100|587910870|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
162781257|NCT03974100|587910871|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162781258|NCT03974100|587910872|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162781259|NCT03974100|587910873|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162781260|NCT03974100|587910869|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
162781261|NCT03974100|587910870|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
162781262|NCT03974100|587910871|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
162781263|NCT03974100|587910872|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
162781264|NCT03974100|587910873|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
162781265|NCT03974100|587910869|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
162781266|NCT03974100|587910870|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
162781267|NCT03974100|587910871|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
162781268|NCT03974100|587910872|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
162781269|NCT03974100|587910873|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
162781270|NCT03974100|587910869|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162781271|NCT03974100|587910870|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162781272|NCT03974100|587910871|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162781273|NCT03974100|587910872|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
162781274|NCT03974100|587910873|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162781275|NCT03974100|587910869|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
162781276|NCT03974100|587910870|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
162781277|NCT03974100|587910871|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
162781278|NCT03974100|587910872|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
162781279|NCT03974100|587910873|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
162781280|NCT03318783|587910874|FG000|Overall Study|Withdrawal by Subject|0|||
162781281|NCT03318783|587910875|FG001|Overall Study|Withdrawal by Subject|1|||
162781282|NCT03318783|587910874|FG000|Overall Study|Death|0|||
162781283|NCT03318783|587910875|FG001|Overall Study|Death|1|||
162781284|NCT03856047|587910876|FG000|Overall Study|Withdrawal by Subject|0|||
162781285|NCT03856047|587910877|FG001|Overall Study|Withdrawal by Subject|1|||
162781286|NCT03856047|587910878|FG002|Overall Study|Withdrawal by Subject|1|||
162781287|NCT03856047|587910879|FG003|Overall Study|Withdrawal by Subject|0|||
162781288|NCT03856047|587910880|FG004|Overall Study|Withdrawal by Subject|3|||
162781289|NCT03856047|587910881|FG005|Overall Study|Withdrawal by Subject|0|||
162781290|NCT03856047|587910882|FG006|Overall Study|Withdrawal by Subject|2|||
162781291|NCT03856047|587910876|FG000|Overall Study|Lost to Follow-up|4|||
162781292|NCT03856047|587910877|FG001|Overall Study|Lost to Follow-up|2|||
162781293|NCT03856047|587910878|FG002|Overall Study|Lost to Follow-up|3|||
162781294|NCT03856047|587910879|FG003|Overall Study|Lost to Follow-up|1|||
162781295|NCT03856047|587910880|FG004|Overall Study|Lost to Follow-up|4|||
162781296|NCT03856047|587910881|FG005|Overall Study|Lost to Follow-up|4|||
162781297|NCT03856047|587910882|FG006|Overall Study|Lost to Follow-up|4|||
162781298|NCT00338949|587910883|FG000|Subject Screening|Screen failures|11|||
162781299|NCT00338949|587910884|FG001|Subject Screening|Screen failures|11|||
162781300|NCT00338949|587910883|FG000|Randomization|Withdrawal by Subject|1|||
162781301|NCT00338949|587910884|FG001|Randomization|Withdrawal by Subject|0|||
162781302|NCT00338949|587910883|FG000|Randomization|Adverse Event|0|||
162781303|NCT00338949|587910884|FG001|Randomization|Adverse Event|5|||
162781304|NCT00436956|587910887|FG000|Overall Study|Not evaluable|1|||
162781305|NCT00436956|587910888|FG001|Overall Study|Not evaluable|0|||
162781306|NCT02719743|587910894|FG000|Overall Study|Consent withdrawal|0|||
162781307|NCT02719743|587910895|FG001|Overall Study|Consent withdrawal|2|||
162781308|NCT02719743|587910896|FG002|Overall Study|Consent withdrawal|0|||
162781309|NCT02719743|587910897|FG003|Overall Study|Consent withdrawal|1|||
162781310|NCT02719743|587910898|FG004|Overall Study|Consent withdrawal|0|||
162781311|NCT02719743|587910894|FG000|Overall Study|Migrated/moved from study area|0|||
162781312|NCT02719743|587910895|FG001|Overall Study|Migrated/moved from study area|0|||
162781313|NCT02719743|587910896|FG002|Overall Study|Migrated/moved from study area|0|||
162781314|NCT02719743|587910897|FG003|Overall Study|Migrated/moved from study area|0|||
162781315|NCT02719743|587910898|FG004|Overall Study|Migrated/moved from study area|2|||
162781316|NCT02719743|587910894|FG000|Overall Study|Lost to Follow-up|1|||
162781317|NCT02719743|587910895|FG001|Overall Study|Lost to Follow-up|1|||
162781318|NCT02719743|587910896|FG002|Overall Study|Lost to Follow-up|0|||
162781319|NCT02719743|587910897|FG003|Overall Study|Lost to Follow-up|0|||
162781320|NCT02719743|587910898|FG004|Overall Study|Lost to Follow-up|0|||
162781321|NCT01930214|587910899|FG000|Overall Study|Death|4|||
162781322|NCT01930214|587910900|FG001|Overall Study|Death|4|||
162781323|NCT01930214|587910901|FG002|Overall Study|Death|11|||
162781324|NCT01930214|587910899|FG000|Overall Study|Lost to Follow-up|12|||
162781325|NCT01930214|587910900|FG001|Overall Study|Lost to Follow-up|13|||
162781326|NCT01930214|587910901|FG002|Overall Study|Lost to Follow-up|12|||
162781327|NCT01930214|587910899|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
162781328|NCT01930214|587910900|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
162781329|NCT01930214|587910901|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
162781330|NCT01930214|587910899|FG000|Overall Study|Physician Decision|2|||
162781331|NCT01930214|587910900|FG001|Overall Study|Physician Decision|0|||
162781332|NCT01930214|587910901|FG002|Overall Study|Physician Decision|0|||
162781333|NCT02601209|587910902|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162781334|NCT02601209|587910903|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162781335|NCT02601209|587910904|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162781336|NCT02601209|587910905|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781337|NCT02601209|587910906|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781338|NCT02601209|587910907|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781339|NCT02601209|587910908|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781340|NCT02601209|587910909|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781341|NCT02601209|587910910|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162781342|NCT02601209|587910902|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781343|NCT02601209|587910903|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781344|NCT02601209|587910904|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781345|NCT02601209|587910905|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781346|NCT02601209|587910906|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
162781347|NCT02601209|587910907|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
162781348|NCT02601209|587910908|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
162781349|NCT02601209|587910909|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781350|NCT02601209|587910910|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162781351|NCT02024750|587910912|FG000|Overall Study|Withdrawal by Subject|2|||
162781352|NCT02024750|587910913|FG001|Overall Study|Withdrawal by Subject|1|||
162781353|NCT02261285|587910914|FG000|Overall Study|Disease progression|0|||
162781354|NCT02261285|587910915|FG001|Overall Study|Disease progression|0|||
162781355|NCT02261285|587910916|FG002|Overall Study|Disease progression|1|||
162781356|NCT01209286|587910918|FG000|Overall Study|Adverse Event|4|||
162781357|NCT01209286|587910919|FG001|Overall Study|Adverse Event|3|||
162781358|NCT01209286|587910920|FG002|Overall Study|Adverse Event|1|||
162781359|NCT01209286|587910918|FG000|Overall Study|Hematological Relapse After Remission|0|||
162781360|NCT01209286|587910919|FG001|Overall Study|Hematological Relapse After Remission|1|||
162781361|NCT01209286|587910920|FG002|Overall Study|Hematological Relapse After Remission|1|||
162781362|NCT01209286|587910918|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
162781363|NCT01209286|587910919|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
162781364|NCT01209286|587910920|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
162781365|NCT01209286|587910918|FG000|Overall Study|Physician Decision|0|||
162781366|NCT01209286|587910919|FG001|Overall Study|Physician Decision|2|||
162781367|NCT01209286|587910920|FG002|Overall Study|Physician Decision|0|||
162781368|NCT01209286|587910918|FG000|Overall Study|Other|0|||
162781369|NCT01209286|587910919|FG001|Overall Study|Other|1|||
162781370|NCT01209286|587910920|FG002|Overall Study|Other|0|||
162781371|NCT01891890|587910921|FG000|Overall Study|Lost to Follow-up|0|||
162781372|NCT01891890|587910922|FG001|Overall Study|Lost to Follow-up|0|||
162781373|NCT01891890|587910923|FG002|Overall Study|Lost to Follow-up|1|||
162781374|NCT01891890|587910921|FG000|Overall Study|Study ended before endpoint reached|7|||
162781375|NCT01891890|587910922|FG001|Overall Study|Study ended before endpoint reached|3|||
162781376|NCT01891890|587910923|FG002|Overall Study|Study ended before endpoint reached|6|||
162781377|NCT03029819|587910924|FG000|Overall Study|Lost to Follow-up|3|||
162781378|NCT03029819|587910925|FG001|Overall Study|Lost to Follow-up|5|||
162781379|NCT03029819|587910924|FG000|Overall Study|Removed due to disruptive behavior|0|||
162781380|NCT03029819|587910925|FG001|Overall Study|Removed due to disruptive behavior|1|||
162781381|NCT03605368|587910927|FG000|Overall Study|Lost to Follow-up|2|||
162781382|NCT03605368|587910928|FG001|Overall Study|Lost to Follow-up|1|||
162781383|NCT03605368|587910929|FG002|Overall Study|Lost to Follow-up|3|||
162781384|NCT03605368|587910930|FG003|Overall Study|Lost to Follow-up|2|||
162781385|NCT03605368|587910927|FG000|Overall Study|Withdrawal by Subject|0|||
162781386|NCT03605368|587910928|FG001|Overall Study|Withdrawal by Subject|0|||
162781387|NCT03605368|587910929|FG002|Overall Study|Withdrawal by Subject|4|||
162781388|NCT03605368|587910930|FG003|Overall Study|Withdrawal by Subject|3|||
162781389|NCT01020747|587910931|FG000|Overall Study|Withdrawal by Subject|1|||
162781390|NCT02881047|587910936|FG000|Overall Study|Adverse Event|1|||
162781391|NCT02881047|587910936|FG000|Overall Study|Withdrawal by Subject|1|||
162781392|NCT03015181|587910940|FG000|Overall Study|Enrolled, but product never administered|1|||
162781393|NCT03015181|587910941|FG001|Overall Study|Enrolled, but product never administered|0|||
162781394|NCT03015181|587910942|FG002|Overall Study|Enrolled, but product never administered|0|||
162781395|NCT03015181|587910943|FG003|Overall Study|Enrolled, but product never administered|0|||
162781396|NCT03015181|587910944|FG004|Overall Study|Enrolled, but product never administered|0|||
162781397|NCT03015181|587910945|FG005|Overall Study|Enrolled, but product never administered|0|||
162781398|NCT03015181|587910946|FG006|Overall Study|Enrolled, but product never administered|0|||
162781399|NCT03015181|587910940|FG000|Overall Study|Withdrawal by Subject|0|||
162781400|NCT03015181|587910941|FG001|Overall Study|Withdrawal by Subject|0|||
162781401|NCT03015181|587910942|FG002|Overall Study|Withdrawal by Subject|0|||
162781402|NCT03015181|587910943|FG003|Overall Study|Withdrawal by Subject|0|||
162781403|NCT03015181|587910944|FG004|Overall Study|Withdrawal by Subject|0|||
162781404|NCT03015181|587910945|FG005|Overall Study|Withdrawal by Subject|1|||
162781405|NCT03015181|587910946|FG006|Overall Study|Withdrawal by Subject|0|||
162781406|NCT03015181|587910940|FG000|Overall Study|Physician Decision|0|||
162781407|NCT03015181|587910941|FG001|Overall Study|Physician Decision|0|||
162781408|NCT03015181|587910942|FG002|Overall Study|Physician Decision|0|||
162781409|NCT03015181|587910943|FG003|Overall Study|Physician Decision|0|||
162781410|NCT03015181|587910944|FG004|Overall Study|Physician Decision|0|||
162781411|NCT03015181|587910945|FG005|Overall Study|Physician Decision|0|||
162781412|NCT03015181|587910946|FG006|Overall Study|Physician Decision|1|||
162781413|NCT01177228|587910956|FG000|Overall Study|Positive tuberculosis test|0|||
162781414|NCT01177228|587910957|FG001|Overall Study|Positive tuberculosis test|1|||
162781415|NCT01177228|587910958|FG002|Overall Study|Positive tuberculosis test|0|||
162781416|NCT01177228|587910959|FG003|Overall Study|Positive tuberculosis test|0|||
162781417|NCT01177228|587910956|FG000|Overall Study|Worsening disease activity|1|||
162781418|NCT01177228|587910957|FG001|Overall Study|Worsening disease activity|0|||
162781419|NCT01177228|587910958|FG002|Overall Study|Worsening disease activity|0|||
162781420|NCT01177228|587910959|FG003|Overall Study|Worsening disease activity|0|||
162781421|NCT01177228|587910956|FG000|Overall Study|Withdrawal by Subject|0|||
162781422|NCT01177228|587910957|FG001|Overall Study|Withdrawal by Subject|1|||
162781423|NCT01177228|587910958|FG002|Overall Study|Withdrawal by Subject|0|||
162781424|NCT01177228|587910959|FG003|Overall Study|Withdrawal by Subject|0|||
162781425|NCT01251887|587910960|FG000|Overall Study|Scheduling conflict|1|||
162781426|NCT01251887|587910961|FG001|Overall Study|Scheduling conflict|2|||
162781427|NCT01251887|587910962|FG002|Overall Study|Scheduling conflict|2|||
162781428|NCT01251887|587910960|FG000|Overall Study|Physician Decision|0|||
162781429|NCT01251887|587910961|FG001|Overall Study|Physician Decision|1|||
162781430|NCT01251887|587910962|FG002|Overall Study|Physician Decision|0|||
162781431|NCT01283971|587910965|FG000|Overall Study|Adverse Event|3|||
162781432|NCT01283971|587910966|FG001|Overall Study|Adverse Event|5|||
162781433|NCT01283971|587910965|FG000|Overall Study|Insufficient therapeutic responses|3|||
162781434|NCT01283971|587910966|FG001|Overall Study|Insufficient therapeutic responses|3|||
162781435|NCT01283971|587910965|FG000|Overall Study|Protocol Violation|5|||
162781436|NCT01283971|587910966|FG001|Overall Study|Protocol Violation|1|||
162781437|NCT01283971|587910965|FG000|Overall Study|Refused treatment|3|||
162781438|NCT01283971|587910966|FG001|Overall Study|Refused treatment|1|||
162781439|NCT01283971|587910965|FG000|Overall Study|Failure to return|0|||
162781440|NCT01283971|587910966|FG001|Overall Study|Failure to return|1|||
162781441|NCT01283971|587910965|FG000|Overall Study|Administrative reasons|1|||
162781442|NCT01283971|587910966|FG001|Overall Study|Administrative reasons|1|||
162781443|NCT03302559|587910977|FG000|Overall Study|Adverse Event|2|||
162781444|NCT03302559|587910977|FG000|Overall Study|Lost to Follow-up|1|||
162781445|NCT03302559|587910977|FG000|Overall Study|Withdrew Consent|3|||
162781446|NCT02080403|587912270|FG000|Overall Study|Adverse Event|5|||
162781447|NCT02080403|587912271|FG001|Overall Study|Adverse Event|1|||
162781448|NCT02080403|587912270|FG000|Overall Study|Death|0|||
162781449|NCT02080403|587912271|FG001|Overall Study|Death|2|||
162781450|NCT02080403|587912270|FG000|Overall Study|Lost to Follow-up|2|||
162781451|NCT02080403|587912271|FG001|Overall Study|Lost to Follow-up|0|||
162781452|NCT02080403|587912270|FG000|Overall Study|Pregnancy|0|||
162781453|NCT02080403|587912271|FG001|Overall Study|Pregnancy|1|||
162781454|NCT02080403|587912270|FG000|Overall Study|Protocol Violation|3|||
162781455|NCT02080403|587912271|FG001|Overall Study|Protocol Violation|7|||
162781456|NCT02080403|587912270|FG000|Overall Study|Withdrawal by Subject|5|||
162781457|NCT02080403|587912271|FG001|Overall Study|Withdrawal by Subject|1|||
162781458|NCT01999972|587912272|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
162781459|NCT01999972|587912273|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
162781460|NCT01999972|587912274|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
162781461|NCT01999972|587912275|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
162781462|NCT01999972|587912276|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
162781463|NCT01999972|587912277|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
162781464|NCT01999972|587912272|FG000|Dose Escalation Part|Death|0|||
162781465|NCT01999972|587912273|FG001|Dose Escalation Part|Death|1|||
162781466|NCT01999972|587912274|FG002|Dose Escalation Part|Death|0|||
162781467|NCT01999972|587912275|FG003|Dose Escalation Part|Death|0|||
162781468|NCT01999972|587912276|FG004|Dose Escalation Part|Death|0|||
162781469|NCT01999972|587912277|FG005|Dose Escalation Part|Death|0|||
162781470|NCT01999972|587912272|FG000|Dose Escalation Part|Enrolled but not treated|0|||
162781471|NCT01999972|587912273|FG001|Dose Escalation Part|Enrolled but not treated|0|||
162781472|NCT01999972|587912274|FG002|Dose Escalation Part|Enrolled but not treated|1|||
162781473|NCT01999972|587912275|FG003|Dose Escalation Part|Enrolled but not treated|1|||
162781474|NCT01999972|587912276|FG004|Dose Escalation Part|Enrolled but not treated|0|||
162781475|NCT01999972|587912277|FG005|Dose Escalation Part|Enrolled but not treated|0|||
162781476|NCT01999972|587912272|FG000|Dose Escalation Part|Disease progression|3|||
162781477|NCT01999972|587912273|FG001|Dose Escalation Part|Disease progression|2|||
162781478|NCT01999972|587912274|FG002|Dose Escalation Part|Disease progression|3|||
162781479|NCT01999972|587912275|FG003|Dose Escalation Part|Disease progression|6|||
162781480|NCT01999972|587912276|FG004|Dose Escalation Part|Disease progression|0|||
162781481|NCT01999972|587912277|FG005|Dose Escalation Part|Disease progression|0|||
162781482|NCT01999972|587912272|FG000|Dose Escalation Part|Adverse Event|0|||
162781483|NCT01999972|587912273|FG001|Dose Escalation Part|Adverse Event|0|||
162781484|NCT01999972|587912274|FG002|Dose Escalation Part|Adverse Event|0|||
162781485|NCT01999972|587912275|FG003|Dose Escalation Part|Adverse Event|2|||
162781486|NCT01999972|587912276|FG004|Dose Escalation Part|Adverse Event|0|||
162781487|NCT01999972|587912277|FG005|Dose Escalation Part|Adverse Event|0|||
162781488|NCT01999972|587912272|FG000|Dose Escalation Part|Global deterioration of health status|1|||
162781489|NCT01999972|587912273|FG001|Dose Escalation Part|Global deterioration of health status|0|||
162781490|NCT01999972|587912274|FG002|Dose Escalation Part|Global deterioration of health status|0|||
162781491|NCT01999972|587912275|FG003|Dose Escalation Part|Global deterioration of health status|1|||
162781492|NCT01999972|587912276|FG004|Dose Escalation Part|Global deterioration of health status|0|||
162781493|NCT01999972|587912277|FG005|Dose Escalation Part|Global deterioration of health status|0|||
162781494|NCT01999972|587912272|FG000|Dose Expansion Part|Death|0|||
162781495|NCT01999972|587912273|FG001|Dose Expansion Part|Death|0|||
162781496|NCT01999972|587912274|FG002|Dose Expansion Part|Death|0|||
162781497|NCT01999972|587912275|FG003|Dose Expansion Part|Death|0|||
162781498|NCT01999972|587912276|FG004|Dose Expansion Part|Death|2|||
162781499|NCT01999972|587912277|FG005|Dose Expansion Part|Death|1|||
162781500|NCT01999972|587912272|FG000|Dose Expansion Part|Disease progression|0|||
162781501|NCT01999972|587912273|FG001|Dose Expansion Part|Disease progression|0|||
162781502|NCT01999972|587912274|FG002|Dose Expansion Part|Disease progression|0|||
162781503|NCT01999972|587912275|FG003|Dose Expansion Part|Disease progression|0|||
162781504|NCT01999972|587912276|FG004|Dose Expansion Part|Disease progression|9|||
162781505|NCT01999972|587912277|FG005|Dose Expansion Part|Disease progression|3|||
162781506|NCT01999972|587912272|FG000|Dose Expansion Part|Sponsor decision|0|||
162781507|NCT01999972|587912273|FG001|Dose Expansion Part|Sponsor decision|0|||
162781508|NCT01999972|587912274|FG002|Dose Expansion Part|Sponsor decision|0|||
162781509|NCT01999972|587912275|FG003|Dose Expansion Part|Sponsor decision|0|||
162781510|NCT01999972|587912276|FG004|Dose Expansion Part|Sponsor decision|1|||
162781511|NCT01999972|587912277|FG005|Dose Expansion Part|Sponsor decision|0|||
162781512|NCT01999972|587912272|FG000|Dose Expansion Part|Adverse Event|0|||
162781513|NCT01999972|587912273|FG001|Dose Expansion Part|Adverse Event|0|||
162781514|NCT01999972|587912274|FG002|Dose Expansion Part|Adverse Event|0|||
162781515|NCT01999972|587912275|FG003|Dose Expansion Part|Adverse Event|0|||
162781516|NCT01999972|587912276|FG004|Dose Expansion Part|Adverse Event|4|||
162781517|NCT01999972|587912277|FG005|Dose Expansion Part|Adverse Event|2|||
162781518|NCT01999972|587912272|FG000|Dose Expansion Part|Participant's non-compliance|0|||
162781519|NCT01999972|587912273|FG001|Dose Expansion Part|Participant's non-compliance|0|||
162781520|NCT01999972|587912274|FG002|Dose Expansion Part|Participant's non-compliance|0|||
162781521|NCT01999972|587912275|FG003|Dose Expansion Part|Participant's non-compliance|0|||
162781522|NCT01999972|587912276|FG004|Dose Expansion Part|Participant's non-compliance|0|||
162781523|NCT01999972|587912277|FG005|Dose Expansion Part|Participant's non-compliance|1|||
162781524|NCT01999972|587912272|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
162781525|NCT01999972|587912273|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
162781526|NCT01999972|587912274|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
162781527|NCT01999972|587912275|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
162781528|NCT01999972|587912276|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
162781529|NCT01999972|587912277|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
162781530|NCT01999972|587912272|FG000|Dose Expansion Part|Changed to standard of care|0|||
162781531|NCT01999972|587912273|FG001|Dose Expansion Part|Changed to standard of care|0|||
162781532|NCT01999972|587912274|FG002|Dose Expansion Part|Changed to standard of care|0|||
162781533|NCT01999972|587912275|FG003|Dose Expansion Part|Changed to standard of care|0|||
162781534|NCT01999972|587912276|FG004|Dose Expansion Part|Changed to standard of care|1|||
162781535|NCT01999972|587912277|FG005|Dose Expansion Part|Changed to standard of care|0|||
162781536|NCT01171183|587912278|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
162781537|NCT01171183|587912279|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
162781538|NCT01171183|587912278|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
162781539|NCT01171183|587912279|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
162781540|NCT01171183|587912278|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
162781541|NCT01171183|587912279|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
162781542|NCT01171183|587912278|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
162781543|NCT01171183|587912279|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
162781544|NCT01171183|587912278|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
162781545|NCT01171183|587912279|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
162781546|NCT01171183|587912278|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
162781547|NCT01171183|587912279|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
162781548|NCT02826798|587912284|FG000|Overall Study|Withdrawal by Subject|0|||
162781549|NCT02826798|587912285|FG001|Overall Study|Withdrawal by Subject|1|||
162781550|NCT02826798|587912286|FG002|Overall Study|Withdrawal by Subject|0|||
162781551|NCT02826798|587912287|FG003|Overall Study|Withdrawal by Subject|1|||
162781552|NCT02826798|587912288|FG004|Overall Study|Withdrawal by Subject|0|||
162781553|NCT02806505|587912290|FG000|Overall Study|Adverse event/intercurrent illness|1|||
162781554|NCT02806505|587912291|FG001|Overall Study|Adverse event/intercurrent illness|3|||
162781555|NCT02806505|587912290|FG000|Overall Study|Death|4|||
162781556|NCT02806505|587912291|FG001|Overall Study|Death|0|||
162781557|NCT02806505|587912290|FG000|Overall Study|Did not cooperate/refused treatment|3|||
162781558|NCT02806505|587912291|FG001|Overall Study|Did not cooperate/refused treatment|3|||
162781559|NCT02806505|587912290|FG000|Overall Study|Failure to return|0|||
162781560|NCT02806505|587912291|FG001|Overall Study|Failure to return|1|||
162781561|NCT02806505|587912290|FG000|Overall Study|Insufficient therapeutic response|2|||
162781562|NCT02806505|587912291|FG001|Overall Study|Insufficient therapeutic response|4|||
162781563|NCT01722045|587912293|FG000|Overall Study|Adverse Event|8|||
162781564|NCT01722045|587912293|FG000|Overall Study|Death|3|||
162781565|NCT01722045|587912293|FG000|Overall Study|Withdrawal by Subject|8|||
162781566|NCT01722045|587912293|FG000|Overall Study|Lost to Follow-up|4|||
162781567|NCT01722045|587912293|FG000|Overall Study|Protocol Deviation|1|||
162781568|NCT01722045|587912293|FG000|Overall Study|Physician Decision|3|||
162781569|NCT01722045|587912293|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
162781570|NCT03898700|587912295|FG000|Overall Study|Withdrawal by Subject|2|||
162781571|NCT00701909|587912299|FG000|Overall Study|Withdrawal by Subject|0|||
162781572|NCT00701909|587912300|FG001|Overall Study|Withdrawal by Subject|1|||
162781573|NCT00511836|587912304|FG000|Double-blind Period|Lost to Follow-up|1|||
162781574|NCT00511836|587912305|FG001|Double-blind Period|Lost to Follow-up|0|||
162781575|NCT00030823|587912306|FG000|Overall Study|Withdrawal by Subject|1|||
162781576|NCT00891046|587912312|FG000|Overall Study|Protocol Violation|1|||
162781577|NCT00891046|587912313|FG001|Overall Study|Protocol Violation|1|||
162781578|NCT00891046|587912314|FG002|Overall Study|Protocol Violation|0|||
162781579|NCT00891046|587912315|FG003|Overall Study|Protocol Violation|0|||
162781580|NCT00891046|587912316|FG004|Overall Study|Protocol Violation|1|||
162781581|NCT00891046|587912312|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
162781582|NCT00891046|587912313|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162781583|NCT00891046|587912314|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
162781584|NCT00891046|587912315|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162781585|NCT00891046|587912316|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
162781586|NCT00891046|587912312|FG000|Overall Study|Administrative problems|0|||
162781587|NCT00891046|587912313|FG001|Overall Study|Administrative problems|0|||
162781588|NCT00891046|587912314|FG002|Overall Study|Administrative problems|0|||
162781589|NCT00891046|587912315|FG003|Overall Study|Administrative problems|0|||
162781590|NCT00891046|587912316|FG004|Overall Study|Administrative problems|1|||
162781591|NCT00891046|587912312|FG000|Overall Study|Participant no longer required drug|0|||
162781592|NCT00891046|587912313|FG001|Overall Study|Participant no longer required drug|2|||
162781593|NCT00891046|587912314|FG002|Overall Study|Participant no longer required drug|0|||
162781594|NCT00891046|587912315|FG003|Overall Study|Participant no longer required drug|0|||
162781595|NCT00891046|587912316|FG004|Overall Study|Participant no longer required drug|1|||
162781596|NCT00891046|587912312|FG000|Overall Study|Adverse Event|4|||
162781597|NCT00891046|587912313|FG001|Overall Study|Adverse Event|3|||
162781598|NCT00891046|587912314|FG002|Overall Study|Adverse Event|2|||
162781599|NCT00891046|587912315|FG003|Overall Study|Adverse Event|0|||
162781600|NCT00891046|587912316|FG004|Overall Study|Adverse Event|14|||
162781601|NCT00891046|587912312|FG000|Overall Study|Withdrawal by Subject|2|||
162781602|NCT00891046|587912313|FG001|Overall Study|Withdrawal by Subject|1|||
162781603|NCT00891046|587912314|FG002|Overall Study|Withdrawal by Subject|2|||
162781604|NCT00891046|587912315|FG003|Overall Study|Withdrawal by Subject|1|||
162781605|NCT00891046|587912316|FG004|Overall Study|Withdrawal by Subject|1|||
162781606|NCT00891046|587912312|FG000|Overall Study|Lost to Follow-up|0|||
162781607|NCT00891046|587912313|FG001|Overall Study|Lost to Follow-up|0|||
162781608|NCT00891046|587912314|FG002|Overall Study|Lost to Follow-up|0|||
162781609|NCT00891046|587912315|FG003|Overall Study|Lost to Follow-up|0|||
162781610|NCT00891046|587912316|FG004|Overall Study|Lost to Follow-up|1|||
162781611|NCT00362375|587912317|FG000|Overall Study|Lost to Follow-up|40|||
162781612|NCT00362375|587912318|FG001|Overall Study|Lost to Follow-up|35|||
162781613|NCT02106195|587912319|FG000|Overall Study|Adverse Event|2|||
162781614|NCT02106195|587912319|FG000|Overall Study|Protocol Violation|1|||
162781615|NCT04984239|587912320|FG000|Overall Study|Lost to Follow-up|1|||
162781616|NCT00916305|587912321|FG000|Overall Study|Lost to Follow-up|21|||
162781617|NCT00916305|587912322|FG001|Overall Study|Lost to Follow-up|27|||
162781618|NCT00916305|587912321|FG000|Overall Study|Withdrawal by Subject|0|||
162781619|NCT00916305|587912322|FG001|Overall Study|Withdrawal by Subject|1|||
162781620|NCT01379703|587912323|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
162781621|NCT01379703|587912324|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
162781622|NCT01379703|587912325|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
162781623|NCT01379703|587912323|FG000|Study Start Through 9 Months|Adverse Event|0|||
162781624|NCT01379703|587912324|FG001|Study Start Through 9 Months|Adverse Event|14|||
162781625|NCT01379703|587912325|FG002|Study Start Through 9 Months|Adverse Event|10|||
162781626|NCT01379703|587912323|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
162781627|NCT01379703|587912324|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
162781628|NCT01379703|587912325|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
162781629|NCT01379703|587912323|FG000|Study Start Through 9 Months|Treatment Failure|0|||
162781630|NCT01379703|587912324|FG001|Study Start Through 9 Months|Treatment Failure|2|||
162781631|NCT01379703|587912325|FG002|Study Start Through 9 Months|Treatment Failure|2|||
162781632|NCT01379703|587912323|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
162781633|NCT01379703|587912324|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
162781634|NCT01379703|587912325|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
162781635|NCT01379703|587912323|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
162781636|NCT01379703|587912324|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
162781637|NCT01379703|587912325|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
162781638|NCT01379703|587912323|FG000|Study Start Through 9 Months|Medication not available|0|||
162781639|NCT01379703|587912324|FG001|Study Start Through 9 Months|Medication not available|2|||
162781640|NCT01379703|587912325|FG002|Study Start Through 9 Months|Medication not available|1|||
162781641|NCT01379703|587912323|FG000|Study Start Through 9 Months|Poor general condition|0|||
162781642|NCT01379703|587912324|FG001|Study Start Through 9 Months|Poor general condition|1|||
162781643|NCT01379703|587912325|FG002|Study Start Through 9 Months|Poor general condition|0|||
162781644|NCT01379703|587912323|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
162781645|NCT01379703|587912324|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
162781646|NCT01379703|587912325|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
162781647|NCT01379703|587912323|FG000|Study Start Through 9 Months|Reason unknown|2|||
162781648|NCT01379703|587912324|FG001|Study Start Through 9 Months|Reason unknown|31|||
162781649|NCT01379703|587912325|FG002|Study Start Through 9 Months|Reason unknown|24|||
162781650|NCT01379703|587912323|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
162781651|NCT01379703|587912324|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
162781652|NCT01379703|587912325|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
162781653|NCT01379703|587912323|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
162781654|NCT01379703|587912324|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
162781655|NCT01379703|587912325|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
162781656|NCT01379703|587912323|FG000|9 Months Through 18 Months|Adverse Event|0|||
162781657|NCT01379703|587912324|FG001|9 Months Through 18 Months|Adverse Event|6|||
162781658|NCT01379703|587912325|FG002|9 Months Through 18 Months|Adverse Event|0|||
162781659|NCT01379703|587912323|FG000|9 Months Through 18 Months|Treatment failure|0|||
162781660|NCT01379703|587912324|FG001|9 Months Through 18 Months|Treatment failure|5|||
162781661|NCT01379703|587912325|FG002|9 Months Through 18 Months|Treatment failure|0|||
162781662|NCT01379703|587912323|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
162781663|NCT01379703|587912324|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
162781664|NCT01379703|587912325|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
162781665|NCT01379703|587912323|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
162781666|NCT01379703|587912324|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
162781667|NCT01379703|587912325|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
162781668|NCT01379703|587912323|FG000|9 Months Through 18 Months|Fatigue|0|||
162781669|NCT01379703|587912324|FG001|9 Months Through 18 Months|Fatigue|1|||
162781670|NCT01379703|587912325|FG002|9 Months Through 18 Months|Fatigue|0|||
162781671|NCT01379703|587912323|FG000|9 Months Through 18 Months|Reason Unknown|0|||
162781672|NCT01379703|587912324|FG001|9 Months Through 18 Months|Reason Unknown|23|||
162781673|NCT01379703|587912325|FG002|9 Months Through 18 Months|Reason Unknown|0|||
162781674|NCT03481556|587912326|FG000|Overall Study|Adverse Event|1|||
162781675|NCT03481556|587912327|FG001|Overall Study|Adverse Event|0|||
162781676|NCT03481556|587912328|FG002|Overall Study|Adverse Event|0|||
162781677|NCT03481556|587912329|FG003|Overall Study|Adverse Event|0|||
162781678|NCT03481556|587912326|FG000|Overall Study|Death|4|||
162781679|NCT03481556|587912327|FG001|Overall Study|Death|2|||
162781680|NCT03481556|587912328|FG002|Overall Study|Death|3|||
162781681|NCT03481556|587912329|FG003|Overall Study|Death|16|||
162781682|NCT03481556|587912326|FG000|Overall Study|Study Terminated by Sponsor|10|||
162781683|NCT03481556|587912327|FG001|Overall Study|Study Terminated by Sponsor|5|||
162781684|NCT03481556|587912328|FG002|Overall Study|Study Terminated by Sponsor|2|||
162781685|NCT03481556|587912329|FG003|Overall Study|Study Terminated by Sponsor|9|||
162781686|NCT01101997|587912330|FG000|Overall Study|Withdrawal by Subject|2|||
162781687|NCT01316887|587912331|FG000|Overall Study|Adverse Event|13|||
162781688|NCT01316887|587912332|FG001|Overall Study|Adverse Event|21|||
162781689|NCT01316887|587912333|FG002|Overall Study|Adverse Event|17|||
162781690|NCT01316887|587912331|FG000|Overall Study|Lack of Efficacy|9|||
162781691|NCT01316887|587912332|FG001|Overall Study|Lack of Efficacy|3|||
162781692|NCT01316887|587912333|FG002|Overall Study|Lack of Efficacy|1|||
162781693|NCT01316887|587912331|FG000|Overall Study|Protocol Violation|2|||
162781694|NCT01316887|587912332|FG001|Overall Study|Protocol Violation|6|||
162781695|NCT01316887|587912333|FG002|Overall Study|Protocol Violation|6|||
162781696|NCT01316887|587912331|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
162781697|NCT01316887|587912332|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
162781698|NCT01316887|587912333|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
162781699|NCT01316887|587912331|FG000|Overall Study|Study Closed/Terminated|2|||
162781700|NCT01316887|587912332|FG001|Overall Study|Study Closed/Terminated|4|||
162781701|NCT01316887|587912333|FG002|Overall Study|Study Closed/Terminated|3|||
162781702|NCT01316887|587912331|FG000|Overall Study|Lost to Follow-up|1|||
162781703|NCT01316887|587912332|FG001|Overall Study|Lost to Follow-up|7|||
162781704|NCT01316887|587912333|FG002|Overall Study|Lost to Follow-up|5|||
162781705|NCT01316887|587912331|FG000|Overall Study|Withdrawal by Subject|8|||
162781706|NCT01316887|587912332|FG001|Overall Study|Withdrawal by Subject|16|||
162781707|NCT01316887|587912333|FG002|Overall Study|Withdrawal by Subject|15|||
162781708|NCT00469456|587912334|FG000|Overall Study|Adverse Event|4|||
162781709|NCT00469456|587912335|FG001|Overall Study|Adverse Event|3|||
162781710|NCT00469456|587912334|FG000|Overall Study|Protocol Violation|1|||
162781711|NCT00469456|587912335|FG001|Overall Study|Protocol Violation|0|||
162781712|NCT00469456|587912334|FG000|Overall Study|Withdrawal by Subject|4|||
162781713|NCT00469456|587912335|FG001|Overall Study|Withdrawal by Subject|1|||
162781714|NCT00704171|587912340|FG000|Overall Study|Withdrawal by Subject|1|||
162781715|NCT00704171|587912341|FG001|Overall Study|Withdrawal by Subject|0|||
162781716|NCT00813098|587912344|FG000|Overall Study|Adverse Event|2|||
162781717|NCT00813098|587912345|FG001|Overall Study|Adverse Event|4|||
162781718|NCT00813098|587912346|FG002|Overall Study|Adverse Event|1|||
162781719|NCT00813098|587912344|FG000|Overall Study|Withdrawal by Subject|0|||
162781720|NCT00813098|587912345|FG001|Overall Study|Withdrawal by Subject|1|||
162781721|NCT00813098|587912346|FG002|Overall Study|Withdrawal by Subject|0|||
162781722|NCT00813098|587912344|FG000|Overall Study|Inability to complete study procedures|1|||
162781723|NCT00813098|587912345|FG001|Overall Study|Inability to complete study procedures|0|||
162781724|NCT00813098|587912346|FG002|Overall Study|Inability to complete study procedures|0|||
162781725|NCT00813098|587912344|FG000|Overall Study|Lost to Follow-up|0|||
162781726|NCT00813098|587912345|FG001|Overall Study|Lost to Follow-up|1|||
162781727|NCT00813098|587912346|FG002|Overall Study|Lost to Follow-up|0|||
162781728|NCT00813098|587912344|FG000|Overall Study|Protocol Violation|0|||
162781729|NCT00813098|587912345|FG001|Overall Study|Protocol Violation|0|||
162781730|NCT00813098|587912346|FG002|Overall Study|Protocol Violation|1|||
162781731|NCT00813098|587912344|FG000|Overall Study|Principal Investigator decision|0|||
162781732|NCT00813098|587912345|FG001|Overall Study|Principal Investigator decision|1|||
162781733|NCT00813098|587912346|FG002|Overall Study|Principal Investigator decision|0|||
162781734|NCT00813098|587912344|FG000|Overall Study|Withdrew Consent|0|||
162781735|NCT00813098|587912345|FG001|Overall Study|Withdrew Consent|1|||
162781736|NCT00813098|587912346|FG002|Overall Study|Withdrew Consent|0|||
162781737|NCT01772563|587912349|FG000|Cycle 1|Dose limiting toxicity|2|||
162781738|NCT01772563|587912349|FG000|Cycle 1|Progressive disease|2|||
162781739|NCT01772563|587912349|FG000|Cycle 2 and Beyond|Progressive disease|17|||
162781740|NCT01772563|587912349|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
162781741|NCT01772563|587912349|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
162781742|NCT02980705|587912360|FG000|Overall Study|Adverse Event|0|||
162781743|NCT02980705|587912361|FG001|Overall Study|Adverse Event|1|||
162781744|NCT02980705|587912360|FG000|Overall Study|Withdrawal by Subject|6|||
162781745|NCT02980705|587912361|FG001|Overall Study|Withdrawal by Subject|9|||
162781746|NCT02980705|587912360|FG000|Overall Study|withdrew participation|0|||
162781747|NCT02980705|587912361|FG001|Overall Study|withdrew participation|1|||
162781748|NCT02980705|587912360|FG000|Overall Study|Lost to Follow-up|2|||
162781749|NCT02980705|587912361|FG001|Overall Study|Lost to Follow-up|0|||
162781750|NCT00263575|587912362|FG000|Titration Period|Adverse Event|14|||
162781751|NCT00263575|587912362|FG000|Titration Period|Withdrawal by Subject|10|||
162781752|NCT00263575|587912362|FG000|Titration Period|Protocol Violation|9|||
162781753|NCT00263575|587912362|FG000|Titration Period|Sponsor Decision|2|||
162781754|NCT00263575|587912362|FG000|Titration Period|Other|2|||
162781755|NCT00263575|587912362|FG000|Titration Period|Lack of Efficacy|6|||
162781756|NCT00263575|587912362|FG000|Maintence Period|Adverse Event|23|||
162781757|NCT00263575|587912362|FG000|Maintence Period|Withdrawal by Subject|8|||
162781758|NCT00263575|587912362|FG000|Maintence Period|Protocol Violation|4|||
162781759|NCT00263575|587912362|FG000|Maintence Period|Lack of Efficacy|4|||
162781760|NCT00263575|587912362|FG000|Maintence Period|Physician Decision|6|||
162781761|NCT00263575|587912362|FG000|Maintence Period|Lost to Follow-up|1|||
162781762|NCT00263575|587912362|FG000|Maintence Period|Sponsor Decision|24|||
162781763|NCT00263575|587912362|FG000|Maintence Period|Other|7|||
162781764|NCT01880437|587912365|FG000|Overall Study|Death|12|||
162781765|NCT01880437|587912366|FG001|Overall Study|Death|4|||
162781766|NCT01880437|587912367|FG002|Overall Study|Death|17|||
162781767|NCT01880437|587912365|FG000|Overall Study|Study terminated by Sponsor|3|||
162781768|NCT01880437|587912366|FG001|Overall Study|Study terminated by Sponsor|0|||
162781769|NCT01880437|587912367|FG002|Overall Study|Study terminated by Sponsor|2|||
162781770|NCT01438840|587912368|FG000|Core Study|Adverse Event|0|||
162781771|NCT01438840|587912369|FG001|Core Study|Adverse Event|3|||
162781772|NCT01438840|587912370|FG002|Core Study|Adverse Event|0|||
162781773|NCT01438840|587912368|FG000|Core Study|Lack of Efficacy|15|||
162781774|NCT01438840|587912369|FG001|Core Study|Lack of Efficacy|7|||
162781775|NCT01438840|587912370|FG002|Core Study|Lack of Efficacy|0|||
162781776|NCT01438840|587912368|FG000|Core Study|Withdrawal of consent|1|||
162781777|NCT01438840|587912369|FG001|Core Study|Withdrawal of consent|0|||
162781778|NCT01438840|587912370|FG002|Core Study|Withdrawal of consent|0|||
162781779|NCT01438840|587912368|FG000|Extension Phase|Adverse Event|0|||
162781780|NCT01438840|587912369|FG001|Extension Phase|Adverse Event|0|||
162781781|NCT01438840|587912370|FG002|Extension Phase|Adverse Event|3|||
162781782|NCT01438840|587912368|FG000|Extension Phase|Lost to Follow-up|0|||
162781783|NCT01438840|587912369|FG001|Extension Phase|Lost to Follow-up|0|||
162781784|NCT01438840|587912370|FG002|Extension Phase|Lost to Follow-up|1|||
162781785|NCT01438840|587912368|FG000|Extension Phase|Withdrawal by Subject|0|||
162781786|NCT01438840|587912369|FG001|Extension Phase|Withdrawal by Subject|0|||
162781787|NCT01438840|587912370|FG002|Extension Phase|Withdrawal by Subject|3|||
162781788|NCT01438840|587912368|FG000|Extension Phase|Lack of Efficacy|0|||
162781789|NCT01438840|587912369|FG001|Extension Phase|Lack of Efficacy|0|||
162781790|NCT01438840|587912370|FG002|Extension Phase|Lack of Efficacy|2|||
162781791|NCT01438840|587912368|FG000|Extension Phase|Other|0|||
162781792|NCT01438840|587912369|FG001|Extension Phase|Other|0|||
162781793|NCT01438840|587912370|FG002|Extension Phase|Other|1|||
162781794|NCT02604342|587912371|FG000|Overall Study|Death|32|||
162781795|NCT02604342|587912372|FG001|Overall Study|Death|16|||
162781796|NCT02604342|587912371|FG000|Overall Study|Progression of disease|1|||
162781797|NCT02604342|587912372|FG001|Overall Study|Progression of disease|0|||
162781798|NCT02604342|587912371|FG000|Overall Study|Withdrawal by Subject|5|||
162781799|NCT02604342|587912372|FG001|Overall Study|Withdrawal by Subject|6|||
162781800|NCT02604342|587912371|FG000|Overall Study|Other|1|||
162781801|NCT02604342|587912372|FG001|Overall Study|Other|0|||
162781802|NCT02604342|587912371|FG000|Overall Study|Study Termination by Sponsor|1|||
162781803|NCT02604342|587912372|FG001|Overall Study|Study Termination by Sponsor|0|||
162781804|NCT02604342|587912371|FG000|Overall Study|Lost to Follow-up|1|||
162781805|NCT02604342|587912372|FG001|Overall Study|Lost to Follow-up|1|||
162781806|NCT02604342|587912371|FG000|Overall Study|Physician Decision|2|||
162781807|NCT02604342|587912372|FG001|Overall Study|Physician Decision|0|||
162781808|NCT01702519|587912373|FG000|Washout Period|Lost to Follow-up|1|||
162781809|NCT01702519|587912374|FG001|Washout Period|Lost to Follow-up|0|||
162781810|NCT01702519|587912373|FG000|Washout Period|Withdrawal by Subject|0|||
162781811|NCT01702519|587912374|FG001|Washout Period|Withdrawal by Subject|2|||
162781812|NCT04688086|587912375|FG000|Overall Study|Lost to Follow-up|164|||
162781813|NCT04688086|587912375|FG000|Overall Study|Imaging error;|64|||
162781814|NCT01329419|587912378|FG000|Overall Study|Protocol Violation|235|||
162781815|NCT00514813|587912383|FG000|Overall Study|Study terminated|14|||
162781816|NCT00514813|587912384|FG001|Overall Study|Study terminated|74|||
162781817|NCT00514813|587912385|FG002|Overall Study|Study terminated|40|||
162781818|NCT00514813|587912386|FG003|Overall Study|Study terminated|2|||
162781819|NCT00514813|587912383|FG000|Overall Study|Adverse Event|0|||
162781820|NCT00514813|587912384|FG001|Overall Study|Adverse Event|2|||
162781821|NCT00514813|587912385|FG002|Overall Study|Adverse Event|2|||
162781822|NCT00514813|587912386|FG003|Overall Study|Adverse Event|0|||
162781823|NCT00514813|587912383|FG000|Overall Study|Protocol Violation|1|||
162781824|NCT00514813|587912384|FG001|Overall Study|Protocol Violation|0|||
162781825|NCT00514813|587912385|FG002|Overall Study|Protocol Violation|0|||
162781826|NCT00514813|587912386|FG003|Overall Study|Protocol Violation|0|||
162781827|NCT00514813|587912383|FG000|Overall Study|Withdrawal by Subject|0|||
162781828|NCT00514813|587912384|FG001|Overall Study|Withdrawal by Subject|1|||
162781829|NCT00514813|587912385|FG002|Overall Study|Withdrawal by Subject|0|||
162781830|NCT00514813|587912386|FG003|Overall Study|Withdrawal by Subject|0|||
162781831|NCT00514813|587912383|FG000|Overall Study|Lack of Efficacy|0|||
162781832|NCT00514813|587912384|FG001|Overall Study|Lack of Efficacy|1|||
162781833|NCT00514813|587912385|FG002|Overall Study|Lack of Efficacy|0|||
162781834|NCT00514813|587912386|FG003|Overall Study|Lack of Efficacy|0|||
162781835|NCT00514813|587912383|FG000|Overall Study|Kidney transplant|0|||
162781836|NCT00514813|587912384|FG001|Overall Study|Kidney transplant|6|||
162781837|NCT00514813|587912385|FG002|Overall Study|Kidney transplant|2|||
162781838|NCT00514813|587912386|FG003|Overall Study|Kidney transplant|0|||
162781839|NCT00514813|587912383|FG000|Overall Study|Death|0|||
162781840|NCT00514813|587912384|FG001|Overall Study|Death|2|||
162781841|NCT00514813|587912385|FG002|Overall Study|Death|3|||
162781842|NCT00514813|587912386|FG003|Overall Study|Death|2|||
162781843|NCT01075100|587912389|FG000|Overall Study|Adverse Event|15|||
162781844|NCT01075100|587912390|FG001|Overall Study|Adverse Event|18|||
162781845|NCT01075100|587912389|FG000|Overall Study|Patient Request|4|||
162781846|NCT01075100|587912390|FG001|Overall Study|Patient Request|4|||
162781847|NCT01075100|587912389|FG000|Overall Study|Investigator Request|2|||
162781848|NCT01075100|587912390|FG001|Overall Study|Investigator Request|1|||
162781849|NCT01075100|587912389|FG000|Overall Study|Disease Progression|25|||
162781850|NCT01075100|587912390|FG001|Overall Study|Disease Progression|29|||
162781851|NCT01075100|587912389|FG000|Overall Study|Other|3|||
162781852|NCT01075100|587912390|FG001|Overall Study|Other|1|||
162781853|NCT00966264|587913595|FG000|Overall Study|Lost to Follow-up|4|||
162781854|NCT00966264|587913596|FG001|Overall Study|Lost to Follow-up|3|||
162781855|NCT03614676|587913597|FG000|Overall Study|Delivery before planned visit|2|||
162781856|NCT03614676|587913598|FG001|Overall Study|Delivery before planned visit|0|||
162781857|NCT03614676|587913597|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
162781858|NCT03614676|587913598|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
162781859|NCT03614676|587913597|FG000|Overall Study|Migrated / moved from the study area|30|||
162781860|NCT03614676|587913598|FG001|Overall Study|Migrated / moved from the study area|22|||
162781861|NCT03614676|587913597|FG000|Overall Study|Lost to Follow-up|17|||
162781862|NCT03614676|587913598|FG001|Overall Study|Lost to Follow-up|42|||
162781863|NCT03614676|587913597|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
162781864|NCT03614676|587913598|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
162781865|NCT03614676|587913597|FG000|Overall Study|Other|16|||
162781866|NCT03614676|587913598|FG001|Overall Study|Other|47|||
162781867|NCT03614676|587913597|FG000|Overall Study|Protocol Violation|0|||
162781868|NCT03614676|587913598|FG001|Overall Study|Protocol Violation|2|||
162781869|NCT03614676|587913597|FG000|Overall Study|Neonatal event of interest|0|||
162781870|NCT03614676|587913598|FG001|Overall Study|Neonatal event of interest|6|||
162781871|NCT03614676|587913597|FG000|Overall Study|Death in infant greater than 28 days old|0|||
162781872|NCT03614676|587913598|FG001|Overall Study|Death in infant greater than 28 days old|12|||
162781873|NCT03614676|587913597|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
162781874|NCT03614676|587913598|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
162781875|NCT00416598|587913599|FG000|Induction & Intensification|Adverse Event|38|||
162781876|NCT00416598|587913599|FG000|Induction & Intensification|Death|32|||
162781877|NCT00416598|587913599|FG000|Induction & Intensification|Withdrawal by Subject|46|||
162781878|NCT00416598|587913599|FG000|Induction & Intensification|Alternative Treatment|135|||
162781879|NCT00416598|587913599|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
162781880|NCT00416598|587913599|FG000|Induction & Intensification|Relapse/progression|29|||
162781881|NCT00416598|587913599|FG000|Induction & Intensification|Failed induction|87|||
162781882|NCT00416598|587913599|FG000|Decitabine Maintenance|Adverse Event|5|||
162781883|NCT00416598|587913599|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
162781884|NCT00416598|587913599|FG000|Decitabine Maintenance|Progression/relapse|38|||
162781885|NCT00416598|587913599|FG000|Decitabine Maintenance|Alternative treatment|2|||
162781886|NCT00416598|587913599|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
162781887|NCT02166476|587913606|FG000|Overall Study|Withdrawal by Subject|5|||
162781888|NCT02166476|587913607|FG001|Overall Study|Withdrawal by Subject|7|||
162781889|NCT02166476|587913606|FG000|Overall Study|Adverse Event|3|||
162781890|NCT02166476|587913607|FG001|Overall Study|Adverse Event|3|||
162781891|NCT02166476|587913606|FG000|Overall Study|Lost to Follow-up|5|||
162781892|NCT02166476|587913607|FG001|Overall Study|Lost to Follow-up|10|||
162781893|NCT02166476|587913606|FG000|Overall Study|Physician Decision|1|||
162781894|NCT02166476|587913607|FG001|Overall Study|Physician Decision|0|||
162781895|NCT02166476|587913606|FG000|Overall Study|Unable to Come for Visit|0|||
162781896|NCT02166476|587913607|FG001|Overall Study|Unable to Come for Visit|3|||
162781897|NCT04523207|587913612|FG000|Overall Study|Adverse Event|5|||
162781898|NCT04523207|587913613|FG001|Overall Study|Adverse Event|1|||
162781899|NCT04523207|587913612|FG000|Overall Study|Lost to Follow-up|2|||
162781900|NCT04523207|587913613|FG001|Overall Study|Lost to Follow-up|0|||
162781901|NCT04523207|587913612|FG000|Overall Study|Withdrawal by Subject|2|||
162781902|NCT04523207|587913613|FG001|Overall Study|Withdrawal by Subject|0|||
162781903|NCT04523207|587913612|FG000|Overall Study|Progressive Disease|2|||
162781904|NCT04523207|587913613|FG001|Overall Study|Progressive Disease|1|||
162781905|NCT04523207|587913612|FG000|Overall Study|Other|7|||
162781906|NCT04523207|587913613|FG001|Overall Study|Other|1|||
162781907|NCT04469465|587913614|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
162781908|NCT04469465|587913615|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
162781909|NCT04469465|587913614|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
162781910|NCT04469465|587913615|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
162781911|NCT04469465|587913614|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
162781912|NCT04469465|587913615|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
162781913|NCT04469465|587913614|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
162781914|NCT04469465|587913615|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
162781915|NCT04469465|587913614|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
162781916|NCT04469465|587913615|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
162781917|NCT04469465|587913614|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
162781918|NCT04469465|587913615|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
162781919|NCT04469465|587913614|FG000|Long-Term Extension (LTE)|Death|0|||
162781920|NCT04469465|587913615|FG001|Long-Term Extension (LTE)|Death|1|||
162781921|NCT04469465|587913614|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
162781922|NCT04469465|587913615|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
162781923|NCT02438371|587913616|FG000|Overall Study|Lost to Follow-up|3|||
162781924|NCT02438371|587913617|FG001|Overall Study|Lost to Follow-up|2|||
162781925|NCT02438371|587913616|FG000|Overall Study|Withdrawal by Subject|1|||
162781926|NCT02438371|587913617|FG001|Overall Study|Withdrawal by Subject|1|||
162781927|NCT03065933|587913621|FG000|Overall Study|study terminated|5|||
162781928|NCT02536742|587913622|FG000|Overall Study|Did not start protocol therapy|1|||
162781929|NCT02536742|587913622|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
162781930|NCT01010204|587913623|FG000|Overall Study|Lost to Follow-up|2|||
162781931|NCT01010204|587913624|FG001|Overall Study|Lost to Follow-up|2|||
162781932|NCT01010204|587913623|FG000|Overall Study|Adverse Event|1|||
162781933|NCT01010204|587913624|FG001|Overall Study|Adverse Event|3|||
162781934|NCT01010204|587913623|FG000|Overall Study|Withdrawal by Subject|2|||
162781935|NCT01010204|587913624|FG001|Overall Study|Withdrawal by Subject|3|||
162781936|NCT01010204|587913623|FG000|Overall Study|psychiatric hospitalization|2|||
162781937|NCT01010204|587913624|FG001|Overall Study|psychiatric hospitalization|1|||
162781938|NCT01513330|587913625|FG000|SenSura Mio First,|Adverse Event|2|||
162781939|NCT01513330|587913626|FG001|SenSura Mio First,|Adverse Event|0|||
162781940|NCT01513330|587913625|FG000|SenSura Mio First,|Lack of Efficacy|0|||
162781941|NCT01513330|587913626|FG001|SenSura Mio First,|Lack of Efficacy|1|||
162781942|NCT01513330|587913625|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
162781943|NCT01513330|587913626|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
162781944|NCT01513330|587913625|FG000|SenSura Mio First,|Other|1|||
162781945|NCT01513330|587913626|FG001|SenSura Mio First,|Other|0|||
162781946|NCT01513330|587913625|FG000|Standard Care First,|Lack of Efficacy|2|||
162781947|NCT01513330|587913626|FG001|Standard Care First,|Lack of Efficacy|2|||
162781948|NCT01513330|587913625|FG000|Standard Care First,|Withdrawal by Subject|1|||
162781949|NCT01513330|587913626|FG001|Standard Care First,|Withdrawal by Subject|2|||
162781950|NCT01513330|587913625|FG000|Standard Care First,|Other|1|||
162781951|NCT01513330|587913626|FG001|Standard Care First,|Other|0|||
162781952|NCT01519778|587913627|FG000|Overall Study|Withdrawal by Subject|3|||
162781953|NCT01519778|587913627|FG000|Overall Study|Lost to Follow-up|10|||
162781954|NCT01519778|587913627|FG000|Overall Study|Physician Decision|1|||
162781955|NCT01547117|587913632|FG000|Overall Study|Physician Decision|0|||
162781956|NCT01547117|587913633|FG001|Overall Study|Physician Decision|1|||
162781957|NCT01547117|587913634|FG002|Overall Study|Physician Decision|1|||
162781958|NCT01547117|587913635|FG003|Overall Study|Physician Decision|3|||
162781959|NCT01547117|587913632|FG000|Overall Study|Withdrawal by Subject|1|||
162781960|NCT01547117|587913633|FG001|Overall Study|Withdrawal by Subject|2|||
162781961|NCT01547117|587913634|FG002|Overall Study|Withdrawal by Subject|1|||
162781962|NCT01547117|587913635|FG003|Overall Study|Withdrawal by Subject|2|||
162781963|NCT01844726|587913638|FG000|Overall Study|Withdrawal by Subject|0|||
162781964|NCT01844726|587913639|FG001|Overall Study|Withdrawal by Subject|1|||
162781965|NCT01844726|587913638|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
162781966|NCT01844726|587913639|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
162781967|NCT02229578|587913640|FG000|Overall Study|Withdrawal by Subject|1|||
162781968|NCT02229578|587913641|FG001|Overall Study|Withdrawal by Subject|3|||
162781969|NCT02229578|587913640|FG000|Overall Study|Protocol Violation|2|||
162781970|NCT02229578|587913641|FG001|Overall Study|Protocol Violation|0|||
162781971|NCT01288209|587913642|FG000|Overall Study|Withdrawal by Subject|1|||
162781972|NCT01288209|587913643|FG001|Overall Study|Withdrawal by Subject|3|||
162781973|NCT01288209|587913642|FG000|Overall Study|Other|1|||
162781974|NCT01288209|587913643|FG001|Overall Study|Other|0|||
162781975|NCT01496365|587913644|FG000|Overall Study|Adverse Event|2|||
162781976|NCT01496365|587913645|FG001|Overall Study|Adverse Event|3|||
162781977|NCT01496365|587913646|FG002|Overall Study|Adverse Event|3|||
162781978|NCT01496365|587913647|FG003|Overall Study|Adverse Event|2|||
162781979|NCT01496365|587913648|FG004|Overall Study|Adverse Event|5|||
162781980|NCT01496365|587913649|FG005|Overall Study|Adverse Event|6|||
162781981|NCT01496365|587913650|FG006|Overall Study|Adverse Event|4|||
162781982|NCT01496365|587913644|FG000|Overall Study|Withdrawal by Subject|6|||
162781983|NCT01496365|587913645|FG001|Overall Study|Withdrawal by Subject|6|||
162781984|NCT01496365|587913646|FG002|Overall Study|Withdrawal by Subject|0|||
162781985|NCT01496365|587913647|FG003|Overall Study|Withdrawal by Subject|1|||
162781986|NCT01496365|587913648|FG004|Overall Study|Withdrawal by Subject|3|||
162781987|NCT01496365|587913649|FG005|Overall Study|Withdrawal by Subject|2|||
162781988|NCT01496365|587913650|FG006|Overall Study|Withdrawal by Subject|1|||
162781989|NCT01496365|587913644|FG000|Overall Study|Protocol Violation|2|||
162781990|NCT01496365|587913645|FG001|Overall Study|Protocol Violation|1|||
162781991|NCT01496365|587913646|FG002|Overall Study|Protocol Violation|1|||
162781992|NCT01496365|587913647|FG003|Overall Study|Protocol Violation|0|||
162781993|NCT01496365|587913648|FG004|Overall Study|Protocol Violation|0|||
162781994|NCT01496365|587913649|FG005|Overall Study|Protocol Violation|1|||
162781995|NCT01496365|587913650|FG006|Overall Study|Protocol Violation|0|||
162781996|NCT01496365|587913644|FG000|Overall Study|Lack of Efficacy|1|||
162781997|NCT01496365|587913645|FG001|Overall Study|Lack of Efficacy|0|||
162781998|NCT01496365|587913646|FG002|Overall Study|Lack of Efficacy|0|||
162781999|NCT01496365|587913647|FG003|Overall Study|Lack of Efficacy|0|||
162782000|NCT01496365|587913648|FG004|Overall Study|Lack of Efficacy|0|||
162782001|NCT01496365|587913649|FG005|Overall Study|Lack of Efficacy|1|||
162782002|NCT01496365|587913650|FG006|Overall Study|Lack of Efficacy|0|||
162782003|NCT01496365|587913644|FG000|Overall Study|Lost to Follow-up|0|||
162782004|NCT01496365|587913645|FG001|Overall Study|Lost to Follow-up|1|||
162782005|NCT01496365|587913646|FG002|Overall Study|Lost to Follow-up|0|||
162782006|NCT01496365|587913647|FG003|Overall Study|Lost to Follow-up|0|||
162782007|NCT01496365|587913648|FG004|Overall Study|Lost to Follow-up|2|||
162782008|NCT01496365|587913649|FG005|Overall Study|Lost to Follow-up|0|||
162782009|NCT01496365|587913650|FG006|Overall Study|Lost to Follow-up|0|||
162782010|NCT01496365|587913644|FG000|Overall Study|Other|4|||
162782011|NCT01496365|587913645|FG001|Overall Study|Other|4|||
162782012|NCT01496365|587913646|FG002|Overall Study|Other|2|||
162782013|NCT01496365|587913647|FG003|Overall Study|Other|1|||
162782014|NCT01496365|587913648|FG004|Overall Study|Other|3|||
162782015|NCT01496365|587913649|FG005|Overall Study|Other|0|||
162782016|NCT01496365|587913650|FG006|Overall Study|Other|1|||
162782017|NCT01015677|587913651|FG000|Overall Study|Adverse Event|0|||
162782018|NCT01015677|587913652|FG001|Overall Study|Adverse Event|1|||
162782019|NCT01015677|587913653|FG002|Overall Study|Adverse Event|0|||
162782020|NCT01015677|587913651|FG000|Overall Study|Lack of Efficacy|0|||
162782021|NCT01015677|587913652|FG001|Overall Study|Lack of Efficacy|1|||
162782022|NCT01015677|587913653|FG002|Overall Study|Lack of Efficacy|0|||
162782023|NCT01015677|587913651|FG000|Overall Study|Protocol Violation|0|||
162782024|NCT01015677|587913652|FG001|Overall Study|Protocol Violation|1|||
162782025|NCT01015677|587913653|FG002|Overall Study|Protocol Violation|0|||
162782026|NCT01015677|587913651|FG000|Overall Study|Withdrawal by Subject|1|||
162782027|NCT01015677|587913652|FG001|Overall Study|Withdrawal by Subject|1|||
162782028|NCT01015677|587913653|FG002|Overall Study|Withdrawal by Subject|0|||
162782029|NCT01660256|587913654|FG000|Overall Study|Adverse Event|4|||
162782030|NCT01660256|587913655|FG001|Overall Study|Adverse Event|0|||
162782031|NCT01660256|587913656|FG002|Overall Study|Adverse Event|2|||
162782032|NCT01660256|587913654|FG000|Overall Study|Withdrawal by Subject|1|||
162782033|NCT01660256|587913655|FG001|Overall Study|Withdrawal by Subject|0|||
162782034|NCT01660256|587913656|FG002|Overall Study|Withdrawal by Subject|2|||
162782035|NCT01646385|587913658|FG000|Overall Study|Death|202|||
162782036|NCT01646385|587913659|FG001|Overall Study|Death|222|||
162782037|NCT01646385|587913658|FG000|Overall Study|Switched to alternate biologic|636|||
162782038|NCT01646385|587913659|FG001|Overall Study|Switched to alternate biologic|649|||
162782039|NCT03603639|587913663|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162782040|NCT03603639|587913664|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162782041|NCT03603639|587913665|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162782042|NCT03603639|587913666|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
162782043|NCT03603639|587913667|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162782044|NCT03603639|587913668|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162782045|NCT03603639|587913663|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162782046|NCT03603639|587913664|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162782047|NCT03603639|587913665|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162782048|NCT03603639|587913666|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162782049|NCT03603639|587913667|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162782050|NCT03603639|587913668|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162782051|NCT00858247|587913672|FG000|Baseline Assessment|Withdrawal by Subject|1|||
162782052|NCT00858247|587913673|FG001|Baseline Assessment|Withdrawal by Subject|1|||
162782053|NCT00858247|587913672|FG000|Baseline Assessment|Poor IV access|1|||
162782054|NCT00858247|587913673|FG001|Baseline Assessment|Poor IV access|0|||
162782055|NCT00858247|587913672|FG000|Baseline Assessment|Protocol Violation|0|||
162782056|NCT00858247|587913673|FG001|Baseline Assessment|Protocol Violation|1|||
162782057|NCT00858247|587913672|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
162782058|NCT00858247|587913673|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
162782059|NCT02165397|587913676|FG000|Overall Study|Death|7|||
162782060|NCT02165397|587913677|FG001|Overall Study|Death|10|||
162782061|NCT02165397|587913678|FG002|Overall Study|Death|8|||
162782062|NCT02165397|587913676|FG000|Overall Study|Lost to Follow-up|1|||
162782063|NCT02165397|587913677|FG001|Overall Study|Lost to Follow-up|3|||
162782064|NCT02165397|587913678|FG002|Overall Study|Lost to Follow-up|0|||
162782065|NCT02165397|587913676|FG000|Overall Study|Withdrawal by Subject|6|||
162782066|NCT02165397|587913677|FG001|Overall Study|Withdrawal by Subject|6|||
162782067|NCT02165397|587913678|FG002|Overall Study|Withdrawal by Subject|1|||
162782068|NCT02165397|587913676|FG000|Overall Study|Other, Not Specified|0|||
162782069|NCT02165397|587913677|FG001|Overall Study|Other, Not Specified|0|||
162782070|NCT02165397|587913678|FG002|Overall Study|Other, Not Specified|1|||
162782071|NCT03898960|587913679|FG000|Overall Study|Death|10|||
162782072|NCT03463577|587913682|FG000|Overall Study|Lost to Follow-up|238|||
162782073|NCT03463577|587913683|FG001|Overall Study|Lost to Follow-up|435|||
162782074|NCT03463577|587913684|FG002|Overall Study|Lost to Follow-up|0|||
162782075|NCT03463577|587913685|FG003|Overall Study|Lost to Follow-up|0|||
162782076|NCT03463577|587913686|FG004|Overall Study|Lost to Follow-up|0|||
162782077|NCT03463577|587913687|FG005|Overall Study|Lost to Follow-up|0|||
162782078|NCT03463577|587913682|FG000|Overall Study|With unknown pregnancy outcome|0|||
162782079|NCT03463577|587913683|FG001|Overall Study|With unknown pregnancy outcome|5|||
162782080|NCT03463577|587913684|FG002|Overall Study|With unknown pregnancy outcome|0|||
162782081|NCT03463577|587913685|FG003|Overall Study|With unknown pregnancy outcome|0|||
162782082|NCT03463577|587913686|FG004|Overall Study|With unknown pregnancy outcome|0|||
162782083|NCT03463577|587913687|FG005|Overall Study|With unknown pregnancy outcome|0|||
162782084|NCT03463577|587913682|FG000|Overall Study|Maternal death|2|||
162782085|NCT03463577|587913683|FG001|Overall Study|Maternal death|0|||
162782086|NCT03463577|587913684|FG002|Overall Study|Maternal death|0|||
162782087|NCT03463577|587913685|FG003|Overall Study|Maternal death|0|||
162782088|NCT03463577|587913686|FG004|Overall Study|Maternal death|0|||
162782089|NCT03463577|587913687|FG005|Overall Study|Maternal death|0|||
162782090|NCT03463577|587913682|FG000|Overall Study|Neonatal death|0|||
162782091|NCT03463577|587913683|FG001|Overall Study|Neonatal death|0|||
162782092|NCT03463577|587913684|FG002|Overall Study|Neonatal death|0|||
162782093|NCT03463577|587913685|FG003|Overall Study|Neonatal death|15|||
162782094|NCT03463577|587913686|FG004|Overall Study|Neonatal death|17|||
162782095|NCT03463577|587913687|FG005|Overall Study|Neonatal death|0|||
162782096|NCT00236184|587913688|FG000|Overall Study|Adverse Event|5|||
162782097|NCT00236184|587913689|FG001|Overall Study|Adverse Event|2|||
162782098|NCT00236184|587913688|FG000|Overall Study|Lack of Efficacy|0|||
162782099|NCT00236184|587913689|FG001|Overall Study|Lack of Efficacy|1|||
162782100|NCT00236184|587913688|FG000|Overall Study|Lost to Follow-up|3|||
162782101|NCT00236184|587913689|FG001|Overall Study|Lost to Follow-up|4|||
162782102|NCT00236184|587913688|FG000|Overall Study|Physician Decision|1|||
162782103|NCT00236184|587913689|FG001|Overall Study|Physician Decision|1|||
162782104|NCT00236184|587913688|FG000|Overall Study|Withdrawal by Subject|3|||
162782105|NCT00236184|587913689|FG001|Overall Study|Withdrawal by Subject|0|||
162782106|NCT00236184|587913688|FG000|Overall Study|Protocol Violation|3|||
162782107|NCT00236184|587913689|FG001|Overall Study|Protocol Violation|0|||
162782108|NCT00236184|587913688|FG000|Overall Study|non-compliance with study drug|2|||
162782109|NCT00236184|587913689|FG001|Overall Study|non-compliance with study drug|1|||
162782110|NCT00236184|587913688|FG000|Overall Study|other|1|||
162782111|NCT00236184|587913689|FG001|Overall Study|other|2|||
162782112|NCT01841697|587913690|FG000|Overall Study|Death|0|||
162782113|NCT01841697|587913691|FG001|Overall Study|Death|1|||
162782114|NCT01841697|587913690|FG000|Overall Study|Lost to Follow-up|4|||
162782115|NCT01841697|587913691|FG001|Overall Study|Lost to Follow-up|1|||
162782116|NCT01841697|587913690|FG000|Overall Study|Withdrawal by Subject|16|||
162782117|NCT01841697|587913691|FG001|Overall Study|Withdrawal by Subject|16|||
162782118|NCT01777490|587913692|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
162782119|NCT01777490|587913693|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
162782120|NCT01777490|587913694|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
162782121|NCT01777490|587913695|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
162782122|NCT01898442|587913697|FG000|Overall Study|Hemolysis/technical problems|1|||
162782123|NCT01898442|587913698|FG001|Overall Study|Hemolysis/technical problems|2|||
162782124|NCT01898442|587913699|FG002|Overall Study|Hemolysis/technical problems|2|||
162782125|NCT01898442|587913697|FG000|Overall Study|Patient vomited pills|0|||
162782126|NCT01898442|587913698|FG001|Overall Study|Patient vomited pills|0|||
162782127|NCT01898442|587913699|FG002|Overall Study|Patient vomited pills|1|||
162782128|NCT00255944|587913700|FG000|Overall Study|Lost to Follow-up|797|||
162782129|NCT00255944|587913701|FG001|Overall Study|Lost to Follow-up|834|||
162782130|NCT00935259|587913709|FG000|Period 1|Administrative (scheduling conflict)|1|||
162782131|NCT00935259|587913710|FG001|Period 1|Administrative (scheduling conflict)|1|||
162782132|NCT01721746|587913713|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
162782133|NCT01721746|587913714|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
162782134|NCT01721746|587913713|FG000|Pre-Treatment|Withdrawal by Subject|1|||
162782135|NCT01721746|587913714|FG001|Pre-Treatment|Withdrawal by Subject|16|||
162782136|NCT01721746|587913713|FG000|Pre-Treatment|Poor/Non-compliance|1|||
162782137|NCT01721746|587913714|FG001|Pre-Treatment|Poor/Non-compliance|0|||
162782138|NCT01721746|587913713|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
162782139|NCT01721746|587913714|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
162782140|NCT01721746|587913713|FG000|Treatment|Disease Progression|192|||
162782141|NCT01721746|587913714|FG001|Treatment|Disease Progression|74|||
162782142|NCT01721746|587913713|FG000|Treatment|Study Drug Toxicity|19|||
162782143|NCT01721746|587913714|FG001|Treatment|Study Drug Toxicity|11|||
162782144|NCT01721746|587913713|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
162782145|NCT01721746|587913714|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
162782146|NCT01721746|587913713|FG000|Treatment|Participant request to discontinue Study treatment|26|||
162782147|NCT01721746|587913714|FG001|Treatment|Participant request to discontinue Study treatment|7|||
162782148|NCT01721746|587913713|FG000|Treatment|Participant withdrew consent|4|||
162782149|NCT01721746|587913714|FG001|Treatment|Participant withdrew consent|2|||
162782150|NCT01721746|587913713|FG000|Treatment|Maximum Clinical Benefit|9|||
162782151|NCT01721746|587913714|FG001|Treatment|Maximum Clinical Benefit|3|||
162782152|NCT01721746|587913713|FG000|Treatment|Poor/Non-compliance|2|||
162782153|NCT01721746|587913714|FG001|Treatment|Poor/Non-compliance|0|||
162782154|NCT01721746|587913713|FG000|Treatment|Participant no longer met Study criteria|4|||
162782155|NCT01721746|587913714|FG001|Treatment|Participant no longer met Study criteria|0|||
162782156|NCT01721746|587913713|FG000|Treatment|Other reasons|6|||
162782157|NCT01721746|587913714|FG001|Treatment|Other reasons|2|||
162782158|NCT01841112|587913717|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
162782159|NCT01841112|587913718|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
162782160|NCT01841112|587913719|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
162782161|NCT01841112|587913720|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
162782162|NCT01841112|587913721|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
162782163|NCT01209598|587913724|FG000|Overall Study|Withdrawal by Subject|1|||
162782164|NCT01209598|587913725|FG001|Overall Study|Withdrawal by Subject|0|||
162782165|NCT00085566|587913727|FG000|Overall Study|Adverse Event|0|||
162782166|NCT00085566|587913728|FG001|Overall Study|Adverse Event|0|||
162782167|NCT00085566|587913729|FG002|Overall Study|Adverse Event|10|||
162782168|NCT00085566|587913727|FG000|Overall Study|Patient Not treated|0|||
162782169|NCT00085566|587913728|FG001|Overall Study|Patient Not treated|0|||
162782170|NCT00085566|587913729|FG002|Overall Study|Patient Not treated|3|||
162782171|NCT00085566|587913727|FG000|Overall Study|Clinical progression|0|||
162782172|NCT00085566|587913728|FG001|Overall Study|Clinical progression|0|||
162782173|NCT00085566|587913729|FG002|Overall Study|Clinical progression|1|||
162782174|NCT02725008|587913736|FG000|Overall Study|Lost to Follow-up|7|||
162782175|NCT02725008|587913737|FG001|Overall Study|Lost to Follow-up|9|||
162782176|NCT02725008|587913736|FG000|Overall Study|Withdrawal by Subject|2|||
162782177|NCT02725008|587913737|FG001|Overall Study|Withdrawal by Subject|2|||
162782178|NCT02725008|587913736|FG000|Overall Study|Admitted to hospital|0|||
162782179|NCT02725008|587913737|FG001|Overall Study|Admitted to hospital|1|||
162782180|NCT00361842|587913738|FG000|Overall Study|Withdrawal by Subject|2|||
162782181|NCT00361842|587913739|FG001|Overall Study|Withdrawal by Subject|3|||
162782182|NCT00361842|587913738|FG000|Overall Study|Death|2|||
162782183|NCT00361842|587913739|FG001|Overall Study|Death|1|||
162782184|NCT00361842|587913738|FG000|Overall Study|Disease progression|19|||
162782185|NCT00361842|587913739|FG001|Overall Study|Disease progression|20|||
162782186|NCT00361842|587913738|FG000|Overall Study|Adverse Event|2|||
162782187|NCT00361842|587913739|FG001|Overall Study|Adverse Event|3|||
162782188|NCT00361842|587913738|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
162782189|NCT00361842|587913739|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
162782190|NCT00361842|587913738|FG000|Overall Study|Other|1|||
162782191|NCT00361842|587913739|FG001|Overall Study|Other|0|||
162782192|NCT00361842|587913738|FG000|Overall Study|Other|0|||
162782193|NCT00361842|587913739|FG001|Overall Study|Other|2|||
162782194|NCT00934700|587913742|FG000|Overall Study|missing scan|5|||
162782195|NCT00934700|587913743|FG001|Overall Study|missing scan|9|||
162782196|NCT00934700|587913742|FG000|Overall Study|Death|8|||
162782197|NCT00934700|587913743|FG001|Overall Study|Death|3|||
162782198|NCT01831726|587913744|FG000|Overall Study|Adverse Event|16|||
162782199|NCT01831726|587913744|FG000|Overall Study|Death|7|||
162782200|NCT01831726|587913744|FG000|Overall Study|Disease Progression|49|||
162782201|NCT01831726|587913744|FG000|Overall Study|Physician Decision|1|||
162782202|NCT01831726|587913744|FG000|Overall Study|Subject/guardian decision|7|||
162782203|NCT03821064|587913745|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
162782204|NCT00474383|587913747|FG000|Main Study|Adverse Event|11|||
162782205|NCT00474383|587913748|FG001|Main Study|Adverse Event|0|||
162782206|NCT00474383|587913747|FG000|Main Study|Symptomatic Deterioration|1|||
162782207|NCT00474383|587913748|FG001|Main Study|Symptomatic Deterioration|0|||
162782208|NCT00474383|587913747|FG000|Main Study|Progressive Disease|23|||
162782209|NCT00474383|587913748|FG001|Main Study|Progressive Disease|0|||
162782210|NCT00474383|587913747|FG000|Main Study|Other|1|||
162782211|NCT00474383|587913748|FG001|Main Study|Other|0|||
162782212|NCT00474383|587913747|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
162782213|NCT00474383|587913748|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
162782214|NCT00474383|587913747|FG000|Extension|Progressive Disease|0|||
162782215|NCT00474383|587913748|FG001|Extension|Progressive Disease|5|||
162782216|NCT02034162|587915732|FG000|Double-blind|Lost to Follow-up|3|||
162782217|NCT02034162|587915733|FG001|Double-blind|Lost to Follow-up|0|||
162782218|NCT02034162|587915734|FG002|Double-blind|Lost to Follow-up|0|||
162782219|NCT02034162|587915732|FG000|Double-blind|Physician Decision|1|||
162782220|NCT02034162|587915733|FG001|Double-blind|Physician Decision|0|||
162782221|NCT02034162|587915734|FG002|Double-blind|Physician Decision|0|||
162782222|NCT02034162|587915732|FG000|Double-blind|Protocol Violation|0|||
162782223|NCT02034162|587915733|FG001|Double-blind|Protocol Violation|1|||
162782224|NCT02034162|587915734|FG002|Double-blind|Protocol Violation|0|||
162782225|NCT02034162|587915732|FG000|Double-blind|Withdrawal by Subject|5|||
162782226|NCT02034162|587915733|FG001|Double-blind|Withdrawal by Subject|7|||
162782227|NCT02034162|587915734|FG002|Double-blind|Withdrawal by Subject|0|||
162782228|NCT00760513|587915735|FG000|Overall Study|Withdrawal by Subject|5|||
162782229|NCT00760513|587915736|FG001|Overall Study|Withdrawal by Subject|7|||
162782230|NCT02808975|587915741|FG000|Overall Study|Adverse Event|3|||
162782231|NCT02808975|587915742|FG001|Overall Study|Adverse Event|4|||
162782232|NCT02808975|587915741|FG000|Overall Study|Withdrew consent|9|||
162782233|NCT02808975|587915742|FG001|Overall Study|Withdrew consent|8|||
162782234|NCT02808975|587915741|FG000|Overall Study|Lost to Follow-up|4|||
162782235|NCT02808975|587915742|FG001|Overall Study|Lost to Follow-up|6|||
162782236|NCT02808975|587915741|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
162782237|NCT02808975|587915742|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
162782238|NCT02808975|587915741|FG000|Overall Study|Other, not specified|5|||
162782239|NCT02808975|587915742|FG001|Overall Study|Other, not specified|1|||
162782240|NCT04367480|587915747|FG000|Overall Study|Adverse Event|1|||
162782241|NCT04367480|587915748|FG001|Overall Study|Adverse Event|1|||
162782242|NCT04367480|587915747|FG000|Overall Study|Death|1|||
162782243|NCT04367480|587915748|FG001|Overall Study|Death|0|||
162782244|NCT04367480|587915747|FG000|Overall Study|Lost to Follow-up|1|||
162782245|NCT04367480|587915748|FG001|Overall Study|Lost to Follow-up|1|||
162782246|NCT04367480|587915747|FG000|Overall Study|Withdrawal by Subject|0|||
162782247|NCT04367480|587915748|FG001|Overall Study|Withdrawal by Subject|3|||
162782248|NCT04367480|587915747|FG000|Overall Study|App glitch during the study|1|||
162782249|NCT04367480|587915748|FG001|Overall Study|App glitch during the study|0|||
162782250|NCT04367480|587915747|FG000|Overall Study|Device Distribution Error|0|||
162782251|NCT04367480|587915748|FG001|Overall Study|Device Distribution Error|2|||
162782252|NCT04367480|587915747|FG000|Overall Study|Ineligible after Randomization|0|||
162782253|NCT04367480|587915748|FG001|Overall Study|Ineligible after Randomization|1|||
162782254|NCT04367480|587915747|FG000|Overall Study|Other Medical Reasons|0|||
162782255|NCT04367480|587915748|FG001|Overall Study|Other Medical Reasons|2|||
162782256|NCT03382561|587915749|FG000|Overall Study|Disease progression|47|||
162782257|NCT03382561|587915750|FG001|Overall Study|Disease progression|6|||
162782258|NCT03382561|587915749|FG000|Overall Study|Adverse Event|10|||
162782259|NCT03382561|587915750|FG001|Overall Study|Adverse Event|2|||
162782260|NCT03382561|587915749|FG000|Overall Study|Death|8|||
162782261|NCT03382561|587915750|FG001|Overall Study|Death|3|||
162782262|NCT03382561|587915749|FG000|Overall Study|Withdrawal by Subject|6|||
162782263|NCT03382561|587915750|FG001|Overall Study|Withdrawal by Subject|5|||
162782264|NCT03382561|587915749|FG000|Overall Study|Alternative therapy|2|||
162782265|NCT03382561|587915750|FG001|Overall Study|Alternative therapy|8|||
162782266|NCT03382561|587915749|FG000|Overall Study|Never started treatment|3|||
162782267|NCT03382561|587915750|FG001|Overall Study|Never started treatment|6|||
162782268|NCT03382561|587915749|FG000|Overall Study|Lack of Efficacy|0|||
162782269|NCT03382561|587915750|FG001|Overall Study|Lack of Efficacy|1|||
162782270|NCT03382561|587915749|FG000|Overall Study|Physician Decision|0|||
162782271|NCT03382561|587915750|FG001|Overall Study|Physician Decision|1|||
162782272|NCT03382561|587915749|FG000|Overall Study|Other complicating disease|0|||
162782273|NCT03382561|587915750|FG001|Overall Study|Other complicating disease|1|||
162782274|NCT01131104|587915751|FG000|Overall Study|Withdrawal by Subject|3|||
162782275|NCT01131104|587915751|FG000|Overall Study|Physician Decision|4|||
162782276|NCT01131104|587915751|FG000|Overall Study|Information Not Available|5|||
162782277|NCT01131104|587915751|FG000|Overall Study|No Information on Index Date of Onset|1|||
162782278|NCT03113383|587915753|FG000|Overall Study|Death|4|||
162782279|NCT03113383|587915754|FG001|Overall Study|Death|0|||
162782280|NCT02641587|587915755|FG000|Confinement Period|Adverse Event|1|||
162782281|NCT02641587|587915756|FG001|Confinement Period|Adverse Event|0|||
162782282|NCT02641587|587915755|FG000|Confinement Period|Withdrawal by Subject|2|||
162782283|NCT02641587|587915756|FG001|Confinement Period|Withdrawal by Subject|1|||
162782284|NCT02641587|587915755|FG000|Ambulatory Period|Withdrawal by Subject|1|||
162782285|NCT02641587|587915756|FG001|Ambulatory Period|Withdrawal by Subject|0|||
162782286|NCT01150045|587915760|FG000|Overall Study|Protocol Violation|0|||
162782287|NCT01150045|587915761|FG001|Overall Study|Protocol Violation|1|||
162782288|NCT01150045|587915762|FG002|Overall Study|Protocol Violation|0|||
162782289|NCT01150045|587915763|FG003|Overall Study|Protocol Violation|1|||
162782290|NCT03194867|587915764|FG000|Overall Study|Incorrect completion of end of study form|0|||
162782291|NCT03194867|587915765|FG001|Overall Study|Incorrect completion of end of study form|0|||
162782292|NCT03194867|587915766|FG002|Overall Study|Incorrect completion of end of study form|1|||
162782293|NCT03194867|587915767|FG003|Overall Study|Incorrect completion of end of study form|0|||
162782294|NCT00464945|587915768|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
162782295|NCT00464945|587915769|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
162782296|NCT00464945|587915768|FG000|Infant Series|Protocol Violation|1|||
162782297|NCT00464945|587915769|FG001|Infant Series|Protocol Violation|0|||
162782298|NCT00464945|587915768|FG000|Infant Series|Lost to Follow-up|1|||
162782299|NCT00464945|587915769|FG001|Infant Series|Lost to Follow-up|0|||
162782300|NCT00464945|587915768|FG000|After Infant Series|Withdrawal by Subject|0|||
162782301|NCT00464945|587915769|FG001|After Infant Series|Withdrawal by Subject|2|||
162782302|NCT00464945|587915768|FG000|Toddler Dose|Lost to Follow-up|0|||
162782303|NCT00464945|587915769|FG001|Toddler Dose|Lost to Follow-up|1|||
162782304|NCT02094898|587915773|FG000|Overall Study|Clinical Worsening|2|||
162782305|NCT02094898|587915773|FG000|Overall Study|Adverse Event|2|||
162782306|NCT02094898|587915773|FG000|Overall Study|Lack of Efficacy|1|||
162782307|NCT03520075|587915774|FG000|Phase 1 (Dose Escalation)|Death|2|||
162782308|NCT03520075|587915775|FG001|Phase 1 (Dose Escalation)|Death|2|||
162782309|NCT03520075|587915776|FG002|Phase 1 (Dose Escalation)|Death|3|||
162782310|NCT03520075|587915777|FG003|Phase 1 (Dose Escalation)|Death|2|||
162782311|NCT03520075|587915778|FG004|Phase 1 (Dose Escalation)|Death|6|||
162782312|NCT03520075|587915779|FG005|Phase 1 (Dose Escalation)|Death|5|||
162782313|NCT03520075|587915780|FG006|Phase 1 (Dose Escalation)|Death|3|||
162782314|NCT03520075|587915781|FG007|Phase 1 (Dose Escalation)|Death|2|||
162782315|NCT03520075|587915782|FG008|Phase 1 (Dose Escalation)|Death|3|||
162782316|NCT03520075|587915783|FG009|Phase 1 (Dose Escalation)|Death|1|||
162782317|NCT03520075|587915784|FG010|Phase 1 (Dose Escalation)|Death|5|||
162782318|NCT03520075|587915785|FG011|Phase 1 (Dose Escalation)|Death|7|||
162782319|NCT03520075|587915786|FG012|Phase 1 (Dose Escalation)|Death|11|||
162782320|NCT03520075|587915787|FG013|Phase 1 (Dose Escalation)|Death|0|||
162782321|NCT03520075|587915788|FG014|Phase 1 (Dose Escalation)|Death|0|||
162782322|NCT03520075|587915789|FG015|Phase 1 (Dose Escalation)|Death|0|||
162782323|NCT03520075|587915790|FG016|Phase 1 (Dose Escalation)|Death|0|||
162782324|NCT03520075|587915791|FG017|Phase 1 (Dose Escalation)|Death|0|||
162782325|NCT03520075|587915792|FG018|Phase 1 (Dose Escalation)|Death|0|||
162782326|NCT03520075|587915774|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
162782327|NCT03520075|587915775|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782328|NCT03520075|587915776|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782329|NCT03520075|587915777|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
162782330|NCT03520075|587915778|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
162782331|NCT03520075|587915779|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
162782332|NCT03520075|587915780|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782333|NCT03520075|587915781|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
162782334|NCT03520075|587915782|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782335|NCT03520075|587915783|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
162782336|NCT03520075|587915784|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782337|NCT03520075|587915785|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782338|NCT03520075|587915786|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
162782339|NCT03520075|587915787|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782340|NCT03520075|587915788|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782341|NCT03520075|587915789|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782342|NCT03520075|587915790|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782343|NCT03520075|587915791|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782344|NCT03520075|587915792|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162782345|NCT03520075|587915774|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782346|NCT03520075|587915775|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162782347|NCT03520075|587915776|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782348|NCT03520075|587915777|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162782349|NCT03520075|587915778|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162782350|NCT03520075|587915779|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782351|NCT03520075|587915780|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782352|NCT03520075|587915781|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782353|NCT03520075|587915782|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782354|NCT03520075|587915783|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782355|NCT03520075|587915784|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162782356|NCT03520075|587915785|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782357|NCT03520075|587915786|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162782358|NCT03520075|587915787|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782359|NCT03520075|587915788|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782360|NCT03520075|587915789|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782361|NCT03520075|587915790|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782362|NCT03520075|587915791|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782363|NCT03520075|587915792|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162782364|NCT03520075|587915774|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782365|NCT03520075|587915775|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782366|NCT03520075|587915776|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782367|NCT03520075|587915777|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782368|NCT03520075|587915778|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782369|NCT03520075|587915779|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782370|NCT03520075|587915780|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782371|NCT03520075|587915781|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782372|NCT03520075|587915782|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782373|NCT03520075|587915783|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
162782374|NCT03520075|587915784|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782375|NCT03520075|587915785|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782376|NCT03520075|587915786|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
162782377|NCT03520075|587915787|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782378|NCT03520075|587915788|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782379|NCT03520075|587915789|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782380|NCT03520075|587915790|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782381|NCT03520075|587915791|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782382|NCT03520075|587915792|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162782383|NCT03520075|587915774|FG000|Phase 2 (Dose Expansion)|Death|0|||
162782384|NCT03520075|587915775|FG001|Phase 2 (Dose Expansion)|Death|0|||
162782385|NCT03520075|587915776|FG002|Phase 2 (Dose Expansion)|Death|0|||
162782386|NCT03520075|587915777|FG003|Phase 2 (Dose Expansion)|Death|0|||
162782387|NCT03520075|587915778|FG004|Phase 2 (Dose Expansion)|Death|0|||
162782388|NCT03520075|587915779|FG005|Phase 2 (Dose Expansion)|Death|0|||
162782389|NCT03520075|587915780|FG006|Phase 2 (Dose Expansion)|Death|0|||
162782390|NCT03520075|587915781|FG007|Phase 2 (Dose Expansion)|Death|0|||
162782391|NCT03520075|587915782|FG008|Phase 2 (Dose Expansion)|Death|0|||
162782392|NCT03520075|587915783|FG009|Phase 2 (Dose Expansion)|Death|0|||
162782393|NCT03520075|587915784|FG010|Phase 2 (Dose Expansion)|Death|0|||
162782394|NCT03520075|587915785|FG011|Phase 2 (Dose Expansion)|Death|0|||
162782395|NCT03520075|587915786|FG012|Phase 2 (Dose Expansion)|Death|0|||
162782396|NCT03520075|587915787|FG013|Phase 2 (Dose Expansion)|Death|20|||
162782397|NCT03520075|587915788|FG014|Phase 2 (Dose Expansion)|Death|13|||
162782398|NCT03520075|587915789|FG015|Phase 2 (Dose Expansion)|Death|9|||
162782399|NCT03520075|587915790|FG016|Phase 2 (Dose Expansion)|Death|5|||
162782400|NCT03520075|587915791|FG017|Phase 2 (Dose Expansion)|Death|14|||
162782401|NCT03520075|587915792|FG018|Phase 2 (Dose Expansion)|Death|12|||
162782402|NCT03520075|587915774|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782403|NCT03520075|587915775|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782404|NCT03520075|587915776|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782405|NCT03520075|587915777|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782406|NCT03520075|587915778|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782407|NCT03520075|587915779|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782408|NCT03520075|587915780|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782409|NCT03520075|587915781|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782410|NCT03520075|587915782|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782411|NCT03520075|587915783|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782412|NCT03520075|587915784|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782413|NCT03520075|587915785|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782414|NCT03520075|587915786|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782415|NCT03520075|587915787|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162782416|NCT03520075|587915788|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
162782417|NCT03520075|587915789|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
162782418|NCT03520075|587915790|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
162782419|NCT03520075|587915791|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
162782420|NCT03520075|587915792|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
162782421|NCT03520075|587915774|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782422|NCT03520075|587915775|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782423|NCT03520075|587915776|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782424|NCT03520075|587915777|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782425|NCT03520075|587915778|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782426|NCT03520075|587915779|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782427|NCT03520075|587915780|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782428|NCT03520075|587915781|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782429|NCT03520075|587915782|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782430|NCT03520075|587915783|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782431|NCT03520075|587915784|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782432|NCT03520075|587915785|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782433|NCT03520075|587915786|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782434|NCT03520075|587915787|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782435|NCT03520075|587915788|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162782436|NCT03520075|587915789|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162782437|NCT03520075|587915790|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782438|NCT03520075|587915791|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162782439|NCT03520075|587915792|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162782440|NCT03520075|587915774|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782441|NCT03520075|587915775|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782442|NCT03520075|587915776|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782443|NCT03520075|587915777|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782444|NCT03520075|587915778|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162925395|NCT05302414|588428962|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
162925396|NCT05302414|588428963|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
162925397|NCT00742859|588428964|FG000|Overall Study|Adverse Event|5|||
162925398|NCT00742859|588428965|FG001|Overall Study|Adverse Event|6|||
162925399|NCT00742859|588428966|FG002|Overall Study|Adverse Event|3|||
162925400|NCT00742859|588428967|FG003|Overall Study|Adverse Event|1|||
162925401|NCT00742859|588428964|FG000|Overall Study|Death|1|||
162925402|NCT00742859|588428965|FG001|Overall Study|Death|0|||
162925403|NCT00742859|588428966|FG002|Overall Study|Death|0|||
162925404|NCT00742859|588428967|FG003|Overall Study|Death|1|||
162925405|NCT00742859|588428964|FG000|Overall Study|Physician Decision|1|||
162925406|NCT00742859|588428965|FG001|Overall Study|Physician Decision|2|||
162925407|NCT00742859|588428966|FG002|Overall Study|Physician Decision|0|||
162925408|NCT00742859|588428967|FG003|Overall Study|Physician Decision|0|||
162925409|NCT00742859|588428964|FG000|Overall Study|Withdrawal by Subject|4|||
162925410|NCT00742859|588428965|FG001|Overall Study|Withdrawal by Subject|2|||
162925411|NCT00742859|588428966|FG002|Overall Study|Withdrawal by Subject|4|||
162925412|NCT00742859|588428967|FG003|Overall Study|Withdrawal by Subject|1|||
162925413|NCT00742859|588428964|FG000|Overall Study|Endpoint|0|||
162925414|NCT00742859|588428965|FG001|Overall Study|Endpoint|1|||
162925415|NCT00742859|588428966|FG002|Overall Study|Endpoint|1|||
162925416|NCT00742859|588428967|FG003|Overall Study|Endpoint|2|||
162925417|NCT00742859|588428964|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
162925418|NCT00742859|588428965|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
162925419|NCT00742859|588428966|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
162925420|NCT00742859|588428967|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
162925421|NCT00742859|588428964|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925422|NCT00742859|588428965|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925423|NCT00742859|588428966|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
162925424|NCT00742859|588428967|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
162925425|NCT00742859|588428964|FG000|Overall Study|Sponsor request patient out of town|0|||
162925426|NCT00742859|588428965|FG001|Overall Study|Sponsor request patient out of town|0|||
162925427|NCT00742859|588428966|FG002|Overall Study|Sponsor request patient out of town|1|||
162782445|NCT03520075|587915779|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782446|NCT03520075|587915780|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782447|NCT03520075|587915781|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782448|NCT03520075|587915782|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782449|NCT03520075|587915783|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782450|NCT03520075|587915784|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782451|NCT03520075|587915785|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782452|NCT03520075|587915786|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782453|NCT03520075|587915787|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
162782454|NCT03520075|587915788|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782455|NCT03520075|587915789|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782456|NCT03520075|587915790|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
162782457|NCT03520075|587915791|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
162782458|NCT03520075|587915792|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162782459|NCT01432626|587915795|FG000|Overall Study|LV function recovered|2|||
162782460|NCT01432626|587915795|FG000|Overall Study|Withdrawal by Subject|2|||
162782461|NCT01432626|587915795|FG000|Overall Study|Only 1 image competed|2|||
162782462|NCT01432626|587915795|FG000|Overall Study|Imaging agent not available|1|||
162782463|NCT03305809|587915796|FG000|Overall Study|Adverse Event|2|||
162782464|NCT03305809|587915797|FG001|Overall Study|Adverse Event|2|||
162782465|NCT03305809|587915798|FG002|Overall Study|Adverse Event|6|||
162782466|NCT03305809|587915799|FG003|Overall Study|Adverse Event|6|||
162782467|NCT03305809|587915796|FG000|Overall Study|Death|0|||
162782468|NCT03305809|587915797|FG001|Overall Study|Death|0|||
162782469|NCT03305809|587915798|FG002|Overall Study|Death|1|||
162782470|NCT03305809|587915799|FG003|Overall Study|Death|1|||
162782471|NCT03305809|587915796|FG000|Overall Study|Lost to Follow-up|1|||
162782472|NCT03305809|587915797|FG001|Overall Study|Lost to Follow-up|2|||
162782473|NCT03305809|587915798|FG002|Overall Study|Lost to Follow-up|0|||
162782474|NCT03305809|587915799|FG003|Overall Study|Lost to Follow-up|0|||
162782475|NCT03305809|587915796|FG000|Overall Study|Sponsor Decision|1|||
162782476|NCT03305809|587915797|FG001|Overall Study|Sponsor Decision|0|||
162782477|NCT03305809|587915798|FG002|Overall Study|Sponsor Decision|1|||
162782478|NCT03305809|587915799|FG003|Overall Study|Sponsor Decision|8|||
162782479|NCT03305809|587915796|FG000|Overall Study|Physician Decision|0|||
162782480|NCT03305809|587915797|FG001|Overall Study|Physician Decision|0|||
162782481|NCT03305809|587915798|FG002|Overall Study|Physician Decision|2|||
162782482|NCT03305809|587915799|FG003|Overall Study|Physician Decision|4|||
162782483|NCT03305809|587915796|FG000|Overall Study|Progressive Disease|0|||
162782484|NCT03305809|587915797|FG001|Overall Study|Progressive Disease|0|||
162782485|NCT03305809|587915798|FG002|Overall Study|Progressive Disease|1|||
162782486|NCT03305809|587915799|FG003|Overall Study|Progressive Disease|0|||
162782487|NCT03305809|587915796|FG000|Overall Study|Protocol Violation|1|||
162782488|NCT03305809|587915797|FG001|Overall Study|Protocol Violation|0|||
162782489|NCT03305809|587915798|FG002|Overall Study|Protocol Violation|2|||
162782490|NCT03305809|587915799|FG003|Overall Study|Protocol Violation|3|||
162782491|NCT03305809|587915796|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162782492|NCT03305809|587915797|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162782493|NCT03305809|587915798|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162782494|NCT03305809|587915799|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
162782495|NCT03305809|587915796|FG000|Overall Study|Withdrawal by Subject|2|||
162782496|NCT03305809|587915797|FG001|Overall Study|Withdrawal by Subject|4|||
162782497|NCT03305809|587915798|FG002|Overall Study|Withdrawal by Subject|5|||
162782498|NCT03305809|587915799|FG003|Overall Study|Withdrawal by Subject|2|||
162782499|NCT03305809|587915796|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
162782500|NCT03305809|587915797|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
162782501|NCT03305809|587915798|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
162782502|NCT03305809|587915799|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
162782503|NCT00816556|587915802|FG000|Overall Study|Adverse Event|1|||
162782504|NCT00816556|587915803|FG001|Overall Study|Adverse Event|1|||
162782505|NCT00816556|587915804|FG002|Overall Study|Adverse Event|1|||
162782506|NCT00816556|587915802|FG000|Overall Study|Withdrawal by Subject|1|||
162782507|NCT00816556|587915803|FG001|Overall Study|Withdrawal by Subject|1|||
162782508|NCT00816556|587915804|FG002|Overall Study|Withdrawal by Subject|1|||
162782509|NCT00816556|587915802|FG000|Overall Study|Lost to Follow-up|0|||
162782510|NCT00816556|587915803|FG001|Overall Study|Lost to Follow-up|0|||
162782511|NCT00816556|587915804|FG002|Overall Study|Lost to Follow-up|1|||
162782512|NCT01657799|587915807|FG000|Overall Study|Adverse Event Related to progression|6|||
162782513|NCT01657799|587915808|FG001|Overall Study|Adverse Event Related to progression|8|||
162782514|NCT01657799|587915809|FG002|Overall Study|Adverse Event Related to progression|12|||
162782515|NCT01657799|587915807|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
162782516|NCT01657799|587915808|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
162782517|NCT01657799|587915809|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
162782518|NCT01657799|587915807|FG000|Overall Study|Withdrawal by Subject|13|||
162782519|NCT01657799|587915808|FG001|Overall Study|Withdrawal by Subject|10|||
162782520|NCT01657799|587915809|FG002|Overall Study|Withdrawal by Subject|10|||
162782521|NCT01657799|587915807|FG000|Overall Study|Lost to Follow-up|1|||
162782522|NCT01657799|587915808|FG001|Overall Study|Lost to Follow-up|0|||
162782523|NCT01657799|587915809|FG002|Overall Study|Lost to Follow-up|1|||
162782524|NCT01657799|587915807|FG000|Overall Study|Disease Progression|2|||
162782525|NCT01657799|587915808|FG001|Overall Study|Disease Progression|4|||
162782526|NCT01657799|587915809|FG002|Overall Study|Disease Progression|4|||
162782527|NCT01657799|587915807|FG000|Overall Study|Progressive Disease Clinical|7|||
162782528|NCT01657799|587915808|FG001|Overall Study|Progressive Disease Clinical|4|||
162782529|NCT01657799|587915809|FG002|Overall Study|Progressive Disease Clinical|7|||
162782530|NCT01657799|587915807|FG000|Overall Study|Radiographic & Clinical Progression|16|||
162782531|NCT01657799|587915808|FG001|Overall Study|Radiographic & Clinical Progression|11|||
162782532|NCT01657799|587915809|FG002|Overall Study|Radiographic & Clinical Progression|15|||
162782533|NCT01657799|587915807|FG000|Overall Study|Other|52|||
162782534|NCT01657799|587915808|FG001|Overall Study|Other|62|||
162782535|NCT01657799|587915809|FG002|Overall Study|Other|49|||
162782536|NCT01588366|587915812|FG000|Overall Study|Adverse Event|0|||
162782537|NCT01588366|587915813|FG001|Overall Study|Adverse Event|1|||
162782538|NCT01588366|587915814|FG002|Overall Study|Adverse Event|0|||
162782539|NCT01588366|587915815|FG003|Overall Study|Adverse Event|1|||
162782540|NCT01588366|587915816|FG004|Overall Study|Adverse Event|0|||
162782541|NCT01588366|587915817|FG005|Overall Study|Adverse Event|2|||
162782542|NCT04962698|587915818|FG000|Motor Imagery|Technical difficulty|1|||
162782543|NCT04962698|587915819|FG001|Motor Imagery|Technical difficulty|0|||
162782544|NCT04962698|587915818|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
162782545|NCT04962698|587915819|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
162782546|NCT04962698|587915818|FG000|Kinesthetic MI|Technical difficulty|1|||
162782547|NCT04962698|587915819|FG001|Kinesthetic MI|Technical difficulty|0|||
162782548|NCT04962698|587915818|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
162782549|NCT04962698|587915819|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
162782550|NCT04962698|587915818|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
162782551|NCT04962698|587915819|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
162782552|NCT04962698|587915818|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
162782553|NCT04962698|587915819|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
162782554|NCT04962698|587915818|FG000|Virtual-hand Interaction|Technical difficulty|1|||
162782555|NCT04962698|587915819|FG001|Virtual-hand Interaction|Technical difficulty|0|||
162782556|NCT04962698|587915818|FG000|Robotic Action Observation|Technical difficulty|1|||
162782557|NCT04962698|587915819|FG001|Robotic Action Observation|Technical difficulty|0|||
162782558|NCT04962698|587915818|FG000|Rest|Technical difficulty|1|||
162782559|NCT04962698|587915819|FG001|Rest|Technical difficulty|0|||
162782560|NCT04962698|587915818|FG000|Rest|Exclusion criteria met after enrollment|0|||
162782561|NCT04962698|587915819|FG001|Rest|Exclusion criteria met after enrollment|2|||
162782562|NCT00585975|587915820|FG000|Overall Study|Withdrawal by Subject|3|||
162782563|NCT00585975|587915821|FG001|Overall Study|Withdrawal by Subject|3|||
162782564|NCT00585975|587915820|FG000|Overall Study|Lost to Follow-up|2|||
162782565|NCT00585975|587915821|FG001|Overall Study|Lost to Follow-up|1|||
162782566|NCT00585975|587915820|FG000|Overall Study|Enrollment met/over-enrolled|10|||
162782567|NCT00585975|587915821|FG001|Overall Study|Enrollment met/over-enrolled|9|||
162782568|NCT01129115|587915828|FG000|Overall Study|Adverse Event|1|||
162782569|NCT01129115|587915829|FG001|Overall Study|Adverse Event|2|||
162782570|NCT01129115|587915830|FG002|Overall Study|Adverse Event|3|||
162782571|NCT01129115|587915831|FG003|Overall Study|Adverse Event|3|||
162782572|NCT01129115|587915828|FG000|Overall Study|Withdrawal by Subject|1|||
162782573|NCT01129115|587915829|FG001|Overall Study|Withdrawal by Subject|3|||
162782574|NCT01129115|587915830|FG002|Overall Study|Withdrawal by Subject|1|||
162782575|NCT01129115|587915831|FG003|Overall Study|Withdrawal by Subject|4|||
162782576|NCT01129115|587915828|FG000|Overall Study|Protocol Violation|0|||
162782577|NCT01129115|587915829|FG001|Overall Study|Protocol Violation|2|||
162782578|NCT01129115|587915830|FG002|Overall Study|Protocol Violation|2|||
162782579|NCT01129115|587915831|FG003|Overall Study|Protocol Violation|2|||
162782580|NCT01121913|587915832|FG000|First Intervention Period|Adverse Event|0|||
162782581|NCT01121913|587915833|FG001|First Intervention Period|Adverse Event|0|||
162782582|NCT01121913|587915834|FG002|First Intervention Period|Adverse Event|1|||
162782583|NCT01121913|587915835|FG003|First Intervention Period|Adverse Event|0|||
162782584|NCT01121913|587915832|FG000|First Washout Period|Withdrawal by Subject|1|||
162782585|NCT01121913|587915833|FG001|First Washout Period|Withdrawal by Subject|0|||
162782586|NCT01121913|587915834|FG002|First Washout Period|Withdrawal by Subject|0|||
162782587|NCT01121913|587915835|FG003|First Washout Period|Withdrawal by Subject|0|||
162782588|NCT01121913|587915832|FG000|Second Intervention Period|Adverse Event|0|||
162782589|NCT01121913|587915833|FG001|Second Intervention Period|Adverse Event|0|||
162782590|NCT01121913|587915834|FG002|Second Intervention Period|Adverse Event|1|||
162782591|NCT01121913|587915835|FG003|Second Intervention Period|Adverse Event|0|||
162782592|NCT01121913|587915832|FG000|Second Washout Period|Withdrawal by Subject|0|||
162782593|NCT01121913|587915833|FG001|Second Washout Period|Withdrawal by Subject|0|||
162782594|NCT01121913|587915834|FG002|Second Washout Period|Withdrawal by Subject|1|||
162782595|NCT01121913|587915835|FG003|Second Washout Period|Withdrawal by Subject|0|||
162782596|NCT01121913|587915832|FG000|Third Washout Period|Adverse Event|1|||
162782597|NCT01121913|587915833|FG001|Third Washout Period|Adverse Event|0|||
162782598|NCT01121913|587915834|FG002|Third Washout Period|Adverse Event|0|||
162782599|NCT01121913|587915835|FG003|Third Washout Period|Adverse Event|0|||
162782600|NCT02019641|587915836|FG000|10-Week Follow up|Withdrawal by investigator|2|||
162782601|NCT02019641|587915837|FG001|10-Week Follow up|Withdrawal by investigator|0|||
162782602|NCT02019641|587915838|FG002|10-Week Follow up|Withdrawal by investigator|0|||
162782603|NCT02019641|587915836|FG000|10-Week Follow up|Withdrawal by Subject|1|||
162782604|NCT02019641|587915837|FG001|10-Week Follow up|Withdrawal by Subject|1|||
162782605|NCT02019641|587915838|FG002|10-Week Follow up|Withdrawal by Subject|0|||
162782606|NCT02019641|587915836|FG000|20-Week Follow up|Withdrawal by investigator|0|||
162782607|NCT02019641|587915837|FG001|20-Week Follow up|Withdrawal by investigator|0|||
162782608|NCT02019641|587915838|FG002|20-Week Follow up|Withdrawal by investigator|1|||
162782609|NCT05043883|587915839|FG000|Overall Study|Minimum required measurements could not be taken|4|||
162782610|NCT02447718|587915842|FG000|Overall Study|Lost to Follow-up|8|||
162782611|NCT02447718|587915843|FG001|Overall Study|Lost to Follow-up|0|||
162782612|NCT02447718|587915842|FG000|Overall Study|Withdrawal by Subject|3|||
162782613|NCT02447718|587915843|FG001|Overall Study|Withdrawal by Subject|0|||
162782614|NCT02447718|587915842|FG000|Overall Study|Screen Failure|1|||
162782615|NCT02447718|587915843|FG001|Overall Study|Screen Failure|0|||
162782616|NCT00468130|587915846|FG000|Overall Study|Adverse Event|2|||
162782617|NCT00468130|587915847|FG001|Overall Study|Adverse Event|1|||
162782618|NCT00468130|587915846|FG000|Overall Study|Withdrawal by Subject|0|||
162782619|NCT00468130|587915847|FG001|Overall Study|Withdrawal by Subject|1|||
162782620|NCT03772613|587915848|FG000|Overall Study|Lost to Follow-up|0|||
162782621|NCT03772613|587915849|FG001|Overall Study|Lost to Follow-up|1|||
162782622|NCT03772613|587915850|FG002|Overall Study|Lost to Follow-up|1|||
162782623|NCT01837797|587915859|FG000|Period 1|Adverse Event|9|||
162782624|NCT01837797|587915860|FG001|Period 1|Adverse Event|0|||
162782625|NCT01837797|587915861|FG002|Period 1|Adverse Event|0|||
162782626|NCT01837797|587915862|FG003|Period 1|Adverse Event|0|||
162782627|NCT01837797|587915863|FG004|Period 1|Adverse Event|0|||
162782628|NCT01837797|587915859|FG000|Period 1|Withdrawal by Subject|6|||
162782629|NCT01837797|587915860|FG001|Period 1|Withdrawal by Subject|0|||
162782630|NCT01837797|587915861|FG002|Period 1|Withdrawal by Subject|0|||
162782631|NCT01837797|587915862|FG003|Period 1|Withdrawal by Subject|0|||
162782632|NCT01837797|587915863|FG004|Period 1|Withdrawal by Subject|0|||
162782633|NCT01837797|587915859|FG000|Period 1|Administrative reasons|76|||
162782634|NCT01837797|587915860|FG001|Period 1|Administrative reasons|0|||
162782635|NCT01837797|587915861|FG002|Period 1|Administrative reasons|0|||
162782636|NCT01837797|587915862|FG003|Period 1|Administrative reasons|0|||
162782637|NCT01837797|587915863|FG004|Period 1|Administrative reasons|0|||
162782638|NCT01837797|587915859|FG000|Period 1|Withdrawal of consent before treatment|1|||
162782639|NCT01837797|587915860|FG001|Period 1|Withdrawal of consent before treatment|0|||
162782640|NCT01837797|587915861|FG002|Period 1|Withdrawal of consent before treatment|0|||
162782641|NCT01837797|587915862|FG003|Period 1|Withdrawal of consent before treatment|0|||
162782642|NCT01837797|587915863|FG004|Period 1|Withdrawal of consent before treatment|0|||
162782643|NCT01837797|587915859|FG000|Period 1|Other|10|||
162782644|NCT01837797|587915860|FG001|Period 1|Other|0|||
162782645|NCT01837797|587915861|FG002|Period 1|Other|0|||
162782646|NCT01837797|587915862|FG003|Period 1|Other|0|||
162782647|NCT01837797|587915863|FG004|Period 1|Other|0|||
162782648|NCT01837797|587915859|FG000|Period 2|Administrative or other reasons|0|||
162782649|NCT01837797|587915860|FG001|Period 2|Administrative or other reasons|5|||
162782650|NCT01837797|587915861|FG002|Period 2|Administrative or other reasons|2|||
162782651|NCT01837797|587915862|FG003|Period 2|Administrative or other reasons|4|||
162782652|NCT01837797|587915863|FG004|Period 2|Administrative or other reasons|0|||
162782653|NCT01837797|587915859|FG000|Period 2|Adverse Event|0|||
162782654|NCT01837797|587915860|FG001|Period 2|Adverse Event|0|||
162782655|NCT01837797|587915861|FG002|Period 2|Adverse Event|0|||
162782656|NCT01837797|587915862|FG003|Period 2|Adverse Event|1|||
162782657|NCT01837797|587915863|FG004|Period 2|Adverse Event|0|||
162782658|NCT01837797|587915859|FG000|Period 3|Adverse Event|0|||
162782659|NCT01837797|587915860|FG001|Period 3|Adverse Event|0|||
162782660|NCT01837797|587915861|FG002|Period 3|Adverse Event|0|||
162782661|NCT01837797|587915862|FG003|Period 3|Adverse Event|0|||
162782662|NCT01837797|587915863|FG004|Period 3|Adverse Event|1|||
162782663|NCT01837797|587915859|FG000|Period 3|Administrative reasons|0|||
162782664|NCT01837797|587915860|FG001|Period 3|Administrative reasons|0|||
162782665|NCT01837797|587915861|FG002|Period 3|Administrative reasons|0|||
162782666|NCT01837797|587915862|FG003|Period 3|Administrative reasons|0|||
162782667|NCT01837797|587915863|FG004|Period 3|Administrative reasons|20|||
162782668|NCT01837797|587915859|FG000|Period 3|Other|0|||
162782669|NCT01837797|587915860|FG001|Period 3|Other|0|||
162782670|NCT01837797|587915861|FG002|Period 3|Other|0|||
162782671|NCT01837797|587915862|FG003|Period 3|Other|0|||
162782672|NCT01837797|587915863|FG004|Period 3|Other|2|||
162782673|NCT03797989|587915884|FG000|VAC069A|Withdrawal by Subject|0|||
162782674|NCT03797989|587915885|FG001|VAC069A|Withdrawal by Subject|0|||
162782675|NCT03797989|587915886|FG002|VAC069A|Withdrawal by Subject|1|||
162782676|NCT03797989|587915887|FG003|VAC069A|Withdrawal by Subject|0|||
162782677|NCT03797989|587915888|FG004|VAC069A|Withdrawal by Subject|0|||
162782678|NCT03797989|587915889|FG005|VAC069A|Withdrawal by Subject|0|||
162782679|NCT03797989|587915890|FG006|VAC069A|Withdrawal by Subject|0|||
162782680|NCT03797989|587915891|FG007|VAC069A|Withdrawal by Subject|0|||
162782681|NCT03797989|587915892|FG008|VAC069A|Withdrawal by Subject|0|||
162782682|NCT03797989|587915893|FG009|VAC069A|Withdrawal by Subject|0|||
162782683|NCT03797989|587915894|FG010|VAC069A|Withdrawal by Subject|0|||
162782684|NCT03797989|587915895|FG011|VAC069A|Withdrawal by Subject|0|||
162782685|NCT04522778|587915897|FG000|Overall Study|Patient did not want to wear the device|1|||
162782686|NCT04522778|587915898|FG001|Overall Study|Patient did not want to wear the device|0|||
162782687|NCT04522778|587915897|FG000|Overall Study|Lost to Follow-up|0|||
162782688|NCT04522778|587915898|FG001|Overall Study|Lost to Follow-up|1|||
162782689|NCT04052997|587915899|FG000|Overall Study|Withdrawal by Subject|17|||
162782690|NCT04052997|587915899|FG000|Overall Study|Physician Decision|50|||
162782691|NCT04052997|587915899|FG000|Overall Study|Death|43|||
162782692|NCT04052997|587915899|FG000|Overall Study|Lost to Follow-up|5|||
162782693|NCT04052997|587915899|FG000|Overall Study|Progression of Disease|1|||
162782694|NCT00069277|587915900|FG000|Overall Study|Adverse Event|3|||
162782695|NCT00069277|587915900|FG000|Overall Study|Withdrawal by Subject|1|||
162782696|NCT00069277|587915900|FG000|Overall Study|Progressive Disease|15|||
162782697|NCT00069277|587915900|FG000|Overall Study|Physician Decision|2|||
162782698|NCT04594733|587915901|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162782699|NCT04594733|587915902|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162782700|NCT04594733|587915901|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
162782701|NCT04594733|587915902|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
162782702|NCT04594733|587915901|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
162782703|NCT04594733|587915902|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162782704|NCT01024036|587915907|FG000|Blinded Treatment|Adverse Event|1|||
162782705|NCT01024036|587915908|FG001|Blinded Treatment|Adverse Event|1|||
162782706|NCT01024036|587915907|FG000|Blinded Treatment|Lack of Efficacy|16|||
162782707|NCT01024036|587915908|FG001|Blinded Treatment|Lack of Efficacy|14|||
162782708|NCT01024036|587915907|FG000|Blinded Treatment|Physician Decision|1|||
162782709|NCT01024036|587915908|FG001|Blinded Treatment|Physician Decision|0|||
162782710|NCT01024036|587915907|FG000|Blinded Treatment|Death|0|||
162782711|NCT01024036|587915908|FG001|Blinded Treatment|Death|2|||
162782712|NCT01024036|587915907|FG000|Blinded Treatment|Withdrawal by Subject|4|||
162782713|NCT01024036|587915908|FG001|Blinded Treatment|Withdrawal by Subject|3|||
162782714|NCT01024036|587915907|FG000|Unblinded Treatment|Adverse Event|0|||
162782715|NCT01024036|587915908|FG001|Unblinded Treatment|Adverse Event|1|||
162782716|NCT01024036|587915907|FG000|Unblinded Treatment|Lack of Efficacy|0|||
162782717|NCT01024036|587915908|FG001|Unblinded Treatment|Lack of Efficacy|2|||
162782718|NCT01024036|587915907|FG000|Follow-Up Period|Lost to Follow-up|1|||
162782719|NCT01024036|587915908|FG001|Follow-Up Period|Lost to Follow-up|1|||
162782720|NCT01024036|587915907|FG000|Follow-Up Period|Withdrawal by Subject|0|||
162782721|NCT01024036|587915908|FG001|Follow-Up Period|Withdrawal by Subject|1|||
162782722|NCT01024036|587915907|FG000|Follow-Up Period|Adverse Event|4|||
162782723|NCT01024036|587915908|FG001|Follow-Up Period|Adverse Event|1|||
162782724|NCT03512288|587915913|FG000|Overall Study|Adverse Event|1|||
162782725|NCT03512288|587915914|FG001|Overall Study|Adverse Event|0|||
162782726|NCT03512288|587915913|FG000|Overall Study|Lost to Follow-up|12|||
162782727|NCT03512288|587915914|FG001|Overall Study|Lost to Follow-up|15|||
162782728|NCT03512288|587915913|FG000|Overall Study|Physician Decision|0|||
162782729|NCT03512288|587915914|FG001|Overall Study|Physician Decision|2|||
162782730|NCT03512288|587915913|FG000|Overall Study|Protocol Violation|6|||
162782731|NCT03512288|587915914|FG001|Overall Study|Protocol Violation|4|||
162782732|NCT03512288|587915913|FG000|Overall Study|Medication error without associated adverse event|1|||
162782733|NCT03512288|587915914|FG001|Overall Study|Medication error without associated adverse event|0|||
162782734|NCT03512288|587915913|FG000|Overall Study|No longer met eligibility criteria|5|||
162782735|NCT03512288|587915914|FG001|Overall Study|No longer met eligibility criteria|2|||
162782736|NCT03512288|587915913|FG000|Overall Study|Withdrawal by parent/guardian|14|||
162782737|NCT03512288|587915914|FG001|Overall Study|Withdrawal by parent/guardian|18|||
162782738|NCT03512288|587915913|FG000|Overall Study|Other|1|||
162782739|NCT03512288|587915914|FG001|Overall Study|Other|1|||
162782740|NCT03512288|587915913|FG000|Overall Study|Randomized but not treated|1|||
162782741|NCT03512288|587915914|FG001|Overall Study|Randomized but not treated|1|||
162782742|NCT01482819|587915917|FG000|Overall Study|Lost to Follow-up|2|||
162782743|NCT00942188|587915920|FG000|Overall Study|Adverse Event|0|||
162782744|NCT00942188|587915921|FG001|Overall Study|Adverse Event|3|||
162782745|NCT00942188|587915922|FG002|Overall Study|Adverse Event|2|||
162782746|NCT00942188|587915923|FG003|Overall Study|Adverse Event|0|||
162782747|NCT00942188|587915920|FG000|Overall Study|Lack of Efficacy|0|||
162782748|NCT00942188|587915921|FG001|Overall Study|Lack of Efficacy|0|||
162782749|NCT00942188|587915922|FG002|Overall Study|Lack of Efficacy|0|||
162782750|NCT00942188|587915923|FG003|Overall Study|Lack of Efficacy|1|||
162782751|NCT00942188|587915920|FG000|Overall Study|Protocol Violation|1|||
162782752|NCT00942188|587915921|FG001|Overall Study|Protocol Violation|1|||
162782753|NCT00942188|587915922|FG002|Overall Study|Protocol Violation|0|||
162782754|NCT00942188|587915923|FG003|Overall Study|Protocol Violation|0|||
162782755|NCT00942188|587915920|FG000|Overall Study|Lost to Follow-up|2|||
162782756|NCT00942188|587915921|FG001|Overall Study|Lost to Follow-up|1|||
162782757|NCT00942188|587915922|FG002|Overall Study|Lost to Follow-up|2|||
162782758|NCT00942188|587915923|FG003|Overall Study|Lost to Follow-up|0|||
162782759|NCT00942188|587915920|FG000|Overall Study|Withdrawal by Subject|1|||
162782760|NCT00942188|587915921|FG001|Overall Study|Withdrawal by Subject|3|||
162782761|NCT00942188|587915922|FG002|Overall Study|Withdrawal by Subject|4|||
162782762|NCT00942188|587915923|FG003|Overall Study|Withdrawal by Subject|2|||
162782763|NCT00942188|587915920|FG000|Overall Study|Physician Decision|0|||
162782764|NCT00942188|587915921|FG001|Overall Study|Physician Decision|0|||
162782765|NCT00942188|587915922|FG002|Overall Study|Physician Decision|1|||
162782766|NCT00942188|587915923|FG003|Overall Study|Physician Decision|0|||
162782767|NCT00942188|587915920|FG000|Overall Study|Sponsor Decision|0|||
162782768|NCT00942188|587915921|FG001|Overall Study|Sponsor Decision|2|||
162782769|NCT00942188|587915922|FG002|Overall Study|Sponsor Decision|0|||
162782770|NCT00942188|587915923|FG003|Overall Study|Sponsor Decision|1|||
162782771|NCT04811339|587915925|FG000|Overall Study|lack of transportation not wanting to return|4|||
162782772|NCT04811339|587915926|FG001|Overall Study|lack of transportation not wanting to return|8|||
162782773|NCT04811339|587915927|FG002|Overall Study|lack of transportation not wanting to return|0|||
162782774|NCT04811339|587915925|FG000|Overall Study|Adverse Event|3|||
162782775|NCT04811339|587915926|FG001|Overall Study|Adverse Event|0|||
162782776|NCT04811339|587915927|FG002|Overall Study|Adverse Event|0|||
162782777|NCT04811339|587915925|FG000|Overall Study|Lost to Follow-up|1|||
162782778|NCT04811339|587915926|FG001|Overall Study|Lost to Follow-up|0|||
162782779|NCT04811339|587915927|FG002|Overall Study|Lost to Follow-up|0|||
162782780|NCT04811339|587915925|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
162782781|NCT04811339|587915926|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
162782782|NCT04811339|587915927|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
162782783|NCT04811339|587915925|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
162782784|NCT04811339|587915926|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
162782785|NCT04811339|587915927|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
162782786|NCT04811339|587915925|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
162782787|NCT04811339|587915926|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
162782788|NCT04811339|587915927|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
162782789|NCT04811339|587915925|FG000|Overall Study|Withdrawal by Subject|0|||
162782790|NCT04811339|587915926|FG001|Overall Study|Withdrawal by Subject|3|||
162782791|NCT04811339|587915927|FG002|Overall Study|Withdrawal by Subject|0|||
162782792|NCT04811339|587915925|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
162782793|NCT04811339|587915926|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
162782794|NCT04811339|587915927|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
162782795|NCT04811339|587915925|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
162782796|NCT04811339|587915926|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
162782797|NCT04811339|587915927|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
162782798|NCT00143598|587915928|FG000|Overall Study|Lost to Follow-up|23|||
162782799|NCT00143598|587915929|FG001|Overall Study|Lost to Follow-up|21|||
162782800|NCT00143598|587915928|FG000|Overall Study|Withdrawal by Subject|33|||
162782801|NCT00143598|587915929|FG001|Overall Study|Withdrawal by Subject|37|||
162782802|NCT00143598|587915928|FG000|Overall Study|Death|36|||
162782803|NCT00143598|587915929|FG001|Overall Study|Death|36|||
162782804|NCT04944784|587915932|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
162782805|NCT04944784|587915933|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
162782806|NCT04944784|587915934|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
162782807|NCT04944784|587915935|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
162782808|NCT04944784|587915932|FG000|Double-blind Period|Adverse Event|20|||
162782809|NCT04944784|587915933|FG001|Double-blind Period|Adverse Event|4|||
162782810|NCT04944784|587915934|FG002|Double-blind Period|Adverse Event|0|||
162782811|NCT04944784|587915935|FG003|Double-blind Period|Adverse Event|0|||
162782812|NCT04944784|587915932|FG000|Double-blind Period|Withdrawal by Subject|15|||
162782813|NCT04944784|587915933|FG001|Double-blind Period|Withdrawal by Subject|4|||
162782814|NCT04944784|587915934|FG002|Double-blind Period|Withdrawal by Subject|0|||
162782815|NCT04944784|587915935|FG003|Double-blind Period|Withdrawal by Subject|0|||
162782816|NCT04944784|587915932|FG000|Double-blind Period|Death|7|||
162782817|NCT04944784|587915933|FG001|Double-blind Period|Death|2|||
162782818|NCT04944784|587915934|FG002|Double-blind Period|Death|0|||
162782819|NCT04944784|587915935|FG003|Double-blind Period|Death|0|||
162782820|NCT04944784|587915932|FG000|Double-blind Period|Physician Decision|2|||
162782821|NCT04944784|587915933|FG001|Double-blind Period|Physician Decision|1|||
162782822|NCT04944784|587915934|FG002|Double-blind Period|Physician Decision|0|||
162782823|NCT04944784|587915935|FG003|Double-blind Period|Physician Decision|0|||
162782824|NCT04944784|587915932|FG000|Double-blind Period|Lack of Efficacy|0|||
162782825|NCT04944784|587915933|FG001|Double-blind Period|Lack of Efficacy|1|||
162782826|NCT04944784|587915934|FG002|Double-blind Period|Lack of Efficacy|0|||
162782827|NCT04944784|587915935|FG003|Double-blind Period|Lack of Efficacy|0|||
162782828|NCT04944784|587915932|FG000|Double-blind Period|Sponsor Request|2|||
162782829|NCT04944784|587915933|FG001|Double-blind Period|Sponsor Request|1|||
162782830|NCT04944784|587915934|FG002|Double-blind Period|Sponsor Request|0|||
162782831|NCT04944784|587915935|FG003|Double-blind Period|Sponsor Request|0|||
162782832|NCT04944784|587915932|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
162782833|NCT04944784|587915933|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
162782834|NCT04944784|587915934|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
162782835|NCT04944784|587915935|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
162782836|NCT04944784|587915932|FG000|Double-blind Period|Participant Choice|1|||
162782837|NCT04944784|587915933|FG001|Double-blind Period|Participant Choice|1|||
162782838|NCT04944784|587915934|FG002|Double-blind Period|Participant Choice|0|||
162782839|NCT04944784|587915935|FG003|Double-blind Period|Participant Choice|0|||
162782840|NCT04944784|587915932|FG000|Double-blind Period|Progressive Disease|2|||
162782841|NCT04944784|587915933|FG001|Double-blind Period|Progressive Disease|2|||
162782842|NCT04944784|587915934|FG002|Double-blind Period|Progressive Disease|0|||
162782843|NCT04944784|587915935|FG003|Double-blind Period|Progressive Disease|0|||
162782844|NCT04944784|587915932|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
162782845|NCT04944784|587915933|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
162782846|NCT04944784|587915934|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
162782847|NCT04944784|587915935|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
162782848|NCT04944784|587915932|FG000|Active Drug Period|Adverse Event|0|||
162782849|NCT04944784|587915933|FG001|Active Drug Period|Adverse Event|0|||
162782850|NCT04944784|587915934|FG002|Active Drug Period|Adverse Event|3|||
162782851|NCT04944784|587915935|FG003|Active Drug Period|Adverse Event|6|||
162782852|NCT04944784|587915932|FG000|Active Drug Period|Withdrawal by Subject|0|||
162782853|NCT04944784|587915933|FG001|Active Drug Period|Withdrawal by Subject|0|||
162782854|NCT04944784|587915934|FG002|Active Drug Period|Withdrawal by Subject|4|||
162782855|NCT04944784|587915935|FG003|Active Drug Period|Withdrawal by Subject|7|||
162782856|NCT04944784|587915932|FG000|Active Drug Period|Death|0|||
162782857|NCT04944784|587915933|FG001|Active Drug Period|Death|0|||
162782858|NCT04944784|587915934|FG002|Active Drug Period|Death|3|||
162782859|NCT04944784|587915935|FG003|Active Drug Period|Death|4|||
162782860|NCT04944784|587915932|FG000|Active Drug Period|Lack of Efficacy|0|||
162782861|NCT04944784|587915933|FG001|Active Drug Period|Lack of Efficacy|0|||
162782862|NCT04944784|587915934|FG002|Active Drug Period|Lack of Efficacy|2|||
162782863|NCT04944784|587915935|FG003|Active Drug Period|Lack of Efficacy|2|||
162782864|NCT04944784|587915932|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
162782865|NCT04944784|587915933|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
162782866|NCT04944784|587915934|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
162782867|NCT04944784|587915935|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
162782868|NCT04944784|587915932|FG000|Active Drug Period|Participant Choice|0|||
162782869|NCT04944784|587915933|FG001|Active Drug Period|Participant Choice|0|||
162782870|NCT04944784|587915934|FG002|Active Drug Period|Participant Choice|0|||
162782871|NCT04944784|587915935|FG003|Active Drug Period|Participant Choice|1|||
162782872|NCT04944784|587915932|FG000|Active Drug Period|Progressive Disease|0|||
162782873|NCT04944784|587915933|FG001|Active Drug Period|Progressive Disease|0|||
162782874|NCT04944784|587915934|FG002|Active Drug Period|Progressive Disease|4|||
162782875|NCT04944784|587915935|FG003|Active Drug Period|Progressive Disease|4|||
162782876|NCT04944784|587915932|FG000|Active Drug Period|Lost to Follow-up|0|||
162782877|NCT04944784|587915933|FG001|Active Drug Period|Lost to Follow-up|0|||
162782878|NCT04944784|587915934|FG002|Active Drug Period|Lost to Follow-up|0|||
162782879|NCT04944784|587915935|FG003|Active Drug Period|Lost to Follow-up|1|||
162782880|NCT03900715|587915936|FG000|Overall Study|Protocol Deviation|1|||
162782881|NCT03900715|587915936|FG000|Overall Study|Lack of Efficacy|1|||
162782882|NCT03900715|587915936|FG000|Overall Study|Progressive Disease|6|||
162782883|NCT03900715|587915936|FG000|Overall Study|Adverse Event|2|||
162782884|NCT03900715|587915936|FG000|Overall Study|Other reasons|11|||
162782885|NCT00730015|587918303|FG000|Overall Study|Adverse Event|11|||
162782886|NCT00730015|587918304|FG001|Overall Study|Adverse Event|10|||
162782887|NCT00730015|587918305|FG002|Overall Study|Adverse Event|8|||
162782888|NCT00730015|587918303|FG000|Overall Study|Protocol Violation|2|||
162782889|NCT00730015|587918304|FG001|Overall Study|Protocol Violation|6|||
162782890|NCT00730015|587918305|FG002|Overall Study|Protocol Violation|4|||
162782891|NCT00730015|587918303|FG000|Overall Study|Withdrawal by Subject|12|||
162782892|NCT00730015|587918304|FG001|Overall Study|Withdrawal by Subject|12|||
162782893|NCT00730015|587918305|FG002|Overall Study|Withdrawal by Subject|8|||
162782894|NCT00730015|587918303|FG000|Overall Study|Lost to Follow-up|4|||
162782895|NCT00730015|587918304|FG001|Overall Study|Lost to Follow-up|10|||
162782896|NCT00730015|587918305|FG002|Overall Study|Lost to Follow-up|3|||
162782897|NCT00730015|587918303|FG000|Overall Study|Lack of Efficacy|1|||
162782898|NCT00730015|587918304|FG001|Overall Study|Lack of Efficacy|2|||
162782899|NCT00730015|587918305|FG002|Overall Study|Lack of Efficacy|8|||
162782900|NCT00730015|587918303|FG000|Overall Study|Other Reason|1|||
162782901|NCT00730015|587918304|FG001|Overall Study|Other Reason|0|||
162782902|NCT00730015|587918305|FG002|Overall Study|Other Reason|1|||
162782903|NCT03062449|587918307|FG000|Overall Study|Withdrawal by Subject|7|||
162782904|NCT03062449|587918308|FG001|Overall Study|Withdrawal by Subject|1|||
162782905|NCT02370251|587918309|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
162782906|NCT02370251|587918309|FG000|Overall Study|Death|4|||
162782907|NCT04120376|587918310|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
162782908|NCT04120376|587918311|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
162782909|NCT02053610|587918312|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
162782910|NCT02053610|587918313|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
162782911|NCT02053610|587918312|FG000|Overall Study|Withdrew Consent|2|||
162782912|NCT02053610|587918313|FG001|Overall Study|Withdrew Consent|9|||
162782913|NCT02053610|587918312|FG000|Overall Study|Death|5|||
162782914|NCT02053610|587918313|FG001|Overall Study|Death|5|||
162782915|NCT02053610|587918312|FG000|Overall Study|Administrative/Other|1|||
162782916|NCT02053610|587918313|FG001|Overall Study|Administrative/Other|1|||
162782917|NCT02053610|587918312|FG000|Overall Study|Disease Progression|2|||
162782918|NCT02053610|587918313|FG001|Overall Study|Disease Progression|3|||
162782919|NCT02053610|587918312|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
162782920|NCT02053610|587918313|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
162782921|NCT02053610|587918312|FG000|Overall Study|Did not Receive Treatment|4|||
162782922|NCT02053610|587918313|FG001|Overall Study|Did not Receive Treatment|2|||
162782923|NCT02053610|587918312|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162782924|NCT02053610|587918313|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162782925|NCT02053610|587918312|FG000|Overall Study|Violation of Selection Criteria|1|||
162782926|NCT02053610|587918313|FG001|Overall Study|Violation of Selection Criteria|0|||
162782927|NCT01165177|587918314|FG000|Overall Study|Serious Adverse Event|227|||
162782928|NCT01165177|587918315|FG001|Overall Study|Serious Adverse Event|235|||
162782929|NCT01165177|587918314|FG000|Overall Study|Withdrawal by Subject|368|||
162782930|NCT01165177|587918315|FG001|Overall Study|Withdrawal by Subject|354|||
162782931|NCT01165177|587918314|FG000|Overall Study|Protocol Violation|19|||
162782932|NCT01165177|587918315|FG001|Overall Study|Protocol Violation|21|||
162782933|NCT01165177|587918314|FG000|Overall Study|Non-serious adverse event|30|||
162782934|NCT01165177|587918315|FG001|Overall Study|Non-serious adverse event|18|||
162782935|NCT01165177|587918314|FG000|Overall Study|Other unspecified reasons|47|||
162782936|NCT01165177|587918315|FG001|Overall Study|Other unspecified reasons|35|||
162782937|NCT01165177|587918314|FG000|Overall Study|Suspected HZ episode|0|||
162782938|NCT01165177|587918315|FG001|Overall Study|Suspected HZ episode|2|||
162782939|NCT01165177|587918314|FG000|Overall Study|Lost to Follow-up|183|||
162782940|NCT01165177|587918315|FG001|Overall Study|Lost to Follow-up|194|||
162782941|NCT01165177|587918314|FG000|Overall Study|Migrated/ moved from study area|48|||
162782942|NCT01165177|587918315|FG001|Overall Study|Migrated/ moved from study area|43|||
162782943|NCT05499130|587918316|FG000|Overall Study|Adverse Event|2|||
162782944|NCT05499130|587918317|FG001|Overall Study|Adverse Event|0|||
162782945|NCT05499130|587918318|FG002|Overall Study|Adverse Event|1|||
162782946|NCT05499130|587918319|FG003|Overall Study|Adverse Event|0|||
162782947|NCT05499130|587918320|FG004|Overall Study|Adverse Event|1|||
162782948|NCT05499130|587918321|FG005|Overall Study|Adverse Event|4|||
162782949|NCT05499130|587918322|FG006|Overall Study|Adverse Event|1|||
162782950|NCT05499130|587918323|FG007|Overall Study|Adverse Event|0|||
162782951|NCT05499130|587918316|FG000|Overall Study|Lack of Efficacy|1|||
162782952|NCT05499130|587918317|FG001|Overall Study|Lack of Efficacy|0|||
162782953|NCT05499130|587918318|FG002|Overall Study|Lack of Efficacy|0|||
162782954|NCT05499130|587918319|FG003|Overall Study|Lack of Efficacy|0|||
162782955|NCT05499130|587918320|FG004|Overall Study|Lack of Efficacy|5|||
162782956|NCT05499130|587918321|FG005|Overall Study|Lack of Efficacy|0|||
162782957|NCT05499130|587918322|FG006|Overall Study|Lack of Efficacy|1|||
162782958|NCT05499130|587918323|FG007|Overall Study|Lack of Efficacy|0|||
162782959|NCT05499130|587918316|FG000|Overall Study|Withdrawal by Subject|2|||
162782960|NCT05499130|587918317|FG001|Overall Study|Withdrawal by Subject|0|||
162782961|NCT05499130|587918318|FG002|Overall Study|Withdrawal by Subject|0|||
162782962|NCT05499130|587918319|FG003|Overall Study|Withdrawal by Subject|0|||
162782963|NCT05499130|587918320|FG004|Overall Study|Withdrawal by Subject|1|||
162782964|NCT05499130|587918321|FG005|Overall Study|Withdrawal by Subject|2|||
162782965|NCT05499130|587918322|FG006|Overall Study|Withdrawal by Subject|0|||
162782966|NCT05499130|587918323|FG007|Overall Study|Withdrawal by Subject|0|||
162782967|NCT05499130|587918316|FG000|Overall Study|Lost to Follow-up|0|||
162782968|NCT05499130|587918317|FG001|Overall Study|Lost to Follow-up|0|||
162782969|NCT05499130|587918318|FG002|Overall Study|Lost to Follow-up|0|||
162782970|NCT05499130|587918319|FG003|Overall Study|Lost to Follow-up|0|||
162782971|NCT05499130|587918320|FG004|Overall Study|Lost to Follow-up|0|||
162782972|NCT05499130|587918321|FG005|Overall Study|Lost to Follow-up|2|||
162782973|NCT05499130|587918322|FG006|Overall Study|Lost to Follow-up|0|||
162782974|NCT05499130|587918323|FG007|Overall Study|Lost to Follow-up|0|||
162782975|NCT05499130|587918316|FG000|Overall Study|Other Than Specified|0|||
162782976|NCT05499130|587918317|FG001|Overall Study|Other Than Specified|0|||
162782977|NCT05499130|587918318|FG002|Overall Study|Other Than Specified|0|||
162782978|NCT05499130|587918319|FG003|Overall Study|Other Than Specified|0|||
162782979|NCT05499130|587918320|FG004|Overall Study|Other Than Specified|1|||
162782980|NCT05499130|587918321|FG005|Overall Study|Other Than Specified|1|||
162782981|NCT05499130|587918322|FG006|Overall Study|Other Than Specified|2|||
162782982|NCT05499130|587918323|FG007|Overall Study|Other Than Specified|0|||
162782983|NCT05499130|587918316|FG000|Overall Study|Protocol Violation|0|||
162782984|NCT05499130|587918317|FG001|Overall Study|Protocol Violation|0|||
162782985|NCT05499130|587918318|FG002|Overall Study|Protocol Violation|0|||
162782986|NCT05499130|587918319|FG003|Overall Study|Protocol Violation|0|||
162782987|NCT05499130|587918320|FG004|Overall Study|Protocol Violation|1|||
162782988|NCT05499130|587918321|FG005|Overall Study|Protocol Violation|0|||
162782989|NCT05499130|587918322|FG006|Overall Study|Protocol Violation|0|||
162782990|NCT05499130|587918323|FG007|Overall Study|Protocol Violation|0|||
162782991|NCT00781937|587918325|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
162782992|NCT00781937|587918326|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
162782993|NCT00781937|587918325|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
162782994|NCT00781937|587918326|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
162782995|NCT00781937|587918325|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
162782996|NCT00781937|587918326|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
162782997|NCT00781937|587918325|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
162782998|NCT00781937|587918326|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
162782999|NCT00781937|587918325|FG000|Main Trial Period Through Week 56|Unclassified|10|||
162783000|NCT00781937|587918326|FG001|Main Trial Period Through Week 56|Unclassified|15|||
162783001|NCT00781937|587918325|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
162783002|NCT00781937|587918326|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
162783003|NCT00781937|587918325|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
162783004|NCT00781937|587918326|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
162783005|NCT00013611|587918327|FG000|Overall Study|Lost to Follow-up|91|||
162783006|NCT00013611|587918328|FG001|Overall Study|Lost to Follow-up|100|||
162783007|NCT00543062|587918329|FG000|Overall Study|Withdrawal by Subject|1|||
162783008|NCT00543062|587918330|FG001|Overall Study|Withdrawal by Subject|0|||
162783009|NCT00543062|587918331|FG002|Overall Study|Withdrawal by Subject|2|||
162783010|NCT00543062|587918332|FG003|Overall Study|Withdrawal by Subject|0|||
162783011|NCT00543062|587918329|FG000|Overall Study|Adverse Event|0|||
162783012|NCT00543062|587918330|FG001|Overall Study|Adverse Event|1|||
162783013|NCT00543062|587918331|FG002|Overall Study|Adverse Event|1|||
162783014|NCT00543062|587918332|FG003|Overall Study|Adverse Event|1|||
162783015|NCT00543062|587918329|FG000|Overall Study|Protocol Violation|1|||
162783016|NCT00543062|587918330|FG001|Overall Study|Protocol Violation|0|||
162783017|NCT00543062|587918331|FG002|Overall Study|Protocol Violation|0|||
162783018|NCT00543062|587918332|FG003|Overall Study|Protocol Violation|0|||
162783019|NCT01663506|587918333|FG000|Overall Study|Lack of Efficacy|3|||
162783020|NCT01663506|587918333|FG000|Overall Study|Consent Withdrawal by Subject|1|||
162783021|NCT01663506|587918333|FG000|Overall Study|Lost to Follow-up|1|||
162783022|NCT01663506|587918333|FG000|Overall Study|Adverse Event|1|||
162783023|NCT01663506|587918333|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
162783024|NCT00328562|587918339|FG000|Overall Study|Disease progression|1|||
162783025|NCT04014790|587918340|FG000|Overall Study|Death|4|||
162783026|NCT04014790|587918340|FG000|Overall Study|Adverse Event|1|||
162783027|NCT04014790|587918340|FG000|Overall Study|Withdrawal by Subject|1|||
162783028|NCT03546816|587918341|FG000|Overall Study|Adverse Event|5|||
162783029|NCT03546816|587918342|FG001|Overall Study|Adverse Event|3|||
162783030|NCT03546816|587918341|FG000|Overall Study|Lack of Efficacy|2|||
162783031|NCT03546816|587918342|FG001|Overall Study|Lack of Efficacy|4|||
162783032|NCT03546816|587918341|FG000|Overall Study|Pregnancy|1|||
162783033|NCT03546816|587918342|FG001|Overall Study|Pregnancy|0|||
162783034|NCT03546816|587918341|FG000|Overall Study|Physician Decision|2|||
162783035|NCT03546816|587918342|FG001|Overall Study|Physician Decision|0|||
162783036|NCT03546816|587918341|FG000|Overall Study|Withdrawal by Subject|8|||
162783037|NCT03546816|587918342|FG001|Overall Study|Withdrawal by Subject|10|||
162783038|NCT03546816|587918341|FG000|Overall Study|Lost to Follow-up|3|||
162783039|NCT03546816|587918342|FG001|Overall Study|Lost to Follow-up|2|||
162783040|NCT01161446|587918343|FG000|Overall Study|Lost to Follow-up|18|||
162783041|NCT01161446|587918344|FG001|Overall Study|Lost to Follow-up|14|||
162783042|NCT01161446|587918343|FG000|Overall Study|Withdrawal by Subject|0|||
162783043|NCT01161446|587918344|FG001|Overall Study|Withdrawal by Subject|1|||
162783044|NCT00810342|587918345|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
162783045|NCT00810342|587918346|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
162783046|NCT00810342|587918345|FG000|Month 1 Follow-up|Pregnancy|1|||
162783047|NCT00810342|587918346|FG001|Month 1 Follow-up|Pregnancy|0|||
162783048|NCT00810342|587918345|FG000|6-month Follow-up|Lost to Follow-up|18|||
162783049|NCT00810342|587918346|FG001|6-month Follow-up|Lost to Follow-up|6|||
162783050|NCT00810342|587918345|FG000|6-month Follow-up|Pregnancy|6|||
162783051|NCT00810342|587918346|FG001|6-month Follow-up|Pregnancy|2|||
162783052|NCT00810342|587918345|FG000|12-month Followup|Pregnancy|9|||
162783053|NCT00810342|587918346|FG001|12-month Followup|Pregnancy|10|||
162783054|NCT00810342|587918345|FG000|12-month Followup|Lost to Follow-up|3|||
162783055|NCT00810342|587918346|FG001|12-month Followup|Lost to Follow-up|1|||
162783056|NCT02270671|587918347|FG000|Overall Study|Withdrawal by Subject|1|||
162783057|NCT02270671|587918348|FG001|Overall Study|Withdrawal by Subject|1|||
162783058|NCT02270671|587918347|FG000|Overall Study|Protocol Violation|0|||
162783059|NCT02270671|587918348|FG001|Overall Study|Protocol Violation|1|||
162783060|NCT02270671|587918347|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
162783061|NCT02270671|587918348|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
162783062|NCT02270671|587918347|FG000|Overall Study|Lost to Follow-up|2|||
162783063|NCT02270671|587918348|FG001|Overall Study|Lost to Follow-up|1|||
162783064|NCT02330562|587918351|FG000|Overall Study|Adverse Event|0|||
162783065|NCT02330562|587918352|FG001|Overall Study|Adverse Event|0|||
162783066|NCT02330562|587918353|FG002|Overall Study|Adverse Event|3|||
162783067|NCT02330562|587918354|FG003|Overall Study|Adverse Event|0|||
162783068|NCT02330562|587918355|FG004|Overall Study|Adverse Event|3|||
162783069|NCT02330562|587918356|FG005|Overall Study|Adverse Event|1|||
162783070|NCT02330562|587918357|FG006|Overall Study|Adverse Event|0|||
162783071|NCT02330562|587918358|FG007|Overall Study|Adverse Event|0|||
162783072|NCT02330562|587918359|FG008|Overall Study|Adverse Event|0|||
162783073|NCT02330562|587918360|FG009|Overall Study|Adverse Event|1|||
162783074|NCT02330562|587918361|FG010|Overall Study|Adverse Event|1|||
162783075|NCT02330562|587918351|FG000|Overall Study|Participant decision|1|||
162783076|NCT02330562|587918352|FG001|Overall Study|Participant decision|0|||
162783077|NCT02330562|587918353|FG002|Overall Study|Participant decision|4|||
162783078|NCT02330562|587918354|FG003|Overall Study|Participant decision|1|||
162783079|NCT02330562|587918355|FG004|Overall Study|Participant decision|5|||
162783080|NCT02330562|587918356|FG005|Overall Study|Participant decision|2|||
162783081|NCT02330562|587918357|FG006|Overall Study|Participant decision|0|||
162783082|NCT02330562|587918358|FG007|Overall Study|Participant decision|0|||
162783083|NCT02330562|587918359|FG008|Overall Study|Participant decision|0|||
162783084|NCT02330562|587918360|FG009|Overall Study|Participant decision|3|||
162783085|NCT02330562|587918361|FG010|Overall Study|Participant decision|0|||
162783086|NCT02330562|587918351|FG000|Overall Study|Disease progression|5|||
162783087|NCT02330562|587918352|FG001|Overall Study|Disease progression|3|||
162783088|NCT02330562|587918353|FG002|Overall Study|Disease progression|20|||
162783089|NCT02330562|587918354|FG003|Overall Study|Disease progression|28|||
162783090|NCT02330562|587918355|FG004|Overall Study|Disease progression|23|||
162783091|NCT02330562|587918356|FG005|Overall Study|Disease progression|7|||
162783092|NCT02330562|587918357|FG006|Overall Study|Disease progression|1|||
162783093|NCT02330562|587918358|FG007|Overall Study|Disease progression|1|||
162783094|NCT02330562|587918359|FG008|Overall Study|Disease progression|1|||
162783095|NCT02330562|587918360|FG009|Overall Study|Disease progression|0|||
162783096|NCT02330562|587918361|FG010|Overall Study|Disease progression|5|||
162783097|NCT02330562|587918351|FG000|Overall Study|Other reasons|0|||
162783098|NCT02330562|587918352|FG001|Overall Study|Other reasons|0|||
162783099|NCT02330562|587918353|FG002|Overall Study|Other reasons|0|||
162783100|NCT02330562|587918354|FG003|Overall Study|Other reasons|1|||
162783101|NCT02330562|587918355|FG004|Overall Study|Other reasons|0|||
162783102|NCT02330562|587918356|FG005|Overall Study|Other reasons|0|||
162783103|NCT02330562|587918357|FG006|Overall Study|Other reasons|0|||
162783104|NCT02330562|587918358|FG007|Overall Study|Other reasons|0|||
162783105|NCT02330562|587918359|FG008|Overall Study|Other reasons|0|||
162783106|NCT02330562|587918360|FG009|Overall Study|Other reasons|0|||
162783107|NCT02330562|587918361|FG010|Overall Study|Other reasons|0|||
162783108|NCT02330562|587918351|FG000|Overall Study|Withdrawal by Subject|0|||
162783109|NCT02330562|587918352|FG001|Overall Study|Withdrawal by Subject|0|||
162783110|NCT02330562|587918353|FG002|Overall Study|Withdrawal by Subject|0|||
162783111|NCT02330562|587918354|FG003|Overall Study|Withdrawal by Subject|0|||
162783112|NCT02330562|587918355|FG004|Overall Study|Withdrawal by Subject|0|||
162783113|NCT02330562|587918356|FG005|Overall Study|Withdrawal by Subject|0|||
162783114|NCT02330562|587918357|FG006|Overall Study|Withdrawal by Subject|0|||
162783115|NCT02330562|587918358|FG007|Overall Study|Withdrawal by Subject|0|||
162783116|NCT02330562|587918359|FG008|Overall Study|Withdrawal by Subject|0|||
162783117|NCT02330562|587918360|FG009|Overall Study|Withdrawal by Subject|1|||
162783118|NCT02330562|587918361|FG010|Overall Study|Withdrawal by Subject|0|||
162783119|NCT03927690|587918362|FG000|Overall Study|Withdrawal by Subject|3|||
162783120|NCT03927690|587918363|FG001|Overall Study|Withdrawal by Subject|1|||
162783121|NCT03927690|587918364|FG002|Overall Study|Withdrawal by Subject|1|||
162783122|NCT03927690|587918362|FG000|Overall Study|Adverse Event|1|||
162783123|NCT03927690|587918363|FG001|Overall Study|Adverse Event|0|||
162783124|NCT03927690|587918364|FG002|Overall Study|Adverse Event|0|||
162783125|NCT03927690|587918362|FG000|Overall Study|Death|1|||
162783126|NCT03927690|587918363|FG001|Overall Study|Death|0|||
162783127|NCT03927690|587918364|FG002|Overall Study|Death|0|||
162783128|NCT03927690|587918362|FG000|Overall Study|Lost to Follow-up|2|||
162783129|NCT03927690|587918363|FG001|Overall Study|Lost to Follow-up|2|||
162783130|NCT03927690|587918364|FG002|Overall Study|Lost to Follow-up|1|||
162783131|NCT00126659|587918367|FG000|Overall Study|Adverse Event|0|||
162783132|NCT00126659|587918368|FG001|Overall Study|Adverse Event|0|||
162783133|NCT00126659|587918369|FG002|Overall Study|Adverse Event|2|||
162783134|NCT00174447|587918372|FG000|Overall Study|Adverse Event|19|||
162783135|NCT00174447|587918372|FG000|Overall Study|Withdrawal by Subject|15|||
162783136|NCT00174447|587918372|FG000|Overall Study|Protocol Violation|1|||
162783137|NCT00174447|587918372|FG000|Overall Study|Lack of Efficacy|1|||
162783138|NCT00174447|587918372|FG000|Overall Study|Administrative reason/Other|2|||
162783139|NCT00551135|587918384|FG000|Overall Study|Adverse Event|1|||
162783140|NCT00551135|587918385|FG001|Overall Study|Adverse Event|0|||
162783141|NCT00551135|587918386|FG002|Overall Study|Adverse Event|1|||
162783142|NCT00551135|587918387|FG003|Overall Study|Adverse Event|1|||
162783143|NCT00551135|587918384|FG000|Overall Study|Lost to Follow-up|0|||
162783144|NCT00551135|587918385|FG001|Overall Study|Lost to Follow-up|0|||
162783145|NCT00551135|587918386|FG002|Overall Study|Lost to Follow-up|0|||
162783146|NCT00551135|587918387|FG003|Overall Study|Lost to Follow-up|1|||
162783147|NCT00551135|587918384|FG000|Overall Study|Other|3|||
162783148|NCT00551135|587918385|FG001|Overall Study|Other|2|||
162783149|NCT00551135|587918386|FG002|Overall Study|Other|1|||
162783150|NCT00551135|587918387|FG003|Overall Study|Other|2|||
162783151|NCT00551135|587918384|FG000|Overall Study|Withdrawal by Subject|1|||
162783152|NCT00551135|587918385|FG001|Overall Study|Withdrawal by Subject|0|||
162783153|NCT00551135|587918386|FG002|Overall Study|Withdrawal by Subject|3|||
162783154|NCT00551135|587918387|FG003|Overall Study|Withdrawal by Subject|1|||
162783155|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
162783156|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
162783157|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
162783158|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
162783159|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
162783160|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
162783161|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
162783162|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
162783163|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
162783164|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
162783165|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
162783166|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
162783167|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
162783168|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
162783169|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
162783170|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
162783171|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
162783172|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
162783173|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
162783174|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
162783175|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
162783176|NCT04599855|587918388|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
162783177|NCT04599855|587918389|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
162783178|NCT04599855|587918390|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
162783179|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
162783180|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
162783181|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
162783182|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
162783183|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
162783184|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
162783185|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
162783186|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
162783187|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
162783188|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
162783189|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
162783190|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
162783191|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
162783192|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
162783193|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
162783194|NCT04599855|587918388|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
162783195|NCT04599855|587918389|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
162783196|NCT04599855|587918390|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
162783197|NCT04294667|587918391|FG000|Overall Study|Lack of Efficacy|4|||
162783198|NCT04294667|587918392|FG001|Overall Study|Lack of Efficacy|4|||
162783199|NCT04294667|587918391|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
162783200|NCT04294667|587918392|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
162783201|NCT04294667|587918391|FG000|Overall Study|Patient has a Renal Flare|1|||
162783202|NCT04294667|587918392|FG001|Overall Study|Patient has a Renal Flare|0|||
162783203|NCT04294667|587918391|FG000|Overall Study|SLE Worsening|0|||
162783204|NCT04294667|587918392|FG001|Overall Study|SLE Worsening|1|||
162783205|NCT04294667|587918391|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
162783206|NCT04294667|587918392|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
162783207|NCT04294667|587918391|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
162783208|NCT04294667|587918392|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
162783209|NCT04294667|587918391|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
162783210|NCT04294667|587918392|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
162783211|NCT04294667|587918391|FG000|Overall Study|Subject Moved to Another State|0|||
162783212|NCT04294667|587918392|FG001|Overall Study|Subject Moved to Another State|1|||
162783213|NCT04294667|587918391|FG000|Overall Study|Adverse event, serious fatal|0|||
162783214|NCT04294667|587918392|FG001|Overall Study|Adverse event, serious fatal|1|||
162783215|NCT04294667|587918391|FG000|Overall Study|Adverse event, non-fatal|3|||
162783216|NCT04294667|587918392|FG001|Overall Study|Adverse event, non-fatal|4|||
162783217|NCT00548847|587918393|FG000|Overall Study|Disease progression|7|||
162783218|NCT00727415|587918394|FG000|Phase I|Dose Limiting Toxicity|2|||
162783219|NCT00302159|587918397|FG000|Overall Study|pt declined before treatment started|1|||
162783220|NCT00302159|587918397|FG000|Overall Study|pt started Avastin|1|||
162783221|NCT00853229|587918400|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
162783222|NCT00853229|587918401|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
162783223|NCT02312206|587918408|FG000|Overall Study|Adverse Event|3|||
162783224|NCT02312206|587918409|FG001|Overall Study|Adverse Event|6|||
162783225|NCT02312206|587918408|FG000|Overall Study|Withdrawal by Subject|6|||
162783226|NCT02312206|587918409|FG001|Overall Study|Withdrawal by Subject|6|||
162783227|NCT02312206|587918408|FG000|Overall Study|Physician Decision|7|||
162783228|NCT02312206|587918409|FG001|Overall Study|Physician Decision|6|||
162783229|NCT02312206|587918408|FG000|Overall Study|Death|31|||
162783230|NCT02312206|587918409|FG001|Overall Study|Death|36|||
162783231|NCT02312206|587918408|FG000|Overall Study|Study Terminated by Sponsor|81|||
162783232|NCT02312206|587918409|FG001|Overall Study|Study Terminated by Sponsor|74|||
162783233|NCT02312206|587918408|FG000|Overall Study|Patient transferred to hospice|0|||
162783234|NCT02312206|587918409|FG001|Overall Study|Patient transferred to hospice|1|||
162783235|NCT02312206|587918408|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
162783236|NCT02312206|587918409|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
162783237|NCT02312206|587918408|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
162783238|NCT02312206|587918409|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
162783239|NCT02312206|587918408|FG000|Overall Study|Disease Progression|1|||
162783240|NCT02312206|587918409|FG001|Overall Study|Disease Progression|0|||
162783241|NCT03082612|587918410|FG000|Overall Study|Lost to Follow-up|2|||
162783242|NCT03082612|587918411|FG001|Overall Study|Lost to Follow-up|0|||
162783243|NCT01006616|587918412|FG000|Period 1 (6 Months)|Adverse Event|10|||
162783244|NCT01006616|587918413|FG001|Period 1 (6 Months)|Adverse Event|31|||
162783245|NCT01006616|587918414|FG002|Period 1 (6 Months)|Adverse Event|37|||
162783246|NCT01006616|587918415|FG003|Period 1 (6 Months)|Adverse Event|9|||
162783247|NCT01006616|587918412|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
162783248|NCT01006616|587918413|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
162783249|NCT01006616|587918414|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
162783250|NCT01006616|587918415|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
162783251|NCT01006616|587918412|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
162783252|NCT01006616|587918413|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
162783253|NCT01006616|587918414|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
162783254|NCT01006616|587918415|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
162783255|NCT01006616|587918412|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
162783256|NCT01006616|587918413|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
162783257|NCT01006616|587918414|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
162783258|NCT01006616|587918415|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162783259|NCT01006616|587918412|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
162783260|NCT01006616|587918413|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
162783261|NCT01006616|587918414|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
162783262|NCT01006616|587918415|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
162783263|NCT01006616|587918412|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
162783264|NCT01006616|587918413|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
162783265|NCT01006616|587918414|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
162783266|NCT01006616|587918415|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
162783267|NCT01006616|587918412|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162783268|NCT01006616|587918413|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
162783269|NCT01006616|587918414|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162783270|NCT01006616|587918415|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162783271|NCT01006616|587918412|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
162783272|NCT01006616|587918413|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
162783273|NCT01006616|587918414|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
162783274|NCT01006616|587918415|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
162783275|NCT01006616|587918412|FG000|Period 1 (6 Months)|Not Treated|0|||
162783276|NCT01006616|587918413|FG001|Period 1 (6 Months)|Not Treated|0|||
162783277|NCT01006616|587918414|FG002|Period 1 (6 Months)|Not Treated|1|||
162783278|NCT01006616|587918415|FG003|Period 1 (6 Months)|Not Treated|1|||
162783279|NCT01006616|587918412|FG000|Period 2 (18 Months)|Adverse Event|6|||
162783280|NCT01006616|587918413|FG001|Period 2 (18 Months)|Adverse Event|6|||
162783281|NCT01006616|587918414|FG002|Period 2 (18 Months)|Adverse Event|6|||
162783282|NCT01006616|587918415|FG003|Period 2 (18 Months)|Adverse Event|4|||
162783283|NCT01006616|587918412|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
162783284|NCT01006616|587918413|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
162783285|NCT01006616|587918414|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
162783286|NCT01006616|587918415|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
162783287|NCT01006616|587918412|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
162783288|NCT01006616|587918413|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
162783289|NCT01006616|587918414|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
162783290|NCT01006616|587918415|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
162783291|NCT01006616|587918412|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162783292|NCT01006616|587918413|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
162783293|NCT01006616|587918414|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162783294|NCT01006616|587918415|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
162783295|NCT01006616|587918412|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
162783296|NCT01006616|587918413|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
162783297|NCT01006616|587918414|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
162783298|NCT01006616|587918415|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
162783299|NCT01006616|587918412|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
162783300|NCT01006616|587918413|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
162783301|NCT01006616|587918414|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
162783302|NCT01006616|587918415|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
162783303|NCT01006616|587918412|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
162783304|NCT01006616|587918413|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
162783305|NCT01006616|587918414|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
162783306|NCT01006616|587918415|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
162783307|NCT01006616|587918412|FG000|Period 2 (18 Months)|Study Terminated|63|||
162783308|NCT01006616|587918413|FG001|Period 2 (18 Months)|Study Terminated|46|||
162783309|NCT01006616|587918414|FG002|Period 2 (18 Months)|Study Terminated|44|||
162783310|NCT01006616|587918415|FG003|Period 2 (18 Months)|Study Terminated|70|||
162783311|NCT03672175|587918416|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
162783312|NCT03672175|587918417|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
162783313|NCT03672175|587918418|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
162783314|NCT03672175|587918416|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
162783315|NCT03672175|587918417|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
162783316|NCT03672175|587918418|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
162783317|NCT03672175|587918416|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
162783318|NCT03672175|587918417|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
162783319|NCT03672175|587918418|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
162783320|NCT03672175|587918416|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
162783321|NCT03672175|587918417|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
162783322|NCT03672175|587918418|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
162783323|NCT03672175|587918416|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
162783324|NCT03672175|587918417|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
162783325|NCT03672175|587918418|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
162783326|NCT03672175|587918416|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
162783327|NCT03672175|587918417|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
162783328|NCT03672175|587918418|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
162783329|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
162783330|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
162783331|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
162783332|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
162783333|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
162783334|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
162783335|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
162783336|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
162783337|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
162783338|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
162783339|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
162783340|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
162783341|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
162783342|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
162783343|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
162783344|NCT03672175|587918416|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
162783345|NCT03672175|587918417|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
162783346|NCT03672175|587918418|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
162783347|NCT03414047|587918419|FG000|Overall Study|Adverse Event|0|||
162783348|NCT03414047|587918420|FG001|Overall Study|Adverse Event|0|||
162783349|NCT03414047|587918421|FG002|Overall Study|Adverse Event|1|||
162783350|NCT03414047|587918422|FG003|Overall Study|Adverse Event|1|||
162783351|NCT03414047|587918419|FG000|Overall Study|Physician Decision|1|||
162783352|NCT03414047|587918420|FG001|Overall Study|Physician Decision|0|||
162783353|NCT03414047|587918421|FG002|Overall Study|Physician Decision|0|||
162783354|NCT03414047|587918422|FG003|Overall Study|Physician Decision|1|||
162783355|NCT03414047|587918419|FG000|Overall Study|Withdrawal by Subject|1|||
162783356|NCT03414047|587918420|FG001|Overall Study|Withdrawal by Subject|0|||
162783357|NCT03414047|587918421|FG002|Overall Study|Withdrawal by Subject|2|||
162783358|NCT03414047|587918422|FG003|Overall Study|Withdrawal by Subject|0|||
162783359|NCT01747837|587918427|FG000|Overall Study|Lost to Follow-up|5|||
162783360|NCT01747837|587918428|FG001|Overall Study|Lost to Follow-up|2|||
162783361|NCT01747837|587918427|FG000|Overall Study|Death|4|||
162783362|NCT01747837|587918428|FG001|Overall Study|Death|4|||
162783363|NCT00690378|587918429|FG000|Overall Study|Adverse Event|1|||
162783364|NCT00690378|587918430|FG001|Overall Study|Adverse Event|0|||
162783365|NCT00690378|587918429|FG000|Overall Study|Withdrawal by Subject|2|||
162783366|NCT00690378|587918430|FG001|Overall Study|Withdrawal by Subject|0|||
162783367|NCT00690378|587918429|FG000|Overall Study|Protocol Violation|1|||
162783368|NCT00690378|587918430|FG001|Overall Study|Protocol Violation|0|||
162783369|NCT00690378|587918429|FG000|Overall Study|Lost to Follow-up|2|||
162783370|NCT00690378|587918430|FG001|Overall Study|Lost to Follow-up|3|||
162783371|NCT00690378|587918429|FG000|Overall Study|Did not meet inc/exc criteria|13|||
162783372|NCT00690378|587918430|FG001|Overall Study|Did not meet inc/exc criteria|11|||
162783373|NCT00690378|587918429|FG000|Overall Study|Social problem|1|||
162783374|NCT00690378|587918430|FG001|Overall Study|Social problem|0|||
162783375|NCT03410108|587918436|FG000|Overall Study|Ongoing|41|||
162783376|NCT03410108|587918436|FG000|Overall Study|Adverse Event|4|||
162783377|NCT03410108|587918436|FG000|Overall Study|Progressive Disease|58|||
162783378|NCT03410108|587918436|FG000|Overall Study|Withdrawal by Subject|1|||
162783379|NCT03269695|587918438|FG000|Overall Study|Adverse Event|2|||
162783380|NCT03269695|587918439|FG001|Overall Study|Adverse Event|1|||
162783381|NCT03269695|587918438|FG000|Overall Study|Lack of Efficacy|0|||
162783382|NCT03269695|587918439|FG001|Overall Study|Lack of Efficacy|1|||
162783383|NCT03269695|587918438|FG000|Overall Study|Withdrawal by Subject|0|||
162783384|NCT03269695|587918439|FG001|Overall Study|Withdrawal by Subject|1|||
162783385|NCT01313624|587918440|FG000|Double-Blind Phase|Adverse Event|27|||
162783386|NCT01313624|587918441|FG001|Double-Blind Phase|Adverse Event|4|||
162783387|NCT01313624|587918440|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
162783388|NCT01313624|587918441|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
162783389|NCT01313624|587918440|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162783390|NCT01313624|587918441|FG001|Double-Blind Phase|Lost to Follow-up|2|||
162783391|NCT01313624|587918440|FG000|Double-Blind Phase|Physician Decision|1|||
162783392|NCT01313624|587918441|FG001|Double-Blind Phase|Physician Decision|0|||
162783393|NCT01313624|587918440|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162783394|NCT01313624|587918441|FG001|Double-Blind Phase|Lack of Efficacy|0|||
162783395|NCT01313624|587918440|FG000|Open-Label Phase|Adverse Event|1|||
162783396|NCT01313624|587918441|FG001|Open-Label Phase|Adverse Event|10|||
162783397|NCT01313624|587918440|FG000|Open-Label Phase|Withdrawal by Subject|2|||
162783398|NCT01313624|587918441|FG001|Open-Label Phase|Withdrawal by Subject|2|||
162783399|NCT01313624|587918440|FG000|Open-Label Phase|Lost to Follow-up|1|||
162783400|NCT01313624|587918441|FG001|Open-Label Phase|Lost to Follow-up|1|||
162783401|NCT01017263|587918442|FG000|Overall Study|not eligible|12|||
162783402|NCT00239681|587918443|FG000|Overall Study|Adverse Event|100|||
162783403|NCT00239681|587918444|FG001|Overall Study|Adverse Event|99|||
162783404|NCT00239681|587918443|FG000|Overall Study|Withdrawal by Subject|458|||
162783405|NCT00239681|587918444|FG001|Overall Study|Withdrawal by Subject|489|||
162783406|NCT00239681|587918443|FG000|Overall Study|Lost to Follow-up|28|||
162783407|NCT00239681|587918444|FG001|Overall Study|Lost to Follow-up|22|||
162783408|NCT00239681|587918443|FG000|Overall Study|Protocol Violation|4|||
162783409|NCT00239681|587918444|FG001|Overall Study|Protocol Violation|4|||
162783410|NCT00239681|587918443|FG000|Overall Study|Physician Decision|13|||
162783411|NCT00239681|587918444|FG001|Overall Study|Physician Decision|17|||
162783412|NCT00239681|587918443|FG000|Overall Study|No information chacked on CaseReportForm|90|||
162783413|NCT00239681|587918444|FG001|Overall Study|No information chacked on CaseReportForm|84|||
162783414|NCT00905359|587918447|FG000|Overall Study|Lost to Follow-up|17|||
162783415|NCT00905359|587918448|FG001|Overall Study|Lost to Follow-up|10|||
162783416|NCT00905359|587918447|FG000|Overall Study|Death|2|||
162783417|NCT00905359|587918448|FG001|Overall Study|Death|0|||
162783418|NCT00905359|587918447|FG000|Overall Study|Withdrawal consent|5|||
162783419|NCT00905359|587918448|FG001|Overall Study|Withdrawal consent|6|||
162783420|NCT02654132|587918449|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
162783421|NCT02654132|587918450|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
162783422|NCT02654132|587918449|FG000|Treatment Period|Disease progression|43|||
162783423|NCT02654132|587918450|FG001|Treatment Period|Disease progression|38|||
162783424|NCT02654132|587918449|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
162783425|NCT02654132|587918450|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
162783426|NCT02654132|587918449|FG000|Treatment Period|Other reasons|4|||
162783427|NCT02654132|587918450|FG001|Treatment Period|Other reasons|2|||
162783428|NCT02654132|587918449|FG000|Treatment Period|Study drug toxicity|2|||
162783429|NCT02654132|587918450|FG001|Treatment Period|Study drug toxicity|2|||
162783430|NCT02654132|587918449|FG000|Treatment Period|Withdrawal by Subject|2|||
162783431|NCT02654132|587918450|FG001|Treatment Period|Withdrawal by Subject|1|||
162783432|NCT02654132|587918449|FG000|Treatment Period|Maximum Clinical Benefit|0|||
162783433|NCT02654132|587918450|FG001|Treatment Period|Maximum Clinical Benefit|2|||
162783434|NCT02654132|587918449|FG000|Treatment Period|Participant request to discontinue|2|||
162783435|NCT02654132|587918450|FG001|Treatment Period|Participant request to discontinue|0|||
162783436|NCT02654132|587918449|FG000|Treatment Period|Administrative reasons by sponsor|0|||
162783437|NCT02654132|587918450|FG001|Treatment Period|Administrative reasons by sponsor|1|||
162783438|NCT02654132|587918449|FG000|Treatment Period|Death|1|||
162783439|NCT02654132|587918450|FG001|Treatment Period|Death|0|||
162783440|NCT00623363|587918451|FG000|Overall Study|Adverse Event|2|||
162783441|NCT00623363|587918452|FG001|Overall Study|Adverse Event|2|||
162783442|NCT04706793|587918453|FG000|Treatment|Disease worsening|10|||
162783443|NCT04706793|587918454|FG001|Treatment|Disease worsening|10|||
162783444|NCT04706793|587918453|FG000|Follow-up|Lack of Efficacy|1|||
162783445|NCT04706793|587918454|FG001|Follow-up|Lack of Efficacy|0|||
162783446|NCT04706793|587918453|FG000|Follow-up|Disease worsening|8|||
162783447|NCT04706793|587918454|FG001|Follow-up|Disease worsening|10|||
162783448|NCT04706793|587918453|FG000|Follow-up|Adverse Event|1|||
162783449|NCT04706793|587918454|FG001|Follow-up|Adverse Event|0|||
162783450|NCT03713320|587918455|FG000|Randomized Period|Adverse Event|1|||
162783451|NCT03713320|587918456|FG001|Randomized Period|Adverse Event|5|||
162783452|NCT03713320|587918457|FG002|Randomized Period|Adverse Event|0|||
162783453|NCT03713320|587918455|FG000|Randomized Period|Physician Decision|1|||
162783454|NCT03713320|587918456|FG001|Randomized Period|Physician Decision|1|||
162783455|NCT03713320|587918457|FG002|Randomized Period|Physician Decision|0|||
162783456|NCT03713320|587918455|FG000|Randomized Period|Withdrawal by Subject|4|||
162783457|NCT03713320|587918456|FG001|Randomized Period|Withdrawal by Subject|0|||
162783458|NCT03713320|587918457|FG002|Randomized Period|Withdrawal by Subject|0|||
162783459|NCT03713320|587918455|FG000|Randomized Period|Participant decision|3|||
162783460|NCT03713320|587918456|FG001|Randomized Period|Participant decision|1|||
162783461|NCT03713320|587918457|FG002|Randomized Period|Participant decision|0|||
162783462|NCT03713320|587918455|FG000|Randomized Period|Study terminated by sponsor|6|||
162783463|NCT03713320|587918456|FG001|Randomized Period|Study terminated by sponsor|3|||
162783464|NCT03713320|587918457|FG002|Randomized Period|Study terminated by sponsor|0|||
162783465|NCT03713320|587918455|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
162783466|NCT03713320|587918456|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
162783467|NCT03713320|587918457|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
162783468|NCT03713320|587918455|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
162783469|NCT03713320|587918456|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
162783470|NCT03713320|587918457|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
162783471|NCT02725528|587918458|FG000|Overall Study|Lost to Follow-up|1|||
162783472|NCT02725528|587918459|FG001|Overall Study|Lost to Follow-up|4|||
162783473|NCT02725528|587918458|FG000|Overall Study|Withdrawal by Subject|0|||
162783474|NCT02725528|587918459|FG001|Overall Study|Withdrawal by Subject|1|||
162783475|NCT04354168|587918460|FG000|Overall Study|Lost to Follow-up|22|||
162783476|NCT02287233|587918461|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
162783477|NCT02287233|587918462|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
162783478|NCT02287233|587918463|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
162783479|NCT02287233|587918461|FG000|Overall Study|Adverse Event Related to Progression|0|||
162783480|NCT02287233|587918462|FG001|Overall Study|Adverse Event Related to Progression|2|||
162783481|NCT02287233|587918463|FG002|Overall Study|Adverse Event Related to Progression|8|||
162783482|NCT02287233|587918461|FG000|Overall Study|Physician Decision|1|||
162783483|NCT02287233|587918462|FG001|Overall Study|Physician Decision|2|||
162783484|NCT02287233|587918463|FG002|Overall Study|Physician Decision|4|||
162783485|NCT02287233|587918461|FG000|Overall Study|Progressive Disease with Death|0|||
162783486|NCT02287233|587918462|FG001|Overall Study|Progressive Disease with Death|0|||
162783487|NCT02287233|587918463|FG002|Overall Study|Progressive Disease with Death|10|||
162783488|NCT02287233|587918461|FG000|Overall Study|Progressive Disease Without Death|2|||
162783489|NCT02287233|587918462|FG001|Overall Study|Progressive Disease Without Death|3|||
162783490|NCT02287233|587918463|FG002|Overall Study|Progressive Disease Without Death|20|||
162783491|NCT02287233|587918461|FG000|Overall Study|Withdrawal by Subject|1|||
162783492|NCT02287233|587918462|FG001|Overall Study|Withdrawal by Subject|1|||
162783493|NCT02287233|587918463|FG002|Overall Study|Withdrawal by Subject|7|||
162783494|NCT02287233|587918461|FG000|Overall Study|Other|3|||
162783495|NCT02287233|587918462|FG001|Overall Study|Other|0|||
162783496|NCT02287233|587918463|FG002|Overall Study|Other|15|||
162783497|NCT02287233|587918461|FG000|Overall Study|Did Not Receive Treatment|0|||
162783498|NCT02287233|587918462|FG001|Overall Study|Did Not Receive Treatment|0|||
162783499|NCT02287233|587918463|FG002|Overall Study|Did Not Receive Treatment|2|||
162783500|NCT02706847|587918464|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
162783501|NCT02706847|587918465|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
162783502|NCT02706847|587918466|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
162783503|NCT02706847|587918467|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
162783504|NCT02706847|587918464|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
162783505|NCT02706847|587918465|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
162783506|NCT02706847|587918466|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
162783507|NCT02706847|587918467|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
162783508|NCT02706847|587918464|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
162783509|NCT02706847|587918465|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
162783510|NCT02706847|587918466|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
162783511|NCT02706847|587918467|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
162783512|NCT02706847|587918464|FG000|Period 1: Day 1 to Week 12|Other|4|||
162783513|NCT02706847|587918465|FG001|Period 1: Day 1 to Week 12|Other|4|||
162783514|NCT02706847|587918466|FG002|Period 1: Day 1 to Week 12|Other|2|||
162783515|NCT02706847|587918467|FG003|Period 1: Day 1 to Week 12|Other|2|||
162783516|NCT02706847|587918464|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162783517|NCT02706847|587918465|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162783518|NCT02706847|587918466|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
162783519|NCT02706847|587918467|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162783520|NCT02706847|587918464|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
162783521|NCT02706847|587918465|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
162783522|NCT02706847|587918466|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
162783523|NCT02706847|587918467|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
162783524|NCT02706847|587918464|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
162783525|NCT02706847|587918465|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
162783526|NCT02706847|587918466|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
162783527|NCT02706847|587918467|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
162783528|NCT02706847|587918464|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162783529|NCT02706847|587918465|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162783530|NCT02706847|587918466|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162783531|NCT02706847|587918467|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
162783532|NCT02706847|587918464|FG000|Period 1: Week 12 to Week 24|Other|1|||
162783533|NCT02706847|587918465|FG001|Period 1: Week 12 to Week 24|Other|0|||
162783534|NCT02706847|587918466|FG002|Period 1: Week 12 to Week 24|Other|1|||
162783535|NCT02706847|587918467|FG003|Period 1: Week 12 to Week 24|Other|4|||
162783536|NCT02706847|587918464|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
162783537|NCT02706847|587918465|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
162783538|NCT02706847|587918466|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
162783539|NCT02706847|587918467|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
162783540|NCT02706847|587918464|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
162783541|NCT02706847|587918465|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
162783542|NCT02706847|587918466|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
162783543|NCT02706847|587918467|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
162783544|NCT02706847|587918464|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
162783545|NCT02706847|587918465|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
162783546|NCT02706847|587918466|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
162783547|NCT02706847|587918467|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
162783548|NCT02706847|587918464|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
162783549|NCT02706847|587918465|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
162783550|NCT02706847|587918466|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
162783551|NCT02706847|587918467|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
162783552|NCT02706847|587918464|FG000|Period 2: Week 24 to Week 260|Other|8|||
162783553|NCT02706847|587918465|FG001|Period 2: Week 24 to Week 260|Other|5|||
162783554|NCT02706847|587918466|FG002|Period 2: Week 24 to Week 260|Other|15|||
162783555|NCT02706847|587918467|FG003|Period 2: Week 24 to Week 260|Other|15|||
162783556|NCT01174264|587918468|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
162783557|NCT01174264|587918469|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
162783558|NCT01174264|587918470|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
162783559|NCT01174264|587918468|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
162783560|NCT01174264|587918469|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
162783561|NCT01174264|587918470|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
162783562|NCT01174264|587918468|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
162783563|NCT01174264|587918469|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
162783564|NCT01174264|587918470|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
162783565|NCT03432390|587918471|FG000|Apnea Period|Protocol Violation|2|||
162783566|NCT03432390|587918472|FG001|Apnea Period|Protocol Violation|2|||
162783567|NCT01774305|587918475|FG000|Overall Study|Physician Decision|1|||
162783568|NCT01774305|587918476|FG001|Overall Study|Physician Decision|0|||
162783569|NCT01185171|587918485|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
162783570|NCT01185171|587918485|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
162783571|NCT01185171|587918485|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
162783572|NCT01185171|587918485|FG000|Maintenance|Elevated liver transaminases|3|||
162783573|NCT01185171|587918485|FG000|Maintenance|Rush|2|||
162783574|NCT01185171|587918485|FG000|Maintenance|Diarrhea|1|||
162783575|NCT01185171|587918485|FG000|Maintenance|Xerostomia|1|||
162783576|NCT01185171|587918485|FG000|Maintenance|Nausea|1|||
162783577|NCT01185171|587918485|FG000|Maintenance|Comorbid Illness|2|||
162783578|NCT01185171|587918485|FG000|Maintenance|Withdrawal by Subject|1|||
162783579|NCT01185171|587918485|FG000|Maintenance|Disease Recurrence|1|||
162783580|NCT01482429|587918486|FG000|Care Usual|Protocol Violation|0|||
162783581|NCT01482429|587918487|FG001|Care Usual|Protocol Violation|172|||
162783582|NCT01482429|587918486|FG000|Care Usual|Lost to Follow-up|0|||
162783583|NCT01482429|587918487|FG001|Care Usual|Lost to Follow-up|1|||
162783584|NCT01482429|587918486|FG000|Protocol|Protocol Violation|275|||
162783585|NCT01482429|587918487|FG001|Protocol|Protocol Violation|0|||
162783586|NCT01502371|587918490|FG000|Overall Study|Withdrawal by Subject|1|||
162783587|NCT01502371|587918491|FG001|Overall Study|Withdrawal by Subject|2|||
162783588|NCT01502371|587918492|FG002|Overall Study|Withdrawal by Subject|1|||
162783589|NCT01502371|587918493|FG003|Overall Study|Withdrawal by Subject|1|||
162783590|NCT01502371|587918494|FG004|Overall Study|Withdrawal by Subject|1|||
162783591|NCT01502371|587918490|FG000|Overall Study|Adverse Event|2|||
162783592|NCT01502371|587918491|FG001|Overall Study|Adverse Event|1|||
162783593|NCT01502371|587918492|FG002|Overall Study|Adverse Event|0|||
162783594|NCT01502371|587918493|FG003|Overall Study|Adverse Event|4|||
162783595|NCT01502371|587918494|FG004|Overall Study|Adverse Event|3|||
162783596|NCT01502371|587918490|FG000|Overall Study|Treatment Failure|22|||
162783597|NCT01502371|587918491|FG001|Overall Study|Treatment Failure|20|||
162783598|NCT01502371|587918492|FG002|Overall Study|Treatment Failure|12|||
162783599|NCT01502371|587918493|FG003|Overall Study|Treatment Failure|19|||
162783600|NCT01502371|587918494|FG004|Overall Study|Treatment Failure|30|||
162783601|NCT01502371|587918490|FG000|Overall Study|Lack of Efficacy|3|||
162783602|NCT01502371|587918491|FG001|Overall Study|Lack of Efficacy|3|||
162783603|NCT01502371|587918492|FG002|Overall Study|Lack of Efficacy|2|||
162783604|NCT01502371|587918493|FG003|Overall Study|Lack of Efficacy|2|||
162783605|NCT01502371|587918494|FG004|Overall Study|Lack of Efficacy|4|||
162783606|NCT01502371|587918490|FG000|Overall Study|Physician Decision|3|||
162783607|NCT01502371|587918491|FG001|Overall Study|Physician Decision|0|||
162783608|NCT01502371|587918492|FG002|Overall Study|Physician Decision|0|||
162783609|NCT01502371|587918493|FG003|Overall Study|Physician Decision|0|||
162783610|NCT01502371|587918494|FG004|Overall Study|Physician Decision|1|||
162783611|NCT01502371|587918490|FG000|Overall Study|Noncompliance with Study Drug|0|||
162783612|NCT01502371|587918491|FG001|Overall Study|Noncompliance with Study Drug|0|||
162783613|NCT01502371|587918492|FG002|Overall Study|Noncompliance with Study Drug|1|||
162783614|NCT01502371|587918493|FG003|Overall Study|Noncompliance with Study Drug|2|||
162783615|NCT01502371|587918494|FG004|Overall Study|Noncompliance with Study Drug|1|||
162783616|NCT01502371|587918490|FG000|Overall Study|Technical Problems|1|||
162783617|NCT01502371|587918491|FG001|Overall Study|Technical Problems|0|||
162783618|NCT01502371|587918492|FG002|Overall Study|Technical Problems|2|||
162783619|NCT01502371|587918493|FG003|Overall Study|Technical Problems|4|||
162783620|NCT01502371|587918494|FG004|Overall Study|Technical Problems|1|||
162783621|NCT01502371|587918490|FG000|Overall Study|Protocol Violation|9|||
162783622|NCT01502371|587918491|FG001|Overall Study|Protocol Violation|5|||
162783623|NCT01502371|587918492|FG002|Overall Study|Protocol Violation|6|||
162783624|NCT01502371|587918493|FG003|Overall Study|Protocol Violation|5|||
162783625|NCT01502371|587918494|FG004|Overall Study|Protocol Violation|10|||
162783626|NCT01502371|587918490|FG000|Overall Study|Excluded Medication|0|||
162783627|NCT01502371|587918491|FG001|Overall Study|Excluded Medication|1|||
162783628|NCT01502371|587918492|FG002|Overall Study|Excluded Medication|1|||
162783629|NCT01502371|587918493|FG003|Overall Study|Excluded Medication|0|||
162783630|NCT01502371|587918494|FG004|Overall Study|Excluded Medication|1|||
162783631|NCT03325608|587918495|FG000|Overall Study|Lost to Follow-up|23|||
162783632|NCT03325608|587918496|FG001|Overall Study|Lost to Follow-up|23|||
162783633|NCT03325608|587918497|FG002|Overall Study|Lost to Follow-up|30|||
162783634|NCT03325608|587918498|FG003|Overall Study|Lost to Follow-up|30|||
162783635|NCT03325608|587918495|FG000|Overall Study|Death of Caregiver|0|||
162783636|NCT03325608|587918496|FG001|Overall Study|Death of Caregiver|0|||
162783637|NCT03325608|587918497|FG002|Overall Study|Death of Caregiver|2|||
162783638|NCT03325608|587918498|FG003|Overall Study|Death of Caregiver|2|||
162783639|NCT03325608|587918495|FG000|Overall Study|Death of Care Recipient|34|||
162783640|NCT03325608|587918496|FG001|Overall Study|Death of Care Recipient|34|||
162783641|NCT03325608|587918497|FG002|Overall Study|Death of Care Recipient|28|||
162783642|NCT03325608|587918498|FG003|Overall Study|Death of Care Recipient|28|||
162783643|NCT03325608|587918495|FG000|Overall Study|Withdrawal by Subject|49|||
162783644|NCT03325608|587918496|FG001|Overall Study|Withdrawal by Subject|49|||
162783645|NCT03325608|587918497|FG002|Overall Study|Withdrawal by Subject|35|||
162783646|NCT03325608|587918498|FG003|Overall Study|Withdrawal by Subject|35|||
162783647|NCT03325608|587918495|FG000|Overall Study|Ineligible|7|||
162783648|NCT03325608|587918496|FG001|Overall Study|Ineligible|7|||
162783649|NCT03325608|587918497|FG002|Overall Study|Ineligible|5|||
162783650|NCT03325608|587918498|FG003|Overall Study|Ineligible|5|||
162783651|NCT02188784|587918499|FG000|Overall Study|Death|3|||
162783652|NCT02188784|587918500|FG001|Overall Study|Death|1|||
162783653|NCT02188784|587918499|FG000|Overall Study|Lost to Follow-up|1|||
162783654|NCT02188784|587918500|FG001|Overall Study|Lost to Follow-up|0|||
162783655|NCT02188784|587918499|FG000|Overall Study|Withdrawal by Subject|3|||
162783656|NCT02188784|587918500|FG001|Overall Study|Withdrawal by Subject|9|||
162783657|NCT02188784|587918499|FG000|Overall Study|Physician Decision|2|||
162783658|NCT02188784|587918500|FG001|Overall Study|Physician Decision|3|||
162783659|NCT01568112|587918503|FG000|Overall Study|Randomized But Not Treated|0|||
162783660|NCT01568112|587918504|FG001|Overall Study|Randomized But Not Treated|1|||
162783661|NCT01568112|587918505|FG002|Overall Study|Randomized But Not Treated|0|||
162783662|NCT01568112|587918506|FG003|Overall Study|Randomized But Not Treated|0|||
162783663|NCT01568112|587918503|FG000|Overall Study|Withdrew due to Adverse Event|2|||
162783664|NCT01568112|587918504|FG001|Overall Study|Withdrew due to Adverse Event|4|||
162783665|NCT01568112|587918505|FG002|Overall Study|Withdrew due to Adverse Event|6|||
162783666|NCT01568112|587918506|FG003|Overall Study|Withdrew due to Adverse Event|3|||
162783667|NCT01568112|587918503|FG000|Overall Study|Lost to Follow-up|0|||
162783668|NCT01568112|587918504|FG001|Overall Study|Lost to Follow-up|0|||
162783669|NCT01568112|587918505|FG002|Overall Study|Lost to Follow-up|0|||
162783670|NCT01568112|587918506|FG003|Overall Study|Lost to Follow-up|1|||
162783671|NCT01568112|587918503|FG000|Overall Study|Withdrawal by Subject|2|||
162783672|NCT01568112|587918504|FG001|Overall Study|Withdrawal by Subject|3|||
162783673|NCT01568112|587918505|FG002|Overall Study|Withdrawal by Subject|0|||
162783674|NCT01568112|587918506|FG003|Overall Study|Withdrawal by Subject|7|||
162783675|NCT01568112|587918503|FG000|Overall Study|Withdrawal by Physician|1|||
162783676|NCT01568112|587918504|FG001|Overall Study|Withdrawal by Physician|0|||
162783677|NCT01568112|587918505|FG002|Overall Study|Withdrawal by Physician|1|||
162783678|NCT01568112|587918506|FG003|Overall Study|Withdrawal by Physician|1|||
162783679|NCT00487825|587920339|FG000|Overall Study|Adverse Event|2|||
162783680|NCT00487825|587920340|FG001|Overall Study|Adverse Event|2|||
162783681|NCT00487825|587920339|FG000|Overall Study|Lack of Efficacy|1|||
162783682|NCT00487825|587920340|FG001|Overall Study|Lack of Efficacy|1|||
162783683|NCT00487825|587920339|FG000|Overall Study|Other|3|||
162783684|NCT00487825|587920340|FG001|Overall Study|Other|2|||
162783685|NCT01639742|587920341|FG000|Overall Study|Study Ongoing|17|||
162783686|NCT01639742|587920341|FG000|Overall Study|Lost to Follow-up|1|||
162783687|NCT01256671|587920342|FG000|Overall Study|Adverse Event|29|||
162783688|NCT01256671|587920342|FG000|Overall Study|Lost to Follow-up|16|||
162783689|NCT01256671|587920342|FG000|Overall Study|Withdrawal by Subject|31|||
162783690|NCT01256671|587920342|FG000|Overall Study|Physician Decision|3|||
162783691|NCT01256671|587920342|FG000|Overall Study|Lack of Efficacy|4|||
162783692|NCT01256671|587920342|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
162783693|NCT01986114|587920343|FG000|Overall Study|Adverse Event|59|||
162783694|NCT01986114|587920343|FG000|Overall Study|Lack of Efficacy|23|||
162783695|NCT01986114|587920343|FG000|Overall Study|Withdrawal by Subject|58|||
162783696|NCT01986114|587920343|FG000|Overall Study|Noncompliance|3|||
162783697|NCT01986114|587920343|FG000|Overall Study|Protocol Violation|1|||
162783698|NCT01986114|587920343|FG000|Overall Study|Lost to Follow-up|5|||
162783699|NCT01986114|587920343|FG000|Overall Study|Other reason|7|||
162783700|NCT01190644|587920344|FG000|Overall Study|Death|2|||
162783701|NCT01190644|587920344|FG000|Overall Study|Disease progression|1|||
162783702|NCT02366143|587920345|FG000|Overall Study|Death|307|||
162783703|NCT02366143|587920346|FG001|Overall Study|Death|278|||
162783704|NCT02366143|587920347|FG002|Overall Study|Death|280|||
162783705|NCT02366143|587920345|FG000|Overall Study|Lost to Follow-up|2|||
162783706|NCT02366143|587920346|FG001|Overall Study|Lost to Follow-up|4|||
162783707|NCT02366143|587920347|FG002|Overall Study|Lost to Follow-up|2|||
162783708|NCT02366143|587920345|FG000|Overall Study|Physician Decision|1|||
162783709|NCT02366143|587920346|FG001|Overall Study|Physician Decision|2|||
162783710|NCT02366143|587920347|FG002|Overall Study|Physician Decision|1|||
162783711|NCT02366143|587920345|FG000|Overall Study|Protocol Violation|0|||
162783712|NCT02366143|587920346|FG001|Overall Study|Protocol Violation|0|||
162783713|NCT02366143|587920347|FG002|Overall Study|Protocol Violation|2|||
162783714|NCT02366143|587920345|FG000|Overall Study|Withdrawal by Subject|16|||
162783715|NCT02366143|587920346|FG001|Overall Study|Withdrawal by Subject|17|||
162783716|NCT02366143|587920347|FG002|Overall Study|Withdrawal by Subject|22|||
162783717|NCT02366143|587920345|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
162783718|NCT02366143|587920346|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
162783719|NCT02366143|587920347|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
162783720|NCT02366143|587920345|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
162783721|NCT02366143|587920346|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
162783722|NCT02366143|587920347|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
162783723|NCT02366143|587920345|FG000|Overall Study|Randomization Error|1|||
162783724|NCT02366143|587920346|FG001|Overall Study|Randomization Error|0|||
162783725|NCT02366143|587920347|FG002|Overall Study|Randomization Error|0|||
162783726|NCT02366143|587920345|FG000|Overall Study|PI Move and Site Closure|1|||
162783727|NCT02366143|587920346|FG001|Overall Study|PI Move and Site Closure|0|||
162783728|NCT02366143|587920347|FG002|Overall Study|PI Move and Site Closure|1|||
162783729|NCT02366143|587920345|FG000|Overall Study|Study Terminated By Sponsor|0|||
162783730|NCT02366143|587920346|FG001|Overall Study|Study Terminated By Sponsor|0|||
162783731|NCT02366143|587920347|FG002|Overall Study|Study Terminated By Sponsor|2|||
162783732|NCT02366143|587920345|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
162783733|NCT02366143|587920346|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
162783734|NCT02366143|587920347|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
162783735|NCT02366143|587920345|FG000|Overall Study|Patient moved to roll-over study|1|||
162783736|NCT02366143|587920346|FG001|Overall Study|Patient moved to roll-over study|19|||
162783737|NCT02366143|587920347|FG002|Overall Study|Patient moved to roll-over study|28|||
162783738|NCT02366143|587920345|FG000|Overall Study|Patient moved to commercial stock|0|||
162783739|NCT02366143|587920346|FG001|Overall Study|Patient moved to commercial stock|0|||
162783740|NCT02366143|587920347|FG002|Overall Study|Patient moved to commercial stock|1|||
162783741|NCT02366143|587920345|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
162783742|NCT02366143|587920346|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
162783743|NCT02366143|587920347|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
162783744|NCT02366143|587920345|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
162783745|NCT02366143|587920346|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
162783746|NCT02366143|587920347|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
162783747|NCT02366143|587920345|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
162783748|NCT02366143|587920346|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
162783749|NCT02366143|587920347|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
162783750|NCT02366143|587920345|FG000|Overall Study|Requester's instructions|1|||
162783751|NCT02366143|587920346|FG001|Overall Study|Requester's instructions|1|||
162783752|NCT02366143|587920347|FG002|Overall Study|Requester's instructions|1|||
162783753|NCT02366143|587920345|FG000|Overall Study|Uneligible|0|||
162783754|NCT02366143|587920346|FG001|Overall Study|Uneligible|1|||
162783755|NCT02366143|587920347|FG002|Overall Study|Uneligible|0|||
162783756|NCT02366143|587920345|FG000|Overall Study|Post Trial Migration|0|||
162783757|NCT02366143|587920346|FG001|Overall Study|Post Trial Migration|1|||
162783758|NCT02366143|587920347|FG002|Overall Study|Post Trial Migration|0|||
162783759|NCT02366143|587920345|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
162783760|NCT02366143|587920346|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
162783761|NCT02366143|587920347|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
162783762|NCT02366143|587920345|FG000|Overall Study|Patient switched to PTAP|0|||
162783763|NCT02366143|587920346|FG001|Overall Study|Patient switched to PTAP|1|||
162783764|NCT02366143|587920347|FG002|Overall Study|Patient switched to PTAP|0|||
162783765|NCT02366143|587920345|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
162783766|NCT02366143|587920346|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
162783767|NCT02366143|587920347|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
162783768|NCT04411186|587920348|FG000|Overall Study|Withdrawn due to protocol violation|0|||
162783769|NCT04411186|587920349|FG001|Overall Study|Withdrawn due to protocol violation|1|||
162783770|NCT02172911|587920350|FG000|Overall Study|Serious Adverse Event|0|||
162783771|NCT02172911|587920351|FG001|Overall Study|Serious Adverse Event|1|||
162783772|NCT02172911|587920350|FG000|Overall Study|Progression of Disease|0|||
162783773|NCT02172911|587920351|FG001|Overall Study|Progression of Disease|1|||
162783774|NCT02172911|587920350|FG000|Overall Study|Loss of insurance coverage|1|||
162783775|NCT02172911|587920351|FG001|Overall Study|Loss of insurance coverage|0|||
162783776|NCT00575042|587920354|FG000|Overall Study|Adverse Event|2|||
162783777|NCT00575042|587920354|FG000|Overall Study|Lost to Follow-up|1|||
162783778|NCT04795336|587920357|FG000|Overall Study|Withdrawal by Subject|3|||
162783779|NCT04795336|587920358|FG001|Overall Study|Withdrawal by Subject|4|||
162783780|NCT04795336|587920359|FG002|Overall Study|Withdrawal by Subject|3|||
162783781|NCT04795336|587920360|FG003|Overall Study|Withdrawal by Subject|12|||
162783782|NCT04795336|587920357|FG000|Overall Study|Lost study logs|0|||
162783783|NCT04795336|587920358|FG001|Overall Study|Lost study logs|1|||
162783784|NCT04795336|587920359|FG002|Overall Study|Lost study logs|0|||
162783785|NCT04795336|587920360|FG003|Overall Study|Lost study logs|2|||
162783786|NCT04795336|587920357|FG000|Overall Study|Did not take study medication|2|||
162783787|NCT04795336|587920358|FG001|Overall Study|Did not take study medication|0|||
162783788|NCT04795336|587920359|FG002|Overall Study|Did not take study medication|0|||
162783789|NCT04795336|587920360|FG003|Overall Study|Did not take study medication|0|||
162783790|NCT01266018|587920361|FG000|Overall Study|Physician Decision|1|||
162783791|NCT01266018|587920362|FG001|Overall Study|Physician Decision|0|||
162783792|NCT01266018|587920361|FG000|Overall Study|Progressive disease|0|||
162783793|NCT01266018|587920362|FG001|Overall Study|Progressive disease|1|||
162783794|NCT03167151|587920363|FG000|Overall Study|Withdrawal by Subject|1|||
162783795|NCT03167151|587920364|FG001|Overall Study|Withdrawal by Subject|0|||
162783796|NCT03167151|587920365|FG002|Overall Study|Withdrawal by Subject|0|||
162783797|NCT03167151|587920363|FG000|Overall Study|No evidence of tumour at surgery|0|||
162783798|NCT03167151|587920364|FG001|Overall Study|No evidence of tumour at surgery|1|||
162783799|NCT03167151|587920365|FG002|Overall Study|No evidence of tumour at surgery|1|||
162783800|NCT01458522|587920366|FG000|Overall Study|Withdrawal by Subject|2|||
162783801|NCT01458522|587920367|FG001|Overall Study|Withdrawal by Subject|2|||
162783802|NCT01458522|587920366|FG000|Overall Study|Physician Decision|1|||
162783803|NCT01458522|587920367|FG001|Overall Study|Physician Decision|9|||
162783804|NCT00516139|587920368|FG000|Overall Study|Adverse Event|27|||
162783805|NCT00516139|587920368|FG000|Overall Study|Lost to Follow-up|1|||
162783806|NCT00516139|587920368|FG000|Overall Study|Protocol Violation|1|||
162783807|NCT00516139|587920368|FG000|Overall Study|Withdrawal by Subject|8|||
162783808|NCT00516139|587920368|FG000|Overall Study|Lack of Efficacy|1|||
162783809|NCT00589303|587920369|FG000|Overall Study|Withdrawal by Subject|2|||
162783810|NCT00589303|587920370|FG001|Overall Study|Withdrawal by Subject|1|||
162783811|NCT03021551|587920372|FG000|Overall Study|Equipment Issues|2|||
162783812|NCT03021551|587920372|FG000|Overall Study|Protocol Violation|1|||
162783813|NCT00490945|587920375|FG000|Overall Study|Adverse Event|0|||
162783814|NCT00490945|587920376|FG001|Overall Study|Adverse Event|1|||
162783815|NCT00490945|587920377|FG002|Overall Study|Adverse Event|0|||
162783816|NCT00490945|587920378|FG003|Overall Study|Adverse Event|0|||
162783817|NCT00490945|587920379|FG004|Overall Study|Adverse Event|0|||
162783818|NCT02706951|587920381|FG000|Period 1|Adverse Event|1|||
162783819|NCT02706951|587920382|FG001|Period 1|Adverse Event|5|||
162783820|NCT02706951|587920383|FG002|Period 1|Adverse Event|3|||
162783821|NCT02706951|587920384|FG003|Period 1|Adverse Event|0|||
162783822|NCT02706951|587920385|FG004|Period 1|Adverse Event|0|||
162783823|NCT02706951|587920381|FG000|Period 1|Withdrawal by Subject|10|||
162783824|NCT02706951|587920382|FG001|Period 1|Withdrawal by Subject|6|||
162783825|NCT02706951|587920383|FG002|Period 1|Withdrawal by Subject|6|||
162783826|NCT02706951|587920384|FG003|Period 1|Withdrawal by Subject|0|||
162783827|NCT02706951|587920385|FG004|Period 1|Withdrawal by Subject|0|||
162783828|NCT02706951|587920381|FG000|Period 1|Lost to Follow-up|0|||
162783829|NCT02706951|587920382|FG001|Period 1|Lost to Follow-up|4|||
162783830|NCT02706951|587920383|FG002|Period 1|Lost to Follow-up|1|||
162783831|NCT02706951|587920384|FG003|Period 1|Lost to Follow-up|0|||
162783832|NCT02706951|587920385|FG004|Period 1|Lost to Follow-up|0|||
162783833|NCT02706951|587920381|FG000|Period 1|Other|2|||
162783834|NCT02706951|587920382|FG001|Period 1|Other|1|||
162783835|NCT02706951|587920383|FG002|Period 1|Other|0|||
162783836|NCT02706951|587920384|FG003|Period 1|Other|0|||
162783837|NCT02706951|587920385|FG004|Period 1|Other|0|||
162783838|NCT02706951|587920381|FG000|Period 2|Adverse Event|0|||
162783839|NCT02706951|587920382|FG001|Period 2|Adverse Event|0|||
162783840|NCT02706951|587920383|FG002|Period 2|Adverse Event|0|||
162783841|NCT02706951|587920384|FG003|Period 2|Adverse Event|25|||
162783842|NCT02706951|587920385|FG004|Period 2|Adverse Event|34|||
162783843|NCT02706951|587920381|FG000|Period 2|Withdrawal by Subject|0|||
162783844|NCT02706951|587920382|FG001|Period 2|Withdrawal by Subject|0|||
162783845|NCT02706951|587920383|FG002|Period 2|Withdrawal by Subject|0|||
162783846|NCT02706951|587920384|FG003|Period 2|Withdrawal by Subject|38|||
162783847|NCT02706951|587920385|FG004|Period 2|Withdrawal by Subject|44|||
162783848|NCT02706951|587920381|FG000|Period 2|Lost to Follow-up|0|||
162783849|NCT02706951|587920382|FG001|Period 2|Lost to Follow-up|0|||
162783850|NCT02706951|587920383|FG002|Period 2|Lost to Follow-up|0|||
162783851|NCT02706951|587920384|FG003|Period 2|Lost to Follow-up|17|||
162783852|NCT02706951|587920385|FG004|Period 2|Lost to Follow-up|9|||
162783853|NCT02706951|587920381|FG000|Period 2|COVID-19 Related|0|||
162783854|NCT02706951|587920382|FG001|Period 2|COVID-19 Related|0|||
162783855|NCT02706951|587920383|FG002|Period 2|COVID-19 Related|0|||
162783856|NCT02706951|587920384|FG003|Period 2|COVID-19 Related|1|||
162783857|NCT02706951|587920385|FG004|Period 2|COVID-19 Related|2|||
162783858|NCT02706951|587920381|FG000|Period 2|Other|0|||
162783859|NCT02706951|587920382|FG001|Period 2|Other|0|||
162783860|NCT02706951|587920383|FG002|Period 2|Other|0|||
162783861|NCT02706951|587920384|FG003|Period 2|Other|37|||
162783862|NCT02706951|587920385|FG004|Period 2|Other|31|||
162783863|NCT03491215|587920386|FG000|Overall Study|Death|6|||
162783864|NCT03491215|587920387|FG001|Overall Study|Death|2|||
162783865|NCT03491215|587920388|FG002|Overall Study|Death|1|||
162783866|NCT03491215|587920389|FG003|Overall Study|Death|0|||
162783867|NCT03491215|587920386|FG000|Overall Study|Physician Decision|1|||
162783868|NCT03491215|587920387|FG001|Overall Study|Physician Decision|0|||
162783869|NCT03491215|587920388|FG002|Overall Study|Physician Decision|0|||
162783870|NCT03491215|587920389|FG003|Overall Study|Physician Decision|0|||
162783871|NCT03297398|587920394|FG000|Overall Study|Sponsor's decision|6|||
162783872|NCT03297398|587920395|FG001|Overall Study|Sponsor's decision|9|||
162783873|NCT03297398|587920396|FG002|Overall Study|Sponsor's decision|7|||
162783874|NCT03297398|587920394|FG000|Overall Study|Adverse Event|1|||
162783875|NCT03297398|587920395|FG001|Overall Study|Adverse Event|4|||
162783876|NCT03297398|587920396|FG002|Overall Study|Adverse Event|4|||
162783877|NCT03297398|587920394|FG000|Overall Study|Withdrawal by Subject|1|||
162783878|NCT03297398|587920395|FG001|Overall Study|Withdrawal by Subject|2|||
162783879|NCT03297398|587920396|FG002|Overall Study|Withdrawal by Subject|2|||
162783880|NCT03297398|587920394|FG000|Overall Study|Protocol Violation|0|||
162783881|NCT03297398|587920395|FG001|Overall Study|Protocol Violation|2|||
162783882|NCT03297398|587920396|FG002|Overall Study|Protocol Violation|0|||
162783883|NCT03297398|587920394|FG000|Overall Study|Physician Decision|0|||
162783884|NCT03297398|587920395|FG001|Overall Study|Physician Decision|0|||
162783885|NCT03297398|587920396|FG002|Overall Study|Physician Decision|1|||
162783886|NCT03297398|587920394|FG000|Overall Study|Lost to Follow-up|0|||
162783887|NCT03297398|587920395|FG001|Overall Study|Lost to Follow-up|0|||
162783888|NCT03297398|587920396|FG002|Overall Study|Lost to Follow-up|1|||
162783889|NCT00611715|587920399|FG000|Overall Study|Disease Progression|24|||
162783890|NCT00611715|587920400|FG001|Overall Study|Disease Progression|4|||
162783891|NCT00611715|587920399|FG000|Overall Study|Withdrawal by Subject|5|||
162783892|NCT00611715|587920400|FG001|Overall Study|Withdrawal by Subject|1|||
162783893|NCT00611715|587920399|FG000|Overall Study|Adverse Event|9|||
162783894|NCT00611715|587920400|FG001|Overall Study|Adverse Event|1|||
162783895|NCT00611715|587920399|FG000|Overall Study|Death|1|||
162783896|NCT00611715|587920400|FG001|Overall Study|Death|0|||
162783897|NCT00611715|587920399|FG000|Overall Study|two patients are still on treatment|2|||
162783898|NCT00611715|587920400|FG001|Overall Study|two patients are still on treatment|0|||
162783899|NCT00350298|587920402|FG000|Overall Study|Death|7|||
162783900|NCT00350298|587920403|FG001|Overall Study|Death|8|||
162783901|NCT00350298|587920402|FG000|Overall Study|Lost to Follow-up|1|||
162783902|NCT00350298|587920403|FG001|Overall Study|Lost to Follow-up|2|||
162783903|NCT00350298|587920402|FG000|Overall Study|Withdrawal by Subject|1|||
162783904|NCT00350298|587920403|FG001|Overall Study|Withdrawal by Subject|3|||
162783905|NCT03634839|587920404|FG000|First Intervention (2 Hours)|Adverse Event|0|||
162783906|NCT03634839|587920405|FG001|First Intervention (2 Hours)|Adverse Event|2|||
162783907|NCT00233389|587920408|FG000|Overall Study|Adverse Event|5|||
162783908|NCT00233389|587920409|FG001|Overall Study|Adverse Event|5|||
162783909|NCT00233389|587920408|FG000|Overall Study|Lack of Efficacy|11|||
162783910|NCT00233389|587920409|FG001|Overall Study|Lack of Efficacy|8|||
162783911|NCT00233389|587920408|FG000|Overall Study|Lost to Follow-up|1|||
162783912|NCT00233389|587920409|FG001|Overall Study|Lost to Follow-up|1|||
162783913|NCT00233389|587920408|FG000|Overall Study|Physician Decision|1|||
162783914|NCT00233389|587920409|FG001|Overall Study|Physician Decision|0|||
162783915|NCT00233389|587920408|FG000|Overall Study|Protocol Violation|0|||
162783916|NCT00233389|587920409|FG001|Overall Study|Protocol Violation|1|||
162783917|NCT00233389|587920408|FG000|Overall Study|Withdrawal by Subject|0|||
162783918|NCT00233389|587920409|FG001|Overall Study|Withdrawal by Subject|1|||
162783919|NCT00719043|587920415|FG000|Overall Study|Adverse Event|5|||
162783920|NCT00719043|587920416|FG001|Overall Study|Adverse Event|1|||
162783921|NCT00719043|587920417|FG002|Overall Study|Adverse Event|2|||
162783922|NCT00719043|587920418|FG003|Overall Study|Adverse Event|2|||
162783923|NCT00719043|587920419|FG004|Overall Study|Adverse Event|1|||
162783924|NCT00719043|587920420|FG005|Overall Study|Adverse Event|4|||
162783925|NCT00719043|587920421|FG006|Overall Study|Adverse Event|4|||
162783926|NCT00719043|587920415|FG000|Overall Study|Lost to Follow-up|14|||
162783927|NCT00719043|587920416|FG001|Overall Study|Lost to Follow-up|10|||
162783928|NCT00719043|587920417|FG002|Overall Study|Lost to Follow-up|8|||
162783929|NCT00719043|587920418|FG003|Overall Study|Lost to Follow-up|9|||
162783930|NCT00719043|587920419|FG004|Overall Study|Lost to Follow-up|10|||
162783931|NCT00719043|587920420|FG005|Overall Study|Lost to Follow-up|9|||
162783932|NCT00719043|587920421|FG006|Overall Study|Lost to Follow-up|9|||
162783933|NCT00719043|587920415|FG000|Overall Study|Protocol Violation|0|||
162783934|NCT00719043|587920416|FG001|Overall Study|Protocol Violation|0|||
162783935|NCT00719043|587920417|FG002|Overall Study|Protocol Violation|0|||
162783936|NCT00719043|587920418|FG003|Overall Study|Protocol Violation|0|||
162783937|NCT00719043|587920419|FG004|Overall Study|Protocol Violation|0|||
162783938|NCT00719043|587920420|FG005|Overall Study|Protocol Violation|1|||
162783939|NCT00719043|587920421|FG006|Overall Study|Protocol Violation|0|||
162783940|NCT00719043|587920415|FG000|Overall Study|Other|1|||
162783941|NCT00719043|587920416|FG001|Overall Study|Other|0|||
162783942|NCT00719043|587920417|FG002|Overall Study|Other|1|||
162783943|NCT00719043|587920418|FG003|Overall Study|Other|2|||
162783944|NCT00719043|587920419|FG004|Overall Study|Other|0|||
162783945|NCT00719043|587920420|FG005|Overall Study|Other|2|||
162783946|NCT00719043|587920421|FG006|Overall Study|Other|1|||
162783947|NCT00719043|587920415|FG000|Overall Study|Withdrawal by Subject|12|||
162783948|NCT00719043|587920416|FG001|Overall Study|Withdrawal by Subject|14|||
162783949|NCT00719043|587920417|FG002|Overall Study|Withdrawal by Subject|9|||
162783950|NCT00719043|587920418|FG003|Overall Study|Withdrawal by Subject|10|||
162783951|NCT00719043|587920419|FG004|Overall Study|Withdrawal by Subject|16|||
162783952|NCT00719043|587920420|FG005|Overall Study|Withdrawal by Subject|18|||
162783953|NCT00719043|587920421|FG006|Overall Study|Withdrawal by Subject|14|||
162783954|NCT04593823|587920422|FG000|Overall Study|Withdrawal by Subject|1|||
162783955|NCT04593823|587920423|FG001|Overall Study|Withdrawal by Subject|1|||
162783956|NCT04593823|587920422|FG000|Overall Study|Lost to Follow-up|0|||
162783957|NCT04593823|587920423|FG001|Overall Study|Lost to Follow-up|1|||
162783958|NCT00952848|587920430|FG000|Overall Study|Withdrawal by Subject|4|||
162783959|NCT02725567|587920431|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
162783960|NCT02725567|587920432|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
162783961|NCT02725567|587920431|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
162783962|NCT02725567|587920432|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
162783963|NCT02725567|587920431|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
162783964|NCT02725567|587920432|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
162783965|NCT02413593|587920436|FG000|Overall Study|Lost to Follow-up|3|||
162783966|NCT02413593|587920436|FG000|Overall Study|Adverse Event|1|||
162783967|NCT00409409|587920437|FG000|Overall Study|Adverse Event|7|||
162783968|NCT00409409|587920438|FG001|Overall Study|Adverse Event|2|||
162783969|NCT00409409|587920437|FG000|Overall Study|Withdrawal by Subject|1|||
162783970|NCT00409409|587920438|FG001|Overall Study|Withdrawal by Subject|1|||
162783971|NCT00409409|587920437|FG000|Overall Study|Any other reason not above-mentioned|0|||
162783972|NCT00409409|587920438|FG001|Overall Study|Any other reason not above-mentioned|1|||
162783973|NCT03599622|587920439|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
162783974|NCT03599622|587920440|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
162783975|NCT03599622|587920441|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
162783976|NCT03599622|587920442|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
162783977|NCT03599622|587920439|FG000|Pre-Treatment Period|Other reasons|1|||
162783978|NCT03599622|587920440|FG001|Pre-Treatment Period|Other reasons|1|||
162783979|NCT03599622|587920441|FG002|Pre-Treatment Period|Other reasons|1|||
162783980|NCT03599622|587920442|FG003|Pre-Treatment Period|Other reasons|0|||
162783981|NCT03599622|587920439|FG000|Treatment Period|Adverse Event|11|||
162783982|NCT03599622|587920440|FG001|Treatment Period|Adverse Event|20|||
162783983|NCT03599622|587920441|FG002|Treatment Period|Adverse Event|18|||
162783984|NCT03599622|587920442|FG003|Treatment Period|Adverse Event|2|||
162783985|NCT03599622|587920439|FG000|Treatment Period|Lack of Efficacy|18|||
162783986|NCT03599622|587920440|FG001|Treatment Period|Lack of Efficacy|12|||
162783987|NCT03599622|587920441|FG002|Treatment Period|Lack of Efficacy|13|||
162783988|NCT03599622|587920442|FG003|Treatment Period|Lack of Efficacy|2|||
162783989|NCT03599622|587920439|FG000|Treatment Period|Withdrawal by Subject|5|||
162783990|NCT03599622|587920440|FG001|Treatment Period|Withdrawal by Subject|11|||
162783991|NCT03599622|587920441|FG002|Treatment Period|Withdrawal by Subject|16|||
162783992|NCT03599622|587920442|FG003|Treatment Period|Withdrawal by Subject|1|||
162783993|NCT03599622|587920439|FG000|Treatment Period|Other reasons|4|||
162783994|NCT03599622|587920440|FG001|Treatment Period|Other reasons|6|||
162783995|NCT03599622|587920441|FG002|Treatment Period|Other reasons|7|||
162783996|NCT03599622|587920442|FG003|Treatment Period|Other reasons|0|||
162783997|NCT03599622|587920439|FG000|Treatment Period|Lost to Follow-up|1|||
162783998|NCT03599622|587920440|FG001|Treatment Period|Lost to Follow-up|0|||
162783999|NCT03599622|587920441|FG002|Treatment Period|Lost to Follow-up|0|||
162784000|NCT03599622|587920442|FG003|Treatment Period|Lost to Follow-up|0|||
162784001|NCT03599622|587920439|FG000|Treatment Period|Study terminated by sponsor|7|||
162784002|NCT03599622|587920440|FG001|Treatment Period|Study terminated by sponsor|20|||
162784003|NCT03599622|587920441|FG002|Treatment Period|Study terminated by sponsor|15|||
162784004|NCT03599622|587920442|FG003|Treatment Period|Study terminated by sponsor|0|||
162784005|NCT03599622|587920439|FG000|Treatment Period|Site terminated by sponsor|0|||
162784006|NCT03599622|587920440|FG001|Treatment Period|Site terminated by sponsor|1|||
162784007|NCT03599622|587920441|FG002|Treatment Period|Site terminated by sponsor|0|||
162784008|NCT03599622|587920442|FG003|Treatment Period|Site terminated by sponsor|0|||
162784009|NCT02485899|587920443|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
162784010|NCT02485899|587920444|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162784011|NCT02485899|587920443|FG000|Overall Study|Withdrawal by Subject|1|||
162784012|NCT02485899|587920444|FG001|Overall Study|Withdrawal by Subject|0|||
162784013|NCT02485899|587920443|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
162784014|NCT02485899|587920444|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
162784015|NCT01006889|587920445|FG000|Overall Study|Withdrawal by Subject|3|||
162784016|NCT00823836|587920446|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
162784017|NCT00823836|587920447|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
162784018|NCT00823836|587920446|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
162784019|NCT00823836|587920447|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
162784020|NCT00823836|587920446|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
162784021|NCT00823836|587920447|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
162784022|NCT00823836|587920446|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
162784023|NCT00823836|587920447|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
162784024|NCT00823836|587920446|FG000|Long-term Phase|Adverse Event|3|||
162784025|NCT00823836|587920447|FG001|Long-term Phase|Adverse Event|2|||
162784026|NCT00823836|587920446|FG000|Long-term Phase|Physician Decision|1|||
162784027|NCT00823836|587920447|FG001|Long-term Phase|Physician Decision|2|||
162784028|NCT00823836|587920446|FG000|Long-term Phase|Withdrawal by Subject|1|||
162784029|NCT00823836|587920447|FG001|Long-term Phase|Withdrawal by Subject|1|||
162784030|NCT01130168|587920448|FG000|Period 1|Withdrawal by Subject|0|||
162784031|NCT01130168|587920449|FG001|Period 1|Withdrawal by Subject|1|||
162784032|NCT01130168|587920450|FG002|Period 1|Withdrawal by Subject|0|||
162784033|NCT01130168|587920451|FG003|Period 1|Withdrawal by Subject|1|||
162784034|NCT01130168|587920452|FG004|Period 1|Withdrawal by Subject|0|||
162784035|NCT01130168|587920453|FG005|Period 1|Withdrawal by Subject|0|||
162784036|NCT01130168|587920448|FG000|Period 1|Discontinued For Other Reason|0|||
162784037|NCT01130168|587920449|FG001|Period 1|Discontinued For Other Reason|0|||
162784038|NCT01130168|587920450|FG002|Period 1|Discontinued For Other Reason|1|||
162784039|NCT01130168|587920451|FG003|Period 1|Discontinued For Other Reason|1|||
162784040|NCT01130168|587920452|FG004|Period 1|Discontinued For Other Reason|0|||
162784041|NCT01130168|587920453|FG005|Period 1|Discontinued For Other Reason|0|||
162784042|NCT01130168|587920448|FG000|Period 1|Adverse Event|0|||
162784043|NCT01130168|587920449|FG001|Period 1|Adverse Event|0|||
162784044|NCT01130168|587920450|FG002|Period 1|Adverse Event|0|||
162784045|NCT01130168|587920451|FG003|Period 1|Adverse Event|1|||
162784046|NCT01130168|587920452|FG004|Period 1|Adverse Event|0|||
162784047|NCT01130168|587920453|FG005|Period 1|Adverse Event|0|||
162784048|NCT02635386|587920454|FG000|Overall Study|Pregnancy|2|||
162784049|NCT02635386|587920455|FG001|Overall Study|Pregnancy|0|||
162784050|NCT02635386|587920456|FG002|Overall Study|Pregnancy|0|||
162784051|NCT02635386|587920457|FG003|Overall Study|Pregnancy|0|||
162784052|NCT02635386|587920458|FG004|Overall Study|Pregnancy|2|||
162784053|NCT02635386|587920454|FG000|Overall Study|Withdrawal by Subject|1|||
162784054|NCT02635386|587920455|FG001|Overall Study|Withdrawal by Subject|1|||
162784055|NCT02635386|587920456|FG002|Overall Study|Withdrawal by Subject|0|||
162784056|NCT02635386|587920457|FG003|Overall Study|Withdrawal by Subject|1|||
162784057|NCT02635386|587920458|FG004|Overall Study|Withdrawal by Subject|0|||
162784058|NCT02635386|587920454|FG000|Overall Study|Physician Decision|0|||
162784059|NCT02635386|587920455|FG001|Overall Study|Physician Decision|1|||
162784060|NCT02635386|587920456|FG002|Overall Study|Physician Decision|0|||
162784061|NCT02635386|587920457|FG003|Overall Study|Physician Decision|0|||
162784062|NCT02635386|587920458|FG004|Overall Study|Physician Decision|0|||
162784063|NCT02635386|587920454|FG000|Overall Study|Moved Out of State|0|||
162784064|NCT02635386|587920455|FG001|Overall Study|Moved Out of State|1|||
162784065|NCT02635386|587920456|FG002|Overall Study|Moved Out of State|0|||
162784066|NCT02635386|587920457|FG003|Overall Study|Moved Out of State|0|||
162784067|NCT02635386|587920458|FG004|Overall Study|Moved Out of State|0|||
162784068|NCT02635386|587920454|FG000|Overall Study|Noncompliant|0|||
162784069|NCT02635386|587920455|FG001|Overall Study|Noncompliant|2|||
162784070|NCT02635386|587920456|FG002|Overall Study|Noncompliant|1|||
162784071|NCT02635386|587920457|FG003|Overall Study|Noncompliant|1|||
162784072|NCT02635386|587920458|FG004|Overall Study|Noncompliant|1|||
162784073|NCT02635386|587920454|FG000|Overall Study|side effects|0|||
162784074|NCT02635386|587920455|FG001|Overall Study|side effects|0|||
162784075|NCT02635386|587920456|FG002|Overall Study|side effects|1|||
162784076|NCT02635386|587920457|FG003|Overall Study|side effects|4|||
162784077|NCT02635386|587920458|FG004|Overall Study|side effects|6|||
162784078|NCT02635386|587920454|FG000|Overall Study|needed other major surgery|0|||
162784079|NCT02635386|587920455|FG001|Overall Study|needed other major surgery|1|||
162784080|NCT02635386|587920456|FG002|Overall Study|needed other major surgery|0|||
162784081|NCT02635386|587920457|FG003|Overall Study|needed other major surgery|0|||
162784082|NCT02635386|587920458|FG004|Overall Study|needed other major surgery|0|||
162784083|NCT02635386|587920454|FG000|Overall Study|Other medical problems not drug related|0|||
162784084|NCT02635386|587920455|FG001|Overall Study|Other medical problems not drug related|0|||
162784085|NCT02635386|587920456|FG002|Overall Study|Other medical problems not drug related|0|||
162784086|NCT02635386|587920457|FG003|Overall Study|Other medical problems not drug related|1|||
162784087|NCT02635386|587920458|FG004|Overall Study|Other medical problems not drug related|0|||
162784088|NCT01781832|587920459|FG000|Overall Study|Withdrawal by Subject|1|||
162784089|NCT00745498|587920460|FG000|Overall Study|Lost to Follow-up|1|||
162784090|NCT00745498|587920461|FG001|Overall Study|Lost to Follow-up|1|||
162784091|NCT00745498|587920462|FG002|Overall Study|Lost to Follow-up|3|||
162784092|NCT00745498|587920460|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
162784093|NCT00745498|587920461|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
162784094|NCT00745498|587920462|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
162784095|NCT00745498|587920460|FG000|Overall Study|Non-PDR related VH|0|||
162784096|NCT00745498|587920461|FG001|Overall Study|Non-PDR related VH|1|||
162784097|NCT00745498|587920462|FG002|Overall Study|Non-PDR related VH|1|||
162784098|NCT00745498|587920460|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
162784099|NCT00745498|587920461|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
162784100|NCT00745498|587920462|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
162784101|NCT02804399|587920465|FG000|Period 2|Adverse Event|0|||
162784102|NCT02804399|587920466|FG001|Period 2|Adverse Event|1|||
162784103|NCT02058836|587920468|FG000|Overall Study|Withdrawal by Subject|1|||
162784104|NCT02058836|587920469|FG001|Overall Study|Withdrawal by Subject|1|||
162784105|NCT00904722|587920471|FG000|Overall Study|Physician Decision|1|||
162784106|NCT03561597|587920472|FG000|Overall Study|Lost to Follow-up|20|||
162784107|NCT00573651|587920473|FG000|Overall Study|Lost to Follow-up|3|||
162784108|NCT00573651|587920473|FG000|Overall Study|Withdrawal by Subject|1|||
162784109|NCT01225159|587920474|FG000|Overall Study|Change operation|1|||
162784110|NCT01225159|587920475|FG001|Overall Study|Change operation|0|||
162784111|NCT01220856|587920480|FG000|Overall Study|graft loss|3|||
162784112|NCT01220856|587920481|FG001|Overall Study|graft loss|3|||
162784113|NCT01220856|587920480|FG000|Overall Study|Lost to Follow-up|1|||
162784114|NCT01220856|587920481|FG001|Overall Study|Lost to Follow-up|0|||
162784115|NCT04814992|587920482|FG000|Overall Study|Withdrawal by Subject|6|||
162784116|NCT04814992|587920483|FG001|Overall Study|Withdrawal by Subject|3|||
162784117|NCT04814992|587920482|FG000|Overall Study|Lost to Follow-up|1|||
162784118|NCT04814992|587920483|FG001|Overall Study|Lost to Follow-up|4|||
162784119|NCT00691678|587920484|FG000|Overall Study|Adverse Event|5|||
162784120|NCT00691678|587920484|FG000|Overall Study|life events, pain|11|||
162784121|NCT05347485|587920488|FG000|Overall Study|Death|14|||
162784122|NCT05347485|587920488|FG000|Overall Study|Lost to Follow-up|2|||
162784123|NCT05347485|587920488|FG000|Overall Study|Withdrawal by Subject|13|||
162784124|NCT05347485|587920488|FG000|Overall Study|Progressive Disease|1|||
162784125|NCT05347485|587920488|FG000|Overall Study|Study Terminated by Sponsor|49|||
162784126|NCT05347485|587920488|FG000|Overall Study|Other|1|||
162784127|NCT05347485|587920488|FG000|Overall Study|Enrolled (consented) but not treated|4|||
162784128|NCT05347485|587920488|FG000|Overall Study|Disease Relapse|2|||
162784129|NCT05896696|587920489|FG000|Overall Study|Screening Failure|7|||
162784130|NCT05896696|587920489|FG000|Overall Study|Withdrawal by Subject|2|||
162810525|NCT00762970|588018251|FG001|Overall Study|Difficulty of handling lens|2|||
162810526|NCT00762970|588018252|FG002|Overall Study|Difficulty of handling lens|0|||
162810527|NCT02901041|588018253|FG000|Overall Study|Withdrawal by PI|4|||
162810528|NCT02901041|588018254|FG001|Overall Study|Withdrawal by PI|8|||
162810529|NCT02901041|588018253|FG000|Overall Study|Withdrawal by Subject|7|||
162810530|NCT02901041|588018254|FG001|Overall Study|Withdrawal by Subject|3|||
162810531|NCT01480674|588018255|FG000|Overall Study|Death|23|||
162810532|NCT01480674|588018255|FG000|Overall Study|Lost to Follow-up|2|||
162810533|NCT01480674|588018255|FG000|Overall Study|visit not done|10|||
162810534|NCT03818204|588018256|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810535|NCT03818204|588018257|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810536|NCT03818204|588018258|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810537|NCT03818204|588018259|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810538|NCT03818204|588018260|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
162810539|NCT03818204|588018261|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810540|NCT03818204|588018262|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810541|NCT03818204|588018263|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810542|NCT03818204|588018264|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810543|NCT03818204|588018265|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810544|NCT03818204|588018266|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810545|NCT03818204|588018267|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810546|NCT03818204|588018268|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810547|NCT03818204|588018269|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
162810548|NCT03818204|588018270|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810549|NCT03818204|588018271|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810550|NCT03818204|588018272|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810551|NCT03818204|588018273|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810552|NCT03818204|588018274|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162810553|NCT03818204|588018256|FG000|Overall Study|Physician Decision|0|||
162810554|NCT03818204|588018257|FG001|Overall Study|Physician Decision|0|||
162810555|NCT03818204|588018258|FG002|Overall Study|Physician Decision|0|||
162810556|NCT03818204|588018259|FG003|Overall Study|Physician Decision|0|||
162810557|NCT03818204|588018260|FG004|Overall Study|Physician Decision|0|||
162810558|NCT03818204|588018261|FG005|Overall Study|Physician Decision|0|||
162810559|NCT03818204|588018262|FG006|Overall Study|Physician Decision|0|||
162810560|NCT03818204|588018263|FG007|Overall Study|Physician Decision|0|||
162810561|NCT03818204|588018264|FG008|Overall Study|Physician Decision|0|||
162810562|NCT03818204|588018265|FG009|Overall Study|Physician Decision|0|||
162810563|NCT03818204|588018266|FG010|Overall Study|Physician Decision|0|||
162810564|NCT03818204|588018267|FG011|Overall Study|Physician Decision|0|||
162810565|NCT03818204|588018268|FG012|Overall Study|Physician Decision|0|||
162810566|NCT03818204|588018269|FG013|Overall Study|Physician Decision|0|||
162810567|NCT03818204|588018270|FG014|Overall Study|Physician Decision|1|||
162810568|NCT03818204|588018271|FG015|Overall Study|Physician Decision|0|||
162810569|NCT03818204|588018272|FG016|Overall Study|Physician Decision|0|||
162810570|NCT03818204|588018273|FG017|Overall Study|Physician Decision|0|||
162784131|NCT00903760|587922399|FG000|Overall Study|Disease Progression/Death|8|||
162784132|NCT00903760|587922400|FG001|Overall Study|Disease Progression/Death|6|||
162784133|NCT00903760|587922399|FG000|Overall Study|Stem Cell Transplant|8|||
162784134|NCT00903760|587922400|FG001|Overall Study|Stem Cell Transplant|4|||
162784135|NCT00903760|587922399|FG000|Overall Study|Physician Decision|1|||
162784136|NCT00903760|587922400|FG001|Overall Study|Physician Decision|2|||
162784137|NCT00903760|587922399|FG000|Overall Study|Death|0|||
162784138|NCT00903760|587922400|FG001|Overall Study|Death|1|||
162784139|NCT00903760|587922399|FG000|Overall Study|Lost to Follow-up|1|||
162784140|NCT00903760|587922400|FG001|Overall Study|Lost to Follow-up|0|||
162784141|NCT00903760|587922399|FG000|Overall Study|Withdrawal by Subject|1|||
162784142|NCT00903760|587922400|FG001|Overall Study|Withdrawal by Subject|2|||
162784143|NCT00903760|587922399|FG000|Overall Study|Off treatment for long period|0|||
162784144|NCT00903760|587922400|FG001|Overall Study|Off treatment for long period|1|||
162784145|NCT01638390|587922402|FG000|Overall Study|screening failures|21|||
162784146|NCT01536587|587922405|FG000|Overall Study|Adverse Event|2|||
162784147|NCT02666664|587922406|FG000|Overall Study|Physician Decision|0|||
162784148|NCT02666664|587922407|FG001|Overall Study|Physician Decision|1|||
162784149|NCT02666664|587922406|FG000|Overall Study|Protocol Violation|0|||
162784150|NCT02666664|587922407|FG001|Overall Study|Protocol Violation|2|||
162784151|NCT02666664|587922406|FG000|Overall Study|Other|0|||
162784152|NCT02666664|587922407|FG001|Overall Study|Other|1|||
162784153|NCT02666664|587922406|FG000|Overall Study|Adverse Event|12|||
162784154|NCT02666664|587922407|FG001|Overall Study|Adverse Event|37|||
162784155|NCT02666664|587922406|FG000|Overall Study|Withdrawal by participant|23|||
162784156|NCT02666664|587922407|FG001|Overall Study|Withdrawal by participant|40|||
162784157|NCT02666664|587922406|FG000|Overall Study|Sponsor decision|0|||
162784158|NCT02666664|587922407|FG001|Overall Study|Sponsor decision|1|||
162784159|NCT02666664|587922406|FG000|Overall Study|Lost to Follow-up|1|||
162784160|NCT02666664|587922407|FG001|Overall Study|Lost to Follow-up|2|||
162784161|NCT03210519|587922408|FG000|Overall Study|Adverse Event|2|||
162784162|NCT03210519|587922409|FG001|Overall Study|Adverse Event|0|||
162784163|NCT03865953|587922424|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
162784164|NCT03865953|587922425|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162784165|NCT03865953|587922424|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
162784166|NCT03865953|587922425|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
162784167|NCT03865953|587922424|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
162784168|NCT03865953|587922425|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
162784169|NCT00412880|587922426|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
162784170|NCT00412880|587922426|FG000|Overall Study|Consent withdrawn|1|||
162784171|NCT00412880|587922426|FG000|Overall Study|Adverse Event|1|||
162784172|NCT00412880|587922426|FG000|Overall Study|Progressive disease|20|||
162784173|NCT02232399|587922427|FG000|Overall Study|Adverse Event|1|||
162784174|NCT02232399|587922428|FG001|Overall Study|Adverse Event|0|||
162784175|NCT02232399|587922427|FG000|Overall Study|Withdrawal by Subject|0|||
162784176|NCT02232399|587922428|FG001|Overall Study|Withdrawal by Subject|1|||
162784177|NCT01162135|587922436|FG000|Overall Study|Withdrawal by Subject|1|||
162784178|NCT01162135|587922436|FG000|Overall Study|Severe back pain|1|||
162784179|NCT01162135|587922436|FG000|Overall Study|Ineligible|1|||
162784180|NCT01777334|587922437|FG000|Overall Study|Adverse Event|18|||
162784181|NCT01777334|587922438|FG001|Overall Study|Adverse Event|14|||
162784182|NCT01777334|587922437|FG000|Overall Study|Lack of Efficacy|15|||
162784183|NCT01777334|587922438|FG001|Overall Study|Lack of Efficacy|29|||
162784184|NCT01777334|587922437|FG000|Overall Study|Protocol Violation|3|||
162784185|NCT01777334|587922438|FG001|Overall Study|Protocol Violation|7|||
162784186|NCT01777334|587922437|FG000|Overall Study|Lost to Follow-up|3|||
162784187|NCT01777334|587922438|FG001|Overall Study|Lost to Follow-up|2|||
162784188|NCT01777334|587922437|FG000|Overall Study|Withdrawal by Subject|14|||
162784189|NCT01777334|587922438|FG001|Overall Study|Withdrawal by Subject|11|||
162784190|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
162784191|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
162784192|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
162784193|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
162784194|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
162784195|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
162784196|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
162784197|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
162784198|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
162784199|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
162784200|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
162784201|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
162784202|NCT01216072|587922446|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
162784203|NCT01216072|587922447|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
162784204|NCT01216072|587922446|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
162784205|NCT01216072|587922447|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
162784206|NCT01216072|587922446|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
162784207|NCT01216072|587922447|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
162784208|NCT01216072|587922446|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
162784209|NCT01216072|587922447|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
162784210|NCT04799418|587922451|FG000|Overall Study|Death|1|||
162784211|NCT04799418|587922452|FG001|Overall Study|Death|1|||
162784212|NCT04799418|587922451|FG000|Overall Study|Lack of Efficacy|14|||
162784213|NCT04799418|587922452|FG001|Overall Study|Lack of Efficacy|14|||
162784214|NCT04799418|587922451|FG000|Overall Study|Withdrawal by Subject|10|||
162784215|NCT04799418|587922452|FG001|Overall Study|Withdrawal by Subject|7|||
162784216|NCT04799418|587922451|FG000|Overall Study|Adverse Event|3|||
162784217|NCT04799418|587922452|FG001|Overall Study|Adverse Event|2|||
162784218|NCT00107978|587922455|FG000|Overall Study|Adverse Event|1|||
162784219|NCT00107978|587922456|FG001|Overall Study|Adverse Event|5|||
162784220|NCT00107978|587922455|FG000|Overall Study|Death|3|||
162784221|NCT00107978|587922456|FG001|Overall Study|Death|3|||
162784222|NCT00107978|587922455|FG000|Overall Study|Lost to Follow-up|20|||
162784223|NCT00107978|587922456|FG001|Overall Study|Lost to Follow-up|28|||
162784224|NCT00107978|587922455|FG000|Overall Study|Withdrawal by Subject|4|||
162784225|NCT00107978|587922456|FG001|Overall Study|Withdrawal by Subject|9|||
162784226|NCT00107978|587922455|FG000|Overall Study|Protocol Violation|0|||
162784227|NCT00107978|587922456|FG001|Overall Study|Protocol Violation|1|||
162784228|NCT00107978|587922455|FG000|Overall Study|Other|5|||
162784229|NCT00107978|587922456|FG001|Overall Study|Other|4|||
162784230|NCT02669407|587922457|FG000|Overall Study|Physician Decision|3|||
162784231|NCT00822770|587922459|FG000|Overall Study|Not treated|1|||
162784232|NCT00822770|587922460|FG001|Overall Study|Not treated|0|||
162784233|NCT00822770|587922459|FG000|Overall Study|Complication/Incomplete treatment|1|||
162784234|NCT00822770|587922460|FG001|Overall Study|Complication/Incomplete treatment|0|||
162784235|NCT00822770|587922459|FG000|Overall Study|Death|1|||
162784236|NCT00822770|587922460|FG001|Overall Study|Death|1|||
162784237|NCT01296555|587922461|FG000|Overall Study|Adverse Event|0|||
162784238|NCT01296555|587922462|FG001|Overall Study|Adverse Event|0|||
162784239|NCT01296555|587922463|FG002|Overall Study|Adverse Event|1|||
162784240|NCT01296555|587922464|FG003|Overall Study|Adverse Event|1|||
162784241|NCT01296555|587922465|FG004|Overall Study|Adverse Event|2|||
162784242|NCT01296555|587922466|FG005|Overall Study|Adverse Event|4|||
162784243|NCT01296555|587922467|FG006|Overall Study|Adverse Event|1|||
162784244|NCT01296555|587922468|FG007|Overall Study|Adverse Event|4|||
162784245|NCT01296555|587922469|FG008|Overall Study|Adverse Event|3|||
162784246|NCT01296555|587922470|FG009|Overall Study|Adverse Event|1|||
162784247|NCT01296555|587922471|FG010|Overall Study|Adverse Event|0|||
162784248|NCT01296555|587922472|FG011|Overall Study|Adverse Event|4|||
162784249|NCT01296555|587922473|FG012|Overall Study|Adverse Event|1|||
162784250|NCT01296555|587922474|FG013|Overall Study|Adverse Event|4|||
162784251|NCT01296555|587922475|FG014|Overall Study|Adverse Event|0|||
162784252|NCT01296555|587922476|FG015|Overall Study|Adverse Event|0|||
162784253|NCT01296555|587922477|FG016|Overall Study|Adverse Event|0|||
162784254|NCT01296555|587922478|FG017|Overall Study|Adverse Event|0|||
162784255|NCT01296555|587922479|FG018|Overall Study|Adverse Event|0|||
162784256|NCT01296555|587922480|FG019|Overall Study|Adverse Event|1|||
162784257|NCT01296555|587922481|FG020|Overall Study|Adverse Event|0|||
162784258|NCT01296555|587922482|FG021|Overall Study|Adverse Event|0|||
162784259|NCT01296555|587922483|FG022|Overall Study|Adverse Event|0|||
162784260|NCT01296555|587922484|FG023|Overall Study|Adverse Event|0|||
162784261|NCT01296555|587922485|FG024|Overall Study|Adverse Event|0|||
162784262|NCT01296555|587922486|FG025|Overall Study|Adverse Event|0|||
162784263|NCT01296555|587922487|FG026|Overall Study|Adverse Event|0|||
162784264|NCT01296555|587922488|FG027|Overall Study|Adverse Event|0|||
162784265|NCT01296555|587922489|FG028|Overall Study|Adverse Event|0|||
162784266|NCT01296555|587922461|FG000|Overall Study|Reason Not Specified|0|||
162784267|NCT01296555|587922462|FG001|Overall Study|Reason Not Specified|0|||
162784268|NCT01296555|587922463|FG002|Overall Study|Reason Not Specified|0|||
162784269|NCT01296555|587922464|FG003|Overall Study|Reason Not Specified|0|||
162784270|NCT01296555|587922465|FG004|Overall Study|Reason Not Specified|0|||
162784271|NCT01296555|587922466|FG005|Overall Study|Reason Not Specified|0|||
162784272|NCT01296555|587922467|FG006|Overall Study|Reason Not Specified|0|||
162784273|NCT01296555|587922468|FG007|Overall Study|Reason Not Specified|0|||
162784274|NCT01296555|587922469|FG008|Overall Study|Reason Not Specified|0|||
162784275|NCT01296555|587922470|FG009|Overall Study|Reason Not Specified|0|||
162784276|NCT01296555|587922471|FG010|Overall Study|Reason Not Specified|0|||
162784277|NCT01296555|587922472|FG011|Overall Study|Reason Not Specified|0|||
162784278|NCT01296555|587922473|FG012|Overall Study|Reason Not Specified|0|||
162784279|NCT01296555|587922474|FG013|Overall Study|Reason Not Specified|1|||
162784280|NCT01296555|587922475|FG014|Overall Study|Reason Not Specified|2|||
162784281|NCT01296555|587922476|FG015|Overall Study|Reason Not Specified|3|||
162784282|NCT01296555|587922477|FG016|Overall Study|Reason Not Specified|7|||
162784283|NCT01296555|587922478|FG017|Overall Study|Reason Not Specified|4|||
162784284|NCT01296555|587922479|FG018|Overall Study|Reason Not Specified|3|||
162784285|NCT01296555|587922480|FG019|Overall Study|Reason Not Specified|7|||
162784286|NCT01296555|587922481|FG020|Overall Study|Reason Not Specified|11|||
162784287|NCT01296555|587922482|FG021|Overall Study|Reason Not Specified|5|||
162784288|NCT01296555|587922483|FG022|Overall Study|Reason Not Specified|5|||
162784289|NCT01296555|587922484|FG023|Overall Study|Reason Not Specified|7|||
162784290|NCT01296555|587922485|FG024|Overall Study|Reason Not Specified|2|||
162784291|NCT01296555|587922486|FG025|Overall Study|Reason Not Specified|2|||
162784292|NCT01296555|587922487|FG026|Overall Study|Reason Not Specified|19|||
162784293|NCT01296555|587922488|FG027|Overall Study|Reason Not Specified|11|||
162784294|NCT01296555|587922489|FG028|Overall Study|Reason Not Specified|9|||
162784295|NCT01296555|587922461|FG000|Overall Study|Physician Decision|0|||
162784296|NCT01296555|587922462|FG001|Overall Study|Physician Decision|0|||
162784297|NCT01296555|587922463|FG002|Overall Study|Physician Decision|0|||
162784298|NCT01296555|587922464|FG003|Overall Study|Physician Decision|0|||
162784299|NCT01296555|587922465|FG004|Overall Study|Physician Decision|1|||
162784300|NCT01296555|587922466|FG005|Overall Study|Physician Decision|0|||
162784301|NCT01296555|587922467|FG006|Overall Study|Physician Decision|0|||
162784302|NCT01296555|587922468|FG007|Overall Study|Physician Decision|0|||
162784303|NCT01296555|587922469|FG008|Overall Study|Physician Decision|0|||
162784304|NCT01296555|587922470|FG009|Overall Study|Physician Decision|0|||
162784305|NCT01296555|587922471|FG010|Overall Study|Physician Decision|0|||
162784306|NCT01296555|587922472|FG011|Overall Study|Physician Decision|0|||
162784307|NCT01296555|587922473|FG012|Overall Study|Physician Decision|0|||
162784308|NCT01296555|587922474|FG013|Overall Study|Physician Decision|1|||
162784309|NCT01296555|587922475|FG014|Overall Study|Physician Decision|0|||
162784310|NCT01296555|587922476|FG015|Overall Study|Physician Decision|0|||
162784311|NCT01296555|587922477|FG016|Overall Study|Physician Decision|0|||
162784312|NCT01296555|587922478|FG017|Overall Study|Physician Decision|0|||
162784313|NCT01296555|587922479|FG018|Overall Study|Physician Decision|0|||
162784314|NCT01296555|587922480|FG019|Overall Study|Physician Decision|1|||
162784315|NCT01296555|587922481|FG020|Overall Study|Physician Decision|0|||
162784316|NCT01296555|587922482|FG021|Overall Study|Physician Decision|0|||
162784317|NCT01296555|587922483|FG022|Overall Study|Physician Decision|0|||
162784318|NCT01296555|587922484|FG023|Overall Study|Physician Decision|0|||
162784319|NCT01296555|587922485|FG024|Overall Study|Physician Decision|0|||
162784320|NCT01296555|587922486|FG025|Overall Study|Physician Decision|0|||
162784321|NCT01296555|587922487|FG026|Overall Study|Physician Decision|0|||
162784322|NCT01296555|587922488|FG027|Overall Study|Physician Decision|0|||
162784323|NCT01296555|587922489|FG028|Overall Study|Physician Decision|0|||
162784324|NCT01296555|587922461|FG000|Overall Study|Progressive Disease|6|||
162784325|NCT01296555|587922462|FG001|Overall Study|Progressive Disease|3|||
162784326|NCT01296555|587922463|FG002|Overall Study|Progressive Disease|3|||
162784327|NCT01296555|587922464|FG003|Overall Study|Progressive Disease|7|||
162784328|NCT01296555|587922465|FG004|Overall Study|Progressive Disease|6|||
162784329|NCT01296555|587922466|FG005|Overall Study|Progressive Disease|16|||
162784330|NCT01296555|587922467|FG006|Overall Study|Progressive Disease|16|||
162784331|NCT01296555|587922468|FG007|Overall Study|Progressive Disease|8|||
162784332|NCT01296555|587922469|FG008|Overall Study|Progressive Disease|7|||
162784333|NCT01296555|587922470|FG009|Overall Study|Progressive Disease|18|||
162784334|NCT01296555|587922471|FG010|Overall Study|Progressive Disease|7|||
162784335|NCT01296555|587922472|FG011|Overall Study|Progressive Disease|14|||
162784336|NCT01296555|587922473|FG012|Overall Study|Progressive Disease|5|||
162784337|NCT01296555|587922474|FG013|Overall Study|Progressive Disease|12|||
162784338|NCT01296555|587922475|FG014|Overall Study|Progressive Disease|1|||
162784339|NCT01296555|587922476|FG015|Overall Study|Progressive Disease|1|||
162784340|NCT01296555|587922477|FG016|Overall Study|Progressive Disease|0|||
162784341|NCT01296555|587922478|FG017|Overall Study|Progressive Disease|0|||
162784342|NCT01296555|587922479|FG018|Overall Study|Progressive Disease|0|||
162784343|NCT01296555|587922480|FG019|Overall Study|Progressive Disease|1|||
162784344|NCT01296555|587922481|FG020|Overall Study|Progressive Disease|0|||
162784345|NCT01296555|587922482|FG021|Overall Study|Progressive Disease|0|||
162784346|NCT01296555|587922483|FG022|Overall Study|Progressive Disease|0|||
162784347|NCT01296555|587922484|FG023|Overall Study|Progressive Disease|0|||
162784348|NCT01296555|587922485|FG024|Overall Study|Progressive Disease|1|||
162784349|NCT01296555|587922486|FG025|Overall Study|Progressive Disease|0|||
162784350|NCT01296555|587922487|FG026|Overall Study|Progressive Disease|5|||
162784351|NCT01296555|587922488|FG027|Overall Study|Progressive Disease|1|||
162784352|NCT01296555|587922489|FG028|Overall Study|Progressive Disease|0|||
162784353|NCT01296555|587922461|FG000|Overall Study|Protocol Violation|0|||
162784354|NCT01296555|587922462|FG001|Overall Study|Protocol Violation|0|||
162784355|NCT01296555|587922463|FG002|Overall Study|Protocol Violation|0|||
162784356|NCT01296555|587922464|FG003|Overall Study|Protocol Violation|0|||
162784357|NCT01296555|587922465|FG004|Overall Study|Protocol Violation|0|||
162784358|NCT01296555|587922466|FG005|Overall Study|Protocol Violation|0|||
162784359|NCT01296555|587922467|FG006|Overall Study|Protocol Violation|0|||
162784360|NCT01296555|587922468|FG007|Overall Study|Protocol Violation|0|||
162784361|NCT01296555|587922469|FG008|Overall Study|Protocol Violation|0|||
162784362|NCT01296555|587922470|FG009|Overall Study|Protocol Violation|0|||
162784363|NCT01296555|587922471|FG010|Overall Study|Protocol Violation|0|||
162784364|NCT01296555|587922472|FG011|Overall Study|Protocol Violation|0|||
162784365|NCT01296555|587922473|FG012|Overall Study|Protocol Violation|0|||
162784366|NCT01296555|587922474|FG013|Overall Study|Protocol Violation|1|||
162784367|NCT01296555|587922475|FG014|Overall Study|Protocol Violation|0|||
162784368|NCT01296555|587922476|FG015|Overall Study|Protocol Violation|0|||
162784369|NCT01296555|587922477|FG016|Overall Study|Protocol Violation|0|||
162784370|NCT01296555|587922478|FG017|Overall Study|Protocol Violation|0|||
162784371|NCT01296555|587922479|FG018|Overall Study|Protocol Violation|0|||
162784372|NCT01296555|587922480|FG019|Overall Study|Protocol Violation|0|||
162784373|NCT01296555|587922481|FG020|Overall Study|Protocol Violation|0|||
162784374|NCT01296555|587922482|FG021|Overall Study|Protocol Violation|0|||
162784375|NCT01296555|587922483|FG022|Overall Study|Protocol Violation|0|||
162784376|NCT01296555|587922484|FG023|Overall Study|Protocol Violation|0|||
162784377|NCT01296555|587922485|FG024|Overall Study|Protocol Violation|0|||
162784378|NCT01296555|587922486|FG025|Overall Study|Protocol Violation|0|||
162784379|NCT01296555|587922487|FG026|Overall Study|Protocol Violation|0|||
162784380|NCT01296555|587922488|FG027|Overall Study|Protocol Violation|0|||
162784381|NCT01296555|587922489|FG028|Overall Study|Protocol Violation|0|||
162784382|NCT01296555|587922461|FG000|Overall Study|Study Terminated By Sponsor|0|||
162784383|NCT01296555|587922462|FG001|Overall Study|Study Terminated By Sponsor|0|||
162784384|NCT01296555|587922463|FG002|Overall Study|Study Terminated By Sponsor|0|||
162784385|NCT01296555|587922464|FG003|Overall Study|Study Terminated By Sponsor|0|||
162784386|NCT01296555|587922465|FG004|Overall Study|Study Terminated By Sponsor|0|||
162784387|NCT01296555|587922466|FG005|Overall Study|Study Terminated By Sponsor|0|||
162784388|NCT01296555|587922467|FG006|Overall Study|Study Terminated By Sponsor|0|||
162784389|NCT01296555|587922468|FG007|Overall Study|Study Terminated By Sponsor|0|||
162784390|NCT01296555|587922469|FG008|Overall Study|Study Terminated By Sponsor|0|||
162784391|NCT01296555|587922470|FG009|Overall Study|Study Terminated By Sponsor|0|||
162784392|NCT01296555|587922471|FG010|Overall Study|Study Terminated By Sponsor|0|||
162784393|NCT01296555|587922472|FG011|Overall Study|Study Terminated By Sponsor|0|||
162784394|NCT01296555|587922473|FG012|Overall Study|Study Terminated By Sponsor|0|||
162784395|NCT01296555|587922474|FG013|Overall Study|Study Terminated By Sponsor|0|||
162784396|NCT01296555|587922475|FG014|Overall Study|Study Terminated By Sponsor|0|||
162784397|NCT01296555|587922476|FG015|Overall Study|Study Terminated By Sponsor|0|||
162784398|NCT01296555|587922477|FG016|Overall Study|Study Terminated By Sponsor|0|||
162784399|NCT01296555|587922478|FG017|Overall Study|Study Terminated By Sponsor|0|||
162784400|NCT01296555|587922479|FG018|Overall Study|Study Terminated By Sponsor|0|||
162784401|NCT01296555|587922480|FG019|Overall Study|Study Terminated By Sponsor|0|||
162784402|NCT01296555|587922481|FG020|Overall Study|Study Terminated By Sponsor|0|||
162784403|NCT01296555|587922482|FG021|Overall Study|Study Terminated By Sponsor|0|||
162784404|NCT01296555|587922483|FG022|Overall Study|Study Terminated By Sponsor|0|||
162784405|NCT01296555|587922484|FG023|Overall Study|Study Terminated By Sponsor|0|||
162784406|NCT01296555|587922485|FG024|Overall Study|Study Terminated By Sponsor|0|||
162784407|NCT01296555|587922486|FG025|Overall Study|Study Terminated By Sponsor|1|||
162784408|NCT01296555|587922487|FG026|Overall Study|Study Terminated By Sponsor|0|||
162784409|NCT01296555|587922488|FG027|Overall Study|Study Terminated By Sponsor|0|||
162784410|NCT01296555|587922489|FG028|Overall Study|Study Terminated By Sponsor|0|||
162784411|NCT01296555|587922461|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784412|NCT01296555|587922462|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784413|NCT01296555|587922463|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784414|NCT01296555|587922464|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784415|NCT01296555|587922465|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784416|NCT01296555|587922466|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784417|NCT01296555|587922467|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784418|NCT01296555|587922468|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784419|NCT01296555|587922469|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784420|NCT01296555|587922470|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784421|NCT01296555|587922471|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784422|NCT01296555|587922472|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784423|NCT01296555|587922473|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784424|NCT01296555|587922474|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784425|NCT01296555|587922475|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784426|NCT01296555|587922476|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784427|NCT01296555|587922477|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784428|NCT01296555|587922478|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784429|NCT01296555|587922479|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784430|NCT01296555|587922480|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
162784431|NCT01296555|587922481|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784432|NCT01296555|587922482|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784433|NCT01296555|587922483|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784434|NCT01296555|587922484|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784435|NCT01296555|587922485|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784436|NCT01296555|587922486|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784437|NCT01296555|587922487|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162810571|NCT03818204|588018274|FG018|Overall Study|Physician Decision|0|||
162784438|NCT01296555|587922488|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784439|NCT01296555|587922489|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162784440|NCT01296555|587922461|FG000|Overall Study|Death|0|||
162784441|NCT01296555|587922462|FG001|Overall Study|Death|0|||
162784442|NCT01296555|587922463|FG002|Overall Study|Death|0|||
162784443|NCT01296555|587922464|FG003|Overall Study|Death|2|||
162784444|NCT01296555|587922465|FG004|Overall Study|Death|1|||
162784445|NCT01296555|587922466|FG005|Overall Study|Death|0|||
162784446|NCT01296555|587922467|FG006|Overall Study|Death|2|||
162784447|NCT01296555|587922468|FG007|Overall Study|Death|0|||
162784448|NCT01296555|587922469|FG008|Overall Study|Death|0|||
162784449|NCT01296555|587922470|FG009|Overall Study|Death|1|||
162784450|NCT01296555|587922471|FG010|Overall Study|Death|0|||
162784451|NCT01296555|587922472|FG011|Overall Study|Death|1|||
162784452|NCT01296555|587922473|FG012|Overall Study|Death|0|||
162784453|NCT01296555|587922474|FG013|Overall Study|Death|2|||
162784454|NCT01296555|587922475|FG014|Overall Study|Death|27|||
162784455|NCT01296555|587922476|FG015|Overall Study|Death|15|||
162784456|NCT01296555|587922477|FG016|Overall Study|Death|11|||
162784457|NCT01296555|587922478|FG017|Overall Study|Death|11|||
162784458|NCT01296555|587922479|FG018|Overall Study|Death|17|||
162784459|NCT01296555|587922480|FG019|Overall Study|Death|12|||
162784460|NCT01296555|587922481|FG020|Overall Study|Death|13|||
162784461|NCT01296555|587922482|FG021|Overall Study|Death|12|||
162784462|NCT01296555|587922483|FG022|Overall Study|Death|12|||
162784463|NCT01296555|587922484|FG023|Overall Study|Death|13|||
162784464|NCT01296555|587922485|FG024|Overall Study|Death|7|||
162784465|NCT01296555|587922486|FG025|Overall Study|Death|7|||
162784466|NCT01296555|587922487|FG026|Overall Study|Death|35|||
162784467|NCT01296555|587922488|FG027|Overall Study|Death|92|||
162784468|NCT01296555|587922489|FG028|Overall Study|Death|44|||
162784469|NCT01296555|587922461|FG000|Overall Study|Lost to Follow-up|0|||
162784470|NCT01296555|587922462|FG001|Overall Study|Lost to Follow-up|0|||
162784471|NCT01296555|587922463|FG002|Overall Study|Lost to Follow-up|0|||
162784472|NCT01296555|587922464|FG003|Overall Study|Lost to Follow-up|0|||
162784473|NCT01296555|587922465|FG004|Overall Study|Lost to Follow-up|0|||
162784474|NCT01296555|587922466|FG005|Overall Study|Lost to Follow-up|0|||
162784475|NCT01296555|587922467|FG006|Overall Study|Lost to Follow-up|0|||
162784476|NCT01296555|587922468|FG007|Overall Study|Lost to Follow-up|0|||
162784477|NCT01296555|587922469|FG008|Overall Study|Lost to Follow-up|0|||
162784478|NCT01296555|587922470|FG009|Overall Study|Lost to Follow-up|0|||
162784479|NCT01296555|587922471|FG010|Overall Study|Lost to Follow-up|0|||
162784480|NCT01296555|587922472|FG011|Overall Study|Lost to Follow-up|0|||
162784481|NCT01296555|587922473|FG012|Overall Study|Lost to Follow-up|0|||
162784482|NCT01296555|587922474|FG013|Overall Study|Lost to Follow-up|0|||
162784483|NCT01296555|587922475|FG014|Overall Study|Lost to Follow-up|2|||
162784484|NCT01296555|587922476|FG015|Overall Study|Lost to Follow-up|1|||
162784485|NCT01296555|587922477|FG016|Overall Study|Lost to Follow-up|0|||
162784486|NCT01296555|587922478|FG017|Overall Study|Lost to Follow-up|2|||
162784487|NCT01296555|587922479|FG018|Overall Study|Lost to Follow-up|0|||
162784488|NCT01296555|587922480|FG019|Overall Study|Lost to Follow-up|2|||
162784489|NCT01296555|587922481|FG020|Overall Study|Lost to Follow-up|3|||
162784490|NCT01296555|587922482|FG021|Overall Study|Lost to Follow-up|2|||
162784491|NCT01296555|587922483|FG022|Overall Study|Lost to Follow-up|0|||
162784492|NCT01296555|587922484|FG023|Overall Study|Lost to Follow-up|0|||
162784493|NCT01296555|587922485|FG024|Overall Study|Lost to Follow-up|0|||
162784494|NCT01296555|587922486|FG025|Overall Study|Lost to Follow-up|0|||
162784495|NCT01296555|587922487|FG026|Overall Study|Lost to Follow-up|3|||
162784496|NCT01296555|587922488|FG027|Overall Study|Lost to Follow-up|13|||
162784497|NCT01296555|587922489|FG028|Overall Study|Lost to Follow-up|5|||
162784498|NCT01296555|587922461|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162784499|NCT01296555|587922462|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162784500|NCT01296555|587922463|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162784501|NCT01296555|587922464|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162784502|NCT01296555|587922465|FG004|Overall Study|Non-Compliance With Study Drug|0|||
162784503|NCT01296555|587922466|FG005|Overall Study|Non-Compliance With Study Drug|0|||
162784504|NCT01296555|587922467|FG006|Overall Study|Non-Compliance With Study Drug|0|||
162784505|NCT01296555|587922468|FG007|Overall Study|Non-Compliance With Study Drug|1|||
162784506|NCT01296555|587922469|FG008|Overall Study|Non-Compliance With Study Drug|0|||
162784507|NCT01296555|587922470|FG009|Overall Study|Non-Compliance With Study Drug|0|||
162784508|NCT01296555|587922471|FG010|Overall Study|Non-Compliance With Study Drug|0|||
162784509|NCT01296555|587922472|FG011|Overall Study|Non-Compliance With Study Drug|0|||
162784510|NCT01296555|587922473|FG012|Overall Study|Non-Compliance With Study Drug|0|||
162784511|NCT01296555|587922474|FG013|Overall Study|Non-Compliance With Study Drug|0|||
162784512|NCT01296555|587922475|FG014|Overall Study|Non-Compliance With Study Drug|0|||
162784513|NCT01296555|587922476|FG015|Overall Study|Non-Compliance With Study Drug|0|||
162784514|NCT01296555|587922477|FG016|Overall Study|Non-Compliance With Study Drug|0|||
162784515|NCT01296555|587922478|FG017|Overall Study|Non-Compliance With Study Drug|0|||
162784516|NCT01296555|587922479|FG018|Overall Study|Non-Compliance With Study Drug|0|||
162784517|NCT01296555|587922480|FG019|Overall Study|Non-Compliance With Study Drug|0|||
162784518|NCT01296555|587922481|FG020|Overall Study|Non-Compliance With Study Drug|0|||
162784519|NCT01296555|587922482|FG021|Overall Study|Non-Compliance With Study Drug|0|||
162784520|NCT01296555|587922483|FG022|Overall Study|Non-Compliance With Study Drug|0|||
162784521|NCT01296555|587922484|FG023|Overall Study|Non-Compliance With Study Drug|0|||
162784522|NCT01296555|587922485|FG024|Overall Study|Non-Compliance With Study Drug|0|||
162784523|NCT01296555|587922486|FG025|Overall Study|Non-Compliance With Study Drug|0|||
162784524|NCT01296555|587922487|FG026|Overall Study|Non-Compliance With Study Drug|0|||
162784525|NCT01296555|587922488|FG027|Overall Study|Non-Compliance With Study Drug|0|||
162784526|NCT01296555|587922489|FG028|Overall Study|Non-Compliance With Study Drug|0|||
162784527|NCT01296555|587922461|FG000|Overall Study|Withdrawal by Subject|0|||
162784528|NCT01296555|587922462|FG001|Overall Study|Withdrawal by Subject|0|||
162784529|NCT01296555|587922463|FG002|Overall Study|Withdrawal by Subject|0|||
162784530|NCT01296555|587922464|FG003|Overall Study|Withdrawal by Subject|0|||
162784531|NCT01296555|587922465|FG004|Overall Study|Withdrawal by Subject|1|||
162784532|NCT01296555|587922466|FG005|Overall Study|Withdrawal by Subject|0|||
162784533|NCT01296555|587922467|FG006|Overall Study|Withdrawal by Subject|1|||
162784534|NCT01296555|587922468|FG007|Overall Study|Withdrawal by Subject|0|||
162784535|NCT01296555|587922469|FG008|Overall Study|Withdrawal by Subject|0|||
162784536|NCT01296555|587922470|FG009|Overall Study|Withdrawal by Subject|0|||
162784537|NCT01296555|587922471|FG010|Overall Study|Withdrawal by Subject|1|||
162784538|NCT01296555|587922472|FG011|Overall Study|Withdrawal by Subject|1|||
162784539|NCT01296555|587922473|FG012|Overall Study|Withdrawal by Subject|0|||
162784540|NCT01296555|587922474|FG013|Overall Study|Withdrawal by Subject|0|||
162784541|NCT01296555|587922475|FG014|Overall Study|Withdrawal by Subject|3|||
162784542|NCT01296555|587922476|FG015|Overall Study|Withdrawal by Subject|0|||
162784543|NCT01296555|587922477|FG016|Overall Study|Withdrawal by Subject|2|||
162784544|NCT01296555|587922478|FG017|Overall Study|Withdrawal by Subject|1|||
162784545|NCT01296555|587922479|FG018|Overall Study|Withdrawal by Subject|0|||
162784546|NCT01296555|587922480|FG019|Overall Study|Withdrawal by Subject|1|||
162784547|NCT01296555|587922481|FG020|Overall Study|Withdrawal by Subject|1|||
162784548|NCT01296555|587922482|FG021|Overall Study|Withdrawal by Subject|1|||
162784549|NCT01296555|587922483|FG022|Overall Study|Withdrawal by Subject|3|||
162784550|NCT01296555|587922484|FG023|Overall Study|Withdrawal by Subject|0|||
162784551|NCT01296555|587922485|FG024|Overall Study|Withdrawal by Subject|0|||
162784552|NCT01296555|587922486|FG025|Overall Study|Withdrawal by Subject|0|||
162784553|NCT01296555|587922487|FG026|Overall Study|Withdrawal by Subject|8|||
162784554|NCT01296555|587922488|FG027|Overall Study|Withdrawal by Subject|4|||
162784555|NCT01296555|587922489|FG028|Overall Study|Withdrawal by Subject|2|||
162784556|NCT00458393|587922490|FG000|Overall Study|Withdrawal by Subject|67|||
162784557|NCT00458393|587922491|FG001|Overall Study|Withdrawal by Subject|80|||
162784558|NCT00458393|587922490|FG000|Overall Study|Physician Decision|31|||
162784559|NCT00458393|587922491|FG001|Overall Study|Physician Decision|22|||
162784560|NCT00458393|587922490|FG000|Overall Study|Relocated|77|||
162784561|NCT00458393|587922491|FG001|Overall Study|Relocated|81|||
162784562|NCT00458393|587922490|FG000|Overall Study|Lost to Follow-up|115|||
162784563|NCT00458393|587922491|FG001|Overall Study|Lost to Follow-up|92|||
162784564|NCT00458393|587922490|FG000|Overall Study|Sites marked other on the form.|19|||
162784565|NCT00458393|587922491|FG001|Overall Study|Sites marked other on the form.|20|||
162784566|NCT02777242|587922493|FG000|Overall Study|Other|2|||
162784567|NCT02777242|587922493|FG000|Overall Study|Lost to Follow-up|1|||
162784568|NCT02777242|587922493|FG000|Overall Study|Multiple|1|||
162784569|NCT02777242|587922493|FG000|Overall Study|Sponsor's request|1|||
162784570|NCT02777242|587922493|FG000|Overall Study|Withdrawal by Subject|1|||
162784571|NCT05178979|587922494|FG000|Overall Study|Death|0|||
162784572|NCT05178979|587922495|FG001|Overall Study|Death|5|||
162784573|NCT05178979|587922496|FG002|Overall Study|Death|0|||
162784574|NCT05178979|587922497|FG003|Overall Study|Death|3|||
162784575|NCT05178979|587922494|FG000|Overall Study|Adverse Event|0|||
162784576|NCT05178979|587922495|FG001|Overall Study|Adverse Event|1|||
162784577|NCT05178979|587922496|FG002|Overall Study|Adverse Event|0|||
162784578|NCT05178979|587922497|FG003|Overall Study|Adverse Event|0|||
162784579|NCT05178979|587922494|FG000|Overall Study|Lost to Follow-up|1|||
162784580|NCT05178979|587922495|FG001|Overall Study|Lost to Follow-up|8|||
162784581|NCT05178979|587922496|FG002|Overall Study|Lost to Follow-up|3|||
162784582|NCT05178979|587922497|FG003|Overall Study|Lost to Follow-up|8|||
162784583|NCT01253447|587922498|FG000|Overall Study|Adverse Event|2|||
162784584|NCT00817336|587922499|FG000|Overall Study|Withdrawal by Subject|1|||
162784585|NCT00817336|587922500|FG001|Overall Study|Withdrawal by Subject|1|||
162784586|NCT02299427|587922501|FG000|Overall Study|Withdrawal by Subject|1|||
162784587|NCT02299427|587922502|FG001|Overall Study|Withdrawal by Subject|0|||
162784588|NCT02299427|587922501|FG000|Overall Study|Lost to Follow-up|1|||
162784589|NCT02299427|587922502|FG001|Overall Study|Lost to Follow-up|3|||
162784590|NCT02299427|587922501|FG000|Overall Study|not adherent to dog website use|21|||
162784591|NCT02299427|587922502|FG001|Overall Study|not adherent to dog website use|0|||
162784592|NCT02108652|587922503|FG000|Overall Study|Death|253|||
162784593|NCT02108652|587922503|FG000|Overall Study|Lost to Follow-up|2|||
162784594|NCT02108652|587922503|FG000|Overall Study|Withdrawal by Subject|16|||
162784595|NCT02108652|587922503|FG000|Overall Study|Study Terminated By Sponsor|31|||
162784596|NCT02108652|587922503|FG000|Overall Study|Non-Compliance|1|||
162784597|NCT02108652|587922503|FG000|Overall Study|Physician Decision|6|||
162784598|NCT02108652|587922503|FG000|Overall Study|Progression Of Disease|1|||
162784599|NCT01182181|587922509|FG000|First Intervention|Adverse Event|1|||
162784600|NCT01182181|587922510|FG001|First Intervention|Adverse Event|0|||
162784601|NCT01182181|587922509|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
162784602|NCT01182181|587922510|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
162784603|NCT00511797|587922511|FG000|Overall Study|Adverse Event|1|||
162784604|NCT00511797|587922512|FG001|Overall Study|Adverse Event|2|||
162784605|NCT00511797|587922513|FG002|Overall Study|Adverse Event|2|||
162784606|NCT00511797|587922514|FG003|Overall Study|Adverse Event|2|||
162784607|NCT00511797|587922511|FG000|Overall Study|Lost to Follow-up|1|||
162784608|NCT00511797|587922512|FG001|Overall Study|Lost to Follow-up|0|||
162784609|NCT00511797|587922513|FG002|Overall Study|Lost to Follow-up|0|||
162784610|NCT00511797|587922514|FG003|Overall Study|Lost to Follow-up|1|||
162784611|NCT00511797|587922511|FG000|Overall Study|Pregnancy|0|||
162784612|NCT00511797|587922512|FG001|Overall Study|Pregnancy|0|||
162784613|NCT00511797|587922513|FG002|Overall Study|Pregnancy|0|||
162784614|NCT00511797|587922514|FG003|Overall Study|Pregnancy|1|||
162784615|NCT00511797|587922511|FG000|Overall Study|Protocol Violation|0|||
162784616|NCT00511797|587922512|FG001|Overall Study|Protocol Violation|2|||
162784617|NCT00511797|587922513|FG002|Overall Study|Protocol Violation|2|||
162784618|NCT00511797|587922514|FG003|Overall Study|Protocol Violation|3|||
162784619|NCT00511797|587922511|FG000|Overall Study|Withdrawal by Subject|3|||
162784620|NCT00511797|587922512|FG001|Overall Study|Withdrawal by Subject|3|||
162784621|NCT00511797|587922513|FG002|Overall Study|Withdrawal by Subject|4|||
162784622|NCT00511797|587922514|FG003|Overall Study|Withdrawal by Subject|2|||
162784623|NCT00511797|587922511|FG000|Overall Study|Never dispensed|1|||
162784624|NCT00511797|587922512|FG001|Overall Study|Never dispensed|0|||
162784625|NCT00511797|587922513|FG002|Overall Study|Never dispensed|1|||
162784626|NCT00511797|587922514|FG003|Overall Study|Never dispensed|3|||
162784627|NCT00511797|587922511|FG000|Overall Study|Study drug not taken|0|||
162784628|NCT00511797|587922512|FG001|Overall Study|Study drug not taken|1|||
162784629|NCT00511797|587922513|FG002|Overall Study|Study drug not taken|0|||
162784630|NCT00511797|587922514|FG003|Overall Study|Study drug not taken|1|||
162784631|NCT00511797|587922511|FG000|Overall Study|Partially missing diary|0|||
162784632|NCT00511797|587922512|FG001|Overall Study|Partially missing diary|0|||
162784633|NCT00511797|587922513|FG002|Overall Study|Partially missing diary|1|||
162784634|NCT00511797|587922514|FG003|Overall Study|Partially missing diary|0|||
162784635|NCT00511797|587922511|FG000|Overall Study|Other (moving etc)|1|||
162784636|NCT00511797|587922512|FG001|Overall Study|Other (moving etc)|0|||
162784637|NCT00511797|587922513|FG002|Overall Study|Other (moving etc)|1|||
162784638|NCT00511797|587922514|FG003|Overall Study|Other (moving etc)|2|||
162784639|NCT01704547|587922515|FG000|Overall Study|Physician Decision|4|||
162784640|NCT01704547|587922515|FG000|Overall Study|Withdrawal by Subject|1|||
162784641|NCT03845075|587922516|FG000|Part 1 - DB|Withdrawal by Subject|1|||
162784642|NCT03845075|587922517|FG001|Part 1 - DB|Withdrawal by Subject|1|||
162784643|NCT03845075|587922518|FG002|Part 1 - DB|Withdrawal by Subject|0|||
162784644|NCT03845075|587922519|FG003|Part 1 - DB|Withdrawal by Subject|0|||
162784645|NCT03845075|587922516|FG000|Part 1 - DB|Adverse Event|0|||
162784646|NCT03845075|587922517|FG001|Part 1 - DB|Adverse Event|1|||
162784647|NCT03845075|587922518|FG002|Part 1 - DB|Adverse Event|0|||
162784648|NCT03845075|587922519|FG003|Part 1 - DB|Adverse Event|0|||
162784649|NCT03845075|587922516|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
162784650|NCT03845075|587922517|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162784651|NCT03845075|587922518|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162784652|NCT03845075|587922519|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162784653|NCT02564718|587922520|FG000|Overall Study|Withdrew from treatment|0|||
162784654|NCT02564718|587922521|FG001|Overall Study|Withdrew from treatment|1|||
162784655|NCT00104637|587922522|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
162784656|NCT00104637|587922523|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
162784657|NCT02138253|587922527|FG000|Overall Study|Adverse Event|3|||
162784658|NCT02138253|587922528|FG001|Overall Study|Adverse Event|3|||
162784659|NCT02138253|587922527|FG000|Overall Study|Lost to Follow-up|2|||
162784660|NCT02138253|587922528|FG001|Overall Study|Lost to Follow-up|1|||
162784661|NCT02138253|587922527|FG000|Overall Study|Physician Decision|2|||
162784662|NCT02138253|587922528|FG001|Overall Study|Physician Decision|0|||
162784663|NCT02138253|587922527|FG000|Overall Study|Non compliance|1|||
162784664|NCT02138253|587922528|FG001|Overall Study|Non compliance|0|||
162784665|NCT02138253|587922527|FG000|Overall Study|Withdrawal by Subject|1|||
162784666|NCT02138253|587922528|FG001|Overall Study|Withdrawal by Subject|0|||
162784667|NCT01918371|587922529|FG000|Overall Study|Missing Data|1|||
162784668|NCT01918371|587922530|FG001|Overall Study|Missing Data|1|||
162784669|NCT03802617|587922531|FG000|Overall Study|Adverse Event|0|||
162784670|NCT03802617|587922532|FG001|Overall Study|Adverse Event|4|||
162784671|NCT03802617|587922533|FG002|Overall Study|Adverse Event|5|||
162784672|NCT03802617|587922534|FG003|Overall Study|Adverse Event|1|||
162784673|NCT03802617|587922531|FG000|Overall Study|Lack of Efficacy|0|||
162784674|NCT03802617|587922532|FG001|Overall Study|Lack of Efficacy|1|||
162784675|NCT03802617|587922533|FG002|Overall Study|Lack of Efficacy|0|||
162784676|NCT03802617|587922534|FG003|Overall Study|Lack of Efficacy|2|||
162784677|NCT03802617|587922531|FG000|Overall Study|Protocol Violation|1|||
162784678|NCT03802617|587922532|FG001|Overall Study|Protocol Violation|1|||
162784679|NCT03802617|587922533|FG002|Overall Study|Protocol Violation|1|||
162784680|NCT03802617|587922534|FG003|Overall Study|Protocol Violation|0|||
162784681|NCT03802617|587922531|FG000|Overall Study|Withdrawal by Subject|1|||
162784682|NCT03802617|587922532|FG001|Overall Study|Withdrawal by Subject|1|||
162784683|NCT03802617|587922533|FG002|Overall Study|Withdrawal by Subject|1|||
162784684|NCT03802617|587922534|FG003|Overall Study|Withdrawal by Subject|0|||
162784685|NCT03802617|587922531|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
162784686|NCT03802617|587922532|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
162784687|NCT03802617|587922533|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
162784688|NCT03802617|587922534|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
162784689|NCT00621192|587922535|FG000|Overall Study|Withdrawal by Subject|0|||
162784690|NCT00621192|587922536|FG001|Overall Study|Withdrawal by Subject|0|||
162784691|NCT00621192|587922537|FG002|Overall Study|Withdrawal by Subject|2|||
162784692|NCT00621192|587922538|FG003|Overall Study|Withdrawal by Subject|0|||
162784693|NCT00621192|587922535|FG000|Overall Study|Physician Decision|1|||
162784694|NCT00621192|587922536|FG001|Overall Study|Physician Decision|3|||
162784695|NCT00621192|587922537|FG002|Overall Study|Physician Decision|0|||
162784696|NCT00621192|587922538|FG003|Overall Study|Physician Decision|0|||
162784697|NCT00621192|587922535|FG000|Overall Study|Protocol Violation|1|||
162784698|NCT00621192|587922536|FG001|Overall Study|Protocol Violation|0|||
162784699|NCT00621192|587922537|FG002|Overall Study|Protocol Violation|0|||
162784700|NCT00621192|587922538|FG003|Overall Study|Protocol Violation|1|||
162784701|NCT00621192|587922535|FG000|Overall Study|Adverse Event|0|||
162784702|NCT00621192|587922536|FG001|Overall Study|Adverse Event|1|||
162784703|NCT00621192|587922537|FG002|Overall Study|Adverse Event|0|||
162784704|NCT00621192|587922538|FG003|Overall Study|Adverse Event|1|||
162784705|NCT00621192|587922535|FG000|Overall Study|Death|2|||
162784706|NCT00621192|587922536|FG001|Overall Study|Death|5|||
162784707|NCT00621192|587922537|FG002|Overall Study|Death|0|||
162784708|NCT00621192|587922538|FG003|Overall Study|Death|0|||
162784709|NCT00621192|587922535|FG000|Overall Study|Final Assessments not Completed|0|||
162784710|NCT00621192|587922536|FG001|Overall Study|Final Assessments not Completed|0|||
162784711|NCT00621192|587922537|FG002|Overall Study|Final Assessments not Completed|3|||
162784712|NCT00621192|587922538|FG003|Overall Study|Final Assessments not Completed|1|||
162784713|NCT00267098|587922541|FG000|Overall Study|Death|0|||
162784714|NCT00267098|587922542|FG001|Overall Study|Death|0|||
162784715|NCT00267098|587922543|FG002|Overall Study|Death|57|||
162784716|NCT00267098|587922544|FG003|Overall Study|Death|66|||
162784717|NCT00267098|587922545|FG004|Overall Study|Death|14|||
162784718|NCT00267098|587922546|FG005|Overall Study|Death|23|||
162784719|NCT00267098|587922547|FG006|Overall Study|Death|28|||
162784720|NCT00267098|587922548|FG007|Overall Study|Death|9|||
162784721|NCT00267098|587922541|FG000|Overall Study|Lost to Follow-up|0|||
162784722|NCT00267098|587922542|FG001|Overall Study|Lost to Follow-up|0|||
162784723|NCT00267098|587922543|FG002|Overall Study|Lost to Follow-up|6|||
162784724|NCT00267098|587922544|FG003|Overall Study|Lost to Follow-up|5|||
162784725|NCT00267098|587922545|FG004|Overall Study|Lost to Follow-up|2|||
162784726|NCT00267098|587922546|FG005|Overall Study|Lost to Follow-up|3|||
162784727|NCT00267098|587922547|FG006|Overall Study|Lost to Follow-up|1|||
162784728|NCT00267098|587922548|FG007|Overall Study|Lost to Follow-up|1|||
162784729|NCT00267098|587922541|FG000|Overall Study|Withdrawal by Subject|8|||
162784730|NCT00267098|587922542|FG001|Overall Study|Withdrawal by Subject|0|||
162784731|NCT00267098|587922543|FG002|Overall Study|Withdrawal by Subject|24|||
162784732|NCT00267098|587922544|FG003|Overall Study|Withdrawal by Subject|21|||
162784733|NCT00267098|587922545|FG004|Overall Study|Withdrawal by Subject|12|||
162784734|NCT00267098|587922546|FG005|Overall Study|Withdrawal by Subject|9|||
162784735|NCT00267098|587922547|FG006|Overall Study|Withdrawal by Subject|12|||
162784736|NCT00267098|587922548|FG007|Overall Study|Withdrawal by Subject|5|||
162784737|NCT00267098|587922541|FG000|Overall Study|Physician Decision|5|||
162784738|NCT00267098|587922542|FG001|Overall Study|Physician Decision|0|||
162784739|NCT00267098|587922543|FG002|Overall Study|Physician Decision|7|||
162784740|NCT00267098|587922544|FG003|Overall Study|Physician Decision|11|||
162784741|NCT00267098|587922545|FG004|Overall Study|Physician Decision|5|||
162784742|NCT00267098|587922546|FG005|Overall Study|Physician Decision|4|||
162784743|NCT00267098|587922547|FG006|Overall Study|Physician Decision|3|||
162784744|NCT00267098|587922548|FG007|Overall Study|Physician Decision|0|||
162784745|NCT00267098|587922541|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
162784746|NCT00267098|587922542|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784747|NCT00267098|587922543|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784748|NCT00267098|587922544|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784749|NCT00267098|587922545|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
162784750|NCT00267098|587922546|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784751|NCT00267098|587922547|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784752|NCT00267098|587922548|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162784753|NCT00267098|587922541|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784754|NCT00267098|587922542|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
162784755|NCT00267098|587922543|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784756|NCT00267098|587922544|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784757|NCT00267098|587922545|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784758|NCT00267098|587922546|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784759|NCT00267098|587922547|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784760|NCT00267098|587922548|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162784761|NCT00267098|587922541|FG000|Overall Study|Site closure|0|||
162784762|NCT00267098|587922542|FG001|Overall Study|Site closure|0|||
162784763|NCT00267098|587922543|FG002|Overall Study|Site closure|0|||
162784764|NCT00267098|587922544|FG003|Overall Study|Site closure|1|||
162784765|NCT00267098|587922545|FG004|Overall Study|Site closure|0|||
162784766|NCT00267098|587922546|FG005|Overall Study|Site closure|1|||
162784767|NCT00267098|587922547|FG006|Overall Study|Site closure|1|||
162784768|NCT00267098|587922548|FG007|Overall Study|Site closure|0|||
162784769|NCT00267098|587922541|FG000|Overall Study|Explanted Medtronic device|0|||
162784770|NCT00267098|587922542|FG001|Overall Study|Explanted Medtronic device|0|||
162784771|NCT00267098|587922543|FG002|Overall Study|Explanted Medtronic device|0|||
162784772|NCT00267098|587922544|FG003|Overall Study|Explanted Medtronic device|1|||
162784773|NCT00267098|587922545|FG004|Overall Study|Explanted Medtronic device|0|||
162784774|NCT00267098|587922546|FG005|Overall Study|Explanted Medtronic device|0|||
162784775|NCT00267098|587922547|FG006|Overall Study|Explanted Medtronic device|0|||
162784776|NCT00267098|587922548|FG007|Overall Study|Explanted Medtronic device|0|||
162784777|NCT00267098|587922541|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784778|NCT00267098|587922542|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784779|NCT00267098|587922543|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784780|NCT00267098|587922544|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784781|NCT00267098|587922545|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
162784782|NCT00267098|587922546|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784783|NCT00267098|587922547|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784784|NCT00267098|587922548|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162784785|NCT00267098|587922541|FG000|Overall Study|Subject listed for heart transplant|0|||
162784786|NCT00267098|587922542|FG001|Overall Study|Subject listed for heart transplant|0|||
162784787|NCT00267098|587922543|FG002|Overall Study|Subject listed for heart transplant|0|||
162784788|NCT00267098|587922544|FG003|Overall Study|Subject listed for heart transplant|0|||
162784789|NCT00267098|587922545|FG004|Overall Study|Subject listed for heart transplant|0|||
162784790|NCT00267098|587922546|FG005|Overall Study|Subject listed for heart transplant|0|||
162784791|NCT00267098|587922547|FG006|Overall Study|Subject listed for heart transplant|1|||
162784792|NCT00267098|587922548|FG007|Overall Study|Subject listed for heart transplant|0|||
162784793|NCT00267098|587922541|FG000|Overall Study|Sponsor withdrew subject|0|||
162784794|NCT00267098|587922542|FG001|Overall Study|Sponsor withdrew subject|0|||
162784795|NCT00267098|587922543|FG002|Overall Study|Sponsor withdrew subject|0|||
162784796|NCT00267098|587922544|FG003|Overall Study|Sponsor withdrew subject|1|||
162784797|NCT00267098|587922545|FG004|Overall Study|Sponsor withdrew subject|0|||
162784798|NCT00267098|587922546|FG005|Overall Study|Sponsor withdrew subject|0|||
162784799|NCT00267098|587922547|FG006|Overall Study|Sponsor withdrew subject|0|||
162784800|NCT00267098|587922548|FG007|Overall Study|Sponsor withdrew subject|0|||
162784801|NCT04211389|587922550|FG000|Overall Study|Adverse Event|1|||
162784802|NCT04211389|587922551|FG001|Overall Study|Adverse Event|2|||
162784803|NCT04211389|587922550|FG000|Overall Study|Lost to Follow-up|15|||
162784804|NCT04211389|587922551|FG001|Overall Study|Lost to Follow-up|7|||
162784805|NCT04211389|587922550|FG000|Overall Study|Protocol Violation|0|||
162784806|NCT04211389|587922551|FG001|Overall Study|Protocol Violation|1|||
162784807|NCT04211389|587922550|FG000|Overall Study|Withdrawal by Subject|10|||
162784808|NCT04211389|587922551|FG001|Overall Study|Withdrawal by Subject|11|||
162784809|NCT00547534|587922552|FG000|Overall Study|Adverse Event|7|||
162784810|NCT00547534|587922552|FG000|Overall Study|Disease Progression|4|||
162784811|NCT01157377|587922553|FG000|Overall Study|Lost to Follow-up|0|||
162784812|NCT01157377|587922554|FG001|Overall Study|Lost to Follow-up|0|||
162784813|NCT01157377|587922555|FG002|Overall Study|Lost to Follow-up|1|||
162784814|NCT01157377|587922556|FG003|Overall Study|Lost to Follow-up|0|||
162784815|NCT01157377|587922557|FG004|Overall Study|Lost to Follow-up|1|||
162784816|NCT01157377|587922558|FG005|Overall Study|Lost to Follow-up|1|||
162784817|NCT01157377|587922559|FG006|Overall Study|Lost to Follow-up|0|||
162784818|NCT01157377|587922553|FG000|Overall Study|Personal Reasons|2|||
162784819|NCT01157377|587922554|FG001|Overall Study|Personal Reasons|1|||
162784820|NCT01157377|587922555|FG002|Overall Study|Personal Reasons|0|||
162784821|NCT01157377|587922556|FG003|Overall Study|Personal Reasons|1|||
162784822|NCT01157377|587922557|FG004|Overall Study|Personal Reasons|0|||
162784823|NCT01157377|587922558|FG005|Overall Study|Personal Reasons|0|||
162784824|NCT01157377|587922559|FG006|Overall Study|Personal Reasons|0|||
162784825|NCT01157377|587922553|FG000|Overall Study|Protocol Violation|0|||
162784826|NCT01157377|587922554|FG001|Overall Study|Protocol Violation|0|||
162784827|NCT01157377|587922555|FG002|Overall Study|Protocol Violation|0|||
162784828|NCT01157377|587922556|FG003|Overall Study|Protocol Violation|0|||
162784829|NCT01157377|587922557|FG004|Overall Study|Protocol Violation|0|||
162784830|NCT01157377|587922558|FG005|Overall Study|Protocol Violation|1|||
162784831|NCT01157377|587922559|FG006|Overall Study|Protocol Violation|0|||
162784832|NCT01157377|587922553|FG000|Overall Study|Lack of Efficacy|0|||
162784833|NCT01157377|587922554|FG001|Overall Study|Lack of Efficacy|0|||
162784834|NCT01157377|587922555|FG002|Overall Study|Lack of Efficacy|0|||
162784835|NCT01157377|587922556|FG003|Overall Study|Lack of Efficacy|0|||
162784836|NCT01157377|587922557|FG004|Overall Study|Lack of Efficacy|0|||
162784837|NCT01157377|587922558|FG005|Overall Study|Lack of Efficacy|0|||
162784838|NCT01157377|587922559|FG006|Overall Study|Lack of Efficacy|1|||
162784839|NCT01157377|587922553|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162784840|NCT01157377|587922554|FG001|Overall Study|Other Miscellaneous Reasons|2|||
162784841|NCT01157377|587922555|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162784842|NCT01157377|587922556|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162784843|NCT01157377|587922557|FG004|Overall Study|Other Miscellaneous Reasons|1|||
162784844|NCT01157377|587922558|FG005|Overall Study|Other Miscellaneous Reasons|1|||
162784845|NCT01157377|587922559|FG006|Overall Study|Other Miscellaneous Reasons|1|||
162784846|NCT01182207|587922568|FG000|First Intervention|Positive Hepatitis Results|0|||
162784847|NCT01182207|587922569|FG001|First Intervention|Positive Hepatitis Results|1|||
162784848|NCT01182207|587922568|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
162784849|NCT01182207|587922569|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
162784850|NCT01427738|587922570|FG000|Overall Study|Death|12|||
162784851|NCT01427738|587922571|FG001|Overall Study|Death|9|||
162784852|NCT01427738|587922570|FG000|Overall Study|Severe debilitation, unable to continue|0|||
162784853|NCT01427738|587922571|FG001|Overall Study|Severe debilitation, unable to continue|1|||
162784854|NCT01427738|587922570|FG000|Overall Study|Subject unable to get to clinic|5|||
162784855|NCT01427738|587922571|FG001|Overall Study|Subject unable to get to clinic|2|||
162784856|NCT01427738|587922570|FG000|Overall Study|Withdrawal by Subject|0|||
162784857|NCT01427738|587922571|FG001|Overall Study|Withdrawal by Subject|2|||
162784858|NCT01427738|587922570|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
162784859|NCT01427738|587922571|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
162784860|NCT01427738|587922570|FG000|Overall Study|Lost to Follow-up|1|||
162784861|NCT01427738|587922571|FG001|Overall Study|Lost to Follow-up|5|||
162784862|NCT01801982|587922572|FG000|Overall Study|Lost to Follow-up|1|||
162784863|NCT00727506|587922575|FG000|Overall Study|Adverse Event|0|||
162784864|NCT00727506|587922576|FG001|Overall Study|Adverse Event|0|||
162784865|NCT00727506|587922577|FG002|Overall Study|Adverse Event|4|||
162784866|NCT00727506|587922578|FG003|Overall Study|Adverse Event|4|||
162784867|NCT00727506|587922579|FG004|Overall Study|Adverse Event|1|||
162784868|NCT00727506|587922580|FG005|Overall Study|Adverse Event|8|||
162784869|NCT00727506|587922575|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162784870|NCT00727506|587922576|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162784871|NCT00727506|587922577|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162784872|NCT00727506|587922578|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162784873|NCT00727506|587922579|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162784874|NCT00727506|587922580|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162784875|NCT00727506|587922575|FG000|Overall Study|Progressive disease|4|||
162784876|NCT00727506|587922576|FG001|Overall Study|Progressive disease|7|||
162784877|NCT00727506|587922577|FG002|Overall Study|Progressive disease|9|||
162784878|NCT00727506|587922578|FG003|Overall Study|Progressive disease|28|||
162784879|NCT00727506|587922579|FG004|Overall Study|Progressive disease|38|||
162784880|NCT00727506|587922580|FG005|Overall Study|Progressive disease|28|||
162784881|NCT00727506|587922575|FG000|Overall Study|Refused to continue medication|0|||
162784882|NCT00727506|587922576|FG001|Overall Study|Refused to continue medication|1|||
162784883|NCT00727506|587922577|FG002|Overall Study|Refused to continue medication|2|||
162784884|NCT00727506|587922578|FG003|Overall Study|Refused to continue medication|3|||
162784885|NCT00727506|587922579|FG004|Overall Study|Refused to continue medication|1|||
162784886|NCT00727506|587922580|FG005|Overall Study|Refused to continue medication|2|||
162784887|NCT00727506|587922575|FG000|Overall Study|Other reason not described above|0|||
162784888|NCT00727506|587922576|FG001|Overall Study|Other reason not described above|0|||
162784889|NCT00727506|587922577|FG002|Overall Study|Other reason not described above|1|||
162784890|NCT00727506|587922578|FG003|Overall Study|Other reason not described above|4|||
162784891|NCT00727506|587922579|FG004|Overall Study|Other reason not described above|1|||
162784892|NCT00727506|587922580|FG005|Overall Study|Other reason not described above|1|||
162784893|NCT02650466|587922582|FG000|Overall Study|Physician Decision|1|||
162784894|NCT02650466|587922582|FG000|Overall Study|Withdrawal by Subject|5|||
162784895|NCT02650466|587922582|FG000|Overall Study|Lost to Follow-up|1|||
162784896|NCT01214421|587922586|FG000|Overall Study|Lost to Follow-up|7|||
162784897|NCT01214421|587922587|FG001|Overall Study|Lost to Follow-up|3|||
162784898|NCT01214421|587922588|FG002|Overall Study|Lost to Follow-up|7|||
162784899|NCT01214421|587922589|FG003|Overall Study|Lost to Follow-up|3|||
162784900|NCT01214421|587922586|FG000|Overall Study|Adverse Event|16|||
162784901|NCT01214421|587922587|FG001|Overall Study|Adverse Event|35|||
162784902|NCT01214421|587922588|FG002|Overall Study|Adverse Event|14|||
162784903|NCT01214421|587922589|FG003|Overall Study|Adverse Event|3|||
162784904|NCT01214421|587922586|FG000|Overall Study|Sponsor Discontinued Site|1|||
162784905|NCT01214421|587922587|FG001|Overall Study|Sponsor Discontinued Site|2|||
162784906|NCT01214421|587922588|FG002|Overall Study|Sponsor Discontinued Site|0|||
162784907|NCT01214421|587922589|FG003|Overall Study|Sponsor Discontinued Site|0|||
162784908|NCT01214421|587922586|FG000|Overall Study|Withdrawal Criteria Met|3|||
162784909|NCT01214421|587922587|FG001|Overall Study|Withdrawal Criteria Met|0|||
162784910|NCT01214421|587922588|FG002|Overall Study|Withdrawal Criteria Met|2|||
162784911|NCT01214421|587922589|FG003|Overall Study|Withdrawal Criteria Met|1|||
162784912|NCT01214421|587922586|FG000|Overall Study|Physician Decision|2|||
162784913|NCT01214421|587922587|FG001|Overall Study|Physician Decision|0|||
162784914|NCT01214421|587922588|FG002|Overall Study|Physician Decision|4|||
162784915|NCT01214421|587922589|FG003|Overall Study|Physician Decision|0|||
162784916|NCT01214421|587922586|FG000|Overall Study|Withdrawal by Subject|21|||
162784917|NCT01214421|587922587|FG001|Overall Study|Withdrawal by Subject|18|||
162784918|NCT01214421|587922588|FG002|Overall Study|Withdrawal by Subject|11|||
162784919|NCT01214421|587922589|FG003|Overall Study|Withdrawal by Subject|2|||
162784920|NCT02392104|587922591|FG000|Overall Study|discontinuation of warfarin|3|||
162784921|NCT02392104|587922591|FG000|Overall Study|bleeding event|1|||
162784922|NCT02392104|587922591|FG000|Overall Study|transferred care to another doctor|2|||
162784923|NCT02392104|587922591|FG000|Overall Study|INR goal range changed|1|||
162784924|NCT02392104|587922591|FG000|Overall Study|admitted to skilled nursing facility|3|||
162784925|NCT02392104|587922591|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
162784926|NCT04590404|587922592|FG000|Overall Study|Death|16|||
162784927|NCT04590404|587922593|FG001|Overall Study|Death|17|||
162784928|NCT04590404|587922592|FG000|Overall Study|Withdrawal by Subject|7|||
162784929|NCT04590404|587922593|FG001|Overall Study|Withdrawal by Subject|2|||
162784930|NCT03912532|587922594|FG000|Overall Study|Adverse Event|3|||
162784931|NCT03912532|587922595|FG001|Overall Study|Adverse Event|3|||
162784932|NCT03912532|587922596|FG002|Overall Study|Adverse Event|2|||
162784933|NCT03912532|587922597|FG003|Overall Study|Adverse Event|2|||
162784934|NCT03912532|587922594|FG000|Overall Study|Lost to Follow-up|3|||
162784935|NCT03912532|587922595|FG001|Overall Study|Lost to Follow-up|2|||
162784936|NCT03912532|587922596|FG002|Overall Study|Lost to Follow-up|1|||
162784937|NCT03912532|587922597|FG003|Overall Study|Lost to Follow-up|2|||
162784938|NCT03912532|587922594|FG000|Overall Study|Withdrawal by Subject|1|||
162784939|NCT03912532|587922595|FG001|Overall Study|Withdrawal by Subject|1|||
162784940|NCT03912532|587922596|FG002|Overall Study|Withdrawal by Subject|2|||
162784941|NCT03912532|587922597|FG003|Overall Study|Withdrawal by Subject|0|||
162784942|NCT03912532|587922594|FG000|Overall Study|Physician Decision|1|||
162784943|NCT03912532|587922595|FG001|Overall Study|Physician Decision|0|||
162784944|NCT03912532|587922596|FG002|Overall Study|Physician Decision|0|||
162784945|NCT03912532|587922597|FG003|Overall Study|Physician Decision|3|||
162784946|NCT03912532|587922594|FG000|Overall Study|Other|0|||
162784947|NCT03912532|587922595|FG001|Overall Study|Other|1|||
162784948|NCT03912532|587922596|FG002|Overall Study|Other|1|||
162784949|NCT03912532|587922597|FG003|Overall Study|Other|0|||
162784950|NCT03783871|587922600|FG000|Overall Study|Withdrawal by Subject|15|||
162784951|NCT03783871|587922600|FG000|Overall Study|Death|13|||
162784952|NCT03783871|587922600|FG000|Overall Study|Lost to Follow-up|2|||
162784953|NCT05990387|587922601|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
162784954|NCT05990387|587922602|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
162784955|NCT03522389|587922603|FG000|Overall Study|Lost to Follow-up|1|||
162784956|NCT03522389|587922604|FG001|Overall Study|Lost to Follow-up|1|||
162784957|NCT03522389|587922605|FG002|Overall Study|Lost to Follow-up|2|||
162784958|NCT03522389|587922603|FG000|Overall Study|had herniated nucleus pulposus|0|||
162784959|NCT03522389|587922604|FG001|Overall Study|had herniated nucleus pulposus|1|||
162784960|NCT03522389|587922605|FG002|Overall Study|had herniated nucleus pulposus|0|||
162784961|NCT03522389|587922603|FG000|Overall Study|go to work in other province|1|||
162784962|NCT03522389|587922604|FG001|Overall Study|go to work in other province|0|||
162784963|NCT03522389|587922605|FG002|Overall Study|go to work in other province|0|||
162784964|NCT00604188|587922610|FG000|Overall Study|Adverse Event|1|||
162784965|NCT00604188|587922611|FG001|Overall Study|Adverse Event|4|||
162784966|NCT00604188|587922610|FG000|Overall Study|Lost to Follow-up|17|||
162784967|NCT00604188|587922611|FG001|Overall Study|Lost to Follow-up|15|||
162784968|NCT00604188|587922610|FG000|Overall Study|Withdrawal by Subject|5|||
162784969|NCT00604188|587922611|FG001|Overall Study|Withdrawal by Subject|1|||
162784970|NCT00604188|587922610|FG000|Overall Study|Non-compliance with protocol|4|||
162784971|NCT00604188|587922611|FG001|Overall Study|Non-compliance with protocol|4|||
162784972|NCT00604188|587922610|FG000|Overall Study|Did not receive study drug|0|||
162784973|NCT00604188|587922611|FG001|Overall Study|Did not receive study drug|1|||
162784974|NCT02242643|587922614|FG000|Overall Study|Protocol Violation|1|||
162784975|NCT02242643|587922615|FG001|Overall Study|Protocol Violation|2|||
162784976|NCT02242643|587922614|FG000|Overall Study|Withdrawal by Subject|15|||
162784977|NCT02242643|587922615|FG001|Overall Study|Withdrawal by Subject|10|||
162784978|NCT02242643|587922614|FG000|Overall Study|Migrated/moved from study area|1|||
162784979|NCT02242643|587922615|FG001|Overall Study|Migrated/moved from study area|3|||
162784980|NCT02242643|587922614|FG000|Overall Study|Lost to Follow-up|54|||
162784981|NCT02242643|587922615|FG001|Overall Study|Lost to Follow-up|61|||
162784982|NCT02242643|587922614|FG000|Overall Study|Child placed in foster care by family|0|||
162784983|NCT02242643|587922615|FG001|Overall Study|Child placed in foster care by family|1|||
162784984|NCT02242643|587922614|FG000|Overall Study|Non-compliance|1|||
162784985|NCT02242643|587922615|FG001|Overall Study|Non-compliance|0|||
162784986|NCT02242643|587922614|FG000|Overall Study|Consent withdrawal by parent|1|||
162784987|NCT02242643|587922615|FG001|Overall Study|Consent withdrawal by parent|0|||
162784988|NCT02242643|587922614|FG000|Overall Study|Protocol requirements not followed|1|||
162784989|NCT02242643|587922615|FG001|Overall Study|Protocol requirements not followed|0|||
162784990|NCT02242643|587922614|FG000|Overall Study|Language barrier|1|||
162784991|NCT02242643|587922615|FG001|Overall Study|Language barrier|0|||
162784992|NCT02242643|587922614|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
162784993|NCT02242643|587922615|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
162784994|NCT03049306|587922622|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
162784995|NCT03049306|587922623|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
162784996|NCT02056626|587924153|FG000|Overall Study|patient did not follow directions|3|||
162784997|NCT02056626|587924154|FG001|Overall Study|patient did not follow directions|1|||
162784998|NCT02056626|587924155|FG002|Overall Study|patient did not follow directions|0|||
162784999|NCT02056626|587924156|FG003|Overall Study|patient did not follow directions|0|||
162785000|NCT04916002|587924158|FG000|Overall Study|Adverse Event|0|||
162785001|NCT04916002|587924159|FG001|Overall Study|Adverse Event|1|||
162785002|NCT04916002|587924160|FG002|Overall Study|Adverse Event|0|||
162785003|NCT04916002|587924161|FG003|Overall Study|Adverse Event|1|||
162785004|NCT04916002|587924162|FG004|Overall Study|Adverse Event|0|||
162785005|NCT04916002|587924158|FG000|Overall Study|Withdrawal by Subject|3|||
162785006|NCT04916002|587924159|FG001|Overall Study|Withdrawal by Subject|1|||
162785007|NCT04916002|587924160|FG002|Overall Study|Withdrawal by Subject|0|||
162785008|NCT04916002|587924161|FG003|Overall Study|Withdrawal by Subject|1|||
162785009|NCT04916002|587924162|FG004|Overall Study|Withdrawal by Subject|0|||
162785010|NCT04916002|587924158|FG000|Overall Study|Death|8|||
162785011|NCT04916002|587924159|FG001|Overall Study|Death|7|||
162785012|NCT04916002|587924160|FG002|Overall Study|Death|4|||
162785013|NCT04916002|587924161|FG003|Overall Study|Death|9|||
162785014|NCT04916002|587924162|FG004|Overall Study|Death|0|||
162785015|NCT04916002|587924158|FG000|Overall Study|Study Terminated by Sponsor|11|||
162785016|NCT04916002|587924159|FG001|Overall Study|Study Terminated by Sponsor|10|||
162785017|NCT04916002|587924160|FG002|Overall Study|Study Terminated by Sponsor|8|||
162785018|NCT04916002|587924161|FG003|Overall Study|Study Terminated by Sponsor|5|||
162785019|NCT04916002|587924162|FG004|Overall Study|Study Terminated by Sponsor|4|||
162785020|NCT04916002|587924158|FG000|Overall Study|End of trial|1|||
162785021|NCT04916002|587924159|FG001|Overall Study|End of trial|0|||
162785022|NCT04916002|587924160|FG002|Overall Study|End of trial|0|||
162785023|NCT04916002|587924161|FG003|Overall Study|End of trial|0|||
162785024|NCT04916002|587924162|FG004|Overall Study|End of trial|0|||
162785025|NCT04916002|587924158|FG000|Overall Study|Progressive disease|0|||
162785026|NCT04916002|587924159|FG001|Overall Study|Progressive disease|0|||
162785027|NCT04916002|587924160|FG002|Overall Study|Progressive disease|1|||
162785028|NCT04916002|587924161|FG003|Overall Study|Progressive disease|0|||
162785029|NCT04916002|587924162|FG004|Overall Study|Progressive disease|0|||
162785030|NCT04916002|587924158|FG000|Overall Study|Participant non-compliance|2|||
162785031|NCT04916002|587924159|FG001|Overall Study|Participant non-compliance|0|||
162785032|NCT04916002|587924160|FG002|Overall Study|Participant non-compliance|0|||
162785033|NCT04916002|587924161|FG003|Overall Study|Participant non-compliance|0|||
162785034|NCT04916002|587924162|FG004|Overall Study|Participant non-compliance|0|||
162785035|NCT04978350|587924163|FG000|Overall Study|Lost to Follow-up|6|||
162785036|NCT05923112|587924164|FG000|Overall Study|Protocol Violation|4|||
162785037|NCT05923112|587924164|FG000|Overall Study|No informed consent on publication of study results|243|||
162785038|NCT04991766|587924165|FG000|Overall Study|Withdrawal by Subject|2|||
162785039|NCT04991766|587924166|FG001|Overall Study|Withdrawal by Subject|0|||
162785040|NCT05147350|587924172|FG000|Overall Study|Death|2|||
162785041|NCT05147350|587924173|FG001|Overall Study|Death|3|||
162785042|NCT05147350|587924174|FG002|Overall Study|Death|3|||
162785043|NCT05147350|587924175|FG003|Overall Study|Death|2|||
162785044|NCT05147350|587924176|FG004|Overall Study|Death|2|||
162785045|NCT05147350|587924177|FG005|Overall Study|Death|1|||
162785046|NCT05147350|587924178|FG006|Overall Study|Death|1|||
162785047|NCT05147350|587924179|FG007|Overall Study|Death|3|||
162785048|NCT05147350|587924172|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
162785049|NCT05147350|587924173|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
162785050|NCT05147350|587924174|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
162785051|NCT05147350|587924175|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
162785052|NCT05147350|587924176|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
162785053|NCT05147350|587924177|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
162785054|NCT05147350|587924178|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
162785055|NCT05147350|587924179|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
162785056|NCT05147350|587924172|FG000|Overall Study|Withdrawal by Subject|0|||
162785057|NCT05147350|587924173|FG001|Overall Study|Withdrawal by Subject|0|||
162785058|NCT05147350|587924174|FG002|Overall Study|Withdrawal by Subject|3|||
162785059|NCT05147350|587924175|FG003|Overall Study|Withdrawal by Subject|1|||
162785060|NCT05147350|587924176|FG004|Overall Study|Withdrawal by Subject|1|||
162785061|NCT05147350|587924177|FG005|Overall Study|Withdrawal by Subject|0|||
162785062|NCT05147350|587924178|FG006|Overall Study|Withdrawal by Subject|1|||
162785063|NCT05147350|587924179|FG007|Overall Study|Withdrawal by Subject|0|||
162785064|NCT05147350|587924172|FG000|Overall Study|Other Reasons|0|||
162785065|NCT05147350|587924173|FG001|Overall Study|Other Reasons|0|||
162785066|NCT05147350|587924174|FG002|Overall Study|Other Reasons|2|||
162785067|NCT05147350|587924175|FG003|Overall Study|Other Reasons|0|||
162785068|NCT05147350|587924176|FG004|Overall Study|Other Reasons|0|||
162785069|NCT05147350|587924177|FG005|Overall Study|Other Reasons|2|||
162785070|NCT05147350|587924178|FG006|Overall Study|Other Reasons|1|||
162785071|NCT05147350|587924179|FG007|Overall Study|Other Reasons|1|||
162785072|NCT06136897|587924180|FG000|Overall Study|Ineligible|3|||
162785073|NCT06136897|587924180|FG000|Overall Study|Mutation status not confirmed|7|||
162785074|NCT06136897|587924180|FG000|Overall Study|Adverse Event|2|||
162785075|NCT06136897|587924180|FG000|Overall Study|Death|1|||
162785076|NCT06136897|587924180|FG000|Overall Study|Disease progression|18|||
162785077|NCT06136897|587924180|FG000|Overall Study|Other complicating disease|1|||
162785078|NCT06136897|587924180|FG000|Overall Study|Withdrawal by Subject|1|||
162785079|NCT06136897|587924180|FG000|Overall Study|Still on treatment|1|||
162785080|NCT06136897|587924180|FG000|Overall Study|Lost to Follow-up|1|||
162785081|NCT00992992|587924181|FG000|Overall Study|Lost to Follow-up|3|||
162785082|NCT00992992|587924181|FG000|Overall Study|Death|16|||
162785083|NCT00992992|587924181|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
162785084|NCT00992992|587924181|FG000|Overall Study|Sponsor Closed the Study|4|||
162785085|NCT00217022|587924183|FG000|Overall Study|Withdrawal by Subject|1|||
162785086|NCT00217022|587924184|FG001|Overall Study|Withdrawal by Subject|1|||
162785087|NCT00857233|587924185|FG000|Overall Study|Adverse Event|24|||
162785088|NCT00857233|587924185|FG000|Overall Study|Lack of Efficacy|1|||
162785089|NCT00857233|587924185|FG000|Overall Study|Non-compliance|1|||
162785090|NCT00857233|587924185|FG000|Overall Study|Withdrawal of Consent|9|||
162785091|NCT00857233|587924185|FG000|Overall Study|Lost to Follow-up|4|||
162785092|NCT00857233|587924185|FG000|Overall Study|Nursing Home Placement|14|||
162785093|NCT00857233|587924185|FG000|Overall Study|Other Reasons|2|||
162785094|NCT01560871|587924186|FG000|Overall Study|transportation issues|2|||
162785095|NCT01560871|587924187|FG001|Overall Study|transportation issues|1|||
162785096|NCT01560871|587924186|FG000|Overall Study|relocation|1|||
162785097|NCT01560871|587924187|FG001|Overall Study|relocation|0|||
162785098|NCT01560871|587924186|FG000|Overall Study|readmission to a hospital|2|||
162785099|NCT01560871|587924187|FG001|Overall Study|readmission to a hospital|1|||
162785100|NCT01560871|587924186|FG000|Overall Study|Lost to Follow-up|1|||
162785101|NCT01560871|587924187|FG001|Overall Study|Lost to Follow-up|0|||
162785102|NCT01278615|587924188|FG000|Overall Study|Withdrawal by Subject|2|||
162785103|NCT01390441|587924193|FG000|Treatment Period|Protocol Violation|0|||
162785104|NCT01390441|587924194|FG001|Treatment Period|Protocol Violation|1|||
162785105|NCT01390441|587924195|FG002|Treatment Period|Protocol Violation|0|||
162785106|NCT01390441|587924196|FG003|Treatment Period|Protocol Violation|0|||
162785107|NCT01390441|587924197|FG004|Treatment Period|Protocol Violation|0|||
162785108|NCT01390441|587924193|FG000|Treatment Period|Physician Decision|0|||
162785109|NCT01390441|587924194|FG001|Treatment Period|Physician Decision|0|||
162785110|NCT01390441|587924195|FG002|Treatment Period|Physician Decision|0|||
162785111|NCT01390441|587924196|FG003|Treatment Period|Physician Decision|1|||
162785112|NCT01390441|587924197|FG004|Treatment Period|Physician Decision|0|||
162785113|NCT01390441|587924193|FG000|Treatment Period|Lack of Efficacy|0|||
162785114|NCT01390441|587924194|FG001|Treatment Period|Lack of Efficacy|0|||
162785115|NCT01390441|587924195|FG002|Treatment Period|Lack of Efficacy|0|||
162785116|NCT01390441|587924196|FG003|Treatment Period|Lack of Efficacy|0|||
162785117|NCT01390441|587924197|FG004|Treatment Period|Lack of Efficacy|1|||
162785118|NCT01390441|587924193|FG000|Treatment Period|Unknown due to early stopping of study|0|||
162785119|NCT01390441|587924194|FG001|Treatment Period|Unknown due to early stopping of study|0|||
162785120|NCT01390441|587924195|FG002|Treatment Period|Unknown due to early stopping of study|8|||
162785121|NCT01390441|587924196|FG003|Treatment Period|Unknown due to early stopping of study|11|||
162785122|NCT01390441|587924197|FG004|Treatment Period|Unknown due to early stopping of study|7|||
162785123|NCT01390441|587924193|FG000|Treatment Period|Adverse Event|0|||
162785124|NCT01390441|587924194|FG001|Treatment Period|Adverse Event|0|||
162785125|NCT01390441|587924195|FG002|Treatment Period|Adverse Event|1|||
162785126|NCT01390441|587924196|FG003|Treatment Period|Adverse Event|1|||
162785127|NCT01390441|587924197|FG004|Treatment Period|Adverse Event|2|||
162785128|NCT01390441|587924193|FG000|Treatment Period|Withdrawal by Subject|0|||
162785129|NCT01390441|587924194|FG001|Treatment Period|Withdrawal by Subject|0|||
162785130|NCT01390441|587924195|FG002|Treatment Period|Withdrawal by Subject|1|||
162785131|NCT01390441|587924196|FG003|Treatment Period|Withdrawal by Subject|0|||
162785132|NCT01390441|587924197|FG004|Treatment Period|Withdrawal by Subject|1|||
162785133|NCT01390441|587924193|FG000|Treatment Period|Lost to Follow-up|1|||
162785134|NCT01390441|587924194|FG001|Treatment Period|Lost to Follow-up|0|||
162785135|NCT01390441|587924195|FG002|Treatment Period|Lost to Follow-up|0|||
162785136|NCT01390441|587924196|FG003|Treatment Period|Lost to Follow-up|0|||
162785137|NCT01390441|587924197|FG004|Treatment Period|Lost to Follow-up|0|||
162785138|NCT01390441|587924193|FG000|Extension Period|Protocol Violation|3|||
162785139|NCT01390441|587924194|FG001|Extension Period|Protocol Violation|1|||
162785140|NCT01390441|587924195|FG002|Extension Period|Protocol Violation|0|||
162785141|NCT01390441|587924196|FG003|Extension Period|Protocol Violation|1|||
162785142|NCT01390441|587924197|FG004|Extension Period|Protocol Violation|0|||
162785143|NCT04788511|587924200|FG000|Overall Study|Withdrawal by Subject|2|||
162785144|NCT04788511|587924201|FG001|Overall Study|Withdrawal by Subject|1|||
162785145|NCT04788511|587924200|FG000|Overall Study|Lost to Follow-up|2|||
162785146|NCT04788511|587924201|FG001|Overall Study|Lost to Follow-up|7|||
162785147|NCT04788511|587924200|FG000|Overall Study|Death|3|||
162785148|NCT04788511|587924201|FG001|Overall Study|Death|4|||
162785149|NCT03174782|587924202|FG000|Overall Study|Protocol Violation|1|||
162785150|NCT03174782|587924203|FG001|Overall Study|Protocol Violation|0|||
162785151|NCT03174782|587924202|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
162785152|NCT03174782|587924203|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
162785153|NCT00778921|587924204|FG000|Overall Study|Adverse Event|9|||
162785154|NCT00778921|587924205|FG001|Overall Study|Adverse Event|10|||
162785155|NCT00778921|587924206|FG002|Overall Study|Adverse Event|14|||
162785156|NCT00778921|587924204|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162785157|NCT00778921|587924205|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
162785158|NCT00778921|587924206|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162785159|NCT00778921|587924204|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
162785160|NCT00778921|587924205|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
162785161|NCT00778921|587924206|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
162785162|NCT00778921|587924204|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
162785163|NCT00778921|587924205|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
162785164|NCT00778921|587924206|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
162785165|NCT00778921|587924204|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
162785166|NCT00778921|587924205|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
162785167|NCT00778921|587924206|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
162785168|NCT00778921|587924204|FG000|Overall Study|Patient withdrew request|3|||
162785169|NCT00778921|587924205|FG001|Overall Study|Patient withdrew request|1|||
162785170|NCT00778921|587924206|FG002|Overall Study|Patient withdrew request|6|||
162785171|NCT00778921|587924204|FG000|Overall Study|Lost to Follow-up|0|||
162785172|NCT00778921|587924205|FG001|Overall Study|Lost to Follow-up|2|||
162785173|NCT00778921|587924206|FG002|Overall Study|Lost to Follow-up|1|||
162785174|NCT00778921|587924204|FG000|Overall Study|Administrative Problems|1|||
162785175|NCT00778921|587924205|FG001|Overall Study|Administrative Problems|2|||
162785176|NCT00778921|587924206|FG002|Overall Study|Administrative Problems|0|||
162785177|NCT00778921|587924204|FG000|Overall Study|Protocol Violation|3|||
162785178|NCT00778921|587924205|FG001|Overall Study|Protocol Violation|0|||
162785179|NCT00778921|587924206|FG002|Overall Study|Protocol Violation|2|||
162785180|NCT00778921|587924204|FG000|Overall Study|Not treated|0|||
162785181|NCT00778921|587924205|FG001|Overall Study|Not treated|2|||
162785182|NCT00778921|587924206|FG002|Overall Study|Not treated|2|||
162785183|NCT03178045|587924207|FG000|Overall Study|Withdrawal by Subject|5|||
162785184|NCT03178045|587924208|FG001|Overall Study|Withdrawal by Subject|7|||
162785185|NCT03178045|587924207|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
162785186|NCT03178045|587924208|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
162785187|NCT03178045|587924207|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
162785188|NCT03178045|587924208|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
162785189|NCT01078922|587924209|FG000|Overall Study|Adverse Event|1|||
162785190|NCT02353468|587924210|FG000|Overall Study|Study terminated|3|||
162785191|NCT00003477|587924213|FG000|Overall Study|Not evalauable|4|||
162785192|NCT00798304|587924214|FG000|Overall Study|Adverse Event|0|||
162785193|NCT00798304|587924215|FG001|Overall Study|Adverse Event|1|||
162785194|NCT00798304|587924216|FG002|Overall Study|Adverse Event|1|||
162785195|NCT00798304|587924214|FG000|Overall Study|Discontinuation by Sponsor|14|||
162785196|NCT00798304|587924215|FG001|Overall Study|Discontinuation by Sponsor|21|||
162785197|NCT00798304|587924216|FG002|Overall Study|Discontinuation by Sponsor|9|||
162785198|NCT02031536|587924218|FG000|Overall Study|ineligible|1|||
162785199|NCT02031536|587924219|FG001|Overall Study|ineligible|0|||
162785200|NCT04206085|587924225|FG000|Overall Study|Lost to Follow-up|0|||
162785201|NCT04206085|587924226|FG001|Overall Study|Lost to Follow-up|1|||
162785202|NCT04206085|587924227|FG002|Overall Study|Lost to Follow-up|0|||
162785203|NCT04206085|587924225|FG000|Overall Study|Lost to Follow-up|0|||
162785204|NCT04206085|587924226|FG001|Overall Study|Lost to Follow-up|0|||
162785205|NCT04206085|587924227|FG002|Overall Study|Lost to Follow-up|1|||
162785206|NCT00725543|587924231|FG000|Overall Study|Adverse Event|10|||
162785207|NCT00725543|587924231|FG000|Overall Study|Lack of Efficacy|3|||
162785208|NCT00725543|587924231|FG000|Overall Study|Withdrawal by Subject|10|||
162785209|NCT00725543|587924231|FG000|Overall Study|Physician Decision|5|||
162785210|NCT00725543|587924231|FG000|Overall Study|Lost to Follow-up|4|||
162785211|NCT00725543|587924231|FG000|Overall Study|Non-compliance|2|||
162785212|NCT00725543|587924231|FG000|Overall Study|Other|119|||
162785213|NCT02168478|587924232|FG000|Overall Study|Withdrawal by Subject|1|||
162785214|NCT02168478|587924232|FG000|Overall Study|Did Not Consent to Participation|2|||
162785215|NCT02168478|587924232|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
162785216|NCT00087555|587924233|FG000|Overall Study|Adverse Event|3|||
162785217|NCT00087555|587924234|FG001|Overall Study|Adverse Event|6|||
162785218|NCT00087555|587924235|FG002|Overall Study|Adverse Event|14|||
162785219|NCT00087555|587924233|FG000|Overall Study|Lost to Follow-up|0|||
162785220|NCT00087555|587924234|FG001|Overall Study|Lost to Follow-up|1|||
162785221|NCT00087555|587924235|FG002|Overall Study|Lost to Follow-up|1|||
162785222|NCT00087555|587924233|FG000|Overall Study|Non - Compliance|1|||
162785223|NCT00087555|587924234|FG001|Overall Study|Non - Compliance|0|||
162785224|NCT00087555|587924235|FG002|Overall Study|Non - Compliance|0|||
162785225|NCT00087555|587924233|FG000|Overall Study|Protocol Violation|0|||
162785226|NCT00087555|587924234|FG001|Overall Study|Protocol Violation|0|||
162785227|NCT00087555|587924235|FG002|Overall Study|Protocol Violation|2|||
162785228|NCT00087555|587924233|FG000|Overall Study|Screen Failure|1|||
162785229|NCT00087555|587924234|FG001|Overall Study|Screen Failure|1|||
162785230|NCT00087555|587924235|FG002|Overall Study|Screen Failure|0|||
162785231|NCT00087555|587924233|FG000|Overall Study|Pregnancy|0|||
162785232|NCT00087555|587924234|FG001|Overall Study|Pregnancy|1|||
162785233|NCT00087555|587924235|FG002|Overall Study|Pregnancy|1|||
162785234|NCT00087555|587924233|FG000|Overall Study|Withdrawal by Subject|3|||
162785235|NCT00087555|587924234|FG001|Overall Study|Withdrawal by Subject|2|||
162785236|NCT00087555|587924235|FG002|Overall Study|Withdrawal by Subject|1|||
162785237|NCT00087555|587924233|FG000|Overall Study|Lack of Efficacy|2|||
162785238|NCT00087555|587924234|FG001|Overall Study|Lack of Efficacy|0|||
162785239|NCT00087555|587924235|FG002|Overall Study|Lack of Efficacy|1|||
162785240|NCT00087555|587924233|FG000|Overall Study|Non Compliance|0|||
162785241|NCT00087555|587924234|FG001|Overall Study|Non Compliance|0|||
162785242|NCT00087555|587924235|FG002|Overall Study|Non Compliance|1|||
162785243|NCT00087555|587924233|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
162785244|NCT00087555|587924234|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
162785245|NCT00087555|587924235|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
162785246|NCT00087555|587924233|FG000|Overall Study|Patient wanted to go back on Med|1|||
162785247|NCT00087555|587924234|FG001|Overall Study|Patient wanted to go back on Med|0|||
162785248|NCT00087555|587924235|FG002|Overall Study|Patient wanted to go back on Med|0|||
162785249|NCT01062971|587924236|FG000|Overall Study|Protocol Violation|1|||
162785250|NCT01062971|587924237|FG001|Overall Study|Protocol Violation|3|||
162785251|NCT01062971|587924236|FG000|Overall Study|Lost to Follow-up|3|||
162785252|NCT01062971|587924237|FG001|Overall Study|Lost to Follow-up|4|||
162785253|NCT05523219|587924238|FG000|Overall Study|Wrong inclusion|1|||
162785254|NCT05523219|587924238|FG000|Overall Study|Lost to Follow-up|7|||
162785255|NCT02760485|587924239|FG000|Phase 1|Death|3|||
162785256|NCT02760485|587924240|FG001|Phase 1|Death|6|||
162785257|NCT02760485|587924241|FG002|Phase 1|Death|0|||
162785258|NCT02760485|587924239|FG000|Phase 1|Withdrawal by Subject|2|||
162785259|NCT02760485|587924240|FG001|Phase 1|Withdrawal by Subject|0|||
162785260|NCT02760485|587924241|FG002|Phase 1|Withdrawal by Subject|0|||
162785261|NCT02760485|587924239|FG000|Phase 1|Progressive Disease|1|||
162785262|NCT02760485|587924240|FG001|Phase 1|Progressive Disease|0|||
162785263|NCT02760485|587924241|FG002|Phase 1|Progressive Disease|0|||
162785264|NCT02760485|587924239|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
162785265|NCT02760485|587924240|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
162785266|NCT02760485|587924241|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
162785267|NCT02760485|587924239|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
162785268|NCT02760485|587924240|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
162785269|NCT02760485|587924241|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
162785270|NCT02760485|587924239|FG000|Phase 2|Death|0|||
162785271|NCT02760485|587924240|FG001|Phase 2|Death|0|||
162785272|NCT02760485|587924241|FG002|Phase 2|Death|12|||
162785273|NCT02760485|587924239|FG000|Phase 2|Withdrawal by Subject|0|||
162785274|NCT02760485|587924240|FG001|Phase 2|Withdrawal by Subject|0|||
162785275|NCT02760485|587924241|FG002|Phase 2|Withdrawal by Subject|3|||
162785276|NCT02760485|587924239|FG000|Phase 2|Progressive Disease|0|||
162785277|NCT02760485|587924240|FG001|Phase 2|Progressive Disease|0|||
162785278|NCT02760485|587924241|FG002|Phase 2|Progressive Disease|1|||
162785279|NCT02760485|587924239|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
162785280|NCT02760485|587924240|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
162785281|NCT02760485|587924241|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
162785282|NCT03738397|587924242|FG000|Overall Study|Adverse Event|3|||
162785283|NCT03738397|587924243|FG001|Overall Study|Adverse Event|7|||
162785284|NCT03738397|587924242|FG000|Overall Study|Withdrawal by Subject|8|||
162785285|NCT03738397|587924243|FG001|Overall Study|Withdrawal by Subject|11|||
162785286|NCT03738397|587924242|FG000|Overall Study|Lost to Follow-up|7|||
162785287|NCT03738397|587924243|FG001|Overall Study|Lost to Follow-up|5|||
162785288|NCT03738397|587924242|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
162785289|NCT03738397|587924243|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
162785290|NCT03738397|587924242|FG000|Overall Study|Other|4|||
162785291|NCT03738397|587924243|FG001|Overall Study|Other|6|||
162785292|NCT01087814|587924246|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
162785293|NCT01087814|587924247|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
162785294|NCT01087814|587924246|FG000|Second Intervention (5 Days)|Physician Decision|1|||
162785295|NCT01087814|587924247|FG001|Second Intervention (5 Days)|Physician Decision|0|||
162785296|NCT00661713|587924248|FG000|Overall Study|Death|1|||
162785297|NCT00661713|587924249|FG001|Overall Study|Death|0|||
162785298|NCT00661713|587924250|FG002|Overall Study|Death|0|||
162785299|NCT00661713|587924251|FG003|Overall Study|Death|0|||
162785300|NCT00661713|587924252|FG004|Overall Study|Death|1|||
162785301|NCT00661713|587924253|FG005|Overall Study|Death|0|||
162785302|NCT00661713|587924254|FG006|Overall Study|Death|0|||
162785303|NCT00661713|587924255|FG007|Overall Study|Death|0|||
162785304|NCT00661713|587924248|FG000|Overall Study|Unable to Classify|1|||
162785305|NCT00661713|587924249|FG001|Overall Study|Unable to Classify|0|||
162785306|NCT00661713|587924250|FG002|Overall Study|Unable to Classify|0|||
162785307|NCT00661713|587924251|FG003|Overall Study|Unable to Classify|0|||
162785308|NCT00661713|587924252|FG004|Overall Study|Unable to Classify|0|||
162785309|NCT00661713|587924253|FG005|Overall Study|Unable to Classify|0|||
162785310|NCT00661713|587924254|FG006|Overall Study|Unable to Classify|0|||
162785311|NCT00661713|587924255|FG007|Overall Study|Unable to Classify|0|||
162785312|NCT00661713|587924248|FG000|Overall Study|Protocol Violation|1|||
162785313|NCT00661713|587924249|FG001|Overall Study|Protocol Violation|6|||
162785314|NCT00661713|587924250|FG002|Overall Study|Protocol Violation|3|||
162785315|NCT00661713|587924251|FG003|Overall Study|Protocol Violation|3|||
162785316|NCT00661713|587924252|FG004|Overall Study|Protocol Violation|0|||
162785317|NCT00661713|587924253|FG005|Overall Study|Protocol Violation|2|||
162785318|NCT00661713|587924254|FG006|Overall Study|Protocol Violation|2|||
162785319|NCT00661713|587924255|FG007|Overall Study|Protocol Violation|1|||
162785320|NCT00661713|587924248|FG000|Overall Study|Withdrawal by Subject|11|||
162785321|NCT00661713|587924249|FG001|Overall Study|Withdrawal by Subject|25|||
162785322|NCT00661713|587924250|FG002|Overall Study|Withdrawal by Subject|12|||
162785323|NCT00661713|587924251|FG003|Overall Study|Withdrawal by Subject|21|||
162785324|NCT00661713|587924252|FG004|Overall Study|Withdrawal by Subject|12|||
162785325|NCT00661713|587924253|FG005|Overall Study|Withdrawal by Subject|26|||
162785326|NCT00661713|587924254|FG006|Overall Study|Withdrawal by Subject|45|||
162785327|NCT00661713|587924255|FG007|Overall Study|Withdrawal by Subject|9|||
162785328|NCT00661713|587924248|FG000|Overall Study|Lost to Follow-up|2|||
162785329|NCT00661713|587924249|FG001|Overall Study|Lost to Follow-up|7|||
162785330|NCT00661713|587924250|FG002|Overall Study|Lost to Follow-up|2|||
162785331|NCT00661713|587924251|FG003|Overall Study|Lost to Follow-up|2|||
162785332|NCT00661713|587924252|FG004|Overall Study|Lost to Follow-up|5|||
162785333|NCT00661713|587924253|FG005|Overall Study|Lost to Follow-up|7|||
162785334|NCT00661713|587924254|FG006|Overall Study|Lost to Follow-up|14|||
162785335|NCT00661713|587924255|FG007|Overall Study|Lost to Follow-up|1|||
162785336|NCT00661713|587924248|FG000|Overall Study|Administrative Reason|0|||
162785337|NCT00661713|587924249|FG001|Overall Study|Administrative Reason|1|||
162785338|NCT00661713|587924250|FG002|Overall Study|Administrative Reason|0|||
162785339|NCT00661713|587924251|FG003|Overall Study|Administrative Reason|2|||
162785340|NCT00661713|587924252|FG004|Overall Study|Administrative Reason|2|||
162785341|NCT00661713|587924253|FG005|Overall Study|Administrative Reason|2|||
162785342|NCT00661713|587924254|FG006|Overall Study|Administrative Reason|1|||
162785343|NCT00661713|587924255|FG007|Overall Study|Administrative Reason|0|||
162785344|NCT00661713|587924248|FG000|Overall Study|Adverse Event|0|||
162785345|NCT00661713|587924249|FG001|Overall Study|Adverse Event|0|||
162785346|NCT00661713|587924250|FG002|Overall Study|Adverse Event|0|||
162785347|NCT00661713|587924251|FG003|Overall Study|Adverse Event|0|||
162785348|NCT00661713|587924252|FG004|Overall Study|Adverse Event|0|||
162785349|NCT00661713|587924253|FG005|Overall Study|Adverse Event|0|||
162785350|NCT00661713|587924254|FG006|Overall Study|Adverse Event|1|||
162785351|NCT00661713|587924255|FG007|Overall Study|Adverse Event|0|||
162785352|NCT00661713|587924248|FG000|Overall Study|Inappropriate Enrollment|0|||
162785353|NCT00661713|587924249|FG001|Overall Study|Inappropriate Enrollment|0|||
162785354|NCT00661713|587924250|FG002|Overall Study|Inappropriate Enrollment|0|||
162785355|NCT00661713|587924251|FG003|Overall Study|Inappropriate Enrollment|0|||
162785356|NCT00661713|587924252|FG004|Overall Study|Inappropriate Enrollment|0|||
162785357|NCT00661713|587924253|FG005|Overall Study|Inappropriate Enrollment|0|||
162785358|NCT00661713|587924254|FG006|Overall Study|Inappropriate Enrollment|1|||
162785359|NCT00661713|587924255|FG007|Overall Study|Inappropriate Enrollment|0|||
162785360|NCT05314374|587924256|FG000|Overall Study|Adverse Event|2|||
162785361|NCT05314374|587924257|FG001|Overall Study|Adverse Event|2|||
162785362|NCT03783689|587924260|FG000|Overall Study|Adverse Event|2|||
162785363|NCT03783689|587924261|FG001|Overall Study|Adverse Event|0|||
162785364|NCT03783689|587924260|FG000|Overall Study|Lost to Follow-up|2|||
162785365|NCT03783689|587924261|FG001|Overall Study|Lost to Follow-up|1|||
162785366|NCT03783689|587924260|FG000|Overall Study|Physician Decision|2|||
162785367|NCT03783689|587924261|FG001|Overall Study|Physician Decision|1|||
162785368|NCT03783689|587924260|FG000|Overall Study|Withdrawal by Subject|3|||
162785369|NCT03783689|587924261|FG001|Overall Study|Withdrawal by Subject|3|||
162785370|NCT02165826|587924263|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
162785371|NCT02165826|587924264|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
162785372|NCT02165826|587924265|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
162785373|NCT02165826|587924263|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
162785374|NCT02165826|587924264|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
162785375|NCT02165826|587924265|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
162785376|NCT02165826|587924263|FG000|Main Treatment Period|Lost to Follow-up|4|||
162785377|NCT02165826|587924264|FG001|Main Treatment Period|Lost to Follow-up|2|||
162785378|NCT02165826|587924265|FG002|Main Treatment Period|Lost to Follow-up|1|||
162785379|NCT02165826|587924263|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
162785380|NCT02165826|587924264|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
162785381|NCT02165826|587924265|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
162785382|NCT02165826|587924263|FG000|Main Treatment Period|Lack of Efficacy|2|||
162785383|NCT02165826|587924264|FG001|Main Treatment Period|Lack of Efficacy|0|||
162785384|NCT02165826|587924265|FG002|Main Treatment Period|Lack of Efficacy|0|||
162785385|NCT02165826|587924263|FG000|Main Treatment Period|Reason Not Specified|8|||
162785386|NCT02165826|587924264|FG001|Main Treatment Period|Reason Not Specified|5|||
162785387|NCT02165826|587924265|FG002|Main Treatment Period|Reason Not Specified|16|||
162785388|NCT02165826|587924263|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
162785389|NCT02165826|587924264|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
162785390|NCT02165826|587924265|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
162785391|NCT02165826|587924263|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
162785392|NCT02165826|587924264|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
162785393|NCT02165826|587924265|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
162785394|NCT02165826|587924263|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
162785395|NCT02165826|587924264|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
162785396|NCT02165826|587924265|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
162785397|NCT02165826|587924263|FG000|Down-Titration Period|Reason Not Specified|1|||
162785398|NCT02165826|587924264|FG001|Down-Titration Period|Reason Not Specified|0|||
162785399|NCT02165826|587924265|FG002|Down-Titration Period|Reason Not Specified|2|||
162785400|NCT04887506|587924266|FG000|Overall Study|Death|1|||
162785401|NCT04887506|587924267|FG001|Overall Study|Death|1|||
162785402|NCT04887506|587924266|FG000|Overall Study|Withdrawal by Subject|0|||
162785403|NCT04887506|587924267|FG001|Overall Study|Withdrawal by Subject|3|||
162785404|NCT04887506|587924266|FG000|Overall Study|Adverse Event|4|||
162785405|NCT04887506|587924267|FG001|Overall Study|Adverse Event|3|||
162785406|NCT04887506|587924266|FG000|Overall Study|Other - Not Reported|1|||
162785407|NCT04887506|587924267|FG001|Overall Study|Other - Not Reported|1|||
162785408|NCT02636608|587924271|FG000|Overall Study|Failure to Return|4|||
162785409|NCT02636608|587924271|FG000|Overall Study|Insufficient Virological Response|1|||
162785410|NCT02636608|587924271|FG000|Overall Study|Death|3|||
162785411|NCT02636608|587924271|FG000|Overall Study|Other|2|||
162785412|NCT02636608|587924271|FG000|Overall Study|Did Not Receive Treatment|1|||
162785413|NCT04913948|587924273|FG000|Overall Study|Withdrawal by Subject|2|||
162785414|NCT04913948|587924273|FG000|Overall Study|Sample processing issues|1|||
162785415|NCT04913948|587924273|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
162785416|NCT05739994|587924277|FG000|Overall Study|Withdrawal by Subject|2|||
162785417|NCT05739994|587924278|FG001|Overall Study|Withdrawal by Subject|2|||
162785418|NCT05739994|587924279|FG002|Overall Study|Withdrawal by Subject|4|||
162785419|NCT00815919|587924280|FG000|Overall Study|Unrelated Fungal Infection|1|||
162785420|NCT00815919|587924280|FG000|Overall Study|AML Relapse|1|||
162785421|NCT00815919|587924280|FG000|Overall Study|Lack of Efficacy|2|||
162785422|NCT04750577|587924281|FG000|Overall Study|Adverse Event|2|||
162785423|NCT04750577|587924282|FG001|Overall Study|Adverse Event|10|||
162785424|NCT04750577|587924283|FG002|Overall Study|Adverse Event|8|||
162785425|NCT04750577|587924284|FG003|Overall Study|Adverse Event|1|||
162785426|NCT04750577|587924281|FG000|Overall Study|Change of residence|0|||
162785427|NCT04750577|587924282|FG001|Overall Study|Change of residence|0|||
162785428|NCT04750577|587924283|FG002|Overall Study|Change of residence|1|||
162785429|NCT04750577|587924284|FG003|Overall Study|Change of residence|0|||
162785430|NCT04750577|587924281|FG000|Overall Study|Burden of study procedures|0|||
162785431|NCT04750577|587924282|FG001|Overall Study|Burden of study procedures|2|||
162785432|NCT04750577|587924283|FG002|Overall Study|Burden of study procedures|2|||
162785433|NCT04750577|587924284|FG003|Overall Study|Burden of study procedures|0|||
162785434|NCT04750577|587924281|FG000|Overall Study|Prematurely discontinued|0|||
162785435|NCT04750577|587924282|FG001|Overall Study|Prematurely discontinued|0|||
162785436|NCT04750577|587924283|FG002|Overall Study|Prematurely discontinued|0|||
162785437|NCT04750577|587924284|FG003|Overall Study|Prematurely discontinued|2|||
162785438|NCT04750577|587924281|FG000|Overall Study|Protocol deviation|1|||
162785439|NCT04750577|587924282|FG001|Overall Study|Protocol deviation|1|||
162785440|NCT04750577|587924283|FG002|Overall Study|Protocol deviation|1|||
162785441|NCT04750577|587924284|FG003|Overall Study|Protocol deviation|1|||
162785442|NCT04750577|587924281|FG000|Overall Study|Other than listed|3|||
162785443|NCT04750577|587924282|FG001|Overall Study|Other than listed|2|||
162785444|NCT04750577|587924283|FG002|Overall Study|Other than listed|2|||
162785445|NCT04750577|587924284|FG003|Overall Study|Other than listed|1|||
162785446|NCT04750577|587924281|FG000|Overall Study|Not treated|0|||
162785447|NCT04750577|587924282|FG001|Overall Study|Not treated|0|||
162785448|NCT04750577|587924283|FG002|Overall Study|Not treated|0|||
162785449|NCT04750577|587924284|FG003|Overall Study|Not treated|2|||
162785450|NCT02473042|587924286|FG000|Overall Study|Withdrawal by Subject|1|||
162785451|NCT02473042|587924287|FG001|Overall Study|Withdrawal by Subject|0|||
162785452|NCT02473042|587924286|FG000|Overall Study|Patient became ineligible after enrollment|2|||
162785453|NCT02473042|587924287|FG001|Overall Study|Patient became ineligible after enrollment|5|||
162785454|NCT02473042|587924286|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
162785455|NCT02473042|587924287|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
162785456|NCT02473042|587924286|FG000|Overall Study|PACU data unable to be collected|3|||
162785457|NCT02473042|587924287|FG001|Overall Study|PACU data unable to be collected|0|||
162785458|NCT04680637|587924290|FG000|Overall Study|Lost to Follow-up|0|||
162785459|NCT04680637|587924291|FG001|Overall Study|Lost to Follow-up|1|||
162785460|NCT04680637|587924292|FG002|Overall Study|Lost to Follow-up|0|||
162785461|NCT04680637|587924293|FG003|Overall Study|Lost to Follow-up|1|||
162785462|NCT04680637|587924290|FG000|Overall Study|Death|1|||
162785463|NCT04680637|587924291|FG001|Overall Study|Death|0|||
162785464|NCT04680637|587924292|FG002|Overall Study|Death|0|||
162785465|NCT04680637|587924293|FG003|Overall Study|Death|0|||
162785466|NCT04680637|587924290|FG000|Overall Study|Withdrawal by Subject|7|||
162785467|NCT04680637|587924291|FG001|Overall Study|Withdrawal by Subject|10|||
162785468|NCT04680637|587924292|FG002|Overall Study|Withdrawal by Subject|17|||
162785469|NCT04680637|587924293|FG003|Overall Study|Withdrawal by Subject|15|||
162785470|NCT04680637|587924290|FG000|Overall Study|Decision by Sponsor|21|||
162785471|NCT04680637|587924291|FG001|Overall Study|Decision by Sponsor|15|||
162785472|NCT04680637|587924292|FG002|Overall Study|Decision by Sponsor|7|||
162785473|NCT04680637|587924293|FG003|Overall Study|Decision by Sponsor|32|||
162785474|NCT01103232|587924296|FG000|Overall Study|Withdrawal by Subject|1|||
162785475|NCT01103232|587924297|FG001|Overall Study|Withdrawal by Subject|1|||
162785476|NCT01103232|587924296|FG000|Overall Study|Protocol Violation|0|||
162785477|NCT01103232|587924297|FG001|Overall Study|Protocol Violation|1|||
162785478|NCT00443599|587924298|FG000|Overall Study|Physician Decision|2|||
162785479|NCT00443599|587924299|FG001|Overall Study|Physician Decision|1|||
162785480|NCT00443599|587924298|FG000|Overall Study|Death|1|||
162785481|NCT00443599|587924299|FG001|Overall Study|Death|1|||
162785482|NCT00443599|587924298|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
162785483|NCT00443599|587924299|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
162785484|NCT05093504|587924300|FG000|Overall Study|Death|0|||
162785485|NCT05093504|587924301|FG001|Overall Study|Death|1|||
162785486|NCT03151551|587924302|FG000|Open-Label Treatment Period|Adverse Event|0|||
162785487|NCT03151551|587924303|FG001|Open-Label Treatment Period|Adverse Event|2|||
162785488|NCT03151551|587924302|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
162785489|NCT03151551|587924303|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
162785490|NCT03151551|587924302|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
162785491|NCT03151551|587924303|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
162785492|NCT03151551|587924302|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
162785493|NCT03151551|587924303|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
162785494|NCT03151551|587924302|FG000|Open-Label Treatment Period|Physician Decision|3|||
162785495|NCT03151551|587924303|FG001|Open-Label Treatment Period|Physician Decision|0|||
162785496|NCT03151551|587924302|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
162785497|NCT03151551|587924303|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
162785498|NCT03151551|587924302|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
162785499|NCT03151551|587924303|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
162785500|NCT03151551|587924302|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
162785501|NCT03151551|587924303|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
162785502|NCT03151551|587924302|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
162785503|NCT03151551|587924303|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
162785504|NCT03151551|587924302|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
162785505|NCT03151551|587924303|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
162785506|NCT01190449|587924304|FG000|Overall Study|Ineligible|0|||
162785507|NCT01190449|587924305|FG001|Overall Study|Ineligible|4|||
162785508|NCT03526679|587926161|FG000|Overall Study|still under treatment|2|||
162785509|NCT01246999|587926162|FG000|Overall Study|Lost to Follow-up|0|||
162785510|NCT01246999|587926163|FG001|Overall Study|Lost to Follow-up|1|||
162785511|NCT01246999|587926164|FG002|Overall Study|Lost to Follow-up|0|||
162785512|NCT01246999|587926165|FG003|Overall Study|Lost to Follow-up|0|||
162785513|NCT01246999|587926162|FG000|Overall Study|Withdrawal by Subject|0|||
162785514|NCT01246999|587926163|FG001|Overall Study|Withdrawal by Subject|0|||
162785515|NCT01246999|587926164|FG002|Overall Study|Withdrawal by Subject|0|||
162785516|NCT01246999|587926165|FG003|Overall Study|Withdrawal by Subject|2|||
162785517|NCT01867047|587926166|FG000|Overall Study|Lost to Follow-up|3|||
162785518|NCT01867047|587926167|FG001|Overall Study|Lost to Follow-up|3|||
162785519|NCT01867047|587926166|FG000|Overall Study|Withdrawal by Subject|2|||
162785520|NCT01867047|587926167|FG001|Overall Study|Withdrawal by Subject|0|||
162785521|NCT01867047|587926166|FG000|Overall Study|Physician Decision|2|||
162785522|NCT01867047|587926167|FG001|Overall Study|Physician Decision|0|||
162785523|NCT01867047|587926166|FG000|Overall Study|surgery not indicated in protocol|1|||
162785524|NCT01867047|587926167|FG001|Overall Study|surgery not indicated in protocol|2|||
162785525|NCT00307047|587926168|FG000|Overall Study|Lost to Follow-up|35|||
162785526|NCT00307047|587926169|FG001|Overall Study|Lost to Follow-up|24|||
162785527|NCT00307047|587926168|FG000|Overall Study|Withdrawal by Subject|6|||
162785528|NCT00307047|587926169|FG001|Overall Study|Withdrawal by Subject|6|||
162785529|NCT00307047|587926168|FG000|Overall Study|Physician Decision|1|||
162785530|NCT00307047|587926169|FG001|Overall Study|Physician Decision|2|||
162785531|NCT00307047|587926168|FG000|Overall Study|Lost to follow-up for other reasons|0|||
162785532|NCT00307047|587926169|FG001|Overall Study|Lost to follow-up for other reasons|1|||
162785533|NCT00307047|587926168|FG000|Overall Study|All death, all MI, all Revascularization|27|||
162785534|NCT00307047|587926169|FG001|Overall Study|All death, all MI, all Revascularization|16|||
162785535|NCT02825251|587926170|FG000|Overall Study|Adverse Event|0|||
162785536|NCT02825251|587926171|FG001|Overall Study|Adverse Event|1|||
162785537|NCT02825251|587926170|FG000|Overall Study|Lost to Follow-up|0|||
162785538|NCT02825251|587926171|FG001|Overall Study|Lost to Follow-up|1|||
162785539|NCT02825251|587926170|FG000|Overall Study|Withdrawal by Subject|1|||
162785540|NCT02825251|587926171|FG001|Overall Study|Withdrawal by Subject|4|||
162785541|NCT02825251|587926170|FG000|Overall Study|Unclassified|2|||
162785542|NCT02825251|587926171|FG001|Overall Study|Unclassified|0|||
162785543|NCT01689363|587926176|FG000|Overall Study|Protocol Violation|0|||
162785544|NCT01689363|587926177|FG001|Overall Study|Protocol Violation|1|||
162785545|NCT01689363|587926178|FG002|Overall Study|Protocol Violation|0|||
162785546|NCT01689363|587926179|FG003|Overall Study|Protocol Violation|0|||
162785547|NCT01689363|587926180|FG004|Overall Study|Protocol Violation|0|||
162785548|NCT01689363|587926181|FG005|Overall Study|Protocol Violation|0|||
162785549|NCT01689363|587926182|FG006|Overall Study|Protocol Violation|0|||
162785550|NCT01689363|587926183|FG007|Overall Study|Protocol Violation|0|||
162785551|NCT00321685|587926184|FG000|Overall Study|Adverse Event|18|||
162785552|NCT00321685|587926184|FG000|Overall Study|Death|2|||
162785553|NCT00321685|587926184|FG000|Overall Study|Withdrawal by Subject|8|||
162785554|NCT00321685|587926184|FG000|Overall Study|Alternative therapy|1|||
162785555|NCT00321685|587926184|FG000|Overall Study|Complicating disese|1|||
162785556|NCT00321685|587926184|FG000|Overall Study|Other|5|||
162785557|NCT00321685|587926184|FG000|Overall Study|Not start protocol therapy|2|||
162785558|NCT00321685|587926184|FG000|Overall Study|Ineligible|2|||
162785559|NCT05064488|587926188|FG000|Overall Study|Withdrawal by Subject|2|||
162785560|NCT05064488|587926189|FG001|Overall Study|Withdrawal by Subject|0|||
162785561|NCT03023722|587926190|FG000|Overall Study|No follow-up assessment|4|||
162785562|NCT03616964|587926191|FG000|Overall Study|Adverse Event|15|||
162785563|NCT03616964|587926192|FG001|Overall Study|Adverse Event|10|||
162785564|NCT03616964|587926193|FG002|Overall Study|Adverse Event|16|||
162785565|NCT03616964|587926191|FG000|Overall Study|Death|3|||
162785566|NCT03616964|587926192|FG001|Overall Study|Death|0|||
162785567|NCT03616964|587926193|FG002|Overall Study|Death|4|||
162785568|NCT03616964|587926191|FG000|Overall Study|Lack of Efficacy|4|||
162785569|NCT03616964|587926192|FG001|Overall Study|Lack of Efficacy|8|||
162785570|NCT03616964|587926193|FG002|Overall Study|Lack of Efficacy|8|||
162785571|NCT03616964|587926191|FG000|Overall Study|Lost to Follow-up|2|||
162785572|NCT03616964|587926192|FG001|Overall Study|Lost to Follow-up|1|||
162785573|NCT03616964|587926193|FG002|Overall Study|Lost to Follow-up|3|||
162785574|NCT03616964|587926191|FG000|Overall Study|Withdrawal by Subject|18|||
162785575|NCT03616964|587926192|FG001|Overall Study|Withdrawal by Subject|14|||
162785576|NCT03616964|587926193|FG002|Overall Study|Withdrawal by Subject|21|||
162785577|NCT03616964|587926191|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162785578|NCT03616964|587926192|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162785579|NCT03616964|587926193|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162785580|NCT03616964|587926191|FG000|Overall Study|Sponsor's Decision|1|||
162785581|NCT03616964|587926192|FG001|Overall Study|Sponsor's Decision|0|||
162785582|NCT03616964|587926193|FG002|Overall Study|Sponsor's Decision|0|||
162785583|NCT03616964|587926191|FG000|Overall Study|Physician Decision|0|||
162785584|NCT03616964|587926192|FG001|Overall Study|Physician Decision|2|||
162785585|NCT03616964|587926193|FG002|Overall Study|Physician Decision|0|||
162785586|NCT03616964|587926191|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
162785587|NCT03616964|587926192|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
162785588|NCT03616964|587926193|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
162785589|NCT03616964|587926191|FG000|Overall Study|Protocol Violation|0|||
162785590|NCT03616964|587926192|FG001|Overall Study|Protocol Violation|1|||
162785591|NCT03616964|587926193|FG002|Overall Study|Protocol Violation|0|||
162785592|NCT03616964|587926191|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
162785593|NCT03616964|587926192|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
162785594|NCT03616964|587926193|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
162785595|NCT03616964|587926191|FG000|Overall Study|Randomized but Never Treated|1|||
162785596|NCT03616964|587926192|FG001|Overall Study|Randomized but Never Treated|1|||
162785597|NCT03616964|587926193|FG002|Overall Study|Randomized but Never Treated|1|||
162785598|NCT04596995|587926194|FG000|Overall Study|Lack of Efficacy|8|||
162785599|NCT04596995|587926194|FG000|Overall Study|Lost to Follow-up|3|||
162785600|NCT04596995|587926194|FG000|Overall Study|Withdrawal by Subject|12|||
162785601|NCT04596995|587926194|FG000|Overall Study|Sponsor decision|3|||
162785602|NCT04596995|587926194|FG000|Overall Study|Enrolled in managed access program|3|||
162785603|NCT00129935|587926195|FG000|Overall Study|Adverse Event|18|||
162785604|NCT00129935|587926196|FG001|Overall Study|Adverse Event|56|||
162785605|NCT00129935|587926195|FG000|Overall Study|Death|1|||
162785606|NCT00129935|587926196|FG001|Overall Study|Death|1|||
162785607|NCT00129935|587926195|FG000|Overall Study|Withdrawal by Subject|7|||
162785608|NCT00129935|587926196|FG001|Overall Study|Withdrawal by Subject|20|||
162785609|NCT00129935|587926195|FG000|Overall Study|Protocol Violation|0|||
162785610|NCT00129935|587926196|FG001|Overall Study|Protocol Violation|4|||
162785611|NCT00129935|587926195|FG000|Overall Study|Physician Decision|3|||
162785612|NCT00129935|587926196|FG001|Overall Study|Physician Decision|4|||
162785613|NCT00129935|587926195|FG000|Overall Study|Recurrence|1|||
162785614|NCT00129935|587926196|FG001|Overall Study|Recurrence|3|||
162785615|NCT00129935|587926195|FG000|Overall Study|Second primary|0|||
162785616|NCT00129935|587926196|FG001|Overall Study|Second primary|1|||
162785617|NCT00129935|587926195|FG000|Overall Study|Other|3|||
162785618|NCT00129935|587926196|FG001|Overall Study|Other|2|||
162785619|NCT00129935|587926195|FG000|Overall Study|Crossed to the other arm|2|||
162785620|NCT00129935|587926196|FG001|Overall Study|Crossed to the other arm|1|||
162785621|NCT00129935|587926195|FG000|Overall Study|Incorrect study treatment|1|||
162785622|NCT00129935|587926196|FG001|Overall Study|Incorrect study treatment|0|||
162785623|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
162785624|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
162785625|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
162785626|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Death|4|||
162785627|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Death|2|||
162785628|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Death|3|||
162785629|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
162785630|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
162785631|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
162785632|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
162785633|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
162785634|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
162785635|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
162785636|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
162785637|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
162785638|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
162785639|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
162785640|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
162785641|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
162785642|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
162785643|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
162785644|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
162785645|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
162785646|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
162785647|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
162785648|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
162785649|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
162785650|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
162785651|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
162785652|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
162785653|NCT02783573|587926198|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
162785654|NCT02783573|587926199|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
162785655|NCT02783573|587926200|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
162785656|NCT02783573|587926198|FG000|Delayed-Start Period|Sponsor Decision|0|||
162785657|NCT02783573|587926199|FG001|Delayed-Start Period|Sponsor Decision|17|||
162785658|NCT02783573|587926200|FG002|Delayed-Start Period|Sponsor Decision|12|||
162785659|NCT00590564|587926201|FG000|Overall Study|Withdrawal by Subject|4|||
162785660|NCT00590564|587926201|FG000|Overall Study|Lost to Follow-up|6|||
162785661|NCT00590564|587926201|FG000|Overall Study|Protocol Violation|1|||
162785662|NCT00590564|587926201|FG000|Overall Study|Patient Found to be Ineligible|1|||
162785663|NCT00590564|587926201|FG000|Overall Study|Patient Non-compliance|6|||
162785664|NCT01434680|587926204|FG000|Overall Study|Withdrawal by Subject|1|||
162785665|NCT01434680|587926205|FG001|Overall Study|Withdrawal by Subject|0|||
162785666|NCT01434680|587926206|FG002|Overall Study|Withdrawal by Subject|2|||
162785667|NCT01434680|587926207|FG003|Overall Study|Withdrawal by Subject|0|||
162785668|NCT01434680|587926204|FG000|Overall Study|Lost to Follow-up|1|||
162785669|NCT01434680|587926205|FG001|Overall Study|Lost to Follow-up|1|||
162785670|NCT01434680|587926206|FG002|Overall Study|Lost to Follow-up|0|||
162785671|NCT01434680|587926207|FG003|Overall Study|Lost to Follow-up|0|||
162785672|NCT01434680|587926204|FG000|Overall Study|Protocol Violation|1|||
162785673|NCT01434680|587926205|FG001|Overall Study|Protocol Violation|1|||
162785674|NCT01434680|587926206|FG002|Overall Study|Protocol Violation|0|||
162785675|NCT01434680|587926207|FG003|Overall Study|Protocol Violation|0|||
162785676|NCT01367847|587926209|FG000|Overall Study|Withdrawal by Subject|2|||
162785677|NCT01367847|587926210|FG001|Overall Study|Withdrawal by Subject|2|||
162785678|NCT04836559|587926213|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162785679|NCT04836559|587926214|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
162785680|NCT04836559|587926215|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
162785681|NCT04836559|587926216|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
162785682|NCT04836559|587926217|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162785683|NCT04836559|587926218|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162785684|NCT04836559|587926219|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162785685|NCT04836559|587926220|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162785686|NCT04836559|587926213|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162785687|NCT04836559|587926214|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
162785688|NCT04836559|587926215|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
162785689|NCT04836559|587926216|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
162785690|NCT04836559|587926217|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162785691|NCT04836559|587926218|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162785692|NCT04836559|587926219|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162785693|NCT04836559|587926220|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162785694|NCT04836559|587926213|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
162785695|NCT04836559|587926214|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785696|NCT04836559|587926215|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785697|NCT04836559|587926216|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785698|NCT04836559|587926217|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785699|NCT04836559|587926218|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785700|NCT04836559|587926219|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785701|NCT04836559|587926220|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162785702|NCT04836559|587926213|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
162785703|NCT04836559|587926214|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785704|NCT04836559|587926215|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785705|NCT04836559|587926216|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785706|NCT04836559|587926217|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785707|NCT04836559|587926218|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785708|NCT04836559|587926219|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785709|NCT04836559|587926220|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
162785710|NCT04836559|587926213|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785711|NCT04836559|587926214|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785712|NCT04836559|587926215|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785713|NCT04836559|587926216|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
162785714|NCT04836559|587926217|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785715|NCT04836559|587926218|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785716|NCT04836559|587926219|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785717|NCT04836559|587926220|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162785718|NCT04836559|587926213|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162785719|NCT04836559|587926214|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162785720|NCT04836559|587926215|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162785721|NCT04836559|587926216|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162785722|NCT04836559|587926217|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
162785723|NCT04836559|587926218|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
162785724|NCT04836559|587926219|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
162785725|NCT04836559|587926220|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
162785726|NCT04836559|587926213|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162785727|NCT04836559|587926214|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162785728|NCT04836559|587926215|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162785729|NCT04836559|587926216|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162785730|NCT04836559|587926217|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
162785731|NCT04836559|587926218|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
162785732|NCT04836559|587926219|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
162785733|NCT04836559|587926220|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
162785734|NCT04836559|587926213|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162785735|NCT04836559|587926214|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162785736|NCT04836559|587926215|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162785737|NCT04836559|587926216|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162785738|NCT04836559|587926217|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
162785739|NCT04836559|587926218|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
162785740|NCT04836559|587926219|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162785741|NCT04836559|587926220|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
162785742|NCT04836559|587926213|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785743|NCT04836559|587926214|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785744|NCT04836559|587926215|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785745|NCT04836559|587926216|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785746|NCT04836559|587926217|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785747|NCT04836559|587926218|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785748|NCT04836559|587926219|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162785749|NCT04836559|587926220|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
162785750|NCT01952847|587926223|FG000|Overall Study|Ineligible|1|||
162785751|NCT01952847|587926224|FG001|Overall Study|Ineligible|0|||
162785752|NCT01952847|587926225|FG002|Overall Study|Ineligible|0|||
162785753|NCT01952847|587926226|FG003|Overall Study|Ineligible|0|||
162785754|NCT01952847|587926223|FG000|Overall Study|Lack of Insurance Coverage|0|||
162785755|NCT01952847|587926224|FG001|Overall Study|Lack of Insurance Coverage|1|||
162785756|NCT01952847|587926225|FG002|Overall Study|Lack of Insurance Coverage|0|||
162785757|NCT01952847|587926226|FG003|Overall Study|Lack of Insurance Coverage|0|||
162785758|NCT01952847|587926223|FG000|Overall Study|Withdrawal by Subject|1|||
162785759|NCT01952847|587926224|FG001|Overall Study|Withdrawal by Subject|1|||
162785760|NCT01952847|587926225|FG002|Overall Study|Withdrawal by Subject|0|||
162785761|NCT01952847|587926226|FG003|Overall Study|Withdrawal by Subject|1|||
162785762|NCT05382039|587926227|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
162785763|NCT05382039|587926228|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
162785764|NCT05382039|587926229|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
162785765|NCT05382039|587926227|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
162785766|NCT05382039|587926228|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
162785767|NCT05382039|587926229|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
162785768|NCT05382039|587926227|FG000|Overall Study|waiting for confirmation|0|||
162785769|NCT05382039|587926228|FG001|Overall Study|waiting for confirmation|0|||
162785770|NCT05382039|587926229|FG002|Overall Study|waiting for confirmation|1|||
162785771|NCT04464421|587926230|FG000|Overall Study|Lost to Follow-up|2|||
162785772|NCT04464421|587926231|FG001|Overall Study|Lost to Follow-up|2|||
162785773|NCT02577003|587926232|FG000|Overall Study|Adverse Event|2|||
162785774|NCT02577003|587926233|FG001|Overall Study|Adverse Event|4|||
162785775|NCT02577003|587926232|FG000|Overall Study|Withdrawal by Subject|0|||
162785776|NCT02577003|587926233|FG001|Overall Study|Withdrawal by Subject|1|||
162785777|NCT02786004|587926234|FG000|Overall Study|Withdrawal by Subject|0|||
162785778|NCT02786004|587926235|FG001|Overall Study|Withdrawal by Subject|1|||
162785779|NCT01234883|587926236|FG000|Overall Study|Early treatment release|8|||
162785780|NCT01234883|587926237|FG001|Overall Study|Early treatment release|10|||
162785781|NCT01234883|587926236|FG000|Overall Study|Parent/guardian withdrew consent|1|||
162785782|NCT01234883|587926237|FG001|Overall Study|Parent/guardian withdrew consent|2|||
162785783|NCT01234883|587926236|FG000|Overall Study|Technical difficulties with IV infusion|0|||
162785784|NCT01234883|587926237|FG001|Overall Study|Technical difficulties with IV infusion|1|||
162785785|NCT01234883|587926236|FG000|Overall Study|Inclusion/exclusion failure|1|||
162785786|NCT01234883|587926237|FG001|Overall Study|Inclusion/exclusion failure|0|||
162785787|NCT01013961|587926238|FG000|Overall Study|Adverse Event|2|||
162785788|NCT01013961|587926239|FG001|Overall Study|Adverse Event|2|||
162785789|NCT01013961|587926238|FG000|Overall Study|Withdrawal by Subject|1|||
162785790|NCT01013961|587926239|FG001|Overall Study|Withdrawal by Subject|0|||
162785791|NCT01013961|587926238|FG000|Overall Study|Physician Decision|0|||
162785792|NCT01013961|587926239|FG001|Overall Study|Physician Decision|1|||
162785793|NCT01271504|587926240|FG000|Overall Study|Death|7|||
162785794|NCT01271504|587926241|FG001|Overall Study|Death|6|||
162785795|NCT01271504|587926242|FG002|Overall Study|Death|32|||
162785796|NCT01271504|587926243|FG003|Overall Study|Death|32|||
162785797|NCT01271504|587926240|FG000|Overall Study|Lost to Follow-up|0|||
162785798|NCT01271504|587926241|FG001|Overall Study|Lost to Follow-up|1|||
162785799|NCT01271504|587926242|FG002|Overall Study|Lost to Follow-up|3|||
162785800|NCT01271504|587926243|FG003|Overall Study|Lost to Follow-up|1|||
162785801|NCT01271504|587926240|FG000|Overall Study|Protocol Violation|0|||
162785802|NCT01271504|587926241|FG001|Overall Study|Protocol Violation|0|||
162785803|NCT01271504|587926242|FG002|Overall Study|Protocol Violation|0|||
162785804|NCT01271504|587926243|FG003|Overall Study|Protocol Violation|2|||
162785805|NCT01271504|587926240|FG000|Overall Study|Administrative Reasons|0|||
162785806|NCT01271504|587926241|FG001|Overall Study|Administrative Reasons|0|||
162785807|NCT01271504|587926242|FG002|Overall Study|Administrative Reasons|6|||
162785808|NCT01271504|587926243|FG003|Overall Study|Administrative Reasons|5|||
162785809|NCT01271504|587926240|FG000|Overall Study|Withdrawal by Subject|0|||
162785810|NCT01271504|587926241|FG001|Overall Study|Withdrawal by Subject|0|||
162785811|NCT01271504|587926242|FG002|Overall Study|Withdrawal by Subject|1|||
162785812|NCT01271504|587926243|FG003|Overall Study|Withdrawal by Subject|3|||
162785813|NCT01271504|587926240|FG000|Overall Study|Other|0|||
162785814|NCT01271504|587926241|FG001|Overall Study|Other|1|||
162785815|NCT01271504|587926242|FG002|Overall Study|Other|2|||
162785816|NCT01271504|587926243|FG003|Overall Study|Other|0|||
162785817|NCT00756457|587926252|FG000|Overall Study|Lost to Follow-up|1|||
162785818|NCT00756457|587926253|FG001|Overall Study|Lost to Follow-up|2|||
162785819|NCT02947100|587926256|FG000|Overall Study|study terminated early|3|||
162785820|NCT02947100|587926256|FG000|Overall Study|did not meet inclusion criteria|1|||
162785821|NCT02402322|587926257|FG000|Pretreatment|Withdrawal by Subject|3|||
162785822|NCT02402322|587926258|FG001|Pretreatment|Withdrawal by Subject|1|||
162785823|NCT02402322|587926259|FG002|Pretreatment|Withdrawal by Subject|1|||
162785824|NCT02402322|587926257|FG000|Follow-up|Withdrawal by Subject|6|||
162785825|NCT02402322|587926258|FG001|Follow-up|Withdrawal by Subject|3|||
162785826|NCT02402322|587926259|FG002|Follow-up|Withdrawal by Subject|24|||
162785827|NCT02818998|587926260|FG000|Overall Study|Adverse Event|3|||
162785828|NCT02818998|587926261|FG001|Overall Study|Adverse Event|2|||
162785829|NCT02818998|587926262|FG002|Overall Study|Adverse Event|1|||
162785830|NCT02818998|587926260|FG000|Overall Study|Lost to Follow-up|4|||
162785831|NCT02818998|587926261|FG001|Overall Study|Lost to Follow-up|1|||
162785832|NCT02818998|587926262|FG002|Overall Study|Lost to Follow-up|2|||
162785833|NCT02818998|587926260|FG000|Overall Study|Withdrawal by sponsor|0|||
162785834|NCT02818998|587926261|FG001|Overall Study|Withdrawal by sponsor|1|||
162785835|NCT02818998|587926262|FG002|Overall Study|Withdrawal by sponsor|1|||
162785836|NCT02818998|587926260|FG000|Overall Study|Death|3|||
162785837|NCT02818998|587926261|FG001|Overall Study|Death|6|||
162785838|NCT02818998|587926262|FG002|Overall Study|Death|8|||
162785839|NCT02818998|587926260|FG000|Overall Study|Withdrawal by Subject|7|||
162785840|NCT02818998|587926261|FG001|Overall Study|Withdrawal by Subject|6|||
162785841|NCT02818998|587926262|FG002|Overall Study|Withdrawal by Subject|6|||
162785842|NCT02818998|587926260|FG000|Overall Study|Physician Decision|1|||
162785843|NCT02818998|587926261|FG001|Overall Study|Physician Decision|0|||
162785844|NCT02818998|587926262|FG002|Overall Study|Physician Decision|0|||
162785845|NCT02472145|587926266|FG000|Overall Study|Death|10|||
162785846|NCT02472145|587926267|FG001|Overall Study|Death|101|||
162785847|NCT02472145|587926268|FG002|Overall Study|Death|99|||
162785848|NCT02472145|587926266|FG000|Overall Study|Lost to Follow-up|0|||
162785849|NCT02472145|587926267|FG001|Overall Study|Lost to Follow-up|1|||
162785850|NCT02472145|587926268|FG002|Overall Study|Lost to Follow-up|0|||
162785851|NCT02472145|587926266|FG000|Overall Study|Withdrawal by Subject|0|||
162785852|NCT02472145|587926267|FG001|Overall Study|Withdrawal by Subject|9|||
162785853|NCT02472145|587926268|FG002|Overall Study|Withdrawal by Subject|13|||
162785854|NCT02472145|587926266|FG000|Overall Study|Sponsor decision|0|||
162785855|NCT02472145|587926267|FG001|Overall Study|Sponsor decision|3|||
162785856|NCT02472145|587926268|FG002|Overall Study|Sponsor decision|2|||
162785857|NCT02472145|587926266|FG000|Overall Study|Other|0|||
162785858|NCT02472145|587926267|FG001|Overall Study|Other|45|||
162785859|NCT02472145|587926268|FG002|Overall Study|Other|43|||
162785860|NCT01080326|587926269|FG000|Overall Study|Patient deterioration prior to procedure|3|||
162785861|NCT01080326|587926269|FG000|Overall Study|Surgeon decision|1|||
162785862|NCT00632021|587926271|FG000|Overall Study|Withdrawal/death|4|||
162785863|NCT00632021|587926272|FG001|Overall Study|Withdrawal/death|7|||
162785864|NCT02250534|587926275|FG000|Overall Study|Lost to Follow-up|18|||
162785865|NCT02250534|587926276|FG001|Overall Study|Lost to Follow-up|28|||
162785866|NCT02250534|587926277|FG002|Overall Study|Lost to Follow-up|33|||
162785867|NCT02250534|587926275|FG000|Overall Study|Personal reasons|7|||
162785868|NCT02250534|587926276|FG001|Overall Study|Personal reasons|8|||
162785869|NCT02250534|587926277|FG002|Overall Study|Personal reasons|14|||
162785870|NCT02250534|587926275|FG000|Overall Study|Adverse Event|6|||
162785871|NCT02250534|587926276|FG001|Overall Study|Adverse Event|3|||
162785872|NCT02250534|587926277|FG002|Overall Study|Adverse Event|8|||
162785873|NCT02250534|587926275|FG000|Overall Study|incarcerated|2|||
162785874|NCT02250534|587926276|FG001|Overall Study|incarcerated|1|||
162785875|NCT02250534|587926277|FG002|Overall Study|incarcerated|2|||
162785876|NCT02250534|587926275|FG000|Overall Study|Withdrawal by Subject|0|||
162785877|NCT02250534|587926276|FG001|Overall Study|Withdrawal by Subject|1|||
162785878|NCT02250534|587926277|FG002|Overall Study|Withdrawal by Subject|2|||
162785879|NCT02250534|587926275|FG000|Overall Study|Death|0|||
162785880|NCT02250534|587926276|FG001|Overall Study|Death|1|||
162785881|NCT02250534|587926277|FG002|Overall Study|Death|1|||
162785882|NCT02250534|587926275|FG000|Overall Study|Physician Decision|1|||
162785883|NCT02250534|587926276|FG001|Overall Study|Physician Decision|3|||
162785884|NCT02250534|587926277|FG002|Overall Study|Physician Decision|1|||
162785885|NCT02250534|587926275|FG000|Overall Study|Protocol Violation|1|||
162785886|NCT02250534|587926276|FG001|Overall Study|Protocol Violation|0|||
162785887|NCT02250534|587926277|FG002|Overall Study|Protocol Violation|1|||
162785888|NCT02250534|587926275|FG000|Overall Study|Reason unknown|1|||
162785889|NCT02250534|587926276|FG001|Overall Study|Reason unknown|0|||
162785890|NCT02250534|587926277|FG002|Overall Study|Reason unknown|0|||
162785891|NCT01628692|587926280|FG000|Overall Study|Lack of Efficacy|4|||
162785892|NCT01628692|587926281|FG001|Overall Study|Lack of Efficacy|4|||
162785893|NCT01628692|587926282|FG002|Overall Study|Lack of Efficacy|5|||
162785894|NCT01628692|587926283|FG003|Overall Study|Lack of Efficacy|1|||
162785895|NCT01628692|587926284|FG004|Overall Study|Lack of Efficacy|4|||
162785896|NCT01628692|587926285|FG005|Overall Study|Lack of Efficacy|7|||
162785897|NCT01628692|587926280|FG000|Overall Study|Adverse Event|2|||
162785898|NCT01628692|587926281|FG001|Overall Study|Adverse Event|0|||
162785899|NCT01628692|587926282|FG002|Overall Study|Adverse Event|2|||
162785900|NCT01628692|587926283|FG003|Overall Study|Adverse Event|0|||
162785901|NCT01628692|587926284|FG004|Overall Study|Adverse Event|0|||
162785902|NCT01628692|587926285|FG005|Overall Study|Adverse Event|0|||
162785903|NCT01628692|587926280|FG000|Overall Study|Withdrawal by Subject|0|||
162785904|NCT01628692|587926281|FG001|Overall Study|Withdrawal by Subject|1|||
162785905|NCT01628692|587926282|FG002|Overall Study|Withdrawal by Subject|1|||
162785906|NCT01628692|587926283|FG003|Overall Study|Withdrawal by Subject|0|||
162785907|NCT01628692|587926284|FG004|Overall Study|Withdrawal by Subject|0|||
162785908|NCT01628692|587926285|FG005|Overall Study|Withdrawal by Subject|0|||
162785909|NCT01628692|587926280|FG000|Overall Study|Death|0|||
162785910|NCT01628692|587926281|FG001|Overall Study|Death|1|||
162785911|NCT01628692|587926282|FG002|Overall Study|Death|0|||
162785912|NCT01628692|587926283|FG003|Overall Study|Death|0|||
162785913|NCT01628692|587926284|FG004|Overall Study|Death|0|||
162785914|NCT01628692|587926285|FG005|Overall Study|Death|0|||
162785915|NCT01628692|587926280|FG000|Overall Study|Poor compliance/noncompliance|1|||
162785916|NCT01628692|587926281|FG001|Overall Study|Poor compliance/noncompliance|0|||
162785917|NCT01628692|587926282|FG002|Overall Study|Poor compliance/noncompliance|0|||
162785918|NCT01628692|587926283|FG003|Overall Study|Poor compliance/noncompliance|0|||
162785919|NCT01628692|587926284|FG004|Overall Study|Poor compliance/noncompliance|0|||
162785920|NCT01628692|587926285|FG005|Overall Study|Poor compliance/noncompliance|0|||
162785921|NCT01628692|587926280|FG000|Overall Study|Administrative reason by sponsor|0|||
162785922|NCT01628692|587926281|FG001|Overall Study|Administrative reason by sponsor|0|||
162785923|NCT01628692|587926282|FG002|Overall Study|Administrative reason by sponsor|0|||
162785924|NCT01628692|587926283|FG003|Overall Study|Administrative reason by sponsor|0|||
162785925|NCT01628692|587926284|FG004|Overall Study|Administrative reason by sponsor|0|||
162785926|NCT01628692|587926285|FG005|Overall Study|Administrative reason by sponsor|1|||
162785927|NCT01628692|587926280|FG000|Overall Study|Completed 12 Week only|0|||
162785928|NCT01628692|587926281|FG001|Overall Study|Completed 12 Week only|0|||
162785929|NCT01628692|587926282|FG002|Overall Study|Completed 12 Week only|0|||
162785930|NCT01628692|587926283|FG003|Overall Study|Completed 12 Week only|0|||
162785931|NCT01628692|587926284|FG004|Overall Study|Completed 12 Week only|0|||
162785932|NCT01628692|587926285|FG005|Overall Study|Completed 12 Week only|1|||
162785933|NCT02437071|587926286|FG000|Overall Study|Withdrawal by Subject|1|||
162785934|NCT02437071|587926287|FG001|Overall Study|Withdrawal by Subject|0|||
162785935|NCT01587118|587926288|FG000|Overall Study|Adverse Event|3|||
162785936|NCT01587118|587926288|FG000|Overall Study|Lost to Follow-up|2|||
162785937|NCT01587118|587926288|FG000|Overall Study|Relocation|1|||
162785938|NCT01587118|587926288|FG000|Overall Study|nonresponse|1|||
162785939|NCT00537329|587926289|FG000|Overall Study|Death|10|||
162785940|NCT00537329|587926289|FG000|Overall Study|Adverse Event|3|||
162785941|NCT00537329|587926289|FG000|Overall Study|Lack of Efficacy|2|||
162785942|NCT00537329|587926289|FG000|Overall Study|Lost to Follow-up|6|||
162785943|NCT00537329|587926289|FG000|Overall Study|Withdrawal by Subject|4|||
162785944|NCT00537329|587926289|FG000|Overall Study|Other|1|||
162785945|NCT00243022|587926291|FG000|Overall Study|Withdrawal by Subject|1|||
162785946|NCT00243022|587926292|FG001|Overall Study|Withdrawal by Subject|0|||
162785947|NCT00243022|587926291|FG000|Overall Study|Death|1|||
162785948|NCT00243022|587926292|FG001|Overall Study|Death|0|||
162785949|NCT00243022|587926291|FG000|Overall Study|Difficult Travel Distance|0|||
162785950|NCT00243022|587926292|FG001|Overall Study|Difficult Travel Distance|1|||
162785951|NCT02569957|587926293|FG000|Overall Study|Withdrawal by Subject|0|||
162785952|NCT02569957|587926294|FG001|Overall Study|Withdrawal by Subject|1|||
162785953|NCT00572533|587926297|FG000|Overall Study|Death|4|||
162785954|NCT00572533|587926298|FG001|Overall Study|Death|1|||
162785955|NCT00572533|587926297|FG000|Overall Study|Received Kidney Transplant|2|||
162785956|NCT00572533|587926298|FG001|Overall Study|Received Kidney Transplant|1|||
162785957|NCT00572533|587926297|FG000|Overall Study|Social Issues|1|||
162785958|NCT00572533|587926298|FG001|Overall Study|Social Issues|0|||
162785959|NCT00572533|587926297|FG000|Overall Study|Transfer out of Facility|0|||
162785960|NCT00572533|587926298|FG001|Overall Study|Transfer out of Facility|1|||
162785961|NCT01530087|587926305|FG000|Overall Study|Physician Decision|2|||
162785962|NCT03845023|587926306|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
162785963|NCT03845023|587926307|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
162785964|NCT03845023|587926308|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
162785965|NCT03845023|587926309|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
162785966|NCT03845023|587926306|FG000|Follow-Up (14 Days)|Adverse Event|0|||
162785967|NCT03845023|587926307|FG001|Follow-Up (14 Days)|Adverse Event|0|||
162785968|NCT03845023|587926308|FG002|Follow-Up (14 Days)|Adverse Event|1|||
162785969|NCT03845023|587926309|FG003|Follow-Up (14 Days)|Adverse Event|1|||
162785970|NCT02353871|587926310|FG000|Overall Study|Protocol deviation|0|||
162785971|NCT02353871|587926311|FG001|Overall Study|Protocol deviation|1|||
162785972|NCT02353871|587926310|FG000|Overall Study|Consent withdrawn|1|||
162785973|NCT02353871|587926311|FG001|Overall Study|Consent withdrawn|8|||
162785974|NCT02353871|587926310|FG000|Overall Study|Lost to Follow-up|2|||
162785975|NCT02353871|587926311|FG001|Overall Study|Lost to Follow-up|0|||
162785976|NCT02658175|587926312|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
162785977|NCT02658175|587926313|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
162785978|NCT02658175|587926314|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
162785979|NCT02658175|587926312|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
162785980|NCT02658175|587926313|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
162785981|NCT02658175|587926314|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
162785982|NCT02658175|587926312|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
162785983|NCT02658175|587926313|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
162785984|NCT02658175|587926314|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
162785985|NCT02658175|587926312|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
162785986|NCT02658175|587926313|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
162785987|NCT02658175|587926314|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
162785988|NCT02658175|587926312|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
162785989|NCT02658175|587926313|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
162785990|NCT02658175|587926314|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
162785991|NCT02658175|587926312|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
162785992|NCT02658175|587926313|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
162785993|NCT02658175|587926314|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
162785994|NCT02658175|587926312|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
162785995|NCT02658175|587926313|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
162785996|NCT02658175|587926314|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
162785997|NCT02658175|587926312|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
162785998|NCT02658175|587926313|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
162785999|NCT02658175|587926314|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
162786000|NCT02658175|587926312|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
162786001|NCT02658175|587926313|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
162786002|NCT02658175|587926314|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
162786003|NCT02658175|587926312|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
162786004|NCT02658175|587926313|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
162786005|NCT02658175|587926314|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
162786006|NCT02554383|587926318|FG000|Overall Study|Ineligible|3|||
162786007|NCT02554383|587926319|FG001|Overall Study|Ineligible|2|||
162786008|NCT02554383|587926318|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
162786009|NCT02554383|587926319|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
162786010|NCT02554383|587926318|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
162786011|NCT02554383|587926319|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
162786012|NCT02554383|587926318|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
162786013|NCT02554383|587926319|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
162786014|NCT02918292|587926322|FG000|Study Enrollment Prior to Transplant|Death|1|||
162786015|NCT02918292|587926322|FG000|Study Follow up After Transplant|Death|6|||
162786016|NCT02581059|587926323|FG000|Study Treatment|Disease Progression|1|||
162786017|NCT02581059|587926324|FG001|Study Treatment|Disease Progression|1|||
162786018|NCT02581059|587926323|FG000|Study Treatment|Adverse Event|2|||
162786019|NCT02581059|587926324|FG001|Study Treatment|Adverse Event|1|||
162786020|NCT02581059|587926323|FG000|Study Treatment|Death|1|||
162786021|NCT02581059|587926324|FG001|Study Treatment|Death|1|||
162786022|NCT02581059|587926323|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
162786023|NCT02581059|587926324|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
162786024|NCT02581059|587926323|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
162786025|NCT02581059|587926324|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
162786026|NCT02581059|587926323|FG000|Follow up|Death|1|||
162786027|NCT02581059|587926324|FG001|Follow up|Death|3|||
162786028|NCT02581059|587926323|FG000|Follow up|study terminated|1|||
162786029|NCT02581059|587926324|FG001|Follow up|study terminated|1|||
162786030|NCT02581059|587926323|FG000|Follow up|screen failure|0|||
162786031|NCT02581059|587926324|FG001|Follow up|screen failure|1|||
162786032|NCT02581059|587926323|FG000|Follow up|Patient started new clinical trial|1|||
162786033|NCT02581059|587926324|FG001|Follow up|Patient started new clinical trial|0|||
162786034|NCT04021043|587927944|FG000|Overall Study|Adverse Event|3|||
162786035|NCT04021043|587927945|FG001|Overall Study|Adverse Event|1|||
162786036|NCT04021043|587927946|FG002|Overall Study|Adverse Event|1|||
162786037|NCT04021043|587927947|FG003|Overall Study|Adverse Event|0|||
162786038|NCT04021043|587927944|FG000|Overall Study|Death|2|||
162786039|NCT04021043|587927945|FG001|Overall Study|Death|3|||
162786040|NCT04021043|587927946|FG002|Overall Study|Death|1|||
162786041|NCT04021043|587927947|FG003|Overall Study|Death|3|||
162786042|NCT04021043|587927944|FG000|Overall Study|Withdrawal by Subject|1|||
162786043|NCT04021043|587927945|FG001|Overall Study|Withdrawal by Subject|1|||
162786044|NCT04021043|587927946|FG002|Overall Study|Withdrawal by Subject|1|||
162786045|NCT04021043|587927947|FG003|Overall Study|Withdrawal by Subject|6|||
162786046|NCT04021043|587927944|FG000|Overall Study|Discontinued due to disease progression|4|||
162786047|NCT04021043|587927945|FG001|Overall Study|Discontinued due to disease progression|5|||
162786048|NCT04021043|587927946|FG002|Overall Study|Discontinued due to disease progression|7|||
162786049|NCT04021043|587927947|FG003|Overall Study|Discontinued due to disease progression|10|||
162786050|NCT00826228|587927948|FG000|Overall Study|Withdrawal by Subject|1|||
162786051|NCT02035696|587927949|FG000|Overall Study|Lost to Follow-up|0|||
162786052|NCT02035696|587927950|FG001|Overall Study|Lost to Follow-up|3|||
162786053|NCT02035696|587927951|FG002|Overall Study|Lost to Follow-up|1|||
162786054|NCT02035696|587927952|FG003|Overall Study|Lost to Follow-up|2|||
162786055|NCT02035696|587927949|FG000|Overall Study|Withdrawal by Subject|3|||
162786056|NCT02035696|587927950|FG001|Overall Study|Withdrawal by Subject|0|||
162786057|NCT02035696|587927951|FG002|Overall Study|Withdrawal by Subject|2|||
162786058|NCT02035696|587927952|FG003|Overall Study|Withdrawal by Subject|1|||
162786059|NCT00379769|587927953|FG000|Main Study|Death|57|||
162786060|NCT00379769|587927954|FG001|Main Study|Death|67|||
162786061|NCT00379769|587927955|FG002|Main Study|Death|54|||
162786062|NCT00379769|587927956|FG003|Main Study|Death|72|||
162786063|NCT00379769|587927957|FG004|Main Study|Death|0|||
162786064|NCT00379769|587927958|FG005|Main Study|Death|0|||
162786065|NCT00379769|587927953|FG000|Main Study|Adverse Event|5|||
162786066|NCT00379769|587927954|FG001|Main Study|Adverse Event|8|||
162786067|NCT00379769|587927955|FG002|Main Study|Adverse Event|10|||
162786068|NCT00379769|587927956|FG003|Main Study|Adverse Event|11|||
162786069|NCT00379769|587927957|FG004|Main Study|Adverse Event|0|||
162786070|NCT00379769|587927958|FG005|Main Study|Adverse Event|0|||
162786071|NCT00379769|587927953|FG000|Main Study|Lost to Follow-up|29|||
162786072|NCT00379769|587927954|FG001|Main Study|Lost to Follow-up|29|||
162786073|NCT00379769|587927955|FG002|Main Study|Lost to Follow-up|25|||
162786074|NCT00379769|587927956|FG003|Main Study|Lost to Follow-up|26|||
162786075|NCT00379769|587927957|FG004|Main Study|Lost to Follow-up|0|||
162786076|NCT00379769|587927958|FG005|Main Study|Lost to Follow-up|0|||
162786077|NCT00379769|587927953|FG000|Main Study|Withdrawal by Subject|46|||
162786078|NCT00379769|587927954|FG001|Main Study|Withdrawal by Subject|56|||
162786079|NCT00379769|587927955|FG002|Main Study|Withdrawal by Subject|72|||
162786080|NCT00379769|587927956|FG003|Main Study|Withdrawal by Subject|70|||
162786081|NCT00379769|587927957|FG004|Main Study|Withdrawal by Subject|0|||
162786082|NCT00379769|587927958|FG005|Main Study|Withdrawal by Subject|0|||
162786083|NCT00379769|587927953|FG000|Main Study|Moved to survival status follow-up only|27|||
162786084|NCT00379769|587927954|FG001|Main Study|Moved to survival status follow-up only|25|||
162786085|NCT00379769|587927955|FG002|Main Study|Moved to survival status follow-up only|32|||
162786086|NCT00379769|587927956|FG003|Main Study|Moved to survival status follow-up only|36|||
162786087|NCT00379769|587927957|FG004|Main Study|Moved to survival status follow-up only|0|||
162786088|NCT00379769|587927958|FG005|Main Study|Moved to survival status follow-up only|0|||
162786089|NCT00379769|587927953|FG000|Main Study|Participant moved|3|||
162786090|NCT00379769|587927954|FG001|Main Study|Participant moved|2|||
162786091|NCT00379769|587927955|FG002|Main Study|Participant moved|3|||
162786092|NCT00379769|587927956|FG003|Main Study|Participant moved|3|||
162786093|NCT00379769|587927957|FG004|Main Study|Participant moved|0|||
162786094|NCT00379769|587927958|FG005|Main Study|Participant moved|0|||
162786095|NCT00379769|587927953|FG000|Main Study|Poor compliance|3|||
162786096|NCT00379769|587927954|FG001|Main Study|Poor compliance|2|||
162786097|NCT00379769|587927955|FG002|Main Study|Poor compliance|2|||
162786098|NCT00379769|587927956|FG003|Main Study|Poor compliance|1|||
162786099|NCT00379769|587927957|FG004|Main Study|Poor compliance|0|||
162786100|NCT00379769|587927958|FG005|Main Study|Poor compliance|0|||
162786101|NCT00379769|587927953|FG000|Main Study|Prohibited glucose lowering medication|0|||
162786102|NCT00379769|587927954|FG001|Main Study|Prohibited glucose lowering medication|3|||
162786103|NCT00379769|587927955|FG002|Main Study|Prohibited glucose lowering medication|0|||
162786104|NCT00379769|587927956|FG003|Main Study|Prohibited glucose lowering medication|1|||
162786105|NCT00379769|587927957|FG004|Main Study|Prohibited glucose lowering medication|0|||
162786106|NCT00379769|587927958|FG005|Main Study|Prohibited glucose lowering medication|0|||
162786107|NCT00379769|587927953|FG000|Main Study|Site closed|4|||
162786108|NCT00379769|587927954|FG001|Main Study|Site closed|4|||
162786109|NCT00379769|587927955|FG002|Main Study|Site closed|4|||
162786110|NCT00379769|587927956|FG003|Main Study|Site closed|8|||
162786111|NCT00379769|587927957|FG004|Main Study|Site closed|0|||
162786112|NCT00379769|587927958|FG005|Main Study|Site closed|0|||
162786113|NCT00379769|587927953|FG000|Main Study|Entry criteria violation|0|||
162786114|NCT00379769|587927954|FG001|Main Study|Entry criteria violation|0|||
162786115|NCT00379769|587927955|FG002|Main Study|Entry criteria violation|1|||
162786116|NCT00379769|587927956|FG003|Main Study|Entry criteria violation|1|||
162786117|NCT00379769|587927957|FG004|Main Study|Entry criteria violation|0|||
162786118|NCT00379769|587927958|FG005|Main Study|Entry criteria violation|0|||
162786119|NCT00379769|587927953|FG000|Main Study|Participant did not take study drug|0|||
162786120|NCT00379769|587927954|FG001|Main Study|Participant did not take study drug|0|||
162786121|NCT00379769|587927955|FG002|Main Study|Participant did not take study drug|1|||
162786122|NCT00379769|587927956|FG003|Main Study|Participant did not take study drug|0|||
162786123|NCT00379769|587927957|FG004|Main Study|Participant did not take study drug|0|||
162786124|NCT00379769|587927958|FG005|Main Study|Participant did not take study drug|0|||
162786125|NCT00379769|587927953|FG000|Main Study|Physician Decision|2|||
162786126|NCT00379769|587927954|FG001|Main Study|Physician Decision|2|||
162786127|NCT00379769|587927955|FG002|Main Study|Physician Decision|1|||
162786128|NCT00379769|587927956|FG003|Main Study|Physician Decision|1|||
162786129|NCT00379769|587927957|FG004|Main Study|Physician Decision|0|||
162786130|NCT00379769|587927958|FG005|Main Study|Physician Decision|0|||
162786131|NCT00379769|587927953|FG000|Main Study|Participant completed study at visit 27|1|||
162786132|NCT00379769|587927954|FG001|Main Study|Participant completed study at visit 27|0|||
162786133|NCT00379769|587927955|FG002|Main Study|Participant completed study at visit 27|0|||
162786134|NCT00379769|587927956|FG003|Main Study|Participant completed study at visit 27|0|||
162786135|NCT00379769|587927957|FG004|Main Study|Participant completed study at visit 27|0|||
162786136|NCT00379769|587927958|FG005|Main Study|Participant completed study at visit 27|0|||
162786137|NCT00379769|587927953|FG000|Main Study|Personal reasons|1|||
162786138|NCT00379769|587927954|FG001|Main Study|Personal reasons|0|||
162786139|NCT00379769|587927955|FG002|Main Study|Personal reasons|0|||
162786140|NCT00379769|587927956|FG003|Main Study|Personal reasons|0|||
162786141|NCT00379769|587927957|FG004|Main Study|Personal reasons|0|||
162786142|NCT00379769|587927958|FG005|Main Study|Personal reasons|0|||
162786143|NCT00379769|587927953|FG000|Main Study|Risk of heart failure|0|||
162786144|NCT00379769|587927954|FG001|Main Study|Risk of heart failure|1|||
162786145|NCT00379769|587927955|FG002|Main Study|Risk of heart failure|0|||
162786146|NCT00379769|587927956|FG003|Main Study|Risk of heart failure|0|||
162786147|NCT00379769|587927957|FG004|Main Study|Risk of heart failure|0|||
162786148|NCT00379769|587927958|FG005|Main Study|Risk of heart failure|0|||
162786149|NCT00379769|587927953|FG000|Main Study|Investigator refused to log temperature|0|||
162786150|NCT00379769|587927954|FG001|Main Study|Investigator refused to log temperature|0|||
162786151|NCT00379769|587927955|FG002|Main Study|Investigator refused to log temperature|1|||
162786152|NCT00379769|587927956|FG003|Main Study|Investigator refused to log temperature|0|||
162786153|NCT00379769|587927957|FG004|Main Study|Investigator refused to log temperature|0|||
162786154|NCT00379769|587927958|FG005|Main Study|Investigator refused to log temperature|0|||
162786155|NCT00379769|587927953|FG000|Main Study|Reason unspecified|0|||
162786156|NCT00379769|587927954|FG001|Main Study|Reason unspecified|0|||
162786157|NCT00379769|587927955|FG002|Main Study|Reason unspecified|1|||
162786158|NCT00379769|587927956|FG003|Main Study|Reason unspecified|0|||
162786159|NCT00379769|587927957|FG004|Main Study|Reason unspecified|0|||
162786160|NCT00379769|587927958|FG005|Main Study|Reason unspecified|0|||
162786161|NCT00379769|587927953|FG000|Observational Follow-up|Death|0|||
162786162|NCT00379769|587927954|FG001|Observational Follow-up|Death|0|||
162786163|NCT00379769|587927955|FG002|Observational Follow-up|Death|0|||
162786164|NCT00379769|587927956|FG003|Observational Follow-up|Death|0|||
162786165|NCT00379769|587927957|FG004|Observational Follow-up|Death|78|||
162786166|NCT00379769|587927958|FG005|Observational Follow-up|Death|70|||
162786167|NCT00379769|587927953|FG000|Observational Follow-up|Adverse Event|0|||
162786168|NCT00379769|587927954|FG001|Observational Follow-up|Adverse Event|0|||
162786169|NCT00379769|587927955|FG002|Observational Follow-up|Adverse Event|0|||
162786170|NCT00379769|587927956|FG003|Observational Follow-up|Adverse Event|0|||
162786171|NCT00379769|587927957|FG004|Observational Follow-up|Adverse Event|1|||
162786172|NCT00379769|587927958|FG005|Observational Follow-up|Adverse Event|0|||
162786173|NCT00379769|587927953|FG000|Observational Follow-up|Lost to Follow-up|0|||
162786174|NCT00379769|587927954|FG001|Observational Follow-up|Lost to Follow-up|0|||
162786175|NCT00379769|587927955|FG002|Observational Follow-up|Lost to Follow-up|0|||
162786176|NCT00379769|587927956|FG003|Observational Follow-up|Lost to Follow-up|0|||
162786177|NCT00379769|587927957|FG004|Observational Follow-up|Lost to Follow-up|25|||
162786178|NCT00379769|587927958|FG005|Observational Follow-up|Lost to Follow-up|27|||
162786179|NCT00379769|587927953|FG000|Observational Follow-up|Withdrawal by Subject|0|||
162786180|NCT00379769|587927954|FG001|Observational Follow-up|Withdrawal by Subject|0|||
162786181|NCT00379769|587927955|FG002|Observational Follow-up|Withdrawal by Subject|0|||
162786182|NCT00379769|587927956|FG003|Observational Follow-up|Withdrawal by Subject|0|||
162786183|NCT00379769|587927957|FG004|Observational Follow-up|Withdrawal by Subject|12|||
162786184|NCT00379769|587927958|FG005|Observational Follow-up|Withdrawal by Subject|12|||
162786185|NCT00379769|587927953|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
162786186|NCT00379769|587927954|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
162786187|NCT00379769|587927955|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
162786188|NCT00379769|587927956|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
162786189|NCT00379769|587927957|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
162786190|NCT00379769|587927958|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
162786191|NCT00379769|587927953|FG000|Observational Follow-up|Physician Decision|0|||
162786192|NCT00379769|587927954|FG001|Observational Follow-up|Physician Decision|0|||
162786193|NCT00379769|587927955|FG002|Observational Follow-up|Physician Decision|0|||
162786194|NCT00379769|587927956|FG003|Observational Follow-up|Physician Decision|0|||
162786195|NCT00379769|587927957|FG004|Observational Follow-up|Physician Decision|8|||
162786196|NCT00379769|587927958|FG005|Observational Follow-up|Physician Decision|8|||
162786197|NCT00379769|587927953|FG000|Observational Follow-up|Site Closed Early|0|||
162786198|NCT00379769|587927954|FG001|Observational Follow-up|Site Closed Early|0|||
162786199|NCT00379769|587927955|FG002|Observational Follow-up|Site Closed Early|0|||
162786200|NCT00379769|587927956|FG003|Observational Follow-up|Site Closed Early|0|||
162786201|NCT00379769|587927957|FG004|Observational Follow-up|Site Closed Early|6|||
162786202|NCT00379769|587927958|FG005|Observational Follow-up|Site Closed Early|7|||
162786203|NCT00379769|587927953|FG000|Observational Follow-up|Participant Moved|0|||
162786204|NCT00379769|587927954|FG001|Observational Follow-up|Participant Moved|0|||
162786205|NCT00379769|587927955|FG002|Observational Follow-up|Participant Moved|0|||
162786206|NCT00379769|587927956|FG003|Observational Follow-up|Participant Moved|0|||
162786207|NCT00379769|587927957|FG004|Observational Follow-up|Participant Moved|0|||
162786208|NCT00379769|587927958|FG005|Observational Follow-up|Participant Moved|1|||
162786209|NCT00379769|587927953|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
162786210|NCT00379769|587927954|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
162786211|NCT00379769|587927955|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
162786212|NCT00379769|587927956|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
162786213|NCT00379769|587927957|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
162786214|NCT00379769|587927958|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
162786215|NCT04546217|587927965|FG000|Overall Study|Withdrawal by Subject|2|||
162786216|NCT04546217|587927966|FG001|Overall Study|Withdrawal by Subject|0|||
162786217|NCT04546217|587927965|FG000|Overall Study|Uncontrolled hypertension|1|||
162786218|NCT04546217|587927966|FG001|Overall Study|Uncontrolled hypertension|0|||
162786219|NCT02550938|587927967|FG000|Overall Study|Lost to Follow-up|8|||
162786220|NCT02550938|587927968|FG001|Overall Study|Lost to Follow-up|7|||
162786221|NCT02550938|587927969|FG002|Overall Study|Lost to Follow-up|12|||
162786222|NCT02550938|587927970|FG003|Overall Study|Lost to Follow-up|11|||
162786223|NCT01245140|587927975|FG000|Overall Study|Adverse Event|1|||
162786224|NCT01245140|587927976|FG001|Overall Study|Adverse Event|3|||
162786225|NCT01245140|587927975|FG000|Overall Study|Lack of Efficacy|2|||
162786226|NCT01245140|587927976|FG001|Overall Study|Lack of Efficacy|4|||
162786227|NCT01245140|587927975|FG000|Overall Study|Protocol Violation|0|||
162786228|NCT01245140|587927976|FG001|Overall Study|Protocol Violation|1|||
162786229|NCT01245140|587927975|FG000|Overall Study|Withdrawal by Subject|0|||
162786230|NCT01245140|587927976|FG001|Overall Study|Withdrawal by Subject|1|||
162786231|NCT01245140|587927975|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
162786232|NCT01245140|587927976|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
162786233|NCT02037477|587927977|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162786234|NCT02037477|587927978|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162786235|NCT02037477|587927979|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
162786236|NCT02037477|587927980|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162786237|NCT02635360|587927981|FG000|Overall Study|Adverse Event|0|||
162786238|NCT02635360|587927982|FG001|Overall Study|Adverse Event|3|||
162786239|NCT02635360|587927981|FG000|Overall Study|Withdrawal by Subject|2|||
162786240|NCT02635360|587927982|FG001|Overall Study|Withdrawal by Subject|0|||
162786241|NCT02635360|587927981|FG000|Overall Study|Non-Compliance|3|||
162786242|NCT02635360|587927982|FG001|Overall Study|Non-Compliance|1|||
162786243|NCT02635360|587927981|FG000|Overall Study|Disease Progression|0|||
162786244|NCT02635360|587927982|FG001|Overall Study|Disease Progression|2|||
162786245|NCT02635360|587927981|FG000|Overall Study|Lost to Follow-up|1|||
162786246|NCT02635360|587927982|FG001|Overall Study|Lost to Follow-up|1|||
162786247|NCT04082429|587927983|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162786248|NCT04082429|587927984|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162786249|NCT04082429|587927985|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162786250|NCT04082429|587927986|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162786251|NCT04082429|587927987|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
162810572|NCT00887250|588018275|FG000|Overall Study|Adverse Event|3|||
162786252|NCT04082429|587927988|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162786253|NCT04082429|587927989|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162786254|NCT04082429|587927990|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162786255|NCT04082429|587927991|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162786256|NCT04082429|587927983|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786257|NCT04082429|587927984|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786258|NCT04082429|587927985|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786259|NCT04082429|587927986|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786260|NCT04082429|587927987|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
162786261|NCT04082429|587927988|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786262|NCT04082429|587927989|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786263|NCT04082429|587927990|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786264|NCT04082429|587927991|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162786265|NCT04082429|587927983|FG000|Main Part (After the Treatment Pause)|Death|0|||
162786266|NCT04082429|587927984|FG001|Main Part (After the Treatment Pause)|Death|0|||
162786267|NCT04082429|587927985|FG002|Main Part (After the Treatment Pause)|Death|0|||
162786268|NCT04082429|587927986|FG003|Main Part (After the Treatment Pause)|Death|0|||
162786269|NCT04082429|587927987|FG004|Main Part (After the Treatment Pause)|Death|1|||
162786270|NCT04082429|587927988|FG005|Main Part (After the Treatment Pause)|Death|0|||
162786271|NCT04082429|587927989|FG006|Main Part (After the Treatment Pause)|Death|0|||
162786272|NCT04082429|587927990|FG007|Main Part (After the Treatment Pause)|Death|0|||
162786273|NCT04082429|587927991|FG008|Main Part (After the Treatment Pause)|Death|0|||
162786274|NCT04082429|587927983|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786275|NCT04082429|587927984|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786276|NCT04082429|587927985|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786277|NCT04082429|587927986|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
162786278|NCT04082429|587927987|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786279|NCT04082429|587927988|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
162786280|NCT04082429|587927989|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786281|NCT04082429|587927990|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786282|NCT04082429|587927991|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
162786283|NCT04082429|587927983|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162786284|NCT04082429|587927984|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162786285|NCT04082429|587927985|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162786286|NCT04082429|587927986|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162786287|NCT04082429|587927987|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162786288|NCT04082429|587927988|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162786289|NCT04082429|587927989|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162786290|NCT04082429|587927990|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162786291|NCT04082429|587927991|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
162786292|NCT04082429|587927983|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
162786293|NCT04082429|587927984|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786294|NCT04082429|587927985|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786295|NCT04082429|587927986|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786296|NCT04082429|587927987|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786297|NCT04082429|587927988|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
162786298|NCT04082429|587927989|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786299|NCT04082429|587927990|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786300|NCT04082429|587927991|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162786301|NCT04082429|587927983|FG000|Extension Part|Ongoing|0|||
162786302|NCT04082429|587927984|FG001|Extension Part|Ongoing|7|||
162786303|NCT04082429|587927985|FG002|Extension Part|Ongoing|17|||
162786304|NCT04082429|587927986|FG003|Extension Part|Ongoing|6|||
162786305|NCT04082429|587927987|FG004|Extension Part|Ongoing|45|||
162786306|NCT04082429|587927988|FG005|Extension Part|Ongoing|0|||
162786307|NCT04082429|587927989|FG006|Extension Part|Ongoing|10|||
162786308|NCT04082429|587927990|FG007|Extension Part|Ongoing|23|||
162786309|NCT04082429|587927991|FG008|Extension Part|Ongoing|25|||
162786310|NCT00334542|587927992|FG000|Overall Study|Adverse Event|3|||
162786311|NCT00334542|587927992|FG000|Overall Study|Withdrawal by Subject|1|||
162786312|NCT00334542|587927992|FG000|Overall Study|New cancer diagnosis|1|||
162786313|NCT03118050|587927993|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
162786314|NCT03118050|587927994|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162786315|NCT03118050|587927995|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
162786316|NCT03118050|587927996|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162786317|NCT03118050|587927997|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
162786318|NCT03118050|587927998|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
162786319|NCT03118050|587927999|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162786320|NCT01454739|587928001|FG000|Overall Study|Protocol Violation|2|||
162786321|NCT01454739|587928002|FG001|Overall Study|Protocol Violation|3|||
162786322|NCT01454739|587928001|FG000|Overall Study|Withdrawal by Subject|2|||
162786323|NCT01454739|587928002|FG001|Overall Study|Withdrawal by Subject|6|||
162786324|NCT01454739|587928001|FG000|Overall Study|Other|3|||
162786325|NCT01454739|587928002|FG001|Overall Study|Other|5|||
162786326|NCT01454739|587928001|FG000|Overall Study|Physician Decision|0|||
162786327|NCT01454739|587928002|FG001|Overall Study|Physician Decision|5|||
162786328|NCT01454739|587928001|FG000|Overall Study|Lost to Follow-up|0|||
162786329|NCT01454739|587928002|FG001|Overall Study|Lost to Follow-up|1|||
162786330|NCT01454739|587928001|FG000|Overall Study|Adverse Event|0|||
162786331|NCT01454739|587928002|FG001|Overall Study|Adverse Event|1|||
162786332|NCT05765435|587928003|FG000|Overall Study|Lost to Follow-up|0|||
162786333|NCT05765435|587928004|FG001|Overall Study|Lost to Follow-up|1|||
162786334|NCT05765435|587928005|FG002|Overall Study|Lost to Follow-up|0|||
162786335|NCT05765435|587928003|FG000|Overall Study|Withdrawal by Subject|0|||
162786336|NCT05765435|587928004|FG001|Overall Study|Withdrawal by Subject|0|||
162786337|NCT05765435|587928005|FG002|Overall Study|Withdrawal by Subject|1|||
162786338|NCT04351269|587928006|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
162786339|NCT04351269|587928007|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
162786340|NCT04351269|587928008|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
162786341|NCT04351269|587928006|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
162786342|NCT04351269|587928007|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
162786343|NCT04351269|587928008|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
162786344|NCT04351269|587928006|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
162786345|NCT04351269|587928007|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
162786346|NCT04351269|587928008|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
162786347|NCT04351269|587928006|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
162786348|NCT04351269|587928007|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
162786349|NCT04351269|587928008|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
162786350|NCT04351269|587928006|FG000|Overall Study|Lost to Follow-up|1|||
162786351|NCT04351269|587928007|FG001|Overall Study|Lost to Follow-up|3|||
162786352|NCT04351269|587928008|FG002|Overall Study|Lost to Follow-up|0|||
162786353|NCT02980523|587928009|FG000|Overall Study|Lost to Follow-up|1|||
162786354|NCT02980523|587928010|FG001|Overall Study|Lost to Follow-up|4|||
162786355|NCT02980523|587928011|FG002|Overall Study|Lost to Follow-up|1|||
162786356|NCT02980523|587928012|FG003|Overall Study|Lost to Follow-up|2|||
162786357|NCT02980523|587928013|FG004|Overall Study|Lost to Follow-up|1|||
162786358|NCT02980523|587928009|FG000|Overall Study|Excluded from analysis|1|||
162786359|NCT02980523|587928010|FG001|Overall Study|Excluded from analysis|3|||
162786360|NCT02980523|587928011|FG002|Overall Study|Excluded from analysis|1|||
162786361|NCT02980523|587928012|FG003|Overall Study|Excluded from analysis|1|||
162786362|NCT02980523|587928013|FG004|Overall Study|Excluded from analysis|1|||
162786363|NCT02980523|587928009|FG000|Overall Study|Lack of Efficacy|1|||
162786364|NCT02980523|587928010|FG001|Overall Study|Lack of Efficacy|4|||
162786365|NCT02980523|587928011|FG002|Overall Study|Lack of Efficacy|4|||
162786366|NCT02980523|587928012|FG003|Overall Study|Lack of Efficacy|5|||
162786367|NCT02980523|587928013|FG004|Overall Study|Lack of Efficacy|8|||
162786368|NCT02980523|587928009|FG000|Overall Study|Did not receive intervention|0|||
162786369|NCT02980523|587928010|FG001|Overall Study|Did not receive intervention|0|||
162786370|NCT02980523|587928011|FG002|Overall Study|Did not receive intervention|0|||
162786371|NCT02980523|587928012|FG003|Overall Study|Did not receive intervention|1|||
162786372|NCT02980523|587928013|FG004|Overall Study|Did not receive intervention|0|||
162786373|NCT01850589|587928016|FG000|Overall Study|Withdrawal by Subject|8|||
162786374|NCT01850589|587928017|FG001|Overall Study|Withdrawal by Subject|0|||
162786375|NCT03912662|587928018|FG000|Overall Study|Adverse Event|3|||
162786376|NCT03912662|587928018|FG000|Overall Study|Adverse Event and Death|1|||
162786377|NCT03912662|587928018|FG000|Overall Study|Death|1|||
162786378|NCT03912662|587928018|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
162786379|NCT03912662|587928018|FG000|Overall Study|Mesh Removal|1|||
162786380|NCT03912662|587928018|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
162786381|NCT03912662|587928018|FG000|Overall Study|Early study termination|20|||
162786382|NCT03845140|587928019|FG000|Overall Study|Participant travelled outside study area|0|||
162786383|NCT03845140|587928020|FG001|Overall Study|Participant travelled outside study area|1|||
162786384|NCT03845140|587928021|FG002|Overall Study|Participant travelled outside study area|0|||
162786385|NCT03845140|587928022|FG003|Overall Study|Participant travelled outside study area|0|||
162786386|NCT03845140|587928023|FG004|Overall Study|Participant travelled outside study area|0|||
162786387|NCT03845140|587928024|FG005|Overall Study|Participant travelled outside study area|0|||
162786388|NCT01592045|587928025|FG000|Overall Study|Disease Progression|1|||
162786389|NCT01592045|587928026|FG001|Overall Study|Disease Progression|1|||
162786390|NCT01592045|587928025|FG000|Overall Study|Adverse Event|1|||
162786391|NCT01592045|587928026|FG001|Overall Study|Adverse Event|1|||
162786392|NCT01592045|587928025|FG000|Overall Study|Withdrawal by Subject|1|||
162786393|NCT01592045|587928026|FG001|Overall Study|Withdrawal by Subject|0|||
162786394|NCT01592045|587928025|FG000|Overall Study|Moved out of country|2|||
162786395|NCT01592045|587928026|FG001|Overall Study|Moved out of country|0|||
162786396|NCT03721705|587928029|FG000|Overall Study|Adverse Event|2|||
162786397|NCT03721705|587928030|FG001|Overall Study|Adverse Event|0|||
162786398|NCT03721705|587928029|FG000|Overall Study|Withdrawal by Subject|4|||
162786399|NCT03721705|587928030|FG001|Overall Study|Withdrawal by Subject|10|||
162786400|NCT03721705|587928029|FG000|Overall Study|No Suitable Study Partner|1|||
162786401|NCT03721705|587928030|FG001|Overall Study|No Suitable Study Partner|0|||
162786402|NCT03721705|587928029|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
162786403|NCT03721705|587928030|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
162786404|NCT03721705|587928029|FG000|Overall Study|Death|0|||
162786405|NCT03721705|587928030|FG001|Overall Study|Death|1|||
162786406|NCT01790295|587928031|FG000|Overall Study|Adverse Event|1|||
162786407|NCT01790295|587928031|FG000|Overall Study|Death|4|||
162786408|NCT01790295|587928031|FG000|Overall Study|Lack of Efficacy|2|||
162786409|NCT01790295|587928031|FG000|Overall Study|Study closure|4|||
162786410|NCT01843777|587928032|FG000|Overall Study|Withdrawal by Subject|1|||
162786411|NCT01843777|587928033|FG001|Overall Study|Withdrawal by Subject|0|||
162786412|NCT00420784|587928039|FG000|Overall Study|Adverse Event|11|||
162786413|NCT00420784|587928040|FG001|Overall Study|Adverse Event|29|||
162786414|NCT00420784|587928041|FG002|Overall Study|Adverse Event|10|||
162786415|NCT00420784|587928042|FG003|Overall Study|Adverse Event|5|||
162786416|NCT00420784|587928039|FG000|Overall Study|Withdrawal by Subject|0|||
162786417|NCT00420784|587928040|FG001|Overall Study|Withdrawal by Subject|1|||
162786418|NCT00420784|587928041|FG002|Overall Study|Withdrawal by Subject|0|||
162786419|NCT00420784|587928042|FG003|Overall Study|Withdrawal by Subject|0|||
162786420|NCT00420784|587928039|FG000|Overall Study|Lost to Follow-up|0|||
162786421|NCT00420784|587928040|FG001|Overall Study|Lost to Follow-up|0|||
162786422|NCT00420784|587928041|FG002|Overall Study|Lost to Follow-up|2|||
162786423|NCT00420784|587928042|FG003|Overall Study|Lost to Follow-up|1|||
162786424|NCT00420784|587928039|FG000|Overall Study|Virologic Stopping Rule|17|||
162786425|NCT00420784|587928040|FG001|Overall Study|Virologic Stopping Rule|26|||
162786426|NCT00420784|587928041|FG002|Overall Study|Virologic Stopping Rule|41|||
162786427|NCT00420784|587928042|FG003|Overall Study|Virologic Stopping Rule|67|||
162786428|NCT00420784|587928039|FG000|Overall Study|Other|1|||
162786429|NCT00420784|587928040|FG001|Overall Study|Other|2|||
162786430|NCT00420784|587928041|FG002|Overall Study|Other|0|||
162786431|NCT00420784|587928042|FG003|Overall Study|Other|5|||
162786432|NCT02599688|587928045|FG000|Overall Study|Lack of Efficacy|1|||
162786433|NCT02599688|587928045|FG000|Overall Study|Withdrawal by Subject|1|||
162786434|NCT02599688|587928045|FG000|Overall Study|Termination by Sponsor|2|||
162786435|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
162786436|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
162786437|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
162786438|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
162786439|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
162786440|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
162786441|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
162786442|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
162786443|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
162786444|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
162786445|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
162786446|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
162786447|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
162786448|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
162786449|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
162786450|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
162786451|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
162786452|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
162786453|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Missing|2|||
162786454|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Missing|1|||
162786455|NCT00443209|587928047|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
162786456|NCT00443209|587928048|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
162786457|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
162786458|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
162786459|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
162786460|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
162786461|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
162786462|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
162786463|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
162786464|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
162786465|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
162786466|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
162786467|NCT00443209|587928047|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
162786468|NCT00443209|587928048|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
162786469|NCT01318876|587928049|FG000|Day 8 Survey|email address invalid|96|||
162786470|NCT01318876|587928049|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
162786471|NCT01318876|587928049|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
162786472|NCT02049515|587928052|FG000|Overall Study|Adverse Event|46|||
162786473|NCT02049515|587928053|FG001|Overall Study|Adverse Event|2|||
162786474|NCT02049515|587928052|FG000|Overall Study|Protocol-specified Disease Progression|23|||
162786475|NCT02049515|587928053|FG001|Overall Study|Protocol-specified Disease Progression|2|||
162786476|NCT02049515|587928052|FG000|Overall Study|Death|6|||
162786477|NCT02049515|587928053|FG001|Overall Study|Death|0|||
162786478|NCT02049515|587928052|FG000|Overall Study|Physician Decision|5|||
162786479|NCT02049515|587928053|FG001|Overall Study|Physician Decision|1|||
162786480|NCT02049515|587928052|FG000|Overall Study|Withdrawal by Subject|3|||
162786481|NCT02049515|587928053|FG001|Overall Study|Withdrawal by Subject|0|||
162786482|NCT02049515|587928052|FG000|Overall Study|Termination of the Study by Sponsor|2|||
162786483|NCT02049515|587928053|FG001|Overall Study|Termination of the Study by Sponsor|0|||
162786484|NCT02049515|587928052|FG000|Overall Study|Protocol Violation|1|||
162786485|NCT02049515|587928053|FG001|Overall Study|Protocol Violation|1|||
162786486|NCT02049515|587928052|FG000|Overall Study|Clinical Deterioration|1|||
162786487|NCT02049515|587928053|FG001|Overall Study|Clinical Deterioration|0|||
162786488|NCT02049515|587928052|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
162786489|NCT02049515|587928053|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
162786490|NCT02049515|587928052|FG000|Overall Study|Treatment Interruption >42 Days|1|||
162786491|NCT02049515|587928053|FG001|Overall Study|Treatment Interruption >42 Days|0|||
162786492|NCT02049515|587928052|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
162786493|NCT02049515|587928053|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
162786494|NCT00224029|587928056|FG000|Overall Study|Lost to Follow-up|1|||
162786495|NCT00224029|587928056|FG000|Overall Study|Withdrawal by Subject|4|||
162786496|NCT00224029|587928056|FG000|Overall Study|Other|1|||
162786497|NCT01099579|587928057|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
162786498|NCT01099579|587928058|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
162786499|NCT01099579|587928059|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
162786500|NCT01099579|587928057|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
162786501|NCT01099579|587928058|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
162786502|NCT01099579|587928059|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
162786503|NCT01099579|587928057|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
162786504|NCT01099579|587928058|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
162786505|NCT01099579|587928059|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
162786506|NCT01099579|587928057|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
162786507|NCT01099579|587928058|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
162786508|NCT01099579|587928059|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
162786509|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
162786510|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
162786511|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
162786512|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
162786513|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
162786514|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
162786515|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
162786516|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
162786517|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
162786518|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162786519|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162786520|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162786521|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
162786522|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
162786523|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
162786524|NCT01099579|587928057|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
162786525|NCT01099579|587928058|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
162786526|NCT01099579|587928059|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
162786527|NCT03513068|587928060|FG000|Overall Study|Death|1|||
162786528|NCT03513068|587928061|FG001|Overall Study|Death|0|||
162786529|NCT03513068|587928060|FG000|Overall Study|Withdrawal by Subject|4|||
162786530|NCT03513068|587928061|FG001|Overall Study|Withdrawal by Subject|6|||
162786531|NCT03636373|587928063|FG000|Overall Study|Study closure due to Covid-19|1|||
162786532|NCT03636373|587928064|FG001|Overall Study|Study closure due to Covid-19|0|||
162786533|NCT01575873|587928065|FG000|Overall Study|Withdrawal by Subject|15|||
162786534|NCT01575873|587928066|FG001|Overall Study|Withdrawal by Subject|20|||
162786535|NCT01575873|587928067|FG002|Overall Study|Withdrawal by Subject|34|||
162786536|NCT01575873|587928068|FG003|Overall Study|Withdrawal by Subject|34|||
162786537|NCT01575873|587928065|FG000|Overall Study|Adverse Event|7|||
162786538|NCT01575873|587928066|FG001|Overall Study|Adverse Event|7|||
162786539|NCT01575873|587928067|FG002|Overall Study|Adverse Event|9|||
162786540|NCT01575873|587928068|FG003|Overall Study|Adverse Event|12|||
162786541|NCT01575873|587928065|FG000|Overall Study|Lost to Follow-up|1|||
162786542|NCT01575873|587928066|FG001|Overall Study|Lost to Follow-up|3|||
162786543|NCT01575873|587928067|FG002|Overall Study|Lost to Follow-up|13|||
162786544|NCT01575873|587928068|FG003|Overall Study|Lost to Follow-up|5|||
162786545|NCT01575873|587928065|FG000|Overall Study|Death|3|||
162786546|NCT01575873|587928066|FG001|Overall Study|Death|2|||
162786547|NCT01575873|587928067|FG002|Overall Study|Death|8|||
162786548|NCT01575873|587928068|FG003|Overall Study|Death|9|||
162786549|NCT01575873|587928065|FG000|Overall Study|Noncompliance|1|||
162786550|NCT01575873|587928066|FG001|Overall Study|Noncompliance|2|||
162786551|NCT01575873|587928067|FG002|Overall Study|Noncompliance|4|||
162786552|NCT01575873|587928068|FG003|Overall Study|Noncompliance|3|||
162786553|NCT01575873|587928065|FG000|Overall Study|Administrative decision|1|||
162786554|NCT01575873|587928066|FG001|Overall Study|Administrative decision|1|||
162786555|NCT01575873|587928067|FG002|Overall Study|Administrative decision|1|||
162786556|NCT01575873|587928068|FG003|Overall Study|Administrative decision|0|||
162786557|NCT01575873|587928065|FG000|Overall Study|Protocol deviation|0|||
162786558|NCT01575873|587928066|FG001|Overall Study|Protocol deviation|1|||
162786559|NCT01575873|587928067|FG002|Overall Study|Protocol deviation|0|||
162786560|NCT01575873|587928068|FG003|Overall Study|Protocol deviation|1|||
162786561|NCT01575873|587928065|FG000|Overall Study|Requirement for Alternative Therapy|0|||
162786562|NCT01575873|587928066|FG001|Overall Study|Requirement for Alternative Therapy|0|||
162786563|NCT01575873|587928067|FG002|Overall Study|Requirement for Alternative Therapy|1|||
162786564|NCT01575873|587928068|FG003|Overall Study|Requirement for Alternative Therapy|1|||
162786565|NCT01575873|587928065|FG000|Overall Study|Other|0|||
162786566|NCT01575873|587928066|FG001|Overall Study|Other|0|||
162786567|NCT01575873|587928067|FG002|Overall Study|Other|4|||
162786568|NCT01575873|587928068|FG003|Overall Study|Other|2|||
162786569|NCT01850030|587928069|FG000|Overall Study|Adverse Event|64|||
162786570|NCT01850030|587928070|FG001|Overall Study|Adverse Event|82|||
162786571|NCT01850030|587928069|FG000|Overall Study|Lack of Efficacy|3|||
162786572|NCT01850030|587928070|FG001|Overall Study|Lack of Efficacy|1|||
162786573|NCT01850030|587928069|FG000|Overall Study|Lost to Follow-up|5|||
162786574|NCT01850030|587928070|FG001|Overall Study|Lost to Follow-up|5|||
162786575|NCT01850030|587928069|FG000|Overall Study|Withdrawal by Subject|3|||
162786576|NCT01850030|587928070|FG001|Overall Study|Withdrawal by Subject|4|||
162786577|NCT01850030|587928069|FG000|Overall Study|Protocol Violation|24|||
162786578|NCT01850030|587928070|FG001|Overall Study|Protocol Violation|28|||
162786579|NCT01850030|587928069|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
162786580|NCT01850030|587928070|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
162786581|NCT02688530|587928074|FG000|Overall Study|Withdrawal by Subject|0|||
162786582|NCT02688530|587928075|FG001|Overall Study|Withdrawal by Subject|1|||
162786583|NCT02688530|587928076|FG002|Overall Study|Withdrawal by Subject|0|||
162786584|NCT02688530|587928077|FG003|Overall Study|Withdrawal by Subject|0|||
162786585|NCT02688530|587928074|FG000|Overall Study|Lost to Follow-up|0|||
162786586|NCT02688530|587928075|FG001|Overall Study|Lost to Follow-up|0|||
162786587|NCT02688530|587928076|FG002|Overall Study|Lost to Follow-up|2|||
162786588|NCT02688530|587928077|FG003|Overall Study|Lost to Follow-up|0|||
162786589|NCT01658020|587928078|FG000|Overall Study|Adverse Event|3|||
162786590|NCT01658020|587928079|FG001|Overall Study|Adverse Event|3|||
162786591|NCT01658020|587928078|FG000|Overall Study|Lost to Follow-up|1|||
162786592|NCT01658020|587928079|FG001|Overall Study|Lost to Follow-up|0|||
162786593|NCT01658020|587928078|FG000|Overall Study|Withdrawal by Subject|4|||
162786594|NCT01658020|587928079|FG001|Overall Study|Withdrawal by Subject|5|||
162786595|NCT01658020|587928078|FG000|Overall Study|Protocol Violation|0|||
162786596|NCT01658020|587928079|FG001|Overall Study|Protocol Violation|1|||
162786597|NCT03698019|587928082|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
162786598|NCT03698019|587928083|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
162786599|NCT03698019|587928082|FG000|Step 1: Registration|Withdrawal by Subject|7|||
162786600|NCT03698019|587928083|FG001|Step 1: Registration|Withdrawal by Subject|2|||
162786601|NCT03698019|587928082|FG000|Step 1: Registration|Toxicity|0|||
162786602|NCT03698019|587928083|FG001|Step 1: Registration|Toxicity|1|||
162786603|NCT03698019|587928082|FG000|Step 1: Registration|Disease Progression|0|||
162786604|NCT03698019|587928083|FG001|Step 1: Registration|Disease Progression|12|||
162786605|NCT03698019|587928082|FG000|Step 1: Registration|Co-morbidities|0|||
162786606|NCT03698019|587928083|FG001|Step 1: Registration|Co-morbidities|1|||
162786607|NCT03698019|587928082|FG000|Step 1: Registration|Scheduling Issues|1|||
162786608|NCT03698019|587928083|FG001|Step 1: Registration|Scheduling Issues|0|||
162786609|NCT03698019|587928082|FG000|Step 1: Registration|Participant Refusal|0|||
162786610|NCT03698019|587928083|FG001|Step 1: Registration|Participant Refusal|1|||
162786611|NCT03698019|587928082|FG000|Step 2: Surgery|Participant Refusal|2|||
162786612|NCT03698019|587928083|FG001|Step 2: Surgery|Participant Refusal|1|||
162786613|NCT03698019|587928082|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
162786614|NCT03698019|587928083|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
162786615|NCT03698019|587928082|FG000|Step 2: Surgery|Metastatic Disease|16|||
162786616|NCT03698019|587928083|FG001|Step 2: Surgery|Metastatic Disease|9|||
162786617|NCT03698019|587928082|FG000|Step 2: Surgery|Residual Disease|2|||
162786618|NCT03698019|587928083|FG001|Step 2: Surgery|Residual Disease|1|||
162786619|NCT03698019|587928082|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
162786620|NCT03698019|587928083|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
162786621|NCT03698019|587928082|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
162786622|NCT03698019|587928083|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
162786623|NCT03698019|587928082|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
162786624|NCT03698019|587928083|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
162786625|NCT03698019|587928082|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
162786626|NCT03698019|587928083|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
162786627|NCT03698019|587928082|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
162786628|NCT03698019|587928083|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
162786629|NCT03698019|587928082|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
162786630|NCT03698019|587928083|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
162786631|NCT03698019|587928082|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
162786632|NCT03698019|587928083|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
162786633|NCT03698019|587928082|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
162786634|NCT03698019|587928083|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
162786635|NCT02647645|587928084|FG000|Overall Study|Lost to Follow-up|2|||
162786636|NCT02647645|587928085|FG001|Overall Study|Lost to Follow-up|1|||
162786637|NCT04599907|587928088|FG000|Overall Study|Withdrawal by Subject|1|||
162786638|NCT04599907|587928089|FG001|Overall Study|Withdrawal by Subject|7|||
162786639|NCT04599907|587928090|FG002|Overall Study|Withdrawal by Subject|6|||
162786640|NCT04599907|587928088|FG000|Overall Study|Lost to Follow-up|0|||
162786641|NCT04599907|587928089|FG001|Overall Study|Lost to Follow-up|1|||
162786642|NCT04599907|587928090|FG002|Overall Study|Lost to Follow-up|0|||
162786643|NCT03007732|587928091|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
162786644|NCT03007732|587928092|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
162786645|NCT03007732|587928093|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
162786646|NCT03007732|587928094|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
162786647|NCT03371823|587928095|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
162786648|NCT03371823|587928096|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
162786649|NCT01466790|587928098|FG000|Overall Study|Adverse Event|1|||
162786650|NCT01466790|587928099|FG001|Overall Study|Adverse Event|0|||
162786651|NCT01466790|587928100|FG002|Overall Study|Adverse Event|0|||
162786652|NCT01466790|587928101|FG003|Overall Study|Adverse Event|0|||
162786653|NCT01466790|587928102|FG004|Overall Study|Adverse Event|2|||
162786654|NCT01466790|587928103|FG005|Overall Study|Adverse Event|0|||
162786655|NCT01466790|587928104|FG006|Overall Study|Adverse Event|0|||
162786656|NCT01466790|587928105|FG007|Overall Study|Adverse Event|0|||
162786657|NCT01466790|587928098|FG000|Overall Study|Lost to Follow-up|2|||
162786658|NCT01466790|587928099|FG001|Overall Study|Lost to Follow-up|0|||
162786659|NCT01466790|587928100|FG002|Overall Study|Lost to Follow-up|0|||
162786660|NCT01466790|587928101|FG003|Overall Study|Lost to Follow-up|0|||
162786661|NCT01466790|587928102|FG004|Overall Study|Lost to Follow-up|0|||
162786662|NCT01466790|587928103|FG005|Overall Study|Lost to Follow-up|0|||
162786663|NCT01466790|587928104|FG006|Overall Study|Lost to Follow-up|0|||
162786664|NCT01466790|587928105|FG007|Overall Study|Lost to Follow-up|0|||
162786665|NCT01466790|587928098|FG000|Overall Study|Withdrawal by Subject|1|||
162786666|NCT01466790|587928099|FG001|Overall Study|Withdrawal by Subject|1|||
162786667|NCT01466790|587928100|FG002|Overall Study|Withdrawal by Subject|0|||
162786668|NCT01466790|587928101|FG003|Overall Study|Withdrawal by Subject|0|||
162786669|NCT01466790|587928102|FG004|Overall Study|Withdrawal by Subject|1|||
162786670|NCT01466790|587928103|FG005|Overall Study|Withdrawal by Subject|0|||
162786671|NCT01466790|587928104|FG006|Overall Study|Withdrawal by Subject|1|||
162786672|NCT01466790|587928105|FG007|Overall Study|Withdrawal by Subject|1|||
162786673|NCT03668223|587928106|FG000|Overall Study|Death|10|||
162786674|NCT03668223|587928107|FG001|Overall Study|Death|5|||
162786675|NCT03668223|587928106|FG000|Overall Study|Lost to Follow-up|12|||
162786676|NCT03668223|587928107|FG001|Overall Study|Lost to Follow-up|12|||
162786677|NCT03668223|587928106|FG000|Overall Study|Withdrawal by Subject|8|||
162786678|NCT03668223|587928107|FG001|Overall Study|Withdrawal by Subject|3|||
162786679|NCT05502783|587928108|FG000|Overall Study|Lack of Efficacy|1|||
162786680|NCT04870957|587928109|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162786681|NCT04870957|587928110|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162786682|NCT04870957|587928111|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162786683|NCT04870957|587928112|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162786684|NCT04870957|587928113|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
162810573|NCT00887250|588018276|FG001|Overall Study|Adverse Event|0|||
162786685|NCT04870957|587928114|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162786686|NCT04870957|587928109|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162786687|NCT04870957|587928110|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162786688|NCT04870957|587928111|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162786689|NCT04870957|587928112|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162786690|NCT04870957|587928113|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
162786691|NCT04870957|587928114|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162786692|NCT04870957|587928109|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162786693|NCT04870957|587928110|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162786694|NCT04870957|587928111|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162786695|NCT04870957|587928112|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162786696|NCT04870957|587928113|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
162786697|NCT04870957|587928114|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162786698|NCT04870957|587928109|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162786699|NCT04870957|587928110|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162786700|NCT04870957|587928111|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162786701|NCT04870957|587928112|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162786702|NCT04870957|587928113|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
162786703|NCT04870957|587928114|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162786704|NCT04870957|587928109|FG000|T2 (Randomization) - T3|Adverse Event|1|||
162786705|NCT04870957|587928110|FG001|T2 (Randomization) - T3|Adverse Event|1|||
162786706|NCT04870957|587928111|FG002|T2 (Randomization) - T3|Adverse Event|0|||
162786707|NCT04870957|587928112|FG003|T2 (Randomization) - T3|Adverse Event|0|||
162786708|NCT04870957|587928113|FG004|T2 (Randomization) - T3|Adverse Event|0|||
162786709|NCT04870957|587928114|FG005|T2 (Randomization) - T3|Adverse Event|0|||
162786710|NCT04870957|587928109|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
162786711|NCT04870957|587928110|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
162786712|NCT04870957|587928111|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
162786713|NCT04870957|587928112|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
162786714|NCT04870957|587928113|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
162786715|NCT04870957|587928114|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
162786716|NCT04870957|587928109|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
162786717|NCT04870957|587928110|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
162786718|NCT04870957|587928111|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
162786719|NCT04870957|587928112|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
162786720|NCT04870957|587928113|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
162786721|NCT04870957|587928114|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
162786722|NCT04870957|587928109|FG000|T2 (Randomization) - T3|Physician Decision|0|||
162786723|NCT04870957|587928110|FG001|T2 (Randomization) - T3|Physician Decision|0|||
162786724|NCT04870957|587928111|FG002|T2 (Randomization) - T3|Physician Decision|2|||
162786725|NCT04870957|587928112|FG003|T2 (Randomization) - T3|Physician Decision|1|||
162786726|NCT04870957|587928113|FG004|T2 (Randomization) - T3|Physician Decision|0|||
162786727|NCT04870957|587928114|FG005|T2 (Randomization) - T3|Physician Decision|0|||
162786728|NCT04870957|587928109|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
162786729|NCT04870957|587928110|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
162786730|NCT04870957|587928111|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
162786731|NCT04870957|587928112|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
162786732|NCT04870957|587928113|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
162786733|NCT04870957|587928114|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
162786734|NCT04870957|587928109|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
162786735|NCT04870957|587928110|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
162786736|NCT04870957|587928111|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
162786737|NCT04870957|587928112|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
162786738|NCT04870957|587928113|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
162786739|NCT04870957|587928114|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
162786740|NCT04870957|587928109|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
162786741|NCT04870957|587928110|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
162786742|NCT04870957|587928111|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
162786743|NCT04870957|587928112|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
162786744|NCT04870957|587928113|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
162786745|NCT04870957|587928114|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
162786746|NCT04870957|587928109|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
162786747|NCT04870957|587928110|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
162786748|NCT04870957|587928111|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
162786749|NCT04870957|587928112|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
162786750|NCT04870957|587928113|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
162786751|NCT04870957|587928114|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
162786752|NCT04870957|587928109|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
162786753|NCT04870957|587928110|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
162810574|NCT00887250|588018277|FG002|Overall Study|Adverse Event|7|||
162786754|NCT04870957|587928111|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
162786755|NCT04870957|587928112|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
162786756|NCT04870957|587928113|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
162786757|NCT04870957|587928114|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
162786758|NCT04870957|587928109|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
162786759|NCT04870957|587928110|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
162786760|NCT04870957|587928111|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
162786761|NCT04870957|587928112|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
162786762|NCT04870957|587928113|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
162786763|NCT04870957|587928114|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
162786764|NCT04870957|587928109|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162786765|NCT04870957|587928110|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162786766|NCT04870957|587928111|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162786767|NCT04870957|587928112|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162786768|NCT04870957|587928113|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162786769|NCT04870957|587928114|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
162786770|NCT04870957|587928109|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162786771|NCT04870957|587928110|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162786772|NCT04870957|587928111|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162786773|NCT04870957|587928112|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162786774|NCT04870957|587928113|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162786775|NCT04870957|587928114|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
162786776|NCT04870957|587928109|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
162786777|NCT04870957|587928110|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
162786778|NCT04870957|587928111|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
162786779|NCT04870957|587928112|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
162786780|NCT04870957|587928113|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
162786781|NCT04870957|587928114|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
162786782|NCT04340843|587928117|FG000|Overall Study|Adverse Event|0|||
162786783|NCT04340843|587928118|FG001|Overall Study|Adverse Event|2|||
162786784|NCT04340843|587928117|FG000|Overall Study|Withdrawal by Subject|0|||
162786785|NCT04340843|587928118|FG001|Overall Study|Withdrawal by Subject|2|||
162786786|NCT03733899|587928121|FG000|Period 1|Protocol Violation|0|||
162786787|NCT03733899|587928122|FG001|Period 1|Protocol Violation|0|||
162786788|NCT03733899|587928123|FG002|Period 1|Protocol Violation|0|||
162786789|NCT03733899|587928124|FG003|Period 1|Protocol Violation|0|||
162786790|NCT03733899|587928125|FG004|Period 1|Protocol Violation|0|||
162786791|NCT03733899|587928126|FG005|Period 1|Protocol Violation|1|||
162786792|NCT03733899|587928121|FG000|Period 2|Unscuccessful Treatment|0|||
162786793|NCT03733899|587928122|FG001|Period 2|Unscuccessful Treatment|1|||
162786794|NCT03733899|587928123|FG002|Period 2|Unscuccessful Treatment|0|||
162786795|NCT03733899|587928124|FG003|Period 2|Unscuccessful Treatment|0|||
162786796|NCT03733899|587928125|FG004|Period 2|Unscuccessful Treatment|0|||
162786797|NCT03733899|587928126|FG005|Period 2|Unscuccessful Treatment|0|||
162786798|NCT03733899|587928121|FG000|Period 3|Withdrawal by Subject|1|||
162786799|NCT03733899|587928122|FG001|Period 3|Withdrawal by Subject|0|||
162786800|NCT03733899|587928123|FG002|Period 3|Withdrawal by Subject|0|||
162786801|NCT03733899|587928124|FG003|Period 3|Withdrawal by Subject|0|||
162786802|NCT03733899|587928125|FG004|Period 3|Withdrawal by Subject|0|||
162786803|NCT03733899|587928126|FG005|Period 3|Withdrawal by Subject|0|||
162786804|NCT02859064|587929725|FG000|Overall Study|Progressive Disease|3|||
162786805|NCT02859064|587929725|FG000|Overall Study|Physician Decision|1|||
162786806|NCT02859064|587929725|FG000|Overall Study|Withdrawal by Subject|1|||
162786807|NCT02859064|587929725|FG000|Overall Study|Death|1|||
162786808|NCT00667459|587929729|FG000|Overall Study|Death|0|||
162786809|NCT00667459|587929730|FG001|Overall Study|Death|2|||
162786810|NCT00667459|587929729|FG000|Overall Study|Lost to Follow-up|8|||
162786811|NCT00667459|587929730|FG001|Overall Study|Lost to Follow-up|43|||
162786812|NCT02568397|587929731|FG000|Period 2|Withdrawal by Subject|0|||
162786813|NCT02568397|587929732|FG001|Period 2|Withdrawal by Subject|1|||
162786814|NCT02568397|587929731|FG000|Period 2|Physician Decision|0|||
162786815|NCT02568397|587929732|FG001|Period 2|Physician Decision|1|||
162786816|NCT00078377|587929733|FG000|Overall Study|Adverse Event|2|||
162786817|NCT00078377|587929734|FG001|Overall Study|Adverse Event|5|||
162786818|NCT00078377|587929735|FG002|Overall Study|Adverse Event|1|||
162786819|NCT00078377|587929733|FG000|Overall Study|Lack of Efficacy|2|||
162786820|NCT00078377|587929734|FG001|Overall Study|Lack of Efficacy|0|||
162786821|NCT00078377|587929735|FG002|Overall Study|Lack of Efficacy|2|||
162786822|NCT00078377|587929733|FG000|Overall Study|Lost to Follow-up|0|||
162786823|NCT00078377|587929734|FG001|Overall Study|Lost to Follow-up|1|||
162786824|NCT00078377|587929735|FG002|Overall Study|Lost to Follow-up|1|||
162786825|NCT00078377|587929733|FG000|Overall Study|Physician Decision|2|||
162786826|NCT00078377|587929734|FG001|Overall Study|Physician Decision|0|||
162786827|NCT00078377|587929735|FG002|Overall Study|Physician Decision|0|||
162786828|NCT00078377|587929733|FG000|Overall Study|Withdrawal by Subject|3|||
162786829|NCT00078377|587929734|FG001|Overall Study|Withdrawal by Subject|4|||
162786830|NCT00078377|587929735|FG002|Overall Study|Withdrawal by Subject|4|||
162786831|NCT00078377|587929733|FG000|Overall Study|Miscellaneous|2|||
162786832|NCT00078377|587929734|FG001|Overall Study|Miscellaneous|6|||
162786833|NCT00078377|587929735|FG002|Overall Study|Miscellaneous|1|||
162786834|NCT00581893|587929736|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
162786835|NCT00581893|587929737|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
162786836|NCT01381575|587929738|FG000|Overall Study|Serious Adverse Event|1|||
162786837|NCT01381575|587929739|FG001|Overall Study|Serious Adverse Event|0|||
162786838|NCT01381575|587929740|FG002|Overall Study|Serious Adverse Event|0|||
162786839|NCT01381575|587929738|FG000|Overall Study|Non-Serious Adverse Event|0|||
162786840|NCT01381575|587929739|FG001|Overall Study|Non-Serious Adverse Event|0|||
162786841|NCT01381575|587929740|FG002|Overall Study|Non-Serious Adverse Event|1|||
162786842|NCT01381575|587929738|FG000|Overall Study|Protocol Violation|0|||
162786843|NCT01381575|587929739|FG001|Overall Study|Protocol Violation|1|||
162786844|NCT01381575|587929740|FG002|Overall Study|Protocol Violation|1|||
162786845|NCT01381575|587929738|FG000|Overall Study|Withdrawal by Subject|15|||
162786846|NCT01381575|587929739|FG001|Overall Study|Withdrawal by Subject|9|||
162786847|NCT01381575|587929740|FG002|Overall Study|Withdrawal by Subject|7|||
162786848|NCT01381575|587929738|FG000|Overall Study|Migrated/moved from study area|2|||
162786849|NCT01381575|587929739|FG001|Overall Study|Migrated/moved from study area|12|||
162786850|NCT01381575|587929740|FG002|Overall Study|Migrated/moved from study area|2|||
162786851|NCT01381575|587929738|FG000|Overall Study|Lost to Follow-up|8|||
162786852|NCT01381575|587929739|FG001|Overall Study|Lost to Follow-up|17|||
162786853|NCT01381575|587929740|FG002|Overall Study|Lost to Follow-up|9|||
162786854|NCT04090528|587929741|FG000|Overall Study|participants still on study|9|||
162786855|NCT04090528|587929742|FG001|Overall Study|participants still on study|13|||
162786856|NCT03020069|587929743|FG000|Overall Study|Lost to Follow-up|0|||
162786857|NCT03020069|587929744|FG001|Overall Study|Lost to Follow-up|1|||
162786858|NCT02684123|587929745|FG000|Phase 1|Lack of Efficacy|5|||
162786859|NCT02684123|587929746|FG001|Phase 1|Lack of Efficacy|0|||
162786860|NCT02684123|587929745|FG000|Phase 1|Adverse Event|3|||
162786861|NCT02684123|587929746|FG001|Phase 1|Adverse Event|0|||
162786862|NCT02684123|587929745|FG000|Phase 1|Lost to Follow-up|0|||
162786863|NCT02684123|587929746|FG001|Phase 1|Lost to Follow-up|1|||
162786864|NCT02684123|587929745|FG000|Phase 2|Lack of Efficacy|1|||
162786865|NCT02684123|587929746|FG001|Phase 2|Lack of Efficacy|8|||
162786866|NCT01920932|587929747|FG000|Overall Study|Death|1|||
162786867|NCT01920932|587929747|FG000|Overall Study|Withdrawal of consent|1|||
162786868|NCT04486313|587929750|FG000|Overall Study|Lost to Follow-up|7|||
162786869|NCT04486313|587929751|FG001|Overall Study|Lost to Follow-up|9|||
162786870|NCT04486313|587929750|FG000|Overall Study|Withdrawal by Subject|8|||
162786871|NCT04486313|587929751|FG001|Overall Study|Withdrawal by Subject|6|||
162786872|NCT04486313|587929750|FG000|Overall Study|Physician Decision|1|||
162786873|NCT04486313|587929751|FG001|Overall Study|Physician Decision|1|||
162786874|NCT04486313|587929750|FG000|Overall Study|Death|2|||
162786875|NCT04486313|587929751|FG001|Overall Study|Death|0|||
162786876|NCT04486313|587929750|FG000|Overall Study|Protocol Violation|1|||
162786877|NCT04486313|587929751|FG001|Overall Study|Protocol Violation|1|||
162786878|NCT01375751|587929759|FG000|Overall Study|Other|0|||
162786879|NCT01375751|587929760|FG001|Overall Study|Other|1|||
162786880|NCT01375751|587929761|FG002|Overall Study|Other|0|||
162786881|NCT00633945|587929762|FG000|Overall Study|Physician Decision|2|||
162786882|NCT00882115|587929763|FG000|Overall Study|Withdrawal by Subject|3|||
162786883|NCT00882115|587929763|FG000|Overall Study|did not respond to DEP challe|6|||
162786884|NCT02552147|587929764|FG000|First Intervention (7 Days)|Protocol Violation|1|||
162786885|NCT02552147|587929765|FG001|First Intervention (7 Days)|Protocol Violation|0|||
162786886|NCT02552147|587929764|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
162786887|NCT02552147|587929765|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
162786888|NCT00940875|587929766|FG000|Treatment Phase|Adverse Event|9|||
162786889|NCT00940875|587929767|FG001|Treatment Phase|Adverse Event|3|||
162786890|NCT00940875|587929766|FG000|Treatment Phase|Death|3|||
162786891|NCT00940875|587929767|FG001|Treatment Phase|Death|5|||
162786892|NCT00940875|587929766|FG000|Treatment Phase|Lack of Efficacy|1|||
162786893|NCT00940875|587929767|FG001|Treatment Phase|Lack of Efficacy|0|||
162786894|NCT00940875|587929766|FG000|Treatment Phase|Withdrawal by Subject|3|||
162786895|NCT00940875|587929767|FG001|Treatment Phase|Withdrawal by Subject|0|||
162786896|NCT00940875|587929766|FG000|Treatment Phase|Disease progression|9|||
162786897|NCT00940875|587929767|FG001|Treatment Phase|Disease progression|11|||
162786898|NCT00940875|587929766|FG000|Treatment Phase|Physician Decision|1|||
162786899|NCT00940875|587929767|FG001|Treatment Phase|Physician Decision|0|||
162786900|NCT00940875|587929766|FG000|Post-Study Treatment|Death|0|||
162786901|NCT00940875|587929767|FG001|Post-Study Treatment|Death|1|||
162786902|NCT00940875|587929766|FG000|Post-Study Treatment|Disease Progression|0|||
162786903|NCT00940875|587929767|FG001|Post-Study Treatment|Disease Progression|2|||
162786904|NCT00943787|587929768|FG000|Overall Study|Physician Decision|4|||
162786905|NCT00943787|587929768|FG000|Overall Study|Withdrawal by Subject|3|||
162786906|NCT01547598|587929769|FG000|Overall Study|Withdrew consent|1|||
162786907|NCT01547598|587929770|FG001|Overall Study|Withdrew consent|1|||
162786908|NCT01547598|587929769|FG000|Overall Study|Lost to Follow-up|1|||
162786909|NCT01547598|587929770|FG001|Overall Study|Lost to Follow-up|1|||
162786910|NCT01547598|587929769|FG000|Overall Study|Adverse Event|1|||
162786911|NCT01547598|587929770|FG001|Overall Study|Adverse Event|1|||
162786912|NCT01547598|587929769|FG000|Overall Study|Protocol Violation|1|||
162786913|NCT01547598|587929770|FG001|Overall Study|Protocol Violation|1|||
162786914|NCT01547598|587929769|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162786915|NCT01547598|587929770|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162786916|NCT00872001|587929774|FG000|Overall Study|Adverse Event|34|||
162786917|NCT00872001|587929775|FG001|Overall Study|Adverse Event|23|||
162786918|NCT00872001|587929774|FG000|Overall Study|Protocol Defined Clinical Event|5|||
162786919|NCT00872001|587929775|FG001|Overall Study|Protocol Defined Clinical Event|7|||
162786920|NCT00872001|587929774|FG000|Overall Study|Lost to Follow-up|13|||
162786921|NCT00872001|587929775|FG001|Overall Study|Lost to Follow-up|12|||
162786922|NCT00872001|587929774|FG000|Overall Study|Withdrawal by Subject|18|||
162786923|NCT00872001|587929775|FG001|Overall Study|Withdrawal by Subject|30|||
162786924|NCT00872001|587929774|FG000|Overall Study|Protocol Violation|5|||
162786925|NCT00872001|587929775|FG001|Overall Study|Protocol Violation|8|||
162786926|NCT00872001|587929774|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
162786927|NCT00872001|587929775|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
162786928|NCT00872001|587929774|FG000|Overall Study|Administrative|23|||
162786929|NCT00872001|587929775|FG001|Overall Study|Administrative|15|||
162786930|NCT04071301|587929776|FG000|Overall Study|Withdrawal by Subject|6|||
162786931|NCT04071301|587929776|FG000|Overall Study|Death|1|||
162786932|NCT05186311|587929777|FG000|Part A: Serum|Withdrawal by Subject|1|||
162786933|NCT02879383|587929778|FG000|First 24 Weeks|Physician Decision|0|||
162786934|NCT02879383|587929779|FG001|First 24 Weeks|Physician Decision|1|||
162786935|NCT02879383|587929780|FG002|First 24 Weeks|Physician Decision|0|||
162786936|NCT02879383|587929781|FG003|First 24 Weeks|Physician Decision|0|||
162786937|NCT02125279|587929782|FG000|Overall Study|Lack of Efficacy|2|||
162786938|NCT02125279|587929782|FG000|Overall Study|Withdrawal by Subject|6|||
162786939|NCT02125279|587929782|FG000|Overall Study|Protocol Violation|1|||
162786940|NCT02125279|587929782|FG000|Overall Study|Lost to Follow-up|4|||
162786941|NCT01607879|587929787|FG000|Overall Study|Death|1|||
162786942|NCT01607879|587929788|FG001|Overall Study|Death|0|||
162786943|NCT01101061|587929800|FG000|Overall Study|Adverse Event|0|||
162786944|NCT01101061|587929801|FG001|Overall Study|Adverse Event|0|||
162786945|NCT01101061|587929802|FG002|Overall Study|Adverse Event|1|||
162786946|NCT01101061|587929803|FG003|Overall Study|Adverse Event|0|||
162786947|NCT01101061|587929804|FG004|Overall Study|Adverse Event|0|||
162786948|NCT01101061|587929805|FG005|Overall Study|Adverse Event|0|||
162786949|NCT01236352|587929812|FG000|Overall Study|Death|0|||
162786950|NCT01236352|587929813|FG001|Overall Study|Death|0|||
162786951|NCT01236352|587929814|FG002|Overall Study|Death|0|||
162786952|NCT01236352|587929815|FG003|Overall Study|Death|0|||
162786953|NCT01236352|587929816|FG004|Overall Study|Death|0|||
162786954|NCT01236352|587929817|FG005|Overall Study|Death|0|||
162786955|NCT01236352|587929818|FG006|Overall Study|Death|0|||
162786956|NCT01236352|587929819|FG007|Overall Study|Death|1|||
162786957|NCT01236352|587929820|FG008|Overall Study|Death|0|||
162786958|NCT01236352|587929821|FG009|Overall Study|Death|0|||
162786959|NCT01236352|587929822|FG010|Overall Study|Death|0|||
162786960|NCT01236352|587929812|FG000|Overall Study|Withdrawal by Subject|0|||
162786961|NCT01236352|587929813|FG001|Overall Study|Withdrawal by Subject|0|||
162786962|NCT01236352|587929814|FG002|Overall Study|Withdrawal by Subject|0|||
162786963|NCT01236352|587929815|FG003|Overall Study|Withdrawal by Subject|0|||
162786964|NCT01236352|587929816|FG004|Overall Study|Withdrawal by Subject|0|||
162786965|NCT01236352|587929817|FG005|Overall Study|Withdrawal by Subject|0|||
162786966|NCT01236352|587929818|FG006|Overall Study|Withdrawal by Subject|0|||
162786967|NCT01236352|587929819|FG007|Overall Study|Withdrawal by Subject|0|||
162786968|NCT01236352|587929820|FG008|Overall Study|Withdrawal by Subject|0|||
162786969|NCT01236352|587929821|FG009|Overall Study|Withdrawal by Subject|2|||
162786970|NCT01236352|587929822|FG010|Overall Study|Withdrawal by Subject|1|||
162786971|NCT01236352|587929812|FG000|Overall Study|Adverse Event|0|||
162786972|NCT01236352|587929813|FG001|Overall Study|Adverse Event|0|||
162786973|NCT01236352|587929814|FG002|Overall Study|Adverse Event|0|||
162786974|NCT01236352|587929815|FG003|Overall Study|Adverse Event|0|||
162786975|NCT01236352|587929816|FG004|Overall Study|Adverse Event|0|||
162786976|NCT01236352|587929817|FG005|Overall Study|Adverse Event|0|||
162786977|NCT01236352|587929818|FG006|Overall Study|Adverse Event|2|||
162786978|NCT01236352|587929819|FG007|Overall Study|Adverse Event|0|||
162786979|NCT01236352|587929820|FG008|Overall Study|Adverse Event|0|||
162786980|NCT01236352|587929821|FG009|Overall Study|Adverse Event|4|||
162786981|NCT01236352|587929822|FG010|Overall Study|Adverse Event|1|||
162786982|NCT01236352|587929812|FG000|Overall Study|Study drug toxicity|0|||
162786983|NCT01236352|587929813|FG001|Overall Study|Study drug toxicity|0|||
162786984|NCT01236352|587929814|FG002|Overall Study|Study drug toxicity|0|||
162786985|NCT01236352|587929815|FG003|Overall Study|Study drug toxicity|0|||
162786986|NCT01236352|587929816|FG004|Overall Study|Study drug toxicity|0|||
162786987|NCT01236352|587929817|FG005|Overall Study|Study drug toxicity|1|||
162786988|NCT01236352|587929818|FG006|Overall Study|Study drug toxicity|1|||
162786989|NCT01236352|587929819|FG007|Overall Study|Study drug toxicity|0|||
162786990|NCT01236352|587929820|FG008|Overall Study|Study drug toxicity|0|||
162786991|NCT01236352|587929821|FG009|Overall Study|Study drug toxicity|2|||
162786992|NCT01236352|587929822|FG010|Overall Study|Study drug toxicity|2|||
162786993|NCT01236352|587929812|FG000|Overall Study|Disease progression|1|||
162786994|NCT01236352|587929813|FG001|Overall Study|Disease progression|2|||
162786995|NCT01236352|587929814|FG002|Overall Study|Disease progression|1|||
162786996|NCT01236352|587929815|FG003|Overall Study|Disease progression|2|||
162786997|NCT01236352|587929816|FG004|Overall Study|Disease progression|2|||
162786998|NCT01236352|587929817|FG005|Overall Study|Disease progression|2|||
162786999|NCT01236352|587929818|FG006|Overall Study|Disease progression|1|||
162787000|NCT01236352|587929819|FG007|Overall Study|Disease progression|3|||
162787001|NCT01236352|587929820|FG008|Overall Study|Disease progression|2|||
162787002|NCT01236352|587929821|FG009|Overall Study|Disease progression|2|||
162787003|NCT01236352|587929822|FG010|Overall Study|Disease progression|2|||
162787004|NCT01236352|587929812|FG000|Overall Study|Poor/Non-compliance|1|||
162787005|NCT01236352|587929813|FG001|Overall Study|Poor/Non-compliance|0|||
162787006|NCT01236352|587929814|FG002|Overall Study|Poor/Non-compliance|0|||
162787007|NCT01236352|587929815|FG003|Overall Study|Poor/Non-compliance|0|||
162787008|NCT01236352|587929816|FG004|Overall Study|Poor/Non-compliance|0|||
162787009|NCT01236352|587929817|FG005|Overall Study|Poor/Non-compliance|0|||
162787010|NCT01236352|587929818|FG006|Overall Study|Poor/Non-compliance|0|||
162787011|NCT01236352|587929819|FG007|Overall Study|Poor/Non-compliance|0|||
162787012|NCT01236352|587929820|FG008|Overall Study|Poor/Non-compliance|0|||
162787013|NCT01236352|587929821|FG009|Overall Study|Poor/Non-compliance|0|||
162787014|NCT01236352|587929822|FG010|Overall Study|Poor/Non-compliance|0|||
162787015|NCT01236352|587929812|FG000|Overall Study|Maximum clinical benefit|1|||
162787016|NCT01236352|587929813|FG001|Overall Study|Maximum clinical benefit|1|||
162787017|NCT01236352|587929814|FG002|Overall Study|Maximum clinical benefit|1|||
162787018|NCT01236352|587929815|FG003|Overall Study|Maximum clinical benefit|0|||
162787019|NCT01236352|587929816|FG004|Overall Study|Maximum clinical benefit|2|||
162787020|NCT01236352|587929817|FG005|Overall Study|Maximum clinical benefit|0|||
162787021|NCT01236352|587929818|FG006|Overall Study|Maximum clinical benefit|3|||
162787022|NCT01236352|587929819|FG007|Overall Study|Maximum clinical benefit|1|||
162787023|NCT01236352|587929820|FG008|Overall Study|Maximum clinical benefit|1|||
162787024|NCT01236352|587929821|FG009|Overall Study|Maximum clinical benefit|4|||
162787025|NCT01236352|587929822|FG010|Overall Study|Maximum clinical benefit|2|||
162787026|NCT01236352|587929812|FG000|Overall Study|Subject request to discontinue treatment|0|||
162787027|NCT01236352|587929813|FG001|Overall Study|Subject request to discontinue treatment|0|||
162787028|NCT01236352|587929814|FG002|Overall Study|Subject request to discontinue treatment|1|||
162787029|NCT01236352|587929815|FG003|Overall Study|Subject request to discontinue treatment|1|||
162787030|NCT01236352|587929816|FG004|Overall Study|Subject request to discontinue treatment|0|||
162787031|NCT01236352|587929817|FG005|Overall Study|Subject request to discontinue treatment|1|||
162787032|NCT01236352|587929818|FG006|Overall Study|Subject request to discontinue treatment|0|||
162787033|NCT01236352|587929819|FG007|Overall Study|Subject request to discontinue treatment|0|||
162787034|NCT01236352|587929820|FG008|Overall Study|Subject request to discontinue treatment|0|||
162787035|NCT01236352|587929821|FG009|Overall Study|Subject request to discontinue treatment|1|||
162787036|NCT01236352|587929822|FG010|Overall Study|Subject request to discontinue treatment|4|||
162787037|NCT01236352|587929812|FG000|Overall Study|Subject to receive drug via EAP|1|||
162787038|NCT01236352|587929813|FG001|Overall Study|Subject to receive drug via EAP|1|||
162787039|NCT01236352|587929814|FG002|Overall Study|Subject to receive drug via EAP|1|||
162787040|NCT01236352|587929815|FG003|Overall Study|Subject to receive drug via EAP|0|||
162787041|NCT01236352|587929816|FG004|Overall Study|Subject to receive drug via EAP|0|||
162787042|NCT01236352|587929817|FG005|Overall Study|Subject to receive drug via EAP|0|||
162787043|NCT01236352|587929818|FG006|Overall Study|Subject to receive drug via EAP|0|||
162787044|NCT01236352|587929819|FG007|Overall Study|Subject to receive drug via EAP|2|||
162787045|NCT01236352|587929820|FG008|Overall Study|Subject to receive drug via EAP|0|||
162787046|NCT01236352|587929821|FG009|Overall Study|Subject to receive drug via EAP|4|||
162787047|NCT01236352|587929822|FG010|Overall Study|Subject to receive drug via EAP|0|||
162787048|NCT01236352|587929812|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
162787049|NCT01236352|587929813|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
162787050|NCT01236352|587929814|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
162787051|NCT01236352|587929815|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
162787052|NCT01236352|587929816|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
162787053|NCT01236352|587929817|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
162787054|NCT01236352|587929818|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
162787055|NCT01236352|587929819|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
162787056|NCT01236352|587929820|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
162787057|NCT01236352|587929821|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
162787058|NCT01236352|587929822|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
162787059|NCT01236352|587929812|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787060|NCT01236352|587929813|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787061|NCT01236352|587929814|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787062|NCT01236352|587929815|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787063|NCT01236352|587929816|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787064|NCT01236352|587929817|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787065|NCT01236352|587929818|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787066|NCT01236352|587929819|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787067|NCT01236352|587929820|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787068|NCT01236352|587929821|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162787069|NCT01236352|587929822|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
162787070|NCT01236352|587929812|FG000|Overall Study|Lack of response to drug|0|||
162787071|NCT01236352|587929813|FG001|Overall Study|Lack of response to drug|0|||
162787072|NCT01236352|587929814|FG002|Overall Study|Lack of response to drug|0|||
162787073|NCT01236352|587929815|FG003|Overall Study|Lack of response to drug|0|||
162787074|NCT01236352|587929816|FG004|Overall Study|Lack of response to drug|0|||
162787075|NCT01236352|587929817|FG005|Overall Study|Lack of response to drug|0|||
162787076|NCT01236352|587929818|FG006|Overall Study|Lack of response to drug|0|||
162787077|NCT01236352|587929819|FG007|Overall Study|Lack of response to drug|0|||
162787078|NCT01236352|587929820|FG008|Overall Study|Lack of response to drug|0|||
162787079|NCT01236352|587929821|FG009|Overall Study|Lack of response to drug|1|||
162787080|NCT01236352|587929822|FG010|Overall Study|Lack of response to drug|1|||
162787081|NCT01236352|587929812|FG000|Overall Study|Patient transferred to IST|0|||
162787082|NCT01236352|587929813|FG001|Overall Study|Patient transferred to IST|0|||
162787083|NCT01236352|587929814|FG002|Overall Study|Patient transferred to IST|0|||
162787084|NCT01236352|587929815|FG003|Overall Study|Patient transferred to IST|0|||
162787085|NCT01236352|587929816|FG004|Overall Study|Patient transferred to IST|0|||
162787086|NCT01236352|587929817|FG005|Overall Study|Patient transferred to IST|0|||
162787087|NCT01236352|587929818|FG006|Overall Study|Patient transferred to IST|0|||
162787088|NCT01236352|587929819|FG007|Overall Study|Patient transferred to IST|0|||
162787089|NCT01236352|587929820|FG008|Overall Study|Patient transferred to IST|0|||
162787090|NCT01236352|587929821|FG009|Overall Study|Patient transferred to IST|2|||
162787091|NCT01236352|587929822|FG010|Overall Study|Patient transferred to IST|6|||
162787092|NCT05903183|587929827|FG000|Main Trial Part (365 Days)|Death|1|||
162787093|NCT05903183|587929828|FG001|Main Trial Part (365 Days)|Death|0|||
162787094|NCT05903183|587929829|FG002|Main Trial Part (365 Days)|Death|0|||
162787095|NCT05903183|587929830|FG003|Main Trial Part (365 Days)|Death|0|||
162787096|NCT05903183|587929831|FG004|Main Trial Part (365 Days)|Death|0|||
162787097|NCT05903183|587929827|FG000|Main Trial Part (365 Days)|Other|1|||
162787098|NCT05903183|587929828|FG001|Main Trial Part (365 Days)|Other|2|||
162787099|NCT05903183|587929829|FG002|Main Trial Part (365 Days)|Other|1|||
162787100|NCT05903183|587929830|FG003|Main Trial Part (365 Days)|Other|0|||
162787101|NCT05903183|587929831|FG004|Main Trial Part (365 Days)|Other|0|||
162787102|NCT05903183|587929827|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162787103|NCT05903183|587929828|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162787104|NCT05903183|587929829|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
162787105|NCT05903183|587929830|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162787106|NCT05903183|587929831|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162787107|NCT05903183|587929827|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
162787108|NCT05903183|587929828|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162787109|NCT05903183|587929829|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162787110|NCT05903183|587929830|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162787111|NCT05903183|587929831|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162787112|NCT05903183|587929827|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162787113|NCT05903183|587929828|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162787114|NCT05903183|587929829|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162787115|NCT05903183|587929830|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
162787116|NCT05903183|587929831|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
162787117|NCT03149029|587929832|FG000|Overall Study|Adverse Event|2|||
162787118|NCT03149029|587929833|FG001|Overall Study|Adverse Event|0|||
162787119|NCT03735121|587929834|FG000|Overall Study|Death|3|||
162787120|NCT03735121|587929835|FG001|Overall Study|Death|6|||
162787121|NCT03735121|587929836|FG002|Overall Study|Death|19|||
162787122|NCT03735121|587929837|FG003|Overall Study|Death|97|||
162787123|NCT03735121|587929838|FG004|Overall Study|Death|205|||
162787124|NCT03735121|587929834|FG000|Overall Study|Lost to Follow-up|0|||
162787125|NCT03735121|587929835|FG001|Overall Study|Lost to Follow-up|0|||
162787126|NCT03735121|587929836|FG002|Overall Study|Lost to Follow-up|0|||
162787127|NCT03735121|587929837|FG003|Overall Study|Lost to Follow-up|2|||
162787128|NCT03735121|587929838|FG004|Overall Study|Lost to Follow-up|3|||
162787129|NCT03735121|587929834|FG000|Overall Study|New Therapy|0|||
162787130|NCT03735121|587929835|FG001|Overall Study|New Therapy|1|||
162787131|NCT03735121|587929836|FG002|Overall Study|New Therapy|0|||
162787132|NCT03735121|587929837|FG003|Overall Study|New Therapy|0|||
162787133|NCT03735121|587929838|FG004|Overall Study|New Therapy|0|||
162787134|NCT03735121|587929834|FG000|Overall Study|Study Ended by Sponsor|1|||
162787135|NCT03735121|587929835|FG001|Overall Study|Study Ended by Sponsor|0|||
162787136|NCT03735121|587929836|FG002|Overall Study|Study Ended by Sponsor|1|||
162787137|NCT03735121|587929837|FG003|Overall Study|Study Ended by Sponsor|17|||
162787138|NCT03735121|587929838|FG004|Overall Study|Study Ended by Sponsor|28|||
162787139|NCT03735121|587929834|FG000|Overall Study|Withdrawal by Subject|1|||
162787140|NCT03735121|587929835|FG001|Overall Study|Withdrawal by Subject|1|||
162787141|NCT03735121|587929836|FG002|Overall Study|Withdrawal by Subject|6|||
162787142|NCT03735121|587929837|FG003|Overall Study|Withdrawal by Subject|8|||
162787143|NCT03735121|587929838|FG004|Overall Study|Withdrawal by Subject|11|||
162787144|NCT02176863|587929839|FG000|Overall Study|Physician Decision|1|||
162787145|NCT02176863|587929840|FG001|Overall Study|Physician Decision|0|||
162787146|NCT02176863|587929841|FG002|Overall Study|Physician Decision|0|||
162787147|NCT02176863|587929842|FG003|Overall Study|Physician Decision|0|||
162787148|NCT02176863|587929843|FG004|Overall Study|Physician Decision|0|||
162787149|NCT02176863|587929839|FG000|Overall Study|Adverse Event|10|||
162787150|NCT02176863|587929840|FG001|Overall Study|Adverse Event|4|||
162787151|NCT02176863|587929841|FG002|Overall Study|Adverse Event|4|||
162787152|NCT02176863|587929842|FG003|Overall Study|Adverse Event|1|||
162787153|NCT02176863|587929843|FG004|Overall Study|Adverse Event|1|||
162787154|NCT02176863|587929839|FG000|Overall Study|Protocol Violation|2|||
162787155|NCT02176863|587929840|FG001|Overall Study|Protocol Violation|0|||
162787156|NCT02176863|587929841|FG002|Overall Study|Protocol Violation|1|||
162787157|NCT02176863|587929842|FG003|Overall Study|Protocol Violation|1|||
162787158|NCT02176863|587929843|FG004|Overall Study|Protocol Violation|0|||
162787159|NCT02176863|587929839|FG000|Overall Study|Withdrawal by Subject|4|||
162787160|NCT02176863|587929840|FG001|Overall Study|Withdrawal by Subject|2|||
162787161|NCT02176863|587929841|FG002|Overall Study|Withdrawal by Subject|2|||
162787162|NCT02176863|587929842|FG003|Overall Study|Withdrawal by Subject|3|||
162787163|NCT02176863|587929843|FG004|Overall Study|Withdrawal by Subject|4|||
162787164|NCT02176863|587929839|FG000|Overall Study|Reason not specified|0|||
162787165|NCT02176863|587929840|FG001|Overall Study|Reason not specified|1|||
162787166|NCT02176863|587929841|FG002|Overall Study|Reason not specified|1|||
162787167|NCT02176863|587929842|FG003|Overall Study|Reason not specified|2|||
162787168|NCT02176863|587929843|FG004|Overall Study|Reason not specified|1|||
162787169|NCT02176863|587929839|FG000|Overall Study|Lost to Follow-up|0|||
162787170|NCT02176863|587929840|FG001|Overall Study|Lost to Follow-up|1|||
162787171|NCT02176863|587929841|FG002|Overall Study|Lost to Follow-up|1|||
162787172|NCT02176863|587929842|FG003|Overall Study|Lost to Follow-up|0|||
162787173|NCT02176863|587929843|FG004|Overall Study|Lost to Follow-up|0|||
162787174|NCT02037256|587929844|FG000|Overall Study|Protocol Violation|0|||
162787175|NCT02037256|587929845|FG001|Overall Study|Protocol Violation|1|||
162787176|NCT02037256|587929844|FG000|Overall Study|Withdrawn prior to Velcade|0|||
162787177|NCT02037256|587929845|FG001|Overall Study|Withdrawn prior to Velcade|2|||
162787178|NCT01310699|587929848|FG000|Overall Study|Patients did not complete tandem.|4|||
162787179|NCT01310699|587929849|FG001|Overall Study|Patients did not complete tandem.|6|||
162787180|NCT02386839|587929850|FG000|Overall Study|Death|1|||
162787181|NCT02386839|587929851|FG001|Overall Study|Death|0|||
162787182|NCT02386839|587929850|FG000|Overall Study|Withdrawal by Subject|9|||
162787183|NCT02386839|587929851|FG001|Overall Study|Withdrawal by Subject|10|||
162787184|NCT02386839|587929850|FG000|Overall Study|Lost to Follow-up|4|||
162787185|NCT02386839|587929851|FG001|Overall Study|Lost to Follow-up|4|||
162787186|NCT02386839|587929850|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
162787187|NCT02386839|587929851|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
162787188|NCT02386839|587929850|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
162787189|NCT02386839|587929851|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
162787190|NCT02386839|587929850|FG000|Overall Study|Other (unspecified)|1|||
162787191|NCT02386839|587929851|FG001|Overall Study|Other (unspecified)|0|||
162787192|NCT00926575|587929852|FG000|Overall Study|Adverse Event|1|||
162787193|NCT00926575|587929853|FG001|Overall Study|Adverse Event|1|||
162787194|NCT00926575|587929852|FG000|Overall Study|Death|4|||
162787195|NCT00926575|587929853|FG001|Overall Study|Death|4|||
162787196|NCT00926575|587929852|FG000|Overall Study|Lost to Follow-up|1|||
162787197|NCT00926575|587929853|FG001|Overall Study|Lost to Follow-up|1|||
162787198|NCT00926575|587929852|FG000|Overall Study|Physician Decision|1|||
162787199|NCT00926575|587929853|FG001|Overall Study|Physician Decision|2|||
162787200|NCT00926575|587929852|FG000|Overall Study|Protocol Violation|1|||
162787201|NCT00926575|587929853|FG001|Overall Study|Protocol Violation|0|||
162787202|NCT00926575|587929852|FG000|Overall Study|Withdrawal by Subject|8|||
162787203|NCT00926575|587929853|FG001|Overall Study|Withdrawal by Subject|9|||
162787204|NCT00490698|587929854|FG000|Overall Study|Withdrawal by Subject|1|||
162787205|NCT00490698|587929854|FG000|Overall Study|Disease Progression|7|||
162787206|NCT00490698|587929854|FG000|Overall Study|Physician Decision|2|||
162787207|NCT02101983|587929855|FG000|Overall Study|Physician Decision|1|||
162787208|NCT02101983|587929856|FG001|Overall Study|Physician Decision|0|||
162787209|NCT03725605|587929861|FG000|Overall Study|Unsuccessful TIL expansion|2|||
162787210|NCT04124471|587929862|FG000|Overall Study|screen failure|1|||
162787211|NCT01503086|587929863|FG000|Overall Study|Lost to Follow-up|0|||
162787212|NCT01503086|587929864|FG001|Overall Study|Lost to Follow-up|1|||
162787213|NCT01503086|587929865|FG002|Overall Study|Lost to Follow-up|0|||
162787214|NCT01503086|587929863|FG000|Overall Study|Did Not Start Treatment|4|||
162787215|NCT01503086|587929864|FG001|Overall Study|Did Not Start Treatment|3|||
162787216|NCT01503086|587929865|FG002|Overall Study|Did Not Start Treatment|3|||
162787217|NCT01503086|587929863|FG000|Overall Study|Progressive disease|3|||
162787218|NCT01503086|587929864|FG001|Overall Study|Progressive disease|1|||
162787219|NCT01503086|587929865|FG002|Overall Study|Progressive disease|0|||
162787220|NCT01503086|587929863|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
162787221|NCT01503086|587929864|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
162787222|NCT01503086|587929865|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
162787223|NCT01503086|587929863|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
162787224|NCT01503086|587929864|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
162787225|NCT01503086|587929865|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
162787226|NCT05970640|587929868|FG000|Overall Study|Adverse Event|1|||
162787227|NCT05970640|587929869|FG001|Overall Study|Adverse Event|3|||
162787228|NCT05970640|587929870|FG002|Overall Study|Adverse Event|1|||
162787229|NCT05970640|587929871|FG003|Overall Study|Adverse Event|0|||
162787230|NCT05970640|587929868|FG000|Overall Study|Withdrawal by Subject|0|||
162787231|NCT05970640|587929869|FG001|Overall Study|Withdrawal by Subject|0|||
162787232|NCT05970640|587929870|FG002|Overall Study|Withdrawal by Subject|1|||
162787233|NCT05970640|587929871|FG003|Overall Study|Withdrawal by Subject|1|||
162787234|NCT05970640|587929868|FG000|Overall Study|Sponsor decision|0|||
162787235|NCT05970640|587929869|FG001|Overall Study|Sponsor decision|0|||
162787236|NCT05970640|587929870|FG002|Overall Study|Sponsor decision|1|||
162787237|NCT05970640|587929871|FG003|Overall Study|Sponsor decision|1|||
162787238|NCT02394925|587929872|FG000|Overall Study|Adverse Event|1|||
162787239|NCT02394925|587929872|FG000|Overall Study|Lens Discomfort|3|||
162787240|NCT02394925|587929872|FG000|Overall Study|Lens handling difficulities|5|||
162787241|NCT02394925|587929872|FG000|Overall Study|Lost to Follow-up|9|||
162787242|NCT02394925|587929872|FG000|Overall Study|Protocol Violation|5|||
162787243|NCT02394925|587929872|FG000|Overall Study|No longer meet eligibility criteria|1|||
162787244|NCT02394925|587929872|FG000|Overall Study|Unsatisfactory Visual Response|5|||
162787245|NCT04650698|587931608|FG000|Overall Study|Protocol Violation|2|||
162787246|NCT04650698|587931609|FG001|Overall Study|Protocol Violation|1|||
162787247|NCT04650698|587931608|FG000|Overall Study|Withdrawal by Subject|0|||
162787248|NCT04650698|587931609|FG001|Overall Study|Withdrawal by Subject|1|||
162787249|NCT02358668|587931610|FG000|Overall Study|Adverse Event|2|||
162787250|NCT02358668|587931611|FG001|Overall Study|Adverse Event|0|||
162787251|NCT02358668|587931612|FG002|Overall Study|Adverse Event|0|||
162787252|NCT02358668|587931610|FG000|Overall Study|Withdrawal by Subject|0|||
162787253|NCT02358668|587931611|FG001|Overall Study|Withdrawal by Subject|1|||
162787254|NCT02358668|587931612|FG002|Overall Study|Withdrawal by Subject|0|||
162787255|NCT02104505|587931613|FG000|First Intervention (14 Days)|Adverse Event|2|||
162787256|NCT02104505|587931614|FG001|First Intervention (14 Days)|Adverse Event|0|||
162787257|NCT02104505|587931613|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
162787258|NCT02104505|587931614|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
162787259|NCT02104505|587931613|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
162787260|NCT02104505|587931614|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
162787261|NCT02104505|587931613|FG000|First Intervention (14 Days)|exclusionary condition|0|||
162787262|NCT02104505|587931614|FG001|First Intervention (14 Days)|exclusionary condition|1|||
162787263|NCT02104505|587931613|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
162787264|NCT02104505|587931614|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
162787265|NCT02104505|587931613|FG000|Second Intervention (14 Days)|Adverse Event|2|||
162787266|NCT02104505|587931614|FG001|Second Intervention (14 Days)|Adverse Event|0|||
162787267|NCT01730950|587931617|FG000|Overall Study|Protocol Violation|6|||
162787268|NCT01730950|587931618|FG001|Overall Study|Protocol Violation|6|||
162787269|NCT02737826|587931619|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
162787270|NCT02737826|587931620|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
162787271|NCT02737826|587931621|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
162787272|NCT02354651|587931622|FG000|Overall Study|Withdrawal by Subject|2|||
162787273|NCT02354651|587931622|FG000|Overall Study|Physician Decision|1|||
162787274|NCT01317875|587931623|FG000|Overall Study|Other|0|||
162787275|NCT01317875|587931624|FG001|Overall Study|Other|0|||
162787276|NCT01317875|587931625|FG002|Overall Study|Other|1|||
162787277|NCT01317875|587931626|FG003|Overall Study|Other|0|||
162787278|NCT01317875|587931627|FG004|Overall Study|Other|0|||
162787279|NCT01317875|587931628|FG005|Overall Study|Other|0|||
162787280|NCT01317875|587931629|FG006|Overall Study|Other|0|||
162787281|NCT01317875|587931630|FG007|Overall Study|Other|0|||
162787282|NCT01317875|587931631|FG008|Overall Study|Other|0|||
162787283|NCT01317875|587931632|FG009|Overall Study|Other|0|||
162787284|NCT01317875|587931623|FG000|Overall Study|Noncompliance with study drug|0|||
162787285|NCT01317875|587931624|FG001|Overall Study|Noncompliance with study drug|0|||
162787286|NCT01317875|587931625|FG002|Overall Study|Noncompliance with study drug|1|||
162787287|NCT01317875|587931626|FG003|Overall Study|Noncompliance with study drug|0|||
162787288|NCT01317875|587931627|FG004|Overall Study|Noncompliance with study drug|0|||
162787289|NCT01317875|587931628|FG005|Overall Study|Noncompliance with study drug|0|||
162787290|NCT01317875|587931629|FG006|Overall Study|Noncompliance with study drug|0|||
162787291|NCT01317875|587931630|FG007|Overall Study|Noncompliance with study drug|0|||
162787292|NCT01317875|587931631|FG008|Overall Study|Noncompliance with study drug|0|||
162787293|NCT01317875|587931632|FG009|Overall Study|Noncompliance with study drug|0|||
162787294|NCT01317875|587931623|FG000|Overall Study|Progressive Disease|1|||
162787295|NCT01317875|587931624|FG001|Overall Study|Progressive Disease|0|||
162787296|NCT01317875|587931625|FG002|Overall Study|Progressive Disease|2|||
162787297|NCT01317875|587931626|FG003|Overall Study|Progressive Disease|0|||
162787298|NCT01317875|587931627|FG004|Overall Study|Progressive Disease|1|||
162787299|NCT01317875|587931628|FG005|Overall Study|Progressive Disease|0|||
162787300|NCT01317875|587931629|FG006|Overall Study|Progressive Disease|0|||
162787301|NCT01317875|587931630|FG007|Overall Study|Progressive Disease|1|||
162787302|NCT01317875|587931631|FG008|Overall Study|Progressive Disease|0|||
162787303|NCT01317875|587931632|FG009|Overall Study|Progressive Disease|0|||
162787304|NCT01317875|587931623|FG000|Overall Study|Withdrawal by Subject|0|||
162787305|NCT01317875|587931624|FG001|Overall Study|Withdrawal by Subject|0|||
162787306|NCT01317875|587931625|FG002|Overall Study|Withdrawal by Subject|0|||
162787307|NCT01317875|587931626|FG003|Overall Study|Withdrawal by Subject|0|||
162787308|NCT01317875|587931627|FG004|Overall Study|Withdrawal by Subject|1|||
162787309|NCT01317875|587931628|FG005|Overall Study|Withdrawal by Subject|0|||
162787310|NCT01317875|587931629|FG006|Overall Study|Withdrawal by Subject|0|||
162787311|NCT01317875|587931630|FG007|Overall Study|Withdrawal by Subject|3|||
162787312|NCT01317875|587931631|FG008|Overall Study|Withdrawal by Subject|0|||
162787313|NCT01317875|587931632|FG009|Overall Study|Withdrawal by Subject|0|||
162787314|NCT01317875|587931623|FG000|Overall Study|Physician Decision|0|||
162787315|NCT01317875|587931624|FG001|Overall Study|Physician Decision|1|||
162787316|NCT01317875|587931625|FG002|Overall Study|Physician Decision|1|||
162787317|NCT01317875|587931626|FG003|Overall Study|Physician Decision|0|||
162787318|NCT01317875|587931627|FG004|Overall Study|Physician Decision|2|||
162787319|NCT01317875|587931628|FG005|Overall Study|Physician Decision|0|||
162787320|NCT01317875|587931629|FG006|Overall Study|Physician Decision|0|||
162787321|NCT01317875|587931630|FG007|Overall Study|Physician Decision|2|||
162787322|NCT01317875|587931631|FG008|Overall Study|Physician Decision|0|||
162787323|NCT01317875|587931632|FG009|Overall Study|Physician Decision|0|||
162787324|NCT01317875|587931623|FG000|Overall Study|Death|0|||
162787325|NCT01317875|587931624|FG001|Overall Study|Death|0|||
162787326|NCT01317875|587931625|FG002|Overall Study|Death|2|||
162787327|NCT01317875|587931626|FG003|Overall Study|Death|1|||
162787328|NCT01317875|587931627|FG004|Overall Study|Death|0|||
162787329|NCT01317875|587931628|FG005|Overall Study|Death|1|||
162787330|NCT01317875|587931629|FG006|Overall Study|Death|0|||
162787331|NCT01317875|587931630|FG007|Overall Study|Death|4|||
162787332|NCT01317875|587931631|FG008|Overall Study|Death|0|||
162787333|NCT01317875|587931632|FG009|Overall Study|Death|0|||
162787334|NCT01317875|587931623|FG000|Overall Study|Adverse Event|2|||
162787335|NCT01317875|587931624|FG001|Overall Study|Adverse Event|1|||
162787336|NCT01317875|587931625|FG002|Overall Study|Adverse Event|2|||
162787337|NCT01317875|587931626|FG003|Overall Study|Adverse Event|1|||
162787338|NCT01317875|587931627|FG004|Overall Study|Adverse Event|5|||
162787339|NCT01317875|587931628|FG005|Overall Study|Adverse Event|1|||
162787340|NCT01317875|587931629|FG006|Overall Study|Adverse Event|2|||
162787341|NCT01317875|587931630|FG007|Overall Study|Adverse Event|5|||
162787342|NCT01317875|587931631|FG008|Overall Study|Adverse Event|0|||
162787343|NCT01317875|587931632|FG009|Overall Study|Adverse Event|0|||
162787344|NCT01377389|587931633|FG000|Overall Study|Withdrawal by Subject|1|||
162787345|NCT01377389|587931633|FG000|Overall Study|Screen failure|2|||
162787346|NCT05274750|587931638|FG000|Overall Study|Adverse Event|0|||
162787347|NCT05274750|587931639|FG001|Overall Study|Adverse Event|1|||
162787348|NCT05274750|587931638|FG000|Overall Study|Lost to Follow-up|2|||
162787349|NCT05274750|587931639|FG001|Overall Study|Lost to Follow-up|3|||
162787350|NCT05274750|587931638|FG000|Overall Study|Physician Decision|3|||
162787351|NCT05274750|587931639|FG001|Overall Study|Physician Decision|0|||
162787352|NCT05274750|587931638|FG000|Overall Study|Withdrawal by Subject|10|||
162787353|NCT05274750|587931639|FG001|Overall Study|Withdrawal by Subject|9|||
162787354|NCT05274750|587931638|FG000|Overall Study|GCP Violation|0|||
162787355|NCT05274750|587931639|FG001|Overall Study|GCP Violation|4|||
162787356|NCT05274750|587931638|FG000|Overall Study|Randomized, not treated|0|||
162787357|NCT05274750|587931639|FG001|Overall Study|Randomized, not treated|1|||
162787358|NCT04328623|587931644|FG000|Overall Study|Protocol Violation|0|||
162787359|NCT04328623|587931645|FG001|Overall Study|Protocol Violation|1|||
162787360|NCT04340947|587931646|FG000|7-day Washout Period|Lost to Follow-up|5|||
162787361|NCT04340947|587931647|FG001|7-day Washout Period|Lost to Follow-up|4|||
162787362|NCT02312557|587931648|FG000|Overall Study|Survival follow-up|4|||
162787363|NCT01437423|587931654|FG000|Overall Study|Lost to Follow-up|12|||
162787364|NCT01437423|587931654|FG000|Overall Study|Off label usage|3|||
162787365|NCT03721172|587931655|FG000|Placebo-controlled Phase|Adverse Event|7|||
162787366|NCT03721172|587931656|FG001|Placebo-controlled Phase|Adverse Event|7|||
162787367|NCT03721172|587931657|FG002|Placebo-controlled Phase|Adverse Event|0|||
162787368|NCT03721172|587931655|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
162787369|NCT03721172|587931656|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
162787370|NCT03721172|587931657|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
162787371|NCT03721172|587931655|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
162787372|NCT03721172|587931656|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
162787373|NCT03721172|587931657|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
162787374|NCT03721172|587931655|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
162787375|NCT03721172|587931656|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
162787376|NCT03721172|587931657|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
162787377|NCT03721172|587931655|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
162787378|NCT03721172|587931656|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
162787379|NCT03721172|587931657|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
162787380|NCT03721172|587931655|FG000|Placebo-controlled Phase|Other|3|||
162787381|NCT03721172|587931656|FG001|Placebo-controlled Phase|Other|0|||
162787382|NCT03721172|587931657|FG002|Placebo-controlled Phase|Other|0|||
162787383|NCT03721172|587931655|FG000|Apremilast Extension Phase|Adverse Event|0|||
162787384|NCT03721172|587931656|FG001|Apremilast Extension Phase|Adverse Event|0|||
162787385|NCT03721172|587931657|FG002|Apremilast Extension Phase|Adverse Event|10|||
162787386|NCT03721172|587931655|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
162787387|NCT03721172|587931656|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
162787388|NCT03721172|587931657|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
162787389|NCT03721172|587931655|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
162787390|NCT03721172|587931656|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
162787391|NCT03721172|587931657|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
162787392|NCT03721172|587931655|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
162787393|NCT03721172|587931656|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
162787394|NCT03721172|587931657|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
162787395|NCT03721172|587931655|FG000|Apremilast Extension Phase|Protocol Violation|0|||
162787396|NCT03721172|587931656|FG001|Apremilast Extension Phase|Protocol Violation|0|||
162787397|NCT03721172|587931657|FG002|Apremilast Extension Phase|Protocol Violation|1|||
162787398|NCT03721172|587931655|FG000|Apremilast Extension Phase|Physician Decision|0|||
162787399|NCT03721172|587931656|FG001|Apremilast Extension Phase|Physician Decision|0|||
162787400|NCT03721172|587931657|FG002|Apremilast Extension Phase|Physician Decision|1|||
162787401|NCT03721172|587931655|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
162787402|NCT03721172|587931656|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
162787403|NCT03721172|587931657|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
162787404|NCT03721172|587931655|FG000|Apremilast Extension Phase|Other|0|||
162787405|NCT03721172|587931656|FG001|Apremilast Extension Phase|Other|0|||
162787406|NCT03721172|587931657|FG002|Apremilast Extension Phase|Other|3|||
162787407|NCT03721172|587931655|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
162787408|NCT03721172|587931656|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
162787409|NCT03721172|587931657|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
162787410|NCT02417441|587931658|FG000|Overall Study|Inconclusive due to missing data|52|||
162787411|NCT02417441|587931659|FG001|Overall Study|Inconclusive due to missing data|19|||
162787412|NCT05628285|587931660|FG000|Overall Study|Lost to Follow-up|1|||
162787413|NCT00983853|587931661|FG000|Overall Study|Lost to Follow-up|1|||
162787414|NCT00983853|587931662|FG001|Overall Study|Lost to Follow-up|1|||
162787415|NCT00983853|587931663|FG002|Overall Study|Lost to Follow-up|2|||
162787416|NCT00983853|587931664|FG003|Overall Study|Lost to Follow-up|2|||
162787417|NCT00983853|587931665|FG004|Overall Study|Lost to Follow-up|2|||
162787418|NCT00983853|587931666|FG005|Overall Study|Lost to Follow-up|1|||
162787419|NCT00983853|587931661|FG000|Overall Study|Withdrawal by Subject|0|||
162787420|NCT00983853|587931662|FG001|Overall Study|Withdrawal by Subject|0|||
162787421|NCT00983853|587931663|FG002|Overall Study|Withdrawal by Subject|1|||
162787422|NCT00983853|587931664|FG003|Overall Study|Withdrawal by Subject|0|||
162787423|NCT00983853|587931665|FG004|Overall Study|Withdrawal by Subject|1|||
162787424|NCT00983853|587931666|FG005|Overall Study|Withdrawal by Subject|0|||
162787425|NCT00983853|587931661|FG000|Overall Study|Unable to come to study follow-up visits|0|||
162787426|NCT00983853|587931662|FG001|Overall Study|Unable to come to study follow-up visits|1|||
162787427|NCT00983853|587931663|FG002|Overall Study|Unable to come to study follow-up visits|0|||
162787428|NCT00983853|587931664|FG003|Overall Study|Unable to come to study follow-up visits|0|||
162787429|NCT00983853|587931665|FG004|Overall Study|Unable to come to study follow-up visits|0|||
162787430|NCT00983853|587931666|FG005|Overall Study|Unable to come to study follow-up visits|0|||
162787431|NCT02339506|587931667|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
162787432|NCT02339506|587931668|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
162787433|NCT02339506|587931667|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
162787434|NCT02339506|587931668|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
162787435|NCT03016598|587931672|FG000|Overall Study|Lost to Follow-up|0|||
162787436|NCT03016598|587931673|FG001|Overall Study|Lost to Follow-up|2|||
162787437|NCT00478205|587931677|FG000|Overall Study|Adverse Event|182|||
162787438|NCT00478205|587931678|FG001|Overall Study|Adverse Event|39|||
162787439|NCT00478205|587931677|FG000|Overall Study|Medication Non-compliance|9|||
162787440|NCT00478205|587931678|FG001|Overall Study|Medication Non-compliance|4|||
162787441|NCT00478205|587931677|FG000|Overall Study|Protocol Violation|15|||
162787442|NCT00478205|587931678|FG001|Overall Study|Protocol Violation|5|||
162787443|NCT00478205|587931677|FG000|Overall Study|Request of Investigator or Sponsor|4|||
162787444|NCT00478205|587931678|FG001|Overall Study|Request of Investigator or Sponsor|5|||
162787445|NCT00478205|587931677|FG000|Overall Study|Withdrawal by Subject|61|||
162787446|NCT00478205|587931678|FG001|Overall Study|Withdrawal by Subject|22|||
162787447|NCT00478205|587931677|FG000|Overall Study|Lack of Efficacy|1|||
162787448|NCT00478205|587931678|FG001|Overall Study|Lack of Efficacy|0|||
162787449|NCT00478205|587931677|FG000|Overall Study|Other|24|||
162787450|NCT00478205|587931678|FG001|Overall Study|Other|12|||
162787451|NCT01791413|587931679|FG000|Overall Study|Lost to Follow-up|5|||
162787452|NCT01791413|587931680|FG001|Overall Study|Lost to Follow-up|1|||
162787453|NCT00825305|587931688|FG000|Overall Study|Adverse Event|1|||
162787454|NCT00825305|587931689|FG001|Overall Study|Adverse Event|1|||
162787455|NCT00825305|587931688|FG000|Overall Study|Withdrawal by Subject|6|||
162787456|NCT00825305|587931689|FG001|Overall Study|Withdrawal by Subject|12|||
162787457|NCT00825305|587931688|FG000|Overall Study|Inappropriate inclusion|1|||
162787458|NCT00825305|587931689|FG001|Overall Study|Inappropriate inclusion|0|||
162787459|NCT00825305|587931688|FG000|Overall Study|Protocol Violation|9|||
162787460|NCT00825305|587931689|FG001|Overall Study|Protocol Violation|9|||
162787461|NCT00825305|587931688|FG000|Overall Study|Can not be classified|0|||
162787462|NCT00825305|587931689|FG001|Overall Study|Can not be classified|1|||
162787463|NCT04016272|587931690|FG000|Overall Study|Withdrawal by Subject|1|||
162787464|NCT04016272|587931691|FG001|Overall Study|Withdrawal by Subject|2|||
162787465|NCT00246090|587931698|FG000|Overall Study|Adverse Event|25|||
162787466|NCT00246090|587931698|FG000|Overall Study|Withdrawal by Subject|7|||
162787467|NCT00246090|587931698|FG000|Overall Study|Progressive Disease|212|||
162787468|NCT00246090|587931698|FG000|Overall Study|Clinical Progression|30|||
162787469|NCT00246090|587931698|FG000|Overall Study|Physician Decision|11|||
162787470|NCT00246090|587931698|FG000|Overall Study|Not Otherwise Specified|10|||
162787471|NCT03332784|587931701|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787472|NCT03332784|587931702|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
162787473|NCT03332784|587931703|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787474|NCT03332784|587931704|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787475|NCT03332784|587931705|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787476|NCT03332784|587931706|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787477|NCT03332784|587931707|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787478|NCT03332784|587931708|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787479|NCT03332784|587931709|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787480|NCT03332784|587931710|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787481|NCT03332784|587931711|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787482|NCT03332784|587931712|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787483|NCT03332784|587931713|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787484|NCT03332784|587931714|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787485|NCT03332784|587931715|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
162787486|NCT03332784|587931716|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787487|NCT03332784|587931717|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787488|NCT03332784|587931718|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787489|NCT03332784|587931719|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787490|NCT03332784|587931720|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162787491|NCT00763451|587931726|FG000|Overall Study|Adverse Event|4|||
162787492|NCT00763451|587931727|FG001|Overall Study|Adverse Event|6|||
162787493|NCT00763451|587931728|FG002|Overall Study|Adverse Event|19|||
162787494|NCT00763451|587931729|FG003|Overall Study|Adverse Event|14|||
162787495|NCT00763451|587931726|FG000|Overall Study|Lack of Efficacy|1|||
162787496|NCT00763451|587931727|FG001|Overall Study|Lack of Efficacy|4|||
162787497|NCT00763451|587931728|FG002|Overall Study|Lack of Efficacy|3|||
162787498|NCT00763451|587931729|FG003|Overall Study|Lack of Efficacy|2|||
162787499|NCT00763451|587931726|FG000|Overall Study|Withdrawal by Subject|1|||
162787500|NCT00763451|587931727|FG001|Overall Study|Withdrawal by Subject|6|||
162787501|NCT00763451|587931728|FG002|Overall Study|Withdrawal by Subject|9|||
162787502|NCT00763451|587931729|FG003|Overall Study|Withdrawal by Subject|7|||
162787503|NCT00763451|587931726|FG000|Overall Study|Protocol Violation|0|||
162787504|NCT00763451|587931727|FG001|Overall Study|Protocol Violation|0|||
162787505|NCT00763451|587931728|FG002|Overall Study|Protocol Violation|1|||
162787506|NCT00763451|587931729|FG003|Overall Study|Protocol Violation|0|||
162787507|NCT00763451|587931726|FG000|Overall Study|Poor Compliance to Protocol|1|||
162787508|NCT00763451|587931727|FG001|Overall Study|Poor Compliance to Protocol|1|||
162787509|NCT00763451|587931728|FG002|Overall Study|Poor Compliance to Protocol|2|||
162787510|NCT00763451|587931729|FG003|Overall Study|Poor Compliance to Protocol|2|||
162787511|NCT00763451|587931726|FG000|Overall Study|Familial and Personal Reasons|5|||
162787512|NCT00763451|587931727|FG001|Overall Study|Familial and Personal Reasons|3|||
162787513|NCT00763451|587931728|FG002|Overall Study|Familial and Personal Reasons|5|||
162787514|NCT00763451|587931729|FG003|Overall Study|Familial and Personal Reasons|4|||
162787515|NCT00763451|587931726|FG000|Overall Study|Randomized but not Treated|1|||
162787516|NCT00763451|587931727|FG001|Overall Study|Randomized but not Treated|1|||
162787517|NCT00763451|587931728|FG002|Overall Study|Randomized but not Treated|0|||
162787518|NCT00763451|587931729|FG003|Overall Study|Randomized but not Treated|0|||
162787519|NCT00763451|587931726|FG000|Overall Study|Study Site Reason|0|||
162787520|NCT00763451|587931727|FG001|Overall Study|Study Site Reason|1|||
162787521|NCT00763451|587931728|FG002|Overall Study|Study Site Reason|1|||
162787522|NCT00763451|587931729|FG003|Overall Study|Study Site Reason|1|||
162787523|NCT01827046|587931730|FG000|Overall Study|Lost to Follow-up|1|||
162787524|NCT01827046|587931731|FG001|Overall Study|Lost to Follow-up|5|||
162787525|NCT01827046|587931730|FG000|Overall Study|Withdrawal by Subject|0|||
162787526|NCT01827046|587931731|FG001|Overall Study|Withdrawal by Subject|4|||
162787527|NCT05594589|587931735|FG000|Overall Study|Other|0|||
162787528|NCT05594589|587931736|FG001|Overall Study|Other|1|||
162787529|NCT05594589|587931737|FG002|Overall Study|Other|0|||
162787530|NCT02282917|587931739|FG000|Overall Study|Withdrawal by Subject|1|||
162787531|NCT02282917|587931739|FG000|Overall Study|Screen Failure/Not Eligible|1|||
162787532|NCT00115336|587931740|FG000|Overall Study|Hospital discharge before study drug|0|||
162787533|NCT00115336|587931741|FG001|Overall Study|Hospital discharge before study drug|1|||
162787534|NCT00715117|587931750|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
162787535|NCT00715117|587931751|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
162787536|NCT01018732|587931755|FG000|Overall Study|Lost to Follow-up|0|||
162787537|NCT01018732|587931756|FG001|Overall Study|Lost to Follow-up|0|||
162787538|NCT01018732|587931757|FG002|Overall Study|Lost to Follow-up|3|||
162787539|NCT01018732|587931755|FG000|Overall Study|Protocol Violation|1|||
162787540|NCT01018732|587931756|FG001|Overall Study|Protocol Violation|1|||
162787541|NCT01018732|587931757|FG002|Overall Study|Protocol Violation|0|||
162787542|NCT01018732|587931755|FG000|Overall Study|Inappropriate Enrollment|0|||
162787543|NCT01018732|587931756|FG001|Overall Study|Inappropriate Enrollment|1|||
162787544|NCT01018732|587931757|FG002|Overall Study|Inappropriate Enrollment|0|||
162787545|NCT01018732|587931755|FG000|Overall Study|Unable to Classify|0|||
162787546|NCT01018732|587931756|FG001|Overall Study|Unable to Classify|0|||
162787547|NCT01018732|587931757|FG002|Overall Study|Unable to Classify|1|||
162787548|NCT01536171|587931758|FG000|Overall Study|Withdrawal by Subject|1|||
162787549|NCT01262092|587931759|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
162787550|NCT01262092|587931760|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
162787551|NCT01262092|587931759|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
162787552|NCT01262092|587931760|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
162787553|NCT01262092|587931759|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
162787554|NCT01262092|587931760|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
162787555|NCT01262092|587931759|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
162787556|NCT01262092|587931760|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
162787557|NCT03784820|587931761|FG000|Overall Study|Lost to Follow-up|5|||
162787558|NCT03784820|587931762|FG001|Overall Study|Lost to Follow-up|5|||
162787559|NCT03784820|587931763|FG002|Overall Study|Lost to Follow-up|3|||
162787560|NCT03784820|587931764|FG003|Overall Study|Lost to Follow-up|3|||
162787561|NCT00978562|587931765|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
162787562|NCT00356811|587931780|FG000|Overall Study|Death|35|||
162787563|NCT00356811|587931780|FG000|Overall Study|Lost to Follow-up|2|||
162787564|NCT00356811|587931780|FG000|Overall Study|Withdrawal by Subject|6|||
162787565|NCT00356811|587931780|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
162787566|NCT00356811|587931780|FG000|Overall Study|Study Is Terminating|3|||
162787567|NCT00356811|587931780|FG000|Overall Study|Site Closed during Follow-up|2|||
162787568|NCT02201901|587931784|FG000|Overall Study|Randomized but never treated|0|||
162787569|NCT02201901|587931785|FG001|Overall Study|Randomized but never treated|1|||
162787570|NCT02201901|587931786|FG002|Overall Study|Randomized but never treated|0|||
162787571|NCT02201901|587931784|FG000|Overall Study|Lack of Efficacy|7|||
162787572|NCT02201901|587931785|FG001|Overall Study|Lack of Efficacy|1|||
162787573|NCT02201901|587931786|FG002|Overall Study|Lack of Efficacy|6|||
162787574|NCT02201901|587931784|FG000|Overall Study|Death|3|||
162787575|NCT02201901|587931785|FG001|Overall Study|Death|3|||
162787576|NCT02201901|587931786|FG002|Overall Study|Death|3|||
162787577|NCT02201901|587931784|FG000|Overall Study|Lost to Follow-up|2|||
162787578|NCT02201901|587931785|FG001|Overall Study|Lost to Follow-up|3|||
162787579|NCT02201901|587931786|FG002|Overall Study|Lost to Follow-up|2|||
162787580|NCT02201901|587931784|FG000|Overall Study|Withdrew Consent|2|||
162787581|NCT02201901|587931785|FG001|Overall Study|Withdrew Consent|0|||
162787582|NCT02201901|587931786|FG002|Overall Study|Withdrew Consent|2|||
162787583|NCT02201901|587931784|FG000|Overall Study|Adverse Event|1|||
162787584|NCT02201901|587931785|FG001|Overall Study|Adverse Event|1|||
162787585|NCT02201901|587931786|FG002|Overall Study|Adverse Event|0|||
162787586|NCT00469859|587931787|FG000|Overall Study|Inevaluable|0|||
162787587|NCT00469859|587931788|FG001|Overall Study|Inevaluable|2|||
162787588|NCT02419417|587933601|FG000|Overall Study|Disease progression|5|||
162787589|NCT02419417|587933602|FG001|Overall Study|Disease progression|4|||
162787590|NCT02419417|587933603|FG002|Overall Study|Disease progression|13|||
162787591|NCT02419417|587933604|FG003|Overall Study|Disease progression|10|||
162787592|NCT02419417|587933605|FG004|Overall Study|Disease progression|10|||
162787593|NCT02419417|587933606|FG005|Overall Study|Disease progression|3|||
162787594|NCT02419417|587933607|FG006|Overall Study|Disease progression|4|||
162787595|NCT02419417|587933608|FG007|Overall Study|Disease progression|5|||
162787596|NCT02419417|587933609|FG008|Overall Study|Disease progression|13|||
162787597|NCT02419417|587933610|FG009|Overall Study|Disease progression|9|||
162787598|NCT02419417|587933611|FG010|Overall Study|Disease progression|0|||
162787599|NCT02419417|587933601|FG000|Overall Study|Study drug toxicity|0|||
162787600|NCT02419417|587933602|FG001|Overall Study|Study drug toxicity|0|||
162787601|NCT02419417|587933603|FG002|Overall Study|Study drug toxicity|0|||
162787602|NCT02419417|587933604|FG003|Overall Study|Study drug toxicity|0|||
162787603|NCT02419417|587933605|FG004|Overall Study|Study drug toxicity|1|||
162787604|NCT02419417|587933606|FG005|Overall Study|Study drug toxicity|0|||
162787605|NCT02419417|587933607|FG006|Overall Study|Study drug toxicity|0|||
162787606|NCT02419417|587933608|FG007|Overall Study|Study drug toxicity|0|||
162787607|NCT02419417|587933609|FG008|Overall Study|Study drug toxicity|0|||
162787608|NCT02419417|587933610|FG009|Overall Study|Study drug toxicity|0|||
162787609|NCT02419417|587933611|FG010|Overall Study|Study drug toxicity|0|||
162787610|NCT02419417|587933601|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162787611|NCT02419417|587933602|FG001|Overall Study|Adverse event unrelated to study drug|0|||
162787612|NCT02419417|587933603|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162787613|NCT02419417|587933604|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162787614|NCT02419417|587933605|FG004|Overall Study|Adverse event unrelated to study drug|2|||
162787615|NCT02419417|587933606|FG005|Overall Study|Adverse event unrelated to study drug|1|||
162787616|NCT02419417|587933607|FG006|Overall Study|Adverse event unrelated to study drug|0|||
162787617|NCT02419417|587933608|FG007|Overall Study|Adverse event unrelated to study drug|1|||
162787618|NCT02419417|587933609|FG008|Overall Study|Adverse event unrelated to study drug|0|||
162787619|NCT02419417|587933610|FG009|Overall Study|Adverse event unrelated to study drug|0|||
162787620|NCT02419417|587933611|FG010|Overall Study|Adverse event unrelated to study drug|0|||
162787621|NCT02419417|587933601|FG000|Overall Study|Participant request to discontinue|0|||
162787622|NCT02419417|587933602|FG001|Overall Study|Participant request to discontinue|0|||
162787623|NCT02419417|587933603|FG002|Overall Study|Participant request to discontinue|0|||
162787624|NCT02419417|587933604|FG003|Overall Study|Participant request to discontinue|0|||
162787625|NCT02419417|587933605|FG004|Overall Study|Participant request to discontinue|0|||
162787626|NCT02419417|587933606|FG005|Overall Study|Participant request to discontinue|0|||
162787627|NCT02419417|587933607|FG006|Overall Study|Participant request to discontinue|0|||
162787628|NCT02419417|587933608|FG007|Overall Study|Participant request to discontinue|0|||
162787629|NCT02419417|587933609|FG008|Overall Study|Participant request to discontinue|0|||
162787630|NCT02419417|587933610|FG009|Overall Study|Participant request to discontinue|1|||
162787631|NCT02419417|587933611|FG010|Overall Study|Participant request to discontinue|0|||
162787632|NCT02419417|587933601|FG000|Overall Study|Withdrawal by Subject|0|||
162787633|NCT02419417|587933602|FG001|Overall Study|Withdrawal by Subject|0|||
162787634|NCT02419417|587933603|FG002|Overall Study|Withdrawal by Subject|0|||
162787635|NCT02419417|587933604|FG003|Overall Study|Withdrawal by Subject|0|||
162787636|NCT02419417|587933605|FG004|Overall Study|Withdrawal by Subject|0|||
162787637|NCT02419417|587933606|FG005|Overall Study|Withdrawal by Subject|0|||
162787638|NCT02419417|587933607|FG006|Overall Study|Withdrawal by Subject|0|||
162787639|NCT02419417|587933608|FG007|Overall Study|Withdrawal by Subject|0|||
162787640|NCT02419417|587933609|FG008|Overall Study|Withdrawal by Subject|0|||
162787641|NCT02419417|587933610|FG009|Overall Study|Withdrawal by Subject|0|||
162787642|NCT02419417|587933611|FG010|Overall Study|Withdrawal by Subject|1|||
162787643|NCT01240551|587933612|FG000|Overall Study|Refused further treatment|3|||
162787644|NCT01240551|587933613|FG001|Overall Study|Refused further treatment|2|||
162787645|NCT01240551|587933612|FG000|Overall Study|Lost to Follow-up|1|||
162787646|NCT01240551|587933613|FG001|Overall Study|Lost to Follow-up|1|||
162787647|NCT01385748|587933614|FG000|Overall Study|Withdrawal by Subject|7|||
162787648|NCT01385748|587933615|FG001|Overall Study|Withdrawal by Subject|4|||
162787649|NCT01385748|587933616|FG002|Overall Study|Withdrawal by Subject|5|||
162787650|NCT01385748|587933614|FG000|Overall Study|Noncompliance|3|||
162787651|NCT01385748|587933615|FG001|Overall Study|Noncompliance|1|||
162787652|NCT01385748|587933616|FG002|Overall Study|Noncompliance|6|||
162787653|NCT01385748|587933614|FG000|Overall Study|Other|1|||
162787654|NCT01385748|587933615|FG001|Overall Study|Other|7|||
162787655|NCT01385748|587933616|FG002|Overall Study|Other|1|||
162787656|NCT01385748|587933614|FG000|Overall Study|Adverse Event|4|||
162787657|NCT01385748|587933615|FG001|Overall Study|Adverse Event|2|||
162787658|NCT01385748|587933616|FG002|Overall Study|Adverse Event|1|||
162787659|NCT01200342|587933623|FG000|Overall Study|Disease Progression|1|||
162787660|NCT00863512|587933628|FG000|Overall Study|Adverse Event|2|||
162787661|NCT00863512|587933629|FG001|Overall Study|Adverse Event|0|||
162787662|NCT00863512|587933628|FG000|Overall Study|Withdrawal by Subject|11|||
162787663|NCT00863512|587933629|FG001|Overall Study|Withdrawal by Subject|0|||
162787664|NCT00863512|587933628|FG000|Overall Study|Physician Decision|1|||
162787665|NCT00863512|587933629|FG001|Overall Study|Physician Decision|0|||
162787666|NCT03934099|587933637|FG000|Overall Study|Adverse Event|0|||
162787667|NCT03934099|587933638|FG001|Overall Study|Adverse Event|3|||
162787668|NCT03934099|587933639|FG002|Overall Study|Adverse Event|1|||
162787669|NCT03934099|587933640|FG003|Overall Study|Adverse Event|0|||
162787670|NCT03934099|587933637|FG000|Overall Study|Lost to Follow-up|1|||
162787671|NCT03934099|587933638|FG001|Overall Study|Lost to Follow-up|2|||
162787672|NCT03934099|587933639|FG002|Overall Study|Lost to Follow-up|1|||
162787673|NCT03934099|587933640|FG003|Overall Study|Lost to Follow-up|1|||
162787674|NCT03934099|587933637|FG000|Overall Study|Protocol Violation|1|||
162787675|NCT03934099|587933638|FG001|Overall Study|Protocol Violation|0|||
162787676|NCT03934099|587933639|FG002|Overall Study|Protocol Violation|0|||
162787677|NCT03934099|587933640|FG003|Overall Study|Protocol Violation|0|||
162787678|NCT03934099|587933637|FG000|Overall Study|Withdrawal by Subject|2|||
162787679|NCT03934099|587933638|FG001|Overall Study|Withdrawal by Subject|0|||
162787680|NCT03934099|587933639|FG002|Overall Study|Withdrawal by Subject|1|||
162787681|NCT03934099|587933640|FG003|Overall Study|Withdrawal by Subject|1|||
162787682|NCT03934099|587933637|FG000|Overall Study|Other reasons|0|||
162787683|NCT03934099|587933638|FG001|Overall Study|Other reasons|1|||
162787684|NCT03934099|587933639|FG002|Overall Study|Other reasons|0|||
162787685|NCT03934099|587933640|FG003|Overall Study|Other reasons|0|||
162787686|NCT02869867|587933641|FG000|Overall Study|Protocol Violation|1|||
162787687|NCT02869867|587933642|FG001|Overall Study|Protocol Violation|0|||
162787688|NCT02869867|587933641|FG000|Overall Study|Lost to Follow-up|5|||
162787689|NCT02869867|587933642|FG001|Overall Study|Lost to Follow-up|5|||
162787690|NCT05555615|587933643|FG000|Overall Study|Adverse Event|7|||
162787691|NCT05555615|587933643|FG000|Overall Study|Lack of Efficacy|12|||
162787692|NCT05555615|587933643|FG000|Overall Study|Lost to Follow-up|10|||
162787693|NCT05555615|587933643|FG000|Overall Study|Noncompliance with study drug|5|||
162787694|NCT05555615|587933643|FG000|Overall Study|Physician Decision|2|||
162787695|NCT05555615|587933643|FG000|Overall Study|Study terminated by sponsor|80|||
162787696|NCT05555615|587933643|FG000|Overall Study|Prohibited medication use|2|||
162787697|NCT05555615|587933643|FG000|Overall Study|Withdrawal by Subject|20|||
162787698|NCT05555615|587933643|FG000|Overall Study|Not further specified|4|||
162787699|NCT02872012|587933647|FG000|Overall Study|Withdrawal by Subject|1|||
162787700|NCT02872012|587933648|FG001|Overall Study|Withdrawal by Subject|0|||
162787701|NCT02872012|587933649|FG002|Overall Study|Withdrawal by Subject|0|||
162787702|NCT02872012|587933650|FG003|Overall Study|Withdrawal by Subject|0|||
162787703|NCT02872012|587933651|FG004|Overall Study|Withdrawal by Subject|0|||
162787704|NCT01728623|587933652|FG000|Overall Study|Disease progression|26|||
162787705|NCT01728623|587933652|FG000|Overall Study|Adverse Event|1|||
162787706|NCT01728623|587933652|FG000|Overall Study|Withdrawal by Subject|1|||
162787707|NCT03000348|587933653|FG000|Overall Study|Adverse Event|1|||
162787708|NCT03000348|587933654|FG001|Overall Study|Adverse Event|1|||
162787709|NCT03000348|587933655|FG002|Overall Study|Adverse Event|1|||
162787710|NCT03000348|587933656|FG003|Overall Study|Adverse Event|1|||
162787711|NCT03000348|587933657|FG004|Overall Study|Adverse Event|1|||
162787712|NCT03000348|587933658|FG005|Overall Study|Adverse Event|1|||
162787713|NCT03000348|587933653|FG000|Overall Study|Lost to Follow-up|0|||
162787714|NCT03000348|587933654|FG001|Overall Study|Lost to Follow-up|0|||
162787715|NCT03000348|587933655|FG002|Overall Study|Lost to Follow-up|1|||
162787716|NCT03000348|587933656|FG003|Overall Study|Lost to Follow-up|0|||
162787717|NCT03000348|587933657|FG004|Overall Study|Lost to Follow-up|0|||
162787718|NCT03000348|587933658|FG005|Overall Study|Lost to Follow-up|0|||
162787719|NCT03000348|587933653|FG000|Overall Study|Withdrawal by Subject|0|||
162787720|NCT03000348|587933654|FG001|Overall Study|Withdrawal by Subject|1|||
162787721|NCT03000348|587933655|FG002|Overall Study|Withdrawal by Subject|0|||
162787722|NCT03000348|587933656|FG003|Overall Study|Withdrawal by Subject|0|||
162787723|NCT03000348|587933657|FG004|Overall Study|Withdrawal by Subject|0|||
162787724|NCT03000348|587933658|FG005|Overall Study|Withdrawal by Subject|0|||
162787725|NCT03000348|587933653|FG000|Overall Study|Consent|0|||
162787726|NCT03000348|587933654|FG001|Overall Study|Consent|0|||
162787727|NCT03000348|587933655|FG002|Overall Study|Consent|0|||
162787728|NCT03000348|587933656|FG003|Overall Study|Consent|0|||
162787729|NCT03000348|587933657|FG004|Overall Study|Consent|1|||
162787730|NCT03000348|587933658|FG005|Overall Study|Consent|0|||
162787731|NCT03000348|587933653|FG000|Overall Study|Failure to expectorate sputum|1|||
162787732|NCT03000348|587933654|FG001|Overall Study|Failure to expectorate sputum|0|||
162787733|NCT03000348|587933655|FG002|Overall Study|Failure to expectorate sputum|1|||
162787734|NCT03000348|587933656|FG003|Overall Study|Failure to expectorate sputum|0|||
162787735|NCT03000348|587933657|FG004|Overall Study|Failure to expectorate sputum|1|||
162787736|NCT03000348|587933658|FG005|Overall Study|Failure to expectorate sputum|0|||
162787737|NCT03000348|587933653|FG000|Overall Study|No gram negative|1|||
162787738|NCT03000348|587933654|FG001|Overall Study|No gram negative|2|||
162787739|NCT03000348|587933655|FG002|Overall Study|No gram negative|1|||
162787740|NCT03000348|587933656|FG003|Overall Study|No gram negative|1|||
162787741|NCT03000348|587933657|FG004|Overall Study|No gram negative|1|||
162787742|NCT03000348|587933658|FG005|Overall Study|No gram negative|1|||
162787743|NCT03000348|587933653|FG000|Overall Study|Patient had no transport|0|||
162787744|NCT03000348|587933654|FG001|Overall Study|Patient had no transport|0|||
162787745|NCT03000348|587933655|FG002|Overall Study|Patient had no transport|0|||
162787746|NCT03000348|587933656|FG003|Overall Study|Patient had no transport|1|||
162787747|NCT03000348|587933657|FG004|Overall Study|Patient had no transport|0|||
162787748|NCT03000348|587933658|FG005|Overall Study|Patient had no transport|0|||
162787749|NCT03000348|587933653|FG000|Overall Study|Dosing|0|||
162787750|NCT03000348|587933654|FG001|Overall Study|Dosing|0|||
162787751|NCT03000348|587933655|FG002|Overall Study|Dosing|0|||
162787752|NCT03000348|587933656|FG003|Overall Study|Dosing|0|||
162787753|NCT03000348|587933657|FG004|Overall Study|Dosing|1|||
162787754|NCT03000348|587933658|FG005|Overall Study|Dosing|0|||
162787755|NCT00723125|587933659|FG000|Overall Study|Met Dx|1|||
162787756|NCT00723125|587933660|FG001|Overall Study|Met Dx|0|||
162787757|NCT00723125|587933659|FG000|Overall Study|Withdrawal by Subject|15|||
162787758|NCT00723125|587933660|FG001|Overall Study|Withdrawal by Subject|6|||
162787759|NCT00723125|587933659|FG000|Overall Study|Adverse Event|2|||
162787760|NCT00723125|587933660|FG001|Overall Study|Adverse Event|0|||
162787761|NCT01667549|587933661|FG000|Overall Study|Withdrawal by Subject|3|||
162787762|NCT01667549|587933662|FG001|Overall Study|Withdrawal by Subject|5|||
162787763|NCT01667549|587933663|FG002|Overall Study|Withdrawal by Subject|7|||
162787764|NCT01667549|587933664|FG003|Overall Study|Withdrawal by Subject|6|||
162787765|NCT01667549|587933665|FG004|Overall Study|Withdrawal by Subject|1|||
162787766|NCT01407276|587933666|FG000|Overall Study|Withdrawal by Subject|0|||
162787767|NCT01407276|587933667|FG001|Overall Study|Withdrawal by Subject|0|||
162787768|NCT01407276|587933668|FG002|Overall Study|Withdrawal by Subject|0|||
162787769|NCT01407276|587933669|FG003|Overall Study|Withdrawal by Subject|0|||
162787770|NCT01407276|587933670|FG004|Overall Study|Withdrawal by Subject|0|||
162787771|NCT01407276|587933671|FG005|Overall Study|Withdrawal by Subject|0|||
162787772|NCT01407276|587933672|FG006|Overall Study|Withdrawal by Subject|0|||
162787773|NCT01407276|587933673|FG007|Overall Study|Withdrawal by Subject|1|||
162787774|NCT01807182|587933675|FG000|Overall Study|Death|1|||
162787775|NCT01807182|587933675|FG000|Overall Study|New therapy|1|||
162787776|NCT01807182|587933675|FG000|Overall Study|Moved to hospice care|1|||
162787777|NCT04092452|587933677|FG000|Overall Study|Adverse Event|1|||
162787778|NCT04092452|587933678|FG001|Overall Study|Adverse Event|3|||
162787779|NCT04092452|587933679|FG002|Overall Study|Adverse Event|3|||
162787780|NCT04092452|587933680|FG003|Overall Study|Adverse Event|7|||
162787781|NCT04092452|587933677|FG000|Overall Study|Lack of Efficacy|1|||
162787782|NCT04092452|587933678|FG001|Overall Study|Lack of Efficacy|1|||
162787783|NCT04092452|587933679|FG002|Overall Study|Lack of Efficacy|1|||
162787784|NCT04092452|587933680|FG003|Overall Study|Lack of Efficacy|0|||
162787785|NCT04092452|587933677|FG000|Overall Study|Lost to Follow-up|4|||
162787786|NCT04092452|587933678|FG001|Overall Study|Lost to Follow-up|3|||
162787787|NCT04092452|587933679|FG002|Overall Study|Lost to Follow-up|5|||
162787788|NCT04092452|587933680|FG003|Overall Study|Lost to Follow-up|1|||
162787789|NCT04092452|587933677|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162787790|NCT04092452|587933678|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162787791|NCT04092452|587933679|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162787792|NCT04092452|587933680|FG003|Overall Study|Non-Compliance With Study Drug|1|||
162787793|NCT04092452|587933677|FG000|Overall Study|Physician Decision|1|||
162787794|NCT04092452|587933678|FG001|Overall Study|Physician Decision|0|||
162787795|NCT04092452|587933679|FG002|Overall Study|Physician Decision|1|||
162787796|NCT04092452|587933680|FG003|Overall Study|Physician Decision|0|||
162787797|NCT04092452|587933677|FG000|Overall Study|Pregnancy|2|||
162787798|NCT04092452|587933678|FG001|Overall Study|Pregnancy|0|||
162787799|NCT04092452|587933679|FG002|Overall Study|Pregnancy|0|||
162787800|NCT04092452|587933680|FG003|Overall Study|Pregnancy|0|||
162787801|NCT04092452|587933677|FG000|Overall Study|Protocol Deviation|1|||
162787802|NCT04092452|587933678|FG001|Overall Study|Protocol Deviation|0|||
162787803|NCT04092452|587933679|FG002|Overall Study|Protocol Deviation|0|||
162787804|NCT04092452|587933680|FG003|Overall Study|Protocol Deviation|0|||
162787805|NCT04092452|587933677|FG000|Overall Study|Withdrawal by Subject|3|||
162787806|NCT04092452|587933678|FG001|Overall Study|Withdrawal by Subject|10|||
162787807|NCT04092452|587933679|FG002|Overall Study|Withdrawal by Subject|3|||
162787808|NCT04092452|587933680|FG003|Overall Study|Withdrawal by Subject|5|||
162787809|NCT04092452|587933677|FG000|Overall Study|Other|0|||
162787810|NCT04092452|587933678|FG001|Overall Study|Other|0|||
162787811|NCT04092452|587933679|FG002|Overall Study|Other|1|||
162787812|NCT04092452|587933680|FG003|Overall Study|Other|2|||
162787813|NCT01012947|587933689|FG000|Overall Study|Lost to Follow-up|131|||
162787814|NCT01012947|587933690|FG001|Overall Study|Lost to Follow-up|135|||
162787815|NCT01012947|587933691|FG002|Overall Study|Lost to Follow-up|130|||
162787816|NCT01012947|587933692|FG003|Overall Study|Lost to Follow-up|118|||
162787817|NCT01012947|587933693|FG004|Overall Study|Lost to Follow-up|142|||
162787818|NCT02127125|587933694|FG000|Overall Study|Lost to Follow-up|0|||
162787819|NCT02127125|587933695|FG001|Overall Study|Lost to Follow-up|0|||
162787820|NCT02127125|587933696|FG002|Overall Study|Lost to Follow-up|0|||
162787821|NCT02127125|587933697|FG003|Overall Study|Lost to Follow-up|0|||
162787822|NCT02127125|587933698|FG004|Overall Study|Lost to Follow-up|2|||
162787823|NCT02127125|587933699|FG005|Overall Study|Lost to Follow-up|1|||
162787824|NCT02127125|587933700|FG006|Overall Study|Lost to Follow-up|0|||
162787825|NCT02127125|587933701|FG007|Overall Study|Lost to Follow-up|0|||
162787826|NCT02127125|587933702|FG008|Overall Study|Lost to Follow-up|0|||
162787827|NCT02127125|587933694|FG000|Overall Study|Withdrawal by Subject|0|||
162787828|NCT02127125|587933695|FG001|Overall Study|Withdrawal by Subject|0|||
162787829|NCT02127125|587933696|FG002|Overall Study|Withdrawal by Subject|0|||
162787830|NCT02127125|587933697|FG003|Overall Study|Withdrawal by Subject|1|||
162787831|NCT02127125|587933698|FG004|Overall Study|Withdrawal by Subject|0|||
162787832|NCT02127125|587933699|FG005|Overall Study|Withdrawal by Subject|0|||
162787833|NCT02127125|587933700|FG006|Overall Study|Withdrawal by Subject|0|||
162787834|NCT02127125|587933701|FG007|Overall Study|Withdrawal by Subject|0|||
162787835|NCT02127125|587933702|FG008|Overall Study|Withdrawal by Subject|0|||
162787836|NCT02127125|587933694|FG000|Overall Study|Physician Decision|0|||
162787837|NCT02127125|587933695|FG001|Overall Study|Physician Decision|0|||
162787838|NCT02127125|587933696|FG002|Overall Study|Physician Decision|1|||
162787839|NCT02127125|587933697|FG003|Overall Study|Physician Decision|0|||
162787840|NCT02127125|587933698|FG004|Overall Study|Physician Decision|1|||
162787841|NCT02127125|587933699|FG005|Overall Study|Physician Decision|2|||
162787842|NCT02127125|587933700|FG006|Overall Study|Physician Decision|0|||
162787843|NCT02127125|587933701|FG007|Overall Study|Physician Decision|0|||
162787844|NCT02127125|587933702|FG008|Overall Study|Physician Decision|0|||
162787845|NCT02498236|587933706|FG000|Overall Study|Did not show for testing|1|||
162787846|NCT02498236|587933707|FG001|Overall Study|Did not show for testing|0|||
162787847|NCT02498236|587933708|FG002|Overall Study|Did not show for testing|0|||
162787848|NCT02498236|587933709|FG003|Overall Study|Did not show for testing|0|||
162787849|NCT02498236|587933710|FG004|Overall Study|Did not show for testing|0|||
162787850|NCT02498236|587933711|FG005|Overall Study|Did not show for testing|0|||
162787851|NCT02498236|587933712|FG006|Overall Study|Did not show for testing|0|||
162787852|NCT02498236|587933713|FG007|Overall Study|Did not show for testing|1|||
162787853|NCT02498236|587933706|FG000|Overall Study|Equipment failure|0|||
162787854|NCT02498236|587933707|FG001|Overall Study|Equipment failure|0|||
162787855|NCT02498236|587933708|FG002|Overall Study|Equipment failure|0|||
162787856|NCT02498236|587933709|FG003|Overall Study|Equipment failure|0|||
162787857|NCT02498236|587933710|FG004|Overall Study|Equipment failure|0|||
162787858|NCT02498236|587933711|FG005|Overall Study|Equipment failure|0|||
162787859|NCT02498236|587933712|FG006|Overall Study|Equipment failure|1|||
162787860|NCT02498236|587933713|FG007|Overall Study|Equipment failure|0|||
162787861|NCT02498236|587933706|FG000|Overall Study|Withdrawal by Subject|0|||
162787862|NCT02498236|587933707|FG001|Overall Study|Withdrawal by Subject|0|||
162787863|NCT02498236|587933708|FG002|Overall Study|Withdrawal by Subject|0|||
162787864|NCT02498236|587933709|FG003|Overall Study|Withdrawal by Subject|0|||
162787865|NCT02498236|587933710|FG004|Overall Study|Withdrawal by Subject|1|||
162787866|NCT02498236|587933711|FG005|Overall Study|Withdrawal by Subject|0|||
162787867|NCT02498236|587933712|FG006|Overall Study|Withdrawal by Subject|0|||
162787868|NCT02498236|587933713|FG007|Overall Study|Withdrawal by Subject|0|||
162787869|NCT03566979|587933715|FG000|Overall Study|Withdrawal by Subject|2|||
162787870|NCT03566979|587933716|FG001|Overall Study|Withdrawal by Subject|0|||
162787871|NCT03566979|587933717|FG002|Overall Study|Withdrawal by Subject|1|||
162787872|NCT03566979|587933718|FG003|Overall Study|Withdrawal by Subject|1|||
162787873|NCT03566979|587933715|FG000|Overall Study|Lost to Follow-up|2|||
162787874|NCT03566979|587933716|FG001|Overall Study|Lost to Follow-up|7|||
162787875|NCT03566979|587933717|FG002|Overall Study|Lost to Follow-up|9|||
162787876|NCT03566979|587933718|FG003|Overall Study|Lost to Follow-up|5|||
162787877|NCT03566979|587933715|FG000|Overall Study|Adverse Event|1|||
162787878|NCT03566979|587933716|FG001|Overall Study|Adverse Event|0|||
162787879|NCT03566979|587933717|FG002|Overall Study|Adverse Event|0|||
162787880|NCT03566979|587933718|FG003|Overall Study|Adverse Event|0|||
162787881|NCT01255761|587933719|FG000|Overall Study|Adverse Event|29|||
162787882|NCT01255761|587933720|FG001|Overall Study|Adverse Event|43|||
162787883|NCT01255761|587933719|FG000|Overall Study|Lack of Efficacy|86|||
162787884|NCT01255761|587933720|FG001|Overall Study|Lack of Efficacy|74|||
162787885|NCT01255761|587933719|FG000|Overall Study|Protocol Violation|9|||
162787886|NCT01255761|587933720|FG001|Overall Study|Protocol Violation|5|||
162787887|NCT01255761|587933719|FG000|Overall Study|Lost to Follow-up|10|||
162787888|NCT01255761|587933720|FG001|Overall Study|Lost to Follow-up|8|||
162787889|NCT01255761|587933719|FG000|Overall Study|Withdrawal by Subject|11|||
162787890|NCT01255761|587933720|FG001|Overall Study|Withdrawal by Subject|27|||
162787891|NCT01255761|587933719|FG000|Overall Study|Other Reasons|37|||
162787892|NCT01255761|587933720|FG001|Overall Study|Other Reasons|18|||
162787893|NCT02336425|587933721|FG000|Overall Study|Study terminated.|2|||
162787894|NCT02336425|587933722|FG001|Overall Study|Study terminated.|2|||
162787895|NCT02336425|587933723|FG002|Overall Study|Study terminated.|3|||
162787896|NCT02336425|587933724|FG003|Overall Study|Study terminated.|3|||
162787897|NCT00658606|587933725|FG000|Overall Study|Adverse Event|2|||
162787898|NCT00658606|587933726|FG001|Overall Study|Adverse Event|1|||
162787899|NCT00658606|587933725|FG000|Overall Study|Lack of Efficacy|6|||
162787900|NCT00658606|587933726|FG001|Overall Study|Lack of Efficacy|3|||
162787901|NCT00658606|587933725|FG000|Overall Study|Lost to Follow-up|1|||
162787902|NCT00658606|587933726|FG001|Overall Study|Lost to Follow-up|0|||
162787903|NCT00658606|587933725|FG000|Overall Study|Withdrawal by Subject|7|||
162787904|NCT00658606|587933726|FG001|Overall Study|Withdrawal by Subject|16|||
162787905|NCT00658606|587933725|FG000|Overall Study|Lack of Compliance|0|||
162787906|NCT00658606|587933726|FG001|Overall Study|Lack of Compliance|3|||
162787907|NCT01191008|587933727|FG000|Overall Study|Protocol Violation|7|||
162787908|NCT01191008|587933727|FG000|Overall Study|Lost to Follow-up|8|||
162787909|NCT02394665|587933730|FG000|Overall Study|Physician Decision|1|||
162787910|NCT02394665|587933731|FG001|Overall Study|Physician Decision|0|||
162787911|NCT02394665|587933732|FG002|Overall Study|Physician Decision|0|||
162787912|NCT00569127|587933733|FG000|Overall Study|Adverse Event|57|||
162787913|NCT00569127|587933734|FG001|Overall Study|Adverse Event|47|||
162787914|NCT00569127|587933733|FG000|Overall Study|Withdrawal by Subject|13|||
162787915|NCT00569127|587933734|FG001|Overall Study|Withdrawal by Subject|27|||
162787916|NCT00569127|587933733|FG000|Overall Study|Progression|99|||
162787917|NCT00569127|587933734|FG001|Overall Study|Progression|100|||
162787918|NCT00569127|587933733|FG000|Overall Study|Death|4|||
162787919|NCT00569127|587933734|FG001|Overall Study|Death|3|||
162787920|NCT00569127|587933733|FG000|Overall Study|Other|20|||
162787921|NCT00569127|587933734|FG001|Overall Study|Other|19|||
162787922|NCT00569127|587933733|FG000|Overall Study|Lost to Follow-up|0|||
162787923|NCT00569127|587933734|FG001|Overall Study|Lost to Follow-up|3|||
162787924|NCT00569127|587933733|FG000|Overall Study|Not Eligible|14|||
162787925|NCT00569127|587933734|FG001|Overall Study|Not Eligible|11|||
162787926|NCT00569127|587933733|FG000|Overall Study|Still on Treatment|7|||
162787927|NCT00569127|587933734|FG001|Overall Study|Still on Treatment|3|||
162787928|NCT03348631|587933735|FG000|Overall Study|Not Eligible, No treatment|0|||
162787929|NCT03348631|587933736|FG001|Overall Study|Not Eligible, No treatment|1|||
162787930|NCT03348631|587933735|FG000|Overall Study|Not Eligible, Treated|2|||
162787931|NCT03348631|587933736|FG001|Overall Study|Not Eligible, Treated|0|||
162787932|NCT03348631|587933735|FG000|Overall Study|Eligible, No Treatment|1|||
162787933|NCT03348631|587933736|FG001|Overall Study|Eligible, No Treatment|0|||
162787934|NCT01068210|587933737|FG000|Overall Study|Lost to Follow-up|1|||
162787935|NCT01068210|587933738|FG001|Overall Study|Lost to Follow-up|2|||
162787936|NCT01068210|587933739|FG002|Overall Study|Lost to Follow-up|2|||
162787937|NCT01068210|587933740|FG003|Overall Study|Lost to Follow-up|1|||
162787938|NCT01068210|587933737|FG000|Overall Study|Second cancer|0|||
162787939|NCT01068210|587933738|FG001|Overall Study|Second cancer|1|||
162787940|NCT01068210|587933739|FG002|Overall Study|Second cancer|0|||
162787941|NCT01068210|587933740|FG003|Overall Study|Second cancer|0|||
162787942|NCT01068210|587933737|FG000|Overall Study|Disease progression|0|||
162787943|NCT01068210|587933738|FG001|Overall Study|Disease progression|0|||
162787944|NCT01068210|587933739|FG002|Overall Study|Disease progression|0|||
162787945|NCT01068210|587933740|FG003|Overall Study|Disease progression|2|||
162787946|NCT03569891|587933741|FG000|Lead-in|Ineligible during lead-in|8|||
162787947|NCT03569891|587933741|FG000|Lead-in|Withdrawal by Subject|3|||
162787948|NCT03569891|587933741|FG000|Lead-in|Risks related to COVID-19|2|||
162787949|NCT03569891|587933741|FG000|AMT-061|Adverse Event|1|||
162787950|NCT03299959|587933744|FG000|Overall Study|Lost to Follow-up|7|||
162787951|NCT03299959|587933745|FG001|Overall Study|Lost to Follow-up|9|||
162787952|NCT03299959|587933744|FG000|Overall Study|Death|1|||
162787953|NCT03299959|587933745|FG001|Overall Study|Death|0|||
162787954|NCT03299959|587933744|FG000|Overall Study|Withdrawal by Subject|13|||
162787955|NCT03299959|587933745|FG001|Overall Study|Withdrawal by Subject|9|||
162787956|NCT03299959|587933744|FG000|Overall Study|Changes in study team and government regulations|1|||
162787957|NCT03299959|587933745|FG001|Overall Study|Changes in study team and government regulations|1|||
162787958|NCT03299959|587933744|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
162787959|NCT03299959|587933745|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
162787960|NCT00738283|587933746|FG000|Overall Study|Death|1|||
162787961|NCT00738283|587933746|FG000|Overall Study|Transfer to another facility|2|||
162787962|NCT00738283|587933746|FG000|Overall Study|Discharge home prior to end of study|1|||
162787963|NCT03494985|587933747|FG000|Overall Study|Adverse Event|3|||
162787964|NCT03494985|587933748|FG001|Overall Study|Adverse Event|2|||
162787965|NCT03494985|587933749|FG002|Overall Study|Adverse Event|3|||
162787966|NCT03494985|587933750|FG003|Overall Study|Adverse Event|0|||
162787967|NCT03494985|587933747|FG000|Overall Study|Other (Withdrawal of consent)|2|||
162787968|NCT03494985|587933748|FG001|Overall Study|Other (Withdrawal of consent)|3|||
162787969|NCT03494985|587933749|FG002|Overall Study|Other (Withdrawal of consent)|2|||
162787970|NCT03494985|587933750|FG003|Overall Study|Other (Withdrawal of consent)|5|||
162787971|NCT03494985|587933747|FG000|Overall Study|Other (Not specified)|0|||
162787972|NCT03494985|587933748|FG001|Overall Study|Other (Not specified)|1|||
162787973|NCT03494985|587933749|FG002|Overall Study|Other (Not specified)|1|||
162787974|NCT03494985|587933750|FG003|Overall Study|Other (Not specified)|0|||
162787975|NCT02282059|587933751|FG000|Overall Study|Other|15|||
162787976|NCT02282059|587933752|FG001|Overall Study|Other|3|||
162787977|NCT02282059|587933751|FG000|Overall Study|Participant refused further follow-up|8|||
162787978|NCT02282059|587933752|FG001|Overall Study|Participant refused further follow-up|4|||
162787979|NCT02282059|587933751|FG000|Overall Study|Lost to Follow-up|19|||
162787980|NCT02282059|587933752|FG001|Overall Study|Lost to Follow-up|3|||
162787981|NCT02282059|587933751|FG000|Overall Study|Death|40|||
162787982|NCT02282059|587933752|FG001|Overall Study|Death|8|||
162787983|NCT03459846|587933753|FG000|Overall Study|Death|52|||
162787984|NCT03459846|587933754|FG001|Overall Study|Death|46|||
162787985|NCT03459846|587933753|FG000|Overall Study|Study terminated by sponsor|24|||
162787986|NCT03459846|587933754|FG001|Overall Study|Study terminated by sponsor|28|||
162787987|NCT03459846|587933753|FG000|Overall Study|Withdrawal by Subject|2|||
162787988|NCT03459846|587933754|FG001|Overall Study|Withdrawal by Subject|2|||
162787989|NCT04886518|587933761|FG000|Overall Study|Noncompliance with study drug|1|||
162787990|NCT04886518|587933762|FG001|Overall Study|Noncompliance with study drug|0|||
162787991|NCT04886518|587933763|FG002|Overall Study|Noncompliance with study drug|0|||
162787992|NCT04886518|587933761|FG000|Overall Study|Adverse Event|0|||
162787993|NCT04886518|587933762|FG001|Overall Study|Adverse Event|1|||
162787994|NCT04886518|587933763|FG002|Overall Study|Adverse Event|0|||
162787995|NCT04886518|587933761|FG000|Overall Study|Withdrawal by Subject|1|||
162787996|NCT04886518|587933762|FG001|Overall Study|Withdrawal by Subject|0|||
162787997|NCT04886518|587933763|FG002|Overall Study|Withdrawal by Subject|0|||
162787998|NCT01090011|587936145|FG000|Overall Study|Progressive disease|128|||
162787999|NCT01090011|587936145|FG000|Overall Study|Adverse Event|32|||
162788000|NCT01090011|587936145|FG000|Overall Study|Protocol Violation|1|||
162788001|NCT01090011|587936145|FG000|Overall Study|Refusal to start/continue medication|5|||
162788002|NCT01090011|587936145|FG000|Overall Study|Other reason not defined above|5|||
162788003|NCT01443403|587936146|FG000|Overall Study|Adverse Event|1|||
162788004|NCT01443403|587936147|FG001|Overall Study|Adverse Event|1|||
162788005|NCT01443403|587936148|FG002|Overall Study|Adverse Event|4|||
162788006|NCT01443403|587936149|FG003|Overall Study|Adverse Event|5|||
162788007|NCT01443403|587936146|FG000|Overall Study|Withdrawal by Subject|0|||
162788008|NCT01443403|587936147|FG001|Overall Study|Withdrawal by Subject|1|||
162788009|NCT01443403|587936148|FG002|Overall Study|Withdrawal by Subject|2|||
162788010|NCT01443403|587936149|FG003|Overall Study|Withdrawal by Subject|1|||
162788011|NCT01443403|587936146|FG000|Overall Study|Lost to Follow-up|0|||
162788012|NCT01443403|587936147|FG001|Overall Study|Lost to Follow-up|0|||
162788013|NCT01443403|587936148|FG002|Overall Study|Lost to Follow-up|0|||
162788014|NCT01443403|587936149|FG003|Overall Study|Lost to Follow-up|1|||
162788015|NCT01443403|587936146|FG000|Overall Study|Protocol Violation|2|||
162788016|NCT01443403|587936147|FG001|Overall Study|Protocol Violation|1|||
162788017|NCT01443403|587936148|FG002|Overall Study|Protocol Violation|1|||
162788018|NCT01443403|587936149|FG003|Overall Study|Protocol Violation|1|||
162788019|NCT01443403|587936146|FG000|Overall Study|Use of Prohibited Treatment|2|||
162788020|NCT01443403|587936147|FG001|Overall Study|Use of Prohibited Treatment|3|||
162788021|NCT01443403|587936148|FG002|Overall Study|Use of Prohibited Treatment|0|||
162788022|NCT01443403|587936149|FG003|Overall Study|Use of Prohibited Treatment|0|||
162788023|NCT01443403|587936146|FG000|Overall Study|Other - Miscellaneous|1|||
162788024|NCT01443403|587936147|FG001|Overall Study|Other - Miscellaneous|0|||
162788025|NCT01443403|587936148|FG002|Overall Study|Other - Miscellaneous|0|||
162788026|NCT01443403|587936149|FG003|Overall Study|Other - Miscellaneous|1|||
162788027|NCT03945773|587936150|FG000|Overall Study|Consent Withdrawn|1|||
162788028|NCT03945773|587936151|FG001|Overall Study|Consent Withdrawn|1|||
162788029|NCT03945773|587936150|FG000|Overall Study|Lost to Follow-up|1|||
162788030|NCT03945773|587936151|FG001|Overall Study|Lost to Follow-up|0|||
162788031|NCT03945773|587936150|FG000|Overall Study|Death|46|||
162788032|NCT03945773|587936151|FG001|Overall Study|Death|22|||
162788033|NCT03945773|587936150|FG000|Overall Study|Physician Decision|1|||
162788034|NCT03945773|587936151|FG001|Overall Study|Physician Decision|0|||
162788035|NCT03945773|587936150|FG000|Overall Study|Other|1|||
162788036|NCT03945773|587936151|FG001|Overall Study|Other|0|||
162788037|NCT03945773|587936150|FG000|Overall Study|Ongoing at the time of DCO|4|||
162788038|NCT03945773|587936151|FG001|Overall Study|Ongoing at the time of DCO|3|||
162788039|NCT00725712|587936154|FG000|Overall Study|Withdrawal by Subject|2|||
162788040|NCT00725712|587936155|FG001|Overall Study|Withdrawal by Subject|1|||
162788041|NCT00725712|587936154|FG000|Overall Study|Protocol Violation|1|||
162788042|NCT00725712|587936155|FG001|Overall Study|Protocol Violation|0|||
162788043|NCT00725712|587936154|FG000|Overall Study|Progressive disease|37|||
162788044|NCT00725712|587936155|FG001|Overall Study|Progressive disease|16|||
162788045|NCT00725712|587936154|FG000|Overall Study|Clinical progression not based on RECIST|0|||
162788046|NCT00725712|587936155|FG001|Overall Study|Clinical progression not based on RECIST|3|||
162788047|NCT00725712|587936154|FG000|Overall Study|Adverse Event|5|||
162788048|NCT00725712|587936155|FG001|Overall Study|Adverse Event|5|||
162788049|NCT00725712|587936154|FG000|Overall Study|Death|2|||
162788050|NCT00725712|587936155|FG001|Overall Study|Death|0|||
162788051|NCT00725712|587936154|FG000|Overall Study|Other: Death|1|||
162788052|NCT00725712|587936155|FG001|Overall Study|Other: Death|0|||
162788053|NCT00725712|587936154|FG000|Overall Study|Hospitalized, unable to continue|0|||
162788054|NCT00725712|587936155|FG001|Overall Study|Hospitalized, unable to continue|1|||
162788055|NCT03607422|587936156|FG000|Overall Study|Adverse Event|7|||
162788056|NCT03607422|587936157|FG001|Overall Study|Adverse Event|3|||
162788057|NCT03607422|587936158|FG002|Overall Study|Adverse Event|2|||
162788058|NCT03607422|587936159|FG003|Overall Study|Adverse Event|0|||
162788059|NCT03607422|587936160|FG004|Overall Study|Adverse Event|2|||
162788060|NCT03607422|587936161|FG005|Overall Study|Adverse Event|0|||
162788061|NCT03607422|587936156|FG000|Overall Study|Withdrawal by Subject|11|||
162788062|NCT03607422|587936157|FG001|Overall Study|Withdrawal by Subject|3|||
162788063|NCT03607422|587936158|FG002|Overall Study|Withdrawal by Subject|6|||
162788064|NCT03607422|587936159|FG003|Overall Study|Withdrawal by Subject|2|||
162788065|NCT03607422|587936160|FG004|Overall Study|Withdrawal by Subject|0|||
162788066|NCT03607422|587936161|FG005|Overall Study|Withdrawal by Subject|0|||
162788067|NCT03607422|587936156|FG000|Overall Study|Lost to Follow-up|0|||
162788068|NCT03607422|587936157|FG001|Overall Study|Lost to Follow-up|0|||
162788069|NCT03607422|587936158|FG002|Overall Study|Lost to Follow-up|1|||
162788070|NCT03607422|587936159|FG003|Overall Study|Lost to Follow-up|0|||
162788071|NCT03607422|587936160|FG004|Overall Study|Lost to Follow-up|0|||
162788072|NCT03607422|587936161|FG005|Overall Study|Lost to Follow-up|0|||
162788073|NCT03607422|587936156|FG000|Overall Study|Other|12|||
162788074|NCT03607422|587936157|FG001|Overall Study|Other|4|||
162788075|NCT03607422|587936158|FG002|Overall Study|Other|1|||
162788076|NCT03607422|587936159|FG003|Overall Study|Other|2|||
162788077|NCT03607422|587936160|FG004|Overall Study|Other|0|||
162788078|NCT03607422|587936161|FG005|Overall Study|Other|2|||
162788079|NCT03607422|587936156|FG000|Overall Study|Ongoing at Time of Analysis|8|||
162788080|NCT03607422|587936157|FG001|Overall Study|Ongoing at Time of Analysis|0|||
162788081|NCT03607422|587936158|FG002|Overall Study|Ongoing at Time of Analysis|2|||
162788082|NCT03607422|587936159|FG003|Overall Study|Ongoing at Time of Analysis|1|||
162788083|NCT03607422|587936160|FG004|Overall Study|Ongoing at Time of Analysis|1|||
162788084|NCT03607422|587936161|FG005|Overall Study|Ongoing at Time of Analysis|1|||
162788085|NCT03258723|587936164|FG000|Overall Study|COVID Interruption of study|54|||
162788086|NCT03258723|587936164|FG000|Overall Study|Lost to Follow-up|8|||
162788087|NCT04832971|587936165|FG000|Double-Blind (DB) Treatment Period|Death|1|||
162788088|NCT04832971|587936166|FG001|Double-Blind (DB) Treatment Period|Death|0|||
162788089|NCT04832971|587936167|FG002|Double-Blind (DB) Treatment Period|Death|0|||
162788090|NCT04832971|587936168|FG003|Double-Blind (DB) Treatment Period|Death|0|||
162788091|NCT04832971|587936169|FG004|Double-Blind (DB) Treatment Period|Death|0|||
162788092|NCT04832971|587936170|FG005|Double-Blind (DB) Treatment Period|Death|0|||
162788093|NCT04832971|587936171|FG006|Double-Blind (DB) Treatment Period|Death|0|||
162788094|NCT04832971|587936172|FG007|Double-Blind (DB) Treatment Period|Death|0|||
162788095|NCT04832971|587936173|FG008|Double-Blind (DB) Treatment Period|Death|0|||
162788096|NCT04832971|587936174|FG009|Double-Blind (DB) Treatment Period|Death|0|||
162788097|NCT04832971|587936165|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162788098|NCT04832971|587936166|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162788099|NCT04832971|587936167|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162788100|NCT04832971|587936168|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788101|NCT04832971|587936169|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788102|NCT04832971|587936170|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788103|NCT04832971|587936171|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788104|NCT04832971|587936172|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788105|NCT04832971|587936173|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788106|NCT04832971|587936174|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162788107|NCT04832971|587936165|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162788108|NCT04832971|587936166|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
162788109|NCT04832971|587936167|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
162788110|NCT04832971|587936168|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162788111|NCT04832971|587936169|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788112|NCT04832971|587936170|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788113|NCT04832971|587936171|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788114|NCT04832971|587936172|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788115|NCT04832971|587936173|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788116|NCT04832971|587936174|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162788117|NCT04832971|587936165|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788118|NCT04832971|587936166|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
162788119|NCT04832971|587936167|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788120|NCT04832971|587936168|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788121|NCT04832971|587936169|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788122|NCT04832971|587936170|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788123|NCT04832971|587936171|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788124|NCT04832971|587936172|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788125|NCT04832971|587936173|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788126|NCT04832971|587936174|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162788127|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788128|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788129|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788130|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788131|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788132|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
162788133|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
162788134|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
162788135|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
162810575|NCT00887250|588018275|FG000|Overall Study|Lack of Efficacy|9|||
162788136|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
162788137|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Death|0|||
162788138|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Death|0|||
162788139|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Death|0|||
162788140|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Death|0|||
162788141|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Death|0|||
162788142|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Death|0|||
162788143|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Death|0|||
162788144|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Death|1|||
162788145|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Death|0|||
162788146|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Death|0|||
162788147|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788148|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788149|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788150|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788151|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788152|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788153|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
162788154|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
162788155|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788156|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162788157|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162788158|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162788159|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162788160|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162788161|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
162788162|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
162788163|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
162788164|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
162788165|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
162788166|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
162788167|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162788168|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162788169|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162788170|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162788171|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
162788172|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
162788173|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162788174|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162788175|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162788176|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
162788177|NCT04832971|587936165|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788178|NCT04832971|587936166|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788179|NCT04832971|587936167|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788180|NCT04832971|587936168|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788181|NCT04832971|587936169|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788182|NCT04832971|587936170|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788183|NCT04832971|587936171|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162788184|NCT04832971|587936172|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162788185|NCT04832971|587936173|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162788186|NCT04832971|587936174|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162788187|NCT01107899|587936175|FG000|Overall Study|Physician Decision|5|||
162788188|NCT01107899|587936176|FG001|Overall Study|Physician Decision|0|||
162788189|NCT01107899|587936177|FG002|Overall Study|Physician Decision|3|||
162788190|NCT01107899|587936175|FG000|Overall Study|Withdrawal by Subject|0|||
162788191|NCT01107899|587936176|FG001|Overall Study|Withdrawal by Subject|0|||
162788192|NCT01107899|587936177|FG002|Overall Study|Withdrawal by Subject|1|||
162788193|NCT03584152|587936178|FG000|Overall Study|Discontinued intervention|7|||
162788194|NCT03584152|587936179|FG001|Overall Study|Discontinued intervention|4|||
162788195|NCT04024462|587936180|FG000|Overall Study|Withdrawal by Subject|6|||
162788196|NCT04024462|587936181|FG001|Overall Study|Withdrawal by Subject|7|||
162788197|NCT04024462|587936180|FG000|Overall Study|Progressive Disease|0|||
162788198|NCT04024462|587936181|FG001|Overall Study|Progressive Disease|1|||
162788199|NCT04024462|587936180|FG000|Overall Study|Adverse Event|0|||
162788200|NCT04024462|587936181|FG001|Overall Study|Adverse Event|1|||
162788201|NCT04024462|587936180|FG000|Overall Study|Death|0|||
162788202|NCT04024462|587936181|FG001|Overall Study|Death|1|||
162788203|NCT04024462|587936180|FG000|Overall Study|Lost to Follow-up|1|||
162788204|NCT04024462|587936181|FG001|Overall Study|Lost to Follow-up|0|||
162788205|NCT04024462|587936180|FG000|Overall Study|Ongoing in the Study|94|||
162788206|NCT04024462|587936181|FG001|Overall Study|Ongoing in the Study|89|||
162788207|NCT00983749|587936186|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
162788208|NCT00983749|587936187|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
162788209|NCT04292470|587936188|FG000|Overall Study|Withdrawal by Subject|0|||
162788210|NCT04292470|587936189|FG001|Overall Study|Withdrawal by Subject|1|||
162788211|NCT02906020|587936203|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
162788212|NCT02906020|587936204|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
162788213|NCT02906020|587936205|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
162788214|NCT02906020|587936206|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
162788215|NCT02906020|587936207|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
162788216|NCT02906020|587936208|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
162788217|NCT02906020|587936209|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
162788218|NCT02906020|587936210|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
162788219|NCT02906020|587936211|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
162788220|NCT02906020|587936212|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
162788221|NCT02906020|587936213|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
162788222|NCT02906020|587936214|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
162788223|NCT02906020|587936215|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
162788224|NCT02906020|587936216|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
162788225|NCT02906020|587936217|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
162788226|NCT02906020|587936218|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
162788227|NCT02906020|587936203|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788228|NCT02906020|587936204|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788229|NCT02906020|587936205|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788230|NCT02906020|587936206|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788231|NCT02906020|587936207|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788232|NCT02906020|587936208|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788233|NCT02906020|587936209|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788234|NCT02906020|587936210|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788235|NCT02906020|587936211|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
162788236|NCT02906020|587936212|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
162788237|NCT02906020|587936213|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788238|NCT02906020|587936214|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788239|NCT02906020|587936215|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788240|NCT02906020|587936216|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788241|NCT02906020|587936217|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788242|NCT02906020|587936218|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162788243|NCT02906020|587936203|FG000|Part 2: Double-blind Treatment Period|Other|0|||
162788244|NCT02906020|587936204|FG001|Part 2: Double-blind Treatment Period|Other|0|||
162788245|NCT02906020|587936205|FG002|Part 2: Double-blind Treatment Period|Other|0|||
162788246|NCT02906020|587936206|FG003|Part 2: Double-blind Treatment Period|Other|0|||
162788247|NCT02906020|587936207|FG004|Part 2: Double-blind Treatment Period|Other|0|||
162788248|NCT02906020|587936208|FG005|Part 2: Double-blind Treatment Period|Other|0|||
162788249|NCT02906020|587936209|FG006|Part 2: Double-blind Treatment Period|Other|0|||
162788250|NCT02906020|587936210|FG007|Part 2: Double-blind Treatment Period|Other|0|||
162788251|NCT02906020|587936211|FG008|Part 2: Double-blind Treatment Period|Other|6|||
162788252|NCT02906020|587936212|FG009|Part 2: Double-blind Treatment Period|Other|10|||
162788253|NCT02906020|587936213|FG010|Part 2: Double-blind Treatment Period|Other|0|||
162788254|NCT02906020|587936214|FG011|Part 2: Double-blind Treatment Period|Other|0|||
162788255|NCT02906020|587936215|FG012|Part 2: Double-blind Treatment Period|Other|0|||
162788256|NCT02906020|587936216|FG013|Part 2: Double-blind Treatment Period|Other|0|||
162788257|NCT02906020|587936217|FG014|Part 2: Double-blind Treatment Period|Other|0|||
162788258|NCT02906020|587936218|FG015|Part 2: Double-blind Treatment Period|Other|0|||
162788259|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788260|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788261|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788262|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788263|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788264|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788265|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788266|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788267|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788268|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788269|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788270|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788271|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
162788272|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
162788273|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788274|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162788275|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788276|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788277|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788278|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788279|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788280|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788281|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788282|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788283|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788284|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788285|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788286|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788287|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
162788288|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
162788289|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162788290|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
162788291|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788292|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788293|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788294|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788295|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788296|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788297|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788298|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788299|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788300|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788301|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788302|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788303|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
162788304|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
162788305|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788306|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162788307|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788308|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788309|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788310|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788311|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788312|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788313|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788314|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788315|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788316|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788317|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788318|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788319|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
162788320|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
162788321|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788322|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162788323|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788324|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788325|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788326|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788327|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788328|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788329|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788330|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788331|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788332|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788333|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788334|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162788335|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
162788336|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
162810576|NCT00887250|588018276|FG001|Overall Study|Lack of Efficacy|6|||
162788337|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
162788338|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
162788339|NCT02906020|587936203|FG000|Part 2: Long-term Follow-up Period|Other|0|||
162788340|NCT02906020|587936204|FG001|Part 2: Long-term Follow-up Period|Other|0|||
162788341|NCT02906020|587936205|FG002|Part 2: Long-term Follow-up Period|Other|0|||
162788342|NCT02906020|587936206|FG003|Part 2: Long-term Follow-up Period|Other|0|||
162788343|NCT02906020|587936207|FG004|Part 2: Long-term Follow-up Period|Other|0|||
162788344|NCT02906020|587936208|FG005|Part 2: Long-term Follow-up Period|Other|0|||
162788345|NCT02906020|587936209|FG006|Part 2: Long-term Follow-up Period|Other|0|||
162788346|NCT02906020|587936210|FG007|Part 2: Long-term Follow-up Period|Other|0|||
162788347|NCT02906020|587936211|FG008|Part 2: Long-term Follow-up Period|Other|0|||
162788348|NCT02906020|587936212|FG009|Part 2: Long-term Follow-up Period|Other|0|||
162788349|NCT02906020|587936213|FG010|Part 2: Long-term Follow-up Period|Other|0|||
162788350|NCT02906020|587936214|FG011|Part 2: Long-term Follow-up Period|Other|0|||
162788351|NCT02906020|587936215|FG012|Part 2: Long-term Follow-up Period|Other|13|||
162788352|NCT02906020|587936216|FG013|Part 2: Long-term Follow-up Period|Other|8|||
162788353|NCT02906020|587936217|FG014|Part 2: Long-term Follow-up Period|Other|3|||
162788354|NCT02906020|587936218|FG015|Part 2: Long-term Follow-up Period|Other|2|||
162788355|NCT01375673|587936224|FG000|Overall Study|Withdrawal by Subject|0|||
162788356|NCT01375673|587936225|FG001|Overall Study|Withdrawal by Subject|1|||
162788357|NCT04698915|587936230|FG000|Overall Study|Adverse Event|2|||
162788358|NCT04698915|587936231|FG001|Overall Study|Adverse Event|0|||
162788359|NCT04698915|587936230|FG000|Overall Study|Death|23|||
162788360|NCT04698915|587936231|FG001|Overall Study|Death|20|||
162788361|NCT04698915|587936230|FG000|Overall Study|Physician Decision|1|||
162788362|NCT04698915|587936231|FG001|Overall Study|Physician Decision|1|||
162788363|NCT04698915|587936230|FG000|Overall Study|Lost to Follow-up|1|||
162788364|NCT04698915|587936231|FG001|Overall Study|Lost to Follow-up|0|||
162788365|NCT04698915|587936230|FG000|Overall Study|Study Terminated by Sponsor|55|||
162788366|NCT04698915|587936231|FG001|Overall Study|Study Terminated by Sponsor|60|||
162788367|NCT04698915|587936230|FG000|Overall Study|Withdrawal by Subject|2|||
162788368|NCT04698915|587936231|FG001|Overall Study|Withdrawal by Subject|3|||
162788369|NCT01907906|587936232|FG000|Overall Study|Withdrawal by Subject|1|||
162788370|NCT01907906|587936233|FG001|Overall Study|Withdrawal by Subject|0|||
162788371|NCT01907906|587936232|FG000|Overall Study|Physician Decision|3|||
162788372|NCT01907906|587936233|FG001|Overall Study|Physician Decision|1|||
162788373|NCT01124097|587936234|FG000|Overall Study|Withdrawal by Subject|4|||
162788374|NCT01124097|587936235|FG001|Overall Study|Withdrawal by Subject|3|||
162788375|NCT01124097|587936236|FG002|Overall Study|Withdrawal by Subject|2|||
162788376|NCT01124097|587936237|FG003|Overall Study|Withdrawal by Subject|3|||
162788377|NCT01124097|587936234|FG000|Overall Study|Lack of Efficacy|2|||
162788378|NCT01124097|587936235|FG001|Overall Study|Lack of Efficacy|3|||
162788379|NCT01124097|587936236|FG002|Overall Study|Lack of Efficacy|1|||
162788380|NCT01124097|587936237|FG003|Overall Study|Lack of Efficacy|3|||
162788381|NCT01124097|587936234|FG000|Overall Study|Adverse Event|24|||
162788382|NCT01124097|587936235|FG001|Overall Study|Adverse Event|15|||
162788383|NCT01124097|587936236|FG002|Overall Study|Adverse Event|15|||
162788384|NCT01124097|587936237|FG003|Overall Study|Adverse Event|7|||
162788385|NCT01124097|587936234|FG000|Overall Study|Protocol Violation|2|||
162788386|NCT01124097|587936235|FG001|Overall Study|Protocol Violation|0|||
162788387|NCT01124097|587936236|FG002|Overall Study|Protocol Violation|2|||
162788388|NCT01124097|587936237|FG003|Overall Study|Protocol Violation|1|||
162788389|NCT01124097|587936234|FG000|Overall Study|Physician Decision|2|||
162788390|NCT01124097|587936235|FG001|Overall Study|Physician Decision|1|||
162788391|NCT01124097|587936236|FG002|Overall Study|Physician Decision|0|||
162788392|NCT01124097|587936237|FG003|Overall Study|Physician Decision|0|||
162788393|NCT05687032|587936238|FG000|Treatment Phase|Adverse Event|13|||
162788394|NCT05687032|587936238|FG000|Treatment Phase|Death|1|||
162788395|NCT05687032|587936238|FG000|Treatment Phase|Physician Decision|3|||
162788396|NCT05687032|587936238|FG000|Treatment Phase|Progressive disease|9|||
162788397|NCT05687032|587936238|FG000|Treatment Phase|Withdrawal by Subject|5|||
162788398|NCT05687032|587936238|FG000|Follow-Up Phase|Death|16|||
162788399|NCT05687032|587936238|FG000|Follow-Up Phase|Ongoing|26|||
162788400|NCT04829747|587936242|FG000|Overall Study|Protocol Violation|1|||
162788401|NCT02367352|587936245|FG000|Overall Study|Progressive disease|7|||
162788402|NCT02367352|587936246|FG001|Overall Study|Progressive disease|0|||
162788403|NCT02367352|587936247|FG002|Overall Study|Progressive disease|0|||
162788404|NCT02367352|587936245|FG000|Overall Study|Participant Received Alternative Therapy|1|||
162788405|NCT02367352|587936246|FG001|Overall Study|Participant Received Alternative Therapy|0|||
162788406|NCT02367352|587936247|FG002|Overall Study|Participant Received Alternative Therapy|0|||
162788407|NCT02367352|587936245|FG000|Overall Study|Adverse Event|1|||
162788408|NCT02367352|587936246|FG001|Overall Study|Adverse Event|0|||
162788409|NCT02367352|587936247|FG002|Overall Study|Adverse Event|0|||
162788410|NCT05878873|587936248|FG000|Overall Study|Lost to Follow-up|2|||
162788411|NCT05878873|587936249|FG001|Overall Study|Lost to Follow-up|0|||
162788412|NCT02375347|587936251|FG000|Overall Study|Protocol Violation|1|||
162788413|NCT00425607|587936252|FG000|Overall Study|Death|1|||
162788414|NCT00425607|587936252|FG000|Overall Study|Withdrawal by Subject|1|||
162788415|NCT00193479|587936253|FG000|Induction Chemotherapy|Adverse Event|2|||
162788416|NCT00193479|587936253|FG000|Induction Chemotherapy|Disease Progression|1|||
162788417|NCT00193479|587936253|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
162788418|NCT00193479|587936253|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
162788419|NCT00079339|587936254|FG000|Overall Study|Adverse Event|1|||
162788420|NCT00079339|587936255|FG001|Overall Study|Adverse Event|7|||
162788421|NCT00079339|587936256|FG002|Overall Study|Adverse Event|2|||
162788422|NCT00079339|587936254|FG000|Overall Study|Death|1|||
162788423|NCT00079339|587936255|FG001|Overall Study|Death|0|||
162788424|NCT00079339|587936256|FG002|Overall Study|Death|0|||
162788425|NCT00079339|587936254|FG000|Overall Study|Non-compliance|0|||
162788426|NCT00079339|587936255|FG001|Overall Study|Non-compliance|0|||
162788427|NCT00079339|587936256|FG002|Overall Study|Non-compliance|1|||
162788428|NCT00079339|587936254|FG000|Overall Study|Withdrawal by Subject|0|||
162788429|NCT00079339|587936255|FG001|Overall Study|Withdrawal by Subject|4|||
162788430|NCT00079339|587936256|FG002|Overall Study|Withdrawal by Subject|1|||
162788431|NCT00079339|587936254|FG000|Overall Study|Disease progression|3|||
162788432|NCT00079339|587936255|FG001|Overall Study|Disease progression|28|||
162788433|NCT00079339|587936256|FG002|Overall Study|Disease progression|2|||
162788434|NCT02563548|587936257|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
162788435|NCT02563548|587936258|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162788436|NCT02563548|587936259|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162788437|NCT02563548|587936260|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
162788438|NCT02563548|587936261|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162788439|NCT02563548|587936262|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162788440|NCT02563548|587936257|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
162788441|NCT02563548|587936258|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
162788442|NCT02563548|587936259|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
162788443|NCT02563548|587936260|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162788444|NCT02563548|587936261|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162788445|NCT02563548|587936262|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162788446|NCT02563548|587936257|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162788447|NCT02563548|587936258|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162788448|NCT02563548|587936259|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
162788449|NCT02563548|587936260|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162788450|NCT02563548|587936261|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162788451|NCT02563548|587936262|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162788452|NCT02563548|587936257|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162788453|NCT02563548|587936258|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162788454|NCT02563548|587936259|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
162788455|NCT02563548|587936260|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
162788456|NCT02563548|587936261|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162788457|NCT02563548|587936262|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162788458|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162788459|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162788460|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162788461|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162788462|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
162788463|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
162788464|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162788465|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162788466|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162788467|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162788468|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
162788469|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
162788470|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162788471|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162788472|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162788473|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162788474|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
162788475|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162788476|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162788477|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162788478|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162788479|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162788480|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
162788481|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
162788482|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162788483|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162788484|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162788485|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162788486|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162788487|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
162788488|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162788489|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162788490|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162788491|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162788492|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162788493|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
162788494|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162788495|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162788496|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162788497|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162788498|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162788499|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
162788500|NCT02563548|587936257|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162788501|NCT02563548|587936258|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162788502|NCT02563548|587936259|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162788503|NCT02563548|587936260|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162788504|NCT02563548|587936261|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
162788505|NCT02563548|587936262|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162788506|NCT00559377|587936263|FG000|Overall Study|Withdrawal by Subject|9|||
162788507|NCT00203047|587936270|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
162788508|NCT00203047|587936271|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
162788509|NCT00203047|587936270|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
162788510|NCT00203047|587936271|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
162788511|NCT00203047|587936270|FG000|Overall Study|Withdrawal by Subject|13|||
162788512|NCT00203047|587936271|FG001|Overall Study|Withdrawal by Subject|47|||
162788513|NCT00203047|587936270|FG000|Overall Study|Teva requested participant withdrawal|1|||
162788514|NCT00203047|587936271|FG001|Overall Study|Teva requested participant withdrawal|1|||
162788515|NCT00203047|587936270|FG000|Overall Study|Physician Decision|8|||
162788516|NCT00203047|587936271|FG001|Overall Study|Physician Decision|7|||
162788517|NCT00203047|587936270|FG000|Overall Study|Non-compliance|4|||
162788518|NCT00203047|587936271|FG001|Overall Study|Non-compliance|8|||
162788519|NCT00203047|587936270|FG000|Overall Study|Protocol Violation|1|||
162788520|NCT00203047|587936271|FG001|Overall Study|Protocol Violation|0|||
162788521|NCT00203047|587936270|FG000|Overall Study|Lost to Follow-up|11|||
162788522|NCT00203047|587936271|FG001|Overall Study|Lost to Follow-up|5|||
162788523|NCT00203047|587936270|FG000|Overall Study|Adverse Event|8|||
162788524|NCT00203047|587936271|FG001|Overall Study|Adverse Event|18|||
162788525|NCT00203047|587936270|FG000|Overall Study|Death|1|||
162788526|NCT00203047|587936271|FG001|Overall Study|Death|2|||
162788527|NCT00203047|587936270|FG000|Overall Study|Pregnancy|3|||
162788528|NCT00203047|587936271|FG001|Overall Study|Pregnancy|0|||
162788529|NCT00203047|587936270|FG000|Overall Study|Other|5|||
162788530|NCT00203047|587936271|FG001|Overall Study|Other|5|||
162788531|NCT02229227|587936272|FG000|Overall Study|Adverse Event|14|||
162788532|NCT02229227|587936273|FG001|Overall Study|Adverse Event|9|||
162788533|NCT02229227|587936272|FG000|Overall Study|Lack of Efficacy|3|||
162788534|NCT02229227|587936273|FG001|Overall Study|Lack of Efficacy|3|||
162788535|NCT02229227|587936272|FG000|Overall Study|Protocol Violation|6|||
162788536|NCT02229227|587936273|FG001|Overall Study|Protocol Violation|8|||
162788537|NCT02229227|587936272|FG000|Overall Study|Protocol defined stopping criteria|1|||
162788538|NCT02229227|587936273|FG001|Overall Study|Protocol defined stopping criteria|3|||
162788539|NCT02229227|587936272|FG000|Overall Study|Lost to Follow-up|3|||
162788540|NCT02229227|587936273|FG001|Overall Study|Lost to Follow-up|3|||
162788541|NCT02229227|587936272|FG000|Overall Study|Study terminated by sponsor|11|||
162788542|NCT02229227|587936273|FG001|Overall Study|Study terminated by sponsor|11|||
162788543|NCT02229227|587936272|FG000|Overall Study|Withdrawal by Subject|8|||
162788544|NCT02229227|587936273|FG001|Overall Study|Withdrawal by Subject|12|||
162788545|NCT02229227|587936272|FG000|Overall Study|Other|0|||
162788546|NCT02229227|587936273|FG001|Overall Study|Other|1|||
162788547|NCT02229227|587936272|FG000|Overall Study|Physician Decision|5|||
162788548|NCT02229227|587936273|FG001|Overall Study|Physician Decision|12|||
162788549|NCT00340704|587936276|FG000|PK Study|Adverse Event|0|||
162788550|NCT00340704|587936277|FG001|PK Study|Adverse Event|1|||
162788551|NCT00340704|587936278|FG002|PK Study|Adverse Event|0|||
162788552|NCT00340704|587936279|FG003|PK Study|Adverse Event|0|||
162788553|NCT00340704|587936280|FG004|PK Study|Adverse Event|0|||
162788554|NCT00340704|587936281|FG005|PK Study|Adverse Event|0|||
162788555|NCT00340704|587936282|FG006|PK Study|Adverse Event|0|||
162788556|NCT00340704|587936283|FG007|PK Study|Adverse Event|0|||
162788557|NCT00340704|587936284|FG008|PK Study|Adverse Event|0|||
162788558|NCT00340704|587936276|FG000|PK Study|Not treated|0|||
162788559|NCT00340704|587936277|FG001|PK Study|Not treated|0|||
162788560|NCT00340704|587936278|FG002|PK Study|Not treated|1|||
162788561|NCT00340704|587936279|FG003|PK Study|Not treated|0|||
162788562|NCT00340704|587936280|FG004|PK Study|Not treated|0|||
162788563|NCT00340704|587936281|FG005|PK Study|Not treated|0|||
162788564|NCT00340704|587936282|FG006|PK Study|Not treated|0|||
162788565|NCT00340704|587936283|FG007|PK Study|Not treated|0|||
162788566|NCT00340704|587936284|FG008|PK Study|Not treated|0|||
162788567|NCT00340704|587936276|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162788568|NCT00340704|587936277|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162788569|NCT00340704|587936278|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162788570|NCT00340704|587936279|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
162788571|NCT00340704|587936280|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
162788572|NCT00340704|587936281|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162788573|NCT00340704|587936282|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162788574|NCT00340704|587936283|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
162788575|NCT00340704|587936284|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
162788576|NCT00340704|587936276|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788577|NCT00340704|587936277|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788578|NCT00340704|587936278|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788579|NCT00340704|587936279|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788580|NCT00340704|587936280|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788581|NCT00340704|587936281|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
162788582|NCT00340704|587936282|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788583|NCT00340704|587936283|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788584|NCT00340704|587936284|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162788585|NCT00340704|587936276|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788586|NCT00340704|587936277|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788587|NCT00340704|587936278|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788588|NCT00340704|587936279|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788589|NCT00340704|587936280|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
162788590|NCT00340704|587936281|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
162788591|NCT00340704|587936282|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788592|NCT00340704|587936283|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788593|NCT00340704|587936284|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162788594|NCT00340704|587936276|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162788595|NCT00340704|587936277|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162788596|NCT00340704|587936278|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162788597|NCT00340704|587936279|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162788598|NCT00340704|587936280|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162788599|NCT00340704|587936281|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
162788600|NCT00340704|587936282|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
162788601|NCT00340704|587936283|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
162788602|NCT00340704|587936284|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
162788603|NCT00121667|587936285|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
162788604|NCT00121667|587936286|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
162788605|NCT00121667|587936287|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
162788606|NCT00121667|587936288|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
162788607|NCT00121667|587936285|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
162788608|NCT00121667|587936286|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
162788609|NCT00121667|587936287|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
162788610|NCT00121667|587936288|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
162788611|NCT00121667|587936285|FG000|Short Term (ST) Period|Adverse Event|5|||
162788612|NCT00121667|587936286|FG001|Short Term (ST) Period|Adverse Event|6|||
162788613|NCT00121667|587936287|FG002|Short Term (ST) Period|Adverse Event|5|||
162788614|NCT00121667|587936288|FG003|Short Term (ST) Period|Adverse Event|3|||
162788615|NCT00121667|587936285|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
162788616|NCT00121667|587936286|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
162788617|NCT00121667|587936287|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
162788618|NCT00121667|587936288|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
162788619|NCT00121667|587936285|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
162788620|NCT00121667|587936286|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
162788621|NCT00121667|587936287|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
162788622|NCT00121667|587936288|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
162788623|NCT00121667|587936285|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
162788624|NCT00121667|587936286|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
162788625|NCT00121667|587936287|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
162788626|NCT00121667|587936288|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
162788627|NCT00121667|587936285|FG000|Short Term (ST) Period|Other Reason|3|||
162788628|NCT00121667|587936286|FG001|Short Term (ST) Period|Other Reason|0|||
162788629|NCT00121667|587936287|FG002|Short Term (ST) Period|Other Reason|0|||
162788630|NCT00121667|587936288|FG003|Short Term (ST) Period|Other Reason|0|||
162788631|NCT00121667|587936285|FG000|Short Term (ST) Period|Death|0|||
162788632|NCT00121667|587936286|FG001|Short Term (ST) Period|Death|0|||
162788633|NCT00121667|587936287|FG002|Short Term (ST) Period|Death|0|||
162788634|NCT00121667|587936288|FG003|Short Term (ST) Period|Death|1|||
162788635|NCT00121667|587936285|FG000|Short Term (ST) Period|Pregnancy|0|||
162788636|NCT00121667|587936286|FG001|Short Term (ST) Period|Pregnancy|0|||
162788637|NCT00121667|587936287|FG002|Short Term (ST) Period|Pregnancy|0|||
162788638|NCT00121667|587936288|FG003|Short Term (ST) Period|Pregnancy|1|||
162788639|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
162788640|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
162788641|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
162788642|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
162788643|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
162788644|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
162788645|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
162788646|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
162788647|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
162788648|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
162788649|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
162788650|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
162788651|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
162788652|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
162788653|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
162788654|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
162788655|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
162788656|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
162788657|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
162788658|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
162788659|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
162788660|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
162788661|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
162788662|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
162788663|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
162788664|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
162788665|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
162788666|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
162788667|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162788668|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162788669|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
162788670|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162788671|NCT00121667|587936285|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
162788672|NCT00121667|587936286|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
162788673|NCT00121667|587936287|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
162788674|NCT00121667|587936288|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
162788675|NCT01453023|587936289|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
162788676|NCT01453023|587936290|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
162788677|NCT01453023|587936289|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
162788678|NCT01453023|587936290|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
162788679|NCT01453023|587936289|FG000|Treatment Period 2|Protocol Violation|0|||
162788680|NCT01453023|587936290|FG001|Treatment Period 2|Protocol Violation|1|||
162788681|NCT04468230|587936296|FG000|Overall Study|Adverse Event|2|||
162788682|NCT01056263|587936317|FG000|Overall Study|Adverse Event|12|||
162788683|NCT01056263|587936317|FG000|Overall Study|Death|1|||
162788684|NCT01056263|587936317|FG000|Overall Study|Withdrawal by Subject|1|||
162788685|NCT01056263|587936317|FG000|Overall Study|Lack of Efficacy|29|||
162788686|NCT01056263|587936317|FG000|Overall Study|Progressive disease|2|||
162788687|NCT01056263|587936317|FG000|Overall Study|Neoplasm progression|1|||
162788688|NCT01056263|587936317|FG000|Overall Study|Objective progression or relapse|1|||
162788689|NCT01056263|587936317|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
162788690|NCT00365547|587936326|FG000|Overall Study|Insurance did not cover Avastin|1|||
162788691|NCT00365547|587936326|FG000|Overall Study|Screen failure|1|||
162788692|NCT00365547|587936326|FG000|Overall Study|Withdrawal by Subject|1|||
162788693|NCT03170518|587936327|FG000|Overall Study|Lost to Follow-up|4|||
162788694|NCT03170518|587936328|FG001|Overall Study|Lost to Follow-up|1|||
162788695|NCT03170518|587936329|FG002|Overall Study|Lost to Follow-up|0|||
162788696|NCT03170518|587936327|FG000|Overall Study|Physician Decision|1|||
162788697|NCT03170518|587936328|FG001|Overall Study|Physician Decision|0|||
162788698|NCT03170518|587936329|FG002|Overall Study|Physician Decision|0|||
162788699|NCT03170518|587936327|FG000|Overall Study|Withdrawal by Subject|4|||
162788700|NCT03170518|587936328|FG001|Overall Study|Withdrawal by Subject|5|||
162788701|NCT03170518|587936329|FG002|Overall Study|Withdrawal by Subject|2|||
162788702|NCT03170518|587936327|FG000|Overall Study|Site terminated by sponsor|0|||
162788703|NCT03170518|587936328|FG001|Overall Study|Site terminated by sponsor|1|||
162788704|NCT03170518|587936329|FG002|Overall Study|Site terminated by sponsor|0|||
162788705|NCT03170518|587936327|FG000|Overall Study|Non-compliance with study drug|1|||
162788706|NCT03170518|587936328|FG001|Overall Study|Non-compliance with study drug|0|||
162788707|NCT03170518|587936329|FG002|Overall Study|Non-compliance with study drug|1|||
162788708|NCT03170518|587936327|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162788709|NCT03170518|587936328|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162788710|NCT03170518|587936329|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162788711|NCT00546078|587936330|FG000|Overall Study|Lost to Follow-up|1|||
162788712|NCT00546078|587936331|FG001|Overall Study|Lost to Follow-up|3|||
162788713|NCT00546078|587936330|FG000|Overall Study|Withdrawal by Subject|2|||
162788714|NCT00546078|587936331|FG001|Overall Study|Withdrawal by Subject|3|||
162788715|NCT00546078|587936330|FG000|Overall Study|Other reason|1|||
162788716|NCT00546078|587936331|FG001|Overall Study|Other reason|1|||
162788717|NCT03512197|587936332|FG000|Overall Study|Guardian decision|1|||
162788718|NCT03512197|587936333|FG001|Overall Study|Guardian decision|1|||
162788719|NCT03512197|587936332|FG000|Overall Study|Lack of Efficacy|19|||
162788720|NCT03512197|587936333|FG001|Overall Study|Lack of Efficacy|11|||
162788721|NCT03512197|587936332|FG000|Overall Study|New Therapy for Study Indication|16|||
162788722|NCT03512197|587936333|FG001|Overall Study|New Therapy for Study Indication|16|||
162788723|NCT03512197|587936332|FG000|Overall Study|Physician Decision|60|||
162788724|NCT03512197|587936333|FG001|Overall Study|Physician Decision|60|||
162788725|NCT03512197|587936332|FG000|Overall Study|Protocol Violation|0|||
162788726|NCT03512197|587936333|FG001|Overall Study|Protocol Violation|2|||
162788727|NCT03512197|587936332|FG000|Overall Study|Terminated by Sponsored|46|||
162788728|NCT03512197|587936333|FG001|Overall Study|Terminated by Sponsored|50|||
162788729|NCT03512197|587936332|FG000|Overall Study|Subject Decision|15|||
162788730|NCT03512197|587936333|FG001|Overall Study|Subject Decision|12|||
162788731|NCT03512197|587936332|FG000|Overall Study|Withdrawal of informed consent|20|||
162788732|NCT03512197|587936333|FG001|Overall Study|Withdrawal of informed consent|14|||
162788733|NCT03512197|587936332|FG000|Overall Study|Adverse Event|30|||
162788734|NCT03512197|587936333|FG001|Overall Study|Adverse Event|34|||
162788735|NCT03512197|587936332|FG000|Overall Study|Death|14|||
162788736|NCT03512197|587936333|FG001|Overall Study|Death|9|||
162788737|NCT03512197|587936332|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
162788738|NCT03512197|587936333|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
162788739|NCT03512197|587936332|FG000|Overall Study|Missing|3|||
162788740|NCT03512197|587936333|FG001|Overall Study|Missing|13|||
162788741|NCT03842436|587936334|FG000|Overall Study|Lost to Follow-up|1|||
162788742|NCT01806389|587936335|FG000|Overall Study|Withdrawal by Subject|4|||
162788743|NCT01948076|587936336|FG000|Overall Study|Withdrawal by Subject|0|||
162788744|NCT01948076|587936337|FG001|Overall Study|Withdrawal by Subject|1|||
162788745|NCT00936598|587936343|FG000|Overall Study|Withdrawal by Subject|1|||
162788746|NCT00936598|587936344|FG001|Overall Study|Withdrawal by Subject|0|||
162788747|NCT00936598|587936343|FG000|Overall Study|Ineligible after consent|1|||
162788748|NCT00936598|587936344|FG001|Overall Study|Ineligible after consent|0|||
162788749|NCT01431950|587936345|FG000|Overall Study|Study Site Closed/Terminated|7|||
162788750|NCT01431950|587936346|FG001|Overall Study|Study Site Closed/Terminated|3|||
162788751|NCT01431950|587936345|FG000|Overall Study|Withdrawal by Subject|4|||
162788752|NCT01431950|587936346|FG001|Overall Study|Withdrawal by Subject|3|||
162788753|NCT01431950|587936345|FG000|Overall Study|Protocol Violation|2|||
162788754|NCT01431950|587936346|FG001|Overall Study|Protocol Violation|3|||
162788755|NCT01431950|587936345|FG000|Overall Study|Adverse Event|2|||
162788756|NCT01431950|587936346|FG001|Overall Study|Adverse Event|2|||
162788757|NCT01431950|587936345|FG000|Overall Study|Physician Decision|2|||
162788758|NCT01431950|587936346|FG001|Overall Study|Physician Decision|1|||
162788759|NCT01431950|587936345|FG000|Overall Study|Lack of Efficacy|2|||
162788760|NCT01431950|587936346|FG001|Overall Study|Lack of Efficacy|1|||
162788761|NCT01431950|587936345|FG000|Overall Study|Lost to Follow-up|0|||
162788762|NCT01431950|587936346|FG001|Overall Study|Lost to Follow-up|1|||
162788763|NCT01431950|587936345|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162788764|NCT01431950|587936346|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162788765|NCT00486252|587936349|FG000|Overall Study|Adverse Event|7|||
162788766|NCT00486252|587936349|FG000|Overall Study|Lack of Efficacy|9|||
162788767|NCT00486252|587936349|FG000|Overall Study|Lost to Follow-up|24|||
162788768|NCT00486252|587936349|FG000|Overall Study|Other|18|||
162788769|NCT01210651|587936350|FG000|Overall Study|Lost to Follow-up|1|||
162788770|NCT01210651|587936351|FG001|Overall Study|Lost to Follow-up|1|||
162788771|NCT01210651|587936350|FG000|Overall Study|schedule conflicts|1|||
162788772|NCT01210651|587936351|FG001|Overall Study|schedule conflicts|5|||
162788773|NCT01210651|587936350|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
162788774|NCT01210651|587936351|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
162788775|NCT01210651|587936350|FG000|Overall Study|Withdrawal by Subject|1|||
162788776|NCT01210651|587936351|FG001|Overall Study|Withdrawal by Subject|1|||
162788777|NCT01210651|587936350|FG000|Overall Study|Injury outside study|2|||
162788778|NCT01210651|587936351|FG001|Overall Study|Injury outside study|0|||
162788779|NCT02559310|587936352|FG000|Overall Study|Death|4|||
162788780|NCT02559310|587936353|FG001|Overall Study|Death|3|||
162788781|NCT02559310|587936352|FG000|Overall Study|Lost to Follow-up|5|||
162788782|NCT02559310|587936353|FG001|Overall Study|Lost to Follow-up|3|||
162788783|NCT02559310|587936352|FG000|Overall Study|Physician Decision|2|||
162788784|NCT02559310|587936353|FG001|Overall Study|Physician Decision|1|||
162788785|NCT02559310|587936352|FG000|Overall Study|Withdrawal by Subject|13|||
162788786|NCT02559310|587936353|FG001|Overall Study|Withdrawal by Subject|9|||
162788787|NCT02559310|587936352|FG000|Overall Study|Sponsor Decision|0|||
162788788|NCT02559310|587936353|FG001|Overall Study|Sponsor Decision|1|||
162788789|NCT02559310|587936352|FG000|Overall Study|Randomized but not treated|3|||
162788790|NCT02559310|587936353|FG001|Overall Study|Randomized but not treated|2|||
162788791|NCT04596540|587936354|FG000|Overall Study|Withdrawal by Subject|9|||
162788792|NCT04596540|587936355|FG001|Overall Study|Withdrawal by Subject|8|||
162788793|NCT04596540|587936356|FG002|Overall Study|Withdrawal by Subject|5|||
162788794|NCT04596540|587936354|FG000|Overall Study|Lost to Follow-up|1|||
162788795|NCT04596540|587936355|FG001|Overall Study|Lost to Follow-up|2|||
162788796|NCT04596540|587936356|FG002|Overall Study|Lost to Follow-up|1|||
162788797|NCT04596540|587936354|FG000|Overall Study|Sponsor Decision|2|||
162788798|NCT04596540|587936355|FG001|Overall Study|Sponsor Decision|0|||
162788799|NCT04596540|587936356|FG002|Overall Study|Sponsor Decision|0|||
162788800|NCT04596540|587936354|FG000|Overall Study|Physician Decision|0|||
162788801|NCT04596540|587936355|FG001|Overall Study|Physician Decision|1|||
162788802|NCT04596540|587936356|FG002|Overall Study|Physician Decision|1|||
162788803|NCT04596540|587936354|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
162788804|NCT04596540|587936355|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
162788805|NCT04596540|587936356|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
162788806|NCT04596540|587936354|FG000|Overall Study|Other Than Specified|5|||
162788807|NCT04596540|587936355|FG001|Overall Study|Other Than Specified|5|||
162788808|NCT04596540|587936356|FG002|Overall Study|Other Than Specified|2|||
162788809|NCT04949802|587937704|FG000|Overall Study|Lost to Follow-up|3|||
162788810|NCT03778294|587937705|FG000|Overall Study|Death|1|||
162788811|NCT03778294|587937705|FG000|Overall Study|Issues with insurance|1|||
162788812|NCT03778294|587937705|FG000|Overall Study|disease progression before treatment|2|||
162788813|NCT01845805|587937706|FG000|Overall Study|Withdrawal by Subject|1|||
162788814|NCT01845805|587937707|FG001|Overall Study|Withdrawal by Subject|2|||
162788815|NCT01845805|587937706|FG000|Overall Study|Disease Progression|13|||
162788816|NCT01845805|587937707|FG001|Overall Study|Disease Progression|14|||
162788817|NCT01845805|587937706|FG000|Overall Study|Drug-related Toxicity|4|||
162788818|NCT01845805|587937707|FG001|Overall Study|Drug-related Toxicity|0|||
162788819|NCT00127842|587937708|FG000|Overall Study|Adverse Event|15|||
162788820|NCT00127842|587937708|FG000|Overall Study|Withdrawal by Subject|3|||
162788821|NCT00127842|587937708|FG000|Overall Study|Lost to Follow-up|1|||
162788822|NCT00127842|587937708|FG000|Overall Study|Lack of Efficacy|12|||
162788823|NCT00127842|587937708|FG000|Overall Study|Noncompliance|2|||
162788824|NCT00127842|587937708|FG000|Overall Study|Protocol Violation|1|||
162788825|NCT00127842|587937708|FG000|Overall Study|Other|5|||
162788826|NCT03595124|587937712|FG000|Overall Study|Physician Decision|1|||
162788827|NCT03595124|587937713|FG001|Overall Study|Physician Decision|1|||
162788828|NCT03595124|587937714|FG002|Overall Study|Physician Decision|1|||
162788829|NCT03595124|587937712|FG000|Overall Study|Ineligible|1|||
162788830|NCT03595124|587937713|FG001|Overall Study|Ineligible|1|||
162788831|NCT03595124|587937714|FG002|Overall Study|Ineligible|0|||
162788832|NCT03595124|587937712|FG000|Overall Study|Disease Progression|4|||
162788833|NCT03595124|587937713|FG001|Overall Study|Disease Progression|1|||
162788834|NCT03595124|587937714|FG002|Overall Study|Disease Progression|4|||
162788835|NCT00433511|587937715|FG000|Step 1|Adverse Event|50|||
162788836|NCT00433511|587937716|FG001|Step 1|Adverse Event|157|||
162788837|NCT00433511|587937717|FG002|Step 1|Adverse Event|153|||
162788838|NCT00433511|587937715|FG000|Step 1|Withdrawal by Subject|45|||
162788839|NCT00433511|587937716|FG001|Step 1|Withdrawal by Subject|143|||
162788840|NCT00433511|587937717|FG002|Step 1|Withdrawal by Subject|154|||
162788841|NCT00433511|587937715|FG000|Step 1|Death|3|||
162788842|NCT00433511|587937716|FG001|Step 1|Death|1|||
162788843|NCT00433511|587937717|FG002|Step 1|Death|1|||
162788844|NCT00433511|587937715|FG000|Step 1|Physician Decision|1|||
162788845|NCT00433511|587937716|FG001|Step 1|Physician Decision|4|||
162788846|NCT00433511|587937717|FG002|Step 1|Physician Decision|3|||
162788847|NCT00433511|587937715|FG000|Step 1|Never started protocol therapy|28|||
162788848|NCT00433511|587937716|FG001|Step 1|Never started protocol therapy|64|||
162788849|NCT00433511|587937717|FG002|Step 1|Never started protocol therapy|66|||
162788850|NCT00433511|587937715|FG000|Step 1|Alternative therapy|2|||
162788851|NCT00433511|587937716|FG001|Step 1|Alternative therapy|1|||
162788852|NCT00433511|587937717|FG002|Step 1|Alternative therapy|3|||
162788853|NCT00433511|587937715|FG000|Step 1|Disease progression, relapse|5|||
162788854|NCT00433511|587937716|FG001|Step 1|Disease progression, relapse|3|||
162788855|NCT00433511|587937717|FG002|Step 1|Disease progression, relapse|3|||
162788856|NCT00433511|587937715|FG000|Step 1|Other complicating disease|2|||
162788857|NCT00433511|587937716|FG001|Step 1|Other complicating disease|6|||
162788858|NCT00433511|587937717|FG002|Step 1|Other complicating disease|3|||
162788859|NCT00433511|587937715|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
162788860|NCT00433511|587937716|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
162788861|NCT00433511|587937717|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
162788862|NCT00433511|587937715|FG000|Step 1|Suspected recurrence|0|||
162788863|NCT00433511|587937716|FG001|Step 1|Suspected recurrence|1|||
162788864|NCT00433511|587937717|FG002|Step 1|Suspected recurrence|0|||
162788865|NCT00433511|587937715|FG000|Step 1|Insurance/drug distribution issues|0|||
162788866|NCT00433511|587937716|FG001|Step 1|Insurance/drug distribution issues|1|||
162788867|NCT00433511|587937717|FG002|Step 1|Insurance/drug distribution issues|2|||
162788868|NCT00433511|587937715|FG000|Step 1|Patient moved|0|||
162788869|NCT00433511|587937716|FG001|Step 1|Patient moved|0|||
162788870|NCT00433511|587937717|FG002|Step 1|Patient moved|1|||
162788871|NCT00433511|587937715|FG000|Step 2 (Arm D)|Adverse Event|0|||
162788872|NCT00433511|587937716|FG001|Step 2 (Arm D)|Adverse Event|0|||
162788873|NCT00433511|587937717|FG002|Step 2 (Arm D)|Adverse Event|135|||
162788874|NCT00433511|587937715|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
162788875|NCT00433511|587937716|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
162788876|NCT00433511|587937717|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
162788877|NCT00433511|587937715|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
162788878|NCT00433511|587937716|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
162788879|NCT00433511|587937717|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
162788880|NCT00433511|587937715|FG000|Step 2 (Arm D)|Physician Decision|0|||
162788881|NCT00433511|587937716|FG001|Step 2 (Arm D)|Physician Decision|0|||
162788882|NCT00433511|587937717|FG002|Step 2 (Arm D)|Physician Decision|9|||
162788883|NCT00433511|587937715|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
162788884|NCT00433511|587937716|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
162788885|NCT00433511|587937717|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
162788886|NCT00433511|587937715|FG000|Step 2 (Arm D)|Other complicating disease|0|||
162788887|NCT00433511|587937716|FG001|Step 2 (Arm D)|Other complicating disease|0|||
162788888|NCT00433511|587937717|FG002|Step 2 (Arm D)|Other complicating disease|3|||
162788889|NCT00433511|587937715|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
162788890|NCT00433511|587937716|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
162788891|NCT00433511|587937717|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
162788892|NCT00433511|587937715|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
162788893|NCT00433511|587937716|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
162788894|NCT00433511|587937717|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
162788895|NCT00433511|587937715|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
162788896|NCT00433511|587937716|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
162788897|NCT00433511|587937717|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
162788898|NCT00433511|587937715|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
162788899|NCT00433511|587937716|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
162788900|NCT00433511|587937717|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
162788901|NCT00979953|587937722|FG000|Overall Study|Adverse Event|5|||
162788902|NCT00979953|587937723|FG001|Overall Study|Adverse Event|2|||
162788903|NCT00979953|587937724|FG002|Overall Study|Adverse Event|17|||
162788904|NCT00979953|587937725|FG003|Overall Study|Adverse Event|4|||
162788905|NCT00979953|587937722|FG000|Overall Study|Lack of Efficacy|1|||
162788906|NCT00979953|587937723|FG001|Overall Study|Lack of Efficacy|2|||
162788907|NCT00979953|587937724|FG002|Overall Study|Lack of Efficacy|0|||
162788908|NCT00979953|587937725|FG003|Overall Study|Lack of Efficacy|0|||
162788909|NCT00979953|587937722|FG000|Overall Study|Lost to Follow-up|1|||
162788910|NCT00979953|587937723|FG001|Overall Study|Lost to Follow-up|1|||
162788911|NCT00979953|587937724|FG002|Overall Study|Lost to Follow-up|1|||
162788912|NCT00979953|587937725|FG003|Overall Study|Lost to Follow-up|0|||
162788913|NCT00979953|587937722|FG000|Overall Study|Withdrawal by Subject|0|||
162788914|NCT00979953|587937723|FG001|Overall Study|Withdrawal by Subject|0|||
162788915|NCT00979953|587937724|FG002|Overall Study|Withdrawal by Subject|2|||
162788916|NCT00979953|587937725|FG003|Overall Study|Withdrawal by Subject|1|||
162788917|NCT00979953|587937722|FG000|Overall Study|Protocol Violation|1|||
162788918|NCT00979953|587937723|FG001|Overall Study|Protocol Violation|0|||
162788919|NCT00979953|587937724|FG002|Overall Study|Protocol Violation|2|||
162788920|NCT00979953|587937725|FG003|Overall Study|Protocol Violation|2|||
162788921|NCT01732549|587937730|FG000|Overall Study|Adverse Event|13|||
162788922|NCT01732549|587937731|FG001|Overall Study|Adverse Event|3|||
162788923|NCT01732549|587937730|FG000|Overall Study|Consent withdrawn|13|||
162788924|NCT01732549|587937731|FG001|Overall Study|Consent withdrawn|6|||
162788925|NCT01732549|587937730|FG000|Overall Study|Disease progression|37|||
162788926|NCT01732549|587937731|FG001|Overall Study|Disease progression|50|||
162788927|NCT01732549|587937730|FG000|Overall Study|Other|8|||
162788928|NCT01732549|587937731|FG001|Overall Study|Other|14|||
162788929|NCT03994731|587937732|FG000|Pegloticase + IMM Period|Death|2|||
162788930|NCT03994731|587937733|FG001|Pegloticase + IMM Period|Death|0|||
162788931|NCT03994731|587937732|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
162788932|NCT03994731|587937733|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
162788933|NCT03994731|587937732|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
162788934|NCT03994731|587937733|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
162788935|NCT03377361|587937736|FG000|Pre-Treatment|Subject withdrew consent|0|||
162788936|NCT03377361|587937737|FG001|Pre-Treatment|Subject withdrew consent|0|||
162788937|NCT03377361|587937738|FG002|Pre-Treatment|Subject withdrew consent|0|||
162788938|NCT03377361|587937739|FG003|Pre-Treatment|Subject withdrew consent|0|||
162788939|NCT03377361|587937740|FG004|Pre-Treatment|Subject withdrew consent|0|||
162788940|NCT03377361|587937741|FG005|Pre-Treatment|Subject withdrew consent|0|||
162788941|NCT03377361|587937742|FG006|Pre-Treatment|Subject withdrew consent|0|||
162788942|NCT03377361|587937743|FG007|Pre-Treatment|Subject withdrew consent|3|||
162788943|NCT03377361|587937744|FG008|Pre-Treatment|Subject withdrew consent|1|||
162788944|NCT03377361|587937745|FG009|Pre-Treatment|Subject withdrew consent|0|||
162788945|NCT03377361|587937736|FG000|Pre-Treatment|Not Reported|0|||
162788946|NCT03377361|587937737|FG001|Pre-Treatment|Not Reported|0|||
162788947|NCT03377361|587937738|FG002|Pre-Treatment|Not Reported|0|||
162788948|NCT03377361|587937739|FG003|Pre-Treatment|Not Reported|0|||
162788949|NCT03377361|587937740|FG004|Pre-Treatment|Not Reported|0|||
162788950|NCT03377361|587937741|FG005|Pre-Treatment|Not Reported|0|||
162788951|NCT03377361|587937742|FG006|Pre-Treatment|Not Reported|0|||
162788952|NCT03377361|587937743|FG007|Pre-Treatment|Not Reported|0|||
162788953|NCT03377361|587937744|FG008|Pre-Treatment|Not Reported|3|||
162788954|NCT03377361|587937745|FG009|Pre-Treatment|Not Reported|0|||
162788955|NCT03377361|587937736|FG000|Treatment Period|Disease Progression|3|||
162788956|NCT03377361|587937737|FG001|Treatment Period|Disease Progression|2|||
162788957|NCT03377361|587937738|FG002|Treatment Period|Disease Progression|5|||
162788958|NCT03377361|587937739|FG003|Treatment Period|Disease Progression|3|||
162788959|NCT03377361|587937740|FG004|Treatment Period|Disease Progression|3|||
162788960|NCT03377361|587937741|FG005|Treatment Period|Disease Progression|3|||
162788961|NCT03377361|587937742|FG006|Treatment Period|Disease Progression|6|||
162788962|NCT03377361|587937743|FG007|Treatment Period|Disease Progression|106|||
162788963|NCT03377361|587937744|FG008|Treatment Period|Disease Progression|48|||
162788964|NCT03377361|587937745|FG009|Treatment Period|Disease Progression|59|||
162788965|NCT03377361|587937736|FG000|Treatment Period|Study Drug Toxicity|0|||
162788966|NCT03377361|587937737|FG001|Treatment Period|Study Drug Toxicity|0|||
162788967|NCT03377361|587937738|FG002|Treatment Period|Study Drug Toxicity|0|||
162788968|NCT03377361|587937739|FG003|Treatment Period|Study Drug Toxicity|1|||
162788969|NCT03377361|587937740|FG004|Treatment Period|Study Drug Toxicity|0|||
162788970|NCT03377361|587937741|FG005|Treatment Period|Study Drug Toxicity|0|||
162788971|NCT03377361|587937742|FG006|Treatment Period|Study Drug Toxicity|0|||
162788972|NCT03377361|587937743|FG007|Treatment Period|Study Drug Toxicity|7|||
162788973|NCT03377361|587937744|FG008|Treatment Period|Study Drug Toxicity|2|||
162788974|NCT03377361|587937745|FG009|Treatment Period|Study Drug Toxicity|16|||
162788975|NCT03377361|587937736|FG000|Treatment Period|Death|0|||
162788976|NCT03377361|587937737|FG001|Treatment Period|Death|0|||
162788977|NCT03377361|587937738|FG002|Treatment Period|Death|1|||
162788978|NCT03377361|587937739|FG003|Treatment Period|Death|0|||
162788979|NCT03377361|587937740|FG004|Treatment Period|Death|0|||
162788980|NCT03377361|587937741|FG005|Treatment Period|Death|0|||
162788981|NCT03377361|587937742|FG006|Treatment Period|Death|0|||
162788982|NCT03377361|587937743|FG007|Treatment Period|Death|2|||
162788983|NCT03377361|587937744|FG008|Treatment Period|Death|1|||
162788984|NCT03377361|587937745|FG009|Treatment Period|Death|3|||
162788985|NCT03377361|587937736|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788986|NCT03377361|587937737|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788987|NCT03377361|587937738|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788988|NCT03377361|587937739|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788989|NCT03377361|587937740|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788990|NCT03377361|587937741|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788991|NCT03377361|587937742|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
162788992|NCT03377361|587937743|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
162788993|NCT03377361|587937744|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
162788994|NCT03377361|587937745|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162788995|NCT03377361|587937736|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
162788996|NCT03377361|587937737|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
162788997|NCT03377361|587937738|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
162788998|NCT03377361|587937739|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
162788999|NCT03377361|587937740|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
162789000|NCT03377361|587937741|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
162789001|NCT03377361|587937742|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
162789002|NCT03377361|587937743|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
162789003|NCT03377361|587937744|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
162789004|NCT03377361|587937745|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
162789005|NCT03377361|587937736|FG000|Treatment Period|Subject Withdrew Consent|0|||
162789006|NCT03377361|587937737|FG001|Treatment Period|Subject Withdrew Consent|0|||
162789007|NCT03377361|587937738|FG002|Treatment Period|Subject Withdrew Consent|0|||
162789008|NCT03377361|587937739|FG003|Treatment Period|Subject Withdrew Consent|0|||
162789009|NCT03377361|587937740|FG004|Treatment Period|Subject Withdrew Consent|0|||
162789010|NCT03377361|587937741|FG005|Treatment Period|Subject Withdrew Consent|0|||
162789011|NCT03377361|587937742|FG006|Treatment Period|Subject Withdrew Consent|0|||
162789012|NCT03377361|587937743|FG007|Treatment Period|Subject Withdrew Consent|0|||
162789013|NCT03377361|587937744|FG008|Treatment Period|Subject Withdrew Consent|2|||
162789014|NCT03377361|587937745|FG009|Treatment Period|Subject Withdrew Consent|1|||
162789015|NCT03377361|587937736|FG000|Treatment Period|No longer meets study criteria|0|||
162789016|NCT03377361|587937737|FG001|Treatment Period|No longer meets study criteria|1|||
162789017|NCT03377361|587937738|FG002|Treatment Period|No longer meets study criteria|0|||
162789018|NCT03377361|587937739|FG003|Treatment Period|No longer meets study criteria|0|||
162789019|NCT03377361|587937740|FG004|Treatment Period|No longer meets study criteria|0|||
162789020|NCT03377361|587937741|FG005|Treatment Period|No longer meets study criteria|0|||
162789021|NCT03377361|587937742|FG006|Treatment Period|No longer meets study criteria|0|||
162789022|NCT03377361|587937743|FG007|Treatment Period|No longer meets study criteria|1|||
162789023|NCT03377361|587937744|FG008|Treatment Period|No longer meets study criteria|0|||
162789024|NCT03377361|587937745|FG009|Treatment Period|No longer meets study criteria|0|||
162789025|NCT03377361|587937736|FG000|Treatment Period|Other Reasons|0|||
162789026|NCT03377361|587937737|FG001|Treatment Period|Other Reasons|0|||
162789027|NCT03377361|587937738|FG002|Treatment Period|Other Reasons|0|||
162789028|NCT03377361|587937739|FG003|Treatment Period|Other Reasons|3|||
162789029|NCT03377361|587937740|FG004|Treatment Period|Other Reasons|0|||
162789030|NCT03377361|587937741|FG005|Treatment Period|Other Reasons|0|||
162789031|NCT03377361|587937742|FG006|Treatment Period|Other Reasons|0|||
162789032|NCT03377361|587937743|FG007|Treatment Period|Other Reasons|2|||
162789033|NCT03377361|587937744|FG008|Treatment Period|Other Reasons|0|||
162789034|NCT03377361|587937745|FG009|Treatment Period|Other Reasons|1|||
162789035|NCT00742326|587937746|FG000|Overall Study|Physician Decision|0|||
162789036|NCT00742326|587937747|FG001|Overall Study|Physician Decision|1|||
162789037|NCT03698994|587937751|FG000|Overall Study|Adverse Event|2|||
162789038|NCT03698994|587937751|FG000|Overall Study|Death|1|||
162789039|NCT03698994|587937751|FG000|Overall Study|Physician Decision|1|||
162789040|NCT03698994|587937751|FG000|Overall Study|Withdrawal by Subject|3|||
162789041|NCT03698994|587937751|FG000|Overall Study|Progressive Disease|12|||
162789042|NCT03635086|587937754|FG000|Overall Study|Withdrawal of consent|0|||
162789043|NCT03635086|587937755|FG001|Overall Study|Withdrawal of consent|0|||
162789044|NCT03635086|587937756|FG002|Overall Study|Withdrawal of consent|1|||
162789045|NCT03635086|587937757|FG003|Overall Study|Withdrawal of consent|0|||
162789046|NCT03635086|587937758|FG004|Overall Study|Withdrawal of consent|0|||
162789047|NCT03635086|587937754|FG000|Overall Study|Adverse Event|0|||
162789048|NCT03635086|587937755|FG001|Overall Study|Adverse Event|1|||
162789049|NCT03635086|587937756|FG002|Overall Study|Adverse Event|0|||
162789050|NCT03635086|587937757|FG003|Overall Study|Adverse Event|0|||
162789051|NCT03635086|587937758|FG004|Overall Study|Adverse Event|0|||
162789052|NCT03635086|587937754|FG000|Overall Study|Lost to Follow-up|1|||
162789053|NCT03635086|587937755|FG001|Overall Study|Lost to Follow-up|0|||
162789054|NCT03635086|587937756|FG002|Overall Study|Lost to Follow-up|0|||
162789055|NCT03635086|587937757|FG003|Overall Study|Lost to Follow-up|0|||
162789056|NCT03635086|587937758|FG004|Overall Study|Lost to Follow-up|0|||
162789057|NCT02196077|587937759|FG000|Overall Study|Adverse Event|4|||
162789058|NCT02196077|587937759|FG000|Overall Study|Lack of Efficacy|1|||
162789059|NCT02196077|587937759|FG000|Overall Study|Withdrawal by Subject|14|||
162789060|NCT02196077|587937759|FG000|Overall Study|Physician Decision|1|||
162789061|NCT02196077|587937759|FG000|Overall Study|Lost to Follow-up|3|||
162789062|NCT02196077|587937759|FG000|Overall Study|Protocol Violation|24|||
162789063|NCT00732992|587937760|FG000|Overall Study|Adverse Event|1|||
162789064|NCT00732992|587937761|FG001|Overall Study|Adverse Event|1|||
162789065|NCT00732992|587937760|FG000|Overall Study|Objective Progression or Relapse|3|||
162789066|NCT00732992|587937761|FG001|Overall Study|Objective Progression or Relapse|5|||
162789067|NCT00732992|587937760|FG000|Overall Study|Global Deterioration of Health Status|1|||
162789068|NCT00732992|587937761|FG001|Overall Study|Global Deterioration of Health Status|0|||
162789069|NCT00732992|587937760|FG000|Overall Study|Withdrawal by Subject|1|||
162789070|NCT00732992|587937761|FG001|Overall Study|Withdrawal by Subject|0|||
162789071|NCT03482752|587937768|FG000|Overall Study|Withdrawal by Subject|2|||
162789072|NCT03482752|587937768|FG000|Overall Study|Lost to Follow-up|1|||
162789073|NCT03482752|587937768|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
162789074|NCT02844777|587937769|FG000|Overall Study|Withdrawal by Subject|2|||
162789075|NCT02844777|587937770|FG001|Overall Study|Withdrawal by Subject|0|||
162789076|NCT02844777|587937771|FG002|Overall Study|Withdrawal by Subject|0|||
162789077|NCT01776008|587937772|FG000|Overall Study|ineligible|2|||
162789078|NCT00150618|587937773|FG000|Overall Study|Adverse Event|2|||
162789079|NCT00150618|587937774|FG001|Overall Study|Adverse Event|2|||
162789080|NCT00150618|587937775|FG002|Overall Study|Adverse Event|6|||
162789081|NCT00150618|587937776|FG003|Overall Study|Adverse Event|9|||
162789082|NCT00150618|587937777|FG004|Overall Study|Adverse Event|5|||
162789083|NCT00150618|587937773|FG000|Overall Study|Withdrawal by Subject|6|||
162789084|NCT00150618|587937774|FG001|Overall Study|Withdrawal by Subject|8|||
162789085|NCT00150618|587937775|FG002|Overall Study|Withdrawal by Subject|8|||
162789086|NCT00150618|587937776|FG003|Overall Study|Withdrawal by Subject|4|||
162789087|NCT00150618|587937777|FG004|Overall Study|Withdrawal by Subject|5|||
162789088|NCT00150618|587937773|FG000|Overall Study|Lost to Follow-up|4|||
162789089|NCT00150618|587937774|FG001|Overall Study|Lost to Follow-up|1|||
162789090|NCT00150618|587937775|FG002|Overall Study|Lost to Follow-up|5|||
162789091|NCT00150618|587937776|FG003|Overall Study|Lost to Follow-up|8|||
162789092|NCT00150618|587937777|FG004|Overall Study|Lost to Follow-up|4|||
162789093|NCT00150618|587937773|FG000|Overall Study|Protocol Violation|1|||
162789094|NCT00150618|587937774|FG001|Overall Study|Protocol Violation|0|||
162789095|NCT00150618|587937775|FG002|Overall Study|Protocol Violation|0|||
162789096|NCT00150618|587937776|FG003|Overall Study|Protocol Violation|0|||
162789097|NCT00150618|587937777|FG004|Overall Study|Protocol Violation|1|||
162789098|NCT00150618|587937773|FG000|Overall Study|Lack of Efficacy|1|||
162789099|NCT00150618|587937774|FG001|Overall Study|Lack of Efficacy|4|||
162789100|NCT00150618|587937775|FG002|Overall Study|Lack of Efficacy|7|||
162789101|NCT00150618|587937776|FG003|Overall Study|Lack of Efficacy|4|||
162789102|NCT00150618|587937777|FG004|Overall Study|Lack of Efficacy|6|||
162789103|NCT00150618|587937773|FG000|Overall Study|No study meds|0|||
162789104|NCT00150618|587937774|FG001|Overall Study|No study meds|0|||
162789105|NCT00150618|587937775|FG002|Overall Study|No study meds|0|||
162789106|NCT00150618|587937776|FG003|Overall Study|No study meds|0|||
162789107|NCT00150618|587937777|FG004|Overall Study|No study meds|2|||
162789108|NCT00150618|587937773|FG000|Overall Study|Physician Decision|0|||
162789109|NCT00150618|587937774|FG001|Overall Study|Physician Decision|2|||
162789110|NCT00150618|587937775|FG002|Overall Study|Physician Decision|0|||
162789111|NCT00150618|587937776|FG003|Overall Study|Physician Decision|0|||
162789112|NCT00150618|587937777|FG004|Overall Study|Physician Decision|1|||
162789113|NCT00150618|587937773|FG000|Overall Study|Lack of compliance|2|||
162789114|NCT00150618|587937774|FG001|Overall Study|Lack of compliance|1|||
162789115|NCT00150618|587937775|FG002|Overall Study|Lack of compliance|1|||
162789116|NCT00150618|587937776|FG003|Overall Study|Lack of compliance|0|||
162789117|NCT00150618|587937777|FG004|Overall Study|Lack of compliance|1|||
162789118|NCT00150618|587937773|FG000|Overall Study|Abnormal ECG|1|||
162789119|NCT00150618|587937774|FG001|Overall Study|Abnormal ECG|0|||
162789120|NCT00150618|587937775|FG002|Overall Study|Abnormal ECG|0|||
162789121|NCT00150618|587937776|FG003|Overall Study|Abnormal ECG|0|||
162789122|NCT00150618|587937777|FG004|Overall Study|Abnormal ECG|0|||
162789123|NCT00150618|587937773|FG000|Overall Study|Sponsor's decision|0|||
162789124|NCT00150618|587937774|FG001|Overall Study|Sponsor's decision|0|||
162789125|NCT00150618|587937775|FG002|Overall Study|Sponsor's decision|0|||
162789126|NCT00150618|587937776|FG003|Overall Study|Sponsor's decision|1|||
162789127|NCT00150618|587937777|FG004|Overall Study|Sponsor's decision|0|||
162789128|NCT01162486|587937778|FG000|Overall Study|low ANC|1|||
162789129|NCT01162486|587937779|FG001|Overall Study|low ANC|0|||
162789130|NCT01162486|587937780|FG002|Overall Study|low ANC|0|||
162789131|NCT01162486|587937781|FG003|Overall Study|low ANC|0|||
162789132|NCT01162486|587937782|FG004|Overall Study|low ANC|0|||
162789133|NCT01162486|587937778|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
162789134|NCT01162486|587937779|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162789135|NCT01162486|587937780|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162789136|NCT01162486|587937781|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162789137|NCT01162486|587937782|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162789138|NCT01162486|587937778|FG000|Overall Study|elevated LFTs|0|||
162789139|NCT01162486|587937779|FG001|Overall Study|elevated LFTs|0|||
162789140|NCT01162486|587937780|FG002|Overall Study|elevated LFTs|1|||
162789141|NCT01162486|587937781|FG003|Overall Study|elevated LFTs|0|||
162789142|NCT01162486|587937782|FG004|Overall Study|elevated LFTs|0|||
162789143|NCT01162486|587937778|FG000|Overall Study|Pregnancy|0|||
162789144|NCT01162486|587937779|FG001|Overall Study|Pregnancy|0|||
162789145|NCT01162486|587937780|FG002|Overall Study|Pregnancy|0|||
162789146|NCT01162486|587937781|FG003|Overall Study|Pregnancy|1|||
162789147|NCT01162486|587937782|FG004|Overall Study|Pregnancy|0|||
162789148|NCT02296892|587937787|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
162789149|NCT02296892|587937788|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
162789150|NCT02296892|587937789|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
162789151|NCT02296892|587937787|FG000|Overall Study|Lost to Follow-up|5|||
162789152|NCT02296892|587937788|FG001|Overall Study|Lost to Follow-up|0|||
162789153|NCT02296892|587937789|FG002|Overall Study|Lost to Follow-up|1|||
162789154|NCT00383123|587937792|FG000|Overall Study|Adverse Event|1|||
162789155|NCT00383123|587937793|FG001|Overall Study|Adverse Event|0|||
162789156|NCT00383123|587937792|FG000|Overall Study|Lost to Follow-up|68|||
162789157|NCT00383123|587937793|FG001|Overall Study|Lost to Follow-up|61|||
162789158|NCT00383123|587937792|FG000|Overall Study|Protocol Violation|5|||
162789159|NCT00383123|587937793|FG001|Overall Study|Protocol Violation|1|||
162789160|NCT00383123|587937792|FG000|Overall Study|Withdrawal by Subject|27|||
162789161|NCT00383123|587937793|FG001|Overall Study|Withdrawal by Subject|18|||
162789162|NCT00383123|587937792|FG000|Overall Study|Other reason|10|||
162789163|NCT00383123|587937793|FG001|Overall Study|Other reason|6|||
162789164|NCT04147858|587937796|FG000|Overall Study|Adverse Event|6|||
162789165|NCT04147858|587937797|FG001|Overall Study|Adverse Event|6|||
162789166|NCT04147858|587937798|FG002|Overall Study|Adverse Event|6|||
162789167|NCT04147858|587937796|FG000|Overall Study|Lack of Efficacy|3|||
162789168|NCT04147858|587937797|FG001|Overall Study|Lack of Efficacy|3|||
162789169|NCT04147858|587937798|FG002|Overall Study|Lack of Efficacy|1|||
162789170|NCT04147858|587937796|FG000|Overall Study|Lost to Follow-up|1|||
162789171|NCT04147858|587937797|FG001|Overall Study|Lost to Follow-up|6|||
162789172|NCT04147858|587937798|FG002|Overall Study|Lost to Follow-up|2|||
162789173|NCT04147858|587937796|FG000|Overall Study|Withdrawal by Subject|3|||
162789174|NCT04147858|587937797|FG001|Overall Study|Withdrawal by Subject|4|||
162789175|NCT04147858|587937798|FG002|Overall Study|Withdrawal by Subject|10|||
162789176|NCT04147858|587937796|FG000|Overall Study|Subject Noncompliance, Other|4|||
162789177|NCT04147858|587937797|FG001|Overall Study|Subject Noncompliance, Other|3|||
162789178|NCT04147858|587937798|FG002|Overall Study|Subject Noncompliance, Other|1|||
162789179|NCT03375320|587937804|FG000|Overall Study|Adverse Event|34|||
162789180|NCT03375320|587937805|FG001|Overall Study|Adverse Event|9|||
162789181|NCT03375320|587937806|FG002|Overall Study|Adverse Event|10|||
162789182|NCT03375320|587937807|FG003|Overall Study|Adverse Event|0|||
162789183|NCT03375320|587937804|FG000|Overall Study|Death|6|||
162789184|NCT03375320|587937805|FG001|Overall Study|Death|3|||
162789185|NCT03375320|587937806|FG002|Overall Study|Death|0|||
162789186|NCT03375320|587937807|FG003|Overall Study|Death|0|||
162789187|NCT03375320|587937804|FG000|Overall Study|Withdrawal by Subject|7|||
162789188|NCT03375320|587937805|FG001|Overall Study|Withdrawal by Subject|4|||
162789189|NCT03375320|587937806|FG002|Overall Study|Withdrawal by Subject|5|||
162789190|NCT03375320|587937807|FG003|Overall Study|Withdrawal by Subject|4|||
162789191|NCT03375320|587937804|FG000|Overall Study|Progressive disease|55|||
162789192|NCT03375320|587937805|FG001|Overall Study|Progressive disease|41|||
162789193|NCT03375320|587937806|FG002|Overall Study|Progressive disease|29|||
162789194|NCT03375320|587937807|FG003|Overall Study|Progressive disease|24|||
162789195|NCT03375320|587937804|FG000|Overall Study|Alternative treatment|6|||
162789196|NCT03375320|587937805|FG001|Overall Study|Alternative treatment|1|||
162789197|NCT03375320|587937806|FG002|Overall Study|Alternative treatment|1|||
162789198|NCT03375320|587937807|FG003|Overall Study|Alternative treatment|0|||
162789199|NCT03375320|587937804|FG000|Overall Study|Other disease|1|||
162789200|NCT03375320|587937805|FG001|Overall Study|Other disease|1|||
162789201|NCT03375320|587937806|FG002|Overall Study|Other disease|3|||
162789202|NCT03375320|587937807|FG003|Overall Study|Other disease|0|||
162789203|NCT03375320|587937804|FG000|Overall Study|Withdrawal prior to initiation|2|||
162789204|NCT03375320|587937805|FG001|Overall Study|Withdrawal prior to initiation|2|||
162789205|NCT03375320|587937806|FG002|Overall Study|Withdrawal prior to initiation|1|||
162789206|NCT03375320|587937807|FG003|Overall Study|Withdrawal prior to initiation|0|||
162789207|NCT03375320|587937804|FG000|Overall Study|Physician Decision|1|||
162789208|NCT03375320|587937805|FG001|Overall Study|Physician Decision|1|||
162789209|NCT03375320|587937806|FG002|Overall Study|Physician Decision|1|||
162789210|NCT03375320|587937807|FG003|Overall Study|Physician Decision|1|||
162789211|NCT03375320|587937804|FG000|Overall Study|Non-compliance|1|||
162789212|NCT03375320|587937805|FG001|Overall Study|Non-compliance|0|||
162789213|NCT03375320|587937806|FG002|Overall Study|Non-compliance|0|||
162789214|NCT03375320|587937807|FG003|Overall Study|Non-compliance|0|||
162789215|NCT04907357|587937810|FG000|Overall Study|Death|0|||
162789216|NCT04907357|587937811|FG001|Overall Study|Death|1|||
162789217|NCT04907357|587937810|FG000|Overall Study|Lost to Follow-up|9|||
162789218|NCT04907357|587937811|FG001|Overall Study|Lost to Follow-up|18|||
162789219|NCT04907357|587937810|FG000|Overall Study|Physician Decision|1|||
162789220|NCT04907357|587937811|FG001|Overall Study|Physician Decision|0|||
162789221|NCT04907357|587937810|FG000|Overall Study|Withdrawal by Subject|0|||
162789222|NCT04907357|587937811|FG001|Overall Study|Withdrawal by Subject|1|||
162789223|NCT04907357|587937810|FG000|Overall Study|Unable to attend visits|1|||
162789224|NCT04907357|587937811|FG001|Overall Study|Unable to attend visits|0|||
162789225|NCT04907357|587937810|FG000|Overall Study|Incarcerated|1|||
162789226|NCT04907357|587937811|FG001|Overall Study|Incarcerated|1|||
162789227|NCT03358238|587937812|FG000|Overall Study|Withdrawal by Subject|0|||
162789228|NCT03358238|587937813|FG001|Overall Study|Withdrawal by Subject|1|||
162789229|NCT02633397|587937814|FG000|Overall Study|Adverse Event|8|||
162789230|NCT02633397|587937815|FG001|Overall Study|Adverse Event|8|||
162789231|NCT02633397|587937814|FG000|Overall Study|Study Burden|4|||
162789232|NCT02633397|587937815|FG001|Overall Study|Study Burden|1|||
162789233|NCT02633397|587937814|FG000|Overall Study|Treatment interruption|2|||
162789234|NCT02633397|587937815|FG001|Overall Study|Treatment interruption|5|||
162789235|NCT02633397|587937814|FG000|Overall Study|Death|2|||
162789236|NCT02633397|587937815|FG001|Overall Study|Death|2|||
162789237|NCT02633397|587937814|FG000|Overall Study|Physician Decision|0|||
162789238|NCT02633397|587937815|FG001|Overall Study|Physician Decision|1|||
162789239|NCT03595878|587937816|FG000|Overall Study|Death|2|||
162789240|NCT03595878|587937817|FG001|Overall Study|Death|1|||
162789241|NCT03595878|587937818|FG002|Overall Study|Death|0|||
162789242|NCT03595878|587937816|FG000|Overall Study|Disease progression|2|||
162789243|NCT03595878|587937817|FG001|Overall Study|Disease progression|1|||
162789244|NCT03595878|587937818|FG002|Overall Study|Disease progression|2|||
162789245|NCT03036124|587937819|FG000|Overall Study|Lost to Follow-up|0|||
162789246|NCT03036124|587937820|FG001|Overall Study|Lost to Follow-up|2|||
162789247|NCT03036124|587937819|FG000|Overall Study|Withdrawal by Subject|5|||
162789248|NCT03036124|587937820|FG001|Overall Study|Withdrawal by Subject|4|||
162789249|NCT01340014|587937821|FG000|Period 1, First 7 Days|Adverse Event|1|||
162789250|NCT01340014|587937822|FG001|Period 1, First 7 Days|Adverse Event|0|||
162789251|NCT01340014|587937821|FG000|Period 1, First 7 Days|Personal Reasons|1|||
162789252|NCT01340014|587937822|FG001|Period 1, First 7 Days|Personal Reasons|0|||
162789253|NCT01340014|587937821|FG000|Period 2, Second 7 Days|Adverse Event|0|||
162789254|NCT01340014|587937822|FG001|Period 2, Second 7 Days|Adverse Event|1|||
162789255|NCT05101993|587937827|FG000|Overall Study|Withdrawal by Subject|1|||
162789256|NCT04577573|587937828|FG000|Overall Study|Technical - invalid protocol|0|||
162789257|NCT04577573|587937829|FG001|Overall Study|Technical - invalid protocol|2|||
162789258|NCT04577573|587937830|FG002|Overall Study|Technical - invalid protocol|0|||
162789259|NCT04526665|587937833|FG000|Overall Study|Withdrawal by Subject|6|||
162789260|NCT04526665|587937834|FG001|Overall Study|Withdrawal by Subject|3|||
162789261|NCT04526665|587937833|FG000|Overall Study|Adverse Event|4|||
162789262|NCT04526665|587937834|FG001|Overall Study|Adverse Event|1|||
162789263|NCT04526665|587937833|FG000|Overall Study|Physician Decision|2|||
162789264|NCT04526665|587937834|FG001|Overall Study|Physician Decision|2|||
162789265|NCT04526665|587937833|FG000|Overall Study|Death|2|||
162789266|NCT04526665|587937834|FG001|Overall Study|Death|0|||
162789267|NCT04526665|587937833|FG000|Overall Study|Other|0|||
162789268|NCT04526665|587937834|FG001|Overall Study|Other|1|||
162789269|NCT02113124|587939506|FG000|Overall Study|Unable to retrieve blood sample|1|||
162789270|NCT02113124|587939507|FG001|Overall Study|Unable to retrieve blood sample|1|||
162789271|NCT01439867|587939508|FG000|Overall Study|Non-compliance|0|||
162789272|NCT01439867|587939509|FG001|Overall Study|Non-compliance|1|||
162789273|NCT01439867|587939508|FG000|Overall Study|Withdrawal by Subject|1|||
162789274|NCT01439867|587939509|FG001|Overall Study|Withdrawal by Subject|2|||
162789275|NCT01439867|587939508|FG000|Overall Study|Administrative Decision|4|||
162789276|NCT01439867|587939509|FG001|Overall Study|Administrative Decision|5|||
162789277|NCT01439867|587939508|FG000|Overall Study|Protocol-specified Criteria|1|||
162789278|NCT01439867|587939509|FG001|Overall Study|Protocol-specified Criteria|0|||
162789279|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162789280|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162789281|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
162789282|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
162789283|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
162789284|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
162789285|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
162789286|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
162789287|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
162789288|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
162789289|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
162789290|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
162789291|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
162789292|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
162789293|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789294|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789295|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789296|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789297|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789298|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162789299|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
162789300|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162789301|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
162789302|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
162789303|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
162789304|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
162789305|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
162789306|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162789307|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789308|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789309|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789310|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789311|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
162789312|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789313|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162789314|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789315|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
162789316|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789317|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789318|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789319|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789320|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162789321|NCT01888874|587939510|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162789322|NCT01888874|587939511|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
162789323|NCT01888874|587939512|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162789324|NCT01888874|587939513|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162789325|NCT01888874|587939514|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162789326|NCT01888874|587939515|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
162789327|NCT01888874|587939516|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162789328|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162789329|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162789330|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
162789331|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162789332|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162789333|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162789334|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162789335|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789336|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789337|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789338|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789339|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
162789340|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789341|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162789342|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162789343|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162789344|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
162789345|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162789346|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162789347|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
162789348|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162789349|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789350|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789351|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
162789352|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789353|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789354|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789355|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162789356|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
162789357|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
162789358|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
162789359|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
162789360|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
162789361|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
162789362|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
162789363|NCT01888874|587939510|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162789364|NCT01888874|587939511|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
162789365|NCT01888874|587939512|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162789366|NCT01888874|587939513|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162789367|NCT01888874|587939514|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162789368|NCT01888874|587939515|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
162789369|NCT01888874|587939516|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162789370|NCT02763215|587939517|FG000|Overall Study|Participants withdrew from study|3|||
162789371|NCT02763215|587939517|FG000|Overall Study|Missed visit|1|||
162789372|NCT02763215|587939517|FG000|Overall Study|Visit outside visit-window|1|||
162789373|NCT02763215|587939517|FG000|Overall Study|Death|1|||
162789374|NCT02763215|587939517|FG000|Overall Study|Lost to Follow-up|1|||
162789375|NCT01020877|587939520|FG000|Second Intervention|Withdrawal by Subject|1|||
162789376|NCT01020877|587939521|FG001|Second Intervention|Withdrawal by Subject|0|||
162789377|NCT02963090|587939523|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
162789378|NCT02963090|587939524|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
162789379|NCT01784523|587939525|FG000|Overall Study|Study closed early|7|||
162789380|NCT01784523|587939526|FG001|Overall Study|Study closed early|4|||
162789381|NCT00709228|587939527|FG000|Overall Study|Not treated|14|||
162789382|NCT00709228|587939527|FG000|Overall Study|Eligibility criteria not met|281|||
162789383|NCT00709228|587939527|FG000|Overall Study|Adverse events|2|||
162789384|NCT00709228|587939527|FG000|Overall Study|Discontinued treatment|14|||
162789385|NCT00709228|587939527|FG000|Overall Study|Did not enter follow-up|4|||
162789386|NCT00709228|587939527|FG000|Overall Study|Discontinued follow-up|5|||
162789387|NCT00709228|587939527|FG000|Overall Study|Disease progression|1|||
162789388|NCT00709228|587939527|FG000|Overall Study|Lost to Follow-up|6|||
162789389|NCT00709228|587939527|FG000|Overall Study|Non-compliance|5|||
162789390|NCT02179177|587939528|FG000|Overall Study|Lost to Follow-up|1|||
162789391|NCT02179177|587939529|FG001|Overall Study|Lost to Follow-up|1|||
162789392|NCT02179177|587939528|FG000|Overall Study|Withdrawal by Subject|1|||
162789393|NCT02179177|587939529|FG001|Overall Study|Withdrawal by Subject|1|||
162789394|NCT00022659|587939530|FG000|Overall Study|Ineligible: wrong primary|1|||
162789395|NCT00022659|587939530|FG000|Overall Study|Never treated|1|||
162789396|NCT00884650|587939531|FG000|Overall Study|Did not return complete pain diaries|7|||
162789397|NCT00884650|587939532|FG001|Overall Study|Did not return complete pain diaries|7|||
162789398|NCT00884650|587939531|FG000|Overall Study|Admitted Post-Op|1|||
162789399|NCT00884650|587939532|FG001|Overall Study|Admitted Post-Op|0|||
162789400|NCT00884650|587939531|FG000|Overall Study|Femoral Stress Fracture|1|||
162789401|NCT00884650|587939532|FG001|Overall Study|Femoral Stress Fracture|0|||
162789402|NCT00884650|587939531|FG000|Overall Study|Pain Pump Complication|0|||
162789403|NCT00884650|587939532|FG001|Overall Study|Pain Pump Complication|1|||
162789404|NCT04334278|587939533|FG000|Overall Study|Lost to Follow-up|0|||
162789405|NCT04334278|587939534|FG001|Overall Study|Lost to Follow-up|3|||
162789406|NCT04334278|587939533|FG000|Overall Study|Withdrawal by Subject|4|||
162789407|NCT04334278|587939534|FG001|Overall Study|Withdrawal by Subject|2|||
162789408|NCT01516749|587939535|FG000|Active Therapy|Lost to Follow-up|1|||
162789409|NCT01516749|587939535|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
162789410|NCT01163474|587939550|FG000|Overall Study|Withdrawal by Subject|1|||
162789411|NCT01163474|587939550|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
162789412|NCT01163474|587939550|FG000|Overall Study|Lost to Follow-up|3|||
162789413|NCT02493946|587939551|FG000|DB Period|Withdrawal by Subject|8|||
162789414|NCT02493946|587939552|FG001|DB Period|Withdrawal by Subject|5|||
162789415|NCT02493946|587939553|FG002|DB Period|Withdrawal by Subject|0|||
162789416|NCT02493946|587939551|FG000|Open Label Period|Withdrawal by Subject|0|||
162789417|NCT02493946|587939552|FG001|Open Label Period|Withdrawal by Subject|0|||
162789418|NCT02493946|587939553|FG002|Open Label Period|Withdrawal by Subject|74|||
162789419|NCT02493946|587939551|FG000|Open Label Period|Adverse Event|0|||
162789420|NCT02493946|587939552|FG001|Open Label Period|Adverse Event|0|||
162789421|NCT02493946|587939553|FG002|Open Label Period|Adverse Event|4|||
162789422|NCT02493946|587939551|FG000|Open Label Period|Lost to Follow-up|0|||
162789423|NCT02493946|587939552|FG001|Open Label Period|Lost to Follow-up|0|||
162789424|NCT02493946|587939553|FG002|Open Label Period|Lost to Follow-up|1|||
162789425|NCT02493946|587939551|FG000|Open Label Period|Investigator decision, non-compliance|0|||
162789426|NCT02493946|587939552|FG001|Open Label Period|Investigator decision, non-compliance|0|||
162789427|NCT02493946|587939553|FG002|Open Label Period|Investigator decision, non-compliance|2|||
162789428|NCT02493946|587939551|FG000|Open Label Period|Investigator decision, non-availability|0|||
162789429|NCT02493946|587939552|FG001|Open Label Period|Investigator decision, non-availability|0|||
162789430|NCT02493946|587939553|FG002|Open Label Period|Investigator decision, non-availability|1|||
162789431|NCT02493946|587939551|FG000|Open Label Period|Pregnancy|0|||
162789432|NCT02493946|587939552|FG001|Open Label Period|Pregnancy|0|||
162789433|NCT02493946|587939553|FG002|Open Label Period|Pregnancy|3|||
162789434|NCT02493946|587939551|FG000|Open Label Period|Site error|0|||
162789435|NCT02493946|587939552|FG001|Open Label Period|Site error|0|||
162789436|NCT02493946|587939553|FG002|Open Label Period|Site error|1|||
162789437|NCT00965497|587939554|FG000|Overall Study|Physician Decision|1|||
162789438|NCT02878603|587939555|FG000|Overall Study|Lost to Follow-up|4|||
162789439|NCT02878603|587939556|FG001|Overall Study|Lost to Follow-up|1|||
162789440|NCT02878603|587939555|FG000|Overall Study|Withdrawal by Subject|1|||
162789441|NCT02878603|587939556|FG001|Overall Study|Withdrawal by Subject|1|||
162789442|NCT02878603|587939555|FG000|Overall Study|Death|1|||
162789443|NCT02878603|587939556|FG001|Overall Study|Death|0|||
162789444|NCT02878603|587939555|FG000|Overall Study|Physician Decision|0|||
162789445|NCT02878603|587939556|FG001|Overall Study|Physician Decision|3|||
162789446|NCT02689453|587939557|FG000|Overall Study|Progressive disease|0|||
162789447|NCT02689453|587939558|FG001|Overall Study|Progressive disease|1|||
162789448|NCT02689453|587939559|FG002|Overall Study|Progressive disease|1|||
162789449|NCT00794924|587939560|FG000|Overall Study|Lost to Follow-up|6|||
162789450|NCT00794924|587939561|FG001|Overall Study|Lost to Follow-up|8|||
162789451|NCT00794924|587939560|FG000|Overall Study|Withdrawal by Subject|48|||
162789452|NCT00794924|587939561|FG001|Overall Study|Withdrawal by Subject|60|||
162789453|NCT00794924|587939560|FG000|Overall Study|Adverse Event|6|||
162789454|NCT00794924|587939561|FG001|Overall Study|Adverse Event|2|||
162789455|NCT00953615|587939562|FG000|Overall Study|Adverse Event|1|||
162789456|NCT03274895|587939563|FG000|Overall Study|Lack of Efficacy|1|||
162789457|NCT03274895|587939564|FG001|Overall Study|Lack of Efficacy|0|||
162789458|NCT03274895|587939563|FG000|Overall Study|Adverse Event|8|||
162789459|NCT03274895|587939564|FG001|Overall Study|Adverse Event|7|||
162789460|NCT03274895|587939563|FG000|Overall Study|Lost to Follow-up|1|||
162789461|NCT03274895|587939564|FG001|Overall Study|Lost to Follow-up|0|||
162789462|NCT03274895|587939563|FG000|Overall Study|Diagnosis not confirmed|3|||
162789463|NCT03274895|587939564|FG001|Overall Study|Diagnosis not confirmed|4|||
162789464|NCT01969851|587939565|FG000|Overall Study|Adverse Event|0|||
162789465|NCT01969851|587939566|FG001|Overall Study|Adverse Event|0|||
162789466|NCT01969851|587939567|FG002|Overall Study|Adverse Event|3|||
162789467|NCT01969851|587939565|FG000|Overall Study|Lack of Efficacy|0|||
162789468|NCT01969851|587939566|FG001|Overall Study|Lack of Efficacy|3|||
162789469|NCT01969851|587939567|FG002|Overall Study|Lack of Efficacy|1|||
162789470|NCT01969851|587939565|FG000|Overall Study|Withdrawal by Subject|1|||
162789471|NCT01969851|587939566|FG001|Overall Study|Withdrawal by Subject|0|||
162789472|NCT01969851|587939567|FG002|Overall Study|Withdrawal by Subject|1|||
162789473|NCT01969851|587939565|FG000|Overall Study|No effective dose in Titration period|0|||
162789474|NCT01969851|587939566|FG001|Overall Study|No effective dose in Titration period|0|||
162789475|NCT01969851|587939567|FG002|Overall Study|No effective dose in Titration period|1|||
162789476|NCT01969851|587939565|FG000|Overall Study|Sponsor decision|0|||
162789477|NCT01969851|587939566|FG001|Overall Study|Sponsor decision|0|||
162789478|NCT01969851|587939567|FG002|Overall Study|Sponsor decision|1|||
162789479|NCT01294436|587939572|FG000|Overall Study|Adverse Event|10|||
162789480|NCT01294436|587939573|FG001|Overall Study|Adverse Event|17|||
162789481|NCT01294436|587939572|FG000|Overall Study|Withdrawal by Subject|11|||
162789482|NCT01294436|587939573|FG001|Overall Study|Withdrawal by Subject|28|||
162789483|NCT01294436|587939572|FG000|Overall Study|subject no longer meets study criteria|5|||
162789484|NCT01294436|587939573|FG001|Overall Study|subject no longer meets study criteria|20|||
162789485|NCT01294436|587939572|FG000|Overall Study|poor/non-compliance|2|||
162789486|NCT01294436|587939573|FG001|Overall Study|poor/non-compliance|5|||
162789487|NCT02389764|587939574|FG000|Overall Study|Lack of Efficacy|9|||
162789488|NCT00585078|587939577|FG000|Overall Study|Withdrawal by Subject|4|||
162789489|NCT00585078|587939577|FG000|Overall Study|Poor performance status|1|||
162789490|NCT00585078|587939577|FG000|Overall Study|Disease Progression|24|||
162789491|NCT00585078|587939577|FG000|Overall Study|Adverse Event|10|||
162789492|NCT00585078|587939577|FG000|Overall Study|Death|1|||
162789493|NCT01814072|587939580|FG000|Overall Study|Lost to Follow-up|2|||
162789494|NCT01814072|587939581|FG001|Overall Study|Lost to Follow-up|2|||
162789495|NCT01814072|587939582|FG002|Overall Study|Lost to Follow-up|2|||
162789496|NCT01814072|587939583|FG003|Overall Study|Lost to Follow-up|0|||
162789497|NCT01814072|587939584|FG004|Overall Study|Lost to Follow-up|2|||
162789498|NCT01814072|587939585|FG005|Overall Study|Lost to Follow-up|3|||
162789499|NCT01814072|587939586|FG006|Overall Study|Lost to Follow-up|3|||
162789500|NCT01814072|587939587|FG007|Overall Study|Lost to Follow-up|1|||
162789501|NCT01814072|587939588|FG008|Overall Study|Lost to Follow-up|2|||
162789502|NCT01814072|587939589|FG009|Overall Study|Lost to Follow-up|3|||
162789503|NCT01814072|587939590|FG010|Overall Study|Lost to Follow-up|1|||
162789504|NCT01814072|587939591|FG011|Overall Study|Lost to Follow-up|2|||
162789505|NCT01814072|587939592|FG012|Overall Study|Lost to Follow-up|2|||
162789506|NCT01814072|587939593|FG013|Overall Study|Lost to Follow-up|1|||
162789507|NCT01814072|587939594|FG014|Overall Study|Lost to Follow-up|2|||
162789508|NCT01814072|587939595|FG015|Overall Study|Lost to Follow-up|1|||
162789509|NCT01814072|587939596|FG016|Overall Study|Lost to Follow-up|3|||
162789510|NCT01814072|587939597|FG017|Overall Study|Lost to Follow-up|1|||
162789511|NCT01814072|587939598|FG018|Overall Study|Lost to Follow-up|3|||
162789512|NCT01814072|587939599|FG019|Overall Study|Lost to Follow-up|3|||
162789513|NCT01814072|587939600|FG020|Overall Study|Lost to Follow-up|2|||
162789514|NCT01814072|587939601|FG021|Overall Study|Lost to Follow-up|1|||
162789515|NCT01814072|587939602|FG022|Overall Study|Lost to Follow-up|3|||
162789516|NCT01814072|587939603|FG023|Overall Study|Lost to Follow-up|1|||
162789517|NCT01814072|587939604|FG024|Overall Study|Lost to Follow-up|4|||
162789518|NCT01814072|587939605|FG025|Overall Study|Lost to Follow-up|1|||
162789519|NCT01814072|587939606|FG026|Overall Study|Lost to Follow-up|1|||
162789520|NCT01814072|587939607|FG027|Overall Study|Lost to Follow-up|2|||
162789521|NCT01814072|587939608|FG028|Overall Study|Lost to Follow-up|3|||
162789522|NCT01814072|587939609|FG029|Overall Study|Lost to Follow-up|3|||
162789523|NCT01814072|587939610|FG030|Overall Study|Lost to Follow-up|2|||
162789524|NCT01814072|587939611|FG031|Overall Study|Lost to Follow-up|0|||
162789525|NCT01814072|587939580|FG000|Overall Study|Withdrawal by Subject|2|||
162789526|NCT01814072|587939581|FG001|Overall Study|Withdrawal by Subject|0|||
162789527|NCT01814072|587939582|FG002|Overall Study|Withdrawal by Subject|1|||
162789528|NCT01814072|587939583|FG003|Overall Study|Withdrawal by Subject|0|||
162789529|NCT01814072|587939584|FG004|Overall Study|Withdrawal by Subject|2|||
162789530|NCT01814072|587939585|FG005|Overall Study|Withdrawal by Subject|3|||
162789531|NCT01814072|587939586|FG006|Overall Study|Withdrawal by Subject|1|||
162789532|NCT01814072|587939587|FG007|Overall Study|Withdrawal by Subject|0|||
162789533|NCT01814072|587939588|FG008|Overall Study|Withdrawal by Subject|1|||
162789534|NCT01814072|587939589|FG009|Overall Study|Withdrawal by Subject|2|||
162789535|NCT01814072|587939590|FG010|Overall Study|Withdrawal by Subject|0|||
162789536|NCT01814072|587939591|FG011|Overall Study|Withdrawal by Subject|0|||
162789537|NCT01814072|587939592|FG012|Overall Study|Withdrawal by Subject|1|||
162789538|NCT01814072|587939593|FG013|Overall Study|Withdrawal by Subject|1|||
162789539|NCT01814072|587939594|FG014|Overall Study|Withdrawal by Subject|1|||
162789540|NCT01814072|587939595|FG015|Overall Study|Withdrawal by Subject|1|||
162789541|NCT01814072|587939596|FG016|Overall Study|Withdrawal by Subject|0|||
162789542|NCT01814072|587939597|FG017|Overall Study|Withdrawal by Subject|0|||
162789543|NCT01814072|587939598|FG018|Overall Study|Withdrawal by Subject|0|||
162789544|NCT01814072|587939599|FG019|Overall Study|Withdrawal by Subject|2|||
162789545|NCT01814072|587939600|FG020|Overall Study|Withdrawal by Subject|0|||
162789546|NCT01814072|587939601|FG021|Overall Study|Withdrawal by Subject|0|||
162789547|NCT01814072|587939602|FG022|Overall Study|Withdrawal by Subject|1|||
162789548|NCT01814072|587939603|FG023|Overall Study|Withdrawal by Subject|0|||
162789549|NCT01814072|587939604|FG024|Overall Study|Withdrawal by Subject|2|||
162789550|NCT01814072|587939605|FG025|Overall Study|Withdrawal by Subject|1|||
162789551|NCT01814072|587939606|FG026|Overall Study|Withdrawal by Subject|1|||
162789552|NCT01814072|587939607|FG027|Overall Study|Withdrawal by Subject|2|||
162789553|NCT01814072|587939608|FG028|Overall Study|Withdrawal by Subject|1|||
162789554|NCT01814072|587939609|FG029|Overall Study|Withdrawal by Subject|0|||
162789555|NCT01814072|587939610|FG030|Overall Study|Withdrawal by Subject|0|||
162789556|NCT01814072|587939611|FG031|Overall Study|Withdrawal by Subject|0|||
162789557|NCT02781311|587939612|FG000|Overall Study|Adverse Event|2|||
162789558|NCT02781311|587939613|FG001|Overall Study|Adverse Event|6|||
162789559|NCT02781311|587939614|FG002|Overall Study|Adverse Event|1|||
162789560|NCT02781311|587939612|FG000|Overall Study|Withdrawal of Consent|11|||
162789561|NCT02781311|587939613|FG001|Overall Study|Withdrawal of Consent|12|||
162789562|NCT02781311|587939614|FG002|Overall Study|Withdrawal of Consent|2|||
162789563|NCT02781311|587939612|FG000|Overall Study|Lost to Follow-up|11|||
162789564|NCT02781311|587939613|FG001|Overall Study|Lost to Follow-up|8|||
162789565|NCT02781311|587939614|FG002|Overall Study|Lost to Follow-up|1|||
162789566|NCT02781311|587939612|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162789567|NCT02781311|587939613|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162789568|NCT02781311|587939614|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162789569|NCT00250432|587939619|FG000|Overall Study|Adverse Event|25|||
162789570|NCT00250432|587939620|FG001|Overall Study|Adverse Event|29|||
162789571|NCT00250432|587939619|FG000|Overall Study|Lack of Efficacy|2|||
162789572|NCT00250432|587939620|FG001|Overall Study|Lack of Efficacy|1|||
162789573|NCT00250432|587939619|FG000|Overall Study|Lost to Follow-up|6|||
162789574|NCT00250432|587939620|FG001|Overall Study|Lost to Follow-up|5|||
162789575|NCT00250432|587939619|FG000|Overall Study|Patient Moved|0|||
162789576|NCT00250432|587939620|FG001|Overall Study|Patient Moved|1|||
162789577|NCT00250432|587939619|FG000|Overall Study|Protocol Violation|0|||
162789578|NCT00250432|587939620|FG001|Overall Study|Protocol Violation|3|||
162789579|NCT00250432|587939619|FG000|Overall Study|Withdrawal by Subject|6|||
162789580|NCT00250432|587939620|FG001|Overall Study|Withdrawal by Subject|2|||
162789581|NCT00250432|587939619|FG000|Overall Study|Pt died out of posttherapy report period|6|||
162789582|NCT00250432|587939620|FG001|Overall Study|Pt died out of posttherapy report period|5|||
162789583|NCT00250432|587939619|FG000|Overall Study|Pt was considered untreatable|0|||
162789584|NCT00250432|587939620|FG001|Overall Study|Pt was considered untreatable|1|||
162789585|NCT01011868|587939621|FG000|After Week 18 Follow-up|Adverse Event|8|||
162789586|NCT01011868|587939622|FG001|After Week 18 Follow-up|Adverse Event|6|||
162789587|NCT01011868|587939623|FG002|After Week 18 Follow-up|Adverse Event|13|||
162789588|NCT01011868|587939621|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
162789589|NCT01011868|587939622|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
162789590|NCT01011868|587939623|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
162789591|NCT01011868|587939621|FG000|After Week 18 Follow-up|Protocol Violation|1|||
162789592|NCT01011868|587939622|FG001|After Week 18 Follow-up|Protocol Violation|1|||
162789593|NCT01011868|587939623|FG002|After Week 18 Follow-up|Protocol Violation|1|||
162789594|NCT01011868|587939621|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
162789595|NCT01011868|587939622|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
162789596|NCT01011868|587939623|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
162789597|NCT01011868|587939621|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
162789598|NCT01011868|587939622|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
162789599|NCT01011868|587939623|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
162789600|NCT01011868|587939621|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
162789601|NCT01011868|587939622|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
162789602|NCT01011868|587939623|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
162789603|NCT01011868|587939621|FG000|After Week 78 Follow-up|Adverse Event|14|||
162789604|NCT01011868|587939622|FG001|After Week 78 Follow-up|Adverse Event|18|||
162789605|NCT01011868|587939623|FG002|After Week 78 Follow-up|Adverse Event|21|||
162789606|NCT01011868|587939621|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
162789607|NCT01011868|587939622|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
162789608|NCT01011868|587939623|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
162789609|NCT01011868|587939621|FG000|After Week 78 Follow-up|Protocol Violation|9|||
162789610|NCT01011868|587939622|FG001|After Week 78 Follow-up|Protocol Violation|1|||
162789611|NCT01011868|587939623|FG002|After Week 78 Follow-up|Protocol Violation|2|||
162789612|NCT01011868|587939621|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
162789613|NCT01011868|587939622|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
162789614|NCT01011868|587939623|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
162789615|NCT01011868|587939621|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
162789616|NCT01011868|587939622|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
162789617|NCT01011868|587939623|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
162789618|NCT01011868|587939621|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
162789619|NCT01011868|587939622|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
162789620|NCT01011868|587939623|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
162789621|NCT02615938|587939624|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
162789622|NCT02615938|587939625|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
162789623|NCT02615938|587939626|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162789624|NCT02615938|587939627|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162789625|NCT02615938|587939624|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
162789626|NCT02615938|587939625|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162789627|NCT02615938|587939626|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162789628|NCT02615938|587939627|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162789629|NCT02615938|587939624|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162789630|NCT02615938|587939625|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162789631|NCT02615938|587939626|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
162789632|NCT02615938|587939627|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162789633|NCT04905849|587939629|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
162789634|NCT04905849|587939630|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
162789635|NCT00838929|587939635|FG000|Overall Study|Protocol Violation|0|||
162789636|NCT00838929|587939636|FG001|Overall Study|Protocol Violation|1|||
162789637|NCT00838929|587939637|FG002|Overall Study|Protocol Violation|0|||
162789638|NCT00838929|587939635|FG000|Overall Study|Disease progression|0|||
162789639|NCT00838929|587939636|FG001|Overall Study|Disease progression|2|||
162789640|NCT00838929|587939637|FG002|Overall Study|Disease progression|1|||
162789641|NCT04199052|587939645|FG000|Overall Study|Lost to Follow-up|11|||
162789642|NCT04199052|587939646|FG001|Overall Study|Lost to Follow-up|18|||
162789643|NCT00699842|587939647|FG000|Overall Study|Death|0|||
162789644|NCT00699842|587939648|FG001|Overall Study|Death|1|||
162789645|NCT00699842|587939649|FG002|Overall Study|Death|0|||
162789646|NCT01358331|587939650|FG000|Overall Study|Lost to Follow-up|0|||
162789647|NCT01358331|587939651|FG001|Overall Study|Lost to Follow-up|0|||
162789648|NCT01358331|587939652|FG002|Overall Study|Lost to Follow-up|0|||
162789649|NCT01358331|587939653|FG003|Overall Study|Lost to Follow-up|1|||
162789650|NCT01358331|587939654|FG004|Overall Study|Lost to Follow-up|0|||
162789651|NCT01358331|587939655|FG005|Overall Study|Lost to Follow-up|0|||
162789652|NCT01358331|587939650|FG000|Overall Study|Withdrawal by Subject|0|||
162789653|NCT01358331|587939651|FG001|Overall Study|Withdrawal by Subject|0|||
162789654|NCT01358331|587939652|FG002|Overall Study|Withdrawal by Subject|0|||
162789655|NCT01358331|587939653|FG003|Overall Study|Withdrawal by Subject|1|||
162789656|NCT01358331|587939654|FG004|Overall Study|Withdrawal by Subject|1|||
162789657|NCT01358331|587939655|FG005|Overall Study|Withdrawal by Subject|1|||
162789658|NCT01358331|587939650|FG000|Overall Study|Adverse Events|1|||
162789659|NCT01358331|587939651|FG001|Overall Study|Adverse Events|1|||
162789660|NCT01358331|587939652|FG002|Overall Study|Adverse Events|1|||
162789661|NCT01358331|587939653|FG003|Overall Study|Adverse Events|0|||
162789662|NCT01358331|587939654|FG004|Overall Study|Adverse Events|1|||
162789663|NCT01358331|587939655|FG005|Overall Study|Adverse Events|5|||
162789664|NCT01358331|587939650|FG000|Overall Study|Symptomatic Deterioration|0|||
162789665|NCT01358331|587939651|FG001|Overall Study|Symptomatic Deterioration|0|||
162789666|NCT01358331|587939652|FG002|Overall Study|Symptomatic Deterioration|0|||
162789667|NCT01358331|587939653|FG003|Overall Study|Symptomatic Deterioration|0|||
162789668|NCT01358331|587939654|FG004|Overall Study|Symptomatic Deterioration|1|||
162789669|NCT01358331|587939655|FG005|Overall Study|Symptomatic Deterioration|0|||
162789670|NCT01358331|587939650|FG000|Overall Study|Participants did not wish to continue|0|||
162789671|NCT01358331|587939651|FG001|Overall Study|Participants did not wish to continue|0|||
162789672|NCT01358331|587939652|FG002|Overall Study|Participants did not wish to continue|0|||
162789673|NCT01358331|587939653|FG003|Overall Study|Participants did not wish to continue|0|||
162789674|NCT01358331|587939654|FG004|Overall Study|Participants did not wish to continue|1|||
162789675|NCT01358331|587939655|FG005|Overall Study|Participants did not wish to continue|0|||
162789676|NCT01358331|587939650|FG000|Overall Study|Progress of disease under investigation|1|||
162789677|NCT01358331|587939651|FG001|Overall Study|Progress of disease under investigation|2|||
162789678|NCT01358331|587939652|FG002|Overall Study|Progress of disease under investigation|3|||
162789679|NCT01358331|587939653|FG003|Overall Study|Progress of disease under investigation|1|||
162789680|NCT01358331|587939654|FG004|Overall Study|Progress of disease under investigation|3|||
162789681|NCT01358331|587939655|FG005|Overall Study|Progress of disease under investigation|0|||
162789682|NCT04946942|587939656|FG000|Overall Study|Lost to Follow-up|6|||
162789683|NCT04946942|587939657|FG001|Overall Study|Lost to Follow-up|2|||
162789684|NCT04946942|587939658|FG002|Overall Study|Lost to Follow-up|0|||
162789685|NCT03342196|587939659|FG000|Overall Study|Physician Decision|1|||
162789686|NCT02257918|587939660|FG000|Overall Study|Lost to Follow-up|4|||
162789687|NCT02257918|587939661|FG001|Overall Study|Lost to Follow-up|1|||
162789688|NCT02257918|587939662|FG002|Overall Study|Lost to Follow-up|0|||
162789689|NCT02257918|587939660|FG000|Overall Study|Withdrawal by Subject|0|||
162789690|NCT02257918|587939661|FG001|Overall Study|Withdrawal by Subject|0|||
162789691|NCT02257918|587939662|FG002|Overall Study|Withdrawal by Subject|1|||
162789692|NCT02257918|587939660|FG000|Overall Study|Pregnancy|0|||
162789693|NCT02257918|587939661|FG001|Overall Study|Pregnancy|0|||
162789694|NCT02257918|587939662|FG002|Overall Study|Pregnancy|1|||
162789695|NCT01151423|587939665|FG000|Overall Study|Study terminated by Sponsor|9|||
162789696|NCT01151423|587939666|FG001|Overall Study|Study terminated by Sponsor|10|||
162789697|NCT01151423|587939665|FG000|Overall Study|Protocol Violation|0|||
162789698|NCT01151423|587939666|FG001|Overall Study|Protocol Violation|1|||
162789699|NCT01151423|587939665|FG000|Overall Study|Physician Decision|1|||
162789700|NCT01151423|587939666|FG001|Overall Study|Physician Decision|1|||
162789701|NCT01151423|587939665|FG000|Overall Study|Pregnancy|0|||
162789702|NCT01151423|587939666|FG001|Overall Study|Pregnancy|1|||
162789703|NCT01151423|587939665|FG000|Overall Study|Death|0|||
162789704|NCT01151423|587939666|FG001|Overall Study|Death|1|||
162789705|NCT01151423|587939665|FG000|Overall Study|Adverse Event|3|||
162789706|NCT01151423|587939666|FG001|Overall Study|Adverse Event|0|||
162789707|NCT01151423|587939665|FG000|Overall Study|Withdrawal by Subject|1|||
162789708|NCT01151423|587939666|FG001|Overall Study|Withdrawal by Subject|3|||
162789709|NCT01151423|587939665|FG000|Overall Study|Lost to Follow-up|1|||
162789710|NCT01151423|587939666|FG001|Overall Study|Lost to Follow-up|0|||
162789711|NCT01151423|587939665|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
162789712|NCT01151423|587939666|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
162789713|NCT01151423|587939665|FG000|Overall Study|Participated in other clinical trial|1|||
162789714|NCT01151423|587939666|FG001|Overall Study|Participated in other clinical trial|0|||
162789715|NCT01263054|587939667|FG000|Overall Study|Death|1|||
162789716|NCT01263054|587939668|FG001|Overall Study|Death|0|||
162789717|NCT01263054|587939667|FG000|Overall Study|Lost to Follow-up|2|||
162789718|NCT01263054|587939668|FG001|Overall Study|Lost to Follow-up|2|||
162789719|NCT01263054|587939667|FG000|Overall Study|Withdrawal by Subject|1|||
162789720|NCT01263054|587939668|FG001|Overall Study|Withdrawal by Subject|3|||
162789721|NCT01263054|587939667|FG000|Overall Study|Qualification Violation|1|||
162789722|NCT01263054|587939668|FG001|Overall Study|Qualification Violation|0|||
162789723|NCT01263054|587939667|FG000|Overall Study|Other|0|||
162789724|NCT01263054|587939668|FG001|Overall Study|Other|1|||
162789725|NCT02520310|587939671|FG000|At 6 Months Clinical Follow-up|Death|1|||
162789726|NCT02520310|587939671|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
162789727|NCT02520310|587939671|FG000|AT 3 Year Clinical Follow-up|Death|2|||
162789728|NCT02520310|587939671|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
162789729|NCT02520310|587939671|FG000|AT 4 Year Clinical Follow-up|Death|1|||
162789730|NCT02520310|587939671|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
162789731|NCT02065882|587939674|FG000|Part I: PK/PD|Screening failure|5|||
162789732|NCT02065882|587939674|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
162789733|NCT02065882|587939674|FG000|Part I: PK/PD|Adverse Event|1|||
162789734|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|Screening failure|7|||
162789735|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
162789736|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
162789737|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
162789738|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
162789739|NCT02065882|587939674|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
162789740|NCT01667926|587941211|FG000|Overall Study|Withdrawal by Subject|1|||
162789741|NCT01667926|587941212|FG001|Overall Study|Withdrawal by Subject|2|||
162789742|NCT01667926|587941213|FG002|Overall Study|Withdrawal by Subject|2|||
162789743|NCT01667926|587941211|FG000|Overall Study|Physician Decision|0|||
162789744|NCT01667926|587941212|FG001|Overall Study|Physician Decision|0|||
162789745|NCT01667926|587941213|FG002|Overall Study|Physician Decision|1|||
162789746|NCT01667926|587941211|FG000|Overall Study|Time committment|0|||
162789747|NCT01667926|587941212|FG001|Overall Study|Time committment|0|||
162789748|NCT01667926|587941213|FG002|Overall Study|Time committment|2|||
162789749|NCT01667926|587941211|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
162789750|NCT01667926|587941212|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
162789751|NCT01667926|587941213|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
162789752|NCT01667926|587941211|FG000|Overall Study|Lost to Follow-up|1|||
162789753|NCT01667926|587941212|FG001|Overall Study|Lost to Follow-up|2|||
162789754|NCT01667926|587941213|FG002|Overall Study|Lost to Follow-up|1|||
162789755|NCT01667926|587941211|FG000|Overall Study|Side effects|3|||
162789756|NCT01667926|587941212|FG001|Overall Study|Side effects|0|||
162789757|NCT01667926|587941213|FG002|Overall Study|Side effects|0|||
162789758|NCT01411241|587941215|FG000|Overall Study|Protocol Violation|0|||
162789759|NCT01411241|587941216|FG001|Overall Study|Protocol Violation|5|||
162789760|NCT01411241|587941215|FG000|Overall Study|Withdrawal by Subject|9|||
162789761|NCT01411241|587941216|FG001|Overall Study|Withdrawal by Subject|10|||
162789762|NCT01411241|587941215|FG000|Overall Study|Serious Adverse Event|0|||
162789763|NCT01411241|587941216|FG001|Overall Study|Serious Adverse Event|3|||
162789764|NCT01411241|587941215|FG000|Overall Study|Lost to Follow-up|2|||
162789765|NCT01411241|587941216|FG001|Overall Study|Lost to Follow-up|4|||
162789766|NCT04052425|587941219|FG000|24-Week Double-blind Period|Adverse Event|0|||
162789767|NCT04052425|587941220|FG001|24-Week Double-blind Period|Adverse Event|1|||
162789768|NCT04052425|587941221|FG002|24-Week Double-blind Period|Adverse Event|0|||
162789769|NCT04052425|587941222|FG003|24-Week Double-blind Period|Adverse Event|0|||
162789770|NCT04052425|587941219|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
162789771|NCT04052425|587941220|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
162789772|NCT04052425|587941221|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
162789773|NCT04052425|587941222|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
162789774|NCT04052425|587941219|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
162789775|NCT04052425|587941220|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
162789776|NCT04052425|587941221|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
162789777|NCT04052425|587941222|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
162789778|NCT04052425|587941219|FG000|24-Week Double-blind Period|Physician Decision|1|||
162789779|NCT04052425|587941220|FG001|24-Week Double-blind Period|Physician Decision|0|||
162789780|NCT04052425|587941221|FG002|24-Week Double-blind Period|Physician Decision|0|||
162789781|NCT04052425|587941222|FG003|24-Week Double-blind Period|Physician Decision|0|||
162789782|NCT04052425|587941219|FG000|24-Week Double-blind Period|Protocol Violation|1|||
162789783|NCT04052425|587941220|FG001|24-Week Double-blind Period|Protocol Violation|0|||
162789784|NCT04052425|587941221|FG002|24-Week Double-blind Period|Protocol Violation|0|||
162789785|NCT04052425|587941222|FG003|24-Week Double-blind Period|Protocol Violation|0|||
162789786|NCT04052425|587941219|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
162789787|NCT04052425|587941220|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
162789788|NCT04052425|587941221|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
162789789|NCT04052425|587941222|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
162789790|NCT04052425|587941219|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
162789791|NCT04052425|587941220|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162789792|NCT04052425|587941221|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162789793|NCT04052425|587941222|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162789794|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
162789795|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
162789796|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
162789797|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
162789798|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162789799|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162789800|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
162789801|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162789802|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
162789803|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
162789804|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
162789805|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
162789806|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
162789807|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
162789808|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
162789809|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
162789810|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
162789811|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
162789812|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
162789813|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
162789814|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162789815|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162789816|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
162789817|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162789818|NCT04052425|587941219|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
162789819|NCT04052425|587941220|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
162789820|NCT04052425|587941221|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
162789821|NCT04052425|587941222|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
162789822|NCT00945672|587941225|FG000|Overall Study|Withdrawal by Subject|0|||
162789823|NCT00945672|587941226|FG001|Overall Study|Withdrawal by Subject|0|||
162789824|NCT00945672|587941227|FG002|Overall Study|Withdrawal by Subject|0|||
162789825|NCT00945672|587941228|FG003|Overall Study|Withdrawal by Subject|1|||
162789826|NCT01681992|587941231|FG000|Overall Study|Adverse Event|3|||
162789827|NCT01681992|587941232|FG001|Overall Study|Adverse Event|2|||
162789828|NCT01681992|587941233|FG002|Overall Study|Adverse Event|3|||
162789829|NCT01681992|587941231|FG000|Overall Study|Lost to Follow-up|36|||
162789830|NCT01681992|587941232|FG001|Overall Study|Lost to Follow-up|38|||
162789831|NCT01681992|587941233|FG002|Overall Study|Lost to Follow-up|53|||
162789832|NCT01681992|587941231|FG000|Overall Study|As Per Sponsor Decision|0|||
162789833|NCT01681992|587941232|FG001|Overall Study|As Per Sponsor Decision|0|||
162789834|NCT01681992|587941233|FG002|Overall Study|As Per Sponsor Decision|1|||
162789835|NCT01681992|587941231|FG000|Overall Study|Protocol Violation|0|||
162789836|NCT01681992|587941232|FG001|Overall Study|Protocol Violation|0|||
162789837|NCT01681992|587941233|FG002|Overall Study|Protocol Violation|1|||
162789838|NCT01681992|587941231|FG000|Overall Study|Withdrawal by Subject|27|||
162789839|NCT01681992|587941232|FG001|Overall Study|Withdrawal by Subject|30|||
162789840|NCT01681992|587941233|FG002|Overall Study|Withdrawal by Subject|25|||
162789841|NCT00447590|587941234|FG000|Overall Study|Withdrawal by Subject|26|||
162789842|NCT00447590|587941234|FG000|Overall Study|Lost to Follow-up|24|||
162789843|NCT00447590|587941234|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
162789844|NCT03880019|587941235|FG000|Overall Study|Competing disease|1|||
162789845|NCT03812029|587941240|FG000|Overall Study|Protocol Violation|1|||
162789846|NCT03812029|587941241|FG001|Overall Study|Protocol Violation|0|||
162789847|NCT03812029|587941242|FG002|Overall Study|Protocol Violation|0|||
162789848|NCT03812029|587941243|FG003|Overall Study|Protocol Violation|1|||
162789849|NCT03812029|587941244|FG004|Overall Study|Protocol Violation|0|||
162789850|NCT03812029|587941240|FG000|Overall Study|Withdrawal by Subject|1|||
162789851|NCT03812029|587941241|FG001|Overall Study|Withdrawal by Subject|0|||
162789852|NCT03812029|587941242|FG002|Overall Study|Withdrawal by Subject|0|||
162789853|NCT03812029|587941243|FG003|Overall Study|Withdrawal by Subject|2|||
162789854|NCT03812029|587941244|FG004|Overall Study|Withdrawal by Subject|2|||
162789855|NCT03812029|587941240|FG000|Overall Study|Stopping rules|0|||
162789856|NCT03812029|587941241|FG001|Overall Study|Stopping rules|1|||
162789857|NCT03812029|587941242|FG002|Overall Study|Stopping rules|0|||
162789858|NCT03812029|587941243|FG003|Overall Study|Stopping rules|0|||
162789859|NCT03812029|587941244|FG004|Overall Study|Stopping rules|0|||
162789860|NCT03812029|587941240|FG000|Overall Study|Adverse Event|0|||
162789861|NCT03812029|587941241|FG001|Overall Study|Adverse Event|9|||
162789862|NCT03812029|587941242|FG002|Overall Study|Adverse Event|0|||
162789863|NCT03812029|587941243|FG003|Overall Study|Adverse Event|3|||
162789864|NCT03812029|587941244|FG004|Overall Study|Adverse Event|5|||
162789865|NCT03812029|587941240|FG000|Overall Study|Lost to Follow-up|0|||
162789866|NCT03812029|587941241|FG001|Overall Study|Lost to Follow-up|0|||
162789867|NCT03812029|587941242|FG002|Overall Study|Lost to Follow-up|0|||
162789868|NCT03812029|587941243|FG003|Overall Study|Lost to Follow-up|0|||
162789869|NCT03812029|587941244|FG004|Overall Study|Lost to Follow-up|3|||
162789870|NCT04042077|587941245|FG000|Overall Study|Adverse Event|0|||
162789871|NCT04042077|587941246|FG001|Overall Study|Adverse Event|1|||
162789872|NCT04042077|587941245|FG000|Overall Study|Death|2|||
162789873|NCT04042077|587941246|FG001|Overall Study|Death|1|||
162789874|NCT04042077|587941245|FG000|Overall Study|Physician Decision|2|||
162789875|NCT04042077|587941246|FG001|Overall Study|Physician Decision|0|||
162789876|NCT04042077|587941245|FG000|Overall Study|Withdrawal by Subject|3|||
162789877|NCT04042077|587941246|FG001|Overall Study|Withdrawal by Subject|2|||
162789878|NCT04042077|587941245|FG000|Overall Study|Lack of Efficacy|0|||
162789879|NCT04042077|587941246|FG001|Overall Study|Lack of Efficacy|1|||
162789880|NCT01080300|587941247|FG000|Overall Study|Adverse Event|49|||
162789881|NCT01080300|587941248|FG001|Overall Study|Adverse Event|35|||
162789882|NCT01080300|587941247|FG000|Overall Study|Lack of Efficacy|12|||
162789883|NCT01080300|587941248|FG001|Overall Study|Lack of Efficacy|15|||
162789884|NCT01080300|587941247|FG000|Overall Study|Protocol Violation|7|||
162789885|NCT01080300|587941248|FG001|Overall Study|Protocol Violation|13|||
162789886|NCT01080300|587941247|FG000|Overall Study|Lost to Follow-up|10|||
162789887|NCT01080300|587941248|FG001|Overall Study|Lost to Follow-up|6|||
162789888|NCT01080300|587941247|FG000|Overall Study|Death|0|||
162789889|NCT01080300|587941248|FG001|Overall Study|Death|1|||
162789890|NCT01080300|587941247|FG000|Overall Study|Withdrawal by Subject|12|||
162789891|NCT01080300|587941248|FG001|Overall Study|Withdrawal by Subject|28|||
162789892|NCT01080300|587941247|FG000|Overall Study|Reasons not specified|4|||
162789893|NCT01080300|587941248|FG001|Overall Study|Reasons not specified|6|||
162789894|NCT02269423|587941254|FG000|Overall Study|Discontinued due to change in residence|0|||
162789895|NCT02269423|587941255|FG001|Overall Study|Discontinued due to change in residence|1|||
162789896|NCT02269423|587941256|FG002|Overall Study|Discontinued due to change in residence|0|||
162789897|NCT02269423|587941257|FG003|Overall Study|Discontinued due to change in residence|1|||
162789898|NCT01305239|587941258|FG000|Overall Study|Adverse Event|22|||
162789899|NCT01305239|587941258|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
162789900|NCT01754753|587941260|FG000|Overall Study|Study close|43|||
162789901|NCT01754753|587941261|FG001|Overall Study|Study close|44|||
162789902|NCT01754753|587941260|FG000|Overall Study|Lost to Follow-up|9|||
162789903|NCT01754753|587941261|FG001|Overall Study|Lost to Follow-up|5|||
162789904|NCT03229486|587941262|FG000|Overall Study|Protocol Violation|0|||
162789905|NCT03229486|587941263|FG001|Overall Study|Protocol Violation|1|||
162789906|NCT00856245|587941264|FG000|Overall Study|Was not transplanted|5|||
162789907|NCT01782690|587941268|FG000|Overall Study|Not reported|7|||
162789908|NCT01782690|587941268|FG000|Overall Study|Toxicity of gemcitabine|1|||
162789909|NCT01782690|587941268|FG000|Overall Study|Toxicity of erlotinib|1|||
162789910|NCT01782690|587941268|FG000|Overall Study|Lost to Follow-up|31|||
162789911|NCT01782690|587941268|FG000|Overall Study|Withdrawal of informed consent|2|||
162789912|NCT01782690|587941268|FG000|Overall Study|Absent rash|9|||
162789913|NCT01782690|587941268|FG000|Overall Study|Physician Decision|13|||
162789914|NCT01782690|587941268|FG000|Overall Study|Patient's wish|21|||
162789915|NCT01782690|587941268|FG000|Overall Study|Tumor progression|74|||
162789916|NCT01782690|587941268|FG000|Overall Study|Death|133|||
162789917|NCT01782690|587941268|FG000|Overall Study|Study completion unknown|7|||
162789918|NCT01637077|587941274|FG000|Overall Study|Cancel|1|||
162789919|NCT01637077|587941275|FG001|Overall Study|Cancel|1|||
162789920|NCT01637077|587941274|FG000|Overall Study|Withdrawal by Subject|1|||
162789921|NCT01637077|587941275|FG001|Overall Study|Withdrawal by Subject|0|||
162789922|NCT01637077|587941274|FG000|Overall Study|No cycle 1 questionnaire data|2|||
162789923|NCT01637077|587941275|FG001|Overall Study|No cycle 1 questionnaire data|0|||
162789924|NCT02638103|587941276|FG000|Overall Study|Adverse Event|13|||
162789925|NCT02638103|587941277|FG001|Overall Study|Adverse Event|12|||
162789926|NCT02638103|587941278|FG002|Overall Study|Adverse Event|19|||
162789927|NCT02638103|587941279|FG003|Overall Study|Adverse Event|12|||
162789928|NCT02638103|587941276|FG000|Overall Study|Withdrawal by Subject|43|||
162789929|NCT02638103|587941277|FG001|Overall Study|Withdrawal by Subject|53|||
162789930|NCT02638103|587941278|FG002|Overall Study|Withdrawal by Subject|30|||
162789931|NCT02638103|587941279|FG003|Overall Study|Withdrawal by Subject|61|||
162789932|NCT02638103|587941276|FG000|Overall Study|Protocol Violation|1|||
162789933|NCT02638103|587941277|FG001|Overall Study|Protocol Violation|2|||
162789934|NCT02638103|587941278|FG002|Overall Study|Protocol Violation|1|||
162789935|NCT02638103|587941279|FG003|Overall Study|Protocol Violation|4|||
162789936|NCT02638103|587941276|FG000|Overall Study|Pregnancy|2|||
162789937|NCT02638103|587941277|FG001|Overall Study|Pregnancy|3|||
162789938|NCT02638103|587941278|FG002|Overall Study|Pregnancy|0|||
162789939|NCT02638103|587941279|FG003|Overall Study|Pregnancy|1|||
162789940|NCT02638103|587941276|FG000|Overall Study|Non-compliance to Study Procedures|2|||
162789941|NCT02638103|587941277|FG001|Overall Study|Non-compliance to Study Procedures|1|||
162789942|NCT02638103|587941278|FG002|Overall Study|Non-compliance to Study Procedures|1|||
162789943|NCT02638103|587941279|FG003|Overall Study|Non-compliance to Study Procedures|1|||
162789944|NCT02638103|587941276|FG000|Overall Study|Lost to Follow-up|26|||
162789945|NCT02638103|587941277|FG001|Overall Study|Lost to Follow-up|33|||
162789946|NCT02638103|587941278|FG002|Overall Study|Lost to Follow-up|20|||
162789947|NCT02638103|587941279|FG003|Overall Study|Lost to Follow-up|37|||
162789948|NCT02638103|587941276|FG000|Overall Study|Lack of Efficacy|14|||
162789949|NCT02638103|587941277|FG001|Overall Study|Lack of Efficacy|10|||
162789950|NCT02638103|587941278|FG002|Overall Study|Lack of Efficacy|12|||
162789951|NCT02638103|587941279|FG003|Overall Study|Lack of Efficacy|22|||
162789952|NCT02638103|587941276|FG000|Overall Study|Other than specified|5|||
162789953|NCT02638103|587941277|FG001|Overall Study|Other than specified|4|||
162789954|NCT02638103|587941278|FG002|Overall Study|Other than specified|2|||
162789955|NCT02638103|587941279|FG003|Overall Study|Other than specified|4|||
162789956|NCT03023423|587941280|FG000|Overall Study|Death|5|||
162789957|NCT03023423|587941281|FG001|Overall Study|Death|12|||
162789958|NCT03023423|587941282|FG002|Overall Study|Death|20|||
162789959|NCT03023423|587941280|FG000|Overall Study|Other|0|||
162789960|NCT03023423|587941281|FG001|Overall Study|Other|2|||
162789961|NCT03023423|587941282|FG002|Overall Study|Other|2|||
162789962|NCT03023423|587941280|FG000|Overall Study|Ongoing|2|||
162789963|NCT03023423|587941281|FG001|Overall Study|Ongoing|32|||
162789964|NCT03023423|587941282|FG002|Overall Study|Ongoing|24|||
162789965|NCT00681668|587941283|FG000|Overall Study|Protocol Violation|1|||
162789966|NCT00681668|587941283|FG000|Overall Study|Withdrawal by Subject|1|||
162789967|NCT04277507|587941285|FG000|Overall Study|Lost to Follow-up|17|||
162789968|NCT04277507|587941285|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
162789969|NCT04277507|587941285|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
162789970|NCT04277507|587941285|FG000|Overall Study|Withdrawal by Subject|3|||
162789971|NCT04277507|587941285|FG000|Overall Study|Death due to COVID-19|1|||
162789972|NCT04277507|587941285|FG000|Overall Study|Data missing for full evaluation|5|||
162789973|NCT00583947|587941291|FG000|Cross-over Period|Adverse Event|2|||
162789974|NCT00583947|587941292|FG001|Cross-over Period|Adverse Event|0|||
162789975|NCT00583947|587941291|FG000|Cross-over Period|Withdrawal by Subject|2|||
162789976|NCT00583947|587941292|FG001|Cross-over Period|Withdrawal by Subject|0|||
162789977|NCT00583947|587941291|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
162789978|NCT00583947|587941292|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
162789979|NCT00583947|587941291|FG000|Cross-over Period|Other|1|||
162789980|NCT00583947|587941292|FG001|Cross-over Period|Other|1|||
162789981|NCT01261247|587941294|FG000|Overall Study|Ineligible|2|||
162789982|NCT01740154|587941295|FG000|Overall Study|Adverse Event|1|||
162789983|NCT05226130|587941299|FG000|Overall Study|Lost to Follow-up|0|||
162789984|NCT05226130|587941300|FG001|Overall Study|Lost to Follow-up|1|||
162789985|NCT05226130|587941299|FG000|Overall Study|Not treatment adherent|0|||
162789986|NCT05226130|587941300|FG001|Overall Study|Not treatment adherent|2|||
162789987|NCT03358472|587941301|FG000|Overall Study|Death|6|||
162789988|NCT03358472|587941302|FG001|Overall Study|Death|3|||
162789989|NCT03358472|587941303|FG002|Overall Study|Death|10|||
162789990|NCT03358472|587941301|FG000|Overall Study|Physician Decision|0|||
162789991|NCT03358472|587941302|FG001|Overall Study|Physician Decision|1|||
162789992|NCT03358472|587941303|FG002|Overall Study|Physician Decision|0|||
162789993|NCT03358472|587941301|FG000|Overall Study|Withdrawal by Subject|0|||
162789994|NCT03358472|587941302|FG001|Overall Study|Withdrawal by Subject|0|||
162789995|NCT03358472|587941303|FG002|Overall Study|Withdrawal by Subject|1|||
162789996|NCT03358472|587941301|FG000|Overall Study|On-going at clinical cut off date|9|||
162789997|NCT03358472|587941302|FG001|Overall Study|On-going at clinical cut off date|6|||
162789998|NCT03358472|587941303|FG002|Overall Study|On-going at clinical cut off date|5|||
162789999|NCT03974022|587941304|FG000|Overall Study|Death|0|||
162790000|NCT03974022|587941305|FG001|Overall Study|Death|1|||
162790001|NCT03974022|587941306|FG002|Overall Study|Death|0|||
162790002|NCT03974022|587941307|FG003|Overall Study|Death|2|||
162790003|NCT03974022|587941308|FG004|Overall Study|Death|0|||
162790004|NCT03974022|587941309|FG005|Overall Study|Death|1|||
162790005|NCT03974022|587941310|FG006|Overall Study|Death|0|||
162790006|NCT03974022|587941311|FG007|Overall Study|Death|2|||
162790007|NCT03974022|587941312|FG008|Overall Study|Death|1|||
162790008|NCT03974022|587941313|FG009|Overall Study|Death|4|||
162790009|NCT03974022|587941314|FG010|Overall Study|Death|0|||
162790010|NCT03974022|587941315|FG011|Overall Study|Death|0|||
162790011|NCT03974022|587941316|FG012|Overall Study|Death|0|||
162790012|NCT03974022|587941317|FG013|Overall Study|Death|33|||
162790013|NCT03974022|587941318|FG014|Overall Study|Death|40|||
162790014|NCT03974022|587941304|FG000|Overall Study|Withdrawal by Subject|0|||
162790015|NCT03974022|587941305|FG001|Overall Study|Withdrawal by Subject|0|||
162790016|NCT03974022|587941306|FG002|Overall Study|Withdrawal by Subject|0|||
162790017|NCT03974022|587941307|FG003|Overall Study|Withdrawal by Subject|0|||
162790018|NCT03974022|587941308|FG004|Overall Study|Withdrawal by Subject|0|||
162790019|NCT03974022|587941309|FG005|Overall Study|Withdrawal by Subject|4|||
162790020|NCT03974022|587941310|FG006|Overall Study|Withdrawal by Subject|4|||
162790021|NCT03974022|587941311|FG007|Overall Study|Withdrawal by Subject|2|||
162790022|NCT03974022|587941312|FG008|Overall Study|Withdrawal by Subject|2|||
162790023|NCT03974022|587941313|FG009|Overall Study|Withdrawal by Subject|3|||
162790024|NCT03974022|587941314|FG010|Overall Study|Withdrawal by Subject|0|||
162790025|NCT03974022|587941315|FG011|Overall Study|Withdrawal by Subject|1|||
162790026|NCT03974022|587941316|FG012|Overall Study|Withdrawal by Subject|0|||
162790027|NCT03974022|587941317|FG013|Overall Study|Withdrawal by Subject|3|||
162790028|NCT03974022|587941318|FG014|Overall Study|Withdrawal by Subject|9|||
162790029|NCT03974022|587941304|FG000|Overall Study|Lost to Follow-up|0|||
162790030|NCT03974022|587941305|FG001|Overall Study|Lost to Follow-up|0|||
162790031|NCT03974022|587941306|FG002|Overall Study|Lost to Follow-up|0|||
162790032|NCT03974022|587941307|FG003|Overall Study|Lost to Follow-up|0|||
162790033|NCT03974022|587941308|FG004|Overall Study|Lost to Follow-up|0|||
162790034|NCT03974022|587941309|FG005|Overall Study|Lost to Follow-up|0|||
162790035|NCT03974022|587941310|FG006|Overall Study|Lost to Follow-up|1|||
162790036|NCT03974022|587941311|FG007|Overall Study|Lost to Follow-up|0|||
162790037|NCT03974022|587941312|FG008|Overall Study|Lost to Follow-up|0|||
162790038|NCT03974022|587941313|FG009|Overall Study|Lost to Follow-up|0|||
162790039|NCT03974022|587941314|FG010|Overall Study|Lost to Follow-up|0|||
162790040|NCT03974022|587941315|FG011|Overall Study|Lost to Follow-up|0|||
162790041|NCT03974022|587941316|FG012|Overall Study|Lost to Follow-up|0|||
162790042|NCT03974022|587941317|FG013|Overall Study|Lost to Follow-up|1|||
162790043|NCT03974022|587941318|FG014|Overall Study|Lost to Follow-up|1|||
162790044|NCT03974022|587941304|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
162790045|NCT03974022|587941305|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
162790046|NCT03974022|587941306|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
162790047|NCT03974022|587941307|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
162790048|NCT03974022|587941308|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
162790049|NCT03974022|587941309|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
162790050|NCT03974022|587941310|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
162790051|NCT03974022|587941311|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
162790052|NCT03974022|587941312|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
162790053|NCT03974022|587941313|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
162790054|NCT03974022|587941314|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
162790055|NCT03974022|587941315|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
162790056|NCT03974022|587941316|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
162790057|NCT03974022|587941317|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
162790058|NCT03974022|587941318|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
162790059|NCT05032066|587941323|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
162790060|NCT05032066|587941324|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
162790061|NCT05032066|587941325|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
162790062|NCT05032066|587941323|FG000|Part 1: Core Phase|Physician Decision|0|||
162790063|NCT05032066|587941324|FG001|Part 1: Core Phase|Physician Decision|1|||
162790064|NCT05032066|587941325|FG002|Part 1: Core Phase|Physician Decision|1|||
162790065|NCT05032066|587941323|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
162790066|NCT05032066|587941324|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
162790067|NCT05032066|587941325|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
162790068|NCT05032066|587941323|FG000|Part 1: Core Phase|Death|3|||
162790069|NCT05032066|587941324|FG001|Part 1: Core Phase|Death|4|||
162790070|NCT05032066|587941325|FG002|Part 1: Core Phase|Death|2|||
162790071|NCT05032066|587941323|FG000|Part 1: Core Phase|Adverse Event|2|||
162790072|NCT05032066|587941324|FG001|Part 1: Core Phase|Adverse Event|3|||
162790073|NCT05032066|587941325|FG002|Part 1: Core Phase|Adverse Event|0|||
162790074|NCT05032066|587941323|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
162790075|NCT05032066|587941324|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
162790076|NCT05032066|587941325|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
162790077|NCT05032066|587941323|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
162790078|NCT05032066|587941324|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
162790079|NCT05032066|587941325|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
162790080|NCT05032066|587941323|FG000|Part 2: Extension Phase|Physician Decision|1|||
162790081|NCT05032066|587941324|FG001|Part 2: Extension Phase|Physician Decision|2|||
162790082|NCT05032066|587941325|FG002|Part 2: Extension Phase|Physician Decision|0|||
162790083|NCT05032066|587941323|FG000|Part 2: Extension Phase|Death|2|||
162790084|NCT05032066|587941324|FG001|Part 2: Extension Phase|Death|4|||
162790085|NCT05032066|587941325|FG002|Part 2: Extension Phase|Death|5|||
162790086|NCT01124838|587941326|FG000|Overall Study|Miscellaneous|4|||
162790087|NCT01124838|587941327|FG001|Overall Study|Miscellaneous|2|||
162790088|NCT01124838|587941326|FG000|Overall Study|Adverse Event|7|||
162790089|NCT01124838|587941327|FG001|Overall Study|Adverse Event|11|||
162790090|NCT01124838|587941326|FG000|Overall Study|Lack of Efficacy|2|||
162790091|NCT01124838|587941327|FG001|Overall Study|Lack of Efficacy|0|||
162790092|NCT01124838|587941326|FG000|Overall Study|Withdrawal by Subject|3|||
162790093|NCT01124838|587941327|FG001|Overall Study|Withdrawal by Subject|2|||
162790094|NCT01124838|587941326|FG000|Overall Study|Lost to Follow-up|2|||
162790095|NCT01124838|587941327|FG001|Overall Study|Lost to Follow-up|0|||
162790096|NCT06719986|587941328|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
162790097|NCT06719986|587941329|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
162790098|NCT06719986|587941330|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
162790099|NCT06719986|587941328|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
162790100|NCT06719986|587941329|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
162790101|NCT06719986|587941330|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
162790102|NCT03213704|587941332|FG000|Overall Study|Physician Decision|3|||
162790103|NCT03213704|587941332|FG000|Overall Study|Protocol Violation|1|||
162790104|NCT03213704|587941332|FG000|Overall Study|Progressive disease|4|||
162790105|NCT01183390|587942836|FG000|First Intervention|Adverse Event|0|||
162790106|NCT01183390|587942837|FG001|First Intervention|Adverse Event|1|||
162790107|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Adverse Event|2|||
162790108|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Adverse Event|0|||
162790109|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Adverse Event|0|||
162790110|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Adverse Event|0|||
162790111|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
162790112|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
162790113|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
162790114|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
162790115|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
162790116|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
162790117|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
162790118|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
162790119|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Physician Decision|1|||
162790120|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Physician Decision|0|||
162790121|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Physician Decision|0|||
162790122|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Physician Decision|0|||
162790123|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Pregnancy|1|||
162790124|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Pregnancy|0|||
162790125|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Pregnancy|0|||
162790126|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Pregnancy|0|||
162790127|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
162790128|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
162790129|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
162790130|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
162790131|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
162790132|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
162790133|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
162790134|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
162790135|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
162790136|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162790137|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162790138|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162790139|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162790140|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
162790141|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162790142|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162790143|NCT04057573|587942840|FG000|24-Week Double-Blind Period|Not Treated|1|||
162790144|NCT04057573|587942841|FG001|24-Week Double-Blind Period|Not Treated|0|||
162790145|NCT04057573|587942842|FG002|24-Week Double-Blind Period|Not Treated|0|||
162790146|NCT04057573|587942843|FG003|24-Week Double-Blind Period|Not Treated|0|||
162790147|NCT04057573|587942840|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
162790148|NCT04057573|587942841|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
162790149|NCT04057573|587942842|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
162790150|NCT04057573|587942843|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
162790151|NCT04057573|587942840|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162790152|NCT04057573|587942841|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162790153|NCT04057573|587942842|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
162790154|NCT04057573|587942843|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162790155|NCT04057573|587942840|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
162790156|NCT04057573|587942841|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
162790157|NCT04057573|587942842|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
162790158|NCT04057573|587942843|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
162790159|NCT04057573|587942840|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
162790160|NCT04057573|587942841|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
162790161|NCT04057573|587942842|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
162790162|NCT04057573|587942843|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
162790163|NCT04057573|587942840|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162790164|NCT04057573|587942841|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162790165|NCT04057573|587942842|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
162790166|NCT04057573|587942843|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162790167|NCT04991753|587942844|FG000|Overall Study|Withdrawal by Subject|0|||
162790168|NCT04991753|587942845|FG001|Overall Study|Withdrawal by Subject|1|||
162790169|NCT00233480|587942848|FG000|Overall Study|Underwent status II heart transplant|0|||
162790170|NCT00233480|587942849|FG001|Overall Study|Underwent status II heart transplant|1|||
162790171|NCT02980042|587942859|FG000|Overall Study|Lost to Follow-up|5|||
162790172|NCT02980042|587942860|FG001|Overall Study|Lost to Follow-up|0|||
162790173|NCT02980042|587942859|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
162790174|NCT02980042|587942860|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
162790175|NCT02521363|587942861|FG000|Overall Study|Withdrawal by Subject|1|||
162790176|NCT02521363|587942862|FG001|Overall Study|Withdrawal by Subject|2|||
162790177|NCT00953771|587942866|FG000|Overall Study|Death|1|||
162790178|NCT00953771|587942867|FG001|Overall Study|Death|0|||
162790179|NCT00974259|587942868|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
162790180|NCT00974259|587942869|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
162790181|NCT04201288|587942875|FG000|Overall Study|Death|1|||
162790182|NCT04201288|587942876|FG001|Overall Study|Death|1|||
162790183|NCT04201288|587942875|FG000|Overall Study|Lost to Follow-up|5|||
162790184|NCT04201288|587942876|FG001|Overall Study|Lost to Follow-up|3|||
162790185|NCT04201288|587942875|FG000|Overall Study|Withdrawal by Subject|1|||
162790186|NCT04201288|587942876|FG001|Overall Study|Withdrawal by Subject|0|||
162790187|NCT00592293|587942877|FG000|Overall Study|Withdrawal by Subject|1|||
162790188|NCT01606319|587942880|FG000|Overall Study|Lost to Follow-up|17|||
162790189|NCT01606319|587942881|FG001|Overall Study|Lost to Follow-up|14|||
162790190|NCT01606319|587942880|FG000|Overall Study|Withdrawal by Subject|9|||
162790191|NCT01606319|587942881|FG001|Overall Study|Withdrawal by Subject|12|||
162790192|NCT01606319|587942880|FG000|Overall Study|Physician Decision|1|||
162790193|NCT01606319|587942881|FG001|Overall Study|Physician Decision|2|||
162790194|NCT01606319|587942880|FG000|Overall Study|Lack of Efficacy|6|||
162790195|NCT01606319|587942881|FG001|Overall Study|Lack of Efficacy|8|||
162790196|NCT01606319|587942880|FG000|Overall Study|Adverse Event|1|||
162790197|NCT01606319|587942881|FG001|Overall Study|Adverse Event|4|||
162790198|NCT01270828|587942882|FG000|Pregabalin CR SB|Reason Unspecified|0|||
162790199|NCT01270828|587942883|FG001|Pregabalin CR SB|Reason Unspecified|0|||
162790200|NCT01270828|587942884|FG002|Pregabalin CR SB|Reason Unspecified|8|||
162790201|NCT01270828|587942882|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
162790202|NCT01270828|587942883|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
162790203|NCT01270828|587942884|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
162790204|NCT01270828|587942882|FG000|Pregabalin CR SB|Related adverse event|0|||
162790205|NCT01270828|587942883|FG001|Pregabalin CR SB|Related adverse event|0|||
162790206|NCT01270828|587942884|FG002|Pregabalin CR SB|Related adverse event|46|||
162790207|NCT01270828|587942882|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
162790208|NCT01270828|587942883|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
162790209|NCT01270828|587942884|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
162790210|NCT01270828|587942882|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
162790211|NCT01270828|587942883|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
162790212|NCT01270828|587942884|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
162790213|NCT01270828|587942882|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
162790214|NCT01270828|587942883|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
162790215|NCT01270828|587942884|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
162790216|NCT01270828|587942882|FG000|Pregabalin CR SB|Unrelated AE|0|||
162790217|NCT01270828|587942883|FG001|Pregabalin CR SB|Unrelated AE|0|||
162790218|NCT01270828|587942884|FG002|Pregabalin CR SB|Unrelated AE|8|||
162790219|NCT01270828|587942882|FG000|Pregabalin CR SB|Protocol Violation|0|||
162790220|NCT01270828|587942883|FG001|Pregabalin CR SB|Protocol Violation|0|||
162790221|NCT01270828|587942884|FG002|Pregabalin CR SB|Protocol Violation|8|||
162790222|NCT01270828|587942882|FG000|Double Blind Phase|Death|0|||
162790223|NCT01270828|587942883|FG001|Double Blind Phase|Death|1|||
162790224|NCT01270828|587942884|FG002|Double Blind Phase|Death|0|||
162790225|NCT01270828|587942882|FG000|Double Blind Phase|Protocol Violation|0|||
162790226|NCT01270828|587942883|FG001|Double Blind Phase|Protocol Violation|1|||
162790227|NCT01270828|587942884|FG002|Double Blind Phase|Protocol Violation|0|||
162790228|NCT01270828|587942882|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
162790229|NCT01270828|587942883|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
162790230|NCT01270828|587942884|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
162790231|NCT01270828|587942882|FG000|Double Blind Phase|Reason Unspecified|7|||
162790232|NCT01270828|587942883|FG001|Double Blind Phase|Reason Unspecified|4|||
162790233|NCT01270828|587942884|FG002|Double Blind Phase|Reason Unspecified|0|||
162790234|NCT01270828|587942882|FG000|Double Blind Phase|Withdrawal by Subject|6|||
162790235|NCT01270828|587942883|FG001|Double Blind Phase|Withdrawal by Subject|15|||
162790236|NCT01270828|587942884|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162790237|NCT01270828|587942882|FG000|Double Blind Phase|Lost to Follow-up|1|||
162790238|NCT01270828|587942883|FG001|Double Blind Phase|Lost to Follow-up|2|||
162790239|NCT01270828|587942884|FG002|Double Blind Phase|Lost to Follow-up|0|||
162790240|NCT01270828|587942882|FG000|Double Blind Phase|Lack of Efficacy|2|||
162790241|NCT01270828|587942883|FG001|Double Blind Phase|Lack of Efficacy|11|||
162790242|NCT01270828|587942884|FG002|Double Blind Phase|Lack of Efficacy|0|||
162790243|NCT01270828|587942882|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
162790244|NCT01270828|587942883|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
162790245|NCT01270828|587942884|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
162790246|NCT01270828|587942882|FG000|Double Blind Phase|Adverse event related to study drug|5|||
162790247|NCT01270828|587942883|FG001|Double Blind Phase|Adverse event related to study drug|7|||
162790248|NCT01270828|587942884|FG002|Double Blind Phase|Adverse event related to study drug|0|||
162790249|NCT02870972|587942888|FG000|Overall Study|Adverse Event|1|||
162790250|NCT02870972|587942889|FG001|Overall Study|Adverse Event|0|||
162790251|NCT02870972|587942890|FG002|Overall Study|Adverse Event|0|||
162790252|NCT02870972|587942891|FG003|Overall Study|Adverse Event|0|||
162790253|NCT02870972|587942892|FG004|Overall Study|Adverse Event|0|||
162790254|NCT01821937|587942897|FG000|Overall Study|Adverse Event|0|||
162790255|NCT01821937|587942898|FG001|Overall Study|Adverse Event|3|||
162790256|NCT02030002|587942900|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
162790257|NCT02030002|587942900|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
162790258|NCT02030002|587942900|FG000|Follow-up|Lost to Follow-up|2|||
162790259|NCT02406248|587942901|FG000|Overall Study|Death|7|||
162790260|NCT02406248|587942901|FG000|Overall Study|Withdrawal by Subject|2|||
162790261|NCT01689857|587942903|FG000|Overall Study|Lost to Follow-up|5|||
162790262|NCT01689857|587942904|FG001|Overall Study|Lost to Follow-up|2|||
162790263|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
162790264|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
162790265|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
162790266|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
162790267|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
162790268|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162790269|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162790270|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162810577|NCT00887250|588018277|FG002|Overall Study|Lack of Efficacy|1|||
162790271|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
162790272|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
162790273|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
162790274|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
162790275|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
162790276|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
162790277|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
162790278|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
162790279|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
162790280|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
162790281|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
162790282|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
162790283|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
162790284|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
162790285|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
162790286|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
162790287|NCT00479882|587942907|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
162790288|NCT00479882|587942908|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
162790289|NCT00479882|587942909|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
162790290|NCT00479882|587942910|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
162790291|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
162790292|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
162790293|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
162790294|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
162790295|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
162790296|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
162790297|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
162790298|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
162790299|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162790300|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
162790301|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162790302|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162790303|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
162790304|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
162790305|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
162790306|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
162790307|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
162790308|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
162790309|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
162790310|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
162790311|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162790312|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162790313|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
162790314|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162790315|NCT00479882|587942907|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162790316|NCT00479882|587942908|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162790317|NCT00479882|587942909|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
162790318|NCT00479882|587942910|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162790319|NCT03106753|587942911|FG000|Overall Study|Withdrawal by Subject|0|||
162790320|NCT03106753|587942912|FG001|Overall Study|Withdrawal by Subject|1|||
162790321|NCT01643044|587942914|FG000|Overall Study|Lost to Follow-up|1|||
162790322|NCT01643044|587942915|FG001|Overall Study|Lost to Follow-up|1|||
162790323|NCT01643044|587942914|FG000|Overall Study|Miscarried baby|2|||
162790324|NCT01643044|587942915|FG001|Overall Study|Miscarried baby|2|||
162790325|NCT01643044|587942914|FG000|Overall Study|Delivered outside of hospital|1|||
162790326|NCT01643044|587942915|FG001|Overall Study|Delivered outside of hospital|2|||
162790327|NCT03149042|587942916|FG000|Overall Study|Invasive FFR not performed|21|||
162790328|NCT03149042|587942916|FG000|Overall Study|Poor CT Image Quality|1|||
162790329|NCT03149042|587942916|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
162790330|NCT01023958|587942919|FG000|Overall Study|Progressive disease|48|||
162790331|NCT01023958|587942919|FG000|Overall Study|Other adverse event|1|||
162790332|NCT01023958|587942919|FG000|Overall Study|Refused to continue medication|1|||
162790333|NCT02362503|587942920|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
162790334|NCT02362503|587942921|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
162790335|NCT02362503|587942922|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
162790336|NCT02362503|587942920|FG000|Double-blind Period-Up to 8 Days|Death|1|||
162790337|NCT02362503|587942921|FG001|Double-blind Period-Up to 8 Days|Death|0|||
162790338|NCT02362503|587942922|FG002|Double-blind Period-Up to 8 Days|Death|0|||
162790339|NCT02362503|587942920|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
162790340|NCT02362503|587942921|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
162790341|NCT02362503|587942922|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
162790342|NCT02362503|587942920|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
162790343|NCT02362503|587942921|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
162790344|NCT02362503|587942922|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
162790345|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
162790346|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
162790347|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
162790348|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
162790349|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
162790350|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
162790351|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
162790352|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
162790353|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
162790354|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
162790355|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
162790356|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
162790357|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
162790358|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
162790359|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
162790360|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
162790361|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
162790362|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
162790363|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
162790364|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
162790365|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
162790366|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
162790367|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
162790368|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
162790369|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
162790370|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
162790371|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
162790372|NCT02362503|587942920|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
162790373|NCT02362503|587942921|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
162790374|NCT02362503|587942922|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
162790375|NCT00762476|587942923|FG000|Overall Study|Adverse Event|7|||
162790376|NCT00762476|587942924|FG001|Overall Study|Adverse Event|1|||
162790377|NCT00762476|587942923|FG000|Overall Study|Lost to Follow-up|2|||
162790378|NCT00762476|587942924|FG001|Overall Study|Lost to Follow-up|0|||
162790379|NCT00762476|587942923|FG000|Overall Study|Protocol Violation|5|||
162790380|NCT00762476|587942924|FG001|Overall Study|Protocol Violation|6|||
162790381|NCT00762476|587942923|FG000|Overall Study|Physician Decision|2|||
162790382|NCT00762476|587942924|FG001|Overall Study|Physician Decision|14|||
162790383|NCT00762476|587942923|FG000|Overall Study|Withdrawal by Subject|6|||
162790384|NCT00762476|587942924|FG001|Overall Study|Withdrawal by Subject|12|||
162790385|NCT00762476|587942923|FG000|Overall Study|antibiotic use|0|||
162790386|NCT00762476|587942924|FG001|Overall Study|antibiotic use|1|||
162790387|NCT00762476|587942923|FG000|Overall Study|non-compliance with study visits|0|||
162790388|NCT00762476|587942924|FG001|Overall Study|non-compliance with study visits|2|||
162790389|NCT00762476|587942923|FG000|Overall Study|Seasonal allergies|1|||
162790390|NCT00762476|587942924|FG001|Overall Study|Seasonal allergies|0|||
162790391|NCT02838134|587942925|FG000|Overall Study|Lost to Follow-up|1|||
162790392|NCT02838134|587942926|FG001|Overall Study|Lost to Follow-up|2|||
162790393|NCT02838134|587942925|FG000|Overall Study|logistic problems|1|||
162790394|NCT02838134|587942926|FG001|Overall Study|logistic problems|1|||
162790395|NCT01912404|587942930|FG000|Overall Study|Due to personal reasons|1|||
162790396|NCT01912404|587942931|FG001|Overall Study|Due to personal reasons|0|||
162790397|NCT01430468|587942932|FG000|Overall Study|Physician Decision|2|||
162790398|NCT01430468|587942933|FG001|Overall Study|Physician Decision|1|||
162790399|NCT01430468|587942932|FG000|Overall Study|Withdrawal by Subject|5|||
162790400|NCT01430468|587942933|FG001|Overall Study|Withdrawal by Subject|5|||
162790401|NCT01281839|587942934|FG000|Overall Study|Lost to Follow-up|6|||
162790402|NCT01281839|587942935|FG001|Overall Study|Lost to Follow-up|3|||
162790403|NCT01281839|587942934|FG000|Overall Study|Withdrawal by Subject|4|||
162790404|NCT01281839|587942935|FG001|Overall Study|Withdrawal by Subject|10|||
162790405|NCT01281839|587942934|FG000|Overall Study|Reason not specified|0|||
162790406|NCT01281839|587942935|FG001|Overall Study|Reason not specified|1|||
162790407|NCT01443923|587942936|FG000|Overall Study|Adverse Event|1|||
162790408|NCT01443923|587942937|FG001|Overall Study|Adverse Event|0|||
162790409|NCT04547023|587942940|FG000|Overall Study|Did Not Receive Intervention|3|||
162790410|NCT04547023|587942941|FG001|Overall Study|Did Not Receive Intervention|2|||
162790411|NCT04547023|587942940|FG000|Overall Study|Lost to Follow-up|1|||
162790412|NCT04547023|587942941|FG001|Overall Study|Lost to Follow-up|1|||
162790413|NCT01245374|587942942|FG000|Overall Study|Protocol Violation|1|||
162790414|NCT01245374|587942942|FG000|Overall Study|Withdrawal by Subject|3|||
162790415|NCT04674189|587942944|FG000|Overall Study|Adverse Event|0|||
162790416|NCT04674189|587942945|FG001|Overall Study|Adverse Event|0|||
162790417|NCT04674189|587942946|FG002|Overall Study|Adverse Event|1|||
162790418|NCT04674189|587942944|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
162790419|NCT04674189|587942945|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
162790420|NCT04674189|587942946|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
162790421|NCT04674189|587942944|FG000|Overall Study|Physician Decision|1|||
162790422|NCT04674189|587942945|FG001|Overall Study|Physician Decision|0|||
162790423|NCT04674189|587942946|FG002|Overall Study|Physician Decision|0|||
162790424|NCT04674189|587942944|FG000|Overall Study|Withdrawal by Participant|83|||
162790425|NCT04674189|587942945|FG001|Overall Study|Withdrawal by Participant|71|||
162790426|NCT04674189|587942946|FG002|Overall Study|Withdrawal by Participant|142|||
162790427|NCT04674189|587942944|FG000|Overall Study|Lost to Follow-up|55|||
162790428|NCT04674189|587942945|FG001|Overall Study|Lost to Follow-up|53|||
162790429|NCT04674189|587942946|FG002|Overall Study|Lost to Follow-up|44|||
162790430|NCT04674189|587942944|FG000|Overall Study|Miscellaneous|27|||
162790431|NCT04674189|587942945|FG001|Overall Study|Miscellaneous|23|||
162790432|NCT04674189|587942946|FG002|Overall Study|Miscellaneous|207|||
162790433|NCT04674189|587942944|FG000|Overall Study|Did Not Receive Treatment|3|||
162790434|NCT04674189|587942945|FG001|Overall Study|Did Not Receive Treatment|1|||
162790435|NCT04674189|587942946|FG002|Overall Study|Did Not Receive Treatment|2|||
162790436|NCT04013971|587942951|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
162790437|NCT04013971|587942952|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
162790438|NCT04013971|587942951|FG000|Overall Study|Missing biomechanical data|0|||
162790439|NCT04013971|587942952|FG001|Overall Study|Missing biomechanical data|1|||
162790440|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Adverse Event|10|||
162790441|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Adverse Event|9|||
162790442|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Adverse Event|7|||
162790443|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
162790444|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
162790445|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
162790446|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
162790447|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
162790448|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
162790449|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Physician Decision|7|||
162790450|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Physician Decision|3|||
162790451|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Physician Decision|2|||
162790452|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Pregnancy|2|||
162790453|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Pregnancy|1|||
162790454|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Pregnancy|3|||
162790455|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
162790456|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
162790457|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
162790458|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
162790459|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
162790460|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
162790461|NCT02614183|587942955|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
162790462|NCT02614183|587942956|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
162790463|NCT02614183|587942957|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
162790464|NCT02614183|587942955|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
162790465|NCT02614183|587942956|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162790466|NCT02614183|587942957|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
162790467|NCT02614183|587942955|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
162790468|NCT02614183|587942956|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
162790469|NCT02614183|587942957|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
162790470|NCT02614183|587942955|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
162790471|NCT02614183|587942956|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
162790472|NCT02614183|587942957|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
162790473|NCT02614183|587942955|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
162790474|NCT02614183|587942956|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
162790475|NCT02614183|587942957|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
162790476|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162790477|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162790478|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162790479|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
162790480|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162790481|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162790482|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162790483|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
162790484|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162790485|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162790486|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162790487|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
162790488|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162790489|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162790490|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162790491|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
162790492|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162790493|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162790494|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162790495|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
162790496|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162790497|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162790498|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162790499|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
162790500|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162790501|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162790502|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162790503|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
162790504|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
162790505|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
162790506|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
162790507|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
162790508|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162790509|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162790510|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162790511|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
162790512|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162790513|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162790514|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162790515|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
162790516|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162790517|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162790518|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162790519|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
162790520|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
162790521|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
162790522|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
162790523|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
162790524|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162790525|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162790526|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162790527|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
162790528|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162790529|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162790530|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162790531|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
162790532|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162790533|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162790534|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162790535|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
162790536|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
162790537|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
162790538|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
162790539|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
162790540|NCT00217737|587942958|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
162790541|NCT00217737|587942959|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
162790542|NCT00217737|587942960|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
162790543|NCT00217737|587942961|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
162790544|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
162790545|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
162790546|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
162790547|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
162790548|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
162790549|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
162790550|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
162790551|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
162790552|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Study suspension|0|||
162790553|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Study suspension|45|||
162790554|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Study suspension|0|||
162790555|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Study suspension|0|||
162790556|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
162790557|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
162790558|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
162790559|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
162790560|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Death|2|||
162790561|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Death|3|||
162790562|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Death|0|||
162790563|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Death|0|||
162790564|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
162790565|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
162790566|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
162790567|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
162790568|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
162790569|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
162790570|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
162790571|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
162790572|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
162790573|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
162790574|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
162790575|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
162790576|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162790577|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
162790578|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162790579|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162790580|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162790581|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
162790582|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162790583|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162790584|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
162790585|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162790586|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162790587|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162790588|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
162790589|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
162790590|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
162790591|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
162790592|NCT00217737|587942958|FG000|Step 2 Randomization/Registration|Other|1|||
162790593|NCT00217737|587942959|FG001|Step 2 Randomization/Registration|Other|2|||
162790594|NCT00217737|587942960|FG002|Step 2 Randomization/Registration|Other|0|||
162790595|NCT00217737|587942961|FG003|Step 2 Randomization/Registration|Other|0|||
162790596|NCT04680533|587942962|FG000|Overall Study|Screen failure|1|||
162790597|NCT00474526|587944928|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
162790598|NCT00474526|587944929|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
162790599|NCT00474526|587944930|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
162790600|NCT00474526|587944931|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
162790601|NCT00474526|587944932|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
162790602|NCT00474526|587944933|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
162790603|NCT00474526|587944934|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
162790604|NCT00474526|587944935|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
162790605|NCT00474526|587944936|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
162790606|NCT00474526|587944937|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
162790607|NCT00474526|587944938|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
162790608|NCT00474526|587944939|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
162790609|NCT00474526|587944940|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
162790610|NCT00474526|587944941|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
162790611|NCT00474526|587944942|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
162790612|NCT00474526|587944943|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
162790613|NCT00474526|587944944|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
162790614|NCT00474526|587944928|FG000|Overall Study|Adverse Event|2|||
162790615|NCT00474526|587944929|FG001|Overall Study|Adverse Event|0|||
162790616|NCT00474526|587944930|FG002|Overall Study|Adverse Event|2|||
162790617|NCT00474526|587944931|FG003|Overall Study|Adverse Event|4|||
162790618|NCT00474526|587944932|FG004|Overall Study|Adverse Event|2|||
162790619|NCT00474526|587944933|FG005|Overall Study|Adverse Event|1|||
162790620|NCT00474526|587944934|FG006|Overall Study|Adverse Event|1|||
162790621|NCT00474526|587944935|FG007|Overall Study|Adverse Event|0|||
162790622|NCT00474526|587944936|FG008|Overall Study|Adverse Event|0|||
162790623|NCT00474526|587944937|FG009|Overall Study|Adverse Event|0|||
162790624|NCT00474526|587944938|FG010|Overall Study|Adverse Event|0|||
162790625|NCT00474526|587944939|FG011|Overall Study|Adverse Event|0|||
162790626|NCT00474526|587944940|FG012|Overall Study|Adverse Event|0|||
162790627|NCT00474526|587944941|FG013|Overall Study|Adverse Event|0|||
162790628|NCT00474526|587944942|FG014|Overall Study|Adverse Event|1|||
162790629|NCT00474526|587944943|FG015|Overall Study|Adverse Event|1|||
162790630|NCT00474526|587944944|FG016|Overall Study|Adverse Event|0|||
162790631|NCT00474526|587944928|FG000|Overall Study|Death|0|||
162790632|NCT00474526|587944929|FG001|Overall Study|Death|0|||
162790633|NCT00474526|587944930|FG002|Overall Study|Death|0|||
162790634|NCT00474526|587944931|FG003|Overall Study|Death|0|||
162790635|NCT00474526|587944932|FG004|Overall Study|Death|0|||
162790636|NCT00474526|587944933|FG005|Overall Study|Death|0|||
162790637|NCT00474526|587944934|FG006|Overall Study|Death|0|||
162790638|NCT00474526|587944935|FG007|Overall Study|Death|0|||
162790639|NCT00474526|587944936|FG008|Overall Study|Death|0|||
162790640|NCT00474526|587944937|FG009|Overall Study|Death|0|||
162790641|NCT00474526|587944938|FG010|Overall Study|Death|0|||
162790642|NCT00474526|587944939|FG011|Overall Study|Death|0|||
162790643|NCT00474526|587944940|FG012|Overall Study|Death|0|||
162790644|NCT00474526|587944941|FG013|Overall Study|Death|3|||
162790645|NCT00474526|587944942|FG014|Overall Study|Death|0|||
162790646|NCT00474526|587944943|FG015|Overall Study|Death|0|||
162790647|NCT00474526|587944944|FG016|Overall Study|Death|0|||
162790648|NCT00474526|587944928|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790649|NCT00474526|587944929|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
162790650|NCT00474526|587944930|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790651|NCT00474526|587944931|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
162790652|NCT00474526|587944932|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162790653|NCT00474526|587944933|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790654|NCT00474526|587944934|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790655|NCT00474526|587944935|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790656|NCT00474526|587944936|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790657|NCT00474526|587944937|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790658|NCT00474526|587944938|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790659|NCT00474526|587944939|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790660|NCT00474526|587944940|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790661|NCT00474526|587944941|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162790662|NCT00474526|587944942|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162790663|NCT00474526|587944943|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790664|NCT00474526|587944944|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162790665|NCT00474526|587944928|FG000|Overall Study|Lost to Follow-up|8|||
162790666|NCT00474526|587944929|FG001|Overall Study|Lost to Follow-up|6|||
162790667|NCT00474526|587944930|FG002|Overall Study|Lost to Follow-up|13|||
162790668|NCT00474526|587944931|FG003|Overall Study|Lost to Follow-up|29|||
162790669|NCT00474526|587944932|FG004|Overall Study|Lost to Follow-up|11|||
162790670|NCT00474526|587944933|FG005|Overall Study|Lost to Follow-up|5|||
162790671|NCT00474526|587944934|FG006|Overall Study|Lost to Follow-up|8|||
162790672|NCT00474526|587944935|FG007|Overall Study|Lost to Follow-up|1|||
162790673|NCT00474526|587944936|FG008|Overall Study|Lost to Follow-up|0|||
162790674|NCT00474526|587944937|FG009|Overall Study|Lost to Follow-up|6|||
162790675|NCT00474526|587944938|FG010|Overall Study|Lost to Follow-up|2|||
162790676|NCT00474526|587944939|FG011|Overall Study|Lost to Follow-up|4|||
162790677|NCT00474526|587944940|FG012|Overall Study|Lost to Follow-up|6|||
162790678|NCT00474526|587944941|FG013|Overall Study|Lost to Follow-up|74|||
162790679|NCT00474526|587944942|FG014|Overall Study|Lost to Follow-up|29|||
162790680|NCT00474526|587944943|FG015|Overall Study|Lost to Follow-up|4|||
162790681|NCT00474526|587944944|FG016|Overall Study|Lost to Follow-up|5|||
162790682|NCT00474526|587944928|FG000|Overall Study|Protocol Violation|2|||
162790683|NCT00474526|587944929|FG001|Overall Study|Protocol Violation|6|||
162790684|NCT00474526|587944930|FG002|Overall Study|Protocol Violation|4|||
162790685|NCT00474526|587944931|FG003|Overall Study|Protocol Violation|12|||
162790686|NCT00474526|587944932|FG004|Overall Study|Protocol Violation|3|||
162790687|NCT00474526|587944933|FG005|Overall Study|Protocol Violation|1|||
162790688|NCT00474526|587944934|FG006|Overall Study|Protocol Violation|3|||
162790689|NCT00474526|587944935|FG007|Overall Study|Protocol Violation|0|||
162790690|NCT00474526|587944936|FG008|Overall Study|Protocol Violation|0|||
162790691|NCT00474526|587944937|FG009|Overall Study|Protocol Violation|4|||
162790692|NCT00474526|587944938|FG010|Overall Study|Protocol Violation|2|||
162790693|NCT00474526|587944939|FG011|Overall Study|Protocol Violation|2|||
162790694|NCT00474526|587944940|FG012|Overall Study|Protocol Violation|4|||
162790695|NCT00474526|587944941|FG013|Overall Study|Protocol Violation|19|||
162790696|NCT00474526|587944942|FG014|Overall Study|Protocol Violation|9|||
162790697|NCT00474526|587944943|FG015|Overall Study|Protocol Violation|6|||
162790698|NCT00474526|587944944|FG016|Overall Study|Protocol Violation|2|||
162790699|NCT00474526|587944928|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
162790700|NCT00474526|587944929|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
162790701|NCT00474526|587944930|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
162790702|NCT00474526|587944931|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
162790703|NCT00474526|587944932|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
162790704|NCT00474526|587944933|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
162790705|NCT00474526|587944934|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
162790706|NCT00474526|587944935|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
162790707|NCT00474526|587944936|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
162790708|NCT00474526|587944937|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
162790709|NCT00474526|587944938|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
162790710|NCT00474526|587944939|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
162790711|NCT00474526|587944940|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
162790712|NCT00474526|587944941|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
162790713|NCT00474526|587944942|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
162790714|NCT00474526|587944943|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
162790715|NCT00474526|587944944|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
162790716|NCT00474526|587944928|FG000|Overall Study|Withdrawal by Subject|9|||
162790717|NCT00474526|587944929|FG001|Overall Study|Withdrawal by Subject|24|||
162790718|NCT00474526|587944930|FG002|Overall Study|Withdrawal by Subject|21|||
162790719|NCT00474526|587944931|FG003|Overall Study|Withdrawal by Subject|52|||
162790720|NCT00474526|587944932|FG004|Overall Study|Withdrawal by Subject|38|||
162790721|NCT00474526|587944933|FG005|Overall Study|Withdrawal by Subject|6|||
162790722|NCT00474526|587944934|FG006|Overall Study|Withdrawal by Subject|12|||
162790723|NCT00474526|587944935|FG007|Overall Study|Withdrawal by Subject|4|||
162790724|NCT00474526|587944936|FG008|Overall Study|Withdrawal by Subject|4|||
162790725|NCT00474526|587944937|FG009|Overall Study|Withdrawal by Subject|13|||
162790726|NCT00474526|587944938|FG010|Overall Study|Withdrawal by Subject|5|||
162790727|NCT00474526|587944939|FG011|Overall Study|Withdrawal by Subject|4|||
162790728|NCT00474526|587944940|FG012|Overall Study|Withdrawal by Subject|4|||
162790729|NCT00474526|587944941|FG013|Overall Study|Withdrawal by Subject|37|||
162790730|NCT00474526|587944942|FG014|Overall Study|Withdrawal by Subject|22|||
162790731|NCT00474526|587944943|FG015|Overall Study|Withdrawal by Subject|1|||
162790732|NCT00474526|587944944|FG016|Overall Study|Withdrawal by Subject|1|||
162790733|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
162790734|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
162790735|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
162790736|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
162790737|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
162790738|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
162790739|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
162790740|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
162790741|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
162790742|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
162790743|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
162790744|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
162790745|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
162790746|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
162790747|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
162790748|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
162790749|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
162790750|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
162790751|NCT00132678|587944945|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
162790752|NCT00132678|587944946|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
162790753|NCT00132678|587944947|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
162790754|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Death|2|||
162790755|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Death|0|||
162790756|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Death|0|||
162790757|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
162790758|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
162790759|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
162790760|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
162790761|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
162790762|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
162790763|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
162790764|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
162790765|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
162790766|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
162790767|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
162790768|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
162790769|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
162790770|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
162790771|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
162790772|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
162790773|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
162790774|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
162790775|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
162790776|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
162790777|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
162790778|NCT00132678|587944945|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
162790779|NCT00132678|587944946|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
162790780|NCT00132678|587944947|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
162790781|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
162790782|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
162790783|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
162790784|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
162790785|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
162790786|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
162790787|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
162790788|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
162790789|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
162790790|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
162790791|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
162790792|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
162790793|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
162790794|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
162790795|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
162790796|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
162790797|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
162790798|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
162790799|NCT00132678|587944945|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
162790800|NCT00132678|587944946|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
162790801|NCT00132678|587944947|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
162790802|NCT00953147|587944948|FG000|Overall Study|Adverse Event|8|||
162790803|NCT00953147|587944949|FG001|Overall Study|Adverse Event|16|||
162790804|NCT00953147|587944950|FG002|Overall Study|Adverse Event|6|||
162790805|NCT00953147|587944948|FG000|Overall Study|Protocol Violation|2|||
162790806|NCT00953147|587944949|FG001|Overall Study|Protocol Violation|8|||
162790807|NCT00953147|587944950|FG002|Overall Study|Protocol Violation|4|||
162790808|NCT00953147|587944948|FG000|Overall Study|Withdrawal by Subject|13|||
162790809|NCT00953147|587944949|FG001|Overall Study|Withdrawal by Subject|15|||
162790810|NCT00953147|587944950|FG002|Overall Study|Withdrawal by Subject|12|||
162790811|NCT00953147|587944948|FG000|Overall Study|Lost to Follow-up|8|||
162790812|NCT00953147|587944949|FG001|Overall Study|Lost to Follow-up|9|||
162790813|NCT00953147|587944950|FG002|Overall Study|Lost to Follow-up|4|||
162790814|NCT00953147|587944948|FG000|Overall Study|Physician Decision|2|||
162790815|NCT00953147|587944949|FG001|Overall Study|Physician Decision|7|||
162790816|NCT00953147|587944950|FG002|Overall Study|Physician Decision|3|||
162790817|NCT00953147|587944948|FG000|Overall Study|Other|4|||
162790818|NCT00953147|587944949|FG001|Overall Study|Other|11|||
162790819|NCT00953147|587944950|FG002|Overall Study|Other|13|||
162790820|NCT01484431|587944951|FG000|Period 1: High Dose|Physician Decision|0|||
162790821|NCT01484431|587944952|FG001|Period 1: High Dose|Physician Decision|1|||
162790822|NCT01484431|587944953|FG002|Period 1: High Dose|Physician Decision|0|||
162790823|NCT01484431|587944951|FG000|Period 2|Death|0|||
162790824|NCT01484431|587944952|FG001|Period 2|Death|1|||
162790825|NCT01484431|587944953|FG002|Period 2|Death|1|||
162790826|NCT01484431|587944951|FG000|Period 2|Physician Decision|0|||
162790827|NCT01484431|587944952|FG001|Period 2|Physician Decision|0|||
162790828|NCT01484431|587944953|FG002|Period 2|Physician Decision|1|||
162790829|NCT01484431|587944951|FG000|Period 2|Non-Compliance with Study Drug|1|||
162790830|NCT01484431|587944952|FG001|Period 2|Non-Compliance with Study Drug|0|||
162790831|NCT01484431|587944953|FG002|Period 2|Non-Compliance with Study Drug|0|||
162790832|NCT01251770|587944954|FG000|Overall Study|Protocol Violation|13|||
162790833|NCT01251770|587944955|FG001|Overall Study|Protocol Violation|7|||
162790834|NCT02514239|587944956|FG000|Overall Study|Refused to continue trial medication|0|||
162790835|NCT02514239|587944957|FG001|Overall Study|Refused to continue trial medication|0|||
162790836|NCT02514239|587944958|FG002|Overall Study|Refused to continue trial medication|0|||
162810578|NCT00887250|588018275|FG000|Overall Study|Lost to Follow-up|2|||
162790837|NCT02514239|587944959|FG003|Overall Study|Refused to continue trial medication|0|||
162790838|NCT02514239|587944960|FG004|Overall Study|Refused to continue trial medication|0|||
162790839|NCT02514239|587944961|FG005|Overall Study|Refused to continue trial medication|0|||
162790840|NCT02514239|587944962|FG006|Overall Study|Refused to continue trial medication|0|||
162790841|NCT02514239|587944963|FG007|Overall Study|Refused to continue trial medication|0|||
162790842|NCT02514239|587944964|FG008|Overall Study|Refused to continue trial medication|0|||
162790843|NCT02514239|587944965|FG009|Overall Study|Refused to continue trial medication|1|||
162790844|NCT02514239|587944956|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790845|NCT02514239|587944957|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790846|NCT02514239|587944958|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790847|NCT02514239|587944959|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790848|NCT02514239|587944960|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790849|NCT02514239|587944961|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790850|NCT02514239|587944962|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790851|NCT02514239|587944963|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
162790852|NCT02514239|587944964|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
162790853|NCT02514239|587944965|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
162790854|NCT02514239|587944956|FG000|Overall Study|Not treated|0|||
162790855|NCT02514239|587944957|FG001|Overall Study|Not treated|1|||
162790856|NCT02514239|587944958|FG002|Overall Study|Not treated|0|||
162790857|NCT02514239|587944959|FG003|Overall Study|Not treated|0|||
162790858|NCT02514239|587944960|FG004|Overall Study|Not treated|0|||
162790859|NCT02514239|587944961|FG005|Overall Study|Not treated|0|||
162790860|NCT02514239|587944962|FG006|Overall Study|Not treated|0|||
162790861|NCT02514239|587944963|FG007|Overall Study|Not treated|0|||
162790862|NCT02514239|587944964|FG008|Overall Study|Not treated|0|||
162790863|NCT02514239|587944965|FG009|Overall Study|Not treated|0|||
162790864|NCT02514239|587944956|FG000|Overall Study|Other Adverse Events|2|||
162790865|NCT02514239|587944957|FG001|Overall Study|Other Adverse Events|0|||
162790866|NCT02514239|587944958|FG002|Overall Study|Other Adverse Events|0|||
162790867|NCT02514239|587944959|FG003|Overall Study|Other Adverse Events|1|||
162790868|NCT02514239|587944960|FG004|Overall Study|Other Adverse Events|0|||
162790869|NCT02514239|587944961|FG005|Overall Study|Other Adverse Events|1|||
162790870|NCT02514239|587944962|FG006|Overall Study|Other Adverse Events|0|||
162790871|NCT02514239|587944963|FG007|Overall Study|Other Adverse Events|1|||
162790872|NCT02514239|587944964|FG008|Overall Study|Other Adverse Events|2|||
162790873|NCT02514239|587944965|FG009|Overall Study|Other Adverse Events|0|||
162790874|NCT02514239|587944956|FG000|Overall Study|Progressive disease|3|||
162790875|NCT02514239|587944957|FG001|Overall Study|Progressive disease|3|||
162790876|NCT02514239|587944958|FG002|Overall Study|Progressive disease|2|||
162790877|NCT02514239|587944959|FG003|Overall Study|Progressive disease|2|||
162790878|NCT02514239|587944960|FG004|Overall Study|Progressive disease|3|||
162790879|NCT02514239|587944961|FG005|Overall Study|Progressive disease|3|||
162790880|NCT02514239|587944962|FG006|Overall Study|Progressive disease|4|||
162790881|NCT02514239|587944963|FG007|Overall Study|Progressive disease|2|||
162790882|NCT02514239|587944964|FG008|Overall Study|Progressive disease|5|||
162790883|NCT02514239|587944965|FG009|Overall Study|Progressive disease|0|||
162790884|NCT03299049|587944966|FG000|Overall Study|On-going|486|||
162790885|NCT03299049|587944967|FG001|Overall Study|On-going|481|||
162790886|NCT03299049|587944966|FG000|Overall Study|Withdrawal by Subject|6|||
162790887|NCT03299049|587944967|FG001|Overall Study|Withdrawal by Subject|21|||
162790888|NCT03299049|587944966|FG000|Overall Study|Physician Decision|5|||
162790889|NCT03299049|587944967|FG001|Overall Study|Physician Decision|1|||
162790890|NCT03299049|587944966|FG000|Overall Study|Lost to Follow-up|2|||
162790891|NCT03299049|587944967|FG001|Overall Study|Lost to Follow-up|0|||
162790892|NCT03299049|587944966|FG000|Overall Study|Pregnancy|1|||
162790893|NCT03299049|587944967|FG001|Overall Study|Pregnancy|3|||
162790894|NCT03299049|587944966|FG000|Overall Study|Protocol Violation|1|||
162790895|NCT03299049|587944967|FG001|Overall Study|Protocol Violation|1|||
162790896|NCT03299049|587944966|FG000|Overall Study|Lack of Efficacy|9|||
162790897|NCT03299049|587944967|FG001|Overall Study|Lack of Efficacy|3|||
162790898|NCT03299049|587944966|FG000|Overall Study|Adverse Event|12|||
162790899|NCT03299049|587944967|FG001|Overall Study|Adverse Event|13|||
162790900|NCT01901419|587944968|FG000|Overall Study|Protocol Violation|2|||
162790901|NCT01901419|587944969|FG001|Overall Study|Protocol Violation|6|||
162790902|NCT01901419|587944968|FG000|Overall Study|unavailable researchers|6|||
162790903|NCT01901419|587944969|FG001|Overall Study|unavailable researchers|3|||
162790904|NCT00475644|587944970|FG000|Overall Study|Protocol Violation|13|||
162790905|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
162790906|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
162790907|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
162790908|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
162790909|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
162790910|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
162790911|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
162790912|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
162790913|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
162790914|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
162790915|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
162790916|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
162790917|NCT00790400|587944977|FG000|Double-blind Period (Core Phase)|Death|1|||
162790918|NCT00790400|587944978|FG001|Double-blind Period (Core Phase)|Death|0|||
162790919|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
162790920|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
162790921|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
162790922|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
162790923|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
162790924|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
162790925|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
162790926|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
162790927|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
162790928|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
162790929|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Death|1|||
162790930|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Death|0|||
162790931|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
162790932|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
162790933|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
162790934|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
162790935|NCT00790400|587944977|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
162790936|NCT00790400|587944978|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
162790937|NCT00699153|587944979|FG000|Overall Study|Lost to Follow-up|1|||
162790938|NCT00699153|587944980|FG001|Overall Study|Lost to Follow-up|0|||
162790939|NCT00699153|587944979|FG000|Overall Study|Adverse Event|0|||
162790940|NCT00699153|587944980|FG001|Overall Study|Adverse Event|2|||
162790941|NCT00699153|587944979|FG000|Overall Study|Protocol Violation|1|||
162790942|NCT00699153|587944980|FG001|Overall Study|Protocol Violation|0|||
162790943|NCT00699153|587944979|FG000|Overall Study|Travel Problem|1|||
162790944|NCT00699153|587944980|FG001|Overall Study|Travel Problem|0|||
162790945|NCT02412735|587944983|FG000|Overall Study|Adverse Event|0|||
162790946|NCT02412735|587944984|FG001|Overall Study|Adverse Event|1|||
162790947|NCT02412735|587944985|FG002|Overall Study|Adverse Event|2|||
162790948|NCT02412735|587944983|FG000|Overall Study|Withdrawal by Subject|23|||
162790949|NCT02412735|587944984|FG001|Overall Study|Withdrawal by Subject|27|||
162790950|NCT02412735|587944985|FG002|Overall Study|Withdrawal by Subject|22|||
162790951|NCT02412735|587944983|FG000|Overall Study|Investigator Decision|3|||
162790952|NCT02412735|587944984|FG001|Overall Study|Investigator Decision|3|||
162790953|NCT02412735|587944985|FG002|Overall Study|Investigator Decision|2|||
162790954|NCT02412735|587944983|FG000|Overall Study|Lost to Follow-up|17|||
162790955|NCT02412735|587944984|FG001|Overall Study|Lost to Follow-up|11|||
162790956|NCT02412735|587944985|FG002|Overall Study|Lost to Follow-up|18|||
162790957|NCT02412735|587944983|FG000|Overall Study|Reason not Specified|3|||
162790958|NCT02412735|587944984|FG001|Overall Study|Reason not Specified|2|||
162790959|NCT02412735|587944985|FG002|Overall Study|Reason not Specified|2|||
162790960|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
162790961|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
162790962|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
162790963|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
162790964|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Death|13|||
162790965|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Death|12|||
162790966|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Progression|257|||
162790967|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Progression|218|||
162790968|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
162790969|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
162790970|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
162790971|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
162790972|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
162790973|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
162790974|NCT01006980|587944987|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
162790975|NCT01006980|587944988|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
162790976|NCT01006980|587944987|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
162790977|NCT01006980|587944988|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
162790978|NCT01006980|587944987|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
162790979|NCT01006980|587944988|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
162790980|NCT01006980|587944987|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
162790981|NCT01006980|587944988|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
162790982|NCT01006980|587944987|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
162790983|NCT01006980|587944988|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
162790984|NCT01006980|587944987|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
162790985|NCT01006980|587944988|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
162790986|NCT00078338|587944989|FG000|Overall Study|Adverse Event|31|||
162790987|NCT00078338|587944990|FG001|Overall Study|Adverse Event|24|||
162790988|NCT00078338|587944989|FG000|Overall Study|Lost to Follow-up|17|||
162790989|NCT00078338|587944990|FG001|Overall Study|Lost to Follow-up|2|||
162790990|NCT00078338|587944989|FG000|Overall Study|Protocol Violation|2|||
162790991|NCT00078338|587944990|FG001|Overall Study|Protocol Violation|2|||
162790992|NCT00078338|587944989|FG000|Overall Study|Disease Progression|4|||
162790993|NCT00078338|587944990|FG001|Overall Study|Disease Progression|7|||
162790994|NCT00078338|587944989|FG000|Overall Study|Other|28|||
162790995|NCT00078338|587944990|FG001|Overall Study|Other|16|||
162790996|NCT00078338|587944989|FG000|Overall Study|Subjects randomized, but not treated|3|||
162790997|NCT00078338|587944990|FG001|Overall Study|Subjects randomized, but not treated|3|||
162790998|NCT02124811|587944991|FG000|Overall Study|Early termination|2|||
162790999|NCT02124811|587944992|FG001|Overall Study|Early termination|2|||
162791000|NCT02124811|587944991|FG000|Overall Study|Withdrawal by Subject|1|||
162791001|NCT02124811|587944992|FG001|Overall Study|Withdrawal by Subject|0|||
162791002|NCT03445533|587944995|FG000|Overall Study|Progressive Disease|48|||
162791003|NCT03445533|587944996|FG001|Overall Study|Progressive Disease|81|||
162791004|NCT03445533|587944995|FG000|Overall Study|Adverse Event|60|||
162791005|NCT03445533|587944996|FG001|Overall Study|Adverse Event|64|||
162791006|NCT03445533|587944995|FG000|Overall Study|Death|9|||
162791007|NCT03445533|587944996|FG001|Overall Study|Death|19|||
162791008|NCT03445533|587944995|FG000|Overall Study|Miscellaneous|0|||
162791009|NCT03445533|587944996|FG001|Overall Study|Miscellaneous|16|||
162791010|NCT03445533|587944995|FG000|Overall Study|Withdrawal by Subject|3|||
162791011|NCT03445533|587944996|FG001|Overall Study|Withdrawal by Subject|4|||
162791012|NCT03445533|587944995|FG000|Overall Study|Physician Decision|1|||
162791013|NCT03445533|587944996|FG001|Overall Study|Physician Decision|3|||
162791014|NCT03445533|587944995|FG000|Overall Study|Sponsor Decision|0|||
162791015|NCT03445533|587944996|FG001|Overall Study|Sponsor Decision|1|||
162791016|NCT03445533|587944995|FG000|Overall Study|Lost to Follow-up|0|||
162791017|NCT03445533|587944996|FG001|Overall Study|Lost to Follow-up|1|||
162791018|NCT03445533|587944995|FG000|Overall Study|Never Received any Study Treatment|7|||
162791019|NCT03445533|587944996|FG001|Overall Study|Never Received any Study Treatment|4|||
162791020|NCT02615509|587944997|FG000|Overall Study|Lost to Follow-up|134|||
162791021|NCT02615509|587944997|FG000|Overall Study|Death|4|||
162791022|NCT02615509|587944997|FG000|Overall Study|Withdrawal by Subject|8|||
162791023|NCT03334253|587944998|FG000|Overall Study|Withdrawal by Subject|1|||
162791024|NCT03334253|587944999|FG001|Overall Study|Withdrawal by Subject|0|||
162791025|NCT03334253|587944998|FG000|Overall Study|Lost to Follow-up|4|||
162791026|NCT03334253|587944999|FG001|Overall Study|Lost to Follow-up|3|||
162791027|NCT03334253|587944998|FG000|Overall Study|Moved residence|2|||
162791028|NCT03334253|587944999|FG001|Overall Study|Moved residence|2|||
162791029|NCT03274453|587945000|FG000|Overall Study|Lost to Follow-up|2|||
162791030|NCT03274453|587945001|FG001|Overall Study|Lost to Follow-up|5|||
162791031|NCT03274453|587945002|FG002|Overall Study|Lost to Follow-up|4|||
162791032|NCT03274453|587945003|FG003|Overall Study|Lost to Follow-up|1|||
162791033|NCT03274453|587945000|FG000|Overall Study|Physician Decision|2|||
162791034|NCT03274453|587945001|FG001|Overall Study|Physician Decision|0|||
162791035|NCT03274453|587945002|FG002|Overall Study|Physician Decision|0|||
162791036|NCT03274453|587945003|FG003|Overall Study|Physician Decision|3|||
162791037|NCT03274453|587945000|FG000|Overall Study|Surgery Cancelled|0|||
162791038|NCT03274453|587945001|FG001|Overall Study|Surgery Cancelled|1|||
162791039|NCT03274453|587945002|FG002|Overall Study|Surgery Cancelled|0|||
162791040|NCT03274453|587945003|FG003|Overall Study|Surgery Cancelled|0|||
162791041|NCT00968526|587945004|FG000|Overall Study|Adverse Event|2|||
162791042|NCT00968526|587945005|FG001|Overall Study|Adverse Event|0|||
162791043|NCT00968526|587945004|FG000|Overall Study|Migrated/moved from study area|1|||
162791044|NCT00968526|587945005|FG001|Overall Study|Migrated/moved from study area|0|||
162791045|NCT01294397|587945008|FG000|Overall Study|Withdrawal by Subject|1|||
162791046|NCT01294397|587945008|FG000|Overall Study|Administrative Decision|1|||
162791047|NCT00609947|587945010|FG000|Overall Study|Death|1|||
162791048|NCT00504075|587945011|FG000|Overall Study|Adverse Event|1|||
162791049|NCT00504075|587945011|FG000|Overall Study|Lost to Follow-up|5|||
162791050|NCT00504075|587945011|FG000|Overall Study|Withdrawal by Subject|1|||
162791051|NCT00504075|587945011|FG000|Overall Study|Required other therapeutic intervention|1|||
162791052|NCT01736540|587945012|FG000|Overall Study|Did not complete scan within 45 days|2|||
162791053|NCT01736540|587945012|FG000|Overall Study|Death|1|||
162791054|NCT01736540|587945012|FG000|Overall Study|Abnormal test procedure|1|||
162791055|NCT01736540|587945012|FG000|Overall Study|Withdrawal by Subject|5|||
162791056|NCT01736540|587945012|FG000|Overall Study|Protocol Violation|1|||
162791057|NCT01736540|587945012|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
162791058|NCT01736540|587945012|FG000|Overall Study|No show for MRI appointment|1|||
162791059|NCT01736540|587945012|FG000|Overall Study|Unable to make MRI appointment|3|||
162791060|NCT01031628|587945020|FG000|Overall Study|Study terminated early|0|||
162791061|NCT01031628|587945021|FG001|Overall Study|Study terminated early|1|||
162791062|NCT01031628|587945022|FG002|Overall Study|Study terminated early|3|||
162791063|NCT01031628|587945023|FG003|Overall Study|Study terminated early|0|||
162791064|NCT04245345|587945025|FG000|Overall Study|Death|1|||
162791065|NCT04245345|587945025|FG000|Overall Study|Exited prior to implant|5|||
162791066|NCT04245345|587945025|FG000|Overall Study|Exited prior to 1-month|9|||
162791067|NCT04245345|587945025|FG000|Overall Study|Missed 1-month visit|3|||
162791068|NCT04245345|587945025|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
162791069|NCT04245345|587945025|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
162791070|NCT04805073|587945029|FG000|Overall Study|study personnel not available|2|||
162791071|NCT04805073|587945030|FG001|Overall Study|study personnel not available|0|||
162791072|NCT04805073|587945029|FG000|Overall Study|spinal anesthesia failure|0|||
162791073|NCT04805073|587945030|FG001|Overall Study|spinal anesthesia failure|1|||
162791074|NCT04805073|587945029|FG000|Overall Study|Lost to Follow-up|0|||
162791075|NCT04805073|587945030|FG001|Overall Study|Lost to Follow-up|2|||
162791076|NCT00422734|587945034|FG000|Overall Study|Physician Decision|1|||
162791077|NCT00422734|587945035|FG001|Overall Study|Physician Decision|1|||
162791078|NCT00422734|587945034|FG000|Overall Study|Protocol Violation|1|||
162791079|NCT00422734|587945035|FG001|Overall Study|Protocol Violation|6|||
162791080|NCT00422734|587945034|FG000|Overall Study|Withdrawal by Subject|12|||
162791081|NCT00422734|587945035|FG001|Overall Study|Withdrawal by Subject|8|||
162791082|NCT00422734|587945034|FG000|Overall Study|Adverse Event|0|||
162791083|NCT00422734|587945035|FG001|Overall Study|Adverse Event|3|||
162791084|NCT00422734|587945034|FG000|Overall Study|Partner Decision|0|||
162791085|NCT00422734|587945035|FG001|Overall Study|Partner Decision|3|||
162791086|NCT01081886|587945036|FG000|Overall Study|Study termination|11|||
162791087|NCT01081886|587945037|FG001|Overall Study|Study termination|13|||
162791088|NCT02975102|587945041|FG000|Overall Study|Adverse Event|2|||
162791089|NCT02975102|587945042|FG001|Overall Study|Adverse Event|1|||
162791090|NCT03017742|587945043|FG000|Overall Study|Protocol Violation|36|||
162791091|NCT03017742|587945043|FG000|Overall Study|Withdrawal by Subject|37|||
162791092|NCT04148651|587945046|FG000|Overall Study|Lost to Follow-up|2|||
162791093|NCT05262751|587945047|FG000|Washout Period 2|Adverse Event|1|||
162791094|NCT05262751|587945048|FG001|Washout Period 2|Adverse Event|0|||
162791095|NCT05262751|587945049|FG002|Washout Period 2|Adverse Event|0|||
162791096|NCT05262751|587945050|FG003|Washout Period 2|Adverse Event|0|||
162791097|NCT05262751|587945051|FG004|Washout Period 2|Adverse Event|0|||
162791098|NCT05262751|587945052|FG005|Washout Period 2|Adverse Event|0|||
162791099|NCT05262751|587945047|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
162791100|NCT05262751|587945048|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
162791101|NCT05262751|587945049|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
162791102|NCT05262751|587945050|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
162791103|NCT05262751|587945051|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
162791104|NCT05262751|587945052|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
162791105|NCT03690427|587945055|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
162791106|NCT03690427|587945056|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
162791107|NCT02609672|587945057|FG000|Overall Study|Lost to Follow-up|3|||
162791108|NCT02609672|587945058|FG001|Overall Study|Lost to Follow-up|1|||
162791109|NCT03519204|587945059|FG000|Overall Study|Lost to Follow-up|3|||
162791110|NCT03519204|587945060|FG001|Overall Study|Lost to Follow-up|8|||
162791111|NCT03519204|587945059|FG000|Overall Study|Withdrawal by Subject|9|||
162791112|NCT03519204|587945060|FG001|Overall Study|Withdrawal by Subject|7|||
162791113|NCT03519204|587945059|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162791114|NCT03519204|587945060|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162791115|NCT03392168|587945064|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
162791116|NCT03392168|587945065|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
162791117|NCT03392168|587945066|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
162791118|NCT03392168|587945067|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
162791119|NCT03392168|587945064|FG000|Period 2: Cohort 2|Other|0|||
162791120|NCT03392168|587945065|FG001|Period 2: Cohort 2|Other|1|||
162791121|NCT03392168|587945066|FG002|Period 2: Cohort 2|Other|0|||
162791122|NCT03392168|587945067|FG003|Period 2: Cohort 2|Other|0|||
162791123|NCT01441635|587945068|FG000|Overall Study|Adverse Event|4|||
162791124|NCT01441635|587945069|FG001|Overall Study|Adverse Event|3|||
162791125|NCT01441635|587945070|FG002|Overall Study|Adverse Event|1|||
162791126|NCT01441635|587945071|FG003|Overall Study|Adverse Event|5|||
162791127|NCT01441635|587945072|FG004|Overall Study|Adverse Event|1|||
162791128|NCT01441635|587945073|FG005|Overall Study|Adverse Event|2|||
162791129|NCT01441635|587945074|FG006|Overall Study|Adverse Event|2|||
162791130|NCT01441635|587945075|FG007|Overall Study|Adverse Event|2|||
162791131|NCT01441635|587945076|FG008|Overall Study|Adverse Event|1|||
162791132|NCT01441635|587945077|FG009|Overall Study|Adverse Event|0|||
162791133|NCT01441635|587945068|FG000|Overall Study|Withdrawal by Subject|1|||
162791134|NCT01441635|587945069|FG001|Overall Study|Withdrawal by Subject|1|||
162791135|NCT01441635|587945070|FG002|Overall Study|Withdrawal by Subject|0|||
162791136|NCT01441635|587945071|FG003|Overall Study|Withdrawal by Subject|1|||
162791137|NCT01441635|587945072|FG004|Overall Study|Withdrawal by Subject|0|||
162791138|NCT01441635|587945073|FG005|Overall Study|Withdrawal by Subject|0|||
162791139|NCT01441635|587945074|FG006|Overall Study|Withdrawal by Subject|2|||
162791140|NCT01441635|587945075|FG007|Overall Study|Withdrawal by Subject|0|||
162791141|NCT01441635|587945076|FG008|Overall Study|Withdrawal by Subject|1|||
162791142|NCT01441635|587945077|FG009|Overall Study|Withdrawal by Subject|1|||
162791143|NCT01441635|587945068|FG000|Overall Study|Lost to Follow-up|0|||
162791144|NCT01441635|587945069|FG001|Overall Study|Lost to Follow-up|1|||
162791145|NCT01441635|587945070|FG002|Overall Study|Lost to Follow-up|1|||
162791146|NCT01441635|587945071|FG003|Overall Study|Lost to Follow-up|1|||
162791147|NCT01441635|587945072|FG004|Overall Study|Lost to Follow-up|1|||
162791148|NCT01441635|587945073|FG005|Overall Study|Lost to Follow-up|3|||
162791149|NCT01441635|587945074|FG006|Overall Study|Lost to Follow-up|1|||
162791150|NCT01441635|587945075|FG007|Overall Study|Lost to Follow-up|1|||
162791151|NCT01441635|587945076|FG008|Overall Study|Lost to Follow-up|0|||
162791152|NCT01441635|587945077|FG009|Overall Study|Lost to Follow-up|1|||
162791153|NCT01441635|587945068|FG000|Overall Study|Noncompliance|0|||
162791154|NCT01441635|587945069|FG001|Overall Study|Noncompliance|1|||
162791155|NCT01441635|587945070|FG002|Overall Study|Noncompliance|0|||
162791156|NCT01441635|587945071|FG003|Overall Study|Noncompliance|0|||
162791157|NCT01441635|587945072|FG004|Overall Study|Noncompliance|0|||
162791158|NCT01441635|587945073|FG005|Overall Study|Noncompliance|0|||
162791159|NCT01441635|587945074|FG006|Overall Study|Noncompliance|1|||
162791160|NCT01441635|587945075|FG007|Overall Study|Noncompliance|0|||
162791161|NCT01441635|587945076|FG008|Overall Study|Noncompliance|0|||
162791162|NCT01441635|587945077|FG009|Overall Study|Noncompliance|0|||
162791163|NCT01441635|587945068|FG000|Overall Study|Surgery or Invasive Intervention|0|||
162791164|NCT01441635|587945069|FG001|Overall Study|Surgery or Invasive Intervention|0|||
162791165|NCT01441635|587945070|FG002|Overall Study|Surgery or Invasive Intervention|1|||
162791166|NCT01441635|587945071|FG003|Overall Study|Surgery or Invasive Intervention|0|||
162791167|NCT01441635|587945072|FG004|Overall Study|Surgery or Invasive Intervention|0|||
162791168|NCT01441635|587945073|FG005|Overall Study|Surgery or Invasive Intervention|0|||
162791169|NCT01441635|587945074|FG006|Overall Study|Surgery or Invasive Intervention|0|||
162791170|NCT01441635|587945075|FG007|Overall Study|Surgery or Invasive Intervention|0|||
162791171|NCT01441635|587945076|FG008|Overall Study|Surgery or Invasive Intervention|0|||
162791172|NCT01441635|587945077|FG009|Overall Study|Surgery or Invasive Intervention|0|||
162791173|NCT01441635|587945068|FG000|Overall Study|Received Exclusionary Medication|1|||
162791174|NCT01441635|587945069|FG001|Overall Study|Received Exclusionary Medication|0|||
162791175|NCT01441635|587945070|FG002|Overall Study|Received Exclusionary Medication|0|||
162791176|NCT01441635|587945071|FG003|Overall Study|Received Exclusionary Medication|0|||
162791177|NCT01441635|587945072|FG004|Overall Study|Received Exclusionary Medication|0|||
162791178|NCT01441635|587945073|FG005|Overall Study|Received Exclusionary Medication|0|||
162791179|NCT01441635|587945074|FG006|Overall Study|Received Exclusionary Medication|0|||
162791180|NCT01441635|587945075|FG007|Overall Study|Received Exclusionary Medication|0|||
162791181|NCT01441635|587945076|FG008|Overall Study|Received Exclusionary Medication|0|||
162791182|NCT01441635|587945077|FG009|Overall Study|Received Exclusionary Medication|0|||
162791183|NCT01441635|587945068|FG000|Overall Study|Other|0|||
162791184|NCT01441635|587945069|FG001|Overall Study|Other|0|||
162791185|NCT01441635|587945070|FG002|Overall Study|Other|0|||
162791186|NCT01441635|587945071|FG003|Overall Study|Other|0|||
162791187|NCT01441635|587945072|FG004|Overall Study|Other|0|||
162791188|NCT01441635|587945073|FG005|Overall Study|Other|0|||
162791189|NCT01441635|587945074|FG006|Overall Study|Other|0|||
162791190|NCT01441635|587945075|FG007|Overall Study|Other|1|||
162791191|NCT01441635|587945076|FG008|Overall Study|Other|0|||
162791192|NCT01441635|587945077|FG009|Overall Study|Other|0|||
162791193|NCT02637323|587945079|FG000|Overall Study|Lost to Follow-up|2|||
162791194|NCT02637323|587945080|FG001|Overall Study|Lost to Follow-up|0|||
162791195|NCT02637323|587945079|FG000|Overall Study|Protocol Violation|0|||
162791196|NCT02637323|587945080|FG001|Overall Study|Protocol Violation|1|||
162791197|NCT01154140|587945081|FG000|Overall Study|Death|71|||
162791198|NCT01154140|587945082|FG001|Overall Study|Death|81|||
162791199|NCT01154140|587945081|FG000|Overall Study|Lost to Follow-up|4|||
162791200|NCT01154140|587945082|FG001|Overall Study|Lost to Follow-up|5|||
162791201|NCT01154140|587945081|FG000|Overall Study|Withdrawal by Subject|12|||
162791202|NCT01154140|587945082|FG001|Overall Study|Withdrawal by Subject|13|||
162791203|NCT01154140|587945081|FG000|Overall Study|Other|3|||
162791204|NCT01154140|587945082|FG001|Overall Study|Other|1|||
162791205|NCT01154140|587945081|FG000|Overall Study|Randomized but not treated|1|||
162791206|NCT01154140|587945082|FG001|Overall Study|Randomized but not treated|2|||
162791207|NCT00358644|587945083|FG000|Overall Study|Progressive Disease|21|||
162791208|NCT00358644|587945083|FG000|Overall Study|Adverse Event|7|||
162791209|NCT00358644|587945083|FG000|Overall Study|Death|11|||
162791210|NCT00358644|587945083|FG000|Overall Study|Withdrawal by Subject|4|||
162791211|NCT00358644|587945083|FG000|Overall Study|Physician Decision|6|||
162791212|NCT00358644|587945083|FG000|Overall Study|Patient not eligible for study|1|||
162791213|NCT03327831|587945084|FG000|Overall Study|Lost to Follow-up|2|||
162791214|NCT00368875|587945085|FG000|Overall Study|Adverse Event|0|||
162791215|NCT00368875|587945086|FG001|Overall Study|Adverse Event|12|||
162791216|NCT00368875|587945085|FG000|Overall Study|Progressive disease|3|||
162791217|NCT00368875|587945086|FG001|Overall Study|Progressive disease|27|||
162791218|NCT00368875|587945085|FG000|Overall Study|Withdrawal by Subject|2|||
162791219|NCT00368875|587945086|FG001|Overall Study|Withdrawal by Subject|6|||
162791220|NCT00368875|587945085|FG000|Overall Study|Other Reason|0|||
162791221|NCT00368875|587945086|FG001|Overall Study|Other Reason|2|||
162791222|NCT00368875|587945085|FG000|Overall Study|Alternative Therapy|1|||
162791223|NCT00368875|587945086|FG001|Overall Study|Alternative Therapy|1|||
162791224|NCT02595372|587945087|FG000|Overall Study|Adverse Event|6|||
162791225|NCT02595372|587945087|FG000|Overall Study|Physician Decision|2|||
162791226|NCT02595372|587945087|FG000|Overall Study|Disease Progression|1|||
162791227|NCT00401258|587945090|FG000|Overall Study|Adverse Event|7|||
162791228|NCT04704219|587945091|FG000|Overall Study|Screen Failure|1|||
162791229|NCT04704219|587945091|FG000|Overall Study|Withdrawal by Subject|1|||
162791230|NCT04704219|587945091|FG000|Overall Study|Death|78|||
162791231|NCT04704219|587945091|FG000|Overall Study|Participants Ongoing|80|||
162791232|NCT02600897|587945092|FG000|Overall Study|Death|1|||
162791233|NCT02600897|587945093|FG001|Overall Study|Death|2|||
162791234|NCT02600897|587945094|FG002|Overall Study|Death|1|||
162791235|NCT02600897|587945095|FG003|Overall Study|Death|2|||
162791236|NCT02600897|587945096|FG004|Overall Study|Death|3|||
162791237|NCT02600897|587945097|FG005|Overall Study|Death|2|||
162791238|NCT02600897|587945098|FG006|Overall Study|Death|10|||
162791239|NCT02600897|587945099|FG007|Overall Study|Death|7|||
162791240|NCT02600897|587945100|FG008|Overall Study|Death|20|||
162791241|NCT02600897|587945092|FG000|Overall Study|Lost to Follow-up|1|||
162791242|NCT02600897|587945093|FG001|Overall Study|Lost to Follow-up|0|||
162791243|NCT02600897|587945094|FG002|Overall Study|Lost to Follow-up|0|||
162791244|NCT02600897|587945095|FG003|Overall Study|Lost to Follow-up|0|||
162791245|NCT02600897|587945096|FG004|Overall Study|Lost to Follow-up|0|||
162791246|NCT02600897|587945097|FG005|Overall Study|Lost to Follow-up|0|||
162791247|NCT02600897|587945098|FG006|Overall Study|Lost to Follow-up|0|||
162791248|NCT02600897|587945099|FG007|Overall Study|Lost to Follow-up|1|||
162791249|NCT02600897|587945100|FG008|Overall Study|Lost to Follow-up|0|||
162791250|NCT02600897|587945092|FG000|Overall Study|Withdrawal by Subject|0|||
162791251|NCT02600897|587945093|FG001|Overall Study|Withdrawal by Subject|0|||
162791252|NCT02600897|587945094|FG002|Overall Study|Withdrawal by Subject|0|||
162791253|NCT02600897|587945095|FG003|Overall Study|Withdrawal by Subject|0|||
162791254|NCT02600897|587945096|FG004|Overall Study|Withdrawal by Subject|0|||
162791255|NCT02600897|587945097|FG005|Overall Study|Withdrawal by Subject|0|||
162791256|NCT02600897|587945098|FG006|Overall Study|Withdrawal by Subject|0|||
162791257|NCT02600897|587945099|FG007|Overall Study|Withdrawal by Subject|4|||
162791258|NCT02600897|587945100|FG008|Overall Study|Withdrawal by Subject|2|||
162791259|NCT02600897|587945092|FG000|Overall Study|Reason Not Specified|0|||
162791260|NCT02600897|587945093|FG001|Overall Study|Reason Not Specified|0|||
162791261|NCT02600897|587945094|FG002|Overall Study|Reason Not Specified|0|||
162791262|NCT02600897|587945095|FG003|Overall Study|Reason Not Specified|0|||
162791263|NCT02600897|587945096|FG004|Overall Study|Reason Not Specified|0|||
162791264|NCT02600897|587945097|FG005|Overall Study|Reason Not Specified|0|||
162791265|NCT02600897|587945098|FG006|Overall Study|Reason Not Specified|0|||
162791266|NCT02600897|587945099|FG007|Overall Study|Reason Not Specified|0|||
162791267|NCT02600897|587945100|FG008|Overall Study|Reason Not Specified|1|||
162791268|NCT03816761|587947193|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162791269|NCT03816761|587947194|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162791270|NCT03816761|587947195|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162791271|NCT03816761|587947196|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162791272|NCT03816761|587947197|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162791273|NCT03816761|587947198|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
162791274|NCT03816761|587947193|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
162791275|NCT03816761|587947194|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
162791276|NCT03816761|587947195|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
162791277|NCT03816761|587947196|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
162791278|NCT03816761|587947197|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
162791279|NCT03816761|587947198|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
162791280|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
162791281|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
162791282|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162791283|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
162791284|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162791285|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162791286|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
162791287|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
162791288|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162791289|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162791290|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
162791291|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162791292|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162791293|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
162791294|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162791295|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
162791296|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
162791297|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
162791298|NCT00603525|587947208|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
162791299|NCT00603525|587947209|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
162791300|NCT00603525|587947210|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
162791301|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162791302|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
162791303|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162791304|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162791305|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
162791306|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162791307|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162791308|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
162791309|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162791310|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162791311|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
162791312|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162791313|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
162791314|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
162791315|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
162791316|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162791317|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
162791318|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162791319|NCT00603525|587947208|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162791320|NCT00603525|587947209|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
162791321|NCT00603525|587947210|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162791322|NCT00603525|587947208|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
162791323|NCT00603525|587947209|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
162791324|NCT00603525|587947210|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
162791325|NCT01483144|587947211|FG000|Overall Study|Adverse Event|9|||
162791326|NCT01483144|587947212|FG001|Overall Study|Adverse Event|4|||
162791327|NCT01483144|587947213|FG002|Overall Study|Adverse Event|6|||
162791328|NCT01483144|587947211|FG000|Overall Study|Withdrawal by Subject|0|||
162791329|NCT01483144|587947212|FG001|Overall Study|Withdrawal by Subject|2|||
162791330|NCT01483144|587947213|FG002|Overall Study|Withdrawal by Subject|5|||
162791331|NCT01483144|587947211|FG000|Overall Study|Physician Decision|1|||
162791332|NCT01483144|587947212|FG001|Overall Study|Physician Decision|0|||
162791333|NCT01483144|587947213|FG002|Overall Study|Physician Decision|0|||
162791334|NCT01483144|587947211|FG000|Overall Study|Lost to Follow-up|2|||
162791335|NCT01483144|587947212|FG001|Overall Study|Lost to Follow-up|4|||
162791336|NCT01483144|587947213|FG002|Overall Study|Lost to Follow-up|1|||
162791337|NCT01483144|587947211|FG000|Overall Study|Protocol Violation|3|||
162791338|NCT01483144|587947212|FG001|Overall Study|Protocol Violation|3|||
162791339|NCT01483144|587947213|FG002|Overall Study|Protocol Violation|3|||
162791340|NCT02460575|587947214|FG000|Overall Study|Lost to Follow-up|1|||
162791341|NCT02460575|587947215|FG001|Overall Study|Lost to Follow-up|0|||
162791342|NCT04043143|587947216|FG000|Overall Study|Lost to Follow-up|5|||
162791343|NCT04043143|587947217|FG001|Overall Study|Lost to Follow-up|5|||
162791344|NCT04043143|587947216|FG000|Overall Study|screen failure|1|||
162791345|NCT04043143|587947217|FG001|Overall Study|screen failure|0|||
162791346|NCT04307940|587947218|FG000|Overall Study|Adverse Event|1|||
162791347|NCT04307940|587947219|FG001|Overall Study|Adverse Event|0|||
162791348|NCT04307940|587947220|FG002|Overall Study|Adverse Event|0|||
162791349|NCT04307940|587947218|FG000|Overall Study|Withdrawal by Subject|2|||
162791350|NCT04307940|587947219|FG001|Overall Study|Withdrawal by Subject|3|||
162791351|NCT04307940|587947220|FG002|Overall Study|Withdrawal by Subject|1|||
162791352|NCT04307940|587947218|FG000|Overall Study|Lost to Follow-up|2|||
162791353|NCT04307940|587947219|FG001|Overall Study|Lost to Follow-up|0|||
162791354|NCT04307940|587947220|FG002|Overall Study|Lost to Follow-up|1|||
162791355|NCT04624243|587947224|FG000|Overall Study|Death|0|||
162791356|NCT04624243|587947225|FG001|Overall Study|Death|1|||
162791357|NCT04624243|587947226|FG002|Overall Study|Death|0|||
162791358|NCT04624243|587947227|FG003|Overall Study|Death|0|||
162791359|NCT04624243|587947228|FG004|Overall Study|Death|0|||
162791360|NCT04624243|587947224|FG000|Overall Study|Lost to Follow-up|2|||
162791361|NCT04624243|587947225|FG001|Overall Study|Lost to Follow-up|3|||
162791362|NCT04624243|587947226|FG002|Overall Study|Lost to Follow-up|7|||
162791363|NCT04624243|587947227|FG003|Overall Study|Lost to Follow-up|1|||
162791364|NCT04624243|587947228|FG004|Overall Study|Lost to Follow-up|3|||
162791365|NCT04624243|587947224|FG000|Overall Study|Physician Decision|3|||
162791366|NCT04624243|587947225|FG001|Overall Study|Physician Decision|8|||
162791367|NCT04624243|587947226|FG002|Overall Study|Physician Decision|15|||
162791368|NCT04624243|587947227|FG003|Overall Study|Physician Decision|2|||
162791369|NCT04624243|587947228|FG004|Overall Study|Physician Decision|11|||
162791370|NCT04624243|587947224|FG000|Overall Study|Withdrawal by Subject|19|||
162791371|NCT04624243|587947225|FG001|Overall Study|Withdrawal by Subject|44|||
162791372|NCT04624243|587947226|FG002|Overall Study|Withdrawal by Subject|40|||
162791373|NCT04624243|587947227|FG003|Overall Study|Withdrawal by Subject|21|||
162791374|NCT04624243|587947228|FG004|Overall Study|Withdrawal by Subject|39|||
162791375|NCT04624243|587947224|FG000|Overall Study|Miscellaneous|3|||
162791376|NCT04624243|587947225|FG001|Overall Study|Miscellaneous|12|||
162791377|NCT04624243|587947226|FG002|Overall Study|Miscellaneous|9|||
162791378|NCT04624243|587947227|FG003|Overall Study|Miscellaneous|4|||
162791379|NCT04624243|587947228|FG004|Overall Study|Miscellaneous|6|||
162791380|NCT04996004|587947229|FG000|Phase I|Death|1|||
162791381|NCT04996004|587947230|FG001|Phase I|Death|2|||
162791382|NCT04996004|587947231|FG002|Phase I|Death|1|||
162791383|NCT04996004|587947232|FG003|Phase I|Death|0|||
162791384|NCT04996004|587947233|FG004|Phase I|Death|0|||
162791385|NCT04996004|587947234|FG005|Phase I|Death|0|||
162791386|NCT04996004|587947229|FG000|Phase I|Study terminated by sponsor|2|||
162791387|NCT04996004|587947230|FG001|Phase I|Study terminated by sponsor|1|||
162791388|NCT04996004|587947231|FG002|Phase I|Study terminated by sponsor|2|||
162791389|NCT04996004|587947232|FG003|Phase I|Study terminated by sponsor|0|||
162791390|NCT04996004|587947233|FG004|Phase I|Study terminated by sponsor|0|||
162791391|NCT04996004|587947234|FG005|Phase I|Study terminated by sponsor|0|||
162791392|NCT04996004|587947229|FG000|Phase II|Study terminated by sponsor|0|||
162791393|NCT04996004|587947230|FG001|Phase II|Study terminated by sponsor|0|||
162791394|NCT04996004|587947231|FG002|Phase II|Study terminated by sponsor|0|||
162791395|NCT04996004|587947232|FG003|Phase II|Study terminated by sponsor|20|||
162791396|NCT04996004|587947233|FG004|Phase II|Study terminated by sponsor|10|||
162791397|NCT04996004|587947234|FG005|Phase II|Study terminated by sponsor|10|||
162791398|NCT04996004|587947229|FG000|Phase II|Withdrawal by Subject|0|||
162791399|NCT04996004|587947230|FG001|Phase II|Withdrawal by Subject|0|||
162791400|NCT04996004|587947231|FG002|Phase II|Withdrawal by Subject|0|||
162791401|NCT04996004|587947232|FG003|Phase II|Withdrawal by Subject|0|||
162791402|NCT04996004|587947233|FG004|Phase II|Withdrawal by Subject|1|||
162791403|NCT04996004|587947234|FG005|Phase II|Withdrawal by Subject|2|||
162791404|NCT04996004|587947229|FG000|Phase II|Death|0|||
162791405|NCT04996004|587947230|FG001|Phase II|Death|0|||
162791406|NCT04996004|587947231|FG002|Phase II|Death|0|||
162791407|NCT04996004|587947232|FG003|Phase II|Death|12|||
162791408|NCT04996004|587947233|FG004|Phase II|Death|2|||
162791409|NCT04996004|587947234|FG005|Phase II|Death|9|||
162791410|NCT04996004|587947229|FG000|Phase II|Other|0|||
162791411|NCT04996004|587947230|FG001|Phase II|Other|0|||
162791412|NCT04996004|587947231|FG002|Phase II|Other|0|||
162791413|NCT04996004|587947232|FG003|Phase II|Other|0|||
162791414|NCT04996004|587947233|FG004|Phase II|Other|0|||
162791415|NCT04996004|587947234|FG005|Phase II|Other|1|||
162791416|NCT05543174|587947235|FG000|Overall Study|Ongoing|7|||
162791417|NCT03374488|587947236|FG000|Overall Study|Death|13|||
162791418|NCT03374488|587947237|FG001|Overall Study|Death|13|||
162791419|NCT03374488|587947236|FG000|Overall Study|Withdrawal by Subject|3|||
162791420|NCT03374488|587947237|FG001|Overall Study|Withdrawal by Subject|1|||
162791421|NCT03374488|587947236|FG000|Overall Study|Physician Decision|3|||
162791422|NCT03374488|587947237|FG001|Overall Study|Physician Decision|0|||
162791423|NCT03104075|587947238|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
162791424|NCT03104075|587947239|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
162791425|NCT04896008|587947240|FG000|Overall Study|Ongoing|70|||
162791426|NCT04896008|587947241|FG001|Overall Study|Ongoing|38|||
162791427|NCT04896008|587947240|FG000|Overall Study|Adverse Event|0|||
162791428|NCT04896008|587947241|FG001|Overall Study|Adverse Event|2|||
162791429|NCT04896008|587947240|FG000|Overall Study|Death|5|||
162791430|NCT04896008|587947241|FG001|Overall Study|Death|10|||
162791431|NCT04896008|587947240|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
162791432|NCT04896008|587947241|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
162791433|NCT04896008|587947240|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
162791434|NCT04896008|587947241|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
162791435|NCT04896008|587947240|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
162791436|NCT04896008|587947241|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
162791437|NCT04896008|587947240|FG000|Overall Study|Withdrawal by Subject|1|||
162791438|NCT04896008|587947241|FG001|Overall Study|Withdrawal by Subject|4|||
162791439|NCT04896008|587947240|FG000|Overall Study|Investigator Decision|2|||
162791440|NCT04896008|587947241|FG001|Overall Study|Investigator Decision|0|||
162791441|NCT04896008|587947240|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
162791442|NCT04896008|587947241|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
162791443|NCT00944229|587947244|FG000|Overall Study|Withdrawal by Subject|11|||
162791444|NCT00944229|587947244|FG000|Overall Study|Physician Decision|14|||
162791445|NCT01810939|587947247|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
162791446|NCT01810939|587947248|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
162791447|NCT01810939|587947249|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
162791448|NCT01810939|587947247|FG000|Part A Treatment Period|Protocol Violation|2|||
162791449|NCT01810939|587947248|FG001|Part A Treatment Period|Protocol Violation|0|||
162791450|NCT01810939|587947249|FG002|Part A Treatment Period|Protocol Violation|0|||
162791451|NCT01810939|587947247|FG000|Part A Treatment Period|Adverse Event|10|||
162791452|NCT01810939|587947248|FG001|Part A Treatment Period|Adverse Event|0|||
162791453|NCT01810939|587947249|FG002|Part A Treatment Period|Adverse Event|0|||
162791454|NCT01810939|587947247|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
162791455|NCT01810939|587947248|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
162791456|NCT01810939|587947249|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
162791457|NCT01810939|587947247|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
162791458|NCT01810939|587947248|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
162791459|NCT01810939|587947249|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
162791460|NCT01810939|587947247|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
162791461|NCT01810939|587947248|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
162791462|NCT01810939|587947249|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
162791463|NCT01810939|587947247|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
162791464|NCT01810939|587947248|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
162791465|NCT01810939|587947249|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
162791466|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
162791467|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
162791468|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
162791469|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
162791470|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
162791471|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
162791472|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
162791473|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
162791474|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
162791475|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
162791476|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
162791477|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
162791478|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
162791479|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
162791480|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
162791481|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
162791482|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
162791483|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
162791484|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
162791485|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
162791486|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
162791487|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
162791488|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
162791489|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
162791490|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
162791491|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
162791492|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
162791493|NCT01810939|587947247|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
162791494|NCT01810939|587947248|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
162791495|NCT01810939|587947249|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
162791496|NCT04497389|587947252|FG000|Overall Study|Withdrawal by Subject|1|||
162791497|NCT04497389|587947253|FG001|Overall Study|Withdrawal by Subject|0|||
162791498|NCT04400487|587947254|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162791499|NCT04400487|587947254|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
162791500|NCT04400487|587947254|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
162791501|NCT03322540|587947259|FG000|Overall Study|Death|21|||
162791502|NCT03322540|587947260|FG001|Overall Study|Death|28|||
162791503|NCT03322540|587947259|FG000|Overall Study|Lost to Follow-up|0|||
162791504|NCT03322540|587947260|FG001|Overall Study|Lost to Follow-up|1|||
162791505|NCT03322540|587947259|FG000|Overall Study|Physician Decision|7|||
162791506|NCT03322540|587947260|FG001|Overall Study|Physician Decision|6|||
162791507|NCT03322540|587947259|FG000|Overall Study|Withdrawal by Subject|3|||
162791508|NCT03322540|587947260|FG001|Overall Study|Withdrawal by Subject|1|||
162791509|NCT03322540|587947259|FG000|Overall Study|Study terminated by sponsor|0|||
162791510|NCT03322540|587947260|FG001|Overall Study|Study terminated by sponsor|1|||
162791511|NCT01594827|587947261|FG000|Overall Study|Adverse Event|1|||
162791512|NCT01594827|587947262|FG001|Overall Study|Adverse Event|0|||
162791513|NCT01594827|587947261|FG000|Overall Study|Physician Decision|3|||
162791514|NCT01594827|587947262|FG001|Overall Study|Physician Decision|0|||
162791515|NCT02153905|587947263|FG000|Overall Study|Death|1|||
162791516|NCT02153905|587947264|FG001|Overall Study|Death|0|||
162791517|NCT00520845|587947265|FG000|Overall Study|Death|3|||
162791518|NCT00520845|587947265|FG000|Overall Study|Adverse Event|4|||
162791519|NCT00520845|587947265|FG000|Overall Study|Disease Progression, relapse|13|||
162791520|NCT00520845|587947265|FG000|Overall Study|Withdrawal by Subject|1|||
162791521|NCT00520845|587947265|FG000|Overall Study|Alternative Therapy|1|||
162791522|NCT02493062|587947267|FG000|Overall Study|Physician Decision|12|||
162791523|NCT03926195|587947268|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
162791524|NCT03926195|587947269|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
162791525|NCT03926195|587947268|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
162791526|NCT03926195|587947269|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
162791527|NCT03926195|587947268|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
162791528|NCT03926195|587947269|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
162791529|NCT03926195|587947268|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
162791530|NCT03926195|587947269|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
162791531|NCT03926195|587947268|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
162791532|NCT03926195|587947269|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
162791533|NCT03926195|587947268|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
162791534|NCT03926195|587947269|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
162791535|NCT03054337|587947270|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162791536|NCT03054337|587947271|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
162791537|NCT03054337|587947272|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162791538|NCT03054337|587947273|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
162791539|NCT03054337|587947274|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
162791540|NCT03054337|587947275|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162791541|NCT01327612|587947276|FG000|Overall Study|Withdrawal by Subject|0|||
162791542|NCT01327612|587947277|FG001|Overall Study|Withdrawal by Subject|0|||
162791543|NCT01327612|587947278|FG002|Overall Study|Withdrawal by Subject|0|||
162791544|NCT01327612|587947279|FG003|Overall Study|Withdrawal by Subject|0|||
162791545|NCT01327612|587947280|FG004|Overall Study|Withdrawal by Subject|0|||
162791546|NCT01327612|587947281|FG005|Overall Study|Withdrawal by Subject|1|||
162791547|NCT01327612|587947282|FG006|Overall Study|Withdrawal by Subject|0|||
162791548|NCT01327612|587947276|FG000|Overall Study|Disease Progression|1|||
162791549|NCT01327612|587947277|FG001|Overall Study|Disease Progression|1|||
162791550|NCT01327612|587947278|FG002|Overall Study|Disease Progression|1|||
162791551|NCT01327612|587947279|FG003|Overall Study|Disease Progression|0|||
162791552|NCT01327612|587947280|FG004|Overall Study|Disease Progression|1|||
162791553|NCT01327612|587947281|FG005|Overall Study|Disease Progression|2|||
162791554|NCT01327612|587947282|FG006|Overall Study|Disease Progression|2|||
162791555|NCT01327612|587947276|FG000|Overall Study|Administrative Decision|0|||
162791556|NCT01327612|587947277|FG001|Overall Study|Administrative Decision|0|||
162791557|NCT01327612|587947278|FG002|Overall Study|Administrative Decision|0|||
162791558|NCT01327612|587947279|FG003|Overall Study|Administrative Decision|1|||
162791559|NCT01327612|587947280|FG004|Overall Study|Administrative Decision|0|||
162791560|NCT01327612|587947281|FG005|Overall Study|Administrative Decision|0|||
162791561|NCT01327612|587947282|FG006|Overall Study|Administrative Decision|0|||
162791562|NCT01327612|587947276|FG000|Overall Study|Death|0|||
162791563|NCT01327612|587947277|FG001|Overall Study|Death|0|||
162791564|NCT01327612|587947278|FG002|Overall Study|Death|0|||
162791565|NCT01327612|587947279|FG003|Overall Study|Death|0|||
162791566|NCT01327612|587947280|FG004|Overall Study|Death|1|||
162791567|NCT01327612|587947281|FG005|Overall Study|Death|0|||
162791568|NCT01327612|587947282|FG006|Overall Study|Death|0|||
162791569|NCT01967069|587947285|FG000|Overall Study|Adverse Event|2|||
162791570|NCT01967069|587947286|FG001|Overall Study|Adverse Event|2|||
162791571|NCT01967069|587947285|FG000|Overall Study|Lost to Follow-up|5|||
162791572|NCT01967069|587947286|FG001|Overall Study|Lost to Follow-up|2|||
162791573|NCT01967069|587947285|FG000|Overall Study|Withdrawal by Subject|1|||
162791574|NCT01967069|587947286|FG001|Overall Study|Withdrawal by Subject|3|||
162791575|NCT01967069|587947285|FG000|Overall Study|Lack of Efficacy|0|||
162791576|NCT01967069|587947286|FG001|Overall Study|Lack of Efficacy|1|||
162791577|NCT05569421|587947288|FG000|Overall Study|Withdrawal by Subject|1|||
162791578|NCT05569421|587947289|FG001|Overall Study|Withdrawal by Subject|0|||
162791579|NCT05569421|587947290|FG002|Overall Study|Withdrawal by Subject|0|||
162791580|NCT00874731|587947291|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
162791581|NCT00874731|587947292|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
162791582|NCT00874731|587947293|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
162791583|NCT00874731|587947291|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
162791584|NCT00874731|587947292|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
162791585|NCT00874731|587947293|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
162791586|NCT00874731|587947291|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
162791587|NCT00874731|587947292|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
162791588|NCT00874731|587947293|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
162791589|NCT00581477|587947295|FG000|Overall Study|Physician Decision|2|||
162791590|NCT00790205|587947298|FG000|Overall Study|Lost to Follow-up|61|||
162791591|NCT00790205|587947299|FG001|Overall Study|Lost to Follow-up|71|||
162791592|NCT00790205|587947298|FG000|Overall Study|Withdrawal by Subject|299|||
162791593|NCT00790205|587947299|FG001|Overall Study|Withdrawal by Subject|363|||
162791594|NCT02643628|587947301|FG000|Overall Study|Lost to Follow-up|1|||
162791595|NCT02643628|587947302|FG001|Overall Study|Lost to Follow-up|4|||
162791596|NCT02643628|587947301|FG000|Overall Study|Withdrawal by Subject|0|||
162791597|NCT02643628|587947302|FG001|Overall Study|Withdrawal by Subject|1|||
162791598|NCT02643628|587947301|FG000|Overall Study|Relocated out of state|0|||
162791599|NCT02643628|587947302|FG001|Overall Study|Relocated out of state|1|||
162791600|NCT02803593|587947303|FG000|Overall Study|Lost to Follow-up|17|||
162791601|NCT02803593|587947304|FG001|Overall Study|Lost to Follow-up|35|||
162791602|NCT05143138|587947305|FG000|Overall Study|Death|5|||
162791603|NCT05143138|587947306|FG001|Overall Study|Death|35|||
162791604|NCT05143138|587947307|FG002|Overall Study|Death|1|||
162791605|NCT05143138|587947305|FG000|Overall Study|Lost to Follow-up|2|||
162791606|NCT05143138|587947306|FG001|Overall Study|Lost to Follow-up|4|||
162791607|NCT05143138|587947307|FG002|Overall Study|Lost to Follow-up|0|||
162791608|NCT05143138|587947305|FG000|Overall Study|withdrawal|1|||
162791609|NCT05143138|587947306|FG001|Overall Study|withdrawal|1|||
162791610|NCT05143138|587947307|FG002|Overall Study|withdrawal|0|||
162791611|NCT01436305|587947316|FG000|Overall Study|Death|1|||
162791612|NCT01436305|587947317|FG001|Overall Study|Death|0|||
162791613|NCT01436305|587947318|FG002|Overall Study|Death|0|||
162791614|NCT01436305|587947316|FG000|Overall Study|Lost to Follow-up|0|||
162791615|NCT01436305|587947317|FG001|Overall Study|Lost to Follow-up|1|||
162791616|NCT01436305|587947318|FG002|Overall Study|Lost to Follow-up|0|||
162791617|NCT01436305|587947316|FG000|Overall Study|Withdrawal by Subject|1|||
162791618|NCT01436305|587947317|FG001|Overall Study|Withdrawal by Subject|3|||
162791619|NCT01436305|587947318|FG002|Overall Study|Withdrawal by Subject|0|||
162791620|NCT01485120|587947319|FG000|Overall Study|Withdrawal by Subject|2|||
162791621|NCT02344342|587947320|FG000|Overall Study|Industry partner dropped out|11|||
162791622|NCT02344342|587947321|FG001|Overall Study|Industry partner dropped out|9|||
162791623|NCT02344342|587947322|FG002|Overall Study|Industry partner dropped out|14|||
162791624|NCT02344342|587947323|FG003|Overall Study|Industry partner dropped out|10|||
162791625|NCT00848484|587947324|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
162791626|NCT00848484|587947325|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
162791627|NCT00848484|587947324|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
162791628|NCT00848484|587947325|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
162791629|NCT00848484|587947324|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
162791630|NCT00848484|587947325|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
162791631|NCT00848484|587947324|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
162791632|NCT00848484|587947325|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
162791633|NCT00848484|587947324|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
162791634|NCT00848484|587947325|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
162791635|NCT02567708|587947327|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
162791636|NCT02567708|587947328|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
162791637|NCT02567708|587947327|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
162791638|NCT02567708|587947328|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
162791639|NCT02567708|587947327|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
162791640|NCT02567708|587947328|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
162791641|NCT02567708|587947327|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
162791642|NCT02567708|587947328|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
162791643|NCT00706654|587947329|FG000|Conversion Phase|Lost to Follow-up|4|||
162791644|NCT00706654|587947330|FG001|Conversion Phase|Lost to Follow-up|0|||
162791645|NCT00706654|587947331|FG002|Conversion Phase|Lost to Follow-up|0|||
162791646|NCT00706654|587947332|FG003|Conversion Phase|Lost to Follow-up|0|||
162791647|NCT00706654|587947329|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
162791648|NCT00706654|587947330|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
162791649|NCT00706654|587947331|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
162791650|NCT00706654|587947332|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
162791651|NCT00706654|587947329|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
162791652|NCT00706654|587947330|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
162791653|NCT00706654|587947331|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
162791654|NCT00706654|587947332|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
162791655|NCT00706654|587947329|FG000|Conversion Phase|Withdrawn by Investigator|14|||
162791656|NCT00706654|587947330|FG001|Conversion Phase|Withdrawn by Investigator|0|||
162791657|NCT00706654|587947331|FG002|Conversion Phase|Withdrawn by Investigator|0|||
162791658|NCT00706654|587947332|FG003|Conversion Phase|Withdrawn by Investigator|0|||
162791659|NCT00706654|587947329|FG000|Conversion Phase|Withdrew Consent|38|||
162791660|NCT00706654|587947330|FG001|Conversion Phase|Withdrew Consent|0|||
162791661|NCT00706654|587947331|FG002|Conversion Phase|Withdrew Consent|0|||
162791662|NCT00706654|587947332|FG003|Conversion Phase|Withdrew Consent|0|||
162791663|NCT00706654|587947329|FG000|Conversion Phase|Adverse Event|18|||
162791664|NCT00706654|587947330|FG001|Conversion Phase|Adverse Event|0|||
162791665|NCT00706654|587947331|FG002|Conversion Phase|Adverse Event|0|||
162791666|NCT00706654|587947332|FG003|Conversion Phase|Adverse Event|0|||
162791667|NCT00706654|587947329|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
162791668|NCT00706654|587947330|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162791669|NCT00706654|587947331|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162791670|NCT00706654|587947332|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162791671|NCT00706654|587947329|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
162791672|NCT00706654|587947330|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162791673|NCT00706654|587947331|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162791674|NCT00706654|587947332|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162791675|NCT00706654|587947329|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
162791676|NCT00706654|587947330|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
162791677|NCT00706654|587947331|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
162791678|NCT00706654|587947332|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
162791679|NCT00706654|587947329|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
162791680|NCT00706654|587947330|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162791681|NCT00706654|587947331|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162791682|NCT00706654|587947332|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162791683|NCT00706654|587947329|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
162791684|NCT00706654|587947330|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162791685|NCT00706654|587947331|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162791686|NCT00706654|587947332|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162791687|NCT00706654|587947329|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
162791688|NCT00706654|587947330|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162791689|NCT00706654|587947331|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162791690|NCT00706654|587947332|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162791691|NCT00706654|587947329|FG000|Oral Stabilization Phase|Withdrew consent|55|||
162791692|NCT00706654|587947330|FG001|Oral Stabilization Phase|Withdrew consent|0|||
162791693|NCT00706654|587947331|FG002|Oral Stabilization Phase|Withdrew consent|0|||
162791694|NCT00706654|587947332|FG003|Oral Stabilization Phase|Withdrew consent|0|||
162791695|NCT00706654|587947329|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
162791696|NCT00706654|587947330|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
162791697|NCT00706654|587947331|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
162791698|NCT00706654|587947332|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
162791699|NCT00706654|587947329|FG000|Oral Stabilization Phase|Adverse Event|21|||
162791700|NCT00706654|587947330|FG001|Oral Stabilization Phase|Adverse Event|0|||
162791701|NCT00706654|587947331|FG002|Oral Stabilization Phase|Adverse Event|0|||
162791702|NCT00706654|587947332|FG003|Oral Stabilization Phase|Adverse Event|0|||
162791703|NCT00706654|587947329|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
162791704|NCT00706654|587947330|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162791705|NCT00706654|587947331|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162791706|NCT00706654|587947332|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162791707|NCT00706654|587947329|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
162791708|NCT00706654|587947330|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162791709|NCT00706654|587947331|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162791710|NCT00706654|587947332|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162791711|NCT00706654|587947329|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
162791712|NCT00706654|587947330|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
162791713|NCT00706654|587947331|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
162791714|NCT00706654|587947332|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
162791715|NCT00706654|587947329|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
162791716|NCT00706654|587947330|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
162791717|NCT00706654|587947331|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
162791718|NCT00706654|587947332|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
162791719|NCT00706654|587947329|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
162791720|NCT00706654|587947330|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
162791721|NCT00706654|587947331|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
162791722|NCT00706654|587947332|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
162791723|NCT00706654|587947329|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
162791724|NCT00706654|587947330|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
162791725|NCT00706654|587947331|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
162791726|NCT00706654|587947332|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
162791727|NCT00706654|587947329|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
162791728|NCT00706654|587947330|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
162791729|NCT00706654|587947331|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
162791730|NCT00706654|587947332|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
162791731|NCT00706654|587947329|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
162791732|NCT00706654|587947330|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
162791733|NCT00706654|587947331|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
162791734|NCT00706654|587947332|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
162791735|NCT00706654|587947329|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
162791736|NCT00706654|587947330|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
162791737|NCT00706654|587947331|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
162791738|NCT00706654|587947332|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
162791739|NCT00706654|587947329|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
162791740|NCT00706654|587947330|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
162791741|NCT00706654|587947331|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
162791742|NCT00706654|587947332|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
162791743|NCT01001390|587947333|FG000|Overall Study|Failure to wear AFO device|2|||
162791744|NCT01001390|587947334|FG001|Overall Study|Failure to wear AFO device|0|||
162791745|NCT01151215|587947338|FG000|Overall Study|Worsening of condition under study|1|||
162791746|NCT01151215|587947339|FG001|Overall Study|Worsening of condition under study|1|||
162791747|NCT01151215|587947340|FG002|Overall Study|Worsening of condition under study|1|||
162791748|NCT01151215|587947338|FG000|Overall Study|Death|16|||
162791749|NCT01151215|587947339|FG001|Overall Study|Death|20|||
162791750|NCT01151215|587947340|FG002|Overall Study|Death|11|||
162791751|NCT01151215|587947338|FG000|Overall Study|Lost to Follow-up|0|||
162791752|NCT01151215|587947339|FG001|Overall Study|Lost to Follow-up|0|||
162791753|NCT01151215|587947340|FG002|Overall Study|Lost to Follow-up|3|||
162791754|NCT01151215|587947338|FG000|Overall Study|Withdrawal by Subject|3|||
162791755|NCT01151215|587947339|FG001|Overall Study|Withdrawal by Subject|1|||
162791756|NCT01151215|587947340|FG002|Overall Study|Withdrawal by Subject|2|||
162791757|NCT01151215|587947338|FG000|Overall Study|Disease progression|0|||
162791758|NCT01151215|587947339|FG001|Overall Study|Disease progression|1|||
162791759|NCT01151215|587947340|FG002|Overall Study|Disease progression|1|||
162791760|NCT01151215|587947338|FG000|Overall Study|Safety as judged by the investigator|0|||
162791761|NCT01151215|587947339|FG001|Overall Study|Safety as judged by the investigator|0|||
162791762|NCT01151215|587947340|FG002|Overall Study|Safety as judged by the investigator|1|||
162791763|NCT02956837|587947341|FG000|Overall Study|Serious Adverse Events|0|||
162791764|NCT02956837|587947342|FG001|Overall Study|Serious Adverse Events|1|||
162791765|NCT02956837|587947343|FG002|Overall Study|Serious Adverse Events|0|||
162791766|NCT02956837|587947344|FG003|Overall Study|Serious Adverse Events|0|||
162791767|NCT02956837|587947341|FG000|Overall Study|Withdrawal by Subject|0|||
162791768|NCT02956837|587947342|FG001|Overall Study|Withdrawal by Subject|1|||
162791769|NCT02956837|587947343|FG002|Overall Study|Withdrawal by Subject|0|||
162791770|NCT02956837|587947344|FG003|Overall Study|Withdrawal by Subject|3|||
162791771|NCT02956837|587947341|FG000|Overall Study|Lost to Follow-up|0|||
162791772|NCT02956837|587947342|FG001|Overall Study|Lost to Follow-up|1|||
162791773|NCT02956837|587947343|FG002|Overall Study|Lost to Follow-up|2|||
162791774|NCT02956837|587947344|FG003|Overall Study|Lost to Follow-up|0|||
162791775|NCT02597712|587947349|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
162791776|NCT02597712|587947350|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
162791777|NCT02597712|587947349|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
162791778|NCT02597712|587947350|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
162791779|NCT02597712|587947349|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
162791780|NCT02597712|587947350|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
162791781|NCT01727505|587947351|FG000|First 24 Hours|Adverse Event|0|||
162791782|NCT01727505|587947352|FG001|First 24 Hours|Adverse Event|1|||
162791783|NCT01727505|587947351|FG000|Second 24 Hours|Missing data|0|||
162791784|NCT01727505|587947352|FG001|Second 24 Hours|Missing data|1|||
162791785|NCT00513708|587947356|FG000|Overall Study|Lost to Follow-up|4|||
162791786|NCT00513708|587947357|FG001|Overall Study|Lost to Follow-up|4|||
162791787|NCT00513708|587947358|FG002|Overall Study|Lost to Follow-up|4|||
162791788|NCT01564277|587947359|FG000|Overall Study|Protocol Violation|0|||
162791789|NCT01564277|587947360|FG001|Overall Study|Protocol Violation|1|||
162791790|NCT01564277|587947359|FG000|Overall Study|Physician Decision|1|||
162791791|NCT01564277|587947360|FG001|Overall Study|Physician Decision|0|||
162791792|NCT01594970|587947361|FG000|Overall Study|Non-Adverse Event Related|4|||
162791793|NCT01594970|587947362|FG001|Overall Study|Non-Adverse Event Related|5|||
162791794|NCT01594970|587947363|FG002|Overall Study|Non-Adverse Event Related|6|||
162791795|NCT01594970|587947361|FG000|Overall Study|Adverse Event|17|||
162791796|NCT01594970|587947362|FG001|Overall Study|Adverse Event|23|||
162791797|NCT01594970|587947363|FG002|Overall Study|Adverse Event|23|||
162791798|NCT01594970|587947361|FG000|Overall Study|Lost to Follow-up|54|||
162791799|NCT01594970|587947362|FG001|Overall Study|Lost to Follow-up|54|||
162791800|NCT01594970|587947363|FG002|Overall Study|Lost to Follow-up|37|||
162791801|NCT01299480|587947366|FG000|Overall Study|No longer willing to participate|19|||
162791802|NCT01299480|587947367|FG001|Overall Study|No longer willing to participate|17|||
162791803|NCT01299480|587947368|FG002|Overall Study|No longer willing to participate|14|||
162791804|NCT01299480|587947369|FG003|Overall Study|No longer willing to participate|13|||
162791805|NCT01299480|587947370|FG004|Overall Study|No longer willing to participate|10|||
162791806|NCT01299480|587947366|FG000|Overall Study|Protocol Violation|7|||
162791807|NCT01299480|587947367|FG001|Overall Study|Protocol Violation|5|||
162791808|NCT01299480|587947368|FG002|Overall Study|Protocol Violation|8|||
162791809|NCT01299480|587947369|FG003|Overall Study|Protocol Violation|1|||
162791810|NCT01299480|587947370|FG004|Overall Study|Protocol Violation|1|||
162791811|NCT01299480|587947366|FG000|Overall Study|Withdrawal by Subject|3|||
162791812|NCT01299480|587947367|FG001|Overall Study|Withdrawal by Subject|4|||
162791813|NCT01299480|587947368|FG002|Overall Study|Withdrawal by Subject|7|||
162791814|NCT01299480|587947369|FG003|Overall Study|Withdrawal by Subject|3|||
162791815|NCT01299480|587947370|FG004|Overall Study|Withdrawal by Subject|4|||
162791816|NCT01299480|587947366|FG000|Overall Study|Adverse Event|6|||
162791817|NCT01299480|587947367|FG001|Overall Study|Adverse Event|4|||
162791818|NCT01299480|587947368|FG002|Overall Study|Adverse Event|5|||
162791819|NCT01299480|587947369|FG003|Overall Study|Adverse Event|4|||
162791820|NCT01299480|587947370|FG004|Overall Study|Adverse Event|0|||
162791821|NCT01299480|587947366|FG000|Overall Study|Withdrawal due to pregnancy|0|||
162791822|NCT01299480|587947367|FG001|Overall Study|Withdrawal due to pregnancy|1|||
162791823|NCT01299480|587947368|FG002|Overall Study|Withdrawal due to pregnancy|1|||
162791824|NCT01299480|587947369|FG003|Overall Study|Withdrawal due to pregnancy|0|||
162791825|NCT01299480|587947370|FG004|Overall Study|Withdrawal due to pregnancy|0|||
162791826|NCT01299480|587947366|FG000|Overall Study|Physician Decision|1|||
162791827|NCT01299480|587947367|FG001|Overall Study|Physician Decision|1|||
162791828|NCT01299480|587947368|FG002|Overall Study|Physician Decision|0|||
162791829|NCT01299480|587947369|FG003|Overall Study|Physician Decision|2|||
162791830|NCT01299480|587947370|FG004|Overall Study|Physician Decision|0|||
162791831|NCT01299480|587947366|FG000|Overall Study|Lost to Follow-up|3|||
162791832|NCT01299480|587947367|FG001|Overall Study|Lost to Follow-up|1|||
162791833|NCT01299480|587947368|FG002|Overall Study|Lost to Follow-up|2|||
162791834|NCT01299480|587947369|FG003|Overall Study|Lost to Follow-up|1|||
162791835|NCT01299480|587947370|FG004|Overall Study|Lost to Follow-up|2|||
162791836|NCT01299480|587947366|FG000|Overall Study|Other|3|||
162791837|NCT01299480|587947367|FG001|Overall Study|Other|2|||
162791838|NCT01299480|587947368|FG002|Overall Study|Other|3|||
162791839|NCT01299480|587947369|FG003|Overall Study|Other|0|||
162791840|NCT01299480|587947370|FG004|Overall Study|Other|3|||
162791841|NCT01299480|587947366|FG000|Overall Study|Started, but not vaccinated|0|||
162791842|NCT01299480|587947367|FG001|Overall Study|Started, but not vaccinated|0|||
162791843|NCT01299480|587947368|FG002|Overall Study|Started, but not vaccinated|1|||
162791844|NCT01299480|587947369|FG003|Overall Study|Started, but not vaccinated|1|||
162791845|NCT01299480|587947370|FG004|Overall Study|Started, but not vaccinated|0|||
162791846|NCT04276051|587947371|FG000|Overall Study|Lost to Follow-up|0|||
162791847|NCT04276051|587947372|FG001|Overall Study|Lost to Follow-up|1|||
162791848|NCT04276051|587947371|FG000|Overall Study|Physician Decision|0|||
162791849|NCT04276051|587947372|FG001|Overall Study|Physician Decision|1|||
162791850|NCT04276051|587947371|FG000|Overall Study|Withdrawal by Subject|1|||
162791851|NCT04276051|587947372|FG001|Overall Study|Withdrawal by Subject|1|||
162791852|NCT04297618|587947382|FG000|Overall Study|Adverse Event|1|||
162791853|NCT04297618|587947382|FG000|Overall Study|Withdrawal by Subject|1|||
162791854|NCT03838731|587949271|FG000|Overall Study|Pregnancy|0|||
162791855|NCT03838731|587949272|FG001|Overall Study|Pregnancy|1|||
162791856|NCT03838731|587949271|FG000|Overall Study|Withdrawal of consent|1|||
162791857|NCT03838731|587949272|FG001|Overall Study|Withdrawal of consent|0|||
162791858|NCT02706405|587949281|FG000|Overall Study|Death|3|||
162791859|NCT02706405|587949282|FG001|Overall Study|Death|2|||
162791860|NCT02706405|587949283|FG002|Overall Study|Death|0|||
162791861|NCT02706405|587949284|FG003|Overall Study|Death|1|||
162791862|NCT02706405|587949285|FG004|Overall Study|Death|0|||
162791863|NCT02706405|587949286|FG005|Overall Study|Death|0|||
162791864|NCT02706405|587949287|FG006|Overall Study|Death|3|||
162791865|NCT02706405|587949288|FG007|Overall Study|Death|4|||
162791866|NCT02706405|587949281|FG000|Overall Study|Disease progression|0|||
162791867|NCT02706405|587949282|FG001|Overall Study|Disease progression|0|||
162791868|NCT02706405|587949283|FG002|Overall Study|Disease progression|0|||
162791869|NCT02706405|587949284|FG003|Overall Study|Disease progression|0|||
162791870|NCT02706405|587949285|FG004|Overall Study|Disease progression|0|||
162791871|NCT02706405|587949286|FG005|Overall Study|Disease progression|0|||
162791872|NCT02706405|587949287|FG006|Overall Study|Disease progression|0|||
162791873|NCT02706405|587949288|FG007|Overall Study|Disease progression|1|||
162791874|NCT02706405|587949281|FG000|Overall Study|Pt moved to new therapy|0|||
162791875|NCT02706405|587949282|FG001|Overall Study|Pt moved to new therapy|0|||
162791876|NCT02706405|587949283|FG002|Overall Study|Pt moved to new therapy|0|||
162791877|NCT02706405|587949284|FG003|Overall Study|Pt moved to new therapy|0|||
162791878|NCT02706405|587949285|FG004|Overall Study|Pt moved to new therapy|0|||
162791879|NCT02706405|587949286|FG005|Overall Study|Pt moved to new therapy|1|||
162791880|NCT02706405|587949287|FG006|Overall Study|Pt moved to new therapy|0|||
162791881|NCT02706405|587949288|FG007|Overall Study|Pt moved to new therapy|1|||
162791882|NCT02706405|587949281|FG000|Overall Study|Physician Decision|1|||
162791883|NCT02706405|587949282|FG001|Overall Study|Physician Decision|0|||
162791884|NCT02706405|587949283|FG002|Overall Study|Physician Decision|0|||
162791885|NCT02706405|587949284|FG003|Overall Study|Physician Decision|0|||
162791886|NCT02706405|587949285|FG004|Overall Study|Physician Decision|0|||
162791887|NCT02706405|587949286|FG005|Overall Study|Physician Decision|0|||
162791888|NCT02706405|587949287|FG006|Overall Study|Physician Decision|0|||
162791889|NCT02706405|587949288|FG007|Overall Study|Physician Decision|0|||
162791890|NCT00789360|587949295|FG000|Overall Study|Protocol Violation|3|||
162791891|NCT00789360|587949296|FG001|Overall Study|Protocol Violation|1|||
162791892|NCT03559062|587949297|FG000|Overall Study|Other|0|||
162791893|NCT03559062|587949298|FG001|Overall Study|Other|1|||
162791894|NCT03559062|587949299|FG002|Overall Study|Other|0|||
162791895|NCT01757197|587949300|FG000|Overall Study|Death|2|||
162791896|NCT01677299|587949304|FG000|Overall Study|Adverse Event|0|||
162791897|NCT01677299|587949305|FG001|Overall Study|Adverse Event|2|||
162791898|NCT01677299|587949306|FG002|Overall Study|Adverse Event|1|||
162791899|NCT01677299|587949307|FG003|Overall Study|Adverse Event|0|||
162791900|NCT01677299|587949304|FG000|Overall Study|Withdrawal by Subject|0|||
162791901|NCT01677299|587949305|FG001|Overall Study|Withdrawal by Subject|1|||
162791902|NCT01677299|587949306|FG002|Overall Study|Withdrawal by Subject|0|||
162791903|NCT01677299|587949307|FG003|Overall Study|Withdrawal by Subject|1|||
162791904|NCT00351377|587949309|FG000|Overall Study|Adverse Event|5|||
162791905|NCT00351377|587949309|FG000|Overall Study|Death|1|||
162791906|NCT00351377|587949309|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162791907|NCT01661205|587949310|FG000|Overall Study|Physician Decision|2|||
162791908|NCT00955708|587949311|FG000|Overall Study|Death|269|||
162791909|NCT00955708|587949311|FG000|Overall Study|Lost to Follow-up|72|||
162791910|NCT00955708|587949311|FG000|Overall Study|Physician Decision|36|||
162791911|NCT00955708|587949311|FG000|Overall Study|Protocol Violation|134|||
162791912|NCT00955708|587949311|FG000|Overall Study|Registry Conclusion|186|||
162791913|NCT00955708|587949311|FG000|Overall Study|Product removed from service|94|||
162791914|NCT00955708|587949311|FG000|Overall Study|Patient Refused to participate further|116|||
162791915|NCT00955708|587949311|FG000|Overall Study|Closure of study location|60|||
162791916|NCT00955708|587949311|FG000|Overall Study|Patient changed care provider/moved|91|||
162791917|NCT05105087|587949312|FG000|Overall Study|Withdrawal by Subject|2|||
162791918|NCT05105087|587949312|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
162791919|NCT01735175|587949317|FG000|Overall Study|Withdrawal by Subject|9|||
162791920|NCT01735175|587949318|FG001|Overall Study|Withdrawal by Subject|2|||
162791921|NCT01735175|587949317|FG000|Overall Study|Lost to Follow-up|4|||
162791922|NCT01735175|587949318|FG001|Overall Study|Lost to Follow-up|2|||
162791923|NCT01735175|587949317|FG000|Overall Study|Death|3|||
162791924|NCT01735175|587949318|FG001|Overall Study|Death|2|||
162791925|NCT01735175|587949317|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
162791926|NCT01735175|587949318|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
162791927|NCT00755417|587949319|FG000|Overall Study|Adverse Event|28|||
162791928|NCT00755417|587949320|FG001|Overall Study|Adverse Event|20|||
162791929|NCT00755417|587949321|FG002|Overall Study|Adverse Event|7|||
162791930|NCT00755417|587949319|FG000|Overall Study|Lack of Efficacy|8|||
162791931|NCT00755417|587949320|FG001|Overall Study|Lack of Efficacy|4|||
162791932|NCT00755417|587949321|FG002|Overall Study|Lack of Efficacy|9|||
162791933|NCT00755417|587949319|FG000|Overall Study|Protocol Violation|2|||
162791934|NCT00755417|587949320|FG001|Overall Study|Protocol Violation|1|||
162791935|NCT00755417|587949321|FG002|Overall Study|Protocol Violation|1|||
162791936|NCT00755417|587949319|FG000|Overall Study|Lost to Follow-up|3|||
162791937|NCT00755417|587949320|FG001|Overall Study|Lost to Follow-up|0|||
162791938|NCT00755417|587949321|FG002|Overall Study|Lost to Follow-up|1|||
162791939|NCT00755417|587949319|FG000|Overall Study|Withdrawal by Subject|12|||
162791940|NCT00755417|587949320|FG001|Overall Study|Withdrawal by Subject|12|||
162791941|NCT00755417|587949321|FG002|Overall Study|Withdrawal by Subject|12|||
162791942|NCT00755417|587949319|FG000|Overall Study|Not specified or missing data|9|||
162791943|NCT00755417|587949320|FG001|Overall Study|Not specified or missing data|18|||
162791944|NCT00755417|587949321|FG002|Overall Study|Not specified or missing data|12|||
162791945|NCT03443414|587949322|FG000|Overall Study|Adverse Event|6|||
162791946|NCT03443414|587949323|FG001|Overall Study|Adverse Event|0|||
162791947|NCT03443414|587949324|FG002|Overall Study|Adverse Event|4|||
162791948|NCT03443414|587949325|FG003|Overall Study|Adverse Event|2|||
162791949|NCT03443414|587949326|FG004|Overall Study|Adverse Event|3|||
162791950|NCT03443414|587949322|FG000|Overall Study|Withdrawal by Subject|3|||
162791951|NCT03443414|587949323|FG001|Overall Study|Withdrawal by Subject|2|||
162791952|NCT03443414|587949324|FG002|Overall Study|Withdrawal by Subject|2|||
162791953|NCT03443414|587949325|FG003|Overall Study|Withdrawal by Subject|2|||
162791954|NCT03443414|587949326|FG004|Overall Study|Withdrawal by Subject|1|||
162791955|NCT03443414|587949322|FG000|Overall Study|Death|0|||
162791956|NCT03443414|587949323|FG001|Overall Study|Death|1|||
162791957|NCT03443414|587949324|FG002|Overall Study|Death|0|||
162791958|NCT03443414|587949325|FG003|Overall Study|Death|1|||
162791959|NCT03443414|587949326|FG004|Overall Study|Death|0|||
162791960|NCT03443414|587949322|FG000|Overall Study|Reason not specified|2|||
162791961|NCT03443414|587949323|FG001|Overall Study|Reason not specified|0|||
162791962|NCT03443414|587949324|FG002|Overall Study|Reason not specified|0|||
162791963|NCT03443414|587949325|FG003|Overall Study|Reason not specified|0|||
162791964|NCT03443414|587949326|FG004|Overall Study|Reason not specified|1|||
162791965|NCT03933462|587949329|FG000|Overall Study|Adverse Event|2|||
162791966|NCT03933462|587949330|FG001|Overall Study|Adverse Event|0|||
162791967|NCT02522728|587949331|FG000|Overall Study|Withdrawal by Subject|6|||
162791968|NCT02522728|587949332|FG001|Overall Study|Withdrawal by Subject|6|||
162791969|NCT02522728|587949331|FG000|Overall Study|Death|4|||
162791970|NCT02522728|587949332|FG001|Overall Study|Death|3|||
162791971|NCT02522728|587949331|FG000|Overall Study|Adverse Event|2|||
162791972|NCT02522728|587949332|FG001|Overall Study|Adverse Event|1|||
162791973|NCT02522728|587949331|FG000|Overall Study|Did not receive randomized study device|0|||
162791974|NCT02522728|587949332|FG001|Overall Study|Did not receive randomized study device|1|||
162791975|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
162791976|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
162791977|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
162791978|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
162791979|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
162791980|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162791981|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
162791982|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
162791983|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
162791984|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
162791985|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
162791986|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
162791987|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
162791988|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
162791989|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
162791990|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
162791991|NCT04210843|587949333|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
162791992|NCT04210843|587949334|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
162791993|NCT04210843|587949333|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
162791994|NCT04210843|587949334|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
162791995|NCT04210843|587949333|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
162791996|NCT04210843|587949334|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
162791997|NCT04210843|587949333|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162791998|NCT04210843|587949334|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162791999|NCT04210843|587949333|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
162792000|NCT04210843|587949334|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
162792001|NCT04210843|587949333|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
162792002|NCT04210843|587949334|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
162792003|NCT04210843|587949333|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
162792004|NCT04210843|587949334|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
162792005|NCT04210843|587949333|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
162792006|NCT04210843|587949334|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
162792007|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
162792008|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
162792009|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
162792010|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
162792011|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
162792012|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
162792013|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
162792014|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
162792015|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
162792016|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
162792017|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
162792018|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
162792019|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
162792020|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
162792021|NCT04210843|587949333|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
162792022|NCT04210843|587949334|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
162792023|NCT01266161|587949335|FG000|Overall Study|Ineligible|1|||
162792024|NCT01266161|587949336|FG001|Overall Study|Ineligible|0|||
162792025|NCT01266161|587949335|FG000|Overall Study|Lack of Efficacy|0|||
162792026|NCT01266161|587949336|FG001|Overall Study|Lack of Efficacy|1|||
162792027|NCT01266161|587949335|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
162792028|NCT01266161|587949336|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
162792029|NCT03355209|587949339|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
162792030|NCT03355209|587949340|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
162792031|NCT03355209|587949341|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
162792032|NCT03355209|587949342|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
162792033|NCT03355209|587949343|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
162792034|NCT03355209|587949344|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
162792035|NCT03355209|587949339|FG000|Part 1: Double-Blind Period|Death|0|||
162792036|NCT03355209|587949340|FG001|Part 1: Double-Blind Period|Death|0|||
162792037|NCT03355209|587949341|FG002|Part 1: Double-Blind Period|Death|1|||
162792038|NCT03355209|587949342|FG003|Part 1: Double-Blind Period|Death|0|||
162792039|NCT03355209|587949343|FG004|Part 1: Double-Blind Period|Death|0|||
162792040|NCT03355209|587949344|FG005|Part 1: Double-Blind Period|Death|0|||
162792041|NCT03355209|587949339|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
162792042|NCT03355209|587949340|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
162792043|NCT03355209|587949341|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
162792044|NCT03355209|587949342|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
162792045|NCT03355209|587949343|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
162792046|NCT03355209|587949344|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
162792047|NCT03355209|587949339|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162792048|NCT03355209|587949340|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162792049|NCT03355209|587949341|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162792050|NCT03355209|587949342|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162792051|NCT03355209|587949343|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162792052|NCT03355209|587949344|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162792053|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
162792054|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
162792055|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
162792056|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
162792057|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
162792058|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
162792059|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162792060|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
162792061|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162792062|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162792063|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162792064|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162792065|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
162792066|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
162792067|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
162792068|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
162792069|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
162792070|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
162792071|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162792072|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162792073|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162792074|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
162792075|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
162792076|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
162792077|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
162792078|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
162792079|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
162792080|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162792081|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162792082|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162792083|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162792084|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162792085|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162792086|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
162792087|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162792088|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
162792089|NCT03355209|587949339|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
162792090|NCT03355209|587949340|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162792091|NCT03355209|587949341|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
162792092|NCT03355209|587949342|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162792093|NCT03355209|587949343|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162792094|NCT03355209|587949344|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162792095|NCT00604708|587949350|FG000|Overall Study|Withdrawal by Subject|9|||
162792096|NCT00604708|587949351|FG001|Overall Study|Withdrawal by Subject|10|||
162792097|NCT00604708|587949350|FG000|Overall Study|Protocol Violation|2|||
162792098|NCT00604708|587949351|FG001|Overall Study|Protocol Violation|8|||
162792099|NCT00604708|587949350|FG000|Overall Study|Lost to Follow-up|5|||
162792100|NCT00604708|587949351|FG001|Overall Study|Lost to Follow-up|5|||
162792101|NCT00604708|587949350|FG000|Overall Study|administrative reasons|9|||
162792102|NCT00604708|587949351|FG001|Overall Study|administrative reasons|11|||
162792103|NCT00604708|587949350|FG000|Overall Study|Adverse Event|6|||
162792104|NCT00604708|587949351|FG001|Overall Study|Adverse Event|6|||
162792105|NCT01277887|587949353|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
162792106|NCT01277887|587949354|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
162792107|NCT01277887|587949353|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
162792108|NCT01277887|587949354|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
162792109|NCT01277887|587949353|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
162792110|NCT01277887|587949354|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
162792111|NCT00415051|587949355|FG000|Overall Study|Protocol Violation|1|||
162792112|NCT04916730|587949356|FG000|Overall Study|Withdrawal by Subject|4|||
162792113|NCT04916730|587949357|FG001|Overall Study|Withdrawal by Subject|2|||
162792114|NCT04916730|587949356|FG000|Overall Study|Lost to Follow-up|0|||
162792115|NCT04916730|587949357|FG001|Overall Study|Lost to Follow-up|2|||
162792116|NCT04916730|587949356|FG000|Overall Study|Physician Decision|1|||
162792117|NCT04916730|587949357|FG001|Overall Study|Physician Decision|0|||
162792118|NCT00617929|587949360|FG000|Overall Study|Physician Decision|1|||
162792119|NCT00760747|587949370|FG000|Study Period II|Adverse Event|3|||
162792120|NCT00760747|587949371|FG001|Study Period II|Adverse Event|4|||
162792121|NCT00760747|587949370|FG000|Study Period II|Lack of Efficacy|0|||
162792122|NCT00760747|587949371|FG001|Study Period II|Lack of Efficacy|6|||
162792123|NCT00760747|587949370|FG000|Study Period II|Parent/Caregiver Decision|3|||
162792124|NCT00760747|587949371|FG001|Study Period II|Parent/Caregiver Decision|0|||
162792125|NCT00760747|587949370|FG000|Study Period II|Protocol Violation|6|||
162792126|NCT00760747|587949371|FG001|Study Period II|Protocol Violation|3|||
162792127|NCT00760747|587949370|FG000|Study Period II|Withdrawal by Subject|1|||
162792128|NCT00760747|587949371|FG001|Study Period II|Withdrawal by Subject|0|||
162792129|NCT00760747|587949370|FG000|Study Period II|No drug administered|0|||
162792130|NCT00760747|587949371|FG001|Study Period II|No drug administered|1|||
162792131|NCT00760747|587949370|FG000|Study Period III|Adverse Event|1|||
162792132|NCT00760747|587949371|FG001|Study Period III|Adverse Event|0|||
162792133|NCT00760747|587949370|FG000|Study Period III|Lack of Efficacy|1|||
162792134|NCT00760747|587949371|FG001|Study Period III|Lack of Efficacy|0|||
162792135|NCT00760747|587949370|FG000|Study Period III|Parent/Caregiver Decision|0|||
162792136|NCT00760747|587949371|FG001|Study Period III|Parent/Caregiver Decision|1|||
162792137|NCT00760747|587949370|FG000|Study Period III|Protocol Violation|1|||
162792138|NCT00760747|587949371|FG001|Study Period III|Protocol Violation|1|||
162792139|NCT00760747|587949370|FG000|Study Period III|Physician Decision|0|||
162792140|NCT00760747|587949371|FG001|Study Period III|Physician Decision|1|||
162792141|NCT04160988|587949372|FG000|Overall Study|poor image quality|28|||
162792142|NCT00844597|587949373|FG000|Overall Study|Adverse Event|0|||
162792143|NCT00844597|587949374|FG001|Overall Study|Adverse Event|0|||
162792144|NCT00844597|587949375|FG002|Overall Study|Adverse Event|0|||
162792145|NCT00844597|587949376|FG003|Overall Study|Adverse Event|1|||
162792146|NCT00844597|587949377|FG004|Overall Study|Adverse Event|0|||
162792147|NCT00844597|587949378|FG005|Overall Study|Adverse Event|0|||
162792148|NCT01250509|587949379|FG000|Overall Study|Lost to Follow-up|5|||
162792149|NCT01250509|587949380|FG001|Overall Study|Lost to Follow-up|2|||
162792150|NCT01228175|587949384|FG000|Overall Study|Lost to Follow-up|64|||
162792151|NCT01228175|587949385|FG001|Overall Study|Lost to Follow-up|50|||
162792152|NCT01228175|587949384|FG000|Overall Study|Withdrawal by Subject|1|||
162792153|NCT01228175|587949385|FG001|Overall Study|Withdrawal by Subject|2|||
162792154|NCT01228175|587949384|FG000|Overall Study|Physician Decision|1|||
162792155|NCT01228175|587949385|FG001|Overall Study|Physician Decision|1|||
162792156|NCT00243074|587949386|FG000|Overall Study|Ineligible|6|||
162792157|NCT00243074|587949386|FG000|Overall Study|Adverse Event|6|||
162792158|NCT00243074|587949386|FG000|Overall Study|Withdrawal by Subject|2|||
162792159|NCT00243074|587949386|FG000|Overall Study|Lack of Efficacy|36|||
162792160|NCT00243074|587949386|FG000|Overall Study|Death|2|||
162792161|NCT00243074|587949386|FG000|Overall Study|not protocol specified|1|||
162792162|NCT00243074|587949386|FG000|Overall Study|Did not receive any treatment|1|||
162792163|NCT00402051|587949389|FG000|Overall Study|Progressive Disease|13|||
162792164|NCT00402051|587949390|FG001|Overall Study|Progressive Disease|20|||
162792165|NCT00402051|587949389|FG000|Overall Study|Adverse Event|11|||
162792166|NCT00402051|587949390|FG001|Overall Study|Adverse Event|4|||
162792167|NCT00402051|587949389|FG000|Overall Study|Physician Decision|7|||
162792168|NCT00402051|587949390|FG001|Overall Study|Physician Decision|3|||
162792169|NCT00402051|587949389|FG000|Overall Study|Withdrawal by Subject|3|||
162792170|NCT00402051|587949390|FG001|Overall Study|Withdrawal by Subject|3|||
162792171|NCT00402051|587949389|FG000|Overall Study|Death - Related to Study Drug|1|||
162792172|NCT00402051|587949390|FG001|Overall Study|Death - Related to Study Drug|2|||
162792173|NCT00402051|587949389|FG000|Overall Study|Death Due to Study Disease|2|||
162792174|NCT00402051|587949390|FG001|Overall Study|Death Due to Study Disease|1|||
162792175|NCT00402051|587949389|FG000|Overall Study|Death Due to Adverse Event|0|||
162792176|NCT00402051|587949390|FG001|Overall Study|Death Due to Adverse Event|2|||
162792177|NCT00402051|587949389|FG000|Overall Study|Lost to Follow-up|1|||
162792178|NCT00402051|587949390|FG001|Overall Study|Lost to Follow-up|0|||
162792179|NCT02998476|587949395|FG000|Overall Study|Lost to Follow-up|1|||
162792180|NCT02998476|587949396|FG001|Overall Study|Lost to Follow-up|0|||
162792181|NCT02998476|587949395|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
162792182|NCT02998476|587949396|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
162792183|NCT02998476|587949395|FG000|Overall Study|Withdrawal by Subject|1|||
162792184|NCT02998476|587949396|FG001|Overall Study|Withdrawal by Subject|2|||
162792185|NCT02998476|587949395|FG000|Overall Study|Death|45|||
162792186|NCT02998476|587949396|FG001|Overall Study|Death|2|||
162792187|NCT02998476|587949395|FG000|Overall Study|Other|6|||
162792188|NCT02998476|587949396|FG001|Overall Study|Other|1|||
162792189|NCT00344032|587949399|FG000|Overall Study|Adverse Event|0|||
162792190|NCT00344032|587949400|FG001|Overall Study|Adverse Event|1|||
162792191|NCT00344032|587949399|FG000|Overall Study|Withdrawal by Subject|6|||
162792192|NCT00344032|587949400|FG001|Overall Study|Withdrawal by Subject|2|||
162792193|NCT00344032|587949399|FG000|Overall Study|Lost to Follow-up|4|||
162792194|NCT00344032|587949400|FG001|Overall Study|Lost to Follow-up|6|||
162792195|NCT00344032|587949399|FG000|Overall Study|Physician Decision|4|||
162792196|NCT00344032|587949400|FG001|Overall Study|Physician Decision|1|||
162792197|NCT05131477|587949403|FG000|PART 1|Withdrawal by Subject|2|||
162792198|NCT05131477|587949404|FG001|PART 1|Withdrawal by Subject|9|||
162792199|NCT05131477|587949405|FG002|PART 1|Withdrawal by Subject|6|||
162792200|NCT05131477|587949406|FG003|PART 1|Withdrawal by Subject|2|||
162792201|NCT05131477|587949407|FG004|PART 1|Withdrawal by Subject|8|||
162792202|NCT05131477|587949408|FG005|PART 1|Withdrawal by Subject|0|||
162792203|NCT05131477|587949409|FG006|PART 1|Withdrawal by Subject|0|||
162792204|NCT05131477|587949410|FG007|PART 1|Withdrawal by Subject|0|||
162792205|NCT05131477|587949411|FG008|PART 1|Withdrawal by Subject|0|||
162792206|NCT05131477|587949412|FG009|PART 1|Withdrawal by Subject|0|||
162792207|NCT05131477|587949413|FG010|PART 1|Withdrawal by Subject|0|||
162792208|NCT05131477|587949414|FG011|PART 1|Withdrawal by Subject|0|||
162792209|NCT05131477|587949415|FG012|PART 1|Withdrawal by Subject|0|||
162792210|NCT05131477|587949416|FG013|PART 1|Withdrawal by Subject|0|||
162792211|NCT05131477|587949403|FG000|PART 1|Physician Decision|1|||
162792212|NCT05131477|587949404|FG001|PART 1|Physician Decision|0|||
162792213|NCT05131477|587949405|FG002|PART 1|Physician Decision|0|||
162792214|NCT05131477|587949406|FG003|PART 1|Physician Decision|0|||
162792215|NCT05131477|587949407|FG004|PART 1|Physician Decision|0|||
162792216|NCT05131477|587949408|FG005|PART 1|Physician Decision|0|||
162792217|NCT05131477|587949409|FG006|PART 1|Physician Decision|0|||
162792218|NCT05131477|587949410|FG007|PART 1|Physician Decision|0|||
162792219|NCT05131477|587949411|FG008|PART 1|Physician Decision|0|||
162792220|NCT05131477|587949412|FG009|PART 1|Physician Decision|0|||
162792221|NCT05131477|587949413|FG010|PART 1|Physician Decision|0|||
162792222|NCT05131477|587949414|FG011|PART 1|Physician Decision|0|||
162792223|NCT05131477|587949415|FG012|PART 1|Physician Decision|0|||
162792224|NCT05131477|587949416|FG013|PART 1|Physician Decision|0|||
162792225|NCT05131477|587949403|FG000|PART 1|Adverse Event|3|||
162792226|NCT05131477|587949404|FG001|PART 1|Adverse Event|5|||
162792227|NCT05131477|587949405|FG002|PART 1|Adverse Event|1|||
162792228|NCT05131477|587949406|FG003|PART 1|Adverse Event|6|||
162792229|NCT05131477|587949407|FG004|PART 1|Adverse Event|4|||
162792230|NCT05131477|587949408|FG005|PART 1|Adverse Event|0|||
162792231|NCT05131477|587949409|FG006|PART 1|Adverse Event|0|||
162792232|NCT05131477|587949410|FG007|PART 1|Adverse Event|0|||
162792233|NCT05131477|587949411|FG008|PART 1|Adverse Event|0|||
162792234|NCT05131477|587949412|FG009|PART 1|Adverse Event|0|||
162792235|NCT05131477|587949413|FG010|PART 1|Adverse Event|0|||
162792236|NCT05131477|587949414|FG011|PART 1|Adverse Event|0|||
162792237|NCT05131477|587949415|FG012|PART 1|Adverse Event|0|||
162792238|NCT05131477|587949416|FG013|PART 1|Adverse Event|0|||
162792239|NCT05131477|587949403|FG000|PART 1|unclassified|1|||
162792240|NCT05131477|587949404|FG001|PART 1|unclassified|1|||
162792241|NCT05131477|587949405|FG002|PART 1|unclassified|0|||
162792242|NCT05131477|587949406|FG003|PART 1|unclassified|0|||
162792243|NCT05131477|587949407|FG004|PART 1|unclassified|4|||
162792244|NCT05131477|587949408|FG005|PART 1|unclassified|0|||
162792245|NCT05131477|587949409|FG006|PART 1|unclassified|0|||
162792246|NCT05131477|587949410|FG007|PART 1|unclassified|0|||
162792247|NCT05131477|587949411|FG008|PART 1|unclassified|0|||
162792248|NCT05131477|587949412|FG009|PART 1|unclassified|0|||
162792249|NCT05131477|587949413|FG010|PART 1|unclassified|0|||
162792250|NCT05131477|587949414|FG011|PART 1|unclassified|0|||
162792251|NCT05131477|587949415|FG012|PART 1|unclassified|0|||
162792252|NCT05131477|587949416|FG013|PART 1|unclassified|0|||
162792253|NCT05131477|587949403|FG000|PART 1|Randomized and not treated|0|||
162792254|NCT05131477|587949404|FG001|PART 1|Randomized and not treated|0|||
162792255|NCT05131477|587949405|FG002|PART 1|Randomized and not treated|0|||
162792256|NCT05131477|587949406|FG003|PART 1|Randomized and not treated|1|||
162792257|NCT05131477|587949407|FG004|PART 1|Randomized and not treated|1|||
162792258|NCT05131477|587949408|FG005|PART 1|Randomized and not treated|0|||
162792259|NCT05131477|587949409|FG006|PART 1|Randomized and not treated|0|||
162792260|NCT05131477|587949410|FG007|PART 1|Randomized and not treated|0|||
162792261|NCT05131477|587949411|FG008|PART 1|Randomized and not treated|0|||
162792262|NCT05131477|587949412|FG009|PART 1|Randomized and not treated|0|||
162792263|NCT05131477|587949413|FG010|PART 1|Randomized and not treated|0|||
162792264|NCT05131477|587949414|FG011|PART 1|Randomized and not treated|0|||
162792265|NCT05131477|587949415|FG012|PART 1|Randomized and not treated|0|||
162792266|NCT05131477|587949416|FG013|PART 1|Randomized and not treated|0|||
162792267|NCT05131477|587949403|FG000|PART 1|Protocol Violation|2|||
162792268|NCT05131477|587949404|FG001|PART 1|Protocol Violation|0|||
162792269|NCT05131477|587949405|FG002|PART 1|Protocol Violation|0|||
162792270|NCT05131477|587949406|FG003|PART 1|Protocol Violation|1|||
162792271|NCT05131477|587949407|FG004|PART 1|Protocol Violation|0|||
162792272|NCT05131477|587949408|FG005|PART 1|Protocol Violation|0|||
162792273|NCT05131477|587949409|FG006|PART 1|Protocol Violation|0|||
162792274|NCT05131477|587949410|FG007|PART 1|Protocol Violation|0|||
162792275|NCT05131477|587949411|FG008|PART 1|Protocol Violation|0|||
162792276|NCT05131477|587949412|FG009|PART 1|Protocol Violation|0|||
162792277|NCT05131477|587949413|FG010|PART 1|Protocol Violation|0|||
162792278|NCT05131477|587949414|FG011|PART 1|Protocol Violation|0|||
162792279|NCT05131477|587949415|FG012|PART 1|Protocol Violation|0|||
162792280|NCT05131477|587949416|FG013|PART 1|Protocol Violation|0|||
162792281|NCT05131477|587949403|FG000|PART 1|Lack of Efficacy|0|||
162792282|NCT05131477|587949404|FG001|PART 1|Lack of Efficacy|1|||
162792283|NCT05131477|587949405|FG002|PART 1|Lack of Efficacy|1|||
162792284|NCT05131477|587949406|FG003|PART 1|Lack of Efficacy|2|||
162792285|NCT05131477|587949407|FG004|PART 1|Lack of Efficacy|5|||
162792286|NCT05131477|587949408|FG005|PART 1|Lack of Efficacy|0|||
162792287|NCT05131477|587949409|FG006|PART 1|Lack of Efficacy|0|||
162792288|NCT05131477|587949410|FG007|PART 1|Lack of Efficacy|0|||
162792289|NCT05131477|587949411|FG008|PART 1|Lack of Efficacy|0|||
162792290|NCT05131477|587949412|FG009|PART 1|Lack of Efficacy|0|||
162792291|NCT05131477|587949413|FG010|PART 1|Lack of Efficacy|0|||
162792292|NCT05131477|587949414|FG011|PART 1|Lack of Efficacy|0|||
162792293|NCT05131477|587949415|FG012|PART 1|Lack of Efficacy|0|||
162792294|NCT05131477|587949416|FG013|PART 1|Lack of Efficacy|0|||
162792295|NCT05131477|587949403|FG000|PART 2|Withdrawal by Subject|0|||
162792296|NCT05131477|587949404|FG001|PART 2|Withdrawal by Subject|0|||
162792297|NCT05131477|587949405|FG002|PART 2|Withdrawal by Subject|0|||
162792298|NCT05131477|587949406|FG003|PART 2|Withdrawal by Subject|0|||
162792299|NCT05131477|587949407|FG004|PART 2|Withdrawal by Subject|0|||
162792300|NCT05131477|587949408|FG005|PART 2|Withdrawal by Subject|0|||
162792301|NCT05131477|587949409|FG006|PART 2|Withdrawal by Subject|2|||
162792302|NCT05131477|587949410|FG007|PART 2|Withdrawal by Subject|0|||
162792303|NCT05131477|587949411|FG008|PART 2|Withdrawal by Subject|0|||
162792304|NCT05131477|587949412|FG009|PART 2|Withdrawal by Subject|0|||
162792305|NCT05131477|587949413|FG010|PART 2|Withdrawal by Subject|2|||
162792306|NCT05131477|587949414|FG011|PART 2|Withdrawal by Subject|0|||
162792307|NCT05131477|587949415|FG012|PART 2|Withdrawal by Subject|2|||
162792308|NCT05131477|587949416|FG013|PART 2|Withdrawal by Subject|2|||
162792309|NCT05131477|587949403|FG000|PART 2|Other|0|||
162792310|NCT05131477|587949404|FG001|PART 2|Other|0|||
162792311|NCT05131477|587949405|FG002|PART 2|Other|0|||
162792312|NCT05131477|587949406|FG003|PART 2|Other|0|||
162792313|NCT05131477|587949407|FG004|PART 2|Other|0|||
162792314|NCT05131477|587949408|FG005|PART 2|Other|0|||
162792315|NCT05131477|587949409|FG006|PART 2|Other|0|||
162792316|NCT05131477|587949410|FG007|PART 2|Other|0|||
162792317|NCT05131477|587949411|FG008|PART 2|Other|1|||
162792318|NCT05131477|587949412|FG009|PART 2|Other|1|||
162792319|NCT05131477|587949413|FG010|PART 2|Other|0|||
162792320|NCT05131477|587949414|FG011|PART 2|Other|0|||
162792321|NCT05131477|587949415|FG012|PART 2|Other|1|||
162792322|NCT05131477|587949416|FG013|PART 2|Other|0|||
162792323|NCT05131477|587949403|FG000|PART 2|Lack of Efficacy|0|||
162792324|NCT05131477|587949404|FG001|PART 2|Lack of Efficacy|0|||
162792325|NCT05131477|587949405|FG002|PART 2|Lack of Efficacy|0|||
162792326|NCT05131477|587949406|FG003|PART 2|Lack of Efficacy|0|||
162792327|NCT05131477|587949407|FG004|PART 2|Lack of Efficacy|0|||
162792328|NCT05131477|587949408|FG005|PART 2|Lack of Efficacy|1|||
162792329|NCT05131477|587949409|FG006|PART 2|Lack of Efficacy|1|||
162792330|NCT05131477|587949410|FG007|PART 2|Lack of Efficacy|0|||
162792331|NCT05131477|587949411|FG008|PART 2|Lack of Efficacy|3|||
162792332|NCT05131477|587949412|FG009|PART 2|Lack of Efficacy|0|||
162792333|NCT05131477|587949413|FG010|PART 2|Lack of Efficacy|1|||
162792334|NCT05131477|587949414|FG011|PART 2|Lack of Efficacy|0|||
162792335|NCT05131477|587949415|FG012|PART 2|Lack of Efficacy|2|||
162792336|NCT05131477|587949416|FG013|PART 2|Lack of Efficacy|0|||
162792337|NCT05131477|587949403|FG000|PART 2|Unclassified|0|||
162792338|NCT05131477|587949404|FG001|PART 2|Unclassified|0|||
162792339|NCT05131477|587949405|FG002|PART 2|Unclassified|0|||
162792340|NCT05131477|587949406|FG003|PART 2|Unclassified|0|||
162792341|NCT05131477|587949407|FG004|PART 2|Unclassified|0|||
162792342|NCT05131477|587949408|FG005|PART 2|Unclassified|0|||
162792343|NCT05131477|587949409|FG006|PART 2|Unclassified|0|||
162792344|NCT05131477|587949410|FG007|PART 2|Unclassified|0|||
162792345|NCT05131477|587949411|FG008|PART 2|Unclassified|0|||
162792346|NCT05131477|587949412|FG009|PART 2|Unclassified|0|||
162792347|NCT05131477|587949413|FG010|PART 2|Unclassified|1|||
162792348|NCT05131477|587949414|FG011|PART 2|Unclassified|0|||
162792349|NCT05131477|587949415|FG012|PART 2|Unclassified|0|||
162792350|NCT05131477|587949416|FG013|PART 2|Unclassified|0|||
162792351|NCT05131477|587949403|FG000|PART 2|Re-randomized and not treated|0|||
162792352|NCT05131477|587949404|FG001|PART 2|Re-randomized and not treated|0|||
162792353|NCT05131477|587949405|FG002|PART 2|Re-randomized and not treated|0|||
162792354|NCT05131477|587949406|FG003|PART 2|Re-randomized and not treated|0|||
162792355|NCT05131477|587949407|FG004|PART 2|Re-randomized and not treated|0|||
162792356|NCT05131477|587949408|FG005|PART 2|Re-randomized and not treated|0|||
162792357|NCT05131477|587949409|FG006|PART 2|Re-randomized and not treated|0|||
162792358|NCT05131477|587949410|FG007|PART 2|Re-randomized and not treated|1|||
162792359|NCT05131477|587949411|FG008|PART 2|Re-randomized and not treated|0|||
162792360|NCT05131477|587949412|FG009|PART 2|Re-randomized and not treated|0|||
162792361|NCT05131477|587949413|FG010|PART 2|Re-randomized and not treated|1|||
162792362|NCT05131477|587949414|FG011|PART 2|Re-randomized and not treated|0|||
162792363|NCT05131477|587949415|FG012|PART 2|Re-randomized and not treated|1|||
162792364|NCT05131477|587949416|FG013|PART 2|Re-randomized and not treated|1|||
162792365|NCT02194829|587949417|FG000|Overall Study|Adverse Event|2|||
162792366|NCT02194829|587949418|FG001|Overall Study|Adverse Event|2|||
162792367|NCT02194829|587949417|FG000|Overall Study|Death|0|||
162792368|NCT02194829|587949418|FG001|Overall Study|Death|1|||
162792369|NCT02194829|587949417|FG000|Overall Study|Disease progression|0|||
162792370|NCT02194829|587949418|FG001|Overall Study|Disease progression|1|||
162792371|NCT02194829|587949417|FG000|Overall Study|Withdrawal by Subject|0|||
162792372|NCT02194829|587949418|FG001|Overall Study|Withdrawal by Subject|1|||
162792373|NCT02194829|587949417|FG000|Overall Study|Never started protocol therapy|0|||
162792374|NCT02194829|587949418|FG001|Overall Study|Never started protocol therapy|1|||
162792375|NCT06840769|587949420|FG000|Overall Study|Withdrawal by Subject|1|||
162792376|NCT06840769|587949421|FG001|Overall Study|Withdrawal by Subject|0|||
162792377|NCT06840769|587949422|FG002|Overall Study|Withdrawal by Subject|0|||
162792378|NCT06840769|587949423|FG003|Overall Study|Withdrawal by Subject|0|||
162792379|NCT06840769|587949424|FG004|Overall Study|Withdrawal by Subject|0|||
162792380|NCT02726945|587949425|FG000|Overall Study|Withdrawal by Subject|0|||
162792381|NCT02726945|587949426|FG001|Overall Study|Withdrawal by Subject|0|||
162792382|NCT02726945|587949427|FG002|Overall Study|Withdrawal by Subject|1|||
162792383|NCT02726945|587949425|FG000|Overall Study|Elected to have total knee replacement|0|||
162792384|NCT02726945|587949426|FG001|Overall Study|Elected to have total knee replacement|1|||
162792385|NCT02726945|587949427|FG002|Overall Study|Elected to have total knee replacement|0|||
162792386|NCT05992922|587949428|FG000|Overall Study|Adverse Event|6|||
162792387|NCT05992922|587949429|FG001|Overall Study|Adverse Event|0|||
162792388|NCT05992922|587949428|FG000|Overall Study|Sponsor Termination of Study|14|||
162792389|NCT05992922|587949429|FG001|Overall Study|Sponsor Termination of Study|20|||
162792390|NCT01681277|587950498|FG000|Overall Study|Adverse Event|1|||
162792391|NCT01681277|587950499|FG001|Overall Study|Adverse Event|0|||
162792392|NCT01681277|587950500|FG002|Overall Study|Adverse Event|0|||
162792393|NCT01681277|587950501|FG003|Overall Study|Adverse Event|0|||
162792394|NCT01681277|587950502|FG004|Overall Study|Adverse Event|0|||
162792395|NCT03057847|587950506|FG000|Overall Study|Lost to Follow-up|16|||
162792396|NCT02088957|587950507|FG000|Overall Study|Lack of Efficacy|1|||
162792397|NCT02088957|587950508|FG001|Overall Study|Lack of Efficacy|0|||
162792398|NCT00426127|587950509|FG000|Overall Study|Adverse Event|1|||
162792399|NCT00426127|587950509|FG000|Overall Study|Removed due to disease progression|1|||
162792400|NCT03111095|587950510|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
162792401|NCT03111095|587950511|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
162792402|NCT03111095|587950510|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
162792403|NCT03111095|587950511|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
162792404|NCT04638660|587950516|FG000|Overall Study|Withdrawal by Subject|2|||
162792405|NCT04638660|587950517|FG001|Overall Study|Withdrawal by Subject|0|||
162792406|NCT04638660|587950516|FG000|Overall Study|Lost to Follow-up|1|||
162792407|NCT04638660|587950517|FG001|Overall Study|Lost to Follow-up|0|||
162792408|NCT04076943|587950522|FG000|Overall Study|Withdrawal by Subject|12|||
162792409|NCT04076943|587950522|FG000|Overall Study|Adverse Event|1|||
162792410|NCT04076943|587950522|FG000|Overall Study|Progressive Disease|2|||
162792411|NCT04076943|587950522|FG000|Overall Study|Death|13|||
162792412|NCT04076943|587950522|FG000|Overall Study|Other than specified|6|||
162792413|NCT03080493|587950523|FG000|Overall Study|Did not provide NRS pain results|1|||
162792414|NCT03080493|587950524|FG001|Overall Study|Did not provide NRS pain results|0|||
162792415|NCT03080493|587950523|FG000|Overall Study|Adverse Event|0|||
162792416|NCT03080493|587950524|FG001|Overall Study|Adverse Event|1|||
162792417|NCT03080493|587950523|FG000|Overall Study|Randomization error (parity group)|0|||
162792418|NCT03080493|587950524|FG001|Overall Study|Randomization error (parity group)|1|||
162792419|NCT01099917|587950526|FG000|Overall Study|Adverse Event|3|||
162792420|NCT01099917|587950526|FG000|Overall Study|Not Treated|24|||
162792421|NCT01825577|587950527|FG000|Overall Study|Physician Decision|2|||
162792422|NCT01825577|587950527|FG000|Overall Study|Withdrawal by Subject|1|||
162792423|NCT01825577|587950527|FG000|Overall Study|Withdrawn by family members|2|||
162792424|NCT01825577|587950527|FG000|Overall Study|Lack of Efficacy|3|||
162792425|NCT01427725|587950532|FG000|Overall Study|Lost to Follow-up|17|||
162792426|NCT01427725|587950532|FG000|Overall Study|Protocol Violation|1|||
162792427|NCT01427725|587950532|FG000|Overall Study|Drug not administered|1|||
162792428|NCT01427725|587950532|FG000|Overall Study|Failure to visit|7|||
162792429|NCT01427725|587950532|FG000|Overall Study|Adverse Event|46|||
162792430|NCT01427725|587950532|FG000|Overall Study|Failure to visit after administration|40|||
162792431|NCT01427725|587950532|FG000|Overall Study|Patient's rejection|27|||
162792432|NCT01427725|587950532|FG000|Overall Study|Transfer to a different hospital|17|||
162792433|NCT01427725|587950532|FG000|Overall Study|Lack of Efficacy|8|||
162792434|NCT01427725|587950532|FG000|Overall Study|Death|7|||
162792435|NCT01427725|587950532|FG000|Overall Study|Symptom improvement|6|||
162792436|NCT01427725|587950532|FG000|Overall Study|AE and Patient's rejection|5|||
162792437|NCT01427725|587950532|FG000|Overall Study|Physician Decision|5|||
162792438|NCT01427725|587950532|FG000|Overall Study|Exacerbation of underlying disease|5|||
162792439|NCT01427725|587950532|FG000|Overall Study|Oral feeding difficulty|5|||
162792440|NCT01427725|587950532|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
162792441|NCT01427725|587950532|FG000|Overall Study|Forgetting prescription|1|||
162792442|NCT01427725|587950532|FG000|Overall Study|Other|2|||
162792443|NCT01374568|587950533|FG000|Overall Study|Lab unable to analyze BTM|0|||
162792444|NCT01374568|587950534|FG001|Overall Study|Lab unable to analyze BTM|2|||
162792445|NCT04230122|587950535|FG000|Overall Study|Lost to Follow-up|1|||
162792446|NCT04230122|587950536|FG001|Overall Study|Lost to Follow-up|0|||
162792447|NCT01361594|587950538|FG000|Overall Study|Withdrawal by Subject|1|||
162792448|NCT01361594|587950539|FG001|Overall Study|Withdrawal by Subject|2|||
162792449|NCT02762903|587950543|FG000|Overall Study|Lost to Follow-up|0|||
162792450|NCT02762903|587950544|FG001|Overall Study|Lost to Follow-up|1|||
162792451|NCT00108745|587950545|FG000|Overall Study|Withdrawal by Subject|19|||
162792452|NCT00108745|587950546|FG001|Overall Study|Withdrawal by Subject|12|||
162792453|NCT00108745|587950547|FG002|Overall Study|Withdrawal by Subject|12|||
162792454|NCT00108745|587950545|FG000|Overall Study|Never Treated|8|||
162792455|NCT00108745|587950546|FG001|Overall Study|Never Treated|10|||
162792456|NCT00108745|587950547|FG002|Overall Study|Never Treated|12|||
162792457|NCT00108745|587950545|FG000|Overall Study|Ineligible|7|||
162792458|NCT00108745|587950546|FG001|Overall Study|Ineligible|13|||
162792459|NCT00108745|587950547|FG002|Overall Study|Ineligible|13|||
162792460|NCT00570908|587950554|FG000|Overall Study|Adverse Event|5|||
162792461|NCT00570908|587950554|FG000|Overall Study|Withdrawal by Subject|2|||
162792462|NCT00277095|587950555|FG000|Overall Study|Death|2|||
162792463|NCT00277095|587950555|FG000|Overall Study|Explanted|7|||
162792464|NCT00277095|587950555|FG000|Overall Study|Lost to Follow-up|2|||
162792465|NCT00277095|587950555|FG000|Overall Study|Missed Follow-up|9|||
162792466|NCT00277095|587950555|FG000|Overall Study|Physician Decision|1|||
162792467|NCT01213524|587950556|FG000|Baseline|Withdrawal by Subject|5|||
162792468|NCT01213524|587950556|FG000|Baseline|high breath alcohol levels|1|||
162792469|NCT01213524|587950556|FG000|Baseline|Physician Decision|1|||
162792470|NCT01213524|587950556|FG000|Session 2|Withdrawal by Subject|5|||
162792471|NCT01213524|587950556|FG000|Session 3|Withdrawal by Subject|4|||
162792472|NCT01213524|587950556|FG000|Session 4|Physician Decision|1|||
162792473|NCT01213524|587950556|FG000|Session 4|Withdrawal by Subject|2|||
162792474|NCT05415748|587950557|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
162792475|NCT05415748|587950558|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
162792476|NCT05415748|587950559|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
162792477|NCT05415748|587950560|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
162792478|NCT05415748|587950557|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
162792479|NCT05415748|587950558|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162792480|NCT05415748|587950559|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162792481|NCT05415748|587950560|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162792482|NCT01447576|587950561|FG000|Overall Study|Lost to Follow-up|52|||
162792483|NCT01447576|587950561|FG000|Overall Study|Adverse Event|127|||
162792484|NCT01447576|587950561|FG000|Overall Study|Participant met withdrawal criteria|40|||
162792485|NCT01447576|587950561|FG000|Overall Study|Withdrawal by Subject|100|||
162792486|NCT01447576|587950561|FG000|Overall Study|Protocol deviation|83|||
162792487|NCT01447576|587950561|FG000|Overall Study|Lack of Efficacy|68|||
162792488|NCT01447576|587950561|FG000|Overall Study|Physician Decision|6|||
162792489|NCT00975676|587950562|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
162792490|NCT00975676|587950563|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
162792491|NCT02209181|587950564|FG000|Overall Study|Adverse Event|1|||
162792492|NCT02209181|587950565|FG001|Overall Study|Adverse Event|0|||
162792493|NCT02209181|587950566|FG002|Overall Study|Adverse Event|1|||
162792494|NCT02209181|587950567|FG003|Overall Study|Adverse Event|0|||
162792495|NCT02209181|587950564|FG000|Overall Study|Withdrawal by Subject|0|||
162792496|NCT02209181|587950565|FG001|Overall Study|Withdrawal by Subject|1|||
162792497|NCT02209181|587950566|FG002|Overall Study|Withdrawal by Subject|0|||
162792498|NCT02209181|587950567|FG003|Overall Study|Withdrawal by Subject|0|||
162792499|NCT02579772|587950568|FG000|Overall Study|Withdrawal by Subject|0|||
162792500|NCT02579772|587950569|FG001|Overall Study|Withdrawal by Subject|1|||
162792501|NCT02579772|587950568|FG000|Overall Study|Usage of additional antioxidants|1|||
162792502|NCT02579772|587950569|FG001|Overall Study|Usage of additional antioxidants|0|||
162792503|NCT02579772|587950568|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
162792504|NCT02579772|587950569|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
162792505|NCT03128671|587950570|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
162792506|NCT03128671|587950571|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
162792507|NCT03128671|587950570|FG000|Allocation|Death|1|||
162792508|NCT03128671|587950571|FG001|Allocation|Death|0|||
162792509|NCT03128671|587950570|FG000|Allocation|Withdrawal by Subject|4|||
162792510|NCT03128671|587950571|FG001|Allocation|Withdrawal by Subject|0|||
162792511|NCT03128671|587950570|FG000|Intervention|Withdrawal by Subject|11|||
162792512|NCT03128671|587950571|FG001|Intervention|Withdrawal by Subject|10|||
162792513|NCT03128671|587950570|FG000|Intervention|Palliative/hospice care initiated|9|||
162792514|NCT03128671|587950571|FG001|Intervention|Palliative/hospice care initiated|10|||
162792515|NCT03128671|587950570|FG000|Intervention|Death|13|||
162792516|NCT03128671|587950571|FG001|Intervention|Death|11|||
162792517|NCT03128671|587950570|FG000|Intervention|Interrupted by hurricane|1|||
162792518|NCT03128671|587950571|FG001|Intervention|Interrupted by hurricane|0|||
162792519|NCT03128671|587950570|FG000|Intervention|Physician Decision|2|||
162792520|NCT03128671|587950571|FG001|Intervention|Physician Decision|3|||
162792521|NCT04641962|587950572|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
162792522|NCT04641962|587950573|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
162792523|NCT04641962|587950574|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
162792524|NCT04641962|587950575|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
162792525|NCT04641962|587950576|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
162792526|NCT04641962|587950572|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162792527|NCT04641962|587950573|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162792528|NCT04641962|587950574|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162792529|NCT04641962|587950575|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
162792530|NCT04641962|587950576|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162792531|NCT04641962|587950572|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
162792532|NCT04641962|587950573|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162792533|NCT04641962|587950574|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162792534|NCT04641962|587950575|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
162792535|NCT04641962|587950576|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162792536|NCT04641962|587950572|FG000|DBT Period: Up to 52 Weeks|Death|1|||
162792537|NCT04641962|587950573|FG001|DBT Period: Up to 52 Weeks|Death|0|||
162792538|NCT04641962|587950574|FG002|DBT Period: Up to 52 Weeks|Death|0|||
162792539|NCT04641962|587950575|FG003|DBT Period: Up to 52 Weeks|Death|0|||
162792540|NCT04641962|587950576|FG004|DBT Period: Up to 52 Weeks|Death|0|||
162792541|NCT04641962|587950572|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162792542|NCT04641962|587950573|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
162792543|NCT04641962|587950574|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162792544|NCT04641962|587950575|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
162792545|NCT04641962|587950576|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162792546|NCT04641962|587950572|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162792547|NCT04641962|587950573|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162792548|NCT04641962|587950574|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
162792549|NCT04641962|587950575|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162792550|NCT04641962|587950576|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
162792551|NCT04641962|587950572|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162792552|NCT04641962|587950573|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162792553|NCT04641962|587950574|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
162792554|NCT04641962|587950575|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162792555|NCT04641962|587950576|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162792556|NCT00862836|587950577|FG000|Overall Study|Withdrawal by Subject|1|||
162792557|NCT04463680|587950580|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
162792558|NCT04463680|587950580|FG000|Overall Study|Not eligible due to implant duration of use|1|||
162792559|NCT04463680|587950580|FG000|Overall Study|Withdrawal by Subject|3|||
162792560|NCT05239598|587950583|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
162792561|NCT05239598|587950584|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
162792562|NCT05239598|587950583|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
162792563|NCT05239598|587950584|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
162792564|NCT02592707|587950585|FG000|Overall Study|Consent Withdrawn|0|||
162792565|NCT02592707|587950586|FG001|Overall Study|Consent Withdrawn|1|||
162792566|NCT02592707|587950587|FG002|Overall Study|Consent Withdrawn|2|||
162792567|NCT02592707|587950588|FG003|Overall Study|Consent Withdrawn|0|||
162792568|NCT02592707|587950585|FG000|Overall Study|Death|1|||
162792569|NCT02592707|587950586|FG001|Overall Study|Death|0|||
162792570|NCT02592707|587950587|FG002|Overall Study|Death|0|||
162792571|NCT02592707|587950588|FG003|Overall Study|Death|0|||
162792572|NCT02592707|587950585|FG000|Overall Study|Progressive Disease|4|||
162792573|NCT02592707|587950586|FG001|Overall Study|Progressive Disease|4|||
162792574|NCT02592707|587950587|FG002|Overall Study|Progressive Disease|3|||
162792575|NCT02592707|587950588|FG003|Overall Study|Progressive Disease|3|||
162792576|NCT02592707|587950585|FG000|Overall Study|Other|0|||
162792577|NCT02592707|587950586|FG001|Overall Study|Other|0|||
162792578|NCT02592707|587950587|FG002|Overall Study|Other|1|||
162792579|NCT02592707|587950588|FG003|Overall Study|Other|2|||
162792580|NCT02592707|587950585|FG000|Overall Study|Never entered LTFU period|1|||
162792581|NCT02592707|587950586|FG001|Overall Study|Never entered LTFU period|0|||
162792582|NCT02592707|587950587|FG002|Overall Study|Never entered LTFU period|0|||
162792583|NCT02592707|587950588|FG003|Overall Study|Never entered LTFU period|2|||
162792584|NCT04855734|587950589|FG000|Overall Study|Lost to Follow-up|2|||
162792585|NCT04855734|587950590|FG001|Overall Study|Lost to Follow-up|2|||
162792586|NCT03832595|587950591|FG000|Overall Study|Death|142|||
162792587|NCT03832595|587950592|FG001|Overall Study|Death|130|||
162792588|NCT03832595|587950591|FG000|Overall Study|Medical management without dialysis|37|||
162792589|NCT03832595|587950592|FG001|Overall Study|Medical management without dialysis|1|||
162792590|NCT03277352|587950593|FG000|Overall Study|Study Terminated By Sponsor|2|||
162792591|NCT03277352|587950593|FG000|Overall Study|Withdrawal by Subject|4|||
162792592|NCT03277352|587950593|FG000|Overall Study|Death|4|||
162792593|NCT03939689|587952619|FG000|Overall Study|Radiographic progression|14|||
162792594|NCT03939689|587952620|FG001|Overall Study|Radiographic progression|17|||
162792595|NCT03939689|587952619|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
162792596|NCT03939689|587952620|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
162792597|NCT03939689|587952619|FG000|Overall Study|Adverse Event|1|||
162792598|NCT03939689|587952620|FG001|Overall Study|Adverse Event|8|||
162792599|NCT03939689|587952619|FG000|Overall Study|Unequivocal clinical progression|2|||
162792600|NCT03939689|587952620|FG001|Overall Study|Unequivocal clinical progression|5|||
162792601|NCT03939689|587952619|FG000|Overall Study|Other|1|||
162792602|NCT03939689|587952620|FG001|Overall Study|Other|4|||
162792603|NCT03939689|587952619|FG000|Overall Study|Death|0|||
162792604|NCT03939689|587952620|FG001|Overall Study|Death|3|||
162792605|NCT03939689|587952619|FG000|Overall Study|Participant decision|0|||
162792606|NCT03939689|587952620|FG001|Overall Study|Participant decision|3|||
162792607|NCT03939689|587952619|FG000|Overall Study|Withdrawal of consent|2|||
162792608|NCT03939689|587952620|FG001|Overall Study|Withdrawal of consent|1|||
162792609|NCT03939689|587952619|FG000|Overall Study|Investigator decision|1|||
162792610|NCT03939689|587952620|FG001|Overall Study|Investigator decision|0|||
162792611|NCT04427280|587952621|FG000|Overall Study|Withdrawal by Subject|0|||
162792612|NCT04427280|587952622|FG001|Overall Study|Withdrawal by Subject|2|||
162792613|NCT02473965|587952624|FG000|Overall Study|Adverse Event|6|||
162792614|NCT02473965|587952625|FG001|Overall Study|Adverse Event|4|||
162792615|NCT02473965|587952624|FG000|Overall Study|MG worsening|4|||
162792616|NCT02473965|587952625|FG001|Overall Study|MG worsening|1|||
162792617|NCT02473965|587952624|FG000|Overall Study|Withdrawal by Subject|2|||
162792618|NCT02473965|587952625|FG001|Overall Study|Withdrawal by Subject|3|||
162792619|NCT02473965|587952624|FG000|Overall Study|Physician Decision|0|||
162792620|NCT02473965|587952625|FG001|Overall Study|Physician Decision|2|||
162792621|NCT01920477|587952628|FG000|Overall Study|Adverse Event|0|||
162792622|NCT01920477|587952629|FG001|Overall Study|Adverse Event|1|||
162792623|NCT01920477|587952628|FG000|Overall Study|Lack of Efficacy|1|||
162792624|NCT01920477|587952629|FG001|Overall Study|Lack of Efficacy|0|||
162792625|NCT01920477|587952628|FG000|Overall Study|Study closed/terminated|14|||
162792626|NCT01920477|587952629|FG001|Overall Study|Study closed/terminated|15|||
162792627|NCT01920477|587952628|FG000|Overall Study|Withdrawal by Subject|0|||
162792628|NCT01920477|587952629|FG001|Overall Study|Withdrawal by Subject|1|||
162792629|NCT02271984|587952632|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792630|NCT02271984|587952633|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792631|NCT02271984|587952634|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792632|NCT02271984|587952635|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792633|NCT02271984|587952636|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792634|NCT02271984|587952637|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162792635|NCT02271984|587952638|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792636|NCT02271984|587952639|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162792637|NCT02271984|587952640|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792638|NCT02271984|587952641|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792639|NCT02271984|587952642|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792640|NCT02271984|587952643|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162792641|NCT01088984|587952644|FG000|Phase 1|Death|2|||
162792642|NCT01088984|587952645|FG001|Phase 1|Death|1|||
162792643|NCT01088984|587952644|FG000|Phase 1|Disease Progression|2|||
162792644|NCT01088984|587952645|FG001|Phase 1|Disease Progression|4|||
162792645|NCT01088984|587952644|FG000|Phase 1|Other|1|||
162792646|NCT01088984|587952645|FG001|Phase 1|Other|1|||
162792647|NCT01088984|587952644|FG000|Phase 2|Death|0|||
162792648|NCT01088984|587952645|FG001|Phase 2|Death|5|||
162792649|NCT01088984|587952644|FG000|Phase 2|Withdrawal by Subject|0|||
162792650|NCT01088984|587952645|FG001|Phase 2|Withdrawal by Subject|1|||
162792651|NCT01088984|587952644|FG000|Phase 2|DIsease Progression|0|||
162792652|NCT01088984|587952645|FG001|Phase 2|DIsease Progression|25|||
162792653|NCT01088984|587952644|FG000|Phase 2|Other|0|||
162792654|NCT01088984|587952645|FG001|Phase 2|Other|1|||
162792655|NCT01228318|587952646|FG000|Overall Study|Clinic no show to receive intervention|1|||
162792656|NCT01228318|587952647|FG001|Overall Study|Clinic no show to receive intervention|0|||
162792657|NCT01228318|587952646|FG000|Overall Study|Unable to contact|2|||
162792658|NCT01228318|587952647|FG001|Overall Study|Unable to contact|5|||
162792659|NCT01228318|587952646|FG000|Overall Study|Moved|0|||
162792660|NCT01228318|587952647|FG001|Overall Study|Moved|2|||
162792661|NCT01228318|587952646|FG000|Overall Study|Incarcerated|1|||
162792662|NCT01228318|587952647|FG001|Overall Study|Incarcerated|0|||
162792663|NCT02304705|587952648|FG000|Overall Study|Withdrawal by Subject|2|||
162792664|NCT02304705|587952649|FG001|Overall Study|Withdrawal by Subject|0|||
162792665|NCT02304705|587952648|FG000|Overall Study|Physician Decision|2|||
162792666|NCT02304705|587952649|FG001|Overall Study|Physician Decision|4|||
162792667|NCT02304705|587952648|FG000|Overall Study|Death|0|||
162792668|NCT02304705|587952649|FG001|Overall Study|Death|1|||
162792669|NCT02304705|587952648|FG000|Overall Study|Lost to Follow-up|0|||
162792670|NCT02304705|587952649|FG001|Overall Study|Lost to Follow-up|2|||
162792671|NCT00770029|587952650|FG000|Overall Study|Lost to Follow-up|2|||
162792672|NCT00770029|587952651|FG001|Overall Study|Lost to Follow-up|0|||
162792673|NCT00770029|587952650|FG000|Overall Study|Withdrawal by Subject|3|||
162792674|NCT00770029|587952651|FG001|Overall Study|Withdrawal by Subject|3|||
162792675|NCT00770029|587952650|FG000|Overall Study|Adverse Event|1|||
162792676|NCT00770029|587952651|FG001|Overall Study|Adverse Event|0|||
162792677|NCT05620108|587952654|FG000|Overall Study|Physician Decision|1|||
162792678|NCT05620108|587952655|FG001|Overall Study|Physician Decision|2|||
162792679|NCT05602727|587952656|FG000|Overall Study|Physician Decision|0|||
162792680|NCT05602727|587952657|FG001|Overall Study|Physician Decision|1|||
162792681|NCT05602727|587952658|FG002|Overall Study|Physician Decision|0|||
162792682|NCT05602727|587952656|FG000|Overall Study|Randomized by mistake without study medication|1|||
162792683|NCT05602727|587952657|FG001|Overall Study|Randomized by mistake without study medication|0|||
162792684|NCT05602727|587952658|FG002|Overall Study|Randomized by mistake without study medication|0|||
162792685|NCT05602727|587952656|FG000|Overall Study|Study termination by Sponsor|18|||
162792686|NCT05602727|587952657|FG001|Overall Study|Study termination by Sponsor|15|||
162792687|NCT05602727|587952658|FG002|Overall Study|Study termination by Sponsor|19|||
162792688|NCT05602727|587952656|FG000|Overall Study|Withdrawal by Subject|2|||
162792689|NCT05602727|587952657|FG001|Overall Study|Withdrawal by Subject|1|||
162792690|NCT05602727|587952658|FG002|Overall Study|Withdrawal by Subject|1|||
162792691|NCT05602727|587952656|FG000|Overall Study|Various reasons|1|||
162792692|NCT05602727|587952657|FG001|Overall Study|Various reasons|6|||
162792693|NCT05602727|587952658|FG002|Overall Study|Various reasons|1|||
162792694|NCT02038842|587952660|FG000|Overall Study|Withdrawal by Subject|2|||
162792695|NCT02038842|587952661|FG001|Overall Study|Withdrawal by Subject|2|||
162792696|NCT02038842|587952662|FG002|Overall Study|Withdrawal by Subject|0|||
162792697|NCT02038842|587952663|FG003|Overall Study|Withdrawal by Subject|0|||
162792698|NCT02038842|587952660|FG000|Overall Study|Participant decision|0|||
162792699|NCT02038842|587952661|FG001|Overall Study|Participant decision|0|||
162792700|NCT02038842|587952662|FG002|Overall Study|Participant decision|2|||
162792701|NCT02038842|587952663|FG003|Overall Study|Participant decision|1|||
162792702|NCT02038842|587952660|FG000|Overall Study|Adverse Event|0|||
162792703|NCT02038842|587952661|FG001|Overall Study|Adverse Event|0|||
162792704|NCT02038842|587952662|FG002|Overall Study|Adverse Event|3|||
162792705|NCT02038842|587952663|FG003|Overall Study|Adverse Event|1|||
162792706|NCT02038842|587952660|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
162792707|NCT02038842|587952661|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
162792708|NCT02038842|587952662|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
162792709|NCT02038842|587952663|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
162792710|NCT03412773|587952666|FG000|Overall Study|Lost to Follow-up|0|||
162792711|NCT03412773|587952667|FG001|Overall Study|Lost to Follow-up|7|||
162792712|NCT03412773|587952668|FG002|Overall Study|Lost to Follow-up|6|||
162792713|NCT03412773|587952666|FG000|Overall Study|Withdrawal by Subject|0|||
162792714|NCT03412773|587952667|FG001|Overall Study|Withdrawal by Subject|15|||
162792715|NCT03412773|587952668|FG002|Overall Study|Withdrawal by Subject|19|||
162792716|NCT03412773|587952666|FG000|Overall Study|Study Closed By Sponsor|3|||
162792717|NCT03412773|587952667|FG001|Overall Study|Study Closed By Sponsor|46|||
162792718|NCT03412773|587952668|FG002|Overall Study|Study Closed By Sponsor|33|||
162792719|NCT03412773|587952666|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
162792720|NCT03412773|587952667|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
162792721|NCT03412773|587952668|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
162792722|NCT03412773|587952666|FG000|Overall Study|Death|7|||
162792723|NCT03412773|587952667|FG001|Overall Study|Death|259|||
162792724|NCT03412773|587952668|FG002|Overall Study|Death|273|||
162792725|NCT03412773|587952666|FG000|Overall Study|Physician Decision|0|||
162792726|NCT03412773|587952667|FG001|Overall Study|Physician Decision|0|||
162792727|NCT03412773|587952668|FG002|Overall Study|Physician Decision|1|||
162792728|NCT05282121|587952670|FG000|Overall Study|Adverse Event|1|||
162792729|NCT05282121|587952671|FG001|Overall Study|Adverse Event|1|||
162792730|NCT05282121|587952672|FG002|Overall Study|Adverse Event|4|||
162792731|NCT05282121|587952673|FG003|Overall Study|Adverse Event|1|||
162792732|NCT05282121|587952670|FG000|Overall Study|Study Terminated by Sponsor|1|||
162792733|NCT05282121|587952671|FG001|Overall Study|Study Terminated by Sponsor|2|||
162792734|NCT05282121|587952672|FG002|Overall Study|Study Terminated by Sponsor|2|||
162792735|NCT05282121|587952673|FG003|Overall Study|Study Terminated by Sponsor|2|||
162792736|NCT05282121|587952670|FG000|Overall Study|Other than listed|0|||
162792737|NCT05282121|587952671|FG001|Overall Study|Other than listed|0|||
162792738|NCT05282121|587952672|FG002|Overall Study|Other than listed|1|||
162792739|NCT05282121|587952673|FG003|Overall Study|Other than listed|0|||
162792740|NCT05282121|587952670|FG000|Overall Study|No reason available|0|||
162792741|NCT05282121|587952671|FG001|Overall Study|No reason available|0|||
162792742|NCT05282121|587952672|FG002|Overall Study|No reason available|1|||
162792743|NCT05282121|587952673|FG003|Overall Study|No reason available|0|||
162792744|NCT00847626|587952678|FG000|Overall Study|Adverse Event|10|||
162792745|NCT00847626|587952679|FG001|Overall Study|Adverse Event|10|||
162792746|NCT00847626|587952680|FG002|Overall Study|Adverse Event|6|||
162792747|NCT00847626|587952681|FG003|Overall Study|Adverse Event|19|||
162792748|NCT00847626|587952682|FG004|Overall Study|Adverse Event|11|||
162792749|NCT00847626|587952683|FG005|Overall Study|Adverse Event|22|||
162792750|NCT00847626|587952684|FG006|Overall Study|Adverse Event|4|||
162792751|NCT00847626|587952685|FG007|Overall Study|Adverse Event|6|||
162792752|NCT00847626|587952686|FG008|Overall Study|Adverse Event|3|||
162792753|NCT00847626|587952687|FG009|Overall Study|Adverse Event|6|||
162792754|NCT00847626|587952688|FG010|Overall Study|Adverse Event|6|||
162792755|NCT00847626|587952678|FG000|Overall Study|Protocol Violation|2|||
162792756|NCT00847626|587952679|FG001|Overall Study|Protocol Violation|1|||
162792757|NCT00847626|587952680|FG002|Overall Study|Protocol Violation|2|||
162792758|NCT00847626|587952681|FG003|Overall Study|Protocol Violation|1|||
162792759|NCT00847626|587952682|FG004|Overall Study|Protocol Violation|1|||
162792760|NCT00847626|587952683|FG005|Overall Study|Protocol Violation|1|||
162792761|NCT00847626|587952684|FG006|Overall Study|Protocol Violation|1|||
162792762|NCT00847626|587952685|FG007|Overall Study|Protocol Violation|1|||
162792763|NCT00847626|587952686|FG008|Overall Study|Protocol Violation|0|||
162792764|NCT00847626|587952687|FG009|Overall Study|Protocol Violation|1|||
162792765|NCT00847626|587952688|FG010|Overall Study|Protocol Violation|1|||
162792766|NCT00847626|587952678|FG000|Overall Study|Lost to Follow-up|0|||
162792767|NCT00847626|587952679|FG001|Overall Study|Lost to Follow-up|1|||
162792768|NCT00847626|587952680|FG002|Overall Study|Lost to Follow-up|1|||
162792769|NCT00847626|587952681|FG003|Overall Study|Lost to Follow-up|1|||
162792770|NCT00847626|587952682|FG004|Overall Study|Lost to Follow-up|0|||
162792771|NCT00847626|587952683|FG005|Overall Study|Lost to Follow-up|3|||
162792772|NCT00847626|587952684|FG006|Overall Study|Lost to Follow-up|1|||
162792773|NCT00847626|587952685|FG007|Overall Study|Lost to Follow-up|3|||
162792774|NCT00847626|587952686|FG008|Overall Study|Lost to Follow-up|1|||
162792775|NCT00847626|587952687|FG009|Overall Study|Lost to Follow-up|0|||
162792776|NCT00847626|587952688|FG010|Overall Study|Lost to Follow-up|1|||
162792777|NCT00847626|587952678|FG000|Overall Study|Withdrawal by Subject|5|||
162792778|NCT00847626|587952679|FG001|Overall Study|Withdrawal by Subject|5|||
162792779|NCT00847626|587952680|FG002|Overall Study|Withdrawal by Subject|3|||
162792780|NCT00847626|587952681|FG003|Overall Study|Withdrawal by Subject|8|||
162792781|NCT00847626|587952682|FG004|Overall Study|Withdrawal by Subject|12|||
162792782|NCT00847626|587952683|FG005|Overall Study|Withdrawal by Subject|9|||
162792783|NCT00847626|587952684|FG006|Overall Study|Withdrawal by Subject|8|||
162792784|NCT00847626|587952685|FG007|Overall Study|Withdrawal by Subject|4|||
162792785|NCT00847626|587952686|FG008|Overall Study|Withdrawal by Subject|4|||
162792786|NCT00847626|587952687|FG009|Overall Study|Withdrawal by Subject|5|||
162792787|NCT00847626|587952688|FG010|Overall Study|Withdrawal by Subject|2|||
162792788|NCT00847626|587952678|FG000|Overall Study|Lack of Efficacy|3|||
162792789|NCT00847626|587952679|FG001|Overall Study|Lack of Efficacy|1|||
162792790|NCT00847626|587952680|FG002|Overall Study|Lack of Efficacy|0|||
162792791|NCT00847626|587952681|FG003|Overall Study|Lack of Efficacy|1|||
162792792|NCT00847626|587952682|FG004|Overall Study|Lack of Efficacy|2|||
162792793|NCT00847626|587952683|FG005|Overall Study|Lack of Efficacy|0|||
162792794|NCT00847626|587952684|FG006|Overall Study|Lack of Efficacy|6|||
162792795|NCT00847626|587952685|FG007|Overall Study|Lack of Efficacy|2|||
162792796|NCT00847626|587952686|FG008|Overall Study|Lack of Efficacy|5|||
162792797|NCT00847626|587952687|FG009|Overall Study|Lack of Efficacy|1|||
162792798|NCT00847626|587952688|FG010|Overall Study|Lack of Efficacy|7|||
162792799|NCT00847626|587952678|FG000|Overall Study|Other|1|||
162792800|NCT00847626|587952679|FG001|Overall Study|Other|5|||
162792801|NCT00847626|587952680|FG002|Overall Study|Other|4|||
162792802|NCT00847626|587952681|FG003|Overall Study|Other|1|||
162792803|NCT00847626|587952682|FG004|Overall Study|Other|2|||
162792804|NCT00847626|587952683|FG005|Overall Study|Other|2|||
162792805|NCT00847626|587952684|FG006|Overall Study|Other|2|||
162792806|NCT00847626|587952685|FG007|Overall Study|Other|3|||
162792807|NCT00847626|587952686|FG008|Overall Study|Other|1|||
162792808|NCT00847626|587952687|FG009|Overall Study|Other|1|||
162792809|NCT00847626|587952688|FG010|Overall Study|Other|3|||
162792810|NCT02942004|587952694|FG000|Overall Study|Withdrawal by Subject|0|||
162792811|NCT02942004|587952695|FG001|Overall Study|Withdrawal by Subject|2|||
162792812|NCT02942004|587952696|FG002|Overall Study|Withdrawal by Subject|3|||
162792813|NCT02942004|587952694|FG000|Overall Study|Lost to Follow-up|1|||
162792814|NCT02942004|587952695|FG001|Overall Study|Lost to Follow-up|1|||
162792815|NCT02942004|587952696|FG002|Overall Study|Lost to Follow-up|2|||
162792816|NCT02942004|587952694|FG000|Overall Study|Randomized but not dosed|3|||
162792817|NCT02942004|587952695|FG001|Overall Study|Randomized but not dosed|9|||
162792818|NCT02942004|587952696|FG002|Overall Study|Randomized but not dosed|4|||
162792819|NCT05627258|587952697|FG000|Overall Study|Lost to Follow-up|1|||
162792820|NCT05627258|587952698|FG001|Overall Study|Lost to Follow-up|0|||
162792821|NCT05627258|587952699|FG002|Overall Study|Lost to Follow-up|0|||
162792822|NCT05627258|587952700|FG003|Overall Study|Lost to Follow-up|0|||
162792823|NCT05627258|587952701|FG004|Overall Study|Lost to Follow-up|0|||
162792824|NCT05627258|587952702|FG005|Overall Study|Lost to Follow-up|0|||
162792825|NCT05627258|587952697|FG000|Overall Study|Withdrawal by Subject|0|||
162792826|NCT05627258|587952698|FG001|Overall Study|Withdrawal by Subject|0|||
162792827|NCT05627258|587952699|FG002|Overall Study|Withdrawal by Subject|0|||
162792828|NCT05627258|587952700|FG003|Overall Study|Withdrawal by Subject|0|||
162792829|NCT05627258|587952701|FG004|Overall Study|Withdrawal by Subject|2|||
162792830|NCT05627258|587952702|FG005|Overall Study|Withdrawal by Subject|0|||
162792831|NCT05627258|587952697|FG000|Overall Study|Enrolled, but product not administered|1|||
162792832|NCT05627258|587952698|FG001|Overall Study|Enrolled, but product not administered|0|||
162792833|NCT05627258|587952699|FG002|Overall Study|Enrolled, but product not administered|0|||
162792834|NCT05627258|587952700|FG003|Overall Study|Enrolled, but product not administered|0|||
162792835|NCT05627258|587952701|FG004|Overall Study|Enrolled, but product not administered|0|||
162792836|NCT05627258|587952702|FG005|Overall Study|Enrolled, but product not administered|0|||
162792837|NCT05627258|587952697|FG000|Overall Study|Other subject illness/injury|1|||
162792838|NCT05627258|587952698|FG001|Overall Study|Other subject illness/injury|0|||
162792839|NCT05627258|587952699|FG002|Overall Study|Other subject illness/injury|0|||
162792840|NCT05627258|587952700|FG003|Overall Study|Other subject illness/injury|0|||
162792841|NCT05627258|587952701|FG004|Overall Study|Other subject illness/injury|0|||
162792842|NCT05627258|587952702|FG005|Overall Study|Other subject illness/injury|0|||
162792843|NCT05627258|587952697|FG000|Overall Study|Subject moved from area|0|||
162792844|NCT05627258|587952698|FG001|Overall Study|Subject moved from area|0|||
162792845|NCT05627258|587952699|FG002|Overall Study|Subject moved from area|1|||
162792846|NCT05627258|587952700|FG003|Overall Study|Subject moved from area|0|||
162792847|NCT05627258|587952701|FG004|Overall Study|Subject moved from area|0|||
162792848|NCT05627258|587952702|FG005|Overall Study|Subject moved from area|0|||
162792849|NCT04517669|587952703|FG000|Overall Study|Lost to Follow-up|2|||
162792850|NCT04517669|587952703|FG000|Overall Study|Withdrawal by Subject|3|||
162792851|NCT04517669|587952703|FG000|Overall Study|Drug withdrawn|44|||
162792852|NCT04517669|587952703|FG000|Overall Study|Other|1|||
162792853|NCT04517669|587952703|FG000|Overall Study|Eligibility criteria not met|4|||
162792854|NCT04517669|587952703|FG000|Overall Study|Did not receive treatment|3|||
162792855|NCT02138786|587952704|FG000|Overall Study|Adverse Event|0|||
162792856|NCT02138786|587952705|FG001|Overall Study|Adverse Event|2|||
162792857|NCT02138786|587952706|FG002|Overall Study|Adverse Event|1|||
162792858|NCT02138786|587952704|FG000|Overall Study|Death|1|||
162792859|NCT02138786|587952705|FG001|Overall Study|Death|7|||
162792860|NCT02138786|587952706|FG002|Overall Study|Death|2|||
162792861|NCT02138786|587952704|FG000|Overall Study|Disease Progression|1|||
162792862|NCT02138786|587952705|FG001|Overall Study|Disease Progression|1|||
162792863|NCT02138786|587952706|FG002|Overall Study|Disease Progression|3|||
162792864|NCT02138786|587952704|FG000|Overall Study|Withdrawal by Subject|1|||
162792865|NCT02138786|587952705|FG001|Overall Study|Withdrawal by Subject|2|||
162792866|NCT02138786|587952706|FG002|Overall Study|Withdrawal by Subject|0|||
162792867|NCT02138786|587952704|FG000|Overall Study|Patient's Wish|0|||
162792868|NCT02138786|587952705|FG001|Overall Study|Patient's Wish|2|||
162792869|NCT02138786|587952706|FG002|Overall Study|Patient's Wish|0|||
162792870|NCT02138786|587952704|FG000|Overall Study|Sponsor Terminated Study|0|||
162792871|NCT02138786|587952705|FG001|Overall Study|Sponsor Terminated Study|1|||
162792872|NCT02138786|587952706|FG002|Overall Study|Sponsor Terminated Study|1|||
162792873|NCT02138786|587952704|FG000|Overall Study|Non-Compliance|0|||
162792874|NCT02138786|587952705|FG001|Overall Study|Non-Compliance|0|||
162792875|NCT02138786|587952706|FG002|Overall Study|Non-Compliance|1|||
162792876|NCT01923662|587952707|FG000|Overall Study|Withdrawal by Subject|1|||
162792877|NCT01199068|587952708|FG000|Overall Study|Unacceptable toxicity|0|||
162792878|NCT01199068|587952709|FG001|Overall Study|Unacceptable toxicity|0|||
162792879|NCT01199068|587952710|FG002|Overall Study|Unacceptable toxicity|2|||
162792880|NCT01199068|587952708|FG000|Overall Study|Progressive disease|3|||
162792881|NCT01199068|587952709|FG001|Overall Study|Progressive disease|3|||
162792882|NCT01199068|587952710|FG002|Overall Study|Progressive disease|6|||
162792883|NCT01199068|587952708|FG000|Overall Study|Withdrawal by Subject|0|||
162792884|NCT01199068|587952709|FG001|Overall Study|Withdrawal by Subject|0|||
162792885|NCT01199068|587952710|FG002|Overall Study|Withdrawal by Subject|1|||
162792886|NCT01250925|587952711|FG000|Overall Study|Lost to Follow-up|1|||
162792887|NCT01250925|587952712|FG001|Overall Study|Lost to Follow-up|1|||
162792888|NCT01250925|587952713|FG002|Overall Study|Lost to Follow-up|0|||
162792889|NCT01250925|587952711|FG000|Overall Study|Withdrawal by Subject|2|||
162792890|NCT01250925|587952712|FG001|Overall Study|Withdrawal by Subject|0|||
162792891|NCT01250925|587952713|FG002|Overall Study|Withdrawal by Subject|0|||
162792892|NCT01250925|587952711|FG000|Overall Study|Protocol Violation|2|||
162792893|NCT01250925|587952712|FG001|Overall Study|Protocol Violation|0|||
162792894|NCT01250925|587952713|FG002|Overall Study|Protocol Violation|0|||
162792895|NCT01250925|587952711|FG000|Overall Study|Physician Decision|0|||
162792896|NCT01250925|587952712|FG001|Overall Study|Physician Decision|2|||
162792897|NCT01250925|587952713|FG002|Overall Study|Physician Decision|1|||
162792898|NCT01250925|587952711|FG000|Overall Study|Adverse Event|0|||
162792899|NCT01250925|587952712|FG001|Overall Study|Adverse Event|0|||
162792900|NCT01250925|587952713|FG002|Overall Study|Adverse Event|1|||
162792901|NCT00678301|587952717|FG000|Overall Study|Non-compliance with study procedures|0|||
162792902|NCT00678301|587952718|FG001|Overall Study|Non-compliance with study procedures|1|||
162792903|NCT00678301|587952717|FG000|Overall Study|Adverse Event|1|||
162792904|NCT00678301|587952718|FG001|Overall Study|Adverse Event|0|||
162792905|NCT00678301|587952717|FG000|Overall Study|Withdrawal by Subject|4|||
162792906|NCT00678301|587952718|FG001|Overall Study|Withdrawal by Subject|0|||
162792907|NCT00678301|587952717|FG000|Overall Study|Lost to Follow-up|3|||
162792908|NCT00678301|587952718|FG001|Overall Study|Lost to Follow-up|1|||
162792909|NCT02476175|587952721|FG000|Overall Study|Adverse Event|2|||
162792910|NCT01016262|587952727|FG000|Double-blind Phase|Adverse Event|0|||
162792911|NCT01016262|587952728|FG001|Double-blind Phase|Adverse Event|0|||
162792912|NCT01016262|587952729|FG002|Double-blind Phase|Adverse Event|1|||
162792913|NCT01016262|587952730|FG003|Double-blind Phase|Adverse Event|0|||
162792914|NCT01016262|587952731|FG004|Double-blind Phase|Adverse Event|0|||
162792915|NCT01016262|587952732|FG005|Double-blind Phase|Adverse Event|0|||
162792916|NCT01016262|587952727|FG000|Double-blind Phase|Lack of Efficacy|1|||
162792917|NCT01016262|587952728|FG001|Double-blind Phase|Lack of Efficacy|0|||
162792918|NCT01016262|587952729|FG002|Double-blind Phase|Lack of Efficacy|5|||
162792919|NCT01016262|587952730|FG003|Double-blind Phase|Lack of Efficacy|0|||
162792920|NCT01016262|587952731|FG004|Double-blind Phase|Lack of Efficacy|0|||
162792921|NCT01016262|587952732|FG005|Double-blind Phase|Lack of Efficacy|0|||
162792922|NCT01016262|587952727|FG000|Double-blind Phase|Disease Progression|0|||
162792923|NCT01016262|587952728|FG001|Double-blind Phase|Disease Progression|1|||
162792924|NCT01016262|587952729|FG002|Double-blind Phase|Disease Progression|2|||
162792925|NCT01016262|587952730|FG003|Double-blind Phase|Disease Progression|0|||
162792926|NCT01016262|587952731|FG004|Double-blind Phase|Disease Progression|0|||
162792927|NCT01016262|587952732|FG005|Double-blind Phase|Disease Progression|0|||
162792928|NCT01016262|587952727|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
162792929|NCT01016262|587952728|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
162792930|NCT01016262|587952729|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
162792931|NCT01016262|587952730|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
162792932|NCT01016262|587952731|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
162792933|NCT01016262|587952732|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
162792934|NCT01016262|587952727|FG000|Open-Label Phase|Adverse Event|0|||
162792935|NCT01016262|587952728|FG001|Open-Label Phase|Adverse Event|0|||
162792936|NCT01016262|587952729|FG002|Open-Label Phase|Adverse Event|0|||
162792937|NCT01016262|587952730|FG003|Open-Label Phase|Adverse Event|1|||
162792938|NCT01016262|587952731|FG004|Open-Label Phase|Adverse Event|0|||
162792939|NCT01016262|587952732|FG005|Open-Label Phase|Adverse Event|0|||
162792940|NCT01016262|587952727|FG000|Open-Label Phase|Lost to Follow-up|0|||
162792941|NCT01016262|587952728|FG001|Open-Label Phase|Lost to Follow-up|0|||
162792942|NCT01016262|587952729|FG002|Open-Label Phase|Lost to Follow-up|0|||
162792943|NCT01016262|587952730|FG003|Open-Label Phase|Lost to Follow-up|0|||
162792944|NCT01016262|587952731|FG004|Open-Label Phase|Lost to Follow-up|1|||
162792945|NCT01016262|587952732|FG005|Open-Label Phase|Lost to Follow-up|0|||
162792946|NCT01016262|587952727|FG000|Open-Label Phase|Lack of Efficacy|0|||
162792947|NCT01016262|587952728|FG001|Open-Label Phase|Lack of Efficacy|0|||
162792948|NCT01016262|587952729|FG002|Open-Label Phase|Lack of Efficacy|0|||
162792949|NCT01016262|587952730|FG003|Open-Label Phase|Lack of Efficacy|1|||
162792950|NCT01016262|587952731|FG004|Open-Label Phase|Lack of Efficacy|0|||
162792951|NCT01016262|587952732|FG005|Open-Label Phase|Lack of Efficacy|0|||
162792952|NCT01016262|587952727|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
162792953|NCT01016262|587952728|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
162792954|NCT01016262|587952729|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
162792955|NCT01016262|587952730|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
162792956|NCT01016262|587952731|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
162792957|NCT01016262|587952732|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
162792958|NCT03738475|587952733|FG000|Overall Study|Participant Non-Compliance|1|||
162792959|NCT03738475|587952734|FG001|Overall Study|Participant Non-Compliance|0|||
162792960|NCT00677534|587952735|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
162792961|NCT00677534|587952735|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
162792962|NCT00677534|587952735|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
162792963|NCT00667394|587952736|FG000|Overall Study|Adverse Event|3|||
162792964|NCT00667394|587952737|FG001|Overall Study|Adverse Event|0|||
162792965|NCT00667394|587952736|FG000|Overall Study|Progressive disease|1|||
162792966|NCT00667394|587952737|FG001|Overall Study|Progressive disease|0|||
162792967|NCT02224703|587952744|FG000|Overall Study|Adverse Event|0|||
162792968|NCT02224703|587952745|FG001|Overall Study|Adverse Event|5|||
162792969|NCT02224703|587952746|FG002|Overall Study|Adverse Event|0|||
162792970|NCT02224703|587952744|FG000|Overall Study|Withdrawn by investigator|1|||
162792971|NCT02224703|587952745|FG001|Overall Study|Withdrawn by investigator|0|||
162792972|NCT02224703|587952746|FG002|Overall Study|Withdrawn by investigator|0|||
162792973|NCT02224703|587952744|FG000|Overall Study|Advised by medical monitor|1|||
162792974|NCT02224703|587952745|FG001|Overall Study|Advised by medical monitor|0|||
162792975|NCT02224703|587952746|FG002|Overall Study|Advised by medical monitor|0|||
162792976|NCT02224703|587952744|FG000|Overall Study|Withdrawn by parent/guardian|0|||
162792977|NCT02224703|587952745|FG001|Overall Study|Withdrawn by parent/guardian|1|||
162792978|NCT02224703|587952746|FG002|Overall Study|Withdrawn by parent/guardian|0|||
162792979|NCT02224703|587952744|FG000|Overall Study|Lack of Efficacy|1|||
162792980|NCT02224703|587952745|FG001|Overall Study|Lack of Efficacy|0|||
162792981|NCT02224703|587952746|FG002|Overall Study|Lack of Efficacy|0|||
162792982|NCT02922023|587952749|FG000|Overall Study|Lost to Follow-up|2|||
162792983|NCT02922023|587952750|FG001|Overall Study|Lost to Follow-up|0|||
162792984|NCT00863681|587952751|FG000|Overall Study|Other|2|||
162792985|NCT00863681|587952752|FG001|Overall Study|Other|0|||
162792986|NCT00863681|587952753|FG002|Overall Study|Other|0|||
162792987|NCT00863681|587952751|FG000|Overall Study|Missing|1|||
162792988|NCT00863681|587952752|FG001|Overall Study|Missing|0|||
162792989|NCT00863681|587952753|FG002|Overall Study|Missing|0|||
162792990|NCT00863681|587952751|FG000|Overall Study|Death|40|||
162792991|NCT00863681|587952752|FG001|Overall Study|Death|23|||
162792992|NCT00863681|587952753|FG002|Overall Study|Death|6|||
162792993|NCT00863681|587952751|FG000|Overall Study|Withdrawal by Subject|12|||
162792994|NCT00863681|587952752|FG001|Overall Study|Withdrawal by Subject|5|||
162792995|NCT00863681|587952753|FG002|Overall Study|Withdrawal by Subject|2|||
162792996|NCT00863681|587952751|FG000|Overall Study|Protocol Violation|2|||
162792997|NCT00863681|587952752|FG001|Overall Study|Protocol Violation|0|||
162792998|NCT00863681|587952753|FG002|Overall Study|Protocol Violation|0|||
162792999|NCT00863681|587952751|FG000|Overall Study|Lost to Follow-up|3|||
162793000|NCT00863681|587952752|FG001|Overall Study|Lost to Follow-up|0|||
162793001|NCT00863681|587952753|FG002|Overall Study|Lost to Follow-up|3|||
162793002|NCT00863681|587952751|FG000|Overall Study|Adverse Event|28|||
162793003|NCT00863681|587952752|FG001|Overall Study|Adverse Event|10|||
162793004|NCT00863681|587952753|FG002|Overall Study|Adverse Event|6|||
162793005|NCT00863681|587952751|FG000|Overall Study|Lack of Efficacy|2|||
162793006|NCT00863681|587952752|FG001|Overall Study|Lack of Efficacy|2|||
162793007|NCT00863681|587952753|FG002|Overall Study|Lack of Efficacy|1|||
162793008|NCT00863681|587952751|FG000|Overall Study|Non-compliance with study drug|1|||
162793009|NCT00863681|587952752|FG001|Overall Study|Non-compliance with study drug|3|||
162793010|NCT00863681|587952753|FG002|Overall Study|Non-compliance with study drug|0|||
162793011|NCT01304498|587952755|FG000|Overall Study|Adverse Event|1|||
162793012|NCT01304498|587952756|FG001|Overall Study|Adverse Event|1|||
162793013|NCT01304498|587952755|FG000|Overall Study|Withdrawal by Subject|2|||
162793014|NCT01304498|587952756|FG001|Overall Study|Withdrawal by Subject|3|||
162793015|NCT01304498|587952755|FG000|Overall Study|Protocol Violation|1|||
162793016|NCT01304498|587952756|FG001|Overall Study|Protocol Violation|0|||
162793017|NCT01304498|587952755|FG000|Overall Study|Lost to Follow-up|2|||
162793018|NCT01304498|587952756|FG001|Overall Study|Lost to Follow-up|1|||
162793019|NCT03325777|587952757|FG000|Overall Study|Lost to Follow-up|9|||
162793020|NCT03325777|587952758|FG001|Overall Study|Lost to Follow-up|12|||
162793021|NCT03004404|587952760|FG000|Period 2|Adverse Event|0|||
162793022|NCT03004404|587952761|FG001|Period 2|Adverse Event|0|||
162793023|NCT03004404|587952762|FG002|Period 2|Adverse Event|0|||
162793024|NCT03004404|587952763|FG003|Period 2|Adverse Event|0|||
162793025|NCT03004404|587952764|FG004|Period 2|Adverse Event|0|||
162793026|NCT03004404|587952765|FG005|Period 2|Adverse Event|0|||
162793027|NCT03004404|587952766|FG006|Period 2|Adverse Event|0|||
162793028|NCT03004404|587952767|FG007|Period 2|Adverse Event|0|||
162793029|NCT03004404|587952768|FG008|Period 2|Adverse Event|1|||
162793030|NCT03004404|587952769|FG009|Period 2|Adverse Event|0|||
162793031|NCT03004404|587952770|FG010|Period 2|Adverse Event|0|||
162793032|NCT03004404|587952771|FG011|Period 2|Adverse Event|0|||
162793033|NCT03004404|587952772|FG012|Period 2|Adverse Event|0|||
162793034|NCT03004404|587952773|FG013|Period 2|Adverse Event|0|||
162793035|NCT03004404|587952774|FG014|Period 2|Adverse Event|0|||
162793036|NCT03004404|587952775|FG015|Period 2|Adverse Event|1|||
162793037|NCT02990468|587952779|FG000|Phase 2: MTD|Change in treatment|0|||
162793038|NCT02990468|587952780|FG001|Phase 2: MTD|Change in treatment|0|||
162793039|NCT02990468|587952781|FG002|Phase 2: MTD|Change in treatment|1|||
162793040|NCT01602510|587952786|FG000|Open Label Phase|Adverse Event|46|||
162793041|NCT01602510|587952787|FG001|Open Label Phase|Adverse Event|0|||
162793042|NCT01602510|587952788|FG002|Open Label Phase|Adverse Event|0|||
162793043|NCT01602510|587952786|FG000|Open Label Phase|Lack of Efficacy|22|||
162793044|NCT01602510|587952787|FG001|Open Label Phase|Lack of Efficacy|0|||
162793045|NCT01602510|587952788|FG002|Open Label Phase|Lack of Efficacy|0|||
162793046|NCT01602510|587952786|FG000|Open Label Phase|Protocol Violation|15|||
162793047|NCT01602510|587952787|FG001|Open Label Phase|Protocol Violation|0|||
162793048|NCT01602510|587952788|FG002|Open Label Phase|Protocol Violation|0|||
162793049|NCT01602510|587952786|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
162793050|NCT01602510|587952787|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
162793051|NCT01602510|587952788|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
162793052|NCT01602510|587952786|FG000|Open Label Phase|Lost to Follow-up|22|||
162793053|NCT01602510|587952787|FG001|Open Label Phase|Lost to Follow-up|0|||
162793054|NCT01602510|587952788|FG002|Open Label Phase|Lost to Follow-up|0|||
162793055|NCT01602510|587952786|FG000|Open Label Phase|Physician Decision|19|||
162793056|NCT01602510|587952787|FG001|Open Label Phase|Physician Decision|0|||
162793057|NCT01602510|587952788|FG002|Open Label Phase|Physician Decision|0|||
162793058|NCT01602510|587952786|FG000|Open Label Phase|Withdrawal by Subject|57|||
162793059|NCT01602510|587952787|FG001|Open Label Phase|Withdrawal by Subject|0|||
162793060|NCT01602510|587952788|FG002|Open Label Phase|Withdrawal by Subject|0|||
162793061|NCT01602510|587952786|FG000|Randomized Phase|Adverse Event|0|||
162793062|NCT01602510|587952787|FG001|Randomized Phase|Adverse Event|2|||
162793063|NCT01602510|587952788|FG002|Randomized Phase|Adverse Event|6|||
162793064|NCT01602510|587952786|FG000|Randomized Phase|Lack of Efficacy|0|||
162793065|NCT01602510|587952787|FG001|Randomized Phase|Lack of Efficacy|4|||
162793066|NCT01602510|587952788|FG002|Randomized Phase|Lack of Efficacy|4|||
162793067|NCT01602510|587952786|FG000|Randomized Phase|Protocol Violation|0|||
162793068|NCT01602510|587952787|FG001|Randomized Phase|Protocol Violation|3|||
162793069|NCT01602510|587952788|FG002|Randomized Phase|Protocol Violation|3|||
162793070|NCT01602510|587952786|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
162793071|NCT01602510|587952787|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
162793072|NCT01602510|587952788|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
162793073|NCT01602510|587952786|FG000|Randomized Phase|Lost to Follow-up|0|||
162793074|NCT01602510|587952787|FG001|Randomized Phase|Lost to Follow-up|1|||
162793075|NCT01602510|587952788|FG002|Randomized Phase|Lost to Follow-up|3|||
162793076|NCT01602510|587952786|FG000|Randomized Phase|Physician Decision|0|||
162793077|NCT01602510|587952787|FG001|Randomized Phase|Physician Decision|0|||
162793078|NCT01602510|587952788|FG002|Randomized Phase|Physician Decision|2|||
162793079|NCT01602510|587952786|FG000|Randomized Phase|Withdrawal by Subject|0|||
162793080|NCT01602510|587952787|FG001|Randomized Phase|Withdrawal by Subject|6|||
162793081|NCT01602510|587952788|FG002|Randomized Phase|Withdrawal by Subject|7|||
162793082|NCT01261000|587952789|FG000|Overall Study|Screen failure|1|||
162793083|NCT01721954|587952790|FG000|Overall Study|Death|58|||
162793084|NCT01721954|587952791|FG001|Overall Study|Death|64|||
162793085|NCT01721954|587952790|FG000|Overall Study|Withdrawal by Subject|8|||
162793086|NCT01721954|587952791|FG001|Overall Study|Withdrawal by Subject|4|||
162793087|NCT01721954|587952790|FG000|Overall Study|Adverse Event|2|||
162793088|NCT01721954|587952791|FG001|Overall Study|Adverse Event|0|||
162793089|NCT01721954|587952790|FG000|Overall Study|Lost to Follow-up|2|||
162793090|NCT01721954|587952791|FG001|Overall Study|Lost to Follow-up|1|||
162793091|NCT01195623|587952792|FG000|Overall Study|Lost to Follow-up|35|||
162793092|NCT01195623|587952793|FG001|Overall Study|Lost to Follow-up|37|||
162793093|NCT00534495|587952795|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
162793094|NCT00534495|587952796|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
162793095|NCT00534495|587952797|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
162793096|NCT00534495|587952795|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
162793097|NCT00534495|587952796|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
162793098|NCT00534495|587952797|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
162793099|NCT00534495|587952795|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
162793100|NCT00534495|587952796|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
162793101|NCT00534495|587952797|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
162793102|NCT00534495|587952795|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
162793103|NCT00534495|587952796|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
162793104|NCT00534495|587952797|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
162793105|NCT00534495|587952795|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
162793106|NCT00534495|587952796|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
162793107|NCT00534495|587952797|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
162793108|NCT00534495|587952795|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
162793109|NCT00534495|587952796|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
162793110|NCT00534495|587952797|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
162793111|NCT00534495|587952795|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
162793112|NCT00534495|587952796|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
162793113|NCT00534495|587952797|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
162793114|NCT00534495|587952795|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
162793115|NCT00534495|587952796|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
162793116|NCT00534495|587952797|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
162793117|NCT00534495|587952795|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
162793118|NCT00534495|587952796|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
162793119|NCT00534495|587952797|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
162793120|NCT02920970|587952800|FG000|First Intervention|Protocol Violation|0|||
162793121|NCT02920970|587952801|FG001|First Intervention|Protocol Violation|1|||
162793122|NCT02920970|587952800|FG000|First Intervention|Adverse Event|0|||
162793123|NCT02920970|587952801|FG001|First Intervention|Adverse Event|1|||
162793124|NCT02920970|587952800|FG000|Second Intervention|Poor Lens Fit|1|||
162793125|NCT02920970|587952801|FG001|Second Intervention|Poor Lens Fit|0|||
162793126|NCT01711853|587952802|FG000|Overall Study|Not treated|3|||
162793127|NCT04191616|587952803|FG000|Pre-assignment Period|Did not receive study treatment|2|||
162793128|NCT04191616|587952803|FG000|Treatment Period|Death|37|||
162793129|NCT04191616|587952803|FG000|Treatment Period|Sponsor decision|11|||
162793130|NCT04191616|587952803|FG000|Treatment Period|Withdrawal by Subject|4|||
162793131|NCT02670122|587952807|FG000|Overall Study|Lost to Follow-up|4|||
162793132|NCT00632502|587952808|FG000|Overall Study|Adverse Event|0|||
162793133|NCT00632502|587952809|FG001|Overall Study|Adverse Event|1|||
162793134|NCT00632502|587952808|FG000|Overall Study|Randomized not treated|3|||
162793135|NCT00632502|587952809|FG001|Overall Study|Randomized not treated|0|||
162793136|NCT02548078|587952816|FG000|Overall Study|Serious adverse event/Adverse event|1|||
162793137|NCT02548078|587952817|FG001|Overall Study|Serious adverse event/Adverse event|0|||
162793138|NCT02548078|587952816|FG000|Overall Study|Moved from study area|3|||
162793139|NCT02548078|587952817|FG001|Overall Study|Moved from study area|3|||
162793140|NCT02548078|587952816|FG000|Overall Study|Lost to Follow-up|1|||
162793141|NCT02548078|587952817|FG001|Overall Study|Lost to Follow-up|3|||
162793142|NCT01040169|587952818|FG000|Overall Study|Lost to Follow-up|3|||
162793143|NCT01040169|587952819|FG001|Overall Study|Lost to Follow-up|8|||
162793144|NCT00350727|587952820|FG000|Phase I: Dose Escalation|Adverse Event|4|||
162793145|NCT00350727|587952821|FG001|Phase I: Dose Escalation|Adverse Event|0|||
162793146|NCT00350727|587952822|FG002|Phase I: Dose Escalation|Adverse Event|0|||
162793147|NCT00350727|587952820|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
162793148|NCT00350727|587952821|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
162793149|NCT00350727|587952822|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
162793150|NCT00350727|587952820|FG000|Phase I: Dose Escalation|Death|1|||
162793151|NCT00350727|587952821|FG001|Phase I: Dose Escalation|Death|0|||
162793152|NCT00350727|587952822|FG002|Phase I: Dose Escalation|Death|0|||
162793153|NCT00350727|587952820|FG000|Phase I: Dose Escalation|Physician Decision|1|||
162793154|NCT00350727|587952821|FG001|Phase I: Dose Escalation|Physician Decision|0|||
162793155|NCT00350727|587952822|FG002|Phase I: Dose Escalation|Physician Decision|0|||
162793156|NCT00350727|587952820|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
162793157|NCT00350727|587952821|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
162793158|NCT00350727|587952822|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
162793159|NCT00350727|587952820|FG000|Phase II|Disease Progression|0|||
162793160|NCT00350727|587952821|FG001|Phase II|Disease Progression|15|||
162793161|NCT00350727|587952822|FG002|Phase II|Disease Progression|16|||
162793162|NCT00350727|587952820|FG000|Phase II|Clinical Deterioration|0|||
162793163|NCT00350727|587952821|FG001|Phase II|Clinical Deterioration|1|||
162793164|NCT00350727|587952822|FG002|Phase II|Clinical Deterioration|0|||
162793165|NCT00350727|587952820|FG000|Phase II|Withdrawal by Subject|0|||
162793166|NCT00350727|587952821|FG001|Phase II|Withdrawal by Subject|2|||
162793167|NCT00350727|587952822|FG002|Phase II|Withdrawal by Subject|1|||
162793168|NCT00350727|587952820|FG000|Phase II|Adverse Event|0|||
162793169|NCT00350727|587952821|FG001|Phase II|Adverse Event|1|||
162793170|NCT00350727|587952822|FG002|Phase II|Adverse Event|1|||
162793171|NCT00350727|587952820|FG000|Phase II|Death|0|||
162793172|NCT00350727|587952821|FG001|Phase II|Death|0|||
162793173|NCT00350727|587952822|FG002|Phase II|Death|2|||
162793174|NCT00350727|587952820|FG000|Phase II|Sponsor Terminated Study|0|||
162793175|NCT00350727|587952821|FG001|Phase II|Sponsor Terminated Study|0|||
162793176|NCT00350727|587952822|FG002|Phase II|Sponsor Terminated Study|1|||
162793177|NCT00350727|587952820|FG000|Phase II|Enrolled in Rollover Study|0|||
162793178|NCT00350727|587952821|FG001|Phase II|Enrolled in Rollover Study|0|||
162793179|NCT00350727|587952822|FG002|Phase II|Enrolled in Rollover Study|1|||
162793180|NCT04535544|587952825|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162793181|NCT04535544|587952826|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162793182|NCT04535544|587952827|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
162793183|NCT04535544|587952828|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162793184|NCT04535544|587952825|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
162793185|NCT04535544|587952826|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
162793186|NCT04535544|587952827|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
162793187|NCT04535544|587952828|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
162793188|NCT04535544|587952825|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
162793189|NCT04535544|587952826|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
162793190|NCT04535544|587952827|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
162793191|NCT04535544|587952828|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
162793192|NCT04535544|587952825|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
162793193|NCT04535544|587952826|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
162793194|NCT04535544|587952827|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
162793195|NCT04535544|587952828|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
162793196|NCT04535544|587952825|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
162793197|NCT04535544|587952826|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
162793198|NCT04535544|587952827|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
162793199|NCT04535544|587952828|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
162793200|NCT04535544|587952825|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
162793201|NCT04535544|587952826|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
162793202|NCT04535544|587952827|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
162793203|NCT04535544|587952828|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
162793204|NCT04535544|587952825|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
162793205|NCT04535544|587952826|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162793206|NCT04535544|587952827|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162793207|NCT04535544|587952828|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162793208|NCT04535544|587952825|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
162793209|NCT04535544|587952826|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
162793210|NCT04535544|587952827|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
162793211|NCT04535544|587952828|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
162793212|NCT03554629|587955219|FG000|Overall Study|Inadequate data|6|||
162793213|NCT01182441|587955222|FG000|Overall Study|Patient Still in Follow-up|152|||
162793214|NCT01182441|587955223|FG001|Overall Study|Patient Still in Follow-up|72|||
162793215|NCT01182441|587955222|FG000|Overall Study|Death|37|||
162793216|NCT01182441|587955223|FG001|Overall Study|Death|25|||
162793217|NCT01182441|587955222|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
162793218|NCT01182441|587955223|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
162793219|NCT01182441|587955222|FG000|Overall Study|Lost to Follow-up|5|||
162793220|NCT01182441|587955223|FG001|Overall Study|Lost to Follow-up|8|||
162793221|NCT01182441|587955222|FG000|Overall Study|Withdrawal by Subject|6|||
162793222|NCT01182441|587955223|FG001|Overall Study|Withdrawal by Subject|13|||
162793223|NCT01182441|587955222|FG000|Overall Study|Implant Not Attempted|4|||
162793224|NCT01182441|587955223|FG001|Overall Study|Implant Not Attempted|0|||
162793225|NCT01182441|587955222|FG000|Overall Study|Adverse Event|2|||
162793226|NCT01182441|587955223|FG001|Overall Study|Adverse Event|0|||
162793227|NCT01182441|587955222|FG000|Overall Study|Physician Decision|1|||
162793228|NCT01182441|587955223|FG001|Overall Study|Physician Decision|1|||
162793229|NCT03140280|587955224|FG000|Overall Study|Physician Decision|5|||
162793230|NCT00663702|587955233|FG000|Overall Study|Adverse Event|8|||
162793231|NCT00663702|587955234|FG001|Overall Study|Adverse Event|4|||
162793232|NCT00663702|587955233|FG000|Overall Study|Withdrawal by Subject|3|||
162793233|NCT00663702|587955234|FG001|Overall Study|Withdrawal by Subject|1|||
162793234|NCT00663702|587955233|FG000|Overall Study|Pregnancy|0|||
162793235|NCT00663702|587955234|FG001|Overall Study|Pregnancy|1|||
162793236|NCT00663702|587955233|FG000|Overall Study|Lost to Follow-up|3|||
162793237|NCT00663702|587955234|FG001|Overall Study|Lost to Follow-up|0|||
162793238|NCT00663702|587955233|FG000|Overall Study|Death|1|||
162793239|NCT00663702|587955234|FG001|Overall Study|Death|1|||
162793240|NCT00663702|587955233|FG000|Overall Study|Lack of Efficacy|3|||
162793241|NCT00663702|587955234|FG001|Overall Study|Lack of Efficacy|3|||
162793242|NCT05577715|587955241|FG000|Overall Study|Withdrawal by Subject|1|||
162793243|NCT05577715|587955241|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
162793244|NCT05577715|587955241|FG000|Overall Study|Lost to Follow-up|1|||
162793245|NCT05577715|587955241|FG000|Overall Study|Death|6|||
162793246|NCT02643303|587955247|FG000|Overall Study|Progressive Disease|4|||
162793247|NCT02643303|587955248|FG001|Overall Study|Progressive Disease|4|||
162793248|NCT02643303|587955249|FG002|Overall Study|Progressive Disease|1|||
162793249|NCT02643303|587955250|FG003|Overall Study|Progressive Disease|12|||
162793250|NCT02643303|587955251|FG004|Overall Study|Progressive Disease|6|||
162793251|NCT02643303|587955252|FG005|Overall Study|Progressive Disease|4|||
162793252|NCT02643303|587955253|FG006|Overall Study|Progressive Disease|8|||
162793253|NCT02643303|587955254|FG007|Overall Study|Progressive Disease|2|||
162793254|NCT02643303|587955255|FG008|Overall Study|Progressive Disease|6|||
162793255|NCT02643303|587955247|FG000|Overall Study|Adverse Event|0|||
162793256|NCT02643303|587955248|FG001|Overall Study|Adverse Event|1|||
162793257|NCT02643303|587955249|FG002|Overall Study|Adverse Event|0|||
162793258|NCT02643303|587955250|FG003|Overall Study|Adverse Event|0|||
162793259|NCT02643303|587955251|FG004|Overall Study|Adverse Event|1|||
162793260|NCT02643303|587955252|FG005|Overall Study|Adverse Event|0|||
162793261|NCT02643303|587955253|FG006|Overall Study|Adverse Event|0|||
162793262|NCT02643303|587955254|FG007|Overall Study|Adverse Event|0|||
162793263|NCT02643303|587955255|FG008|Overall Study|Adverse Event|0|||
162793264|NCT02643303|587955247|FG000|Overall Study|Withdrawal by Subject|0|||
162793265|NCT02643303|587955248|FG001|Overall Study|Withdrawal by Subject|0|||
162793266|NCT02643303|587955249|FG002|Overall Study|Withdrawal by Subject|0|||
162793267|NCT02643303|587955250|FG003|Overall Study|Withdrawal by Subject|1|||
162793268|NCT02643303|587955251|FG004|Overall Study|Withdrawal by Subject|0|||
162793269|NCT02643303|587955252|FG005|Overall Study|Withdrawal by Subject|0|||
162793270|NCT02643303|587955253|FG006|Overall Study|Withdrawal by Subject|1|||
162793271|NCT02643303|587955254|FG007|Overall Study|Withdrawal by Subject|1|||
162793272|NCT02643303|587955255|FG008|Overall Study|Withdrawal by Subject|1|||
162793273|NCT00626197|587955258|FG000|Overall Study|Did not cooperate|2|||
162793274|NCT00626197|587955259|FG001|Overall Study|Did not cooperate|6|||
162793275|NCT00626197|587955260|FG002|Overall Study|Did not cooperate|1|||
162793276|NCT00626197|587955258|FG000|Overall Study|Failure to return|6|||
162793277|NCT00626197|587955259|FG001|Overall Study|Failure to return|5|||
162793278|NCT00626197|587955260|FG002|Overall Study|Failure to return|6|||
162793279|NCT00626197|587955258|FG000|Overall Study|Adverse event, serious fatal|3|||
162793280|NCT00626197|587955259|FG001|Overall Study|Adverse event, serious fatal|6|||
162793281|NCT00626197|587955260|FG002|Overall Study|Adverse event, serious fatal|6|||
162793282|NCT00626197|587955258|FG000|Overall Study|Adverse Event|1|||
162793283|NCT00626197|587955259|FG001|Overall Study|Adverse Event|1|||
162793284|NCT00626197|587955260|FG002|Overall Study|Adverse Event|2|||
162793285|NCT00626197|587955258|FG000|Overall Study|Withdrawal by Subject|17|||
162793286|NCT00626197|587955259|FG001|Overall Study|Withdrawal by Subject|17|||
162793287|NCT00626197|587955260|FG002|Overall Study|Withdrawal by Subject|7|||
162793288|NCT00626197|587955258|FG000|Overall Study|Administrative reasons|15|||
162793289|NCT00626197|587955259|FG001|Overall Study|Administrative reasons|19|||
162793290|NCT00626197|587955260|FG002|Overall Study|Administrative reasons|55|||
162793291|NCT05332912|587955265|FG000|Overall Study|Withdrawal by Subject|0|||
162793292|NCT05332912|587955266|FG001|Overall Study|Withdrawal by Subject|1|||
162793293|NCT05332912|587955267|FG002|Overall Study|Withdrawal by Subject|2|||
162793294|NCT05332912|587955268|FG003|Overall Study|Withdrawal by Subject|0|||
162793295|NCT05332912|587955265|FG000|Overall Study|Lost to Follow-up|0|||
162793296|NCT05332912|587955266|FG001|Overall Study|Lost to Follow-up|0|||
162793297|NCT05332912|587955267|FG002|Overall Study|Lost to Follow-up|1|||
162793298|NCT05332912|587955268|FG003|Overall Study|Lost to Follow-up|0|||
162793299|NCT01174446|587955269|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162793300|NCT01174446|587955270|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162793301|NCT01174446|587955271|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
162793302|NCT01174446|587955272|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162793303|NCT01174446|587955269|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162793304|NCT01174446|587955270|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162793305|NCT01174446|587955271|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
162793306|NCT01174446|587955272|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162793307|NCT01174446|587955269|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
162793308|NCT01174446|587955270|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
162793309|NCT01174446|587955271|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
162793310|NCT01174446|587955272|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
162793311|NCT01174446|587955269|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162793312|NCT01174446|587955270|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
162793313|NCT01174446|587955271|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162793314|NCT01174446|587955272|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162793315|NCT03301155|587955273|FG000|Overall Study|Сompliance with exclusion criteria|8|||
162793316|NCT03301155|587955274|FG001|Overall Study|Сompliance with exclusion criteria|7|||
162793317|NCT03510455|587955275|FG000|Overall Study|Physician Decision|1|||
162793318|NCT00384189|587955276|FG000|Overall Study|Reason Not Specified|50|||
162793319|NCT00384189|587955277|FG001|Overall Study|Reason Not Specified|57|||
162793320|NCT00384189|587955278|FG002|Overall Study|Reason Not Specified|58|||
162793321|NCT00384189|587955279|FG003|Overall Study|Reason Not Specified|40|||
162793322|NCT04958642|587955280|FG000|Overall Study|Transferred to OLEX program|3|||
162793323|NCT04958642|587955281|FG001|Overall Study|Transferred to OLEX program|0|||
162793324|NCT04958642|587955282|FG002|Overall Study|Transferred to OLEX program|5|||
162793325|NCT04958642|587955280|FG000|Overall Study|Death|0|||
162793326|NCT04958642|587955281|FG001|Overall Study|Death|0|||
162793327|NCT04958642|587955282|FG002|Overall Study|Death|1|||
162793328|NCT04958642|587955280|FG000|Overall Study|Withdrawal by Subject|4|||
162793329|NCT04958642|587955281|FG001|Overall Study|Withdrawal by Subject|9|||
162793330|NCT04958642|587955282|FG002|Overall Study|Withdrawal by Subject|13|||
162793331|NCT04958642|587955280|FG000|Overall Study|Investigator's Decision|0|||
162793332|NCT04958642|587955281|FG001|Overall Study|Investigator's Decision|0|||
162793333|NCT04958642|587955282|FG002|Overall Study|Investigator's Decision|1|||
162793334|NCT04958642|587955280|FG000|Overall Study|Adverse Event|1|||
162793335|NCT04958642|587955281|FG001|Overall Study|Adverse Event|0|||
162793336|NCT04958642|587955282|FG002|Overall Study|Adverse Event|1|||
162793337|NCT04958642|587955280|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
162793338|NCT04958642|587955281|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
162793339|NCT04958642|587955282|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
162793340|NCT04958642|587955280|FG000|Overall Study|Lost to Follow-up|1|||
162793341|NCT04958642|587955281|FG001|Overall Study|Lost to Follow-up|0|||
162793342|NCT04958642|587955282|FG002|Overall Study|Lost to Follow-up|0|||
162793343|NCT04958642|587955280|FG000|Overall Study|Transferred to EAP following study termination|0|||
162793344|NCT04958642|587955281|FG001|Overall Study|Transferred to EAP following study termination|0|||
162793345|NCT04958642|587955282|FG002|Overall Study|Transferred to EAP following study termination|1|||
162793346|NCT04958642|587955280|FG000|Overall Study|Transferred to Expanded Access Program|1|||
162793347|NCT04958642|587955281|FG001|Overall Study|Transferred to Expanded Access Program|0|||
162793348|NCT04958642|587955282|FG002|Overall Study|Transferred to Expanded Access Program|0|||
162793349|NCT05048238|587955283|FG000|Overall Study|Withdrawal by Subject|1|||
162793350|NCT01370655|587955287|FG000|Period 1|Adverse Event|2|||
162793351|NCT01370655|587955288|FG001|Period 1|Adverse Event|0|||
162793352|NCT01370655|587955289|FG002|Period 1|Adverse Event|0|||
162793353|NCT01370655|587955290|FG003|Period 1|Adverse Event|0|||
162793354|NCT01370655|587955291|FG004|Period 1|Adverse Event|0|||
162793355|NCT01370655|587955292|FG005|Period 1|Adverse Event|0|||
162793356|NCT01370655|587955293|FG006|Period 1|Adverse Event|1|||
162793357|NCT01370655|587955294|FG007|Period 1|Adverse Event|0|||
162793358|NCT01370655|587955295|FG008|Period 1|Adverse Event|0|||
162793359|NCT01370655|587955296|FG009|Period 1|Adverse Event|0|||
162793360|NCT01370655|587955297|FG010|Period 1|Adverse Event|0|||
162793361|NCT01370655|587955298|FG011|Period 1|Adverse Event|0|||
162793362|NCT01370655|587955287|FG000|Period 2|Adverse Event|0|||
162793363|NCT01370655|587955288|FG001|Period 2|Adverse Event|0|||
162793364|NCT01370655|587955289|FG002|Period 2|Adverse Event|1|||
162793365|NCT01370655|587955290|FG003|Period 2|Adverse Event|0|||
162793366|NCT01370655|587955291|FG004|Period 2|Adverse Event|1|||
162793367|NCT01370655|587955292|FG005|Period 2|Adverse Event|0|||
162793368|NCT01370655|587955293|FG006|Period 2|Adverse Event|0|||
162793369|NCT01370655|587955294|FG007|Period 2|Adverse Event|1|||
162793370|NCT01370655|587955295|FG008|Period 2|Adverse Event|0|||
162793371|NCT01370655|587955296|FG009|Period 2|Adverse Event|0|||
162793372|NCT01370655|587955297|FG010|Period 2|Adverse Event|0|||
162793373|NCT01370655|587955298|FG011|Period 2|Adverse Event|0|||
162793374|NCT01370655|587955287|FG000|Period 2|met protocol specified stopping criteria|0|||
162793375|NCT01370655|587955288|FG001|Period 2|met protocol specified stopping criteria|0|||
162793376|NCT01370655|587955289|FG002|Period 2|met protocol specified stopping criteria|1|||
162793377|NCT01370655|587955290|FG003|Period 2|met protocol specified stopping criteria|0|||
162793378|NCT01370655|587955291|FG004|Period 2|met protocol specified stopping criteria|0|||
162793379|NCT01370655|587955292|FG005|Period 2|met protocol specified stopping criteria|0|||
162793380|NCT01370655|587955293|FG006|Period 2|met protocol specified stopping criteria|1|||
162793381|NCT01370655|587955294|FG007|Period 2|met protocol specified stopping criteria|0|||
162793382|NCT01370655|587955295|FG008|Period 2|met protocol specified stopping criteria|1|||
162793383|NCT01370655|587955296|FG009|Period 2|met protocol specified stopping criteria|0|||
162793384|NCT01370655|587955297|FG010|Period 2|met protocol specified stopping criteria|1|||
162793385|NCT01370655|587955298|FG011|Period 2|met protocol specified stopping criteria|0|||
162793386|NCT01370655|587955287|FG000|Period 2|Withdrawal by Subject|0|||
162793387|NCT01370655|587955288|FG001|Period 2|Withdrawal by Subject|0|||
162793388|NCT01370655|587955289|FG002|Period 2|Withdrawal by Subject|0|||
162793389|NCT01370655|587955290|FG003|Period 2|Withdrawal by Subject|0|||
162793390|NCT01370655|587955291|FG004|Period 2|Withdrawal by Subject|0|||
162793391|NCT01370655|587955292|FG005|Period 2|Withdrawal by Subject|0|||
162793392|NCT01370655|587955293|FG006|Period 2|Withdrawal by Subject|0|||
162793393|NCT01370655|587955294|FG007|Period 2|Withdrawal by Subject|0|||
162793394|NCT01370655|587955295|FG008|Period 2|Withdrawal by Subject|1|||
162793395|NCT01370655|587955296|FG009|Period 2|Withdrawal by Subject|0|||
162793396|NCT01370655|587955297|FG010|Period 2|Withdrawal by Subject|0|||
162793397|NCT01370655|587955298|FG011|Period 2|Withdrawal by Subject|0|||
162793398|NCT01730378|587955299|FG000|Overall Study|Lost to Follow-up|1|||
162793399|NCT01730378|587955300|FG001|Overall Study|Lost to Follow-up|0|||
162793400|NCT04481373|587955304|FG000|Overall Study|Protocol Violation|1|||
162793401|NCT04481373|587955305|FG001|Overall Study|Protocol Violation|0|||
162793402|NCT04481373|587955304|FG000|Overall Study|Viral load in hospital not over 1000|2|||
162793403|NCT04481373|587955305|FG001|Overall Study|Viral load in hospital not over 1000|1|||
162793404|NCT04481373|587955304|FG000|Overall Study|Death before hospital discharge|1|||
162793405|NCT04481373|587955305|FG001|Overall Study|Death before hospital discharge|0|||
162793406|NCT02057575|587955307|FG000|Overall Study|Adverse Event|0|||
162793407|NCT02057575|587955308|FG001|Overall Study|Adverse Event|2|||
162793408|NCT02057575|587955309|FG002|Overall Study|Adverse Event|0|||
162793409|NCT02057575|587955310|FG003|Overall Study|Adverse Event|1|||
162793410|NCT02057575|587955307|FG000|Overall Study|Withdrawal by Subject|1|||
162793411|NCT02057575|587955308|FG001|Overall Study|Withdrawal by Subject|0|||
162793412|NCT02057575|587955309|FG002|Overall Study|Withdrawal by Subject|0|||
162793413|NCT02057575|587955310|FG003|Overall Study|Withdrawal by Subject|0|||
162793414|NCT02057575|587955307|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
162810579|NCT00887250|588018276|FG001|Overall Study|Lost to Follow-up|3|||
162793415|NCT02057575|587955308|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
162793416|NCT02057575|587955309|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
162793417|NCT02057575|587955310|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
162793418|NCT02057575|587955307|FG000|Overall Study|Protocol Violation|0|||
162793419|NCT02057575|587955308|FG001|Overall Study|Protocol Violation|1|||
162793420|NCT02057575|587955309|FG002|Overall Study|Protocol Violation|0|||
162793421|NCT02057575|587955310|FG003|Overall Study|Protocol Violation|0|||
162793422|NCT00332462|587955311|FG000|Overall Study|Adverse Event|5|||
162793423|NCT00332462|587955311|FG000|Overall Study|Abnormal Lab Value|1|||
162793424|NCT00332462|587955311|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162793425|NCT00332462|587955311|FG000|Overall Study|no longer requires study drug|1|||
162793426|NCT00332462|587955311|FG000|Overall Study|Death|3|||
162793427|NCT00332462|587955311|FG000|Overall Study|Graft Loss|2|||
162793428|NCT02979249|587955315|FG000|Overall Study|Lost to Follow-up|2|||
162793429|NCT02979249|587955315|FG000|Overall Study|Withdrawal by Subject|4|||
162793430|NCT01125046|587955316|FG000|First 6 Months of Treatment|Death|1|||
162793431|NCT01125046|587955316|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
162793432|NCT01125046|587955316|FG000|First 6 Months of Treatment|Non-compliance|1|||
162793433|NCT01125046|587955316|FG000|First 6 Months of Treatment|Surgery|1|||
162793434|NCT01125046|587955316|FG000|First 6 Months of Treatment|Progressive Disease|7|||
162793435|NCT01125046|587955316|FG000|First 6 Months of Treatment|Adverse Event|2|||
162793436|NCT01125046|587955316|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
162793437|NCT01125046|587955316|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
162793438|NCT01125046|587955316|FG000|Follow-up/Data Cut Off Point|Death|29|||
162793439|NCT01125046|587955316|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
162793440|NCT01685229|587955317|FG000|Overall Study|Subjects missing Study Exit form|3|||
162793441|NCT01685229|587955318|FG001|Overall Study|Subjects missing Study Exit form|1|||
162793442|NCT01685229|587955317|FG000|Overall Study|Lost to Follow-up|16|||
162793443|NCT01685229|587955318|FG001|Overall Study|Lost to Follow-up|10|||
162793444|NCT01685229|587955317|FG000|Overall Study|Withdrawal by Subject|6|||
162793445|NCT01685229|587955318|FG001|Overall Study|Withdrawal by Subject|5|||
162793446|NCT01685229|587955317|FG000|Overall Study|Death|1|||
162793447|NCT01685229|587955318|FG001|Overall Study|Death|0|||
162793448|NCT00659880|587955333|FG000|Overall Study|Lost to Follow-up|5|||
162793449|NCT01853475|587955334|FG000|Overall Study|Withdrawal by Subject|0|||
162793450|NCT01853475|587955335|FG001|Overall Study|Withdrawal by Subject|1|||
162793451|NCT01853475|587955336|FG002|Overall Study|Withdrawal by Subject|0|||
162793452|NCT02159040|587955337|FG000|Overall Study|Death|1|||
162793453|NCT02766777|587955341|FG000|Overall Study|Adverse Event|12|||
162793454|NCT02766777|587955341|FG000|Overall Study|Lost to Follow-up|16|||
162793455|NCT02766777|587955341|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162793456|NCT02766777|587955341|FG000|Overall Study|Protocol Violation|1|||
162793457|NCT02766777|587955341|FG000|Overall Study|Withdrawal by Subject|4|||
162793458|NCT01886287|587955342|FG000|Overall Study|Radiographic disease progression|1|||
162793459|NCT01886287|587955342|FG000|Overall Study|Clinical progression due to disease|1|||
162793460|NCT02964325|587955343|FG000|Overall Study|Lost to Follow-up|3|||
162793461|NCT02964325|587955344|FG001|Overall Study|Lost to Follow-up|3|||
162793462|NCT02964325|587955343|FG000|Overall Study|Physician Decision|5|||
162793463|NCT02964325|587955344|FG001|Overall Study|Physician Decision|4|||
162793464|NCT02964325|587955343|FG000|Overall Study|Death|1|||
162793465|NCT02964325|587955344|FG001|Overall Study|Death|3|||
162793466|NCT02964325|587955343|FG000|Overall Study|Withdrawal by Subject|2|||
162793467|NCT02964325|587955344|FG001|Overall Study|Withdrawal by Subject|1|||
162793468|NCT02964325|587955343|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
162793469|NCT02964325|587955344|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
162793470|NCT03596762|587955345|FG000|Overall Study|Protocol Violation|0|||
162793471|NCT03596762|587955346|FG001|Overall Study|Protocol Violation|0|||
162793472|NCT03596762|587955347|FG002|Overall Study|Protocol Violation|0|||
162793473|NCT03596762|587955348|FG003|Overall Study|Protocol Violation|0|||
162793474|NCT03596762|587955349|FG004|Overall Study|Protocol Violation|1|||
162793475|NCT03596762|587955345|FG000|Overall Study|Adverse Event|2|||
162793476|NCT03596762|587955346|FG001|Overall Study|Adverse Event|0|||
162793477|NCT03596762|587955347|FG002|Overall Study|Adverse Event|1|||
162793478|NCT03596762|587955348|FG003|Overall Study|Adverse Event|0|||
162793479|NCT03596762|587955349|FG004|Overall Study|Adverse Event|5|||
162793480|NCT03596762|587955345|FG000|Overall Study|Withdrawal by Subject|2|||
162793481|NCT03596762|587955346|FG001|Overall Study|Withdrawal by Subject|1|||
162793482|NCT03596762|587955347|FG002|Overall Study|Withdrawal by Subject|0|||
162793483|NCT03596762|587955348|FG003|Overall Study|Withdrawal by Subject|1|||
162793484|NCT03596762|587955349|FG004|Overall Study|Withdrawal by Subject|1|||
162793485|NCT02510040|587955350|FG000|Overall Study|Deemed no longer eligible|18|||
162793486|NCT02510040|587955351|FG001|Overall Study|Deemed no longer eligible|3|||
162793487|NCT02510040|587955352|FG002|Overall Study|Deemed no longer eligible|1|||
162793488|NCT03842228|587955353|FG000|Overall Study|Adverse Event|1|||
162793489|NCT03842228|587955354|FG001|Overall Study|Adverse Event|1|||
162793490|NCT03842228|587955355|FG002|Overall Study|Adverse Event|1|||
162793491|NCT03842228|587955356|FG003|Overall Study|Adverse Event|0|||
162793492|NCT03842228|587955357|FG004|Overall Study|Adverse Event|0|||
162793493|NCT03842228|587955358|FG005|Overall Study|Adverse Event|0|||
162793494|NCT03842228|587955359|FG006|Overall Study|Adverse Event|0|||
162793495|NCT03842228|587955353|FG000|Overall Study|Death|0|||
162793496|NCT03842228|587955354|FG001|Overall Study|Death|1|||
162793497|NCT03842228|587955355|FG002|Overall Study|Death|0|||
162793498|NCT03842228|587955356|FG003|Overall Study|Death|0|||
162793499|NCT03842228|587955357|FG004|Overall Study|Death|0|||
162793500|NCT03842228|587955358|FG005|Overall Study|Death|0|||
162793501|NCT03842228|587955359|FG006|Overall Study|Death|0|||
162793502|NCT03842228|587955353|FG000|Overall Study|Withdrawal by Subject|0|||
162793503|NCT03842228|587955354|FG001|Overall Study|Withdrawal by Subject|0|||
162793504|NCT03842228|587955355|FG002|Overall Study|Withdrawal by Subject|2|||
162793505|NCT03842228|587955356|FG003|Overall Study|Withdrawal by Subject|1|||
162793506|NCT03842228|587955357|FG004|Overall Study|Withdrawal by Subject|0|||
162793507|NCT03842228|587955358|FG005|Overall Study|Withdrawal by Subject|0|||
162793508|NCT03842228|587955359|FG006|Overall Study|Withdrawal by Subject|2|||
162793509|NCT03842228|587955353|FG000|Overall Study|Progression|8|||
162793510|NCT03842228|587955354|FG001|Overall Study|Progression|1|||
162793511|NCT03842228|587955355|FG002|Overall Study|Progression|7|||
162793512|NCT03842228|587955356|FG003|Overall Study|Progression|5|||
162793513|NCT03842228|587955357|FG004|Overall Study|Progression|4|||
162793514|NCT03842228|587955358|FG005|Overall Study|Progression|2|||
162793515|NCT03842228|587955359|FG006|Overall Study|Progression|3|||
162793516|NCT02195479|587955372|FG000|Overall Study|Lost to Follow-up|18|||
162793517|NCT02195479|587955373|FG001|Overall Study|Lost to Follow-up|15|||
162793518|NCT02195479|587955372|FG000|Overall Study|Death|217|||
162793519|NCT02195479|587955373|FG001|Overall Study|Death|171|||
162793520|NCT02195479|587955372|FG000|Overall Study|Physician Decision|1|||
162793521|NCT02195479|587955373|FG001|Overall Study|Physician Decision|0|||
162793522|NCT02195479|587955372|FG000|Overall Study|Withdrawal by Subject|30|||
162793523|NCT02195479|587955373|FG001|Overall Study|Withdrawal by Subject|30|||
162793524|NCT02195479|587955372|FG000|Overall Study|Other|3|||
162793525|NCT02195479|587955373|FG001|Overall Study|Other|4|||
162793526|NCT02195479|587955372|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
162793527|NCT02195479|587955373|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
162793528|NCT01834586|587955374|FG000|Overall Study|Adverse Event|1|||
162793529|NCT01263509|587955377|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
162793530|NCT01263509|587955378|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
162793531|NCT01263509|587955379|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
162793532|NCT01263509|587955380|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
162793533|NCT01263509|587955377|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162793534|NCT01263509|587955378|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162793535|NCT01263509|587955379|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162793536|NCT01263509|587955380|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162793537|NCT01263509|587955377|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162793538|NCT01263509|587955378|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162793539|NCT01263509|587955379|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162793540|NCT01263509|587955380|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162793541|NCT01263509|587955377|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162793542|NCT01263509|587955378|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162793543|NCT01263509|587955379|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162793544|NCT01263509|587955380|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162793545|NCT01263509|587955377|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162793546|NCT01263509|587955378|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162793547|NCT01263509|587955379|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162925428|NCT00742859|588428967|FG003|Overall Study|Sponsor request patient out of town|1|||
162793548|NCT01263509|587955380|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
162793549|NCT01371825|587955388|FG000|Overall Study|Death|4|||
162793550|NCT00895895|587955389|FG000|Period 1|Adverse Event|7|||
162793551|NCT00895895|587955390|FG001|Period 1|Adverse Event|6|||
162793552|NCT00895895|587955391|FG002|Period 1|Adverse Event|4|||
162793553|NCT00895895|587955392|FG003|Period 1|Adverse Event|6|||
162793554|NCT00895895|587955393|FG004|Period 1|Adverse Event|7|||
162793555|NCT00895895|587955389|FG000|Period 1|Death|0|||
162793556|NCT00895895|587955390|FG001|Period 1|Death|0|||
162793557|NCT00895895|587955391|FG002|Period 1|Death|0|||
162793558|NCT00895895|587955392|FG003|Period 1|Death|0|||
162793559|NCT00895895|587955393|FG004|Period 1|Death|1|||
162793560|NCT00895895|587955389|FG000|Period 1|discontinued by sponsor|2|||
162793561|NCT00895895|587955390|FG001|Period 1|discontinued by sponsor|1|||
162793562|NCT00895895|587955391|FG002|Period 1|discontinued by sponsor|2|||
162793563|NCT00895895|587955392|FG003|Period 1|discontinued by sponsor|1|||
162793564|NCT00895895|587955393|FG004|Period 1|discontinued by sponsor|1|||
162793565|NCT00895895|587955389|FG000|Period 1|failed to return|0|||
162793566|NCT00895895|587955390|FG001|Period 1|failed to return|0|||
162793567|NCT00895895|587955391|FG002|Period 1|failed to return|1|||
162793568|NCT00895895|587955392|FG003|Period 1|failed to return|0|||
162793569|NCT00895895|587955393|FG004|Period 1|failed to return|1|||
162793570|NCT00895895|587955389|FG000|Period 1|investigator request|0|||
162793571|NCT00895895|587955390|FG001|Period 1|investigator request|1|||
162793572|NCT00895895|587955391|FG002|Period 1|investigator request|0|||
162793573|NCT00895895|587955392|FG003|Period 1|investigator request|0|||
162793574|NCT00895895|587955393|FG004|Period 1|investigator request|0|||
162793575|NCT00895895|587955389|FG000|Period 1|Lost to Follow-up|2|||
162793576|NCT00895895|587955390|FG001|Period 1|Lost to Follow-up|1|||
162793577|NCT00895895|587955391|FG002|Period 1|Lost to Follow-up|3|||
162793578|NCT00895895|587955392|FG003|Period 1|Lost to Follow-up|2|||
162793579|NCT00895895|587955393|FG004|Period 1|Lost to Follow-up|3|||
162793580|NCT00895895|587955389|FG000|Period 1|Other|1|||
162793581|NCT00895895|587955390|FG001|Period 1|Other|2|||
162793582|NCT00895895|587955391|FG002|Period 1|Other|1|||
162793583|NCT00895895|587955392|FG003|Period 1|Other|1|||
162793584|NCT00895895|587955393|FG004|Period 1|Other|1|||
162793585|NCT00895895|587955389|FG000|Period 1|Protocol Violation|0|||
162793586|NCT00895895|587955390|FG001|Period 1|Protocol Violation|1|||
162793587|NCT00895895|587955391|FG002|Period 1|Protocol Violation|0|||
162793588|NCT00895895|587955392|FG003|Period 1|Protocol Violation|0|||
162793589|NCT00895895|587955393|FG004|Period 1|Protocol Violation|0|||
162793590|NCT00895895|587955389|FG000|Period 1|Withdrawal by Subject|6|||
162793591|NCT00895895|587955390|FG001|Period 1|Withdrawal by Subject|6|||
162793592|NCT00895895|587955391|FG002|Period 1|Withdrawal by Subject|8|||
162793593|NCT00895895|587955392|FG003|Period 1|Withdrawal by Subject|2|||
162793594|NCT00895895|587955393|FG004|Period 1|Withdrawal by Subject|4|||
162793595|NCT00895895|587955389|FG000|Period 1|unsatisfactory response-efficacy|2|||
162793596|NCT00895895|587955390|FG001|Period 1|unsatisfactory response-efficacy|0|||
162793597|NCT00895895|587955391|FG002|Period 1|unsatisfactory response-efficacy|0|||
162793598|NCT00895895|587955392|FG003|Period 1|unsatisfactory response-efficacy|0|||
162793599|NCT00895895|587955393|FG004|Period 1|unsatisfactory response-efficacy|0|||
162793600|NCT00895895|587955389|FG000|Period 1|randomized and not treated|1|||
162793601|NCT00895895|587955390|FG001|Period 1|randomized and not treated|3|||
162793602|NCT00895895|587955391|FG002|Period 1|randomized and not treated|1|||
162793603|NCT00895895|587955392|FG003|Period 1|randomized and not treated|1|||
162793604|NCT00895895|587955393|FG004|Period 1|randomized and not treated|2|||
162793605|NCT00895895|587955389|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
162793606|NCT00895895|587955390|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
162793607|NCT00895895|587955391|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
162793608|NCT00895895|587955392|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
162793609|NCT00895895|587955393|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
162793610|NCT00895895|587955389|FG000|After Period 1, Prior to Period 2|Other|0|||
162793611|NCT00895895|587955390|FG001|After Period 1, Prior to Period 2|Other|0|||
162793612|NCT00895895|587955391|FG002|After Period 1, Prior to Period 2|Other|1|||
162793613|NCT00895895|587955392|FG003|After Period 1, Prior to Period 2|Other|0|||
162793614|NCT00895895|587955393|FG004|After Period 1, Prior to Period 2|Other|0|||
162793615|NCT00895895|587955389|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
162793616|NCT00895895|587955390|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
162793617|NCT00895895|587955391|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
162793618|NCT00895895|587955392|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
162793619|NCT00895895|587955393|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
162793620|NCT00895895|587955389|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162793621|NCT00895895|587955390|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162793622|NCT00895895|587955391|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162793623|NCT00895895|587955392|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162793624|NCT00895895|587955393|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
162793625|NCT00895895|587955389|FG000|Period 2|Adverse Event|3|||
162793626|NCT00895895|587955390|FG001|Period 2|Adverse Event|3|||
162793627|NCT00895895|587955391|FG002|Period 2|Adverse Event|5|||
162793628|NCT00895895|587955392|FG003|Period 2|Adverse Event|2|||
162793629|NCT00895895|587955393|FG004|Period 2|Adverse Event|5|||
162793630|NCT00895895|587955389|FG000|Period 2|Death|0|||
162793631|NCT00895895|587955390|FG001|Period 2|Death|0|||
162793632|NCT00895895|587955391|FG002|Period 2|Death|1|||
162793633|NCT00895895|587955392|FG003|Period 2|Death|0|||
162793634|NCT00895895|587955393|FG004|Period 2|Death|0|||
162793635|NCT00895895|587955389|FG000|Period 2|discontinued by sponsor|44|||
162793636|NCT00895895|587955390|FG001|Period 2|discontinued by sponsor|44|||
162793637|NCT00895895|587955391|FG002|Period 2|discontinued by sponsor|38|||
162793638|NCT00895895|587955392|FG003|Period 2|discontinued by sponsor|46|||
162793639|NCT00895895|587955393|FG004|Period 2|discontinued by sponsor|37|||
162793640|NCT00895895|587955389|FG000|Period 2|failed to return|2|||
162793641|NCT00895895|587955390|FG001|Period 2|failed to return|0|||
162793642|NCT00895895|587955391|FG002|Period 2|failed to return|0|||
162793643|NCT00895895|587955392|FG003|Period 2|failed to return|0|||
162793644|NCT00895895|587955393|FG004|Period 2|failed to return|0|||
162793645|NCT00895895|587955389|FG000|Period 2|investigator request|2|||
162793646|NCT00895895|587955390|FG001|Period 2|investigator request|0|||
162793647|NCT00895895|587955391|FG002|Period 2|investigator request|0|||
162793648|NCT00895895|587955392|FG003|Period 2|investigator request|0|||
162793649|NCT00895895|587955393|FG004|Period 2|investigator request|0|||
162793650|NCT00895895|587955389|FG000|Period 2|Lost to Follow-up|1|||
162793651|NCT00895895|587955390|FG001|Period 2|Lost to Follow-up|2|||
162793652|NCT00895895|587955391|FG002|Period 2|Lost to Follow-up|1|||
162793653|NCT00895895|587955392|FG003|Period 2|Lost to Follow-up|1|||
162793654|NCT00895895|587955393|FG004|Period 2|Lost to Follow-up|0|||
162793655|NCT00895895|587955389|FG000|Period 2|Other|1|||
162793656|NCT00895895|587955390|FG001|Period 2|Other|1|||
162793657|NCT00895895|587955391|FG002|Period 2|Other|3|||
162793658|NCT00895895|587955392|FG003|Period 2|Other|1|||
162793659|NCT00895895|587955393|FG004|Period 2|Other|1|||
162793660|NCT00895895|587955389|FG000|Period 2|Protocol Violation|1|||
162793661|NCT00895895|587955390|FG001|Period 2|Protocol Violation|0|||
162793662|NCT00895895|587955391|FG002|Period 2|Protocol Violation|1|||
162793663|NCT00895895|587955392|FG003|Period 2|Protocol Violation|1|||
162793664|NCT00895895|587955393|FG004|Period 2|Protocol Violation|1|||
162793665|NCT00895895|587955389|FG000|Period 2|Withdrawal by Subject|0|||
162793666|NCT00895895|587955390|FG001|Period 2|Withdrawal by Subject|2|||
162793667|NCT00895895|587955391|FG002|Period 2|Withdrawal by Subject|0|||
162793668|NCT00895895|587955392|FG003|Period 2|Withdrawal by Subject|3|||
162793669|NCT00895895|587955393|FG004|Period 2|Withdrawal by Subject|5|||
162793670|NCT00895895|587955389|FG000|Period 2|unsatisfactory response-efficacy|2|||
162793671|NCT00895895|587955390|FG001|Period 2|unsatisfactory response-efficacy|1|||
162793672|NCT00895895|587955391|FG002|Period 2|unsatisfactory response-efficacy|0|||
162793673|NCT00895895|587955392|FG003|Period 2|unsatisfactory response-efficacy|0|||
162793674|NCT00895895|587955393|FG004|Period 2|unsatisfactory response-efficacy|0|||
162793675|NCT03019640|587955394|FG000|Overall Study|Screen Failures|4|||
162793676|NCT03019640|587955394|FG000|Overall Study|Adverse Event|3|||
162793677|NCT03019640|587955394|FG000|Overall Study|Participant Relapsed|1|||
162793678|NCT01889069|587955395|FG000|Overall Study|Death|18|||
162793679|NCT01889069|587955395|FG000|Overall Study|Progression of Disease|14|||
162793680|NCT01889069|587955395|FG000|Overall Study|Lost to Follow-up|6|||
162793681|NCT01889069|587955395|FG000|Overall Study|Other|4|||
162793682|NCT01889069|587955395|FG000|Overall Study|Consent Withdrawal|3|||
162793683|NCT04978090|587955396|FG000|Overall Study|unable to adequately fit device|2|||
162793684|NCT02227992|587955399|FG000|Overall Study|Lost to Follow-up|1|||
162793685|NCT02227992|587955400|FG001|Overall Study|Lost to Follow-up|1|||
162793686|NCT01509547|587955403|FG000|Overall Study|Lost to Follow-up|24|||
162793687|NCT01509547|587955404|FG001|Overall Study|Lost to Follow-up|14|||
162793688|NCT01509547|587955403|FG000|Overall Study|Withdrawal by Subject|11|||
162793689|NCT01509547|587955404|FG001|Overall Study|Withdrawal by Subject|24|||
162793690|NCT01509547|587955403|FG000|Overall Study|Physician Decision|0|||
162793691|NCT01509547|587955404|FG001|Overall Study|Physician Decision|1|||
162793692|NCT01371708|587955407|FG000|Overall Study|Insufficient clinical response|3|||
162793693|NCT01371708|587955408|FG001|Overall Study|Insufficient clinical response|2|||
162793694|NCT01371708|587955409|FG002|Overall Study|Insufficient clinical response|0|||
162793695|NCT01371708|587955407|FG000|Overall Study|Lost to Follow-up|5|||
162793696|NCT01371708|587955408|FG001|Overall Study|Lost to Follow-up|9|||
162793697|NCT01371708|587955409|FG002|Overall Study|Lost to Follow-up|7|||
162793698|NCT01371708|587955407|FG000|Overall Study|Protocol Violation|2|||
162793699|NCT01371708|587955408|FG001|Overall Study|Protocol Violation|1|||
162793700|NCT01371708|587955409|FG002|Overall Study|Protocol Violation|2|||
162793701|NCT01371708|587955407|FG000|Overall Study|No longer willing to participate|7|||
162793702|NCT01371708|587955408|FG001|Overall Study|No longer willing to participate|7|||
162793703|NCT01371708|587955409|FG002|Overall Study|No longer willing to participate|13|||
162793704|NCT01371708|587955407|FG000|Overall Study|Medication error/not related to AE|0|||
162793705|NCT01371708|587955408|FG001|Overall Study|Medication error/not related to AE|1|||
162793706|NCT01371708|587955409|FG002|Overall Study|Medication error/not related to AE|0|||
162793707|NCT01371708|587955407|FG000|Overall Study|Other|3|||
162793708|NCT01371708|587955408|FG001|Overall Study|Other|2|||
162793709|NCT01371708|587955409|FG002|Overall Study|Other|4|||
162793710|NCT01371708|587955407|FG000|Overall Study|Adverse Event|5|||
162793711|NCT01371708|587955408|FG001|Overall Study|Adverse Event|8|||
162793712|NCT01371708|587955409|FG002|Overall Study|Adverse Event|12|||
162793713|NCT01371708|587955407|FG000|Overall Study|Started but did not receive treatment|1|||
162793714|NCT01371708|587955408|FG001|Overall Study|Started but did not receive treatment|0|||
162793715|NCT01371708|587955409|FG002|Overall Study|Started but did not receive treatment|1|||
162793716|NCT02514551|587955410|FG000|Overall Study|Lost to Follow-up|0|||
162925429|NCT00742859|588428964|FG000|Overall Study|Site error|0|||
162793717|NCT02514551|587955411|FG001|Overall Study|Lost to Follow-up|1|||
162793718|NCT02514551|587955410|FG000|Overall Study|Participant Never Treated|0|||
162793719|NCT02514551|587955411|FG001|Overall Study|Participant Never Treated|2|||
162793720|NCT00996606|587955422|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
162793721|NCT00996606|587955422|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162793722|NCT00996606|587955422|FG000|Overall Study|Protocol Violation|1|||
162793723|NCT00996606|587955422|FG000|Overall Study|Withdrawal by Subject|3|||
162925430|NCT00742859|588428965|FG001|Overall Study|Site error|0|||
162793724|NCT03197766|587955423|FG000|Overall Study|Withdrawal by Subject|2|||
162793725|NCT03197766|587955424|FG001|Overall Study|Withdrawal by Subject|0|||
162793726|NCT02964013|587957840|FG000|Overall Study|Death|58|||
162793727|NCT02964013|587957841|FG001|Overall Study|Death|239|||
162793728|NCT02964013|587957842|FG002|Overall Study|Death|38|||
162793729|NCT02964013|587957843|FG003|Overall Study|Death|10|||
162793730|NCT02964013|587957844|FG004|Overall Study|Death|33|||
162793731|NCT02964013|587957840|FG000|Overall Study|Lost to Follow-up|1|||
162793732|NCT02964013|587957841|FG001|Overall Study|Lost to Follow-up|4|||
162793733|NCT02964013|587957842|FG002|Overall Study|Lost to Follow-up|2|||
162793734|NCT02964013|587957843|FG003|Overall Study|Lost to Follow-up|0|||
162793735|NCT02964013|587957844|FG004|Overall Study|Lost to Follow-up|0|||
162793736|NCT02964013|587957840|FG000|Overall Study|Physician Decision|0|||
162793737|NCT02964013|587957841|FG001|Overall Study|Physician Decision|1|||
162793738|NCT02964013|587957842|FG002|Overall Study|Physician Decision|0|||
162793739|NCT02964013|587957843|FG003|Overall Study|Physician Decision|0|||
162793740|NCT02964013|587957844|FG004|Overall Study|Physician Decision|0|||
162793741|NCT02964013|587957840|FG000|Overall Study|Sponsor Decision|3|||
162793742|NCT02964013|587957841|FG001|Overall Study|Sponsor Decision|22|||
162793743|NCT02964013|587957842|FG002|Overall Study|Sponsor Decision|11|||
162793744|NCT02964013|587957843|FG003|Overall Study|Sponsor Decision|0|||
162793745|NCT02964013|587957844|FG004|Overall Study|Sponsor Decision|7|||
162793746|NCT02964013|587957840|FG000|Overall Study|Withdrawal by Subject|6|||
162793747|NCT02964013|587957841|FG001|Overall Study|Withdrawal by Subject|27|||
162793748|NCT02964013|587957842|FG002|Overall Study|Withdrawal by Subject|9|||
162793749|NCT02964013|587957843|FG003|Overall Study|Withdrawal by Subject|0|||
162793750|NCT02964013|587957844|FG004|Overall Study|Withdrawal by Subject|0|||
162793751|NCT02964013|587957840|FG000|Overall Study|Not Treated|0|||
162793752|NCT02964013|587957841|FG001|Overall Study|Not Treated|2|||
162793753|NCT02964013|587957842|FG002|Overall Study|Not Treated|0|||
162793754|NCT02964013|587957843|FG003|Overall Study|Not Treated|1|||
162793755|NCT02964013|587957844|FG004|Overall Study|Not Treated|0|||
162793756|NCT01123070|587957845|FG000|Part B Double Blind Period|Protocol Violation|0|||
162793757|NCT01123070|587957846|FG001|Part B Double Blind Period|Protocol Violation|0|||
162793758|NCT01123070|587957847|FG002|Part B Double Blind Period|Protocol Violation|0|||
162793759|NCT01123070|587957848|FG003|Part B Double Blind Period|Protocol Violation|1|||
162793760|NCT01123070|587957845|FG000|Part B Double Blind Period|Adverse Event|0|||
162793761|NCT01123070|587957846|FG001|Part B Double Blind Period|Adverse Event|0|||
162793762|NCT01123070|587957847|FG002|Part B Double Blind Period|Adverse Event|2|||
162793763|NCT01123070|587957848|FG003|Part B Double Blind Period|Adverse Event|0|||
162793764|NCT01123070|587957845|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
162793765|NCT01123070|587957846|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
162793766|NCT01123070|587957847|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
162793767|NCT01123070|587957848|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
162793768|NCT04942366|587957849|FG000|Overall Study|Withdrawal by Subject|5|||
162793769|NCT04942366|587957850|FG001|Overall Study|Withdrawal by Subject|5|||
162793770|NCT00747227|587957853|FG000|Overall Study|Death|3|||
162793771|NCT00747227|587957854|FG001|Overall Study|Death|1|||
162793772|NCT00747227|587957853|FG000|Overall Study|Withdrawal by Subject|1|||
162793773|NCT00747227|587957854|FG001|Overall Study|Withdrawal by Subject|0|||
162793774|NCT00747227|587957853|FG000|Overall Study|Lost to Follow-up|1|||
162793775|NCT00747227|587957854|FG001|Overall Study|Lost to Follow-up|2|||
162793776|NCT00747227|587957853|FG000|Overall Study|Illness|1|||
162793777|NCT00747227|587957854|FG001|Overall Study|Illness|1|||
162793778|NCT03284229|587957855|FG000|Overall Study|Lost to Follow-up|3|||
162793779|NCT00918879|587957856|FG000|Overall Study|Withdrawal by Subject|4|||
162793780|NCT00918879|587957857|FG001|Overall Study|Withdrawal by Subject|4|||
162793781|NCT00918879|587957856|FG000|Overall Study|Lost to Follow-up|1|||
162793782|NCT00918879|587957857|FG001|Overall Study|Lost to Follow-up|1|||
162793783|NCT00918879|587957856|FG000|Overall Study|Severe non-compliance to protocol|1|||
162793784|NCT00918879|587957857|FG001|Overall Study|Severe non-compliance to protocol|1|||
162793785|NCT03339245|587957865|FG000|Overall Study|Adverse Event|1|||
162793786|NCT03339245|587957866|FG001|Overall Study|Adverse Event|1|||
162793787|NCT03339245|587957865|FG000|Overall Study|Withdrawal by Subject|1|||
162793788|NCT03339245|587957866|FG001|Overall Study|Withdrawal by Subject|0|||
162793789|NCT03480932|587957874|FG000|Overall Study|Death|1|||
162793790|NCT03480932|587957875|FG001|Overall Study|Death|1|||
162793791|NCT03480932|587957876|FG002|Overall Study|Death|0|||
162793792|NCT03480932|587957874|FG000|Overall Study|Lost to Follow-up|0|||
162793793|NCT03480932|587957875|FG001|Overall Study|Lost to Follow-up|2|||
162793794|NCT03480932|587957876|FG002|Overall Study|Lost to Follow-up|3|||
162793795|NCT03480932|587957874|FG000|Overall Study|Incarcerated|2|||
162793796|NCT03480932|587957875|FG001|Overall Study|Incarcerated|2|||
162793797|NCT03480932|587957876|FG002|Overall Study|Incarcerated|2|||
162793798|NCT03056300|587957877|FG000|Overall Study|Surgical reason per study protocol|3|||
162793799|NCT05262517|587957878|FG000|Overall Study|Randomized but not treated|5|||
162793800|NCT05262517|587957879|FG001|Overall Study|Randomized but not treated|11|||
162793801|NCT00335140|587957882|FG000|Overall Study|Ineligible|1|||
162793802|NCT00737477|587957886|FG000|Overall Study|Adverse Event|9|||
162793803|NCT00737477|587957886|FG000|Overall Study|Death|9|||
162793804|NCT00737477|587957886|FG000|Overall Study|Treatment Refusal|1|||
162793805|NCT00737477|587957886|FG000|Overall Study|Withdrawal by Subject|1|||
162793806|NCT00737477|587957886|FG000|Overall Study|Renal Transplantation|10|||
162793807|NCT00737477|587957886|FG000|Overall Study|Other|4|||
162793808|NCT01132820|587957887|FG000|Overall Study|Ineligible: wrong cell type|1|||
162793809|NCT01132820|587957887|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
162793810|NCT01132820|587957887|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
162793811|NCT01132820|587957887|FG000|Overall Study|Never treated|1|||
162793812|NCT01132820|587957887|FG000|Overall Study|Inadequate data|1|||
162793813|NCT02687035|587957888|FG000|Overall Study|Withdrawal by Subject|1|||
162793814|NCT02687035|587957888|FG000|Overall Study|Death|87|||
162793815|NCT02687035|587957888|FG000|Overall Study|Lost to Follow-up|1|||
162793816|NCT02687035|587957888|FG000|Overall Study|Missed Visit|87|||
162793817|NCT02687035|587957888|FG000|Overall Study|Did not receive Study Device|8|||
162793818|NCT05000216|587957889|FG000|Stage 1|Lost to Follow-up|0|||
162793819|NCT05000216|587957890|FG001|Stage 1|Lost to Follow-up|0|||
162793820|NCT05000216|587957891|FG002|Stage 1|Lost to Follow-up|0|||
162793821|NCT05000216|587957892|FG003|Stage 1|Lost to Follow-up|0|||
162793822|NCT05000216|587957893|FG004|Stage 1|Lost to Follow-up|0|||
162793823|NCT05000216|587957894|FG005|Stage 1|Lost to Follow-up|0|||
162793824|NCT05000216|587957895|FG006|Stage 1|Lost to Follow-up|1|||
162793825|NCT05000216|587957896|FG007|Stage 1|Lost to Follow-up|1|||
162793826|NCT05000216|587957897|FG008|Stage 1|Lost to Follow-up|0|||
162793827|NCT05000216|587957898|FG009|Stage 1|Lost to Follow-up|2|||
162793828|NCT05000216|587957899|FG010|Stage 1|Lost to Follow-up|3|||
162793829|NCT05000216|587957900|FG011|Stage 1|Lost to Follow-up|0|||
162793830|NCT05000216|587957901|FG012|Stage 1|Lost to Follow-up|0|||
162793831|NCT05000216|587957902|FG013|Stage 1|Lost to Follow-up|0|||
162793832|NCT05000216|587957903|FG014|Stage 1|Lost to Follow-up|0|||
162793833|NCT05000216|587957904|FG015|Stage 1|Lost to Follow-up|0|||
162793834|NCT05000216|587957905|FG016|Stage 1|Lost to Follow-up|0|||
162793835|NCT05000216|587957906|FG017|Stage 1|Lost to Follow-up|0|||
162793836|NCT05000216|587957907|FG018|Stage 1|Lost to Follow-up|0|||
162793837|NCT05000216|587957908|FG019|Stage 1|Lost to Follow-up|0|||
162793838|NCT05000216|587957909|FG020|Stage 1|Lost to Follow-up|0|||
162793839|NCT05000216|587957910|FG021|Stage 1|Lost to Follow-up|0|||
162793840|NCT05000216|587957889|FG000|Stage 1|Physician Decision|0|||
162793841|NCT05000216|587957890|FG001|Stage 1|Physician Decision|0|||
162793842|NCT05000216|587957891|FG002|Stage 1|Physician Decision|0|||
162793843|NCT05000216|587957892|FG003|Stage 1|Physician Decision|0|||
162793844|NCT05000216|587957893|FG004|Stage 1|Physician Decision|0|||
162793845|NCT05000216|587957894|FG005|Stage 1|Physician Decision|0|||
162793846|NCT05000216|587957895|FG006|Stage 1|Physician Decision|0|||
162793847|NCT05000216|587957896|FG007|Stage 1|Physician Decision|1|||
162793848|NCT05000216|587957897|FG008|Stage 1|Physician Decision|1|||
162793849|NCT05000216|587957898|FG009|Stage 1|Physician Decision|0|||
162793850|NCT05000216|587957899|FG010|Stage 1|Physician Decision|0|||
162793851|NCT05000216|587957900|FG011|Stage 1|Physician Decision|0|||
162793852|NCT05000216|587957901|FG012|Stage 1|Physician Decision|0|||
162793853|NCT05000216|587957902|FG013|Stage 1|Physician Decision|0|||
162793854|NCT05000216|587957903|FG014|Stage 1|Physician Decision|0|||
162793855|NCT05000216|587957904|FG015|Stage 1|Physician Decision|0|||
162793856|NCT05000216|587957905|FG016|Stage 1|Physician Decision|0|||
162793857|NCT05000216|587957906|FG017|Stage 1|Physician Decision|0|||
162793858|NCT05000216|587957907|FG018|Stage 1|Physician Decision|0|||
162793859|NCT05000216|587957908|FG019|Stage 1|Physician Decision|0|||
162793860|NCT05000216|587957909|FG020|Stage 1|Physician Decision|0|||
162793861|NCT05000216|587957910|FG021|Stage 1|Physician Decision|0|||
162793862|NCT05000216|587957889|FG000|Stage 1|Withdrawal by Subject|0|||
162793863|NCT05000216|587957890|FG001|Stage 1|Withdrawal by Subject|1|||
162793864|NCT05000216|587957891|FG002|Stage 1|Withdrawal by Subject|0|||
162793865|NCT05000216|587957892|FG003|Stage 1|Withdrawal by Subject|0|||
162793866|NCT05000216|587957893|FG004|Stage 1|Withdrawal by Subject|0|||
162793867|NCT05000216|587957894|FG005|Stage 1|Withdrawal by Subject|0|||
162793868|NCT05000216|587957895|FG006|Stage 1|Withdrawal by Subject|0|||
162793869|NCT05000216|587957896|FG007|Stage 1|Withdrawal by Subject|0|||
162793870|NCT05000216|587957897|FG008|Stage 1|Withdrawal by Subject|0|||
162793871|NCT05000216|587957898|FG009|Stage 1|Withdrawal by Subject|3|||
162793872|NCT05000216|587957899|FG010|Stage 1|Withdrawal by Subject|10|||
162793873|NCT05000216|587957900|FG011|Stage 1|Withdrawal by Subject|0|||
162793874|NCT05000216|587957901|FG012|Stage 1|Withdrawal by Subject|0|||
162793875|NCT05000216|587957902|FG013|Stage 1|Withdrawal by Subject|0|||
162793876|NCT05000216|587957903|FG014|Stage 1|Withdrawal by Subject|0|||
162793877|NCT05000216|587957904|FG015|Stage 1|Withdrawal by Subject|0|||
162793878|NCT05000216|587957905|FG016|Stage 1|Withdrawal by Subject|0|||
162793879|NCT05000216|587957906|FG017|Stage 1|Withdrawal by Subject|0|||
162793880|NCT05000216|587957907|FG018|Stage 1|Withdrawal by Subject|0|||
162793881|NCT05000216|587957908|FG019|Stage 1|Withdrawal by Subject|0|||
162793882|NCT05000216|587957909|FG020|Stage 1|Withdrawal by Subject|0|||
162793883|NCT05000216|587957910|FG021|Stage 1|Withdrawal by Subject|0|||
162793884|NCT05000216|587957889|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
162793885|NCT05000216|587957890|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
162793886|NCT05000216|587957891|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
162793887|NCT05000216|587957892|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
162793888|NCT05000216|587957893|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
162793889|NCT05000216|587957894|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
162793890|NCT05000216|587957895|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
162793891|NCT05000216|587957896|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
162793892|NCT05000216|587957897|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
162793893|NCT05000216|587957898|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
162793894|NCT05000216|587957899|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
162793895|NCT05000216|587957900|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
162793896|NCT05000216|587957901|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
162793897|NCT05000216|587957902|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
162793898|NCT05000216|587957903|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
162793899|NCT05000216|587957904|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
162793900|NCT05000216|587957905|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
162793901|NCT05000216|587957906|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
162793902|NCT05000216|587957907|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
162793903|NCT05000216|587957908|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
162793904|NCT05000216|587957909|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
162793905|NCT05000216|587957910|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
162793906|NCT05000216|587957889|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793907|NCT05000216|587957890|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793908|NCT05000216|587957891|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793909|NCT05000216|587957892|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793910|NCT05000216|587957893|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793911|NCT05000216|587957894|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793912|NCT05000216|587957895|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793913|NCT05000216|587957896|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793914|NCT05000216|587957897|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
162793915|NCT05000216|587957898|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793916|NCT05000216|587957899|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793917|NCT05000216|587957900|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793918|NCT05000216|587957901|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793919|NCT05000216|587957902|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793920|NCT05000216|587957903|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793921|NCT05000216|587957904|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793922|NCT05000216|587957905|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793923|NCT05000216|587957906|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793924|NCT05000216|587957907|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793925|NCT05000216|587957908|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793926|NCT05000216|587957909|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793927|NCT05000216|587957910|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162793928|NCT05000216|587957889|FG000|Stage 1|Other|0|||
162793929|NCT05000216|587957890|FG001|Stage 1|Other|0|||
162793930|NCT05000216|587957891|FG002|Stage 1|Other|0|||
162793931|NCT05000216|587957892|FG003|Stage 1|Other|0|||
162793932|NCT05000216|587957893|FG004|Stage 1|Other|1|||
162793933|NCT05000216|587957894|FG005|Stage 1|Other|0|||
162793934|NCT05000216|587957895|FG006|Stage 1|Other|0|||
162793935|NCT05000216|587957896|FG007|Stage 1|Other|2|||
162793936|NCT05000216|587957897|FG008|Stage 1|Other|0|||
162793937|NCT05000216|587957898|FG009|Stage 1|Other|0|||
162793938|NCT05000216|587957899|FG010|Stage 1|Other|1|||
162793939|NCT05000216|587957900|FG011|Stage 1|Other|1|||
162793940|NCT05000216|587957901|FG012|Stage 1|Other|0|||
162793941|NCT05000216|587957902|FG013|Stage 1|Other|0|||
162793942|NCT05000216|587957903|FG014|Stage 1|Other|0|||
162793943|NCT05000216|587957904|FG015|Stage 1|Other|0|||
162793944|NCT05000216|587957905|FG016|Stage 1|Other|0|||
162793945|NCT05000216|587957906|FG017|Stage 1|Other|0|||
162793946|NCT05000216|587957907|FG018|Stage 1|Other|0|||
162793947|NCT05000216|587957908|FG019|Stage 1|Other|0|||
162793948|NCT05000216|587957909|FG020|Stage 1|Other|0|||
162793949|NCT05000216|587957910|FG021|Stage 1|Other|0|||
162793950|NCT05000216|587957889|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
162793951|NCT05000216|587957890|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
162793952|NCT05000216|587957891|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
162793953|NCT05000216|587957892|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
162793954|NCT05000216|587957893|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
162793955|NCT05000216|587957894|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
162793956|NCT05000216|587957895|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
162793957|NCT05000216|587957896|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
162793958|NCT05000216|587957897|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
162793959|NCT05000216|587957898|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
162793960|NCT05000216|587957899|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
162793961|NCT05000216|587957900|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
162810580|NCT00887250|588018277|FG002|Overall Study|Lost to Follow-up|1|||
162793962|NCT05000216|587957901|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
162793963|NCT05000216|587957902|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
162793964|NCT05000216|587957903|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
162793965|NCT05000216|587957904|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
162793966|NCT05000216|587957905|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
162793967|NCT05000216|587957906|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
162793968|NCT05000216|587957907|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
162793969|NCT05000216|587957908|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
162793970|NCT05000216|587957909|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
162793971|NCT05000216|587957910|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
162793972|NCT05000216|587957889|FG000|Stage 2|Lost to Follow-up|0|||
162793973|NCT05000216|587957890|FG001|Stage 2|Lost to Follow-up|0|||
162793974|NCT05000216|587957891|FG002|Stage 2|Lost to Follow-up|0|||
162793975|NCT05000216|587957892|FG003|Stage 2|Lost to Follow-up|0|||
162793976|NCT05000216|587957893|FG004|Stage 2|Lost to Follow-up|0|||
162793977|NCT05000216|587957894|FG005|Stage 2|Lost to Follow-up|0|||
162793978|NCT05000216|587957895|FG006|Stage 2|Lost to Follow-up|0|||
162793979|NCT05000216|587957896|FG007|Stage 2|Lost to Follow-up|0|||
162793980|NCT05000216|587957897|FG008|Stage 2|Lost to Follow-up|0|||
162793981|NCT05000216|587957898|FG009|Stage 2|Lost to Follow-up|0|||
162793982|NCT05000216|587957899|FG010|Stage 2|Lost to Follow-up|0|||
162793983|NCT05000216|587957900|FG011|Stage 2|Lost to Follow-up|0|||
162793984|NCT05000216|587957901|FG012|Stage 2|Lost to Follow-up|0|||
162793985|NCT05000216|587957902|FG013|Stage 2|Lost to Follow-up|0|||
162793986|NCT05000216|587957903|FG014|Stage 2|Lost to Follow-up|0|||
162793987|NCT05000216|587957904|FG015|Stage 2|Lost to Follow-up|0|||
162793988|NCT05000216|587957905|FG016|Stage 2|Lost to Follow-up|4|||
162793989|NCT05000216|587957906|FG017|Stage 2|Lost to Follow-up|0|||
162793990|NCT05000216|587957907|FG018|Stage 2|Lost to Follow-up|0|||
162793991|NCT05000216|587957908|FG019|Stage 2|Lost to Follow-up|0|||
162793992|NCT05000216|587957909|FG020|Stage 2|Lost to Follow-up|0|||
162793993|NCT05000216|587957910|FG021|Stage 2|Lost to Follow-up|0|||
162793994|NCT05000216|587957889|FG000|Stage 2|Physician Decision|0|||
162793995|NCT05000216|587957890|FG001|Stage 2|Physician Decision|0|||
162793996|NCT05000216|587957891|FG002|Stage 2|Physician Decision|0|||
162793997|NCT05000216|587957892|FG003|Stage 2|Physician Decision|0|||
162793998|NCT05000216|587957893|FG004|Stage 2|Physician Decision|0|||
162793999|NCT05000216|587957894|FG005|Stage 2|Physician Decision|0|||
162794000|NCT05000216|587957895|FG006|Stage 2|Physician Decision|0|||
162794001|NCT05000216|587957896|FG007|Stage 2|Physician Decision|0|||
162794002|NCT05000216|587957897|FG008|Stage 2|Physician Decision|0|||
162794003|NCT05000216|587957898|FG009|Stage 2|Physician Decision|0|||
162794004|NCT05000216|587957899|FG010|Stage 2|Physician Decision|0|||
162794005|NCT05000216|587957900|FG011|Stage 2|Physician Decision|0|||
162794006|NCT05000216|587957901|FG012|Stage 2|Physician Decision|1|||
162794007|NCT05000216|587957902|FG013|Stage 2|Physician Decision|0|||
162794008|NCT05000216|587957903|FG014|Stage 2|Physician Decision|0|||
162794009|NCT05000216|587957904|FG015|Stage 2|Physician Decision|0|||
162794010|NCT05000216|587957905|FG016|Stage 2|Physician Decision|0|||
162794011|NCT05000216|587957906|FG017|Stage 2|Physician Decision|0|||
162794012|NCT05000216|587957907|FG018|Stage 2|Physician Decision|0|||
162794013|NCT05000216|587957908|FG019|Stage 2|Physician Decision|0|||
162794014|NCT05000216|587957909|FG020|Stage 2|Physician Decision|0|||
162794015|NCT05000216|587957910|FG021|Stage 2|Physician Decision|0|||
162794016|NCT05000216|587957889|FG000|Stage 2|Withdrawal by Subject|0|||
162794017|NCT05000216|587957890|FG001|Stage 2|Withdrawal by Subject|0|||
162794018|NCT05000216|587957891|FG002|Stage 2|Withdrawal by Subject|0|||
162794019|NCT05000216|587957892|FG003|Stage 2|Withdrawal by Subject|0|||
162794020|NCT05000216|587957893|FG004|Stage 2|Withdrawal by Subject|0|||
162794021|NCT05000216|587957894|FG005|Stage 2|Withdrawal by Subject|0|||
162794022|NCT05000216|587957895|FG006|Stage 2|Withdrawal by Subject|0|||
162794023|NCT05000216|587957896|FG007|Stage 2|Withdrawal by Subject|0|||
162794024|NCT05000216|587957897|FG008|Stage 2|Withdrawal by Subject|0|||
162794025|NCT05000216|587957898|FG009|Stage 2|Withdrawal by Subject|0|||
162794026|NCT05000216|587957899|FG010|Stage 2|Withdrawal by Subject|0|||
162794027|NCT05000216|587957900|FG011|Stage 2|Withdrawal by Subject|0|||
162794028|NCT05000216|587957901|FG012|Stage 2|Withdrawal by Subject|0|||
162794029|NCT05000216|587957902|FG013|Stage 2|Withdrawal by Subject|0|||
162794030|NCT05000216|587957903|FG014|Stage 2|Withdrawal by Subject|2|||
162794031|NCT05000216|587957904|FG015|Stage 2|Withdrawal by Subject|0|||
162794032|NCT05000216|587957905|FG016|Stage 2|Withdrawal by Subject|9|||
162794033|NCT05000216|587957906|FG017|Stage 2|Withdrawal by Subject|0|||
162794034|NCT05000216|587957907|FG018|Stage 2|Withdrawal by Subject|0|||
162794035|NCT05000216|587957908|FG019|Stage 2|Withdrawal by Subject|0|||
162794036|NCT05000216|587957909|FG020|Stage 2|Withdrawal by Subject|0|||
162794037|NCT05000216|587957910|FG021|Stage 2|Withdrawal by Subject|0|||
162794038|NCT05000216|587957889|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
162794039|NCT05000216|587957890|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
162794040|NCT05000216|587957891|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
162794041|NCT05000216|587957892|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
162794042|NCT05000216|587957893|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
162794043|NCT05000216|587957894|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
162794044|NCT05000216|587957895|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
162794045|NCT05000216|587957896|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
162794046|NCT05000216|587957897|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
162794047|NCT05000216|587957898|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
162794048|NCT05000216|587957899|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
162794049|NCT05000216|587957900|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
162794050|NCT05000216|587957901|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
162794051|NCT05000216|587957902|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
162794052|NCT05000216|587957903|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
162794053|NCT05000216|587957904|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
162794054|NCT05000216|587957905|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
162794055|NCT05000216|587957906|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
162794056|NCT05000216|587957907|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
162794057|NCT05000216|587957908|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
162794058|NCT05000216|587957909|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
162794059|NCT05000216|587957910|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
162794060|NCT05000216|587957889|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794061|NCT05000216|587957890|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794062|NCT05000216|587957891|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794063|NCT05000216|587957892|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794064|NCT05000216|587957893|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794065|NCT05000216|587957894|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794066|NCT05000216|587957895|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794067|NCT05000216|587957896|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794068|NCT05000216|587957897|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794069|NCT05000216|587957898|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794070|NCT05000216|587957899|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794071|NCT05000216|587957900|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794072|NCT05000216|587957901|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794073|NCT05000216|587957902|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794074|NCT05000216|587957903|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
162794075|NCT05000216|587957904|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794076|NCT05000216|587957905|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
162794077|NCT05000216|587957906|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794078|NCT05000216|587957907|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794079|NCT05000216|587957908|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794080|NCT05000216|587957909|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794081|NCT05000216|587957910|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162794082|NCT05000216|587957889|FG000|Stage 2|Other reason|0|||
162794083|NCT05000216|587957890|FG001|Stage 2|Other reason|0|||
162794084|NCT05000216|587957891|FG002|Stage 2|Other reason|0|||
162794085|NCT05000216|587957892|FG003|Stage 2|Other reason|0|||
162794086|NCT05000216|587957893|FG004|Stage 2|Other reason|0|||
162794087|NCT05000216|587957894|FG005|Stage 2|Other reason|0|||
162794088|NCT05000216|587957895|FG006|Stage 2|Other reason|0|||
162794089|NCT05000216|587957896|FG007|Stage 2|Other reason|0|||
162794090|NCT05000216|587957897|FG008|Stage 2|Other reason|0|||
162794091|NCT05000216|587957898|FG009|Stage 2|Other reason|0|||
162794092|NCT05000216|587957899|FG010|Stage 2|Other reason|0|||
162794093|NCT05000216|587957900|FG011|Stage 2|Other reason|0|||
162794094|NCT05000216|587957901|FG012|Stage 2|Other reason|0|||
162794095|NCT05000216|587957902|FG013|Stage 2|Other reason|0|||
162794096|NCT05000216|587957903|FG014|Stage 2|Other reason|0|||
162794097|NCT05000216|587957904|FG015|Stage 2|Other reason|0|||
162794098|NCT05000216|587957905|FG016|Stage 2|Other reason|1|||
162794099|NCT05000216|587957906|FG017|Stage 2|Other reason|0|||
162794100|NCT05000216|587957907|FG018|Stage 2|Other reason|0|||
162794101|NCT05000216|587957908|FG019|Stage 2|Other reason|0|||
162794102|NCT05000216|587957909|FG020|Stage 2|Other reason|0|||
162794103|NCT05000216|587957910|FG021|Stage 2|Other reason|0|||
162794104|NCT05000216|587957889|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
162794105|NCT05000216|587957890|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
162794106|NCT05000216|587957891|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
162794107|NCT05000216|587957892|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
162794108|NCT05000216|587957893|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
162794109|NCT05000216|587957894|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
162794110|NCT05000216|587957895|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
162794111|NCT05000216|587957896|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
162794112|NCT05000216|587957897|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
162794113|NCT05000216|587957898|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
162794114|NCT05000216|587957899|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
162794115|NCT05000216|587957900|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
162794116|NCT05000216|587957901|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
162794117|NCT05000216|587957902|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
162794118|NCT05000216|587957903|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
162794119|NCT05000216|587957904|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
162794120|NCT05000216|587957905|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
162794121|NCT05000216|587957906|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
162794122|NCT05000216|587957907|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
162794123|NCT05000216|587957908|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
162794124|NCT05000216|587957909|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
162794125|NCT05000216|587957910|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
162794126|NCT05000216|587957889|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794127|NCT05000216|587957890|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794128|NCT05000216|587957891|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794129|NCT05000216|587957892|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794130|NCT05000216|587957893|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794131|NCT05000216|587957894|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794132|NCT05000216|587957895|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794133|NCT05000216|587957896|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794134|NCT05000216|587957897|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794135|NCT05000216|587957898|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794136|NCT05000216|587957899|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794137|NCT05000216|587957900|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794138|NCT05000216|587957901|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794139|NCT05000216|587957902|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794140|NCT05000216|587957903|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794141|NCT05000216|587957904|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
162794142|NCT05000216|587957905|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794143|NCT05000216|587957906|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794144|NCT05000216|587957907|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794145|NCT05000216|587957908|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794146|NCT05000216|587957909|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794147|NCT05000216|587957910|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
162794148|NCT05000216|587957889|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794149|NCT05000216|587957890|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794150|NCT05000216|587957891|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794151|NCT05000216|587957892|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794152|NCT05000216|587957893|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794153|NCT05000216|587957894|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794154|NCT05000216|587957895|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794155|NCT05000216|587957896|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794156|NCT05000216|587957897|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794157|NCT05000216|587957898|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794158|NCT05000216|587957899|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794159|NCT05000216|587957900|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794160|NCT05000216|587957901|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794161|NCT05000216|587957902|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
162794162|NCT05000216|587957903|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794163|NCT05000216|587957904|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
162794164|NCT05000216|587957905|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794165|NCT05000216|587957906|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794166|NCT05000216|587957907|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
162794167|NCT05000216|587957908|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794168|NCT05000216|587957909|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794169|NCT05000216|587957910|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162794170|NCT03435692|587957911|FG000|Overall Study|Lack of Efficacy|2|||
162794171|NCT03435692|587957912|FG001|Overall Study|Lack of Efficacy|2|||
162794172|NCT03435692|587957913|FG002|Overall Study|Lack of Efficacy|0|||
162794173|NCT01818531|587957919|FG000|Overall Study|Withdrawn for case delay after block|1|||
162794174|NCT01818531|587957920|FG001|Overall Study|Withdrawn for case delay after block|0|||
162794175|NCT01818531|587957919|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
162794176|NCT01818531|587957920|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
162794177|NCT01818531|587957919|FG000|Overall Study|Withdrawn for failure to place block|0|||
162794178|NCT01818531|587957920|FG001|Overall Study|Withdrawn for failure to place block|1|||
162794179|NCT00214019|587957921|FG000|Overall Study|Lost to Follow-up|11|||
162794180|NCT00214019|587957921|FG000|Overall Study|Withdrawal by Subject|2|||
162794181|NCT00214019|587957921|FG000|Overall Study|Screen Failed prior to randomization|17|||
162794182|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
162794183|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
162794184|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
162794185|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
162794186|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
162794187|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
162794188|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
162794189|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
162794190|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
162794191|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
162810581|NCT00887250|588018275|FG000|Overall Study|Protocol Violation|2|||
162794192|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794193|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794194|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
162794195|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
162794196|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794197|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794198|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794199|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162794200|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
162794201|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794202|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794203|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794204|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
162794205|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794206|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794207|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794208|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
162794209|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
162794210|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
162794211|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
162794212|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
162794213|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
162794214|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162794215|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162794216|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162794217|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162794218|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
162794219|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
162794220|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
162794221|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
162794222|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
162794223|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162794224|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162794225|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162794226|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162794227|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
162794228|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
162794229|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
162794230|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
162794231|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
162794232|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
162794233|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
162794234|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
162794235|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
162794236|NCT00477490|587957922|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
162794237|NCT00477490|587957923|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
162794238|NCT00477490|587957924|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
162794239|NCT00477490|587957925|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
162794240|NCT00477490|587957926|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
162794241|NCT00477490|587957927|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
162794242|NCT00477490|587957928|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
162794243|NCT00477490|587957929|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
162794244|NCT00477490|587957930|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
162794245|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
162794246|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
162794247|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
162794248|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
162794249|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
162794250|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
162794251|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
162794252|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
162794253|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
162794254|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
162794255|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
162794256|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
162794257|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162794258|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162794259|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162794260|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162810582|NCT00887250|588018276|FG001|Overall Study|Protocol Violation|2|||
162794261|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162794262|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
162794263|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162794264|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
162794265|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
162794266|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162794267|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
162794268|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162794269|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
162794270|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162794271|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162794272|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794273|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794274|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794275|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794276|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162794277|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794278|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162794279|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162794280|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162794281|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794282|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
162794283|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794284|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794285|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794286|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794287|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794288|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794289|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162794290|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
162794291|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
162794292|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
162794293|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
162794294|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
162794295|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162794296|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162794297|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
162794298|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162794299|NCT00477490|587957922|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794300|NCT00477490|587957923|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
162794301|NCT00477490|587957924|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
162794302|NCT00477490|587957925|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794303|NCT00477490|587957926|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
162794304|NCT00477490|587957927|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794305|NCT00477490|587957928|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794306|NCT00477490|587957929|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794307|NCT00477490|587957930|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162794308|NCT01465763|587957933|FG000|Overall Study|Withdrawal by Subject|4|||
162794309|NCT01465763|587957934|FG001|Overall Study|Withdrawal by Subject|0|||
162794310|NCT01465763|587957935|FG002|Overall Study|Withdrawal by Subject|1|||
162794311|NCT01465763|587957933|FG000|Overall Study|Insufficient Clinical Response|11|||
162794312|NCT01465763|587957934|FG001|Overall Study|Insufficient Clinical Response|0|||
162794313|NCT01465763|587957935|FG002|Overall Study|Insufficient Clinical Response|1|||
162794314|NCT01465763|587957933|FG000|Overall Study|Adverse Event|9|||
162794315|NCT01465763|587957934|FG001|Overall Study|Adverse Event|0|||
162794316|NCT01465763|587957935|FG002|Overall Study|Adverse Event|1|||
162794317|NCT01465763|587957933|FG000|Overall Study|Other|2|||
162794318|NCT01465763|587957934|FG001|Overall Study|Other|0|||
162794319|NCT01465763|587957935|FG002|Overall Study|Other|0|||
162794320|NCT01465763|587957933|FG000|Overall Study|Protocol Violation|4|||
162794321|NCT01465763|587957934|FG001|Overall Study|Protocol Violation|1|||
162794322|NCT01465763|587957935|FG002|Overall Study|Protocol Violation|1|||
162794323|NCT01465763|587957933|FG000|Overall Study|Death|1|||
162794324|NCT01465763|587957934|FG001|Overall Study|Death|0|||
162794325|NCT01465763|587957935|FG002|Overall Study|Death|0|||
162794326|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
162794327|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
162794328|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
162794329|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
162794330|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794331|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794332|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794333|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794334|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794335|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794336|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794337|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162794338|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
162794339|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
162794340|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
162794341|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
162794342|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794343|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794344|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794345|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794346|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794347|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794348|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794349|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162794350|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
162794351|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
162794352|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
162794353|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
162794354|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794355|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794356|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794357|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794358|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794359|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794360|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794361|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162794362|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
162794363|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
162794364|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
162794365|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
162794366|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794367|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794368|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794369|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794370|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794371|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794372|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794373|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162794374|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794375|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794376|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
162794377|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
162794378|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794379|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794380|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794381|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794382|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794383|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794384|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794385|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162794386|NCT01646177|587957936|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
162794387|NCT01646177|587957937|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
162794388|NCT01646177|587957938|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
162794389|NCT01646177|587957939|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794390|NCT01646177|587957940|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794391|NCT01646177|587957941|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794392|NCT01646177|587957942|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794393|NCT01646177|587957943|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794394|NCT01646177|587957944|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794395|NCT01646177|587957945|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794396|NCT01646177|587957946|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794397|NCT01646177|587957947|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162794398|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794399|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794400|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794401|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794402|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
162794403|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
162794404|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
162794405|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
162794406|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794407|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794408|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794409|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162794410|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794411|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794412|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794413|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794414|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
162794415|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
162794416|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
162794417|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
162794418|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794419|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794420|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794421|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162794422|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794423|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794424|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794425|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794426|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
162794427|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
162794428|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
162794429|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
162794430|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794431|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794432|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794433|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162794434|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794435|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794436|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794437|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794438|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
162794439|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
162794440|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
162794441|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
162794442|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794443|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794444|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794445|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162794446|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794447|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794448|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794449|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794450|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
162794451|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162794452|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162794453|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162794454|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794455|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794456|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794457|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162794458|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794459|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794460|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794461|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794462|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
162794463|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
162794464|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794465|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
162794466|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794467|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794468|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794469|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162794470|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794471|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794472|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794473|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794474|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
162794475|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
162794476|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
162794477|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
162794478|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794479|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794480|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794481|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162794482|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
162794483|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
162794484|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
162794485|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
162794486|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
162794487|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
162794488|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
162794489|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
162794490|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
162794491|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
162794492|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
162794493|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
162794494|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794495|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794496|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794497|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794498|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162794499|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162794500|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162794501|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
162794502|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794503|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794504|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794505|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162794506|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794507|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794508|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794509|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794510|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794511|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794512|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794513|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
162794514|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794515|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794516|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794517|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162794518|NCT01646177|587957936|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794519|NCT01646177|587957937|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794520|NCT01646177|587957938|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794521|NCT01646177|587957939|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794522|NCT01646177|587957940|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794523|NCT01646177|587957941|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
162794524|NCT01646177|587957942|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
162794525|NCT01646177|587957943|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
162794526|NCT01646177|587957944|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794527|NCT01646177|587957945|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794528|NCT01646177|587957946|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794529|NCT01646177|587957947|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162794530|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794531|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794532|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794533|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794534|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794535|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794536|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794537|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162794538|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
162794539|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
162794540|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
162794541|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
162794542|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794543|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794544|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794545|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794546|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794547|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794548|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794549|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162794550|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
162794551|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
162794552|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
162794553|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
162794554|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794555|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794556|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794557|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794558|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794559|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794560|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794561|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162794562|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
162794563|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
162794564|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
162794565|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
162794566|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794567|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794568|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794569|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794570|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794571|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794572|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794573|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162794574|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
162794575|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
162794576|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
162794577|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
162794578|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794579|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794580|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794581|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794582|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794583|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794584|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794585|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162794586|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
162794587|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
162794588|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
162794589|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
162794590|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794591|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794592|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794593|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794594|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794595|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794596|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794597|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162794598|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
162794599|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
162794600|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
162794601|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
162794602|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794603|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794604|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794605|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794606|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794607|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794608|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794609|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794610|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162794611|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
162794612|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
162794613|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
162794614|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794615|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794616|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794617|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794618|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794619|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794620|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794621|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794622|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162794623|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162794624|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162794625|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162794626|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794627|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794628|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794629|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794630|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794631|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794632|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794633|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794634|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162794635|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162794636|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162794637|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162794638|NCT01646177|587957936|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794639|NCT01646177|587957937|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794640|NCT01646177|587957938|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794641|NCT01646177|587957939|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794642|NCT01646177|587957940|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794643|NCT01646177|587957941|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794644|NCT01646177|587957942|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794645|NCT01646177|587957943|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794646|NCT01646177|587957944|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794647|NCT01646177|587957945|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162794648|NCT01646177|587957946|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
162794649|NCT01646177|587957947|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
162794650|NCT01038427|587957950|FG000|Overall Study|Lost to follow up|1|||
162794651|NCT01038427|587957951|FG001|Overall Study|Lost to follow up|1|||
162794652|NCT01038427|587957952|FG002|Overall Study|Lost to follow up|0|||
162794653|NCT01038427|587957950|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162794654|NCT01038427|587957951|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162794655|NCT01038427|587957952|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
162794656|NCT01038427|587957950|FG000|Overall Study|Withdrew consent|0|||
162794657|NCT01038427|587957951|FG001|Overall Study|Withdrew consent|0|||
162794658|NCT01038427|587957952|FG002|Overall Study|Withdrew consent|1|||
162794659|NCT01038427|587957950|FG000|Overall Study|Adverse Event|2|||
162794660|NCT01038427|587957951|FG001|Overall Study|Adverse Event|2|||
162794661|NCT01038427|587957952|FG002|Overall Study|Adverse Event|1|||
162794662|NCT01038427|587957950|FG000|Overall Study|Enrolled in error|0|||
162794663|NCT01038427|587957951|FG001|Overall Study|Enrolled in error|1|||
162794664|NCT01038427|587957952|FG002|Overall Study|Enrolled in error|1|||
162794665|NCT01038427|587957950|FG000|Overall Study|Other|0|||
162794666|NCT01038427|587957951|FG001|Overall Study|Other|2|||
162794667|NCT01038427|587957952|FG002|Overall Study|Other|0|||
162794668|NCT02992691|587957953|FG000|Overall Study|Adverse Event|2|||
162794669|NCT02992691|587957953|FG000|Overall Study|Withdrawal by Subject|1|||
162794670|NCT00588692|587957954|FG000|Overall Study|Withdrawal by Subject|4|||
162794671|NCT00588692|587957955|FG001|Overall Study|Withdrawal by Subject|2|||
162794672|NCT00588692|587957954|FG000|Overall Study|Hip Surgery|0|||
162794673|NCT00588692|587957955|FG001|Overall Study|Hip Surgery|1|||
162794674|NCT00588692|587957954|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
162794675|NCT00588692|587957955|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
162794676|NCT00588692|587957954|FG000|Overall Study|Cancer|1|||
162794677|NCT00588692|587957955|FG001|Overall Study|Cancer|0|||
162794678|NCT00588692|587957954|FG000|Overall Study|Death|1|||
162794679|NCT00588692|587957955|FG001|Overall Study|Death|0|||
162794680|NCT00820170|587957957|FG000|Overall Study|Adverse Event|0|||
162794681|NCT00820170|587957958|FG001|Overall Study|Adverse Event|0|||
162794682|NCT00820170|587957959|FG002|Overall Study|Adverse Event|0|||
162794683|NCT00820170|587957960|FG003|Overall Study|Adverse Event|0|||
162794684|NCT00820170|587957961|FG004|Overall Study|Adverse Event|2|||
162794685|NCT00820170|587957957|FG000|Overall Study|Progressive Disease|0|||
162794686|NCT00820170|587957958|FG001|Overall Study|Progressive Disease|0|||
162794687|NCT00820170|587957959|FG002|Overall Study|Progressive Disease|0|||
162794688|NCT00820170|587957960|FG003|Overall Study|Progressive Disease|0|||
162794689|NCT00820170|587957961|FG004|Overall Study|Progressive Disease|2|||
162794690|NCT03538938|587957962|FG000|Overall Study|Death|0|||
162794691|NCT03538938|587957963|FG001|Overall Study|Death|0|||
162794692|NCT03538938|587957964|FG002|Overall Study|Death|2|||
162794693|NCT03538938|587957965|FG003|Overall Study|Death|0|||
162794694|NCT03538938|587957966|FG004|Overall Study|Death|0|||
162794695|NCT03538938|587957967|FG005|Overall Study|Death|1|||
162794696|NCT03538938|587957968|FG006|Overall Study|Death|0|||
162794697|NCT03538938|587957969|FG007|Overall Study|Death|1|||
162794698|NCT03538938|587957970|FG008|Overall Study|Death|1|||
162794699|NCT03538938|587957971|FG009|Overall Study|Death|1|||
162794700|NCT03538938|587957972|FG010|Overall Study|Death|0|||
162794701|NCT03538938|587957973|FG011|Overall Study|Death|0|||
162794702|NCT03538938|587957974|FG012|Overall Study|Death|1|||
162794703|NCT03538938|587957975|FG013|Overall Study|Death|1|||
162794704|NCT03538938|587957976|FG014|Overall Study|Death|0|||
162794705|NCT03538938|587957977|FG015|Overall Study|Death|1|||
162794706|NCT03538938|587957962|FG000|Overall Study|Withdrawal by Subject|4|||
162794707|NCT03538938|587957963|FG001|Overall Study|Withdrawal by Subject|6|||
162794708|NCT03538938|587957964|FG002|Overall Study|Withdrawal by Subject|5|||
162794709|NCT03538938|587957965|FG003|Overall Study|Withdrawal by Subject|3|||
162794710|NCT03538938|587957966|FG004|Overall Study|Withdrawal by Subject|0|||
162794711|NCT03538938|587957967|FG005|Overall Study|Withdrawal by Subject|0|||
162794712|NCT03538938|587957968|FG006|Overall Study|Withdrawal by Subject|3|||
162794713|NCT03538938|587957969|FG007|Overall Study|Withdrawal by Subject|1|||
162794714|NCT03538938|587957970|FG008|Overall Study|Withdrawal by Subject|5|||
162794715|NCT03538938|587957971|FG009|Overall Study|Withdrawal by Subject|1|||
162794716|NCT03538938|587957972|FG010|Overall Study|Withdrawal by Subject|2|||
162794717|NCT03538938|587957973|FG011|Overall Study|Withdrawal by Subject|1|||
162794718|NCT03538938|587957974|FG012|Overall Study|Withdrawal by Subject|3|||
162794719|NCT03538938|587957975|FG013|Overall Study|Withdrawal by Subject|0|||
162794720|NCT03538938|587957976|FG014|Overall Study|Withdrawal by Subject|2|||
162794721|NCT03538938|587957977|FG015|Overall Study|Withdrawal by Subject|4|||
162794722|NCT03538938|587957962|FG000|Overall Study|Incarcerated|0|||
162794723|NCT03538938|587957963|FG001|Overall Study|Incarcerated|0|||
162794724|NCT03538938|587957964|FG002|Overall Study|Incarcerated|0|||
162794725|NCT03538938|587957965|FG003|Overall Study|Incarcerated|0|||
162794726|NCT03538938|587957966|FG004|Overall Study|Incarcerated|0|||
162794727|NCT03538938|587957967|FG005|Overall Study|Incarcerated|0|||
162794728|NCT03538938|587957968|FG006|Overall Study|Incarcerated|0|||
162794729|NCT03538938|587957969|FG007|Overall Study|Incarcerated|0|||
162794730|NCT03538938|587957970|FG008|Overall Study|Incarcerated|0|||
162794731|NCT03538938|587957971|FG009|Overall Study|Incarcerated|0|||
162794732|NCT03538938|587957972|FG010|Overall Study|Incarcerated|0|||
162794733|NCT03538938|587957973|FG011|Overall Study|Incarcerated|1|||
162794734|NCT03538938|587957974|FG012|Overall Study|Incarcerated|0|||
162794735|NCT03538938|587957975|FG013|Overall Study|Incarcerated|0|||
162794736|NCT03538938|587957976|FG014|Overall Study|Incarcerated|0|||
162794737|NCT03538938|587957977|FG015|Overall Study|Incarcerated|0|||
162794738|NCT00755105|587957978|FG000|Overall Study|Withdrawal by Subject|9|||
162794739|NCT00755105|587957979|FG001|Overall Study|Withdrawal by Subject|11|||
162794740|NCT00755105|587957980|FG002|Overall Study|Withdrawal by Subject|4|||
162794741|NCT03995316|587957981|FG000|Overall Study|Lost to Follow-up|10|||
162794742|NCT03995316|587957982|FG001|Overall Study|Lost to Follow-up|3|||
162794743|NCT02202785|587957983|FG000|Overall Study|Study Terminated by Sponsor|1|||
162794744|NCT02202785|587957984|FG001|Overall Study|Study Terminated by Sponsor|6|||
162794745|NCT02202785|587957985|FG002|Overall Study|Study Terminated by Sponsor|4|||
162794746|NCT02202785|587957983|FG000|Overall Study|Withdrawal by Subject|0|||
162794747|NCT02202785|587957984|FG001|Overall Study|Withdrawal by Subject|1|||
162794748|NCT02202785|587957985|FG002|Overall Study|Withdrawal by Subject|0|||
162794749|NCT02202785|587957983|FG000|Overall Study|Lost to Follow-up|0|||
162794750|NCT02202785|587957984|FG001|Overall Study|Lost to Follow-up|1|||
162794751|NCT02202785|587957985|FG002|Overall Study|Lost to Follow-up|0|||
162794752|NCT02202785|587957983|FG000|Overall Study|Reason not Specified|10|||
162794753|NCT02202785|587957984|FG001|Overall Study|Reason not Specified|7|||
162794754|NCT02202785|587957985|FG002|Overall Study|Reason not Specified|13|||
162794755|NCT02180243|587957986|FG000|Overall Study|Withdrawal by Subject|12|||
162794756|NCT02180243|587957987|FG001|Overall Study|Withdrawal by Subject|12|||
162794757|NCT02180243|587957986|FG000|Overall Study|Lost to Follow-up|12|||
162794758|NCT02180243|587957987|FG001|Overall Study|Lost to Follow-up|2|||
162794759|NCT01137578|587957988|FG000|Overall Study|Participant requested to Discontinue|3|||
162794760|NCT01137578|587957989|FG001|Overall Study|Participant requested to Discontinue|0|||
162794761|NCT01137578|587957990|FG002|Overall Study|Participant requested to Discontinue|0|||
162794762|NCT01137578|587957988|FG000|Overall Study|Withdrawal by Subject|1|||
162794763|NCT01137578|587957989|FG001|Overall Study|Withdrawal by Subject|0|||
162794764|NCT01137578|587957990|FG002|Overall Study|Withdrawal by Subject|0|||
162794765|NCT01137578|587957988|FG000|Overall Study|Other|12|||
162794766|NCT01137578|587957989|FG001|Overall Study|Other|2|||
162794767|NCT01137578|587957990|FG002|Overall Study|Other|6|||
162794768|NCT03651700|587957993|FG000|Overall Study|Withdrawal by Subject|1|||
162794769|NCT03651700|587957994|FG001|Overall Study|Withdrawal by Subject|0|||
162794770|NCT05479734|587957996|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
162794771|NCT05479734|587957997|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162794772|NCT05479734|587957996|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162794773|NCT05479734|587957997|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
162794774|NCT05479734|587957996|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162794775|NCT05479734|587957997|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
162794776|NCT05479734|587957996|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
162794777|NCT05479734|587957997|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
162794778|NCT01461005|587957998|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
162794779|NCT01426347|587958002|FG000|Overall Study|Lost to Follow-up|0|||
162794780|NCT01426347|587958003|FG001|Overall Study|Lost to Follow-up|3|||
162794781|NCT01426347|587958002|FG000|Overall Study|Protocol Violation|2|||
162794782|NCT01426347|587958003|FG001|Overall Study|Protocol Violation|0|||
162794783|NCT01426347|587958002|FG000|Overall Study|Withdrawal by Subject|5|||
162794784|NCT01426347|587958003|FG001|Overall Study|Withdrawal by Subject|0|||
162794785|NCT00455741|587958004|FG000|Overall Study|Physician Decision|0|||
162794786|NCT00455741|587958005|FG001|Overall Study|Physician Decision|1|||
162794787|NCT00203268|587958006|FG000|Early Treatment|only treated one headache|2|||
162794788|NCT00203268|587958006|FG000|Early Treatment|Lost to Follow-up|1|||
162794789|NCT00203268|587958006|FG000|Early Treatment|Withdrawal by Subject|1|||
162794790|NCT00600613|587958007|FG000|Overall Study|Protocol Deviation|1|||
162794791|NCT00664534|587958008|FG000|Overall Study|Adverse Event|2|||
162794792|NCT00664534|587958009|FG001|Overall Study|Adverse Event|3|||
162794793|NCT00664534|587958008|FG000|Overall Study|Lost to Follow-up|6|||
162794794|NCT00664534|587958009|FG001|Overall Study|Lost to Follow-up|10|||
162794795|NCT00664534|587958008|FG000|Overall Study|Protocol Violation|10|||
162794796|NCT00664534|587958009|FG001|Overall Study|Protocol Violation|8|||
162794797|NCT00664534|587958008|FG000|Overall Study|Withdrawal by Subject|7|||
162794798|NCT00664534|587958009|FG001|Overall Study|Withdrawal by Subject|6|||
162794799|NCT00664534|587958008|FG000|Overall Study|Physician Decision|8|||
162794800|NCT00664534|587958009|FG001|Overall Study|Physician Decision|0|||
162794801|NCT00664534|587958008|FG000|Overall Study|Sponsor decision|8|||
162794802|NCT00664534|587958009|FG001|Overall Study|Sponsor decision|6|||
162794803|NCT03041792|587958012|FG000|Overall Study|Adverse Event|4|||
162794804|NCT03041792|587958013|FG001|Overall Study|Adverse Event|0|||
162794805|NCT03041792|587958012|FG000|Overall Study|Death in the family|0|||
162794806|NCT03041792|587958013|FG001|Overall Study|Death in the family|2|||
162794807|NCT03041792|587958012|FG000|Overall Study|Randomized but not treated|0|||
162794808|NCT03041792|587958013|FG001|Overall Study|Randomized but not treated|1|||
162794809|NCT00935532|587958016|FG000|Overall Study|Adverse Event|11|||
162794810|NCT00935532|587958017|FG001|Overall Study|Adverse Event|6|||
162794811|NCT00935532|587958016|FG000|Overall Study|Death|1|||
162794812|NCT00935532|587958017|FG001|Overall Study|Death|0|||
162794813|NCT00935532|587958016|FG000|Overall Study|Lost to Follow-up|1|||
162794814|NCT00935532|587958017|FG001|Overall Study|Lost to Follow-up|0|||
162794815|NCT00935532|587958016|FG000|Overall Study|Physician Decision|1|||
162794816|NCT00935532|587958017|FG001|Overall Study|Physician Decision|2|||
162794817|NCT00935532|587958016|FG000|Overall Study|Protocol Violation|2|||
162794818|NCT00935532|587958017|FG001|Overall Study|Protocol Violation|1|||
162794819|NCT00935532|587958016|FG000|Overall Study|Subject Decision|2|||
162794820|NCT00935532|587958017|FG001|Overall Study|Subject Decision|1|||
162794821|NCT00935532|587958016|FG000|Overall Study|Sponsor Decision|0|||
162794822|NCT00935532|587958017|FG001|Overall Study|Sponsor Decision|1|||
162794823|NCT00935532|587958016|FG000|Overall Study|Loss Glucose Control|4|||
162794824|NCT00935532|587958017|FG001|Overall Study|Loss Glucose Control|0|||
162794825|NCT01399918|587958019|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
162794826|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
162794827|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
162794828|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
162794829|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
162794830|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
162794831|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
162794832|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
162794833|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
162794834|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
162794835|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
162794836|NCT00245960|587958020|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
162794837|NCT00245960|587958021|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
162794838|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
162794839|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
162794840|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
162794841|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
162794842|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
162794843|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
162794844|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
162794845|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
162794846|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
162794847|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
162794848|NCT00245960|587958020|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
162794849|NCT00245960|587958021|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
162794850|NCT01436253|587958023|FG000|Overall Study|Lost to Follow-up|182|||
162794851|NCT01436253|587958023|FG000|Overall Study|Not meeting all eligibility criteria|117|||
162794852|NCT03083665|587958025|FG000|Double-Blind Period|Adverse Event|5|||
162794853|NCT03083665|587958026|FG001|Double-Blind Period|Adverse Event|4|||
162794854|NCT03083665|587958027|FG002|Double-Blind Period|Adverse Event|5|||
162794855|NCT03083665|587958028|FG003|Double-Blind Period|Adverse Event|0|||
162794856|NCT03083665|587958029|FG004|Double-Blind Period|Adverse Event|0|||
162794857|NCT03083665|587958030|FG005|Double-Blind Period|Adverse Event|0|||
162794858|NCT03083665|587958025|FG000|Double-Blind Period|Lack of Efficacy|0|||
162794859|NCT03083665|587958026|FG001|Double-Blind Period|Lack of Efficacy|0|||
162794860|NCT03083665|587958027|FG002|Double-Blind Period|Lack of Efficacy|1|||
162794861|NCT03083665|587958028|FG003|Double-Blind Period|Lack of Efficacy|0|||
162794862|NCT03083665|587958029|FG004|Double-Blind Period|Lack of Efficacy|0|||
162794863|NCT03083665|587958030|FG005|Double-Blind Period|Lack of Efficacy|0|||
162794864|NCT03083665|587958025|FG000|Double-Blind Period|Protocol Violation|1|||
162794865|NCT03083665|587958026|FG001|Double-Blind Period|Protocol Violation|0|||
162794866|NCT03083665|587958027|FG002|Double-Blind Period|Protocol Violation|1|||
162794867|NCT03083665|587958028|FG003|Double-Blind Period|Protocol Violation|0|||
162794868|NCT03083665|587958029|FG004|Double-Blind Period|Protocol Violation|0|||
162794869|NCT03083665|587958030|FG005|Double-Blind Period|Protocol Violation|0|||
162794870|NCT03083665|587958025|FG000|Double-Blind Period|Lost to Follow-up|1|||
162794871|NCT03083665|587958026|FG001|Double-Blind Period|Lost to Follow-up|0|||
162794872|NCT03083665|587958027|FG002|Double-Blind Period|Lost to Follow-up|1|||
162794873|NCT03083665|587958028|FG003|Double-Blind Period|Lost to Follow-up|0|||
162794874|NCT03083665|587958029|FG004|Double-Blind Period|Lost to Follow-up|0|||
162794875|NCT03083665|587958030|FG005|Double-Blind Period|Lost to Follow-up|0|||
162794876|NCT03083665|587958025|FG000|Double-Blind Period|Withdrawal by Subject|3|||
162794877|NCT03083665|587958026|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162794878|NCT03083665|587958027|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162794879|NCT03083665|587958028|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162794880|NCT03083665|587958029|FG004|Double-Blind Period|Withdrawal by Subject|0|||
162794881|NCT03083665|587958030|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162794882|NCT03083665|587958025|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
162794883|NCT03083665|587958026|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162794884|NCT03083665|587958027|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162794885|NCT03083665|587958028|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162794886|NCT03083665|587958029|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162794887|NCT03083665|587958030|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162794888|NCT03083665|587958025|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
162794889|NCT03083665|587958026|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
162794890|NCT03083665|587958027|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
162794891|NCT03083665|587958028|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
162794892|NCT03083665|587958029|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
162794893|NCT03083665|587958030|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
162794894|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162794895|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162794896|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162794897|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
162794898|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162794899|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162794900|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162794901|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162794902|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162794903|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162794904|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162794905|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
162794906|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162794907|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162794908|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162794909|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162794910|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162794911|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162794912|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162794913|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162794914|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162794915|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162794916|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162794917|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
162794918|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162794919|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162794920|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162794921|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
162794922|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162794923|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162794924|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162794925|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162794926|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162794927|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162794928|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162794929|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
162794930|NCT03083665|587958025|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162794931|NCT03083665|587958026|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162794932|NCT03083665|587958027|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162794933|NCT03083665|587958028|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162794934|NCT03083665|587958029|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162794935|NCT03083665|587958030|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
162794936|NCT02519348|587958031|FG000|Overall Study|Death|31|||
162794937|NCT02519348|587958032|FG001|Overall Study|Death|74|||
162794938|NCT02519348|587958033|FG002|Overall Study|Death|47|||
162794939|NCT02519348|587958034|FG003|Overall Study|Death|54|||
162794940|NCT02519348|587958035|FG004|Overall Study|Death|63|||
162794941|NCT02519348|587958036|FG005|Overall Study|Death|18|||
162794942|NCT02519348|587958037|FG006|Overall Study|Death|2|||
162794943|NCT02519348|587958038|FG007|Overall Study|Death|5|||
162794944|NCT02519348|587958039|FG008|Overall Study|Death|5|||
162794945|NCT02519348|587958031|FG000|Overall Study|Withdrawal by Subject|4|||
162794946|NCT02519348|587958032|FG001|Overall Study|Withdrawal by Subject|7|||
162794947|NCT02519348|587958033|FG002|Overall Study|Withdrawal by Subject|4|||
162794948|NCT02519348|587958034|FG003|Overall Study|Withdrawal by Subject|3|||
162794949|NCT02519348|587958035|FG004|Overall Study|Withdrawal by Subject|3|||
162794950|NCT02519348|587958036|FG005|Overall Study|Withdrawal by Subject|2|||
162794951|NCT02519348|587958037|FG006|Overall Study|Withdrawal by Subject|0|||
162794952|NCT02519348|587958038|FG007|Overall Study|Withdrawal by Subject|0|||
162794953|NCT02519348|587958039|FG008|Overall Study|Withdrawal by Subject|1|||
162794954|NCT02519348|587958031|FG000|Overall Study|Lost to Follow-up|0|||
162794955|NCT02519348|587958032|FG001|Overall Study|Lost to Follow-up|0|||
162794956|NCT02519348|587958033|FG002|Overall Study|Lost to Follow-up|1|||
162794957|NCT02519348|587958034|FG003|Overall Study|Lost to Follow-up|0|||
162794958|NCT02519348|587958035|FG004|Overall Study|Lost to Follow-up|2|||
162794959|NCT02519348|587958036|FG005|Overall Study|Lost to Follow-up|1|||
162794960|NCT02519348|587958037|FG006|Overall Study|Lost to Follow-up|1|||
162794961|NCT02519348|587958038|FG007|Overall Study|Lost to Follow-up|0|||
162794962|NCT02519348|587958039|FG008|Overall Study|Lost to Follow-up|0|||
162794963|NCT02519348|587958031|FG000|Overall Study|Other|0|||
162794964|NCT02519348|587958032|FG001|Overall Study|Other|3|||
162794965|NCT02519348|587958033|FG002|Overall Study|Other|0|||
162794966|NCT02519348|587958034|FG003|Overall Study|Other|0|||
162794967|NCT02519348|587958035|FG004|Overall Study|Other|1|||
162794968|NCT02519348|587958036|FG005|Overall Study|Other|0|||
162794969|NCT02519348|587958037|FG006|Overall Study|Other|0|||
162794970|NCT02519348|587958038|FG007|Overall Study|Other|0|||
162794971|NCT02519348|587958039|FG008|Overall Study|Other|0|||
162794972|NCT02519348|587958031|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
162794973|NCT02519348|587958032|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
162794974|NCT02519348|587958033|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
162794975|NCT02519348|587958034|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
162794976|NCT02519348|587958035|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
162794977|NCT02519348|587958036|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
162794978|NCT02519348|587958037|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
162794979|NCT02519348|587958038|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
162794980|NCT02519348|587958039|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
162794981|NCT04844879|587958040|FG000|Overall Study|Death|1|||
162794982|NCT04844879|587958040|FG000|Overall Study|Withdrawal by Subject|1|||
162794983|NCT04844879|587958040|FG000|Overall Study|Adverse Event|1|||
162794984|NCT04103892|587958046|FG000|Overall Study|Adverse Event|0|||
162794985|NCT04103892|587958047|FG001|Overall Study|Adverse Event|0|||
162794986|NCT04103892|587958048|FG002|Overall Study|Adverse Event|0|||
162794987|NCT04103892|587958049|FG003|Overall Study|Adverse Event|3|||
162794988|NCT04103892|587958046|FG000|Overall Study|Lost to Follow-up|0|||
162794989|NCT04103892|587958047|FG001|Overall Study|Lost to Follow-up|0|||
162794990|NCT04103892|587958048|FG002|Overall Study|Lost to Follow-up|2|||
162794991|NCT04103892|587958049|FG003|Overall Study|Lost to Follow-up|0|||
162794992|NCT04103892|587958046|FG000|Overall Study|Protocol Violation|0|||
162794993|NCT04103892|587958047|FG001|Overall Study|Protocol Violation|0|||
162794994|NCT04103892|587958048|FG002|Overall Study|Protocol Violation|1|||
162794995|NCT04103892|587958049|FG003|Overall Study|Protocol Violation|1|||
162794996|NCT04103892|587958046|FG000|Overall Study|Withdrawal by Subject|1|||
162794997|NCT04103892|587958047|FG001|Overall Study|Withdrawal by Subject|0|||
162794998|NCT04103892|587958048|FG002|Overall Study|Withdrawal by Subject|2|||
162794999|NCT04103892|587958049|FG003|Overall Study|Withdrawal by Subject|5|||
162795000|NCT04103892|587958046|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
162795001|NCT04103892|587958047|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
162795002|NCT04103892|587958048|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
162795003|NCT04103892|587958049|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
162795004|NCT05576662|587958050|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
162795005|NCT05576662|587958051|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
162795006|NCT05576662|587958050|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
162795007|NCT05576662|587958051|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
162795008|NCT05576662|587958050|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
162795009|NCT05576662|587958051|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
162795010|NCT05576662|587958050|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
162795011|NCT05576662|587958051|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
162795012|NCT00281320|587958052|FG000|Overall Study|Adverse Event|12|||
162795013|NCT00281320|587958053|FG001|Overall Study|Adverse Event|9|||
162795014|NCT00281320|587958052|FG000|Overall Study|Lack of Efficacy|4|||
162795015|NCT00281320|587958053|FG001|Overall Study|Lack of Efficacy|3|||
162795016|NCT00281320|587958052|FG000|Overall Study|Withdrawal by Subject|5|||
162795017|NCT00281320|587958053|FG001|Overall Study|Withdrawal by Subject|6|||
162795018|NCT00281320|587958052|FG000|Overall Study|Lost to Follow-up|1|||
162795019|NCT00281320|587958053|FG001|Overall Study|Lost to Follow-up|2|||
162795020|NCT00281320|587958052|FG000|Overall Study|Other|3|||
162795021|NCT00281320|587958053|FG001|Overall Study|Other|1|||
162795022|NCT03008005|587958056|FG000|Overall Study|Physician Decision|1|||
162795023|NCT03008005|587958057|FG001|Overall Study|Physician Decision|0|||
162795024|NCT03008005|587958058|FG002|Overall Study|Physician Decision|0|||
162795025|NCT03008005|587958056|FG000|Overall Study|Withdrawal by Subject|1|||
162795026|NCT03008005|587958057|FG001|Overall Study|Withdrawal by Subject|0|||
162795027|NCT03008005|587958058|FG002|Overall Study|Withdrawal by Subject|0|||
162795028|NCT03008005|587958056|FG000|Overall Study|Ineligible|0|||
162795029|NCT03008005|587958057|FG001|Overall Study|Ineligible|1|||
162795030|NCT03008005|587958058|FG002|Overall Study|Ineligible|0|||
162795031|NCT00475228|587958060|FG000|Overall Study|Lost to Follow-up|17|||
162795032|NCT00475228|587958061|FG001|Overall Study|Lost to Follow-up|17|||
162795033|NCT03633799|587958070|FG000|Overall Study|Adverse Event|349|||
162795034|NCT03633799|587958070|FG000|Overall Study|Withdrawal by Subject|288|||
162795035|NCT03633799|587958070|FG000|Overall Study|Lost to Follow-up|97|||
162795036|NCT03633799|587958070|FG000|Overall Study|Physician Decision|9|||
162795037|NCT03633799|587958070|FG000|Overall Study|Protocol Violation|4|||
162795038|NCT03633799|587958070|FG000|Overall Study|Pregnancy|20|||
162795039|NCT03633799|587958070|FG000|Overall Study|other|39|||
162795040|NCT03633799|587958070|FG000|Overall Study|ongoing within third year of study|106|||
162795041|NCT03633799|587958070|FG000|Overall Study|unsuccessful study drug placement|19|||
162795042|NCT03551691|587958073|FG000|Overall Study|Withdrawal by Subject|3|||
162795043|NCT03551691|587958074|FG001|Overall Study|Withdrawal by Subject|3|||
162795044|NCT01876082|587960445|FG000|Overall Study|Withdrawal by Subject|0|||
162795045|NCT01876082|587960446|FG001|Overall Study|Withdrawal by Subject|2|||
162795046|NCT01876082|587960445|FG000|Overall Study|Protocol Violation|1|||
162795047|NCT01876082|587960446|FG001|Overall Study|Protocol Violation|0|||
162795048|NCT01876082|587960445|FG000|Overall Study|Adverse Event|1|||
162795049|NCT01876082|587960446|FG001|Overall Study|Adverse Event|1|||
162795050|NCT01876082|587960445|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
162795051|NCT01876082|587960446|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
162795052|NCT03829501|587960455|FG000|Overall Study|Withdrawal of Consent|2|||
162795053|NCT03829501|587960456|FG001|Overall Study|Withdrawal of Consent|0|||
162795054|NCT03829501|587960457|FG002|Overall Study|Withdrawal of Consent|3|||
162795055|NCT03829501|587960458|FG003|Overall Study|Withdrawal of Consent|0|||
162795056|NCT03829501|587960459|FG004|Overall Study|Withdrawal of Consent|1|||
162795057|NCT03829501|587960460|FG005|Overall Study|Withdrawal of Consent|1|||
162795058|NCT03829501|587960461|FG006|Overall Study|Withdrawal of Consent|0|||
162795059|NCT03829501|587960462|FG007|Overall Study|Withdrawal of Consent|10|||
162795060|NCT03829501|587960463|FG008|Overall Study|Withdrawal of Consent|10|||
162795061|NCT03829501|587960464|FG009|Overall Study|Withdrawal of Consent|3|||
162795062|NCT03829501|587960465|FG010|Overall Study|Withdrawal of Consent|4|||
162795063|NCT03829501|587960466|FG011|Overall Study|Withdrawal of Consent|4|||
162795064|NCT03829501|587960467|FG012|Overall Study|Withdrawal of Consent|4|||
162795065|NCT03829501|587960468|FG013|Overall Study|Withdrawal of Consent|0|||
162795066|NCT03829501|587960469|FG014|Overall Study|Withdrawal of Consent|3|||
162795067|NCT03829501|587960470|FG015|Overall Study|Withdrawal of Consent|0|||
162795068|NCT03829501|587960471|FG016|Overall Study|Withdrawal of Consent|1|||
162795069|NCT03829501|587960472|FG017|Overall Study|Withdrawal of Consent|1|||
162795070|NCT03829501|587960473|FG018|Overall Study|Withdrawal of Consent|0|||
162795071|NCT03829501|587960474|FG019|Overall Study|Withdrawal of Consent|0|||
162795072|NCT03829501|587960475|FG020|Overall Study|Withdrawal of Consent|3|||
162795073|NCT03829501|587960476|FG021|Overall Study|Withdrawal of Consent|0|||
162795074|NCT03829501|587960477|FG022|Overall Study|Withdrawal of Consent|1|||
162795075|NCT03829501|587960455|FG000|Overall Study|PD|0|||
162795076|NCT03829501|587960456|FG001|Overall Study|PD|0|||
162795077|NCT03829501|587960457|FG002|Overall Study|PD|0|||
162795078|NCT03829501|587960458|FG003|Overall Study|PD|2|||
162795079|NCT03829501|587960459|FG004|Overall Study|PD|0|||
162795080|NCT03829501|587960460|FG005|Overall Study|PD|0|||
162795081|NCT03829501|587960461|FG006|Overall Study|PD|0|||
162795082|NCT03829501|587960462|FG007|Overall Study|PD|0|||
162795083|NCT03829501|587960463|FG008|Overall Study|PD|0|||
162795084|NCT03829501|587960464|FG009|Overall Study|PD|0|||
162795085|NCT03829501|587960465|FG010|Overall Study|PD|0|||
162795086|NCT03829501|587960466|FG011|Overall Study|PD|0|||
162795087|NCT03829501|587960467|FG012|Overall Study|PD|0|||
162795088|NCT03829501|587960468|FG013|Overall Study|PD|0|||
162795089|NCT03829501|587960469|FG014|Overall Study|PD|0|||
162795090|NCT03829501|587960470|FG015|Overall Study|PD|1|||
162795091|NCT03829501|587960471|FG016|Overall Study|PD|0|||
162795092|NCT03829501|587960472|FG017|Overall Study|PD|0|||
162795093|NCT03829501|587960473|FG018|Overall Study|PD|0|||
162795094|NCT03829501|587960474|FG019|Overall Study|PD|0|||
162795095|NCT03829501|587960475|FG020|Overall Study|PD|1|||
162795096|NCT03829501|587960476|FG021|Overall Study|PD|0|||
162795097|NCT03829501|587960477|FG022|Overall Study|PD|0|||
162795098|NCT03829501|587960455|FG000|Overall Study|Study Terminated by Sponsor|0|||
162795099|NCT03829501|587960456|FG001|Overall Study|Study Terminated by Sponsor|0|||
162795100|NCT03829501|587960457|FG002|Overall Study|Study Terminated by Sponsor|0|||
162795101|NCT03829501|587960458|FG003|Overall Study|Study Terminated by Sponsor|0|||
162795102|NCT03829501|587960459|FG004|Overall Study|Study Terminated by Sponsor|0|||
162795103|NCT03829501|587960460|FG005|Overall Study|Study Terminated by Sponsor|0|||
162795104|NCT03829501|587960461|FG006|Overall Study|Study Terminated by Sponsor|0|||
162795105|NCT03829501|587960462|FG007|Overall Study|Study Terminated by Sponsor|3|||
162795106|NCT03829501|587960463|FG008|Overall Study|Study Terminated by Sponsor|1|||
162795107|NCT03829501|587960464|FG009|Overall Study|Study Terminated by Sponsor|0|||
162795108|NCT03829501|587960465|FG010|Overall Study|Study Terminated by Sponsor|0|||
162795109|NCT03829501|587960466|FG011|Overall Study|Study Terminated by Sponsor|0|||
162795110|NCT03829501|587960467|FG012|Overall Study|Study Terminated by Sponsor|0|||
162795111|NCT03829501|587960468|FG013|Overall Study|Study Terminated by Sponsor|0|||
162795112|NCT03829501|587960469|FG014|Overall Study|Study Terminated by Sponsor|3|||
162795113|NCT03829501|587960470|FG015|Overall Study|Study Terminated by Sponsor|2|||
162795114|NCT03829501|587960471|FG016|Overall Study|Study Terminated by Sponsor|2|||
162795115|NCT03829501|587960472|FG017|Overall Study|Study Terminated by Sponsor|0|||
162795116|NCT03829501|587960473|FG018|Overall Study|Study Terminated by Sponsor|0|||
162795117|NCT03829501|587960474|FG019|Overall Study|Study Terminated by Sponsor|0|||
162795118|NCT03829501|587960475|FG020|Overall Study|Study Terminated by Sponsor|1|||
162795119|NCT03829501|587960476|FG021|Overall Study|Study Terminated by Sponsor|0|||
162795120|NCT03829501|587960477|FG022|Overall Study|Study Terminated by Sponsor|3|||
162795121|NCT03829501|587960455|FG000|Overall Study|Lost to Follow Up|0|||
162795122|NCT03829501|587960456|FG001|Overall Study|Lost to Follow Up|0|||
162795123|NCT03829501|587960457|FG002|Overall Study|Lost to Follow Up|0|||
162795124|NCT03829501|587960458|FG003|Overall Study|Lost to Follow Up|0|||
162795125|NCT03829501|587960459|FG004|Overall Study|Lost to Follow Up|1|||
162795126|NCT03829501|587960460|FG005|Overall Study|Lost to Follow Up|0|||
162795127|NCT03829501|587960461|FG006|Overall Study|Lost to Follow Up|0|||
162795128|NCT03829501|587960462|FG007|Overall Study|Lost to Follow Up|2|||
162795129|NCT03829501|587960463|FG008|Overall Study|Lost to Follow Up|2|||
162795130|NCT03829501|587960464|FG009|Overall Study|Lost to Follow Up|0|||
162795131|NCT03829501|587960465|FG010|Overall Study|Lost to Follow Up|2|||
162795132|NCT03829501|587960466|FG011|Overall Study|Lost to Follow Up|1|||
162795133|NCT03829501|587960467|FG012|Overall Study|Lost to Follow Up|0|||
162795134|NCT03829501|587960468|FG013|Overall Study|Lost to Follow Up|1|||
162795135|NCT03829501|587960469|FG014|Overall Study|Lost to Follow Up|1|||
162795136|NCT03829501|587960470|FG015|Overall Study|Lost to Follow Up|0|||
162795137|NCT03829501|587960471|FG016|Overall Study|Lost to Follow Up|0|||
162795138|NCT03829501|587960472|FG017|Overall Study|Lost to Follow Up|0|||
162795139|NCT03829501|587960473|FG018|Overall Study|Lost to Follow Up|0|||
162795140|NCT03829501|587960474|FG019|Overall Study|Lost to Follow Up|0|||
162795141|NCT03829501|587960475|FG020|Overall Study|Lost to Follow Up|0|||
162795142|NCT03829501|587960476|FG021|Overall Study|Lost to Follow Up|0|||
162795143|NCT03829501|587960477|FG022|Overall Study|Lost to Follow Up|1|||
162795144|NCT03829501|587960455|FG000|Overall Study|Death|2|||
162795145|NCT03829501|587960456|FG001|Overall Study|Death|4|||
162795146|NCT03829501|587960457|FG002|Overall Study|Death|5|||
162795147|NCT03829501|587960458|FG003|Overall Study|Death|6|||
162795148|NCT03829501|587960459|FG004|Overall Study|Death|5|||
162795149|NCT03829501|587960460|FG005|Overall Study|Death|4|||
162795150|NCT03829501|587960461|FG006|Overall Study|Death|5|||
162795151|NCT03829501|587960462|FG007|Overall Study|Death|24|||
162795152|NCT03829501|587960463|FG008|Overall Study|Death|22|||
162795153|NCT03829501|587960464|FG009|Overall Study|Death|6|||
162795154|NCT03829501|587960465|FG010|Overall Study|Death|3|||
162795155|NCT03829501|587960466|FG011|Overall Study|Death|10|||
162795156|NCT03829501|587960467|FG012|Overall Study|Death|10|||
162795157|NCT03829501|587960468|FG013|Overall Study|Death|5|||
162795158|NCT03829501|587960469|FG014|Overall Study|Death|7|||
162795159|NCT03829501|587960470|FG015|Overall Study|Death|2|||
162795160|NCT03829501|587960471|FG016|Overall Study|Death|2|||
162795161|NCT03829501|587960472|FG017|Overall Study|Death|1|||
162795162|NCT03829501|587960473|FG018|Overall Study|Death|1|||
162795163|NCT03829501|587960474|FG019|Overall Study|Death|1|||
162795164|NCT03829501|587960475|FG020|Overall Study|Death|1|||
162795165|NCT03829501|587960476|FG021|Overall Study|Death|2|||
162795166|NCT03829501|587960477|FG022|Overall Study|Death|3|||
162795167|NCT03829501|587960455|FG000|Overall Study|Miscellaneous|0|||
162795168|NCT03829501|587960456|FG001|Overall Study|Miscellaneous|0|||
162795169|NCT03829501|587960457|FG002|Overall Study|Miscellaneous|1|||
162795170|NCT03829501|587960458|FG003|Overall Study|Miscellaneous|0|||
162795171|NCT03829501|587960459|FG004|Overall Study|Miscellaneous|0|||
162795172|NCT03829501|587960460|FG005|Overall Study|Miscellaneous|0|||
162795173|NCT03829501|587960461|FG006|Overall Study|Miscellaneous|0|||
162795174|NCT03829501|587960462|FG007|Overall Study|Miscellaneous|1|||
162795175|NCT03829501|587960463|FG008|Overall Study|Miscellaneous|0|||
162795176|NCT03829501|587960464|FG009|Overall Study|Miscellaneous|0|||
162795177|NCT03829501|587960465|FG010|Overall Study|Miscellaneous|0|||
162795178|NCT03829501|587960466|FG011|Overall Study|Miscellaneous|0|||
162795179|NCT03829501|587960467|FG012|Overall Study|Miscellaneous|0|||
162795180|NCT03829501|587960468|FG013|Overall Study|Miscellaneous|0|||
162795181|NCT03829501|587960469|FG014|Overall Study|Miscellaneous|0|||
162795182|NCT03829501|587960470|FG015|Overall Study|Miscellaneous|0|||
162795183|NCT03829501|587960471|FG016|Overall Study|Miscellaneous|0|||
162795184|NCT03829501|587960472|FG017|Overall Study|Miscellaneous|0|||
162795185|NCT03829501|587960473|FG018|Overall Study|Miscellaneous|0|||
162795186|NCT03829501|587960474|FG019|Overall Study|Miscellaneous|0|||
162795187|NCT03829501|587960475|FG020|Overall Study|Miscellaneous|0|||
162795188|NCT03829501|587960476|FG021|Overall Study|Miscellaneous|0|||
162795189|NCT03829501|587960477|FG022|Overall Study|Miscellaneous|1|||
162795190|NCT04707664|587960483|FG000|Overall Study|Adverse Event|2|||
162795191|NCT04707664|587960484|FG001|Overall Study|Adverse Event|0|||
162795192|NCT04707664|587960483|FG000|Overall Study|Death|1|||
162795193|NCT04707664|587960484|FG001|Overall Study|Death|2|||
162795194|NCT04707664|587960483|FG000|Overall Study|Withdrawal by Subject|13|||
162795195|NCT04707664|587960484|FG001|Overall Study|Withdrawal by Subject|21|||
162795196|NCT04707664|587960483|FG000|Overall Study|Lost to Follow-up|11|||
162795197|NCT04707664|587960484|FG001|Overall Study|Lost to Follow-up|13|||
162795198|NCT04707664|587960483|FG000|Overall Study|Not treated|2|||
162795199|NCT04707664|587960484|FG001|Overall Study|Not treated|0|||
162795200|NCT00357110|587960485|FG000|Overall Study|Early study termination|5|||
162795201|NCT00357110|587960486|FG001|Overall Study|Early study termination|5|||
162795202|NCT00288639|587960487|FG000|Overall Study|Adverse Event|5|||
162795203|NCT00288639|587960487|FG000|Overall Study|Lack of Efficacy|4|||
162795204|NCT00288639|587960487|FG000|Overall Study|Withdrawal by Subject|2|||
162795205|NCT00288639|587960487|FG000|Overall Study|Other|1|||
162795206|NCT04335591|587960488|FG000|Overall Study|Adverse Event|5|||
162795207|NCT04335591|587960489|FG001|Overall Study|Adverse Event|2|||
162795208|NCT04335591|587960490|FG002|Overall Study|Adverse Event|3|||
162795209|NCT04335591|587960491|FG003|Overall Study|Adverse Event|2|||
162795210|NCT04335591|587960488|FG000|Overall Study|Protocol Violation|1|||
162795211|NCT04335591|587960489|FG001|Overall Study|Protocol Violation|0|||
162795212|NCT04335591|587960490|FG002|Overall Study|Protocol Violation|0|||
162795213|NCT04335591|587960491|FG003|Overall Study|Protocol Violation|0|||
162795214|NCT04335591|587960488|FG000|Overall Study|Withdrawal by Subject|8|||
162795215|NCT04335591|587960489|FG001|Overall Study|Withdrawal by Subject|4|||
162795216|NCT04335591|587960490|FG002|Overall Study|Withdrawal by Subject|4|||
162795217|NCT04335591|587960491|FG003|Overall Study|Withdrawal by Subject|5|||
162795218|NCT04335591|587960488|FG000|Overall Study|Subject planning pregnancy|0|||
162795219|NCT04335591|587960489|FG001|Overall Study|Subject planning pregnancy|1|||
162795220|NCT04335591|587960490|FG002|Overall Study|Subject planning pregnancy|0|||
162795221|NCT04335591|587960491|FG003|Overall Study|Subject planning pregnancy|0|||
162795222|NCT04335591|587960488|FG000|Overall Study|Ukrainian Russian war conflict|4|||
162795223|NCT04335591|587960489|FG001|Overall Study|Ukrainian Russian war conflict|5|||
162795224|NCT04335591|587960490|FG002|Overall Study|Ukrainian Russian war conflict|2|||
162795225|NCT04335591|587960491|FG003|Overall Study|Ukrainian Russian war conflict|0|||
162795226|NCT01077128|587960498|FG000|Overall Study|Adverse Event|8|||
162795227|NCT01077128|587960498|FG000|Overall Study|Lack of Efficacy|1|||
162795228|NCT01077128|587960498|FG000|Overall Study|Disease exacerbation|1|||
162795229|NCT01077128|587960498|FG000|Overall Study|Adverse event and consent withdrawal|1|||
162795230|NCT01077128|587960498|FG000|Overall Study|Adverse event and disease exacerbation|1|||
162795231|NCT01077128|587960498|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
162795232|NCT01077128|587960498|FG000|Overall Study|Other|54|||
162795233|NCT01939353|587960506|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
162795234|NCT01939353|587960506|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
162795235|NCT01939353|587960506|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
162795236|NCT01939353|587960506|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
162795237|NCT01939353|587960506|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
162795238|NCT04421950|587960510|FG000|Overall Study|Dropped or lost to follow up|4|||
162795239|NCT04421950|587960511|FG001|Overall Study|Dropped or lost to follow up|2|||
162795240|NCT04546425|587960512|FG000|Overall Study|Protocol Violation|1|||
162795241|NCT04546425|587960513|FG001|Overall Study|Protocol Violation|1|||
162795242|NCT04546425|587960514|FG002|Overall Study|Protocol Violation|0|||
162795243|NCT04546425|587960515|FG003|Overall Study|Protocol Violation|0|||
162795244|NCT04546425|587960512|FG000|Overall Study|Adverse Event|3|||
162795245|NCT04546425|587960513|FG001|Overall Study|Adverse Event|0|||
162795246|NCT04546425|587960514|FG002|Overall Study|Adverse Event|0|||
162795247|NCT04546425|587960515|FG003|Overall Study|Adverse Event|0|||
162795248|NCT04546425|587960512|FG000|Overall Study|Lost to Follow-up|5|||
162795249|NCT04546425|587960513|FG001|Overall Study|Lost to Follow-up|4|||
162795250|NCT04546425|587960514|FG002|Overall Study|Lost to Follow-up|0|||
162795251|NCT04546425|587960515|FG003|Overall Study|Lost to Follow-up|0|||
162795252|NCT04546425|587960512|FG000|Overall Study|No Longer met eligibility criteria|3|||
162795253|NCT04546425|587960513|FG001|Overall Study|No Longer met eligibility criteria|3|||
162795254|NCT04546425|587960514|FG002|Overall Study|No Longer met eligibility criteria|1|||
162795255|NCT04546425|587960515|FG003|Overall Study|No Longer met eligibility criteria|1|||
162795256|NCT04546425|587960512|FG000|Overall Study|Withdrawal by parent/guardian|6|||
162795257|NCT04546425|587960513|FG001|Overall Study|Withdrawal by parent/guardian|5|||
162795258|NCT04546425|587960514|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162795259|NCT04546425|587960515|FG003|Overall Study|Withdrawal by parent/guardian|1|||
162795260|NCT00967005|587960516|FG000|Overall Study|Lost to Follow-up|7|||
162795261|NCT00967005|587960517|FG001|Overall Study|Lost to Follow-up|10|||
162795262|NCT05071053|587960518|FG000|Overall Study|Progressive disease|30|||
162795263|NCT05071053|587960518|FG000|Overall Study|Adverse Event|5|||
162795264|NCT02593123|587960519|FG000|Overall Study|Physician Decision|2|||
162795265|NCT02593123|587960520|FG001|Overall Study|Physician Decision|1|||
162795266|NCT02593123|587960519|FG000|Overall Study|Relapse|1|||
162795267|NCT02593123|587960520|FG001|Overall Study|Relapse|1|||
162795268|NCT03945825|587960527|FG000|Overall Study|Enrolled but treatment not administered|0|||
162795269|NCT03945825|587960528|FG001|Overall Study|Enrolled but treatment not administered|0|||
162795270|NCT03945825|587960529|FG002|Overall Study|Enrolled but treatment not administered|0|||
162795271|NCT03945825|587960530|FG003|Overall Study|Enrolled but treatment not administered|0|||
162795272|NCT03945825|587960531|FG004|Overall Study|Enrolled but treatment not administered|1|||
162795273|NCT03945825|587960532|FG005|Overall Study|Enrolled but treatment not administered|0|||
162795274|NCT03945825|587960527|FG000|Overall Study|Lost to Follow-up|1|||
162795275|NCT03945825|587960528|FG001|Overall Study|Lost to Follow-up|5|||
162795276|NCT03945825|587960529|FG002|Overall Study|Lost to Follow-up|0|||
162795277|NCT03945825|587960530|FG003|Overall Study|Lost to Follow-up|1|||
162795278|NCT03945825|587960531|FG004|Overall Study|Lost to Follow-up|2|||
162795279|NCT03945825|587960532|FG005|Overall Study|Lost to Follow-up|2|||
162795280|NCT03945825|587960527|FG000|Overall Study|Withdrawal by Subject|1|||
162795281|NCT03945825|587960528|FG001|Overall Study|Withdrawal by Subject|0|||
162795282|NCT03945825|587960529|FG002|Overall Study|Withdrawal by Subject|1|||
162795283|NCT03945825|587960530|FG003|Overall Study|Withdrawal by Subject|1|||
162795284|NCT03945825|587960531|FG004|Overall Study|Withdrawal by Subject|0|||
162795285|NCT03945825|587960532|FG005|Overall Study|Withdrawal by Subject|1|||
162795286|NCT00846807|587960535|FG000|Overall Study|Adverse Event|270|||
162795287|NCT00846807|587960535|FG000|Overall Study|Lost to Follow-up|94|||
162795288|NCT00846807|587960535|FG000|Overall Study|Withdrawal by Subject|56|||
162795289|NCT00846807|587960535|FG000|Overall Study|Non compliant with European label|7|||
162795290|NCT00846807|587960535|FG000|Overall Study|Switch to other anticoagulants|89|||
162795291|NCT00846807|587960535|FG000|Overall Study|No prescription after hospital discharge|56|||
162795292|NCT00846807|587960535|FG000|Overall Study|Other|60|||
162795293|NCT00737698|587960536|FG000|Overall Study|Withdrawal by Subject|6|||
162795294|NCT00737698|587960537|FG001|Overall Study|Withdrawal by Subject|5|||
162795295|NCT00737698|587960538|FG002|Overall Study|Withdrawal by Subject|3|||
162795296|NCT00737698|587960536|FG000|Overall Study|Death|0|||
162795297|NCT00737698|587960537|FG001|Overall Study|Death|0|||
162795298|NCT00737698|587960538|FG002|Overall Study|Death|1|||
162795299|NCT01067846|587960539|FG000|Overall Study|Lost to Follow-up|17|||
162795300|NCT01067846|587960540|FG001|Overall Study|Lost to Follow-up|19|||
162795301|NCT01067846|587960539|FG000|Overall Study|Withdrawal by Subject|1|||
162795302|NCT01067846|587960540|FG001|Overall Study|Withdrawal by Subject|0|||
162795303|NCT01067846|587960539|FG000|Overall Study|participation in other tx study|1|||
162795304|NCT01067846|587960540|FG001|Overall Study|participation in other tx study|0|||
162795305|NCT02817906|587960541|FG000|Overall Study|Adverse Event|3|||
162795306|NCT02817906|587960542|FG001|Overall Study|Adverse Event|0|||
162795307|NCT02817906|587960541|FG000|Overall Study|Lack of Efficacy|1|||
162795308|NCT02817906|587960542|FG001|Overall Study|Lack of Efficacy|0|||
162795309|NCT02817906|587960541|FG000|Overall Study|Protocol Violation|1|||
162795310|NCT02817906|587960542|FG001|Overall Study|Protocol Violation|1|||
162795311|NCT02817906|587960541|FG000|Overall Study|Study Terminated by Sponsor|2|||
162795312|NCT02817906|587960542|FG001|Overall Study|Study Terminated by Sponsor|2|||
162795313|NCT02817906|587960541|FG000|Overall Study|Withdrawal by Subject|7|||
162795314|NCT02817906|587960542|FG001|Overall Study|Withdrawal by Subject|0|||
162795315|NCT02817906|587960541|FG000|Overall Study|Other|2|||
162795316|NCT02817906|587960542|FG001|Overall Study|Other|2|||
162795317|NCT03686423|587960551|FG000|Overall Study|Withdrawal by Subject|9|||
162795318|NCT03686423|587960551|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
162795319|NCT04954326|587960552|FG000|Overall Study|Protocol Violation|0|||
162795320|NCT04954326|587960553|FG001|Overall Study|Protocol Violation|1|||
162795321|NCT04954326|587960552|FG000|Overall Study|Death|0|||
162795322|NCT04954326|587960553|FG001|Overall Study|Death|2|||
162795323|NCT04954326|587960552|FG000|Overall Study|Physician Decision|0|||
162795324|NCT04954326|587960553|FG001|Overall Study|Physician Decision|1|||
162795325|NCT01495598|587960556|FG000|Overall Study|Death during follow up period|2|||
162795326|NCT01495598|587960556|FG000|Overall Study|Death on study|1|||
162795327|NCT01495598|587960556|FG000|Overall Study|Lost to Follow-up|3|||
162795328|NCT01495598|587960556|FG000|Overall Study|Physician Decision|8|||
162795329|NCT00669877|587960559|FG000|Overall Study|Disease Progression/Death|4|||
162795330|NCT01110408|587960560|FG000|Overall Study|Protocol Violation|1|||
162795331|NCT01110408|587960561|FG001|Overall Study|Protocol Violation|0|||
162795332|NCT03635099|587960562|FG000|Period 1|Adverse Event|1|||
162795333|NCT03635099|587960563|FG001|Period 1|Adverse Event|0|||
162795334|NCT03635099|587960564|FG002|Period 1|Adverse Event|0|||
162795335|NCT03635099|587960565|FG003|Period 1|Adverse Event|1|||
162795336|NCT03635099|587960566|FG004|Period 1|Adverse Event|0|||
162795337|NCT03635099|587960567|FG005|Period 1|Adverse Event|0|||
162795338|NCT03635099|587960568|FG006|Period 1|Adverse Event|0|||
162795339|NCT03635099|587960569|FG007|Period 1|Adverse Event|0|||
162795340|NCT03635099|587960562|FG000|Period 1|Protocol Violation|0|||
162795341|NCT03635099|587960563|FG001|Period 1|Protocol Violation|0|||
162795342|NCT03635099|587960564|FG002|Period 1|Protocol Violation|1|||
162795343|NCT03635099|587960565|FG003|Period 1|Protocol Violation|0|||
162795344|NCT03635099|587960566|FG004|Period 1|Protocol Violation|0|||
162795345|NCT03635099|587960567|FG005|Period 1|Protocol Violation|0|||
162795346|NCT03635099|587960568|FG006|Period 1|Protocol Violation|0|||
162795347|NCT03635099|587960569|FG007|Period 1|Protocol Violation|0|||
162795348|NCT03635099|587960562|FG000|Period 1|Lost to Follow-up|0|||
162795349|NCT03635099|587960563|FG001|Period 1|Lost to Follow-up|0|||
162795350|NCT03635099|587960564|FG002|Period 1|Lost to Follow-up|1|||
162795351|NCT03635099|587960565|FG003|Period 1|Lost to Follow-up|2|||
162795352|NCT03635099|587960566|FG004|Period 1|Lost to Follow-up|1|||
162795353|NCT03635099|587960567|FG005|Period 1|Lost to Follow-up|0|||
162795354|NCT03635099|587960568|FG006|Period 1|Lost to Follow-up|1|||
162795355|NCT03635099|587960569|FG007|Period 1|Lost to Follow-up|2|||
162795356|NCT03635099|587960562|FG000|Period 1|Withdrawal by Subject|3|||
162795357|NCT03635099|587960563|FG001|Period 1|Withdrawal by Subject|3|||
162795358|NCT03635099|587960564|FG002|Period 1|Withdrawal by Subject|5|||
162795359|NCT03635099|587960565|FG003|Period 1|Withdrawal by Subject|2|||
162795360|NCT03635099|587960566|FG004|Period 1|Withdrawal by Subject|2|||
162795361|NCT03635099|587960567|FG005|Period 1|Withdrawal by Subject|0|||
162795362|NCT03635099|587960568|FG006|Period 1|Withdrawal by Subject|3|||
162795363|NCT03635099|587960569|FG007|Period 1|Withdrawal by Subject|0|||
162795364|NCT03635099|587960562|FG000|Period 1|History of suicidal ideation|0|||
162795365|NCT03635099|587960563|FG001|Period 1|History of suicidal ideation|0|||
162795366|NCT03635099|587960564|FG002|Period 1|History of suicidal ideation|1|||
162795367|NCT03635099|587960565|FG003|Period 1|History of suicidal ideation|0|||
162795368|NCT03635099|587960566|FG004|Period 1|History of suicidal ideation|0|||
162795369|NCT03635099|587960567|FG005|Period 1|History of suicidal ideation|0|||
162795370|NCT03635099|587960568|FG006|Period 1|History of suicidal ideation|0|||
162795371|NCT03635099|587960569|FG007|Period 1|History of suicidal ideation|0|||
162795372|NCT03635099|587960562|FG000|Period 1|pursue other treatment options|0|||
162795373|NCT03635099|587960563|FG001|Period 1|pursue other treatment options|0|||
162795374|NCT03635099|587960564|FG002|Period 1|pursue other treatment options|0|||
162795375|NCT03635099|587960565|FG003|Period 1|pursue other treatment options|0|||
162795376|NCT03635099|587960566|FG004|Period 1|pursue other treatment options|0|||
162795377|NCT03635099|587960567|FG005|Period 1|pursue other treatment options|1|||
162795378|NCT03635099|587960568|FG006|Period 1|pursue other treatment options|0|||
162795379|NCT03635099|587960569|FG007|Period 1|pursue other treatment options|0|||
162795380|NCT03635099|587960562|FG000|Not Eligible for Period 2|Pregnancy|0|||
162795381|NCT03635099|587960563|FG001|Not Eligible for Period 2|Pregnancy|0|||
162795382|NCT03635099|587960564|FG002|Not Eligible for Period 2|Pregnancy|0|||
162795383|NCT03635099|587960565|FG003|Not Eligible for Period 2|Pregnancy|1|||
162795384|NCT03635099|587960566|FG004|Not Eligible for Period 2|Pregnancy|0|||
162795385|NCT03635099|587960567|FG005|Not Eligible for Period 2|Pregnancy|0|||
162795386|NCT03635099|587960568|FG006|Not Eligible for Period 2|Pregnancy|0|||
162795387|NCT03635099|587960569|FG007|Not Eligible for Period 2|Pregnancy|0|||
162795388|NCT03635099|587960562|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
162795389|NCT03635099|587960563|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795390|NCT03635099|587960564|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795391|NCT03635099|587960565|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795392|NCT03635099|587960566|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795393|NCT03635099|587960567|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795394|NCT03635099|587960568|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795395|NCT03635099|587960569|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
162795396|NCT03635099|587960562|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162795397|NCT03635099|587960563|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162795398|NCT03635099|587960564|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162795399|NCT03635099|587960565|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162795400|NCT03635099|587960566|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162795401|NCT03635099|587960567|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
162795402|NCT03635099|587960568|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
162795403|NCT03635099|587960569|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
162795404|NCT03635099|587960562|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
162795405|NCT03635099|587960563|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
162795406|NCT03635099|587960564|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
162795407|NCT03635099|587960565|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
162795408|NCT03635099|587960566|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162795409|NCT03635099|587960567|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162795410|NCT03635099|587960568|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162795411|NCT03635099|587960569|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162795412|NCT03635099|587960562|FG000|Period 2|Adverse Event|0|||
162795413|NCT03635099|587960563|FG001|Period 2|Adverse Event|0|||
162795414|NCT03635099|587960564|FG002|Period 2|Adverse Event|1|||
162795415|NCT03635099|587960565|FG003|Period 2|Adverse Event|0|||
162795416|NCT03635099|587960566|FG004|Period 2|Adverse Event|1|||
162795417|NCT03635099|587960567|FG005|Period 2|Adverse Event|0|||
162795418|NCT03635099|587960568|FG006|Period 2|Adverse Event|0|||
162795419|NCT03635099|587960569|FG007|Period 2|Adverse Event|0|||
162795420|NCT03635099|587960562|FG000|Period 2|Lost to Follow-up|0|||
162795421|NCT03635099|587960563|FG001|Period 2|Lost to Follow-up|0|||
162795422|NCT03635099|587960564|FG002|Period 2|Lost to Follow-up|1|||
162795423|NCT03635099|587960565|FG003|Period 2|Lost to Follow-up|0|||
162795424|NCT03635099|587960566|FG004|Period 2|Lost to Follow-up|4|||
162795425|NCT03635099|587960567|FG005|Period 2|Lost to Follow-up|0|||
162795426|NCT03635099|587960568|FG006|Period 2|Lost to Follow-up|0|||
162795427|NCT03635099|587960569|FG007|Period 2|Lost to Follow-up|0|||
162795428|NCT03635099|587960562|FG000|Period 2|Withdrawal by Subject|0|||
162795429|NCT03635099|587960563|FG001|Period 2|Withdrawal by Subject|0|||
162795430|NCT03635099|587960564|FG002|Period 2|Withdrawal by Subject|7|||
162795431|NCT03635099|587960565|FG003|Period 2|Withdrawal by Subject|4|||
162795432|NCT03635099|587960566|FG004|Period 2|Withdrawal by Subject|7|||
162795433|NCT03635099|587960567|FG005|Period 2|Withdrawal by Subject|0|||
162795434|NCT03635099|587960568|FG006|Period 2|Withdrawal by Subject|0|||
162795435|NCT03635099|587960569|FG007|Period 2|Withdrawal by Subject|0|||
162795436|NCT01289210|587960570|FG000|Overall Study|Adverse Event|1|||
162795437|NCT06285240|587960571|FG000|Overall Study|Withdrawal by Subject|2|||
162795438|NCT06285240|587960572|FG001|Overall Study|Withdrawal by Subject|0|||
162795439|NCT06285240|587960573|FG002|Overall Study|Withdrawal by Subject|0|||
162795440|NCT06285240|587960574|FG003|Overall Study|Withdrawal by Subject|0|||
162795441|NCT06285240|587960571|FG000|Overall Study|Serious Adverse Event|0|||
162795442|NCT06285240|587960572|FG001|Overall Study|Serious Adverse Event|0|||
162795443|NCT06285240|587960573|FG002|Overall Study|Serious Adverse Event|1|||
162795444|NCT06285240|587960574|FG003|Overall Study|Serious Adverse Event|0|||
162795445|NCT05292586|587960581|FG000|Overall Study|Withdrawal by Subject|3|||
162795446|NCT05292586|587960582|FG001|Overall Study|Withdrawal by Subject|10|||
162795447|NCT05292586|587960581|FG000|Overall Study|Randomization error|3|||
162795448|NCT05292586|587960582|FG001|Overall Study|Randomization error|7|||
162795449|NCT05292586|587960581|FG000|Overall Study|Adverse Event|3|||
162795450|NCT05292586|587960582|FG001|Overall Study|Adverse Event|0|||
162795451|NCT05292586|587960581|FG000|Overall Study|Lost to Follow-up|0|||
162795452|NCT05292586|587960582|FG001|Overall Study|Lost to Follow-up|1|||
162795453|NCT05292586|587960581|FG000|Overall Study|Patient refused treatment|1|||
162795454|NCT05292586|587960582|FG001|Overall Study|Patient refused treatment|0|||
162795455|NCT05292586|587960581|FG000|Overall Study|Patient could not travel to the study site|1|||
162795456|NCT05292586|587960582|FG001|Overall Study|Patient could not travel to the study site|0|||
162795457|NCT05292586|587960581|FG000|Overall Study|Technical issues with the masterscope|0|||
162795458|NCT05292586|587960582|FG001|Overall Study|Technical issues with the masterscope|3|||
162795459|NCT05292586|587960581|FG000|Overall Study|Patient moved to a different state|0|||
162795460|NCT05292586|587960582|FG001|Overall Study|Patient moved to a different state|1|||
162795461|NCT02367040|587960595|FG000|Overall Study|Lost to Follow-up|1|||
162795462|NCT02367040|587960596|FG001|Overall Study|Lost to Follow-up|1|||
162795463|NCT02367040|587960595|FG000|Overall Study|Lack of Efficacy|1|||
162795464|NCT02367040|587960596|FG001|Overall Study|Lack of Efficacy|0|||
162795465|NCT02367040|587960595|FG000|Overall Study|Additional primary malignancy|1|||
162795466|NCT02367040|587960596|FG001|Overall Study|Additional primary malignancy|1|||
162795467|NCT02367040|587960595|FG000|Overall Study|AE not associated with clinical disease progression|117|||
162795468|NCT02367040|587960596|FG001|Overall Study|AE not associated with clinical disease progression|12|||
162795469|NCT02367040|587960595|FG000|Overall Study|AE associated with clinical disease progression|1|||
162795470|NCT02367040|587960596|FG001|Overall Study|AE associated with clinical disease progression|4|||
162795471|NCT02367040|587960595|FG000|Overall Study|Physician Decision|2|||
162795472|NCT02367040|587960596|FG001|Overall Study|Physician Decision|8|||
162795473|NCT02367040|587960595|FG000|Overall Study|Non-compliance to study drug|1|||
162795474|NCT02367040|587960596|FG001|Overall Study|Non-compliance to study drug|0|||
162795475|NCT02367040|587960595|FG000|Overall Study|Failure to meet continuation criteria|1|||
162795476|NCT02367040|587960596|FG001|Overall Study|Failure to meet continuation criteria|0|||
162795477|NCT02367040|587960595|FG000|Overall Study|Switching to other therapy|2|||
162795478|NCT02367040|587960596|FG001|Overall Study|Switching to other therapy|0|||
162795479|NCT02367040|587960595|FG000|Overall Study|Withdrawal by Subject|51|||
162795480|NCT02367040|587960596|FG001|Overall Study|Withdrawal by Subject|16|||
162795481|NCT02367040|587960595|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
162795482|NCT02367040|587960596|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162795483|NCT02367040|587960595|FG000|Overall Study|Patient decision|40|||
162795484|NCT02367040|587960596|FG001|Overall Study|Patient decision|14|||
162795485|NCT02367040|587960595|FG000|Overall Study|Required procedure failed|1|||
162795486|NCT02367040|587960596|FG001|Overall Study|Required procedure failed|0|||
162795487|NCT02367040|587960595|FG000|Overall Study|Randomized by mistake with study treatment|1|||
162795488|NCT02367040|587960596|FG001|Overall Study|Randomized by mistake with study treatment|0|||
162795489|NCT02367040|587960595|FG000|Overall Study|Protocol Violation|1|||
162795490|NCT02367040|587960596|FG001|Overall Study|Protocol Violation|0|||
162795491|NCT02367040|587960595|FG000|Overall Study|Progressive disease - radiological progression|54|||
162795492|NCT02367040|587960596|FG001|Overall Study|Progressive disease - radiological progression|80|||
162795493|NCT02367040|587960595|FG000|Overall Study|Progressive disease - clinical progression|6|||
162795494|NCT02367040|587960596|FG001|Overall Study|Progressive disease - clinical progression|6|||
162795495|NCT02367040|587960595|FG000|Overall Study|Drug not administered|3|||
162795496|NCT02367040|587960596|FG001|Overall Study|Drug not administered|2|||
162795497|NCT02367040|587960595|FG000|Overall Study|Progressive disease|0|||
162795498|NCT02367040|587960596|FG001|Overall Study|Progressive disease|1|||
162795499|NCT02367040|587960595|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
162795500|NCT02367040|587960596|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
162795501|NCT02367040|587960595|FG000|Overall Study|Death|2|||
162795502|NCT02367040|587960596|FG001|Overall Study|Death|0|||
162795503|NCT02367040|587960595|FG000|Overall Study|Study terminated by sponsor|19|||
162795504|NCT02367040|587960596|FG001|Overall Study|Study terminated by sponsor|2|||
162795505|NCT02477618|587960597|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
162795506|NCT02477618|587960598|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
162795507|NCT02477618|587960597|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
162795508|NCT02477618|587960598|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
162795509|NCT02477618|587960597|FG000|Overall Study|Adverse Event|1|||
162795510|NCT02477618|587960598|FG001|Overall Study|Adverse Event|1|||
162795511|NCT02477618|587960597|FG000|Overall Study|Transferred Away from Study Site|1|||
162795512|NCT02477618|587960598|FG001|Overall Study|Transferred Away from Study Site|0|||
162795513|NCT02477618|587960597|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
162795514|NCT02477618|587960598|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
162795515|NCT05855967|587960599|FG000|Overall Study|Withdrawal by Subject|7|||
162795516|NCT05855967|587960600|FG001|Overall Study|Withdrawal by Subject|5|||
162795517|NCT05855967|587960599|FG000|Overall Study|Lost to Follow-up|2|||
162795518|NCT05855967|587960600|FG001|Overall Study|Lost to Follow-up|1|||
162795519|NCT02446821|587960601|FG000|Overall Study|Adverse Event|28|||
162795520|NCT02446821|587960601|FG000|Overall Study|Withdrawal by Subject|6|||
162795521|NCT02446821|587960601|FG000|Overall Study|Lost to Follow-up|22|||
162795522|NCT02446821|587960601|FG000|Overall Study|other|9|||
162795523|NCT02446821|587960601|FG000|Overall Study|insertion failure|3|||
162795524|NCT03007420|587960602|FG000|Overall Study|Withdrawal by Subject|0|||
162795525|NCT03007420|587960603|FG001|Overall Study|Withdrawal by Subject|2|||
162795526|NCT03007420|587960602|FG000|Overall Study|Physician Decision|0|||
162795527|NCT03007420|587960603|FG001|Overall Study|Physician Decision|1|||
162795528|NCT02284009|587960607|FG000|Overall Study|Adverse Event|3|||
162795529|NCT02284009|587960608|FG001|Overall Study|Adverse Event|0|||
162795530|NCT02284009|587960607|FG000|Overall Study|Lost to Follow-up|1|||
162795531|NCT02284009|587960608|FG001|Overall Study|Lost to Follow-up|3|||
162795532|NCT02284009|587960607|FG000|Overall Study|Physician Decision|0|||
162795533|NCT02284009|587960608|FG001|Overall Study|Physician Decision|2|||
162795534|NCT02284009|587960607|FG000|Overall Study|Withdrawal by Subject|2|||
162795535|NCT02284009|587960608|FG001|Overall Study|Withdrawal by Subject|5|||
162795536|NCT04147195|587960609|FG000|Overall Study|Adverse Event|0|||
162795537|NCT04147195|587960610|FG001|Overall Study|Adverse Event|3|||
162795538|NCT04147195|587960609|FG000|Overall Study|Study Terminated by Sponsor|4|||
162795539|NCT04147195|587960610|FG001|Overall Study|Study Terminated by Sponsor|2|||
162795540|NCT04147195|587960609|FG000|Overall Study|Withdrawal by Subject|0|||
162795541|NCT04147195|587960610|FG001|Overall Study|Withdrawal by Subject|1|||
162795542|NCT03841526|587960611|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
162795543|NCT03841526|587960612|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162795544|NCT03841526|587960613|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162795545|NCT03841526|587960614|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
162795546|NCT03841526|587960615|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162795547|NCT03841526|587960616|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162795548|NCT03841526|587960611|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
162795549|NCT03841526|587960612|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
162795550|NCT03841526|587960613|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
162795551|NCT03841526|587960614|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
162795552|NCT03841526|587960615|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
162795553|NCT03841526|587960616|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
162795554|NCT03841526|587960611|FG000|Outpatient Phase Treatment|Physician Decision|0|||
162795555|NCT03841526|587960612|FG001|Outpatient Phase Treatment|Physician Decision|1|||
162795556|NCT03841526|587960613|FG002|Outpatient Phase Treatment|Physician Decision|0|||
162795557|NCT03841526|587960614|FG003|Outpatient Phase Treatment|Physician Decision|0|||
162795558|NCT03841526|587960615|FG004|Outpatient Phase Treatment|Physician Decision|0|||
162795559|NCT03841526|587960616|FG005|Outpatient Phase Treatment|Physician Decision|0|||
162795560|NCT03841526|587960611|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162795561|NCT03841526|587960612|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162795562|NCT03841526|587960613|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
162795563|NCT03841526|587960614|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162795564|NCT03841526|587960615|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162795565|NCT03841526|587960616|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
162795566|NCT01435772|587960620|FG000|Overall Study|Adverse Event|1|||
162795567|NCT01435772|587960621|FG001|Overall Study|Adverse Event|0|||
162795568|NCT01435772|587960622|FG002|Overall Study|Adverse Event|2|||
162795569|NCT01435772|587960620|FG000|Overall Study|Withdrawal by Subject|0|||
162795570|NCT01435772|587960621|FG001|Overall Study|Withdrawal by Subject|1|||
162795571|NCT01435772|587960622|FG002|Overall Study|Withdrawal by Subject|3|||
162795572|NCT01435772|587960620|FG000|Overall Study|Other - study termination|2|||
162795573|NCT01435772|587960621|FG001|Overall Study|Other - study termination|2|||
162795574|NCT01435772|587960622|FG002|Overall Study|Other - study termination|10|||
162795575|NCT05823012|587960623|FG000|Titration Period|Adverse Event|1|||
162795576|NCT05823012|587960623|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
162795577|NCT05823012|587960623|FG000|Maintenance Period|Adverse Event|1|||
162795578|NCT05823012|587960623|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
162795579|NCT05823012|587960623|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
162795580|NCT01424813|587960624|FG000|Overall Study|Withdrawal by Subject|3|||
162795581|NCT01424813|587960625|FG001|Overall Study|Withdrawal by Subject|0|||
162795582|NCT01424813|587960624|FG000|Overall Study|Protocol Violation|1|||
162795583|NCT01424813|587960625|FG001|Overall Study|Protocol Violation|0|||
162795584|NCT01424813|587960624|FG000|Overall Study|Other|1|||
162795585|NCT01424813|587960625|FG001|Overall Study|Other|2|||
162795586|NCT07149155|587960629|FG000|Overall Study|Lost to Follow-up|10|||
162795587|NCT00515671|587961903|FG000|Overall Study|Lost to Follow-up|13|||
162795588|NCT00515671|587961904|FG001|Overall Study|Lost to Follow-up|10|||
162795589|NCT00515671|587961903|FG000|Overall Study|Withdrawal by Subject|3|||
162795590|NCT00515671|587961904|FG001|Overall Study|Withdrawal by Subject|5|||
162795591|NCT00515671|587961903|FG000|Overall Study|incarcerated|1|||
162795592|NCT00515671|587961904|FG001|Overall Study|incarcerated|2|||
162795593|NCT01195948|587961907|FG000|Overall Study|Lost to Follow-up|0|||
162795594|NCT01195948|587961908|FG001|Overall Study|Lost to Follow-up|1|||
162795595|NCT01195948|587961909|FG002|Overall Study|Lost to Follow-up|2|||
162795596|NCT01498887|587961914|FG000|Overall Study|Administrative problems|1|||
162795597|NCT01498887|587961915|FG001|Overall Study|Administrative problems|0|||
162795598|NCT01498887|587961914|FG000|Overall Study|Lost to Follow-up|1|||
162795599|NCT01498887|587961915|FG001|Overall Study|Lost to Follow-up|1|||
162795600|NCT01498887|587961914|FG000|Overall Study|Withdrawal by Subject|1|||
162795601|NCT01498887|587961915|FG001|Overall Study|Withdrawal by Subject|0|||
162795602|NCT01498887|587961914|FG000|Overall Study|Protocol Violation|1|||
162795603|NCT01498887|587961915|FG001|Overall Study|Protocol Violation|3|||
162795604|NCT01498887|587961914|FG000|Overall Study|Lack of Efficacy|5|||
162795605|NCT01498887|587961915|FG001|Overall Study|Lack of Efficacy|3|||
162795606|NCT01498887|587961914|FG000|Overall Study|Abnormal result from test procedure|1|||
162795607|NCT01498887|587961915|FG001|Overall Study|Abnormal result from test procedure|1|||
162795608|NCT01498887|587961914|FG000|Overall Study|Abnormal laboratory value|2|||
162795609|NCT01498887|587961915|FG001|Overall Study|Abnormal laboratory value|2|||
162795610|NCT01498887|587961914|FG000|Overall Study|Adverse Event|4|||
162795611|NCT01498887|587961915|FG001|Overall Study|Adverse Event|1|||
162795612|NCT02993406|587961916|FG000|Overall Study|Withdrawal by Subject|170|||
162795613|NCT02993406|587961917|FG001|Overall Study|Withdrawal by Subject|196|||
162795614|NCT02993406|587961916|FG000|Overall Study|Physician Decision|3|||
162795615|NCT02993406|587961917|FG001|Overall Study|Physician Decision|5|||
162795616|NCT02993406|587961916|FG000|Overall Study|Lost to Follow-up|12|||
162795617|NCT02993406|587961917|FG001|Overall Study|Lost to Follow-up|13|||
162795618|NCT02993406|587961916|FG000|Overall Study|Unclassifiable Response|105|||
162795619|NCT02993406|587961917|FG001|Overall Study|Unclassifiable Response|139|||
162795620|NCT02993406|587961916|FG000|Overall Study|Administrative decision|1|||
162795621|NCT02993406|587961917|FG001|Overall Study|Administrative decision|0|||
162795622|NCT02993406|587961916|FG000|Overall Study|Sponsor decision|4|||
162795623|NCT02993406|587961917|FG001|Overall Study|Sponsor decision|5|||
162795624|NCT04079868|587961918|FG000|Overall Study|Lost to Follow-up|100|||
162795625|NCT04079868|587961919|FG001|Overall Study|Lost to Follow-up|200|||
162795626|NCT04079868|587961918|FG000|Overall Study|Physician Decision|100|||
162795627|NCT04079868|587961919|FG001|Overall Study|Physician Decision|0|||
162795628|NCT04325282|587961920|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
162795629|NCT04325282|587961921|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
162795630|NCT04325282|587961920|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
162795631|NCT04325282|587961921|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
162795632|NCT04020185|587961926|FG000|Overall Study|Death|0|||
162795633|NCT04020185|587961927|FG001|Overall Study|Death|0|||
162795634|NCT04020185|587961928|FG002|Overall Study|Death|1|||
162795635|NCT04020185|587961929|FG003|Overall Study|Death|2|||
162795636|NCT04020185|587961930|FG004|Overall Study|Death|1|||
162795637|NCT04020185|587961931|FG005|Overall Study|Death|0|||
162795638|NCT04020185|587961932|FG006|Overall Study|Death|1|||
162795639|NCT04020185|587961933|FG007|Overall Study|Death|0|||
162795640|NCT04020185|587961926|FG000|Overall Study|Consent withdrawn|1|||
162795641|NCT04020185|587961927|FG001|Overall Study|Consent withdrawn|0|||
162795642|NCT04020185|587961928|FG002|Overall Study|Consent withdrawn|0|||
162795643|NCT04020185|587961929|FG003|Overall Study|Consent withdrawn|0|||
162795644|NCT04020185|587961930|FG004|Overall Study|Consent withdrawn|2|||
162795645|NCT04020185|587961931|FG005|Overall Study|Consent withdrawn|0|||
162795646|NCT04020185|587961932|FG006|Overall Study|Consent withdrawn|1|||
162795647|NCT04020185|587961933|FG007|Overall Study|Consent withdrawn|1|||
162795648|NCT04020185|587961926|FG000|Overall Study|Patient in hospice|0|||
162795649|NCT04020185|587961927|FG001|Overall Study|Patient in hospice|1|||
162795650|NCT04020185|587961928|FG002|Overall Study|Patient in hospice|0|||
162795651|NCT04020185|587961929|FG003|Overall Study|Patient in hospice|0|||
162795652|NCT04020185|587961930|FG004|Overall Study|Patient in hospice|0|||
162795653|NCT04020185|587961931|FG005|Overall Study|Patient in hospice|0|||
162795654|NCT04020185|587961932|FG006|Overall Study|Patient in hospice|0|||
162795655|NCT04020185|587961933|FG007|Overall Study|Patient in hospice|0|||
162795656|NCT04020185|587961926|FG000|Overall Study|Continuing on expanded access|0|||
162795657|NCT04020185|587961927|FG001|Overall Study|Continuing on expanded access|0|||
162795658|NCT04020185|587961928|FG002|Overall Study|Continuing on expanded access|0|||
162795659|NCT04020185|587961929|FG003|Overall Study|Continuing on expanded access|0|||
162795660|NCT04020185|587961930|FG004|Overall Study|Continuing on expanded access|0|||
162795661|NCT04020185|587961931|FG005|Overall Study|Continuing on expanded access|0|||
162795662|NCT04020185|587961932|FG006|Overall Study|Continuing on expanded access|1|||
162795663|NCT04020185|587961933|FG007|Overall Study|Continuing on expanded access|1|||
162795664|NCT00527787|587961935|FG000|Overall Study|Adverse Event|14|||
162795665|NCT00527787|587961936|FG001|Overall Study|Adverse Event|24|||
162795666|NCT00527787|587961935|FG000|Overall Study|Withdrawal by Subject|13|||
162795667|NCT00527787|587961936|FG001|Overall Study|Withdrawal by Subject|25|||
162795668|NCT00527787|587961935|FG000|Overall Study|Lost to Follow-up|5|||
162795669|NCT00527787|587961936|FG001|Overall Study|Lost to Follow-up|2|||
162795670|NCT00527787|587961935|FG000|Overall Study|Duodenal Ulcer|1|||
162795671|NCT00527787|587961936|FG001|Overall Study|Duodenal Ulcer|10|||
162795672|NCT00527787|587961935|FG000|Overall Study|misc|5|||
162795673|NCT00527787|587961936|FG001|Overall Study|misc|2|||
162795674|NCT01706705|587961942|FG000|Overall Study|Death|1|||
162795675|NCT01706705|587961942|FG000|Overall Study|Lack of Efficacy|13|||
162795676|NCT01706705|587961942|FG000|Overall Study|Non-clinical|6|||
162795677|NCT00608868|587961945|FG000|Overall Study|Withdrawal by Subject|7|||
162795678|NCT00608868|587961945|FG000|Overall Study|Protocol Violation|3|||
162795679|NCT00608868|587961945|FG000|Overall Study|Lost to Follow-up|2|||
162795680|NCT00608868|587961945|FG000|Overall Study|Adverse Event|1|||
162795681|NCT00608868|587961945|FG000|Overall Study|Physician Decision|2|||
162795682|NCT03338296|587961946|FG000|Overall Study|Adverse Event|0|||
162795683|NCT03338296|587961947|FG001|Overall Study|Adverse Event|1|||
162795684|NCT03338296|587961946|FG000|Overall Study|Withdrawal by Subject|14|||
162795685|NCT03338296|587961947|FG001|Overall Study|Withdrawal by Subject|13|||
162795686|NCT03338296|587961946|FG000|Overall Study|Lost to Follow-up|10|||
162795687|NCT03338296|587961947|FG001|Overall Study|Lost to Follow-up|10|||
162795688|NCT03338296|587961946|FG000|Overall Study|Study Terminated by Sponsor|77|||
162795689|NCT03338296|587961947|FG001|Overall Study|Study Terminated by Sponsor|76|||
162795690|NCT03338296|587961946|FG000|Overall Study|Other|2|||
162795691|NCT03338296|587961947|FG001|Overall Study|Other|7|||
162795692|NCT03338296|587961946|FG000|Overall Study|Missing|0|||
162795693|NCT03338296|587961947|FG001|Overall Study|Missing|1|||
162795694|NCT00702962|587961950|FG000|Overall Study|Progressive disease|0|||
162795695|NCT00702962|587961951|FG001|Overall Study|Progressive disease|1|||
162795696|NCT00702962|587961950|FG000|Overall Study|Hospitalized for other health disorder|1|||
162795697|NCT00702962|587961951|FG001|Overall Study|Hospitalized for other health disorder|0|||
162795698|NCT01252355|587961952|FG000|Overall Study|Adverse Event|9|||
162795699|NCT01252355|587961953|FG001|Overall Study|Adverse Event|17|||
162795700|NCT01252355|587961954|FG002|Overall Study|Adverse Event|22|||
162795701|NCT01252355|587961952|FG000|Overall Study|Lack of Efficacy|6|||
162795702|NCT01252355|587961953|FG001|Overall Study|Lack of Efficacy|4|||
162795703|NCT01252355|587961954|FG002|Overall Study|Lack of Efficacy|2|||
162795704|NCT01252355|587961952|FG000|Overall Study|Lost to Follow-up|0|||
162795705|NCT01252355|587961953|FG001|Overall Study|Lost to Follow-up|0|||
162795706|NCT01252355|587961954|FG002|Overall Study|Lost to Follow-up|1|||
162795707|NCT01252355|587961952|FG000|Overall Study|Poor Compliance to Protocol|1|||
162795708|NCT01252355|587961953|FG001|Overall Study|Poor Compliance to Protocol|1|||
162795709|NCT01252355|587961954|FG002|Overall Study|Poor Compliance to Protocol|1|||
162795710|NCT01252355|587961952|FG000|Overall Study|Progressive Disease|2|||
162795711|NCT01252355|587961953|FG001|Overall Study|Progressive Disease|0|||
162795712|NCT01252355|587961954|FG002|Overall Study|Progressive Disease|0|||
162795713|NCT01252355|587961952|FG000|Overall Study|Sponsor Early Termination of Study|149|||
162795714|NCT01252355|587961953|FG001|Overall Study|Sponsor Early Termination of Study|149|||
162795715|NCT01252355|587961954|FG002|Overall Study|Sponsor Early Termination of Study|146|||
162795716|NCT01252355|587961952|FG000|Overall Study|Randomized but not Treated|2|||
162795717|NCT01252355|587961953|FG001|Overall Study|Randomized but not Treated|0|||
162795718|NCT01252355|587961954|FG002|Overall Study|Randomized but not Treated|0|||
162795719|NCT01252355|587961952|FG000|Overall Study|Other Than Above|8|||
162795720|NCT01252355|587961953|FG001|Overall Study|Other Than Above|7|||
162795721|NCT01252355|587961954|FG002|Overall Study|Other Than Above|7|||
162795722|NCT02175641|587961956|FG000|Overall Study|Death|3|||
162795723|NCT02175641|587961957|FG001|Overall Study|Death|4|||
162795724|NCT02175641|587961956|FG000|Overall Study|Lost to Follow-up|4|||
162795725|NCT02175641|587961957|FG001|Overall Study|Lost to Follow-up|4|||
162795726|NCT02175641|587961956|FG000|Overall Study|Withdrawal by Subject|7|||
162795727|NCT02175641|587961957|FG001|Overall Study|Withdrawal by Subject|4|||
162795728|NCT02175641|587961956|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
162795729|NCT02175641|587961957|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
162795730|NCT02175641|587961956|FG000|Overall Study|Developed Contraindicated Condition|8|||
162795731|NCT02175641|587961957|FG001|Overall Study|Developed Contraindicated Condition|0|||
162795732|NCT01876901|587961960|FG000|Overall Study|Protocol Violation|10|||
162795733|NCT01876901|587961961|FG001|Overall Study|Protocol Violation|2|||
162795734|NCT01876901|587961960|FG000|Overall Study|No or other surgical intervention|7|||
162795735|NCT01876901|587961961|FG001|Overall Study|No or other surgical intervention|5|||
162795736|NCT02242097|587961964|FG000|Ibrutinib Treatment|Adverse Event|16|||
162795737|NCT02242097|587961964|FG000|Ibrutinib Treatment|Physician Decision|1|||
162795738|NCT02242097|587961964|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
162795739|NCT02242097|587961964|FG000|Ibrutinib Treatment|Death|1|||
162795740|NCT02242097|587961964|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
162795741|NCT02242097|587961964|FG000|Post Therapy Follow Up|Death|3|||
162795742|NCT02242097|587961964|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
162795743|NCT03031496|587961966|FG000|Period 1|Adverse Event|2|||
162795744|NCT03031496|587961967|FG001|Period 1|Adverse Event|0|||
162795745|NCT03031496|587961966|FG000|Period 1|Withdrawal by Subject|0|||
162795746|NCT03031496|587961967|FG001|Period 1|Withdrawal by Subject|2|||
162795747|NCT03868787|587961969|FG000|Overall Study|Withdrawal by Subject|2|||
162795748|NCT03868787|587961970|FG001|Overall Study|Withdrawal by Subject|1|||
162795749|NCT01399697|587961971|FG000|Overall Study|Adverse Event|13|||
162795750|NCT01399697|587961972|FG001|Overall Study|Adverse Event|3|||
162795751|NCT01399697|587961973|FG002|Overall Study|Adverse Event|1|||
162795752|NCT01399697|587961971|FG000|Overall Study|Lost to Follow-up|2|||
162795753|NCT01399697|587961972|FG001|Overall Study|Lost to Follow-up|0|||
162795754|NCT01399697|587961973|FG002|Overall Study|Lost to Follow-up|0|||
162795755|NCT01399697|587961971|FG000|Overall Study|Withdrawal by Subject|8|||
162795756|NCT01399697|587961972|FG001|Overall Study|Withdrawal by Subject|0|||
162795757|NCT01399697|587961973|FG002|Overall Study|Withdrawal by Subject|0|||
162795758|NCT01399697|587961971|FG000|Overall Study|Investigator Decisión|1|||
162795759|NCT01399697|587961972|FG001|Overall Study|Investigator Decisión|0|||
162795760|NCT01399697|587961973|FG002|Overall Study|Investigator Decisión|2|||
162795761|NCT01399697|587961971|FG000|Overall Study|Lack of Efficacy|9|||
162795762|NCT01399697|587961972|FG001|Overall Study|Lack of Efficacy|0|||
162795763|NCT01399697|587961973|FG002|Overall Study|Lack of Efficacy|1|||
162795764|NCT01399697|587961971|FG000|Overall Study|Protocol Violation|2|||
162795765|NCT01399697|587961972|FG001|Overall Study|Protocol Violation|0|||
162795766|NCT01399697|587961973|FG002|Overall Study|Protocol Violation|0|||
162795767|NCT01399697|587961971|FG000|Overall Study|Non-Compliant|1|||
162795768|NCT01399697|587961972|FG001|Overall Study|Non-Compliant|0|||
162795769|NCT01399697|587961973|FG002|Overall Study|Non-Compliant|0|||
162795770|NCT01399697|587961971|FG000|Overall Study|Inclusion Error|2|||
162795771|NCT01399697|587961972|FG001|Overall Study|Inclusion Error|0|||
162795772|NCT01399697|587961973|FG002|Overall Study|Inclusion Error|0|||
162795773|NCT01399697|587961971|FG000|Overall Study|Positive result for hepatitis B|1|||
162795774|NCT01399697|587961972|FG001|Overall Study|Positive result for hepatitis B|0|||
162795775|NCT01399697|587961973|FG002|Overall Study|Positive result for hepatitis B|0|||
162795776|NCT01399697|587961971|FG000|Overall Study|Clinical RA remission|1|||
162795777|NCT01399697|587961972|FG001|Overall Study|Clinical RA remission|0|||
162795778|NCT01399697|587961973|FG002|Overall Study|Clinical RA remission|0|||
162795779|NCT01399697|587961971|FG000|Overall Study|Sponsor Decision|1|||
162795780|NCT01399697|587961972|FG001|Overall Study|Sponsor Decision|0|||
162795781|NCT01399697|587961973|FG002|Overall Study|Sponsor Decision|0|||
162795782|NCT01712061|587961975|FG000|Overall Study|Adverse Event|4|||
162795783|NCT01712061|587961976|FG001|Overall Study|Adverse Event|9|||
162795784|NCT01712061|587961977|FG002|Overall Study|Adverse Event|5|||
162795785|NCT01712061|587961975|FG000|Overall Study|Death|0|||
162795786|NCT01712061|587961976|FG001|Overall Study|Death|0|||
162795787|NCT01712061|587961977|FG002|Overall Study|Death|1|||
162795788|NCT01712061|587961975|FG000|Overall Study|Lost to Follow-up|1|||
162795789|NCT01712061|587961976|FG001|Overall Study|Lost to Follow-up|0|||
162795790|NCT01712061|587961977|FG002|Overall Study|Lost to Follow-up|1|||
162795791|NCT01712061|587961975|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
162795792|NCT01712061|587961976|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
162795793|NCT01712061|587961977|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
162795794|NCT01712061|587961975|FG000|Overall Study|Medication Error Without Associated AE|0|||
162795795|NCT01712061|587961976|FG001|Overall Study|Medication Error Without Associated AE|1|||
162795796|NCT01712061|587961977|FG002|Overall Study|Medication Error Without Associated AE|0|||
162795797|NCT01712061|587961975|FG000|Overall Study|Withdrawal by Subject|1|||
162795798|NCT01712061|587961976|FG001|Overall Study|Withdrawal by Subject|7|||
162795799|NCT01712061|587961977|FG002|Overall Study|Withdrawal by Subject|1|||
162795800|NCT01712061|587961975|FG000|Overall Study|Other|0|||
162795801|NCT01712061|587961976|FG001|Overall Study|Other|3|||
162795802|NCT01712061|587961977|FG002|Overall Study|Other|0|||
162795803|NCT00504777|587961982|FG000|Overall Study|Adverse Event|1|||
162795804|NCT04868539|587961986|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
162795805|NCT04868539|587961987|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
162795806|NCT01572740|587961988|FG000|Overall Study|Adverse Event|1|||
162795807|NCT01572740|587961989|FG001|Overall Study|Adverse Event|1|||
162795808|NCT01572740|587961988|FG000|Overall Study|Withdrawal by Subject|1|||
162795809|NCT01572740|587961989|FG001|Overall Study|Withdrawal by Subject|1|||
162795810|NCT01572740|587961988|FG000|Overall Study|unclassified|4|||
162795811|NCT01572740|587961989|FG001|Overall Study|unclassified|3|||
162795812|NCT01401153|587961990|FG000|First Test Day|Learning disabilities; illness|1|||
162795813|NCT01401153|587961991|FG001|First Test Day|Learning disabilities; illness|10|||
162795814|NCT01401153|587961990|FG000|Second Test Day|illness|0|||
162795815|NCT01401153|587961991|FG001|Second Test Day|illness|5|||
162795816|NCT01677767|587961994|FG000|Overall Study|Adverse Event|1|||
162795817|NCT01677767|587961994|FG000|Overall Study|Death|4|||
162795818|NCT01677767|587961994|FG000|Overall Study|Protocol Violation|4|||
162795819|NCT01677767|587961994|FG000|Overall Study|Withdrawal by Subject|10|||
162795820|NCT01677767|587961994|FG000|Overall Study|Non-compliance by the participants|3|||
162795821|NCT00842244|587961995|FG000|Overall Study|Death|3|||
162795822|NCT00842244|587961995|FG000|Overall Study|Withdrawal by Subject|1|||
162795823|NCT00842244|587961995|FG000|Overall Study|Other|17|||
162795824|NCT01068665|587962000|FG000|Overall Study|Adverse Event|5|||
162795825|NCT01068665|587962001|FG001|Overall Study|Adverse Event|4|||
162795826|NCT01068665|587962000|FG000|Overall Study|Lack of Efficacy|0|||
162795827|NCT01068665|587962001|FG001|Overall Study|Lack of Efficacy|2|||
162795828|NCT01068665|587962000|FG000|Overall Study|Protocol Violation|5|||
162795829|NCT01068665|587962001|FG001|Overall Study|Protocol Violation|2|||
162795830|NCT01068665|587962000|FG000|Overall Study|Withdrawal Criteria|3|||
162795831|NCT01068665|587962001|FG001|Overall Study|Withdrawal Criteria|9|||
162795832|NCT01068665|587962000|FG000|Overall Study|Other|17|||
162795833|NCT01068665|587962001|FG001|Overall Study|Other|12|||
162795834|NCT02807272|587962002|FG000|Overall Study|Death|9|||
162795835|NCT02807272|587962003|FG001|Overall Study|Death|5|||
162795836|NCT02807272|587962004|FG002|Overall Study|Death|2|||
162795837|NCT02807272|587962005|FG003|Overall Study|Death|0|||
162795838|NCT02807272|587962006|FG004|Overall Study|Death|1|||
162795839|NCT02807272|587962002|FG000|Overall Study|Lost to Follow-up|1|||
162795840|NCT02807272|587962003|FG001|Overall Study|Lost to Follow-up|0|||
162795841|NCT02807272|587962004|FG002|Overall Study|Lost to Follow-up|0|||
162795842|NCT02807272|587962005|FG003|Overall Study|Lost to Follow-up|0|||
162795843|NCT02807272|587962006|FG004|Overall Study|Lost to Follow-up|0|||
162795844|NCT02807272|587962002|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
162795845|NCT02807272|587962003|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
162795846|NCT02807272|587962004|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
162795847|NCT02807272|587962005|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
162795848|NCT02807272|587962006|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
162795849|NCT02807272|587962002|FG000|Overall Study|Protocol-defined Disease Progression|0|||
162795850|NCT02807272|587962003|FG001|Overall Study|Protocol-defined Disease Progression|1|||
162795851|NCT02807272|587962004|FG002|Overall Study|Protocol-defined Disease Progression|0|||
162795852|NCT02807272|587962005|FG003|Overall Study|Protocol-defined Disease Progression|0|||
162795853|NCT02807272|587962006|FG004|Overall Study|Protocol-defined Disease Progression|1|||
162795854|NCT02807272|587962002|FG000|Overall Study|Study Terminated by Sponsor|1|||
162795855|NCT02807272|587962003|FG001|Overall Study|Study Terminated by Sponsor|0|||
162795856|NCT02807272|587962004|FG002|Overall Study|Study Terminated by Sponsor|0|||
162795857|NCT02807272|587962005|FG003|Overall Study|Study Terminated by Sponsor|1|||
162795858|NCT02807272|587962006|FG004|Overall Study|Study Terminated by Sponsor|0|||
162795859|NCT02807272|587962002|FG000|Overall Study|Other|1|||
162795860|NCT02807272|587962003|FG001|Overall Study|Other|0|||
162795861|NCT02807272|587962004|FG002|Overall Study|Other|0|||
162795862|NCT02807272|587962005|FG003|Overall Study|Other|0|||
162795863|NCT02807272|587962006|FG004|Overall Study|Other|1|||
162795864|NCT03552523|587962008|FG000|Overall Study|Withdrawal by Subject|1|||
162795865|NCT03552523|587962009|FG001|Overall Study|Withdrawal by Subject|1|||
162795866|NCT00839956|587962010|FG000|Overall Study|Adverse Event|2|||
162795867|NCT00839956|587962010|FG000|Overall Study|Lack of Efficacy|6|||
162795868|NCT00839956|587962010|FG000|Overall Study|Physician Decision|1|||
162810583|NCT00887250|588018277|FG002|Overall Study|Protocol Violation|1|||
162795869|NCT00839956|587962010|FG000|Overall Study|Withdrawal by Subject|3|||
162795870|NCT00594880|587962011|FG000|Overall Study|Withdrawal by Subject|1|||
162795871|NCT00594880|587962012|FG001|Overall Study|Withdrawal by Subject|1|||
162795872|NCT00594880|587962011|FG000|Overall Study|Lost to Follow-up|1|||
162795873|NCT00594880|587962012|FG001|Overall Study|Lost to Follow-up|0|||
162795874|NCT05140915|587962015|FG000|Overall Study|Lost to Follow-up|2|||
162795875|NCT05140915|587962016|FG001|Overall Study|Lost to Follow-up|1|||
162795876|NCT04520659|587962017|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
162795877|NCT04520659|587962018|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
162795878|NCT04520659|587962019|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
162795879|NCT04520659|587962020|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
162795880|NCT04485611|587962025|FG000|Prehabilitation|Physician Decision|1|||
162795881|NCT04879849|587962026|FG000|Overall Study|Lost to Follow-up|0|||
162795882|NCT04879849|587962027|FG001|Overall Study|Lost to Follow-up|0|||
162795883|NCT04879849|587962028|FG002|Overall Study|Lost to Follow-up|0|||
162795884|NCT04879849|587962029|FG003|Overall Study|Lost to Follow-up|1|||
162795885|NCT04879849|587962030|FG004|Overall Study|Lost to Follow-up|0|||
162795886|NCT04879849|587962031|FG005|Overall Study|Lost to Follow-up|0|||
162795887|NCT04879849|587962032|FG006|Overall Study|Lost to Follow-up|0|||
162795888|NCT04879849|587962033|FG007|Overall Study|Lost to Follow-up|0|||
162795889|NCT04879849|587962026|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
162795890|NCT04879849|587962027|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
162795891|NCT04879849|587962028|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
162795892|NCT04879849|587962029|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
162795893|NCT04879849|587962030|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
162795894|NCT04879849|587962031|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
162795895|NCT04879849|587962032|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
162795896|NCT04879849|587962033|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
162795897|NCT04879849|587962026|FG000|Overall Study|Withdrawal by Subject|0|||
162795898|NCT04879849|587962027|FG001|Overall Study|Withdrawal by Subject|0|||
162795899|NCT04879849|587962028|FG002|Overall Study|Withdrawal by Subject|0|||
162795900|NCT04879849|587962029|FG003|Overall Study|Withdrawal by Subject|0|||
162795901|NCT04879849|587962030|FG004|Overall Study|Withdrawal by Subject|2|||
162795902|NCT04879849|587962031|FG005|Overall Study|Withdrawal by Subject|0|||
162795903|NCT04879849|587962032|FG006|Overall Study|Withdrawal by Subject|1|||
162795904|NCT04879849|587962033|FG007|Overall Study|Withdrawal by Subject|0|||
162795905|NCT04879849|587962026|FG000|Overall Study|Progressive Disease|0|||
162795906|NCT04879849|587962027|FG001|Overall Study|Progressive Disease|0|||
162795907|NCT04879849|587962028|FG002|Overall Study|Progressive Disease|1|||
162795908|NCT04879849|587962029|FG003|Overall Study|Progressive Disease|0|||
162795909|NCT04879849|587962030|FG004|Overall Study|Progressive Disease|0|||
162795910|NCT04879849|587962031|FG005|Overall Study|Progressive Disease|0|||
162795911|NCT04879849|587962032|FG006|Overall Study|Progressive Disease|0|||
162795912|NCT04879849|587962033|FG007|Overall Study|Progressive Disease|0|||
162795913|NCT04879849|587962026|FG000|Overall Study|Death|0|||
162795914|NCT04879849|587962027|FG001|Overall Study|Death|0|||
162795915|NCT04879849|587962028|FG002|Overall Study|Death|1|||
162795916|NCT04879849|587962029|FG003|Overall Study|Death|1|||
162795917|NCT04879849|587962030|FG004|Overall Study|Death|1|||
162795918|NCT04879849|587962031|FG005|Overall Study|Death|2|||
162795919|NCT04879849|587962032|FG006|Overall Study|Death|1|||
162795920|NCT04879849|587962033|FG007|Overall Study|Death|2|||
162795921|NCT04879849|587962026|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
162795922|NCT04879849|587962027|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
162795923|NCT04879849|587962028|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
162795924|NCT04879849|587962029|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
162795925|NCT04879849|587962030|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
162795926|NCT04879849|587962031|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
162795927|NCT04879849|587962032|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
162795928|NCT04879849|587962033|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
162795929|NCT04879849|587962026|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795930|NCT04879849|587962027|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795931|NCT04879849|587962028|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795932|NCT04879849|587962029|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795933|NCT04879849|587962030|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795934|NCT04879849|587962031|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795935|NCT04879849|587962032|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
162795936|NCT04879849|587962033|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162795937|NCT04879849|587962026|FG000|Overall Study|Reason Not Specified|1|||
162795938|NCT04879849|587962027|FG001|Overall Study|Reason Not Specified|0|||
162795939|NCT04879849|587962028|FG002|Overall Study|Reason Not Specified|0|||
162795940|NCT04879849|587962029|FG003|Overall Study|Reason Not Specified|0|||
162795941|NCT04879849|587962030|FG004|Overall Study|Reason Not Specified|0|||
162795942|NCT04879849|587962031|FG005|Overall Study|Reason Not Specified|0|||
162795943|NCT04879849|587962032|FG006|Overall Study|Reason Not Specified|0|||
162795944|NCT04879849|587962033|FG007|Overall Study|Reason Not Specified|0|||
162795945|NCT03238963|587962035|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
162795946|NCT03238963|587962036|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
162795947|NCT03238963|587962035|FG000|Overall Study|Withdrawal by Subject|1|||
162795948|NCT03238963|587962036|FG001|Overall Study|Withdrawal by Subject|1|||
162795949|NCT03238963|587962035|FG000|Overall Study|Lost to Follow-up|1|||
162795950|NCT03238963|587962036|FG001|Overall Study|Lost to Follow-up|0|||
162795951|NCT03238963|587962035|FG000|Overall Study|Protocol Violation|1|||
162795952|NCT03238963|587962036|FG001|Overall Study|Protocol Violation|1|||
162795953|NCT03238963|587962035|FG000|Overall Study|Adverse Event|1|||
162795954|NCT03238963|587962036|FG001|Overall Study|Adverse Event|0|||
162795955|NCT03345576|587962037|FG000|Overall Study|Withdrawal by Subject|2|||
162795956|NCT03345576|587962038|FG001|Overall Study|Withdrawal by Subject|2|||
162795957|NCT03345576|587962037|FG000|Overall Study|Adverse Event|1|||
162795958|NCT03345576|587962038|FG001|Overall Study|Adverse Event|0|||
162795959|NCT05718466|587963920|FG000|Overall Study|Withdrawal by Subject|1|||
162795960|NCT05718466|587963921|FG001|Overall Study|Withdrawal by Subject|2|||
162795961|NCT05718466|587963920|FG000|Overall Study|Death|0|||
162795962|NCT05718466|587963921|FG001|Overall Study|Death|1|||
162795963|NCT01253135|587963924|FG000|Original Protocol|Protocol Amendment|15|||
162795964|NCT01253135|587963924|FG000|Amended Protocol|Non-compliance|1|||
162795965|NCT01255631|587963932|FG000|Overall Study|poor enrollment, no data analyzed|9|||
162795966|NCT01255631|587963933|FG001|Overall Study|poor enrollment, no data analyzed|6|||
162795967|NCT00264303|587963941|FG000|Overall Study|Adverse Event|4|||
162795968|NCT00264303|587963942|FG001|Overall Study|Adverse Event|3|||
162795969|NCT00264303|587963941|FG000|Overall Study|Lack of Efficacy|10|||
162795970|NCT00264303|587963942|FG001|Overall Study|Lack of Efficacy|13|||
162795971|NCT00264303|587963941|FG000|Overall Study|Lost to Follow-up|3|||
162795972|NCT00264303|587963942|FG001|Overall Study|Lost to Follow-up|3|||
162795973|NCT00264303|587963941|FG000|Overall Study|Withdrawal by Subject|2|||
162795974|NCT00264303|587963942|FG001|Overall Study|Withdrawal by Subject|3|||
162795975|NCT00264303|587963941|FG000|Overall Study|Various reasons listed in study report|6|||
162795976|NCT00264303|587963942|FG001|Overall Study|Various reasons listed in study report|7|||
162795977|NCT02815579|587963943|FG000|Overall Study|Non-payment of loan down-payment|16|||
162795978|NCT02815579|587963944|FG001|Overall Study|Non-payment of loan down-payment|0|||
162795979|NCT02815579|587963943|FG000|Overall Study|Withdrawal by Subject|7|||
162795980|NCT02815579|587963944|FG001|Overall Study|Withdrawal by Subject|1|||
162795981|NCT02815579|587963943|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
162795982|NCT02815579|587963944|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
162795983|NCT02815579|587963943|FG000|Overall Study|Lost to Follow-up|7|||
162795984|NCT02815579|587963944|FG001|Overall Study|Lost to Follow-up|4|||
162795985|NCT02815579|587963943|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
162795986|NCT02815579|587963944|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
162795987|NCT02815579|587963943|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
162795988|NCT02815579|587963944|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
162795989|NCT02815579|587963943|FG000|Overall Study|Death|5|||
162795990|NCT02815579|587963944|FG001|Overall Study|Death|4|||
162795991|NCT02815579|587963943|FG000|Overall Study|Imprisoned|0|||
162795992|NCT02815579|587963944|FG001|Overall Study|Imprisoned|2|||
162795993|NCT02815579|587963943|FG000|Overall Study|Did not meet enrollment criteria|0|||
162795994|NCT02815579|587963944|FG001|Overall Study|Did not meet enrollment criteria|1|||
162795995|NCT02389452|587963945|FG000|Overall Study|Lost to Follow-up|13|||
162795996|NCT02389452|587963945|FG000|Overall Study|Adverse Event|1|||
162795997|NCT02389452|587963945|FG000|Overall Study|Withdrawal by Subject|5|||
162795998|NCT02389452|587963945|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
162795999|NCT02311673|587963946|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162796000|NCT02311673|587963947|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162796001|NCT02311673|587963948|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
162796002|NCT02311673|587963949|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162796003|NCT00414908|587963955|FG000|Overall Study|Protocol Violation|1|||
162796004|NCT00414908|587963956|FG001|Overall Study|Protocol Violation|1|||
162796005|NCT00818168|587963959|FG000|Overall Study|Lack of Efficacy|18|||
162796006|NCT00818168|587963959|FG000|Overall Study|Pregnancy|2|||
162796007|NCT00818168|587963959|FG000|Overall Study|Withdrawal by Subject|16|||
162796008|NCT00818168|587963959|FG000|Overall Study|Lost to Follow-up|7|||
162796009|NCT00818168|587963959|FG000|Overall Study|Adverse Event|19|||
162796010|NCT00818168|587963959|FG000|Overall Study|Reason for Non-completion Not reported|6|||
162796011|NCT00818168|587963959|FG000|Overall Study|Participant Moved|2|||
162796012|NCT01977677|587963960|FG000|Overall Study|Unrelated Adverse Event|0|||
162796013|NCT01977677|587963961|FG001|Overall Study|Unrelated Adverse Event|0|||
162796014|NCT01977677|587963962|FG002|Overall Study|Unrelated Adverse Event|1|||
162796015|NCT00667225|587963967|FG000|Overall Study|Subject had no more lesions to treat.|1|||
162796016|NCT00667225|587963968|FG001|Overall Study|Subject had no more lesions to treat.|0|||
162796017|NCT00667225|587963967|FG000|Overall Study|Lost to Follow-up|0|||
162796018|NCT00667225|587963968|FG001|Overall Study|Lost to Follow-up|1|||
162796019|NCT02248818|587963969|FG000|Screening|Protocol Violation|0|||
162796020|NCT02248818|587963970|FG001|Screening|Protocol Violation|0|||
162796021|NCT02248818|587963971|FG002|Screening|Protocol Violation|0|||
162796022|NCT02248818|587963972|FG003|Screening|Protocol Violation|0|||
162796023|NCT02248818|587963973|FG004|Screening|Protocol Violation|0|||
162796024|NCT02248818|587963974|FG005|Screening|Protocol Violation|0|||
162796025|NCT02248818|587963975|FG006|Screening|Protocol Violation|0|||
162796026|NCT02248818|587963976|FG007|Screening|Protocol Violation|0|||
162796027|NCT02248818|587963977|FG008|Screening|Protocol Violation|7|||
162796028|NCT02248818|587963969|FG000|Screening|Study fully enrolled|0|||
162796029|NCT02248818|587963970|FG001|Screening|Study fully enrolled|0|||
162796030|NCT02248818|587963971|FG002|Screening|Study fully enrolled|0|||
162796031|NCT02248818|587963972|FG003|Screening|Study fully enrolled|0|||
162796032|NCT02248818|587963973|FG004|Screening|Study fully enrolled|0|||
162796033|NCT02248818|587963974|FG005|Screening|Study fully enrolled|0|||
162796034|NCT02248818|587963975|FG006|Screening|Study fully enrolled|0|||
162796035|NCT02248818|587963976|FG007|Screening|Study fully enrolled|0|||
162796036|NCT02248818|587963977|FG008|Screening|Study fully enrolled|14|||
162796037|NCT02248818|587963969|FG000|Screening|Physician Decision|0|||
162796038|NCT02248818|587963970|FG001|Screening|Physician Decision|0|||
162796039|NCT02248818|587963971|FG002|Screening|Physician Decision|0|||
162796040|NCT02248818|587963972|FG003|Screening|Physician Decision|0|||
162796041|NCT02248818|587963973|FG004|Screening|Physician Decision|0|||
162796042|NCT02248818|587963974|FG005|Screening|Physician Decision|0|||
162796043|NCT02248818|587963975|FG006|Screening|Physician Decision|0|||
162796044|NCT02248818|587963976|FG007|Screening|Physician Decision|0|||
162796045|NCT02248818|587963977|FG008|Screening|Physician Decision|73|||
162796046|NCT02248818|587963969|FG000|Screening|Withdrawal by Subject|0|||
162796047|NCT02248818|587963970|FG001|Screening|Withdrawal by Subject|0|||
162796048|NCT02248818|587963971|FG002|Screening|Withdrawal by Subject|0|||
162796049|NCT02248818|587963972|FG003|Screening|Withdrawal by Subject|0|||
162796050|NCT02248818|587963973|FG004|Screening|Withdrawal by Subject|0|||
162796051|NCT02248818|587963974|FG005|Screening|Withdrawal by Subject|0|||
162796052|NCT02248818|587963975|FG006|Screening|Withdrawal by Subject|0|||
162796053|NCT02248818|587963976|FG007|Screening|Withdrawal by Subject|0|||
162796054|NCT02248818|587963977|FG008|Screening|Withdrawal by Subject|6|||
162796055|NCT02248818|587963969|FG000|Screening|Lost to Follow-up|0|||
162796056|NCT02248818|587963970|FG001|Screening|Lost to Follow-up|0|||
162796057|NCT02248818|587963971|FG002|Screening|Lost to Follow-up|0|||
162796058|NCT02248818|587963972|FG003|Screening|Lost to Follow-up|0|||
162796059|NCT02248818|587963973|FG004|Screening|Lost to Follow-up|0|||
162796060|NCT02248818|587963974|FG005|Screening|Lost to Follow-up|0|||
162796061|NCT02248818|587963975|FG006|Screening|Lost to Follow-up|0|||
162796062|NCT02248818|587963976|FG007|Screening|Lost to Follow-up|0|||
162796063|NCT02248818|587963977|FG008|Screening|Lost to Follow-up|7|||
162796064|NCT02248818|587963969|FG000|Randomised Study|Administrative - randomization error|0|||
162796065|NCT02248818|587963970|FG001|Randomised Study|Administrative - randomization error|0|||
162796066|NCT02248818|587963971|FG002|Randomised Study|Administrative - randomization error|0|||
162796067|NCT02248818|587963972|FG003|Randomised Study|Administrative - randomization error|0|||
162796068|NCT02248818|587963973|FG004|Randomised Study|Administrative - randomization error|0|||
162796069|NCT02248818|587963974|FG005|Randomised Study|Administrative - randomization error|8|||
162796070|NCT02248818|587963975|FG006|Randomised Study|Administrative - randomization error|0|||
162796071|NCT02248818|587963976|FG007|Randomised Study|Administrative - randomization error|0|||
162796072|NCT02248818|587963977|FG008|Randomised Study|Administrative - randomization error|0|||
162796073|NCT02942277|587963980|FG000|Year 1|Withdrawal by Subject|0|||
162796074|NCT02942277|587963981|FG001|Year 1|Withdrawal by Subject|0|||
162796075|NCT02942277|587963982|FG002|Year 1|Withdrawal by Subject|0|||
162796076|NCT02942277|587963983|FG003|Year 1|Withdrawal by Subject|0|||
162796077|NCT02942277|587963984|FG004|Year 1|Withdrawal by Subject|1|||
162796078|NCT02942277|587963985|FG005|Year 1|Withdrawal by Subject|3|||
162796079|NCT02942277|587963986|FG006|Year 1|Withdrawal by Subject|0|||
162796080|NCT02942277|587963987|FG007|Year 1|Withdrawal by Subject|1|||
162796081|NCT02942277|587963988|FG008|Year 1|Withdrawal by Subject|0|||
162796082|NCT02942277|587963989|FG009|Year 1|Withdrawal by Subject|0|||
162796083|NCT02942277|587963990|FG010|Year 1|Withdrawal by Subject|3|||
162796084|NCT02942277|587963980|FG000|Year 1|Travel|0|||
162796085|NCT02942277|587963981|FG001|Year 1|Travel|1|||
162796086|NCT02942277|587963982|FG002|Year 1|Travel|0|||
162796087|NCT02942277|587963983|FG003|Year 1|Travel|0|||
162796088|NCT02942277|587963984|FG004|Year 1|Travel|4|||
162796089|NCT02942277|587963985|FG005|Year 1|Travel|5|||
162796090|NCT02942277|587963986|FG006|Year 1|Travel|0|||
162796091|NCT02942277|587963987|FG007|Year 1|Travel|0|||
162796092|NCT02942277|587963988|FG008|Year 1|Travel|0|||
162796093|NCT02942277|587963989|FG009|Year 1|Travel|0|||
162796094|NCT02942277|587963990|FG010|Year 1|Travel|8|||
162796095|NCT02942277|587963980|FG000|Year 1|Joined Army|0|||
162796096|NCT02942277|587963981|FG001|Year 1|Joined Army|1|||
162796097|NCT02942277|587963982|FG002|Year 1|Joined Army|0|||
162796098|NCT02942277|587963983|FG003|Year 1|Joined Army|0|||
162796099|NCT02942277|587963984|FG004|Year 1|Joined Army|0|||
162796100|NCT02942277|587963985|FG005|Year 1|Joined Army|0|||
162796101|NCT02942277|587963986|FG006|Year 1|Joined Army|0|||
162796102|NCT02942277|587963987|FG007|Year 1|Joined Army|0|||
162796103|NCT02942277|587963988|FG008|Year 1|Joined Army|0|||
162796104|NCT02942277|587963989|FG009|Year 1|Joined Army|0|||
162796105|NCT02942277|587963990|FG010|Year 1|Joined Army|0|||
162796106|NCT02942277|587963980|FG000|Year 1|Subject met withdrawal criteria|0|||
162796107|NCT02942277|587963981|FG001|Year 1|Subject met withdrawal criteria|0|||
162796108|NCT02942277|587963982|FG002|Year 1|Subject met withdrawal criteria|0|||
162796109|NCT02942277|587963983|FG003|Year 1|Subject met withdrawal criteria|1|||
162796110|NCT02942277|587963984|FG004|Year 1|Subject met withdrawal criteria|0|||
162796111|NCT02942277|587963985|FG005|Year 1|Subject met withdrawal criteria|0|||
162796112|NCT02942277|587963986|FG006|Year 1|Subject met withdrawal criteria|0|||
162796113|NCT02942277|587963987|FG007|Year 1|Subject met withdrawal criteria|0|||
162796114|NCT02942277|587963988|FG008|Year 1|Subject met withdrawal criteria|0|||
162796115|NCT02942277|587963989|FG009|Year 1|Subject met withdrawal criteria|0|||
162796116|NCT02942277|587963990|FG010|Year 1|Subject met withdrawal criteria|0|||
162796117|NCT02942277|587963980|FG000|Year 1|Lost to Follow-up|0|||
162796118|NCT02942277|587963981|FG001|Year 1|Lost to Follow-up|0|||
162796119|NCT02942277|587963982|FG002|Year 1|Lost to Follow-up|0|||
162796120|NCT02942277|587963983|FG003|Year 1|Lost to Follow-up|0|||
162796121|NCT02942277|587963984|FG004|Year 1|Lost to Follow-up|1|||
162796122|NCT02942277|587963985|FG005|Year 1|Lost to Follow-up|0|||
162796123|NCT02942277|587963986|FG006|Year 1|Lost to Follow-up|0|||
162796124|NCT02942277|587963987|FG007|Year 1|Lost to Follow-up|0|||
162796125|NCT02942277|587963988|FG008|Year 1|Lost to Follow-up|0|||
162796126|NCT02942277|587963989|FG009|Year 1|Lost to Follow-up|0|||
162796127|NCT02942277|587963990|FG010|Year 1|Lost to Follow-up|2|||
162796128|NCT02942277|587963980|FG000|Year 1|Protocol Violation|0|||
162796129|NCT02942277|587963981|FG001|Year 1|Protocol Violation|0|||
162796130|NCT02942277|587963982|FG002|Year 1|Protocol Violation|0|||
162796131|NCT02942277|587963983|FG003|Year 1|Protocol Violation|0|||
162796132|NCT02942277|587963984|FG004|Year 1|Protocol Violation|1|||
162796133|NCT02942277|587963985|FG005|Year 1|Protocol Violation|1|||
162796134|NCT02942277|587963986|FG006|Year 1|Protocol Violation|0|||
162796135|NCT02942277|587963987|FG007|Year 1|Protocol Violation|0|||
162796136|NCT02942277|587963988|FG008|Year 1|Protocol Violation|0|||
162796137|NCT02942277|587963989|FG009|Year 1|Protocol Violation|0|||
162796138|NCT02942277|587963990|FG010|Year 1|Protocol Violation|2|||
162796139|NCT02942277|587963980|FG000|Year 1|Pregnancy|0|||
162796140|NCT02942277|587963981|FG001|Year 1|Pregnancy|0|||
162796141|NCT02942277|587963982|FG002|Year 1|Pregnancy|0|||
162796142|NCT02942277|587963983|FG003|Year 1|Pregnancy|0|||
162796143|NCT02942277|587963984|FG004|Year 1|Pregnancy|0|||
162796144|NCT02942277|587963985|FG005|Year 1|Pregnancy|1|||
162796145|NCT02942277|587963986|FG006|Year 1|Pregnancy|0|||
162796146|NCT02942277|587963987|FG007|Year 1|Pregnancy|0|||
162796147|NCT02942277|587963988|FG008|Year 1|Pregnancy|0|||
162796148|NCT02942277|587963989|FG009|Year 1|Pregnancy|0|||
162796149|NCT02942277|587963990|FG010|Year 1|Pregnancy|0|||
162796150|NCT02942277|587963980|FG000|Year 2|Lost to Follow-up|0|||
162796151|NCT02942277|587963981|FG001|Year 2|Lost to Follow-up|0|||
162796152|NCT02942277|587963982|FG002|Year 2|Lost to Follow-up|0|||
162796153|NCT02942277|587963983|FG003|Year 2|Lost to Follow-up|0|||
162796154|NCT02942277|587963984|FG004|Year 2|Lost to Follow-up|2|||
162796155|NCT02942277|587963985|FG005|Year 2|Lost to Follow-up|1|||
162796156|NCT02942277|587963986|FG006|Year 2|Lost to Follow-up|0|||
162796157|NCT02942277|587963987|FG007|Year 2|Lost to Follow-up|0|||
162796158|NCT02942277|587963988|FG008|Year 2|Lost to Follow-up|0|||
162796159|NCT02942277|587963989|FG009|Year 2|Lost to Follow-up|0|||
162796160|NCT02942277|587963990|FG010|Year 2|Lost to Follow-up|0|||
162796161|NCT02942277|587963980|FG000|Year 2|Did not rescreen|0|||
162796162|NCT02942277|587963981|FG001|Year 2|Did not rescreen|0|||
162796163|NCT02942277|587963982|FG002|Year 2|Did not rescreen|1|||
162796164|NCT02942277|587963983|FG003|Year 2|Did not rescreen|1|||
162796165|NCT02942277|587963984|FG004|Year 2|Did not rescreen|9|||
162796166|NCT02942277|587963985|FG005|Year 2|Did not rescreen|6|||
162796167|NCT02942277|587963986|FG006|Year 2|Did not rescreen|0|||
162796168|NCT02942277|587963987|FG007|Year 2|Did not rescreen|1|||
162796169|NCT02942277|587963988|FG008|Year 2|Did not rescreen|0|||
162796170|NCT02942277|587963989|FG009|Year 2|Did not rescreen|0|||
162796171|NCT02942277|587963990|FG010|Year 2|Did not rescreen|21|||
162796172|NCT02942277|587963980|FG000|Year 2|Met withdrawal criteria|0|||
162796173|NCT02942277|587963981|FG001|Year 2|Met withdrawal criteria|0|||
162796174|NCT02942277|587963982|FG002|Year 2|Met withdrawal criteria|0|||
162796175|NCT02942277|587963983|FG003|Year 2|Met withdrawal criteria|0|||
162796176|NCT02942277|587963984|FG004|Year 2|Met withdrawal criteria|1|||
162796177|NCT02942277|587963985|FG005|Year 2|Met withdrawal criteria|2|||
162796178|NCT02942277|587963986|FG006|Year 2|Met withdrawal criteria|0|||
162796179|NCT02942277|587963987|FG007|Year 2|Met withdrawal criteria|0|||
162796180|NCT02942277|587963988|FG008|Year 2|Met withdrawal criteria|0|||
162796181|NCT02942277|587963989|FG009|Year 2|Met withdrawal criteria|0|||
162796182|NCT02942277|587963990|FG010|Year 2|Met withdrawal criteria|1|||
162796183|NCT02942277|587963980|FG000|Year 2|Travel|0|||
162796184|NCT02942277|587963981|FG001|Year 2|Travel|1|||
162796185|NCT02942277|587963982|FG002|Year 2|Travel|0|||
162796186|NCT02942277|587963983|FG003|Year 2|Travel|0|||
162796187|NCT02942277|587963984|FG004|Year 2|Travel|0|||
162796188|NCT02942277|587963985|FG005|Year 2|Travel|1|||
162796189|NCT02942277|587963986|FG006|Year 2|Travel|0|||
162796190|NCT02942277|587963987|FG007|Year 2|Travel|0|||
162796191|NCT02942277|587963988|FG008|Year 2|Travel|0|||
162796192|NCT02942277|587963989|FG009|Year 2|Travel|1|||
162796193|NCT02942277|587963990|FG010|Year 2|Travel|3|||
162796194|NCT02942277|587963980|FG000|Year 2|Non-compliant|0|||
162796195|NCT02942277|587963981|FG001|Year 2|Non-compliant|0|||
162796196|NCT02942277|587963982|FG002|Year 2|Non-compliant|0|||
162796197|NCT02942277|587963983|FG003|Year 2|Non-compliant|0|||
162796198|NCT02942277|587963984|FG004|Year 2|Non-compliant|1|||
162796199|NCT02942277|587963985|FG005|Year 2|Non-compliant|1|||
162796200|NCT02942277|587963986|FG006|Year 2|Non-compliant|0|||
162796201|NCT02942277|587963987|FG007|Year 2|Non-compliant|0|||
162796202|NCT02942277|587963988|FG008|Year 2|Non-compliant|0|||
162796203|NCT02942277|587963989|FG009|Year 2|Non-compliant|0|||
162796204|NCT02942277|587963990|FG010|Year 2|Non-compliant|0|||
162796205|NCT02942277|587963980|FG000|Year 2|Withdrawal by Subject|0|||
162796206|NCT02942277|587963981|FG001|Year 2|Withdrawal by Subject|0|||
162796207|NCT02942277|587963982|FG002|Year 2|Withdrawal by Subject|0|||
162796208|NCT02942277|587963983|FG003|Year 2|Withdrawal by Subject|0|||
162796209|NCT02942277|587963984|FG004|Year 2|Withdrawal by Subject|0|||
162796210|NCT02942277|587963985|FG005|Year 2|Withdrawal by Subject|0|||
162796211|NCT02942277|587963986|FG006|Year 2|Withdrawal by Subject|1|||
162796212|NCT02942277|587963987|FG007|Year 2|Withdrawal by Subject|0|||
162796213|NCT02942277|587963988|FG008|Year 2|Withdrawal by Subject|0|||
162796214|NCT02942277|587963989|FG009|Year 2|Withdrawal by Subject|0|||
162796215|NCT02942277|587963990|FG010|Year 2|Withdrawal by Subject|0|||
162796216|NCT04313608|587963991|FG000|Overall Study|Death|12|||
162796217|NCT04313608|587963992|FG001|Overall Study|Death|3|||
162796218|NCT01867333|587963993|FG000|Overall Study|Withdrawal by Subject|1|||
162796219|NCT01867333|587963994|FG001|Overall Study|Withdrawal by Subject|0|||
162796220|NCT01867333|587963993|FG000|Overall Study|Adverse Event|1|||
162796221|NCT01867333|587963994|FG001|Overall Study|Adverse Event|0|||
162796222|NCT01867333|587963993|FG000|Overall Study|Participant choice|1|||
162796223|NCT01867333|587963994|FG001|Overall Study|Participant choice|2|||
162796224|NCT01867333|587963993|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
162796225|NCT01867333|587963994|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
162796226|NCT01867333|587963993|FG000|Overall Study|Death|0|||
162796227|NCT01867333|587963994|FG001|Overall Study|Death|1|||
162796228|NCT01867333|587963993|FG000|Overall Study|Physician Decision|3|||
162796229|NCT01867333|587963994|FG001|Overall Study|Physician Decision|2|||
162796230|NCT01867333|587963993|FG000|Overall Study|Switched to alternative treatment|1|||
162796231|NCT01867333|587963994|FG001|Overall Study|Switched to alternative treatment|0|||
162796232|NCT01145898|587963995|FG000|3-year Treatment|medication change by treating physician|3|||
162796233|NCT01145898|587963996|FG001|3-year Treatment|medication change by treating physician|16|||
162796234|NCT00879775|587963997|FG000|Overall Study|Lost to Follow-up|2|||
162796235|NCT00879775|587963998|FG001|Overall Study|Lost to Follow-up|1|||
162796236|NCT01162863|587964002|FG000|Overall Study|Lack of Efficacy|1|||
162796237|NCT01162863|587964003|FG001|Overall Study|Lack of Efficacy|0|||
162796238|NCT01162863|587964004|FG002|Overall Study|Lack of Efficacy|0|||
162796239|NCT01162863|587964002|FG000|Overall Study|Adverse Event|0|||
162796240|NCT01162863|587964003|FG001|Overall Study|Adverse Event|1|||
162796241|NCT01162863|587964004|FG002|Overall Study|Adverse Event|0|||
162796242|NCT00392925|587964005|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
162796243|NCT00392925|587964006|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
162796244|NCT00392925|587964007|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
162796245|NCT00392925|587964008|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
162796246|NCT00392925|587964005|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
162796247|NCT00392925|587964006|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162796248|NCT00392925|587964007|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162796249|NCT00392925|587964008|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162796250|NCT00392925|587964005|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
162796251|NCT00392925|587964006|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162796252|NCT00392925|587964007|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162796253|NCT00392925|587964008|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162796254|NCT00392925|587964005|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
162796255|NCT00392925|587964006|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162796256|NCT00392925|587964007|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162796257|NCT00392925|587964008|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162796258|NCT00392925|587964005|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
162796259|NCT00392925|587964006|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162796260|NCT00392925|587964007|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162796261|NCT00392925|587964008|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162796262|NCT00392925|587964005|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
162796263|NCT00392925|587964006|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
162796264|NCT00392925|587964007|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
162796265|NCT00392925|587964008|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
162796266|NCT00392925|587964005|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
162796267|NCT00392925|587964006|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
162796268|NCT00392925|587964007|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
162796269|NCT00392925|587964008|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
162796270|NCT00392925|587964005|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
162796271|NCT00392925|587964006|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
162796272|NCT00392925|587964007|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
162796273|NCT00392925|587964008|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
162796274|NCT00392925|587964005|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
162796275|NCT00392925|587964006|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
162796276|NCT00392925|587964007|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
162796277|NCT00392925|587964008|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
162796278|NCT04145700|587964009|FG000|Overall Study|Withdrawal by Subject|8|||
162796279|NCT04145700|587964010|FG001|Overall Study|Withdrawal by Subject|3|||
162796280|NCT00780559|587964013|FG000|Overall Study|Lost to Follow-up|2|||
162796281|NCT00780559|587964014|FG001|Overall Study|Lost to Follow-up|7|||
162796282|NCT00780559|587964013|FG000|Overall Study|Death|1|||
162796283|NCT00780559|587964014|FG001|Overall Study|Death|0|||
162796284|NCT01840410|587964019|FG000|Overall Study|Physician Decision|1|||
162796285|NCT01840410|587964020|FG001|Overall Study|Physician Decision|2|||
162796286|NCT01840410|587964019|FG000|Overall Study|Pregnancy|1|||
162796287|NCT01840410|587964020|FG001|Overall Study|Pregnancy|0|||
162796288|NCT01840410|587964019|FG000|Overall Study|Protocol deviation|1|||
162796289|NCT01840410|587964020|FG001|Overall Study|Protocol deviation|0|||
162796290|NCT01840410|587964019|FG000|Overall Study|Lost to Follow-up|1|||
162796291|NCT01840410|587964020|FG001|Overall Study|Lost to Follow-up|0|||
162796292|NCT01840410|587964019|FG000|Overall Study|Withdrawal by Subject|2|||
162796293|NCT01840410|587964020|FG001|Overall Study|Withdrawal by Subject|1|||
162796294|NCT01840410|587964019|FG000|Overall Study|Adverse Event|1|||
162796295|NCT01840410|587964020|FG001|Overall Study|Adverse Event|1|||
162796296|NCT02206061|587964021|FG000|Overall Study|Withdrawal by Subject|4|||
162796297|NCT02206061|587964022|FG001|Overall Study|Withdrawal by Subject|7|||
162796298|NCT02206061|587964023|FG002|Overall Study|Withdrawal by Subject|1|||
162796299|NCT02206061|587964021|FG000|Overall Study|Lost to Follow-up|14|||
162796300|NCT02206061|587964022|FG001|Overall Study|Lost to Follow-up|7|||
162796301|NCT02206061|587964023|FG002|Overall Study|Lost to Follow-up|20|||
162796302|NCT00694109|587964024|FG000|Overall Study|Physician Decision|3|||
162796303|NCT00694109|587964024|FG000|Overall Study|Adverse Event|74|||
162796304|NCT00694109|587964024|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
162796305|NCT00694109|587964024|FG000|Overall Study|Lack of Efficacy|2|||
162796306|NCT00694109|587964024|FG000|Overall Study|Withdrawal by Subject|13|||
162796307|NCT00694109|587964024|FG000|Overall Study|Pregnancy|1|||
162796308|NCT00694109|587964024|FG000|Overall Study|Enrolled but not treated|1|||
162796309|NCT00694109|587964024|FG000|Overall Study|Other|2|||
162796310|NCT00694109|587964024|FG000|Overall Study|Consented but no additional treatment|3|||
162796311|NCT04608773|587964025|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
162796312|NCT04608773|587964026|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
162796313|NCT04608773|587964025|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
162796314|NCT04608773|587964026|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
162796315|NCT04608773|587964025|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
162796316|NCT04608773|587964026|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
162796317|NCT04608773|587964025|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
162796318|NCT04608773|587964026|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
162796319|NCT04608773|587964025|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
162796320|NCT04608773|587964026|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
162796321|NCT02833077|587964027|FG000|Overall Study|Adverse Event|1|||
162796322|NCT02833077|587964028|FG001|Overall Study|Adverse Event|2|||
162796323|NCT02833077|587964027|FG000|Overall Study|Lost to Follow-up|10|||
162796324|NCT02833077|587964028|FG001|Overall Study|Lost to Follow-up|1|||
162796325|NCT02833077|587964027|FG000|Overall Study|Personal Reasons|6|||
162796326|NCT02833077|587964028|FG001|Overall Study|Personal Reasons|4|||
162796327|NCT02833077|587964027|FG000|Overall Study|Protocol Deviation|0|||
162796328|NCT02833077|587964028|FG001|Overall Study|Protocol Deviation|1|||
162796329|NCT01077518|587964031|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
162796330|NCT01077518|587964032|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
162796331|NCT01077518|587964033|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
162796332|NCT01077518|587964031|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
162796333|NCT01077518|587964032|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
162796334|NCT01077518|587964033|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
162796335|NCT01077518|587964031|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
162796336|NCT01077518|587964032|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
162796337|NCT01077518|587964033|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
162796338|NCT01077518|587964031|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
162796339|NCT01077518|587964032|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
162796340|NCT01077518|587964033|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
162796341|NCT01077518|587964031|FG000|Optional Ofa Phase|Physician Decision|0|||
162796342|NCT01077518|587964032|FG001|Optional Ofa Phase|Physician Decision|0|||
162796343|NCT01077518|587964033|FG002|Optional Ofa Phase|Physician Decision|1|||
162796344|NCT01077518|587964031|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
162796345|NCT01077518|587964032|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
162796346|NCT01077518|587964033|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
162796347|NCT01077518|587964031|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
162796348|NCT01077518|587964032|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
162796349|NCT01077518|587964033|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
162796350|NCT00972322|587964034|FG000|Overall Study|Adverse Event|2|||
162796351|NCT00972322|587964035|FG001|Overall Study|Adverse Event|1|||
162796352|NCT00972322|587964034|FG000|Overall Study|Positive drug screen|0|||
162796353|NCT00972322|587964035|FG001|Overall Study|Positive drug screen|1|||
162796354|NCT00972322|587964034|FG000|Overall Study|Lost to Follow-up|0|||
162796355|NCT00972322|587964035|FG001|Overall Study|Lost to Follow-up|1|||
162796356|NCT00972322|587964034|FG000|Overall Study|Consistently high glucose values|1|||
162796357|NCT00972322|587964035|FG001|Overall Study|Consistently high glucose values|0|||
162796358|NCT04958200|587964036|FG000|Overall Study|Withdrawal by Subject|0|||
162796359|NCT04958200|587964037|FG001|Overall Study|Withdrawal by Subject|2|||
162796360|NCT04958200|587964036|FG000|Overall Study|Lost to Follow-up|3|||
162796361|NCT04958200|587964037|FG001|Overall Study|Lost to Follow-up|2|||
162796362|NCT00316017|587964040|FG000|Overall Study|Protocol Violation|11|||
162796363|NCT00316017|587964041|FG001|Overall Study|Protocol Violation|13|||
162796364|NCT00316017|587964042|FG002|Overall Study|Protocol Violation|19|||
162796365|NCT04157400|587964043|FG000|Overall Study|Withdrawal by Subject|1|||
162796366|NCT04157400|587964043|FG000|Overall Study|Lost to Follow-up|3|||
162796367|NCT00623805|587964048|FG000|Overall Study|Adverse Event|9|||
162796368|NCT00623805|587964049|FG001|Overall Study|Adverse Event|6|||
162796369|NCT00623805|587964048|FG000|Overall Study|Death|2|||
162796370|NCT00623805|587964049|FG001|Overall Study|Death|0|||
162796371|NCT00623805|587964048|FG000|Overall Study|Lack of Efficacy|3|||
162796372|NCT00623805|587964049|FG001|Overall Study|Lack of Efficacy|7|||
162796373|NCT00623805|587964048|FG000|Overall Study|Lost to Follow-up|2|||
162796374|NCT00623805|587964049|FG001|Overall Study|Lost to Follow-up|2|||
162796375|NCT00623805|587964048|FG000|Overall Study|Protocol Violation|1|||
162796376|NCT00623805|587964049|FG001|Overall Study|Protocol Violation|1|||
162796377|NCT00623805|587964048|FG000|Overall Study|Reason not Specified|3|||
162796378|NCT00623805|587964049|FG001|Overall Study|Reason not Specified|6|||
162796379|NCT02671500|587964052|FG000|Overall Study|Lack of Efficacy|12|||
162796380|NCT02671500|587964052|FG000|Overall Study|Lost to Follow-up|2|||
162796381|NCT05235269|587964054|FG000|Overall Study|Adverse Event|1|||
162796382|NCT05235269|587964054|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
162796383|NCT05235269|587964054|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
162796384|NCT03361865|587964055|FG000|Overall Study|Death|17|||
162796385|NCT03361865|587964056|FG001|Overall Study|Death|18|||
162796386|NCT03361865|587964055|FG000|Overall Study|Physician Decision|1|||
162796387|NCT03361865|587964056|FG001|Overall Study|Physician Decision|9|||
162796388|NCT03361865|587964055|FG000|Overall Study|Withdrawal by Subject|1|||
162796389|NCT03361865|587964056|FG001|Overall Study|Withdrawal by Subject|0|||
162796390|NCT03852719|587964057|FG000|Overall Study|Withdrawal of consent|8|||
162796391|NCT03852719|587964058|FG001|Overall Study|Withdrawal of consent|8|||
162796392|NCT03852719|587964059|FG002|Overall Study|Withdrawal of consent|9|||
162796393|NCT03852719|587964057|FG000|Overall Study|Physician Decision|5|||
162796394|NCT03852719|587964058|FG001|Overall Study|Physician Decision|4|||
162796395|NCT03852719|587964059|FG002|Overall Study|Physician Decision|1|||
162796396|NCT03852719|587964057|FG000|Overall Study|Pregnancy|2|||
162796397|NCT03852719|587964058|FG001|Overall Study|Pregnancy|1|||
162796398|NCT03852719|587964059|FG002|Overall Study|Pregnancy|0|||
162796399|NCT03852719|587964057|FG000|Overall Study|Death|1|||
162796400|NCT03852719|587964058|FG001|Overall Study|Death|0|||
162796401|NCT03852719|587964059|FG002|Overall Study|Death|0|||
162796402|NCT03852719|587964057|FG000|Overall Study|Reason not Specified|3|||
162796403|NCT03852719|587964058|FG001|Overall Study|Reason not Specified|3|||
162796404|NCT03852719|587964059|FG002|Overall Study|Reason not Specified|5|||
162796405|NCT03852719|587964057|FG000|Overall Study|Adverse Event|2|||
162796406|NCT03852719|587964058|FG001|Overall Study|Adverse Event|1|||
162796407|NCT03852719|587964059|FG002|Overall Study|Adverse Event|4|||
162796408|NCT03852719|587964057|FG000|Overall Study|Progressive disease|1|||
162796409|NCT03852719|587964058|FG001|Overall Study|Progressive disease|4|||
162796410|NCT03852719|587964059|FG002|Overall Study|Progressive disease|1|||
162796411|NCT03852719|587964057|FG000|Overall Study|Lost to Follow-up|1|||
162796412|NCT03852719|587964058|FG001|Overall Study|Lost to Follow-up|0|||
162796413|NCT03852719|587964059|FG002|Overall Study|Lost to Follow-up|0|||
162796414|NCT03810235|587964060|FG000|Overall Study|Withdrawal by Subject|2|||
162796415|NCT03810235|587964061|FG001|Overall Study|Withdrawal by Subject|0|||
162796416|NCT04201262|587964062|FG000|Primary Treatment Period|Adverse Event|1|||
162796417|NCT04201262|587964063|FG001|Primary Treatment Period|Adverse Event|2|||
162796418|NCT04201262|587964062|FG000|Primary Treatment Period|Physician Decision|1|||
162796419|NCT04201262|587964063|FG001|Primary Treatment Period|Physician Decision|1|||
162796420|NCT04201262|587964062|FG000|Long-term Extension Period|Death|1|||
162796421|NCT04201262|587964063|FG001|Long-term Extension Period|Death|0|||
162796422|NCT01647542|587964065|FG000|Overall Study|Major Protocol Deviation|1|||
162796423|NCT01647542|587964066|FG001|Overall Study|Major Protocol Deviation|0|||
162796424|NCT01647542|587964067|FG002|Overall Study|Major Protocol Deviation|0|||
162796425|NCT01647542|587964065|FG000|Overall Study|Adverse Event|4|||
162796426|NCT01647542|587964066|FG001|Overall Study|Adverse Event|5|||
162796427|NCT01647542|587964067|FG002|Overall Study|Adverse Event|4|||
162796428|NCT01647542|587964065|FG000|Overall Study|Lost to Follow-up|0|||
162796429|NCT01647542|587964066|FG001|Overall Study|Lost to Follow-up|2|||
162796430|NCT01647542|587964067|FG002|Overall Study|Lost to Follow-up|2|||
162796431|NCT01647542|587964065|FG000|Overall Study|Withdrawal by Subject|6|||
162796432|NCT01647542|587964066|FG001|Overall Study|Withdrawal by Subject|4|||
162796433|NCT01647542|587964067|FG002|Overall Study|Withdrawal by Subject|0|||
162796434|NCT01647542|587964065|FG000|Overall Study|Study Termination|64|||
162796435|NCT01647542|587964066|FG001|Overall Study|Study Termination|61|||
162796436|NCT01647542|587964067|FG002|Overall Study|Study Termination|65|||
162796437|NCT01647542|587964065|FG000|Overall Study|Lack of Efficacy|1|||
162796438|NCT01647542|587964066|FG001|Overall Study|Lack of Efficacy|1|||
162796439|NCT01647542|587964067|FG002|Overall Study|Lack of Efficacy|0|||
162796440|NCT01647542|587964065|FG000|Overall Study|Death|0|||
162796441|NCT01647542|587964066|FG001|Overall Study|Death|0|||
162796442|NCT01647542|587964067|FG002|Overall Study|Death|1|||
162796443|NCT02819024|587964068|FG000|Overall Study|Withdrawal by Subject|1|||
162796444|NCT05217641|587964072|FG000|Overall Study|Lost to Follow-up|1|||
162796445|NCT05217641|587964073|FG001|Overall Study|Lost to Follow-up|1|||
162796446|NCT05217641|587964074|FG002|Overall Study|Lost to Follow-up|0|||
162796447|NCT05217641|587964075|FG003|Overall Study|Lost to Follow-up|1|||
162796448|NCT05217641|587964076|FG004|Overall Study|Lost to Follow-up|1|||
162796449|NCT05217641|587964077|FG005|Overall Study|Lost to Follow-up|0|||
162796450|NCT05217641|587964072|FG000|Overall Study|Withdrawal by Subject|0|||
162796451|NCT05217641|587964073|FG001|Overall Study|Withdrawal by Subject|0|||
162796452|NCT05217641|587964074|FG002|Overall Study|Withdrawal by Subject|0|||
162796453|NCT05217641|587964075|FG003|Overall Study|Withdrawal by Subject|3|||
162796454|NCT05217641|587964076|FG004|Overall Study|Withdrawal by Subject|1|||
162796455|NCT05217641|587964077|FG005|Overall Study|Withdrawal by Subject|0|||
162796456|NCT05217641|587964072|FG000|Overall Study|Other: participant did not specify reason|0|||
162796457|NCT05217641|587964073|FG001|Overall Study|Other: participant did not specify reason|0|||
162796458|NCT05217641|587964074|FG002|Overall Study|Other: participant did not specify reason|0|||
162796459|NCT05217641|587964075|FG003|Overall Study|Other: participant did not specify reason|0|||
162796460|NCT05217641|587964076|FG004|Overall Study|Other: participant did not specify reason|1|||
162796461|NCT05217641|587964077|FG005|Overall Study|Other: participant did not specify reason|0|||
162796462|NCT05217641|587964072|FG000|Overall Study|Extended Follow up|1|||
162796463|NCT05217641|587964073|FG001|Overall Study|Extended Follow up|1|||
162796464|NCT05217641|587964074|FG002|Overall Study|Extended Follow up|0|||
162796465|NCT05217641|587964075|FG003|Overall Study|Extended Follow up|0|||
162796466|NCT05217641|587964076|FG004|Overall Study|Extended Follow up|1|||
162796467|NCT05217641|587964077|FG005|Overall Study|Extended Follow up|0|||
162796468|NCT03548220|587964079|FG000|Overall Study|Lost to Follow-up|1|||
162796469|NCT03548220|587964080|FG001|Overall Study|Lost to Follow-up|0|||
162796470|NCT03548220|587964081|FG002|Overall Study|Lost to Follow-up|0|||
162796471|NCT03548220|587964082|FG003|Overall Study|Lost to Follow-up|0|||
162796472|NCT02397447|587964083|FG000|Overall Study|Lost to Follow-up|2|||
162796473|NCT02397447|587964084|FG001|Overall Study|Lost to Follow-up|2|||
162796474|NCT02994069|587964087|FG000|Overall Study|Death|7|||
162796475|NCT02994069|587964088|FG001|Overall Study|Death|13|||
162796476|NCT02994069|587964087|FG000|Overall Study|Adverse Event|1|||
162796477|NCT02994069|587964088|FG001|Overall Study|Adverse Event|0|||
162796478|NCT02994069|587964087|FG000|Overall Study|Other|2|||
162796479|NCT02994069|587964088|FG001|Overall Study|Other|0|||
162796480|NCT02994069|587964087|FG000|Overall Study|still on follow up/treatment|5|||
162796481|NCT02994069|587964088|FG001|Overall Study|still on follow up/treatment|6|||
162796482|NCT00833261|587965377|FG000|Overall Study|Withdrawal by Subject|4|||
162796483|NCT01076153|587965380|FG000|Overall Study|Symptoms improved/resolved|10|||
162796484|NCT01076153|587965380|FG000|Overall Study|Adverse Event|1|||
162796485|NCT04165031|587965381|FG000|Overall Study|Adverse Event|1|||
162796486|NCT04165031|587965382|FG001|Overall Study|Adverse Event|1|||
162796487|NCT04165031|587965383|FG002|Overall Study|Adverse Event|0|||
162796488|NCT04165031|587965384|FG003|Overall Study|Adverse Event|0|||
162796489|NCT04165031|587965385|FG004|Overall Study|Adverse Event|0|||
162796490|NCT04165031|587965386|FG005|Overall Study|Adverse Event|0|||
162796491|NCT04165031|587965381|FG000|Overall Study|Withdrawal by Subject|0|||
162796492|NCT04165031|587965382|FG001|Overall Study|Withdrawal by Subject|0|||
162796493|NCT04165031|587965383|FG002|Overall Study|Withdrawal by Subject|1|||
162796494|NCT04165031|587965384|FG003|Overall Study|Withdrawal by Subject|0|||
162796495|NCT04165031|587965385|FG004|Overall Study|Withdrawal by Subject|0|||
162796496|NCT04165031|587965386|FG005|Overall Study|Withdrawal by Subject|0|||
162796497|NCT03563157|587965391|FG000|Overall Study|Progressive Disease|2|||
162796498|NCT02187159|587965392|FG000|Overall Study|Protocol Violation|4|||
162796499|NCT02187159|587965393|FG001|Overall Study|Protocol Violation|6|||
162796500|NCT02187159|587965394|FG002|Overall Study|Protocol Violation|3|||
162796501|NCT02187159|587965395|FG003|Overall Study|Protocol Violation|4|||
162796502|NCT02187159|587965392|FG000|Overall Study|Lack of Efficacy|10|||
162796503|NCT02187159|587965393|FG001|Overall Study|Lack of Efficacy|5|||
162796504|NCT02187159|587965394|FG002|Overall Study|Lack of Efficacy|4|||
162796505|NCT02187159|587965395|FG003|Overall Study|Lack of Efficacy|7|||
162796506|NCT02187159|587965392|FG000|Overall Study|Adverse Event|28|||
162796507|NCT02187159|587965393|FG001|Overall Study|Adverse Event|33|||
162796508|NCT02187159|587965394|FG002|Overall Study|Adverse Event|42|||
162796509|NCT02187159|587965395|FG003|Overall Study|Adverse Event|50|||
162796510|NCT02187159|587965392|FG000|Overall Study|Withdrawal by Subject|24|||
162796511|NCT02187159|587965393|FG001|Overall Study|Withdrawal by Subject|28|||
162796512|NCT02187159|587965394|FG002|Overall Study|Withdrawal by Subject|25|||
162796513|NCT02187159|587965395|FG003|Overall Study|Withdrawal by Subject|26|||
162796514|NCT02187159|587965392|FG000|Overall Study|Other|3|||
162796515|NCT02187159|587965393|FG001|Overall Study|Other|7|||
162796516|NCT02187159|587965394|FG002|Overall Study|Other|3|||
162796517|NCT02187159|587965395|FG003|Overall Study|Other|9|||
162796518|NCT03482466|587965396|FG000|Overall Study|Protocol Violation|2|||
162796519|NCT04833127|587965397|FG000|Overall Study|Lost to Follow-up|1|||
162796520|NCT04833127|587965398|FG001|Overall Study|Lost to Follow-up|1|||
162796521|NCT01736189|587965399|FG000|Overall Study|Violation of registration criteria|41|||
162796522|NCT01736189|587965399|FG000|Overall Study|Protocol Violation|4|||
162796523|NCT01736189|587965399|FG000|Overall Study|Criteria and protocol violations|1|||
162796524|NCT01499303|587965400|FG000|Overall Study|Ongoing|2|||
162796525|NCT01499303|587965401|FG001|Overall Study|Ongoing|1|||
162796526|NCT01499303|587965400|FG000|Overall Study|Withdrawal by Subject|0|||
162796527|NCT01499303|587965401|FG001|Overall Study|Withdrawal by Subject|1|||
162796528|NCT01499303|587965400|FG000|Overall Study|Adverse Event|1|||
162796529|NCT01499303|587965401|FG001|Overall Study|Adverse Event|4|||
162796530|NCT01499303|587965400|FG000|Overall Study|Other|0|||
162796531|NCT01499303|587965401|FG001|Overall Study|Other|1|||
162796532|NCT01896557|587965402|FG000|Clopidogrel Alone|Adverse Event|1|||
162796533|NCT01896557|587965403|FG001|Clopidogrel Alone|Adverse Event|0|||
162796534|NCT01896557|587965402|FG000|Clopidogrel + GI Protector|low adherence|1|||
162796535|NCT01896557|587965403|FG001|Clopidogrel + GI Protector|low adherence|1|||
162796536|NCT01896557|587965402|FG000|Clopidogrel + GI Protector|Reading error|1|||
162796537|NCT01896557|587965403|FG001|Clopidogrel + GI Protector|Reading error|3|||
162796538|NCT01517295|587965404|FG000|Overall Study|Physician Decision|1|||
162796539|NCT01517295|587965405|FG001|Overall Study|Physician Decision|0|||
162796540|NCT00565773|587965406|FG000|Overall Study|Withdrawal by Subject|1|||
162796541|NCT00565773|587965406|FG000|Overall Study|Physician Decision|1|||
162796542|NCT03853551|587965407|FG000|Overall Study|Death|2|||
162796543|NCT03853551|587965407|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
162796544|NCT01923467|587965410|FG000|Overall Study|Lost to Follow-up|62|||
162796545|NCT01923467|587965410|FG000|Overall Study|Subject non-interest|479|||
162796546|NCT01075958|587965411|FG000|Overall Study|Blood sample could not be obtained|44|||
162796547|NCT01240915|587965414|FG000|Overall Study|Adverse Event|0|||
162796548|NCT01240915|587965415|FG001|Overall Study|Adverse Event|0|||
162796549|NCT01240915|587965416|FG002|Overall Study|Adverse Event|0|||
162796550|NCT01240915|587965417|FG003|Overall Study|Adverse Event|1|||
162796551|NCT01240915|587965418|FG004|Overall Study|Adverse Event|0|||
162796552|NCT01240915|587965419|FG005|Overall Study|Adverse Event|2|||
162796553|NCT01240915|587965420|FG006|Overall Study|Adverse Event|0|||
162796554|NCT01240915|587965421|FG007|Overall Study|Adverse Event|0|||
162796555|NCT01240915|587965422|FG008|Overall Study|Adverse Event|1|||
162796556|NCT01240915|587965414|FG000|Overall Study|Lost to Follow-up|0|||
162796557|NCT01240915|587965415|FG001|Overall Study|Lost to Follow-up|0|||
162796558|NCT01240915|587965416|FG002|Overall Study|Lost to Follow-up|0|||
162796559|NCT01240915|587965417|FG003|Overall Study|Lost to Follow-up|0|||
162796560|NCT01240915|587965418|FG004|Overall Study|Lost to Follow-up|1|||
162796561|NCT01240915|587965419|FG005|Overall Study|Lost to Follow-up|1|||
162796562|NCT01240915|587965420|FG006|Overall Study|Lost to Follow-up|0|||
162796563|NCT01240915|587965421|FG007|Overall Study|Lost to Follow-up|1|||
162796564|NCT01240915|587965422|FG008|Overall Study|Lost to Follow-up|1|||
162796565|NCT01240915|587965414|FG000|Overall Study|Withdrawal by Subject|2|||
162796566|NCT01240915|587965415|FG001|Overall Study|Withdrawal by Subject|1|||
162796567|NCT01240915|587965416|FG002|Overall Study|Withdrawal by Subject|0|||
162796568|NCT01240915|587965417|FG003|Overall Study|Withdrawal by Subject|2|||
162796569|NCT01240915|587965418|FG004|Overall Study|Withdrawal by Subject|0|||
162796570|NCT01240915|587965419|FG005|Overall Study|Withdrawal by Subject|4|||
162796571|NCT01240915|587965420|FG006|Overall Study|Withdrawal by Subject|2|||
162796572|NCT01240915|587965421|FG007|Overall Study|Withdrawal by Subject|3|||
162796573|NCT01240915|587965422|FG008|Overall Study|Withdrawal by Subject|3|||
162796574|NCT01240915|587965414|FG000|Overall Study|Other|0|||
162796575|NCT01240915|587965415|FG001|Overall Study|Other|0|||
162796576|NCT01240915|587965416|FG002|Overall Study|Other|0|||
162796577|NCT01240915|587965417|FG003|Overall Study|Other|0|||
162796578|NCT01240915|587965418|FG004|Overall Study|Other|2|||
162796579|NCT01240915|587965419|FG005|Overall Study|Other|0|||
162796580|NCT01240915|587965420|FG006|Overall Study|Other|0|||
162796581|NCT01240915|587965421|FG007|Overall Study|Other|0|||
162796582|NCT01240915|587965422|FG008|Overall Study|Other|0|||
162796583|NCT01240915|587965414|FG000|Overall Study|Insufficient Clinical Response|0|||
162796584|NCT01240915|587965415|FG001|Overall Study|Insufficient Clinical Response|0|||
162796585|NCT01240915|587965416|FG002|Overall Study|Insufficient Clinical Response|0|||
162796586|NCT01240915|587965417|FG003|Overall Study|Insufficient Clinical Response|0|||
162796587|NCT01240915|587965418|FG004|Overall Study|Insufficient Clinical Response|1|||
162796588|NCT01240915|587965419|FG005|Overall Study|Insufficient Clinical Response|3|||
162796589|NCT01240915|587965420|FG006|Overall Study|Insufficient Clinical Response|6|||
162796590|NCT01240915|587965421|FG007|Overall Study|Insufficient Clinical Response|0|||
162796591|NCT01240915|587965422|FG008|Overall Study|Insufficient Clinical Response|3|||
162796592|NCT02574845|587965424|FG000|Overall Study|Consent withdrawn further participation|0|||
162796593|NCT02574845|587965425|FG001|Overall Study|Consent withdrawn further participation|0|||
162796594|NCT02574845|587965426|FG002|Overall Study|Consent withdrawn further participation|0|||
162796595|NCT02574845|587965427|FG003|Overall Study|Consent withdrawn further participation|0|||
162796596|NCT02574845|587965428|FG004|Overall Study|Consent withdrawn further participation|1|||
162796597|NCT02574845|587965429|FG005|Overall Study|Consent withdrawn further participation|0|||
162796598|NCT02574845|587965424|FG000|Overall Study|Adverse Event|0|||
162796599|NCT02574845|587965425|FG001|Overall Study|Adverse Event|1|||
162796600|NCT02574845|587965426|FG002|Overall Study|Adverse Event|0|||
162796601|NCT02574845|587965427|FG003|Overall Study|Adverse Event|0|||
162796602|NCT02574845|587965428|FG004|Overall Study|Adverse Event|0|||
162796603|NCT02574845|587965429|FG005|Overall Study|Adverse Event|1|||
162796604|NCT02440425|587965434|FG000|Overall Study|Death likely due to disease progression|1|||
162796605|NCT02440425|587965434|FG000|Overall Study|Withdrawal by Subject|2|||
162796606|NCT02440425|587965434|FG000|Overall Study|Adverse Event|1|||
162796607|NCT02440425|587965434|FG000|Overall Study|Adverse Event/Ineligible|1|||
162796608|NCT03101462|587965435|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
162796609|NCT03101462|587965436|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
162796610|NCT01696045|587965440|FG000|Overall Study|Study drug toxicity|1|||
162796611|NCT01696045|587965441|FG001|Overall Study|Study drug toxicity|5|||
162796612|NCT01696045|587965440|FG000|Overall Study|Disease progression|2|||
162796613|NCT01696045|587965441|FG001|Overall Study|Disease progression|2|||
162796614|NCT01559129|587965442|FG000|Treatment Phase|Adverse Event|0|||
162796615|NCT01559129|587965443|FG001|Treatment Phase|Adverse Event|2|||
162796616|NCT01559129|587965442|FG000|Treatment Phase|Progressive Disease|1|||
162796617|NCT01559129|587965443|FG001|Treatment Phase|Progressive Disease|1|||
162796618|NCT01559129|587965442|FG000|Treatment Phase|Lack of Efficacy|0|||
162796619|NCT01559129|587965443|FG001|Treatment Phase|Lack of Efficacy|1|||
162796620|NCT01559129|587965442|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
162796621|NCT01559129|587965443|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
162796622|NCT01559129|587965442|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
162796623|NCT01559129|587965443|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
162796624|NCT01559129|587965442|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
162796625|NCT01559129|587965443|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
162796626|NCT01559129|587965442|FG000|Open-label Extension Period|Adverse Event|1|||
162796627|NCT01559129|587965443|FG001|Open-label Extension Period|Adverse Event|0|||
162796628|NCT01559129|587965442|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
162796629|NCT01559129|587965443|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
162796630|NCT03525392|587965444|FG000|Overall Study|Adverse Event|1|||
162796631|NCT03525392|587965445|FG001|Overall Study|Adverse Event|0|||
162796632|NCT03525392|587965446|FG002|Overall Study|Adverse Event|2|||
162796633|NCT03525392|587965447|FG003|Overall Study|Adverse Event|0|||
162796634|NCT03525392|587965448|FG004|Overall Study|Adverse Event|0|||
162796635|NCT03525392|587965444|FG000|Overall Study|Progressive disease|0|||
162796636|NCT03525392|587965445|FG001|Overall Study|Progressive disease|1|||
162796637|NCT03525392|587965446|FG002|Overall Study|Progressive disease|1|||
162796638|NCT03525392|587965447|FG003|Overall Study|Progressive disease|3|||
162796639|NCT03525392|587965448|FG004|Overall Study|Progressive disease|1|||
162796640|NCT00831129|587965451|FG000|Overall Study|Adverse Event|0|||
162796641|NCT00831129|587965452|FG001|Overall Study|Adverse Event|1|||
162796642|NCT00831129|587965451|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
162796643|NCT00831129|587965452|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
162796644|NCT01669577|587965454|FG000|Overall Study|Death|22|||
162796645|NCT01669577|587965454|FG000|Overall Study|Lost to Follow-up|78|||
162796646|NCT01669577|587965454|FG000|Overall Study|Physician Decision|34|||
162796647|NCT00818779|587965455|FG000|Overall Study|Protocol Violation|1|||
162796648|NCT00818779|587965456|FG001|Overall Study|Protocol Violation|0|||
162796649|NCT00818779|587965455|FG000|Overall Study|Lost to Follow-up|1|||
162796650|NCT00818779|587965456|FG001|Overall Study|Lost to Follow-up|0|||
162796651|NCT00818779|587965455|FG000|Overall Study|Adverse Event|4|||
162796652|NCT00818779|587965456|FG001|Overall Study|Adverse Event|1|||
162796653|NCT00132873|587965457|FG000|Overall Study|Adverse Event|3|||
162796654|NCT00132873|587965457|FG000|Overall Study|Lost to Follow-up|1|||
162796655|NCT00132873|587965457|FG000|Overall Study|Lack of Efficacy|1|||
162796656|NCT00132873|587965457|FG000|Overall Study|Withdrawal by Subject|3|||
162796657|NCT00132873|587965457|FG000|Overall Study|Planned Pregnancy|1|||
162796658|NCT03309813|587965458|FG000|Main Randomized Study|Withdrawal by Subject|1|||
162796659|NCT03309813|587965459|FG001|Main Randomized Study|Withdrawal by Subject|0|||
162796660|NCT01327846|587965460|FG000|Core Phase|Subject decision (vital status: missing)|1|||
162796661|NCT01327846|587965461|FG001|Core Phase|Subject decision (vital status: missing)|2|||
162796662|NCT01327846|587965462|FG002|Core Phase|Subject decision (vital status: missing)|2|||
162796663|NCT01327846|587965463|FG003|Core Phase|Subject decision (vital status: missing)|1|||
162796664|NCT01327846|587965460|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
162796665|NCT01327846|587965461|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
162796666|NCT01327846|587965462|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
162796667|NCT01327846|587965463|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
162796668|NCT01327846|587965460|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
162796669|NCT01327846|587965461|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
162796670|NCT01327846|587965462|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
162796671|NCT01327846|587965463|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
162796672|NCT01327846|587965460|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
162796673|NCT01327846|587965461|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
162796674|NCT01327846|587965462|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
162796675|NCT01327846|587965463|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
162796676|NCT01327846|587965460|FG000|Core Phase|Lost to Follow-up|3|||
162796677|NCT01327846|587965461|FG001|Core Phase|Lost to Follow-up|3|||
162796678|NCT01327846|587965462|FG002|Core Phase|Lost to Follow-up|4|||
162796679|NCT01327846|587965463|FG003|Core Phase|Lost to Follow-up|5|||
162796680|NCT01327846|587965460|FG000|Extension Phase|Study terminated by sponsor|1073|||
162796681|NCT01327846|587965461|FG001|Extension Phase|Study terminated by sponsor|1124|||
162796682|NCT01327846|587965462|FG002|Extension Phase|Study terminated by sponsor|1067|||
162796683|NCT01327846|587965463|FG003|Extension Phase|Study terminated by sponsor|1660|||
162796684|NCT01327846|587965460|FG000|Extension Phase|Withdrawal by Subject|20|||
162796685|NCT01327846|587965461|FG001|Extension Phase|Withdrawal by Subject|13|||
162796686|NCT01327846|587965462|FG002|Extension Phase|Withdrawal by Subject|19|||
162796687|NCT01327846|587965463|FG003|Extension Phase|Withdrawal by Subject|37|||
162796688|NCT01327846|587965460|FG000|Extension Phase|Lost to Follow-up|4|||
162796689|NCT01327846|587965461|FG001|Extension Phase|Lost to Follow-up|3|||
162796690|NCT01327846|587965462|FG002|Extension Phase|Lost to Follow-up|4|||
162796691|NCT01327846|587965463|FG003|Extension Phase|Lost to Follow-up|7|||
162796692|NCT01327846|587965460|FG000|Extension Phase|Technical Problems|2|||
162796693|NCT01327846|587965461|FG001|Extension Phase|Technical Problems|4|||
162796694|NCT01327846|587965462|FG002|Extension Phase|Technical Problems|2|||
162796695|NCT01327846|587965463|FG003|Extension Phase|Technical Problems|2|||
162796696|NCT04343976|587965464|FG000|Overall Study|Withdrawal by Subject|0|||
162796697|NCT04343976|587965465|FG001|Overall Study|Withdrawal by Subject|1|||
162796698|NCT02807883|587965466|FG000|Overall Study|Withdrawal by Subject|2|||
162796699|NCT03682185|587965474|FG000|Overall Study|Lost to Follow-up|4|||
162796700|NCT03682185|587965475|FG001|Overall Study|Lost to Follow-up|7|||
162796701|NCT03682185|587965476|FG002|Overall Study|Lost to Follow-up|4|||
162796702|NCT03682185|587965477|FG003|Overall Study|Lost to Follow-up|7|||
162796703|NCT03682185|587965478|FG004|Overall Study|Lost to Follow-up|1|||
162796704|NCT03682185|587965474|FG000|Overall Study|Withdrawal by Subject|7|||
162796705|NCT03682185|587965475|FG001|Overall Study|Withdrawal by Subject|3|||
162796706|NCT03682185|587965476|FG002|Overall Study|Withdrawal by Subject|7|||
162796707|NCT03682185|587965477|FG003|Overall Study|Withdrawal by Subject|3|||
162796708|NCT03682185|587965478|FG004|Overall Study|Withdrawal by Subject|0|||
162796709|NCT06926673|587965479|FG000|Overall Study|Lost to Follow-up|0|||
162796710|NCT06926673|587965480|FG001|Overall Study|Lost to Follow-up|0|||
162796711|NCT06926673|587965481|FG002|Overall Study|Lost to Follow-up|0|||
162796712|NCT06926673|587965482|FG003|Overall Study|Lost to Follow-up|1|||
162796713|NCT06926673|587965483|FG004|Overall Study|Lost to Follow-up|0|||
162796714|NCT06926673|587965484|FG005|Overall Study|Lost to Follow-up|0|||
162796715|NCT06926673|587965485|FG006|Overall Study|Lost to Follow-up|0|||
162796716|NCT06926673|587965479|FG000|Overall Study|Physician Decision|0|||
162796717|NCT06926673|587965480|FG001|Overall Study|Physician Decision|0|||
162796718|NCT06926673|587965481|FG002|Overall Study|Physician Decision|0|||
162796719|NCT06926673|587965482|FG003|Overall Study|Physician Decision|0|||
162796720|NCT06926673|587965483|FG004|Overall Study|Physician Decision|0|||
162796721|NCT06926673|587965484|FG005|Overall Study|Physician Decision|0|||
162796722|NCT06926673|587965485|FG006|Overall Study|Physician Decision|1|||
162796723|NCT06926673|587965479|FG000|Overall Study|Withdrawal by Subject|0|||
162796724|NCT06926673|587965480|FG001|Overall Study|Withdrawal by Subject|3|||
162796725|NCT06926673|587965481|FG002|Overall Study|Withdrawal by Subject|2|||
162796726|NCT06926673|587965482|FG003|Overall Study|Withdrawal by Subject|1|||
162796727|NCT06926673|587965483|FG004|Overall Study|Withdrawal by Subject|0|||
162796728|NCT06926673|587965484|FG005|Overall Study|Withdrawal by Subject|2|||
162796729|NCT06926673|587965485|FG006|Overall Study|Withdrawal by Subject|0|||
162796730|NCT01967147|587966920|FG000|Overall Study|Adverse Event|5|||
162796731|NCT01967147|587966921|FG001|Overall Study|Adverse Event|2|||
162796732|NCT01967147|587966920|FG000|Overall Study|Lack of Efficacy|1|||
162796733|NCT01967147|587966921|FG001|Overall Study|Lack of Efficacy|4|||
162796734|NCT01967147|587966920|FG000|Overall Study|Lost to Follow-up|1|||
162796735|NCT01967147|587966921|FG001|Overall Study|Lost to Follow-up|2|||
162796736|NCT01967147|587966920|FG000|Overall Study|Withdrawal by Subject|2|||
162796737|NCT01967147|587966921|FG001|Overall Study|Withdrawal by Subject|4|||
162796738|NCT01967147|587966920|FG000|Overall Study|Non-compliance with Study Drug|0|||
162796739|NCT01967147|587966921|FG001|Overall Study|Non-compliance with Study Drug|3|||
162796740|NCT01967147|587966920|FG000|Overall Study|Other|4|||
162796741|NCT01967147|587966921|FG001|Overall Study|Other|5|||
162796742|NCT03843554|587966922|FG000|Overall Study|Physician Decision|0|||
162796743|NCT03843554|587966923|FG001|Overall Study|Physician Decision|2|||
162796744|NCT02218606|587966925|FG000|Overall Study|Adverse Event|1|||
162796745|NCT02218606|587966926|FG001|Overall Study|Adverse Event|1|||
162796746|NCT02218606|587966925|FG000|Overall Study|Death|15|||
162796747|NCT02218606|587966926|FG001|Overall Study|Death|28|||
162796748|NCT02218606|587966925|FG000|Overall Study|Physician Decision|0|||
162796749|NCT02218606|587966926|FG001|Overall Study|Physician Decision|1|||
162796750|NCT02218606|587966925|FG000|Overall Study|Withdrawal by Subject|4|||
162796751|NCT02218606|587966926|FG001|Overall Study|Withdrawal by Subject|0|||
162796752|NCT02218606|587966925|FG000|Overall Study|Noncompliance|1|||
162796753|NCT02218606|587966926|FG001|Overall Study|Noncompliance|0|||
162796754|NCT02218606|587966925|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
162796755|NCT02218606|587966926|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
162796756|NCT02218606|587966925|FG000|Overall Study|Other|2|||
162796757|NCT02218606|587966926|FG001|Overall Study|Other|1|||
162796758|NCT02218606|587966925|FG000|Overall Study|Never started treatment|0|||
162796759|NCT02218606|587966926|FG001|Overall Study|Never started treatment|1|||
162796760|NCT00890695|587966927|FG000|Overall Study|Protocol Violation|1|||
162796761|NCT00890695|587966928|FG001|Overall Study|Protocol Violation|0|||
162796762|NCT04396366|587966931|FG000|Overall Study|Adverse Event|1|||
162796763|NCT04396366|587966932|FG001|Overall Study|Adverse Event|0|||
162796764|NCT01283152|587966940|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
162796765|NCT01283152|587966941|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
162796766|NCT01283152|587966940|FG000|Overall Study|Refused HESA|1|||
162796767|NCT01283152|587966941|FG001|Overall Study|Refused HESA|0|||
162796768|NCT00567567|587966942|FG000|Overall Study|Adverse Event|0|||
162796769|NCT00567567|587966943|FG001|Overall Study|Adverse Event|2|||
162796770|NCT00567567|587966944|FG002|Overall Study|Adverse Event|5|||
162796771|NCT00567567|587966942|FG000|Overall Study|Death|8|||
162796772|NCT00567567|587966943|FG001|Overall Study|Death|1|||
162796773|NCT00567567|587966944|FG002|Overall Study|Death|5|||
162796774|NCT00567567|587966942|FG000|Overall Study|Lack of Efficacy|16|||
162796775|NCT00567567|587966943|FG001|Overall Study|Lack of Efficacy|17|||
162796776|NCT00567567|587966944|FG002|Overall Study|Lack of Efficacy|48|||
162796777|NCT00567567|587966942|FG000|Overall Study|Lost to Follow-up|0|||
162796778|NCT00567567|587966943|FG001|Overall Study|Lost to Follow-up|0|||
162796779|NCT00567567|587966944|FG002|Overall Study|Lost to Follow-up|1|||
162796780|NCT00567567|587966942|FG000|Overall Study|Physician Decision|16|||
162796781|NCT00567567|587966943|FG001|Overall Study|Physician Decision|18|||
162796782|NCT00567567|587966944|FG002|Overall Study|Physician Decision|84|||
162796783|NCT00567567|587966942|FG000|Overall Study|Withdrawal by Subject|0|||
162796784|NCT00567567|587966943|FG001|Overall Study|Withdrawal by Subject|0|||
162796785|NCT00567567|587966944|FG002|Overall Study|Withdrawal by Subject|2|||
162796786|NCT00567567|587966942|FG000|Overall Study|Ineligible|4|||
162796787|NCT00567567|587966943|FG001|Overall Study|Ineligible|0|||
162796788|NCT00567567|587966944|FG002|Overall Study|Ineligible|9|||
162796789|NCT00567567|587966942|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
162796790|NCT00567567|587966943|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
162796791|NCT00567567|587966944|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
162796792|NCT00567567|587966942|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
162796793|NCT00567567|587966943|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
162796794|NCT00567567|587966944|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
162796795|NCT00567567|587966942|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
162796796|NCT00567567|587966943|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
162796797|NCT00567567|587966944|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
162796798|NCT03433677|587966945|FG000|Period 1|Protocol Violation|1|||
162796799|NCT03433677|587966946|FG001|Period 1|Protocol Violation|0|||
162796800|NCT03433677|587966945|FG000|Period 2|Withdrawal by Subject|1|||
162796801|NCT03433677|587966946|FG001|Period 2|Withdrawal by Subject|1|||
162796802|NCT03330405|587966947|FG000|Overall Study|Other|1|||
162796803|NCT03330405|587966948|FG001|Overall Study|Other|3|||
162796804|NCT03330405|587966949|FG002|Overall Study|Other|1|||
162796805|NCT03330405|587966950|FG003|Overall Study|Other|0|||
162796806|NCT03330405|587966951|FG004|Overall Study|Other|2|||
162796807|NCT03330405|587966952|FG005|Overall Study|Other|0|||
162796808|NCT03330405|587966953|FG006|Overall Study|Other|1|||
162796809|NCT03330405|587966954|FG007|Overall Study|Other|0|||
162796810|NCT03330405|587966955|FG008|Overall Study|Other|0|||
162796811|NCT03330405|587966956|FG009|Overall Study|Other|0|||
162796812|NCT03330405|587966957|FG010|Overall Study|Other|0|||
162796813|NCT03330405|587966947|FG000|Overall Study|Progressive disease|8|||
162796814|NCT03330405|587966948|FG001|Overall Study|Progressive disease|27|||
162796815|NCT03330405|587966949|FG002|Overall Study|Progressive disease|4|||
162796816|NCT03330405|587966950|FG003|Overall Study|Progressive disease|18|||
162796817|NCT03330405|587966951|FG004|Overall Study|Progressive disease|16|||
162796818|NCT03330405|587966952|FG005|Overall Study|Progressive disease|14|||
162796819|NCT03330405|587966953|FG006|Overall Study|Progressive disease|7|||
162796820|NCT03330405|587966954|FG007|Overall Study|Progressive disease|29|||
162796821|NCT03330405|587966955|FG008|Overall Study|Progressive disease|9|||
162796822|NCT03330405|587966956|FG009|Overall Study|Progressive disease|11|||
162796823|NCT03330405|587966957|FG010|Overall Study|Progressive disease|5|||
162796824|NCT03330405|587966947|FG000|Overall Study|Withdrawal by Subject|1|||
162796825|NCT03330405|587966948|FG001|Overall Study|Withdrawal by Subject|4|||
162796826|NCT03330405|587966949|FG002|Overall Study|Withdrawal by Subject|0|||
162796827|NCT03330405|587966950|FG003|Overall Study|Withdrawal by Subject|1|||
162796828|NCT03330405|587966951|FG004|Overall Study|Withdrawal by Subject|1|||
162796829|NCT03330405|587966952|FG005|Overall Study|Withdrawal by Subject|1|||
162796830|NCT03330405|587966953|FG006|Overall Study|Withdrawal by Subject|0|||
162796831|NCT03330405|587966954|FG007|Overall Study|Withdrawal by Subject|2|||
162796832|NCT03330405|587966955|FG008|Overall Study|Withdrawal by Subject|2|||
162796833|NCT03330405|587966956|FG009|Overall Study|Withdrawal by Subject|1|||
162796834|NCT03330405|587966957|FG010|Overall Study|Withdrawal by Subject|1|||
162796835|NCT03330405|587966947|FG000|Overall Study|Global deterioration of health status|2|||
162796836|NCT03330405|587966948|FG001|Overall Study|Global deterioration of health status|3|||
162796837|NCT03330405|587966949|FG002|Overall Study|Global deterioration of health status|0|||
162796838|NCT03330405|587966950|FG003|Overall Study|Global deterioration of health status|2|||
162796839|NCT03330405|587966951|FG004|Overall Study|Global deterioration of health status|3|||
162796840|NCT03330405|587966952|FG005|Overall Study|Global deterioration of health status|3|||
162796841|NCT03330405|587966953|FG006|Overall Study|Global deterioration of health status|0|||
162796842|NCT03330405|587966954|FG007|Overall Study|Global deterioration of health status|2|||
162796843|NCT03330405|587966955|FG008|Overall Study|Global deterioration of health status|8|||
162796844|NCT03330405|587966956|FG009|Overall Study|Global deterioration of health status|4|||
162796845|NCT03330405|587966957|FG010|Overall Study|Global deterioration of health status|1|||
162796846|NCT03330405|587966947|FG000|Overall Study|Adverse Event|0|||
162796847|NCT03330405|587966948|FG001|Overall Study|Adverse Event|1|||
162796848|NCT03330405|587966949|FG002|Overall Study|Adverse Event|0|||
162796849|NCT03330405|587966950|FG003|Overall Study|Adverse Event|1|||
162796850|NCT03330405|587966951|FG004|Overall Study|Adverse Event|1|||
162796851|NCT03330405|587966952|FG005|Overall Study|Adverse Event|1|||
162796852|NCT03330405|587966953|FG006|Overall Study|Adverse Event|3|||
162796853|NCT03330405|587966954|FG007|Overall Study|Adverse Event|4|||
162796854|NCT03330405|587966955|FG008|Overall Study|Adverse Event|2|||
162796855|NCT03330405|587966956|FG009|Overall Study|Adverse Event|2|||
162796856|NCT03330405|587966957|FG010|Overall Study|Adverse Event|2|||
162796857|NCT03330405|587966947|FG000|Overall Study|Death|0|||
162796858|NCT03330405|587966948|FG001|Overall Study|Death|4|||
162796859|NCT03330405|587966949|FG002|Overall Study|Death|0|||
162796860|NCT03330405|587966950|FG003|Overall Study|Death|0|||
162796861|NCT03330405|587966951|FG004|Overall Study|Death|0|||
162796862|NCT03330405|587966952|FG005|Overall Study|Death|1|||
162796863|NCT03330405|587966953|FG006|Overall Study|Death|0|||
162796864|NCT03330405|587966954|FG007|Overall Study|Death|2|||
162796865|NCT03330405|587966955|FG008|Overall Study|Death|0|||
162796866|NCT03330405|587966956|FG009|Overall Study|Death|0|||
162796867|NCT03330405|587966957|FG010|Overall Study|Death|0|||
162796868|NCT03330405|587966947|FG000|Overall Study|Physician Decision|0|||
162796869|NCT03330405|587966948|FG001|Overall Study|Physician Decision|0|||
162796870|NCT03330405|587966949|FG002|Overall Study|Physician Decision|0|||
162796871|NCT03330405|587966950|FG003|Overall Study|Physician Decision|0|||
162796872|NCT03330405|587966951|FG004|Overall Study|Physician Decision|0|||
162796873|NCT03330405|587966952|FG005|Overall Study|Physician Decision|0|||
162796874|NCT03330405|587966953|FG006|Overall Study|Physician Decision|0|||
162796875|NCT03330405|587966954|FG007|Overall Study|Physician Decision|1|||
162796876|NCT03330405|587966955|FG008|Overall Study|Physician Decision|0|||
162796877|NCT03330405|587966956|FG009|Overall Study|Physician Decision|0|||
162796878|NCT03330405|587966957|FG010|Overall Study|Physician Decision|0|||
162796879|NCT03889704|587966959|FG000|Overall Study|Study terminated due to pandemic|1|||
162796880|NCT04552899|587966962|FG000|Overall Study|Adverse Event|4|||
162796881|NCT04552899|587966963|FG001|Overall Study|Adverse Event|3|||
162796882|NCT04552899|587966962|FG000|Overall Study|Death|4|||
162796883|NCT04552899|587966963|FG001|Overall Study|Death|4|||
162796884|NCT04552899|587966962|FG000|Overall Study|Lost to Follow-up|8|||
162796885|NCT04552899|587966963|FG001|Overall Study|Lost to Follow-up|13|||
162796886|NCT04552899|587966962|FG000|Overall Study|Lung Transplant|4|||
162796887|NCT04552899|587966963|FG001|Overall Study|Lung Transplant|3|||
162796888|NCT04552899|587966962|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
162796889|NCT04552899|587966963|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
162796890|NCT04552899|587966962|FG000|Overall Study|Physician Decision|3|||
162796891|NCT04552899|587966963|FG001|Overall Study|Physician Decision|4|||
162796892|NCT04552899|587966962|FG000|Overall Study|Study Terminated By Sponsor|237|||
162796893|NCT04552899|587966963|FG001|Overall Study|Study Terminated By Sponsor|239|||
162796894|NCT04552899|587966962|FG000|Overall Study|Withdrawal by Subject|15|||
162796895|NCT04552899|587966963|FG001|Overall Study|Withdrawal by Subject|17|||
162796896|NCT00461981|587966966|FG000|Overall Study|Lost to Follow-up|9|||
162796897|NCT00461981|587966967|FG001|Overall Study|Lost to Follow-up|6|||
162796898|NCT00461981|587966966|FG000|Overall Study|Withdrawal by Subject|2|||
162796899|NCT00461981|587966967|FG001|Overall Study|Withdrawal by Subject|3|||
162796900|NCT02383940|587966970|FG000|Overall Study|Adverse Event|1|||
162796901|NCT02383940|587966971|FG001|Overall Study|Adverse Event|0|||
162796902|NCT02383940|587966970|FG000|Overall Study|Lost to Follow-up|2|||
162796903|NCT02383940|587966971|FG001|Overall Study|Lost to Follow-up|2|||
162796904|NCT02383940|587966970|FG000|Overall Study|Physician Decision|2|||
162796905|NCT02383940|587966971|FG001|Overall Study|Physician Decision|0|||
162796906|NCT02383940|587966970|FG000|Overall Study|Withdrawal by Subject|1|||
162796907|NCT02383940|587966971|FG001|Overall Study|Withdrawal by Subject|1|||
162796908|NCT02383940|587966970|FG000|Overall Study|Randomized but not treated|2|||
162796909|NCT02383940|587966971|FG001|Overall Study|Randomized but not treated|0|||
162796910|NCT02383940|587966970|FG000|Overall Study|Other than specified above|1|||
162796911|NCT02383940|587966971|FG001|Overall Study|Other than specified above|0|||
162796912|NCT01353859|587966972|FG000|Overall Study|Adverse Event|3|||
162796913|NCT01353859|587966972|FG000|Overall Study|Lack of Efficacy|1|||
162796914|NCT02672852|587966973|FG000|Part A1|Disease Worsening|1|||
162796915|NCT02672852|587966974|FG001|Part A1|Disease Worsening|0|||
162796916|NCT02672852|587966975|FG002|Part A1|Disease Worsening|0|||
162796917|NCT02672852|587966976|FG003|Part A1|Disease Worsening|0|||
162796918|NCT02672852|587966977|FG004|Part A1|Disease Worsening|0|||
162796919|NCT02672852|587966978|FG005|Part A1|Disease Worsening|0|||
162796920|NCT02672852|587966979|FG006|Part A1|Disease Worsening|0|||
162796921|NCT02672852|587966973|FG000|Part A1|Adverse Event|0|||
162796922|NCT02672852|587966974|FG001|Part A1|Adverse Event|1|||
162796923|NCT02672852|587966975|FG002|Part A1|Adverse Event|0|||
162796924|NCT02672852|587966976|FG003|Part A1|Adverse Event|0|||
162796925|NCT02672852|587966977|FG004|Part A1|Adverse Event|0|||
162796926|NCT02672852|587966978|FG005|Part A1|Adverse Event|0|||
162796927|NCT02672852|587966979|FG006|Part A1|Adverse Event|0|||
162796928|NCT02672852|587966973|FG000|Part A1|Lost to Follow-up|1|||
162796929|NCT02672852|587966974|FG001|Part A1|Lost to Follow-up|2|||
162796930|NCT02672852|587966975|FG002|Part A1|Lost to Follow-up|0|||
162796931|NCT02672852|587966976|FG003|Part A1|Lost to Follow-up|0|||
162796932|NCT02672852|587966977|FG004|Part A1|Lost to Follow-up|0|||
162796933|NCT02672852|587966978|FG005|Part A1|Lost to Follow-up|0|||
162796934|NCT02672852|587966979|FG006|Part A1|Lost to Follow-up|0|||
162796935|NCT02672852|587966973|FG000|Part A1|Withdrawal by Subject|1|||
162796936|NCT02672852|587966974|FG001|Part A1|Withdrawal by Subject|1|||
162796937|NCT02672852|587966975|FG002|Part A1|Withdrawal by Subject|0|||
162796938|NCT02672852|587966976|FG003|Part A1|Withdrawal by Subject|0|||
162796939|NCT02672852|587966977|FG004|Part A1|Withdrawal by Subject|0|||
162796940|NCT02672852|587966978|FG005|Part A1|Withdrawal by Subject|0|||
162796941|NCT02672852|587966979|FG006|Part A1|Withdrawal by Subject|0|||
162796942|NCT02672852|587966973|FG000|Part A2|Disease worsening|0|||
162796943|NCT02672852|587966974|FG001|Part A2|Disease worsening|0|||
162796944|NCT02672852|587966975|FG002|Part A2|Disease worsening|1|||
162796945|NCT02672852|587966976|FG003|Part A2|Disease worsening|0|||
162796946|NCT02672852|587966977|FG004|Part A2|Disease worsening|0|||
162796947|NCT02672852|587966978|FG005|Part A2|Disease worsening|0|||
162796948|NCT02672852|587966979|FG006|Part A2|Disease worsening|0|||
162796949|NCT02672852|587966973|FG000|Part A2|Adverse Event|0|||
162796950|NCT02672852|587966974|FG001|Part A2|Adverse Event|0|||
162796951|NCT02672852|587966975|FG002|Part A2|Adverse Event|3|||
162796952|NCT02672852|587966976|FG003|Part A2|Adverse Event|0|||
162796953|NCT02672852|587966977|FG004|Part A2|Adverse Event|0|||
162796954|NCT02672852|587966978|FG005|Part A2|Adverse Event|0|||
162796955|NCT02672852|587966979|FG006|Part A2|Adverse Event|0|||
162796956|NCT02672852|587966973|FG000|Part A2|Lost to Follow-up|0|||
162796957|NCT02672852|587966974|FG001|Part A2|Lost to Follow-up|0|||
162796958|NCT02672852|587966975|FG002|Part A2|Lost to Follow-up|2|||
162796959|NCT02672852|587966976|FG003|Part A2|Lost to Follow-up|0|||
162796960|NCT02672852|587966977|FG004|Part A2|Lost to Follow-up|0|||
162796961|NCT02672852|587966978|FG005|Part A2|Lost to Follow-up|0|||
162796962|NCT02672852|587966979|FG006|Part A2|Lost to Follow-up|0|||
162796963|NCT02672852|587966973|FG000|Part A2|Withdrawal by Subject|0|||
162796964|NCT02672852|587966974|FG001|Part A2|Withdrawal by Subject|0|||
162796965|NCT02672852|587966975|FG002|Part A2|Withdrawal by Subject|1|||
162796966|NCT02672852|587966976|FG003|Part A2|Withdrawal by Subject|0|||
162796967|NCT02672852|587966977|FG004|Part A2|Withdrawal by Subject|0|||
162796968|NCT02672852|587966978|FG005|Part A2|Withdrawal by Subject|0|||
162796969|NCT02672852|587966979|FG006|Part A2|Withdrawal by Subject|0|||
162796970|NCT02672852|587966973|FG000|Part A2|Other|0|||
162796971|NCT02672852|587966974|FG001|Part A2|Other|0|||
162796972|NCT02672852|587966975|FG002|Part A2|Other|3|||
162796973|NCT02672852|587966976|FG003|Part A2|Other|0|||
162796974|NCT02672852|587966977|FG004|Part A2|Other|0|||
162796975|NCT02672852|587966978|FG005|Part A2|Other|0|||
162796976|NCT02672852|587966979|FG006|Part A2|Other|0|||
162796977|NCT02672852|587966973|FG000|Part A2|Not entered in Part B|0|||
162796978|NCT02672852|587966974|FG001|Part A2|Not entered in Part B|0|||
162796979|NCT02672852|587966975|FG002|Part A2|Not entered in Part B|0|||
162796980|NCT02672852|587966976|FG003|Part A2|Not entered in Part B|4|||
162796981|NCT02672852|587966977|FG004|Part A2|Not entered in Part B|0|||
162796982|NCT02672852|587966978|FG005|Part A2|Not entered in Part B|0|||
162796983|NCT02672852|587966979|FG006|Part A2|Not entered in Part B|0|||
162796984|NCT02672852|587966973|FG000|Part B|Disease worsening|0|||
162796985|NCT02672852|587966974|FG001|Part B|Disease worsening|0|||
162796986|NCT02672852|587966975|FG002|Part B|Disease worsening|0|||
162796987|NCT02672852|587966976|FG003|Part B|Disease worsening|0|||
162796988|NCT02672852|587966977|FG004|Part B|Disease worsening|1|||
162796989|NCT02672852|587966978|FG005|Part B|Disease worsening|0|||
162796990|NCT02672852|587966979|FG006|Part B|Disease worsening|1|||
162796991|NCT02672852|587966973|FG000|Part B|Worsening pre-existing condition|0|||
162796992|NCT02672852|587966974|FG001|Part B|Worsening pre-existing condition|0|||
162796993|NCT02672852|587966975|FG002|Part B|Worsening pre-existing condition|0|||
162796994|NCT02672852|587966976|FG003|Part B|Worsening pre-existing condition|0|||
162796995|NCT02672852|587966977|FG004|Part B|Worsening pre-existing condition|0|||
162796996|NCT02672852|587966978|FG005|Part B|Worsening pre-existing condition|1|||
162796997|NCT02672852|587966979|FG006|Part B|Worsening pre-existing condition|0|||
162796998|NCT02672852|587966973|FG000|Part B|Other adverse event|0|||
162796999|NCT02672852|587966974|FG001|Part B|Other adverse event|0|||
162797000|NCT02672852|587966975|FG002|Part B|Other adverse event|0|||
162797001|NCT02672852|587966976|FG003|Part B|Other adverse event|0|||
162797002|NCT02672852|587966977|FG004|Part B|Other adverse event|3|||
162797003|NCT02672852|587966978|FG005|Part B|Other adverse event|5|||
162797004|NCT02672852|587966979|FG006|Part B|Other adverse event|1|||
162797005|NCT02672852|587966973|FG000|Part B|Lost to Follow-up|0|||
162797006|NCT02672852|587966974|FG001|Part B|Lost to Follow-up|0|||
162797007|NCT02672852|587966975|FG002|Part B|Lost to Follow-up|0|||
162797008|NCT02672852|587966976|FG003|Part B|Lost to Follow-up|0|||
162797009|NCT02672852|587966977|FG004|Part B|Lost to Follow-up|3|||
162797010|NCT02672852|587966978|FG005|Part B|Lost to Follow-up|4|||
162797011|NCT02672852|587966979|FG006|Part B|Lost to Follow-up|1|||
162797012|NCT02672852|587966973|FG000|Part B|Withdrawal by Subject|0|||
162797013|NCT02672852|587966974|FG001|Part B|Withdrawal by Subject|0|||
162797014|NCT02672852|587966975|FG002|Part B|Withdrawal by Subject|0|||
162797015|NCT02672852|587966976|FG003|Part B|Withdrawal by Subject|0|||
162797016|NCT02672852|587966977|FG004|Part B|Withdrawal by Subject|5|||
162797017|NCT02672852|587966978|FG005|Part B|Withdrawal by Subject|0|||
162797018|NCT02672852|587966979|FG006|Part B|Withdrawal by Subject|7|||
162797019|NCT02672852|587966973|FG000|Part B|Other|0|||
162797020|NCT02672852|587966974|FG001|Part B|Other|0|||
162797021|NCT02672852|587966975|FG002|Part B|Other|0|||
162797022|NCT02672852|587966976|FG003|Part B|Other|0|||
162797023|NCT02672852|587966977|FG004|Part B|Other|4|||
162797024|NCT02672852|587966978|FG005|Part B|Other|1|||
162797025|NCT02672852|587966979|FG006|Part B|Other|2|||
162797026|NCT01725126|587966982|FG000|Overall Study|Protocol Violation|0|||
162797027|NCT01725126|587966983|FG001|Overall Study|Protocol Violation|1|||
162797028|NCT01725126|587966984|FG002|Overall Study|Protocol Violation|0|||
162797029|NCT01725126|587966985|FG003|Overall Study|Protocol Violation|0|||
162797030|NCT01725126|587966986|FG004|Overall Study|Protocol Violation|0|||
162797031|NCT01725126|587966987|FG005|Overall Study|Protocol Violation|0|||
162797032|NCT01725126|587966982|FG000|Overall Study|Withdrawal by Subject|0|||
162797033|NCT01725126|587966983|FG001|Overall Study|Withdrawal by Subject|0|||
162797034|NCT01725126|587966984|FG002|Overall Study|Withdrawal by Subject|0|||
162797035|NCT01725126|587966985|FG003|Overall Study|Withdrawal by Subject|1|||
162797036|NCT01725126|587966986|FG004|Overall Study|Withdrawal by Subject|0|||
162797037|NCT01725126|587966987|FG005|Overall Study|Withdrawal by Subject|0|||
162797038|NCT04462289|587966990|FG000|Overall Study|Lost to Follow-up|4|||
162797039|NCT04462289|587966991|FG001|Overall Study|Lost to Follow-up|5|||
162797040|NCT04462289|587966990|FG000|Overall Study|Death|0|||
162797041|NCT04462289|587966991|FG001|Overall Study|Death|3|||
162797042|NCT04462289|587966990|FG000|Overall Study|Withdrawal by Subject|1|||
162797043|NCT04462289|587966991|FG001|Overall Study|Withdrawal by Subject|3|||
162797044|NCT01518153|587966992|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
162797045|NCT01518153|587966993|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
162797046|NCT01518153|587966994|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
162797047|NCT01518153|587966992|FG000|Stem Cell Transplant|Death|2|||
162797048|NCT01518153|587966993|FG001|Stem Cell Transplant|Death|0|||
162797049|NCT01518153|587966994|FG002|Stem Cell Transplant|Death|0|||
162797050|NCT01518153|587966992|FG000|Stem Cell Transplant|Secondary graft failure|1|||
162797051|NCT01518153|587966993|FG001|Stem Cell Transplant|Secondary graft failure|0|||
162797052|NCT01518153|587966994|FG002|Stem Cell Transplant|Secondary graft failure|0|||
162797053|NCT01518153|587966992|FG000|Stem Cell Transplant|Adverse Event|1|||
162797054|NCT01518153|587966993|FG001|Stem Cell Transplant|Adverse Event|0|||
162797055|NCT01518153|587966994|FG002|Stem Cell Transplant|Adverse Event|0|||
162797056|NCT01518153|587966992|FG000|Donor Lymphocyte Infusion|Death|0|||
162797057|NCT01518153|587966993|FG001|Donor Lymphocyte Infusion|Death|2|||
162797058|NCT01518153|587966994|FG002|Donor Lymphocyte Infusion|Death|1|||
162797059|NCT04276415|587966995|FG000|Overall Study|Adverse Event|0|||
162797060|NCT04276415|587966996|FG001|Overall Study|Adverse Event|0|||
162797061|NCT04276415|587966997|FG002|Overall Study|Adverse Event|0|||
162797062|NCT04276415|587966998|FG003|Overall Study|Adverse Event|3|||
162797063|NCT04276415|587966999|FG004|Overall Study|Adverse Event|0|||
162797064|NCT04276415|587967000|FG005|Overall Study|Adverse Event|0|||
162797065|NCT04276415|587966995|FG000|Overall Study|Clinical progression|1|||
162797066|NCT04276415|587966996|FG001|Overall Study|Clinical progression|1|||
162797067|NCT04276415|587966997|FG002|Overall Study|Clinical progression|0|||
162797068|NCT04276415|587966998|FG003|Overall Study|Clinical progression|0|||
162797069|NCT04276415|587966999|FG004|Overall Study|Clinical progression|1|||
162797070|NCT04276415|587967000|FG005|Overall Study|Clinical progression|0|||
162797071|NCT04276415|587966995|FG000|Overall Study|Other|0|||
162797072|NCT04276415|587966996|FG001|Overall Study|Other|0|||
162797073|NCT04276415|587966997|FG002|Overall Study|Other|0|||
162797074|NCT04276415|587966998|FG003|Overall Study|Other|1|||
162797075|NCT04276415|587966999|FG004|Overall Study|Other|0|||
162797076|NCT04276415|587967000|FG005|Overall Study|Other|0|||
162797077|NCT04276415|587966995|FG000|Overall Study|Physician Decision|0|||
162797078|NCT04276415|587966996|FG001|Overall Study|Physician Decision|0|||
162797079|NCT04276415|587966997|FG002|Overall Study|Physician Decision|1|||
162797080|NCT04276415|587966998|FG003|Overall Study|Physician Decision|3|||
162797081|NCT04276415|587966999|FG004|Overall Study|Physician Decision|2|||
162797082|NCT04276415|587967000|FG005|Overall Study|Physician Decision|0|||
162797083|NCT04276415|587966995|FG000|Overall Study|Progressive disease|3|||
162797084|NCT04276415|587966996|FG001|Overall Study|Progressive disease|3|||
162797085|NCT04276415|587966997|FG002|Overall Study|Progressive disease|4|||
162797086|NCT04276415|587966998|FG003|Overall Study|Progressive disease|5|||
162797087|NCT04276415|587966999|FG004|Overall Study|Progressive disease|1|||
162797088|NCT04276415|587967000|FG005|Overall Study|Progressive disease|2|||
162797089|NCT04276415|587966995|FG000|Overall Study|Withdrawal by patient|0|||
162797090|NCT04276415|587966996|FG001|Overall Study|Withdrawal by patient|0|||
162797091|NCT04276415|587966997|FG002|Overall Study|Withdrawal by patient|0|||
162797092|NCT04276415|587966998|FG003|Overall Study|Withdrawal by patient|1|||
162797093|NCT04276415|587966999|FG004|Overall Study|Withdrawal by patient|2|||
162797094|NCT04276415|587967000|FG005|Overall Study|Withdrawal by patient|0|||
162797095|NCT00208325|587967001|FG000|Overall Study|Death|18|||
162797096|NCT00208325|587967002|FG001|Overall Study|Death|19|||
162797097|NCT00208325|587967003|FG002|Overall Study|Death|7|||
162797098|NCT00208325|587967004|FG003|Overall Study|Death|5|||
162797099|NCT00208325|587967001|FG000|Overall Study|Withdrawal by Subject|0|||
162797100|NCT00208325|587967002|FG001|Overall Study|Withdrawal by Subject|1|||
162797101|NCT00208325|587967003|FG002|Overall Study|Withdrawal by Subject|0|||
162797102|NCT00208325|587967004|FG003|Overall Study|Withdrawal by Subject|0|||
162797103|NCT00208325|587967001|FG000|Overall Study|Revision|4|||
162797104|NCT00208325|587967002|FG001|Overall Study|Revision|1|||
162797105|NCT00208325|587967003|FG002|Overall Study|Revision|0|||
162797106|NCT00208325|587967004|FG003|Overall Study|Revision|4|||
162797107|NCT00208325|587967001|FG000|Overall Study|Lost to Follow-up|1|||
162797108|NCT00208325|587967002|FG001|Overall Study|Lost to Follow-up|0|||
162797109|NCT00208325|587967003|FG002|Overall Study|Lost to Follow-up|2|||
162797110|NCT00208325|587967004|FG003|Overall Study|Lost to Follow-up|0|||
162797111|NCT00208325|587967001|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
162797112|NCT00208325|587967002|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
162797113|NCT00208325|587967003|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
162797114|NCT00208325|587967004|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
162797115|NCT00208325|587967001|FG000|Overall Study|Does not wish to Continue in Study|5|||
162797116|NCT00208325|587967002|FG001|Overall Study|Does not wish to Continue in Study|8|||
162797117|NCT00208325|587967003|FG002|Overall Study|Does not wish to Continue in Study|3|||
162797118|NCT00208325|587967004|FG003|Overall Study|Does not wish to Continue in Study|2|||
162797119|NCT00208325|587967001|FG000|Overall Study|Other|2|||
162797120|NCT00208325|587967002|FG001|Overall Study|Other|1|||
162797121|NCT00208325|587967003|FG002|Overall Study|Other|1|||
162797122|NCT00208325|587967004|FG003|Overall Study|Other|0|||
162797123|NCT00208325|587967001|FG000|Overall Study|Mis-Randomized|17|||
162797124|NCT00208325|587967002|FG001|Overall Study|Mis-Randomized|20|||
162797125|NCT00208325|587967003|FG002|Overall Study|Mis-Randomized|0|||
162797126|NCT00208325|587967004|FG003|Overall Study|Mis-Randomized|0|||
162797127|NCT04662931|587967005|FG000|Overall Study|Withdrawal by Subject|17|||
162797128|NCT04662931|587967005|FG000|Overall Study|Death|3|||
162797129|NCT04662931|587967005|FG000|Overall Study|Lost to Follow-up|3|||
162797130|NCT04662931|587967005|FG000|Overall Study|Guardian Decision|1|||
162797131|NCT01254747|587967008|FG000|Overall Study|Unacceptable subjective vision|0|||
162797132|NCT01254747|587967009|FG001|Overall Study|Unacceptable subjective vision|0|||
162797133|NCT01254747|587967010|FG002|Overall Study|Unacceptable subjective vision|0|||
162797134|NCT01254747|587967011|FG003|Overall Study|Unacceptable subjective vision|2|||
162797135|NCT01254747|587967008|FG000|Overall Study|Difficult removal handling|0|||
162797136|NCT01254747|587967009|FG001|Overall Study|Difficult removal handling|0|||
162797137|NCT01254747|587967010|FG002|Overall Study|Difficult removal handling|1|||
162797138|NCT01254747|587967011|FG003|Overall Study|Difficult removal handling|0|||
162797139|NCT01254747|587967008|FG000|Overall Study|Symptoms and problems|0|||
162797140|NCT01254747|587967009|FG001|Overall Study|Symptoms and problems|2|||
162797141|NCT01254747|587967010|FG002|Overall Study|Symptoms and problems|1|||
162797142|NCT01254747|587967011|FG003|Overall Study|Symptoms and problems|0|||
162797143|NCT01254747|587967008|FG000|Overall Study|Lost to Follow-up|0|||
162797144|NCT01254747|587967009|FG001|Overall Study|Lost to Follow-up|0|||
162797145|NCT01254747|587967010|FG002|Overall Study|Lost to Follow-up|1|||
162797146|NCT01254747|587967011|FG003|Overall Study|Lost to Follow-up|0|||
162797147|NCT01254747|587967008|FG000|Overall Study|Biomicroscopy|0|||
162797148|NCT01254747|587967009|FG001|Overall Study|Biomicroscopy|0|||
162797149|NCT01254747|587967010|FG002|Overall Study|Biomicroscopy|1|||
162797150|NCT01254747|587967011|FG003|Overall Study|Biomicroscopy|0|||
162797151|NCT01254747|587967008|FG000|Overall Study|Discomfort|0|||
162797152|NCT01254747|587967009|FG001|Overall Study|Discomfort|4|||
162797153|NCT01254747|587967010|FG002|Overall Study|Discomfort|0|||
162797154|NCT01254747|587967011|FG003|Overall Study|Discomfort|0|||
162797155|NCT02406677|587967012|FG000|Overall Study|Death|16|||
162797156|NCT02406677|587967013|FG001|Overall Study|Death|8|||
162797157|NCT02406677|587967012|FG000|Overall Study|Discharged without P2Y12|1|||
162797158|NCT02406677|587967013|FG001|Overall Study|Discharged without P2Y12|3|||
162797159|NCT02406677|587967012|FG000|Overall Study|Discharged on prasugrel|283|||
162797160|NCT02406677|587967013|FG001|Overall Study|Discharged on prasugrel|587|||
162797161|NCT02406677|587967012|FG000|Overall Study|Withdrawal by Subject|1|||
162797162|NCT02406677|587967013|FG001|Overall Study|Withdrawal by Subject|0|||
162797163|NCT04531098|587967018|FG000|Stage I|Adverse Event|0|||
162797164|NCT04531098|587967019|FG001|Stage I|Adverse Event|0|||
162797165|NCT04531098|587967020|FG002|Stage I|Adverse Event|3|||
162797166|NCT04531098|587967018|FG000|Stage I|Protocol Violation|0|||
162797167|NCT04531098|587967019|FG001|Stage I|Protocol Violation|0|||
162797168|NCT04531098|587967020|FG002|Stage I|Protocol Violation|5|||
162797169|NCT04531098|587967018|FG000|Stage I|Withdrawal by Subject|0|||
162797170|NCT04531098|587967019|FG001|Stage I|Withdrawal by Subject|5|||
162797171|NCT04531098|587967020|FG002|Stage I|Withdrawal by Subject|10|||
162797172|NCT04531098|587967018|FG000|Stage II|Adverse Event|1|||
162797173|NCT04531098|587967019|FG001|Stage II|Adverse Event|2|||
162797174|NCT04531098|587967020|FG002|Stage II|Adverse Event|0|||
162797175|NCT04531098|587967018|FG000|Stage II|Protocol Violation|1|||
162797176|NCT04531098|587967019|FG001|Stage II|Protocol Violation|2|||
162797177|NCT04531098|587967020|FG002|Stage II|Protocol Violation|0|||
162797178|NCT04531098|587967018|FG000|Stage II|Withdrawal by Subject|3|||
162797179|NCT04531098|587967019|FG001|Stage II|Withdrawal by Subject|1|||
162797180|NCT04531098|587967020|FG002|Stage II|Withdrawal by Subject|0|||
162797181|NCT04531098|587967018|FG000|Stage II|Moved from study area|8|||
162797182|NCT04531098|587967019|FG001|Stage II|Moved from study area|5|||
162797183|NCT04531098|587967020|FG002|Stage II|Moved from study area|0|||
162797184|NCT02145468|587967021|FG000|Overall Study|Withdrawal by Subject|5|||
162797185|NCT02145468|587967022|FG001|Overall Study|Withdrawal by Subject|8|||
162797186|NCT01803282|587967026|FG000|Overall Study|Progressive Disease|4|||
162797187|NCT01803282|587967027|FG001|Overall Study|Progressive Disease|3|||
162797188|NCT01803282|587967028|FG002|Overall Study|Progressive Disease|6|||
162797189|NCT01803282|587967029|FG003|Overall Study|Progressive Disease|22|||
162797190|NCT01803282|587967030|FG004|Overall Study|Progressive Disease|5|||
162797191|NCT01803282|587967031|FG005|Overall Study|Progressive Disease|8|||
162797192|NCT01803282|587967032|FG006|Overall Study|Progressive Disease|23|||
162797193|NCT01803282|587967033|FG007|Overall Study|Progressive Disease|24|||
162797194|NCT01803282|587967034|FG008|Overall Study|Progressive Disease|3|||
162797195|NCT01803282|587967035|FG009|Overall Study|Progressive Disease|29|||
162797196|NCT01803282|587967036|FG010|Overall Study|Progressive Disease|6|||
162797197|NCT01803282|587967037|FG011|Overall Study|Progressive Disease|11|||
162797198|NCT01803282|587967026|FG000|Overall Study|Death|0|||
162797199|NCT01803282|587967027|FG001|Overall Study|Death|0|||
162797200|NCT01803282|587967028|FG002|Overall Study|Death|0|||
162797201|NCT01803282|587967029|FG003|Overall Study|Death|0|||
162797202|NCT01803282|587967030|FG004|Overall Study|Death|2|||
162797203|NCT01803282|587967031|FG005|Overall Study|Death|1|||
162797204|NCT01803282|587967032|FG006|Overall Study|Death|1|||
162797205|NCT01803282|587967033|FG007|Overall Study|Death|5|||
162797206|NCT01803282|587967034|FG008|Overall Study|Death|1|||
162797207|NCT01803282|587967035|FG009|Overall Study|Death|1|||
162797208|NCT01803282|587967036|FG010|Overall Study|Death|0|||
162797209|NCT01803282|587967037|FG011|Overall Study|Death|0|||
162797210|NCT01803282|587967026|FG000|Overall Study|Withdrew Consent|0|||
162797211|NCT01803282|587967027|FG001|Overall Study|Withdrew Consent|0|||
162797212|NCT01803282|587967028|FG002|Overall Study|Withdrew Consent|0|||
162797213|NCT01803282|587967029|FG003|Overall Study|Withdrew Consent|6|||
162797214|NCT01803282|587967030|FG004|Overall Study|Withdrew Consent|1|||
162797215|NCT01803282|587967031|FG005|Overall Study|Withdrew Consent|0|||
162797216|NCT01803282|587967032|FG006|Overall Study|Withdrew Consent|8|||
162797217|NCT01803282|587967033|FG007|Overall Study|Withdrew Consent|3|||
162797218|NCT01803282|587967034|FG008|Overall Study|Withdrew Consent|1|||
162797219|NCT01803282|587967035|FG009|Overall Study|Withdrew Consent|5|||
162797220|NCT01803282|587967036|FG010|Overall Study|Withdrew Consent|0|||
162797221|NCT01803282|587967037|FG011|Overall Study|Withdrew Consent|1|||
162797222|NCT01803282|587967026|FG000|Overall Study|Investigator's Discretion|0|||
162797223|NCT01803282|587967027|FG001|Overall Study|Investigator's Discretion|0|||
162797224|NCT01803282|587967028|FG002|Overall Study|Investigator's Discretion|0|||
162797225|NCT01803282|587967029|FG003|Overall Study|Investigator's Discretion|7|||
162797226|NCT01803282|587967030|FG004|Overall Study|Investigator's Discretion|2|||
162797227|NCT01803282|587967031|FG005|Overall Study|Investigator's Discretion|1|||
162797228|NCT01803282|587967032|FG006|Overall Study|Investigator's Discretion|7|||
162797229|NCT01803282|587967033|FG007|Overall Study|Investigator's Discretion|10|||
162797230|NCT01803282|587967034|FG008|Overall Study|Investigator's Discretion|6|||
162797231|NCT01803282|587967035|FG009|Overall Study|Investigator's Discretion|7|||
162797232|NCT01803282|587967036|FG010|Overall Study|Investigator's Discretion|1|||
162797233|NCT01803282|587967037|FG011|Overall Study|Investigator's Discretion|0|||
162797234|NCT01803282|587967026|FG000|Overall Study|Adverse Event|0|||
162797235|NCT01803282|587967027|FG001|Overall Study|Adverse Event|0|||
162797236|NCT01803282|587967028|FG002|Overall Study|Adverse Event|0|||
162797237|NCT01803282|587967029|FG003|Overall Study|Adverse Event|0|||
162797238|NCT01803282|587967030|FG004|Overall Study|Adverse Event|0|||
162797239|NCT01803282|587967031|FG005|Overall Study|Adverse Event|0|||
162797240|NCT01803282|587967032|FG006|Overall Study|Adverse Event|1|||
162797241|NCT01803282|587967033|FG007|Overall Study|Adverse Event|2|||
162797242|NCT01803282|587967034|FG008|Overall Study|Adverse Event|0|||
162797243|NCT01803282|587967035|FG009|Overall Study|Adverse Event|1|||
162797244|NCT01803282|587967036|FG010|Overall Study|Adverse Event|0|||
162797245|NCT01803282|587967037|FG011|Overall Study|Adverse Event|3|||
162797246|NCT01803282|587967026|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162797247|NCT01803282|587967027|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162797248|NCT01803282|587967028|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162797249|NCT01803282|587967029|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162797250|NCT01803282|587967030|FG004|Overall Study|Non-Compliance with Study Drug|0|||
162797251|NCT01803282|587967031|FG005|Overall Study|Non-Compliance with Study Drug|0|||
162797252|NCT01803282|587967032|FG006|Overall Study|Non-Compliance with Study Drug|0|||
162797253|NCT01803282|587967033|FG007|Overall Study|Non-Compliance with Study Drug|0|||
162797254|NCT01803282|587967034|FG008|Overall Study|Non-Compliance with Study Drug|0|||
162797255|NCT01803282|587967035|FG009|Overall Study|Non-Compliance with Study Drug|0|||
162797256|NCT01803282|587967036|FG010|Overall Study|Non-Compliance with Study Drug|0|||
162797257|NCT01803282|587967037|FG011|Overall Study|Non-Compliance with Study Drug|0|||
162797258|NCT01803282|587967026|FG000|Overall Study|Unknown Reason|0|||
162797259|NCT01803282|587967027|FG001|Overall Study|Unknown Reason|0|||
162797260|NCT01803282|587967028|FG002|Overall Study|Unknown Reason|0|||
162797261|NCT01803282|587967029|FG003|Overall Study|Unknown Reason|0|||
162797262|NCT01803282|587967030|FG004|Overall Study|Unknown Reason|0|||
162797263|NCT01803282|587967031|FG005|Overall Study|Unknown Reason|0|||
162797264|NCT01803282|587967032|FG006|Overall Study|Unknown Reason|0|||
162797265|NCT01803282|587967033|FG007|Overall Study|Unknown Reason|1|||
162797266|NCT01803282|587967034|FG008|Overall Study|Unknown Reason|0|||
162797267|NCT01803282|587967035|FG009|Overall Study|Unknown Reason|0|||
162797268|NCT01803282|587967036|FG010|Overall Study|Unknown Reason|0|||
162797269|NCT01803282|587967037|FG011|Overall Study|Unknown Reason|0|||
162797270|NCT01803282|587967026|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
162797271|NCT01803282|587967027|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
162797272|NCT01803282|587967028|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
162797273|NCT01803282|587967029|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
162797274|NCT01803282|587967030|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
162797275|NCT01803282|587967031|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
162797276|NCT01803282|587967032|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
162797277|NCT01803282|587967033|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
162797278|NCT01803282|587967034|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
162797279|NCT01803282|587967035|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
162797280|NCT01803282|587967036|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
162797281|NCT01803282|587967037|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
162797282|NCT01803282|587967026|FG000|Overall Study|Enrolled but Never Treated|0|||
162797283|NCT01803282|587967027|FG001|Overall Study|Enrolled but Never Treated|0|||
162797284|NCT01803282|587967028|FG002|Overall Study|Enrolled but Never Treated|0|||
162797285|NCT01803282|587967029|FG003|Overall Study|Enrolled but Never Treated|0|||
162797286|NCT01803282|587967030|FG004|Overall Study|Enrolled but Never Treated|1|||
162797287|NCT01803282|587967031|FG005|Overall Study|Enrolled but Never Treated|0|||
162797288|NCT01803282|587967032|FG006|Overall Study|Enrolled but Never Treated|1|||
162797289|NCT01803282|587967033|FG007|Overall Study|Enrolled but Never Treated|1|||
162797290|NCT01803282|587967034|FG008|Overall Study|Enrolled but Never Treated|0|||
162797291|NCT01803282|587967035|FG009|Overall Study|Enrolled but Never Treated|1|||
162797292|NCT01803282|587967036|FG010|Overall Study|Enrolled but Never Treated|0|||
162797293|NCT01803282|587967037|FG011|Overall Study|Enrolled but Never Treated|0|||
162797294|NCT04908631|587967042|FG000|Overall Study|Lost to Follow-up|1|||
162797295|NCT04908631|587967042|FG000|Overall Study|Physician Decision|1|||
162797296|NCT04908631|587967042|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
162797297|NCT03578887|587967044|FG000|Overall Study|Withdrawal by Subject|7|||
162797298|NCT03578887|587967045|FG001|Overall Study|Withdrawal by Subject|2|||
162797299|NCT03578887|587967046|FG002|Overall Study|Withdrawal by Subject|1|||
162797300|NCT03578887|587967044|FG000|Overall Study|Lost to Follow-up|13|||
162797301|NCT03578887|587967045|FG001|Overall Study|Lost to Follow-up|1|||
162797302|NCT03578887|587967046|FG002|Overall Study|Lost to Follow-up|4|||
162797303|NCT03578887|587967044|FG000|Overall Study|Physician Decision|0|||
162797304|NCT03578887|587967045|FG001|Overall Study|Physician Decision|1|||
162797305|NCT03578887|587967046|FG002|Overall Study|Physician Decision|1|||
162797306|NCT00387426|587969268|FG000|Overall Study|Lack of Response|7|||
162797307|NCT00387426|587969268|FG000|Overall Study|Toxicities|4|||
162797308|NCT00387426|587969268|FG000|Overall Study|Disease Progression|3|||
162797309|NCT03203473|587969269|FG000|Induction Phase|Never started primary treatment|2|||
162797310|NCT03203473|587969270|FG001|Induction Phase|Never started primary treatment|0|||
162797311|NCT03203473|587969271|FG002|Induction Phase|Never started primary treatment|0|||
162797312|NCT03203473|587969269|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
162797313|NCT03203473|587969270|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
162797314|NCT03203473|587969271|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
162797315|NCT03203473|587969269|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
162797316|NCT03203473|587969270|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
162797317|NCT03203473|587969271|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
162797318|NCT03203473|587969269|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
162797319|NCT03203473|587969270|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
162797320|NCT03203473|587969271|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
162797321|NCT03203473|587969269|FG000|Arm Allocation Phase|started salvage therapy|0|||
162797322|NCT03203473|587969270|FG001|Arm Allocation Phase|started salvage therapy|5|||
162797323|NCT03203473|587969271|FG002|Arm Allocation Phase|started salvage therapy|0|||
162797324|NCT03203473|587969269|FG000|Arm Allocation Phase|Disease progression|0|||
162797325|NCT03203473|587969270|FG001|Arm Allocation Phase|Disease progression|0|||
162797326|NCT03203473|587969271|FG002|Arm Allocation Phase|Disease progression|37|||
162797327|NCT03203473|587969269|FG000|Arm Allocation Phase|Adverse Event|0|||
162797328|NCT03203473|587969270|FG001|Arm Allocation Phase|Adverse Event|0|||
162797329|NCT03203473|587969271|FG002|Arm Allocation Phase|Adverse Event|11|||
162797330|NCT03203473|587969269|FG000|Arm Allocation Phase|Physician Decision|0|||
162797331|NCT03203473|587969270|FG001|Arm Allocation Phase|Physician Decision|0|||
162797332|NCT03203473|587969271|FG002|Arm Allocation Phase|Physician Decision|3|||
162797333|NCT03203473|587969269|FG000|Arm Allocation Phase|Death|0|||
162797334|NCT03203473|587969270|FG001|Arm Allocation Phase|Death|0|||
162797335|NCT03203473|587969271|FG002|Arm Allocation Phase|Death|1|||
162797336|NCT03203473|587969269|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
162797337|NCT03203473|587969270|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
162797338|NCT03203473|587969271|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
162797339|NCT03203473|587969269|FG000|Arm Allocation Phase|Intercurrent illness|0|||
162797340|NCT03203473|587969270|FG001|Arm Allocation Phase|Intercurrent illness|0|||
162797341|NCT03203473|587969271|FG002|Arm Allocation Phase|Intercurrent illness|1|||
162797342|NCT03203473|587969269|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
162797343|NCT03203473|587969270|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
162797344|NCT03203473|587969271|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
162797345|NCT00095498|587969274|FG000|Overall Study|Physician Decision|9|||
162797346|NCT00095498|587969275|FG001|Overall Study|Physician Decision|10|||
162797347|NCT00095498|587969276|FG002|Overall Study|Physician Decision|8|||
162797348|NCT00095498|587969274|FG000|Overall Study|Adverse Event|1|||
162797349|NCT00095498|587969275|FG001|Overall Study|Adverse Event|0|||
162797350|NCT00095498|587969276|FG002|Overall Study|Adverse Event|1|||
162797351|NCT00095498|587969274|FG000|Overall Study|Withdrawal by Subject|15|||
162797352|NCT00095498|587969275|FG001|Overall Study|Withdrawal by Subject|16|||
162797353|NCT00095498|587969276|FG002|Overall Study|Withdrawal by Subject|15|||
162797354|NCT00095498|587969274|FG000|Overall Study|Disease progression|0|||
162797355|NCT00095498|587969275|FG001|Overall Study|Disease progression|1|||
162797356|NCT00095498|587969276|FG002|Overall Study|Disease progression|1|||
162797357|NCT00095498|587969274|FG000|Overall Study|Ineligibility determined|3|||
162797358|NCT00095498|587969275|FG001|Overall Study|Ineligibility determined|0|||
162797359|NCT00095498|587969276|FG002|Overall Study|Ineligibility determined|2|||
162797360|NCT00095498|587969274|FG000|Overall Study|Lost to Follow-up|1|||
162797361|NCT00095498|587969275|FG001|Overall Study|Lost to Follow-up|1|||
162797362|NCT00095498|587969276|FG002|Overall Study|Lost to Follow-up|2|||
162797363|NCT00095498|587969274|FG000|Overall Study|Noncompliance|1|||
162797364|NCT00095498|587969275|FG001|Overall Study|Noncompliance|0|||
162797365|NCT00095498|587969276|FG002|Overall Study|Noncompliance|1|||
162797366|NCT00095498|587969274|FG000|Overall Study|Other|6|||
162797367|NCT00095498|587969275|FG001|Overall Study|Other|7|||
162797368|NCT00095498|587969276|FG002|Overall Study|Other|6|||
162797369|NCT00095498|587969274|FG000|Overall Study|Protocol Violation|0|||
162797370|NCT00095498|587969275|FG001|Overall Study|Protocol Violation|0|||
162797371|NCT00095498|587969276|FG002|Overall Study|Protocol Violation|1|||
162797372|NCT00095498|587969274|FG000|Overall Study|Requirement for alternative therapy|1|||
162797373|NCT00095498|587969275|FG001|Overall Study|Requirement for alternative therapy|0|||
162797374|NCT00095498|587969276|FG002|Overall Study|Requirement for alternative therapy|2|||
162797375|NCT05020327|587969278|FG000|Overall Study|Physician Decision|3|||
162797376|NCT05020327|587969279|FG001|Overall Study|Physician Decision|0|||
162797377|NCT05020327|587969280|FG002|Overall Study|Physician Decision|0|||
162797378|NCT05020327|587969278|FG000|Overall Study|Withdrawal by Subject|1|||
162797379|NCT05020327|587969279|FG001|Overall Study|Withdrawal by Subject|1|||
162797380|NCT05020327|587969280|FG002|Overall Study|Withdrawal by Subject|0|||
162797381|NCT05020327|587969278|FG000|Overall Study|personal/cultural, ineligible|12|||
162797382|NCT05020327|587969279|FG001|Overall Study|personal/cultural, ineligible|0|||
162797383|NCT05020327|587969280|FG002|Overall Study|personal/cultural, ineligible|0|||
162797384|NCT03002220|587969282|FG000|Overall Study|Lack of Efficacy|2|||
162797385|NCT03002220|587969282|FG000|Overall Study|Withdrawal by Subject|3|||
162797386|NCT03002220|587969282|FG000|Overall Study|Adverse Event|2|||
162797387|NCT03002220|587969282|FG000|Overall Study|Disease progression|13|||
162797388|NCT03002220|587969282|FG000|Overall Study|Physician Decision|1|||
162797389|NCT01015560|587969285|FG000|Overall Study|Adverse Event|1|||
162797390|NCT01015560|587969285|FG000|Overall Study|Not protocol specified|1|||
162797391|NCT01015560|587969285|FG000|Overall Study|Withdrawal by Subject|1|||
162797392|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
162797393|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
162797394|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
162797395|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
162797396|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
162797397|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
162797398|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
162797399|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162797400|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162797401|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162797402|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162797403|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162797404|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Death|1|||
162797405|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Death|2|||
162797406|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Death|2|||
162797407|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Death|0|||
162797408|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Death|0|||
162797409|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Death|0|||
162797410|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162797411|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
162797412|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
162797413|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162797414|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162797415|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162797416|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
162797417|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162797418|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162797419|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162797420|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162797421|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162797422|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
162797423|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162797424|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162797425|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162797426|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162797427|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162797428|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
162797429|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162797430|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162797431|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162797432|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162797433|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162797434|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162797435|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
162797436|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162797437|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162797438|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162797439|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162797440|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
162797441|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
162797442|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
162797443|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
162797444|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
162797445|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
162797446|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162797447|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162797448|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
162797449|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162797450|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162797451|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162797452|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Site closure|0|||
162797453|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Site closure|0|||
162797454|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Site closure|1|||
162797455|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Site closure|0|||
162797456|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Site closure|0|||
162797457|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Site closure|0|||
162797458|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
162797459|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
162797460|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
162797461|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
162797462|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
162797463|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
162797464|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
162797465|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
162797466|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
162797467|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
162797468|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
162797469|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
162797470|NCT03439254|587969286|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
162797471|NCT03439254|587969287|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
162797472|NCT03439254|587969288|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
162797473|NCT03439254|587969289|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162797474|NCT03439254|587969290|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162797475|NCT03439254|587969291|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162797476|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162797477|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162797478|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162797479|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
162797480|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
162797481|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
162797482|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162797483|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162797484|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162797485|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
162797486|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162797487|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
162797488|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162797489|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162797490|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162797491|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162797492|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162797493|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
162797494|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162797495|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162797496|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162797497|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162797498|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
162797499|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162797500|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162797501|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162797502|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162797503|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162797504|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
162797505|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162797506|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162797507|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162797508|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162797509|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162797510|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162797511|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
162797512|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162797513|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162797514|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162797515|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
162797516|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162797517|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162797518|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162797519|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162797520|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162797521|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
162797522|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
162797523|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162797524|NCT03439254|587969286|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162797525|NCT03439254|587969287|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162797526|NCT03439254|587969288|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162797527|NCT03439254|587969289|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
162797528|NCT03439254|587969290|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
162797529|NCT03439254|587969291|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
162797530|NCT00128102|587969294|FG000|Overall Study|Site Discontinued|3|||
162797531|NCT00128102|587969295|FG001|Overall Study|Site Discontinued|6|||
162797532|NCT00128102|587969294|FG000|Overall Study|Other|0|||
162797533|NCT00128102|587969295|FG001|Overall Study|Other|1|||
162797534|NCT00128102|587969294|FG000|Overall Study|Progressive Disease|255|||
162797535|NCT00128102|587969295|FG001|Overall Study|Progressive Disease|285|||
162797536|NCT00128102|587969294|FG000|Overall Study|Adverse Event|34|||
162797537|NCT00128102|587969295|FG001|Overall Study|Adverse Event|11|||
162797538|NCT00128102|587969294|FG000|Overall Study|Death|12|||
162797539|NCT00128102|587969295|FG001|Overall Study|Death|13|||
162797540|NCT00128102|587969294|FG000|Overall Study|Physician Decision|3|||
162797541|NCT00128102|587969295|FG001|Overall Study|Physician Decision|3|||
162797542|NCT00128102|587969294|FG000|Overall Study|Withdrawal by Subject|19|||
162797543|NCT00128102|587969295|FG001|Overall Study|Withdrawal by Subject|11|||
162797544|NCT00128102|587969294|FG000|Overall Study|Protocol Violation|2|||
162797545|NCT00128102|587969295|FG001|Overall Study|Protocol Violation|2|||
162797546|NCT01531673|587969296|FG000|Overall Study|Non-Compliance|0|||
162797547|NCT01531673|587969297|FG001|Overall Study|Non-Compliance|0|||
162797548|NCT01531673|587969298|FG002|Overall Study|Non-Compliance|0|||
162797549|NCT01531673|587969299|FG003|Overall Study|Non-Compliance|0|||
162797550|NCT01531673|587969300|FG004|Overall Study|Non-Compliance|0|||
162797551|NCT01531673|587969301|FG005|Overall Study|Non-Compliance|1|||
162797552|NCT01531673|587969302|FG006|Overall Study|Non-Compliance|0|||
162797553|NCT01531673|587969303|FG007|Overall Study|Non-Compliance|0|||
162797554|NCT01531673|587969304|FG008|Overall Study|Non-Compliance|0|||
162797555|NCT01531673|587969305|FG009|Overall Study|Non-Compliance|0|||
162797556|NCT01531673|587969306|FG010|Overall Study|Non-Compliance|0|||
162797557|NCT01531673|587969307|FG011|Overall Study|Non-Compliance|0|||
162797558|NCT01531673|587969308|FG012|Overall Study|Non-Compliance|0|||
162797559|NCT01531673|587969296|FG000|Overall Study|Adverse Event|0|||
162797560|NCT01531673|587969297|FG001|Overall Study|Adverse Event|1|||
162797561|NCT01531673|587969298|FG002|Overall Study|Adverse Event|0|||
162797562|NCT01531673|587969299|FG003|Overall Study|Adverse Event|0|||
162797563|NCT01531673|587969300|FG004|Overall Study|Adverse Event|0|||
162797564|NCT01531673|587969301|FG005|Overall Study|Adverse Event|0|||
162797565|NCT01531673|587969302|FG006|Overall Study|Adverse Event|0|||
162797566|NCT01531673|587969303|FG007|Overall Study|Adverse Event|0|||
162797567|NCT01531673|587969304|FG008|Overall Study|Adverse Event|0|||
162797568|NCT01531673|587969305|FG009|Overall Study|Adverse Event|0|||
162797569|NCT01531673|587969306|FG010|Overall Study|Adverse Event|0|||
162797570|NCT01531673|587969307|FG011|Overall Study|Adverse Event|0|||
162797571|NCT01531673|587969308|FG012|Overall Study|Adverse Event|0|||
162797572|NCT01531673|587969296|FG000|Overall Study|Lost to Follow-up|0|||
162797573|NCT01531673|587969297|FG001|Overall Study|Lost to Follow-up|0|||
162797574|NCT01531673|587969298|FG002|Overall Study|Lost to Follow-up|0|||
162797575|NCT01531673|587969299|FG003|Overall Study|Lost to Follow-up|0|||
162797576|NCT01531673|587969300|FG004|Overall Study|Lost to Follow-up|1|||
162797577|NCT01531673|587969301|FG005|Overall Study|Lost to Follow-up|0|||
162797578|NCT01531673|587969302|FG006|Overall Study|Lost to Follow-up|0|||
162797579|NCT01531673|587969303|FG007|Overall Study|Lost to Follow-up|0|||
162797580|NCT01531673|587969304|FG008|Overall Study|Lost to Follow-up|0|||
162797581|NCT01531673|587969305|FG009|Overall Study|Lost to Follow-up|0|||
162797582|NCT01531673|587969306|FG010|Overall Study|Lost to Follow-up|0|||
162797583|NCT01531673|587969307|FG011|Overall Study|Lost to Follow-up|0|||
162797584|NCT01531673|587969308|FG012|Overall Study|Lost to Follow-up|0|||
162797585|NCT01531673|587969296|FG000|Overall Study|Other|0|||
162797586|NCT01531673|587969297|FG001|Overall Study|Other|0|||
162797587|NCT01531673|587969298|FG002|Overall Study|Other|0|||
162797588|NCT01531673|587969299|FG003|Overall Study|Other|1|||
162797589|NCT01531673|587969300|FG004|Overall Study|Other|0|||
162797590|NCT01531673|587969301|FG005|Overall Study|Other|0|||
162797591|NCT01531673|587969302|FG006|Overall Study|Other|0|||
162797592|NCT01531673|587969303|FG007|Overall Study|Other|0|||
162797593|NCT01531673|587969304|FG008|Overall Study|Other|0|||
162797594|NCT01531673|587969305|FG009|Overall Study|Other|1|||
162797595|NCT01531673|587969306|FG010|Overall Study|Other|0|||
162797596|NCT01531673|587969307|FG011|Overall Study|Other|0|||
162797597|NCT01531673|587969308|FG012|Overall Study|Other|0|||
162797598|NCT00568178|587969309|FG000|Double Blind Base Study|Adverse Event|0|||
162797599|NCT00568178|587969310|FG001|Double Blind Base Study|Adverse Event|2|||
162797600|NCT00568178|587969311|FG002|Double Blind Base Study|Adverse Event|1|||
162797601|NCT00568178|587969312|FG003|Double Blind Base Study|Adverse Event|2|||
162797602|NCT00568178|587969313|FG004|Double Blind Base Study|Adverse Event|0|||
162797603|NCT00568178|587969314|FG005|Double Blind Base Study|Adverse Event|0|||
162797604|NCT00568178|587969309|FG000|Double Blind Base Study|Lost to Follow-up|1|||
162797605|NCT00568178|587969310|FG001|Double Blind Base Study|Lost to Follow-up|0|||
162797606|NCT00568178|587969311|FG002|Double Blind Base Study|Lost to Follow-up|0|||
162797607|NCT00568178|587969312|FG003|Double Blind Base Study|Lost to Follow-up|1|||
162797608|NCT00568178|587969313|FG004|Double Blind Base Study|Lost to Follow-up|0|||
162797609|NCT00568178|587969314|FG005|Double Blind Base Study|Lost to Follow-up|0|||
162797610|NCT00568178|587969309|FG000|Double Blind Base Study|Physician Decision|1|||
162797611|NCT00568178|587969310|FG001|Double Blind Base Study|Physician Decision|1|||
162797612|NCT00568178|587969311|FG002|Double Blind Base Study|Physician Decision|0|||
162797613|NCT00568178|587969312|FG003|Double Blind Base Study|Physician Decision|1|||
162797614|NCT00568178|587969313|FG004|Double Blind Base Study|Physician Decision|0|||
162797615|NCT00568178|587969314|FG005|Double Blind Base Study|Physician Decision|0|||
162797616|NCT00568178|587969309|FG000|Double Blind Base Study|Protocol Violation|3|||
162797617|NCT00568178|587969310|FG001|Double Blind Base Study|Protocol Violation|2|||
162797618|NCT00568178|587969311|FG002|Double Blind Base Study|Protocol Violation|0|||
162797619|NCT00568178|587969312|FG003|Double Blind Base Study|Protocol Violation|0|||
162797620|NCT00568178|587969313|FG004|Double Blind Base Study|Protocol Violation|0|||
162797621|NCT00568178|587969314|FG005|Double Blind Base Study|Protocol Violation|0|||
162797622|NCT00568178|587969309|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
162797623|NCT00568178|587969310|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
162797624|NCT00568178|587969311|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
162797625|NCT00568178|587969312|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
162797626|NCT00568178|587969313|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
162797627|NCT00568178|587969314|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
162797628|NCT00568178|587969309|FG000|Double Blind Base Study|Progressive Disease|0|||
162797629|NCT00568178|587969310|FG001|Double Blind Base Study|Progressive Disease|0|||
162797630|NCT00568178|587969311|FG002|Double Blind Base Study|Progressive Disease|0|||
162797631|NCT00568178|587969312|FG003|Double Blind Base Study|Progressive Disease|1|||
162797632|NCT00568178|587969313|FG004|Double Blind Base Study|Progressive Disease|0|||
162797633|NCT00568178|587969314|FG005|Double Blind Base Study|Progressive Disease|0|||
162797634|NCT00568178|587969309|FG000|Open Label Extension|Adverse Event|0|||
162797635|NCT00568178|587969310|FG001|Open Label Extension|Adverse Event|0|||
162797636|NCT00568178|587969311|FG002|Open Label Extension|Adverse Event|0|||
162797637|NCT00568178|587969312|FG003|Open Label Extension|Adverse Event|0|||
162797638|NCT00568178|587969313|FG004|Open Label Extension|Adverse Event|11|||
162797639|NCT00568178|587969314|FG005|Open Label Extension|Adverse Event|8|||
162797640|NCT00568178|587969309|FG000|Open Label Extension|Protocol Violation|0|||
162797641|NCT00568178|587969310|FG001|Open Label Extension|Protocol Violation|0|||
162797642|NCT00568178|587969311|FG002|Open Label Extension|Protocol Violation|0|||
162797643|NCT00568178|587969312|FG003|Open Label Extension|Protocol Violation|0|||
162797644|NCT00568178|587969313|FG004|Open Label Extension|Protocol Violation|1|||
162797645|NCT00568178|587969314|FG005|Open Label Extension|Protocol Violation|0|||
162797646|NCT00568178|587969309|FG000|Open Label Extension|Lost to Follow-up|0|||
162797647|NCT00568178|587969310|FG001|Open Label Extension|Lost to Follow-up|0|||
162797648|NCT00568178|587969311|FG002|Open Label Extension|Lost to Follow-up|0|||
162797649|NCT00568178|587969312|FG003|Open Label Extension|Lost to Follow-up|0|||
162797650|NCT00568178|587969313|FG004|Open Label Extension|Lost to Follow-up|6|||
162797651|NCT00568178|587969314|FG005|Open Label Extension|Lost to Follow-up|11|||
162797652|NCT00568178|587969309|FG000|Open Label Extension|Physician Decision|0|||
162797653|NCT00568178|587969310|FG001|Open Label Extension|Physician Decision|0|||
162797654|NCT00568178|587969311|FG002|Open Label Extension|Physician Decision|0|||
162797655|NCT00568178|587969312|FG003|Open Label Extension|Physician Decision|0|||
162797656|NCT00568178|587969313|FG004|Open Label Extension|Physician Decision|9|||
162797657|NCT00568178|587969314|FG005|Open Label Extension|Physician Decision|8|||
162797658|NCT00568178|587969309|FG000|Open Label Extension|Pregnancy|0|||
162797659|NCT00568178|587969310|FG001|Open Label Extension|Pregnancy|0|||
162797660|NCT00568178|587969311|FG002|Open Label Extension|Pregnancy|0|||
162797661|NCT00568178|587969312|FG003|Open Label Extension|Pregnancy|0|||
162797662|NCT00568178|587969313|FG004|Open Label Extension|Pregnancy|0|||
162797663|NCT00568178|587969314|FG005|Open Label Extension|Pregnancy|1|||
162797664|NCT00568178|587969309|FG000|Open Label Extension|Progressive Disease|0|||
162797665|NCT00568178|587969310|FG001|Open Label Extension|Progressive Disease|0|||
162797666|NCT00568178|587969311|FG002|Open Label Extension|Progressive Disease|0|||
162797667|NCT00568178|587969312|FG003|Open Label Extension|Progressive Disease|0|||
162797668|NCT00568178|587969313|FG004|Open Label Extension|Progressive Disease|3|||
162797669|NCT00568178|587969314|FG005|Open Label Extension|Progressive Disease|1|||
162797670|NCT00568178|587969309|FG000|Open Label Extension|Termination of Trial|0|||
162797671|NCT00568178|587969310|FG001|Open Label Extension|Termination of Trial|0|||
162797672|NCT00568178|587969311|FG002|Open Label Extension|Termination of Trial|0|||
162797673|NCT00568178|587969312|FG003|Open Label Extension|Termination of Trial|0|||
162797674|NCT00568178|587969313|FG004|Open Label Extension|Termination of Trial|45|||
162797675|NCT00568178|587969314|FG005|Open Label Extension|Termination of Trial|47|||
162797676|NCT00568178|587969309|FG000|Open Label Extension|Withdrawal by Subject|0|||
162797677|NCT00568178|587969310|FG001|Open Label Extension|Withdrawal by Subject|0|||
162797678|NCT00568178|587969311|FG002|Open Label Extension|Withdrawal by Subject|0|||
162797679|NCT00568178|587969312|FG003|Open Label Extension|Withdrawal by Subject|0|||
162797680|NCT00568178|587969313|FG004|Open Label Extension|Withdrawal by Subject|4|||
162797681|NCT00568178|587969314|FG005|Open Label Extension|Withdrawal by Subject|4|||
162797682|NCT01014208|587969315|FG000|Overall Study|Lost to Follow-up|2|||
162797683|NCT01014208|587969316|FG001|Overall Study|Lost to Follow-up|5|||
162797684|NCT01014208|587969315|FG000|Overall Study|Participant Withdrew Consent|12|||
162797685|NCT01014208|587969316|FG001|Overall Study|Participant Withdrew Consent|12|||
162797686|NCT01014208|587969315|FG000|Overall Study|Did Not Receive Study Drug|2|||
162797687|NCT01014208|587969316|FG001|Overall Study|Did Not Receive Study Drug|0|||
162797688|NCT01014208|587969315|FG000|Overall Study|Study Closed/terminated|78|||
162797689|NCT01014208|587969316|FG001|Overall Study|Study Closed/terminated|83|||
162797690|NCT01332630|587969317|FG000|Overall Study|Withdrawal by Subject|3|||
162797691|NCT04476251|587969320|FG000|Overall Study|Not treated|1|||
162797692|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Physician Decision|2|||
162797693|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Physician Decision|0|||
162797694|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Physician Decision|0|||
162797695|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Adverse Event|33|||
162797696|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Adverse Event|0|||
162797697|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Adverse Event|0|||
162797698|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
162797699|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
162797700|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
162797701|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
162797702|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
162797703|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
162797704|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
162797705|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
162797706|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
162797707|NCT01008553|587969321|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
162797708|NCT01008553|587969322|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
162797709|NCT01008553|587969323|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
162797710|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
162797711|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
162797712|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
162797713|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
162797714|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
162797715|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
162797716|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
162797717|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
162797718|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
162797719|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
162797720|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
162797721|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
162797722|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
162797723|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
162797724|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
162797725|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
162797726|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
162797727|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
162797728|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
162797729|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
162797730|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
162797731|NCT01008553|587969321|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
162797732|NCT01008553|587969322|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
162797733|NCT01008553|587969323|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
162797734|NCT01008410|587969326|FG000|Overall Study|Adverse Event|13|||
162797735|NCT01008410|587969327|FG001|Overall Study|Adverse Event|7|||
162797736|NCT01008410|587969326|FG000|Overall Study|Withdrawal by Subject|6|||
162797737|NCT01008410|587969327|FG001|Overall Study|Withdrawal by Subject|2|||
162797738|NCT01008410|587969326|FG000|Overall Study|Lost to Follow-up|1|||
162797739|NCT01008410|587969327|FG001|Overall Study|Lost to Follow-up|0|||
162797740|NCT01008410|587969326|FG000|Overall Study|Noncompliance|1|||
162797741|NCT01008410|587969327|FG001|Overall Study|Noncompliance|0|||
162797742|NCT01008410|587969326|FG000|Overall Study|Low Cortisol|2|||
162797743|NCT01008410|587969327|FG001|Overall Study|Low Cortisol|0|||
162797744|NCT01008410|587969326|FG000|Overall Study|Lack of Efficacy|2|||
162797745|NCT01008410|587969327|FG001|Overall Study|Lack of Efficacy|6|||
162797746|NCT01008410|587969326|FG000|Overall Study|Met Exclusion Criterion|0|||
162797747|NCT01008410|587969327|FG001|Overall Study|Met Exclusion Criterion|1|||
162797748|NCT00297427|587969330|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
162797749|NCT00297427|587969331|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
162797750|NCT00297427|587969330|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
162797751|NCT00297427|587969331|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
162797752|NCT00297427|587969330|FG000|Phase 1: Initial Intervention|Death|0|||
162797753|NCT00297427|587969331|FG001|Phase 1: Initial Intervention|Death|1|||
162797754|NCT00297427|587969330|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
162797755|NCT00297427|587969331|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
162797756|NCT00297427|587969330|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
162797757|NCT00297427|587969331|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
162797758|NCT00297427|587969330|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
162797759|NCT00297427|587969331|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
162797760|NCT00297427|587969330|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
162797761|NCT00297427|587969331|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
162797762|NCT00297427|587969330|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
162797763|NCT00297427|587969331|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
162797764|NCT01127893|587969332|FG000|Overall Study|Study Termination by the Sponsor|1|||
162797765|NCT01262677|587969333|FG000|Overall Study|Does not meet entrance criteria|0|||
162797766|NCT01262677|587969334|FG001|Overall Study|Does not meet entrance criteria|2|||
162797767|NCT01262677|587969335|FG002|Overall Study|Does not meet entrance criteria|0|||
162797768|NCT01262677|587969333|FG000|Overall Study|Insufficient clinical response|0|||
162797769|NCT01262677|587969334|FG001|Overall Study|Insufficient clinical response|0|||
162797770|NCT01262677|587969335|FG002|Overall Study|Insufficient clinical response|1|||
162797771|NCT01262677|587969333|FG000|Overall Study|Lost to Follow-up|1|||
162797772|NCT01262677|587969334|FG001|Overall Study|Lost to Follow-up|0|||
162797773|NCT01262677|587969335|FG002|Overall Study|Lost to Follow-up|2|||
162797774|NCT01262677|587969333|FG000|Overall Study|No longer willing to participate|3|||
162797775|NCT01262677|587969334|FG001|Overall Study|No longer willing to participate|3|||
162797776|NCT01262677|587969335|FG002|Overall Study|No longer willing to participate|2|||
162797777|NCT01262677|587969333|FG000|Overall Study|Reason not provided|2|||
162797778|NCT01262677|587969334|FG001|Overall Study|Reason not provided|1|||
162797779|NCT01262677|587969335|FG002|Overall Study|Reason not provided|3|||
162797780|NCT01262677|587969333|FG000|Overall Study|Protocol Violation|0|||
162797781|NCT01262677|587969334|FG001|Overall Study|Protocol Violation|1|||
162797782|NCT01262677|587969335|FG002|Overall Study|Protocol Violation|1|||
162797783|NCT01262677|587969333|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
162797784|NCT01262677|587969334|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
162797785|NCT01262677|587969335|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
162797786|NCT00574873|587969336|FG000|Overall Study|Withdrawal by Subject|18|||
162797787|NCT00574873|587969337|FG001|Overall Study|Withdrawal by Subject|19|||
162797788|NCT00574873|587969336|FG000|Overall Study|Investigator request|18|||
162797789|NCT00574873|587969337|FG001|Overall Study|Investigator request|8|||
162797790|NCT00574873|587969336|FG000|Overall Study|Death|15|||
162797791|NCT00574873|587969337|FG001|Overall Study|Death|14|||
162797792|NCT00574873|587969336|FG000|Overall Study|Lost to Follow-up|14|||
162797793|NCT00574873|587969337|FG001|Overall Study|Lost to Follow-up|5|||
162797794|NCT00574873|587969336|FG000|Overall Study|Other|40|||
162797795|NCT00574873|587969337|FG001|Overall Study|Other|4|||
162797796|NCT00574873|587969336|FG000|Overall Study|Discontinuation of study by sponsor|5|||
162797797|NCT00574873|587969337|FG001|Overall Study|Discontinuation of study by sponsor|199|||
162797798|NCT00574873|587969336|FG000|Overall Study|Blank, site closed per local regulations|2|||
162797799|NCT00574873|587969337|FG001|Overall Study|Blank, site closed per local regulations|2|||
162797800|NCT00574873|587969336|FG000|Overall Study|Extension Study|126|||
162797801|NCT00574873|587969337|FG001|Overall Study|Extension Study|0|||
162797802|NCT00581555|587969338|FG000|Overall Study|Adverse Event|4|||
162797803|NCT00581555|587969339|FG001|Overall Study|Adverse Event|3|||
162797804|NCT00581555|587969338|FG000|Overall Study|Physician Decision|3|||
162797805|NCT00581555|587969339|FG001|Overall Study|Physician Decision|2|||
162797806|NCT00581555|587969338|FG000|Overall Study|Withdrawal by Subject|18|||
162797807|NCT00581555|587969339|FG001|Overall Study|Withdrawal by Subject|9|||
162797808|NCT00581555|587969338|FG000|Overall Study|Lost to Follow-up|2|||
162797809|NCT00581555|587969339|FG001|Overall Study|Lost to Follow-up|2|||
162797810|NCT00581555|587969338|FG000|Overall Study|Other reasons|16|||
162797811|NCT00581555|587969339|FG001|Overall Study|Other reasons|4|||
162797812|NCT02787044|587969340|FG000|Overall Study|Lost to Follow-up|15|||
162797813|NCT02787044|587969341|FG001|Overall Study|Lost to Follow-up|19|||
162797814|NCT01638429|587969342|FG000|Overall Study|Withdrawal by Subject|1|||
162797815|NCT02040584|587969343|FG000|Overall Study|Adverse Event|13|||
162797816|NCT02040584|587969344|FG001|Overall Study|Adverse Event|6|||
162797817|NCT02040584|587969343|FG000|Overall Study|Protocol Violation|9|||
162797818|NCT02040584|587969344|FG001|Overall Study|Protocol Violation|11|||
162797819|NCT02040584|587969343|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162797820|NCT02040584|587969344|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162797821|NCT02040584|587969343|FG000|Overall Study|Death|6|||
162797822|NCT02040584|587969344|FG001|Overall Study|Death|3|||
162797823|NCT02040584|587969343|FG000|Overall Study|Transplant rejection/retransplant|0|||
162797824|NCT02040584|587969344|FG001|Overall Study|Transplant rejection/retransplant|1|||
162797825|NCT02040584|587969343|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
162797826|NCT02040584|587969344|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
162797827|NCT02591953|587969345|FG000|Overall Study|Lost to Follow-up|6|||
162797828|NCT02591953|587969346|FG001|Overall Study|Lost to Follow-up|6|||
162797829|NCT02060370|587969347|FG000|Overall Study|Physician Decision|1|||
162797830|NCT00731133|587969348|FG000|Overall Study|Withdrawal by Subject|10|||
162797831|NCT00943852|587969349|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797832|NCT00943852|587969350|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797833|NCT00943852|587969351|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797834|NCT00943852|587969352|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
162797835|NCT00943852|587969353|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797836|NCT00943852|587969354|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797837|NCT00943852|587969355|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797838|NCT00943852|587969356|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797839|NCT00943852|587969357|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797840|NCT00943852|587969358|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162797841|NCT00943852|587969349|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797842|NCT00943852|587969350|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797843|NCT00943852|587969351|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797844|NCT00943852|587969352|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797845|NCT00943852|587969353|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797846|NCT00943852|587969354|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
162797847|NCT00943852|587969355|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797848|NCT00943852|587969356|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797849|NCT00943852|587969357|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797850|NCT00943852|587969358|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162797851|NCT00943852|587969349|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797852|NCT00943852|587969350|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797853|NCT00943852|587969351|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797854|NCT00943852|587969352|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797855|NCT00943852|587969353|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797856|NCT00943852|587969354|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797857|NCT00943852|587969355|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
162797858|NCT00943852|587969356|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797859|NCT00943852|587969357|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797860|NCT00943852|587969358|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162797861|NCT00943852|587969349|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797862|NCT00943852|587969350|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797863|NCT00943852|587969351|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797864|NCT00943852|587969352|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797865|NCT00943852|587969353|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797866|NCT00943852|587969354|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797867|NCT00943852|587969355|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797868|NCT00943852|587969356|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
162797869|NCT00943852|587969357|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797870|NCT00943852|587969358|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162797871|NCT00943852|587969349|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162797872|NCT00943852|587969350|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797873|NCT00943852|587969351|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162797874|NCT00943852|587969352|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162797875|NCT00943852|587969353|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797876|NCT00943852|587969354|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797877|NCT00943852|587969355|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162797878|NCT00943852|587969356|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797879|NCT00943852|587969357|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797880|NCT00943852|587969358|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162797881|NCT02530970|587969378|FG000|Overall Study|Adverse Event|8|||
162797882|NCT02530970|587969378|FG000|Overall Study|Lost to Follow-up|88|||
162797883|NCT02530970|587969378|FG000|Overall Study|Physician Decision|5|||
162797884|NCT02530970|587969378|FG000|Overall Study|Withdrawal by Subject|14|||
162797885|NCT02530970|587969378|FG000|Overall Study|Death|6|||
162797886|NCT02530970|587969378|FG000|Overall Study|Hospitalization|1|||
162797887|NCT02530970|587969378|FG000|Overall Study|Insurance|2|||
162797888|NCT02530970|587969378|FG000|Overall Study|Explant|2|||
162797889|NCT02530970|587969378|FG000|Overall Study|Change in Provider|5|||
162797890|NCT02530970|587969378|FG000|Overall Study|Relocation|3|||
162797891|NCT02636725|587969382|FG000|Overall Study|Adverse Event|1|||
162797892|NCT00743431|587969391|FG000|Overall Study|Toxicity|6|||
162797893|NCT00743431|587969391|FG000|Overall Study|Tumor progression|56|||
162797894|NCT00743431|587969391|FG000|Overall Study|Withdrawal by Subject|13|||
162797895|NCT00743431|587969391|FG000|Overall Study|Death|9|||
162797896|NCT00743431|587969391|FG000|Overall Study|Reason for discontinuation not specified|29|||
162797897|NCT00743431|587969391|FG000|Overall Study|No documentation available|13|||
162797898|NCT03291288|587969392|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
162797899|NCT03291288|587969393|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
162797900|NCT03291288|587969392|FG000|Drug-drug Interaction Phase|Disease progression|1|||
162797901|NCT03291288|587969393|FG001|Drug-drug Interaction Phase|Disease progression|0|||
162797902|NCT03291288|587969392|FG000|Drug-drug Interaction Phase|Other|3|||
162797903|NCT03291288|587969393|FG001|Drug-drug Interaction Phase|Other|0|||
162797904|NCT03291288|587969392|FG000|Pexidartinib Only|Ongoing|0|||
162797905|NCT03291288|587969393|FG001|Pexidartinib Only|Ongoing|2|||
162797906|NCT04978493|587969394|FG000|Overall Study|No reason available|0|||
162797907|NCT04978493|587969395|FG001|Overall Study|No reason available|1|||
162797908|NCT04978493|587969394|FG000|Overall Study|Adverse Event|1|||
162797909|NCT04978493|587969395|FG001|Overall Study|Adverse Event|0|||
162797910|NCT01896726|587969396|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
162797911|NCT01896726|587969396|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
162797912|NCT01128114|587969397|FG000|Overall Study|Treatment Withdrawn|6|||
162797913|NCT01128114|587969397|FG000|Overall Study|Screening Failed|2|||
162797914|NCT05543707|587969402|FG000|Overall Study|Study drug non-compliance/|5|||
162797915|NCT05543707|587969403|FG001|Overall Study|Study drug non-compliance/|0|||
162797916|NCT05543707|587969402|FG000|Overall Study|Withdrawal by Subject|1|||
162797917|NCT05543707|587969403|FG001|Overall Study|Withdrawal by Subject|1|||
162797918|NCT05543707|587969402|FG000|Overall Study|Adverse Event|1|||
162797919|NCT05543707|587969403|FG001|Overall Study|Adverse Event|0|||
162797920|NCT05543707|587969402|FG000|Overall Study|concurrent illness|0|||
162797921|NCT05543707|587969403|FG001|Overall Study|concurrent illness|1|||
162797922|NCT05543707|587969402|FG000|Overall Study|Pregnancy|1|||
162797923|NCT05543707|587969403|FG001|Overall Study|Pregnancy|1|||
162797924|NCT05511038|587969404|FG000|Overall|Withdrawal by Subject|5|||
162797925|NCT05511038|587969405|FG001|Overall|Withdrawal by Subject|3|||
162797926|NCT05511038|587969404|FG000|Overall|Screen Failure|20|||
162797927|NCT05511038|587969405|FG001|Overall|Screen Failure|1|||
162797928|NCT05511038|587969404|FG000|Overall|Physician Decision|3|||
162797929|NCT05511038|587969405|FG001|Overall|Physician Decision|0|||
162797930|NCT05511038|587969404|FG000|Overall|Lost to Follow-up|3|||
162797931|NCT05511038|587969405|FG001|Overall|Lost to Follow-up|0|||
162797932|NCT05511038|587969404|FG000|Overall|Death|1|||
162797933|NCT05511038|587969405|FG001|Overall|Death|0|||
162797934|NCT05511038|587969404|FG000|Screening|Withdrawal by Subject|1|||
162797935|NCT05511038|587969405|FG001|Screening|Withdrawal by Subject|0|||
162797936|NCT05511038|587969404|FG000|Screening|Lost to Follow Up (1 participant)|1|||
162797937|NCT05511038|587969405|FG001|Screening|Lost to Follow Up (1 participant)|0|||
162797938|NCT05511038|587969404|FG000|Screening|Screen Failure|3|||
162797939|NCT05511038|587969405|FG001|Screening|Screen Failure|0|||
162797940|NCT05511038|587969404|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
162797941|NCT05511038|587969405|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
162797942|NCT05511038|587969404|FG000|Treatment|Withdrawal by Subject|5|||
162797943|NCT05511038|587969405|FG001|Treatment|Withdrawal by Subject|3|||
162797944|NCT05511038|587969404|FG000|Treatment|Physician Decision|4|||
162797945|NCT05511038|587969405|FG001|Treatment|Physician Decision|0|||
162797946|NCT05511038|587969404|FG000|Treatment|Lost to Follow-up|2|||
162797947|NCT05511038|587969405|FG001|Treatment|Lost to Follow-up|0|||
162797948|NCT05511038|587969404|FG000|Treatment|Death|1|||
162797949|NCT05511038|587969405|FG001|Treatment|Death|0|||
162797950|NCT05511038|587969404|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
162797951|NCT05511038|587969405|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
162797952|NCT05511038|587969404|FG000|Treatment|Refuse by subject|1|||
162797953|NCT05511038|587969405|FG001|Treatment|Refuse by subject|0|||
162797954|NCT05511038|587969404|FG000|Treatment|Subject did not go to the site for visit|1|||
162797955|NCT05511038|587969405|FG001|Treatment|Subject did not go to the site for visit|0|||
162797956|NCT02108964|587969406|FG000|Overall Study|Progressive disease|15|||
162797957|NCT02108964|587969407|FG001|Overall Study|Progressive disease|31|||
162797958|NCT02108964|587969408|FG002|Overall Study|Progressive disease|54|||
162797959|NCT02108964|587969409|FG003|Overall Study|Progressive disease|7|||
162797960|NCT02108964|587969410|FG004|Overall Study|Progressive disease|20|||
162797961|NCT02108964|587969411|FG005|Overall Study|Progressive disease|4|||
162797962|NCT02108964|587969412|FG006|Overall Study|Progressive disease|6|||
162797963|NCT02108964|587969413|FG007|Overall Study|Progressive disease|33|||
162797964|NCT02108964|587969406|FG000|Overall Study|Physician Decision|1|||
162797965|NCT02108964|587969407|FG001|Overall Study|Physician Decision|5|||
162797966|NCT02108964|587969408|FG002|Overall Study|Physician Decision|7|||
162797967|NCT02108964|587969409|FG003|Overall Study|Physician Decision|1|||
162797968|NCT02108964|587969410|FG004|Overall Study|Physician Decision|2|||
162797969|NCT02108964|587969411|FG005|Overall Study|Physician Decision|1|||
162797970|NCT02108964|587969412|FG006|Overall Study|Physician Decision|1|||
162797971|NCT02108964|587969413|FG007|Overall Study|Physician Decision|3|||
162797972|NCT02108964|587969406|FG000|Overall Study|Adverse Event|0|||
162797973|NCT02108964|587969407|FG001|Overall Study|Adverse Event|0|||
162797974|NCT02108964|587969408|FG002|Overall Study|Adverse Event|4|||
162797975|NCT02108964|587969409|FG003|Overall Study|Adverse Event|0|||
162797976|NCT02108964|587969410|FG004|Overall Study|Adverse Event|1|||
162797977|NCT02108964|587969411|FG005|Overall Study|Adverse Event|0|||
162797978|NCT02108964|587969412|FG006|Overall Study|Adverse Event|3|||
162797979|NCT02108964|587969413|FG007|Overall Study|Adverse Event|2|||
162797980|NCT02108964|587969406|FG000|Overall Study|Death|1|||
162797981|NCT02108964|587969407|FG001|Overall Study|Death|1|||
162797982|NCT02108964|587969408|FG002|Overall Study|Death|4|||
162797983|NCT02108964|587969409|FG003|Overall Study|Death|0|||
162797984|NCT02108964|587969410|FG004|Overall Study|Death|3|||
162797985|NCT02108964|587969411|FG005|Overall Study|Death|0|||
162797986|NCT02108964|587969412|FG006|Overall Study|Death|0|||
162797987|NCT02108964|587969413|FG007|Overall Study|Death|2|||
162797988|NCT02108964|587969406|FG000|Overall Study|Subject/Guardian decision|0|||
162797989|NCT02108964|587969407|FG001|Overall Study|Subject/Guardian decision|1|||
162797990|NCT02108964|587969408|FG002|Overall Study|Subject/Guardian decision|4|||
162797991|NCT02108964|587969409|FG003|Overall Study|Subject/Guardian decision|0|||
162797992|NCT02108964|587969410|FG004|Overall Study|Subject/Guardian decision|2|||
162797993|NCT02108964|587969411|FG005|Overall Study|Subject/Guardian decision|0|||
162797994|NCT02108964|587969412|FG006|Overall Study|Subject/Guardian decision|1|||
162797995|NCT02108964|587969413|FG007|Overall Study|Subject/Guardian decision|2|||
162797996|NCT02108964|587969406|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162797997|NCT02108964|587969407|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162797998|NCT02108964|587969408|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162797999|NCT02108964|587969409|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162798000|NCT02108964|587969410|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162798001|NCT02108964|587969411|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162798002|NCT02108964|587969412|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162798003|NCT02108964|587969413|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
162798004|NCT00798434|587969416|FG000|Double-Blind|Adverse Event|22|||
162798005|NCT00798434|587969417|FG001|Double-Blind|Adverse Event|46|||
162798006|NCT00798434|587969416|FG000|Double-Blind|Death|0|||
162798007|NCT00798434|587969417|FG001|Double-Blind|Death|1|||
162798008|NCT00798434|587969416|FG000|Double-Blind|Lost to Follow-up|1|||
162798009|NCT00798434|587969417|FG001|Double-Blind|Lost to Follow-up|0|||
162798010|NCT00798434|587969416|FG000|Double-Blind|Lack of Efficacy|8|||
162798011|NCT00798434|587969417|FG001|Double-Blind|Lack of Efficacy|12|||
162798012|NCT00798434|587969416|FG000|Double-Blind|Withdrawal by Subject|17|||
162798013|NCT00798434|587969417|FG001|Double-Blind|Withdrawal by Subject|14|||
162798014|NCT00798434|587969416|FG000|Double-Blind|Protocol Violation|1|||
162798015|NCT00798434|587969417|FG001|Double-Blind|Protocol Violation|4|||
162798016|NCT00798434|587969416|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
162798017|NCT00798434|587969417|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
162798018|NCT00798434|587969416|FG000|Double-Blind|Other|1|||
162798019|NCT00798434|587969417|FG001|Double-Blind|Other|0|||
162798020|NCT00798434|587969416|FG000|Double-Blind|Not Treated|3|||
162798021|NCT00798434|587969417|FG001|Double-Blind|Not Treated|6|||
162798022|NCT00798434|587969416|FG000|Open-Label|Adverse Event|33|||
162798023|NCT00798434|587969417|FG001|Open-Label|Adverse Event|11|||
162798024|NCT00798434|587969416|FG000|Open-Label|Lack of Efficacy|5|||
162798025|NCT00798434|587969417|FG001|Open-Label|Lack of Efficacy|11|||
162798026|NCT00798434|587969416|FG000|Open-Label|Withdrawal by Subject|2|||
162798027|NCT00798434|587969417|FG001|Open-Label|Withdrawal by Subject|7|||
162798028|NCT00798434|587969416|FG000|Open-Label|Protocol Violation|1|||
162798029|NCT00798434|587969417|FG001|Open-Label|Protocol Violation|0|||
162798030|NCT00798434|587969416|FG000|Open-Label|Other|1|||
162798031|NCT00798434|587969417|FG001|Open-Label|Other|2|||
162798032|NCT00798434|587969416|FG000|Open-Label|Not Treated|0|||
162798033|NCT00798434|587969417|FG001|Open-Label|Not Treated|1|||
162798034|NCT01217437|587969421|FG000|Overall Study|Adverse Event|0|||
162798035|NCT01217437|587969422|FG001|Overall Study|Adverse Event|8|||
162798036|NCT01217437|587969421|FG000|Overall Study|Death|5|||
162798037|NCT01217437|587969422|FG001|Overall Study|Death|0|||
162798038|NCT01217437|587969421|FG000|Overall Study|Lack of Efficacy|29|||
162798039|NCT01217437|587969422|FG001|Overall Study|Lack of Efficacy|25|||
162798040|NCT01217437|587969421|FG000|Overall Study|Physician Decision|8|||
162798041|NCT01217437|587969422|FG001|Overall Study|Physician Decision|5|||
162798042|NCT01217437|587969421|FG000|Overall Study|Withdrawal by Subject|0|||
162798043|NCT01217437|587969422|FG001|Overall Study|Withdrawal by Subject|2|||
162798044|NCT01217437|587969421|FG000|Overall Study|Ineligible|1|||
162798045|NCT01217437|587969422|FG001|Overall Study|Ineligible|1|||
162798046|NCT02336451|587969426|FG000|Overall Study|Adverse Event|1|||
162798047|NCT02336451|587969427|FG001|Overall Study|Adverse Event|2|||
162798048|NCT02336451|587969428|FG002|Overall Study|Adverse Event|0|||
162798049|NCT02336451|587969429|FG003|Overall Study|Adverse Event|6|||
162798050|NCT02336451|587969430|FG004|Overall Study|Adverse Event|4|||
162798051|NCT02336451|587969426|FG000|Overall Study|Death|6|||
162798052|NCT02336451|587969427|FG001|Overall Study|Death|2|||
162798053|NCT02336451|587969428|FG002|Overall Study|Death|3|||
162798054|NCT02336451|587969429|FG003|Overall Study|Death|6|||
162798055|NCT02336451|587969430|FG004|Overall Study|Death|6|||
162798056|NCT02336451|587969426|FG000|Overall Study|Physician Decision|9|||
162798057|NCT02336451|587969427|FG001|Overall Study|Physician Decision|6|||
162798058|NCT02336451|587969428|FG002|Overall Study|Physician Decision|7|||
162798059|NCT02336451|587969429|FG003|Overall Study|Physician Decision|16|||
162798060|NCT02336451|587969430|FG004|Overall Study|Physician Decision|3|||
162798061|NCT02336451|587969426|FG000|Overall Study|Progressive disease|23|||
162798062|NCT02336451|587969427|FG001|Overall Study|Progressive disease|26|||
162798063|NCT02336451|587969428|FG002|Overall Study|Progressive disease|2|||
162798064|NCT02336451|587969429|FG003|Overall Study|Progressive disease|14|||
162798065|NCT02336451|587969430|FG004|Overall Study|Progressive disease|4|||
162798066|NCT02336451|587969426|FG000|Overall Study|Protocol Violation|1|||
162798067|NCT02336451|587969427|FG001|Overall Study|Protocol Violation|0|||
162798068|NCT02336451|587969428|FG002|Overall Study|Protocol Violation|0|||
162798069|NCT02336451|587969429|FG003|Overall Study|Protocol Violation|0|||
162798070|NCT02336451|587969430|FG004|Overall Study|Protocol Violation|0|||
162798071|NCT02336451|587969426|FG000|Overall Study|Patient/guardian decision|2|||
162798072|NCT02336451|587969427|FG001|Overall Study|Patient/guardian decision|4|||
162798073|NCT02336451|587969428|FG002|Overall Study|Patient/guardian decision|0|||
162798074|NCT02336451|587969429|FG003|Overall Study|Patient/guardian decision|2|||
162798075|NCT02336451|587969430|FG004|Overall Study|Patient/guardian decision|1|||
162798076|NCT06655558|587969433|FG000|Overall Study|Protocol Violation|1|||
162798077|NCT04998812|587969439|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
162798078|NCT04998812|587969440|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
162798079|NCT04998812|587969439|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
162798080|NCT04998812|587969440|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
162798081|NCT04998812|587969439|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
162798082|NCT04998812|587969440|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
162798083|NCT04998812|587969439|FG000|Vaccination Period|Ongoing in study|23|||
162798084|NCT04998812|587969440|FG001|Vaccination Period|Ongoing in study|23|||
162798085|NCT04893460|587969446|FG000|Overall Study|Lost to Follow-up|18|||
162798086|NCT01099215|587970653|FG000|Overall Study|Withdrawal by Subject|1|||
162798087|NCT01099215|587970654|FG001|Overall Study|Withdrawal by Subject|0|||
162798088|NCT01099215|587970653|FG000|Overall Study|Adverse Event|0|||
162798089|NCT01099215|587970654|FG001|Overall Study|Adverse Event|1|||
162798090|NCT01901432|587970658|FG000|Overall Study|Adverse Event|0|||
162798091|NCT01901432|587970659|FG001|Overall Study|Adverse Event|1|||
162798092|NCT01901432|587970660|FG002|Overall Study|Adverse Event|1|||
162798093|NCT01901432|587970661|FG003|Overall Study|Adverse Event|0|||
162798094|NCT01901432|587970662|FG004|Overall Study|Adverse Event|1|||
162798095|NCT01901432|587970658|FG000|Overall Study|Withdrawal by Subject|0|||
162798096|NCT01901432|587970659|FG001|Overall Study|Withdrawal by Subject|0|||
162798097|NCT01901432|587970660|FG002|Overall Study|Withdrawal by Subject|1|||
162798098|NCT01901432|587970661|FG003|Overall Study|Withdrawal by Subject|0|||
162798099|NCT01901432|587970662|FG004|Overall Study|Withdrawal by Subject|5|||
162798100|NCT01901432|587970658|FG000|Overall Study|Physician Decision|0|||
162798101|NCT01901432|587970659|FG001|Overall Study|Physician Decision|0|||
162798102|NCT01901432|587970660|FG002|Overall Study|Physician Decision|0|||
162798103|NCT01901432|587970661|FG003|Overall Study|Physician Decision|0|||
162798104|NCT01901432|587970662|FG004|Overall Study|Physician Decision|2|||
162798105|NCT01901432|587970658|FG000|Overall Study|Patient decision to stop study drug|0|||
162798106|NCT01901432|587970659|FG001|Overall Study|Patient decision to stop study drug|0|||
162798107|NCT01901432|587970660|FG002|Overall Study|Patient decision to stop study drug|0|||
162798108|NCT01901432|587970661|FG003|Overall Study|Patient decision to stop study drug|0|||
162798109|NCT01901432|587970662|FG004|Overall Study|Patient decision to stop study drug|1|||
162798110|NCT01077271|587970668|FG000|Overall Study|Parental desire|8|||
162798111|NCT01077271|587970668|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
162798112|NCT01077271|587970668|FG000|Overall Study|Noncompliance|2|||
162798113|NCT01077271|587970668|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
162798114|NCT01077271|587970668|FG000|Overall Study|Changed doctors|2|||
162798115|NCT01077271|587970668|FG000|Overall Study|Parents thought too many injections|2|||
162798116|NCT01077271|587970668|FG000|Overall Study|End of RSV season nearly reached|1|||
162798117|NCT01077271|587970668|FG000|Overall Study|Mother unconvinced of the necessity|1|||
162798118|NCT00215137|587970669|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
162798119|NCT00215137|587970670|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
162798120|NCT00215137|587970671|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
162798121|NCT00215137|587970669|FG000|Randomization Period|Lost to Follow-up|0|||
162798122|NCT00215137|587970670|FG001|Randomization Period|Lost to Follow-up|1|||
162798123|NCT00215137|587970671|FG002|Randomization Period|Lost to Follow-up|0|||
162798124|NCT00215137|587970669|FG000|Randomization Period|Withdrawal by Subject|0|||
162798125|NCT00215137|587970670|FG001|Randomization Period|Withdrawal by Subject|1|||
162798126|NCT00215137|587970671|FG002|Randomization Period|Withdrawal by Subject|0|||
162798127|NCT03333876|587970672|FG000|Screening Period|Screen Failure|4|||
162798128|NCT03333876|587970672|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
162798129|NCT03333876|587970672|FG000|Mandibular Advancement|Adverse Event|2|||
162798130|NCT03333876|587970672|FG000|Mandibular Advancement|Product Damage|2|||
162798131|NCT00166712|587970674|FG000|Overall Study|Death|0|||
162798132|NCT00166712|587970675|FG001|Overall Study|Death|1|||
162798133|NCT00166712|587970674|FG000|Overall Study|Adverse Event|1|||
162798134|NCT00166712|587970675|FG001|Overall Study|Adverse Event|0|||
162798135|NCT00166712|587970674|FG000|Overall Study|Withdrawal by Subject|1|||
162798136|NCT00166712|587970675|FG001|Overall Study|Withdrawal by Subject|2|||
162798137|NCT00166712|587970674|FG000|Overall Study|Physician Decision|0|||
162798138|NCT00166712|587970675|FG001|Overall Study|Physician Decision|2|||
162798139|NCT04684394|587970676|FG000|Overall Study|Death|1|||
162798140|NCT04684394|587970677|FG001|Overall Study|Death|2|||
162798141|NCT04684394|587970676|FG000|Overall Study|Lost to Follow-up|1|||
162798142|NCT04684394|587970677|FG001|Overall Study|Lost to Follow-up|0|||
162798143|NCT04684394|587970676|FG000|Overall Study|Withdrawal by Subject|2|||
162798144|NCT04684394|587970677|FG001|Overall Study|Withdrawal by Subject|0|||
162798145|NCT04684394|587970676|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
162798146|NCT04684394|587970677|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
162798147|NCT03986944|587970678|FG000|Overall Study|Adverse Event|1|||
162798148|NCT03986944|587970679|FG001|Overall Study|Adverse Event|2|||
162798149|NCT03986944|587970680|FG002|Overall Study|Adverse Event|3|||
162798150|NCT03986944|587970678|FG000|Overall Study|Protocol Violation|0|||
162798151|NCT03986944|587970679|FG001|Overall Study|Protocol Violation|1|||
162798152|NCT03986944|587970680|FG002|Overall Study|Protocol Violation|1|||
162798153|NCT03986944|587970678|FG000|Overall Study|Withdrawal by Subject|3|||
162798154|NCT03986944|587970679|FG001|Overall Study|Withdrawal by Subject|5|||
162798155|NCT03986944|587970680|FG002|Overall Study|Withdrawal by Subject|5|||
162798156|NCT03986944|587970678|FG000|Overall Study|Study termination|10|||
162798157|NCT03986944|587970679|FG001|Overall Study|Study termination|10|||
162798158|NCT03986944|587970680|FG002|Overall Study|Study termination|10|||
162798159|NCT03986944|587970678|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
162798160|NCT03986944|587970679|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
162798161|NCT03986944|587970680|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
162798162|NCT03986944|587970678|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
162798163|NCT03986944|587970679|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
162798164|NCT03986944|587970680|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
162798165|NCT05816330|587970687|FG000|Overall Study|Withdrawal by Subject|4|||
162798166|NCT05816330|587970688|FG001|Overall Study|Withdrawal by Subject|1|||
162798167|NCT00201643|587970689|FG000|Overall Study|Withdrawal by Subject|5|||
162798168|NCT00201643|587970690|FG001|Overall Study|Withdrawal by Subject|4|||
162798169|NCT00996476|587970697|FG000|Overall Study|Withdrawal by Subject|1|||
162798170|NCT00996476|587970698|FG001|Overall Study|Withdrawal by Subject|2|||
162798171|NCT00996476|587970699|FG002|Overall Study|Withdrawal by Subject|1|||
162798172|NCT00996476|587970700|FG003|Overall Study|Withdrawal by Subject|0|||
162798173|NCT00996476|587970701|FG004|Overall Study|Withdrawal by Subject|1|||
162798174|NCT00996476|587970697|FG000|Overall Study|Adverse Event|0|||
162798175|NCT00996476|587970698|FG001|Overall Study|Adverse Event|1|||
162798176|NCT00996476|587970699|FG002|Overall Study|Adverse Event|0|||
162798177|NCT00996476|587970700|FG003|Overall Study|Adverse Event|0|||
162798178|NCT00996476|587970701|FG004|Overall Study|Adverse Event|1|||
162798179|NCT01940939|587970702|FG000|Overall Study|Withdrawal by Subject|2|||
162798180|NCT01940939|587970703|FG001|Overall Study|Withdrawal by Subject|8|||
162798181|NCT01470001|587970704|FG000|Overall Study|Lost to Follow-up|1|||
162798182|NCT01470001|587970705|FG001|Overall Study|Lost to Follow-up|1|||
162798183|NCT01470001|587970704|FG000|Overall Study|Physician Decision|2|||
162798184|NCT01470001|587970705|FG001|Overall Study|Physician Decision|0|||
162798185|NCT01470001|587970704|FG000|Overall Study|Withdrawal by Subject|2|||
162798186|NCT01470001|587970705|FG001|Overall Study|Withdrawal by Subject|1|||
162798187|NCT04187326|587970706|FG000|Overall Study|Lost to Follow-up|2|||
162798188|NCT04187326|587970707|FG001|Overall Study|Lost to Follow-up|1|||
162798189|NCT04187326|587970706|FG000|Overall Study|Computer error- task was only partially completed.|0|||
162798190|NCT04187326|587970707|FG001|Overall Study|Computer error- task was only partially completed.|1|||
162798191|NCT02387970|587970708|FG000|Overall Study|Did not complete 1-year follow up|1|||
162798192|NCT02387970|587970709|FG001|Overall Study|Did not complete 1-year follow up|2|||
162798193|NCT02628028|587970710|FG000|Dosing Period|Withdrawal by Subject|0|||
162798194|NCT02628028|587970711|FG001|Dosing Period|Withdrawal by Subject|0|||
162798195|NCT02628028|587970712|FG002|Dosing Period|Withdrawal by Subject|1|||
162798196|NCT02628028|587970713|FG003|Dosing Period|Withdrawal by Subject|0|||
162798197|NCT02628028|587970714|FG004|Dosing Period|Withdrawal by Subject|2|||
162798198|NCT02628028|587970715|FG005|Dosing Period|Withdrawal by Subject|4|||
162798199|NCT02628028|587970716|FG006|Dosing Period|Withdrawal by Subject|1|||
162798200|NCT02628028|587970717|FG007|Dosing Period|Withdrawal by Subject|1|||
162798201|NCT02628028|587970710|FG000|Dosing Period|Adverse Event|0|||
162798202|NCT02628028|587970711|FG001|Dosing Period|Adverse Event|0|||
162798203|NCT02628028|587970712|FG002|Dosing Period|Adverse Event|0|||
162798204|NCT02628028|587970713|FG003|Dosing Period|Adverse Event|0|||
162798205|NCT02628028|587970714|FG004|Dosing Period|Adverse Event|2|||
162798206|NCT02628028|587970715|FG005|Dosing Period|Adverse Event|1|||
162798207|NCT02628028|587970716|FG006|Dosing Period|Adverse Event|3|||
162798208|NCT02628028|587970717|FG007|Dosing Period|Adverse Event|2|||
162798209|NCT02628028|587970710|FG000|Dosing Period|Death|0|||
162798210|NCT02628028|587970711|FG001|Dosing Period|Death|0|||
162798211|NCT02628028|587970712|FG002|Dosing Period|Death|0|||
162798212|NCT02628028|587970713|FG003|Dosing Period|Death|0|||
162798213|NCT02628028|587970714|FG004|Dosing Period|Death|0|||
162798214|NCT02628028|587970715|FG005|Dosing Period|Death|0|||
162798215|NCT02628028|587970716|FG006|Dosing Period|Death|0|||
162798216|NCT02628028|587970717|FG007|Dosing Period|Death|1|||
162798217|NCT02628028|587970710|FG000|Dosing Period|Lack of Efficacy|0|||
162798218|NCT02628028|587970711|FG001|Dosing Period|Lack of Efficacy|0|||
162798219|NCT02628028|587970712|FG002|Dosing Period|Lack of Efficacy|0|||
162798220|NCT02628028|587970713|FG003|Dosing Period|Lack of Efficacy|0|||
162798221|NCT02628028|587970714|FG004|Dosing Period|Lack of Efficacy|3|||
162798222|NCT02628028|587970715|FG005|Dosing Period|Lack of Efficacy|0|||
162798223|NCT02628028|587970716|FG006|Dosing Period|Lack of Efficacy|1|||
162798224|NCT02628028|587970717|FG007|Dosing Period|Lack of Efficacy|0|||
162798225|NCT02628028|587970710|FG000|Dosing Period|Study Terminated by Sponsor|0|||
162798226|NCT02628028|587970711|FG001|Dosing Period|Study Terminated by Sponsor|0|||
162798227|NCT02628028|587970712|FG002|Dosing Period|Study Terminated by Sponsor|0|||
162798228|NCT02628028|587970713|FG003|Dosing Period|Study Terminated by Sponsor|0|||
162798229|NCT02628028|587970714|FG004|Dosing Period|Study Terminated by Sponsor|7|||
162798230|NCT02628028|587970715|FG005|Dosing Period|Study Terminated by Sponsor|6|||
162798231|NCT02628028|587970716|FG006|Dosing Period|Study Terminated by Sponsor|7|||
162798232|NCT02628028|587970717|FG007|Dosing Period|Study Terminated by Sponsor|7|||
162798233|NCT02628028|587970710|FG000|Dosing Period|Physician Decision|0|||
162798234|NCT02628028|587970711|FG001|Dosing Period|Physician Decision|0|||
162798235|NCT02628028|587970712|FG002|Dosing Period|Physician Decision|0|||
162798236|NCT02628028|587970713|FG003|Dosing Period|Physician Decision|0|||
162798237|NCT02628028|587970714|FG004|Dosing Period|Physician Decision|0|||
162798238|NCT02628028|587970715|FG005|Dosing Period|Physician Decision|1|||
162798239|NCT02628028|587970716|FG006|Dosing Period|Physician Decision|0|||
162798240|NCT02628028|587970717|FG007|Dosing Period|Physician Decision|0|||
162798241|NCT02628028|587970710|FG000|Dosing Period|Site Terminated by Sponsor|0|||
162798242|NCT02628028|587970711|FG001|Dosing Period|Site Terminated by Sponsor|0|||
162798243|NCT02628028|587970712|FG002|Dosing Period|Site Terminated by Sponsor|0|||
162798244|NCT02628028|587970713|FG003|Dosing Period|Site Terminated by Sponsor|0|||
162798245|NCT02628028|587970714|FG004|Dosing Period|Site Terminated by Sponsor|0|||
162798246|NCT02628028|587970715|FG005|Dosing Period|Site Terminated by Sponsor|1|||
162798247|NCT02628028|587970716|FG006|Dosing Period|Site Terminated by Sponsor|1|||
162798248|NCT02628028|587970717|FG007|Dosing Period|Site Terminated by Sponsor|0|||
162798249|NCT02628028|587970710|FG000|Dosing Period|Lost to Follow-up|0|||
162798250|NCT02628028|587970711|FG001|Dosing Period|Lost to Follow-up|0|||
162798251|NCT02628028|587970712|FG002|Dosing Period|Lost to Follow-up|0|||
162798252|NCT02628028|587970713|FG003|Dosing Period|Lost to Follow-up|0|||
162798253|NCT02628028|587970714|FG004|Dosing Period|Lost to Follow-up|0|||
162798254|NCT02628028|587970715|FG005|Dosing Period|Lost to Follow-up|0|||
162798255|NCT02628028|587970716|FG006|Dosing Period|Lost to Follow-up|1|||
162798256|NCT02628028|587970717|FG007|Dosing Period|Lost to Follow-up|0|||
162798257|NCT02628028|587970710|FG000|Dosing Period|Other|0|||
162798258|NCT02628028|587970711|FG001|Dosing Period|Other|0|||
162798259|NCT02628028|587970712|FG002|Dosing Period|Other|0|||
162798260|NCT02628028|587970713|FG003|Dosing Period|Other|0|||
162798261|NCT02628028|587970714|FG004|Dosing Period|Other|2|||
162798262|NCT02628028|587970715|FG005|Dosing Period|Other|1|||
162798263|NCT02628028|587970716|FG006|Dosing Period|Other|2|||
162798264|NCT02628028|587970717|FG007|Dosing Period|Other|4|||
162798265|NCT02628028|587970710|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
162798266|NCT02628028|587970711|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
162798267|NCT02628028|587970712|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
162798268|NCT02628028|587970713|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
162798269|NCT02628028|587970714|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
162798270|NCT02628028|587970715|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
162798271|NCT02628028|587970716|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
162798272|NCT02628028|587970717|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
162798273|NCT02628028|587970710|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798274|NCT02628028|587970711|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798275|NCT02628028|587970712|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798276|NCT02628028|587970713|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798277|NCT02628028|587970714|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798278|NCT02628028|587970715|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
162798279|NCT02628028|587970716|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162798280|NCT02628028|587970717|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
162798281|NCT02628028|587970710|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162798282|NCT02628028|587970711|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162798283|NCT02628028|587970712|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162798284|NCT02628028|587970713|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162798285|NCT02628028|587970714|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162798286|NCT02628028|587970715|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
162798287|NCT02628028|587970716|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
162798288|NCT02628028|587970717|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
162798289|NCT02628028|587970710|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162798290|NCT02628028|587970711|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162798291|NCT02628028|587970712|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162798292|NCT02628028|587970713|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162798293|NCT02628028|587970714|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162798294|NCT02628028|587970715|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
162798295|NCT02628028|587970716|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
162798296|NCT02628028|587970717|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
162798297|NCT02628028|587970710|FG000|Long-term Extension (LTE) Period|Other|0|||
162798298|NCT02628028|587970711|FG001|Long-term Extension (LTE) Period|Other|0|||
162798299|NCT02628028|587970712|FG002|Long-term Extension (LTE) Period|Other|0|||
162798300|NCT02628028|587970713|FG003|Long-term Extension (LTE) Period|Other|0|||
162798301|NCT02628028|587970714|FG004|Long-term Extension (LTE) Period|Other|0|||
162798302|NCT02628028|587970715|FG005|Long-term Extension (LTE) Period|Other|3|||
162798303|NCT02628028|587970716|FG006|Long-term Extension (LTE) Period|Other|4|||
162798304|NCT02628028|587970717|FG007|Long-term Extension (LTE) Period|Other|3|||
162798305|NCT00586612|587970718|FG000|Primary Phase|Protocol Violation|1|||
162798306|NCT00586612|587970719|FG001|Primary Phase|Protocol Violation|0|||
162798307|NCT00586612|587970718|FG000|Primary Phase|Lost to Follow-up|0|||
162798308|NCT00586612|587970719|FG001|Primary Phase|Lost to Follow-up|1|||
162798309|NCT00586612|587970718|FG000|Primary Phase|Withdrawal by Subject|0|||
162798310|NCT00586612|587970719|FG001|Primary Phase|Withdrawal by Subject|2|||
162798311|NCT00586612|587970718|FG000|Booster Phase|Lost to Follow-up|3|||
162798312|NCT00586612|587970719|FG001|Booster Phase|Lost to Follow-up|1|||
162798313|NCT01743989|587970720|FG000|Treatment Phase|Unstable MR4.0|0|||
162798314|NCT01743989|587970721|FG001|Treatment Phase|Unstable MR4.0|6|||
162798315|NCT01743989|587970722|FG002|Treatment Phase|Unstable MR4.0|263|||
162798316|NCT01743989|587970720|FG000|Treatment Phase|Adverse Event|0|||
162798317|NCT01743989|587970721|FG001|Treatment Phase|Adverse Event|4|||
162798318|NCT01743989|587970722|FG002|Treatment Phase|Adverse Event|67|||
162798319|NCT01743989|587970720|FG000|Treatment Phase|Withdrawal by Subject|1|||
162798320|NCT01743989|587970721|FG001|Treatment Phase|Withdrawal by Subject|3|||
162798321|NCT01743989|587970722|FG002|Treatment Phase|Withdrawal by Subject|28|||
162798322|NCT01743989|587970720|FG000|Treatment Phase|Death|0|||
162798323|NCT01743989|587970721|FG001|Treatment Phase|Death|1|||
162798324|NCT01743989|587970722|FG002|Treatment Phase|Death|3|||
162798325|NCT01743989|587970720|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
162798326|NCT01743989|587970721|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
162798327|NCT01743989|587970722|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
162798328|NCT01743989|587970720|FG000|Treatment Phase|Protocol deviation|0|||
162798329|NCT01743989|587970721|FG001|Treatment Phase|Protocol deviation|0|||
162798330|NCT01743989|587970722|FG002|Treatment Phase|Protocol deviation|3|||
162798331|NCT01743989|587970720|FG000|Treatment Phase|Pregnancy|0|||
162798332|NCT01743989|587970721|FG001|Treatment Phase|Pregnancy|0|||
162798333|NCT01743989|587970722|FG002|Treatment Phase|Pregnancy|2|||
162798334|NCT01743989|587970720|FG000|Treatment Phase|Lost to Follow-up|0|||
162798335|NCT01743989|587970721|FG001|Treatment Phase|Lost to Follow-up|0|||
162798336|NCT01743989|587970722|FG002|Treatment Phase|Lost to Follow-up|2|||
162798337|NCT01743989|587970720|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
162798338|NCT01743989|587970721|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
162798339|NCT01743989|587970722|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
162798340|NCT01743989|587970720|FG000|Treatment Phase|Administrative problems|0|||
162798341|NCT01743989|587970721|FG001|Treatment Phase|Administrative problems|0|||
162798342|NCT01743989|587970722|FG002|Treatment Phase|Administrative problems|1|||
162798343|NCT01743989|587970720|FG000|Treatment Phase|New cancer (CML) therapy|0|||
162798344|NCT01743989|587970721|FG001|Treatment Phase|New cancer (CML) therapy|1|||
162798345|NCT01743989|587970722|FG002|Treatment Phase|New cancer (CML) therapy|0|||
162798346|NCT01743989|587970720|FG000|Treatment Phase|Physician Decision|0|||
162798347|NCT01743989|587970721|FG001|Treatment Phase|Physician Decision|0|||
162798348|NCT01743989|587970722|FG002|Treatment Phase|Physician Decision|3|||
162798349|NCT01743989|587970720|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
162798350|NCT01743989|587970721|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
162798351|NCT01743989|587970722|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
162798352|NCT01743989|587970720|FG000|Treatment Phase|Not randomized by mistake|0|||
162798353|NCT01743989|587970721|FG001|Treatment Phase|Not randomized by mistake|0|||
162798354|NCT01743989|587970722|FG002|Treatment Phase|Not randomized by mistake|1|||
162798355|NCT01743989|587970720|FG000|Treatment Phase|Included by mistake|0|||
162798356|NCT01743989|587970721|FG001|Treatment Phase|Included by mistake|0|||
162798357|NCT01743989|587970722|FG002|Treatment Phase|Included by mistake|1|||
162798358|NCT01743989|587970720|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
162798359|NCT01743989|587970721|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
162798360|NCT01743989|587970722|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
162798361|NCT01743989|587970720|FG000|TFR Phase|Adverse Event|0|||
162798362|NCT01743989|587970721|FG001|TFR Phase|Adverse Event|1|||
162798363|NCT01743989|587970722|FG002|TFR Phase|Adverse Event|0|||
162798364|NCT01743989|587970720|FG000|TFR Phase|Lost to Follow-up|0|||
162798365|NCT01743989|587970721|FG001|TFR Phase|Lost to Follow-up|2|||
162798366|NCT01743989|587970722|FG002|TFR Phase|Lost to Follow-up|0|||
162798367|NCT01743989|587970720|FG000|TFR Phase|Physician Decision|0|||
162798368|NCT01743989|587970721|FG001|TFR Phase|Physician Decision|1|||
162798369|NCT01743989|587970722|FG002|TFR Phase|Physician Decision|0|||
162798370|NCT01743989|587970720|FG000|TFR Phase|Logistical problems|0|||
162798371|NCT01743989|587970721|FG001|TFR Phase|Logistical problems|2|||
162798372|NCT01743989|587970722|FG002|TFR Phase|Logistical problems|0|||
162798373|NCT01743989|587970720|FG000|TFR Phase|Protocol deviation|0|||
162798374|NCT01743989|587970721|FG001|TFR Phase|Protocol deviation|1|||
162798375|NCT01743989|587970722|FG002|TFR Phase|Protocol deviation|0|||
162798376|NCT01743989|587970720|FG000|TFR Phase|Withdrawal by Subject|0|||
162798377|NCT01743989|587970721|FG001|TFR Phase|Withdrawal by Subject|2|||
162798378|NCT01743989|587970722|FG002|TFR Phase|Withdrawal by Subject|0|||
162798379|NCT01743989|587970720|FG000|Re-treatment Phase|Adverse Event|8|||
162798380|NCT01743989|587970721|FG001|Re-treatment Phase|Adverse Event|4|||
162798381|NCT01743989|587970722|FG002|Re-treatment Phase|Adverse Event|0|||
162798382|NCT01743989|587970720|FG000|Re-treatment Phase|Death|1|||
162798383|NCT01743989|587970721|FG001|Re-treatment Phase|Death|1|||
162798384|NCT01743989|587970722|FG002|Re-treatment Phase|Death|0|||
162798385|NCT01743989|587970720|FG000|Re-treatment Phase|Administrative problems|1|||
162798386|NCT01743989|587970721|FG001|Re-treatment Phase|Administrative problems|1|||
162798387|NCT01743989|587970722|FG002|Re-treatment Phase|Administrative problems|0|||
162798388|NCT01743989|587970720|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
162798389|NCT01743989|587970721|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
162798390|NCT01743989|587970722|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
162798391|NCT01743989|587970720|FG000|Re-treatment Phase|Unstable MR|1|||
162798392|NCT01743989|587970721|FG001|Re-treatment Phase|Unstable MR|0|||
162798393|NCT01743989|587970722|FG002|Re-treatment Phase|Unstable MR|0|||
162798394|NCT01743989|587970720|FG000|Re-treatment Phase|Physician Decision|0|||
162798395|NCT01743989|587970721|FG001|Re-treatment Phase|Physician Decision|1|||
162798396|NCT01743989|587970722|FG002|Re-treatment Phase|Physician Decision|0|||
162798397|NCT01743989|587970720|FG000|Re-treatment Phase|Lost to Follow-up|0|||
162798398|NCT01743989|587970721|FG001|Re-treatment Phase|Lost to Follow-up|1|||
162798399|NCT01743989|587970722|FG002|Re-treatment Phase|Lost to Follow-up|0|||
162798400|NCT02235311|587970725|FG000|Overall Study|Lost to Follow-up|0|||
162798401|NCT02235311|587970726|FG001|Overall Study|Lost to Follow-up|1|||
162798402|NCT02235311|587970725|FG000|Overall Study|Protocol Violation|0|||
162798403|NCT02235311|587970726|FG001|Overall Study|Protocol Violation|1|||
162798404|NCT04655027|587970727|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
162798405|NCT04655027|587970728|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
162798406|NCT00658788|587970729|FG000|Overall Study|Adverse Event|11|||
162798407|NCT00658788|587970729|FG000|Overall Study|Withdrawal by Subject|13|||
162798408|NCT00658788|587970729|FG000|Overall Study|Lost to Follow-up|18|||
162798409|NCT00658788|587970729|FG000|Overall Study|Treatment Discontinuation|32|||
162798410|NCT00653523|587970730|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
162798411|NCT00653523|587970730|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
162798412|NCT00653523|587970730|FG000|Overall Study|Adverse Event|7|||
162798413|NCT00653523|587970730|FG000|Overall Study|Withdrawal by Subject|6|||
162798414|NCT00653523|587970730|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
162798415|NCT00653523|587970730|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
162798416|NCT00186888|587970733|FG000|Overall Study|Toxicity|0|||
162798417|NCT00186888|587970734|FG001|Overall Study|Toxicity|1|||
162798418|NCT00186888|587970735|FG002|Overall Study|Toxicity|0|||
162798419|NCT00186888|587970733|FG000|Overall Study|Relapse or progression of disease|4|||
162798420|NCT00186888|587970734|FG001|Overall Study|Relapse or progression of disease|2|||
162798421|NCT00186888|587970735|FG002|Overall Study|Relapse or progression of disease|0|||
162798422|NCT03006848|587970736|FG000|Overall Study|Adverse Event|1|||
162798423|NCT03006848|587970736|FG000|Overall Study|Physician Decision|1|||
162798424|NCT03006848|587970736|FG000|Overall Study|Lack of Efficacy|16|||
162798425|NCT05543187|587970737|FG000|Overall Study|Ongoing|3|||
162798426|NCT05543187|587970738|FG001|Overall Study|Ongoing|2|||
162798427|NCT04777864|587970739|FG000|Overall Study|Lost to Follow-up|8|||
162798428|NCT04777864|587970740|FG001|Overall Study|Lost to Follow-up|19|||
162798429|NCT03086655|587970741|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
162798430|NCT03086655|587970742|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
162798431|NCT03086655|587970741|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
162798432|NCT03086655|587970742|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
162798433|NCT03086655|587970741|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
162798434|NCT03086655|587970742|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
162798435|NCT03086655|587970741|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
162925431|NCT00742859|588428966|FG002|Overall Study|Site error|1|||
162798436|NCT03086655|587970742|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
162798437|NCT03086655|587970741|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
162798438|NCT03086655|587970742|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
162798439|NCT03086655|587970741|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
162798440|NCT03086655|587970742|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
162798441|NCT03086655|587970741|FG000|12 Month Follow-up = Final Assessment|Death|0|||
162798442|NCT03086655|587970742|FG001|12 Month Follow-up = Final Assessment|Death|1|||
162798443|NCT00384397|587970743|FG000|Overall Study|Adverse Event|0|||
162798444|NCT00384397|587970744|FG001|Overall Study|Adverse Event|1|||
162798445|NCT00384397|587970745|FG002|Overall Study|Adverse Event|2|||
162798446|NCT00384397|587970743|FG000|Overall Study|Protocol Violation|7|||
162798447|NCT00384397|587970744|FG001|Overall Study|Protocol Violation|15|||
162798448|NCT00384397|587970745|FG002|Overall Study|Protocol Violation|13|||
162798449|NCT00384397|587970743|FG000|Overall Study|Lost to Follow-up|11|||
162798450|NCT00384397|587970744|FG001|Overall Study|Lost to Follow-up|13|||
162798451|NCT00384397|587970745|FG002|Overall Study|Lost to Follow-up|3|||
162798452|NCT00384397|587970743|FG000|Overall Study|Withdrawal by Subject|14|||
162798453|NCT00384397|587970744|FG001|Overall Study|Withdrawal by Subject|17|||
162798454|NCT00384397|587970745|FG002|Overall Study|Withdrawal by Subject|15|||
162798455|NCT04531982|587970746|FG000|Overall Study|Withdrawal by Subject|10|||
162798456|NCT04531982|587970747|FG001|Overall Study|Withdrawal by Subject|11|||
162798457|NCT04531982|587970746|FG000|Overall Study|Adverse Event|6|||
162798458|NCT04531982|587970747|FG001|Overall Study|Adverse Event|14|||
162798459|NCT04531982|587970746|FG000|Overall Study|Protocol Violation|6|||
162798460|NCT04531982|587970747|FG001|Overall Study|Protocol Violation|9|||
162798461|NCT04531982|587970746|FG000|Overall Study|Non-compliance with study drug|3|||
162798462|NCT04531982|587970747|FG001|Overall Study|Non-compliance with study drug|2|||
162798463|NCT04531982|587970746|FG000|Overall Study|Use of prohibited medication|2|||
162798464|NCT04531982|587970747|FG001|Overall Study|Use of prohibited medication|0|||
162798465|NCT04531982|587970746|FG000|Overall Study|Lost to Follow-up|0|||
162798466|NCT04531982|587970747|FG001|Overall Study|Lost to Follow-up|1|||
162798467|NCT04531982|587970746|FG000|Overall Study|Geopolitical conflict|2|||
162798468|NCT04531982|587970747|FG001|Overall Study|Geopolitical conflict|0|||
162798469|NCT04531982|587970746|FG000|Overall Study|Lack of Efficacy|3|||
162798470|NCT04531982|587970747|FG001|Overall Study|Lack of Efficacy|1|||
162798471|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
162798472|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
162798473|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
162798474|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162798475|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162798476|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162798477|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
162798478|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
162798479|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
162798480|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162798481|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162798482|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162798483|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162798484|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
162798485|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162798486|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162798487|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162798488|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162798489|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162798490|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
162798491|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162798492|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162798493|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162798494|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162798495|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162798496|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162798497|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
162798498|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162798499|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162798500|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162798501|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162798502|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
162798503|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
162798504|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162798505|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162925432|NCT00742859|588428967|FG003|Overall Study|Site error|1|||
162798506|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162798507|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
162798508|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
162798509|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
162798510|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162798511|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162798512|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162798513|NCT03524092|587970748|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
162798514|NCT03524092|587970749|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
162798515|NCT03524092|587970750|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
162798516|NCT03524092|587970751|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162798517|NCT03524092|587970752|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162798518|NCT03524092|587970753|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162798519|NCT03524092|587970748|FG000|Loss of Response Rescue Period|Adverse Event|0|||
162798520|NCT03524092|587970749|FG001|Loss of Response Rescue Period|Adverse Event|0|||
162798521|NCT03524092|587970750|FG002|Loss of Response Rescue Period|Adverse Event|0|||
162798522|NCT03524092|587970751|FG003|Loss of Response Rescue Period|Adverse Event|2|||
162798523|NCT03524092|587970752|FG004|Loss of Response Rescue Period|Adverse Event|0|||
162798524|NCT03524092|587970753|FG005|Loss of Response Rescue Period|Adverse Event|0|||
162798525|NCT03524092|587970748|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
162798526|NCT03524092|587970749|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
162798527|NCT03524092|587970750|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
162798528|NCT03524092|587970751|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
162798529|NCT03524092|587970752|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
162798530|NCT03524092|587970753|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
162798531|NCT03524092|587970748|FG000|Loss of Response Rescue Period|Pregnancy|0|||
162798532|NCT03524092|587970749|FG001|Loss of Response Rescue Period|Pregnancy|0|||
162798533|NCT03524092|587970750|FG002|Loss of Response Rescue Period|Pregnancy|0|||
162798534|NCT03524092|587970751|FG003|Loss of Response Rescue Period|Pregnancy|1|||
162798535|NCT03524092|587970752|FG004|Loss of Response Rescue Period|Pregnancy|0|||
162798536|NCT03524092|587970753|FG005|Loss of Response Rescue Period|Pregnancy|0|||
162798537|NCT03524092|587970748|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162798538|NCT03524092|587970749|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162798539|NCT03524092|587970750|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162798540|NCT03524092|587970751|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
162798541|NCT03524092|587970752|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162798542|NCT03524092|587970753|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162798543|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162798544|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162798545|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162798546|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162798547|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
162798548|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162798549|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162798550|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162798551|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162798552|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162798553|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
162798554|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162798555|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162798556|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162798557|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162798558|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162798559|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
162798560|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162798561|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162798562|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162798563|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162798564|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162798565|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
162798566|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162798567|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162798568|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162798569|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162798570|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162798571|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
162798572|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162798573|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162798574|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162798575|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162798576|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162798577|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
162798578|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162798579|NCT03524092|587970748|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162798580|NCT03524092|587970749|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162798581|NCT03524092|587970750|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162798582|NCT03524092|587970751|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162798583|NCT03524092|587970752|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
162798584|NCT03524092|587970753|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162798585|NCT03524092|587970748|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162798586|NCT03524092|587970749|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162798587|NCT03524092|587970750|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162798588|NCT03524092|587970751|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162798589|NCT03524092|587970752|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162798590|NCT03524092|587970753|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
162798591|NCT03524092|587970748|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162798592|NCT03524092|587970749|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162798593|NCT03524092|587970750|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162798594|NCT03524092|587970751|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162798595|NCT03524092|587970752|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162798596|NCT03524092|587970753|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
162798597|NCT03524092|587970748|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162798598|NCT03524092|587970749|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162798599|NCT03524092|587970750|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162798600|NCT03524092|587970751|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162798601|NCT03524092|587970752|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162798602|NCT03524092|587970753|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
162798603|NCT03524092|587970748|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162798604|NCT03524092|587970749|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162798605|NCT03524092|587970750|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162798606|NCT03524092|587970751|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162798607|NCT03524092|587970752|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162798608|NCT03524092|587970753|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
162798609|NCT04303780|587970754|FG000|Overall Study|Death|104|||
162798610|NCT04303780|587970755|FG001|Overall Study|Death|85|||
162798611|NCT04303780|587970754|FG000|Overall Study|Lost to Follow-up|5|||
162798612|NCT04303780|587970755|FG001|Overall Study|Lost to Follow-up|2|||
162798613|NCT04303780|587970754|FG000|Overall Study|Withdrawal by Subject|12|||
162798614|NCT04303780|587970755|FG001|Overall Study|Withdrawal by Subject|39|||
162798615|NCT04303780|587970754|FG000|Overall Study|Ongoing in study|50|||
162798616|NCT04303780|587970755|FG001|Overall Study|Ongoing in study|45|||
162798617|NCT03826030|587970756|FG000|Overall Study|Withdrawal by Subject|2|||
162798618|NCT03826030|587970757|FG001|Overall Study|Withdrawal by Subject|0|||
162798619|NCT03826030|587970758|FG002|Overall Study|Withdrawal by Subject|1|||
162798620|NCT03826030|587970756|FG000|Overall Study|Lost to Follow-up|1|||
162798621|NCT03826030|587970757|FG001|Overall Study|Lost to Follow-up|1|||
162798622|NCT03826030|587970758|FG002|Overall Study|Lost to Follow-up|1|||
162798623|NCT03826030|587970756|FG000|Overall Study|Too busy to return for visits|1|||
162798624|NCT03826030|587970757|FG001|Overall Study|Too busy to return for visits|0|||
162798625|NCT03826030|587970758|FG002|Overall Study|Too busy to return for visits|0|||
162798626|NCT01732822|587972989|FG000|Overall Study|Withdrawal by Subject|123|||
162798627|NCT01732822|587972990|FG001|Overall Study|Withdrawal by Subject|113|||
162798628|NCT02314780|587972991|FG000|Overall Study|organizational reasons|0|||
162798629|NCT02314780|587972992|FG001|Overall Study|organizational reasons|2|||
162798630|NCT02314780|587972993|FG002|Overall Study|organizational reasons|0|||
162798631|NCT02314780|587972991|FG000|Overall Study|Adverse Event|0|||
162798632|NCT02314780|587972992|FG001|Overall Study|Adverse Event|1|||
162798633|NCT02314780|587972993|FG002|Overall Study|Adverse Event|0|||
162798634|NCT00379288|587972994|FG000|Overall Study|Adverse Event|5|||
162798635|NCT00379288|587972995|FG001|Overall Study|Adverse Event|6|||
162798636|NCT00379288|587972996|FG002|Overall Study|Adverse Event|2|||
162798637|NCT00379288|587972997|FG003|Overall Study|Adverse Event|0|||
162798638|NCT00379288|587972994|FG000|Overall Study|Treatment Failure|0|||
162798639|NCT00379288|587972995|FG001|Overall Study|Treatment Failure|1|||
162798640|NCT00379288|587972996|FG002|Overall Study|Treatment Failure|0|||
162798641|NCT00379288|587972997|FG003|Overall Study|Treatment Failure|1|||
162798642|NCT00379288|587972994|FG000|Overall Study|Lost to Follow-up|3|||
162798643|NCT00379288|587972995|FG001|Overall Study|Lost to Follow-up|3|||
162798644|NCT00379288|587972996|FG002|Overall Study|Lost to Follow-up|2|||
162798645|NCT00379288|587972997|FG003|Overall Study|Lost to Follow-up|0|||
162798646|NCT00379288|587972994|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
162798647|NCT00379288|587972995|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
162798648|NCT00379288|587972996|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
162798649|NCT00379288|587972997|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
162798650|NCT00379288|587972994|FG000|Overall Study|Subject withdrew-related to study drug|1|||
162798651|NCT00379288|587972995|FG001|Overall Study|Subject withdrew-related to study drug|0|||
162798652|NCT00379288|587972996|FG002|Overall Study|Subject withdrew-related to study drug|0|||
162798653|NCT00379288|587972997|FG003|Overall Study|Subject withdrew-related to study drug|1|||
162798654|NCT00379288|587972994|FG000|Overall Study|Noncompliance with protocol|8|||
162798655|NCT00379288|587972995|FG001|Overall Study|Noncompliance with protocol|6|||
162798656|NCT00379288|587972996|FG002|Overall Study|Noncompliance with protocol|2|||
162798657|NCT00379288|587972997|FG003|Overall Study|Noncompliance with protocol|1|||
162798658|NCT00379288|587972994|FG000|Overall Study|Did not meet protocol eligibility|0|||
162798659|NCT00379288|587972995|FG001|Overall Study|Did not meet protocol eligibility|1|||
162798660|NCT00379288|587972996|FG002|Overall Study|Did not meet protocol eligibility|0|||
162798661|NCT00379288|587972997|FG003|Overall Study|Did not meet protocol eligibility|2|||
162798662|NCT00379288|587972994|FG000|Overall Study|Administrative|2|||
162798663|NCT00379288|587972995|FG001|Overall Study|Administrative|2|||
162798664|NCT00379288|587972996|FG002|Overall Study|Administrative|0|||
162798665|NCT00379288|587972997|FG003|Overall Study|Administrative|1|||
162798666|NCT01183260|587972998|FG000|Overall Study|Intraop screen failure|2|||
162798667|NCT01183260|587972999|FG001|Overall Study|Intraop screen failure|0|||
162798668|NCT01183260|587972998|FG000|Overall Study|Withdrawal by Subject|1|||
162798669|NCT01183260|587972999|FG001|Overall Study|Withdrawal by Subject|1|||
162798670|NCT01183260|587972998|FG000|Overall Study|Revised within 30 days|0|||
162798671|NCT01183260|587972999|FG001|Overall Study|Revised within 30 days|1|||
162798672|NCT01183260|587972998|FG000|Overall Study|Death|1|||
162798673|NCT01183260|587972999|FG001|Overall Study|Death|0|||
162798674|NCT00095056|587973002|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
162798675|NCT00095056|587973003|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
162798676|NCT00095056|587973002|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
162798677|NCT00095056|587973003|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
162798678|NCT00095056|587973002|FG000|Phase A (Weeks 0-12)|Death|1|||
162798679|NCT00095056|587973003|FG001|Phase A (Weeks 0-12)|Death|0|||
162798680|NCT00095056|587973002|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
162798681|NCT00095056|587973003|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
162798682|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
162798683|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
162798684|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
162798685|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
162798686|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
162798687|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
162798688|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
162798689|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
162798690|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Death|3|||
162798691|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Death|1|||
162798692|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
162798693|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
162798694|NCT00095056|587973002|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
162798695|NCT00095056|587973003|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
162798696|NCT02735577|587973007|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
162798697|NCT02735577|587973007|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
162798698|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162798699|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162798700|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
162798701|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
162798702|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162798703|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162798704|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
162798705|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
162798706|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
162798707|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
162798708|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798709|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798710|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
162798711|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162798712|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
162798713|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
162798714|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162798715|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162798716|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
162798717|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
162798718|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
162798719|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
162798720|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
162798721|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
162798722|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
162798723|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798724|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
162798725|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798726|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798727|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798728|NCT00833833|587973008|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
162798729|NCT00833833|587973009|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
162798730|NCT00833833|587973010|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
162798731|NCT00833833|587973011|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
162798732|NCT00833833|587973012|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
162798733|NCT00833833|587973013|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
162798734|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162798735|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162798736|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162798737|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162798738|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
162798739|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
162798740|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162798741|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162798742|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162798743|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162798744|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
162798745|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
162798746|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
162798747|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
162798748|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
162798749|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
162798750|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
162798751|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
162798752|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798753|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798754|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798755|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162798756|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
162798757|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
162798758|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798759|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798760|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798761|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162798762|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
162798763|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
162798764|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
162798765|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
162798766|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
162798767|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
162798768|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
162798769|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
162798770|NCT00833833|587973008|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162798771|NCT00833833|587973009|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162798772|NCT00833833|587973010|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162798773|NCT00833833|587973011|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162798774|NCT00833833|587973012|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162798775|NCT00833833|587973013|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
162798776|NCT02040259|587973014|FG000|Overall Study|Death|280|||
162798777|NCT02040259|587973014|FG000|Overall Study|Lost to Follow-up|76|||
162798778|NCT02040259|587973014|FG000|Overall Study|Assessment not completed|3|||
162798779|NCT02040259|587973014|FG000|Overall Study|Withdrawal by Subject|4|||
162798780|NCT00316602|587973024|FG000|Overall Study|Withdrawal by Subject|3|||
162798781|NCT00316602|587973025|FG001|Overall Study|Withdrawal by Subject|2|||
162798782|NCT00316602|587973024|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
162798783|NCT00316602|587973025|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
162798784|NCT00316602|587973024|FG000|Overall Study|Adverse Event|1|||
162798785|NCT00316602|587973025|FG001|Overall Study|Adverse Event|0|||
162798786|NCT00316602|587973024|FG000|Overall Study|Other|3|||
162798787|NCT00316602|587973025|FG001|Overall Study|Other|6|||
162798788|NCT01142232|587973026|FG000|Overall Study|Adverse Event|1|||
162798789|NCT01142232|587973027|FG001|Overall Study|Adverse Event|2|||
162798790|NCT01142232|587973028|FG002|Overall Study|Adverse Event|1|||
162798791|NCT01142232|587973029|FG003|Overall Study|Adverse Event|0|||
162798792|NCT01142232|587973030|FG004|Overall Study|Adverse Event|4|||
162798793|NCT01142232|587973026|FG000|Overall Study|Death|0|||
162798794|NCT01142232|587973027|FG001|Overall Study|Death|0|||
162798795|NCT01142232|587973028|FG002|Overall Study|Death|0|||
162798796|NCT01142232|587973029|FG003|Overall Study|Death|0|||
162798797|NCT01142232|587973030|FG004|Overall Study|Death|1|||
162798798|NCT01142232|587973026|FG000|Overall Study|Disease Progression|2|||
162798799|NCT01142232|587973027|FG001|Overall Study|Disease Progression|0|||
162798800|NCT01142232|587973028|FG002|Overall Study|Disease Progression|1|||
162798801|NCT01142232|587973029|FG003|Overall Study|Disease Progression|2|||
162798802|NCT01142232|587973030|FG004|Overall Study|Disease Progression|12|||
162798803|NCT01142232|587973026|FG000|Overall Study|Withdrawal by Subject|0|||
162798804|NCT01142232|587973027|FG001|Overall Study|Withdrawal by Subject|0|||
162798805|NCT01142232|587973028|FG002|Overall Study|Withdrawal by Subject|0|||
162798806|NCT01142232|587973029|FG003|Overall Study|Withdrawal by Subject|1|||
162798807|NCT01142232|587973030|FG004|Overall Study|Withdrawal by Subject|3|||
162798808|NCT01142232|587973026|FG000|Overall Study|Physician Decision|0|||
162798809|NCT01142232|587973027|FG001|Overall Study|Physician Decision|1|||
162798810|NCT01142232|587973028|FG002|Overall Study|Physician Decision|0|||
162798811|NCT01142232|587973029|FG003|Overall Study|Physician Decision|2|||
162798812|NCT01142232|587973030|FG004|Overall Study|Physician Decision|10|||
162798813|NCT01142232|587973026|FG000|Overall Study|Alternative Therapy|0|||
162798814|NCT01142232|587973027|FG001|Overall Study|Alternative Therapy|1|||
162798815|NCT01142232|587973028|FG002|Overall Study|Alternative Therapy|1|||
162798816|NCT01142232|587973029|FG003|Overall Study|Alternative Therapy|0|||
162798817|NCT01142232|587973030|FG004|Overall Study|Alternative Therapy|1|||
162798818|NCT01142232|587973026|FG000|Overall Study|Off Trt for other complicating disease|0|||
162798819|NCT01142232|587973027|FG001|Overall Study|Off Trt for other complicating disease|0|||
162798820|NCT01142232|587973028|FG002|Overall Study|Off Trt for other complicating disease|0|||
162798821|NCT01142232|587973029|FG003|Overall Study|Off Trt for other complicating disease|0|||
162798822|NCT01142232|587973030|FG004|Overall Study|Off Trt for other complicating disease|1|||
162798823|NCT01142232|587973026|FG000|Overall Study|Noncompliance|0|||
162798824|NCT01142232|587973027|FG001|Overall Study|Noncompliance|0|||
162798825|NCT01142232|587973028|FG002|Overall Study|Noncompliance|0|||
162798826|NCT01142232|587973029|FG003|Overall Study|Noncompliance|0|||
162798827|NCT01142232|587973030|FG004|Overall Study|Noncompliance|2|||
162798828|NCT00626990|587973031|FG000|Overall Study|Lack of Efficacy|6|||
162798829|NCT00626990|587973032|FG001|Overall Study|Lack of Efficacy|7|||
162798830|NCT00626990|587973033|FG002|Overall Study|Lack of Efficacy|49|||
162798831|NCT00626990|587973034|FG003|Overall Study|Lack of Efficacy|40|||
162798832|NCT00626990|587973031|FG000|Overall Study|Adverse Event|1|||
162798833|NCT00626990|587973032|FG001|Overall Study|Adverse Event|7|||
162798834|NCT00626990|587973033|FG002|Overall Study|Adverse Event|14|||
162798835|NCT00626990|587973034|FG003|Overall Study|Adverse Event|28|||
162798836|NCT00626990|587973031|FG000|Overall Study|Death|0|||
162798837|NCT00626990|587973032|FG001|Overall Study|Death|1|||
162798838|NCT00626990|587973033|FG002|Overall Study|Death|0|||
162798839|NCT00626990|587973034|FG003|Overall Study|Death|0|||
162798840|NCT00626990|587973031|FG000|Overall Study|Withdrawal by Subject|3|||
162798841|NCT00626990|587973032|FG001|Overall Study|Withdrawal by Subject|1|||
162798842|NCT00626990|587973033|FG002|Overall Study|Withdrawal by Subject|5|||
162798843|NCT00626990|587973034|FG003|Overall Study|Withdrawal by Subject|11|||
162798844|NCT00626990|587973031|FG000|Overall Study|Protocol Violation|0|||
162798845|NCT00626990|587973032|FG001|Overall Study|Protocol Violation|1|||
162798846|NCT00626990|587973033|FG002|Overall Study|Protocol Violation|1|||
162798847|NCT00626990|587973034|FG003|Overall Study|Protocol Violation|0|||
162798848|NCT00626990|587973031|FG000|Overall Study|Various different reasons/missing|4|||
162798849|NCT00626990|587973032|FG001|Overall Study|Various different reasons/missing|8|||
162798850|NCT00626990|587973033|FG002|Overall Study|Various different reasons/missing|8|||
162798851|NCT00626990|587973034|FG003|Overall Study|Various different reasons/missing|16|||
162798852|NCT03446781|587973036|FG000|Overall Study|Lost to Follow-up|11|||
162798853|NCT03446781|587973037|FG001|Overall Study|Lost to Follow-up|5|||
162798854|NCT03446781|587973036|FG000|Overall Study|Withdrawal by Subject|9|||
162798855|NCT03446781|587973037|FG001|Overall Study|Withdrawal by Subject|7|||
162798856|NCT03446781|587973036|FG000|Overall Study|Adverse Event|8|||
162798857|NCT03446781|587973037|FG001|Overall Study|Adverse Event|2|||
162798858|NCT03446781|587973036|FG000|Overall Study|Protocol Violation|0|||
162798859|NCT03446781|587973037|FG001|Overall Study|Protocol Violation|3|||
162798860|NCT02898077|587973038|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
162798861|NCT02898077|587973039|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
162798862|NCT02898077|587973038|FG000|Overall Study|Lost to Follow-up|4|||
162798863|NCT02898077|587973039|FG001|Overall Study|Lost to Follow-up|3|||
162798864|NCT02898077|587973038|FG000|Overall Study|Physician Decision|0|||
162798865|NCT02898077|587973039|FG001|Overall Study|Physician Decision|2|||
162798866|NCT02898077|587973038|FG000|Overall Study|Sponsor Decision|32|||
162798867|NCT02898077|587973039|FG001|Overall Study|Sponsor Decision|13|||
162798868|NCT02898077|587973038|FG000|Overall Study|Withdrawal by Subject|6|||
162798869|NCT02898077|587973039|FG001|Overall Study|Withdrawal by Subject|3|||
162798870|NCT02898077|587973038|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
162798871|NCT02898077|587973039|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
162798872|NCT02898077|587973038|FG000|Overall Study|Ended extension period|3|||
162798873|NCT02898077|587973039|FG001|Overall Study|Ended extension period|0|||
162798874|NCT01802567|587973041|FG000|Overall Study|Withdrawal by Subject|2|||
162798875|NCT01802567|587973041|FG000|Overall Study|Physician Decision|1|||
162798876|NCT01802567|587973041|FG000|Overall Study|Lack of Efficacy|7|||
162798877|NCT01802567|587973041|FG000|Overall Study|Consented but did not start therapy|7|||
162798878|NCT01802567|587973041|FG000|Overall Study|Protocol Violation|1|||
162798879|NCT01895101|587973042|FG000|Overall Study|OPCAB procedure|1|||
162798880|NCT01895101|587973043|FG001|Overall Study|OPCAB procedure|1|||
162798881|NCT01895101|587973044|FG002|Overall Study|OPCAB procedure|3|||
162798882|NCT01895101|587973042|FG000|Overall Study|Withdrawal by Subject|0|||
162798883|NCT01895101|587973043|FG001|Overall Study|Withdrawal by Subject|1|||
162798884|NCT01895101|587973044|FG002|Overall Study|Withdrawal by Subject|2|||
162798885|NCT01895101|587973042|FG000|Overall Study|another study, enrolled in other study|0|||
162798886|NCT01895101|587973043|FG001|Overall Study|another study, enrolled in other study|1|||
162798887|NCT01895101|587973044|FG002|Overall Study|another study, enrolled in other study|0|||
162798888|NCT01895101|587973042|FG000|Overall Study|Death|0|||
162798889|NCT01895101|587973043|FG001|Overall Study|Death|1|||
162798890|NCT01895101|587973044|FG002|Overall Study|Death|0|||
162798891|NCT01895101|587973042|FG000|Overall Study|coagulation disorder|0|||
162798892|NCT01895101|587973043|FG001|Overall Study|coagulation disorder|1|||
162798893|NCT01895101|587973044|FG002|Overall Study|coagulation disorder|0|||
162798894|NCT03268603|587973045|FG000|Overall Study|Withdrawal by Subject|6|||
162798895|NCT03268603|587973045|FG000|Overall Study|Physician Decision|1|||
162798896|NCT03268603|587973045|FG000|Overall Study|Withdrawn due to disease progression|2|||
162798897|NCT04939701|587973049|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
162798898|NCT04939701|587973050|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
162798899|NCT04939701|587973051|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
162798900|NCT04939701|587973049|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
162798901|NCT04939701|587973050|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
162798902|NCT04939701|587973051|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
162798903|NCT04939701|587973049|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
162798904|NCT04939701|587973050|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
162798905|NCT04939701|587973051|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
162798906|NCT04939701|587973049|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
162798907|NCT04939701|587973050|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
162798908|NCT04939701|587973051|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
162798909|NCT04939701|587973049|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
162798910|NCT04939701|587973050|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
162798911|NCT04939701|587973051|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
162798912|NCT04939701|587973049|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
162798913|NCT04939701|587973050|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
162798914|NCT04939701|587973051|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
162798915|NCT04939701|587973049|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
162798916|NCT04939701|587973050|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
162798917|NCT04939701|587973051|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
162798918|NCT03248882|587973053|FG000|Overall Study|Adverse Event|3|||
162798919|NCT03248882|587973054|FG001|Overall Study|Adverse Event|3|||
162798920|NCT03248882|587973055|FG002|Overall Study|Adverse Event|2|||
162798921|NCT03248882|587973056|FG003|Overall Study|Adverse Event|6|||
162798922|NCT03248882|587973057|FG004|Overall Study|Adverse Event|9|||
162798923|NCT03248882|587973053|FG000|Overall Study|Lost to Follow-up|0|||
162798924|NCT03248882|587973054|FG001|Overall Study|Lost to Follow-up|0|||
162798925|NCT03248882|587973055|FG002|Overall Study|Lost to Follow-up|0|||
162798926|NCT03248882|587973056|FG003|Overall Study|Lost to Follow-up|0|||
162798927|NCT03248882|587973057|FG004|Overall Study|Lost to Follow-up|1|||
162798928|NCT03248882|587973053|FG000|Overall Study|Protocol Violation|2|||
162798929|NCT03248882|587973054|FG001|Overall Study|Protocol Violation|0|||
162798930|NCT03248882|587973055|FG002|Overall Study|Protocol Violation|2|||
162798931|NCT03248882|587973056|FG003|Overall Study|Protocol Violation|0|||
162798932|NCT03248882|587973057|FG004|Overall Study|Protocol Violation|1|||
162798933|NCT03248882|587973053|FG000|Overall Study|Withdrawal by Subject|2|||
162798934|NCT03248882|587973054|FG001|Overall Study|Withdrawal by Subject|2|||
162798935|NCT03248882|587973055|FG002|Overall Study|Withdrawal by Subject|3|||
162798936|NCT03248882|587973056|FG003|Overall Study|Withdrawal by Subject|4|||
162798937|NCT03248882|587973057|FG004|Overall Study|Withdrawal by Subject|2|||
162798938|NCT02182947|587973058|FG000|Overall Study|Withdrawal by Subject|7|||
162798939|NCT02182947|587973058|FG000|Overall Study|Lost to Follow-up|3|||
162798940|NCT02182947|587973058|FG000|Overall Study|Failed screening activities|8|||
162798941|NCT02236988|587973059|FG000|Overall Study|Lost to Follow-up|0|||
162798942|NCT02236988|587973060|FG001|Overall Study|Lost to Follow-up|0|||
162798943|NCT02236988|587973061|FG002|Overall Study|Lost to Follow-up|0|||
162798944|NCT02236988|587973062|FG003|Overall Study|Lost to Follow-up|1|||
162798945|NCT02236988|587973059|FG000|Overall Study|Unable to Comply with Study Visits|0|||
162798946|NCT02236988|587973060|FG001|Overall Study|Unable to Comply with Study Visits|0|||
162798947|NCT02236988|587973061|FG002|Overall Study|Unable to Comply with Study Visits|0|||
162798948|NCT02236988|587973062|FG003|Overall Study|Unable to Comply with Study Visits|2|||
162798949|NCT04308590|587973063|FG000|Overall Study|Adverse Event|12|||
162798950|NCT04308590|587973064|FG001|Overall Study|Adverse Event|2|||
162798951|NCT04308590|587973063|FG000|Overall Study|Withdrawal by Subject|10|||
162798952|NCT04308590|587973064|FG001|Overall Study|Withdrawal by Subject|4|||
162798953|NCT04308590|587973063|FG000|Overall Study|Death|1|||
162798954|NCT04308590|587973064|FG001|Overall Study|Death|0|||
162798955|NCT04308590|587973063|FG000|Overall Study|Lost to Follow-up|1|||
162798956|NCT04308590|587973064|FG001|Overall Study|Lost to Follow-up|1|||
162798957|NCT04308590|587973063|FG000|Overall Study|Physician Decision|1|||
162798958|NCT04308590|587973064|FG001|Overall Study|Physician Decision|0|||
162798959|NCT04308590|587973063|FG000|Overall Study|Subject does not want to continue with Pi|0|||
162798960|NCT04308590|587973064|FG001|Overall Study|Subject does not want to continue with Pi|1|||
162798961|NCT01156376|587973066|FG000|Overall Study|Adverse Event|1|||
162798962|NCT01156376|587973067|FG001|Overall Study|Adverse Event|0|||
162798963|NCT01156376|587973068|FG002|Overall Study|Adverse Event|1|||
162798964|NCT01156376|587973066|FG000|Overall Study|Withdrawal by Subject|0|||
162798965|NCT01156376|587973067|FG001|Overall Study|Withdrawal by Subject|0|||
162798966|NCT01156376|587973068|FG002|Overall Study|Withdrawal by Subject|3|||
162798967|NCT01493427|587973069|FG000|Overall Study|Adverse Event|10|||
162798968|NCT01493427|587973069|FG000|Overall Study|Personal Reasons|4|||
162798969|NCT01493427|587973069|FG000|Overall Study|Lost to Follow-up|2|||
162798970|NCT01493427|587973069|FG000|Overall Study|Inability to Follow Instructions|2|||
162798971|NCT01493427|587973069|FG000|Overall Study|Other|2|||
162798972|NCT05775991|587973070|FG000|Overall Study|Withdrawal by Subject|0|||
162798973|NCT05775991|587973071|FG001|Overall Study|Withdrawal by Subject|0|||
162798974|NCT05775991|587973072|FG002|Overall Study|Withdrawal by Subject|2|||
162798975|NCT00939822|587973079|FG000|Overall Study|Lost to Follow-up|1|||
162798976|NCT00939822|587973080|FG001|Overall Study|Lost to Follow-up|0|||
162798977|NCT00939822|587973079|FG000|Overall Study|withdrew from study due to busy schedule|1|||
162798978|NCT00939822|587973080|FG001|Overall Study|withdrew from study due to busy schedule|1|||
162798979|NCT00939822|587973079|FG000|Overall Study|Mental health issues|0|||
162798980|NCT00939822|587973080|FG001|Overall Study|Mental health issues|2|||
162798981|NCT01072630|587973081|FG000|Overall Study|Adverse Event|11|||
162798982|NCT01072630|587973082|FG001|Overall Study|Adverse Event|19|||
162798983|NCT01072630|587973083|FG002|Overall Study|Adverse Event|2|||
162798984|NCT01072630|587973081|FG000|Overall Study|Lack of Efficacy|10|||
162798985|NCT01072630|587973082|FG001|Overall Study|Lack of Efficacy|10|||
162798986|NCT01072630|587973083|FG002|Overall Study|Lack of Efficacy|1|||
162798987|NCT01072630|587973081|FG000|Overall Study|Withdrawal by Subject|8|||
162798988|NCT01072630|587973082|FG001|Overall Study|Withdrawal by Subject|7|||
162798989|NCT01072630|587973083|FG002|Overall Study|Withdrawal by Subject|2|||
162798990|NCT01072630|587973081|FG000|Overall Study|Protocol Violation|10|||
162798991|NCT01072630|587973082|FG001|Overall Study|Protocol Violation|8|||
162798992|NCT01072630|587973083|FG002|Overall Study|Protocol Violation|4|||
162798993|NCT01072630|587973081|FG000|Overall Study|Lost to Follow-up|11|||
162798994|NCT01072630|587973082|FG001|Overall Study|Lost to Follow-up|11|||
162798995|NCT01072630|587973083|FG002|Overall Study|Lost to Follow-up|1|||
162798996|NCT01072630|587973081|FG000|Overall Study|Noncompliance with study medication|1|||
162798997|NCT01072630|587973082|FG001|Overall Study|Noncompliance with study medication|1|||
162798998|NCT01072630|587973083|FG002|Overall Study|Noncompliance with study medication|1|||
162798999|NCT01072630|587973081|FG000|Overall Study|Noncompliance with study procedures|1|||
162799000|NCT01072630|587973082|FG001|Overall Study|Noncompliance with study procedures|2|||
162799001|NCT01072630|587973083|FG002|Overall Study|Noncompliance with study procedures|1|||
162799002|NCT01072630|587973081|FG000|Overall Study|Other|3|||
162799003|NCT01072630|587973082|FG001|Overall Study|Other|2|||
162799004|NCT01072630|587973083|FG002|Overall Study|Other|1|||
162799005|NCT05032872|587973084|FG000|Overall Study|Adverse Event|1|||
162799006|NCT05032872|587973085|FG001|Overall Study|Adverse Event|0|||
162799007|NCT05032872|587973084|FG000|Overall Study|Lost to Follow-up|2|||
162799008|NCT05032872|587973085|FG001|Overall Study|Lost to Follow-up|4|||
162799009|NCT05032872|587973084|FG000|Overall Study|Withdrawal by Subject|4|||
162799010|NCT05032872|587973085|FG001|Overall Study|Withdrawal by Subject|3|||
162799011|NCT00338962|587973086|FG000|Overall Study|Lost to Follow-up|3|||
162799012|NCT00338962|587973087|FG001|Overall Study|Lost to Follow-up|3|||
162799013|NCT00338962|587973088|FG002|Overall Study|Lost to Follow-up|2|||
162799014|NCT00338962|587973089|FG003|Overall Study|Lost to Follow-up|3|||
162799015|NCT00338962|587973086|FG000|Overall Study|Withdrawal by Subject|1|||
162799016|NCT00338962|587973087|FG001|Overall Study|Withdrawal by Subject|0|||
162799017|NCT00338962|587973088|FG002|Overall Study|Withdrawal by Subject|0|||
162799018|NCT00338962|587973089|FG003|Overall Study|Withdrawal by Subject|0|||
162799019|NCT00338962|587973086|FG000|Overall Study|No Transportation|2|||
162799020|NCT00338962|587973087|FG001|Overall Study|No Transportation|0|||
162799021|NCT00338962|587973088|FG002|Overall Study|No Transportation|0|||
162799022|NCT00338962|587973089|FG003|Overall Study|No Transportation|0|||
162799023|NCT00338962|587973086|FG000|Overall Study|Time Constraint|2|||
162799024|NCT00338962|587973087|FG001|Overall Study|Time Constraint|0|||
162799025|NCT00338962|587973088|FG002|Overall Study|Time Constraint|0|||
162799026|NCT00338962|587973089|FG003|Overall Study|Time Constraint|0|||
162799027|NCT00338962|587973086|FG000|Overall Study|Moved|0|||
162799028|NCT00338962|587973087|FG001|Overall Study|Moved|1|||
162799029|NCT00338962|587973088|FG002|Overall Study|Moved|0|||
162799030|NCT00338962|587973089|FG003|Overall Study|Moved|0|||
162799031|NCT00338962|587973086|FG000|Overall Study|Adverse Event|0|||
162799032|NCT00338962|587973087|FG001|Overall Study|Adverse Event|0|||
162799033|NCT00338962|587973088|FG002|Overall Study|Adverse Event|2|||
162799034|NCT00338962|587973089|FG003|Overall Study|Adverse Event|0|||
162799035|NCT00338962|587973086|FG000|Overall Study|Poor Compliance|0|||
162799036|NCT00338962|587973087|FG001|Overall Study|Poor Compliance|0|||
162799037|NCT00338962|587973088|FG002|Overall Study|Poor Compliance|2|||
162799038|NCT00338962|587973089|FG003|Overall Study|Poor Compliance|0|||
162799039|NCT03733314|587973090|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
162799040|NCT03733314|587973091|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
162799041|NCT03733314|587973090|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
162799042|NCT03733314|587973091|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
162799043|NCT03733314|587973090|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
162799044|NCT03733314|587973091|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
162799045|NCT03733314|587973090|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
162799046|NCT03733314|587973091|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
162799047|NCT03733314|587973090|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
162799048|NCT03733314|587973091|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
162799049|NCT03733314|587973090|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
162799050|NCT03733314|587973091|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
162799051|NCT01598662|587973092|FG000|Overall Study|Lost to Follow-up|10|||
162799052|NCT01598662|587973093|FG001|Overall Study|Lost to Follow-up|17|||
162799053|NCT01598662|587973092|FG000|Overall Study|Physician Decision|1|||
162799054|NCT01598662|587973093|FG001|Overall Study|Physician Decision|2|||
162799055|NCT01598662|587973092|FG000|Overall Study|IUD expelled before month 6|0|||
162799056|NCT01598662|587973093|FG001|Overall Study|IUD expelled before month 6|2|||
162799057|NCT00910039|587973094|FG000|Overall Study|Physician Decision|1|||
162799058|NCT04155047|587973099|FG000|Overall Study|Adverse Event|1|||
162799059|NCT04155047|587973100|FG001|Overall Study|Adverse Event|0|||
162799060|NCT04155047|587973099|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
162799061|NCT04155047|587973100|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
162799062|NCT04514510|587973101|FG000|Overall Study|Lost to Follow-up|0|||
162799063|NCT04514510|587973102|FG001|Overall Study|Lost to Follow-up|1|||
162799064|NCT04514510|587973101|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
162799065|NCT04514510|587973102|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
162799066|NCT00821587|587973103|FG000|Overall Study|Physician Decision|0|||
162799067|NCT00821587|587973104|FG001|Overall Study|Physician Decision|1|||
162799068|NCT02781090|587973107|FG000|3-Month Follow-Up|Missed Visit|20|||
162799069|NCT02781090|587973108|FG001|3-Month Follow-Up|Missed Visit|20|||
162799070|NCT02781090|587973107|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
162799071|NCT02781090|587973108|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
162799072|NCT02781090|587973107|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
162799073|NCT02781090|587973108|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
162799074|NCT02781090|587973107|FG000|3-Month Follow-Up|Death|1|||
162799075|NCT02781090|587973108|FG001|3-Month Follow-Up|Death|0|||
162799076|NCT02781090|587973107|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
162799077|NCT02781090|587973108|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
162799078|NCT02781090|587973107|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
162799079|NCT02781090|587973108|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
162799080|NCT02781090|587973107|FG000|6-Month Follow-Up|Death|0|||
162799081|NCT02781090|587973108|FG001|6-Month Follow-Up|Death|1|||
162799082|NCT00643617|587973109|FG000|Overall Study|Death|6|||
162799083|NCT00643617|587973110|FG001|Overall Study|Death|9|||
162799084|NCT00643617|587973109|FG000|Overall Study|Lost to Follow-up|42|||
162799085|NCT00643617|587973110|FG001|Overall Study|Lost to Follow-up|51|||
162799086|NCT02075073|587973111|FG000|Overall Study|Withdrawal by Subject|0|||
162799087|NCT02075073|587973112|FG001|Overall Study|Withdrawal by Subject|1|||
162799088|NCT02075073|587973113|FG002|Overall Study|Withdrawal by Subject|0|||
162799089|NCT01208103|587973120|FG000|Overall Study|Adverse Event|1|||
162799090|NCT01208103|587973120|FG000|Overall Study|Withdrawal by Subject|1|||
162799091|NCT02683785|587973123|FG000|Overall Study|Withdrawal by Subject|1|||
162799092|NCT02683785|587973124|FG001|Overall Study|Withdrawal by Subject|1|||
162799093|NCT02683785|587973123|FG000|Overall Study|Lost to Follow-up|0|||
162799094|NCT02683785|587973124|FG001|Overall Study|Lost to Follow-up|1|||
162799095|NCT02683785|587973123|FG000|Overall Study|Adverse Event|0|||
162799096|NCT02683785|587973124|FG001|Overall Study|Adverse Event|2|||
162799097|NCT00416195|587973125|FG000|Overall Study|Adverse Event|1|||
162799098|NCT00416195|587973126|FG001|Overall Study|Adverse Event|2|||
162799099|NCT00416195|587973125|FG000|Overall Study|Protocol Violation|1|||
162799100|NCT00416195|587973126|FG001|Overall Study|Protocol Violation|1|||
162799101|NCT00416195|587973125|FG000|Overall Study|Other|0|||
162799102|NCT00416195|587973126|FG001|Overall Study|Other|1|||
162799103|NCT01305408|587973131|FG000|Overall Study|Adverse Event|10|||
162799104|NCT01305408|587973132|FG001|Overall Study|Adverse Event|7|||
162799105|NCT01305408|587973131|FG000|Overall Study|Lack of Efficacy|3|||
162799106|NCT01305408|587973132|FG001|Overall Study|Lack of Efficacy|4|||
162799107|NCT01305408|587973131|FG000|Overall Study|Withdrawal by Subject|9|||
162799108|NCT01305408|587973132|FG001|Overall Study|Withdrawal by Subject|9|||
162799109|NCT01305408|587973131|FG000|Overall Study|Protocol Violation|4|||
162799110|NCT01305408|587973132|FG001|Overall Study|Protocol Violation|6|||
162799111|NCT01305408|587973131|FG000|Overall Study|Lost to Follow-up|5|||
162799112|NCT01305408|587973132|FG001|Overall Study|Lost to Follow-up|3|||
162799113|NCT01305408|587973131|FG000|Overall Study|Noncompliance with study medication|0|||
162799114|NCT01305408|587973132|FG001|Overall Study|Noncompliance with study medication|1|||
162799115|NCT01305408|587973131|FG000|Overall Study|Noncompliance with study procedures|0|||
162799116|NCT01305408|587973132|FG001|Overall Study|Noncompliance with study procedures|1|||
162799117|NCT01305408|587973131|FG000|Overall Study|Other|1|||
162799118|NCT01305408|587973132|FG001|Overall Study|Other|0|||
162799119|NCT02770612|587973133|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
162799120|NCT02233803|587973134|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
162799121|NCT02233803|587973135|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
162799122|NCT02233803|587973134|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
162799123|NCT02233803|587973135|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
162799124|NCT02233803|587973134|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
162799125|NCT02233803|587973135|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
162799126|NCT02233803|587973134|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
162799127|NCT02233803|587973135|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
162799128|NCT02233803|587973134|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
162799129|NCT02233803|587973135|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
162799130|NCT02233803|587973134|FG000|Washout Period (4-Wks)|Physician Decision|1|||
162799131|NCT02233803|587973135|FG001|Washout Period (4-Wks)|Physician Decision|0|||
162799132|NCT02233803|587973134|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
162799133|NCT02233803|587973135|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
162799134|NCT02233803|587973134|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
162799135|NCT02233803|587973135|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
162799136|NCT02233803|587973134|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
162799137|NCT02233803|587973135|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
162799138|NCT03846453|587973136|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
162799139|NCT03846453|587973137|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
162799140|NCT03846453|587973138|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
162799141|NCT03846453|587973136|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
162799142|NCT03846453|587973137|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
162799143|NCT03846453|587973138|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
162799144|NCT03846453|587973136|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
162799145|NCT03846453|587973137|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
162799146|NCT03846453|587973138|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
162799147|NCT03846453|587973136|FG000|Placebo Run-in (14 Days)|Other|2|||
162799148|NCT03846453|587973137|FG001|Placebo Run-in (14 Days)|Other|0|||
162799149|NCT03846453|587973138|FG002|Placebo Run-in (14 Days)|Other|0|||
162799150|NCT03846453|587973136|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
162799151|NCT03846453|587973137|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
162799152|NCT03846453|587973138|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
162799153|NCT03846453|587973136|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
162799154|NCT03846453|587973137|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
162799155|NCT03846453|587973138|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
162799156|NCT03846453|587973136|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
162799157|NCT03846453|587973137|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
162799158|NCT03846453|587973138|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
162799159|NCT03846453|587973136|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
162799160|NCT03846453|587973137|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
162799161|NCT03846453|587973138|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
162799162|NCT03846453|587973136|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
162799163|NCT03846453|587973137|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
162799164|NCT03846453|587973138|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
162799165|NCT01877239|587973139|FG000|Overall Study|Adverse Event|4|||
162799166|NCT01877239|587973139|FG000|Overall Study|Disease Remission|1|||
162799167|NCT01877239|587973139|FG000|Overall Study|Withdrawal by Subject|4|||
162799168|NCT01877239|587973139|FG000|Overall Study|Other|2|||
162799169|NCT01877239|587973139|FG000|Overall Study|Lack of Efficacy|4|||
162799170|NCT01877239|587973139|FG000|Overall Study|Data not available|35|||
162799171|NCT01283516|587973143|FG000|Overall Study|Adverse Event|0|||
162799172|NCT01283516|587973144|FG001|Overall Study|Adverse Event|0|||
162799173|NCT01283516|587973145|FG002|Overall Study|Adverse Event|0|||
162799174|NCT01283516|587973146|FG003|Overall Study|Adverse Event|0|||
162799175|NCT01283516|587973147|FG004|Overall Study|Adverse Event|0|||
162799176|NCT01283516|587973148|FG005|Overall Study|Adverse Event|0|||
162799177|NCT01283516|587973149|FG006|Overall Study|Adverse Event|2|||
162799178|NCT01283516|587973150|FG007|Overall Study|Adverse Event|0|||
162799179|NCT01283516|587973151|FG008|Overall Study|Adverse Event|28|||
162799180|NCT01283516|587973143|FG000|Overall Study|Death|0|||
162799181|NCT01283516|587973144|FG001|Overall Study|Death|0|||
162799182|NCT01283516|587973145|FG002|Overall Study|Death|0|||
162799183|NCT01283516|587973146|FG003|Overall Study|Death|0|||
162799184|NCT01283516|587973147|FG004|Overall Study|Death|0|||
162799185|NCT01283516|587973148|FG005|Overall Study|Death|1|||
162799186|NCT01283516|587973149|FG006|Overall Study|Death|0|||
162799187|NCT01283516|587973150|FG007|Overall Study|Death|1|||
162799188|NCT01283516|587973151|FG008|Overall Study|Death|12|||
162799189|NCT01283516|587973143|FG000|Overall Study|Disease Progression|2|||
162799190|NCT01283516|587973144|FG001|Overall Study|Disease Progression|2|||
162799191|NCT01283516|587973145|FG002|Overall Study|Disease Progression|3|||
162799192|NCT01283516|587973146|FG003|Overall Study|Disease Progression|3|||
162799193|NCT01283516|587973147|FG004|Overall Study|Disease Progression|13|||
162799194|NCT01283516|587973148|FG005|Overall Study|Disease Progression|8|||
162799195|NCT01283516|587973149|FG006|Overall Study|Disease Progression|6|||
162799196|NCT01283516|587973150|FG007|Overall Study|Disease Progression|3|||
162799197|NCT01283516|587973151|FG008|Overall Study|Disease Progression|139|||
162799198|NCT01283516|587973143|FG000|Overall Study|Withdrawal by Subject|0|||
162799199|NCT01283516|587973144|FG001|Overall Study|Withdrawal by Subject|0|||
162799200|NCT01283516|587973145|FG002|Overall Study|Withdrawal by Subject|0|||
162799201|NCT01283516|587973146|FG003|Overall Study|Withdrawal by Subject|0|||
162799202|NCT01283516|587973147|FG004|Overall Study|Withdrawal by Subject|1|||
162799203|NCT01283516|587973148|FG005|Overall Study|Withdrawal by Subject|0|||
162799204|NCT01283516|587973149|FG006|Overall Study|Withdrawal by Subject|1|||
162799205|NCT01283516|587973150|FG007|Overall Study|Withdrawal by Subject|0|||
162799206|NCT01283516|587973151|FG008|Overall Study|Withdrawal by Subject|36|||
162799207|NCT01283516|587973143|FG000|Overall Study|Administrative problems|0|||
162799208|NCT01283516|587973144|FG001|Overall Study|Administrative problems|0|||
162799209|NCT01283516|587973145|FG002|Overall Study|Administrative problems|0|||
162799210|NCT01283516|587973146|FG003|Overall Study|Administrative problems|0|||
162799211|NCT01283516|587973147|FG004|Overall Study|Administrative problems|0|||
162799212|NCT01283516|587973148|FG005|Overall Study|Administrative problems|1|||
162799213|NCT01283516|587973149|FG006|Overall Study|Administrative problems|1|||
162799214|NCT01283516|587973150|FG007|Overall Study|Administrative problems|1|||
162799215|NCT01283516|587973151|FG008|Overall Study|Administrative problems|39|||
162799216|NCT01283516|587973143|FG000|Overall Study|Lost to Follow-up|0|||
162799217|NCT01283516|587973144|FG001|Overall Study|Lost to Follow-up|0|||
162799218|NCT01283516|587973145|FG002|Overall Study|Lost to Follow-up|0|||
162799219|NCT01283516|587973146|FG003|Overall Study|Lost to Follow-up|0|||
162799220|NCT01283516|587973147|FG004|Overall Study|Lost to Follow-up|0|||
162799221|NCT01283516|587973148|FG005|Overall Study|Lost to Follow-up|0|||
162799222|NCT01283516|587973149|FG006|Overall Study|Lost to Follow-up|0|||
162799223|NCT01283516|587973150|FG007|Overall Study|Lost to Follow-up|0|||
162799224|NCT01283516|587973151|FG008|Overall Study|Lost to Follow-up|1|||
162799225|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
162799226|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
162799227|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
162799228|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
162799229|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
162799230|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
162799231|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
162799232|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
162799233|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
162799234|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
162799235|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162799236|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Adverse Event|0|||
162799237|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Adverse Event|3|||
162799238|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Adverse Event|2|||
162799239|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Adverse Event|13|||
162799240|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162799241|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162799242|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
162799243|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162799244|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
162799245|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Patient's wish|0|||
162799246|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Patient's wish|0|||
162799247|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Patient's wish|19|||
162799248|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Patient's wish|9|||
162799249|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Patient's wish|20|||
162799250|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
162799251|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
162799252|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
162799253|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
162799254|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
162799255|NCT00444275|587973154|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
162799256|NCT00444275|587973155|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
162799257|NCT00444275|587973156|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
162799258|NCT00444275|587973157|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
162799259|NCT00444275|587973158|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
162799260|NCT00283244|587973159|FG000|Overall Study|Adverse Event|0|||
162799261|NCT00283244|587973160|FG001|Overall Study|Adverse Event|8|||
162799262|NCT00283244|587973161|FG002|Overall Study|Adverse Event|11|||
162799263|NCT00283244|587973159|FG000|Overall Study|Death|4|||
162799264|NCT00283244|587973160|FG001|Overall Study|Death|3|||
162799265|NCT00283244|587973161|FG002|Overall Study|Death|2|||
162799266|NCT00283244|587973159|FG000|Overall Study|Lack of Efficacy|8|||
162799267|NCT00283244|587973160|FG001|Overall Study|Lack of Efficacy|32|||
162799268|NCT00283244|587973161|FG002|Overall Study|Lack of Efficacy|26|||
162799269|NCT00283244|587973159|FG000|Overall Study|Withdrawal by Subject|1|||
162799270|NCT00283244|587973160|FG001|Overall Study|Withdrawal by Subject|2|||
162799271|NCT00283244|587973161|FG002|Overall Study|Withdrawal by Subject|2|||
162799272|NCT00283244|587973159|FG000|Overall Study|Physician Decision|0|||
162799273|NCT00283244|587973160|FG001|Overall Study|Physician Decision|0|||
162799274|NCT00283244|587973161|FG002|Overall Study|Physician Decision|1|||
162799275|NCT00283244|587973159|FG000|Overall Study|Medical illness (other complicating dz)|4|||
162799276|NCT00283244|587973160|FG001|Overall Study|Medical illness (other complicating dz)|3|||
162799277|NCT00283244|587973161|FG002|Overall Study|Medical illness (other complicating dz)|6|||
162799278|NCT00283244|587973159|FG000|Overall Study|Clinical deterioration|1|||
162799279|NCT00283244|587973160|FG001|Overall Study|Clinical deterioration|3|||
162799280|NCT00283244|587973161|FG002|Overall Study|Clinical deterioration|3|||
162799281|NCT02344290|587973165|FG000|Overall Study|Withdrawal by Subject|315|||
162799282|NCT02344290|587973166|FG001|Overall Study|Withdrawal by Subject|324|||
162799283|NCT02344290|587973165|FG000|Overall Study|Lost to Follow-up|258|||
162799284|NCT02344290|587973166|FG001|Overall Study|Lost to Follow-up|249|||
162799285|NCT02344290|587973165|FG000|Overall Study|Unable to get to clinic|69|||
162799286|NCT02344290|587973166|FG001|Overall Study|Unable to get to clinic|60|||
162799287|NCT02344290|587973165|FG000|Overall Study|Physician Decision|25|||
162799288|NCT02344290|587973166|FG001|Overall Study|Physician Decision|25|||
162799289|NCT02344290|587973165|FG000|Overall Study|Site Closure|15|||
162799290|NCT02344290|587973166|FG001|Overall Study|Site Closure|19|||
162799291|NCT02344290|587973165|FG000|Overall Study|Other|5|||
162799292|NCT02344290|587973166|FG001|Overall Study|Other|3|||
162799293|NCT06748729|587973168|FG000|Overall Study|Withdrawal by Subject|1|||
162799294|NCT00591370|587974509|FG000|Overall Study|Not Treated|2|||
162799295|NCT01202903|587974511|FG000|Overall Study|Administrative Probelms|1|||
162799296|NCT01202903|587974512|FG001|Overall Study|Administrative Probelms|4|||
162799297|NCT01202903|587974511|FG000|Overall Study|Protocol Violation|0|||
162799298|NCT01202903|587974512|FG001|Overall Study|Protocol Violation|1|||
162799299|NCT01202903|587974511|FG000|Overall Study|Death|1|||
162799300|NCT01202903|587974512|FG001|Overall Study|Death|0|||
162799301|NCT01202903|587974511|FG000|Overall Study|Lost to Follow-up|1|||
162799302|NCT01202903|587974512|FG001|Overall Study|Lost to Follow-up|1|||
162799303|NCT01202903|587974511|FG000|Overall Study|Lack of Efficacy|1|||
162799304|NCT01202903|587974512|FG001|Overall Study|Lack of Efficacy|3|||
162799305|NCT01202903|587974511|FG000|Overall Study|Adverse Event|3|||
162799306|NCT01202903|587974512|FG001|Overall Study|Adverse Event|3|||
162799307|NCT01202903|587974511|FG000|Overall Study|Withdrawal by Subject|4|||
162799308|NCT01202903|587974512|FG001|Overall Study|Withdrawal by Subject|4|||
162799309|NCT01302080|587974513|FG000|Overall Study|Withdrew Consent|92|||
162799310|NCT01302080|587974514|FG001|Overall Study|Withdrew Consent|39|||
162799311|NCT01302080|587974513|FG000|Overall Study|Patient/Family Moved|28|||
162799312|NCT01302080|587974514|FG001|Overall Study|Patient/Family Moved|3|||
162799313|NCT01302080|587974513|FG000|Overall Study|Lost to Follow-up|192|||
162799314|NCT01302080|587974514|FG001|Overall Study|Lost to Follow-up|93|||
162799315|NCT01302080|587974513|FG000|Overall Study|Death|1|||
162799316|NCT01302080|587974514|FG001|Overall Study|Death|0|||
162799317|NCT01302080|587974513|FG000|Overall Study|Other|52|||
162799318|NCT01302080|587974514|FG001|Overall Study|Other|8|||
162799319|NCT01302080|587974513|FG000|Overall Study|Reason Missing For Discontinuation|1|||
162799320|NCT01302080|587974514|FG001|Overall Study|Reason Missing For Discontinuation|0|||
162799321|NCT00837694|587974515|FG000|Overall Study|Lost to Follow-up|2|||
162799322|NCT00837694|587974516|FG001|Overall Study|Lost to Follow-up|0|||
162799323|NCT00837694|587974517|FG002|Overall Study|Lost to Follow-up|2|||
162799324|NCT00837694|587974518|FG003|Overall Study|Lost to Follow-up|1|||
162799325|NCT00837694|587974519|FG004|Overall Study|Lost to Follow-up|1|||
162799326|NCT00837694|587974520|FG005|Overall Study|Lost to Follow-up|1|||
162799327|NCT00306670|587974521|FG000|Overall Study|patients recruited; Genentech, the st|0|||
162799328|NCT00306670|587974522|FG001|Overall Study|patients recruited; Genentech, the st|2|||
162799329|NCT00503139|587974523|FG000|Overall Study|Case Report Forms were not collected|4|||
162799330|NCT00503139|587974523|FG000|Overall Study|Protocol Violation|4|||
162799331|NCT00091169|587974527|FG000|Overall Study|Disease progression|3|||
162799332|NCT00091169|587974528|FG001|Overall Study|Disease progression|1|||
162799333|NCT00091169|587974527|FG000|Overall Study|Adverse Event|11|||
162799334|NCT00091169|587974528|FG001|Overall Study|Adverse Event|17|||
162799335|NCT00091169|587974527|FG000|Overall Study|Death|4|||
162799336|NCT00091169|587974528|FG001|Overall Study|Death|1|||
162799337|NCT00091169|587974527|FG000|Overall Study|Withdrawal by Subject|10|||
162799338|NCT00091169|587974528|FG001|Overall Study|Withdrawal by Subject|13|||
162799339|NCT00091169|587974527|FG000|Overall Study|Other|3|||
162799340|NCT00091169|587974528|FG001|Overall Study|Other|4|||
162799341|NCT00091169|587974527|FG000|Overall Study|Not start protocol therapy|26|||
162799342|NCT00091169|587974528|FG001|Overall Study|Not start protocol therapy|17|||
162799343|NCT04138576|587974533|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
162799344|NCT04410523|587974537|FG000|Overall Study|Study terminated by sponsor|1|||
162799345|NCT04410523|587974538|FG001|Overall Study|Study terminated by sponsor|3|||
162799346|NCT04410523|587974539|FG002|Overall Study|Study terminated by sponsor|2|||
162799347|NCT04410523|587974540|FG003|Overall Study|Study terminated by sponsor|6|||
162799348|NCT04410523|587974541|FG004|Overall Study|Study terminated by sponsor|3|||
162799349|NCT04410523|587974542|FG005|Overall Study|Study terminated by sponsor|4|||
162799350|NCT04410523|587974537|FG000|Overall Study|Adverse Event|1|||
162799351|NCT04410523|587974538|FG001|Overall Study|Adverse Event|0|||
162799352|NCT04410523|587974539|FG002|Overall Study|Adverse Event|0|||
162799353|NCT04410523|587974540|FG003|Overall Study|Adverse Event|0|||
162799354|NCT04410523|587974541|FG004|Overall Study|Adverse Event|0|||
162799355|NCT04410523|587974542|FG005|Overall Study|Adverse Event|2|||
162799356|NCT04410523|587974537|FG000|Overall Study|Lost to Follow-up|0|||
162799357|NCT04410523|587974538|FG001|Overall Study|Lost to Follow-up|1|||
162799358|NCT04410523|587974539|FG002|Overall Study|Lost to Follow-up|0|||
162799359|NCT04410523|587974540|FG003|Overall Study|Lost to Follow-up|0|||
162799360|NCT04410523|587974541|FG004|Overall Study|Lost to Follow-up|0|||
162799361|NCT04410523|587974542|FG005|Overall Study|Lost to Follow-up|0|||
162799362|NCT04410523|587974537|FG000|Overall Study|Physician Decision|0|||
162799363|NCT04410523|587974538|FG001|Overall Study|Physician Decision|1|||
162799364|NCT04410523|587974539|FG002|Overall Study|Physician Decision|0|||
162799365|NCT04410523|587974540|FG003|Overall Study|Physician Decision|0|||
162799366|NCT04410523|587974541|FG004|Overall Study|Physician Decision|0|||
162799367|NCT04410523|587974542|FG005|Overall Study|Physician Decision|0|||
162799368|NCT04410523|587974537|FG000|Overall Study|Pregnancy|0|||
162799369|NCT04410523|587974538|FG001|Overall Study|Pregnancy|0|||
162799370|NCT04410523|587974539|FG002|Overall Study|Pregnancy|0|||
162799371|NCT04410523|587974540|FG003|Overall Study|Pregnancy|0|||
162799372|NCT04410523|587974541|FG004|Overall Study|Pregnancy|0|||
162799373|NCT04410523|587974542|FG005|Overall Study|Pregnancy|1|||
162799374|NCT04410523|587974537|FG000|Overall Study|Protocol deviation|0|||
162799375|NCT04410523|587974538|FG001|Overall Study|Protocol deviation|0|||
162799376|NCT04410523|587974539|FG002|Overall Study|Protocol deviation|0|||
162799377|NCT04410523|587974540|FG003|Overall Study|Protocol deviation|0|||
162799378|NCT04410523|587974541|FG004|Overall Study|Protocol deviation|0|||
162799379|NCT04410523|587974542|FG005|Overall Study|Protocol deviation|2|||
162799380|NCT04410523|587974537|FG000|Overall Study|Subject decision|2|||
162799381|NCT04410523|587974538|FG001|Overall Study|Subject decision|0|||
162799382|NCT04410523|587974539|FG002|Overall Study|Subject decision|0|||
162799383|NCT04410523|587974540|FG003|Overall Study|Subject decision|1|||
162799384|NCT04410523|587974541|FG004|Overall Study|Subject decision|0|||
162799385|NCT04410523|587974542|FG005|Overall Study|Subject decision|1|||
162799386|NCT00490490|587974543|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
162799387|NCT00490490|587974543|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
162799388|NCT00772330|587974544|FG000|Overall Study|Lost to Follow-up|3|||
162799389|NCT00734591|587974545|FG000|Screening for Prospective Period|Site did not participate|1604|||
162799390|NCT00734591|587974546|FG001|Screening for Prospective Period|Site did not participate|1488|||
162799391|NCT00734591|587974545|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
162799392|NCT00734591|587974546|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
162799393|NCT00734591|587974545|FG000|Prospective Period|Withdrawal by Subject|11|||
162799394|NCT00734591|587974546|FG001|Prospective Period|Withdrawal by Subject|9|||
162799395|NCT00734591|587974545|FG000|Prospective Period|Lost to Follow-up|37|||
162799396|NCT00734591|587974546|FG001|Prospective Period|Lost to Follow-up|33|||
162799397|NCT00734591|587974545|FG000|Prospective Period|Study Terminated|1|||
162799398|NCT00734591|587974546|FG001|Prospective Period|Study Terminated|0|||
162799399|NCT00734591|587974545|FG000|Prospective Period|Other|2|||
162799400|NCT00734591|587974546|FG001|Prospective Period|Other|2|||
162799401|NCT01656200|587974549|FG000|Overall Study|Withdrawal by Subject|1|||
162799402|NCT01461811|587974550|FG000|Overall Study|Adverse Event|2|||
162799403|NCT01461811|587974551|FG001|Overall Study|Adverse Event|1|||
162799404|NCT01461811|587974550|FG000|Overall Study|Subject decision unrelated to an AE|1|||
162799405|NCT01461811|587974551|FG001|Overall Study|Subject decision unrelated to an AE|1|||
162799406|NCT01461811|587974550|FG000|Overall Study|Noncompliance|1|||
162799407|NCT01461811|587974551|FG001|Overall Study|Noncompliance|1|||
162799408|NCT03015129|587974552|FG000|Overall Study|Death|2|||
162799409|NCT03015129|587974553|FG001|Overall Study|Death|2|||
162799410|NCT03015129|587974552|FG000|Overall Study|Lost to Follow-up|0|||
162799411|NCT03015129|587974553|FG001|Overall Study|Lost to Follow-up|1|||
162799412|NCT03015129|587974552|FG000|Overall Study|Progression of disease|38|||
162799413|NCT03015129|587974553|FG001|Overall Study|Progression of disease|33|||
162799414|NCT03015129|587974552|FG000|Overall Study|Adverse Event|0|||
162799415|NCT03015129|587974553|FG001|Overall Study|Adverse Event|4|||
162799416|NCT00468143|587974554|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
162799417|NCT00468143|587974555|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
162799418|NCT00468143|587974554|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
162799419|NCT00468143|587974555|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
162799420|NCT01606670|587974558|FG000|Overall Study|Adverse Event|6|||
162799421|NCT01606670|587974558|FG000|Overall Study|Lack of Efficacy|2|||
162799422|NCT01606670|587974558|FG000|Overall Study|Lost to Follow-up|3|||
162799423|NCT01606670|587974558|FG000|Overall Study|Withdrawal by Subject|3|||
162799424|NCT01606670|587974558|FG000|Overall Study|Other Reason|2|||
162799425|NCT03192475|587974569|FG000|Overall Study|Death|0|||
162799426|NCT03192475|587974570|FG001|Overall Study|Death|1|||
162799427|NCT03192475|587974569|FG000|Overall Study|Lost to Follow-up|13|||
162799428|NCT03192475|587974570|FG001|Overall Study|Lost to Follow-up|8|||
162799429|NCT00798590|587974571|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
162799430|NCT00798590|587974572|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
162799431|NCT03653208|587974577|FG000|Overall Study|Withdrawal by Subject|0|||
162799432|NCT03653208|587974578|FG001|Overall Study|Withdrawal by Subject|0|||
162799433|NCT03653208|587974579|FG002|Overall Study|Withdrawal by Subject|0|||
162799434|NCT03653208|587974580|FG003|Overall Study|Withdrawal by Subject|0|||
162799435|NCT03653208|587974581|FG004|Overall Study|Withdrawal by Subject|1|||
162799436|NCT03653208|587974582|FG005|Overall Study|Withdrawal by Subject|0|||
162799437|NCT03653208|587974583|FG006|Overall Study|Withdrawal by Subject|0|||
162799438|NCT03653208|587974584|FG007|Overall Study|Withdrawal by Subject|1|||
162799439|NCT03653208|587974585|FG008|Overall Study|Withdrawal by Subject|1|||
162799440|NCT00368927|587974586|FG000|Overall Study|Lost to Follow-up|2|||
162799441|NCT00368927|587974587|FG001|Overall Study|Lost to Follow-up|0|||
162799442|NCT00368927|587974586|FG000|Overall Study|Adverse Event|1|||
162799443|NCT00368927|587974587|FG001|Overall Study|Adverse Event|1|||
162799444|NCT00368927|587974586|FG000|Overall Study|Withdrawal by Subject|1|||
162799445|NCT00368927|587974587|FG001|Overall Study|Withdrawal by Subject|2|||
162799446|NCT00368927|587974586|FG000|Overall Study|Physician Decision|1|||
162799447|NCT00368927|587974587|FG001|Overall Study|Physician Decision|0|||
162799448|NCT00886795|587974588|FG000|Overall Study|Lack of Efficacy|1|||
162799449|NCT01204710|587974591|FG000|Randomization Treatment|Lost to Follow-up|1|||
162799450|NCT01204710|587974592|FG001|Randomization Treatment|Lost to Follow-up|0|||
162799451|NCT01204710|587974591|FG000|Randomization Treatment|Withdrawal by Subject|6|||
162799452|NCT01204710|587974592|FG001|Randomization Treatment|Withdrawal by Subject|5|||
162799453|NCT01204710|587974591|FG000|Randomization Treatment|Physician Decision|3|||
162799454|NCT01204710|587974592|FG001|Randomization Treatment|Physician Decision|2|||
162799455|NCT01204710|587974591|FG000|Randomization Treatment|Entry criteria not met|0|||
162799456|NCT01204710|587974592|FG001|Randomization Treatment|Entry criteria not met|1|||
162799457|NCT01204710|587974591|FG000|Randomization Treatment|Adverse Event|4|||
162799458|NCT01204710|587974592|FG001|Randomization Treatment|Adverse Event|2|||
162799459|NCT01204710|587974591|FG000|Randomization Treatment|Sponsor Decision|0|||
162799460|NCT01204710|587974592|FG001|Randomization Treatment|Sponsor Decision|1|||
162799461|NCT01204710|587974591|FG000|Randomization Treatment|Worsening of General condition|0|||
162799462|NCT01204710|587974592|FG001|Randomization Treatment|Worsening of General condition|1|||
162799463|NCT01204710|587974591|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
162799464|NCT01204710|587974592|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
162799465|NCT01204710|587974591|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
162799466|NCT01204710|587974592|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
162799467|NCT01204710|587974591|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
162799468|NCT01204710|587974592|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
162799469|NCT01204710|587974591|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
162799470|NCT01204710|587974592|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
162799471|NCT01989169|587974595|FG000|Period 2|Adverse Event|0|||
162799472|NCT01989169|587974596|FG001|Period 2|Adverse Event|1|||
162799473|NCT01114880|587974597|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
162799474|NCT01114880|587974598|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
162799475|NCT01114880|587974597|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
162799476|NCT01114880|587974598|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
162799477|NCT01114880|587974597|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
162799478|NCT01114880|587974598|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
162799479|NCT01114880|587974597|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
162799480|NCT01114880|587974598|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
162799481|NCT01114880|587974597|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
162799482|NCT01114880|587974598|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
162799483|NCT01114880|587974597|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
162799484|NCT01114880|587974598|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
162799485|NCT04531904|587974600|FG000|Overall Study|Lost to Follow-up|1|||
162799486|NCT04531904|587974600|FG000|Overall Study|Death|14|||
162799487|NCT02738853|587974603|FG000|Enrollment|Inclusion/Exclusion not met|21|||
162799488|NCT02738853|587974603|FG000|Enrollment|Withdrawal by Subject|3|||
162799489|NCT02738853|587974603|FG000|Enrollment|Subject treated with commercially available device|6|||
162799490|NCT02738853|587974603|FG000|Enrollment|Study Enrollment Closed|3|||
162799491|NCT02738853|587974603|FG000|Procedure|Death|1|||
162799492|NCT02738853|587974603|FG000|1 Month|Death|2|||
162799493|NCT02738853|587974603|FG000|6 Month|Death|4|||
162799494|NCT02738853|587974603|FG000|6 Month|Withdrawal by Subject|2|||
162799495|NCT02738853|587974603|FG000|1 Year|Death|6|||
162799496|NCT02738853|587974603|FG000|1 Year|Withdrawal by Subject|1|||
162799497|NCT02738853|587974603|FG000|2 Year|Death|2|||
162799498|NCT02738853|587974603|FG000|2 Year|Lost to Follow-up|1|||
162799499|NCT02738853|587974603|FG000|3 Year|Death|2|||
162799500|NCT02738853|587974603|FG000|3 Year|Withdrawal by Subject|1|||
162799501|NCT02738853|587974603|FG000|4 Year|Death|9|||
162799502|NCT02738853|587974603|FG000|5 Year|Lost to Follow-up|4|||
162799503|NCT03519997|587974604|FG000|Overall Study|Adverse Event|4|||
162799504|NCT03519997|587974604|FG000|Overall Study|Withdrawal by Subject|2|||
162799505|NCT03519997|587974604|FG000|Overall Study|Protocol Violation|1|||
162799506|NCT03361605|587974605|FG000|Overall Study|Analyzable data not available|3|||
162799507|NCT03898167|587974606|FG000|Overall Study|Terminated phone call early|7|||
162799508|NCT03898167|587974607|FG001|Overall Study|Terminated phone call early|0|||
162799509|NCT03898167|587974608|FG002|Overall Study|Terminated phone call early|0|||
162799510|NCT03898167|587974606|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
162799511|NCT03898167|587974607|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
162799512|NCT03898167|587974608|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
162799513|NCT00151281|587974609|FG000|Overall Study|Not evaluable|3|||
162799514|NCT02906007|587974612|FG000|Overall Study|Physician Decision|0|||
162799515|NCT02906007|587974613|FG001|Overall Study|Physician Decision|0|||
162799516|NCT02906007|587974614|FG002|Overall Study|Physician Decision|1|||
162799517|NCT02906007|587974612|FG000|Overall Study|Died|1|||
162799518|NCT02906007|587974613|FG001|Overall Study|Died|0|||
162799519|NCT02906007|587974614|FG002|Overall Study|Died|0|||
162799520|NCT04696653|587974615|FG000|Overall Study|left organization|18|||
162799521|NCT04696653|587974615|FG000|Overall Study|Lost to Follow-up|3|||
162799522|NCT03520712|587974616|FG000|Overall Study|Early termination of the study by Sponsor|2|||
162799523|NCT04372121|587974617|FG000|Overall Study|Lost to Follow-up|0|||
162799524|NCT04372121|587974618|FG001|Overall Study|Lost to Follow-up|0|||
162799525|NCT04372121|587974619|FG002|Overall Study|Lost to Follow-up|0|||
162799526|NCT04372121|587974620|FG003|Overall Study|Lost to Follow-up|1|||
162799527|NCT04372121|587974617|FG000|Overall Study|Protocol Violation|0|||
162799528|NCT04372121|587974618|FG001|Overall Study|Protocol Violation|0|||
162799529|NCT04372121|587974619|FG002|Overall Study|Protocol Violation|1|||
162799530|NCT04372121|587974620|FG003|Overall Study|Protocol Violation|0|||
162799531|NCT04372121|587974617|FG000|Overall Study|Withdrawal by Subject|3|||
162799532|NCT04372121|587974618|FG001|Overall Study|Withdrawal by Subject|1|||
162799533|NCT04372121|587974619|FG002|Overall Study|Withdrawal by Subject|0|||
162799534|NCT04372121|587974620|FG003|Overall Study|Withdrawal by Subject|0|||
162799535|NCT04372121|587974617|FG000|Overall Study|Study termination|6|||
162799536|NCT04372121|587974618|FG001|Overall Study|Study termination|5|||
162925433|NCT01346501|588428971|FG000|Overall Study|Initiated Other Biological Agents|3|||
162799537|NCT04372121|587974619|FG002|Overall Study|Study termination|1|||
162799538|NCT04372121|587974620|FG003|Overall Study|Study termination|1|||
162799539|NCT04372121|587974617|FG000|Overall Study|Hysterectomy planned|1|||
162799540|NCT04372121|587974618|FG001|Overall Study|Hysterectomy planned|0|||
162799541|NCT04372121|587974619|FG002|Overall Study|Hysterectomy planned|0|||
162799542|NCT04372121|587974620|FG003|Overall Study|Hysterectomy planned|0|||
162799543|NCT00640133|587976555|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
162799544|NCT00640133|587976556|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
162799545|NCT00640133|587976555|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
162799546|NCT00640133|587976556|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
162799547|NCT00640133|587976555|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
162799548|NCT00640133|587976556|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
162799549|NCT03896152|587976558|FG000|Overall Study|Patient/guardian decision|1|||
162799550|NCT03896152|587976559|FG001|Overall Study|Patient/guardian decision|1|||
162799551|NCT03896152|587976558|FG000|Overall Study|Adverse Event|0|||
162799552|NCT03896152|587976559|FG001|Overall Study|Adverse Event|1|||
162799553|NCT03896152|587976558|FG000|Overall Study|Physician Decision|1|||
162799554|NCT03896152|587976559|FG001|Overall Study|Physician Decision|0|||
162799555|NCT03896152|587976558|FG000|Overall Study|Technical problems|1|||
162799556|NCT03896152|587976559|FG001|Overall Study|Technical problems|0|||
162799557|NCT00224887|587976560|FG000|Overall Study|Pregnancy|6|||
162799558|NCT00224887|587976561|FG001|Overall Study|Pregnancy|6|||
162799559|NCT03921723|587976562|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
162799560|NCT03921723|587976562|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
162799561|NCT03046121|587976564|FG000|Overall Study|Death|32|||
162799562|NCT03046121|587976565|FG001|Overall Study|Death|60|||
162799563|NCT03046121|587976564|FG000|Overall Study|Withdrawal by Subject|14|||
162799564|NCT03046121|587976565|FG001|Overall Study|Withdrawal by Subject|12|||
162799565|NCT03214640|587976566|FG000|Overall Study|Protocol Violation|1|||
162799566|NCT03214640|587976567|FG001|Overall Study|Protocol Violation|2|||
162799567|NCT03214640|587976568|FG002|Overall Study|Protocol Violation|1|||
162799568|NCT03214640|587976569|FG003|Overall Study|Protocol Violation|4|||
162799569|NCT00406692|587976577|FG000|Overall Study|Withdrawal by Subject|4|||
162799570|NCT00406692|587976577|FG000|Overall Study|Physician Decision|1|||
162799571|NCT00406692|587976577|FG000|Overall Study|Adverse Event|1|||
162799572|NCT00406692|587976577|FG000|Overall Study|Lack of Efficacy|1|||
162799573|NCT04488770|587976578|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799574|NCT04488770|587976579|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799575|NCT04488770|587976580|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799576|NCT04488770|587976581|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
162799577|NCT04488770|587976582|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799578|NCT04488770|587976583|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799579|NCT04488770|587976584|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799580|NCT04488770|587976585|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799581|NCT04488770|587976586|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799582|NCT04488770|587976587|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799583|NCT04488770|587976588|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799584|NCT04488770|587976589|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799585|NCT04488770|587976590|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162799586|NCT04488770|587976578|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
162799587|NCT04488770|587976579|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799588|NCT04488770|587976580|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799589|NCT04488770|587976581|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799590|NCT04488770|587976582|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799591|NCT04488770|587976583|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799592|NCT04488770|587976584|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799593|NCT04488770|587976585|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799594|NCT04488770|587976586|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799595|NCT04488770|587976587|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799596|NCT04488770|587976588|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799597|NCT04488770|587976589|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799598|NCT04488770|587976590|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162799599|NCT04488770|587976578|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799600|NCT04488770|587976579|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799601|NCT04488770|587976580|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799602|NCT04488770|587976581|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799603|NCT04488770|587976582|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799604|NCT04488770|587976583|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162799605|NCT04488770|587976584|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162799606|NCT04488770|587976585|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799607|NCT04488770|587976586|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799608|NCT04488770|587976587|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799609|NCT04488770|587976588|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799610|NCT04488770|587976589|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799611|NCT04488770|587976590|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162799612|NCT04488770|587976578|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799613|NCT04488770|587976579|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799614|NCT04488770|587976580|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799615|NCT04488770|587976581|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799616|NCT04488770|587976582|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
162799617|NCT04488770|587976583|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799618|NCT04488770|587976584|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799619|NCT04488770|587976585|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799620|NCT04488770|587976586|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799621|NCT04488770|587976587|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799622|NCT04488770|587976588|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799623|NCT04488770|587976589|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799624|NCT04488770|587976590|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162799625|NCT03547739|587976591|FG000|Overall Study|Death|0|||
162799626|NCT03547739|587976592|FG001|Overall Study|Death|1|||
162799627|NCT03547739|587976593|FG002|Overall Study|Death|5|||
162799628|NCT03547739|587976591|FG000|Overall Study|Adverse Event|24|||
162799629|NCT03547739|587976592|FG001|Overall Study|Adverse Event|11|||
162799630|NCT03547739|587976593|FG002|Overall Study|Adverse Event|13|||
162799631|NCT03547739|587976591|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
162799632|NCT03547739|587976592|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
162799633|NCT03547739|587976593|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
162799634|NCT03547739|587976591|FG000|Overall Study|Lost to Follow-up|80|||
162799635|NCT03547739|587976592|FG001|Overall Study|Lost to Follow-up|84|||
162799636|NCT03547739|587976593|FG002|Overall Study|Lost to Follow-up|116|||
162799637|NCT01696955|587976594|FG000|Main Study|Protocol Violation|1|||
162799638|NCT01696955|587976595|FG001|Main Study|Protocol Violation|0|||
162799639|NCT01696955|587976594|FG000|Main Study|Withdrawal by Subject|1|||
162799640|NCT01696955|587976595|FG001|Main Study|Withdrawal by Subject|1|||
162799641|NCT01641159|587976596|FG000|Overall Study|Lost to Follow-up|2|||
162799642|NCT01641159|587976597|FG001|Overall Study|Lost to Follow-up|1|||
162799643|NCT01641159|587976596|FG000|Overall Study|Withdrawal by Subject|0|||
162799644|NCT01641159|587976597|FG001|Overall Study|Withdrawal by Subject|1|||
162799645|NCT03980808|587976598|FG000|Overall Study|Lost to Follow-up|2|||
162799646|NCT03980808|587976599|FG001|Overall Study|Lost to Follow-up|2|||
162799647|NCT05330676|587976600|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
162799648|NCT05330676|587976601|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
162799649|NCT00436605|587976602|FG000|Overall Study|Protocol Violation|3|||
162799650|NCT00573859|587976607|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
162799651|NCT00573859|587976607|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
162799652|NCT02416453|587976608|FG000|Overall Study|Adverse Event|0|||
162799653|NCT02416453|587976609|FG001|Overall Study|Adverse Event|0|||
162799654|NCT02416453|587976610|FG002|Overall Study|Adverse Event|0|||
162799655|NCT02416453|587976611|FG003|Overall Study|Adverse Event|2|||
162799656|NCT02416453|587976612|FG004|Overall Study|Adverse Event|0|||
162799657|NCT02416453|587976613|FG005|Overall Study|Adverse Event|1|||
162799658|NCT02416453|587976614|FG006|Overall Study|Adverse Event|0|||
162799659|NCT02416453|587976615|FG007|Overall Study|Adverse Event|0|||
162799660|NCT02416453|587976616|FG008|Overall Study|Adverse Event|0|||
162799661|NCT02416453|587976617|FG009|Overall Study|Adverse Event|0|||
162799662|NCT02416453|587976618|FG010|Overall Study|Adverse Event|0|||
162799663|NCT02416453|587976608|FG000|Overall Study|Lost to Follow-up|1|||
162799664|NCT02416453|587976609|FG001|Overall Study|Lost to Follow-up|3|||
162799665|NCT02416453|587976610|FG002|Overall Study|Lost to Follow-up|0|||
162799666|NCT02416453|587976611|FG003|Overall Study|Lost to Follow-up|8|||
162799667|NCT02416453|587976612|FG004|Overall Study|Lost to Follow-up|0|||
162799668|NCT02416453|587976613|FG005|Overall Study|Lost to Follow-up|5|||
162799669|NCT02416453|587976614|FG006|Overall Study|Lost to Follow-up|1|||
162799670|NCT02416453|587976615|FG007|Overall Study|Lost to Follow-up|3|||
162799671|NCT02416453|587976616|FG008|Overall Study|Lost to Follow-up|1|||
162799672|NCT02416453|587976617|FG009|Overall Study|Lost to Follow-up|0|||
162799673|NCT02416453|587976618|FG010|Overall Study|Lost to Follow-up|0|||
162799674|NCT02416453|587976608|FG000|Overall Study|Physician Decision|0|||
162799675|NCT02416453|587976609|FG001|Overall Study|Physician Decision|0|||
162799676|NCT02416453|587976610|FG002|Overall Study|Physician Decision|0|||
162799677|NCT02416453|587976611|FG003|Overall Study|Physician Decision|0|||
162799678|NCT02416453|587976612|FG004|Overall Study|Physician Decision|0|||
162799679|NCT02416453|587976613|FG005|Overall Study|Physician Decision|1|||
162799680|NCT02416453|587976614|FG006|Overall Study|Physician Decision|1|||
162799681|NCT02416453|587976615|FG007|Overall Study|Physician Decision|1|||
162799682|NCT02416453|587976616|FG008|Overall Study|Physician Decision|0|||
162799683|NCT02416453|587976617|FG009|Overall Study|Physician Decision|0|||
162799684|NCT02416453|587976618|FG010|Overall Study|Physician Decision|0|||
162799685|NCT02416453|587976608|FG000|Overall Study|Withdrawal by Subject|2|||
162799686|NCT02416453|587976609|FG001|Overall Study|Withdrawal by Subject|0|||
162799687|NCT02416453|587976610|FG002|Overall Study|Withdrawal by Subject|0|||
162799688|NCT02416453|587976611|FG003|Overall Study|Withdrawal by Subject|5|||
162799689|NCT02416453|587976612|FG004|Overall Study|Withdrawal by Subject|1|||
162799690|NCT02416453|587976613|FG005|Overall Study|Withdrawal by Subject|8|||
162799691|NCT02416453|587976614|FG006|Overall Study|Withdrawal by Subject|0|||
162799692|NCT02416453|587976615|FG007|Overall Study|Withdrawal by Subject|8|||
162799693|NCT02416453|587976616|FG008|Overall Study|Withdrawal by Subject|4|||
162799694|NCT02416453|587976617|FG009|Overall Study|Withdrawal by Subject|0|||
162799695|NCT02416453|587976618|FG010|Overall Study|Withdrawal by Subject|0|||
162799696|NCT02416453|587976608|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799697|NCT02416453|587976609|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799698|NCT02416453|587976610|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
162799699|NCT02416453|587976611|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799700|NCT02416453|587976612|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799701|NCT02416453|587976613|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799702|NCT02416453|587976614|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799703|NCT02416453|587976615|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799704|NCT02416453|587976616|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799705|NCT02416453|587976617|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799706|NCT02416453|587976618|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162799707|NCT02416453|587976608|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799708|NCT02416453|587976609|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799709|NCT02416453|587976610|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799710|NCT02416453|587976611|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799711|NCT02416453|587976612|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799712|NCT02416453|587976613|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
162799713|NCT02416453|587976614|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799714|NCT02416453|587976615|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799715|NCT02416453|587976616|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799716|NCT02416453|587976617|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799717|NCT02416453|587976618|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162799718|NCT01152814|587976619|FG000|Overall Study|Lost to Follow-up|2|||
162799719|NCT02729831|587976621|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
162799720|NCT02729831|587976622|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
162799721|NCT02729831|587976623|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
162799722|NCT02729831|587976624|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
162799723|NCT02729831|587976621|FG000|1 Week Post-visit|Lost to Follow-up|43|||
162799724|NCT02729831|587976622|FG001|1 Week Post-visit|Lost to Follow-up|40|||
162799725|NCT02729831|587976623|FG002|1 Week Post-visit|Lost to Follow-up|38|||
162799726|NCT02729831|587976624|FG003|1 Week Post-visit|Lost to Follow-up|36|||
162799727|NCT02729831|587976621|FG000|6 Month Follow-up|Lost to Follow-up|54|||
162799728|NCT02729831|587976622|FG001|6 Month Follow-up|Lost to Follow-up|51|||
162799729|NCT02729831|587976623|FG002|6 Month Follow-up|Lost to Follow-up|48|||
162799730|NCT02729831|587976624|FG003|6 Month Follow-up|Lost to Follow-up|42|||
162799731|NCT02729831|587976621|FG000|6 Month Follow-up|Death|1|||
162799732|NCT02729831|587976622|FG001|6 Month Follow-up|Death|3|||
162799733|NCT02729831|587976623|FG002|6 Month Follow-up|Death|0|||
162799734|NCT02729831|587976624|FG003|6 Month Follow-up|Death|1|||
162799735|NCT00864253|587976625|FG000|Overall Study|Adverse Event|56|||
162799736|NCT00864253|587976626|FG001|Overall Study|Adverse Event|11|||
162799737|NCT00864253|587976625|FG000|Overall Study|Unrelated Adverse Event|3|||
162799738|NCT00864253|587976626|FG001|Overall Study|Unrelated Adverse Event|1|||
162799739|NCT00864253|587976625|FG000|Overall Study|Physician Decision|11|||
162799740|NCT00864253|587976626|FG001|Overall Study|Physician Decision|15|||
162799741|NCT00864253|587976625|FG000|Overall Study|Protocol Violation|0|||
162799742|NCT00864253|587976626|FG001|Overall Study|Protocol Violation|2|||
162799743|NCT00864253|587976625|FG000|Overall Study|Lost to Follow-up|1|||
162799744|NCT00864253|587976626|FG001|Overall Study|Lost to Follow-up|1|||
162799745|NCT00864253|587976625|FG000|Overall Study|Withdrawal by Subject|18|||
162799746|NCT00864253|587976626|FG001|Overall Study|Withdrawal by Subject|18|||
162799747|NCT00864253|587976625|FG000|Overall Study|Death|1|||
162799748|NCT00864253|587976626|FG001|Overall Study|Death|0|||
162799749|NCT00864253|587976625|FG000|Overall Study|Ongoing|2|||
162799750|NCT00864253|587976626|FG001|Overall Study|Ongoing|3|||
162799751|NCT00864253|587976625|FG000|Overall Study|Untreated|7|||
162799752|NCT00864253|587976626|FG001|Overall Study|Untreated|7|||
162799753|NCT01111240|587976627|FG000|Overall Study|Adverse Event|190|||
162799754|NCT01111240|587976627|FG000|Overall Study|Lack of Efficacy|545|||
162799755|NCT01111240|587976627|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
162799756|NCT01111240|587976627|FG000|Overall Study|Other|312|||
162799757|NCT01747551|587976628|FG000|Overall Study|Progressive Disease|24|||
162799758|NCT01747551|587976629|FG001|Overall Study|Progressive Disease|17|||
162799759|NCT01747551|587976628|FG000|Overall Study|Death|3|||
162799760|NCT01747551|587976629|FG001|Overall Study|Death|1|||
162799761|NCT01747551|587976628|FG000|Overall Study|Adverse Event|7|||
162799762|NCT01747551|587976629|FG001|Overall Study|Adverse Event|1|||
162799763|NCT01747551|587976628|FG000|Overall Study|Prolonged Treatment Delay|2|||
162799764|NCT01747551|587976629|FG001|Overall Study|Prolonged Treatment Delay|0|||
162799765|NCT01747551|587976628|FG000|Overall Study|Withdrawal by Subject|3|||
162799766|NCT01747551|587976629|FG001|Overall Study|Withdrawal by Subject|1|||
162799767|NCT01747551|587976628|FG000|Overall Study|Physician Decision|2|||
162799768|NCT01747551|587976629|FG001|Overall Study|Physician Decision|1|||
162799769|NCT01747551|587976628|FG000|Overall Study|Other|2|||
162799770|NCT01747551|587976629|FG001|Overall Study|Other|0|||
162799771|NCT01609062|587976630|FG000|Extension Phase|Terminated by Sponsor|14|||
162799772|NCT01609062|587976631|FG001|Extension Phase|Terminated by Sponsor|9|||
162799773|NCT01609062|587976630|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
162799774|NCT01609062|587976631|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
162799775|NCT01609062|587976630|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
162799776|NCT01609062|587976631|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
162799777|NCT00680992|587976632|FG000|Overall Study|Complete Resection (as per protocol)|25|||
162799778|NCT00680992|587976633|FG001|Overall Study|Complete Resection (as per protocol)|121|||
162799779|NCT00680992|587976634|FG002|Overall Study|Complete Resection (as per protocol)|0|||
162799780|NCT00680992|587976632|FG000|Overall Study|Administrative Decision|83|||
162799781|NCT00680992|587976633|FG001|Overall Study|Administrative Decision|42|||
162799782|NCT00680992|587976634|FG002|Overall Study|Administrative Decision|5|||
162799783|NCT00680992|587976632|FG000|Overall Study|End of Trial|32|||
162799784|NCT00680992|587976633|FG001|Overall Study|End of Trial|12|||
162799785|NCT00680992|587976634|FG002|Overall Study|End of Trial|3|||
162799786|NCT00680992|587976632|FG000|Overall Study|Withdrawal by Subject|33|||
162799787|NCT00680992|587976633|FG001|Overall Study|Withdrawal by Subject|11|||
162799788|NCT00680992|587976634|FG002|Overall Study|Withdrawal by Subject|1|||
162799789|NCT00680992|587976632|FG000|Overall Study|Adverse Event|21|||
162799790|NCT00680992|587976633|FG001|Overall Study|Adverse Event|19|||
162799791|NCT00680992|587976634|FG002|Overall Study|Adverse Event|1|||
162799792|NCT00680992|587976632|FG000|Overall Study|Other|19|||
162799793|NCT00680992|587976633|FG001|Overall Study|Other|14|||
162799794|NCT00680992|587976634|FG002|Overall Study|Other|1|||
162799795|NCT00680992|587976632|FG000|Overall Study|Disease Progression|21|||
162799796|NCT00680992|587976633|FG001|Overall Study|Disease Progression|9|||
162799797|NCT00680992|587976634|FG002|Overall Study|Disease Progression|0|||
162799798|NCT00680992|587976632|FG000|Overall Study|Lost to Follow-up|12|||
162799799|NCT00680992|587976633|FG001|Overall Study|Lost to Follow-up|14|||
162799800|NCT00680992|587976634|FG002|Overall Study|Lost to Follow-up|0|||
162799801|NCT00680992|587976632|FG000|Overall Study|Noncompliance|4|||
162799802|NCT00680992|587976633|FG001|Overall Study|Noncompliance|6|||
162799803|NCT00680992|587976634|FG002|Overall Study|Noncompliance|0|||
162799804|NCT00680992|587976632|FG000|Overall Study|Requirement for Alternative Therapy|8|||
162799805|NCT00680992|587976633|FG001|Overall Study|Requirement for Alternative Therapy|2|||
162799806|NCT00680992|587976634|FG002|Overall Study|Requirement for Alternative Therapy|0|||
162799807|NCT00680992|587976632|FG000|Overall Study|Pregnancy|5|||
162799808|NCT00680992|587976633|FG001|Overall Study|Pregnancy|0|||
162799809|NCT00680992|587976634|FG002|Overall Study|Pregnancy|1|||
162799810|NCT00680992|587976632|FG000|Overall Study|Death|5|||
162799811|NCT00680992|587976633|FG001|Overall Study|Death|1|||
162799812|NCT00680992|587976634|FG002|Overall Study|Death|0|||
162799813|NCT00680992|587976632|FG000|Overall Study|Ineligibility Determined|0|||
162799814|NCT00680992|587976633|FG001|Overall Study|Ineligibility Determined|1|||
162799815|NCT00680992|587976634|FG002|Overall Study|Ineligibility Determined|0|||
162799816|NCT03842358|587976639|FG000|Overall Study|Poor DOT probe contact with breast|2|||
162799817|NCT03842358|587976639|FG000|Overall Study|DOT system problem|1|||
162799818|NCT03842358|587976639|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
162799819|NCT03842358|587976639|FG000|Overall Study|No biopsy after physician review|4|||
162799820|NCT03842358|587976639|FG000|Overall Study|Patient withdrew|2|||
162799821|NCT05384938|587976640|FG000|Overall Study|Withdrawal by Subject|8|||
162799822|NCT05384938|587976640|FG000|Overall Study|Lost to Follow-up|6|||
162799823|NCT05384938|587976640|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
162799824|NCT02626455|587976641|FG000|Overall Study|Other|1|||
162799825|NCT02626455|587976642|FG001|Overall Study|Other|1|||
162799826|NCT02626455|587976643|FG002|Overall Study|Other|0|||
162799827|NCT02626455|587976644|FG003|Overall Study|Other|0|||
162799828|NCT02626455|587976645|FG004|Overall Study|Other|0|||
162799829|NCT02626455|587976646|FG005|Overall Study|Other|17|||
162799830|NCT02626455|587976647|FG006|Overall Study|Other|23|||
162799831|NCT02626455|587976641|FG000|Overall Study|Withdrawal by Subject|1|||
162799832|NCT02626455|587976642|FG001|Overall Study|Withdrawal by Subject|0|||
162799833|NCT02626455|587976643|FG002|Overall Study|Withdrawal by Subject|0|||
162799834|NCT02626455|587976644|FG003|Overall Study|Withdrawal by Subject|0|||
162799835|NCT02626455|587976645|FG004|Overall Study|Withdrawal by Subject|0|||
162799836|NCT02626455|587976646|FG005|Overall Study|Withdrawal by Subject|10|||
162799837|NCT02626455|587976647|FG006|Overall Study|Withdrawal by Subject|6|||
162799838|NCT02626455|587976641|FG000|Overall Study|Physician Decision|0|||
162799839|NCT02626455|587976642|FG001|Overall Study|Physician Decision|2|||
162799840|NCT02626455|587976643|FG002|Overall Study|Physician Decision|2|||
162799841|NCT02626455|587976644|FG003|Overall Study|Physician Decision|2|||
162799842|NCT02626455|587976645|FG004|Overall Study|Physician Decision|1|||
162799843|NCT02626455|587976646|FG005|Overall Study|Physician Decision|10|||
162799844|NCT02626455|587976647|FG006|Overall Study|Physician Decision|3|||
162799845|NCT02626455|587976641|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799846|NCT02626455|587976642|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799847|NCT02626455|587976643|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799848|NCT02626455|587976644|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799849|NCT02626455|587976645|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799850|NCT02626455|587976646|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162799851|NCT02626455|587976647|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
162799852|NCT02626455|587976641|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799853|NCT02626455|587976642|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799854|NCT02626455|587976643|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799855|NCT02626455|587976644|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799856|NCT02626455|587976645|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799857|NCT02626455|587976646|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162799858|NCT02626455|587976647|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
162799859|NCT02626455|587976641|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162799860|NCT02626455|587976642|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162799861|NCT02626455|587976643|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162799862|NCT02626455|587976644|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162799863|NCT02626455|587976645|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162799864|NCT02626455|587976646|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
162799865|NCT02626455|587976647|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
162799866|NCT02626455|587976641|FG000|Overall Study|Patient decision|0|||
162799867|NCT02626455|587976642|FG001|Overall Study|Patient decision|1|||
162799868|NCT02626455|587976643|FG002|Overall Study|Patient decision|0|||
162799869|NCT02626455|587976644|FG003|Overall Study|Patient decision|0|||
162799870|NCT02626455|587976645|FG004|Overall Study|Patient decision|1|||
162799871|NCT02626455|587976646|FG005|Overall Study|Patient decision|36|||
162799872|NCT02626455|587976647|FG006|Overall Study|Patient decision|22|||
162799873|NCT02626455|587976641|FG000|Overall Study|Protocol Violation|0|||
162799874|NCT02626455|587976642|FG001|Overall Study|Protocol Violation|0|||
162799875|NCT02626455|587976643|FG002|Overall Study|Protocol Violation|0|||
162799876|NCT02626455|587976644|FG003|Overall Study|Protocol Violation|0|||
162799877|NCT02626455|587976645|FG004|Overall Study|Protocol Violation|0|||
162799878|NCT02626455|587976646|FG005|Overall Study|Protocol Violation|0|||
162799879|NCT02626455|587976647|FG006|Overall Study|Protocol Violation|1|||
162799880|NCT02626455|587976641|FG000|Overall Study|Progressive disease - radiological progression|0|||
162799881|NCT02626455|587976642|FG001|Overall Study|Progressive disease - radiological progression|0|||
162799882|NCT02626455|587976643|FG002|Overall Study|Progressive disease - radiological progression|0|||
162799883|NCT02626455|587976644|FG003|Overall Study|Progressive disease - radiological progression|0|||
162799884|NCT02626455|587976645|FG004|Overall Study|Progressive disease - radiological progression|0|||
162799885|NCT02626455|587976646|FG005|Overall Study|Progressive disease - radiological progression|11|||
162799886|NCT02626455|587976647|FG006|Overall Study|Progressive disease - radiological progression|22|||
162799887|NCT02626455|587976641|FG000|Overall Study|Progressive disease - clinical progression|0|||
162799888|NCT02626455|587976642|FG001|Overall Study|Progressive disease - clinical progression|0|||
162799889|NCT02626455|587976643|FG002|Overall Study|Progressive disease - clinical progression|0|||
162799890|NCT02626455|587976644|FG003|Overall Study|Progressive disease - clinical progression|0|||
162799891|NCT02626455|587976645|FG004|Overall Study|Progressive disease - clinical progression|0|||
162799892|NCT02626455|587976646|FG005|Overall Study|Progressive disease - clinical progression|1|||
162799893|NCT02626455|587976647|FG006|Overall Study|Progressive disease - clinical progression|2|||
162799894|NCT02626455|587976641|FG000|Overall Study|Lost to Follow-up|0|||
162799895|NCT02626455|587976642|FG001|Overall Study|Lost to Follow-up|0|||
162799896|NCT02626455|587976643|FG002|Overall Study|Lost to Follow-up|0|||
162799897|NCT02626455|587976644|FG003|Overall Study|Lost to Follow-up|0|||
162799898|NCT02626455|587976645|FG004|Overall Study|Lost to Follow-up|0|||
162799899|NCT02626455|587976646|FG005|Overall Study|Lost to Follow-up|1|||
162799900|NCT02626455|587976647|FG006|Overall Study|Lost to Follow-up|0|||
162799901|NCT02626455|587976641|FG000|Overall Study|AE not associated with clinical disease progression|1|||
162799902|NCT02626455|587976642|FG001|Overall Study|AE not associated with clinical disease progression|1|||
162799903|NCT02626455|587976643|FG002|Overall Study|AE not associated with clinical disease progression|0|||
162799904|NCT02626455|587976644|FG003|Overall Study|AE not associated with clinical disease progression|2|||
162799905|NCT02626455|587976645|FG004|Overall Study|AE not associated with clinical disease progression|1|||
162799906|NCT02626455|587976646|FG005|Overall Study|AE not associated with clinical disease progression|65|||
162799907|NCT02626455|587976647|FG006|Overall Study|AE not associated with clinical disease progression|21|||
162799908|NCT02626455|587976641|FG000|Overall Study|AE associated with clinical disease progression|0|||
162799909|NCT02626455|587976642|FG001|Overall Study|AE associated with clinical disease progression|0|||
162799910|NCT02626455|587976643|FG002|Overall Study|AE associated with clinical disease progression|0|||
162799911|NCT02626455|587976644|FG003|Overall Study|AE associated with clinical disease progression|0|||
162799912|NCT02626455|587976645|FG004|Overall Study|AE associated with clinical disease progression|0|||
162799913|NCT02626455|587976646|FG005|Overall Study|AE associated with clinical disease progression|1|||
162799914|NCT02626455|587976647|FG006|Overall Study|AE associated with clinical disease progression|2|||
162799915|NCT02626455|587976641|FG000|Overall Study|Study intervention never administered|0|||
162799916|NCT02626455|587976642|FG001|Overall Study|Study intervention never administered|0|||
162799917|NCT02626455|587976643|FG002|Overall Study|Study intervention never administered|0|||
162799918|NCT02626455|587976644|FG003|Overall Study|Study intervention never administered|0|||
162799919|NCT02626455|587976645|FG004|Overall Study|Study intervention never administered|0|||
162799920|NCT02626455|587976646|FG005|Overall Study|Study intervention never administered|1|||
162799921|NCT02626455|587976647|FG006|Overall Study|Study intervention never administered|3|||
162799922|NCT06665919|587976648|FG000|Overall Study|Withdrawal by Subject|4|||
162799923|NCT06665919|587976649|FG001|Overall Study|Withdrawal by Subject|4|||
162799924|NCT06665919|587976650|FG002|Overall Study|Withdrawal by Subject|4|||
162799925|NCT06665919|587976648|FG000|Overall Study|Non-compliance to Treatment|4|||
162799926|NCT06665919|587976649|FG001|Overall Study|Non-compliance to Treatment|1|||
162799927|NCT06665919|587976650|FG002|Overall Study|Non-compliance to Treatment|6|||
162799928|NCT06665919|587976648|FG000|Overall Study|Lost to Follow-up|3|||
162799929|NCT06665919|587976649|FG001|Overall Study|Lost to Follow-up|0|||
162799930|NCT06665919|587976650|FG002|Overall Study|Lost to Follow-up|2|||
162799931|NCT06665919|587976648|FG000|Overall Study|Physician Decision|4|||
162799932|NCT06665919|587976649|FG001|Overall Study|Physician Decision|0|||
162799933|NCT06665919|587976650|FG002|Overall Study|Physician Decision|1|||
162799934|NCT05148962|587976651|FG000|Overall Study|Withdrawal by Subject|1|||
162799935|NCT05148962|587976652|FG001|Overall Study|Withdrawal by Subject|1|||
162799936|NCT05148962|587976653|FG002|Overall Study|Withdrawal by Subject|0|||
162799937|NCT05148962|587976654|FG003|Overall Study|Withdrawal by Subject|1|||
162799938|NCT05148962|587976655|FG004|Overall Study|Withdrawal by Subject|0|||
162799939|NCT05148962|587976651|FG000|Overall Study|Participant was early terminated per protocol|0|||
162799940|NCT05148962|587976652|FG001|Overall Study|Participant was early terminated per protocol|0|||
162799941|NCT05148962|587976653|FG002|Overall Study|Participant was early terminated per protocol|3|||
162799942|NCT05148962|587976654|FG003|Overall Study|Participant was early terminated per protocol|5|||
162799943|NCT05148962|587976655|FG004|Overall Study|Participant was early terminated per protocol|2|||
162799944|NCT05148962|587976651|FG000|Overall Study|Miscellaneous|0|||
162799945|NCT05148962|587976652|FG001|Overall Study|Miscellaneous|0|||
162799946|NCT05148962|587976653|FG002|Overall Study|Miscellaneous|0|||
162799947|NCT05148962|587976654|FG003|Overall Study|Miscellaneous|1|||
162799948|NCT05148962|587976655|FG004|Overall Study|Miscellaneous|0|||
162799949|NCT01200290|587976657|FG000|Treatment Period|Adverse Event|1|||
162799950|NCT01200290|587976657|FG000|Post-Treatment Follow-Up Period|Death|2|||
162799951|NCT01525238|587976658|FG000|Overall Study|Withdrawal by Subject|1|||
162799952|NCT01525238|587976659|FG001|Overall Study|Withdrawal by Subject|0|||
162799953|NCT01525238|587976660|FG002|Overall Study|Withdrawal by Subject|0|||
162799954|NCT00607724|587976661|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
162799955|NCT00607724|587976662|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
162799956|NCT00607724|587976663|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
162799957|NCT00607724|587976664|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162799958|NCT00607724|587976665|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162799959|NCT00607724|587976666|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162799960|NCT00607724|587976667|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162799961|NCT00607724|587976661|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
162799962|NCT00607724|587976662|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
162799963|NCT00607724|587976663|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
162799964|NCT00607724|587976664|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
162799965|NCT00607724|587976665|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
162799966|NCT00607724|587976666|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
162799967|NCT00607724|587976667|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
162799968|NCT00607724|587976661|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162799969|NCT00607724|587976662|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162799970|NCT00607724|587976663|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162799971|NCT00607724|587976664|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
162799972|NCT00607724|587976665|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
162799973|NCT00607724|587976666|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
162799974|NCT00607724|587976667|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
162799975|NCT00607724|587976661|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
162799976|NCT00607724|587976662|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
162799977|NCT00607724|587976663|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
162799978|NCT00607724|587976664|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
162799979|NCT00607724|587976665|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
162799980|NCT00607724|587976666|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
162799981|NCT00607724|587976667|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
162799982|NCT00607724|587976661|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799983|NCT00607724|587976662|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799984|NCT00607724|587976663|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799985|NCT00607724|587976664|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
162799986|NCT00607724|587976665|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799987|NCT00607724|587976666|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799988|NCT00607724|587976667|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162799989|NCT04047862|587976677|FG000|Overall Study|Death|0|||
162799990|NCT04047862|587976678|FG001|Overall Study|Death|0|||
162799991|NCT04047862|587976679|FG002|Overall Study|Death|4|||
162799992|NCT04047862|587976680|FG003|Overall Study|Death|7|||
162799993|NCT04047862|587976681|FG004|Overall Study|Death|2|||
162799994|NCT04047862|587976682|FG005|Overall Study|Death|4|||
162799995|NCT04047862|587976683|FG006|Overall Study|Death|3|||
162799996|NCT04047862|587976684|FG007|Overall Study|Death|24|||
162799997|NCT04047862|587976685|FG008|Overall Study|Death|24|||
162799998|NCT04047862|587976686|FG009|Overall Study|Death|22|||
162799999|NCT04047862|587976687|FG010|Overall Study|Death|35|||
162800000|NCT04047862|587976688|FG011|Overall Study|Death|18|||
162800001|NCT04047862|587976689|FG012|Overall Study|Death|14|||
162800002|NCT04047862|587976690|FG013|Overall Study|Death|6|||
162800003|NCT04047862|587976691|FG014|Overall Study|Death|19|||
162800004|NCT04047862|587976692|FG015|Overall Study|Death|42|||
162800005|NCT04047862|587976693|FG016|Overall Study|Death|9|||
162800006|NCT04047862|587976694|FG017|Overall Study|Death|8|||
162800007|NCT04047862|587976695|FG018|Overall Study|Death|10|||
162800008|NCT04047862|587976677|FG000|Overall Study|Withdrawal by Subject|0|||
162800009|NCT04047862|587976678|FG001|Overall Study|Withdrawal by Subject|0|||
162800010|NCT04047862|587976679|FG002|Overall Study|Withdrawal by Subject|0|||
162800011|NCT04047862|587976680|FG003|Overall Study|Withdrawal by Subject|5|||
162800012|NCT04047862|587976681|FG004|Overall Study|Withdrawal by Subject|2|||
162800013|NCT04047862|587976682|FG005|Overall Study|Withdrawal by Subject|0|||
162800014|NCT04047862|587976683|FG006|Overall Study|Withdrawal by Subject|1|||
162800015|NCT04047862|587976684|FG007|Overall Study|Withdrawal by Subject|0|||
162800016|NCT04047862|587976685|FG008|Overall Study|Withdrawal by Subject|4|||
162800017|NCT04047862|587976686|FG009|Overall Study|Withdrawal by Subject|4|||
162800018|NCT04047862|587976687|FG010|Overall Study|Withdrawal by Subject|4|||
162800019|NCT04047862|587976688|FG011|Overall Study|Withdrawal by Subject|2|||
162800020|NCT04047862|587976689|FG012|Overall Study|Withdrawal by Subject|3|||
162800021|NCT04047862|587976690|FG013|Overall Study|Withdrawal by Subject|0|||
162800022|NCT04047862|587976691|FG014|Overall Study|Withdrawal by Subject|9|||
162800023|NCT04047862|587976692|FG015|Overall Study|Withdrawal by Subject|5|||
162800024|NCT04047862|587976693|FG016|Overall Study|Withdrawal by Subject|1|||
162800025|NCT04047862|587976694|FG017|Overall Study|Withdrawal by Subject|3|||
162800026|NCT04047862|587976695|FG018|Overall Study|Withdrawal by Subject|1|||
162800027|NCT04047862|587976677|FG000|Overall Study|Lost to Follow-up|0|||
162800028|NCT04047862|587976678|FG001|Overall Study|Lost to Follow-up|0|||
162800029|NCT04047862|587976679|FG002|Overall Study|Lost to Follow-up|1|||
162800030|NCT04047862|587976680|FG003|Overall Study|Lost to Follow-up|0|||
162800031|NCT04047862|587976681|FG004|Overall Study|Lost to Follow-up|0|||
162800032|NCT04047862|587976682|FG005|Overall Study|Lost to Follow-up|0|||
162800033|NCT04047862|587976683|FG006|Overall Study|Lost to Follow-up|0|||
162800034|NCT04047862|587976684|FG007|Overall Study|Lost to Follow-up|1|||
162800035|NCT04047862|587976685|FG008|Overall Study|Lost to Follow-up|0|||
162800036|NCT04047862|587976686|FG009|Overall Study|Lost to Follow-up|1|||
162800037|NCT04047862|587976687|FG010|Overall Study|Lost to Follow-up|0|||
162800038|NCT04047862|587976688|FG011|Overall Study|Lost to Follow-up|3|||
162800039|NCT04047862|587976689|FG012|Overall Study|Lost to Follow-up|0|||
162800040|NCT04047862|587976690|FG013|Overall Study|Lost to Follow-up|0|||
162800041|NCT04047862|587976691|FG014|Overall Study|Lost to Follow-up|2|||
162800042|NCT04047862|587976692|FG015|Overall Study|Lost to Follow-up|2|||
162800043|NCT04047862|587976693|FG016|Overall Study|Lost to Follow-up|1|||
162800044|NCT04047862|587976694|FG017|Overall Study|Lost to Follow-up|0|||
162800045|NCT04047862|587976695|FG018|Overall Study|Lost to Follow-up|0|||
162800046|NCT04047862|587976677|FG000|Overall Study|Physician Decision|0|||
162800047|NCT04047862|587976678|FG001|Overall Study|Physician Decision|0|||
162800048|NCT04047862|587976679|FG002|Overall Study|Physician Decision|0|||
162800049|NCT04047862|587976680|FG003|Overall Study|Physician Decision|1|||
162800050|NCT04047862|587976681|FG004|Overall Study|Physician Decision|0|||
162800051|NCT04047862|587976682|FG005|Overall Study|Physician Decision|0|||
162800052|NCT04047862|587976683|FG006|Overall Study|Physician Decision|0|||
162800053|NCT04047862|587976684|FG007|Overall Study|Physician Decision|0|||
162800054|NCT04047862|587976685|FG008|Overall Study|Physician Decision|0|||
162800055|NCT04047862|587976686|FG009|Overall Study|Physician Decision|0|||
162800056|NCT04047862|587976687|FG010|Overall Study|Physician Decision|0|||
162800057|NCT04047862|587976688|FG011|Overall Study|Physician Decision|0|||
162800058|NCT04047862|587976689|FG012|Overall Study|Physician Decision|0|||
162800059|NCT04047862|587976690|FG013|Overall Study|Physician Decision|0|||
162800060|NCT04047862|587976691|FG014|Overall Study|Physician Decision|1|||
162800061|NCT04047862|587976692|FG015|Overall Study|Physician Decision|0|||
162800062|NCT04047862|587976693|FG016|Overall Study|Physician Decision|1|||
162800063|NCT04047862|587976694|FG017|Overall Study|Physician Decision|0|||
162800064|NCT04047862|587976695|FG018|Overall Study|Physician Decision|0|||
162800065|NCT04047862|587976677|FG000|Overall Study|Completed all Assessments|1|||
162800066|NCT04047862|587976678|FG001|Overall Study|Completed all Assessments|3|||
162800067|NCT04047862|587976679|FG002|Overall Study|Completed all Assessments|1|||
162800068|NCT04047862|587976680|FG003|Overall Study|Completed all Assessments|3|||
162800069|NCT04047862|587976681|FG004|Overall Study|Completed all Assessments|2|||
162800070|NCT04047862|587976682|FG005|Overall Study|Completed all Assessments|5|||
162800071|NCT04047862|587976683|FG006|Overall Study|Completed all Assessments|7|||
162800072|NCT04047862|587976684|FG007|Overall Study|Completed all Assessments|0|||
162800073|NCT04047862|587976685|FG008|Overall Study|Completed all Assessments|0|||
162800074|NCT04047862|587976686|FG009|Overall Study|Completed all Assessments|0|||
162800075|NCT04047862|587976687|FG010|Overall Study|Completed all Assessments|0|||
162800076|NCT04047862|587976688|FG011|Overall Study|Completed all Assessments|0|||
162800077|NCT04047862|587976689|FG012|Overall Study|Completed all Assessments|0|||
162800078|NCT04047862|587976690|FG013|Overall Study|Completed all Assessments|0|||
162800079|NCT04047862|587976691|FG014|Overall Study|Completed all Assessments|0|||
162800080|NCT04047862|587976692|FG015|Overall Study|Completed all Assessments|0|||
162800081|NCT04047862|587976693|FG016|Overall Study|Completed all Assessments|0|||
162800082|NCT04047862|587976694|FG017|Overall Study|Completed all Assessments|0|||
162800083|NCT04047862|587976695|FG018|Overall Study|Completed all Assessments|0|||
162800084|NCT04047862|587976677|FG000|Overall Study|Sponsor Decision|0|||
162800085|NCT04047862|587976678|FG001|Overall Study|Sponsor Decision|0|||
162800086|NCT04047862|587976679|FG002|Overall Study|Sponsor Decision|0|||
162800087|NCT04047862|587976680|FG003|Overall Study|Sponsor Decision|0|||
162800088|NCT04047862|587976681|FG004|Overall Study|Sponsor Decision|0|||
162800089|NCT04047862|587976682|FG005|Overall Study|Sponsor Decision|0|||
162800090|NCT04047862|587976683|FG006|Overall Study|Sponsor Decision|0|||
162800091|NCT04047862|587976684|FG007|Overall Study|Sponsor Decision|13|||
162800092|NCT04047862|587976685|FG008|Overall Study|Sponsor Decision|10|||
162800093|NCT04047862|587976686|FG009|Overall Study|Sponsor Decision|18|||
162800094|NCT04047862|587976687|FG010|Overall Study|Sponsor Decision|3|||
162800095|NCT04047862|587976688|FG011|Overall Study|Sponsor Decision|3|||
162800096|NCT04047862|587976689|FG012|Overall Study|Sponsor Decision|4|||
162800097|NCT04047862|587976690|FG013|Overall Study|Sponsor Decision|0|||
162800098|NCT04047862|587976691|FG014|Overall Study|Sponsor Decision|7|||
162800099|NCT04047862|587976692|FG015|Overall Study|Sponsor Decision|8|||
162800100|NCT04047862|587976693|FG016|Overall Study|Sponsor Decision|9|||
162800101|NCT04047862|587976694|FG017|Overall Study|Sponsor Decision|7|||
162800102|NCT04047862|587976695|FG018|Overall Study|Sponsor Decision|8|||
162800103|NCT04047862|587976677|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800104|NCT04047862|587976678|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800105|NCT04047862|587976679|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800106|NCT04047862|587976680|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800107|NCT04047862|587976681|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800108|NCT04047862|587976682|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800109|NCT04047862|587976683|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800110|NCT04047862|587976684|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
162800111|NCT04047862|587976685|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
162800112|NCT04047862|587976686|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800113|NCT04047862|587976687|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162800114|NCT04047862|587976688|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800115|NCT04047862|587976689|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800116|NCT04047862|587976690|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162800117|NCT04047862|587976691|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162800118|NCT04047862|587976692|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162800119|NCT04047862|587976693|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162800120|NCT04047862|587976694|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162800121|NCT04047862|587976695|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162800122|NCT04047862|587976677|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800123|NCT04047862|587976678|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800124|NCT04047862|587976679|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800125|NCT04047862|587976680|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800126|NCT04047862|587976681|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800127|NCT04047862|587976682|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800128|NCT04047862|587976683|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800129|NCT04047862|587976684|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800130|NCT04047862|587976685|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800131|NCT04047862|587976686|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800132|NCT04047862|587976687|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800133|NCT04047862|587976688|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800134|NCT04047862|587976689|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800135|NCT04047862|587976690|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800136|NCT04047862|587976691|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800137|NCT04047862|587976692|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
162800138|NCT04047862|587976693|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800139|NCT04047862|587976694|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162800140|NCT04047862|587976695|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
162800141|NCT04047862|587976677|FG000|Overall Study|Other|0|||
162800142|NCT04047862|587976678|FG001|Overall Study|Other|0|||
162800143|NCT04047862|587976679|FG002|Overall Study|Other|0|||
162800144|NCT04047862|587976680|FG003|Overall Study|Other|0|||
162800145|NCT04047862|587976681|FG004|Overall Study|Other|0|||
162800146|NCT04047862|587976682|FG005|Overall Study|Other|0|||
162800147|NCT04047862|587976683|FG006|Overall Study|Other|0|||
162800148|NCT04047862|587976684|FG007|Overall Study|Other|0|||
162800149|NCT04047862|587976685|FG008|Overall Study|Other|0|||
162800150|NCT04047862|587976686|FG009|Overall Study|Other|0|||
162800151|NCT04047862|587976687|FG010|Overall Study|Other|0|||
162800152|NCT04047862|587976688|FG011|Overall Study|Other|0|||
162800153|NCT04047862|587976689|FG012|Overall Study|Other|0|||
162800154|NCT04047862|587976690|FG013|Overall Study|Other|0|||
162800155|NCT04047862|587976691|FG014|Overall Study|Other|2|||
162800156|NCT04047862|587976692|FG015|Overall Study|Other|1|||
162800157|NCT04047862|587976693|FG016|Overall Study|Other|1|||
162800158|NCT04047862|587976694|FG017|Overall Study|Other|1|||
162800159|NCT04047862|587976695|FG018|Overall Study|Other|0|||
162800160|NCT04349631|587976700|FG000|Overall Study|Lost to Follow-up|3|||
162800161|NCT04349631|587976700|FG000|Overall Study|Withdrawal by Subject|7|||
162800162|NCT00775463|587978509|FG000|Overall Study|Withdrawal by Subject|0|||
162800163|NCT00775463|587978510|FG001|Overall Study|Withdrawal by Subject|1|||
162800164|NCT00775463|587978509|FG000|Overall Study|Adverse Event|7|||
162800165|NCT00775463|587978510|FG001|Overall Study|Adverse Event|9|||
162800166|NCT00775463|587978509|FG000|Overall Study|Protocol Violation|2|||
162800167|NCT00775463|587978510|FG001|Overall Study|Protocol Violation|2|||
162800168|NCT00775463|587978509|FG000|Overall Study|Lost to Follow-up|1|||
162800169|NCT00775463|587978510|FG001|Overall Study|Lost to Follow-up|0|||
162800170|NCT00775463|587978509|FG000|Overall Study|Lack of Efficacy|1|||
162800171|NCT00775463|587978510|FG001|Overall Study|Lack of Efficacy|1|||
162800172|NCT01789567|587978511|FG000|Overall Study|Death|6|||
162800173|NCT01994837|587978512|FG000|Overall Study|Progressive disease per protocol|23|||
162800174|NCT01994837|587978512|FG000|Overall Study|Adv event related to progressive disease|3|||
162800175|NCT01994837|587978512|FG000|Overall Study|Fatal progressive disease|2|||
162800176|NCT01994837|587978512|FG000|Overall Study|Adverse event not related to progression|1|||
162800177|NCT01994837|587978512|FG000|Overall Study|Chose palliative care|1|||
162800178|NCT01994837|587978512|FG000|Overall Study|Proceeded to transplant|1|||
162800179|NCT01994837|587978512|FG000|Overall Study|Removed from study due to no response|1|||
162800180|NCT03900416|587978514|FG000|Six Week Follow-up|Lost to Follow-up|1|||
162800181|NCT03900416|587978515|FG001|Six Week Follow-up|Lost to Follow-up|0|||
162800182|NCT03900416|587978514|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
162800183|NCT03900416|587978515|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
162800184|NCT03900416|587978514|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
162800185|NCT03900416|587978515|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
162800186|NCT03900416|587978514|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
162800187|NCT03900416|587978515|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
162800188|NCT03900416|587978514|FG000|Twelve Week Follow-up|Adverse Event|1|||
162800189|NCT03900416|587978515|FG001|Twelve Week Follow-up|Adverse Event|1|||
162800190|NCT03900416|587978514|FG000|Six Month Follow-up|Lost to Follow-up|4|||
162800191|NCT03900416|587978515|FG001|Six Month Follow-up|Lost to Follow-up|3|||
162800192|NCT03900416|587978514|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
162800193|NCT03900416|587978515|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
162800194|NCT03207451|587978518|FG000|Overall Study|scheduling conflict|1|||
162800195|NCT03207451|587978519|FG001|Overall Study|scheduling conflict|0|||
162800196|NCT03207451|587978520|FG002|Overall Study|scheduling conflict|2|||
162800197|NCT03207451|587978521|FG003|Overall Study|scheduling conflict|2|||
162800198|NCT03207451|587978518|FG000|Overall Study|Adverse Event|0|||
162800199|NCT03207451|587978519|FG001|Overall Study|Adverse Event|0|||
162800200|NCT03207451|587978520|FG002|Overall Study|Adverse Event|0|||
162800201|NCT03207451|587978521|FG003|Overall Study|Adverse Event|1|||
162800202|NCT00436852|587978522|FG000|Overall Study|Death|23|||
162800203|NCT00436852|587978523|FG001|Overall Study|Death|34|||
162800204|NCT00436852|587978522|FG000|Overall Study|Lack of Efficacy|9|||
162800205|NCT00436852|587978523|FG001|Overall Study|Lack of Efficacy|7|||
162800206|NCT00436852|587978522|FG000|Overall Study|Withdrawal by Subject|2|||
162800207|NCT00436852|587978523|FG001|Overall Study|Withdrawal by Subject|4|||
162800208|NCT00436852|587978522|FG000|Overall Study|Ineligible|1|||
162800209|NCT00436852|587978523|FG001|Overall Study|Ineligible|0|||
162800210|NCT00370682|587978524|FG000|Overall Study|Moved from area|0|||
162800211|NCT00370682|587978525|FG001|Overall Study|Moved from area|2|||
162800212|NCT00370682|587978526|FG002|Overall Study|Moved from area|0|||
162800213|NCT00370682|587978524|FG000|Overall Study|Lost to Follow-up|0|||
162800214|NCT00370682|587978525|FG001|Overall Study|Lost to Follow-up|1|||
162800215|NCT00370682|587978526|FG002|Overall Study|Lost to Follow-up|1|||
162800216|NCT03167359|587978527|FG000|Overall Study|Physician Decision|1|||
162800217|NCT03167359|587978527|FG000|Overall Study|Lost to Follow-up|1|||
162800218|NCT03339583|587978528|FG000|First Intervention (14 Days)|Adverse Event|1|||
162800219|NCT03339583|587978529|FG001|First Intervention (14 Days)|Adverse Event|0|||
162800220|NCT03339583|587978528|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
162800221|NCT03339583|587978529|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
162800222|NCT03339583|587978528|FG000|Second Intervention (14 Days)|Adverse Event|0|||
162800223|NCT03339583|587978529|FG001|Second Intervention (14 Days)|Adverse Event|1|||
162800224|NCT03339583|587978528|FG000|Follow-up (14 Days)|Physician Decision|6|||
162800225|NCT03339583|587978529|FG001|Follow-up (14 Days)|Physician Decision|3|||
162800226|NCT02141620|587978530|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
162800227|NCT02141620|587978531|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
162800228|NCT03651622|587978532|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
162800229|NCT03651622|587978533|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
162800230|NCT03651622|587978534|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
162800231|NCT03651622|587978532|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
162800232|NCT03651622|587978533|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
162800233|NCT03651622|587978534|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
162800234|NCT03651622|587978532|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
162800235|NCT03651622|587978533|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
162800236|NCT03651622|587978534|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
162800237|NCT03651622|587978532|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
162800238|NCT03651622|587978533|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
162800239|NCT03651622|587978534|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
162800240|NCT03651622|587978532|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
162800241|NCT03651622|587978533|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
162800242|NCT03651622|587978534|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
162800243|NCT01519089|587978535|FG000|Overall Study|Adverse Event|4|||
162800244|NCT01519089|587978536|FG001|Overall Study|Adverse Event|4|||
162800245|NCT01519089|587978535|FG000|Overall Study|Lack of Efficacy|0|||
162800246|NCT01519089|587978536|FG001|Overall Study|Lack of Efficacy|2|||
162800247|NCT01519089|587978535|FG000|Overall Study|Lost to Follow-up|1|||
162800248|NCT01519089|587978536|FG001|Overall Study|Lost to Follow-up|0|||
162800249|NCT01519089|587978535|FG000|Overall Study|Withdrawal by Subject|0|||
162800250|NCT01519089|587978536|FG001|Overall Study|Withdrawal by Subject|2|||
162800251|NCT01519089|587978535|FG000|Overall Study|Other|2|||
162800252|NCT01519089|587978536|FG001|Overall Study|Other|6|||
162800253|NCT01519089|587978535|FG000|Overall Study|Not received study drug|0|||
162800254|NCT01519089|587978536|FG001|Overall Study|Not received study drug|1|||
162800255|NCT00307684|587978537|FG000|Open Label Phase|Lack of Efficacy|0|||
162800256|NCT00307684|587978538|FG001|Open Label Phase|Lack of Efficacy|0|||
162800257|NCT00307684|587978539|FG002|Open Label Phase|Lack of Efficacy|3|||
162800258|NCT00307684|587978537|FG000|Open Label Phase|Adverse Event|0|||
162800259|NCT00307684|587978538|FG001|Open Label Phase|Adverse Event|0|||
162800260|NCT00307684|587978539|FG002|Open Label Phase|Adverse Event|16|||
162800261|NCT00307684|587978537|FG000|Open Label Phase|Withdrawal by Subject|0|||
162800262|NCT00307684|587978538|FG001|Open Label Phase|Withdrawal by Subject|0|||
162800263|NCT00307684|587978539|FG002|Open Label Phase|Withdrawal by Subject|15|||
162800264|NCT00307684|587978537|FG000|Open Label Phase|Lost to Follow-up|0|||
162800265|NCT00307684|587978538|FG001|Open Label Phase|Lost to Follow-up|0|||
162800266|NCT00307684|587978539|FG002|Open Label Phase|Lost to Follow-up|11|||
162800267|NCT00307684|587978537|FG000|Open Label Phase|non compliance|0|||
162800268|NCT00307684|587978538|FG001|Open Label Phase|non compliance|0|||
162800269|NCT00307684|587978539|FG002|Open Label Phase|non compliance|5|||
162800270|NCT00307684|587978537|FG000|Open Label Phase|other|0|||
162800271|NCT00307684|587978538|FG001|Open Label Phase|other|0|||
162800272|NCT00307684|587978539|FG002|Open Label Phase|other|6|||
162800273|NCT00307684|587978537|FG000|Double Blind Phase|Lack of Efficacy|2|||
162800274|NCT00307684|587978538|FG001|Double Blind Phase|Lack of Efficacy|5|||
162800275|NCT00307684|587978539|FG002|Double Blind Phase|Lack of Efficacy|0|||
162800276|NCT00730275|587978540|FG000|Overall Study|Withdrawal by Subject|0|||
162800277|NCT00730275|587978541|FG001|Overall Study|Withdrawal by Subject|0|||
162800278|NCT00730275|587978542|FG002|Overall Study|Withdrawal by Subject|0|||
162800279|NCT00730275|587978543|FG003|Overall Study|Withdrawal by Subject|1|||
162800280|NCT00356408|587978544|FG000|Overall Study|Adverse Event|9|||
162800281|NCT00356408|587978544|FG000|Overall Study|Lack of Efficacy|36|||
162800282|NCT00356408|587978544|FG000|Overall Study|Lost to Follow-up|2|||
162800283|NCT00356408|587978544|FG000|Overall Study|Withdrawal by Subject|6|||
162800284|NCT00356408|587978544|FG000|Overall Study|Other: Principal investigator discretion|3|||
162800285|NCT00356408|587978544|FG000|Overall Study|Other: Sponsor request|1|||
162800286|NCT00356408|587978544|FG000|Overall Study|Other: Azathioprine stopped|1|||
162800287|NCT00356408|587978544|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
162800288|NCT00356408|587978544|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
162800289|NCT04032613|587978545|FG000|Overall Study|Did not complete post-program assessment|5|||
162800290|NCT04032613|587978546|FG001|Overall Study|Did not complete post-program assessment|2|||
162800291|NCT01659853|587978549|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
162800292|NCT01659853|587978550|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
162800293|NCT01659853|587978549|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
162800294|NCT01659853|587978550|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
162800295|NCT05487586|587978553|FG000|Overall Study|Death|22|||
162800296|NCT05487586|587978553|FG000|Overall Study|Physician Decision|1|||
162800297|NCT05487586|587978553|FG000|Overall Study|Transfer to another hospital|4|||
162800298|NCT05487586|587978553|FG000|Overall Study|Other|1|||
162800299|NCT01744392|587978557|FG000|Overall Study|Physician Decision|1|||
162800300|NCT00299494|587978558|FG000|Overall Study|Withdrawal by Subject|0|||
162800301|NCT00299494|587978559|FG001|Overall Study|Withdrawal by Subject|0|||
162800302|NCT00299494|587978560|FG002|Overall Study|Withdrawal by Subject|0|||
162800303|NCT00299494|587978561|FG003|Overall Study|Withdrawal by Subject|3|||
162800304|NCT00299494|587978562|FG004|Overall Study|Withdrawal by Subject|1|||
162800305|NCT00299494|587978563|FG005|Overall Study|Withdrawal by Subject|4|||
162800306|NCT00299494|587978558|FG000|Overall Study|Physician Decision|0|||
162800307|NCT00299494|587978559|FG001|Overall Study|Physician Decision|0|||
162800308|NCT00299494|587978560|FG002|Overall Study|Physician Decision|0|||
162800309|NCT00299494|587978561|FG003|Overall Study|Physician Decision|0|||
162800310|NCT00299494|587978562|FG004|Overall Study|Physician Decision|1|||
162800311|NCT00299494|587978563|FG005|Overall Study|Physician Decision|0|||
162800312|NCT00299494|587978558|FG000|Overall Study|Death|3|||
162800313|NCT00299494|587978559|FG001|Overall Study|Death|1|||
162800314|NCT00299494|587978560|FG002|Overall Study|Death|4|||
162800315|NCT00299494|587978561|FG003|Overall Study|Death|6|||
162800316|NCT00299494|587978562|FG004|Overall Study|Death|18|||
162800317|NCT00299494|587978563|FG005|Overall Study|Death|19|||
162800318|NCT00299494|587978558|FG000|Overall Study|Lost to Follow-up|0|||
162800319|NCT00299494|587978559|FG001|Overall Study|Lost to Follow-up|0|||
162800320|NCT00299494|587978560|FG002|Overall Study|Lost to Follow-up|0|||
162800321|NCT00299494|587978561|FG003|Overall Study|Lost to Follow-up|0|||
162800322|NCT00299494|587978562|FG004|Overall Study|Lost to Follow-up|3|||
162800323|NCT00299494|587978563|FG005|Overall Study|Lost to Follow-up|1|||
162800324|NCT00299494|587978558|FG000|Overall Study|Other - Unspecified|0|||
162800325|NCT00299494|587978559|FG001|Overall Study|Other - Unspecified|0|||
162800326|NCT00299494|587978560|FG002|Overall Study|Other - Unspecified|0|||
162800327|NCT00299494|587978561|FG003|Overall Study|Other - Unspecified|0|||
162800328|NCT00299494|587978562|FG004|Overall Study|Other - Unspecified|3|||
162800329|NCT00299494|587978563|FG005|Overall Study|Other - Unspecified|1|||
162800330|NCT00299494|587978558|FG000|Overall Study|Other - site closure|0|||
162800331|NCT00299494|587978559|FG001|Overall Study|Other - site closure|0|||
162800332|NCT00299494|587978560|FG002|Overall Study|Other - site closure|0|||
162800333|NCT00299494|587978561|FG003|Overall Study|Other - site closure|1|||
162800334|NCT00299494|587978562|FG004|Overall Study|Other - site closure|1|||
162800335|NCT00299494|587978563|FG005|Overall Study|Other - site closure|1|||
162800336|NCT01417104|587978567|FG000|Overall Study|Withdrawal by Subject|5|||
162800337|NCT01417104|587978568|FG001|Overall Study|Withdrawal by Subject|1|||
162800338|NCT01417104|587978567|FG000|Overall Study|Failure to make contact|0|||
162800339|NCT01417104|587978568|FG001|Overall Study|Failure to make contact|1|||
162800340|NCT01417104|587978567|FG000|Overall Study|Adverse Event|1|||
162800341|NCT01417104|587978568|FG001|Overall Study|Adverse Event|0|||
162800342|NCT01365481|587978574|FG000|Overall Study|Adverse Event|6|||
162800343|NCT01365481|587978575|FG001|Overall Study|Adverse Event|9|||
162800344|NCT01365481|587978576|FG002|Overall Study|Adverse Event|0|||
162800345|NCT01365481|587978577|FG003|Overall Study|Adverse Event|2|||
162800346|NCT01365481|587978574|FG000|Overall Study|Withdrawal by Subject|0|||
162800347|NCT01365481|587978575|FG001|Overall Study|Withdrawal by Subject|2|||
162800348|NCT01365481|587978576|FG002|Overall Study|Withdrawal by Subject|1|||
162800349|NCT01365481|587978577|FG003|Overall Study|Withdrawal by Subject|1|||
162800350|NCT01365481|587978574|FG000|Overall Study|Lost to Follow-up|1|||
162800351|NCT01365481|587978575|FG001|Overall Study|Lost to Follow-up|1|||
162800352|NCT01365481|587978576|FG002|Overall Study|Lost to Follow-up|2|||
162800353|NCT01365481|587978577|FG003|Overall Study|Lost to Follow-up|3|||
162800354|NCT01365481|587978574|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162800355|NCT01365481|587978575|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162800356|NCT01365481|587978576|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162800357|NCT01365481|587978577|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162800358|NCT01365481|587978574|FG000|Overall Study|Administrative problems|0|||
162800359|NCT01365481|587978575|FG001|Overall Study|Administrative problems|1|||
162800360|NCT01365481|587978576|FG002|Overall Study|Administrative problems|0|||
162800361|NCT01365481|587978577|FG003|Overall Study|Administrative problems|0|||
162800362|NCT01365481|587978574|FG000|Overall Study|Protocol deviation|0|||
162800363|NCT01365481|587978575|FG001|Overall Study|Protocol deviation|1|||
162800364|NCT01365481|587978576|FG002|Overall Study|Protocol deviation|0|||
162800365|NCT01365481|587978577|FG003|Overall Study|Protocol deviation|1|||
162800366|NCT01365481|587978574|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162800367|NCT01365481|587978575|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162800368|NCT01365481|587978576|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
162800369|NCT01365481|587978577|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162800370|NCT00757627|587978578|FG000|Overall Study|Adverse Event|15|||
162800371|NCT00757627|587978578|FG000|Overall Study|Lack of Efficacy|10|||
162800372|NCT00757627|587978578|FG000|Overall Study|Lost to Follow-up|28|||
162800373|NCT00757627|587978578|FG000|Overall Study|Withdrawal by Subject|27|||
162800374|NCT00757627|587978578|FG000|Overall Study|Other|1|||
162800375|NCT00635661|587978583|FG000|Overall Study|Withdrawal by Subject|4|||
162800376|NCT00403767|587978589|FG000|Overall Study|Adverse Event|993|||
162800377|NCT00403767|587978590|FG001|Overall Study|Adverse Event|919|||
162800378|NCT00403767|587978589|FG000|Overall Study|Non-compliant with study medication|134|||
162800379|NCT00403767|587978590|FG001|Overall Study|Non-compliant with study medication|164|||
162800380|NCT00403767|587978589|FG000|Overall Study|Consent withdrawn|671|||
162800381|NCT00403767|587978590|FG001|Overall Study|Consent withdrawn|673|||
162800382|NCT00403767|587978589|FG000|Overall Study|Investigator dec./not protocol-related|191|||
162800383|NCT00403767|587978590|FG001|Overall Study|Investigator dec./not protocol-related|178|||
162800384|NCT00403767|587978589|FG000|Overall Study|Lost to Follow-up|6|||
162800385|NCT00403767|587978590|FG001|Overall Study|Lost to Follow-up|8|||
162800386|NCT00403767|587978589|FG000|Overall Study|Protocol Violation|142|||
162800387|NCT00403767|587978590|FG001|Overall Study|Protocol Violation|124|||
162800388|NCT00403767|587978589|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
162800389|NCT00403767|587978590|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
162800390|NCT00403767|587978589|FG000|Overall Study|Study terminated by sponsor|82|||
162800391|NCT00403767|587978590|FG001|Overall Study|Study terminated by sponsor|69|||
162800392|NCT00403767|587978589|FG000|Overall Study|Missing/incomplete data|1|||
162800393|NCT00403767|587978590|FG001|Overall Study|Missing/incomplete data|1|||
162800394|NCT02755818|587978591|FG000|Overall Study|Withdrawal by Subject|0|||
162800395|NCT02755818|587978592|FG001|Overall Study|Withdrawal by Subject|0|||
162800396|NCT02755818|587978593|FG002|Overall Study|Withdrawal by Subject|0|||
162800397|NCT02755818|587978594|FG003|Overall Study|Withdrawal by Subject|2|||
162800398|NCT02755818|587978591|FG000|Overall Study|withdrawal by PI|0|||
162800399|NCT02755818|587978592|FG001|Overall Study|withdrawal by PI|0|||
162800400|NCT02755818|587978593|FG002|Overall Study|withdrawal by PI|1|||
162800401|NCT02755818|587978594|FG003|Overall Study|withdrawal by PI|1|||
162800402|NCT03014011|587978595|FG000|First Intervention|Withdrawal by Subject|1|||
162800403|NCT03014011|587978596|FG001|First Intervention|Withdrawal by Subject|0|||
162800404|NCT03014011|587978595|FG000|Washout|Withdrawal by Subject|1|||
162800405|NCT03014011|587978596|FG001|Washout|Withdrawal by Subject|0|||
162800406|NCT03223662|587978603|FG000|Overall Study|Physician Decision|1|||
162800407|NCT03223662|587978603|FG000|Overall Study|Study closure|1|||
162800408|NCT01280357|587978608|FG000|Overall Study|Excluded no internal monitoring|14|||
162800409|NCT01280357|587978608|FG000|Overall Study|IInsufficient data/No data supplied|12|||
162800410|NCT02229851|587978609|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
162800411|NCT02229851|587978610|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
162800412|NCT02229851|587978611|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
162800413|NCT02229851|587978612|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
162800414|NCT02229851|587978613|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
162800415|NCT02229851|587978614|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
162800416|NCT02229851|587978615|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
162800417|NCT02229851|587978609|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800418|NCT02229851|587978610|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
162800419|NCT02229851|587978611|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800420|NCT02229851|587978612|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800421|NCT02229851|587978613|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800422|NCT02229851|587978614|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800423|NCT02229851|587978615|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162800424|NCT02229851|587978609|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
162800425|NCT02229851|587978610|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
162800426|NCT02229851|587978611|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
162800427|NCT02229851|587978612|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162800428|NCT02229851|587978613|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162800429|NCT02229851|587978614|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162800430|NCT02229851|587978615|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162800431|NCT02229851|587978609|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800432|NCT02229851|587978610|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800433|NCT02229851|587978611|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
162800434|NCT02229851|587978612|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800435|NCT02229851|587978613|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800436|NCT02229851|587978614|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800437|NCT02229851|587978615|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162800438|NCT02229851|587978609|FG000|Main Phase (Double-blind Phase)|Death|1|||
162800439|NCT02229851|587978610|FG001|Main Phase (Double-blind Phase)|Death|1|||
162800440|NCT02229851|587978611|FG002|Main Phase (Double-blind Phase)|Death|0|||
162800441|NCT02229851|587978612|FG003|Main Phase (Double-blind Phase)|Death|0|||
162800442|NCT02229851|587978613|FG004|Main Phase (Double-blind Phase)|Death|0|||
162800443|NCT02229851|587978614|FG005|Main Phase (Double-blind Phase)|Death|0|||
162800444|NCT02229851|587978615|FG006|Main Phase (Double-blind Phase)|Death|0|||
162800445|NCT02229851|587978609|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162800446|NCT02229851|587978610|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162800447|NCT02229851|587978611|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162800448|NCT02229851|587978612|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162800449|NCT02229851|587978613|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162800450|NCT02229851|587978614|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162800451|NCT02229851|587978615|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162800452|NCT02229851|587978609|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162800453|NCT02229851|587978610|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162800454|NCT02229851|587978611|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162800455|NCT02229851|587978612|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
162800456|NCT02229851|587978613|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
162800457|NCT02229851|587978614|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
162800458|NCT02229851|587978615|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
162800459|NCT02229851|587978609|FG000|Extension Phase (Open-label Phase)|Death|0|||
162800460|NCT02229851|587978610|FG001|Extension Phase (Open-label Phase)|Death|0|||
162800461|NCT02229851|587978611|FG002|Extension Phase (Open-label Phase)|Death|0|||
162800462|NCT02229851|587978612|FG003|Extension Phase (Open-label Phase)|Death|1|||
162800463|NCT02229851|587978613|FG004|Extension Phase (Open-label Phase)|Death|0|||
162800464|NCT02229851|587978614|FG005|Extension Phase (Open-label Phase)|Death|1|||
162800465|NCT02229851|587978615|FG006|Extension Phase (Open-label Phase)|Death|1|||
162800466|NCT03284203|587978616|FG000|Overall Study|Lost to Follow-up|3|||
162800467|NCT00528931|587978617|FG000|Overall Study|Lost to Follow-up|1|||
162800468|NCT03682302|587978620|FG000|Overall Study|Lost to Follow-up|1|||
162800469|NCT03682302|587978621|FG001|Overall Study|Lost to Follow-up|2|||
162800470|NCT03682302|587978622|FG002|Overall Study|Lost to Follow-up|0|||
162800471|NCT03682302|587978623|FG003|Overall Study|Lost to Follow-up|1|||
162800472|NCT03682302|587978620|FG000|Overall Study|Study drug was not administered|0|||
162800473|NCT03682302|587978621|FG001|Overall Study|Study drug was not administered|0|||
162800474|NCT03682302|587978622|FG002|Overall Study|Study drug was not administered|1|||
162800475|NCT03682302|587978623|FG003|Overall Study|Study drug was not administered|1|||
162800476|NCT01489891|587978626|FG000|Overall Study|Endoscopy failure|1|||
162800477|NCT01489891|587978627|FG001|Overall Study|Endoscopy failure|0|||
162800478|NCT03459443|587978628|FG000|Overall Study|Lack of Efficacy|3|||
162800479|NCT03459443|587978628|FG000|Overall Study|Adverse Event|1|||
162800480|NCT03459443|587978628|FG000|Overall Study|Sponsor's decision to close the study|18|||
162800481|NCT02153073|587978629|FG000|Overall Study|Case Report Forms Uncollected|230|||
162800482|NCT02153073|587978629|FG000|Overall Study|Protocol Deviation|68|||
162800483|NCT03189745|587978630|FG000|Overall Study|Conflict in work schedule of participant|1|||
162800484|NCT03189745|587978631|FG001|Overall Study|Conflict in work schedule of participant|1|||
162800485|NCT01276379|587978632|FG000|Overall Study|Screening failure|40|||
162800486|NCT01278173|587978633|FG000|Overall Study|Lack of Efficacy|13|||
162800487|NCT01278173|587978633|FG000|Overall Study|Adverse Event|8|||
162800488|NCT01278173|587978633|FG000|Overall Study|Administrative or other reason|4|||
162800489|NCT01278173|587978633|FG000|Overall Study|Protocol Violation|1|||
162800490|NCT01278173|587978633|FG000|Overall Study|Withdrawal by Subject|1|||
162800491|NCT01946529|587978640|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
162800492|NCT01946529|587978641|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
162800493|NCT01946529|587978642|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
162800494|NCT01946529|587978640|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
162800495|NCT01946529|587978641|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
162800496|NCT01946529|587978642|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
162800497|NCT02980731|587979906|FG000|Overall Study|Death|63|||
162800498|NCT02980731|587979906|FG000|Overall Study|Withdrawal by Subject|6|||
162800499|NCT02980731|587979906|FG000|Overall Study|Lost to Follow-up|5|||
162800500|NCT02980731|587979906|FG000|Overall Study|Study terminated by Sponsor|4|||
162800501|NCT02980731|587979906|FG000|Overall Study|Completed survival follow-up period|65|||
162800502|NCT02980731|587979906|FG000|Overall Study|COVID-19 infection|1|||
162800503|NCT02980731|587979906|FG000|Overall Study|Other, not specified|66|||
162800504|NCT03037931|587979907|FG000|Overall Study|Death|354|||
162800505|NCT03037931|587979908|FG001|Overall Study|Death|367|||
162800506|NCT03037931|587979907|FG000|Overall Study|Lost to Follow-up|7|||
162800507|NCT03037931|587979908|FG001|Overall Study|Lost to Follow-up|4|||
162800508|NCT03037931|587979907|FG000|Overall Study|Withdrawal by Subject|48|||
162800509|NCT03037931|587979908|FG001|Overall Study|Withdrawal by Subject|41|||
162800510|NCT02075476|587979909|FG000|Overall Study|Death|2|||
162800511|NCT02075476|587979910|FG001|Overall Study|Death|2|||
162800512|NCT02075476|587979909|FG000|Overall Study|Lost to Follow-up|1|||
162800513|NCT02075476|587979910|FG001|Overall Study|Lost to Follow-up|3|||
162800514|NCT01850446|587979911|FG000|Overall Study|Lack of Efficacy|1|||
162800515|NCT01850446|587979912|FG001|Overall Study|Lack of Efficacy|0|||
162800516|NCT01850446|587979911|FG000|Overall Study|Withdrawal by Subject|4|||
162800517|NCT01850446|587979912|FG001|Overall Study|Withdrawal by Subject|0|||
162800518|NCT01850446|587979911|FG000|Overall Study|Protocol Violation|0|||
162800519|NCT01850446|587979912|FG001|Overall Study|Protocol Violation|2|||
162800520|NCT00591721|587979913|FG000|Overall Study|Withdrawal by Subject|10|||
162800521|NCT00591721|587979914|FG001|Overall Study|Withdrawal by Subject|10|||
162800522|NCT00591721|587979913|FG000|Overall Study|Lost to Follow-up|1|||
162800523|NCT00591721|587979914|FG001|Overall Study|Lost to Follow-up|4|||
162800524|NCT00591721|587979913|FG000|Overall Study|Intervention not received|10|||
162800525|NCT00591721|587979914|FG001|Overall Study|Intervention not received|8|||
162800526|NCT03527550|587979921|FG000|Overall Study|Lost to Follow-up|4|||
162800527|NCT03527550|587979922|FG001|Overall Study|Lost to Follow-up|2|||
162800528|NCT03527550|587979921|FG000|Overall Study|Withdrawal by Subject|4|||
162800529|NCT03527550|587979922|FG001|Overall Study|Withdrawal by Subject|1|||
162800530|NCT03527550|587979921|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
162800531|NCT03527550|587979922|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
162800532|NCT00488475|587979928|FG000|Overall Study|Other|1754|||
162800533|NCT00400725|587979939|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
162800534|NCT00400725|587979940|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
162800535|NCT00400725|587979941|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
162800536|NCT00400725|587979939|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
162800537|NCT00400725|587979940|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
162800538|NCT00400725|587979941|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
162800539|NCT00400725|587979939|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
162800540|NCT00400725|587979940|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
162800541|NCT00400725|587979941|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
162800542|NCT00400725|587979939|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
162800543|NCT00400725|587979940|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
162800544|NCT00400725|587979941|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
162800545|NCT00400725|587979939|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
162800546|NCT00400725|587979940|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
162800547|NCT00400725|587979941|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
162800548|NCT00400725|587979939|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
162800549|NCT00400725|587979940|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
162800550|NCT00400725|587979941|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
162800551|NCT00400725|587979939|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
162800552|NCT00400725|587979940|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
162800553|NCT00400725|587979941|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
162800554|NCT00400725|587979939|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
162800555|NCT00400725|587979940|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
162800556|NCT00400725|587979941|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
162800557|NCT00400725|587979939|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
162800558|NCT00400725|587979940|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
162800559|NCT00400725|587979941|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
162800560|NCT00992225|587979945|FG000|Overall Study|Entry Criteria Not Met|8|||
162800561|NCT00992225|587979945|FG000|Overall Study|Adverse Event|2|||
162800562|NCT03122223|587979946|FG000|Overall Study|Withdrawal by Subject|2|||
162800563|NCT03122223|587979947|FG001|Overall Study|Withdrawal by Subject|2|||
162800564|NCT03122223|587979948|FG002|Overall Study|Withdrawal by Subject|1|||
162800565|NCT03122223|587979949|FG003|Overall Study|Withdrawal by Subject|0|||
162800566|NCT03122223|587979946|FG000|Overall Study|Lost to Follow-up|0|||
162800567|NCT03122223|587979947|FG001|Overall Study|Lost to Follow-up|2|||
162800568|NCT03122223|587979948|FG002|Overall Study|Lost to Follow-up|2|||
162800569|NCT03122223|587979949|FG003|Overall Study|Lost to Follow-up|0|||
162800570|NCT03122223|587979946|FG000|Overall Study|Participant unable to adhere|1|||
162800571|NCT03122223|587979947|FG001|Overall Study|Participant unable to adhere|1|||
162800572|NCT03122223|587979948|FG002|Overall Study|Participant unable to adhere|1|||
162800573|NCT03122223|587979949|FG003|Overall Study|Participant unable to adhere|0|||
162800574|NCT03466073|587979950|FG000|Overall Study|Death|1|||
162800575|NCT03466073|587979951|FG001|Overall Study|Death|0|||
162800576|NCT03466073|587979952|FG002|Overall Study|Death|0|||
162800577|NCT03466073|587979953|FG003|Overall Study|Death|0|||
162800578|NCT03466073|587979954|FG004|Overall Study|Death|0|||
162800579|NCT03466073|587979955|FG005|Overall Study|Death|1|||
162800580|NCT02285153|587979956|FG000|Overall Study|Adverse Event|1|||
162800581|NCT02285153|587979957|FG001|Overall Study|Adverse Event|0|||
162800582|NCT00532493|587979958|FG000|Overall Study|Death|1|||
162800583|NCT00532493|587979959|FG001|Overall Study|Death|1|||
162800584|NCT00532493|587979958|FG000|Overall Study|Lost to Follow-up|10|||
162800585|NCT00532493|587979959|FG001|Overall Study|Lost to Follow-up|7|||
162800586|NCT00532493|587979958|FG000|Overall Study|Withdrawal by Subject|7|||
162800587|NCT00532493|587979959|FG001|Overall Study|Withdrawal by Subject|9|||
162800588|NCT00532493|587979958|FG000|Overall Study|Physician Decision|1|||
162800589|NCT00532493|587979959|FG001|Overall Study|Physician Decision|6|||
162800590|NCT00532493|587979958|FG000|Overall Study|Adverse Event|6|||
162800591|NCT00532493|587979959|FG001|Overall Study|Adverse Event|5|||
162800592|NCT00532493|587979958|FG000|Overall Study|Protocol Deviation|1|||
162800593|NCT00532493|587979959|FG001|Overall Study|Protocol Deviation|0|||
162800594|NCT00532493|587979958|FG000|Overall Study|Subject Moved Away|3|||
162800595|NCT00532493|587979959|FG001|Overall Study|Subject Moved Away|1|||
162800596|NCT00532493|587979958|FG000|Overall Study|Contraindicative Medication|1|||
162800597|NCT00532493|587979959|FG001|Overall Study|Contraindicative Medication|0|||
162800598|NCT02045875|587979963|FG000|Overall Study|Lost to Follow-up|3|||
162800599|NCT02045875|587979964|FG001|Overall Study|Lost to Follow-up|0|||
162800600|NCT02045875|587979963|FG000|Overall Study|Withdrawal by Subject|4|||
162800601|NCT02045875|587979964|FG001|Overall Study|Withdrawal by Subject|3|||
162800602|NCT00948766|587979965|FG000|Core Study|Adverse Event|73|||
162800603|NCT00948766|587979966|FG001|Core Study|Adverse Event|51|||
162800604|NCT00948766|587979965|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
162800605|NCT00948766|587979966|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
162800606|NCT00948766|587979965|FG000|Core Study|Patient Withdrew Consent|27|||
162800607|NCT00948766|587979966|FG001|Core Study|Patient Withdrew Consent|46|||
162800608|NCT00948766|587979965|FG000|Core Study|Lost to Follow-up|3|||
162800609|NCT00948766|587979966|FG001|Core Study|Lost to Follow-up|2|||
162800610|NCT00948766|587979965|FG000|Core Study|Administrative Problems|2|||
162800611|NCT00948766|587979966|FG001|Core Study|Administrative Problems|2|||
162800612|NCT00948766|587979965|FG000|Core Study|Death|1|||
162800613|NCT00948766|587979966|FG001|Core Study|Death|1|||
162800614|NCT00948766|587979965|FG000|Core Study|Protocol Deviation|8|||
162800615|NCT00948766|587979966|FG001|Core Study|Protocol Deviation|10|||
162800616|NCT00948766|587979965|FG000|Extension Study|Adverse Event|43|||
162800617|NCT00948766|587979966|FG001|Extension Study|Adverse Event|0|||
162800618|NCT00948766|587979965|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
162800619|NCT00948766|587979966|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
162800620|NCT00948766|587979965|FG000|Extension Study|Study Drug No Longer Required|1|||
162800621|NCT00948766|587979966|FG001|Extension Study|Study Drug No Longer Required|0|||
162800622|NCT00948766|587979965|FG000|Extension Study|Patient Withdrew Consent|32|||
162800623|NCT00948766|587979966|FG001|Extension Study|Patient Withdrew Consent|0|||
162800624|NCT00948766|587979965|FG000|Extension Study|Lost to Follow-up|8|||
162800625|NCT00948766|587979966|FG001|Extension Study|Lost to Follow-up|0|||
162800626|NCT00948766|587979965|FG000|Extension Study|Administrative Problems|1|||
162800627|NCT00948766|587979966|FG001|Extension Study|Administrative Problems|0|||
162800628|NCT00948766|587979965|FG000|Extension Study|Death|4|||
162800629|NCT00948766|587979966|FG001|Extension Study|Death|0|||
162800630|NCT03702231|587979969|FG000|Overall Study|Withdrawal by Subject|1|||
162800631|NCT03702231|587979970|FG001|Overall Study|Withdrawal by Subject|0|||
162800632|NCT03702231|587979971|FG002|Overall Study|Withdrawal by Subject|0|||
162800633|NCT03702231|587979969|FG000|Overall Study|Protocol Violation|0|||
162800634|NCT03702231|587979970|FG001|Overall Study|Protocol Violation|0|||
162800635|NCT03702231|587979971|FG002|Overall Study|Protocol Violation|1|||
162800636|NCT03702231|587979969|FG000|Overall Study|Change in CLL Treatment|0|||
162800637|NCT03702231|587979970|FG001|Overall Study|Change in CLL Treatment|0|||
162800638|NCT03702231|587979971|FG002|Overall Study|Change in CLL Treatment|1|||
162800639|NCT03702231|587979969|FG000|Overall Study|COVID Pandemic|1|||
162800640|NCT03702231|587979970|FG001|Overall Study|COVID Pandemic|4|||
162800641|NCT03702231|587979971|FG002|Overall Study|COVID Pandemic|1|||
162800642|NCT03702231|587979969|FG000|Overall Study|Non-compliance|0|||
162800643|NCT03702231|587979970|FG001|Overall Study|Non-compliance|0|||
162800644|NCT03702231|587979971|FG002|Overall Study|Non-compliance|1|||
162800645|NCT02270515|587979972|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
162800646|NCT02270515|587979972|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
162800647|NCT02270515|587979972|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
162800648|NCT02270515|587979972|FG000|Intervention Period 1: 0-6 Months|Death|7|||
162800649|NCT02270515|587979972|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
162800650|NCT02270515|587979972|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
162800651|NCT02270515|587979972|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
162800652|NCT02270515|587979972|FG000|Intervention Period 2: 6-12 Months|Death|5|||
162800653|NCT02270515|587979972|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
162800654|NCT02270515|587979972|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
162800655|NCT02270515|587979972|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
162800656|NCT02270515|587979972|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
162800657|NCT02270515|587979972|FG000|Intervention Period 3: 12-18 Months|Death|3|||
162800658|NCT02270515|587979972|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
162800659|NCT01607476|587979975|FG000|Overall Study|Withdrawal by Subject|1|||
162800660|NCT01607476|587979976|FG001|Overall Study|Withdrawal by Subject|0|||
162800661|NCT01607476|587979977|FG002|Overall Study|Withdrawal by Subject|1|||
162800662|NCT01607476|587979975|FG000|Overall Study|Lost to Follow-up|0|||
162800663|NCT01607476|587979976|FG001|Overall Study|Lost to Follow-up|0|||
162800664|NCT01607476|587979977|FG002|Overall Study|Lost to Follow-up|2|||
162800665|NCT04445987|587979978|FG000|Overall Study|Adverse Event|0|||
162800666|NCT04445987|587979979|FG001|Overall Study|Adverse Event|0|||
162800667|NCT04445987|587979980|FG002|Overall Study|Adverse Event|1|||
162800668|NCT04445987|587979981|FG003|Overall Study|Adverse Event|0|||
162800669|NCT04445987|587979982|FG004|Overall Study|Adverse Event|4|||
162800670|NCT04445987|587979983|FG005|Overall Study|Adverse Event|0|||
162800671|NCT04445987|587979978|FG000|Overall Study|Lost to Follow-up|4|||
162800672|NCT04445987|587979979|FG001|Overall Study|Lost to Follow-up|3|||
162800673|NCT04445987|587979980|FG002|Overall Study|Lost to Follow-up|1|||
162800674|NCT04445987|587979981|FG003|Overall Study|Lost to Follow-up|1|||
162800675|NCT04445987|587979982|FG004|Overall Study|Lost to Follow-up|29|||
162800676|NCT04445987|587979983|FG005|Overall Study|Lost to Follow-up|0|||
162800677|NCT04445987|587979978|FG000|Overall Study|Physician Decision|0|||
162800678|NCT04445987|587979979|FG001|Overall Study|Physician Decision|0|||
162800679|NCT04445987|587979980|FG002|Overall Study|Physician Decision|0|||
162800680|NCT04445987|587979981|FG003|Overall Study|Physician Decision|0|||
162800681|NCT04445987|587979982|FG004|Overall Study|Physician Decision|1|||
162800682|NCT04445987|587979983|FG005|Overall Study|Physician Decision|0|||
162800683|NCT04445987|587979978|FG000|Overall Study|Protocol Violation|1|||
162800684|NCT04445987|587979979|FG001|Overall Study|Protocol Violation|0|||
162800685|NCT04445987|587979980|FG002|Overall Study|Protocol Violation|0|||
162800686|NCT04445987|587979981|FG003|Overall Study|Protocol Violation|0|||
162800687|NCT04445987|587979982|FG004|Overall Study|Protocol Violation|2|||
162800688|NCT04445987|587979983|FG005|Overall Study|Protocol Violation|0|||
162800689|NCT04445987|587979978|FG000|Overall Study|Withdrawal by Subject|4|||
162800690|NCT04445987|587979979|FG001|Overall Study|Withdrawal by Subject|0|||
162800691|NCT04445987|587979980|FG002|Overall Study|Withdrawal by Subject|1|||
162800692|NCT04445987|587979981|FG003|Overall Study|Withdrawal by Subject|0|||
162800693|NCT04445987|587979982|FG004|Overall Study|Withdrawal by Subject|18|||
162800694|NCT04445987|587979983|FG005|Overall Study|Withdrawal by Subject|1|||
162800695|NCT04445987|587979978|FG000|Overall Study|Other reason|0|||
162800696|NCT04445987|587979979|FG001|Overall Study|Other reason|0|||
162800697|NCT04445987|587979980|FG002|Overall Study|Other reason|1|||
162800698|NCT04445987|587979981|FG003|Overall Study|Other reason|0|||
162800699|NCT04445987|587979982|FG004|Overall Study|Other reason|2|||
162800700|NCT04445987|587979983|FG005|Overall Study|Other reason|0|||
162800701|NCT02091206|587979984|FG000|Treatment Period|Adverse Event|0|||
162800702|NCT02091206|587979985|FG001|Treatment Period|Adverse Event|1|||
162800703|NCT02091206|587979986|FG002|Treatment Period|Adverse Event|0|||
162800704|NCT02091206|587979987|FG003|Treatment Period|Adverse Event|0|||
162800705|NCT02091206|587979984|FG000|Treatment Period|Met withdrawal criteria|0|||
162800706|NCT02091206|587979985|FG001|Treatment Period|Met withdrawal criteria|0|||
162800707|NCT02091206|587979986|FG002|Treatment Period|Met withdrawal criteria|1|||
162800708|NCT02091206|587979987|FG003|Treatment Period|Met withdrawal criteria|0|||
162800709|NCT02091206|587979984|FG000|Taper Period|Participant refused study drug|1|||
162800710|NCT02091206|587979985|FG001|Taper Period|Participant refused study drug|0|||
162800711|NCT02091206|587979986|FG002|Taper Period|Participant refused study drug|0|||
162800712|NCT02091206|587979987|FG003|Taper Period|Participant refused study drug|1|||
162800713|NCT02091206|587979984|FG000|Taper Period|Lost to Follow-up|0|||
162800714|NCT02091206|587979985|FG001|Taper Period|Lost to Follow-up|0|||
162800715|NCT02091206|587979986|FG002|Taper Period|Lost to Follow-up|0|||
162800716|NCT02091206|587979987|FG003|Taper Period|Lost to Follow-up|1|||
162800717|NCT03772587|587979993|FG000|Overall Study|COVID-19|0|||
162800718|NCT03772587|587979994|FG001|Overall Study|COVID-19|0|||
162800719|NCT03772587|587979995|FG002|Overall Study|COVID-19|1|||
162800720|NCT03772587|587979996|FG003|Overall Study|COVID-19|1|||
162800721|NCT03772587|587979997|FG004|Overall Study|COVID-19|0|||
162800722|NCT03772587|587979993|FG000|Overall Study|Withdrawal by Subject|1|||
162800723|NCT03772587|587979994|FG001|Overall Study|Withdrawal by Subject|0|||
162800724|NCT03772587|587979995|FG002|Overall Study|Withdrawal by Subject|0|||
162800725|NCT03772587|587979996|FG003|Overall Study|Withdrawal by Subject|0|||
162800726|NCT03772587|587979997|FG004|Overall Study|Withdrawal by Subject|0|||
162800727|NCT02297139|587979998|FG000|Overall Study|Disease progression|0|||
162800728|NCT02297139|587979999|FG001|Overall Study|Disease progression|1|||
162800729|NCT02297139|587979998|FG000|Overall Study|Study drug toxicity|0|||
162800730|NCT02297139|587979999|FG001|Overall Study|Study drug toxicity|4|||
162800731|NCT02297139|587979998|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162800732|NCT02297139|587979999|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162800733|NCT02297139|587979998|FG000|Overall Study|Maximum clinical benefit|1|||
162800734|NCT02297139|587979999|FG001|Overall Study|Maximum clinical benefit|0|||
162800735|NCT02297139|587979998|FG000|Overall Study|Administrative reason by sponsor|0|||
162800736|NCT02297139|587979999|FG001|Overall Study|Administrative reason by sponsor|2|||
162800737|NCT02297139|587979998|FG000|Overall Study|Other reasons|0|||
162800738|NCT02297139|587979999|FG001|Overall Study|Other reasons|8|||
162800739|NCT05051462|587980005|FG000|Overall Study|Lost to Follow-up|1|||
162800740|NCT05051462|587980006|FG001|Overall Study|Lost to Follow-up|8|||
162800741|NCT05051462|587980005|FG000|Overall Study|Withdrawal by Subject|1|||
162800742|NCT05051462|587980006|FG001|Overall Study|Withdrawal by Subject|0|||
162800743|NCT05051462|587980005|FG000|Overall Study|Protocol Violation|0|||
162800744|NCT05051462|587980006|FG001|Overall Study|Protocol Violation|2|||
162800745|NCT02425904|587980007|FG000|Overall Study|Lost to Follow-up|1|||
162800746|NCT02425904|587980008|FG001|Overall Study|Lost to Follow-up|0|||
162800747|NCT02425904|587980007|FG000|Overall Study|Withdrawal by Subject|2|||
162800748|NCT02425904|587980008|FG001|Overall Study|Withdrawal by Subject|0|||
162800749|NCT02425904|587980007|FG000|Overall Study|Death|0|||
162800750|NCT02425904|587980008|FG001|Overall Study|Death|3|||
162800751|NCT05260021|587980009|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
162800752|NCT05260021|587980010|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
162800753|NCT05260021|587980011|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
162800754|NCT05260021|587980009|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
162800755|NCT05260021|587980010|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
162800756|NCT05260021|587980011|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
162800757|NCT05260021|587980009|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
162800758|NCT05260021|587980010|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
162800759|NCT05260021|587980011|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
162800760|NCT05260021|587980009|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
162800761|NCT05260021|587980010|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
162800762|NCT05260021|587980011|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
162800763|NCT05260021|587980009|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
162800764|NCT05260021|587980010|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
162800765|NCT05260021|587980011|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
162800766|NCT05597787|587980012|FG000|Overall Study|Withdrawal by Subject|0|||
162800767|NCT05597787|587980013|FG001|Overall Study|Withdrawal by Subject|0|||
162800768|NCT05597787|587980014|FG002|Overall Study|Withdrawal by Subject|1|||
162800769|NCT01144377|587980015|FG000|52 Week Treatment Period|Adverse Event|0|||
162800770|NCT01144377|587980016|FG001|52 Week Treatment Period|Adverse Event|0|||
162800771|NCT01144377|587980017|FG002|52 Week Treatment Period|Adverse Event|3|||
162800772|NCT01144377|587980018|FG003|52 Week Treatment Period|Adverse Event|2|||
162800773|NCT01144377|587980019|FG004|52 Week Treatment Period|Adverse Event|1|||
162800774|NCT01144377|587980015|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
162800775|NCT01144377|587980016|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
162800776|NCT01144377|587980017|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
162800777|NCT01144377|587980018|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
162800778|NCT01144377|587980019|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
162800779|NCT01144377|587980015|FG000|52 Week Treatment Period|Protocol Violation|0|||
162800780|NCT01144377|587980016|FG001|52 Week Treatment Period|Protocol Violation|0|||
162800781|NCT01144377|587980017|FG002|52 Week Treatment Period|Protocol Violation|0|||
162800782|NCT01144377|587980018|FG003|52 Week Treatment Period|Protocol Violation|0|||
162800783|NCT01144377|587980019|FG004|52 Week Treatment Period|Protocol Violation|1|||
162800784|NCT01144377|587980015|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
162800785|NCT01144377|587980016|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
162800786|NCT01144377|587980017|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
162800787|NCT01144377|587980018|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
162800788|NCT01144377|587980019|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
162800789|NCT01144377|587980015|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
162800790|NCT01144377|587980016|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
162800791|NCT01144377|587980017|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
162800792|NCT01144377|587980018|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
162800793|NCT01144377|587980019|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
162800794|NCT01144377|587980015|FG000|52 Week Treatment Period|Sponsor Decision|0|||
162800795|NCT01144377|587980016|FG001|52 Week Treatment Period|Sponsor Decision|0|||
162800796|NCT01144377|587980017|FG002|52 Week Treatment Period|Sponsor Decision|0|||
162800797|NCT01144377|587980018|FG003|52 Week Treatment Period|Sponsor Decision|0|||
162800798|NCT01144377|587980019|FG004|52 Week Treatment Period|Sponsor Decision|1|||
162800799|NCT01144377|587980015|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162800800|NCT01144377|587980016|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
162800801|NCT01144377|587980017|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162800802|NCT01144377|587980018|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162800803|NCT01144377|587980019|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
162800804|NCT01144377|587980015|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162800805|NCT01144377|587980016|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162800806|NCT01144377|587980017|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162800807|NCT01144377|587980018|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162800808|NCT01144377|587980019|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
162800809|NCT01144377|587980015|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
162800810|NCT01144377|587980016|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162800811|NCT01144377|587980017|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162800812|NCT01144377|587980018|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162800813|NCT01144377|587980019|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162800814|NCT01214642|587980021|FG000|Overall Study|Progressive Disease|3|||
162800815|NCT01214642|587980022|FG001|Overall Study|Progressive Disease|2|||
162800816|NCT01214642|587980023|FG002|Overall Study|Progressive Disease|3|||
162800817|NCT01214642|587980024|FG003|Overall Study|Progressive Disease|5|||
162800818|NCT01214642|587980025|FG004|Overall Study|Progressive Disease|5|||
162800819|NCT01214642|587980026|FG005|Overall Study|Progressive Disease|3|||
162800820|NCT01214642|587980027|FG006|Overall Study|Progressive Disease|5|||
162800821|NCT01214642|587980028|FG007|Overall Study|Progressive Disease|3|||
162800822|NCT01214642|587980029|FG008|Overall Study|Progressive Disease|10|||
162800823|NCT01214642|587980030|FG009|Overall Study|Progressive Disease|2|||
162800824|NCT01214642|587980031|FG010|Overall Study|Progressive Disease|1|||
162800825|NCT01214642|587980032|FG011|Overall Study|Progressive Disease|4|||
162800826|NCT01214642|587980021|FG000|Overall Study|Adverse Event|0|||
162800827|NCT01214642|587980022|FG001|Overall Study|Adverse Event|1|||
162800828|NCT01214642|587980023|FG002|Overall Study|Adverse Event|0|||
162800829|NCT01214642|587980024|FG003|Overall Study|Adverse Event|0|||
162800830|NCT01214642|587980025|FG004|Overall Study|Adverse Event|0|||
162800831|NCT01214642|587980026|FG005|Overall Study|Adverse Event|0|||
162800832|NCT01214642|587980027|FG006|Overall Study|Adverse Event|1|||
162800833|NCT01214642|587980028|FG007|Overall Study|Adverse Event|0|||
162800834|NCT01214642|587980029|FG008|Overall Study|Adverse Event|0|||
162800835|NCT01214642|587980030|FG009|Overall Study|Adverse Event|1|||
162800836|NCT01214642|587980031|FG010|Overall Study|Adverse Event|1|||
162800837|NCT01214642|587980032|FG011|Overall Study|Adverse Event|0|||
162800838|NCT01214642|587980021|FG000|Overall Study|Death|0|||
162800839|NCT01214642|587980022|FG001|Overall Study|Death|0|||
162800840|NCT01214642|587980023|FG002|Overall Study|Death|1|||
162800841|NCT01214642|587980024|FG003|Overall Study|Death|0|||
162800842|NCT01214642|587980025|FG004|Overall Study|Death|0|||
162800843|NCT01214642|587980026|FG005|Overall Study|Death|0|||
162800844|NCT01214642|587980027|FG006|Overall Study|Death|0|||
162800845|NCT01214642|587980028|FG007|Overall Study|Death|0|||
162800846|NCT01214642|587980029|FG008|Overall Study|Death|0|||
162800847|NCT01214642|587980030|FG009|Overall Study|Death|0|||
162800848|NCT01214642|587980031|FG010|Overall Study|Death|1|||
162800849|NCT01214642|587980032|FG011|Overall Study|Death|0|||
162800850|NCT01214642|587980021|FG000|Overall Study|Withdrawal by Subject|0|||
162800851|NCT01214642|587980022|FG001|Overall Study|Withdrawal by Subject|0|||
162800852|NCT01214642|587980023|FG002|Overall Study|Withdrawal by Subject|1|||
162800853|NCT01214642|587980024|FG003|Overall Study|Withdrawal by Subject|0|||
162800854|NCT01214642|587980025|FG004|Overall Study|Withdrawal by Subject|0|||
162800855|NCT01214642|587980026|FG005|Overall Study|Withdrawal by Subject|0|||
162800856|NCT01214642|587980027|FG006|Overall Study|Withdrawal by Subject|0|||
162800857|NCT01214642|587980028|FG007|Overall Study|Withdrawal by Subject|0|||
162800858|NCT01214642|587980029|FG008|Overall Study|Withdrawal by Subject|3|||
162800859|NCT01214642|587980030|FG009|Overall Study|Withdrawal by Subject|1|||
162800860|NCT01214642|587980031|FG010|Overall Study|Withdrawal by Subject|1|||
162800861|NCT01214642|587980032|FG011|Overall Study|Withdrawal by Subject|0|||
162800862|NCT01214642|587980021|FG000|Overall Study|Physician Decision|0|||
162800863|NCT01214642|587980022|FG001|Overall Study|Physician Decision|0|||
162800864|NCT01214642|587980023|FG002|Overall Study|Physician Decision|1|||
162800865|NCT01214642|587980024|FG003|Overall Study|Physician Decision|1|||
162800866|NCT01214642|587980025|FG004|Overall Study|Physician Decision|1|||
162800867|NCT01214642|587980026|FG005|Overall Study|Physician Decision|0|||
162800868|NCT01214642|587980027|FG006|Overall Study|Physician Decision|0|||
162800869|NCT01214642|587980028|FG007|Overall Study|Physician Decision|0|||
162800870|NCT01214642|587980029|FG008|Overall Study|Physician Decision|0|||
162800871|NCT01214642|587980030|FG009|Overall Study|Physician Decision|0|||
162800872|NCT01214642|587980031|FG010|Overall Study|Physician Decision|0|||
162800873|NCT01214642|587980032|FG011|Overall Study|Physician Decision|2|||
162800874|NCT01241604|587980033|FG000|Screening Period|Screen Failure|3|||
162800875|NCT01241604|587980034|FG001|Screening Period|Screen Failure|0|||
162800876|NCT01241604|587980035|FG002|Screening Period|Screen Failure|0|||
162800877|NCT01593787|587980036|FG000|Overall Study|Adverse Event|1|||
162800878|NCT01593787|587980037|FG001|Overall Study|Adverse Event|0|||
162800879|NCT01593787|587980038|FG002|Overall Study|Adverse Event|0|||
162800880|NCT01133418|587980041|FG000|Overall Study|Lost to Follow-up|5|||
162800881|NCT01133418|587980042|FG001|Overall Study|Lost to Follow-up|6|||
162800882|NCT04150068|587980043|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
162800883|NCT04150068|587980044|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
162800884|NCT04150068|587980045|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
162800885|NCT04150068|587980043|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
162800886|NCT04150068|587980044|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
162800887|NCT04150068|587980045|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
162800888|NCT05316701|587980046|FG000|Overall Study|Adverse Event|0|||
162800889|NCT05316701|587980047|FG001|Overall Study|Adverse Event|1|||
162800890|NCT05316701|587980046|FG000|Overall Study|Death|3|||
162800891|NCT05316701|587980047|FG001|Overall Study|Death|9|||
162800892|NCT05316701|587980046|FG000|Overall Study|Lost to Follow-up|1|||
162800893|NCT05316701|587980047|FG001|Overall Study|Lost to Follow-up|0|||
162800894|NCT05316701|587980046|FG000|Overall Study|Physician Decision|1|||
162800895|NCT05316701|587980047|FG001|Overall Study|Physician Decision|4|||
162800896|NCT05316701|587980046|FG000|Overall Study|Withdrawal by Subject|3|||
162800897|NCT05316701|587980047|FG001|Overall Study|Withdrawal by Subject|5|||
162800898|NCT05316701|587980046|FG000|Overall Study|Progression/Relapse|14|||
162800899|NCT05316701|587980047|FG001|Overall Study|Progression/Relapse|9|||
162800900|NCT05316701|587980046|FG000|Overall Study|Received Standard of Care|1|||
162800901|NCT05316701|587980047|FG001|Overall Study|Received Standard of Care|0|||
162800902|NCT05316701|587980046|FG000|Overall Study|Ongoing|70|||
162800903|NCT05316701|587980047|FG001|Overall Study|Ongoing|64|||
162800904|NCT04679935|587980048|FG000|Overall Study|Death|0|||
162800905|NCT04679935|587980049|FG001|Overall Study|Death|1|||
162800906|NCT02731690|587981592|FG000|Overall Study|Adverse Event|1|||
162800907|NCT02731690|587981592|FG000|Overall Study|Withdrawal by Subject|3|||
162800908|NCT02731690|587981592|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
162800909|NCT00872989|587981593|FG000|Overall Study|Adverse Event|7|||
162800910|NCT00872989|587981594|FG001|Overall Study|Adverse Event|15|||
162800911|NCT00872989|587981593|FG000|Overall Study|Withdrawal by Subject|8|||
162800912|NCT00872989|587981594|FG001|Overall Study|Withdrawal by Subject|5|||
162800913|NCT00872989|587981593|FG000|Overall Study|Progression/relapse|47|||
162800914|NCT00872989|587981594|FG001|Overall Study|Progression/relapse|35|||
162800915|NCT00872989|587981593|FG000|Overall Study|Not protocol specified|3|||
162800916|NCT00872989|587981594|FG001|Overall Study|Not protocol specified|8|||
162800917|NCT02407990|587981595|FG000|Overall Study|Death|2|||
162800918|NCT02407990|587981596|FG001|Overall Study|Death|22|||
162800919|NCT02407990|587981597|FG002|Overall Study|Death|23|||
162800920|NCT02407990|587981598|FG003|Overall Study|Death|7|||
162800921|NCT02407990|587981599|FG004|Overall Study|Death|17|||
162800922|NCT02407990|587981600|FG005|Overall Study|Death|16|||
162800923|NCT02407990|587981601|FG006|Overall Study|Death|10|||
162800924|NCT02407990|587981602|FG007|Overall Study|Death|248|||
162800925|NCT02407990|587981595|FG000|Overall Study|Lost to Follow-up|0|||
162800926|NCT02407990|587981596|FG001|Overall Study|Lost to Follow-up|1|||
162800927|NCT02407990|587981597|FG002|Overall Study|Lost to Follow-up|0|||
162800928|NCT02407990|587981598|FG003|Overall Study|Lost to Follow-up|0|||
162800929|NCT02407990|587981599|FG004|Overall Study|Lost to Follow-up|0|||
162800930|NCT02407990|587981600|FG005|Overall Study|Lost to Follow-up|0|||
162800931|NCT02407990|587981601|FG006|Overall Study|Lost to Follow-up|0|||
162800932|NCT02407990|587981602|FG007|Overall Study|Lost to Follow-up|17|||
162800933|NCT02407990|587981595|FG000|Overall Study|Progressive Disease|0|||
162800934|NCT02407990|587981596|FG001|Overall Study|Progressive Disease|0|||
162800935|NCT02407990|587981597|FG002|Overall Study|Progressive Disease|0|||
162800936|NCT02407990|587981598|FG003|Overall Study|Progressive Disease|0|||
162800937|NCT02407990|587981599|FG004|Overall Study|Progressive Disease|0|||
162800938|NCT02407990|587981600|FG005|Overall Study|Progressive Disease|0|||
162800939|NCT02407990|587981601|FG006|Overall Study|Progressive Disease|0|||
162800940|NCT02407990|587981602|FG007|Overall Study|Progressive Disease|1|||
162800941|NCT02407990|587981595|FG000|Overall Study|Withdrawal by Subject|0|||
162800942|NCT02407990|587981596|FG001|Overall Study|Withdrawal by Subject|0|||
162800943|NCT02407990|587981597|FG002|Overall Study|Withdrawal by Subject|0|||
162800944|NCT02407990|587981598|FG003|Overall Study|Withdrawal by Subject|0|||
162800945|NCT02407990|587981599|FG004|Overall Study|Withdrawal by Subject|1|||
162800946|NCT02407990|587981600|FG005|Overall Study|Withdrawal by Subject|0|||
162800947|NCT02407990|587981601|FG006|Overall Study|Withdrawal by Subject|0|||
162800948|NCT02407990|587981602|FG007|Overall Study|Withdrawal by Subject|30|||
162800949|NCT02407990|587981595|FG000|Overall Study|Study Terminated by Sponsor|1|||
162800950|NCT02407990|587981596|FG001|Overall Study|Study Terminated by Sponsor|3|||
162800951|NCT02407990|587981597|FG002|Overall Study|Study Terminated by Sponsor|3|||
162800952|NCT02407990|587981598|FG003|Overall Study|Study Terminated by Sponsor|0|||
162800953|NCT02407990|587981599|FG004|Overall Study|Study Terminated by Sponsor|3|||
162800954|NCT02407990|587981600|FG005|Overall Study|Study Terminated by Sponsor|4|||
162800955|NCT02407990|587981601|FG006|Overall Study|Study Terminated by Sponsor|3|||
162800956|NCT02407990|587981602|FG007|Overall Study|Study Terminated by Sponsor|37|||
162800957|NCT02407990|587981595|FG000|Overall Study|Logistics|0|||
162800958|NCT02407990|587981596|FG001|Overall Study|Logistics|0|||
162800959|NCT02407990|587981597|FG002|Overall Study|Logistics|0|||
162800960|NCT02407990|587981598|FG003|Overall Study|Logistics|0|||
162800961|NCT02407990|587981599|FG004|Overall Study|Logistics|0|||
162800962|NCT02407990|587981600|FG005|Overall Study|Logistics|0|||
162800963|NCT02407990|587981601|FG006|Overall Study|Logistics|0|||
162800964|NCT02407990|587981602|FG007|Overall Study|Logistics|1|||
162800965|NCT02407990|587981595|FG000|Overall Study|Rolled into long-term extension study|0|||
162800966|NCT02407990|587981596|FG001|Overall Study|Rolled into long-term extension study|0|||
162800967|NCT02407990|587981597|FG002|Overall Study|Rolled into long-term extension study|0|||
162800968|NCT02407990|587981598|FG003|Overall Study|Rolled into long-term extension study|0|||
162800969|NCT02407990|587981599|FG004|Overall Study|Rolled into long-term extension study|0|||
162800970|NCT02407990|587981600|FG005|Overall Study|Rolled into long-term extension study|0|||
162800971|NCT02407990|587981601|FG006|Overall Study|Rolled into long-term extension study|0|||
162800972|NCT02407990|587981602|FG007|Overall Study|Rolled into long-term extension study|1|||
162800973|NCT01238900|587981603|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
162800974|NCT01238900|587981603|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
162800975|NCT03241927|587981604|FG000|Overall Study|study terminated|1|||
162800976|NCT03241927|587981605|FG001|Overall Study|study terminated|0|||
162800977|NCT03573583|587981606|FG000|Overall Study|Lost to Follow-up|1|||
162800978|NCT03573583|587981607|FG001|Overall Study|Lost to Follow-up|0|||
162800979|NCT03573583|587981606|FG000|Overall Study|Withdrawal by Subject|1|||
162800980|NCT03573583|587981607|FG001|Overall Study|Withdrawal by Subject|1|||
162800981|NCT01198756|587981608|FG000|Overall Study|Adverse Event|0|||
162800982|NCT01198756|587981609|FG001|Overall Study|Adverse Event|0|||
162800983|NCT01198756|587981610|FG002|Overall Study|Adverse Event|0|||
162800984|NCT01198756|587981611|FG003|Overall Study|Adverse Event|1|||
162800985|NCT01198756|587981608|FG000|Overall Study|Protocol Violation|0|||
162800986|NCT01198756|587981609|FG001|Overall Study|Protocol Violation|0|||
162800987|NCT01198756|587981610|FG002|Overall Study|Protocol Violation|0|||
162800988|NCT01198756|587981611|FG003|Overall Study|Protocol Violation|2|||
162800989|NCT01198756|587981608|FG000|Overall Study|Withdrawal by Subject|9|||
162800990|NCT01198756|587981609|FG001|Overall Study|Withdrawal by Subject|4|||
162800991|NCT01198756|587981610|FG002|Overall Study|Withdrawal by Subject|7|||
162800992|NCT01198756|587981611|FG003|Overall Study|Withdrawal by Subject|5|||
162800993|NCT01198756|587981608|FG000|Overall Study|Lost to Follow-up|29|||
162800994|NCT01198756|587981609|FG001|Overall Study|Lost to Follow-up|36|||
162800995|NCT01198756|587981610|FG002|Overall Study|Lost to Follow-up|23|||
162800996|NCT01198756|587981611|FG003|Overall Study|Lost to Follow-up|18|||
162800997|NCT02915302|587981614|FG000|Overall Study|Adverse Event|3|||
162800998|NCT02915302|587981615|FG001|Overall Study|Adverse Event|0|||
162800999|NCT02915302|587981614|FG000|Overall Study|Protocol Violation|20|||
162801000|NCT02915302|587981615|FG001|Overall Study|Protocol Violation|27|||
162801001|NCT02915302|587981614|FG000|Overall Study|Lost to Follow-up|19|||
162801002|NCT02915302|587981615|FG001|Overall Study|Lost to Follow-up|22|||
162801003|NCT02915302|587981614|FG000|Overall Study|Withdrawal by Subject|22|||
162801004|NCT02915302|587981615|FG001|Overall Study|Withdrawal by Subject|29|||
162801005|NCT02915302|587981614|FG000|Overall Study|Other|1|||
162801006|NCT02915302|587981615|FG001|Overall Study|Other|0|||
162801007|NCT04343872|587981618|FG000|Overall Study|Lost to Follow-up|6|||
162801008|NCT04343872|587981619|FG001|Overall Study|Lost to Follow-up|3|||
162801009|NCT01639495|587981620|FG000|Overall Study|Lost to Follow-up|6|||
162801010|NCT01639495|587981620|FG000|Overall Study|Consented but didn't have study catheter|4|||
162801011|NCT01639495|587981620|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
162801012|NCT01639495|587981620|FG000|Overall Study|No radiofrequency energy applied|2|||
162801013|NCT01119105|587981621|FG000|Overall Study|Withdrawal by Subject|1|||
162801014|NCT01119105|587981622|FG001|Overall Study|Withdrawal by Subject|1|||
162801015|NCT01119105|587981623|FG002|Overall Study|Withdrawal by Subject|1|||
162801016|NCT01119105|587981621|FG000|Overall Study|Lost to Follow-up|0|||
162801017|NCT01119105|587981622|FG001|Overall Study|Lost to Follow-up|2|||
162801018|NCT01119105|587981623|FG002|Overall Study|Lost to Follow-up|5|||
162801019|NCT01119105|587981621|FG000|Overall Study|Adverse Event|1|||
162801020|NCT01119105|587981622|FG001|Overall Study|Adverse Event|0|||
162801021|NCT01119105|587981623|FG002|Overall Study|Adverse Event|1|||
162801022|NCT01119105|587981621|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
162801023|NCT01119105|587981622|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
162801024|NCT01119105|587981623|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
162801025|NCT01119105|587981621|FG000|Overall Study|Other|1|||
162801026|NCT01119105|587981622|FG001|Overall Study|Other|1|||
162801027|NCT01119105|587981623|FG002|Overall Study|Other|0|||
162801028|NCT02366468|587981625|FG000|Overall Study|Adverse Event|2|||
162801029|NCT02366468|587981626|FG001|Overall Study|Adverse Event|0|||
162801030|NCT02366468|587981625|FG000|Overall Study|Withdrawal by Subject|1|||
162801031|NCT02366468|587981626|FG001|Overall Study|Withdrawal by Subject|5|||
162801032|NCT02366468|587981625|FG000|Overall Study|Lost to Follow-up|2|||
162801033|NCT02366468|587981626|FG001|Overall Study|Lost to Follow-up|0|||
162801034|NCT02366468|587981625|FG000|Overall Study|Death|1|||
162801035|NCT02366468|587981626|FG001|Overall Study|Death|2|||
162801036|NCT02366468|587981625|FG000|Overall Study|Other|0|||
162801037|NCT02366468|587981626|FG001|Overall Study|Other|2|||
162801038|NCT05540717|587981629|FG000|Overall Study|Lost to Follow-up|2|||
162801039|NCT05540717|587981630|FG001|Overall Study|Lost to Follow-up|5|||
162801040|NCT05540717|587981629|FG000|Overall Study|Withdrawal by Subject|6|||
162801041|NCT05540717|587981630|FG001|Overall Study|Withdrawal by Subject|6|||
162801042|NCT05540717|587981629|FG000|Overall Study|Sponsor request|1|||
162801043|NCT05540717|587981630|FG001|Overall Study|Sponsor request|0|||
162801044|NCT05540717|587981629|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
162801045|NCT05540717|587981630|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
162801046|NCT05540717|587981629|FG000|Overall Study|Other|0|||
162801047|NCT05540717|587981630|FG001|Overall Study|Other|1|||
162801048|NCT01144052|587981631|FG000|Overall Study|Withdrawal by Subject|1|||
162801049|NCT01144052|587981632|FG001|Overall Study|Withdrawal by Subject|1|||
162801050|NCT03836716|587981636|FG000|Overall Study|Adverse Event|3|||
162801051|NCT03836716|587981636|FG000|Overall Study|Death|22|||
162801052|NCT03836716|587981636|FG000|Overall Study|Withdrawal by Subject|8|||
162801053|NCT03836716|587981636|FG000|Overall Study|Study terminated by sponsor|87|||
162801054|NCT01879722|587981637|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162801055|NCT01879722|587981638|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162801056|NCT01879722|587981639|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162801057|NCT01879722|587981640|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162801058|NCT01879722|587981641|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
162801059|NCT01879722|587981642|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162801060|NCT01879722|587981643|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
162801061|NCT01879722|587981644|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
162801062|NCT01879722|587981645|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
162801063|NCT01879722|587981646|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
162801064|NCT01879722|587981637|FG000|Overall Study|Voluntary Withdrawal|0|||
162801065|NCT01879722|587981638|FG001|Overall Study|Voluntary Withdrawal|0|||
162801066|NCT01879722|587981639|FG002|Overall Study|Voluntary Withdrawal|0|||
162801067|NCT01879722|587981640|FG003|Overall Study|Voluntary Withdrawal|0|||
162801068|NCT01879722|587981641|FG004|Overall Study|Voluntary Withdrawal|0|||
162801069|NCT01879722|587981642|FG005|Overall Study|Voluntary Withdrawal|0|||
162801070|NCT01879722|587981643|FG006|Overall Study|Voluntary Withdrawal|0|||
162801071|NCT01879722|587981644|FG007|Overall Study|Voluntary Withdrawal|0|||
162801072|NCT01879722|587981645|FG008|Overall Study|Voluntary Withdrawal|1|||
162801073|NCT01879722|587981646|FG009|Overall Study|Voluntary Withdrawal|0|||
162801074|NCT01983254|587981647|FG000|Overall Study|Death|6|||
162801075|NCT01983254|587981648|FG001|Overall Study|Death|6|||
162801076|NCT01983254|587981647|FG000|Overall Study|Lost to Follow-up|17|||
162801077|NCT01983254|587981648|FG001|Overall Study|Lost to Follow-up|16|||
162801078|NCT01983254|587981647|FG000|Overall Study|too ill|11|||
162801079|NCT01983254|587981648|FG001|Overall Study|too ill|8|||
162801080|NCT00037830|587981649|FG000|Overall Study|Adverse Event|2|||
162801081|NCT00037830|587981650|FG001|Overall Study|Adverse Event|0|||
162801082|NCT00037830|587981651|FG002|Overall Study|Adverse Event|0|||
162801083|NCT00037830|587981649|FG000|Overall Study|Withdrawal by Subject|4|||
162801084|NCT00037830|587981650|FG001|Overall Study|Withdrawal by Subject|5|||
162801085|NCT00037830|587981651|FG002|Overall Study|Withdrawal by Subject|1|||
162801086|NCT00037830|587981649|FG000|Overall Study|Protocol Violation|2|||
162801087|NCT00037830|587981650|FG001|Overall Study|Protocol Violation|2|||
162801088|NCT00037830|587981651|FG002|Overall Study|Protocol Violation|0|||
162801089|NCT00037830|587981649|FG000|Overall Study|Unrelated Medical Problem|2|||
162801090|NCT00037830|587981650|FG001|Overall Study|Unrelated Medical Problem|0|||
162801091|NCT00037830|587981651|FG002|Overall Study|Unrelated Medical Problem|0|||
162801092|NCT00127205|587981652|FG000|Overall Study|Adverse Event|228|||
162801093|NCT00127205|587981653|FG001|Overall Study|Adverse Event|387|||
162801094|NCT00127205|587981654|FG002|Overall Study|Adverse Event|273|||
162801095|NCT00127205|587981652|FG000|Overall Study|Death|8|||
162801096|NCT00127205|587981653|FG001|Overall Study|Death|6|||
162801097|NCT00127205|587981654|FG002|Overall Study|Death|5|||
162801098|NCT00127205|587981652|FG000|Overall Study|Withdrawal by Subject|318|||
162801099|NCT00127205|587981653|FG001|Overall Study|Withdrawal by Subject|310|||
162801100|NCT00127205|587981654|FG002|Overall Study|Withdrawal by Subject|172|||
162801101|NCT00127205|587981652|FG000|Overall Study|Other-non protocol specified|142|||
162801102|NCT00127205|587981653|FG001|Overall Study|Other-non protocol specified|129|||
162801103|NCT00127205|587981654|FG002|Overall Study|Other-non protocol specified|77|||
162801104|NCT00127205|587981652|FG000|Overall Study|Data not reported|6|||
162801105|NCT00127205|587981653|FG001|Overall Study|Data not reported|10|||
162801106|NCT00127205|587981654|FG002|Overall Study|Data not reported|1|||
162801107|NCT00127205|587981652|FG000|Overall Study|Progression|127|||
162801108|NCT00127205|587981653|FG001|Overall Study|Progression|131|||
162801109|NCT00127205|587981654|FG002|Overall Study|Progression|84|||
162801110|NCT01327495|587981655|FG000|Overall Study|Adverse Event|2|||
162801111|NCT01327495|587981656|FG001|Overall Study|Adverse Event|1|||
162801112|NCT01327495|587981657|FG002|Overall Study|Adverse Event|1|||
162801113|NCT01327495|587981658|FG003|Overall Study|Adverse Event|0|||
162801114|NCT01327495|587981659|FG004|Overall Study|Adverse Event|0|||
162801115|NCT01327495|587981660|FG005|Overall Study|Adverse Event|2|||
162801116|NCT01327495|587981655|FG000|Overall Study|Withdrawal by Subject|0|||
162801117|NCT01327495|587981656|FG001|Overall Study|Withdrawal by Subject|1|||
162801118|NCT01327495|587981657|FG002|Overall Study|Withdrawal by Subject|1|||
162801119|NCT01327495|587981658|FG003|Overall Study|Withdrawal by Subject|0|||
162801120|NCT01327495|587981659|FG004|Overall Study|Withdrawal by Subject|1|||
162801121|NCT01327495|587981660|FG005|Overall Study|Withdrawal by Subject|0|||
162801122|NCT01327495|587981655|FG000|Overall Study|Physician Decision|0|||
162801123|NCT01327495|587981656|FG001|Overall Study|Physician Decision|0|||
162801124|NCT01327495|587981657|FG002|Overall Study|Physician Decision|0|||
162801125|NCT01327495|587981658|FG003|Overall Study|Physician Decision|0|||
162801126|NCT01327495|587981659|FG004|Overall Study|Physician Decision|2|||
162801127|NCT01327495|587981660|FG005|Overall Study|Physician Decision|0|||
162801128|NCT03377699|587981661|FG000|Overall Study|Withdrawal by Subject|2|||
162801129|NCT03377699|587981662|FG001|Overall Study|Withdrawal by Subject|9|||
162801130|NCT03377699|587981661|FG000|Overall Study|Lost to Follow-up|1|||
162801131|NCT03377699|587981662|FG001|Overall Study|Lost to Follow-up|1|||
162801132|NCT03377699|587981661|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
162801133|NCT03377699|587981662|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
162801134|NCT03377699|587981661|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
162801135|NCT03377699|587981662|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
162801136|NCT03377699|587981661|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
162801137|NCT03377699|587981662|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
162801138|NCT03377699|587981661|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
162801139|NCT03377699|587981662|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
162801140|NCT02580305|587981666|FG000|Overall Study|Adverse Event|15|||
162801141|NCT02580305|587981667|FG001|Overall Study|Adverse Event|19|||
162801142|NCT02580305|587981668|FG002|Overall Study|Adverse Event|10|||
162801143|NCT02580305|587981666|FG000|Overall Study|Lack of Efficacy|5|||
162801144|NCT02580305|587981667|FG001|Overall Study|Lack of Efficacy|0|||
162801145|NCT02580305|587981668|FG002|Overall Study|Lack of Efficacy|2|||
162801146|NCT02580305|587981666|FG000|Overall Study|Protocol Violation|4|||
162801147|NCT02580305|587981667|FG001|Overall Study|Protocol Violation|9|||
162801148|NCT02580305|587981668|FG002|Overall Study|Protocol Violation|6|||
162801149|NCT02580305|587981666|FG000|Overall Study|Lost to Follow-up|4|||
162801150|NCT02580305|587981667|FG001|Overall Study|Lost to Follow-up|4|||
162801151|NCT02580305|587981668|FG002|Overall Study|Lost to Follow-up|2|||
162801152|NCT02580305|587981666|FG000|Overall Study|Withdrawal by Subject|11|||
162801153|NCT02580305|587981667|FG001|Overall Study|Withdrawal by Subject|9|||
162801154|NCT02580305|587981668|FG002|Overall Study|Withdrawal by Subject|7|||
162801155|NCT02580305|587981666|FG000|Overall Study|Randomized in error and never treated|4|||
162801156|NCT02580305|587981667|FG001|Overall Study|Randomized in error and never treated|8|||
162801157|NCT02580305|587981668|FG002|Overall Study|Randomized in error and never treated|5|||
162801158|NCT03582943|587981669|FG000|Allocated to Groups|Withdrawal by Subject|1|||
162801159|NCT03582943|587981670|FG001|Allocated to Groups|Withdrawal by Subject|1|||
162801160|NCT03582943|587981669|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
162801161|NCT03582943|587981670|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
162801162|NCT03582943|587981669|FG000|Analyzed|Protocol Violation|4|||
162801163|NCT03582943|587981670|FG001|Analyzed|Protocol Violation|1|||
162801164|NCT01631227|587981673|FG000|Overall Study|withdrawn consent|27|||
162801165|NCT01631227|587981674|FG001|Overall Study|withdrawn consent|21|||
162801166|NCT01631227|587981673|FG000|Overall Study|Adverse Event|1|||
162801167|NCT01631227|587981674|FG001|Overall Study|Adverse Event|0|||
162801168|NCT01631227|587981673|FG000|Overall Study|administrative|2|||
162801169|NCT01631227|587981674|FG001|Overall Study|administrative|1|||
162801170|NCT01153321|587981675|FG000|Overall Study|Development of study withdrawal criteria|0|||
162801171|NCT01153321|587981676|FG001|Overall Study|Development of study withdrawal criteria|1|||
162801172|NCT01153321|587981675|FG000|Overall Study|Withdrawal by Subject|0|||
162801173|NCT01153321|587981676|FG001|Overall Study|Withdrawal by Subject|1|||
162801174|NCT01153321|587981675|FG000|Overall Study|Adverse Event|1|||
162801175|NCT01153321|587981676|FG001|Overall Study|Adverse Event|1|||
162801176|NCT01177800|587981678|FG000|Overall Study|Adverse Event|9|||
162801177|NCT01177800|587981679|FG001|Overall Study|Adverse Event|3|||
162801178|NCT01177800|587981678|FG000|Overall Study|Protocol Violation|0|||
162801179|NCT01177800|587981679|FG001|Overall Study|Protocol Violation|1|||
162801180|NCT01177800|587981678|FG000|Overall Study|Physician Decision|1|||
162801181|NCT01177800|587981679|FG001|Overall Study|Physician Decision|0|||
162801182|NCT01177800|587981678|FG000|Overall Study|Withdrawal of informed consent|0|||
162801183|NCT01177800|587981679|FG001|Overall Study|Withdrawal of informed consent|1|||
162801184|NCT03053518|587981683|FG000|Overall Study|Withdrawal by Subject|3|||
162801185|NCT03053518|587981683|FG000|Overall Study|Lost to Follow-up|2|||
162801186|NCT03053518|587981683|FG000|Overall Study|Ineligible|5|||
162801187|NCT02683876|587981684|FG000|Overall Study|samples damaged during shipping|2|||
162801188|NCT02683876|587981685|FG001|Overall Study|samples damaged during shipping|0|||
162801189|NCT05560243|587981686|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
162801190|NCT01232738|587981688|FG000|Overall Study|Death|3|||
162801191|NCT01232738|587981688|FG000|Overall Study|Physician Decision|2|||
162801192|NCT01232738|587981688|FG000|Overall Study|Lost to Follow-up|1|||
162801193|NCT01232738|587981688|FG000|Overall Study|Withdrawal by Subject|2|||
162801194|NCT01232738|587981688|FG000|Overall Study|Adverse Event|5|||
162801195|NCT05870228|587981689|FG000|Overall Study|Lost to Follow-up|2|||
162801196|NCT05870228|587981690|FG001|Overall Study|Lost to Follow-up|0|||
162801197|NCT05870228|587981689|FG000|Overall Study|Withdrawal by Subject|1|||
162801198|NCT05870228|587981690|FG001|Overall Study|Withdrawal by Subject|0|||
162801199|NCT03231800|587981691|FG000|Overall Study|Lost to Follow-up|0|||
162801200|NCT03231800|587981692|FG001|Overall Study|Lost to Follow-up|2|||
162801201|NCT03231800|587981691|FG000|Overall Study|Protocol Violation|1|||
162801202|NCT03231800|587981692|FG001|Overall Study|Protocol Violation|1|||
162801203|NCT03231800|587981691|FG000|Overall Study|reason not provided|2|||
162801204|NCT03231800|587981692|FG001|Overall Study|reason not provided|0|||
162801205|NCT00859222|587981693|FG000|Overall Study|Adverse Event|2|||
162801206|NCT00859222|587981694|FG001|Overall Study|Adverse Event|3|||
162801207|NCT00859222|587981695|FG002|Overall Study|Adverse Event|6|||
162801208|NCT00859222|587981696|FG003|Overall Study|Adverse Event|24|||
162801209|NCT00859222|587981697|FG004|Overall Study|Adverse Event|15|||
162801210|NCT00859222|587981693|FG000|Overall Study|DLT|1|||
162801211|NCT00859222|587981694|FG001|Overall Study|DLT|0|||
162801212|NCT00859222|587981695|FG002|Overall Study|DLT|0|||
162801213|NCT00859222|587981696|FG003|Overall Study|DLT|0|||
162801214|NCT00859222|587981697|FG004|Overall Study|DLT|0|||
162801215|NCT00252577|587981705|FG000|Overall Study|Lost to Follow-up|20|||
162801216|NCT00560066|587981708|FG000|Overall Study|Death|2|||
162801217|NCT00560066|587981709|FG001|Overall Study|Death|1|||
162801218|NCT00560066|587981708|FG000|Overall Study|Withdrawal by Subject|0|||
162801219|NCT00560066|587981709|FG001|Overall Study|Withdrawal by Subject|3|||
162801220|NCT00560066|587981708|FG000|Overall Study|Lost to Follow-up|4|||
162801221|NCT00560066|587981709|FG001|Overall Study|Lost to Follow-up|10|||
162801222|NCT00560066|587981708|FG000|Overall Study|Protocol Violation|0|||
162801223|NCT00560066|587981709|FG001|Overall Study|Protocol Violation|1|||
162801224|NCT00560066|587981708|FG000|Overall Study|Administrative reason|0|||
162801225|NCT00560066|587981709|FG001|Overall Study|Administrative reason|5|||
162801226|NCT00560066|587981708|FG000|Overall Study|Missing primary reason|0|||
162801227|NCT00560066|587981709|FG001|Overall Study|Missing primary reason|2|||
162801228|NCT02797080|587981710|FG000|Overall Study|Lost to Follow-up|1|||
162801229|NCT02797080|587981710|FG000|Overall Study|Withdrawal by Subject|1|||
162801230|NCT04035499|587981711|FG000|Overall Study|Death|2|||
162801231|NCT04035499|587981711|FG000|Overall Study|Withdrawal by Subject|1|||
162801232|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Adverse Event|1|||
162801233|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Adverse Event|1|||
162801234|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Adverse Event|2|||
162801235|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Adverse Event|5|||
162801236|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Adverse Event|0|||
162801237|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
162801238|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
162801239|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
162801240|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
162801241|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
162801242|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
162801243|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
162801244|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
162801245|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
162801246|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
162801247|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162801248|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162801249|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162801250|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
162801251|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162801252|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
162801253|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
162801254|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
162801255|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
162801256|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
162801257|NCT00951015|587981712|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162801258|NCT00951015|587981713|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
162801259|NCT00951015|587981714|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
162801260|NCT00951015|587981715|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162801261|NCT00951015|587981716|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
162801262|NCT00951015|587981712|FG000|Open-label Phase|Adverse Event|0|||
162801263|NCT00951015|587981713|FG001|Open-label Phase|Adverse Event|0|||
162801264|NCT00951015|587981714|FG002|Open-label Phase|Adverse Event|0|||
162801265|NCT00951015|587981715|FG003|Open-label Phase|Adverse Event|0|||
162801266|NCT00951015|587981716|FG004|Open-label Phase|Adverse Event|3|||
162801267|NCT00951015|587981712|FG000|Open-label Phase|Lack of Efficacy|0|||
162801268|NCT00951015|587981713|FG001|Open-label Phase|Lack of Efficacy|0|||
162801269|NCT00951015|587981714|FG002|Open-label Phase|Lack of Efficacy|0|||
162801270|NCT00951015|587981715|FG003|Open-label Phase|Lack of Efficacy|0|||
162801271|NCT00951015|587981716|FG004|Open-label Phase|Lack of Efficacy|1|||
162801272|NCT00951015|587981712|FG000|Open-label Phase|Protocol Violation|0|||
162801273|NCT00951015|587981713|FG001|Open-label Phase|Protocol Violation|0|||
162801274|NCT00951015|587981714|FG002|Open-label Phase|Protocol Violation|0|||
162801275|NCT00951015|587981715|FG003|Open-label Phase|Protocol Violation|0|||
162801276|NCT00951015|587981716|FG004|Open-label Phase|Protocol Violation|12|||
162801277|NCT00951015|587981712|FG000|Open-label Phase|Lost to Follow-up|0|||
162801278|NCT00951015|587981713|FG001|Open-label Phase|Lost to Follow-up|0|||
162801279|NCT00951015|587981714|FG002|Open-label Phase|Lost to Follow-up|0|||
162801280|NCT00951015|587981715|FG003|Open-label Phase|Lost to Follow-up|0|||
162801281|NCT00951015|587981716|FG004|Open-label Phase|Lost to Follow-up|12|||
162801282|NCT00951015|587981712|FG000|Open-label Phase|Withdrawal by Subject|0|||
162801283|NCT00951015|587981713|FG001|Open-label Phase|Withdrawal by Subject|0|||
162801284|NCT00951015|587981714|FG002|Open-label Phase|Withdrawal by Subject|0|||
162801285|NCT00951015|587981715|FG003|Open-label Phase|Withdrawal by Subject|0|||
162801286|NCT00951015|587981716|FG004|Open-label Phase|Withdrawal by Subject|14|||
162801287|NCT00951015|587981712|FG000|Open-label Phase|Physician Decision|0|||
162801288|NCT00951015|587981713|FG001|Open-label Phase|Physician Decision|0|||
162801289|NCT00951015|587981714|FG002|Open-label Phase|Physician Decision|0|||
162801290|NCT00951015|587981715|FG003|Open-label Phase|Physician Decision|0|||
162801291|NCT00951015|587981716|FG004|Open-label Phase|Physician Decision|8|||
162801292|NCT01416389|587981717|FG000|Overall Study|Lost to Follow-up|1|||
162801293|NCT01416389|587981718|FG001|Overall Study|Lost to Follow-up|0|||
162801294|NCT01416389|587981717|FG000|Overall Study|Started New Therapy|2|||
162801295|NCT01416389|587981718|FG001|Overall Study|Started New Therapy|0|||
162801296|NCT02535091|587981725|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
162801297|NCT02535091|587981726|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
162801298|NCT02535091|587981727|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
162801299|NCT02535091|587981725|FG000|Overall Study|Withdrawal by Subject|14|||
162801300|NCT02535091|587981726|FG001|Overall Study|Withdrawal by Subject|5|||
162801301|NCT02535091|587981727|FG002|Overall Study|Withdrawal by Subject|121|||
162801302|NCT02535091|587981725|FG000|Overall Study|Adverse Event|9|||
162801303|NCT02535091|587981726|FG001|Overall Study|Adverse Event|4|||
162801304|NCT02535091|587981727|FG002|Overall Study|Adverse Event|170|||
162801305|NCT02535091|587981725|FG000|Overall Study|Other|4|||
162801306|NCT02535091|587981726|FG001|Overall Study|Other|3|||
162801307|NCT02535091|587981727|FG002|Overall Study|Other|81|||
162801308|NCT02535091|587981725|FG000|Overall Study|Lost to Follow-up|0|||
162801309|NCT02535091|587981726|FG001|Overall Study|Lost to Follow-up|1|||
162801310|NCT02535091|587981727|FG002|Overall Study|Lost to Follow-up|19|||
162801311|NCT02535091|587981725|FG000|Overall Study|Protocol Violation|0|||
162801312|NCT02535091|587981726|FG001|Overall Study|Protocol Violation|1|||
162801313|NCT02535091|587981727|FG002|Overall Study|Protocol Violation|11|||
162801314|NCT02535091|587981725|FG000|Overall Study|Pregnancy|0|||
162801315|NCT02535091|587981726|FG001|Overall Study|Pregnancy|0|||
162801316|NCT02535091|587981727|FG002|Overall Study|Pregnancy|7|||
162801317|NCT01151410|587981728|FG000|Overall Study|Withdrawal by Subject|3|||
162801318|NCT01151410|587981729|FG001|Overall Study|Withdrawal by Subject|5|||
162801319|NCT01151410|587981728|FG000|Overall Study|Lost to Follow-up|3|||
162801320|NCT01151410|587981729|FG001|Overall Study|Lost to Follow-up|4|||
162801321|NCT01151410|587981728|FG000|Overall Study|Adverse Event|1|||
162801322|NCT01151410|587981729|FG001|Overall Study|Adverse Event|2|||
162801323|NCT01151410|587981728|FG000|Overall Study|Protocol deviation|2|||
162801324|NCT01151410|587981729|FG001|Overall Study|Protocol deviation|1|||
162801325|NCT01151410|587981728|FG000|Overall Study|Administrative problems|1|||
162801326|NCT01151410|587981729|FG001|Overall Study|Administrative problems|1|||
162801327|NCT01151410|587981728|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162801328|NCT01151410|587981729|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162801329|NCT01151410|587981728|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162801330|NCT01151410|587981729|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162801331|NCT01253018|587981730|FG000|Overall Study|Lost to Follow-up|1|||
162801332|NCT01253018|587981731|FG001|Overall Study|Lost to Follow-up|1|||
162801333|NCT01253018|587981730|FG000|Overall Study|Robot Repair Issues|2|||
162801334|NCT01253018|587981731|FG001|Overall Study|Robot Repair Issues|0|||
162801335|NCT01253018|587981730|FG000|Overall Study|Withdrawal by Subject|1|||
162801336|NCT01253018|587981731|FG001|Overall Study|Withdrawal by Subject|1|||
162801337|NCT00744757|587981732|FG000|Overall Study|Objective disease progression|7|||
162801338|NCT00744757|587981732|FG000|Overall Study|Physician Decision|5|||
162801339|NCT00744757|587981732|FG000|Overall Study|Withdrawal by Subject|1|||
162801340|NCT00744757|587981732|FG000|Overall Study|Death|6|||
162801341|NCT00744757|587981732|FG000|Overall Study|Adverse Event|2|||
162801342|NCT00548262|587981733|FG000|Overall Study|Death|21|||
162801343|NCT00548262|587981733|FG000|Overall Study|Adverse Event|2|||
162801344|NCT00548262|587981733|FG000|Overall Study|Lack of Efficacy|4|||
162801345|NCT00548262|587981733|FG000|Overall Study|Lost to Follow-up|1|||
162801346|NCT00548262|587981733|FG000|Overall Study|Other|3|||
162801347|NCT00548262|587981733|FG000|Overall Study|Withdrawal by Subject|1|||
162801348|NCT01712659|587981734|FG000|Dose Escalation|Physician Decision|0|||
162801349|NCT01712659|587981735|FG001|Dose Escalation|Physician Decision|1|||
162801350|NCT01712659|587981736|FG002|Dose Escalation|Physician Decision|0|||
162801351|NCT01712659|587981737|FG003|Dose Escalation|Physician Decision|0|||
162801352|NCT01712659|587981738|FG004|Dose Escalation|Physician Decision|0|||
162801353|NCT01712659|587981734|FG000|Dose Escalation|Unable to take study drug|0|||
162801354|NCT01712659|587981735|FG001|Dose Escalation|Unable to take study drug|1|||
162801355|NCT01712659|587981736|FG002|Dose Escalation|Unable to take study drug|0|||
162801356|NCT01712659|587981737|FG003|Dose Escalation|Unable to take study drug|0|||
162801357|NCT01712659|587981738|FG004|Dose Escalation|Unable to take study drug|0|||
162801358|NCT01712659|587981734|FG000|Dose Expansion|Early disease progression|1|||
162801359|NCT01712659|587981735|FG001|Dose Expansion|Early disease progression|0|||
162801360|NCT01712659|587981736|FG002|Dose Expansion|Early disease progression|0|||
162801361|NCT01712659|587981737|FG003|Dose Expansion|Early disease progression|0|||
162801362|NCT01712659|587981738|FG004|Dose Expansion|Early disease progression|0|||
162801363|NCT01712659|587981734|FG000|Dose Expansion|Physician Decision|1|||
162801364|NCT01712659|587981735|FG001|Dose Expansion|Physician Decision|0|||
162801365|NCT01712659|587981736|FG002|Dose Expansion|Physician Decision|0|||
162801366|NCT01712659|587981737|FG003|Dose Expansion|Physician Decision|0|||
162801367|NCT01712659|587981738|FG004|Dose Expansion|Physician Decision|0|||
162801368|NCT01769326|587981742|FG000|Overall Study|Lost to Follow-up|1|||
162801369|NCT01769326|587981743|FG001|Overall Study|Lost to Follow-up|2|||
162801370|NCT01769326|587981744|FG002|Overall Study|Lost to Follow-up|0|||
162801371|NCT01769326|587981745|FG003|Overall Study|Lost to Follow-up|0|||
162801372|NCT01769326|587981742|FG000|Overall Study|unrelated injry|1|||
162801373|NCT01769326|587981743|FG001|Overall Study|unrelated injry|1|||
162801374|NCT01769326|587981744|FG002|Overall Study|unrelated injry|0|||
162801375|NCT01769326|587981745|FG003|Overall Study|unrelated injry|0|||
162801376|NCT01769326|587981742|FG000|Overall Study|got a job|0|||
162801377|NCT01769326|587981743|FG001|Overall Study|got a job|1|||
162801378|NCT01769326|587981744|FG002|Overall Study|got a job|0|||
162801379|NCT01769326|587981745|FG003|Overall Study|got a job|0|||
162801380|NCT01769326|587981742|FG000|Overall Study|Got sick and could not complete study|0|||
162801381|NCT01769326|587981743|FG001|Overall Study|Got sick and could not complete study|0|||
162801382|NCT01769326|587981744|FG002|Overall Study|Got sick and could not complete study|1|||
162801383|NCT01769326|587981745|FG003|Overall Study|Got sick and could not complete study|0|||
162801384|NCT01036438|587981746|FG000|Overall Study|Adverse Event|7|||
162801385|NCT01036438|587981747|FG001|Overall Study|Adverse Event|8|||
162801386|NCT01036438|587981746|FG000|Overall Study|Death|0|||
162801387|NCT01036438|587981747|FG001|Overall Study|Death|1|||
162801388|NCT01036438|587981746|FG000|Overall Study|No effect of study treatment|3|||
162801389|NCT01036438|587981747|FG001|Overall Study|No effect of study treatment|1|||
162801390|NCT00888927|587981748|FG000|Overall Study|Adverse Event|0|||
162801391|NCT00888927|587981749|FG001|Overall Study|Adverse Event|0|||
162801392|NCT00888927|587981750|FG002|Overall Study|Adverse Event|0|||
162801393|NCT00888927|587981751|FG003|Overall Study|Adverse Event|1|||
162801394|NCT00888927|587981748|FG000|Overall Study|Withdrawal of consent|0|||
162801395|NCT00888927|587981749|FG001|Overall Study|Withdrawal of consent|0|||
162801396|NCT00888927|587981750|FG002|Overall Study|Withdrawal of consent|0|||
162801397|NCT00888927|587981751|FG003|Overall Study|Withdrawal of consent|1|||
162801398|NCT00969709|587983474|FG000|Overall Study|Adverse Event|3|||
162801399|NCT00969709|587983475|FG001|Overall Study|Adverse Event|13|||
162801400|NCT00969709|587983476|FG002|Overall Study|Adverse Event|26|||
162801401|NCT00969709|587983477|FG003|Overall Study|Adverse Event|12|||
162801402|NCT00969709|587983474|FG000|Overall Study|Lack of Efficacy|7|||
162801403|NCT00969709|587983475|FG001|Overall Study|Lack of Efficacy|4|||
162801404|NCT00969709|587983476|FG002|Overall Study|Lack of Efficacy|1|||
162801405|NCT00969709|587983477|FG003|Overall Study|Lack of Efficacy|3|||
162801406|NCT00969709|587983474|FG000|Overall Study|Protocol Violation|9|||
162801407|NCT00969709|587983475|FG001|Overall Study|Protocol Violation|5|||
162801408|NCT00969709|587983476|FG002|Overall Study|Protocol Violation|9|||
162801409|NCT00969709|587983477|FG003|Overall Study|Protocol Violation|10|||
162801410|NCT00969709|587983474|FG000|Overall Study|Withdrawal by Subject|9|||
162801411|NCT00969709|587983475|FG001|Overall Study|Withdrawal by Subject|12|||
162801412|NCT00969709|587983476|FG002|Overall Study|Withdrawal by Subject|11|||
162801413|NCT00969709|587983477|FG003|Overall Study|Withdrawal by Subject|23|||
162801414|NCT00969709|587983474|FG000|Overall Study|Lost to Follow-up|10|||
162801415|NCT00969709|587983475|FG001|Overall Study|Lost to Follow-up|14|||
162801416|NCT00969709|587983476|FG002|Overall Study|Lost to Follow-up|8|||
162801417|NCT00969709|587983477|FG003|Overall Study|Lost to Follow-up|15|||
162801418|NCT00969709|587983474|FG000|Overall Study|Other reasons|0|||
162801419|NCT00969709|587983475|FG001|Overall Study|Other reasons|0|||
162801420|NCT00969709|587983476|FG002|Overall Study|Other reasons|3|||
162801421|NCT00969709|587983477|FG003|Overall Study|Other reasons|0|||
162801422|NCT03695237|587983478|FG000|Overall Study|Withdrawal by Subject|1|||
162801423|NCT03695237|587983479|FG001|Overall Study|Withdrawal by Subject|3|||
162801424|NCT03695237|587983478|FG000|Overall Study|Lost to Follow-up|1|||
162801425|NCT03695237|587983479|FG001|Overall Study|Lost to Follow-up|2|||
162801426|NCT03695237|587983478|FG000|Overall Study|Other, Not Specified|8|||
162801427|NCT03695237|587983479|FG001|Overall Study|Other, Not Specified|2|||
162801428|NCT02516332|587983480|FG000|Overall Study|Withdrawal by Subject|2|||
162801429|NCT02516332|587983481|FG001|Overall Study|Withdrawal by Subject|1|||
162801430|NCT02516332|587983482|FG002|Overall Study|Withdrawal by Subject|2|||
162801431|NCT00055601|587983483|FG000|Overall Study|Protocol Violation|1|||
162801432|NCT00055601|587983484|FG001|Overall Study|Protocol Violation|1|||
162801433|NCT00055601|587983483|FG000|Overall Study|No protocol treatment received|1|||
162801434|NCT00055601|587983484|FG001|Overall Study|No protocol treatment received|1|||
162801435|NCT02217332|587983485|FG000|Overall Study|Adverse Event|3|||
162801436|NCT02217332|587983485|FG000|Overall Study|Dose interruption >1 month|1|||
162801437|NCT02217332|587983485|FG000|Overall Study|Protocol Violation (eligibility)|1|||
162801438|NCT02217332|587983485|FG000|Overall Study|Withdrawal by Subject|1|||
162801439|NCT02217332|587983485|FG000|Overall Study|Lost to Follow-up|1|||
162801440|NCT02914275|587983491|FG000|Overall Study|Lost to Follow-up|84|||
162801441|NCT02914275|587983492|FG001|Overall Study|Lost to Follow-up|29|||
162801442|NCT02914275|587983491|FG000|Overall Study|Withdrawal by Subject|26|||
162801443|NCT02914275|587983492|FG001|Overall Study|Withdrawal by Subject|10|||
162801444|NCT02914275|587983491|FG000|Overall Study|Protocol Violation|1|||
162801445|NCT02914275|587983492|FG001|Overall Study|Protocol Violation|1|||
162801446|NCT02914275|587983491|FG000|Overall Study|Physician Decision|3|||
162801447|NCT02914275|587983492|FG001|Overall Study|Physician Decision|1|||
162801448|NCT02914275|587983491|FG000|Overall Study|Other|4|||
162801449|NCT02914275|587983492|FG001|Overall Study|Other|1|||
162801450|NCT02914275|587983491|FG000|Overall Study|Excluded due to invalid informed consent|3|||
162801451|NCT02914275|587983492|FG001|Overall Study|Excluded due to invalid informed consent|0|||
162801452|NCT00923260|587983493|FG000|Overall Study|Lost to Follow-up|1|||
162801453|NCT00923260|587983494|FG001|Overall Study|Lost to Follow-up|1|||
162801454|NCT02134977|587983507|FG000|Overall Study|Protocol Deviation|102|||
162801455|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Adverse Event|6|||
162801456|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Adverse Event|6|||
162801457|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Death|1|||
162801458|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Death|1|||
162801459|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162801460|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162801461|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
162801462|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
162801463|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Physician Decision|1|||
162801464|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Physician Decision|4|||
162801465|NCT03828747|587983508|FG000|Double-Blind Treatment Period|Various reasons|5|||
162801466|NCT03828747|587983509|FG001|Double-Blind Treatment Period|Various reasons|3|||
162801467|NCT03828747|587983508|FG000|Open-Label Extension|Adverse Event|9|||
162801468|NCT03828747|587983509|FG001|Open-Label Extension|Adverse Event|7|||
162801469|NCT03828747|587983508|FG000|Open-Label Extension|Death|0|||
162801470|NCT03828747|587983509|FG001|Open-Label Extension|Death|2|||
162801471|NCT03828747|587983508|FG000|Open-Label Extension|Lost to Follow-up|4|||
162801472|NCT03828747|587983509|FG001|Open-Label Extension|Lost to Follow-up|0|||
162801473|NCT03828747|587983508|FG000|Open-Label Extension|Withdrawal by Subject|31|||
162801474|NCT03828747|587983509|FG001|Open-Label Extension|Withdrawal by Subject|30|||
162801475|NCT03828747|587983508|FG000|Open-Label Extension|Various reasons|4|||
162801476|NCT03828747|587983509|FG001|Open-Label Extension|Various reasons|4|||
162801477|NCT03828747|587983508|FG000|Open-Label Extension|Physician Decision|6|||
162801478|NCT03828747|587983509|FG001|Open-Label Extension|Physician Decision|2|||
162801479|NCT01658150|587983510|FG000|Overall Study|Withdrawal by Subject|1|||
162801480|NCT04187989|587983511|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
162801481|NCT04187989|587983512|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
162801482|NCT04187989|587983511|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
162801483|NCT04187989|587983512|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
162801484|NCT03646656|587983513|FG000|Overall Study|Lost to Follow-up|1|||
162801485|NCT03646656|587983514|FG001|Overall Study|Lost to Follow-up|0|||
162801486|NCT03646656|587983513|FG000|Overall Study|Withdrawal by Subject|2|||
162801487|NCT03646656|587983514|FG001|Overall Study|Withdrawal by Subject|0|||
162801488|NCT03507777|587983515|FG000|Overall Study|Lost to Follow-up|5|||
162801489|NCT03507777|587983516|FG001|Overall Study|Lost to Follow-up|7|||
162801490|NCT03507777|587983515|FG000|Overall Study|Withdrawal by Subject|6|||
162801491|NCT03507777|587983516|FG001|Overall Study|Withdrawal by Subject|11|||
162801492|NCT03507777|587983515|FG000|Overall Study|Death|30|||
162801493|NCT03507777|587983516|FG001|Overall Study|Death|44|||
162801494|NCT03507777|587983515|FG000|Overall Study|Other Reasons|3|||
162801495|NCT03507777|587983516|FG001|Overall Study|Other Reasons|8|||
162801496|NCT00446043|587983517|FG000|Overall Study|Adverse Event|9|||
162801497|NCT00446043|587983517|FG000|Overall Study|Withdrawal by Subject|70|||
162801498|NCT00446043|587983517|FG000|Overall Study|Protocol Violation|2|||
162801499|NCT00446043|587983517|FG000|Overall Study|Lost to Follow-up|42|||
162801500|NCT00446043|587983517|FG000|Overall Study|Pregnancy|2|||
162801501|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
162801502|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162801503|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162801504|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162801505|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162801506|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
162801507|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162801508|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162801509|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162801510|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162801511|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
162801512|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162801513|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162801514|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162801515|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162801516|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
162801517|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162801518|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162801519|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162801520|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162801521|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
162801522|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162801523|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162801524|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162801525|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162801526|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
162801527|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162801528|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162801529|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162801530|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162801531|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
162801532|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162801533|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162801534|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162801535|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162801536|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
162801537|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162801538|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162801539|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162801540|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162801541|NCT00700427|587983518|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
162801542|NCT00700427|587983519|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162801543|NCT00700427|587983520|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162801544|NCT00700427|587983521|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162801545|NCT00700427|587983522|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162801546|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162801547|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
162801548|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162801549|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162801550|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162801551|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162801552|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
162801553|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162801554|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162801555|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162801556|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162801557|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
162801558|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162801559|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162801560|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162801561|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162801562|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
162801563|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162801564|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162801565|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162801566|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162801567|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
162801568|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162801569|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162801570|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162801571|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162801572|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
162801573|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162801574|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162801575|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162801576|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162801577|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
162801578|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162801579|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162801580|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162801581|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162801582|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
162801583|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162801584|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162801585|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162801586|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162801587|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
162801588|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162801589|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162801590|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162801591|NCT00700427|587983518|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162801592|NCT00700427|587983519|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
162801593|NCT00700427|587983520|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162801594|NCT00700427|587983521|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162801595|NCT00700427|587983522|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162801596|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162801597|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162801598|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
162801599|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
162801600|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162801601|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162801602|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162801603|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
162801604|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
162801605|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162801606|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162801607|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162801608|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
162801609|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
162801610|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162801611|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162801612|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162801613|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
162801614|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
162801615|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162801616|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162925434|NCT01346501|588428972|FG001|Overall Study|Initiated Other Biological Agents|1|||
162925435|NCT01346501|588428971|FG000|Overall Study|Other|8|||
162801617|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162801618|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
162801619|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
162801620|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162801621|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162801622|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162801623|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162801624|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
162801625|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162801626|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162801627|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162801628|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162801629|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
162801630|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162801631|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162801632|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162801633|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
162801634|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
162801635|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162801636|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162801637|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162801638|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
162801639|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162801640|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162801641|NCT00700427|587983518|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
162801642|NCT00700427|587983519|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
162801643|NCT00700427|587983520|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
162801644|NCT00700427|587983521|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
162801645|NCT00700427|587983522|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
162801646|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162801647|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162801648|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162801649|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162801650|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
162801651|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
162801652|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
162801653|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
162801654|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
162801655|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
162801656|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162801657|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162801658|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162801659|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162801660|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
162801661|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162801662|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162801663|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162801664|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162801665|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
162801666|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162801667|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162801668|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162801669|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162801670|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
162801671|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162801672|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162801673|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162801674|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162801675|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
162801676|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162801677|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162801678|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162801679|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162801680|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
162801681|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162801682|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162801683|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162801684|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162801685|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
162801686|NCT00700427|587983518|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162801687|NCT00700427|587983519|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162801688|NCT00700427|587983520|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162801689|NCT00700427|587983521|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162801690|NCT00700427|587983522|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
162801691|NCT03500159|587983524|FG000|Overall Study|Study Terminated|2|||
162801692|NCT03500159|587983525|FG001|Overall Study|Study Terminated|1|||
162801693|NCT04075994|587983526|FG000|Overall Study|Withdrawal by Subject|8|||
162801694|NCT04075994|587983527|FG001|Overall Study|Withdrawal by Subject|9|||
162801695|NCT04075994|587983526|FG000|Overall Study|Adverse Event|2|||
162801696|NCT04075994|587983527|FG001|Overall Study|Adverse Event|2|||
162801697|NCT04075994|587983526|FG000|Overall Study|Investigator withdrew|3|||
162801698|NCT04075994|587983527|FG001|Overall Study|Investigator withdrew|1|||
162801699|NCT01941719|587983533|FG000|Overall Study|Lost to Follow-up|20|||
162801700|NCT01941719|587983534|FG001|Overall Study|Lost to Follow-up|19|||
162801701|NCT03819634|587983536|FG000|Overall Study|Physician Decision|2|||
162801702|NCT00958841|587983537|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162801703|NCT00958841|587983537|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162801704|NCT00958841|587983537|FG000|Overall Study|Administrative problems|1|||
162801705|NCT00958841|587983537|FG000|Overall Study|Adverse Event|8|||
162801706|NCT00958841|587983537|FG000|Overall Study|New cancer therapy|5|||
162801707|NCT00958841|587983537|FG000|Overall Study|Withdrawal by Subject|1|||
162801708|NCT00958841|587983537|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
162801709|NCT00958841|587983537|FG000|Overall Study|Completed M6/did not enter extension|27|||
162801710|NCT00958841|587983537|FG000|Overall Study|Discontinued prior to M*|28|||
162801711|NCT01125514|587983539|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
162801712|NCT01125514|587983539|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
162801713|NCT01125514|587983539|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
162801714|NCT01125514|587983539|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
162801715|NCT01125514|587983539|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
162801716|NCT01125514|587983539|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
162801717|NCT00858364|587983540|FG000|Overall Study|Administrative Decision|3|||
162801718|NCT00858364|587983541|FG001|Overall Study|Administrative Decision|2|||
162801719|NCT00858364|587983540|FG000|Overall Study|Adverse Event|5|||
162801720|NCT00858364|587983541|FG001|Overall Study|Adverse Event|2|||
162801721|NCT00858364|587983540|FG000|Overall Study|Withdrawal by Subject|44|||
162801722|NCT00858364|587983541|FG001|Overall Study|Withdrawal by Subject|118|||
162801723|NCT00858364|587983540|FG000|Overall Study|Ineligibility Determined|1|||
162801724|NCT00858364|587983541|FG001|Overall Study|Ineligibility Determined|10|||
162801725|NCT00858364|587983540|FG000|Overall Study|Lost to Follow-up|24|||
162801726|NCT00858364|587983541|FG001|Overall Study|Lost to Follow-up|54|||
162801727|NCT00858364|587983540|FG000|Overall Study|Noncompliance|3|||
162801728|NCT00858364|587983541|FG001|Overall Study|Noncompliance|4|||
162801729|NCT00858364|587983540|FG000|Overall Study|Protocol Deviation|0|||
162801730|NCT00858364|587983541|FG001|Overall Study|Protocol Deviation|2|||
162801731|NCT00858364|587983540|FG000|Overall Study|Other|9|||
162801732|NCT00858364|587983541|FG001|Overall Study|Other|17|||
162801733|NCT00858364|587983540|FG000|Overall Study|Missing|1|||
162801734|NCT00858364|587983541|FG001|Overall Study|Missing|1|||
162801735|NCT00858364|587983540|FG000|Overall Study|Still on-study|114|||
162801736|NCT00858364|587983541|FG001|Overall Study|Still on-study|247|||
162801737|NCT01655693|587983545|FG000|Overall Study|Progression of Disease|92|||
162801738|NCT01655693|587983546|FG001|Overall Study|Progression of Disease|76|||
162801739|NCT01655693|587983547|FG002|Overall Study|Progression of Disease|58|||
162801740|NCT01655693|587983545|FG000|Overall Study|Death|8|||
162801741|NCT01655693|587983546|FG001|Overall Study|Death|9|||
162801742|NCT01655693|587983547|FG002|Overall Study|Death|12|||
162801743|NCT01655693|587983545|FG000|Overall Study|Serious Adverse Event|3|||
162801744|NCT01655693|587983546|FG001|Overall Study|Serious Adverse Event|15|||
162801745|NCT01655693|587983547|FG002|Overall Study|Serious Adverse Event|11|||
162801746|NCT01655693|587983545|FG000|Overall Study|Withdrawal by Subject|3|||
162801747|NCT01655693|587983546|FG001|Overall Study|Withdrawal by Subject|2|||
162801748|NCT01655693|587983547|FG002|Overall Study|Withdrawal by Subject|20|||
162801749|NCT01655693|587983545|FG000|Overall Study|Adverse Event|3|||
162801750|NCT01655693|587983546|FG001|Overall Study|Adverse Event|11|||
162801751|NCT01655693|587983547|FG002|Overall Study|Adverse Event|3|||
162801752|NCT01655693|587983545|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
162801753|NCT01655693|587983546|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
162801754|NCT01655693|587983547|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
162801755|NCT01655693|587983545|FG000|Overall Study|Non-Compliance|0|||
162801756|NCT01655693|587983546|FG001|Overall Study|Non-Compliance|0|||
162801757|NCT01655693|587983547|FG002|Overall Study|Non-Compliance|7|||
162801758|NCT01655693|587983545|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
162801759|NCT01655693|587983546|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
162801760|NCT01655693|587983547|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
162801761|NCT01655693|587983545|FG000|Overall Study|Protocol Violation|1|||
162801762|NCT01655693|587983546|FG001|Overall Study|Protocol Violation|0|||
162801763|NCT01655693|587983547|FG002|Overall Study|Protocol Violation|3|||
162801764|NCT01655693|587983545|FG000|Overall Study|Lost to Follow-up|1|||
162801765|NCT01655693|587983546|FG001|Overall Study|Lost to Follow-up|0|||
162801766|NCT01655693|587983547|FG002|Overall Study|Lost to Follow-up|1|||
162801767|NCT01655693|587983545|FG000|Overall Study|Screening Failure|1|||
162801768|NCT01655693|587983546|FG001|Overall Study|Screening Failure|0|||
162801769|NCT01655693|587983547|FG002|Overall Study|Screening Failure|0|||
162801770|NCT01655693|587983545|FG000|Overall Study|Other|8|||
162801771|NCT01655693|587983546|FG001|Overall Study|Other|6|||
162801772|NCT01655693|587983547|FG002|Overall Study|Other|15|||
162801773|NCT00929110|587983550|FG000|Overall Study|Adverse Event|40|||
162801774|NCT00929110|587983551|FG001|Overall Study|Adverse Event|29|||
162801775|NCT00929110|587983552|FG002|Overall Study|Adverse Event|18|||
162801776|NCT00929110|587983550|FG000|Overall Study|Subject withdrew consent|40|||
162801777|NCT00929110|587983551|FG001|Overall Study|Subject withdrew consent|23|||
162801778|NCT00929110|587983552|FG002|Overall Study|Subject withdrew consent|26|||
162801779|NCT00929110|587983550|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
162801780|NCT00929110|587983551|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
162801781|NCT00929110|587983552|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
162801782|NCT00929110|587983550|FG000|Overall Study|Lost to Follow-up|7|||
162801783|NCT00929110|587983551|FG001|Overall Study|Lost to Follow-up|7|||
162801784|NCT00929110|587983552|FG002|Overall Study|Lost to Follow-up|3|||
162801785|NCT00929110|587983550|FG000|Overall Study|Protocol deviation|5|||
162801786|NCT00929110|587983551|FG001|Overall Study|Protocol deviation|2|||
162801787|NCT00929110|587983552|FG002|Overall Study|Protocol deviation|4|||
162801788|NCT00929110|587983550|FG000|Overall Study|Administrative problems|4|||
162801789|NCT00929110|587983551|FG001|Overall Study|Administrative problems|1|||
162801790|NCT00929110|587983552|FG002|Overall Study|Administrative problems|2|||
162801791|NCT00929110|587983550|FG000|Overall Study|Death|2|||
162801792|NCT00929110|587983551|FG001|Overall Study|Death|2|||
162801793|NCT00929110|587983552|FG002|Overall Study|Death|2|||
162801794|NCT00929110|587983550|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162801795|NCT00929110|587983551|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162801796|NCT00929110|587983552|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162801797|NCT00929110|587983550|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162801798|NCT00929110|587983551|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162801799|NCT00929110|587983552|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162801800|NCT00929110|587983550|FG000|Overall Study|Patient inability to use the device|0|||
162801801|NCT00929110|587983551|FG001|Overall Study|Patient inability to use the device|1|||
162801802|NCT00929110|587983552|FG002|Overall Study|Patient inability to use the device|0|||
162801803|NCT01163292|587983556|FG000|Overall Study|Lack of Efficacy|9|||
162801804|NCT01163292|587983557|FG001|Overall Study|Lack of Efficacy|0|||
162801805|NCT01163292|587983556|FG000|Overall Study|Adverse Event|6|||
162801806|NCT01163292|587983557|FG001|Overall Study|Adverse Event|0|||
162801807|NCT01163292|587983556|FG000|Overall Study|Initiation of biological therapy|0|||
162801808|NCT01163292|587983557|FG001|Overall Study|Initiation of biological therapy|15|||
162801809|NCT01163292|587983556|FG000|Overall Study|Sufficient response to adalimumab|8|||
162801810|NCT01163292|587983557|FG001|Overall Study|Sufficient response to adalimumab|0|||
162801811|NCT01163292|587983556|FG000|Overall Study|Refusal to receive adalimumab|7|||
162801812|NCT01163292|587983557|FG001|Overall Study|Refusal to receive adalimumab|0|||
162801813|NCT01163292|587983556|FG000|Overall Study|Economic reasons|6|||
162801814|NCT01163292|587983557|FG001|Overall Study|Economic reasons|0|||
162801815|NCT01163292|587983556|FG000|Overall Study|No further visits|5|||
162801816|NCT01163292|587983557|FG001|Overall Study|No further visits|7|||
162801817|NCT01259089|587983565|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162801818|NCT01259089|587983566|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162801819|NCT01259089|587983567|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162801820|NCT01259089|587983568|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162801821|NCT01259089|587983569|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162801822|NCT01259089|587983570|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
162801823|NCT01259089|587983565|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
162801824|NCT01259089|587983566|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
162801825|NCT01259089|587983567|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
162801826|NCT01259089|587983568|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
162801827|NCT01259089|587983569|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
162801828|NCT01259089|587983570|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
162801829|NCT01259089|587983565|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162801830|NCT01259089|587983566|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162801831|NCT01259089|587983567|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162801832|NCT01259089|587983568|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162801833|NCT01259089|587983569|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162801834|NCT01259089|587983570|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
162801835|NCT01259089|587983565|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
162801836|NCT01259089|587983566|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
162801837|NCT01259089|587983567|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
162801838|NCT01259089|587983568|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
162801839|NCT01259089|587983569|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
162801840|NCT01259089|587983570|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
162801841|NCT01259089|587983565|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
162801842|NCT01259089|587983566|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
162801843|NCT01259089|587983567|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
162801844|NCT01259089|587983568|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
162801845|NCT01259089|587983569|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
162801846|NCT01259089|587983570|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
162801847|NCT01259089|587983565|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
162801848|NCT01259089|587983566|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162801849|NCT01259089|587983567|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162801850|NCT01259089|587983568|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162801851|NCT01259089|587983569|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162801852|NCT01259089|587983570|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162801853|NCT01259089|587983565|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
162801854|NCT01259089|587983566|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
162801855|NCT01259089|587983567|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
162801856|NCT01259089|587983568|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
162801857|NCT01259089|587983569|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
162801858|NCT01259089|587983570|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
162801859|NCT01259089|587983565|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
162801860|NCT01259089|587983566|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
162801861|NCT01259089|587983567|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
162801862|NCT01259089|587983568|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
162801863|NCT01259089|587983569|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
162801864|NCT01259089|587983570|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
162801865|NCT01259089|587983565|FG000|Survival Follow up for Two Years|Death|3|||
162801866|NCT01259089|587983566|FG001|Survival Follow up for Two Years|Death|2|||
162801867|NCT01259089|587983567|FG002|Survival Follow up for Two Years|Death|2|||
162801868|NCT01259089|587983568|FG003|Survival Follow up for Two Years|Death|3|||
162801869|NCT01259089|587983569|FG004|Survival Follow up for Two Years|Death|6|||
162801870|NCT01259089|587983570|FG005|Survival Follow up for Two Years|Death|13|||
162801871|NCT01259089|587983565|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
162801872|NCT01259089|587983566|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
162801873|NCT01259089|587983567|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
162801874|NCT01259089|587983568|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
162801875|NCT01259089|587983569|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
162801876|NCT01259089|587983570|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
162801877|NCT01259089|587983565|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162801878|NCT01259089|587983566|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162801879|NCT01259089|587983567|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162801880|NCT01259089|587983568|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162801881|NCT01259089|587983569|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162801882|NCT01259089|587983570|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
162801883|NCT02643472|587983571|FG000|Overall Study|Death|2|||
162801884|NCT02643472|587983572|FG001|Overall Study|Death|5|||
162801885|NCT02643472|587983571|FG000|Overall Study|Withdrawal by Subject|3|||
162801886|NCT02643472|587983572|FG001|Overall Study|Withdrawal by Subject|2|||
162801887|NCT02643472|587983571|FG000|Overall Study|Protocol Violation|0|||
162801888|NCT02643472|587983572|FG001|Overall Study|Protocol Violation|1|||
162801889|NCT02643472|587983571|FG000|Overall Study|Lost to Follow-up|22|||
162801890|NCT02643472|587983572|FG001|Overall Study|Lost to Follow-up|26|||
162801891|NCT01258595|587983573|FG000|Overall Study|Lost to Follow-up|1|||
162801892|NCT01258595|587983574|FG001|Overall Study|Lost to Follow-up|0|||
162801893|NCT01258595|587983573|FG000|Overall Study|Withdrawal by Subject|0|||
162801894|NCT01258595|587983574|FG001|Overall Study|Withdrawal by Subject|1|||
162801895|NCT01215188|587983575|FG000|Overall Study|Lost to Follow-up|22|||
162801896|NCT01215188|587983576|FG001|Overall Study|Lost to Follow-up|22|||
162801897|NCT01215188|587983577|FG002|Overall Study|Lost to Follow-up|16|||
162801898|NCT01215188|587983575|FG000|Overall Study|Adverse Event|1|||
162801899|NCT01215188|587983576|FG001|Overall Study|Adverse Event|1|||
162801900|NCT01215188|587983577|FG002|Overall Study|Adverse Event|3|||
162801901|NCT01215188|587983575|FG000|Overall Study|Physician Decision|2|||
162801902|NCT01215188|587983576|FG001|Overall Study|Physician Decision|1|||
162801903|NCT01215188|587983577|FG002|Overall Study|Physician Decision|0|||
162801904|NCT01215188|587983575|FG000|Overall Study|Lack of Efficacy|0|||
162801905|NCT01215188|587983576|FG001|Overall Study|Lack of Efficacy|0|||
162801906|NCT01215188|587983577|FG002|Overall Study|Lack of Efficacy|1|||
162801907|NCT01215188|587983575|FG000|Overall Study|Protocol Violation|1|||
162801908|NCT01215188|587983576|FG001|Overall Study|Protocol Violation|1|||
162801909|NCT01215188|587983577|FG002|Overall Study|Protocol Violation|1|||
162801910|NCT01215188|587983575|FG000|Overall Study|Withdrawal by Subject|32|||
162801911|NCT01215188|587983576|FG001|Overall Study|Withdrawal by Subject|34|||
162801912|NCT01215188|587983577|FG002|Overall Study|Withdrawal by Subject|31|||
162801913|NCT02310100|587983578|FG000|Overall Study|Physician Decision|3|||
162801914|NCT02310100|587983578|FG000|Overall Study|Withdrawal by Subject|10|||
162801915|NCT02310100|587983578|FG000|Overall Study|Enrollment closure|1|||
162801916|NCT02310100|587983578|FG000|Overall Study|Unapproved ablation operator|1|||
162801917|NCT02310100|587983578|FG000|Overall Study|Visit compliance|1|||
162801918|NCT02310100|587983578|FG000|Overall Study|Lost to Follow-up|2|||
162801919|NCT00688870|587983582|FG000|Infant Series|Parent or legal guardian request|4|||
162801920|NCT00688870|587983583|FG001|Infant Series|Parent or legal guardian request|0|||
162801921|NCT01820585|587983587|FG000|Overall Study|Adverse Event|9|||
162801922|NCT01820585|587983588|FG001|Overall Study|Adverse Event|13|||
162801923|NCT01820585|587983589|FG002|Overall Study|Adverse Event|23|||
162801924|NCT01820585|587983590|FG003|Overall Study|Adverse Event|34|||
162801925|NCT01820585|587983587|FG000|Overall Study|Lack of Efficacy|9|||
162801926|NCT01820585|587983588|FG001|Overall Study|Lack of Efficacy|7|||
162801927|NCT01820585|587983589|FG002|Overall Study|Lack of Efficacy|5|||
162801928|NCT01820585|587983590|FG003|Overall Study|Lack of Efficacy|1|||
162801929|NCT01820585|587983587|FG000|Overall Study|Withdrawal by Subject|3|||
162801930|NCT01820585|587983588|FG001|Overall Study|Withdrawal by Subject|7|||
162801931|NCT01820585|587983589|FG002|Overall Study|Withdrawal by Subject|3|||
162801932|NCT01820585|587983590|FG003|Overall Study|Withdrawal by Subject|8|||
162801933|NCT01820585|587983587|FG000|Overall Study|Lost to Follow-up|3|||
162801934|NCT01820585|587983588|FG001|Overall Study|Lost to Follow-up|3|||
162801935|NCT01820585|587983589|FG002|Overall Study|Lost to Follow-up|0|||
162801936|NCT01820585|587983590|FG003|Overall Study|Lost to Follow-up|3|||
162801937|NCT01820585|587983587|FG000|Overall Study|Protocol Violation|3|||
162801938|NCT01820585|587983588|FG001|Overall Study|Protocol Violation|1|||
162801939|NCT01820585|587983589|FG002|Overall Study|Protocol Violation|1|||
162801940|NCT01820585|587983590|FG003|Overall Study|Protocol Violation|1|||
162801941|NCT01820585|587983587|FG000|Overall Study|Subject non-compliance|0|||
162801942|NCT01820585|587983588|FG001|Overall Study|Subject non-compliance|0|||
162801943|NCT01820585|587983589|FG002|Overall Study|Subject non-compliance|1|||
162801944|NCT01820585|587983590|FG003|Overall Study|Subject non-compliance|2|||
162801945|NCT01820585|587983587|FG000|Overall Study|at sponsor request|0|||
162801946|NCT01820585|587983588|FG001|Overall Study|at sponsor request|0|||
162801947|NCT01820585|587983589|FG002|Overall Study|at sponsor request|1|||
162801948|NCT01820585|587983590|FG003|Overall Study|at sponsor request|0|||
162801949|NCT01820585|587983587|FG000|Overall Study|Pregnancy|0|||
162801950|NCT01820585|587983588|FG001|Overall Study|Pregnancy|1|||
162801951|NCT01820585|587983589|FG002|Overall Study|Pregnancy|0|||
162801952|NCT01820585|587983590|FG003|Overall Study|Pregnancy|0|||
162801953|NCT03592745|587983593|FG000|Overall Study|Adverse Event|0|||
162801954|NCT03592745|587983594|FG001|Overall Study|Adverse Event|2|||
162801955|NCT03592745|587983593|FG000|Overall Study|Lost to Follow-up|2|||
162801956|NCT03592745|587983594|FG001|Overall Study|Lost to Follow-up|0|||
162801957|NCT03592745|587983593|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
162801958|NCT03592745|587983594|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
162801959|NCT00293059|587983595|FG000|Overall Study|Adverse Event|12|||
162801960|NCT00293059|587983596|FG001|Overall Study|Adverse Event|4|||
162801961|NCT00293059|587983595|FG000|Overall Study|Lack of Efficacy|2|||
162801962|NCT00293059|587983596|FG001|Overall Study|Lack of Efficacy|0|||
162801963|NCT00293059|587983595|FG000|Overall Study|Lost to Follow-up|2|||
162801964|NCT00293059|587983596|FG001|Overall Study|Lost to Follow-up|3|||
162801965|NCT00293059|587983595|FG000|Overall Study|Pregnancy|1|||
162801966|NCT00293059|587983596|FG001|Overall Study|Pregnancy|1|||
162801967|NCT00293059|587983595|FG000|Overall Study|Protocol Violation|2|||
162801968|NCT00293059|587983596|FG001|Overall Study|Protocol Violation|0|||
162801969|NCT00293059|587983595|FG000|Overall Study|Withdrawal by Subject|11|||
162801970|NCT00293059|587983596|FG001|Overall Study|Withdrawal by Subject|5|||
162801971|NCT00293059|587983595|FG000|Overall Study|Participant moved out of state|1|||
162801972|NCT00293059|587983596|FG001|Overall Study|Participant moved out of state|0|||
162801973|NCT00293059|587983595|FG000|Overall Study|Participant stopped study drug|1|||
162801974|NCT00293059|587983596|FG001|Overall Study|Participant stopped study drug|0|||
162801975|NCT00293059|587983595|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
162801976|NCT00293059|587983596|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
162801977|NCT00293059|587983595|FG000|Overall Study|missing|3|||
162801978|NCT00293059|587983596|FG001|Overall Study|missing|5|||
162801979|NCT04362189|587983600|FG000|Overall Study|Lost to Follow-up|0|||
162801980|NCT04362189|587983601|FG001|Overall Study|Lost to Follow-up|1|||
162801981|NCT04362189|587983600|FG000|Overall Study|Withdrawal by Subject|1|||
162801982|NCT04362189|587983601|FG001|Overall Study|Withdrawal by Subject|0|||
162801983|NCT04362189|587983600|FG000|Overall Study|FDA Clinical Hold|7|||
162801984|NCT04362189|587983601|FG001|Overall Study|FDA Clinical Hold|2|||
162801985|NCT04362189|587983600|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
162801986|NCT04362189|587983601|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
162801987|NCT04362189|587983600|FG000|Overall Study|Adverse Event|0|||
162801988|NCT04362189|587983601|FG001|Overall Study|Adverse Event|2|||
162801989|NCT04362189|587983600|FG000|Overall Study|Death|4|||
162801990|NCT04362189|587983601|FG001|Overall Study|Death|1|||
162801991|NCT02111681|587983602|FG000|Overall Study|Death|5|||
162801992|NCT02111681|587983602|FG000|Overall Study|Lack of Efficacy|2|||
162801993|NCT02111681|587983602|FG000|Overall Study|Progression of disease|4|||
162801994|NCT03981861|587983603|FG000|Overall Study|Withdrawal by Subject|3|||
162801995|NCT01227577|587985816|FG000|Overall Study|Protocol deviation|3|||
162801996|NCT01227577|587985816|FG000|Overall Study|Death|3|||
162801997|NCT01227577|587985816|FG000|Overall Study|Administrative problems|2|||
162801998|NCT01227577|587985816|FG000|Overall Study|Lost to Follow-up|1|||
162801999|NCT01227577|587985816|FG000|Overall Study|Withdrawal by Subject|4|||
162802000|NCT01227577|587985816|FG000|Overall Study|Lack of Efficacy|5|||
162802001|NCT01227577|587985816|FG000|Overall Study|Adverse Event|17|||
162802002|NCT03809429|587985817|FG000|Overall Study|Withdrawal by Subject|7|||
162802003|NCT03809429|587985818|FG001|Overall Study|Withdrawal by Subject|3|||
162802004|NCT03809429|587985817|FG000|Overall Study|Adverse Event|6|||
162802005|NCT03809429|587985818|FG001|Overall Study|Adverse Event|9|||
162802006|NCT03809429|587985817|FG000|Overall Study|COVID-19|3|||
162802007|NCT03809429|587985818|FG001|Overall Study|COVID-19|1|||
162802008|NCT03809429|587985817|FG000|Overall Study|Participant was discontinued by investigator|12|||
162802009|NCT03809429|587985818|FG001|Overall Study|Participant was discontinued by investigator|7|||
162802010|NCT02245737|587985819|FG000|Overall Study|Adverse Event|23|||
162802011|NCT02245737|587985820|FG001|Overall Study|Adverse Event|26|||
162802012|NCT02245737|587985821|FG002|Overall Study|Adverse Event|33|||
162802013|NCT02245737|587985819|FG000|Overall Study|Condition Worsened|9|||
162802014|NCT02245737|587985820|FG001|Overall Study|Condition Worsened|10|||
162802015|NCT02245737|587985821|FG002|Overall Study|Condition Worsened|9|||
162802016|NCT02245737|587985819|FG000|Overall Study|Death|2|||
162802017|NCT02245737|587985820|FG001|Overall Study|Death|4|||
162802018|NCT02245737|587985821|FG002|Overall Study|Death|4|||
162802019|NCT02245737|587985819|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
162802020|NCT02245737|587985820|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
162802021|NCT02245737|587985821|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
162802022|NCT02245737|587985819|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
162802023|NCT02245737|587985820|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
162802024|NCT02245737|587985821|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
162802025|NCT02245737|587985819|FG000|Overall Study|Lost to Follow-up|2|||
162802026|NCT02245737|587985820|FG001|Overall Study|Lost to Follow-up|5|||
162802027|NCT02245737|587985821|FG002|Overall Study|Lost to Follow-up|4|||
162802028|NCT02245737|587985819|FG000|Overall Study|Other-determined by Investigator|9|||
162802029|NCT02245737|587985820|FG001|Overall Study|Other-determined by Investigator|10|||
162802030|NCT02245737|587985821|FG002|Overall Study|Other-determined by Investigator|10|||
162802031|NCT02245737|587985819|FG000|Overall Study|Physician Decision|6|||
162802032|NCT02245737|587985820|FG001|Overall Study|Physician Decision|3|||
162802033|NCT02245737|587985821|FG002|Overall Study|Physician Decision|6|||
162802034|NCT02245737|587985819|FG000|Overall Study|Protocol Violation|3|||
162802035|NCT02245737|587985820|FG001|Overall Study|Protocol Violation|2|||
162802036|NCT02245737|587985821|FG002|Overall Study|Protocol Violation|3|||
162802037|NCT02245737|587985819|FG000|Overall Study|Withdrawal by Subject|40|||
162802038|NCT02245737|587985820|FG001|Overall Study|Withdrawal by Subject|41|||
162802039|NCT02245737|587985821|FG002|Overall Study|Withdrawal by Subject|44|||
162802040|NCT02245737|587985819|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
162802041|NCT02245737|587985820|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
162802042|NCT02245737|587985821|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
162802043|NCT02245737|587985819|FG000|Overall Study|Sponsor Decision|445|||
162802044|NCT02245737|587985820|FG001|Overall Study|Sponsor Decision|430|||
162802045|NCT02245737|587985821|FG002|Overall Study|Sponsor Decision|432|||
162802046|NCT00836745|587985825|FG000|Overall Study|Death|2|||
162802047|NCT00836745|587985825|FG000|Overall Study|Lost to Follow-up|10|||
162802048|NCT00836745|587985825|FG000|Overall Study|Adverse Event|3|||
162802049|NCT00836745|587985825|FG000|Overall Study|Objective progression or relapse|4|||
162802050|NCT00836745|587985825|FG000|Overall Study|Other|2|||
162802051|NCT01239043|587985828|FG000|Overall Study|Protocol Violation|2|||
162802052|NCT01239043|587985829|FG001|Overall Study|Protocol Violation|1|||
162802053|NCT02929329|587985832|FG000|Overall Study|Withdrawal by Subject|24|||
162802054|NCT02929329|587985833|FG001|Overall Study|Withdrawal by Subject|21|||
162802055|NCT02929329|587985832|FG000|Overall Study|Lost to Follow-up|26|||
162802056|NCT02929329|587985833|FG001|Overall Study|Lost to Follow-up|20|||
162802057|NCT02929329|587985832|FG000|Overall Study|Death|1054|||
162802058|NCT02929329|587985833|FG001|Overall Study|Death|1051|||
162802059|NCT02121301|587985834|FG000|Overall Study|Protocol Violation|1|||
162802060|NCT02121301|587985835|FG001|Overall Study|Protocol Violation|4|||
162802061|NCT02121301|587985836|FG002|Overall Study|Protocol Violation|1|||
162802062|NCT00434213|587985842|FG000|Overall Study|Adverse Event|12|||
162802063|NCT00434213|587985842|FG000|Overall Study|Lack of Efficacy|9|||
162802064|NCT00434213|587985842|FG000|Overall Study|Lost to Follow-up|14|||
162802065|NCT00434213|587985842|FG000|Overall Study|Withdrawal by Subject|7|||
162802066|NCT00434213|587985842|FG000|Overall Study|Protocol Violation|3|||
162802067|NCT00434213|587985842|FG000|Overall Study|Unable to comply with study visit window|2|||
162802068|NCT00434213|587985842|FG000|Overall Study|Application site reaction|1|||
162802069|NCT00434213|587985842|FG000|Overall Study|Non-compliant to study schedule|1|||
162802070|NCT01699503|587985843|FG000|Overall Study|Death|31|||
162802071|NCT01699503|587985844|FG001|Overall Study|Death|40|||
162802072|NCT01699503|587985843|FG000|Overall Study|Withdrawal by Subject|65|||
162802073|NCT01699503|587985844|FG001|Overall Study|Withdrawal by Subject|57|||
162802074|NCT01699503|587985843|FG000|Overall Study|Lost to Follow-up|121|||
162802075|NCT01699503|587985844|FG001|Overall Study|Lost to Follow-up|117|||
162802076|NCT01699503|587985843|FG000|Overall Study|Excluded due to quality|783|||
162802077|NCT01699503|587985844|FG001|Overall Study|Excluded due to quality|791|||
162802078|NCT01639560|587985847|FG000|Overall Study|Withdrawal by Subject|9|||
162802079|NCT01639560|587985848|FG001|Overall Study|Withdrawal by Subject|14|||
162802080|NCT01639560|587985847|FG000|Overall Study|Lack of Efficacy|1|||
162802081|NCT01639560|587985848|FG001|Overall Study|Lack of Efficacy|2|||
162802082|NCT01639560|587985847|FG000|Overall Study|Lost to Follow-up|9|||
162802083|NCT01639560|587985848|FG001|Overall Study|Lost to Follow-up|11|||
162802084|NCT01639560|587985847|FG000|Overall Study|Adverse Event|0|||
162802085|NCT01639560|587985848|FG001|Overall Study|Adverse Event|2|||
162802086|NCT00774930|587985850|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
162802087|NCT00774930|587985851|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
162802088|NCT00774930|587985850|FG000|DB Phase|Adverse Event|1|||
162802089|NCT00774930|587985851|FG001|DB Phase|Adverse Event|2|||
162802090|NCT00774930|587985850|FG000|DB Phase|Subject Decision|1|||
162802091|NCT00774930|587985851|FG001|DB Phase|Subject Decision|5|||
162802092|NCT00774930|587985850|FG000|DB Phase|Sponsor Decision|0|||
162802093|NCT00774930|587985851|FG001|DB Phase|Sponsor Decision|1|||
162802094|NCT00774930|587985850|FG000|DB Phase|Disease Progression|1|||
162802095|NCT00774930|587985851|FG001|DB Phase|Disease Progression|1|||
162802096|NCT00774930|587985850|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
162802097|NCT00774930|587985851|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
162802098|NCT00774930|587985850|FG000|IOL Phase|Adverse Event|1|||
162802099|NCT00774930|587985851|FG001|IOL Phase|Adverse Event|1|||
162802100|NCT00774930|587985850|FG000|IOL Phase|Subject Decision|4|||
162802101|NCT00774930|587985851|FG001|IOL Phase|Subject Decision|3|||
162802102|NCT00774930|587985850|FG000|IOL Phase|Physician Decision|3|||
162802103|NCT00774930|587985851|FG001|IOL Phase|Physician Decision|2|||
162802104|NCT00774930|587985850|FG000|IOL Phase|Sponsor Decision|1|||
162802105|NCT00774930|587985851|FG001|IOL Phase|Sponsor Decision|0|||
162802106|NCT00774930|587985850|FG000|IOL Phase|Disease Progression|2|||
162802107|NCT00774930|587985851|FG001|IOL Phase|Disease Progression|1|||
162802108|NCT00774930|587985850|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
162802109|NCT00774930|587985851|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
162802110|NCT00774930|587985850|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
162802111|NCT00774930|587985851|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
162802112|NCT00774930|587985850|FG000|IOL Phase|Other|1|||
162802113|NCT00774930|587985851|FG001|IOL Phase|Other|0|||
162802114|NCT00774930|587985850|FG000|IOL Phase|Brain radiation|0|||
162802115|NCT00774930|587985851|FG001|IOL Phase|Brain radiation|1|||
162802116|NCT00774930|587985850|FG000|LTOLE Phase|Adverse Event|7|||
162802117|NCT00774930|587985851|FG001|LTOLE Phase|Adverse Event|3|||
162802118|NCT00774930|587985850|FG000|LTOLE Phase|Subject decision|0|||
162802119|NCT00774930|587985851|FG001|LTOLE Phase|Subject decision|5|||
162802120|NCT00774930|587985850|FG000|LTOLE Phase|Physician Decision|4|||
162802121|NCT00774930|587985851|FG001|LTOLE Phase|Physician Decision|1|||
162802122|NCT00774930|587985850|FG000|LTOLE Phase|Sponsor decision|2|||
162802123|NCT00774930|587985851|FG001|LTOLE Phase|Sponsor decision|1|||
162802124|NCT00774930|587985850|FG000|LTOLE Phase|Disease Progression|2|||
162802125|NCT00774930|587985851|FG001|LTOLE Phase|Disease Progression|5|||
162802126|NCT00774930|587985850|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
162802127|NCT00774930|587985851|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
162802128|NCT00774930|587985850|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
162802129|NCT00774930|587985851|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
162802130|NCT00766363|587985856|FG000|Overall Study|Withdrawal by Subject|1|||
162802131|NCT00766363|587985857|FG001|Overall Study|Withdrawal by Subject|0|||
162802132|NCT00766363|587985858|FG002|Overall Study|Withdrawal by Subject|0|||
162802133|NCT00766363|587985859|FG003|Overall Study|Withdrawal by Subject|0|||
162802134|NCT00766363|587985856|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
162802135|NCT00766363|587985857|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
162802136|NCT00766363|587985858|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
162802137|NCT00766363|587985859|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
162802138|NCT03020576|587985860|FG000|Overall Study|Withdrawal by Subject|1|||
162802139|NCT03020576|587985861|FG001|Overall Study|Withdrawal by Subject|2|||
162802140|NCT03292432|587985862|FG000|Overall Study|Lost to Follow-up|11|||
162802141|NCT03292432|587985863|FG001|Overall Study|Lost to Follow-up|8|||
162802142|NCT03292432|587985862|FG000|Overall Study|Death|2|||
162802143|NCT03292432|587985863|FG001|Overall Study|Death|1|||
162802144|NCT03292432|587985862|FG000|Overall Study|Withdrawal by Subject|1|||
162802145|NCT03292432|587985863|FG001|Overall Study|Withdrawal by Subject|2|||
162802146|NCT03292432|587985862|FG000|Overall Study|Site closed before any data collected|1|||
162802147|NCT03292432|587985863|FG001|Overall Study|Site closed before any data collected|0|||
162802148|NCT00911937|587985864|FG000|Overall Study|Death|1|||
162802149|NCT00911937|587985865|FG001|Overall Study|Death|0|||
162802150|NCT00911937|587985864|FG000|Overall Study|Lost to Follow-up|8|||
162802151|NCT00911937|587985865|FG001|Overall Study|Lost to Follow-up|5|||
162802152|NCT00911937|587985864|FG000|Overall Study|Withdrawal by Subject|10|||
162802153|NCT00911937|587985865|FG001|Overall Study|Withdrawal by Subject|7|||
162802154|NCT00911937|587985864|FG000|Overall Study|Withdrawn due to pregnancy|1|||
162802155|NCT00911937|587985865|FG001|Overall Study|Withdrawn due to pregnancy|0|||
162802156|NCT00911937|587985864|FG000|Overall Study|Adverse Event|11|||
162802157|NCT00911937|587985865|FG001|Overall Study|Adverse Event|25|||
162802158|NCT00911937|587985864|FG000|Overall Study|Lack of Efficacy|11|||
162802159|NCT00911937|587985865|FG001|Overall Study|Lack of Efficacy|6|||
162802160|NCT00911937|587985864|FG000|Overall Study|Did not meet inclusion criteria|9|||
162802161|NCT00911937|587985865|FG001|Overall Study|Did not meet inclusion criteria|11|||
162802162|NCT00911937|587985864|FG000|Overall Study|Protocol Violation|14|||
162802163|NCT00911937|587985865|FG001|Overall Study|Protocol Violation|23|||
162802164|NCT00911937|587985864|FG000|Overall Study|Randomized but not treated|13|||
162802165|NCT00911937|587985865|FG001|Overall Study|Randomized but not treated|13|||
162802166|NCT00911937|587985864|FG000|Overall Study|Other|9|||
162802167|NCT00911937|587985865|FG001|Overall Study|Other|5|||
162802168|NCT01498679|587985866|FG000|Overall Study|Adverse Event|1|||
162802169|NCT01498679|587985867|FG001|Overall Study|Adverse Event|4|||
162802170|NCT01498679|587985866|FG000|Overall Study|Lack of Efficacy|72|||
162802171|NCT01498679|587985867|FG001|Overall Study|Lack of Efficacy|12|||
162802172|NCT01498679|587985866|FG000|Overall Study|Protocol Violation|4|||
162802173|NCT01498679|587985867|FG001|Overall Study|Protocol Violation|0|||
162802174|NCT01498679|587985866|FG000|Overall Study|Physician Decision|0|||
162802175|NCT01498679|587985867|FG001|Overall Study|Physician Decision|2|||
162802176|NCT01498679|587985866|FG000|Overall Study|Withdrawal by Subject|12|||
162802177|NCT01498679|587985867|FG001|Overall Study|Withdrawal by Subject|4|||
162802178|NCT00424385|587985871|FG000|Cohort 0|Withdrawal by Subject|5|||
162802179|NCT00424385|587985871|FG000|Cohort 0|Physician Decision|1|||
162802180|NCT00424385|587985871|FG000|Cohort 1|Withdrawal by Subject|1|||
162802181|NCT02057523|587985874|FG000|Overall Study|Withdrawal by Subject|1|||
162802182|NCT02057523|587985874|FG000|Overall Study|Lack of Efficacy|1|||
162802183|NCT02071290|587985875|FG000|Overall Study|Death|1|||
162802184|NCT02071290|587985876|FG001|Overall Study|Death|0|||
162802185|NCT02071290|587985875|FG000|Overall Study|Withdrawal by Subject|0|||
162802186|NCT02071290|587985876|FG001|Overall Study|Withdrawal by Subject|1|||
162802187|NCT02071290|587985875|FG000|Overall Study|Protocol Violation|3|||
162802188|NCT02071290|587985876|FG001|Overall Study|Protocol Violation|5|||
162802189|NCT02071290|587985875|FG000|Overall Study|Physician Decision|0|||
162802190|NCT02071290|587985876|FG001|Overall Study|Physician Decision|1|||
162802191|NCT00964886|587985885|FG000|Overall Study|Lost to Follow-up|2|||
162802192|NCT00964886|587985886|FG001|Overall Study|Lost to Follow-up|2|||
162802193|NCT00964886|587985887|FG002|Overall Study|Lost to Follow-up|6|||
162802194|NCT00964886|587985888|FG003|Overall Study|Lost to Follow-up|4|||
162802195|NCT00964886|587985885|FG000|Overall Study|Withdrawal by Subject|6|||
162802196|NCT00964886|587985886|FG001|Overall Study|Withdrawal by Subject|2|||
162802197|NCT00964886|587985887|FG002|Overall Study|Withdrawal by Subject|5|||
162802198|NCT00964886|587985888|FG003|Overall Study|Withdrawal by Subject|3|||
162802199|NCT00964886|587985885|FG000|Overall Study|Adverse Event|3|||
162802200|NCT00964886|587985886|FG001|Overall Study|Adverse Event|1|||
162802201|NCT00964886|587985887|FG002|Overall Study|Adverse Event|5|||
162802202|NCT00964886|587985888|FG003|Overall Study|Adverse Event|2|||
162802203|NCT00964886|587985885|FG000|Overall Study|Protocol Violation|0|||
162802204|NCT00964886|587985886|FG001|Overall Study|Protocol Violation|2|||
162802205|NCT00964886|587985887|FG002|Overall Study|Protocol Violation|0|||
162802206|NCT00964886|587985888|FG003|Overall Study|Protocol Violation|0|||
162802207|NCT01871805|587985892|FG000|Phase I|Death|7|||
162802208|NCT01871805|587985893|FG001|Phase I|Death|4|||
162802209|NCT01871805|587985894|FG002|Phase I|Death|6|||
162802210|NCT01871805|587985895|FG003|Phase I|Death|2|||
162802211|NCT01871805|587985896|FG004|Phase I|Death|9|||
162802212|NCT01871805|587985897|FG005|Phase I|Death|0|||
162802213|NCT01871805|587985892|FG000|Phase I|Alive in Survival Follow-up|0|||
162802214|NCT01871805|587985893|FG001|Phase I|Alive in Survival Follow-up|2|||
162802215|NCT01871805|587985894|FG002|Phase I|Alive in Survival Follow-up|4|||
162802216|NCT01871805|587985895|FG003|Phase I|Alive in Survival Follow-up|5|||
162802217|NCT01871805|587985896|FG004|Phase I|Alive in Survival Follow-up|4|||
162802218|NCT01871805|587985897|FG005|Phase I|Alive in Survival Follow-up|0|||
162802219|NCT01871805|587985892|FG000|Phase I|Lost to Follow-up|0|||
162802220|NCT01871805|587985893|FG001|Phase I|Lost to Follow-up|1|||
162802221|NCT01871805|587985894|FG002|Phase I|Lost to Follow-up|3|||
162802222|NCT01871805|587985895|FG003|Phase I|Lost to Follow-up|0|||
162802223|NCT01871805|587985896|FG004|Phase I|Lost to Follow-up|0|||
162802224|NCT01871805|587985897|FG005|Phase I|Lost to Follow-up|0|||
162802225|NCT01871805|587985892|FG000|Phase II|Death|0|||
162802226|NCT01871805|587985893|FG001|Phase II|Death|0|||
162802227|NCT01871805|587985894|FG002|Phase II|Death|0|||
162802228|NCT01871805|587985895|FG003|Phase II|Death|0|||
162802229|NCT01871805|587985896|FG004|Phase II|Death|0|||
162802230|NCT01871805|587985897|FG005|Phase II|Death|45|||
162802231|NCT01871805|587985892|FG000|Phase II|Alive in Survival Follow-up|0|||
162802232|NCT01871805|587985893|FG001|Phase II|Alive in Survival Follow-up|0|||
162802233|NCT01871805|587985894|FG002|Phase II|Alive in Survival Follow-up|0|||
162802234|NCT01871805|587985895|FG003|Phase II|Alive in Survival Follow-up|0|||
162802235|NCT01871805|587985896|FG004|Phase II|Alive in Survival Follow-up|0|||
162802236|NCT01871805|587985897|FG005|Phase II|Alive in Survival Follow-up|29|||
162802237|NCT01871805|587985892|FG000|Phase II|Lost to Follow-up|0|||
162802238|NCT01871805|587985893|FG001|Phase II|Lost to Follow-up|0|||
162802239|NCT01871805|587985894|FG002|Phase II|Lost to Follow-up|0|||
162802240|NCT01871805|587985895|FG003|Phase II|Lost to Follow-up|0|||
162802241|NCT01871805|587985896|FG004|Phase II|Lost to Follow-up|0|||
162802242|NCT01871805|587985897|FG005|Phase II|Lost to Follow-up|13|||
162802243|NCT00941070|587985902|FG000|Overall Study|Patient non-compliant|1|||
162802244|NCT03174431|587985903|FG000|Overall Study|Withdrawal by Subject|14|||
162802245|NCT03174431|587985904|FG001|Overall Study|Withdrawal by Subject|11|||
162802246|NCT03174431|587985903|FG000|Overall Study|alternative treatment|2|||
162802247|NCT03174431|587985904|FG001|Overall Study|alternative treatment|0|||
162802248|NCT03174431|587985903|FG000|Overall Study|Lost to Follow-up|1|||
162802249|NCT03174431|587985904|FG001|Overall Study|Lost to Follow-up|5|||
162802250|NCT03484273|587985909|FG000|Overall Study|Equipment Malfunction|1|||
162802251|NCT03484273|587985909|FG000|Overall Study|Data excluded from analysis|1|||
162802252|NCT00468104|587985915|FG000|First Intervention|Protocol Violation|2|||
162802253|NCT00468104|587985916|FG001|First Intervention|Protocol Violation|1|||
162802254|NCT00468104|587985915|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
162802255|NCT00468104|587985916|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
162802256|NCT00468104|587985915|FG000|First Intervention|died within 3 weeks|1|||
162802257|NCT00468104|587985916|FG001|First Intervention|died within 3 weeks|0|||
162802258|NCT00468104|587985915|FG000|First Intervention|malposition/blocked chest tube tube|2|||
162802259|NCT00468104|587985916|FG001|First Intervention|malposition/blocked chest tube tube|0|||
162802260|NCT00468104|587985915|FG000|First Intervention|large lung mass with minimal effusion|1|||
162802261|NCT00468104|587985916|FG001|First Intervention|large lung mass with minimal effusion|0|||
162802262|NCT00468104|587985915|FG000|First Intervention|associated prolonged pneumothorax|1|||
162802263|NCT00468104|587985916|FG001|First Intervention|associated prolonged pneumothorax|0|||
162802264|NCT00468104|587985915|FG000|First Intervention|trapped lung|1|||
162802265|NCT00468104|587985916|FG001|First Intervention|trapped lung|0|||
162802266|NCT00468104|587985915|FG000|Second Intervention|Withdrawal by Subject|5|||
162802267|NCT00468104|587985916|FG001|Second Intervention|Withdrawal by Subject|2|||
162802268|NCT00468104|587985915|FG000|Second Intervention|discarded for malposition of chest tube|0|||
162802269|NCT00468104|587985916|FG001|Second Intervention|discarded for malposition of chest tube|2|||
162802270|NCT01263665|587985917|FG000|Overall Study|Withdrew Consent|1|||
162802271|NCT01263665|587985917|FG000|Overall Study|Lost to Follow-up|3|||
162802272|NCT01263665|587985917|FG000|Overall Study|Death|2|||
162802273|NCT01263665|587985917|FG000|Overall Study|Amputation above the ankle|1|||
162802274|NCT01263665|587985917|FG000|Overall Study|Surgical Bypass|2|||
162802275|NCT02706899|587985922|FG000|Overall Study|Withdrawal by Subject|1|||
162802276|NCT02706899|587985923|FG001|Overall Study|Withdrawal by Subject|0|||
162802277|NCT02706899|587985922|FG000|Overall Study|Death|8|||
162802278|NCT02706899|587985923|FG001|Overall Study|Death|0|||
162802279|NCT02706899|587985922|FG000|Overall Study|Study Termination by Sponsor|4|||
162802280|NCT02706899|587985923|FG001|Overall Study|Study Termination by Sponsor|6|||
162802281|NCT00324675|587985924|FG000|Overall Study|Adverse Event|1|||
162802282|NCT00324675|587985925|FG001|Overall Study|Adverse Event|0|||
162802283|NCT00381615|587985926|FG000|Overall Study|Withdrawal by Subject|1|||
162802284|NCT00381615|587985927|FG001|Overall Study|Withdrawal by Subject|3|||
162802285|NCT00381615|587985928|FG002|Overall Study|Withdrawal by Subject|0|||
162802286|NCT00381615|587985929|FG003|Overall Study|Withdrawal by Subject|1|||
162802287|NCT00381615|587985926|FG000|Overall Study|Lost to Follow-up|3|||
162802288|NCT00381615|587985927|FG001|Overall Study|Lost to Follow-up|2|||
162802289|NCT00381615|587985928|FG002|Overall Study|Lost to Follow-up|0|||
162802290|NCT00381615|587985929|FG003|Overall Study|Lost to Follow-up|1|||
162802291|NCT00381615|587985926|FG000|Overall Study|Protocol Violation|0|||
162802292|NCT00381615|587985927|FG001|Overall Study|Protocol Violation|0|||
162802293|NCT00381615|587985928|FG002|Overall Study|Protocol Violation|1|||
162802294|NCT00381615|587985929|FG003|Overall Study|Protocol Violation|0|||
162802295|NCT01012414|587985931|FG000|Overall Study|Withdrawal by Subject|2|||
162802296|NCT01012414|587985931|FG000|Overall Study|Lost to Follow-up|1|||
162802297|NCT01012414|587985931|FG000|Overall Study|Trial was stopped before completed|7|||
162802298|NCT02601300|587985932|FG000|Induction Phase|Lack of Efficacy|2|||
162802299|NCT02601300|587985932|FG000|Induction Phase|Protocol Violation|1|||
162802300|NCT02601300|587985932|FG000|Extension Phase|Withdrawal by Subject|3|||
162802301|NCT02601300|587985932|FG000|Extension Phase|Adverse Event|4|||
162802302|NCT02601300|587985932|FG000|Extension Phase|Lack of Efficacy|10|||
162802303|NCT00291642|587985937|FG000|Overall Study|Adverse Event|1|||
162802304|NCT00291642|587985938|FG001|Overall Study|Adverse Event|0|||
162802305|NCT00291642|587985939|FG002|Overall Study|Adverse Event|1|||
162802306|NCT00291642|587985940|FG003|Overall Study|Adverse Event|0|||
162802307|NCT00291642|587985941|FG004|Overall Study|Adverse Event|1|||
162802308|NCT00291642|587985937|FG000|Overall Study|Patient missed visit|0|||
162802309|NCT00291642|587985938|FG001|Overall Study|Patient missed visit|0|||
162802310|NCT00291642|587985939|FG002|Overall Study|Patient missed visit|1|||
162802311|NCT00291642|587985940|FG003|Overall Study|Patient missed visit|0|||
162802312|NCT00291642|587985941|FG004|Overall Study|Patient missed visit|0|||
162802313|NCT00291642|587985937|FG000|Overall Study|Intake of prohibited medication|1|||
162802314|NCT00291642|587985938|FG001|Overall Study|Intake of prohibited medication|0|||
162802315|NCT00291642|587985939|FG002|Overall Study|Intake of prohibited medication|0|||
162802316|NCT00291642|587985940|FG003|Overall Study|Intake of prohibited medication|0|||
162802317|NCT00291642|587985941|FG004|Overall Study|Intake of prohibited medication|0|||
162802318|NCT02544451|587985945|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
162802319|NCT02544451|587985946|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
162802320|NCT02544451|587985947|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
162802321|NCT02544451|587985948|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
162802322|NCT02544451|587985945|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
162802323|NCT02544451|587985946|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
162802324|NCT02544451|587985947|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
162802325|NCT02544451|587985948|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
162802326|NCT02544451|587985945|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
162802327|NCT02544451|587985946|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162802328|NCT02544451|587985947|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162802329|NCT02544451|587985948|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162802330|NCT02544451|587985945|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
162802331|NCT02544451|587985946|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162802332|NCT02544451|587985947|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162802333|NCT02544451|587985948|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162802334|NCT02544451|587985945|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
162802335|NCT02544451|587985946|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
162802336|NCT02544451|587985947|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
162802337|NCT02544451|587985948|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
162802338|NCT02544451|587985945|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162802339|NCT02544451|587985946|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162802340|NCT02544451|587985947|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162802341|NCT02544451|587985948|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
162802342|NCT04602221|587985952|FG000|Overall Study|Discontinuation of trial treatment|0|||
162802343|NCT04602221|587985953|FG001|Overall Study|Discontinuation of trial treatment|0|||
162802344|NCT04602221|587985954|FG002|Overall Study|Discontinuation of trial treatment|1|||
162802345|NCT04602221|587985955|FG003|Overall Study|Discontinuation of trial treatment|0|||
162802346|NCT04602221|587985956|FG004|Overall Study|Discontinuation of trial treatment|0|||
162802347|NCT04602221|587985957|FG005|Overall Study|Discontinuation of trial treatment|0|||
162802348|NCT04602221|587985958|FG006|Overall Study|Discontinuation of trial treatment|0|||
162802349|NCT04602221|587985959|FG007|Overall Study|Discontinuation of trial treatment|0|||
162802350|NCT04602221|587985960|FG008|Overall Study|Discontinuation of trial treatment|0|||
162802351|NCT04602221|587985961|FG009|Overall Study|Discontinuation of trial treatment|0|||
162802352|NCT04602221|587985962|FG010|Overall Study|Discontinuation of trial treatment|0|||
162802353|NCT04602221|587985963|FG011|Overall Study|Discontinuation of trial treatment|0|||
162802354|NCT04602221|587985964|FG012|Overall Study|Discontinuation of trial treatment|0|||
162802355|NCT04602221|587985965|FG013|Overall Study|Discontinuation of trial treatment|0|||
162802356|NCT04602221|587985966|FG014|Overall Study|Discontinuation of trial treatment|0|||
162802357|NCT04602221|587985967|FG015|Overall Study|Discontinuation of trial treatment|0|||
162802358|NCT04602221|587985968|FG016|Overall Study|Discontinuation of trial treatment|0|||
162802359|NCT04602221|587985969|FG017|Overall Study|Discontinuation of trial treatment|0|||
162802360|NCT04602221|587985952|FG000|Overall Study|Other than listed|0|||
162802361|NCT04602221|587985953|FG001|Overall Study|Other than listed|0|||
162802362|NCT04602221|587985954|FG002|Overall Study|Other than listed|0|||
162802363|NCT04602221|587985955|FG003|Overall Study|Other than listed|0|||
162802364|NCT04602221|587985956|FG004|Overall Study|Other than listed|0|||
162802365|NCT04602221|587985957|FG005|Overall Study|Other than listed|0|||
162802366|NCT04602221|587985958|FG006|Overall Study|Other than listed|0|||
162802367|NCT04602221|587985959|FG007|Overall Study|Other than listed|0|||
162802368|NCT04602221|587985960|FG008|Overall Study|Other than listed|0|||
162802369|NCT04602221|587985961|FG009|Overall Study|Other than listed|0|||
162802370|NCT04602221|587985962|FG010|Overall Study|Other than listed|0|||
162802371|NCT04602221|587985963|FG011|Overall Study|Other than listed|0|||
162802372|NCT04602221|587985964|FG012|Overall Study|Other than listed|0|||
162802373|NCT04602221|587985965|FG013|Overall Study|Other than listed|0|||
162802374|NCT04602221|587985966|FG014|Overall Study|Other than listed|0|||
162802375|NCT04602221|587985967|FG015|Overall Study|Other than listed|1|||
162802376|NCT04602221|587985968|FG016|Overall Study|Other than listed|0|||
162802377|NCT04602221|587985969|FG017|Overall Study|Other than listed|1|||
162802378|NCT04602221|587985952|FG000|Overall Study|Withdrawal by Subject|0|||
162802379|NCT04602221|587985953|FG001|Overall Study|Withdrawal by Subject|0|||
162802380|NCT04602221|587985954|FG002|Overall Study|Withdrawal by Subject|0|||
162802381|NCT04602221|587985955|FG003|Overall Study|Withdrawal by Subject|0|||
162802382|NCT04602221|587985956|FG004|Overall Study|Withdrawal by Subject|0|||
162802383|NCT04602221|587985957|FG005|Overall Study|Withdrawal by Subject|0|||
162802384|NCT04602221|587985958|FG006|Overall Study|Withdrawal by Subject|0|||
162802385|NCT04602221|587985959|FG007|Overall Study|Withdrawal by Subject|0|||
162802386|NCT04602221|587985960|FG008|Overall Study|Withdrawal by Subject|0|||
162802387|NCT04602221|587985961|FG009|Overall Study|Withdrawal by Subject|0|||
162802388|NCT04602221|587985962|FG010|Overall Study|Withdrawal by Subject|0|||
162802389|NCT04602221|587985963|FG011|Overall Study|Withdrawal by Subject|0|||
162802390|NCT04602221|587985964|FG012|Overall Study|Withdrawal by Subject|1|||
162802391|NCT04602221|587985965|FG013|Overall Study|Withdrawal by Subject|0|||
162802392|NCT04602221|587985966|FG014|Overall Study|Withdrawal by Subject|0|||
162802393|NCT04602221|587985967|FG015|Overall Study|Withdrawal by Subject|0|||
162802394|NCT04602221|587985968|FG016|Overall Study|Withdrawal by Subject|0|||
162802395|NCT04602221|587985969|FG017|Overall Study|Withdrawal by Subject|0|||
162802396|NCT04602221|587985952|FG000|Overall Study|Lost to Follow-up|0|||
162802397|NCT04602221|587985953|FG001|Overall Study|Lost to Follow-up|0|||
162802398|NCT04602221|587985954|FG002|Overall Study|Lost to Follow-up|0|||
162802399|NCT04602221|587985955|FG003|Overall Study|Lost to Follow-up|0|||
162802400|NCT04602221|587985956|FG004|Overall Study|Lost to Follow-up|0|||
162802401|NCT04602221|587985957|FG005|Overall Study|Lost to Follow-up|1|||
162802402|NCT04602221|587985958|FG006|Overall Study|Lost to Follow-up|0|||
162802403|NCT04602221|587985959|FG007|Overall Study|Lost to Follow-up|0|||
162802404|NCT04602221|587985960|FG008|Overall Study|Lost to Follow-up|0|||
162802405|NCT04602221|587985961|FG009|Overall Study|Lost to Follow-up|0|||
162802406|NCT04602221|587985962|FG010|Overall Study|Lost to Follow-up|0|||
162802407|NCT04602221|587985963|FG011|Overall Study|Lost to Follow-up|0|||
162802408|NCT04602221|587985964|FG012|Overall Study|Lost to Follow-up|0|||
162802409|NCT04602221|587985965|FG013|Overall Study|Lost to Follow-up|0|||
162802410|NCT04602221|587985966|FG014|Overall Study|Lost to Follow-up|0|||
162802411|NCT04602221|587985967|FG015|Overall Study|Lost to Follow-up|0|||
162802412|NCT04602221|587985968|FG016|Overall Study|Lost to Follow-up|0|||
162802413|NCT04602221|587985969|FG017|Overall Study|Lost to Follow-up|0|||
162802414|NCT03001076|587985971|FG000|Overall Study|Withdrawal by patient|2|||
162802415|NCT03001076|587985972|FG001|Overall Study|Withdrawal by patient|0|||
162802416|NCT03001076|587985971|FG000|Overall Study|Other|1|||
162802417|NCT03001076|587985972|FG001|Overall Study|Other|0|||
162802418|NCT03001076|587985971|FG000|Overall Study|Adverse Event|3|||
162802419|NCT03001076|587985972|FG001|Overall Study|Adverse Event|3|||
162802420|NCT03001076|587985971|FG000|Overall Study|Sponsor decision|1|||
162802421|NCT03001076|587985972|FG001|Overall Study|Sponsor decision|0|||
162802422|NCT03001076|587985971|FG000|Overall Study|Lost to Follow-up|0|||
162802423|NCT03001076|587985972|FG001|Overall Study|Lost to Follow-up|2|||
162802424|NCT00844532|587985973|FG000|Overall Study|Death|16|||
162802425|NCT00844532|587985973|FG000|Overall Study|Withdrawal by Subject|16|||
162802426|NCT00844532|587985973|FG000|Overall Study|Lost to Follow-up|7|||
162802427|NCT02576587|587985974|FG000|Baseline|Equipment failure|0|||
162802428|NCT02576587|587985975|FG001|Baseline|Equipment failure|1|||
162802429|NCT02576587|587985974|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
162802430|NCT02576587|587985975|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
162802431|NCT02576587|587985974|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
162802432|NCT02576587|587985975|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
162802433|NCT02576587|587985974|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
162802434|NCT02576587|587985975|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
162802435|NCT01080716|587985976|FG000|Part 1|Physician Decision|1|||
162802436|NCT01080716|587985977|FG001|Part 1|Physician Decision|0|||
162802437|NCT01080716|587985978|FG002|Part 1|Physician Decision|0|||
162802438|NCT01080716|587985979|FG003|Part 1|Physician Decision|0|||
162802439|NCT01056718|587985980|FG000|Overall Study|Withdrawal by Subject|2|||
162802440|NCT01056718|587985980|FG000|Overall Study|Ischemia on baseline stress test|1|||
162802441|NCT03590366|587985981|FG000|Overall Study|Adverse Event|0|||
162802442|NCT03590366|587985982|FG001|Overall Study|Adverse Event|3|||
162802443|NCT03590366|587985981|FG000|Overall Study|Lost to Follow-up|3|||
162802444|NCT03590366|587985982|FG001|Overall Study|Lost to Follow-up|3|||
162802445|NCT03590366|587985981|FG000|Overall Study|Withdrawal by Subject|0|||
162802446|NCT03590366|587985982|FG001|Overall Study|Withdrawal by Subject|2|||
162802447|NCT00738894|587985983|FG000|Overall Study|Lost to Follow-up|23|||
162802448|NCT00738894|587985984|FG001|Overall Study|Lost to Follow-up|13|||
162802449|NCT00738894|587985983|FG000|Overall Study|Withdrawal by Subject|10|||
162802450|NCT00738894|587985984|FG001|Overall Study|Withdrawal by Subject|15|||
162802451|NCT00738894|587985983|FG000|Overall Study|Physician Decision|4|||
162802452|NCT00738894|587985984|FG001|Overall Study|Physician Decision|5|||
162802453|NCT00738894|587985983|FG000|Overall Study|Death|2|||
162802454|NCT00738894|587985984|FG001|Overall Study|Death|0|||
162802455|NCT05017103|587985985|FG000|Overall Study|Death|2|||
162802456|NCT02656329|587985986|FG000|Overall Study|Lost to Follow-up|2|||
162802457|NCT02656329|587985987|FG001|Overall Study|Lost to Follow-up|3|||
162802458|NCT02656329|587985986|FG000|Overall Study|Withdrawal by Subject|7|||
162802459|NCT02656329|587985987|FG001|Overall Study|Withdrawal by Subject|6|||
162802460|NCT02656329|587985986|FG000|Overall Study|Study termination by Sponsor|150|||
162802461|NCT02656329|587985987|FG001|Overall Study|Study termination by Sponsor|142|||
162802462|NCT02656329|587985986|FG000|Overall Study|Other than specified above|5|||
162802463|NCT02656329|587985987|FG001|Overall Study|Other than specified above|6|||
162802464|NCT01081665|587985989|FG000|Overall Study|Death|41|||
162802465|NCT01081665|587985989|FG000|Overall Study|Lost to Follow-up|18|||
162802466|NCT01081665|587985989|FG000|Overall Study|Withdrawal by Subject|17|||
162802467|NCT01081665|587985989|FG000|Overall Study|Change of dialysis unit|10|||
162802468|NCT01081665|587985989|FG000|Overall Study|Regulation of iPTH|5|||
162802469|NCT01081665|587985989|FG000|Overall Study|Change in renal replacement therapy|2|||
162802470|NCT01081665|587985989|FG000|Overall Study|Adverse Event|1|||
162802471|NCT01081665|587985989|FG000|Overall Study|Lack of Efficacy|1|||
162802472|NCT01413503|587986002|FG000|Overall Study|Lost to Follow-up|1|||
162802473|NCT02546921|587986003|FG000|Overall Study|Adverse Event|0|||
162802474|NCT02546921|587986004|FG001|Overall Study|Adverse Event|5|||
162802475|NCT02546921|587986005|FG002|Overall Study|Adverse Event|2|||
162802476|NCT02546921|587986006|FG003|Overall Study|Adverse Event|0|||
162802477|NCT02546921|587986007|FG004|Overall Study|Adverse Event|0|||
162802478|NCT02546921|587986008|FG005|Overall Study|Adverse Event|0|||
162802479|NCT02546921|587986009|FG006|Overall Study|Adverse Event|0|||
162802480|NCT02546921|587986003|FG000|Overall Study|Evidence of Disease Progression|1|||
162802481|NCT02546921|587986004|FG001|Overall Study|Evidence of Disease Progression|0|||
162802482|NCT02546921|587986005|FG002|Overall Study|Evidence of Disease Progression|0|||
162802483|NCT02546921|587986006|FG003|Overall Study|Evidence of Disease Progression|0|||
162802484|NCT02546921|587986007|FG004|Overall Study|Evidence of Disease Progression|1|||
162802485|NCT02546921|587986008|FG005|Overall Study|Evidence of Disease Progression|0|||
162802486|NCT02546921|587986009|FG006|Overall Study|Evidence of Disease Progression|0|||
162802487|NCT02546921|587986003|FG000|Overall Study|Patient Choice|0|||
162802488|NCT02546921|587986004|FG001|Overall Study|Patient Choice|1|||
162802489|NCT02546921|587986005|FG002|Overall Study|Patient Choice|0|||
162802490|NCT02546921|587986006|FG003|Overall Study|Patient Choice|0|||
162802491|NCT02546921|587986007|FG004|Overall Study|Patient Choice|0|||
162802492|NCT02546921|587986008|FG005|Overall Study|Patient Choice|1|||
162802493|NCT02546921|587986009|FG006|Overall Study|Patient Choice|0|||
162802494|NCT01373151|587986010|FG000|Period 1|Lack of Efficacy|3|||
162802495|NCT01373151|587986011|FG001|Period 1|Lack of Efficacy|0|||
162802496|NCT01373151|587986012|FG002|Period 1|Lack of Efficacy|0|||
162802497|NCT01373151|587986013|FG003|Period 1|Lack of Efficacy|0|||
162802498|NCT01373151|587986014|FG004|Period 1|Lack of Efficacy|1|||
162802499|NCT01373151|587986015|FG005|Period 1|Lack of Efficacy|0|||
162802500|NCT01373151|587986016|FG006|Period 1|Lack of Efficacy|0|||
162802501|NCT01373151|587986010|FG000|Period 1|Adverse Event|0|||
162802502|NCT01373151|587986011|FG001|Period 1|Adverse Event|0|||
162802503|NCT01373151|587986012|FG002|Period 1|Adverse Event|1|||
162802504|NCT01373151|587986013|FG003|Period 1|Adverse Event|0|||
162802505|NCT01373151|587986014|FG004|Period 1|Adverse Event|4|||
162802506|NCT01373151|587986015|FG005|Period 1|Adverse Event|3|||
162802507|NCT01373151|587986016|FG006|Period 1|Adverse Event|0|||
162802508|NCT01373151|587986010|FG000|Period 1|Withdrawal by Subject|2|||
162802509|NCT01373151|587986011|FG001|Period 1|Withdrawal by Subject|0|||
162802510|NCT01373151|587986012|FG002|Period 1|Withdrawal by Subject|3|||
162802511|NCT01373151|587986013|FG003|Period 1|Withdrawal by Subject|1|||
162802512|NCT01373151|587986014|FG004|Period 1|Withdrawal by Subject|0|||
162802513|NCT01373151|587986015|FG005|Period 1|Withdrawal by Subject|1|||
162802514|NCT01373151|587986016|FG006|Period 1|Withdrawal by Subject|0|||
162802515|NCT01373151|587986010|FG000|Period 2|Lack of Efficacy|9|||
162802516|NCT01373151|587986011|FG001|Period 2|Lack of Efficacy|0|||
162802517|NCT01373151|587986012|FG002|Period 2|Lack of Efficacy|0|||
162802518|NCT01373151|587986013|FG003|Period 2|Lack of Efficacy|1|||
162802519|NCT01373151|587986014|FG004|Period 2|Lack of Efficacy|2|||
162802520|NCT01373151|587986015|FG005|Period 2|Lack of Efficacy|0|||
162802521|NCT01373151|587986016|FG006|Period 2|Lack of Efficacy|3|||
162802522|NCT01373151|587986010|FG000|Period 2|Adverse Event|0|||
162802523|NCT01373151|587986011|FG001|Period 2|Adverse Event|0|||
162802524|NCT01373151|587986012|FG002|Period 2|Adverse Event|3|||
162802525|NCT01373151|587986013|FG003|Period 2|Adverse Event|3|||
162802526|NCT01373151|587986014|FG004|Period 2|Adverse Event|0|||
162802527|NCT01373151|587986015|FG005|Period 2|Adverse Event|0|||
162802528|NCT01373151|587986016|FG006|Period 2|Adverse Event|1|||
162802529|NCT01373151|587986010|FG000|Period 2|subject request to discontinue|0|||
162802530|NCT01373151|587986011|FG001|Period 2|subject request to discontinue|1|||
162802531|NCT01373151|587986012|FG002|Period 2|subject request to discontinue|0|||
162802532|NCT01373151|587986013|FG003|Period 2|subject request to discontinue|0|||
162802533|NCT01373151|587986014|FG004|Period 2|subject request to discontinue|0|||
162802534|NCT01373151|587986015|FG005|Period 2|subject request to discontinue|0|||
162802535|NCT01373151|587986016|FG006|Period 2|subject request to discontinue|0|||
162802536|NCT01373151|587986010|FG000|Period 2|Withdrawal by Subject|0|||
162802537|NCT01373151|587986011|FG001|Period 2|Withdrawal by Subject|0|||
162802538|NCT01373151|587986012|FG002|Period 2|Withdrawal by Subject|0|||
162802539|NCT01373151|587986013|FG003|Period 2|Withdrawal by Subject|1|||
162802540|NCT01373151|587986014|FG004|Period 2|Withdrawal by Subject|0|||
162802541|NCT01373151|587986015|FG005|Period 2|Withdrawal by Subject|0|||
162802542|NCT01373151|587986016|FG006|Period 2|Withdrawal by Subject|0|||
162802543|NCT01373151|587986010|FG000|Period 2|Other|0|||
162802544|NCT01373151|587986011|FG001|Period 2|Other|0|||
162802545|NCT01373151|587986012|FG002|Period 2|Other|1|||
162802546|NCT01373151|587986013|FG003|Period 2|Other|0|||
162802547|NCT01373151|587986014|FG004|Period 2|Other|0|||
162802548|NCT01373151|587986015|FG005|Period 2|Other|0|||
162802549|NCT01373151|587986016|FG006|Period 2|Other|1|||
162802550|NCT03026075|587986020|FG000|Overall Study|Physician Decision|1|||
162802551|NCT03381339|587986021|FG000|Overall Study|Protocol Violation|4|||
162802552|NCT03381339|587986022|FG001|Overall Study|Protocol Violation|3|||
162802553|NCT03381339|587986021|FG000|Overall Study|Lost to Follow-up|0|||
162802554|NCT03381339|587986022|FG001|Overall Study|Lost to Follow-up|1|||
162802555|NCT03541174|587987230|FG000|Part 1 Double-Blind|Adverse Event|6|||
162802556|NCT03541174|587987231|FG001|Part 1 Double-Blind|Adverse Event|5|||
162802557|NCT03541174|587987232|FG002|Part 1 Double-Blind|Adverse Event|2|||
162802558|NCT03541174|587987233|FG003|Part 1 Double-Blind|Adverse Event|0|||
162802559|NCT03541174|587987234|FG004|Part 1 Double-Blind|Adverse Event|0|||
162802560|NCT03541174|587987235|FG005|Part 1 Double-Blind|Adverse Event|0|||
162802561|NCT03541174|587987230|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
162802562|NCT03541174|587987231|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
162802563|NCT03541174|587987232|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
162802564|NCT03541174|587987233|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
162802565|NCT03541174|587987234|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
162802566|NCT03541174|587987235|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
162802567|NCT03541174|587987230|FG000|Part 1 Double-Blind|Other reasons|3|||
162802568|NCT03541174|587987231|FG001|Part 1 Double-Blind|Other reasons|2|||
162802569|NCT03541174|587987232|FG002|Part 1 Double-Blind|Other reasons|3|||
162802570|NCT03541174|587987233|FG003|Part 1 Double-Blind|Other reasons|0|||
162802571|NCT03541174|587987234|FG004|Part 1 Double-Blind|Other reasons|0|||
162802572|NCT03541174|587987235|FG005|Part 1 Double-Blind|Other reasons|0|||
162802573|NCT03541174|587987230|FG000|Part 2 Single-Blind|Adverse Event|0|||
162802574|NCT03541174|587987231|FG001|Part 2 Single-Blind|Adverse Event|0|||
162802575|NCT03541174|587987232|FG002|Part 2 Single-Blind|Adverse Event|0|||
162802576|NCT03541174|587987233|FG003|Part 2 Single-Blind|Adverse Event|25|||
162802577|NCT03541174|587987234|FG004|Part 2 Single-Blind|Adverse Event|0|||
162802578|NCT03541174|587987235|FG005|Part 2 Single-Blind|Adverse Event|0|||
162802579|NCT03541174|587987230|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
162802580|NCT03541174|587987231|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
162802581|NCT03541174|587987232|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
162802582|NCT03541174|587987233|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
162802583|NCT03541174|587987234|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
162802584|NCT03541174|587987235|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
162802585|NCT03541174|587987230|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
162802586|NCT03541174|587987231|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
162802587|NCT03541174|587987232|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
162802588|NCT03541174|587987233|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
162802589|NCT03541174|587987234|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
162802590|NCT03541174|587987235|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
162802591|NCT03541174|587987230|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
162802592|NCT03541174|587987231|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
162802593|NCT03541174|587987232|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
162802594|NCT03541174|587987233|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
162802595|NCT03541174|587987234|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
162802596|NCT03541174|587987235|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
162802597|NCT03541174|587987230|FG000|Part 2 Single-Blind|Death|0|||
162802598|NCT03541174|587987231|FG001|Part 2 Single-Blind|Death|0|||
162802599|NCT03541174|587987232|FG002|Part 2 Single-Blind|Death|0|||
162802600|NCT03541174|587987233|FG003|Part 2 Single-Blind|Death|5|||
162802601|NCT03541174|587987234|FG004|Part 2 Single-Blind|Death|0|||
162802602|NCT03541174|587987235|FG005|Part 2 Single-Blind|Death|0|||
162802603|NCT03541174|587987230|FG000|Part 2 Single-Blind|Pregnancy|0|||
162802604|NCT03541174|587987231|FG001|Part 2 Single-Blind|Pregnancy|0|||
162802605|NCT03541174|587987232|FG002|Part 2 Single-Blind|Pregnancy|0|||
162802606|NCT03541174|587987233|FG003|Part 2 Single-Blind|Pregnancy|1|||
162802607|NCT03541174|587987234|FG004|Part 2 Single-Blind|Pregnancy|0|||
162802608|NCT03541174|587987235|FG005|Part 2 Single-Blind|Pregnancy|0|||
162802609|NCT03541174|587987230|FG000|Part 2 Single-Blind|Other reasons|0|||
162802610|NCT03541174|587987231|FG001|Part 2 Single-Blind|Other reasons|0|||
162802611|NCT03541174|587987232|FG002|Part 2 Single-Blind|Other reasons|0|||
162802612|NCT03541174|587987233|FG003|Part 2 Single-Blind|Other reasons|32|||
162802613|NCT03541174|587987234|FG004|Part 2 Single-Blind|Other reasons|0|||
162802614|NCT03541174|587987235|FG005|Part 2 Single-Blind|Other reasons|0|||
162802615|NCT03541174|587987230|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162802616|NCT03541174|587987231|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162802617|NCT03541174|587987232|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162802618|NCT03541174|587987233|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162802619|NCT03541174|587987234|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
162802620|NCT03541174|587987235|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
162802621|NCT03541174|587987230|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162802622|NCT03541174|587987231|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162802623|NCT03541174|587987232|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162802624|NCT03541174|587987233|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162802625|NCT03541174|587987234|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
162802626|NCT03541174|587987235|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
162802627|NCT03541174|587987230|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162802628|NCT03541174|587987231|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162802629|NCT03541174|587987232|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162802630|NCT03541174|587987233|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162802631|NCT03541174|587987234|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162802632|NCT03541174|587987235|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
162802633|NCT03541174|587987230|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162802634|NCT03541174|587987231|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162802635|NCT03541174|587987232|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162802636|NCT03541174|587987233|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162802637|NCT03541174|587987234|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
162802638|NCT03541174|587987235|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
162802639|NCT03541174|587987230|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162802640|NCT03541174|587987231|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162802641|NCT03541174|587987232|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162802642|NCT03541174|587987233|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162802643|NCT03541174|587987234|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
162802644|NCT03541174|587987235|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162802645|NCT00605215|587987236|FG000|Overall Study|Death|0|||
162802646|NCT00605215|587987237|FG001|Overall Study|Death|0|||
162802647|NCT00605215|587987238|FG002|Overall Study|Death|1|||
162802648|NCT00605215|587987236|FG000|Overall Study|Adverse Event|19|||
162802649|NCT00605215|587987237|FG001|Overall Study|Adverse Event|21|||
162802650|NCT00605215|587987238|FG002|Overall Study|Adverse Event|26|||
162802651|NCT00605215|587987236|FG000|Overall Study|Refusal to sign the re-consent form|8|||
162802652|NCT00605215|587987237|FG001|Overall Study|Refusal to sign the re-consent form|3|||
162802653|NCT00605215|587987238|FG002|Overall Study|Refusal to sign the re-consent form|3|||
162802654|NCT00605215|587987236|FG000|Overall Study|Withdrawal by Subject|39|||
162802655|NCT00605215|587987237|FG001|Overall Study|Withdrawal by Subject|37|||
162802656|NCT00605215|587987238|FG002|Overall Study|Withdrawal by Subject|27|||
162802657|NCT00605215|587987236|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
162802658|NCT00605215|587987237|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
162802659|NCT00605215|587987238|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
162802660|NCT00605215|587987236|FG000|Overall Study|Protocol Violation|3|||
162802661|NCT00605215|587987237|FG001|Overall Study|Protocol Violation|4|||
162802662|NCT00605215|587987238|FG002|Overall Study|Protocol Violation|1|||
162802663|NCT00605215|587987236|FG000|Overall Study|Pregnancy|8|||
162802664|NCT00605215|587987237|FG001|Overall Study|Pregnancy|5|||
162802665|NCT00605215|587987238|FG002|Overall Study|Pregnancy|4|||
162802666|NCT00605215|587987236|FG000|Overall Study|Lost to Follow-up|8|||
162802667|NCT00605215|587987237|FG001|Overall Study|Lost to Follow-up|5|||
162802668|NCT00605215|587987238|FG002|Overall Study|Lost to Follow-up|2|||
162802669|NCT00605215|587987236|FG000|Overall Study|Other than specified|0|||
162802670|NCT00605215|587987237|FG001|Overall Study|Other than specified|2|||
162802671|NCT00605215|587987238|FG002|Overall Study|Other than specified|1|||
162802672|NCT00275262|587987245|FG000|Overall Study|Adverse Event|2|||
162802673|NCT00275262|587987246|FG001|Overall Study|Adverse Event|0|||
162802674|NCT00275262|587987245|FG000|Overall Study|Disease progression|2|||
162802675|NCT00275262|587987246|FG001|Overall Study|Disease progression|5|||
162802676|NCT00275262|587987245|FG000|Overall Study|Lost to Follow-up|0|||
162802677|NCT00275262|587987246|FG001|Overall Study|Lost to Follow-up|2|||
162802678|NCT00275262|587987245|FG000|Overall Study|Protocol Violation|0|||
162802679|NCT00275262|587987246|FG001|Overall Study|Protocol Violation|2|||
162802680|NCT00275262|587987245|FG000|Overall Study|Death|1|||
162802681|NCT00275262|587987246|FG001|Overall Study|Death|0|||
162802682|NCT00275262|587987245|FG000|Overall Study|Started Chemotherapy|1|||
162802683|NCT00275262|587987246|FG001|Overall Study|Started Chemotherapy|0|||
162802684|NCT04058366|587987249|FG000|Overall Study|Adverse Event|14|||
162802685|NCT04058366|587987249|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
162802686|NCT04058366|587987249|FG000|Overall Study|Commercial drug is available for participants|6|||
162802687|NCT04058366|587987249|FG000|Overall Study|Death|1|||
162802688|NCT04058366|587987249|FG000|Overall Study|Other non-compliance|2|||
162802689|NCT04058366|587987249|FG000|Overall Study|Other|6|||
162802690|NCT02738203|587987250|FG000|Overall Study|Failed IUD Insertion|2|||
162802691|NCT02738203|587987251|FG001|Overall Study|Failed IUD Insertion|2|||
162802692|NCT02738203|587987250|FG000|Overall Study|Protocol Violation|0|||
162802693|NCT02738203|587987251|FG001|Overall Study|Protocol Violation|1|||
162802694|NCT05087979|587987252|FG000|Overall Study|Converted to general anesthesia|1|||
162802695|NCT05087979|587987253|FG001|Overall Study|Converted to general anesthesia|0|||
162802696|NCT00194987|587987254|FG000|Overall Study|Withdrawal by Subject|0|||
162802697|NCT00194987|587987255|FG001|Overall Study|Withdrawal by Subject|3|||
162802698|NCT01664598|587987256|FG000|Overall Study|Sponsor Decision|1|||
162802699|NCT01664598|587987256|FG000|Overall Study|Withdrawal of Informed Consent|4|||
162802700|NCT01664598|587987256|FG000|Overall Study|Adverse Event|1|||
162802701|NCT04988867|587987263|FG000|Overall Study|Study terminated by Sponsor|12|||
162802702|NCT04988867|587987263|FG000|Overall Study|Adverse Event|2|||
162802703|NCT04988867|587987263|FG000|Overall Study|Study drug noncompliance|1|||
162802704|NCT01097707|587987264|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162802705|NCT01097707|587987265|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162802706|NCT01097707|587987266|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162802707|NCT01097707|587987267|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162802708|NCT01097707|587987268|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162802709|NCT01097707|587987264|FG000|Overall Study|Adverse Event|4|||
162802710|NCT01097707|587987265|FG001|Overall Study|Adverse Event|2|||
162802711|NCT01097707|587987266|FG002|Overall Study|Adverse Event|3|||
162802712|NCT01097707|587987267|FG003|Overall Study|Adverse Event|1|||
162802713|NCT01097707|587987268|FG004|Overall Study|Adverse Event|3|||
162802714|NCT01097707|587987264|FG000|Overall Study|Entry Criteria Not Met|2|||
162802715|NCT01097707|587987265|FG001|Overall Study|Entry Criteria Not Met|1|||
162802716|NCT01097707|587987266|FG002|Overall Study|Entry Criteria Not Met|1|||
162802717|NCT01097707|587987267|FG003|Overall Study|Entry Criteria Not Met|0|||
162802718|NCT01097707|587987268|FG004|Overall Study|Entry Criteria Not Met|1|||
162802719|NCT01097707|587987264|FG000|Overall Study|Lack of Efficacy|1|||
162802720|NCT01097707|587987265|FG001|Overall Study|Lack of Efficacy|0|||
162802721|NCT01097707|587987266|FG002|Overall Study|Lack of Efficacy|0|||
162802722|NCT01097707|587987267|FG003|Overall Study|Lack of Efficacy|1|||
162802723|NCT01097707|587987268|FG004|Overall Study|Lack of Efficacy|0|||
162802724|NCT01097707|587987264|FG000|Overall Study|Lost to Follow-up|1|||
162802725|NCT01097707|587987265|FG001|Overall Study|Lost to Follow-up|1|||
162802726|NCT01097707|587987266|FG002|Overall Study|Lost to Follow-up|2|||
162802727|NCT01097707|587987267|FG003|Overall Study|Lost to Follow-up|0|||
162802728|NCT01097707|587987268|FG004|Overall Study|Lost to Follow-up|3|||
162802729|NCT01097707|587987264|FG000|Overall Study|Protocol Violation|2|||
162802730|NCT01097707|587987265|FG001|Overall Study|Protocol Violation|2|||
162802731|NCT01097707|587987266|FG002|Overall Study|Protocol Violation|3|||
162802732|NCT01097707|587987267|FG003|Overall Study|Protocol Violation|2|||
162802733|NCT01097707|587987268|FG004|Overall Study|Protocol Violation|2|||
162802734|NCT01097707|587987264|FG000|Overall Study|Sponsor Decision|31|||
162802735|NCT01097707|587987265|FG001|Overall Study|Sponsor Decision|31|||
162802736|NCT01097707|587987266|FG002|Overall Study|Sponsor Decision|34|||
162802737|NCT01097707|587987267|FG003|Overall Study|Sponsor Decision|35|||
162802738|NCT01097707|587987268|FG004|Overall Study|Sponsor Decision|36|||
162802739|NCT01097707|587987264|FG000|Overall Study|Withdrawal by Subject|3|||
162802740|NCT01097707|587987265|FG001|Overall Study|Withdrawal by Subject|6|||
162802741|NCT01097707|587987266|FG002|Overall Study|Withdrawal by Subject|1|||
162802742|NCT01097707|587987267|FG003|Overall Study|Withdrawal by Subject|4|||
162802743|NCT01097707|587987268|FG004|Overall Study|Withdrawal by Subject|3|||
162802744|NCT01097707|587987264|FG000|Overall Study|Reason unknown|0|||
162802745|NCT01097707|587987265|FG001|Overall Study|Reason unknown|0|||
162802746|NCT01097707|587987266|FG002|Overall Study|Reason unknown|0|||
162802747|NCT01097707|587987267|FG003|Overall Study|Reason unknown|0|||
162802748|NCT01097707|587987268|FG004|Overall Study|Reason unknown|1|||
162802749|NCT04811131|587987273|FG000|Overall Study|Adverse Event|0|||
162802750|NCT04811131|587987274|FG001|Overall Study|Adverse Event|0|||
162802751|NCT04811131|587987275|FG002|Overall Study|Adverse Event|1|||
162802752|NCT04811131|587987276|FG003|Overall Study|Adverse Event|0|||
162802753|NCT04811131|587987273|FG000|Overall Study|Lack of Efficacy|0|||
162802754|NCT04811131|587987274|FG001|Overall Study|Lack of Efficacy|0|||
162802755|NCT04811131|587987275|FG002|Overall Study|Lack of Efficacy|0|||
162802756|NCT04811131|587987276|FG003|Overall Study|Lack of Efficacy|1|||
162802757|NCT04811131|587987273|FG000|Overall Study|Lost to Follow-up|0|||
162802758|NCT04811131|587987274|FG001|Overall Study|Lost to Follow-up|1|||
162802759|NCT04811131|587987275|FG002|Overall Study|Lost to Follow-up|0|||
162802760|NCT04811131|587987276|FG003|Overall Study|Lost to Follow-up|0|||
162802761|NCT04811131|587987273|FG000|Overall Study|Sponsor request|31|||
162802762|NCT04811131|587987274|FG001|Overall Study|Sponsor request|35|||
162802763|NCT04811131|587987275|FG002|Overall Study|Sponsor request|27|||
162802764|NCT04811131|587987276|FG003|Overall Study|Sponsor request|10|||
162802765|NCT04811131|587987273|FG000|Overall Study|Withdrawal by Subject|3|||
162802766|NCT04811131|587987274|FG001|Overall Study|Withdrawal by Subject|1|||
162802767|NCT04811131|587987275|FG002|Overall Study|Withdrawal by Subject|3|||
162802768|NCT04811131|587987276|FG003|Overall Study|Withdrawal by Subject|1|||
162802769|NCT01127763|587987279|FG000|Overall Study|Adverse Event|2|||
162802770|NCT01127763|587987279|FG000|Overall Study|Withdrawal by Subject|1|||
162802771|NCT01127763|587987279|FG000|Overall Study|Physician Decision|2|||
162802772|NCT03181789|587987281|FG000|Overall Study|Withdrawal by Subject|0|||
162802773|NCT03181789|587987282|FG001|Overall Study|Withdrawal by Subject|1|||
162802774|NCT03181789|587987283|FG002|Overall Study|Withdrawal by Subject|1|||
162802775|NCT03181789|587987284|FG003|Overall Study|Withdrawal by Subject|0|||
162802776|NCT03181789|587987281|FG000|Overall Study|Lost to Follow-up|7|||
162802777|NCT03181789|587987282|FG001|Overall Study|Lost to Follow-up|1|||
162802778|NCT03181789|587987283|FG002|Overall Study|Lost to Follow-up|0|||
162802779|NCT03181789|587987284|FG003|Overall Study|Lost to Follow-up|0|||
162802780|NCT03181789|587987281|FG000|Overall Study|Participant unable to adhere to visit|0|||
162802781|NCT03181789|587987282|FG001|Overall Study|Participant unable to adhere to visit|1|||
162802782|NCT03181789|587987283|FG002|Overall Study|Participant unable to adhere to visit|0|||
162802783|NCT03181789|587987284|FG003|Overall Study|Participant unable to adhere to visit|0|||
162802784|NCT01131182|587987285|FG000|Overall Study|Withdrawal by Subject|1|||
162802785|NCT01131182|587987286|FG001|Overall Study|Withdrawal by Subject|1|||
162802786|NCT01131182|587987285|FG000|Overall Study|Lost to Follow-up|14|||
162802787|NCT01131182|587987286|FG001|Overall Study|Lost to Follow-up|15|||
162802788|NCT01131182|587987285|FG000|Overall Study|Other Reason|1|||
162802789|NCT01131182|587987286|FG001|Overall Study|Other Reason|0|||
162802790|NCT00735475|587987287|FG000|Overall Study|Adverse Event|0|||
162802791|NCT00735475|587987288|FG001|Overall Study|Adverse Event|1|||
162802792|NCT00735475|587987287|FG000|Overall Study|Death|1|||
162802793|NCT00735475|587987288|FG001|Overall Study|Death|1|||
162802794|NCT00735475|587987287|FG000|Overall Study|Lost to Follow-up|3|||
162802795|NCT00735475|587987288|FG001|Overall Study|Lost to Follow-up|3|||
162802796|NCT00735475|587987287|FG000|Overall Study|Physician Decision|0|||
162802797|NCT00735475|587987288|FG001|Overall Study|Physician Decision|1|||
162802798|NCT00735475|587987287|FG000|Overall Study|Withdrawal by Subject|4|||
162802799|NCT00735475|587987288|FG001|Overall Study|Withdrawal by Subject|5|||
162802800|NCT05086276|587987289|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
162802801|NCT05086276|587987290|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
162802802|NCT00777088|587987291|FG000|Overall Study|PED Treatment not attempted|1|||
162802803|NCT00633880|587987292|FG000|Open Label Titration|Lack of Efficacy|1|||
162802804|NCT00633880|587987293|FG001|Open Label Titration|Lack of Efficacy|0|||
162802805|NCT00633880|587987294|FG002|Open Label Titration|Lack of Efficacy|0|||
162802806|NCT00633880|587987292|FG000|Open Label Titration|Adverse Event|13|||
162802807|NCT00633880|587987293|FG001|Open Label Titration|Adverse Event|0|||
162802808|NCT00633880|587987294|FG002|Open Label Titration|Adverse Event|0|||
162802809|NCT00633880|587987292|FG000|Open Label Titration|Treatment Failure|55|||
162802810|NCT00633880|587987293|FG001|Open Label Titration|Treatment Failure|0|||
162802811|NCT00633880|587987294|FG002|Open Label Titration|Treatment Failure|0|||
162802812|NCT00633880|587987292|FG000|Open Label Titration|Protocol Violation|6|||
162802813|NCT00633880|587987293|FG001|Open Label Titration|Protocol Violation|0|||
162802814|NCT00633880|587987294|FG002|Open Label Titration|Protocol Violation|0|||
162802815|NCT00633880|587987292|FG000|Open Label Titration|Physician Decision|1|||
162802816|NCT00633880|587987293|FG001|Open Label Titration|Physician Decision|0|||
162802817|NCT00633880|587987294|FG002|Open Label Titration|Physician Decision|0|||
162802818|NCT00633880|587987292|FG000|Open Label Titration|Withdrawal by Subject|4|||
162802819|NCT00633880|587987293|FG001|Open Label Titration|Withdrawal by Subject|0|||
162802820|NCT00633880|587987294|FG002|Open Label Titration|Withdrawal by Subject|0|||
162802821|NCT03117998|587987297|FG000|Overall Study|Adverse Event|1|||
162802822|NCT03117998|587987298|FG001|Overall Study|Adverse Event|0|||
162802823|NCT03117998|587987299|FG002|Overall Study|Adverse Event|0|||
162802824|NCT03117998|587987300|FG003|Overall Study|Adverse Event|0|||
162802825|NCT03117998|587987301|FG004|Overall Study|Adverse Event|0|||
162802826|NCT03117998|587987302|FG005|Overall Study|Adverse Event|0|||
162802827|NCT03117998|587987297|FG000|Overall Study|Withdrawal by Subject|0|||
162802828|NCT03117998|587987298|FG001|Overall Study|Withdrawal by Subject|0|||
162802829|NCT03117998|587987299|FG002|Overall Study|Withdrawal by Subject|2|||
162802830|NCT03117998|587987300|FG003|Overall Study|Withdrawal by Subject|3|||
162802831|NCT03117998|587987301|FG004|Overall Study|Withdrawal by Subject|3|||
162802832|NCT03117998|587987302|FG005|Overall Study|Withdrawal by Subject|0|||
162802833|NCT03117998|587987297|FG000|Overall Study|Physician Decision|0|||
162802834|NCT03117998|587987298|FG001|Overall Study|Physician Decision|1|||
162802835|NCT03117998|587987299|FG002|Overall Study|Physician Decision|1|||
162802836|NCT03117998|587987300|FG003|Overall Study|Physician Decision|0|||
162802837|NCT03117998|587987301|FG004|Overall Study|Physician Decision|0|||
162802838|NCT03117998|587987302|FG005|Overall Study|Physician Decision|0|||
162802839|NCT03117998|587987297|FG000|Overall Study|Lost to Follow-up|0|||
162802840|NCT03117998|587987298|FG001|Overall Study|Lost to Follow-up|0|||
162802841|NCT03117998|587987299|FG002|Overall Study|Lost to Follow-up|0|||
162802842|NCT03117998|587987300|FG003|Overall Study|Lost to Follow-up|1|||
162802843|NCT03117998|587987301|FG004|Overall Study|Lost to Follow-up|4|||
162802844|NCT03117998|587987302|FG005|Overall Study|Lost to Follow-up|0|||
162802845|NCT03117998|587987297|FG000|Overall Study|Subject noncompliance|0|||
162802846|NCT03117998|587987298|FG001|Overall Study|Subject noncompliance|0|||
162802847|NCT03117998|587987299|FG002|Overall Study|Subject noncompliance|1|||
162802848|NCT03117998|587987300|FG003|Overall Study|Subject noncompliance|0|||
162802849|NCT03117998|587987301|FG004|Overall Study|Subject noncompliance|0|||
162802850|NCT03117998|587987302|FG005|Overall Study|Subject noncompliance|2|||
162802851|NCT03117998|587987297|FG000|Overall Study|Protocol Violation|0|||
162802852|NCT03117998|587987298|FG001|Overall Study|Protocol Violation|0|||
162802853|NCT03117998|587987299|FG002|Overall Study|Protocol Violation|0|||
162802854|NCT03117998|587987300|FG003|Overall Study|Protocol Violation|0|||
162802855|NCT03117998|587987301|FG004|Overall Study|Protocol Violation|0|||
162802856|NCT03117998|587987302|FG005|Overall Study|Protocol Violation|1|||
162802857|NCT04927247|587987303|FG000|Overall Study|Other|2|||
162802858|NCT04927247|587987304|FG001|Overall Study|Other|1|||
162802859|NCT04927247|587987303|FG000|Overall Study|Physician Decision|0|||
162802860|NCT04927247|587987304|FG001|Overall Study|Physician Decision|1|||
162802861|NCT04927247|587987303|FG000|Overall Study|Adverse Event|1|||
162802862|NCT04927247|587987304|FG001|Overall Study|Adverse Event|0|||
162802863|NCT02001064|587987305|FG000|Overall Study|Withdrawal by Subject|2|||
162802864|NCT02001064|587987306|FG001|Overall Study|Withdrawal by Subject|1|||
162802865|NCT01468181|587987308|FG000|Overall Study|Adverse Event|8|||
162802866|NCT01468181|587987309|FG001|Overall Study|Adverse Event|1|||
162802867|NCT01468181|587987310|FG002|Overall Study|Adverse Event|6|||
162802868|NCT01468181|587987311|FG003|Overall Study|Adverse Event|2|||
162802869|NCT01468181|587987312|FG004|Overall Study|Adverse Event|2|||
162802870|NCT01468181|587987308|FG000|Overall Study|Protocol Violation|2|||
162802871|NCT01468181|587987309|FG001|Overall Study|Protocol Violation|0|||
162802872|NCT01468181|587987310|FG002|Overall Study|Protocol Violation|1|||
162802873|NCT01468181|587987311|FG003|Overall Study|Protocol Violation|0|||
162802874|NCT01468181|587987312|FG004|Overall Study|Protocol Violation|1|||
162802875|NCT01468181|587987308|FG000|Overall Study|Physician Decision|0|||
162802876|NCT01468181|587987309|FG001|Overall Study|Physician Decision|0|||
162802877|NCT01468181|587987310|FG002|Overall Study|Physician Decision|0|||
162802878|NCT01468181|587987311|FG003|Overall Study|Physician Decision|1|||
162802879|NCT01468181|587987312|FG004|Overall Study|Physician Decision|1|||
162802880|NCT01468181|587987308|FG000|Overall Study|Lost to Follow-up|0|||
162802881|NCT01468181|587987309|FG001|Overall Study|Lost to Follow-up|0|||
162802882|NCT01468181|587987310|FG002|Overall Study|Lost to Follow-up|1|||
162802883|NCT01468181|587987311|FG003|Overall Study|Lost to Follow-up|0|||
162802884|NCT01468181|587987312|FG004|Overall Study|Lost to Follow-up|1|||
162802885|NCT01468181|587987308|FG000|Overall Study|Withdrawal by Subject|0|||
162802886|NCT01468181|587987309|FG001|Overall Study|Withdrawal by Subject|1|||
162802887|NCT01468181|587987310|FG002|Overall Study|Withdrawal by Subject|0|||
162802888|NCT01468181|587987311|FG003|Overall Study|Withdrawal by Subject|0|||
162802889|NCT01468181|587987312|FG004|Overall Study|Withdrawal by Subject|0|||
162802890|NCT00545753|587987316|FG000|Overall Study|Withdrawal by Subject|0|||
162802891|NCT00545753|587987317|FG001|Overall Study|Withdrawal by Subject|1|||
162802892|NCT00545753|587987318|FG002|Overall Study|Withdrawal by Subject|10|||
162802893|NCT00545753|587987316|FG000|Overall Study|Lost to Follow-up|13|||
162802894|NCT00545753|587987317|FG001|Overall Study|Lost to Follow-up|3|||
162802895|NCT00545753|587987318|FG002|Overall Study|Lost to Follow-up|12|||
162802896|NCT00545753|587987316|FG000|Overall Study|Protocol Violation|3|||
162802897|NCT00545753|587987317|FG001|Overall Study|Protocol Violation|1|||
162802898|NCT00545753|587987318|FG002|Overall Study|Protocol Violation|4|||
162802899|NCT00513305|587987319|FG000|Overall Study|Adverse Event|6|||
162802900|NCT00513305|587987320|FG001|Overall Study|Adverse Event|2|||
162802901|NCT00513305|587987319|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
162802902|NCT00513305|587987320|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
162802903|NCT00513305|587987319|FG000|Overall Study|Lack of Efficacy|8|||
162802904|NCT00513305|587987320|FG001|Overall Study|Lack of Efficacy|13|||
162802905|NCT00513305|587987319|FG000|Overall Study|Withdrawal by Subject|1|||
162802906|NCT00513305|587987320|FG001|Overall Study|Withdrawal by Subject|2|||
162802907|NCT00513305|587987319|FG000|Overall Study|Disease progression|8|||
162802908|NCT00513305|587987320|FG001|Overall Study|Disease progression|5|||
162802909|NCT00513305|587987319|FG000|Overall Study|Eligible for stem cell transplant|1|||
162802910|NCT00513305|587987320|FG001|Overall Study|Eligible for stem cell transplant|0|||
162802911|NCT00513305|587987319|FG000|Overall Study|Hematologic counts did not recover|1|||
162802912|NCT00513305|587987320|FG001|Overall Study|Hematologic counts did not recover|0|||
162802913|NCT00513305|587987319|FG000|Overall Study|Physician Decision|1|||
162802914|NCT00513305|587987320|FG001|Overall Study|Physician Decision|0|||
162802915|NCT00513305|587987319|FG000|Overall Study|Persistent hypocellularity|0|||
162802916|NCT00513305|587987320|FG001|Overall Study|Persistent hypocellularity|1|||
162802917|NCT00513305|587987319|FG000|Overall Study|Sponsor Decision|0|||
162802918|NCT00513305|587987320|FG001|Overall Study|Sponsor Decision|2|||
162802919|NCT01262027|587987322|FG000|Overall Study|Adverse Event|1|||
162802920|NCT01262027|587987322|FG000|Overall Study|Withdrawal by Subject|3|||
162802921|NCT01262027|587987322|FG000|Overall Study|Protocol Violation|1|||
162802922|NCT01011153|587987326|FG000|Overall Study|Less than 78 cases completed|8|||
162802923|NCT01011153|587987327|FG001|Overall Study|Less than 78 cases completed|11|||
162802924|NCT01011153|587987328|FG002|Overall Study|Less than 78 cases completed|9|||
162802925|NCT03014479|587987334|FG000|Overall Study|Adverse Event|0|||
162802926|NCT03014479|587987335|FG001|Overall Study|Adverse Event|1|||
162802927|NCT03014479|587987334|FG000|Overall Study|Voluntary Withdrawal|0|||
162802928|NCT03014479|587987335|FG001|Overall Study|Voluntary Withdrawal|2|||
162802929|NCT03014479|587987334|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
162802930|NCT03014479|587987335|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
162802931|NCT01081132|587987340|FG000|Overall Study|Lack of Efficacy|25|||
162802932|NCT01081132|587987341|FG001|Overall Study|Lack of Efficacy|9|||
162802933|NCT01081132|587987340|FG000|Overall Study|Withdrawal by Subject|13|||
162802934|NCT01081132|587987341|FG001|Overall Study|Withdrawal by Subject|16|||
162802935|NCT01081132|587987340|FG000|Overall Study|Lost to Follow-up|4|||
162802936|NCT01081132|587987341|FG001|Overall Study|Lost to Follow-up|11|||
162802937|NCT01081132|587987340|FG000|Overall Study|Adverse Event|3|||
162802938|NCT01081132|587987341|FG001|Overall Study|Adverse Event|9|||
162802939|NCT01081132|587987340|FG000|Overall Study|Non Compliance|4|||
162802940|NCT01081132|587987341|FG001|Overall Study|Non Compliance|2|||
162802941|NCT01081132|587987340|FG000|Overall Study|Lack Of Compliance|0|||
162802942|NCT01081132|587987341|FG001|Overall Study|Lack Of Compliance|1|||
162802943|NCT01081132|587987340|FG000|Overall Study|Missed Visits|1|||
162802944|NCT01081132|587987341|FG001|Overall Study|Missed Visits|1|||
162802945|NCT01081132|587987340|FG000|Overall Study|Stopped Taking Meds|2|||
162802946|NCT01081132|587987341|FG001|Overall Study|Stopped Taking Meds|0|||
162802947|NCT01081132|587987340|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
162802948|NCT01081132|587987341|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
162802949|NCT01081132|587987340|FG000|Overall Study|Declined Taper Phase|0|||
162802950|NCT01081132|587987341|FG001|Overall Study|Declined Taper Phase|1|||
162802951|NCT01081132|587987340|FG000|Overall Study|Protocol Violation|3|||
162802952|NCT01081132|587987341|FG001|Overall Study|Protocol Violation|1|||
162802953|NCT02101385|587987342|FG000|Study Treatment|Disease Progression|9|||
162802954|NCT02101385|587987343|FG001|Study Treatment|Disease Progression|3|||
162802955|NCT02101385|587987342|FG000|Study Treatment|Alternative therapy|0|||
162802956|NCT02101385|587987343|FG001|Study Treatment|Alternative therapy|1|||
162802957|NCT02101385|587987342|FG000|Study Treatment|No treatment, per protocol criteria|0|||
162802958|NCT02101385|587987343|FG001|Study Treatment|No treatment, per protocol criteria|4|||
162802959|NCT02101385|587987342|FG000|Study Treatment|Patient Non compliance|0|||
162802960|NCT02101385|587987343|FG001|Study Treatment|Patient Non compliance|2|||
162802961|NCT02101385|587987342|FG000|Study Treatment|Withdrawal by Subject|5|||
162802962|NCT02101385|587987343|FG001|Study Treatment|Withdrawal by Subject|2|||
162802963|NCT02101385|587987342|FG000|Study Treatment|screen failure|1|||
162802964|NCT02101385|587987343|FG001|Study Treatment|screen failure|0|||
162802965|NCT02101385|587987342|FG000|Study Treatment|AE/Side Effects/Complications|8|||
162802966|NCT02101385|587987343|FG001|Study Treatment|AE/Side Effects/Complications|0|||
162802967|NCT02101385|587987342|FG000|Study Treatment|Lost to Follow-up|1|||
162802968|NCT02101385|587987343|FG001|Study Treatment|Lost to Follow-up|0|||
162802969|NCT02101385|587987342|FG000|Study Treatment|Disease Progression before treatment|1|||
162802970|NCT02101385|587987343|FG001|Study Treatment|Disease Progression before treatment|0|||
162802971|NCT02101385|587987342|FG000|Study Treatment|Death|1|||
162802972|NCT02101385|587987343|FG001|Study Treatment|Death|0|||
162802973|NCT02101385|587987342|FG000|Follow up|Lost to Follow-up|4|||
162802974|NCT02101385|587987343|FG001|Follow up|Lost to Follow-up|9|||
162802975|NCT02101385|587987342|FG000|Follow up|Refused to follow up|5|||
162802976|NCT02101385|587987343|FG001|Follow up|Refused to follow up|4|||
162802977|NCT02101385|587987342|FG000|Follow up|Death|21|||
162802978|NCT02101385|587987343|FG001|Follow up|Death|39|||
162802979|NCT02101385|587987342|FG000|Follow up|study completed|33|||
162802980|NCT02101385|587987343|FG001|Follow up|study completed|52|||
162802981|NCT02101385|587987342|FG000|Follow up|screen failure|2|||
162802982|NCT02101385|587987343|FG001|Follow up|screen failure|0|||
162802983|NCT02101385|587987342|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
162802984|NCT02101385|587987343|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
162810584|NCT00887250|588018275|FG000|Overall Study|Withdrawal by Subject|2|||
162802985|NCT02101385|587987342|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
162802986|NCT02101385|587987343|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
162802987|NCT02101385|587987342|FG000|Follow up|Withdrawal by Subject|2|||
162802988|NCT02101385|587987343|FG001|Follow up|Withdrawal by Subject|2|||
162802989|NCT02101385|587987342|FG000|Follow up|PI requested closure of site|0|||
162802990|NCT02101385|587987343|FG001|Follow up|PI requested closure of site|5|||
162802991|NCT02489968|587987346|FG000|Open-label Treatment Period|Adverse Event|14|||
162802992|NCT02489968|587987347|FG001|Open-label Treatment Period|Adverse Event|7|||
162802993|NCT02489968|587987348|FG002|Open-label Treatment Period|Adverse Event|0|||
162802994|NCT02489968|587987349|FG003|Open-label Treatment Period|Adverse Event|0|||
162802995|NCT02489968|587987350|FG004|Open-label Treatment Period|Adverse Event|0|||
162802996|NCT02489968|587987351|FG005|Open-label Treatment Period|Adverse Event|0|||
162802997|NCT02489968|587987346|FG000|Open-label Treatment Period|Protocol Violation|2|||
162802998|NCT02489968|587987347|FG001|Open-label Treatment Period|Protocol Violation|2|||
162802999|NCT02489968|587987348|FG002|Open-label Treatment Period|Protocol Violation|0|||
162803000|NCT02489968|587987349|FG003|Open-label Treatment Period|Protocol Violation|0|||
162803001|NCT02489968|587987350|FG004|Open-label Treatment Period|Protocol Violation|0|||
162803002|NCT02489968|587987351|FG005|Open-label Treatment Period|Protocol Violation|0|||
162803003|NCT02489968|587987346|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
162803004|NCT02489968|587987347|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
162803005|NCT02489968|587987348|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
162803006|NCT02489968|587987349|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
162803007|NCT02489968|587987350|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
162803008|NCT02489968|587987351|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
162803009|NCT02489968|587987346|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
162803010|NCT02489968|587987347|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
162803011|NCT02489968|587987348|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
162803012|NCT02489968|587987349|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
162803013|NCT02489968|587987350|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
162803014|NCT02489968|587987351|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
162803015|NCT02489968|587987346|FG000|Open-label Treatment Period|Other than specified above|204|||
162803016|NCT02489968|587987347|FG001|Open-label Treatment Period|Other than specified above|189|||
162803017|NCT02489968|587987348|FG002|Open-label Treatment Period|Other than specified above|0|||
162803018|NCT02489968|587987349|FG003|Open-label Treatment Period|Other than specified above|0|||
162803019|NCT02489968|587987350|FG004|Open-label Treatment Period|Other than specified above|0|||
162803020|NCT02489968|587987351|FG005|Open-label Treatment Period|Other than specified above|0|||
162803021|NCT02489968|587987346|FG000|Double-blind Treatment Period|Adverse Event|0|||
162803022|NCT02489968|587987347|FG001|Double-blind Treatment Period|Adverse Event|0|||
162803023|NCT02489968|587987348|FG002|Double-blind Treatment Period|Adverse Event|2|||
162803024|NCT02489968|587987349|FG003|Double-blind Treatment Period|Adverse Event|6|||
162803025|NCT02489968|587987350|FG004|Double-blind Treatment Period|Adverse Event|4|||
162803026|NCT02489968|587987351|FG005|Double-blind Treatment Period|Adverse Event|5|||
162803027|NCT02489968|587987346|FG000|Double-blind Treatment Period|Protocol Violation|0|||
162803028|NCT02489968|587987347|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162803029|NCT02489968|587987348|FG002|Double-blind Treatment Period|Protocol Violation|0|||
162803030|NCT02489968|587987349|FG003|Double-blind Treatment Period|Protocol Violation|0|||
162803031|NCT02489968|587987350|FG004|Double-blind Treatment Period|Protocol Violation|1|||
162803032|NCT02489968|587987351|FG005|Double-blind Treatment Period|Protocol Violation|1|||
162803033|NCT02489968|587987346|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
162803034|NCT02489968|587987347|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
162803035|NCT02489968|587987348|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162803036|NCT02489968|587987349|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
162803037|NCT02489968|587987350|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
162803038|NCT02489968|587987351|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
162803039|NCT02489968|587987346|FG000|Double-blind Treatment Period|Other than specified above|0|||
162803040|NCT02489968|587987347|FG001|Double-blind Treatment Period|Other than specified above|0|||
162803041|NCT02489968|587987348|FG002|Double-blind Treatment Period|Other than specified above|0|||
162803042|NCT02489968|587987349|FG003|Double-blind Treatment Period|Other than specified above|0|||
162803043|NCT02489968|587987350|FG004|Double-blind Treatment Period|Other than specified above|1|||
162803044|NCT02489968|587987351|FG005|Double-blind Treatment Period|Other than specified above|0|||
162803045|NCT03973931|587987356|FG000|Overall Study|Lost to Follow-up|47|||
162803046|NCT03973931|587987357|FG001|Overall Study|Lost to Follow-up|63|||
162803047|NCT03973931|587987358|FG002|Overall Study|Lost to Follow-up|51|||
162803048|NCT03973931|587987359|FG003|Overall Study|Lost to Follow-up|54|||
162803049|NCT03973931|587987356|FG000|Overall Study|opted out|6|||
162803050|NCT03973931|587987357|FG001|Overall Study|opted out|5|||
162803051|NCT03973931|587987358|FG002|Overall Study|opted out|5|||
162803052|NCT03973931|587987359|FG003|Overall Study|opted out|1|||
162803053|NCT00432666|587988938|FG000|Main Period|Adverse Event|1|||
162803054|NCT00432666|587988939|FG001|Main Period|Adverse Event|1|||
162803055|NCT00432666|587988938|FG000|Main Period|Consent Withdrawn|1|||
162803056|NCT00432666|587988939|FG001|Main Period|Consent Withdrawn|0|||
162803057|NCT00432666|587988938|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
162803058|NCT00432666|587988939|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
162803059|NCT00432666|587988938|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
162803060|NCT00432666|587988939|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
162803061|NCT00432666|587988938|FG000|Open-Label Extension Period|Adverse Event|5|||
162803062|NCT00432666|587988939|FG001|Open-Label Extension Period|Adverse Event|0|||
162803063|NCT00432666|587988938|FG000|Open-Label Extension Period|Consent withdrawn|10|||
162803064|NCT00432666|587988939|FG001|Open-Label Extension Period|Consent withdrawn|0|||
162803065|NCT00432666|587988938|FG000|Open-Label Extension Period|Physician Decision|3|||
162803066|NCT00432666|587988939|FG001|Open-Label Extension Period|Physician Decision|0|||
162803067|NCT00978627|587988940|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
162803068|NCT00978627|587988941|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
162803069|NCT00978627|587988940|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
162803070|NCT00978627|587988941|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
162803071|NCT00978627|587988940|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
162803072|NCT00978627|587988941|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
162803073|NCT00978627|587988940|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
162803074|NCT00978627|587988941|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
162803075|NCT00978627|587988940|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
162803076|NCT00978627|587988941|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
162803077|NCT00978627|587988940|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
162803078|NCT00978627|587988941|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
162803079|NCT00978627|587988940|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
162803080|NCT00978627|587988941|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
162803081|NCT00978627|587988940|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
162803082|NCT00978627|587988941|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
162803083|NCT00978627|587988940|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
162803084|NCT00978627|587988941|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
162803085|NCT01506453|587988942|FG000|Overall Study|Withdrawal prior to treatment|0|||
162803086|NCT01506453|587988943|FG001|Overall Study|Withdrawal prior to treatment|2|||
162803087|NCT00603304|587988954|FG000|Overall Study|Lost to Follow-up|5|||
162803088|NCT00603304|587988955|FG001|Overall Study|Lost to Follow-up|7|||
162803089|NCT00603304|587988954|FG000|Overall Study|Withdrawal by Subject|8|||
162803090|NCT00603304|587988955|FG001|Overall Study|Withdrawal by Subject|5|||
162803091|NCT00603304|587988954|FG000|Overall Study|Protocol Violation|1|||
162803092|NCT00603304|587988955|FG001|Overall Study|Protocol Violation|0|||
162803093|NCT00603304|587988954|FG000|Overall Study|Adverse Event|4|||
162803094|NCT00603304|587988955|FG001|Overall Study|Adverse Event|2|||
162803095|NCT00603304|587988954|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
162803096|NCT00603304|587988955|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
162803097|NCT00603304|587988954|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
162803098|NCT00603304|587988955|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
162803099|NCT00603304|587988954|FG000|Overall Study|Exclusionary Medication|2|||
162803100|NCT00603304|587988955|FG001|Overall Study|Exclusionary Medication|3|||
162803101|NCT00603304|587988954|FG000|Overall Study|Non-Compliant|0|||
162803102|NCT00603304|587988955|FG001|Overall Study|Non-Compliant|1|||
162803103|NCT00603304|587988954|FG000|Overall Study|Moved Away|0|||
162803104|NCT00603304|587988955|FG001|Overall Study|Moved Away|2|||
162803105|NCT00603304|587988954|FG000|Overall Study|Other|2|||
162803106|NCT00603304|587988955|FG001|Overall Study|Other|0|||
162803107|NCT00603304|587988954|FG000|Overall Study|Patient Decision|2|||
162803108|NCT00603304|587988955|FG001|Overall Study|Patient Decision|0|||
162803109|NCT01076192|587988956|FG000|Overall Study|Other|197|||
162803110|NCT01290315|587988957|FG000|Overall Study|Adverse Event|0|||
162803111|NCT01290315|587988958|FG001|Overall Study|Adverse Event|0|||
162803112|NCT01290315|587988959|FG002|Overall Study|Adverse Event|0|||
162803113|NCT01290315|587988960|FG003|Overall Study|Adverse Event|3|||
162803114|NCT01290315|587988957|FG000|Overall Study|Selection criteria/compliance|2|||
162803115|NCT01290315|587988958|FG001|Overall Study|Selection criteria/compliance|1|||
162803116|NCT01290315|587988959|FG002|Overall Study|Selection criteria/compliance|0|||
162803117|NCT01290315|587988960|FG003|Overall Study|Selection criteria/compliance|2|||
162803118|NCT01290315|587988957|FG000|Overall Study|Lost to Follow-up|0|||
162803119|NCT01290315|587988958|FG001|Overall Study|Lost to Follow-up|1|||
162803120|NCT01290315|587988959|FG002|Overall Study|Lost to Follow-up|0|||
162803121|NCT01290315|587988960|FG003|Overall Study|Lost to Follow-up|0|||
162803122|NCT01290315|587988957|FG000|Overall Study|Withdrawal by Subject|1|||
162803123|NCT01290315|587988958|FG001|Overall Study|Withdrawal by Subject|1|||
162803124|NCT01290315|587988959|FG002|Overall Study|Withdrawal by Subject|0|||
162803125|NCT01290315|587988960|FG003|Overall Study|Withdrawal by Subject|0|||
162803126|NCT03725085|587988961|FG000|Overall Study|Lost to Follow-up|2|||
162803127|NCT00705679|587988962|FG000|Overall Study|Adverse Event|1|||
162803128|NCT00705679|587988963|FG001|Overall Study|Adverse Event|1|||
162803129|NCT00705679|587988964|FG002|Overall Study|Adverse Event|0|||
162803130|NCT00705679|587988965|FG003|Overall Study|Adverse Event|0|||
162803131|NCT00705679|587988966|FG004|Overall Study|Adverse Event|0|||
162803132|NCT00705679|587988962|FG000|Overall Study|Death|0|||
162803133|NCT00705679|587988963|FG001|Overall Study|Death|0|||
162803134|NCT00705679|587988964|FG002|Overall Study|Death|3|||
162803135|NCT00705679|587988965|FG003|Overall Study|Death|2|||
162803136|NCT00705679|587988966|FG004|Overall Study|Death|1|||
162803137|NCT00705679|587988962|FG000|Overall Study|Lost to Follow-up|32|||
162803138|NCT00705679|587988963|FG001|Overall Study|Lost to Follow-up|60|||
162803139|NCT00705679|587988964|FG002|Overall Study|Lost to Follow-up|44|||
162803140|NCT00705679|587988965|FG003|Overall Study|Lost to Follow-up|30|||
162803141|NCT00705679|587988966|FG004|Overall Study|Lost to Follow-up|35|||
162803142|NCT00705679|587988962|FG000|Overall Study|Physician Decision|0|||
162803143|NCT00705679|587988963|FG001|Overall Study|Physician Decision|1|||
162803144|NCT00705679|587988964|FG002|Overall Study|Physician Decision|0|||
162803145|NCT00705679|587988965|FG003|Overall Study|Physician Decision|1|||
162803146|NCT00705679|587988966|FG004|Overall Study|Physician Decision|0|||
162803147|NCT00705679|587988962|FG000|Overall Study|Withdrawal by Subject|32|||
162803148|NCT00705679|587988963|FG001|Overall Study|Withdrawal by Subject|77|||
162803149|NCT00705679|587988964|FG002|Overall Study|Withdrawal by Subject|68|||
162803150|NCT00705679|587988965|FG003|Overall Study|Withdrawal by Subject|47|||
162803151|NCT00705679|587988966|FG004|Overall Study|Withdrawal by Subject|33|||
162803152|NCT03527173|587988967|FG000|Overall Study|Lost to Follow-up|4|||
162803153|NCT03527173|587988968|FG001|Overall Study|Lost to Follow-up|2|||
162803154|NCT03527173|587988967|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
162803155|NCT03527173|587988968|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
162803156|NCT03527173|587988967|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
162803157|NCT03527173|587988968|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
162803158|NCT03527173|587988967|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
162803159|NCT03527173|587988968|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
162803160|NCT02704754|587988969|FG000|Overall Study|Lost to Follow-up|1|||
162803161|NCT02704754|587988970|FG001|Overall Study|Lost to Follow-up|1|||
162803162|NCT02704754|587988969|FG000|Overall Study|Lack of Efficacy|1|||
162803163|NCT02704754|587988970|FG001|Overall Study|Lack of Efficacy|0|||
162803164|NCT02704754|587988969|FG000|Overall Study|Withdrawal by Subject|1|||
162803165|NCT02704754|587988970|FG001|Overall Study|Withdrawal by Subject|0|||
162803166|NCT00423943|587988973|FG000|Overall Study|Withdrawal by Subject|3|||
162803167|NCT00423943|587988974|FG001|Overall Study|Withdrawal by Subject|1|||
162803168|NCT03730480|587988975|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
162803169|NCT01248780|587988976|FG000|Overall Study|Lack of Efficacy|2|||
162803170|NCT01248780|587988977|FG001|Overall Study|Lack of Efficacy|0|||
162803171|NCT01248780|587988976|FG000|Overall Study|Lost to Follow-up|0|||
162803172|NCT01248780|587988977|FG001|Overall Study|Lost to Follow-up|1|||
162803173|NCT01248780|587988976|FG000|Overall Study|Death|0|||
162803174|NCT01248780|587988977|FG001|Overall Study|Death|1|||
162803175|NCT01248780|587988976|FG000|Overall Study|Adverse Event|2|||
162803176|NCT01248780|587988977|FG001|Overall Study|Adverse Event|7|||
162803177|NCT01248780|587988976|FG000|Overall Study|Protocol Violation|1|||
162803178|NCT01248780|587988977|FG001|Overall Study|Protocol Violation|1|||
162803179|NCT01248780|587988976|FG000|Overall Study|Withdrawal by Subject|4|||
162803180|NCT01248780|587988977|FG001|Overall Study|Withdrawal by Subject|4|||
162803181|NCT01248780|587988976|FG000|Overall Study|Not treated|0|||
162803182|NCT01248780|587988977|FG001|Overall Study|Not treated|1|||
162803183|NCT00107120|587988981|FG000|Overall Study|Adverse Event|4|||
162803184|NCT00107120|587988982|FG001|Overall Study|Adverse Event|1|||
162803185|NCT00107120|587988981|FG000|Overall Study|Lack of Efficacy|5|||
162803186|NCT00107120|587988982|FG001|Overall Study|Lack of Efficacy|5|||
162803187|NCT00107120|587988981|FG000|Overall Study|Protocol Violation|3|||
162803188|NCT00107120|587988982|FG001|Overall Study|Protocol Violation|0|||
162803189|NCT00107120|587988981|FG000|Overall Study|Withdrawal by Subject|8|||
162803190|NCT00107120|587988982|FG001|Overall Study|Withdrawal by Subject|9|||
162803191|NCT00107120|587988981|FG000|Overall Study|Lost to Follow-up|8|||
162803192|NCT00107120|587988982|FG001|Overall Study|Lost to Follow-up|6|||
162803193|NCT00107120|587988981|FG000|Overall Study|Pregnancy|0|||
162803194|NCT00107120|587988982|FG001|Overall Study|Pregnancy|1|||
162803195|NCT00107120|587988981|FG000|Overall Study|moving away from site|1|||
162803196|NCT00107120|587988982|FG001|Overall Study|moving away from site|1|||
162803197|NCT00107120|587988981|FG000|Overall Study|death of parent|0|||
162803198|NCT00107120|587988982|FG001|Overall Study|death of parent|1|||
162803199|NCT04214600|587988985|FG000|Overall Study|Lost to Follow-up|9|||
162803200|NCT04214600|587988986|FG001|Overall Study|Lost to Follow-up|14|||
162803201|NCT00896051|587988987|FG000|Overall Study|Adverse Event|2|||
162803202|NCT00896051|587988988|FG001|Overall Study|Adverse Event|1|||
162803203|NCT00896051|587988987|FG000|Overall Study|Lost to Follow-up|3|||
162803204|NCT00896051|587988988|FG001|Overall Study|Lost to Follow-up|2|||
162803205|NCT00896051|587988987|FG000|Overall Study|Withdrawal by Subject|3|||
162803206|NCT00896051|587988988|FG001|Overall Study|Withdrawal by Subject|2|||
162803207|NCT00896051|587988987|FG000|Overall Study|Subject noncompliant|1|||
162803208|NCT00896051|587988988|FG001|Overall Study|Subject noncompliant|3|||
162803209|NCT00896051|587988987|FG000|Overall Study|Other|1|||
162803210|NCT00896051|587988988|FG001|Overall Study|Other|1|||
162803211|NCT02935452|587988989|FG000|Overall Study|work and life commintment|3|||
162803212|NCT02935452|587988990|FG001|Overall Study|work and life commintment|1|||
162803213|NCT01635920|587988992|FG000|Overall Study|Adverse Event|1|||
162803214|NCT01635920|587988993|FG001|Overall Study|Adverse Event|0|||
162803215|NCT01635920|587988992|FG000|Overall Study|Lost to Follow-up|0|||
162803216|NCT01635920|587988993|FG001|Overall Study|Lost to Follow-up|1|||
162803217|NCT01635920|587988992|FG000|Overall Study|Subject decision|2|||
162803218|NCT01635920|587988993|FG001|Overall Study|Subject decision|0|||
162803219|NCT01813929|587988994|FG000|Overall Study|Withdrawal by Subject|0|||
162803220|NCT01813929|587988995|FG001|Overall Study|Withdrawal by Subject|1|||
162803221|NCT00007345|587988996|FG000|Overall Study|Refused further treatment|0|||
162803222|NCT00007345|587988997|FG001|Overall Study|Refused further treatment|7|||
162803223|NCT00007345|587988996|FG000|Overall Study|Switched to alternative treatment|0|||
162803224|NCT00007345|587988997|FG001|Overall Study|Switched to alternative treatment|3|||
162803225|NCT00007345|587988996|FG000|Overall Study|Intercurrent illness|1|||
162803226|NCT00007345|587988997|FG001|Overall Study|Intercurrent illness|0|||
162803227|NCT00007345|587988996|FG000|Overall Study|Death on study|1|||
162803228|NCT00007345|587988997|FG001|Overall Study|Death on study|1|||
162803229|NCT04433585|587988998|FG000|Overall Study|Withdrawal by Subject|15|||
162803230|NCT04433585|587988999|FG001|Overall Study|Withdrawal by Subject|3|||
162803231|NCT04433585|587989000|FG002|Overall Study|Withdrawal by Subject|15|||
162803232|NCT04433585|587989001|FG003|Overall Study|Withdrawal by Subject|6|||
162803233|NCT04433585|587988998|FG000|Overall Study|Adverse Event|10|||
162803234|NCT04433585|587988999|FG001|Overall Study|Adverse Event|4|||
162803235|NCT04433585|587989000|FG002|Overall Study|Adverse Event|1|||
162803236|NCT04433585|587989001|FG003|Overall Study|Adverse Event|0|||
162803237|NCT04433585|587988998|FG000|Overall Study|Due to the conflict in Ukraine|2|||
162803238|NCT04433585|587988999|FG001|Overall Study|Due to the conflict in Ukraine|1|||
162803239|NCT04433585|587989000|FG002|Overall Study|Due to the conflict in Ukraine|1|||
162803240|NCT04433585|587989001|FG003|Overall Study|Due to the conflict in Ukraine|2|||
162803241|NCT04433585|587988998|FG000|Overall Study|Physician Decision|1|||
162803242|NCT04433585|587988999|FG001|Overall Study|Physician Decision|2|||
162803243|NCT04433585|587989000|FG002|Overall Study|Physician Decision|0|||
162803244|NCT04433585|587989001|FG003|Overall Study|Physician Decision|0|||
162803245|NCT04433585|587988998|FG000|Overall Study|Lost to Follow-up|1|||
162803246|NCT04433585|587988999|FG001|Overall Study|Lost to Follow-up|1|||
162803247|NCT04433585|587989000|FG002|Overall Study|Lost to Follow-up|1|||
162803248|NCT04433585|587989001|FG003|Overall Study|Lost to Follow-up|0|||
162803249|NCT04433585|587988998|FG000|Overall Study|Lack of Efficacy|0|||
162803250|NCT04433585|587988999|FG001|Overall Study|Lack of Efficacy|1|||
162803251|NCT04433585|587989000|FG002|Overall Study|Lack of Efficacy|1|||
162803252|NCT04433585|587989001|FG003|Overall Study|Lack of Efficacy|1|||
162803253|NCT04433585|587988998|FG000|Overall Study|Death|0|||
162803254|NCT04433585|587988999|FG001|Overall Study|Death|1|||
162803255|NCT04433585|587989000|FG002|Overall Study|Death|0|||
162803256|NCT04433585|587989001|FG003|Overall Study|Death|0|||
162803257|NCT03212989|587989016|FG000|Overall Study|Physician Decision|8|||
162803258|NCT03775434|587989017|FG000|Overall Study|Adverse Event|2|||
162803259|NCT03775434|587989017|FG000|Overall Study|Withdrawal by Subject|1|||
162803260|NCT03047395|587989018|FG000|Overall Study|Adverse Event|142|||
162803261|NCT03047395|587989018|FG000|Overall Study|Withdrawal by Subject|155|||
162803262|NCT03047395|587989018|FG000|Overall Study|Lost to Follow-up|144|||
162803263|NCT03047395|587989018|FG000|Overall Study|COVID-19 Infection|2|||
162803264|NCT03047395|587989018|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
162803265|NCT03047395|587989018|FG000|Overall Study|Other, Not Specified|117|||
162803266|NCT00620282|587989026|FG000|Overall Study|Adverse Event|0|||
162803267|NCT00620282|587989027|FG001|Overall Study|Adverse Event|1|||
162803268|NCT00620282|587989028|FG002|Overall Study|Adverse Event|0|||
162803269|NCT00620282|587989026|FG000|Overall Study|Arterial line unable to be placed|0|||
162803270|NCT00620282|587989027|FG001|Overall Study|Arterial line unable to be placed|0|||
162803271|NCT00620282|587989028|FG002|Overall Study|Arterial line unable to be placed|1|||
162803272|NCT00620282|587989026|FG000|Overall Study|Withdrawal by Subject|0|||
162803273|NCT00620282|587989027|FG001|Overall Study|Withdrawal by Subject|1|||
162803274|NCT00620282|587989028|FG002|Overall Study|Withdrawal by Subject|0|||
162803275|NCT02217475|587989029|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
162803276|NCT02217475|587989030|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
162803277|NCT02217475|587989031|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
162803278|NCT02217475|587989029|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
162803279|NCT02217475|587989030|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
162803280|NCT02217475|587989031|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
162803281|NCT02217475|587989029|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
162803282|NCT02217475|587989030|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
162803283|NCT02217475|587989031|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
162925436|NCT01346501|588428972|FG001|Overall Study|Other|12|||
162803284|NCT02217475|587989029|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
162803285|NCT02217475|587989030|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
162803286|NCT02217475|587989031|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
162803287|NCT02217475|587989029|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
162803288|NCT02217475|587989030|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
162803289|NCT02217475|587989031|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
162803290|NCT02217475|587989029|FG000|Discontinued After Period 1|Adverse Event|1|||
162803291|NCT02217475|587989030|FG001|Discontinued After Period 1|Adverse Event|2|||
162803292|NCT02217475|587989031|FG002|Discontinued After Period 1|Adverse Event|0|||
162803293|NCT02217475|587989029|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
162803294|NCT02217475|587989030|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
162803295|NCT02217475|587989031|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
162803296|NCT02217475|587989029|FG000|Discontinued After Period 1|Physician Decision|0|||
162803297|NCT02217475|587989030|FG001|Discontinued After Period 1|Physician Decision|0|||
162803298|NCT02217475|587989031|FG002|Discontinued After Period 1|Physician Decision|1|||
162803299|NCT02217475|587989029|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
162803300|NCT02217475|587989030|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
162803301|NCT02217475|587989031|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
162803302|NCT02217475|587989029|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
162803303|NCT02217475|587989030|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
162803304|NCT02217475|587989031|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
162803305|NCT02217475|587989029|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
162803306|NCT02217475|587989030|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
162803307|NCT02217475|587989031|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
162803308|NCT02217475|587989029|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
162803309|NCT02217475|587989030|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
162803310|NCT02217475|587989031|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
162803311|NCT02217475|587989029|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
162803312|NCT02217475|587989030|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
162803313|NCT02217475|587989031|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
162803314|NCT04738292|587989036|FG000|Overall Study|Death|1|||
162803315|NCT02442336|587989037|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
162803316|NCT02442336|587989037|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
162803317|NCT02442336|587989037|FG000|Overall Study|Lost to Follow-up|11|||
162803318|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
162803319|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
162803320|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
162803321|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
162803322|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
162803323|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
162803324|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
162803325|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
162803326|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
162803327|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
162803328|NCT01237587|587989038|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
162803329|NCT01237587|587989039|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
162803330|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
162803331|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
162803332|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
162803333|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
162803334|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
162803335|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
162803336|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
162803337|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
162803338|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
162803339|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
162803340|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
162803341|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
162803342|NCT01237587|587989038|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
162803343|NCT01237587|587989039|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
162803344|NCT01237587|587989038|FG000|Taper Phase|Adverse Event|0|||
162803345|NCT01237587|587989039|FG001|Taper Phase|Adverse Event|2|||
162803346|NCT01237587|587989038|FG000|Taper Phase|Protocol Violation|2|||
162803347|NCT01237587|587989039|FG001|Taper Phase|Protocol Violation|0|||
162803348|NCT01237587|587989038|FG000|Taper Phase|Lack of Efficacy|2|||
162803349|NCT01237587|587989039|FG001|Taper Phase|Lack of Efficacy|5|||
162803350|NCT01237587|587989038|FG000|Taper Phase|Parent/Guardian Decision|0|||
162803351|NCT01237587|587989039|FG001|Taper Phase|Parent/Guardian Decision|2|||
162803352|NCT01237587|587989038|FG000|Taper Phase|Sponsor Decision|1|||
162803353|NCT01237587|587989039|FG001|Taper Phase|Sponsor Decision|0|||
162803354|NCT01237587|587989038|FG000|Taper Phase|Withdrawal by Subject|0|||
162803355|NCT01237587|587989039|FG001|Taper Phase|Withdrawal by Subject|1|||
162803356|NCT01011387|587989040|FG000|Overall Study|Withdrawal by Subject|3|||
162803357|NCT01011387|587989040|FG000|Overall Study|Adverse Event|2|||
162803358|NCT01011387|587989040|FG000|Overall Study|Protocol Violation|1|||
162803359|NCT01139580|587989041|FG000|Overall Study|Adverse Event|5|||
162803360|NCT01139580|587989042|FG001|Overall Study|Adverse Event|4|||
162803361|NCT01139580|587989041|FG000|Overall Study|Lost to Follow-up|9|||
162803362|NCT01139580|587989042|FG001|Overall Study|Lost to Follow-up|1|||
162803363|NCT01139580|587989041|FG000|Overall Study|Lack of Efficacy|0|||
162803364|NCT01139580|587989042|FG001|Overall Study|Lack of Efficacy|2|||
162803365|NCT01139580|587989041|FG000|Overall Study|Withdrawal by Subject|6|||
162803366|NCT01139580|587989042|FG001|Overall Study|Withdrawal by Subject|9|||
162803367|NCT01139580|587989041|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
162803368|NCT01139580|587989042|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
162803369|NCT01139580|587989041|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
162803370|NCT01139580|587989042|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
162803371|NCT01139580|587989041|FG000|Overall Study|Misrandomized|1|||
162803372|NCT01139580|587989042|FG001|Overall Study|Misrandomized|0|||
162803373|NCT01139580|587989041|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
162803374|NCT01139580|587989042|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
162803375|NCT01139580|587989041|FG000|Overall Study|Participant Randomization in Error|0|||
162803376|NCT01139580|587989042|FG001|Overall Study|Participant Randomization in Error|1|||
162803377|NCT01285609|587989043|FG000|Randomized|Progressive Disease|41|||
162803378|NCT01285609|587989044|FG001|Randomized|Progressive Disease|61|||
162803379|NCT01285609|587989043|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
162803380|NCT01285609|587989044|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
162803381|NCT01285609|587989043|FG000|Randomized|Study Drug Toxicity|13|||
162803382|NCT01285609|587989044|FG001|Randomized|Study Drug Toxicity|14|||
162803383|NCT01285609|587989043|FG000|Randomized|Death|5|||
162803384|NCT01285609|587989044|FG001|Randomized|Death|7|||
162803385|NCT01285609|587989043|FG000|Randomized|Withdrawal by Subject|8|||
162803386|NCT01285609|587989044|FG001|Randomized|Withdrawal by Subject|11|||
162803387|NCT01285609|587989043|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
162803388|NCT01285609|587989044|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
162803389|NCT01285609|587989043|FG000|Randomized|Undisclosed Reasons|1|||
162803390|NCT01285609|587989044|FG001|Randomized|Undisclosed Reasons|0|||
162803391|NCT01285609|587989043|FG000|Randomized|Randomized but not Treated|4|||
162803392|NCT01285609|587989044|FG001|Randomized|Randomized but not Treated|4|||
162803393|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
162803394|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
162803395|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
162803396|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
162803397|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
162803398|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
162803399|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
162803400|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
162803401|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Death|11|||
162803402|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Death|3|||
162803403|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
162803404|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
162803405|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Not Reported|0|||
162803406|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Not Reported|2|||
162803407|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
162803408|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
162803409|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
162803410|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
162803411|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
162803412|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
162803413|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
162803414|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
162803415|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
162803416|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
162803417|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
162803418|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
162803419|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
162803420|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
162803421|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
162803422|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
162803423|NCT01285609|587989043|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
162803424|NCT01285609|587989044|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
162803425|NCT01285609|587989043|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
162803426|NCT01285609|587989044|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
162803427|NCT01142115|587989045|FG000|First Intervention|Lack of Efficacy|1|||
162803428|NCT01142115|587989046|FG001|First Intervention|Lack of Efficacy|1|||
162803429|NCT01142115|587989045|FG000|First Intervention|Adverse Event|1|||
162803430|NCT01142115|587989046|FG001|First Intervention|Adverse Event|0|||
162803431|NCT00320528|587989049|FG000|Study Period II|Adverse Event|3|||
162803432|NCT00320528|587989050|FG001|Study Period II|Adverse Event|4|||
162803433|NCT00320528|587989051|FG002|Study Period II|Adverse Event|8|||
162803434|NCT00320528|587989049|FG000|Study Period II|Parent/Caregiver Decision|8|||
162803435|NCT00320528|587989050|FG001|Study Period II|Parent/Caregiver Decision|3|||
162803436|NCT00320528|587989051|FG002|Study Period II|Parent/Caregiver Decision|11|||
162803437|NCT00320528|587989049|FG000|Study Period II|Withdrawal by Subject|0|||
162803438|NCT00320528|587989050|FG001|Study Period II|Withdrawal by Subject|1|||
162803439|NCT00320528|587989051|FG002|Study Period II|Withdrawal by Subject|1|||
162803440|NCT00320528|587989049|FG000|Study Period II|Entry Criteria Exclusion|0|||
162803441|NCT00320528|587989050|FG001|Study Period II|Entry Criteria Exclusion|2|||
162803442|NCT00320528|587989051|FG002|Study Period II|Entry Criteria Exclusion|2|||
162803443|NCT00320528|587989049|FG000|Study Period III|Adverse Event|1|||
162803444|NCT00320528|587989050|FG001|Study Period III|Adverse Event|0|||
162803445|NCT00320528|587989051|FG002|Study Period III|Adverse Event|0|||
162803446|NCT00320528|587989049|FG000|Study Period III|Lost to Follow-up|1|||
162803447|NCT00320528|587989050|FG001|Study Period III|Lost to Follow-up|0|||
162803448|NCT00320528|587989051|FG002|Study Period III|Lost to Follow-up|0|||
162803449|NCT00320528|587989049|FG000|Study Period III|Withdrawal by Subject|1|||
162803450|NCT00320528|587989050|FG001|Study Period III|Withdrawal by Subject|1|||
162803451|NCT00320528|587989051|FG002|Study Period III|Withdrawal by Subject|2|||
162803452|NCT00320528|587989049|FG000|Study Period III|Lack of Efficacy|2|||
162803453|NCT00320528|587989050|FG001|Study Period III|Lack of Efficacy|0|||
162803454|NCT00320528|587989051|FG002|Study Period III|Lack of Efficacy|0|||
162803455|NCT00320528|587989049|FG000|Study Period III|Parent/Caregiver Decision|14|||
162803456|NCT00320528|587989050|FG001|Study Period III|Parent/Caregiver Decision|3|||
162803457|NCT00320528|587989051|FG002|Study Period III|Parent/Caregiver Decision|11|||
162803458|NCT00320528|587989049|FG000|Study Period III|Protocol Violation|0|||
162803459|NCT00320528|587989050|FG001|Study Period III|Protocol Violation|1|||
162803460|NCT00320528|587989051|FG002|Study Period III|Protocol Violation|0|||
162803461|NCT00320528|587989049|FG000|Study Period III|Physician Decision|0|||
162803462|NCT00320528|587989050|FG001|Study Period III|Physician Decision|1|||
162803463|NCT00320528|587989051|FG002|Study Period III|Physician Decision|2|||
162803464|NCT00320528|587989049|FG000|Study Period III|Sponsor Decision|0|||
162803465|NCT00320528|587989050|FG001|Study Period III|Sponsor Decision|0|||
162803466|NCT00320528|587989051|FG002|Study Period III|Sponsor Decision|1|||
162803467|NCT00320528|587989049|FG000|Study Period III|Atomoxetine Commercially Available|68|||
162803468|NCT00320528|587989050|FG001|Study Period III|Atomoxetine Commercially Available|25|||
162803469|NCT00320528|587989051|FG002|Study Period III|Atomoxetine Commercially Available|90|||
162803470|NCT04828837|587989052|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
162803471|NCT04828837|587989053|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
162803472|NCT04828837|587989052|FG000|Overall Study|Lost to Follow-up|2|||
162803473|NCT04828837|587989053|FG001|Overall Study|Lost to Follow-up|6|||
162803474|NCT04828837|587989052|FG000|Overall Study|Lack of Efficacy|1|||
162803475|NCT04828837|587989053|FG001|Overall Study|Lack of Efficacy|0|||
162803476|NCT04828837|587989052|FG000|Overall Study|Admitted due to pneumothorax.|1|||
162803477|NCT04828837|587989053|FG001|Overall Study|Admitted due to pneumothorax.|0|||
162803478|NCT04828837|587989052|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
162803479|NCT04828837|587989053|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
162803480|NCT01397422|587989054|FG000|Overall Study|Adverse Event|0|||
162803481|NCT01397422|587989055|FG001|Overall Study|Adverse Event|3|||
162803482|NCT01397422|587989056|FG002|Overall Study|Adverse Event|3|||
162803483|NCT01397422|587989057|FG003|Overall Study|Adverse Event|8|||
162803484|NCT01397422|587989054|FG000|Overall Study|Withdrawal by Subject|1|||
162803485|NCT01397422|587989055|FG001|Overall Study|Withdrawal by Subject|0|||
162803486|NCT01397422|587989056|FG002|Overall Study|Withdrawal by Subject|0|||
162803487|NCT01397422|587989057|FG003|Overall Study|Withdrawal by Subject|0|||
162803488|NCT01397422|587989054|FG000|Overall Study|Increased bradykinesia related to PD|1|||
162803489|NCT01397422|587989055|FG001|Overall Study|Increased bradykinesia related to PD|0|||
162803490|NCT01397422|587989056|FG002|Overall Study|Increased bradykinesia related to PD|0|||
162803491|NCT01397422|587989057|FG003|Overall Study|Increased bradykinesia related to PD|0|||
162803492|NCT03738423|587989065|FG000|Overall Study|Withdrawal by Subject|9|||
162803493|NCT03738423|587989066|FG001|Overall Study|Withdrawal by Subject|12|||
162803494|NCT03738423|587989067|FG002|Overall Study|Withdrawal by Subject|9|||
162803495|NCT03738423|587989068|FG003|Overall Study|Withdrawal by Subject|12|||
162803496|NCT03738423|587989069|FG004|Overall Study|Withdrawal by Subject|10|||
162803497|NCT03738423|587989065|FG000|Overall Study|Lack of Efficacy|3|||
162803498|NCT03738423|587989066|FG001|Overall Study|Lack of Efficacy|1|||
162803499|NCT03738423|587989067|FG002|Overall Study|Lack of Efficacy|1|||
162803500|NCT03738423|587989068|FG003|Overall Study|Lack of Efficacy|1|||
162803501|NCT03738423|587989069|FG004|Overall Study|Lack of Efficacy|2|||
162803502|NCT03738423|587989065|FG000|Overall Study|Lost to Follow-up|1|||
162803503|NCT03738423|587989066|FG001|Overall Study|Lost to Follow-up|0|||
162803504|NCT03738423|587989067|FG002|Overall Study|Lost to Follow-up|1|||
162803505|NCT03738423|587989068|FG003|Overall Study|Lost to Follow-up|1|||
162803506|NCT03738423|587989069|FG004|Overall Study|Lost to Follow-up|0|||
162803507|NCT03738423|587989065|FG000|Overall Study|Protocol Violation|1|||
162803508|NCT03738423|587989066|FG001|Overall Study|Protocol Violation|0|||
162803509|NCT03738423|587989067|FG002|Overall Study|Protocol Violation|0|||
162803510|NCT03738423|587989068|FG003|Overall Study|Protocol Violation|0|||
162803511|NCT03738423|587989069|FG004|Overall Study|Protocol Violation|1|||
162803512|NCT03738423|587989065|FG000|Overall Study|Physician Decision|0|||
162803513|NCT03738423|587989066|FG001|Overall Study|Physician Decision|0|||
162803514|NCT03738423|587989067|FG002|Overall Study|Physician Decision|1|||
162803515|NCT03738423|587989068|FG003|Overall Study|Physician Decision|0|||
162803516|NCT03738423|587989069|FG004|Overall Study|Physician Decision|1|||
162803517|NCT03738423|587989065|FG000|Overall Study|Death|0|||
162803518|NCT03738423|587989066|FG001|Overall Study|Death|0|||
162803519|NCT03738423|587989067|FG002|Overall Study|Death|0|||
162803520|NCT03738423|587989068|FG003|Overall Study|Death|0|||
162803521|NCT03738423|587989069|FG004|Overall Study|Death|1|||
162803522|NCT03738423|587989065|FG000|Overall Study|Randomized but never treated|0|||
162803523|NCT03738423|587989066|FG001|Overall Study|Randomized but never treated|0|||
162803524|NCT03738423|587989067|FG002|Overall Study|Randomized but never treated|1|||
162803525|NCT03738423|587989068|FG003|Overall Study|Randomized but never treated|1|||
162803526|NCT03738423|587989069|FG004|Overall Study|Randomized but never treated|0|||
162803527|NCT02592876|587989075|FG000|Overall Study|Withdrawal by Subject|3|||
162803528|NCT02592876|587989076|FG001|Overall Study|Withdrawal by Subject|3|||
162803529|NCT02592876|587989075|FG000|Overall Study|Study Termination by Sponsor|32|||
162803530|NCT02592876|587989076|FG001|Overall Study|Study Termination by Sponsor|27|||
162803531|NCT02592876|587989075|FG000|Overall Study|Lost to Follow-up|0|||
162803532|NCT02592876|587989076|FG001|Overall Study|Lost to Follow-up|1|||
162803533|NCT02592876|587989075|FG000|Overall Study|Death|6|||
162803534|NCT02592876|587989076|FG001|Overall Study|Death|9|||
162803535|NCT01865747|587989077|FG000|Overall Study (ITT)|Adverse Event|32|||
162803536|NCT01865747|587989078|FG001|Overall Study (ITT)|Adverse Event|31|||
162803537|NCT01865747|587989077|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
162803538|NCT01865747|587989078|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
162803539|NCT01865747|587989077|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
162803540|NCT01865747|587989078|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
162803541|NCT01865747|587989077|FG000|Overall Study (ITT)|Protocol Violation|1|||
162803542|NCT01865747|587989078|FG001|Overall Study (ITT)|Protocol Violation|1|||
162803543|NCT01865747|587989077|FG000|Overall Study (ITT)|Physician Decision|5|||
162803544|NCT01865747|587989078|FG001|Overall Study (ITT)|Physician Decision|2|||
162803545|NCT01865747|587989077|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
162803546|NCT01865747|587989078|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
162803547|NCT01865747|587989077|FG000|Overall Study (ITT)|Sponsor Decision|0|||
162803548|NCT01865747|587989078|FG001|Overall Study (ITT)|Sponsor Decision|1|||
162803549|NCT01865747|587989077|FG000|Overall Study (ITT)|Progressive Disease|122|||
162803550|NCT01865747|587989078|FG001|Overall Study (ITT)|Progressive Disease|158|||
162803551|NCT01865747|587989077|FG000|Overall Study (ITT)|Reason Not Provided|0|||
162803552|NCT01865747|587989078|FG001|Overall Study (ITT)|Reason Not Provided|1|||
162803553|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
162803554|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
162803555|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
162803556|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
162803557|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
162803558|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
162803559|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
162803560|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
162803561|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
162803562|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
162803563|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
162803564|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
162803565|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
162803566|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
162803567|NCT01865747|587989077|FG000|Primary Intent to Treat (PITT)|Other|0|||
162803568|NCT01865747|587989078|FG001|Primary Intent to Treat (PITT)|Other|1|||
162803569|NCT00867308|587989079|FG000|Overall Study|Death|1|||
162803570|NCT00867308|587989080|FG001|Overall Study|Death|0|||
162803571|NCT00867308|587989079|FG000|Overall Study|Adverse Event|1|||
162803572|NCT00867308|587989080|FG001|Overall Study|Adverse Event|4|||
162803573|NCT00867308|587989079|FG000|Overall Study|Lack of Efficacy|6|||
162803574|NCT00867308|587989080|FG001|Overall Study|Lack of Efficacy|12|||
162803575|NCT00867308|587989079|FG000|Overall Study|Withdrawal by Subject|1|||
162803576|NCT00867308|587989080|FG001|Overall Study|Withdrawal by Subject|2|||
162803577|NCT00611975|587989083|FG000|Overall Study|Withdrawal by Subject|3|||
162803578|NCT00611975|587989084|FG001|Overall Study|Withdrawal by Subject|7|||
162803579|NCT00611975|587989083|FG000|Overall Study|Pregnancy|2|||
162803580|NCT00611975|587989084|FG001|Overall Study|Pregnancy|1|||
162803581|NCT04625413|587989085|FG000|Overall Study|Hospice|2|||
162803582|NCT04625413|587989085|FG000|Overall Study|Distress|1|||
162803583|NCT04625413|587989085|FG000|Overall Study|Not feeling well|1|||
162803584|NCT01982448|587989089|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162803585|NCT01982448|587989090|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162803586|NCT01982448|587989089|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
162803587|NCT01982448|587989090|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
162803588|NCT01982448|587989089|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
162803589|NCT01982448|587989090|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
162803590|NCT01982448|587989089|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
162803591|NCT01982448|587989090|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
162803592|NCT02594163|587990709|FG000|Treatment Period|Progressive disease|2|||
162803593|NCT02594163|587990710|FG001|Treatment Period|Progressive disease|3|||
162803594|NCT02594163|587990709|FG000|Treatment Period|Adverse Event|1|||
162803595|NCT02594163|587990710|FG001|Treatment Period|Adverse Event|5|||
162803596|NCT02594163|587990709|FG000|Treatment Period|Physician Decision|1|||
162803597|NCT02594163|587990710|FG001|Treatment Period|Physician Decision|3|||
162803598|NCT02594163|587990709|FG000|Treatment Period|Study termination by sponsor|2|||
162803599|NCT02594163|587990710|FG001|Treatment Period|Study termination by sponsor|1|||
162803600|NCT02594163|587990709|FG000|Treatment Period|Other, Non-AE|1|||
162803601|NCT02594163|587990710|FG001|Treatment Period|Other, Non-AE|0|||
162803602|NCT02594163|587990709|FG000|Follow-up Period|Withdrawal by Subject|0|||
162803603|NCT02594163|587990710|FG001|Follow-up Period|Withdrawal by Subject|1|||
162803604|NCT02594163|587990709|FG000|Follow-up Period|Study Termination by Sponsor|6|||
162803605|NCT02594163|587990710|FG001|Follow-up Period|Study Termination by Sponsor|4|||
162803606|NCT02594163|587990709|FG000|Follow-up Period|Lost to Follow-up|1|||
162803607|NCT02594163|587990710|FG001|Follow-up Period|Lost to Follow-up|0|||
162803608|NCT02594163|587990709|FG000|Follow-up Period|Death|2|||
162803609|NCT02594163|587990710|FG001|Follow-up Period|Death|5|||
162803610|NCT02594163|587990709|FG000|Follow-up Period|Adverse Event|0|||
162803611|NCT02594163|587990710|FG001|Follow-up Period|Adverse Event|1|||
162803612|NCT02594163|587990709|FG000|Follow-up Period|Progressive Disease|2|||
162803613|NCT02594163|587990710|FG001|Follow-up Period|Progressive Disease|0|||
162803614|NCT02594163|587990709|FG000|Follow-up Period|Physician Decision|0|||
162803615|NCT02594163|587990710|FG001|Follow-up Period|Physician Decision|1|||
162803616|NCT01342341|587990711|FG000|Overall Study|Lost to Follow-up|4|||
162803617|NCT01342341|587990712|FG001|Overall Study|Lost to Follow-up|4|||
162803618|NCT01022268|587990715|FG000|Overall Study|Withdrawal by Subject|1|||
162803619|NCT01022268|587990716|FG001|Overall Study|Withdrawal by Subject|0|||
162803620|NCT01022268|587990715|FG000|Overall Study|Withdrawal by Subject|1|||
162803621|NCT01022268|587990716|FG001|Overall Study|Withdrawal by Subject|0|||
162803622|NCT01034176|587990717|FG000|Overall Study|Physician Decision|2|||
162803623|NCT01034176|587990718|FG001|Overall Study|Physician Decision|0|||
162803624|NCT01034176|587990717|FG000|Overall Study|Withdrawal by Subject|0|||
162803625|NCT01034176|587990718|FG001|Overall Study|Withdrawal by Subject|1|||
162803626|NCT01034176|587990717|FG000|Overall Study|Lost to Follow-up|0|||
162803627|NCT01034176|587990718|FG001|Overall Study|Lost to Follow-up|1|||
162803628|NCT00266227|587990721|FG000|Initial Treatment|Adverse Event|0|||
162803629|NCT00266227|587990722|FG001|Initial Treatment|Adverse Event|0|||
162803630|NCT00266227|587990723|FG002|Initial Treatment|Adverse Event|13|||
162803631|NCT00266227|587990721|FG000|Initial Treatment|Lost to Follow-up|0|||
162803632|NCT00266227|587990722|FG001|Initial Treatment|Lost to Follow-up|0|||
162803633|NCT00266227|587990723|FG002|Initial Treatment|Lost to Follow-up|6|||
162803634|NCT00266227|587990721|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
162803635|NCT00266227|587990722|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
162803636|NCT00266227|587990723|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
162803637|NCT00266227|587990721|FG000|Initial Treatment|Physician decision to withdraw|0|||
162803638|NCT00266227|587990722|FG001|Initial Treatment|Physician decision to withdraw|0|||
162803639|NCT00266227|587990723|FG002|Initial Treatment|Physician decision to withdraw|12|||
162803640|NCT00266227|587990721|FG000|Initial Treatment|Pregnancy|0|||
162803641|NCT00266227|587990722|FG001|Initial Treatment|Pregnancy|0|||
162803642|NCT00266227|587990723|FG002|Initial Treatment|Pregnancy|1|||
162803643|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Death|1|||
162803644|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Death|0|||
162803645|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Death|0|||
162803646|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
162803647|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
162803648|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
162803649|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
162803650|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
162803651|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
162803652|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
162803653|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
162803654|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
162803655|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
162803656|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
162803657|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
162803658|NCT00266227|587990721|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
162803659|NCT00266227|587990722|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
162803660|NCT00266227|587990723|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
162803661|NCT00266227|587990721|FG000|Retreatment: Week 48 to Week 72|Death|1|||
162803662|NCT00266227|587990722|FG001|Retreatment: Week 48 to Week 72|Death|1|||
162803663|NCT00266227|587990723|FG002|Retreatment: Week 48 to Week 72|Death|0|||
162803664|NCT00266227|587990721|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
162803665|NCT00266227|587990722|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
162803666|NCT00266227|587990723|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
162803667|NCT00266227|587990721|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
162803668|NCT00266227|587990722|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
162803669|NCT00266227|587990723|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
162803670|NCT00266227|587990721|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
162803671|NCT00266227|587990722|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
162803672|NCT00266227|587990723|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
162803673|NCT00266227|587990721|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
162803674|NCT00266227|587990722|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
162803675|NCT00266227|587990723|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
162803676|NCT02680002|587990725|FG000|Overall Study|Lost to Follow-up|5|||
162803677|NCT02680002|587990726|FG001|Overall Study|Lost to Follow-up|1|||
162803678|NCT02680002|587990727|FG002|Overall Study|Lost to Follow-up|4|||
162803679|NCT02680002|587990728|FG003|Overall Study|Lost to Follow-up|2|||
162803680|NCT02680002|587990729|FG004|Overall Study|Lost to Follow-up|0|||
162803681|NCT02680002|587990730|FG005|Overall Study|Lost to Follow-up|2|||
162803682|NCT02680002|587990725|FG000|Overall Study|Physician Decision|5|||
162803683|NCT02680002|587990726|FG001|Overall Study|Physician Decision|1|||
162803684|NCT02680002|587990727|FG002|Overall Study|Physician Decision|1|||
162803685|NCT02680002|587990728|FG003|Overall Study|Physician Decision|1|||
162803686|NCT02680002|587990729|FG004|Overall Study|Physician Decision|1|||
162803687|NCT02680002|587990730|FG005|Overall Study|Physician Decision|1|||
162803688|NCT02680002|587990725|FG000|Overall Study|Protocol Violation|1|||
162803689|NCT02680002|587990726|FG001|Overall Study|Protocol Violation|0|||
162803690|NCT02680002|587990727|FG002|Overall Study|Protocol Violation|1|||
162803691|NCT02680002|587990728|FG003|Overall Study|Protocol Violation|0|||
162803692|NCT02680002|587990729|FG004|Overall Study|Protocol Violation|1|||
162803693|NCT02680002|587990730|FG005|Overall Study|Protocol Violation|2|||
162803694|NCT02680002|587990725|FG000|Overall Study|Withdrawal by Subject|0|||
162803695|NCT02680002|587990726|FG001|Overall Study|Withdrawal by Subject|0|||
162803696|NCT02680002|587990727|FG002|Overall Study|Withdrawal by Subject|1|||
162803697|NCT02680002|587990728|FG003|Overall Study|Withdrawal by Subject|0|||
162803698|NCT02680002|587990729|FG004|Overall Study|Withdrawal by Subject|2|||
162803699|NCT02680002|587990730|FG005|Overall Study|Withdrawal by Subject|2|||
162803700|NCT02680002|587990725|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
162803701|NCT02680002|587990726|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
162803702|NCT02680002|587990727|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
162803703|NCT02680002|587990728|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
162803704|NCT02680002|587990729|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
162803705|NCT02680002|587990730|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
162803706|NCT02680002|587990725|FG000|Overall Study|Other|0|||
162803707|NCT02680002|587990726|FG001|Overall Study|Other|1|||
162803708|NCT02680002|587990727|FG002|Overall Study|Other|0|||
162803709|NCT02680002|587990728|FG003|Overall Study|Other|0|||
162803710|NCT02680002|587990729|FG004|Overall Study|Other|1|||
162803711|NCT02680002|587990730|FG005|Overall Study|Other|0|||
162803712|NCT02680002|587990725|FG000|Overall Study|Adverse Event|0|||
162803713|NCT02680002|587990726|FG001|Overall Study|Adverse Event|0|||
162803714|NCT02680002|587990727|FG002|Overall Study|Adverse Event|0|||
162803715|NCT02680002|587990728|FG003|Overall Study|Adverse Event|0|||
162803716|NCT02680002|587990729|FG004|Overall Study|Adverse Event|1|||
162803717|NCT02680002|587990730|FG005|Overall Study|Adverse Event|2|||
162803718|NCT04097301|587990733|FG000|Overall Study|Death|1|||
162803719|NCT04097301|587990733|FG000|Overall Study|Withdrawal by Subject|1|||
162803720|NCT04097301|587990733|FG000|Overall Study|Screening Failure|5|||
162803721|NCT01403610|587990737|FG000|Overall Study|Withdrawal by Subject|2|||
162803722|NCT01403610|587990738|FG001|Overall Study|Withdrawal by Subject|0|||
162925437|NCT02564952|588428975|FG000|Overall Study|Adverse Event|6|||
162803723|NCT01403610|587990739|FG002|Overall Study|Withdrawal by Subject|0|||
162803724|NCT01403610|587990740|FG003|Overall Study|Withdrawal by Subject|0|||
162803725|NCT01403610|587990737|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
162803726|NCT01403610|587990738|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
162803727|NCT01403610|587990739|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
162803728|NCT01403610|587990740|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
162803729|NCT00901186|587990741|FG000|Overall Study|Lack of Efficacy|0|||
162803730|NCT00901186|587990742|FG001|Overall Study|Lack of Efficacy|1|||
162803731|NCT00901186|587990741|FG000|Overall Study|Abnormal laboratory values|0|||
162803732|NCT00901186|587990742|FG001|Overall Study|Abnormal laboratory values|1|||
162803733|NCT00901186|587990741|FG000|Overall Study|Lost to Follow-up|2|||
162803734|NCT00901186|587990742|FG001|Overall Study|Lost to Follow-up|0|||
162803735|NCT00901186|587990741|FG000|Overall Study|Adverse Event|2|||
162803736|NCT00901186|587990742|FG001|Overall Study|Adverse Event|4|||
162803737|NCT00901186|587990741|FG000|Overall Study|Administration problems|0|||
162803738|NCT00901186|587990742|FG001|Overall Study|Administration problems|1|||
162803739|NCT00901186|587990741|FG000|Overall Study|Protocol deviations|5|||
162803740|NCT00901186|587990742|FG001|Overall Study|Protocol deviations|4|||
162803741|NCT02383056|587990743|FG000|Overall Study|Adverse Event|1|||
162803742|NCT02383056|587990744|FG001|Overall Study|Adverse Event|0|||
162803743|NCT02383056|587990743|FG000|Overall Study|Lost to Follow-up|0|||
162803744|NCT02383056|587990744|FG001|Overall Study|Lost to Follow-up|2|||
162803745|NCT01775475|587990745|FG000|Overall Study|Death|3|||
162803746|NCT01775475|587990746|FG001|Overall Study|Death|3|||
162803747|NCT02074553|587990750|FG000|Intervention Period 1|Family Emergency|0|||
162803748|NCT02074553|587990751|FG001|Intervention Period 1|Family Emergency|0|||
162803749|NCT02074553|587990752|FG002|Intervention Period 1|Family Emergency|0|||
162803750|NCT02074553|587990753|FG003|Intervention Period 1|Family Emergency|1|||
162803751|NCT02074553|587990754|FG004|Intervention Period 1|Family Emergency|0|||
162803752|NCT02074553|587990755|FG005|Intervention Period 1|Family Emergency|0|||
162803753|NCT02074553|587990756|FG006|Intervention Period 1|Family Emergency|0|||
162803754|NCT02074553|587990757|FG007|Intervention Period 1|Family Emergency|0|||
162803755|NCT02074553|587990750|FG000|Washout Period 1|Adverse Event|1|||
162803756|NCT02074553|587990751|FG001|Washout Period 1|Adverse Event|0|||
162803757|NCT02074553|587990752|FG002|Washout Period 1|Adverse Event|0|||
162803758|NCT02074553|587990753|FG003|Washout Period 1|Adverse Event|0|||
162803759|NCT02074553|587990754|FG004|Washout Period 1|Adverse Event|0|||
162803760|NCT02074553|587990755|FG005|Washout Period 1|Adverse Event|0|||
162803761|NCT02074553|587990756|FG006|Washout Period 1|Adverse Event|0|||
162803762|NCT02074553|587990757|FG007|Washout Period 1|Adverse Event|0|||
162803763|NCT02074553|587990750|FG000|Washout Period 1|Physician Decision|0|||
162803764|NCT02074553|587990751|FG001|Washout Period 1|Physician Decision|0|||
162803765|NCT02074553|587990752|FG002|Washout Period 1|Physician Decision|0|||
162803766|NCT02074553|587990753|FG003|Washout Period 1|Physician Decision|1|||
162803767|NCT02074553|587990754|FG004|Washout Period 1|Physician Decision|0|||
162803768|NCT02074553|587990755|FG005|Washout Period 1|Physician Decision|0|||
162803769|NCT02074553|587990756|FG006|Washout Period 1|Physician Decision|0|||
162803770|NCT02074553|587990757|FG007|Washout Period 1|Physician Decision|0|||
162803771|NCT02074553|587990750|FG000|Washout Period 1|Other|0|||
162803772|NCT02074553|587990751|FG001|Washout Period 1|Other|0|||
162803773|NCT02074553|587990752|FG002|Washout Period 1|Other|0|||
162803774|NCT02074553|587990753|FG003|Washout Period 1|Other|0|||
162803775|NCT02074553|587990754|FG004|Washout Period 1|Other|0|||
162803776|NCT02074553|587990755|FG005|Washout Period 1|Other|1|||
162803777|NCT02074553|587990756|FG006|Washout Period 1|Other|0|||
162803778|NCT02074553|587990757|FG007|Washout Period 1|Other|0|||
162803779|NCT02074553|587990750|FG000|Washout Period 2|Adverse Event|0|||
162803780|NCT02074553|587990751|FG001|Washout Period 2|Adverse Event|0|||
162803781|NCT02074553|587990752|FG002|Washout Period 2|Adverse Event|0|||
162803782|NCT02074553|587990753|FG003|Washout Period 2|Adverse Event|0|||
162803783|NCT02074553|587990754|FG004|Washout Period 2|Adverse Event|0|||
162803784|NCT02074553|587990755|FG005|Washout Period 2|Adverse Event|0|||
162803785|NCT02074553|587990756|FG006|Washout Period 2|Adverse Event|1|||
162803786|NCT02074553|587990757|FG007|Washout Period 2|Adverse Event|0|||
162803787|NCT02074553|587990750|FG000|Washout Period 2|Physician Decision|0|||
162803788|NCT02074553|587990751|FG001|Washout Period 2|Physician Decision|0|||
162803789|NCT02074553|587990752|FG002|Washout Period 2|Physician Decision|0|||
162803790|NCT02074553|587990753|FG003|Washout Period 2|Physician Decision|0|||
162803791|NCT02074553|587990754|FG004|Washout Period 2|Physician Decision|0|||
162803792|NCT02074553|587990755|FG005|Washout Period 2|Physician Decision|1|||
162803793|NCT02074553|587990756|FG006|Washout Period 2|Physician Decision|0|||
162803794|NCT02074553|587990757|FG007|Washout Period 2|Physician Decision|0|||
162803795|NCT02074553|587990750|FG000|Washout Period 2|Lost to Follow-up|0|||
162803796|NCT02074553|587990751|FG001|Washout Period 2|Lost to Follow-up|0|||
162803797|NCT02074553|587990752|FG002|Washout Period 2|Lost to Follow-up|1|||
162803798|NCT02074553|587990753|FG003|Washout Period 2|Lost to Follow-up|0|||
162803799|NCT02074553|587990754|FG004|Washout Period 2|Lost to Follow-up|0|||
162803800|NCT02074553|587990755|FG005|Washout Period 2|Lost to Follow-up|0|||
162803801|NCT02074553|587990756|FG006|Washout Period 2|Lost to Follow-up|0|||
162803802|NCT02074553|587990757|FG007|Washout Period 2|Lost to Follow-up|0|||
162803803|NCT02074553|587990750|FG000|Washout Period 3|Physician Decision|0|||
162803804|NCT02074553|587990751|FG001|Washout Period 3|Physician Decision|0|||
162803805|NCT02074553|587990752|FG002|Washout Period 3|Physician Decision|0|||
162803806|NCT02074553|587990753|FG003|Washout Period 3|Physician Decision|0|||
162803807|NCT02074553|587990754|FG004|Washout Period 3|Physician Decision|0|||
162803808|NCT02074553|587990755|FG005|Washout Period 3|Physician Decision|0|||
162803809|NCT02074553|587990756|FG006|Washout Period 3|Physician Decision|0|||
162803810|NCT02074553|587990757|FG007|Washout Period 3|Physician Decision|1|||
162803811|NCT02342743|587990758|FG000|Baseline Period|Withdrawal by Subject|3|||
162803812|NCT02342743|587990758|FG000|Baseline Period|Lost to Follow-up|2|||
162803813|NCT02342743|587990758|FG000|Baseline Period|Change in prophylactic medication|3|||
162803814|NCT02342743|587990758|FG000|Baseline Period|Screening failure regarding baseline|7|||
162803815|NCT02342743|587990758|FG000|Treatment Period|Withdrawal by Subject|2|||
162803816|NCT02342743|587990758|FG000|Treatment Period|Lost to Follow-up|8|||
162803817|NCT02342743|587990758|FG000|Treatment Period|Change in prophylactic medication|1|||
162803818|NCT00686725|587990759|FG000|Overall Study|Adverse Event|1|||
162803819|NCT00686725|587990760|FG001|Overall Study|Adverse Event|1|||
162803820|NCT00686725|587990759|FG000|Overall Study|Progressive Disease|17|||
162803821|NCT00686725|587990760|FG001|Overall Study|Progressive Disease|23|||
162803822|NCT00686725|587990759|FG000|Overall Study|Lost to Follow-up|7|||
162803823|NCT00686725|587990760|FG001|Overall Study|Lost to Follow-up|5|||
162803824|NCT00686725|587990759|FG000|Overall Study|Death|6|||
162803825|NCT00686725|587990760|FG001|Overall Study|Death|3|||
162803826|NCT00686725|587990759|FG000|Overall Study|Withdrawal by Subject|13|||
162803827|NCT00686725|587990760|FG001|Overall Study|Withdrawal by Subject|4|||
162803828|NCT00686725|587990759|FG000|Overall Study|Protocol Violation|1|||
162803829|NCT00686725|587990760|FG001|Overall Study|Protocol Violation|3|||
162803830|NCT00686725|587990759|FG000|Overall Study|Other|1|||
162803831|NCT00686725|587990760|FG001|Overall Study|Other|3|||
162803832|NCT03602066|587990761|FG000|Overall Study|Withdrawal by Subject|2|||
162803833|NCT03602066|587990762|FG001|Overall Study|Withdrawal by Subject|0|||
162803834|NCT03602066|587990761|FG000|Overall Study|Physician Decision|1|||
162803835|NCT03602066|587990762|FG001|Overall Study|Physician Decision|0|||
162803836|NCT00092495|587990763|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
162803837|NCT00092495|587990764|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
162803838|NCT00092495|587990765|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162803839|NCT00092495|587990766|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
162803840|NCT00092495|587990767|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162803841|NCT00092495|587990763|FG000|Base Study Vaccination Period|Extended|0|||
162803842|NCT00092495|587990764|FG001|Base Study Vaccination Period|Extended|0|||
162803843|NCT00092495|587990765|FG002|Base Study Vaccination Period|Extended|0|||
162803844|NCT00092495|587990766|FG003|Base Study Vaccination Period|Extended|1|||
162803845|NCT00092495|587990767|FG004|Base Study Vaccination Period|Extended|0|||
162803846|NCT00092495|587990763|FG000|Base Study Vaccination Period|*Clinical AE|1|||
162803847|NCT00092495|587990764|FG001|Base Study Vaccination Period|*Clinical AE|0|||
162803848|NCT00092495|587990765|FG002|Base Study Vaccination Period|*Clinical AE|1|||
162803849|NCT00092495|587990766|FG003|Base Study Vaccination Period|*Clinical AE|2|||
162803850|NCT00092495|587990767|FG004|Base Study Vaccination Period|*Clinical AE|0|||
162803851|NCT00092495|587990763|FG000|Base Study Vaccination Period|*Other reasons|1|||
162803852|NCT00092495|587990764|FG001|Base Study Vaccination Period|*Other reasons|0|||
162803853|NCT00092495|587990765|FG002|Base Study Vaccination Period|*Other reasons|0|||
162803854|NCT00092495|587990766|FG003|Base Study Vaccination Period|*Other reasons|1|||
162803855|NCT00092495|587990767|FG004|Base Study Vaccination Period|*Other reasons|0|||
162803856|NCT00092495|587990763|FG000|Base Study Vaccination Period|*Pregnancy|0|||
162803857|NCT00092495|587990764|FG001|Base Study Vaccination Period|*Pregnancy|2|||
162803858|NCT00092495|587990765|FG002|Base Study Vaccination Period|*Pregnancy|5|||
162803859|NCT00092495|587990766|FG003|Base Study Vaccination Period|*Pregnancy|7|||
162803860|NCT00092495|587990767|FG004|Base Study Vaccination Period|*Pregnancy|0|||
162803861|NCT00092495|587990763|FG000|Base Study Vaccination Period|Adverse Event|1|||
162803862|NCT00092495|587990764|FG001|Base Study Vaccination Period|Adverse Event|0|||
162803863|NCT00092495|587990765|FG002|Base Study Vaccination Period|Adverse Event|0|||
162803864|NCT00092495|587990766|FG003|Base Study Vaccination Period|Adverse Event|3|||
162803865|NCT00092495|587990767|FG004|Base Study Vaccination Period|Adverse Event|0|||
162803866|NCT00092495|587990763|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
162803867|NCT00092495|587990764|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
162803868|NCT00092495|587990765|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
162803869|NCT00092495|587990766|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
162803870|NCT00092495|587990767|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
162803871|NCT00092495|587990763|FG000|Base Study Vaccination Period|Moved|3|||
162803872|NCT00092495|587990764|FG001|Base Study Vaccination Period|Moved|1|||
162803873|NCT00092495|587990765|FG002|Base Study Vaccination Period|Moved|2|||
162803874|NCT00092495|587990766|FG003|Base Study Vaccination Period|Moved|2|||
162803875|NCT00092495|587990767|FG004|Base Study Vaccination Period|Moved|0|||
162803876|NCT00092495|587990763|FG000|Base Study Vaccination Period|Other|1|||
162803877|NCT00092495|587990764|FG001|Base Study Vaccination Period|Other|1|||
162803878|NCT00092495|587990765|FG002|Base Study Vaccination Period|Other|0|||
162803879|NCT00092495|587990766|FG003|Base Study Vaccination Period|Other|2|||
162803880|NCT00092495|587990767|FG004|Base Study Vaccination Period|Other|0|||
162803881|NCT00092495|587990763|FG000|Base Study Vaccination Period|Pregnancy|2|||
162803882|NCT00092495|587990764|FG001|Base Study Vaccination Period|Pregnancy|0|||
162803883|NCT00092495|587990765|FG002|Base Study Vaccination Period|Pregnancy|0|||
162803884|NCT00092495|587990766|FG003|Base Study Vaccination Period|Pregnancy|0|||
162803885|NCT00092495|587990767|FG004|Base Study Vaccination Period|Pregnancy|0|||
162803886|NCT00092495|587990763|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162803887|NCT00092495|587990764|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162803888|NCT00092495|587990765|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162803889|NCT00092495|587990766|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
162803890|NCT00092495|587990767|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
162803891|NCT00092495|587990763|FG000|Base Study Vaccination Period|Protocol Violation|1|||
162803892|NCT00092495|587990764|FG001|Base Study Vaccination Period|Protocol Violation|0|||
162803893|NCT00092495|587990765|FG002|Base Study Vaccination Period|Protocol Violation|0|||
162803894|NCT00092495|587990766|FG003|Base Study Vaccination Period|Protocol Violation|0|||
162803895|NCT00092495|587990767|FG004|Base Study Vaccination Period|Protocol Violation|0|||
162803896|NCT00092495|587990763|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
162803897|NCT00092495|587990764|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
162803898|NCT00092495|587990765|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
162803899|NCT00092495|587990766|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
162803900|NCT00092495|587990767|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
162803901|NCT00092495|587990763|FG000|Base Study Follow-up Period|Extended|0|||
162803902|NCT00092495|587990764|FG001|Base Study Follow-up Period|Extended|0|||
162803903|NCT00092495|587990765|FG002|Base Study Follow-up Period|Extended|1|||
162803904|NCT00092495|587990766|FG003|Base Study Follow-up Period|Extended|2|||
162803905|NCT00092495|587990767|FG004|Base Study Follow-up Period|Extended|0|||
162803906|NCT00092495|587990763|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
162803907|NCT00092495|587990764|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
162803908|NCT00092495|587990765|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
162803909|NCT00092495|587990766|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
162803910|NCT00092495|587990767|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
162803911|NCT00092495|587990763|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
162803912|NCT00092495|587990764|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
162803913|NCT00092495|587990765|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
162803914|NCT00092495|587990766|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
162803915|NCT00092495|587990767|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
162803916|NCT00938470|587990768|FG000|Overall Study|Disease Progression|3|||
162803917|NCT00938470|587990769|FG001|Overall Study|Disease Progression|0|||
162803918|NCT00938470|587990768|FG000|Overall Study|Alternate Treatment|1|||
162803919|NCT00938470|587990769|FG001|Overall Study|Alternate Treatment|0|||
162803920|NCT00938470|587990768|FG000|Overall Study|Death|3|||
162803921|NCT00938470|587990769|FG001|Overall Study|Death|2|||
162803922|NCT00938470|587990768|FG000|Overall Study|Other Reason|0|||
162803923|NCT00938470|587990769|FG001|Overall Study|Other Reason|1|||
162803924|NCT01552603|587990770|FG000|Overall Study|Physician Decision|1|||
162803925|NCT00618618|587990771|FG000|Overall Study|Patient Request|0|||
162803926|NCT00618618|587990772|FG001|Overall Study|Patient Request|0|||
162803927|NCT00618618|587990773|FG002|Overall Study|Patient Request|2|||
162803928|NCT00618618|587990774|FG003|Overall Study|Patient Request|0|||
162803929|NCT00618618|587990771|FG000|Overall Study|Inability to Complete Study Procedures|0|||
162803930|NCT00618618|587990772|FG001|Overall Study|Inability to Complete Study Procedures|1|||
162803931|NCT00618618|587990773|FG002|Overall Study|Inability to Complete Study Procedures|0|||
162803932|NCT00618618|587990774|FG003|Overall Study|Inability to Complete Study Procedures|0|||
162803933|NCT00618618|587990771|FG000|Overall Study|Lost to Follow-up|3|||
162803934|NCT00618618|587990772|FG001|Overall Study|Lost to Follow-up|0|||
162803935|NCT00618618|587990773|FG002|Overall Study|Lost to Follow-up|0|||
162803936|NCT00618618|587990774|FG003|Overall Study|Lost to Follow-up|1|||
162803937|NCT00618618|587990771|FG000|Overall Study|Non-compliance|1|||
162803938|NCT00618618|587990772|FG001|Overall Study|Non-compliance|1|||
162803939|NCT00618618|587990773|FG002|Overall Study|Non-compliance|0|||
162803940|NCT00618618|587990774|FG003|Overall Study|Non-compliance|0|||
162803941|NCT00618618|587990771|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
162803942|NCT00618618|587990772|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
162803943|NCT00618618|587990773|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
162803944|NCT00618618|587990774|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
162803945|NCT00618618|587990771|FG000|Overall Study|Death|0|||
162803946|NCT00618618|587990772|FG001|Overall Study|Death|1|||
162803947|NCT00618618|587990773|FG002|Overall Study|Death|0|||
162803948|NCT00618618|587990774|FG003|Overall Study|Death|0|||
162803949|NCT01236365|587990778|FG000|Overall Study|Lost to Follow-up|0|||
162803950|NCT01236365|587990779|FG001|Overall Study|Lost to Follow-up|2|||
162803951|NCT01236365|587990778|FG000|Overall Study|Moved Out of State|1|||
162803952|NCT01236365|587990779|FG001|Overall Study|Moved Out of State|0|||
162803953|NCT01236365|587990778|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
162803954|NCT01236365|587990779|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
162803955|NCT00006011|587990785|FG000|Overall Study|Disease progression|13|||
162803956|NCT00006011|587990786|FG001|Overall Study|Disease progression|6|||
162803957|NCT00006011|587990787|FG002|Overall Study|Disease progression|26|||
162803958|NCT00006011|587990785|FG000|Overall Study|Refused further treatment|15|||
162803959|NCT00006011|587990786|FG001|Overall Study|Refused further treatment|13|||
162803960|NCT00006011|587990787|FG002|Overall Study|Refused further treatment|26|||
162803961|NCT00006011|587990785|FG000|Overall Study|Adverse Event|15|||
162803962|NCT00006011|587990786|FG001|Overall Study|Adverse Event|39|||
162803963|NCT00006011|587990787|FG002|Overall Study|Adverse Event|5|||
162803964|NCT00006011|587990785|FG000|Overall Study|Death|0|||
162803965|NCT00006011|587990786|FG001|Overall Study|Death|1|||
162803966|NCT00006011|587990787|FG002|Overall Study|Death|2|||
162803967|NCT00006011|587990785|FG000|Overall Study|Other|4|||
162803968|NCT00006011|587990786|FG001|Overall Study|Other|2|||
162803969|NCT00006011|587990787|FG002|Overall Study|Other|5|||
162803970|NCT00006011|587990785|FG000|Overall Study|Ineligible|18|||
162803971|NCT00006011|587990786|FG001|Overall Study|Ineligible|16|||
162803972|NCT00006011|587990787|FG002|Overall Study|Ineligible|9|||
162803973|NCT01236534|587990793|FG000|Overall Study|Adverse Event|3|||
162803974|NCT01236534|587990794|FG001|Overall Study|Adverse Event|0|||
162803975|NCT01844687|587990797|FG000|Visit 1|Protocol Violation|3|||
162803976|NCT01844687|587990797|FG000|Visit 1|Lost to Follow-up|5|||
162803977|NCT01844687|587990797|FG000|Visit 2|Withdrawal by Subject|1|||
162803978|NCT01844687|587990797|FG000|Visit 2|Protocol Violation|1|||
162803979|NCT01844687|587990797|FG000|Visit 3|Lost to Follow-up|1|||
162803980|NCT01844687|587990797|FG000|Visit 3|Withdrawal by Subject|3|||
162803981|NCT01844687|587990797|FG000|Visit 3|child care problems|1|||
162803982|NCT01844687|587990797|FG000|Visit 4|Pregnancy|1|||
162803983|NCT01844687|587990797|FG000|Visit 4|Lost to Follow-up|1|||
162803984|NCT01844687|587990797|FG000|Visit 4|Withdrawal by Subject|2|||
162803985|NCT00158860|587990812|FG000|Overall Study|Adverse Event|3|||
162803986|NCT00158860|587990813|FG001|Overall Study|Adverse Event|6|||
162803987|NCT00158860|587990812|FG000|Overall Study|Lost to Follow-up|11|||
162803988|NCT00158860|587990813|FG001|Overall Study|Lost to Follow-up|17|||
162803989|NCT00158860|587990812|FG000|Overall Study|Protocol Violation|8|||
162803990|NCT00158860|587990813|FG001|Overall Study|Protocol Violation|23|||
162803991|NCT00158860|587990812|FG000|Overall Study|Withdrawal by Subject|7|||
162803992|NCT00158860|587990813|FG001|Overall Study|Withdrawal by Subject|17|||
162803993|NCT00158860|587990812|FG000|Overall Study|MOVING OUT OF STATE|1|||
162803994|NCT00158860|587990813|FG001|Overall Study|MOVING OUT OF STATE|0|||
162803995|NCT00158860|587990812|FG000|Overall Study|Pregnancy|3|||
162803996|NCT00158860|587990813|FG001|Overall Study|Pregnancy|3|||
162803997|NCT00158860|587990812|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
162803998|NCT00158860|587990813|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
162803999|NCT00158860|587990812|FG000|Overall Study|SPONSOR REQUEST|0|||
162804000|NCT00158860|587990813|FG001|Overall Study|SPONSOR REQUEST|1|||
162804001|NCT00158860|587990812|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
162804002|NCT00158860|587990813|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
162804003|NCT00158860|587990812|FG000|Overall Study|Closed per sponsor|0|||
162804004|NCT00158860|587990813|FG001|Overall Study|Closed per sponsor|1|||
162804005|NCT04638920|587990814|FG000|Overall Study|Withdrawal by Subject|5|||
162804006|NCT01801735|587990815|FG000|Overall Study|Adverse Event|79|||
162804007|NCT01801735|587990815|FG000|Overall Study|Lack of Efficacy|28|||
162804008|NCT01801735|587990815|FG000|Overall Study|Withdrawal by Subject|27|||
162804009|NCT01801735|587990815|FG000|Overall Study|Protocol Violation|25|||
162804010|NCT01801735|587990815|FG000|Overall Study|Lost to Follow-up|15|||
162804011|NCT01801735|587990815|FG000|Overall Study|Non-compliance with Trial Drug|13|||
162804012|NCT01801735|587990815|FG000|Overall Study|Physician Decision|3|||
162804013|NCT01801735|587990815|FG000|Overall Study|Death|1|||
162804014|NCT01801735|587990815|FG000|Overall Study|Other, including site closure|19|||
162804015|NCT01435616|587990816|FG000|Overall Study|Adverse Event|39|||
162804016|NCT01435616|587990817|FG001|Overall Study|Adverse Event|21|||
162804017|NCT01435616|587990816|FG000|Overall Study|Death|7|||
162804018|NCT01435616|587990817|FG001|Overall Study|Death|2|||
162804019|NCT01435616|587990816|FG000|Overall Study|Lost to Follow-up|22|||
162804020|NCT01435616|587990817|FG001|Overall Study|Lost to Follow-up|13|||
162804021|NCT01435616|587990816|FG000|Overall Study|Protocol Violation|16|||
162804022|NCT01435616|587990817|FG001|Overall Study|Protocol Violation|13|||
162804023|NCT01435616|587990816|FG000|Overall Study|Withdrawal by Subject|66|||
162804024|NCT01435616|587990817|FG001|Overall Study|Withdrawal by Subject|24|||
162804025|NCT01435616|587990816|FG000|Overall Study|Physician Decision|20|||
162804026|NCT01435616|587990817|FG001|Overall Study|Physician Decision|7|||
162804027|NCT01435616|587990816|FG000|Overall Study|Sponsor Decision|1|||
162804028|NCT01435616|587990817|FG001|Overall Study|Sponsor Decision|0|||
162925438|NCT02564952|588428975|FG000|Overall Study|Lost to Follow-up|1|||
162804029|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|Death|1|||
162804030|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|Death|1|||
162804031|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
162804032|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
162804033|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
162804034|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
162804035|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
162804036|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
162804037|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
162804038|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
162804039|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
162804040|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
162804041|NCT00371683|587990819|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
162804042|NCT00371683|587990820|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
162804043|NCT00371683|587990819|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
162804044|NCT00371683|587990820|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
162804045|NCT00371683|587990819|FG000|Follow-Up Period - Randomized Patients|Death|0|||
162804046|NCT00371683|587990820|FG001|Follow-Up Period - Randomized Patients|Death|2|||
162804047|NCT00371683|587990819|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
162804048|NCT00371683|587990820|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
162804049|NCT00371683|587990819|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
162804050|NCT00371683|587990820|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
162804051|NCT03208036|587990822|FG000|Baseline Assessment|Withdrawal by Subject|1|||
162804052|NCT03208036|587990823|FG001|Baseline Assessment|Withdrawal by Subject|1|||
162804053|NCT03208036|587990822|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
162804054|NCT03208036|587990823|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
162804055|NCT03208036|587990822|FG000|Intervention|Withdrawal by Subject|3|||
162804056|NCT03208036|587990823|FG001|Intervention|Withdrawal by Subject|2|||
162804057|NCT03208036|587990822|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
162804058|NCT03208036|587990823|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
162804059|NCT00700778|587990824|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
162804060|NCT00350103|587990828|FG000|Overall Study|Adverse Event|12|||
162804061|NCT00350103|587990829|FG001|Overall Study|Adverse Event|29|||
162804062|NCT00350103|587990830|FG002|Overall Study|Adverse Event|17|||
162804063|NCT00350103|587990828|FG000|Overall Study|Lack of Efficacy|5|||
162804064|NCT00350103|587990829|FG001|Overall Study|Lack of Efficacy|1|||
162804065|NCT00350103|587990830|FG002|Overall Study|Lack of Efficacy|3|||
162804066|NCT00350103|587990828|FG000|Overall Study|Withdrawal by Subject|6|||
162804067|NCT00350103|587990829|FG001|Overall Study|Withdrawal by Subject|6|||
162804068|NCT00350103|587990830|FG002|Overall Study|Withdrawal by Subject|8|||
162804069|NCT00350103|587990828|FG000|Overall Study|Protocol Violation|0|||
162804070|NCT00350103|587990829|FG001|Overall Study|Protocol Violation|0|||
162804071|NCT00350103|587990830|FG002|Overall Study|Protocol Violation|1|||
162804072|NCT00350103|587990828|FG000|Overall Study|Unsatisfactory Compliance|2|||
162804073|NCT00350103|587990829|FG001|Overall Study|Unsatisfactory Compliance|2|||
162804074|NCT00350103|587990830|FG002|Overall Study|Unsatisfactory Compliance|1|||
162804075|NCT00350103|587990828|FG000|Overall Study|Investigator´s decision|1|||
162804076|NCT00350103|587990829|FG001|Overall Study|Investigator´s decision|1|||
162804077|NCT00350103|587990830|FG002|Overall Study|Investigator´s decision|0|||
162804078|NCT00350103|587990828|FG000|Overall Study|Exclusion criteria met|0|||
162804079|NCT00350103|587990829|FG001|Overall Study|Exclusion criteria met|0|||
162804080|NCT00350103|587990830|FG002|Overall Study|Exclusion criteria met|1|||
162804081|NCT00350103|587990828|FG000|Overall Study|Patient relocated|0|||
162804082|NCT00350103|587990829|FG001|Overall Study|Patient relocated|0|||
162804083|NCT00350103|587990830|FG002|Overall Study|Patient relocated|1|||
162804084|NCT00350103|587990828|FG000|Overall Study|Need for prohibited medication|1|||
162804085|NCT00350103|587990829|FG001|Overall Study|Need for prohibited medication|0|||
162804086|NCT00350103|587990830|FG002|Overall Study|Need for prohibited medication|0|||
162804087|NCT00350103|587990828|FG000|Overall Study|Personal reasons|0|||
162804088|NCT00350103|587990829|FG001|Overall Study|Personal reasons|0|||
162804089|NCT00350103|587990830|FG002|Overall Study|Personal reasons|1|||
162804090|NCT00350103|587990828|FG000|Overall Study|Patient stopped feeling pain|1|||
162804091|NCT00350103|587990829|FG001|Overall Study|Patient stopped feeling pain|0|||
162804092|NCT00350103|587990830|FG002|Overall Study|Patient stopped feeling pain|0|||
162804093|NCT00350103|587990828|FG000|Overall Study|PR greater than 250ms|0|||
162804094|NCT00350103|587990829|FG001|Overall Study|PR greater than 250ms|0|||
162804095|NCT00350103|587990830|FG002|Overall Study|PR greater than 250ms|1|||
162804096|NCT00350103|587990828|FG000|Overall Study|Wrong calculation of QT interval|0|||
162804097|NCT00350103|587990829|FG001|Overall Study|Wrong calculation of QT interval|0|||
162804098|NCT00350103|587990830|FG002|Overall Study|Wrong calculation of QT interval|1|||
162804099|NCT00350103|587990828|FG000|Overall Study|Sponsor mistake|1|||
162804100|NCT00350103|587990829|FG001|Overall Study|Sponsor mistake|0|||
162804101|NCT00350103|587990830|FG002|Overall Study|Sponsor mistake|0|||
162804102|NCT00350103|587990828|FG000|Overall Study|Randomization mistake|0|||
162804103|NCT00350103|587990829|FG001|Overall Study|Randomization mistake|1|||
162804104|NCT00350103|587990830|FG002|Overall Study|Randomization mistake|1|||
162804105|NCT00350103|587990828|FG000|Overall Study|Sponsor´s decision|0|||
162804106|NCT00350103|587990829|FG001|Overall Study|Sponsor´s decision|1|||
162804107|NCT00350103|587990830|FG002|Overall Study|Sponsor´s decision|0|||
162804108|NCT00350103|587990828|FG000|Overall Study|Lost, Reason unknown|1|||
162804109|NCT00350103|587990829|FG001|Overall Study|Lost, Reason unknown|1|||
162804110|NCT00350103|587990830|FG002|Overall Study|Lost, Reason unknown|0|||
162804111|NCT01879553|587990831|FG000|Overall Study|Withdrawal by Subject|1|||
162804112|NCT01879553|587990832|FG001|Overall Study|Withdrawal by Subject|0|||
162804113|NCT02559895|587990833|FG000|Overall Study|Adverse Event|3|||
162804114|NCT02559895|587990834|FG001|Overall Study|Adverse Event|3|||
162804115|NCT02559895|587990835|FG002|Overall Study|Adverse Event|2|||
162804116|NCT02559895|587990836|FG003|Overall Study|Adverse Event|1|||
162804117|NCT02559895|587990833|FG000|Overall Study|Lack of Efficacy|2|||
162804118|NCT02559895|587990834|FG001|Overall Study|Lack of Efficacy|3|||
162804119|NCT02559895|587990835|FG002|Overall Study|Lack of Efficacy|2|||
162804120|NCT02559895|587990836|FG003|Overall Study|Lack of Efficacy|8|||
162804121|NCT02559895|587990833|FG000|Overall Study|Lost to Follow-up|22|||
162804122|NCT02559895|587990834|FG001|Overall Study|Lost to Follow-up|16|||
162804123|NCT02559895|587990835|FG002|Overall Study|Lost to Follow-up|12|||
162804124|NCT02559895|587990836|FG003|Overall Study|Lost to Follow-up|17|||
162804125|NCT02559895|587990833|FG000|Overall Study|Physician Decision|1|||
162804126|NCT02559895|587990834|FG001|Overall Study|Physician Decision|1|||
162804127|NCT02559895|587990835|FG002|Overall Study|Physician Decision|3|||
162804128|NCT02559895|587990836|FG003|Overall Study|Physician Decision|0|||
162804129|NCT02559895|587990833|FG000|Overall Study|Withdrawal by Subject|16|||
162804130|NCT02559895|587990834|FG001|Overall Study|Withdrawal by Subject|9|||
162804131|NCT02559895|587990835|FG002|Overall Study|Withdrawal by Subject|20|||
162804132|NCT02559895|587990836|FG003|Overall Study|Withdrawal by Subject|9|||
162804133|NCT02559895|587990833|FG000|Overall Study|Study Burden|10|||
162804134|NCT02559895|587990834|FG001|Overall Study|Study Burden|16|||
162804135|NCT02559895|587990835|FG002|Overall Study|Study Burden|12|||
162804136|NCT02559895|587990836|FG003|Overall Study|Study Burden|22|||
162804137|NCT02559895|587990833|FG000|Overall Study|Other|1|||
162804138|NCT02559895|587990834|FG001|Overall Study|Other|5|||
162804139|NCT02559895|587990835|FG002|Overall Study|Other|3|||
162804140|NCT02559895|587990836|FG003|Overall Study|Other|3|||
162804141|NCT00760474|587990837|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
162804142|NCT00760474|587990838|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
162804143|NCT00760474|587990837|FG000|Placebo Washout Period|Other|0|||
162804144|NCT00760474|587990838|FG001|Placebo Washout Period|Other|1|||
162804145|NCT00760474|587990837|FG000|Period 2 (P2)|Lost to Follow-up|1|||
162804146|NCT00760474|587990838|FG001|Period 2 (P2)|Lost to Follow-up|0|||
162804147|NCT00760474|587990837|FG000|Period 2 (P2)|Adverse Event|0|||
162804148|NCT00760474|587990838|FG001|Period 2 (P2)|Adverse Event|1|||
162804149|NCT04540887|587990839|FG000|Overall Study|Withdrawal by Subject|2|||
162804150|NCT04664400|587990840|FG000|Overall Study|Withdrawal by Subject|2|||
162804151|NCT03762200|587990846|FG000|Overall Study|Death|2|||
162804152|NCT05618912|587990847|FG000|Overall Study|Lost to Follow-up|14|||
162804153|NCT05618912|587990848|FG001|Overall Study|Lost to Follow-up|19|||
162804154|NCT00734097|587992703|FG000|Screening|Protocol Violation|12|||
162804155|NCT00734097|587992703|FG000|Screening|Withdrawal by Subject|5|||
162804156|NCT00734097|587992703|FG000|Screening|Lost to Follow-up|2|||
162804157|NCT00734097|587992703|FG000|Screening|Unconfirmed pregnancy|1|||
162804158|NCT00734097|587992703|FG000|Open Label|Lost to Follow-up|7|||
162804159|NCT00734097|587992703|FG000|Open Label|Withdrawal by Subject|5|||
162804160|NCT00734097|587992703|FG000|Open Label|Protocol Violation|4|||
162804161|NCT02233543|587992706|FG000|Period 1|Withdrawal by Subject|1|||
162804162|NCT02233543|587992707|FG001|Period 1|Withdrawal by Subject|0|||
162804163|NCT02233543|587992706|FG000|Period 1|Participants required other treatment.|2|||
162804164|NCT02233543|587992707|FG001|Period 1|Participants required other treatment.|3|||
162804165|NCT02233543|587992706|FG000|Period 2|Adverse Event|1|||
162804166|NCT02233543|587992707|FG001|Period 2|Adverse Event|0|||
162804167|NCT02233543|587992706|FG000|Period 2|Participant required other treatment.|0|||
162804168|NCT02233543|587992707|FG001|Period 2|Participant required other treatment.|1|||
162804169|NCT02233543|587992706|FG000|Period 2|COPD exacerbation|1|||
162804170|NCT02233543|587992707|FG001|Period 2|COPD exacerbation|0|||
162804171|NCT01302067|587992708|FG000|Overall Study|Death|0|||
162804172|NCT01302067|587992709|FG001|Overall Study|Death|0|||
162804173|NCT01302067|587992710|FG002|Overall Study|Death|1|||
162804174|NCT01302067|587992708|FG000|Overall Study|Physician Decision|9|||
162804175|NCT01302067|587992709|FG001|Overall Study|Physician Decision|5|||
162804176|NCT01302067|587992710|FG002|Overall Study|Physician Decision|14|||
162804177|NCT01302067|587992708|FG000|Overall Study|Lack of Efficacy|8|||
162804178|NCT01302067|587992709|FG001|Overall Study|Lack of Efficacy|4|||
162804179|NCT01302067|587992710|FG002|Overall Study|Lack of Efficacy|2|||
162804180|NCT01302067|587992708|FG000|Overall Study|Lost to Follow-up|9|||
162804181|NCT01302067|587992709|FG001|Overall Study|Lost to Follow-up|4|||
162804182|NCT01302067|587992710|FG002|Overall Study|Lost to Follow-up|15|||
162804183|NCT01302067|587992708|FG000|Overall Study|Withdrawal by Subject|13|||
162804184|NCT01302067|587992709|FG001|Overall Study|Withdrawal by Subject|6|||
162804185|NCT01302067|587992710|FG002|Overall Study|Withdrawal by Subject|10|||
162804186|NCT01302067|587992708|FG000|Overall Study|Other|1|||
162804187|NCT01302067|587992709|FG001|Overall Study|Other|1|||
162804188|NCT01302067|587992710|FG002|Overall Study|Other|3|||
162804189|NCT01302067|587992708|FG000|Overall Study|Protocol Violation|11|||
162804190|NCT01302067|587992709|FG001|Overall Study|Protocol Violation|0|||
162804191|NCT01302067|587992710|FG002|Overall Study|Protocol Violation|8|||
162804192|NCT01302067|587992708|FG000|Overall Study|Adverse Event|27|||
162804193|NCT01302067|587992709|FG001|Overall Study|Adverse Event|14|||
162804194|NCT01302067|587992710|FG002|Overall Study|Adverse Event|45|||
162804195|NCT02924428|587992711|FG000|Overall Study|Adverse Event|1|||
162804196|NCT02924428|587992712|FG001|Overall Study|Adverse Event|0|||
162804197|NCT02924428|587992711|FG000|Overall Study|Physician Decision|1|||
162804198|NCT02924428|587992712|FG001|Overall Study|Physician Decision|0|||
162804199|NCT02924428|587992711|FG000|Overall Study|Lost to Follow-up|2|||
162804200|NCT02924428|587992712|FG001|Overall Study|Lost to Follow-up|4|||
162804201|NCT02924428|587992711|FG000|Overall Study|Pregnancy|0|||
162804202|NCT02924428|587992712|FG001|Overall Study|Pregnancy|1|||
162804203|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
162804204|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
162804205|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
162804206|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
162804207|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
162804208|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
162804209|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
162804210|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
162804211|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
162804212|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
162804213|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
162804214|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
162804215|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
162804216|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
162804217|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
162804218|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
162804219|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
162804220|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
162804221|NCT02480153|587992713|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
162804222|NCT02480153|587992714|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
162804223|NCT02480153|587992715|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
162804224|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
162804225|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
162804226|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
162804227|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
162804228|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
162804229|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
162804230|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
162804231|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
162804232|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
162804233|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
162804234|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
162804235|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
162804236|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
162804237|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
162804238|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
162804239|NCT02480153|587992713|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
162804240|NCT02480153|587992714|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
162804241|NCT02480153|587992715|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
162804242|NCT02480153|587992713|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
162804243|NCT02480153|587992714|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
162804244|NCT02480153|587992715|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
162804245|NCT02480153|587992713|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
162804246|NCT02480153|587992714|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
162804247|NCT02480153|587992715|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
162804248|NCT02480153|587992713|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
162804249|NCT02480153|587992714|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
162804250|NCT02480153|587992715|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
162804251|NCT02480153|587992713|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
162804252|NCT02480153|587992714|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
162804253|NCT02480153|587992715|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
162804254|NCT02480153|587992713|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
162804255|NCT02480153|587992714|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
162804256|NCT02480153|587992715|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
162804257|NCT03241225|587992719|FG000|Overall Study|Lost to Follow-up|2|||
162804258|NCT03241225|587992720|FG001|Overall Study|Lost to Follow-up|1|||
162804259|NCT03241225|587992719|FG000|Overall Study|Protocol Violation|4|||
162804260|NCT03241225|587992720|FG001|Overall Study|Protocol Violation|1|||
162804261|NCT03241225|587992719|FG000|Overall Study|Withdrawal by Subject|1|||
162804262|NCT03241225|587992720|FG001|Overall Study|Withdrawal by Subject|0|||
162804263|NCT00852540|587992721|FG000|Overall Study|Adverse Event|10|||
162804264|NCT00852540|587992722|FG001|Overall Study|Adverse Event|3|||
162804265|NCT00852540|587992721|FG000|Overall Study|Lack of Efficacy|15|||
162804266|NCT00852540|587992722|FG001|Overall Study|Lack of Efficacy|3|||
162804267|NCT00852540|587992721|FG000|Overall Study|Protocol Violation|1|||
162804268|NCT00852540|587992722|FG001|Overall Study|Protocol Violation|2|||
162804269|NCT00852540|587992721|FG000|Overall Study|Lost to Follow-up|2|||
162804270|NCT00852540|587992722|FG001|Overall Study|Lost to Follow-up|3|||
162804271|NCT00852540|587992721|FG000|Overall Study|Investigator Discretion|2|||
162804272|NCT00852540|587992722|FG001|Overall Study|Investigator Discretion|3|||
162804273|NCT00852540|587992721|FG000|Overall Study|Withdrawal by Subject|3|||
162804274|NCT00852540|587992722|FG001|Overall Study|Withdrawal by Subject|1|||
162804275|NCT00852540|587992721|FG000|Overall Study|Did Not Receive Study Drug|3|||
162804276|NCT00852540|587992722|FG001|Overall Study|Did Not Receive Study Drug|3|||
162804277|NCT04875676|587992732|FG000|Overall Study|Lost to Follow-up|1|||
162804278|NCT04875676|587992733|FG001|Overall Study|Lost to Follow-up|0|||
162804279|NCT04875676|587992734|FG002|Overall Study|Lost to Follow-up|0|||
162804280|NCT03064035|587992735|FG000|Overall Study|Did not receive allocated intervention|4|||
162804281|NCT03064035|587992736|FG001|Overall Study|Did not receive allocated intervention|2|||
162804282|NCT03064035|587992735|FG000|Overall Study|Lost to Follow-up|1|||
162804283|NCT03064035|587992736|FG001|Overall Study|Lost to Follow-up|1|||
162804284|NCT03103763|587992739|FG000|Overall Study|Death|15|||
162804285|NCT03103763|587992740|FG001|Overall Study|Death|5|||
162804286|NCT03103763|587992741|FG002|Overall Study|Death|5|||
162804287|NCT03103763|587992739|FG000|Overall Study|Withdrawal by Subject|0|||
162804288|NCT03103763|587992740|FG001|Overall Study|Withdrawal by Subject|3|||
162804289|NCT03103763|587992741|FG002|Overall Study|Withdrawal by Subject|2|||
162804290|NCT02336178|587992742|FG000|Overall Study|Lost to Follow-up|1|||
162804291|NCT02336178|587992742|FG000|Overall Study|Protocol Violation|1|||
162804292|NCT02336178|587992742|FG000|Overall Study|Withdrawal by Subject|1|||
162804293|NCT02336178|587992742|FG000|Overall Study|Other|1|||
162804294|NCT03245151|587992743|FG000|Overall Study|Withdrawal by Subject|2|||
162804295|NCT03245151|587992744|FG001|Overall Study|Withdrawal by Subject|0|||
162804296|NCT03245151|587992745|FG002|Overall Study|Withdrawal by Subject|0|||
162804297|NCT03245151|587992746|FG003|Overall Study|Withdrawal by Subject|2|||
162804298|NCT03245151|587992747|FG004|Overall Study|Withdrawal by Subject|1|||
162804299|NCT03245151|587992743|FG000|Overall Study|Death|3|||
162804300|NCT03245151|587992744|FG001|Overall Study|Death|14|||
162804301|NCT03245151|587992745|FG002|Overall Study|Death|9|||
162804302|NCT03245151|587992746|FG003|Overall Study|Death|16|||
162804303|NCT03245151|587992747|FG004|Overall Study|Death|7|||
162804304|NCT03245151|587992743|FG000|Overall Study|Sponsor's decision|0|||
162804305|NCT03245151|587992744|FG001|Overall Study|Sponsor's decision|1|||
162804306|NCT03245151|587992745|FG002|Overall Study|Sponsor's decision|0|||
162804307|NCT03245151|587992746|FG003|Overall Study|Sponsor's decision|0|||
162804308|NCT03245151|587992747|FG004|Overall Study|Sponsor's decision|0|||
162804309|NCT01970345|587992748|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162804310|NCT01970345|587992749|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162804311|NCT01970345|587992748|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
162804312|NCT01970345|587992749|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162804313|NCT01346475|587992750|FG000|First Intervention|Lost to Follow-up|4|||
162804314|NCT01346475|587992751|FG001|First Intervention|Lost to Follow-up|3|||
162804315|NCT00621777|587992752|FG000|Open Phase|Adverse Event|20|||
162804316|NCT00621777|587992753|FG001|Open Phase|Adverse Event|0|||
162804317|NCT00621777|587992752|FG000|Open Phase|Did not abstain during open phase|56|||
162804318|NCT00621777|587992753|FG001|Open Phase|Did not abstain during open phase|0|||
162804319|NCT00621777|587992752|FG000|Open Phase|Withdrawal by Subject|17|||
162804320|NCT00621777|587992753|FG001|Open Phase|Withdrawal by Subject|0|||
162804321|NCT00621777|587992752|FG000|Open Phase|administrative|13|||
162804322|NCT00621777|587992753|FG001|Open Phase|administrative|0|||
162804323|NCT00621777|587992752|FG000|Open Phase|Lost to Follow-up|10|||
162804324|NCT00621777|587992753|FG001|Open Phase|Lost to Follow-up|0|||
162804325|NCT00621777|587992752|FG000|Randomized Phase|Adverse Event|3|||
162804326|NCT00621777|587992753|FG001|Randomized Phase|Adverse Event|3|||
162804327|NCT00621777|587992752|FG000|Randomized Phase|Lost to Follow-up|3|||
162804328|NCT00621777|587992753|FG001|Randomized Phase|Lost to Follow-up|3|||
162804329|NCT00621777|587992752|FG000|Randomized Phase|Withdrawal by Subject|1|||
162804330|NCT00621777|587992753|FG001|Randomized Phase|Withdrawal by Subject|9|||
162804331|NCT00621777|587992752|FG000|Randomized Phase|administrative|0|||
162804332|NCT00621777|587992753|FG001|Randomized Phase|administrative|3|||
162804333|NCT00621777|587992752|FG000|Randomized Phase|Death|0|||
162804334|NCT00621777|587992753|FG001|Randomized Phase|Death|1|||
162804335|NCT00558259|587992754|FG000|Overall Study|Adverse Event|50|||
162804336|NCT00558259|587992755|FG001|Overall Study|Adverse Event|81|||
162804337|NCT00558259|587992754|FG000|Overall Study|Protocol Violation|9|||
162804338|NCT00558259|587992755|FG001|Overall Study|Protocol Violation|5|||
162804339|NCT00558259|587992754|FG000|Overall Study|Withdrawal by Subject|12|||
162804340|NCT00558259|587992755|FG001|Overall Study|Withdrawal by Subject|13|||
162804341|NCT00700258|587992762|FG000|Overall Study|Premature discontinuation of documentation|136|||
162804342|NCT00700258|587992762|FG000|Overall Study|Type of study end not documented|1|||
162804343|NCT00700258|587992762|FG000|Overall Study|Lost to Follow-up|81|||
162804344|NCT00700258|587992762|FG000|Overall Study|Premature discontinuation of therapy|1013|||
162804345|NCT00473265|587992763|FG000|Overall Study|Unrelated adverse event|5|||
162804346|NCT00473265|587992763|FG000|Overall Study|Off treatment early|15|||
162804347|NCT02663518|587992766|FG000|Part 1: Phase 1a Escalation|Death|0|||
162804348|NCT02663518|587992767|FG001|Part 1: Phase 1a Escalation|Death|0|||
162804349|NCT02663518|587992768|FG002|Part 1: Phase 1a Escalation|Death|1|||
162804350|NCT02663518|587992769|FG003|Part 1: Phase 1a Escalation|Death|0|||
162804351|NCT02663518|587992770|FG004|Part 1: Phase 1a Escalation|Death|0|||
162804352|NCT02663518|587992771|FG005|Part 1: Phase 1a Escalation|Death|0|||
162804353|NCT02663518|587992772|FG006|Part 1: Phase 1a Escalation|Death|0|||
162804354|NCT02663518|587992773|FG007|Part 1: Phase 1a Escalation|Death|0|||
162804355|NCT02663518|587992774|FG008|Part 1: Phase 1a Escalation|Death|0|||
162804356|NCT02663518|587992775|FG009|Part 1: Phase 1a Escalation|Death|0|||
162804357|NCT02663518|587992776|FG010|Part 1: Phase 1a Escalation|Death|0|||
162804358|NCT02663518|587992777|FG011|Part 1: Phase 1a Escalation|Death|0|||
162804359|NCT02663518|587992778|FG012|Part 1: Phase 1a Escalation|Death|0|||
162804360|NCT02663518|587992779|FG013|Part 1: Phase 1a Escalation|Death|0|||
162804361|NCT02663518|587992766|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804362|NCT02663518|587992767|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804363|NCT02663518|587992768|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
162804364|NCT02663518|587992769|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804365|NCT02663518|587992770|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804366|NCT02663518|587992771|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804367|NCT02663518|587992772|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804368|NCT02663518|587992773|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804369|NCT02663518|587992774|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804370|NCT02663518|587992775|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804371|NCT02663518|587992776|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804372|NCT02663518|587992777|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804373|NCT02663518|587992778|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804374|NCT02663518|587992779|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162804375|NCT02663518|587992766|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
162804376|NCT02663518|587992767|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
162804377|NCT02663518|587992768|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
162804378|NCT02663518|587992769|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
162804379|NCT02663518|587992770|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804380|NCT02663518|587992771|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804381|NCT02663518|587992772|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804382|NCT02663518|587992773|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804383|NCT02663518|587992774|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804384|NCT02663518|587992775|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804385|NCT02663518|587992776|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804386|NCT02663518|587992777|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804387|NCT02663518|587992778|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804388|NCT02663518|587992779|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162804389|NCT02663518|587992766|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162804390|NCT02663518|587992767|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804391|NCT02663518|587992768|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162804392|NCT02663518|587992769|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162804393|NCT02663518|587992770|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804394|NCT02663518|587992771|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804395|NCT02663518|587992772|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804396|NCT02663518|587992773|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804397|NCT02663518|587992774|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804398|NCT02663518|587992775|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804399|NCT02663518|587992776|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804400|NCT02663518|587992777|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804401|NCT02663518|587992778|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804402|NCT02663518|587992779|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162804403|NCT02663518|587992766|FG000|Part 1: Phase 1a Escalation|Other|0|||
162804404|NCT02663518|587992767|FG001|Part 1: Phase 1a Escalation|Other|0|||
162804405|NCT02663518|587992768|FG002|Part 1: Phase 1a Escalation|Other|2|||
162804406|NCT02663518|587992769|FG003|Part 1: Phase 1a Escalation|Other|0|||
162804407|NCT02663518|587992770|FG004|Part 1: Phase 1a Escalation|Other|0|||
162804408|NCT02663518|587992771|FG005|Part 1: Phase 1a Escalation|Other|0|||
162804409|NCT02663518|587992772|FG006|Part 1: Phase 1a Escalation|Other|0|||
162804410|NCT02663518|587992773|FG007|Part 1: Phase 1a Escalation|Other|0|||
162804411|NCT02663518|587992774|FG008|Part 1: Phase 1a Escalation|Other|0|||
162804412|NCT02663518|587992775|FG009|Part 1: Phase 1a Escalation|Other|0|||
162804413|NCT02663518|587992776|FG010|Part 1: Phase 1a Escalation|Other|0|||
162804414|NCT02663518|587992777|FG011|Part 1: Phase 1a Escalation|Other|0|||
162804415|NCT02663518|587992778|FG012|Part 1: Phase 1a Escalation|Other|0|||
162804416|NCT02663518|587992779|FG013|Part 1: Phase 1a Escalation|Other|0|||
162804417|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804418|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804419|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804420|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804421|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
162804422|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804423|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
162804424|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
162804425|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804426|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804427|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804428|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804429|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804430|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
162804431|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804432|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804433|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804434|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804435|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
162804436|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804437|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
162804438|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
162804439|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804440|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804441|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804442|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804443|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804444|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162804445|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804446|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804447|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804448|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804449|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
162804450|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804451|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804452|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804453|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804454|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804455|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804456|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804457|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804458|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162804459|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804460|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804461|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804462|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804463|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
162804464|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
162804465|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
162804466|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
162804467|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804468|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804469|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804470|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804471|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804472|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162804473|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804474|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804475|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804476|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804477|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
162804478|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804479|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
162804480|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804481|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804482|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804483|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804484|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804485|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804486|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
162804487|NCT02663518|587992766|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804488|NCT02663518|587992767|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804489|NCT02663518|587992768|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804490|NCT02663518|587992769|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804491|NCT02663518|587992770|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804492|NCT02663518|587992771|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804493|NCT02663518|587992772|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
162804494|NCT02663518|587992773|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804495|NCT02663518|587992774|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804496|NCT02663518|587992775|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804497|NCT02663518|587992776|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804498|NCT02663518|587992777|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804499|NCT02663518|587992778|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804500|NCT02663518|587992779|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162804501|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
162804502|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
162804503|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
162804504|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
162804505|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
162804506|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
162804507|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
162804508|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
162804509|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
162804510|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
162804511|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
162804512|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
162804513|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
162804514|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
162804515|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804516|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804517|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804518|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804519|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804520|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804521|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804522|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804523|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804524|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804525|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804526|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804527|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
162804528|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162804529|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804530|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804531|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804532|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804533|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804534|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804535|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804536|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804537|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804538|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804539|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804540|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
162804541|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804542|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162804543|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804544|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804545|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804546|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804547|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804548|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804549|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804550|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804551|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804552|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
162804553|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162804554|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162804555|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162804556|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162804557|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
162804558|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
162804559|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
162804560|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
162804561|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
162804562|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
162804563|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
162804564|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
162804565|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
162804566|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
162804567|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
162804568|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
162804569|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
162804570|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
162804571|NCT02663518|587992766|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804572|NCT02663518|587992767|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804573|NCT02663518|587992768|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804574|NCT02663518|587992769|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804575|NCT02663518|587992770|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804576|NCT02663518|587992771|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804577|NCT02663518|587992772|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804578|NCT02663518|587992773|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804579|NCT02663518|587992774|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804580|NCT02663518|587992775|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804581|NCT02663518|587992776|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804582|NCT02663518|587992777|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804583|NCT02663518|587992778|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
162804584|NCT02663518|587992779|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162804585|NCT01004848|587992780|FG000|Overall Study|Lost to Follow-up|55|||
162804586|NCT01004848|587992781|FG001|Overall Study|Lost to Follow-up|45|||
162804587|NCT03215810|587992782|FG000|Overall Study|Still responding to nivolumab|1|||
162804588|NCT03215810|587992782|FG000|Overall Study|Insufficient TIL growth|1|||
162804589|NCT03215810|587992782|FG000|Overall Study|Decline in performance status|1|||
162804590|NCT03215810|587992782|FG000|Overall Study|Withdrawal by Subject|1|||
162804591|NCT01157676|587992789|FG000|Randomization|Death|1|||
162804592|NCT01157676|587992790|FG001|Randomization|Death|1|||
162804593|NCT01157676|587992789|FG000|Randomization|unresectable|2|||
162804594|NCT01157676|587992790|FG001|Randomization|unresectable|3|||
162804595|NCT01157676|587992789|FG000|Randomization|Withdrawal by Subject|17|||
162804596|NCT01157676|587992790|FG001|Randomization|Withdrawal by Subject|13|||
162804597|NCT01157676|587992789|FG000|Randomization|Physician Decision|1|||
162804598|NCT01157676|587992790|FG001|Randomization|Physician Decision|0|||
162804599|NCT01157676|587992789|FG000|Surgery|underwent open cystectomy|0|||
162804600|NCT01157676|587992790|FG001|Surgery|underwent open cystectomy|4|||
162804601|NCT01157676|587992789|FG000|Surgery|converted to open procedure|0|||
162804602|NCT01157676|587992790|FG001|Surgery|converted to open procedure|5|||
162804603|NCT01157676|587992789|FG000|Surgery|underwent robotic cystectomy|1|||
162804604|NCT01157676|587992790|FG001|Surgery|underwent robotic cystectomy|0|||
162804605|NCT00682890|587992791|FG000|Overall Study|Lost to Follow-up|1|||
162804606|NCT00682890|587992792|FG001|Overall Study|Lost to Follow-up|1|||
162804607|NCT00682890|587992791|FG000|Overall Study|subject moved away|0|||
162804608|NCT00682890|587992792|FG001|Overall Study|subject moved away|1|||
162804609|NCT00682890|587992791|FG000|Overall Study|heavy menstrual bleeding|1|||
162804610|NCT00682890|587992792|FG001|Overall Study|heavy menstrual bleeding|0|||
162804611|NCT00141219|587992795|FG000|Overall Study|Protocol violations|5|||
162804612|NCT00141219|587992796|FG001|Overall Study|Protocol violations|4|||
162804613|NCT00141219|587992795|FG000|Overall Study|Adverse Event|8|||
162804614|NCT00141219|587992796|FG001|Overall Study|Adverse Event|6|||
162804615|NCT00141219|587992795|FG000|Overall Study|Lack of Efficacy|5|||
162804616|NCT00141219|587992796|FG001|Overall Study|Lack of Efficacy|4|||
162804617|NCT00141219|587992795|FG000|Overall Study|Withdrawal by Subject|6|||
162804618|NCT00141219|587992796|FG001|Overall Study|Withdrawal by Subject|2|||
162804619|NCT01577745|587992797|FG000|Overall Study|Withdrawal by Subject|0|||
162804620|NCT01577745|587992798|FG001|Overall Study|Withdrawal by Subject|1|||
162804621|NCT01577745|587992799|FG002|Overall Study|Withdrawal by Subject|0|||
162804622|NCT01577745|587992800|FG003|Overall Study|Withdrawal by Subject|3|||
162804623|NCT01577745|587992801|FG004|Overall Study|Withdrawal by Subject|2|||
162804624|NCT01577745|587992802|FG005|Overall Study|Withdrawal by Subject|0|||
162804625|NCT01577745|587992797|FG000|Overall Study|Death|3|||
162804626|NCT01577745|587992798|FG001|Overall Study|Death|2|||
162804627|NCT01577745|587992799|FG002|Overall Study|Death|2|||
162804628|NCT01577745|587992800|FG003|Overall Study|Death|1|||
162804629|NCT01577745|587992801|FG004|Overall Study|Death|1|||
162804630|NCT01577745|587992802|FG005|Overall Study|Death|3|||
162804631|NCT01577745|587992797|FG000|Overall Study|Physician Decision|0|||
162804632|NCT01577745|587992798|FG001|Overall Study|Physician Decision|0|||
162804633|NCT01577745|587992799|FG002|Overall Study|Physician Decision|0|||
162804634|NCT01577745|587992800|FG003|Overall Study|Physician Decision|1|||
162804635|NCT01577745|587992801|FG004|Overall Study|Physician Decision|1|||
162804636|NCT01577745|587992802|FG005|Overall Study|Physician Decision|0|||
162804637|NCT01577745|587992797|FG000|Overall Study|Lost to Follow-up|0|||
162804638|NCT01577745|587992798|FG001|Overall Study|Lost to Follow-up|0|||
162804639|NCT01577745|587992799|FG002|Overall Study|Lost to Follow-up|0|||
162804640|NCT01577745|587992800|FG003|Overall Study|Lost to Follow-up|0|||
162804641|NCT01577745|587992801|FG004|Overall Study|Lost to Follow-up|0|||
162804642|NCT01577745|587992802|FG005|Overall Study|Lost to Follow-up|1|||
162804643|NCT01577745|587992797|FG000|Overall Study|Alternative Therapy|0|||
162804644|NCT01577745|587992798|FG001|Overall Study|Alternative Therapy|0|||
162804645|NCT01577745|587992799|FG002|Overall Study|Alternative Therapy|0|||
162804646|NCT01577745|587992800|FG003|Overall Study|Alternative Therapy|1|||
162804647|NCT01577745|587992801|FG004|Overall Study|Alternative Therapy|1|||
162804648|NCT01577745|587992802|FG005|Overall Study|Alternative Therapy|0|||
162804649|NCT02971761|587992804|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
162804650|NCT02624791|587992805|FG000|Overall Study|Withdrawal by Subject|2|||
162804651|NCT02624791|587992806|FG001|Overall Study|Withdrawal by Subject|0|||
162804652|NCT02624791|587992807|FG002|Overall Study|Withdrawal by Subject|0|||
162804653|NCT02624791|587992808|FG003|Overall Study|Withdrawal by Subject|0|||
162804654|NCT02624791|587992809|FG004|Overall Study|Withdrawal by Subject|0|||
162804655|NCT02624791|587992810|FG005|Overall Study|Withdrawal by Subject|0|||
162804656|NCT01146782|587992814|FG000|Screening Cohort|Screen Failure|187|||
162804657|NCT01146782|587992814|FG000|Screening Cohort|Lost to Follow-up|4|||
162804658|NCT01146782|587992814|FG000|Screening Cohort|Physician Decision|1|||
162804659|NCT01146782|587992814|FG000|Screening Cohort|Withdrawal by Subject|29|||
162804660|NCT01146782|587992814|FG000|Safety Cohort|Screen Failure|61|||
162804661|NCT01146782|587992814|FG000|Safety Cohort|Withdrawal by Subject|4|||
162804662|NCT01146782|587992814|FG000|Safety Cohort|Control AHI <5|4|||
162804663|NCT01146782|587992814|FG000|Safety Cohort|TST <4 hrs|14|||
162804664|NCT01146782|587992814|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
162804665|NCT01146782|587992814|FG000|Primary Endpoint Cohort|Physician Decision|1|||
162804666|NCT01605916|587992815|FG000|Overall Study|Adverse Event|1|||
162804667|NCT01605916|587992816|FG001|Overall Study|Adverse Event|0|||
162804668|NCT01605916|587992817|FG002|Overall Study|Adverse Event|0|||
162804669|NCT01605916|587992818|FG003|Overall Study|Adverse Event|1|||
162804670|NCT01605916|587992819|FG004|Overall Study|Adverse Event|0|||
162804671|NCT01605916|587992815|FG000|Overall Study|Lack of Efficacy|2|||
162804672|NCT01605916|587992816|FG001|Overall Study|Lack of Efficacy|3|||
162804673|NCT01605916|587992817|FG002|Overall Study|Lack of Efficacy|3|||
162804674|NCT01605916|587992818|FG003|Overall Study|Lack of Efficacy|5|||
162804675|NCT01605916|587992819|FG004|Overall Study|Lack of Efficacy|4|||
162804676|NCT01605916|587992815|FG000|Overall Study|Withdrawal by Subject|1|||
162804677|NCT01605916|587992816|FG001|Overall Study|Withdrawal by Subject|1|||
162804678|NCT01605916|587992817|FG002|Overall Study|Withdrawal by Subject|0|||
162804679|NCT01605916|587992818|FG003|Overall Study|Withdrawal by Subject|0|||
162804680|NCT01605916|587992819|FG004|Overall Study|Withdrawal by Subject|2|||
162804681|NCT02842151|587992822|FG000|Overall Study|Adverse Event|1|||
162804682|NCT02842151|587992822|FG000|Overall Study|Subject moved too far away|1|||
162804683|NCT00438672|587992823|FG000|Overall Study|Lost to Follow-up|7|||
162804684|NCT00438672|587992824|FG001|Overall Study|Lost to Follow-up|9|||
162804685|NCT03965351|587992827|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162804686|NCT03965351|587992828|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
162804687|NCT03965351|587992827|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
162804688|NCT03965351|587992828|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
162804689|NCT02217501|587992835|FG000|Overall Study|Death|3|||
162804690|NCT02217501|587992836|FG001|Overall Study|Death|4|||
162804691|NCT01394978|587992837|FG000|Overall Study|Withdrawal by Subject|2|||
162804692|NCT01394978|587992838|FG001|Overall Study|Withdrawal by Subject|4|||
162804693|NCT01394978|587992837|FG000|Overall Study|Lost to Follow-up|13|||
162804694|NCT01394978|587992838|FG001|Overall Study|Lost to Follow-up|20|||
162804695|NCT01394978|587992837|FG000|Overall Study|Death|6|||
162804696|NCT01394978|587992838|FG001|Overall Study|Death|7|||
162804697|NCT02019667|587992839|FG000|First Intervention (6 Months)|Adverse Event|0|||
162804698|NCT02019667|587992840|FG001|First Intervention (6 Months)|Adverse Event|1|||
162804699|NCT02019667|587992839|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
162804700|NCT02019667|587992840|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
162804701|NCT02019667|587992839|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
162804702|NCT02019667|587992840|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
162804703|NCT05038163|587992849|FG000|Stage 1|Did not complete survey|374|||
162804704|NCT05038163|587992850|FG001|Stage 1|Did not complete survey|0|||
162804705|NCT05038163|587992851|FG002|Stage 1|Did not complete survey|0|||
162804706|NCT05038163|587992852|FG003|Stage 1|Did not complete survey|0|||
162804707|NCT05038163|587992853|FG004|Stage 1|Did not complete survey|0|||
162804708|NCT05038163|587992854|FG005|Stage 1|Did not complete survey|0|||
162804709|NCT05038163|587992849|FG000|Stage 2|Did not complete Stage 2 survey|0|||
162804710|NCT05038163|587992850|FG001|Stage 2|Did not complete Stage 2 survey|29|||
162804711|NCT05038163|587992851|FG002|Stage 2|Did not complete Stage 2 survey|30|||
162804712|NCT05038163|587992852|FG003|Stage 2|Did not complete Stage 2 survey|24|||
162804713|NCT05038163|587992853|FG004|Stage 2|Did not complete Stage 2 survey|21|||
162804714|NCT05038163|587992854|FG005|Stage 2|Did not complete Stage 2 survey|100|||
162804715|NCT05453201|587992856|FG000|Overall Study|Withdrawal by Subject|1|||
162804716|NCT03562975|587992857|FG000|Overall Study|Death|1|||
162804717|NCT03562975|587992857|FG000|Overall Study|Lost to Follow-up|1|||
162804718|NCT03562975|587992857|FG000|Overall Study|Withdrawal by Subject|1|||
162804719|NCT01934790|587992858|FG000|Treatment|Adverse Event|3|||
162804720|NCT01934790|587992858|FG000|Treatment|Clinical progression|6|||
162804721|NCT01934790|587992858|FG000|Treatment|Radiological progression|4|||
162804722|NCT01934790|587992858|FG000|Treatment|Withdrawal by Subject|2|||
162804723|NCT01934790|587992858|FG000|Treatment|Study drug never administered|1|||
162804724|NCT01934790|587992858|FG000|Active Follow up|Death|20|||
162804725|NCT01934790|587992858|FG000|Active Follow up|Physician Decision|2|||
162804726|NCT01934790|587992858|FG000|Active Follow up|Progressive disease|1|||
162804727|NCT01934790|587992858|FG000|Active Follow up|Other reason|1|||
162804728|NCT00552929|587992861|FG000|Overall Study|Lost to Follow-up|0|||
162804729|NCT00552929|587992862|FG001|Overall Study|Lost to Follow-up|0|||
162804730|NCT00552929|587992863|FG002|Overall Study|Lost to Follow-up|0|||
162804731|NCT00552929|587992864|FG003|Overall Study|Lost to Follow-up|0|||
162804732|NCT00552929|587992865|FG004|Overall Study|Lost to Follow-up|0|||
162804733|NCT00552929|587992866|FG005|Overall Study|Lost to Follow-up|0|||
162804734|NCT00552929|587992867|FG006|Overall Study|Lost to Follow-up|0|||
162804735|NCT00552929|587992868|FG007|Overall Study|Lost to Follow-up|0|||
162804736|NCT00552929|587992869|FG008|Overall Study|Lost to Follow-up|1|||
162804737|NCT00552929|587992870|FG009|Overall Study|Lost to Follow-up|0|||
162804738|NCT00552929|587992861|FG000|Overall Study|Not Eligible|0|||
162804739|NCT00552929|587992862|FG001|Overall Study|Not Eligible|0|||
162804740|NCT00552929|587992863|FG002|Overall Study|Not Eligible|0|||
162804741|NCT00552929|587992864|FG003|Overall Study|Not Eligible|0|||
162804742|NCT00552929|587992865|FG004|Overall Study|Not Eligible|0|||
162804743|NCT00552929|587992866|FG005|Overall Study|Not Eligible|1|||
162804744|NCT00552929|587992867|FG006|Overall Study|Not Eligible|0|||
162804745|NCT00552929|587992868|FG007|Overall Study|Not Eligible|0|||
162804746|NCT00552929|587992869|FG008|Overall Study|Not Eligible|0|||
162804747|NCT00552929|587992870|FG009|Overall Study|Not Eligible|0|||
162804748|NCT01758900|587992873|FG000|Overall Study|difficulty for further intubation|7|||
162804749|NCT01758900|587992874|FG001|Overall Study|difficulty for further intubation|8|||
162804750|NCT04577001|587992875|FG000|Overall Study|Subject became ineligible|0|||
162804751|NCT04577001|587992876|FG001|Overall Study|Subject became ineligible|1|||
162804752|NCT03694275|587994430|FG000|Overall Study|Adverse Event|0|||
162804753|NCT03694275|587994431|FG001|Overall Study|Adverse Event|1|||
162804754|NCT03694275|587994430|FG000|Overall Study|Reason not Specified|0|||
162804755|NCT03694275|587994431|FG001|Overall Study|Reason not Specified|1|||
162804756|NCT00910689|587994435|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
162804757|NCT00910689|587994436|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
162804758|NCT00910689|587994437|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
162804759|NCT00910689|587994438|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
162804760|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
162804761|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
162804762|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
162804763|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
162804764|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
162804765|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
162804766|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
162804767|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
162804768|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
162804769|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
162804770|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
162804771|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
162804772|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
162804773|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
162804774|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
162804775|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
162804776|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162804777|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162804778|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
162804779|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162804780|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
162804781|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
162804782|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
162804783|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
162804784|NCT00910689|587994435|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
162804785|NCT00910689|587994436|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
162804786|NCT00910689|587994437|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
162804787|NCT00910689|587994438|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
162804788|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
162804789|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
162804790|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
162804791|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
162804792|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
162804793|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
162804794|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
162804795|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
162804796|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
162804797|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162804798|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162804799|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162804800|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
162804801|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
162804802|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
162804803|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
162804804|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162804805|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162804806|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
162804807|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162804808|NCT00910689|587994435|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
162804809|NCT00910689|587994436|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
162804810|NCT00910689|587994437|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
162804811|NCT00910689|587994438|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
162804812|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
162804813|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
162804814|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
162804815|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
162804816|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162804817|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
162804818|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162804819|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162804820|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
162804821|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162804822|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162804823|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162804824|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
162804825|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
162804826|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
162804827|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
162804828|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
162804829|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
162804830|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
162804831|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
162804832|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162804833|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162804834|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162804835|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
162804836|NCT00910689|587994435|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
162804837|NCT00910689|587994436|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
162804838|NCT00910689|587994437|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
162804839|NCT00910689|587994438|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
162804840|NCT01290029|587994439|FG000|Overall Study|Other|2|||
162804841|NCT00616902|587994442|FG000|Overall Study|Termination of study|6|||
162804842|NCT00616902|587994443|FG001|Overall Study|Termination of study|6|||
162804843|NCT01877837|587994444|FG000|Overall Study|Lost to Follow-up|1|||
162804844|NCT01877837|587994444|FG000|Overall Study|Ineligible|4|||
162804845|NCT00645801|587994445|FG000|Overall Study|unclear if patient took all the medication.|1|||
162804846|NCT00645801|587994446|FG001|Overall Study|unclear if patient took all the medication.|0|||
162804847|NCT00645801|587994445|FG000|Overall Study|Lost to Follow-up|19|||
162804848|NCT00645801|587994446|FG001|Overall Study|Lost to Follow-up|15|||
162804849|NCT00759915|587994447|FG000|Overall Study|Withdrawal by Subject|1|||
162804850|NCT00759915|587994448|FG001|Overall Study|Withdrawal by Subject|0|||
162804851|NCT00759915|587994447|FG000|Overall Study|Adverse Event|0|||
162804852|NCT00759915|587994448|FG001|Overall Study|Adverse Event|1|||
162804853|NCT00932113|587994451|FG000|Overall Study|Lost to Follow-up|1|||
162804854|NCT00932113|587994452|FG001|Overall Study|Lost to Follow-up|0|||
162804855|NCT01773291|587994453|FG000|Overall Study|Protocol Violation|1|||
162804856|NCT01773291|587994454|FG001|Overall Study|Protocol Violation|0|||
162804857|NCT01773291|587994455|FG002|Overall Study|Protocol Violation|0|||
162804858|NCT01773291|587994453|FG000|Overall Study|Withdrawal by Subject|0|||
162804859|NCT01773291|587994454|FG001|Overall Study|Withdrawal by Subject|0|||
162804860|NCT01773291|587994455|FG002|Overall Study|Withdrawal by Subject|1|||
162804861|NCT00203476|587994456|FG000|Overall Study|Lost to Follow-up|1|||
162804862|NCT00203476|587994457|FG001|Overall Study|Lost to Follow-up|0|||
162804863|NCT00203476|587994458|FG002|Overall Study|Lost to Follow-up|0|||
162804864|NCT00203476|587994456|FG000|Overall Study|Withdrawal by Subject|0|||
162804865|NCT00203476|587994457|FG001|Overall Study|Withdrawal by Subject|1|||
162804866|NCT00203476|587994458|FG002|Overall Study|Withdrawal by Subject|0|||
162804867|NCT03310268|587994459|FG000|Overall Study|(Not specified)|1|||
162804868|NCT03310268|587994460|FG001|Overall Study|(Not specified)|5|||
162804869|NCT03310268|587994461|FG002|Overall Study|(Not specified)|0|||
162804870|NCT04797650|587994462|FG000|Overall Study|Reason Not Specified|5|||
162804871|NCT04797650|587994463|FG001|Overall Study|Reason Not Specified|12|||
162804872|NCT04797650|587994464|FG002|Overall Study|Reason Not Specified|5|||
162804873|NCT04797650|587994462|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
162804874|NCT04797650|587994463|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
162804875|NCT04797650|587994464|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
162804876|NCT04797650|587994462|FG000|Overall Study|Lack of Efficacy|1|||
162804877|NCT04797650|587994463|FG001|Overall Study|Lack of Efficacy|0|||
162804878|NCT04797650|587994464|FG002|Overall Study|Lack of Efficacy|1|||
162804879|NCT04797650|587994462|FG000|Overall Study|Non-compliance with Study Drug|0|||
162804880|NCT04797650|587994463|FG001|Overall Study|Non-compliance with Study Drug|0|||
162804881|NCT04797650|587994464|FG002|Overall Study|Non-compliance with Study Drug|2|||
162804882|NCT04797650|587994462|FG000|Overall Study|Lost to Follow-up|4|||
162804883|NCT04797650|587994463|FG001|Overall Study|Lost to Follow-up|6|||
162804884|NCT04797650|587994464|FG002|Overall Study|Lost to Follow-up|1|||
162804885|NCT04772898|587994467|FG000|Overall Study|Withdrawal by Subject|0|||
162804886|NCT04772898|587994468|FG001|Overall Study|Withdrawal by Subject|1|||
162804887|NCT00309959|587994470|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
162804888|NCT02937454|587994471|FG000|Overall Study|Adverse Event|0|||
162804889|NCT02937454|587994472|FG001|Overall Study|Adverse Event|1|||
162804890|NCT02937454|587994471|FG000|Overall Study|Death|98|||
162804891|NCT02937454|587994472|FG001|Overall Study|Death|95|||
162804892|NCT02937454|587994471|FG000|Overall Study|Lost to Follow-up|1|||
162804893|NCT02937454|587994472|FG001|Overall Study|Lost to Follow-up|1|||
162804894|NCT02937454|587994471|FG000|Overall Study|Physician Decision|0|||
162804895|NCT02937454|587994472|FG001|Overall Study|Physician Decision|1|||
162804896|NCT02937454|587994471|FG000|Overall Study|Protocol Violation|6|||
162804897|NCT02937454|587994472|FG001|Overall Study|Protocol Violation|10|||
162804898|NCT02937454|587994471|FG000|Overall Study|Withdrawal by Subject|27|||
162804899|NCT02937454|587994472|FG001|Overall Study|Withdrawal by Subject|15|||
162804900|NCT02937454|587994471|FG000|Overall Study|Other|8|||
162804901|NCT02937454|587994472|FG001|Overall Study|Other|5|||
162804902|NCT01253304|587994473|FG000|Overall Study|Adverse Event|0|||
162804903|NCT01253304|587994474|FG001|Overall Study|Adverse Event|0|||
162804904|NCT01253304|587994475|FG002|Overall Study|Adverse Event|0|||
162804905|NCT01253304|587994476|FG003|Overall Study|Adverse Event|1|||
162804906|NCT01888900|587994484|FG000|Overall Study|failed treatment|0|||
162804907|NCT01888900|587994485|FG001|Overall Study|failed treatment|2|||
162804908|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
162804909|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162804910|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162804911|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162804912|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162804913|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162804914|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
162804915|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162804916|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162804917|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162804918|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162804919|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162804920|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
162804921|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162804922|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162804923|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162804924|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162804925|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162804926|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
162804927|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162804928|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162804929|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162804930|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162804931|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162804932|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
162804933|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162804934|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162804935|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162804936|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162804937|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162804938|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
162804939|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162804940|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162804941|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162804942|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162804943|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162804944|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
162804945|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162804946|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162804947|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162804948|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162804949|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162804950|NCT01160289|587994486|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
162804951|NCT01160289|587994487|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162804952|NCT01160289|587994488|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162804953|NCT01160289|587994489|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162804954|NCT01160289|587994490|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162804955|NCT01160289|587994491|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162804956|NCT01160289|587994486|FG000|Post-Randomization Period|Adverse Event|0|||
162804957|NCT01160289|587994487|FG001|Post-Randomization Period|Adverse Event|4|||
162804958|NCT01160289|587994488|FG002|Post-Randomization Period|Adverse Event|4|||
162804959|NCT01160289|587994489|FG003|Post-Randomization Period|Adverse Event|2|||
162804960|NCT01160289|587994490|FG004|Post-Randomization Period|Adverse Event|0|||
162804961|NCT01160289|587994491|FG005|Post-Randomization Period|Adverse Event|0|||
162804962|NCT01160289|587994486|FG000|Post-Randomization Period|Death|0|||
162804963|NCT01160289|587994487|FG001|Post-Randomization Period|Death|0|||
162804964|NCT01160289|587994488|FG002|Post-Randomization Period|Death|0|||
162804965|NCT01160289|587994489|FG003|Post-Randomization Period|Death|1|||
162804966|NCT01160289|587994490|FG004|Post-Randomization Period|Death|0|||
162804967|NCT01160289|587994491|FG005|Post-Randomization Period|Death|0|||
162804968|NCT01160289|587994486|FG000|Post-Randomization Period|Lack of Efficacy|0|||
162804969|NCT01160289|587994487|FG001|Post-Randomization Period|Lack of Efficacy|1|||
162804970|NCT01160289|587994488|FG002|Post-Randomization Period|Lack of Efficacy|0|||
162804971|NCT01160289|587994489|FG003|Post-Randomization Period|Lack of Efficacy|3|||
162804972|NCT01160289|587994490|FG004|Post-Randomization Period|Lack of Efficacy|0|||
162804973|NCT01160289|587994491|FG005|Post-Randomization Period|Lack of Efficacy|0|||
162804974|NCT01160289|587994486|FG000|Post-Randomization Period|Lost to Follow-up|0|||
162804975|NCT01160289|587994487|FG001|Post-Randomization Period|Lost to Follow-up|3|||
162804976|NCT01160289|587994488|FG002|Post-Randomization Period|Lost to Follow-up|2|||
162804977|NCT01160289|587994489|FG003|Post-Randomization Period|Lost to Follow-up|5|||
162804978|NCT01160289|587994490|FG004|Post-Randomization Period|Lost to Follow-up|3|||
162804979|NCT01160289|587994491|FG005|Post-Randomization Period|Lost to Follow-up|4|||
162804980|NCT01160289|587994486|FG000|Post-Randomization Period|Physician Decision|0|||
162804981|NCT01160289|587994487|FG001|Post-Randomization Period|Physician Decision|0|||
162804982|NCT01160289|587994488|FG002|Post-Randomization Period|Physician Decision|1|||
162804983|NCT01160289|587994489|FG003|Post-Randomization Period|Physician Decision|0|||
162804984|NCT01160289|587994490|FG004|Post-Randomization Period|Physician Decision|0|||
162804985|NCT01160289|587994491|FG005|Post-Randomization Period|Physician Decision|0|||
162804986|NCT01160289|587994486|FG000|Post-Randomization Period|Protocol Violation|0|||
162804987|NCT01160289|587994487|FG001|Post-Randomization Period|Protocol Violation|4|||
162804988|NCT01160289|587994488|FG002|Post-Randomization Period|Protocol Violation|2|||
162804989|NCT01160289|587994489|FG003|Post-Randomization Period|Protocol Violation|0|||
162804990|NCT01160289|587994490|FG004|Post-Randomization Period|Protocol Violation|1|||
162804991|NCT01160289|587994491|FG005|Post-Randomization Period|Protocol Violation|3|||
162804992|NCT01160289|587994486|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
162804993|NCT01160289|587994487|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
162804994|NCT01160289|587994488|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
162804995|NCT01160289|587994489|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
162804996|NCT01160289|587994490|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
162804997|NCT01160289|587994491|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
162804998|NCT01160289|587994486|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
162804999|NCT01160289|587994487|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
162805000|NCT01160289|587994488|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
162805001|NCT01160289|587994489|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
162805002|NCT01160289|587994490|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
162805003|NCT01160289|587994491|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
162805004|NCT01160289|587994486|FG000|Post-Randomization Period|Sponsor Decision|0|||
162805005|NCT01160289|587994487|FG001|Post-Randomization Period|Sponsor Decision|1|||
162805006|NCT01160289|587994488|FG002|Post-Randomization Period|Sponsor Decision|0|||
162805007|NCT01160289|587994489|FG003|Post-Randomization Period|Sponsor Decision|0|||
162805008|NCT01160289|587994490|FG004|Post-Randomization Period|Sponsor Decision|0|||
162805009|NCT01160289|587994491|FG005|Post-Randomization Period|Sponsor Decision|0|||
162805010|NCT00768079|587994496|FG000|Overall Study|Lost to Follow-up|2|||
162805011|NCT00768079|587994497|FG001|Overall Study|Lost to Follow-up|0|||
162805012|NCT00768079|587994498|FG002|Overall Study|Lost to Follow-up|4|||
162805013|NCT00768079|587994496|FG000|Overall Study|Participant incarcerated|0|||
162805014|NCT00768079|587994497|FG001|Overall Study|Participant incarcerated|1|||
162805015|NCT00768079|587994498|FG002|Overall Study|Participant incarcerated|0|||
162805016|NCT01156792|587994499|FG000|Overall Study|Adverse Event|1|||
162805017|NCT01156792|587994499|FG000|Overall Study|Lack of Efficacy|36|||
162805018|NCT01156792|587994499|FG000|Overall Study|Protocol Violation|6|||
162805019|NCT01156792|587994499|FG000|Overall Study|Lost to Follow-up|3|||
162805020|NCT01156792|587994499|FG000|Overall Study|Physician Decision|3|||
162805021|NCT01156792|587994499|FG000|Overall Study|Withdrawal by Subject|9|||
162805022|NCT01156792|587994499|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
162805023|NCT03271021|587994500|FG000|Overall Study|Adverse Event|3|||
162805024|NCT03271021|587994501|FG001|Overall Study|Adverse Event|2|||
162805025|NCT03271021|587994500|FG000|Overall Study|Withdrawal by Subject|36|||
162805026|NCT03271021|587994501|FG001|Overall Study|Withdrawal by Subject|53|||
162805027|NCT03271021|587994500|FG000|Overall Study|Lost to Follow-up|34|||
162805028|NCT03271021|587994501|FG001|Overall Study|Lost to Follow-up|39|||
162805029|NCT03271021|587994500|FG000|Overall Study|Protocol Violation|6|||
162805030|NCT03271021|587994501|FG001|Overall Study|Protocol Violation|4|||
162805031|NCT03271021|587994500|FG000|Overall Study|Abnormal Lab Results|1|||
162805032|NCT03271021|587994501|FG001|Overall Study|Abnormal Lab Results|0|||
162805033|NCT03271021|587994500|FG000|Overall Study|Miscellaneous|9|||
162805034|NCT03271021|587994501|FG001|Overall Study|Miscellaneous|8|||
162805035|NCT01474434|587994502|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
162805036|NCT01474434|587994503|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
162805037|NCT01474434|587994504|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
162805038|NCT01474434|587994505|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
162805039|NCT01474434|587994502|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162805040|NCT01474434|587994503|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162805041|NCT01474434|587994504|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162805042|NCT01474434|587994505|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
162805043|NCT01474434|587994502|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
162805044|NCT01474434|587994503|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162805045|NCT01474434|587994504|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162805046|NCT01474434|587994505|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162805047|NCT02207569|587994508|FG000|1-Month|Death|6|||
162805048|NCT02207569|587994508|FG000|1-Month|Withdrawal by Subject|2|||
162805049|NCT02207569|587994508|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
162805050|NCT02207569|587994508|FG000|6-Month|Death|8|||
162805051|NCT02207569|587994508|FG000|6-Month|Withdrawal by Subject|2|||
162805052|NCT02207569|587994508|FG000|12-Month|Death|14|||
162805053|NCT02207569|587994508|FG000|12-Month|Withdrawal by Subject|2|||
162805054|NCT02207569|587994508|FG000|24-Month|Death|23|||
162805055|NCT02207569|587994508|FG000|24-Month|Withdrawal by Subject|3|||
162805056|NCT02207569|587994508|FG000|36-Month|Death|23|||
162805057|NCT02207569|587994508|FG000|36-Month|Withdrawal by Subject|4|||
162805058|NCT02207569|587994508|FG000|48-Month|Death|25|||
162805059|NCT02207569|587994508|FG000|48-Month|Withdrawal by Subject|2|||
162805060|NCT02207569|587994508|FG000|48-Month|Lost to Follow-up|4|||
162805061|NCT02207569|587994508|FG000|60-Month|Death|1|||
162805062|NCT02207569|587994508|FG000|60-Month|Lost to Follow-up|1|||
162805063|NCT02207569|587994508|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
162805064|NCT02207569|587994508|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
162805065|NCT02585232|587994509|FG000|Overall Study|Lost to Follow-up|8|||
162805066|NCT02585232|587994510|FG001|Overall Study|Lost to Follow-up|8|||
162805067|NCT02585232|587994509|FG000|Overall Study|Withdrawal by Subject|4|||
162805068|NCT02585232|587994510|FG001|Overall Study|Withdrawal by Subject|8|||
162805069|NCT02095951|587994511|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
162805070|NCT02095951|587994512|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
162805071|NCT03618823|587994513|FG000|Overall Study|Lost to Follow-up|63|||
162805072|NCT03618823|587994514|FG001|Overall Study|Lost to Follow-up|61|||
162805073|NCT05383508|587994515|FG000|Overall Study|Withdrawal by Subject|1|||
162805074|NCT05383508|587994516|FG001|Overall Study|Withdrawal by Subject|0|||
162805075|NCT05383508|587994517|FG002|Overall Study|Withdrawal by Subject|1|||
162805076|NCT05383508|587994518|FG003|Overall Study|Withdrawal by Subject|1|||
162805077|NCT05383508|587994519|FG004|Overall Study|Withdrawal by Subject|2|||
162805078|NCT05383508|587994520|FG005|Overall Study|Withdrawal by Subject|0|||
162805079|NCT01621568|587994521|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
162805080|NCT01621568|587994522|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
162805081|NCT01621568|587994521|FG000|Week 5-6 No Treatment|Death|1|||
162805082|NCT01621568|587994522|FG001|Week 5-6 No Treatment|Death|0|||
162805083|NCT02930226|587994523|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
162805084|NCT02930226|587994524|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
162805085|NCT02930226|587994525|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
162805086|NCT02930226|587994526|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
162805087|NCT02930226|587994527|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
162805088|NCT02930226|587994528|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
162805089|NCT01506609|587994536|FG000|Overall Study|Adverse Event Related to Progression|0|||
162805090|NCT01506609|587994537|FG001|Overall Study|Adverse Event Related to Progression|0|||
162805091|NCT01506609|587994538|FG002|Overall Study|Adverse Event Related to Progression|0|||
162805092|NCT01506609|587994539|FG003|Overall Study|Adverse Event Related to Progression|3|||
162805093|NCT01506609|587994540|FG004|Overall Study|Adverse Event Related to Progression|7|||
162805094|NCT01506609|587994541|FG005|Overall Study|Adverse Event Related to Progression|3|||
162805095|NCT01506609|587994536|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
162805096|NCT01506609|587994537|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
162805097|NCT01506609|587994538|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
162805098|NCT01506609|587994539|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
162805099|NCT01506609|587994540|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
162805100|NCT01506609|587994541|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
162805101|NCT01506609|587994536|FG000|Overall Study|Withdrawal by Subject|0|||
162805102|NCT01506609|587994537|FG001|Overall Study|Withdrawal by Subject|0|||
162805103|NCT01506609|587994538|FG002|Overall Study|Withdrawal by Subject|0|||
162805104|NCT01506609|587994539|FG003|Overall Study|Withdrawal by Subject|9|||
162805105|NCT01506609|587994540|FG004|Overall Study|Withdrawal by Subject|7|||
162805106|NCT01506609|587994541|FG005|Overall Study|Withdrawal by Subject|7|||
162805107|NCT01506609|587994536|FG000|Overall Study|Lost to Follow-up|0|||
162805108|NCT01506609|587994537|FG001|Overall Study|Lost to Follow-up|0|||
162805109|NCT01506609|587994538|FG002|Overall Study|Lost to Follow-up|0|||
162805110|NCT01506609|587994539|FG003|Overall Study|Lost to Follow-up|1|||
162805111|NCT01506609|587994540|FG004|Overall Study|Lost to Follow-up|2|||
162805112|NCT01506609|587994541|FG005|Overall Study|Lost to Follow-up|0|||
162805113|NCT01506609|587994536|FG000|Overall Study|Sponsor Discontinued Study|0|||
162805114|NCT01506609|587994537|FG001|Overall Study|Sponsor Discontinued Study|0|||
162805115|NCT01506609|587994538|FG002|Overall Study|Sponsor Discontinued Study|0|||
162805116|NCT01506609|587994539|FG003|Overall Study|Sponsor Discontinued Study|2|||
162805117|NCT01506609|587994540|FG004|Overall Study|Sponsor Discontinued Study|2|||
162805118|NCT01506609|587994541|FG005|Overall Study|Sponsor Discontinued Study|0|||
162805119|NCT01506609|587994536|FG000|Overall Study|Progressive Disease per Protocol|1|||
162805120|NCT01506609|587994537|FG001|Overall Study|Progressive Disease per Protocol|0|||
162805121|NCT01506609|587994538|FG002|Overall Study|Progressive Disease per Protocol|0|||
162805122|NCT01506609|587994539|FG003|Overall Study|Progressive Disease per Protocol|64|||
162805123|NCT01506609|587994540|FG004|Overall Study|Progressive Disease per Protocol|57|||
162805124|NCT01506609|587994541|FG005|Overall Study|Progressive Disease per Protocol|74|||
162805125|NCT01506609|587994536|FG000|Overall Study|Other, Not Specified|0|||
162805126|NCT01506609|587994537|FG001|Overall Study|Other, Not Specified|0|||
162805127|NCT01506609|587994538|FG002|Overall Study|Other, Not Specified|0|||
162805128|NCT01506609|587994539|FG003|Overall Study|Other, Not Specified|10|||
162805129|NCT01506609|587994540|FG004|Overall Study|Other, Not Specified|7|||
162805130|NCT01506609|587994541|FG005|Overall Study|Other, Not Specified|3|||
162805131|NCT01506609|587994536|FG000|Overall Study|Missing / Unknown Reason|1|||
162805132|NCT01506609|587994537|FG001|Overall Study|Missing / Unknown Reason|0|||
162805133|NCT01506609|587994538|FG002|Overall Study|Missing / Unknown Reason|1|||
162805134|NCT01506609|587994539|FG003|Overall Study|Missing / Unknown Reason|4|||
162805135|NCT01506609|587994540|FG004|Overall Study|Missing / Unknown Reason|4|||
162805136|NCT01506609|587994541|FG005|Overall Study|Missing / Unknown Reason|2|||
162805137|NCT01990560|587994548|FG000|Overall Study|Withdrawal by Subject|1|||
162805138|NCT00468559|587994552|FG000|Open-label Treatment Phase|Adverse Event|5|||
162805139|NCT00468559|587994553|FG001|Open-label Treatment Phase|Adverse Event|0|||
162805140|NCT00468559|587994554|FG002|Open-label Treatment Phase|Adverse Event|0|||
162805141|NCT00468559|587994552|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
162805142|NCT00468559|587994553|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
162805143|NCT00468559|587994554|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
162805144|NCT00468559|587994552|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
162805145|NCT00468559|587994553|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
162805146|NCT00468559|587994554|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
162805147|NCT00468559|587994552|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
162805148|NCT00468559|587994553|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
162805149|NCT00468559|587994554|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
162805150|NCT00468559|587994552|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
162805151|NCT00468559|587994553|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
162805152|NCT00468559|587994554|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
162805153|NCT01153958|587994555|FG000|Overall Study|Study Terminated|36|||
162805154|NCT01153958|587994556|FG001|Overall Study|Study Terminated|32|||
162805155|NCT02432196|587994559|FG000|Overall Study|Exit - did not receive study device|1|||
162805156|NCT02432196|587994559|FG000|Overall Study|Death|2|||
162805157|NCT02432196|587994559|FG000|Overall Study|Reoperation|3|||
162805158|NCT01942785|587994563|FG000|Overall Study|Adverse Event|2|||
162805159|NCT01942785|587994563|FG000|Overall Study|Withdrawal by Subject|1|||
162805160|NCT01942785|587994563|FG000|Overall Study|Protocol Violation|1|||
162805161|NCT01905150|587994567|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
162805162|NCT01905150|587994568|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
162805163|NCT01147536|587994569|FG000|Overall Study|Administrative study close|2|||
162805164|NCT01147536|587994569|FG000|Overall Study|Death|1|||
162805165|NCT00935818|587994570|FG000|Overall Study|Withdrawal by Subject|45|||
162805166|NCT00935818|587994571|FG001|Overall Study|Withdrawal by Subject|50|||
162805167|NCT00935818|587994570|FG000|Overall Study|Lost to Follow-up|40|||
162805168|NCT00935818|587994571|FG001|Overall Study|Lost to Follow-up|42|||
162805169|NCT00935818|587994570|FG000|Overall Study|Adverse Event|6|||
162805170|NCT00935818|587994571|FG001|Overall Study|Adverse Event|7|||
162805171|NCT00935818|587994570|FG000|Overall Study|Physician Decision|0|||
162805172|NCT00935818|587994571|FG001|Overall Study|Physician Decision|1|||
162805173|NCT02631577|587994572|FG000|Overall Study|Death|1|||
162805174|NCT02631577|587994573|FG001|Overall Study|Death|7|||
162805175|NCT02631577|587994572|FG000|Overall Study|Withdrawal by Subject|0|||
162805176|NCT02631577|587994573|FG001|Overall Study|Withdrawal by Subject|3|||
162805177|NCT00604825|587994576|FG000|Overall Study|Adverse Event|2|||
162805178|NCT00604825|587994577|FG001|Overall Study|Adverse Event|6|||
162805179|NCT00604825|587994578|FG002|Overall Study|Adverse Event|7|||
162805180|NCT00604825|587994579|FG003|Overall Study|Adverse Event|4|||
162805181|NCT00604825|587994576|FG000|Overall Study|Lost to Follow-up|0|||
162805182|NCT00604825|587994577|FG001|Overall Study|Lost to Follow-up|3|||
162805183|NCT00604825|587994578|FG002|Overall Study|Lost to Follow-up|1|||
162805184|NCT00604825|587994579|FG003|Overall Study|Lost to Follow-up|0|||
162805185|NCT00604825|587994576|FG000|Overall Study|Protocol Violation|0|||
162805186|NCT00604825|587994577|FG001|Overall Study|Protocol Violation|1|||
162805187|NCT00604825|587994578|FG002|Overall Study|Protocol Violation|0|||
162805188|NCT00604825|587994579|FG003|Overall Study|Protocol Violation|0|||
162805189|NCT00604825|587994576|FG000|Overall Study|Withdrawal by Subject|4|||
162805190|NCT00604825|587994577|FG001|Overall Study|Withdrawal by Subject|3|||
162805191|NCT00604825|587994578|FG002|Overall Study|Withdrawal by Subject|5|||
162805192|NCT00604825|587994579|FG003|Overall Study|Withdrawal by Subject|5|||
162805193|NCT00604825|587994576|FG000|Overall Study|Lack of Efficacy|3|||
162805194|NCT00604825|587994577|FG001|Overall Study|Lack of Efficacy|2|||
162805195|NCT00604825|587994578|FG002|Overall Study|Lack of Efficacy|1|||
162805196|NCT00604825|587994579|FG003|Overall Study|Lack of Efficacy|0|||
162805197|NCT00604825|587994576|FG000|Overall Study|Did not meet eligibility criteria|0|||
162805198|NCT00604825|587994577|FG001|Overall Study|Did not meet eligibility criteria|0|||
162805199|NCT00604825|587994578|FG002|Overall Study|Did not meet eligibility criteria|2|||
162805200|NCT00604825|587994579|FG003|Overall Study|Did not meet eligibility criteria|0|||
162805201|NCT00604825|587994576|FG000|Overall Study|Physician Decision|0|||
162805202|NCT00604825|587994577|FG001|Overall Study|Physician Decision|0|||
162805203|NCT00604825|587994578|FG002|Overall Study|Physician Decision|0|||
162805204|NCT00604825|587994579|FG003|Overall Study|Physician Decision|1|||
162805205|NCT00604825|587994576|FG000|Overall Study|Exclusion criterion met|0|||
162805206|NCT00604825|587994577|FG001|Overall Study|Exclusion criterion met|0|||
162805207|NCT00604825|587994578|FG002|Overall Study|Exclusion criterion met|0|||
162805208|NCT00604825|587994579|FG003|Overall Study|Exclusion criterion met|1|||
162805209|NCT03465904|587994580|FG000|Overall Study|Withdrawal by Subject|9|||
162805210|NCT03465904|587994581|FG001|Overall Study|Withdrawal by Subject|5|||
162805211|NCT03465904|587994580|FG000|Overall Study|Lost to Follow-up|11|||
162805212|NCT03465904|587994581|FG001|Overall Study|Lost to Follow-up|9|||
162805213|NCT03465904|587994580|FG000|Overall Study|Protocol Violation|20|||
162805214|NCT03465904|587994581|FG001|Overall Study|Protocol Violation|15|||
162805215|NCT05593445|587994582|FG000|12-Week DBVC Period|Adverse Event|1|||
162805216|NCT05593445|587994583|FG001|12-Week DBVC Period|Adverse Event|0|||
162805217|NCT05593445|587994584|FG002|12-Week DBVC Period|Adverse Event|0|||
162805218|NCT05593445|587994585|FG003|12-Week DBVC Period|Adverse Event|0|||
162805219|NCT05593445|587994582|FG000|12-Week DBVC Period|Physician Decision|0|||
162805220|NCT05593445|587994583|FG001|12-Week DBVC Period|Physician Decision|1|||
162805221|NCT05593445|587994584|FG002|12-Week DBVC Period|Physician Decision|0|||
162805222|NCT05593445|587994585|FG003|12-Week DBVC Period|Physician Decision|0|||
162805223|NCT05593445|587994582|FG000|12-Week DBVC Period|Protocol Violation|0|||
162805224|NCT05593445|587994583|FG001|12-Week DBVC Period|Protocol Violation|1|||
162805225|NCT05593445|587994584|FG002|12-Week DBVC Period|Protocol Violation|0|||
162805226|NCT05593445|587994585|FG003|12-Week DBVC Period|Protocol Violation|0|||
162805227|NCT05593445|587994582|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
162805228|NCT05593445|587994583|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
162805229|NCT05593445|587994584|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
162805230|NCT05593445|587994585|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
162805231|NCT05593445|587994582|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
162805232|NCT05593445|587994583|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162805233|NCT05593445|587994584|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162805234|NCT05593445|587994585|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162805235|NCT05593445|587994582|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
162805236|NCT05593445|587994583|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
162805237|NCT05593445|587994584|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
162805238|NCT05593445|587994585|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
162805239|NCT05593445|587994582|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
162805240|NCT05593445|587994583|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
162805241|NCT05593445|587994584|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
162805242|NCT05593445|587994585|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
162805243|NCT05593445|587994582|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162805244|NCT05593445|587994583|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162805245|NCT05593445|587994584|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
162805246|NCT05593445|587994585|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162805247|NCT00925353|587994586|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
162805248|NCT03647488|587996537|FG000|Overall Study|Progressive disease|10|||
162805249|NCT03647488|587996538|FG001|Overall Study|Progressive disease|0|||
162805250|NCT03647488|587996539|FG002|Overall Study|Progressive disease|0|||
162805251|NCT03647488|587996537|FG000|Overall Study|Adverse Event|5|||
162805252|NCT03647488|587996538|FG001|Overall Study|Adverse Event|0|||
162805253|NCT03647488|587996539|FG002|Overall Study|Adverse Event|0|||
162805254|NCT03647488|587996537|FG000|Overall Study|Clinical progression|2|||
162805255|NCT03647488|587996538|FG001|Overall Study|Clinical progression|0|||
162805256|NCT03647488|587996539|FG002|Overall Study|Clinical progression|0|||
162805257|NCT03647488|587996537|FG000|Overall Study|Participant refused to take investigational product|1|||
162805258|NCT03647488|587996538|FG001|Overall Study|Participant refused to take investigational product|0|||
162805259|NCT03647488|587996539|FG002|Overall Study|Participant refused to take investigational product|0|||
162805260|NCT00812331|587996540|FG000|Overall Study|Adverse Event|1|||
162805261|NCT00812331|587996541|FG001|Overall Study|Adverse Event|0|||
162805262|NCT00812331|587996542|FG002|Overall Study|Adverse Event|0|||
162805263|NCT00812331|587996543|FG003|Overall Study|Adverse Event|0|||
162805264|NCT00812331|587996544|FG004|Overall Study|Adverse Event|0|||
162805265|NCT00153062|587996548|FG000|Overall Study|Death|360|||
162805266|NCT00153062|587996549|FG001|Overall Study|Death|352|||
162805267|NCT00153062|587996550|FG002|Overall Study|Death|369|||
162805268|NCT00153062|587996551|FG003|Overall Study|Death|365|||
162805269|NCT00153062|587996548|FG000|Overall Study|Withdrawal by Subject|14|||
162805270|NCT00153062|587996549|FG001|Overall Study|Withdrawal by Subject|30|||
162805271|NCT00153062|587996550|FG002|Overall Study|Withdrawal by Subject|27|||
162805272|NCT00153062|587996551|FG003|Overall Study|Withdrawal by Subject|28|||
162805273|NCT00153062|587996548|FG000|Overall Study|Lost to Follow-up|12|||
162805274|NCT00153062|587996549|FG001|Overall Study|Lost to Follow-up|20|||
162805275|NCT00153062|587996550|FG002|Overall Study|Lost to Follow-up|15|||
162805276|NCT00153062|587996551|FG003|Overall Study|Lost to Follow-up|16|||
162805277|NCT00153062|587996548|FG000|Overall Study|Adverse Event|0|||
162805278|NCT00153062|587996549|FG001|Overall Study|Adverse Event|1|||
162805279|NCT00153062|587996550|FG002|Overall Study|Adverse Event|1|||
162805280|NCT00153062|587996551|FG003|Overall Study|Adverse Event|0|||
162805281|NCT00153062|587996548|FG000|Overall Study|Protocol Violation|0|||
162805282|NCT00153062|587996549|FG001|Overall Study|Protocol Violation|2|||
162805283|NCT00153062|587996550|FG002|Overall Study|Protocol Violation|1|||
162805284|NCT00153062|587996551|FG003|Overall Study|Protocol Violation|1|||
162805285|NCT00153062|587996548|FG000|Overall Study|No disposition data available|1|||
162805286|NCT00153062|587996549|FG001|Overall Study|No disposition data available|1|||
162805287|NCT00153062|587996550|FG002|Overall Study|No disposition data available|1|||
162805288|NCT00153062|587996551|FG003|Overall Study|No disposition data available|1|||
162805289|NCT00153062|587996548|FG000|Overall Study|Other|0|||
162805290|NCT00153062|587996549|FG001|Overall Study|Other|0|||
162805291|NCT00153062|587996550|FG002|Overall Study|Other|1|||
162805292|NCT00153062|587996551|FG003|Overall Study|Other|0|||
162805293|NCT02359877|587996552|FG000|Overall Study|Withdrawal by Subject|1|||
162805294|NCT02359877|587996553|FG001|Overall Study|Withdrawal by Subject|0|||
162805295|NCT02359877|587996554|FG002|Overall Study|Withdrawal by Subject|0|||
162805296|NCT02359877|587996555|FG003|Overall Study|Withdrawal by Subject|2|||
162805297|NCT02359877|587996552|FG000|Overall Study|Adverse Event|0|||
162805298|NCT02359877|587996553|FG001|Overall Study|Adverse Event|0|||
162805299|NCT02359877|587996554|FG002|Overall Study|Adverse Event|0|||
162805300|NCT02359877|587996555|FG003|Overall Study|Adverse Event|1|||
162805301|NCT00189488|587996566|FG000|Overall Study|Ineligibility determined|1|||
162805302|NCT00189488|587996567|FG001|Overall Study|Ineligibility determined|0|||
162805303|NCT00189488|587996566|FG000|Overall Study|Protocol deviation|2|||
162805304|NCT00189488|587996567|FG001|Overall Study|Protocol deviation|1|||
162805305|NCT00189488|587996566|FG000|Overall Study|Adverse Event|2|||
162805306|NCT00189488|587996567|FG001|Overall Study|Adverse Event|1|||
162805307|NCT00189488|587996566|FG000|Overall Study|Withdrawal by Subject|2|||
162805308|NCT00189488|587996567|FG001|Overall Study|Withdrawal by Subject|6|||
162805309|NCT00189488|587996566|FG000|Overall Study|Disease progression|2|||
162805310|NCT00189488|587996567|FG001|Overall Study|Disease progression|4|||
162805311|NCT00189488|587996566|FG000|Overall Study|Administrative Decision|0|||
162805312|NCT00189488|587996567|FG001|Overall Study|Administrative Decision|2|||
162805313|NCT00189488|587996566|FG000|Overall Study|Death|5|||
162805314|NCT00189488|587996567|FG001|Overall Study|Death|8|||
162805315|NCT00189488|587996566|FG000|Overall Study|Other|1|||
162805316|NCT00189488|587996567|FG001|Overall Study|Other|0|||
162805317|NCT01143038|587996568|FG000|Overall Study|Withdrawal by Subject|4|||
162805318|NCT01143038|587996568|FG000|Overall Study|Requirement for alternative therapy|5|||
162805319|NCT01143038|587996568|FG000|Overall Study|Adverse Event|3|||
162805320|NCT01143038|587996568|FG000|Overall Study|Lost to Follow-up|2|||
162805321|NCT01143038|587996568|FG000|Overall Study|Protocol Deviation|1|||
162805322|NCT01143038|587996568|FG000|Overall Study|Death|1|||
162805323|NCT00657020|587996569|FG000|PERIOD 1|Adverse Event|0|||
162805324|NCT00657020|587996570|FG001|PERIOD 1|Adverse Event|1|||
162805325|NCT01183234|587996571|FG000|First Intervention|Adverse Event|1|||
162805326|NCT01183234|587996572|FG001|First Intervention|Adverse Event|0|||
162805327|NCT02029846|587996575|FG000|Overall Study|n=1 each arm|1|||
162805328|NCT02029846|587996576|FG001|Overall Study|n=1 each arm|1|||
162805329|NCT00370331|587996577|FG000|Overall Study|Adverse Event|4|||
162805330|NCT00370331|587996578|FG001|Overall Study|Adverse Event|13|||
162805331|NCT00370331|587996577|FG000|Overall Study|Withdrawal by Subject|2|||
162805332|NCT00370331|587996578|FG001|Overall Study|Withdrawal by Subject|4|||
162805333|NCT00370331|587996577|FG000|Overall Study|Lost to Follow-up|0|||
162805334|NCT00370331|587996578|FG001|Overall Study|Lost to Follow-up|3|||
162805335|NCT00370331|587996577|FG000|Overall Study|Lack of Efficacy|0|||
162805336|NCT00370331|587996578|FG001|Overall Study|Lack of Efficacy|1|||
162805337|NCT00370331|587996577|FG000|Overall Study|Non-compliance|0|||
162805338|NCT00370331|587996578|FG001|Overall Study|Non-compliance|1|||
162805339|NCT00370331|587996577|FG000|Overall Study|Protocol Violation|1|||
162805340|NCT00370331|587996578|FG001|Overall Study|Protocol Violation|1|||
162805341|NCT00993668|587996580|FG000|Single-Blind Period|Adverse Event|1|||
162805342|NCT00993668|587996581|FG001|Single-Blind Period|Adverse Event|1|||
162805343|NCT00993668|587996580|FG000|Single-Blind Period|Lack of Efficacy|0|||
162805344|NCT00993668|587996581|FG001|Single-Blind Period|Lack of Efficacy|1|||
162805345|NCT00993668|587996580|FG000|Single-Blind Period|Lost to Follow-up|3|||
162805346|NCT00993668|587996581|FG001|Single-Blind Period|Lost to Follow-up|1|||
162805347|NCT00993668|587996580|FG000|Open-Label Period|Adverse Event|9|||
162805348|NCT00993668|587996581|FG001|Open-Label Period|Adverse Event|8|||
162805349|NCT00993668|587996580|FG000|Open-Label Period|Lack of Efficacy|4|||
162805350|NCT00993668|587996581|FG001|Open-Label Period|Lack of Efficacy|3|||
162805351|NCT00993668|587996580|FG000|Open-Label Period|Withdrawal by Subject|4|||
162805352|NCT00993668|587996581|FG001|Open-Label Period|Withdrawal by Subject|3|||
162805353|NCT00993668|587996580|FG000|Open-Label Period|Lost to Follow-up|6|||
162805354|NCT00993668|587996581|FG001|Open-Label Period|Lost to Follow-up|1|||
162805355|NCT02313233|587996584|FG000|Overall Study|Withdrawal by Subject|1|||
162805356|NCT02313233|587996585|FG001|Overall Study|Withdrawal by Subject|2|||
162805357|NCT02313233|587996584|FG000|Overall Study|Administrative reason|1|||
162805358|NCT02313233|587996585|FG001|Overall Study|Administrative reason|1|||
162805359|NCT01859988|587996587|FG000|Overall Study|Withdrawal by Subject|6|||
162805360|NCT01859988|587996588|FG001|Overall Study|Withdrawal by Subject|3|||
162805361|NCT01859988|587996589|FG002|Overall Study|Withdrawal by Subject|4|||
162805362|NCT01859988|587996590|FG003|Overall Study|Withdrawal by Subject|3|||
162805363|NCT01859988|587996591|FG004|Overall Study|Withdrawal by Subject|2|||
162805364|NCT01859988|587996592|FG005|Overall Study|Withdrawal by Subject|2|||
162805365|NCT01859988|587996587|FG000|Overall Study|Lack of Efficacy|1|||
162805366|NCT01859988|587996588|FG001|Overall Study|Lack of Efficacy|1|||
162805367|NCT01859988|587996589|FG002|Overall Study|Lack of Efficacy|5|||
162805368|NCT01859988|587996590|FG003|Overall Study|Lack of Efficacy|0|||
162805369|NCT01859988|587996591|FG004|Overall Study|Lack of Efficacy|7|||
162805370|NCT01859988|587996592|FG005|Overall Study|Lack of Efficacy|9|||
162805371|NCT01859988|587996587|FG000|Overall Study|Physician Decision|1|||
162805372|NCT01859988|587996588|FG001|Overall Study|Physician Decision|3|||
162805373|NCT01859988|587996589|FG002|Overall Study|Physician Decision|1|||
162805374|NCT01859988|587996590|FG003|Overall Study|Physician Decision|3|||
162805375|NCT01859988|587996591|FG004|Overall Study|Physician Decision|4|||
162805376|NCT01859988|587996592|FG005|Overall Study|Physician Decision|1|||
162805377|NCT01859988|587996587|FG000|Overall Study|Adverse Event|2|||
162805378|NCT01859988|587996588|FG001|Overall Study|Adverse Event|1|||
162805379|NCT01859988|587996589|FG002|Overall Study|Adverse Event|3|||
162805380|NCT01859988|587996590|FG003|Overall Study|Adverse Event|1|||
162805381|NCT01859988|587996591|FG004|Overall Study|Adverse Event|2|||
162805382|NCT01859988|587996592|FG005|Overall Study|Adverse Event|2|||
162805383|NCT01859988|587996587|FG000|Overall Study|Lost to Follow-up|1|||
162805384|NCT01859988|587996588|FG001|Overall Study|Lost to Follow-up|2|||
162805385|NCT01859988|587996589|FG002|Overall Study|Lost to Follow-up|3|||
162805386|NCT01859988|587996590|FG003|Overall Study|Lost to Follow-up|0|||
162805387|NCT01859988|587996591|FG004|Overall Study|Lost to Follow-up|3|||
162805388|NCT01859988|587996592|FG005|Overall Study|Lost to Follow-up|2|||
162805389|NCT01859988|587996587|FG000|Overall Study|Protocol Violation|0|||
162805390|NCT01859988|587996588|FG001|Overall Study|Protocol Violation|0|||
162805391|NCT01859988|587996589|FG002|Overall Study|Protocol Violation|1|||
162805392|NCT01859988|587996590|FG003|Overall Study|Protocol Violation|0|||
162805393|NCT01859988|587996591|FG004|Overall Study|Protocol Violation|0|||
162805394|NCT01859988|587996592|FG005|Overall Study|Protocol Violation|0|||
162805395|NCT01859988|587996587|FG000|Overall Study|Other than specified above|0|||
162805396|NCT01859988|587996588|FG001|Overall Study|Other than specified above|2|||
162805397|NCT01859988|587996589|FG002|Overall Study|Other than specified above|11|||
162805398|NCT01859988|587996590|FG003|Overall Study|Other than specified above|3|||
162805399|NCT01859988|587996591|FG004|Overall Study|Other than specified above|5|||
162805400|NCT01859988|587996592|FG005|Overall Study|Other than specified above|3|||
162805401|NCT00652327|587996593|FG000|Overall Study|Adverse Event|0|||
162805402|NCT00652327|587996594|FG001|Overall Study|Adverse Event|2|||
162805403|NCT00652327|587996593|FG000|Overall Study|Lost to Follow-up|0|||
162805404|NCT00652327|587996594|FG001|Overall Study|Lost to Follow-up|3|||
162805405|NCT00564889|587996595|FG000|Overall Study|Death|7|||
162805406|NCT00564889|587996595|FG000|Overall Study|Adverse Event|12|||
162805407|NCT00564889|587996595|FG000|Overall Study|Alternative treatment|3|||
162805408|NCT00564889|587996595|FG000|Overall Study|Disease progression|3|||
162805409|NCT00564889|587996595|FG000|Overall Study|Other, not specified|4|||
162805410|NCT00635427|587996596|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162805411|NCT00635427|587996597|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162805412|NCT00635427|587996598|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
162805413|NCT00635427|587996599|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162805414|NCT00635427|587996600|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162805415|NCT00635427|587996596|FG000|Overall Study|Death|0|||
162805416|NCT00635427|587996597|FG001|Overall Study|Death|0|||
162805417|NCT00635427|587996598|FG002|Overall Study|Death|0|||
162805418|NCT00635427|587996599|FG003|Overall Study|Death|1|||
162805419|NCT00635427|587996600|FG004|Overall Study|Death|0|||
162805420|NCT00635427|587996596|FG000|Overall Study|Termination Of Study By Sponsor|12|||
162805421|NCT00635427|587996597|FG001|Overall Study|Termination Of Study By Sponsor|6|||
162805422|NCT00635427|587996598|FG002|Overall Study|Termination Of Study By Sponsor|10|||
162805423|NCT00635427|587996599|FG003|Overall Study|Termination Of Study By Sponsor|6|||
162805424|NCT00635427|587996600|FG004|Overall Study|Termination Of Study By Sponsor|6|||
162805425|NCT00635427|587996596|FG000|Overall Study|Withdrawal Of Consent|0|||
162805426|NCT00635427|587996597|FG001|Overall Study|Withdrawal Of Consent|0|||
162805427|NCT00635427|587996598|FG002|Overall Study|Withdrawal Of Consent|0|||
162805428|NCT00635427|587996599|FG003|Overall Study|Withdrawal Of Consent|2|||
162805429|NCT00635427|587996600|FG004|Overall Study|Withdrawal Of Consent|2|||
162805430|NCT02224690|587996603|FG000|Overall Study|Adverse Event|8|||
162805431|NCT02224690|587996604|FG001|Overall Study|Adverse Event|1|||
162805432|NCT02224690|587996603|FG000|Overall Study|Met Withdrawal Criteria|4|||
162805433|NCT02224690|587996604|FG001|Overall Study|Met Withdrawal Criteria|0|||
162805434|NCT02224690|587996603|FG000|Overall Study|Use of G-tube|1|||
162805435|NCT02224690|587996604|FG001|Overall Study|Use of G-tube|0|||
162805436|NCT02224690|587996603|FG000|Overall Study|Did not meet eligibility criteria|1|||
162805437|NCT02224690|587996604|FG001|Overall Study|Did not meet eligibility criteria|0|||
162805438|NCT05753670|587996605|FG000|Overall Study|Withdrawal by Subject|6|||
162805439|NCT05753670|587996606|FG001|Overall Study|Withdrawal by Subject|8|||
162805440|NCT05753670|587996605|FG000|Overall Study|Protocol Violation|3|||
162805441|NCT05753670|587996606|FG001|Overall Study|Protocol Violation|1|||
162805442|NCT00577473|587996609|FG000|Overall Study|Protocol Violation|1|||
162805443|NCT00577473|587996610|FG001|Overall Study|Protocol Violation|4|||
162805444|NCT00577473|587996609|FG000|Overall Study|Adverse Event|8|||
162805445|NCT00577473|587996610|FG001|Overall Study|Adverse Event|5|||
162805446|NCT00577473|587996609|FG000|Overall Study|Withdrawal by Subject|2|||
162805447|NCT00577473|587996610|FG001|Overall Study|Withdrawal by Subject|6|||
162805448|NCT00577473|587996609|FG000|Overall Study|Physician Decision|2|||
162805449|NCT00577473|587996610|FG001|Overall Study|Physician Decision|2|||
162805450|NCT00577473|587996609|FG000|Overall Study|Lack of Efficacy|8|||
162805451|NCT00577473|587996610|FG001|Overall Study|Lack of Efficacy|7|||
162805452|NCT02595073|587996611|FG000|Overall Study|Progressive Disease|0|||
162805453|NCT02595073|587996612|FG001|Overall Study|Progressive Disease|1|||
162805454|NCT02595073|587996611|FG000|Overall Study|Protocol Violation|2|||
162805455|NCT02595073|587996612|FG001|Overall Study|Protocol Violation|0|||
162805456|NCT02884908|587996618|FG000|Overall Study|Lost to Follow-up|13|||
162805457|NCT02884908|587996619|FG001|Overall Study|Lost to Follow-up|18|||
162805458|NCT01324440|587996620|FG000|Overall Study|Subject moved|0|||
162805459|NCT01324440|587996621|FG001|Overall Study|Subject moved|1|||
162805460|NCT02325557|587996625|FG000|Overall Study|Progressive disease|1|||
162805461|NCT02325557|587996626|FG001|Overall Study|Progressive disease|0|||
162805462|NCT02325557|587996627|FG002|Overall Study|Progressive disease|0|||
162805463|NCT02325557|587996628|FG003|Overall Study|Progressive disease|0|||
162805464|NCT02325557|587996625|FG000|Overall Study|Withdrawal by Subject|4|||
162805465|NCT02325557|587996626|FG001|Overall Study|Withdrawal by Subject|0|||
162805466|NCT02325557|587996627|FG002|Overall Study|Withdrawal by Subject|0|||
162805467|NCT02325557|587996628|FG003|Overall Study|Withdrawal by Subject|15|||
162805468|NCT02325557|587996625|FG000|Overall Study|Death|5|||
162805469|NCT02325557|587996626|FG001|Overall Study|Death|1|||
162805470|NCT02325557|587996627|FG002|Overall Study|Death|1|||
162805471|NCT02325557|587996628|FG003|Overall Study|Death|16|||
162805472|NCT02325557|587996625|FG000|Overall Study|Lost to Follow-up|0|||
162805473|NCT02325557|587996626|FG001|Overall Study|Lost to Follow-up|0|||
162805474|NCT02325557|587996627|FG002|Overall Study|Lost to Follow-up|1|||
162805475|NCT02325557|587996628|FG003|Overall Study|Lost to Follow-up|1|||
162805476|NCT02325557|587996625|FG000|Overall Study|Other|0|||
162805477|NCT02325557|587996626|FG001|Overall Study|Other|0|||
162805478|NCT02325557|587996627|FG002|Overall Study|Other|0|||
162805479|NCT02325557|587996628|FG003|Overall Study|Other|5|||
162805480|NCT01293487|587996629|FG000|Overall Study|Lost to Follow-up|0|||
162805481|NCT01293487|587996630|FG001|Overall Study|Lost to Follow-up|0|||
162805482|NCT01293487|587996631|FG002|Overall Study|Lost to Follow-up|0|||
162805483|NCT01293487|587996632|FG003|Overall Study|Lost to Follow-up|1|||
162805484|NCT01293487|587996633|FG004|Overall Study|Lost to Follow-up|0|||
162805485|NCT01293487|587996634|FG005|Overall Study|Lost to Follow-up|0|||
162805486|NCT01293487|587996635|FG006|Overall Study|Lost to Follow-up|0|||
162805487|NCT01293487|587996636|FG007|Overall Study|Lost to Follow-up|0|||
162805488|NCT01293487|587996629|FG000|Overall Study|Withdrawal by Subject|0|||
162805489|NCT01293487|587996630|FG001|Overall Study|Withdrawal by Subject|0|||
162805490|NCT01293487|587996631|FG002|Overall Study|Withdrawal by Subject|0|||
162805491|NCT01293487|587996632|FG003|Overall Study|Withdrawal by Subject|0|||
162805492|NCT01293487|587996633|FG004|Overall Study|Withdrawal by Subject|0|||
162805493|NCT01293487|587996634|FG005|Overall Study|Withdrawal by Subject|0|||
162805494|NCT01293487|587996635|FG006|Overall Study|Withdrawal by Subject|0|||
162805495|NCT01293487|587996636|FG007|Overall Study|Withdrawal by Subject|2|||
162805496|NCT04860297|587996637|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
162805497|NCT04860297|587996638|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
162805498|NCT04860297|587996639|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
162805499|NCT04860297|587996640|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
162805500|NCT04860297|587996641|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
162805501|NCT04860297|587996642|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
162805502|NCT04860297|587996643|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
162805503|NCT04860297|587996644|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
162805504|NCT04860297|587996637|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
162805505|NCT04860297|587996638|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
162805506|NCT04860297|587996639|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
162805507|NCT04860297|587996640|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
162805508|NCT04860297|587996641|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
162805509|NCT04860297|587996642|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
162805510|NCT04860297|587996643|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
162805511|NCT04860297|587996644|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
162805512|NCT04860297|587996637|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
162805513|NCT04860297|587996638|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
162805514|NCT04860297|587996639|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
162805515|NCT04860297|587996640|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
162805516|NCT04860297|587996641|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
162805517|NCT04860297|587996642|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
162805518|NCT04860297|587996643|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
162805519|NCT04860297|587996644|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
162805520|NCT04860297|587996637|FG000|Part B (Booster Dose)|Other Than Specified|0|||
162805521|NCT04860297|587996638|FG001|Part B (Booster Dose)|Other Than Specified|0|||
162805522|NCT04860297|587996639|FG002|Part B (Booster Dose)|Other Than Specified|0|||
162805523|NCT04860297|587996640|FG003|Part B (Booster Dose)|Other Than Specified|0|||
162805524|NCT04860297|587996641|FG004|Part B (Booster Dose)|Other Than Specified|0|||
162805525|NCT04860297|587996642|FG005|Part B (Booster Dose)|Other Than Specified|1|||
162805526|NCT04860297|587996643|FG006|Part B (Booster Dose)|Other Than Specified|1|||
162805527|NCT04860297|587996644|FG007|Part B (Booster Dose)|Other Than Specified|0|||
162805528|NCT04860297|587996637|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805529|NCT04860297|587996638|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805530|NCT04860297|587996639|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805531|NCT04860297|587996640|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805532|NCT04860297|587996641|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805533|NCT04860297|587996642|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
162805534|NCT04860297|587996643|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
162805535|NCT04860297|587996644|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
162805536|NCT04860297|587996637|FG000|Part B (Booster Dose)|Death|0|||
162805537|NCT04860297|587996638|FG001|Part B (Booster Dose)|Death|0|||
162805538|NCT04860297|587996639|FG002|Part B (Booster Dose)|Death|0|||
162805539|NCT04860297|587996640|FG003|Part B (Booster Dose)|Death|0|||
162805540|NCT04860297|587996641|FG004|Part B (Booster Dose)|Death|1|||
162805541|NCT04860297|587996642|FG005|Part B (Booster Dose)|Death|2|||
162805542|NCT04860297|587996643|FG006|Part B (Booster Dose)|Death|1|||
162805543|NCT04860297|587996644|FG007|Part B (Booster Dose)|Death|0|||
162805544|NCT04860297|587996637|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
162805545|NCT04860297|587996638|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
162805546|NCT04860297|587996639|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
162805547|NCT04860297|587996640|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
162805548|NCT04860297|587996641|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
162805549|NCT04860297|587996642|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
162805550|NCT04860297|587996643|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
162805551|NCT04860297|587996644|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
162805552|NCT00862719|587996645|FG000|Overall Study|Disease Progression|5|||
162805553|NCT00862719|587996646|FG001|Overall Study|Disease Progression|0|||
162805554|NCT00862719|587996647|FG002|Overall Study|Disease Progression|1|||
162805555|NCT00862719|587996648|FG003|Overall Study|Disease Progression|0|||
162805556|NCT00862719|587996645|FG000|Overall Study|Death|5|||
162805557|NCT00862719|587996646|FG001|Overall Study|Death|6|||
162805558|NCT00862719|587996647|FG002|Overall Study|Death|1|||
162805559|NCT00862719|587996648|FG003|Overall Study|Death|1|||
162805560|NCT00862719|587996645|FG000|Overall Study|Engraftment failure|0|||
162805561|NCT00862719|587996646|FG001|Overall Study|Engraftment failure|0|||
162805562|NCT00862719|587996647|FG002|Overall Study|Engraftment failure|1|||
162805563|NCT00862719|587996648|FG003|Overall Study|Engraftment failure|0|||
162805564|NCT00862719|587996645|FG000|Overall Study|Veno-Occlusive Disease|0|||
162805565|NCT00862719|587996646|FG001|Overall Study|Veno-Occlusive Disease|0|||
162805566|NCT00862719|587996647|FG002|Overall Study|Veno-Occlusive Disease|1|||
162805567|NCT00862719|587996648|FG003|Overall Study|Veno-Occlusive Disease|0|||
162805568|NCT02703259|587996649|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
162805569|NCT02703259|587996650|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
162805570|NCT02703259|587996649|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
162805571|NCT02703259|587996650|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
162805572|NCT02703259|587996649|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
162805573|NCT02703259|587996650|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
162805574|NCT01993927|587996652|FG000|Overall Study|Case Report Forms Uncollected|18|||
162805575|NCT01993927|587996652|FG000|Overall Study|Protocol Violation|11|||
162805576|NCT00895154|587996653|FG000|Overall Study|Lost to Follow-up|1|||
162805577|NCT00895154|587996654|FG001|Overall Study|Lost to Follow-up|1|||
162805578|NCT00895154|587996653|FG000|Overall Study|Withdrawal by Subject|0|||
162805579|NCT00895154|587996654|FG001|Overall Study|Withdrawal by Subject|1|||
162805580|NCT02414932|587996655|FG000|Overall Study|Withdrawal by Subject|2|||
162805581|NCT02414932|587996656|FG001|Overall Study|Withdrawal by Subject|3|||
162805582|NCT02414932|587996655|FG000|Overall Study|Adverse Event|1|||
162805583|NCT02414932|587996656|FG001|Overall Study|Adverse Event|0|||
162805584|NCT00470366|587996657|FG000|Overall Study|Adverse Event|3|||
162805585|NCT00470366|587996657|FG000|Overall Study|Poor compliance|1|||
162805586|NCT00540046|587996658|FG000|Overall Study|Lost to Follow-up|33|||
162805587|NCT00540046|587996659|FG001|Overall Study|Lost to Follow-up|23|||
162805588|NCT01021215|587996667|FG000|Overall Study|Lost to Follow-up|3|||
162805589|NCT01021215|587996668|FG001|Overall Study|Lost to Follow-up|0|||
162805590|NCT00185965|587996671|FG000|Overall Study|Adverse Event|0|||
162805591|NCT00185965|587996672|FG001|Overall Study|Adverse Event|1|||
162805592|NCT02533531|587996673|FG000|Overall Study|Device did not turn on|1|||
162805593|NCT01103362|587996674|FG000|Overall Study|study terminated|596|||
162805594|NCT03814187|587996675|FG000|Overall Study|Sponsor's Administrative Decision|0|||
162805595|NCT03814187|587996676|FG001|Overall Study|Sponsor's Administrative Decision|0|||
162805596|NCT03814187|587996677|FG002|Overall Study|Sponsor's Administrative Decision|272|||
162805597|NCT03814187|587996675|FG000|Overall Study|Death|80|||
162805598|NCT03814187|587996676|FG001|Overall Study|Death|81|||
162805599|NCT03814187|587996677|FG002|Overall Study|Death|4|||
162805600|NCT03814187|587996675|FG000|Overall Study|Withdrew Consent|77|||
162805601|NCT03814187|587996676|FG001|Overall Study|Withdrew Consent|78|||
162805602|NCT03814187|587996677|FG002|Overall Study|Withdrew Consent|2|||
162805603|NCT03814187|587996675|FG000|Overall Study|Lost to Follow-up|47|||
162805604|NCT03814187|587996676|FG001|Overall Study|Lost to Follow-up|52|||
162805605|NCT03814187|587996677|FG002|Overall Study|Lost to Follow-up|1|||
162805606|NCT03814187|587996675|FG000|Overall Study|Adverse Event|22|||
162805607|NCT03814187|587996676|FG001|Overall Study|Adverse Event|23|||
162805608|NCT03814187|587996677|FG002|Overall Study|Adverse Event|0|||
162805609|NCT03814187|587996675|FG000|Overall Study|Physician Decision|7|||
162805610|NCT03814187|587996676|FG001|Overall Study|Physician Decision|4|||
162805611|NCT03814187|587996677|FG002|Overall Study|Physician Decision|2|||
162805612|NCT03814187|587996675|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
162805613|NCT03814187|587996676|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
162805614|NCT03814187|587996677|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
162805615|NCT03814187|587996675|FG000|Overall Study|Other reasons|34|||
162805616|NCT03814187|587996676|FG001|Overall Study|Other reasons|40|||
162805617|NCT03814187|587996677|FG002|Overall Study|Other reasons|2|||
162805618|NCT01014533|587996678|FG000|Overall Study|Protocol Violation|3|||
162805619|NCT01014533|587996679|FG001|Overall Study|Protocol Violation|2|||
162805620|NCT01014533|587996678|FG000|Overall Study|Withdrawal by Subject|2|||
162805621|NCT01014533|587996679|FG001|Overall Study|Withdrawal by Subject|0|||
162805622|NCT01014533|587996678|FG000|Overall Study|unable to come to appointment|0|||
162805623|NCT01014533|587996679|FG001|Overall Study|unable to come to appointment|3|||
162805624|NCT00513604|587996680|FG000|Overall Study|Not treated|2|||
162805625|NCT00513604|587996681|FG001|Overall Study|Not treated|0|||
162805626|NCT00513604|587996682|FG002|Overall Study|Not treated|1|||
162805627|NCT00513604|587996683|FG003|Overall Study|Not treated|0|||
162805628|NCT00513604|587996684|FG004|Overall Study|Not treated|0|||
162805629|NCT00513604|587996680|FG000|Overall Study|Death during treatment|0|||
162805630|NCT00513604|587996681|FG001|Overall Study|Death during treatment|3|||
162805631|NCT00513604|587996682|FG002|Overall Study|Death during treatment|2|||
162805632|NCT00513604|587996683|FG003|Overall Study|Death during treatment|0|||
162805633|NCT00513604|587996684|FG004|Overall Study|Death during treatment|0|||
162805634|NCT00412061|587996686|FG000|Double Blind Phase|Disease Progression|101|||
162805635|NCT00412061|587996687|FG001|Double Blind Phase|Disease Progression|154|||
162805636|NCT00412061|587996686|FG000|Double Blind Phase|Adverse Event|61|||
162805637|NCT00412061|587996687|FG001|Double Blind Phase|Adverse Event|16|||
162805638|NCT00412061|587996686|FG000|Double Blind Phase|Final Primary Analysis|26|||
162805639|NCT00412061|587996687|FG001|Double Blind Phase|Final Primary Analysis|14|||
162805640|NCT00412061|587996686|FG000|Double Blind Phase|Withdrawal by Subject|18|||
162805641|NCT00412061|587996687|FG001|Double Blind Phase|Withdrawal by Subject|20|||
162805642|NCT00412061|587996686|FG000|Double Blind Phase|Death|6|||
162805643|NCT00412061|587996687|FG001|Double Blind Phase|Death|3|||
162805644|NCT00412061|587996686|FG000|Double Blind Phase|Protocol Violation|3|||
162805645|NCT00412061|587996687|FG001|Double Blind Phase|Protocol Violation|4|||
162805646|NCT00412061|587996686|FG000|Double Blind Phase|New Cander Therapy|1|||
162805647|NCT00412061|587996687|FG001|Double Blind Phase|New Cander Therapy|1|||
162805648|NCT00412061|587996686|FG000|Double Blind Phase|Lost to Follow-up|0|||
162805649|NCT00412061|587996687|FG001|Double Blind Phase|Lost to Follow-up|1|||
162805650|NCT00412061|587996686|FG000|Open Label Phase|Disease Progression|0|||
162805651|NCT00412061|587996687|FG001|Open Label Phase|Disease Progression|86|||
162805652|NCT00412061|587996686|FG000|Open Label Phase|Adverse Event|0|||
162805653|NCT00412061|587996687|FG001|Open Label Phase|Adverse Event|46|||
162805654|NCT00412061|587996686|FG000|Open Label Phase|Withdrawal by Subject|0|||
162805655|NCT00412061|587996687|FG001|Open Label Phase|Withdrawal by Subject|15|||
162805656|NCT00412061|587996686|FG000|Open Label Phase|Administrative Problems|0|||
162805657|NCT00412061|587996687|FG001|Open Label Phase|Administrative Problems|13|||
162805658|NCT00412061|587996686|FG000|Open Label Phase|Death|0|||
162805659|NCT00412061|587996687|FG001|Open Label Phase|Death|7|||
162805660|NCT00412061|587996686|FG000|Open Label Phase|Lost to Follow-up|0|||
162805661|NCT00412061|587996687|FG001|Open Label Phase|Lost to Follow-up|2|||
162805662|NCT00412061|587996686|FG000|Open Label Phase|New Cancer Therapy|0|||
162805663|NCT00412061|587996687|FG001|Open Label Phase|New Cancer Therapy|1|||
162805664|NCT02689518|587996688|FG000|Overall Study|Withdrawal by Subject|3|||
162805665|NCT01688830|587996693|FG000|Overall Study|Lost to Follow-up|0|||
162805666|NCT01688830|587996694|FG001|Overall Study|Lost to Follow-up|0|||
162805667|NCT01688830|587996695|FG002|Overall Study|Lost to Follow-up|0|||
162805668|NCT01688830|587996696|FG003|Overall Study|Lost to Follow-up|0|||
162805669|NCT01688830|587996697|FG004|Overall Study|Lost to Follow-up|0|||
162805670|NCT01688830|587996698|FG005|Overall Study|Lost to Follow-up|0|||
162805671|NCT01688830|587996699|FG006|Overall Study|Lost to Follow-up|0|||
162805672|NCT01688830|587996700|FG007|Overall Study|Lost to Follow-up|0|||
162805673|NCT01688830|587996701|FG008|Overall Study|Lost to Follow-up|0|||
162805674|NCT01688830|587996702|FG009|Overall Study|Lost to Follow-up|0|||
162805675|NCT01688830|587996703|FG010|Overall Study|Lost to Follow-up|1|||
162805676|NCT01688830|587996704|FG011|Overall Study|Lost to Follow-up|0|||
162805677|NCT01688830|587996705|FG012|Overall Study|Lost to Follow-up|0|||
162805678|NCT01688830|587996706|FG013|Overall Study|Lost to Follow-up|0|||
162805679|NCT01688830|587996707|FG014|Overall Study|Lost to Follow-up|0|||
162805680|NCT01688830|587996708|FG015|Overall Study|Lost to Follow-up|0|||
162805681|NCT01688830|587996709|FG016|Overall Study|Lost to Follow-up|0|||
162805682|NCT01688830|587996710|FG017|Overall Study|Lost to Follow-up|0|||
162805683|NCT01688830|587996711|FG018|Overall Study|Lost to Follow-up|0|||
162805684|NCT01688830|587996712|FG019|Overall Study|Lost to Follow-up|0|||
162805685|NCT01688830|587996713|FG020|Overall Study|Lost to Follow-up|0|||
162805686|NCT04822597|587996714|FG000|Overall Study|Withdrawal by Subject|0|||
162805687|NCT04822597|587996715|FG001|Overall Study|Withdrawal by Subject|1|||
162805688|NCT04822597|587996716|FG002|Overall Study|Withdrawal by Subject|1|||
162805689|NCT04822597|587996717|FG003|Overall Study|Withdrawal by Subject|0|||
162805690|NCT04822597|587996714|FG000|Overall Study|Physician Decision|0|||
162805691|NCT04822597|587996715|FG001|Overall Study|Physician Decision|0|||
162805692|NCT04822597|587996716|FG002|Overall Study|Physician Decision|1|||
162805693|NCT04822597|587996717|FG003|Overall Study|Physician Decision|1|||
162805694|NCT04822597|587996714|FG000|Overall Study|Subject withdrawn after enrollment|0|||
162805695|NCT04822597|587996715|FG001|Overall Study|Subject withdrawn after enrollment|1|||
162805696|NCT04822597|587996716|FG002|Overall Study|Subject withdrawn after enrollment|0|||
162805697|NCT04822597|587996717|FG003|Overall Study|Subject withdrawn after enrollment|1|||
162805698|NCT04822597|587996714|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
162805699|NCT04822597|587996715|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162805700|NCT04822597|587996716|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162805701|NCT04822597|587996717|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162805702|NCT02859324|587996718|FG000|Overall Study|Death|4|||
162805703|NCT02859324|587996719|FG001|Overall Study|Death|6|||
162805704|NCT02859324|587996720|FG002|Overall Study|Death|5|||
162805705|NCT02859324|587996718|FG000|Overall Study|Other reasons|3|||
162805706|NCT02859324|587996719|FG001|Overall Study|Other reasons|3|||
162805707|NCT02859324|587996720|FG002|Overall Study|Other reasons|0|||
162805708|NCT02665338|587996722|FG000|Overall Study|Withdrawal by Subject|0|||
162805709|NCT02665338|587996723|FG001|Overall Study|Withdrawal by Subject|1|||
162805710|NCT00998335|587996724|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
162805711|NCT00998335|587996725|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
162805712|NCT01305200|587996726|FG000|Overall Study|Physician Decision|4|||
162805713|NCT01305200|587996727|FG001|Overall Study|Physician Decision|6|||
162805714|NCT01305200|587996728|FG002|Overall Study|Physician Decision|1|||
162805715|NCT01305200|587996726|FG000|Overall Study|Withdrawal by Subject|24|||
162805716|NCT01305200|587996727|FG001|Overall Study|Withdrawal by Subject|21|||
162805717|NCT01305200|587996728|FG002|Overall Study|Withdrawal by Subject|1|||
162805718|NCT01305200|587996726|FG000|Overall Study|Ineligible|1|||
162805719|NCT01305200|587996727|FG001|Overall Study|Ineligible|2|||
162805720|NCT01305200|587996728|FG002|Overall Study|Ineligible|1|||
162805721|NCT01305200|587996726|FG000|Overall Study|Death|0|||
162805722|NCT01305200|587996727|FG001|Overall Study|Death|2|||
162805723|NCT01305200|587996728|FG002|Overall Study|Death|0|||
162805724|NCT05559476|587996729|FG000|Overall Study|Adverse Event|2|||
162805725|NCT05559476|587996730|FG001|Overall Study|Adverse Event|0|||
162805726|NCT05559476|587996729|FG000|Overall Study|Lost to Follow-up|13|||
162805727|NCT05559476|587996730|FG001|Overall Study|Lost to Follow-up|12|||
162805728|NCT05559476|587996729|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
162805729|NCT05559476|587996730|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
162805730|NCT05559476|587996729|FG000|Overall Study|Other|0|||
162805731|NCT05559476|587996730|FG001|Overall Study|Other|2|||
162805732|NCT05110690|587996731|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
162805733|NCT05110690|587996731|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
162805734|NCT05110690|587996731|FG000|Completion of Intervention|Lost to Follow-up|1|||
162805735|NCT05110690|587996731|FG000|Completion of Intervention|Death|1|||
162805736|NCT05110690|587996731|FG000|Completion of Intervention|Withdrawal by Subject|2|||
162805737|NCT02502799|587999311|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162805738|NCT02502799|587999312|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162805739|NCT02502799|587999313|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162805740|NCT02502799|587999314|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
162805741|NCT02502799|587999311|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162805742|NCT02502799|587999312|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162805743|NCT02502799|587999313|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162805744|NCT02502799|587999314|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
162805745|NCT02502799|587999311|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
162805746|NCT02502799|587999312|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
162805747|NCT02502799|587999313|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
162805748|NCT02502799|587999314|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
162805749|NCT02502799|587999311|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
162805750|NCT02502799|587999312|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
162805751|NCT02502799|587999313|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
162805752|NCT02502799|587999314|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
162805753|NCT02502799|587999311|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
162805754|NCT02502799|587999312|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
162805755|NCT02502799|587999313|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
162805756|NCT02502799|587999314|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
162805757|NCT01589237|587999323|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
162805758|NCT01589237|587999324|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
162805759|NCT01589237|587999325|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
162805760|NCT01589237|587999326|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
162805761|NCT01589237|587999323|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162805762|NCT01589237|587999324|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
162805763|NCT01589237|587999325|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162805764|NCT01589237|587999326|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162805765|NCT01589237|587999323|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
162805766|NCT01589237|587999324|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
162805767|NCT01589237|587999325|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
162805768|NCT01589237|587999326|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
162805769|NCT01589237|587999323|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162805770|NCT01589237|587999324|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162805771|NCT01589237|587999325|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162805772|NCT01589237|587999326|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
162805773|NCT00117845|587999327|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
162805774|NCT02349425|587999328|FG000|Period 1|Adverse Event|1|||
162805775|NCT02349425|587999329|FG001|Period 1|Adverse Event|1|||
162805776|NCT02349425|587999330|FG002|Period 1|Adverse Event|0|||
162805777|NCT02349425|587999331|FG003|Period 1|Adverse Event|0|||
162805778|NCT02349425|587999328|FG000|Period 2|Adverse Event|0|||
162805779|NCT02349425|587999329|FG001|Period 2|Adverse Event|1|||
162805780|NCT02349425|587999330|FG002|Period 2|Adverse Event|1|||
162805781|NCT02349425|587999331|FG003|Period 2|Adverse Event|0|||
162805782|NCT03207009|587999332|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
162805783|NCT01190514|587999333|FG000|First Intervention (Period 1)|Adverse Event|1|||
162805784|NCT01190514|587999334|FG001|First Intervention (Period 1)|Adverse Event|0|||
162805785|NCT01190514|587999335|FG002|First Intervention (Period 1)|Adverse Event|0|||
162805786|NCT01190514|587999336|FG003|First Intervention (Period 1)|Adverse Event|0|||
162805787|NCT01190514|587999333|FG000|Third Intervention (Period 3)|Adverse Event|1|||
162805788|NCT01190514|587999334|FG001|Third Intervention (Period 3)|Adverse Event|0|||
162805789|NCT01190514|587999335|FG002|Third Intervention (Period 3)|Adverse Event|0|||
162805790|NCT01190514|587999336|FG003|Third Intervention (Period 3)|Adverse Event|0|||
162805791|NCT00512317|587999337|FG000|Overall Study|Insufficient clinical response|36|||
162805792|NCT00512317|587999337|FG000|Overall Study|Withdrawal by Subject|23|||
162805793|NCT00512317|587999337|FG000|Overall Study|Sponsor closure of study|21|||
162805794|NCT00512317|587999337|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
162805795|NCT00512317|587999337|FG000|Overall Study|Adverse Event|13|||
162805796|NCT00512317|587999337|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
162805797|NCT00512317|587999337|FG000|Overall Study|Lost to Follow-up|2|||
162805798|NCT00512317|587999337|FG000|Overall Study|Other|2|||
162805799|NCT01491672|587999338|FG000|Overall Study|Lost to Follow-up|0|||
162805800|NCT01491672|587999339|FG001|Overall Study|Lost to Follow-up|4|||
162805801|NCT01491672|587999340|FG002|Overall Study|Lost to Follow-up|1|||
162805802|NCT01491672|587999338|FG000|Overall Study|Withdrawal by Subject|6|||
162805803|NCT01491672|587999339|FG001|Overall Study|Withdrawal by Subject|7|||
162805804|NCT01491672|587999340|FG002|Overall Study|Withdrawal by Subject|0|||
162805805|NCT01491672|587999338|FG000|Overall Study|Adverse Event|8|||
162805806|NCT01491672|587999339|FG001|Overall Study|Adverse Event|10|||
162805807|NCT01491672|587999340|FG002|Overall Study|Adverse Event|4|||
162805808|NCT01491672|587999338|FG000|Overall Study|Disease progression|42|||
162805809|NCT01491672|587999339|FG001|Overall Study|Disease progression|34|||
162805810|NCT01491672|587999340|FG002|Overall Study|Disease progression|6|||
162805811|NCT01491672|587999338|FG000|Overall Study|Protocol deviation|0|||
162805812|NCT01491672|587999339|FG001|Overall Study|Protocol deviation|1|||
162805813|NCT01491672|587999340|FG002|Overall Study|Protocol deviation|0|||
162805814|NCT01491672|587999338|FG000|Overall Study|Death|0|||
162805815|NCT01491672|587999339|FG001|Overall Study|Death|4|||
162805816|NCT01491672|587999340|FG002|Overall Study|Death|0|||
162805817|NCT00706433|587999346|FG000|Overall Study|Lost to Follow-up|3|||
162805818|NCT00706433|587999347|FG001|Overall Study|Lost to Follow-up|1|||
162805819|NCT00706433|587999348|FG002|Overall Study|Lost to Follow-up|6|||
162805820|NCT00706433|587999349|FG003|Overall Study|Lost to Follow-up|0|||
162805821|NCT00706433|587999346|FG000|Overall Study|Withdrawal by Subject|1|||
162805822|NCT00706433|587999347|FG001|Overall Study|Withdrawal by Subject|2|||
162805823|NCT00706433|587999348|FG002|Overall Study|Withdrawal by Subject|3|||
162805824|NCT00706433|587999349|FG003|Overall Study|Withdrawal by Subject|1|||
162805825|NCT00706433|587999346|FG000|Overall Study|Adverse Event|0|||
162805826|NCT00706433|587999347|FG001|Overall Study|Adverse Event|0|||
162805827|NCT00706433|587999348|FG002|Overall Study|Adverse Event|1|||
162805828|NCT00706433|587999349|FG003|Overall Study|Adverse Event|0|||
162805829|NCT00706433|587999346|FG000|Overall Study|Protocol Violation|1|||
162805830|NCT00706433|587999347|FG001|Overall Study|Protocol Violation|0|||
162805831|NCT00706433|587999348|FG002|Overall Study|Protocol Violation|0|||
162805832|NCT00706433|587999349|FG003|Overall Study|Protocol Violation|0|||
162805833|NCT00706433|587999346|FG000|Overall Study|new job|0|||
162805834|NCT00706433|587999347|FG001|Overall Study|new job|0|||
162805835|NCT00706433|587999348|FG002|Overall Study|new job|0|||
162805836|NCT00706433|587999349|FG003|Overall Study|new job|1|||
162805837|NCT04101318|587999351|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
162805838|NCT04101318|587999352|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
162805839|NCT04101318|587999351|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
162805840|NCT04101318|587999352|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
162805841|NCT04101318|587999351|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
162805842|NCT04101318|587999352|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
162805843|NCT00717067|587999353|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162805844|NCT00717067|587999354|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162805845|NCT00717067|587999355|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
162805846|NCT00717067|587999356|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162805847|NCT00717067|587999357|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162805848|NCT02090959|587999358|FG000|Overall Study|Withdrawal by Subject|10|||
162805849|NCT02090959|587999358|FG000|Overall Study|Adverse Event|1|||
162805850|NCT02090959|587999358|FG000|Overall Study|Investigator decision|2|||
162805851|NCT02090959|587999358|FG000|Overall Study|Study termination|6|||
162805852|NCT02090959|587999358|FG000|Overall Study|Enrolled but not treated|1|||
162805853|NCT02090959|587999358|FG000|Overall Study|Transfer for compassionate use medicine|4|||
162805854|NCT02090959|587999358|FG000|Overall Study|Move to medical need program|3|||
162805855|NCT02090959|587999358|FG000|Overall Study|Entered in to other study|34|||
162805856|NCT02090959|587999358|FG000|Overall Study|Switched to commercial supply|88|||
162805857|NCT02090959|587999358|FG000|Overall Study|Other than specified|2|||
162805858|NCT00522873|587999359|FG000|Overall Study|Adverse Event|41|||
162805859|NCT00522873|587999360|FG001|Overall Study|Adverse Event|26|||
162805860|NCT00522873|587999359|FG000|Overall Study|Withdrawal by Subject|20|||
162805861|NCT00522873|587999360|FG001|Overall Study|Withdrawal by Subject|9|||
162805862|NCT00522873|587999359|FG000|Overall Study|Protocol Violation|14|||
162805863|NCT00522873|587999360|FG001|Overall Study|Protocol Violation|4|||
162805864|NCT00522873|587999359|FG000|Overall Study|Lost to Follow-up|11|||
162805865|NCT00522873|587999360|FG001|Overall Study|Lost to Follow-up|3|||
162805866|NCT00522873|587999359|FG000|Overall Study|Personal Reasons|8|||
162805867|NCT00522873|587999360|FG001|Overall Study|Personal Reasons|1|||
162805868|NCT00522873|587999359|FG000|Overall Study|Medication Errors|1|||
162805869|NCT00522873|587999360|FG001|Overall Study|Medication Errors|1|||
162805870|NCT00522873|587999359|FG000|Overall Study|Never Received Medication|1|||
162805871|NCT00522873|587999360|FG001|Overall Study|Never Received Medication|0|||
162805872|NCT02966301|587999361|FG000|Overall Study|Death|2|||
162805873|NCT02966301|587999361|FG000|Overall Study|Withdrawal by Subject|1|||
162805874|NCT00822172|587999365|FG000|Overall Study|Adverse Event|10|||
162805875|NCT00822172|587999366|FG001|Overall Study|Adverse Event|12|||
162805876|NCT00822172|587999365|FG000|Overall Study|Death|1|||
162805877|NCT00822172|587999366|FG001|Overall Study|Death|0|||
162805878|NCT00822172|587999365|FG000|Overall Study|Lost to Follow-up|3|||
162805879|NCT00822172|587999366|FG001|Overall Study|Lost to Follow-up|1|||
162805880|NCT00822172|587999365|FG000|Overall Study|Withdrawal by Subject|1|||
162805881|NCT00822172|587999366|FG001|Overall Study|Withdrawal by Subject|4|||
162805882|NCT00822172|587999365|FG000|Overall Study|site closed|0|||
162805883|NCT00822172|587999366|FG001|Overall Study|site closed|1|||
162805884|NCT00822172|587999365|FG000|Overall Study|Other|0|||
162805885|NCT00822172|587999366|FG001|Overall Study|Other|1|||
162805886|NCT02947087|587999368|FG000|Overall Study|Withdrawal by Subject|3|||
162805887|NCT02947087|587999369|FG001|Overall Study|Withdrawal by Subject|2|||
162805888|NCT00545051|587999371|FG000|Overall Study|Adverse Event|7|||
162805889|NCT00545051|587999372|FG001|Overall Study|Adverse Event|3|||
162805890|NCT00545051|587999371|FG000|Overall Study|Death|1|||
162805891|NCT00545051|587999372|FG001|Overall Study|Death|0|||
162805892|NCT00545051|587999371|FG000|Overall Study|Violation of inclusion/exclusion|0|||
162805893|NCT00545051|587999372|FG001|Overall Study|Violation of inclusion/exclusion|2|||
162805894|NCT00545051|587999371|FG000|Overall Study|Protocol Violation|1|||
162805895|NCT00545051|587999372|FG001|Overall Study|Protocol Violation|0|||
162805896|NCT00545051|587999371|FG000|Overall Study|Withdrawal by Subject|0|||
162805897|NCT00545051|587999372|FG001|Overall Study|Withdrawal by Subject|1|||
162805898|NCT00545051|587999371|FG000|Overall Study|Administrative reasons|0|||
162805899|NCT00545051|587999372|FG001|Overall Study|Administrative reasons|1|||
162805900|NCT01375114|587999373|FG000|Overall Study|Lost to Follow-up|1|||
162805901|NCT01375114|587999374|FG001|Overall Study|Lost to Follow-up|0|||
162805902|NCT01375114|587999375|FG002|Overall Study|Lost to Follow-up|1|||
162805903|NCT01375114|587999373|FG000|Overall Study|Disease Progression|3|||
162805904|NCT01375114|587999374|FG001|Overall Study|Disease Progression|2|||
162805905|NCT01375114|587999375|FG002|Overall Study|Disease Progression|2|||
162805906|NCT01375114|587999373|FG000|Overall Study|Patient Changed Mind|0|||
162805907|NCT01375114|587999374|FG001|Overall Study|Patient Changed Mind|0|||
162805908|NCT01375114|587999375|FG002|Overall Study|Patient Changed Mind|2|||
162805909|NCT01375114|587999373|FG000|Overall Study|Pruritus|0|||
162805910|NCT01375114|587999374|FG001|Overall Study|Pruritus|0|||
162805911|NCT01375114|587999375|FG002|Overall Study|Pruritus|1|||
162805912|NCT01375114|587999373|FG000|Overall Study|Restlessness|0|||
162805913|NCT01375114|587999374|FG001|Overall Study|Restlessness|0|||
162805914|NCT01375114|587999375|FG002|Overall Study|Restlessness|1|||
162805915|NCT01375114|587999373|FG000|Overall Study|Diarrhea|0|||
162805916|NCT01375114|587999374|FG001|Overall Study|Diarrhea|0|||
162805917|NCT01375114|587999375|FG002|Overall Study|Diarrhea|1|||
162805918|NCT01375114|587999373|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
162805919|NCT01375114|587999374|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
162805920|NCT01375114|587999375|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
162805921|NCT01375114|587999373|FG000|Overall Study|Nausea|0|||
162805922|NCT01375114|587999374|FG001|Overall Study|Nausea|1|||
162805923|NCT01375114|587999375|FG002|Overall Study|Nausea|0|||
162805924|NCT01375114|587999373|FG000|Overall Study|Increased AST/ALT|0|||
162805925|NCT01375114|587999374|FG001|Overall Study|Increased AST/ALT|1|||
162805926|NCT01375114|587999375|FG002|Overall Study|Increased AST/ALT|0|||
162805927|NCT01375114|587999373|FG000|Overall Study|Vaginal Hemorrhage|0|||
162805928|NCT01375114|587999374|FG001|Overall Study|Vaginal Hemorrhage|1|||
162805929|NCT01375114|587999375|FG002|Overall Study|Vaginal Hemorrhage|0|||
162805930|NCT01375114|587999373|FG000|Overall Study|Family problem|0|||
162805931|NCT01375114|587999374|FG001|Overall Study|Family problem|1|||
162805932|NCT01375114|587999375|FG002|Overall Study|Family problem|0|||
162805933|NCT01375114|587999373|FG000|Overall Study|Protocol Violation|2|||
162805934|NCT01375114|587999374|FG001|Overall Study|Protocol Violation|0|||
162805935|NCT01375114|587999375|FG002|Overall Study|Protocol Violation|0|||
162805936|NCT00477334|587999376|FG000|Overall Study|Discontinued prior to taking study drug|106|||
162805937|NCT00477334|587999377|FG001|Overall Study|Discontinued prior to taking study drug|53|||
162805938|NCT00477334|587999376|FG000|Overall Study|Adverse Event|1|||
162805939|NCT00477334|587999377|FG001|Overall Study|Adverse Event|2|||
162805940|NCT00477334|587999376|FG000|Overall Study|Withdrawal by Subject|2|||
162805941|NCT00477334|587999377|FG001|Overall Study|Withdrawal by Subject|1|||
162805942|NCT00477334|587999376|FG000|Overall Study|Lost to Follow-up|15|||
162805943|NCT00477334|587999377|FG001|Overall Study|Lost to Follow-up|4|||
162805944|NCT00477334|587999376|FG000|Overall Study|Administrative Problems|39|||
162805945|NCT00477334|587999377|FG001|Overall Study|Administrative Problems|15|||
162805946|NCT00477334|587999376|FG000|Overall Study|Protocol Violation|7|||
162805947|NCT00477334|587999377|FG001|Overall Study|Protocol Violation|1|||
162805948|NCT04745026|587999381|FG000|Overall Study|Physician Decision|1|||
162805949|NCT04745026|587999382|FG001|Overall Study|Physician Decision|0|||
162805950|NCT04745026|587999381|FG000|Overall Study|Adverse Event|2|||
162805951|NCT04745026|587999382|FG001|Overall Study|Adverse Event|2|||
162805952|NCT04745026|587999381|FG000|Overall Study|Protocol Violation|1|||
162805953|NCT04745026|587999382|FG001|Overall Study|Protocol Violation|3|||
162805954|NCT04745026|587999381|FG000|Overall Study|Lost to Follow-up|4|||
162805955|NCT04745026|587999382|FG001|Overall Study|Lost to Follow-up|3|||
162805956|NCT04745026|587999381|FG000|Overall Study|Withdrawal by Subject|5|||
162805957|NCT04745026|587999382|FG001|Overall Study|Withdrawal by Subject|5|||
162805958|NCT01656733|587999383|FG000|Overall Study|No permission to collect birth outcomes|0|||
162805959|NCT01656733|587999384|FG001|Overall Study|No permission to collect birth outcomes|1|||
162805960|NCT01656733|587999383|FG000|Overall Study|Delivery at another hospital|0|||
162805961|NCT01656733|587999384|FG001|Overall Study|Delivery at another hospital|2|||
162805962|NCT01656733|587999383|FG000|Overall Study|Spontaneous abortion|0|||
162805963|NCT01656733|587999384|FG001|Overall Study|Spontaneous abortion|1|||
162805964|NCT01415531|587999385|FG000|Overall Study|Adverse Event|7|||
162805965|NCT01415531|587999386|FG001|Overall Study|Adverse Event|10|||
162805966|NCT01415531|587999385|FG000|Overall Study|Lack of Efficacy|3|||
162805967|NCT01415531|587999386|FG001|Overall Study|Lack of Efficacy|2|||
162805968|NCT01415531|587999385|FG000|Overall Study|Protocol Violation|0|||
162805969|NCT01415531|587999386|FG001|Overall Study|Protocol Violation|1|||
162805970|NCT01415531|587999385|FG000|Overall Study|Withdrawal by Subject|5|||
162805971|NCT01415531|587999386|FG001|Overall Study|Withdrawal by Subject|4|||
162805972|NCT01415531|587999385|FG000|Overall Study|Lost to Follow-up|6|||
162805973|NCT01415531|587999386|FG001|Overall Study|Lost to Follow-up|14|||
162805974|NCT01415531|587999385|FG000|Overall Study|Lack of Compliance|1|||
162805975|NCT01415531|587999386|FG001|Overall Study|Lack of Compliance|4|||
162805976|NCT01415531|587999385|FG000|Overall Study|Other Reasons|3|||
162805977|NCT01415531|587999386|FG001|Overall Study|Other Reasons|2|||
162805978|NCT00122460|587999387|FG000|Overall Study|investigational study phase ongoing|7|||
162805979|NCT00122460|587999388|FG001|Overall Study|investigational study phase ongoing|1|||
162805980|NCT01236339|587999389|FG000|Overall Study|Termination of study by sponsor|11|||
162805981|NCT01236339|587999390|FG001|Overall Study|Termination of study by sponsor|13|||
162805982|NCT02084056|587999391|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
162805983|NCT02084056|587999392|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162805984|NCT02084056|587999393|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162805985|NCT02084056|587999394|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162805986|NCT02084056|587999391|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
162805987|NCT02084056|587999392|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162805988|NCT02084056|587999393|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162805989|NCT02084056|587999394|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162805990|NCT00938860|587999397|FG000|Overall Study|Adverse Event|2|||
162805991|NCT00938860|587999398|FG001|Overall Study|Adverse Event|1|||
162805992|NCT00938860|587999397|FG000|Overall Study|Abnormal laboratory values|2|||
162805993|NCT00938860|587999398|FG001|Overall Study|Abnormal laboratory values|2|||
162805994|NCT00938860|587999397|FG000|Overall Study|Withdrawal by Subject|11|||
162805995|NCT00938860|587999398|FG001|Overall Study|Withdrawal by Subject|8|||
162805996|NCT00938860|587999397|FG000|Overall Study|Lost to Follow-up|4|||
162805997|NCT00938860|587999398|FG001|Overall Study|Lost to Follow-up|4|||
162805998|NCT00938860|587999397|FG000|Overall Study|Administration problems|2|||
162805999|NCT00938860|587999398|FG001|Overall Study|Administration problems|0|||
162806000|NCT00938860|587999397|FG000|Overall Study|Death|1|||
162806001|NCT00938860|587999398|FG001|Overall Study|Death|1|||
162806002|NCT00938860|587999397|FG000|Overall Study|Protocol Violation|3|||
162806003|NCT00938860|587999398|FG001|Overall Study|Protocol Violation|1|||
162806004|NCT01605019|587999399|FG000|Overall Study|pt did not meet transplant endpoint|3|||
162806005|NCT01605019|587999400|FG001|Overall Study|pt did not meet transplant endpoint|0|||
162806006|NCT04223830|587999404|FG000|Overall Study|Lost to Follow-up|9|||
162806007|NCT04223830|587999404|FG000|Overall Study|Adverse Event|1|||
162806008|NCT00324116|587999405|FG000|Overall Study|Adverse Event|5|||
162806009|NCT00324116|587999405|FG000|Overall Study|Lack of Efficacy|17|||
162806010|NCT00324116|587999405|FG000|Overall Study|Withdrawal by Subject|5|||
162806011|NCT00324116|587999405|FG000|Overall Study|Other|5|||
162806012|NCT01806623|587999406|FG000|Overall Study|Withdrawal by Subject|1|||
162806013|NCT01806623|587999406|FG000|Overall Study|Adverse Event|1|||
162806014|NCT01806623|587999406|FG000|Overall Study|Did not meet the inclusion criteria|56|||
162806015|NCT01451827|587999407|FG000|Overall Study|Adverse Event|2|||
162806016|NCT01451827|587999408|FG001|Overall Study|Adverse Event|0|||
162806017|NCT01451827|587999409|FG002|Overall Study|Adverse Event|1|||
162806018|NCT01451827|587999410|FG003|Overall Study|Adverse Event|1|||
162806019|NCT01451827|587999407|FG000|Overall Study|Protocol deviation|1|||
162806020|NCT01451827|587999408|FG001|Overall Study|Protocol deviation|0|||
162806021|NCT01451827|587999409|FG002|Overall Study|Protocol deviation|0|||
162806022|NCT01451827|587999410|FG003|Overall Study|Protocol deviation|0|||
162806023|NCT01451827|587999407|FG000|Overall Study|Lost to Follow-up|0|||
162806024|NCT01451827|587999408|FG001|Overall Study|Lost to Follow-up|3|||
162806025|NCT01451827|587999409|FG002|Overall Study|Lost to Follow-up|0|||
162806026|NCT01451827|587999410|FG003|Overall Study|Lost to Follow-up|2|||
162806027|NCT01451827|587999407|FG000|Overall Study|Participant met withdrawal criteria|0|||
162806028|NCT01451827|587999408|FG001|Overall Study|Participant met withdrawal criteria|2|||
162806029|NCT01451827|587999409|FG002|Overall Study|Participant met withdrawal criteria|0|||
162806030|NCT01451827|587999410|FG003|Overall Study|Participant met withdrawal criteria|0|||
162806031|NCT01451827|587999407|FG000|Overall Study|Withdrawal by Subject|0|||
162806032|NCT01451827|587999408|FG001|Overall Study|Withdrawal by Subject|0|||
162806033|NCT01451827|587999409|FG002|Overall Study|Withdrawal by Subject|1|||
162806034|NCT01451827|587999410|FG003|Overall Study|Withdrawal by Subject|1|||
162806035|NCT01964924|587999411|FG000|Trametinib Monotherapy|Progression|19|||
162806036|NCT01964924|587999412|FG001|Trametinib Monotherapy|Progression|0|||
162806037|NCT01528345|587999413|FG000|Overall Study|Adverse Event|10|||
162806038|NCT01528345|587999414|FG001|Overall Study|Adverse Event|1|||
162806039|NCT01528345|587999413|FG000|Overall Study|Death|1|||
162806040|NCT01528345|587999414|FG001|Overall Study|Death|1|||
162806041|NCT01528345|587999413|FG000|Overall Study|Non-compliance with study treatment|1|||
162806042|NCT01528345|587999414|FG001|Overall Study|Non-compliance with study treatment|0|||
162806043|NCT01528345|587999413|FG000|Overall Study|Progressive Disease|26|||
162806044|NCT01528345|587999414|FG001|Overall Study|Progressive Disease|40|||
162806045|NCT01528345|587999413|FG000|Overall Study|Study Terminated by Sponsor|4|||
162806046|NCT01528345|587999414|FG001|Overall Study|Study Terminated by Sponsor|8|||
162806047|NCT01528345|587999413|FG000|Overall Study|Subject/Guardian Decision|5|||
162806048|NCT01528345|587999414|FG001|Overall Study|Subject/Guardian Decision|0|||
162806049|NCT01034163|587999415|FG000|Overall Study|Treatment completed as per protocol|8|||
162806050|NCT01034163|587999416|FG001|Overall Study|Treatment completed as per protocol|7|||
162806051|NCT01034163|587999415|FG000|Overall Study|Withdrawal by Subject|8|||
162806052|NCT01034163|587999416|FG001|Overall Study|Withdrawal by Subject|2|||
162806053|NCT01034163|587999415|FG000|Overall Study|Protocol deviation|1|||
162806054|NCT01034163|587999416|FG001|Overall Study|Protocol deviation|0|||
162806055|NCT01034163|587999415|FG000|Overall Study|Disease progression|3|||
162806056|NCT01034163|587999416|FG001|Overall Study|Disease progression|4|||
162806057|NCT01034163|587999415|FG000|Overall Study|Adverse Event|6|||
162806058|NCT01034163|587999416|FG001|Overall Study|Adverse Event|0|||
162806059|NCT01034163|587999415|FG000|Overall Study|Administrative problems|0|||
162806060|NCT01034163|587999416|FG001|Overall Study|Administrative problems|1|||
162806061|NCT01034163|587999415|FG000|Overall Study|Abnormal laboratory value|1|||
162806062|NCT01034163|587999416|FG001|Overall Study|Abnormal laboratory value|0|||
162806063|NCT00528645|587999417|FG000|Overall Study|Adverse Event|3|||
162806064|NCT01642251|587999418|FG000|Overall Study|Progressive disease|0|||
162806065|NCT01642251|587999419|FG001|Overall Study|Progressive disease|0|||
162806066|NCT01642251|587999420|FG002|Overall Study|Progressive disease|3|||
162806067|NCT01642251|587999421|FG003|Overall Study|Progressive disease|3|||
162806068|NCT01642251|587999418|FG000|Overall Study|Adverse Event|0|||
162806069|NCT01642251|587999419|FG001|Overall Study|Adverse Event|0|||
162806070|NCT01642251|587999420|FG002|Overall Study|Adverse Event|5|||
162806071|NCT01642251|587999421|FG003|Overall Study|Adverse Event|4|||
162806072|NCT01642251|587999418|FG000|Overall Study|Death|0|||
162806073|NCT01642251|587999419|FG001|Overall Study|Death|0|||
162806074|NCT01642251|587999420|FG002|Overall Study|Death|1|||
162806075|NCT01642251|587999421|FG003|Overall Study|Death|3|||
162806076|NCT01642251|587999418|FG000|Overall Study|Withdrawal by Subject|0|||
162806077|NCT01642251|587999419|FG001|Overall Study|Withdrawal by Subject|0|||
162806078|NCT01642251|587999420|FG002|Overall Study|Withdrawal by Subject|1|||
162806079|NCT01642251|587999421|FG003|Overall Study|Withdrawal by Subject|3|||
162806080|NCT01642251|587999418|FG000|Overall Study|Alternative therapy|0|||
162806081|NCT01642251|587999419|FG001|Overall Study|Alternative therapy|0|||
162806082|NCT01642251|587999420|FG002|Overall Study|Alternative therapy|0|||
162806083|NCT01642251|587999421|FG003|Overall Study|Alternative therapy|2|||
162806084|NCT01642251|587999418|FG000|Overall Study|Other complicating disease|0|||
162806085|NCT01642251|587999419|FG001|Overall Study|Other complicating disease|0|||
162806086|NCT01642251|587999420|FG002|Overall Study|Other complicating disease|1|||
162806087|NCT01642251|587999421|FG003|Overall Study|Other complicating disease|0|||
162806088|NCT01642251|587999418|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
162806089|NCT01642251|587999419|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
162806090|NCT01642251|587999420|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
162806091|NCT01642251|587999421|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
162806092|NCT00998790|587999422|FG000|Overall Study|Withdrawal by Subject|21|||
162806093|NCT00287690|587999425|FG000|Overall Study|Protocol Violation|20|||
162806094|NCT00287690|587999426|FG001|Overall Study|Protocol Violation|26|||
162806095|NCT02047903|587999427|FG000|Overall Study|Adverse Event|14|||
162806096|NCT02047903|587999427|FG000|Overall Study|Serious adverse event|10|||
162806097|NCT02047903|587999427|FG000|Overall Study|Withdrawal by Subject|16|||
162806098|NCT02047903|587999427|FG000|Overall Study|Lost to Follow-up|4|||
162806099|NCT02047903|587999427|FG000|Overall Study|Reason not listed|6|||
162806100|NCT02047903|587999427|FG000|Overall Study|Not Treated|9|||
162806101|NCT01942590|587999431|FG000|Overall Study|Withdrawal by Subject|0|||
162806102|NCT01942590|587999432|FG001|Overall Study|Withdrawal by Subject|1|||
162806103|NCT01942590|587999431|FG000|Overall Study|Adverse Event|1|||
162806104|NCT01942590|587999432|FG001|Overall Study|Adverse Event|0|||
162806105|NCT02433340|587999433|FG000|Overall Study|Adverse Event|0|||
162806106|NCT02433340|587999434|FG001|Overall Study|Adverse Event|0|||
162806107|NCT02433340|587999435|FG002|Overall Study|Adverse Event|1|||
162806108|NCT02433340|587999436|FG003|Overall Study|Adverse Event|0|||
162806109|NCT02433340|587999433|FG000|Overall Study|Withdrawal by Subject|1|||
162806110|NCT02433340|587999434|FG001|Overall Study|Withdrawal by Subject|0|||
162806111|NCT02433340|587999435|FG002|Overall Study|Withdrawal by Subject|1|||
162806112|NCT02433340|587999436|FG003|Overall Study|Withdrawal by Subject|2|||
162806113|NCT02433340|587999433|FG000|Overall Study|Lost to Follow-up|0|||
162806114|NCT02433340|587999434|FG001|Overall Study|Lost to Follow-up|1|||
162806115|NCT02433340|587999435|FG002|Overall Study|Lost to Follow-up|0|||
162806116|NCT02433340|587999436|FG003|Overall Study|Lost to Follow-up|0|||
162806117|NCT02433340|587999433|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
162806118|NCT02433340|587999434|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
162806119|NCT02433340|587999435|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
162806120|NCT02433340|587999436|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
162806121|NCT02433340|587999433|FG000|Overall Study|Other|0|||
162806122|NCT02433340|587999434|FG001|Overall Study|Other|1|||
162806123|NCT02433340|587999435|FG002|Overall Study|Other|0|||
162806124|NCT02433340|587999436|FG003|Overall Study|Other|0|||
162806125|NCT01226095|587999437|FG000|Overall Study|Poor compliance|1|||
162806126|NCT00911768|587999448|FG000|Overall Study|Protocol Violation|5|||
162806127|NCT00911768|587999449|FG001|Overall Study|Protocol Violation|4|||
162806128|NCT00911768|587999448|FG000|Overall Study|Withdrawal by Subject|1|||
162806129|NCT00911768|587999449|FG001|Overall Study|Withdrawal by Subject|0|||
162806130|NCT03406078|587999451|FG000|Overall Study|Death|1|||
162806131|NCT03406078|587999452|FG001|Overall Study|Death|0|||
162806132|NCT03406078|587999451|FG000|Overall Study|Lost to Follow-up|0|||
162806133|NCT03406078|587999452|FG001|Overall Study|Lost to Follow-up|1|||
162806134|NCT03406078|587999451|FG000|Overall Study|Withdrawal by Subject|5|||
162806135|NCT03406078|587999452|FG001|Overall Study|Withdrawal by Subject|2|||
162806136|NCT03616977|587999456|FG000|Period 1|Physician Decision|0|||
162806137|NCT03616977|587999457|FG001|Period 1|Physician Decision|1|||
162806138|NCT03616977|587999456|FG000|Period 3|Adverse Event|1|||
162806139|NCT03616977|587999457|FG001|Period 3|Adverse Event|1|||
162806140|NCT01111474|588001222|FG000|Overall Study|Lost to Follow-up|12|||
162806141|NCT00618982|588001223|FG000|Overall Study|Adverse Event|23|||
162806142|NCT00618982|588001223|FG000|Overall Study|Withdrawal by Subject|1|||
162806143|NCT00618982|588001223|FG000|Overall Study|Protocol Violation|1|||
162806144|NCT00618982|588001223|FG000|Overall Study|ongoing, still treated with study med.|25|||
162806145|NCT00642772|588001225|FG000|Overall Study|Lost to Follow-up|3|||
162806146|NCT00642772|588001225|FG000|Overall Study|Withdrawal by Subject|7|||
162806147|NCT05398237|588001230|FG000|Overall Study|Withdrawal by Subject|1|||
162806148|NCT01312857|588001233|FG000|Overall Study|Adverse Event|1|||
162806149|NCT01312857|588001234|FG001|Overall Study|Adverse Event|1|||
162806150|NCT01312857|588001233|FG000|Overall Study|Lost to Follow-up|2|||
162806151|NCT01312857|588001234|FG001|Overall Study|Lost to Follow-up|0|||
162806152|NCT01312857|588001233|FG000|Overall Study|Physician Decision|3|||
162806153|NCT01312857|588001234|FG001|Overall Study|Physician Decision|0|||
162806154|NCT01312857|588001233|FG000|Overall Study|Withdrawal by Subject|2|||
162806155|NCT01312857|588001234|FG001|Overall Study|Withdrawal by Subject|0|||
162806156|NCT01248065|588001235|FG000|Overall Study|Lost to Follow-up|3|||
162806157|NCT01248065|588001236|FG001|Overall Study|Lost to Follow-up|5|||
162806158|NCT01248065|588001235|FG000|Overall Study|Withdrawal by Subject|14|||
162806159|NCT01248065|588001236|FG001|Overall Study|Withdrawal by Subject|11|||
162806160|NCT01248065|588001235|FG000|Overall Study|Adverse Event|3|||
162806161|NCT01248065|588001236|FG001|Overall Study|Adverse Event|0|||
162806162|NCT01248065|588001235|FG000|Overall Study|Third treatment failure event|3|||
162806163|NCT01248065|588001236|FG001|Overall Study|Third treatment failure event|1|||
162806164|NCT01248065|588001235|FG000|Overall Study|Other|3|||
162806165|NCT01248065|588001236|FG001|Overall Study|Other|5|||
162806166|NCT02781844|588001246|FG000|Treatment Period 1|Adverse Event|0|||
162806167|NCT02781844|588001247|FG001|Treatment Period 1|Adverse Event|0|||
162806168|NCT02781844|588001248|FG002|Treatment Period 1|Adverse Event|0|||
162806169|NCT02781844|588001249|FG003|Treatment Period 1|Adverse Event|0|||
162806170|NCT02781844|588001250|FG004|Treatment Period 1|Adverse Event|0|||
162806171|NCT02781844|588001251|FG005|Treatment Period 1|Adverse Event|1|||
162806172|NCT02781844|588001252|FG006|Treatment Period 1|Adverse Event|0|||
162806173|NCT02781844|588001253|FG007|Treatment Period 1|Adverse Event|0|||
162806174|NCT04256629|588001256|FG000|Overall Study|Adverse Event|0|||
162806175|NCT04256629|588001257|FG001|Overall Study|Adverse Event|0|||
162806176|NCT04256629|588001258|FG002|Overall Study|Adverse Event|0|||
162806177|NCT04256629|588001259|FG003|Overall Study|Adverse Event|0|||
162806178|NCT04256629|588001260|FG004|Overall Study|Adverse Event|0|||
162806179|NCT04256629|588001261|FG005|Overall Study|Adverse Event|1|||
162806180|NCT04256629|588001256|FG000|Overall Study|Protocol Violation|0|||
162806181|NCT04256629|588001257|FG001|Overall Study|Protocol Violation|1|||
162806182|NCT04256629|588001258|FG002|Overall Study|Protocol Violation|0|||
162806183|NCT04256629|588001259|FG003|Overall Study|Protocol Violation|0|||
162806184|NCT04256629|588001260|FG004|Overall Study|Protocol Violation|0|||
162806185|NCT04256629|588001261|FG005|Overall Study|Protocol Violation|0|||
162806186|NCT00321373|588001262|FG000|Overall Study|Adverse Event|0|||
162806187|NCT00321373|588001263|FG001|Overall Study|Adverse Event|0|||
162806188|NCT00321373|588001264|FG002|Overall Study|Adverse Event|1|||
162806189|NCT00321373|588001262|FG000|Overall Study|Lost to Follow-up|1|||
162806190|NCT00321373|588001263|FG001|Overall Study|Lost to Follow-up|0|||
162806191|NCT00321373|588001264|FG002|Overall Study|Lost to Follow-up|1|||
162806192|NCT00321373|588001262|FG000|Overall Study|Withdrawal by Subject|1|||
162806193|NCT00321373|588001263|FG001|Overall Study|Withdrawal by Subject|0|||
162806194|NCT00321373|588001264|FG002|Overall Study|Withdrawal by Subject|0|||
162806195|NCT00321373|588001262|FG000|Overall Study|Other|0|||
162806196|NCT00321373|588001263|FG001|Overall Study|Other|0|||
162806197|NCT00321373|588001264|FG002|Overall Study|Other|1|||
162806198|NCT01774487|588001265|FG000|Overall Study|Did not tolerate taste|4|||
162806199|NCT01774487|588001266|FG001|Overall Study|Did not tolerate taste|4|||
162806200|NCT01383499|588001267|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
162806201|NCT01383499|588001268|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162806202|NCT01383499|588001269|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162806203|NCT01383499|588001270|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162806204|NCT02572882|588001275|FG000|Overall Study|Withdrawal by Subject|1|||
162806205|NCT02572882|588001275|FG000|Overall Study|Participant received kidney transplant|1|||
162806206|NCT04275089|588001278|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
162806207|NCT01079663|588001279|FG000|Overall Study|Adverse Event|0|||
162806208|NCT01079663|588001280|FG001|Overall Study|Adverse Event|2|||
162806209|NCT01079663|588001279|FG000|Overall Study|Protocol Violation|0|||
162806210|NCT01079663|588001280|FG001|Overall Study|Protocol Violation|2|||
162806211|NCT03606668|588001281|FG000|Overall Study|Screen Failure|1|||
162806212|NCT03606668|588001281|FG000|Overall Study|Lost to Follow-up|1|||
162806213|NCT01014143|588001285|FG000|Second Intervention|Lost to Follow-up|2|||
162806214|NCT01014143|588001286|FG001|Second Intervention|Lost to Follow-up|0|||
162806215|NCT01014143|588001287|FG002|Second Intervention|Lost to Follow-up|0|||
162806216|NCT02354508|588001288|FG000|Period 1: Core Phase|Adverse Event|1|||
162806217|NCT02354508|588001289|FG001|Period 1: Core Phase|Adverse Event|1|||
162806218|NCT02354508|588001290|FG002|Period 1: Core Phase|Adverse Event|2|||
162806219|NCT02354508|588001288|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
162806220|NCT02354508|588001289|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
162806221|NCT02354508|588001290|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
162806222|NCT02354508|588001288|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
162806223|NCT02354508|588001289|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
162806224|NCT02354508|588001290|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
162806225|NCT02354508|588001288|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
162806226|NCT02354508|588001289|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
162806227|NCT02354508|588001290|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
162806228|NCT02354508|588001288|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
162806229|NCT02354508|588001289|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
162806230|NCT02354508|588001290|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
162806231|NCT02354508|588001288|FG000|Period 2: Extension Phase|Physician Decision|5|||
162806232|NCT02354508|588001289|FG001|Period 2: Extension Phase|Physician Decision|0|||
162806233|NCT02354508|588001290|FG002|Period 2: Extension Phase|Physician Decision|1|||
162806234|NCT02354508|588001288|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
162806235|NCT02354508|588001289|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
162806236|NCT02354508|588001290|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
162806237|NCT02354508|588001288|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
162806238|NCT02354508|588001289|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
162806239|NCT02354508|588001290|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
162806240|NCT02354508|588001288|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
162806241|NCT02354508|588001289|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
162806242|NCT02354508|588001290|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
162806243|NCT00461032|588001292|FG000|Overall Study|Adverse Event|5|||
162806244|NCT00461032|588001293|FG001|Overall Study|Adverse Event|6|||
162806245|NCT00461032|588001292|FG000|Overall Study|Lack of Efficacy|5|||
162806246|NCT00461032|588001293|FG001|Overall Study|Lack of Efficacy|1|||
162806247|NCT00461032|588001292|FG000|Overall Study|Lost to Follow-up|7|||
162806248|NCT00461032|588001293|FG001|Overall Study|Lost to Follow-up|12|||
162806249|NCT00461032|588001292|FG000|Overall Study|Protocol Violation|4|||
162806250|NCT00461032|588001293|FG001|Overall Study|Protocol Violation|4|||
162806251|NCT00461032|588001292|FG000|Overall Study|Withdrawal by Subject|7|||
162806252|NCT00461032|588001293|FG001|Overall Study|Withdrawal by Subject|15|||
162806253|NCT00461032|588001292|FG000|Overall Study|Patient Moved or Relocated|2|||
162806254|NCT00461032|588001293|FG001|Overall Study|Patient Moved or Relocated|1|||
162806255|NCT00461032|588001292|FG000|Overall Study|Other|7|||
162806256|NCT00461032|588001293|FG001|Overall Study|Other|5|||
162925439|NCT02564952|588428975|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
162925440|NCT02564952|588428975|FG000|Overall Study|Withdrawal by Subject|1|||
162806257|NCT04447846|588001294|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
162806258|NCT00297232|588001297|FG000|Overall Study|Lack of Efficacy|7|||
162806259|NCT00297232|588001297|FG000|Overall Study|Lost to Follow-up|10|||
162806260|NCT00297232|588001297|FG000|Overall Study|Adverse Event|63|||
162806261|NCT00297232|588001297|FG000|Overall Study|Voluntary Withdrawal|120|||
162806262|NCT00297232|588001297|FG000|Overall Study|Subject was Noncompliant|9|||
162806263|NCT00297232|588001297|FG000|Overall Study|Death|9|||
162806264|NCT00297232|588001297|FG000|Overall Study|Anti-natalizumab Positive|8|||
162806265|NCT00297232|588001297|FG000|Overall Study|Switched to Commercial Tysabri|22|||
162806266|NCT00297232|588001297|FG000|Overall Study|Disease Progression|8|||
162806267|NCT00297232|588001297|FG000|Overall Study|Fear of PML|10|||
162806268|NCT00297232|588001297|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
162806269|NCT00297232|588001297|FG000|Overall Study|Miscellaneous|5|||
162806270|NCT00297232|588001297|FG000|Overall Study|Sponsor Decision|34|||
162806271|NCT00297232|588001297|FG000|Overall Study|Subject Relocated|7|||
162806272|NCT00297232|588001297|FG000|Overall Study|Subject Withdrew Consent|37|||
162806273|NCT00297232|588001297|FG000|Overall Study|Persistently Positive Antibodies|11|||
162806274|NCT00297232|588001297|FG000|Overall Study|Investigator Withdrew From Program|19|||
162806275|NCT00297232|588001297|FG000|Overall Study|Did Not Enroll to Week 264|34|||
162806276|NCT00297232|588001297|FG000|Overall Study|Did Not Enroll to Week 480|17|||
162806277|NCT00297232|588001297|FG000|Overall Study|No data available after Week 264|161|||
162806278|NCT00297232|588001297|FG000|Overall Study|Other|1|||
162806279|NCT03536143|588001300|FG000|Overall Study|Early termination, Sponsor decision|1|||
162806280|NCT00523640|588001306|FG000|Overall Study|Death|1|||
162806281|NCT06377488|588001307|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
162806282|NCT06377488|588001307|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
162806283|NCT06377488|588001307|FG000|Overall Study|Protocol Violation|1|||
162806284|NCT06377488|588001307|FG000|Overall Study|Lost to Follow-up|1|||
162806285|NCT06377488|588001307|FG000|Overall Study|Incorrect Lens Dispensed|2|||
162806286|NCT01076647|588001308|FG000|Overall Study|Adverse Event|4|||
162806287|NCT01076647|588001309|FG001|Overall Study|Adverse Event|1|||
162806288|NCT01076647|588001308|FG000|Overall Study|Lack of Efficacy|0|||
162806289|NCT01076647|588001309|FG001|Overall Study|Lack of Efficacy|1|||
162806290|NCT01076647|588001308|FG000|Overall Study|Protocol Violation|7|||
162806291|NCT01076647|588001309|FG001|Overall Study|Protocol Violation|9|||
162806292|NCT01076647|588001308|FG000|Overall Study|Withdrawal criteria|2|||
162806293|NCT01076647|588001309|FG001|Overall Study|Withdrawal criteria|2|||
162806294|NCT01076647|588001308|FG000|Overall Study|Unclassified|12|||
162806295|NCT01076647|588001309|FG001|Overall Study|Unclassified|12|||
162806296|NCT02292927|588001312|FG000|Overall Study|Protocol Violation|13|||
162806297|NCT02292927|588001313|FG001|Overall Study|Protocol Violation|7|||
162806298|NCT02962960|588001315|FG000|Overall Study|Withdrawal by Subject|1|||
162806299|NCT02962960|588001316|FG001|Overall Study|Withdrawal by Subject|1|||
162806300|NCT02962960|588001317|FG002|Overall Study|Withdrawal by Subject|0|||
162806301|NCT02962960|588001315|FG000|Overall Study|Adverse Event|1|||
162806302|NCT02962960|588001316|FG001|Overall Study|Adverse Event|1|||
162806303|NCT02962960|588001317|FG002|Overall Study|Adverse Event|0|||
162806304|NCT02962960|588001315|FG000|Overall Study|Protocol Violation|1|||
162806305|NCT02962960|588001316|FG001|Overall Study|Protocol Violation|0|||
162806306|NCT02962960|588001317|FG002|Overall Study|Protocol Violation|0|||
162806307|NCT02054741|588001318|FG000|Overall Study|Protocol Violation|13|||
162806308|NCT02054741|588001319|FG001|Overall Study|Protocol Violation|2|||
162806309|NCT02054741|588001318|FG000|Overall Study|Withdrawal by Subject|10|||
162806310|NCT02054741|588001319|FG001|Overall Study|Withdrawal by Subject|5|||
162806311|NCT02054741|588001318|FG000|Overall Study|Death|94|||
162806312|NCT02054741|588001319|FG001|Overall Study|Death|90|||
162806313|NCT02054741|588001318|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
162806314|NCT02054741|588001319|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
162806315|NCT00394082|588001320|FG000|Overall Study|Unacceptable toxicity|15|||
162806316|NCT00394082|588001320|FG000|Overall Study|Adverse Event|4|||
162806317|NCT00394082|588001320|FG000|Overall Study|Physician Decision|4|||
162806318|NCT00394082|588001320|FG000|Overall Study|Withdrawal by Subject|2|||
162806319|NCT00394082|588001320|FG000|Overall Study|Other|1|||
162806320|NCT02344004|588001322|FG000|Overall Study|Adverse Event|11|||
162806321|NCT02344004|588001323|FG001|Overall Study|Adverse Event|1|||
162806322|NCT02344004|588001322|FG000|Overall Study|Death|9|||
162806323|NCT02344004|588001323|FG001|Overall Study|Death|7|||
162806324|NCT02344004|588001322|FG000|Overall Study|Physician Decision|4|||
162806325|NCT02344004|588001323|FG001|Overall Study|Physician Decision|1|||
162806326|NCT02344004|588001322|FG000|Overall Study|Withdrawal by Subject|22|||
162806327|NCT02344004|588001323|FG001|Overall Study|Withdrawal by Subject|5|||
162806328|NCT02344004|588001322|FG000|Overall Study|Rescue Medication|2|||
162806329|NCT02344004|588001323|FG001|Overall Study|Rescue Medication|0|||
162806330|NCT02344004|588001322|FG000|Overall Study|Other Not Specified|12|||
162806331|NCT02344004|588001323|FG001|Overall Study|Other Not Specified|0|||
162806332|NCT02344004|588001322|FG000|Overall Study|Protocol Violation|1|||
162806333|NCT02344004|588001323|FG001|Overall Study|Protocol Violation|0|||
162806334|NCT01768117|588001324|FG000|Overall Study|Lost to Follow-up|1|||
162806335|NCT01768117|588001324|FG000|Overall Study|Withdrawal by Subject|2|||
162806336|NCT01768117|588001324|FG000|Overall Study|Protocol Violation|3|||
162806337|NCT01945060|588001325|FG000|Overall Study|Lost to follow up|1|||
162806338|NCT01945060|588001326|FG001|Overall Study|Lost to follow up|0|||
162806339|NCT01945060|588001325|FG000|Overall Study|Distress related to IV access|0|||
162806340|NCT01945060|588001326|FG001|Overall Study|Distress related to IV access|1|||
162806341|NCT00138671|588001327|FG000|Overall Study|Death|0|||
162806342|NCT00138671|588001328|FG001|Overall Study|Death|3|||
162806343|NCT00138671|588001327|FG000|Overall Study|Adverse Event|6|||
162806344|NCT00138671|588001328|FG001|Overall Study|Adverse Event|3|||
162806345|NCT00138671|588001327|FG000|Overall Study|Lost to Follow-up|1|||
162806346|NCT00138671|588001328|FG001|Overall Study|Lost to Follow-up|2|||
162806347|NCT00138671|588001327|FG000|Overall Study|Withdrawal by Subject|3|||
162806348|NCT00138671|588001328|FG001|Overall Study|Withdrawal by Subject|5|||
162806349|NCT00138671|588001327|FG000|Overall Study|Other|3|||
162806350|NCT00138671|588001328|FG001|Overall Study|Other|3|||
162806351|NCT01488487|588001329|FG000|Overall Study|Adverse Event|6|||
162806352|NCT01488487|588001329|FG000|Overall Study|Death|1|||
162806353|NCT01488487|588001329|FG000|Overall Study|Withdrawal by Subject|2|||
162806354|NCT00395460|588001332|FG000|Overall Study|Withdrawal by Subject|1|||
162806355|NCT00395460|588001333|FG001|Overall Study|Withdrawal by Subject|0|||
162806356|NCT01737827|588001339|FG000|Overall Study|Adverse Event|3|||
162806357|NCT01737827|588001340|FG001|Overall Study|Adverse Event|6|||
162806358|NCT01737827|588001341|FG002|Overall Study|Adverse Event|0|||
162806359|NCT01737827|588001339|FG000|Overall Study|Lost to Follow-up|0|||
162806360|NCT01737827|588001340|FG001|Overall Study|Lost to Follow-up|1|||
162806361|NCT01737827|588001341|FG002|Overall Study|Lost to Follow-up|0|||
162806362|NCT01737827|588001339|FG000|Overall Study|Physician Decision|0|||
162806363|NCT01737827|588001340|FG001|Overall Study|Physician Decision|2|||
162806364|NCT01737827|588001341|FG002|Overall Study|Physician Decision|0|||
162806365|NCT01737827|588001339|FG000|Overall Study|Progressive Disease|5|||
162806366|NCT01737827|588001340|FG001|Overall Study|Progressive Disease|16|||
162806367|NCT01737827|588001341|FG002|Overall Study|Progressive Disease|2|||
162806368|NCT01737827|588001339|FG000|Overall Study|Study Terminated by Sponsor|0|||
162806369|NCT01737827|588001340|FG001|Overall Study|Study Terminated by Sponsor|1|||
162806370|NCT01737827|588001341|FG002|Overall Study|Study Terminated by Sponsor|0|||
162806371|NCT01737827|588001339|FG000|Overall Study|Subject/Guardian Decision|0|||
162806372|NCT01737827|588001340|FG001|Overall Study|Subject/Guardian Decision|2|||
162806373|NCT01737827|588001341|FG002|Overall Study|Subject/Guardian Decision|0|||
162806374|NCT00296400|588001342|FG000|Overall Study|Adverse Event|7|||
162806375|NCT00296400|588001343|FG001|Overall Study|Adverse Event|7|||
162806376|NCT00296400|588001344|FG002|Overall Study|Adverse Event|7|||
162806377|NCT00296400|588001342|FG000|Overall Study|Withdrawal by Subject|5|||
162806378|NCT00296400|588001343|FG001|Overall Study|Withdrawal by Subject|6|||
162806379|NCT00296400|588001344|FG002|Overall Study|Withdrawal by Subject|2|||
162806380|NCT00296400|588001342|FG000|Overall Study|Incorrect enrollment|2|||
162806381|NCT00296400|588001343|FG001|Overall Study|Incorrect enrollment|0|||
162806382|NCT00296400|588001344|FG002|Overall Study|Incorrect enrollment|0|||
162806383|NCT00296400|588001342|FG000|Overall Study|Protocol Violation|1|||
162806384|NCT00296400|588001343|FG001|Overall Study|Protocol Violation|1|||
162806385|NCT00296400|588001344|FG002|Overall Study|Protocol Violation|1|||
162806386|NCT00296400|588001342|FG000|Overall Study|Lost to Follow-up|1|||
162806387|NCT00296400|588001343|FG001|Overall Study|Lost to Follow-up|1|||
162806388|NCT00296400|588001344|FG002|Overall Study|Lost to Follow-up|2|||
162806389|NCT00296400|588001342|FG000|Overall Study|Study specific discontinuation criteria|0|||
162806390|NCT00296400|588001343|FG001|Overall Study|Study specific discontinuation criteria|0|||
162806391|NCT00296400|588001344|FG002|Overall Study|Study specific discontinuation criteria|1|||
162806392|NCT00296400|588001342|FG000|Overall Study|Visit 10 was performed earlier|0|||
162806393|NCT00296400|588001343|FG001|Overall Study|Visit 10 was performed earlier|1|||
162806394|NCT00296400|588001344|FG002|Overall Study|Visit 10 was performed earlier|0|||
162806395|NCT00296400|588001342|FG000|Overall Study|Pregnancy|1|||
162806396|NCT00296400|588001343|FG001|Overall Study|Pregnancy|2|||
162806397|NCT00296400|588001344|FG002|Overall Study|Pregnancy|0|||
162806398|NCT03538301|588001346|FG000|Overall Study|Adverse Event|1|||
162806399|NCT03538301|588001347|FG001|Overall Study|Adverse Event|4|||
162806400|NCT03538301|588001348|FG002|Overall Study|Adverse Event|4|||
162806401|NCT03538301|588001346|FG000|Overall Study|Death|1|||
162806402|NCT03538301|588001347|FG001|Overall Study|Death|1|||
162806403|NCT03538301|588001348|FG002|Overall Study|Death|0|||
162806404|NCT03538301|588001346|FG000|Overall Study|Physician Decision|0|||
162806405|NCT03538301|588001347|FG001|Overall Study|Physician Decision|1|||
162806406|NCT03538301|588001348|FG002|Overall Study|Physician Decision|0|||
162806407|NCT03538301|588001346|FG000|Overall Study|Protocol Violation|0|||
162806408|NCT03538301|588001347|FG001|Overall Study|Protocol Violation|0|||
162806409|NCT03538301|588001348|FG002|Overall Study|Protocol Violation|1|||
162806410|NCT03538301|588001346|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
162806411|NCT03538301|588001347|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
162806412|NCT03538301|588001348|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
162806413|NCT00591851|588001349|FG000|Overall Study|Withdrawal by Subject|3|||
162806414|NCT00591851|588001349|FG000|Overall Study|Adverse Event|2|||
162806415|NCT00591851|588001349|FG000|Overall Study|Progressive Disease|1|||
162806416|NCT00515853|588001350|FG000|Overall Study|Lost to Follow-up|9|||
162806417|NCT00515853|588001351|FG001|Overall Study|Lost to Follow-up|13|||
162806418|NCT00515853|588001350|FG000|Overall Study|Withdrawal by Subject|6|||
162806419|NCT00515853|588001351|FG001|Overall Study|Withdrawal by Subject|4|||
162806420|NCT00943111|588001356|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
162806421|NCT00943111|588001357|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
162806422|NCT00943111|588001358|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
162806423|NCT00943111|588001356|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
162806424|NCT00943111|588001357|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
162806425|NCT00943111|588001358|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
162806426|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
162806427|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
162806428|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
162806429|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
162806430|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
162806431|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
162806432|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
162806433|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
162806434|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
162806435|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
162806436|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
162806437|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
162806438|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
162806439|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
162806440|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
162806441|NCT00943111|588001356|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
162806442|NCT00943111|588001357|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
162806443|NCT00943111|588001358|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
162806444|NCT03798691|588001359|FG000|Overall Study|Lost to Follow-up|2|||
162806445|NCT03798691|588001360|FG001|Overall Study|Lost to Follow-up|2|||
162806446|NCT01586910|588003438|FG000|Overall Study|Death|4|||
162806447|NCT01586910|588003439|FG001|Overall Study|Death|4|||
162806448|NCT01586910|588003438|FG000|Overall Study|Withdrawal by Subject|6|||
162806449|NCT01586910|588003439|FG001|Overall Study|Withdrawal by Subject|43|||
162806450|NCT01586910|588003438|FG000|Overall Study|Physician withdrew Subject|5|||
162806451|NCT01586910|588003439|FG001|Overall Study|Physician withdrew Subject|24|||
162806452|NCT00953407|588003440|FG000|Overall Study|Failed inclusion criteria|1|||
162806453|NCT00953407|588003441|FG001|Overall Study|Failed inclusion criteria|1|||
162806454|NCT00953407|588003442|FG002|Overall Study|Failed inclusion criteria|1|||
162806455|NCT00953407|588003443|FG003|Overall Study|Failed inclusion criteria|1|||
162806456|NCT00953407|588003444|FG004|Overall Study|Failed inclusion criteria|1|||
162806457|NCT00953407|588003440|FG000|Overall Study|Lost to Follow-up|0|||
162806458|NCT00953407|588003441|FG001|Overall Study|Lost to Follow-up|0|||
162806459|NCT00953407|588003442|FG002|Overall Study|Lost to Follow-up|0|||
162806460|NCT00953407|588003443|FG003|Overall Study|Lost to Follow-up|1|||
162806461|NCT00953407|588003444|FG004|Overall Study|Lost to Follow-up|0|||
162806462|NCT02502097|588003445|FG000|Period 1|Adverse Event|0|||
162806463|NCT02502097|588003446|FG001|Period 1|Adverse Event|0|||
162806464|NCT02502097|588003447|FG002|Period 1|Adverse Event|1|||
162806465|NCT02502097|588003448|FG003|Period 1|Adverse Event|0|||
162806466|NCT02502097|588003445|FG000|Wash Out Period|Adverse Event|0|||
162806467|NCT02502097|588003446|FG001|Wash Out Period|Adverse Event|1|||
162806468|NCT02502097|588003447|FG002|Wash Out Period|Adverse Event|1|||
162806469|NCT02502097|588003448|FG003|Wash Out Period|Adverse Event|1|||
162806470|NCT02502097|588003445|FG000|Period 2|Adverse Event|0|||
162806471|NCT02502097|588003446|FG001|Period 2|Adverse Event|0|||
162806472|NCT02502097|588003447|FG002|Period 2|Adverse Event|1|||
162806473|NCT02502097|588003448|FG003|Period 2|Adverse Event|0|||
162806474|NCT02186223|588003449|FG000|Overall Study|Not eligible for device placement|6|||
162806475|NCT02186223|588003449|FG000|Overall Study|Unable to obtain femoral access|3|||
162806476|NCT02186223|588003449|FG000|Overall Study|Death|3|||
162806477|NCT02186223|588003449|FG000|Overall Study|Device in place less than 48 hours|9|||
162806478|NCT00252733|588003450|FG000|Overall Study|Withdrawal by Subject|73|||
162806479|NCT00252733|588003451|FG001|Overall Study|Withdrawal by Subject|67|||
162806480|NCT00252733|588003450|FG000|Overall Study|Death|7|||
162806481|NCT00252733|588003451|FG001|Overall Study|Death|5|||
162806482|NCT00252733|588003450|FG000|Overall Study|Lost to Follow-up|12|||
162806483|NCT00252733|588003451|FG001|Overall Study|Lost to Follow-up|6|||
162806484|NCT00252733|588003450|FG000|Overall Study|Multiple Reasons|14|||
162806485|NCT00252733|588003451|FG001|Overall Study|Multiple Reasons|14|||
162806486|NCT04289051|588003452|FG000|Overall Study|Lost to Follow-up|0|||
162806487|NCT04289051|588003453|FG001|Overall Study|Lost to Follow-up|0|||
162806488|NCT04289051|588003454|FG002|Overall Study|Lost to Follow-up|2|||
162806489|NCT00156819|588003457|FG000|Overall Study|Lost to Follow-up|1|||
162806490|NCT00156819|588003458|FG001|Overall Study|Lost to Follow-up|1|||
162806491|NCT00156819|588003459|FG002|Overall Study|Lost to Follow-up|3|||
162806492|NCT01689337|588003460|FG000|Overall Study|Study Discontinuation|1|||
162806493|NCT01878214|588003464|FG000|Overall Study|Withdrawal by Subject|18|||
162806494|NCT01878214|588003465|FG001|Overall Study|Withdrawal by Subject|7|||
162806495|NCT01878214|588003464|FG000|Overall Study|Death|0|||
162806496|NCT01878214|588003465|FG001|Overall Study|Death|1|||
162806497|NCT01878214|588003464|FG000|Overall Study|Lost to Follow-up|35|||
162806498|NCT01878214|588003465|FG001|Overall Study|Lost to Follow-up|36|||
162806499|NCT00495586|588003466|FG000|Overall Study|Withdrawal by Subject|4|||
162806500|NCT00495586|588003467|FG001|Overall Study|Withdrawal by Subject|4|||
162806501|NCT03038438|588003468|FG000|Overall Study|Death|3|||
162806502|NCT03038438|588003468|FG000|Overall Study|Lost to Follow-up|8|||
162806503|NCT03038438|588003468|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
162806504|NCT03038438|588003468|FG000|Overall Study|Withdrawal by Subject|5|||
162806505|NCT03038438|588003468|FG000|Overall Study|No 36-Month Follow-Up|18|||
162806506|NCT01174160|588003469|FG000|Overall Study|Adverse Event|1|||
162806507|NCT01174160|588003470|FG001|Overall Study|Adverse Event|0|||
162806508|NCT01174160|588003469|FG000|Overall Study|Lost to Follow-up|1|||
162806509|NCT01174160|588003470|FG001|Overall Study|Lost to Follow-up|0|||
162806510|NCT01174160|588003469|FG000|Overall Study|Physician Decision|1|||
162806511|NCT01174160|588003470|FG001|Overall Study|Physician Decision|0|||
162806512|NCT01174160|588003469|FG000|Overall Study|Protocol Violation|4|||
162806513|NCT01174160|588003470|FG001|Overall Study|Protocol Violation|6|||
162806514|NCT01174160|588003469|FG000|Overall Study|Withdrawal by Subject|1|||
162806515|NCT01174160|588003470|FG001|Overall Study|Withdrawal by Subject|0|||
162806516|NCT02038543|588003473|FG000|Overall Study|Screen Failure|0|||
162806517|NCT02038543|588003474|FG001|Overall Study|Screen Failure|0|||
162806518|NCT02038543|588003475|FG002|Overall Study|Screen Failure|0|||
162806519|NCT02038543|588003476|FG003|Overall Study|Screen Failure|1|||
162806520|NCT02038543|588003473|FG000|Overall Study|Withdrawal by Subject|0|||
162806521|NCT02038543|588003474|FG001|Overall Study|Withdrawal by Subject|0|||
162806522|NCT02038543|588003475|FG002|Overall Study|Withdrawal by Subject|0|||
162806523|NCT02038543|588003476|FG003|Overall Study|Withdrawal by Subject|1|||
162806524|NCT00093808|588003477|FG000|Overall Study|Cancel participation before receiving tx|1|||
162806525|NCT00093808|588003477|FG000|Overall Study|Protocol Violation|1|||
162806526|NCT03406260|588003478|FG000|Period 1|Adverse Event|0|||
162806527|NCT03406260|588003479|FG001|Period 1|Adverse Event|0|||
162806528|NCT03406260|588003480|FG002|Period 1|Adverse Event|0|||
162806529|NCT03406260|588003481|FG003|Period 1|Adverse Event|0|||
162806530|NCT03406260|588003482|FG004|Period 1|Adverse Event|1|||
162806531|NCT03406260|588003483|FG005|Period 1|Adverse Event|0|||
162806532|NCT02647866|588003484|FG000|Overall Study|Adverse Event|0|||
162806533|NCT02647866|588003485|FG001|Overall Study|Adverse Event|0|||
162806534|NCT02647866|588003486|FG002|Overall Study|Adverse Event|2|||
162806535|NCT02647866|588003487|FG003|Overall Study|Adverse Event|2|||
162806536|NCT02647866|588003488|FG004|Overall Study|Adverse Event|1|||
162806537|NCT02647866|588003484|FG000|Overall Study|Disease Worsening|3|||
162806538|NCT02647866|588003485|FG001|Overall Study|Disease Worsening|1|||
162806539|NCT02647866|588003486|FG002|Overall Study|Disease Worsening|0|||
162806540|NCT02647866|588003487|FG003|Overall Study|Disease Worsening|0|||
162806541|NCT02647866|588003488|FG004|Overall Study|Disease Worsening|1|||
162806542|NCT02647866|588003484|FG000|Overall Study|Withdrawal by Subject|1|||
162806543|NCT02647866|588003485|FG001|Overall Study|Withdrawal by Subject|1|||
162806544|NCT02647866|588003486|FG002|Overall Study|Withdrawal by Subject|2|||
162806545|NCT02647866|588003487|FG003|Overall Study|Withdrawal by Subject|4|||
162806546|NCT02647866|588003488|FG004|Overall Study|Withdrawal by Subject|4|||
162806547|NCT02647866|588003484|FG000|Overall Study|Physician Decision|0|||
162806548|NCT02647866|588003485|FG001|Overall Study|Physician Decision|1|||
162806549|NCT02647866|588003486|FG002|Overall Study|Physician Decision|1|||
162806550|NCT02647866|588003487|FG003|Overall Study|Physician Decision|0|||
162806551|NCT02647866|588003488|FG004|Overall Study|Physician Decision|2|||
162806552|NCT02647866|588003484|FG000|Overall Study|Death|0|||
162806553|NCT02647866|588003485|FG001|Overall Study|Death|1|||
162806554|NCT02647866|588003486|FG002|Overall Study|Death|0|||
162806555|NCT02647866|588003487|FG003|Overall Study|Death|0|||
162806556|NCT02647866|588003488|FG004|Overall Study|Death|0|||
162806557|NCT02647866|588003484|FG000|Overall Study|Subject moved to different country|1|||
162806558|NCT02647866|588003485|FG001|Overall Study|Subject moved to different country|0|||
162806559|NCT02647866|588003486|FG002|Overall Study|Subject moved to different country|0|||
162806560|NCT02647866|588003487|FG003|Overall Study|Subject moved to different country|0|||
162806561|NCT02647866|588003488|FG004|Overall Study|Subject moved to different country|0|||
162806562|NCT00871780|588003489|FG000|Overall Study|Enrolled But Not Treated|6|||
162806563|NCT00871780|588003489|FG000|Overall Study|Withdrawal by Subject|9|||
162806564|NCT00871780|588003489|FG000|Overall Study|Adverse Event|6|||
162806565|NCT00871780|588003489|FG000|Overall Study|Voluntary Discontinuation|4|||
162806566|NCT00871780|588003489|FG000|Overall Study|Death|1|||
162806567|NCT00871780|588003489|FG000|Overall Study|Physician Decision|1|||
162806568|NCT02527343|588003490|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
162806569|NCT02527343|588003491|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162806570|NCT02527343|588003492|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162806571|NCT02527343|588003493|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162806572|NCT02527343|588003494|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162806573|NCT02527343|588003495|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162806574|NCT02527343|588003490|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
162806575|NCT02527343|588003491|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162806576|NCT02527343|588003492|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162806577|NCT02527343|588003493|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162806578|NCT02527343|588003494|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162806579|NCT02527343|588003495|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162806580|NCT02527343|588003490|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162806581|NCT02527343|588003491|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
162806582|NCT02527343|588003492|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162806583|NCT02527343|588003493|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162806584|NCT02527343|588003494|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162806585|NCT02527343|588003495|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162806586|NCT02527343|588003490|FG000|RT Period: Weeks 1 to 52|Other|4|||
162806587|NCT02527343|588003491|FG001|RT Period: Weeks 1 to 52|Other|3|||
162806588|NCT02527343|588003492|FG002|RT Period: Weeks 1 to 52|Other|0|||
162806589|NCT02527343|588003493|FG003|RT Period: Weeks 1 to 52|Other|0|||
162806590|NCT02527343|588003494|FG004|RT Period: Weeks 1 to 52|Other|0|||
162806591|NCT02527343|588003495|FG005|RT Period: Weeks 1 to 52|Other|0|||
162806592|NCT02527343|588003490|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162806593|NCT02527343|588003491|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162806594|NCT02527343|588003492|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
162806595|NCT02527343|588003493|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162806596|NCT02527343|588003494|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162806597|NCT02527343|588003495|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162806598|NCT02527343|588003490|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162806599|NCT02527343|588003491|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162806600|NCT02527343|588003492|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162806601|NCT02527343|588003493|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
162806602|NCT02527343|588003494|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162806603|NCT02527343|588003495|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162806604|NCT02527343|588003490|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162806605|NCT02527343|588003491|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162806606|NCT02527343|588003492|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162806607|NCT02527343|588003493|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162806608|NCT02527343|588003494|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
162806609|NCT02527343|588003495|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162806610|NCT02527343|588003490|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162806611|NCT02527343|588003491|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162806612|NCT02527343|588003492|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162806613|NCT02527343|588003493|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162806614|NCT02527343|588003494|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
162806615|NCT02527343|588003495|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
162806616|NCT02527343|588003490|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162806617|NCT02527343|588003491|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162806618|NCT02527343|588003492|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162806619|NCT02527343|588003493|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162806620|NCT02527343|588003494|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
162806621|NCT02527343|588003495|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
162806622|NCT02527343|588003490|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
162806623|NCT02527343|588003491|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
162806624|NCT02527343|588003492|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
162806625|NCT02527343|588003493|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
162806626|NCT02527343|588003494|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
162806627|NCT02527343|588003495|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
162806628|NCT02527343|588003490|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
162806629|NCT02527343|588003491|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
162806630|NCT02527343|588003492|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
162806631|NCT02527343|588003493|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
162806632|NCT02527343|588003494|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
162806633|NCT02527343|588003495|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
162806634|NCT02527343|588003490|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162806635|NCT02527343|588003491|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162806636|NCT02527343|588003492|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162806637|NCT02527343|588003493|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162806638|NCT02527343|588003494|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
162806639|NCT02527343|588003495|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162806640|NCT02527343|588003490|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
162806641|NCT02527343|588003491|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
162806642|NCT02527343|588003492|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
162806643|NCT02527343|588003493|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
162806644|NCT02527343|588003494|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
162806645|NCT02527343|588003495|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
162806646|NCT01029652|588003496|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
162806647|NCT01029652|588003497|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
162806648|NCT01029652|588003496|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
162806649|NCT01029652|588003497|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
162806650|NCT01029652|588003496|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
162806651|NCT01029652|588003497|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
162806652|NCT01029652|588003496|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
162806653|NCT01029652|588003497|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
162806654|NCT01029652|588003496|FG000|Core Study (0-12 Weeks)|Death|0|||
162806655|NCT01029652|588003497|FG001|Core Study (0-12 Weeks)|Death|1|||
162806656|NCT01029652|588003496|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
162806657|NCT01029652|588003497|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
162806658|NCT01029652|588003496|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
162806659|NCT01029652|588003497|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
162806660|NCT01029652|588003496|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
162806661|NCT01029652|588003497|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
162806662|NCT01029652|588003496|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
162806663|NCT01029652|588003497|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
162806664|NCT01029652|588003496|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
162806665|NCT01029652|588003497|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
162806666|NCT01029652|588003496|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
162806667|NCT01029652|588003497|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
162806668|NCT01029652|588003496|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
162806669|NCT01029652|588003497|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
162806670|NCT05767021|588003498|FG000|Overall Study|Adverse Event|2|||
162806671|NCT05767021|588003498|FG000|Overall Study|Protocol Deviation|1|||
162806672|NCT05767021|588003498|FG000|Overall Study|Withdrawal by Subject|1|||
162806673|NCT05767021|588003498|FG000|Overall Study|Physician Decision|1|||
162806674|NCT05767021|588003498|FG000|Overall Study|Lack of Efficacy|11|||
162806675|NCT05767021|588003498|FG000|Overall Study|Assigned Treatment by Mistake|1|||
162806676|NCT02399254|588003503|FG000|Overall Study|Physician Decision|2|||
162806677|NCT02334423|588003504|FG000|Overall Study|Protocol Violation|10|||
162806678|NCT02334423|588003505|FG001|Overall Study|Protocol Violation|3|||
162806679|NCT04426851|588003510|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
162806680|NCT04426851|588003511|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
162806681|NCT04426851|588003510|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
162806682|NCT04426851|588003511|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
162806683|NCT03545503|588003513|FG000|Overall Study|Protocol Violation|14|||
162806684|NCT03545503|588003514|FG001|Overall Study|Protocol Violation|16|||
162806685|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
162806686|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
162806687|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
162806688|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
162806689|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
162806690|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
162806691|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
162806692|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806693|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806694|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806695|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806696|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
162806697|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806698|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162806699|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806700|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806701|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806702|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806703|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
162806704|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806705|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
162806706|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806707|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806708|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806709|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
162806710|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
162806711|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806712|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806713|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162806714|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162806715|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162806716|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162806717|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162806718|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162806719|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162806720|NCT04494256|588003515|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806721|NCT04494256|588003516|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806722|NCT04494256|588003517|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806723|NCT04494256|588003518|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806724|NCT04494256|588003519|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
162806725|NCT04494256|588003520|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806726|NCT04494256|588003521|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
162806727|NCT04494256|588003515|FG000|Part 2: Open Label Period|Death|0|||
162806728|NCT04494256|588003516|FG001|Part 2: Open Label Period|Death|0|||
162806729|NCT04494256|588003517|FG002|Part 2: Open Label Period|Death|0|||
162806730|NCT04494256|588003518|FG003|Part 2: Open Label Period|Death|0|||
162806731|NCT04494256|588003519|FG004|Part 2: Open Label Period|Death|0|||
162806732|NCT04494256|588003520|FG005|Part 2: Open Label Period|Death|4|||
162806733|NCT04494256|588003521|FG006|Part 2: Open Label Period|Death|2|||
162806734|NCT04494256|588003515|FG000|Part 2: Open Label Period|Adverse Event|0|||
162806735|NCT04494256|588003516|FG001|Part 2: Open Label Period|Adverse Event|0|||
162806736|NCT04494256|588003517|FG002|Part 2: Open Label Period|Adverse Event|0|||
162806737|NCT04494256|588003518|FG003|Part 2: Open Label Period|Adverse Event|0|||
162806738|NCT04494256|588003519|FG004|Part 2: Open Label Period|Adverse Event|0|||
162806739|NCT04494256|588003520|FG005|Part 2: Open Label Period|Adverse Event|0|||
162806740|NCT04494256|588003521|FG006|Part 2: Open Label Period|Adverse Event|2|||
162806741|NCT04494256|588003515|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162806742|NCT04494256|588003516|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162806743|NCT04494256|588003517|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162806744|NCT04494256|588003518|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162806745|NCT04494256|588003519|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162806746|NCT04494256|588003520|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
162806747|NCT04494256|588003521|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
162806748|NCT04494256|588003515|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806749|NCT04494256|588003516|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806750|NCT04494256|588003517|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806751|NCT04494256|588003518|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806752|NCT04494256|588003519|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806753|NCT04494256|588003520|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162806754|NCT04494256|588003521|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
162806755|NCT04494256|588003515|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162806756|NCT04494256|588003516|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162806757|NCT04494256|588003517|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162806758|NCT04494256|588003518|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162806759|NCT04494256|588003519|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162806760|NCT04494256|588003520|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
162806761|NCT04494256|588003521|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
162806762|NCT04494256|588003515|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806763|NCT04494256|588003516|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806764|NCT04494256|588003517|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162925441|NCT02564952|588428975|FG000|Overall Study|Low Efficacy|1|||
162806765|NCT04494256|588003518|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806766|NCT04494256|588003519|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162806767|NCT04494256|588003520|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
162806768|NCT04494256|588003521|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
162806769|NCT04494256|588003515|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162806770|NCT04494256|588003516|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162806771|NCT04494256|588003517|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162806772|NCT04494256|588003518|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162806773|NCT04494256|588003519|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162806774|NCT04494256|588003520|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
162806775|NCT04494256|588003521|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
162806776|NCT00262951|588003522|FG000|Overall Study|Progressive disease/relapse|3|||
162806777|NCT00262951|588003522|FG000|Overall Study|Adverse Event|7|||
162806778|NCT00262951|588003522|FG000|Overall Study|Death|1|||
162806779|NCT00262951|588003522|FG000|Overall Study|Withdrawal by Subject|1|||
162806780|NCT00262951|588003522|FG000|Overall Study|Alternative treatment|3|||
162806781|NCT00262951|588003522|FG000|Overall Study|Off treatment for other disease|1|||
162806782|NCT02483585|588003523|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
162806783|NCT02483585|588003524|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
162806784|NCT02483585|588003523|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
162806785|NCT02483585|588003524|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
162806786|NCT02483585|588003523|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
162806787|NCT02483585|588003524|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
162806788|NCT02483585|588003523|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
162806789|NCT02483585|588003524|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
162806790|NCT02483585|588003523|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
162806791|NCT02483585|588003524|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
162806792|NCT02483585|588003523|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
162806793|NCT02483585|588003524|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
162806794|NCT02483585|588003523|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
162806795|NCT02483585|588003524|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
162806796|NCT00825916|588003528|FG000|Overall Study|Lost to Follow-up|4|||
162806797|NCT00825916|588003529|FG001|Overall Study|Lost to Follow-up|2|||
162806798|NCT00825916|588003530|FG002|Overall Study|Lost to Follow-up|1|||
162806799|NCT01778023|588003531|FG000|Overall Study|Withdrawal by Subject|0|||
162806800|NCT01778023|588003532|FG001|Overall Study|Withdrawal by Subject|3|||
162806801|NCT01098097|588003533|FG000|Overall Study|Adverse Event|17|||
162806802|NCT01098097|588003533|FG000|Overall Study|Lost to Follow-up|18|||
162806803|NCT01098097|588003533|FG000|Overall Study|Status unknown|16|||
162806804|NCT01098097|588003533|FG000|Overall Study|No reason reported|31|||
162806805|NCT01000636|588003534|FG000|Overall Study|Withdrawal by Subject|1|||
162806806|NCT01000636|588003534|FG000|Overall Study|Adverse Event|1|||
162806807|NCT00577577|588003536|FG000|Overall Study|Adverse Event|3|||
162806808|NCT00577577|588003537|FG001|Overall Study|Adverse Event|2|||
162806809|NCT00577577|588003536|FG000|Overall Study|Lost to Follow-up|1|||
162806810|NCT00577577|588003537|FG001|Overall Study|Lost to Follow-up|0|||
162806811|NCT00577577|588003536|FG000|Overall Study|Protocol Violation|0|||
162806812|NCT00577577|588003537|FG001|Overall Study|Protocol Violation|3|||
162806813|NCT00577577|588003536|FG000|Overall Study|Transportation|1|||
162806814|NCT00577577|588003537|FG001|Overall Study|Transportation|0|||
162806815|NCT01090427|588003538|FG000|After Controlled Period|Death|0|||
162806816|NCT01090427|588003539|FG001|After Controlled Period|Death|0|||
162806817|NCT01090427|588003540|FG002|After Controlled Period|Death|0|||
162806818|NCT01090427|588003541|FG003|After Controlled Period|Death|0|||
162806819|NCT01090427|588003542|FG004|After Controlled Period|Death|0|||
162806820|NCT01090427|588003543|FG005|After Controlled Period|Death|1|||
162806821|NCT01090427|588003544|FG006|After Controlled Period|Death|0|||
162806822|NCT01090427|588003538|FG000|After Controlled Period|Lack of Efficacy|0|||
162806823|NCT01090427|588003539|FG001|After Controlled Period|Lack of Efficacy|0|||
162806824|NCT01090427|588003540|FG002|After Controlled Period|Lack of Efficacy|0|||
162806825|NCT01090427|588003541|FG003|After Controlled Period|Lack of Efficacy|0|||
162806826|NCT01090427|588003542|FG004|After Controlled Period|Lack of Efficacy|0|||
162806827|NCT01090427|588003543|FG005|After Controlled Period|Lack of Efficacy|3|||
162806828|NCT01090427|588003544|FG006|After Controlled Period|Lack of Efficacy|2|||
162806829|NCT01090427|588003538|FG000|After Controlled Period|Adverse Event|0|||
162806830|NCT01090427|588003539|FG001|After Controlled Period|Adverse Event|0|||
162806831|NCT01090427|588003540|FG002|After Controlled Period|Adverse Event|0|||
162806832|NCT01090427|588003541|FG003|After Controlled Period|Adverse Event|2|||
162806833|NCT01090427|588003542|FG004|After Controlled Period|Adverse Event|0|||
162806834|NCT01090427|588003543|FG005|After Controlled Period|Adverse Event|1|||
162806835|NCT01090427|588003544|FG006|After Controlled Period|Adverse Event|0|||
162806836|NCT01154010|588003545|FG000|Overall Study|Lost to Follow-up|0|||
162806837|NCT01154010|588003546|FG001|Overall Study|Lost to Follow-up|1|||
162806838|NCT02413333|588003552|FG000|Period 1|Adverse Event|1|||
162806839|NCT02413333|588003553|FG001|Period 1|Adverse Event|0|||
162806840|NCT02413333|588003552|FG000|Period 1|Reason Not Specified|0|||
162806841|NCT02413333|588003553|FG001|Period 1|Reason Not Specified|1|||
162806842|NCT02413333|588003552|FG000|Period 2|Protocol Deviation|1|||
162806843|NCT02413333|588003553|FG001|Period 2|Protocol Deviation|0|||
162806844|NCT01465347|588003554|FG000|Overall Study|Withdrawal by Subject|1|||
162806845|NCT01465347|588003555|FG001|Overall Study|Withdrawal by Subject|1|||
162806846|NCT01465347|588003554|FG000|Overall Study|Physician Decision|0|||
162806847|NCT01465347|588003555|FG001|Overall Study|Physician Decision|1|||
162806848|NCT01465347|588003554|FG000|Overall Study|Admitted to hospice|0|||
162806849|NCT01465347|588003555|FG001|Overall Study|Admitted to hospice|1|||
162806850|NCT00906945|588003556|FG000|Overall Study|Found to be not eligible|0|||
162806851|NCT00906945|588003557|FG001|Overall Study|Found to be not eligible|0|||
162806852|NCT00906945|588003558|FG002|Overall Study|Found to be not eligible|0|||
162806853|NCT00906945|588003559|FG003|Overall Study|Found to be not eligible|1|||
162806854|NCT00906945|588003560|FG004|Overall Study|Found to be not eligible|1|||
162806855|NCT00906945|588003561|FG005|Overall Study|Found to be not eligible|1|||
162806856|NCT00906945|588003556|FG000|Overall Study|Physician Decision|0|||
162806857|NCT00906945|588003557|FG001|Overall Study|Physician Decision|0|||
162806858|NCT00906945|588003558|FG002|Overall Study|Physician Decision|0|||
162806859|NCT00906945|588003559|FG003|Overall Study|Physician Decision|0|||
162806860|NCT00906945|588003560|FG004|Overall Study|Physician Decision|0|||
162806861|NCT00906945|588003561|FG005|Overall Study|Physician Decision|1|||
162806862|NCT02996474|588003563|FG000|Overall Study|Physician Decision|5|||
162806863|NCT01210664|588003564|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162806864|NCT01210664|588003565|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162806865|NCT01210664|588003566|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
162806866|NCT01210664|588003567|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162806867|NCT01210664|588003564|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806868|NCT01210664|588003565|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806869|NCT01210664|588003566|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
162806870|NCT01210664|588003567|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806871|NCT01210664|588003564|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806872|NCT01210664|588003565|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806873|NCT01210664|588003566|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
162806874|NCT01210664|588003567|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
162806875|NCT01853644|588003568|FG000|Registration and Treatment Start|Did not start treatment|1|||
162806876|NCT01853644|588003568|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
162806877|NCT01853644|588003568|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
162806878|NCT01853644|588003568|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
162806879|NCT01853644|588003568|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
162806880|NCT01853644|588003568|FG000|Continued Treatment After First Response|Adverse Event|2|||
162806881|NCT01853644|588003568|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
162806882|NCT02891837|588003569|FG000|Overall Study|Lost to Follow-up|2|||
162806883|NCT02891837|588003570|FG001|Overall Study|Lost to Follow-up|0|||
162806884|NCT02891837|588003569|FG000|Overall Study|Withdrawal by Subject|1|||
162806885|NCT02891837|588003570|FG001|Overall Study|Withdrawal by Subject|0|||
162806886|NCT01048671|588003571|FG000|Overall Study|Protocol Violation|0|||
162806887|NCT01048671|588003572|FG001|Overall Study|Protocol Violation|1|||
162806888|NCT01048671|588003573|FG002|Overall Study|Protocol Violation|1|||
162806889|NCT01535560|588003575|FG000|Overall Study|Adverse Event|12|||
162806890|NCT01535560|588003576|FG001|Overall Study|Adverse Event|7|||
162806891|NCT01535560|588003575|FG000|Overall Study|Lost to Follow-up|1|||
162806892|NCT01535560|588003576|FG001|Overall Study|Lost to Follow-up|3|||
162806893|NCT01535560|588003575|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
162806894|NCT01535560|588003576|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
162806895|NCT01535560|588003575|FG000|Overall Study|Treatment Failure|21|||
162806896|NCT01535560|588003576|FG001|Overall Study|Treatment Failure|83|||
162806897|NCT01535560|588003575|FG000|Overall Study|Other|0|||
162806898|NCT01535560|588003576|FG001|Overall Study|Other|1|||
162806899|NCT01535560|588003575|FG000|Overall Study|Randomized in Error|0|||
162806900|NCT01535560|588003576|FG001|Overall Study|Randomized in Error|1|||
162806901|NCT01178385|588003580|FG000|Overall Study|Withdrawal by Subject|2|||
162806902|NCT01178385|588003581|FG001|Overall Study|Withdrawal by Subject|0|||
162806903|NCT00985946|588003582|FG000|Overall Study|Lost to Follow-up|6|||
162806904|NCT00985946|588003582|FG000|Overall Study|Withdrawal by Subject|1|||
162806905|NCT00928018|588003587|FG000|Overall Study|Withdrawal by Subject|1|||
162806906|NCT00928018|588003588|FG001|Overall Study|Withdrawal by Subject|0|||
162806907|NCT02008877|588003589|FG000|Overall Study|Inevaluable|0|||
162806908|NCT02008877|588003590|FG001|Overall Study|Inevaluable|1|||
162806909|NCT02008877|588003591|FG002|Overall Study|Inevaluable|0|||
162806910|NCT00847808|588003592|FG000|Overall Study|Adverse Event|7|||
162806911|NCT00847808|588003592|FG000|Overall Study|Protocol Violation|1|||
162806912|NCT00847808|588003592|FG000|Overall Study|Lost to Follow-up|1|||
162806913|NCT00847808|588003592|FG000|Overall Study|Withdrawal by Subject|4|||
162806914|NCT00847808|588003592|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
162806915|NCT00847808|588003592|FG000|Overall Study|Participant Took Excluded Medication|1|||
162806916|NCT05000931|588003602|FG000|Overall Study|Lost to Follow-up|1|||
162806917|NCT05326815|588003603|FG000|Overall Study|Withdrawal by Subject|3|||
162806918|NCT05326815|588003603|FG000|Overall Study|Did not complete required labs|6|||
162806919|NCT05326815|588003603|FG000|Overall Study|Screen fail- abnormal labs|5|||
162806920|NCT00979134|588003604|FG000|Overall Study|Disease progression|18|||
162806921|NCT00979134|588003605|FG001|Overall Study|Disease progression|2|||
162806922|NCT00979134|588003606|FG002|Overall Study|Disease progression|5|||
162806923|NCT00979134|588003604|FG000|Overall Study|Adverse Event|0|||
162806924|NCT00979134|588003605|FG001|Overall Study|Adverse Event|0|||
162806925|NCT00979134|588003606|FG002|Overall Study|Adverse Event|2|||
162806926|NCT00979134|588003604|FG000|Overall Study|Withdrawal by Subject|1|||
162806927|NCT00979134|588003605|FG001|Overall Study|Withdrawal by Subject|1|||
162806928|NCT00979134|588003606|FG002|Overall Study|Withdrawal by Subject|2|||
162806929|NCT00979134|588003604|FG000|Overall Study|Lost to Follow-up|2|||
162806930|NCT00979134|588003605|FG001|Overall Study|Lost to Follow-up|2|||
162806931|NCT00979134|588003606|FG002|Overall Study|Lost to Follow-up|0|||
162806932|NCT00979134|588003604|FG000|Overall Study|Death|4|||
162806933|NCT00979134|588003605|FG001|Overall Study|Death|0|||
162806934|NCT00979134|588003606|FG002|Overall Study|Death|26|||
162806935|NCT00979134|588003604|FG000|Overall Study|Other|8|||
162806936|NCT00979134|588003605|FG001|Overall Study|Other|1|||
162806937|NCT00979134|588003606|FG002|Overall Study|Other|5|||
162806938|NCT05172050|588003607|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
162806939|NCT05172050|588003608|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
162806940|NCT05172050|588003609|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
162806941|NCT05172050|588003607|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
162806942|NCT05172050|588003608|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
162806943|NCT05172050|588003609|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
162806944|NCT05172050|588003607|FG000|Overall Study|Other|2|||
162806945|NCT05172050|588003608|FG001|Overall Study|Other|2|||
162806946|NCT05172050|588003609|FG002|Overall Study|Other|1|||
162806947|NCT04617275|588003614|FG000|Treatment Period|Adverse Event|1|||
162806948|NCT04617275|588003615|FG001|Treatment Period|Adverse Event|6|||
162806949|NCT04617275|588003616|FG002|Treatment Period|Adverse Event|4|||
162806950|NCT04617275|588003617|FG003|Treatment Period|Adverse Event|6|||
162806951|NCT04617275|588003618|FG004|Treatment Period|Adverse Event|7|||
162806952|NCT04617275|588003619|FG005|Treatment Period|Adverse Event|8|||
162806953|NCT04617275|588003620|FG006|Treatment Period|Adverse Event|0|||
162806954|NCT04617275|588003621|FG007|Treatment Period|Adverse Event|12|||
162806955|NCT04617275|588003614|FG000|Treatment Period|Lost to Follow-up|0|||
162806956|NCT04617275|588003615|FG001|Treatment Period|Lost to Follow-up|0|||
162806957|NCT04617275|588003616|FG002|Treatment Period|Lost to Follow-up|2|||
162806958|NCT04617275|588003617|FG003|Treatment Period|Lost to Follow-up|0|||
162806959|NCT04617275|588003618|FG004|Treatment Period|Lost to Follow-up|0|||
162806960|NCT04617275|588003619|FG005|Treatment Period|Lost to Follow-up|3|||
162806961|NCT04617275|588003620|FG006|Treatment Period|Lost to Follow-up|0|||
162806962|NCT04617275|588003621|FG007|Treatment Period|Lost to Follow-up|2|||
162806963|NCT04617275|588003614|FG000|Treatment Period|No longer meets eligibility criteria|0|||
162806964|NCT04617275|588003615|FG001|Treatment Period|No longer meets eligibility criteria|0|||
162806965|NCT04617275|588003616|FG002|Treatment Period|No longer meets eligibility criteria|0|||
162806966|NCT04617275|588003617|FG003|Treatment Period|No longer meets eligibility criteria|1|||
162806967|NCT04617275|588003618|FG004|Treatment Period|No longer meets eligibility criteria|0|||
162806968|NCT04617275|588003619|FG005|Treatment Period|No longer meets eligibility criteria|0|||
162806969|NCT04617275|588003620|FG006|Treatment Period|No longer meets eligibility criteria|0|||
162806970|NCT04617275|588003621|FG007|Treatment Period|No longer meets eligibility criteria|0|||
162806971|NCT04617275|588003614|FG000|Treatment Period|Other|0|||
162806972|NCT04617275|588003615|FG001|Treatment Period|Other|1|||
162806973|NCT04617275|588003616|FG002|Treatment Period|Other|0|||
162806974|NCT04617275|588003617|FG003|Treatment Period|Other|0|||
162806975|NCT04617275|588003618|FG004|Treatment Period|Other|0|||
162806976|NCT04617275|588003619|FG005|Treatment Period|Other|0|||
162806977|NCT04617275|588003620|FG006|Treatment Period|Other|0|||
162806978|NCT04617275|588003621|FG007|Treatment Period|Other|0|||
162806979|NCT04617275|588003614|FG000|Treatment Period|Withdrawal by Subject|2|||
162806980|NCT04617275|588003615|FG001|Treatment Period|Withdrawal by Subject|0|||
162806981|NCT04617275|588003616|FG002|Treatment Period|Withdrawal by Subject|0|||
162806982|NCT04617275|588003617|FG003|Treatment Period|Withdrawal by Subject|2|||
162806983|NCT04617275|588003618|FG004|Treatment Period|Withdrawal by Subject|2|||
162806984|NCT04617275|588003619|FG005|Treatment Period|Withdrawal by Subject|0|||
162806985|NCT04617275|588003620|FG006|Treatment Period|Withdrawal by Subject|1|||
162806986|NCT04617275|588003621|FG007|Treatment Period|Withdrawal by Subject|2|||
162806987|NCT04617275|588003614|FG000|Follow-up Period|Adverse Event|1|||
162806988|NCT04617275|588003615|FG001|Follow-up Period|Adverse Event|1|||
162806989|NCT04617275|588003616|FG002|Follow-up Period|Adverse Event|2|||
162806990|NCT04617275|588003617|FG003|Follow-up Period|Adverse Event|3|||
162806991|NCT04617275|588003618|FG004|Follow-up Period|Adverse Event|4|||
162806992|NCT04617275|588003619|FG005|Follow-up Period|Adverse Event|3|||
162806993|NCT04617275|588003620|FG006|Follow-up Period|Adverse Event|0|||
162806994|NCT04617275|588003621|FG007|Follow-up Period|Adverse Event|3|||
162806995|NCT04617275|588003614|FG000|Follow-up Period|Lost to Follow-up|0|||
162806996|NCT04617275|588003615|FG001|Follow-up Period|Lost to Follow-up|1|||
162806997|NCT04617275|588003616|FG002|Follow-up Period|Lost to Follow-up|2|||
162806998|NCT04617275|588003617|FG003|Follow-up Period|Lost to Follow-up|0|||
162806999|NCT04617275|588003618|FG004|Follow-up Period|Lost to Follow-up|0|||
162807000|NCT04617275|588003619|FG005|Follow-up Period|Lost to Follow-up|4|||
162807001|NCT04617275|588003620|FG006|Follow-up Period|Lost to Follow-up|0|||
162807002|NCT04617275|588003621|FG007|Follow-up Period|Lost to Follow-up|3|||
162807003|NCT04617275|588003614|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
162807004|NCT04617275|588003615|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
162807005|NCT04617275|588003616|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
162807006|NCT04617275|588003617|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
162807007|NCT04617275|588003618|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
162807008|NCT04617275|588003619|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
162807009|NCT04617275|588003620|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
162807010|NCT04617275|588003621|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
162807011|NCT04617275|588003614|FG000|Follow-up Period|Other|0|||
162807012|NCT04617275|588003615|FG001|Follow-up Period|Other|1|||
162807013|NCT04617275|588003616|FG002|Follow-up Period|Other|0|||
162807014|NCT04617275|588003617|FG003|Follow-up Period|Other|0|||
162807015|NCT04617275|588003618|FG004|Follow-up Period|Other|0|||
162807016|NCT04617275|588003619|FG005|Follow-up Period|Other|0|||
162807017|NCT04617275|588003620|FG006|Follow-up Period|Other|0|||
162807018|NCT04617275|588003621|FG007|Follow-up Period|Other|0|||
162807019|NCT04617275|588003614|FG000|Follow-up Period|Withdrawal by Subject|2|||
162807020|NCT04617275|588003615|FG001|Follow-up Period|Withdrawal by Subject|0|||
162807021|NCT04617275|588003616|FG002|Follow-up Period|Withdrawal by Subject|0|||
162807022|NCT04617275|588003617|FG003|Follow-up Period|Withdrawal by Subject|2|||
162807023|NCT04617275|588003618|FG004|Follow-up Period|Withdrawal by Subject|2|||
162807024|NCT04617275|588003619|FG005|Follow-up Period|Withdrawal by Subject|0|||
162807025|NCT04617275|588003620|FG006|Follow-up Period|Withdrawal by Subject|1|||
162807026|NCT04617275|588003621|FG007|Follow-up Period|Withdrawal by Subject|2|||
162807027|NCT04227704|588003622|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
162807028|NCT04227704|588003623|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
162807029|NCT04227704|588003624|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
162807030|NCT04227704|588003622|FG000|Overall Study|due to C/S being cancelled|1|||
162807031|NCT04227704|588003623|FG001|Overall Study|due to C/S being cancelled|0|||
162807032|NCT04227704|588003624|FG002|Overall Study|due to C/S being cancelled|0|||
162807033|NCT00729378|588006088|FG000|Baseline|Did not complete study measurements|72|||
162807034|NCT00729378|588006089|FG001|Baseline|Did not complete study measurements|33|||
162807035|NCT00729378|588006088|FG000|Baseline|Withdrawal by Subject|66|||
162807036|NCT00729378|588006089|FG001|Baseline|Withdrawal by Subject|59|||
162807037|NCT00729378|588006088|FG000|12-months|Lost to Follow-up|100|||
162807038|NCT00729378|588006089|FG001|12-months|Lost to Follow-up|65|||
162807039|NCT00729378|588006088|FG000|24-months|Lost to Follow-up|72|||
162807040|NCT00729378|588006089|FG001|24-months|Lost to Follow-up|51|||
162807041|NCT00729378|588006088|FG000|36-months|Lost to Follow-up|15|||
162807042|NCT00729378|588006089|FG001|36-months|Lost to Follow-up|6|||
162807043|NCT00484289|588006097|FG000|Long Term Phase|Adverse Event|1|||
162807044|NCT00484289|588006098|FG001|Long Term Phase|Adverse Event|17|||
162807045|NCT00484289|588006099|FG002|Long Term Phase|Adverse Event|5|||
162807046|NCT00484289|588006097|FG000|Long Term Phase|Withdrawal by Subject|0|||
162807047|NCT00484289|588006098|FG001|Long Term Phase|Withdrawal by Subject|7|||
162807048|NCT00484289|588006099|FG002|Long Term Phase|Withdrawal by Subject|6|||
162807049|NCT00484289|588006097|FG000|Long Term Phase|Inadequate response|2|||
162807050|NCT00484289|588006098|FG001|Long Term Phase|Inadequate response|7|||
162807051|NCT00484289|588006099|FG002|Long Term Phase|Inadequate response|4|||
162807052|NCT00484289|588006097|FG000|Long Term Phase|Other Reason|0|||
162807053|NCT00484289|588006098|FG001|Long Term Phase|Other Reason|5|||
162807054|NCT00484289|588006099|FG002|Long Term Phase|Other Reason|1|||
162807055|NCT00484289|588006097|FG000|Post Marketing Phase|Adverse Event|0|||
162807056|NCT00484289|588006098|FG001|Post Marketing Phase|Adverse Event|1|||
162807057|NCT00484289|588006099|FG002|Post Marketing Phase|Adverse Event|0|||
162807058|NCT00690443|588006100|FG000|Overall Study|Adverse Event|1|||
162807059|NCT00690443|588006101|FG001|Overall Study|Adverse Event|2|||
162807060|NCT02874924|588006104|FG000|Overall Study|Adverse Event|2|||
162807061|NCT02874924|588006105|FG001|Overall Study|Adverse Event|0|||
162807062|NCT02874924|588006106|FG002|Overall Study|Adverse Event|0|||
162807063|NCT02874924|588006104|FG000|Overall Study|Withdrawal by Subject|1|||
162807064|NCT02874924|588006105|FG001|Overall Study|Withdrawal by Subject|0|||
162807065|NCT02874924|588006106|FG002|Overall Study|Withdrawal by Subject|0|||
162807066|NCT02808143|588006107|FG000|Maintenance Phase|Disease recurrence|1|||
162807067|NCT02808143|588006108|FG001|Maintenance Phase|Disease recurrence|3|||
162807068|NCT02808143|588006107|FG000|Maintenance Phase|Disease progression|1|||
162807069|NCT02808143|588006108|FG001|Maintenance Phase|Disease progression|2|||
162807070|NCT02808143|588006107|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
162807071|NCT02808143|588006108|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
162807072|NCT02808143|588006107|FG000|Survival Follow-Up|Disease recurrence|0|||
162807073|NCT02808143|588006108|FG001|Survival Follow-Up|Disease recurrence|2|||
162807074|NCT02808143|588006107|FG000|Survival Follow-Up|Adverse Event|0|||
162807075|NCT02808143|588006108|FG001|Survival Follow-Up|Adverse Event|1|||
162807076|NCT02808143|588006107|FG000|Survival Follow-Up|Death|1|||
162807077|NCT02808143|588006108|FG001|Survival Follow-Up|Death|0|||
162807078|NCT01874431|588006109|FG000|Overall Study|Physician Decision|0|||
162807079|NCT01874431|588006110|FG001|Overall Study|Physician Decision|0|||
162807080|NCT01874431|588006111|FG002|Overall Study|Physician Decision|1|||
162807081|NCT01874431|588006112|FG003|Overall Study|Physician Decision|0|||
162807082|NCT01874431|588006113|FG004|Overall Study|Physician Decision|0|||
162807083|NCT01874431|588006114|FG005|Overall Study|Physician Decision|0|||
162807084|NCT01874431|588006115|FG006|Overall Study|Physician Decision|0|||
162807085|NCT01874431|588006116|FG007|Overall Study|Physician Decision|0|||
162807086|NCT01874431|588006109|FG000|Overall Study|Adverse Event|5|||
162807087|NCT01874431|588006110|FG001|Overall Study|Adverse Event|4|||
162807088|NCT01874431|588006111|FG002|Overall Study|Adverse Event|6|||
162807089|NCT01874431|588006112|FG003|Overall Study|Adverse Event|5|||
162807090|NCT01874431|588006113|FG004|Overall Study|Adverse Event|2|||
162807091|NCT01874431|588006114|FG005|Overall Study|Adverse Event|8|||
162807092|NCT01874431|588006115|FG006|Overall Study|Adverse Event|2|||
162807093|NCT01874431|588006116|FG007|Overall Study|Adverse Event|3|||
162807094|NCT01874431|588006109|FG000|Overall Study|Protocol Violation|1|||
162807095|NCT01874431|588006110|FG001|Overall Study|Protocol Violation|1|||
162807096|NCT01874431|588006111|FG002|Overall Study|Protocol Violation|1|||
162807097|NCT01874431|588006112|FG003|Overall Study|Protocol Violation|0|||
162807098|NCT01874431|588006113|FG004|Overall Study|Protocol Violation|3|||
162807099|NCT01874431|588006114|FG005|Overall Study|Protocol Violation|2|||
162807100|NCT01874431|588006115|FG006|Overall Study|Protocol Violation|1|||
162807101|NCT01874431|588006116|FG007|Overall Study|Protocol Violation|1|||
162807102|NCT01874431|588006109|FG000|Overall Study|Non-compliance|0|||
162807103|NCT01874431|588006110|FG001|Overall Study|Non-compliance|0|||
162807104|NCT01874431|588006111|FG002|Overall Study|Non-compliance|0|||
162807105|NCT01874431|588006112|FG003|Overall Study|Non-compliance|0|||
162807106|NCT01874431|588006113|FG004|Overall Study|Non-compliance|1|||
162807107|NCT01874431|588006114|FG005|Overall Study|Non-compliance|0|||
162807108|NCT01874431|588006115|FG006|Overall Study|Non-compliance|1|||
162807109|NCT01874431|588006116|FG007|Overall Study|Non-compliance|0|||
162807110|NCT01874431|588006109|FG000|Overall Study|Logistical difficulties|0|||
162807111|NCT01874431|588006110|FG001|Overall Study|Logistical difficulties|0|||
162807112|NCT01874431|588006111|FG002|Overall Study|Logistical difficulties|0|||
162807113|NCT01874431|588006112|FG003|Overall Study|Logistical difficulties|0|||
162807114|NCT01874431|588006113|FG004|Overall Study|Logistical difficulties|0|||
162807115|NCT01874431|588006114|FG005|Overall Study|Logistical difficulties|0|||
162807116|NCT01874431|588006115|FG006|Overall Study|Logistical difficulties|1|||
162807117|NCT01874431|588006116|FG007|Overall Study|Logistical difficulties|0|||
162807118|NCT01874431|588006109|FG000|Overall Study|Withdrawal by Subject|0|||
162807119|NCT01874431|588006110|FG001|Overall Study|Withdrawal by Subject|0|||
162807120|NCT01874431|588006111|FG002|Overall Study|Withdrawal by Subject|1|||
162807121|NCT01874431|588006112|FG003|Overall Study|Withdrawal by Subject|2|||
162807122|NCT01874431|588006113|FG004|Overall Study|Withdrawal by Subject|1|||
162807123|NCT01874431|588006114|FG005|Overall Study|Withdrawal by Subject|1|||
162807124|NCT01874431|588006115|FG006|Overall Study|Withdrawal by Subject|3|||
162807125|NCT01874431|588006116|FG007|Overall Study|Withdrawal by Subject|0|||
162807126|NCT01874431|588006109|FG000|Overall Study|Sponsor decision|0|||
162807127|NCT01874431|588006110|FG001|Overall Study|Sponsor decision|0|||
162807128|NCT01874431|588006111|FG002|Overall Study|Sponsor decision|0|||
162807129|NCT01874431|588006112|FG003|Overall Study|Sponsor decision|0|||
162807130|NCT01874431|588006113|FG004|Overall Study|Sponsor decision|1|||
162807131|NCT01874431|588006114|FG005|Overall Study|Sponsor decision|0|||
162807132|NCT01874431|588006115|FG006|Overall Study|Sponsor decision|0|||
162807133|NCT01874431|588006116|FG007|Overall Study|Sponsor decision|0|||
162807134|NCT01874431|588006109|FG000|Overall Study|Lost to Follow-up|0|||
162807135|NCT01874431|588006110|FG001|Overall Study|Lost to Follow-up|0|||
162807136|NCT01874431|588006111|FG002|Overall Study|Lost to Follow-up|1|||
162807137|NCT01874431|588006112|FG003|Overall Study|Lost to Follow-up|0|||
162807138|NCT01874431|588006113|FG004|Overall Study|Lost to Follow-up|0|||
162807139|NCT01874431|588006114|FG005|Overall Study|Lost to Follow-up|0|||
162807140|NCT01874431|588006115|FG006|Overall Study|Lost to Follow-up|0|||
162807141|NCT01874431|588006116|FG007|Overall Study|Lost to Follow-up|0|||
162807142|NCT03718533|588006118|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
162807143|NCT03718533|588006118|FG000|Overall Study|Protocol deviation|1|||
162807144|NCT03718533|588006118|FG000|Overall Study|Disease progression|1|||
162807145|NCT03718533|588006118|FG000|Overall Study|Relapse|1|||
162807146|NCT03718533|588006118|FG000|Overall Study|Physician Decision|2|||
162807147|NCT03718533|588006118|FG000|Overall Study|Physician Decision and Adverse Event|1|||
162807148|NCT02257567|588006119|FG000|Overall Study|Adverse Event|0|||
162807149|NCT02257567|588006120|FG001|Overall Study|Adverse Event|0|||
162807150|NCT02257567|588006121|FG002|Overall Study|Adverse Event|0|||
162807151|NCT02257567|588006122|FG003|Overall Study|Adverse Event|1|||
162807152|NCT02257567|588006123|FG004|Overall Study|Adverse Event|1|||
162807153|NCT02257567|588006124|FG005|Overall Study|Adverse Event|0|||
162807154|NCT02257567|588006125|FG006|Overall Study|Adverse Event|0|||
162807155|NCT02257567|588006126|FG007|Overall Study|Adverse Event|0|||
162807156|NCT02257567|588006127|FG008|Overall Study|Adverse Event|1|||
162807157|NCT02257567|588006128|FG009|Overall Study|Adverse Event|0|||
162807158|NCT02257567|588006129|FG010|Overall Study|Adverse Event|0|||
162807159|NCT02257567|588006119|FG000|Overall Study|Death|2|||
162807160|NCT02257567|588006120|FG001|Overall Study|Death|2|||
162807161|NCT02257567|588006121|FG002|Overall Study|Death|2|||
162807162|NCT02257567|588006122|FG003|Overall Study|Death|4|||
162807163|NCT02257567|588006123|FG004|Overall Study|Death|15|||
162807164|NCT02257567|588006124|FG005|Overall Study|Death|11|||
162807165|NCT02257567|588006125|FG006|Overall Study|Death|26|||
162807166|NCT02257567|588006126|FG007|Overall Study|Death|30|||
162807167|NCT02257567|588006127|FG008|Overall Study|Death|2|||
162807168|NCT02257567|588006128|FG009|Overall Study|Death|18|||
162807169|NCT02257567|588006129|FG010|Overall Study|Death|65|||
162807170|NCT02257567|588006119|FG000|Overall Study|Lost to Follow-up|0|||
162807171|NCT02257567|588006120|FG001|Overall Study|Lost to Follow-up|0|||
162807172|NCT02257567|588006121|FG002|Overall Study|Lost to Follow-up|0|||
162807173|NCT02257567|588006122|FG003|Overall Study|Lost to Follow-up|0|||
162807174|NCT02257567|588006123|FG004|Overall Study|Lost to Follow-up|2|||
162807175|NCT02257567|588006124|FG005|Overall Study|Lost to Follow-up|2|||
162807176|NCT02257567|588006125|FG006|Overall Study|Lost to Follow-up|0|||
162807177|NCT02257567|588006126|FG007|Overall Study|Lost to Follow-up|0|||
162807178|NCT02257567|588006127|FG008|Overall Study|Lost to Follow-up|0|||
162807179|NCT02257567|588006128|FG009|Overall Study|Lost to Follow-up|1|||
162807180|NCT02257567|588006129|FG010|Overall Study|Lost to Follow-up|1|||
162807181|NCT02257567|588006119|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807182|NCT02257567|588006120|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807183|NCT02257567|588006121|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807184|NCT02257567|588006122|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807185|NCT02257567|588006123|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
162807186|NCT02257567|588006124|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807187|NCT02257567|588006125|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
162807188|NCT02257567|588006126|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807189|NCT02257567|588006127|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807190|NCT02257567|588006128|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807191|NCT02257567|588006129|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162807192|NCT02257567|588006119|FG000|Overall Study|Physician Decision|0|||
162807193|NCT02257567|588006120|FG001|Overall Study|Physician Decision|0|||
162807194|NCT02257567|588006121|FG002|Overall Study|Physician Decision|0|||
162807195|NCT02257567|588006122|FG003|Overall Study|Physician Decision|0|||
162807196|NCT02257567|588006123|FG004|Overall Study|Physician Decision|0|||
162807197|NCT02257567|588006124|FG005|Overall Study|Physician Decision|0|||
162807198|NCT02257567|588006125|FG006|Overall Study|Physician Decision|0|||
162807199|NCT02257567|588006126|FG007|Overall Study|Physician Decision|2|||
162807200|NCT02257567|588006127|FG008|Overall Study|Physician Decision|0|||
162807201|NCT02257567|588006128|FG009|Overall Study|Physician Decision|1|||
162807202|NCT02257567|588006129|FG010|Overall Study|Physician Decision|0|||
162807203|NCT02257567|588006119|FG000|Overall Study|Withdrawal by Subject|0|||
162807204|NCT02257567|588006120|FG001|Overall Study|Withdrawal by Subject|0|||
162807205|NCT02257567|588006121|FG002|Overall Study|Withdrawal by Subject|2|||
162807206|NCT02257567|588006122|FG003|Overall Study|Withdrawal by Subject|0|||
162807207|NCT02257567|588006123|FG004|Overall Study|Withdrawal by Subject|0|||
162807208|NCT02257567|588006124|FG005|Overall Study|Withdrawal by Subject|6|||
162807209|NCT02257567|588006125|FG006|Overall Study|Withdrawal by Subject|6|||
162807210|NCT02257567|588006126|FG007|Overall Study|Withdrawal by Subject|6|||
162807211|NCT02257567|588006127|FG008|Overall Study|Withdrawal by Subject|1|||
162807212|NCT02257567|588006128|FG009|Overall Study|Withdrawal by Subject|1|||
162807213|NCT02257567|588006129|FG010|Overall Study|Withdrawal by Subject|10|||
162807214|NCT00946101|588006130|FG000|Overall Study|Lost to Follow-up|2|||
162807215|NCT00946101|588006131|FG001|Overall Study|Lost to Follow-up|1|||
162807216|NCT00946101|588006130|FG000|Overall Study|Withdrawal of consent|2|||
162807217|NCT00946101|588006131|FG001|Overall Study|Withdrawal of consent|0|||
162807218|NCT00946101|588006130|FG000|Overall Study|Physician Decision|0|||
162807219|NCT00946101|588006131|FG001|Overall Study|Physician Decision|1|||
162807220|NCT01590017|588006132|FG000|Overall Study|Adverse Event|1|||
162807221|NCT01590017|588006132|FG000|Overall Study|Withdrawal by Subject|1|||
162807222|NCT01590017|588006132|FG000|Overall Study|Lack of Efficacy|1|||
162807223|NCT01590017|588006132|FG000|Overall Study|Physician Decision|1|||
162807224|NCT03625895|588006133|FG000|Overall Study|Protocol Violation|585|||
162807225|NCT03256851|588006134|FG000|Overall Study|Withdrawal by Subject|1|||
162807226|NCT03256851|588006135|FG001|Overall Study|Withdrawal by Subject|0|||
162807227|NCT02081417|588006138|FG000|Overall Study|Lost to Follow-up|26|||
162807228|NCT02081417|588006139|FG001|Overall Study|Lost to Follow-up|23|||
162807229|NCT02081417|588006138|FG000|Overall Study|Moved Away|1|||
162807230|NCT02081417|588006139|FG001|Overall Study|Moved Away|2|||
162807231|NCT02081417|588006138|FG000|Overall Study|Incarcerated|2|||
162807232|NCT02081417|588006139|FG001|Overall Study|Incarcerated|2|||
162807233|NCT02081417|588006138|FG000|Overall Study|Death|4|||
162807234|NCT02081417|588006139|FG001|Overall Study|Death|3|||
162807235|NCT02081417|588006138|FG000|Overall Study|Withdrawal by Subject|4|||
162807236|NCT02081417|588006139|FG001|Overall Study|Withdrawal by Subject|0|||
162807237|NCT02081417|588006138|FG000|Overall Study|Admitted to Residential Treatment|2|||
162807238|NCT02081417|588006139|FG001|Overall Study|Admitted to Residential Treatment|0|||
162807239|NCT02081417|588006138|FG000|Overall Study|Did not start treatment|17|||
162807240|NCT02081417|588006139|FG001|Overall Study|Did not start treatment|21|||
162807241|NCT01065844|588006140|FG000|Overall Study|Adverse Event|5|||
162807242|NCT01502631|588006146|FG000|Overall Study|Adverse Event|5|||
162807243|NCT01502631|588006147|FG001|Overall Study|Adverse Event|8|||
162807244|NCT01502631|588006146|FG000|Overall Study|Lost to Follow-up|2|||
162807245|NCT01502631|588006147|FG001|Overall Study|Lost to Follow-up|2|||
162807246|NCT01502631|588006146|FG000|Overall Study|Participant withdrew consent|2|||
162807247|NCT01502631|588006147|FG001|Overall Study|Participant withdrew consent|4|||
162807248|NCT01502631|588006146|FG000|Overall Study|Participant non-compliant|1|||
162807249|NCT01502631|588006147|FG001|Overall Study|Participant non-compliant|0|||
162807250|NCT01502631|588006146|FG000|Overall Study|Investigator's decision|0|||
162807251|NCT01502631|588006147|FG001|Overall Study|Investigator's decision|1|||
162807252|NCT01502631|588006146|FG000|Overall Study|Other|10|||
162807253|NCT01502631|588006147|FG001|Overall Study|Other|5|||
162807254|NCT02319525|588006150|FG000|Overall Study|Withdrawal by Subject|2|||
162807255|NCT02319525|588006151|FG001|Overall Study|Withdrawal by Subject|1|||
162807256|NCT02424734|588006155|FG000|Overall Study|Treatment stopped to be discharged home|2|||
162807257|NCT02424734|588006156|FG001|Overall Study|Treatment stopped to be discharged home|2|||
162807258|NCT02424734|588006157|FG002|Overall Study|Treatment stopped to be discharged home|0|||
162807259|NCT01445301|588006158|FG000|Overall Study|Adverse Event|15|||
162807260|NCT01445301|588006159|FG001|Overall Study|Adverse Event|25|||
162807261|NCT01445301|588006160|FG002|Overall Study|Adverse Event|4|||
162807262|NCT01445301|588006158|FG000|Overall Study|Lack of Efficacy|0|||
162807263|NCT01445301|588006159|FG001|Overall Study|Lack of Efficacy|1|||
162807264|NCT01445301|588006160|FG002|Overall Study|Lack of Efficacy|0|||
162807265|NCT01445301|588006158|FG000|Overall Study|Protocol Violation|1|||
162807266|NCT01445301|588006159|FG001|Overall Study|Protocol Violation|0|||
162807267|NCT01445301|588006160|FG002|Overall Study|Protocol Violation|0|||
162807268|NCT01445301|588006158|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
162807269|NCT01445301|588006159|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
162807270|NCT01445301|588006160|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
162807271|NCT01445301|588006158|FG000|Overall Study|Physician Decision|0|||
162807272|NCT01445301|588006159|FG001|Overall Study|Physician Decision|2|||
162807273|NCT01445301|588006160|FG002|Overall Study|Physician Decision|0|||
162807274|NCT01445301|588006158|FG000|Overall Study|Withdrawal by Subject|5|||
162807275|NCT01445301|588006159|FG001|Overall Study|Withdrawal by Subject|6|||
162807276|NCT01445301|588006160|FG002|Overall Study|Withdrawal by Subject|4|||
162807277|NCT00752557|588006161|FG000|Overall Study|Withdrawal by Subject|4|||
162807278|NCT00752557|588006162|FG001|Overall Study|Withdrawal by Subject|3|||
162807279|NCT00752557|588006163|FG002|Overall Study|Withdrawal by Subject|3|||
162807280|NCT00752557|588006161|FG000|Overall Study|Unspecified resaons|0|||
162807281|NCT00752557|588006162|FG001|Overall Study|Unspecified resaons|2|||
162807282|NCT00752557|588006163|FG002|Overall Study|Unspecified resaons|2|||
162807283|NCT00752557|588006161|FG000|Overall Study|Lost to Follow-up|1|||
162807284|NCT00752557|588006162|FG001|Overall Study|Lost to Follow-up|0|||
162807285|NCT00752557|588006163|FG002|Overall Study|Lost to Follow-up|1|||
162807286|NCT02150343|588006168|FG000|Overall Study|Adverse Event|2|||
162807287|NCT02150343|588006169|FG001|Overall Study|Adverse Event|0|||
162807288|NCT02150343|588006170|FG002|Overall Study|Adverse Event|1|||
162807289|NCT02150343|588006171|FG003|Overall Study|Adverse Event|1|||
162807290|NCT02150343|588006168|FG000|Overall Study|Withdrawal by Subject|13|||
162807291|NCT02150343|588006169|FG001|Overall Study|Withdrawal by Subject|10|||
162807292|NCT02150343|588006170|FG002|Overall Study|Withdrawal by Subject|9|||
162807293|NCT02150343|588006171|FG003|Overall Study|Withdrawal by Subject|4|||
162807294|NCT02150343|588006168|FG000|Overall Study|Lost to Follow-up|4|||
162807295|NCT02150343|588006169|FG001|Overall Study|Lost to Follow-up|4|||
162807296|NCT02150343|588006170|FG002|Overall Study|Lost to Follow-up|2|||
162807297|NCT02150343|588006171|FG003|Overall Study|Lost to Follow-up|3|||
162807298|NCT02150343|588006168|FG000|Overall Study|Other|2|||
162807299|NCT02150343|588006169|FG001|Overall Study|Other|6|||
162807300|NCT02150343|588006170|FG002|Overall Study|Other|0|||
162807301|NCT02150343|588006171|FG003|Overall Study|Other|2|||
162807302|NCT02729753|588006172|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
162807303|NCT02729753|588006173|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
162807304|NCT00190749|588006174|FG000|Overall Study|Lost to Follow-up|8|||
162807305|NCT00190749|588006175|FG001|Overall Study|Lost to Follow-up|11|||
162807306|NCT00190749|588006174|FG000|Overall Study|Withdrawal by Subject|10|||
162807307|NCT00190749|588006175|FG001|Overall Study|Withdrawal by Subject|6|||
162807308|NCT00190749|588006174|FG000|Overall Study|Protocol Violation|5|||
162807309|NCT00190749|588006175|FG001|Overall Study|Protocol Violation|4|||
162807310|NCT00190749|588006174|FG000|Overall Study|Adverse Event|0|||
162807311|NCT00190749|588006175|FG001|Overall Study|Adverse Event|5|||
162807312|NCT00190749|588006174|FG000|Overall Study|Lack of Efficacy|2|||
162807313|NCT00190749|588006175|FG001|Overall Study|Lack of Efficacy|3|||
162807314|NCT00190749|588006174|FG000|Overall Study|Reason Not Specified|0|||
162807315|NCT00190749|588006175|FG001|Overall Study|Reason Not Specified|2|||
162807316|NCT00190749|588006174|FG000|Overall Study|Sponsor Decision|1|||
162807317|NCT00190749|588006175|FG001|Overall Study|Sponsor Decision|0|||
162807318|NCT00439231|588006176|FG000|Overall Study|Lack of Efficacy|28|||
162807319|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
162807320|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
162807321|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
162807322|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
162807323|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
162807324|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
162807325|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
162807326|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
162807327|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
162807328|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
162807329|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
162807330|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
162807331|NCT04493502|588006177|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
162807332|NCT04493502|588006178|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
162807333|NCT04493502|588006177|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
162807334|NCT04493502|588006178|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
162807335|NCT04493502|588006177|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
162807336|NCT04493502|588006178|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
162807337|NCT04493502|588006177|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
162807338|NCT04493502|588006178|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
162807339|NCT04493502|588006177|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
162807340|NCT04493502|588006178|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
162807341|NCT04493502|588006177|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
162807342|NCT04493502|588006178|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
162807343|NCT04493502|588006177|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
162807344|NCT04493502|588006178|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
162807345|NCT02891408|588006179|FG000|Overall Study|Lost to Follow-up|0|||
162807346|NCT02891408|588006180|FG001|Overall Study|Lost to Follow-up|0|||
162807347|NCT02891408|588006181|FG002|Overall Study|Lost to Follow-up|1|||
162807348|NCT02891408|588006182|FG003|Overall Study|Lost to Follow-up|0|||
162807349|NCT02891408|588006183|FG004|Overall Study|Lost to Follow-up|0|||
162807350|NCT02891408|588006184|FG005|Overall Study|Lost to Follow-up|0|||
162807351|NCT02891408|588006185|FG006|Overall Study|Lost to Follow-up|0|||
162807352|NCT00709852|588006186|FG000|Period 1|Adverse Event|2|||
162807353|NCT00709852|588006187|FG001|Period 1|Adverse Event|0|||
162807354|NCT00709852|588006186|FG000|Period 1|Withdrawal by Subject|4|||
162807355|NCT00709852|588006187|FG001|Period 1|Withdrawal by Subject|2|||
162807356|NCT00709852|588006186|FG000|Period 1|Protocol Violation|1|||
162807357|NCT00709852|588006187|FG001|Period 1|Protocol Violation|0|||
162807358|NCT00709852|588006186|FG000|Period 1|Defective scanner|0|||
162807359|NCT00709852|588006187|FG001|Period 1|Defective scanner|1|||
162807360|NCT00709852|588006186|FG000|Period 1|Lost to Follow-up|1|||
162807361|NCT00709852|588006187|FG001|Period 1|Lost to Follow-up|0|||
162807362|NCT00709852|588006186|FG000|Period 2|Protocol Violation|4|||
162807363|NCT00709852|588006187|FG001|Period 2|Protocol Violation|1|||
162807364|NCT00709852|588006186|FG000|Period 2|Adverse Event|1|||
162807365|NCT00709852|588006187|FG001|Period 2|Adverse Event|1|||
162807366|NCT00709852|588006186|FG000|Period 2|Lost to Follow-up|1|||
162807367|NCT00709852|588006187|FG001|Period 2|Lost to Follow-up|0|||
162807368|NCT00709852|588006186|FG000|Period 2|No 72-hour follow-up|3|||
162807369|NCT00709852|588006187|FG001|Period 2|No 72-hour follow-up|0|||
162807370|NCT05249829|588006188|FG000|Overall Study|Participant Relocation|0|||
162807371|NCT05249829|588006189|FG001|Overall Study|Participant Relocation|1|||
162807372|NCT05249829|588006190|FG002|Overall Study|Participant Relocation|2|||
162807373|NCT05249829|588006191|FG003|Overall Study|Participant Relocation|2|||
162807374|NCT05249829|588006188|FG000|Overall Study|Withdrawal by Subject|9|||
162807375|NCT05249829|588006189|FG001|Overall Study|Withdrawal by Subject|17|||
162807376|NCT05249829|588006190|FG002|Overall Study|Withdrawal by Subject|40|||
162807377|NCT05249829|588006191|FG003|Overall Study|Withdrawal by Subject|35|||
162807378|NCT05249829|588006188|FG000|Overall Study|Physician Decision|1|||
162807379|NCT05249829|588006189|FG001|Overall Study|Physician Decision|0|||
162807380|NCT05249829|588006190|FG002|Overall Study|Physician Decision|0|||
162807381|NCT05249829|588006191|FG003|Overall Study|Physician Decision|0|||
162807382|NCT05249829|588006188|FG000|Overall Study|Lost to Follow-up|16|||
162807383|NCT05249829|588006189|FG001|Overall Study|Lost to Follow-up|16|||
162807384|NCT05249829|588006190|FG002|Overall Study|Lost to Follow-up|57|||
162807385|NCT05249829|588006191|FG003|Overall Study|Lost to Follow-up|60|||
162807386|NCT05249829|588006188|FG000|Overall Study|Adverse Event|2|||
162807387|NCT05249829|588006189|FG001|Overall Study|Adverse Event|2|||
162807388|NCT05249829|588006190|FG002|Overall Study|Adverse Event|2|||
162807389|NCT05249829|588006191|FG003|Overall Study|Adverse Event|2|||
162807390|NCT05249829|588006188|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
162807391|NCT05249829|588006189|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
162807392|NCT05249829|588006190|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
162807393|NCT05249829|588006191|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
162807394|NCT05249829|588006188|FG000|Overall Study|Protocol Violation|2|||
162807395|NCT05249829|588006189|FG001|Overall Study|Protocol Violation|0|||
162807396|NCT05249829|588006190|FG002|Overall Study|Protocol Violation|5|||
162807397|NCT05249829|588006191|FG003|Overall Study|Protocol Violation|3|||
162807398|NCT05249829|588006188|FG000|Overall Study|Death|0|||
162807399|NCT05249829|588006189|FG001|Overall Study|Death|1|||
162807400|NCT05249829|588006190|FG002|Overall Study|Death|2|||
162807401|NCT05249829|588006191|FG003|Overall Study|Death|4|||
162807402|NCT00196976|588006192|FG000|Primary Study|Migrated from study area|0|||
162807403|NCT00196976|588006193|FG001|Primary Study|Migrated from study area|0|||
162807404|NCT00196976|588006194|FG002|Primary Study|Migrated from study area|0|||
162807405|NCT00196976|588006195|FG003|Primary Study|Migrated from study area|0|||
162807406|NCT00196976|588006196|FG004|Primary Study|Migrated from study area|0|||
162807407|NCT00196976|588006197|FG005|Primary Study|Migrated from study area|0|||
162807408|NCT00196976|588006198|FG006|Primary Study|Migrated from study area|0|||
162807409|NCT00196976|588006199|FG007|Primary Study|Migrated from study area|1|||
162807410|NCT00196976|588006200|FG008|Primary Study|Migrated from study area|0|||
162807411|NCT00196976|588006201|FG009|Primary Study|Migrated from study area|0|||
162807412|NCT00196976|588006202|FG010|Primary Study|Migrated from study area|0|||
162807413|NCT00196976|588006203|FG011|Primary Study|Migrated from study area|0|||
162807414|NCT00196976|588006204|FG012|Primary Study|Migrated from study area|0|||
162807415|NCT00196976|588006205|FG013|Primary Study|Migrated from study area|0|||
162807416|NCT00196976|588006192|FG000|Primary Study|Protocol Violation|0|||
162807417|NCT00196976|588006193|FG001|Primary Study|Protocol Violation|1|||
162807418|NCT00196976|588006194|FG002|Primary Study|Protocol Violation|1|||
162807419|NCT00196976|588006195|FG003|Primary Study|Protocol Violation|0|||
162807420|NCT00196976|588006196|FG004|Primary Study|Protocol Violation|0|||
162807421|NCT00196976|588006197|FG005|Primary Study|Protocol Violation|0|||
162807422|NCT00196976|588006198|FG006|Primary Study|Protocol Violation|0|||
162807423|NCT00196976|588006199|FG007|Primary Study|Protocol Violation|0|||
162807424|NCT00196976|588006200|FG008|Primary Study|Protocol Violation|0|||
162807425|NCT00196976|588006201|FG009|Primary Study|Protocol Violation|0|||
162807426|NCT00196976|588006202|FG010|Primary Study|Protocol Violation|0|||
162807427|NCT00196976|588006203|FG011|Primary Study|Protocol Violation|0|||
162807428|NCT00196976|588006204|FG012|Primary Study|Protocol Violation|0|||
162807429|NCT00196976|588006205|FG013|Primary Study|Protocol Violation|0|||
162807430|NCT00196976|588006192|FG000|Primary Study|Withdrawal by Subject|1|||
162807431|NCT00196976|588006193|FG001|Primary Study|Withdrawal by Subject|0|||
162807432|NCT00196976|588006194|FG002|Primary Study|Withdrawal by Subject|1|||
162807433|NCT00196976|588006195|FG003|Primary Study|Withdrawal by Subject|1|||
162807434|NCT00196976|588006196|FG004|Primary Study|Withdrawal by Subject|2|||
162807435|NCT00196976|588006197|FG005|Primary Study|Withdrawal by Subject|1|||
162807436|NCT00196976|588006198|FG006|Primary Study|Withdrawal by Subject|0|||
162807437|NCT00196976|588006199|FG007|Primary Study|Withdrawal by Subject|0|||
162807438|NCT00196976|588006200|FG008|Primary Study|Withdrawal by Subject|0|||
162807439|NCT00196976|588006201|FG009|Primary Study|Withdrawal by Subject|1|||
162807440|NCT00196976|588006202|FG010|Primary Study|Withdrawal by Subject|0|||
162807441|NCT00196976|588006203|FG011|Primary Study|Withdrawal by Subject|0|||
162807442|NCT00196976|588006204|FG012|Primary Study|Withdrawal by Subject|0|||
162807443|NCT00196976|588006205|FG013|Primary Study|Withdrawal by Subject|0|||
162807444|NCT00196976|588006192|FG000|Primary Study|Lost to Follow-up|0|||
162807445|NCT00196976|588006193|FG001|Primary Study|Lost to Follow-up|0|||
162807446|NCT00196976|588006194|FG002|Primary Study|Lost to Follow-up|0|||
162807447|NCT00196976|588006195|FG003|Primary Study|Lost to Follow-up|0|||
162807448|NCT00196976|588006196|FG004|Primary Study|Lost to Follow-up|1|||
162807449|NCT00196976|588006197|FG005|Primary Study|Lost to Follow-up|1|||
162807450|NCT00196976|588006198|FG006|Primary Study|Lost to Follow-up|0|||
162807451|NCT00196976|588006199|FG007|Primary Study|Lost to Follow-up|2|||
162807452|NCT00196976|588006200|FG008|Primary Study|Lost to Follow-up|0|||
162807453|NCT00196976|588006201|FG009|Primary Study|Lost to Follow-up|0|||
162807454|NCT00196976|588006202|FG010|Primary Study|Lost to Follow-up|0|||
162807455|NCT00196976|588006203|FG011|Primary Study|Lost to Follow-up|0|||
162807456|NCT00196976|588006204|FG012|Primary Study|Lost to Follow-up|0|||
162807457|NCT00196976|588006205|FG013|Primary Study|Lost to Follow-up|0|||
162807458|NCT00196976|588006192|FG000|Primary Study|Other|0|||
162807459|NCT00196976|588006193|FG001|Primary Study|Other|0|||
162807460|NCT00196976|588006194|FG002|Primary Study|Other|2|||
162807461|NCT00196976|588006195|FG003|Primary Study|Other|0|||
162807462|NCT00196976|588006196|FG004|Primary Study|Other|0|||
162807463|NCT00196976|588006197|FG005|Primary Study|Other|0|||
162807464|NCT00196976|588006198|FG006|Primary Study|Other|0|||
162807465|NCT00196976|588006199|FG007|Primary Study|Other|0|||
162807466|NCT00196976|588006200|FG008|Primary Study|Other|0|||
162807467|NCT00196976|588006201|FG009|Primary Study|Other|0|||
162807468|NCT00196976|588006202|FG010|Primary Study|Other|0|||
162807469|NCT00196976|588006203|FG011|Primary Study|Other|0|||
162807470|NCT00196976|588006204|FG012|Primary Study|Other|0|||
162807471|NCT00196976|588006205|FG013|Primary Study|Other|0|||
162807472|NCT00196976|588006192|FG000|Booster Study|Withdrawal by Subject|0|||
162807473|NCT00196976|588006193|FG001|Booster Study|Withdrawal by Subject|0|||
162807474|NCT00196976|588006194|FG002|Booster Study|Withdrawal by Subject|0|||
162807475|NCT00196976|588006195|FG003|Booster Study|Withdrawal by Subject|0|||
162807476|NCT00196976|588006196|FG004|Booster Study|Withdrawal by Subject|0|||
162807477|NCT00196976|588006197|FG005|Booster Study|Withdrawal by Subject|0|||
162807478|NCT00196976|588006198|FG006|Booster Study|Withdrawal by Subject|0|||
162807479|NCT00196976|588006199|FG007|Booster Study|Withdrawal by Subject|0|||
162807480|NCT00196976|588006200|FG008|Booster Study|Withdrawal by Subject|0|||
162807481|NCT00196976|588006201|FG009|Booster Study|Withdrawal by Subject|0|||
162807482|NCT00196976|588006202|FG010|Booster Study|Withdrawal by Subject|1|||
162807483|NCT00196976|588006203|FG011|Booster Study|Withdrawal by Subject|0|||
162807484|NCT00196976|588006204|FG012|Booster Study|Withdrawal by Subject|0|||
162807485|NCT00196976|588006205|FG013|Booster Study|Withdrawal by Subject|0|||
162807486|NCT00196976|588006192|FG000|Booster Study|Lost to Follow-up|0|||
162807487|NCT00196976|588006193|FG001|Booster Study|Lost to Follow-up|0|||
162807488|NCT00196976|588006194|FG002|Booster Study|Lost to Follow-up|0|||
162807489|NCT00196976|588006195|FG003|Booster Study|Lost to Follow-up|0|||
162807490|NCT00196976|588006196|FG004|Booster Study|Lost to Follow-up|0|||
162807491|NCT00196976|588006197|FG005|Booster Study|Lost to Follow-up|0|||
162807492|NCT00196976|588006198|FG006|Booster Study|Lost to Follow-up|0|||
162807493|NCT00196976|588006199|FG007|Booster Study|Lost to Follow-up|0|||
162807494|NCT00196976|588006200|FG008|Booster Study|Lost to Follow-up|0|||
162807495|NCT00196976|588006201|FG009|Booster Study|Lost to Follow-up|0|||
162807496|NCT00196976|588006202|FG010|Booster Study|Lost to Follow-up|1|||
162807497|NCT00196976|588006203|FG011|Booster Study|Lost to Follow-up|2|||
162807498|NCT00196976|588006204|FG012|Booster Study|Lost to Follow-up|0|||
162807499|NCT00196976|588006205|FG013|Booster Study|Lost to Follow-up|0|||
162807500|NCT02009761|588006206|FG000|Overall Study|Adverse Event|4|||
162807501|NCT02842827|588006207|FG000|Overall Study|Adverse Event|0|||
162807502|NCT02842827|588006208|FG001|Overall Study|Adverse Event|1|||
162807503|NCT02842827|588006209|FG002|Overall Study|Adverse Event|0|||
162807504|NCT02842827|588006210|FG003|Overall Study|Adverse Event|1|||
162807505|NCT02842827|588006211|FG004|Overall Study|Adverse Event|0|||
162807506|NCT02842827|588006212|FG005|Overall Study|Adverse Event|1|||
162807507|NCT02842827|588006213|FG006|Overall Study|Adverse Event|0|||
162807508|NCT02842827|588006214|FG007|Overall Study|Adverse Event|0|||
162807509|NCT02842827|588006207|FG000|Overall Study|Death|1|||
162807510|NCT02842827|588006208|FG001|Overall Study|Death|0|||
162807511|NCT02842827|588006209|FG002|Overall Study|Death|2|||
162807512|NCT02842827|588006210|FG003|Overall Study|Death|3|||
162807513|NCT02842827|588006211|FG004|Overall Study|Death|2|||
162807514|NCT02842827|588006212|FG005|Overall Study|Death|1|||
162807515|NCT02842827|588006213|FG006|Overall Study|Death|0|||
162807516|NCT02842827|588006214|FG007|Overall Study|Death|4|||
162807517|NCT02842827|588006207|FG000|Overall Study|Physician Decision|1|||
162807518|NCT02842827|588006208|FG001|Overall Study|Physician Decision|3|||
162807519|NCT02842827|588006209|FG002|Overall Study|Physician Decision|0|||
162807520|NCT02842827|588006210|FG003|Overall Study|Physician Decision|0|||
162807521|NCT02842827|588006211|FG004|Overall Study|Physician Decision|1|||
162807522|NCT02842827|588006212|FG005|Overall Study|Physician Decision|4|||
162807523|NCT02842827|588006213|FG006|Overall Study|Physician Decision|2|||
162807524|NCT02842827|588006214|FG007|Overall Study|Physician Decision|1|||
162807525|NCT02842827|588006207|FG000|Overall Study|Protocol Defined Disease Progression|0|||
162807526|NCT02842827|588006208|FG001|Overall Study|Protocol Defined Disease Progression|0|||
162807527|NCT02842827|588006209|FG002|Overall Study|Protocol Defined Disease Progression|0|||
162807528|NCT02842827|588006210|FG003|Overall Study|Protocol Defined Disease Progression|0|||
162807529|NCT02842827|588006211|FG004|Overall Study|Protocol Defined Disease Progression|0|||
162807530|NCT02842827|588006212|FG005|Overall Study|Protocol Defined Disease Progression|1|||
162807531|NCT02842827|588006213|FG006|Overall Study|Protocol Defined Disease Progression|0|||
162807532|NCT02842827|588006214|FG007|Overall Study|Protocol Defined Disease Progression|0|||
162807533|NCT02842827|588006207|FG000|Overall Study|Participant Withdrawal of Consent|1|||
162807534|NCT02842827|588006208|FG001|Overall Study|Participant Withdrawal of Consent|2|||
162807535|NCT02842827|588006209|FG002|Overall Study|Participant Withdrawal of Consent|2|||
162807536|NCT02842827|588006210|FG003|Overall Study|Participant Withdrawal of Consent|2|||
162807537|NCT02842827|588006211|FG004|Overall Study|Participant Withdrawal of Consent|2|||
162807538|NCT02842827|588006212|FG005|Overall Study|Participant Withdrawal of Consent|1|||
162807539|NCT02842827|588006213|FG006|Overall Study|Participant Withdrawal of Consent|2|||
162807540|NCT02842827|588006214|FG007|Overall Study|Participant Withdrawal of Consent|1|||
162807541|NCT01815138|588006215|FG000|Overall Study|Withdrawal by Subject|0|||
162807542|NCT01815138|588006216|FG001|Overall Study|Withdrawal by Subject|1|||
162807543|NCT01815138|588006215|FG000|Overall Study|Physician Decision|8|||
162807544|NCT01815138|588006216|FG001|Overall Study|Physician Decision|5|||
162807545|NCT00825825|588006217|FG000|First Medication Period (14 Days)|Adverse Event|1|||
162807546|NCT00825825|588006218|FG001|First Medication Period (14 Days)|Adverse Event|0|||
162807547|NCT00825825|588006219|FG002|First Medication Period (14 Days)|Adverse Event|0|||
162807548|NCT00825825|588006220|FG003|First Medication Period (14 Days)|Adverse Event|0|||
162807549|NCT00825825|588006221|FG004|First Medication Period (14 Days)|Adverse Event|0|||
162807550|NCT00825825|588006222|FG005|First Medication Period (14 Days)|Adverse Event|1|||
162807551|NCT00825825|588006217|FG000|First Medication Period (14 Days)|Physician Decision|2|||
162807552|NCT00825825|588006218|FG001|First Medication Period (14 Days)|Physician Decision|0|||
162807553|NCT00825825|588006219|FG002|First Medication Period (14 Days)|Physician Decision|1|||
162807554|NCT00825825|588006220|FG003|First Medication Period (14 Days)|Physician Decision|0|||
162807555|NCT00825825|588006221|FG004|First Medication Period (14 Days)|Physician Decision|0|||
162807556|NCT00825825|588006222|FG005|First Medication Period (14 Days)|Physician Decision|1|||
162807557|NCT00825825|588006217|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
162807558|NCT00825825|588006218|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
162807559|NCT00825825|588006219|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
162807560|NCT00825825|588006220|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
162807561|NCT00825825|588006221|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
162807562|NCT00825825|588006222|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
162807563|NCT00825825|588006217|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
162807564|NCT00825825|588006218|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
162807565|NCT00825825|588006219|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
162807566|NCT00825825|588006220|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
162807567|NCT00825825|588006221|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
162807568|NCT00825825|588006222|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
162807569|NCT00825825|588006217|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
162807570|NCT00825825|588006218|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
162807571|NCT00825825|588006219|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
162807572|NCT00825825|588006220|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
162807573|NCT00825825|588006221|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
162807574|NCT00825825|588006222|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
162807575|NCT00825825|588006217|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
162807576|NCT00825825|588006218|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
162807577|NCT00825825|588006219|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
162807578|NCT00825825|588006220|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
162807579|NCT00825825|588006221|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
162807580|NCT00825825|588006222|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
162807581|NCT00825825|588006217|FG000|Third Medication Period (14 Days)|poor data quality|0|||
162807582|NCT00825825|588006218|FG001|Third Medication Period (14 Days)|poor data quality|1|||
162807583|NCT00825825|588006219|FG002|Third Medication Period (14 Days)|poor data quality|0|||
162807584|NCT00825825|588006220|FG003|Third Medication Period (14 Days)|poor data quality|0|||
162807585|NCT00825825|588006221|FG004|Third Medication Period (14 Days)|poor data quality|0|||
162807586|NCT00825825|588006222|FG005|Third Medication Period (14 Days)|poor data quality|0|||
162807587|NCT02649946|588006228|FG000|Overall Study|Withdrawal by Subject|1|||
162807588|NCT02649946|588006229|FG001|Overall Study|Withdrawal by Subject|1|||
162807589|NCT02649946|588006228|FG000|Overall Study|Death|7|||
162807590|NCT02649946|588006229|FG001|Overall Study|Death|9|||
162807591|NCT02649946|588006228|FG000|Overall Study|Physician Decision|1|||
162807592|NCT02649946|588006229|FG001|Overall Study|Physician Decision|0|||
162807593|NCT02649946|588006228|FG000|Overall Study|Lost to Follow-up|2|||
162807594|NCT02649946|588006229|FG001|Overall Study|Lost to Follow-up|1|||
162807595|NCT02649946|588006228|FG000|Overall Study|Erroneously enrolled|1|||
162807596|NCT02649946|588006229|FG001|Overall Study|Erroneously enrolled|0|||
162807597|NCT02649946|588006228|FG000|Overall Study|Missed 6-month follow-up visit|0|||
162807598|NCT02649946|588006229|FG001|Overall Study|Missed 6-month follow-up visit|4|||
162807599|NCT00950950|588006230|FG000|Overall Study|Adverse Event|1|||
162807600|NCT00950950|588006231|FG001|Overall Study|Adverse Event|0|||
162807601|NCT00950950|588006230|FG000|Overall Study|Withdrawal by Subject|0|||
162807602|NCT00950950|588006231|FG001|Overall Study|Withdrawal by Subject|1|||
162807603|NCT01047293|588006232|FG000|Overall Study|DLT criteria not fulfilled|1|||
162807604|NCT01047293|588006233|FG001|Overall Study|DLT criteria not fulfilled|1|||
162807605|NCT01047293|588006234|FG002|Overall Study|DLT criteria not fulfilled|0|||
162807606|NCT01047293|588006235|FG003|Overall Study|DLT criteria not fulfilled|0|||
162807607|NCT00757783|588006236|FG000|Overall Study|Adverse Event|0|||
162807608|NCT00757783|588006237|FG001|Overall Study|Adverse Event|2|||
162807609|NCT00757783|588006236|FG000|Overall Study|Lost to Follow-up|1|||
162807610|NCT00757783|588006237|FG001|Overall Study|Lost to Follow-up|1|||
162807611|NCT00757783|588006236|FG000|Overall Study|Protocol Violation|1|||
162807612|NCT00757783|588006237|FG001|Overall Study|Protocol Violation|0|||
162807613|NCT00757783|588006236|FG000|Overall Study|Withdrawal by Subject|2|||
162807614|NCT00757783|588006237|FG001|Overall Study|Withdrawal by Subject|1|||
162807615|NCT00757783|588006236|FG000|Overall Study|Other|1|||
162807616|NCT00757783|588006237|FG001|Overall Study|Other|2|||
162807617|NCT02372136|588006238|FG000|Overall Study|Death|3|||
162807618|NCT02372136|588006239|FG001|Overall Study|Death|1|||
162807619|NCT02679508|588006240|FG000|Healing Phase|Protocol Violation|1|||
162807620|NCT02679508|588006241|FG001|Healing Phase|Protocol Violation|1|||
162807621|NCT02679508|588006240|FG000|Healing Phase|Lost to Follow-up|1|||
162807622|NCT02679508|588006241|FG001|Healing Phase|Lost to Follow-up|0|||
162807623|NCT02679508|588006240|FG000|Maintenance Phase|Adverse Event|12|||
162807624|NCT02679508|588006241|FG001|Maintenance Phase|Adverse Event|2|||
162807625|NCT02679508|588006240|FG000|Maintenance Phase|Lost to Follow-up|0|||
162807626|NCT02679508|588006241|FG001|Maintenance Phase|Lost to Follow-up|1|||
162807627|NCT02679508|588006240|FG000|Maintenance Phase|Withdrawal by Subject|15|||
162807628|NCT02679508|588006241|FG001|Maintenance Phase|Withdrawal by Subject|8|||
162807629|NCT02679508|588006240|FG000|Maintenance Phase|Other|5|||
162807630|NCT02679508|588006241|FG001|Maintenance Phase|Other|4|||
162807631|NCT01588496|588006242|FG000|Overall Study|Withdrawal by Subject|0|||
162807632|NCT01588496|588006243|FG001|Overall Study|Withdrawal by Subject|1|||
162807633|NCT01588496|588006244|FG002|Overall Study|Withdrawal by Subject|0|||
162807634|NCT03143166|588006245|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
162807635|NCT05924945|588006246|FG000|Overall Study|Withdrawal by Subject|3|||
162807636|NCT05924945|588006247|FG001|Overall Study|Withdrawal by Subject|4|||
162807637|NCT02003573|588006262|FG000|Overall Study|Progressive disease|2|||
162807638|NCT02003573|588006263|FG001|Overall Study|Progressive disease|0|||
162807639|NCT02003573|588006264|FG002|Overall Study|Progressive disease|1|||
162807640|NCT02003573|588006262|FG000|Overall Study|Other Adverse event|0|||
162807641|NCT02003573|588006263|FG001|Overall Study|Other Adverse event|1|||
162807642|NCT02003573|588006264|FG002|Overall Study|Other Adverse event|1|||
162807643|NCT02003573|588006262|FG000|Overall Study|Refuse to take trial medication|0|||
162807644|NCT02003573|588006263|FG001|Overall Study|Refuse to take trial medication|1|||
162807645|NCT02003573|588006264|FG002|Overall Study|Refuse to take trial medication|1|||
162807646|NCT02003573|588006262|FG000|Overall Study|Other than specified|1|||
162807647|NCT02003573|588006263|FG001|Overall Study|Other than specified|2|||
162807648|NCT02003573|588006264|FG002|Overall Study|Other than specified|3|||
162807649|NCT03683823|588006271|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
162807650|NCT03683823|588006272|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
162807651|NCT03683823|588006271|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
162807652|NCT03683823|588006272|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
162807653|NCT03683823|588006271|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
162807654|NCT03683823|588006272|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
162807655|NCT05026710|588006274|FG000|Overall Study|No longer met eligibility criteria|3|||
162807656|NCT05026710|588006275|FG001|Overall Study|No longer met eligibility criteria|1|||
162807657|NCT00126503|588006276|FG000|Overall Study|disease progression|23|||
162807658|NCT00126503|588006277|FG001|Overall Study|disease progression|14|||
162807659|NCT00126503|588006276|FG000|Overall Study|Withdrawal by Subject|0|||
162807660|NCT00126503|588006277|FG001|Overall Study|Withdrawal by Subject|1|||
162807661|NCT00126503|588006276|FG000|Overall Study|alternative therapy|1|||
162807662|NCT00126503|588006277|FG001|Overall Study|alternative therapy|1|||
162807663|NCT00126503|588006276|FG000|Overall Study|other complicating disease|4|||
162807664|NCT00126503|588006277|FG001|Overall Study|other complicating disease|1|||
162807665|NCT00126503|588006276|FG000|Overall Study|Death|3|||
162807666|NCT00126503|588006277|FG001|Overall Study|Death|0|||
162807667|NCT00126503|588006276|FG000|Overall Study|Adverse Event|13|||
162807668|NCT00126503|588006277|FG001|Overall Study|Adverse Event|3|||
162807669|NCT00126503|588006276|FG000|Overall Study|non-compliant|1|||
162807670|NCT00126503|588006277|FG001|Overall Study|non-compliant|0|||
162807671|NCT00126503|588006276|FG000|Overall Study|Physician Decision|2|||
162807672|NCT00126503|588006277|FG001|Overall Study|Physician Decision|1|||
162807673|NCT01557283|588008000|FG000|Overall Study|Lost to Follow-up|7|||
162807674|NCT01557283|588008000|FG000|Overall Study|Non-responder|19|||
162807675|NCT01557283|588008000|FG000|Overall Study|Adverse Event|7|||
162807676|NCT01557283|588008000|FG000|Overall Study|Lack of Efficacy|1|||
162807677|NCT01557283|588008000|FG000|Overall Study|Non-compliance|1|||
162807678|NCT01557283|588008000|FG000|Overall Study|Withdrawal by Subject|1|||
162807679|NCT01557283|588008000|FG000|Overall Study|Participant's weight too high for dose|1|||
162807680|NCT01557283|588008000|FG000|Overall Study|Worsening of psoriasis|1|||
162807681|NCT01557283|588008000|FG000|Overall Study|Other|6|||
162807682|NCT01776541|588008006|FG000|Overall Study|Administrative Reason|6|||
162807683|NCT01776541|588008007|FG001|Overall Study|Administrative Reason|2|||
162807684|NCT01776541|588008006|FG000|Overall Study|Death|4|||
162807685|NCT01776541|588008007|FG001|Overall Study|Death|0|||
162807686|NCT01776541|588008006|FG000|Overall Study|Lost to Follow-up|27|||
162807687|NCT01776541|588008007|FG001|Overall Study|Lost to Follow-up|48|||
162807688|NCT01776541|588008006|FG000|Overall Study|Unclassified|5|||
162807689|NCT01776541|588008007|FG001|Overall Study|Unclassified|4|||
162807690|NCT01776541|588008006|FG000|Overall Study|Protocol Violation|2|||
162807691|NCT01776541|588008007|FG001|Overall Study|Protocol Violation|1|||
162807692|NCT01776541|588008006|FG000|Overall Study|Withdrawal by Subject|12|||
162807693|NCT01776541|588008007|FG001|Overall Study|Withdrawal by Subject|20|||
162807694|NCT01981473|588008008|FG000|Overall Study|Incorrect diagnosis of RA|0|||
162807695|NCT01981473|588008009|FG001|Overall Study|Incorrect diagnosis of RA|0|||
162807696|NCT01981473|588008010|FG002|Overall Study|Incorrect diagnosis of RA|1|||
162807697|NCT01981473|588008008|FG000|Overall Study|Received treatment for < 6 months|0|||
162807698|NCT01981473|588008009|FG001|Overall Study|Received treatment for < 6 months|0|||
162807699|NCT01981473|588008010|FG002|Overall Study|Received treatment for < 6 months|1|||
162807700|NCT01981473|588008008|FG000|Overall Study|Received treatment for >24 months|2|||
162807701|NCT01981473|588008009|FG001|Overall Study|Received treatment for >24 months|0|||
162807702|NCT01981473|588008010|FG002|Overall Study|Received treatment for >24 months|6|||
162807703|NCT00738582|588008011|FG000|Combination Therapy|Completed Combination Therapy|1|||
162807704|NCT00738582|588008012|FG001|Combination Therapy|Completed Combination Therapy|0|||
162807705|NCT00738582|588008011|FG000|Combination Therapy|Physician Decision|1|||
162807706|NCT00738582|588008012|FG001|Combination Therapy|Physician Decision|0|||
162807707|NCT00738582|588008011|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
162807708|NCT00738582|588008012|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
162807709|NCT00738582|588008011|FG000|Combination Therapy|Other|5|||
162807710|NCT00738582|588008012|FG001|Combination Therapy|Other|0|||
162807711|NCT00738582|588008011|FG000|Combination Therapy|Adverse Event|16|||
162807712|NCT00738582|588008012|FG001|Combination Therapy|Adverse Event|0|||
162807713|NCT00738582|588008011|FG000|Combination Therapy|Progressive Disease|9|||
162807714|NCT00738582|588008012|FG001|Combination Therapy|Progressive Disease|0|||
162807715|NCT00738582|588008011|FG000|Maintenance Therapy|Other|0|||
162807716|NCT00738582|588008012|FG001|Maintenance Therapy|Other|2|||
162807717|NCT00738582|588008011|FG000|Maintenance Therapy|Adverse Event|0|||
162807718|NCT00738582|588008012|FG001|Maintenance Therapy|Adverse Event|6|||
162807719|NCT00738582|588008011|FG000|Maintenance Therapy|Progressive Disease|0|||
162807720|NCT00738582|588008012|FG001|Maintenance Therapy|Progressive Disease|47|||
162807721|NCT00738582|588008011|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
162807722|NCT00738582|588008012|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
162807723|NCT00903006|588008018|FG000|Overall Study|Withdrawal by Subject|2|||
162807724|NCT00903006|588008019|FG001|Overall Study|Withdrawal by Subject|0|||
162807725|NCT00903006|588008020|FG002|Overall Study|Withdrawal by Subject|0|||
162807726|NCT00903006|588008021|FG003|Overall Study|Withdrawal by Subject|0|||
162807727|NCT00903006|588008018|FG000|Overall Study|Progressive Disease|0|||
162807728|NCT00903006|588008019|FG001|Overall Study|Progressive Disease|3|||
162807729|NCT00903006|588008020|FG002|Overall Study|Progressive Disease|1|||
162807730|NCT00903006|588008021|FG003|Overall Study|Progressive Disease|0|||
162807731|NCT03405792|588008022|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
162807732|NCT03405792|588008023|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
162807733|NCT03405792|588008022|FG000|Overall Study|o Did not receive pembrolizumab|1|||
162807734|NCT03405792|588008023|FG001|Overall Study|o Did not receive pembrolizumab|0|||
162807735|NCT02518490|588008027|FG000|Overall Study|Withdrawal by Subject|1|||
162807736|NCT02518490|588008028|FG001|Overall Study|Withdrawal by Subject|1|||
162807737|NCT00346632|588008029|FG000|Overall Study|Progressive Disease|2|||
162807738|NCT00346632|588008030|FG001|Overall Study|Progressive Disease|2|||
162807739|NCT00346632|588008031|FG002|Overall Study|Progressive Disease|4|||
162807740|NCT00346632|588008032|FG003|Overall Study|Progressive Disease|3|||
162807741|NCT00346632|588008033|FG004|Overall Study|Progressive Disease|3|||
162807742|NCT00346632|588008034|FG005|Overall Study|Progressive Disease|1|||
162807743|NCT00346632|588008035|FG006|Overall Study|Progressive Disease|2|||
162807744|NCT00346632|588008036|FG007|Overall Study|Progressive Disease|2|||
162807745|NCT00346632|588008037|FG008|Overall Study|Progressive Disease|2|||
162807746|NCT00346632|588008038|FG009|Overall Study|Progressive Disease|2|||
162807747|NCT00346632|588008029|FG000|Overall Study|Adverse Event|0|||
162807748|NCT00346632|588008030|FG001|Overall Study|Adverse Event|0|||
162807749|NCT00346632|588008031|FG002|Overall Study|Adverse Event|0|||
162807750|NCT00346632|588008032|FG003|Overall Study|Adverse Event|0|||
162807751|NCT00346632|588008033|FG004|Overall Study|Adverse Event|1|||
162807752|NCT00346632|588008034|FG005|Overall Study|Adverse Event|1|||
162807753|NCT00346632|588008035|FG006|Overall Study|Adverse Event|1|||
162807754|NCT00346632|588008036|FG007|Overall Study|Adverse Event|0|||
162807755|NCT00346632|588008037|FG008|Overall Study|Adverse Event|0|||
162807756|NCT00346632|588008038|FG009|Overall Study|Adverse Event|0|||
162807757|NCT00346632|588008029|FG000|Overall Study|Death|0|||
162807758|NCT00346632|588008030|FG001|Overall Study|Death|0|||
162807759|NCT00346632|588008031|FG002|Overall Study|Death|1|||
162807760|NCT00346632|588008032|FG003|Overall Study|Death|0|||
162807761|NCT00346632|588008033|FG004|Overall Study|Death|0|||
162807762|NCT00346632|588008034|FG005|Overall Study|Death|0|||
162807763|NCT00346632|588008035|FG006|Overall Study|Death|0|||
162807764|NCT00346632|588008036|FG007|Overall Study|Death|0|||
162807765|NCT00346632|588008037|FG008|Overall Study|Death|0|||
162807766|NCT00346632|588008038|FG009|Overall Study|Death|0|||
162807767|NCT00346632|588008029|FG000|Overall Study|Protocol Violation|0|||
162807768|NCT00346632|588008030|FG001|Overall Study|Protocol Violation|0|||
162807769|NCT00346632|588008031|FG002|Overall Study|Protocol Violation|0|||
162807770|NCT00346632|588008032|FG003|Overall Study|Protocol Violation|0|||
162807771|NCT00346632|588008033|FG004|Overall Study|Protocol Violation|0|||
162807772|NCT00346632|588008034|FG005|Overall Study|Protocol Violation|0|||
162807773|NCT00346632|588008035|FG006|Overall Study|Protocol Violation|1|||
162807774|NCT00346632|588008036|FG007|Overall Study|Protocol Violation|0|||
162807775|NCT00346632|588008037|FG008|Overall Study|Protocol Violation|0|||
162807776|NCT00346632|588008038|FG009|Overall Study|Protocol Violation|0|||
162807777|NCT00346632|588008029|FG000|Overall Study|Withdrawal by Subject|0|||
162807778|NCT00346632|588008030|FG001|Overall Study|Withdrawal by Subject|0|||
162807779|NCT00346632|588008031|FG002|Overall Study|Withdrawal by Subject|0|||
162807780|NCT00346632|588008032|FG003|Overall Study|Withdrawal by Subject|0|||
162807781|NCT00346632|588008033|FG004|Overall Study|Withdrawal by Subject|0|||
162807782|NCT00346632|588008034|FG005|Overall Study|Withdrawal by Subject|0|||
162807783|NCT00346632|588008035|FG006|Overall Study|Withdrawal by Subject|1|||
162807784|NCT00346632|588008036|FG007|Overall Study|Withdrawal by Subject|0|||
162807785|NCT00346632|588008037|FG008|Overall Study|Withdrawal by Subject|0|||
162807786|NCT00346632|588008038|FG009|Overall Study|Withdrawal by Subject|0|||
162807787|NCT00346632|588008029|FG000|Overall Study|Switched to alternative treatment|0|||
162807788|NCT00346632|588008030|FG001|Overall Study|Switched to alternative treatment|0|||
162807789|NCT00346632|588008031|FG002|Overall Study|Switched to alternative treatment|1|||
162807790|NCT00346632|588008032|FG003|Overall Study|Switched to alternative treatment|0|||
162807791|NCT00346632|588008033|FG004|Overall Study|Switched to alternative treatment|0|||
162807792|NCT00346632|588008034|FG005|Overall Study|Switched to alternative treatment|0|||
162807793|NCT00346632|588008035|FG006|Overall Study|Switched to alternative treatment|0|||
162807794|NCT00346632|588008036|FG007|Overall Study|Switched to alternative treatment|0|||
162807795|NCT00346632|588008037|FG008|Overall Study|Switched to alternative treatment|0|||
162807796|NCT00346632|588008038|FG009|Overall Study|Switched to alternative treatment|0|||
162807797|NCT00346632|588008029|FG000|Overall Study|Not Stated|1|||
162807798|NCT00346632|588008030|FG001|Overall Study|Not Stated|1|||
162807799|NCT00346632|588008031|FG002|Overall Study|Not Stated|0|||
162807800|NCT00346632|588008032|FG003|Overall Study|Not Stated|0|||
162807801|NCT00346632|588008033|FG004|Overall Study|Not Stated|0|||
162807802|NCT00346632|588008034|FG005|Overall Study|Not Stated|0|||
162807803|NCT00346632|588008035|FG006|Overall Study|Not Stated|0|||
162807804|NCT00346632|588008036|FG007|Overall Study|Not Stated|2|||
162807805|NCT00346632|588008037|FG008|Overall Study|Not Stated|2|||
162807806|NCT00346632|588008038|FG009|Overall Study|Not Stated|1|||
162807807|NCT04882995|588008039|FG000|Overall Study|Withdrawal by Subject|1|||
162807808|NCT04882995|588008040|FG001|Overall Study|Withdrawal by Subject|2|||
162807809|NCT04882995|588008039|FG000|Overall Study|Protocol Violation|4|||
162807810|NCT04882995|588008040|FG001|Overall Study|Protocol Violation|4|||
162807811|NCT04882995|588008039|FG000|Overall Study|Surgery postponed due to COVID|1|||
162807812|NCT04882995|588008040|FG001|Overall Study|Surgery postponed due to COVID|1|||
162807813|NCT03587974|588008041|FG000|Overall Study|caregiver demented, care recipient died|3|||
162807814|NCT03587974|588008042|FG001|Overall Study|caregiver demented, care recipient died|3|||
162807815|NCT03587974|588008041|FG000|Overall Study|Withdrawal by Subject|2|||
162807816|NCT03587974|588008042|FG001|Overall Study|Withdrawal by Subject|1|||
162807817|NCT03486457|588008043|FG000|Up to Month 3|Adverse Event|2|||
162807818|NCT03486457|588008044|FG001|Up to Month 3|Adverse Event|5|||
162807819|NCT03486457|588008043|FG000|Up to Month 3|Lack of Efficacy|1|||
162807820|NCT03486457|588008044|FG001|Up to Month 3|Lack of Efficacy|0|||
162807821|NCT03486457|588008043|FG000|Up to Month 3|Withdrawal by Subject|1|||
162807822|NCT03486457|588008044|FG001|Up to Month 3|Withdrawal by Subject|0|||
162807823|NCT03486457|588008043|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
162807824|NCT03486457|588008044|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
162807825|NCT03486457|588008043|FG000|Up to Month 3|Other|1|||
162807826|NCT03486457|588008044|FG001|Up to Month 3|Other|0|||
162807827|NCT03486457|588008043|FG000|Month 3 to Month 6|Adverse Event|2|||
162807828|NCT03486457|588008044|FG001|Month 3 to Month 6|Adverse Event|0|||
162807829|NCT03486457|588008043|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
162807830|NCT03486457|588008044|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
162807831|NCT03486457|588008043|FG000|Month 3 to Month 6|Pregnancy|0|||
162807832|NCT03486457|588008044|FG001|Month 3 to Month 6|Pregnancy|1|||
162807833|NCT03486457|588008043|FG000|Month 3 to Month 6|Other|1|||
162807834|NCT03486457|588008044|FG001|Month 3 to Month 6|Other|0|||
162807835|NCT00372229|588008045|FG000|Study Phase|Graft loss|0|||
162807836|NCT00372229|588008046|FG001|Study Phase|Graft loss|3|||
162807837|NCT00372229|588008045|FG000|Study Phase|Protocol Violation|3|||
162807838|NCT00372229|588008046|FG001|Study Phase|Protocol Violation|4|||
162807839|NCT00372229|588008045|FG000|Study Phase|Consent withdrawn|16|||
162807840|NCT00372229|588008046|FG001|Study Phase|Consent withdrawn|14|||
162807841|NCT00372229|588008045|FG000|Study Phase|Refused treatment/did not cooperate|3|||
162807842|NCT00372229|588008046|FG001|Study Phase|Refused treatment/did not cooperate|1|||
162807843|NCT00372229|588008045|FG000|Study Phase|Death|3|||
162807844|NCT00372229|588008046|FG001|Study Phase|Death|2|||
162807845|NCT00372229|588008045|FG000|Study Phase|Reason not specified|3|||
162807846|NCT00372229|588008046|FG001|Study Phase|Reason not specified|2|||
162807847|NCT00372229|588008045|FG000|Study Phase|Lost to Follow-up|3|||
162807848|NCT00372229|588008046|FG001|Study Phase|Lost to Follow-up|3|||
162807849|NCT00372229|588008045|FG000|Follow-Up Phase|Graft loss|8|||
162807850|NCT00372229|588008046|FG001|Follow-Up Phase|Graft loss|7|||
162807851|NCT00372229|588008045|FG000|Follow-Up Phase|Consent withdrawn|13|||
162807852|NCT00372229|588008046|FG001|Follow-Up Phase|Consent withdrawn|19|||
162807853|NCT00372229|588008045|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
162807854|NCT00372229|588008046|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
162807855|NCT00372229|588008045|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
162807856|NCT00372229|588008046|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
162807857|NCT00372229|588008045|FG000|Follow-Up Phase|Death|9|||
162807858|NCT00372229|588008046|FG001|Follow-Up Phase|Death|12|||
162807859|NCT00372229|588008045|FG000|Follow-Up Phase|Administrative|1|||
162807860|NCT00372229|588008046|FG001|Follow-Up Phase|Administrative|0|||
162807861|NCT00372229|588008045|FG000|Follow-Up Phase|Reason not specified|2|||
162807862|NCT00372229|588008046|FG001|Follow-Up Phase|Reason not specified|3|||
162807863|NCT00372229|588008045|FG000|Follow-Up Phase|Lost to Follow-up|12|||
162807864|NCT00372229|588008046|FG001|Follow-Up Phase|Lost to Follow-up|10|||
162807865|NCT01347762|588008047|FG000|Overall Study|Lost to Follow-up|0|||
162807866|NCT01347762|588008048|FG001|Overall Study|Lost to Follow-up|1|||
162807867|NCT01347762|588008049|FG002|Overall Study|Lost to Follow-up|6|||
162807868|NCT01347762|588008050|FG003|Overall Study|Lost to Follow-up|5|||
162807869|NCT01347762|588008047|FG000|Overall Study|Withdrawal by Subject|4|||
162807870|NCT01347762|588008048|FG001|Overall Study|Withdrawal by Subject|1|||
162807871|NCT01347762|588008049|FG002|Overall Study|Withdrawal by Subject|3|||
162807872|NCT01347762|588008050|FG003|Overall Study|Withdrawal by Subject|3|||
162807873|NCT03235284|588008051|FG000|Overall Study|Adverse Event|1|||
162807874|NCT03235284|588008052|FG001|Overall Study|Adverse Event|2|||
162807875|NCT03235284|588008053|FG002|Overall Study|Adverse Event|1|||
162807876|NCT01382706|588008054|FG000|Overall Study|Adverse Event|1|||
162807877|NCT01382706|588008054|FG000|Overall Study|Withdrawal by Subject|1|||
162807878|NCT04055090|588008055|FG000|Overall Study|screen failure|1|||
162807879|NCT04055090|588008056|FG001|Overall Study|screen failure|0|||
162807880|NCT04055090|588008055|FG000|Overall Study|Withdrawal by Subject|1|||
162807881|NCT04055090|588008056|FG001|Overall Study|Withdrawal by Subject|0|||
162807882|NCT05478499|588008059|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
162807883|NCT05478499|588008060|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
162807884|NCT05478499|588008059|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
162807885|NCT05478499|588008060|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
162807886|NCT05478499|588008059|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
162807887|NCT05478499|588008060|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
162807888|NCT05478499|588008059|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
162807889|NCT05478499|588008060|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
162807890|NCT05478499|588008059|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
162807891|NCT05478499|588008060|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
162807892|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
162807893|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
162807894|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
162807895|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
162807896|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
162807897|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
162807898|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
162807899|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
162807900|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
162807901|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
162807902|NCT05478499|588008059|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
162807903|NCT05478499|588008060|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
162807904|NCT00249002|588008064|FG000|Overall Study|Adverse Event|2|||
162807905|NCT00249002|588008064|FG000|Overall Study|Study cancellation|3|||
162807906|NCT00249002|588008064|FG000|Overall Study|Other|2|||
162807907|NCT00552240|588008065|FG000|Overall Study|Adverse Event|9|||
162807908|NCT00552240|588008066|FG001|Overall Study|Adverse Event|9|||
162807909|NCT00552240|588008065|FG000|Overall Study|Protocol Violation|1|||
162807910|NCT00552240|588008066|FG001|Overall Study|Protocol Violation|1|||
162807911|NCT00552240|588008065|FG000|Overall Study|Lost to Follow-up|5|||
162807912|NCT00552240|588008066|FG001|Overall Study|Lost to Follow-up|6|||
162807913|NCT00552240|588008065|FG000|Overall Study|Withdrawal by Subject|2|||
162807914|NCT00552240|588008066|FG001|Overall Study|Withdrawal by Subject|2|||
162807915|NCT00552240|588008065|FG000|Overall Study|Lack of Efficacy|6|||
162807916|NCT00552240|588008066|FG001|Overall Study|Lack of Efficacy|0|||
162807917|NCT00552240|588008065|FG000|Overall Study|Other|1|||
162807918|NCT00552240|588008066|FG001|Overall Study|Other|0|||
162807919|NCT02679573|588008067|FG000|Overall Study|Adverse Event|13|||
162807920|NCT02679573|588008068|FG001|Overall Study|Adverse Event|6|||
162807921|NCT02679573|588008067|FG000|Overall Study|Lack of Efficacy|12|||
162807922|NCT02679573|588008068|FG001|Overall Study|Lack of Efficacy|15|||
162807923|NCT02679573|588008067|FG000|Overall Study|Could not complete required study visits|6|||
162807924|NCT02679573|588008068|FG001|Overall Study|Could not complete required study visits|2|||
162807925|NCT02679573|588008067|FG000|Overall Study|Withdrawal by Subject|2|||
162807926|NCT02679573|588008068|FG001|Overall Study|Withdrawal by Subject|9|||
162807927|NCT02679573|588008067|FG000|Overall Study|Death|2|||
162807928|NCT02679573|588008068|FG001|Overall Study|Death|0|||
162807929|NCT02679573|588008067|FG000|Overall Study|Physician Decision|2|||
162807930|NCT02679573|588008068|FG001|Overall Study|Physician Decision|4|||
162807931|NCT02679573|588008067|FG000|Overall Study|Lost to Follow-up|0|||
162807932|NCT02679573|588008068|FG001|Overall Study|Lost to Follow-up|3|||
162807933|NCT02476279|588008069|FG000|Overall Study|Lost to Follow-up|1|||
162807934|NCT02476279|588008070|FG001|Overall Study|Lost to Follow-up|1|||
162807935|NCT02128542|588008071|FG000|Overall Study|Lost to Follow-up|3|||
162807936|NCT02128542|588008072|FG001|Overall Study|Lost to Follow-up|0|||
162807937|NCT02128542|588008071|FG000|Overall Study|Withdrew Consent|1|||
162807938|NCT02128542|588008072|FG001|Overall Study|Withdrew Consent|0|||
162807939|NCT03451162|588008078|FG000|Overall Study|Lost to Follow-up|1|||
162807940|NCT03451162|588008079|FG001|Overall Study|Lost to Follow-up|0|||
162807941|NCT03451162|588008080|FG002|Overall Study|Lost to Follow-up|0|||
162807942|NCT03451162|588008081|FG003|Overall Study|Lost to Follow-up|0|||
162807943|NCT03451162|588008082|FG004|Overall Study|Lost to Follow-up|0|||
162807944|NCT03451162|588008078|FG000|Overall Study|Physician Decision|0|||
162807945|NCT03451162|588008079|FG001|Overall Study|Physician Decision|1|||
162807946|NCT03451162|588008080|FG002|Overall Study|Physician Decision|0|||
162807947|NCT03451162|588008081|FG003|Overall Study|Physician Decision|0|||
162807948|NCT03451162|588008082|FG004|Overall Study|Physician Decision|0|||
162807949|NCT03451162|588008078|FG000|Overall Study|Withdrawal by Subject|1|||
162807950|NCT03451162|588008079|FG001|Overall Study|Withdrawal by Subject|1|||
162807951|NCT03451162|588008080|FG002|Overall Study|Withdrawal by Subject|0|||
162807952|NCT03451162|588008081|FG003|Overall Study|Withdrawal by Subject|0|||
162807953|NCT03451162|588008082|FG004|Overall Study|Withdrawal by Subject|0|||
162807954|NCT01952054|588008083|FG000|Overall Study|Physician Decision|1|||
162807955|NCT00232544|588008084|FG000|Overall Study|Lost to Follow-up|20|||
162807956|NCT00232544|588008085|FG001|Overall Study|Lost to Follow-up|15|||
162807957|NCT00116753|588008086|FG000|Overall Study|Adverse Event|16|||
162807958|NCT00116753|588008087|FG001|Overall Study|Adverse Event|10|||
162807959|NCT00116753|588008088|FG002|Overall Study|Adverse Event|7|||
162807960|NCT00116753|588008086|FG000|Overall Study|Withdrawal by Subject|11|||
162807961|NCT00116753|588008087|FG001|Overall Study|Withdrawal by Subject|12|||
162807962|NCT00116753|588008088|FG002|Overall Study|Withdrawal by Subject|8|||
162807963|NCT00116753|588008086|FG000|Overall Study|Lost to Follow-up|0|||
162807964|NCT00116753|588008087|FG001|Overall Study|Lost to Follow-up|2|||
162807965|NCT00116753|588008088|FG002|Overall Study|Lost to Follow-up|1|||
162807966|NCT00116753|588008086|FG000|Overall Study|Protocol Violation|0|||
162807967|NCT00116753|588008087|FG001|Overall Study|Protocol Violation|0|||
162807968|NCT00116753|588008088|FG002|Overall Study|Protocol Violation|1|||
162807969|NCT00116753|588008086|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
162807970|NCT00116753|588008087|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
162807971|NCT00116753|588008088|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
162807972|NCT00116753|588008086|FG000|Overall Study|Disease Progression|3|||
162807973|NCT00116753|588008087|FG001|Overall Study|Disease Progression|4|||
162807974|NCT00116753|588008088|FG002|Overall Study|Disease Progression|3|||
162807975|NCT00116753|588008086|FG000|Overall Study|Abnormal Echocardiogram|0|||
162807976|NCT00116753|588008087|FG001|Overall Study|Abnormal Echocardiogram|0|||
162807977|NCT00116753|588008088|FG002|Overall Study|Abnormal Echocardiogram|1|||
162807978|NCT00116753|588008086|FG000|Overall Study|Progressive Parkinson's Disease|1|||
162807979|NCT00116753|588008087|FG001|Overall Study|Progressive Parkinson's Disease|0|||
162807980|NCT00116753|588008088|FG002|Overall Study|Progressive Parkinson's Disease|0|||
162807981|NCT00116753|588008086|FG000|Overall Study|Dosing Error|0|||
162807982|NCT00116753|588008087|FG001|Overall Study|Dosing Error|1|||
162807983|NCT00116753|588008088|FG002|Overall Study|Dosing Error|0|||
162807984|NCT01200589|588008089|FG000|Overall Study|Withdrawal by Subject|13|||
162807985|NCT01200589|588008090|FG001|Overall Study|Withdrawal by Subject|11|||
162807986|NCT01200589|588008089|FG000|Overall Study|Physician Decision|2|||
162807987|NCT01200589|588008090|FG001|Overall Study|Physician Decision|2|||
162807988|NCT01200589|588008089|FG000|Overall Study|Lost to Follow-up|5|||
162807989|NCT01200589|588008090|FG001|Overall Study|Lost to Follow-up|4|||
162807990|NCT01200589|588008089|FG000|Overall Study|Study terminated|170|||
162807991|NCT01200589|588008090|FG001|Overall Study|Study terminated|172|||
162807992|NCT00986973|588008091|FG000|Overall Study|Withdrawn by study team|1|||
162807993|NCT00598273|588008092|FG000|Overall Study|Adverse Event|4|||
162807994|NCT00598273|588008093|FG001|Overall Study|Adverse Event|5|||
162807995|NCT00598273|588008094|FG002|Overall Study|Adverse Event|2|||
162807996|NCT00598273|588008092|FG000|Overall Study|Death|6|||
162807997|NCT00598273|588008093|FG001|Overall Study|Death|12|||
162807998|NCT00598273|588008094|FG002|Overall Study|Death|8|||
162807999|NCT00598273|588008092|FG000|Overall Study|Lost to Follow-up|8|||
162808000|NCT00598273|588008093|FG001|Overall Study|Lost to Follow-up|3|||
162808001|NCT00598273|588008094|FG002|Overall Study|Lost to Follow-up|5|||
162808002|NCT00598273|588008092|FG000|Overall Study|Physician Decision|0|||
162808003|NCT00598273|588008093|FG001|Overall Study|Physician Decision|0|||
162808004|NCT00598273|588008094|FG002|Overall Study|Physician Decision|1|||
162808005|NCT00598273|588008092|FG000|Overall Study|Withdrawal by Subject|12|||
162808006|NCT00598273|588008093|FG001|Overall Study|Withdrawal by Subject|10|||
162808007|NCT00598273|588008094|FG002|Overall Study|Withdrawal by Subject|10|||
162808008|NCT00598273|588008092|FG000|Overall Study|Noncompliance|3|||
162808009|NCT00598273|588008093|FG001|Overall Study|Noncompliance|2|||
162808010|NCT00598273|588008094|FG002|Overall Study|Noncompliance|3|||
162808011|NCT00598273|588008092|FG000|Overall Study|Relocation|0|||
162808012|NCT00598273|588008093|FG001|Overall Study|Relocation|2|||
162808013|NCT00598273|588008094|FG002|Overall Study|Relocation|4|||
162808014|NCT00598273|588008092|FG000|Overall Study|Renal transplant|1|||
162808015|NCT00598273|588008093|FG001|Overall Study|Renal transplant|0|||
162808016|NCT00598273|588008094|FG002|Overall Study|Renal transplant|1|||
162808017|NCT00598273|588008092|FG000|Overall Study|Site elected to close|1|||
162808018|NCT00598273|588008093|FG001|Overall Study|Site elected to close|0|||
162808019|NCT00598273|588008094|FG002|Overall Study|Site elected to close|0|||
162808020|NCT00598273|588008092|FG000|Overall Study|Started dialysis|6|||
162808021|NCT00598273|588008093|FG001|Overall Study|Started dialysis|4|||
162808022|NCT00598273|588008094|FG002|Overall Study|Started dialysis|5|||
162808023|NCT01590082|588008095|FG000|Overall Study|Withdrawal by Subject|1|||
162808024|NCT01590082|588008096|FG001|Overall Study|Withdrawal by Subject|0|||
162808025|NCT01590082|588008095|FG000|Overall Study|Ineligible|1|||
162808026|NCT01590082|588008096|FG001|Overall Study|Ineligible|0|||
162808027|NCT02549196|588008097|FG000|Overall Study|Protocol Violation|0|||
162808028|NCT02549196|588008098|FG001|Overall Study|Protocol Violation|0|||
162808029|NCT02549196|588008099|FG002|Overall Study|Protocol Violation|0|||
162808030|NCT02549196|588008100|FG003|Overall Study|Protocol Violation|1|||
162808031|NCT02549196|588008097|FG000|Overall Study|Withdrawal by Subject|1|||
162808032|NCT02549196|588008098|FG001|Overall Study|Withdrawal by Subject|0|||
162808033|NCT02549196|588008099|FG002|Overall Study|Withdrawal by Subject|1|||
162808034|NCT02549196|588008100|FG003|Overall Study|Withdrawal by Subject|0|||
162808035|NCT01442779|588008101|FG000|Overall Study|Withdrawal by Subject|3|||
162808036|NCT01442779|588008101|FG000|Overall Study|Death|3|||
162808037|NCT01442779|588008101|FG000|Overall Study|Non-compliance|1|||
162808038|NCT01323972|588008102|FG000|Overall Study|Withdrawal by Subject|1|||
162808039|NCT01323972|588008103|FG001|Overall Study|Withdrawal by Subject|0|||
162808040|NCT01323972|588008104|FG002|Overall Study|Withdrawal by Subject|1|||
162808041|NCT01323972|588008105|FG003|Overall Study|Withdrawal by Subject|0|||
162808042|NCT01323972|588008102|FG000|Overall Study|Migrated/moved from study area|1|||
162808043|NCT01323972|588008103|FG001|Overall Study|Migrated/moved from study area|2|||
162808044|NCT01323972|588008104|FG002|Overall Study|Migrated/moved from study area|0|||
162808045|NCT01323972|588008105|FG003|Overall Study|Migrated/moved from study area|0|||
162808046|NCT01323972|588008102|FG000|Overall Study|Lost to Follow-up|0|||
162808047|NCT01323972|588008103|FG001|Overall Study|Lost to Follow-up|1|||
162808048|NCT01323972|588008104|FG002|Overall Study|Lost to Follow-up|1|||
162808049|NCT01323972|588008105|FG003|Overall Study|Lost to Follow-up|1|||
162808050|NCT00994682|588008106|FG000|Double Bilnd|Withdrawal by Subject|5|||
162808051|NCT00994682|588008107|FG001|Double Bilnd|Withdrawal by Subject|6|||
162808052|NCT00994682|588008106|FG000|Double Bilnd|Lost to Follow-up|3|||
162808053|NCT00994682|588008107|FG001|Double Bilnd|Lost to Follow-up|3|||
162808054|NCT00994682|588008106|FG000|Double Bilnd|Adverse Event|1|||
162808055|NCT00994682|588008107|FG001|Double Bilnd|Adverse Event|0|||
162808056|NCT00994682|588008106|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
162808057|NCT00994682|588008107|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
162808058|NCT00994682|588008106|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
162808059|NCT00994682|588008107|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
162808060|NCT00994682|588008106|FG000|Pioglitazone Open Label|Physician Decision|6|||
162808061|NCT00994682|588008107|FG001|Pioglitazone Open Label|Physician Decision|1|||
162808062|NCT03218397|588008108|FG000|Overall Study|Prior positive blood culture|8|||
162808063|NCT03218397|588008109|FG001|Overall Study|Prior positive blood culture|13|||
162808064|NCT03218397|588008108|FG000|Overall Study|Comfort care|8|||
162808065|NCT03218397|588008109|FG001|Overall Study|Comfort care|5|||
162808066|NCT03218397|588008108|FG000|Overall Study|Comfort care and positive blood culture|1|||
162808067|NCT03218397|588008109|FG001|Overall Study|Comfort care and positive blood culture|0|||
162808068|NCT03218397|588008108|FG000|Overall Study|Comfort care and mixed culture|0|||
162808069|NCT03218397|588008109|FG001|Overall Study|Comfort care and mixed culture|1|||
162808070|NCT03218397|588008108|FG000|Overall Study|Mixed culture|2|||
162808071|NCT03218397|588008109|FG001|Overall Study|Mixed culture|2|||
162808072|NCT03218397|588008108|FG000|Overall Study|Inaccessible hospital records|2|||
162808073|NCT03218397|588008109|FG001|Overall Study|Inaccessible hospital records|5|||
162808074|NCT03218397|588008108|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
162808075|NCT03218397|588008109|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
162808076|NCT03218397|588008108|FG000|Overall Study|Randomized during laboratory off hours|2|||
162808077|NCT03218397|588008109|FG001|Overall Study|Randomized during laboratory off hours|1|||
162808078|NCT01796548|588008112|FG000|Overall Study|Lost to Follow-up|1|||
162808079|NCT01796548|588008112|FG000|Overall Study|Other|2|||
162808080|NCT01049217|588008115|FG000|Overall Study|Adverse Event|2|||
162808081|NCT01049217|588008116|FG001|Overall Study|Adverse Event|1|||
162808082|NCT01049217|588008115|FG000|Overall Study|Lack of Efficacy|1|||
162808083|NCT01049217|588008116|FG001|Overall Study|Lack of Efficacy|1|||
162808084|NCT01049217|588008115|FG000|Overall Study|Lost to Follow-up|3|||
162808085|NCT01049217|588008116|FG001|Overall Study|Lost to Follow-up|8|||
162808086|NCT01049217|588008115|FG000|Overall Study|Withdrawal by Subject|4|||
162808087|NCT01049217|588008116|FG001|Overall Study|Withdrawal by Subject|3|||
162808088|NCT01049217|588008115|FG000|Overall Study|Protocol Violation|1|||
162808089|NCT01049217|588008116|FG001|Overall Study|Protocol Violation|3|||
162808090|NCT01049217|588008115|FG000|Overall Study|Pregnancy|1|||
162808091|NCT01049217|588008116|FG001|Overall Study|Pregnancy|0|||
162808092|NCT01049217|588008115|FG000|Overall Study|Study Terminated by Sponsor|43|||
162808093|NCT01049217|588008116|FG001|Overall Study|Study Terminated by Sponsor|43|||
162808094|NCT01049217|588008115|FG000|Overall Study|Other|1|||
162808095|NCT01049217|588008116|FG001|Overall Study|Other|2|||
162808096|NCT01049217|588008115|FG000|Overall Study|Randomized but not Treated|0|||
162808097|NCT01049217|588008116|FG001|Overall Study|Randomized but not Treated|2|||
162808098|NCT00589121|588008117|FG000|Overall Study|Protocol Violation|2|||
162808099|NCT00589121|588008118|FG001|Overall Study|Protocol Violation|6|||
162808100|NCT00589121|588008117|FG000|Overall Study|No protocol treatment received|0|||
162808101|NCT00589121|588008118|FG001|Overall Study|No protocol treatment received|1|||
162808102|NCT02495792|588008119|FG000|Overall Study|Lost to Follow-up|5|||
162808103|NCT02495792|588008120|FG001|Overall Study|Lost to Follow-up|9|||
162808104|NCT02495792|588008119|FG000|Overall Study|Protocol Violation|32|||
162808105|NCT02495792|588008120|FG001|Overall Study|Protocol Violation|31|||
162808106|NCT03519971|588008121|FG000|Overall Study|Death|142|||
162808107|NCT03519971|588008122|FG001|Overall Study|Death|69|||
162808108|NCT03519971|588008121|FG000|Overall Study|Lost to Follow-up|0|||
162808109|NCT03519971|588008122|FG001|Overall Study|Lost to Follow-up|1|||
162808110|NCT03519971|588008121|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
162808111|NCT03519971|588008122|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
162808112|NCT03519971|588008121|FG000|Overall Study|Withdrawal by Subject|3|||
162808113|NCT03519971|588008122|FG001|Overall Study|Withdrawal by Subject|2|||
162808114|NCT03519971|588008121|FG000|Overall Study|Other|1|||
162808115|NCT03519971|588008122|FG001|Overall Study|Other|0|||
162808116|NCT00925132|588008123|FG000|Overall Study|Withdrawal by Subject|2|||
162808117|NCT00925132|588008124|FG001|Overall Study|Withdrawal by Subject|0|||
162808118|NCT00925132|588008125|FG002|Overall Study|Withdrawal by Subject|0|||
162808119|NCT00925132|588008126|FG003|Overall Study|Withdrawal by Subject|0|||
162808120|NCT00925132|588008127|FG004|Overall Study|Withdrawal by Subject|1|||
162808121|NCT00925132|588008123|FG000|Overall Study|Removed due to disease progression|0|||
162808122|NCT00925132|588008124|FG001|Overall Study|Removed due to disease progression|0|||
162808123|NCT00925132|588008125|FG002|Overall Study|Removed due to disease progression|0|||
162808124|NCT00925132|588008126|FG003|Overall Study|Removed due to disease progression|0|||
162808125|NCT00925132|588008127|FG004|Overall Study|Removed due to disease progression|4|||
162808126|NCT02545933|588008128|FG000|Overall Study|Adverse Event|3|||
162808127|NCT02545933|588008129|FG001|Overall Study|Adverse Event|0|||
162808128|NCT02545933|588008130|FG002|Overall Study|Adverse Event|0|||
162808129|NCT02545933|588008128|FG000|Overall Study|Withdrawal by Subject|2|||
162808130|NCT02545933|588008129|FG001|Overall Study|Withdrawal by Subject|3|||
162808131|NCT02545933|588008130|FG002|Overall Study|Withdrawal by Subject|3|||
162808132|NCT02545933|588008128|FG000|Overall Study|Protocol Violation|1|||
162808133|NCT02545933|588008129|FG001|Overall Study|Protocol Violation|0|||
162808134|NCT02545933|588008130|FG002|Overall Study|Protocol Violation|1|||
162808135|NCT03149549|588008131|FG000|Study Discontinuation--Treatment Period|Death|0|||
162808136|NCT03149549|588008132|FG001|Study Discontinuation--Treatment Period|Death|0|||
162808137|NCT03149549|588008133|FG002|Study Discontinuation--Treatment Period|Death|0|||
162808138|NCT03149549|588008134|FG003|Study Discontinuation--Treatment Period|Death|1|||
162808139|NCT03149549|588008135|FG004|Study Discontinuation--Treatment Period|Death|2|||
162808140|NCT03149549|588008136|FG005|Study Discontinuation--Treatment Period|Death|1|||
162808141|NCT03149549|588008137|FG006|Study Discontinuation--Treatment Period|Death|1|||
162808142|NCT03149549|588008138|FG007|Study Discontinuation--Treatment Period|Death|2|||
162808143|NCT03149549|588008139|FG008|Study Discontinuation--Treatment Period|Death|4|||
162808144|NCT03149549|588008140|FG009|Study Discontinuation--Treatment Period|Death|1|||
162808145|NCT03149549|588008141|FG010|Study Discontinuation--Treatment Period|Death|0|||
162808146|NCT03149549|588008142|FG011|Study Discontinuation--Treatment Period|Death|0|||
162808147|NCT03149549|588008143|FG012|Study Discontinuation--Treatment Period|Death|1|||
162808148|NCT03149549|588008131|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808149|NCT03149549|588008132|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808150|NCT03149549|588008133|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808151|NCT03149549|588008134|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808152|NCT03149549|588008135|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808153|NCT03149549|588008136|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808154|NCT03149549|588008137|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808155|NCT03149549|588008138|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
162808156|NCT03149549|588008139|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808157|NCT03149549|588008140|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808158|NCT03149549|588008141|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808159|NCT03149549|588008142|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162808160|NCT03149549|588008143|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
162808161|NCT03149549|588008131|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808162|NCT03149549|588008132|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808163|NCT03149549|588008133|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808164|NCT03149549|588008134|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
162808165|NCT03149549|588008135|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162808166|NCT03149549|588008136|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
162808167|NCT03149549|588008137|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162808168|NCT03149549|588008138|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808169|NCT03149549|588008139|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162808170|NCT03149549|588008140|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808171|NCT03149549|588008141|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808172|NCT03149549|588008142|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808173|NCT03149549|588008143|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162808174|NCT03149549|588008131|FG000|Study Discontinuation--Treatment Period|Other|0|||
162808175|NCT03149549|588008132|FG001|Study Discontinuation--Treatment Period|Other|0|||
162808176|NCT03149549|588008133|FG002|Study Discontinuation--Treatment Period|Other|0|||
162808177|NCT03149549|588008134|FG003|Study Discontinuation--Treatment Period|Other|0|||
162808178|NCT03149549|588008135|FG004|Study Discontinuation--Treatment Period|Other|0|||
162808179|NCT03149549|588008136|FG005|Study Discontinuation--Treatment Period|Other|0|||
162808180|NCT03149549|588008137|FG006|Study Discontinuation--Treatment Period|Other|0|||
162808181|NCT03149549|588008138|FG007|Study Discontinuation--Treatment Period|Other|1|||
162808182|NCT03149549|588008139|FG008|Study Discontinuation--Treatment Period|Other|0|||
162808183|NCT03149549|588008140|FG009|Study Discontinuation--Treatment Period|Other|1|||
162808184|NCT03149549|588008141|FG010|Study Discontinuation--Treatment Period|Other|0|||
162808185|NCT03149549|588008142|FG011|Study Discontinuation--Treatment Period|Other|0|||
162808186|NCT03149549|588008143|FG012|Study Discontinuation--Treatment Period|Other|0|||
162808187|NCT03149549|588008131|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808188|NCT03149549|588008132|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808189|NCT03149549|588008133|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808190|NCT03149549|588008134|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808191|NCT03149549|588008135|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808192|NCT03149549|588008136|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
162808193|NCT03149549|588008137|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
162808194|NCT03149549|588008138|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808195|NCT03149549|588008139|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
162808196|NCT03149549|588008140|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808197|NCT03149549|588008141|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808198|NCT03149549|588008142|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808199|NCT03149549|588008143|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162808200|NCT03149549|588008131|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808201|NCT03149549|588008132|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162925442|NCT02564952|588428975|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
162808202|NCT03149549|588008133|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808203|NCT03149549|588008134|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808204|NCT03149549|588008135|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
162808205|NCT03149549|588008136|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808206|NCT03149549|588008137|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808207|NCT03149549|588008138|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
162808208|NCT03149549|588008139|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
162808209|NCT03149549|588008140|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808210|NCT03149549|588008141|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162808211|NCT03149549|588008142|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
162808212|NCT03149549|588008143|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
162808213|NCT03149549|588008131|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808214|NCT03149549|588008132|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808215|NCT03149549|588008133|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808216|NCT03149549|588008134|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808217|NCT03149549|588008135|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162808218|NCT03149549|588008136|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808219|NCT03149549|588008137|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808220|NCT03149549|588008138|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
162808221|NCT03149549|588008139|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162808222|NCT03149549|588008140|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162808223|NCT03149549|588008141|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
162808224|NCT03149549|588008142|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162808225|NCT03149549|588008143|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162808226|NCT03149549|588008131|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
162808227|NCT03149549|588008132|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
162808228|NCT03149549|588008133|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
162808229|NCT03149549|588008134|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
162808230|NCT03149549|588008135|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
162808231|NCT03149549|588008136|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
162808232|NCT03149549|588008137|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
162808233|NCT03149549|588008138|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
162808234|NCT03149549|588008139|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
162808235|NCT03149549|588008140|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
162808236|NCT03149549|588008141|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
162808237|NCT03149549|588008142|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
162808238|NCT03149549|588008143|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
162808239|NCT03149549|588008131|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
162808240|NCT03149549|588008132|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
162808241|NCT03149549|588008133|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
162808242|NCT03149549|588008134|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
162808243|NCT03149549|588008135|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
162808244|NCT03149549|588008136|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
162808245|NCT03149549|588008137|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
162808246|NCT03149549|588008138|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
162808247|NCT03149549|588008139|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
162808248|NCT03149549|588008140|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
162808249|NCT03149549|588008141|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
162808250|NCT03149549|588008142|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
162808251|NCT03149549|588008143|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
162808252|NCT03141905|588008144|FG000|Overall Study|Death|3|||
162808253|NCT03141905|588008145|FG001|Overall Study|Death|2|||
162808254|NCT03141905|588008144|FG000|Overall Study|Withdrawal by Subject|1|||
162808255|NCT03141905|588008145|FG001|Overall Study|Withdrawal by Subject|0|||
162808256|NCT03141905|588008144|FG000|Overall Study|Lost to Follow-up|3|||
162808257|NCT03141905|588008145|FG001|Overall Study|Lost to Follow-up|7|||
162808258|NCT03141905|588008144|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
162808259|NCT03141905|588008145|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
162808260|NCT05180500|588008146|FG000|Overall Study|Adverse Event|1|||
162808261|NCT05180500|588008147|FG001|Overall Study|Adverse Event|0|||
162808262|NCT05180500|588008146|FG000|Overall Study|Withdrawal by Subject|2|||
162808263|NCT05180500|588008147|FG001|Overall Study|Withdrawal by Subject|0|||
162808264|NCT04927884|588008152|FG000|Overall Study|Progressive Disease|2|||
162808265|NCT01775124|588008153|FG000|Core Period|Disease Progression|0|||
162808266|NCT01775124|588008154|FG001|Core Period|Disease Progression|1|||
162808267|NCT01775124|588008153|FG000|Core Period|Physician Decision|1|||
162808268|NCT01775124|588008154|FG001|Core Period|Physician Decision|1|||
162808269|NCT01775124|588008153|FG000|Core Period|Death|0|||
162808270|NCT01775124|588008154|FG001|Core Period|Death|1|||
162808271|NCT01775124|588008153|FG000|Core Period|Administrative problems|1|||
162808272|NCT01775124|588008154|FG001|Core Period|Administrative problems|0|||
162808273|NCT01775124|588008153|FG000|Core Period|Withdrawal by Subject|4|||
162808274|NCT01775124|588008154|FG001|Core Period|Withdrawal by Subject|2|||
162808275|NCT01775124|588008153|FG000|Core Period|Adverse Event|5|||
162808276|NCT01775124|588008154|FG001|Core Period|Adverse Event|5|||
162808277|NCT01775124|588008153|FG000|Extension Period|Adverse Event|3|||
162808278|NCT01775124|588008154|FG001|Extension Period|Adverse Event|2|||
162808279|NCT01775124|588008153|FG000|Extension Period|Physician Decision|0|||
162808280|NCT01775124|588008154|FG001|Extension Period|Physician Decision|2|||
162808281|NCT01775124|588008153|FG000|Extension Period|Administrative problems|0|||
162808282|NCT01775124|588008154|FG001|Extension Period|Administrative problems|1|||
162808283|NCT01775124|588008153|FG000|Extension Period|Lost to Follow-up|0|||
162808284|NCT01775124|588008154|FG001|Extension Period|Lost to Follow-up|1|||
162808285|NCT01775124|588008153|FG000|Extension Period|Withdrawal by Subject|9|||
162808286|NCT01775124|588008154|FG001|Extension Period|Withdrawal by Subject|12|||
162808287|NCT05917470|588008155|FG000|Overall Study|Progressive Disease|1|||
162808288|NCT05917470|588008156|FG001|Overall Study|Progressive Disease|1|||
162808289|NCT05917470|588008157|FG002|Overall Study|Progressive Disease|2|||
162808290|NCT05917470|588008158|FG003|Overall Study|Progressive Disease|3|||
162808291|NCT05917470|588008159|FG004|Overall Study|Progressive Disease|1|||
162808292|NCT05917470|588008160|FG005|Overall Study|Progressive Disease|1|||
162808293|NCT05917470|588008161|FG006|Overall Study|Progressive Disease|0|||
162808294|NCT05917470|588008162|FG007|Overall Study|Progressive Disease|0|||
162808295|NCT05917470|588008155|FG000|Overall Study|Withdrawal by Subject|0|||
162808296|NCT05917470|588008156|FG001|Overall Study|Withdrawal by Subject|0|||
162808297|NCT05917470|588008157|FG002|Overall Study|Withdrawal by Subject|1|||
162808298|NCT05917470|588008158|FG003|Overall Study|Withdrawal by Subject|0|||
162808299|NCT05917470|588008159|FG004|Overall Study|Withdrawal by Subject|0|||
162808300|NCT05917470|588008160|FG005|Overall Study|Withdrawal by Subject|0|||
162808301|NCT05917470|588008161|FG006|Overall Study|Withdrawal by Subject|0|||
162808302|NCT05917470|588008162|FG007|Overall Study|Withdrawal by Subject|0|||
162808303|NCT05917470|588008155|FG000|Overall Study|Sponsor Decision|0|||
162808304|NCT05917470|588008156|FG001|Overall Study|Sponsor Decision|0|||
162808305|NCT05917470|588008157|FG002|Overall Study|Sponsor Decision|1|||
162808306|NCT05917470|588008158|FG003|Overall Study|Sponsor Decision|0|||
162808307|NCT05917470|588008159|FG004|Overall Study|Sponsor Decision|2|||
162808308|NCT05917470|588008160|FG005|Overall Study|Sponsor Decision|1|||
162808309|NCT05917470|588008161|FG006|Overall Study|Sponsor Decision|3|||
162808310|NCT05917470|588008162|FG007|Overall Study|Sponsor Decision|3|||
162808311|NCT05917470|588008155|FG000|Overall Study|Adverse Event|0|||
162808312|NCT05917470|588008156|FG001|Overall Study|Adverse Event|0|||
162808313|NCT05917470|588008157|FG002|Overall Study|Adverse Event|0|||
162808314|NCT05917470|588008158|FG003|Overall Study|Adverse Event|0|||
162808315|NCT05917470|588008159|FG004|Overall Study|Adverse Event|0|||
162808316|NCT05917470|588008160|FG005|Overall Study|Adverse Event|1|||
162808317|NCT05917470|588008161|FG006|Overall Study|Adverse Event|0|||
162808318|NCT05917470|588008162|FG007|Overall Study|Adverse Event|0|||
162808319|NCT02317432|588008163|FG000|Overall Study|Death|4|||
162808320|NCT02317432|588008164|FG001|Overall Study|Death|1|||
162808321|NCT02317432|588008163|FG000|Overall Study|Lost to Follow-up|0|||
162808322|NCT02317432|588008164|FG001|Overall Study|Lost to Follow-up|5|||
162808323|NCT02317432|588008163|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
162808324|NCT02317432|588008164|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
162808325|NCT01328717|588010173|FG000|Overall Study|Adverse Event|1|||
162808326|NCT00346268|588010174|FG000|Overall Study|Adverse Event|1|||
162808327|NCT00346268|588010175|FG001|Overall Study|Adverse Event|0|||
162808328|NCT00346268|588010174|FG000|Overall Study|Protocol Violation|1|||
162808329|NCT00346268|588010175|FG001|Overall Study|Protocol Violation|0|||
162808330|NCT00346268|588010174|FG000|Overall Study|Participant refused|0|||
162808331|NCT00346268|588010175|FG001|Overall Study|Participant refused|3|||
162808332|NCT01036763|588010176|FG000|Overall Study|Adverse Event|25|||
162808333|NCT01036763|588010176|FG000|Overall Study|Lost to Follow-up|28|||
162808334|NCT01036763|588010176|FG000|Overall Study|Other reason (not specified)|40|||
162808335|NCT01177722|588010179|FG000|Overall Study|Serious Adverse Event|0|||
162808336|NCT01177722|588010180|FG001|Overall Study|Serious Adverse Event|0|||
162808337|NCT01177722|588010181|FG002|Overall Study|Serious Adverse Event|1|||
162808338|NCT01177722|588010182|FG003|Overall Study|Serious Adverse Event|0|||
162808339|NCT01177722|588010179|FG000|Overall Study|Protocol Violation|0|||
162808340|NCT01177722|588010180|FG001|Overall Study|Protocol Violation|0|||
162808341|NCT01177722|588010181|FG002|Overall Study|Protocol Violation|1|||
162808342|NCT01177722|588010182|FG003|Overall Study|Protocol Violation|0|||
162808343|NCT01177722|588010179|FG000|Overall Study|Lost to Follow-up|3|||
162808344|NCT01177722|588010180|FG001|Overall Study|Lost to Follow-up|4|||
162808345|NCT01177722|588010181|FG002|Overall Study|Lost to Follow-up|3|||
162808346|NCT01177722|588010182|FG003|Overall Study|Lost to Follow-up|1|||
162808347|NCT01177722|588010179|FG000|Overall Study|Withdrawal by Subject|10|||
162808348|NCT01177722|588010180|FG001|Overall Study|Withdrawal by Subject|6|||
162808349|NCT01177722|588010181|FG002|Overall Study|Withdrawal by Subject|4|||
162808350|NCT01177722|588010182|FG003|Overall Study|Withdrawal by Subject|6|||
162808351|NCT02831387|588010183|FG000|Overall Study|Withdrawal by Subject|1|||
162808352|NCT02831387|588010184|FG001|Overall Study|Withdrawal by Subject|1|||
162808353|NCT02831387|588010183|FG000|Overall Study|Discontinued due to stock recovery|0|||
162808354|NCT02831387|588010184|FG001|Overall Study|Discontinued due to stock recovery|1|||
162808355|NCT00192647|588010185|FG000|Overall Study|Death|1|||
162808356|NCT00192647|588010186|FG001|Overall Study|Death|1|||
162808357|NCT00192647|588010185|FG000|Overall Study|Adverse Event|35|||
162808358|NCT00192647|588010186|FG001|Overall Study|Adverse Event|29|||
162808359|NCT00192647|588010185|FG000|Overall Study|Laboratory Test Abnormality|4|||
162808360|NCT00192647|588010186|FG001|Overall Study|Laboratory Test Abnormality|2|||
162808361|NCT00192647|588010185|FG000|Overall Study|Insufficient Therapeutic Response|53|||
162808362|NCT00192647|588010186|FG001|Overall Study|Insufficient Therapeutic Response|83|||
162808363|NCT00192647|588010185|FG000|Overall Study|Entry Criteria Violation|6|||
162808364|NCT00192647|588010186|FG001|Overall Study|Entry Criteria Violation|6|||
162808365|NCT00192647|588010185|FG000|Overall Study|Protocol Violation|3|||
162808366|NCT00192647|588010186|FG001|Overall Study|Protocol Violation|1|||
162808367|NCT00192647|588010185|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
162808368|NCT00192647|588010186|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
162808369|NCT00192647|588010185|FG000|Overall Study|Failure to Return|11|||
162808370|NCT00192647|588010186|FG001|Overall Study|Failure to Return|13|||
162808371|NCT00192647|588010185|FG000|Overall Study|Other/Administrative|5|||
162808372|NCT00192647|588010186|FG001|Overall Study|Other/Administrative|3|||
162808373|NCT01828073|588010187|FG000|Overall Study|Lost to Follow-up|1|||
162808374|NCT01828073|588010188|FG001|Overall Study|Lost to Follow-up|2|||
162808375|NCT05220254|588010193|FG000|Overall Study|Withdrawal by Subject|4|||
162808376|NCT05220254|588010193|FG000|Overall Study|Removed due to ineligibility|1|||
162808377|NCT05220254|588010193|FG000|Overall Study|Lost to Follow-up|7|||
162808378|NCT01765192|588010196|FG000|Treatment Period 1|Adverse Event|0|||
162808379|NCT01765192|588010197|FG001|Treatment Period 1|Adverse Event|1|||
162808380|NCT01765192|588010196|FG000|Washout Period|Voluntary Withdrawal|1|||
162808381|NCT01765192|588010197|FG001|Washout Period|Voluntary Withdrawal|1|||
162808382|NCT01765192|588010196|FG000|Washout Period|Reason not specified|1|||
162808383|NCT01765192|588010197|FG001|Washout Period|Reason not specified|0|||
162808384|NCT01765192|588010196|FG000|Treatment Period 2|Reason not specified|0|||
162808385|NCT01765192|588010197|FG001|Treatment Period 2|Reason not specified|2|||
162808386|NCT01765192|588010196|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
162808387|NCT01765192|588010197|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
162808388|NCT01016977|588010200|FG000|Overall Study|Lost to Follow-up|1|||
162808389|NCT01016977|588010201|FG001|Overall Study|Lost to Follow-up|0|||
162808390|NCT01016977|588010200|FG000|Overall Study|Withdrawal by Subject|2|||
162808391|NCT01016977|588010201|FG001|Overall Study|Withdrawal by Subject|2|||
162808392|NCT02080221|588010202|FG000|Overall Study|Withdrawal by Subject|1|||
162808393|NCT02080221|588010202|FG000|Overall Study|Clinical Progression of Disease|1|||
162808394|NCT03184870|588010203|FG000|Initial Treatment|Death|6|||
162808395|NCT03184870|588010204|FG001|Initial Treatment|Death|6|||
162808396|NCT03184870|588010205|FG002|Initial Treatment|Death|8|||
162808397|NCT03184870|588010206|FG003|Initial Treatment|Death|8|||
162808398|NCT03184870|588010207|FG004|Initial Treatment|Death|6|||
162808399|NCT03184870|588010208|FG005|Initial Treatment|Death|6|||
162808400|NCT03184870|588010209|FG006|Initial Treatment|Death|6|||
162808401|NCT03184870|588010210|FG007|Initial Treatment|Death|7|||
162808402|NCT03184870|588010211|FG008|Initial Treatment|Death|1|||
162808403|NCT03184870|588010212|FG009|Initial Treatment|Death|2|||
162808404|NCT03184870|588010213|FG010|Initial Treatment|Death|26|||
162808405|NCT03184870|588010214|FG011|Initial Treatment|Death|28|||
162808406|NCT03184870|588010215|FG012|Initial Treatment|Death|10|||
162808407|NCT03184870|588010216|FG013|Initial Treatment|Death|33|||
162808408|NCT03184870|588010217|FG014|Initial Treatment|Death|34|||
162808409|NCT03184870|588010218|FG015|Initial Treatment|Death|26|||
162808410|NCT03184870|588010219|FG016|Initial Treatment|Death|20|||
162808411|NCT03184870|588010220|FG017|Initial Treatment|Death|18|||
162808412|NCT03184870|588010203|FG000|Initial Treatment|Other Reasons|2|||
162808413|NCT03184870|588010204|FG001|Initial Treatment|Other Reasons|2|||
162808414|NCT03184870|588010205|FG002|Initial Treatment|Other Reasons|0|||
162808415|NCT03184870|588010206|FG003|Initial Treatment|Other Reasons|1|||
162808416|NCT03184870|588010207|FG004|Initial Treatment|Other Reasons|0|||
162808417|NCT03184870|588010208|FG005|Initial Treatment|Other Reasons|0|||
162808418|NCT03184870|588010209|FG006|Initial Treatment|Other Reasons|0|||
162808419|NCT03184870|588010210|FG007|Initial Treatment|Other Reasons|2|||
162808420|NCT03184870|588010211|FG008|Initial Treatment|Other Reasons|0|||
162808421|NCT03184870|588010212|FG009|Initial Treatment|Other Reasons|0|||
162808422|NCT03184870|588010213|FG010|Initial Treatment|Other Reasons|4|||
162808423|NCT03184870|588010214|FG011|Initial Treatment|Other Reasons|2|||
162808424|NCT03184870|588010215|FG012|Initial Treatment|Other Reasons|2|||
162808425|NCT03184870|588010216|FG013|Initial Treatment|Other Reasons|0|||
162808426|NCT03184870|588010217|FG014|Initial Treatment|Other Reasons|0|||
162808427|NCT03184870|588010218|FG015|Initial Treatment|Other Reasons|1|||
162808428|NCT03184870|588010219|FG016|Initial Treatment|Other Reasons|0|||
162808429|NCT03184870|588010220|FG017|Initial Treatment|Other Reasons|2|||
162808430|NCT03184870|588010203|FG000|Initial Treatment|Lost to Follow-up|2|||
162808431|NCT03184870|588010204|FG001|Initial Treatment|Lost to Follow-up|0|||
162808432|NCT03184870|588010205|FG002|Initial Treatment|Lost to Follow-up|0|||
162808433|NCT03184870|588010206|FG003|Initial Treatment|Lost to Follow-up|1|||
162808434|NCT03184870|588010207|FG004|Initial Treatment|Lost to Follow-up|1|||
162808435|NCT03184870|588010208|FG005|Initial Treatment|Lost to Follow-up|1|||
162808436|NCT03184870|588010209|FG006|Initial Treatment|Lost to Follow-up|0|||
162808437|NCT03184870|588010210|FG007|Initial Treatment|Lost to Follow-up|2|||
162808438|NCT03184870|588010211|FG008|Initial Treatment|Lost to Follow-up|0|||
162808439|NCT03184870|588010212|FG009|Initial Treatment|Lost to Follow-up|0|||
162808440|NCT03184870|588010213|FG010|Initial Treatment|Lost to Follow-up|2|||
162808441|NCT03184870|588010214|FG011|Initial Treatment|Lost to Follow-up|0|||
162808442|NCT03184870|588010215|FG012|Initial Treatment|Lost to Follow-up|2|||
162808443|NCT03184870|588010216|FG013|Initial Treatment|Lost to Follow-up|2|||
162808444|NCT03184870|588010217|FG014|Initial Treatment|Lost to Follow-up|0|||
162808445|NCT03184870|588010218|FG015|Initial Treatment|Lost to Follow-up|0|||
162808446|NCT03184870|588010219|FG016|Initial Treatment|Lost to Follow-up|2|||
162808447|NCT03184870|588010220|FG017|Initial Treatment|Lost to Follow-up|2|||
162808448|NCT03184870|588010203|FG000|Initial Treatment|Withdrawal by Subject|0|||
162808449|NCT03184870|588010204|FG001|Initial Treatment|Withdrawal by Subject|0|||
162808450|NCT03184870|588010205|FG002|Initial Treatment|Withdrawal by Subject|2|||
162808451|NCT03184870|588010206|FG003|Initial Treatment|Withdrawal by Subject|1|||
162808452|NCT03184870|588010207|FG004|Initial Treatment|Withdrawal by Subject|1|||
162808453|NCT03184870|588010208|FG005|Initial Treatment|Withdrawal by Subject|0|||
162808454|NCT03184870|588010209|FG006|Initial Treatment|Withdrawal by Subject|1|||
162808455|NCT03184870|588010210|FG007|Initial Treatment|Withdrawal by Subject|0|||
162808456|NCT03184870|588010211|FG008|Initial Treatment|Withdrawal by Subject|0|||
162808457|NCT03184870|588010212|FG009|Initial Treatment|Withdrawal by Subject|0|||
162808458|NCT03184870|588010213|FG010|Initial Treatment|Withdrawal by Subject|0|||
162808459|NCT03184870|588010214|FG011|Initial Treatment|Withdrawal by Subject|2|||
162808460|NCT03184870|588010215|FG012|Initial Treatment|Withdrawal by Subject|3|||
162808461|NCT03184870|588010216|FG013|Initial Treatment|Withdrawal by Subject|0|||
162808462|NCT03184870|588010217|FG014|Initial Treatment|Withdrawal by Subject|1|||
162808463|NCT03184870|588010218|FG015|Initial Treatment|Withdrawal by Subject|5|||
162808464|NCT03184870|588010219|FG016|Initial Treatment|Withdrawal by Subject|2|||
162808465|NCT03184870|588010220|FG017|Initial Treatment|Withdrawal by Subject|2|||
162808466|NCT03184870|588010203|FG000|Initial Treatment|Moved to crossover treatment|0|||
162808467|NCT03184870|588010204|FG001|Initial Treatment|Moved to crossover treatment|0|||
162808468|NCT03184870|588010205|FG002|Initial Treatment|Moved to crossover treatment|0|||
162808469|NCT03184870|588010206|FG003|Initial Treatment|Moved to crossover treatment|0|||
162808470|NCT03184870|588010207|FG004|Initial Treatment|Moved to crossover treatment|0|||
162808471|NCT03184870|588010208|FG005|Initial Treatment|Moved to crossover treatment|0|||
162808472|NCT03184870|588010209|FG006|Initial Treatment|Moved to crossover treatment|0|||
162808473|NCT03184870|588010210|FG007|Initial Treatment|Moved to crossover treatment|0|||
162808474|NCT03184870|588010211|FG008|Initial Treatment|Moved to crossover treatment|0|||
162808475|NCT03184870|588010212|FG009|Initial Treatment|Moved to crossover treatment|0|||
162808476|NCT03184870|588010213|FG010|Initial Treatment|Moved to crossover treatment|0|||
162808477|NCT03184870|588010214|FG011|Initial Treatment|Moved to crossover treatment|0|||
162808478|NCT03184870|588010215|FG012|Initial Treatment|Moved to crossover treatment|9|||
162808479|NCT03184870|588010216|FG013|Initial Treatment|Moved to crossover treatment|0|||
162808480|NCT03184870|588010217|FG014|Initial Treatment|Moved to crossover treatment|0|||
162808481|NCT03184870|588010218|FG015|Initial Treatment|Moved to crossover treatment|0|||
162808482|NCT03184870|588010219|FG016|Initial Treatment|Moved to crossover treatment|0|||
162808483|NCT03184870|588010220|FG017|Initial Treatment|Moved to crossover treatment|0|||
162808484|NCT03184870|588010203|FG000|Crossover Treatment|Other reasons|0|||
162808485|NCT03184870|588010204|FG001|Crossover Treatment|Other reasons|0|||
162808486|NCT03184870|588010205|FG002|Crossover Treatment|Other reasons|0|||
162808487|NCT03184870|588010206|FG003|Crossover Treatment|Other reasons|0|||
162808488|NCT03184870|588010207|FG004|Crossover Treatment|Other reasons|0|||
162808489|NCT03184870|588010208|FG005|Crossover Treatment|Other reasons|0|||
162808490|NCT03184870|588010209|FG006|Crossover Treatment|Other reasons|0|||
162808491|NCT03184870|588010210|FG007|Crossover Treatment|Other reasons|0|||
162808492|NCT03184870|588010211|FG008|Crossover Treatment|Other reasons|0|||
162808493|NCT03184870|588010212|FG009|Crossover Treatment|Other reasons|0|||
162808494|NCT03184870|588010213|FG010|Crossover Treatment|Other reasons|0|||
162808495|NCT03184870|588010214|FG011|Crossover Treatment|Other reasons|0|||
162808496|NCT03184870|588010215|FG012|Crossover Treatment|Other reasons|0|||
162808497|NCT03184870|588010216|FG013|Crossover Treatment|Other reasons|0|||
162808498|NCT03184870|588010217|FG014|Crossover Treatment|Other reasons|0|||
162808499|NCT03184870|588010218|FG015|Crossover Treatment|Other reasons|0|||
162808500|NCT03184870|588010219|FG016|Crossover Treatment|Other reasons|0|||
162808501|NCT03184870|588010220|FG017|Crossover Treatment|Other reasons|2|||
162808502|NCT03184870|588010203|FG000|Crossover Treatment|Death|0|||
162808503|NCT03184870|588010204|FG001|Crossover Treatment|Death|0|||
162808504|NCT03184870|588010205|FG002|Crossover Treatment|Death|0|||
162808505|NCT03184870|588010206|FG003|Crossover Treatment|Death|0|||
162808506|NCT03184870|588010207|FG004|Crossover Treatment|Death|0|||
162808507|NCT03184870|588010208|FG005|Crossover Treatment|Death|0|||
162808508|NCT03184870|588010209|FG006|Crossover Treatment|Death|0|||
162808509|NCT03184870|588010210|FG007|Crossover Treatment|Death|0|||
162808510|NCT03184870|588010211|FG008|Crossover Treatment|Death|0|||
162808511|NCT03184870|588010212|FG009|Crossover Treatment|Death|0|||
162808512|NCT03184870|588010213|FG010|Crossover Treatment|Death|0|||
162808513|NCT03184870|588010214|FG011|Crossover Treatment|Death|0|||
162808514|NCT03184870|588010215|FG012|Crossover Treatment|Death|0|||
162808515|NCT03184870|588010216|FG013|Crossover Treatment|Death|0|||
162808516|NCT03184870|588010217|FG014|Crossover Treatment|Death|0|||
162808517|NCT03184870|588010218|FG015|Crossover Treatment|Death|0|||
162808518|NCT03184870|588010219|FG016|Crossover Treatment|Death|0|||
162808519|NCT03184870|588010220|FG017|Crossover Treatment|Death|7|||
162808520|NCT05081388|588010221|FG000|Overall Study|Adverse Event|1|||
162808521|NCT05081388|588010222|FG001|Overall Study|Adverse Event|0|||
162808522|NCT05081388|588010223|FG002|Overall Study|Adverse Event|0|||
162808523|NCT05081388|588010224|FG003|Overall Study|Adverse Event|0|||
162808524|NCT05081388|588010225|FG004|Overall Study|Adverse Event|0|||
162808525|NCT05081388|588010221|FG000|Overall Study|Lost to Follow-up|0|||
162808526|NCT05081388|588010222|FG001|Overall Study|Lost to Follow-up|1|||
162808527|NCT05081388|588010223|FG002|Overall Study|Lost to Follow-up|0|||
162808528|NCT05081388|588010224|FG003|Overall Study|Lost to Follow-up|0|||
162808529|NCT05081388|588010225|FG004|Overall Study|Lost to Follow-up|0|||
162808530|NCT05081388|588010221|FG000|Overall Study|Subject decision|0|||
162808531|NCT05081388|588010222|FG001|Overall Study|Subject decision|0|||
162808532|NCT05081388|588010223|FG002|Overall Study|Subject decision|0|||
162808533|NCT05081388|588010224|FG003|Overall Study|Subject decision|1|||
162808534|NCT05081388|588010225|FG004|Overall Study|Subject decision|0|||
162808535|NCT03786783|588010226|FG000|Overall Study|Death|1|||
162808536|NCT03786783|588010226|FG000|Overall Study|Physician Decision|6|||
162808537|NCT03786783|588010226|FG000|Overall Study|Withdrawal by Subject|2|||
162808538|NCT03786783|588010226|FG000|Overall Study|Disease Progression|7|||
162808539|NCT03786783|588010226|FG000|Overall Study|Patient/Parent Refusal|4|||
162808540|NCT04279392|588010229|FG000|Overall Study|Physician Decision|1|||
162808541|NCT04279392|588010230|FG001|Overall Study|Physician Decision|0|||
162808542|NCT00918580|588010231|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
162808543|NCT00918580|588010231|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
162808544|NCT00918580|588010231|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
162808545|NCT00918580|588010231|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
162808546|NCT00918580|588010231|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
162808547|NCT00918580|588010231|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
162808548|NCT00918580|588010231|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
162808549|NCT01411215|588010232|FG000|Overall Study|Adverse Event|1|||
162808550|NCT01411215|588010233|FG001|Overall Study|Adverse Event|2|||
162808551|NCT01411215|588010232|FG000|Overall Study|Lack of Efficacy|2|||
162808552|NCT01411215|588010233|FG001|Overall Study|Lack of Efficacy|4|||
162808553|NCT01411215|588010232|FG000|Overall Study|Lost to Follow-up|12|||
162808554|NCT01411215|588010233|FG001|Overall Study|Lost to Follow-up|18|||
162808555|NCT01411215|588010232|FG000|Overall Study|Did not meet entrance criteria|0|||
162808556|NCT01411215|588010233|FG001|Overall Study|Did not meet entrance criteria|1|||
162808557|NCT01411215|588010232|FG000|Overall Study|Study terminated by sponsor|2|||
162808558|NCT01411215|588010233|FG001|Overall Study|Study terminated by sponsor|15|||
162808559|NCT01411215|588010232|FG000|Overall Study|Protocol Violation|3|||
162808560|NCT01411215|588010233|FG001|Overall Study|Protocol Violation|5|||
162808561|NCT01411215|588010232|FG000|Overall Study|Withdrawal by Subject|34|||
162808562|NCT01411215|588010233|FG001|Overall Study|Withdrawal by Subject|21|||
162808563|NCT01411215|588010232|FG000|Overall Study|Other|12|||
162808564|NCT01411215|588010233|FG001|Overall Study|Other|17|||
162808565|NCT01411215|588010232|FG000|Overall Study|Screen failure|0|||
162808566|NCT01411215|588010233|FG001|Overall Study|Screen failure|1|||
162808567|NCT01100034|588010234|FG000|Overall Study|Lost to Follow-up|11|||
162808568|NCT01100034|588010234|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
162808569|NCT01100034|588010234|FG000|Overall Study|Withdrawal by Subject|4|||
162808570|NCT01100034|588010234|FG000|Overall Study|Sponsor decision|21|||
162808571|NCT01100034|588010234|FG000|Overall Study|Participated in another clinical trial|1|||
162808572|NCT01100034|588010234|FG000|Overall Study|Participants moved to another hospital|4|||
162808573|NCT01100034|588010234|FG000|Overall Study|Site closed due to non-responsiveness|1|||
162808574|NCT00402597|588010235|FG000|Overall Study|Death|15|||
162808575|NCT00402597|588010236|FG001|Overall Study|Death|7|||
162808576|NCT00402597|588010237|FG002|Overall Study|Death|6|||
162808577|NCT00402597|588010238|FG003|Overall Study|Death|4|||
162808578|NCT00402597|588010239|FG004|Overall Study|Death|6|||
162808579|NCT00402597|588010235|FG000|Overall Study|Adverse Event|81|||
162808580|NCT00402597|588010236|FG001|Overall Study|Adverse Event|18|||
162808581|NCT00402597|588010237|FG002|Overall Study|Adverse Event|106|||
162808582|NCT00402597|588010238|FG003|Overall Study|Adverse Event|39|||
162808583|NCT00402597|588010239|FG004|Overall Study|Adverse Event|71|||
162808584|NCT00402597|588010235|FG000|Overall Study|Lost to Follow-up|8|||
162808585|NCT00402597|588010236|FG001|Overall Study|Lost to Follow-up|1|||
162808586|NCT00402597|588010237|FG002|Overall Study|Lost to Follow-up|8|||
162808587|NCT00402597|588010238|FG003|Overall Study|Lost to Follow-up|2|||
162808588|NCT00402597|588010239|FG004|Overall Study|Lost to Follow-up|3|||
162808589|NCT00402597|588010235|FG000|Overall Study|Withdrawal by Subject|57|||
162808590|NCT00402597|588010236|FG001|Overall Study|Withdrawal by Subject|16|||
162808591|NCT00402597|588010237|FG002|Overall Study|Withdrawal by Subject|65|||
162808592|NCT00402597|588010238|FG003|Overall Study|Withdrawal by Subject|15|||
162808593|NCT00402597|588010239|FG004|Overall Study|Withdrawal by Subject|24|||
162808594|NCT00402597|588010235|FG000|Overall Study|reason not specified|30|||
162808595|NCT00402597|588010236|FG001|Overall Study|reason not specified|4|||
162808596|NCT00402597|588010237|FG002|Overall Study|reason not specified|27|||
162808597|NCT00402597|588010238|FG003|Overall Study|reason not specified|14|||
162808598|NCT00402597|588010239|FG004|Overall Study|reason not specified|20|||
162808599|NCT01831856|588010240|FG000|Overall Study|Adverse Event|5|||
162808600|NCT01831856|588010241|FG001|Overall Study|Adverse Event|8|||
162808601|NCT01831856|588010240|FG000|Overall Study|Lack of Efficacy|13|||
162808602|NCT01831856|588010241|FG001|Overall Study|Lack of Efficacy|11|||
162808603|NCT01831856|588010240|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
162808604|NCT01831856|588010241|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
162808605|NCT05208866|588010243|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
162808606|NCT00836095|588010246|FG000|Overall Study|Physician Decision|0|||
162808607|NCT00836095|588010247|FG001|Overall Study|Physician Decision|3|||
162808608|NCT01602562|588010248|FG000|Overall Study|Adverse Event|3|||
162808609|NCT01602562|588010249|FG001|Overall Study|Adverse Event|1|||
162808610|NCT01602562|588010248|FG000|Overall Study|Physician Decision|1|||
162808611|NCT01602562|588010249|FG001|Overall Study|Physician Decision|1|||
162808612|NCT01602562|588010248|FG000|Overall Study|Withdrawal by Subject|1|||
162808613|NCT01602562|588010249|FG001|Overall Study|Withdrawal by Subject|1|||
162808614|NCT04964414|588010251|FG000|Overall Study|Lost to Follow-up|10|||
162808615|NCT04964414|588010252|FG001|Overall Study|Lost to Follow-up|8|||
162808616|NCT04964414|588010251|FG000|Overall Study|Withdrawal by Subject|1|||
162808617|NCT04964414|588010252|FG001|Overall Study|Withdrawal by Subject|1|||
162808618|NCT03881553|588010253|FG000|Overall Study|Discharged prior to participation|1|||
162808619|NCT03881553|588010254|FG001|Overall Study|Discharged prior to participation|1|||
162808620|NCT03881553|588010255|FG002|Overall Study|Discharged prior to participation|0|||
162808621|NCT03881553|588010253|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
162808622|NCT03881553|588010254|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
162808623|NCT03881553|588010255|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
162808624|NCT00336895|588010260|FG000|Overall Study|diarrhea|1|||
162808625|NCT00336895|588010260|FG000|Overall Study|nausea and upset stomach|1|||
162808626|NCT00336895|588010260|FG000|Overall Study|Physician Decision|1|||
162808627|NCT00336895|588010260|FG000|Overall Study|screen failed|1|||
162808628|NCT01959334|588010261|FG000|Second Dose|Adverse Event|1|||
162808629|NCT01959334|588010262|FG001|Second Dose|Adverse Event|0|||
162808630|NCT01959334|588010261|FG000|Third Dose|Adverse Event|0|||
162808631|NCT01959334|588010262|FG001|Third Dose|Adverse Event|1|||
162808632|NCT01313689|588010263|FG000|24-Week Randomization 1|Adverse Event|10|||
162808633|NCT01313689|588010264|FG001|24-Week Randomization 1|Adverse Event|5|||
162808634|NCT01313689|588010265|FG002|24-Week Randomization 1|Adverse Event|0|||
162808635|NCT01313689|588010266|FG003|24-Week Randomization 1|Adverse Event|0|||
162808636|NCT01313689|588010267|FG004|24-Week Randomization 1|Adverse Event|0|||
162808637|NCT01313689|588010263|FG000|24-Week Randomization 1|Physician Decision|4|||
162808638|NCT01313689|588010264|FG001|24-Week Randomization 1|Physician Decision|5|||
162808639|NCT01313689|588010265|FG002|24-Week Randomization 1|Physician Decision|0|||
162808640|NCT01313689|588010266|FG003|24-Week Randomization 1|Physician Decision|0|||
162808641|NCT01313689|588010267|FG004|24-Week Randomization 1|Physician Decision|0|||
162808642|NCT01313689|588010263|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
162808643|NCT01313689|588010264|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
162808644|NCT01313689|588010265|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
162808645|NCT01313689|588010266|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
162808646|NCT01313689|588010267|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
162808647|NCT01313689|588010263|FG000|24-Week Randomization 2|Adverse Event|0|||
162808648|NCT01313689|588010264|FG001|24-Week Randomization 2|Adverse Event|0|||
162808649|NCT01313689|588010265|FG002|24-Week Randomization 2|Adverse Event|2|||
162808650|NCT01313689|588010266|FG003|24-Week Randomization 2|Adverse Event|0|||
162808651|NCT01313689|588010267|FG004|24-Week Randomization 2|Adverse Event|8|||
162808652|NCT01313689|588010263|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
162808653|NCT01313689|588010264|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
162808654|NCT01313689|588010265|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
162808655|NCT01313689|588010266|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
162808656|NCT01313689|588010267|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
162808657|NCT01313689|588010263|FG000|24-Week Randomization 2|Physician Decision|0|||
162808658|NCT01313689|588010264|FG001|24-Week Randomization 2|Physician Decision|0|||
162808659|NCT01313689|588010265|FG002|24-Week Randomization 2|Physician Decision|0|||
162808660|NCT01313689|588010266|FG003|24-Week Randomization 2|Physician Decision|0|||
162808661|NCT01313689|588010267|FG004|24-Week Randomization 2|Physician Decision|4|||
162808662|NCT01768637|588010268|FG000|Overall Study|Lost to Follow-up|2|||
162808663|NCT01768637|588010269|FG001|Overall Study|Lost to Follow-up|7|||
162808664|NCT01768637|588010268|FG000|Overall Study|Difficult blood draw|1|||
162808665|NCT01768637|588010269|FG001|Overall Study|Difficult blood draw|0|||
162808666|NCT01054170|588010270|FG000|Overall Study|Protocol Violation|1|||
162808667|NCT01054170|588010271|FG001|Overall Study|Protocol Violation|0|||
162808668|NCT01054170|588010270|FG000|Overall Study|Withdrawal by Subject|3|||
162808669|NCT01054170|588010271|FG001|Overall Study|Withdrawal by Subject|2|||
162808670|NCT01054170|588010270|FG000|Overall Study|Adverse Event|0|||
162808671|NCT01054170|588010271|FG001|Overall Study|Adverse Event|4|||
162808672|NCT02951767|588010272|FG000|Overall Study|Study Terminated By Sponsor|9|||
162808673|NCT02951767|588010272|FG000|Overall Study|Withdrawal by Subject|11|||
162808674|NCT02951767|588010272|FG000|Overall Study|Death|96|||
162808675|NCT02951767|588010272|FG000|Overall Study|Lost to Follow-up|2|||
162808676|NCT02951767|588010272|FG000|Overall Study|Physician Decision|1|||
162808677|NCT01337115|588010276|FG000|Overall Study|Protocol Violation|2|||
162808678|NCT01337115|588010277|FG001|Overall Study|Protocol Violation|0|||
162808679|NCT03426267|588010286|FG000|Overall Study|Physician Decision|1|||
162808680|NCT03426267|588010287|FG001|Overall Study|Physician Decision|4|||
162808681|NCT03426267|588010286|FG000|Overall Study|Lost to Follow-up|1|||
162808682|NCT03426267|588010287|FG001|Overall Study|Lost to Follow-up|0|||
162808683|NCT03426267|588010286|FG000|Overall Study|Withdrawal by Subject|4|||
162808684|NCT03426267|588010287|FG001|Overall Study|Withdrawal by Subject|10|||
162808685|NCT03426267|588010286|FG000|Overall Study|Protocol Violation|1|||
162808686|NCT03426267|588010287|FG001|Overall Study|Protocol Violation|3|||
162808687|NCT03426267|588010286|FG000|Overall Study|Adverse Event|9|||
162808688|NCT03426267|588010287|FG001|Overall Study|Adverse Event|27|||
162808689|NCT03426267|588010286|FG000|Overall Study|Prohibited Treatment Intake|2|||
162808690|NCT03426267|588010287|FG001|Overall Study|Prohibited Treatment Intake|3|||
162808691|NCT03426267|588010286|FG000|Overall Study|Lack of Efficacy|0|||
162808692|NCT03426267|588010287|FG001|Overall Study|Lack of Efficacy|25|||
162808693|NCT03426267|588010286|FG000|Overall Study|other|3|||
162808694|NCT03426267|588010287|FG001|Overall Study|other|0|||
162808695|NCT00609765|588010288|FG000|Overall Study|Study ended prior to 12 months|1|||
162808696|NCT02054520|588010292|FG000|Overall Study|Adverse Event|1|||
162808697|NCT02054520|588010293|FG001|Overall Study|Adverse Event|4|||
162808698|NCT02054520|588010294|FG002|Overall Study|Adverse Event|2|||
162808699|NCT02054520|588010295|FG003|Overall Study|Adverse Event|1|||
162808700|NCT02054520|588010296|FG004|Overall Study|Adverse Event|1|||
162808701|NCT02054520|588010297|FG005|Overall Study|Adverse Event|0|||
162808702|NCT02054520|588010292|FG000|Overall Study|Lack of Efficacy|7|||
162808703|NCT02054520|588010293|FG001|Overall Study|Lack of Efficacy|0|||
162808704|NCT02054520|588010294|FG002|Overall Study|Lack of Efficacy|2|||
162808705|NCT02054520|588010295|FG003|Overall Study|Lack of Efficacy|1|||
162808706|NCT02054520|588010296|FG004|Overall Study|Lack of Efficacy|3|||
162808707|NCT02054520|588010297|FG005|Overall Study|Lack of Efficacy|2|||
162808708|NCT02054520|588010292|FG000|Overall Study|Withdrawal by Subject|1|||
162808709|NCT02054520|588010293|FG001|Overall Study|Withdrawal by Subject|0|||
162808710|NCT02054520|588010294|FG002|Overall Study|Withdrawal by Subject|0|||
162808711|NCT02054520|588010295|FG003|Overall Study|Withdrawal by Subject|2|||
162808712|NCT02054520|588010296|FG004|Overall Study|Withdrawal by Subject|1|||
162808713|NCT02054520|588010297|FG005|Overall Study|Withdrawal by Subject|0|||
162808714|NCT02054520|588010292|FG000|Overall Study|Physician Decision|0|||
162808715|NCT02054520|588010293|FG001|Overall Study|Physician Decision|1|||
162808716|NCT02054520|588010294|FG002|Overall Study|Physician Decision|0|||
162808717|NCT02054520|588010295|FG003|Overall Study|Physician Decision|1|||
162808718|NCT02054520|588010296|FG004|Overall Study|Physician Decision|0|||
162808719|NCT02054520|588010297|FG005|Overall Study|Physician Decision|1|||
162808720|NCT02054520|588010292|FG000|Overall Study|Study terminated by Sponsor|0|||
162808721|NCT02054520|588010293|FG001|Overall Study|Study terminated by Sponsor|0|||
162808722|NCT02054520|588010294|FG002|Overall Study|Study terminated by Sponsor|2|||
162808723|NCT02054520|588010295|FG003|Overall Study|Study terminated by Sponsor|1|||
162808724|NCT02054520|588010296|FG004|Overall Study|Study terminated by Sponsor|0|||
162808725|NCT02054520|588010297|FG005|Overall Study|Study terminated by Sponsor|0|||
162808726|NCT01272804|588010300|FG000|Overall Study|Adverse Event|1|||
162808727|NCT01272804|588010301|FG001|Overall Study|Adverse Event|0|||
162808728|NCT01272804|588010302|FG002|Overall Study|Adverse Event|0|||
162808729|NCT01272804|588010303|FG003|Overall Study|Adverse Event|0|||
162808730|NCT01272804|588010304|FG004|Overall Study|Adverse Event|2|||
162808731|NCT01272804|588010305|FG005|Overall Study|Adverse Event|1|||
162808732|NCT03801915|588010306|FG000|Overall Study|Screen failure|0|||
162808733|NCT03801915|588010307|FG001|Overall Study|Screen failure|0|||
162808734|NCT03801915|588010308|FG002|Overall Study|Screen failure|1|||
162808735|NCT03801915|588010306|FG000|Overall Study|Ineligible|1|||
162808736|NCT03801915|588010307|FG001|Overall Study|Ineligible|0|||
162808737|NCT03801915|588010308|FG002|Overall Study|Ineligible|0|||
162808738|NCT03801915|588010306|FG000|Overall Study|Physician Decision|2|||
162808739|NCT03801915|588010307|FG001|Overall Study|Physician Decision|1|||
162808740|NCT03801915|588010308|FG002|Overall Study|Physician Decision|0|||
162808741|NCT02308020|588010309|FG000|Overall Study|Lost to Follow-up|1|||
162808742|NCT02308020|588010310|FG001|Overall Study|Lost to Follow-up|7|||
162808743|NCT02308020|588010311|FG002|Overall Study|Lost to Follow-up|0|||
162808744|NCT02308020|588010312|FG003|Overall Study|Lost to Follow-up|0|||
162808745|NCT02308020|588010313|FG004|Overall Study|Lost to Follow-up|1|||
162808746|NCT02308020|588010314|FG005|Overall Study|Lost to Follow-up|2|||
162808747|NCT02308020|588010309|FG000|Overall Study|Sponsor Decision|0|||
162808748|NCT02308020|588010310|FG001|Overall Study|Sponsor Decision|8|||
162808749|NCT02308020|588010311|FG002|Overall Study|Sponsor Decision|0|||
162808750|NCT02308020|588010312|FG003|Overall Study|Sponsor Decision|2|||
162808751|NCT02308020|588010313|FG004|Overall Study|Sponsor Decision|2|||
162808752|NCT02308020|588010314|FG005|Overall Study|Sponsor Decision|1|||
162808753|NCT02308020|588010309|FG000|Overall Study|Withdrawal by Subject|3|||
162808754|NCT02308020|588010310|FG001|Overall Study|Withdrawal by Subject|5|||
162808755|NCT02308020|588010311|FG002|Overall Study|Withdrawal by Subject|3|||
162808756|NCT02308020|588010312|FG003|Overall Study|Withdrawal by Subject|2|||
162808757|NCT02308020|588010313|FG004|Overall Study|Withdrawal by Subject|1|||
162808758|NCT02308020|588010314|FG005|Overall Study|Withdrawal by Subject|2|||
162808759|NCT03265938|588010315|FG000|Overall Study|Withdrawal by Subject|1|||
162808760|NCT03265938|588010315|FG000|Overall Study|Physician Decision|1|||
162808761|NCT03265938|588010315|FG000|Overall Study|friable mass|6|||
162808762|NCT02471833|588010316|FG000|Overall Study|Lost to Follow-up|1|||
162808763|NCT02471833|588010317|FG001|Overall Study|Lost to Follow-up|0|||
162808764|NCT02471833|588010318|FG002|Overall Study|Lost to Follow-up|0|||
162808765|NCT02471833|588010316|FG000|Overall Study|Withdrawal by Subject|2|||
162808766|NCT02471833|588010317|FG001|Overall Study|Withdrawal by Subject|1|||
162808767|NCT02471833|588010318|FG002|Overall Study|Withdrawal by Subject|5|||
162808768|NCT02673515|588010319|FG000|Overall Study|Lack of motivation|2|||
162808769|NCT02673515|588010320|FG001|Overall Study|Lack of motivation|1|||
162808770|NCT02523599|588010323|FG000|Overall Study|Adverse Event|1|||
162808771|NCT02523599|588010324|FG001|Overall Study|Adverse Event|0|||
162808772|NCT02523599|588010323|FG000|Overall Study|Physician Decision|1|||
162808773|NCT02523599|588010324|FG001|Overall Study|Physician Decision|0|||
162808774|NCT02523599|588010323|FG000|Overall Study|Lost to Follow-up|4|||
162808775|NCT02523599|588010324|FG001|Overall Study|Lost to Follow-up|1|||
162808776|NCT02523599|588010323|FG000|Overall Study|Did not return for Day 30 visit|2|||
162808777|NCT02523599|588010324|FG001|Overall Study|Did not return for Day 30 visit|0|||
162808778|NCT01892540|588010325|FG000|Overall Study|Did not complete PET/MRI|0|||
162808779|NCT01892540|588010326|FG001|Overall Study|Did not complete PET/MRI|0|||
162808780|NCT01892540|588010327|FG002|Overall Study|Did not complete PET/MRI|2|||
162808781|NCT01892540|588010325|FG000|Overall Study|Did not fit in scanner|0|||
162808782|NCT01892540|588010326|FG001|Overall Study|Did not fit in scanner|0|||
162808783|NCT01892540|588010327|FG002|Overall Study|Did not fit in scanner|1|||
162808784|NCT01370590|588010328|FG000|Period 1|Adverse Event|8|||
162808785|NCT01370590|588010329|FG001|Period 1|Adverse Event|4|||
162808786|NCT01370590|588010328|FG000|Period 1|Lost to Follow-up|2|||
162808787|NCT01370590|588010329|FG001|Period 1|Lost to Follow-up|2|||
162808788|NCT01370590|588010328|FG000|Period 1|Protocol Violation|2|||
162808789|NCT01370590|588010329|FG001|Period 1|Protocol Violation|2|||
162808790|NCT01370590|588010328|FG000|Period 1|Withdrawal by Subject|4|||
162808791|NCT01370590|588010329|FG001|Period 1|Withdrawal by Subject|2|||
162808792|NCT01370590|588010328|FG000|Period 1|Could not access randomization system|0|||
162808793|NCT01370590|588010329|FG001|Period 1|Could not access randomization system|1|||
162808794|NCT01370590|588010328|FG000|Crossover Washout Period|Adverse Event|1|||
162808795|NCT01370590|588010329|FG001|Crossover Washout Period|Adverse Event|4|||
162808796|NCT01370590|588010328|FG000|Crossover Washout Period|Lost to Follow-up|2|||
162808797|NCT01370590|588010329|FG001|Crossover Washout Period|Lost to Follow-up|0|||
162808798|NCT01370590|588010328|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
162808799|NCT01370590|588010329|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
162808800|NCT01370590|588010328|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
162808801|NCT01370590|588010329|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
162808802|NCT01370590|588010328|FG000|Period 2|Adverse Event|0|||
162808803|NCT01370590|588010329|FG001|Period 2|Adverse Event|1|||
162808804|NCT01370590|588010328|FG000|Period 2|Withdrawal by Subject|1|||
162808805|NCT01370590|588010329|FG001|Period 2|Withdrawal by Subject|1|||
162808806|NCT03110224|588010330|FG000|Overall Study|Death|3|||
162808807|NCT03110224|588010330|FG000|Overall Study|Lost to Follow-up|132|||
162808808|NCT03110224|588010330|FG000|Overall Study|Physician Decision|2|||
162808809|NCT03110224|588010330|FG000|Overall Study|Site Closed by Physician|35|||
162808810|NCT03110224|588010330|FG000|Overall Study|Site Closed by Sponsor|202|||
162808811|NCT03110224|588010330|FG000|Overall Study|Withdrawal by Subject|9|||
162808812|NCT00727311|588010331|FG000|Overall Study|Did not receive drug|316|||
162808813|NCT00727311|588010331|FG000|Overall Study|Missing end of therapy data|205|||
162808814|NCT00727311|588010331|FG000|Overall Study|Adverse Event|58|||
162808815|NCT00727311|588010331|FG000|Overall Study|Lack of Efficacy|242|||
162808816|NCT00727311|588010331|FG000|Overall Study|Lost to Follow-up|73|||
162808817|NCT00727311|588010331|FG000|Overall Study|Withdrawal by Subject|77|||
162808818|NCT00727311|588010331|FG000|Overall Study|Other|97|||
162808819|NCT00727311|588010331|FG000|Overall Study|Multiple reasons|39|||
162808820|NCT03992846|588010332|FG000|Overall Study|Adverse Event|8|||
162808821|NCT03992846|588010333|FG001|Overall Study|Adverse Event|6|||
162808822|NCT03992846|588010334|FG002|Overall Study|Adverse Event|3|||
162808823|NCT03992846|588010332|FG000|Overall Study|Lost to Follow-up|0|||
162808824|NCT03992846|588010333|FG001|Overall Study|Lost to Follow-up|1|||
162808825|NCT03992846|588010334|FG002|Overall Study|Lost to Follow-up|1|||
162808826|NCT03992846|588010332|FG000|Overall Study|Pregnancy|2|||
162808827|NCT03992846|588010333|FG001|Overall Study|Pregnancy|0|||
162808828|NCT03992846|588010334|FG002|Overall Study|Pregnancy|1|||
162808829|NCT03992846|588010332|FG000|Overall Study|Protocol Violation|1|||
162808830|NCT03992846|588010333|FG001|Overall Study|Protocol Violation|2|||
162808831|NCT03992846|588010334|FG002|Overall Study|Protocol Violation|0|||
162808832|NCT03992846|588010332|FG000|Overall Study|Withdrawal by Subject|8|||
162808833|NCT03992846|588010333|FG001|Overall Study|Withdrawal by Subject|10|||
162808834|NCT03992846|588010334|FG002|Overall Study|Withdrawal by Subject|20|||
162808835|NCT03992846|588010332|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
162808836|NCT03992846|588010333|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
162808837|NCT03992846|588010334|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
162808838|NCT05195489|588012204|FG000|Overall Study|Lost to Follow-up|1|||
162808839|NCT05195489|588012205|FG001|Overall Study|Lost to Follow-up|0|||
162808840|NCT05195489|588012204|FG000|Overall Study|Protocol Violation|0|||
162808841|NCT05195489|588012205|FG001|Overall Study|Protocol Violation|2|||
162808842|NCT05195489|588012204|FG000|Overall Study|Withdrawal by Subject|1|||
162808843|NCT05195489|588012205|FG001|Overall Study|Withdrawal by Subject|1|||
162808844|NCT05195489|588012204|FG000|Overall Study|Removed|0|||
162808845|NCT05195489|588012205|FG001|Overall Study|Removed|1|||
162808846|NCT00031551|588012207|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
162808847|NCT00031551|588012208|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
162808848|NCT00409773|588012211|FG000|Overall Study|Adverse Event|3|||
162808849|NCT00409773|588012212|FG001|Overall Study|Adverse Event|4|||
162808850|NCT00409773|588012213|FG002|Overall Study|Adverse Event|4|||
162808851|NCT00409773|588012214|FG003|Overall Study|Adverse Event|2|||
162808852|NCT00409773|588012215|FG004|Overall Study|Adverse Event|6|||
162808853|NCT00409773|588012211|FG000|Overall Study|Lost to Follow-up|6|||
162808854|NCT00409773|588012212|FG001|Overall Study|Lost to Follow-up|1|||
162808855|NCT00409773|588012213|FG002|Overall Study|Lost to Follow-up|2|||
162808856|NCT00409773|588012214|FG003|Overall Study|Lost to Follow-up|3|||
162808857|NCT00409773|588012215|FG004|Overall Study|Lost to Follow-up|1|||
162808858|NCT00409773|588012211|FG000|Overall Study|Physician Decision|0|||
162808859|NCT00409773|588012212|FG001|Overall Study|Physician Decision|0|||
162808860|NCT00409773|588012213|FG002|Overall Study|Physician Decision|0|||
162808861|NCT00409773|588012214|FG003|Overall Study|Physician Decision|2|||
162808862|NCT00409773|588012215|FG004|Overall Study|Physician Decision|0|||
162808863|NCT00409773|588012211|FG000|Overall Study|Protocol Violation|0|||
162808864|NCT00409773|588012212|FG001|Overall Study|Protocol Violation|2|||
162808865|NCT00409773|588012213|FG002|Overall Study|Protocol Violation|3|||
162808866|NCT00409773|588012214|FG003|Overall Study|Protocol Violation|3|||
162808867|NCT00409773|588012215|FG004|Overall Study|Protocol Violation|1|||
162808868|NCT00409773|588012211|FG000|Overall Study|Withdrawal by Subject|0|||
162808869|NCT00409773|588012212|FG001|Overall Study|Withdrawal by Subject|0|||
162808870|NCT00409773|588012213|FG002|Overall Study|Withdrawal by Subject|0|||
162808871|NCT00409773|588012214|FG003|Overall Study|Withdrawal by Subject|2|||
162808872|NCT00409773|588012215|FG004|Overall Study|Withdrawal by Subject|1|||
162808873|NCT00409773|588012211|FG000|Overall Study|Lack of Eligibility|0|||
162808874|NCT00409773|588012212|FG001|Overall Study|Lack of Eligibility|0|||
162808875|NCT00409773|588012213|FG002|Overall Study|Lack of Eligibility|0|||
162808876|NCT00409773|588012214|FG003|Overall Study|Lack of Eligibility|0|||
162808877|NCT00409773|588012215|FG004|Overall Study|Lack of Eligibility|1|||
162808878|NCT01201343|588012216|FG000|Overall Study|Adverse Event|6|||
162808879|NCT01201343|588012216|FG000|Overall Study|Withdrawal by Subject|5|||
162808880|NCT01201343|588012216|FG000|Overall Study|Lost to Follow-up|2|||
162808881|NCT01201343|588012216|FG000|Overall Study|Lack of Efficacy|2|||
162808882|NCT01201343|588012216|FG000|Overall Study|Participant wrongly included in trial|1|||
162808883|NCT01201343|588012216|FG000|Overall Study|Randomized, not treated|3|||
162808884|NCT01919814|588012217|FG000|Overall Study|Adverse Event|1|||
162808885|NCT01919814|588012218|FG001|Overall Study|Adverse Event|0|||
162808886|NCT01919814|588012217|FG000|Overall Study|Protocol Violation|1|||
162808887|NCT01919814|588012218|FG001|Overall Study|Protocol Violation|0|||
162808888|NCT01919814|588012217|FG000|Overall Study|Withdrawal by Subject|1|||
162808889|NCT01919814|588012218|FG001|Overall Study|Withdrawal by Subject|0|||
162808890|NCT02164383|588012219|FG000|Overall Study|Lost to Follow-up|1|||
162808891|NCT02164383|588012220|FG001|Overall Study|Lost to Follow-up|0|||
162808892|NCT01440374|588012221|FG000|Part 1: Open-label Phase|Adverse Event|5|||
162808893|NCT01440374|588012222|FG001|Part 1: Open-label Phase|Adverse Event|0|||
162808894|NCT01440374|588012223|FG002|Part 1: Open-label Phase|Adverse Event|0|||
162808895|NCT01440374|588012224|FG003|Part 1: Open-label Phase|Adverse Event|0|||
162808896|NCT01440374|588012221|FG000|Part 1: Open-label Phase|Physician Decision|1|||
162808897|NCT01440374|588012222|FG001|Part 1: Open-label Phase|Physician Decision|0|||
162808898|NCT01440374|588012223|FG002|Part 1: Open-label Phase|Physician Decision|0|||
162808899|NCT01440374|588012224|FG003|Part 1: Open-label Phase|Physician Decision|0|||
162808900|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
162808901|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
162808902|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
162808903|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
162808904|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
162808905|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
162808906|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
162808907|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
162808908|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
162808909|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
162808910|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
162808911|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
162808912|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162808913|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
162808914|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162808915|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162808916|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
162808917|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
162808918|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
162808919|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
162808920|NCT01440374|588012221|FG000|Part 2; Double-blind Phase|Not treated|0|||
162808921|NCT01440374|588012222|FG001|Part 2; Double-blind Phase|Not treated|0|||
162808922|NCT01440374|588012223|FG002|Part 2; Double-blind Phase|Not treated|1|||
162808923|NCT01440374|588012224|FG003|Part 2; Double-blind Phase|Not treated|0|||
162808924|NCT01440374|588012221|FG000|Part 3: Extension|Withdrawal by Subject|0|||
162808925|NCT01440374|588012222|FG001|Part 3: Extension|Withdrawal by Subject|0|||
162808926|NCT01440374|588012223|FG002|Part 3: Extension|Withdrawal by Subject|0|||
162808927|NCT01440374|588012224|FG003|Part 3: Extension|Withdrawal by Subject|5|||
162808928|NCT01440374|588012221|FG000|Part 3: Extension|Adverse Event|0|||
162808929|NCT01440374|588012222|FG001|Part 3: Extension|Adverse Event|0|||
162808930|NCT01440374|588012223|FG002|Part 3: Extension|Adverse Event|0|||
162808931|NCT01440374|588012224|FG003|Part 3: Extension|Adverse Event|13|||
162808932|NCT01440374|588012221|FG000|Part 3: Extension|Physician Decision|0|||
162808933|NCT01440374|588012222|FG001|Part 3: Extension|Physician Decision|0|||
162808934|NCT01440374|588012223|FG002|Part 3: Extension|Physician Decision|0|||
162808935|NCT01440374|588012224|FG003|Part 3: Extension|Physician Decision|14|||
162808936|NCT01672723|588012225|FG000|First Intervention|Adverse Event|3|||
162808937|NCT01672723|588012226|FG001|First Intervention|Adverse Event|0|||
162808938|NCT00743275|588012227|FG000|Overall Study|Protocol Violation|0|||
162808939|NCT00743275|588012228|FG001|Overall Study|Protocol Violation|1|||
162808940|NCT04812548|588012231|FG000|Overall Study|Adverse Event|2|||
162808941|NCT04812548|588012232|FG001|Overall Study|Adverse Event|7|||
162808942|NCT04812548|588012231|FG000|Overall Study|HSCT Planned|2|||
162808943|NCT04812548|588012232|FG001|Overall Study|HSCT Planned|3|||
162808944|NCT04812548|588012231|FG000|Overall Study|Progressive Disease|0|||
162808945|NCT04812548|588012232|FG001|Overall Study|Progressive Disease|2|||
162808946|NCT04812548|588012231|FG000|Overall Study|Death|0|||
162808947|NCT04812548|588012232|FG001|Overall Study|Death|1|||
162808948|NCT04812548|588012231|FG000|Overall Study|Post Study Access to Treatment|0|||
162808949|NCT04812548|588012232|FG001|Overall Study|Post Study Access to Treatment|1|||
162808950|NCT04812548|588012231|FG000|Overall Study|Withdrawal by Subject|0|||
162808951|NCT04812548|588012232|FG001|Overall Study|Withdrawal by Subject|1|||
162808952|NCT04812548|588012231|FG000|Overall Study|Physician Decision|1|||
162808953|NCT04812548|588012232|FG001|Overall Study|Physician Decision|0|||
162808954|NCT02141984|588012235|FG000|Overall Study|Lack of Efficacy|2|||
162808955|NCT03057977|588012239|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
162808956|NCT03057977|588012240|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
162808957|NCT03057977|588012239|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
162808958|NCT03057977|588012240|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
162808959|NCT03057977|588012239|FG000|Discontinuation From Treatment|Protocol Violation|6|||
162808960|NCT03057977|588012240|FG001|Discontinuation From Treatment|Protocol Violation|5|||
162808961|NCT03057977|588012239|FG000|Discontinuation From Treatment|Not treated|4|||
162808962|NCT03057977|588012240|FG001|Discontinuation From Treatment|Not treated|0|||
162808963|NCT03057977|588012239|FG000|Discontinuation From Treatment|Adverse Event|343|||
162808964|NCT03057977|588012240|FG001|Discontinuation From Treatment|Adverse Event|337|||
162808965|NCT03057977|588012239|FG000|Discontinuation From Treatment|Reason Unknown|0|||
162808966|NCT03057977|588012240|FG001|Discontinuation From Treatment|Reason Unknown|1|||
162808967|NCT03057977|588012239|FG000|Discontinuation From Treatment|Personal Reasons|1|||
162808968|NCT03057977|588012240|FG001|Discontinuation From Treatment|Personal Reasons|1|||
162808969|NCT03057977|588012239|FG000|Discontinuation From Treatment|Unblinded medication|1|||
162808970|NCT03057977|588012240|FG001|Discontinuation From Treatment|Unblinded medication|0|||
162808971|NCT03057977|588012239|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
162808972|NCT03057977|588012240|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
162808973|NCT03057977|588012239|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
162808974|NCT03057977|588012240|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
162808975|NCT03057977|588012239|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
162808976|NCT03057977|588012240|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
162808977|NCT03057977|588012239|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
162808978|NCT03057977|588012240|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
162808979|NCT03057977|588012239|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
162808980|NCT03057977|588012240|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
162808981|NCT03057977|588012239|FG000|Discontinuation From Treatment|Not attending study visit|3|||
162808982|NCT03057977|588012240|FG001|Discontinuation From Treatment|Not attending study visit|10|||
162808983|NCT03057977|588012239|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
162808984|NCT03057977|588012240|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
162808985|NCT03057977|588012239|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
162808986|NCT03057977|588012240|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
162808987|NCT03057977|588012239|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
162808988|NCT03057977|588012240|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
162808989|NCT03057977|588012239|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
162808990|NCT03057977|588012240|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
162808991|NCT03057977|588012239|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
162808992|NCT03057977|588012240|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
162808993|NCT01201317|588012241|FG000|Overall Study|Withdrawal by Subject|5|||
162808994|NCT01201317|588012242|FG001|Overall Study|Withdrawal by Subject|0|||
162808995|NCT01201317|588012243|FG002|Overall Study|Withdrawal by Subject|3|||
162808996|NCT01201317|588012241|FG000|Overall Study|Adverse Event|2|||
162808997|NCT01201317|588012242|FG001|Overall Study|Adverse Event|2|||
162808998|NCT01201317|588012243|FG002|Overall Study|Adverse Event|2|||
162808999|NCT01201317|588012241|FG000|Overall Study|Screen failure|1|||
162809000|NCT01201317|588012242|FG001|Overall Study|Screen failure|1|||
162809001|NCT01201317|588012243|FG002|Overall Study|Screen failure|0|||
162809002|NCT01201317|588012241|FG000|Overall Study|Protocol Violation|0|||
162809003|NCT01201317|588012242|FG001|Overall Study|Protocol Violation|1|||
162809004|NCT01201317|588012243|FG002|Overall Study|Protocol Violation|1|||
162809005|NCT01201317|588012241|FG000|Overall Study|Death|0|||
162809006|NCT01201317|588012242|FG001|Overall Study|Death|1|||
162809007|NCT01201317|588012243|FG002|Overall Study|Death|0|||
162809008|NCT01201317|588012241|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162809009|NCT01201317|588012242|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162809010|NCT01201317|588012243|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162809011|NCT01201317|588012241|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
162809012|NCT01201317|588012242|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
162809013|NCT01201317|588012243|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
162809014|NCT01201317|588012241|FG000|Overall Study|Decrease in renal function|0|||
162809015|NCT01201317|588012242|FG001|Overall Study|Decrease in renal function|1|||
162809016|NCT01201317|588012243|FG002|Overall Study|Decrease in renal function|0|||
162809017|NCT01201317|588012241|FG000|Overall Study|Lack of Efficacy|1|||
162809018|NCT01201317|588012242|FG001|Overall Study|Lack of Efficacy|0|||
162809019|NCT01201317|588012243|FG002|Overall Study|Lack of Efficacy|0|||
162809020|NCT01201317|588012241|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
162809021|NCT01201317|588012242|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
162809022|NCT01201317|588012243|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
162809023|NCT01350336|588012244|FG000|Overall Study|Lost to Follow-up|31|||
162809024|NCT01350336|588012244|FG000|Overall Study|Withdrawal by Subject|14|||
162809025|NCT01350336|588012244|FG000|Overall Study|Physician Decision|8|||
162809026|NCT01350336|588012244|FG000|Overall Study|Death|4|||
162809027|NCT00876928|588012246|FG000|Overall Study|Lost to Follow-up|2|||
162809028|NCT00876928|588012247|FG001|Overall Study|Lost to Follow-up|5|||
162809029|NCT00876928|588012246|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
162809030|NCT00876928|588012247|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
162809031|NCT02795429|588012248|FG000|Overall Study|Adverse Event|1|||
162809032|NCT02795429|588012249|FG001|Overall Study|Adverse Event|2|||
162809033|NCT02795429|588012250|FG002|Overall Study|Adverse Event|1|||
162809034|NCT02795429|588012251|FG003|Overall Study|Adverse Event|2|||
162809035|NCT02795429|588012252|FG004|Overall Study|Adverse Event|1|||
162809036|NCT02795429|588012248|FG000|Overall Study|Death|1|||
162809037|NCT02795429|588012249|FG001|Overall Study|Death|0|||
162809038|NCT02795429|588012250|FG002|Overall Study|Death|1|||
162809039|NCT02795429|588012251|FG003|Overall Study|Death|2|||
162809040|NCT02795429|588012252|FG004|Overall Study|Death|1|||
162809041|NCT02795429|588012248|FG000|Overall Study|Physician Decision|0|||
162809042|NCT02795429|588012249|FG001|Overall Study|Physician Decision|0|||
162809043|NCT02795429|588012250|FG002|Overall Study|Physician Decision|2|||
162809044|NCT02795429|588012251|FG003|Overall Study|Physician Decision|1|||
162809045|NCT02795429|588012252|FG004|Overall Study|Physician Decision|5|||
162809046|NCT02795429|588012248|FG000|Overall Study|Progressive disease|3|||
162809047|NCT02795429|588012249|FG001|Overall Study|Progressive disease|7|||
162809048|NCT02795429|588012250|FG002|Overall Study|Progressive disease|6|||
162809049|NCT02795429|588012251|FG003|Overall Study|Progressive disease|26|||
162809050|NCT02795429|588012252|FG004|Overall Study|Progressive disease|20|||
162809051|NCT02795429|588012248|FG000|Overall Study|Subject/guardian decision|1|||
162809052|NCT02795429|588012249|FG001|Overall Study|Subject/guardian decision|1|||
162809053|NCT02795429|588012250|FG002|Overall Study|Subject/guardian decision|1|||
162809054|NCT02795429|588012251|FG003|Overall Study|Subject/guardian decision|1|||
162809055|NCT02795429|588012252|FG004|Overall Study|Subject/guardian decision|3|||
162809056|NCT02079610|588012253|FG000|Overall Study|Withdrawal by Subject|1|||
162809057|NCT02079610|588012254|FG001|Overall Study|Withdrawal by Subject|1|||
162809058|NCT01716117|588012255|FG000|Overall Study|Death|5|||
162809059|NCT01716117|588012256|FG001|Overall Study|Death|2|||
162809060|NCT01716117|588012255|FG000|Overall Study|Withdrawal by Subject|2|||
162809061|NCT01716117|588012256|FG001|Overall Study|Withdrawal by Subject|0|||
162809062|NCT03645057|588012258|FG000|Randomization to Baseline|Lost to Follow-up|1|||
162809063|NCT03645057|588012259|FG001|Randomization to Baseline|Lost to Follow-up|0|||
162809064|NCT03645057|588012260|FG002|Randomization to Baseline|Lost to Follow-up|1|||
162809065|NCT03645057|588012261|FG003|Randomization to Baseline|Lost to Follow-up|0|||
162809066|NCT03645057|588012258|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
162809067|NCT03645057|588012259|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
162809068|NCT03645057|588012260|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
162809069|NCT03645057|588012261|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
162809070|NCT03645057|588012258|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
162809071|NCT03645057|588012259|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
162809072|NCT03645057|588012260|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
162809073|NCT03645057|588012261|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
162809074|NCT03645057|588012258|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
162809075|NCT03645057|588012259|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
162809076|NCT03645057|588012260|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
162809077|NCT03645057|588012261|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
162809078|NCT01171807|588012265|FG000|Overall Study|Treatment failure|2|||
162809079|NCT01171807|588012266|FG001|Overall Study|Treatment failure|4|||
162809080|NCT01171807|588012265|FG000|Overall Study|Non compliance|1|||
162809081|NCT01171807|588012266|FG001|Overall Study|Non compliance|0|||
162809082|NCT01171807|588012265|FG000|Overall Study|Lost to Follow-up|3|||
162809083|NCT01171807|588012266|FG001|Overall Study|Lost to Follow-up|0|||
162809084|NCT01901341|588012267|FG000|Overall Study|Adverse Event|4|||
162809085|NCT01901341|588012268|FG001|Overall Study|Adverse Event|2|||
162809086|NCT01901341|588012267|FG000|Overall Study|Lack of Efficacy|0|||
162809087|NCT01901341|588012268|FG001|Overall Study|Lack of Efficacy|2|||
162809088|NCT01901341|588012267|FG000|Overall Study|Lost to Follow-up|0|||
162809089|NCT01901341|588012268|FG001|Overall Study|Lost to Follow-up|1|||
162809090|NCT01901341|588012267|FG000|Overall Study|Protocol Violation|2|||
162809091|NCT01901341|588012268|FG001|Overall Study|Protocol Violation|0|||
162809092|NCT01901341|588012267|FG000|Overall Study|Study Terminated by Sponsor|13|||
162809093|NCT01901341|588012268|FG001|Overall Study|Study Terminated by Sponsor|15|||
162809094|NCT01901341|588012267|FG000|Overall Study|Withdrawal by Subject|1|||
162809095|NCT01901341|588012268|FG001|Overall Study|Withdrawal by Subject|1|||
162809096|NCT04964388|588012269|FG000|Overall Study|Lost to Follow-up|3|||
162809097|NCT04964388|588012270|FG001|Overall Study|Lost to Follow-up|2|||
162809098|NCT00250679|588012271|FG000|Overall Study|Adverse Event|12|||
162809099|NCT00250679|588012272|FG001|Overall Study|Adverse Event|15|||
162809100|NCT00250679|588012273|FG002|Overall Study|Adverse Event|16|||
162809101|NCT00250679|588012271|FG000|Overall Study|Protocol Violation|2|||
162809102|NCT00250679|588012272|FG001|Overall Study|Protocol Violation|4|||
162809103|NCT00250679|588012273|FG002|Overall Study|Protocol Violation|3|||
162809104|NCT00250679|588012271|FG000|Overall Study|Withdrawal by Subject|15|||
162809105|NCT00250679|588012272|FG001|Overall Study|Withdrawal by Subject|18|||
162809106|NCT00250679|588012273|FG002|Overall Study|Withdrawal by Subject|15|||
162809107|NCT00250679|588012271|FG000|Overall Study|Lost to Follow-up|3|||
162809108|NCT00250679|588012272|FG001|Overall Study|Lost to Follow-up|4|||
162809109|NCT00250679|588012273|FG002|Overall Study|Lost to Follow-up|2|||
162809110|NCT00250679|588012271|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
162809111|NCT00250679|588012272|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
162809112|NCT00250679|588012273|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
162809113|NCT00250679|588012271|FG000|Overall Study|Lack of Efficacy|0|||
162809114|NCT00250679|588012272|FG001|Overall Study|Lack of Efficacy|1|||
162809115|NCT00250679|588012273|FG002|Overall Study|Lack of Efficacy|3|||
162809116|NCT00250679|588012271|FG000|Overall Study|Technical Holter issues|1|||
162809117|NCT00250679|588012272|FG001|Overall Study|Technical Holter issues|0|||
162809118|NCT00250679|588012273|FG002|Overall Study|Technical Holter issues|2|||
162809119|NCT00250679|588012271|FG000|Overall Study|Moved|1|||
162809120|NCT00250679|588012272|FG001|Overall Study|Moved|1|||
162809121|NCT00250679|588012273|FG002|Overall Study|Moved|0|||
162809122|NCT00250679|588012271|FG000|Overall Study|Non-compliance|1|||
162809123|NCT00250679|588012272|FG001|Overall Study|Non-compliance|1|||
162809124|NCT00250679|588012273|FG002|Overall Study|Non-compliance|0|||
162809125|NCT00250679|588012271|FG000|Overall Study|various single events: hip surgery,diary|3|||
162809126|NCT00250679|588012272|FG001|Overall Study|various single events: hip surgery,diary|1|||
162809127|NCT00250679|588012273|FG002|Overall Study|various single events: hip surgery,diary|1|||
162809128|NCT00448279|588012275|FG000|Overall Study|Lost to Follow-up|2|||
162809129|NCT00448279|588012276|FG001|Overall Study|Lost to Follow-up|2|||
162809130|NCT00448279|588012275|FG000|Overall Study|Adverse Event|1|||
162809131|NCT00448279|588012276|FG001|Overall Study|Adverse Event|1|||
162809132|NCT00448279|588012275|FG000|Overall Study|Disease progression|16|||
162809133|NCT00448279|588012276|FG001|Overall Study|Disease progression|18|||
162809134|NCT00448279|588012275|FG000|Overall Study|Withdrawal by Subject|4|||
162809135|NCT00448279|588012276|FG001|Overall Study|Withdrawal by Subject|3|||
162809136|NCT00448279|588012275|FG000|Overall Study|Other|6|||
162809137|NCT00448279|588012276|FG001|Overall Study|Other|4|||
162809138|NCT00448279|588012275|FG000|Overall Study|Protocol Violation|0|||
162809139|NCT00448279|588012276|FG001|Overall Study|Protocol Violation|1|||
162809140|NCT03907410|588012277|FG000|Overall Study|Lost to Follow-up|4|||
162809141|NCT03907410|588012278|FG001|Overall Study|Lost to Follow-up|1|||
162809142|NCT03907410|588012279|FG002|Overall Study|Lost to Follow-up|1|||
162809143|NCT03907410|588012277|FG000|Overall Study|Lost to follow-up and research burden|0|||
162809144|NCT03907410|588012278|FG001|Overall Study|Lost to follow-up and research burden|0|||
162809145|NCT03907410|588012279|FG002|Overall Study|Lost to follow-up and research burden|1|||
162809146|NCT04776148|588012280|FG000|Overall Study|Death|249|||
162809147|NCT04776148|588012281|FG001|Overall Study|Death|260|||
162809148|NCT04776148|588012280|FG000|Overall Study|Lost to Follow-up|0|||
162809149|NCT04776148|588012281|FG001|Overall Study|Lost to Follow-up|1|||
162809150|NCT04776148|588012280|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162809151|NCT04776148|588012281|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162809152|NCT04776148|588012280|FG000|Overall Study|Withdrawal by Subject|3|||
162809153|NCT04776148|588012281|FG001|Overall Study|Withdrawal by Subject|4|||
162809154|NCT04776148|588012280|FG000|Overall Study|Sponsor Decision|30|||
162809155|NCT04776148|588012281|FG001|Overall Study|Sponsor Decision|15|||
162809156|NCT01155375|588012282|FG000|Overall Study|Adverse Event|1|||
162809157|NCT01155375|588012283|FG001|Overall Study|Adverse Event|0|||
162809158|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
162809159|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
162809160|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
162809161|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
162809162|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
162809163|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
162809164|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
162809165|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
162809166|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
162809167|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
162809168|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
162809169|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
162809170|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
162809171|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
162809172|NCT00757588|588012284|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
162809173|NCT00757588|588012285|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
162809174|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
162809175|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
162809176|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
162809177|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
162809178|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
162809179|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
162809180|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
162809181|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
162809182|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
162809183|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
162809184|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
162809185|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
162809186|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
162809187|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
162809188|NCT00757588|588012284|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
162809189|NCT00757588|588012285|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
162809190|NCT02563522|588012286|FG000|Overall Study|Adverse Event|2|||
162809191|NCT02563522|588012287|FG001|Overall Study|Adverse Event|3|||
162809192|NCT02563522|588012286|FG000|Overall Study|Lost to Follow-up|1|||
162809193|NCT02563522|588012287|FG001|Overall Study|Lost to Follow-up|0|||
162809194|NCT02563522|588012286|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
162809195|NCT02563522|588012287|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
162809196|NCT01052103|588012288|FG000|Overall Study|Adverse Event|10|||
162809197|NCT01052103|588012289|FG001|Overall Study|Adverse Event|6|||
162809198|NCT01052103|588012288|FG000|Overall Study|Entry Criteria Not Met|3|||
162809199|NCT01052103|588012289|FG001|Overall Study|Entry Criteria Not Met|1|||
162809200|NCT01052103|588012288|FG000|Overall Study|Lost to Follow-up|3|||
162809201|NCT01052103|588012289|FG001|Overall Study|Lost to Follow-up|5|||
162809202|NCT01052103|588012288|FG000|Overall Study|Protocol Violation|10|||
162809203|NCT01052103|588012289|FG001|Overall Study|Protocol Violation|4|||
162809204|NCT01052103|588012288|FG000|Overall Study|Scheduling conflict|2|||
162809205|NCT01052103|588012289|FG001|Overall Study|Scheduling conflict|1|||
162809206|NCT01052103|588012288|FG000|Overall Study|Sponsor Decision|2|||
162809207|NCT01052103|588012289|FG001|Overall Study|Sponsor Decision|0|||
162809208|NCT01052103|588012288|FG000|Overall Study|Withdrawal by Subject|3|||
162809209|NCT01052103|588012289|FG001|Overall Study|Withdrawal by Subject|6|||
162809210|NCT01052103|588012288|FG000|Overall Study|Perceived Lack of Efficacy|1|||
162809211|NCT01052103|588012289|FG001|Overall Study|Perceived Lack of Efficacy|0|||
162809212|NCT00666679|588012293|FG000|First Intervention|Lost to Follow-up|1|||
162809213|NCT00666679|588012294|FG001|First Intervention|Lost to Follow-up|0|||
162809214|NCT00666679|588012293|FG000|First Intervention|Protocol Violation|1|||
162809215|NCT00666679|588012294|FG001|First Intervention|Protocol Violation|0|||
162809216|NCT00666679|588012293|FG000|First Intervention|Withdrawal by Subject|1|||
162809217|NCT00666679|588012294|FG001|First Intervention|Withdrawal by Subject|0|||
162809218|NCT00666679|588012293|FG000|First Intervention|Randomized did not start treatment|1|||
162809219|NCT00666679|588012294|FG001|First Intervention|Randomized did not start treatment|1|||
162809220|NCT00666679|588012293|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
162809221|NCT00666679|588012294|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
162809222|NCT00666679|588012293|FG000|Washout Period of 1 Week|Protocol Violation|0|||
162809223|NCT00666679|588012294|FG001|Washout Period of 1 Week|Protocol Violation|1|||
162809224|NCT00666679|588012293|FG000|Second Intervention|Adverse Event|1|||
162809225|NCT00666679|588012294|FG001|Second Intervention|Adverse Event|0|||
162809226|NCT00666679|588012293|FG000|Second Intervention|Death|0|||
162809227|NCT00666679|588012294|FG001|Second Intervention|Death|1|||
162809228|NCT04874415|588012295|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809229|NCT04874415|588012296|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809230|NCT04874415|588012297|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809231|NCT04874415|588012298|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809232|NCT04874415|588012299|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809233|NCT04874415|588012300|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809234|NCT04874415|588012301|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162809235|NCT04874415|588012302|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809236|NCT04874415|588012303|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
162809237|NCT04874415|588012304|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162809238|NCT04874415|588012305|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809239|NCT04874415|588012306|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162809240|NCT04874415|588012307|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162809241|NCT04874415|588012308|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162809242|NCT04874415|588012309|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
162809243|NCT04874415|588012310|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162809244|NCT04874415|588012295|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809245|NCT04874415|588012296|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809246|NCT04874415|588012297|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809247|NCT04874415|588012298|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809248|NCT04874415|588012299|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809249|NCT04874415|588012300|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809250|NCT04874415|588012301|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809251|NCT04874415|588012302|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809252|NCT04874415|588012303|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809253|NCT04874415|588012304|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
162809254|NCT04874415|588012305|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809255|NCT04874415|588012306|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809256|NCT04874415|588012307|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809257|NCT04874415|588012308|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809258|NCT04874415|588012309|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
162809259|NCT04874415|588012310|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
162809260|NCT04874415|588012295|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809261|NCT04874415|588012296|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809262|NCT04874415|588012297|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809263|NCT04874415|588012298|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809264|NCT04874415|588012299|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
162809265|NCT04874415|588012300|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809266|NCT04874415|588012301|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809267|NCT04874415|588012302|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809268|NCT04874415|588012303|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809269|NCT04874415|588012304|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809270|NCT04874415|588012305|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809271|NCT04874415|588012306|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809272|NCT04874415|588012307|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809273|NCT04874415|588012308|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809274|NCT04874415|588012309|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809275|NCT04874415|588012310|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162809276|NCT00881608|588012311|FG000|Overall Study|Study prematurely terminated|11|||
162809277|NCT00701220|588012312|FG000|Overall Study|Withdrawal by Subject|0|||
162809278|NCT00701220|588012313|FG001|Overall Study|Withdrawal by Subject|2|||
162809279|NCT00701220|588012312|FG000|Overall Study|Protocol Violation|2|||
162809280|NCT00701220|588012313|FG001|Overall Study|Protocol Violation|0|||
162809281|NCT00211185|588012314|FG000|Overall Study|Death|2|||
162809282|NCT00211185|588012314|FG000|Overall Study|Disease progression|7|||
162809283|NCT00211185|588012314|FG000|Overall Study|Withdrawal by Subject|6|||
162809284|NCT00211185|588012314|FG000|Overall Study|Physician Decision|5|||
162809285|NCT00069108|588012315|FG000|Overall Study|Withdrawal by Subject|5|||
162809286|NCT00069108|588012316|FG001|Overall Study|Withdrawal by Subject|9|||
162809287|NCT00069108|588012315|FG000|Overall Study|Adverse Event|64|||
162809288|NCT00069108|588012316|FG001|Overall Study|Adverse Event|42|||
162809289|NCT00069108|588012315|FG000|Overall Study|Death|6|||
162809290|NCT00069108|588012316|FG001|Overall Study|Death|6|||
162809291|NCT00069108|588012315|FG000|Overall Study|Administration|15|||
162809292|NCT00069108|588012316|FG001|Overall Study|Administration|4|||
162809293|NCT00069108|588012315|FG000|Overall Study|Insufficient therapy|117|||
162809294|NCT00069108|588012316|FG001|Overall Study|Insufficient therapy|144|||
162809295|NCT00069108|588012315|FG000|Overall Study|Violation criteria|1|||
162809296|NCT00069108|588012316|FG001|Overall Study|Violation criteria|4|||
162809297|NCT00069108|588012315|FG000|Overall Study|Refused treatment|5|||
162809298|NCT00069108|588012316|FG001|Overall Study|Refused treatment|10|||
162809299|NCT00903630|588012317|FG000|Phase 2|Adverse Event|0|||
162809300|NCT00903630|588012318|FG001|Phase 2|Adverse Event|0|||
162809301|NCT00903630|588012319|FG002|Phase 2|Adverse Event|1|||
162809302|NCT03658668|588012322|FG000|Overall Study|Time Commitment|1|||
162809303|NCT03658668|588012323|FG001|Overall Study|Time Commitment|1|||
162809304|NCT03305731|588012324|FG000|Overall Study|Protocol Violation|1|||
162809305|NCT04634825|588012325|FG000|Overall Study|Death|10|||
162809306|NCT04634825|588012326|FG001|Overall Study|Death|3|||
162809307|NCT04634825|588012325|FG000|Overall Study|Lost to Follow-up|1|||
162809308|NCT04634825|588012326|FG001|Overall Study|Lost to Follow-up|0|||
162809309|NCT04634825|588012325|FG000|Overall Study|Study terminated by sponsor|35|||
162809310|NCT04634825|588012326|FG001|Overall Study|Study terminated by sponsor|11|||
162809311|NCT04634825|588012325|FG000|Overall Study|Withdrawal by Subject|2|||
162809312|NCT04634825|588012326|FG001|Overall Study|Withdrawal by Subject|0|||
162809313|NCT01127139|588012329|FG000|Overall Study|Adverse Event|40|||
162809314|NCT01127139|588012329|FG000|Overall Study|Incompliance|12|||
162809315|NCT01127139|588012329|FG000|Overall Study|Lack of Efficacy|4|||
162809316|NCT01127139|588012329|FG000|Overall Study|Reason not specified|1|||
162809317|NCT01136772|588012330|FG000|Overall Study|Adverse Event|15|||
162809318|NCT01136772|588012331|FG001|Overall Study|Adverse Event|14|||
162809319|NCT01136772|588012330|FG000|Overall Study|Lack of Efficacy|42|||
162809320|NCT01136772|588012331|FG001|Overall Study|Lack of Efficacy|39|||
162809321|NCT01136772|588012330|FG000|Overall Study|Administrative|14|||
162809322|NCT01136772|588012331|FG001|Overall Study|Administrative|12|||
162809323|NCT01136772|588012330|FG000|Overall Study|Withdrawal by Subject|33|||
162809324|NCT01136772|588012331|FG001|Overall Study|Withdrawal by Subject|36|||
162809325|NCT01136772|588012330|FG000|Overall Study|Did not receive injection|10|||
162809326|NCT01136772|588012331|FG001|Overall Study|Did not receive injection|7|||
162809327|NCT01136772|588012330|FG000|Overall Study|Did not follow up after first injection|2|||
162809328|NCT01136772|588012331|FG001|Overall Study|Did not follow up after first injection|2|||
162809329|NCT01718353|588012337|FG000|Overall Study|Lost to Follow-up|0|||
162809330|NCT01718353|588012338|FG001|Overall Study|Lost to Follow-up|1|||
162809331|NCT01718353|588012337|FG000|Overall Study|Principal Investigator's Decision|10|||
162809332|NCT01718353|588012338|FG001|Overall Study|Principal Investigator's Decision|4|||
162809333|NCT01718353|588012337|FG000|Overall Study|Randomized but not treated|2|||
162809334|NCT01718353|588012338|FG001|Overall Study|Randomized but not treated|0|||
162809335|NCT01959516|588012339|FG000|Epoch 1|Adverse Event|4|||
162809336|NCT01959516|588012340|FG001|Epoch 1|Adverse Event|1|||
162809337|NCT01959516|588012339|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
162809338|NCT01959516|588012340|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
162809339|NCT01959516|588012339|FG000|Epoch 1|Subject withdrew consent|3|||
162809340|NCT01959516|588012340|FG001|Epoch 1|Subject withdrew consent|2|||
162809341|NCT01959516|588012339|FG000|Epoch 1|Administrative problems|1|||
162809342|NCT01959516|588012340|FG001|Epoch 1|Administrative problems|0|||
162809343|NCT01959516|588012339|FG000|Epoch 1|Use of prohibited treatment|1|||
162809344|NCT01959516|588012340|FG001|Epoch 1|Use of prohibited treatment|0|||
162809345|NCT01959516|588012339|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
162809346|NCT01959516|588012340|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
162809347|NCT01959516|588012339|FG000|Epoch 1|Protocol deviation|0|||
162809348|NCT01959516|588012340|FG001|Epoch 1|Protocol deviation|1|||
162809349|NCT01959516|588012339|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
162809350|NCT01959516|588012340|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
162809351|NCT01959516|588012339|FG000|Epoch 2|Subject withdrew consent|1|||
162809352|NCT01959516|588012340|FG001|Epoch 2|Subject withdrew consent|0|||
162809353|NCT01959516|588012339|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
162809354|NCT01959516|588012340|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
162809355|NCT02581631|588012347|FG000|Overall Study|Disease progression|29|||
162809356|NCT02581631|588012348|FG001|Overall Study|Disease progression|19|||
162809357|NCT02581631|588012349|FG002|Overall Study|Disease progression|13|||
162809358|NCT02581631|588012350|FG003|Overall Study|Disease progression|5|||
162809359|NCT02581631|588012351|FG004|Overall Study|Disease progression|8|||
162809360|NCT02581631|588012347|FG000|Overall Study|Study drug toxicity|4|||
162809361|NCT02581631|588012348|FG001|Overall Study|Study drug toxicity|6|||
162809362|NCT02581631|588012349|FG002|Overall Study|Study drug toxicity|7|||
162809363|NCT02581631|588012350|FG003|Overall Study|Study drug toxicity|0|||
162809364|NCT02581631|588012351|FG004|Overall Study|Study drug toxicity|3|||
162809365|NCT02581631|588012347|FG000|Overall Study|AE unrelated to study drug|3|||
162809366|NCT02581631|588012348|FG001|Overall Study|AE unrelated to study drug|1|||
162809367|NCT02581631|588012349|FG002|Overall Study|AE unrelated to study drug|1|||
162809368|NCT02581631|588012350|FG003|Overall Study|AE unrelated to study drug|0|||
162809369|NCT02581631|588012351|FG004|Overall Study|AE unrelated to study drug|2|||
162809370|NCT02581631|588012347|FG000|Overall Study|Request to discontinue|1|||
162809371|NCT02581631|588012348|FG001|Overall Study|Request to discontinue|0|||
162809372|NCT02581631|588012349|FG002|Overall Study|Request to discontinue|3|||
162809373|NCT02581631|588012350|FG003|Overall Study|Request to discontinue|0|||
162809374|NCT02581631|588012351|FG004|Overall Study|Request to discontinue|1|||
162809375|NCT02581631|588012347|FG000|Overall Study|participant withdrew consent|3|||
162809376|NCT02581631|588012348|FG001|Overall Study|participant withdrew consent|0|||
162809377|NCT02581631|588012349|FG002|Overall Study|participant withdrew consent|1|||
162809378|NCT02581631|588012350|FG003|Overall Study|participant withdrew consent|0|||
162809379|NCT02581631|588012351|FG004|Overall Study|participant withdrew consent|0|||
162809380|NCT02581631|588012347|FG000|Overall Study|Maximum clinical benefit|1|||
162809381|NCT02581631|588012348|FG001|Overall Study|Maximum clinical benefit|7|||
162809382|NCT02581631|588012349|FG002|Overall Study|Maximum clinical benefit|1|||
162809383|NCT02581631|588012350|FG003|Overall Study|Maximum clinical benefit|3|||
162809384|NCT02581631|588012351|FG004|Overall Study|Maximum clinical benefit|13|||
162809385|NCT02581631|588012347|FG000|Overall Study|Other Reasons|1|||
162809386|NCT02581631|588012348|FG001|Overall Study|Other Reasons|0|||
162809387|NCT02581631|588012349|FG002|Overall Study|Other Reasons|2|||
162809388|NCT02581631|588012350|FG003|Overall Study|Other Reasons|2|||
162809389|NCT02581631|588012351|FG004|Overall Study|Other Reasons|3|||
162809390|NCT02581631|588012347|FG000|Overall Study|Poor/Non-Compliance|0|||
162809391|NCT02581631|588012348|FG001|Overall Study|Poor/Non-Compliance|0|||
162809392|NCT02581631|588012349|FG002|Overall Study|Poor/Non-Compliance|1|||
162809393|NCT02581631|588012350|FG003|Overall Study|Poor/Non-Compliance|0|||
162809394|NCT02581631|588012351|FG004|Overall Study|Poor/Non-Compliance|0|||
162809395|NCT01759368|588012352|FG000|Overall Study|Lost to Follow-up|1|||
162809396|NCT01759368|588012353|FG001|Overall Study|Lost to Follow-up|0|||
162809397|NCT01191268|588012354|FG000|Overall Study|Withdrawal by Subject|19|||
162809398|NCT01191268|588012355|FG001|Overall Study|Withdrawal by Subject|25|||
162809399|NCT01191268|588012356|FG002|Overall Study|Withdrawal by Subject|21|||
162809400|NCT01191268|588012354|FG000|Overall Study|Adverse Event|21|||
162809401|NCT01191268|588012355|FG001|Overall Study|Adverse Event|13|||
162809402|NCT01191268|588012356|FG002|Overall Study|Adverse Event|8|||
162809403|NCT01191268|588012354|FG000|Overall Study|Physician Decision|6|||
162809404|NCT01191268|588012355|FG001|Overall Study|Physician Decision|8|||
162809405|NCT01191268|588012356|FG002|Overall Study|Physician Decision|9|||
162809406|NCT01191268|588012354|FG000|Overall Study|Lost to Follow-up|8|||
162809407|NCT01191268|588012355|FG001|Overall Study|Lost to Follow-up|5|||
162809408|NCT01191268|588012356|FG002|Overall Study|Lost to Follow-up|9|||
162809409|NCT01191268|588012354|FG000|Overall Study|Entry Criteria Not Met|3|||
162809410|NCT01191268|588012355|FG001|Overall Study|Entry Criteria Not Met|1|||
162809411|NCT01191268|588012356|FG002|Overall Study|Entry Criteria Not Met|1|||
162809412|NCT01191268|588012354|FG000|Overall Study|Death|0|||
162809413|NCT01191268|588012355|FG001|Overall Study|Death|1|||
162809414|NCT01191268|588012356|FG002|Overall Study|Death|3|||
162809415|NCT01191268|588012354|FG000|Overall Study|Protocol Violation|1|||
162809416|NCT01191268|588012355|FG001|Overall Study|Protocol Violation|0|||
162809417|NCT01191268|588012356|FG002|Overall Study|Protocol Violation|1|||
162809418|NCT01191268|588012354|FG000|Overall Study|Sponsor Decision|0|||
162809419|NCT01191268|588012355|FG001|Overall Study|Sponsor Decision|2|||
162809420|NCT01191268|588012356|FG002|Overall Study|Sponsor Decision|0|||
162809421|NCT02027623|588012360|FG000|Overall Study|Lost to Follow-up|3|||
162809422|NCT02027623|588012361|FG001|Overall Study|Lost to Follow-up|3|||
162809423|NCT02027623|588012360|FG000|Overall Study|Withdrawal by Subject|6|||
162809424|NCT02027623|588012361|FG001|Overall Study|Withdrawal by Subject|9|||
162809425|NCT01211288|588012362|FG000|Overall Study|Lost to Follow-up|1|||
162809426|NCT01211288|588012363|FG001|Overall Study|Lost to Follow-up|1|||
162809427|NCT01270971|588012364|FG000|Overall Study|Withdrawal by Subject|24|||
162809428|NCT01270971|588012365|FG001|Overall Study|Withdrawal by Subject|11|||
162809429|NCT01270971|588012364|FG000|Overall Study|Lost to Follow-up|18|||
162809430|NCT01270971|588012365|FG001|Overall Study|Lost to Follow-up|5|||
162809431|NCT01270971|588012364|FG000|Overall Study|Adverse Event|1|||
162809432|NCT01270971|588012365|FG001|Overall Study|Adverse Event|2|||
162809433|NCT01270971|588012364|FG000|Overall Study|Non compliance|2|||
162809434|NCT01270971|588012365|FG001|Overall Study|Non compliance|2|||
162809435|NCT01270971|588012364|FG000|Overall Study|Non-specific|7|||
162809436|NCT01270971|588012365|FG001|Overall Study|Non-specific|3|||
162809437|NCT01551212|588012366|FG000|Overall Study|Graft loss/Retransplantation|0|||
162809438|NCT01551212|588012367|FG001|Overall Study|Graft loss/Retransplantation|1|||
162809439|NCT01551212|588012366|FG000|Overall Study|Administrative problems|1|||
162809440|NCT01551212|588012367|FG001|Overall Study|Administrative problems|2|||
162809441|NCT01551212|588012366|FG000|Overall Study|Lost to Follow-up|0|||
162809442|NCT01551212|588012367|FG001|Overall Study|Lost to Follow-up|1|||
162809443|NCT01551212|588012366|FG000|Overall Study|Protocol Violation|0|||
162809444|NCT01551212|588012367|FG001|Overall Study|Protocol Violation|1|||
162809445|NCT01551212|588012366|FG000|Overall Study|Withdrawal by Subject|0|||
162809446|NCT01551212|588012367|FG001|Overall Study|Withdrawal by Subject|7|||
162809447|NCT01551212|588012366|FG000|Overall Study|Death|2|||
162809448|NCT01551212|588012367|FG001|Overall Study|Death|4|||
162809449|NCT01551212|588012366|FG000|Overall Study|Never Received Study Treatment|2|||
162809450|NCT01551212|588012367|FG001|Overall Study|Never Received Study Treatment|4|||
162809451|NCT00705523|588012368|FG000|Overall Study|Lost to Follow-up|2|||
162809452|NCT00705523|588012369|FG001|Overall Study|Lost to Follow-up|3|||
162809453|NCT01946438|588012370|FG000|Overall Study|Adverse Event|0|||
162809454|NCT01946438|588012371|FG001|Overall Study|Adverse Event|0|||
162809455|NCT01946438|588012372|FG002|Overall Study|Adverse Event|0|||
162809456|NCT01946438|588012373|FG003|Overall Study|Adverse Event|1|||
162809457|NCT01946438|588012370|FG000|Overall Study|Serious Adverse event|1|||
162809458|NCT01946438|588012371|FG001|Overall Study|Serious Adverse event|0|||
162809459|NCT01946438|588012372|FG002|Overall Study|Serious Adverse event|0|||
162809460|NCT01946438|588012373|FG003|Overall Study|Serious Adverse event|0|||
162809461|NCT01946438|588012370|FG000|Overall Study|Protocol Violation|0|||
162809462|NCT01946438|588012371|FG001|Overall Study|Protocol Violation|0|||
162809463|NCT01946438|588012372|FG002|Overall Study|Protocol Violation|1|||
162809464|NCT01946438|588012373|FG003|Overall Study|Protocol Violation|0|||
162809465|NCT01946438|588012370|FG000|Overall Study|Withdrawal by Subject|1|||
162809466|NCT01946438|588012371|FG001|Overall Study|Withdrawal by Subject|0|||
162809467|NCT01946438|588012372|FG002|Overall Study|Withdrawal by Subject|0|||
162809468|NCT01946438|588012373|FG003|Overall Study|Withdrawal by Subject|0|||
162809469|NCT02412371|588012374|FG000|Overall Study|Withdrawal by Subject|0|||
162809470|NCT02412371|588012375|FG001|Overall Study|Withdrawal by Subject|2|||
162809471|NCT02412371|588012376|FG002|Overall Study|Withdrawal by Subject|0|||
162809472|NCT02412371|588012377|FG003|Overall Study|Withdrawal by Subject|1|||
162809473|NCT02412371|588012378|FG004|Overall Study|Withdrawal by Subject|1|||
162809474|NCT02412371|588012379|FG005|Overall Study|Withdrawal by Subject|0|||
162809475|NCT02412371|588012374|FG000|Overall Study|Sponsor Discontinued Study|1|||
162809476|NCT02412371|588012375|FG001|Overall Study|Sponsor Discontinued Study|4|||
162809477|NCT02412371|588012376|FG002|Overall Study|Sponsor Discontinued Study|6|||
162809478|NCT02412371|588012377|FG003|Overall Study|Sponsor Discontinued Study|4|||
162809479|NCT02412371|588012378|FG004|Overall Study|Sponsor Discontinued Study|5|||
162809480|NCT02412371|588012379|FG005|Overall Study|Sponsor Discontinued Study|0|||
162809481|NCT02412371|588012374|FG000|Overall Study|Death|4|||
162809482|NCT02412371|588012375|FG001|Overall Study|Death|2|||
162809483|NCT02412371|588012376|FG002|Overall Study|Death|1|||
162809484|NCT02412371|588012377|FG003|Overall Study|Death|3|||
162809485|NCT02412371|588012378|FG004|Overall Study|Death|5|||
162809486|NCT02412371|588012379|FG005|Overall Study|Death|2|||
162809487|NCT02412371|588012374|FG000|Overall Study|Other|2|||
162809488|NCT02412371|588012375|FG001|Overall Study|Other|1|||
162809489|NCT02412371|588012376|FG002|Overall Study|Other|0|||
162809490|NCT02412371|588012377|FG003|Overall Study|Other|0|||
162809491|NCT02412371|588012378|FG004|Overall Study|Other|1|||
162809492|NCT02412371|588012379|FG005|Overall Study|Other|3|||
162809493|NCT01620255|588014461|FG000|Overall Study|Withdrawal by Subject|4|||
162809494|NCT01620255|588014462|FG001|Overall Study|Withdrawal by Subject|1|||
162809495|NCT01620255|588014463|FG002|Overall Study|Withdrawal by Subject|1|||
162809496|NCT01620255|588014464|FG003|Overall Study|Withdrawal by Subject|2|||
162809497|NCT01620255|588014465|FG004|Overall Study|Withdrawal by Subject|4|||
162809498|NCT01620255|588014461|FG000|Overall Study|Participant underwent fecal transplant|0|||
162809499|NCT01620255|588014462|FG001|Overall Study|Participant underwent fecal transplant|0|||
162809500|NCT01620255|588014463|FG002|Overall Study|Participant underwent fecal transplant|1|||
162809501|NCT01620255|588014464|FG003|Overall Study|Participant underwent fecal transplant|0|||
162809502|NCT01620255|588014465|FG004|Overall Study|Participant underwent fecal transplant|0|||
162809503|NCT01620255|588014461|FG000|Overall Study|Non-compliance|0|||
162809504|NCT01620255|588014462|FG001|Overall Study|Non-compliance|1|||
162809505|NCT01620255|588014463|FG002|Overall Study|Non-compliance|0|||
162809506|NCT01620255|588014464|FG003|Overall Study|Non-compliance|0|||
162809507|NCT01620255|588014465|FG004|Overall Study|Non-compliance|0|||
162809508|NCT01620255|588014461|FG000|Overall Study|Adverse Event|0|||
162809509|NCT01620255|588014462|FG001|Overall Study|Adverse Event|4|||
162809510|NCT01620255|588014463|FG002|Overall Study|Adverse Event|0|||
162809511|NCT01620255|588014464|FG003|Overall Study|Adverse Event|1|||
162809512|NCT01620255|588014465|FG004|Overall Study|Adverse Event|1|||
162809513|NCT01620255|588014461|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
162809514|NCT01620255|588014462|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
162809515|NCT01620255|588014463|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
162809516|NCT01620255|588014464|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
162809517|NCT01620255|588014465|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
162809518|NCT01873495|588014472|FG000|Overall Study|Withdrawal by Subject|1|||
162809519|NCT01873495|588014472|FG000|Overall Study|Physician Decision|3|||
162809520|NCT01873495|588014472|FG000|Overall Study|Adverse Event|1|||
162809521|NCT01873495|588014472|FG000|Overall Study|Removed for Transplantation|1|||
162809522|NCT01873495|588014472|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
162809523|NCT03864146|588014473|FG000|Overall Study|Lost to Follow-up|14|||
162809524|NCT03864146|588014474|FG001|Overall Study|Lost to Follow-up|23|||
162809525|NCT03864146|588014473|FG000|Overall Study|Withdrawal by Subject|3|||
162809526|NCT03864146|588014474|FG001|Overall Study|Withdrawal by Subject|2|||
162809527|NCT00799513|588014475|FG000|Overall Study|Physician Decision|1|||
162809528|NCT00799513|588014475|FG000|Overall Study|Adverse Event|1|||
162809529|NCT04981366|588014478|FG000|Overall Study|Withdrawal by Subject|5|||
162809530|NCT04981366|588014479|FG001|Overall Study|Withdrawal by Subject|4|||
162809531|NCT04981366|588014480|FG002|Overall Study|Withdrawal by Subject|8|||
162809532|NCT04981366|588014478|FG000|Overall Study|Health issues unrelated to the trial|1|||
162809533|NCT04981366|588014479|FG001|Overall Study|Health issues unrelated to the trial|2|||
162809534|NCT04981366|588014480|FG002|Overall Study|Health issues unrelated to the trial|0|||
162809535|NCT04371198|588014481|FG000|Overall Study|inadequate sample|4|||
162809536|NCT01112306|588014482|FG000|Overall Study|Death|175|||
162809537|NCT01112306|588014482|FG000|Overall Study|Lost to Follow-up|9|||
162809538|NCT01112306|588014482|FG000|Overall Study|Withdrawal by Subject|31|||
162809539|NCT01112306|588014482|FG000|Overall Study|Other|70|||
162809540|NCT03214094|588014483|FG000|Overall Study|Case Report Forms Uncollected|14|||
162809541|NCT03214094|588014483|FG000|Overall Study|Protocol Deviation|46|||
162809542|NCT05559099|588014501|FG000|Overall Study|Death|5|||
162809543|NCT05559099|588014502|FG001|Overall Study|Death|4|||
162809544|NCT05559099|588014501|FG000|Overall Study|Lost to Follow-up|0|||
162809545|NCT05559099|588014502|FG001|Overall Study|Lost to Follow-up|2|||
162809546|NCT05559099|588014501|FG000|Overall Study|Adverse Event|1|||
162809547|NCT05559099|588014502|FG001|Overall Study|Adverse Event|1|||
162809548|NCT04018092|588014503|FG000|Overall Study|Withdrawal by Subject|1|||
162809549|NCT04018092|588014504|FG001|Overall Study|Withdrawal by Subject|1|||
162809550|NCT04018092|588014503|FG000|Overall Study|Withdrawal by Subject|1|||
162809551|NCT04018092|588014504|FG001|Overall Study|Withdrawal by Subject|1|||
162809552|NCT04218084|588014505|FG000|Overall Study|Adverse Event|7|||
162809553|NCT04218084|588014506|FG001|Overall Study|Adverse Event|2|||
162809554|NCT04218084|588014505|FG000|Overall Study|Withdrawal of Consent|4|||
162809555|NCT04218084|588014506|FG001|Overall Study|Withdrawal of Consent|5|||
162809556|NCT04218084|588014505|FG000|Overall Study|Physician Decision|1|||
162809557|NCT04218084|588014506|FG001|Overall Study|Physician Decision|1|||
162809558|NCT04218084|588014505|FG000|Overall Study|Lost to Follow-up|1|||
162809559|NCT04218084|588014506|FG001|Overall Study|Lost to Follow-up|1|||
162809560|NCT04218084|588014505|FG000|Overall Study|Non-compliance with study drug|1|||
162809561|NCT04218084|588014506|FG001|Overall Study|Non-compliance with study drug|1|||
162809562|NCT04218084|588014505|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
162809563|NCT04218084|588014506|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
162809564|NCT04218084|588014505|FG000|Overall Study|Other|0|||
162809565|NCT04218084|588014506|FG001|Overall Study|Other|1|||
162809566|NCT04218084|588014505|FG000|Overall Study|Ongoing at data cut-off date|62|||
162809567|NCT04218084|588014506|FG001|Overall Study|Ongoing at data cut-off date|58|||
162809568|NCT06469242|588014507|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
162809569|NCT06469242|588014508|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
162809570|NCT06469242|588014507|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
162809571|NCT06469242|588014508|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
162809572|NCT05041101|588014509|FG000|Overall Study|Adverse Event|1|||
162809573|NCT05041101|588014510|FG001|Overall Study|Adverse Event|0|||
162809574|NCT05041101|588014511|FG002|Overall Study|Adverse Event|0|||
162809575|NCT05041101|588014509|FG000|Overall Study|Diease Progression|5|||
162809576|NCT05041101|588014510|FG001|Overall Study|Diease Progression|0|||
162809577|NCT05041101|588014511|FG002|Overall Study|Diease Progression|0|||
162809578|NCT01205152|588014512|FG000|Overall Study|Death|1|||
162809579|NCT02783768|588014513|FG000|Overall Study|Lost to Follow-up|1|||
162809580|NCT02783768|588014514|FG001|Overall Study|Lost to Follow-up|0|||
162809581|NCT02208999|588014515|FG000|Overall Study|Lost to Follow-up|1|||
162809582|NCT00319839|588014516|FG000|Overall Study|Adverse Event|5|||
162809583|NCT00319839|588014516|FG000|Overall Study|Withdrawal by Subject|1|||
162809584|NCT00986674|588014517|FG000|Overall Study|Lack of Efficacy|28|||
162809585|NCT00986674|588014518|FG001|Overall Study|Lack of Efficacy|25|||
162809586|NCT00986674|588014519|FG002|Overall Study|Lack of Efficacy|23|||
162809587|NCT00986674|588014517|FG000|Overall Study|Adverse Event|4|||
162809588|NCT00986674|588014518|FG001|Overall Study|Adverse Event|8|||
162809589|NCT00986674|588014519|FG002|Overall Study|Adverse Event|9|||
162809590|NCT00986674|588014517|FG000|Overall Study|Death|5|||
162809591|NCT00986674|588014518|FG001|Overall Study|Death|0|||
162809592|NCT00986674|588014519|FG002|Overall Study|Death|4|||
162809593|NCT00986674|588014517|FG000|Overall Study|Withdrawal by Subject|6|||
162809594|NCT00986674|588014518|FG001|Overall Study|Withdrawal by Subject|2|||
162809595|NCT00986674|588014519|FG002|Overall Study|Withdrawal by Subject|1|||
162809596|NCT00986674|588014517|FG000|Overall Study|alternative therapy|0|||
162809597|NCT00986674|588014518|FG001|Overall Study|alternative therapy|0|||
162809598|NCT00986674|588014519|FG002|Overall Study|alternative therapy|1|||
162809599|NCT00986674|588014517|FG000|Overall Study|not start protocol therapy|4|||
162809600|NCT00986674|588014518|FG001|Overall Study|not start protocol therapy|3|||
162809601|NCT00986674|588014519|FG002|Overall Study|not start protocol therapy|1|||
162809602|NCT00986674|588014517|FG000|Overall Study|unknown/not specify|0|||
162809603|NCT00986674|588014518|FG001|Overall Study|unknown/not specify|7|||
162809604|NCT00986674|588014519|FG002|Overall Study|unknown/not specify|9|||
162809605|NCT01853137|588014520|FG000|Overall Study|Lost to Follow-up|4|||
162809606|NCT01853137|588014521|FG001|Overall Study|Lost to Follow-up|1|||
162809607|NCT01037244|588014522|FG000|Overall Study|Adverse Event|3|||
162809608|NCT01037244|588014523|FG001|Overall Study|Adverse Event|2|||
162809609|NCT01037244|588014524|FG002|Overall Study|Adverse Event|6|||
162809610|NCT01037244|588014525|FG003|Overall Study|Adverse Event|3|||
162809611|NCT01037244|588014522|FG000|Overall Study|Lack of Efficacy|1|||
162809612|NCT01037244|588014523|FG001|Overall Study|Lack of Efficacy|1|||
162809613|NCT01037244|588014524|FG002|Overall Study|Lack of Efficacy|0|||
162809614|NCT01037244|588014525|FG003|Overall Study|Lack of Efficacy|1|||
162809615|NCT01037244|588014522|FG000|Overall Study|Lost to Follow-up|3|||
162809616|NCT01037244|588014523|FG001|Overall Study|Lost to Follow-up|3|||
162809617|NCT01037244|588014524|FG002|Overall Study|Lost to Follow-up|4|||
162809618|NCT01037244|588014525|FG003|Overall Study|Lost to Follow-up|4|||
162809619|NCT01037244|588014522|FG000|Overall Study|Withdrawal by Subject|1|||
162809620|NCT01037244|588014523|FG001|Overall Study|Withdrawal by Subject|5|||
162809621|NCT01037244|588014524|FG002|Overall Study|Withdrawal by Subject|3|||
162809622|NCT01037244|588014525|FG003|Overall Study|Withdrawal by Subject|5|||
162809623|NCT01037244|588014522|FG000|Overall Study|Partner Withdrew Consent|2|||
162809624|NCT01037244|588014523|FG001|Overall Study|Partner Withdrew Consent|1|||
162809625|NCT01037244|588014524|FG002|Overall Study|Partner Withdrew Consent|0|||
162809626|NCT01037244|588014525|FG003|Overall Study|Partner Withdrew Consent|0|||
162809627|NCT01037244|588014522|FG000|Overall Study|Various|3|||
162809628|NCT01037244|588014523|FG001|Overall Study|Various|2|||
162809629|NCT01037244|588014524|FG002|Overall Study|Various|1|||
162809630|NCT01037244|588014525|FG003|Overall Study|Various|1|||
162925443|NCT01071083|588428986|FG000|Overall Study|Adverse Event|1|||
162809631|NCT00690820|588014526|FG000|Period 1|Withdrawal by Subject|0|||
162809632|NCT00690820|588014527|FG001|Period 1|Withdrawal by Subject|1|||
162809633|NCT00848926|588014528|FG000|Treatment Period|Progressive disease|45|||
162809634|NCT00848926|588014528|FG000|Treatment Period|Adverse Event|20|||
162809635|NCT00848926|588014528|FG000|Treatment Period|Physician Decision|12|||
162809636|NCT00848926|588014528|FG000|Treatment Period|Withdrawal by Subject|7|||
162809637|NCT00848926|588014528|FG000|Follow-up Period|Lost to Follow-up|7|||
162809638|NCT00848926|588014528|FG000|Follow-up Period|Withdrawal by Subject|3|||
162809639|NCT00848926|588014528|FG000|Follow-up Period|Other|2|||
162809640|NCT04025580|588014529|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
162925444|NCT01071083|588428987|FG001|Overall Study|Adverse Event|0|||
162809641|NCT04025580|588014530|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
162809642|NCT04025580|588014531|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
162809643|NCT02216357|588014532|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
162809644|NCT02216357|588014533|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
162809645|NCT01790126|588014535|FG000|Overall Study|PSA Progression|12|||
162809646|NCT01790126|588014536|FG001|Overall Study|PSA Progression|16|||
162809647|NCT01790126|588014537|FG002|Overall Study|PSA Progression|16|||
162809648|NCT01790126|588014535|FG000|Overall Study|Other|5|||
162809649|NCT01790126|588014536|FG001|Overall Study|Other|4|||
162809650|NCT01790126|588014537|FG002|Overall Study|Other|8|||
162809651|NCT01790126|588014535|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
162809652|NCT01790126|588014536|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
162809653|NCT01790126|588014537|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
162809654|NCT01790126|588014535|FG000|Overall Study|Withdrawal by Physician|1|||
162809655|NCT01790126|588014536|FG001|Overall Study|Withdrawal by Physician|1|||
162809656|NCT01790126|588014537|FG002|Overall Study|Withdrawal by Physician|2|||
162809657|NCT01790126|588014535|FG000|Overall Study|Withdrawal by Subject|3|||
162809658|NCT01790126|588014536|FG001|Overall Study|Withdrawal by Subject|1|||
162809659|NCT01790126|588014537|FG002|Overall Study|Withdrawal by Subject|2|||
162809660|NCT01790126|588014535|FG000|Overall Study|Lost to Follow-up|1|||
162809661|NCT01790126|588014536|FG001|Overall Study|Lost to Follow-up|0|||
162809662|NCT01790126|588014537|FG002|Overall Study|Lost to Follow-up|1|||
162809663|NCT01790126|588014535|FG000|Overall Study|Adverse Event|0|||
162809664|NCT01790126|588014536|FG001|Overall Study|Adverse Event|2|||
162809665|NCT01790126|588014537|FG002|Overall Study|Adverse Event|0|||
162809666|NCT01790126|588014535|FG000|Overall Study|Death|2|||
162809667|NCT01790126|588014536|FG001|Overall Study|Death|0|||
162809668|NCT01790126|588014537|FG002|Overall Study|Death|0|||
162809669|NCT01790126|588014535|FG000|Overall Study|Radiographic Progression|3|||
162809670|NCT01790126|588014536|FG001|Overall Study|Radiographic Progression|1|||
162809671|NCT01790126|588014537|FG002|Overall Study|Radiographic Progression|0|||
162809672|NCT00455325|588014538|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
162809673|NCT00455325|588014539|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
162809674|NCT00455325|588014540|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
162809675|NCT00455325|588014541|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
162809676|NCT00455325|588014538|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
162809677|NCT00455325|588014539|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
162809678|NCT00455325|588014540|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
162809679|NCT00455325|588014541|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
162809680|NCT00455325|588014538|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
162809681|NCT00455325|588014539|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
162809682|NCT00455325|588014540|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
162809683|NCT00455325|588014541|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
162809684|NCT00455325|588014538|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
162809685|NCT00455325|588014539|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162809686|NCT00455325|588014540|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162809687|NCT00455325|588014541|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162809688|NCT00455325|588014538|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
162809689|NCT00455325|588014539|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162809690|NCT00455325|588014540|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162809691|NCT00455325|588014541|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162809692|NCT00455325|588014538|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162809693|NCT00455325|588014539|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
162809694|NCT00455325|588014540|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162809695|NCT00455325|588014541|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162809696|NCT00455325|588014538|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162809697|NCT00455325|588014539|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162809698|NCT00455325|588014540|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
162809699|NCT00455325|588014541|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162809700|NCT02435966|588014542|FG000|Overall Study|Withdrawal by Subject|0|||
162809701|NCT02435966|588014543|FG001|Overall Study|Withdrawal by Subject|1|||
162809702|NCT02435966|588014544|FG002|Overall Study|Withdrawal by Subject|0|||
162809703|NCT00928746|588014546|FG000|Overall Study|Adverse Event|2|||
162809704|NCT00928746|588014546|FG000|Overall Study|Protocol Violation|1|||
162809705|NCT00928746|588014546|FG000|Overall Study|Withdrawal by Subject|1|||
162809706|NCT00928746|588014546|FG000|Overall Study|Other|2|||
162809707|NCT02745392|588014551|FG000|Overall Study|Lost to Follow-up|0|||
162809708|NCT02745392|588014552|FG001|Overall Study|Lost to Follow-up|1|||
162809709|NCT02745392|588014553|FG002|Overall Study|Lost to Follow-up|0|||
162809710|NCT02745392|588014554|FG003|Overall Study|Lost to Follow-up|0|||
162809711|NCT02004353|588014559|FG000|Overall Study|Voluntary participation|1334|||
162809712|NCT01691768|588014560|FG000|Overall Study|Death|0|||
162809713|NCT01691768|588014561|FG001|Overall Study|Death|2|||
162809714|NCT01691768|588014560|FG000|Overall Study|Lost to Follow-up|4|||
162809715|NCT01691768|588014561|FG001|Overall Study|Lost to Follow-up|3|||
162809716|NCT01691768|588014560|FG000|Overall Study|Withdrawal by Subject|10|||
162809717|NCT01691768|588014561|FG001|Overall Study|Withdrawal by Subject|9|||
162809718|NCT01691768|588014560|FG000|Overall Study|Relocated|0|||
162809719|NCT01691768|588014561|FG001|Overall Study|Relocated|1|||
162809720|NCT01691768|588014560|FG000|Overall Study|Investigator decision|1|||
162809721|NCT01691768|588014561|FG001|Overall Study|Investigator decision|1|||
162809722|NCT01007448|588014572|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
162809723|NCT01007448|588014573|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
162809724|NCT01007448|588014572|FG000|Overall Study|Staph Skin Infection Flare|1|||
162809725|NCT01007448|588014573|FG001|Overall Study|Staph Skin Infection Flare|0|||
162809726|NCT01007448|588014572|FG000|Overall Study|Participant Leaving the Country|1|||
162809727|NCT01007448|588014573|FG001|Overall Study|Participant Leaving the Country|0|||
162809728|NCT01007448|588014572|FG000|Overall Study|Participant Given Prohibited Medication|1|||
162809729|NCT01007448|588014573|FG001|Overall Study|Participant Given Prohibited Medication|0|||
162809730|NCT01007448|588014572|FG000|Overall Study|Progressive Disease|1|||
162809731|NCT01007448|588014573|FG001|Overall Study|Progressive Disease|2|||
162809732|NCT01007448|588014572|FG000|Overall Study|Lack of Efficacy|2|||
162809733|NCT01007448|588014573|FG001|Overall Study|Lack of Efficacy|0|||
162809734|NCT01007448|588014572|FG000|Overall Study|Withdrawal by Subject|2|||
162809735|NCT01007448|588014573|FG001|Overall Study|Withdrawal by Subject|3|||
162809736|NCT01007448|588014572|FG000|Overall Study|Adverse Event|1|||
162809737|NCT01007448|588014573|FG001|Overall Study|Adverse Event|4|||
162809738|NCT02481947|588014574|FG000|Overall Study|Withdrawal by Subject|24|||
162809739|NCT02481947|588014575|FG001|Overall Study|Withdrawal by Subject|10|||
162809740|NCT02481947|588014574|FG000|Overall Study|Lost to Follow-up|11|||
162809741|NCT02481947|588014575|FG001|Overall Study|Lost to Follow-up|5|||
162809742|NCT02481947|588014574|FG000|Overall Study|Adverse Event|6|||
162809743|NCT02481947|588014575|FG001|Overall Study|Adverse Event|11|||
162809744|NCT02481947|588014574|FG000|Overall Study|Physician Decision|4|||
162809745|NCT02481947|588014575|FG001|Overall Study|Physician Decision|5|||
162809746|NCT02481947|588014574|FG000|Overall Study|Protocol Violation|1|||
162809747|NCT02481947|588014575|FG001|Overall Study|Protocol Violation|5|||
162809748|NCT02751320|588014576|FG000|Overall Study|Adverse Event|2|||
162809749|NCT02751320|588014576|FG000|Overall Study|Withdrawal by Subject|1|||
162809750|NCT03426605|588014577|FG000|Overall Study|AML relapse or progression|2|||
162809751|NCT03426605|588014578|FG001|Overall Study|AML relapse or progression|1|||
162809752|NCT03426605|588014579|FG002|Overall Study|AML relapse or progression|2|||
162809753|NCT03426605|588014580|FG003|Overall Study|AML relapse or progression|2|||
162809754|NCT03426605|588014577|FG000|Overall Study|Treatment failure|3|||
162809755|NCT03426605|588014578|FG001|Overall Study|Treatment failure|2|||
162809756|NCT03426605|588014579|FG002|Overall Study|Treatment failure|0|||
162809757|NCT03426605|588014580|FG003|Overall Study|Treatment failure|0|||
162809758|NCT03426605|588014577|FG000|Overall Study|Adverse Event|1|||
162809759|NCT03426605|588014578|FG001|Overall Study|Adverse Event|0|||
162809760|NCT03426605|588014579|FG002|Overall Study|Adverse Event|1|||
162809761|NCT03426605|588014580|FG003|Overall Study|Adverse Event|1|||
162809762|NCT03426605|588014577|FG000|Overall Study|Withdrawal by Subject|0|||
162809763|NCT03426605|588014578|FG001|Overall Study|Withdrawal by Subject|0|||
162809764|NCT03426605|588014579|FG002|Overall Study|Withdrawal by Subject|1|||
162809765|NCT03426605|588014580|FG003|Overall Study|Withdrawal by Subject|1|||
162809766|NCT01920854|588014583|FG000|Overall Study|Withdrawal by Subject|1|||
162809767|NCT01920854|588014584|FG001|Overall Study|Withdrawal by Subject|0|||
162809768|NCT01920854|588014585|FG002|Overall Study|Withdrawal by Subject|0|||
162809769|NCT01920854|588014586|FG003|Overall Study|Withdrawal by Subject|0|||
162809770|NCT01920854|588014587|FG004|Overall Study|Withdrawal by Subject|1|||
162809771|NCT01920854|588014588|FG005|Overall Study|Withdrawal by Subject|0|||
162809772|NCT01920854|588014589|FG006|Overall Study|Withdrawal by Subject|1|||
162809773|NCT01886378|588014590|FG000|Overall Study|Adverse Event|1|||
162809774|NCT01886378|588014590|FG000|Overall Study|Withdrawal by Subject|4|||
162809775|NCT03333837|588014600|FG000|Overall Study|Adverse Event|2|||
162809776|NCT03333837|588014601|FG001|Overall Study|Adverse Event|1|||
162809777|NCT03333837|588014602|FG002|Overall Study|Adverse Event|1|||
162809778|NCT03333837|588014603|FG003|Overall Study|Adverse Event|1|||
162809779|NCT03333837|588014604|FG004|Overall Study|Adverse Event|0|||
162809780|NCT03333837|588014600|FG000|Overall Study|Caregiver withdrew|0|||
162809781|NCT03333837|588014601|FG001|Overall Study|Caregiver withdrew|2|||
162809782|NCT03333837|588014602|FG002|Overall Study|Caregiver withdrew|1|||
162809783|NCT03333837|588014603|FG003|Overall Study|Caregiver withdrew|0|||
162809784|NCT03333837|588014604|FG004|Overall Study|Caregiver withdrew|0|||
162809785|NCT03333837|588014600|FG000|Overall Study|Withdrawal by Subject|0|||
162809786|NCT03333837|588014601|FG001|Overall Study|Withdrawal by Subject|0|||
162809787|NCT03333837|588014602|FG002|Overall Study|Withdrawal by Subject|1|||
162809788|NCT03333837|588014603|FG003|Overall Study|Withdrawal by Subject|1|||
162809789|NCT03333837|588014604|FG004|Overall Study|Withdrawal by Subject|3|||
162809790|NCT03333837|588014600|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162809791|NCT03333837|588014601|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162925445|NCT01071083|588428988|FG002|Overall Study|Adverse Event|1|||
162809792|NCT03333837|588014602|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
162809793|NCT03333837|588014603|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162809794|NCT03333837|588014604|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162809795|NCT04217590|588014606|FG000|Overall Study|Other|1|||
162809796|NCT04217590|588014607|FG001|Overall Study|Other|1|||
162809797|NCT04217590|588014606|FG000|Overall Study|Withdrawal by Subject|3|||
162809798|NCT04217590|588014607|FG001|Overall Study|Withdrawal by Subject|1|||
162809799|NCT04217590|588014606|FG000|Overall Study|Death|0|||
162809800|NCT04217590|588014607|FG001|Overall Study|Death|1|||
162809801|NCT01013285|588014608|FG000|Overall Study|Death|48|||
162809802|NCT01013285|588014609|FG001|Overall Study|Death|89|||
162809803|NCT02232243|588014612|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
162809804|NCT02232243|588014613|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
162809805|NCT02232243|588014614|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
162809806|NCT00704405|588014615|FG000|Overall Study (NC Population)|Adverse Event|1|||
162809807|NCT00704405|588014616|FG001|Overall Study (NC Population)|Adverse Event|0|||
162809808|NCT00704405|588014617|FG002|Overall Study (NC Population)|Adverse Event|0|||
162809809|NCT00704405|588014618|FG003|Overall Study (NC Population)|Adverse Event|0|||
162809810|NCT00704405|588014619|FG004|Overall Study (NC Population)|Adverse Event|0|||
162809811|NCT00704405|588014615|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
162809812|NCT00704405|588014616|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
162809813|NCT00704405|588014617|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
162809814|NCT00704405|588014618|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
162809815|NCT00704405|588014619|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
162809816|NCT00704405|588014615|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
162809817|NCT00704405|588014616|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
162809818|NCT00704405|588014617|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
162809819|NCT00704405|588014618|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
162809820|NCT00704405|588014619|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
162809821|NCT00704405|588014615|FG000|Overall Study (NC Population)|Other|0|||
162809822|NCT00704405|588014616|FG001|Overall Study (NC Population)|Other|0|||
162809823|NCT00704405|588014617|FG002|Overall Study (NC Population)|Other|0|||
162809824|NCT00704405|588014618|FG003|Overall Study (NC Population)|Other|0|||
162809825|NCT00704405|588014619|FG004|Overall Study (NC Population)|Other|1|||
162809826|NCT00704405|588014615|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
162809827|NCT00704405|588014616|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
162809828|NCT00704405|588014617|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
162809829|NCT00704405|588014618|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
162809830|NCT00704405|588014619|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
162809831|NCT00704405|588014615|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
162809832|NCT00704405|588014616|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
162809833|NCT00704405|588014617|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
162809834|NCT00704405|588014618|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
162809835|NCT00704405|588014619|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
162809836|NCT01395888|588014620|FG000|2-week Run-in Period|Adverse Event|2|||
162809837|NCT01395888|588014621|FG001|2-week Run-in Period|Adverse Event|0|||
162809838|NCT01395888|588014622|FG002|2-week Run-in Period|Adverse Event|0|||
162809839|NCT01395888|588014620|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
162809840|NCT01395888|588014621|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
162809841|NCT01395888|588014622|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
162809842|NCT01395888|588014620|FG000|2-week Run-in Period|Lost to Follow-up|1|||
162809843|NCT01395888|588014621|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162809844|NCT01395888|588014622|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162809845|NCT01395888|588014620|FG000|2-week Run-in Period|Protocol Violation|2|||
162809846|NCT01395888|588014621|FG001|2-week Run-in Period|Protocol Violation|0|||
162809847|NCT01395888|588014622|FG002|2-week Run-in Period|Protocol Violation|0|||
162809848|NCT01395888|588014620|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
162809849|NCT01395888|588014621|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162809850|NCT01395888|588014622|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162809851|NCT01395888|588014620|FG000|Treatment Period (TP)|Adverse Event|0|||
162809852|NCT01395888|588014621|FG001|Treatment Period (TP)|Adverse Event|7|||
162809853|NCT01395888|588014622|FG002|Treatment Period (TP)|Adverse Event|6|||
162809854|NCT01395888|588014620|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
162809855|NCT01395888|588014621|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
162809856|NCT01395888|588014622|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
162809857|NCT01395888|588014620|FG000|Treatment Period (TP)|Protocol Violation|0|||
162809858|NCT01395888|588014621|FG001|Treatment Period (TP)|Protocol Violation|1|||
162809859|NCT01395888|588014622|FG002|Treatment Period (TP)|Protocol Violation|5|||
162809860|NCT01395888|588014620|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
162809861|NCT01395888|588014621|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
162809862|NCT01395888|588014622|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
162809863|NCT01395888|588014620|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
162809864|NCT01395888|588014621|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
162809865|NCT01395888|588014622|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
162809866|NCT02457559|588014623|FG000|Overall Study|Progressive Disease|1|||
162809867|NCT02457559|588014624|FG001|Overall Study|Progressive Disease|2|||
162809868|NCT02457559|588014625|FG002|Overall Study|Progressive Disease|3|||
162809869|NCT02457559|588014626|FG003|Overall Study|Progressive Disease|0|||
162809870|NCT02457559|588014627|FG004|Overall Study|Progressive Disease|0|||
162809871|NCT02457559|588014628|FG005|Overall Study|Progressive Disease|2|||
162809872|NCT02457559|588014629|FG006|Overall Study|Progressive Disease|1|||
162809873|NCT02457559|588014630|FG007|Overall Study|Progressive Disease|0|||
162809874|NCT02457559|588014631|FG008|Overall Study|Progressive Disease|1|||
162809875|NCT02457559|588014632|FG009|Overall Study|Progressive Disease|1|||
162809876|NCT02457559|588014633|FG010|Overall Study|Progressive Disease|1|||
162809877|NCT02457559|588014623|FG000|Overall Study|Investigator's Discretion|0|||
162809878|NCT02457559|588014624|FG001|Overall Study|Investigator's Discretion|0|||
162809879|NCT02457559|588014625|FG002|Overall Study|Investigator's Discretion|2|||
162809880|NCT02457559|588014626|FG003|Overall Study|Investigator's Discretion|0|||
162809881|NCT02457559|588014627|FG004|Overall Study|Investigator's Discretion|1|||
162809882|NCT02457559|588014628|FG005|Overall Study|Investigator's Discretion|0|||
162809883|NCT02457559|588014629|FG006|Overall Study|Investigator's Discretion|1|||
162809884|NCT02457559|588014630|FG007|Overall Study|Investigator's Discretion|0|||
162809885|NCT02457559|588014631|FG008|Overall Study|Investigator's Discretion|1|||
162809886|NCT02457559|588014632|FG009|Overall Study|Investigator's Discretion|0|||
162809887|NCT02457559|588014633|FG010|Overall Study|Investigator's Discretion|1|||
162809888|NCT02457559|588014623|FG000|Overall Study|Adverse Event|0|||
162809889|NCT02457559|588014624|FG001|Overall Study|Adverse Event|1|||
162809890|NCT02457559|588014625|FG002|Overall Study|Adverse Event|2|||
162809891|NCT02457559|588014626|FG003|Overall Study|Adverse Event|0|||
162809892|NCT02457559|588014627|FG004|Overall Study|Adverse Event|0|||
162809893|NCT02457559|588014628|FG005|Overall Study|Adverse Event|0|||
162809894|NCT02457559|588014629|FG006|Overall Study|Adverse Event|0|||
162809895|NCT02457559|588014630|FG007|Overall Study|Adverse Event|0|||
162809896|NCT02457559|588014631|FG008|Overall Study|Adverse Event|0|||
162809897|NCT02457559|588014632|FG009|Overall Study|Adverse Event|0|||
162809898|NCT02457559|588014633|FG010|Overall Study|Adverse Event|0|||
162809899|NCT02457559|588014623|FG000|Overall Study|Reason not Specified|1|||
162809900|NCT02457559|588014624|FG001|Overall Study|Reason not Specified|0|||
162809901|NCT02457559|588014625|FG002|Overall Study|Reason not Specified|0|||
162809902|NCT02457559|588014626|FG003|Overall Study|Reason not Specified|0|||
162809903|NCT02457559|588014627|FG004|Overall Study|Reason not Specified|0|||
162809904|NCT02457559|588014628|FG005|Overall Study|Reason not Specified|0|||
162809905|NCT02457559|588014629|FG006|Overall Study|Reason not Specified|0|||
162809906|NCT02457559|588014630|FG007|Overall Study|Reason not Specified|0|||
162809907|NCT02457559|588014631|FG008|Overall Study|Reason not Specified|0|||
162809908|NCT02457559|588014632|FG009|Overall Study|Reason not Specified|2|||
162809909|NCT02457559|588014633|FG010|Overall Study|Reason not Specified|0|||
162809910|NCT02457559|588014623|FG000|Overall Study|Death|0|||
162925446|NCT01071083|588428989|FG003|Overall Study|Adverse Event|0|||
162809911|NCT02457559|588014624|FG001|Overall Study|Death|0|||
162809912|NCT02457559|588014625|FG002|Overall Study|Death|0|||
162809913|NCT02457559|588014626|FG003|Overall Study|Death|0|||
162809914|NCT02457559|588014627|FG004|Overall Study|Death|0|||
162809915|NCT02457559|588014628|FG005|Overall Study|Death|0|||
162809916|NCT02457559|588014629|FG006|Overall Study|Death|0|||
162809917|NCT02457559|588014630|FG007|Overall Study|Death|0|||
162809918|NCT02457559|588014631|FG008|Overall Study|Death|1|||
162809919|NCT02457559|588014632|FG009|Overall Study|Death|1|||
162809920|NCT02457559|588014633|FG010|Overall Study|Death|0|||
162809921|NCT02374671|588014634|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
162809922|NCT02374671|588014635|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
162809923|NCT02374671|588014636|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
162809924|NCT02374671|588014634|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
162809925|NCT02374671|588014635|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
162809926|NCT02374671|588014636|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
162809927|NCT02374671|588014634|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
162809928|NCT02374671|588014635|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
162809929|NCT02374671|588014636|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
162809930|NCT02374671|588014634|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
162809931|NCT02374671|588014635|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
162809932|NCT02374671|588014636|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
162809933|NCT02374671|588014634|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
162809934|NCT02374671|588014635|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
162809935|NCT02374671|588014636|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
162809936|NCT03169101|588014640|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
162809937|NCT03169101|588014641|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
162809938|NCT03169101|588014642|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
162809939|NCT03169101|588014643|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
162925447|NCT01071083|588428990|FG004|Overall Study|Adverse Event|1|||
162925448|NCT01071083|588428986|FG000|Overall Study|Withdrawal by Subject|3|||
162925449|NCT01071083|588428987|FG001|Overall Study|Withdrawal by Subject|0|||
162925450|NCT01071083|588428988|FG002|Overall Study|Withdrawal by Subject|2|||
162925451|NCT01071083|588428989|FG003|Overall Study|Withdrawal by Subject|0|||
162925452|NCT01071083|588428990|FG004|Overall Study|Withdrawal by Subject|3|||
162925453|NCT01071083|588428986|FG000|Overall Study|Physician Decision|1|||
162925454|NCT01071083|588428987|FG001|Overall Study|Physician Decision|0|||
162925455|NCT01071083|588428988|FG002|Overall Study|Physician Decision|0|||
162925456|NCT01071083|588428989|FG003|Overall Study|Physician Decision|1|||
162925457|NCT01071083|588428990|FG004|Overall Study|Physician Decision|1|||
162925458|NCT01071083|588428986|FG000|Overall Study|Early Rescue|1|||
162925459|NCT01071083|588428987|FG001|Overall Study|Early Rescue|0|||
162925460|NCT01071083|588428988|FG002|Overall Study|Early Rescue|0|||
162809940|NCT02641496|588014644|FG000|Overall Study|Lost to Follow-up|13|||
162809941|NCT02641496|588014645|FG001|Overall Study|Lost to Follow-up|12|||
162809942|NCT02641496|588014644|FG000|Overall Study|Withdrawal by Subject|1|||
162809943|NCT02641496|588014645|FG001|Overall Study|Withdrawal by Subject|0|||
162809944|NCT05590884|588014648|FG000|Overall Study|Withdrawal by Subject|1|||
162809945|NCT05590884|588014649|FG001|Overall Study|Withdrawal by Subject|0|||
162809946|NCT05590884|588014650|FG002|Overall Study|Withdrawal by Subject|0|||
162809947|NCT04134845|588014660|FG000|Overall Study|withdrawl by PI|12|||
162809948|NCT04134845|588014661|FG001|Overall Study|withdrawl by PI|5|||
162809949|NCT01912456|588016052|FG000|Period 1|Physician Decision|0|||
162809950|NCT01912456|588016053|FG001|Period 1|Physician Decision|0|||
162809951|NCT01912456|588016054|FG002|Period 1|Physician Decision|1|||
162809952|NCT01912456|588016055|FG003|Period 1|Physician Decision|0|||
162809953|NCT01912456|588016052|FG000|Period 1|non-compliance|1|||
162809954|NCT01912456|588016053|FG001|Period 1|non-compliance|0|||
162809955|NCT01912456|588016054|FG002|Period 1|non-compliance|0|||
162809956|NCT01912456|588016055|FG003|Period 1|non-compliance|1|||
162809957|NCT01912456|588016052|FG000|Period 1|Adverse Event|1|||
162809958|NCT01912456|588016053|FG001|Period 1|Adverse Event|0|||
162809959|NCT01912456|588016054|FG002|Period 1|Adverse Event|0|||
162809960|NCT01912456|588016055|FG003|Period 1|Adverse Event|1|||
162809961|NCT01912456|588016052|FG000|Period 1|Withdrawal by Subject|0|||
162809962|NCT01912456|588016053|FG001|Period 1|Withdrawal by Subject|1|||
162809963|NCT01912456|588016054|FG002|Period 1|Withdrawal by Subject|1|||
162809964|NCT01912456|588016055|FG003|Period 1|Withdrawal by Subject|1|||
162809965|NCT01912456|588016052|FG000|Period 2|Lack of Efficacy|0|||
162809966|NCT01912456|588016053|FG001|Period 2|Lack of Efficacy|2|||
162809967|NCT01912456|588016054|FG002|Period 2|Lack of Efficacy|0|||
162809968|NCT01912456|588016055|FG003|Period 2|Lack of Efficacy|0|||
162809969|NCT01912456|588016052|FG000|Period 2|Adverse Event|0|||
162809970|NCT01912456|588016053|FG001|Period 2|Adverse Event|0|||
162809971|NCT01912456|588016054|FG002|Period 2|Adverse Event|0|||
162809972|NCT01912456|588016055|FG003|Period 2|Adverse Event|1|||
162809973|NCT01340196|588016056|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
162809974|NCT00171704|588016062|FG000|Overall Study|Adverse Event|24|||
162809975|NCT00171704|588016063|FG001|Overall Study|Adverse Event|33|||
162809976|NCT00171704|588016062|FG000|Overall Study|Disease Progression|14|||
162809977|NCT00171704|588016063|FG001|Overall Study|Disease Progression|9|||
162809978|NCT00171704|588016062|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
162809979|NCT00171704|588016063|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
162809980|NCT00171704|588016062|FG000|Overall Study|Administrative Problems|2|||
162809981|NCT00171704|588016063|FG001|Overall Study|Administrative Problems|1|||
162809982|NCT00171704|588016062|FG000|Overall Study|Death|2|||
162809983|NCT00171704|588016063|FG001|Overall Study|Death|2|||
162809984|NCT00171704|588016062|FG000|Overall Study|Withdrawal by Subject|1|||
162809985|NCT00171704|588016063|FG001|Overall Study|Withdrawal by Subject|3|||
162809986|NCT00171704|588016062|FG000|Overall Study|Protocol Violation|0|||
162809987|NCT00171704|588016063|FG001|Overall Study|Protocol Violation|1|||
162809988|NCT00320541|588016065|FG000|Overall Study|Adverse Event|21|||
162809989|NCT00320541|588016066|FG001|Overall Study|Adverse Event|19|||
162809990|NCT00320541|588016065|FG000|Overall Study|Protocol Violation|0|||
162809991|NCT00320541|588016066|FG001|Overall Study|Protocol Violation|1|||
162809992|NCT00320541|588016065|FG000|Overall Study|Withdrawal by Subject|12|||
162809993|NCT00320541|588016066|FG001|Overall Study|Withdrawal by Subject|16|||
162809994|NCT00320541|588016065|FG000|Overall Study|Physician Decision|9|||
162809995|NCT00320541|588016066|FG001|Overall Study|Physician Decision|13|||
162809996|NCT00320541|588016065|FG000|Overall Study|Other|3|||
162809997|NCT00320541|588016066|FG001|Overall Study|Other|4|||
162809998|NCT00320541|588016065|FG000|Overall Study|Sponsor Decision|2|||
162809999|NCT00320541|588016066|FG001|Overall Study|Sponsor Decision|1|||
162810000|NCT00320541|588016065|FG000|Overall Study|Death due to Study Disease|1|||
162810001|NCT00320541|588016066|FG001|Overall Study|Death due to Study Disease|3|||
162925461|NCT01071083|588428989|FG003|Overall Study|Early Rescue|0|||
162925462|NCT01071083|588428990|FG004|Overall Study|Early Rescue|1|||
162925463|NCT01071083|588428986|FG000|Overall Study|Subject Moved|0|||
162810002|NCT00320541|588016065|FG000|Overall Study|Death due to Adverse Event(s)|1|||
162810003|NCT00320541|588016066|FG001|Overall Study|Death due to Adverse Event(s)|0|||
162810004|NCT00320541|588016065|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
162810005|NCT00320541|588016066|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
162810006|NCT04335812|588016069|FG000|Overall Study|Withdrawal by Subject|1|||
162810007|NCT04335812|588016070|FG001|Overall Study|Withdrawal by Subject|3|||
162810008|NCT04335812|588016069|FG000|Overall Study|Lost to Follow-up|12|||
162810009|NCT04335812|588016070|FG001|Overall Study|Lost to Follow-up|12|||
162810010|NCT04335812|588016069|FG000|Overall Study|Did not engage in the intervention|22|||
162810011|NCT04335812|588016070|FG001|Overall Study|Did not engage in the intervention|18|||
162810012|NCT05062759|588016074|FG000|Overall Study|Death|0|||
162810013|NCT05062759|588016075|FG001|Overall Study|Death|1|||
162810014|NCT05062759|588016074|FG000|Overall Study|Lost to Follow-up|1|||
162810015|NCT05062759|588016075|FG001|Overall Study|Lost to Follow-up|0|||
162810016|NCT00655486|588016076|FG000|Overall Study|Adverse Event|10|||
162810017|NCT00655486|588016076|FG000|Overall Study|Lack of Efficacy|8|||
162810018|NCT00655486|588016076|FG000|Overall Study|Withdrawal by Subject|4|||
162810019|NCT00655486|588016076|FG000|Overall Study|Protocol Violation|1|||
162810020|NCT00655486|588016076|FG000|Overall Study|Unsatisfactory compliance|2|||
162810021|NCT00655486|588016076|FG000|Overall Study|Other: Pregnancy|1|||
162810022|NCT00655486|588016076|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
162810023|NCT00655486|588016076|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
162810024|NCT00310037|588016077|FG000|Overall Study|Adverse Event|7|||
162810025|NCT00310037|588016078|FG001|Overall Study|Adverse Event|14|||
162810026|NCT00310037|588016077|FG000|Overall Study|Withdrawal by Subject|4|||
162810027|NCT00310037|588016078|FG001|Overall Study|Withdrawal by Subject|3|||
162810028|NCT00310037|588016077|FG000|Overall Study|Progression|6|||
162810029|NCT00310037|588016078|FG001|Overall Study|Progression|0|||
162810030|NCT00310037|588016077|FG000|Overall Study|Non-protocol treatment|1|||
162810031|NCT00310037|588016078|FG001|Overall Study|Non-protocol treatment|0|||
162810032|NCT00842985|588016079|FG000|Screening|Did not meet entrance requirements|27|||
162810033|NCT00842985|588016079|FG000|First Intervention|Withdrawal by Subject|3|||
162810034|NCT00842985|588016079|FG000|First Intervention|Protocol Violation|3|||
162810035|NCT00842985|588016079|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
162925464|NCT01071083|588428987|FG001|Overall Study|Subject Moved|1|||
162925465|NCT01071083|588428988|FG002|Overall Study|Subject Moved|0|||
162925466|NCT01071083|588428989|FG003|Overall Study|Subject Moved|0|||
162925467|NCT01071083|588428990|FG004|Overall Study|Subject Moved|0|||
162925468|NCT01071083|588428986|FG000|Overall Study|Images Not Usable (Motion)|0|||
162925469|NCT01071083|588428987|FG001|Overall Study|Images Not Usable (Motion)|1|||
162925470|NCT01071083|588428988|FG002|Overall Study|Images Not Usable (Motion)|0|||
162925471|NCT01071083|588428989|FG003|Overall Study|Images Not Usable (Motion)|0|||
162925472|NCT01071083|588428990|FG004|Overall Study|Images Not Usable (Motion)|0|||
162810036|NCT00842985|588016079|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
162810037|NCT01122862|588016080|FG000|Period 1|Protocol Violation|0|||
162810038|NCT01122862|588016081|FG001|Period 1|Protocol Violation|1|||
162810039|NCT01122862|588016082|FG002|Period 1|Protocol Violation|0|||
162810040|NCT01122862|588016080|FG000|Period 2|Adverse Event|0|||
162810041|NCT01122862|588016081|FG001|Period 2|Adverse Event|0|||
162810042|NCT01122862|588016082|FG002|Period 2|Adverse Event|1|||
162810043|NCT00966277|588016085|FG000|Overall Study|Withdrawal by Subject|3|||
162810044|NCT00966277|588016086|FG001|Overall Study|Withdrawal by Subject|0|||
162810045|NCT00966277|588016085|FG000|Overall Study|Ineligible|1|||
162810046|NCT00966277|588016086|FG001|Overall Study|Ineligible|3|||
162810047|NCT00966277|588016085|FG000|Overall Study|Treatment Plan Changed|0|||
162810048|NCT00966277|588016086|FG001|Overall Study|Treatment Plan Changed|1|||
162810049|NCT01249274|588016087|FG000|Overall Study|Lost to Follow-up|3|||
162810050|NCT01249274|588016088|FG001|Overall Study|Lost to Follow-up|4|||
162810051|NCT01249274|588016087|FG000|Overall Study|Received inpatient substance treatment|1|||
162810052|NCT01249274|588016088|FG001|Overall Study|Received inpatient substance treatment|2|||
162810053|NCT01498653|588016089|FG000|Overall Study|Adverse Event|2|||
162810054|NCT01498653|588016090|FG001|Overall Study|Adverse Event|2|||
162810055|NCT01498653|588016089|FG000|Overall Study|Lack of Efficacy|12|||
162810056|NCT01498653|588016090|FG001|Overall Study|Lack of Efficacy|26|||
162810057|NCT01498653|588016089|FG000|Overall Study|Protocol Violation|0|||
162810058|NCT01498653|588016090|FG001|Overall Study|Protocol Violation|4|||
162810059|NCT01498653|588016089|FG000|Overall Study|Lost to Follow-up|1|||
162810060|NCT01498653|588016090|FG001|Overall Study|Lost to Follow-up|0|||
162810061|NCT01498653|588016089|FG000|Overall Study|Physician Decision|2|||
162810062|NCT01498653|588016090|FG001|Overall Study|Physician Decision|0|||
162810063|NCT01498653|588016089|FG000|Overall Study|Withdrawal by Subject|2|||
162810064|NCT01498653|588016090|FG001|Overall Study|Withdrawal by Subject|3|||
162810065|NCT02070588|588016096|FG000|Overall Study|Withdrawal by Subject|29|||
162810066|NCT02070588|588016097|FG001|Overall Study|Withdrawal by Subject|1|||
162810067|NCT02070588|588016098|FG002|Overall Study|Withdrawal by Subject|0|||
162810068|NCT02070588|588016096|FG000|Overall Study|Writhdrawal due to early termination|9|||
162925473|NCT01071083|588428986|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162810069|NCT02070588|588016097|FG001|Overall Study|Writhdrawal due to early termination|0|||
162810070|NCT02070588|588016098|FG002|Overall Study|Writhdrawal due to early termination|0|||
162810071|NCT02070588|588016096|FG000|Overall Study|Adverse Event|1|||
162810072|NCT02070588|588016097|FG001|Overall Study|Adverse Event|0|||
162810073|NCT02070588|588016098|FG002|Overall Study|Adverse Event|0|||
162810074|NCT03421431|588016099|FG000|Overall Study|Adverse Event|2|||
162810075|NCT03421431|588016100|FG001|Overall Study|Adverse Event|1|||
162810076|NCT03421431|588016101|FG002|Overall Study|Adverse Event|12|||
162810077|NCT03421431|588016099|FG000|Overall Study|Lost to Follow-up|1|||
162810078|NCT03421431|588016100|FG001|Overall Study|Lost to Follow-up|1|||
162810079|NCT03421431|588016101|FG002|Overall Study|Lost to Follow-up|1|||
162810080|NCT03421431|588016099|FG000|Overall Study|Withdrawal by Subject|3|||
162810081|NCT03421431|588016100|FG001|Overall Study|Withdrawal by Subject|2|||
162810082|NCT03421431|588016101|FG002|Overall Study|Withdrawal by Subject|1|||
162810083|NCT03421431|588016099|FG000|Overall Study|Protocol Violation|0|||
162810084|NCT03421431|588016100|FG001|Overall Study|Protocol Violation|1|||
162810085|NCT03421431|588016101|FG002|Overall Study|Protocol Violation|0|||
162810086|NCT03421431|588016099|FG000|Overall Study|Participant met Stopping Rules|0|||
162810087|NCT03421431|588016100|FG001|Overall Study|Participant met Stopping Rules|1|||
162810088|NCT03421431|588016101|FG002|Overall Study|Participant met Stopping Rules|0|||
162810089|NCT00141726|588016102|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
162810090|NCT00235326|588016111|FG000|Overall Study|Lost to Follow-up|746|||
162810091|NCT00235326|588016112|FG001|Overall Study|Lost to Follow-up|1400|||
162810092|NCT01477333|588016114|FG000|Overall Study|Adverse Event|1|||
162810093|NCT01477333|588016114|FG000|Overall Study|Withdrawal by Subject|1|||
162810094|NCT01477333|588016114|FG000|Overall Study|Clinical Deterioration|1|||
162810095|NCT01178671|588016115|FG000|Overall Study|Adverse Event|4|||
162810096|NCT01178671|588016116|FG001|Overall Study|Adverse Event|6|||
162810097|NCT01178671|588016115|FG000|Overall Study|Protocol Violation|1|||
162810098|NCT01178671|588016116|FG001|Overall Study|Protocol Violation|1|||
162810099|NCT01178671|588016115|FG000|Overall Study|Lack of Efficacy|0|||
162810100|NCT01178671|588016116|FG001|Overall Study|Lack of Efficacy|1|||
162810101|NCT01178671|588016115|FG000|Overall Study|Lost to Follow-up|3|||
162810102|NCT01178671|588016116|FG001|Overall Study|Lost to Follow-up|1|||
162810103|NCT01178671|588016115|FG000|Overall Study|Physician Decision|4|||
162810104|NCT01178671|588016116|FG001|Overall Study|Physician Decision|6|||
162810105|NCT04620811|588016117|FG000|Overall Study|Withdrawal by Subject|18|||
162810106|NCT04620811|588016118|FG001|Overall Study|Withdrawal by Subject|15|||
162810107|NCT04620811|588016117|FG000|Overall Study|Adverse Event|6|||
162810108|NCT04620811|588016118|FG001|Overall Study|Adverse Event|11|||
162810109|NCT04620811|588016117|FG000|Overall Study|Lost to Follow-up|4|||
162810110|NCT04620811|588016118|FG001|Overall Study|Lost to Follow-up|8|||
162810111|NCT04620811|588016117|FG000|Overall Study|Physician Decision|1|||
162810112|NCT04620811|588016118|FG001|Overall Study|Physician Decision|4|||
162810113|NCT04620811|588016117|FG000|Overall Study|Sponsor Decision|0|||
162810114|NCT04620811|588016118|FG001|Overall Study|Sponsor Decision|1|||
162810115|NCT04620811|588016117|FG000|Overall Study|Elevation of ALT or AST|1|||
162810116|NCT04620811|588016118|FG001|Overall Study|Elevation of ALT or AST|0|||
162810117|NCT04620811|588016117|FG000|Overall Study|Other|3|||
162810118|NCT04620811|588016118|FG001|Overall Study|Other|5|||
162810119|NCT01078675|588016119|FG000|Overall Study|Withdrawal by Subject|7|||
162810120|NCT01078675|588016120|FG001|Overall Study|Withdrawal by Subject|3|||
162810121|NCT01078675|588016119|FG000|Overall Study|Protocol Violation|56|||
162810122|NCT01078675|588016120|FG001|Overall Study|Protocol Violation|0|||
162810123|NCT01078675|588016119|FG000|Overall Study|Provided in CRF for specific reasons|2|||
162810124|NCT01078675|588016120|FG001|Overall Study|Provided in CRF for specific reasons|3|||
162810125|NCT01078675|588016119|FG000|Overall Study|Adverse Event|3|||
162810126|NCT01078675|588016120|FG001|Overall Study|Adverse Event|0|||
162810127|NCT02513303|588016121|FG000|Overall Study|Withdrawal by Subject|9|||
162810128|NCT02513303|588016122|FG001|Overall Study|Withdrawal by Subject|7|||
162810129|NCT02513303|588016123|FG002|Overall Study|Withdrawal by Subject|2|||
162810130|NCT02513303|588016121|FG000|Overall Study|Lost to Follow-up|2|||
162810131|NCT02513303|588016122|FG001|Overall Study|Lost to Follow-up|4|||
162810132|NCT02513303|588016123|FG002|Overall Study|Lost to Follow-up|0|||
162810133|NCT02513303|588016121|FG000|Overall Study|Adverse Event|0|||
162810134|NCT02513303|588016122|FG001|Overall Study|Adverse Event|1|||
162810135|NCT02513303|588016123|FG002|Overall Study|Adverse Event|0|||
162810136|NCT02513303|588016121|FG000|Overall Study|Physician Decision|1|||
162810137|NCT02513303|588016122|FG001|Overall Study|Physician Decision|1|||
162810138|NCT02513303|588016123|FG002|Overall Study|Physician Decision|0|||
162810139|NCT02513303|588016121|FG000|Overall Study|Death|8|||
162810140|NCT02513303|588016122|FG001|Overall Study|Death|4|||
162810141|NCT02513303|588016123|FG002|Overall Study|Death|2|||
162810142|NCT00679627|588016124|FG000|Overall Study|Death|41|||
162810143|NCT00679627|588016125|FG001|Overall Study|Death|29|||
162810144|NCT00679627|588016124|FG000|Overall Study|Adverse Event|43|||
162810145|NCT00679627|588016125|FG001|Overall Study|Adverse Event|53|||
162810146|NCT00679627|588016124|FG000|Overall Study|Withdrawal by Subject|168|||
162810147|NCT00679627|588016125|FG001|Overall Study|Withdrawal by Subject|172|||
162810148|NCT00679627|588016124|FG000|Overall Study|Lost to Follow-up|22|||
162810149|NCT00679627|588016125|FG001|Overall Study|Lost to Follow-up|26|||
162810150|NCT00679627|588016124|FG000|Overall Study|Early Study Closure|425|||
162810151|NCT00679627|588016125|FG001|Overall Study|Early Study Closure|405|||
162810152|NCT03513588|588016127|FG000|Overall Study|Lost to Follow-up|0|||
162810153|NCT03513588|588016128|FG001|Overall Study|Lost to Follow-up|1|||
162810154|NCT03513588|588016129|FG002|Overall Study|Lost to Follow-up|1|||
162810155|NCT03513588|588016127|FG000|Overall Study|Study dosing paused by sponsor|1|||
162810156|NCT03513588|588016128|FG001|Overall Study|Study dosing paused by sponsor|1|||
162810157|NCT03513588|588016129|FG002|Overall Study|Study dosing paused by sponsor|0|||
162810158|NCT03513588|588016127|FG000|Overall Study|Death|0|||
162810159|NCT03513588|588016128|FG001|Overall Study|Death|0|||
162810160|NCT03513588|588016129|FG002|Overall Study|Death|1|||
162810161|NCT01275131|588016130|FG000|Period 1|Withdrawal by Subject|1|||
162810162|NCT01275131|588016131|FG001|Period 1|Withdrawal by Subject|0|||
162810163|NCT01275131|588016132|FG002|Period 1|Withdrawal by Subject|3|||
162810164|NCT01275131|588016133|FG003|Period 1|Withdrawal by Subject|2|||
162810165|NCT01275131|588016130|FG000|Period 1|Physician Decision|1|||
162810166|NCT01275131|588016131|FG001|Period 1|Physician Decision|0|||
162810167|NCT01275131|588016132|FG002|Period 1|Physician Decision|0|||
162810168|NCT01275131|588016133|FG003|Period 1|Physician Decision|0|||
162810169|NCT01275131|588016130|FG000|Period 2 (Crossover)|Adverse Event|0|||
162810170|NCT01275131|588016131|FG001|Period 2 (Crossover)|Adverse Event|1|||
162810171|NCT01275131|588016132|FG002|Period 2 (Crossover)|Adverse Event|0|||
162810172|NCT01275131|588016133|FG003|Period 2 (Crossover)|Adverse Event|0|||
162810173|NCT01275131|588016130|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
162810174|NCT01275131|588016131|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
162810175|NCT01275131|588016132|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
162810176|NCT01275131|588016133|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
162810177|NCT00490724|588016135|FG000|Period I|Physician Decision|0|||
162810178|NCT00490724|588016136|FG001|Period I|Physician Decision|0|||
162810179|NCT00490724|588016137|FG002|Period I|Physician Decision|1|||
162810180|NCT00490724|588016135|FG000|Period II|Treatment Discontinuation|3|||
162810181|NCT00490724|588016136|FG001|Period II|Treatment Discontinuation|1|||
162810182|NCT00490724|588016137|FG002|Period II|Treatment Discontinuation|3|||
162810183|NCT00903682|588016139|FG000|Overall Study|Adverse Event|6|||
162810184|NCT00903682|588016140|FG001|Overall Study|Adverse Event|13|||
162810185|NCT00903682|588016139|FG000|Overall Study|Lost to Follow-up|1|||
162810186|NCT00903682|588016140|FG001|Overall Study|Lost to Follow-up|0|||
162810187|NCT00903682|588016139|FG000|Overall Study|Withdrawal by Subject|5|||
162810188|NCT00903682|588016140|FG001|Overall Study|Withdrawal by Subject|0|||
162810189|NCT00903682|588016139|FG000|Overall Study|Pregnancy|0|||
162810190|NCT00903682|588016140|FG001|Overall Study|Pregnancy|1|||
162810191|NCT00903682|588016139|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
162810192|NCT00903682|588016140|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
162810193|NCT00903682|588016139|FG000|Overall Study|Subject Non-Compliant|1|||
162810194|NCT00903682|588016140|FG001|Overall Study|Subject Non-Compliant|0|||
162810195|NCT00903682|588016139|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
162810196|NCT00903682|588016140|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
162810197|NCT00903682|588016139|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
162810198|NCT00903682|588016140|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
162810199|NCT03110185|588016141|FG000|Overall Study|Death|0|||
162810200|NCT03110185|588016142|FG001|Overall Study|Death|1|||
162810201|NCT03110185|588016141|FG000|Overall Study|Withdrawal by Subject|2|||
162810202|NCT03110185|588016142|FG001|Overall Study|Withdrawal by Subject|7|||
162810203|NCT03110185|588016141|FG000|Overall Study|Time Constraints|0|||
162810204|NCT03110185|588016142|FG001|Overall Study|Time Constraints|6|||
162810205|NCT03110185|588016141|FG000|Overall Study|Conflict with care|5|||
162810206|NCT03110185|588016142|FG001|Overall Study|Conflict with care|12|||
162810207|NCT03110185|588016141|FG000|Overall Study|Protocol Violation|1|||
162810208|NCT03110185|588016142|FG001|Overall Study|Protocol Violation|4|||
162810209|NCT03110185|588016141|FG000|Overall Study|MRI Incompatible|2|||
162810210|NCT03110185|588016142|FG001|Overall Study|MRI Incompatible|0|||
162810211|NCT03110185|588016141|FG000|Overall Study|Patient Refusal|0|||
162810212|NCT03110185|588016142|FG001|Overall Study|Patient Refusal|1|||
162810213|NCT02053792|588016143|FG000|Overall Study|Physician Decision|0|||
162810214|NCT02053792|588016144|FG001|Overall Study|Physician Decision|1|||
162810215|NCT02053792|588016143|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
162810216|NCT02053792|588016144|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
162810217|NCT02053792|588016143|FG000|Overall Study|Lack of Efficacy|1|||
162810218|NCT02053792|588016144|FG001|Overall Study|Lack of Efficacy|0|||
162810219|NCT02053792|588016143|FG000|Overall Study|Adverse Event|1|||
162810220|NCT02053792|588016144|FG001|Overall Study|Adverse Event|0|||
162810221|NCT02053792|588016143|FG000|Overall Study|Withdrawal by Subject|2|||
162810222|NCT02053792|588016144|FG001|Overall Study|Withdrawal by Subject|2|||
162810223|NCT02053792|588016143|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
162810224|NCT02053792|588016144|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
162810225|NCT02053792|588016143|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
162810226|NCT02053792|588016144|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
162810227|NCT01427751|588016145|FG000|Overall Study|Adverse Event|18|||
162810228|NCT01427751|588016146|FG001|Overall Study|Adverse Event|2|||
162810229|NCT01427751|588016145|FG000|Overall Study|No further treatment benefit expected|5|||
162810230|NCT01427751|588016146|FG001|Overall Study|No further treatment benefit expected|1|||
162810231|NCT01427751|588016145|FG000|Overall Study|Lost to Follow-up|3|||
162810232|NCT01427751|588016146|FG001|Overall Study|Lost to Follow-up|1|||
162810233|NCT01427751|588016145|FG000|Overall Study|Withdrawal of consent|2|||
162810234|NCT01427751|588016146|FG001|Overall Study|Withdrawal of consent|2|||
162810235|NCT01427751|588016145|FG000|Overall Study|Protocol Violation|6|||
162810236|NCT01427751|588016146|FG001|Overall Study|Protocol Violation|4|||
162810237|NCT01427751|588016145|FG000|Overall Study|Death|2|||
162810238|NCT01427751|588016146|FG001|Overall Study|Death|0|||
162810239|NCT01427751|588016145|FG000|Overall Study|Other miscellaneous reasons|6|||
162810240|NCT01427751|588016146|FG001|Overall Study|Other miscellaneous reasons|4|||
162810241|NCT01028027|588016147|FG000|Overall Study|Lost to Follow-up|4|||
162810242|NCT01028027|588016148|FG001|Overall Study|Lost to Follow-up|1|||
162810243|NCT01028027|588016147|FG000|Overall Study|Withdrawal by Subject|5|||
162810244|NCT01028027|588016148|FG001|Overall Study|Withdrawal by Subject|3|||
162810245|NCT01028027|588016147|FG000|Overall Study|Adverse Event|4|||
162810246|NCT01028027|588016148|FG001|Overall Study|Adverse Event|7|||
162810247|NCT01028027|588016147|FG000|Overall Study|Protocol Violation|3|||
162810248|NCT01028027|588016148|FG001|Overall Study|Protocol Violation|1|||
162810249|NCT01028027|588016147|FG000|Overall Study|Lack of Efficacy|0|||
162810250|NCT01028027|588016148|FG001|Overall Study|Lack of Efficacy|1|||
162810251|NCT00368992|588016153|FG000|Overall Study|Ineligible|5|||
162810252|NCT00368992|588016153|FG000|Overall Study|Refused treatment|3|||
162810253|NCT00368992|588016153|FG000|Overall Study|Lack of Efficacy|63|||
162810254|NCT00368992|588016153|FG000|Overall Study|Adverse Event|26|||
162810255|NCT00368992|588016153|FG000|Overall Study|Death|4|||
162810256|NCT00368992|588016153|FG000|Overall Study|Other|9|||
162810257|NCT00790751|588016154|FG000|Overall Study|Protocol non-compliance|16|||
162810258|NCT00790751|588016155|FG001|Overall Study|Protocol non-compliance|16|||
162810259|NCT00790751|588016156|FG002|Overall Study|Protocol non-compliance|10|||
162925474|NCT01071083|588428987|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162925475|NCT01071083|588428988|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925476|NCT01071083|588428989|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925477|NCT01071083|588428990|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
162925478|NCT01071083|588428986|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925479|NCT01071083|588428987|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925480|NCT01071083|588428988|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
162925481|NCT01071083|588428989|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
162925482|NCT01071083|588428990|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
162925483|NCT01071083|588428986|FG000|Overall Study|Subject Refused to Continue|1|||
162925484|NCT01071083|588428987|FG001|Overall Study|Subject Refused to Continue|0|||
162925485|NCT01071083|588428988|FG002|Overall Study|Subject Refused to Continue|0|||
162925486|NCT01071083|588428989|FG003|Overall Study|Subject Refused to Continue|0|||
162925487|NCT01071083|588428990|FG004|Overall Study|Subject Refused to Continue|0|||
162925488|NCT00038467|588428991|FG000|Overall Study|Adverse Event|170|||
162925489|NCT00038467|588428992|FG001|Overall Study|Adverse Event|145|||
162925490|NCT00038467|588428991|FG000|Overall Study|Withdrawal by Subject|150|||
162925491|NCT00038467|588428992|FG001|Overall Study|Withdrawal by Subject|107|||
162925492|NCT00038467|588428991|FG000|Overall Study|Protocol Violation|19|||
162925493|NCT00038467|588428992|FG001|Overall Study|Protocol Violation|22|||
162925494|NCT00038467|588428991|FG000|Overall Study|Death|22|||
162925495|NCT00038467|588428992|FG001|Overall Study|Death|16|||
162925496|NCT00038467|588428991|FG000|Overall Study|Lost to Follow-up|15|||
162925497|NCT00038467|588428992|FG001|Overall Study|Lost to Follow-up|10|||
162925498|NCT00038467|588428991|FG000|Overall Study|Recurrence|109|||
162925499|NCT00038467|588428992|FG001|Overall Study|Recurrence|179|||
162925500|NCT00038467|588428991|FG000|Overall Study|Randomized, but not treated|31|||
162925501|NCT00038467|588428992|FG001|Overall Study|Randomized, but not treated|35|||
162925502|NCT00038467|588428991|FG000|Overall Study|Other|26|||
162925503|NCT00038467|588428992|FG001|Overall Study|Other|28|||
162925504|NCT03972709|588428993|FG000|Overall Study|Withdrawal by Subject|18|||
162925505|NCT03972709|588428994|FG001|Overall Study|Withdrawal by Subject|7|||
162925506|NCT03972709|588428995|FG002|Overall Study|Withdrawal by Subject|14|||
162925507|NCT03972709|588428993|FG000|Overall Study|Study Terminated by Sponsor|48|||
162925508|NCT03972709|588428994|FG001|Overall Study|Study Terminated by Sponsor|25|||
162810260|NCT00790751|588016157|FG003|Overall Study|Protocol non-compliance|11|||
162810261|NCT00790751|588016154|FG000|Overall Study|Lost to Follow-up|4|||
162810262|NCT00790751|588016155|FG001|Overall Study|Lost to Follow-up|9|||
162810263|NCT00790751|588016156|FG002|Overall Study|Lost to Follow-up|4|||
162810264|NCT00790751|588016157|FG003|Overall Study|Lost to Follow-up|5|||
162810265|NCT00790751|588016154|FG000|Overall Study|Adverse Event|5|||
162925509|NCT03972709|588428995|FG002|Overall Study|Study Terminated by Sponsor|50|||
162925510|NCT03972709|588428993|FG000|Overall Study|Physician Decision|1|||
162925511|NCT03972709|588428994|FG001|Overall Study|Physician Decision|0|||
162810266|NCT00790751|588016155|FG001|Overall Study|Adverse Event|3|||
162810267|NCT00790751|588016156|FG002|Overall Study|Adverse Event|5|||
162810268|NCT00790751|588016157|FG003|Overall Study|Adverse Event|4|||
162810269|NCT00790751|588016154|FG000|Overall Study|Requirement for restricted medication|0|||
162810270|NCT00790751|588016155|FG001|Overall Study|Requirement for restricted medication|2|||
162810271|NCT00790751|588016156|FG002|Overall Study|Requirement for restricted medication|0|||
162810272|NCT00790751|588016157|FG003|Overall Study|Requirement for restricted medication|0|||
162810273|NCT00790751|588016154|FG000|Overall Study|Death|0|||
162810274|NCT00790751|588016155|FG001|Overall Study|Death|0|||
162810275|NCT00790751|588016156|FG002|Overall Study|Death|1|||
162810276|NCT00790751|588016157|FG003|Overall Study|Death|0|||
162810277|NCT00790751|588016154|FG000|Overall Study|Physician Decision|0|||
162810278|NCT00790751|588016155|FG001|Overall Study|Physician Decision|0|||
162810279|NCT00790751|588016156|FG002|Overall Study|Physician Decision|0|||
162810280|NCT00790751|588016157|FG003|Overall Study|Physician Decision|1|||
162810281|NCT01078454|588016163|FG000|Overall Study|Adverse Event|1|||
162810282|NCT01078454|588016164|FG001|Overall Study|Adverse Event|1|||
162810283|NCT01078454|588016163|FG000|Overall Study|Death|0|||
162810284|NCT01078454|588016164|FG001|Overall Study|Death|1|||
162810285|NCT04737187|588016165|FG000|Overall Study|Switched to marketed drug|32|||
162810286|NCT04737187|588016166|FG001|Overall Study|Switched to marketed drug|4|||
162810287|NCT04737187|588016165|FG000|Overall Study|Radiological Progressive Disease|145|||
162810288|NCT04737187|588016166|FG001|Overall Study|Radiological Progressive Disease|146|||
162810289|NCT04737187|588016165|FG000|Overall Study|Clinical Progressive Disease|20|||
162810290|NCT04737187|588016166|FG001|Overall Study|Clinical Progressive Disease|20|||
162810291|NCT04737187|588016165|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
162810292|NCT04737187|588016166|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
162810293|NCT04737187|588016165|FG000|Overall Study|Adverse Event|16|||
162810294|NCT04737187|588016166|FG001|Overall Study|Adverse Event|16|||
162810295|NCT04737187|588016165|FG000|Overall Study|Physician Decision|2|||
162810296|NCT04737187|588016166|FG001|Overall Study|Physician Decision|0|||
162810297|NCT04737187|588016165|FG000|Overall Study|Withdrawal by Subject|5|||
162925512|NCT03972709|588428995|FG002|Overall Study|Physician Decision|0|||
162925513|NCT03972709|588428993|FG000|Overall Study|COVID-19|0|||
162925514|NCT03972709|588428994|FG001|Overall Study|COVID-19|1|||
162925515|NCT03972709|588428995|FG002|Overall Study|COVID-19|1|||
162925516|NCT03972709|588428993|FG000|Overall Study|Lost to Follow-up|6|||
162925517|NCT03972709|588428994|FG001|Overall Study|Lost to Follow-up|1|||
162925518|NCT03972709|588428995|FG002|Overall Study|Lost to Follow-up|2|||
162925519|NCT03972709|588428993|FG000|Overall Study|Death|5|||
162925520|NCT03972709|588428994|FG001|Overall Study|Death|1|||
162925521|NCT03972709|588428995|FG002|Overall Study|Death|4|||
162925522|NCT03972709|588428993|FG000|Overall Study|Adverse Event|3|||
162925523|NCT03972709|588428994|FG001|Overall Study|Adverse Event|1|||
162925524|NCT03972709|588428995|FG002|Overall Study|Adverse Event|4|||
162925525|NCT03972709|588428993|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
162925526|NCT03972709|588428994|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
162925527|NCT03972709|588428995|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
162810298|NCT04737187|588016166|FG001|Overall Study|Withdrawal by Subject|8|||
162810299|NCT05227703|588016167|FG000|Overall Study|Adverse Event|2|||
162925528|NCT03972709|588428993|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
162925529|NCT03972709|588428994|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
162925530|NCT03972709|588428995|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
162925531|NCT03972709|588428993|FG000|Overall Study|Subject Unable to be Contacted|0|||
162925532|NCT03972709|588428994|FG001|Overall Study|Subject Unable to be Contacted|1|||
162925533|NCT03972709|588428995|FG002|Overall Study|Subject Unable to be Contacted|0|||
162925534|NCT03972709|588428993|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
162925535|NCT03972709|588428994|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
162925536|NCT03972709|588428995|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
162925537|NCT03972709|588428993|FG000|Overall Study|Subject Moved|0|||
162925538|NCT03972709|588428994|FG001|Overall Study|Subject Moved|1|||
162925539|NCT03972709|588428995|FG002|Overall Study|Subject Moved|0|||
162925540|NCT03972709|588428993|FG000|Overall Study|Missed Study Visits|1|||
162925541|NCT03972709|588428994|FG001|Overall Study|Missed Study Visits|0|||
162925542|NCT03972709|588428995|FG002|Overall Study|Missed Study Visits|0|||
162925543|NCT01523301|588428996|FG000|Overall Study|Adverse Event|25|||
162925544|NCT01523301|588428997|FG001|Overall Study|Adverse Event|16|||
162925545|NCT01523301|588428996|FG000|Overall Study|Lack of Efficacy|0|||
162925546|NCT01523301|588428997|FG001|Overall Study|Lack of Efficacy|2|||
162925547|NCT01523301|588428996|FG000|Overall Study|Protocol Violation|3|||
162925548|NCT01523301|588428997|FG001|Overall Study|Protocol Violation|4|||
162925549|NCT01523301|588428996|FG000|Overall Study|Lost to Follow-up|1|||
162925550|NCT01523301|588428997|FG001|Overall Study|Lost to Follow-up|0|||
162925551|NCT01523301|588428996|FG000|Overall Study|Withdrawal by Subject|6|||
162925552|NCT01523301|588428997|FG001|Overall Study|Withdrawal by Subject|8|||
162925553|NCT01523301|588428996|FG000|Overall Study|Other Reason|0|||
162925554|NCT01523301|588428997|FG001|Overall Study|Other Reason|2|||
162925555|NCT01339000|588428998|FG000|Overall Study|study closed due to lack of drug supply|1|||
162925556|NCT01339000|588428999|FG001|Overall Study|study closed due to lack of drug supply|0|||
162925557|NCT00728988|588429000|FG000|Overall Study|Not Treated|2|||
162925558|NCT00728988|588429001|FG001|Overall Study|Not Treated|2|||
162925559|NCT00728988|588429000|FG000|Overall Study|Death|1|||
162925560|NCT00728988|588429001|FG001|Overall Study|Death|1|||
162925561|NCT00728988|588429000|FG000|Overall Study|Adverse Event|3|||
162925562|NCT00728988|588429001|FG001|Overall Study|Adverse Event|2|||
162925563|NCT00728988|588429000|FG000|Overall Study|Other|85|||
162925564|NCT00728988|588429001|FG001|Overall Study|Other|77|||
162925565|NCT00728988|588429000|FG000|Overall Study|Withdrawal by Subject|2|||
162925566|NCT00728988|588429001|FG001|Overall Study|Withdrawal by Subject|6|||
162925567|NCT02017535|588429004|FG000|Overall Study|Withdrawal by Subject|1|||
162925568|NCT02017535|588429005|FG001|Overall Study|Withdrawal by Subject|0|||
162925569|NCT02017535|588429006|FG002|Overall Study|Withdrawal by Subject|0|||
162925570|NCT02017535|588429007|FG003|Overall Study|Withdrawal by Subject|0|||
162925571|NCT05511428|588429008|FG000|Overall Study|Withdrawal by Subject|1|||
162925572|NCT05511428|588429008|FG000|Overall Study|Adverse Event|1|||
162925573|NCT04088734|588429009|FG000|Overall Study|Other, Not Specified|5|||
162925574|NCT00664066|588429014|FG000|Overall Study|Study terminated|3|||
162925575|NCT00481871|588429016|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
162925576|NCT00481871|588429017|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
162925577|NCT00481871|588429018|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
162925578|NCT00481871|588429019|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
162925579|NCT00481871|588429020|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
162925580|NCT01721369|588429026|FG000|Overall Study|Not initial etiological diagnosis|12|||
162810300|NCT05227703|588016168|FG001|Overall Study|Adverse Event|6|||
162810301|NCT05227703|588016169|FG002|Overall Study|Adverse Event|4|||
162810302|NCT05227703|588016167|FG000|Overall Study|Lack of Efficacy|4|||
162810303|NCT05227703|588016168|FG001|Overall Study|Lack of Efficacy|0|||
162810304|NCT05227703|588016169|FG002|Overall Study|Lack of Efficacy|1|||
162810305|NCT05227703|588016167|FG000|Overall Study|Physician Decision|2|||
162810306|NCT05227703|588016168|FG001|Overall Study|Physician Decision|2|||
162810307|NCT05227703|588016169|FG002|Overall Study|Physician Decision|1|||
162810308|NCT05227703|588016167|FG000|Overall Study|Protocol Violation|2|||
162810309|NCT05227703|588016168|FG001|Overall Study|Protocol Violation|1|||
162810310|NCT05227703|588016169|FG002|Overall Study|Protocol Violation|0|||
162810311|NCT05227703|588016167|FG000|Overall Study|Withdrawal by Subject|17|||
162810312|NCT05227703|588016168|FG001|Overall Study|Withdrawal by Subject|26|||
162810313|NCT05227703|588016169|FG002|Overall Study|Withdrawal by Subject|32|||
162810314|NCT05227703|588016167|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
162810315|NCT05227703|588016168|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
162810316|NCT05227703|588016169|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
162810317|NCT05227703|588016167|FG000|Overall Study|Other|1|||
162810318|NCT05227703|588016168|FG001|Overall Study|Other|1|||
162810319|NCT05227703|588016169|FG002|Overall Study|Other|0|||
162810320|NCT03464097|588016176|FG000|Overall Study|Withdrawal by Subject|15|||
162810321|NCT03464097|588016177|FG001|Overall Study|Withdrawal by Subject|13|||
162810322|NCT03464097|588016178|FG002|Overall Study|Withdrawal by Subject|11|||
162810323|NCT03464097|588016176|FG000|Overall Study|Study terminated by sponsor|47|||
162810324|NCT03464097|588016177|FG001|Overall Study|Study terminated by sponsor|44|||
162810325|NCT03464097|588016178|FG002|Overall Study|Study terminated by sponsor|40|||
162810326|NCT03464097|588016176|FG000|Overall Study|Pregnancy|0|||
162810327|NCT03464097|588016177|FG001|Overall Study|Pregnancy|1|||
162810328|NCT03464097|588016178|FG002|Overall Study|Pregnancy|0|||
162810329|NCT03464097|588016176|FG000|Overall Study|Other reasons|5|||
162810330|NCT03464097|588016177|FG001|Overall Study|Other reasons|12|||
162810331|NCT03464097|588016178|FG002|Overall Study|Other reasons|14|||
162810332|NCT03464097|588016176|FG000|Overall Study|Lost to Follow-up|0|||
162810333|NCT03464097|588016177|FG001|Overall Study|Lost to Follow-up|1|||
162810334|NCT03464097|588016178|FG002|Overall Study|Lost to Follow-up|1|||
162810335|NCT03464097|588016176|FG000|Overall Study|Lack of Efficacy|11|||
162810336|NCT03464097|588016177|FG001|Overall Study|Lack of Efficacy|18|||
162810337|NCT03464097|588016178|FG002|Overall Study|Lack of Efficacy|30|||
162810338|NCT03464097|588016176|FG000|Overall Study|Death|1|||
162810339|NCT03464097|588016177|FG001|Overall Study|Death|0|||
162810340|NCT03464097|588016178|FG002|Overall Study|Death|0|||
162810341|NCT03464097|588016176|FG000|Overall Study|Adverse Event|13|||
162810342|NCT03464097|588016177|FG001|Overall Study|Adverse Event|6|||
162810343|NCT03464097|588016178|FG002|Overall Study|Adverse Event|8|||
162810344|NCT03035201|588016179|FG000|Overall Study|Death|9|||
162810345|NCT03035201|588016180|FG001|Overall Study|Death|12|||
162810346|NCT03035201|588016181|FG002|Overall Study|Death|9|||
162810347|NCT03035201|588016182|FG003|Overall Study|Death|10|||
162810348|NCT03035201|588016179|FG000|Overall Study|Withdrawal by Subject|51|||
162810349|NCT03035201|588016180|FG001|Overall Study|Withdrawal by Subject|49|||
162810350|NCT03035201|588016181|FG002|Overall Study|Withdrawal by Subject|37|||
162810351|NCT03035201|588016182|FG003|Overall Study|Withdrawal by Subject|46|||
162810352|NCT03035201|588016179|FG000|Overall Study|Lost to Follow-up|67|||
162810353|NCT03035201|588016180|FG001|Overall Study|Lost to Follow-up|51|||
162810354|NCT03035201|588016181|FG002|Overall Study|Lost to Follow-up|64|||
162810355|NCT03035201|588016182|FG003|Overall Study|Lost to Follow-up|69|||
162810356|NCT03727438|588016189|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
162810357|NCT03727438|588016190|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
162810358|NCT03727438|588016189|FG000|Intervention Period|Excluded (health)|1|||
162810359|NCT03727438|588016190|FG001|Intervention Period|Excluded (health)|0|||
162810360|NCT03727438|588016189|FG000|Intervention Period|Withdrawal by Subject|3|||
162810361|NCT03727438|588016190|FG001|Intervention Period|Withdrawal by Subject|1|||
162810362|NCT03727438|588016189|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
162810363|NCT03727438|588016190|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
162810364|NCT03727438|588016189|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
162810365|NCT03727438|588016190|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
162810366|NCT03727438|588016189|FG000|8 Week Assessment|Withdrawal by Subject|6|||
162810367|NCT03727438|588016190|FG001|8 Week Assessment|Withdrawal by Subject|1|||
162810368|NCT03727438|588016189|FG000|6 mo Assessment|did not complete assessment|10|||
162810369|NCT03727438|588016190|FG001|6 mo Assessment|did not complete assessment|11|||
162810370|NCT06729606|588016191|FG000|Overall Study|Adverse Event|0|||
162810371|NCT06729606|588016192|FG001|Overall Study|Adverse Event|2|||
162810372|NCT06729606|588016191|FG000|Overall Study|Death|1|||
162810373|NCT06729606|588016192|FG001|Overall Study|Death|0|||
162810374|NCT06729606|588016191|FG000|Overall Study|Physician Decision|0|||
162810375|NCT06729606|588016192|FG001|Overall Study|Physician Decision|1|||
162810376|NCT06729606|588016191|FG000|Overall Study|Withdrawal by Subject|2|||
162810377|NCT06729606|588016192|FG001|Overall Study|Withdrawal by Subject|4|||
162810378|NCT03440320|588018194|FG000|Overall Study|Withdrawal by Subject|0|||
162810379|NCT03440320|588018195|FG001|Overall Study|Withdrawal by Subject|1|||
162810380|NCT00001962|588018196|FG000|Overall Study|Lack of Efficacy|18|||
162810381|NCT00001962|588018196|FG000|Overall Study|Lack of Accrual|6|||
162810382|NCT00001962|588018196|FG000|Overall Study|Death|1|||
162810383|NCT00001962|588018196|FG000|Overall Study|Lost to Follow-up|2|||
162810384|NCT00001962|588018196|FG000|Overall Study|Adverse Event|1|||
162810385|NCT00604279|588018202|FG000|Overall Study|Lack of Efficacy|22|||
162810386|NCT00604279|588018203|FG001|Overall Study|Lack of Efficacy|9|||
162810387|NCT00604279|588018202|FG000|Overall Study|Lost to Follow-up|9|||
162810388|NCT00604279|588018203|FG001|Overall Study|Lost to Follow-up|14|||
162810389|NCT00604279|588018202|FG000|Overall Study|Pregnancy|2|||
162810390|NCT00604279|588018203|FG001|Overall Study|Pregnancy|0|||
162810391|NCT00604279|588018202|FG000|Overall Study|Protocol Violation|3|||
162810392|NCT00604279|588018203|FG001|Overall Study|Protocol Violation|1|||
162810393|NCT00604279|588018202|FG000|Overall Study|Withdrawal by Subject|16|||
162810394|NCT00604279|588018203|FG001|Overall Study|Withdrawal by Subject|5|||
162810395|NCT00604279|588018202|FG000|Overall Study|Adverse Event|4|||
162810396|NCT00604279|588018203|FG001|Overall Study|Adverse Event|5|||
162810397|NCT00604279|588018202|FG000|Overall Study|Other|8|||
162810398|NCT00604279|588018203|FG001|Overall Study|Other|4|||
162810399|NCT03938545|588018204|FG000|Overall Study|Lost to Follow-up|0|||
162810400|NCT03938545|588018205|FG001|Overall Study|Lost to Follow-up|0|||
162810401|NCT03938545|588018206|FG002|Overall Study|Lost to Follow-up|0|||
162810402|NCT03938545|588018207|FG003|Overall Study|Lost to Follow-up|1|||
162810403|NCT03938545|588018204|FG000|Overall Study|Non-compliance with study drug|0|||
162810404|NCT03938545|588018205|FG001|Overall Study|Non-compliance with study drug|0|||
162810405|NCT03938545|588018206|FG002|Overall Study|Non-compliance with study drug|1|||
162810406|NCT03938545|588018207|FG003|Overall Study|Non-compliance with study drug|0|||
162810407|NCT03938545|588018204|FG000|Overall Study|Pregnancy|1|||
162810408|NCT03938545|588018205|FG001|Overall Study|Pregnancy|0|||
162810409|NCT03938545|588018206|FG002|Overall Study|Pregnancy|0|||
162810410|NCT03938545|588018207|FG003|Overall Study|Pregnancy|0|||
162810411|NCT03938545|588018204|FG000|Overall Study|Study terminated by sponsor|6|||
162810412|NCT03938545|588018205|FG001|Overall Study|Study terminated by sponsor|4|||
162810413|NCT03938545|588018206|FG002|Overall Study|Study terminated by sponsor|2|||
162810414|NCT03938545|588018207|FG003|Overall Study|Study terminated by sponsor|4|||
162810415|NCT03938545|588018204|FG000|Overall Study|Withdrawal by Subject|0|||
162810416|NCT03938545|588018205|FG001|Overall Study|Withdrawal by Subject|1|||
162810417|NCT03938545|588018206|FG002|Overall Study|Withdrawal by Subject|0|||
162810418|NCT03938545|588018207|FG003|Overall Study|Withdrawal by Subject|0|||
162810419|NCT03938545|588018204|FG000|Overall Study|Adverse Event|1|||
162810420|NCT03938545|588018205|FG001|Overall Study|Adverse Event|0|||
162810421|NCT03938545|588018206|FG002|Overall Study|Adverse Event|0|||
162810422|NCT03938545|588018207|FG003|Overall Study|Adverse Event|0|||
162810423|NCT00355056|588018208|FG000|Randomization Period|Early Termination|4|||
162810424|NCT00355056|588018209|FG001|Randomization Period|Early Termination|6|||
162810425|NCT01060540|588018210|FG000|Overall Study|Withdrawal by Subject|10|||
162810426|NCT01060540|588018211|FG001|Overall Study|Withdrawal by Subject|20|||
162810427|NCT01060540|588018210|FG000|Overall Study|Lost to Follow-up|52|||
162810428|NCT01060540|588018211|FG001|Overall Study|Lost to Follow-up|43|||
162810429|NCT01060540|588018210|FG000|Overall Study|Death|2|||
162810430|NCT01060540|588018211|FG001|Overall Study|Death|1|||
162810431|NCT01060540|588018210|FG000|Overall Study|Physician Decision|0|||
162810432|NCT01060540|588018211|FG001|Overall Study|Physician Decision|1|||
162810433|NCT00816400|588018215|FG000|Overall Study|Death|2|||
162810434|NCT00816400|588018216|FG001|Overall Study|Death|3|||
162810435|NCT00816400|588018217|FG002|Overall Study|Death|3|||
162810436|NCT00816400|588018218|FG003|Overall Study|Death|3|||
162810437|NCT00816400|588018219|FG004|Overall Study|Death|2|||
162810438|NCT00816400|588018220|FG005|Overall Study|Death|3|||
162810439|NCT00816400|588018221|FG006|Overall Study|Death|2|||
162810440|NCT00816400|588018222|FG007|Overall Study|Death|5|||
162810441|NCT00816400|588018223|FG008|Overall Study|Death|6|||
162810442|NCT00816400|588018215|FG000|Overall Study|In hospice care at the end of the study|0|||
162810443|NCT00816400|588018216|FG001|Overall Study|In hospice care at the end of the study|0|||
162810444|NCT00816400|588018217|FG002|Overall Study|In hospice care at the end of the study|2|||
162810445|NCT00816400|588018218|FG003|Overall Study|In hospice care at the end of the study|0|||
162810446|NCT00816400|588018219|FG004|Overall Study|In hospice care at the end of the study|0|||
162810447|NCT00816400|588018220|FG005|Overall Study|In hospice care at the end of the study|0|||
162810448|NCT00816400|588018221|FG006|Overall Study|In hospice care at the end of the study|0|||
162810449|NCT00816400|588018222|FG007|Overall Study|In hospice care at the end of the study|0|||
162810450|NCT00816400|588018223|FG008|Overall Study|In hospice care at the end of the study|0|||
162810451|NCT00596427|588018224|FG000|Overall Study|Withdrawal by Subject|2|||
162810452|NCT00596427|588018225|FG001|Overall Study|Withdrawal by Subject|2|||
162810453|NCT00596427|588018224|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
162810454|NCT00596427|588018225|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
162810455|NCT00596427|588018224|FG000|Overall Study|Protocol Violation|1|||
162810456|NCT00596427|588018225|FG001|Overall Study|Protocol Violation|0|||
162810457|NCT02401867|588018226|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
162810458|NCT02401867|588018226|FG000|Analysis|Cervical assay could not be conducted|9|||
162810459|NCT01650246|588018227|FG000|Overall Study|Adverse Event|23|||
162810460|NCT01650246|588018227|FG000|Overall Study|Protocol Violation|5|||
162810461|NCT01650246|588018227|FG000|Overall Study|Sponsor terminated study|53|||
162810462|NCT01650246|588018227|FG000|Overall Study|Lost to Follow-up|5|||
162810463|NCT01650246|588018227|FG000|Overall Study|Withdrawal by Subject|26|||
162810464|NCT01650246|588018227|FG000|Overall Study|Death|1|||
162810465|NCT01650246|588018227|FG000|Overall Study|Lack of Efficacy|30|||
162810466|NCT03435497|588018229|FG000|Overall Study|Lost to Follow-up|1|||
162810467|NCT03435497|588018230|FG001|Overall Study|Lost to Follow-up|0|||
162810468|NCT03435497|588018229|FG000|Overall Study|Death|1|||
162810739|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
162810740|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
162810741|NCT00600886|588018324|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
162810742|NCT00600886|588018325|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
162810743|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
162810744|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
162810745|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
162810746|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
162810747|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
162810748|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
162810749|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
162810750|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
162810751|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
162810752|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
162810753|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
162810754|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
162810755|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Death|1|||
162810756|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Death|1|||
162810757|NCT00600886|588018324|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
162810758|NCT00600886|588018325|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
162810759|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
162810760|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
162810761|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
162810762|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
162810763|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
162810764|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
162810765|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
162810766|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
162810767|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
162810768|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
162810769|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
162810770|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
162810771|NCT00600886|588018324|FG000|Extension - After Crossover (CAS)|Death|1|||
162810772|NCT00600886|588018325|FG001|Extension - After Crossover (CAS)|Death|0|||
162810773|NCT03075410|588018326|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
162810774|NCT03075410|588018327|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810775|NCT03075410|588018328|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
162810776|NCT03075410|588018329|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810777|NCT03075410|588018330|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810778|NCT03075410|588018331|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810779|NCT03075410|588018332|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810780|NCT03075410|588018333|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810781|NCT03075410|588018334|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
162810782|NCT03075410|588018326|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
162810783|NCT03075410|588018327|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810784|NCT03075410|588018328|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810785|NCT03075410|588018329|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810786|NCT03075410|588018330|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810787|NCT03075410|588018331|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810788|NCT03075410|588018332|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810789|NCT03075410|588018333|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810790|NCT03075410|588018334|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162810791|NCT02427464|588018347|FG000|Overall Study|Adverse Event|6|||
162810792|NCT02427464|588018348|FG001|Overall Study|Adverse Event|1|||
162810793|NCT02427464|588018347|FG000|Overall Study|Lost to Follow-up|16|||
162810794|NCT02427464|588018348|FG001|Overall Study|Lost to Follow-up|5|||
162810795|NCT02427464|588018347|FG000|Overall Study|Physician Decision|2|||
162810796|NCT02427464|588018348|FG001|Overall Study|Physician Decision|0|||
162810797|NCT02427464|588018347|FG000|Overall Study|Withdrawal by Subject|10|||
162810798|NCT02427464|588018348|FG001|Overall Study|Withdrawal by Subject|8|||
162810799|NCT02427464|588018347|FG000|Overall Study|Noncompliance|16|||
162810800|NCT02427464|588018348|FG001|Overall Study|Noncompliance|10|||
162810801|NCT04443153|588018352|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
162810802|NCT04443153|588018353|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
162810803|NCT04443153|588018352|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
162810804|NCT04443153|588018353|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
162810805|NCT04443153|588018352|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
162810806|NCT04443153|588018353|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
162810807|NCT04443153|588018352|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
162810808|NCT04443153|588018353|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
162810809|NCT02572843|588018354|FG000|Accrual|Brain metastasis retrospectively detected|1|||
162810810|NCT02572843|588018354|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
162810811|NCT02572843|588018354|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
162810812|NCT02572843|588018354|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
162810813|NCT02572843|588018354|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
162810814|NCT02572843|588018354|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
162810815|NCT02572843|588018354|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
162810816|NCT02572843|588018354|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
162810817|NCT02572843|588018354|FG000|Surgery|lost to follow up|7|||
162810818|NCT02572843|588018354|FG000|Surgery|Death|1|||
162810819|NCT03756129|588018355|FG000|Overall Study|Adverse Event|1|||
162810820|NCT03756129|588018356|FG001|Overall Study|Adverse Event|1|||
162810821|NCT03756129|588018357|FG002|Overall Study|Adverse Event|0|||
162810822|NCT03756129|588018358|FG003|Overall Study|Adverse Event|2|||
162810823|NCT03756129|588018359|FG004|Overall Study|Adverse Event|0|||
162810824|NCT03756129|588018360|FG005|Overall Study|Adverse Event|0|||
162810825|NCT03756129|588018355|FG000|Overall Study|Withdrawal by Subject|2|||
162810826|NCT03756129|588018356|FG001|Overall Study|Withdrawal by Subject|1|||
162810827|NCT03756129|588018357|FG002|Overall Study|Withdrawal by Subject|3|||
162810828|NCT03756129|588018358|FG003|Overall Study|Withdrawal by Subject|1|||
162810829|NCT03756129|588018359|FG004|Overall Study|Withdrawal by Subject|1|||
162810830|NCT03756129|588018360|FG005|Overall Study|Withdrawal by Subject|3|||
162810831|NCT03756129|588018355|FG000|Overall Study|Lost to Follow-up|0|||
162810832|NCT03756129|588018356|FG001|Overall Study|Lost to Follow-up|0|||
162810833|NCT03756129|588018357|FG002|Overall Study|Lost to Follow-up|0|||
162810834|NCT03756129|588018358|FG003|Overall Study|Lost to Follow-up|0|||
162810835|NCT03756129|588018359|FG004|Overall Study|Lost to Follow-up|0|||
162810836|NCT03756129|588018360|FG005|Overall Study|Lost to Follow-up|1|||
162810837|NCT03756129|588018355|FG000|Overall Study|Physician Decision|0|||
162810838|NCT03756129|588018356|FG001|Overall Study|Physician Decision|0|||
162810839|NCT03756129|588018357|FG002|Overall Study|Physician Decision|0|||
162810840|NCT03756129|588018358|FG003|Overall Study|Physician Decision|0|||
162810841|NCT03756129|588018359|FG004|Overall Study|Physician Decision|0|||
162810842|NCT03756129|588018360|FG005|Overall Study|Physician Decision|1|||
162810843|NCT03432260|588018361|FG000|Overall Study|Lost to Follow-up|1|||
162810844|NCT03432260|588018362|FG001|Overall Study|Lost to Follow-up|1|||
162810845|NCT03432260|588018363|FG002|Overall Study|Lost to Follow-up|0|||
162810846|NCT03432260|588018364|FG003|Overall Study|Lost to Follow-up|0|||
162810847|NCT03432260|588018365|FG004|Overall Study|Lost to Follow-up|1|||
162810848|NCT02186847|588018367|FG000|Overall Study|Protocol Violation|3|||
162810849|NCT02186847|588018368|FG001|Overall Study|Protocol Violation|0|||
162810850|NCT05328167|588018369|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
162810851|NCT05328167|588018369|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
162810852|NCT00345293|588018370|FG000|Overall Study|Unable to access line for sample|1|||
162810853|NCT00345293|588018371|FG001|Overall Study|Unable to access line for sample|0|||
162810854|NCT00345293|588018370|FG000|Overall Study|Withdrawal by Subject|1|||
162810855|NCT00345293|588018371|FG001|Overall Study|Withdrawal by Subject|0|||
162810856|NCT03170349|588018372|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
162810857|NCT03170349|588018372|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
162810858|NCT03170349|588018372|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
162810859|NCT03170349|588018372|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
162810860|NCT03170349|588018372|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
162810861|NCT03170349|588018372|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
162810862|NCT03170349|588018372|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
162810863|NCT03170349|588018372|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
162810864|NCT03170349|588018372|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
162810865|NCT03170349|588018372|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
162810866|NCT03170349|588018372|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
162810867|NCT03170349|588018372|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
162810868|NCT03170349|588018372|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
162810869|NCT03170349|588018372|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
162810870|NCT03170349|588018372|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
162810871|NCT03170349|588018372|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
